data_3ezb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 3ezb _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.722 0 CA-C-O 121.191 0.519 . . . . 3.19 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 94.9 mt -109.41 124.72 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.914 -0.773 . . . . 1.71 108.914 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.6 m -130.07 130.31 44.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.978 -0.749 . . . . 1.66 108.978 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.704 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -115.49 -166.93 15.05 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 108.754 -1.738 . . . . 1.05 108.754 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.4 ' O ' ' O ' ' A' ' 6' ' ' LEU . 72.5 mt -91.06 -10.48 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.033 -1.275 . . . . 1.59 110.562 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 5' ' ' ILE . 57.5 tp 53.3 98.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.684 -1.26 . . . . 1.47 109.8 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.97 -38.7 44.57 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.848 -0.797 . . . . 1.39 108.848 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 m -141.27 140.2 20.43 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.498 -0.751 . . . . 2.09 109.595 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -80.48 140.33 13.38 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.529 2.153 . . . . 0.91 112.821 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 165.99 -163.68 36.94 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.05 -1.62 . . . . 0.92 109.05 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 11' ' ' ILE . 85.2 mt -148.64 149.63 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.208 -1.172 . . . . 1.35 108.156 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.38 155.58 33.88 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.572 -1.33 . . . . 1.14 110.721 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -137.89 129.68 28.43 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.072 -1.084 . . . . 0.7 108.072 178.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.43 -178.13 46.35 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 118.699 -1.715 . . . . 0.58 110.905 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -80.07 156.51 27.05 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.811 -0.817 . . . . 2.63 109.519 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.11 129.75 51.81 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.449 -0.782 . . . . 1.27 110.934 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.3 tp -100.09 135.83 40.93 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.307 -1.368 . . . . 1.41 107.307 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.2 tp -117.77 127.45 53.92 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.262 -0.899 . . . . 1.49 109.951 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.4 mt -88.28 101.22 13.64 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 120.115 -0.634 . . . . 1.52 109.352 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.31 137.58 32.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 3.17 108.701 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -130.48 133.33 46.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.217 -0.927 . . . . 3.0 108.998 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -81.42 149.84 28.63 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.105 -0.997 . . . . 2.77 108.94 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -66.75 146.84 54.02 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.0 -1.062 . . . . 2.94 108.893 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.8 mt -94.45 130.91 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.283 -0.886 . . . . 1.46 108.633 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.3 t -101.61 129.66 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.271 -0.893 . . . . 1.7 110.752 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -108.34 132.1 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.585 -0.894 . . . . 1.54 108.585 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -87.36 120.59 28.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.79 -1.194 . . . . 1.81 109.495 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -88.71 0.1 56.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.388 -0.82 . . . . 3.23 108.879 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -68.83 146.49 52.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 3.29 109.252 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -89.22 150.07 22.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 2.8 109.335 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.5 pt -93.92 166.18 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.321 -0.862 . . . . 1.43 109.793 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.5 p -97.59 171.12 8.56 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.224 -1.028 . . . . 1.54 108.224 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.69 -49.39 77.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.948 -1.095 . . . . 1.6 108.94 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -53.89 -29.94 43.84 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.81 -1.181 . . . . 2.56 109.516 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -82.84 -10.0 59.05 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.395 -0.816 . . . . 2.36 110.413 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.57 -53.84 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.831 -1.168 . . . . 1.43 108.691 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.21 -40.07 88.83 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.481 -0.762 . . . . 1.77 109.677 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.23 -41.96 93.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -0.901 . . . . 3.32 110.891 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -65.76 -39.98 91.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 1.51 110.419 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.0 -46.17 94.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.701 -1.249 . . . . 1.41 108.491 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -59.98 -40.63 89.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.01 -1.056 . . . . 1.81 109.192 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -60.07 -43.03 95.73 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.901 -1.125 . . . . 3.26 108.438 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -66.39 -42.97 87.09 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.842 -0.799 . . . . 0.81 108.842 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.91 -50.63 73.01 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.282 -1.007 . . . . 1.59 108.282 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.8 t -63.86 -42.76 97.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.371 -0.932 . . . . 1.38 108.872 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.33 -42.51 98.85 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.575 -1.81 . . . . 0.87 108.575 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.419 HH11 ' HG2' ' A' ' 47' ' ' ARG . 21.4 ttt-85 -64.95 -35.12 80.16 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.184 -1.043 . . . . 3.62 108.184 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.76 -39.94 65.77 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.773 -0.825 . . . . 1.43 108.773 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 50' ' ' ALA . 7.0 ttpm? -72.46 -73.7 0.19 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.89 -1.152 . . . . 3.08 107.89 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.02 -41.11 0.33 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.334 -0.854 . . . . 1.33 112.084 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.2 p -57.93 -55.07 39.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.591 -1.318 . . . . 1.85 108.816 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.06 95.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.446 -0.784 . . . . 1.35 110.85 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -62.16 -46.05 90.71 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.997 -1.064 . . . . 2.34 110.685 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.74 -40.21 94.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.13 -0.981 . . . . 2.2 109.418 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -62.84 -40.02 96.15 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.306 -0.871 . . . . 1.35 109.603 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.9 m -65.87 -41.5 91.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.021 -1.05 . . . . 1.34 109.983 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 57' ' ' ILE . 88.1 mt -61.64 -40.0 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.112 -0.992 . . . . 1.26 108.793 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -55.44 -50.87 68.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.471 -0.768 . . . . 1.7 109.771 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -58.82 -37.51 76.56 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.329 -0.857 . . . . 1.35 110.254 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -61.7 -38.74 88.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.073 -1.017 . . . . 2.08 109.39 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.98 -46.9 73.19 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.745 -0.597 . . . . 1.21 110.162 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.84 -53.27 37.41 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.829 -1.308 . . . . 0.75 109.829 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.54 -44.82 66.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.05 -1.265 . . . . 1.59 110.462 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.5 m -66.53 -64.04 0.94 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.124 -0.985 . . . . 1.41 112.74 -177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -95.8 -45.25 7.06 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.747 -1.221 . . . . 0.79 111.002 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.4 -167.47 25.5 Favored Glycine 0 N--CA 1.498 2.786 0 C-N-CA 119.771 -1.204 . . . . 1.22 110.792 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.21 -24.18 63.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 122.032 -0.687 . . . . 5.81 109.819 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.516 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.4 tp10 -60.96 -35.83 77.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.407 -0.808 . . . . 3.37 110.786 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -97.62 -19.46 18.29 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.133 -0.979 . . . . 2.37 109.764 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -68.89 -40.22 79.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.248 -0.908 . . . . 1.65 110.402 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.48 -32.65 74.14 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.393 -0.817 . . . . 1.42 110.144 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.06 -40.41 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 118.836 -1.145 . . . . 1.43 108.672 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -64.43 -40.14 95.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.104 -0.998 . . . . 1.08 109.15 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -60.08 -41.93 93.5 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.299 -0.876 . . . . 1.37 109.438 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.05 -43.73 97.95 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.173 -1.571 . . . . 0.67 109.173 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.4 m170 -70.0 -40.02 75.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -1.117 . . . . 1.99 109.167 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.0 -47.22 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.101 -0.999 . . . . 1.22 109.019 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.1 ttp -60.08 -40.49 89.75 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.992 -1.068 . . . . 2.11 109.836 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.414 ' CD1' ' CE2' ' B' ' 348' ' ' PHE . 32.2 tp -68.53 -39.93 80.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.444 -0.785 . . . . 1.33 109.289 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.34 -39.97 94.83 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.424 -0.798 . . . . 1.29 109.481 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -79.42 1.72 24.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.319 -0.863 . . . . 1.47 110.171 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -49.42 128.19 16.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.831 -1.168 . . . . 1.47 109.953 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -62.41 -16.82 57.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.55 -0.719 . . . . 1.78 110.566 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.67 -32.71 66.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.788 -1.195 . . . . 2.53 108.813 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.8 mt -70.74 -43.58 68.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.69 -0.631 . . . . 1.36 110.442 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -60.03 -43.31 95.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.046 -1.034 . . . . 1.42 110.47 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.96 -42.87 72.6 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.05 -1.031 . . . . 2.27 110.812 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.14 -39.97 75.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.959 -1.088 . . . . 1.57 111.333 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.6 mt -64.05 -50.03 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 1.19 109.985 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.5 mt -69.34 -35.36 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.448 -0.783 . . . . 1.39 110.173 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.63 -45.85 92.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 1.39 110.847 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.56 -47.53 85.77 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.911 -1.118 . . . . 1.5 109.982 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.9 mt -60.24 -49.67 83.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 122.093 0.949 . . . . 1.29 108.932 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -69.8 -39.94 76.28 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.15 -0.62 . . . . 2.64 111.175 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -84.83 -57.99 2.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.769 -1.207 . . . . 1.65 112.345 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -83.61 -0.94 52.69 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.964 -1.085 . . . . 2.5 111.419 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 57.34 36.63 27.44 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.117 -0.99 . . . . 1.88 109.854 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.5 mtt -90.27 167.96 12.28 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.568 -0.707 . . . . 1.71 109.976 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.444 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 73.9 p -80.88 160.58 24.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.473 -0.767 . . . . 1.61 109.339 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.56 -40.86 80.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.102 -0.999 . . . . 1.33 110.069 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.444 ' OD1' ' OG1' ' A' ' 99' ' ' THR . 31.4 p-10 -64.36 -36.78 85.24 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.252 -0.905 . . . . 2.07 109.221 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.431 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.96 -48.61 12.05 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.036 -1.04 . . . . 1.37 109.844 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.65 -48.95 79.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.527 -0.733 . . . . 1.14 110.952 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.09 93.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.032 -1.043 . . . . 1.26 110.296 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.417 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 81.6 t60 -59.08 -38.27 79.06 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.055 -1.028 . . . . 2.02 110.397 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.71 -41.12 97.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.874 -1.141 . . . . 1.33 110.968 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.05 -52.19 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.013 -1.055 . . . . 1.3 110.715 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.0 mm -66.96 -39.96 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.063 -1.023 . . . . 1.32 108.402 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.417 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 89.2 tt0 -66.22 -38.2 87.37 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.737 -0.838 . . . . 2.44 108.737 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.88 -47.36 90.92 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.312 -1.115 . . . . 0.99 110.312 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -68.33 -53.48 23.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.688 -1.478 . . . . 1.97 108.677 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.89 -39.95 59.86 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.096 -1.002 . . . . 1.43 109.106 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 46.2 t -60.06 -42.74 95.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.099 -1.001 . . . . 2.12 108.544 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.89 87.37 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.394 -0.816 . . . . 1.64 109.188 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.6 mt -67.44 -41.6 84.48 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.909 -1.119 . . . . 1.93 108.986 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -53.65 -31.42 47.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.071 -1.018 . . . . 2.2 109.164 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.6 -24.88 65.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.275 -0.89 . . . . 2.12 108.717 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 61.0 mt -62.79 143.55 57.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 2.34 109.272 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -99.33 48.98 0.95 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.325 -0.86 . . . . 3.23 109.257 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 56.9 t0 -134.61 132.89 39.55 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.296 -0.878 . . . . 2.49 109.795 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.441 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 18.4 pt-20 -70.25 -29.01 65.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.568 -0.707 . . . . 3.95 109.898 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.478 ' OH ' ' NH1' ' A' ' 126' ' ' ARG . 3.5 t80 -71.1 -39.92 71.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.38 -0.825 . . . . 2.25 110.383 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 88.9 mt -79.63 -40.05 30.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.99 . . . . 2.27 109.775 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -60.15 -49.91 75.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.982 -1.074 . . . . 3.31 109.706 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.82 -40.17 94.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 2.73 108.862 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.652 ' CG ' HE22 ' B' ' 351' ' ' GLN . 31.6 ttt180 -60.03 -40.07 88.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.857 -1.164 . . . . 3.2 107.857 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.66 -23.51 66.81 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.261 -1.015 . . . . 1.66 108.261 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.46 -40.03 93.05 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.58 -1.267 . . . . 1.67 107.58 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -61.54 -41.44 97.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.515 -0.741 . . . . 1.55 109.082 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 73.1 t -63.65 -40.08 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.273 -1.01 . . . . 1.32 108.273 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -62.7 -33.52 75.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.608 -0.683 . . . . 3.58 109.476 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -59.95 -41.58 92.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 1.46 109.487 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.1 mt -60.09 -45.58 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.163 -0.961 . . . . 1.22 109.863 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.66 -43.31 99.17 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.397 -0.906 . . . . 0.61 111.014 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -59.99 -47.87 84.05 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.011 -1.288 . . . . 3.1 110.901 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.575 HH12 ' CB ' ' A' ' 166' ' ' SER . 99.0 mtt180 -69.32 -29.02 66.77 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.832 -1.167 . . . . 3.71 109.903 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 57.6 tp -59.52 -41.57 90.25 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.555 -0.906 . . . . 1.87 108.555 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.6 mt -61.89 -40.12 94.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.141 -0.974 . . . . 1.29 109.317 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.87 -39.97 83.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.488 -0.757 . . . . 3.05 108.978 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.516 HD21 ' N ' ' A' ' 140' ' ' ASN . 1.9 m120 -60.09 -39.11 84.98 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.583 -0.698 . . . . 1.26 111.279 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.1 mt -73.46 -41.2 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.764 -1.21 . . . . 1.34 109.675 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.2 mt -70.43 -31.79 69.13 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.55 -0.719 . . . . 1.6 109.434 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.12 37.94 6.98 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.215 -1.554 . . . . 0.96 109.215 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.0 tp -73.63 142.56 46.51 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.263 -1.139 . . . . 1.67 108.644 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -69.16 142.72 54.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.207 -0.933 . . . . 4.96 110.668 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.02 129.99 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-O 122.063 0.935 . . . . 1.68 109.343 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.2 mt -61.48 -43.91 97.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.865 -0.607 . . . . 2.14 110.691 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.411 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 24.6 t0 63.76 103.36 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.38 -0.825 . . . . 1.5 109.094 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.5 mt -70.53 -6.04 33.39 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.522 -0.736 . . . . 1.39 110.184 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.411 ' OG ' ' OD1' ' A' ' 148' ' ' ASP . 93.7 p -85.09 -14.0 48.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.128 -0.983 . . . . 1.83 108.681 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.87 14.65 2.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.687 -0.633 . . . . 1.46 111.176 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.5 mp -89.4 134.34 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.603 -1.31 . . . . 1.42 108.188 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -117.53 -9.02 10.9 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.736 -0.602 . . . . 2.94 109.741 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -119.03 149.98 40.75 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.21 -0.932 . . . . 1.52 110.473 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -63.65 130.97 46.48 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.689 -0.856 . . . . 1.58 108.689 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.4 m -152.07 163.59 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.883 . . . . 1.32 109.518 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.0 mt -94.42 147.85 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 106.036 -1.839 . . . . 1.27 106.036 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.2 tp -97.31 117.4 31.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.086 -1.009 . . . . 1.41 110.905 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.91 126.42 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.215 -1.031 . . . . 1.23 108.215 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.88 161.26 40.61 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.094 -1.004 . . . . 1.32 109.201 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.42 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.35 -31.45 69.89 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.133 -1.604 . . . . 1.49 107.847 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -167.59 173.92 8.2 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.559 -0.904 . . . . 2.25 108.559 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 89.9 mt -141.22 130.04 22.99 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.076 -1.015 . . . . 1.35 108.823 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.8 p -87.89 147.91 42.17 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.03 -1.044 . . . . 1.56 109.23 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -43.38 -36.43 6.55 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.817 1.678 . . . . 0.87 112.125 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.575 ' CB ' HH12 ' A' ' 136' ' ' ARG . 50.3 m -60.04 -39.94 87.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.371 -0.831 . . . . 1.36 109.875 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.1 -40.87 78.12 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.155 -0.966 . . . . 1.61 109.751 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.8 p -55.64 -29.75 59.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.96 -1.087 . . . . 1.21 110.605 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.79 -51.21 23.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.879 -1.138 . . . . 1.21 109.573 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -85.02 38.52 0.72 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.417 -0.957 . . . . 2.11 108.417 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.8 tp -102.92 130.6 50.02 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.693 -0.63 . . . . 1.29 109.303 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -83.75 103.65 13.22 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.868 -0.789 . . . . 2.81 108.868 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 77.6 mt -64.86 -43.65 92.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.416 -0.803 . . . . 2.09 111.344 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -69.83 -25.24 63.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.893 -1.13 . . . . 2.86 112.417 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -93.18 -10.12 36.89 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.615 -1.303 . . . . 2.39 110.517 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 62.3 t -109.18 119.94 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.137 -1.06 . . . . 1.27 108.137 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.1 mt -90.94 8.09 36.9 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.184 -0.947 . . . . 2.17 111.09 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.96 172.64 37.4 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.153 -1.499 . . . . 0.52 109.87 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -133.7 128.51 35.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.656 -0.908 . . . . 0.55 108.594 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 97.3 mt -132.67 127.2 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.778 . . . . 1.27 109.204 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 50.4 p -150.02 162.0 41.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.904 -1.123 . . . . 1.39 110.516 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 38.1 p-10 -104.0 23.27 13.19 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.186 -0.672 . . . . 2.46 109.186 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.44 -159.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.057 -1.027 . . . . 1.51 111.644 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.66 -54.22 6.09 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.906 -0.877 . . . . 2.23 110.906 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 160.7 -131.46 2.63 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.147 -1.501 . . . . 2.23 110.732 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.484 HH11 ' HG2' ' A' ' 186' ' ' ARG . 12.5 mtt-85 -69.91 -20.78 63.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.67 -0.9 . . . . 6.44 111.065 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 25.1 p -73.04 -0.17 13.13 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.938 -1.101 . . . . 4.09 110.322 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.9 m -91.09 132.36 36.09 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.067 -1.021 . . . . 2.2 110.064 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -49.89 -48.19 51.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.334 -0.854 . . . . 1.15 109.526 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -39.83 74.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.33 -0.856 . . . . 2.01 110.085 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 19.7 t -60.09 -43.04 95.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.928 -1.108 . . . . 1.93 109.907 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.33 -41.34 91.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.181 -0.95 . . . . 2.2 109.798 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 86.6 mtp -63.31 -39.98 96.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.168 -0.957 . . . . 1.32 110.175 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.74 -42.89 76.05 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.561 -1.337 . . . . 1.3 108.821 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -59.89 -50.1 75.11 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.455 -0.778 . . . . 3.38 110.041 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.0 m -70.32 -33.95 72.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.093 -1.004 . . . . 1.15 110.711 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 81.8 mt -70.0 -21.36 63.23 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.107 -0.996 . . . . 1.28 109.264 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 60.74 48.89 6.67 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.239 0.542 . . . . 1.5 110.751 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.8 mt -126.42 149.57 67.9 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.218 -1.401 . . . . 1.37 107.218 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.44 137.71 66.59 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.84 1.693 . . . . 0.76 111.593 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.17 151.0 3.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.876 -1.14 . . . . 1.19 111.478 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 202' ' ' ILE . 89.8 mt -126.87 143.62 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.964 -1.124 . . . . 1.31 107.964 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.8 m -128.49 -8.8 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 O-C-N 120.736 -1.227 . . . . 1.38 110.864 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.58 21.53 25.77 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 110.397 -1.081 . . . . 1.03 110.397 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 23.0 p -44.46 -44.17 8.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.114 -1.227 . . . . 1.38 110.048 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 93.94 -51.86 2.25 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 120.328 -0.939 . . . . 1.17 111.03 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.9 p -157.34 35.01 0.28 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.516 -1.579 . . . . 2.07 111.444 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.0 t -73.37 -39.86 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.969 -1.082 . . . . 1.35 108.907 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.504 ' HG1' ' N ' ' A' ' 210' ' ' SER . 3.0 p -56.14 -34.01 65.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.761 . . . . 1.49 110.666 -178.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.504 ' N ' ' HG1' ' A' ' 209' ' ' THR . 23.0 t -71.19 -31.64 67.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.136 -0.977 . . . . 2.16 109.794 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -89.84 -8.22 52.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.838 . . . . 2.89 110.728 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 75.0 t -102.79 131.99 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.011 -1.056 . . . . 1.33 110.528 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -111.33 145.08 39.46 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.066 -1.457 . . . . 2.73 107.066 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.477 ' O ' ' OD1' ' A' ' 215' ' ' ASP . 44.4 p-10 -54.25 137.8 40.29 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.201 -0.937 . . . . 2.7 111.051 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER 89.3 -2.53 0.38 Allowed 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.321 0.581 . . . . 2.38 110.768 178.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -71.36 150.51 45.0 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.336 -0.853 . . . . 2.09 109.497 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -99.09 120.0 38.76 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.234 -1.024 . . . . 1.45 108.234 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 73.8 mt -126.64 149.78 49.31 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.565 -0.709 . . . . 1.31 109.861 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.9 mt -119.26 129.95 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.301 -1.37 . . . . 1.29 107.301 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 23.9 tp -102.25 119.95 39.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.23 -0.919 . . . . 1.31 109.437 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 223' ' ' VAL . 29.0 t70 -80.1 -41.86 24.71 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.303 -0.873 . . . . 2.31 108.769 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 46.76 11.67 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.691 -0.63 . . . . 1.19 109.96 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 221' ' ' ASP . 46.7 t -118.84 -35.22 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 106.693 -1.595 . . . . 1.45 106.693 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.452 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 19.9 m120 -112.85 4.6 17.01 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.375 -1.343 . . . . 3.13 107.375 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.704 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.9 OUTLIER 57.58 50.61 10.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.855 -0.528 . . . . 2.2 110.235 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -136.95 147.5 46.38 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.216 -0.927 . . . . 2.32 109.548 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 76.0 t -115.02 129.3 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.545 -0.909 . . . . 1.4 108.545 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -104.48 121.06 42.67 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.768 -0.827 . . . . 1.29 108.768 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 43.1 t -100.08 110.95 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.593 -0.692 . . . . 1.38 109.805 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.47 HD21 ' C ' ' A' ' 230' ' ' ASN . 0.4 OUTLIER 51.69 69.94 2.22 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.41 -0.806 . . . . 2.33 110.911 179.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -90.67 147.64 4.06 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.33 2.687 . . . . 0.95 112.245 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 11.0 m -71.02 165.38 23.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.057 -1.027 . . . . 2.31 109.932 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -59.98 -39.92 87.33 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.318 -0.864 . . . . 3.45 109.88 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -60.02 -39.86 87.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.984 . . . . 2.89 109.64 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.32 -44.21 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.155 -0.965 . . . . 1.73 109.049 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.43 HD11 HG22 ' A' ' 236' ' ' ILE . 96.9 mt . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 1.57 109.655 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 21.8 ttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -153.95 150.84 28.73 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.36 -0.838 . . . . 0.0 108.965 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -148.66 160.05 43.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.98 -1.075 . . . . 0.0 110.171 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -152.12 149.24 28.58 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -109.82 130.24 55.54 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.39 -0.818 . . . . 0.0 109.673 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 1.5 p -131.95 121.51 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 122.167 0.984 . . . . 0.0 112.021 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 50.6 m -75.74 106.1 7.13 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.828 0.823 . . . . 0.0 110.524 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 77.9 mt -52.16 123.17 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 122.476 1.131 . . . . 0.0 110.296 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 77.7 p -104.0 23.2 13.3 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.776 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -82.66 119.47 74.63 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.142 -0.974 . . . . 0.0 109.262 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -66.3 -7.91 18.92 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 120.362 1.165 . . . . 0.0 111.884 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -117.39 6.44 12.64 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.69 176.93 34.25 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.229 -1.949 . . . . 0.0 108.229 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.465 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.3 tp -86.74 96.18 10.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.946 -1.326 . . . . 0.0 108.723 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -97.69 -159.97 0.77 Allowed 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.29 -0.881 . . . . 0.0 110.71 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 24.5 m -59.82 -43.03 94.73 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.033 -1.042 . . . . 0.0 112.303 -175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.516 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 1.5 tpt180 -59.74 -64.33 3.14 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 120.356 -1.465 . . . . 0.0 111.428 -178.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -55.37 -33.78 86.66 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 CA-C-N 120.281 1.136 . . . . 0.0 111.782 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.95 71.72 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.46 -40.88 62.8 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.247 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -70.43 -40.06 74.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.031 -1.043 . . . . 0.0 108.674 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -61.44 -53.04 61.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.437 -0.789 . . . . 0.0 110.432 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 77.7 t -68.93 -35.12 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.766 -1.208 . . . . 0.0 109.756 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -59.97 -47.06 87.38 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.869 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -66.34 -40.05 89.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.096 -1.002 . . . . 0.0 109.999 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' B' ' 328' ' ' GLY . . . -64.65 -52.33 57.91 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.019 -1.051 . . . . 0.0 110.789 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -54.49 -10.21 0.39 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.021 -1.049 . . . . 0.0 109.555 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' B' ' 326' ' ' ALA . . . -71.94 -26.19 73.12 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -101.99 144.99 29.91 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.39 -1.065 . . . . 0.0 109.272 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 8.8 m -90.87 -13.73 33.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.907 -1.121 . . . . 0.0 108.996 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.0 t -62.61 149.88 42.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 109.04 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -67.61 134.62 51.51 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.256 -0.903 . . . . 0.0 109.171 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . 0.429 HG22 HD11 ' B' ' 333' ' ' ILE . 90.3 mt -131.12 130.45 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.711 -0.618 . . . . 0.0 109.654 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 98.3 m -129.62 152.36 49.22 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.594 -0.691 . . . . 0.0 109.187 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 61.6 t -116.94 140.47 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 70.4 m -130.36 126.12 36.31 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.211 -0.931 . . . . 0.0 109.497 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 10.8 t -138.65 111.75 7.93 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.232 -0.917 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 46.39 56.38 6.42 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 84.56 -16.2 36.87 Favored Glycine 0 N--CA 1.499 2.873 0 O-C-N 120.223 -1.548 . . . . 0.0 112.299 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -110.65 121.61 45.74 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.922 -1.34 . . . . 0.0 109.482 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 88.4 p -128.25 148.19 50.63 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.811 0.815 . . . . 0.0 109.855 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.84 170.38 16.23 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.662 0.744 . . . . 0.0 110.11 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 70.4 m -88.53 140.47 29.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.605 -0.684 . . . . 0.0 109.582 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.429 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -83.13 -12.45 57.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.024 -1.048 . . . . 0.0 110.248 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -88.93 20.56 3.51 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.429 ' H ' ' C ' ' B' ' 344' ' ' ALA . 56.1 m -147.81 98.06 2.9 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.734 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 29.1 tp -60.0 -34.68 73.66 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . 0.414 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 55.7 m-85 -57.65 -53.53 57.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.709 -1.244 . . . . 0.0 109.942 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -70.05 -21.4 63.18 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.09 -1.006 . . . . 0.0 111.17 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' B' ' 352' ' ' THR . 21.4 mt -69.42 -52.68 24.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.771 -1.206 . . . . 0.0 108.165 178.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.652 HE22 ' CG ' ' A' ' 126' ' ' ARG . 10.3 mm100 -38.33 -22.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.293 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.533 ' N ' ' O ' ' B' ' 350' ' ' LEU . 58.5 p -82.08 -10.2 59.29 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.962 -1.086 . . . . 0.0 110.215 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 70.6 mt -95.5 116.24 28.55 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.066 -1.021 . . . . 0.0 109.076 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -80.27 94.43 1.49 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 27.8 mt -99.82 92.64 5.4 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.237 -1.155 . . . . 0.0 108.556 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 68.4 p -94.6 179.82 5.13 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.07 -1.019 . . . . 0.0 110.632 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' B' ' 359' ' ' THR . 62.2 tt0 -48.62 157.44 0.37 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.232 1.015 . . . . 0.0 111.236 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.61 23.98 0.02 OUTLIER Glycine 0 N--CA 1.497 2.708 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.499 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 359' ' ' THR . . . . . 0.5 ' N ' ' O ' ' B' ' 357' ' ' GLN . 19.1 m -84.4 111.58 19.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.732 -1.452 . . . . 0.0 109.448 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 23.4 t -76.27 115.68 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 122.318 1.056 . . . . 0.0 109.629 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 19.0 m -112.66 176.6 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 45.9 m -130.74 129.49 42.58 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 84.3 mt -102.96 118.24 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 22.1 m -123.67 134.0 53.81 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.322 -0.861 . . . . 0.0 109.232 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.29 150.55 38.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.179 -0.951 . . . . 0.0 109.74 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -140.09 119.81 13.34 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.541 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.74 -160.93 32.37 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 118.855 -1.641 . . . . 0.0 111.691 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -59.95 -51.65 68.78 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 122.371 -0.487 . . . . 0.0 112.311 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -105.52 9.36 33.49 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.857 -1.152 . . . . 0.0 110.939 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.9 pt-20 -42.7 -34.08 0.84 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.151 -0.968 . . . . 0.0 111.088 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -70.11 -41.31 74.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.963 . . . . 0.0 110.135 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -68.12 -49.89 58.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.2 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.27 -76.03 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.382 -0.824 . . . . 0.0 110.997 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 82.0 t -45.3 -36.49 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.98 -1.075 . . . . 0.0 111.033 -177.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -64.53 -52.57 57.11 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.427 -1.421 . . . . 0.0 110.637 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -76.81 -40.18 48.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.665 -1.272 . . . . 0.0 110.588 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 87.7 mt -59.62 -39.28 83.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.014 . . . . 0.0 109.088 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 50.6 t -60.98 -41.1 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.104 -0.998 . . . . 0.0 109.283 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' B' ' 383' ' ' GLU . 7.7 mtmp? -69.05 -55.2 11.5 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.567 -1.333 . . . . 0.0 108.62 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 63.3 tp -55.97 -35.07 66.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.946 -1.096 . . . . 0.0 109.783 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 6.0 ttm -70.29 -39.99 74.53 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.661 -1.275 . . . . 0.0 107.759 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.27 -7.02 58.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.766 -0.584 . . . . 0.0 110.782 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' B' ' 379' ' ' LYS . 49.3 mt-10 -111.34 1.77 17.26 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.953 -1.092 . . . . 0.0 110.989 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 17.8 mt -87.1 126.62 34.89 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.283 -1.511 . . . . 0.0 109.224 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.302 -179.775 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.028 -0.731 . . . . 3.19 109.028 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 95.2 mt -110.02 128.49 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.542 -0.724 . . . . 1.71 109.306 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.7 m -140.06 150.08 43.92 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.398 -0.813 . . . . 1.66 109.654 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.402 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -136.99 -162.94 9.55 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.297 -1.921 . . . . 1.05 108.297 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' LEU . 93.7 mt -90.4 -17.45 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.745 -1.444 . . . . 1.59 109.875 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.9 tp 51.51 103.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.365 -0.834 . . . . 1.47 109.304 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.7 -29.09 12.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.099 -1.0 . . . . 1.39 109.008 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.1 m -130.84 115.11 16.7 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.636 -0.665 . . . . 2.09 109.276 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -80.15 151.02 20.59 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 121.924 1.749 . . . . 0.91 112.627 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 150.18 169.18 16.01 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.704 -1.759 . . . . 0.92 108.704 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.9 mt -120.04 129.99 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 O-C-N 121.046 -1.267 . . . . 1.35 109.839 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.33 150.38 50.94 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.083 -1.01 . . . . 1.14 110.455 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.5 m-85 -126.87 128.46 46.53 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 107.924 -1.139 . . . . 0.7 107.924 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.56 178.55 48.47 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.583 -1.77 . . . . 0.58 110.977 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -79.98 158.81 26.48 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.892 -0.77 . . . . 2.63 109.244 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.92 129.71 54.7 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.331 -0.855 . . . . 1.27 110.92 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.7 tp -100.34 133.12 45.24 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.11 -1.441 . . . . 1.41 107.11 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.4 tp -114.83 127.32 55.65 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.258 -0.901 . . . . 1.49 109.536 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.4 mt -89.45 102.08 14.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.473 -0.767 . . . . 1.52 110.368 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -103.0 131.82 49.7 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.132 -0.692 . . . . 3.17 109.132 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -130.52 133.82 46.55 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.323 -0.861 . . . . 3.0 109.389 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -73.48 153.49 40.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.063 -1.023 . . . . 2.77 109.521 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -67.63 143.16 56.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 2.94 109.766 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.2 mt -83.13 128.15 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.895 . . . . 1.46 109.342 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.1 t -93.57 131.53 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.234 -0.916 . . . . 1.7 110.652 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.6 mt -107.97 133.57 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.861 -0.792 . . . . 1.54 108.861 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -92.29 119.25 31.69 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.04 -1.038 . . . . 1.81 109.317 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -90.7 -2.51 57.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.299 -0.875 . . . . 3.23 109.506 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -69.17 139.59 54.61 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.16 -0.963 . . . . 3.29 109.218 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -86.05 153.51 22.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.178 -0.951 . . . . 2.8 109.059 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 pt -98.29 166.19 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.223 -0.923 . . . . 1.43 109.711 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 81.3 p -90.08 171.66 9.38 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.299 -0.876 . . . . 1.54 109.041 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.53 -17.06 64.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.056 -1.027 . . . . 1.6 110.611 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -86.5 -26.64 24.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.863 -1.148 . . . . 2.56 108.012 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -82.31 -8.43 59.64 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.769 -0.826 . . . . 2.36 108.769 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 t -58.4 -50.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.351 -0.981 . . . . 1.43 108.351 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.98 -40.01 87.66 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.208 -0.933 . . . . 1.77 108.707 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -61.48 -46.55 89.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.404 -0.81 . . . . 3.32 110.926 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -60.16 -44.07 95.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.727 -1.233 . . . . 1.51 109.961 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.05 -46.15 94.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 120.918 -1.114 . . . . 1.41 108.737 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -60.03 -41.25 91.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 1.81 109.193 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -60.01 -45.99 90.96 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.914 -1.116 . . . . 3.26 108.092 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -60.52 -48.23 82.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.531 -0.731 . . . . 0.81 109.075 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.04 -49.93 75.73 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.873 -0.788 . . . . 1.59 108.873 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.6 t -61.47 -44.58 96.84 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.175 -0.953 . . . . 1.38 108.515 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.52 -42.84 99.85 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.454 -1.859 . . . . 0.87 108.454 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.0 ttt-85 -66.08 -31.08 71.73 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.324 -0.991 . . . . 3.62 108.324 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.59 -40.02 82.01 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.175 -0.676 . . . . 1.43 109.175 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.7 ttmt -72.33 -73.43 0.19 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.979 -1.076 . . . . 3.08 108.178 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.53 -34.7 0.15 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.339 -0.851 . . . . 1.33 110.736 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.0 m -57.14 -61.29 2.56 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.65 -1.281 . . . . 1.85 108.54 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.0 82.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 1.35 111.248 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -66.28 -42.63 88.12 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.77 -1.206 . . . . 2.34 110.374 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.98 -39.99 96.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.837 -1.165 . . . . 2.2 108.899 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.25 -35.18 79.75 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.324 -0.86 . . . . 1.35 108.822 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -63.66 -41.68 98.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 1.34 109.779 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.22 -40.05 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.124 -0.985 . . . . 1.26 108.917 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -54.75 -49.93 69.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.46 -0.775 . . . . 1.7 109.712 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -58.38 -37.33 75.03 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.344 -0.848 . . . . 1.35 109.868 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -68.18 -37.52 81.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.001 -1.062 . . . . 2.08 109.277 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.65 -46.56 75.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.657 -0.652 . . . . 1.21 109.862 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.96 -50.02 72.26 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.57 -1.012 . . . . 0.75 110.57 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -70.0 -40.66 75.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.944 -1.327 . . . . 1.59 110.103 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.4 m -69.98 -58.26 4.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.061 -1.025 . . . . 1.41 111.474 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.416 ' CE1' ' O ' ' A' ' 168' ' ' THR . 89.2 m-85 -96.3 -51.39 4.4 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.031 -1.043 . . . . 0.79 111.189 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.86 -167.66 25.88 Favored Glycine 0 N--CA 1.503 3.167 0 C-N-CA 119.555 -1.307 . . . . 1.22 111.339 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -66.9 -25.12 66.22 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.866 -0.785 . . . . 5.81 109.991 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.442 ' OE2' ' NH1' ' B' ' 317' ' ' ARG . 23.3 tp10 -60.06 -34.86 74.0 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.604 -0.685 . . . . 3.37 110.81 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -98.12 -19.54 17.87 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.175 -0.953 . . . . 2.37 110.529 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -69.36 -40.01 77.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.785 -1.197 . . . . 1.65 110.029 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.22 -33.98 76.66 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.367 -0.833 . . . . 1.42 109.695 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.8 mt -60.0 -42.88 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.077 -1.015 . . . . 1.43 109.813 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -63.34 -38.67 92.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.911 -1.118 . . . . 1.08 110.327 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -59.96 -39.99 87.49 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.859 -1.151 . . . . 1.37 109.038 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.53 -54.57 34.79 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.424 -1.47 . . . . 0.67 109.424 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -61.31 -48.21 82.43 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.167 -1.196 . . . . 1.99 109.256 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.6 mt -61.79 -50.01 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.257 -0.902 . . . . 1.22 109.18 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.0 ttp -59.98 -40.79 90.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.073 -1.017 . . . . 2.11 110.173 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.0 tp -66.54 -39.89 88.79 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.31 -0.868 . . . . 1.33 109.343 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -64.03 -38.76 92.25 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.528 -0.733 . . . . 1.29 109.329 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -80.22 2.54 23.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 1.47 110.06 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -49.17 130.5 19.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.136 -0.978 . . . . 1.47 109.689 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -63.01 -19.07 64.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.696 -0.627 . . . . 1.78 111.411 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -71.98 -32.38 67.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.656 -1.277 . . . . 2.53 108.611 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.1 mt -71.13 -41.39 70.55 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.541 0.686 . . . . 1.36 109.957 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -60.04 -45.66 92.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.868 . . . . 1.42 110.277 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.97 -41.9 73.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.895 . . . . 2.27 110.734 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.97 -39.96 75.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.157 -0.965 . . . . 1.57 111.746 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 89' ' ' ILE . 93.8 mt -65.4 -49.09 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.977 -1.077 . . . . 1.19 109.652 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -68.25 -37.71 78.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.619 -0.676 . . . . 1.39 110.877 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -60.03 -47.97 83.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.057 -1.027 . . . . 1.39 111.054 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 96' ' ' LYS . 78.5 mt -61.89 -46.21 90.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.908 -1.12 . . . . 1.5 110.28 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.0 mt -60.02 -49.77 82.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.084 -1.01 . . . . 1.29 108.655 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -69.95 -40.15 75.63 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.907 -0.588 . . . . 2.64 110.67 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 91' ' ' ALA . 47.2 t0 -84.02 -46.96 11.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.016 -1.053 . . . . 1.65 111.72 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 92' ' ' LEU . 30.9 mmtp -94.64 -2.22 51.74 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.014 -1.053 . . . . 2.5 111.952 -177.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 56.26 35.82 26.43 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.788 -1.195 . . . . 1.88 109.638 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.7 mtp -91.64 167.92 11.86 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.461 -0.774 . . . . 1.71 109.54 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.1 p -82.58 160.23 22.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.145 -0.972 . . . . 1.61 109.407 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.5 -39.92 85.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.237 -0.915 . . . . 1.33 110.195 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -65.06 -37.98 89.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.123 -0.986 . . . . 2.07 109.679 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.13 -48.98 11.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.319 -0.863 . . . . 1.37 110.034 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.91 -49.56 74.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.403 -0.81 . . . . 1.14 110.532 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.06 -43.01 95.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -0.967 . . . . 1.26 109.72 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -59.99 -40.0 87.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 2.02 110.531 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.06 -39.98 91.91 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.962 -1.086 . . . . 1.33 109.902 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.5 t -62.2 -53.48 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.232 -0.917 . . . . 1.3 110.991 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.4 mm -69.95 -39.98 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.983 -1.073 . . . . 1.32 109.409 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.21 -39.85 94.13 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.393 -0.966 . . . . 2.44 108.393 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.06 -52.78 50.76 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.712 -0.955 . . . . 0.99 110.712 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -69.28 -44.79 71.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.762 -1.434 . . . . 1.97 109.861 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.88 -44.49 91.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.881 -1.137 . . . . 1.43 108.55 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 88.7 p -59.96 -36.74 77.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 2.12 109.066 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.99 94.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 1.64 109.067 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.4 mt -65.8 -42.27 90.9 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.12 -0.988 . . . . 1.93 109.508 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.43 ' C ' ' N ' ' A' ' 118' ' ' LEU . 85.5 tt0 -59.97 -39.59 86.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.909 -1.119 . . . . 2.2 110.082 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -49.26 -17.92 0.3 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.941 -1.1 . . . . 2.12 109.168 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.43 ' N ' ' C ' ' A' ' 116' ' ' GLU . 68.0 mt -62.65 140.4 58.69 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.526 -0.916 . . . . 2.34 108.526 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 49.8 t0 -93.94 44.15 1.12 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.006 -1.059 . . . . 3.23 111.124 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -137.44 150.9 47.96 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.971 -1.08 . . . . 2.49 109.575 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 124' ' ' LYS . 71.8 mm-40 -72.63 -65.82 0.74 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.144 -0.972 . . . . 3.95 109.13 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.638 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 4.0 t80 -39.11 -42.16 0.89 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.836 -0.54 . . . . 2.25 110.404 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.558 ' CD2' HH22 ' A' ' 126' ' ' ARG . 87.6 mt -70.58 -39.95 73.57 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.845 -1.159 . . . . 2.27 108.03 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 121' ' ' GLU . 32.8 ttmt -62.07 -38.34 88.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.673 -0.642 . . . . 3.31 110.256 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -60.06 -47.32 86.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.082 -1.011 . . . . 2.73 110.633 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.638 ' NH1' ' CE1' ' A' ' 122' ' ' TYR . 21.8 mtm-85 -70.08 -30.16 67.33 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.888 -1.133 . . . . 3.2 108.964 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.99 -27.95 67.28 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.428 -1.323 . . . . 1.66 107.428 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.17 -38.94 72.14 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.49 -0.93 . . . . 1.67 108.49 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -62.27 -42.4 99.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.583 -0.698 . . . . 1.55 110.504 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.75 -40.39 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.058 -1.026 . . . . 1.32 109.112 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.504 ' CG ' HH11 ' A' ' 131' ' ' ARG . 2.4 ttt-85 -60.62 -38.63 85.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.907 . . . . 3.58 109.356 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.02 -40.03 87.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.35 -0.844 . . . . 1.46 110.563 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.0 mt -59.94 -45.21 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.796 -1.19 . . . . 1.22 109.446 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.19 -39.98 96.48 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.928 -1.269 . . . . 0.61 109.928 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -59.98 -49.95 75.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.255 -1.144 . . . . 3.1 110.028 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -68.42 -32.15 71.98 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.017 -1.052 . . . . 3.71 110.062 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.5 tp -60.0 -40.58 89.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.098 -1.001 . . . . 1.87 108.758 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.03 -40.55 89.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.173 -0.954 . . . . 1.29 109.26 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -69.97 -40.08 75.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.476 -0.765 . . . . 3.05 109.72 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -62.72 -35.86 81.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.478 -0.764 . . . . 1.26 111.249 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.0 mt -72.92 -41.39 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.617 -1.302 . . . . 1.34 109.273 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.04 -26.32 63.98 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.668 -0.645 . . . . 1.6 109.462 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.27 35.53 20.33 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.688 -1.765 . . . . 0.96 108.688 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 tp -73.27 144.77 46.53 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.484 -1.009 . . . . 1.67 108.831 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -67.06 140.32 57.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -0.914 . . . . 4.96 110.427 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 89.5 mt -110.03 128.6 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.443 -0.947 . . . . 1.68 108.443 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 14.0 mm -60.21 -44.44 95.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.775 -0.578 . . . . 2.14 110.58 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 42.2 t0 62.62 113.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.438 -0.789 . . . . 1.5 108.951 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.12 -1.93 42.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.366 -0.834 . . . . 1.39 110.079 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.2 m -89.02 -17.18 29.91 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.932 -1.105 . . . . 1.83 110.543 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.27 17.75 0.34 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.107 -0.996 . . . . 1.46 111.721 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 152' ' ' ILE . 32.7 mm -80.21 132.26 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.469 -1.395 . . . . 1.42 109.978 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -110.43 -11.32 14.51 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.685 -0.634 . . . . 2.94 109.525 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -129.96 152.13 49.77 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.578 -0.701 . . . . 1.52 110.012 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -65.36 136.51 56.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.089 -1.007 . . . . 1.58 109.514 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.8 m -153.36 166.69 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.411 -0.806 . . . . 1.32 109.838 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 157' ' ' ILE . 85.4 mt -95.84 149.59 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.026 -1.842 . . . . 1.27 106.026 176.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.1 tp -104.31 119.38 38.82 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.969 -1.082 . . . . 1.41 110.815 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 4.2 t -123.32 132.12 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.663 -0.865 . . . . 1.23 108.663 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -158.46 163.99 36.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.843 -1.161 . . . . 1.32 109.605 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.04 -35.44 71.96 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.3 -1.5 . . . . 1.49 108.485 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 62.8 t0 -169.56 142.76 2.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.133 -0.692 . . . . 2.25 109.133 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.466 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 90.7 mt -111.62 139.52 47.0 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.397 -0.815 . . . . 1.35 109.651 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 64.2 p -94.62 142.88 25.36 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.337 -0.852 . . . . 1.56 109.409 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -40.28 -38.31 2.23 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.195 1.93 . . . . 0.87 112.751 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.5 m -56.77 -40.08 75.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.044 -1.035 . . . . 1.36 108.514 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -66.31 -40.66 90.12 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.392 -0.817 . . . . 1.61 109.901 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.416 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 75.6 p -55.66 -24.23 32.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.996 -1.065 . . . . 1.21 110.083 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.74 -58.2 3.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.112 -0.993 . . . . 1.21 109.784 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -82.27 39.75 0.6 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.558 -0.904 . . . . 2.11 108.558 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.5 tp -104.43 133.48 49.24 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.794 -0.817 . . . . 1.29 108.794 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -93.26 103.51 15.76 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.142 -0.974 . . . . 2.81 108.752 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.37 -45.76 89.64 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.26 -0.9 . . . . 2.09 110.084 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -63.79 -28.48 69.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.967 -1.083 . . . . 2.86 112.207 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -92.51 -10.27 38.36 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.521 -1.362 . . . . 2.39 109.825 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 63.1 t -109.64 119.91 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.76 -1.2 . . . . 1.27 107.76 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 89.5 mt -89.26 4.92 47.15 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.201 -0.937 . . . . 2.17 111.422 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 171.26 173.65 38.43 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.134 -1.508 . . . . 0.52 109.679 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -137.4 129.99 29.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.372 -1.076 . . . . 0.55 108.84 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.3 mt -127.98 125.72 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.463 -0.94 . . . . 1.27 108.463 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 19.7 p -145.54 156.86 43.97 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.746 -1.221 . . . . 1.39 111.113 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 183' ' ' ALA . 0.7 OUTLIER -101.04 26.54 6.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.624 -0.673 . . . . 2.46 109.371 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -47.85 -172.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.364 1.078 . . . . 1.51 112.417 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.14 -55.17 4.89 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 111.062 -0.815 . . . . 2.23 111.062 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -160.5 -156.52 8.23 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 118.876 -1.63 . . . . 2.23 111.129 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -79.94 -10.06 59.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.696 -0.885 . . . . 6.44 109.918 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 60.6 p -74.6 3.14 8.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.153 -0.967 . . . . 4.09 109.477 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.9 t -76.85 133.37 39.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.859 . . . . 2.2 110.049 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -48.26 -50.68 28.82 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.3 -0.875 . . . . 1.15 110.026 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.7 t -58.26 -38.62 77.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.274 -0.891 . . . . 2.01 110.584 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 25.8 t -60.0 -40.16 88.26 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.0 -1.063 . . . . 1.93 110.288 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.17 -39.91 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 2.2 109.753 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.3 mtp -60.51 -41.58 94.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 1.32 110.901 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.1 95.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.547 -1.346 . . . . 1.3 109.673 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 66.9 mtt-85 -59.97 -47.54 85.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.108 -0.995 . . . . 3.38 109.952 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.5 m -76.57 -32.44 58.16 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.998 -1.063 . . . . 1.15 111.792 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 96.1 mt -79.98 -12.14 59.74 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.641 -1.287 . . . . 1.28 110.364 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 58.33 51.75 8.0 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.38 -0.825 . . . . 1.5 110.917 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.0 mt -127.44 131.94 24.09 Favored Pre-proline 0 N--CA 1.502 2.127 0 N-CA-C 108.892 -0.781 . . . . 1.37 108.892 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -43.45 123.53 3.65 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.937 1.758 . . . . 0.76 112.112 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.96 140.29 9.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.694 -1.254 . . . . 1.19 111.587 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.4 mt -122.84 141.74 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 107.155 -1.424 . . . . 1.31 107.155 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.7 m -124.88 -8.4 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 120.956 -1.09 . . . . 1.38 111.273 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.05 21.24 25.19 Favored Glycine 0 N--CA 1.501 3.024 0 N-CA-C 110.866 -0.894 . . . . 1.03 110.866 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.436 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.0 p -45.28 -43.79 10.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.891 -1.358 . . . . 1.38 110.048 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 93.01 -51.28 2.52 Favored Glycine 0 N--CA 1.5 2.935 0 C-N-CA 120.076 -1.059 . . . . 1.17 111.726 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.428 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 3.6 m -156.92 38.36 0.31 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.528 -1.571 . . . . 2.07 111.209 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.7 t -80.01 -31.26 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.024 -1.048 . . . . 1.35 108.518 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 55.6 p -58.79 -30.78 67.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.43 -0.794 . . . . 1.49 110.576 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 20.9 t -78.81 -17.94 54.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.926 -1.109 . . . . 2.16 109.731 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -98.64 -8.85 25.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.238 -0.914 . . . . 2.89 110.377 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 55.1 t -104.83 130.25 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.282 -0.886 . . . . 1.33 110.869 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -108.31 148.79 29.54 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.371 -1.344 . . . . 2.73 107.371 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.439 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 30.0 p-10 -59.97 136.99 58.18 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.101 -1.0 . . . . 2.7 110.901 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.9 m-20 82.59 -0.03 1.3 Allowed 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 116.187 -0.461 . . . . 2.38 111.547 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -74.04 158.54 34.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.418 -1.426 . . . . 2.09 108.385 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -99.29 119.56 38.12 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.385 -0.969 . . . . 1.45 108.385 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 80.7 mt -125.85 148.73 49.08 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.479 -0.763 . . . . 1.31 109.99 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 78.8 mt -116.16 129.97 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 107.086 -1.449 . . . . 1.29 107.086 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 40.6 tp -105.88 124.33 49.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.029 -1.045 . . . . 1.31 109.11 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.617 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 29.6 p-10 -87.95 -37.47 16.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.043 -1.036 . . . . 2.31 109.866 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.466 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 45.71 16.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.968 -0.752 . . . . 1.19 108.968 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.5 t -126.06 -41.19 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.497 -1.297 . . . . 1.45 107.497 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -106.53 -0.15 24.16 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.831 -1.174 . . . . 3.13 107.831 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.445 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 0.4 OUTLIER 61.69 49.66 4.83 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.401 0.619 . . . . 2.2 109.771 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.617 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 43.9 mt-30 -139.97 150.31 44.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.452 -0.78 . . . . 2.32 109.502 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.1 t -122.68 129.99 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.194 -1.039 . . . . 1.4 108.194 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -101.11 116.66 33.36 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.251 -0.906 . . . . 1.29 109.208 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 36.0 t -98.33 117.09 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.49 -0.756 . . . . 1.38 109.251 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 68.55 70.17 0.42 Allowed Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.27 -0.894 . . . . 2.33 109.408 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -89.79 118.27 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 123.376 2.717 . . . . 0.95 112.744 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.435 ' CG2' ' N ' ' A' ' 233' ' ' ASN . 96.4 m -67.97 170.52 8.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.174 -0.954 . . . . 2.31 108.989 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.435 ' N ' ' CG2' ' A' ' 232' ' ' THR . 11.9 m120 -59.84 -40.12 87.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.0 -1.062 . . . . 3.45 109.238 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.58 -39.91 92.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.838 . . . . 2.89 109.197 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.54 -42.74 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 1.73 109.882 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.194 -0.941 . . . . 1.57 109.577 -179.804 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 49.7 ttp . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.448 0.642 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -150.11 147.35 27.67 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -147.7 157.13 43.4 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.865 -1.147 . . . . 0.0 110.817 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -153.51 148.92 27.14 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -112.59 131.05 55.8 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.142 -0.974 . . . . 0.0 109.656 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.407 ' CG1' ' SD ' ' B' ' 381' ' ' MET . 1.9 p -132.79 125.15 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-O 122.146 0.974 . . . . 0.0 112.073 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 21.1 m -77.21 104.8 7.93 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.046 0.927 . . . . 0.0 110.766 -178.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' B' ' 358' ' ' GLY . 97.0 mt -52.81 124.64 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 122.429 1.109 . . . . 0.0 111.026 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 62.4 p -112.5 20.19 16.86 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.682 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.15 118.68 55.12 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.988 -1.07 . . . . 0.0 108.891 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -49.58 -26.07 12.05 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 CA-C-N 120.354 1.162 . . . . 0.0 112.718 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -120.52 17.58 12.09 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.642 -0.661 . . . . 0.0 109.352 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.76 179.75 32.74 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.469 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -87.86 94.8 9.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -1.223 . . . . 0.0 109.309 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -96.08 -160.43 0.79 Allowed 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.948 -1.095 . . . . 0.0 110.09 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 15.5 m -58.87 -42.79 90.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.076 -1.015 . . . . 0.0 112.546 -175.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.448 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.5 tpt180 -61.13 -61.41 8.02 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 120.452 -1.405 . . . . 0.0 112.119 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -59.3 -33.67 97.82 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 CA-C-N 120.394 1.176 . . . . 0.0 111.656 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.98 75.53 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.13 -41.4 65.01 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.474 -0.766 . . . . 0.0 109.801 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -69.97 -40.03 75.62 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.971 -1.08 . . . . 0.0 108.24 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -61.2 -52.47 64.65 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.2 -0.937 . . . . 0.0 110.432 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 94.7 t -62.79 -28.92 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.659 -1.275 . . . . 0.0 109.587 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -59.95 -44.6 94.3 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.537 -0.727 . . . . 0.0 109.041 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -67.65 -42.71 81.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.89 . . . . 0.0 111.378 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' B' ' 328' ' ' GLY . . . -59.9 -53.89 52.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.556 -1.34 . . . . 0.0 110.97 -178.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 32.3 mttp -52.82 -12.57 0.32 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 109.768 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' B' ' 326' ' ' ALA . . . -77.74 -24.14 65.49 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -105.82 140.09 39.38 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.558 -0.966 . . . . 0.0 109.087 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 26.1 p -90.43 -10.93 41.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.109 -0.994 . . . . 0.0 109.926 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 79.7 p -67.49 152.36 45.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -0.939 . . . . 0.0 109.502 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.9 137.71 51.84 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.138 -0.976 . . . . 0.0 108.559 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 76.8 mt -131.85 132.68 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.666 -0.646 . . . . 0.0 109.293 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 24.0 m -129.52 148.67 51.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.552 -0.718 . . . . 0.0 109.089 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 70.0 t -123.19 116.16 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 45.9 m -105.57 130.35 53.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.304 -0.872 . . . . 0.0 109.337 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 43.2 t -139.32 119.07 13.17 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.028 0.918 . . . . 0.0 111.272 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 43.92 50.1 7.11 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.13 -14.41 60.78 Favored Glycine 0 N--CA 1.501 3.03 0 O-C-N 120.15 -1.594 . . . . 0.0 112.786 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -117.24 128.45 55.1 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-N 119.208 1.504 . . . . 0.0 110.082 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 80.3 p -126.33 148.33 49.57 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.774 0.797 . . . . 0.0 110.453 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -142.91 166.01 25.79 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 121.534 0.683 . . . . 0.0 110.145 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 25.1 m -87.25 133.62 33.65 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.473 -0.767 . . . . 0.0 110.377 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -72.63 -17.37 61.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.073 -1.017 . . . . 0.0 109.911 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -87.21 20.94 2.55 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.465 ' H ' ' C ' ' B' ' 344' ' ' ALA . 7.3 m -149.08 96.02 2.48 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.836 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 61.6 tp -58.16 -36.2 72.66 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -54.68 -54.01 47.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.796 -1.19 . . . . 0.0 110.193 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -71.3 -19.56 62.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.923 . . . . 0.0 111.699 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' B' ' 352' ' ' THR . 73.6 mt -71.01 -57.96 4.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.453 -1.404 . . . . 0.0 110.318 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.571 ' NE2' ' HE ' ' A' ' 126' ' ' ARG . 9.2 mm100 -43.16 -12.56 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.681 -0.637 . . . . 0.0 111.348 -176.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.571 ' N ' ' O ' ' B' ' 350' ' ' LEU . 77.1 p -86.01 -10.89 54.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.328 -1.483 . . . . 0.0 110.104 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 59.1 mt -92.74 117.98 30.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.03 -1.044 . . . . 0.0 109.021 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -71.96 90.24 0.49 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 23.7 mt -100.4 90.13 4.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.353 -1.086 . . . . 0.0 109.043 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 31.7 p -92.65 154.59 18.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.906 -1.121 . . . . 0.0 110.436 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -50.87 119.34 3.82 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.611 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 102.09 3.07 51.62 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 44.2 m -87.72 114.92 24.79 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.219 -1.165 . . . . 0.0 111.852 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.99 115.16 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 122.171 0.986 . . . . 0.0 109.939 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 14.5 m -110.49 177.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 22.5 m -130.53 129.3 42.68 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 48.5 mt -102.64 112.95 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 69.2 p -118.62 131.05 56.18 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.157 -0.964 . . . . 0.0 109.287 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.15 151.28 39.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.201 -0.937 . . . . 0.0 109.627 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -146.45 125.93 13.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.346 -0.846 . . . . 0.0 109.394 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.534 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.05 -156.24 26.92 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.496 -1.335 . . . . 0.0 111.182 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.03 -50.71 72.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.109 -0.642 . . . . 0.0 112.271 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -106.42 11.36 30.91 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.868 -1.145 . . . . 0.0 111.336 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.9 pt-20 -44.75 -35.7 2.83 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.986 -1.071 . . . . 0.0 111.117 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -70.53 -42.67 70.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.926 -1.109 . . . . 0.0 110.026 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.95 -48.97 66.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.397 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -46.61 -75.13 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.432 -0.792 . . . . 0.0 110.882 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 32.6 t -44.66 -34.81 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.068 -1.02 . . . . 0.0 110.942 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -66.47 -46.09 77.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.421 -1.424 . . . . 0.0 110.301 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -80.37 -42.31 23.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.766 -1.209 . . . . 0.0 109.742 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 109.485 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 44.0 t -61.95 -42.0 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.003 -1.061 . . . . 0.0 109.51 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -69.89 -55.1 10.61 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.451 -1.3 . . . . 0.0 107.909 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 48.8 tp -57.56 -35.07 69.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.231 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 381' ' ' MET . . . . . 0.407 ' SD ' ' CG1' ' B' ' 306' ' ' VAL . 39.6 ttm -70.46 -39.94 74.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.217 -1.552 . . . . 0.0 108.359 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.49 -4.83 58.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.586 -0.696 . . . . 0.0 110.335 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -113.6 -3.39 13.63 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.034 -1.041 . . . . 0.0 111.072 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 13.7 mt -79.29 135.36 36.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.331 -1.481 . . . . 0.0 109.437 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.497 -179.572 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 mmt . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.466 -0.568 . . . . 3.19 109.466 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.415 HD11 HG22 ' A' ' 2' ' ' ILE . 85.5 mt -110.18 129.69 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.689 -0.856 . . . . 1.71 108.689 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.9 m -138.37 119.49 14.52 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.288 -0.883 . . . . 1.66 109.05 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.81 -162.02 36.64 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.123 -1.591 . . . . 1.05 109.123 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 5' ' ' ILE . 97.2 mt -93.5 -9.91 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.046 -1.267 . . . . 1.59 110.058 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.8 tp 54.94 96.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.18 -0.95 . . . . 1.47 109.184 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.66 -40.15 73.17 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.665 -0.865 . . . . 1.39 108.665 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 3.4 p -145.9 143.22 19.05 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.482 -0.761 . . . . 2.09 109.049 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.52 143.17 16.89 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.21 1.94 . . . . 0.91 112.705 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 165.45 -163.88 36.88 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.299 -1.52 . . . . 0.92 109.299 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.1 mt -149.34 149.69 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.051 -1.264 . . . . 1.35 108.332 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.88 151.62 31.52 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.954 -1.091 . . . . 1.14 110.183 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.5 m-85 -134.88 125.27 26.43 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.391 -0.966 . . . . 0.7 108.391 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.75 179.32 47.11 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 118.87 -1.633 . . . . 0.58 110.607 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -76.96 154.73 33.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.759 -0.848 . . . . 2.63 109.006 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.02 136.52 39.8 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.336 -0.852 . . . . 1.27 111.052 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.1 tp -104.99 133.28 50.05 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.533 -1.284 . . . . 1.41 107.533 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 64.4 tp -115.14 122.27 45.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.252 -0.905 . . . . 1.49 110.222 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.7 mt -88.71 100.51 13.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.677 -0.639 . . . . 1.52 109.761 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -86.84 139.51 30.6 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.072 -1.084 . . . . 3.17 108.072 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -130.93 136.6 48.73 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.025 -1.047 . . . . 3.0 109.41 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -91.77 137.89 31.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.11 -0.994 . . . . 2.77 109.147 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.03 139.97 57.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 2.94 109.857 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.5 mt -82.51 130.11 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.449 -0.782 . . . . 1.46 109.597 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.5 t -97.21 128.16 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.231 -0.918 . . . . 1.7 110.066 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -109.98 130.05 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.746 -0.835 . . . . 1.54 108.746 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -82.03 127.03 32.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.091 -1.005 . . . . 1.81 110.355 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -89.96 -1.64 58.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.384 -0.823 . . . . 3.23 109.149 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.37 142.18 52.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 3.29 109.681 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -85.19 150.1 25.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.279 -0.888 . . . . 2.8 109.275 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 pt -91.09 164.56 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.162 -0.961 . . . . 1.43 110.072 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.2 p -89.55 170.59 10.37 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.425 -0.954 . . . . 1.54 108.425 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.32 -19.8 63.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.848 -1.158 . . . . 1.6 110.402 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -82.74 -24.02 33.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.776 -1.203 . . . . 2.56 107.925 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -81.88 -8.75 59.7 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.889 -0.782 . . . . 2.36 108.889 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.68 -53.85 39.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.089 -1.007 . . . . 1.43 108.646 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -62.79 -40.15 96.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 1.77 109.644 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -69.96 -40.07 75.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.079 -1.013 . . . . 3.32 109.976 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -67.09 -40.0 86.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.067 -1.021 . . . . 1.51 109.689 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.31 -46.44 96.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.92 -1.113 . . . . 1.41 108.34 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -60.07 -40.88 91.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.918 . . . . 1.81 108.941 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.413 HH11 ' HG2' ' A' ' 42' ' ' ARG . 52.1 mtt-85 -60.08 -45.98 91.09 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.897 -1.149 . . . . 3.26 107.897 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -60.07 -49.2 78.57 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.442 -0.786 . . . . 0.81 108.944 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.04 -47.72 84.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.287 -0.883 . . . . 1.59 108.7 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.7 t -61.8 -41.38 97.68 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.228 -1.027 . . . . 1.38 108.228 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.54 -49.77 73.39 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.819 -1.712 . . . . 0.87 108.819 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -65.38 -35.47 81.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.343 -1.093 . . . . 3.62 108.468 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.53 -47.71 72.83 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.356 -0.84 . . . . 1.43 109.097 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 50' ' ' ALA . 32.5 ttpt -63.5 -72.97 0.12 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.889 -1.124 . . . . 3.08 107.972 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.88 -34.0 0.1 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.298 -0.876 . . . . 1.33 111.34 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.5 t -57.22 -52.85 63.67 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.616 -1.303 . . . . 1.85 108.526 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.14 -40.07 78.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 1.35 110.914 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -64.65 -40.13 94.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.081 -1.012 . . . . 2.34 109.974 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.6 -40.02 95.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.854 -1.154 . . . . 2.2 108.487 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -62.1 -34.36 76.18 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.657 -0.868 . . . . 1.35 108.657 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -65.32 -42.96 92.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 1.34 109.086 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.07 -39.94 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.302 -0.873 . . . . 1.26 108.815 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -55.17 -49.71 71.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.618 -0.677 . . . . 1.7 109.38 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.1 m -56.86 -33.47 66.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.337 -0.852 . . . . 1.35 110.747 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -68.17 -38.63 82.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.891 -1.131 . . . . 2.08 109.869 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.07 -47.22 68.9 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.606 -0.684 . . . . 1.21 110.915 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.03 -52.15 50.98 Favored Glycine 0 N--CA 1.486 1.983 0 C-N-CA 119.79 -1.195 . . . . 0.75 110.283 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.03 -42.91 72.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.838 -1.389 . . . . 1.59 110.592 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.0 m -69.96 -58.43 3.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.129 -0.982 . . . . 1.41 112.232 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -95.62 -54.58 3.32 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.978 -1.076 . . . . 0.79 111.159 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.01 -160.49 26.72 Favored Glycine 0 N--CA 1.501 3.033 0 O-C-N 120.849 -1.157 . . . . 1.22 110.415 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -70.01 -22.94 63.06 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.481 -1.011 . . . . 5.81 110.311 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -59.9 -37.66 80.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 3.37 110.296 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -98.59 -18.48 18.1 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.33 -0.856 . . . . 2.37 110.829 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -70.0 -42.79 72.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.575 -1.328 . . . . 1.65 110.542 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.52 -30.35 71.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 1.42 109.672 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.03 -43.64 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.104 -0.997 . . . . 1.43 109.943 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -66.03 -39.97 90.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.949 -1.094 . . . . 1.08 110.531 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -60.07 -39.98 87.93 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.808 -1.182 . . . . 1.37 108.949 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.06 -49.77 64.95 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.929 -1.669 . . . . 0.67 108.929 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -64.72 -41.22 96.14 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.368 -1.078 . . . . 1.99 108.852 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.431 HD11 HG22 ' A' ' 77' ' ' ILE . 82.8 mt -69.96 -42.58 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.114 -0.991 . . . . 1.22 109.214 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.31 -39.98 88.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.985 -1.072 . . . . 2.11 109.737 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.455 ' CD1' ' CZ ' ' B' ' 348' ' ' PHE . 59.1 tp -66.56 -40.03 88.83 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.503 -0.748 . . . . 1.33 109.806 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.4 tp -60.05 -40.09 88.22 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.638 -0.825 . . . . 1.29 109.155 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -82.64 10.03 8.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.272 -0.893 . . . . 1.47 109.55 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 55.8 t0 -59.94 133.27 55.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.892 . . . . 1.47 110.421 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.468 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 96.7 mt-10 -59.91 -16.04 26.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.699 -0.625 . . . . 1.78 110.445 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -70.05 -37.46 75.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.969 -1.082 . . . . 2.53 108.859 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -73.69 -43.66 58.72 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.461 0.648 . . . . 1.36 110.642 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -59.95 -50.0 75.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.935 . . . . 1.42 110.851 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.51 -42.15 71.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.082 -1.011 . . . . 2.27 111.11 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.88 -39.97 72.54 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.058 -1.026 . . . . 1.57 112.273 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.04 -42.26 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.813 -1.179 . . . . 1.19 109.86 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.03 -39.29 77.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.584 -0.698 . . . . 1.39 110.303 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.93 -50.0 75.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.122 -0.986 . . . . 1.39 111.723 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.94 -44.3 94.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.661 -1.275 . . . . 1.5 109.641 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.6 mt -61.77 -46.66 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -0.866 . . . . 1.29 108.883 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -70.02 -40.98 74.88 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.924 -0.71 . . . . 2.64 110.74 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -82.24 -51.88 7.5 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.071 -1.018 . . . . 1.65 112.151 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.07 -3.16 58.1 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.961 -1.087 . . . . 2.5 111.684 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.2 m170 57.62 38.58 27.8 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.954 -1.091 . . . . 1.88 109.78 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.0 mtp -89.3 169.94 11.0 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.476 -0.765 . . . . 1.71 110.015 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.7 p -79.9 159.73 26.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.921 . . . . 1.61 109.664 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.03 -40.04 75.4 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.46 -0.775 . . . . 1.33 109.99 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 31.4 p-10 -69.49 -38.82 77.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.14 -0.975 . . . . 2.07 110.229 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.02 -40.67 23.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.972 -1.08 . . . . 1.37 109.933 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.11 -47.43 61.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 1.14 110.623 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.87 92.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.003 -1.061 . . . . 1.26 110.008 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -59.94 -38.6 82.88 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.289 -0.882 . . . . 2.02 110.406 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.0 -39.95 93.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.017 -1.052 . . . . 1.33 110.682 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.7 t -64.76 -50.14 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.938 -1.101 . . . . 1.3 110.815 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.17 -39.92 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.873 -1.142 . . . . 1.32 108.599 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -66.36 -37.42 85.26 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.718 -0.845 . . . . 2.44 108.718 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.44 ' O ' ' OG ' ' A' ' 113' ' ' SER . . . -60.07 -49.9 73.5 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 120.547 -0.835 . . . . 0.99 111.019 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -66.0 -50.43 64.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.503 -1.586 . . . . 1.97 109.746 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.15 84.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.844 . . . . 1.43 109.693 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 110' ' ' GLY . 85.0 p -55.56 -39.75 71.03 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.062 -1.024 . . . . 2.12 109.0 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.43 ' N ' ' HG ' ' A' ' 113' ' ' SER . . . -69.91 -31.36 69.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.913 . . . . 1.64 109.883 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.4 mt -69.93 -41.15 74.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.784 -1.197 . . . . 1.93 110.235 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -69.33 -22.57 63.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.131 -1.606 . . . . 2.2 109.367 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -59.85 -20.58 57.9 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.387 -1.338 . . . . 2.12 107.387 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 35.0 mt -62.94 140.06 58.81 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.106 -1.072 . . . . 2.34 108.106 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -85.76 41.51 0.91 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.952 -1.093 . . . . 3.23 109.134 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 53.3 t0 -131.96 142.46 49.63 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.575 -0.703 . . . . 2.49 109.707 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.499 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 81.6 mm-40 -73.87 -65.33 0.85 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.799 0.809 . . . . 3.95 108.835 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.633 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 4.1 t80 -39.28 -42.33 1.0 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.937 -0.477 . . . . 2.25 111.082 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.482 ' CD2' HH22 ' A' ' 126' ' ' ARG . 66.1 mt -70.56 -40.04 73.58 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.561 -1.337 . . . . 2.27 108.225 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 121' ' ' GLU . 62.8 tttp -68.67 -33.69 74.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.545 -0.722 . . . . 3.31 109.491 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 187' ' ' THR . 69.1 mm-40 -59.99 -44.9 94.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.806 -1.184 . . . . 2.73 109.629 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.633 ' NH1' ' CE1' ' A' ' 122' ' ' TYR . 20.5 mtm-85 -69.97 -30.36 67.7 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.895 -1.128 . . . . 3.2 108.592 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.89 -28.08 67.26 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.888 -1.153 . . . . 1.66 107.888 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.91 -38.88 69.85 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.158 -1.053 . . . . 1.67 108.158 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.85 -40.08 94.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 1.55 110.229 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.01 -40.0 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.993 -1.067 . . . . 1.32 108.446 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -60.01 -38.68 83.37 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.48 -0.933 . . . . 3.58 108.48 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -59.98 -37.43 79.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.567 -0.708 . . . . 1.46 109.545 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.98 -41.84 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 1.22 110.253 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.35 -31.75 53.74 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.574 -1.298 . . . . 0.61 110.354 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -60.05 -49.9 75.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.121 -1.223 . . . . 3.1 110.129 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -65.41 -31.99 73.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.912 -1.117 . . . . 3.71 109.829 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.89 -40.03 87.33 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.674 -0.862 . . . . 1.87 108.674 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.6 mt -61.03 -40.06 92.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 1.29 109.287 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.428 HH11 ' HG2' ' A' ' 139' ' ' ARG . 46.8 mtt-85 -65.44 -39.76 92.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 3.05 108.908 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -67.0 -33.38 75.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.606 -0.684 . . . . 1.26 111.759 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.03 -39.91 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.29 -1.507 . . . . 1.34 109.409 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.1 mt -77.26 -21.05 54.28 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.774 -0.77 . . . . 1.6 110.275 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.9 37.15 13.55 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.343 -1.903 . . . . 0.96 108.343 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 tp -73.1 140.83 47.42 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.591 -0.947 . . . . 1.67 108.761 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -73.92 138.38 44.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 4.96 109.613 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.1 mt -107.0 135.01 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-O 122.262 1.03 . . . . 1.68 110.065 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 148' ' ' ASP . 11.4 mt -69.52 -39.92 79.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.396 -0.82 . . . . 2.14 110.651 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 147' ' ' ILE . 48.9 t0 60.17 125.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.565 -0.709 . . . . 1.5 109.651 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.447 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 43.0 mt -83.84 -3.41 57.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.24 -0.912 . . . . 1.39 109.783 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.6 m -81.79 -12.9 58.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.135 -0.978 . . . . 1.83 109.188 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.72 27.97 0.28 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.575 -0.703 . . . . 1.46 110.418 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.447 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 57.9 mt -91.29 119.88 39.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.123 -0.986 . . . . 1.42 109.739 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -101.38 -9.49 21.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.297 -0.877 . . . . 2.94 109.997 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -139.17 158.38 44.28 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.072 -1.018 . . . . 1.52 110.207 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.73 138.59 58.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.864 . . . . 1.58 109.026 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 24.6 m -153.12 166.24 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.439 -0.788 . . . . 1.32 109.772 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.7 mt -96.63 146.15 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 105.415 -2.069 . . . . 1.27 105.415 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 45.7 tp -95.94 116.81 29.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.907 -1.12 . . . . 1.41 110.461 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.9 t -120.03 127.92 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.684 -1.228 . . . . 1.23 107.684 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -158.97 164.5 35.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.997 -1.064 . . . . 1.32 108.903 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.29 -35.11 68.6 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.405 -1.434 . . . . 1.49 108.806 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 58.5 t0 -170.51 146.48 2.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.366 -0.834 . . . . 2.25 109.586 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.515 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 39.3 mt -118.36 140.03 50.45 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.274 -0.891 . . . . 1.35 109.75 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.6 p -101.91 151.59 38.01 Favored Pre-proline 0 N--CA 1.5 2.075 0 O-C-N 121.351 -0.843 . . . . 1.56 109.785 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -40.26 -40.11 2.84 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.652 2.235 . . . . 0.87 113.233 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.8 m -59.96 -40.01 87.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 1.36 109.7 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.31 -40.6 86.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.125 -0.984 . . . . 1.61 110.375 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 67.3 p -58.73 -32.79 69.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.107 -0.995 . . . . 1.21 111.311 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.64 -49.63 51.95 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.693 -1.254 . . . . 1.21 109.966 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -86.99 38.08 0.79 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.919 -1.141 . . . . 2.11 107.919 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.9 tp -106.28 130.3 54.16 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.002 -0.74 . . . . 1.29 109.002 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -84.06 105.39 14.89 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.482 -0.933 . . . . 2.81 108.482 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.49 -40.53 93.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.808 . . . . 2.09 110.816 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -69.81 -23.1 63.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.779 -1.201 . . . . 2.86 111.836 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -93.31 -8.64 41.48 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.669 -1.27 . . . . 2.39 110.003 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 90.1 t -110.03 119.97 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.541 -0.911 . . . . 1.27 108.541 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 65.9 mt -90.65 6.61 43.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.294 -0.879 . . . . 2.17 110.476 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.58 170.39 36.3 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.279 -1.528 . . . . 0.52 109.279 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -129.98 129.09 43.3 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.508 -0.995 . . . . 0.55 108.834 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 72.7 mt -131.05 121.85 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.546 -0.909 . . . . 1.27 108.546 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.3 p -142.5 156.68 45.17 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.332 -0.855 . . . . 1.39 111.197 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.464 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 94.3 m-20 -90.09 18.61 5.69 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.596 -0.69 . . . . 2.46 109.266 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.37 -162.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.872 -1.143 . . . . 1.51 111.355 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -102.51 -33.99 4.3 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.527 -1.029 . . . . 2.23 110.527 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 157.24 -143.1 9.2 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 118.822 -1.656 . . . . 2.23 111.235 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -59.96 -28.39 67.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.826 -0.808 . . . . 6.44 110.692 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' THR . . . . . 0.431 ' O ' ' OE1' ' A' ' 125' ' ' GLU . 61.4 p -59.99 -10.27 3.98 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.991 -1.068 . . . . 4.09 109.145 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.5 t -91.64 124.66 35.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 2.2 109.41 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 62.0 t60 -48.05 -49.76 30.26 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.034 -1.041 . . . . 1.15 109.868 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -40.48 64.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.32 -0.863 . . . . 2.01 110.358 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 56.1 m -60.04 -40.0 87.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.958 -1.089 . . . . 1.93 110.529 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.6 mm -61.12 -43.58 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.288 -0.882 . . . . 2.2 110.115 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.4 mtp -62.87 -40.06 96.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 1.32 110.681 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.92 78.11 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.58 -1.325 . . . . 1.3 109.054 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -60.03 -49.92 75.78 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.413 -0.805 . . . . 3.38 110.089 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.0 m -72.75 -33.44 66.35 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.086 -1.009 . . . . 1.15 110.534 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.7 mt -71.55 -26.82 62.79 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.144 -0.973 . . . . 1.28 108.384 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 61.45 50.57 4.57 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.978 -0.451 . . . . 1.5 110.833 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.44 ' O ' ' OG ' ' A' ' 8' ' ' SER . 73.4 mt -124.36 146.88 53.38 Favored Pre-proline 0 N--CA 1.505 2.307 0 N-CA-C 108.792 -0.818 . . . . 1.37 108.792 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -45.06 121.83 3.9 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.829 1.686 . . . . 0.76 111.715 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -158.18 136.78 11.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.382 -1.449 . . . . 1.19 111.966 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 61.6 mt -121.03 145.32 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 106.691 -1.596 . . . . 1.31 106.691 177.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.5 -7.19 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.731 -1.231 . . . . 1.38 111.287 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -106.4 22.61 30.42 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.874 -1.29 . . . . 1.03 109.874 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.464 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 2.0 p -51.16 -41.41 60.13 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.051 -1.264 . . . . 1.38 110.333 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.407 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 84.67 -77.15 2.14 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.667 -1.254 . . . . 1.17 111.781 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 79.5 p -125.13 27.68 6.59 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 121.253 -1.145 . . . . 2.07 112.882 -177.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.96 -40.89 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.295 -1.503 . . . . 1.35 109.123 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.4 p -52.64 -26.75 14.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.878 . . . . 1.49 110.222 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.2 m -80.42 -15.83 55.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.016 -1.053 . . . . 2.16 109.931 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -103.78 -9.54 18.98 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.364 -0.835 . . . . 2.89 110.257 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 63.3 t -110.4 134.61 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.404 -0.81 . . . . 1.33 111.645 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -113.87 150.69 33.26 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.362 -1.348 . . . . 2.73 107.362 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 8.8 p30 -54.51 139.49 37.64 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.815 -1.178 . . . . 2.7 109.983 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.8 m-20 83.53 10.72 0.48 Allowed 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 121.19 0.519 . . . . 2.38 110.188 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.8 t0 -80.06 139.88 36.73 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.334 -0.853 . . . . 2.09 109.407 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.54 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 28.0 t80 -88.98 115.26 26.4 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.32 -0.993 . . . . 1.45 108.32 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 83.0 mt -127.78 149.23 50.35 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.49 -0.756 . . . . 1.31 110.505 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 85.6 mt -115.24 129.06 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 106.859 -1.534 . . . . 1.29 106.859 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 26.1 tp -99.89 119.31 38.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.063 -1.023 . . . . 1.31 110.044 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.496 ' C ' ' N ' ' A' ' 223' ' ' VAL . 84.1 m-20 -76.47 -44.46 35.43 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.233 -0.917 . . . . 2.31 108.569 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 48.89 15.8 0.1 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.35 -0.982 . . . . 1.19 108.35 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.496 ' N ' ' C ' ' A' ' 221' ' ' ASP . 41.6 t -132.19 -46.12 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.293 -1.373 . . . . 1.45 107.293 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -97.8 0.51 46.95 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.469 -1.308 . . . . 3.13 107.469 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 60.07 45.35 12.01 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.036 -0.728 . . . . 2.2 109.036 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -138.68 150.07 45.81 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.402 -0.811 . . . . 2.32 109.83 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.0 t -121.08 130.01 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.615 -0.883 . . . . 1.4 108.615 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -98.1 119.91 37.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.317 -0.864 . . . . 1.29 108.955 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.9 t -100.35 113.52 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.632 -0.667 . . . . 1.38 109.981 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 8.1 t30 69.25 69.92 0.4 Allowed Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.439 -0.788 . . . . 2.33 109.425 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -90.8 126.39 1.17 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 123.588 2.858 . . . . 0.95 112.73 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 35.0 p -70.97 166.55 21.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.16 -0.963 . . . . 2.31 109.48 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -59.96 -40.0 87.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.27 -0.894 . . . . 3.45 110.558 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -59.94 -40.03 87.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 2.89 110.337 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.21 -40.01 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.985 -1.072 . . . . 1.73 109.49 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.191 -0.943 . . . . 1.57 110.017 -179.571 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 10.9 ttt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.471 0.653 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -152.38 151.99 31.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 109.512 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -147.84 158.84 44.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.128 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . 0.43 ' NE2' ' OE2' ' B' ' 305' ' ' GLU . 54.3 tp60 -152.51 148.32 27.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . 0.486 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 1.4 pm0 -114.9 133.49 55.94 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.266 -0.896 . . . . 0.0 110.103 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.31 123.69 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 CA-C-O 122.006 0.907 . . . . 0.0 112.22 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 35.9 m -78.01 105.47 9.23 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.972 0.892 . . . . 0.0 110.343 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.0 mt -51.66 122.15 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 122.434 1.111 . . . . 0.0 110.505 -177.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 19.3 p -107.36 18.87 21.05 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.226 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . 0.478 ' O ' ' CG ' ' B' ' 357' ' ' GLN . . . -74.94 133.21 76.12 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.048 -1.032 . . . . 0.0 108.329 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -69.99 -13.13 33.7 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 CA-C-N 120.161 1.093 . . . . 0.0 112.298 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -120.67 8.94 10.68 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.436 -0.79 . . . . 0.0 109.619 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.55 179.95 32.39 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.483 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.6 tp -86.92 93.12 9.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.079 -1.248 . . . . 0.0 109.641 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -96.54 -159.78 0.75 Allowed 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.138 -0.976 . . . . 0.0 110.204 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.2 m -57.12 -45.11 83.74 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.17 -0.956 . . . . 0.0 112.816 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.452 HH11 ' HG2' ' B' ' 317' ' ' ARG . 3.1 tpt180 -61.59 -61.46 7.8 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 120.571 -1.33 . . . . 0.0 112.166 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -59.69 -31.91 94.95 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 120.335 1.155 . . . . 0.0 111.797 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.03 -50.29 74.32 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -50.81 -40.89 56.68 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.432 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . 0.436 ' NE2' ' NE ' ' B' ' 317' ' ' ARG . 56.8 mt-30 -69.95 -40.19 75.59 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.16 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -61.99 -52.61 63.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.466 -0.771 . . . . 0.0 110.483 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 86.4 t -69.21 -32.35 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.729 -1.232 . . . . 0.0 110.005 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -59.98 -47.55 85.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.226 -0.921 . . . . 0.0 110.038 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.99 -42.36 73.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.077 -1.014 . . . . 0.0 110.819 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.71 -54.02 11.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.746 -1.222 . . . . 0.0 110.011 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -49.96 -17.34 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.573 -0.704 . . . . 0.0 109.619 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.16 -17.88 79.72 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -106.09 147.2 29.21 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.289 -1.124 . . . . 0.0 109.067 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 3.6 t -90.49 -13.05 35.5 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.065 -1.022 . . . . 0.0 109.831 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 331' ' ' SER . . . . . 0.649 ' HG ' ' N ' ' B' ' 369' ' ' ASP . 52.8 m -58.04 144.09 41.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 0.0 109.673 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -67.7 131.59 45.86 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.6 mt -132.61 132.68 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.47 -0.769 . . . . 0.0 109.645 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 50.7 m -128.93 148.88 50.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.448 -0.782 . . . . 0.0 109.328 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.96 114.99 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 55.2 m -103.15 123.53 46.87 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.246 -0.909 . . . . 0.0 108.818 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 47.8 t -136.58 120.29 17.3 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.003 0.906 . . . . 0.0 111.639 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 49.45 49.2 20.25 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 86.05 -11.13 63.46 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 119.863 -1.773 . . . . 0.0 112.438 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -122.59 133.45 54.55 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.008 -1.289 . . . . 0.0 109.503 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 14.8 m -128.46 150.24 50.23 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.973 0.892 . . . . 0.0 110.713 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -145.69 168.02 21.7 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.539 0.685 . . . . 0.0 109.825 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 28.6 m -89.06 139.6 30.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.518 -0.739 . . . . 0.0 110.136 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -77.64 -15.87 58.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 108.985 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -87.19 17.19 4.46 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.467 ' H ' ' C ' ' B' ' 344' ' ' ALA . 49.8 m -145.71 95.34 2.63 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.045 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.03 -38.29 82.3 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . 0.455 ' CZ ' ' CD1' ' A' ' 79' ' ' LEU . 59.9 m-85 -55.22 -51.65 65.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.076 -1.015 . . . . 0.0 110.849 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.447 ' O ' ' OG1' ' B' ' 352' ' ' THR . 19.2 mtmm -69.11 -39.92 78.67 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.767 -1.208 . . . . 0.0 109.799 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' B' ' 352' ' ' THR . 36.8 mt -48.18 -58.28 4.75 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.836 -1.165 . . . . 0.0 109.35 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.604 HE22 ' HE ' ' A' ' 126' ' ' ARG . 73.9 mm-40 -38.37 -23.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.523 -0.736 . . . . 0.0 111.355 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.522 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.6 p -80.09 -13.14 59.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.753 -1.217 . . . . 0.0 110.876 -178.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 27.5 mt -93.25 119.29 32.25 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.682 -1.262 . . . . 0.0 109.32 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.23 94.0 1.12 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 21.0 mt -101.67 92.05 4.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.336 -1.096 . . . . 0.0 108.835 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 74.3 p -92.22 175.22 6.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.217 -0.927 . . . . 0.0 110.608 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . 0.478 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 15.2 tm0? -63.92 111.32 2.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.742 -0.599 . . . . 0.0 110.926 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 102.12 9.97 40.73 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 51.9 m -84.74 111.79 19.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.225 -1.162 . . . . 0.0 110.514 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 20.1 t -76.74 115.32 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.277 1.037 . . . . 0.0 109.732 -177.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 10.8 m -111.9 176.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 56.0 m -131.9 129.19 40.01 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.5 mt -103.41 117.41 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 61.4 p -120.3 132.92 55.51 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.26 151.92 38.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.006 -1.059 . . . . 0.0 110.589 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -144.82 122.84 12.07 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.456 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 159.55 -158.61 29.77 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.02 -1.562 . . . . 0.0 111.596 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.07 -51.7 68.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.049 -0.677 . . . . 0.0 112.524 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.649 ' N ' ' HG ' ' B' ' 331' ' ' SER . 91.7 m-20 -109.65 13.59 23.76 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.796 -1.19 . . . . 0.0 111.047 -177.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -44.39 -36.68 2.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.033 -1.042 . . . . 0.0 111.278 -178.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . 0.533 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 78.1 mt-30 -70.02 -41.7 73.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.855 -1.153 . . . . 0.0 109.816 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -68.06 -49.52 60.85 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.685 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' B' ' 374' ' ' VAL . . . -50.18 -74.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.325 -0.86 . . . . 0.0 110.95 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' B' ' 373' ' ' ALA . 38.9 t -44.1 -40.01 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -65.46 -45.76 82.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.793 -1.192 . . . . 0.0 110.171 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -80.41 -43.42 21.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.945 -1.097 . . . . 0.0 110.132 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 98.6 mt -59.99 -37.77 80.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.081 -1.012 . . . . 0.0 108.872 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 30.7 t -61.32 -40.96 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.088 -1.008 . . . . 0.0 108.8 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' B' ' 383' ' ' GLU . 62.0 mttp -67.92 -55.32 13.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.849 -1.157 . . . . 0.0 108.21 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 59.6 tp -57.82 -36.26 72.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.008 -1.057 . . . . 0.0 109.285 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 38.1 ttm -74.56 -41.53 60.38 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.99 -10.0 59.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.27 -0.894 . . . . 0.0 109.415 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' B' ' 379' ' ' LYS . 71.3 mm-40 -108.19 10.43 27.92 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.512 -0.742 . . . . 0.0 110.966 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 16.6 mt -66.19 109.55 2.67 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.416 -1.428 . . . . 0.0 109.181 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.499 1.98 0 CA-C-O 118.003 -0.999 . . . . 0.0 108.927 179.524 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.136 -0.69 . . . . 3.19 109.136 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.7 mt -110.07 126.82 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.481 -0.762 . . . . 1.71 109.125 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.3 m -130.01 138.6 50.88 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.092 -0.707 . . . . 1.66 109.092 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.49 -161.92 19.43 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.221 -1.552 . . . . 1.05 109.221 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.7 mt -89.54 -18.55 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -1.211 . . . . 1.59 109.877 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 5' ' ' ILE . 62.6 tp 51.02 103.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.348 -0.845 . . . . 1.47 109.69 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.94 -29.39 12.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.254 -0.904 . . . . 1.39 109.037 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 64.8 m -119.67 115.87 33.5 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.513 -0.742 . . . . 2.09 109.47 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.64 146.46 16.89 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.029 1.819 . . . . 0.91 112.249 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 151.18 -152.13 23.98 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.878 -1.689 . . . . 0.92 108.878 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.5 mt -150.31 151.52 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 120.768 -1.43 . . . . 1.35 108.801 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.1 150.83 32.25 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.908 -1.12 . . . . 1.14 110.545 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -133.74 125.32 28.31 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.821 -1.178 . . . . 0.7 107.821 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.52 177.39 47.15 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 118.476 -1.821 . . . . 0.58 110.999 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 157' ' ' ILE . 85.2 mttt -79.87 160.02 26.21 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.831 -0.805 . . . . 2.63 108.905 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -105.44 134.89 47.81 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.355 -0.841 . . . . 1.27 111.527 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.1 tp -101.48 138.72 38.12 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.352 -1.351 . . . . 1.41 107.352 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.8 tp -118.64 124.9 48.53 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.156 -0.965 . . . . 1.49 110.199 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.8 mt -93.14 103.45 15.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.8 -0.563 . . . . 1.52 110.189 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.422 ' HZ1' ' CB ' ' A' ' 20' ' ' LYS . 9.3 mtpm? -98.66 133.06 43.52 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.388 -0.967 . . . . 3.17 108.388 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -130.07 128.23 41.5 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.62 -0.882 . . . . 3.0 108.62 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -75.46 149.83 38.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 2.77 109.901 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -69.13 143.12 54.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.486 -0.758 . . . . 2.94 108.992 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.2 mt -80.13 131.28 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 1.46 109.387 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 56.0 t -97.27 125.08 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.25 -0.906 . . . . 1.7 109.542 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.0 mt -107.9 135.32 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.434 -0.791 . . . . 1.54 108.921 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -93.87 121.13 35.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.12 -0.988 . . . . 1.81 109.699 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.473 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.8 mmt-85 -89.1 2.12 54.58 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.512 -0.742 . . . . 3.23 110.228 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -67.48 149.5 50.11 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.93 -1.106 . . . . 3.29 109.356 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -93.01 149.77 20.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.164 -0.96 . . . . 2.8 109.596 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 pt -96.44 167.7 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.213 -0.929 . . . . 1.43 110.246 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 61.8 p -100.66 176.2 5.39 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.484 -0.932 . . . . 1.54 108.484 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.85 76.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.156 -0.965 . . . . 1.6 110.695 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -58.05 -27.92 64.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.687 -1.258 . . . . 2.56 109.697 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -81.68 -11.01 59.25 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.34 -0.85 . . . . 2.36 109.808 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.5 t -62.91 -51.89 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.003 -1.061 . . . . 1.43 108.95 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.91 -40.11 96.59 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.247 -0.908 . . . . 1.77 110.113 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -66.28 -40.08 89.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.005 -1.059 . . . . 3.32 110.579 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -67.91 -40.07 83.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.778 -1.201 . . . . 1.51 110.302 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.04 -45.26 95.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 120.648 -1.283 . . . . 1.41 108.297 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -58.28 -39.9 80.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.997 -1.064 . . . . 1.81 108.594 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.433 HH11 ' HG2' ' A' ' 42' ' ' ARG . 44.5 mtt-85 -59.93 -43.68 94.81 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.287 -1.375 . . . . 3.26 107.287 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -63.5 -45.78 89.09 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.522 -0.736 . . . . 0.81 109.254 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.05 -50.08 75.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 1.59 108.567 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.7 t -63.45 -44.1 95.5 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.483 -0.887 . . . . 1.38 108.852 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.08 -43.33 99.57 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.859 -1.696 . . . . 0.87 108.859 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -67.44 -32.7 73.73 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.427 -1.043 . . . . 3.62 108.323 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.416 ' O ' ' OG ' ' A' ' 51' ' ' SER . . . -59.55 -40.99 89.06 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.508 -0.745 . . . . 1.43 109.348 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 34.6 ttpt -68.91 -74.73 0.12 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.953 -1.092 . . . . 3.08 108.447 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.1 -35.08 0.14 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.346 -0.846 . . . . 1.33 111.504 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 48' ' ' ALA . 95.5 p -57.46 -56.63 19.33 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.55 -1.26 . . . . 1.85 108.586 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.03 -40.74 75.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.419 -0.8 . . . . 1.35 111.413 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.41 -40.04 95.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.633 -1.292 . . . . 2.34 110.889 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.18 -40.01 93.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.848 -1.158 . . . . 2.2 109.367 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -60.01 -37.46 79.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 1.35 109.834 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.24 -40.55 96.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.078 -1.014 . . . . 1.34 110.198 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.407 HD12 HH22 ' A' ' 136' ' ' ARG . 96.8 mt -62.11 -39.94 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.25 -0.906 . . . . 1.26 109.58 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -59.5 -50.0 75.63 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.457 -0.777 . . . . 1.7 109.577 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.3 m -59.37 -39.5 83.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.99 -1.069 . . . . 1.35 110.097 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -64.35 -38.37 90.8 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.09 -1.006 . . . . 2.08 109.247 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.46 -43.98 92.52 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.594 -0.691 . . . . 1.21 109.915 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.24 -50.04 66.08 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.836 -1.173 . . . . 0.75 110.174 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.13 -45.54 80.71 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.228 -1.16 . . . . 1.59 109.708 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.9 m -72.56 -57.9 3.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.327 -0.858 . . . . 1.41 112.306 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -94.81 -54.35 3.51 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.8 -1.187 . . . . 0.79 111.09 -177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.35 -169.18 25.54 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 119.692 -1.242 . . . . 1.22 111.464 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.07 -28.78 66.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 122.043 -0.681 . . . . 5.81 111.145 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.448 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 50.8 tp10 -61.47 -34.86 76.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.066 -1.021 . . . . 3.37 110.516 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -99.46 -21.01 16.15 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.202 -0.936 . . . . 2.37 110.22 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -66.84 -42.61 85.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.115 -0.991 . . . . 1.65 110.314 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.21 -32.21 73.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.514 -0.741 . . . . 1.42 110.53 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.1 -42.49 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.996 -1.065 . . . . 1.43 109.987 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -71.56 -34.19 69.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.977 -1.077 . . . . 1.08 109.951 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -59.94 -39.81 86.8 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.228 -0.92 . . . . 1.37 109.284 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.45 -42.31 97.64 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.209 -1.557 . . . . 0.67 109.209 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -60.25 -41.42 93.15 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.357 -1.084 . . . . 1.99 108.893 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.8 mt -70.03 -45.44 76.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.239 -0.913 . . . . 1.22 109.45 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.6 ttp -60.25 -40.6 90.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.111 -0.993 . . . . 2.11 109.935 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.2 tp -67.26 -39.3 86.09 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.256 -0.902 . . . . 1.33 109.198 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.41 -39.94 92.57 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.039 -0.726 . . . . 1.29 109.039 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -83.07 5.81 21.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.316 -0.865 . . . . 1.47 109.585 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -49.83 130.36 21.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.219 -0.926 . . . . 1.47 109.428 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.16 -21.32 61.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.381 -0.824 . . . . 1.78 111.699 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.13 -33.02 69.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.623 -1.298 . . . . 2.53 108.878 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.7 mt -70.42 -40.74 73.65 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.488 0.661 . . . . 1.36 109.827 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.13 -49.66 76.76 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.449 -0.782 . . . . 1.42 109.827 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -69.97 -41.16 74.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.407 -0.808 . . . . 2.27 111.243 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.05 -39.97 75.39 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.934 -1.104 . . . . 1.57 111.682 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.08 -44.37 81.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 120.831 -1.168 . . . . 1.19 109.767 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.03 -38.6 75.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.403 -0.811 . . . . 1.39 110.131 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.5 -45.06 88.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.272 -0.892 . . . . 1.39 111.672 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 66.3 mt -61.57 -45.97 91.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.706 -1.247 . . . . 1.5 109.56 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 57.1 mt -61.36 -47.66 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.906 0.86 . . . . 1.29 109.082 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -70.04 -40.0 75.41 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.039 -0.664 . . . . 2.64 110.652 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -81.46 -61.55 1.9 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.039 -1.038 . . . . 1.65 112.116 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -82.2 0.54 40.67 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.097 -1.002 . . . . 2.5 111.68 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 57.17 37.8 28.59 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.132 -0.98 . . . . 1.88 109.923 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 79.7 mtp -90.85 166.97 12.79 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.63 -0.668 . . . . 1.71 109.499 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.2 p -80.89 161.88 24.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.948 . . . . 1.61 109.274 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.31 -39.93 85.95 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.256 -0.902 . . . . 1.33 109.581 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -68.45 -37.38 80.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.268 -0.895 . . . . 2.07 109.42 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.56 -45.56 21.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 1.37 109.445 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.43 -48.89 75.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.486 -0.759 . . . . 1.14 109.766 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.08 -36.0 76.42 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 1.26 109.284 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.544 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 84.5 t60 -59.96 -40.71 89.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.381 -0.824 . . . . 2.02 109.511 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -65.04 -40.53 94.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.334 -0.854 . . . . 1.33 111.149 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.34 -57.19 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.085 -1.01 . . . . 1.3 111.767 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.5 mm -66.92 -40.04 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.82 -1.175 . . . . 1.32 109.01 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.544 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 88.0 tt0 -63.11 -40.09 96.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 2.44 108.678 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.28 -52.61 50.54 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.504 -0.855 . . . . 0.99 110.987 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -62.8 -48.95 76.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.803 -1.41 . . . . 1.97 109.375 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.35 88.79 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.16 -0.962 . . . . 1.43 109.014 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.2 m -59.97 -40.26 88.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.1 -1.0 . . . . 2.12 108.876 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.85 87.26 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.255 -0.903 . . . . 1.64 109.116 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.8 mt -64.84 -39.97 94.43 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.873 -1.142 . . . . 1.93 108.774 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -59.23 -30.92 68.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.054 -1.029 . . . . 2.2 109.306 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.0 -27.54 66.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.105 -0.997 . . . . 2.12 108.514 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 28.4 mt -62.32 143.76 56.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 2.34 109.283 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -97.42 52.57 1.12 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.154 -0.966 . . . . 3.23 109.531 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -136.12 133.05 36.86 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.252 -0.905 . . . . 2.49 109.811 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 45.1 mp0 -70.04 -30.72 68.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.367 -0.833 . . . . 3.95 110.061 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.459 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.9 t80 -69.9 -38.06 76.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.195 -0.941 . . . . 2.25 110.091 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.1 mt -77.57 -39.81 44.47 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.094 -1.004 . . . . 2.27 109.788 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -61.58 -43.72 98.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.96 . . . . 3.31 110.445 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -67.12 -41.09 86.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.92 -1.112 . . . . 2.73 109.755 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.577 ' CD ' HE22 ' B' ' 351' ' ' GLN . 27.4 ttp180 -60.08 -40.03 88.12 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.779 -1.193 . . . . 3.2 107.779 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.81 -23.14 67.12 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.418 -0.956 . . . . 1.66 108.418 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.9 -40.02 87.35 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.606 -1.257 . . . . 1.67 107.606 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -66.75 -40.42 88.28 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.008 -0.677 . . . . 1.55 109.916 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 59.5 t -62.4 -40.0 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.933 -1.104 . . . . 1.32 108.437 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.472 HH11 ' HG2' ' A' ' 131' ' ' ARG . 9.1 ttt-85 -63.37 -36.22 82.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.414 -0.804 . . . . 3.58 109.931 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.36 -40.15 85.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.224 -0.922 . . . . 1.46 109.59 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.94 -43.18 91.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.038 -1.039 . . . . 1.22 108.805 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.43 -45.37 96.53 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.678 -0.969 . . . . 0.61 110.678 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -60.03 -44.68 94.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -1.23 . . . . 3.1 110.831 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.407 HH22 HD12 ' A' ' 57' ' ' ILE . 60.2 mtp180 -69.22 -34.88 75.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.482 -1.386 . . . . 3.71 110.157 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.7 tp -59.8 -45.25 92.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.149 -0.969 . . . . 1.87 109.731 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.57 -39.84 92.59 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.119 -0.988 . . . . 1.29 108.87 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -67.2 -39.8 86.4 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.62 -0.675 . . . . 3.05 110.238 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -68.62 -25.54 64.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.137 -0.977 . . . . 1.26 111.383 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.72 -43.64 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.334 -1.479 . . . . 1.34 108.36 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.5 mt -69.94 -31.16 68.76 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.752 -0.592 . . . . 1.6 109.918 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.53 36.95 7.18 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.074 -1.61 . . . . 0.96 109.074 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 56.7 tp -73.2 143.0 47.35 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.432 -1.04 . . . . 1.67 109.229 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -60.7 144.98 51.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.369 -0.832 . . . . 4.96 109.877 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.2 mt -114.88 121.31 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.29 -1.004 . . . . 1.68 108.29 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.425 HG22 HD11 ' A' ' 147' ' ' ILE . 16.9 mm -52.98 -52.17 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.568 -0.707 . . . . 2.14 110.409 -177.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.8 t0 66.01 102.46 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.779 -0.822 . . . . 1.5 108.779 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.1 mt -73.34 -1.77 19.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.538 -0.726 . . . . 1.39 110.45 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.3 p -80.01 -11.54 59.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.899 -1.126 . . . . 1.83 109.343 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -88.37 21.05 3.01 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.615 -0.678 . . . . 1.46 111.448 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 48.9 mt -92.74 111.72 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.771 -1.205 . . . . 1.42 108.734 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -100.11 -8.45 23.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.195 -0.94 . . . . 2.94 111.165 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -117.22 147.43 42.51 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.152 -0.967 . . . . 1.52 110.176 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.38 131.35 46.95 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.979 -0.749 . . . . 1.58 108.979 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -152.42 164.72 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.506 -0.746 . . . . 1.32 109.515 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 15' ' ' LYS . 97.0 mt -92.62 152.37 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 105.384 -2.08 . . . . 1.27 105.384 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.9 tp -101.23 120.07 39.69 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.976 -1.077 . . . . 1.41 111.131 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.51 129.93 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.898 -0.779 . . . . 1.23 108.898 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.03 163.44 36.37 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.37 -0.974 . . . . 1.32 108.37 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.07 -36.69 75.14 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.416 -1.427 . . . . 1.49 108.223 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -170.54 146.35 2.74 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.889 -0.782 . . . . 2.25 108.889 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.7 mt -115.09 131.18 57.01 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.309 -0.869 . . . . 1.35 110.382 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.4 p -93.4 151.75 40.49 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.467 -0.771 . . . . 1.56 109.226 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -39.76 -36.43 1.23 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 122.118 1.878 . . . . 0.87 112.52 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.3 m -58.12 -45.16 87.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 1.36 109.221 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -69.94 -42.6 73.02 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.096 -1.003 . . . . 1.61 109.991 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 27.5 p -57.42 -16.1 8.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.198 -0.939 . . . . 1.21 110.731 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.66 -51.8 5.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.827 -1.171 . . . . 1.21 110.043 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -85.39 42.18 0.94 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.001 -1.111 . . . . 2.11 108.001 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.7 tp -109.99 132.8 53.83 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.704 -0.851 . . . . 1.29 108.704 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.445 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 0.8 OUTLIER -91.23 108.52 19.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.226 -0.921 . . . . 2.81 109.285 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.75 -43.63 98.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.469 -0.77 . . . . 2.09 110.99 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -64.53 -23.58 67.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.924 -1.11 . . . . 2.86 111.957 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -93.58 -11.11 32.56 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.689 -1.257 . . . . 2.39 109.794 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 98.8 t -110.05 118.89 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.186 -0.946 . . . . 1.27 109.413 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.1 mt -89.87 6.38 42.13 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.142 -0.973 . . . . 2.17 111.248 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.22 170.11 37.8 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.169 -1.572 . . . . 0.52 109.169 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -132.67 128.88 37.96 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.269 -1.136 . . . . 0.55 109.901 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 98.4 mt -132.17 125.11 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.727 -0.842 . . . . 1.27 108.727 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.1 p -143.21 157.94 44.06 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.22 -0.925 . . . . 1.39 110.625 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 183' ' ' ALA . 1.1 m-20 -99.2 22.69 10.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.557 -0.715 . . . . 2.46 109.803 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.513 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -45.41 -175.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.41 1.1 . . . . 1.51 112.586 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.71 -54.59 4.89 Favored Glycine 0 N--CA 1.492 2.412 0 O-C-N 121.527 -0.733 . . . . 2.23 111.315 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -149.97 -161.84 10.11 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 120.631 -1.511 . . . . 2.23 111.278 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.425 ' O ' ' OG ' ' A' ' 191' ' ' SER . 41.1 ttp180 -80.01 -9.87 59.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.789 -0.83 . . . . 6.44 110.205 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 64.0 p -79.94 4.85 15.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.97 . . . . 4.09 109.85 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 191' ' ' SER . 47.7 t -71.57 134.46 46.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.265 -0.897 . . . . 2.2 110.81 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -41.3 -60.84 1.15 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.528 0.68 . . . . 1.15 110.758 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.7 t -51.12 -33.65 27.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.189 -0.944 . . . . 2.01 110.452 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 188' ' ' SER . 28.0 p -60.0 -40.12 88.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.973 -1.08 . . . . 1.93 109.689 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.5 -40.09 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.823 . . . . 2.2 110.176 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 35.1 mtm -59.89 -49.27 78.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.808 -1.182 . . . . 1.32 110.494 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.08 -44.17 94.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.753 -1.217 . . . . 1.3 110.626 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -60.03 -52.07 66.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 3.38 110.459 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.2 m -70.94 -33.58 70.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.125 -0.984 . . . . 1.15 110.723 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.04 -22.99 59.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.018 -1.051 . . . . 1.28 109.652 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 66.45 52.37 1.07 Allowed 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.576 0.703 . . . . 1.5 110.543 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.414 ' O ' ' CB ' ' A' ' 8' ' ' SER . 62.9 mt -127.28 132.31 24.26 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 107.722 -1.214 . . . . 1.37 107.722 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -43.45 134.35 6.83 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.805 1.67 . . . . 0.76 112.317 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -166.85 145.35 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.71 -1.196 . . . . 1.19 111.824 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.5 mt -123.16 145.67 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.403 -1.332 . . . . 1.31 107.403 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.1 m -129.7 -12.24 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 120.795 -1.191 . . . . 1.38 111.143 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.72 24.86 22.72 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 110.06 -1.216 . . . . 1.03 110.06 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.427 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 6.3 p -46.32 -42.29 14.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.059 -1.259 . . . . 1.38 110.04 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.78 -57.36 4.66 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.947 -1.121 . . . . 1.17 111.308 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 24.5 m -150.8 32.78 0.61 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.56 -1.553 . . . . 2.07 111.786 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.0 t -70.15 -44.63 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.796 -1.19 . . . . 1.35 109.134 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.0 p -50.59 -29.96 12.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.54 -0.725 . . . . 1.49 111.33 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 29.6 t -69.97 -27.13 64.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.723 -1.236 . . . . 2.16 109.844 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -96.94 -7.02 34.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.151 -0.968 . . . . 2.89 110.53 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 73.8 t -105.93 132.15 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.249 -0.907 . . . . 1.33 110.912 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.439 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 9.9 mtpt -120.12 149.54 42.05 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.621 -1.252 . . . . 2.73 107.621 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.469 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 23.6 p-10 -50.07 138.65 15.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.11 -0.994 . . . . 2.7 111.326 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.469 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 8.3 t0 82.3 5.44 1.07 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 116.165 -0.47 . . . . 2.38 110.538 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 91.9 m-20 -77.56 143.49 38.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.965 -1.084 . . . . 2.09 108.877 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -92.28 119.93 32.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.183 -0.948 . . . . 1.45 108.587 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 86.4 mt -127.21 146.6 50.35 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.41 -0.806 . . . . 1.31 110.636 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.2 mt -118.75 129.28 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 107.193 -1.41 . . . . 1.29 107.193 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.6 tp -104.1 119.93 40.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.107 -0.995 . . . . 1.31 108.787 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.597 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 21.6 p-10 -79.78 -39.09 31.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.214 -0.929 . . . . 2.31 109.114 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 47.69 16.61 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.782 -0.822 . . . . 1.19 108.782 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 221' ' ' ASP . 47.6 t -126.28 -38.76 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.526 -1.287 . . . . 1.45 107.526 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -109.81 -1.1 18.08 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.797 -1.186 . . . . 3.13 107.797 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 61.45 49.97 4.92 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.369 0.604 . . . . 2.2 109.935 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.597 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 27.4 mt-30 -137.64 153.34 49.88 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.573 -0.705 . . . . 2.32 109.305 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.93 128.87 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.144 -0.687 . . . . 1.4 109.144 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -103.05 122.44 44.65 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.784 -1.191 . . . . 1.29 107.784 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.8 t -101.04 111.86 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.429 -0.794 . . . . 1.38 110.89 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 42.8 t30 49.96 63.5 10.02 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.318 -0.864 . . . . 2.33 110.318 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.4 150.2 15.1 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.705 2.27 . . . . 0.95 111.9 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 68.1 p -67.47 163.74 20.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.142 -0.974 . . . . 2.31 110.131 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -60.18 -40.2 89.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.5 -0.75 . . . . 3.45 110.19 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -62.05 -34.57 76.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -0.917 . . . . 2.89 109.997 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.78 -39.99 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.343 -0.848 . . . . 1.73 109.299 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 236' ' ' ILE . 89.7 mt . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 1.57 109.404 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 44.4 ttp . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.407 0.622 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -154.6 151.8 29.26 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -146.8 158.52 43.93 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.042 -1.036 . . . . 0.0 110.354 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . 0.495 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 7.4 tm0? -149.53 145.22 26.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.461 -0.774 . . . . 0.0 108.977 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . 0.495 ' N ' ' CD ' ' B' ' 304' ' ' GLN . 93.4 mt-10 -111.69 131.13 55.5 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.16 -0.963 . . . . 0.0 110.09 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 1.2 p -130.17 120.84 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.799 0.809 . . . . 0.0 111.31 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 86.3 m -73.88 113.88 11.55 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.217 1.008 . . . . 0.0 110.563 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 60.9 mt -57.95 115.78 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 122.623 1.201 . . . . 0.0 111.317 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 67.5 p -111.72 19.95 17.54 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.643 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.95 124.4 90.67 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.888 -1.132 . . . . 0.0 109.206 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -55.27 -18.38 18.27 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 CA-C-N 120.154 1.091 . . . . 0.0 112.921 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -121.32 10.1 10.51 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.293 -0.879 . . . . 0.0 110.027 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.85 -178.21 40.31 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.459 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -87.11 93.65 9.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.151 -1.205 . . . . 0.0 110.301 -178.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -96.37 -160.63 0.81 Allowed 'General case' 0 N--CA 1.509 2.496 0 O-C-N 120.662 -1.274 . . . . 0.0 110.134 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 13.6 m -58.73 -45.05 90.48 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.93 -1.106 . . . . 0.0 112.064 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.464 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.4 tpt180 -53.13 -62.43 3.49 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 120.564 -1.335 . . . . 0.0 111.127 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -57.25 -32.7 94.38 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 CA-C-N 120.135 1.084 . . . . 0.0 112.184 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.85 76.07 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.488 -0.885 . . . . 0.0 108.901 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.46 -45.49 76.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.459 -0.775 . . . . 0.0 110.474 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . 0.644 HE22 ' NZ ' ' B' ' 324' ' ' LYS . 94.0 mm-40 -70.13 -40.04 75.08 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.879 -1.138 . . . . 0.0 108.641 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -61.07 -51.81 67.57 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.596 -0.69 . . . . 0.0 110.643 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . 0.555 ' CG1' ' HZ1' ' B' ' 327' ' ' LYS . 75.4 t -70.21 -33.1 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.775 -1.203 . . . . 0.0 110.017 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . 0.644 ' NZ ' HE22 ' B' ' 321' ' ' GLN . 32.3 ttpt -60.04 -46.36 89.78 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 108.878 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -62.32 -45.33 93.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.169 -0.957 . . . . 0.0 109.819 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.91 -50.93 71.84 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.207 -0.933 . . . . 0.0 110.742 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . 0.555 ' HZ1' ' CG1' ' B' ' 323' ' ' VAL . 42.4 mttp -55.96 -14.37 2.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.981 -1.074 . . . . 0.0 109.456 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -68.99 -30.04 72.31 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -104.67 145.06 30.87 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.333 -1.098 . . . . 0.0 109.096 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 37.9 p -90.63 -11.8 38.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.017 -1.052 . . . . 0.0 109.547 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 331' ' ' SER . . . . . 0.404 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 81.1 p -60.01 153.4 21.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -0.844 . . . . 0.0 109.568 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -71.12 132.94 45.8 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.178 -0.951 . . . . 0.0 108.701 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.6 mt -129.78 129.95 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.669 -0.644 . . . . 0.0 109.458 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 30.6 m -126.61 150.05 49.13 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 92.1 t -115.15 137.47 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 56.7 m -130.07 122.57 28.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.281 -0.887 . . . . 0.0 109.157 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 83.1 p -136.1 119.5 16.86 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.805 0.812 . . . . 0.0 110.215 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 36.27 61.08 0.82 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.76 -15.34 20.69 Favored Glycine 0 N--CA 1.499 2.834 0 O-C-N 120.608 -1.307 . . . . 0.0 113.129 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -108.28 119.57 39.86 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 119.463 1.631 . . . . 0.0 109.642 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 66.1 m -118.74 142.24 47.88 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.812 0.815 . . . . 0.0 110.168 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.19 163.21 33.57 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.572 0.701 . . . . 0.0 109.779 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 4.7 t -87.97 140.01 29.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.475 -0.766 . . . . 0.0 109.318 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.449 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -82.35 -10.0 59.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.937 -1.102 . . . . 0.0 110.157 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -90.26 22.18 3.45 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.449 ' H ' ' C ' ' B' ' 344' ' ' ALA . 48.1 t -149.72 99.51 2.87 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.611 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.83 -31.89 70.15 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -59.87 -54.54 44.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.009 -1.057 . . . . 0.0 110.031 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -68.98 -24.1 64.19 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.079 -1.013 . . . . 0.0 111.717 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' B' ' 352' ' ' THR . 82.6 mt -68.01 -51.76 43.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.386 -1.446 . . . . 0.0 108.191 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.577 HE22 ' CD ' ' A' ' 126' ' ' ARG . 61.8 mm-40 -39.06 -26.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.65 -178.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.43 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.9 p -79.88 -7.07 58.52 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.69 -1.256 . . . . 0.0 110.717 -177.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 60.5 mt -92.52 109.33 20.73 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.956 -1.09 . . . . 0.0 109.308 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.53 88.82 0.62 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.7 mt -97.24 90.13 5.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.219 -1.166 . . . . 0.0 109.165 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 28.9 p -96.4 142.81 28.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.096 -1.002 . . . . 0.0 110.076 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -44.99 119.98 2.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.695 -0.628 . . . . 0.0 110.187 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 114.44 -3.95 23.39 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 52.4 m -99.17 129.75 45.44 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.424 -1.044 . . . . 0.0 109.084 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 13.8 t -92.44 134.79 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 119.773 -1.829 . . . . 0.0 109.109 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 29.8 m -112.07 174.98 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 30.3 m -131.13 127.88 38.98 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 84.2 mt -100.91 114.26 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 88.3 p -119.89 132.81 55.66 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.521 -0.737 . . . . 0.0 109.035 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.28 154.45 41.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.352 -0.842 . . . . 0.0 109.494 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -146.64 124.49 11.95 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 159.52 -158.58 29.74 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 118.798 -1.668 . . . . 0.0 111.59 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -60.04 -53.67 55.05 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.404 ' H ' ' HB3' ' B' ' 331' ' ' SER . 95.8 m-20 -110.51 9.98 23.17 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.98 -1.075 . . . . 0.0 110.897 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -42.08 -32.29 0.45 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.234 -0.916 . . . . 0.0 111.634 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -69.98 -39.77 75.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.737 -1.227 . . . . 0.0 109.849 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -68.75 -52.26 32.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.959 . . . . 0.0 109.326 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.8 -32.94 6.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.394 -0.816 . . . . 0.0 111.248 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 84.2 t -75.74 -39.33 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.611 -1.305 . . . . 0.0 109.615 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.59 -49.86 75.83 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.346 -0.846 . . . . 0.0 111.804 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -77.46 -41.37 39.9 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.888 -1.132 . . . . 0.0 111.514 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' B' ' 381' ' ' MET . 87.9 mt -60.09 -41.43 92.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.724 -1.235 . . . . 0.0 108.543 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.46 -46.12 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.285 -0.884 . . . . 0.0 109.22 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' B' ' 383' ' ' GLU . 65.6 mttm -69.99 -55.81 8.61 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 58.7 tp -57.64 -35.85 71.05 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.527 -0.733 . . . . 0.0 109.645 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 381' ' ' MET . . . . . 0.429 ' N ' ' O ' ' B' ' 377' ' ' LEU . 34.7 ttm -71.25 -40.04 71.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.387 -1.446 . . . . 0.0 108.016 177.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -79.07 -7.66 58.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.705 -0.622 . . . . 0.0 110.613 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' B' ' 379' ' ' LYS . 76.8 mm-40 -111.88 2.96 17.27 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.063 -1.023 . . . . 0.0 111.269 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 22.5 mt -96.19 126.6 41.53 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.667 -1.27 . . . . 0.0 109.508 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.896 -1.05 . . . . 0.0 109.246 179.471 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.179 0.514 . . . . 3.19 109.805 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 225' ' ' ASN . 88.1 mt -110.05 130.01 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.429 -0.794 . . . . 1.71 109.26 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.1 m -127.47 129.34 47.28 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.584 -0.697 . . . . 1.66 109.629 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.624 ' N ' HD22 ' A' ' 225' ' ' ASN . . . -113.93 -160.48 13.66 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 108.814 -1.714 . . . . 1.05 108.814 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.5 mt -88.85 -17.26 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.985 -1.303 . . . . 1.59 109.943 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.3 tp 55.4 105.46 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.291 -0.881 . . . . 1.47 108.828 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.64 -24.82 16.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.141 -0.974 . . . . 1.39 109.672 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.8 t -142.52 127.46 10.14 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.283 -0.886 . . . . 2.09 109.853 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.92 143.13 17.99 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.908 1.739 . . . . 0.91 111.624 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 167.64 -168.89 40.9 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.312 -1.515 . . . . 0.92 109.312 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.408 HD12 HG22 ' A' ' 11' ' ' ILE . 79.6 mt -149.14 126.77 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.352 -1.087 . . . . 1.35 108.222 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.99 149.76 43.63 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.958 -1.089 . . . . 1.14 111.025 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 3.0 m-85 -124.66 129.94 51.49 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.733 -1.21 . . . . 0.7 107.733 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.81 177.32 47.88 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 118.695 -1.717 . . . . 0.58 111.02 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -78.48 157.94 28.76 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.707 -0.878 . . . . 2.63 109.289 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.34 126.09 51.8 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.336 -0.852 . . . . 1.27 110.873 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.4 tp -97.27 138.02 35.4 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.378 -1.341 . . . . 1.41 107.378 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 39.5 tp -116.6 123.31 47.02 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.247 -0.908 . . . . 1.49 109.448 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.2 mt -88.06 106.66 18.3 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.556 0.693 . . . . 1.52 110.55 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -98.77 133.66 42.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.485 -0.759 . . . . 3.17 109.281 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -128.86 128.24 43.46 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.275 -0.891 . . . . 3.0 108.853 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -79.01 153.68 30.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.969 . . . . 2.77 110.067 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -73.78 140.91 46.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.282 -0.886 . . . . 2.94 108.769 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.7 mt -80.02 132.48 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.958 . . . . 1.46 108.83 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.9 t -95.65 122.35 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.321 -0.862 . . . . 1.7 108.995 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.9 mt -105.3 138.68 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.538 -0.726 . . . . 1.54 109.09 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -87.82 123.4 32.56 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.163 -0.961 . . . . 1.81 109.712 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -93.04 2.79 56.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.886 . . . . 3.23 109.833 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -69.98 149.77 47.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.059 -1.026 . . . . 3.29 110.077 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -87.93 144.03 26.78 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.384 -0.969 . . . . 2.8 108.384 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 pt -90.36 164.33 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.845 -1.159 . . . . 1.43 109.947 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.0 p -93.64 170.83 9.29 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.993 -1.114 . . . . 1.54 107.993 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.94 -48.27 82.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.764 -1.21 . . . . 1.6 109.222 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 62.8 t0 -54.13 -30.16 47.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.997 -1.064 . . . . 2.56 109.68 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -81.26 -9.09 59.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.358 -0.838 . . . . 2.36 110.362 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -65.6 -55.18 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.543 -1.348 . . . . 1.43 109.042 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -39.93 87.64 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.352 -0.843 . . . . 1.77 109.81 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.38 -41.78 76.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 3.32 111.033 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -64.25 -40.14 95.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.693 -1.255 . . . . 1.51 110.179 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.09 -44.66 95.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.79 -1.194 . . . . 1.41 107.993 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -59.97 -40.1 87.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 1.81 108.321 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.454 HH11 ' HG2' ' A' ' 42' ' ' ARG . 20.6 mtt-85 -59.96 -44.33 94.49 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.489 -1.3 . . . . 3.26 107.489 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -60.88 -47.62 85.53 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.601 -0.889 . . . . 0.81 108.601 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.01 -47.15 87.01 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.247 -1.02 . . . . 1.59 108.247 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.7 t -59.95 -41.44 91.88 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.322 -0.992 . . . . 1.38 108.322 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.61 -42.9 99.84 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.363 -1.895 . . . . 0.87 108.363 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -65.54 -38.81 90.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.121 -1.066 . . . . 3.62 108.121 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.02 -42.8 77.05 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.885 -0.51 . . . . 1.43 109.734 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.3 ttpt -71.19 -74.4 0.15 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.999 -1.111 . . . . 3.08 107.999 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.27 -38.78 0.37 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.267 -0.896 . . . . 1.33 111.443 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.0 t -55.71 -54.92 38.42 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.393 -1.442 . . . . 1.85 108.494 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.99 -41.75 73.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.377 -0.827 . . . . 1.35 111.356 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -66.87 -40.26 87.78 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.758 -1.213 . . . . 2.34 110.521 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.3 mt -60.37 -39.96 89.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.812 -1.18 . . . . 2.2 109.067 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -61.84 -32.05 72.35 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.348 -0.845 . . . . 1.35 109.724 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.4 m -67.87 -44.75 76.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.795 -1.191 . . . . 1.34 110.124 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.5 mt -59.98 -37.98 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.127 -0.983 . . . . 1.26 108.573 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -56.6 -50.03 73.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.708 -0.62 . . . . 1.7 109.376 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 m -56.62 -31.95 64.82 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.23 -0.919 . . . . 1.35 110.332 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -69.86 -39.8 76.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 2.08 110.192 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.09 -48.33 65.81 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.526 -0.734 . . . . 1.21 109.662 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -51.51 -56.57 14.83 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 110.209 -1.157 . . . . 0.75 110.209 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.06 -42.0 73.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.127 -1.219 . . . . 1.59 111.061 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.6 m -66.09 -62.39 1.51 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.844 -1.16 . . . . 1.41 111.996 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -94.56 -45.88 7.21 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.864 -1.148 . . . . 0.79 111.239 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.73 -167.93 25.43 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.908 -1.139 . . . . 1.22 110.819 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -70.16 -23.93 63.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.863 -0.786 . . . . 5.81 110.261 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.494 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.8 tp10 -59.93 -33.39 71.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.465 -0.772 . . . . 3.37 110.086 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -98.76 -18.91 17.74 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.252 -0.905 . . . . 2.37 110.469 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -67.71 -40.06 84.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.893 -1.129 . . . . 1.65 109.83 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.49 -32.82 74.38 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.414 -0.804 . . . . 1.42 110.218 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.7 mt -59.94 -41.83 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.902 -1.124 . . . . 1.43 109.594 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -64.57 -39.84 94.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.129 -0.982 . . . . 1.08 110.881 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -60.07 -40.0 88.0 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.916 -1.115 . . . . 1.37 109.458 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.81 -47.07 92.55 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.07 -1.612 . . . . 0.67 109.07 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -61.17 -47.88 84.15 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.408 -1.054 . . . . 1.99 109.326 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 77' ' ' ILE . 96.7 mt -64.15 -48.79 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.303 -0.873 . . . . 1.22 109.788 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.4 ttp -59.97 -41.52 92.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.964 -1.085 . . . . 2.11 110.588 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.4 ' CD1' ' CE2' ' B' ' 348' ' ' PHE . 57.9 tp -65.89 -39.94 91.11 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.358 -0.839 . . . . 1.33 109.928 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.46 -40.07 95.03 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.562 -0.711 . . . . 1.29 109.663 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -82.14 5.84 18.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.057 -1.027 . . . . 1.47 110.228 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -50.03 133.21 23.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.0 . . . . 1.47 110.423 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.49 -22.58 63.69 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.606 -0.684 . . . . 1.78 110.919 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.58 -34.12 71.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.928 -1.108 . . . . 2.53 109.1 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.0 -42.11 73.49 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.388 0.613 . . . . 1.36 110.257 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.03 -50.03 75.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 1.42 110.191 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -70.28 -42.53 71.95 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.352 -0.843 . . . . 2.27 110.983 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.07 -40.11 75.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.043 -1.035 . . . . 1.57 111.068 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 84.5 mt -67.47 -49.07 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.043 -1.036 . . . . 1.19 109.451 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.4 HG21 ' HZ1' ' A' ' 94' ' ' LYS . 88.1 mt -66.25 -36.76 78.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.608 -0.683 . . . . 1.39 110.248 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.27 82.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.174 -0.954 . . . . 1.39 110.988 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 96' ' ' LYS . 93.5 mt -59.95 -45.81 91.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.051 -1.031 . . . . 1.5 110.3 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.0 mt -60.39 -49.91 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.029 -1.044 . . . . 1.29 108.833 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.4 ' HZ1' HG21 ' A' ' 90' ' ' ILE . 31.9 mttp -65.79 -45.83 80.98 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.992 -0.683 . . . . 2.64 110.525 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -79.01 -48.83 13.71 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.044 -1.035 . . . . 1.65 112.103 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 92' ' ' LEU . 96.5 mttt -92.79 -3.03 55.43 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 120.719 -1.238 . . . . 2.5 112.48 -177.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 57.32 39.73 28.22 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.788 -1.195 . . . . 1.88 109.945 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 95.2 mtp -93.5 168.1 11.26 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.61 -0.681 . . . . 1.71 110.291 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.1 p -82.67 161.12 22.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.433 -0.792 . . . . 1.61 109.663 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.72 -40.04 88.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.344 -0.848 . . . . 1.33 109.491 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.414 ' C ' ' OD1' ' A' ' 101' ' ' ASP . 39.5 t0 -63.24 -40.07 96.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.149 -0.97 . . . . 2.07 109.541 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.48 -51.21 9.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.431 -0.793 . . . . 1.37 110.35 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.02 75.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.362 -0.836 . . . . 1.14 110.444 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.03 -41.83 93.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.023 -1.048 . . . . 1.26 109.81 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -59.8 -40.19 87.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.352 -0.843 . . . . 2.02 110.141 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 110' ' ' GLY . 88.7 tt0 -64.93 -40.11 94.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 1.33 111.077 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 86.1 t -64.79 -50.46 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.001 -1.062 . . . . 1.3 110.689 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.3 mm -70.05 -40.03 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.879 -1.138 . . . . 1.32 108.387 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -65.34 -38.54 90.44 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.257 -1.016 . . . . 2.44 108.257 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -60.69 -52.91 49.53 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.106 -1.198 . . . . 0.99 110.106 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -60.73 -49.93 75.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.902 -1.352 . . . . 1.97 108.987 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.13 -39.95 88.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.372 -0.83 . . . . 1.43 109.498 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.1 m -59.94 -40.09 87.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.11 -0.994 . . . . 2.12 109.119 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.4 -39.62 87.99 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.237 -0.914 . . . . 1.64 108.876 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.0 mt -62.47 -42.8 99.74 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.273 -0.892 . . . . 1.93 109.514 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -53.99 -31.34 50.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.99 -1.069 . . . . 2.2 109.676 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.97 -24.52 64.48 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.169 -0.957 . . . . 2.12 108.526 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 54.1 mt -62.74 139.98 58.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.931 . . . . 2.34 109.235 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -96.39 45.66 1.06 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.139 -0.975 . . . . 3.23 109.737 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 41.1 t0 -133.33 143.59 49.1 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.333 -0.855 . . . . 2.49 109.182 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.495 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 77.8 mm-40 -71.56 -64.86 0.84 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.195 -1.039 . . . . 3.95 108.195 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.616 ' HH ' HH12 ' A' ' 126' ' ' ARG . 2.7 t80 -39.11 -39.97 0.64 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.023 -0.423 . . . . 2.25 110.904 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.2 mt -79.98 -40.04 28.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.61 -1.306 . . . . 2.27 108.884 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.99 -40.57 96.09 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.502 -0.925 . . . . 3.31 108.502 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.89 -34.05 73.04 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.2 -1.037 . . . . 2.73 108.2 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.616 HH12 ' HH ' ' A' ' 122' ' ' TYR . 1.9 tpt180 -59.92 -39.42 85.37 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.389 -1.337 . . . . 3.2 107.389 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.55 -25.49 66.68 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.456 0.646 . . . . 1.66 109.285 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.11 94.3 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.037 -1.098 . . . . 1.67 108.037 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.5 -40.07 85.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.759 . . . . 1.55 109.613 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.88 -40.07 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.047 -1.033 . . . . 1.32 108.904 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -60.09 -40.6 90.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.149 -0.969 . . . . 3.58 108.985 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.09 -39.05 84.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.65 -0.656 . . . . 1.46 110.832 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.9 mt -59.96 -42.87 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.919 -1.113 . . . . 1.22 110.248 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.19 -27.47 71.78 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.407 -1.477 . . . . 0.61 109.407 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -59.91 -50.0 75.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.389 -1.065 . . . . 3.1 110.301 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.447 HH11 ' HG2' ' A' ' 136' ' ' ARG . 22.2 mtt-85 -65.71 -37.89 87.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.855 -1.153 . . . . 3.71 109.98 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.5 tp -55.22 -44.25 75.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -0.915 . . . . 1.87 109.323 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.38 -39.98 89.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.24 -0.912 . . . . 1.29 109.511 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.406 HH11 ' HG2' ' A' ' 139' ' ' ARG . 51.9 mtt-85 -69.43 -39.83 77.6 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.28 -0.887 . . . . 3.05 108.831 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -64.5 -34.16 77.58 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.704 -0.623 . . . . 1.26 111.104 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.92 -45.74 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.18 -1.575 . . . . 1.34 107.788 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 99.4 mt -70.06 -37.42 75.5 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.392 0.615 . . . . 1.6 109.488 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.89 45.73 7.05 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.116 -1.993 . . . . 0.96 108.116 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.8 tp -76.51 160.05 29.82 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.532 -0.981 . . . . 1.67 109.498 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -68.54 143.83 54.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.447 -0.783 . . . . 4.96 109.823 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.421 HG22 HD11 ' A' ' 146' ' ' ILE . 86.6 mt -120.0 125.1 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 122.004 0.907 . . . . 1.68 109.188 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 148' ' ' ASP . 5.3 mt -64.86 -41.98 93.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 115.962 -0.563 . . . . 2.14 110.225 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 147' ' ' ILE . 23.4 t0 63.73 125.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.213 -1.032 . . . . 1.5 108.213 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.462 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 40.7 mt -86.17 0.47 53.55 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.105 -0.997 . . . . 1.39 110.019 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.7 p -87.29 -8.55 56.6 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.178 -0.951 . . . . 1.83 109.397 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.96 21.82 1.26 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.353 -0.842 . . . . 1.46 111.255 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 152' ' ' ILE . 32.2 mm -88.4 119.97 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.614 -1.304 . . . . 1.42 108.796 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -100.33 -9.36 22.37 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.453 -0.779 . . . . 2.94 110.687 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -130.14 152.86 49.11 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.232 -0.918 . . . . 1.52 110.499 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -63.52 133.87 54.6 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.369 -0.832 . . . . 1.58 109.218 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.1 m -152.49 164.23 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.911 -0.774 . . . . 1.32 108.911 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.1 mt -92.59 151.53 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 106.029 -1.841 . . . . 1.27 106.029 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 33.7 tp -102.56 118.89 37.83 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.992 -1.068 . . . . 1.41 110.231 -177.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 12.3 t -125.72 134.34 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.805 -0.813 . . . . 1.23 108.805 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.31 166.13 28.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.931 . . . . 1.32 108.981 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.401 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -70.08 -38.74 75.81 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.34 -1.475 . . . . 1.49 107.306 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -171.17 144.15 2.02 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.961 -0.755 . . . . 2.25 108.961 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 40.9 mt -109.79 137.08 48.1 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.267 -0.896 . . . . 1.35 109.268 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 58.7 p -87.54 149.1 45.74 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 120.993 -1.067 . . . . 1.56 108.979 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -41.71 -36.97 3.59 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.128 1.885 . . . . 0.87 112.827 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.9 m -59.94 -47.18 86.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 1.36 109.661 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.66 -43.81 97.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.915 . . . . 1.61 110.024 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 30.6 p -55.22 -26.67 41.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.266 -0.896 . . . . 1.21 111.702 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -83.19 -43.9 15.62 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.555 -1.34 . . . . 1.21 110.099 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -89.28 36.93 0.84 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.028 -1.101 . . . . 2.11 108.028 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.1 tp -103.24 133.55 48.14 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.454 0.645 . . . . 1.29 109.697 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.645 ' ND2' ' NZ ' ' A' ' 175' ' ' LYS . 2.9 p30 -82.9 99.26 9.65 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.332 -0.988 . . . . 2.81 108.332 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 90.9 mt -65.07 -42.28 94.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 2.09 110.975 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -62.68 -32.36 73.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.988 -1.07 . . . . 2.86 112.678 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.645 ' NZ ' ' ND2' ' A' ' 172' ' ' ASN . 9.4 mtmp? -92.04 -5.09 53.56 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.64 -1.287 . . . . 2.39 110.341 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 72.3 t -104.68 116.46 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.067 -1.086 . . . . 1.27 108.067 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.6 mt -85.93 7.23 25.03 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.17 -0.957 . . . . 2.17 111.326 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.45 172.86 37.24 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.128 -1.511 . . . . 0.52 109.82 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -134.3 129.34 35.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.501 -0.999 . . . . 0.55 108.87 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 93.9 mt -134.72 130.33 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.329 -0.857 . . . . 1.27 108.973 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.7 p -151.6 162.17 41.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.956 -1.09 . . . . 1.39 110.531 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 183' ' ' ALA . 38.3 p-10 -109.63 26.73 10.31 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.905 -0.776 . . . . 2.46 108.905 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -54.31 -164.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.987 -1.071 . . . . 1.51 111.64 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.07 -59.33 5.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.562 -1.015 . . . . 2.23 110.562 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -174.07 -156.8 14.2 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 118.748 -1.691 . . . . 2.23 111.22 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.519 ' C ' ' H ' ' A' ' 188' ' ' SER . 46.8 ttp180 -62.33 -30.05 70.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.923 -0.751 . . . . 6.44 110.614 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 30.6 p -61.85 5.17 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.819 -1.176 . . . . 4.09 110.692 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.782 ' HG ' ' HG ' ' A' ' 191' ' ' SER . 50.2 p -90.87 140.18 30.05 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.871 -1.143 . . . . 2.2 110.419 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -50.0 -43.47 50.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.423 -0.798 . . . . 1.15 109.672 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.8 m -56.97 -40.49 76.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.625 -0.672 . . . . 2.01 109.633 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.782 ' HG ' ' HG ' ' A' ' 188' ' ' SER . 69.9 m -60.14 -39.9 87.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.208 -0.933 . . . . 1.93 110.116 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.8 mt -60.04 -45.12 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.463 -0.773 . . . . 2.2 110.504 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 30.1 mtm -59.94 -47.61 85.08 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.88 -1.137 . . . . 1.32 110.496 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.71 -45.74 63.67 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.681 -1.262 . . . . 1.3 109.897 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -59.93 -50.33 74.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.926 -1.109 . . . . 3.38 110.994 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.1 m -77.02 -30.19 55.68 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.612 -1.305 . . . . 1.15 111.104 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.0 -29.41 66.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.741 -1.224 . . . . 1.28 108.449 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 68.49 47.98 0.87 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.277 0.561 . . . . 1.5 110.317 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 89.4 mt -128.7 149.93 73.43 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 107.865 -1.161 . . . . 1.37 107.865 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.73 138.76 85.05 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 121.925 1.75 . . . . 0.76 111.69 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -172.7 149.17 2.0 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.147 -1.021 . . . . 1.19 110.891 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.5 mt -124.99 150.41 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.173 -1.417 . . . . 1.31 107.173 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.0 -12.11 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.464 0 O-C-N 120.931 -1.106 . . . . 1.38 111.869 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -114.68 25.98 9.84 Favored Glycine 0 N--CA 1.502 3.063 0 N-CA-C 110.076 -1.21 . . . . 1.03 110.076 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 58.3 p -44.26 -47.29 9.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -1.165 . . . . 1.38 110.469 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 106.73 -51.39 0.74 Allowed Glycine 0 N--CA 1.5 2.941 0 N-CA-C 111.018 -0.833 . . . . 1.17 111.018 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 81.1 p -162.82 44.66 0.13 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.473 -1.604 . . . . 2.07 111.962 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.8 t -71.38 -41.02 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.685 -1.26 . . . . 1.35 108.513 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.3 p -50.66 -29.94 12.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.841 . . . . 1.49 109.512 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.1 m -81.92 -12.4 58.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 2.16 109.346 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -115.53 15.16 16.68 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.63 -0.669 . . . . 2.89 109.798 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 42.7 t -138.05 134.55 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.407 -0.808 . . . . 1.33 110.394 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.455 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 10.8 mptt -117.42 153.0 33.82 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.368 -1.345 . . . . 2.73 107.368 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.462 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 11.2 p30 -55.51 140.84 39.16 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.995 -1.066 . . . . 2.7 110.367 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.0 m-20 83.06 2.43 1.05 Allowed 'General case' 0 N--CA 1.502 2.147 0 CA-C-N 116.27 -0.423 . . . . 2.38 110.747 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.455 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 94.1 m-20 -74.82 141.58 44.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.743 -1.223 . . . . 2.09 109.153 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -90.69 116.42 28.55 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.933 -1.136 . . . . 1.45 107.933 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 79.9 mt -125.56 147.55 49.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.441 -0.787 . . . . 1.31 110.365 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.5 mt -115.86 129.83 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 106.627 -1.62 . . . . 1.29 106.627 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 61.0 tp -102.59 119.84 39.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.875 -1.141 . . . . 1.31 109.528 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.601 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 23.2 p-10 -76.22 -40.03 53.14 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.148 -1.056 . . . . 2.31 108.148 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.426 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 48.46 18.42 0.17 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.769 -0.826 . . . . 1.19 108.769 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.45 ' N ' ' C ' ' A' ' 221' ' ' ASP . 53.9 t -129.18 -36.66 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.953 -1.129 . . . . 1.45 107.953 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -110.07 -2.81 16.79 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.135 -1.431 . . . . 3.13 107.135 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.624 HD22 ' N ' ' A' ' 4' ' ' GLY . 27.8 t-20 63.66 51.4 2.48 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.498 0.666 . . . . 2.2 109.689 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.601 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 42.4 mt-30 -137.31 152.72 50.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.499 -0.751 . . . . 2.32 109.213 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.86 130.01 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.426 -0.953 . . . . 1.4 108.426 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -102.52 120.82 41.19 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.776 -0.824 . . . . 1.29 108.776 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.6 t -100.95 113.23 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.506 -0.746 . . . . 1.38 110.149 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 50.02 66.75 5.16 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.187 -0.946 . . . . 2.33 111.127 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -89.17 148.07 5.48 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 123.186 2.591 . . . . 0.95 112.339 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 24.8 p -70.72 166.17 21.44 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.18 -0.95 . . . . 2.31 110.744 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.666 -0.646 . . . . 3.45 109.773 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.02 -37.73 80.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.249 -0.907 . . . . 2.89 109.611 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.02 -41.84 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.169 -0.957 . . . . 1.73 109.056 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 1.57 109.932 -179.664 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 56.9 ttm . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -149.55 146.89 27.6 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.41 162.32 41.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.004 -1.06 . . . . 0.0 110.375 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -156.03 153.9 30.18 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -114.93 134.57 55.05 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.077 -1.014 . . . . 0.0 110.056 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 p -131.82 124.0 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 CA-C-O 122.173 0.987 . . . . 0.0 112.751 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 89.0 m -77.25 104.29 7.67 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.935 0.874 . . . . 0.0 110.673 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . 0.434 HD11 HG22 ' B' ' 308' ' ' ILE . 92.7 mt -52.15 124.94 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.368 1.08 . . . . 0.0 110.657 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 71.2 p -110.03 20.05 18.34 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.027 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . 0.404 ' O ' ' CG ' ' B' ' 357' ' ' GLN . . . -74.8 118.5 70.79 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.944 -1.098 . . . . 0.0 109.233 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -53.4 -16.05 6.8 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 CA-C-N 120.251 1.125 . . . . 0.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -120.28 10.08 11.2 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.558 -0.714 . . . . 0.0 109.268 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 69.29 -176.75 30.37 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.714 -1.755 . . . . 0.0 108.714 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.457 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.4 tp -85.45 89.59 7.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.055 -1.262 . . . . 0.0 110.129 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . 0.494 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 4.3 p80 -94.94 -159.97 0.75 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.981 -1.074 . . . . 0.0 109.641 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.8 m -59.73 -47.43 85.68 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.859 -1.151 . . . . 0.0 112.916 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.494 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 1.4 tpt180 -57.98 -55.89 40.43 Favored Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 120.44 -1.412 . . . . 0.0 112.223 -178.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . 0.494 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 18.1 Cg_endo -64.84 -30.21 58.41 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 CA-C-N 120.583 1.244 . . . . 0.0 111.37 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.03 75.35 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.14 -41.83 72.27 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.569 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -69.97 -43.13 72.12 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.026 -1.046 . . . . 0.0 108.615 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -60.41 -50.96 71.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.414 -0.804 . . . . 0.0 110.556 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 58.4 t -66.49 -26.52 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.722 -1.236 . . . . 0.0 109.889 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.33 -45.69 93.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.398 -0.814 . . . . 0.0 110.219 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -69.75 -41.6 75.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.229 -0.919 . . . . 0.0 112.205 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.24 -51.76 68.2 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.455 -1.403 . . . . 0.0 110.954 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -57.71 -11.91 2.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.044 -1.035 . . . . 0.0 109.415 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -70.33 -28.59 71.12 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -105.68 144.66 32.11 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.661 -0.905 . . . . 0.0 109.325 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 18.2 p -91.03 -11.74 37.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.138 -0.976 . . . . 0.0 110.055 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 90.6 p -58.03 153.64 14.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.164 -0.96 . . . . 0.0 110.135 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.11 130.81 42.47 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 79.8 mt -132.45 131.13 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.465 -0.772 . . . . 0.0 109.646 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 29.3 m -128.12 154.11 46.11 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 76.3 t -118.36 139.56 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 54.6 m -130.5 121.29 25.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.387 -0.82 . . . . 0.0 109.213 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 337' ' ' SER . . . . . 0.524 ' O ' ' ND2' ' B' ' 338' ' ' ASN . 29.3 t -136.61 117.7 14.39 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.906 0.86 . . . . 0.0 110.921 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' B' ' 337' ' ' SER . 7.3 p30 42.22 52.26 4.51 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 88.52 -13.39 62.41 Favored Glycine 0 N--CA 1.501 3.015 0 O-C-N 120.31 -1.494 . . . . 0.0 113.507 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -113.84 122.12 46.09 Favored 'General case' 0 N--CA 1.508 2.469 0 CA-C-N 119.602 1.701 . . . . 0.0 110.457 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 77.8 p -103.53 154.97 18.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.421 -0.799 . . . . 0.0 110.701 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -154.18 154.31 33.29 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.765 -0.584 . . . . 0.0 109.916 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 4.6 t -91.05 138.09 31.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.346 -0.846 . . . . 0.0 109.971 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -78.09 -14.87 59.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.987 -1.071 . . . . 0.0 110.624 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -87.74 21.12 2.71 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.48 ' H ' ' C ' ' B' ' 344' ' ' ALA . 12.3 t -149.17 97.03 2.62 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.856 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 19.6 tp -59.55 -32.12 70.04 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . 0.4 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 61.0 m-85 -57.63 -51.64 68.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.375 -0.828 . . . . 0.0 110.529 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.45 ' O ' ' OG1' ' B' ' 352' ' ' THR . 36.2 mtmm -69.59 -40.01 76.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.572 -1.33 . . . . 0.0 110.002 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.612 ' O ' ' N ' ' B' ' 352' ' ' THR . 86.3 mt -50.62 -55.81 14.65 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.743 -1.223 . . . . 0.0 108.117 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -38.51 -16.07 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.039 -0.413 . . . . 0.0 111.294 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.612 ' N ' ' O ' ' B' ' 350' ' ' LEU . 75.4 p -91.68 -12.02 35.28 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.813 -1.18 . . . . 0.0 110.952 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 55.8 mt -92.56 119.41 31.99 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.896 -1.128 . . . . 0.0 109.179 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.8 91.63 0.99 Allowed Glycine 0 N--CA 1.485 1.958 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 66.2 mt -100.85 94.91 6.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.412 -1.052 . . . . 0.0 108.521 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 75.2 p -91.68 178.79 5.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.349 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . 0.404 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 16.1 tm0? -69.16 113.97 7.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.69 -0.631 . . . . 0.0 110.246 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 102.08 9.49 42.13 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 25.5 m -86.45 111.98 21.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.187 -1.184 . . . . 0.0 110.593 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 42.0 t -77.36 116.24 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 122.018 0.913 . . . . 0.0 110.325 -177.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.7 m -110.74 176.6 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 36.8 m -131.43 130.65 42.78 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 76.3 mt -103.93 115.67 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 77.4 p -118.11 131.66 56.41 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.351 -0.843 . . . . 0.0 109.3 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.27 151.55 38.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.105 -0.997 . . . . 0.0 110.187 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . 0.438 ' OE2' ' OE2' ' B' ' 370' ' ' GLU . 11.7 tp10 -141.98 119.76 11.87 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.443 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 164.19 -163.89 36.28 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 118.323 -1.894 . . . . 0.0 111.963 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 55.1 tp10 -59.85 -50.73 72.66 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.022 -0.589 . . . . 0.0 111.379 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -103.97 8.57 36.76 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.854 -1.154 . . . . 0.0 111.456 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.1 pt-20 -42.04 -32.96 0.5 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.117 -0.99 . . . . 0.0 111.355 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -66.15 -46.92 75.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.674 -1.266 . . . . 0.0 109.801 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -69.98 -52.07 27.38 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.176 -0.952 . . . . 0.0 109.601 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -42.16 -38.05 1.61 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.548 -0.72 . . . . 0.0 111.676 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 62.9 t -79.06 -34.84 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.502 -1.374 . . . . 0.0 110.012 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -65.66 -49.98 66.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.13 -0.981 . . . . 0.0 112.766 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -77.11 -40.37 46.08 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.267 -1.52 . . . . 0.0 110.869 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.9 mt -60.04 -40.46 89.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.875 -1.141 . . . . 0.0 108.99 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 54.5 t -62.27 -45.17 99.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.112 -0.993 . . . . 0.0 109.613 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.8 mttt -69.76 -55.97 8.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 38.7 tp -53.56 -35.71 61.06 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 11.1 tpt -69.97 -39.73 75.81 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.06 -5.78 56.46 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.665 -0.647 . . . . 0.0 110.594 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' B' ' 379' ' ' LYS . 99.2 mt-10 -114.42 -0.54 13.75 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.888 -1.132 . . . . 0.0 111.045 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 10.8 mt -81.14 131.88 35.32 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.406 -1.434 . . . . 0.0 109.746 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 56.4 mp0 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.961 -1.019 . . . . 0.0 108.996 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.349 -0.611 . . . . 3.19 109.349 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.0 mt -110.0 129.92 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.506 -0.746 . . . . 1.71 109.566 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.5 m -130.16 134.95 47.67 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.044 -0.725 . . . . 1.66 109.044 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.72 -163.99 23.32 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.585 -1.806 . . . . 1.05 108.585 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.9 mt -92.18 -11.08 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.91 -1.347 . . . . 1.59 109.539 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' ILE . 52.6 tp 53.55 103.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.293 -0.879 . . . . 1.47 109.533 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.23 -21.15 21.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.239 -0.913 . . . . 1.39 109.99 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.4 m -148.67 135.7 10.57 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 120.895 -1.128 . . . . 2.09 109.596 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.73 142.45 14.24 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.707 2.271 . . . . 0.91 113.489 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 157.53 -158.44 29.0 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.206 -1.558 . . . . 0.92 109.206 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -149.28 150.5 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 107.851 -1.166 . . . . 1.35 107.851 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.67 141.5 21.06 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.808 -1.183 . . . . 1.14 110.712 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -125.76 126.44 44.57 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.884 -1.154 . . . . 0.7 107.884 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.06 178.29 48.16 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 118.482 -1.818 . . . . 0.58 110.879 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -78.32 158.89 28.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.853 -0.792 . . . . 2.63 109.227 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -101.42 128.77 47.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.407 -0.808 . . . . 1.27 110.663 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.8 tp -99.11 134.94 41.23 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 106.865 -1.532 . . . . 1.41 106.865 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -117.39 118.27 31.77 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.408 -0.808 . . . . 1.49 110.121 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.4 mt -84.88 103.46 13.97 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.316 -0.624 . . . . 1.52 109.316 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -100.2 135.39 41.7 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.372 -0.83 . . . . 3.17 110.008 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -130.61 133.94 46.57 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.522 -0.736 . . . . 3.0 109.118 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -79.14 158.05 27.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.969 -1.082 . . . . 2.77 109.14 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -71.88 149.99 44.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.278 -0.889 . . . . 2.94 110.176 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.4 mt -95.48 130.34 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.214 -0.929 . . . . 1.46 108.938 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.17 129.71 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.121 -0.987 . . . . 1.7 110.115 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.7 mt -107.58 137.1 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 108.617 -0.882 . . . . 1.54 108.617 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -94.86 119.89 34.17 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.94 -1.1 . . . . 1.81 110.265 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.464 HH11 ' HG2' ' A' ' 28' ' ' ARG . 5.0 mmt-85 -88.71 0.05 56.83 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.53 -0.731 . . . . 3.23 109.79 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -70.35 141.43 52.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 3.29 109.921 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -82.41 150.55 27.04 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.204 -0.935 . . . . 2.8 109.301 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 pt -95.1 166.2 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.244 -0.91 . . . . 1.43 109.657 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.4 p -96.41 172.95 7.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.178 -0.951 . . . . 1.54 108.767 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.02 -49.29 78.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.047 -1.033 . . . . 1.6 109.335 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -54.86 -30.05 56.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.863 -1.148 . . . . 2.56 109.471 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -82.44 -10.75 58.91 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.407 -0.808 . . . . 2.36 110.265 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.27 -51.84 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.865 -1.147 . . . . 1.43 108.766 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.96 -39.98 93.99 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.364 -0.835 . . . . 1.77 110.055 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -68.38 -39.97 81.54 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.139 -0.976 . . . . 3.32 111.248 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -67.96 -39.96 83.29 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.8 -1.188 . . . . 1.51 110.184 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -62.98 -47.8 91.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 120.861 -1.149 . . . . 1.41 108.771 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -61.89 -41.6 98.08 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.104 -0.998 . . . . 1.81 109.347 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.18 -40.47 90.09 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.827 -1.149 . . . . 3.26 108.217 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -67.3 -42.02 84.4 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.55 -0.907 . . . . 0.81 108.55 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.92 -48.26 82.44 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.914 -1.143 . . . . 1.59 107.914 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.7 t -63.93 -44.02 94.15 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.756 -0.831 . . . . 1.38 108.756 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.14 -45.45 96.51 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.282 -1.927 . . . . 0.87 108.282 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.546 ' NH2' ' O ' ' A' ' 80' ' ' LEU . 8.5 ttt180 -63.75 -34.11 77.15 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.681 -1.229 . . . . 3.62 107.681 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.96 91.19 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.303 -0.628 . . . . 1.43 109.303 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 23.5 ttmt -63.64 -74.39 0.1 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.836 -1.172 . . . . 3.08 107.836 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.17 -39.6 0.43 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.45 -0.782 . . . . 1.33 111.316 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.2 m -53.01 -53.98 42.04 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.517 -1.365 . . . . 1.85 108.527 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.02 -39.96 75.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.469 -0.769 . . . . 1.35 111.501 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -68.89 -39.97 79.48 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.739 -1.225 . . . . 2.34 110.194 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 79.1 mt -63.11 -40.07 96.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.139 -0.976 . . . . 2.2 109.377 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -60.73 -35.26 75.9 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.248 -0.908 . . . . 1.35 109.432 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -62.58 -41.85 99.2 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.159 -0.963 . . . . 1.34 109.402 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.8 mt -62.77 -40.04 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.3 -0.875 . . . . 1.26 109.039 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -56.02 -50.03 72.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.11 -0.994 . . . . 1.7 109.197 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -56.02 -35.4 66.8 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.318 -0.864 . . . . 1.35 109.816 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -69.95 -37.91 75.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 2.08 109.815 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.13 -46.16 85.35 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.491 -0.756 . . . . 1.21 110.183 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.54 -50.03 72.13 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.497 -1.441 . . . . 0.75 109.497 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -68.23 -49.67 59.19 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.204 -1.174 . . . . 1.59 109.502 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.6 m -65.05 -63.8 1.02 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 1.41 112.332 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -95.27 -51.74 4.48 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.879 -1.138 . . . . 0.79 111.288 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.71 -167.99 25.72 Favored Glycine 0 N--CA 1.502 3.073 0 C-N-CA 119.706 -1.235 . . . . 1.22 111.128 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -70.22 -27.01 64.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 122.007 -0.702 . . . . 5.81 110.461 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -60.88 -35.72 77.35 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.3 -0.875 . . . . 3.37 110.571 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -101.04 -20.83 15.21 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.338 -0.851 . . . . 2.37 110.159 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -65.94 -40.06 91.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.026 -1.046 . . . . 1.65 110.002 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.545 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -64.75 -26.77 68.5 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.279 -0.888 . . . . 1.42 109.997 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.04 -39.96 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 118.717 -1.193 . . . . 1.43 108.531 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -66.42 -42.11 88.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.032 . . . . 1.08 110.282 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -60.13 -40.2 88.97 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.853 -1.155 . . . . 1.37 108.939 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.44 -49.95 66.07 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.945 -1.662 . . . . 0.67 108.945 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -62.9 -47.2 84.32 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.328 -1.101 . . . . 1.99 109.181 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.4 mt -65.69 -46.8 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.293 -0.879 . . . . 1.22 108.885 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.9 ttp -59.99 -40.12 88.11 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.01 -1.056 . . . . 2.11 109.048 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.4 tp -64.43 -39.99 94.89 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.457 0.646 . . . . 1.33 109.443 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.546 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 62.8 tp -63.18 -39.99 96.24 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.575 -0.703 . . . . 1.29 110.157 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -84.74 7.23 21.3 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.049 -1.032 . . . . 1.47 110.261 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 61.4 t0 -50.14 134.23 22.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.12 -0.987 . . . . 1.47 109.979 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.485 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 93.6 mt-10 -60.12 -23.51 63.93 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.634 -0.667 . . . . 1.78 110.941 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -70.81 -34.24 71.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.971 -1.08 . . . . 2.53 109.415 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.9 mt -71.02 -40.51 71.72 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.573 0.701 . . . . 1.36 109.692 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -59.98 -46.56 89.04 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.115 -0.991 . . . . 1.42 110.231 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -69.97 -42.24 73.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.211 -0.93 . . . . 2.27 111.594 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -69.99 -39.97 75.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.039 -1.038 . . . . 1.57 112.095 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.07 -48.14 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.142 -0.974 . . . . 1.19 109.625 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.412 HD11 HG22 ' A' ' 90' ' ' ILE . 96.7 mt -68.92 -39.62 80.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 121.262 0.553 . . . . 1.39 110.179 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.17 -47.69 84.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 1.39 110.768 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.4 mt -60.0 -48.35 82.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.989 -1.07 . . . . 1.5 109.941 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.2 mt -61.61 -48.59 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 121.957 0.884 . . . . 1.29 108.878 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -67.76 -40.16 84.11 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 120.203 -0.599 . . . . 2.64 110.857 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -86.57 -50.66 6.67 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.915 -1.115 . . . . 1.65 112.356 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -90.14 -2.9 58.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.984 -1.072 . . . . 2.5 111.71 -177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.9 m170 57.94 35.81 25.65 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.893 -1.129 . . . . 1.88 109.474 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.8 mtp -90.33 163.88 14.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.47 -0.769 . . . . 1.71 109.752 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.6 p -76.06 158.36 31.92 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.29 -0.881 . . . . 1.61 108.648 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.55 -39.97 77.11 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.137 -0.977 . . . . 1.33 110.078 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.84 -39.86 95.66 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.225 -0.922 . . . . 2.07 109.678 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.35 -44.49 19.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 1.37 109.942 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.37 -49.29 76.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.328 -0.857 . . . . 1.14 110.191 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.21 90.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.127 -0.983 . . . . 1.26 110.025 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -60.05 -40.01 87.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 2.02 109.858 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -61.34 -40.12 93.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.063 -1.023 . . . . 1.33 110.395 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.0 t -62.81 -50.62 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.169 -0.957 . . . . 1.3 110.509 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.9 mm -69.99 -39.99 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.103 -0.998 . . . . 1.32 109.674 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -66.47 -39.21 88.67 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.29 -0.881 . . . . 2.44 108.699 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.27 -49.28 80.27 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.564 -1.014 . . . . 0.99 110.564 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -63.9 -47.51 80.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.938 -1.33 . . . . 1.97 110.135 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.43 -39.35 83.24 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.238 -0.914 . . . . 1.43 109.153 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.2 m -59.9 -40.07 87.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.142 -0.974 . . . . 2.12 108.997 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.94 87.67 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.231 -1.026 . . . . 1.64 108.231 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.3 mt -65.18 -41.74 94.3 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.313 -0.955 . . . . 1.93 108.55 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -57.8 -32.29 67.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.117 -0.989 . . . . 2.2 109.688 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.21 -26.71 61.12 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.084 -1.01 . . . . 2.12 108.466 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 25.3 mt -63.2 144.07 57.24 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.451 -0.944 . . . . 2.34 108.451 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -92.8 13.43 20.33 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.189 -0.944 . . . . 3.23 110.757 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 19.2 t0 -102.67 148.7 25.26 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.053 -1.029 . . . . 2.49 110.085 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 98.0 mt-10 -73.8 -65.05 0.88 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.483 -0.761 . . . . 3.95 109.34 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.623 ' HH ' ' CZ ' ' A' ' 126' ' ' ARG . 4.1 t80 -39.33 -35.43 0.26 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.893 -0.504 . . . . 2.25 110.616 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 78.6 mt -78.39 -40.04 37.3 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.834 -1.166 . . . . 2.27 109.342 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 121' ' ' GLU . 87.9 tttt -69.93 -42.6 73.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.189 -0.944 . . . . 3.31 110.807 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -63.35 -43.08 98.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.106 -0.997 . . . . 2.73 109.9 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.623 ' CZ ' ' HH ' ' A' ' 122' ' ' TYR . 26.8 ttp180 -59.99 -38.5 82.77 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.212 -0.93 . . . . 3.2 108.984 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.26 -43.64 92.45 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.141 -1.059 . . . . 1.66 108.141 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -44.7 -41.75 7.03 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.948 -0.76 . . . . 1.67 108.948 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.32 -39.93 94.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 1.55 109.708 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.36 -43.17 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.02 -1.05 . . . . 1.32 108.96 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -60.0 -39.92 87.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.109 -0.994 . . . . 3.58 109.372 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -57.17 -37.92 72.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.888 . . . . 1.46 109.742 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.94 -41.66 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.146 -0.971 . . . . 1.22 109.116 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.24 -30.72 58.37 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.769 -1.332 . . . . 0.61 109.769 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -59.98 -47.47 85.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.148 -1.207 . . . . 3.1 109.799 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -68.15 -31.14 70.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.814 -1.179 . . . . 3.71 109.63 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.09 -41.55 92.74 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.167 -0.958 . . . . 1.87 109.364 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.02 -40.05 87.93 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.209 -1.034 . . . . 1.29 108.209 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 62.3 mtt-85 -68.21 -38.04 81.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.662 -0.649 . . . . 3.05 109.305 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -68.6 -34.8 76.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 1.26 111.668 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.9 mt -70.4 -42.51 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.275 -1.516 . . . . 1.34 108.97 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.1 -25.4 63.49 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.636 -0.665 . . . . 1.6 109.591 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.78 36.24 19.79 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.378 -1.889 . . . . 0.96 108.378 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 tp -73.89 145.46 44.81 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.668 -0.901 . . . . 1.67 109.259 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -68.94 140.09 55.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -0.855 . . . . 4.96 109.924 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.5 mt -106.52 130.05 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-O 121.694 0.759 . . . . 1.68 109.21 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.401 HG22 HD11 ' A' ' 147' ' ' ILE . 16.8 mm -56.27 -49.12 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.682 -0.637 . . . . 2.14 110.367 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.6 t0 70.87 95.12 0.07 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.603 -0.686 . . . . 1.5 109.245 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.406 ' O ' ' OD1' ' A' ' 172' ' ' ASN . 33.4 mt -73.02 -4.08 30.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.352 -0.843 . . . . 1.39 110.968 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 81.2 p -82.85 -14.63 53.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.754 -1.216 . . . . 1.83 109.361 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.21 18.19 2.71 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.329 -0.857 . . . . 1.46 112.605 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.3 mp -91.33 115.82 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.121 -1.612 . . . . 1.42 108.02 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -100.17 -8.52 23.52 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.293 -0.88 . . . . 2.94 109.952 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -108.14 144.96 34.83 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.352 -0.843 . . . . 1.52 110.163 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -66.35 130.82 44.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.339 -0.851 . . . . 1.58 109.028 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.7 m -153.11 167.24 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.472 -0.768 . . . . 1.32 109.565 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -93.77 148.24 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 106.318 -1.734 . . . . 1.27 106.318 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 47.1 tp -96.89 117.45 31.13 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.872 -1.143 . . . . 1.41 111.066 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 8.5 t -121.41 127.97 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 108.516 -0.92 . . . . 1.23 108.516 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.04 162.06 36.61 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.213 -0.929 . . . . 1.32 108.74 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.475 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.94 -33.73 72.52 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.405 -1.434 . . . . 1.49 107.756 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.5 p-10 -166.8 175.33 7.86 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.318 -0.993 . . . . 2.25 108.318 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 51.6 mt -140.23 125.73 19.05 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.118 -1.067 . . . . 1.35 108.118 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 36.1 p -87.11 146.97 41.54 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.032 -1.043 . . . . 1.56 108.768 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -36.54 -38.13 0.32 Allowed 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.365 2.043 . . . . 0.87 112.295 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.2 m -60.04 -40.03 87.99 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.361 -0.837 . . . . 1.36 109.778 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.01 -44.42 69.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.105 -0.997 . . . . 1.61 110.192 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.8 p -55.53 -20.44 13.1 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.265 -0.897 . . . . 1.21 111.116 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.51 -47.57 12.03 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.868 -1.145 . . . . 1.21 109.871 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -90.24 38.41 0.93 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.221 -1.029 . . . . 2.11 108.221 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.3 tp -100.25 135.96 40.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 1.29 108.811 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 149' ' ' LEU . 30.7 m120 -86.67 102.12 13.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.194 -0.941 . . . . 2.81 109.307 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 80.9 mt -64.83 -41.67 95.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 2.09 110.799 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -69.12 -28.04 66.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.939 -1.101 . . . . 2.86 111.911 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -92.84 -11.43 33.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.748 -1.22 . . . . 2.39 109.159 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.9 t -99.07 108.16 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.611 -1.255 . . . . 1.27 107.611 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.8 4.07 30.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.269 -0.894 . . . . 2.17 110.265 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.08 171.04 38.09 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.679 -1.768 . . . . 0.52 108.679 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -129.49 128.6 43.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.348 -1.089 . . . . 0.55 108.834 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 91.3 mt -131.44 123.2 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.595 -0.891 . . . . 1.27 108.595 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 203' ' ' VAL . 41.0 p -147.1 158.91 44.09 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.008 -1.057 . . . . 1.39 110.252 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 50.1 p30 -108.51 25.2 11.97 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.208 -0.664 . . . . 2.46 109.208 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.77 -162.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.029 -1.044 . . . . 1.51 111.358 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -64.22 -64.74 3.42 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.198 -1.161 . . . . 2.23 110.198 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.79 -131.45 1.66 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.19 -1.481 . . . . 2.23 110.8 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -79.95 -9.78 59.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.62 -0.929 . . . . 6.44 110.563 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 52.2 p -84.7 0.92 48.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.985 -1.072 . . . . 4.09 110.708 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 81.0 p -88.36 144.23 26.52 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.907 -1.121 . . . . 2.2 110.298 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -53.18 -41.06 64.86 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.344 -0.847 . . . . 1.15 108.844 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.38 -36.39 61.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.628 -0.67 . . . . 2.01 109.462 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 53.5 m -60.0 -40.02 87.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.194 -0.942 . . . . 1.93 109.981 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.6 mt -60.01 -40.09 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.926 . . . . 2.2 109.597 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 90.5 mtp -57.39 -48.83 78.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.082 -1.012 . . . . 1.32 110.435 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.94 -42.82 94.83 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.727 -1.233 . . . . 1.3 109.768 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -61.98 -59.25 5.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.131 -0.981 . . . . 3.38 110.389 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 61.5 m -67.11 -39.39 86.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.139 -0.975 . . . . 1.15 112.421 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 91.2 mt -70.22 -26.64 63.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.616 -1.303 . . . . 1.28 109.306 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 68.08 45.19 1.34 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.21 0.528 . . . . 1.5 110.535 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 93.6 mt -120.74 149.93 51.56 Favored Pre-proline 0 N--CA 1.503 2.202 0 N-CA-C 107.64 -1.245 . . . . 1.37 107.64 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.11 141.69 94.64 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.927 1.751 . . . . 0.76 111.301 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -171.49 152.41 3.23 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.523 -1.271 . . . . 1.19 111.898 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 202' ' ' ILE . 89.6 mt -121.84 146.4 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.695 -1.224 . . . . 1.31 107.695 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 181' ' ' THR . 21.4 m -127.66 -15.43 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 O-C-N 121.149 -0.97 . . . . 1.38 110.694 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.0 27.4 14.56 Favored Glycine 0 N--CA 1.504 3.193 0 O-C-N 121.389 -0.819 . . . . 1.03 111.098 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.0 p -49.14 -33.42 12.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.741 -1.446 . . . . 1.38 110.164 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 84.68 -87.31 1.55 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.708 -1.357 . . . . 1.17 109.708 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' A' ' 207' ' ' SER . 27.5 t -125.31 39.16 4.03 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.558 -0.966 . . . . 2.07 112.571 -177.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.15 -40.62 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.444 -1.41 . . . . 1.35 109.036 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.493 ' HG1' ' N ' ' A' ' 210' ' ' SER . 1.4 p -56.36 -31.41 63.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.263 -0.898 . . . . 1.49 109.94 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.493 ' N ' ' HG1' ' A' ' 209' ' ' THR . 23.0 t -71.71 -28.96 64.05 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.168 -0.957 . . . . 2.16 109.338 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -94.92 -9.57 33.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.283 -0.885 . . . . 2.89 111.176 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 63.6 t -102.61 137.14 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.95 -1.093 . . . . 1.33 110.632 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -114.11 155.04 26.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.751 -1.203 . . . . 2.73 107.751 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 57.5 t-20 -59.89 139.89 57.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.004 -1.06 . . . . 2.7 109.92 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.0 t0 84.55 6.44 0.57 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.407 0.622 . . . . 2.38 109.434 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 54.8 t0 -76.01 136.81 39.97 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.374 -0.829 . . . . 2.09 108.959 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.508 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 35.5 t80 -89.84 117.47 28.7 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.674 -1.232 . . . . 1.45 107.674 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 86.6 mt -125.97 145.01 50.47 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.287 -0.883 . . . . 1.31 110.808 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.1 mt -115.27 129.95 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.102 -1.073 . . . . 1.29 108.102 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 35.5 tp -103.95 117.66 34.85 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.14 -0.975 . . . . 1.31 109.133 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 223' ' ' VAL . 92.4 m-20 -74.85 -43.48 54.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.069 -1.019 . . . . 2.31 108.962 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 51.24 9.84 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.255 -0.646 . . . . 1.19 109.255 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.525 ' H ' ' C ' ' A' ' 221' ' ' ASP . 47.0 t -129.82 -40.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 107.5 -1.296 . . . . 1.45 107.5 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -101.97 1.81 37.12 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.771 -0.825 . . . . 3.13 108.771 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 59.99 41.95 16.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.604 -0.685 . . . . 2.2 109.698 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -136.6 146.22 45.81 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.316 -0.865 . . . . 2.32 110.079 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.32 130.01 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.266 -1.013 . . . . 1.4 108.266 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -100.68 123.68 45.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.367 -0.833 . . . . 1.29 108.879 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.0 t -99.1 110.84 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.373 -0.829 . . . . 1.38 110.93 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 34.5 t30 49.68 59.93 16.05 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.503 -0.748 . . . . 2.33 111.047 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.67 151.93 19.57 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.694 2.263 . . . . 0.95 111.925 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 41.7 p -68.39 161.27 27.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.117 -0.99 . . . . 2.31 109.761 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.03 -38.28 82.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 3.45 108.972 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -59.87 -40.08 87.47 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.682 -0.859 . . . . 2.89 108.682 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.33 -39.87 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 1.73 109.36 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 236' ' ' ILE . 91.6 mt . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.186 -0.946 . . . . 1.57 109.147 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 301' ' ' MET . . . . . 0.418 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 27.5 ttp . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.451 0.643 . . . . 0.0 109.573 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . 0.418 ' N ' ' CG ' ' B' ' 301' ' ' MET . 16.3 t80 -152.7 149.91 28.9 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . 0.408 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 14.6 pt20 -149.34 159.75 44.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.988 -1.07 . . . . 0.0 110.413 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -153.16 149.4 27.99 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -111.47 134.86 52.75 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.075 -1.016 . . . . 0.0 109.94 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.86 121.29 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 122.333 1.063 . . . . 0.0 112.735 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 16.9 m -75.92 105.35 6.91 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.941 0.877 . . . . 0.0 109.538 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.0 mt -53.13 123.64 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 122.469 1.128 . . . . 0.0 111.104 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 44.4 p -107.48 23.65 14.11 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.079 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -86.38 114.26 56.66 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.376 -0.828 . . . . 0.0 109.384 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -65.89 -6.9 15.27 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 120.289 1.139 . . . . 0.0 112.17 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -113.31 2.67 15.6 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.28 176.07 18.48 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.483 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -84.18 87.4 7.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.761 -1.435 . . . . 0.0 108.812 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . 0.459 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 3.6 p80 -92.65 -160.26 0.73 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.193 -0.942 . . . . 0.0 109.696 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 5.5 m -57.89 -49.7 75.83 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.912 -1.117 . . . . 0.0 112.168 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.545 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 11.4 tpt180 -52.35 -59.04 9.41 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 120.63 -1.294 . . . . 0.0 112.024 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . 0.459 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 17.8 Cg_endo -63.36 -35.03 64.28 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 CA-C-N 120.613 1.255 . . . . 0.0 111.483 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.35 78.01 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -57.57 -44.86 85.62 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.313 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -69.1 -44.53 72.27 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.626 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -60.01 -50.05 75.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.694 -0.629 . . . . 0.0 111.004 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.52 -29.18 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.529 -1.357 . . . . 0.0 109.206 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -59.93 -46.6 88.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.53 -0.731 . . . . 0.0 109.833 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -69.26 -40.6 77.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 0.0 111.426 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.19 -51.48 69.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.55 -1.344 . . . . 0.0 109.997 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -58.97 -13.33 6.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 109.307 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.6 -30.85 70.67 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -105.54 141.8 36.39 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.54 -0.977 . . . . 0.0 108.534 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 35.2 m -90.2 -11.43 41.04 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.841 -1.162 . . . . 0.0 109.539 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 93.8 p -57.99 151.2 18.96 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.139 -0.976 . . . . 0.0 108.784 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -68.06 130.48 43.09 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.213 -0.929 . . . . 0.0 108.813 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 80.1 mt -130.65 130.48 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.5 -0.75 . . . . 0.0 109.143 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 45.3 m -127.85 152.13 48.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.478 -0.764 . . . . 0.0 108.996 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 75.5 t -119.12 138.43 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 98.8 m -132.21 129.31 39.55 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.262 -0.899 . . . . 0.0 110.204 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 337' ' ' SER . . . . . 0.545 ' C ' ' H ' ' B' ' 339' ' ' GLY . 80.2 p -136.91 126.77 25.72 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.466 -0.771 . . . . 0.0 109.791 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 56.8 t30 57.09 5.58 0.26 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.59 0.71 . . . . 0.0 109.505 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' B' ' 337' ' ' SER . . . 101.91 10.16 40.85 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -100.56 119.27 38.28 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 32.4 m -99.06 149.75 22.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.182 -0.949 . . . . 0.0 111.908 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -149.69 149.54 30.76 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 8.8 t -90.55 131.43 36.28 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.119 -0.988 . . . . 0.0 110.297 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -70.06 -16.63 63.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.152 -0.967 . . . . 0.0 110.047 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . 0.48 ' NZ ' ' CB ' ' B' ' 345' ' ' LYS . 0.1 OUTLIER -89.52 19.59 4.46 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 28.4 t -147.99 99.0 3.02 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.057 0.932 . . . . 0.0 111.572 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 58.9 tp -58.98 -36.2 74.48 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -55.17 -53.05 60.94 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.312 -0.868 . . . . 0.0 111.363 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -70.04 -29.75 66.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 0.0 109.74 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 55.7 mt -59.75 -39.4 84.64 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.414 -0.804 . . . . 0.0 111.196 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.546 ' NE2' ' CZ ' ' A' ' 126' ' ' ARG . 3.0 mm100 -65.78 -14.75 61.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.187 -1.571 . . . . 0.0 111.673 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 40.5 p -77.53 -10.89 59.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.13 -1.607 . . . . 0.0 110.156 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 52.8 mt -93.44 115.08 27.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.113 -0.992 . . . . 0.0 109.043 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -72.24 93.97 0.62 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 107.772 -2.131 . . . . 0.0 107.772 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 80.6 mt -100.21 88.08 3.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.241 -1.152 . . . . 0.0 110.341 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 44.7 p -92.31 -179.99 5.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.977 -1.077 . . . . 0.0 110.651 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -71.23 114.07 8.92 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.597 -0.689 . . . . 0.0 110.605 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.77 10.65 32.33 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 25.6 m -90.99 108.17 19.68 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.353 -1.086 . . . . 0.0 110.578 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 99.8 t -76.99 118.17 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 122.181 0.991 . . . . 0.0 109.366 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 14.9 m -111.92 178.19 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 28.2 m -131.74 129.42 40.62 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 78.6 mt -105.33 120.63 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 75.6 p -120.32 132.32 55.25 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.548 -0.72 . . . . 0.0 109.184 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.21 149.56 36.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 109.799 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -147.0 125.84 12.69 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 158.72 -158.9 29.78 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 118.913 -1.613 . . . . 0.0 111.401 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -59.94 -52.53 65.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 122.178 -0.601 . . . . 0.0 111.794 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' B' ' 370' ' ' GLU . 70.9 m-20 -107.59 11.75 28.32 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.973 -1.079 . . . . 0.0 111.384 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 369' ' ' ASP . 12.9 pt-20 -37.78 -33.59 0.08 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.402 -0.812 . . . . 0.0 111.578 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -66.7 -51.17 59.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.906 -1.121 . . . . 0.0 110.925 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -64.08 -48.9 74.38 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.908 -1.12 . . . . 0.0 108.915 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.31 -40.75 3.7 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.53 -0.731 . . . . 0.0 111.594 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 94.7 t -76.13 -35.86 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.615 -1.303 . . . . 0.0 109.708 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.7 -59.07 5.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.103 -0.998 . . . . 0.0 111.832 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -70.02 -40.79 74.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.762 -1.211 . . . . 0.0 111.867 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.98 -41.14 91.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.676 -1.265 . . . . 0.0 109.422 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.63 -44.6 99.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.897 -1.127 . . . . 0.0 109.732 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' B' ' 383' ' ' GLU . 57.7 mtpt -68.97 -55.99 9.2 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 53.8 tp -54.49 -37.71 65.59 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.732 -0.605 . . . . 0.0 109.404 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 6.4 tpp -72.79 -40.0 66.26 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.602 -1.311 . . . . 0.0 108.441 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -79.97 -5.27 55.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.545 -0.722 . . . . 0.0 110.19 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' B' ' 379' ' ' LYS . 53.7 mm-40 -110.61 0.97 17.76 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.19 -0.944 . . . . 0.0 111.069 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 17.4 mt -90.8 124.59 35.26 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.518 -1.364 . . . . 0.0 109.107 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 N--CA 1.499 1.986 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.376 179.828 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.7 mtm . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.356 -0.609 . . . . 3.19 109.356 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.427 HG22 HD11 ' A' ' 2' ' ' ILE . 85.3 mt -110.36 129.0 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.533 -0.73 . . . . 1.71 109.311 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.7 m -140.79 120.55 13.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.375 -0.828 . . . . 1.66 109.23 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.7 -164.98 39.18 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.743 -1.343 . . . . 1.05 109.743 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.1 mt -86.44 -1.54 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.172 -1.193 . . . . 1.59 110.583 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.2 tp 52.53 88.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.799 -1.188 . . . . 1.47 109.07 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.74 -38.0 64.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.254 -0.904 . . . . 1.39 109.509 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.0 t -149.71 135.52 10.12 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.375 -0.828 . . . . 2.09 109.427 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -80.43 145.56 16.78 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.23 1.954 . . . . 0.91 113.772 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 159.84 -159.37 30.59 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.189 -1.564 . . . . 0.92 109.189 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.2 mt -149.54 150.01 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.047 -1.266 . . . . 1.35 108.955 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.44 150.37 26.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.054 -1.029 . . . . 1.14 110.53 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -130.25 126.22 36.77 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 107.969 -1.123 . . . . 0.7 107.969 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.8 178.04 48.4 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.429 -1.843 . . . . 0.58 111.096 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -80.01 159.61 26.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.89 -0.771 . . . . 2.63 109.679 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.38 132.04 45.97 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.376 -0.828 . . . . 1.27 111.582 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.0 tp -105.27 133.42 50.07 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.717 -1.586 . . . . 1.41 106.717 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.8 tp -117.11 123.51 46.96 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.138 -0.976 . . . . 1.49 110.747 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.7 mt -92.43 104.13 16.49 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.755 -0.59 . . . . 1.52 110.473 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.66 137.56 32.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.318 -0.864 . . . . 3.17 109.341 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -131.12 134.14 46.27 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.241 -0.912 . . . . 3.0 109.492 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -88.21 139.96 29.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.116 -0.99 . . . . 2.77 109.074 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -62.31 140.78 58.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.034 -1.041 . . . . 2.94 109.268 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.3 mt -79.18 132.3 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 1.46 108.766 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.2 t -104.64 126.66 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.426 -0.797 . . . . 1.7 109.897 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -100.27 138.61 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.789 -0.819 . . . . 1.54 108.789 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -90.61 125.65 35.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.997 -1.064 . . . . 1.81 109.204 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -89.94 1.43 56.25 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.692 -0.855 . . . . 3.23 108.692 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.95 139.93 57.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.42 -0.8 . . . . 3.29 109.747 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -88.04 137.92 31.9 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.305 -0.872 . . . . 2.8 109.24 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.8 pt -90.57 159.98 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.994 -1.067 . . . . 1.43 109.442 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.4 p -94.65 171.78 8.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.061 -1.024 . . . . 1.54 108.687 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.58 -46.69 83.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 1.6 108.997 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 25.6 t0 -55.84 -32.7 63.84 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.758 -1.214 . . . . 2.56 109.516 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -81.51 -9.98 59.58 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.12 -0.988 . . . . 2.36 110.425 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 t -64.15 -53.02 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.6 -1.312 . . . . 1.43 108.8 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -61.72 -39.99 93.47 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.439 -0.788 . . . . 1.77 110.027 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -67.96 -41.87 81.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 3.32 110.492 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -65.42 -39.98 92.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.065 -1.022 . . . . 1.51 110.575 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.98 -46.17 94.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.688 -1.258 . . . . 1.41 108.79 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -60.03 -40.01 87.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.846 -1.159 . . . . 1.81 108.94 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.476 HH11 ' HG2' ' A' ' 42' ' ' ARG . 17.9 mtt-85 -60.01 -43.28 95.35 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.973 -1.121 . . . . 3.26 107.973 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 28.6 t80 -60.84 -50.05 74.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.475 -0.766 . . . . 0.81 109.064 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.6 tp -61.87 -44.66 96.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.414 -0.804 . . . . 1.59 109.035 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.6 t -65.47 -43.74 89.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -0.943 . . . . 1.38 109.176 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.98 -45.71 95.43 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.684 -2.166 . . . . 0.87 107.684 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -60.66 -39.28 87.76 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.389 -0.967 . . . . 3.62 108.389 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.26 -40.18 64.42 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.286 -0.635 . . . . 1.43 109.286 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 50' ' ' ALA . 22.3 ttmt -65.81 -73.58 0.13 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.168 -1.419 . . . . 3.08 107.168 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.91 -38.99 0.34 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.35 -0.844 . . . . 1.33 111.222 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 t -51.93 -56.03 16.64 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.603 -1.311 . . . . 1.85 108.816 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.81 -40.72 79.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.86 . . . . 1.35 111.15 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -69.95 -40.05 75.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.748 -1.22 . . . . 2.34 110.008 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.04 -40.05 94.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.996 -1.065 . . . . 2.2 108.964 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -64.26 -33.93 76.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.26 -0.9 . . . . 1.35 109.361 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.5 m -64.87 -42.5 94.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.035 -1.041 . . . . 1.34 109.784 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.575 ' CD1' HH22 ' A' ' 136' ' ' ARG . 97.9 mt -62.27 -40.07 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 1.26 109.086 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -51.92 -49.99 61.99 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.447 -0.783 . . . . 1.7 109.426 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.6 m -59.44 -40.0 85.36 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.124 -0.985 . . . . 1.35 110.878 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -63.5 -37.88 88.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.745 -1.222 . . . . 2.08 109.835 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.32 -46.59 79.7 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.62 -0.675 . . . . 1.21 110.097 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.98 -49.57 77.08 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.274 -1.13 . . . . 0.75 110.274 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.97 -44.95 71.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.857 -1.378 . . . . 1.59 110.161 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.1 m -69.66 -57.23 5.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 1.41 111.54 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -97.11 -57.34 2.29 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.026 -1.046 . . . . 0.79 110.948 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.0 -163.75 26.94 Favored Glycine 0 N--CA 1.503 3.133 0 C-N-CA 119.802 -1.19 . . . . 1.22 111.041 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -67.92 -26.2 65.86 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.712 -0.875 . . . . 5.81 110.605 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -60.0 -36.36 77.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 3.37 110.211 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -100.5 -18.71 16.53 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.471 -0.768 . . . . 2.37 110.729 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -70.27 -43.1 71.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.779 -1.201 . . . . 1.65 110.838 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.41 -32.29 73.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.301 -0.874 . . . . 1.42 110.226 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.08 -39.92 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.854 -1.153 . . . . 1.43 109.307 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -64.48 -40.04 94.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.753 -1.217 . . . . 1.08 109.687 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.51 -40.37 91.2 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.105 -0.997 . . . . 1.37 109.614 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.98 -49.2 63.82 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.76 -1.736 . . . . 0.67 108.76 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.2 m170 -59.98 -43.35 95.18 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.374 -1.074 . . . . 1.99 108.687 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.81 -48.98 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.122 -0.986 . . . . 1.22 109.1 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.0 ttp -60.1 -42.7 95.26 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.043 -1.035 . . . . 2.11 109.491 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.408 ' CD1' ' CE2' ' B' ' 348' ' ' PHE . 46.8 tp -61.96 -39.36 91.88 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.37 -0.831 . . . . 1.33 108.772 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.05 -39.97 87.8 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.501 -0.749 . . . . 1.29 109.328 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -83.73 9.9 10.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.348 -0.845 . . . . 1.47 109.804 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 62.5 t0 -53.37 133.23 40.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.946 . . . . 1.47 109.984 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.469 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 99.2 mt-10 -59.06 -24.04 62.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.684 -0.635 . . . . 1.78 111.496 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -71.09 -34.65 71.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.896 -1.128 . . . . 2.53 109.871 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.9 mt -70.2 -40.02 74.85 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.585 0.707 . . . . 1.36 109.858 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.96 -48.9 79.81 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.364 -0.835 . . . . 1.42 110.31 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -70.13 -42.96 71.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.369 -0.832 . . . . 2.27 111.57 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.01 -40.02 75.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.082 -1.011 . . . . 1.57 112.119 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.75 -47.73 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.852 -1.155 . . . . 1.19 109.842 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.5 mt -66.51 -38.57 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.796 . . . . 1.39 109.904 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.9 88.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.178 -0.951 . . . . 1.39 111.26 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.1 mt -60.0 -46.61 88.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.773 -1.205 . . . . 1.5 109.945 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.1 mt -59.96 -46.14 94.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.751 -1.203 . . . . 1.29 107.751 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -67.99 -40.36 83.1 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.925 -0.71 . . . . 2.64 110.238 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -80.74 -55.9 4.51 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.035 -1.041 . . . . 1.65 112.437 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.01 -3.25 58.09 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.973 -1.08 . . . . 2.5 111.971 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 74.9 m80 57.13 41.12 27.71 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.885 -1.134 . . . . 1.88 109.236 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 68.0 mtp -95.62 169.18 10.21 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.445 0.641 . . . . 1.71 110.103 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 68.2 p -78.58 160.36 27.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.386 -0.821 . . . . 1.61 109.576 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.0 -39.12 87.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 1.33 110.155 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 18.2 p-10 -70.04 -34.06 72.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.013 -1.054 . . . . 2.07 109.349 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.08 -44.08 22.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 1.37 109.776 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.04 -43.12 71.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.448 -0.783 . . . . 1.14 110.229 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.93 87.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.99 -1.069 . . . . 1.26 109.72 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.466 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 82.4 t60 -60.05 -40.01 87.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.394 -0.816 . . . . 2.02 110.574 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.32 -41.87 93.54 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.044 -1.035 . . . . 1.33 110.74 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.89 -50.73 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.002 -1.061 . . . . 1.3 110.851 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.8 mm -69.9 -40.08 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.918 -1.114 . . . . 1.32 109.01 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.466 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.0 tt0 -63.82 -37.83 88.83 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.36 -0.978 . . . . 2.44 108.36 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.96 -54.1 40.25 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.598 -1.001 . . . . 0.99 110.598 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -64.77 -49.87 69.05 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.756 -1.438 . . . . 1.97 109.219 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.89 -41.93 88.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 1.43 109.085 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.9 t -58.84 -39.97 82.83 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.349 -0.844 . . . . 2.12 108.95 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.05 96.25 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.354 -0.841 . . . . 1.64 109.366 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.5 mt -63.58 -40.64 97.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.049 -1.032 . . . . 1.93 109.892 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.86 -36.54 77.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.846 -1.159 . . . . 2.2 109.508 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -53.85 -21.93 8.7 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.247 -0.908 . . . . 2.12 108.89 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 35.5 mt -62.95 142.6 58.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 2.34 109.349 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -91.11 12.78 18.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.406 -0.809 . . . . 3.23 109.425 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -100.4 126.5 46.79 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.261 -0.899 . . . . 2.49 110.147 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.402 ' O ' ' CD ' ' A' ' 121' ' ' GLU . 5.0 tm-20 -69.92 -29.96 67.26 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.686 0.755 . . . . 3.95 109.014 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.426 ' OH ' ' C ' ' B' ' 314' ' ' LEU . 19.3 t80 -62.83 -42.84 99.9 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 122.007 0.908 . . . . 2.25 110.109 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.429 ' CD2' ' O ' ' B' ' 351' ' ' GLN . 79.2 mt -76.16 -31.24 58.46 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.771 -0.825 . . . . 2.27 108.771 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -60.07 -40.85 90.94 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.475 -0.765 . . . . 3.31 108.985 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.11 -44.24 95.01 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.574 -0.899 . . . . 2.73 108.574 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.671 HH21 ' NE2' ' B' ' 351' ' ' GLN . 62.5 mtp180 -62.07 -39.67 93.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 3.2 109.138 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.98 -32.57 70.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.448 -0.782 . . . . 1.66 109.449 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.06 94.29 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.656 -0.868 . . . . 1.67 108.656 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -62.61 -40.08 95.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.421 -0.799 . . . . 1.55 110.192 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.06 -43.04 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 1.32 109.924 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -60.01 -40.0 87.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.081 -1.012 . . . . 3.58 109.538 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.03 -38.23 82.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.348 -0.845 . . . . 1.46 109.931 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.97 -43.31 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.122 -0.986 . . . . 1.22 110.358 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.2 -32.62 62.67 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.673 -1.251 . . . . 0.61 110.114 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -59.96 -49.97 75.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.107 -1.231 . . . . 3.1 109.283 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.575 HH22 ' CD1' ' A' ' 57' ' ' ILE . 59.5 mtp180 -65.61 -34.99 79.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 3.71 109.994 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.0 tp -59.96 -43.46 95.05 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.224 -0.922 . . . . 1.87 109.48 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.14 -39.96 94.36 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.087 -1.008 . . . . 1.29 108.815 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.407 ' NH1' ' CD2' ' A' ' 144' ' ' LEU . 58.6 mtt-85 -70.11 -39.9 75.22 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.461 -0.94 . . . . 3.05 108.461 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -62.04 -37.05 83.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.811 -0.556 . . . . 1.26 111.165 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.06 -43.56 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.698 -1.251 . . . . 1.34 108.221 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.98 -38.03 75.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.695 -0.628 . . . . 1.6 109.579 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.49 45.45 5.24 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.255 -1.938 . . . . 0.96 108.255 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.407 ' CD2' ' NH1' ' A' ' 139' ' ' ARG . 12.0 tp -74.58 150.02 39.88 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.499 -1.001 . . . . 1.67 109.548 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -63.02 142.84 58.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.341 -0.85 . . . . 4.96 110.428 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.2 mt -119.9 126.72 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.565 -0.902 . . . . 1.68 108.565 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.4 mt -59.97 -44.89 95.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.826 -0.546 . . . . 2.14 110.298 -178.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.4 t0 67.72 94.63 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.83 -0.804 . . . . 1.5 108.83 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.448 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 34.7 mt -67.07 -8.1 27.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.457 -0.777 . . . . 1.39 109.951 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.8 t -79.94 -13.8 59.09 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.993 -1.067 . . . . 1.83 108.286 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.12 24.76 0.76 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.786 -0.571 . . . . 1.46 110.395 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.448 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 42.6 mt -92.97 118.1 37.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.021 -1.05 . . . . 1.42 108.688 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -104.83 -11.22 16.88 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.222 -0.924 . . . . 2.94 110.391 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -119.71 147.31 44.73 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.615 -0.678 . . . . 1.52 110.12 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -64.11 136.52 57.33 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.408 -0.96 . . . . 1.58 108.408 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.2 m -153.52 168.54 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.233 -0.917 . . . . 1.32 109.99 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 74.0 mt -95.94 144.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 105.883 -1.895 . . . . 1.27 105.883 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 22.1 tp -92.99 115.86 28.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.905 -1.122 . . . . 1.41 110.48 -177.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.7 t -123.38 129.94 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 108.76 -0.829 . . . . 1.23 108.76 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.16 164.67 27.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.905 . . . . 1.32 108.795 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.44 -35.35 70.89 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.257 -1.527 . . . . 1.49 107.781 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -164.56 173.87 11.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.411 -0.959 . . . . 2.25 108.411 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.4 mt -136.48 143.1 43.64 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.115 -0.991 . . . . 1.35 109.201 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 74.7 p -95.27 141.99 23.99 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.241 -0.912 . . . . 1.56 109.342 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -39.99 -39.88 2.48 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.278 1.985 . . . . 0.87 112.514 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 68.9 m -60.04 -39.97 87.78 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.26 -0.9 . . . . 1.36 109.097 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.5 -43.69 96.47 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.27 -0.894 . . . . 1.61 110.108 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.9 p -53.87 -25.85 21.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.187 -0.946 . . . . 1.21 110.823 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.55 -54.76 5.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.82 -1.175 . . . . 1.21 109.817 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -83.76 39.85 0.71 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.698 -0.853 . . . . 2.11 108.698 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.0 tp -105.2 135.66 46.14 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.709 -0.849 . . . . 1.29 108.709 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -84.96 103.41 13.98 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.194 -0.941 . . . . 2.81 108.93 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 36.3 mt -67.14 -40.53 86.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.511 -0.743 . . . . 2.09 110.881 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -69.97 -24.15 63.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.757 -1.215 . . . . 2.86 111.433 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -92.78 -6.79 48.2 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.802 -1.186 . . . . 2.39 109.853 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 178' ' ' GLY . 84.0 t -106.56 116.67 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.329 -0.857 . . . . 1.27 108.702 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 71.3 mt -89.99 7.24 38.52 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.283 -0.886 . . . . 2.17 110.243 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.411 ' O ' ' CG1' ' A' ' 176' ' ' VAL . . . 171.89 171.88 37.32 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.176 -1.57 . . . . 0.52 109.176 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -132.37 129.66 39.69 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.321 -1.105 . . . . 0.55 109.207 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 94.7 mt -134.07 127.51 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.525 -0.917 . . . . 1.27 108.525 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.1 p -149.94 162.75 39.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.938 -1.101 . . . . 1.39 110.681 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.481 ' O ' ' O ' ' A' ' 183' ' ' ALA . 0.9 OUTLIER -100.24 20.31 14.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.506 -0.747 . . . . 2.46 109.726 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -46.69 -174.7 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 122.322 1.058 . . . . 1.51 112.823 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.36 -56.69 3.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 111.396 -0.682 . . . . 2.23 111.396 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -167.36 -159.09 12.34 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 118.484 -1.817 . . . . 2.23 111.416 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.419 ' C ' ' H ' ' A' ' 188' ' ' SER . 17.8 ptt-85 -72.29 -15.93 61.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.749 -0.854 . . . . 6.44 110.849 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 71.5 p -71.23 3.42 3.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.831 -1.168 . . . . 4.09 109.271 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.419 ' H ' ' C ' ' A' ' 186' ' ' ARG . 40.7 t -83.4 134.29 34.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 2.2 110.275 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -49.88 -38.96 37.91 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.169 -1.049 . . . . 1.15 108.169 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.6 p -59.94 -41.49 91.93 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.928 -0.578 . . . . 2.01 110.493 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 41.2 t -62.06 -38.61 89.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.113 -0.992 . . . . 1.93 110.669 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.3 mm -60.0 -39.35 80.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.236 -0.915 . . . . 2.2 109.19 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.1 mtp -59.5 -44.43 93.11 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.245 -0.909 . . . . 1.32 110.102 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.36 -44.48 80.15 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.647 -1.283 . . . . 1.3 109.712 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -62.96 -57.81 9.49 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.142 -1.023 . . . . 3.38 110.778 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.1 m -62.7 -39.97 95.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.997 -1.064 . . . . 1.15 112.111 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.9 mt -69.95 -15.7 63.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.864 -1.147 . . . . 1.28 110.25 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 62.13 49.67 4.35 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.626 -0.671 . . . . 1.5 110.175 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 78.5 mt -130.39 149.91 74.73 Favored Pre-proline 0 N--CA 1.499 1.999 0 N-CA-C 107.682 -1.229 . . . . 1.37 107.682 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.79 147.5 62.82 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.316 2.01 . . . . 0.76 111.846 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -173.88 158.76 3.27 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.922 -1.111 . . . . 1.19 112.035 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.8 mt -130.96 144.75 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.281 -1.007 . . . . 1.31 108.281 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 28.0 m -128.98 -7.53 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.99 -1.069 . . . . 1.38 111.064 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.75 24.48 13.17 Favored Glycine 0 N--CA 1.501 3.032 0 N-CA-C 110.799 -0.92 . . . . 1.03 110.799 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.429 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.1 p -46.77 -44.14 18.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.876 -1.367 . . . . 1.38 109.748 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.57 -55.5 2.71 Favored Glycine 0 N--CA 1.498 2.803 0 C-N-CA 120.166 -1.016 . . . . 1.17 111.825 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 34.3 p -149.82 25.92 0.83 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.6 -1.53 . . . . 2.07 111.646 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.97 -39.62 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.773 -1.205 . . . . 1.35 108.964 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.474 ' HG1' ' N ' ' A' ' 210' ' ' SER . 50.4 p -58.0 -36.65 72.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.498 -0.751 . . . . 1.49 110.173 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.474 ' N ' ' HG1' ' A' ' 209' ' ' THR . 80.9 p -84.99 -11.74 54.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.013 -1.054 . . . . 2.16 110.25 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -95.87 -14.93 22.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.054 -1.029 . . . . 2.89 110.305 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.79 154.37 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.275 -0.891 . . . . 1.33 110.469 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.457 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 11.1 mptt -117.2 156.45 27.67 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.701 -1.222 . . . . 2.73 107.701 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 27.5 p30 -60.02 142.68 53.53 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.053 -1.029 . . . . 2.7 110.431 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 11.0 t0 86.62 0.83 0.56 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 120.919 0.39 . . . . 2.38 110.359 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.457 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 91.8 m-20 -75.05 153.78 38.25 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.938 -1.101 . . . . 2.09 108.814 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -96.44 131.27 43.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.226 -1.027 . . . . 1.45 108.226 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 82.6 mt -129.52 149.65 51.2 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.192 -0.943 . . . . 1.31 110.994 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 219' ' ' ILE . 85.5 mt -120.59 122.64 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.816 -1.549 . . . . 1.29 106.816 175.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 57.2 tp -98.73 115.51 28.89 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.733 -1.23 . . . . 1.31 109.223 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 223' ' ' VAL . 96.0 m-20 -75.57 -44.61 42.36 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.031 -1.043 . . . . 2.31 108.29 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 46.95 17.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.978 0.894 . . . . 1.19 108.62 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.1 t -132.08 -45.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 106.654 -1.609 . . . . 1.45 106.654 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -100.33 1.93 42.04 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.685 -1.228 . . . . 3.13 107.685 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 60.53 44.15 12.1 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.79 -0.569 . . . . 2.2 109.824 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -139.65 141.84 37.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.323 -0.86 . . . . 2.32 109.525 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 97.2 t -119.98 120.85 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 109.112 -0.699 . . . . 1.4 109.112 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -89.04 131.67 35.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.981 -1.074 . . . . 1.29 108.715 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 64.2 t -109.33 122.92 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.709 -0.619 . . . . 1.38 109.64 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 62.49 69.15 0.94 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.524 -0.735 . . . . 2.33 109.745 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -90.18 127.85 1.48 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 123.417 2.744 . . . . 0.95 112.276 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.0 167.18 12.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.095 -1.003 . . . . 2.31 109.341 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -59.94 -40.0 87.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 3.45 110.07 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.438 ' OE1' ' N ' ' A' ' 234' ' ' GLU . 58.3 mp0 -60.0 -39.98 87.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -0.945 . . . . 2.89 110.085 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.32 -39.4 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 1.73 110.049 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.9 mt . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 1.57 110.903 -179.234 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 301' ' ' MET . . . . . 0.485 ' N ' ' OE1' ' B' ' 366' ' ' GLU . 21.6 ttt . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 22.3 t80 -156.08 154.55 31.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 109.48 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . 0.506 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 20.6 pt20 -148.5 160.03 43.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.288 -0.883 . . . . 0.0 109.674 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -151.81 149.97 29.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.309 -0.869 . . . . 0.0 109.596 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 56.5 mp0 -105.94 130.63 53.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.382 -0.824 . . . . 0.0 109.742 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 10.2 p -130.58 117.73 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-O 122.25 1.024 . . . . 0.0 113.071 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 86.7 m -78.24 105.21 9.32 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.057 0.932 . . . . 0.0 110.53 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.7 mt -53.13 125.96 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 122.429 1.109 . . . . 0.0 111.264 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 22.6 p -112.04 19.94 17.37 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.557 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.71 120.65 82.31 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.746 -1.221 . . . . 0.0 109.402 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -50.96 -18.9 4.86 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 CA-C-N 120.205 1.109 . . . . 0.0 113.463 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -119.43 14.29 12.81 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.233 -0.917 . . . . 0.0 109.603 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.61 179.45 35.25 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.426 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 3.9 tp -85.38 95.41 9.23 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.05 -1.265 . . . . 0.0 109.477 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . 0.401 ' CA ' ' OH ' ' A' ' 122' ' ' TYR . 3.7 p80 -97.96 -160.72 0.82 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.934 -1.104 . . . . 0.0 110.108 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 7.9 m -59.92 -41.94 92.83 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.095 -1.003 . . . . 0.0 112.295 -176.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.639 HH21 ' NE2' ' B' ' 321' ' ' GLN . 1.0 OUTLIER -55.33 -62.13 4.89 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.538 -1.351 . . . . 0.0 111.224 -178.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.05 -33.23 97.05 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 120.242 1.122 . . . . 0.0 111.765 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.95 -50.79 72.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.254 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.46 -43.12 75.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.464 -0.772 . . . . 0.0 110.736 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . 0.639 ' NE2' HH21 ' B' ' 317' ' ' ARG . 27.7 mt-30 -73.49 -40.08 64.36 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.037 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -60.09 -50.26 74.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 0.0 110.431 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.45 -40.02 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.566 -1.334 . . . . 0.0 108.981 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -59.9 -45.77 91.48 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -62.49 -45.88 91.0 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.103 -0.998 . . . . 0.0 108.437 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' B' ' 328' ' ' GLY . . . -60.09 -51.21 70.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.617 -0.677 . . . . 0.0 110.308 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -57.72 -10.46 1.63 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.913 -1.117 . . . . 0.0 109.082 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' B' ' 326' ' ' ALA . . . -69.91 -29.89 70.57 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -103.36 144.89 30.78 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.561 -0.964 . . . . 0.0 108.915 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 16.6 p -91.39 -13.19 32.85 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.789 -1.195 . . . . 0.0 109.916 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 83.9 p -58.97 151.34 22.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.983 -1.073 . . . . 0.0 108.905 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.1 133.36 47.96 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.006 -1.059 . . . . 0.0 108.579 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.1 mt -131.88 131.05 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.753 -0.592 . . . . 0.0 109.802 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 89.2 m -129.82 153.51 48.19 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 84.9 t -116.11 138.27 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 77.6 m -130.03 125.4 35.2 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.119 -0.988 . . . . 0.0 109.133 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 51.6 p -139.58 117.0 11.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.197 -0.939 . . . . 0.0 110.906 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 34.4 m120 42.75 57.75 3.43 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 83.98 -14.26 44.53 Favored Glycine 0 N--CA 1.499 2.858 0 O-C-N 120.303 -1.498 . . . . 0.0 112.806 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -115.58 126.88 54.78 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-N 119.108 1.454 . . . . 0.0 109.974 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 80.0 p -127.27 148.92 50.22 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.929 0.871 . . . . 0.0 110.28 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -140.97 164.28 30.69 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.508 0.67 . . . . 0.0 109.903 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 23.2 t -87.35 137.23 32.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.493 -0.754 . . . . 0.0 109.202 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.438 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -76.73 -13.39 60.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.979 -1.076 . . . . 0.0 109.858 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.07 20.67 4.13 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.438 ' H ' ' C ' ' B' ' 344' ' ' ALA . 67.4 m -146.25 94.25 2.43 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.714 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . 0.484 ' CD1' HE22 ' B' ' 351' ' ' GLN . 56.9 tp -59.92 -33.34 71.74 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . 0.408 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 54.9 m-85 -56.75 -52.79 63.65 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.396 -0.815 . . . . 0.0 110.616 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.436 ' O ' ' OG1' ' B' ' 352' ' ' THR . 47.6 mtmt -69.33 -39.79 77.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.632 -1.292 . . . . 0.0 110.089 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' B' ' 352' ' ' THR . 20.9 mt -48.59 -58.49 4.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.062 -1.024 . . . . 0.0 109.07 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.671 ' NE2' HH21 ' A' ' 126' ' ' ARG . 1.3 mp0 -41.6 -14.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.555 -0.716 . . . . 0.0 111.19 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.574 ' N ' ' O ' ' B' ' 350' ' ' LEU . 50.2 p -87.65 -7.62 57.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.039 -1.663 . . . . 0.0 109.966 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 66.5 mt -97.42 116.14 29.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.129 -0.982 . . . . 0.0 109.493 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.67 93.06 1.02 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 21.8 mt -103.31 96.27 6.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.35 -1.088 . . . . 0.0 108.9 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 19.2 p -94.67 170.55 9.38 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.147 -0.971 . . . . 0.0 110.774 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.44 115.83 3.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.831 -0.543 . . . . 0.0 111.035 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 100.62 7.36 51.31 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 53.4 m -85.03 111.5 19.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.205 -1.173 . . . . 0.0 110.827 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 7.6 t -78.03 116.25 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 122.222 1.01 . . . . 0.0 109.503 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.1 m -113.64 178.62 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 86.6 m -130.45 130.86 44.79 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . 0.438 HD11 HG22 ' B' ' 363' ' ' ILE . 85.4 mt -106.86 126.26 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 177.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 71.1 m -129.96 137.17 50.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.554 -0.716 . . . . 0.0 109.48 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.32 156.54 43.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.337 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . 0.485 ' OE1' ' N ' ' B' ' 301' ' ' MET . 8.8 tp10 -145.96 122.84 11.31 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 157.42 -152.88 24.16 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 118.853 -1.641 . . . . 0.0 111.715 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -60.0 -52.96 63.15 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 122.268 -0.548 . . . . 0.0 112.357 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -110.2 11.26 23.66 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.838 -1.164 . . . . 0.0 111.224 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -42.58 -38.0 1.85 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.073 -1.017 . . . . 0.0 111.817 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -69.32 -44.17 72.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.531 -1.356 . . . . 0.0 110.158 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -70.83 -54.28 12.17 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.016 -1.053 . . . . 0.0 109.242 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.62 -35.95 1.95 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.627 -0.671 . . . . 0.0 110.771 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 53.2 t -70.04 -40.02 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.799 -1.188 . . . . 0.0 109.283 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.39 -65.38 0.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.985 -1.072 . . . . 0.0 111.668 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -59.96 -42.05 93.24 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.626 -1.296 . . . . 0.0 111.57 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 93.3 mt -59.92 -42.04 93.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.652 -1.28 . . . . 0.0 108.311 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.03 -42.36 96.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.297 -0.877 . . . . 0.0 109.684 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.4 mttt -69.99 -56.17 7.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.708 -1.245 . . . . 0.0 107.915 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 54.3 tp -54.51 -36.09 63.85 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 28.2 ttm -70.52 -40.25 73.58 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.391 -1.324 . . . . 0.0 108.413 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.46 -5.56 58.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.654 -0.654 . . . . 0.0 110.682 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' B' ' 379' ' ' LYS . 67.9 mt-10 -112.24 -1.96 15.03 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.052 -1.03 . . . . 0.0 110.708 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.3 mt -83.68 136.94 34.01 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.427 -1.42 . . . . 0.0 109.066 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.405 -179.639 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.7 mmm . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.448 -0.575 . . . . 3.19 109.448 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.4 mt -110.06 129.95 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.54 -0.911 . . . . 1.71 108.54 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.6 m -135.85 150.1 49.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.39 -0.819 . . . . 1.66 110.405 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.596 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -132.93 -164.62 10.94 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 108.081 -2.008 . . . . 1.05 108.081 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.6 mt -89.2 -14.46 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.632 -1.511 . . . . 1.59 110.353 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.0 tp 55.27 102.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.148 -0.97 . . . . 1.47 108.53 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.04 -22.86 19.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.994 -1.066 . . . . 1.39 109.633 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.5 m -149.99 133.4 8.62 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.097 -1.002 . . . . 2.09 109.677 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -80.37 141.01 13.98 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.4 2.067 . . . . 0.91 112.15 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 166.0 -165.58 38.19 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.712 -1.355 . . . . 0.92 109.712 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 11' ' ' ILE . 76.6 mt -147.54 148.01 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.22 -1.164 . . . . 1.35 108.52 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.17 156.55 34.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.939 -1.101 . . . . 1.14 110.487 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -137.01 129.64 30.26 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.315 -1.365 . . . . 0.7 107.315 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.38 -174.81 47.23 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 118.37 -1.871 . . . . 0.58 110.986 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -80.04 156.7 27.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.942 -0.74 . . . . 2.63 109.95 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.5 117.73 34.86 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.436 -0.79 . . . . 1.27 110.118 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.4 tp -89.99 131.55 35.82 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.507 -1.294 . . . . 1.41 107.507 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.5 tp -113.55 120.0 39.46 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.329 -0.857 . . . . 1.49 109.243 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.2 mt -82.74 102.76 11.75 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.515 0.674 . . . . 1.52 109.656 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -103.0 129.39 49.74 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.751 -0.833 . . . . 3.17 108.751 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.456 ' OE2' ' NZ ' ' A' ' 135' ' ' LYS . 87.0 tt0 -130.36 140.76 50.6 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.223 -0.923 . . . . 3.0 109.372 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -80.16 142.99 34.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.351 -0.843 . . . . 2.77 109.501 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -61.7 143.53 56.03 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.129 -0.982 . . . . 2.94 108.801 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.6 mt -78.16 129.16 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.084 -1.01 . . . . 1.46 109.119 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.7 t -94.14 127.59 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.223 -0.923 . . . . 1.7 109.998 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.6 mt -110.02 134.33 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.637 -0.664 . . . . 1.54 109.229 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -93.84 123.08 36.95 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.169 -0.957 . . . . 1.81 110.249 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.7 mmm-85 -90.0 -0.2 57.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.446 -0.784 . . . . 3.23 109.182 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -67.32 145.37 55.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.264 -0.897 . . . . 3.29 109.92 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -92.01 149.28 21.62 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.239 -0.913 . . . . 2.8 109.253 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.0 pt -95.7 165.81 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.998 -1.064 . . . . 1.43 109.046 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.2 p -93.11 173.93 7.48 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.419 -0.956 . . . . 1.54 108.419 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.26 78.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.898 -1.126 . . . . 1.6 109.669 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 51.8 t0 -54.93 -30.68 59.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.93 -1.106 . . . . 2.56 110.162 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -82.17 -8.67 59.66 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.177 -0.952 . . . . 2.36 110.249 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.98 -50.31 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.763 -1.21 . . . . 1.43 108.578 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -60.41 -39.96 89.26 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.359 -0.838 . . . . 1.77 108.926 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -62.25 -40.99 98.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.494 -0.753 . . . . 3.32 110.598 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -64.36 -41.63 96.62 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.813 -1.179 . . . . 1.51 110.166 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.07 -46.7 93.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.909 -1.119 . . . . 1.41 109.069 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -60.05 -40.79 90.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.055 -1.028 . . . . 1.81 109.551 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -60.06 -44.56 94.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.9 -1.125 . . . . 3.26 108.458 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -60.09 -49.16 78.76 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.313 -0.995 . . . . 0.81 108.313 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.1 -46.63 88.96 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.402 -0.962 . . . . 1.59 108.402 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.2 t -60.56 -44.47 96.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 1.38 108.875 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.02 -40.01 96.44 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.247 -1.941 . . . . 0.87 108.247 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.492 ' NH1' ' CG ' ' A' ' 47' ' ' ARG . 1.4 ttt-85 -69.11 -22.61 63.96 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.562 -0.964 . . . . 3.62 108.64 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.07 -46.37 88.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.259 -0.901 . . . . 1.43 109.155 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.598 ' CG ' ' H ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -78.15 -68.96 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.554 -1.258 . . . . 3.08 108.585 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.598 ' H ' ' CG ' ' A' ' 49' ' ' LYS . . . -37.84 -35.79 0.16 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 120.058 1.299 . . . . 1.33 110.462 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.3 t -57.97 -64.43 0.91 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.907 -1.121 . . . . 1.85 108.666 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.97 -40.07 79.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.475 -0.765 . . . . 1.35 110.832 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -63.11 -40.96 99.16 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.812 -1.18 . . . . 2.34 110.361 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 57.5 mt -62.94 -39.86 95.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.881 -1.137 . . . . 2.2 109.216 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -60.11 -38.95 84.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 1.35 110.014 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.6 m -61.24 -41.96 97.78 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.075 -1.015 . . . . 1.34 109.9 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.654 ' CD1' HH22 ' A' ' 136' ' ' ARG . 82.2 mt -61.2 -39.91 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -0.837 . . . . 1.26 109.522 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -59.97 -50.43 73.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.083 -1.011 . . . . 1.7 109.659 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -59.96 -39.14 84.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.281 -0.887 . . . . 1.35 110.125 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -66.03 -37.75 86.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.989 -1.07 . . . . 2.08 109.14 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.79 -45.53 85.91 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.599 -0.688 . . . . 1.21 109.89 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.41 -50.03 71.06 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.626 -1.39 . . . . 0.75 109.626 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -67.3 -45.87 75.24 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.294 -1.121 . . . . 1.59 109.871 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.9 m -65.23 -64.16 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.363 -0.836 . . . . 1.41 112.347 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.42 -47.91 6.65 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.723 -1.236 . . . . 0.79 111.188 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.35 -169.83 24.92 Favored Glycine 0 N--CA 1.501 3.016 0 C-N-CA 119.824 -1.179 . . . . 1.22 111.467 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.65 -27.3 64.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 122.01 -0.7 . . . . 5.81 110.41 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.514 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.3 tp10 -59.95 -32.92 71.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.275 -0.89 . . . . 3.37 110.258 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.578 ' NZ ' ' NE2' ' A' ' 189' ' ' HIS . 14.5 mmmt -98.99 -22.46 15.73 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.226 -0.921 . . . . 2.37 110.259 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.94 -40.07 94.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.954 -1.091 . . . . 1.65 109.893 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.82 -37.57 79.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.87 . . . . 1.42 110.309 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.01 -40.6 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.782 -1.199 . . . . 1.43 109.87 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -70.02 -34.11 72.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.858 -1.151 . . . . 1.08 109.609 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -61.18 -39.98 92.21 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.875 -1.141 . . . . 1.37 109.221 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.91 -41.84 95.2 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.547 -1.421 . . . . 0.67 109.547 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 60.9 m170 -60.16 -43.42 95.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -1.122 . . . . 1.99 109.582 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.3 mt -69.91 -43.55 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.116 -0.99 . . . . 1.22 109.491 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.2 ttp -59.96 -44.92 94.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.845 -1.159 . . . . 2.11 110.309 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.414 ' CD1' ' CE2' ' B' ' 348' ' ' PHE . 53.9 tp -62.02 -39.82 93.59 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.358 -0.839 . . . . 1.33 109.987 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.5 tp -62.16 -39.57 93.09 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.44 -0.788 . . . . 1.29 110.157 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -82.02 8.66 10.08 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.996 -1.065 . . . . 1.47 110.204 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 59.7 t0 -56.71 130.51 45.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.976 -1.077 . . . . 1.47 109.977 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.407 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.8 mt-10 -59.69 -18.43 42.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.482 -0.761 . . . . 1.78 111.019 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.89 -36.92 72.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.723 -1.235 . . . . 2.53 108.592 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.6 mt -69.99 -40.05 75.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.594 -0.691 . . . . 1.36 110.177 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.02 -49.99 75.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 1.42 110.483 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.13 -39.94 75.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.174 -0.954 . . . . 2.27 111.269 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.97 -40.18 75.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.835 -1.166 . . . . 1.57 111.66 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.2 mt -69.99 -44.15 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.739 -1.225 . . . . 1.19 109.917 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.9 mt -70.02 -37.83 73.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.616 -0.678 . . . . 1.39 110.374 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.68 84.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.988 . . . . 1.39 110.796 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 96' ' ' LYS . 84.8 mt -60.22 -47.06 87.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.082 -1.012 . . . . 1.5 109.986 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.2 mt -60.66 -50.04 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.309 -0.869 . . . . 1.29 109.447 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -70.08 -42.32 72.94 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.727 -0.789 . . . . 2.64 110.576 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -80.09 -52.79 7.36 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.188 -0.945 . . . . 1.65 112.417 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 92' ' ' LEU . 31.6 mtpt -90.12 -3.05 58.14 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.973 -1.08 . . . . 2.5 111.675 -177.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.1 m80 59.69 37.5 22.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.959 -1.088 . . . . 1.88 109.467 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 53.2 mtt -93.87 166.24 12.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.443 -0.786 . . . . 1.71 109.782 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.43 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 33.7 p -80.55 162.32 24.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.381 -0.824 . . . . 1.61 109.28 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.51 -37.61 85.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 1.33 110.102 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.43 ' OD1' ' OG1' ' A' ' 99' ' ' THR . 27.4 p-10 -69.87 -35.71 74.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 2.07 109.458 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.85 -41.05 27.09 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.296 -0.878 . . . . 1.37 109.56 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.2 -48.17 53.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.345 -0.847 . . . . 1.14 110.339 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.6 91.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 1.26 109.612 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.53 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 78.5 t60 -60.12 -40.0 88.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 2.02 109.617 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.54 -41.3 98.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.893 . . . . 1.33 110.81 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.28 -53.18 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.012 -1.055 . . . . 1.3 111.313 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.6 mm -70.0 -39.93 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.817 -1.177 . . . . 1.32 109.36 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.53 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 88.4 tt0 -64.65 -38.62 91.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.118 -0.989 . . . . 2.44 108.877 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.95 -43.7 97.86 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.479 -1.049 . . . . 0.99 110.479 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -69.94 -55.26 10.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.922 -1.34 . . . . 1.97 109.531 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.73 -40.31 69.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.183 -0.948 . . . . 1.43 109.343 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 33.8 t -57.77 -40.06 78.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.063 -1.023 . . . . 2.12 108.29 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.81 -39.56 87.77 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.743 -0.836 . . . . 1.64 108.743 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.9 mt -61.78 -42.48 99.04 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.119 -0.988 . . . . 1.93 109.673 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.43 -33.37 72.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.665 -1.272 . . . . 2.2 109.684 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.37 -23.17 35.98 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.984 -1.072 . . . . 2.12 108.506 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 21.9 mt -61.83 139.49 58.35 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.226 -1.027 . . . . 2.34 108.226 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -92.65 46.25 1.23 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.056 -1.027 . . . . 3.23 108.983 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -132.11 129.61 40.12 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.688 0.756 . . . . 2.49 109.664 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -70.05 -29.98 67.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.735 -0.603 . . . . 3.95 109.946 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.448 ' OH ' ' CA ' ' B' ' 315' ' ' HIS . 17.1 t80 -66.97 -42.97 84.24 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.958 0.885 . . . . 2.25 110.802 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.603 ' CD2' HH21 ' A' ' 126' ' ' ARG . 91.4 mt -70.67 -32.79 70.19 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.569 -0.707 . . . . 2.27 109.774 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -60.07 -39.98 87.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.312 -0.868 . . . . 3.31 108.86 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 125' ' ' GLU . 0.4 OUTLIER -59.51 -49.1 79.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.191 -0.943 . . . . 2.73 109.493 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.603 HH21 ' CD2' ' A' ' 123' ' ' LEU . 59.4 mtm180 -60.21 -39.6 87.18 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.569 -1.252 . . . . 3.2 108.418 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.44 -28.32 66.85 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.472 -0.936 . . . . 1.66 108.472 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.75 88.52 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.407 -0.808 . . . . 1.67 108.978 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -61.29 -41.3 96.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 1.55 109.703 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.72 -44.39 98.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.299 -0.875 . . . . 1.32 109.445 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -63.6 -40.04 95.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.127 -0.983 . . . . 3.58 109.914 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -60.01 -41.09 91.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 1.46 110.341 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.96 -46.8 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.916 -1.115 . . . . 1.22 109.85 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.3 -40.34 98.89 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.756 -1.338 . . . . 0.61 109.756 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.456 ' NZ ' ' OE2' ' A' ' 21' ' ' GLU . 57.6 tttm -59.97 -49.78 76.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -1.081 . . . . 3.1 110.472 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.654 HH22 ' CD1' ' A' ' 57' ' ' ILE . 63.1 mtp180 -63.12 -39.37 94.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.123 -0.985 . . . . 3.71 110.952 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.81 -40.11 87.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 1.87 110.111 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.35 -40.0 94.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.776 -1.203 . . . . 1.29 109.109 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -68.97 -38.74 79.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -0.846 . . . . 3.05 109.782 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -69.99 -31.22 68.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.45 -0.781 . . . . 1.26 111.887 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.56 -46.07 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.136 -1.603 . . . . 1.34 108.484 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.1 -31.23 68.7 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.634 -0.666 . . . . 1.6 109.561 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.61 45.93 4.46 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.507 -1.437 . . . . 0.96 109.507 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 tp -74.32 145.63 43.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.39 -1.065 . . . . 1.67 108.939 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -69.89 139.1 52.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.012 -1.055 . . . . 4.96 109.245 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.4 mt -111.75 129.96 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.936 0.874 . . . . 1.68 109.26 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.6 mt -59.89 -44.17 93.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.873 -0.517 . . . . 2.14 109.955 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.2 t0 66.37 99.03 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.516 0.674 . . . . 1.5 109.23 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.5 mt -66.46 -7.28 18.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.518 -0.739 . . . . 1.39 109.208 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -84.78 -16.82 40.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.463 -0.773 . . . . 1.83 109.208 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.31 13.08 3.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.436 -0.79 . . . . 1.46 111.162 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.539 ' N ' ' CD1' ' A' ' 152' ' ' ILE . 1.4 mp -90.28 126.21 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.58 -1.325 . . . . 1.42 108.804 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -104.09 -7.47 20.21 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.547 -0.721 . . . . 2.94 110.213 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -119.94 147.8 44.3 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.444 -0.785 . . . . 1.52 110.481 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.67 136.9 57.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.438 -0.789 . . . . 1.58 109.442 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.8 m -152.11 163.22 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -0.781 . . . . 1.32 109.334 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 79.5 mt -91.15 148.96 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 106.008 -1.849 . . . . 1.27 106.008 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 35.3 tp -96.38 113.98 25.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.869 -1.145 . . . . 1.41 110.39 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 50.4 t -121.76 129.92 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.83 -0.804 . . . . 1.23 108.83 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.96 162.26 34.35 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.243 -1.021 . . . . 1.32 108.243 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.9 -34.78 71.9 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.26 -1.525 . . . . 1.49 108.03 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -159.93 171.38 19.5 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.442 -0.947 . . . . 2.25 108.442 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.7 mt -139.76 140.04 36.62 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.063 -1.023 . . . . 1.35 109.592 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.3 p -100.19 135.43 20.33 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.415 -0.803 . . . . 1.56 109.501 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -38.61 -35.61 0.51 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.358 2.039 . . . . 0.87 113.437 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.5 m -59.9 -40.01 87.35 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.921 -1.112 . . . . 1.36 109.205 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.23 -40.98 90.63 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.308 -0.87 . . . . 1.61 109.948 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 67.3 p -57.21 -29.8 64.03 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.204 -0.935 . . . . 1.21 111.271 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.82 -53.91 13.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.682 -1.261 . . . . 1.21 109.768 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -86.98 36.36 0.72 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.022 -0.733 . . . . 2.11 109.022 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.4 tp -101.19 139.42 36.9 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.866 -0.79 . . . . 1.29 108.866 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -85.83 101.96 13.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.984 . . . . 2.81 108.954 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.09 -40.04 94.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.33 -0.856 . . . . 2.09 110.821 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -69.56 -25.46 64.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.966 -1.084 . . . . 2.86 111.458 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -93.15 -9.37 39.64 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.848 -1.157 . . . . 2.39 110.548 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 70.8 t -101.44 111.19 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.185 -1.043 . . . . 1.27 108.185 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.2 mt -83.52 3.27 33.03 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.228 -0.92 . . . . 2.17 110.577 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.29 170.49 37.62 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.147 -1.581 . . . . 0.52 109.147 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -131.31 128.62 40.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.454 -1.027 . . . . 0.55 109.374 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 84.9 mt -132.4 126.25 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.485 -0.931 . . . . 1.27 108.485 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 23.6 p -148.67 161.5 41.61 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.024 -1.048 . . . . 1.39 110.876 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.476 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 55.8 t0 -105.78 24.54 12.13 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.426 -0.583 . . . . 2.46 109.426 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.93 -161.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.241 -1.537 . . . . 1.51 111.195 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.02 -50.61 7.57 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.097 -1.201 . . . . 2.23 110.097 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 161.79 -133.68 3.23 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.27 -1.443 . . . . 2.23 110.909 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.533 ' C ' ' H ' ' A' ' 188' ' ' SER . 41.5 ttt-85 -60.02 -39.98 87.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.563 -0.963 . . . . 6.44 111.415 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 67.2 p -59.7 2.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.616 -1.302 . . . . 4.09 110.385 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 186' ' ' ARG . 24.8 t -92.0 127.96 37.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.969 -1.082 . . . . 2.2 109.898 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.578 ' NE2' ' NZ ' ' A' ' 69' ' ' LYS . 56.9 t60 -43.9 -48.52 8.47 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.356 -0.84 . . . . 1.15 109.458 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 61.6 m -55.04 -36.83 65.95 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.763 -0.585 . . . . 2.01 110.949 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.3 m -59.96 -39.99 87.53 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.679 -1.263 . . . . 1.93 110.441 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.8 mm -64.52 -39.91 87.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.134 -0.979 . . . . 2.2 109.122 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.0 mtp -59.94 -45.0 94.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.275 -0.891 . . . . 1.32 110.532 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.45 -45.52 84.65 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.381 -1.449 . . . . 1.3 109.956 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -62.4 -57.21 12.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.975 -1.078 . . . . 3.38 110.737 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.3 m -63.36 -40.02 96.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.002 -1.061 . . . . 1.15 111.997 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.34 -25.36 61.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.821 -1.175 . . . . 1.28 109.744 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 70.2 47.33 0.56 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.3 0.571 . . . . 1.5 110.218 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 62.7 mt -124.21 149.78 61.72 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 107.8 -1.185 . . . . 1.37 107.8 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.67 138.62 59.68 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 122.268 1.979 . . . . 0.76 111.832 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -171.77 152.01 2.97 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.605 -1.238 . . . . 1.19 111.713 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.8 mt -125.98 147.69 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.473 -1.306 . . . . 1.31 107.473 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.8 m -128.55 -9.92 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 O-C-N 120.932 -1.105 . . . . 1.38 110.812 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -114.73 24.58 10.91 Favored Glycine 0 N--CA 1.502 3.063 0 N-CA-C 110.435 -1.066 . . . . 1.03 110.435 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 204' ' ' GLY . 3.1 p -42.73 -47.17 5.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.262 -1.14 . . . . 1.38 110.192 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.443 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 98.71 -56.69 0.98 Allowed Glycine 0 N--CA 1.503 3.13 0 C-N-CA 120.221 -0.99 . . . . 1.17 111.549 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 26.1 p -148.99 26.62 0.88 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.445 -1.621 . . . . 2.07 111.103 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.23 -40.04 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.989 -1.069 . . . . 1.35 109.395 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.458 ' HG1' ' N ' ' A' ' 210' ' ' SER . 31.7 p -62.06 -29.27 70.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.169 -0.957 . . . . 1.49 109.765 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.458 ' N ' ' HG1' ' A' ' 209' ' ' THR . 94.9 p -79.94 -20.99 44.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.209 -0.932 . . . . 2.16 109.561 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -96.5 -8.34 32.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.25 -0.906 . . . . 2.89 109.534 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.94 138.72 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-O 121.622 0.725 . . . . 1.33 110.853 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.492 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 2.1 mptp? -112.59 154.72 25.57 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.655 -1.239 . . . . 2.73 107.655 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.466 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 17.9 p-10 -59.85 139.8 57.08 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.025 -1.047 . . . . 2.7 110.113 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.4 m-20 83.82 4.32 0.81 Allowed 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.121 0.486 . . . . 2.38 110.162 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.492 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 86.2 m-20 -73.57 138.16 44.76 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.136 -0.978 . . . . 2.09 109.231 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -90.09 117.91 29.23 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.501 -1.296 . . . . 1.45 107.501 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 74.5 mt -127.18 150.82 49.34 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.519 -0.738 . . . . 1.31 110.927 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.2 mt -117.61 129.99 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.147 -1.427 . . . . 1.29 107.147 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 22.2 tp -102.38 120.19 40.08 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.001 -1.062 . . . . 1.31 109.701 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.614 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 25.1 p-10 -80.05 -39.9 28.84 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.082 -1.011 . . . . 2.31 108.863 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.411 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 48.04 19.68 0.2 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.338 -0.986 . . . . 1.19 108.338 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.451 ' N ' ' C ' ' A' ' 221' ' ' ASP . 21.4 t -133.12 -44.3 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.339 -1.356 . . . . 1.45 107.339 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -100.1 0.02 39.91 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.747 -1.205 . . . . 3.13 107.747 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.596 HD22 ' H ' ' A' ' 4' ' ' GLY . 38.6 t30 60.02 46.88 10.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.714 -0.616 . . . . 2.2 109.57 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.614 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 76.9 mt-30 -140.04 151.82 45.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.43 -0.794 . . . . 2.32 109.622 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 83.1 t -119.12 129.96 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.419 -0.956 . . . . 1.4 108.419 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -99.95 118.79 37.11 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.477 -0.934 . . . . 1.29 108.477 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.4 t -99.98 115.13 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.544 -0.722 . . . . 1.38 110.503 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 52.45 63.09 9.39 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 2.33 111.164 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -88.99 148.46 5.67 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.557 2.172 . . . . 0.95 111.871 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 58.9 p -68.78 161.38 28.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 2.31 109.576 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -60.03 -39.97 87.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.843 . . . . 3.45 110.519 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -60.32 -32.96 71.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.932 -1.105 . . . . 2.89 109.816 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.33 -39.98 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -0.985 . . . . 1.73 109.141 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.883 . . . . 1.57 109.284 179.433 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 40.7 ttp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.46 0.648 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 30.1 t80 -155.78 155.37 32.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.482 -0.761 . . . . 0.0 109.1 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . 0.539 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 12.9 pt20 -146.75 157.03 43.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.166 -0.959 . . . . 0.0 109.939 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -152.94 150.07 28.88 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -114.99 135.2 54.49 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.169 -0.957 . . . . 0.0 110.638 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.0 p -134.89 123.45 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 CA-C-O 122.033 0.92 . . . . 0.0 112.277 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 89.8 m -80.19 107.19 12.79 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.957 0.884 . . . . 0.0 111.201 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . 0.417 HD11 HG22 ' B' ' 308' ' ' ILE . 96.0 mt -51.65 121.21 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 122.329 1.062 . . . . 0.0 110.438 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 23.7 p -108.61 16.86 22.58 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.786 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.7 129.06 84.37 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 120.743 -1.223 . . . . 0.0 108.175 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -64.34 -10.99 25.98 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 CA-C-N 120.154 1.091 . . . . 0.0 112.752 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -115.78 8.6 14.9 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.364 -0.835 . . . . 0.0 109.782 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.59 173.91 14.8 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.422 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 3.2 tp -81.66 90.24 6.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.895 -1.356 . . . . 0.0 109.693 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . 0.448 ' CA ' ' OH ' ' A' ' 122' ' ' TYR . 4.4 p80 -95.13 -161.37 0.85 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.84 -1.162 . . . . 0.0 109.939 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.0 m -58.01 -40.4 80.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.007 -1.058 . . . . 0.0 112.31 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.553 HH21 ' NE2' ' B' ' 321' ' ' GLN . 2.2 tpt180 -59.58 -61.94 6.87 Favored Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 120.402 -1.436 . . . . 0.0 111.591 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.07 -32.79 87.82 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 CA-C-N 120.028 1.046 . . . . 0.0 111.832 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.95 -51.6 68.96 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.416 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.61 64.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.227 -0.92 . . . . 0.0 110.006 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . 0.553 ' NE2' HH21 ' B' ' 317' ' ' ARG . 86.9 mt-30 -70.82 -39.95 72.74 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.829 -1.17 . . . . 0.0 109.062 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -62.73 -54.79 33.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.364 -0.835 . . . . 0.0 110.463 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 60.1 t -63.6 -38.51 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.666 -1.271 . . . . 0.0 108.806 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -59.98 -47.1 87.2 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.217 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -62.58 -49.76 73.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.359 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.16 -51.56 52.29 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.256 -0.903 . . . . 0.0 110.883 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -52.04 -14.42 0.41 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.118 -0.989 . . . . 0.0 109.897 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -79.92 -17.23 75.31 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -106.01 140.55 38.83 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.319 -1.106 . . . . 0.0 108.758 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 5.3 p -91.42 -13.79 31.73 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.792 -1.192 . . . . 0.0 110.158 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 29.5 p -57.28 150.46 17.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.938 -1.101 . . . . 0.0 108.474 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.05 132.46 46.66 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.855 -1.153 . . . . 0.0 108.627 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.8 mt -133.4 133.64 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.615 -0.678 . . . . 0.0 109.531 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.7 m -130.04 152.28 49.66 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.481 -0.762 . . . . 0.0 109.117 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 72.0 t -123.88 114.68 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 87.0 m -105.22 130.45 53.37 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.144 -0.972 . . . . 0.0 109.177 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 97.0 p -136.47 114.01 10.97 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.92 0.867 . . . . 0.0 110.777 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 45.35 51.85 9.22 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.98 -13.82 63.63 Favored Glycine 0 N--CA 1.503 3.135 0 O-C-N 120.102 -1.624 . . . . 0.0 112.935 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -118.67 130.37 55.81 Favored 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 119.414 1.607 . . . . 0.0 109.367 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 82.2 p -128.51 150.75 50.03 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.968 0.889 . . . . 0.0 110.845 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -145.24 166.64 24.9 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.573 0.701 . . . . 0.0 110.126 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.8 m -88.99 139.94 29.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.449 -0.782 . . . . 0.0 110.052 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.457 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -78.78 -14.35 59.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.916 -1.115 . . . . 0.0 110.071 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -89.98 20.3 4.32 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.457 ' H ' ' C ' ' B' ' 344' ' ' ALA . 90.5 p -145.8 92.14 2.18 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.407 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . 0.558 ' CD1' HE22 ' B' ' 351' ' ' GLN . 57.1 tp -59.98 -34.54 73.44 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . 0.414 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 64.2 m-85 -56.33 -53.48 56.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.169 -0.957 . . . . 0.0 110.393 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.407 ' O ' ' OG1' ' B' ' 352' ' ' THR . 47.2 mtpt -69.43 -39.81 77.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 110.387 -177.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' B' ' 352' ' ' THR . 23.2 mt -47.67 -59.66 3.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.158 -0.964 . . . . 0.0 108.978 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.558 HE22 ' CD1' ' B' ' 347' ' ' LEU . 1.5 mp0 -39.27 -21.12 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.721 -0.612 . . . . 0.0 111.298 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.528 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.1 p -78.03 -10.1 59.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.102 -1.624 . . . . 0.0 110.216 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 49.9 mt -96.09 118.32 32.45 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.134 -0.979 . . . . 0.0 109.14 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.35 96.74 0.92 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 32.2 mt -106.77 95.29 5.63 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.447 -1.031 . . . . 0.0 109.582 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 356' ' ' THR . . . . . 0.406 ' H ' ' HG1' ' B' ' 356' ' ' THR . 17.8 p -98.31 176.42 5.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.217 -0.927 . . . . 0.0 110.462 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -63.93 111.89 2.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.806 -0.559 . . . . 0.0 110.586 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.76 7.7 38.49 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 46.9 m -84.83 110.23 18.67 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.087 -1.243 . . . . 0.0 111.067 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 4.9 t -78.12 115.62 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 122.113 0.959 . . . . 0.0 110.167 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 29.1 m -112.65 177.52 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 86.6 m -131.11 130.31 42.97 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 82.3 mt -105.34 120.35 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 58.7 m -121.38 132.56 54.83 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.25 153.9 41.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 110.034 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -146.77 122.91 10.83 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.455 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 159.53 -155.29 26.38 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 118.586 -1.768 . . . . 0.0 111.932 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.93 -53.36 58.78 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -107.31 11.61 28.97 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.898 -1.126 . . . . 0.0 111.383 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.3 pt-20 -40.23 -37.54 0.65 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.431 -0.793 . . . . 0.0 111.581 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.04 -44.31 72.92 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.73 -1.231 . . . . 0.0 110.787 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -69.79 -51.78 30.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.782 -1.199 . . . . 0.0 109.167 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -45.81 -37.22 5.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.646 -0.659 . . . . 0.0 111.278 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 81.8 t -69.98 -39.98 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.698 -1.251 . . . . 0.0 109.151 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.99 -64.45 0.86 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 111.163 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -60.06 -45.82 91.59 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.683 -1.261 . . . . 0.0 111.771 -177.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.9 mt -59.98 -41.39 91.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.623 -1.298 . . . . 0.0 108.813 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 54.7 t -65.88 -42.05 91.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.158 -0.964 . . . . 0.0 109.742 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -71.29 -57.96 3.98 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.742 -1.224 . . . . 0.0 107.85 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . 0.411 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 60.2 tp -56.22 -32.48 64.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.397 -0.814 . . . . 0.0 109.839 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 45.2 ttm -74.44 -40.02 62.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.007 -1.058 . . . . 0.0 108.813 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.67 -4.45 46.18 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.682 -0.636 . . . . 0.0 110.121 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -110.84 3.36 18.9 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.319 -0.863 . . . . 0.0 110.963 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . 0.411 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 32.3 mt -69.87 130.03 41.13 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.397 -1.439 . . . . 0.0 109.764 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.079 179.45 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.301 -0.629 . . . . 3.19 109.301 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.5 mt -108.88 128.69 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.644 -0.873 . . . . 1.71 108.644 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.1 m -118.85 154.04 33.54 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.081 -0.711 . . . . 1.66 109.081 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.752 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -141.75 179.05 20.12 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.359 -1.897 . . . . 1.05 108.359 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.5 mt -85.21 -4.69 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.88 -1.365 . . . . 1.59 110.607 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.5 tp 52.31 93.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.64 -1.288 . . . . 1.47 109.362 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.22 -40.03 78.2 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.219 -1.03 . . . . 1.39 108.219 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 2.6 p -154.08 146.88 17.73 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 108.943 -0.762 . . . . 2.09 108.943 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -80.32 144.2 16.12 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.74 2.293 . . . . 0.91 113.5 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.67 164.51 13.27 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.544 -1.422 . . . . 0.92 109.544 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -117.42 152.82 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.13 -1.218 . . . . 1.35 110.072 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.91 155.98 35.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.228 -0.92 . . . . 1.14 109.83 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.9 OUTLIER -137.71 128.07 26.35 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.604 -0.888 . . . . 0.7 108.604 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.91 179.32 47.25 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 118.902 -1.618 . . . . 0.58 110.534 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -78.94 157.08 28.27 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.629 -0.924 . . . . 2.63 109.064 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.31 134.28 45.85 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.376 -0.827 . . . . 1.27 110.701 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.9 tp -106.93 139.39 41.41 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.346 -1.353 . . . . 1.41 107.346 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.0 tp -119.06 121.03 38.91 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.309 -0.87 . . . . 1.49 110.146 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.8 mt -81.91 102.89 11.18 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.003 -0.679 . . . . 1.52 109.809 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -95.5 131.48 41.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.413 -0.804 . . . . 3.17 109.543 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -126.12 137.83 53.63 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.714 -0.847 . . . . 3.0 108.714 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 47.5 t0 -87.24 147.86 25.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.07 -1.019 . . . . 2.77 109.557 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.461 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 88.3 tt0 -64.18 149.88 46.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.906 . . . . 2.94 109.335 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.9 mt -91.87 127.46 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.374 -0.829 . . . . 1.46 108.897 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.6 t -93.62 124.07 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.159 -0.963 . . . . 1.7 109.738 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -106.74 135.66 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.796 -0.816 . . . . 1.54 108.796 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -95.04 117.04 29.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.001 -1.062 . . . . 1.81 109.328 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -89.83 2.11 55.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.431 -0.793 . . . . 3.23 109.097 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -58.81 146.13 38.27 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.291 -0.881 . . . . 3.29 109.583 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -84.76 137.6 33.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.423 -0.798 . . . . 2.8 109.035 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 pt -91.73 163.25 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.966 -1.084 . . . . 1.43 109.92 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.3 p -97.18 174.93 6.48 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.925 . . . . 1.54 108.761 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.05 83.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 1.6 109.689 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -57.35 -30.22 64.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.741 -1.224 . . . . 2.56 109.433 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -81.45 -10.2 59.55 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.185 -0.947 . . . . 2.36 109.891 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.9 -53.42 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.705 -1.247 . . . . 1.43 108.519 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.14 -40.01 94.52 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.59 -0.694 . . . . 1.77 110.14 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -69.87 -41.2 75.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.024 -1.047 . . . . 3.32 110.436 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -64.91 -40.02 94.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.832 -1.168 . . . . 1.51 110.069 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.3 t -62.84 -47.0 94.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.905 -1.122 . . . . 1.41 108.937 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -64.59 -42.8 95.35 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.047 -1.033 . . . . 1.81 110.063 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -60.07 -42.19 94.02 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.425 -1.324 . . . . 3.26 107.425 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -61.16 -50.04 74.8 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.151 -0.685 . . . . 0.81 109.151 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.9 tp -59.99 -42.32 93.95 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.444 -0.947 . . . . 1.59 108.444 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.8 t -63.6 -39.98 95.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 1.38 109.325 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.56 -48.98 77.69 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.702 -1.759 . . . . 0.87 108.702 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -61.1 -39.99 92.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.337 -1.096 . . . . 3.62 108.256 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.64 -43.27 17.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.558 -0.714 . . . . 1.43 109.14 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 50' ' ' ALA . 24.7 ttmt -66.07 -72.83 0.15 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.678 -1.23 . . . . 3.08 107.678 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.92 -42.45 0.62 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.359 -0.838 . . . . 1.33 111.37 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.2 t -51.37 -56.36 13.54 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.59 -1.319 . . . . 1.85 109.177 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.71 -41.95 74.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.195 -0.94 . . . . 1.35 110.794 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.7 -40.06 88.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.932 -1.105 . . . . 2.34 109.794 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.7 mt -60.62 -40.05 90.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.99 -1.069 . . . . 2.2 108.713 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -60.85 -33.54 73.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.455 -0.778 . . . . 1.35 109.429 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -65.15 -44.09 89.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.039 -1.038 . . . . 1.34 109.427 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.05 -38.98 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.884 -0.784 . . . . 1.26 108.884 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -59.45 -49.97 75.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.468 -0.77 . . . . 1.7 109.67 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -59.58 -37.45 78.55 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.273 -0.892 . . . . 1.35 110.223 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -63.93 -38.91 92.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.96 -1.087 . . . . 2.08 109.595 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.27 99.12 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.373 -0.829 . . . . 1.21 109.15 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.44 -51.4 58.97 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.101 -1.2 . . . . 0.75 110.101 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.39 -46.72 66.24 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.928 -1.337 . . . . 1.59 110.02 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.1 m -67.25 -63.08 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 1.41 112.442 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.474 ' CE2' ' O ' ' A' ' 168' ' ' THR . 95.4 m-85 -92.9 -50.5 5.52 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.749 -1.219 . . . . 0.79 110.917 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.46 -169.9 24.93 Favored Glycine 0 N--CA 1.499 2.894 0 C-N-CA 119.954 -1.117 . . . . 1.22 110.939 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -69.74 -24.19 63.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.894 -0.768 . . . . 5.81 109.714 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -60.04 -35.55 75.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.569 -0.707 . . . . 3.37 110.175 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -100.37 -18.5 16.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.329 -0.857 . . . . 2.37 110.415 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -70.05 -40.01 75.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.778 -1.202 . . . . 1.65 110.643 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.51 -30.58 70.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.217 -0.927 . . . . 1.42 110.22 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.9 mt -59.94 -40.63 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.051 -1.031 . . . . 1.43 109.291 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -70.04 -38.18 75.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 1.08 110.947 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -60.05 -39.93 87.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.859 -1.151 . . . . 1.37 109.8 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.97 -43.36 99.01 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.306 -1.518 . . . . 0.67 109.306 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -61.98 -42.93 99.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.388 -1.066 . . . . 1.99 109.705 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 98.7 mt -70.05 -43.34 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.225 -0.922 . . . . 1.22 109.741 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.8 ttp -59.97 -40.09 87.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.841 -1.162 . . . . 2.11 109.512 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.405 ' CD1' ' CE2' ' B' ' 348' ' ' PHE . 31.7 tp -65.21 -38.03 89.16 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.471 -0.768 . . . . 1.33 109.699 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.9 -40.09 95.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.455 -0.778 . . . . 1.29 109.964 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -81.0 6.29 13.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.238 -0.914 . . . . 1.47 110.219 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -52.75 133.47 36.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.073 -1.017 . . . . 1.47 110.473 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.44 -19.45 63.5 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.556 -0.715 . . . . 1.78 110.658 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.07 -33.87 72.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.92 -1.113 . . . . 2.53 108.887 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.0 mt -70.13 -41.46 73.89 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.41 0.624 . . . . 1.36 110.055 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -60.05 -48.79 80.25 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.3 -0.875 . . . . 1.42 110.943 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -70.0 -40.93 74.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.07 -1.019 . . . . 2.27 111.323 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -69.97 -40.02 75.63 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.031 -1.043 . . . . 1.57 111.485 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 84.2 mt -65.88 -49.87 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.975 -1.078 . . . . 1.19 109.69 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.7 mt -65.1 -37.15 79.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.686 -0.634 . . . . 1.39 110.401 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.03 -49.63 76.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.103 -0.998 . . . . 1.39 110.763 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.43 -45.89 91.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.83 -1.169 . . . . 1.5 109.748 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.7 mt -61.51 -49.96 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.981 0.896 . . . . 1.29 109.159 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -67.93 -44.92 75.72 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 120.163 -0.615 . . . . 2.64 111.144 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -80.19 -51.18 9.26 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.878 -1.138 . . . . 1.65 112.152 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -90.1 -3.38 57.95 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.91 -1.119 . . . . 2.5 112.13 -177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 39.0 m80 57.76 34.82 24.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.892 -1.13 . . . . 1.88 110.605 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 71.0 mtm -90.81 169.91 10.55 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.013 -1.054 . . . . 1.71 109.38 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.6 p -75.3 154.28 37.47 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.093 -1.005 . . . . 1.61 108.465 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.95 -36.87 75.59 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.1 -1.0 . . . . 1.33 110.541 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 38.2 p-10 -65.62 -38.71 90.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.99 -1.069 . . . . 2.07 109.766 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.522 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.53 -44.4 19.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.142 -0.974 . . . . 1.37 109.318 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.88 92.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.396 -0.815 . . . . 1.14 109.44 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.06 94.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.87 . . . . 1.26 109.557 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -59.49 -39.97 85.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.822 . . . . 2.02 109.573 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 110' ' ' GLY . 86.1 tt0 -63.12 -40.02 96.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.117 -0.989 . . . . 1.33 109.28 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.5 t -61.61 -52.27 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.471 -0.768 . . . . 1.3 110.731 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.5 mm -70.08 -39.98 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.916 -1.115 . . . . 1.32 108.934 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -67.24 -38.29 84.96 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.231 -1.026 . . . . 2.44 108.231 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.24 -50.0 70.59 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.33 -1.108 . . . . 0.99 110.33 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.402 HE21 ' CB ' ' B' ' 348' ' ' PHE . 14.8 mm100 -66.84 -52.22 46.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.654 -1.497 . . . . 1.97 109.06 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.85 -39.98 75.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 1.43 108.964 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.1 t -55.74 -39.46 71.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.238 -0.914 . . . . 2.12 108.708 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.05 -37.55 75.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.162 -0.961 . . . . 1.64 109.784 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.3 mt -67.47 -48.59 66.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.117 -0.989 . . . . 1.93 110.704 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -60.49 -21.96 62.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.391 -1.443 . . . . 2.2 110.194 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -67.97 -16.0 63.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.814 -1.179 . . . . 2.12 108.783 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 28.4 mt -63.05 145.61 55.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.296 -0.877 . . . . 2.34 108.95 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -90.53 28.81 1.4 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.248 -0.908 . . . . 3.23 110.458 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 55.5 t0 -117.36 131.89 56.7 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.333 -0.854 . . . . 2.49 109.78 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.418 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 47.1 mt-10 -69.97 -28.94 65.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.515 -0.74 . . . . 3.95 109.934 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.68 ' HH ' HH12 ' A' ' 126' ' ' ARG . 2.7 t80 -69.89 -37.87 76.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 2.25 109.999 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 72.4 mt -77.14 -31.32 55.59 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.08 -1.013 . . . . 2.27 109.036 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -60.02 -40.06 87.98 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.195 -0.941 . . . . 3.31 108.645 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -47.01 87.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -0.811 . . . . 2.73 109.305 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.68 HH12 ' HH ' ' A' ' 122' ' ' TYR . 4.2 mmm-85 -60.02 -40.05 87.95 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.282 -0.887 . . . . 3.2 109.898 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.37 76.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.035 -1.04 . . . . 1.66 108.656 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.08 95.65 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.067 -0.716 . . . . 1.67 109.067 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -66.59 -42.43 86.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.369 -0.832 . . . . 1.55 109.453 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.94 -40.38 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.287 -0.883 . . . . 1.32 108.625 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -60.24 -41.31 92.88 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.465 -0.772 . . . . 3.58 109.101 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -59.92 -40.01 87.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.514 -0.741 . . . . 1.46 110.726 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.9 mt -60.07 -41.28 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 1.22 110.304 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.53 -40.44 94.25 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.646 -1.264 . . . . 0.61 110.02 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -60.01 -45.27 93.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.292 -1.122 . . . . 3.1 110.314 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -65.96 -35.88 81.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.589 -1.319 . . . . 3.71 110.038 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.94 -41.6 92.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.107 -0.995 . . . . 1.87 109.441 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.01 -40.01 87.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.108 -0.995 . . . . 1.29 108.908 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -65.77 -39.98 91.55 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.749 -0.834 . . . . 3.05 108.749 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -69.73 -29.03 66.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.628 -0.67 . . . . 1.26 111.85 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.3 mt -70.02 -40.77 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.255 -1.528 . . . . 1.34 108.624 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.7 -29.66 59.07 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.676 -0.64 . . . . 1.6 109.747 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.19 45.82 4.62 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 108.954 -1.658 . . . . 0.96 108.954 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.6 tp -74.81 149.99 39.46 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.457 -1.025 . . . . 1.67 109.503 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -70.21 143.77 52.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.206 -0.934 . . . . 4.96 109.881 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.6 mt -114.91 128.8 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 122.037 0.922 . . . . 1.68 109.274 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.8 mt -69.93 -40.12 78.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.873 -0.603 . . . . 2.14 110.654 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.1 t0 63.39 103.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.27 -0.894 . . . . 1.5 109.223 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 57.7 mt -68.45 -1.25 6.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.395 -0.816 . . . . 1.39 109.88 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.6 p -81.67 -14.61 56.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.02 -1.05 . . . . 1.83 109.878 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.8 26.42 0.83 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.239 -0.913 . . . . 1.46 112.225 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 36.1 mm -90.8 122.49 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 120.367 -1.458 . . . . 1.42 109.122 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -104.39 -12.52 16.52 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.428 -0.795 . . . . 2.94 110.415 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -122.3 147.78 45.82 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.286 -0.884 . . . . 1.52 110.182 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.92 135.76 56.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.82 . . . . 1.58 109.487 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.0 m -152.8 166.63 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.608 -0.682 . . . . 1.32 109.799 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 86.3 mt -94.74 148.9 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.485 -1.672 . . . . 1.27 106.485 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 14.9 tp -97.78 118.19 33.76 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.867 -1.146 . . . . 1.41 110.383 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.8 t -123.12 130.01 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.808 -0.812 . . . . 1.23 108.808 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -156.66 160.67 39.58 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.385 -0.968 . . . . 1.32 108.385 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.84 -31.83 65.04 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.266 -1.521 . . . . 1.49 107.588 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -157.94 165.62 34.7 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.853 -0.795 . . . . 2.25 108.853 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 78.0 mt -136.95 132.16 34.01 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.162 -0.961 . . . . 1.35 108.964 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.1 p -102.44 148.99 36.27 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.389 -0.82 . . . . 1.56 108.975 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -41.59 -34.13 2.02 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.97 1.78 . . . . 0.87 112.211 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 43.7 m -57.46 -43.37 83.95 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.354 -0.841 . . . . 1.36 109.961 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.94 -40.96 75.19 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.126 -0.984 . . . . 1.61 110.252 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.474 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 72.0 p -58.03 -19.9 34.88 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.166 -0.959 . . . . 1.21 111.581 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.69 -43.18 13.62 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.634 -1.291 . . . . 1.21 109.773 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -96.98 41.53 1.11 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.39 -0.967 . . . . 2.11 108.39 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.9 tp -105.29 131.51 52.66 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.588 -0.893 . . . . 1.29 108.588 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -84.03 103.33 13.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.008 -1.058 . . . . 2.81 108.847 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.77 -40.8 95.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.854 . . . . 2.09 110.814 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -65.59 -27.39 68.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.82 -1.175 . . . . 2.86 111.286 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.454 ' N ' ' CD ' ' A' ' 175' ' ' LYS . 1.1 mptm? -93.32 -11.83 31.48 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.895 -1.128 . . . . 2.39 109.723 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 178' ' ' GLY . 87.6 t -100.01 110.03 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.138 -0.977 . . . . 1.27 108.908 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 89.9 mt -83.76 7.32 18.16 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.229 -0.919 . . . . 2.17 110.377 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.407 ' O ' ' CG1' ' A' ' 176' ' ' VAL . . . 167.94 176.26 38.35 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.247 -1.541 . . . . 0.52 109.247 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -133.24 129.9 38.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.353 -1.087 . . . . 0.55 108.658 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.2 mt -132.93 126.51 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.309 -0.869 . . . . 1.27 109.28 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.4 p -145.35 158.03 43.92 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.034 -1.041 . . . . 1.39 111.189 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.529 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -103.14 26.84 7.77 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.789 -0.819 . . . . 2.46 108.789 179.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -67.42 -158.96 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.055 -1.028 . . . . 1.51 112.028 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.14 -50.55 10.23 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.07 -1.212 . . . . 2.23 110.07 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.85 -120.05 1.1 Allowed Glycine 0 N--CA 1.493 2.459 0 O-C-N 120.868 -1.372 . . . . 2.23 110.766 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.547 ' NE ' HH22 ' A' ' 195' ' ' ARG . 58.4 mtp180 -60.96 -37.6 82.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.774 -0.839 . . . . 6.44 111.627 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 32.7 p -67.31 3.02 1.36 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.9 -1.125 . . . . 4.09 110.909 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.8 t -90.39 118.89 30.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.746 -1.222 . . . . 2.2 109.952 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -43.11 -52.63 5.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.355 -0.841 . . . . 1.15 109.636 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -33.16 41.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.352 -0.842 . . . . 2.01 110.706 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.1 t -59.99 -42.03 93.35 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.727 -1.233 . . . . 1.93 110.225 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.3 mm -60.37 -39.95 82.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.357 -0.84 . . . . 2.2 109.005 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.6 mtp -60.01 -40.56 89.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.495 -0.753 . . . . 1.32 110.919 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.36 95.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.673 -1.267 . . . . 1.3 109.149 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.547 HH22 ' NE ' ' A' ' 186' ' ' ARG . 98.4 mtt180 -59.96 -53.34 59.04 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.221 -0.924 . . . . 3.38 110.375 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.3 m -69.73 -35.66 75.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.067 -1.021 . . . . 1.15 111.267 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.03 -28.6 65.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.865 -1.147 . . . . 1.28 108.906 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 70.24 45.73 0.65 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.506 0.669 . . . . 1.5 109.644 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.471 ' O ' ' OG ' ' A' ' 8' ' ' SER . 88.2 mt -122.73 150.04 57.47 Favored Pre-proline 0 N--CA 1.498 1.963 0 N-CA-C 107.84 -1.171 . . . . 1.37 107.84 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.79 142.68 70.78 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.002 1.801 . . . . 0.76 111.536 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.01 151.15 3.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.983 -1.073 . . . . 1.19 111.388 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.402 HG22 HD11 ' A' ' 202' ' ' ILE . 85.7 mt -123.47 143.47 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.783 -1.191 . . . . 1.31 107.783 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 5.8 m -126.67 -10.08 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 120.694 -1.254 . . . . 1.38 110.54 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.1 23.14 26.01 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 110.323 -1.111 . . . . 1.03 110.323 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.43 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.5 p -46.02 -43.24 14.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.089 -1.242 . . . . 1.38 109.715 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.88 -52.6 3.92 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 120.144 -1.027 . . . . 1.17 111.532 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.9 m -157.38 33.76 0.28 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.54 -1.565 . . . . 2.07 111.425 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 56.1 t -72.77 -40.1 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.908 -1.12 . . . . 1.35 109.111 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.4 p -54.82 -32.36 60.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.431 -0.793 . . . . 1.49 110.578 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 84.9 p -76.43 -16.29 59.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.985 -1.072 . . . . 2.16 109.421 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -101.64 -13.73 17.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.498 -0.751 . . . . 2.89 109.95 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 55.9 t -104.77 137.92 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.359 -0.838 . . . . 1.33 110.555 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -112.79 151.7 30.03 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.686 -1.227 . . . . 2.73 107.686 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 30.5 p-10 -57.92 137.03 57.11 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.016 -1.053 . . . . 2.7 110.251 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.8 OUTLIER 82.79 8.69 0.72 Allowed 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.14 0.495 . . . . 2.38 110.432 179.281 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 60.5 t0 -77.8 143.57 37.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.12 -0.987 . . . . 2.09 109.131 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.527 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 33.9 t80 -88.32 118.24 27.8 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.025 -1.047 . . . . 1.45 109.041 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 91.7 mt -130.63 149.42 52.29 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.515 -0.741 . . . . 1.31 110.544 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.7 mt -118.28 128.56 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 106.85 -1.537 . . . . 1.29 106.85 177.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.7 tp -100.61 122.5 43.38 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.961 -1.087 . . . . 1.31 109.466 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.419 ' C ' ' N ' ' A' ' 223' ' ' VAL . 19.3 m-20 -87.53 -42.77 12.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.982 -1.074 . . . . 2.31 109.884 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 47.15 22.81 0.25 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.674 -0.861 . . . . 1.19 108.674 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.419 ' N ' ' C ' ' A' ' 221' ' ' ASP . 18.0 t -127.25 -42.82 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.903 -1.517 . . . . 1.45 106.903 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -109.84 7.39 24.04 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.0 -1.111 . . . . 3.13 108.0 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.752 HD22 ' H ' ' A' ' 4' ' ' GLY . 36.6 t-20 60.04 52.12 5.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.794 -0.566 . . . . 2.2 110.532 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -147.17 158.56 43.99 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.784 -1.198 . . . . 2.32 110.463 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.6 t -126.81 130.04 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.496 -0.927 . . . . 1.4 108.496 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -98.43 122.93 42.22 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.426 -0.796 . . . . 1.29 109.212 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 18.2 t -100.79 111.28 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.551 -0.718 . . . . 1.38 110.083 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 54.98 63.14 7.17 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.235 -0.916 . . . . 2.33 111.244 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -86.87 150.07 8.43 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.571 2.181 . . . . 0.95 112.246 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 39.8 p -74.43 165.02 25.9 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.318 -0.864 . . . . 2.31 109.437 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -60.0 -34.43 73.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.426 -0.796 . . . . 3.45 110.592 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -59.94 -39.29 85.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.053 -1.029 . . . . 2.89 109.756 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 76.1 t -70.02 -40.27 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.031 -1.043 . . . . 1.73 109.18 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 99.4 mt . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.342 -0.849 . . . . 1.57 109.658 -179.715 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 7.5 ttt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -151.69 149.54 29.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.368 -0.832 . . . . 0.0 109.099 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -148.91 159.96 43.71 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.053 -1.029 . . . . 0.0 110.655 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -152.7 148.74 27.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.475 -0.766 . . . . 0.0 109.314 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -107.03 131.11 54.45 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.135 -0.978 . . . . 0.0 109.646 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.59 119.06 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 122.186 0.993 . . . . 0.0 112.782 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 94.6 m -78.34 104.75 9.13 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.919 0.866 . . . . 0.0 110.004 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' B' ' 358' ' ' GLY . 70.4 mt -51.74 118.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 122.317 1.056 . . . . 0.0 110.295 -177.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 51.6 p -108.1 17.08 22.73 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.24 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . 0.405 ' O ' ' CG ' ' B' ' 357' ' ' GLN . . . -71.92 117.14 55.29 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.063 -1.023 . . . . 0.0 108.54 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -51.92 -16.07 3.86 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 CA-C-N 120.35 1.161 . . . . 0.0 113.594 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -120.47 10.57 11.19 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.329 -0.857 . . . . 0.0 109.357 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.14 -179.79 31.4 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.495 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -88.66 93.98 9.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.351 -1.088 . . . . 0.0 109.353 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -96.58 -160.01 0.77 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.897 -1.127 . . . . 0.0 110.564 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 316' ' ' THR . . . . . 0.403 ' H ' ' HG1' ' B' ' 316' ' ' THR . 2.2 m -57.33 -44.03 83.89 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.005 -1.059 . . . . 0.0 112.367 -175.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.556 HH21 ' NE2' ' B' ' 321' ' ' GLN . 2.1 tpt180 -59.92 -60.57 10.17 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 120.651 -1.28 . . . . 0.0 112.233 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -58.73 -29.82 90.72 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 CA-C-N 120.444 1.194 . . . . 0.0 111.595 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.92 -52.01 67.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 108.861 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.65 -41.49 61.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.944 . . . . 0.0 109.4 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . 0.556 ' NE2' HH21 ' B' ' 317' ' ' ARG . 89.5 mt-30 -69.96 -40.04 75.64 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.15 -0.969 . . . . 0.0 108.753 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -60.86 -52.88 63.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.519 -0.738 . . . . 0.0 110.989 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 71.9 t -67.74 -29.34 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.646 -1.284 . . . . 0.0 109.997 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -61.16 -45.53 94.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.942 . . . . 0.0 109.3 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -64.02 -45.04 90.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.332 -0.855 . . . . 0.0 110.178 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -61.44 -53.66 53.59 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.016 -1.053 . . . . 0.0 111.41 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -57.51 -13.26 3.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.868 -1.145 . . . . 0.0 109.496 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -68.24 -29.74 73.37 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -103.85 147.22 27.57 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.503 -0.998 . . . . 0.0 109.253 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 17.6 p -91.06 -11.88 37.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.975 -1.078 . . . . 0.0 109.85 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 80.8 p -64.09 158.01 23.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.342 -0.849 . . . . 0.0 110.478 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -74.85 132.96 41.92 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.0 mt -132.32 133.01 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.617 -0.677 . . . . 0.0 109.209 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 69.4 m -127.92 151.04 49.58 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.48 -0.763 . . . . 0.0 109.491 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 60.8 t -117.04 137.83 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 87.6 m -128.96 125.12 36.76 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.184 -0.948 . . . . 0.0 109.083 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 12.2 t -138.67 119.12 13.8 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.959 0.885 . . . . 0.0 110.798 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' B' ' 338' ' ' ASN . 8.1 p-10 39.01 65.13 0.7 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 79.3 -12.36 26.35 Favored Glycine 0 N--CA 1.5 2.947 0 O-C-N 120.833 -1.167 . . . . 0.0 113.668 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -120.67 133.09 55.38 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-N 119.564 1.682 . . . . 0.0 109.963 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 78.7 p -129.91 150.4 51.21 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.8 0.809 . . . . 0.0 110.513 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.23 167.33 22.68 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.528 0.68 . . . . 0.0 110.11 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 12.2 m -88.93 138.94 30.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.504 -0.748 . . . . 0.0 109.808 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -76.8 -13.03 60.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.907 -1.121 . . . . 0.0 108.974 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -89.69 16.58 7.66 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 67.3 m -145.61 94.79 2.55 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.607 0.717 . . . . 0.0 111.068 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . 0.57 ' O ' ' NE2' ' B' ' 351' ' ' GLN . 52.9 tp -59.89 -33.96 72.54 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . 0.405 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 54.2 m-85 -55.79 -52.84 62.59 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.928 -1.108 . . . . 0.0 109.852 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -69.99 -20.77 63.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -0.898 . . . . 0.0 111.889 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.97 -46.76 64.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.428 -1.42 . . . . 0.0 110.817 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.57 ' NE2' ' O ' ' B' ' 347' ' ' LEU . 0.7 OUTLIER -47.92 -21.11 0.38 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.894 -1.129 . . . . 0.0 111.695 -177.371 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 71.3 p -77.31 -12.97 60.01 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.168 -1.582 . . . . 0.0 109.974 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 30.0 mt -96.21 119.68 35.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.107 -0.995 . . . . 0.0 109.431 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.13 97.3 0.93 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 90.5 mt -98.64 81.56 2.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.327 -1.102 . . . . 0.0 109.399 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 46.5 p -89.77 176.48 6.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.149 -0.969 . . . . 0.0 110.964 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . 0.405 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 21.9 tm0? -70.64 112.19 6.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.694 -0.629 . . . . 0.0 110.379 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 104.26 8.74 37.87 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 19.2 m -86.55 109.2 18.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.122 -1.223 . . . . 0.0 110.357 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 7.9 t -77.6 115.49 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 122.329 1.061 . . . . 0.0 109.556 -177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 33.2 m -113.01 178.41 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 34.6 m -130.5 128.87 42.06 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 38.6 mt -104.69 121.55 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 68.8 p -126.46 136.12 52.23 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.71 153.25 40.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.208 -0.932 . . . . 0.0 109.923 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -146.16 125.82 13.38 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 158.98 -158.76 29.73 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.116 -1.516 . . . . 0.0 111.256 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.81 -51.99 67.36 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 122.077 -0.661 . . . . 0.0 112.177 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -111.27 11.92 21.7 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.998 -1.064 . . . . 0.0 111.023 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -43.53 -31.85 0.81 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.231 -0.918 . . . . 0.0 110.746 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . 0.402 ' HG3' ' H ' ' B' ' 372' ' ' LYS . 3.2 pt20 -65.13 -47.31 77.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.881 -1.137 . . . . 0.0 109.532 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . 0.402 ' H ' ' HG3' ' B' ' 371' ' ' GLN . 99.9 mttt -65.84 -49.28 68.75 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 109.209 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.49 -37.04 3.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.661 -0.649 . . . . 0.0 112.041 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 99.5 t -80.51 -35.38 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.479 -1.388 . . . . 0.0 109.964 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -67.04 -39.97 87.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.898 -1.126 . . . . 0.0 111.072 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -80.5 -46.64 15.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.759 -1.213 . . . . 0.0 110.57 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' B' ' 381' ' ' MET . 89.8 mt -61.69 -39.95 93.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.194 -0.941 . . . . 0.0 109.865 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.19 -49.16 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.041 -1.037 . . . . 0.0 109.624 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' B' ' 383' ' ' GLU . 10.6 mtpm? -68.07 -54.2 20.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.703 -1.199 . . . . 0.0 107.993 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 50.1 tp -56.83 -34.97 68.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 110.182 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 381' ' ' MET . . . . . 0.416 ' N ' ' O ' ' B' ' 377' ' ' LEU . 0.8 OUTLIER -72.09 -40.31 68.31 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 118.286 -1.366 . . . . 0.0 108.805 178.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.07 -6.45 59.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.525 -0.734 . . . . 0.0 110.533 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' B' ' 379' ' ' LYS . 74.2 mm-40 -110.28 -2.42 16.77 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.129 -0.982 . . . . 0.0 111.377 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 12.7 mt -80.98 129.99 34.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.276 -1.515 . . . . 0.0 108.722 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.381 -179.783 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.6 mtp . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.143 -0.688 . . . . 3.19 109.143 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.9 mt -96.39 135.78 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.336 -0.853 . . . . 1.71 109.31 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.6 m -119.34 149.83 41.16 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.775 0.798 . . . . 1.66 109.895 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.781 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -139.79 -173.43 13.21 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.9 -1.68 . . . . 1.05 108.9 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.427 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.5 mt -85.48 -7.18 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.896 -1.355 . . . . 1.59 110.087 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.4 tp 50.42 95.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.91 -1.119 . . . . 1.47 109.453 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.11 -35.06 16.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 1.39 109.378 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 2.8 p -134.67 130.84 19.95 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.495 -0.753 . . . . 2.09 109.364 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.36 141.14 14.07 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.206 1.937 . . . . 0.91 112.779 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 162.94 -162.72 34.87 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.978 -1.249 . . . . 0.92 109.978 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.2 mt -146.28 147.09 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.265 -1.138 . . . . 1.35 108.376 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.69 141.45 18.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.524 -1.36 . . . . 1.14 111.455 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -122.14 126.15 47.7 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 107.773 -1.195 . . . . 0.7 107.773 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.08 178.52 48.53 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 118.551 -1.785 . . . . 0.58 111.188 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -79.13 160.95 26.79 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.863 -0.786 . . . . 2.63 110.135 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -102.44 127.28 49.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.549 -0.719 . . . . 1.27 111.256 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.3 tp -106.87 134.56 49.84 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.618 -1.623 . . . . 1.41 106.618 177.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.6 tp -117.66 123.09 45.29 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.243 -0.911 . . . . 1.49 110.523 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.8 mt -86.0 103.3 14.57 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.358 0.599 . . . . 1.52 109.644 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -93.98 135.21 35.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -0.896 . . . . 3.17 108.75 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -130.14 132.48 46.1 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.555 -0.906 . . . . 3.0 108.555 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -80.97 148.08 29.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.094 -1.004 . . . . 2.77 110.006 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -62.65 149.47 43.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.38 -0.825 . . . . 2.94 109.263 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.0 mt -90.67 125.5 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.223 -0.923 . . . . 1.46 108.89 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.5 t -92.1 125.82 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.096 -1.002 . . . . 1.7 109.989 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.54 130.59 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.028 -1.101 . . . . 1.54 108.028 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -90.68 123.06 33.99 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.824 -1.173 . . . . 1.81 110.245 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -86.63 -1.32 57.58 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.57 -0.9 . . . . 3.23 108.57 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -65.1 140.07 58.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.417 -0.802 . . . . 3.29 109.974 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -87.9 151.31 22.92 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.085 -1.079 . . . . 2.8 108.085 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 pt -101.48 166.91 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.918 -1.114 . . . . 1.43 109.882 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.0 p -97.96 178.83 4.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.259 -0.901 . . . . 1.54 109.407 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.15 -49.39 77.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.362 -0.836 . . . . 1.6 110.469 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -56.37 -31.5 63.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.616 -1.302 . . . . 2.56 110.248 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -81.8 -9.34 59.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.307 -0.871 . . . . 2.36 110.448 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.0 t -59.97 -50.09 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.937 -1.102 . . . . 1.43 108.75 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -62.61 -40.05 95.72 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.278 -0.889 . . . . 1.77 109.152 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -60.58 -46.03 91.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.296 -0.877 . . . . 3.32 110.488 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -60.72 -44.35 96.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.825 -1.172 . . . . 1.51 109.851 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.3 t -60.06 -46.37 94.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.95 -1.094 . . . . 1.41 108.743 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -58.75 -40.06 82.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.38 -0.825 . . . . 1.81 109.099 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -60.91 -44.5 97.09 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.007 -1.108 . . . . 3.26 108.007 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -60.12 -49.48 77.46 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.95 -0.759 . . . . 0.81 108.95 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.0 -47.38 86.06 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.281 -1.007 . . . . 1.59 108.281 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.7 t -60.85 -43.82 97.81 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.353 -0.939 . . . . 1.38 108.869 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.99 -45.16 96.39 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.551 -1.819 . . . . 0.87 108.551 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.0 ttt-85 -60.06 -36.34 77.11 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.132 -1.062 . . . . 3.62 108.132 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.04 -40.39 63.9 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.939 -0.763 . . . . 1.43 108.939 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.1 ttmt -75.08 -74.08 0.22 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.614 -1.254 . . . . 3.08 107.614 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.53 -39.64 0.33 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.533 -0.729 . . . . 1.33 111.222 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.705 ' HG ' ' H ' ' A' ' 52' ' ' ALA . 72.6 p -56.64 -59.09 5.52 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.658 -1.276 . . . . 1.85 108.895 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.705 ' H ' ' HG ' ' A' ' 51' ' ' SER . . . -64.76 -39.97 94.5 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.347 -0.846 . . . . 1.35 110.939 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -67.73 -39.96 84.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.812 -1.18 . . . . 2.34 110.202 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.6 mt -65.64 -40.06 92.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.062 -1.024 . . . . 2.2 109.614 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.425 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 74.9 mm-40 -62.63 -39.95 95.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.089 -1.007 . . . . 1.35 109.846 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -64.14 -41.85 97.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.059 -1.026 . . . . 1.34 110.012 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.8 mt -61.41 -40.0 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.912 . . . . 1.26 109.858 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.425 ' NZ ' ' OE1' ' A' ' 55' ' ' GLU . 5.1 ttpm? -58.16 -49.92 75.32 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.194 -0.941 . . . . 1.7 109.876 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.4 m -58.55 -36.09 73.35 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.364 -0.835 . . . . 1.35 110.886 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -65.83 -38.72 89.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.971 -1.08 . . . . 2.08 109.644 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.97 92.32 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.531 -0.73 . . . . 1.21 110.256 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.08 -50.0 72.2 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.362 -1.495 . . . . 0.75 109.362 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -66.91 -49.5 65.38 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.269 -1.136 . . . . 1.59 109.579 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.8 m -69.74 -61.61 1.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.492 -0.755 . . . . 1.41 112.694 -177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -93.63 -51.82 4.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.763 -1.21 . . . . 0.79 110.949 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.24 -173.01 23.55 Favored Glycine 0 N--CA 1.501 3.019 0 C-N-CA 119.767 -1.206 . . . . 1.22 111.444 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -71.13 -27.75 63.79 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.356 0.598 . . . . 5.81 110.495 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -63.58 -33.99 76.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.372 -0.83 . . . . 3.37 110.8 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -100.73 -24.99 14.29 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.104 -0.997 . . . . 2.37 109.843 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -62.83 -40.02 96.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 1.65 109.935 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.512 ' CB ' HH11 ' B' ' 317' ' ' ARG . . . -59.8 -29.88 68.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.398 -0.814 . . . . 1.42 109.732 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.7 mt -59.98 -40.09 82.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.453 -1.314 . . . . 1.43 107.453 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -70.99 -40.06 72.11 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.605 -0.685 . . . . 1.08 111.005 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -64.12 -42.04 97.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.601 -1.312 . . . . 1.37 109.712 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.88 -40.59 96.99 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.586 -1.806 . . . . 0.67 108.586 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.8 m170 -64.55 -43.15 94.85 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.387 -1.067 . . . . 1.99 109.332 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.1 mt -67.32 -47.59 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 1.22 109.983 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.9 ttp -60.1 -40.62 90.28 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.941 -1.099 . . . . 2.11 110.235 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.5 tp -66.29 -36.81 83.93 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.539 -0.726 . . . . 1.33 109.639 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.49 -39.34 91.79 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.528 -0.733 . . . . 1.29 109.84 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -78.65 6.88 7.81 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.959 -1.088 . . . . 1.47 110.082 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 57.4 t0 -53.46 132.6 40.14 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.215 -0.928 . . . . 1.47 110.93 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.437 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 93.6 mt-10 -63.34 -18.71 63.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.725 -0.609 . . . . 1.78 110.602 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.02 -34.97 69.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 2.53 108.919 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.48 -39.56 81.29 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.694 0.759 . . . . 1.36 109.241 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.9 -44.47 94.23 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.646 -0.659 . . . . 1.42 110.527 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -70.07 -43.15 71.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.157 -0.964 . . . . 2.27 111.628 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -69.95 -40.07 75.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.001 -1.062 . . . . 1.57 112.476 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.63 -44.53 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.75 -1.219 . . . . 1.19 109.938 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.63 -38.59 76.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.487 -0.758 . . . . 1.39 110.168 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.07 -50.11 74.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.159 -0.963 . . . . 1.39 111.501 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.1 mt -60.97 -45.87 93.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.849 -1.157 . . . . 1.5 109.882 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.1 mt -60.86 -50.03 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.182 -0.948 . . . . 1.29 109.025 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -70.0 -40.59 75.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.65 -0.656 . . . . 2.64 110.857 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -81.16 -62.5 1.64 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.197 -0.939 . . . . 1.65 112.189 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -83.59 -1.0 52.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.122 -0.987 . . . . 2.5 111.934 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 58.98 39.08 23.98 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.929 -1.107 . . . . 1.88 109.741 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.6 mtp -92.36 167.43 12.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.482 -0.761 . . . . 1.71 109.645 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.0 p -84.2 163.44 19.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 1.61 109.945 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.57 -39.75 80.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.397 -0.814 . . . . 1.33 109.242 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -62.24 -42.45 99.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.306 -0.871 . . . . 2.07 110.231 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.87 -42.85 18.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.327 -0.858 . . . . 1.37 110.701 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.69 -47.32 66.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.16 -0.962 . . . . 1.14 110.791 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.6 -38.98 93.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.017 -1.052 . . . . 1.26 109.346 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.459 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 77.2 t60 -59.28 -40.85 87.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.519 -0.738 . . . . 2.02 109.808 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 110' ' ' GLY . 87.0 tt0 -64.32 -39.94 94.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 1.33 110.373 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.8 t -62.19 -55.51 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.148 -0.97 . . . . 1.3 111.132 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.6 mm -69.15 -40.04 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.804 -1.185 . . . . 1.32 108.82 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.459 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.4 tt0 -64.89 -39.88 94.22 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.832 -1.173 . . . . 2.44 107.832 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.02 -49.17 77.56 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.882 -1.287 . . . . 0.99 109.882 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -69.52 -51.66 33.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.948 -1.325 . . . . 1.97 109.222 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.91 -42.75 85.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.915 . . . . 1.43 109.282 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 40.5 t -58.36 -38.64 77.63 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.352 -0.842 . . . . 2.12 109.164 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.76 89.52 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.2 -0.938 . . . . 1.64 108.893 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.2 mt -63.05 -42.74 99.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.905 -1.122 . . . . 1.93 109.646 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.99 -33.08 71.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.871 -1.143 . . . . 2.2 109.468 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.57 -20.96 51.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 2.12 109.075 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 29.5 mt -61.59 142.35 57.18 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.97 -1.081 . . . . 2.34 108.293 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -92.37 28.58 1.9 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.03 -1.044 . . . . 3.23 110.883 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -116.89 128.5 55.3 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.189 -0.944 . . . . 2.49 109.733 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -67.86 -28.04 67.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.557 -0.714 . . . . 3.95 109.522 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.584 ' HH ' ' C ' ' B' ' 314' ' ' LEU . 16.3 t80 -63.96 -41.81 97.45 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.237 1.018 . . . . 2.25 109.133 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.427 HD22 HH21 ' A' ' 126' ' ' ARG . 91.7 mt -75.93 -33.03 59.84 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.208 -0.664 . . . . 2.27 109.208 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -60.06 -40.56 89.88 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.861 -0.792 . . . . 3.31 108.861 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -60.0 -48.36 82.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 2.73 109.163 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.749 ' NE ' HE22 ' B' ' 351' ' ' GLN . 61.1 mtm180 -69.33 -30.38 68.41 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.136 -1.026 . . . . 3.2 108.608 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.56 -27.0 68.87 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.39 -0.967 . . . . 1.66 108.39 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.0 -39.93 72.12 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.89 -0.782 . . . . 1.67 108.89 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -60.05 -44.44 94.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.416 -0.802 . . . . 1.55 110.567 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.06 -39.97 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.003 -1.061 . . . . 1.32 108.772 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -61.38 -39.95 92.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.299 -0.875 . . . . 3.58 109.894 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.95 -40.0 87.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 1.46 110.566 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 93.7 mt -60.04 -43.41 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.038 -1.039 . . . . 1.22 109.669 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.05 -43.93 97.75 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.894 -1.283 . . . . 0.61 109.894 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.09 -45.73 91.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -1.188 . . . . 3.1 110.561 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -64.82 -34.95 79.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.831 -1.168 . . . . 3.71 109.641 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.1 tp -59.97 -42.08 93.35 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.315 -0.866 . . . . 1.87 109.333 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 59.3 mt -60.18 -41.83 93.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.088 -1.007 . . . . 1.29 109.703 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 64.4 mtm-85 -70.79 -40.04 72.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.111 -0.993 . . . . 3.05 109.802 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -61.02 -37.18 81.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 1.26 111.048 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.2 mt -69.99 -42.62 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.562 -1.336 . . . . 1.34 108.854 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.6 mt -70.03 -26.96 64.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.248 -0.649 . . . . 1.6 109.248 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.2 41.28 8.07 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.958 -1.657 . . . . 0.96 108.958 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.64 143.85 46.12 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.34 -1.094 . . . . 1.67 108.351 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -69.97 144.64 52.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.244 -0.91 . . . . 4.96 110.163 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.8 mt -109.88 127.93 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 122.176 0.989 . . . . 1.68 108.76 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.7 mt -69.99 -40.03 78.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-N 115.582 -0.736 . . . . 2.14 110.272 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 31.4 t0 64.22 123.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.514 -0.741 . . . . 1.5 109.442 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 mt -89.9 0.01 57.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.592 -0.692 . . . . 1.39 109.569 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.3 m -88.18 -18.46 28.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.234 -0.916 . . . . 1.83 110.716 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.69 16.52 2.16 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.072 -1.017 . . . . 1.46 112.008 -177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.12 119.19 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.427 -1.421 . . . . 1.42 108.72 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -99.38 -9.51 23.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.183 -0.948 . . . . 2.94 110.806 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -110.19 144.82 38.29 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.405 -0.809 . . . . 1.52 110.052 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -65.61 135.61 55.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 1.58 108.993 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.4 m -152.86 166.47 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.571 -0.706 . . . . 1.32 109.419 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.435 HD11 HG22 ' A' ' 157' ' ' ILE . 83.7 mt -94.75 144.65 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 105.563 -2.014 . . . . 1.27 105.563 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 12.2 tp -96.58 117.45 30.98 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.812 -1.18 . . . . 1.41 110.48 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.3 t -122.37 130.03 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.595 -0.891 . . . . 1.23 108.595 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.27 164.2 35.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.095 -1.003 . . . . 1.32 109.074 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.46 ' O ' ' OD1' ' A' ' 162' ' ' ASP . . . -75.3 -30.61 60.41 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.317 -1.489 . . . . 1.49 108.681 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 66.6 m-20 -159.54 167.87 27.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.52 -0.738 . . . . 2.25 109.398 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 86.7 mt -141.68 125.83 17.4 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.175 -0.953 . . . . 1.35 108.473 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 70.3 p -93.23 148.49 35.74 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.083 -1.01 . . . . 1.56 109.827 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.423 ' O ' ' OG1' ' A' ' 168' ' ' THR . 93.5 Cg_exo -39.64 -37.87 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.243 1.962 . . . . 0.87 112.389 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 73.8 m -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.207 -0.933 . . . . 1.36 109.673 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.8 -41.6 97.87 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.194 -0.941 . . . . 1.61 109.497 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 165' ' ' PRO . 59.5 p -55.6 -31.63 62.4 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.178 -0.951 . . . . 1.21 111.389 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -71.82 -55.01 8.36 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.578 -1.326 . . . . 1.21 109.446 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -82.43 40.35 0.65 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.8 -1.185 . . . . 2.11 107.8 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.421 ' H ' ' C ' ' A' ' 169' ' ' ALA . 62.3 tp -105.31 130.92 53.33 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.316 -0.994 . . . . 1.29 108.316 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -88.63 105.43 17.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.024 -1.048 . . . . 2.81 109.104 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 93.4 mt -63.69 -44.12 94.61 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.291 -0.881 . . . . 2.09 110.788 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.428 ' HZ1' ' CB ' ' A' ' 174' ' ' LYS . 9.2 mtmp? -72.4 -22.29 61.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.854 -1.153 . . . . 2.86 112.528 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -93.45 -9.99 36.63 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.527 -1.358 . . . . 2.39 109.663 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 178' ' ' GLY . 99.2 t -107.99 119.05 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.306 -0.871 . . . . 1.27 109.254 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 70.1 mt -85.74 4.92 34.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.403 -0.811 . . . . 2.17 110.525 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.427 ' O ' ' CG1' ' A' ' 176' ' ' VAL . . . 168.03 175.22 37.58 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.296 -1.522 . . . . 0.52 109.296 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -133.61 130.48 38.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.402 -1.058 . . . . 0.55 109.144 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 79.4 mt -130.66 122.21 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.568 -0.901 . . . . 1.27 108.568 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 59.0 p -144.7 159.77 42.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.111 -0.993 . . . . 1.39 111.279 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 53.3 t0 -103.02 25.87 8.87 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.353 -0.61 . . . . 2.46 109.353 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.7 -161.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.178 -1.576 . . . . 1.51 111.747 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.61 -54.87 6.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.588 -1.005 . . . . 2.23 110.588 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.96 -114.37 0.65 Allowed Glycine 0 N--CA 1.495 2.61 0 O-C-N 120.778 -1.424 . . . . 2.23 111.263 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -69.98 -24.14 63.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.677 -0.896 . . . . 6.44 111.648 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 75.7 p -82.85 3.15 30.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.597 -1.314 . . . . 4.09 110.664 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 34.3 t -91.61 126.86 36.84 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.918 -1.114 . . . . 2.2 111.08 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -55.98 -46.37 78.68 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.277 -0.89 . . . . 1.15 110.32 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.19 -39.99 67.14 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.14 -0.975 . . . . 2.01 110.238 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 24.8 p -60.36 -39.6 87.75 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.003 -1.061 . . . . 1.93 110.454 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.9 -41.1 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.966 . . . . 2.2 110.188 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 91.6 mtp -62.57 -40.06 95.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.035 -1.04 . . . . 1.32 110.666 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.99 -40.45 73.34 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.613 -1.304 . . . . 1.3 108.594 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -59.62 -49.67 76.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 3.38 109.699 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 62.9 m -76.12 -31.24 58.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.18 -0.95 . . . . 1.15 110.798 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.82 -21.93 60.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.954 -1.091 . . . . 1.28 109.547 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 64.39 43.93 4.42 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.93 -0.481 . . . . 1.5 111.514 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.456 ' O ' ' OG ' ' A' ' 8' ' ' SER . 46.5 mt -121.08 142.1 34.17 Favored Pre-proline 0 N--CA 1.503 2.219 0 N-CA-C 107.601 -1.259 . . . . 1.37 107.601 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.72 143.84 99.46 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.508 1.472 . . . . 0.76 111.441 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.96 152.22 3.5 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.935 -1.106 . . . . 1.19 111.49 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 202' ' ' ILE . 89.9 mt -124.27 143.46 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.739 -1.208 . . . . 1.31 107.739 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.5 m -125.49 -10.77 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.996 -1.065 . . . . 1.38 111.19 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -113.11 25.97 10.91 Favored Glycine 0 N--CA 1.501 3.012 0 N-CA-C 111.063 -0.815 . . . . 1.03 111.063 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.409 ' C ' ' O ' ' A' ' 204' ' ' GLY . 11.4 p -43.56 -43.75 5.76 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.001 -1.294 . . . . 1.38 109.757 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.434 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 96.01 -50.7 1.71 Allowed Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.439 -0.886 . . . . 1.17 111.418 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.2 m -160.08 40.0 0.18 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.53 -1.571 . . . . 2.07 111.457 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 12.1 t -77.54 -32.02 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.889 -1.132 . . . . 1.35 108.775 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 31.9 p -60.0 -39.89 87.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.558 -0.714 . . . . 1.49 110.829 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 81.8 p -82.47 -10.7 58.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.973 -1.079 . . . . 2.16 110.731 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -98.53 -16.82 19.01 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.21 -0.931 . . . . 2.89 110.724 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 44.8 t -116.56 154.73 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 O-C-N 121.265 -0.897 . . . . 1.33 111.025 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.515 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 2.8 mptp? -116.01 154.83 29.18 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.558 -1.275 . . . . 2.73 107.558 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 20.9 p30 -59.74 140.11 56.76 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.956 -1.09 . . . . 2.7 110.474 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.4 t0 88.97 5.7 0.16 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.049 0.452 . . . . 2.38 110.368 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.515 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 59.4 m-20 -79.78 153.71 28.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.049 -1.032 . . . . 2.09 109.706 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -95.01 129.93 41.88 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.416 -0.802 . . . . 1.45 108.868 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 84.6 mt -130.72 151.18 51.45 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.136 -0.977 . . . . 1.31 110.769 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 219' ' ' ILE . 84.9 mt -120.13 122.03 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 107.235 -1.394 . . . . 1.29 107.235 176.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 45.2 tp -103.33 120.02 39.98 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.823 -1.173 . . . . 1.31 108.73 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 10' ' ' GLY . 32.3 t0 -87.24 -37.36 17.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.936 -1.102 . . . . 2.31 108.918 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 45.52 24.49 0.18 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.594 -0.691 . . . . 1.19 109.363 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 45.0 t -137.28 -44.63 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 106.965 -1.494 . . . . 1.45 106.965 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -99.94 2.69 43.88 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.131 -1.433 . . . . 3.13 107.131 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.781 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.8 OUTLIER 59.94 45.11 12.68 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 116.101 -0.5 . . . . 2.2 110.03 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -139.48 138.38 36.35 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.137 -0.977 . . . . 2.32 109.828 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 97.1 t -120.01 122.38 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.807 -0.812 . . . . 1.4 108.807 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -90.61 130.71 36.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.87 -1.144 . . . . 1.29 108.499 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 62.9 t -107.69 123.19 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.58 -0.7 . . . . 1.38 109.709 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 66.6 t30 56.65 67.34 2.72 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.284 -0.885 . . . . 2.33 109.271 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -88.53 130.87 2.37 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 123.144 2.563 . . . . 0.95 112.827 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.46 ' CG2' ' N ' ' A' ' 233' ' ' ASN . 95.1 m -73.2 173.23 9.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.368 -0.832 . . . . 2.31 109.082 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.46 ' N ' ' CG2' ' A' ' 232' ' ' THR . 70.3 m-80 -60.0 -40.0 87.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.168 -0.957 . . . . 3.45 109.886 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.48 -39.99 92.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 2.89 109.944 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.2 t -68.29 -39.95 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.093 -1.004 . . . . 1.73 109.544 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.4 mt . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.076 -1.015 . . . . 1.57 108.672 179.508 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 31.7 ttp . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.414 0.626 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -154.86 152.43 29.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.057 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -150.04 162.8 39.68 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.061 -1.025 . . . . 0.0 109.958 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -154.3 151.64 29.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 0.0 109.255 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -108.99 130.98 55.48 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.302 -0.874 . . . . 0.0 110.059 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.86 121.75 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-O 122.235 1.017 . . . . 0.0 112.512 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 18.1 m -76.7 106.72 8.53 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.944 0.878 . . . . 0.0 111.086 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 97.1 mt -53.18 121.36 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 122.191 0.996 . . . . 0.0 110.566 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 81.8 p -110.76 19.98 18.06 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.232 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.92 118.02 59.33 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 120.928 -1.108 . . . . 0.0 108.826 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -49.65 -20.34 4.29 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 CA-C-N 120.216 1.113 . . . . 0.0 112.945 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -116.15 15.3 16.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.371 -0.831 . . . . 0.0 109.714 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.53 174.35 20.01 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.175 -1.97 . . . . 0.0 108.175 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.584 ' C ' ' HH ' ' A' ' 122' ' ' TYR . 3.5 tp -83.52 94.27 8.0 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.981 -1.305 . . . . 0.0 109.459 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -99.94 -158.81 0.7 Allowed 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.085 -1.01 . . . . 0.0 109.978 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.7 m -59.95 -43.84 94.77 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.968 -1.083 . . . . 0.0 112.572 -175.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.527 HH12 ' NE2' ' B' ' 321' ' ' GLN . 11.9 tpt180 -54.1 -59.19 10.59 Favored Pre-proline 0 N--CA 1.499 2.025 0 O-C-N 120.335 -1.478 . . . . 0.0 111.271 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -60.59 -34.51 92.34 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 CA-C-N 120.531 1.225 . . . . 0.0 111.503 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.08 -50.88 71.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.364 -0.835 . . . . 0.0 109.034 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.71 -43.0 76.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.785 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . 0.527 ' NE2' HH12 ' B' ' 317' ' ' ARG . 83.0 mm-40 -70.02 -41.47 74.24 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.807 -1.183 . . . . 0.0 108.898 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -62.01 -52.91 62.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.548 -0.72 . . . . 0.0 110.554 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 87.0 t -65.73 -28.01 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.909 -1.119 . . . . 0.0 109.844 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -60.13 -46.66 88.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.123 -0.986 . . . . 0.0 110.057 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -66.1 -47.7 73.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.13 -0.981 . . . . 0.0 111.284 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.9 -53.4 58.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.64 -1.288 . . . . 0.0 111.34 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -57.16 -15.48 5.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.924 -1.11 . . . . 0.0 109.702 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -74.86 -30.07 60.06 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -101.71 146.23 28.03 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.318 -1.107 . . . . 0.0 108.594 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 24.3 p -89.79 -12.83 38.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.916 -1.115 . . . . 0.0 110.218 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 331' ' ' SER . . . . . 0.405 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 23.2 t -55.2 148.2 14.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.122 -0.986 . . . . 0.0 109.577 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -70.24 128.87 37.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.223 -0.923 . . . . 0.0 108.523 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.7 mt -131.48 131.15 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.568 -0.708 . . . . 0.0 109.817 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 89.4 m -130.39 154.48 47.65 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.548 -0.72 . . . . 0.0 109.531 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 56.1 t -116.44 137.87 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 178.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 91.3 m -129.11 126.42 39.3 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.107 -0.995 . . . . 0.0 108.898 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 49.4 p -139.94 114.4 9.24 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.128 -0.983 . . . . 0.0 111.678 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 46.76 52.95 10.79 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 176.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.94 -13.92 63.31 Favored Glycine 0 N--CA 1.502 3.094 0 O-C-N 119.992 -1.692 . . . . 0.0 112.776 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -119.89 131.42 55.24 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-N 119.13 1.465 . . . . 0.0 109.86 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 89.4 p -132.0 151.5 51.7 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.776 0.798 . . . . 0.0 110.332 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.3 169.84 17.13 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.479 0.657 . . . . 0.0 109.929 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 3.6 t -91.63 140.11 30.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.342 -0.849 . . . . 0.0 110.707 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -79.47 -16.01 56.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 0.0 109.798 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -84.05 16.02 3.13 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.491 ' H ' ' C ' ' B' ' 344' ' ' ALA . 93.4 p -149.99 95.7 2.33 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.048 0.928 . . . . 0.0 111.835 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 47.6 tp -60.17 -32.72 71.32 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -54.61 -52.88 60.83 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.902 -1.124 . . . . 0.0 109.817 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.448 ' O ' ' OG1' ' B' ' 352' ' ' THR . 40.0 mtpt -70.01 -39.89 75.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.246 -0.909 . . . . 0.0 110.549 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' B' ' 352' ' ' THR . 88.9 mt -49.93 -59.69 3.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.888 -1.132 . . . . 0.0 109.578 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.749 HE22 ' NE ' ' A' ' 126' ' ' ARG . 17.7 mm100 -42.21 -10.23 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.779 -0.575 . . . . 0.0 112.074 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.603 ' N ' ' O ' ' B' ' 350' ' ' LEU . 60.1 p -88.04 -5.07 58.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.336 -1.477 . . . . 0.0 109.48 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 91.4 mt -96.83 116.76 29.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.344 -0.848 . . . . 0.0 109.074 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.63 96.11 1.14 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 31.1 mt -106.17 96.81 6.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.342 -1.093 . . . . 0.0 109.634 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 21.4 p -97.55 159.64 14.8 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.942 -1.099 . . . . 0.0 110.687 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -52.81 119.29 4.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.691 -0.631 . . . . 0.0 110.66 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 101.51 4.07 52.86 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 63.2 m -87.52 111.25 21.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.454 -1.027 . . . . 0.0 111.093 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 45.2 t -77.12 117.74 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 122.291 1.044 . . . . 0.0 109.448 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 30.3 m -112.11 177.14 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 42.0 m -130.76 129.01 41.92 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 88.5 mt -104.7 122.36 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 69.6 m -126.95 135.98 51.65 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.63 156.21 42.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.199 -0.938 . . . . 0.0 109.527 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -147.95 124.57 11.1 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 159.15 -157.09 28.18 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.629 -1.748 . . . . 0.0 111.848 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -59.95 -55.06 38.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 122.249 -0.56 . . . . 0.0 111.995 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.405 ' H ' ' HB2' ' B' ' 331' ' ' SER . 95.9 m-20 -108.8 10.16 26.71 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.037 -1.039 . . . . 0.0 111.416 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.487 ' OE2' ' NE2' ' B' ' 371' ' ' GLN . 0.6 OUTLIER -43.97 -30.6 0.74 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.979 -1.075 . . . . 0.0 110.618 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . 0.487 ' NE2' ' OE2' ' B' ' 370' ' ' GLU . 92.1 mm-40 -70.04 -41.0 74.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.053 -1.029 . . . . 0.0 109.541 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -67.98 -49.45 61.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.128 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.78 -76.75 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.448 -0.783 . . . . 0.0 111.258 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . 0.42 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 46.3 t -45.31 -37.32 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 120.923 -1.111 . . . . 0.0 110.763 -177.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.73 -43.15 80.63 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.505 -1.372 . . . . 0.0 109.974 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -85.34 -43.18 13.91 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.751 -1.218 . . . . 0.0 110.09 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 84.9 mt -57.22 -38.17 73.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.95 -1.094 . . . . 0.0 108.919 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 54.5 t -66.78 -40.04 85.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.671 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -80.47 -10.08 59.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.67 -1.269 . . . . 0.0 109.727 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 57.2 tp -83.6 -26.78 29.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.654 -1.279 . . . . 0.0 108.08 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 18.3 tpp -80.64 -24.66 38.84 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -85.21 -9.57 57.63 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.767 -0.583 . . . . 0.0 109.736 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -110.6 -2.19 16.5 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.29 -0.881 . . . . 0.0 110.496 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 25.0 mt -91.45 119.63 31.59 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.82 -1.175 . . . . 0.0 109.334 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.498 1.94 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.019 179.751 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.616 -0.512 . . . . 3.19 109.616 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 2' ' ' ILE . 85.5 mt -110.0 129.02 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.806 -0.813 . . . . 1.71 108.806 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -132.5 134.84 45.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.444 -0.785 . . . . 1.66 108.985 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.67 -163.11 19.57 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 108.723 -1.751 . . . . 1.05 108.723 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.436 ' CG2' ' HE ' ' A' ' 186' ' ' ARG . 96.9 mt -90.93 -10.38 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.033 -1.275 . . . . 1.59 109.891 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.4 tp 54.92 98.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.076 -1.015 . . . . 1.47 109.194 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.85 -36.65 62.35 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.565 -0.71 . . . . 1.39 109.5 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -149.75 144.46 17.77 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.135 -0.978 . . . . 2.09 109.949 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -80.05 140.93 14.48 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.693 2.262 . . . . 0.91 113.145 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 164.94 -163.93 36.72 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 109.468 -1.453 . . . . 0.92 109.468 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -149.98 150.0 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 121.12 -1.224 . . . . 1.35 108.784 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.73 155.74 33.65 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.813 -1.179 . . . . 1.14 110.682 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.8 m-85 -137.5 128.53 27.5 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.407 -0.96 . . . . 0.7 108.407 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.09 -179.92 46.92 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 118.814 -1.66 . . . . 0.58 110.769 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -79.9 157.33 26.95 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.734 -0.863 . . . . 2.63 108.97 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -101.02 129.49 46.87 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.434 -0.791 . . . . 1.27 111.157 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.5 tp -97.31 134.29 40.8 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 106.951 -1.5 . . . . 1.41 106.951 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.9 tp -118.71 122.17 41.85 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.333 -0.855 . . . . 1.49 110.836 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.9 mt -100.37 110.36 22.57 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.832 -0.543 . . . . 1.52 110.886 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -114.57 143.84 44.35 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.525 -0.734 . . . . 3.17 109.272 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.434 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 49.9 mp0 -127.93 130.72 48.94 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.34 -0.85 . . . . 3.0 108.99 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -72.47 144.3 48.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 2.77 109.492 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -61.74 140.36 58.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.304 -0.872 . . . . 2.94 108.972 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.4 mt -79.6 131.95 33.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.224 -0.922 . . . . 1.46 108.786 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.93 123.7 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.25 -0.906 . . . . 1.7 109.485 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -105.67 136.44 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.642 -0.874 . . . . 1.54 108.642 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -90.97 128.36 36.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.033 -1.042 . . . . 1.81 110.552 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.409 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.0 mmm-85 -92.57 7.37 43.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.639 -0.663 . . . . 3.23 109.316 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.55 145.27 54.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 3.29 109.744 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -87.86 139.45 30.5 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.386 -0.821 . . . . 2.8 109.267 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -90.59 163.62 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.896 -1.128 . . . . 1.43 109.899 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.7 p -94.52 169.15 10.4 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.244 -0.91 . . . . 1.54 108.939 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.75 -17.91 63.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.278 -0.889 . . . . 1.6 110.603 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -84.33 -28.45 27.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.688 -1.258 . . . . 2.56 108.094 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -82.07 -8.97 59.68 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.094 -0.706 . . . . 2.36 109.094 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.2 t -65.51 -54.73 25.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 120.916 -1.115 . . . . 1.43 108.571 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -59.97 -40.0 87.6 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.286 -0.884 . . . . 1.77 109.655 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -69.25 -41.84 76.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.228 -0.92 . . . . 3.32 110.684 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -63.33 -40.05 96.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.892 -1.13 . . . . 1.51 110.165 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.23 -46.82 95.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.785 -1.197 . . . . 1.41 108.153 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.26 -44.69 95.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.374 -0.829 . . . . 1.81 109.586 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.01 -43.15 95.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.942 -1.099 . . . . 3.26 108.281 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -64.05 -46.06 86.07 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.345 -0.847 . . . . 0.81 108.902 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.04 -48.34 82.11 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.562 -0.903 . . . . 1.59 108.562 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -64.85 -42.79 94.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.183 -0.948 . . . . 1.38 108.551 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.88 -47.46 88.69 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.478 -1.849 . . . . 0.87 108.478 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -63.79 -37.97 89.35 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.076 -1.083 . . . . 3.62 108.076 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.14 -39.99 70.08 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.562 -0.903 . . . . 1.43 108.562 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 50' ' ' ALA . 31.9 ttpt -61.17 -74.06 0.09 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.655 -1.239 . . . . 3.08 107.655 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.18 -33.18 0.05 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.304 -0.872 . . . . 1.33 111.912 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.2 m -60.02 -50.3 74.29 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.385 -1.447 . . . . 1.85 108.603 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.15 75.85 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.412 -0.805 . . . . 1.35 110.943 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -66.6 -40.0 88.66 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.802 -1.186 . . . . 2.34 110.442 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.87 -40.11 95.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.951 -1.093 . . . . 2.2 109.595 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -60.04 -36.13 76.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 1.35 109.557 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.0 -42.28 98.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -0.977 . . . . 1.34 109.678 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.31 -39.99 87.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.401 -0.812 . . . . 1.26 109.714 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -54.64 -51.59 64.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.264 -0.897 . . . . 1.7 110.123 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -59.7 -34.57 73.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 1.35 110.791 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.408 ' O ' ' OG1' ' A' ' 64' ' ' THR . 62.0 mttm -67.13 -39.58 86.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.087 -1.008 . . . . 2.08 109.877 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.18 -42.42 96.71 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.607 -0.683 . . . . 1.21 109.527 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.21 -55.64 29.57 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.926 -1.269 . . . . 0.75 109.926 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.75 -48.09 70.21 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.885 -1.362 . . . . 1.59 109.656 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 21.6 m -62.84 -65.08 0.74 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 1.41 112.17 -178.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -96.45 -48.74 5.44 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.717 -1.24 . . . . 0.79 111.357 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.76 -168.67 25.51 Favored Glycine 0 N--CA 1.502 3.075 0 C-N-CA 119.536 -1.316 . . . . 1.22 111.436 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -70.04 -26.29 63.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.993 -0.71 . . . . 5.81 110.695 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.486 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 52.8 tp10 -61.4 -35.25 76.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.309 -0.869 . . . . 3.37 110.679 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -98.95 -20.8 16.59 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.175 -0.953 . . . . 2.37 109.984 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -70.03 -40.25 75.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.149 -0.97 . . . . 1.65 110.589 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.54 -31.71 72.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 1.42 109.788 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.7 mt -59.97 -40.65 83.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.17 -0.956 . . . . 1.43 109.07 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -62.67 -40.91 98.55 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.131 -0.981 . . . . 1.08 109.503 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.534 ' CD ' ' HZ3' ' B' ' 324' ' ' LYS . 66.5 tt0 -63.32 -39.88 95.79 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.715 -0.794 . . . . 1.37 109.834 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.78 98.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.757 -1.737 . . . . 0.67 108.757 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -67.73 -42.26 82.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.386 -1.067 . . . . 1.99 109.4 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.1 mt -66.86 -46.37 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.209 -0.932 . . . . 1.22 109.106 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.8 ttp -60.09 -44.26 94.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.144 -0.973 . . . . 2.11 110.129 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 tp -59.95 -40.13 87.96 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.172 -0.955 . . . . 1.33 108.909 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.6 -39.23 93.35 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.868 -0.52 . . . . 1.29 110.231 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -81.86 2.39 30.55 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.073 -1.017 . . . . 1.47 111.082 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -48.81 125.96 11.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.777 -1.202 . . . . 1.47 109.056 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.1 -15.33 22.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.259 -0.901 . . . . 1.78 110.259 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -72.0 -35.03 69.32 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.987 -1.07 . . . . 2.53 108.61 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.03 -40.79 74.98 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.363 0.602 . . . . 1.36 110.05 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.28 -43.76 95.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 1.42 109.774 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -70.05 -41.62 73.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.547 -0.721 . . . . 2.27 111.17 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.02 -40.11 75.42 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.905 -1.122 . . . . 1.57 111.301 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.5 mt -64.9 -49.41 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.113 -0.992 . . . . 1.19 109.561 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.506 ' CG2' ' HZ1' ' A' ' 94' ' ' LYS . 85.5 mt -69.41 -39.49 78.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.798 -0.564 . . . . 1.39 110.572 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.81 84.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.016 . . . . 1.39 110.821 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.07 -45.16 93.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.973 -1.079 . . . . 1.5 109.707 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.8 mt -61.37 -49.94 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.092 -1.005 . . . . 1.29 108.599 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.506 ' HZ1' ' CG2' ' A' ' 90' ' ' ILE . 33.5 mttp -64.58 -41.41 96.3 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 120.067 -0.653 . . . . 2.64 110.157 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -80.14 -56.3 4.32 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.992 -1.068 . . . . 1.65 112.177 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -90.54 -2.47 57.9 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.103 -0.998 . . . . 2.5 112.677 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 57.5 39.65 27.73 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.693 -1.254 . . . . 1.88 109.585 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.7 mtp -92.11 169.22 10.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.545 -0.722 . . . . 1.71 109.82 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.513 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 42.9 p -83.37 160.63 21.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.362 -0.836 . . . . 1.61 109.412 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.56 88.55 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.499 -0.751 . . . . 1.33 110.335 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 32.7 p-10 -69.8 -35.91 75.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.189 -0.944 . . . . 2.07 109.627 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.513 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -80.5 -44.09 19.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 1.37 110.124 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.43 -44.97 70.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -0.963 . . . . 1.14 109.974 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.1 -39.39 85.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.134 -0.979 . . . . 1.26 109.655 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.525 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 85.5 t60 -59.93 -41.33 91.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.315 -0.866 . . . . 2.02 110.037 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.17 -39.92 86.53 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.142 -0.974 . . . . 1.33 111.214 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.3 t -58.24 -58.08 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.03 -1.044 . . . . 1.3 111.218 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.2 mm -70.1 -40.0 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.946 -1.097 . . . . 1.32 109.417 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.525 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 87.7 tt0 -60.41 -39.98 89.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 2.44 109.144 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.09 -50.13 71.05 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.432 -1.067 . . . . 0.99 110.432 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -61.12 -50.63 72.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.911 -1.347 . . . . 1.97 109.826 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.6 83.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.323 -0.861 . . . . 1.43 110.521 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.8 m -59.66 -39.97 86.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.892 -1.13 . . . . 2.12 108.781 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.66 -40.0 93.37 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.227 -0.92 . . . . 1.64 108.94 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.7 mt -61.19 -42.67 98.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.977 . . . . 1.93 109.47 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -55.15 -32.45 62.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.046 -1.034 . . . . 2.2 109.433 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -59.99 -23.61 63.79 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.192 -0.943 . . . . 2.12 108.93 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 58.2 mt -62.08 140.02 58.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.97 . . . . 2.34 109.02 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.7 p-10 -91.4 41.43 1.07 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.194 -0.941 . . . . 3.23 110.404 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 40.6 t0 -134.88 145.28 48.12 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.208 -0.932 . . . . 2.49 109.565 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.524 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 97.5 mt-10 -72.99 -64.7 0.92 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.439 -0.788 . . . . 3.95 109.045 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.453 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 4.1 t80 -38.55 -40.13 0.54 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.905 -0.497 . . . . 2.25 110.684 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.1 mt -72.44 -39.97 67.42 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.78 -1.2 . . . . 2.27 108.427 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 121' ' ' GLU . 19.9 ttpp -64.98 -40.87 95.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.485 -0.76 . . . . 3.31 109.058 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -62.53 -42.55 99.59 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.172 -1.047 . . . . 2.73 108.172 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.516 ' NH2' ' CB ' ' B' ' 319' ' ' ALA . 57.7 ttt180 -60.13 -40.02 88.33 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.923 -1.139 . . . . 3.2 107.923 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.73 -25.85 68.39 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.727 -0.842 . . . . 1.66 108.727 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.75 -41.07 94.67 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.168 -1.049 . . . . 1.67 108.168 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.18 -40.1 90.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.49 -0.756 . . . . 1.55 109.637 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.416 ' CG2' ' NE2' ' B' ' 351' ' ' GLN . 56.0 t -63.0 -41.37 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.132 -0.98 . . . . 1.32 109.469 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -63.06 -39.83 95.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.152 -0.967 . . . . 3.58 109.398 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -60.19 -40.55 90.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.363 -0.836 . . . . 1.46 110.393 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 98.3 mt -60.01 -45.77 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.098 -1.001 . . . . 1.22 110.382 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.94 -34.89 55.13 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.826 -1.31 . . . . 0.61 109.826 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.451 ' NZ ' HH21 ' A' ' 139' ' ' ARG . 24.8 tptp -59.99 -49.54 77.29 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.4 -1.059 . . . . 3.1 109.658 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -64.74 -33.57 76.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.917 -1.114 . . . . 3.71 109.793 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.2 tp -59.98 -41.02 91.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.363 -0.836 . . . . 1.87 109.094 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.44 -39.99 89.49 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.258 -0.901 . . . . 1.29 108.698 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.451 HH21 ' NZ ' ' A' ' 135' ' ' LYS . 98.8 mtt180 -67.06 -39.93 87.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.491 -0.756 . . . . 3.05 109.429 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -70.2 -25.68 63.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.45 -0.781 . . . . 1.26 111.64 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.3 mt -70.28 -40.09 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.211 -1.556 . . . . 1.34 109.008 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.6 mt -82.34 -26.83 32.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.459 -0.775 . . . . 1.6 110.202 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.95 47.61 5.22 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.034 -1.626 . . . . 0.96 109.034 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.1 tp -74.29 145.48 43.95 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.381 -1.07 . . . . 1.67 109.448 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.24 137.19 58.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 4.96 109.584 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 146' ' ' ILE . 86.0 mt -113.97 130.03 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-O 121.975 0.893 . . . . 1.68 109.283 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.51 -42.2 94.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.769 -0.582 . . . . 2.14 110.366 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.6 t0 68.22 91.97 0.09 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.49 -0.756 . . . . 1.5 109.011 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.7 mt -64.08 -6.64 6.77 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.515 -0.741 . . . . 1.39 111.231 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.5 m -82.82 -14.74 53.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.651 -1.281 . . . . 1.83 110.069 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.41 30.91 0.4 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.108 -0.995 . . . . 1.46 112.133 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 41.9 mm -90.31 121.19 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 120.485 -1.384 . . . . 1.42 109.205 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -103.06 -12.54 17.34 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.337 -0.852 . . . . 2.94 110.537 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -128.37 152.09 48.58 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.077 -1.015 . . . . 1.52 110.46 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.32 137.0 57.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.497 -0.752 . . . . 1.58 109.402 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.5 m -152.54 164.38 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.943 -0.762 . . . . 1.32 108.943 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -93.77 146.49 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.486 -1.672 . . . . 1.27 106.486 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.5 tp -94.56 114.59 26.58 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.18 -0.95 . . . . 1.41 110.679 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 49.6 t -120.03 127.12 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 108.042 -1.095 . . . . 1.23 108.042 178.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.05 160.0 40.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.168 -0.958 . . . . 1.32 108.999 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.462 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -76.43 -30.09 57.26 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.266 -1.521 . . . . 1.49 107.872 178.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 57.2 t0 -170.05 134.09 1.23 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.334 -0.854 . . . . 2.25 108.894 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.445 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 81.8 mt -111.22 125.02 53.37 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.217 -0.927 . . . . 1.35 108.905 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 51.9 p -83.83 146.6 49.66 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 1.56 109.292 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -39.91 -37.15 1.52 Allowed 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.298 1.998 . . . . 0.87 113.235 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.6 m -59.99 -41.04 91.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.069 -1.019 . . . . 1.36 109.699 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.13 -40.66 71.27 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.222 -0.924 . . . . 1.61 110.342 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.1 p -53.12 -29.88 33.41 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.015 -1.053 . . . . 1.21 111.447 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.515 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -76.46 -56.82 4.28 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.754 -1.216 . . . . 1.21 110.327 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -77.12 37.04 0.19 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.36 -0.978 . . . . 2.11 108.36 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 169' ' ' ALA . 58.6 tp -102.06 137.32 40.5 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.369 -0.604 . . . . 1.29 109.369 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -82.76 101.08 10.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.163 -0.96 . . . . 2.81 109.239 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 99.5 mt -66.19 -41.98 89.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.167 -0.958 . . . . 2.09 110.719 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -65.92 -28.82 69.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.857 -1.152 . . . . 2.86 111.568 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -92.52 -8.26 45.01 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.778 -1.201 . . . . 2.39 110.133 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 94.3 t -101.8 112.18 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.28 -1.008 . . . . 1.27 108.28 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.03 5.15 30.62 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.28 -0.888 . . . . 2.17 110.709 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.97 173.38 38.04 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.309 -1.517 . . . . 0.52 109.309 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -132.08 129.61 40.19 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.467 -1.02 . . . . 0.55 109.186 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.2 mt -134.12 127.09 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.372 -0.83 . . . . 1.27 108.943 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.5 p -149.78 160.26 43.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.982 -1.074 . . . . 1.39 110.387 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 20.1 p-10 -102.41 23.02 12.44 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.411 -0.806 . . . . 2.46 109.458 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -52.68 -165.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.081 -1.012 . . . . 1.51 111.951 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -75.52 -54.31 5.57 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.869 -0.892 . . . . 2.23 110.869 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 173.61 -140.28 5.47 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.053 -1.546 . . . . 2.23 110.824 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.534 ' C ' ' H ' ' A' ' 188' ' ' SER . 0.6 OUTLIER -65.55 -34.14 77.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.634 -0.921 . . . . 6.44 111.159 -178.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 12.9 p -59.95 4.24 0.05 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.942 -1.099 . . . . 4.09 110.879 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 186' ' ' ARG . 17.1 m -91.93 131.66 37.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.771 -1.205 . . . . 2.2 110.29 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -47.26 -37.58 10.86 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.827 -1.175 . . . . 1.15 107.827 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.4 p -57.7 -41.85 82.51 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.546 -0.752 . . . . 2.01 110.368 -179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 75.4 m -61.38 -40.08 93.04 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.158 -0.964 . . . . 1.93 111.518 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.91 -40.48 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.114 -0.991 . . . . 2.2 109.548 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 76.9 mtp -58.89 -49.53 77.43 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.353 -0.842 . . . . 1.32 109.94 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.33 -47.05 62.8 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.961 -1.087 . . . . 1.3 110.024 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -62.53 -57.97 9.24 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 118.565 -1.254 . . . . 3.38 109.957 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.1 m -61.24 -40.01 92.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.048 -1.033 . . . . 1.15 111.657 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.96 -23.69 62.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.887 -1.133 . . . . 1.28 109.824 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 64.9 47.81 2.53 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.444 0.64 . . . . 1.5 109.547 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 86.0 mt -126.95 150.05 70.79 Favored Pre-proline 0 N--CA 1.501 2.103 0 N-CA-C 108.568 -0.901 . . . . 1.37 108.568 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.56 141.58 74.03 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.213 1.942 . . . . 0.76 111.67 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -171.58 153.82 3.56 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.797 -1.161 . . . . 1.19 111.518 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.8 mt -128.08 139.47 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.818 -1.179 . . . . 1.31 107.818 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.5 m -121.83 -11.31 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 120.959 -1.088 . . . . 1.38 111.362 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.1 26.42 15.32 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 110.465 -1.054 . . . . 1.03 110.465 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.8 p -46.42 -42.21 14.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.102 -1.234 . . . . 1.38 109.841 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.59 -54.04 4.1 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 120.125 -1.036 . . . . 1.17 111.104 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 84.9 p -152.58 28.41 0.55 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.556 -1.555 . . . . 2.07 111.567 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 73.0 t -74.03 -40.71 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.666 -1.271 . . . . 1.35 109.136 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.492 ' HG1' ' N ' ' A' ' 210' ' ' SER . 7.7 p -60.95 -30.87 70.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.102 -0.999 . . . . 1.49 110.5 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.492 ' N ' ' HG1' ' A' ' 209' ' ' THR . 79.3 p -79.97 -10.94 59.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.981 -1.074 . . . . 2.16 109.363 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -105.14 -10.92 16.82 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.569 -0.707 . . . . 2.89 109.948 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 79.8 t -101.64 139.99 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.407 -0.808 . . . . 1.33 109.957 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.406 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 0.1 OUTLIER -111.68 145.89 38.45 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.393 -1.336 . . . . 2.73 107.393 178.795 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.476 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 10.4 p30 -54.78 138.2 42.9 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.016 -1.053 . . . . 2.7 110.42 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.3 m-20 86.81 3.66 0.43 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 120.988 0.423 . . . . 2.38 110.434 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.406 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 96.5 m-20 -76.26 150.39 37.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.015 -1.053 . . . . 2.09 109.156 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -99.43 119.84 38.64 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.261 -1.015 . . . . 1.45 108.261 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 67.8 mt -126.57 148.51 49.74 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.398 -0.814 . . . . 1.31 110.782 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.8 mt -115.59 128.3 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 107.502 -1.296 . . . . 1.29 107.502 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.0 tp -100.7 118.19 36.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.122 -0.986 . . . . 1.31 109.432 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 10' ' ' GLY . 94.7 m-20 -77.15 -43.2 34.83 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.213 -0.929 . . . . 2.31 108.557 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 51.89 17.64 0.67 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.857 -1.164 . . . . 1.19 107.857 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.441 ' N ' ' C ' ' A' ' 221' ' ' ASP . 56.4 t -136.05 -36.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.942 -1.133 . . . . 1.45 107.942 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -105.51 3.44 29.43 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.845 -1.169 . . . . 3.13 107.845 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 60.54 43.67 12.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.822 -0.549 . . . . 2.2 111.259 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.415 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 11.9 pt20 -150.0 152.78 35.45 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.723 -1.236 . . . . 2.32 110.314 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 91.1 t -119.94 123.38 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 109.043 -0.725 . . . . 1.4 109.043 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.415 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 74.0 m-85 -84.62 128.19 34.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.011 -1.055 . . . . 1.29 109.221 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.18 116.62 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.472 -0.768 . . . . 1.38 109.152 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 62.32 67.48 1.2 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 2.33 109.989 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -87.05 131.1 3.08 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 123.048 2.498 . . . . 0.95 112.375 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.3 m -68.56 163.85 22.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 2.31 109.59 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -59.93 -42.1 93.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.293 -0.879 . . . . 3.45 110.681 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.42 -33.6 72.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.818 -1.176 . . . . 2.89 109.335 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.77 -40.34 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.252 -0.905 . . . . 1.73 109.361 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.8 mt . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.231 -0.918 . . . . 1.57 109.863 -179.872 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 43.3 ttm . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.468 0.652 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -149.23 144.97 26.87 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -150.76 160.0 44.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.874 -1.141 . . . . 0.0 110.787 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -154.64 149.57 26.75 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -117.66 134.68 54.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.252 -0.905 . . . . 0.0 109.629 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.8 129.97 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 CA-C-O 122.192 0.996 . . . . 0.0 112.356 -177.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 57.3 m -76.24 108.06 8.92 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.31 1.052 . . . . 0.0 110.958 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 90.5 mt -53.82 120.93 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 122.413 1.102 . . . . 0.0 111.278 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 60.3 p -109.82 19.97 18.54 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.005 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.0 136.09 87.32 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.964 -1.085 . . . . 0.0 108.429 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -65.9 -21.82 56.79 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 CA-C-N 119.929 1.01 . . . . 0.0 112.609 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -121.99 15.24 10.78 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.417 -0.802 . . . . 0.0 108.931 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.19 -175.76 52.3 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.453 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -85.85 91.97 8.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.05 -1.265 . . . . 0.0 109.063 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -92.43 -162.8 0.96 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.831 -1.168 . . . . 0.0 109.969 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 16.0 m -58.56 -43.35 89.33 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.888 -1.133 . . . . 0.0 112.47 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.68 HH21 ' NE2' ' B' ' 321' ' ' GLN . 1.9 tpt180 -55.58 -61.07 6.82 Favored Pre-proline 0 N--CA 1.5 2.025 0 O-C-N 120.517 -1.364 . . . . 0.0 111.46 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -60.22 -36.79 86.92 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 CA-C-N 120.229 1.118 . . . . 0.0 111.939 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . 0.516 ' CB ' ' NH2' ' A' ' 126' ' ' ARG . . . -63.26 -16.82 61.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 0.0 109.357 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -82.46 -44.47 15.98 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . 0.68 ' NE2' HH21 ' B' ' 317' ' ' ARG . 95.4 mt-30 -72.48 -39.13 67.93 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -62.08 -54.55 39.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 110.302 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 52.7 t -63.82 -28.58 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.706 -1.246 . . . . 0.0 110.001 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . 0.534 ' HZ3' ' CD ' ' A' ' 74' ' ' GLU . 11.7 ttmm -60.33 -45.69 92.55 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 109.818 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -62.33 -49.55 75.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.52 -0.738 . . . . 0.0 110.375 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.02 -54.03 50.88 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.054 -1.029 . . . . 0.0 111.468 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -53.86 -16.17 1.67 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.788 -1.195 . . . . 0.0 109.904 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.7 -25.16 75.84 Favored Glycine 0 N--CA 1.487 2.033 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -105.97 141.69 36.94 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.518 -0.989 . . . . 0.0 109.726 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 54.3 m -89.04 -10.04 48.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.237 -0.914 . . . . 0.0 109.242 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 331' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 26.8 m -62.36 150.96 38.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.084 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.86 133.47 49.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.061 -1.025 . . . . 0.0 109.086 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 87.1 mt -129.9 130.12 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.557 -0.714 . . . . 0.0 109.167 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 78.2 m -126.85 148.75 49.96 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.502 0.668 . . . . 0.0 109.287 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 48.3 t -114.07 139.55 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 28.7 m -130.18 121.28 25.94 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.173 -0.954 . . . . 0.0 109.046 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 31.0 t -138.5 115.11 10.58 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.888 0.851 . . . . 0.0 110.525 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 47.56 51.92 13.16 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.04 -14.55 48.63 Favored Glycine 0 N--CA 1.5 2.952 0 O-C-N 119.971 -1.705 . . . . 0.0 112.629 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -111.67 121.73 45.9 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 119.104 1.452 . . . . 0.0 110.222 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 39.1 m -106.57 156.31 18.72 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.719 0.771 . . . . 0.0 110.796 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -152.47 152.66 32.22 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.427 0.632 . . . . 0.0 110.036 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 8.6 t -87.99 131.42 34.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.303 -0.873 . . . . 0.0 109.686 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -70.83 -16.21 62.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.093 -1.005 . . . . 0.0 109.771 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -86.83 21.08 2.35 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.485 ' H ' ' C ' ' B' ' 344' ' ' ALA . 10.7 t -150.8 98.53 2.62 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.18 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 19.3 tp -60.06 -30.6 69.31 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -58.09 -54.36 47.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.414 -0.804 . . . . 0.0 110.718 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.468 ' HZ2' ' CB ' ' B' ' 346' ' ' SER . 35.6 mtmm -68.28 -40.06 81.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.885 -1.134 . . . . 0.0 109.509 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.59 ' O ' ' N ' ' B' ' 352' ' ' THR . 30.9 mt -49.87 -56.99 8.37 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.934 -1.104 . . . . 0.0 108.102 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.416 ' NE2' ' CG2' ' A' ' 130' ' ' VAL . 28.6 mt-30 -40.23 -13.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.044 -0.41 . . . . 0.0 111.799 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.59 ' N ' ' O ' ' B' ' 350' ' ' LEU . 77.0 p -93.99 -13.21 27.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.451 -1.406 . . . . 0.0 110.613 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 63.3 mt -90.54 118.89 30.35 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.847 -1.158 . . . . 0.0 109.077 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.8 90.95 0.67 Allowed Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 20.8 mt -96.77 84.69 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -1.168 . . . . 0.0 108.265 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 30.7 p -88.29 174.3 8.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.431 -0.793 . . . . 0.0 110.566 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -69.16 114.71 7.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.532 -0.73 . . . . 0.0 110.891 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.98 8.94 38.25 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 28.7 m -93.58 111.08 22.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -1.167 . . . . 0.0 110.921 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 11.2 t -77.25 120.23 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 122.141 0.972 . . . . 0.0 109.773 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 18.3 m -112.51 177.32 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 62.0 m -131.37 129.57 41.53 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 77.0 mt -104.53 117.46 50.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 96.8 p -126.27 136.75 53.16 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.426 -0.796 . . . . 0.0 109.593 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.23 154.02 40.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.395 -0.816 . . . . 0.0 109.886 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -142.99 122.47 13.17 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.494 ' O ' ' OE1' ' B' ' 370' ' ' GLU . . . 162.23 -160.24 32.39 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 118.689 -1.72 . . . . 0.0 111.81 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . 0.471 ' N ' ' OG ' ' B' ' 331' ' ' SER . 52.2 tp10 -59.97 -50.08 75.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.145 -0.621 . . . . 0.0 112.322 -177.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.491 ' N ' ' OG ' ' B' ' 331' ' ' SER . 49.5 m-20 -113.3 12.8 18.98 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.869 -1.144 . . . . 0.0 111.592 -177.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.584 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 1.1 pm0 -43.09 -27.86 0.24 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.177 -0.952 . . . . 0.0 110.351 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . 0.489 ' N ' ' CD ' ' B' ' 370' ' ' GLU . 4.4 pt20 -70.08 -42.37 72.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 0.0 109.84 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -65.17 -48.38 73.7 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.203 -0.936 . . . . 0.0 108.918 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.23 -76.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.401 -0.812 . . . . 0.0 110.859 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 59.6 t -46.0 -37.41 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.0 -1.062 . . . . 0.0 110.817 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.34 -49.28 74.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.595 -1.316 . . . . 0.0 110.446 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -77.55 -43.59 31.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.004 -1.06 . . . . 0.0 110.521 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 44.5 mt -60.63 -39.73 89.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -0.893 . . . . 0.0 110.197 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.34 -39.99 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.958 -1.089 . . . . 0.0 109.291 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -70.01 -56.55 6.68 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.768 -1.208 . . . . 0.0 107.859 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 64.5 tp -58.01 -28.38 64.38 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.449 -0.782 . . . . 0.0 111.33 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 381' ' ' MET . . . . . 0.517 ' SD ' ' O ' ' B' ' 381' ' ' MET . 0.0 OUTLIER -73.67 -38.13 65.03 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.104 -1.623 . . . . 0.0 108.382 178.24 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.7 -4.52 54.69 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 110.321 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -111.37 -1.91 15.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.158 -0.964 . . . . 0.0 111.075 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . 0.427 ' CD2' ' OE1' ' B' ' 321' ' ' GLN . 23.8 mt -89.16 127.4 35.73 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.332 -1.48 . . . . 0.0 110.179 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 117.974 -1.012 . . . . 0.0 108.75 179.049 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.088 0.471 . . . . 3.19 109.884 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.423 HG22 HD11 ' A' ' 2' ' ' ILE . 94.5 mt -106.94 120.02 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.442 -0.786 . . . . 1.71 109.108 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.8 m -132.42 134.97 45.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.503 -0.748 . . . . 1.66 109.392 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.721 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -119.34 -162.01 11.84 Favored Glycine 0 N--CA 1.501 2.99 0 N-CA-C 108.872 -1.691 . . . . 1.05 108.872 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.468 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.5 mt -89.4 -18.46 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.938 -1.331 . . . . 1.59 110.249 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 5' ' ' ILE . 62.7 tp 54.68 105.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.369 -0.832 . . . . 1.47 108.849 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.15 -24.1 14.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.132 -0.98 . . . . 1.39 109.338 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 19.5 t -138.33 124.74 12.91 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.446 -0.784 . . . . 2.09 109.81 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.65 145.18 16.12 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.974 1.783 . . . . 0.91 112.122 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 158.03 -158.83 29.49 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.481 -1.448 . . . . 0.92 109.481 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.7 mt -149.68 150.81 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.169 -1.194 . . . . 1.35 108.661 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.44 155.47 33.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.073 -1.017 . . . . 1.14 110.168 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.2 m-85 -136.58 129.56 31.02 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.679 -1.23 . . . . 0.7 107.679 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.29 -178.76 47.62 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 118.349 -1.881 . . . . 0.58 110.951 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -79.96 157.09 26.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.814 -0.815 . . . . 2.63 109.53 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.82 129.19 49.4 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.363 -0.836 . . . . 1.27 111.108 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.0 tp -99.66 131.05 45.9 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.629 -1.249 . . . . 1.41 107.629 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.5 tp -111.21 120.09 41.11 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.08 -1.012 . . . . 1.49 109.5 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.7 mt -85.51 104.04 14.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.55 -0.718 . . . . 1.52 109.467 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -93.19 135.48 34.34 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.7 -0.852 . . . . 3.17 108.7 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.01 118.45 20.62 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.686 -0.857 . . . . 3.0 108.686 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -76.7 141.64 40.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.102 -0.998 . . . . 2.77 109.448 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -60.06 140.07 57.07 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.325 -0.859 . . . . 2.94 108.774 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 84.8 mt -77.76 135.24 26.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.556 -0.905 . . . . 1.46 108.556 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.7 t -100.6 122.63 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.271 -0.893 . . . . 1.7 109.878 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.1 mt -95.43 141.86 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.969 -0.752 . . . . 1.54 108.969 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -97.67 119.44 36.24 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.171 -0.956 . . . . 1.81 109.491 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -94.47 3.24 55.4 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.282 -0.886 . . . . 3.23 109.467 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -59.97 139.98 57.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.419 -0.801 . . . . 3.29 109.908 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -93.07 144.94 24.78 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.158 -0.963 . . . . 2.8 108.597 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 pt -103.17 166.92 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.121 -0.987 . . . . 1.43 110.863 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.9 p -96.9 177.63 5.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.349 -0.844 . . . . 1.54 109.332 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.08 -49.9 75.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.452 -0.78 . . . . 1.6 110.877 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -58.06 -29.81 65.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.525 -1.359 . . . . 2.56 109.991 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -81.56 -11.44 59.16 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.147 -0.97 . . . . 2.36 110.242 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.7 t -60.04 -50.03 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.861 -1.149 . . . . 1.43 108.729 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -61.22 -39.96 92.21 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.479 -0.763 . . . . 1.77 109.347 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -64.14 -43.45 95.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.411 -0.806 . . . . 3.32 111.274 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -63.56 -41.11 98.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.74 -1.225 . . . . 1.51 110.168 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.04 -46.08 94.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 118.709 -1.196 . . . . 1.41 108.794 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -60.03 -42.33 94.15 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.068 -1.02 . . . . 1.81 109.382 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.449 HH11 ' HG2' ' A' ' 42' ' ' ARG . 25.1 mtt-85 -60.06 -44.66 94.56 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.937 -1.134 . . . . 3.26 107.937 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -60.18 -45.76 92.03 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.393 -0.966 . . . . 0.81 108.393 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.98 -49.82 76.15 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.801 -0.815 . . . . 1.59 108.801 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.8 t -60.05 -42.2 93.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.048 -1.032 . . . . 1.38 109.174 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.0 -42.55 98.41 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.191 -1.964 . . . . 0.87 108.191 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.1 ttm-85 -60.07 -32.97 71.43 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.225 -1.028 . . . . 3.62 108.225 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.09 83.44 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.743 -0.598 . . . . 1.43 109.631 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 50' ' ' ALA . 12.1 ttmt -75.16 -74.82 0.19 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.55 -1.26 . . . . 3.08 108.384 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -39.0 -39.32 0.53 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.16 -0.963 . . . . 1.33 111.459 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.9 p -55.95 -59.11 5.36 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.704 -1.247 . . . . 1.85 109.252 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.21 -40.01 82.23 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.249 -0.907 . . . . 1.35 111.331 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -63.39 -40.63 97.74 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.772 -1.205 . . . . 2.34 110.975 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.5 -40.07 96.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.758 -1.213 . . . . 2.2 109.078 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -59.92 -38.57 82.72 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.41 -0.806 . . . . 1.35 109.995 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -64.62 -43.68 92.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.915 -1.116 . . . . 1.34 109.226 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.423 ' CD1' HH22 ' A' ' 136' ' ' ARG . 87.9 mt -60.01 -40.01 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 1.26 108.936 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -55.58 -50.03 71.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.39 -0.818 . . . . 1.7 109.958 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -59.41 -36.32 75.64 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.316 -0.865 . . . . 1.35 111.002 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -62.37 -39.64 93.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.914 -1.116 . . . . 2.08 109.534 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.35 -45.25 80.82 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.629 -0.669 . . . . 1.21 110.218 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.63 -52.25 51.6 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.705 -1.358 . . . . 0.75 109.705 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.08 -46.5 64.78 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.135 -1.215 . . . . 1.59 110.214 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.7 m -67.27 -63.45 1.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.195 -0.94 . . . . 1.41 112.697 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -96.23 -45.08 6.99 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.786 -1.196 . . . . 0.79 111.29 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.64 -174.04 23.22 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 119.644 -1.265 . . . . 1.22 111.309 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -70.05 -26.68 64.13 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.395 0.617 . . . . 5.81 110.348 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -60.98 -32.76 72.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.447 -0.783 . . . . 3.37 110.703 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -100.44 -20.51 15.75 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.37 -0.831 . . . . 2.37 109.374 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -66.24 -40.09 89.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 1.65 110.329 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.35 -26.92 67.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 1.42 109.718 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.0 mt -60.03 -41.81 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.952 -1.092 . . . . 1.43 109.174 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -66.56 -39.84 88.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.264 -0.898 . . . . 1.08 110.089 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.537 ' CD ' ' HZ3' ' B' ' 324' ' ' LYS . 61.6 tt0 -60.06 -39.95 87.8 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.232 -0.917 . . . . 1.37 109.387 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.89 -46.06 95.3 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.308 -1.517 . . . . 0.67 109.308 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.4 m170 -60.09 -42.05 93.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.201 -1.176 . . . . 1.99 109.459 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.1 mt -68.43 -45.9 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.342 -0.849 . . . . 1.22 109.526 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.2 ttp -59.98 -44.12 94.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.83 -1.168 . . . . 2.11 110.074 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.5 tp -64.53 -39.94 94.7 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.202 -0.937 . . . . 1.33 109.248 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.2 tp -62.78 -39.87 95.53 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.567 -0.708 . . . . 1.29 109.589 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -84.69 4.15 33.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.215 -0.928 . . . . 1.47 110.152 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.6 t0 -50.02 133.06 23.16 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.127 -0.983 . . . . 1.47 110.867 -178.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.45 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 95.4 mt-10 -61.46 -20.31 62.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.571 -0.706 . . . . 1.78 110.005 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -68.22 -32.73 73.14 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.902 -1.147 . . . . 2.53 107.902 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.0 mt -75.97 -40.0 54.79 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.509 0.671 . . . . 1.36 110.28 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -60.06 -49.98 75.52 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.269 -0.894 . . . . 1.42 110.282 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -70.7 -41.64 71.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.114 -0.991 . . . . 2.27 110.656 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.08 -39.92 75.33 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.21 -0.931 . . . . 1.57 111.822 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.04 -43.9 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.765 -1.21 . . . . 1.19 109.35 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.7 mt -70.04 -39.34 77.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.574 -0.704 . . . . 1.39 110.101 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -60.05 -48.3 82.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.249 -0.907 . . . . 1.39 111.248 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 96' ' ' LYS . 92.5 mt -60.1 -44.96 94.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.855 -1.153 . . . . 1.5 109.862 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.96 -49.19 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.343 -0.984 . . . . 1.29 108.343 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -69.33 -41.79 76.21 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.123 -0.631 . . . . 2.64 110.759 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 91' ' ' ALA . 53.6 t0 -81.34 -50.33 9.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.002 -1.061 . . . . 1.65 112.043 -178.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 92' ' ' LEU . 68.2 mmtt -92.46 -1.85 56.69 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.041 -1.037 . . . . 2.5 111.838 -177.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 55.72 33.84 22.15 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.785 -1.197 . . . . 1.88 109.562 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 93.9 mtp -89.56 168.95 11.76 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.526 -0.734 . . . . 1.71 110.047 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.592 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 43.3 p -81.11 160.01 24.55 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.74 -0.837 . . . . 1.61 108.74 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.41 -38.9 91.33 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.054 -1.029 . . . . 1.33 109.282 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -66.68 -39.3 88.07 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.281 -0.887 . . . . 2.07 109.532 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.592 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -76.76 -44.2 33.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 1.37 110.113 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.13 -45.35 73.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.893 . . . . 1.14 109.895 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.67 83.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.117 -0.989 . . . . 1.26 109.547 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -59.88 -44.63 94.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.351 -0.843 . . . . 2.02 110.266 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.463 ' O ' ' N ' ' A' ' 110' ' ' GLY . 88.6 tt0 -62.6 -40.69 97.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.898 . . . . 1.33 110.441 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.74 -55.74 21.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.229 -0.919 . . . . 1.3 110.84 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.1 mm -70.54 -40.04 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.784 -1.197 . . . . 1.32 109.491 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.438 ' OE2' ' OG ' ' A' ' 113' ' ' SER . 12.2 tm-20 -68.3 -39.97 81.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 2.44 108.8 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -60.57 -45.85 95.52 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.04 -1.224 . . . . 0.99 110.04 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.45 HE21 ' CB ' ' B' ' 348' ' ' PHE . 16.5 mm100 -69.95 -53.06 19.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.989 -1.301 . . . . 1.97 109.749 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.93 -40.04 69.49 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.088 -1.008 . . . . 1.43 109.229 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.438 ' OG ' ' OE2' ' A' ' 109' ' ' GLU . 59.1 m -60.0 -40.07 87.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.959 . . . . 2.12 109.275 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.09 -33.53 75.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 1.64 109.128 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.2 mt -69.06 -39.97 78.78 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.075 -1.016 . . . . 1.93 109.66 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.02 -27.94 67.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.858 -1.151 . . . . 2.2 109.194 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -59.94 -23.49 63.6 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.364 -0.976 . . . . 2.12 108.364 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 24.6 mt -62.15 151.54 35.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 2.34 109.115 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -99.49 30.05 3.75 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.214 -0.929 . . . . 3.23 110.16 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -118.07 131.27 56.46 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.19 -0.944 . . . . 2.49 110.637 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -70.07 -29.77 66.85 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.11 -0.7 . . . . 3.95 109.11 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.469 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.4 t80 -69.72 -38.93 77.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.603 -0.686 . . . . 2.25 110.38 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 88.2 mt -73.15 -32.94 65.19 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.069 -1.019 . . . . 2.27 109.262 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -60.02 -40.06 88.0 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.271 -0.893 . . . . 3.31 108.646 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -59.95 -46.15 90.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.888 . . . . 2.73 109.017 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.476 ' HE ' ' NE2' ' B' ' 351' ' ' GLN . 15.3 mmm-85 -60.11 -39.96 88.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.127 -0.983 . . . . 3.2 108.885 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.13 -34.93 75.77 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.469 -0.937 . . . . 1.66 108.469 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.18 -39.97 92.15 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.394 -0.965 . . . . 1.67 108.394 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -68.57 -39.94 80.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.402 -0.811 . . . . 1.55 109.172 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.44 -39.92 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.11 -1.07 . . . . 1.32 108.11 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.473 HH11 ' HG2' ' A' ' 131' ' ' ARG . 7.2 ttt-85 -67.25 -34.42 77.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.449 -0.782 . . . . 3.58 109.44 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.03 -41.22 91.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 1.46 109.587 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.3 mt -61.06 -44.01 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 1.22 109.272 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.13 -45.0 96.79 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.155 -1.178 . . . . 0.61 110.155 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -59.97 -45.4 92.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.158 -1.201 . . . . 3.1 109.561 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.423 HH22 ' CD1' ' A' ' 57' ' ' ILE . 60.3 mtp180 -67.32 -36.05 80.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.042 -1.036 . . . . 3.71 110.112 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.0 -43.31 95.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 1.87 109.513 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.34 -40.49 97.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.121 -0.987 . . . . 1.29 109.433 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -69.88 -38.09 76.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.188 -0.945 . . . . 3.05 108.672 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -59.97 -38.82 83.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.829 -0.545 . . . . 1.26 110.565 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -73.74 -44.18 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.829 -1.169 . . . . 1.34 108.917 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.96 -40.01 75.68 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.47 -0.769 . . . . 1.6 109.853 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.74 47.06 4.36 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.186 -1.566 . . . . 0.96 109.186 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.7 tp -73.66 148.76 42.47 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.439 -1.036 . . . . 1.67 109.396 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -66.89 140.67 57.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 4.96 109.391 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.3 mt -119.77 129.93 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 CA-C-O 121.77 0.795 . . . . 1.68 109.728 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 148' ' ' ASP . 1.4 mp -66.66 -39.94 84.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.786 -0.571 . . . . 2.14 110.323 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 147' ' ' ILE . 29.1 t0 62.27 127.03 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.822 -0.807 . . . . 1.5 108.822 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.1 mt -85.06 -4.51 59.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.054 -1.029 . . . . 1.39 109.366 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.4 t -86.75 -14.39 42.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.457 -0.777 . . . . 1.83 109.69 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.88 17.02 1.26 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -0.909 . . . . 1.46 110.473 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 38.3 mm -88.86 124.24 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.872 -1.142 . . . . 1.42 109.203 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -105.76 -9.78 17.07 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.423 -0.798 . . . . 2.94 109.833 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -124.05 149.62 45.9 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.319 -0.863 . . . . 1.52 110.311 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.21 134.62 55.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.351 -0.843 . . . . 1.58 109.595 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -151.95 164.64 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.492 -0.755 . . . . 1.32 109.525 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.7 mt -91.67 150.65 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 106.137 -1.801 . . . . 1.27 106.137 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 51.2 tp -99.98 115.9 30.78 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.936 -1.103 . . . . 1.41 110.611 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.62 130.04 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 109.028 -0.73 . . . . 1.23 109.028 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.78 163.35 34.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.184 -0.948 . . . . 1.32 108.647 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.36 -35.42 73.53 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.426 -1.421 . . . . 1.49 107.68 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -160.99 173.46 15.23 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.983 -0.747 . . . . 2.25 108.983 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.7 mt -138.91 139.19 37.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.18 -0.95 . . . . 1.35 109.037 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.4 p -96.09 140.29 22.19 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.168 -0.957 . . . . 1.56 109.141 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -40.25 -34.75 1.12 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.901 1.734 . . . . 0.87 112.216 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 59.3 m -59.94 -42.85 94.88 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.883 . . . . 1.36 109.787 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -69.56 -41.3 76.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.249 -0.907 . . . . 1.61 109.844 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.8 p -54.28 -23.85 16.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 1.21 111.528 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.438 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -86.01 -50.12 7.3 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.407 -1.433 . . . . 1.21 109.867 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -81.49 35.87 0.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.479 -0.934 . . . . 2.11 108.479 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 169' ' ' ALA . 59.1 tp -101.38 132.4 46.98 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.257 -0.645 . . . . 1.29 109.257 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -83.41 101.77 11.59 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.164 -0.96 . . . . 2.81 108.716 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.34 -40.18 96.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 2.09 111.111 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -67.7 -26.11 66.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.837 -1.164 . . . . 2.86 111.915 -177.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -93.74 -11.43 31.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.62 -1.3 . . . . 2.39 110.231 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 63.3 t -101.59 111.53 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.148 -0.97 . . . . 1.27 108.468 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.37 2.93 33.96 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.226 -0.921 . . . . 2.17 111.263 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.8 171.09 37.94 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.37 -1.492 . . . . 0.52 109.37 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.412 ' O ' ' CB ' ' A' ' 201' ' ' ALA . 14.5 m-85 -132.04 128.43 38.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.498 -1.001 . . . . 0.55 109.491 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.95 126.19 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.101 -1.074 . . . . 1.27 108.101 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 203' ' ' VAL . 16.6 p -146.21 158.62 43.89 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.013 -1.055 . . . . 1.39 110.842 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 59.5 t0 -106.15 28.13 7.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.748 -0.595 . . . . 2.46 109.452 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -52.99 -168.52 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.448 -1.408 . . . . 1.51 111.369 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.13 -54.93 6.0 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.49 -1.044 . . . . 2.23 110.49 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -166.51 -156.04 9.3 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.037 -1.554 . . . . 2.23 111.01 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 186' ' ' ARG . 16.6 ptt-85 -70.05 -18.0 63.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.8 -0.823 . . . . 6.44 111.327 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 69.5 p -73.13 5.25 3.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.768 -1.207 . . . . 4.09 110.305 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.7 p -82.11 137.8 34.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.93 -1.106 . . . . 2.2 109.991 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -49.3 -49.93 41.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.321 -0.862 . . . . 1.15 110.152 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -37.62 71.48 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.362 -0.836 . . . . 2.01 110.965 -178.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.9 t -60.03 -39.97 87.7 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.752 -1.217 . . . . 1.93 110.371 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.86 -39.74 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.855 . . . . 2.2 110.17 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.5 mtm -59.93 -45.0 94.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.966 -1.084 . . . . 1.32 110.42 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.99 -45.45 71.42 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.799 -1.188 . . . . 1.3 109.46 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -60.01 -53.44 57.85 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.998 -1.081 . . . . 3.38 110.445 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.4 m -68.21 -37.8 81.26 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.068 -1.02 . . . . 1.15 111.973 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.38 -22.95 62.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.698 -1.251 . . . . 1.28 109.906 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 66.56 49.3 1.35 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.322 0.582 . . . . 1.5 110.079 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.47 ' O ' ' CB ' ' A' ' 8' ' ' SER . 97.0 mt -129.53 148.98 71.54 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 108.027 -1.101 . . . . 1.37 108.027 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.54 138.31 69.59 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.276 1.984 . . . . 0.76 112.194 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 179' ' ' PHE . . . -171.01 149.73 2.97 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.076 -1.05 . . . . 1.19 111.354 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 202' ' ' ILE . 96.5 mt -122.99 144.09 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 107.21 -1.404 . . . . 1.31 107.21 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 181' ' ' THR . 17.9 m -122.34 -12.81 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.006 -1.059 . . . . 1.38 111.127 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -112.65 26.77 10.48 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.88 -0.888 . . . . 1.03 110.88 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 204' ' ' GLY . 14.0 p -41.96 -46.57 4.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.15 -1.206 . . . . 1.38 110.12 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.454 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 94.74 -54.18 1.96 Allowed Glycine 0 N--CA 1.5 2.951 0 C-N-CA 120.332 -0.937 . . . . 1.17 111.587 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 207' ' ' SER . 7.4 t -150.01 29.94 0.72 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.329 -1.689 . . . . 2.07 111.024 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 41.8 t -75.25 -36.87 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.709 -1.244 . . . . 1.35 109.249 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.4 p -60.05 -33.73 72.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.922 . . . . 1.49 111.117 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.2 t -78.37 -22.44 47.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.935 -1.103 . . . . 2.16 110.306 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -94.7 -8.35 38.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.185 -0.947 . . . . 2.89 110.499 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 86.4 t -108.02 140.02 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.28 -0.888 . . . . 1.33 110.729 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.497 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 65.2 mmtt -117.15 156.87 26.91 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.895 -1.521 . . . . 2.73 106.895 177.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 29.9 p-10 -60.04 142.53 53.84 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.802 -1.186 . . . . 2.7 111.115 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.438 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.7 m-20 82.11 3.2 1.28 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 116.061 -0.518 . . . . 2.38 110.832 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.497 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 88.9 m-20 -74.95 145.01 42.93 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.889 -1.132 . . . . 2.09 109.301 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -94.59 120.0 34.13 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.231 -0.918 . . . . 1.45 108.847 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 59.6 mt -126.86 147.49 50.04 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.414 -0.804 . . . . 1.31 110.433 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 85.7 mt -114.11 128.28 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 106.906 -1.516 . . . . 1.29 106.906 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.1 tp -100.83 117.07 34.19 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.866 -1.146 . . . . 1.31 109.595 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.513 ' C ' ' H ' ' A' ' 223' ' ' VAL . 96.1 m-20 -74.03 -43.9 56.26 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.242 -0.911 . . . . 2.31 108.728 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 50.35 11.74 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.846 -0.798 . . . . 1.19 108.846 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.513 ' H ' ' C ' ' A' ' 221' ' ' ASP . 73.5 t -131.05 -44.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.817 -1.179 . . . . 1.45 107.817 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -100.04 3.23 44.0 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.61 -1.255 . . . . 3.13 107.61 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.721 HD22 ' H ' ' A' ' 4' ' ' GLY . 1.0 OUTLIER 59.61 43.67 15.51 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 116.246 -0.433 . . . . 2.2 110.192 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -140.09 144.46 36.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.122 -0.986 . . . . 2.32 110.042 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 87.8 t -120.03 125.68 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.926 -0.768 . . . . 1.4 108.926 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -90.99 118.15 30.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.85 -1.156 . . . . 1.29 109.679 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.76 116.69 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.475 -0.766 . . . . 1.38 109.529 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 68.22 67.67 0.52 Allowed Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.468 -0.77 . . . . 2.33 109.947 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -91.02 121.35 0.71 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 123.426 2.751 . . . . 0.95 112.955 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 233' ' ' ASN . 93.9 m -67.03 169.77 7.85 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.256 -0.903 . . . . 2.31 109.685 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.467 ' N ' ' CG2' ' A' ' 232' ' ' THR . 7.3 m120 -60.06 -40.0 87.97 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.307 -0.871 . . . . 3.45 109.544 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.91 -38.63 82.86 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.189 -0.945 . . . . 2.89 108.753 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.72 -40.06 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 1.73 109.559 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.426 HD11 HG22 ' A' ' 236' ' ' ILE . 96.7 mt . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.291 -0.881 . . . . 1.57 109.86 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 38.1 ttp . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.497 0.665 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -155.84 153.44 29.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.494 -0.754 . . . . 0.0 109.136 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -150.9 161.9 41.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.08 -1.012 . . . . 0.0 110.399 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -153.38 149.95 28.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.644 -0.66 . . . . 0.0 109.389 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.17 128.56 55.54 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -131.66 124.59 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 CA-C-O 122.192 0.996 . . . . 0.0 112.388 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 91.4 m -77.84 103.87 8.04 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.03 0.919 . . . . 0.0 110.869 -178.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . 0.431 HD11 HG22 ' B' ' 308' ' ' ILE . 88.8 mt -51.71 124.75 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 122.467 1.127 . . . . 0.0 110.464 -178.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 75.7 p -110.02 19.33 19.12 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.206 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . 0.404 ' O ' ' CD ' ' B' ' 357' ' ' GLN . . . -69.33 147.21 97.07 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.94 -1.1 . . . . 0.0 108.578 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -72.82 -24.69 17.69 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 120.892 1.061 . . . . 0.0 112.672 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -121.05 17.61 11.66 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.17 -173.37 53.97 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.989 -2.045 . . . . 0.0 107.989 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.469 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.5 tp -86.3 90.42 8.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.889 -1.359 . . . . 0.0 108.88 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -93.14 -161.42 0.84 Allowed 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.033 -1.042 . . . . 0.0 111.102 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.1 m -55.79 -45.32 78.24 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.569 -0.707 . . . . 0.0 112.71 -175.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.458 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.5 tpt180 -61.22 -58.58 17.98 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 120.526 -1.359 . . . . 0.0 112.176 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 11.5 Cg_endo -59.37 -32.03 95.91 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 120.307 1.145 . . . . 0.0 111.907 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.96 75.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.11 -0.994 . . . . 0.0 108.515 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.73 -42.76 68.45 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.248 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -69.95 -42.96 72.51 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.129 -0.982 . . . . 0.0 108.944 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.26 -52.55 64.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.462 -0.774 . . . . 0.0 110.622 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 92.5 t -64.66 -30.84 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.757 -1.214 . . . . 0.0 109.521 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . 0.537 ' HZ3' ' CD ' ' A' ' 74' ' ' GLU . 12.0 ttmm -60.03 -48.11 83.07 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.392 -0.818 . . . . 0.0 110.102 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -67.64 -44.45 77.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 111.239 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.04 -52.43 65.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.587 -1.32 . . . . 0.0 110.465 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -56.42 -14.1 2.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.009 . . . . 0.0 109.376 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -71.94 -21.53 79.02 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -105.8 143.68 33.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.669 -0.9 . . . . 0.0 108.721 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 15.3 t -91.02 -13.16 33.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.027 -1.046 . . . . 0.0 109.279 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 52.8 p -62.72 146.9 51.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.481 -0.762 . . . . 0.0 109.119 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.63 137.04 57.07 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.148 -0.97 . . . . 0.0 108.98 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 94.3 mt -132.94 133.21 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.604 -0.685 . . . . 0.0 109.679 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 46.5 m -130.34 152.42 49.77 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 62.3 t -117.41 139.51 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 97.9 m -130.7 126.09 35.62 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.105 -0.997 . . . . 0.0 109.714 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 73.5 p -140.16 118.19 11.88 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.863 0.84 . . . . 0.0 110.574 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 9.3 m120 42.09 54.45 4.09 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.2 -15.7 43.0 Favored Glycine 0 N--CA 1.502 3.067 0 O-C-N 120.206 -1.559 . . . . 0.0 113.138 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -112.44 124.22 52.03 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 119.327 1.563 . . . . 0.0 109.371 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 85.8 p -122.07 147.59 45.91 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.941 0.876 . . . . 0.0 111.044 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.24 159.78 41.49 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.671 0.748 . . . . 0.0 109.849 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 22.1 m -88.74 136.74 32.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.473 -0.767 . . . . 0.0 110.463 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.468 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -73.93 -16.78 61.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.051 -1.031 . . . . 0.0 109.876 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -87.36 19.9 3.06 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.468 ' H ' ' C ' ' B' ' 344' ' ' ALA . 25.1 t -149.75 94.83 2.23 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.733 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 36.0 tp -59.96 -32.72 71.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . 0.45 ' CB ' HE21 ' A' ' 111' ' ' GLN . 60.4 m-85 -54.75 -53.55 53.64 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.031 -1.043 . . . . 0.0 110.175 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.452 ' O ' ' OG1' ' B' ' 352' ' ' THR . 34.1 mtmm -70.07 -35.89 74.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 0.0 110.273 -178.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 81.8 mt -53.92 -50.1 67.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.878 -1.139 . . . . 0.0 110.232 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.476 ' NE2' ' HE ' ' A' ' 126' ' ' ARG . 3.6 mt-30 -49.99 -17.59 0.41 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.668 -1.27 . . . . 0.0 111.337 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' B' ' 349' ' ' LYS . 82.1 p -79.81 -14.55 58.61 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.275 -1.516 . . . . 0.0 110.972 -178.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 30.9 mt -91.82 118.66 30.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.749 -1.22 . . . . 0.0 109.201 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.35 92.81 0.77 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 20.9 mt -100.47 89.72 4.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.37 -1.077 . . . . 0.0 109.309 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 38.2 p -90.01 177.87 6.35 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.095 -1.003 . . . . 0.0 110.449 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . 0.404 ' CD ' ' O ' ' B' ' 310' ' ' ALA . 48.5 tt0 -69.87 115.14 8.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.632 -0.667 . . . . 0.0 110.926 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 100.2 9.54 47.79 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 52.1 m -87.21 114.12 23.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.228 -1.16 . . . . 0.0 110.888 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.97 115.15 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 122.116 0.96 . . . . 0.0 109.785 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 32.8 m -110.99 176.38 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 33.0 m -130.64 127.64 39.34 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 72.9 mt -102.88 116.64 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 84.1 p -119.98 131.6 55.22 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.304 -0.872 . . . . 0.0 109.47 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.69 151.55 39.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.19 -0.944 . . . . 0.0 109.587 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -144.07 122.99 12.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.406 -0.809 . . . . 0.0 108.889 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.534 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.06 -158.06 29.37 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.062 -1.542 . . . . 0.0 111.481 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -59.85 -50.02 75.44 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -108.99 13.4 24.7 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.819 -1.176 . . . . 0.0 110.963 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.2 pt-20 -44.95 -36.25 3.28 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.077 -1.014 . . . . 0.0 110.89 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.14 -46.25 68.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.95 -1.094 . . . . 0.0 110.226 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -66.39 -48.15 71.03 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.154 -0.966 . . . . 0.0 109.727 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.12 -75.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 110.501 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 68.8 t -45.96 -38.82 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.097 -1.002 . . . . 0.0 110.557 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -63.72 -49.96 71.01 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.598 -1.314 . . . . 0.0 110.475 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . 0.401 ' N ' ' HD1' ' B' ' 376' ' ' HIS . 0.3 OUTLIER -78.11 -40.66 37.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.978 -1.076 . . . . 0.0 110.062 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 82.4 mt -59.99 -38.66 83.22 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.111 -0.993 . . . . 0.0 109.296 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 39.8 t -61.44 -39.96 84.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.28 -0.887 . . . . 0.0 108.647 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.72 -55.55 12.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.963 -1.086 . . . . 0.0 108.218 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 57.6 tp -58.21 -32.25 68.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.127 -0.983 . . . . 0.0 109.932 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.8 tpp -71.78 -40.77 69.04 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.354 -1.338 . . . . 0.0 108.875 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.6 -5.84 59.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -0.775 . . . . 0.0 110.349 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -110.13 -3.86 16.13 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.223 -0.923 . . . . 0.0 111.237 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 12.4 mt -76.48 129.99 37.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.303 -1.498 . . . . 0.0 108.957 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.161 -179.868 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.34 -0.615 . . . . 3.19 109.34 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.0 mt -110.06 129.96 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.579 -0.701 . . . . 1.71 109.251 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.0 m -119.48 152.34 37.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.629 -0.669 . . . . 1.66 109.244 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.57 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -135.66 -165.22 10.61 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 108.441 -1.864 . . . . 1.05 108.441 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 6' ' ' LEU . 97.0 mt -89.49 -18.82 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.69 -1.476 . . . . 1.59 110.571 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' ILE . 37.1 tp 54.79 104.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.174 -0.954 . . . . 1.47 109.17 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.88 -27.02 13.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.258 -0.901 . . . . 1.39 109.238 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.8 t -133.69 118.39 14.52 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.575 -0.703 . . . . 2.09 109.17 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.27 148.58 18.96 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.964 1.776 . . . . 0.91 112.542 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 154.47 -156.77 27.09 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 108.897 -1.681 . . . . 0.92 108.897 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.2 mt -147.66 150.64 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.021 -1.281 . . . . 1.35 108.318 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.8 155.02 35.06 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.776 -1.203 . . . . 1.14 110.807 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.9 OUTLIER -139.01 129.5 25.79 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.551 -1.277 . . . . 0.7 107.551 178.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.08 -178.07 48.23 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.482 -1.818 . . . . 0.58 111.039 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -79.69 159.16 26.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.833 -0.804 . . . . 2.63 109.165 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.5 132.1 54.45 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.479 -0.763 . . . . 1.27 110.859 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.6 tp -102.99 139.39 38.62 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.102 -1.073 . . . . 1.41 108.102 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.9 tp -117.69 122.3 43.15 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.346 -0.846 . . . . 1.49 109.674 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.8 mt -87.98 104.28 16.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.538 -0.726 . . . . 1.52 109.834 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -101.07 132.74 46.37 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.783 -0.821 . . . . 3.17 108.783 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -124.82 136.19 53.6 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.757 -0.831 . . . . 3.0 108.757 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.21 142.98 34.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.093 -1.004 . . . . 2.77 109.641 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.49 140.02 58.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.875 . . . . 2.94 108.824 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.4 mt -81.6 130.53 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.211 -0.93 . . . . 1.46 109.627 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 t -96.43 128.47 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.217 -0.927 . . . . 1.7 110.181 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 26' ' ' ILE . 96.8 mt -109.0 135.41 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.178 -0.675 . . . . 1.54 109.178 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -91.53 121.36 33.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.124 -0.985 . . . . 1.81 109.794 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.419 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.1 mmm-85 -90.02 -0.04 57.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.378 -0.826 . . . . 3.23 109.888 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.54 146.1 54.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.043 -1.035 . . . . 3.29 109.468 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -88.45 147.27 24.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.296 -0.878 . . . . 2.8 109.282 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 pt -94.15 164.02 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.012 -1.055 . . . . 1.43 109.413 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -94.07 168.29 11.04 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.144 -0.972 . . . . 1.54 108.886 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.05 -15.52 59.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.067 -1.021 . . . . 1.6 109.943 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -87.41 -27.96 22.43 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.85 -1.167 . . . . 2.56 107.85 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -81.74 -9.24 59.69 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.723 -0.843 . . . . 2.36 108.723 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.8 t -62.87 -53.88 40.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.124 -0.985 . . . . 1.43 108.572 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -61.94 -39.97 93.91 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.33 -0.856 . . . . 1.77 110.123 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -69.84 -40.12 76.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.132 -0.98 . . . . 3.32 110.563 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -67.62 -39.83 84.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.925 -1.109 . . . . 1.51 110.029 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.14 -46.69 94.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 120.756 -1.215 . . . . 1.41 108.624 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -60.15 -42.18 94.34 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.147 -0.971 . . . . 1.81 109.495 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.02 -45.32 93.19 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.901 -1.119 . . . . 3.26 108.38 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -60.43 -46.13 91.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.326 -0.858 . . . . 0.81 108.764 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.2 tp -60.1 -47.98 83.63 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.616 -0.883 . . . . 1.59 108.616 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.4 t -61.82 -42.29 98.84 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.413 -0.915 . . . . 1.38 108.761 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.13 -45.83 95.3 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.346 -1.902 . . . . 0.87 108.346 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.431 ' NH1' ' HG3' ' A' ' 47' ' ' ARG . 31.9 ttm-85 -62.32 -32.92 73.74 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.433 -1.04 . . . . 3.62 108.307 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.81 -40.01 69.07 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.888 -0.782 . . . . 1.43 108.888 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.8 ttmt -72.44 -73.14 0.21 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.927 -1.138 . . . . 3.08 107.927 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.48 -37.93 0.14 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.362 -0.836 . . . . 1.33 111.844 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 m -59.99 -52.52 65.02 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.433 -1.417 . . . . 1.85 108.517 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.34 -40.0 93.12 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.866 . . . . 1.35 110.809 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -66.63 -40.07 88.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.036 -1.04 . . . . 2.34 110.766 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.87 -39.99 94.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.829 -1.169 . . . . 2.2 108.976 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -65.17 -35.83 82.31 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.274 -0.892 . . . . 1.35 108.926 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -64.52 -43.3 94.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 1.34 109.902 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.16 -39.88 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.987 . . . . 1.26 108.819 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -53.18 -52.48 58.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 1.7 110.064 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -57.01 -33.74 67.47 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.26 -0.9 . . . . 1.35 110.309 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.4 ' O ' ' OG1' ' A' ' 64' ' ' THR . 97.6 mttt -69.32 -37.25 77.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.909 -1.119 . . . . 2.08 109.435 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.99 -45.9 76.23 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.548 -0.72 . . . . 1.21 110.074 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.03 -51.95 55.78 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.333 -1.107 . . . . 0.75 110.333 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.75 -41.11 79.39 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.986 -1.302 . . . . 1.59 110.185 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 89.6 m -70.11 -62.48 1.37 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.053 -1.029 . . . . 1.41 112.739 -177.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -96.52 -45.88 6.57 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.787 -1.195 . . . . 0.79 111.573 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.08 -166.74 25.91 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 119.705 -1.236 . . . . 1.22 110.977 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -71.26 -24.01 62.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.914 -0.757 . . . . 5.81 110.663 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -62.7 -36.12 81.92 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.278 -0.889 . . . . 3.37 111.502 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -98.42 -18.43 18.26 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.034 -1.041 . . . . 2.37 109.548 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -67.23 -40.07 86.31 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.281 -0.887 . . . . 1.65 110.104 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.584 ' CB ' HH11 ' B' ' 317' ' ' ARG . . . -64.94 -28.37 69.48 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.287 -0.883 . . . . 1.42 109.974 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.84 -41.39 85.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 118.951 -1.1 . . . . 1.43 108.704 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -66.43 -42.51 87.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 1.08 110.493 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -63.11 -40.82 98.73 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.804 -1.185 . . . . 1.37 109.154 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.65 -40.71 98.34 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.344 -1.902 . . . . 0.67 108.344 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -70.05 -41.83 73.69 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.516 -0.991 . . . . 1.99 109.209 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.0 mt -69.71 -45.62 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.396 -0.815 . . . . 1.22 109.655 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.3 ttp -60.13 -46.52 89.35 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.916 -1.115 . . . . 2.11 109.802 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.7 tp -60.79 -40.54 93.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.314 -0.866 . . . . 1.33 109.328 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.411 ' HG ' HH12 ' A' ' 47' ' ' ARG . 63.9 tp -62.23 -40.01 94.73 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.538 -0.726 . . . . 1.29 109.931 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -82.12 8.81 9.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.173 -0.954 . . . . 1.47 110.152 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.7 t0 -54.58 132.98 46.23 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.186 -0.946 . . . . 1.47 110.258 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.415 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 39.9 mt-10 -60.38 -19.65 56.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.613 -0.679 . . . . 1.78 111.301 -178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.4 -35.06 73.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.665 -1.272 . . . . 2.53 108.799 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.01 -43.58 71.09 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.491 0.663 . . . . 1.36 110.385 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.11 -48.76 80.39 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.967 -1.083 . . . . 1.42 110.55 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -70.0 -40.26 75.38 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.369 -0.832 . . . . 2.27 111.083 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.0 -40.04 75.52 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.906 -1.121 . . . . 1.57 111.61 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.8 mt -67.47 -45.21 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.946 -1.097 . . . . 1.19 109.756 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.92 -39.82 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.604 -0.685 . . . . 1.39 110.053 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.44 -46.91 88.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 1.39 110.579 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 96' ' ' LYS . 85.3 mt -60.12 -47.51 85.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.857 -1.152 . . . . 1.5 109.693 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.0 mt -63.22 -48.97 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.943 0.878 . . . . 1.29 108.926 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -69.84 -40.21 75.98 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.494 -0.754 . . . . 2.64 110.588 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -85.51 -51.55 6.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.04 -1.037 . . . . 1.65 111.952 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 92' ' ' LEU . 65.4 mmtt -89.76 -1.7 58.06 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.013 -1.054 . . . . 2.5 111.603 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 55.73 32.32 19.2 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.869 -1.145 . . . . 1.88 109.962 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.2 mtt -83.8 166.94 17.56 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.361 -0.837 . . . . 1.71 109.721 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 19.3 p -78.17 155.15 30.58 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.529 -0.915 . . . . 1.61 108.529 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.35 93.0 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.134 -0.979 . . . . 1.33 109.445 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -62.86 -39.83 95.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.546 -0.721 . . . . 2.07 109.985 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.66 -45.95 20.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.103 -0.998 . . . . 1.37 110.181 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.01 -50.68 72.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.403 -0.811 . . . . 1.14 110.56 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.72 86.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.004 -1.06 . . . . 1.26 109.919 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.509 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 78.1 t60 -59.97 -41.03 91.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 2.02 110.082 -178.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -63.54 -39.98 95.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.288 -0.882 . . . . 1.33 111.419 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.8 t -62.9 -53.98 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.76 -1.213 . . . . 1.3 112.018 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.3 mm -69.99 -39.94 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.578 -1.326 . . . . 1.32 108.68 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.509 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 87.5 tt0 -60.89 -39.95 91.21 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.736 -0.838 . . . . 2.44 108.736 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.27 94.53 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 120.512 -0.851 . . . . 0.99 111.018 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -70.02 -60.03 2.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.659 -1.495 . . . . 1.97 110.203 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.05 -41.28 25.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.113 -0.992 . . . . 1.43 110.051 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 78.6 p -59.81 -39.87 86.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.058 -1.026 . . . . 2.12 108.719 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.53 -38.85 81.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.248 -0.908 . . . . 1.64 109.293 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.8 mt -65.97 -40.99 91.75 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.12 -0.988 . . . . 1.93 110.155 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -59.92 -34.83 73.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.719 -1.238 . . . . 2.2 109.625 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -57.47 -19.31 23.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.155 -0.965 . . . . 2.12 109.912 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 40.7 mt -62.65 149.76 42.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.859 -1.15 . . . . 2.34 109.203 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -89.98 10.59 23.44 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.312 -0.868 . . . . 3.23 110.254 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -101.42 128.98 47.37 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.198 -0.939 . . . . 2.49 110.331 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.01 -29.18 66.19 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.581 0.705 . . . . 3.95 109.437 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.581 ' HH ' ' CZ ' ' A' ' 126' ' ' ARG . 6.7 t80 -70.22 -39.28 75.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.587 -0.695 . . . . 2.25 110.342 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.5 mt -69.97 -35.39 74.42 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.02 -1.05 . . . . 2.27 108.416 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -59.99 -39.07 84.46 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.072 -0.714 . . . . 3.31 109.072 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -58.24 -43.56 87.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 2.73 109.198 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.599 ' NH2' ' O ' ' B' ' 314' ' ' LEU . 89.9 mtt180 -62.23 -39.93 94.47 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.176 -1.01 . . . . 3.2 109.22 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.82 80.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 1.66 109.621 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.07 -48.76 80.36 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.363 -0.835 . . . . 1.67 109.416 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -63.5 -40.07 96.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 1.55 109.628 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.42 -40.12 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.085 -1.009 . . . . 1.32 108.471 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.498 HH11 ' HG2' ' A' ' 131' ' ' ARG . 3.8 ttt-85 -60.32 -38.62 84.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.517 -0.739 . . . . 3.58 109.233 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -59.94 -40.08 87.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.425 -0.797 . . . . 1.46 110.363 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.08 -45.99 94.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.905 -1.122 . . . . 1.22 109.377 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.88 -41.06 93.66 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 120.291 -0.957 . . . . 0.61 110.942 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -60.07 -46.33 89.92 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.906 -1.349 . . . . 3.1 109.954 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.611 HH12 ' CB ' ' A' ' 166' ' ' SER . 98.2 mtt180 -68.88 -29.91 68.29 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.932 -1.105 . . . . 3.71 109.48 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.1 tp -60.05 -43.13 95.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.948 . . . . 1.87 109.071 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.9 mt -61.02 -39.82 91.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.281 -0.887 . . . . 1.29 109.89 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -67.39 -39.94 85.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 3.05 108.933 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -61.34 -36.18 79.44 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.623 -0.673 . . . . 1.26 111.217 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.2 mt -70.7 -43.24 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.444 -1.41 . . . . 1.34 109.05 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.1 mt -71.04 -30.15 66.26 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.435 -0.79 . . . . 1.6 109.489 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.18 43.47 6.27 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.862 -1.695 . . . . 0.96 108.862 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.7 tp -74.44 149.47 40.37 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.427 -1.043 . . . . 1.67 109.241 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -72.11 142.29 49.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 4.96 109.58 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 93.9 mt -113.06 128.94 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-O 122.203 1.002 . . . . 1.68 109.927 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.5 mt -64.21 -43.77 97.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 115.485 -0.779 . . . . 2.14 110.87 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.3 t0 65.21 102.66 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.395 -0.816 . . . . 1.5 108.969 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.5 mt -69.02 -1.02 6.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.265 -0.897 . . . . 1.39 110.625 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 74.0 m -87.92 -10.88 49.23 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.852 -1.155 . . . . 1.83 109.395 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.84 15.97 2.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.336 -0.852 . . . . 1.46 112.588 -177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.1 mp -90.32 119.98 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 120.213 -1.554 . . . . 1.42 109.215 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -100.45 -9.26 22.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.467 -0.771 . . . . 2.94 110.217 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -116.92 148.21 41.55 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.291 -0.881 . . . . 1.52 110.442 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -65.06 132.59 49.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.541 -0.724 . . . . 1.58 109.588 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.0 m -152.35 164.66 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.473 -0.767 . . . . 1.32 109.538 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.5 mt -91.84 149.53 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.023 -1.843 . . . . 1.27 106.023 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 52.3 tp -99.3 117.11 33.03 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.967 -1.083 . . . . 1.41 110.035 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.4 t -123.48 129.98 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.481 -0.933 . . . . 1.23 108.481 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.29 164.74 34.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.058 -1.026 . . . . 1.32 108.924 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.17 -38.07 69.22 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.379 -1.451 . . . . 1.49 108.378 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -171.07 142.83 1.87 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.825 -0.806 . . . . 2.25 108.825 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 19.9 mt -117.4 137.49 52.45 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.324 -0.86 . . . . 1.35 109.504 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.4 p -83.08 147.23 53.51 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.94 . . . . 1.56 108.722 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.403 ' O ' ' OG1' ' A' ' 168' ' ' THR . 86.5 Cg_exo -43.52 -31.83 3.34 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.567 1.511 . . . . 0.87 111.814 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.611 ' CB ' HH12 ' A' ' 136' ' ' ARG . 38.5 m -59.96 -40.16 88.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.907 . . . . 1.36 108.975 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.58 -43.21 85.55 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.441 -0.787 . . . . 1.61 109.658 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 165' ' ' PRO . 54.2 p -52.68 -29.08 24.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.13 -0.981 . . . . 1.21 110.092 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.29 -57.74 3.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 1.21 110.063 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -81.83 36.03 0.44 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.066 -0.716 . . . . 2.11 109.066 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.2 tp -97.96 138.21 35.62 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.494 -0.754 . . . . 1.29 109.006 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -86.27 102.92 14.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.08 -1.013 . . . . 2.81 109.196 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 66.2 mt -62.21 -45.64 92.47 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.265 -0.897 . . . . 2.09 110.209 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -66.42 -28.93 69.0 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.058 -1.027 . . . . 2.86 112.715 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -93.17 -13.03 28.92 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.46 -1.4 . . . . 2.39 109.95 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 178' ' ' GLY . 87.2 t -101.41 109.27 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.179 -0.95 . . . . 1.27 108.727 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.2 mt -82.76 6.53 17.82 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.897 . . . . 2.17 110.274 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.416 ' O ' ' CG1' ' A' ' 176' ' ' VAL . . . 169.09 175.85 38.71 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.312 -1.515 . . . . 0.52 109.312 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -135.76 130.16 33.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.394 -1.062 . . . . 0.55 109.299 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 94.5 mt -131.13 126.97 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.736 -0.839 . . . . 1.27 108.736 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.1 p -145.7 157.29 43.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.033 -1.042 . . . . 1.39 110.7 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 206' ' ' GLY . 7.2 m-20 -105.52 27.04 8.76 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.462 -0.94 . . . . 2.46 108.462 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.57 -157.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.201 -0.937 . . . . 1.51 112.225 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.84 -71.2 0.85 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 111.258 -0.737 . . . . 2.23 111.258 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 167.11 -133.66 2.99 Favored Glycine 0 N--CA 1.491 2.342 0 O-C-N 120.705 -1.468 . . . . 2.23 110.563 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.508 ' C ' ' H ' ' A' ' 188' ' ' SER . 28.0 mtm-85 -60.08 -40.04 88.19 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.427 -1.043 . . . . 6.44 111.01 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.4 p -65.78 8.88 0.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.066 -1.021 . . . . 4.09 110.471 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.508 ' H ' ' C ' ' A' ' 186' ' ' ARG . 29.1 t -90.79 129.59 36.85 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.015 -1.053 . . . . 2.2 110.255 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -42.79 -52.0 5.19 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.783 0.801 . . . . 1.15 109.38 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 9.5 p -55.38 -36.69 66.66 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.768 -0.582 . . . . 2.01 111.175 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.7 t -59.94 -40.03 87.57 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.846 -1.159 . . . . 1.93 110.903 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 192' ' ' ILE . 87.6 mt -65.7 -40.02 86.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.123 -0.985 . . . . 2.2 110.109 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.7 mtp -60.05 -45.31 93.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.846 . . . . 1.32 111.06 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.3 -43.8 92.58 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.927 -1.108 . . . . 1.3 109.59 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 51.4 mtt-85 -59.96 -51.61 68.92 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.901 -1.12 . . . . 3.38 109.361 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.5 m -70.11 -35.03 73.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 1.15 110.76 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.0 mt -76.12 -21.44 56.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 1.28 109.66 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 62.15 50.04 4.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.605 -0.684 . . . . 1.5 109.86 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.48 130.59 23.85 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 108.821 -0.807 . . . . 1.37 108.821 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -43.88 130.31 7.78 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.905 1.737 . . . . 0.76 112.343 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -168.84 145.67 3.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.736 -1.227 . . . . 1.19 111.661 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 91.2 mt -124.88 148.87 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 107.168 -1.419 . . . . 1.31 107.168 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 6.9 m -129.98 -9.83 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 O-C-N 120.819 -1.176 . . . . 1.38 110.894 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.68 22.38 26.26 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 110.228 -1.149 . . . . 1.03 110.228 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.44 ' OG1' ' OD2' ' A' ' 182' ' ' ASP . 3.3 p -47.14 -40.0 14.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.894 -1.356 . . . . 1.38 109.836 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.52 ' N ' ' OD2' ' A' ' 182' ' ' ASP . . . 89.11 -52.07 3.81 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 120.914 -1.116 . . . . 1.17 111.342 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.48 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 15.1 m -156.17 37.97 0.34 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.523 -1.575 . . . . 2.07 111.819 -178.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 12.8 t -77.05 -34.88 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.754 -1.216 . . . . 1.35 108.045 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 53.8 p -59.72 -34.26 72.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.571 -0.706 . . . . 1.49 110.284 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.4 t -77.16 -16.97 58.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.046 -1.034 . . . . 2.16 109.962 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -99.27 -11.86 20.89 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.245 -0.909 . . . . 2.89 110.319 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.5 t -102.33 135.3 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.24 -0.913 . . . . 1.33 111.08 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.506 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 43.5 mmtm -110.38 150.48 28.73 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.518 -1.66 . . . . 2.73 106.518 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.489 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 13.1 p-10 -59.91 141.04 56.22 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.789 -1.194 . . . . 2.7 110.85 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.3 t0 85.24 1.04 0.74 Allowed 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.071 0.463 . . . . 2.38 110.012 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.506 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 98.1 m-20 -73.99 147.0 43.37 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.146 -0.971 . . . . 2.09 109.252 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -97.34 119.88 36.67 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.614 -1.254 . . . . 1.45 107.614 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 66.4 mt -126.98 148.99 50.07 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.475 -0.766 . . . . 1.31 110.489 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.0 mt -116.18 129.91 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 107.675 -1.231 . . . . 1.29 107.675 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 35.2 tp -102.28 119.33 38.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.883 -1.136 . . . . 1.31 108.075 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.552 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 6.6 p30 -78.47 -40.13 36.41 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.886 -1.134 . . . . 2.31 108.751 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.456 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 51.35 13.64 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.439 -0.948 . . . . 1.19 108.439 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' A' ' 221' ' ' ASP . 24.9 t -127.65 -40.64 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.457 -1.312 . . . . 1.45 107.457 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -102.5 0.39 33.56 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.976 -1.12 . . . . 3.13 107.976 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.57 HD22 ' H ' ' A' ' 4' ' ' GLY . 48.8 t-20 59.78 44.96 13.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.834 -0.542 . . . . 2.2 110.297 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.552 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 80.5 mt-30 -140.22 158.38 44.13 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.174 -0.954 . . . . 2.32 109.709 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 81.3 t -120.14 130.05 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.032 -0.729 . . . . 1.4 109.032 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -101.61 120.98 41.16 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.383 -0.823 . . . . 1.29 108.918 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 49.0 t -103.36 119.23 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.548 -0.72 . . . . 1.38 109.759 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 63.79 66.9 1.03 Allowed Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.186 -0.946 . . . . 2.33 109.931 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -91.34 128.34 1.17 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 123.255 2.636 . . . . 0.95 112.661 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 30.4 p -69.01 169.37 11.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 2.31 109.422 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -60.07 -39.4 85.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 3.45 108.942 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.02 -38.22 82.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.344 -0.848 . . . . 2.89 110.083 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.61 -40.22 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.841 -1.162 . . . . 1.73 108.836 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 94.3 mt . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.047 -1.033 . . . . 1.57 109.374 179.909 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 33.1 ttp . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.513 0.673 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -150.96 148.53 28.5 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -150.02 159.36 44.46 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.087 -1.008 . . . . 0.0 110.397 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -157.56 154.02 27.85 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 -111.69 131.57 55.2 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.115 -0.99 . . . . 0.0 110.203 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.27 121.77 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-O 122.348 1.071 . . . . 0.0 112.307 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 56.7 m -80.4 101.2 8.87 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.804 0.811 . . . . 0.0 110.799 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' B' ' 358' ' ' GLY . 97.5 mt -50.71 116.73 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.258 1.028 . . . . 0.0 109.673 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 25.1 p -106.59 14.1 27.44 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.946 -177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.42 116.67 42.37 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.994 -1.066 . . . . 0.0 108.445 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -51.85 -17.08 4.79 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 CA-C-N 120.216 1.113 . . . . 0.0 113.725 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -111.0 11.3 22.14 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.257 -0.902 . . . . 0.0 109.991 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 69.47 169.78 6.93 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.599 ' O ' ' NH2' ' A' ' 126' ' ' ARG . 3.1 tp -84.6 93.27 8.34 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.087 -1.243 . . . . 0.0 109.333 -178.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . 0.559 ' C ' HH21 ' A' ' 126' ' ' ARG . 3.8 p80 -96.48 -161.48 0.87 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 120.885 -1.134 . . . . 0.0 109.902 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 4.0 m -58.06 -41.58 83.63 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.884 -1.135 . . . . 0.0 112.726 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.584 HH11 ' CB ' ' A' ' 71' ' ' ALA . 14.7 tpt180 -57.31 -59.44 12.8 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 120.308 -1.495 . . . . 0.0 111.068 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.92 -42.9 17.56 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 CA-C-N 120.485 1.209 . . . . 0.0 111.606 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.89 -17.28 35.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.178 -0.951 . . . . 0.0 110.392 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -82.16 -38.55 24.53 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -72.16 -34.81 68.76 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -64.65 -58.28 6.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.39 -0.819 . . . . 0.0 109.796 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.68 -32.91 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.82 -1.175 . . . . 0.0 109.085 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -59.93 -46.65 88.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.422 -0.799 . . . . 0.0 109.112 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.29 -44.06 84.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 110.422 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . 0.46 ' C ' ' H ' ' B' ' 328' ' ' GLY . . . -60.03 -53.41 58.19 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.855 -1.153 . . . . 0.0 111.248 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -51.72 -10.45 0.11 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.883 -1.135 . . . . 0.0 110.136 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' B' ' 326' ' ' ALA . . . -75.9 -24.75 68.64 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -105.23 139.14 40.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.41 -1.053 . . . . 0.0 109.248 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 8.8 p -90.61 -9.8 45.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.275 -0.89 . . . . 0.0 110.115 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 14.0 t -64.47 155.21 33.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.101 -1.0 . . . . 0.0 109.963 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.6 131.73 45.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.907 . . . . 0.0 108.792 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 82.9 mt -132.44 132.95 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.392 -0.818 . . . . 0.0 109.938 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.4 m -131.56 149.94 52.33 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.484 -0.76 . . . . 0.0 109.128 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 66.6 t -122.43 117.41 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 94.7 m -107.5 133.43 52.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.228 -0.92 . . . . 0.0 109.697 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 4.8 p -139.85 115.94 10.41 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.766 0.793 . . . . 0.0 110.631 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 45.22 50.02 9.77 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.641 -0.662 . . . . 0.0 112.744 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.32 -16.41 48.92 Favored Glycine 0 N--CA 1.5 2.957 0 O-C-N 120.058 -1.651 . . . . 0.0 112.242 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -110.69 121.32 45.03 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 118.87 1.335 . . . . 0.0 109.69 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 86.4 p -126.76 148.33 49.91 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.815 0.816 . . . . 0.0 110.151 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -145.23 170.57 16.02 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.563 0.697 . . . . 0.0 110.093 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 17.3 m -89.04 134.73 33.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.519 -0.738 . . . . 0.0 110.518 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -75.91 -16.38 60.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.053 -1.03 . . . . 0.0 109.504 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -84.7 20.87 1.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.518 ' H ' ' C ' ' B' ' 344' ' ' ALA . 93.8 p -151.61 96.91 2.31 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.43 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . 0.46 ' O ' ' NE2' ' B' ' 351' ' ' GLN . 51.7 tp -60.05 -33.76 72.48 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -56.27 -52.95 62.6 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.931 -1.106 . . . . 0.0 110.034 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -69.82 -28.67 65.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 110.421 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' B' ' 352' ' ' THR . 80.8 mt -59.96 -50.01 75.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.101 -0.999 . . . . 0.0 109.728 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' B' ' 347' ' ' LEU . 1.2 mp0 -45.07 -20.22 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.017 -1.052 . . . . 0.0 111.189 -178.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.415 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.3 p -80.3 -10.61 59.76 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.19 -1.568 . . . . 0.0 109.444 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 45.9 mt -95.79 115.29 27.21 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.176 -0.953 . . . . 0.0 108.77 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.84 95.21 1.24 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 22.8 mt -103.9 94.25 5.31 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.416 -1.05 . . . . 0.0 109.286 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 79.0 p -100.72 153.57 19.33 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.233 -0.917 . . . . 0.0 111.234 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -41.95 111.9 0.28 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.202 0.525 . . . . 0.0 110.664 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 103.14 6.09 45.78 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 91.7 m -83.69 111.24 18.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.157 . . . . 0.0 111.22 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 8.6 t -78.47 111.99 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 122.15 0.976 . . . . 0.0 109.801 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 12.3 m -110.08 177.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 40.4 m -130.26 126.9 38.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 64.0 mt -103.82 117.44 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 53.6 m -121.13 132.33 54.79 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.79 148.31 38.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.279 -0.888 . . . . 0.0 109.572 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -142.38 121.85 13.24 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.512 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.91 -158.39 29.07 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 119.192 -1.48 . . . . 0.0 111.159 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -59.9 -51.08 71.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 122.293 -0.534 . . . . 0.0 112.219 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -108.27 10.78 27.68 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 120.86 -1.15 . . . . 0.0 111.249 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.4 pt-20 -39.9 -34.12 0.25 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.338 -0.852 . . . . 0.0 112.232 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -68.3 -42.64 79.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.535 -1.353 . . . . 0.0 110.432 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -71.1 -52.56 18.66 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.991 -1.068 . . . . 0.0 109.653 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.69 -36.78 2.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.333 -0.854 . . . . 0.0 111.519 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . 0.413 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 58.9 t -81.14 -36.02 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.521 -1.362 . . . . 0.0 109.502 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -69.98 -40.01 75.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.375 -0.828 . . . . 0.0 111.921 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -77.59 -46.78 21.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.612 -1.305 . . . . 0.0 110.151 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.35 -36.38 80.02 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.294 -0.879 . . . . 0.0 109.116 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 53.8 t -73.68 -37.45 49.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -74.83 -17.01 60.67 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' B' ' 383' ' ' GLU . 41.9 tp -78.87 -68.07 0.69 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 57.3 mtt -54.3 -19.5 5.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.01 -1.056 . . . . 0.0 109.136 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.2 -23.72 51.44 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' B' ' 380' ' ' LEU . 97.5 mt-10 -108.62 4.37 23.88 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.626 -0.671 . . . . 0.0 110.962 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 69.0 mt -82.67 122.31 27.98 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.578 -1.326 . . . . 0.0 110.129 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.041 -0.98 . . . . 0.0 108.933 179.231 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.188 0.518 . . . . 3.19 109.691 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 87.7 mt -110.03 127.94 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.73 -0.841 . . . . 1.71 108.73 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.2 m -140.04 150.73 44.75 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.296 -0.877 . . . . 1.66 109.258 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.86 -163.89 9.7 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 108.465 -1.854 . . . . 1.05 108.465 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 6' ' ' LEU . 89.9 mt -90.37 -17.37 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.747 -1.443 . . . . 1.59 109.575 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.4 tp 55.1 106.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.496 -0.752 . . . . 1.47 109.184 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.26 -29.12 12.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.333 -0.855 . . . . 1.39 109.065 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 14.8 m -127.62 116.62 21.09 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 109.356 -0.609 . . . . 2.09 109.356 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.85 148.05 19.61 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 121.991 1.794 . . . . 0.91 112.453 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 143.36 178.78 19.47 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 108.853 -1.699 . . . . 0.92 108.853 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -122.13 156.36 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.231 -1.158 . . . . 1.35 109.436 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.55 156.56 35.36 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.965 -1.084 . . . . 1.14 110.625 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.4 m-85 -137.69 128.99 27.85 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.03 -1.1 . . . . 0.7 108.03 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.43 178.38 47.77 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 118.505 -1.807 . . . . 0.58 110.842 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -78.86 156.7 28.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.786 -0.832 . . . . 2.63 109.14 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.62 133.03 52.65 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.392 -0.817 . . . . 1.27 110.923 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.3 tp -107.45 137.85 44.73 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 107.997 -1.112 . . . . 1.41 107.997 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 66.2 tp -115.76 122.66 46.12 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.526 -0.734 . . . . 1.49 109.561 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.9 mt -82.26 103.21 11.68 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.414 -0.804 . . . . 1.52 109.416 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -94.25 136.56 34.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.296 -0.878 . . . . 3.17 109.496 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 58.2 mp0 -131.02 134.84 47.05 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.361 -0.837 . . . . 3.0 109.086 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.17 150.76 28.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.133 -0.98 . . . . 2.77 109.133 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -65.96 149.22 50.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.943 -1.098 . . . . 2.94 109.245 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.523 ' CG1' HH12 ' A' ' 139' ' ' ARG . 88.2 mt -89.78 124.83 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 1.46 109.22 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.63 122.87 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.236 -0.915 . . . . 1.7 109.477 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.9 mt -108.09 133.22 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.802 -0.814 . . . . 1.54 108.802 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -86.97 118.27 26.24 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.792 -1.192 . . . . 1.81 109.58 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -87.51 -1.0 57.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 3.23 109.613 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.81 136.86 49.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.112 -0.993 . . . . 3.29 109.184 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -80.99 159.51 24.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.952 -1.092 . . . . 2.8 109.488 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.9 pt -102.57 167.67 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.303 -0.873 . . . . 1.43 109.883 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.3 p -94.1 175.27 6.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.229 -0.92 . . . . 1.54 109.093 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.74 -50.97 71.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.089 -1.007 . . . . 1.6 110.746 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 55.8 t0 -54.71 -29.41 53.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.561 -1.337 . . . . 2.56 109.681 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -82.02 -10.04 59.36 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.316 -0.865 . . . . 2.36 110.386 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.0 t -60.22 -50.3 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.824 -1.172 . . . . 1.43 109.068 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.67 -39.9 93.04 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.404 -0.81 . . . . 1.77 109.54 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -62.68 -43.79 97.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.903 . . . . 3.32 110.981 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -61.89 -40.19 94.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.84 -1.162 . . . . 1.51 110.171 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 66.4 t -59.87 -46.23 94.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 C-N-CA 118.722 -1.191 . . . . 1.41 108.86 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -59.93 -42.58 94.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.881 -1.137 . . . . 1.81 109.434 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.26 -41.52 93.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.807 -1.183 . . . . 3.26 108.222 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -64.01 -46.9 82.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.355 -0.841 . . . . 0.81 109.143 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.1 tp -59.96 -48.81 80.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.28 -0.887 . . . . 1.59 108.672 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.0 t -63.26 -41.95 99.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.075 -1.015 . . . . 1.38 109.543 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.62 -46.21 92.73 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.154 -1.578 . . . . 0.87 109.154 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -63.3 -33.56 75.78 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.261 -1.141 . . . . 3.62 108.739 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.424 ' O ' ' OG ' ' A' ' 51' ' ' SER . . . -58.25 -42.85 87.33 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.369 -0.832 . . . . 1.43 109.283 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 50' ' ' ALA . 1.2 ttmp? -63.68 -73.62 0.11 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.792 -1.193 . . . . 3.08 107.915 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.19 -41.14 0.37 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.415 -0.803 . . . . 1.33 111.411 -178.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 48' ' ' ALA . 93.2 p -54.22 -54.77 35.42 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.42 -1.425 . . . . 1.85 108.699 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.99 -39.97 83.17 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.462 -0.774 . . . . 1.35 111.301 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -68.37 -39.95 81.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.77 -1.206 . . . . 2.34 110.668 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.13 -39.97 96.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.979 -1.076 . . . . 2.2 108.736 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -63.91 -34.14 77.29 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.454 -0.779 . . . . 1.35 109.087 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.6 m -65.89 -44.13 86.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 1.34 108.883 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.9 mt -60.14 -37.75 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.675 -0.861 . . . . 1.26 108.675 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -59.8 -51.06 71.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.473 -0.767 . . . . 1.7 110.204 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 m -55.78 -33.28 64.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.051 -1.03 . . . . 1.35 110.042 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -69.92 -37.96 76.11 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.422 -0.798 . . . . 2.08 109.555 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.78 -47.67 65.6 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.204 0.526 . . . . 1.21 111.227 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.68 -50.97 61.81 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 110.004 -1.239 . . . . 0.75 110.004 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.96 -42.11 73.63 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.005 -1.291 . . . . 1.59 110.562 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.5 m -69.28 -60.69 2.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.088 -1.007 . . . . 1.41 112.111 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -96.52 -50.93 4.54 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.935 -1.103 . . . . 0.79 111.422 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.15 -163.86 26.98 Favored Glycine 0 N--CA 1.501 2.974 0 O-C-N 120.731 -1.231 . . . . 1.22 111.048 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.02 -25.15 63.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.772 -0.84 . . . . 5.81 110.65 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -60.33 -36.76 78.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.902 . . . . 3.37 110.197 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.479 ' NZ ' ' CE1' ' A' ' 189' ' ' HIS . 69.3 mmtt -97.78 -19.85 17.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.251 -0.905 . . . . 2.37 110.352 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.1 -46.13 68.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.909 -1.119 . . . . 1.65 110.224 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.7 -32.91 74.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.643 -0.661 . . . . 1.42 110.116 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.09 -40.83 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.867 -1.146 . . . . 1.43 109.045 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -65.11 -39.83 93.67 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.14 -0.975 . . . . 1.08 109.776 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -60.09 -39.98 88.02 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.085 -1.009 . . . . 1.37 109.528 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.14 -49.3 72.55 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.623 -1.791 . . . . 0.67 108.623 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -60.91 -43.61 98.32 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.344 -1.091 . . . . 1.99 108.837 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.1 mt -68.94 -47.71 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.254 -0.903 . . . . 1.22 109.09 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.8 ttp -60.25 -42.94 96.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.899 -1.126 . . . . 2.11 109.792 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.4 tp -64.81 -40.0 94.5 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.376 -0.828 . . . . 1.33 109.772 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.7 tp -64.52 -40.05 94.9 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.292 -0.88 . . . . 1.29 110.189 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -81.55 4.86 19.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.974 -1.078 . . . . 1.47 109.844 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 51.7 t0 -50.26 132.02 24.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 1.47 110.07 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 97.7 mt-10 -62.02 -18.96 62.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.637 -0.664 . . . . 1.78 110.754 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -72.42 -36.05 68.5 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.853 -1.154 . . . . 2.53 108.935 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.17 -40.38 78.18 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.974 -0.75 . . . . 1.36 108.974 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.04 -49.87 75.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.566 -0.709 . . . . 1.42 110.023 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.13 -41.42 73.96 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.329 -0.857 . . . . 2.27 111.284 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.64 -40.35 73.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.947 -1.096 . . . . 1.57 111.512 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 89' ' ' ILE . 96.9 mt -68.8 -49.34 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.88 -1.137 . . . . 1.19 109.591 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.4 mt -65.29 -37.64 80.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.634 -0.666 . . . . 1.39 110.275 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.29 98.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 1.39 110.365 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 96' ' ' LYS . 81.5 mt -61.67 -46.38 89.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.885 -1.134 . . . . 1.5 109.085 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.2 mt -61.06 -50.2 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.963 0.887 . . . . 1.29 109.261 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.02 -40.95 74.9 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 120.008 -0.677 . . . . 2.64 110.451 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -82.34 -49.5 9.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.308 -0.87 . . . . 1.65 111.805 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 92' ' ' LEU . 65.7 mmtt -92.24 -2.05 56.73 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.033 -1.042 . . . . 2.5 111.788 -177.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 38.4 m170 55.51 32.77 19.7 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.844 -1.16 . . . . 1.88 109.082 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 93.5 mtp -90.18 166.72 13.21 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.707 -0.621 . . . . 1.71 109.826 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.2 p -78.39 158.62 28.69 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.451 -0.944 . . . . 1.61 108.451 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.99 -35.73 74.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.985 -1.072 . . . . 1.33 109.901 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -67.14 -40.01 86.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 2.07 109.437 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.41 -41.88 21.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.395 -0.816 . . . . 1.37 109.698 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.68 -50.5 66.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.418 -0.802 . . . . 1.14 110.417 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.07 88.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.164 -0.96 . . . . 1.26 109.836 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -58.34 -39.93 80.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 2.02 109.761 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.79 -40.13 96.39 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.217 -0.927 . . . . 1.33 110.034 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.3 t -66.51 -52.53 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.213 -0.929 . . . . 1.3 111.56 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.9 mm -69.34 -39.91 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.824 -1.173 . . . . 1.32 108.772 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.41 -34.85 76.75 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.615 -0.883 . . . . 2.44 108.615 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.32 -47.49 90.58 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 120.645 -0.788 . . . . 0.99 111.135 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -66.17 -48.12 71.78 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.614 -1.521 . . . . 1.97 109.602 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.74 78.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.895 . . . . 1.43 109.505 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 84.1 p -57.69 -40.2 78.91 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.091 -1.005 . . . . 2.12 108.748 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.8 89.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 1.64 109.614 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.4 mt -63.53 -43.35 97.39 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.798 -1.189 . . . . 1.93 110.274 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.18 -30.47 69.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.681 -1.262 . . . . 2.2 109.739 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.95 -23.72 63.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.991 -1.068 . . . . 2.12 108.598 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.4 147.73 47.59 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.291 -0.881 . . . . 2.34 109.128 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -94.95 49.16 1.21 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.085 -1.009 . . . . 3.23 109.734 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -136.25 130.27 32.8 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.198 -0.939 . . . . 2.49 109.888 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.06 -30.32 67.55 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.445 -0.784 . . . . 3.95 110.248 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.53 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.1 t80 -72.11 -38.24 69.34 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.287 -0.883 . . . . 2.25 110.716 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.4 mt -70.0 -32.28 70.39 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.045 -1.034 . . . . 2.27 108.249 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -60.24 -39.21 85.9 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.601 -0.888 . . . . 3.31 108.601 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -59.75 -48.35 82.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.331 -0.856 . . . . 2.73 110.108 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.576 HH21 ' C ' ' B' ' 315' ' ' HIS . 84.5 mtt180 -60.12 -39.68 87.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.679 -1.263 . . . . 3.2 108.495 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.51 -32.32 68.72 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.294 -0.879 . . . . 1.66 108.65 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.8 -40.22 88.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 1.67 109.588 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -65.55 -40.12 92.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 1.55 109.515 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.49 -41.85 86.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.45 -0.781 . . . . 1.32 109.292 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -62.03 -36.31 81.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 3.58 109.5 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -60.0 -40.01 87.76 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.263 -0.898 . . . . 1.46 110.077 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.26 -44.16 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.151 -0.968 . . . . 1.22 109.791 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.37 -39.72 98.13 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.474 -1.051 . . . . 0.61 110.474 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -58.94 -45.78 89.61 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.893 -1.357 . . . . 3.1 109.624 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.471 HH11 ' HG2' ' A' ' 136' ' ' ARG . 24.3 mtt-85 -63.22 -36.33 83.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.874 -1.141 . . . . 3.71 110.339 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.6 tp -56.19 -44.59 79.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.309 -0.869 . . . . 1.87 109.974 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.96 -40.07 91.96 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.032 -1.043 . . . . 1.29 108.791 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.582 HH11 ' HG2' ' A' ' 139' ' ' ARG . 11.5 mtt-85 -67.73 -39.94 84.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.348 -0.845 . . . . 3.05 109.339 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -68.06 -38.03 81.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.632 -0.667 . . . . 1.26 111.668 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.3 mt -73.73 -45.55 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.227 -1.546 . . . . 1.34 108.571 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.7 mt -70.0 -33.7 72.37 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.614 -0.679 . . . . 1.6 109.493 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.78 40.2 7.27 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.193 -1.563 . . . . 0.96 109.193 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.2 tp -74.94 150.39 39.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.521 -0.987 . . . . 1.67 110.17 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -68.4 141.29 55.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.322 -0.861 . . . . 4.96 110.174 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.9 mt -116.48 129.95 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 121.785 0.802 . . . . 1.68 109.474 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 15.0 mm -56.79 -50.17 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.794 -0.566 . . . . 2.14 111.137 -177.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.0 t0 67.09 104.31 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.266 -0.896 . . . . 1.5 109.5 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.4 mt -81.06 -7.58 59.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.275 -0.89 . . . . 1.39 110.799 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.7 p -80.13 -17.32 52.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.65 -1.281 . . . . 1.83 109.355 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.8 17.62 3.31 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.509 -0.745 . . . . 1.46 111.825 -177.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 50.1 mt -91.04 114.57 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.727 -1.233 . . . . 1.42 109.145 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -101.34 -11.01 19.76 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.385 -0.822 . . . . 2.94 110.604 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -110.53 146.6 35.75 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.16 -0.962 . . . . 1.52 109.442 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.94 130.58 43.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.148 -0.97 . . . . 1.58 109.407 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.1 m -152.27 163.71 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.939 -0.763 . . . . 1.32 108.939 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 157' ' ' ILE . 85.1 mt -93.14 149.75 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 106.028 -1.842 . . . . 1.27 106.028 177.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 52.5 tp -100.44 117.81 35.37 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.996 -1.065 . . . . 1.41 110.908 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.1 t -121.94 129.92 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 N-CA-C 108.694 -0.854 . . . . 1.23 108.694 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.22 164.49 35.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.976 -1.077 . . . . 1.32 109.153 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.433 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.86 -35.69 74.9 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.362 -1.461 . . . . 1.49 108.775 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 52.3 t0 -170.6 143.81 2.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.441 -0.948 . . . . 2.25 108.441 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.545 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 26.1 mt -112.71 129.72 56.31 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.52 -0.919 . . . . 1.35 108.52 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.3 p -83.63 145.42 47.57 Favored Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.239 -0.913 . . . . 1.56 109.004 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -38.01 -36.28 0.46 Allowed 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.031 1.821 . . . . 0.87 111.581 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.4 m -59.87 -40.0 87.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.407 -0.808 . . . . 1.36 109.656 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.5 -40.19 77.14 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.13 -0.982 . . . . 1.61 109.713 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 68.5 p -56.1 -28.14 56.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.067 -1.021 . . . . 1.21 110.739 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -74.58 -56.35 4.92 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.821 -1.174 . . . . 1.21 109.711 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -78.88 39.58 0.37 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.532 -1.285 . . . . 2.11 107.532 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' A' ' 169' ' ' ALA . 15.3 tp -99.93 131.86 45.63 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.695 -0.628 . . . . 1.29 109.522 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -88.05 100.27 12.8 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.144 -1.058 . . . . 2.81 108.144 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 65.9 mt -64.66 -42.98 95.03 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.323 -0.861 . . . . 2.09 110.791 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -69.89 -24.24 63.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.66 -1.275 . . . . 2.86 111.569 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -94.39 -13.51 26.23 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.6 -1.312 . . . . 2.39 109.767 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 69.6 t -104.85 116.17 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.238 -0.914 . . . . 1.27 108.541 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.7 mt -83.25 2.19 37.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.936 . . . . 2.17 111.007 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 171.86 172.33 37.73 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.231 -1.461 . . . . 0.52 109.735 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -130.63 126.67 37.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.516 -0.991 . . . . 0.55 108.846 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.02 126.25 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.2 -0.938 . . . . 1.27 108.623 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 80.6 p -147.94 158.43 44.04 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.903 -1.123 . . . . 1.39 110.771 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 44.1 p30 -103.92 24.67 10.96 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.956 -0.757 . . . . 2.46 108.956 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -57.78 -159.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.993 -1.067 . . . . 1.51 110.794 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.87 -54.38 9.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.155 -1.178 . . . . 2.23 110.155 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 156.69 -129.94 2.55 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 120.937 -1.331 . . . . 2.23 110.502 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 188' ' ' SER . 30.2 ttt-85 -63.2 -39.87 95.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.486 -1.008 . . . . 6.44 110.49 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 37.4 p -62.0 1.88 0.26 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.161 -0.962 . . . . 4.09 110.231 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 186' ' ' ARG . 47.5 t -91.52 130.0 37.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.03 -1.044 . . . . 2.2 109.716 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . 0.479 ' CE1' ' NZ ' ' A' ' 69' ' ' LYS . 84.8 t60 -48.28 -44.15 33.38 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.897 0.856 . . . . 1.15 108.967 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 4.1 p -51.95 -36.33 49.0 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 116.116 -0.493 . . . . 2.01 110.869 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 49.6 m -65.96 -40.83 91.62 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.947 -1.096 . . . . 1.93 111.843 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.2 mm -63.88 -43.2 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.976 -1.077 . . . . 2.2 110.668 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.2 mtp -66.02 -39.95 90.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.249 -0.907 . . . . 1.32 111.036 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.14 -43.34 82.37 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.468 -1.395 . . . . 1.3 109.083 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -59.93 -48.85 80.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.125 -0.984 . . . . 3.38 110.086 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.2 m -68.09 -35.11 77.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.043 -1.036 . . . . 1.15 110.084 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 30.2 mt -71.56 -26.22 62.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.182 -0.949 . . . . 1.28 108.543 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 62.01 51.54 3.64 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.428 0.632 . . . . 1.5 110.494 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 8' ' ' SER . 72.0 mt -129.59 133.07 24.66 Favored Pre-proline 0 N--CA 1.501 2.125 0 N-CA-C 108.541 -0.911 . . . . 1.37 108.541 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -42.16 130.73 4.64 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.0 1.8 . . . . 0.76 112.427 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.31 148.8 3.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.93 -1.106 . . . . 1.19 111.326 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 78.8 mt -127.82 146.2 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 N-CA-C 107.985 -1.117 . . . . 1.31 107.985 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.0 m -126.0 -10.55 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 O-C-N 120.734 -1.229 . . . . 1.38 111.51 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.0 22.52 27.41 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 110.323 -1.111 . . . . 1.03 110.323 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.8 p -43.99 -42.99 6.36 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.317 -1.108 . . . . 1.38 109.834 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.73 -50.96 3.23 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.204 -0.998 . . . . 1.17 111.068 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 29.1 p -159.25 39.27 0.21 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.547 -1.56 . . . . 2.07 111.299 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.2 -35.76 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.952 -1.093 . . . . 1.35 108.378 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 6.4 p -55.72 -32.14 63.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.506 -0.746 . . . . 1.49 110.301 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 72.4 p -80.04 -15.65 56.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.951 -1.093 . . . . 2.16 109.84 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -99.76 -13.07 19.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.412 -0.805 . . . . 2.89 110.041 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 52.7 t -106.72 138.07 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 CA-C-O 121.773 0.797 . . . . 1.33 110.713 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.499 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -114.83 153.67 30.01 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.216 -1.402 . . . . 2.73 107.216 178.339 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.459 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 17.5 p-10 -57.63 138.91 54.83 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.914 -1.116 . . . . 2.7 110.546 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.5 m-20 84.36 5.09 0.67 Allowed 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 120.984 0.421 . . . . 2.38 110.758 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.499 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 74.8 m-20 -74.62 137.88 42.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.935 -1.103 . . . . 2.09 109.638 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -88.1 118.12 27.45 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.504 -1.295 . . . . 1.45 107.504 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 60.6 mt -128.95 150.36 50.41 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.493 -0.754 . . . . 1.31 110.611 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.9 mt -117.67 128.14 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.317 -1.734 . . . . 1.29 106.317 177.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.3 tp -101.08 120.88 40.85 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.043 -1.036 . . . . 1.31 109.385 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 223' ' ' VAL . 95.3 m-20 -76.32 -44.79 35.26 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.951 -1.093 . . . . 2.31 109.491 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 46.25 16.6 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.463 -0.94 . . . . 1.19 108.463 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 221' ' ' ASP . 45.9 t -135.48 -42.97 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.549 -1.278 . . . . 1.45 107.549 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -99.79 2.74 44.33 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.014 -1.106 . . . . 3.13 108.014 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 60.24 42.42 15.19 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.806 -0.559 . . . . 2.2 109.697 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -141.96 155.46 45.47 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.173 -0.955 . . . . 2.32 110.119 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.0 t -124.8 131.39 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.594 -0.891 . . . . 1.4 108.594 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -102.48 121.74 42.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.326 -0.859 . . . . 1.29 109.325 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 43.9 t -100.59 113.93 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.455 -0.778 . . . . 1.38 110.13 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 25.5 t30 53.48 61.96 10.04 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.237 -0.914 . . . . 2.33 111.59 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -87.35 149.27 7.77 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.976 2.451 . . . . 0.95 112.865 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 42.8 p -70.32 162.62 28.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.444 -0.785 . . . . 2.31 110.271 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -59.66 -35.19 73.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.489 -0.757 . . . . 3.45 109.304 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -59.96 -40.12 87.98 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.359 -0.838 . . . . 2.89 109.953 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.5 -39.53 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.0 -1.063 . . . . 1.73 109.328 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 85.5 mt . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.108 -0.995 . . . . 1.57 109.445 179.349 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 45.0 ttp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 42.1 t80 -153.64 152.31 30.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.446 -0.784 . . . . 0.0 109.194 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . 0.443 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 14.0 pt20 -148.75 158.46 44.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.993 -1.067 . . . . 0.0 110.876 -178.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -152.84 149.88 28.75 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -111.93 131.26 55.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.313 -0.867 . . . . 0.0 110.051 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.4 ' CG1' ' SD ' ' B' ' 381' ' ' MET . 7.4 p -131.16 123.1 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 CA-C-O 122.474 1.131 . . . . 0.0 112.987 -177.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 61.2 m -79.38 103.91 9.63 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.805 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.6 mt -50.8 122.68 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 122.346 1.069 . . . . 0.0 110.296 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 34.6 p -108.43 15.71 23.69 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.697 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.77 116.33 48.91 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.919 -1.113 . . . . 0.0 108.716 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -53.53 -15.26 5.94 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 CA-C-N 120.308 1.146 . . . . 0.0 113.879 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -114.65 12.93 17.3 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.229 -0.919 . . . . 0.0 109.375 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 68.03 174.8 8.51 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.56 ' O ' ' NH2' ' A' ' 126' ' ' ARG . 4.0 tp -84.4 92.39 8.03 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.234 -1.156 . . . . 0.0 110.281 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . 0.576 ' C ' HH21 ' A' ' 126' ' ' ARG . 5.1 p80 -95.94 -162.23 0.93 Allowed 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.778 -1.201 . . . . 0.0 110.06 179.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 22.6 m -58.33 -40.1 81.22 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.93 -1.107 . . . . 0.0 112.661 -175.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.468 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.0 OUTLIER -60.82 -62.79 5.26 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 120.17 -1.581 . . . . 0.0 111.395 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -54.56 -34.37 82.35 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 CA-C-N 120.034 1.048 . . . . 0.0 111.812 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.92 -53.35 59.21 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.337 -0.945 . . . . 0.0 108.948 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.72 -40.66 66.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 0.0 109.387 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -69.96 -41.57 74.31 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 108.878 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.07 -50.97 71.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.557 -0.715 . . . . 0.0 110.535 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 89.4 t -70.23 -28.83 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.982 -1.074 . . . . 0.0 110.011 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -60.03 -45.82 91.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.142 -0.973 . . . . 0.0 108.472 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -60.6 -49.31 78.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.397 -0.815 . . . . 0.0 109.745 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . 0.413 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -63.02 -50.91 68.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.302 -0.874 . . . . 0.0 110.85 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt -49.72 -16.65 0.26 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.085 -1.009 . . . . 0.0 109.671 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . 0.413 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -79.3 -23.55 62.89 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.828 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -104.18 139.93 38.53 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.115 -1.227 . . . . 0.0 109.559 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 89.2 m -91.63 -13.32 32.05 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.13 -0.981 . . . . 0.0 110.388 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 331' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 64.6 p -58.85 154.84 14.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.948 -1.095 . . . . 0.0 109.388 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.98 130.87 42.69 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.119 -1.032 . . . . 0.0 108.406 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . 0.425 HD11 HG22 ' B' ' 333' ' ' ILE . 83.9 mt -132.33 133.32 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.603 -0.686 . . . . 0.0 109.583 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.6 m -130.09 151.56 50.5 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.515 -0.741 . . . . 0.0 109.578 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 97.2 t -115.86 139.2 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 336' ' ' THR . . . . . 0.45 ' HG1' ' HG ' ' B' ' 341' ' ' SER . 91.3 m -129.77 123.95 32.23 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.165 -0.959 . . . . 0.0 109.101 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 11.3 p -138.79 118.22 12.87 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.97 0.891 . . . . 0.0 110.768 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 61.6 t30 42.86 58.05 3.37 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.06 -13.53 31.5 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 120.31 -1.494 . . . . 0.0 113.069 176.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -115.61 127.24 55.07 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 119.336 1.568 . . . . 0.0 109.443 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 341' ' ' SER . . . . . 0.45 ' HG ' ' HG1' ' B' ' 336' ' ' THR . 74.6 m -123.98 146.56 48.43 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.882 0.849 . . . . 0.0 110.531 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -140.97 163.1 33.87 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.468 0.651 . . . . 0.0 109.624 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 3.4 t -87.05 137.02 32.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.558 -0.714 . . . . 0.0 109.638 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -76.73 -13.78 60.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.881 -1.137 . . . . 0.0 109.8 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . 0.454 ' C ' ' HG ' ' B' ' 346' ' ' SER . 21.3 pttp -91.12 19.8 5.51 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.454 ' HG ' ' C ' ' B' ' 345' ' ' LYS . 4.6 m -144.28 95.23 2.68 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.269 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . 0.551 ' O ' ' NE2' ' B' ' 351' ' ' GLN . 43.0 tp -59.88 -36.75 77.58 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -56.15 -52.21 65.18 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.092 -1.005 . . . . 0.0 110.964 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -73.77 -23.6 59.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.783 -1.198 . . . . 0.0 110.866 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 29.9 mt -60.08 -45.61 92.34 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.322 -1.351 . . . . 0.0 108.734 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.588 ' N ' ' NE2' ' B' ' 351' ' ' GLN . 0.1 OUTLIER -50.78 -26.57 5.81 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.123 -0.986 . . . . 0.0 111.892 -178.416 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 44.2 p -72.8 -10.08 59.39 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 119.93 -1.731 . . . . 0.0 109.864 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 39.8 mt -97.46 116.17 29.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.212 -0.93 . . . . 0.0 109.398 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.69 96.34 1.16 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 19.3 mt -103.04 92.17 4.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.355 -1.085 . . . . 0.0 109.105 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 64.9 p -93.5 167.08 11.93 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.959 -1.088 . . . . 0.0 110.946 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -57.02 114.74 2.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.705 -0.622 . . . . 0.0 110.699 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 100.09 7.53 52.33 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 52.2 m -83.8 112.59 20.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -1.107 . . . . 0.0 110.634 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 13.5 t -78.03 114.36 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 122.263 1.03 . . . . 0.0 109.625 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 11.8 m -110.81 177.46 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 62.4 m -131.25 129.3 41.41 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 89.3 mt -104.11 118.4 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 37.3 p -121.64 133.65 54.98 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.11 154.07 40.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.087 -1.008 . . . . 0.0 110.239 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -144.61 122.39 11.91 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 160.28 -159.29 30.67 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 118.972 -1.585 . . . . 0.0 111.596 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -59.98 -51.8 68.13 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.169 -0.606 . . . . 0.0 112.295 -177.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.41 ' H ' ' HB3' ' B' ' 331' ' ' SER . 75.2 m-20 -109.31 10.37 25.62 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.775 -1.203 . . . . 0.0 111.059 -177.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.414 ' C ' ' OE1' ' B' ' 370' ' ' GLU . 0.7 OUTLIER -43.64 -34.9 1.58 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.096 -1.003 . . . . 0.0 111.718 -178.352 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -70.06 -42.69 72.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.378 -1.451 . . . . 0.0 110.866 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -69.23 -50.61 45.68 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.902 -1.124 . . . . 0.0 109.562 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -51.45 -31.29 22.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 111.381 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 70.3 t -71.74 -39.92 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.545 -1.347 . . . . 0.0 108.845 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -64.48 -62.4 1.62 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.24 -0.913 . . . . 0.0 110.908 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -60.68 -43.69 97.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.392 -1.443 . . . . 0.0 111.416 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.03 -40.12 88.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.437 -1.414 . . . . 0.0 108.359 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 52.3 t -66.67 -40.22 85.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.535 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -70.94 -58.5 3.52 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . 0.453 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 55.6 tp -54.41 -34.06 60.58 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.8 -0.563 . . . . 0.0 109.952 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 381' ' ' MET . . . . . 0.4 ' SD ' ' CG1' ' B' ' 306' ' ' VAL . 2.8 ttt -73.83 -40.03 63.62 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 108.819 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -79.19 -4.89 52.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.572 -0.705 . . . . 0.0 109.904 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -109.03 0.47 19.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.294 -0.879 . . . . 0.0 111.313 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . 0.453 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 20.4 mt -69.79 131.1 43.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.179 -1.576 . . . . 0.0 108.508 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.593 -179.334 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.7 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.424 -0.584 . . . . 3.19 109.424 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.43 HD11 HG23 ' A' ' 2' ' ' ILE . 85.2 mt -109.97 129.92 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.523 -0.736 . . . . 1.71 109.12 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.6 m -130.3 143.08 50.56 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.46 -0.775 . . . . 1.66 109.558 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.418 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -112.85 -160.0 14.29 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 108.944 -1.662 . . . . 1.05 108.944 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.469 ' O ' ' O ' ' A' ' 6' ' ' LEU . 92.0 mt -94.21 -15.5 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.997 -1.296 . . . . 1.59 110.086 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.9 tp 50.85 103.0 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.248 -0.908 . . . . 1.47 109.505 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.14 -25.79 14.42 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.988 -1.07 . . . . 1.39 109.273 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 35.0 m -133.73 119.67 15.08 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.427 -0.796 . . . . 2.09 109.573 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.91 147.29 16.79 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.08 1.854 . . . . 0.91 112.683 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 159.46 -159.33 30.41 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.082 -1.607 . . . . 0.92 109.082 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.4 mt -149.21 150.14 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.167 -1.196 . . . . 1.35 108.669 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.55 157.84 37.47 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.968 -1.083 . . . . 1.14 110.756 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -139.5 128.7 23.91 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.021 -1.103 . . . . 0.7 108.021 178.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.0 -177.29 47.09 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 118.758 -1.687 . . . . 0.58 110.92 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 157' ' ' ILE . 98.1 mttt -79.8 159.67 26.44 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.589 -0.948 . . . . 2.63 110.099 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.6 137.38 44.72 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.596 -0.69 . . . . 1.27 110.131 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.5 tp -104.05 131.12 51.63 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.882 -1.155 . . . . 1.41 107.882 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.3 tp -113.04 124.33 52.37 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.195 -0.941 . . . . 1.49 110.022 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.3 mt -95.42 103.64 15.51 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.667 -0.646 . . . . 1.52 111.005 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -107.22 136.93 46.22 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.541 -0.724 . . . . 3.17 109.925 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -130.15 138.2 50.52 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.356 -0.84 . . . . 3.0 109.377 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -78.04 158.77 29.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.067 -1.021 . . . . 2.77 109.944 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -72.32 144.21 48.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.424 -0.798 . . . . 2.94 108.905 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.8 mt -84.5 129.61 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.104 -0.998 . . . . 1.46 109.464 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.5 t -94.14 124.73 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.341 -0.849 . . . . 1.7 110.684 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.4 mt -110.37 134.28 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.52 -0.738 . . . . 1.54 109.355 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -93.66 116.45 28.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.978 -1.076 . . . . 1.81 109.141 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -83.72 -1.41 54.06 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.153 -0.967 . . . . 3.23 109.407 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.14 139.99 58.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 3.29 109.655 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -83.13 151.2 25.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.089 -1.007 . . . . 2.8 108.999 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -94.57 166.73 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.864 . . . . 1.43 110.149 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 83.9 p -96.78 173.43 7.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -0.947 . . . . 1.54 108.666 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.79 -49.69 76.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.072 -1.018 . . . . 1.6 109.512 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -53.57 -30.99 44.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.096 -1.003 . . . . 2.56 109.29 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -83.32 -9.92 58.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.58 -0.7 . . . . 2.36 110.669 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.97 -54.0 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.652 -1.28 . . . . 1.43 109.288 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -64.56 -40.14 95.03 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.31 -0.869 . . . . 1.77 110.036 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.475 HE21 HH21 ' A' ' 42' ' ' ARG . 27.3 mt-30 -65.99 -43.63 87.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.976 -1.078 . . . . 3.32 110.351 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -63.9 -40.04 95.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.86 -1.15 . . . . 1.51 110.168 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.0 -48.16 90.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.778 -1.201 . . . . 1.41 108.647 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -62.25 -43.96 97.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.157 -0.965 . . . . 1.81 109.505 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.475 HH21 HE21 ' A' ' 38' ' ' GLN . 21.8 mtt-85 -60.05 -43.15 95.57 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.857 -1.164 . . . . 3.26 107.857 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -60.73 -49.98 75.32 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.454 -0.943 . . . . 0.81 108.454 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.6 tp -60.06 -43.71 95.23 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.69 -0.856 . . . . 1.59 108.69 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.0 t -66.56 -41.96 87.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 1.38 109.292 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.29 -44.3 66.34 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.214 -1.954 . . . . 0.87 108.214 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.2 ttt-85 -62.77 -36.6 83.62 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.14 -1.059 . . . . 3.62 108.14 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.432 ' O ' ' OG ' ' A' ' 51' ' ' SER . . . -58.03 -39.39 78.25 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.581 -0.896 . . . . 1.43 108.581 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.2 ttpt -59.5 -73.66 0.08 Allowed 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.355 -1.35 . . . . 3.08 107.355 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.61 -37.73 0.23 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.439 -0.788 . . . . 1.33 111.153 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 48' ' ' ALA . 21.7 p -53.25 -53.61 48.2 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.578 -1.326 . . . . 1.85 108.478 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.402 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . -67.85 -40.86 83.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -0.899 . . . . 1.35 110.884 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -70.01 -39.96 75.52 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.796 -1.19 . . . . 2.34 109.746 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.13 -40.05 96.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.053 -1.029 . . . . 2.2 109.11 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.37 -38.58 84.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.383 -0.823 . . . . 1.35 109.831 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -61.34 -40.47 94.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 1.34 110.048 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.3 mt -61.58 -39.98 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.374 -0.829 . . . . 1.26 109.188 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -56.58 -50.82 70.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 1.7 109.949 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -60.0 -31.76 70.23 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.376 -0.827 . . . . 1.35 110.729 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -67.87 -39.48 83.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.044 -1.035 . . . . 2.08 109.302 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.7 -41.48 95.99 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.663 -0.648 . . . . 1.21 110.026 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.83 -50.25 69.74 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.493 -1.443 . . . . 0.75 109.493 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.17 -51.55 24.2 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.929 -1.336 . . . . 1.59 109.929 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.7 m -60.11 -65.7 0.64 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 1.41 112.202 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -94.22 -50.15 5.4 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.802 -1.186 . . . . 0.79 111.439 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.65 -168.24 25.61 Favored Glycine 0 N--CA 1.502 3.071 0 C-N-CA 119.732 -1.223 . . . . 1.22 111.198 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.0 -26.78 64.24 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.939 -0.742 . . . . 5.81 110.21 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.508 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.0 tp10 -60.1 -34.29 73.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.378 -0.826 . . . . 3.37 110.629 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -100.0 -18.01 17.24 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.079 -1.013 . . . . 2.37 109.799 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -69.26 -39.99 78.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.103 -0.998 . . . . 1.65 109.974 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.25 -31.5 72.67 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.308 -0.87 . . . . 1.42 109.47 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.0 mt -60.12 -42.21 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -0.985 . . . . 1.43 109.656 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -65.02 -39.88 94.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.994 -1.066 . . . . 1.08 110.317 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -59.79 -40.12 87.23 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.954 -1.091 . . . . 1.37 108.771 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.47 -46.34 94.01 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.649 -1.781 . . . . 0.67 108.649 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -65.34 -45.06 85.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -1.133 . . . . 1.99 109.646 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.7 mt -69.08 -45.0 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.078 -1.049 . . . . 1.22 109.09 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.3 ttp -61.1 -39.9 91.71 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.936 -1.102 . . . . 2.11 109.436 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.0 tp -63.15 -39.13 93.78 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.495 -0.753 . . . . 1.33 109.506 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 34.6 tp -66.1 -30.27 70.74 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.404 -0.81 . . . . 1.29 109.027 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -87.2 6.86 30.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.137 -0.977 . . . . 1.47 110.009 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 63.1 t0 -55.86 130.0 41.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.963 -1.085 . . . . 1.47 109.887 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.407 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 99.8 mt-10 -60.5 -19.43 56.88 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.528 -0.732 . . . . 1.78 111.058 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.96 -33.53 72.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.759 -1.213 . . . . 2.53 108.337 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 76.9 mt -71.94 -41.99 67.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.64 -0.663 . . . . 1.36 110.08 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -60.15 -50.12 74.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.02 -1.05 . . . . 1.42 111.056 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -70.12 -40.09 75.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.107 -0.996 . . . . 2.27 110.876 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.88 -39.99 75.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.22 -0.925 . . . . 1.57 111.01 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.2 -49.99 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.997 -1.064 . . . . 1.19 109.676 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.02 -39.11 80.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.538 -0.726 . . . . 1.39 110.436 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.11 -44.03 95.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 1.39 110.631 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.2 mt -62.47 -46.96 86.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.796 -1.19 . . . . 1.5 109.719 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.8 -50.06 81.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-O 121.911 0.862 . . . . 1.29 108.939 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -67.66 -42.54 82.02 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.456 -0.777 . . . . 2.64 110.758 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -80.33 -54.11 6.01 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.965 -1.085 . . . . 1.65 111.956 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -90.06 -1.94 58.03 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.111 -0.993 . . . . 2.5 112.35 -177.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.9 m80 58.32 35.06 24.6 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.837 -1.164 . . . . 1.88 109.776 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.6 mtp -86.56 165.17 16.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.409 -0.807 . . . . 1.71 110.17 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.5 p -79.22 161.37 26.42 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.0 -0.741 . . . . 1.61 109.0 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.29 -42.0 84.51 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.174 -0.954 . . . . 1.33 109.613 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -62.15 -40.04 94.61 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.192 -0.943 . . . . 2.07 109.445 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.27 -41.44 22.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 1.37 110.111 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.26 -52.02 60.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.333 -0.855 . . . . 1.14 110.402 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.99 87.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.109 -0.994 . . . . 1.26 109.785 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.526 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 82.7 t60 -60.02 -40.22 88.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 2.02 110.048 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.01 -40.05 92.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.145 -0.972 . . . . 1.33 110.671 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.23 -59.95 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.094 -1.004 . . . . 1.3 111.439 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.3 mm -62.28 -42.96 97.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.974 -1.079 . . . . 1.32 109.075 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.526 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 88.7 tt0 -61.47 -40.04 93.1 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.565 -0.902 . . . . 2.44 108.565 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.16 -51.03 61.36 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.367 -1.093 . . . . 0.99 110.367 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -62.15 -49.96 73.75 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.889 -1.36 . . . . 1.97 109.126 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.07 -40.06 88.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 1.43 109.636 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 56.6 m -60.04 -39.97 87.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.116 -0.99 . . . . 2.12 109.213 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.06 82.21 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.023 -1.048 . . . . 1.64 108.407 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 118' ' ' LEU . 51.8 mt -62.0 -46.47 89.08 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.111 -0.993 . . . . 1.93 108.662 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -47.76 -30.82 4.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.897 -1.127 . . . . 2.2 109.689 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.41 -27.12 68.79 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.013 -1.054 . . . . 2.12 108.354 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 115' ' ' LEU . 74.4 mt -63.32 140.6 58.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.862 . . . . 2.34 108.952 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -94.23 10.12 35.27 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.075 -1.016 . . . . 3.23 110.42 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -98.3 147.0 25.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.005 -1.06 . . . . 2.49 109.891 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.488 ' O ' ' N ' ' A' ' 124' ' ' LYS . 98.9 mt-10 -72.98 -65.53 0.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.52 -0.738 . . . . 3.95 109.159 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.434 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 4.7 t80 -39.37 -40.05 0.74 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.867 -0.52 . . . . 2.25 110.602 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.606 ' CD2' HH21 ' A' ' 126' ' ' ARG . 81.0 mt -70.83 -40.0 72.67 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.744 -1.223 . . . . 2.27 108.551 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 121' ' ' GLU . 82.1 tttt -68.3 -34.52 76.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.553 -0.717 . . . . 3.31 109.579 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -60.08 -40.02 88.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.262 -0.899 . . . . 2.73 110.19 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.606 HH21 ' CD2' ' A' ' 123' ' ' LEU . 76.2 mtm180 -68.06 -33.44 74.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.934 -1.104 . . . . 3.2 109.258 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.88 78.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.11 -0.994 . . . . 1.66 108.621 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.27 96.86 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.797 -1.186 . . . . 1.67 107.797 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -69.96 -40.0 75.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.611 -0.681 . . . . 1.55 109.478 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.64 -39.99 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.197 -1.038 . . . . 1.32 108.197 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -65.49 -35.65 81.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.31 -0.868 . . . . 3.58 109.099 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -59.91 -40.12 87.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.252 -0.905 . . . . 1.46 109.541 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.06 -43.09 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.371 -0.83 . . . . 1.22 109.827 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.18 -36.69 50.38 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 120.197 -1.001 . . . . 0.61 110.659 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -59.55 -42.55 92.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.069 -1.254 . . . . 3.1 109.649 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -68.7 -34.37 75.53 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.707 -1.245 . . . . 3.71 109.46 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.6 tp -59.95 -43.07 95.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 1.87 109.478 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.09 -40.17 94.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.003 -1.06 . . . . 1.29 109.146 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -70.11 -36.84 75.13 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 3.05 109.488 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -69.87 -25.58 63.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.353 -0.842 . . . . 1.26 111.24 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.91 -43.76 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.472 -1.393 . . . . 1.34 108.931 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.59 -28.45 58.93 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.494 -0.754 . . . . 1.6 110.079 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.34 5.61 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.112 -1.995 . . . . 0.96 108.112 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.7 tp -73.59 146.87 44.36 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.632 -0.922 . . . . 1.67 109.229 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -60.81 144.12 53.24 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.24 -0.913 . . . . 4.96 109.515 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 97.2 mt -114.49 120.61 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.583 -0.895 . . . . 1.68 108.583 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 10.7 mm -52.6 -53.23 21.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.651 -0.656 . . . . 2.14 110.384 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.2 t0 66.37 103.32 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.548 -0.72 . . . . 1.5 109.285 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 17.1 mt -74.82 -3.08 29.66 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.673 -0.642 . . . . 1.39 110.374 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 53.1 m -86.83 -15.68 38.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.171 -0.955 . . . . 1.83 109.573 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.99 15.83 1.03 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.362 -0.836 . . . . 1.46 111.458 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.534 ' N ' ' CD1' ' A' ' 152' ' ' ILE . 1.3 mp -90.4 124.71 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.541 -1.349 . . . . 1.42 109.068 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -103.67 -7.09 20.96 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.386 -0.822 . . . . 2.94 110.101 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -119.36 149.43 41.84 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.477 -0.764 . . . . 1.52 110.496 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.35 135.42 54.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.419 -0.8 . . . . 1.58 109.161 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.0 m -152.07 166.02 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.428 -0.795 . . . . 1.32 109.538 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.448 ' N ' ' O ' ' A' ' 15' ' ' LYS . 86.3 mt -93.47 149.3 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 105.823 -1.918 . . . . 1.27 105.823 176.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.2 tp -97.06 115.26 27.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.942 -1.099 . . . . 1.41 110.799 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 64.2 t -120.11 124.69 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.679 -0.638 . . . . 1.23 109.436 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.45 162.66 35.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.168 -0.958 . . . . 1.32 108.481 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.02 -36.42 75.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.508 -1.37 . . . . 1.49 108.444 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 20.4 p-10 -170.77 146.79 2.67 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.21 -0.663 . . . . 2.25 109.21 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 44.8 mt -112.98 137.54 51.22 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.362 -0.836 . . . . 1.35 109.906 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 70.9 p -92.82 146.42 32.11 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.157 -0.964 . . . . 1.56 108.483 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -40.2 -37.81 1.98 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.02 1.814 . . . . 0.87 112.731 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.9 m -59.99 -40.76 90.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.912 . . . . 1.36 110.146 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.94 -40.63 75.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.05 -1.031 . . . . 1.61 109.824 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 66.5 p -59.14 -20.33 52.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.364 -0.835 . . . . 1.21 111.833 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.5 -47.45 9.9 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.471 -1.393 . . . . 1.21 109.739 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -85.62 36.29 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.581 -0.896 . . . . 2.11 108.581 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.0 tp -107.91 139.9 41.84 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.932 -0.766 . . . . 1.29 108.932 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' A' ' 172' ' ' ASN . 6.2 p30 -89.37 106.39 18.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.045 -1.034 . . . . 2.81 108.912 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 59.6 mt -67.39 -40.16 85.65 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.576 -0.703 . . . . 2.09 111.678 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -68.75 -21.83 64.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.646 -1.284 . . . . 2.86 111.17 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -94.29 -8.37 39.26 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.89 -1.131 . . . . 2.39 109.96 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 84.4 t -101.0 112.42 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.216 -0.927 . . . . 1.27 108.719 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.52 1.49 29.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -0.91 . . . . 2.17 110.7 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.26 173.33 37.5 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.33 -1.508 . . . . 0.52 109.33 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -127.98 125.07 38.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.562 -0.963 . . . . 0.55 108.713 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 93.4 mt -130.85 125.38 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.399 -0.963 . . . . 1.27 108.399 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 31.6 p -151.42 163.43 38.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.885 -1.134 . . . . 1.39 111.172 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.501 ' O ' ' O ' ' A' ' 183' ' ' ALA . 57.4 t0 -100.84 27.35 6.03 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.993 -0.549 . . . . 2.46 109.675 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -46.96 -177.24 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.001 -1.687 . . . . 1.51 111.862 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.29 -54.39 6.92 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.254 -1.138 . . . . 2.23 110.254 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -161.4 -156.12 8.17 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.416 -1.373 . . . . 2.23 110.357 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.755 ' HE ' HH21 ' A' ' 195' ' ' ARG . 66.6 mtp180 -78.4 -9.48 59.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.633 -0.922 . . . . 6.44 109.354 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 39.6 p -77.75 2.78 15.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 4.09 110.067 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.435 ' OG ' ' OG ' ' A' ' 191' ' ' SER . 78.0 p -82.31 139.61 34.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.954 -1.091 . . . . 2.2 109.655 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -49.18 -50.05 39.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.986 -1.071 . . . . 1.15 109.918 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.6 t -53.64 -36.17 61.78 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.214 -0.929 . . . . 2.01 110.394 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.435 ' OG ' ' OG ' ' A' ' 188' ' ' SER . 66.7 m -59.92 -40.07 87.63 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.804 -1.185 . . . . 1.93 110.155 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.3 mt -61.02 -39.99 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 2.2 109.567 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 76.6 mtp -56.92 -41.39 78.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.251 -0.906 . . . . 1.32 109.978 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.08 -40.8 90.82 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.996 -1.065 . . . . 1.3 108.769 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.755 HH21 ' HE ' ' A' ' 186' ' ' ARG . 95.0 mtt180 -62.62 -59.98 4.16 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.346 -0.942 . . . . 3.38 110.281 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.4 m -63.42 -39.99 95.99 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.213 -0.929 . . . . 1.15 112.101 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.1 -22.42 63.03 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.854 -1.154 . . . . 1.28 109.307 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 61.35 47.02 7.19 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.694 -0.629 . . . . 1.5 109.782 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 8' ' ' SER . 97.5 mt -122.19 148.6 52.43 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 107.757 -1.201 . . . . 1.37 107.757 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.45 138.12 68.96 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.975 1.783 . . . . 0.76 111.39 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.01 150.96 3.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.942 -1.099 . . . . 1.19 111.588 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.6 mt -124.4 141.16 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 107.211 -1.403 . . . . 1.31 107.211 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.8 m -124.22 -9.22 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.52 0 O-C-N 120.522 -1.361 . . . . 1.38 111.406 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -111.36 23.34 18.45 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 110.607 -0.997 . . . . 1.03 110.607 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.412 ' C ' ' O ' ' A' ' 204' ' ' GLY . 2.9 p -43.07 -46.89 5.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.222 -1.163 . . . . 1.38 110.108 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.438 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 95.69 -54.0 1.7 Allowed Glycine 0 N--CA 1.501 2.973 0 C-N-CA 120.163 -1.018 . . . . 1.17 111.587 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 78.7 p -149.03 29.62 0.8 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.49 -1.594 . . . . 2.07 111.505 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 41.7 t -74.34 -36.35 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.691 -1.256 . . . . 1.35 109.299 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 53.5 p -58.96 -26.01 64.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.92 -1.112 . . . . 1.49 109.796 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.7 m -84.2 -15.27 47.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.105 -0.997 . . . . 2.16 109.892 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -102.46 -6.75 22.58 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.268 -0.895 . . . . 2.89 109.868 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 78.6 t -110.19 133.44 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.514 -0.742 . . . . 1.33 110.819 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -115.16 151.08 35.02 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.149 -1.426 . . . . 2.73 107.149 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.454 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 61.7 t30 -54.89 139.76 39.18 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.02 -1.05 . . . . 2.7 110.79 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.454 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.1 m-20 83.18 2.47 1.02 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-N 116.322 -0.399 . . . . 2.38 110.632 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -74.3 145.12 44.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.895 -1.128 . . . . 2.09 109.489 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -95.51 118.85 32.98 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.997 -1.112 . . . . 1.45 107.997 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 58.1 mt -128.04 151.22 49.42 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.559 -0.713 . . . . 1.31 110.151 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 83.0 mt -116.89 130.02 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.224 -1.398 . . . . 1.29 107.224 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 63.5 tp -97.95 115.19 27.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.967 -1.083 . . . . 1.31 109.069 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.556 ' C ' ' H ' ' A' ' 223' ' ' VAL . 20.2 t0 -72.93 -47.15 48.1 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.597 -1.261 . . . . 2.31 107.597 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 52.7 5.52 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.814 -0.554 . . . . 1.19 109.791 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.556 ' H ' ' C ' ' A' ' 221' ' ' ASP . 69.5 t -116.59 -40.21 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 107.473 -1.306 . . . . 1.45 107.473 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -108.43 5.39 25.3 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.976 -1.12 . . . . 3.13 107.976 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.418 HD22 ' H ' ' A' ' 4' ' ' GLY . 1.4 t-20 59.37 49.37 8.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.85 -0.531 . . . . 2.2 110.011 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -138.49 150.9 46.89 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.382 -0.824 . . . . 2.32 109.444 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 49.7 t -119.25 129.77 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.066 -1.087 . . . . 1.4 108.066 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -99.75 119.13 37.66 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.063 -1.088 . . . . 1.29 108.063 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 56.1 t -101.39 116.44 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.505 -0.747 . . . . 1.38 110.595 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 230' ' ' ASN . 16.9 t30 49.98 60.13 15.62 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 2.33 110.836 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -85.69 149.68 9.93 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.571 2.181 . . . . 0.95 112.119 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 68.5 p -67.93 164.11 20.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.288 -0.882 . . . . 2.31 110.568 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -60.1 -38.74 83.84 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.84 -0.8 . . . . 3.45 108.84 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.97 -39.64 86.34 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.55 -0.719 . . . . 2.89 109.473 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.68 -40.09 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.019 -1.05 . . . . 1.73 109.968 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.493 1.724 0 O-C-N 120.996 -1.065 . . . . 1.57 109.157 179.363 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 3.3 ttt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.532 0.682 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -151.56 148.48 28.05 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.11 161.06 43.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.796 -1.19 . . . . 0.0 111.037 -178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -154.01 151.13 29.01 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -106.96 132.71 52.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 109.248 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.3 122.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 CA-C-O 122.387 1.089 . . . . 0.0 112.74 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 29.4 m -79.27 106.84 11.59 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.671 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' B' ' 358' ' ' GLY . 81.7 mt -51.97 117.14 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 122.135 0.969 . . . . 0.0 110.007 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 77.4 p -106.91 18.68 21.5 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.462 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -75.39 116.69 57.06 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.067 -1.02 . . . . 0.0 108.949 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -51.96 -13.11 1.59 Allowed 'Trans proline' 0 N--CA 1.499 1.823 0 CA-C-N 120.261 1.129 . . . . 0.0 113.442 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -118.13 6.77 12.05 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.307 -0.871 . . . . 0.0 109.449 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.85 174.92 27.27 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.434 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.0 tp -85.05 96.07 9.3 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.03 -1.276 . . . . 0.0 108.59 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -97.79 -160.18 0.79 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.082 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 9.2 m -59.0 -41.84 88.64 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.032 -1.042 . . . . 0.0 112.439 -176.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.508 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 1.4 tpt180 -60.4 -62.18 6.45 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 120.429 -1.42 . . . . 0.0 111.794 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -57.9 -32.02 94.06 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.199 1.107 . . . . 0.0 111.461 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.83 72.22 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.64 -41.6 63.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.441 -0.787 . . . . 0.0 109.25 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -69.98 -41.3 74.6 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.167 -1.013 . . . . 0.0 108.7 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -60.97 -51.96 67.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.471 -0.768 . . . . 0.0 110.435 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 70.0 t -68.36 -30.82 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.653 -1.279 . . . . 0.0 109.841 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -59.99 -44.32 94.6 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.231 -0.988 . . . . 0.0 108.608 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -69.41 -40.72 77.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 110.646 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.1 -52.08 66.89 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.516 -1.365 . . . . 0.0 109.343 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -57.33 -15.23 5.81 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.598 -0.689 . . . . 0.0 109.193 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.96 -29.78 70.55 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -104.83 147.23 27.95 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.455 -1.027 . . . . 0.0 109.109 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 22.6 p -91.36 -12.93 33.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.841 -1.162 . . . . 0.0 109.585 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 331' ' ' SER . . . . . 0.522 ' HG ' ' N ' ' B' ' 368' ' ' GLU . 5.8 m -59.46 152.52 21.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.297 -0.877 . . . . 0.0 109.663 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -70.78 134.1 47.11 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.165 -0.96 . . . . 0.0 108.681 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 86.2 mt -132.91 131.24 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.537 -0.727 . . . . 0.0 110.292 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 39.4 m -130.63 153.48 48.88 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 72.4 t -118.61 139.69 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 96.9 m -126.97 123.64 37.59 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.271 -0.893 . . . . 0.0 108.904 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 40.1 p -135.91 116.71 14.07 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.12 -0.988 . . . . 0.0 109.832 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' B' ' 338' ' ' ASN . 9.2 p30 39.95 69.05 0.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 72.31 -11.92 3.66 Favored Glycine 0 N--CA 1.5 2.966 0 O-C-N 120.762 -1.211 . . . . 0.0 113.411 176.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -115.4 129.13 56.48 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-N 119.473 1.637 . . . . 0.0 109.39 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 83.0 p -129.35 151.1 50.36 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.777 0.798 . . . . 0.0 110.699 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -146.14 166.53 25.89 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.595 0.712 . . . . 0.0 110.299 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 34.3 t -89.38 140.09 29.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.554 -0.717 . . . . 0.0 110.061 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.463 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -77.57 -14.66 59.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.015 -1.053 . . . . 0.0 109.613 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -86.98 18.52 3.5 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.463 ' H ' ' C ' ' B' ' 344' ' ' ALA . 88.2 p -146.12 96.54 2.81 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.403 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 11.9 tp -60.01 -34.56 73.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -59.74 -54.94 40.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.536 -0.727 . . . . 0.0 110.6 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.421 ' O ' ' OG1' ' B' ' 352' ' ' THR . 52.9 mtpt -63.64 -40.07 95.94 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.705 -1.247 . . . . 0.0 109.007 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.594 ' O ' ' N ' ' B' ' 352' ' ' THR . 60.0 mt -52.18 -56.49 14.24 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.526 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -39.44 -14.55 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.872 -0.517 . . . . 0.0 111.758 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.594 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.1 p -93.24 -9.99 37.2 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.516 -1.365 . . . . 0.0 110.792 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 47.0 mt -94.36 119.94 33.85 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.854 -1.154 . . . . 0.0 109.914 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -71.02 94.23 0.52 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 85.0 mt -99.98 83.6 2.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.35 -1.088 . . . . 0.0 109.271 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 82.3 p -93.5 169.89 10.01 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.054 -1.029 . . . . 0.0 110.998 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.55 112.55 2.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.868 -0.52 . . . . 0.0 110.339 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 105.48 6.04 38.96 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.0 m -84.81 108.16 17.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -1.204 . . . . 0.0 111.062 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 17.0 t -77.7 115.03 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 122.236 1.017 . . . . 0.0 109.491 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.23 178.45 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 81.6 m -128.87 131.28 47.63 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.9 mt -102.85 120.28 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 41.6 m -120.69 130.06 53.93 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.534 -0.729 . . . . 0.0 109.474 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.16 151.21 40.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.396 -0.815 . . . . 0.0 109.498 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -147.16 122.34 10.18 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.461 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 160.23 -153.56 24.51 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 118.767 -1.683 . . . . 0.0 111.827 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . 0.522 ' N ' ' HG ' ' B' ' 331' ' ' SER . 85.5 tt0 -60.04 -50.42 73.78 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 122.203 -0.587 . . . . 0.0 112.22 -177.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.439 ' N ' ' OG ' ' B' ' 331' ' ' SER . 85.8 m-20 -112.59 12.3 19.82 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 120.924 -1.11 . . . . 0.0 111.628 -177.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.0 OUTLIER -39.65 -33.65 0.19 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.179 -0.951 . . . . 0.0 111.653 -178.494 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . 0.475 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 12.2 pt20 -65.7 -54.03 32.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.763 -1.211 . . . . 0.0 110.404 -178.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -64.43 -49.38 71.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.622 -1.299 . . . . 0.0 108.619 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -41.48 -42.27 2.3 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.724 -0.61 . . . . 0.0 111.186 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 76.3 t -74.71 -36.89 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.546 -1.346 . . . . 0.0 109.574 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -63.19 -64.93 0.77 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.01 -1.056 . . . . 0.0 110.498 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . 0.449 ' O ' ' N ' ' B' ' 380' ' ' LEU . 34.4 m170 -59.97 -45.31 93.11 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.776 -1.202 . . . . 0.0 112.07 -177.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.4 mt -60.0 -40.22 88.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.394 -1.441 . . . . 0.0 108.568 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 46.0 t -64.81 -49.54 79.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 110.164 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -80.17 -9.68 59.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.817 -1.177 . . . . 0.0 110.407 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' B' ' 376' ' ' HIS . 56.7 tp -83.34 -27.92 29.38 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 41.6 ttm -80.46 -30.07 37.5 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.065 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -84.82 -7.66 59.1 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.54 -0.725 . . . . 0.0 109.837 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -110.21 -2.96 16.56 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.253 -0.904 . . . . 0.0 110.029 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 22.0 mt -90.98 125.63 35.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.011 -1.056 . . . . 0.0 109.091 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 117.917 -1.039 . . . . 0.0 109.597 -179.862 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.424 0.63 . . . . 3.19 109.777 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.5 mt -110.1 130.12 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.229 -0.656 . . . . 1.71 109.229 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.431 ' CB ' ' OD1' ' A' ' 225' ' ' ASN . 61.9 m -137.13 153.54 50.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.379 -0.825 . . . . 1.66 109.681 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.85 -158.17 8.1 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 108.47 -1.852 . . . . 1.05 108.47 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.418 ' O ' ' O ' ' A' ' 6' ' ' LEU . 82.3 mt -90.43 -18.56 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.751 -1.44 . . . . 1.59 109.568 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.1 tp 44.01 93.65 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.167 -0.958 . . . . 1.47 110.366 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.41 -22.66 18.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.954 -1.091 . . . . 1.39 109.267 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 70.7 m -121.06 112.4 33.37 Favored Pre-proline 0 N--CA 1.504 2.244 0 O-C-N 121.463 -0.773 . . . . 2.09 109.53 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -80.94 151.35 18.57 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.027 1.818 . . . . 0.91 112.408 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 145.92 175.84 19.3 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.959 -1.656 . . . . 0.92 108.959 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.72 155.7 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 O-C-N 121.427 -1.043 . . . . 1.35 109.609 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.19 155.26 34.96 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.057 -1.027 . . . . 1.14 110.326 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 5.3 m-85 -135.28 126.37 27.92 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.012 -1.107 . . . . 0.7 108.012 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.29 -179.21 48.18 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 118.642 -1.742 . . . . 0.58 110.907 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -79.97 158.09 26.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.985 -0.715 . . . . 2.63 109.822 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.44 125.51 51.1 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.531 -0.731 . . . . 1.27 110.469 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.5 tp -97.53 136.76 37.49 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.03 -1.1 . . . . 1.41 108.03 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.9 tp -120.39 128.02 52.83 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.486 -0.759 . . . . 1.49 109.385 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.86 107.51 19.15 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.485 -0.76 . . . . 1.52 110.278 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -100.12 129.87 46.2 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.145 -1.057 . . . . 3.17 108.145 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -130.95 139.76 50.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.185 -0.947 . . . . 3.0 109.712 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 52.9 t0 -81.85 143.89 31.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 2.77 109.088 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.482 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 86.9 tt0 -64.88 140.41 58.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -0.972 . . . . 2.94 109.493 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.7 mt -81.68 135.3 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.331 -0.855 . . . . 1.46 108.818 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.2 t -110.75 128.89 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.368 -0.832 . . . . 1.7 110.093 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.0 mt -98.06 143.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.483 -0.932 . . . . 1.54 108.483 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -94.85 121.43 36.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.865 -1.147 . . . . 1.81 109.738 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.419 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.8 mmm-85 -88.02 -0.31 56.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.583 -0.698 . . . . 3.23 109.553 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.52 139.65 58.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.071 -1.018 . . . . 3.29 108.761 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -85.26 149.99 25.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 2.8 109.376 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 pt -91.48 165.15 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 1.43 109.494 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.2 p -97.2 172.56 7.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.15 -0.968 . . . . 1.54 108.464 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.56 77.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.952 -1.093 . . . . 1.6 109.355 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.05 -29.64 57.91 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.71 -1.243 . . . . 2.56 109.311 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -81.87 -9.62 59.54 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.256 -0.902 . . . . 2.36 109.971 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.9 t -65.37 -54.54 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.695 -1.253 . . . . 1.43 109.157 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.05 -39.98 87.83 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.294 -0.879 . . . . 1.77 109.56 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -67.82 -44.91 76.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.177 -0.952 . . . . 3.32 110.347 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -61.28 -41.02 96.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.915 -1.116 . . . . 1.51 110.44 -179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.37 -47.16 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.66 -1.275 . . . . 1.41 107.957 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -62.11 -47.57 84.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.552 -0.717 . . . . 1.81 109.697 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -60.1 -41.42 92.47 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.621 -1.252 . . . . 3.26 107.621 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -64.53 -46.34 83.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.69 -0.631 . . . . 0.81 109.341 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 48' ' ' ALA . 63.6 tp -59.86 -44.84 93.92 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.508 -0.923 . . . . 1.59 108.508 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.5 t -65.03 -44.02 90.47 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.441 -0.904 . . . . 1.38 109.007 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.39 -43.13 95.47 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.282 -1.927 . . . . 0.87 108.282 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.493 ' NH2' ' O ' ' A' ' 80' ' ' LEU . 68.1 ttt180 -66.4 -37.0 84.24 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.01 -1.107 . . . . 3.62 108.01 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -60.0 -39.76 86.88 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.921 -0.77 . . . . 1.43 108.921 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 50' ' ' ALA . 18.0 ttpp -60.06 -73.64 0.09 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.108 -0.995 . . . . 3.08 108.486 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.67 -33.95 0.09 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.163 -0.961 . . . . 1.33 111.944 -177.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.0 m -60.0 -49.79 76.3 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.361 -1.462 . . . . 1.85 108.586 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.82 -40.06 79.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.853 . . . . 1.35 110.725 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -65.86 -40.09 91.34 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.897 -1.127 . . . . 2.34 110.021 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.0 mt -60.73 -39.95 90.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.093 -1.004 . . . . 2.2 108.687 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -59.98 -39.71 86.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.618 -0.676 . . . . 1.35 110.168 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.9 m -63.93 -43.38 96.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.72 -1.237 . . . . 1.34 108.609 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.514 ' CD1' HH22 ' A' ' 136' ' ' ARG . 82.3 mt -61.18 -39.94 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.464 -0.772 . . . . 1.26 109.027 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -56.63 -49.99 73.36 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.475 -0.935 . . . . 1.7 108.475 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -59.91 -35.21 74.38 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.675 -0.641 . . . . 1.35 110.464 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -68.16 -39.92 82.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.858 -1.151 . . . . 2.08 109.627 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.98 82.68 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.574 -0.704 . . . . 1.21 110.097 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.01 -51.11 60.91 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 119.905 -1.14 . . . . 0.75 110.394 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.09 -44.72 68.49 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.09 -1.241 . . . . 1.59 109.966 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.9 m -67.17 -62.46 1.42 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.936 . . . . 1.41 112.178 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -94.65 -49.13 5.77 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.905 -1.122 . . . . 0.79 111.058 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.79 -169.6 25.17 Favored Glycine 0 N--CA 1.502 3.043 0 C-N-CA 119.702 -1.237 . . . . 1.22 111.445 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -66.71 -26.32 66.96 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.939 -0.742 . . . . 5.81 110.109 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.12 -36.19 76.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.292 -0.88 . . . . 3.37 110.36 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -97.23 -17.51 19.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.234 -0.916 . . . . 2.37 109.961 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -71.34 -42.79 68.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.054 -1.029 . . . . 1.65 110.264 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.5 -28.41 69.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.542 -0.724 . . . . 1.42 109.756 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.06 -40.76 84.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.095 -1.003 . . . . 1.43 108.9 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -69.99 -37.14 75.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 1.08 111.248 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -60.01 -40.37 89.03 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.626 -1.296 . . . . 1.37 109.63 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.63 -43.2 96.78 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.932 -1.667 . . . . 0.67 108.932 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -60.74 -45.19 95.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.306 -1.114 . . . . 1.99 109.14 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.2 mt -68.75 -47.19 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 1.22 109.786 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.7 ttp -60.0 -43.35 95.27 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.964 -1.085 . . . . 2.11 110.031 -178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.1 tp -60.25 -39.94 88.56 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.445 -0.785 . . . . 1.33 109.565 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.493 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 58.8 tp -61.67 -39.89 93.0 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.726 -0.608 . . . . 1.29 110.074 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.16 9.93 7.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.166 -0.959 . . . . 1.47 110.913 -178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -53.88 130.85 38.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.66 -1.275 . . . . 1.47 109.704 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -57.73 -21.02 38.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.498 -0.751 . . . . 1.78 110.395 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -70.49 -34.43 72.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.004 -1.06 . . . . 2.53 108.991 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 44.9 mt -69.99 -40.51 75.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.634 -0.666 . . . . 1.36 109.827 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.15 -47.14 87.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.151 -0.968 . . . . 1.42 110.45 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -69.91 -42.8 72.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.121 -0.987 . . . . 2.27 111.323 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -70.1 -39.98 75.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.992 -1.068 . . . . 1.57 111.171 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 91.4 mt -66.6 -49.57 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.976 -1.077 . . . . 1.19 109.668 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.503 ' CG2' ' HZ2' ' A' ' 94' ' ' LYS . 84.8 mt -69.66 -39.96 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.587 -0.696 . . . . 1.39 110.521 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.0 -47.86 84.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.081 -1.012 . . . . 1.39 110.888 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.06 -46.84 88.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.987 -1.071 . . . . 1.5 109.897 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.48 -49.54 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 1.29 109.711 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.503 ' HZ2' ' CG2' ' A' ' 90' ' ' ILE . 54.2 mttp -69.91 -45.84 66.69 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.419 -0.801 . . . . 2.64 111.173 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -80.16 -49.55 11.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.998 -1.063 . . . . 1.65 112.148 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -91.13 -3.62 56.92 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.938 -1.101 . . . . 2.5 111.944 -177.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 54.73 36.23 25.8 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.752 -1.217 . . . . 1.88 109.209 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 51.3 mtt -87.24 169.77 12.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.541 -0.725 . . . . 1.71 109.399 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 65.6 p -80.53 156.76 26.35 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.187 -0.946 . . . . 1.61 108.915 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.97 75.64 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.229 -0.919 . . . . 1.33 109.344 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -63.16 -40.08 96.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.897 . . . . 2.07 109.82 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.44 -49.32 10.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 1.37 109.87 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.49 -41.34 96.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.477 -0.764 . . . . 1.14 110.555 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.09 -54.02 36.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.927 -1.108 . . . . 1.26 110.349 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -63.15 -27.75 69.59 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.037 -1.039 . . . . 2.02 109.344 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.12 -40.12 88.59 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.286 -0.883 . . . . 1.33 109.39 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.26 -46.64 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.969 -1.082 . . . . 1.3 109.407 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.9 mm -61.15 -41.89 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.31 -0.869 . . . . 1.32 109.187 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -68.99 -34.3 75.08 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.153 -1.055 . . . . 2.44 108.153 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.48 -45.17 95.97 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.301 -1.12 . . . . 0.99 110.301 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -69.98 -46.85 64.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.755 -1.438 . . . . 1.97 109.807 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.01 86.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 1.43 109.909 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 58.0 m -60.01 -40.09 88.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.052 -1.03 . . . . 2.12 109.441 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.72 91.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 1.64 109.3 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.1 mt -63.75 -40.08 95.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.072 -1.018 . . . . 1.93 109.581 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -58.35 -31.21 67.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.81 -1.181 . . . . 2.2 109.542 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -58.66 -25.59 62.92 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.339 -0.986 . . . . 2.12 108.339 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 44.0 mt -62.71 144.71 56.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.878 . . . . 2.34 108.805 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -96.54 45.4 1.06 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.089 -1.007 . . . . 3.23 109.92 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 51.4 t0 -136.05 146.14 46.78 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.253 -0.904 . . . . 2.49 109.604 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.538 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -73.9 -63.6 1.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.569 -0.9 . . . . 3.95 108.569 178.319 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.496 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.0 t80 -39.23 -41.73 0.9 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.905 -0.497 . . . . 2.25 111.187 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.4 mt -70.02 -40.01 75.45 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.64 -1.287 . . . . 2.27 108.651 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 121' ' ' GLU . 33.4 ttmt -62.38 -39.87 94.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.451 -0.781 . . . . 3.31 109.836 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.07 -40.91 91.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.236 -0.915 . . . . 2.73 110.225 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -62.09 -39.97 94.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.971 -1.081 . . . . 3.2 108.816 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.22 -28.47 70.06 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.507 -0.923 . . . . 1.66 108.507 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.04 93.46 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.323 -0.992 . . . . 1.67 108.323 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.59 -40.01 95.86 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.586 -0.894 . . . . 1.55 108.586 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.8 t -66.26 -40.06 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.884 -0.784 . . . . 1.32 108.884 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.3 ttt-85 -60.56 -37.35 80.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.334 -0.854 . . . . 3.58 108.963 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -60.01 -42.74 94.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.419 -0.801 . . . . 1.46 109.992 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.0 -47.63 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.822 -1.174 . . . . 1.22 109.322 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.94 -41.06 97.67 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.302 -1.519 . . . . 0.61 109.302 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -60.15 -49.86 75.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.352 -1.087 . . . . 3.1 109.671 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.514 HH22 ' CD1' ' A' ' 57' ' ' ILE . 63.3 mtp180 -64.59 -36.04 82.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 3.71 110.333 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.94 -44.39 94.39 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.419 -0.8 . . . . 1.87 109.371 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.25 -42.59 95.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -0.954 . . . . 1.29 110.095 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -72.63 -35.85 67.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.052 -1.03 . . . . 3.05 109.288 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -60.06 -39.84 87.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.609 -0.682 . . . . 1.26 110.845 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.0 mt -74.98 -42.59 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.844 -1.16 . . . . 1.34 109.736 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.99 -29.95 67.17 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.574 -0.704 . . . . 1.6 109.934 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.46 40.6 10.89 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.74 -1.744 . . . . 0.96 108.74 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.3 tp -73.02 148.45 44.14 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.474 -1.015 . . . . 1.67 109.004 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -68.47 148.45 50.59 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.189 -0.944 . . . . 4.96 110.426 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.42 HG23 HD11 ' A' ' 146' ' ' ILE . 95.8 mt -119.98 122.67 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.989 0.899 . . . . 1.68 109.709 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.9 mt -61.0 -42.5 93.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 109.28 -0.637 . . . . 2.14 109.28 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.9 t0 62.47 123.92 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.779 -0.576 . . . . 1.5 110.125 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.4 mt -78.13 -5.78 52.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 1.39 108.68 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.8 t -81.84 -10.07 59.42 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.683 -0.858 . . . . 1.83 108.683 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.74 19.71 1.28 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.754 -0.591 . . . . 1.46 110.109 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 56.3 mt -91.58 120.69 41.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 121.253 -0.905 . . . . 1.42 109.161 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -108.01 -8.53 15.85 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.356 -0.84 . . . . 2.94 109.874 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -129.57 152.07 49.49 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.413 -0.805 . . . . 1.52 109.884 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.15 133.51 53.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -0.91 . . . . 1.58 108.872 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.5 m -152.83 166.35 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.402 -0.812 . . . . 1.32 109.757 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.3 mt -93.06 147.94 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 106.015 -1.846 . . . . 1.27 106.015 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.9 tp -102.13 117.61 35.14 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.052 -1.03 . . . . 1.41 109.9 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.7 t -125.02 134.31 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.36 -0.978 . . . . 1.23 108.36 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.81 168.63 22.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.113 -0.992 . . . . 1.32 109.14 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.91 -38.26 69.93 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.318 -1.489 . . . . 1.49 107.941 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -171.17 145.58 2.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.599 -0.688 . . . . 2.25 109.486 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.2 mt -115.91 137.46 52.08 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.415 -0.803 . . . . 1.35 109.615 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.2 p -91.22 149.97 40.71 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.233 -0.917 . . . . 1.56 109.512 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -42.36 -36.99 4.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.488 2.126 . . . . 0.87 113.564 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 72.3 m -59.99 -40.05 87.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.881 -1.137 . . . . 1.36 109.314 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.75 -43.09 89.99 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.148 -0.97 . . . . 1.61 109.432 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 79.1 p -59.1 -19.57 45.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.39 -0.819 . . . . 1.21 111.555 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -83.86 -46.72 11.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.769 -1.207 . . . . 1.21 110.26 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -90.73 39.32 0.98 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.312 -0.996 . . . . 2.11 108.312 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 56.6 tp -105.6 137.1 44.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.567 -0.708 . . . . 1.29 110.231 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -89.91 101.57 14.27 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.285 -0.884 . . . . 2.81 108.872 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.32 -39.99 94.84 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.385 -0.822 . . . . 2.09 111.109 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -66.54 -24.22 66.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.115 -0.991 . . . . 2.86 111.543 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -93.74 -10.96 32.52 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.706 -1.246 . . . . 2.39 110.358 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 80.4 t -102.76 112.77 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.099 -1.001 . . . . 1.27 109.355 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.7 mt -83.62 3.8 31.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.252 -0.905 . . . . 2.17 110.354 -178.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.38 169.91 36.33 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.554 -1.418 . . . . 0.52 109.554 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -134.47 130.23 36.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.395 -1.062 . . . . 0.55 108.517 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 67.2 mt -130.45 125.48 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.567 -0.901 . . . . 1.27 108.567 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 7.7 p -143.07 154.33 43.84 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.21 -0.931 . . . . 1.39 111.046 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -106.28 27.88 8.27 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.797 -0.816 . . . . 2.46 108.797 179.279 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.04 -157.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.825 -1.172 . . . . 1.51 111.908 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -53.4 -80.98 0.06 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.863 -1.295 . . . . 2.23 109.863 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.45 ' O ' ' OG ' ' A' ' 191' ' ' SER . . . -178.3 -131.97 1.64 Allowed Glycine 0 N--CA 1.488 2.1 0 C-N-CA 119.424 -1.369 . . . . 2.23 110.286 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -73.28 -10.53 59.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.628 -0.925 . . . . 6.44 111.122 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 51.7 p -92.83 7.84 42.08 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.804 -1.185 . . . . 4.09 110.984 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.414 ' OG ' ' OG ' ' A' ' 191' ' ' SER . 78.7 p -89.08 143.43 26.85 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.733 -1.23 . . . . 2.2 110.124 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -47.37 -47.48 26.08 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.383 -0.823 . . . . 1.15 109.338 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.0 m -56.53 -39.64 73.72 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.742 -0.599 . . . . 2.01 109.857 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 185' ' ' GLY . 53.7 m -59.89 -40.04 87.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.98 -1.075 . . . . 1.93 110.923 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.426 HD12 HG22 ' A' ' 192' ' ' ILE . 89.1 mt -60.06 -41.26 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.0 . . . . 2.2 110.161 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.8 mtp -60.07 -50.37 73.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.093 -1.005 . . . . 1.32 111.116 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -50.94 -45.41 60.6 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.908 -1.12 . . . . 1.3 109.646 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -60.03 -51.65 68.75 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.07 -1.052 . . . . 3.38 109.733 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.8 m -71.99 -35.06 69.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.075 -1.016 . . . . 1.15 110.86 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.46 -30.02 65.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.645 -1.284 . . . . 1.28 108.318 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 66.4 49.8 1.37 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.357 0.598 . . . . 1.5 110.138 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.445 ' O ' ' CB ' ' A' ' 8' ' ' SER . 86.1 mt -127.77 141.39 40.94 Favored Pre-proline 0 N--CA 1.503 2.215 0 N-CA-C 108.677 -0.86 . . . . 1.37 108.677 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -44.37 128.42 8.01 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.94 1.76 . . . . 0.76 112.039 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.8 141.51 6.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.875 -1.141 . . . . 1.19 111.471 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.2 mt -123.76 142.3 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.069 -1.456 . . . . 1.31 107.069 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 18.2 m -126.01 -12.03 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 120.952 -1.092 . . . . 1.38 111.382 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -106.11 23.06 29.95 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.014 -1.234 . . . . 1.03 110.014 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.441 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 2.8 p -44.91 -43.58 9.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -1.129 . . . . 1.38 110.083 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.76 -55.38 4.11 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 119.964 -1.112 . . . . 1.17 111.881 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 35.1 m -153.04 36.08 0.48 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.56 -1.553 . . . . 2.07 111.479 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.5 t -72.39 -40.15 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.914 -1.116 . . . . 1.35 108.53 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 38.3 p -52.98 -25.49 12.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.57 -0.706 . . . . 1.49 110.233 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.7 m -77.45 -30.91 53.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.037 -1.039 . . . . 2.16 110.551 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -93.33 -9.29 39.4 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.969 -1.082 . . . . 2.89 111.127 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.8 t -105.88 134.77 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.13 -0.981 . . . . 1.33 111.077 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -111.2 154.89 23.75 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.146 -1.427 . . . . 2.73 107.146 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 57.8 t-20 -59.87 138.9 57.69 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.781 -1.199 . . . . 2.7 109.728 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 7.7 t0 80.76 6.47 1.43 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.015 0.436 . . . . 2.38 110.172 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -71.97 128.96 37.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.029 -1.045 . . . . 2.09 109.059 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -79.45 114.78 18.65 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.914 -1.143 . . . . 1.45 107.914 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 75.1 mt -127.04 150.56 49.39 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.526 -0.734 . . . . 1.31 110.508 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.3 mt -116.35 128.94 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 106.043 -1.836 . . . . 1.29 106.043 177.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 31.5 tp -99.98 118.85 37.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.794 -1.191 . . . . 1.31 108.194 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 223' ' ' VAL . 20.7 t0 -80.66 -39.94 26.41 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.889 -1.132 . . . . 2.31 108.275 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 43.13 19.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.533 0.682 . . . . 1.19 109.377 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.4 t -134.32 -42.99 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.356 -1.35 . . . . 1.45 107.356 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -100.03 2.99 43.89 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.293 -1.373 . . . . 3.13 107.293 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.431 ' OD1' ' CB ' ' A' ' 3' ' ' SER . 9.8 t-20 59.96 48.5 8.69 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.506 -0.553 . . . . 2.2 109.506 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -142.0 150.37 41.24 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.158 -0.964 . . . . 2.32 110.29 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.4 t -119.96 128.75 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.84 -1.17 . . . . 1.4 107.84 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -104.96 120.05 40.5 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.285 -0.884 . . . . 1.29 108.913 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.4 t -100.28 114.7 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.503 -0.748 . . . . 1.38 110.194 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 50.96 69.11 2.78 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.272 -0.892 . . . . 2.33 110.819 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -90.43 144.16 3.87 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.298 2.665 . . . . 0.95 112.135 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 5.2 m -68.59 164.16 22.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 2.31 110.14 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -59.96 -36.74 77.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.532 -0.73 . . . . 3.45 110.051 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.03 -39.56 86.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 2.89 109.466 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.8 t -70.67 -36.09 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.014 -1.054 . . . . 1.73 109.451 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.117 -0.989 . . . . 1.57 109.774 179.605 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.564 0.697 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 19.0 t80 -152.64 151.4 30.55 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . 0.466 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 12.9 pt20 -145.58 155.04 42.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.995 -1.065 . . . . 0.0 110.708 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' B' ' 305' ' ' GLU . 12.5 tm0? -149.58 145.34 26.75 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . 0.506 ' O ' ' NE2' ' B' ' 304' ' ' GLN . 39.2 mp0 -109.09 131.8 54.72 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.067 -1.02 . . . . 0.0 110.46 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.07 119.12 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-O 122.077 0.941 . . . . 0.0 112.452 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 35.6 m -77.3 104.65 7.93 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.99 0.9 . . . . 0.0 111.024 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.8 mt -53.03 123.87 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.318 1.056 . . . . 0.0 110.729 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 71.9 p -111.37 20.11 17.59 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.257 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.14 120.39 80.01 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.831 -1.168 . . . . 0.0 109.682 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -49.57 -21.5 5.34 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 CA-C-N 120.137 1.084 . . . . 0.0 113.069 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -120.74 13.7 11.6 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.46 -0.775 . . . . 0.0 109.775 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.34 -178.6 37.83 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.496 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -84.42 91.06 7.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.111 -1.229 . . . . 0.0 110.191 -178.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -95.35 -160.35 0.78 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.673 -1.267 . . . . 0.0 109.995 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 5.3 m -59.61 -40.6 88.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.847 -1.158 . . . . 0.0 112.492 -175.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.468 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.2 tpt180 -62.75 -61.74 6.96 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 120.329 -1.482 . . . . 0.0 112.069 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.05 -30.32 93.0 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 CA-C-N 120.151 1.09 . . . . 0.0 111.824 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.05 -50.53 73.36 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.55 -39.32 61.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.344 -0.848 . . . . 0.0 109.431 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -68.99 -43.83 74.09 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.998 -1.064 . . . . 0.0 108.342 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -60.04 -52.27 66.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.439 -0.788 . . . . 0.0 110.984 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 72.1 t -68.42 -28.92 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.728 -1.232 . . . . 0.0 110.7 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -61.77 -45.8 92.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.109 -0.994 . . . . 0.0 110.252 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -69.97 -40.05 75.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.987 -1.07 . . . . 0.0 111.417 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . 0.44 ' C ' ' H ' ' B' ' 328' ' ' GLY . . . -61.53 -52.8 62.97 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.469 -1.394 . . . . 0.0 110.26 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -53.34 -11.23 0.28 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.169 -0.957 . . . . 0.0 109.648 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' B' ' 326' ' ' ALA . . . -75.93 -25.62 66.49 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -105.05 141.1 37.21 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.629 -0.924 . . . . 0.0 108.798 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 89.7 m -89.94 -10.51 44.84 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.941 -1.099 . . . . 0.0 109.871 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 331' ' ' SER . . . . . 0.611 ' HG ' ' H ' ' B' ' 369' ' ' ASP . 75.6 m -61.49 149.62 38.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.705 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -67.67 132.77 48.11 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.0 mt -133.33 134.17 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.653 -0.654 . . . . 0.0 109.564 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 51.5 m -131.68 155.04 48.33 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 75.9 t -117.41 140.02 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 70.2 m -130.47 122.25 27.34 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.217 -0.927 . . . . 0.0 109.22 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 1.8 m -140.21 120.22 13.65 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 122.054 0.93 . . . . 0.0 110.657 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 47.56 57.8 5.56 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 75.28 -11.55 8.58 Favored Glycine 0 N--CA 1.498 2.787 0 O-C-N 120.19 -1.569 . . . . 0.0 112.52 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -114.43 125.1 53.45 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 118.923 1.361 . . . . 0.0 109.289 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 51.8 m -126.56 148.32 49.76 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.616 0.722 . . . . 0.0 110.196 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.77 167.44 22.58 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.515 0.674 . . . . 0.0 109.955 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 343' ' ' SER . . . . . 0.459 ' HG ' ' HZ2' ' B' ' 349' ' ' LYS . 19.8 m -87.09 139.05 30.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.43 -0.794 . . . . 0.0 109.595 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.461 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -78.7 -14.27 59.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.001 -1.062 . . . . 0.0 109.195 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -86.81 18.19 3.6 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.461 ' H ' ' C ' ' B' ' 344' ' ' ALA . 61.2 m -145.27 93.23 2.35 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.601 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . 0.507 ' O ' ' NE2' ' B' ' 351' ' ' GLN . 13.4 tp -55.74 -36.66 67.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -58.69 -52.52 65.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 110.165 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.459 ' HZ2' ' HG ' ' B' ' 343' ' ' SER . 56.4 mtpt -68.68 -21.11 64.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.992 -1.067 . . . . 0.0 110.987 -177.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' B' ' 352' ' ' THR . 90.2 mt -69.94 -52.16 26.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.532 -1.355 . . . . 0.0 108.523 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' B' ' 347' ' ' LEU . 0.1 OUTLIER -39.21 -18.85 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.817 -0.552 . . . . 0.0 111.07 -178.301 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.564 ' N ' ' O ' ' B' ' 350' ' ' LEU . 71.1 p -85.92 -11.12 53.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.225 -1.547 . . . . 0.0 110.647 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 42.3 mt -94.82 116.95 29.36 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.931 -1.106 . . . . 0.0 109.247 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.94 94.23 0.98 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 24.1 mt -103.31 94.58 5.58 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.453 -1.028 . . . . 0.0 108.947 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 43.3 p -93.3 161.01 14.57 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.101 -0.999 . . . . 0.0 110.427 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -54.22 119.36 5.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.551 -0.718 . . . . 0.0 110.225 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 98.74 4.65 56.89 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.036 -1.625 . . . . 0.0 109.036 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.9 m -84.2 112.64 20.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.406 -1.055 . . . . 0.0 110.574 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 19.3 t -78.44 116.62 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 122.081 0.943 . . . . 0.0 109.939 -177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 17.3 m -110.38 177.5 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -178.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 58.5 m -131.35 130.01 42.12 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 78.3 mt -102.82 115.39 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 73.3 m -117.28 130.79 56.78 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.558 -0.714 . . . . 0.0 109.13 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.89 152.27 39.98 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.171 -0.956 . . . . 0.0 110.363 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . 0.436 ' OE2' ' OE2' ' B' ' 370' ' ' GLU . 9.9 tp10 -143.02 120.25 11.51 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.16 -163.88 36.78 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.466 -1.826 . . . . 0.0 111.947 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -59.2 -49.95 75.88 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 115.029 -0.586 . . . . 0.0 112.006 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.611 ' H ' ' HG ' ' B' ' 331' ' ' SER . 92.0 m-20 -105.77 10.74 32.58 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.979 -1.076 . . . . 0.0 111.066 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.436 ' OE2' ' OE2' ' B' ' 366' ' ' GLU . 14.7 pt-20 -40.98 -30.6 0.14 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.167 -0.958 . . . . 0.0 110.88 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -69.58 -40.46 76.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.06 -1.025 . . . . 0.0 109.204 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -72.16 -55.11 7.83 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 108.983 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -41.83 -35.63 0.87 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.694 -0.629 . . . . 0.0 111.771 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 62.2 t -79.93 -32.44 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.541 -1.35 . . . . 0.0 109.68 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.3 -60.05 3.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.978 -1.076 . . . . 0.0 111.939 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -73.31 -40.85 64.17 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.483 -1.386 . . . . 0.0 112.66 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.99 -40.05 87.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.528 -1.357 . . . . 0.0 109.042 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 54.5 t -61.08 -47.65 92.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.132 -0.98 . . . . 0.0 109.831 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -69.54 -55.75 9.27 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.728 -1.232 . . . . 0.0 108.154 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . 0.476 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 60.7 tp -53.04 -34.08 54.83 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.504 -0.747 . . . . 0.0 109.7 -178.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 39.5 ttm -75.44 -38.54 59.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.945 -1.097 . . . . 0.0 108.55 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.17 -5.42 51.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.685 -0.634 . . . . 0.0 110.496 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -110.45 4.54 20.62 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.085 -1.009 . . . . 0.0 110.812 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . 0.476 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 26.3 mt -72.2 121.97 20.25 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.34 -1.475 . . . . 0.0 109.947 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.989 -1.005 . . . . 0.0 108.942 179.152 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.6 mtm . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.076 -0.712 . . . . 3.19 109.076 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.7 mt -110.45 122.32 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.414 -0.804 . . . . 1.71 108.958 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.6 m -139.26 146.64 40.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.416 -0.802 . . . . 1.66 109.104 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.68 -162.79 9.25 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 108.719 -1.752 . . . . 1.05 108.719 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.6 mt -89.81 -13.71 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.863 -1.375 . . . . 1.59 110.302 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.3 tp 55.8 102.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 1.47 108.88 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.83 -23.12 17.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.0 . . . . 1.39 109.593 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 16.0 t -147.78 130.55 7.89 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.069 -1.019 . . . . 2.09 109.739 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.34 144.42 16.24 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.13 1.887 . . . . 0.91 112.902 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.28 167.27 16.05 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.745 -1.342 . . . . 0.92 109.745 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.0 mt -123.66 130.42 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.088 -1.243 . . . . 1.35 109.601 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.9 150.07 49.2 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.202 -0.936 . . . . 1.14 110.619 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.1 m-85 -126.29 129.97 49.94 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.793 -1.188 . . . . 0.7 107.793 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.04 178.94 48.59 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 118.354 -1.879 . . . . 0.58 110.969 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -78.87 158.46 28.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.764 -0.845 . . . . 2.63 109.195 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.17 131.55 53.29 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.559 -0.713 . . . . 1.27 110.485 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.8 tp -99.75 136.31 39.86 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.593 -1.262 . . . . 1.41 107.593 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.4 tp -115.84 119.96 37.7 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.309 -0.869 . . . . 1.49 109.613 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.8 mt -90.69 105.79 18.06 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.767 -0.583 . . . . 1.52 109.803 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -101.48 136.61 41.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.368 -0.833 . . . . 3.17 109.252 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -127.34 122.19 33.08 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.799 -0.815 . . . . 3.0 108.799 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -71.19 148.25 47.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 2.77 109.904 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -65.18 141.86 58.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 2.94 109.489 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -82.02 130.12 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 1.46 109.176 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.6 t -93.9 124.06 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.255 -0.903 . . . . 1.7 109.868 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.5 mt -103.74 138.46 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.436 -0.79 . . . . 1.54 109.119 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -97.22 117.73 32.09 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.152 -0.967 . . . . 1.81 109.208 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -86.92 -2.3 58.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.367 -0.833 . . . . 3.23 109.372 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -64.34 141.3 58.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 3.29 109.68 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -87.73 150.14 23.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.913 . . . . 2.8 108.997 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -92.95 165.64 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.365 -0.834 . . . . 1.43 110.475 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.4 p -99.15 171.22 8.15 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.349 -0.982 . . . . 1.54 108.349 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.19 -47.93 80.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 1.6 109.089 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -55.63 -32.3 63.04 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.0 -1.062 . . . . 2.56 109.656 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -82.16 -9.91 59.35 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.287 -0.883 . . . . 2.36 110.246 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.63 -53.31 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.506 -1.371 . . . . 1.43 109.499 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.78 -40.05 95.73 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.023 -1.048 . . . . 1.77 110.006 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -69.98 -39.96 75.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.036 -1.04 . . . . 3.32 110.463 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -67.11 -40.05 86.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.006 -1.058 . . . . 1.51 110.069 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.99 -43.19 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.712 -1.242 . . . . 1.41 108.361 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -59.55 -37.1 77.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 1.81 108.895 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -60.04 -43.14 95.55 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.908 -1.145 . . . . 3.26 107.908 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -62.24 -49.78 74.34 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.449 -0.782 . . . . 0.81 109.409 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.5 tp -59.91 -48.4 81.87 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.397 -0.814 . . . . 1.59 109.024 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.5 t -62.21 -43.32 99.1 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.995 -1.065 . . . . 1.38 108.735 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.29 -45.42 96.02 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.732 -1.747 . . . . 0.87 108.732 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -67.48 -32.67 73.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.396 -1.061 . . . . 3.62 108.423 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.424 ' O ' ' OG ' ' A' ' 51' ' ' SER . . . -59.29 -40.03 84.88 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.643 -0.873 . . . . 1.43 108.643 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 50' ' ' ALA . 27.9 ttpt -67.25 -74.58 0.11 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.417 -0.956 . . . . 3.08 108.417 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.05 -33.22 0.08 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.203 -0.936 . . . . 1.33 111.489 -178.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.702 ' HG ' ' H ' ' A' ' 52' ' ' ALA . 83.3 p -60.06 -54.53 44.89 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.563 -1.336 . . . . 1.85 108.697 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.702 ' H ' ' HG ' ' A' ' 51' ' ' SER . . . -70.02 -40.2 75.36 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.372 -0.83 . . . . 1.35 111.157 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -65.16 -40.13 93.89 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.73 -1.231 . . . . 2.34 110.735 -178.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.28 -39.97 93.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.857 -1.152 . . . . 2.2 109.018 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -60.35 -37.13 79.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.385 -0.822 . . . . 1.35 109.419 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.5 m -65.41 -43.23 91.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.831 -1.168 . . . . 1.34 109.007 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.648 ' CD1' HH22 ' A' ' 136' ' ' ARG . 78.9 mt -62.04 -40.01 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.504 -0.925 . . . . 1.26 108.504 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -55.57 -50.22 70.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.4 -0.813 . . . . 1.7 109.527 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.416 ' H ' ' HG1' ' A' ' 59' ' ' THR . 4.0 m -57.99 -33.0 68.44 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.159 -0.963 . . . . 1.35 110.19 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -68.79 -37.87 79.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 2.08 109.145 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.45 -45.29 76.43 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.702 -0.624 . . . . 1.21 110.393 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.72 -50.78 64.06 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.861 -1.162 . . . . 0.75 110.272 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.07 -42.09 73.25 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.12 -1.223 . . . . 1.59 110.379 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.2 m -69.96 -59.11 3.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.03 -1.043 . . . . 1.41 111.729 -178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -97.07 -52.25 3.92 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.959 -1.088 . . . . 0.79 111.103 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.67 -165.38 26.49 Favored Glycine 0 N--CA 1.5 2.905 0 C-N-CA 119.706 -1.235 . . . . 1.22 110.955 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -70.75 -22.62 62.39 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.89 -0.771 . . . . 5.81 110.354 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.458 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.1 tp10 -62.05 -37.64 85.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 3.37 110.904 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -99.67 -18.02 17.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.184 -0.947 . . . . 2.37 110.12 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -69.76 -39.93 76.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.119 -0.988 . . . . 1.65 110.423 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.04 -30.92 71.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.382 -0.824 . . . . 1.42 109.834 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.0 -41.46 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.036 -1.04 . . . . 1.43 109.085 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -62.61 -40.45 96.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.065 -1.022 . . . . 1.08 109.966 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -60.78 -39.92 90.63 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.188 -1.005 . . . . 1.37 109.335 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.18 -41.26 98.43 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.671 -1.772 . . . . 0.67 108.671 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.7 m170 -69.77 -42.44 73.82 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.376 -1.073 . . . . 1.99 108.935 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.4 mt -70.14 -46.19 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.285 -0.884 . . . . 1.22 109.359 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.1 ttp -61.16 -40.93 95.71 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.087 -1.008 . . . . 2.11 110.05 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.418 ' CD1' ' CE2' ' B' ' 348' ' ' PHE . 59.0 tp -66.47 -40.05 89.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.164 -0.96 . . . . 1.33 109.444 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.2 tp -66.53 -39.88 88.83 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.502 -0.749 . . . . 1.29 110.012 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -79.99 -1.56 40.15 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.186 -0.946 . . . . 1.47 110.192 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -47.88 130.26 14.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.032 . . . . 1.47 109.904 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.28 -16.38 60.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.662 -0.649 . . . . 1.78 110.198 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.26 -35.18 73.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.941 -1.099 . . . . 2.53 108.512 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.12 -40.01 68.44 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.462 0.649 . . . . 1.36 109.275 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.04 -49.96 75.61 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.559 -0.713 . . . . 1.42 109.993 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -70.65 -40.31 73.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.257 -0.902 . . . . 2.27 110.839 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -69.74 -40.02 76.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.059 -1.025 . . . . 1.57 110.567 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.8 mt -68.6 -45.8 81.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.112 -0.992 . . . . 1.19 108.944 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.26 -39.1 80.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.528 -0.733 . . . . 1.39 109.963 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.07 -47.15 87.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.195 -0.94 . . . . 1.39 110.452 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 96' ' ' LYS . 85.7 mt -62.64 -45.77 91.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.896 -1.127 . . . . 1.5 109.43 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.79 -50.05 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 1.29 109.135 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -70.03 -40.56 75.11 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.707 -0.797 . . . . 2.64 110.338 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -81.3 -50.16 9.85 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.997 -1.064 . . . . 1.65 111.716 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 92' ' ' LEU . 19.7 mmmt -90.38 -1.83 57.93 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.933 -1.104 . . . . 2.5 111.64 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.3 m80 55.88 35.3 25.19 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.889 -1.132 . . . . 1.88 109.529 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.5 mtt -89.38 168.57 12.12 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.629 -0.669 . . . . 1.71 110.147 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.9 p -80.72 158.51 25.52 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.42 -0.8 . . . . 1.61 109.26 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.89 -40.06 87.64 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.243 -0.91 . . . . 1.33 109.662 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -67.87 -39.9 83.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.277 -0.89 . . . . 2.07 109.616 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.99 -42.52 21.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 1.37 109.897 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.53 -50.46 71.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 1.14 109.571 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.42 -33.41 72.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.228 -0.92 . . . . 1.26 109.509 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.546 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 86.2 t60 -60.06 -46.12 90.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.264 -0.897 . . . . 2.02 109.734 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -60.36 -40.0 89.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.353 -0.842 . . . . 1.33 111.007 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 41.9 t -63.28 -62.84 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.959 -1.088 . . . . 1.3 111.435 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.5 mm -63.9 -41.67 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.875 -1.141 . . . . 1.32 109.419 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.546 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 80.8 tt0 -63.53 -38.7 92.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 2.44 108.927 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.04 -46.44 94.18 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.712 -0.955 . . . . 0.99 110.712 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.6 mm100 -68.54 -44.04 75.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.746 -1.443 . . . . 1.97 109.67 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.43 78.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.092 -1.005 . . . . 1.43 109.055 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 29.5 t -60.02 -40.42 89.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.182 -0.949 . . . . 2.12 109.144 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.48 97.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 1.64 109.094 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.6 mt -67.82 -41.87 82.38 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.151 -0.968 . . . . 1.93 109.044 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.58 -33.62 70.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.781 -1.199 . . . . 2.2 109.774 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -57.81 -22.15 45.88 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.025 -1.047 . . . . 2.12 108.765 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 48.8 mt -63.28 139.91 58.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 2.34 108.787 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -84.41 -16.8 41.42 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.142 -0.974 . . . . 3.23 110.195 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -66.4 130.02 41.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.169 -0.957 . . . . 2.49 110.124 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 8.0 pm0 -70.13 -30.04 67.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.454 -0.779 . . . . 3.95 110.245 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.491 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.8 t80 -67.58 -34.16 76.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.406 -0.809 . . . . 2.25 110.194 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.4 mt -80.15 -26.67 39.26 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.103 -0.998 . . . . 2.27 108.882 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -61.95 -47.05 86.62 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.212 -0.93 . . . . 3.31 108.604 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 121' ' ' GLU . 7.6 mp0 -65.66 -36.69 84.39 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.264 -0.897 . . . . 2.73 108.77 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.552 ' CZ ' ' NE2' ' B' ' 351' ' ' GLN . 0.2 OUTLIER -59.69 -40.03 86.51 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.855 -1.165 . . . . 3.2 107.855 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.27 -23.4 67.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.425 -0.797 . . . . 1.66 109.008 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.44 -39.96 89.18 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.655 -0.869 . . . . 1.67 108.655 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -64.18 -40.67 96.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.385 -0.822 . . . . 1.55 109.233 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 77.3 t -69.89 -40.15 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.487 -0.931 . . . . 1.32 108.487 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.477 HH11 ' HG2' ' A' ' 131' ' ' ARG . 11.6 ttt-85 -59.98 -40.03 87.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.397 -0.814 . . . . 3.58 108.94 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -60.44 -39.93 89.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.534 -0.729 . . . . 1.46 110.06 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.99 -43.33 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.266 -0.896 . . . . 1.22 110.861 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.71 -33.86 71.82 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.754 -1.212 . . . . 0.61 110.168 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -59.98 -48.6 81.05 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -1.174 . . . . 3.1 110.022 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.648 HH22 ' CD1' ' A' ' 57' ' ' ILE . 67.0 mtp180 -68.32 -32.22 72.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.906 -1.121 . . . . 3.71 109.602 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.88 -45.54 92.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.26 -0.9 . . . . 1.87 108.647 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.54 -40.26 90.91 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.395 -0.816 . . . . 1.29 109.062 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.456 HH11 ' HG2' ' A' ' 139' ' ' ARG . 43.4 mtt-85 -69.91 -40.09 75.8 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.426 -0.953 . . . . 3.05 108.426 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -60.5 -40.04 89.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.848 -0.533 . . . . 1.26 110.759 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.404 HD11 HG23 ' A' ' 141' ' ' ILE . 96.9 mt -73.15 -42.09 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.788 -1.195 . . . . 1.34 108.313 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.8 mt -70.06 -38.4 75.75 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.235 0.541 . . . . 1.6 109.807 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.16 43.78 8.5 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.963 -1.655 . . . . 0.96 108.963 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 tp -75.68 152.78 37.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.58 -0.953 . . . . 1.67 109.652 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -63.91 140.97 58.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 4.96 109.265 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.4 mt -119.83 130.08 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 122.151 0.977 . . . . 1.68 109.77 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.1 mt -59.39 -47.63 89.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 115.657 -0.702 . . . . 2.14 110.922 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 31.2 t0 66.2 99.25 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.652 -0.87 . . . . 1.5 108.652 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 25.1 mt -68.83 -3.78 13.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 1.39 109.709 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 59.3 m -83.45 -13.4 54.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.096 -1.003 . . . . 1.83 108.891 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.17 20.28 1.98 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.459 -0.776 . . . . 1.46 111.08 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 40.9 mm -90.05 121.18 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.598 -1.313 . . . . 1.42 108.708 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -101.32 -9.0 21.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.263 -0.898 . . . . 2.94 110.473 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -125.45 149.78 47.91 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.34 -0.85 . . . . 1.52 110.434 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.87 135.36 56.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.346 -0.847 . . . . 1.58 109.14 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.5 m -152.34 166.37 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.576 -0.703 . . . . 1.32 109.872 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 94.1 mt -95.16 149.57 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.293 -1.743 . . . . 1.27 106.293 177.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 38.3 tp -100.01 117.88 35.21 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.985 -1.072 . . . . 1.41 110.854 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 84.3 t -121.54 129.44 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.408 -0.96 . . . . 1.23 108.408 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.09 165.02 32.57 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.109 -0.994 . . . . 1.32 109.091 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.45 -38.28 74.46 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.178 -1.576 . . . . 1.49 107.841 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -170.68 145.28 2.47 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.76 -0.83 . . . . 2.25 108.76 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.4 mt -112.17 140.22 47.05 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.248 -0.907 . . . . 1.35 109.818 -179.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.0 p -92.18 141.59 25.27 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.279 -0.888 . . . . 1.56 109.121 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -39.64 -36.5 1.15 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.208 1.938 . . . . 0.87 113.194 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.5 m -60.38 -40.03 89.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.033 -1.042 . . . . 1.36 110.242 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.59 -41.52 92.75 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.006 -1.058 . . . . 1.61 109.799 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.9 p -57.54 -32.92 67.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.192 -0.943 . . . . 1.21 111.293 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.14 -43.92 69.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.669 -1.27 . . . . 1.21 109.732 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -94.88 34.94 1.29 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.625 -0.879 . . . . 2.11 108.625 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.7 tp -107.48 138.98 42.71 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.814 -0.81 . . . . 1.29 108.814 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -86.47 103.87 15.41 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.141 -0.974 . . . . 2.81 109.539 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.85 -39.99 95.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.477 -0.764 . . . . 2.09 110.812 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -67.96 -25.92 65.68 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.994 -1.066 . . . . 2.86 111.76 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -93.37 -8.81 40.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.588 -1.32 . . . . 2.39 109.895 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.451 ' CG1' ' O ' ' A' ' 178' ' ' GLY . 81.8 t -97.04 110.38 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.101 -0.999 . . . . 1.27 108.792 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.0 mt -77.77 2.91 15.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.222 -0.924 . . . . 2.17 110.334 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.451 ' O ' ' CG1' ' A' ' 176' ' ' VAL . . . 165.6 177.04 37.6 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.198 -1.561 . . . . 0.52 109.198 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -132.96 129.98 38.96 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.425 -1.044 . . . . 0.55 108.521 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.6 mt -134.47 127.7 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.21 -0.931 . . . . 1.27 109.348 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 29.1 p -149.74 160.02 43.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 1.39 110.401 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' A' ' 182' ' ' ASP . 35.1 p-10 -109.16 27.57 9.38 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.684 -0.858 . . . . 2.46 108.684 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.04 -157.18 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.197 -0.939 . . . . 1.51 111.929 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.3 -80.83 0.06 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.087 -1.205 . . . . 2.23 110.087 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.55 -134.2 2.73 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.839 -1.305 . . . . 2.23 109.839 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.456 ' C ' ' H ' ' A' ' 188' ' ' SER . 14.6 tpp180 -60.01 -40.01 87.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.404 -1.056 . . . . 6.44 110.63 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.1 p -64.97 7.79 0.15 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.065 -1.022 . . . . 4.09 111.258 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 186' ' ' ARG . 15.9 m -90.72 135.32 33.79 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.66 -1.275 . . . . 2.2 110.827 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -46.12 -52.55 11.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.448 -0.783 . . . . 1.15 109.761 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.99 -37.1 63.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.492 -0.755 . . . . 2.01 110.247 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.3 t -60.05 -45.24 93.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.111 -0.993 . . . . 1.93 111.03 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 192' ' ' ILE . 96.4 mt -60.01 -40.49 83.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.321 -0.862 . . . . 2.2 110.406 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.2 mtp -60.14 -45.78 91.9 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.069 -1.019 . . . . 1.32 110.164 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.19 -45.97 65.38 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.549 -1.344 . . . . 1.3 109.484 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -63.48 -58.06 8.23 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.057 -1.057 . . . . 3.38 110.327 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.4 m -60.27 -39.93 88.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.897 -1.127 . . . . 1.15 111.655 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.35 -22.36 62.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.834 -1.167 . . . . 1.28 109.498 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 69.99 47.82 0.57 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.38 0.609 . . . . 1.5 110.31 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.438 ' O ' ' CB ' ' A' ' 8' ' ' SER . 68.6 mt -129.16 149.96 74.09 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 107.994 -1.113 . . . . 1.37 107.994 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.07 146.14 75.85 Favored 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 122.459 2.106 . . . . 0.76 112.05 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -177.0 154.12 1.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.106 -0.996 . . . . 1.19 111.004 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.0 mt -125.67 151.11 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.45 -1.315 . . . . 1.31 107.45 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.2 m -131.06 -12.03 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 120.866 -1.146 . . . . 1.38 111.04 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.01 25.02 17.47 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.09 -1.204 . . . . 1.03 110.09 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 22.4 p -45.32 -42.83 10.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.125 -1.221 . . . . 1.38 109.903 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 94.01 -52.52 2.23 Favored Glycine 0 N--CA 1.497 2.748 0 O-C-N 121.139 -0.976 . . . . 1.17 111.447 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 80.6 p -156.78 34.7 0.3 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.579 -1.542 . . . . 2.07 111.332 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 23.0 t -75.76 -39.42 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.061 -1.024 . . . . 1.35 108.904 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 72.7 p -56.72 -27.2 58.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 1.49 110.674 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.3 m -80.25 -24.62 39.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.835 -1.166 . . . . 2.16 110.308 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -95.55 -8.66 34.47 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.152 -0.967 . . . . 2.89 110.444 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 56.0 t -102.35 136.17 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.226 -0.921 . . . . 1.33 109.943 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.48 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 2.2 mptp? -116.28 152.92 32.87 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.567 -1.271 . . . . 2.73 107.567 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.455 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 16.6 p-10 -56.29 139.46 48.15 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.999 -1.063 . . . . 2.7 110.618 -178.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.0 m-20 82.02 8.74 0.88 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.028 0.442 . . . . 2.38 110.376 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.48 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 90.6 m-20 -79.32 139.82 37.7 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.025 -1.047 . . . . 2.09 109.346 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -91.65 115.04 27.71 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.031 -1.099 . . . . 1.45 108.031 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 59.6 mt -125.42 150.27 47.43 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.651 -0.655 . . . . 1.31 110.627 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.3 mt -115.38 127.67 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.281 -1.377 . . . . 1.29 107.281 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 54.7 tp -100.7 119.99 39.41 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.936 -1.102 . . . . 1.31 108.702 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 223' ' ' VAL . 83.0 m-20 -78.88 -43.1 25.68 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.067 -1.02 . . . . 2.31 109.373 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 47.01 15.34 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.4 -0.963 . . . . 1.19 108.4 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 221' ' ' ASP . 53.2 t -131.5 -38.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.287 -1.375 . . . . 1.45 107.287 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -105.69 0.54 26.39 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.682 -1.229 . . . . 3.13 107.682 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 60.19 44.28 12.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.814 -0.554 . . . . 2.2 110.357 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -141.81 151.37 42.73 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.07 -1.019 . . . . 2.32 109.762 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.5 t -119.48 130.08 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.519 -0.919 . . . . 1.4 108.519 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -101.7 124.01 46.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.52 -0.737 . . . . 1.29 109.25 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 18.0 t -101.05 113.9 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.637 -0.665 . . . . 1.38 109.903 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 50.64 67.66 4.13 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.194 -0.941 . . . . 2.33 111.208 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -90.12 148.68 4.63 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 123.048 2.499 . . . . 0.95 112.346 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 71.5 p -72.45 166.26 22.95 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.099 -1.001 . . . . 2.31 109.897 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -59.94 -35.47 74.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 3.45 109.736 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.95 -39.99 87.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 2.89 109.686 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.85 -39.97 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.142 -0.974 . . . . 1.73 109.144 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 1.57 109.693 179.985 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 6.1 ttt . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.367 0.604 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -153.99 151.56 29.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.411 -0.806 . . . . 0.0 109.17 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -149.56 159.93 43.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.076 -1.015 . . . . 0.0 110.479 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -154.72 150.97 28.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . 0.486 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 2.0 pm0 -116.45 133.89 55.49 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.22 -0.925 . . . . 0.0 110.325 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.48 128.11 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 CA-C-O 122.351 1.072 . . . . 0.0 112.546 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 86.4 m -78.1 103.31 7.96 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.877 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 88.4 mt -51.19 122.65 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 122.446 1.117 . . . . 0.0 109.815 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 54.2 p -103.23 21.09 16.48 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.202 -178.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -86.6 115.29 61.74 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.062 -1.024 . . . . 0.0 108.938 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -68.13 -3.29 10.42 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 CA-C-N 120.309 1.146 . . . . 0.0 111.511 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -111.31 -0.64 16.32 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.91 172.82 26.91 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 107.684 -2.167 . . . . 0.0 107.684 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.491 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -85.58 94.93 9.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.862 -1.375 . . . . 0.0 108.241 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -93.75 -162.79 0.97 Allowed 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.991 -1.068 . . . . 0.0 110.698 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.0 m -56.78 -42.5 79.56 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.098 -1.001 . . . . 0.0 112.514 -176.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.484 HH11 ' HG2' ' B' ' 317' ' ' ARG . 0.9 OUTLIER -61.37 -60.0 11.86 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 120.639 -1.288 . . . . 0.0 112.241 -178.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -60.78 -32.04 92.49 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 120.295 1.141 . . . . 0.0 111.811 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.44 73.74 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.25 -40.65 61.97 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.443 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -70.19 -40.73 74.46 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.043 -1.036 . . . . 0.0 108.768 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -60.26 -51.78 68.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.425 -0.797 . . . . 0.0 110.452 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 87.2 t -69.91 -30.63 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.758 -1.214 . . . . 0.0 110.35 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -60.08 -45.6 92.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 108.999 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -67.19 -40.05 86.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.84 . . . . 0.0 110.528 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' B' ' 328' ' ' GLY . . . -64.91 -53.61 43.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.77 -1.206 . . . . 0.0 111.033 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -52.96 -10.05 0.16 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.121 -0.987 . . . . 0.0 110.458 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' B' ' 326' ' ' ALA . . . -79.23 -21.06 68.27 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -106.23 140.18 39.57 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.55 -0.971 . . . . 0.0 109.26 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 17.2 m -90.89 -11.08 40.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.045 -1.034 . . . . 0.0 110.342 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 331' ' ' SER . . . . . 0.404 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 84.4 p -62.93 153.66 32.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.907 -1.12 . . . . 0.0 109.712 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -69.44 133.14 47.39 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.5 mt -134.47 133.77 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.674 -0.641 . . . . 0.0 109.99 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 85.9 m -131.17 152.01 50.88 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 67.3 t -123.56 117.62 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 49.5 m -106.32 132.72 52.03 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.088 -1.007 . . . . 0.0 109.333 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 82.1 p -140.01 115.46 9.98 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.924 0.869 . . . . 0.0 110.798 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 24.0 m120 46.96 49.8 14.37 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 176.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.97 -12.96 65.92 Favored Glycine 0 N--CA 1.505 3.244 0 O-C-N 120.155 -1.59 . . . . 0.0 113.327 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -118.5 130.06 55.72 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-N 119.579 1.689 . . . . 0.0 109.503 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 38.9 m -128.75 150.4 50.3 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.871 0.843 . . . . 0.0 110.954 -178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -146.45 169.28 19.23 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.646 0.736 . . . . 0.0 110.293 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 60.8 m -88.17 139.57 30.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.637 -0.665 . . . . 0.0 109.903 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.52 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -79.78 -15.8 56.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.938 -1.101 . . . . 0.0 109.852 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -85.38 20.61 1.96 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.559 ' CB ' ' HZ3' ' B' ' 349' ' ' LYS . 17.3 t -147.97 95.95 2.57 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.31 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 61.2 tp -59.92 -34.7 73.57 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . 0.418 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 59.7 m-85 -54.56 -51.85 63.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.63 -0.669 . . . . 0.0 110.994 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.559 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 34.1 mtmm -80.89 -12.73 59.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.731 -1.23 . . . . 0.0 111.207 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 27.4 mt -69.48 -49.78 51.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.48 -1.387 . . . . 0.0 109.214 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.552 ' NE2' ' CZ ' ' A' ' 126' ' ' ARG . 2.0 mm100 -50.0 -20.1 0.86 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.144 -0.972 . . . . 0.0 111.451 -177.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 74.6 p -76.05 -10.02 59.08 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.233 -1.542 . . . . 0.0 109.242 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 53.0 mt -95.43 118.08 31.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.353 -0.842 . . . . 0.0 109.323 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.49 93.07 1.0 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 38.4 mt -97.51 85.49 3.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.232 -1.158 . . . . 0.0 108.344 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 356' ' ' THR . . . . . 0.414 ' C ' ' HG1' ' B' ' 359' ' ' THR . 31.9 p -93.64 179.96 5.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.195 -0.941 . . . . 0.0 110.81 -178.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . 0.52 ' O ' ' N ' ' B' ' 359' ' ' THR . 62.0 tt0 -49.5 156.91 0.57 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 122.371 1.081 . . . . 0.0 111.412 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.23 23.62 0.02 OUTLIER Glycine 0 N--CA 1.496 2.65 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.226 177.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 359' ' ' THR . . . . . 0.52 ' N ' ' O ' ' B' ' 357' ' ' GLN . 27.6 m -83.75 110.04 18.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.803 -1.41 . . . . 0.0 109.858 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 6.8 t -77.28 113.73 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 122.296 1.046 . . . . 0.0 109.833 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.2 m -109.67 176.19 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 56.2 m -131.96 129.95 40.87 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.5 mt -107.84 121.74 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 24.2 p -122.02 133.19 54.8 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.05 149.85 38.77 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.084 -1.01 . . . . 0.0 109.83 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -144.51 121.96 11.69 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.435 -0.79 . . . . 0.0 109.094 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.527 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.05 -152.95 24.28 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.125 -1.512 . . . . 0.0 111.724 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -58.82 -52.82 64.1 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.404 ' H ' ' HB3' ' B' ' 331' ' ' SER . 70.7 m-20 -109.96 12.71 23.65 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.015 -1.053 . . . . 0.0 111.32 -177.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.527 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.8 pt-20 -41.95 -35.56 0.89 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.286 -0.883 . . . . 0.0 111.362 -178.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -69.55 -41.0 76.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.574 -1.329 . . . . 0.0 109.991 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -71.76 -54.3 10.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.966 -1.084 . . . . 0.0 109.413 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.39 -35.27 1.5 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.6 -0.687 . . . . 0.0 111.934 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . 0.457 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 58.7 t -80.19 -33.21 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.492 -1.38 . . . . 0.0 109.297 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -70.0 -40.65 75.16 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.224 -0.922 . . . . 0.0 112.495 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -84.7 -44.65 13.19 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.438 -1.413 . . . . 0.0 110.687 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 90.9 mt -59.92 -39.34 85.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.099 -1.0 . . . . 0.0 109.159 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 49.3 t -64.36 -43.74 97.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.28 -0.888 . . . . 0.0 109.784 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -79.93 -9.86 59.72 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.054 -1.029 . . . . 0.0 109.457 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 43.0 tp -82.34 -24.88 34.32 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.1 tpp -82.79 -25.01 33.14 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -85.03 -11.11 56.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.687 -0.633 . . . . 0.0 110.202 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -107.33 -0.29 22.57 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.233 -0.917 . . . . 0.0 110.835 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 34.4 mt -94.95 119.3 33.24 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.76 -1.212 . . . . 0.0 110.084 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 1.3 pm0 . . . . . 0 N--CA 1.499 2.0 0 CA-C-O 117.94 -1.028 . . . . 0.0 109.479 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.9 mtm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.465 -0.569 . . . . 3.19 109.465 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 94.4 mt -110.06 126.37 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.479 -0.763 . . . . 1.71 109.625 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.5 m -136.75 134.06 36.7 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.893 -0.78 . . . . 1.66 108.893 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.461 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -105.92 -158.59 22.4 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 108.888 -1.685 . . . . 1.05 108.888 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.408 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.8 mt -91.65 -9.95 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.995 -1.297 . . . . 1.59 110.448 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.4 tp 55.01 98.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.956 -1.09 . . . . 1.47 108.773 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.75 -34.1 40.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.626 -0.672 . . . . 1.39 109.515 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 m -150.02 141.6 15.02 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.275 -0.89 . . . . 2.09 109.618 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.91 143.67 16.52 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.459 2.106 . . . . 0.91 112.488 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 165.91 -165.95 38.36 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.472 -1.451 . . . . 0.92 109.472 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.1 mt -149.2 149.97 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.169 -1.194 . . . . 1.35 108.506 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.27 144.2 19.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.945 -1.097 . . . . 1.14 110.363 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 16.3 m-85 -125.23 128.59 48.54 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.21 -1.033 . . . . 0.7 108.21 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.78 -178.84 44.63 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.717 -1.706 . . . . 0.58 110.816 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -80.19 158.14 26.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.774 -0.839 . . . . 2.63 109.542 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -105.04 131.24 52.8 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.434 -0.791 . . . . 1.27 110.671 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.6 tp -97.89 136.4 38.24 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.206 -1.405 . . . . 1.41 107.206 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 tp -120.29 124.61 46.04 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.337 -0.852 . . . . 1.49 109.407 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.8 mt -88.18 106.6 18.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.492 -0.755 . . . . 1.52 109.895 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.458 ' NZ ' ' CB ' ' A' ' 20' ' ' LYS . 7.4 mtpm? -102.23 128.78 48.61 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.744 -0.835 . . . . 3.17 108.744 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.531 ' OE1' ' NH2' ' A' ' 139' ' ' ARG . 98.6 mt-10 -126.19 137.95 53.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.312 -0.867 . . . . 3.0 109.135 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -79.15 143.56 35.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.22 -0.925 . . . . 2.77 109.035 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -61.23 140.01 58.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 2.94 109.547 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.6 mt -81.3 131.17 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.409 -0.807 . . . . 1.46 109.192 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.0 t -101.12 123.24 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.302 -0.874 . . . . 1.7 109.58 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.7 mt -98.13 142.94 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.398 -0.814 . . . . 1.54 108.938 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -91.09 122.16 33.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.019 -1.051 . . . . 1.81 109.48 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.492 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.6 mmt-85 -91.12 0.08 57.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 3.23 109.223 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.67 141.67 53.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -0.851 . . . . 3.29 109.654 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -85.78 146.8 26.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.195 -0.941 . . . . 2.8 109.281 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 pt -90.79 164.69 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 1.43 110.216 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.8 p -97.06 174.14 6.91 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.568 -0.901 . . . . 1.54 108.568 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.96 -48.58 81.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.151 -0.968 . . . . 1.6 110.032 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -54.51 -31.47 56.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.764 -1.21 . . . . 2.56 109.441 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -82.3 -9.05 59.62 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.466 -0.772 . . . . 2.36 110.276 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.2 t -68.05 -56.46 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.436 -1.415 . . . . 1.43 109.146 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.16 -39.97 88.28 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.384 -0.822 . . . . 1.77 109.739 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -67.14 -41.88 85.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.082 -1.011 . . . . 3.32 110.356 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -62.98 -40.08 96.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.904 -1.122 . . . . 1.51 110.405 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 44' ' ' LEU . 54.8 t -64.15 -48.67 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.749 -1.22 . . . . 1.41 109.197 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -61.73 -47.81 83.55 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.184 -0.947 . . . . 1.81 109.861 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.404 HH11 ' HG2' ' A' ' 42' ' ' ARG . 49.6 mtt-85 -60.11 -41.91 93.61 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.078 -1.082 . . . . 3.26 108.078 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -70.07 -39.94 75.32 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.513 -0.742 . . . . 0.81 109.344 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 40' ' ' VAL . 48.5 tp -60.05 -48.53 81.34 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.28 -1.378 . . . . 1.59 107.28 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -63.69 -39.98 95.65 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.288 -1.004 . . . . 1.38 108.288 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.26 -50.02 72.17 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 108.491 -1.844 . . . . 0.87 108.491 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -61.35 -39.78 91.85 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.709 -1.219 . . . . 3.62 107.709 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.96 87.84 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.971 -0.751 . . . . 1.43 108.971 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 33.6 ttpt -58.03 -74.99 0.05 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.021 -1.072 . . . . 3.08 108.21 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.61 -33.01 0.09 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.15 -0.969 . . . . 1.33 111.715 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.6 m -57.58 -47.54 81.82 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.138 -1.425 . . . . 1.85 108.365 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.8 -41.66 74.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.115 -0.991 . . . . 1.35 110.863 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -67.31 -39.97 85.95 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.806 -1.184 . . . . 2.34 110.163 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.47 -39.38 87.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.943 -1.098 . . . . 2.2 109.222 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -59.99 -36.54 77.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 1.35 109.942 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -63.96 -42.83 97.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.827 -1.171 . . . . 1.34 109.109 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.4 mt -61.68 -37.09 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 1.26 109.134 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -58.19 -49.98 75.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.861 . . . . 1.7 109.178 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -59.59 -34.18 72.4 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.372 -0.83 . . . . 1.35 110.709 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -69.22 -39.37 78.61 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.847 -1.158 . . . . 2.08 109.598 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.95 -42.06 99.7 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.591 -0.693 . . . . 1.21 109.971 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.1 -50.53 66.67 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.576 -1.41 . . . . 0.75 109.576 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.28 -51.77 34.12 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.011 -1.287 . . . . 1.59 109.515 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.7 m -60.45 -65.68 0.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.355 -0.841 . . . . 1.41 112.179 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.507 ' CE1' ' O ' ' A' ' 168' ' ' THR . 84.3 m-85 -96.12 -49.31 5.3 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.757 -1.215 . . . . 0.79 111.519 -177.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.03 -169.54 25.28 Favored Glycine 0 N--CA 1.503 3.142 0 C-N-CA 119.659 -1.258 . . . . 1.22 111.298 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.05 -25.23 63.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.877 -0.778 . . . . 5.81 109.991 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.517 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.1 tp10 -59.99 -34.57 73.5 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.52 -0.737 . . . . 3.37 110.267 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -100.8 -16.34 17.33 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.366 -0.833 . . . . 2.37 109.91 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -70.35 -42.03 72.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 1.65 110.501 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.68 -28.47 69.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.898 . . . . 1.42 109.846 -178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 83.7 mt -60.12 -40.06 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.129 -1.029 . . . . 1.43 108.877 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -66.56 -41.72 88.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.035 . . . . 1.08 110.498 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -60.52 -40.03 89.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.888 -1.132 . . . . 1.37 109.832 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.43 99.41 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.24 -1.544 . . . . 0.67 109.24 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 60.2 m170 -66.99 -41.1 87.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -1.158 . . . . 1.99 109.384 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.63 -46.52 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.923 . . . . 1.22 109.826 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.7 ttp -60.08 -43.95 95.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.03 -1.044 . . . . 2.11 110.207 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.4 tp -62.62 -40.03 95.67 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.256 -0.903 . . . . 1.33 109.893 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.5 tp -62.65 -39.95 95.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.27 -0.894 . . . . 1.29 110.215 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -82.75 9.47 9.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.119 -0.988 . . . . 1.47 110.069 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 48.3 t0 -54.88 133.1 47.79 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.118 -0.989 . . . . 1.47 110.445 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 95.5 mt-10 -60.26 -21.07 61.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.64 -0.662 . . . . 1.78 110.734 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.54 -34.72 72.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.667 -1.271 . . . . 2.53 109.355 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.3 mt -70.05 -39.9 75.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 1.36 109.312 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -60.08 -49.95 75.64 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.446 -0.784 . . . . 1.42 109.804 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -70.14 -41.13 74.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 2.27 110.597 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.72 -40.45 69.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.007 -1.058 . . . . 1.57 111.646 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.1 mt -69.98 -40.32 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.981 -1.074 . . . . 1.19 109.885 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.3 mt -68.99 -36.81 75.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.505 -0.747 . . . . 1.39 109.96 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.76 -49.98 75.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 1.39 111.183 -178.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.9 mt -60.55 -46.16 91.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.638 -1.289 . . . . 1.5 109.808 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.93 -50.07 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.926 . . . . 1.29 109.461 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -74.13 -42.41 60.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.645 -0.66 . . . . 2.64 111.393 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 91' ' ' ALA . 54.9 t0 -79.92 -50.06 10.99 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.901 -1.124 . . . . 1.65 112.052 -177.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -91.03 -4.18 56.59 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.964 -1.085 . . . . 2.5 111.497 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 m80 56.02 36.43 27.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.911 -1.118 . . . . 1.88 109.072 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 53.7 mtt -90.87 169.98 10.46 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.661 -0.65 . . . . 1.71 109.639 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 82.1 p -77.79 153.72 32.57 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.928 -1.138 . . . . 1.61 107.928 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.59 -36.64 73.67 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.944 -1.098 . . . . 1.33 111.028 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -68.57 -39.42 81.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.93 -1.106 . . . . 2.07 109.797 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.5 -41.48 32.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 1.37 109.806 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.38 -42.88 67.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.283 -0.886 . . . . 1.14 110.272 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.68 -40.11 96.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.103 -0.998 . . . . 1.26 109.587 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -59.9 -40.05 87.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.5 -0.75 . . . . 2.02 110.3 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 110' ' ' GLY . 86.3 tt0 -60.74 -39.97 90.66 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.138 -0.976 . . . . 1.33 109.994 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.61 -52.15 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.297 -0.877 . . . . 1.3 110.657 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.2 mm -70.06 -40.01 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.989 -1.069 . . . . 1.32 108.327 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -68.15 -32.94 73.56 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.452 -0.944 . . . . 2.44 108.452 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -65.22 -51.3 51.04 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.174 -1.17 . . . . 0.99 110.174 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -60.04 -49.3 78.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.967 -1.314 . . . . 1.97 109.248 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.67 81.4 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.311 -0.868 . . . . 1.43 109.691 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.9 p -59.3 -39.94 84.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.041 -1.037 . . . . 2.12 109.287 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.21 -40.06 94.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 1.64 108.823 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.0 mt -63.4 -42.68 98.79 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.123 -0.986 . . . . 1.93 109.096 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -56.82 -34.38 67.65 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.019 -1.051 . . . . 2.2 109.291 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.11 -23.15 65.29 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.245 -0.91 . . . . 2.12 109.267 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 55.4 mt -62.14 140.75 58.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.04 -1.037 . . . . 2.34 108.519 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -93.84 49.09 1.31 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.911 -1.118 . . . . 3.23 110.836 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -135.35 137.9 42.83 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.129 -0.982 . . . . 2.49 109.835 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 52.0 mp0 -70.12 -31.62 69.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.605 -0.684 . . . . 3.95 110.308 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.62 ' CZ ' ' NH1' ' A' ' 126' ' ' ARG . 3.5 t80 -73.8 -40.11 63.63 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.109 -0.994 . . . . 2.25 110.916 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.596 ' CD2' HH22 ' A' ' 126' ' ' ARG . 60.7 mt -69.44 -36.56 76.76 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.109 -0.995 . . . . 2.27 108.604 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.19 -36.99 85.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 3.31 110.004 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -59.82 -45.19 93.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.948 -1.095 . . . . 2.73 110.796 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.62 ' NH1' ' CZ ' ' A' ' 122' ' ' TYR . 25.6 mtm-85 -66.06 -34.51 78.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.599 -1.313 . . . . 3.2 108.756 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.27 -35.47 73.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 1.66 108.519 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.95 92.93 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.345 -0.983 . . . . 1.67 108.345 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -68.42 -39.94 81.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.407 -0.808 . . . . 1.55 109.856 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.7 t -69.38 -40.03 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.004 -1.06 . . . . 1.32 108.749 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -60.07 -38.91 84.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 3.58 108.42 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -59.97 -38.82 83.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.541 -0.724 . . . . 1.46 109.916 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.9 -42.83 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.046 -1.034 . . . . 1.22 109.679 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.87 -35.27 72.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.724 -1.35 . . . . 0.61 109.724 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.98 -48.9 79.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -1.207 . . . . 3.1 110.185 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 59.1 mtp180 -67.07 -27.89 67.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.615 -1.303 . . . . 3.71 109.914 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.8 tp -59.54 -42.03 91.4 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.232 -1.025 . . . . 1.87 108.232 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.6 -40.05 95.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 1.29 109.414 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.531 ' NH2' ' OE1' ' A' ' 21' ' ' GLU . 99.0 mtt180 -67.58 -39.94 84.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.305 -0.872 . . . . 3.05 109.965 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -69.86 -31.6 69.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 1.26 112.062 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.1 mt -68.91 -51.62 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.087 -1.633 . . . . 1.34 108.226 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 98.5 mt -70.04 -39.94 75.43 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.068 -0.653 . . . . 1.6 109.348 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.16 52.59 2.35 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.497 -1.441 . . . . 0.96 109.497 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 tp -73.84 150.03 41.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.235 -1.156 . . . . 1.67 108.493 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.65 139.56 53.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.03 -1.044 . . . . 4.96 110.051 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.2 mt -110.01 129.96 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 122.046 0.927 . . . . 1.68 109.297 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.0 mt -69.8 -40.0 78.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 115.778 -0.646 . . . . 2.14 110.166 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 39.8 t0 63.29 131.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.451 0.643 . . . . 1.5 109.361 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.3 mt -85.44 -2.62 58.31 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.706 -0.85 . . . . 1.39 108.706 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.5 p -83.95 -9.6 58.57 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.82 -0.807 . . . . 1.83 108.82 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -86.04 22.72 1.65 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.531 -0.731 . . . . 1.46 109.798 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 66.0 mt -90.48 120.99 40.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.337 -0.852 . . . . 1.42 109.045 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -102.74 -13.98 16.84 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.269 -0.895 . . . . 2.94 110.123 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -130.23 151.61 50.56 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.59 -0.693 . . . . 1.52 110.11 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.28 137.15 58.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 1.58 108.768 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.8 m -153.14 168.05 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.519 -0.738 . . . . 1.32 110.067 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -95.11 146.16 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 106.564 -1.643 . . . . 1.27 106.564 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 49.6 tp -96.83 120.21 36.75 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.106 -0.996 . . . . 1.41 110.8 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.41 130.03 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 108.981 -0.748 . . . . 1.23 108.981 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.8 168.57 24.48 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.197 -0.939 . . . . 1.32 109.043 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.78 -37.92 73.36 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.364 -1.46 . . . . 1.49 108.006 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -170.59 145.36 2.53 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.743 -0.836 . . . . 2.25 108.743 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 48.1 mt -112.87 134.67 54.27 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.324 -0.86 . . . . 1.35 109.443 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 11.6 p -90.76 148.84 39.3 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.198 -0.939 . . . . 1.56 109.122 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.35 -32.98 5.73 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.949 1.766 . . . . 0.87 112.485 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 66.7 m -55.88 -45.56 78.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.085 -1.009 . . . . 1.36 109.444 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -69.96 -40.08 75.63 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.372 -0.83 . . . . 1.61 109.539 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.507 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 44.0 p -55.3 -18.37 6.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.233 -0.917 . . . . 1.21 110.935 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -88.46 -46.93 8.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.793 -1.192 . . . . 1.21 109.643 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -90.11 41.2 1.04 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.926 -1.138 . . . . 2.11 107.926 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.1 tp -105.0 131.19 52.84 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.733 -0.604 . . . . 1.29 109.591 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -85.43 97.51 10.06 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.175 -1.046 . . . . 2.81 108.175 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.28 -39.87 95.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.435 -0.791 . . . . 2.09 110.804 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -64.86 -25.51 67.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.082 -1.011 . . . . 2.86 111.033 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -93.96 -10.16 34.61 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.746 -1.221 . . . . 2.39 110.164 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 62.6 t -107.12 119.91 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.225 -0.922 . . . . 1.27 108.678 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.1 mt -94.45 11.58 30.23 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.399 -0.813 . . . . 2.17 111.051 -177.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 171.17 170.27 35.11 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.267 -1.533 . . . . 0.52 109.267 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -136.75 133.56 36.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.365 -1.079 . . . . 0.55 109.118 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 75.6 mt -135.41 128.4 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.751 -0.833 . . . . 1.27 108.751 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' A' ' 205' ' ' THR . 34.3 p -144.98 158.64 43.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 1.39 110.626 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 183' ' ' ALA . 86.2 m-20 -94.05 17.23 12.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.602 -0.686 . . . . 2.46 109.778 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -44.32 -179.51 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.496 1.141 . . . . 1.51 113.029 -177.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.8 -52.99 5.57 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.281 -1.127 . . . . 2.23 110.281 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -168.33 -159.88 14.91 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 118.558 -1.782 . . . . 2.23 111.46 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.424 ' O ' ' OG ' ' A' ' 191' ' ' SER . 11.3 ptt180 -69.98 -13.88 62.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 122.18 -0.6 . . . . 6.44 111.129 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 41.2 p -74.32 5.22 4.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.882 -1.136 . . . . 4.09 109.036 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 91.7 p -87.63 141.23 28.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.368 -0.832 . . . . 2.2 110.39 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -54.88 -38.66 67.82 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.293 -0.879 . . . . 1.15 108.997 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.2 p -59.85 -39.95 86.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.682 -0.637 . . . . 2.01 109.941 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.531 ' HG ' ' N ' ' A' ' 192' ' ' ILE . 93.9 p -61.31 -38.24 86.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 1.93 110.113 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.531 ' N ' ' HG ' ' A' ' 191' ' ' SER . 41.2 mm -60.01 -39.92 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 2.2 109.074 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.0 mtp -56.14 -49.69 73.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.094 -1.004 . . . . 1.32 109.967 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.96 -44.71 78.74 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.093 -1.004 . . . . 1.3 109.915 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -61.64 -58.96 6.01 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.293 -0.963 . . . . 3.38 110.601 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.2 m -63.12 -39.67 95.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.204 -0.935 . . . . 1.15 111.554 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.7 mt -70.04 -30.05 67.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.831 -1.168 . . . . 1.28 109.402 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 70.52 49.56 0.41 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.342 0.592 . . . . 1.5 109.671 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 55.9 mt -130.1 150.03 74.89 Favored Pre-proline 0 N--CA 1.503 2.193 0 N-CA-C 108.256 -1.016 . . . . 1.37 108.256 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.74 138.18 84.82 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 122.204 1.936 . . . . 0.76 112.051 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.43 151.13 3.63 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.402 -0.919 . . . . 1.19 111.139 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 75.7 mt -127.67 139.77 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 107.208 -1.405 . . . . 1.31 107.208 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 32.4 m -123.05 -14.41 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.204 -0.935 . . . . 1.38 111.424 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -106.04 26.94 19.11 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.489 -1.444 . . . . 1.03 109.489 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.468 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 1.7 p -52.64 -37.2 58.12 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.234 -1.156 . . . . 1.38 110.41 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.63 -80.54 1.68 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.488 -1.339 . . . . 1.17 110.668 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.424 ' O ' ' OG ' ' A' ' 207' ' ' SER . 21.9 t -129.81 31.89 4.66 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 121.426 -1.044 . . . . 2.07 112.333 -177.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 55.7 t -69.83 -40.22 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.408 -1.432 . . . . 1.35 107.931 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 72.3 p -53.88 -28.91 39.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.644 -0.66 . . . . 1.49 109.898 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.421 ' OG ' ' OG ' ' A' ' 207' ' ' SER . 28.1 p -80.56 -19.4 45.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.021 -1.05 . . . . 2.16 110.135 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -96.62 -13.56 22.78 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.165 -0.96 . . . . 2.89 110.148 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.2 t -102.53 136.5 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.271 -0.893 . . . . 1.33 110.635 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -115.24 157.04 24.29 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.46 -1.311 . . . . 2.73 107.46 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 46.9 p-10 -60.03 139.99 57.1 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.814 -1.179 . . . . 2.7 110.265 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.7 m-20 80.87 4.29 1.59 Allowed 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.109 0.48 . . . . 2.38 110.028 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -71.13 130.03 40.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.197 -0.939 . . . . 2.09 109.022 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -84.63 112.92 20.88 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.111 -1.07 . . . . 1.45 108.111 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 54.8 mt -123.77 147.26 47.68 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.595 -0.69 . . . . 1.31 110.87 -178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 75.8 mt -114.38 127.68 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.813 -1.551 . . . . 1.29 106.813 177.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.4 tp -100.4 118.14 36.03 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.826 -1.171 . . . . 1.31 109.622 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.552 ' C ' ' H ' ' A' ' 223' ' ' VAL . 96.0 m-20 -75.7 -43.4 47.36 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.096 -1.002 . . . . 2.31 108.407 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 50.04 10.55 0.05 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.948 -0.76 . . . . 1.19 108.948 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.552 ' H ' ' C ' ' A' ' 221' ' ' ASP . 52.9 t -130.31 -37.31 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 106.985 -1.487 . . . . 1.45 106.985 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -102.07 -2.9 28.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.388 -1.338 . . . . 3.13 107.388 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.461 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 62.67 40.11 10.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.902 -0.499 . . . . 2.2 110.578 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -140.95 147.18 38.39 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.112 -0.993 . . . . 2.32 109.923 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.96 123.04 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.492 -0.755 . . . . 1.4 109.388 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -91.26 134.3 34.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.026 -1.046 . . . . 1.29 109.156 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 44.1 t -105.17 115.32 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.545 -0.722 . . . . 1.38 110.115 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 50.12 61.12 14.15 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.145 -0.972 . . . . 2.33 111.712 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -83.17 153.05 14.21 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.745 2.296 . . . . 0.95 111.875 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 82.1 p -70.32 162.3 28.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.145 -0.972 . . . . 2.31 110.697 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.404 ' ND2' ' H ' ' A' ' 233' ' ' ASN . 2.6 p30 -60.13 -36.1 76.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.639 -0.663 . . . . 3.45 110.029 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -60.05 -38.29 82.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.197 -0.939 . . . . 2.89 108.858 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.6 t -69.71 -40.0 78.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.319 -0.863 . . . . 1.73 109.223 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.6 mt . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 1.57 110.299 -179.741 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 301' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' B' ' 302' ' ' PHE . 13.1 tmm? . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.641 0.734 . . . . 0.0 109.649 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . 0.591 ' N ' ' SD ' ' B' ' 301' ' ' MET . 24.5 t80 -152.69 150.1 29.1 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -146.55 155.31 42.41 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.139 -0.976 . . . . 0.0 110.501 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -152.26 147.94 26.96 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -108.88 127.61 54.19 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.0 p -128.43 123.91 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 CA-C-O 122.407 1.099 . . . . 0.0 111.94 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 27.1 m -77.5 103.58 7.52 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.066 0.936 . . . . 0.0 110.926 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 89.5 mt -52.23 122.0 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 122.449 1.118 . . . . 0.0 110.049 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 71.2 p -103.02 23.4 12.36 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.708 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -83.38 116.72 65.9 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.95 . . . . 0.0 109.052 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -66.52 -6.95 16.42 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 CA-C-N 120.23 1.118 . . . . 0.0 111.504 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -118.09 5.96 12.05 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.48 177.47 34.55 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.469 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -87.28 94.34 9.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.153 -1.204 . . . . 0.0 108.824 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -96.88 -159.53 0.74 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.172 -0.955 . . . . 0.0 110.181 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 16.9 m -58.18 -46.84 85.07 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.971 -1.08 . . . . 0.0 112.637 -176.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.624 ' NH2' ' NE2' ' B' ' 321' ' ' GLN . 1.8 tpt180 -58.86 -61.45 7.74 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 120.425 -1.422 . . . . 0.0 112.09 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -58.8 -32.31 96.89 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 CA-C-N 120.373 1.169 . . . . 0.0 111.579 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.31 70.19 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.961 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.89 -41.0 67.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.882 . . . . 0.0 109.815 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . 0.624 ' NE2' ' NH2' ' B' ' 317' ' ' ARG . 40.3 mt-30 -69.97 -42.76 72.73 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.948 -1.095 . . . . 0.0 108.896 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -61.02 -51.67 68.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 110.348 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 73.8 t -67.72 -30.12 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.625 -1.297 . . . . 0.0 109.981 -179.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -60.05 -45.69 92.02 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.335 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -60.16 -49.95 75.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.037 -1.039 . . . . 0.0 109.225 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.97 74.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.305 -0.872 . . . . 0.0 110.657 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -49.65 -20.05 0.72 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.287 -0.883 . . . . 0.0 109.37 -178.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -81.6 -17.05 71.75 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -106.15 140.55 38.94 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.322 -1.105 . . . . 0.0 109.771 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 51.3 m -90.72 -12.98 34.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.109 -0.994 . . . . 0.0 109.34 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 331' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 58.5 m -61.24 144.74 53.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.335 -0.853 . . . . 0.0 109.587 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -67.32 135.98 54.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.059 -1.026 . . . . 0.0 109.298 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 88.8 mt -133.98 134.14 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.615 -0.678 . . . . 0.0 109.983 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 85.5 m -129.26 148.44 51.19 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.504 -0.747 . . . . 0.0 109.152 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 63.3 t -120.5 114.78 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 98.0 m -106.52 130.39 54.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.169 -0.957 . . . . 0.0 109.477 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 25.2 p -139.4 119.36 13.43 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.778 0.799 . . . . 0.0 110.787 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 41.71 52.87 4.01 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 177.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 84.06 -16.26 33.97 Favored Glycine 0 N--CA 1.5 2.938 0 O-C-N 120.293 -1.504 . . . . 0.0 112.507 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -110.56 122.63 48.22 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.796 -1.414 . . . . 0.0 109.472 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 56.7 p -129.84 150.62 51.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.741 0.782 . . . . 0.0 110.431 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -146.46 170.01 17.73 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.644 0.735 . . . . 0.0 110.204 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 16.5 m -88.62 139.04 30.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.575 -0.703 . . . . 0.0 110.011 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -80.49 -13.88 58.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.958 -1.089 . . . . 0.0 110.321 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -88.52 20.29 3.46 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.495 ' H ' ' C ' ' B' ' 344' ' ' ALA . 45.0 t -148.37 95.74 2.5 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.699 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.35 -34.62 74.11 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -55.67 -52.49 63.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.134 -0.979 . . . . 0.0 109.891 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.431 ' O ' ' OG1' ' B' ' 352' ' ' THR . 53.9 mtpt -69.58 -40.13 76.91 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.264 -0.898 . . . . 0.0 110.226 -178.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' B' ' 352' ' ' THR . 80.5 mt -50.88 -54.68 21.9 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.984 -1.073 . . . . 0.0 108.608 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -40.15 -12.43 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.855 -0.528 . . . . 0.0 111.647 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.626 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.5 p -93.64 -10.78 33.39 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.589 -1.319 . . . . 0.0 110.627 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 64.0 mt -93.38 119.79 32.9 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.764 -1.21 . . . . 0.0 109.837 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.06 91.01 1.0 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 29.4 mt -96.56 86.83 4.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -1.127 . . . . 0.0 108.199 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 356' ' ' THR . . . . . 0.515 ' C ' ' HG1' ' B' ' 359' ' ' THR . 65.9 p -92.5 -179.72 5.28 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.19 -0.944 . . . . 0.0 111.257 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' B' ' 359' ' ' THR . 7.4 tt0 -49.53 153.99 1.03 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.331 1.062 . . . . 0.0 111.303 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.73 26.88 0.05 OUTLIER Glycine 0 N--CA 1.495 2.58 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.906 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 359' ' ' THR . . . . . 0.515 ' HG1' ' C ' ' B' ' 356' ' ' THR . 24.1 m -84.87 110.42 18.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.884 -1.363 . . . . 0.0 109.449 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 23.3 t -77.33 114.58 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 122.333 1.063 . . . . 0.0 109.698 -177.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 15.1 m -109.98 177.91 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 27.8 m -130.31 126.9 38.33 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 65.7 mt -102.36 112.65 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 44.8 p -115.5 130.05 56.75 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.2 149.5 38.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.296 -0.877 . . . . 0.0 109.618 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -143.88 123.94 13.63 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.412 ' H ' ' HG2' ' B' ' 370' ' ' GLU . . . 160.82 -161.85 33.09 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.157 -1.497 . . . . 0.0 111.577 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.85 -50.5 73.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 122.211 -0.582 . . . . 0.0 112.296 -177.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.528 ' N ' ' OG ' ' B' ' 331' ' ' SER . 95.8 m-20 -111.08 10.65 22.02 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.919 -1.113 . . . . 0.0 110.837 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.412 ' HG2' ' H ' ' B' ' 367' ' ' GLY . 0.7 OUTLIER -45.59 -32.87 2.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.036 -1.04 . . . . 0.0 111.334 -178.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -71.81 -40.06 69.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.857 -1.152 . . . . 0.0 109.87 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -68.46 -40.38 81.08 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 110.802 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.53 -64.01 0.98 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.58 -1.325 . . . . 0.0 111.088 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 45.2 t -45.33 -39.56 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.015 -1.053 . . . . 0.0 109.988 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -61.37 -51.56 68.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.917 -1.114 . . . . 0.0 110.341 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -75.15 -39.93 60.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.015 -1.053 . . . . 0.0 111.094 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.22 -37.27 77.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.11 -0.994 . . . . 0.0 108.827 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.48 -43.44 98.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.209 -0.932 . . . . 0.0 109.607 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' B' ' 383' ' ' GLU . 0.5 OUTLIER -70.02 -55.72 8.83 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.615 -1.303 . . . . 0.0 107.735 178.525 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 60.4 tp -56.52 -35.92 68.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 109.935 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 33.7 ttm -71.72 -40.6 69.33 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.704 -1.248 . . . . 0.0 109.011 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.39 -5.38 57.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.652 -0.655 . . . . 0.0 110.139 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' B' ' 379' ' ' LYS . 64.3 mm-40 -110.66 -1.07 16.92 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.228 -0.92 . . . . 0.0 110.833 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.9 mt -87.24 128.5 35.15 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.546 -1.346 . . . . 0.0 108.783 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.44 -179.629 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mpp? . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.266 0.555 . . . . 3.19 109.816 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -111.18 130.02 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.608 -0.683 . . . . 1.71 109.346 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.2 m -132.24 121.13 23.16 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.233 -0.917 . . . . 1.66 108.712 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.18 -166.75 32.78 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.611 -1.395 . . . . 1.05 109.611 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.9 mt -87.42 -6.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.03 -1.276 . . . . 1.59 109.758 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 23.7 tp 57.35 89.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.394 -0.816 . . . . 1.47 109.359 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.73 83.14 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.866 -1.161 . . . . 1.39 107.866 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 1.5 p -150.54 146.26 19.49 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 109.006 -0.739 . . . . 2.09 109.006 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.56 143.75 15.37 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.587 2.191 . . . . 0.91 113.272 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 165.88 -163.35 36.68 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.221 -1.552 . . . . 0.92 109.221 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.9 mt -148.58 147.54 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.971 -1.311 . . . . 1.35 108.933 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.88 147.84 28.42 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.875 -1.141 . . . . 1.14 110.537 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -128.5 120.71 27.32 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.818 -1.179 . . . . 0.7 107.818 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.82 -179.91 45.82 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 117.943 -2.075 . . . . 0.58 111.228 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -80.28 160.05 25.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.913 -0.757 . . . . 2.63 110.174 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.59 130.51 49.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.686 -0.634 . . . . 1.27 110.931 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.4 tp -100.38 135.42 41.85 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 107.486 -1.302 . . . . 1.41 107.486 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.1 tp -121.4 124.23 44.01 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.226 -0.921 . . . . 1.49 110.027 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 65.7 mt -81.66 103.31 11.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 1.52 109.758 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -96.88 121.69 39.02 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.267 -1.012 . . . . 3.17 108.267 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -130.36 133.68 46.6 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.27 -0.894 . . . . 3.0 110.153 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 42.5 t0 -69.7 141.76 53.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 2.77 109.505 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.496 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 86.3 tt0 -63.58 142.63 58.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.932 . . . . 2.94 109.232 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 80.4 mt -79.73 128.73 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.145 -0.972 . . . . 1.46 108.898 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.5 t -102.56 128.78 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.26 -0.9 . . . . 1.7 109.646 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.55 139.42 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.352 -0.843 . . . . 1.54 109.319 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -91.38 123.63 34.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.083 -1.011 . . . . 1.81 108.955 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.441 HH11 ' HG2' ' A' ' 28' ' ' ARG . 5.4 mmt-85 -89.96 -0.89 57.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.442 -0.786 . . . . 3.23 109.15 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -68.56 139.78 55.59 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.42 -0.8 . . . . 3.29 109.707 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -86.13 146.17 26.71 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.556 -0.905 . . . . 2.8 108.556 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 pt -92.66 165.98 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 1.43 109.95 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.3 p -99.71 173.87 6.5 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.488 -0.93 . . . . 1.54 108.488 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.01 -48.13 82.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.947 . . . . 1.6 109.3 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -57.37 -29.08 63.74 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.677 -1.264 . . . . 2.56 109.599 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -82.41 -10.52 59.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 2.36 110.257 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.3 t -62.15 -52.21 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.951 -1.093 . . . . 1.43 108.568 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.89 -40.24 96.94 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.407 -0.808 . . . . 1.77 110.156 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -70.9 -40.14 72.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.132 -0.98 . . . . 3.32 110.542 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -66.06 -40.11 90.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.113 -0.992 . . . . 1.51 110.161 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.2 t -61.68 -43.35 96.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.082 -1.011 . . . . 1.41 108.444 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -59.97 -39.71 86.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 1.81 108.984 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -60.06 -40.93 91.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.935 -1.103 . . . . 3.26 108.228 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -63.92 -47.87 78.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 0.81 108.612 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.5 -49.56 77.07 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.435 -0.58 . . . . 1.59 109.435 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.2 t -60.74 -43.3 98.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.113 -0.992 . . . . 1.38 108.81 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.81 -45.66 96.04 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.714 -1.754 . . . . 0.87 108.714 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -65.36 -32.81 74.64 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.954 -1.128 . . . . 3.62 107.954 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.65 -39.16 76.37 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.578 -0.701 . . . . 1.43 109.255 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.7 ttmt -72.78 -72.98 0.22 Allowed 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.768 -1.197 . . . . 3.08 107.768 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.76 -35.7 0.15 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.449 -0.782 . . . . 1.33 111.068 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.729 ' HG ' ' H ' ' A' ' 52' ' ' ALA . 78.3 p -59.86 -56.29 23.61 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.451 -1.406 . . . . 1.85 108.627 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.729 ' H ' ' HG ' ' A' ' 51' ' ' SER . . . -67.67 -42.68 81.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.144 -0.973 . . . . 1.35 110.644 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -65.24 -39.99 93.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.063 -1.023 . . . . 2.34 110.621 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.9 mt -66.63 -40.2 88.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.743 -1.223 . . . . 2.2 109.818 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -62.04 -36.33 81.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.991 -1.068 . . . . 1.35 109.554 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.9 m -64.04 -40.38 96.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.189 -0.944 . . . . 1.34 110.311 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.54 -38.81 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.131 -0.981 . . . . 1.26 109.45 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -55.62 -50.43 70.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.392 -0.817 . . . . 1.7 110.612 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -59.67 -39.92 86.09 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.199 -0.938 . . . . 1.35 110.224 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -66.22 -35.65 80.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 2.08 109.513 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.1 -43.11 99.39 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.498 -0.751 . . . . 1.21 109.942 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.38 -50.69 42.5 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.942 -1.263 . . . . 0.75 109.942 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.41 -45.97 92.12 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.202 -1.175 . . . . 1.59 108.642 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.5 m -68.52 -58.64 4.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.457 -0.777 . . . . 1.41 111.663 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -97.96 -54.17 3.17 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.002 -1.061 . . . . 0.79 111.265 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.35 -169.31 25.49 Favored Glycine 0 N--CA 1.504 3.191 0 O-C-N 120.694 -1.254 . . . . 1.22 111.573 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -68.59 -27.79 66.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.913 -0.757 . . . . 5.81 111.001 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -62.56 -36.31 82.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 3.37 110.089 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -98.51 -22.37 16.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.397 -0.814 . . . . 2.37 110.228 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -67.92 -40.14 83.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.0 -1.062 . . . . 1.65 110.457 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.571 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -69.34 -26.09 64.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 1.42 110.08 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.4 mt -59.88 -40.65 83.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 120.872 -1.142 . . . . 1.43 108.068 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -69.98 -37.61 75.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.428 -0.795 . . . . 1.08 110.139 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.516 ' OE2' ' NZ ' ' B' ' 324' ' ' LYS . 65.6 tt0 -60.65 -40.11 90.81 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.081 -1.012 . . . . 1.37 109.696 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.46 -45.91 81.72 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.381 -1.488 . . . . 0.67 109.381 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -60.43 -42.57 96.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -1.147 . . . . 1.99 109.539 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.1 mt -69.82 -41.09 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.124 -0.985 . . . . 1.22 109.531 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.8 ttp -62.57 -40.2 96.09 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.947 -1.096 . . . . 2.11 109.536 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.1 tp -64.89 -38.55 91.35 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.454 -0.779 . . . . 1.33 109.855 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.5 tp -62.08 -40.14 94.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.438 -0.789 . . . . 1.29 110.305 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -84.29 5.84 25.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.011 -1.055 . . . . 1.47 110.287 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 61.5 t0 -49.29 133.36 19.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.007 -1.058 . . . . 1.47 110.114 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.475 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 45.7 mt-10 -59.15 -21.22 59.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.809 -0.557 . . . . 1.78 110.507 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -71.03 -34.31 71.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.939 -1.101 . . . . 2.53 109.309 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.4 mt -71.07 -41.03 71.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.566 -0.709 . . . . 1.36 110.111 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -60.48 -47.69 85.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.533 -0.729 . . . . 1.42 110.653 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -69.82 -40.61 75.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.06 -1.025 . . . . 2.27 110.227 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.63 -39.9 70.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 1.57 111.875 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.55 -47.82 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.758 -1.213 . . . . 1.19 109.83 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.7 mt -69.66 -38.48 76.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.243 -0.911 . . . . 1.39 109.99 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.81 93.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.011 -1.056 . . . . 1.39 109.964 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.4 -45.98 88.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.839 -1.163 . . . . 1.5 109.406 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.66 -46.8 93.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.303 -0.873 . . . . 1.29 108.88 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -69.82 -42.36 73.77 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.334 -0.854 . . . . 2.64 111.602 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -86.08 -51.64 6.2 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.78 -1.2 . . . . 1.65 112.596 -177.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -88.8 -2.6 58.67 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.941 -1.099 . . . . 2.5 111.479 -177.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 56.8 37.98 29.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.908 -1.12 . . . . 1.88 109.709 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.1 mtt -87.44 169.21 12.43 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.548 -0.72 . . . . 1.71 110.043 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.1 p -84.37 160.3 20.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.875 . . . . 1.61 108.85 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.75 -38.94 87.62 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.05 -1.032 . . . . 1.33 110.032 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 38.6 p-10 -69.66 -36.8 76.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.983 -1.073 . . . . 2.07 110.168 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.48 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -81.57 -47.47 13.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.958 -1.088 . . . . 1.37 110.065 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.19 -49.76 76.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -0.875 . . . . 1.14 109.845 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.38 85.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.1 -1.0 . . . . 1.26 109.561 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.53 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 78.7 t60 -60.19 -41.99 94.1 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 2.02 110.263 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -62.34 -40.03 95.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.077 -1.014 . . . . 1.33 110.804 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.31 -56.33 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.948 -1.095 . . . . 1.3 111.613 -177.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.1 mm -69.24 -39.95 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.654 -1.279 . . . . 1.32 109.627 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.53 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.7 tt0 -60.31 -40.05 89.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.083 -1.011 . . . . 2.44 109.413 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.78 -49.37 79.33 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.405 -1.078 . . . . 0.99 110.405 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -67.97 -56.34 9.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.974 -1.31 . . . . 1.97 109.607 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.22 -42.7 63.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.726 -1.234 . . . . 1.43 109.041 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.4 t -59.84 -40.16 87.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.029 -1.045 . . . . 2.12 108.723 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.29 93.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.34 -0.85 . . . . 1.64 109.206 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.9 mt -66.47 -40.09 89.18 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.239 -0.913 . . . . 1.93 109.385 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.07 -33.52 72.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.986 -1.071 . . . . 2.2 109.941 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -58.74 -21.02 54.25 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.983 -1.073 . . . . 2.12 108.768 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.2 mt -62.77 139.64 58.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.232 -0.918 . . . . 2.34 109.247 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -92.46 46.1 1.23 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.981 -1.075 . . . . 3.23 108.929 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -132.12 130.74 41.57 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.4 -0.812 . . . . 2.49 110.033 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -69.9 -33.83 72.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.534 -0.729 . . . . 3.95 110.641 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.487 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.2 t80 -70.24 -40.21 74.6 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.121 -0.987 . . . . 2.25 110.566 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.569 ' CD2' HH21 ' A' ' 126' ' ' ARG . 82.4 mt -70.05 -35.96 74.64 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.954 -1.091 . . . . 2.27 108.747 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -59.93 -40.0 87.42 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.658 -0.651 . . . . 3.31 109.285 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -59.79 -46.5 89.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.857 -1.152 . . . . 2.73 110.011 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.569 HH21 ' CD2' ' A' ' 123' ' ' LEU . 74.0 mtm180 -62.62 -35.81 80.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.634 -1.291 . . . . 3.2 108.766 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.9 -32.29 70.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.368 -0.833 . . . . 1.66 108.813 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.64 -40.05 94.77 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.803 -0.814 . . . . 1.67 108.803 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -68.07 -40.54 82.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.442 -0.787 . . . . 1.55 110.039 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.436 HG21 HE22 ' B' ' 351' ' ' GLN . 49.9 t -70.22 -40.31 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.049 -1.032 . . . . 1.32 109.263 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -60.9 -40.34 92.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.955 -1.09 . . . . 3.58 108.449 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -60.03 -38.97 84.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.579 -0.701 . . . . 1.46 110.181 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.4 mt -59.75 -42.48 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.199 -0.938 . . . . 1.22 111.262 -178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.94 -32.34 58.91 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.395 -1.384 . . . . 0.61 110.566 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -59.99 -48.57 81.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.037 -1.273 . . . . 3.1 110.408 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -69.33 -29.98 67.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.761 -1.212 . . . . 3.71 110.219 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.6 -40.08 86.3 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.043 -1.036 . . . . 1.87 108.277 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.89 -39.89 93.55 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.192 -1.04 . . . . 1.29 108.192 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -68.65 -39.87 80.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.322 -0.862 . . . . 3.05 109.582 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -64.98 -33.77 76.85 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.401 -0.812 . . . . 1.26 111.16 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 141' ' ' ILE . 96.6 mt -73.19 -45.83 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.571 -1.33 . . . . 1.34 109.615 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.2 mt -69.98 -30.08 67.33 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.681 -0.808 . . . . 1.6 108.989 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.34 40.61 6.02 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.811 -1.716 . . . . 0.96 108.811 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 24.3 tp -74.31 147.52 42.22 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.408 -1.054 . . . . 1.67 109.026 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -65.87 147.31 53.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.309 -0.869 . . . . 4.96 110.217 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.4 mt -115.63 123.17 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 108.524 -0.917 . . . . 1.68 108.524 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.41 HD11 HG23 ' A' ' 147' ' ' ILE . 20.6 mm -59.54 -49.01 85.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.765 -0.585 . . . . 2.14 110.574 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.2 t0 67.72 101.42 0.05 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.51 -0.744 . . . . 1.5 109.085 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.452 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 91.2 mt -72.68 -1.97 18.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -0.867 . . . . 1.39 110.195 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.5 t -81.85 -10.84 59.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 1.83 108.402 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.03 26.25 0.63 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.739 -0.6 . . . . 1.46 110.496 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.452 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 50.3 mt -91.69 123.66 43.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.209 -0.932 . . . . 1.42 109.425 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -105.86 -10.95 16.41 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.213 -0.93 . . . . 2.94 109.975 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -134.02 155.07 50.65 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.137 -0.977 . . . . 1.52 110.512 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.31 134.51 56.59 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.695 0.76 . . . . 1.58 109.53 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.1 m -151.85 164.16 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.729 -0.841 . . . . 1.32 108.729 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.5 mt -94.96 144.72 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.766 -1.568 . . . . 1.27 106.766 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -92.64 117.63 30.18 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.814 -1.178 . . . . 1.41 110.131 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 3.5 t -126.44 132.99 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.619 -0.882 . . . . 1.23 108.619 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.64 165.46 30.59 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.344 -0.847 . . . . 1.32 108.912 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.0 -34.53 71.44 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.452 -1.405 . . . . 1.49 107.464 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 12.9 t70 -162.34 167.37 23.91 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.366 -0.976 . . . . 2.25 108.366 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.421 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 92.8 mt -140.55 132.48 27.67 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.215 -0.928 . . . . 1.35 108.746 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 5.6 p -98.95 153.99 37.55 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.302 -0.874 . . . . 1.56 109.606 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -45.37 -33.62 9.22 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.861 1.708 . . . . 0.87 112.327 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.7 m -53.27 -50.08 65.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.945 . . . . 1.36 109.941 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.65 -40.03 94.73 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.444 -0.785 . . . . 1.61 110.703 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 44.7 p -58.13 -18.67 26.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 1.21 111.749 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.08 -45.95 10.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.814 -1.179 . . . . 1.21 109.034 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -91.69 41.8 1.08 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.762 -1.199 . . . . 2.11 107.762 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.7 tp -108.74 138.79 44.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.639 -0.663 . . . . 1.29 109.513 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -93.38 99.54 12.03 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.291 -0.881 . . . . 2.81 108.78 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 25.1 mt -65.22 -40.36 94.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.195 -0.94 . . . . 2.09 109.679 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -62.48 -29.57 70.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.067 -1.021 . . . . 2.86 110.792 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.17 -9.2 37.13 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.826 -1.171 . . . . 2.39 110.721 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 77.5 t -104.14 118.18 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.036 -1.04 . . . . 1.27 108.578 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.96 9.41 25.12 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.473 -0.767 . . . . 2.17 111.266 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 166.58 175.41 36.79 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.31 -1.516 . . . . 0.52 109.31 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -134.14 131.27 38.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.46 -1.023 . . . . 0.55 108.835 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 98.0 mt -132.05 124.26 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.723 -0.843 . . . . 1.27 108.723 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 17.6 p -145.4 159.6 42.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.901 -1.124 . . . . 1.39 110.947 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -100.35 19.98 15.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.51 -0.744 . . . . 2.46 109.844 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.23 -162.01 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.695 -1.253 . . . . 1.51 111.379 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -87.26 -45.83 5.19 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 111.305 -0.718 . . . . 2.23 111.305 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 166.83 -145.66 10.11 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 118.43 -1.843 . . . . 2.23 111.245 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -60.69 -9.97 4.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.675 -0.897 . . . . 6.44 110.749 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 82.1 p -78.36 -1.09 31.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.862 -1.148 . . . . 4.09 109.868 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.8 t -91.83 129.78 37.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.178 -0.951 . . . . 2.2 109.927 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -46.26 -48.02 18.01 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.149 -0.97 . . . . 1.15 109.617 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 89.7 m -59.71 -38.51 81.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.61 -0.681 . . . . 2.01 110.866 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 96.6 p -59.81 -39.84 86.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.691 -1.255 . . . . 1.93 110.346 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.4 mm -62.61 -37.9 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 2.2 109.199 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.7 mtp -60.15 -43.79 95.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.37 -0.831 . . . . 1.32 110.162 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.28 -42.88 82.49 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.605 -1.309 . . . . 1.3 108.609 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -60.05 -54.12 49.73 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.619 -0.832 . . . . 3.38 110.425 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.4 m -71.26 -34.36 70.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.133 -0.979 . . . . 1.15 111.199 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.36 -29.74 66.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.01 -1.056 . . . . 1.28 108.724 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 69.99 49.87 0.48 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.236 0.541 . . . . 1.5 110.696 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.477 ' O ' ' OG ' ' A' ' 8' ' ' SER . 43.8 mt -128.27 149.28 70.93 Favored Pre-proline 0 N--CA 1.505 2.311 0 N-CA-C 107.799 -1.185 . . . . 1.37 107.799 178.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.14 143.53 99.74 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 122.21 1.94 . . . . 0.76 112.157 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -172.46 153.37 2.88 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.232 -0.987 . . . . 1.19 111.161 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.2 mt -128.0 143.55 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.847 -1.168 . . . . 1.31 107.847 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 28.3 m -128.78 -11.52 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 O-C-N 120.819 -1.176 . . . . 1.38 111.037 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.64 26.59 17.49 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.413 -1.075 . . . . 1.03 110.413 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.447 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.6 p -45.99 -42.2 12.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.105 -1.232 . . . . 1.38 109.542 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.34 -51.44 4.2 Favored Glycine 0 N--CA 1.494 2.547 0 C-N-CA 120.143 -1.027 . . . . 1.17 111.641 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 14.1 t -158.7 35.42 0.22 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.483 -1.598 . . . . 2.07 111.478 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.82 -40.04 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.128 -0.983 . . . . 1.35 108.747 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 47.2 p -54.77 -27.41 41.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.711 -0.618 . . . . 1.49 110.404 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.8 t -85.75 -12.13 51.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.16 -0.962 . . . . 2.16 110.624 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -104.19 -14.59 15.79 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.168 -0.957 . . . . 2.89 110.673 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 18.7 t -110.79 146.12 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.15 -0.969 . . . . 1.33 111.208 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -113.36 150.11 33.08 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.747 -1.575 . . . . 2.73 106.747 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 56.6 t30 -55.82 139.96 43.83 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.944 -1.097 . . . . 2.7 110.014 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.7 t70 88.92 11.86 0.08 Allowed 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.27 0.557 . . . . 2.38 109.988 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 52.7 t0 -83.41 141.86 31.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.2 -0.938 . . . . 2.09 109.31 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.553 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 51.3 t80 -89.97 117.5 28.82 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.982 -1.118 . . . . 1.45 107.982 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.42 142.17 51.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.57 -0.706 . . . . 1.31 109.749 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.41 HD13 HG23 ' A' ' 219' ' ' ILE . 88.7 mt -110.2 124.75 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.968 -1.493 . . . . 1.29 106.968 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 21.4 tp -98.36 115.9 29.43 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.901 -1.124 . . . . 1.31 108.064 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 223' ' ' VAL . 15.0 m-20 -79.43 -44.25 21.74 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.524 -0.917 . . . . 2.31 108.524 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 46.96 14.75 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.043 -0.725 . . . . 1.19 109.043 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' A' ' 221' ' ' ASP . 47.0 t -124.71 -36.29 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.629 -1.619 . . . . 1.45 106.629 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.415 ' OD1' ' NE2' ' A' ' 226' ' ' GLN . 15.6 t-20 -108.61 0.06 20.52 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.864 -1.162 . . . . 3.13 107.864 178.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 65.07 46.22 2.84 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.905 -0.497 . . . . 2.2 111.324 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.415 ' NE2' ' OD1' ' A' ' 224' ' ' ASN . 23.0 pt20 -150.07 150.21 31.4 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.751 -1.218 . . . . 2.32 109.631 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.88 123.84 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.557 -0.905 . . . . 1.4 108.557 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -85.92 129.09 34.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.934 -1.104 . . . . 1.29 109.283 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.59 118.41 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.541 -0.724 . . . . 1.38 109.641 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 60.68 69.8 1.07 Allowed Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.112 -0.993 . . . . 2.33 110.294 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -90.45 132.07 1.73 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 123.532 2.821 . . . . 0.95 112.63 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.8 m -63.96 161.9 14.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.284 -0.885 . . . . 2.31 110.032 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.23 -42.49 95.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.209 -0.932 . . . . 3.45 110.479 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -60.81 -33.0 72.34 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.975 -1.078 . . . . 2.89 109.43 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.17 -40.07 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 1.73 109.3 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.1 mt . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.238 -0.914 . . . . 1.57 109.464 179.528 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 41.5 ttp . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.444 0.64 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -153.31 150.05 28.52 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -150.93 159.7 44.39 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.866 -1.146 . . . . 0.0 111.064 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -157.6 155.53 30.28 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.696 -0.628 . . . . 0.0 109.331 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -115.28 133.48 55.99 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.147 -0.971 . . . . 0.0 110.559 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.2 p -133.59 124.31 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 CA-C-O 122.11 0.957 . . . . 0.0 112.139 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 25.8 m -78.02 107.08 10.32 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.026 0.917 . . . . 0.0 111.195 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.7 mt -52.92 120.21 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 122.477 1.132 . . . . 0.0 110.451 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 30.6 p -108.45 18.68 20.7 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.967 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . 0.457 ' O ' ' CG ' ' B' ' 357' ' ' GLN . . . -73.01 128.47 87.85 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -63.02 -14.63 42.76 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 CA-C-N 120.309 1.146 . . . . 0.0 112.859 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -120.4 10.32 11.17 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.78 -179.13 49.9 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.487 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 2.8 tp -82.28 87.45 6.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.765 -1.432 . . . . 0.0 109.033 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -92.54 -160.89 0.78 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.918 -1.114 . . . . 0.0 109.865 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.8 m -56.87 -45.66 82.36 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.986 -1.071 . . . . 0.0 112.789 -176.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.571 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 11.9 tpt180 -56.14 -59.1 12.8 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 120.613 -1.305 . . . . 0.0 111.933 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.04 -36.62 69.67 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 120.369 1.167 . . . . 0.0 111.921 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.71 84.74 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.26 -46.23 76.11 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.567 -0.708 . . . . 0.0 109.756 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -70.03 -39.88 75.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.824 -1.172 . . . . 0.0 108.355 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -61.57 -54.97 36.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.406 -0.809 . . . . 0.0 110.603 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.91 -30.63 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.667 -1.271 . . . . 0.0 110.091 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . 0.516 ' NZ ' ' OE2' ' A' ' 74' ' ' GLU . 29.7 ttmt -60.01 -45.41 92.87 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.173 -0.954 . . . . 0.0 109.076 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -68.31 -54.87 14.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 111.029 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -65.0 -54.91 23.04 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.848 -1.158 . . . . 0.0 112.284 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -52.97 -17.25 1.33 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.797 -1.189 . . . . 0.0 109.636 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -73.79 -16.85 79.17 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -105.48 150.54 25.22 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.15 -1.206 . . . . 0.0 109.248 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 14.6 t -89.76 -12.85 38.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.062 -1.024 . . . . 0.0 110.261 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 43.7 t -60.22 142.61 54.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -0.957 . . . . 0.0 109.496 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -67.59 136.08 53.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 108.656 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 79.1 mt -135.46 135.82 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.499 -0.751 . . . . 0.0 109.346 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 96.4 m -130.6 149.69 52.14 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 58.8 t -120.29 114.73 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 55.4 m -104.27 123.58 47.61 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.216 -0.927 . . . . 0.0 109.365 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 56.7 p -130.77 115.25 16.37 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.789 0.804 . . . . 0.0 110.489 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 44.67 59.18 3.49 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 177.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.12 -15.04 18.21 Favored Glycine 0 N--CA 1.498 2.805 0 O-C-N 120.321 -1.487 . . . . 0.0 112.688 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -115.98 127.4 54.91 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-N 118.833 1.317 . . . . 0.0 109.285 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 53.9 p -129.61 150.18 51.05 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.844 0.831 . . . . 0.0 110.369 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.83 168.17 20.39 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 5.6 m -87.82 130.0 35.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.388 -0.82 . . . . 0.0 111.086 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.545 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -68.23 -20.27 64.8 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.395 -0.815 . . . . 0.0 109.322 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.02 21.16 1.09 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.545 ' H ' ' C ' ' B' ' 344' ' ' ALA . 16.7 m -151.39 96.29 2.26 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.756 0.789 . . . . 0.0 111.981 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.94 -33.75 72.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -54.62 -52.46 62.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.391 -0.818 . . . . 0.0 110.716 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.426 ' O ' ' OG1' ' B' ' 352' ' ' THR . 34.1 mtmm -70.34 -40.1 74.3 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.05 -1.032 . . . . 0.0 110.255 -178.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.604 ' O ' ' N ' ' B' ' 352' ' ' THR . 79.3 mt -49.76 -55.16 15.06 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.826 -1.171 . . . . 0.0 108.69 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.436 HE22 HG21 ' A' ' 130' ' ' VAL . 32.3 mt-30 -41.42 -13.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.792 -0.568 . . . . 0.0 110.955 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.604 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.0 p -93.33 -10.41 35.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.286 -1.509 . . . . 0.0 110.158 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 70.2 mt -92.07 117.94 30.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.106 -0.996 . . . . 0.0 108.838 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -71.02 88.96 0.39 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.8 mt -98.33 88.51 4.17 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.224 -1.162 . . . . 0.0 109.189 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 34.3 p -89.95 175.82 7.04 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.943 -1.098 . . . . 0.0 110.96 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . 0.457 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 20.5 tm0? -68.97 113.02 5.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.638 -0.664 . . . . 0.0 110.227 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.97 9.14 37.84 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 45.2 m -87.64 112.05 21.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.165 -1.197 . . . . 0.0 110.847 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 39.0 t -76.5 116.98 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 122.137 0.97 . . . . 0.0 109.861 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 27.3 m -112.57 176.03 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 70.5 m -131.52 128.38 39.21 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 88.2 mt -101.16 113.46 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 51.1 m -116.72 130.57 56.81 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.21 152.72 39.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.126 -0.984 . . . . 0.0 110.654 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -143.77 122.99 12.97 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.546 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.62 -156.55 27.24 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.153 -1.499 . . . . 0.0 111.369 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -59.89 -53.8 53.64 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -103.3 11.37 36.84 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.107 -0.995 . . . . 0.0 111.434 -176.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.546 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 10.6 pt-20 -48.02 -41.62 26.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.102 -0.999 . . . . 0.0 111.779 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . 0.415 ' N ' ' CG ' ' B' ' 370' ' ' GLU . 97.7 mt-30 -69.97 -48.52 57.95 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.636 -1.29 . . . . 0.0 110.335 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -66.11 -45.37 81.37 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.463 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -49.74 -74.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.042 -1.036 . . . . 0.0 110.647 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 39.3 t -45.3 -38.62 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.004 -1.06 . . . . 0.0 110.42 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -63.77 -48.15 78.12 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.828 -1.17 . . . . 0.0 109.861 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -79.52 -42.58 24.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.0 -1.063 . . . . 0.0 110.571 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.9 mt -59.4 -37.14 77.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.924 -1.11 . . . . 0.0 109.079 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 43.1 t -63.15 -40.23 88.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 119.204 -0.998 . . . . 0.0 109.309 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.5 mttt -69.45 -55.61 9.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.694 -1.254 . . . . 0.0 108.476 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 58.0 tp -57.09 -32.75 66.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 109.452 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 4.6 tpp -71.29 -40.01 71.13 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.543 -1.263 . . . . 0.0 107.885 177.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.4 -7.97 59.66 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.659 -0.651 . . . . 0.0 110.818 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.449 ' O ' ' OE2' ' B' ' 385' ' ' GLU . 96.5 mt-10 -110.33 -0.27 17.71 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 120.822 -1.173 . . . . 0.0 111.317 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.1 mt -82.31 132.36 35.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.394 -1.441 . . . . 0.0 110.238 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 56.4 mp0 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 118.148 -0.929 . . . . 0.0 108.926 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.104 -0.702 . . . . 3.19 109.104 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.418 HD11 HG21 ' A' ' 2' ' ' ILE . 85.4 mt -110.0 130.04 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.398 -0.814 . . . . 1.71 109.822 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.5 m -133.8 147.86 51.28 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.466 -0.771 . . . . 1.66 109.401 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.493 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -127.42 -162.32 11.09 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 108.766 -1.734 . . . . 1.05 108.766 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.8 mt -92.83 -14.64 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.844 -1.386 . . . . 1.59 109.775 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.8 tp 55.21 103.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.528 -0.916 . . . . 1.47 108.528 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.01 -30.08 17.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 1.39 109.104 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.0 t -141.57 126.89 10.8 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.454 -0.779 . . . . 2.09 109.457 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.55 142.82 18.66 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.738 1.625 . . . . 0.91 111.599 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 165.2 -164.16 36.97 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.35 -1.5 . . . . 0.92 109.35 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -147.32 148.62 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.009 -1.289 . . . . 1.35 109.005 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.33 152.45 32.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.094 -1.004 . . . . 1.14 110.105 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -135.09 124.85 25.35 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.122 -1.066 . . . . 0.7 108.122 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.71 -175.95 47.39 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 118.739 -1.696 . . . . 0.58 110.701 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -79.57 155.63 28.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.868 -0.784 . . . . 2.63 109.534 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.04 130.17 50.08 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.48 -0.763 . . . . 1.27 110.461 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.2 tp -98.36 135.51 39.85 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.024 -1.102 . . . . 1.41 108.024 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.9 tp -117.88 124.44 48.31 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.743 0.783 . . . . 1.49 109.756 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.2 mt -99.97 109.97 22.3 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.742 -0.598 . . . . 1.52 110.916 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -110.66 140.84 44.65 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.559 -0.713 . . . . 3.17 109.191 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -126.78 130.86 51.11 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.31 -0.869 . . . . 3.0 108.782 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.2 p-10 -77.58 155.33 31.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.05 -1.032 . . . . 2.77 109.104 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -72.05 141.26 49.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 2.94 109.511 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -82.44 136.4 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.286 -0.884 . . . . 1.46 108.632 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -95.23 129.42 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.098 -1.001 . . . . 1.7 110.071 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.01 135.87 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.598 -0.688 . . . . 1.54 109.303 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -90.93 123.54 34.51 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.995 -1.066 . . . . 1.81 110.242 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -90.04 -3.91 57.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.591 -0.693 . . . . 3.23 110.469 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -70.33 142.79 52.15 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.004 -1.06 . . . . 3.29 110.6 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp -84.3 153.17 23.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.217 -0.927 . . . . 2.8 108.91 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.6 pt -95.05 165.83 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.161 -0.962 . . . . 1.43 109.835 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -93.74 170.75 9.34 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.144 -1.058 . . . . 1.54 108.144 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.41 77.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.812 -1.18 . . . . 1.6 109.722 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -55.49 -28.73 56.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.744 -1.222 . . . . 2.56 109.303 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -81.52 -11.28 59.24 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.39 -0.818 . . . . 2.36 110.069 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -63.34 -51.71 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.751 -1.218 . . . . 1.43 108.94 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -61.47 -39.99 92.9 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.32 -0.862 . . . . 1.77 109.758 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -69.14 -41.33 77.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.896 . . . . 3.32 110.781 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -65.0 -40.05 94.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.831 -1.168 . . . . 1.51 110.015 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.6 -45.18 97.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.503 -1.295 . . . . 1.41 107.503 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -60.09 -42.7 95.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 1.81 109.125 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -60.05 -40.16 88.44 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.657 -1.238 . . . . 3.26 107.657 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -66.39 -43.95 84.43 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.421 -0.955 . . . . 0.81 108.421 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.08 -50.01 75.4 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.448 -0.945 . . . . 1.59 108.448 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.7 t -62.34 -43.52 98.64 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.542 -0.863 . . . . 1.38 108.731 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.76 -44.22 98.22 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.266 -1.934 . . . . 0.87 108.266 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.403 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 32.8 ttt-85 -64.1 -36.03 82.69 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.35 -0.981 . . . . 3.62 108.35 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.77 -40.04 68.99 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.852 -0.795 . . . . 1.43 108.852 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 50' ' ' ALA . 17.1 ttmt -67.96 -74.79 0.11 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.166 -1.05 . . . . 3.08 108.166 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.27 -31.86 0.06 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.529 -0.732 . . . . 1.33 111.028 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 49' ' ' LYS . 47.4 t -59.57 -58.79 7.05 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.706 -1.246 . . . . 1.85 108.634 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.24 -44.51 71.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.275 -0.891 . . . . 1.35 111.261 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -61.05 -44.43 97.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.89 -1.131 . . . . 2.34 110.879 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.52 -40.01 93.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.947 -1.096 . . . . 2.2 110.066 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -60.01 -35.58 75.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.054 -1.029 . . . . 1.35 109.875 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -64.31 -41.42 96.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.04 -1.037 . . . . 1.34 110.145 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.8 mt -60.15 -39.94 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.099 -1.001 . . . . 1.26 109.455 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -59.74 -50.15 74.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 1.7 109.638 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -60.55 -40.02 90.04 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.453 -0.779 . . . . 1.35 110.804 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.57 -39.62 94.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.831 -1.168 . . . . 2.08 109.493 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.86 -42.8 89.95 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.583 -0.698 . . . . 1.21 110.064 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.06 -50.17 65.65 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.986 -1.102 . . . . 0.75 110.358 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.78 -42.94 76.69 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.949 -1.324 . . . . 1.59 109.658 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -70.25 -59.12 3.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 1.41 111.944 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 168' ' ' THR . 95.8 m-85 -95.09 -53.39 3.83 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.975 -1.078 . . . . 0.79 111.358 -177.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.14 -167.58 26.0 Favored Glycine 0 N--CA 1.502 3.043 0 C-N-CA 119.773 -1.203 . . . . 1.22 111.474 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -73.29 -26.51 61.11 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.97 -0.724 . . . . 5.81 111.251 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -61.97 -34.69 76.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.006 -1.059 . . . . 3.37 110.245 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -98.83 -24.12 15.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.13 -0.981 . . . . 2.37 110.27 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.61 -40.19 92.35 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.983 -1.073 . . . . 1.65 110.913 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.11 -32.02 70.6 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.213 -0.929 . . . . 1.42 109.747 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.97 -41.67 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.11 -0.994 . . . . 1.43 109.313 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -70.13 -38.14 75.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.299 -0.876 . . . . 1.08 111.229 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -59.93 -40.05 87.62 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.723 -1.235 . . . . 1.37 109.683 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.49 -43.94 97.4 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.941 -1.664 . . . . 0.67 108.941 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 59.7 m170 -61.96 -43.03 99.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.457 -1.025 . . . . 1.99 109.403 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.0 mt -68.89 -45.22 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 1.22 109.697 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.0 ttp -59.99 -40.22 88.41 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.024 -1.048 . . . . 2.11 109.902 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.1 tp -65.23 -38.07 89.23 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.493 -0.755 . . . . 1.33 109.912 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.3 tp -66.28 -40.03 89.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.471 -0.768 . . . . 1.29 110.354 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -81.8 4.67 21.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.893 -1.129 . . . . 1.47 109.711 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -50.48 131.86 24.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.364 -0.835 . . . . 1.47 110.183 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -62.34 -17.63 59.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.508 -0.745 . . . . 1.78 110.483 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.95 -35.2 74.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.94 -1.1 . . . . 2.53 108.362 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.07 -40.02 75.29 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.468 0.651 . . . . 1.36 109.83 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.1 -49.99 75.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.508 -0.745 . . . . 1.42 110.12 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -71.9 -41.74 67.57 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.277 -0.89 . . . . 2.27 110.63 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.04 -40.74 74.95 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.054 -1.029 . . . . 1.57 111.596 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.9 mt -68.62 -45.74 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.835 -1.166 . . . . 1.19 109.79 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -69.61 -35.09 64.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.378 -0.826 . . . . 1.39 110.048 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.79 99.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 1.39 110.653 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.75 -48.09 83.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.913 -1.117 . . . . 1.5 109.579 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 55.8 mt -60.13 -48.15 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 121.981 0.896 . . . . 1.29 108.862 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -69.93 -40.05 75.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.759 -0.588 . . . . 2.64 111.187 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -83.54 -52.35 6.56 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.984 -1.073 . . . . 1.65 112.041 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -90.08 -2.27 58.08 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.073 -1.017 . . . . 2.5 111.679 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 56.9 34.68 25.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.918 -1.114 . . . . 1.88 109.305 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.4 mtp -90.31 166.63 13.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.432 -0.793 . . . . 1.71 110.158 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 67.2 p -77.63 160.41 28.54 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.457 -0.777 . . . . 1.61 109.279 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.61 -40.04 84.71 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.182 -0.949 . . . . 1.33 110.114 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 34.1 p-10 -68.37 -37.13 80.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.07 -1.019 . . . . 2.07 109.309 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.469 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -78.99 -39.96 32.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.041 -1.037 . . . . 1.37 109.593 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.46 -46.72 63.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.862 . . . . 1.14 110.498 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.04 93.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.092 -1.005 . . . . 1.26 109.652 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.528 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 85.3 t60 -59.91 -39.91 87.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.839 . . . . 2.02 109.717 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.13 -43.05 95.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.21 -0.931 . . . . 1.33 110.221 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.86 -59.45 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.185 -0.947 . . . . 1.3 110.83 -178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.1 mm -63.57 -40.02 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.891 -1.131 . . . . 1.32 108.974 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.528 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 86.7 tt0 -64.01 -40.13 95.65 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.73 -1.211 . . . . 2.44 107.73 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.07 -48.6 85.31 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.952 -1.259 . . . . 0.99 109.952 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -68.03 -50.73 53.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.933 -1.333 . . . . 1.97 109.188 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.33 88.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 1.43 108.606 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 30.3 t -59.91 -40.8 90.05 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.437 -0.949 . . . . 2.12 108.437 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.22 96.31 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.33 -0.856 . . . . 1.64 108.781 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.8 mt -66.37 -42.13 88.42 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.305 -0.958 . . . . 1.93 109.248 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -60.05 -40.01 87.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.737 -1.227 . . . . 2.2 109.444 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -50.22 -20.17 0.97 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.991 -1.068 . . . . 2.12 109.02 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 54.1 mt -64.19 144.46 57.11 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.141 -0.975 . . . . 2.34 108.611 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 -100.23 52.5 0.89 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.119 -0.988 . . . . 3.23 110.271 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 57.5 t0 -135.58 130.47 34.54 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.134 -0.979 . . . . 2.49 109.627 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 67.0 mt-10 -61.95 -32.97 73.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.741 . . . . 3.95 109.837 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.598 ' HH ' ' NH1' ' A' ' 126' ' ' ARG . 3.0 t80 -70.05 -38.53 75.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 2.25 110.421 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.42 -32.77 37.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.927 -1.108 . . . . 2.27 109.51 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -60.01 -40.48 89.4 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.905 -1.122 . . . . 3.31 108.177 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.1 -40.07 94.06 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.511 -0.922 . . . . 2.73 108.511 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.598 ' NH1' ' HH ' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -61.11 -39.95 91.94 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.643 -0.873 . . . . 3.2 108.643 179.416 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.18 -22.56 66.95 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.929 -0.767 . . . . 1.66 108.929 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.56 -42.59 70.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.645 -0.659 . . . . 1.67 109.78 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -63.88 -40.01 95.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 1.55 110.204 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.24 -41.68 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.106 -0.996 . . . . 1.32 109.427 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.4 ' HG2' HH11 ' A' ' 131' ' ' ARG . 30.3 ttt-85 -60.55 -37.34 80.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 3.58 109.221 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -59.99 -39.82 87.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.631 -0.668 . . . . 1.46 109.387 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.93 -42.04 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.01 -1.056 . . . . 1.22 109.46 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.41 -32.36 68.2 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.785 -1.326 . . . . 0.61 109.785 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.72 ' HZ3' ' HE ' ' A' ' 139' ' ' ARG . 50.3 tttm -59.92 -48.32 82.2 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.133 -1.216 . . . . 3.1 109.028 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.438 HH21 ' HB3' ' A' ' 166' ' ' SER . 1.8 mtt-85 -61.88 -35.34 78.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.993 . . . . 3.71 109.657 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.57 -44.18 93.39 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.507 -0.745 . . . . 1.87 110.275 -177.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 49.6 mt -65.12 -40.14 94.06 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.875 -1.141 . . . . 1.29 109.95 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.72 ' HE ' ' HZ3' ' A' ' 135' ' ' LYS . 59.2 mtt-85 -68.84 -38.96 80.18 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.485 -0.932 . . . . 3.05 108.485 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.486 HD21 ' N ' ' A' ' 140' ' ' ASN . 1.4 m120 -65.07 -38.53 91.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.749 -0.594 . . . . 1.26 110.98 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.6 mt -70.0 -43.16 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.548 -1.345 . . . . 1.34 108.946 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.03 -31.0 68.42 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.623 -0.673 . . . . 1.6 109.727 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.33 39.12 13.04 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.759 -1.737 . . . . 0.96 108.759 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.8 tp -73.96 149.55 41.3 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.469 -1.019 . . . . 1.67 109.623 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -61.42 146.74 47.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.509 -0.745 . . . . 4.96 110.127 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.51 121.93 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-O 122.077 0.941 . . . . 1.68 108.503 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 148' ' ' ASP . 6.0 mt -62.77 -44.32 99.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.839 -0.619 . . . . 2.14 110.823 -178.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 147' ' ' ILE . 50.7 t0 61.87 121.33 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.6 -0.688 . . . . 1.5 109.199 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 59.9 mt -87.97 0.85 55.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.406 -0.808 . . . . 1.39 109.999 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 62.1 m -82.67 -18.8 39.74 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.878 -1.139 . . . . 1.83 110.716 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.52 29.99 0.43 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.965 -1.085 . . . . 1.46 111.642 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 45.7 mm -90.55 119.19 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.682 -1.261 . . . . 1.42 108.38 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -100.15 -9.9 22.02 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.355 -0.841 . . . . 2.94 110.454 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -126.46 150.94 48.38 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.1 -1.0 . . . . 1.52 110.35 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.64 137.2 58.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.835 . . . . 1.58 109.413 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.6 m -152.18 163.5 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.992 -0.744 . . . . 1.32 108.992 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.3 mt -93.42 148.49 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 106.351 -1.722 . . . . 1.27 106.351 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 38.3 tp -96.8 114.28 25.9 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.862 -1.148 . . . . 1.41 110.299 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.51 130.08 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.525 -0.917 . . . . 1.23 108.525 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.08 162.05 39.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.169 -0.957 . . . . 1.32 108.899 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.94 -32.23 65.14 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.209 -1.557 . . . . 1.49 108.713 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 60.1 t0 -167.24 137.8 3.01 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.628 -0.879 . . . . 2.25 108.628 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.514 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 69.3 mt -112.89 131.41 55.74 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.347 -0.845 . . . . 1.35 109.926 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.5 p -100.56 148.92 35.63 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.419 -0.801 . . . . 1.56 108.906 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -38.22 -36.98 0.58 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.274 1.983 . . . . 0.87 112.717 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.438 ' HB3' HH21 ' A' ' 136' ' ' ARG . 4.2 m -50.34 -58.13 6.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 1.36 109.979 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -60.61 -39.85 89.7 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.38 -0.825 . . . . 1.61 110.755 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.445 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 64.4 p -60.03 -19.59 53.53 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.788 -1.195 . . . . 1.21 110.916 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -83.42 -38.6 21.7 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.852 -1.155 . . . . 1.21 109.556 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -104.66 39.3 1.71 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.663 -0.866 . . . . 2.11 108.663 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.6 tp -106.15 140.08 39.67 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.608 -0.886 . . . . 1.29 108.608 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -85.15 106.85 16.9 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.054 -1.029 . . . . 2.81 109.375 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 94.5 mt -62.84 -41.9 99.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.368 -0.833 . . . . 2.09 111.157 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -70.06 -24.49 63.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.155 -0.966 . . . . 2.86 111.859 -177.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -93.69 -10.52 34.14 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.654 -1.279 . . . . 2.39 109.711 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 68.8 t -98.62 107.02 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.154 -0.967 . . . . 1.27 108.6 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.3 mt -81.92 3.83 24.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.227 -0.92 . . . . 2.17 110.062 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 169.95 173.58 37.48 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.866 -1.294 . . . . 0.52 109.866 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 7.8 m-85 -129.31 126.93 40.07 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.411 -1.052 . . . . 0.55 109.24 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 75.5 mt -128.45 123.69 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.815 -1.18 . . . . 1.27 107.815 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 35.1 p -147.05 160.61 42.18 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.806 -1.184 . . . . 1.39 111.504 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 61.6 t0 -103.93 25.95 9.28 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.233 -0.654 . . . . 2.46 109.233 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.42 -162.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.317 -1.49 . . . . 1.51 111.562 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.69 -58.16 4.63 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 111.162 -0.775 . . . . 2.23 111.162 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -168.84 -149.79 6.37 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 118.506 -1.807 . . . . 2.23 111.515 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.461 ' O ' ' OG ' ' A' ' 191' ' ' SER . 33.8 ptt180 -77.93 -9.01 58.87 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.817 -0.814 . . . . 6.44 111.013 -178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 74.5 p -83.13 4.62 25.71 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.814 -1.179 . . . . 4.09 110.557 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 191' ' ' SER . 22.7 p -82.14 143.3 31.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.887 -1.133 . . . . 2.2 110.394 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -46.65 -52.45 13.72 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.335 -0.853 . . . . 1.15 110.096 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.11 -38.0 70.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.361 -0.837 . . . . 2.01 110.725 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.642 ' HG ' ' N ' ' A' ' 192' ' ' ILE . 80.5 p -61.69 -40.54 95.35 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.891 -1.131 . . . . 1.93 111.029 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.642 ' N ' ' HG ' ' A' ' 191' ' ' SER . 97.9 mt -60.09 -39.71 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.014 . . . . 2.2 109.123 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.0 mtp -59.98 -45.3 93.15 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.556 -0.715 . . . . 1.32 110.214 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.72 91.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.601 -1.312 . . . . 1.3 110.292 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -61.1 -52.04 66.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.853 -1.154 . . . . 3.38 110.607 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 62.1 m -70.4 -34.73 72.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.001 -1.062 . . . . 1.15 111.759 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.23 -9.98 59.05 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.702 -1.249 . . . . 1.28 110.543 -178.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 61.91 50.21 4.31 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.482 -0.761 . . . . 1.5 111.423 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 20.9 mt -128.36 149.48 71.61 Favored Pre-proline 0 N--CA 1.5 2.048 0 N-CA-C 107.664 -1.235 . . . . 1.37 107.664 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.06 139.5 46.96 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 122.245 1.963 . . . . 0.76 111.718 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.5 150.56 4.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.845 -1.159 . . . . 1.19 111.725 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 91.9 mt -126.86 142.12 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.792 -1.188 . . . . 1.31 107.792 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 18.2 m -123.03 -8.99 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 120.827 -1.17 . . . . 1.38 111.542 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -113.14 24.29 12.86 Favored Glycine 0 N--CA 1.502 3.07 0 N-CA-C 110.677 -0.969 . . . . 1.03 110.677 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.411 ' C ' ' O ' ' A' ' 204' ' ' GLY . 17.5 p -43.41 -47.91 7.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.121 -1.223 . . . . 1.38 110.074 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.433 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 97.03 -55.04 1.33 Allowed Glycine 0 N--CA 1.499 2.897 0 C-N-CA 120.341 -0.933 . . . . 1.17 111.611 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 85.6 p -148.52 28.59 0.87 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.397 -1.649 . . . . 2.07 111.584 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 18.3 t -70.03 -36.74 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.717 -1.24 . . . . 1.35 108.839 178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.3 p -58.02 -30.66 66.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 1.49 110.964 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.1 t -83.02 -19.4 37.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.803 -1.186 . . . . 2.16 110.389 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -96.98 -11.93 23.97 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.089 -1.007 . . . . 2.89 110.471 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.2 t -107.93 137.41 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.256 -0.902 . . . . 1.33 110.628 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -114.89 149.71 36.76 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.48 -1.304 . . . . 2.73 107.48 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 8.2 t-20 -56.25 138.58 50.12 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.083 -1.011 . . . . 2.7 110.955 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.0 m-20 83.88 7.42 0.62 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.138 0.494 . . . . 2.38 110.229 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -77.91 145.9 35.89 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.207 -0.933 . . . . 2.09 108.871 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -95.34 117.12 29.76 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.273 -1.01 . . . . 1.45 108.273 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 72.0 mt -126.75 150.7 48.94 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.578 -0.701 . . . . 1.31 110.278 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.7 mt -115.93 128.55 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 106.846 -1.539 . . . . 1.29 106.846 177.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 60.9 tp -99.98 120.09 39.27 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.947 -1.096 . . . . 1.31 109.186 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 223' ' ' VAL . 12.2 t70 -80.18 -41.13 25.87 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.281 -1.007 . . . . 2.31 108.281 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 47.27 12.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.775 -0.578 . . . . 1.19 109.55 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 221' ' ' ASP . 42.8 t -124.85 -35.44 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.283 -1.377 . . . . 1.45 107.283 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.519 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 71.9 m-80 -111.76 2.61 17.23 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.99 -1.115 . . . . 3.13 107.99 178.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.493 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.6 OUTLIER 59.63 47.77 10.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.776 -0.578 . . . . 2.2 110.376 179.715 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -135.5 148.22 49.11 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.147 -0.97 . . . . 2.32 109.864 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.7 t -117.84 125.72 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.545 -0.909 . . . . 1.4 108.545 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -101.13 121.87 42.6 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.405 -0.809 . . . . 1.29 109.177 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 32.1 t -101.85 113.16 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.462 -0.774 . . . . 1.38 110.897 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 52.02 60.75 13.2 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.052 -1.03 . . . . 2.33 111.3 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -86.67 152.64 8.83 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.653 2.236 . . . . 0.95 111.822 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.4 p -74.2 168.44 19.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.097 -1.002 . . . . 2.31 110.526 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -59.99 -37.94 81.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.663 -0.648 . . . . 3.45 110.265 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.57 -38.9 82.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 2.89 109.846 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.95 -41.35 79.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.218 -0.927 . . . . 1.73 109.236 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.221 -0.924 . . . . 1.57 109.569 -179.999 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -151.3 149.15 29.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -0.837 . . . . 0.0 108.83 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . 0.491 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 0.4 OUTLIER -146.15 154.65 42.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.199 -0.938 . . . . 0.0 110.171 -178.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -152.73 149.38 28.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.535 -0.728 . . . . 0.0 109.113 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -112.52 131.78 55.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.287 -0.883 . . . . 0.0 109.101 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.0 123.59 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-O 122.284 1.04 . . . . 0.0 112.476 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 29.3 m -77.84 104.05 8.15 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.999 0.904 . . . . 0.0 110.126 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 90.1 mt -51.59 119.58 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 122.487 1.137 . . . . 0.0 110.366 -177.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 23.7 p -99.9 24.63 8.23 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.587 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -88.28 113.62 55.98 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -70.99 -5.24 16.54 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 CA-C-N 120.215 1.113 . . . . 0.0 111.864 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -110.45 0.65 17.9 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 74.26 172.17 26.91 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.496 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.5 tp -86.05 93.81 9.08 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.956 -1.32 . . . . 0.0 108.333 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -93.47 -161.58 0.86 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.205 -0.935 . . . . 0.0 110.418 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.9 m -59.3 -44.59 92.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.126 -0.984 . . . . 0.0 112.416 -176.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.473 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.3 tpt180 -57.11 -62.52 5.03 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 120.436 -1.415 . . . . 0.0 111.532 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.75 -30.68 85.44 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 120.2 1.107 . . . . 0.0 111.539 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.11 -50.62 72.96 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.371 -0.931 . . . . 0.0 108.83 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -54.88 -43.17 72.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 109.874 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -70.1 -41.32 74.18 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.809 -1.156 . . . . 0.0 108.826 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -60.08 -50.19 74.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.455 -0.778 . . . . 0.0 110.356 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 80.4 t -68.93 -27.72 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.713 -1.242 . . . . 0.0 109.74 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -60.02 -49.14 78.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.881 . . . . 0.0 110.332 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -68.52 -40.15 80.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.075 -1.015 . . . . 0.0 111.326 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.87 -53.3 58.99 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.561 -1.337 . . . . 0.0 111.108 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -57.69 -11.61 2.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.095 -1.003 . . . . 0.0 109.426 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -68.07 -29.98 73.72 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -104.98 144.21 32.11 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.451 -1.029 . . . . 0.0 109.159 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 7.7 m -90.22 -11.28 41.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.062 -1.024 . . . . 0.0 109.443 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 331' ' ' SER . . . . . 0.633 ' HG ' ' N ' ' B' ' 369' ' ' ASP . 33.8 m -57.99 149.02 24.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 109.846 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.91 132.9 48.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.905 . . . . 0.0 109.236 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.9 mt -133.4 132.28 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.307 -0.871 . . . . 0.0 110.041 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 52.7 m -128.17 153.15 47.2 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 84.0 t -119.85 139.87 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 96.8 m -130.33 123.03 29.04 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.275 -0.891 . . . . 0.0 108.739 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 59.8 p -140.11 121.86 15.4 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.081 0.943 . . . . 0.0 111.314 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 57.4 t30 43.49 52.68 5.95 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.35 -12.27 59.0 Favored Glycine 0 N--CA 1.5 2.941 0 O-C-N 120.182 -1.574 . . . . 0.0 112.904 176.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -118.94 129.45 55.18 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-N 119.268 1.534 . . . . 0.0 109.925 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 69.7 m -122.32 146.13 47.6 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.763 0.792 . . . . 0.0 110.078 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -140.42 161.05 38.63 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.472 0.653 . . . . 0.0 109.805 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.8 t -86.09 136.29 33.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.517 -0.739 . . . . 0.0 109.246 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -79.11 -14.12 59.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.978 -1.076 . . . . 0.0 110.418 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -87.36 21.47 2.45 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.487 ' H ' ' C ' ' B' ' 344' ' ' ALA . 69.2 m -149.62 99.39 2.87 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.795 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 58.0 tp -60.11 -35.28 74.89 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -55.38 -54.43 43.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.956 -1.09 . . . . 0.0 109.786 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -69.93 -20.57 63.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.29 -0.881 . . . . 0.0 111.29 -177.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' B' ' 352' ' ' THR . 32.8 mt -70.32 -57.91 4.34 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.716 -1.24 . . . . 0.0 110.666 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.455 ' NE2' ' NE ' ' A' ' 126' ' ' ARG . 2.9 mm100 -44.92 -14.77 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.093 -1.005 . . . . 0.0 111.409 -176.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.511 ' N ' ' O ' ' B' ' 350' ' ' LEU . 70.4 p -80.3 -13.44 59.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.196 -1.565 . . . . 0.0 110.278 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 34.9 mt -93.03 119.26 32.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.098 -1.002 . . . . 0.0 108.778 178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.14 91.22 0.91 Allowed Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 18.9 mt -96.5 87.31 4.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.327 -1.102 . . . . 0.0 108.527 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 64.3 p -92.2 -179.48 5.26 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.802 0.81 . . . . 0.0 110.668 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . 0.424 ' O ' ' N ' ' B' ' 359' ' ' THR . 65.8 tt0 -49.41 155.57 0.72 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 122.268 1.033 . . . . 0.0 111.109 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.88 27.58 0.06 OUTLIER Glycine 0 N--CA 1.497 2.729 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.56 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 359' ' ' THR . . . . . 0.424 ' N ' ' O ' ' B' ' 357' ' ' GLN . 11.8 m -86.57 109.95 19.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.767 -1.431 . . . . 0.0 109.864 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.25 114.77 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.343 1.068 . . . . 0.0 110.147 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 9.9 m -111.93 177.52 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 49.7 m -130.95 130.1 43.0 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 81.9 mt -106.36 122.28 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 77.3 p -125.05 134.67 52.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.22 152.2 38.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.142 -0.973 . . . . 0.0 110.119 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -142.18 121.73 13.31 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 164.43 -163.28 36.04 Favored Glycine 0 N--CA 1.485 1.923 0 C-N-CA 118.636 -1.745 . . . . 0.0 111.536 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -59.57 -50.07 75.32 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.01 -0.595 . . . . 0.0 111.673 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.633 ' N ' ' HG ' ' B' ' 331' ' ' SER . 85.2 m-20 -111.6 10.3 21.15 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.974 -1.079 . . . . 0.0 110.936 -177.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.548 ' H ' ' HG ' ' B' ' 331' ' ' SER . 0.7 OUTLIER -44.02 -33.78 1.54 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.113 -0.992 . . . . 0.0 111.596 -178.61 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -69.89 -40.36 75.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.619 -1.301 . . . . 0.0 109.594 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -68.29 -48.15 65.75 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.173 -0.954 . . . . 0.0 109.862 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -50.44 -74.38 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.149 -0.97 . . . . 0.0 110.91 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 67.6 t -44.11 -40.75 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.254 -0.904 . . . . 0.0 110.697 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.86 -50.16 72.03 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.526 -1.358 . . . . 0.0 110.481 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -75.81 -40.03 55.72 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.802 -1.186 . . . . 0.0 110.669 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 98.9 mt -59.0 -37.51 77.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.011 -1.056 . . . . 0.0 108.606 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.74 -40.21 84.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.279 -0.888 . . . . 0.0 109.093 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' B' ' 383' ' ' GLU . 20.3 mmmt -67.97 -55.04 14.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.705 -1.247 . . . . 0.0 107.939 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 63.6 tp -56.36 -35.57 67.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.358 -0.839 . . . . 0.0 110.241 -178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 34.7 ttm -72.45 -41.06 66.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.727 -1.233 . . . . 0.0 109.107 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.59 -5.69 58.27 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.346 -0.846 . . . . 0.0 110.215 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' B' ' 379' ' ' LYS . 96.2 mt-10 -109.72 -2.78 17.19 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.132 -0.98 . . . . 0.0 111.37 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.4 mt -83.7 130.02 34.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.285 -1.509 . . . . 0.0 109.027 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 N--CA 1.499 1.984 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.629 -179.656 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.251 0.548 . . . . 3.19 109.679 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.0 mt -110.18 129.88 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.47 -0.769 . . . . 1.71 109.114 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.8 m -130.81 148.78 52.62 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.514 -0.741 . . . . 1.66 109.173 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.41 ' H ' ' CG ' ' A' ' 225' ' ' ASN . . . -130.95 -163.54 10.99 Favored Glycine 0 N--CA 1.499 2.861 0 N-CA-C 108.142 -1.983 . . . . 1.05 108.142 179.323 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.451 ' O ' ' O ' ' A' ' 6' ' ' LEU . 95.7 mt -89.16 -14.79 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.659 -1.495 . . . . 1.59 110.068 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.0 tp 54.18 103.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.311 -0.868 . . . . 1.47 109.038 -179.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.94 -27.28 14.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.186 -0.946 . . . . 1.39 109.424 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 m -140.57 124.8 10.65 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.426 -0.796 . . . . 2.09 109.465 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.77 150.08 18.48 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.456 2.104 . . . . 0.91 112.904 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 146.93 171.78 16.53 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 109.811 -1.316 . . . . 0.92 109.811 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.429 HG23 HD13 ' A' ' 11' ' ' ILE . 89.7 mt -122.85 130.01 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 O-C-N 121.026 -1.279 . . . . 1.35 110.518 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.74 149.32 51.47 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.354 -0.842 . . . . 1.14 110.046 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.4 m-85 -126.52 129.1 47.96 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.726 -1.213 . . . . 0.7 107.726 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.12 176.39 46.85 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 118.732 -1.699 . . . . 0.58 110.998 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -79.94 158.75 26.55 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.443 -1.033 . . . . 2.63 109.438 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.59 137.04 43.02 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.522 -0.737 . . . . 1.27 111.015 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.1 tp -106.64 133.36 51.42 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 106.936 -1.505 . . . . 1.41 106.936 177.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.0 tp -113.55 122.14 46.33 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.169 -0.957 . . . . 1.49 109.687 -179.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.1 mt -85.17 100.78 11.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.617 -0.677 . . . . 1.52 109.399 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -99.37 133.23 43.97 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.441 -0.787 . . . . 3.17 109.463 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -130.19 134.88 47.6 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.462 -0.774 . . . . 3.0 108.938 179.307 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -79.69 158.21 27.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.294 -0.879 . . . . 2.77 109.995 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -70.45 145.78 50.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.351 -0.843 . . . . 2.94 109.225 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.8 mt -89.64 129.09 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.094 -1.003 . . . . 1.46 108.967 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t -93.78 125.47 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.181 -0.949 . . . . 1.7 110.38 -179.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.06 133.72 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.521 -0.918 . . . . 1.54 108.521 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -94.34 117.94 30.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.008 -1.058 . . . . 1.81 109.847 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.467 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.2 mmt-85 -89.89 3.8 51.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.294 -0.879 . . . . 3.23 109.415 -179.556 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -62.95 149.42 44.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.943 . . . . 3.29 109.647 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -91.77 141.91 28.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.364 -0.835 . . . . 2.8 109.217 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 pt -93.77 164.39 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.852 -1.155 . . . . 1.43 109.995 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.6 p -92.42 171.53 8.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.22 -0.925 . . . . 1.54 108.664 178.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.27 -15.53 63.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.106 -0.996 . . . . 1.6 110.285 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -85.6 -28.61 24.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.874 -1.141 . . . . 2.56 108.447 178.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -81.58 -8.41 59.71 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.14 -0.689 . . . . 2.36 109.14 179.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.0 t -63.72 -54.91 26.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.115 -0.991 . . . . 1.43 109.129 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.45 -39.72 88.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.077 -1.014 . . . . 1.77 109.355 179.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -65.7 -42.63 90.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 3.32 110.156 -179.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.59 -40.15 95.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.901 -1.124 . . . . 1.51 110.66 -179.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.63 -46.59 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.576 -1.328 . . . . 1.41 108.182 179.206 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -60.14 -44.32 95.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.175 -0.953 . . . . 1.81 109.389 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -59.98 -43.41 95.13 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.908 -1.145 . . . . 3.26 107.908 179.217 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -64.45 -40.02 94.92 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.451 -0.944 . . . . 0.81 108.451 179.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.21 -49.95 75.58 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.354 -0.98 . . . . 1.59 108.354 179.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.3 t -63.21 -43.5 97.95 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.22 -0.992 . . . . 1.38 108.92 179.086 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.64 -40.02 95.71 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.347 -1.901 . . . . 0.87 108.347 179.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.557 ' NH2' ' O ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER -66.65 -39.4 88.21 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.871 -1.159 . . . . 3.62 107.871 178.396 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.0 75.15 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.278 -0.638 . . . . 1.43 109.278 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ALA . 22.2 ttmt -60.72 -74.77 0.07 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.102 -1.073 . . . . 3.08 108.102 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.73 -34.12 0.1 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.435 -0.791 . . . . 1.33 111.471 -177.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.6 m -60.27 -54.68 42.84 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.536 -1.352 . . . . 1.85 108.674 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.82 -41.22 75.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.339 -0.851 . . . . 1.35 111.161 -178.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.33 -39.92 95.87 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.783 -1.198 . . . . 2.34 110.218 -179.289 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.1 mt -66.33 -39.79 89.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.0 -1.063 . . . . 2.2 109.963 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -59.97 -38.95 84.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.143 -0.973 . . . . 1.35 109.592 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -61.87 -41.18 97.55 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.059 -1.025 . . . . 1.34 110.095 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.34 -37.19 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.255 -0.903 . . . . 1.26 109.6 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -57.29 -51.16 70.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.432 -0.792 . . . . 1.7 110.665 -178.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -60.62 -37.2 80.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.017 . . . . 1.35 111.672 -177.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.1 -39.85 94.95 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.869 -1.145 . . . . 2.08 110.267 -179.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.3 96.88 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.533 -0.729 . . . . 1.21 109.936 -179.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.84 -52.16 54.11 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.703 -1.359 . . . . 0.75 109.703 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.63 -48.04 73.55 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.167 -1.196 . . . . 1.59 109.806 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.7 m -70.07 -58.74 3.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.344 -0.848 . . . . 1.41 112.144 -177.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -96.85 -53.68 3.45 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.912 -1.117 . . . . 0.79 111.292 -178.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.51 -167.42 25.84 Favored Glycine 0 N--CA 1.5 2.96 0 C-N-CA 119.678 -1.248 . . . . 1.22 111.31 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -70.01 -25.51 63.63 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.799 -0.824 . . . . 5.81 110.685 -179.397 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -61.6 -35.59 78.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -0.954 . . . . 3.37 110.46 -179.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -100.38 -19.83 16.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.31 -0.868 . . . . 2.37 110.282 -179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -69.94 -39.97 75.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.98 -1.075 . . . . 1.65 110.263 -179.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.85 -27.99 68.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.351 -0.843 . . . . 1.42 109.486 -179.174 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 85.3 mt -60.08 -40.49 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.18 -0.95 . . . . 1.43 108.928 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -69.74 -36.84 76.16 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.193 -0.942 . . . . 1.08 110.705 -179.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -59.88 -40.04 87.34 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.919 -1.113 . . . . 1.37 109.289 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.04 -43.82 95.23 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.523 -1.431 . . . . 0.67 109.523 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -62.62 -41.56 99.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -1.113 . . . . 1.99 109.043 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.7 mt -68.67 -46.46 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.766 -0.828 . . . . 1.22 108.766 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.1 ttp -60.25 -42.95 96.4 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.222 -0.924 . . . . 2.11 109.786 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.91 -40.71 97.12 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.416 -0.803 . . . . 1.33 109.44 179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.557 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 61.8 tp -64.99 -39.81 94.02 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.63 -0.669 . . . . 1.29 109.827 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -79.68 2.14 23.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 1.47 110.677 -178.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -48.95 128.01 15.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.843 -1.16 . . . . 1.47 109.777 -179.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.15 -17.17 51.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.595 -0.69 . . . . 1.78 110.211 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -74.09 -32.95 63.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.074 -1.016 . . . . 2.53 109.43 178.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.07 -41.16 74.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.472 -0.767 . . . . 1.36 109.345 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -60.76 -46.22 91.31 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.383 -0.823 . . . . 1.42 110.159 -179.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -70.05 -41.93 73.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.344 -0.847 . . . . 2.27 110.44 -178.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.07 -39.9 75.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.912 . . . . 1.57 110.096 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.7 mt -66.68 -47.06 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.259 -0.901 . . . . 1.19 109.592 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.9 -37.57 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 1.39 110.111 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.04 -48.31 82.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.183 -0.948 . . . . 1.39 110.913 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.2 mt -60.3 -46.99 87.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.074 -1.016 . . . . 1.5 110.191 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.0 mt -61.13 -49.94 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 1.29 108.674 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -65.22 -43.28 92.0 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.107 -0.637 . . . . 2.64 110.491 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -80.02 -53.04 7.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.957 -1.09 . . . . 1.65 111.992 -178.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -90.48 -2.43 57.92 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.957 -1.089 . . . . 2.5 112.37 -177.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.3 m80 57.12 36.55 27.73 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.785 -1.197 . . . . 1.88 109.729 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 77.2 mtp -88.22 165.55 14.97 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.293 -0.879 . . . . 1.71 109.34 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.425 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 33.6 p -76.56 159.48 30.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.064 -1.022 . . . . 1.61 108.49 179.348 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.79 -39.96 91.47 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.285 -0.966 . . . . 1.33 110.047 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 24.1 p-10 -66.58 -34.87 78.86 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.122 -0.986 . . . . 2.07 109.312 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.17 -42.2 23.87 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.282 -0.886 . . . . 1.37 109.708 179.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.12 -48.4 68.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 1.14 109.9 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.7 92.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 1.26 109.845 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -60.0 -40.67 90.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 2.02 110.204 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.03 -40.26 95.09 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.305 -0.872 . . . . 1.33 110.342 -179.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.4 -53.16 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.076 -1.015 . . . . 1.3 111.028 -178.377 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.88 -40.05 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.861 -1.149 . . . . 1.32 109.307 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -64.64 -36.1 83.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 2.44 108.901 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.437 ' O ' ' OG ' ' A' ' 113' ' ' SER . . . -63.51 -49.93 65.99 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.805 -0.712 . . . . 0.99 111.688 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.589 HE21 ' CB ' ' B' ' 348' ' ' PHE . 19.4 mm100 -64.05 -47.01 81.83 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.55 -1.559 . . . . 1.97 110.01 -178.616 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.87 -39.49 85.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.067 -1.021 . . . . 1.43 109.512 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 110' ' ' GLY . 91.2 p -59.79 -40.05 86.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.946 . . . . 2.12 109.746 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.82 -39.86 86.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.858 -1.151 . . . . 1.64 108.929 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 35.3 mt -61.27 -42.89 99.41 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.832 -1.167 . . . . 1.93 108.912 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.541 ' OE2' ' NH2' ' A' ' 131' ' ' ARG . 98.3 mt-10 -50.18 -26.08 4.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.092 -1.005 . . . . 2.2 109.567 -179.387 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -65.53 -26.49 67.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.084 -1.01 . . . . 2.12 108.716 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 59.6 mt -63.09 144.09 57.21 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.382 -0.824 . . . . 2.34 109.521 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -97.04 14.45 25.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.153 -0.967 . . . . 3.23 109.945 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 58.0 t0 -102.98 143.3 32.73 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.174 -0.954 . . . . 2.49 109.788 -179.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.542 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 66.6 mm-40 -71.57 -63.94 1.02 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.979 -1.119 . . . . 3.95 107.979 178.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.733 ' HH ' ' HE ' ' A' ' 126' ' ' ARG . 1.8 t80 -38.49 -40.0 0.52 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 116.032 -0.531 . . . . 2.25 110.818 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.85 -40.09 72.55 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.724 -1.235 . . . . 2.27 109.189 179.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 121' ' ' GLU . 61.4 tttp -60.73 -38.95 86.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.244 -0.91 . . . . 3.31 109.836 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -59.78 -39.78 86.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.371 -0.831 . . . . 2.73 109.258 -179.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.733 ' HE ' ' HH ' ' A' ' 122' ' ' TYR . 1.1 mtt-85 -60.11 -39.96 88.01 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.106 -0.996 . . . . 3.2 109.019 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.92 -31.15 71.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.25 -0.906 . . . . 1.66 109.505 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.52 -40.54 95.0 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.384 -0.926 . . . . 1.67 108.565 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -67.28 -40.17 86.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.435 -0.791 . . . . 1.55 109.681 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.04 -40.54 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.353 -0.98 . . . . 1.32 108.353 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.541 ' NH2' ' OE2' ' A' ' 116' ' ' GLU . 39.6 ttm180 -62.29 -37.48 85.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.619 -0.676 . . . . 3.58 109.472 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -59.74 -40.56 88.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.211 -0.931 . . . . 1.46 109.457 -178.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.09 -43.44 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.092 -1.005 . . . . 1.22 109.313 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.22 -44.61 97.9 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.098 -1.201 . . . . 0.61 110.098 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -60.82 -49.67 76.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.166 -1.196 . . . . 3.1 111.148 -179.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -64.88 -35.92 82.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.81 -1.181 . . . . 3.71 110.246 -178.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 64.9 tp -60.08 -40.6 90.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 1.87 109.04 -179.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.36 -39.93 94.75 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.32 -0.863 . . . . 1.29 109.264 179.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -69.66 -34.63 74.26 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.673 -0.862 . . . . 3.05 108.673 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -66.69 -36.1 81.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.537 -0.727 . . . . 1.26 110.849 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.4 mt -70.66 -40.96 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 120.571 -1.331 . . . . 1.34 108.754 179.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.17 -35.2 68.93 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.569 -0.707 . . . . 1.6 109.73 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.49 34.94 8.19 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.043 -1.623 . . . . 0.96 109.043 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 29.1 tp -73.57 144.67 45.96 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.35 -1.088 . . . . 1.67 109.626 -179.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -61.15 143.76 54.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.449 -0.782 . . . . 4.96 110.486 -179.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.4 mt -111.67 127.27 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.362 -0.977 . . . . 1.68 108.362 178.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 148' ' ' ASP . 14.5 mm -59.94 -48.14 88.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.468 -0.77 . . . . 2.14 110.505 -177.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 147' ' ' ILE . 31.2 t0 62.46 118.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.344 -0.848 . . . . 1.5 109.007 -179.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.0 mt -84.91 -1.73 56.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.699 -0.626 . . . . 1.39 110.39 -178.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 92.4 p -83.38 -10.32 58.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.802 -1.186 . . . . 1.83 108.608 178.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.6 17.61 2.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.728 -0.607 . . . . 1.46 110.955 -177.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 52.2 mt -90.88 122.9 42.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.894 -1.129 . . . . 1.42 108.981 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -104.74 -7.35 19.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.496 -0.752 . . . . 2.94 110.613 -178.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -126.96 150.66 49.27 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.425 -0.797 . . . . 1.52 110.064 -179.067 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.4 136.35 57.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.224 -0.923 . . . . 1.58 108.827 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.8 m -153.08 167.88 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.477 -0.764 . . . . 1.32 109.975 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 76.4 mt -94.8 148.27 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 105.85 -1.907 . . . . 1.27 105.85 176.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 33.6 tp -97.15 118.31 33.29 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.732 -1.23 . . . . 1.41 110.71 -177.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.2 t -120.79 126.39 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.675 -0.64 . . . . 1.23 109.551 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.74 160.71 34.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.12 -0.987 . . . . 1.32 108.986 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.92 -33.12 70.22 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.362 -1.461 . . . . 1.49 108.672 178.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 25.1 p-10 -171.09 142.03 1.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.576 -0.703 . . . . 2.25 109.119 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.9 mt -114.53 131.28 56.7 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.35 -0.844 . . . . 1.35 108.899 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.8 p -88.67 149.41 43.95 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.967 -1.083 . . . . 1.56 108.786 179.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -40.73 -34.39 1.28 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.942 1.761 . . . . 0.87 112.039 179.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 72.5 m -59.03 -40.14 84.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.189 -0.945 . . . . 1.36 109.194 -178.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -70.25 -40.52 74.37 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.305 -0.958 . . . . 1.61 109.615 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.5 p -57.24 -22.6 42.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.354 -0.841 . . . . 1.21 111.87 -177.545 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.407 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -85.09 -49.49 8.22 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.539 -1.351 . . . . 1.21 109.925 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -83.92 38.05 0.63 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.924 -1.139 . . . . 2.11 107.924 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.407 ' H ' ' C ' ' A' ' 169' ' ' ALA . 57.6 tp -107.6 130.99 54.84 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.303 -0.629 . . . . 1.29 109.303 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -86.44 103.52 15.06 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.109 -1.071 . . . . 2.81 108.109 178.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.19 -40.98 94.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.407 -0.808 . . . . 2.09 111.23 -178.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -63.54 -26.07 68.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.701 -1.249 . . . . 2.86 111.541 -177.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -93.57 -9.44 38.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.753 -1.217 . . . . 2.39 110.045 -178.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.1 t -104.71 115.23 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.346 -0.846 . . . . 1.27 108.792 179.044 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.4 mt -85.74 7.71 22.58 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.129 -0.982 . . . . 2.17 110.626 -178.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 166.91 174.66 36.35 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.725 -1.35 . . . . 0.52 109.725 179.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -130.98 129.11 41.68 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.393 -1.063 . . . . 0.55 109.069 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 89.6 mt -131.7 125.53 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.413 -0.804 . . . . 1.27 109.246 178.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 42.0 p -152.51 162.18 41.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.057 -1.027 . . . . 1.39 110.478 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 182' ' ' ASP . 36.7 p30 -107.85 26.89 9.79 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.658 -0.651 . . . . 2.46 109.358 179.354 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.69 -159.39 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.903 -1.123 . . . . 1.51 111.687 -178.285 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.44 -64.01 3.44 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 111.205 -0.758 . . . . 2.23 111.205 -178.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.12 -135.48 3.91 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.021 -1.562 . . . . 2.23 110.84 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.406 HH11 ' HG2' ' A' ' 186' ' ' ARG . 44.8 mtt-85 -61.1 -32.42 72.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.506 -0.996 . . . . 6.44 110.862 -178.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 11.3 p -71.53 1.73 6.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.963 -1.086 . . . . 4.09 110.275 -178.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.9 t -90.95 131.28 36.66 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.995 -1.066 . . . . 2.2 110.49 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -46.16 -44.94 16.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.346 -0.846 . . . . 1.15 108.965 179.285 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.4 p -56.37 -42.79 78.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.809 -0.557 . . . . 2.01 111.001 -178.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.4 m -60.22 -40.08 88.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.922 -1.111 . . . . 1.93 110.919 -178.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 192' ' ' ILE . 91.2 mt -61.9 -40.9 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.084 -1.01 . . . . 2.2 110.157 -178.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 86.9 mtp -60.12 -43.35 95.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.103 -0.998 . . . . 1.32 110.141 -179.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.2 94.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.77 -1.206 . . . . 1.3 110.279 -179.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -60.26 -51.78 68.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 3.38 111.228 -178.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 69.1 m -72.6 -34.44 67.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.914 -1.116 . . . . 1.15 111.93 -178.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.6 -14.05 58.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.71 -1.244 . . . . 1.28 110.378 -178.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 57.97 48.37 13.44 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.355 -0.841 . . . . 1.5 110.349 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 94.8 mt -118.01 122.21 30.71 Favored Pre-proline 0 N--CA 1.501 2.107 0 N-CA-C 108.182 -1.044 . . . . 1.37 108.182 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -42.02 130.3 4.39 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.809 1.673 . . . . 0.76 112.377 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -171.46 152.43 3.25 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.012 -1.075 . . . . 1.19 111.483 -179.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.0 mt -126.91 141.8 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 107.729 -1.212 . . . . 1.31 107.729 178.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.7 m -124.92 -8.86 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 O-C-N 120.731 -1.23 . . . . 1.38 110.983 -178.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.48 22.89 23.64 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.254 -1.139 . . . . 1.03 110.254 -179.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 11.6 p -44.92 -42.56 8.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.163 -1.198 . . . . 1.38 109.835 -179.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.79 -51.24 2.91 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 120.149 -1.024 . . . . 1.17 111.006 179.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.9 m -157.9 37.36 0.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.523 -1.575 . . . . 2.07 111.427 -178.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 35.4 t -79.52 -32.04 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.789 -1.194 . . . . 1.35 108.749 178.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 74.3 p -59.93 -35.02 74.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.503 -0.748 . . . . 1.49 111.143 -178.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 85.2 p -80.14 -12.13 59.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.916 -1.115 . . . . 2.16 110.413 -179.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -100.06 -12.51 19.63 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.24 -0.913 . . . . 2.89 110.465 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 91.9 t -106.31 140.12 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.295 -0.878 . . . . 1.33 111.053 -178.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.476 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 2.0 mptp? -113.7 152.9 29.84 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.306 -1.368 . . . . 2.73 107.306 178.022 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.494 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 28.9 p-10 -57.86 137.59 56.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.011 -1.056 . . . . 2.7 110.561 -178.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 6.2 t0 85.29 2.1 0.69 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 122.117 -0.364 . . . . 2.38 110.734 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.476 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 91.8 m-20 -70.98 143.84 50.69 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.867 -1.146 . . . . 2.09 108.713 179.036 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -93.16 113.72 26.03 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.081 -1.081 . . . . 1.45 108.081 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 61.0 mt -123.29 145.55 48.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.607 -0.683 . . . . 1.31 110.349 -179.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.407 HG23 HD12 ' A' ' 219' ' ' ILE . 79.9 mt -111.36 129.87 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 106.21 -1.774 . . . . 1.29 106.21 176.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 51.4 tp -100.35 118.93 37.63 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.889 -1.132 . . . . 1.31 108.534 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 10' ' ' GLY . 38.5 t0 -77.84 -45.97 22.82 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.189 -0.944 . . . . 2.31 108.819 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 51.75 16.59 0.5 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.991 -1.115 . . . . 1.19 107.991 -178.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.456 ' N ' ' C ' ' A' ' 221' ' ' ASP . 42.0 t -126.17 -46.14 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 106.74 -1.578 . . . . 1.45 106.74 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.509 ' CG ' HE21 ' A' ' 226' ' ' GLN . 55.3 t-20 -102.25 2.92 37.66 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.44 -1.319 . . . . 3.13 107.44 178.129 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.41 ' CG ' ' H ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 59.84 46.24 11.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.976 -0.452 . . . . 2.2 110.048 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.509 HE21 ' CG ' ' A' ' 224' ' ' ASN . 42.9 mt-30 -140.42 154.07 46.53 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.214 -0.929 . . . . 2.32 109.898 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 88.5 t -119.97 131.5 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.079 -0.712 . . . . 1.4 109.079 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -94.99 119.06 32.86 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.177 -0.952 . . . . 1.29 108.487 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 91.6 t -99.69 115.24 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.323 -0.861 . . . . 1.38 109.618 -179.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 67.09 71.07 0.44 Allowed Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.58 -0.7 . . . . 2.33 109.634 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -90.19 124.9 1.18 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.337 2.692 . . . . 0.95 112.6 -179.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 63.6 m -67.01 159.68 28.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.413 -0.804 . . . . 2.31 109.261 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -60.08 -38.74 83.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.087 -1.008 . . . . 3.45 109.972 -179.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -60.12 -40.16 88.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.106 -0.996 . . . . 2.89 109.599 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.61 -39.97 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.218 -0.926 . . . . 1.73 109.919 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.2 mt . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.021 -1.05 . . . . 1.57 109.436 179.726 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 301' ' ' MET . . . . . 0.402 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 50.4 ttp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.485 0.66 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 23.7 t80 -151.58 149.65 29.41 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . 0.418 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 19.2 pt20 -149.65 159.68 44.14 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.876 -1.14 . . . . 0.0 110.521 -178.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -152.48 148.58 27.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.68 -0.638 . . . . 0.0 109.456 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -110.58 131.49 55.01 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.09 -1.006 . . . . 0.0 109.803 179.212 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.74 122.84 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-O 122.262 1.03 . . . . 0.0 112.294 -177.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 46.2 m -77.48 106.77 9.46 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.062 0.934 . . . . 0.0 110.184 -178.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.7 mt -52.44 121.85 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 122.361 1.077 . . . . 0.0 110.651 -177.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 30.0 p -109.97 19.14 19.35 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.38 -178.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.86 129.04 77.47 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.795 -1.19 . . . . 0.0 108.525 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -62.66 -10.7 20.48 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 CA-C-N 120.356 1.163 . . . . 0.0 112.981 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -120.96 5.94 10.39 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.294 -0.879 . . . . 0.0 109.418 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.68 -175.39 37.64 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.461 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.5 tp -83.11 85.62 7.16 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.123 -1.222 . . . . 0.0 109.932 -178.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -91.84 -161.98 0.88 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.864 -1.148 . . . . 0.0 109.914 178.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 10.0 m -58.22 -43.82 87.89 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.864 -1.147 . . . . 0.0 112.831 -175.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.491 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.2 tpt180 -60.08 -61.35 8.09 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 120.42 -1.425 . . . . 0.0 112.29 -178.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -57.7 -29.41 85.5 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 CA-C-N 120.288 1.138 . . . . 0.0 111.655 -179.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.93 -51.78 68.21 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.351 -0.939 . . . . 0.0 108.524 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.18 -42.44 66.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.431 -0.793 . . . . 0.0 109.269 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -70.22 -40.07 74.76 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.929 -1.107 . . . . 0.0 108.719 177.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -63.92 -55.46 22.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.734 -0.604 . . . . 0.0 109.795 -179.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 54.2 t -68.05 -36.71 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.816 -1.178 . . . . 0.0 109.682 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -60.0 -44.62 94.42 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.755 -179.286 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -66.79 -40.07 88.0 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.955 -1.091 . . . . 0.0 109.872 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -64.67 -51.7 61.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.125 -0.984 . . . . 0.0 110.132 -179.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -57.55 -11.54 2.1 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.083 -1.01 . . . . 0.0 109.131 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -67.9 -30.45 74.3 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.716 -1.753 . . . . 0.0 108.716 179.182 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -105.31 143.28 33.7 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.598 -0.942 . . . . 0.0 109.15 179.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 27.9 m -89.95 -11.8 40.65 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.978 -1.076 . . . . 0.0 109.845 -179.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 60.1 p -60.02 153.8 20.63 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.049 -1.032 . . . . 0.0 108.764 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.75 129.5 40.12 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.181 -0.949 . . . . 0.0 109.558 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.3 mt -129.15 129.95 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.626 -0.671 . . . . 0.0 109.35 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.9 m -128.06 152.57 47.81 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.509 -0.744 . . . . 0.0 109.626 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 63.5 t -118.03 137.47 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 336' ' ' THR . . . . . 0.453 ' HG1' ' HG ' ' B' ' 341' ' ' SER . 55.0 m -129.98 122.24 28.09 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.215 -0.928 . . . . 0.0 108.999 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 91.4 p -137.36 118.49 14.45 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.014 0.912 . . . . 0.0 111.102 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 44.38 57.41 4.38 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 177.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 83.16 -12.5 49.87 Favored Glycine 0 N--CA 1.5 2.956 0 O-C-N 120.164 -1.585 . . . . 0.0 113.388 176.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -119.11 131.27 55.9 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-N 119.367 1.584 . . . . 0.0 110.067 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 341' ' ' SER . . . . . 0.453 ' HG ' ' HG1' ' B' ' 336' ' ' THR . 70.6 m -124.86 146.71 49.15 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.903 0.859 . . . . 0.0 110.599 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -138.81 161.81 36.32 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.634 0.73 . . . . 0.0 109.596 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 51.0 m -86.08 131.87 34.17 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.558 -0.713 . . . . 0.0 109.994 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.436 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -69.86 -17.51 63.37 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.075 -1.016 . . . . 0.0 109.141 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . 0.481 ' C ' ' HG ' ' B' ' 346' ' ' SER . 45.2 pttt -89.26 20.93 3.49 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.481 ' HG ' ' C ' ' B' ' 345' ' ' LYS . 5.7 m -145.41 92.34 2.23 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.451 -179.344 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . 0.537 ' O ' ' NE2' ' B' ' 351' ' ' GLN . 58.7 tp -59.95 -37.22 78.92 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.274 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . 0.589 ' CB ' HE21 ' A' ' 111' ' ' GLN . 59.1 m-85 -54.61 -51.34 65.66 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.25 -0.906 . . . . 0.0 111.138 -179.287 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.45 ' O ' ' OG1' ' B' ' 352' ' ' THR . 34.0 mtmm -69.25 -39.98 78.14 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.91 -1.118 . . . . 0.0 109.781 -178.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' B' ' 352' ' ' THR . 18.2 mt -47.16 -57.21 5.37 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.12 -0.988 . . . . 0.0 108.671 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' B' ' 347' ' ' LEU . 1.4 mp0 -39.33 -22.56 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.525 -0.734 . . . . 0.0 111.088 -179.009 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.52 ' N ' ' O ' ' B' ' 350' ' ' LEU . 72.4 p -82.88 -10.89 58.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.348 -1.47 . . . . 0.0 110.796 -178.155 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 49.6 mt -94.89 117.84 30.8 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.816 -1.178 . . . . 0.0 109.513 178.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.05 92.24 0.83 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.3 mt -99.57 91.35 4.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.233 -1.157 . . . . 0.0 109.279 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 33.4 p -89.71 168.29 12.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.812 -1.18 . . . . 0.0 111.046 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -63.13 115.94 4.94 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.228 0.537 . . . . 0.0 110.763 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 100.75 7.39 50.94 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 24.1 m -86.82 114.68 23.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.485 -1.009 . . . . 0.0 111.066 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 14.9 t -76.43 116.56 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.322 1.058 . . . . 0.0 109.865 -177.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.1 m -111.45 176.95 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 29.7 m -130.53 129.44 42.84 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 83.0 mt -104.98 118.97 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 178.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 74.1 m -123.59 133.47 53.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.506 -0.746 . . . . 0.0 109.43 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.44 152.46 40.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.302 -179.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -146.36 123.13 11.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 108.953 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.511 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.96 -156.22 27.15 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 118.987 -1.578 . . . . 0.0 111.342 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.97 -52.82 63.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 122.319 -0.518 . . . . 0.0 112.008 -177.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' B' ' 370' ' ' GLU . 80.1 m-20 -106.93 9.5 30.74 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.782 -1.199 . . . . 0.0 111.567 -177.31 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.2 pt-20 -38.76 -33.29 0.1 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.398 -0.814 . . . . 0.0 111.232 -179.039 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -67.24 -42.3 84.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.889 -1.132 . . . . 0.0 109.618 -178.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -69.98 -52.9 20.49 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.453 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -42.06 -38.55 1.69 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.51 -0.744 . . . . 0.0 111.39 -178.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . 0.408 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 92.0 t -80.05 -34.87 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.687 -1.258 . . . . 0.0 109.928 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.51 -40.06 77.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.945 -1.097 . . . . 0.0 111.702 -178.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -81.63 -45.62 15.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.398 -1.439 . . . . 0.0 110.126 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.9 mt -60.18 -40.33 89.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 109.209 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 53.3 t -61.92 -47.16 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.101 -0.999 . . . . 0.0 109.803 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' B' ' 383' ' ' GLU . 60.9 mttp -68.27 -54.7 15.79 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.515 -1.274 . . . . 0.0 107.762 178.597 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 59.8 tp -55.24 -33.86 63.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 110.088 -178.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 9.0 tpt -72.4 -40.19 67.4 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.378 -1.451 . . . . 0.0 109.013 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.93 -4.67 58.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 110.168 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' B' ' 379' ' ' LYS . 95.6 mt-10 -110.56 -3.47 15.95 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.07 -1.019 . . . . 0.0 111.178 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.1 mt -79.51 130.63 35.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.427 -1.421 . . . . 0.0 109.547 179.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' B' ' 385' ' ' GLU . 2.3 pm0 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.271 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.561 -0.533 . . . . 3.19 109.561 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.7 mt -110.19 129.4 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.433 -0.792 . . . . 1.71 109.321 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.1 m -140.05 151.71 45.63 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.382 -0.824 . . . . 1.66 109.122 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.34 -166.12 10.79 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 108.495 -1.842 . . . . 1.05 108.495 179.251 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.8 mt -93.8 -9.91 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.78 -1.424 . . . . 1.59 110.334 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.3 tp 53.36 101.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.134 -0.979 . . . . 1.47 109.41 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.57 -24.67 20.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.055 -1.028 . . . . 1.39 109.867 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.4 m -146.16 134.82 10.98 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.036 -1.04 . . . . 2.09 109.723 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -80.62 139.63 12.74 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.287 1.991 . . . . 0.91 112.634 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 164.79 -165.4 37.52 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.359 -1.496 . . . . 0.92 109.359 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.6 mt -147.81 149.8 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.091 -1.24 . . . . 1.35 108.196 178.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.77 156.91 38.6 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.867 -1.146 . . . . 1.14 110.543 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -139.63 124.89 18.93 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.013 -1.106 . . . . 0.7 108.013 179.194 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.43 -179.75 48.55 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 118.776 -1.678 . . . . 0.58 110.559 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -79.29 158.62 27.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.743 -0.857 . . . . 2.63 109.462 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -101.45 129.73 47.55 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.37 -0.831 . . . . 1.27 110.923 -178.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.9 tp -98.22 132.17 43.94 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.189 -1.411 . . . . 1.41 107.189 178.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.45 ' H ' HD21 ' A' ' 214' ' ' ASN . 36.8 tp -118.34 122.65 43.38 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.25 -0.906 . . . . 1.49 109.592 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.1 mt -87.35 103.4 15.44 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.599 0.714 . . . . 1.52 110.167 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -93.01 135.32 34.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.447 -0.783 . . . . 3.17 109.233 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 57.3 mp0 -130.94 136.89 48.98 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.349 -0.844 . . . . 3.0 109.485 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 63.0 t0 -86.55 140.74 29.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.109 -0.995 . . . . 2.77 108.889 179.048 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 85.4 tt0 -60.33 139.99 57.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 2.94 109.548 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.5 mt -86.4 134.37 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.31 -0.869 . . . . 1.46 109.172 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.8 t -98.8 129.12 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.253 -0.905 . . . . 1.7 110.459 -179.004 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.8 mt -105.95 137.42 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.618 -0.882 . . . . 1.54 108.618 179.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -88.54 121.81 31.32 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.95 -1.094 . . . . 1.81 109.949 -179.379 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -90.63 -6.22 54.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 3.23 109.717 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -71.03 137.87 49.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.98 -1.075 . . . . 3.29 109.63 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -81.66 158.1 24.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 2.8 108.967 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.9 pt -100.43 166.28 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.139 -0.976 . . . . 1.43 109.495 179.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.0 p -90.46 174.77 7.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.162 -0.961 . . . . 1.54 108.765 178.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.85 -16.78 63.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.091 -1.006 . . . . 1.6 110.758 -179.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.3 -27.45 25.94 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.892 -1.13 . . . . 2.56 108.456 179.195 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -82.69 -7.36 59.65 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.195 -0.668 . . . . 2.36 109.195 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.8 t -59.95 -51.53 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.153 -0.967 . . . . 1.43 108.475 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.91 -40.04 87.48 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.385 -0.822 . . . . 1.77 109.084 179.111 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -63.3 -40.52 97.58 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.337 -0.852 . . . . 3.32 110.277 -178.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.473 ' OE2' ' NH2' ' A' ' 42' ' ' ARG . 60.5 mm-40 -62.93 -44.71 95.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.749 -1.219 . . . . 1.51 109.865 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.5 -49.81 81.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.041 -1.037 . . . . 1.41 109.718 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -60.66 -48.2 82.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.976 -1.077 . . . . 1.81 109.518 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.473 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 86.5 mtm180 -60.03 -40.13 88.28 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.853 -1.154 . . . . 3.26 108.407 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -65.09 -47.52 76.95 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.348 -0.845 . . . . 0.81 109.075 178.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.06 -44.6 94.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 1.59 109.151 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 t -65.36 -43.16 91.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.047 . . . . 1.38 109.315 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.52 -42.54 97.44 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.014 -2.034 . . . . 0.87 108.014 178.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.9 ttt-85 -63.51 -38.52 91.43 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.731 -0.864 . . . . 3.62 108.808 178.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.76 -40.61 72.81 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.505 -0.747 . . . . 1.43 109.083 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 50' ' ' ALA . 6.5 ttpm? -62.52 -73.44 0.11 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.737 -1.209 . . . . 3.08 107.737 178.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.71 -35.64 0.09 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.429 -0.794 . . . . 1.33 112.164 -177.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 98.2 p -59.42 -49.98 75.72 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.318 -1.489 . . . . 1.85 108.335 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.46 -39.85 92.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.47 -0.769 . . . . 1.35 110.646 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -65.99 -40.1 90.88 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.819 -1.176 . . . . 2.34 110.2 -179.159 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 71.4 mt -62.64 -40.05 95.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.146 -0.971 . . . . 2.2 109.689 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -62.56 -39.76 94.67 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.252 -0.905 . . . . 1.35 110.161 -179.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -64.82 -43.84 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.06 -1.025 . . . . 1.34 110.018 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.8 mt -59.93 -39.34 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 1.26 109.222 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -57.51 -51.41 69.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.367 -0.833 . . . . 1.7 110.411 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -56.62 -29.16 61.87 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.447 -0.783 . . . . 1.35 110.556 -177.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -69.75 -39.09 76.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.969 -1.082 . . . . 2.08 110.376 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.6 -46.98 74.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.304 -0.872 . . . . 1.21 110.096 -179.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.21 -50.02 53.74 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 109.743 -1.343 . . . . 0.75 109.743 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.24 -46.34 42.24 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.334 -1.098 . . . . 1.59 111.026 -179.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.4 m -67.57 -62.63 1.32 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.091 -1.005 . . . . 1.41 112.806 -177.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.448 ' CE1' ' O ' ' A' ' 168' ' ' THR . 77.6 m-85 -93.54 -45.77 7.6 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.684 -1.26 . . . . 0.79 110.87 -178.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.29 -170.6 24.59 Favored Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.011 -1.09 . . . . 1.22 110.737 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -70.02 -25.39 63.56 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.844 -0.798 . . . . 5.81 109.878 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.493 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 51.0 tp10 -60.0 -31.34 69.83 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.518 -0.739 . . . . 3.37 109.747 -179.354 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -98.98 -19.67 17.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.306 -0.871 . . . . 2.37 110.065 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -69.89 -40.02 75.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.012 -1.055 . . . . 1.65 109.977 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.55 -31.38 72.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.391 -0.818 . . . . 1.42 109.742 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 88.8 mt -60.04 -40.99 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.108 -0.995 . . . . 1.43 109.116 -179.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -65.57 -39.7 91.96 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.222 -0.924 . . . . 1.08 110.699 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -59.95 -40.04 87.63 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.817 -1.177 . . . . 1.37 108.834 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.61 -47.0 93.32 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.971 -2.052 . . . . 0.67 107.971 178.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -61.58 -49.44 76.65 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.398 -1.06 . . . . 1.99 109.102 179.222 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 77' ' ' ILE . 96.5 mt -63.05 -48.98 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.276 -0.89 . . . . 1.22 109.542 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.7 ttp -60.06 -43.03 95.71 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.108 -0.995 . . . . 2.11 110.063 -178.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.424 ' CD1' ' CE2' ' B' ' 348' ' ' PHE . 56.4 tp -63.29 -40.01 96.16 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.318 -0.864 . . . . 1.33 109.425 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.45 -39.9 89.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.78 -0.822 . . . . 1.29 108.78 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.28 8.15 14.31 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.229 -0.919 . . . . 1.47 110.485 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -56.64 130.89 47.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.785 -1.197 . . . . 1.47 109.529 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.51 -18.47 52.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.468 -0.77 . . . . 1.78 110.467 -179.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -70.14 -36.28 74.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.823 -1.173 . . . . 2.53 109.109 178.531 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.2 mt -70.2 -41.77 73.26 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.411 -0.806 . . . . 1.36 110.031 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -60.03 -48.67 80.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 1.42 110.372 -178.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -70.05 -40.83 74.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 2.27 110.726 -179.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.07 -40.02 75.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.194 -0.941 . . . . 1.57 111.516 -178.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.99 -43.87 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.03 -1.043 . . . . 1.19 109.616 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.5 mt -70.06 -40.0 77.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.379 -0.826 . . . . 1.39 110.309 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.01 75.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.105 -0.997 . . . . 1.39 111.307 -178.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 96' ' ' LYS . 17.6 mt -60.9 -45.73 93.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.089 -1.007 . . . . 1.5 109.703 -178.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.44 -49.89 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 1.29 109.134 179.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -70.38 -41.18 73.41 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.876 -0.73 . . . . 2.64 110.916 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -82.52 -53.68 5.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.998 -1.064 . . . . 1.65 112.1 -178.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 92' ' ' LEU . 90.6 mttt -90.06 -1.39 57.95 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.048 -1.032 . . . . 2.5 112.124 -177.172 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 57.05 35.7 26.72 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.746 -1.221 . . . . 1.88 109.196 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 38.4 mtt -83.8 164.96 19.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.513 -0.742 . . . . 1.71 109.823 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.431 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 43.7 p -79.58 158.73 27.07 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.496 -0.927 . . . . 1.61 108.496 179.147 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.0 -40.08 75.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.994 -1.066 . . . . 1.33 109.702 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.94 -39.94 95.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.975 . . . . 2.07 109.79 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.431 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -81.57 -46.47 14.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.125 -0.984 . . . . 1.37 109.434 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.05 -49.67 76.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.442 -0.786 . . . . 1.14 109.89 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.57 85.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.171 -0.956 . . . . 1.26 109.634 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.534 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 80.7 t60 -59.99 -39.0 84.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.327 -0.858 . . . . 2.02 109.858 -179.207 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 110' ' ' GLY . 41.3 tt0 -60.36 -41.57 93.96 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.106 -0.996 . . . . 1.33 109.541 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.7 t -65.91 -50.87 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.1 -1.0 . . . . 1.3 110.198 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.5 mm -69.31 -40.12 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.044 -1.035 . . . . 1.32 108.581 179.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.534 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 89.1 tt0 -67.09 -37.21 83.55 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.405 -0.961 . . . . 2.44 108.405 178.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -60.02 -47.32 91.61 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.74 -1.344 . . . . 0.99 109.74 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -69.34 -55.8 9.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.052 -1.263 . . . . 1.97 109.004 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.83 -42.83 65.52 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.976 . . . . 1.43 108.937 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 110' ' ' GLY . 63.8 p -59.98 -40.02 87.69 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.192 -0.942 . . . . 2.12 108.67 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.98 -40.06 91.99 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.33 -0.856 . . . . 1.64 108.697 179.066 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.0 mt -65.23 -42.0 93.84 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.134 -0.979 . . . . 1.93 108.914 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -56.75 -32.88 66.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.731 -1.23 . . . . 2.2 109.414 -179.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -59.19 -22.54 61.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.023 -1.048 . . . . 2.12 108.309 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 60.3 mt -62.97 148.05 48.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.342 -0.849 . . . . 2.34 108.861 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -100.21 37.1 1.72 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.242 -0.911 . . . . 3.23 109.955 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 56.8 t0 -125.25 134.64 52.24 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.382 -0.824 . . . . 2.49 110.438 -179.315 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.487 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 12.4 pt-20 -70.44 -30.12 66.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.783 -0.573 . . . . 3.95 110.58 179.529 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.651 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 3.0 t80 -71.87 -40.01 69.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.057 -1.027 . . . . 2.25 110.65 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.476 HD22 HH22 ' A' ' 126' ' ' ARG . 60.1 mt -71.77 -31.76 66.96 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.256 -0.902 . . . . 2.27 108.584 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -66.0 -39.97 90.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.605 -0.685 . . . . 3.31 110.018 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.0 -46.34 89.8 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.21 -0.931 . . . . 2.73 110.824 -178.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.757 ' HE ' HE22 ' B' ' 351' ' ' GLN . 21.3 mtm-85 -70.01 -27.1 64.41 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.755 -1.178 . . . . 3.2 108.863 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.91 -26.07 66.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.902 -1.147 . . . . 1.66 107.902 178.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.97 -40.16 75.56 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.481 -0.933 . . . . 1.67 108.481 178.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -62.23 -44.29 96.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.574 -0.704 . . . . 1.55 109.18 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.6 t -61.48 -40.26 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.654 -0.869 . . . . 1.32 108.654 179.28 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -60.49 -37.34 80.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.49 -0.756 . . . . 3.58 109.713 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -60.0 -41.0 91.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.173 -0.954 . . . . 1.46 109.996 -178.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.02 -49.55 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.97 -1.081 . . . . 1.22 109.176 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.21 -42.87 98.83 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.682 -1.367 . . . . 0.61 109.682 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -60.05 -49.96 75.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.147 -1.207 . . . . 3.1 110.27 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.536 HH12 ' CB ' ' A' ' 166' ' ' SER . 98.9 mtt180 -68.88 -27.18 65.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.774 -1.204 . . . . 3.71 109.838 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.95 -43.43 95.0 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.184 -0.947 . . . . 1.87 108.587 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.69 -40.03 93.56 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.397 -0.814 . . . . 1.29 109.083 178.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -63.54 -39.95 95.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.311 -0.868 . . . . 3.05 108.665 179.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -67.13 -39.95 86.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.711 -0.618 . . . . 1.26 111.258 -179.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.97 -43.05 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.438 -1.414 . . . . 1.34 108.061 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.01 -30.07 67.29 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.256 -0.646 . . . . 1.6 109.256 179.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.01 40.28 9.46 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.832 -1.707 . . . . 0.96 108.832 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 tp -74.68 149.97 39.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.374 -1.074 . . . . 1.67 109.341 -179.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -71.1 147.97 47.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.341 -0.849 . . . . 4.96 109.725 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.409 HG22 HD13 ' A' ' 146' ' ' ILE . 85.4 mt -118.82 129.47 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 122.041 0.924 . . . . 1.68 109.313 179.271 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 11.1 mt -67.05 -40.07 84.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.807 -0.633 . . . . 2.14 110.506 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 41.6 t0 60.89 105.07 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.669 -0.863 . . . . 1.5 108.669 -178.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 55.2 mt -67.76 -0.12 3.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.305 -0.872 . . . . 1.39 110.128 -178.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.2 m -83.2 -11.8 57.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.92 -1.113 . . . . 1.83 109.511 179.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.15 25.57 0.83 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.152 -0.967 . . . . 1.46 111.179 -178.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 40.5 mm -90.97 117.18 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.59 -1.319 . . . . 1.42 108.729 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -99.92 -9.35 22.92 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.258 -0.901 . . . . 2.94 110.481 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -129.18 152.11 49.12 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.296 -0.878 . . . . 1.52 110.057 -179.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.52 136.78 57.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.504 -0.748 . . . . 1.58 109.273 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.5 m -151.92 164.8 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.328 -0.858 . . . . 1.32 109.671 179.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.3 mt -92.1 146.52 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 105.954 -1.869 . . . . 1.27 105.954 177.028 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.6 tp -94.23 115.83 28.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.795 -1.191 . . . . 1.41 110.495 -178.149 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.2 t -123.2 129.94 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.512 -0.921 . . . . 1.23 108.512 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.24 162.24 36.15 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.275 -1.009 . . . . 1.32 108.275 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.6 -35.25 72.91 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.214 -1.553 . . . . 1.49 108.048 178.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -170.48 140.91 1.86 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.186 -1.042 . . . . 2.25 108.186 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.7 mt -113.48 134.61 54.58 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.231 -0.918 . . . . 1.35 109.955 -179.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 18.0 p -87.27 147.19 41.74 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.305 -0.872 . . . . 1.56 108.783 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -43.24 -33.07 3.53 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.12 1.88 . . . . 0.87 113.319 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.536 ' CB ' HH12 ' A' ' 136' ' ' ARG . 13.8 m -59.95 -48.55 81.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.808 -1.183 . . . . 1.36 108.928 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.04 -44.92 94.33 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.386 -0.822 . . . . 1.61 109.438 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.448 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 67.9 p -56.72 -18.87 14.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.877 . . . . 1.21 110.537 -178.67 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.36 -48.76 8.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.949 -1.095 . . . . 1.21 109.378 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -90.82 38.64 0.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.537 -0.912 . . . . 2.11 108.537 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.5 tp -104.85 134.39 48.05 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.92 -0.77 . . . . 1.29 108.92 179.382 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -80.86 101.72 9.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 2.81 108.79 179.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 97.2 mt -62.93 -39.96 96.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.269 -0.894 . . . . 2.09 110.337 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -67.02 -24.25 66.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.081 -1.012 . . . . 2.86 110.883 -178.121 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -93.92 -11.46 30.93 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.737 -1.227 . . . . 2.39 109.478 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 72.4 t -101.17 110.14 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.197 -0.94 . . . . 1.27 108.737 179.064 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.16 5.99 31.42 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.204 -0.935 . . . . 2.17 110.57 -178.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.18 170.41 37.44 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.991 -1.644 . . . . 0.52 108.991 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -130.86 128.93 41.61 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.334 -1.097 . . . . 0.55 109.288 -179.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 90.0 mt -132.55 125.38 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.484 -0.932 . . . . 1.27 108.484 178.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.3 p -145.94 160.04 42.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.062 -1.023 . . . . 1.39 110.84 -179.236 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 59.6 t0 -101.82 23.13 11.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.599 -0.688 . . . . 2.46 109.885 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.41 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -58.19 -161.17 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.287 -1.508 . . . . 1.51 110.792 -178.498 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -83.75 -44.34 6.86 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.607 -0.997 . . . . 2.23 110.607 -179.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.405 ' O ' ' OG ' ' A' ' 191' ' ' SER . . . 147.57 -115.25 0.75 Allowed Glycine 0 N--CA 1.497 2.724 0 O-C-N 120.83 -1.394 . . . . 2.23 110.32 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -59.92 -38.06 81.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.49 -1.006 . . . . 6.44 110.927 -179.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 73.4 p -70.25 0.09 7.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.914 -1.116 . . . . 4.09 110.432 -178.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 39.8 t -92.32 117.27 29.73 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.972 -1.08 . . . . 2.2 110.712 -179.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -47.71 -42.3 24.74 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.197 -0.939 . . . . 1.15 108.541 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 23.4 p -52.18 -34.66 46.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.801 -0.562 . . . . 2.01 109.96 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 185' ' ' GLY . 74.9 m -60.01 -40.06 87.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.011 -1.056 . . . . 1.93 110.472 -179.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.2 mm -63.98 -40.35 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.17 -0.956 . . . . 2.2 110.112 -178.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 82.9 mtp -59.99 -49.04 79.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.956 -1.09 . . . . 1.32 110.969 -178.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.52 -44.17 89.43 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.705 -1.247 . . . . 1.3 109.968 -178.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -61.75 -54.93 35.81 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.29 -0.964 . . . . 3.38 110.503 -179.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.3 m -70.0 -35.89 74.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.027 -1.046 . . . . 1.15 112.148 -178.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.55 -12.35 60.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.604 -1.31 . . . . 1.28 110.585 -178.114 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 62.14 49.56 4.39 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.495 -0.753 . . . . 1.5 111.055 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 96.4 mt -130.62 150.03 75.22 Favored Pre-proline 0 N--CA 1.499 2.002 0 N-CA-C 107.641 -1.244 . . . . 1.37 107.641 178.004 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.11 143.85 73.26 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.035 1.823 . . . . 0.76 111.418 179.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.91 151.74 4.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.746 -1.221 . . . . 1.19 111.889 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.6 mt -125.81 139.67 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.025 -1.102 . . . . 1.31 108.025 178.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.1 m -122.77 -12.67 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 120.985 -1.072 . . . . 1.38 110.968 -178.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.98 26.56 13.63 Favored Glycine 0 N--CA 1.501 2.978 0 N-CA-C 110.897 -0.881 . . . . 1.03 110.897 -178.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.7 p -43.2 -44.82 5.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.066 -1.255 . . . . 1.38 110.096 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.447 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 93.01 -52.12 2.54 Favored Glycine 0 N--CA 1.498 2.795 0 C-N-CA 120.224 -0.988 . . . . 1.17 110.741 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.2 t -158.91 33.64 0.21 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.617 -1.519 . . . . 2.07 111.186 -179.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.6 -40.05 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.985 -1.072 . . . . 1.35 109.082 178.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.0 p -54.54 -30.0 52.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.431 -0.793 . . . . 1.49 110.108 -179.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.5 t -80.89 -21.1 40.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.061 -1.024 . . . . 2.16 110.161 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -96.96 -13.41 22.39 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.128 -0.982 . . . . 2.89 110.125 -179.416 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.8 t -102.05 136.62 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.361 -0.837 . . . . 1.33 110.216 -178.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -112.23 154.54 25.43 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.04 -1.467 . . . . 2.73 107.04 178.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.497 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 15.5 t-20 -60.04 139.02 57.73 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.839 -1.163 . . . . 2.7 110.169 -179.145 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 9.6 t0 84.91 7.24 0.48 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.16 0.505 . . . . 2.38 110.019 179.49 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 55.3 t0 -76.87 142.07 40.35 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.204 -0.935 . . . . 2.09 109.096 179.232 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.493 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 49.3 t80 -92.81 117.98 30.61 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.977 -1.12 . . . . 1.45 107.977 178.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 69.9 mt -127.16 147.47 50.19 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.503 -0.748 . . . . 1.31 110.55 -178.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 80.5 mt -118.39 129.59 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 107.469 -1.308 . . . . 1.29 107.469 177.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 34.3 tp -104.22 123.65 47.71 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.668 -0.864 . . . . 1.31 108.668 -179.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 10' ' ' GLY . 29.1 t0 -85.75 -35.76 20.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.107 -0.995 . . . . 2.31 108.38 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.412 ' HB2' ' H ' ' A' ' 10' ' ' GLY . . . 45.71 21.41 0.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.742 0.782 . . . . 1.19 108.919 -179.319 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 221' ' ' ASP . 42.1 t -133.41 -44.07 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.121 -1.437 . . . . 1.45 107.121 178.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.465 ' ND2' ' OD2' ' A' ' 221' ' ' ASP . 84.3 m-20 -102.25 2.1 36.66 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.057 -1.09 . . . . 3.13 108.057 178.606 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 59.98 43.91 14.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.805 -0.559 . . . . 2.2 110.307 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -136.41 149.37 48.25 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.216 -0.928 . . . . 2.32 110.112 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.6 129.96 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.454 -0.943 . . . . 1.4 108.454 178.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -100.87 123.03 44.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.423 -0.798 . . . . 1.29 109.303 179.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 19.4 t -100.03 110.52 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.373 -0.83 . . . . 1.38 109.98 -179.312 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 230' ' ' ASN . 3.9 t30 56.61 67.43 2.69 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.325 -0.859 . . . . 2.33 111.368 179.221 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -91.05 150.02 3.82 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.266 2.644 . . . . 0.95 112.568 178.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.0 m -70.07 160.03 32.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.345 -0.847 . . . . 2.31 110.29 -179.23 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -59.99 -36.84 78.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.392 -0.817 . . . . 3.45 109.608 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -60.03 -38.43 82.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 2.89 109.221 -179.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.36 -40.05 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.096 -1.003 . . . . 1.73 109.405 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.429 HD12 HG21 ' A' ' 236' ' ' ILE . 96.6 mt . . . . . 0 N--CA 1.496 1.859 0 O-C-N 121.164 -0.96 . . . . 1.57 110.104 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 50.5 ttp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.573 0.701 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 36.2 t80 -154.92 152.83 30.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.706 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . 0.463 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 13.8 pt20 -149.78 159.99 43.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.937 -1.102 . . . . 0.0 110.474 -179.436 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -153.94 150.44 28.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -112.49 134.08 54.21 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.225 -0.922 . . . . 0.0 110.583 -179.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -129.71 121.52 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-O 122.251 1.024 . . . . 0.0 112.546 -177.485 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 25.4 m -76.45 105.1 7.31 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.79 0.805 . . . . 0.0 110.42 -178.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 98.9 mt -53.26 121.62 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 122.318 1.056 . . . . 0.0 110.375 -178.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 78.1 p -110.11 19.95 18.42 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.36 -178.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.14 126.14 91.97 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.901 -1.124 . . . . 0.0 109.168 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.65 -18.72 27.38 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 CA-C-N 120.404 1.18 . . . . 0.0 112.327 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -120.45 10.16 11.1 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 75.33 -176.98 49.47 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.098 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.515 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -83.45 87.54 6.99 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.088 -1.242 . . . . 0.0 108.988 -178.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -90.29 -162.92 0.94 Allowed 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.825 -1.172 . . . . 0.0 110.123 179.09 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 9.6 m -57.09 -41.78 79.49 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.852 -1.155 . . . . 0.0 112.486 -175.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.493 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 0.7 OUTLIER -60.02 -60.88 9.17 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 120.62 -1.3 . . . . 0.0 111.855 -178.835 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.38 -34.33 97.56 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 CA-C-N 120.139 1.085 . . . . 0.0 111.801 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.52 73.42 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.74 -41.96 67.66 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.02 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . 0.505 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 27.3 mm100 -70.0 -41.4 74.42 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 108.692 178.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . 0.486 ' CE1' ' SD ' ' B' ' 381' ' ' MET . 55.1 t80 -61.93 -52.23 64.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.583 -0.698 . . . . 0.0 110.813 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . 0.517 ' CG1' ' HZ2' ' B' ' 327' ' ' LYS . 93.8 t -65.51 -29.23 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.596 -1.315 . . . . 0.0 109.299 -179.288 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . 0.505 ' NZ ' ' OE1' ' B' ' 321' ' ' GLN . 0.2 OUTLIER -60.13 -46.25 90.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.406 -0.809 . . . . 0.0 109.636 179.495 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -67.19 -45.62 76.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.346 -0.846 . . . . 0.0 110.893 -178.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.0 -53.0 62.97 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.706 -1.246 . . . . 0.0 110.833 -178.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . 0.517 ' HZ2' ' CG1' ' B' ' 323' ' ' VAL . 28.5 mttp -54.12 -12.64 0.65 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.067 -1.021 . . . . 0.0 109.452 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.1 -20.14 73.42 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -106.03 146.66 29.82 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.387 -1.066 . . . . 0.0 108.599 179.531 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 70.0 p -91.51 -14.29 30.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.86 -1.15 . . . . 0.0 109.435 179.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 77.9 p -64.52 149.18 49.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.665 -179.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -69.85 138.25 52.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.129 -0.982 . . . . 0.0 108.795 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.6 mt -134.14 134.6 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.603 -0.686 . . . . 0.0 109.56 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 48.4 m -128.62 149.82 50.49 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.451 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 76.5 t -121.99 113.15 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.35 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 44.3 m -105.29 133.16 50.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.951 . . . . 0.0 109.28 -178.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 34.1 p -137.83 110.67 7.66 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.758 0.789 . . . . 0.0 110.248 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 22.4 m120 45.97 53.48 9.02 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 177.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.96 -15.45 59.35 Favored Glycine 0 N--CA 1.504 3.169 0 O-C-N 120.246 -1.534 . . . . 0.0 113.207 176.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . 0.528 ' NZ ' ' O ' ' B' ' 352' ' ' THR . 9.7 mtpm? -116.06 127.92 55.27 Favored 'General case' 0 N--CA 1.507 2.423 0 CA-C-N 119.338 1.569 . . . . 0.0 109.614 -179.517 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 67.2 m -127.2 148.58 50.19 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.968 0.889 . . . . 0.0 111.15 -178.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.94 164.69 29.49 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.348 0.594 . . . . 0.0 109.712 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 47.4 t -88.58 132.41 34.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.474 -0.766 . . . . 0.0 110.922 -178.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -69.86 -21.63 63.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.888 . . . . 0.0 108.871 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' B' ' 345' ' ' LYS . 24.0 ttpp -83.12 18.0 1.82 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.61 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.516 ' H ' ' C ' ' B' ' 344' ' ' ALA . 11.2 t -147.12 95.33 2.54 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.14 -179.489 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 60.8 tp -59.91 -39.7 86.28 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.542 -0.724 . . . . 0.0 109.132 179.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . 0.424 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 60.9 m-85 -54.02 -52.49 60.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.104 -0.998 . . . . 0.0 110.771 -179.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.446 ' O ' ' OG1' ' B' ' 352' ' ' THR . 49.9 mtpt -65.89 -39.99 91.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.152 -0.968 . . . . 0.0 109.704 -178.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' B' ' 352' ' ' THR . 17.6 mt -49.71 -58.35 5.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.193 -0.942 . . . . 0.0 109.915 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.757 HE22 ' HE ' ' A' ' 126' ' ' ARG . 8.2 mm100 -42.58 -13.19 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.239 -0.913 . . . . 0.0 111.869 -177.077 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.569 ' N ' ' O ' ' B' ' 350' ' ' LEU . 81.6 p -85.02 -15.01 45.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 119.95 -1.719 . . . . 0.0 110.275 -179.152 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 43.3 mt -91.32 119.96 31.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.999 -1.063 . . . . 0.0 109.431 179.335 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.26 93.91 0.7 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.175 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 52.0 mt -100.59 88.01 3.51 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.245 -1.15 . . . . 0.0 109.187 179.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 60.0 p -91.53 166.12 13.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.958 -1.089 . . . . 0.0 110.744 -178.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -59.41 116.64 4.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.774 -0.579 . . . . 0.0 111.077 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 101.02 7.11 50.91 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 47.7 m -86.74 110.89 20.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -1.136 . . . . 0.0 110.795 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 46.7 t -77.78 117.52 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 122.169 0.985 . . . . 0.0 109.48 -177.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 25.4 m -110.22 177.67 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 91.1 m -131.35 128.74 40.29 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.174 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 69.6 mt -103.0 116.33 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 67.2 m -116.06 129.99 56.6 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.88 151.8 39.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.353 -0.842 . . . . 0.0 109.724 -178.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -145.01 121.5 11.03 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.459 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.81 -155.38 26.54 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 118.765 -1.683 . . . . 0.0 111.844 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -59.94 -50.9 71.93 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.173 -0.514 . . . . 0.0 112.224 -177.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' B' ' 370' ' ' GLU . 97.0 m-20 -110.27 13.47 22.99 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.777 -1.202 . . . . 0.0 111.137 -177.584 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.7 pt-20 -42.23 -36.42 1.21 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.206 -0.934 . . . . 0.0 110.655 -179.246 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -69.26 -47.06 65.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.043 -1.036 . . . . 0.0 110.162 -179.148 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -69.98 -54.44 13.25 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.003 -1.06 . . . . 0.0 109.51 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.46 -34.18 1.26 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.365 -0.834 . . . . 0.0 111.179 -179.022 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 73.4 t -76.09 -35.66 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.603 -1.311 . . . . 0.0 109.399 179.327 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -65.41 -59.4 4.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 111.853 -178.15 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -69.77 -39.99 76.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.384 -1.448 . . . . 0.0 111.707 -178.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 88.0 mt -58.46 -39.99 81.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.526 -1.359 . . . . 0.0 108.696 -178.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 55.3 t -62.38 -42.72 96.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.103 -0.998 . . . . 0.0 109.596 179.401 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.6 mttt -71.25 -57.54 4.39 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.794 -1.191 . . . . 0.0 108.209 178.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 53.9 tp -53.32 -35.99 60.77 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.173 -0.954 . . . . 0.0 109.015 -178.346 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 381' ' ' MET . . . . . 0.486 ' SD ' ' CE1' ' B' ' 322' ' ' PHE . 0.9 OUTLIER -72.14 -40.0 68.38 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.621 -1.299 . . . . 0.0 108.437 177.648 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.62 -4.87 58.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.595 -0.691 . . . . 0.0 110.601 179.374 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' B' ' 379' ' ' LYS . 94.6 mt-10 -111.43 -3.11 15.34 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.125 -0.985 . . . . 0.0 110.807 -179.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.6 mt -82.98 131.14 35.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.637 -1.289 . . . . 0.0 109.099 179.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.091 179.615 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.358 -0.608 . . . . 3.19 109.358 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.431 ' CD1' ' OE1' ' A' ' 211' ' ' GLN . 97.4 mt -108.37 123.71 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.438 -0.788 . . . . 1.71 109.602 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.8 m -135.98 141.14 44.39 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.72 -0.844 . . . . 1.66 108.72 179.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.731 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -109.0 -160.13 19.45 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.113 -1.595 . . . . 1.05 109.113 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.1 mt -95.23 -15.01 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.118 -1.225 . . . . 1.59 109.589 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.4 tp 51.99 104.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.798 . . . . 1.47 109.666 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.82 -23.57 17.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.079 -1.013 . . . . 1.39 109.302 179.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.459 ' OG ' ' N ' ' A' ' 201' ' ' ALA . 12.5 p -137.42 119.24 11.01 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.405 -0.81 . . . . 2.09 109.06 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.99 150.13 20.51 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.904 1.736 . . . . 0.91 112.375 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 154.35 -155.09 25.96 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.08 -1.608 . . . . 0.92 109.08 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 11' ' ' ILE . 71.7 mt -149.08 150.59 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.016 -1.285 . . . . 1.35 109.112 179.045 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.12 146.12 22.59 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.022 -1.049 . . . . 1.14 110.315 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -127.62 127.92 44.64 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.161 -1.051 . . . . 0.7 108.161 178.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.1 176.08 46.6 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.734 -1.698 . . . . 0.58 110.588 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -77.76 156.31 30.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.699 -0.883 . . . . 2.63 109.022 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.59 128.33 49.29 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.416 -0.802 . . . . 1.27 111.025 -178.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.8 tp -100.13 135.33 41.73 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.069 -1.456 . . . . 1.41 107.069 178.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.0 tp -115.3 121.6 43.37 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.3 -0.875 . . . . 1.49 110.099 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.1 mt -86.69 103.01 14.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.526 -0.734 . . . . 1.52 109.73 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -90.96 142.31 27.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.395 -0.815 . . . . 3.17 109.244 179.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -130.1 133.34 46.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.426 -0.953 . . . . 3.0 108.426 179.222 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -84.07 150.69 25.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.044 -1.035 . . . . 2.77 109.429 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -66.66 147.89 52.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.932 . . . . 2.94 109.301 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 86.5 mt -96.44 126.68 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.187 -0.946 . . . . 1.46 109.05 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.1 t -94.73 126.12 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.133 -0.979 . . . . 1.7 109.997 -179.298 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.5 mt -112.37 131.93 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 109.016 -0.735 . . . . 1.54 109.016 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.01 118.35 28.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.873 -1.142 . . . . 1.81 110.335 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -85.08 -1.06 56.42 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.715 -0.846 . . . . 3.23 108.715 179.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -69.9 140.37 53.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.469 -0.769 . . . . 3.29 110.024 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -80.03 153.3 28.91 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.194 -0.941 . . . . 2.8 109.409 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.0 pt -94.6 167.48 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.179 -0.95 . . . . 1.43 109.711 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.445 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 58.4 p -96.28 173.04 7.59 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.147 -1.057 . . . . 1.54 108.147 178.22 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.99 75.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.913 -1.117 . . . . 1.6 110.501 -179.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.445 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 11.9 p-10 -57.3 -26.45 60.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.703 -1.248 . . . . 2.56 109.513 -179.275 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -82.26 -9.83 59.34 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.302 -0.874 . . . . 2.36 109.762 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.3 t -66.49 -54.59 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.925 -1.11 . . . . 1.43 109.641 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.04 -40.08 88.14 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.269 -0.895 . . . . 1.77 109.102 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -62.87 -42.19 99.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.419 -0.801 . . . . 3.32 110.707 -179.295 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -62.62 -42.55 99.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.615 -1.303 . . . . 1.51 110.221 -179.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.98 -47.39 91.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 120.594 -1.316 . . . . 1.41 108.64 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -59.94 -45.15 93.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -0.942 . . . . 1.81 109.318 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.472 HH11 ' HG2' ' A' ' 42' ' ' ARG . 22.2 mtt-85 -60.08 -43.56 95.39 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.069 -1.086 . . . . 3.26 108.069 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -62.0 -47.2 85.85 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.737 -0.838 . . . . 0.81 108.737 178.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.2 tp -59.94 -48.92 79.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 1.59 108.837 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.4 t -63.04 -43.73 97.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.975 -1.078 . . . . 1.38 108.963 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.06 -47.51 90.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.57 -1.812 . . . . 0.87 108.57 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -61.56 -36.18 79.9 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.006 -1.109 . . . . 3.62 108.006 178.599 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.32 -40.01 70.64 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.317 -0.623 . . . . 1.43 109.317 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ALA . 26.4 ttpp -66.34 -73.73 0.13 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.652 -1.24 . . . . 3.08 107.652 179.153 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.09 -36.34 0.2 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.46 -0.775 . . . . 1.33 111.346 -178.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 t -57.41 -55.94 28.34 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.508 -1.37 . . . . 1.85 108.612 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.08 -40.0 86.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.253 -0.904 . . . . 1.35 111.074 -179.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -67.96 -40.24 83.23 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.841 -1.162 . . . . 2.34 110.322 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.2 mt -62.03 -39.97 94.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.009 -1.057 . . . . 2.2 108.72 179.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -61.21 -38.49 86.79 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.426 -0.796 . . . . 1.35 109.713 179.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -64.27 -43.69 94.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.194 -0.941 . . . . 1.34 110.268 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.64 ' CD1' HH22 ' A' ' 136' ' ' ARG . 85.7 mt -63.04 -38.1 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 1.26 108.969 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -56.15 -50.59 70.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 1.7 109.896 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -59.94 -36.44 77.08 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.43 -0.794 . . . . 1.35 110.367 -177.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -63.79 -39.48 94.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.963 -1.086 . . . . 2.08 109.211 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.54 -45.48 75.54 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.564 -0.71 . . . . 1.21 110.033 -179.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.14 -51.16 60.07 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 110.268 -1.133 . . . . 0.75 110.268 -179.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -69.96 -41.88 73.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.037 -1.272 . . . . 1.59 110.309 -179.446 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.3 m -69.92 -60.4 2.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.912 . . . . 1.41 112.2 -177.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -95.49 -50.77 4.84 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.964 -1.085 . . . . 0.79 111.093 -178.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.42 -163.7 26.75 Favored Glycine 0 N--CA 1.499 2.837 0 O-C-N 120.747 -1.221 . . . . 1.22 110.726 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -70.0 -23.24 63.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.751 -0.852 . . . . 5.81 110.364 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.425 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 52.7 tp10 -60.13 -37.76 81.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 3.37 110.272 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -97.4 -19.02 18.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.293 -0.88 . . . . 2.37 110.388 -178.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -70.09 -40.12 75.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.855 -1.153 . . . . 1.65 110.496 -179.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.82 -29.9 69.17 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.399 -0.813 . . . . 1.42 109.585 -178.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.02 -42.57 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.248 -0.981 . . . . 1.43 109.112 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -64.5 -40.08 94.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.112 -0.993 . . . . 1.08 110.742 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -59.98 -40.02 87.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.831 -1.168 . . . . 1.37 108.833 -179.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.01 -43.53 98.73 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 107.98 -2.048 . . . . 0.67 107.98 178.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -65.21 -48.43 73.41 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.459 -1.024 . . . . 1.99 108.608 179.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.9 mt -64.36 -49.39 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.397 -0.815 . . . . 1.22 109.18 179.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.2 ttp -60.41 -42.73 96.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.167 -0.958 . . . . 2.11 110.37 -179.075 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.0 tp -66.04 -41.57 90.7 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.335 -0.853 . . . . 1.33 109.983 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.4 tp -63.31 -40.11 96.44 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.292 -0.88 . . . . 1.29 110.168 -179.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -82.57 8.03 12.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.188 -0.945 . . . . 1.47 110.08 -179.355 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -50.78 131.91 26.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 1.47 109.352 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.44 -20.66 60.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.701 -0.624 . . . . 1.78 111.027 -178.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.71 -34.32 67.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.901 -1.125 . . . . 2.53 109.552 179.54 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.6 mt -70.08 -40.1 75.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.538 -0.726 . . . . 1.36 109.321 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -60.08 -46.04 90.91 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.389 -0.82 . . . . 1.42 109.613 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -69.99 -40.48 75.29 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.406 -0.809 . . . . 2.27 110.244 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.02 -40.02 75.46 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.051 -1.03 . . . . 1.57 111.14 -179.417 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.0 mt -67.95 -48.88 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.919 -1.113 . . . . 1.19 109.461 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.97 -39.7 84.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.506 -0.746 . . . . 1.39 109.51 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.96 -48.89 79.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 1.39 110.532 -179.246 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 96' ' ' LYS . 84.3 mt -60.22 -47.73 84.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.928 -1.108 . . . . 1.5 109.878 -179.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.81 -50.05 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.89 . . . . 1.29 109.198 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -70.0 -40.49 75.25 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.857 -0.737 . . . . 2.64 110.814 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 91' ' ' ALA . 10.2 t70 -84.17 -50.9 7.49 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.041 -1.037 . . . . 1.65 112.058 -178.147 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 92' ' ' LEU . 67.2 mmtt -90.19 -2.6 58.07 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.885 -1.135 . . . . 2.5 111.606 -177.491 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.7 m80 57.6 36.71 27.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.075 -1.016 . . . . 1.88 109.478 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 79.6 mtp -93.56 164.14 13.29 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.651 -0.655 . . . . 1.71 110.343 -179.361 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.6 p -77.9 161.82 27.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.608 -0.683 . . . . 1.61 109.177 179.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.89 81.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.102 -0.999 . . . . 1.33 109.783 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -64.29 -39.97 95.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.144 -0.972 . . . . 2.07 109.399 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.29 -46.76 19.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.836 . . . . 1.37 109.756 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.55 -50.01 75.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.308 -0.87 . . . . 1.14 109.838 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.57 -37.45 81.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 1.26 109.417 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -60.05 -46.91 87.97 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.514 -0.741 . . . . 2.02 110.109 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -62.65 -40.08 95.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -0.879 . . . . 1.33 110.946 -179.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.4 -56.29 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.005 -1.059 . . . . 1.3 111.039 -178.055 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.5 mm -68.78 -39.97 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.918 -1.114 . . . . 1.32 108.967 -179.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -63.63 -40.04 95.89 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.245 -1.02 . . . . 2.44 108.245 178.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.418 ' O ' ' OG ' ' A' ' 113' ' ' SER . . . -60.77 -50.43 67.67 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.057 -1.217 . . . . 0.99 110.057 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -65.24 -49.49 69.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.956 -1.32 . . . . 1.97 109.262 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.56 -42.67 92.93 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.094 -1.004 . . . . 1.43 108.731 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 110' ' ' GLY . 88.6 p -60.11 -39.86 87.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.243 -0.91 . . . . 2.12 109.023 179.175 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.3 -39.92 80.62 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.056 -1.028 . . . . 1.64 108.629 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.9 mt -62.17 -39.97 94.43 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.138 -0.976 . . . . 1.93 109.047 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -53.85 -24.37 15.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.081 -1.012 . . . . 2.2 109.514 -179.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -59.91 -27.83 67.07 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.534 -1.284 . . . . 2.12 107.534 179.146 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.6 mt -62.99 140.38 58.86 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.712 -0.618 . . . . 2.34 109.511 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -100.12 48.92 0.92 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.232 -0.917 . . . . 3.23 109.538 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 51.1 t0 -136.34 148.53 47.94 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.311 -0.868 . . . . 2.49 109.424 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 71.4 mm-40 -73.28 -65.02 0.86 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.247 -0.908 . . . . 3.95 108.597 178.636 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -40.7 -39.85 1.17 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.83 -0.544 . . . . 2.25 110.948 -179.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.6 mt -76.33 -40.27 51.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.619 -1.301 . . . . 2.27 110.0 -179.455 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -68.64 -39.98 80.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.047 -1.033 . . . . 3.31 109.463 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -59.9 -43.57 94.74 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.135 -0.978 . . . . 2.73 108.527 -179.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.684 ' NE ' HE21 ' B' ' 351' ' ' GLN . 1.6 ttp180 -60.73 -40.02 90.81 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.364 -0.976 . . . . 3.2 108.364 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.04 -19.91 48.25 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.904 -1.147 . . . . 1.66 107.904 178.555 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.72 -40.04 76.5 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.585 -1.265 . . . . 1.67 107.585 178.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -65.02 -40.05 94.3 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.501 -0.749 . . . . 1.55 109.102 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.48 -40.09 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.306 -0.998 . . . . 1.32 108.306 178.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -62.33 -37.81 87.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.542 -0.723 . . . . 3.58 109.294 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -59.98 -40.56 89.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.374 -0.829 . . . . 1.46 110.034 -178.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.01 -47.81 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.129 -0.982 . . . . 1.22 109.45 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.16 -40.24 98.91 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.09 -1.204 . . . . 0.61 110.09 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -59.96 -48.0 83.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.378 -1.071 . . . . 3.1 109.774 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.64 HH22 ' CD1' ' A' ' 57' ' ' ILE . 57.4 mtp180 -65.77 -33.5 76.0 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.038 -1.039 . . . . 3.71 109.729 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.84 -43.15 94.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.41 -0.806 . . . . 1.87 109.374 -179.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.05 -40.06 88.12 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.19 -0.943 . . . . 1.29 109.238 179.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -69.94 -39.9 75.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 3.05 109.477 179.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -67.62 -34.66 77.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.478 -0.763 . . . . 1.26 112.096 -178.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.06 -41.46 79.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.256 -1.527 . . . . 1.34 108.784 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 92.1 mt -73.45 -26.19 60.82 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.802 -0.814 . . . . 1.6 108.802 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.32 43.41 8.02 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.374 -1.89 . . . . 0.96 108.374 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 tp -74.35 150.03 40.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.532 -0.981 . . . . 1.67 109.029 -179.129 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -64.58 142.51 58.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.29 -0.881 . . . . 4.96 110.396 -178.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.7 mt -116.86 127.6 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-O 121.89 0.852 . . . . 1.68 108.771 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.8 mt -65.43 -43.87 94.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.918 -0.489 . . . . 2.14 111.468 -177.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.0 t0 64.53 112.78 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.222 -0.924 . . . . 1.5 109.031 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 86.6 mt -79.05 -3.28 44.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.319 -0.863 . . . . 1.39 110.029 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.9 m -87.3 -15.3 38.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.275 -0.89 . . . . 1.83 109.808 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.31 14.47 2.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.281 -0.887 . . . . 1.46 111.334 -178.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.556 ' N ' ' CD1' ' A' ' 152' ' ' ILE . 1.5 mp -90.23 117.92 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.549 -1.344 . . . . 1.42 108.764 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -101.65 -11.87 18.85 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.303 -0.873 . . . . 2.94 110.196 -179.433 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -112.24 146.66 37.77 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.55 -0.719 . . . . 1.52 110.168 -179.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.06 132.2 47.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.484 -0.76 . . . . 1.58 109.435 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.9 m -152.81 165.05 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.457 -0.777 . . . . 1.32 109.369 179.334 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.4 mt -92.43 147.95 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 105.383 -2.081 . . . . 1.27 105.383 176.485 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -98.52 117.49 33.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.833 -1.167 . . . . 1.41 110.581 -177.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.2 t -121.61 129.43 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.662 -0.866 . . . . 1.23 108.662 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.91 164.77 33.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.104 -0.997 . . . . 1.32 108.928 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.457 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.12 -36.85 77.95 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.069 -1.644 . . . . 1.49 108.381 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 162' ' ' ASP . 33.9 p-10 -170.7 150.47 3.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.195 -0.941 . . . . 2.25 109.563 179.647 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.7 mt -118.91 136.38 54.09 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.561 -0.712 . . . . 1.35 109.629 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 22.9 p -92.94 148.37 35.71 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.262 -0.899 . . . . 1.56 109.146 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.417 ' O ' ' OG1' ' A' ' 168' ' ' THR . 92.8 Cg_exo -39.97 -36.6 1.42 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.044 1.829 . . . . 0.87 112.599 179.613 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.7 m -60.0 -40.07 87.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 1.36 109.156 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.01 -43.09 88.68 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.286 -0.884 . . . . 1.61 109.635 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 165' ' ' PRO . 22.8 p -55.8 -28.78 57.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.149 -0.969 . . . . 1.21 110.308 -178.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.56 -53.34 9.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.11 -0.994 . . . . 1.21 109.678 179.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -85.36 38.34 0.73 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.091 -1.077 . . . . 2.11 108.091 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.4 tp -100.87 129.1 46.69 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.788 -0.819 . . . . 1.29 108.788 179.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.663 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 0.1 OUTLIER -85.62 101.46 12.73 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.908 -1.145 . . . . 2.81 107.908 179.106 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 70.0 mt -64.67 -43.18 94.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.563 -0.71 . . . . 2.09 111.613 -178.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -71.23 -21.65 62.1 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.73 -1.231 . . . . 2.86 111.874 -177.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -93.22 -11.31 32.95 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.583 -1.323 . . . . 2.39 108.849 -179.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 67.9 t -110.02 120.06 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.647 -0.871 . . . . 1.27 108.647 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.9 mt -89.01 6.35 40.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.266 -0.896 . . . . 2.17 110.98 -177.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.58 172.92 37.39 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.378 -1.391 . . . . 0.52 109.808 179.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -134.15 129.17 35.48 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.271 -1.135 . . . . 0.55 109.079 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.21 127.05 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.322 -0.861 . . . . 1.27 109.158 179.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.6 p -148.79 159.84 43.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.849 -1.157 . . . . 1.39 110.771 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 37.2 p-10 -104.07 27.06 8.02 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.595 -0.691 . . . . 2.46 109.333 179.49 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -56.03 -162.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.975 -1.078 . . . . 1.51 111.318 -178.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.2 -59.17 5.14 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.958 -0.857 . . . . 2.23 110.958 -178.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -178.64 -150.66 8.94 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 118.862 -1.637 . . . . 2.23 111.085 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.412 ' C ' ' H ' ' A' ' 188' ' ' SER . 98.5 mtt180 -69.92 -20.62 63.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.604 -0.939 . . . . 6.44 110.54 -178.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 21.4 p -68.85 4.17 1.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.04 -1.038 . . . . 4.09 109.992 -179.136 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 186' ' ' ARG . 46.7 p -88.48 142.51 27.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.151 -0.968 . . . . 2.2 110.638 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -49.99 -47.1 53.08 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.549 -0.719 . . . . 1.15 109.782 -179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.4 m -56.32 -39.99 73.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.498 -0.751 . . . . 2.01 110.313 -178.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.4 t -60.8 -39.96 90.88 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.034 -1.041 . . . . 1.93 111.051 -179.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.02 -41.12 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.018 -1.051 . . . . 2.2 110.095 -178.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.0 mtp -65.16 -41.7 94.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.032 -1.043 . . . . 1.32 111.233 -179.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.6 92.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.108 -1.62 . . . . 1.3 110.188 -179.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.02 -49.3 78.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 3.38 110.586 -178.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.4 m -72.45 -33.73 67.25 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.237 -0.914 . . . . 1.15 111.817 -178.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.1 mt -84.08 -8.1 59.2 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.697 -1.252 . . . . 1.28 111.118 -178.211 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 59.2 49.22 9.41 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.271 -0.893 . . . . 1.5 110.841 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 80.6 mt -121.5 122.73 27.87 Favored Pre-proline 0 N--CA 1.501 2.099 0 N-CA-C 108.588 -0.893 . . . . 1.37 108.588 178.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.17 131.4 8.76 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.8 1.667 . . . . 0.76 112.004 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.459 ' N ' ' OG ' ' A' ' 8' ' ' SER . . . -167.89 146.95 4.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.738 -1.226 . . . . 1.19 111.501 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 90.0 mt -125.47 140.79 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 107.745 -1.205 . . . . 1.31 107.745 178.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.63 -8.85 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.031 -1.043 . . . . 1.38 110.99 -178.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.41 22.0 29.68 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.219 -1.152 . . . . 1.03 110.219 -179.596 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.3 p -45.74 -42.59 12.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.031 -1.276 . . . . 1.38 109.848 -179.248 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.56 -51.09 3.29 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 120.111 -1.042 . . . . 1.17 111.303 178.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.6 t -161.1 37.8 0.15 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.71 -1.465 . . . . 2.07 110.984 -179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.88 -39.95 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.124 -0.985 . . . . 1.35 108.473 177.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.404 ' HG1' ' N ' ' A' ' 210' ' ' SER . 2.9 p -54.18 -29.99 47.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.529 -0.732 . . . . 1.49 110.775 -179.237 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.404 ' N ' ' HG1' ' A' ' 209' ' ' THR . 52.3 m -80.06 -12.64 59.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.002 -1.061 . . . . 2.16 109.643 -179.293 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.431 ' OE1' ' CD1' ' A' ' 2' ' ' ILE . 94.8 mt-30 -104.99 -12.2 16.29 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.485 -0.76 . . . . 2.89 109.773 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 71.5 t -104.64 137.7 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.333 -0.855 . . . . 1.33 110.602 -178.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.483 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -113.16 153.25 28.58 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.564 -1.272 . . . . 2.73 107.564 179.01 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.68 ' N ' HD21 ' A' ' 214' ' ' ASN . 0.0 OUTLIER -59.49 136.49 57.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.073 -1.017 . . . . 2.7 110.744 -178.623 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 10.4 t0 84.49 5.89 0.6 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.99 -0.444 . . . . 2.38 110.715 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.483 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 92.1 m-20 -75.13 145.44 42.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.79 -1.194 . . . . 2.09 109.065 178.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -92.37 117.92 30.4 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.928 -1.138 . . . . 1.45 107.928 178.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 83.4 mt -127.12 146.73 50.28 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.486 -0.758 . . . . 1.31 110.454 -178.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.6 mt -112.25 129.27 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.272 -1.751 . . . . 1.29 106.272 176.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 30.6 tp -98.8 115.68 29.33 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.892 -1.13 . . . . 1.31 109.506 -178.223 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.567 ' C ' ' H ' ' A' ' 223' ' ' VAL . 65.1 m-20 -70.95 -46.34 62.57 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.935 -1.135 . . . . 2.31 107.935 178.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 52.08 7.89 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.761 -0.829 . . . . 1.19 108.761 -179.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.567 ' H ' ' C ' ' A' ' 221' ' ' ASP . 72.1 t -123.86 -42.78 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.192 -1.41 . . . . 1.45 107.192 179.11 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -102.58 0.03 32.78 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.658 -1.238 . . . . 3.13 107.658 178.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.731 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 59.84 42.74 16.04 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.772 -0.58 . . . . 2.2 109.737 -179.955 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -133.12 152.36 51.95 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.398 -0.814 . . . . 2.32 109.462 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.23 129.98 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.997 -0.742 . . . . 1.4 108.997 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -100.05 122.76 43.43 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.505 -0.924 . . . . 1.29 108.505 179.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.2 t -103.12 113.39 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.573 -0.704 . . . . 1.38 109.904 -179.368 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 66.1 t30 53.89 66.87 3.99 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.357 -0.839 . . . . 2.33 111.532 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -90.94 151.36 3.93 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.196 2.597 . . . . 0.95 112.405 178.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 37.9 p -70.01 162.21 28.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.15 -0.969 . . . . 2.31 110.305 -179.34 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.55 -40.05 90.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.483 -0.761 . . . . 3.45 109.958 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -60.11 -37.86 81.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.426 -0.796 . . . . 2.89 109.874 -179.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.3 t -65.86 -41.68 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 1.73 109.481 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 91.9 mt . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.102 -0.999 . . . . 1.57 110.08 -179.888 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' B' B ' 301' ' ' MET . . . . . 0.407 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 37.8 ttp . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.516 0.674 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . 0.407 ' N ' ' CG ' ' B' ' 301' ' ' MET . 28.7 t80 -153.27 150.26 28.77 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.045 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -150.91 161.52 42.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.013 -1.054 . . . . 0.0 110.28 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -157.38 154.22 28.54 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -114.37 130.89 56.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.216 -0.928 . . . . 0.0 110.162 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 4.0 p -129.99 124.09 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 CA-C-O 122.18 0.991 . . . . 0.0 111.362 -178.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 32.8 m -79.92 104.33 10.43 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.868 0.842 . . . . 0.0 110.71 -178.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' B' ' 358' ' ' GLY . 89.7 mt -50.72 116.38 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 122.313 1.054 . . . . 0.0 110.222 -177.558 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 70.0 p -107.28 13.04 27.56 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.746 -178.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.67 116.43 49.79 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.022 -1.049 . . . . 0.0 108.829 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -58.94 -12.01 13.96 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 CA-C-N 120.579 1.243 . . . . 0.0 112.617 -179.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -103.73 2.77 33.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.3 -0.875 . . . . 0.0 109.993 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 65.69 167.49 2.07 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -178.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 2.8 tp -88.72 96.28 10.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.784 -1.421 . . . . 0.0 110.227 -177.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -100.07 -159.59 0.75 Allowed 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.975 -1.078 . . . . 0.0 109.632 178.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 93.4 m -59.95 -42.39 93.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.687 -1.258 . . . . 0.0 112.482 -176.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.455 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.4 tpt180 -57.59 -61.41 7.31 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.536 -1.353 . . . . 0.0 111.367 -178.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.26 -33.18 94.88 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 120.305 1.145 . . . . 0.0 111.454 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.93 -50.15 74.89 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.23 -41.77 65.74 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -69.89 -43.04 72.59 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.704 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -60.32 -51.58 68.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.562 -0.711 . . . . 0.0 110.208 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.34 -28.87 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.864 -1.147 . . . . 0.0 109.962 -179.072 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -59.98 -45.09 93.83 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.171 -0.956 . . . . 0.0 108.894 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.66 -46.35 69.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.305 -0.872 . . . . 0.0 110.969 -178.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.21 -54.64 19.23 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.516 -1.365 . . . . 0.0 111.118 -179.06 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -50.63 -16.56 0.4 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.217 -0.927 . . . . 0.0 109.598 -179.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -75.65 -18.67 79.63 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -103.54 143.48 32.68 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.444 -1.033 . . . . 0.0 108.876 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 86.7 m -90.72 -11.09 40.71 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.041 -1.037 . . . . 0.0 110.779 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 88.8 p -67.04 156.92 34.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.881 -1.137 . . . . 0.0 109.754 -179.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -71.93 133.57 45.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.212 -0.93 . . . . 0.0 109.168 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . 0.415 HG22 HD13 ' B' ' 333' ' ' ILE . 84.2 mt -130.63 131.22 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 84.8 m -129.27 148.14 51.17 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.558 -0.713 . . . . 0.0 109.533 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 96.6 t -122.33 115.84 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 92.6 m -104.53 125.12 50.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.152 -0.968 . . . . 0.0 109.573 -178.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 15.1 p -134.4 117.25 16.11 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.861 0.838 . . . . 0.0 110.339 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 42.93 55.02 4.58 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 177.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.96 -15.19 22.7 Favored Glycine 0 N--CA 1.497 2.74 0 O-C-N 120.349 -1.469 . . . . 0.0 112.44 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -108.45 118.98 38.18 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 119.069 1.434 . . . . 0.0 109.377 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 65.2 m -116.27 143.43 45.54 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.896 0.855 . . . . 0.0 111.151 -178.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.06 159.36 42.38 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.539 0.685 . . . . 0.0 109.668 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 15.9 t -87.04 135.17 33.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.496 -0.752 . . . . 0.0 109.799 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.537 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -72.5 -16.62 61.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.998 -1.064 . . . . 0.0 109.121 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -85.4 20.96 1.87 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.136 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.537 ' H ' ' C ' ' B' ' 344' ' ' ALA . 2.5 m -149.46 95.86 2.41 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.87 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 59.3 tp -59.36 -35.06 73.19 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -56.32 -53.19 60.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.333 -0.854 . . . . 0.0 110.321 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.491 ' O ' ' OG1' ' B' ' 352' ' ' THR . 52.6 mtmt -69.98 -40.06 75.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.986 -1.071 . . . . 0.0 110.505 -178.254 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.559 ' O ' ' N ' ' B' ' 352' ' ' THR . 87.7 mt -52.86 -59.89 3.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.496 -1.378 . . . . 0.0 108.546 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.684 HE21 ' NE ' ' A' ' 126' ' ' ARG . 3.4 tp-100 -42.61 -11.89 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.674 -178.312 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.559 ' N ' ' O ' ' B' ' 350' ' ' LEU . 71.8 p -89.24 -9.96 48.77 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.577 -1.327 . . . . 0.0 109.607 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 54.1 mt -92.71 120.49 33.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.188 -0.945 . . . . 0.0 108.874 178.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.8 92.34 0.81 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 179.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.73 90.59 4.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.263 -1.14 . . . . 0.0 109.663 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 356' ' ' THR . . . . . 0.45 ' O ' ' C ' ' B' ' 357' ' ' GLN . 82.1 p -97.86 139.32 33.89 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.084 -1.01 . . . . 0.0 109.774 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . 0.45 ' C ' ' O ' ' B' ' 356' ' ' THR . 16.4 tm0? -34.68 118.46 0.41 Allowed 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.393 0.616 . . . . 0.0 110.976 -178.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 103.15 5.08 47.15 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 21.6 m -87.25 109.45 19.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.318 -1.107 . . . . 0.0 110.426 -179.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 20.8 t -77.12 114.04 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 122.169 0.985 . . . . 0.0 109.46 -177.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.25 176.59 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.444 -0.946 . . . . 0.0 108.444 -178.152 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 24.9 m -130.41 126.27 36.6 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.958 -1.126 . . . . 0.0 107.958 177.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 84.4 mt -102.06 113.89 39.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 84.5 p -119.88 132.79 55.66 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.604 -0.685 . . . . 0.0 109.339 -178.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.12 150.51 38.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 109.428 -179.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -144.9 125.04 13.64 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.507 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.55 -160.92 30.98 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.679 -179.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -59.98 -50.01 75.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 122.051 -0.676 . . . . 0.0 112.16 -177.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -104.94 9.89 34.44 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.733 -1.229 . . . . 0.0 111.216 -177.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.1 pt-20 -42.49 -33.52 0.69 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.211 -0.931 . . . . 0.0 111.56 -178.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -70.01 -40.19 75.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.689 -1.257 . . . . 0.0 109.92 -178.612 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -66.84 -48.68 68.11 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.074 -1.051 . . . . 0.0 109.321 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.39 -78.16 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.392 -0.818 . . . . 0.0 110.901 -179.1 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . 0.407 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 37.6 t -47.28 -37.89 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.057 -1.027 . . . . 0.0 110.336 -177.384 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -69.82 -41.46 74.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.812 -1.18 . . . . 0.0 109.819 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -80.16 -46.74 15.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.137 -0.977 . . . . 0.0 110.315 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.15 -33.52 73.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 110.164 -179.026 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 71.3 t -75.61 -34.18 28.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.493 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -72.85 -23.24 60.73 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 108.582 178.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' B' ' 383' ' ' GLU . 51.7 tp -79.95 -67.06 0.8 Allowed 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.113 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 50.8 tpp -50.16 -28.24 7.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.496 -0.752 . . . . 0.0 109.068 -178.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -76.14 -22.43 55.46 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.403 178.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' B' ' 380' ' ' LEU . 78.5 mm-40 -106.94 4.63 27.43 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.324 -0.86 . . . . 0.0 111.872 -178.501 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 89.7 mt -78.2 121.64 24.62 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.16 -1.587 . . . . 0.0 108.98 179.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.44 179.688 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.0 mmm . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.588 -0.523 . . . . 3.19 109.588 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.1 mt -105.62 125.75 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.777 -0.823 . . . . 1.71 108.777 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.2 m -129.66 138.05 50.98 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.52 -0.738 . . . . 1.66 109.13 -179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.92 -160.17 19.55 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 109.139 -1.585 . . . . 1.05 109.139 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.7 mt -94.63 -10.87 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.116 -1.226 . . . . 1.59 110.251 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.2 tp 54.18 101.48 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.116 -0.99 . . . . 1.47 108.818 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.54 -28.48 18.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.214 -0.929 . . . . 1.39 109.775 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.6 t -143.14 131.09 11.11 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.289 -0.882 . . . . 2.09 109.646 -179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.32 142.68 15.12 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.302 2.001 . . . . 0.91 113.147 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 161.93 -161.7 33.55 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.291 -1.524 . . . . 0.92 109.291 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.7 mt -149.5 150.02 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 121.198 -1.178 . . . . 1.35 108.435 179.203 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.49 157.99 37.8 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.746 -1.221 . . . . 1.14 110.436 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 9.8 m-85 -139.02 128.11 23.87 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.393 -0.965 . . . . 0.7 108.393 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.04 -178.8 46.66 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 118.585 -1.769 . . . . 0.58 111.188 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -79.99 157.93 26.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.731 -0.864 . . . . 2.63 109.619 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.02 135.36 45.67 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.456 -0.777 . . . . 1.27 111.078 -179.127 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.0 tp -102.1 134.83 44.72 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 107.743 -1.206 . . . . 1.41 107.743 178.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.4 tp -115.2 121.37 42.74 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.314 -0.866 . . . . 1.49 110.362 -179.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.4 mt -89.3 102.11 14.77 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.846 -0.534 . . . . 1.52 110.182 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -101.3 136.04 41.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.347 -0.846 . . . . 3.17 109.463 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -130.28 132.72 46.04 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.442 -0.786 . . . . 3.0 109.232 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -74.64 150.08 39.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.099 -1.0 . . . . 2.77 109.248 179.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -63.74 145.67 55.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.146 -0.971 . . . . 2.94 109.193 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 58.9 mt -84.4 125.84 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.107 -0.996 . . . . 1.46 109.4 -179.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.3 t -93.22 122.6 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.232 -0.918 . . . . 1.7 109.766 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.5 mt -103.73 139.42 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.831 -0.803 . . . . 1.54 108.831 179.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -96.89 114.95 26.61 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.134 -0.979 . . . . 1.81 109.354 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.475 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.4 mmt-85 -90.08 0.13 57.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.249 -0.907 . . . . 3.23 109.695 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -66.28 147.43 53.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.199 -0.938 . . . . 3.29 109.205 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -87.69 147.21 25.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.039 -1.038 . . . . 2.8 109.556 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 pt -93.89 165.28 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 1.43 109.788 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.6 p -96.22 171.25 8.71 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.048 -1.032 . . . . 1.54 108.922 179.163 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.5 -16.58 64.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.113 -0.992 . . . . 1.6 110.603 -179.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.67 -26.1 26.17 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.676 -1.231 . . . . 2.56 107.676 178.296 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -82.45 -9.7 59.33 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.875 -0.787 . . . . 2.36 108.875 179.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.6 t -63.73 -53.8 40.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 120.862 -1.149 . . . . 1.43 108.961 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.44 -40.15 93.42 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.246 -0.909 . . . . 1.77 110.102 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -70.03 -43.01 72.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.038 -1.039 . . . . 3.32 110.347 -179.263 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -63.55 -39.86 95.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.078 -1.014 . . . . 1.51 110.288 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.36 -46.01 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.833 -1.167 . . . . 1.41 108.816 179.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -60.0 -39.8 87.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.143 -0.973 . . . . 1.81 108.69 -179.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -60.0 -41.62 92.49 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.724 -1.213 . . . . 3.26 107.724 178.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -63.45 -49.35 74.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.362 -0.836 . . . . 0.81 109.032 178.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.94 -48.67 80.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.382 -0.823 . . . . 1.59 109.038 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.5 t -63.64 -44.21 94.54 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.01 -1.056 . . . . 1.38 108.741 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.94 -48.58 85.36 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.851 -1.699 . . . . 0.87 108.851 179.315 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -65.34 -32.52 74.21 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.327 -1.102 . . . . 3.62 108.451 179.158 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.36 -39.92 84.82 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.803 -0.814 . . . . 1.43 108.803 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 51' ' ' SER . 33.6 ttpt -65.36 -74.38 0.11 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.962 -1.125 . . . . 3.08 107.962 179.189 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.45 -30.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.51 -0.744 . . . . 1.33 111.26 -178.423 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 49' ' ' LYS . 44.0 t -59.98 -54.39 46.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.706 -1.246 . . . . 1.85 108.397 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.62 -40.09 84.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.835 . . . . 1.35 111.054 -179.139 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -61.9 -46.56 88.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.68 -1.263 . . . . 2.34 110.128 -179.316 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.11 -40.03 88.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.14 -0.975 . . . . 2.2 109.018 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -60.31 -40.04 89.13 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.38 -0.825 . . . . 1.35 109.174 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.4 m -64.45 -44.24 91.74 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.243 -0.91 . . . . 1.34 108.64 178.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.5 mt -61.31 -39.88 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.848 -0.797 . . . . 1.26 108.848 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -59.69 -50.34 74.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.955 . . . . 1.7 109.17 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.9 m -59.95 -36.53 77.27 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.396 -0.815 . . . . 1.35 110.025 -178.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -66.17 -38.48 88.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.976 -1.077 . . . . 2.08 109.161 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.71 -45.02 88.34 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.585 -0.697 . . . . 1.21 109.948 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.9 -51.57 58.17 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 120.025 -1.083 . . . . 0.75 110.435 -179.15 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.95 -45.67 66.92 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.096 -1.238 . . . . 1.59 109.809 -179.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.6 m -67.17 -61.26 2.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 1.41 111.709 -178.36 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.01 -52.7 3.76 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.135 -0.978 . . . . 0.79 111.473 -177.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.11 -165.18 26.7 Favored Glycine 0 N--CA 1.501 3.033 0 C-N-CA 119.615 -1.278 . . . . 1.22 111.152 179.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -70.05 -25.16 63.41 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.804 -0.821 . . . . 5.81 110.696 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -60.75 -37.35 81.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.998 . . . . 3.37 110.224 -179.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -99.59 -18.03 17.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.45 -0.781 . . . . 2.37 110.296 -179.444 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -70.01 -45.37 67.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.973 -1.079 . . . . 1.65 110.457 -179.298 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.14 -27.29 67.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.394 -0.816 . . . . 1.42 109.931 -178.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.7 mt -60.07 -41.49 86.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.038 -1.039 . . . . 1.43 109.14 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -69.1 -37.16 78.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.035 -1.041 . . . . 1.08 109.959 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -60.0 -40.28 88.66 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.799 -1.188 . . . . 1.37 108.867 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.84 -49.52 75.1 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.36 -1.896 . . . . 0.67 108.36 178.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -60.12 -46.63 88.99 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.374 -1.074 . . . . 1.99 108.462 179.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.96 -50.02 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -0.797 . . . . 1.22 109.193 179.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.8 ttp -60.53 -39.97 89.77 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.156 -0.965 . . . . 2.11 109.811 -179.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.3 tp -66.9 -39.93 87.57 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.632 -0.668 . . . . 1.33 110.118 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.92 -39.78 94.95 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.637 -0.825 . . . . 1.29 109.68 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -82.54 7.64 13.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.087 -1.008 . . . . 1.47 109.598 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 63.5 t0 -49.87 134.72 20.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.179 -0.951 . . . . 1.47 110.279 -178.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.479 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 95.2 mt-10 -58.84 -26.7 64.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.784 -0.572 . . . . 1.78 111.637 -178.266 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.09 -31.0 62.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.899 -1.125 . . . . 2.53 110.096 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.4 mt -70.01 -42.53 72.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.337 -0.852 . . . . 1.36 110.095 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.08 -48.17 82.85 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.502 -0.749 . . . . 1.42 110.621 -178.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -69.93 -42.92 72.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.958 . . . . 2.27 111.285 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.39 -40.01 74.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.11 -0.994 . . . . 1.57 111.624 -178.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.37 -45.89 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.897 -1.127 . . . . 1.19 109.786 -179.164 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.6 mt -69.93 -38.29 75.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.433 -0.792 . . . . 1.39 110.294 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.43 -40.87 98.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.083 -1.011 . . . . 1.39 111.049 -179.076 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 96' ' ' LYS . 27.3 mt -61.24 -45.56 94.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.828 -1.17 . . . . 1.5 109.348 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.9 mt -61.92 -48.18 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 122.048 0.928 . . . . 1.29 109.206 179.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -70.02 -40.03 75.47 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.608 -0.682 . . . . 2.64 110.298 -179.23 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.73 -53.67 5.73 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.164 -0.96 . . . . 1.65 111.91 -178.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 92' ' ' LEU . 98.3 mttt -89.97 -0.83 57.79 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.011 -1.056 . . . . 2.5 112.035 -177.274 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 70.7 m80 57.24 36.56 27.53 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.035 -1.041 . . . . 1.88 110.179 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 99.6 mtp -92.07 166.99 12.39 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.519 -0.738 . . . . 1.71 109.375 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 35.0 p -80.75 162.81 23.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 1.61 109.747 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.45 -39.87 81.3 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.357 -0.84 . . . . 1.33 109.744 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -64.36 -39.05 93.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 2.07 109.55 179.319 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.91 -41.21 23.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.407 -0.808 . . . . 1.37 110.322 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.46 -48.0 65.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 1.14 110.19 -179.192 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.94 -45.75 91.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.997 -1.064 . . . . 1.26 109.447 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.488 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 84.9 t60 -60.01 -40.0 87.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.406 -0.809 . . . . 2.02 109.731 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.0 -41.97 93.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.264 -0.897 . . . . 1.33 110.048 -179.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.7 t -68.88 -51.31 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.068 -1.02 . . . . 1.3 110.422 -178.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.39 -40.92 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.035 -1.041 . . . . 1.32 108.512 179.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.488 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 86.3 tt0 -65.29 -40.0 93.28 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.443 -0.947 . . . . 2.44 108.443 178.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.13 -50.16 70.66 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.159 -1.176 . . . . 0.99 110.159 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -65.34 -51.15 62.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.931 -1.335 . . . . 1.97 109.421 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.49 -40.86 75.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.166 -0.959 . . . . 1.43 109.206 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.7 m -59.97 -40.04 87.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.089 -1.007 . . . . 2.12 108.443 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.97 -39.95 90.85 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.641 -0.874 . . . . 1.64 108.641 178.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 87.1 mt -65.71 -42.65 90.88 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.091 -1.005 . . . . 1.93 109.474 -179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -59.88 -39.05 84.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.916 -1.115 . . . . 2.2 109.848 -178.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -49.98 -19.99 0.83 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.005 -1.059 . . . . 2.12 109.555 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 29.2 mt -62.72 140.02 58.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.012 -1.055 . . . . 2.34 109.043 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -93.16 40.41 1.06 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.176 -0.953 . . . . 3.23 110.289 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -126.13 134.2 51.39 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.266 -0.896 . . . . 2.49 109.518 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.53 -30.42 68.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.451 -0.78 . . . . 3.95 109.919 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.497 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.0 t80 -69.99 -39.02 76.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.347 -0.845 . . . . 2.25 110.32 179.327 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.5 mt -80.76 -31.94 35.7 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.06 -1.025 . . . . 2.27 109.248 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -60.94 -40.76 94.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 3.31 109.003 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -64.22 -40.0 95.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 2.73 109.015 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.48 ' NH1' ' CD ' ' B' ' 351' ' ' GLN . 0.1 OUTLIER -59.97 -39.99 87.56 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.295 -1.002 . . . . 3.2 108.295 179.436 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.3 -26.13 66.28 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.595 -0.891 . . . . 1.66 108.595 178.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.68 -39.94 84.45 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.947 -0.76 . . . . 1.67 108.947 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.86 -39.99 79.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 1.55 109.681 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.7 -44.38 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 1.32 108.563 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -60.49 -37.38 80.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 3.58 108.918 178.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -59.82 -39.66 85.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.493 -0.755 . . . . 1.46 109.664 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.96 -40.4 82.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.04 -1.037 . . . . 1.22 108.873 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.08 -35.99 64.31 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.048 -1.221 . . . . 0.61 110.048 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -60.05 -49.9 75.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.115 -1.226 . . . . 3.1 109.931 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -67.66 -33.34 74.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.021 -1.049 . . . . 3.71 109.501 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.04 -43.25 95.49 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.249 -0.907 . . . . 1.87 109.074 -179.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.04 -42.52 94.58 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.192 -0.943 . . . . 1.29 109.985 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 63.1 mtm-85 -71.39 -39.29 71.26 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.394 -0.816 . . . . 3.05 109.352 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -65.57 -34.37 78.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.726 . . . . 1.26 111.259 -179.197 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.408 HD12 HG22 ' A' ' 141' ' ' ILE . 93.3 mt -70.01 -45.35 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.416 -1.427 . . . . 1.34 108.037 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.7 mt -69.89 -30.79 68.31 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 120.137 -0.625 . . . . 1.6 109.454 179.135 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.89 41.73 8.02 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.034 -1.626 . . . . 0.96 109.034 -179.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 tp -74.88 157.23 35.41 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.468 -1.019 . . . . 1.67 109.411 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.21 146.62 53.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.886 . . . . 4.96 110.062 -179.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.408 HG22 HD12 ' A' ' 146' ' ' ILE . 85.7 mt -119.9 127.78 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 108.826 -0.805 . . . . 1.68 108.826 179.351 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.402 HG21 HD11 ' A' ' 147' ' ' ILE . 27.6 mm -55.4 -49.68 71.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.36 -0.837 . . . . 2.14 110.212 -178.251 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.4 t0 66.24 103.92 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.528 -0.732 . . . . 1.5 109.338 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.8 mt -79.61 -5.77 55.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.42 -0.8 . . . . 1.39 110.179 -178.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.3 t -81.67 -20.52 39.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.942 -1.099 . . . . 1.83 109.634 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.04 21.53 0.7 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.297 -0.877 . . . . 1.46 111.66 -178.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 39.5 mm -89.12 129.49 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.565 -1.334 . . . . 1.42 108.965 179.517 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -110.53 -11.31 14.48 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.586 -0.696 . . . . 2.94 110.059 -179.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -118.3 148.11 42.79 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.177 -0.952 . . . . 1.52 110.457 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.24 133.95 52.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 1.58 109.214 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.9 m -153.33 166.33 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.42 -0.8 . . . . 1.32 109.439 179.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.402 HD12 HG23 ' A' ' 157' ' ' ILE . 85.3 mt -94.06 147.42 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.545 -1.65 . . . . 1.27 106.545 177.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 49.7 tp -94.27 113.58 25.51 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.011 -1.055 . . . . 1.41 110.101 -177.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.7 t -118.68 125.22 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 108.663 -0.866 . . . . 1.23 108.663 179.478 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.68 160.65 40.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.991 -1.068 . . . . 1.32 109.465 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.45 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -78.82 -29.08 44.57 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.487 -1.383 . . . . 1.49 109.02 179.199 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 161' ' ' ALA . 14.5 m-20 -167.36 133.41 2.14 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.31 -0.869 . . . . 2.25 109.169 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 57.7 mt -118.15 130.04 55.87 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 108.781 -0.822 . . . . 1.35 108.781 179.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 20.8 p -93.84 149.99 37.9 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.079 -1.013 . . . . 1.56 109.737 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -39.38 -36.58 0.98 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.64 2.227 . . . . 0.87 113.636 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.6 m -59.98 -40.05 87.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.894 -1.129 . . . . 1.36 110.028 -178.194 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.61 -39.82 80.69 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.256 -0.902 . . . . 1.61 110.249 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.427 ' CG2' ' HG1' ' A' ' 190' ' ' THR . 80.7 p -57.39 -38.08 73.71 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.059 -1.025 . . . . 1.21 112.036 -177.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.97 -47.8 70.46 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.521 -1.362 . . . . 1.21 110.027 -179.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -85.68 33.83 0.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.327 -0.99 . . . . 2.11 108.327 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.3 tp -102.78 137.5 40.9 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.788 -0.819 . . . . 1.29 108.788 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.671 ' ND2' ' H ' ' A' ' 175' ' ' LYS . 0.2 OUTLIER -86.96 104.72 16.55 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.476 -0.935 . . . . 2.81 108.476 179.575 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.55 -40.11 92.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.895 . . . . 2.09 111.598 -178.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -69.87 -25.5 63.75 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.746 -1.221 . . . . 2.86 111.744 -177.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.671 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 98.5 mttt -93.73 -10.04 35.66 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.706 -1.246 . . . . 2.39 110.242 -178.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 95.0 t -100.94 113.22 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.029 -1.044 . . . . 1.27 108.339 178.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.4 mt -80.76 2.1 27.6 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.238 -0.913 . . . . 2.17 110.853 -177.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 166.25 177.99 38.67 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.3 -1.52 . . . . 0.52 109.3 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -132.31 128.23 37.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.484 -1.009 . . . . 0.55 109.489 -179.387 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 93.8 mt -130.74 124.21 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.507 -0.746 . . . . 1.27 109.03 179.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 181' ' ' THR . . . . . 0.446 ' C ' ' HG1' ' A' ' 205' ' ' THR . 52.8 p -150.88 161.92 41.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.813 -1.18 . . . . 1.39 110.721 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 37.1 p-10 -103.56 25.17 10.02 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.564 -0.71 . . . . 2.46 109.456 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.43 -158.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.863 -1.148 . . . . 1.51 111.703 -178.259 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.14 -54.4 5.24 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.84 -0.695 . . . . 2.23 111.44 -178.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 165.23 -139.17 5.65 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 118.968 -1.587 . . . . 2.23 111.07 -179.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 186' ' ' ARG . 0.4 OUTLIER -69.93 -22.88 63.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.608 -0.937 . . . . 6.44 111.175 -178.761 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 66.7 p -70.27 1.25 5.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.848 -1.157 . . . . 4.09 109.546 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.0 t -90.89 133.83 34.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.267 -0.896 . . . . 2.2 110.482 -179.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -47.48 -53.22 14.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.497 -0.752 . . . . 1.15 110.21 -179.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.427 ' HG1' ' CG2' ' A' ' 168' ' ' THR . 94.7 m -60.11 -40.44 89.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.341 -0.849 . . . . 2.01 111.473 -178.772 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 17.3 t -60.0 -40.73 90.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.829 -1.169 . . . . 1.93 110.12 -179.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 85.7 mt -61.39 -37.93 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.874 . . . . 2.2 109.728 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.3 mtp -60.07 -39.96 87.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.842 . . . . 1.32 109.692 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.07 88.69 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.713 -1.242 . . . . 1.3 108.633 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -60.06 -51.06 71.24 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.714 -0.794 . . . . 3.38 110.319 -179.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.9 m -74.88 -34.25 62.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.083 -1.011 . . . . 1.15 112.022 -178.374 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.1 mt -73.55 -11.5 60.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.632 -1.293 . . . . 1.28 109.829 -178.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 60.1 50.08 6.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.573 -0.704 . . . . 1.5 110.975 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.2 mt -128.77 149.92 73.48 Favored Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 107.602 -1.258 . . . . 1.37 107.602 178.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.81 140.75 47.22 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 122.16 1.907 . . . . 0.76 112.158 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -171.04 151.52 3.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.965 -1.084 . . . . 1.19 111.418 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.7 mt -123.45 138.15 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.521 -1.288 . . . . 1.31 107.521 178.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 17.3 m -121.83 -11.86 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 O-C-N 120.738 -1.226 . . . . 1.38 111.478 -178.195 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -105.97 23.88 28.08 Favored Glycine 0 N--CA 1.5 2.934 0 N-CA-C 110.309 -1.117 . . . . 1.03 110.309 -179.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.446 ' HG1' ' C ' ' A' ' 181' ' ' THR . 6.7 p -44.29 -41.15 5.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.202 -1.175 . . . . 1.38 109.928 -179.439 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.41 -50.48 4.23 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 120.211 -0.995 . . . . 1.17 110.982 179.17 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 30.5 t -159.12 38.05 0.21 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.611 -1.523 . . . . 2.07 111.402 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.82 -35.54 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.934 -1.104 . . . . 1.35 108.673 178.133 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 76.7 p -54.73 -30.1 55.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.844 . . . . 1.49 110.148 -179.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.0 p -81.92 -12.62 58.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.112 -0.992 . . . . 2.16 110.228 -179.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 30.2 mm100 -101.71 -10.24 20.15 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.339 -0.851 . . . . 2.89 109.674 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 92.5 t -107.37 134.82 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.303 -0.873 . . . . 1.33 111.47 -178.013 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -113.44 155.22 25.68 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.746 -1.576 . . . . 2.73 106.746 177.223 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.7 t-20 -59.98 138.3 57.88 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.935 -1.103 . . . . 2.7 110.572 -178.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 16.3 t0 85.9 0.06 0.69 Allowed 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 116.342 -0.39 . . . . 2.38 110.836 179.054 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -71.8 148.28 46.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.77 -1.206 . . . . 2.09 108.94 179.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -95.3 119.01 33.06 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.083 -1.08 . . . . 1.45 108.083 179.125 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 83.0 mt -125.59 145.14 50.26 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.411 -0.806 . . . . 1.31 110.456 -179.05 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.1 mt -113.88 128.4 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.463 -1.31 . . . . 1.29 107.463 177.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 20.6 tp -100.36 117.56 34.79 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.004 -1.06 . . . . 1.31 108.786 -179.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 10' ' ' GLY . 32.3 t0 -77.13 -44.3 30.88 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.151 -1.055 . . . . 2.31 108.151 179.638 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.405 ' HB1' ' H ' ' A' ' 10' ' ' GLY . . . 54.03 13.71 0.61 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.256 -0.646 . . . . 1.19 109.256 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 87.8 t -130.5 -42.94 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.146 -1.427 . . . . 1.45 107.146 177.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.45 ' ND2' ' OE1' ' A' ' 226' ' ' GLN . 47.9 t-20 -96.69 0.04 49.06 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.226 -1.398 . . . . 3.13 107.226 178.154 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 60.07 44.64 12.88 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.849 -0.532 . . . . 2.2 109.585 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.45 ' OE1' ' ND2' ' A' ' 224' ' ' ASN . 97.8 mt-30 -139.96 151.77 45.8 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.192 -0.943 . . . . 2.32 110.454 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.1 t -118.78 129.96 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.507 -0.923 . . . . 1.4 108.507 178.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -102.95 127.34 50.21 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.758 -0.831 . . . . 1.29 108.758 179.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.0 t -100.19 109.95 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.362 -0.836 . . . . 1.38 110.947 -178.495 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 41.2 t30 50.11 64.43 8.41 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.145 -0.972 . . . . 2.33 110.895 179.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -85.84 156.16 10.17 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.795 2.33 . . . . 0.95 111.986 179.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 82.4 p -70.44 160.42 32.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 2.31 110.078 -179.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -59.9 -34.69 73.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.435 -0.791 . . . . 3.45 108.873 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -59.93 -40.09 87.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.476 -0.765 . . . . 2.89 109.344 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.72 -40.02 83.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.194 -0.941 . . . . 1.73 109.276 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.495 1.799 0 O-C-N 121.24 -0.913 . . . . 1.57 110.31 -179.669 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 41.5 ttm . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.596 0.713 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -150.27 147.09 27.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -150.83 161.77 42.04 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.921 -1.112 . . . . 0.0 110.546 -179.203 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -153.37 150.01 28.41 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' B' ' 305' ' ' GLU . 0.6 OUTLIER -115.81 135.47 53.98 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.244 -0.91 . . . . 0.0 109.971 179.278 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -138.64 129.84 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 CA-C-O 122.523 1.154 . . . . 0.0 113.052 -177.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 90.9 m -76.69 106.36 8.3 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.467 -178.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 92.3 mt -52.45 126.07 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 122.412 1.101 . . . . 0.0 110.82 -177.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 22.3 p -109.99 20.07 18.34 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.372 -178.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -79.4 117.02 64.82 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.851 -1.156 . . . . 0.0 109.109 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.28 -11.68 6.53 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 CA-C-N 120.233 1.119 . . . . 0.0 113.212 -179.095 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -119.45 6.66 11.11 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 179.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.47 -179.4 40.24 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 107.961 -2.055 . . . . 0.0 107.961 -178.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.497 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -85.42 92.24 8.43 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.868 -1.372 . . . . 0.0 108.454 -179.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . 0.461 ' C ' ' NH2' ' A' ' 126' ' ' ARG . 5.2 p80 -94.29 -160.91 0.81 Allowed 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.179 -0.951 . . . . 0.0 110.642 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 316' ' ' THR . . . . . 0.473 ' H ' ' HG1' ' B' ' 316' ' ' THR . 2.9 m -57.35 -43.92 83.88 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.204 -0.935 . . . . 0.0 112.651 -175.813 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.454 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.0 OUTLIER -60.75 -61.74 7.37 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 120.443 -1.411 . . . . 0.0 112.139 -178.508 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -57.33 -31.55 91.31 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 CA-C-N 120.219 1.114 . . . . 0.0 111.781 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.07 -51.51 69.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 109.069 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.7 -41.12 63.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.17 -178.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -72.71 -40.1 66.44 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.882 179.065 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -60.81 -52.46 64.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -0.813 . . . . 0.0 110.869 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . 0.485 ' CG1' ' HZ2' ' B' ' 327' ' ' LYS . 53.6 t -68.28 -38.07 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.685 -1.259 . . . . 0.0 109.334 -178.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . 0.42 ' CB ' ' HZ2' ' B' ' 324' ' ' LYS . 4.1 ttpm? -59.98 -46.17 90.31 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.751 -179.133 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -63.33 -40.06 96.26 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.925 -1.11 . . . . 0.0 108.789 179.127 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -61.08 -51.31 69.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.422 -0.798 . . . . 0.0 110.312 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . 0.485 ' HZ2' ' CG1' ' B' ' 323' ' ' VAL . 18.6 mttp -56.92 -11.95 1.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.373 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -73.25 -27.48 68.06 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -105.4 143.19 33.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 27.4 p -91.16 -12.59 34.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.902 -1.124 . . . . 0.0 110.16 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 67.8 p -60.13 147.64 38.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.075 -1.015 . . . . 0.0 109.418 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -67.11 136.38 55.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.108 -0.995 . . . . 0.0 108.581 179.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 90.0 mt -131.41 130.15 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.653 -0.654 . . . . 0.0 109.803 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 54.1 m -124.23 148.76 47.09 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.109 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 92.3 t -115.87 136.91 51.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.2 m -128.85 122.62 30.8 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.148 -0.97 . . . . 0.0 109.038 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 91.8 p -138.18 116.71 12.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.306 -0.871 . . . . 0.0 110.386 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 33.2 m120 45.7 62.69 2.09 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 75.16 -11.96 7.59 Favored Glycine 0 N--CA 1.498 2.77 0 O-C-N 120.399 -1.438 . . . . 0.0 112.924 176.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -115.81 127.53 55.14 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 118.951 1.375 . . . . 0.0 109.818 -179.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 21.2 m -126.12 148.61 49.35 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.872 0.844 . . . . 0.0 110.399 -179.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -142.43 164.15 30.9 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.405 0.622 . . . . 0.0 109.929 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 58.6 m -86.96 136.59 32.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.606 -0.684 . . . . 0.0 109.934 -179.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -73.77 -13.49 60.96 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.04 -1.037 . . . . 0.0 109.693 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -90.82 21.68 3.99 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.41 ' H ' ' C ' ' B' ' 344' ' ' ALA . 68.0 m -144.84 93.36 2.39 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.944 -179.071 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 37.9 tp -59.12 -34.75 72.4 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -57.87 -56.38 22.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.508 -0.745 . . . . 0.0 109.79 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -70.04 -20.05 63.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.869 . . . . 0.0 111.008 -178.556 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.63 ' O ' ' N ' ' B' ' 352' ' ' THR . 50.2 mt -72.03 -58.32 3.54 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.669 -1.269 . . . . 0.0 108.233 178.073 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.48 ' CD ' ' NH1' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -40.28 -10.25 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.769 -178.279 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.63 ' N ' ' O ' ' B' ' 350' ' ' LEU . 81.0 p -91.93 -11.43 36.25 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.574 -1.329 . . . . 0.0 110.446 -179.224 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 66.0 mt -92.47 120.07 32.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.996 -1.065 . . . . 0.0 108.972 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.88 92.95 0.83 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 31.1 mt -103.25 93.81 5.18 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.396 -1.061 . . . . 0.0 109.343 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 57.8 p -95.72 179.98 4.93 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.046 -1.034 . . . . 0.0 110.548 -179.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -68.45 111.82 4.91 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.506 -0.747 . . . . 0.0 109.945 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 105.75 9.69 32.27 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 97.6 m -87.83 106.21 17.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -1.172 . . . . 0.0 110.302 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 3.9 t -77.01 117.84 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 122.296 1.046 . . . . 0.0 109.004 -177.563 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 19.6 m -113.68 177.73 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.832 -177.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 93.9 m -132.0 130.04 40.89 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 176.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . 0.412 HG22 HD11 ' B' ' 363' ' ' ILE . 96.5 mt -105.35 120.51 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.36 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 58.2 m -120.07 131.72 55.18 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.689 -0.632 . . . . 0.0 109.543 -178.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.71 153.76 41.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 109.715 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -146.33 123.02 11.18 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 160.91 -155.39 26.55 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 118.681 -1.723 . . . . 0.0 111.86 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -58.94 -50.46 73.97 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.154 -0.523 . . . . 0.0 112.394 -177.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' B' ' 370' ' ' GLU . 97.8 m-20 -110.29 15.28 22.41 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.926 -1.109 . . . . 0.0 111.275 -177.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' B' ' 369' ' ' ASP . 16.2 pt-20 -39.54 -38.28 0.58 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.421 -0.8 . . . . 0.0 111.453 -179.034 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -66.73 -48.15 70.07 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.723 -1.236 . . . . 0.0 110.622 -178.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -70.02 -52.52 23.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.977 -1.077 . . . . 0.0 109.899 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.01 -38.71 3.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.429 -0.794 . . . . 0.0 111.229 -178.661 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.05 -39.98 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.515 -1.366 . . . . 0.0 109.251 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.91 -66.83 0.5 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.971 . . . . 0.0 111.637 -178.025 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . 0.448 ' O ' ' N ' ' B' ' 380' ' ' LEU . 32.2 m170 -59.92 -45.2 93.33 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.652 -1.28 . . . . 0.0 112.103 -177.171 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 98.0 mt -59.98 -42.0 93.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.328 -1.483 . . . . 0.0 108.841 -179.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 53.4 t -68.7 -40.14 81.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -80.67 -10.94 59.7 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.969 -1.082 . . . . 0.0 109.831 178.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' B' ' 376' ' ' HIS . 61.3 tp -82.39 -25.98 33.25 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.473 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 3.4 ttp -82.75 -25.68 32.61 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -84.37 -10.07 57.89 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.599 -0.688 . . . . 0.0 110.03 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -108.55 -0.86 20.1 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.309 -0.869 . . . . 0.0 110.344 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 44.4 mt -98.94 119.99 38.64 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.009 -1.057 . . . . 0.0 109.727 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 53.3 mp0 . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 117.967 -1.016 . . . . 0.0 108.978 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.6 mtp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.881 -0.415 . . . . 3.19 109.881 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.2 mt -94.76 121.28 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.066 -1.022 . . . . 1.71 109.814 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.7 m -138.75 149.07 44.63 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.716 -0.846 . . . . 1.66 108.716 179.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.02 -161.4 12.21 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 109.357 -1.497 . . . . 1.05 109.357 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' LEU . 97.8 mt -92.07 -12.89 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -1.189 . . . . 1.59 109.944 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' ILE . 63.0 tp 53.92 101.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.059 -1.025 . . . . 1.47 108.717 -179.515 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.06 -39.94 24.95 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.764 -0.828 . . . . 1.39 108.764 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 m -141.05 135.28 15.16 Favored Pre-proline 0 N--CA 1.5 2.025 0 O-C-N 121.583 -0.698 . . . . 2.09 109.524 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.17 147.4 20.71 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.391 2.061 . . . . 0.91 112.877 179.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 162.45 -162.2 34.21 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.9 -1.68 . . . . 0.92 108.9 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.5 mt -149.56 150.42 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.01 -1.288 . . . . 1.35 108.565 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.45 159.31 38.55 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.701 -1.249 . . . . 1.14 110.615 179.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -140.03 129.08 23.58 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.884 -1.154 . . . . 0.7 107.884 179.068 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.66 -177.95 47.33 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 118.782 -1.675 . . . . 0.58 110.893 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -79.39 159.53 27.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.762 -0.846 . . . . 2.63 109.298 -179.743 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.8 137.39 45.9 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.374 -0.829 . . . . 1.27 111.119 -179.022 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.5 tp -107.32 132.59 52.96 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 107.283 -1.377 . . . . 1.41 107.283 178.501 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.2 tp -111.83 121.17 44.32 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.23 -0.919 . . . . 1.49 109.699 -179.314 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 31.0 mt -85.79 100.19 11.87 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.415 -0.803 . . . . 1.52 109.907 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -88.78 135.98 33.24 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.47 -0.769 . . . . 3.17 109.327 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -132.74 122.87 25.21 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.026 -1.101 . . . . 3.0 108.026 178.392 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -83.06 150.3 26.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.878 -1.139 . . . . 2.77 109.426 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -62.6 140.04 58.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 2.94 109.81 -179.61 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.6 mt -81.67 132.06 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 1.46 108.862 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.53 126.31 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.263 -0.898 . . . . 1.7 110.181 -179.133 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.5 mt -110.01 130.06 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 107.954 -1.128 . . . . 1.54 107.954 179.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -88.79 120.33 30.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.836 -1.165 . . . . 1.81 110.102 -179.218 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -89.95 -4.49 57.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 3.23 108.708 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -69.98 137.99 51.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 3.29 109.255 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -82.91 155.45 24.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 2.8 109.815 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.9 pt -98.84 168.47 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.445 -0.785 . . . . 1.43 109.339 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.9 p -89.99 173.55 8.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.08 -1.012 . . . . 1.54 108.481 178.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.04 -17.04 63.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.009 -1.057 . . . . 1.6 110.994 -179.367 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -84.57 -26.03 28.26 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.659 -1.276 . . . . 2.56 108.42 178.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -82.15 -7.95 59.64 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.131 -0.692 . . . . 2.36 109.131 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.0 t -60.01 -52.82 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.251 -0.905 . . . . 1.43 108.615 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -60.04 -40.05 88.02 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.354 -0.841 . . . . 1.77 109.208 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -64.06 -40.12 95.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 3.32 110.281 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -63.46 -44.41 94.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.756 -1.215 . . . . 1.51 110.023 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -60.03 -47.16 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.865 -1.147 . . . . 1.41 108.665 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -60.03 -46.69 88.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.302 -0.874 . . . . 1.81 108.984 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -60.21 -42.75 95.8 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.919 -1.113 . . . . 3.26 108.17 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -63.44 -47.73 80.68 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.535 -0.913 . . . . 0.81 108.535 178.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.3 tp -60.01 -48.68 80.72 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.516 -0.92 . . . . 1.59 108.516 -179.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.7 t -63.04 -43.85 97.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 1.38 108.903 179.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.99 -46.8 93.51 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.309 -1.917 . . . . 0.87 108.309 179.212 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.405 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 43.1 ttt-85 -60.1 -39.94 87.9 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.347 -0.983 . . . . 3.62 108.347 178.303 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.1 -46.23 33.69 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.148 -0.686 . . . . 1.43 109.148 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 50' ' ' ALA . 6.4 ttpm? -64.06 -74.08 0.11 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.92 -1.141 . . . . 3.08 107.92 179.261 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.62 -35.83 0.21 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.532 -0.73 . . . . 1.33 111.143 -178.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.2 t -53.76 -60.62 3.08 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.619 -1.301 . . . . 1.85 108.716 179.557 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.6 -39.99 84.77 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.508 -0.745 . . . . 1.35 111.648 -178.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -66.77 -41.3 87.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.693 -1.254 . . . . 2.34 110.302 -178.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.54 -39.98 95.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.863 -1.148 . . . . 2.2 108.873 179.198 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -65.83 -38.64 89.44 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.522 -0.736 . . . . 1.35 109.723 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.63 -40.87 98.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.014 . . . . 1.34 109.535 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.497 ' CD1' HH22 ' A' ' 136' ' ' ARG . 82.8 mt -60.19 -40.0 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 1.26 109.218 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -58.94 -50.03 75.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.847 . . . . 1.7 109.579 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -58.14 -28.76 64.98 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.316 -0.865 . . . . 1.35 110.618 -178.064 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -70.05 -39.1 75.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.063 -1.023 . . . . 2.08 109.878 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.04 -46.92 76.1 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.596 -0.69 . . . . 1.21 109.9 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.78 -54.06 32.9 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.928 -1.269 . . . . 0.75 109.928 -179.197 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.02 -45.53 60.51 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.045 -1.268 . . . . 1.59 110.588 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.5 m -68.34 -63.05 1.14 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.952 -1.092 . . . . 1.41 112.717 -177.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -95.7 -46.97 6.39 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.849 -1.157 . . . . 0.79 111.089 -177.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.93 -167.31 25.69 Favored Glycine 0 N--CA 1.5 2.943 0 O-C-N 120.839 -1.163 . . . . 1.22 111.143 179.485 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -75.6 -22.54 56.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.925 -0.75 . . . . 5.81 110.078 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.425 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.5 tp10 -61.12 -36.22 79.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.88 . . . . 3.37 110.211 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -100.72 -20.14 15.73 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.275 -0.89 . . . . 2.37 110.226 -179.486 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -68.51 -39.92 81.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.047 -1.033 . . . . 1.65 110.34 -179.106 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.5 -26.57 67.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.213 -0.93 . . . . 1.42 109.431 -179.362 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.8 mt -60.05 -40.82 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.081 -1.012 . . . . 1.43 108.732 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -70.04 -37.97 75.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.188 -0.945 . . . . 1.08 110.638 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -60.0 -40.11 88.08 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.656 -1.277 . . . . 1.37 108.642 179.351 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.07 -43.01 97.9 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.957 -1.657 . . . . 0.67 108.957 179.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.2 m170 -66.63 -41.31 88.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.302 -1.117 . . . . 1.99 108.969 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.4 mt -69.95 -45.44 76.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.323 -0.861 . . . . 1.22 108.987 179.354 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.4 ttp -60.69 -40.21 91.32 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.099 -1.001 . . . . 2.11 109.536 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 tp -64.95 -40.06 94.45 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.525 -0.735 . . . . 1.33 109.579 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.1 tp -63.62 -38.0 89.46 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.627 -0.67 . . . . 1.29 109.411 -179.213 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -82.4 4.39 24.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.159 -0.963 . . . . 1.47 110.913 -178.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -49.98 130.06 21.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.761 -1.212 . . . . 1.47 109.42 -179.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -57.54 -18.88 21.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.487 -0.758 . . . . 1.78 110.933 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.72 -34.56 69.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.77 -1.207 . . . . 2.53 108.878 178.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.2 mt -72.33 -42.52 65.31 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.73 -0.606 . . . . 1.36 110.567 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -60.0 -48.75 80.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.147 -0.971 . . . . 1.42 110.468 -178.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -69.95 -40.09 75.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.207 -0.933 . . . . 2.27 110.904 -178.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.03 -39.96 75.46 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.042 -1.036 . . . . 1.57 111.413 -179.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.2 mt -66.59 -49.94 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.949 -1.094 . . . . 1.19 109.539 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.3 mt -69.79 -39.99 78.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.562 -0.711 . . . . 1.39 110.013 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.04 -48.77 80.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.12 -0.987 . . . . 1.39 110.783 -179.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 96' ' ' LYS . 55.8 mt -59.97 -46.36 89.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.046 -1.034 . . . . 1.5 110.146 -179.089 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.9 -49.81 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 1.29 108.826 179.451 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -69.99 -40.96 75.0 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 120.276 -0.57 . . . . 2.64 111.19 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -85.07 -49.97 7.83 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.861 -1.15 . . . . 1.65 112.012 -178.228 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 92' ' ' LEU . 32.8 mmtp -89.18 -0.45 57.46 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.111 -0.993 . . . . 2.5 111.164 -177.229 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.2 m80 55.81 32.6 19.87 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.937 -1.102 . . . . 1.88 109.595 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.0 mtt -89.65 168.82 11.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.358 -0.839 . . . . 1.71 109.428 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.7 p -83.45 158.16 22.17 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.19 -0.944 . . . . 1.61 109.051 179.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.61 -39.95 92.07 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.267 -0.896 . . . . 1.33 109.262 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' A' ' 101' ' ' ASP . 40.4 t0 -65.55 -40.02 92.4 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.419 -0.801 . . . . 2.07 109.764 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.45 -41.52 24.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 1.37 110.147 -179.51 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.88 -45.45 64.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -0.946 . . . . 1.14 110.63 -179.316 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.05 -43.31 95.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.039 -1.038 . . . . 1.26 110.122 -179.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -60.01 -39.95 87.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 2.02 110.193 -178.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -61.46 -41.81 97.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.995 -1.066 . . . . 1.33 110.517 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.4 t -60.05 -50.85 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.14 -0.975 . . . . 1.3 110.598 -178.653 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.8 mm -69.94 -39.99 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.116 -0.99 . . . . 1.32 109.252 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -62.11 -39.38 92.31 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.584 -0.895 . . . . 2.44 108.584 179.099 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.0 -52.19 54.38 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.812 -0.915 . . . . 0.99 110.812 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.493 ' NE2' ' CB ' ' B' ' 348' ' ' PHE . 15.5 mm100 -64.04 -49.76 71.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.7 -1.47 . . . . 1.97 109.697 -179.436 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.91 83.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.189 -0.944 . . . . 1.43 109.027 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.8 t -59.98 -42.24 93.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.921 . . . . 2.12 108.873 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.29 -40.0 94.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.858 . . . . 1.64 109.882 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.4 mt -65.42 -40.26 93.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.787 -1.196 . . . . 1.93 109.674 -178.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.06 -31.06 69.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.9 -1.125 . . . . 2.2 109.75 -179.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -55.81 -23.57 31.04 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.084 -1.01 . . . . 2.12 108.396 179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.1 mt -63.23 148.91 46.82 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.576 -0.898 . . . . 2.34 108.576 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -99.81 47.07 0.95 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.025 -1.047 . . . . 3.23 110.204 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 34.6 t0 -137.44 150.17 47.43 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.174 -0.954 . . . . 2.49 109.772 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 124' ' ' LYS . 98.4 mt-10 -74.44 -67.97 0.57 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.299 -0.876 . . . . 3.95 109.259 178.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.634 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 4.8 t80 -39.25 -39.5 0.63 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.863 -0.523 . . . . 2.25 111.153 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.561 ' CD2' HH22 ' A' ' 126' ' ' ARG . 88.9 mt -69.97 -36.59 75.33 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.745 -1.222 . . . . 2.27 108.508 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 121' ' ' GLU . 74.6 tttt -69.23 -35.98 76.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.446 -0.784 . . . . 3.31 110.309 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.536 ' N ' ' OE1' ' A' ' 125' ' ' GLU . 0.4 OUTLIER -60.05 -46.31 89.97 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.966 -1.084 . . . . 2.73 110.603 -178.485 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.634 ' NH1' ' CE1' ' A' ' 122' ' ' TYR . 27.8 mtm-85 -63.14 -39.67 95.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.504 -1.372 . . . . 3.2 108.593 179.413 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.0 -36.6 77.55 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.459 -0.941 . . . . 1.66 108.459 179.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.22 88.58 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.216 -1.031 . . . . 1.67 108.216 179.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.88 -40.02 87.67 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.927 -0.768 . . . . 1.55 108.927 179.15 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 51.2 t -59.95 -42.9 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 1.32 109.052 179.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -60.04 -39.92 87.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 3.58 109.485 179.16 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -59.91 -40.05 87.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.427 -0.796 . . . . 1.46 110.196 -179.617 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.99 -42.17 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.127 -0.983 . . . . 1.22 110.447 -178.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.45 -34.46 54.23 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.805 -1.188 . . . . 0.61 110.236 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -60.05 -46.22 90.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -1.183 . . . . 3.1 109.684 -179.13 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.497 HH22 ' CD1' ' A' ' 57' ' ' ILE . 62.4 mtp180 -65.24 -34.5 78.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.125 -0.984 . . . . 3.71 110.108 -179.316 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.036 -1.04 . . . . 1.87 109.015 -179.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.53 -40.06 90.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 1.29 108.537 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -65.62 -39.93 92.02 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.825 -0.805 . . . . 3.05 108.825 179.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -69.47 -34.23 74.06 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.717 -0.614 . . . . 1.26 111.328 -179.245 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.26 -39.85 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.454 -1.404 . . . . 1.34 109.243 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.9 mt -73.84 -19.17 60.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.597 -0.689 . . . . 1.6 109.943 -179.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.64 39.33 14.54 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.721 -1.752 . . . . 0.96 108.721 -179.289 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.8 tp -73.89 147.05 43.57 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.489 -1.006 . . . . 1.67 110.004 -179.001 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.74 141.05 49.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.351 -0.843 . . . . 4.96 109.713 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 90.2 mt -113.35 130.01 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.825 0.821 . . . . 1.68 108.838 179.108 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.4 mt -68.29 -39.94 81.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.857 -0.527 . . . . 2.14 110.874 -177.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.43 ' CG ' ' HG ' ' A' ' 150' ' ' SER . 32.8 t0 63.92 102.83 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.396 -0.815 . . . . 1.5 109.267 -179.3 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.2 mt -72.95 -1.73 18.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.412 -0.805 . . . . 1.39 110.669 -179.069 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.43 ' HG ' ' CG ' ' A' ' 148' ' ' ASP . 79.2 p -85.24 -16.07 41.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.791 -1.193 . . . . 1.83 109.766 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.62 28.02 0.27 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.172 -0.955 . . . . 1.46 111.859 -177.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 40.9 mm -85.99 125.94 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.491 -1.381 . . . . 1.42 109.191 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -106.91 -13.95 15.09 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.496 -0.752 . . . . 2.94 109.665 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -126.68 150.97 48.7 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.341 -0.85 . . . . 1.52 110.034 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.69 136.62 57.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 1.58 109.0 179.496 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.2 m -152.82 165.96 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.324 -0.86 . . . . 1.32 109.835 179.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.4 mt -95.55 145.95 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 105.661 -1.978 . . . . 1.27 105.661 176.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 37.7 tp -100.23 119.67 38.73 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.907 -1.121 . . . . 1.41 110.54 -178.092 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.0 125.72 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.605 -0.684 . . . . 1.23 109.225 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -152.78 158.67 42.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.985 -1.072 . . . . 1.32 109.494 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.01 -32.12 70.13 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.395 -1.44 . . . . 1.49 108.294 179.076 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 56.2 t0 -169.86 142.15 2.37 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.451 -0.944 . . . . 2.25 108.451 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.528 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 81.4 mt -110.74 129.03 55.94 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.325 -0.859 . . . . 1.35 108.968 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 43.5 p -90.17 149.89 42.24 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.299 -0.876 . . . . 1.56 109.22 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -37.85 -38.92 0.75 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 122.241 1.961 . . . . 0.87 112.439 179.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.1 m -59.51 -39.98 85.6 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.251 -0.906 . . . . 1.36 109.9 -178.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.14 -40.05 86.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.086 -1.009 . . . . 1.61 110.356 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.7 p -57.21 -32.6 66.67 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.981 -1.074 . . . . 1.21 111.124 -178.229 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.3 -46.96 53.47 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.984 -1.073 . . . . 1.21 109.97 -179.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -89.95 40.06 0.99 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.788 -1.19 . . . . 2.11 107.788 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.8 tp -106.96 126.44 52.32 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 109.082 -0.711 . . . . 1.29 109.082 179.208 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -84.68 105.71 15.68 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.075 -1.083 . . . . 2.81 108.075 178.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.12 -44.53 84.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.37 -0.831 . . . . 2.09 111.39 -178.131 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -69.99 -21.76 63.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.76 -1.213 . . . . 2.86 111.809 -177.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -93.91 -9.27 37.7 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.699 -1.251 . . . . 2.39 110.214 -178.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 99.8 t -108.76 119.94 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.385 -0.822 . . . . 1.27 108.912 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 89.5 mt -85.12 3.73 37.62 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.558 -0.714 . . . . 2.17 110.845 -178.182 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 166.55 175.23 36.61 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 119.224 -1.465 . . . . 0.52 109.75 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -133.69 129.41 36.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.551 -0.97 . . . . 0.55 108.411 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 90.3 mt -128.98 123.72 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.552 -0.907 . . . . 1.27 108.552 179.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 69.9 p -149.96 162.38 40.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.654 -1.279 . . . . 1.39 110.9 -179.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 183' ' ' ALA . 7.2 p30 -101.9 22.54 12.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.757 -0.589 . . . . 2.46 109.522 179.64 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -54.32 -162.98 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.817 -1.177 . . . . 1.51 112.048 -178.204 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.99 -54.0 5.97 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.809 -0.917 . . . . 2.23 110.809 -179.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 164.42 -139.01 5.59 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 118.94 -1.6 . . . . 2.23 110.707 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -71.59 -9.99 59.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.931 . . . . 6.44 110.625 -178.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 53.5 p -78.99 1.52 23.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.928 -1.108 . . . . 4.09 109.672 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 12.2 t -90.94 130.8 36.84 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.081 -1.012 . . . . 2.2 110.076 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -47.06 -50.27 19.99 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.447 -0.783 . . . . 1.15 109.966 179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.5 t -57.48 -37.16 72.46 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.304 -0.873 . . . . 2.01 110.973 -178.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 82.6 p -59.99 -41.01 91.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.739 -1.226 . . . . 1.93 110.851 -179.087 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 88.7 mt -61.09 -38.93 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.125 -0.984 . . . . 2.2 109.399 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 92.7 mtp -60.59 -39.93 89.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.555 -0.716 . . . . 1.32 110.395 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.27 -43.49 87.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.737 -1.227 . . . . 1.3 109.388 -179.453 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.58 ' CG ' HH11 ' A' ' 195' ' ' ARG . 2.2 mtt-85 -60.02 -49.92 75.77 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.288 -0.965 . . . . 3.38 109.911 -179.29 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 72.1 m -69.96 -34.43 73.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.088 -1.008 . . . . 1.15 111.026 -179.224 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.5 mt -71.47 -18.24 62.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.921 -1.112 . . . . 1.28 109.499 -179.536 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 60.99 47.92 7.0 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.294 0.569 . . . . 1.5 110.536 -179.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 38.5 mt -126.99 149.48 69.36 Favored Pre-proline 0 N--CA 1.499 2.021 0 N-CA-C 107.724 -1.213 . . . . 1.37 107.724 178.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.79 139.98 49.58 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.122 1.881 . . . . 0.76 112.102 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.99 150.59 3.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.112 -0.992 . . . . 1.19 111.052 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 93.1 mt -125.22 142.32 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 108.399 -0.963 . . . . 1.31 108.399 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.3 m -127.04 -7.97 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 120.816 -1.178 . . . . 1.38 111.322 -178.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.9 21.31 29.92 Favored Glycine 0 N--CA 1.503 3.135 0 O-C-N 121.211 -0.931 . . . . 1.03 110.867 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 8.3 p -45.84 -43.99 13.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.951 -1.323 . . . . 1.38 110.165 -179.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.34 -49.46 2.67 Favored Glycine 0 N--CA 1.498 2.784 0 C-N-CA 120.017 -1.087 . . . . 1.17 111.034 179.445 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.7 m -160.77 37.74 0.16 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.651 -1.5 . . . . 2.07 111.246 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 42.4 t -80.74 -31.5 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.991 -1.068 . . . . 1.35 108.86 178.206 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.583 ' HG1' ' N ' ' A' ' 210' ' ' SER . 2.7 p -59.95 -33.52 72.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.45 -0.781 . . . . 1.49 110.062 -179.081 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.583 ' N ' ' HG1' ' A' ' 209' ' ' THR . 91.2 p -78.21 -10.06 59.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.994 -1.066 . . . . 2.16 109.412 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -103.6 -11.1 17.92 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.491 -0.756 . . . . 2.89 110.228 -179.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.4 t -103.42 136.2 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.213 -0.93 . . . . 1.33 110.806 -178.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -112.32 151.0 30.22 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.462 -1.31 . . . . 2.73 107.462 178.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.444 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 11.3 p-10 -57.92 139.53 54.1 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.058 -1.026 . . . . 2.7 110.069 -179.143 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.7 m-20 81.15 3.02 1.59 Allowed 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.13 0.491 . . . . 2.38 110.007 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 56.7 t0 -72.01 138.61 48.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.156 -0.965 . . . . 2.09 108.803 178.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.489 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 41.3 t80 -89.85 118.63 29.58 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.074 -1.084 . . . . 1.45 108.074 179.078 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 61.5 mt -128.47 149.05 50.74 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.498 -0.751 . . . . 1.31 110.642 -178.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.9 mt -115.15 130.01 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 107.703 -1.221 . . . . 1.29 107.703 177.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 63.5 tp -99.97 115.92 30.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.08 -1.013 . . . . 1.31 109.314 -179.207 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.541 ' C ' ' H ' ' A' ' 223' ' ' VAL . 97.3 m-20 -74.22 -42.72 59.3 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.918 -1.142 . . . . 2.31 107.918 178.368 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 51.54 11.22 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.404 -0.961 . . . . 1.19 108.404 -179.108 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.541 ' H ' ' C ' ' A' ' 221' ' ' ASP . 57.2 t -128.33 -39.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.327 -1.36 . . . . 1.45 107.327 179.057 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.502 ' N ' HD21 ' A' ' 224' ' ' ASN . 1.3 m-80 -100.43 3.23 42.93 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.047 -1.094 . . . . 3.13 108.047 178.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 60.57 43.8 12.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.71 -0.619 . . . . 2.2 110.601 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.406 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 25.1 pt20 -149.18 156.79 42.7 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.885 -1.134 . . . . 2.32 109.976 179.204 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -122.92 124.93 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.685 -0.857 . . . . 1.4 108.685 179.158 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.406 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 84.7 m-85 -84.76 122.83 29.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.701 -1.249 . . . . 1.29 109.556 -179.23 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 62.5 t -98.96 116.3 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.474 -0.766 . . . . 1.38 109.481 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 65.08 68.96 0.69 Allowed Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.227 -0.92 . . . . 2.33 109.372 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -89.18 124.05 1.4 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.181 2.587 . . . . 0.95 112.255 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.2 p -70.41 171.75 9.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 2.31 109.725 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -59.97 -40.16 88.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.323 -0.86 . . . . 3.45 109.921 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -64.33 -34.61 78.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.033 -1.042 . . . . 2.89 109.217 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.79 -42.7 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.121 -0.987 . . . . 1.73 108.613 178.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.421 HD12 HG23 ' A' ' 236' ' ' ILE . 95.1 mt . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.747 -0.834 . . . . 1.57 108.747 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 16.9 ttt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -149.49 147.98 28.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.26 -0.9 . . . . 0.0 109.267 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -149.67 159.63 44.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.066 -1.021 . . . . 0.0 110.618 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -153.66 150.41 28.56 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -109.84 132.25 54.32 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.373 -0.83 . . . . 0.0 109.781 179.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.49 121.63 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 122.371 1.081 . . . . 0.0 112.729 -177.4 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 56.0 m -78.19 104.01 8.49 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.924 0.868 . . . . 0.0 110.02 -178.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . 0.46 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.6 mt -52.64 125.62 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 122.635 1.207 . . . . 0.0 111.073 -177.562 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 67.1 p -109.97 20.9 17.46 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.978 -179.023 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . 0.449 ' O ' ' CG ' ' B' ' 357' ' ' GLN . . . -75.29 116.87 58.55 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.048 -1.032 . . . . 0.0 108.945 179.426 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -54.53 -16.22 10.29 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 CA-C-N 120.276 1.134 . . . . 0.0 113.249 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -120.17 11.41 11.61 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.383 -0.823 . . . . 0.0 109.621 -179.191 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.85 179.25 32.14 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 108.431 -1.867 . . . . 0.0 108.431 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.459 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -87.08 93.13 9.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.952 -1.322 . . . . 0.0 108.998 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -95.43 -160.0 0.76 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.945 -1.097 . . . . 0.0 109.811 179.054 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 9.6 m -58.39 -43.99 88.75 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.021 -1.05 . . . . 0.0 112.629 -176.071 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.473 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.1 tpt180 -61.97 -62.05 6.57 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.352 -1.467 . . . . 0.0 112.184 -178.236 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -58.02 -29.6 87.34 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 CA-C-N 120.136 1.084 . . . . 0.0 111.548 -179.196 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.34 -49.96 75.83 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.34 -41.18 65.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.464 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -70.02 -40.61 75.1 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.768 -1.207 . . . . 0.0 108.911 178.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -65.5 -55.46 17.74 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.521 -0.737 . . . . 0.0 109.951 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.83 -29.72 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.872 -1.142 . . . . 0.0 111.058 -178.482 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -64.05 -42.96 96.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.966 -1.084 . . . . 0.0 109.876 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -66.23 -40.41 90.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.107 -0.995 . . . . 0.0 110.499 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -65.75 -53.13 44.73 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.745 -1.222 . . . . 0.0 110.389 -179.608 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -51.94 -15.64 0.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 109.964 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -75.49 -23.93 71.91 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -105.59 141.32 37.26 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.404 -1.057 . . . . 0.0 108.945 179.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 26.5 m -89.8 -11.48 42.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.997 -1.064 . . . . 0.0 109.937 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 63.3 p -61.32 148.88 39.81 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.973 -1.079 . . . . 0.0 109.241 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -68.53 134.63 50.35 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.116 -0.99 . . . . 0.0 108.908 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.3 mt -133.01 133.22 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.642 -0.661 . . . . 0.0 109.787 -179.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 32.4 m -129.9 149.03 51.81 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.487 -0.758 . . . . 0.0 109.089 179.245 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 87.1 t -122.3 116.48 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.327 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 33.3 m -105.67 132.12 52.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 33.8 t -140.02 116.49 10.7 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.768 0.794 . . . . 0.0 111.105 -179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 45.52 51.96 9.48 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.723 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 90.0 -14.03 63.09 Favored Glycine 0 N--CA 1.503 3.142 0 O-C-N 120.156 -1.59 . . . . 0.0 113.099 176.52 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -119.76 131.16 55.28 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 119.495 1.647 . . . . 0.0 110.06 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 18.1 m -129.99 150.23 51.36 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.83 0.824 . . . . 0.0 110.426 -179.412 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -146.52 171.86 14.44 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.511 0.672 . . . . 0.0 110.145 -179.229 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 9.6 m -89.68 139.95 30.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.533 -0.73 . . . . 0.0 109.725 -179.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -81.51 -12.47 58.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.0 -1.062 . . . . 0.0 109.018 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -86.62 21.26 2.23 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.5 -1.666 . . . . 0.0 106.5 178.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.51 ' H ' ' C ' ' B' ' 344' ' ' ALA . 52.7 m -149.96 98.67 2.75 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.226 -179.053 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . 0.44 ' O ' ' OE1' ' B' ' 351' ' ' GLN . 26.0 tp -59.91 -34.4 73.15 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . 0.493 ' CB ' ' NE2' ' A' ' 111' ' ' GLN . 58.0 m-85 -59.93 -55.56 32.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.265 -0.897 . . . . 0.0 110.11 -179.37 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -69.35 -22.4 63.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 111.178 -177.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' B' ' 352' ' ' THR . 65.1 mt -68.94 -52.78 25.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.645 -1.284 . . . . 0.0 108.09 177.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.552 ' OE1' ' N ' ' B' ' 351' ' ' GLN . 0.8 OUTLIER -40.85 -16.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.977 -178.22 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.545 ' N ' ' O ' ' B' ' 350' ' ' LEU . 63.5 p -87.44 -10.01 53.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.405 -1.435 . . . . 0.0 109.941 -179.167 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 67.8 mt -95.42 117.81 31.02 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.07 -1.019 . . . . 0.0 109.081 178.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.35 94.04 0.91 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 18.1 mt -101.42 88.73 3.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.282 -1.128 . . . . 0.0 108.86 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 77.2 p -90.33 169.99 10.63 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.01 -1.056 . . . . 0.0 110.785 -179.068 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . 0.449 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 1.1 tm0? -61.46 113.78 2.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.721 -0.612 . . . . 0.0 110.973 -179.079 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 100.32 8.07 50.68 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.751 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.1 m -83.31 111.52 19.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.339 -1.095 . . . . 0.0 110.513 -179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 6.1 t -77.31 114.59 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 122.292 1.044 . . . . 0.0 109.257 -177.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 14.5 m -111.7 177.68 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 90.3 m -131.29 129.35 41.39 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 176.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 71.9 mt -102.63 116.42 46.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 56.8 p -120.01 132.3 55.43 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.35 153.14 40.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 0.0 109.873 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -144.88 124.41 13.18 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.289 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.464 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 159.88 -160.34 31.46 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 118.804 -1.665 . . . . 0.0 111.578 -179.773 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -60.06 -50.93 71.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 122.132 -0.628 . . . . 0.0 112.133 -177.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -109.93 10.93 24.27 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.903 -1.123 . . . . 0.0 111.643 -177.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.554 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -42.04 -34.88 0.78 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.988 -1.07 . . . . 0.0 111.848 -178.392 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 26.7 mt-30 -70.72 -38.65 73.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.745 -1.222 . . . . 0.0 110.034 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -65.38 -50.04 67.02 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.926 -1.108 . . . . 0.0 109.011 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.05 -76.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.584 -0.697 . . . . 0.0 111.069 -178.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 23.5 t -43.08 -38.13 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.343 -0.848 . . . . 0.0 110.973 -177.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.92 -42.39 85.48 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.351 -1.468 . . . . 0.0 110.32 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -81.03 -43.43 19.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.795 -1.191 . . . . 0.0 109.909 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.09 -39.41 86.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.223 -179.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 55.9 t -62.02 -43.23 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.057 -1.027 . . . . 0.0 109.342 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -70.02 -56.38 7.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.703 -1.248 . . . . 0.0 107.64 178.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 52.0 tp -56.2 -35.06 66.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.564 -0.71 . . . . 0.0 110.058 -177.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 1.5 tpt -71.49 -39.93 70.53 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.543 -1.348 . . . . 0.0 108.669 178.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.75 -4.44 57.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.473 -0.767 . . . . 0.0 110.574 179.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.428 ' O ' ' OE2' ' B' ' 385' ' ' GLU . 73.2 mm-40 -111.68 -2.61 15.3 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.105 -0.997 . . . . 0.0 110.995 -179.563 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 13.1 mt -80.01 133.02 36.12 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.379 -1.45 . . . . 0.0 109.493 179.129 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . 0.525 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 42.9 mp0 . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.211 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mtp . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.5 -0.556 . . . . 3.19 109.5 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.2 mt -109.97 129.94 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.51 -0.744 . . . . 1.71 109.692 -179.84 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 m -131.65 147.61 52.53 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.719 -0.613 . . . . 1.66 109.456 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.44 -164.99 10.13 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 108.834 -1.706 . . . . 1.05 108.834 179.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.6 mt -87.41 -18.33 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.016 -1.285 . . . . 1.59 109.704 -179.356 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.4 tp 54.86 103.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.668 -0.864 . . . . 1.47 108.668 -179.138 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.5 -24.57 16.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 1.39 108.675 179.509 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 13.4 t -141.77 123.43 8.96 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.574 -0.704 . . . . 2.09 110.011 -179.889 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.98 147.48 21.2 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.184 1.923 . . . . 0.91 112.531 179.284 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 150.29 172.64 19.78 Favored Glycine 0 N--CA 1.5 2.918 0 N-CA-C 108.918 -1.673 . . . . 0.92 108.918 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.9 mt -127.45 132.31 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.875 -1.367 . . . . 1.35 109.677 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.43 151.89 50.0 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.317 -0.864 . . . . 1.14 109.957 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -127.28 130.84 50.31 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.866 -1.161 . . . . 0.7 107.866 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.72 178.82 48.65 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 118.583 -1.77 . . . . 0.58 111.183 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -79.96 155.56 27.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.799 -0.824 . . . . 2.63 109.325 -179.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.52 125.78 51.43 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 121.794 0.807 . . . . 1.27 111.369 -178.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.0 tp -99.47 137.52 37.85 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.529 -1.286 . . . . 1.41 107.529 178.195 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.5 tp -119.53 128.65 54.14 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.476 -0.765 . . . . 1.49 109.692 -179.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.1 mt -91.62 105.91 18.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.694 -0.629 . . . . 1.52 110.275 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -106.1 131.79 52.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.162 -1.051 . . . . 3.17 108.162 178.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -129.23 148.58 51.17 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.383 -0.823 . . . . 3.0 109.381 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -83.15 142.42 31.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.455 -0.778 . . . . 2.77 109.33 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -60.2 142.52 54.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.126 -0.983 . . . . 2.94 109.133 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -75.97 126.58 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.977 . . . . 1.46 109.985 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.57 125.33 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.343 -0.848 . . . . 1.7 110.166 -179.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 84.8 mt -110.18 132.29 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.607 -0.886 . . . . 1.54 108.607 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -92.23 117.92 30.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.764 -1.21 . . . . 1.81 109.474 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.418 HH11 ' HG2' ' A' ' 28' ' ' ARG . 5.3 mmt-85 -87.11 -4.39 59.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.164 -0.96 . . . . 3.23 109.342 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -68.25 140.77 56.03 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.194 -0.941 . . . . 3.29 109.248 179.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -84.02 154.49 23.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.899 . . . . 2.8 109.849 -179.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 pt -96.5 167.17 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 1.43 109.467 179.725 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.7 p -90.31 172.76 8.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.04 -1.037 . . . . 1.54 108.363 178.574 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.08 -18.09 63.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.938 -1.102 . . . . 1.6 110.994 -179.285 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 64.8 t0 -86.37 -24.62 25.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.626 -1.296 . . . . 2.56 108.392 178.842 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -81.29 -9.97 59.66 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.786 -0.82 . . . . 2.36 108.786 179.1 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 t -60.94 -52.02 66.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.799 -0.815 . . . . 1.43 108.799 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -61.08 -39.88 91.57 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.377 -0.827 . . . . 1.77 110.273 -179.619 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -69.24 -40.91 77.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.078 -1.014 . . . . 3.32 111.022 -178.309 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -65.91 -39.86 90.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.0 -1.063 . . . . 1.51 110.854 -179.21 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.8 t -61.33 -45.04 99.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.484 -1.385 . . . . 1.41 108.45 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -60.01 -41.5 92.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.043 -1.036 . . . . 1.81 109.622 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -60.17 -45.25 93.71 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.967 -1.093 . . . . 3.26 108.069 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -60.36 -48.29 82.37 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.889 -0.782 . . . . 0.81 108.889 178.199 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.447 ' CD1' HH21 ' A' ' 47' ' ' ARG . 43.2 tp -60.2 -48.81 80.16 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.048 -0.723 . . . . 1.59 109.048 -179.567 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.4 t -63.56 -43.18 97.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.021 -1.05 . . . . 1.38 108.386 178.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.56 -47.42 91.25 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.537 -1.825 . . . . 0.87 108.537 179.059 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.447 HH21 ' CD1' ' A' ' 44' ' ' LEU . 44.2 ttp180 -60.18 -38.78 84.27 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.888 -1.153 . . . . 3.62 107.888 178.656 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.9 -46.49 68.02 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.952 -0.758 . . . . 1.43 108.952 179.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 50' ' ' ALA . 34.0 ttpt -59.92 -74.82 0.07 Allowed 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.548 -1.279 . . . . 3.08 107.548 179.257 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.35 -39.61 0.3 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.356 -0.84 . . . . 1.33 111.907 -178.148 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.0 m -59.34 -52.17 66.8 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.458 -1.401 . . . . 1.85 108.707 -179.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.52 -40.71 89.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.365 -0.834 . . . . 1.35 110.58 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -63.3 -42.17 99.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.0 -1.062 . . . . 2.34 109.878 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.6 mt -64.11 -40.46 96.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.021 -1.049 . . . . 2.2 109.538 179.553 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.7 -39.87 90.15 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.109 -0.995 . . . . 1.35 108.708 179.671 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.3 m -62.23 -43.49 98.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.361 -0.837 . . . . 1.34 109.711 179.097 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 81.7 mt -61.47 -39.85 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.325 -0.859 . . . . 1.26 109.598 179.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -57.56 -50.22 73.81 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.255 -0.903 . . . . 1.7 109.872 -179.041 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -58.44 -37.68 75.9 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.25 -0.906 . . . . 1.35 110.491 -177.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -68.47 -36.88 79.6 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.911 -1.118 . . . . 2.08 109.352 179.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.27 -47.34 70.97 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.57 -0.706 . . . . 1.21 109.979 -179.636 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -54.59 -52.8 42.89 Favored Glycine 0 N--CA 1.484 1.858 0 C-N-CA 119.993 -1.099 . . . . 0.75 110.452 -178.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.42 -41.84 72.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.032 -1.275 . . . . 1.59 111.083 -178.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.8 m -66.34 -61.93 1.74 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.025 -1.047 . . . . 1.41 112.181 -177.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -96.68 -44.47 7.1 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.827 -1.171 . . . . 0.79 111.439 -177.546 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.39 -168.08 25.58 Favored Glycine 0 N--CA 1.499 2.882 0 C-N-CA 119.822 -1.18 . . . . 1.22 110.925 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -69.95 -22.82 63.14 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.981 -0.717 . . . . 5.81 110.115 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.506 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 50.4 tp10 -59.99 -35.71 75.61 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.466 -0.771 . . . . 3.37 111.31 -179.14 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -96.51 -16.22 21.23 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.166 -0.959 . . . . 2.37 109.748 -179.699 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -71.6 -43.13 66.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.219 -0.926 . . . . 1.65 110.373 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.53 78.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.435 -0.79 . . . . 1.42 110.119 -178.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.86 -40.61 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.909 -1.119 . . . . 1.43 109.108 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -65.04 -39.52 93.47 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.986 -1.071 . . . . 1.08 110.314 -179.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -60.12 -40.06 88.42 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.979 -1.076 . . . . 1.37 109.342 -179.182 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.99 -44.75 95.49 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.181 -1.968 . . . . 0.67 108.181 178.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -63.36 -45.88 89.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.529 -0.983 . . . . 1.99 109.142 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 98.5 mt -70.08 -45.51 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.108 -0.995 . . . . 1.22 109.319 179.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.0 ttp -62.65 -41.49 99.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.847 -1.158 . . . . 2.11 110.09 -179.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 45.7 tp -65.07 -40.83 95.22 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.541 -0.724 . . . . 1.33 110.065 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.7 tp -68.73 -39.52 80.33 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.636 -0.665 . . . . 1.29 110.311 -179.096 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -79.67 0.94 28.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.043 -1.036 . . . . 1.47 109.935 -179.062 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 53.3 t0 -47.28 133.83 11.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.086 -1.009 . . . . 1.47 109.736 -179.311 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.458 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 99.3 mt-10 -64.92 -18.66 65.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.683 -0.636 . . . . 1.78 110.899 -178.749 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -75.51 -33.31 60.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.779 -1.201 . . . . 2.53 109.035 178.68 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -70.02 -39.99 75.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.479 -0.763 . . . . 1.36 109.371 179.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.91 -49.53 77.31 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.429 -0.794 . . . . 1.42 110.16 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.4 -39.41 81.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.855 . . . . 2.27 110.787 -179.226 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -68.87 -40.25 79.37 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.719 -1.238 . . . . 1.57 111.221 -179.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.44 -43.19 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.601 -1.312 . . . . 1.19 109.402 179.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.78 -39.17 77.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.552 -0.717 . . . . 1.39 110.749 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.78 95.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.117 -0.989 . . . . 1.39 110.098 -179.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 21.1 mt -63.65 -45.4 90.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.094 -1.004 . . . . 1.5 109.333 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.9 mt -64.15 -48.98 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.406 -0.809 . . . . 1.29 109.18 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.99 -40.77 75.11 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.733 -0.787 . . . . 2.64 110.576 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -84.82 -55.86 3.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.969 -1.082 . . . . 1.65 112.134 -178.142 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -87.1 -1.44 57.89 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.866 -1.146 . . . . 2.5 111.872 -177.321 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 44.3 m80 58.58 35.01 24.31 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.995 -1.066 . . . . 1.88 110.304 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.2 mtp -86.89 166.27 15.28 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.256 -0.903 . . . . 1.71 109.889 -179.474 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.433 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 64.4 p -79.62 161.9 25.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.206 -0.934 . . . . 1.61 108.864 179.536 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.06 -40.54 87.11 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.0 -1.062 . . . . 1.33 109.541 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 23.9 p-10 -69.94 -35.72 74.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 2.07 109.925 179.825 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.12 -40.09 39.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.094 -1.004 . . . . 1.37 109.333 179.279 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.76 -48.33 63.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.862 . . . . 1.14 110.361 -179.368 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.81 -32.54 73.75 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.81 -1.181 . . . . 1.26 109.757 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.525 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 86.3 t60 -60.53 -45.07 95.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 2.02 109.56 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -66.41 -39.96 89.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.792 . . . . 1.33 110.997 -178.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.1 t -62.3 -53.35 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.165 -0.96 . . . . 1.3 111.493 -177.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.8 mm -72.59 -37.12 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.751 -1.218 . . . . 1.32 110.004 -179.382 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.525 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 84.5 tt0 -67.35 -34.2 76.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.172 -0.955 . . . . 2.44 108.537 179.623 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.59 -49.07 82.66 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.357 -1.097 . . . . 0.99 110.357 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.651 HE21 ' CB ' ' B' ' 348' ' ' PHE . 16.3 mm100 -65.92 -50.71 63.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.802 -1.411 . . . . 1.97 109.192 -179.537 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.87 -40.43 80.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 1.43 109.097 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 109' ' ' GLU . 61.8 m -60.03 -40.18 88.48 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.114 -0.991 . . . . 2.12 108.436 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.26 -39.65 95.19 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.391 -0.818 . . . . 1.64 109.304 179.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.6 mt -67.82 -43.16 80.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.993 -1.083 . . . . 1.93 109.461 -179.468 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -55.5 -25.4 36.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.85 -1.156 . . . . 2.2 109.723 -179.31 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -66.2 -22.0 66.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.973 -1.079 . . . . 2.12 108.765 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 51.8 mt -63.25 143.94 57.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.314 -0.866 . . . . 2.34 109.882 -179.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -92.55 14.31 17.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.201 -0.937 . . . . 3.23 109.358 179.03 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -103.22 127.83 50.41 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.32 -0.862 . . . . 2.49 110.516 -178.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -70.62 -28.94 65.22 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.366 0.603 . . . . 3.95 110.234 179.239 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.535 ' OH ' ' N ' ' B' ' 315' ' ' HIS . 15.7 t80 -64.26 -40.58 96.28 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.209 -0.932 . . . . 2.25 110.212 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.43 ' CD2' ' O ' ' B' ' 351' ' ' GLN . 64.2 mt -77.38 -37.15 52.7 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.51 -0.744 . . . . 2.27 109.875 -178.934 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -59.98 -40.9 90.7 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.249 -0.907 . . . . 3.31 109.329 -179.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -61.28 -46.02 92.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.958 -1.089 . . . . 2.73 108.877 179.401 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.419 HH21 ' CD2' ' A' ' 123' ' ' LEU . 17.5 ttp180 -61.16 -39.96 92.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.899 . . . . 3.2 108.59 179.203 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.88 -28.9 70.36 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.766 -0.827 . . . . 1.66 108.766 179.011 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.03 87.58 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.087 -1.079 . . . . 1.67 108.087 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -62.07 -42.24 98.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.522 -0.736 . . . . 1.55 109.503 179.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.11 -41.4 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.197 -0.939 . . . . 1.32 108.571 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -60.13 -39.33 85.94 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.688 -0.633 . . . . 3.58 109.458 179.32 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -60.04 -41.85 93.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.38 -0.825 . . . . 1.46 110.676 -179.304 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.16 -46.19 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.056 -1.028 . . . . 1.22 110.055 -179.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.99 97.85 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.996 -1.242 . . . . 0.61 109.996 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -59.8 -49.72 76.63 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.326 -1.102 . . . . 3.1 110.142 -179.658 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -70.05 -32.08 70.02 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.101 -0.999 . . . . 3.71 110.501 -179.808 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.9 tp -57.81 -46.74 84.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.97 . . . . 1.87 108.925 -178.884 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.96 -39.64 86.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.138 -0.977 . . . . 1.29 108.565 179.116 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -68.22 -40.0 82.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.356 -0.84 . . . . 3.05 108.884 178.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -60.16 -38.49 83.3 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.862 -0.524 . . . . 1.26 110.999 -178.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.5 mt -72.8 -40.87 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.653 -1.28 . . . . 1.34 108.727 179.397 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.68 -25.58 61.31 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.62 -0.675 . . . . 1.6 109.848 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.6 37.16 27.66 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.96 -1.656 . . . . 0.96 108.96 -179.309 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 58.5 tp -73.14 141.59 47.47 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.497 -1.002 . . . . 1.67 109.381 -179.401 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -61.96 140.06 58.35 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.845 0.831 . . . . 4.96 111.12 -178.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.421 HD12 HG23 ' A' ' 146' ' ' ILE . 97.0 mt -115.66 132.25 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.716 -0.846 . . . . 1.68 108.716 178.604 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 24.7 mm -57.02 -43.74 81.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.455 -0.778 . . . . 2.14 109.924 -178.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 11.8 t0 70.18 94.31 0.08 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.063 -0.718 . . . . 1.5 109.063 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.8 mt -66.36 -6.52 14.54 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.382 -0.824 . . . . 1.39 110.841 -178.761 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.0 t -82.93 -16.85 45.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.716 -1.24 . . . . 1.83 110.534 -179.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.33 24.29 0.83 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.068 -1.02 . . . . 1.46 112.581 -177.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.423 HG23 HD11 ' A' ' 152' ' ' ILE . 42.0 mm -79.28 126.5 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.305 -1.497 . . . . 1.42 108.793 179.531 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . 0.4 ' O ' ' OD1' ' A' ' 154' ' ' ASP . 77.5 mt-30 -102.8 -11.92 17.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.558 -0.714 . . . . 2.94 110.158 -179.247 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 153' ' ' GLN . 97.7 m-20 -136.85 156.09 48.94 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.117 -0.989 . . . . 1.52 110.39 -178.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.08 135.17 56.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.321 -0.862 . . . . 1.58 109.137 179.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.9 m -152.65 164.48 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.42 -0.8 . . . . 1.32 109.802 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.412 HD12 HG22 ' A' ' 157' ' ' ILE . 85.7 mt -92.5 147.15 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 105.752 -1.944 . . . . 1.27 105.752 176.651 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.4 tp -99.69 119.21 37.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.173 -0.954 . . . . 1.41 110.464 -178.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.1 t -125.13 130.3 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.196 -1.038 . . . . 1.23 108.196 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.84 167.21 28.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -0.991 . . . . 1.32 109.221 -179.768 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.26 -37.31 74.88 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.781 -1.199 . . . . 1.49 108.715 179.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.6 p-10 -170.42 149.01 3.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.57 -0.706 . . . . 2.25 109.602 -179.655 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.1 mt -119.36 133.72 55.58 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.453 -0.779 . . . . 1.35 109.663 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.4 p -93.35 143.89 27.41 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.013 . . . . 1.56 108.624 179.157 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.439 ' O ' ' OG1' ' A' ' 168' ' ' THR . 85.2 Cg_exo -41.47 -34.23 1.92 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.302 2.001 . . . . 0.87 113.159 -179.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.7 m -59.92 -40.12 87.8 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.768 -1.207 . . . . 1.36 109.294 -178.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.5 -40.24 80.94 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.012 -1.055 . . . . 1.61 109.308 179.474 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 165' ' ' PRO . 63.8 p -52.94 -30.02 32.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.064 -1.022 . . . . 1.21 110.57 -178.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.405 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -70.72 -57.47 4.64 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.816 -1.178 . . . . 1.21 109.701 179.565 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -80.36 34.83 0.32 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.13 -0.693 . . . . 2.11 109.13 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 169' ' ' ALA . 54.4 tp -100.08 136.54 39.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.426 -0.796 . . . . 1.29 109.763 179.437 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -86.18 96.89 10.07 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.926 -1.139 . . . . 2.81 107.926 178.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.9 -41.72 97.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 2.09 110.87 -178.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -68.02 -25.34 65.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.993 -1.067 . . . . 2.86 111.812 -177.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -93.7 -8.74 39.99 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.727 -1.233 . . . . 2.39 110.541 -178.506 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 87.5 t -107.58 118.58 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.182 -1.044 . . . . 1.27 108.182 178.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 95.3 mt -89.85 6.48 41.66 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.446 -0.784 . . . . 2.17 111.051 -177.342 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.82 166.16 32.87 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.419 -1.472 . . . . 0.52 109.419 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -132.2 128.44 37.96 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.344 -0.984 . . . . 0.55 108.344 179.573 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 86.2 mt -130.47 124.04 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.612 -1.255 . . . . 1.27 107.612 178.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.4 p -140.79 156.81 46.08 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.205 1.002 . . . . 1.39 111.386 -178.189 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.491 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 65.6 t0 -102.97 26.03 8.65 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.914 -0.585 . . . . 2.46 110.101 -179.567 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.67 -164.12 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.233 -1.542 . . . . 1.51 111.551 -178.045 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.82 -54.0 8.93 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.261 -1.136 . . . . 2.23 110.261 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.65 -154.44 13.71 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.764 -1.684 . . . . 2.23 111.68 -179.635 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -64.37 -11.28 31.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.89 -0.771 . . . . 6.44 110.745 -178.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 59.6 p -79.94 5.38 14.07 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.119 -0.988 . . . . 4.09 109.699 -179.005 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.0 t -88.67 142.48 27.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 2.2 109.894 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -53.36 -39.15 63.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.385 -0.822 . . . . 1.15 108.919 -179.831 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 89.5 m -59.77 -42.23 92.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.69 -0.631 . . . . 2.01 110.908 -179.33 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.3 p -60.98 -40.08 92.05 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.846 -1.159 . . . . 1.93 110.962 -178.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.8 mm -61.42 -41.19 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.204 -0.935 . . . . 2.2 110.096 -178.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.5 mtp -61.32 -42.94 99.5 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.989 -1.069 . . . . 1.32 110.333 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.96 -47.0 71.78 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.522 -1.361 . . . . 1.3 109.92 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -60.21 -50.26 74.37 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.903 -1.119 . . . . 3.38 110.003 -179.687 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.7 m -69.14 -36.07 77.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.773 -1.204 . . . . 1.15 111.069 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.7 mt -72.06 -26.39 62.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.822 -1.174 . . . . 1.28 109.45 -179.771 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 68.42 45.26 1.19 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.098 0.475 . . . . 1.5 110.778 -179.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.479 ' O ' ' CB ' ' A' ' 8' ' ' SER . 62.3 mt -126.69 148.67 65.8 Favored Pre-proline 0 N--CA 1.501 2.116 0 N-CA-C 107.852 -1.166 . . . . 1.37 107.852 178.239 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.86 137.82 78.75 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.192 1.928 . . . . 0.76 112.111 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.31 147.49 3.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.03 -1.044 . . . . 1.19 111.319 -179.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.4 mt -125.34 144.27 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.371 -1.344 . . . . 1.31 107.371 178.434 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 23.9 m -126.77 -11.78 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 O-C-N 121.106 -0.996 . . . . 1.38 111.144 -178.602 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -109.97 24.61 18.55 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.734 -1.346 . . . . 1.03 109.734 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 204' ' ' GLY . 3.0 p -43.3 -46.68 6.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.333 -1.099 . . . . 1.38 109.897 -179.008 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.491 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 95.51 -50.95 1.81 Allowed Glycine 0 N--CA 1.498 2.813 0 C-N-CA 120.218 -0.991 . . . . 1.17 111.496 178.998 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 46.8 t -157.07 30.87 0.3 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.245 -1.738 . . . . 2.07 110.745 -178.665 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 40.7 t -72.11 -40.04 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.096 -1.002 . . . . 1.35 109.263 178.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 6.4 p -54.17 -29.39 45.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -0.927 . . . . 1.49 110.191 -179.301 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 47.5 t -79.78 -20.96 44.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.156 -0.965 . . . . 2.16 110.349 -178.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -96.08 -10.61 27.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.044 -1.035 . . . . 2.89 110.393 -179.287 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 56.2 t -106.63 136.75 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.281 -0.887 . . . . 1.33 111.538 -177.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -112.52 154.54 25.76 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.293 -1.373 . . . . 2.73 107.293 178.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 33.6 p-10 -60.5 139.63 57.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.694 -1.253 . . . . 2.7 110.389 -179.166 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.4 t0 81.03 7.66 1.2 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.586 -0.524 . . . . 2.38 109.586 179.688 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 58.2 t0 -76.59 132.95 39.76 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.298 -0.876 . . . . 2.09 109.215 179.457 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.411 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 33.7 t80 -84.05 119.95 25.56 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.012 -1.107 . . . . 1.45 108.012 179.412 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 86.5 mt -130.42 149.82 51.92 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.334 -0.854 . . . . 1.31 110.927 -178.429 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 63.8 mt -115.22 126.62 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 106.907 -1.516 . . . . 1.29 106.907 177.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 45.1 tp -101.24 120.18 39.86 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.09 -1.006 . . . . 1.31 109.031 -178.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.472 ' C ' ' N ' ' A' ' 223' ' ' VAL . 91.8 m-20 -78.11 -46.99 19.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.088 -1.007 . . . . 2.31 110.263 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 50.05 16.45 0.24 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.115 -1.069 . . . . 1.19 108.115 -178.537 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.472 ' N ' ' C ' ' A' ' 221' ' ' ASP . 38.5 t -131.21 -47.04 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.321 -1.363 . . . . 1.45 107.321 179.235 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -99.62 3.62 45.33 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.357 -1.349 . . . . 3.13 107.357 177.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 48.6 t30 60.55 44.28 11.89 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 116.117 -0.492 . . . . 2.2 110.259 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -144.37 156.75 44.37 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.869 -1.144 . . . . 2.32 110.273 179.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 79.7 t -125.96 129.94 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.269 -0.641 . . . . 1.4 109.269 179.791 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -95.97 122.69 39.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.042 -1.036 . . . . 1.29 108.784 179.354 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 39.0 t -98.92 116.24 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.361 -0.837 . . . . 1.38 109.99 -179.157 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 63.53 68.42 0.9 Allowed Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.488 -0.757 . . . . 2.33 110.509 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -91.1 130.3 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.492 2.795 . . . . 0.95 112.471 179.7 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 23.7 m -67.9 166.1 16.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.16 -0.962 . . . . 2.31 109.894 -179.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -60.13 -40.0 88.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.248 -0.907 . . . . 3.45 110.338 -179.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -60.27 -37.21 79.73 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.09 -1.006 . . . . 2.89 108.972 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 70.2 t -64.73 -40.14 88.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.351 -0.843 . . . . 1.73 109.76 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.497 1.89 0 O-C-N 121.111 -0.993 . . . . 1.57 110.017 -179.784 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 3.6 ttt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -150.54 150.32 31.09 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.367 -0.833 . . . . 0.0 109.057 179.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . 0.484 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 3.4 pm0 -150.18 157.83 43.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.135 -0.978 . . . . 0.0 110.926 -179.047 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -155.47 150.89 27.1 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.048 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -113.4 129.45 56.54 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.113 -0.992 . . . . 0.0 109.833 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.59 126.85 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 CA-C-O 122.512 1.149 . . . . 0.0 112.458 -177.737 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 31.4 m -77.99 102.37 7.35 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.925 -178.257 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 87.1 mt -51.48 123.92 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 122.277 1.037 . . . . 0.0 110.053 -178.072 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 25.6 p -109.25 20.05 18.74 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.693 -178.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.6 116.64 55.34 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 108.719 179.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.24 -16.1 44.38 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 CA-C-N 120.362 1.165 . . . . 0.0 112.546 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -112.27 12.15 20.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.523 -0.736 . . . . 0.0 109.652 -179.115 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.25 172.21 5.53 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 -178.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.425 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 2.6 tp -84.53 88.51 7.32 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.871 -1.37 . . . . 0.0 108.427 -179.133 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . 0.535 ' N ' ' OH ' ' A' ' 122' ' ' TYR . 5.0 p80 -90.94 -161.92 0.86 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 120.74 -1.225 . . . . 0.0 109.412 178.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.2 m -56.82 -41.18 77.38 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.147 -0.971 . . . . 0.0 112.605 -176.223 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.534 ' NH2' ' OE1' ' B' ' 321' ' ' GLN . 2.4 tpt180 -62.5 -62.67 5.31 Favored Pre-proline 0 N--CA 1.501 2.124 0 O-C-N 120.478 -1.389 . . . . 0.0 112.159 -178.494 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.77 -31.5 92.42 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 CA-C-N 120.004 1.037 . . . . 0.0 111.975 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.88 -50.53 73.42 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.006 -1.059 . . . . 0.0 108.233 179.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.73 -40.04 59.51 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.904 -179.12 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . 0.534 ' OE1' ' NH2' ' B' ' 317' ' ' ARG . 42.3 mt-30 -69.88 -41.83 74.25 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.981 -1.075 . . . . 0.0 109.57 179.074 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -61.02 -52.69 63.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.33 -0.856 . . . . 0.0 110.101 -179.25 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.19 -30.79 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.798 -1.188 . . . . 0.0 110.014 -178.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -59.36 -47.59 84.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.061 -1.024 . . . . 0.0 109.569 -179.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.53 -50.74 64.09 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.001 -1.062 . . . . 0.0 109.868 -179.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . 0.417 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -60.32 -51.09 71.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.677 -1.264 . . . . 0.0 110.074 -179.622 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -48.31 -19.27 0.28 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.498 -0.751 . . . . 0.0 109.126 -179.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . 0.417 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -80.49 -16.11 76.62 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -105.54 141.07 37.65 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.178 -1.189 . . . . 0.0 109.694 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 46.0 m -90.43 -12.39 37.57 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.307 -0.87 . . . . 0.0 109.165 179.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 95.2 p -61.32 150.02 36.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.147 -0.97 . . . . 0.0 108.862 179.412 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -71.28 135.65 47.54 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.9 132.29 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.575 -0.703 . . . . 0.0 109.861 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 96.7 m -130.86 147.9 52.57 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 63.0 t -121.99 119.07 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.299 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 21.6 m -103.4 121.34 42.59 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.028 -1.045 . . . . 0.0 109.145 -178.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 18.4 t -134.81 119.67 18.43 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.895 0.855 . . . . 0.0 110.569 -179.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 30.3 m120 43.89 57.61 4.03 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 177.468 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 75.26 -12.81 6.64 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.578 -1.326 . . . . 0.0 112.155 177.208 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -111.96 121.13 44.16 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.955 -1.32 . . . . 0.0 109.959 -178.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 69.0 m -108.49 157.49 18.4 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.749 0.785 . . . . 0.0 110.945 -178.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -153.05 153.72 33.44 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.465 0.65 . . . . 0.0 109.984 179.214 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 17.7 m -91.82 136.57 33.05 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.422 -0.799 . . . . 0.0 110.598 -179.142 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -70.71 -20.95 62.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.903 . . . . 0.0 109.757 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -84.07 18.69 2.01 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.635 ' CB ' ' HZ3' ' B' ' 349' ' ' LYS . 13.2 m -148.49 93.14 2.1 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.72 0.771 . . . . 0.0 111.273 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 55.6 tp -56.29 -35.46 67.52 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . 0.651 ' CB ' HE21 ' A' ' 111' ' ' GLN . 50.0 m-85 -56.16 -50.02 72.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.54 -0.725 . . . . 0.0 110.575 -179.06 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.635 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 34.5 mtmm -69.85 -39.86 76.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.705 -1.247 . . . . 0.0 110.243 -178.601 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' B' ' 352' ' ' THR . 38.0 mt -50.04 -56.01 12.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.732 -1.23 . . . . 0.0 108.165 179.481 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.668 HE21 ' N ' ' B' ' 351' ' ' GLN . 0.0 OUTLIER -41.36 -17.05 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.535 -0.728 . . . . 0.0 110.747 -179.151 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.551 ' N ' ' O ' ' B' ' 350' ' ' LEU . 52.7 p -85.87 -13.69 47.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.037 -1.665 . . . . 0.0 110.281 -178.897 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 29.4 mt -95.04 122.5 37.76 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.106 -0.996 . . . . 0.0 109.057 178.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.21 96.3 1.1 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 178.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 46.2 mt -102.33 90.38 3.88 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.293 -1.122 . . . . 0.0 109.925 -179.37 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 21.1 p -97.6 -177.43 3.79 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.267 -0.896 . . . . 0.0 111.253 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -69.74 111.76 5.74 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.9 -179.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.2 10.84 35.51 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 179.267 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 28.5 m -87.12 108.58 18.96 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.059 -1.26 . . . . 0.0 110.791 -179.579 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 32.4 t -77.89 113.79 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 122.058 0.933 . . . . 0.0 109.521 -178.204 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 34.7 m -109.68 178.28 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.409 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 19.1 m -130.43 123.18 29.21 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.5 mt -97.69 111.57 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 52.2 p -116.3 130.48 56.8 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.212 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.45 150.51 37.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.92 . . . . 0.0 109.48 -178.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -142.07 123.61 14.97 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.413 -0.804 . . . . 0.0 108.891 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.569 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.31 -162.64 33.43 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.395 -1.383 . . . . 0.0 111.057 -179.845 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.91 -50.33 74.2 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.207 -0.584 . . . . 0.0 112.518 -177.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -106.38 10.61 31.5 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 120.668 -1.27 . . . . 0.0 110.92 -177.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.569 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.3 pt-20 -44.19 -34.87 2.0 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.29 -0.882 . . . . 0.0 111.45 -179.236 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -70.55 -41.19 72.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.876 -1.14 . . . . 0.0 110.017 -179.414 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -67.06 -47.14 72.19 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.341 -179.307 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.24 -74.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.341 -0.849 . . . . 0.0 110.848 -179.06 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . 0.448 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 64.3 t -45.87 -34.74 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.93 -1.106 . . . . 0.0 110.871 -177.434 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.17 -47.78 72.86 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.361 -1.462 . . . . 0.0 110.592 179.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -78.82 -44.11 23.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.969 -1.082 . . . . 0.0 110.628 -179.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.99 -36.26 76.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 0.0 109.383 -179.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . 0.448 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 39.8 t -63.05 -43.91 99.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.109 -0.994 . . . . 0.0 109.287 179.736 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -69.96 -56.84 5.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.605 -1.309 . . . . 0.0 108.248 178.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 36.1 tp -55.72 -32.21 63.15 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.435 -0.791 . . . . 0.0 109.682 -178.123 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 26.2 ttm -71.97 -40.49 68.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.57 -1.331 . . . . 0.0 109.319 178.236 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.14 -3.93 57.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.458 -0.776 . . . . 0.0 110.17 179.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -111.75 -4.39 14.68 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.196 -0.94 . . . . 0.0 110.917 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.7 mt -80.45 133.67 35.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.36 -1.463 . . . . 0.0 109.365 179.062 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.324 -179.964 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.5 mtt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.365 -0.606 . . . . 3.19 109.365 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.4 mt -109.89 129.92 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.447 -0.783 . . . . 1.71 109.366 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 m -138.83 118.78 13.32 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -0.888 . . . . 1.66 108.771 179.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.666 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -91.83 -161.0 36.61 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.572 -1.411 . . . . 1.05 109.572 -179.848 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.407 ' O ' ' O ' ' A' ' 6' ' ' LEU . 87.0 mt -94.95 -10.42 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.259 -1.142 . . . . 1.59 110.653 -178.953 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.1 tp 55.01 100.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.977 -1.077 . . . . 1.47 109.183 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.96 -34.23 24.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 1.39 108.936 179.56 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.0 t -139.14 133.4 16.21 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.497 -0.752 . . . . 2.09 109.231 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.27 143.74 15.91 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.193 1.929 . . . . 0.91 112.672 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 163.49 -162.03 34.59 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.792 -1.323 . . . . 0.92 109.792 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.6 mt -148.02 146.88 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.169 -1.195 . . . . 1.35 108.334 179.023 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.19 159.62 37.9 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.829 -1.169 . . . . 1.14 110.656 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.8 m-85 -137.93 127.45 24.97 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.547 -1.279 . . . . 0.7 107.547 178.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.59 177.22 48.31 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 118.452 -1.832 . . . . 0.58 110.965 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.46 ' O ' ' N ' ' A' ' 157' ' ' ILE . 68.4 mttm -78.74 159.5 27.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.782 -0.834 . . . . 2.63 110.107 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.94 123.46 45.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.719 . . . . 1.27 110.994 -179.028 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.2 tp -99.3 134.06 42.7 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 106.498 -1.667 . . . . 1.41 106.498 177.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.6 tp -117.63 122.81 44.59 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.146 -0.971 . . . . 1.49 109.908 -179.354 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.4 mt -87.32 104.54 16.51 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.476 0.655 . . . . 1.52 109.986 -179.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -92.47 136.0 33.58 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.681 -0.859 . . . . 3.17 108.681 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -130.57 139.05 50.43 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.323 -0.86 . . . . 3.0 109.623 179.76 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -93.47 140.79 29.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.243 -0.91 . . . . 2.77 109.122 179.656 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -59.94 139.97 57.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.166 -0.959 . . . . 2.94 109.634 -179.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -79.69 131.81 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.906 . . . . 1.46 108.757 179.889 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.5 t -93.91 124.88 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.132 -0.98 . . . . 1.7 110.053 -179.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.3 mt -101.0 139.97 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.403 -0.811 . . . . 1.54 109.036 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -98.5 115.76 29.27 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.08 -1.012 . . . . 1.81 109.88 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -90.98 0.07 57.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.213 -0.93 . . . . 3.23 108.969 179.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -62.67 143.46 57.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.441 -0.787 . . . . 3.29 109.695 -179.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -83.7 139.39 32.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.413 -0.805 . . . . 2.8 109.873 -179.671 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 pt -89.83 165.28 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 1.43 109.807 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.8 p -89.71 170.59 10.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.235 -0.915 . . . . 1.54 108.812 178.783 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.36 -22.02 64.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.988 -1.07 . . . . 1.6 109.939 -179.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -82.13 -24.65 34.99 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.529 -1.286 . . . . 2.56 107.529 178.71 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -82.04 -9.8 59.43 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.547 -0.908 . . . . 2.36 108.547 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.3 t -62.94 -52.49 58.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.099 -1.001 . . . . 1.43 108.903 179.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -63.2 -39.89 95.93 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.259 -0.901 . . . . 1.77 109.466 179.661 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -67.32 -41.11 85.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.03 -1.044 . . . . 3.32 110.292 -178.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.534 ' OE2' ' NH1' ' A' ' 42' ' ' ARG . 61.9 mm-40 -66.51 -39.99 88.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.15 -0.968 . . . . 1.51 110.129 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.45 -44.51 96.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.766 -1.208 . . . . 1.41 108.186 178.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -59.94 -36.08 76.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.319 -0.863 . . . . 1.81 109.472 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.534 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 99.1 mtt180 -59.75 -40.32 87.72 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 118.71 -1.196 . . . . 3.26 108.114 179.522 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -63.83 -48.28 77.43 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.33 -0.856 . . . . 0.81 108.706 177.82 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.6 tp -60.09 -48.86 79.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.46 -0.775 . . . . 1.59 109.216 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.9 t -64.86 -45.11 87.42 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.218 -0.993 . . . . 1.38 108.993 179.557 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.47 -45.06 96.95 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.26 -1.936 . . . . 0.87 108.26 179.098 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -65.6 -31.63 72.77 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.389 -0.967 . . . . 3.62 108.389 178.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.0 87.45 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.451 -0.781 . . . . 1.43 109.019 179.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 51' ' ' SER . 11.9 ttmm -65.51 -73.8 0.12 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.752 -1.203 . . . . 3.08 107.752 179.025 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.72 -32.08 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.552 -0.718 . . . . 1.33 111.222 -178.42 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 49' ' ' LYS . 29.7 t -59.74 -54.65 43.9 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.771 -1.205 . . . . 1.85 108.109 179.141 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.53 -41.02 85.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.383 -0.823 . . . . 1.35 111.292 -179.126 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -67.55 -40.54 84.98 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.726 -1.234 . . . . 2.34 110.037 -179.135 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.3 mt -64.85 -40.14 94.69 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.894 -1.129 . . . . 2.2 108.41 179.661 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -61.36 -39.95 92.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.26 -0.9 . . . . 1.35 109.35 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.9 m -67.13 -44.06 80.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.113 -0.992 . . . . 1.34 109.645 -179.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.55 -39.99 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.158 -0.964 . . . . 1.26 108.86 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -53.88 -50.64 65.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.501 -0.75 . . . . 1.7 110.034 -179.368 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -60.0 -38.8 83.68 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.449 -0.782 . . . . 1.35 111.134 -177.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -63.55 -39.67 95.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.833 -1.167 . . . . 2.08 109.613 -179.621 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.21 -43.89 93.64 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.365 0.602 . . . . 1.21 109.769 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.43 -52.48 52.94 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 120.009 -1.091 . . . . 0.75 110.536 -179.066 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.87 -44.81 69.07 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.073 -1.251 . . . . 1.59 110.465 -179.169 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.4 m -66.23 -62.28 1.56 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.999 -1.063 . . . . 1.41 112.24 -178.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -95.61 -49.56 5.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.889 -1.132 . . . . 0.79 111.171 -178.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.22 -167.72 25.99 Favored Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.843 -1.17 . . . . 1.22 110.905 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.94 -23.74 63.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.802 -0.823 . . . . 5.81 110.461 -179.344 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.423 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.7 tp10 -60.07 -36.02 76.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.254 -0.904 . . . . 3.37 110.211 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -98.23 -19.39 17.88 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.177 -0.952 . . . . 2.37 110.225 -179.283 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -70.12 -45.46 66.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.96 -1.087 . . . . 1.65 110.55 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.95 -30.58 71.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.433 -0.792 . . . . 1.42 110.235 -178.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.5 mt -59.72 -40.29 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.963 -1.086 . . . . 1.43 108.871 -179.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -65.05 -39.96 94.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.031 -1.043 . . . . 1.08 109.987 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -60.21 -40.06 88.79 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.965 -1.085 . . . . 1.37 109.444 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.5 -41.84 99.64 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.16 -1.576 . . . . 0.67 109.16 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -67.66 -39.98 84.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.283 -1.128 . . . . 1.99 109.728 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 77' ' ' ILE . 95.4 mt -69.1 -46.4 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.005 -1.06 . . . . 1.22 109.104 179.555 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.3 ttp -59.9 -45.93 90.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.041 -1.037 . . . . 2.11 110.425 -179.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.2 tp -60.93 -40.07 91.84 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.245 -0.91 . . . . 1.33 109.809 179.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.7 tp -63.14 -40.01 96.35 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.376 -0.828 . . . . 1.29 109.642 -179.047 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -82.46 9.18 9.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.37 -0.831 . . . . 1.47 109.901 -179.34 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -55.68 132.3 48.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.991 -1.068 . . . . 1.47 110.139 -179.246 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -59.94 -21.21 60.85 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.511 -0.743 . . . . 1.78 111.129 -178.562 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -72.03 -34.51 68.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.787 -1.196 . . . . 2.53 109.686 178.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.9 -40.77 75.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.539 -0.726 . . . . 1.36 109.76 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -60.11 -50.1 75.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.857 . . . . 1.42 110.413 -179.137 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -70.61 -40.1 73.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.187 -0.945 . . . . 2.27 111.439 -179.171 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -69.91 -40.12 75.79 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.94 -1.1 . . . . 1.57 111.489 -178.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.57 -41.97 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.076 -1.015 . . . . 1.19 109.422 -179.505 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.02 -37.84 73.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.432 -0.792 . . . . 1.39 110.602 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -60.0 -46.28 89.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 1.39 110.803 -178.592 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 96' ' ' LYS . 29.3 mt -63.27 -45.83 89.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.755 -1.216 . . . . 1.5 109.411 -179.741 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.08 -50.0 81.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.954 0.883 . . . . 1.29 108.796 179.523 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -70.2 -41.0 74.26 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.851 -0.74 . . . . 2.64 110.258 179.616 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 91' ' ' ALA . 58.7 t0 -80.38 -53.05 6.97 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.062 -1.024 . . . . 1.65 112.252 -177.877 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 92' ' ' LEU . 25.9 mtpp -89.96 -3.92 57.76 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.023 -1.048 . . . . 2.5 111.854 -177.395 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 25.9 m170 58.62 38.82 25.12 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.988 -1.07 . . . . 1.88 109.306 -179.362 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.0 mtp -97.87 165.81 11.76 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.592 -0.692 . . . . 1.71 109.959 -179.526 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.417 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 46.4 p -76.65 162.22 27.91 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.402 -0.811 . . . . 1.61 109.586 -179.906 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.82 -37.18 79.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.335 -0.853 . . . . 1.33 110.482 -179.479 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 35.2 p-10 -69.96 -36.94 75.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.86 -1.15 . . . . 2.07 109.633 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.498 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -77.04 -44.97 28.81 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.4 -0.813 . . . . 1.37 109.843 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.02 -41.65 74.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 1.14 109.523 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.16 -37.94 81.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.065 -1.022 . . . . 1.26 109.71 179.651 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -60.11 -41.01 91.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.436 -0.79 . . . . 2.02 109.938 -178.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 110' ' ' GLY . 88.7 tt0 -63.04 -40.12 96.78 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.271 -0.893 . . . . 1.33 110.383 -179.447 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.74 -55.77 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.108 -0.995 . . . . 1.3 111.542 -177.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.3 mm -70.08 -40.04 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.645 -1.284 . . . . 1.32 109.22 -178.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -69.95 -38.11 76.03 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.344 -0.984 . . . . 2.44 108.344 178.869 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -60.08 -46.77 93.61 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.82 -1.312 . . . . 0.99 109.82 -179.712 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -64.88 -49.04 72.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.894 -1.356 . . . . 1.97 108.866 179.577 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.87 -39.68 86.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.465 -0.772 . . . . 1.43 109.269 179.615 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.5 t -54.85 -40.0 69.18 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.326 -0.859 . . . . 2.12 109.035 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.81 -36.74 78.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 1.64 109.917 179.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.35 -46.17 81.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.09 -1.006 . . . . 1.93 110.558 -178.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -62.89 -22.06 66.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.495 -1.378 . . . . 2.2 110.268 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -67.43 -21.08 65.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.803 -1.185 . . . . 2.12 108.566 178.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 19.4 mt -63.88 142.51 58.38 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.158 -1.053 . . . . 2.34 108.158 179.245 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 119' ' ' ASP . 29.4 p-10 -90.78 53.24 2.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.873 -1.142 . . . . 3.23 110.516 -179.65 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 64.9 t0 -136.33 135.07 38.58 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.176 -0.953 . . . . 2.49 109.795 179.331 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.477 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 99.2 mt-10 -70.17 -32.54 70.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.297 -0.877 . . . . 3.95 110.447 -179.881 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.51 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.9 t80 -70.08 -37.22 75.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.257 -0.902 . . . . 2.25 110.46 179.538 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.476 ' CD2' HH21 ' A' ' 126' ' ' ARG . 77.1 mt -74.0 -39.95 63.26 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.236 -0.915 . . . . 2.27 109.256 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.8 -44.32 96.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.941 . . . . 3.31 109.964 179.538 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.1 -41.3 92.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.111 -0.993 . . . . 2.73 109.29 -179.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.476 HH21 ' CD2' ' A' ' 123' ' ' LEU . 9.9 ttp180 -66.73 -38.74 87.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.153 -1.054 . . . . 3.2 108.153 179.057 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.21 -26.22 64.66 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.077 -1.083 . . . . 1.66 108.077 178.62 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.79 -40.25 76.12 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.111 -1.07 . . . . 1.67 108.111 178.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -64.79 -40.15 94.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.405 -0.809 . . . . 1.55 109.206 179.693 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.53 -39.98 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.278 -1.008 . . . . 1.32 108.278 179.471 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -60.28 -39.88 88.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.479 -0.763 . . . . 3.58 109.125 179.267 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -58.14 -40.24 80.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 1.46 109.888 -179.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.01 -46.69 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.998 -1.064 . . . . 1.22 109.42 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.79 -31.54 70.25 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.791 -1.324 . . . . 0.61 109.791 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.69 -49.67 76.84 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.244 -1.151 . . . . 3.1 109.208 -179.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.48 HH11 ' HG2' ' A' ' 136' ' ' ARG . 17.6 mtt-85 -67.07 -36.01 81.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.08 -1.012 . . . . 3.71 109.67 179.672 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.8 tp -54.54 -49.01 71.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.476 -0.765 . . . . 1.87 109.801 -178.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.09 -40.07 88.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.369 -0.832 . . . . 1.29 109.565 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -72.78 -36.1 67.55 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.264 -0.897 . . . . 3.05 108.661 178.542 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.401 ' CG ' ' O ' ' A' ' 136' ' ' ARG . 6.2 m120 -60.15 -39.75 87.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.836 -0.54 . . . . 1.26 110.97 -179.227 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.8 mt -71.09 -45.13 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.758 -1.214 . . . . 1.34 108.65 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.6 mt -69.97 -40.07 75.61 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.523 -0.871 . . . . 1.6 108.949 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.68 51.57 3.04 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.072 -1.611 . . . . 0.96 109.072 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.6 tp -73.72 148.57 42.53 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.314 -1.109 . . . . 1.67 109.009 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -66.57 141.22 57.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 4.96 109.641 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.408 HG21 HD11 ' A' ' 146' ' ' ILE . 85.2 mt -113.53 130.0 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-O 121.762 0.791 . . . . 1.68 110.069 -179.578 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.3 mp -68.01 -40.09 82.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.746 -0.596 . . . . 2.14 110.309 -178.599 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.3 t0 63.29 123.25 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.396 -0.815 . . . . 1.5 108.947 -178.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.9 mt -90.13 -0.74 57.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 1.39 110.088 -179.06 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.5 t -86.08 -17.49 34.95 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.042 -1.036 . . . . 1.83 110.17 -179.553 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.98 24.8 0.73 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.139 -0.975 . . . . 1.46 110.734 -178.838 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 41.8 mm -90.82 120.69 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.77 -1.206 . . . . 1.42 109.276 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -101.23 -17.51 16.56 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.436 -0.79 . . . . 2.94 110.259 -179.379 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -115.34 145.97 41.99 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.637 -0.665 . . . . 1.52 110.874 -178.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -63.8 135.23 56.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.523 -0.736 . . . . 1.58 109.4 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.0 m -151.55 164.57 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.649 -0.657 . . . . 1.32 109.452 179.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 15' ' ' LYS . 86.0 mt -94.96 147.2 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 105.999 -1.852 . . . . 1.27 105.999 177.474 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 51.9 tp -96.99 117.96 32.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.035 -1.04 . . . . 1.41 110.767 -177.374 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.3 t -121.75 127.47 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.451 -0.944 . . . . 1.23 108.451 178.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -156.91 161.53 39.65 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 1.32 108.717 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.93 -31.71 63.19 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.26 -1.525 . . . . 1.49 109.172 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 64.9 t0 -169.23 141.92 2.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.434 -0.791 . . . . 2.25 109.128 -179.706 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 24.6 mt -112.08 142.71 44.17 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.362 -0.837 . . . . 1.35 110.226 -179.24 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.0 p -99.56 146.8 32.42 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.466 -0.771 . . . . 1.56 109.247 179.449 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -43.56 -36.7 7.33 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.952 1.768 . . . . 0.87 112.691 179.215 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.6 m -60.0 -39.94 87.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.267 -0.896 . . . . 1.36 109.767 -178.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.46 -41.31 93.52 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.187 -0.945 . . . . 1.61 109.992 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 41.1 p -56.44 -33.94 66.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 1.21 110.959 -178.4 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.4 -53.9 20.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.91 -1.119 . . . . 1.21 109.58 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -86.47 36.34 0.69 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.604 -0.888 . . . . 2.11 108.604 179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.2 tp -100.46 130.6 46.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.817 . . . . 1.29 109.166 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.523 ' C ' HD21 ' A' ' 172' ' ' ASN . 0.2 OUTLIER -82.79 98.96 9.39 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.276 -1.009 . . . . 2.81 108.276 179.412 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 71.0 mt -65.13 -41.14 95.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.403 -0.811 . . . . 2.09 111.085 -178.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -66.61 -25.59 66.68 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.844 -1.16 . . . . 2.86 111.571 -177.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.41 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 42.8 mmtm -93.32 -8.2 42.68 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.768 -1.207 . . . . 2.39 110.479 -179.037 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 63.3 t -109.31 119.65 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.385 -0.968 . . . . 1.27 108.385 178.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.8 mt -91.42 7.1 42.78 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.262 -0.899 . . . . 2.17 110.947 -177.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.44 171.07 36.97 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.355 -1.402 . . . . 0.52 109.626 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -133.94 129.76 36.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.463 -1.022 . . . . 0.55 109.066 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.3 mt -132.1 127.28 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.235 -1.024 . . . . 1.27 108.235 178.428 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 43.1 p -147.44 159.93 43.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.879 -1.138 . . . . 1.39 110.406 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -104.27 21.74 16.04 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.914 -0.773 . . . . 2.46 108.914 179.813 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.14 -159.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.995 -1.066 . . . . 1.51 111.202 -178.094 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.46 -53.15 8.99 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.357 -1.097 . . . . 2.23 110.357 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 157.07 -124.27 1.41 Allowed Glycine 0 N--CA 1.494 2.558 0 O-C-N 120.897 -1.355 . . . . 2.23 110.64 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -69.69 -23.9 63.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.39 -1.065 . . . . 6.44 111.014 -178.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 59.8 p -70.53 0.12 7.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.928 -1.107 . . . . 4.09 109.756 -179.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 39.2 m -89.46 124.7 34.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.08 -1.013 . . . . 2.2 110.119 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -46.48 -50.87 16.36 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.436 -0.79 . . . . 1.15 109.924 -179.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.82 -35.59 61.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.402 -0.811 . . . . 2.01 110.549 -178.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.5 t -60.07 -45.6 92.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.929 -1.107 . . . . 1.93 110.73 -179.185 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.08 -40.64 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 2.2 109.735 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.0 mtp -61.44 -40.03 92.99 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.084 -1.01 . . . . 1.32 109.964 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.61 -42.71 67.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.737 -1.227 . . . . 1.3 108.915 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -59.57 -50.06 75.36 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.461 -0.895 . . . . 3.38 109.517 -179.02 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 67.1 m -72.4 -33.13 66.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.204 -0.935 . . . . 1.15 111.114 -179.221 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.05 -22.81 63.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.952 -1.093 . . . . 1.28 109.515 -179.5 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 63.71 48.78 3.17 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.437 0.636 . . . . 1.5 110.055 -178.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 60.1 mt -130.25 150.1 75.19 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 107.797 -1.186 . . . . 1.37 107.797 178.693 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.56 144.98 62.71 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.949 1.766 . . . . 0.76 111.567 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -173.36 153.56 2.43 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.064 -1.055 . . . . 1.19 111.102 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 92.7 mt -124.72 151.62 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 107.669 -1.234 . . . . 1.31 107.669 178.832 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.0 m -133.67 -11.44 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 120.844 -1.16 . . . . 1.38 111.249 -178.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -111.17 25.73 13.49 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.655 -0.978 . . . . 1.03 110.655 -179.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.448 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.3 p -47.46 -38.21 13.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.759 -1.436 . . . . 1.38 109.595 -179.206 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.18 -51.06 3.4 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 120.085 -1.055 . . . . 1.17 111.257 178.782 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 207' ' ' SER . 12.9 t -156.51 33.24 0.32 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.558 -1.554 . . . . 2.07 111.4 -178.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 22.8 t -74.52 -36.02 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.66 -1.275 . . . . 1.35 108.348 178.159 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.42 ' HG1' ' N ' ' A' ' 210' ' ' SER . 44.4 p -59.97 -38.37 82.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.449 -0.782 . . . . 1.49 110.159 -179.553 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.42 ' N ' ' HG1' ' A' ' 209' ' ' THR . 50.4 m -82.01 -11.06 59.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.995 -1.065 . . . . 2.16 110.308 -179.162 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -99.05 -13.23 19.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.043 -1.036 . . . . 2.89 110.601 -179.231 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 80.8 t -114.62 154.0 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.247 -0.908 . . . . 1.33 110.955 -178.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -113.17 154.56 26.47 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.261 -1.385 . . . . 2.73 107.261 178.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 24.8 p-10 -59.82 141.52 55.17 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.974 -1.078 . . . . 2.7 110.134 -179.461 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 m-20 85.67 6.36 0.43 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.213 0.53 . . . . 2.38 110.032 179.692 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 53.2 t0 -76.62 150.16 36.46 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.262 -0.898 . . . . 2.09 108.71 179.037 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.526 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 50.8 t80 -95.25 122.85 38.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.066 -1.021 . . . . 1.45 108.844 179.725 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.0 mt -126.88 138.5 53.32 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.299 -0.875 . . . . 1.31 110.702 -179.288 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 83.6 mt -110.19 128.25 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 106.453 -1.684 . . . . 1.29 106.453 176.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 42.9 tp -103.36 119.92 39.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.065 -1.022 . . . . 1.31 109.901 -178.302 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 10' ' ' GLY . 30.9 t0 -83.44 -41.75 17.73 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.631 -0.877 . . . . 2.31 108.631 179.259 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 47.84 25.35 0.72 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.927 -0.768 . . . . 1.19 108.927 -179.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 37.4 t -130.74 -42.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.329 -1.36 . . . . 1.45 107.329 178.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.528 ' ND2' ' OE1' ' A' ' 226' ' ' GLN . 50.7 p30 -111.34 1.66 17.2 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.04 -1.467 . . . . 3.13 107.04 178.228 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.666 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.5 OUTLIER 62.15 50.12 4.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.93 -0.577 . . . . 2.2 110.258 -179.794 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.528 ' OE1' ' ND2' ' A' ' 224' ' ' ASN . 52.5 mt-30 -132.12 145.0 51.1 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.308 -0.87 . . . . 2.32 109.426 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 66.5 t -118.36 129.08 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.345 -0.983 . . . . 1.4 108.345 179.013 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -104.29 124.56 49.39 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.385 -0.969 . . . . 1.29 108.385 179.446 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.7 t -101.25 110.69 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.471 -0.768 . . . . 1.38 110.005 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 230' ' ' ASN . 30.9 t-20 48.64 67.01 4.92 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.31 -0.868 . . . . 2.33 110.571 179.541 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -86.72 157.22 8.96 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.843 2.362 . . . . 0.95 111.96 179.304 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.4 m -69.86 161.63 29.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 2.31 110.216 -179.071 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -60.04 -39.2 85.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.381 -0.824 . . . . 3.45 109.733 -179.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -60.04 -37.02 78.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.208 -0.932 . . . . 2.89 109.56 -179.146 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.27 -40.75 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.017 -1.052 . . . . 1.73 109.123 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.3 mt . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.44 -0.788 . . . . 1.57 109.764 179.873 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 35.1 ttp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.391 0.615 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -153.13 149.01 27.62 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -149.33 160.03 43.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.845 -1.159 . . . . 0.0 110.506 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -152.41 149.69 28.86 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 57.4 mp0 -107.84 130.69 54.97 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.239 -0.913 . . . . 0.0 109.555 179.381 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.83 119.09 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 122.316 1.055 . . . . 0.0 112.503 -177.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 94.9 m -76.86 104.07 7.15 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.159 0.98 . . . . 0.0 110.115 -178.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . 0.42 ' O ' ' N ' ' B' ' 358' ' ' GLY . 66.0 mt -52.56 116.35 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 122.35 1.072 . . . . 0.0 110.61 -178.017 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 30.5 p -102.08 22.3 13.37 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.632 -178.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -81.41 123.21 81.34 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.093 179.463 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -70.09 -9.02 25.03 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 CA-C-N 120.203 1.108 . . . . 0.0 112.058 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -119.76 4.22 11.05 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 75.7 178.52 43.64 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.51 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -88.49 97.21 10.95 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.129 -1.218 . . . . 0.0 108.389 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -95.0 -160.62 0.8 Allowed 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.097 -1.002 . . . . 0.0 110.034 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 19.5 m -59.9 -42.05 92.99 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.017 -1.052 . . . . 0.0 112.681 -175.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.478 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.3 tpt180 -61.82 -64.2 3.36 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 120.229 -1.544 . . . . 0.0 111.396 -178.313 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -55.38 -32.46 81.75 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 CA-C-N 120.096 1.07 . . . . 0.0 111.929 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.88 -51.6 69.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 108.845 179.525 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.51 -40.07 65.11 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 0.0 109.652 -179.274 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . 0.526 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 73.1 tp60 -68.21 -45.19 74.01 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.958 -1.089 . . . . 0.0 108.961 179.258 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -60.0 -50.83 72.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.485 -0.759 . . . . 0.0 110.52 -179.245 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.55 -30.69 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.623 -1.298 . . . . 0.0 109.698 -179.166 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . 0.526 ' NZ ' ' OE1' ' B' ' 321' ' ' GLN . 0.4 OUTLIER -59.96 -45.38 92.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.868 . . . . 0.0 109.093 179.701 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -68.28 -40.06 81.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.392 -0.818 . . . . 0.0 110.951 -178.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' B' ' 328' ' ' GLY . . . -74.08 -53.97 8.82 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.752 -1.218 . . . . 0.0 111.252 -178.74 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -49.51 -14.6 0.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 110.336 -178.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' B' ' 326' ' ' ALA . . . -79.98 -16.27 77.24 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.0 -179.897 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -105.73 143.31 34.06 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.378 -1.072 . . . . 0.0 109.308 179.577 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 31.8 m -90.19 -12.46 38.05 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.984 -1.072 . . . . 0.0 110.301 -179.564 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 13.5 p -60.49 145.01 49.99 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.93 -1.106 . . . . 0.0 109.232 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -67.66 137.06 55.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.087 -1.008 . . . . 0.0 108.75 179.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.3 mt -134.04 134.02 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.535 -0.728 . . . . 0.0 110.137 -179.194 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 51.9 m -129.36 149.02 51.32 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.446 -0.784 . . . . 0.0 109.164 178.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 64.6 t -123.34 116.63 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.063 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 93.0 m -105.95 129.32 54.11 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.088 -1.007 . . . . 0.0 109.153 -179.143 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 1.4 m -136.03 115.37 12.6 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.756 0.789 . . . . 0.0 110.666 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 40.1 t30 46.03 52.57 9.94 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 177.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.15 -13.73 53.19 Favored Glycine 0 N--CA 1.5 2.908 0 O-C-N 120.222 -1.549 . . . . 0.0 112.65 176.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 13.1 tptm -115.46 125.82 53.57 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 118.959 1.379 . . . . 0.0 108.834 -179.517 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 82.6 p -127.42 149.98 49.84 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.92 0.867 . . . . 0.0 110.574 -178.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -145.58 167.75 22.29 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.434 0.635 . . . . 0.0 110.234 -178.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 49.0 m -88.92 138.89 31.0 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.609 -0.682 . . . . 0.0 110.434 -179.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.539 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -81.09 -15.55 55.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.024 -1.048 . . . . 0.0 110.456 -179.366 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -84.05 22.26 1.21 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 178.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.539 ' H ' ' C ' ' B' ' 344' ' ' ALA . 63.6 m -150.81 101.67 2.93 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.661 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . 0.521 ' O ' ' NE2' ' B' ' 351' ' ' GLN . 17.3 tp -59.86 -36.6 77.21 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.388 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -57.95 -53.04 62.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.86 . . . . 0.0 110.299 -179.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -68.53 -21.74 64.55 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.272 -0.892 . . . . 0.0 111.241 -176.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' B' ' 352' ' ' THR . 76.8 mt -69.26 -52.61 25.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.395 -1.44 . . . . 0.0 108.886 178.442 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' B' ' 347' ' ' LEU . 0.8 OUTLIER -39.4 -22.33 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.696 -0.627 . . . . 0.0 110.953 -178.156 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.519 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.1 p -80.12 -10.81 59.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.18 -1.575 . . . . 0.0 110.235 -179.13 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 44.4 mt -96.48 117.79 31.64 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.085 -1.009 . . . . 0.0 108.925 178.729 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.5 95.46 0.78 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.359 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 92.6 mt -95.68 78.62 3.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -1.185 . . . . 0.0 108.691 179.252 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 75.6 p -90.97 179.75 5.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.944 . . . . 0.0 110.549 -178.338 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' B' ' 359' ' ' THR . 12.1 tt0 -50.79 157.47 0.79 Allowed 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 122.188 0.994 . . . . 0.0 111.097 -179.494 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 38.39 26.55 0.04 OUTLIER Glycine 0 N--CA 1.498 2.804 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.336 177.691 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 359' ' ' THR . . . . . 0.465 ' N ' ' O ' ' B' ' 357' ' ' GLN . 13.6 m -84.83 106.77 16.61 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.612 -1.522 . . . . 0.0 110.131 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 11.7 t -78.27 113.52 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 122.248 1.023 . . . . 0.0 110.231 -177.556 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 34.4 m -111.58 179.06 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -178.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 37.2 m -130.16 128.28 41.45 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 176.869 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.17 116.31 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.573 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 24.9 p -120.23 132.92 55.54 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.417 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.79 153.93 40.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 0.0 109.917 -178.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -147.03 125.8 12.64 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.458 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 159.23 -158.45 29.52 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.086 -1.53 . . . . 0.0 111.335 -179.654 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.14 -49.86 75.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 122.017 -0.696 . . . . 0.0 112.485 -177.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -114.28 13.64 17.91 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.914 -1.116 . . . . 0.0 111.528 -177.039 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.551 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -42.91 -33.8 0.85 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.23 -0.919 . . . . 0.0 111.035 -179.1 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . 0.504 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 92.4 mm-40 -69.95 -44.2 70.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.059 -1.026 . . . . 0.0 110.412 -178.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -67.52 -47.63 69.36 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.544 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.67 -76.83 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.334 -0.854 . . . . 0.0 110.61 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 94.4 t -46.4 -35.36 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 110.969 -177.319 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -67.11 -46.16 75.03 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.221 -1.549 . . . . 0.0 110.238 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -77.61 -43.48 31.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.807 -1.183 . . . . 0.0 109.546 179.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.05 -39.59 86.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 0.0 109.968 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.06 -45.21 95.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.772 -1.171 . . . . 0.0 109.168 179.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' B' ' 383' ' ' GLU . 99.3 mttt -70.0 -56.59 6.59 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.655 -1.278 . . . . 0.0 108.114 178.565 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 42.3 tp -54.88 -35.35 63.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.402 -0.811 . . . . 0.0 109.709 -178.024 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 381' ' ' MET . . . . . 0.502 ' O ' ' CE ' ' B' ' 381' ' ' MET . 0.0 OUTLIER -73.47 -39.9 64.55 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.44 -1.304 . . . . 0.0 107.826 177.635 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.48 -4.75 50.09 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.184 -0.948 . . . . 0.0 110.205 179.534 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' B' ' 379' ' ' LYS . 69.6 mm-40 -111.81 1.08 16.42 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.198 -0.939 . . . . 0.0 110.723 179.86 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 16.1 mt -90.36 129.3 36.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.761 -1.212 . . . . 0.0 109.261 179.362 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.326 -179.501 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.8 mtp . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.232 -0.655 . . . . 3.19 109.232 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.401 HG23 HD11 ' A' ' 2' ' ' ILE . 86.1 mt -110.49 124.85 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.499 -0.75 . . . . 1.71 109.601 -179.804 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.5 m -133.28 145.6 50.62 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.563 -0.71 . . . . 1.66 109.154 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.546 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -129.37 -164.36 11.43 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 108.868 -1.693 . . . . 1.05 108.868 179.924 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.1 mt -88.23 -9.93 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.922 -1.34 . . . . 1.59 110.116 -179.098 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 54.6 tp 50.3 98.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.16 -0.963 . . . . 1.47 109.13 179.804 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.11 -31.13 12.27 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.164 -0.96 . . . . 1.39 109.201 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 12.1 t -131.46 119.49 17.44 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 108.947 -0.761 . . . . 2.09 108.947 179.697 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -81.51 148.85 16.39 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.104 1.869 . . . . 0.91 112.812 -179.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 143.76 176.83 18.15 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 108.829 -1.708 . . . . 0.92 108.829 179.755 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 88.4 mt -120.0 153.78 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.147 -1.207 . . . . 1.35 109.833 -179.351 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.11 152.15 29.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 1.14 109.773 179.761 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.3 m-85 -133.47 127.58 33.59 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.334 -0.987 . . . . 0.7 108.334 179.565 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.78 175.47 47.37 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 118.885 -1.626 . . . . 0.58 110.687 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -78.66 155.4 29.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.654 -0.91 . . . . 2.63 109.529 -179.523 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.12 131.48 48.59 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.376 -0.828 . . . . 1.27 111.121 -178.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.9 tp -100.23 134.86 42.54 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.681 -1.229 . . . . 1.41 107.681 178.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.2 tp -115.35 119.97 38.06 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.252 -0.905 . . . . 1.49 110.144 -179.458 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt -88.87 101.11 13.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.503 -0.748 . . . . 1.52 109.944 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -95.78 133.66 39.64 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.235 -1.024 . . . . 3.17 108.235 179.441 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.522 ' CG ' HH21 ' A' ' 139' ' ' ARG . 81.8 tt0 -131.54 141.08 49.64 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.242 -0.911 . . . . 3.0 109.696 -179.398 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -88.24 141.9 28.19 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.453 -0.779 . . . . 2.77 109.662 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.52 139.98 58.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.038 -1.039 . . . . 2.94 109.078 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.5 mt -83.03 136.64 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -0.943 . . . . 1.46 108.915 179.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.7 t -102.69 129.55 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.444 -0.785 . . . . 1.7 109.329 -179.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.6 mt -106.8 138.92 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.834 -0.802 . . . . 1.54 108.834 179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -92.87 119.27 32.02 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.01 -1.056 . . . . 1.81 109.586 -179.59 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.413 HH11 ' HG3' ' A' ' 28' ' ' ARG . 23.8 mmm-85 -86.95 -2.96 59.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.563 -0.711 . . . . 3.23 109.557 -179.5 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.7 144.37 56.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.125 -0.984 . . . . 3.29 109.902 179.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -87.99 151.17 22.98 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.837 -0.801 . . . . 2.8 108.837 179.563 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.5 pt -98.12 166.73 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.076 -1.015 . . . . 1.43 110.46 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.8 p -90.45 174.5 7.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 1.54 108.762 178.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.89 -18.7 63.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.14 -0.975 . . . . 1.6 111.087 -179.332 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -83.27 -27.4 29.89 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.565 -1.334 . . . . 2.56 108.709 178.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -81.19 -8.42 59.75 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.242 -0.651 . . . . 2.36 109.242 179.45 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.5 t -61.54 -54.13 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.224 -0.923 . . . . 1.43 108.917 179.516 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -62.14 -39.89 94.12 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.42 -0.8 . . . . 1.77 109.829 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -63.93 -42.78 97.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.033 -1.042 . . . . 3.32 110.104 -179.36 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -64.15 -39.79 94.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.923 -1.111 . . . . 1.51 110.328 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.85 -47.52 91.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.665 -1.272 . . . . 1.41 108.458 -179.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -60.04 -41.12 91.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.949 -1.094 . . . . 1.81 108.855 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -60.04 -44.47 94.63 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.842 -1.17 . . . . 3.26 107.842 178.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -60.32 -47.58 85.41 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.744 -0.836 . . . . 0.81 108.744 178.129 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.4 tp -59.9 -49.33 78.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 1.59 109.224 179.869 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.0 t -62.42 -43.58 98.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.024 -1.047 . . . . 1.38 109.44 179.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.26 -46.39 94.02 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.132 -1.587 . . . . 0.87 109.132 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -67.24 -30.71 70.68 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.328 -1.101 . . . . 3.62 108.454 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.8 -45.75 91.36 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.458 -0.776 . . . . 1.43 109.244 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 50' ' ' ALA . 30.6 ttpt -61.4 -72.69 0.11 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.901 -1.148 . . . . 3.08 107.901 179.427 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.86 -33.68 0.06 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.477 -0.764 . . . . 1.33 111.725 -178.188 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 64.1 m -59.95 -50.65 72.92 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.064 -1.454 . . . . 1.85 107.95 179.452 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.62 -40.09 76.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.44 -0.788 . . . . 1.35 111.211 -179.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -66.45 -40.04 89.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.663 -1.273 . . . . 2.34 110.116 -179.427 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.1 mt -65.09 -40.0 93.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.925 . . . . 2.2 109.783 -179.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -61.85 -38.04 86.75 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.98 -1.075 . . . . 1.35 109.694 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -63.63 -41.62 98.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 1.34 109.774 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.3 -39.89 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.198 -0.939 . . . . 1.26 109.077 179.756 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -55.67 -50.05 71.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -0.842 . . . . 1.7 109.542 -179.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -57.34 -33.23 67.53 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.223 -0.923 . . . . 1.35 110.062 -178.457 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.431 ' O ' ' OG1' ' A' ' 64' ' ' THR . 98.4 mttt -69.82 -39.76 76.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.944 -1.097 . . . . 2.08 110.594 179.593 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.13 -44.36 80.07 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.232 -0.918 . . . . 1.21 110.218 -178.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.78 -50.89 62.83 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.931 -1.268 . . . . 0.75 109.931 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.9 -43.93 70.75 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.99 -1.3 . . . . 1.59 109.985 -179.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 47.0 m -66.43 -62.73 1.31 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.118 -0.989 . . . . 1.41 111.742 -178.09 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -95.43 -48.71 5.74 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.872 -1.143 . . . . 0.79 111.316 -178.071 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.83 -166.64 25.86 Favored Glycine 0 N--CA 1.504 3.173 0 C-N-CA 119.818 -1.182 . . . . 1.22 111.043 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.51 -23.42 64.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.673 -0.898 . . . . 5.81 109.618 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -60.73 -37.69 82.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.816 . . . . 3.37 110.872 -179.579 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -99.43 -15.01 18.88 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.007 -1.058 . . . . 2.37 109.858 -179.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -70.03 -39.99 75.42 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.081 -1.012 . . . . 1.65 109.085 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.68 -31.5 72.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.622 -0.674 . . . . 1.42 109.946 -179.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 80.8 mt -59.89 -41.2 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.828 -1.17 . . . . 1.43 108.538 179.836 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -65.3 -39.32 92.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.959 . . . . 1.08 110.501 179.707 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -60.01 -39.85 87.21 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.697 -1.252 . . . . 1.37 109.086 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.41 -48.96 68.36 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.462 -1.855 . . . . 0.67 108.462 178.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -62.02 -44.72 96.11 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.264 -1.139 . . . . 1.99 108.682 179.203 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 80.9 mt -68.7 -48.6 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.266 -0.896 . . . . 1.22 109.344 179.429 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 52.3 ttp -60.17 -40.83 91.3 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.939 -1.101 . . . . 2.11 109.764 -179.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.5 tp -64.97 -39.9 94.18 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.338 -0.851 . . . . 1.33 109.907 179.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.0 tp -64.27 -40.1 95.29 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.497 -0.752 . . . . 1.29 110.268 -179.137 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -81.06 7.85 9.95 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.904 -1.123 . . . . 1.47 110.557 -178.853 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -56.91 129.78 43.03 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.081 -1.012 . . . . 1.47 110.134 -178.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -60.33 -15.36 24.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.33 -0.857 . . . . 1.78 110.438 -179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -69.9 -35.98 75.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.956 -1.09 . . . . 2.53 108.675 178.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.2 mt -71.17 -42.84 68.56 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.49 0.662 . . . . 1.36 110.054 179.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.59 -47.77 84.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.907 . . . . 1.42 110.551 -179.138 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -70.74 -43.92 67.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.089 -1.007 . . . . 2.27 111.746 -178.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -70.41 -38.65 74.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.127 -0.983 . . . . 1.57 111.525 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.406 HG21 HD12 ' A' ' 89' ' ' ILE . 95.7 mt -69.53 -42.23 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.044 -1.035 . . . . 1.19 110.016 -179.062 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.81 -37.78 77.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.42 -0.8 . . . . 1.39 110.17 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.01 -46.45 89.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.137 -0.977 . . . . 1.39 111.13 -179.03 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 96' ' ' LYS . 89.2 mt -60.96 -45.55 94.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.734 -1.228 . . . . 1.5 109.992 -178.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.36 -50.02 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 1.29 109.42 -179.577 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.04 -40.91 74.85 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.833 -0.747 . . . . 2.64 110.487 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -81.54 -50.5 9.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.129 -0.982 . . . . 1.65 112.249 -178.185 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 92' ' ' LEU . 42.2 mmtm -93.04 -2.24 55.83 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.071 -1.018 . . . . 2.5 111.982 -176.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 57.4 35.97 26.57 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.059 -1.026 . . . . 1.88 109.793 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.5 mtt -90.39 168.04 12.18 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.45 -0.781 . . . . 1.71 110.128 -179.457 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.5 p -80.15 160.64 25.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.489 -0.757 . . . . 1.61 109.597 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.82 -39.72 76.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 1.33 110.381 -179.557 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 34.2 p-10 -66.31 -39.2 89.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.052 -1.03 . . . . 2.07 109.821 -179.626 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.484 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -78.93 -51.59 9.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 1.37 109.704 179.417 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.48 77.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.537 -0.727 . . . . 1.14 111.131 -179.002 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.04 -45.92 91.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.065 -1.022 . . . . 1.26 110.018 -179.059 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -58.39 -37.16 74.7 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.308 -0.87 . . . . 2.02 109.917 -179.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.92 -39.99 91.5 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.26 -0.9 . . . . 1.33 111.014 -179.127 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.85 -49.97 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.832 -1.168 . . . . 1.3 110.58 -178.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.7 mm -67.42 -40.24 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.992 -1.067 . . . . 1.32 108.237 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -66.92 -37.2 83.89 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.184 -1.043 . . . . 2.44 108.184 178.836 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.93 -49.0 83.34 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.009 -1.236 . . . . 0.99 110.009 -179.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -65.86 -48.05 72.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.853 -1.38 . . . . 1.97 109.123 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.383 -0.823 . . . . 1.43 109.222 -179.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 58.5 m -60.02 -40.1 88.15 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.267 -1.012 . . . . 2.12 108.267 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.35 -43.5 96.45 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.45 -0.944 . . . . 1.64 108.45 179.074 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.7 mt -64.04 -48.83 74.72 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.159 -1.052 . . . . 1.93 108.159 179.302 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -49.48 -31.86 10.91 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.321 -0.862 . . . . 2.2 109.998 -179.11 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.74 -20.28 55.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.892 -1.13 . . . . 2.12 108.668 179.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 74.1 mt -63.15 140.05 58.83 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.511 -0.922 . . . . 2.34 108.511 179.317 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -99.11 49.01 0.95 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.116 -0.99 . . . . 3.23 111.02 -178.531 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 24.7 t0 -137.38 153.22 50.23 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.145 -0.972 . . . . 2.49 109.119 178.993 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.457 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 99.5 mt-10 -72.44 -64.78 0.88 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.95 -1.13 . . . . 3.95 107.95 178.352 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.438 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 6.6 t80 -41.33 -43.74 2.56 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.91 -0.494 . . . . 2.25 110.895 -179.234 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.496 ' CD2' HH21 ' A' ' 126' ' ' ARG . 85.3 mt -69.88 -40.05 75.92 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.604 -1.31 . . . . 2.27 109.028 -179.836 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -65.33 -37.36 86.85 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.525 -0.735 . . . . 3.31 109.563 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -59.83 -42.15 92.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.391 -0.818 . . . . 2.73 110.268 -179.031 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.551 ' NH1' ' OE1' ' B' ' 351' ' ' GLN . 82.2 mtm180 -70.05 -32.72 70.98 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.924 -1.11 . . . . 3.2 108.812 179.621 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.22 -22.77 65.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.735 -1.209 . . . . 1.66 107.735 178.458 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.72 -40.04 63.85 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.511 -0.922 . . . . 1.67 108.511 178.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.99 -41.22 99.51 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.433 -0.792 . . . . 1.55 110.377 -179.587 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.8 t -68.67 -40.45 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.047 -1.033 . . . . 1.32 108.873 179.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.3 ttt-85 -60.19 -37.69 81.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 3.58 108.779 178.602 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 61.6 t0 -59.84 -38.97 83.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.527 -0.733 . . . . 1.46 109.68 -179.483 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.04 -40.65 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.083 -1.011 . . . . 1.22 109.563 -179.486 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.13 -26.85 67.53 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.848 -1.301 . . . . 0.61 109.848 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -60.1 -49.62 76.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -1.186 . . . . 3.1 109.575 -179.217 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -68.32 -32.96 73.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.786 -1.197 . . . . 3.71 110.559 179.545 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.6 tp -54.34 -43.96 71.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.936 -1.103 . . . . 1.87 108.795 -179.338 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.92 -39.98 93.91 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.124 -0.985 . . . . 1.29 109.037 178.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.522 HH21 ' CG ' ' A' ' 21' ' ' GLU . 3.2 mtt-85 -68.13 -40.02 82.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.856 . . . . 3.05 109.714 179.407 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -68.76 -38.27 79.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.458 -0.776 . . . . 1.26 112.265 -178.439 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.91 -40.09 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.321 -1.487 . . . . 1.34 108.791 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 92.2 mt -76.03 -28.69 57.8 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.509 -0.744 . . . . 1.6 110.167 -179.429 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.81 38.95 18.46 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.423 -1.471 . . . . 0.96 109.423 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 tp -73.89 147.18 43.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.259 -1.141 . . . . 1.67 108.619 -179.663 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -66.43 137.02 56.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.034 -1.041 . . . . 4.96 109.653 -179.153 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 83.2 mt -109.83 132.92 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 122.218 1.008 . . . . 1.68 108.512 179.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.3 mt -65.02 -39.97 87.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 115.637 -0.71 . . . . 2.14 110.768 -178.304 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 41.3 t0 63.21 102.23 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.412 -0.805 . . . . 1.5 108.861 -179.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.9 mt -70.02 -1.11 8.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.365 -0.834 . . . . 1.39 111.49 -178.023 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.7 t -84.66 -13.15 52.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.524 -1.36 . . . . 1.83 110.324 -179.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.93 31.64 0.2 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.092 -1.005 . . . . 1.46 112.052 -178.07 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.8 mm -86.04 120.0 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.234 -1.541 . . . . 1.42 109.087 179.546 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -101.41 -9.32 21.22 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.321 -0.862 . . . . 2.94 110.462 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -140.31 159.93 41.1 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.039 -1.038 . . . . 1.52 110.867 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.83 132.88 50.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.501 -0.75 . . . . 1.58 109.162 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.0 m -152.06 165.5 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.274 -0.891 . . . . 1.32 110.074 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 157' ' ' ILE . 84.9 mt -97.09 145.29 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 105.522 -2.029 . . . . 1.27 105.522 176.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.3 tp -95.41 115.49 27.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.873 -1.142 . . . . 1.41 110.614 -177.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.0 t -120.28 128.07 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 N-CA-C 108.257 -1.016 . . . . 1.23 108.257 179.026 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.48 165.58 30.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.025 -1.047 . . . . 1.32 109.27 -179.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.77 -38.0 73.41 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.363 -1.461 . . . . 1.49 108.567 178.61 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 54.0 t0 -171.7 147.16 2.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.582 -0.699 . . . . 2.25 109.468 -179.667 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.412 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 17.6 mt -119.91 136.72 54.4 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.281 -0.887 . . . . 1.35 108.859 179.505 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.5 p -89.98 149.98 42.75 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.179 -0.951 . . . . 1.56 110.009 -179.424 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.418 ' O ' ' OG1' ' A' ' 168' ' ' THR . 77.8 Cg_exo -40.63 -39.39 2.95 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.563 2.175 . . . . 0.87 113.438 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 66.1 m -59.99 -39.96 87.51 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.966 -1.084 . . . . 1.36 109.253 -179.122 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.68 -40.08 94.78 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.346 -0.846 . . . . 1.61 110.129 -179.828 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 165' ' ' PRO . 51.7 p -57.97 -34.55 70.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.163 -0.96 . . . . 1.21 111.225 -177.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.4 -50.91 41.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.962 -1.086 . . . . 1.21 109.914 -179.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -85.7 36.67 0.67 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.421 -0.799 . . . . 2.11 108.9 -179.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.2 tp -99.97 140.01 34.8 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.451 -0.781 . . . . 1.29 109.491 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -84.4 104.63 14.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.021 -1.049 . . . . 2.81 108.62 179.185 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 63.2 mt -65.75 -40.97 92.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.442 -0.786 . . . . 2.09 111.612 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -81.25 -15.01 56.82 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.638 -1.289 . . . . 2.86 112.162 -177.172 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -95.33 -10.63 29.59 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.611 -1.305 . . . . 2.39 109.132 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 99.9 t -110.28 120.08 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.401 -0.812 . . . . 1.27 108.82 178.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -91.64 7.85 39.59 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.027 -1.045 . . . . 2.17 110.723 -178.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.27 172.37 38.04 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.543 -1.423 . . . . 0.52 109.543 179.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -132.94 129.89 38.88 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.326 -1.102 . . . . 0.55 109.403 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.2 mt -132.02 124.26 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.865 -0.791 . . . . 1.27 108.865 178.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 53.6 p -146.97 159.8 43.12 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.132 -0.98 . . . . 1.39 110.761 -179.615 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.8 OUTLIER -96.35 21.63 8.83 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.124 -0.695 . . . . 2.46 109.124 179.686 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.485 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -45.58 -176.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 122.341 1.067 . . . . 1.51 112.847 -177.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.93 -56.77 4.71 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 111.131 -0.788 . . . . 2.23 111.131 -179.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.46 -144.24 5.1 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.118 -1.515 . . . . 2.23 110.79 -179.34 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.51 ' C ' ' H ' ' A' ' 188' ' ' SER . 82.1 mtm180 -69.66 -28.14 65.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.54 -0.976 . . . . 6.44 110.302 -178.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 69.7 p -62.95 5.82 0.12 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.194 -0.942 . . . . 4.09 110.614 -178.756 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 186' ' ' ARG . 40.4 t -90.67 128.35 36.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.987 -1.071 . . . . 2.2 109.894 -179.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -47.52 -44.17 25.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.316 -0.865 . . . . 1.15 108.825 179.687 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.442 ' HG1' ' N ' ' A' ' 191' ' ' SER . 45.3 p -57.8 -39.56 77.82 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.78 -0.575 . . . . 2.01 110.425 -179.058 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.442 ' N ' ' HG1' ' A' ' 190' ' ' THR . 58.5 m -59.94 -40.17 88.04 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.997 -1.064 . . . . 1.93 110.899 -178.868 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 2.2 mp -64.75 -40.07 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.951 -1.093 . . . . 2.2 110.295 -179.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.5 mtp -61.25 -41.14 96.39 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.843 -1.161 . . . . 1.32 110.615 -179.441 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.86 -44.1 94.32 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.505 -1.372 . . . . 1.3 109.541 -179.73 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.409 HH21 ' HG2' ' A' ' 186' ' ' ARG . 30.0 mtt-85 -60.23 -50.1 74.99 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.272 -0.893 . . . . 3.38 109.996 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 39.4 m -72.0 -35.72 69.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.11 -0.994 . . . . 1.15 111.823 -178.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.6 mt -76.67 -13.24 60.07 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.499 -1.376 . . . . 1.28 110.194 -178.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 59.81 46.08 11.87 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.533 -0.73 . . . . 1.5 110.547 179.392 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.409 ' O ' ' CB ' ' A' ' 8' ' ' SER . 90.6 mt -122.85 128.91 25.2 Favored Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 108.687 -0.857 . . . . 1.37 108.687 179.313 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -43.41 133.92 6.8 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.82 1.68 . . . . 0.76 112.073 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -167.27 147.17 5.32 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.575 -1.25 . . . . 1.19 111.89 -179.483 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.7 mt -125.58 141.07 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 107.772 -1.196 . . . . 1.31 107.772 178.362 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 11.2 m -126.71 -7.29 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 120.806 -1.184 . . . . 1.38 110.589 -179.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.15 22.06 25.84 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.544 -1.022 . . . . 1.03 110.544 -179.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.456 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 12.6 p -47.14 -44.58 21.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.834 -1.392 . . . . 1.38 109.782 -179.287 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.69 -53.96 4.07 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 120.022 -1.085 . . . . 1.17 112.036 178.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.434 ' O ' ' OG ' ' A' ' 207' ' ' SER . 13.0 t -150.03 28.27 0.76 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 120.485 -1.597 . . . . 2.07 111.905 -178.2 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 45.6 t -70.25 -40.07 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.74 -1.225 . . . . 1.35 109.126 178.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 75.9 p -53.79 -30.82 46.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.377 -0.827 . . . . 1.49 111.392 -178.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.7 m -81.28 -12.95 58.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.823 -1.173 . . . . 2.16 110.283 -179.132 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -102.57 -12.14 17.98 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.141 -0.974 . . . . 2.89 110.351 -179.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 85.0 t -107.86 139.24 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.177 -0.952 . . . . 1.33 111.675 -177.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -114.25 150.01 35.02 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.356 -1.35 . . . . 2.73 107.356 178.212 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.507 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 21.3 p-10 -57.1 140.45 49.28 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.735 -1.228 . . . . 2.7 109.9 -179.356 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.1 t0 87.15 4.07 0.37 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 109.525 -0.546 . . . . 2.38 109.525 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 64.8 t0 -74.7 139.41 43.44 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.204 -0.935 . . . . 2.09 109.561 179.512 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.469 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 48.4 t80 -91.94 116.56 29.02 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.524 -1.287 . . . . 1.45 107.524 178.456 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 76.4 mt -127.37 149.4 50.08 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.468 -0.77 . . . . 1.31 110.297 -178.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 63.1 mt -114.66 129.71 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 106.859 -1.534 . . . . 1.29 106.859 176.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 55.0 tp -100.14 119.17 37.92 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.078 -1.082 . . . . 1.31 108.078 -179.153 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.459 ' C ' ' N ' ' A' ' 223' ' ' VAL . 78.7 m-20 -81.4 -46.73 14.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.965 -1.084 . . . . 2.31 109.51 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 48.23 17.27 0.11 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.792 -0.818 . . . . 1.19 108.792 -179.251 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.459 ' N ' ' C ' ' A' ' 221' ' ' ASP . 55.3 t -127.19 -49.42 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.256 -1.387 . . . . 1.45 107.256 178.387 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -100.31 2.87 42.98 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.412 -1.329 . . . . 3.13 107.412 178.37 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.546 HD22 ' H ' ' A' ' 4' ' ' GLY . 1.1 t-20 59.82 49.18 8.24 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.04 -0.726 . . . . 2.2 109.04 -179.071 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -136.85 147.11 46.33 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.438 -0.789 . . . . 2.32 109.572 -179.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.5 t -119.89 126.84 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.269 -1.011 . . . . 1.4 108.269 179.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -100.1 117.56 34.61 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.185 -0.947 . . . . 1.29 108.934 179.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.3 t -98.8 111.52 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.734 -0.604 . . . . 1.38 109.914 -179.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 55.18 68.54 2.47 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.311 -0.868 . . . . 2.33 111.235 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -90.67 145.42 3.86 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 123.13 2.553 . . . . 0.95 112.122 178.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 61.2 p -69.95 163.98 24.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.039 -1.038 . . . . 2.31 109.646 -179.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -60.19 -40.38 89.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 3.45 110.071 -178.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -60.07 -39.98 87.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.057 -1.027 . . . . 2.89 109.522 -179.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.69 -40.4 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.052 -1.03 . . . . 1.73 109.299 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.0 mt . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.266 -0.896 . . . . 1.57 109.085 179.72 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' B' B ' 301' ' ' MET . . . . . 0.476 ' N ' ' OE1' ' B' ' 366' ' ' GLU . 11.0 ttt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.488 0.661 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -156.93 154.23 29.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.382 -0.824 . . . . 0.0 109.056 178.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -151.21 162.44 40.88 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.916 -1.115 . . . . 0.0 110.737 -178.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -154.96 152.16 29.37 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.611 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -113.0 133.93 54.74 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.094 -1.004 . . . . 0.0 110.346 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.1 p -134.45 125.61 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 CA-C-O 122.415 1.102 . . . . 0.0 112.475 -178.492 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 93.9 m -77.83 106.29 9.57 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.306 -177.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.9 mt -52.13 122.02 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 122.222 1.01 . . . . 0.0 110.413 -178.186 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 62.4 p -110.73 18.62 19.45 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.697 -178.579 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.25 115.98 53.69 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.083 -1.011 . . . . 0.0 109.584 179.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -49.5 -15.4 0.9 Allowed 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 121.114 1.209 . . . . 0.0 114.266 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -118.92 9.44 11.93 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.199 -0.938 . . . . 0.0 109.694 -179.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.2 177.74 26.64 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -179.118 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.438 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.0 tp -83.73 93.86 8.02 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.034 -1.274 . . . . 0.0 109.716 -178.32 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -95.92 -162.52 0.96 Allowed 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.661 -1.274 . . . . 0.0 110.391 179.274 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 25.8 m -55.9 -40.01 72.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.154 -0.967 . . . . 0.0 112.377 -176.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.498 HH21 ' CD ' ' B' ' 321' ' ' GLN . 1.7 tpt180 -62.9 -61.65 7.09 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 120.677 -1.265 . . . . 0.0 112.507 -178.37 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.98 -32.54 95.53 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 CA-C-N 120.275 1.134 . . . . 0.0 111.896 -179.24 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.94 -50.07 75.21 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.139 -1.024 . . . . 0.0 108.457 179.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.65 -40.61 60.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.71 -179.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . 0.498 ' CD ' HH21 ' B' ' 317' ' ' ARG . 27.2 mt-30 -72.8 -40.06 66.18 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.827 -1.149 . . . . 0.0 109.457 178.631 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -60.28 -51.5 69.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.18 -0.95 . . . . 0.0 109.996 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 92.4 t -69.01 -24.73 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.936 -1.103 . . . . 0.0 110.501 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.03 -42.49 94.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.859 -1.15 . . . . 0.0 108.823 179.9 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -69.5 -60.06 2.58 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.626 -0.671 . . . . 0.0 111.562 -178.185 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.1 -9.01 43.1 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.822 -1.174 . . . . 0.0 112.698 -177.512 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -83.67 -20.3 33.81 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.441 -1.412 . . . . 0.0 110.113 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -87.52 -10.97 69.56 Favored Glycine 0 N--CA 1.498 2.78 0 C-N-CA 120.084 -1.055 . . . . 0.0 111.158 -178.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -102.45 143.23 32.44 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.961 -1.317 . . . . 0.0 109.417 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 57.9 p -89.59 -13.84 36.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.034 -1.041 . . . . 0.0 110.06 -179.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 82.2 p -58.9 145.24 41.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.109 -0.994 . . . . 0.0 109.095 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' B' ' 332' ' ' GLU . 49.5 mp0 -68.26 130.1 41.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.187 -0.946 . . . . 0.0 109.069 -179.804 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 86.1 mt -132.18 132.55 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.589 -0.695 . . . . 0.0 110.21 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 95.3 m -131.06 151.3 51.56 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.5 -0.75 . . . . 0.0 109.725 179.393 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 96.3 t -125.12 120.05 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 95.1 m -116.84 130.09 56.49 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.037 -1.039 . . . . 0.0 110.329 -178.321 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 2.0 m -133.75 117.62 17.13 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.883 0.849 . . . . 0.0 110.037 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 48.3 t30 49.66 50.51 18.17 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 176.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.84 -12.01 65.03 Favored Glycine 0 N--CA 1.504 3.19 0 O-C-N 119.682 -1.886 . . . . 0.0 113.434 176.286 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -120.56 132.5 55.19 Favored 'General case' 0 N--CA 1.506 2.375 0 CA-C-N 119.292 1.546 . . . . 0.0 108.957 -179.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 95.7 p -135.78 156.15 49.26 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 121.94 0.876 . . . . 0.0 111.249 -178.317 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -145.65 167.36 23.29 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.583 0.706 . . . . 0.0 110.183 -179.401 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 3.7 t -85.38 133.54 34.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.614 -0.679 . . . . 0.0 110.212 -179.392 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -70.71 -19.11 62.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.126 -0.984 . . . . 0.0 110.687 -179.361 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -88.49 21.36 2.95 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.491 ' H ' ' C ' ' B' ' 344' ' ' ALA . 59.7 p -144.42 93.81 2.48 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.863 -179.037 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 44.4 tp -59.84 -38.97 83.6 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -54.16 -52.28 61.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.185 -0.947 . . . . 0.0 110.946 -179.22 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.47 ' O ' ' OG1' ' B' ' 352' ' ' THR . 48.3 mtmt -69.64 -39.24 77.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.432 -1.417 . . . . 0.0 110.102 -179.378 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' B' ' 352' ' ' THR . 23.7 mt -50.12 -59.78 3.59 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.73 -1.232 . . . . 0.0 109.534 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.551 ' OE1' ' NH1' ' A' ' 126' ' ' ARG . 13.1 mm-40 -43.29 -11.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.555 -0.716 . . . . 0.0 111.4 -177.499 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.586 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.3 p -89.47 -8.96 51.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.586 -1.321 . . . . 0.0 109.638 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 68.8 mt -93.44 120.0 33.2 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.011 -1.055 . . . . 0.0 108.664 178.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.04 94.81 0.81 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 44.2 mt -102.26 88.22 3.25 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.429 -1.041 . . . . 0.0 109.569 179.691 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 71.8 p -93.11 170.8 9.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.071 -1.018 . . . . 0.0 110.528 -179.566 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -64.45 116.39 6.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.758 -0.589 . . . . 0.0 110.99 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 102.26 4.83 50.14 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 49.7 m -85.67 110.83 19.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.37 -1.077 . . . . 0.0 110.84 -179.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 45.7 t -76.23 115.9 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.965 0.888 . . . . 0.0 109.206 -177.301 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 13.3 m -110.21 175.79 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -178.266 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 26.4 m -130.86 131.29 44.47 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 177.463 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 78.3 mt -108.71 120.84 60.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.432 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 78.3 p -127.2 136.81 52.56 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.021 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.53 155.21 41.64 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.88 -1.138 . . . . 0.0 110.66 -179.271 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' B' ' 301' ' ' MET . 12.6 tp10 -144.84 121.98 11.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.476 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.452 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 161.07 -158.71 30.37 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 118.474 -1.822 . . . . 0.0 112.08 179.573 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -59.98 -51.89 67.73 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.396 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -110.13 11.31 23.78 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.958 -1.089 . . . . 0.0 111.239 -177.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.55 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.0 OUTLIER -40.52 -31.66 0.16 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.279 -0.888 . . . . 0.0 112.469 -178.43 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . 0.502 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 63.9 mt-30 -66.81 -48.3 69.38 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.374 -1.454 . . . . 0.0 110.958 -177.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -66.86 -48.17 69.66 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.53 -1.268 . . . . 0.0 108.339 179.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -42.6 -40.85 2.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.702 -0.624 . . . . 0.0 111.697 -178.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . 0.416 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 62.4 t -80.05 -32.63 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.283 -1.511 . . . . 0.0 109.769 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.98 -41.64 74.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.823 . . . . 0.0 112.392 -177.682 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' B' ' 380' ' ' LEU . 67.1 m80 -86.54 -42.38 13.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.398 -1.438 . . . . 0.0 110.382 -179.513 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.05 -40.01 83.79 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.956 -1.097 . . . . 0.0 108.285 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 51.1 t -64.36 -46.38 93.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.595 179.129 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -80.09 -9.5 59.71 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.785 -1.197 . . . . 0.0 109.786 178.492 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' B' ' 376' ' ' HIS . 49.5 tp -83.54 -28.27 28.74 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 176.769 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 56.9 tpp -81.42 -29.56 33.82 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.121 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.21 -9.6 59.76 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.891 -0.506 . . . . 0.0 109.902 179.413 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -106.96 1.48 24.52 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.231 -0.918 . . . . 0.0 110.998 -179.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . 0.405 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 20.6 mt -78.59 117.89 20.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.275 -1.516 . . . . 0.0 110.002 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 117.912 -1.042 . . . . 0.0 108.736 178.715 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 mmt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.197 -0.668 . . . . 3.19 109.197 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.432 HD12 HG23 ' A' ' 2' ' ' ILE . 99.3 mt -109.77 126.42 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.407 -0.96 . . . . 1.71 108.407 179.202 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -125.13 121.6 34.71 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.604 -0.685 . . . . 1.66 110.018 -178.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.72 -164.97 32.99 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.186 -1.566 . . . . 1.05 109.186 179.166 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' LEU . 88.2 mt -88.68 -13.6 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.02 -1.283 . . . . 1.59 109.854 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 5' ' ' ILE . 56.2 tp 46.07 99.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.227 -0.921 . . . . 1.47 110.342 179.094 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.51 -29.48 12.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.031 -1.043 . . . . 1.39 108.963 179.063 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 40.9 t -119.22 116.46 33.86 Favored Pre-proline 0 N--CA 1.501 2.101 0 N-CA-C 109.039 -0.726 . . . . 2.09 109.039 179.46 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.22 142.83 17.19 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.618 1.545 . . . . 0.91 111.877 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 161.4 -159.72 31.51 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.218 -1.553 . . . . 0.92 109.218 -179.713 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.3 mt -148.51 148.37 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 120.808 -1.407 . . . . 1.35 109.09 179.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.18 153.12 30.24 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.899 -1.126 . . . . 1.14 111.291 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 8.7 m-85 -133.16 129.94 38.52 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.72 -1.585 . . . . 0.7 106.72 177.891 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.67 175.68 46.63 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 117.936 -2.078 . . . . 0.58 111.245 -179.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -77.47 160.02 28.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.889 -0.771 . . . . 2.63 109.11 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.45 127.15 46.87 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.312 -0.867 . . . . 1.27 110.927 -179.06 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.5 tp -100.79 134.35 43.89 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 106.972 -1.492 . . . . 1.41 106.972 178.011 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.2 tp -120.4 122.32 40.49 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.123 -0.985 . . . . 1.49 110.044 -179.564 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 62.0 mt -80.85 102.61 10.14 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.499 0.666 . . . . 1.52 109.678 -179.421 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -99.34 131.09 45.6 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.451 -0.781 . . . . 3.17 109.883 -179.219 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -127.39 139.11 53.07 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.969 -0.752 . . . . 3.0 108.969 -179.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 61.6 t0 -82.7 149.71 27.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.983 -1.073 . . . . 2.77 109.171 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.55 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 70.7 tt0 -68.08 147.31 52.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 2.94 109.269 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.3 mt -97.62 133.78 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.232 -0.918 . . . . 1.46 109.181 -179.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.3 t -103.43 127.86 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.249 -0.907 . . . . 1.7 110.164 -179.056 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 84.1 mt -99.2 142.48 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.477 -0.765 . . . . 1.54 109.293 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -97.11 117.32 31.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.065 -1.022 . . . . 1.81 109.449 -179.762 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -89.27 3.61 51.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.172 -0.955 . . . . 3.23 109.153 -179.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -67.22 140.1 57.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 3.29 110.283 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -84.8 141.93 30.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 2.8 109.333 179.631 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.8 pt -89.84 164.1 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 1.43 109.365 179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 100.0 p -95.86 171.63 8.52 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.042 -1.036 . . . . 1.54 108.77 179.338 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.38 -48.35 80.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.882 -1.136 . . . . 1.6 109.376 -179.443 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -55.91 -30.38 61.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.698 -1.251 . . . . 2.56 109.878 -179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -80.94 -9.69 59.8 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.214 -0.929 . . . . 2.36 109.837 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.41 -50.17 80.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 120.781 -1.199 . . . . 1.43 108.796 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -65.49 -40.11 92.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.842 -1.161 . . . . 1.77 110.199 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -69.97 -40.12 75.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.11 -0.993 . . . . 3.32 109.895 -179.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.544 ' OE2' ' NH1' ' A' ' 42' ' ' ARG . 28.1 mm-40 -68.37 -40.07 81.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 1.51 110.301 -179.242 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.1 t -59.95 -41.21 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.608 -1.256 . . . . 1.41 107.608 179.173 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -58.38 -37.97 76.34 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.563 -0.71 . . . . 1.81 109.626 -179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.544 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 99.3 mtt180 -58.7 -41.71 86.95 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.865 -1.134 . . . . 3.26 108.016 179.443 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -62.73 -47.88 81.65 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.409 -0.959 . . . . 0.81 108.409 178.243 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 65.8 tp -59.85 -49.06 79.17 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.901 -1.148 . . . . 1.59 107.901 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.1 t -60.58 -45.15 95.01 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.464 -0.939 . . . . 1.38 108.464 178.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.93 -43.89 97.66 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.151 -1.98 . . . . 0.87 108.151 178.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -63.26 -33.09 74.75 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.476 -1.014 . . . . 3.62 108.72 178.34 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.25 -39.94 84.39 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.553 -0.717 . . . . 1.43 109.57 -179.207 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 50' ' ' ALA . 26.1 ttmt -70.67 -74.03 0.15 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.258 -1.386 . . . . 3.08 107.258 178.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.59 -39.61 0.34 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.944 -0.472 . . . . 1.33 111.126 -178.763 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.4 t -56.25 -59.04 5.52 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.338 -1.477 . . . . 1.85 108.559 179.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.17 -39.98 90.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.367 -0.833 . . . . 1.35 111.105 -179.267 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -69.82 -40.7 75.74 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.837 -1.164 . . . . 2.34 110.471 -178.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.3 mt -62.49 -39.95 95.15 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.915 -1.116 . . . . 2.2 108.063 179.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -62.87 -38.43 90.85 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.375 -0.828 . . . . 1.35 109.194 178.762 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.7 m -64.01 -43.81 94.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 1.34 109.477 179.137 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.3 mt -61.69 -37.84 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 1.26 109.192 179.693 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -58.8 -50.21 74.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 1.7 109.56 -179.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -57.49 -33.69 68.28 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.494 -0.754 . . . . 1.35 110.676 -177.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.443 ' O ' ' OG1' ' A' ' 64' ' ' THR . 68.1 mttm -69.62 -37.96 77.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.225 -0.922 . . . . 2.08 109.366 -179.438 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.29 -48.6 69.87 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.34 -0.85 . . . . 1.21 109.762 -179.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.08 -55.67 22.88 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 120.169 -1.015 . . . . 0.75 110.572 -179.146 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -70.18 -43.59 70.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.085 -1.244 . . . . 1.59 111.016 -178.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 58.5 m -63.09 -62.81 1.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.0 -1.063 . . . . 1.41 111.617 -177.742 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -97.4 -43.53 7.25 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.954 -1.091 . . . . 0.79 111.541 -177.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.65 -171.4 24.4 Favored Glycine 0 N--CA 1.501 3.032 0 O-C-N 120.703 -1.248 . . . . 1.22 111.298 179.619 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -68.95 -23.02 64.09 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.816 -0.814 . . . . 5.81 109.59 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.512 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.9 tp10 -60.01 -34.3 73.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.807 -0.558 . . . . 3.37 110.741 -179.508 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -98.71 -18.86 17.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.199 -0.938 . . . . 2.37 109.62 -179.695 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -67.68 -39.44 84.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 1.65 109.916 -179.799 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.91 -34.21 76.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 1.42 110.304 -178.685 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 85.1 mt -59.77 -40.43 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.635 -1.291 . . . . 1.43 108.682 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -64.2 -38.74 92.14 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.1 -1.0 . . . . 1.08 110.175 179.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -59.06 -39.7 82.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.161 -0.962 . . . . 1.37 109.141 -179.602 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.0 -41.02 95.47 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.179 -1.568 . . . . 0.67 109.179 179.069 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -66.02 -49.65 66.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.998 -1.295 . . . . 1.99 108.472 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.2 mt -61.91 -49.32 84.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.577 -0.702 . . . . 1.22 109.372 179.279 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 40.5 ttp -59.93 -46.29 89.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.331 -0.855 . . . . 2.11 109.802 -179.698 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.41 ' CD1' ' CE2' ' B' ' 348' ' ' PHE . 57.1 tp -60.13 -41.49 92.77 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.353 -0.842 . . . . 1.33 109.347 179.698 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.2 -39.64 89.81 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.181 -0.608 . . . . 1.29 110.065 -178.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -79.12 2.76 19.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.188 -0.945 . . . . 1.47 109.37 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -51.14 129.41 24.17 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.296 -0.878 . . . . 1.47 110.415 -178.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.63 -16.54 39.68 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.8 -0.562 . . . . 1.78 110.138 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -74.13 -35.74 64.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.027 -1.045 . . . . 2.53 109.494 178.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.58 -41.06 72.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.453 -0.779 . . . . 1.36 110.754 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -60.01 -49.48 77.48 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.246 -0.909 . . . . 1.42 110.394 -178.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -69.77 -40.47 76.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 2.27 110.91 -178.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -67.9 -40.15 83.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.971 -1.081 . . . . 1.57 110.874 -178.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.93 -47.52 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.906 -1.121 . . . . 1.19 109.636 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -65.36 -38.57 82.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.618 -0.676 . . . . 1.39 110.263 179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.63 85.09 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.221 -0.924 . . . . 1.39 111.244 -178.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 96' ' ' LYS . 83.2 mt -59.87 -43.93 94.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.853 -1.154 . . . . 1.5 109.243 -179.043 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.8 mt -63.34 -48.49 87.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.437 -0.79 . . . . 1.29 109.501 179.424 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -68.57 -40.34 80.63 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.116 -0.99 . . . . 2.64 110.189 179.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.74 -52.43 7.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 1.65 111.604 -178.403 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 92' ' ' LEU . 98.5 mttt -91.15 -3.08 57.37 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.117 -0.99 . . . . 2.5 112.247 -177.805 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 80.0 m80 57.29 39.05 28.81 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.816 -1.177 . . . . 1.88 109.834 -179.421 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 94.2 mtp -89.2 170.04 10.94 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.37 -0.832 . . . . 1.71 110.079 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.0 p -80.46 156.52 26.55 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.954 -0.758 . . . . 1.61 108.954 179.586 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.91 -39.9 75.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.11 -0.994 . . . . 1.33 110.2 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.58 -42.57 96.97 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.062 -1.024 . . . . 2.07 110.459 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.71 -46.33 14.43 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.374 -0.829 . . . . 1.37 110.494 -179.253 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.06 -48.26 82.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.372 -0.83 . . . . 1.14 110.364 -179.157 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.97 -47.51 85.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.929 . . . . 1.26 110.522 -179.094 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -60.15 -35.21 74.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.997 -1.065 . . . . 2.02 110.392 -179.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.28 -39.91 88.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.012 -1.055 . . . . 1.33 110.559 -179.222 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.67 -50.09 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.803 -1.185 . . . . 1.3 110.973 -178.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.4 mm -68.96 -40.14 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 120.801 -1.187 . . . . 1.32 109.134 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -64.03 -38.32 90.65 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.799 -0.815 . . . . 2.44 108.799 178.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.97 -50.04 71.94 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 120.247 -0.977 . . . . 0.99 110.839 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -65.24 -53.43 44.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.866 -1.373 . . . . 1.97 110.484 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.54 -39.16 70.21 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.998 -1.064 . . . . 1.43 109.301 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.6 t -53.82 -40.66 66.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.295 -0.878 . . . . 2.12 108.663 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.84 70.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.505 -0.747 . . . . 1.64 109.483 179.025 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.0 mt -65.78 -43.84 87.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.026 -1.046 . . . . 1.93 109.818 -178.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.97 -38.5 82.71 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.499 -1.376 . . . . 2.2 108.912 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -54.74 -18.88 5.21 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.225 -0.922 . . . . 2.12 109.538 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.57 139.98 58.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.085 -1.009 . . . . 2.34 109.479 -179.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -90.9 11.45 22.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.254 -0.904 . . . . 3.23 109.714 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -99.01 117.0 32.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.151 -0.968 . . . . 2.49 109.207 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -60.2 -30.59 69.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.272 -0.892 . . . . 3.95 109.363 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.451 ' OH ' ' CA ' ' B' ' 315' ' ' HIS . 19.8 t80 -61.02 -42.08 97.79 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.995 0.902 . . . . 2.25 109.161 179.274 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.412 ' CD2' ' O ' ' B' ' 351' ' ' GLN . 74.9 mt -80.4 -26.9 38.25 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.975 -0.75 . . . . 2.27 108.975 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -60.07 -43.94 95.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.47 -0.937 . . . . 3.31 108.47 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -60.61 -45.61 93.35 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.115 -1.068 . . . . 2.73 108.115 178.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -60.68 -39.43 88.43 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.748 -0.781 . . . . 3.2 109.08 178.403 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.17 -28.27 66.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.388 -0.82 . . . . 1.66 109.162 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.31 -38.78 71.72 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.225 -0.922 . . . . 1.67 109.677 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.5 -40.58 95.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.025 -1.047 . . . . 1.55 110.466 -179.368 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.414 HG23 HE22 ' B' ' 351' ' ' GLN . 38.1 t -69.82 -42.0 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.873 -1.142 . . . . 1.32 109.801 -179.912 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -60.59 -38.6 85.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.762 -1.211 . . . . 3.58 109.407 179.427 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -58.68 -39.74 81.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.395 -0.816 . . . . 1.46 110.011 -178.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.99 -41.45 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.091 -1.005 . . . . 1.22 109.921 -179.611 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.94 -35.75 92.48 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.919 -1.272 . . . . 0.61 109.919 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -60.05 -48.57 81.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.318 -1.107 . . . . 3.1 110.995 -178.717 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.402 HH22 ' CB ' ' A' ' 166' ' ' SER . 98.0 mtt180 -67.69 -30.89 70.53 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.571 -1.331 . . . . 3.71 110.383 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.9 tp -58.53 -44.96 89.75 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.268 -1.012 . . . . 1.87 108.268 -179.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 66.1 mt -61.43 -43.97 97.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 1.29 110.192 178.631 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -70.02 -40.21 75.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.89 . . . . 3.05 109.891 -179.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -65.79 -37.92 87.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.671 -0.643 . . . . 1.26 111.048 -178.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.4 mt -66.98 -46.79 84.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 120.638 -1.289 . . . . 1.34 108.165 179.583 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 92.3 mt -70.16 -31.71 69.33 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.644 -0.66 . . . . 1.6 109.675 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.87 42.41 6.79 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.017 -1.633 . . . . 0.96 109.017 -178.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 tp -74.52 152.96 39.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.466 -1.02 . . . . 1.67 109.095 -179.654 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -64.23 143.24 58.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.083 -1.01 . . . . 4.96 109.626 -179.487 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.8 mt -115.4 121.77 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 CA-C-O 122.434 1.112 . . . . 1.68 109.22 179.279 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.2 mt -60.13 -47.74 90.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-N 115.019 -0.991 . . . . 2.14 110.858 -178.659 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.5 t0 62.92 106.04 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.615 -0.883 . . . . 1.5 108.615 -178.818 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.5 mt -69.33 0.3 5.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.296 -0.877 . . . . 1.39 110.174 -178.58 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 83.1 p -83.66 -13.87 53.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.048 -1.032 . . . . 1.83 110.379 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.64 28.23 0.49 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.112 -0.992 . . . . 1.46 111.916 -178.374 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 32.3 mm -90.58 118.15 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.484 -1.385 . . . . 1.42 108.405 179.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -104.88 -10.59 17.22 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.391 -0.818 . . . . 2.94 110.337 -178.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -126.48 150.94 48.42 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.097 -1.002 . . . . 1.52 109.832 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -63.98 133.02 52.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.436 -0.79 . . . . 1.58 109.731 -179.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.4 m -152.66 166.43 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.425 -0.797 . . . . 1.32 110.321 179.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 76.3 mt -95.82 147.86 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 105.994 -1.854 . . . . 1.27 105.994 177.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 48.7 tp -100.04 119.22 37.94 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.714 -1.241 . . . . 1.41 110.626 -177.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.84 129.96 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 107.978 -1.119 . . . . 1.23 107.978 178.64 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.46 161.96 35.55 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.125 -0.984 . . . . 1.32 109.069 -179.157 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.94 -37.25 75.82 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.111 -1.618 . . . . 1.49 107.294 178.412 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 13.1 p-10 -171.15 147.0 2.49 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.385 -0.598 . . . . 2.25 109.385 178.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.7 mt -106.04 141.36 37.55 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.336 -0.853 . . . . 1.35 108.926 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 82.1 p -94.38 144.66 28.35 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.22 -0.925 . . . . 1.56 108.828 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -40.13 -40.54 2.85 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.887 1.724 . . . . 0.87 112.268 179.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.402 ' CB ' HH22 ' A' ' 136' ' ' ARG . 61.4 m -60.42 -40.0 89.45 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.391 -0.818 . . . . 1.36 110.218 -179.646 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.45 -43.47 85.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.145 -0.972 . . . . 1.61 110.147 -179.099 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 40.2 p -55.67 -31.87 62.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.067 -1.021 . . . . 1.21 111.007 -178.007 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.73 -50.78 40.26 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.064 -1.023 . . . . 1.21 110.106 -179.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -88.7 39.36 0.92 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.482 -0.933 . . . . 2.11 108.482 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.5 tp -103.35 138.03 40.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.683 -0.636 . . . . 1.29 109.567 179.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -87.55 101.32 13.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.345 -0.847 . . . . 2.81 109.648 179.849 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 46.6 mt -64.23 -42.22 96.65 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.403 -0.811 . . . . 2.09 110.379 -179.34 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.53 -27.56 66.2 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.846 -1.158 . . . . 2.86 112.45 -177.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -92.69 -8.31 44.33 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.584 -1.322 . . . . 2.39 110.429 -178.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 68.9 t -107.7 119.83 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.198 -0.939 . . . . 1.27 108.959 179.112 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.1 mt -88.84 8.37 29.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.287 -0.883 . . . . 2.17 111.227 -177.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 167.58 175.14 37.23 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.535 -1.426 . . . . 0.52 109.535 179.346 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -134.79 130.04 35.5 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.365 -1.079 . . . . 0.55 108.62 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 95.7 mt -132.34 126.54 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.194 -0.941 . . . . 1.27 109.156 179.381 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 41.0 p -149.89 162.87 39.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.925 -1.109 . . . . 1.39 111.051 -179.696 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 183' ' ' ALA . 35.5 p-10 -106.19 23.23 14.4 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.787 -0.57 . . . . 2.46 109.505 -179.767 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -56.62 -161.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.778 -1.201 . . . . 1.51 111.588 -177.689 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.04 -56.54 5.71 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.772 -0.931 . . . . 2.23 110.772 -178.652 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 171.83 -142.37 6.89 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 118.612 -1.756 . . . . 2.23 111.349 -179.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.502 ' C ' ' H ' ' A' ' 188' ' ' SER . 97.3 mtt180 -69.66 -31.02 68.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.853 -0.793 . . . . 6.44 110.905 -178.535 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 82.5 p -62.62 2.17 0.31 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.0 -1.063 . . . . 4.09 109.803 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.502 ' H ' ' C ' ' A' ' 186' ' ' ARG . 78.4 p -91.71 139.71 30.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.937 -1.102 . . . . 2.2 110.552 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -55.5 -39.53 70.59 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.784 -0.821 . . . . 1.15 108.784 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.0 p -57.52 -41.42 80.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.613 -0.68 . . . . 2.01 109.543 -179.538 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 186' ' ' ARG . 82.8 p -69.28 -38.08 78.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.178 -0.951 . . . . 1.93 111.255 -179.402 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.12 -44.48 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.885 -1.134 . . . . 2.2 110.106 -178.375 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.1 mtp -61.41 -40.3 93.92 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.041 -1.037 . . . . 1.32 111.18 -179.374 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.82 -42.66 76.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.683 -1.26 . . . . 1.3 109.113 -179.776 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -59.99 -51.79 68.15 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.088 -1.007 . . . . 3.38 109.263 -179.267 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.0 m -68.5 -36.89 79.56 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.449 -0.782 . . . . 1.15 111.106 -179.128 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 87.6 mt -69.91 -27.89 65.16 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.984 -1.117 . . . . 1.28 107.984 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 63.54 50.0 2.93 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.147 0.499 . . . . 1.5 110.587 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.477 ' O ' ' CB ' ' A' ' 8' ' ' SER . 77.0 mt -130.64 147.86 67.77 Favored Pre-proline 0 N--CA 1.505 2.285 0 N-CA-C 108.401 -0.963 . . . . 1.37 108.401 178.501 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -44.82 126.23 7.21 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.163 1.909 . . . . 0.76 112.65 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.32 139.85 12.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.537 -1.352 . . . . 1.19 111.963 179.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.6 mt -125.28 146.05 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.287 -1.375 . . . . 1.31 107.287 178.147 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.4 -4.82 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 120.84 -1.163 . . . . 1.38 110.588 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.91 21.21 27.9 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 110.831 -0.908 . . . . 1.03 110.831 -179.08 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.1 p -45.01 -41.06 7.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.03 -1.277 . . . . 1.38 110.261 -179.516 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.83 -50.98 3.79 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.201 -0.999 . . . . 1.17 111.005 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.3 t -158.57 38.45 0.23 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.588 -1.536 . . . . 2.07 111.354 -179.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.9 t -76.65 -39.38 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.819 -1.175 . . . . 1.35 108.967 178.582 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.8 p -57.09 -39.79 75.71 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.648 -0.657 . . . . 1.49 111.174 -177.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.0 p -80.03 -13.41 59.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.014 -1.053 . . . . 2.16 110.129 -178.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -95.51 -14.58 23.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.119 -0.988 . . . . 2.89 109.882 -179.404 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 55.1 t -114.16 152.74 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.358 -0.839 . . . . 1.33 110.994 -178.845 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -122.12 158.57 29.02 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.875 -1.158 . . . . 2.73 107.875 179.179 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 13.0 t-20 -54.69 140.36 35.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.177 -0.952 . . . . 2.7 111.075 -179.04 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.7 t70 84.38 10.58 0.39 Allowed 'General case' 0 N--CA 1.504 2.249 0 CA-C-O 120.991 0.424 . . . . 2.38 110.88 179.105 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -80.1 139.75 36.73 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.923 -1.11 . . . . 2.09 109.049 179.211 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -87.44 128.07 35.22 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.034 -1.098 . . . . 1.45 108.034 179.154 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 58.3 mt -131.71 138.76 48.8 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.199 -0.938 . . . . 1.31 110.532 -178.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 219' ' ' ILE . 71.9 mt -111.61 125.48 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.484 -1.673 . . . . 1.29 106.484 176.802 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 29.8 tp -103.51 119.74 39.49 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.861 -1.149 . . . . 1.31 108.944 -179.234 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.56 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 23.2 p-10 -81.51 -37.13 28.35 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.048 -1.093 . . . . 2.31 108.048 178.966 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.448 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 46.86 17.93 0.06 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.732 -0.84 . . . . 1.19 108.732 -179.304 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 221' ' ' ASP . 55.3 t -135.96 -41.02 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.912 -1.144 . . . . 1.45 107.912 178.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -97.75 1.09 48.07 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.623 -1.251 . . . . 3.13 107.623 178.386 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.535 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 29.7 t-20 60.53 42.96 13.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.753 -0.592 . . . . 2.2 109.964 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.56 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 92.0 mt-30 -140.94 148.26 40.11 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.177 -0.952 . . . . 2.32 109.611 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -120.06 126.56 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.115 -1.068 . . . . 1.4 108.115 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -98.67 126.23 44.21 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.526 -1.287 . . . . 1.29 107.526 178.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.86 125.1 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.634 -0.666 . . . . 1.38 110.177 -177.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 53.78 68.4 2.86 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.135 -0.978 . . . . 2.33 108.839 -179.656 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -91.22 131.5 1.42 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 123.25 2.634 . . . . 0.95 112.588 -178.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 23.5 m -63.54 166.51 6.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.315 -0.866 . . . . 2.31 109.769 -179.232 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -60.04 -40.08 88.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.134 -0.979 . . . . 3.45 110.045 -179.311 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -64.55 -32.18 73.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.965 -1.084 . . . . 2.89 110.092 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.53 -39.61 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.058 -1.026 . . . . 1.73 108.532 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.8 mt . . . . . 0 C--N 1.303 -1.424 0 O-C-N 121.377 -0.827 . . . . 1.57 109.022 179.219 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' B' B ' 301' ' ' MET . . . . . 0.415 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 37.0 ttp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.407 0.622 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . 0.415 ' N ' ' CG ' ' B' ' 301' ' ' MET . 16.8 t80 -152.44 148.8 27.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.353 -0.842 . . . . 0.0 108.871 179.552 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -152.36 163.59 39.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.889 -1.132 . . . . 0.0 110.573 -179.317 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -156.81 153.57 28.5 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.618 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 56.4 mp0 -115.08 130.9 57.04 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.203 -0.936 . . . . 0.0 109.414 179.029 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.55 125.32 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.425 0 CA-C-O 122.371 1.082 . . . . 0.0 111.435 -178.13 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 36.6 m -81.07 103.65 11.02 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.913 0.863 . . . . 0.0 111.114 -178.02 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . 0.454 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.6 mt -52.22 121.5 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.456 1.122 . . . . 0.0 110.952 -177.627 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 74.1 p -106.33 18.01 22.6 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.066 -178.427 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.32 118.89 71.45 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.65 -1.281 . . . . 0.0 109.221 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -52.41 -15.01 3.42 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 CA-C-N 120.176 1.098 . . . . 0.0 112.569 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -118.91 8.52 11.71 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.54 177.89 31.98 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -179.298 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.435 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -85.93 93.19 8.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -1.184 . . . . 0.0 108.527 -179.192 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . 0.451 ' CA ' ' OH ' ' A' ' 122' ' ' TYR . 4.1 p80 -96.66 -160.15 0.78 Allowed 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.109 -0.994 . . . . 0.0 109.958 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.3 m -59.38 -43.12 92.96 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.831 -1.168 . . . . 0.0 112.146 -176.032 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.512 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 2.5 tpt180 -57.56 -61.82 6.51 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.453 -1.404 . . . . 0.0 111.703 -178.485 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . 0.405 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 13.8 Cg_endo -59.42 -32.99 97.4 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 CA-C-N 119.932 1.011 . . . . 0.0 111.516 -179.431 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.27 -51.53 69.14 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.162 -0.961 . . . . 0.0 109.072 179.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.2 -41.71 62.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -0.85 . . . . 0.0 109.587 -178.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -71.33 -40.03 71.0 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -61.95 -54.78 37.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.426 -0.796 . . . . 0.0 109.784 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 89.8 t -61.33 -26.56 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.957 -1.09 . . . . 0.0 110.173 -178.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -63.02 -44.24 96.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.426 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -69.89 -40.14 75.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.383 -0.823 . . . . 0.0 111.731 -178.027 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' B' ' 328' ' ' GLY . . . -65.53 -55.86 15.49 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.3 -1.5 . . . . 0.0 111.924 -178.354 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -48.21 -10.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.033 -1.042 . . . . 0.0 110.281 -178.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' B' ' 326' ' ' ALA . . . -81.63 -15.35 76.01 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.23 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -107.07 140.42 39.91 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.377 -1.072 . . . . 0.0 109.255 179.433 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 16.9 m -91.31 -11.64 37.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 110.238 -179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 331' ' ' SER . . . . . 0.7 ' HG ' ' H ' ' B' ' 369' ' ' ASP . 35.9 m -64.77 155.11 34.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.759 -1.213 . . . . 0.0 109.591 179.656 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -70.76 133.83 46.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.89 -1.131 . . . . 0.0 108.315 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 90.2 mt -131.79 133.5 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-O 121.362 0.601 . . . . 0.0 109.954 -179.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.4 m -130.08 148.61 51.95 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.445 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 79.7 t -120.29 114.96 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 177.459 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 92.7 m -105.46 124.95 50.4 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.227 -0.92 . . . . 0.0 109.709 -178.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 48.4 t -134.35 120.5 19.97 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.139 0.971 . . . . 0.0 111.59 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 66.6 t30 45.37 50.99 9.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 176.717 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.7 -11.97 68.62 Favored Glycine 0 N--CA 1.501 3.031 0 O-C-N 120.155 -1.591 . . . . 0.0 113.15 176.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . 0.459 ' HB2' ' HZ1' ' B' ' 340' ' ' LYS . 3.0 ttmp? -126.44 138.87 53.58 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 119.389 1.594 . . . . 0.0 109.432 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 60.2 p -130.58 152.69 49.67 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.118 0.961 . . . . 0.0 111.236 -178.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -143.31 163.59 32.59 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.494 0.664 . . . . 0.0 109.52 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 10.8 t -87.52 135.89 33.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.637 -0.665 . . . . 0.0 110.821 -178.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.551 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -68.06 -21.31 65.0 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.107 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -80.3 25.18 0.41 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.037 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.551 ' H ' ' C ' ' B' ' 344' ' ' ALA . 58.4 m -152.92 92.94 1.69 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.814 -1.154 . . . . 0.0 113.266 -178.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 57.8 tp -59.53 -34.26 72.41 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 177.225 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . 0.41 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 55.4 m-85 -58.81 -53.3 59.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.707 -0.621 . . . . 0.0 110.264 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -78.26 -16.45 57.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.771 -1.206 . . . . 0.0 110.619 -177.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.604 ' O ' ' N ' ' B' ' 352' ' ' THR . 26.4 mt -69.64 -56.16 8.02 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.146 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.414 HE22 HG23 ' A' ' 130' ' ' VAL . 30.3 mt-30 -40.82 -12.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.103 -178.62 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.604 ' N ' ' O ' ' B' ' 350' ' ' LEU . 59.2 p -90.82 -8.19 50.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.52 -1.362 . . . . 0.0 109.954 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 85.0 mt -96.74 121.1 38.22 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.092 -1.005 . . . . 0.0 109.384 179.371 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.5 90.53 0.94 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 20.2 mt -99.79 91.94 5.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.19 -1.182 . . . . 0.0 108.855 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 38.0 p -94.01 -179.19 4.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.276 -0.89 . . . . 0.0 110.545 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -69.84 110.1 4.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.849 -0.532 . . . . 0.0 110.118 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 104.16 9.72 35.94 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 28.4 m -84.76 110.77 19.04 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.156 -1.202 . . . . 0.0 110.888 -179.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 27.2 t -77.12 111.86 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 122.237 1.018 . . . . 0.0 109.747 -177.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 17.5 m -109.03 175.02 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 32.3 m -131.79 128.61 39.15 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 95.0 mt -103.33 115.41 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.521 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 77.3 p -120.13 132.65 55.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.393 -0.817 . . . . 0.0 109.128 -179.356 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.81 152.61 40.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.898 . . . . 0.0 108.949 -179.057 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -147.71 125.45 11.87 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.16 -0.963 . . . . 0.0 109.471 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.495 ' O ' ' OE1' ' B' ' 370' ' ' GLU . . . 154.02 -148.97 20.26 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.277 -1.44 . . . . 0.0 111.532 179.824 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -60.02 -51.69 68.56 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.7 ' H ' ' HG ' ' B' ' 331' ' ' SER . 89.1 m-20 -112.71 13.77 19.89 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 120.835 -1.165 . . . . 0.0 111.267 -177.681 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.584 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 1.0 OUTLIER -42.39 -32.57 0.54 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.271 -0.893 . . . . 0.0 111.477 -179.011 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . 0.553 ' H ' ' CD ' ' B' ' 370' ' ' GLU . 10.3 pt20 -70.94 -43.2 68.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.853 -1.154 . . . . 0.0 110.205 -178.745 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -69.43 -54.25 15.26 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.377 -0.827 . . . . 0.0 109.159 179.473 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.86 -34.51 8.93 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.621 -0.674 . . . . 0.0 112.252 -178.398 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 69.4 t -80.99 -36.29 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.468 -1.395 . . . . 0.0 108.926 178.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -70.89 -38.97 73.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.657 -0.652 . . . . 0.0 111.269 179.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -82.54 -48.98 10.39 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.798 -1.189 . . . . 0.0 111.694 -178.235 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.02 -30.68 69.33 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.164 -0.96 . . . . 0.0 109.464 -179.096 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 55.0 t -79.78 -31.62 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 0.0 109.416 179.25 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -77.35 -22.22 52.11 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.689 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 31.9 tp -78.25 -67.76 0.7 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 5.6 ttp -56.01 -22.99 30.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.925 . . . . 0.0 109.788 -178.619 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.83 -22.2 58.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.928 -1.108 . . . . 0.0 108.705 177.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -104.21 2.52 31.81 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.42 -0.8 . . . . 0.0 111.677 -178.362 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 85.0 mt -85.03 125.47 32.76 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.219 -1.551 . . . . 0.0 109.739 179.739 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.052 179.004 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.2 mtp . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.255 -0.646 . . . . 3.19 109.255 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.446 ' O ' ' O ' ' A' ' 225' ' ' ASN . 89.8 mt -107.58 129.02 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.613 -0.884 . . . . 1.71 108.613 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.9 m -130.76 141.45 50.36 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.606 -0.684 . . . . 1.66 109.744 -179.653 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.689 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -138.07 -165.04 10.2 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 108.291 -1.924 . . . . 1.05 108.291 179.122 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.8 mt -91.99 -10.83 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.888 -1.36 . . . . 1.59 110.377 -179.05 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 5' ' ' ILE . 34.9 tp 52.62 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.973 -1.08 . . . . 1.47 108.839 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.59 -34.25 23.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 1.39 109.042 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -143.4 132.33 11.45 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.416 -0.803 . . . . 2.09 108.881 179.509 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.92 147.19 18.91 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.193 1.929 . . . . 0.91 113.477 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 165.53 -164.66 37.43 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.576 -1.41 . . . . 0.92 109.576 179.474 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.42 HD12 HG21 ' A' ' 11' ' ' ILE . 65.5 mt -146.45 147.82 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.26 -1.141 . . . . 1.35 108.741 179.053 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.91 154.64 31.53 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.541 -1.35 . . . . 1.14 110.979 -179.618 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.5 m-85 -136.31 129.26 31.15 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 108.245 -1.02 . . . . 0.7 108.245 178.819 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.5 -179.7 45.65 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.577 -1.773 . . . . 0.58 110.802 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -80.4 152.85 28.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.613 -0.934 . . . . 2.63 108.95 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.24 132.0 44.87 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.093 -1.004 . . . . 1.27 110.906 -178.078 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.4 tp -100.37 133.61 44.54 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.389 -1.338 . . . . 1.41 107.389 178.084 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.1 tp -115.43 121.34 42.46 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.207 -0.933 . . . . 1.49 109.949 -179.025 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 66.8 mt -91.29 106.22 18.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.521 -0.737 . . . . 1.52 109.881 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.475 ' NZ ' ' CB ' ' A' ' 20' ' ' LYS . 7.8 mtpm? -101.87 137.69 39.83 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.89 -0.781 . . . . 3.17 108.89 179.234 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 55.4 mp0 -127.81 128.76 45.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.373 -0.829 . . . . 3.0 108.795 179.689 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -71.89 149.85 44.77 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.044 -1.035 . . . . 2.77 108.474 179.639 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -67.52 139.98 57.0 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.924 -1.11 . . . . 2.94 108.576 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.8 mt -80.17 130.27 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 1.46 109.172 -179.463 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.1 t -99.24 129.75 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.203 -0.936 . . . . 1.7 111.08 -178.413 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.0 mt -109.85 131.21 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.654 -0.869 . . . . 1.54 108.654 179.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -81.61 127.37 32.8 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.878 -1.139 . . . . 1.81 109.815 -179.449 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.483 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.6 mmt-85 -90.75 -5.72 55.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.514 -0.742 . . . . 3.23 109.221 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -70.76 139.95 51.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 3.29 109.548 -179.668 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -80.96 151.97 28.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 2.8 109.027 179.184 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.2 pt -93.68 165.08 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 1.43 109.884 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.8 p -98.22 168.72 10.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.997 -1.064 . . . . 1.54 108.952 178.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.15 -13.65 39.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.126 -0.984 . . . . 1.6 110.104 -179.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -86.1 -30.19 22.75 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.678 -1.23 . . . . 2.56 107.678 178.511 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -83.38 -7.58 59.54 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.515 -0.55 . . . . 2.36 109.515 179.082 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 t -64.97 -56.33 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.734 -1.229 . . . . 1.43 109.174 179.719 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.06 -39.91 87.62 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.236 -0.915 . . . . 1.77 109.472 179.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -70.22 -41.06 74.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 3.32 110.688 -179.254 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -65.3 -39.98 93.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.031 -1.043 . . . . 1.51 110.134 -179.442 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.94 -44.58 94.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.882 -1.136 . . . . 1.41 107.96 179.424 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -59.91 -38.96 83.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.14 -0.975 . . . . 1.81 108.978 179.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -59.87 -43.03 94.93 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.635 -1.246 . . . . 3.26 107.635 179.335 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.96 -49.28 78.29 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.229 -1.026 . . . . 0.81 108.229 178.053 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.6 tp -60.0 -47.99 83.53 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.954 -0.758 . . . . 1.59 108.954 179.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.5 t -60.75 -44.5 96.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.949 -1.094 . . . . 1.38 108.782 178.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.09 -41.29 98.0 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.723 -2.151 . . . . 0.87 107.723 178.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -64.35 -34.86 79.12 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.557 -0.967 . . . . 3.62 108.514 178.26 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.445 ' O ' ' OG ' ' A' ' 51' ' ' SER . . . -54.48 -42.72 71.03 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.482 -0.761 . . . . 1.43 109.523 -179.286 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.457 ' HZ3' ' CA ' ' A' ' 140' ' ' ASN . 19.7 ttpp -73.9 -73.06 0.24 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.629 -1.249 . . . . 3.08 107.629 179.368 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.57 -34.24 0.09 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.445 -0.784 . . . . 1.33 111.035 -178.852 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 48' ' ' ALA . 90.3 p -57.43 -57.4 12.82 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.576 -1.327 . . . . 1.85 107.699 179.17 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.83 80.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.604 -0.685 . . . . 1.35 111.604 -179.2 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -68.86 -40.28 79.41 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.562 -1.337 . . . . 2.34 110.314 -178.646 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.49 -40.13 89.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.01 -1.056 . . . . 2.2 108.801 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.485 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 65.3 mm-40 -62.87 -40.0 96.15 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.251 -0.906 . . . . 1.35 109.11 179.104 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.463 ' CG2' ' NZ ' ' A' ' 60' ' ' LYS . 94.8 m -63.08 -39.92 96.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 1.34 110.133 179.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.0 mt -61.15 -40.98 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.012 -1.055 . . . . 1.26 108.973 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.485 ' NZ ' ' OE1' ' A' ' 55' ' ' GLU . 5.4 ttpm? -59.91 -50.45 73.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.279 -0.888 . . . . 1.7 110.103 -179.641 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -60.14 -39.98 88.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 1.35 110.841 -177.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.463 ' NZ ' ' CG2' ' A' ' 56' ' ' THR . 24.3 mttp -62.82 -38.66 91.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -0.911 . . . . 2.08 109.442 179.684 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.24 -39.97 96.11 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.541 -0.724 . . . . 1.21 109.435 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.63 -55.99 23.98 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.309 -1.516 . . . . 0.75 109.309 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.07 -49.86 72.86 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.973 -1.31 . . . . 1.59 109.694 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.1 m -65.8 -61.36 2.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.067 -1.02 . . . . 1.41 111.679 -177.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -94.73 -56.24 2.85 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.996 -1.065 . . . . 0.79 111.256 -178.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.4 -165.21 26.79 Favored Glycine 0 N--CA 1.5 2.956 0 C-N-CA 119.811 -1.185 . . . . 1.22 111.131 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -70.01 -25.77 63.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.935 -0.744 . . . . 5.81 110.553 -179.115 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.43 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.6 tp10 -60.29 -37.45 80.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.039 -1.038 . . . . 3.37 110.162 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -100.22 -19.86 16.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.397 -0.814 . . . . 2.37 110.72 -179.179 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -69.92 -42.96 72.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.793 -1.192 . . . . 1.65 110.174 -179.427 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.22 -30.72 70.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.505 -0.747 . . . . 1.42 109.499 -179.315 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 80.0 mt -60.1 -43.18 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.107 -0.996 . . . . 1.43 109.872 -179.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -74.84 -30.61 61.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.242 -0.911 . . . . 1.08 110.579 -178.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.518 ' CD ' ' HZ3' ' B' ' 324' ' ' LYS . 64.8 tt0 -61.57 -39.93 92.92 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.814 -1.179 . . . . 1.37 109.522 178.674 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.23 -46.95 93.44 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.87 -1.692 . . . . 0.67 108.87 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -60.01 -44.44 94.58 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.343 -1.093 . . . . 1.99 108.515 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.4 mt -62.75 -50.02 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 109.053 -0.721 . . . . 1.22 109.053 179.35 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -60.01 -40.59 89.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 2.11 109.54 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.8 tp -63.86 -40.03 95.6 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.518 -0.739 . . . . 1.33 109.552 179.335 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -68.85 -38.42 79.76 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.768 -0.583 . . . . 1.29 110.437 -178.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.34 0.36 29.33 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.017 -1.052 . . . . 1.47 110.048 -179.292 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.7 t0 -47.78 130.86 14.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.201 -0.937 . . . . 1.47 110.38 -178.934 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.41 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 93.9 mt-10 -61.94 -18.54 60.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.659 . . . . 1.78 111.086 -179.192 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.88 -33.72 66.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.818 -1.176 . . . . 2.53 108.855 178.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.07 -41.01 74.68 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.099 -0.704 . . . . 1.36 109.099 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.88 -48.68 80.7 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.216 -0.928 . . . . 1.42 110.76 -179.13 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.23 -39.99 74.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.415 -0.803 . . . . 2.27 111.076 -178.579 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -69.81 -39.93 76.24 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.277 -0.89 . . . . 1.57 110.839 -178.581 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.9 mt -69.02 -41.57 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.28 -0.888 . . . . 1.19 109.398 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.416 HG23 ' HZ1' ' A' ' 94' ' ' LYS . 82.4 mt -69.73 -39.68 78.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.505 -0.747 . . . . 1.39 110.3 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.0 -42.88 99.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.222 -0.924 . . . . 1.39 111.208 -178.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 49.1 mt -60.81 -46.97 88.44 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.709 -1.245 . . . . 1.5 109.372 -179.694 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.3 mt -60.17 -49.2 85.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.851 0.834 . . . . 1.29 108.9 179.509 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.416 ' HZ1' HG23 ' A' ' 90' ' ' ILE . 40.5 mttp -69.98 -40.53 75.3 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.909 -0.495 . . . . 2.64 111.309 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -81.02 -57.0 3.73 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.952 -1.092 . . . . 1.65 112.099 -177.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -90.95 0.08 57.61 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.093 -1.004 . . . . 2.5 112.603 -176.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 54.6 m80 58.29 39.76 25.27 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.928 -1.108 . . . . 1.88 109.877 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.0 mtp -89.54 166.85 13.4 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.516 -0.74 . . . . 1.71 110.036 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.6 p -80.37 159.67 25.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.365 -0.835 . . . . 1.61 108.923 179.491 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.67 -40.06 80.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.113 -0.992 . . . . 1.33 109.965 -179.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 32.2 p-10 -68.0 -37.12 81.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 2.07 109.57 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.503 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -81.56 -41.38 21.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 1.37 109.824 179.216 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.03 -47.68 73.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.277 -0.889 . . . . 1.14 109.705 -179.686 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.86 87.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.115 -0.991 . . . . 1.26 109.543 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -59.89 -40.09 87.54 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.337 -0.852 . . . . 2.02 110.12 -179.244 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -60.92 -44.17 97.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.347 -0.846 . . . . 1.33 110.792 -179.365 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.6 t -61.54 -50.47 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.16 -0.963 . . . . 1.3 111.009 -177.847 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.5 mm -69.32 -39.88 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.021 -1.049 . . . . 1.32 108.637 179.493 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -61.53 -40.0 93.07 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.869 -0.789 . . . . 2.44 108.869 179.198 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.56 -48.41 84.84 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.534 -0.841 . . . . 0.99 111.235 -178.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -69.15 -49.85 53.11 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.686 -1.479 . . . . 1.97 110.827 -178.335 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.98 87.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.916 -1.115 . . . . 1.43 109.559 -179.257 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 40.8 t -59.45 -40.08 85.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.019 -1.05 . . . . 2.12 108.995 179.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.56 -43.85 96.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.3 -0.875 . . . . 1.64 109.2 179.451 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.7 mt -61.7 -41.0 97.02 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.33 -0.856 . . . . 1.93 109.45 -178.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -59.99 -37.77 80.63 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.076 -1.015 . . . . 2.2 109.483 -179.291 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -52.06 -22.18 3.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.043 -1.036 . . . . 2.12 109.169 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 49.7 mt -62.32 140.1 58.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.051 -1.031 . . . . 2.34 109.01 -179.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -89.93 38.01 0.91 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.127 -0.983 . . . . 3.23 110.249 -178.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 57.9 t0 -129.8 145.95 51.56 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.344 -0.848 . . . . 2.49 109.228 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 124' ' ' LYS . 88.0 tt0 -72.71 -66.52 0.65 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.412 -0.805 . . . . 3.95 109.1 179.656 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 121' ' ' GLU . 3.5 t80 -38.71 -36.19 0.24 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.789 -0.569 . . . . 2.25 110.622 -178.874 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.0 mt -79.24 -34.76 42.42 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.736 -1.228 . . . . 2.27 108.569 179.192 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 121' ' ' GLU . 7.4 ttpm? -68.17 -39.99 82.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 3.31 109.546 179.473 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.89 -40.31 94.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 2.73 109.265 -179.615 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.524 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -60.84 -38.23 84.79 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.429 -0.952 . . . . 3.2 108.429 -179.892 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.33 -26.92 65.44 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.518 -0.919 . . . . 1.66 108.518 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.47 -39.99 81.18 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.447 -0.946 . . . . 1.67 108.447 178.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -66.84 -42.72 85.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.505 -0.747 . . . . 1.55 109.998 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.23 -41.25 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 1.32 108.922 179.448 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -60.64 -39.92 90.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.072 -1.017 . . . . 3.58 108.817 178.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -60.15 -34.43 73.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.57 -0.706 . . . . 1.46 109.617 -179.72 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.1 -43.09 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.135 -0.978 . . . . 1.22 109.55 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.92 -27.61 62.24 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.838 -1.305 . . . . 0.61 109.838 -179.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -59.98 -50.19 74.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.981 -1.305 . . . . 3.1 110.094 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -67.75 -32.11 72.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.999 -1.063 . . . . 3.71 109.348 -179.619 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.39 -41.67 89.94 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.914 -0.773 . . . . 1.87 108.914 -179.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.3 -40.01 94.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.967 . . . . 1.29 109.182 179.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -70.04 -40.06 75.38 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.971 0.891 . . . . 3.05 108.729 179.104 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.476 HD21 ' N ' ' A' ' 140' ' ' ASN . 2.2 m120 -60.74 -38.23 84.47 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 116.002 -0.544 . . . . 1.26 111.466 -178.539 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 141' ' ' ILE . 97.3 mt -70.33 -39.94 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.811 -1.181 . . . . 1.34 109.811 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 54.2 mt -71.85 -20.56 61.8 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.397 -0.814 . . . . 1.6 110.241 -178.555 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.9 40.84 13.5 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.044 -1.622 . . . . 0.96 109.044 -179.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 tp -75.24 149.98 38.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.362 -1.081 . . . . 1.67 109.859 -179.361 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -74.71 141.79 44.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.513 -0.742 . . . . 4.96 109.949 -179.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.428 HG23 HD11 ' A' ' 146' ' ' ILE . 96.7 mt -111.3 129.77 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 122.29 1.043 . . . . 1.68 108.84 178.802 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 15.0 mt -69.66 -39.96 78.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 115.411 -0.813 . . . . 2.14 110.398 -177.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.8 t0 68.18 127.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.741 -0.837 . . . . 1.5 108.741 -179.251 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.5 mt -92.03 0.04 57.47 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.316 -0.865 . . . . 1.39 110.266 -178.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 24.5 t -95.61 -11.79 26.7 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.041 -1.037 . . . . 1.83 110.185 -179.683 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.24 15.48 1.55 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.066 -1.021 . . . . 1.46 111.333 -178.581 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.8 mp -86.1 137.14 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.446 -1.409 . . . . 1.42 108.417 179.517 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -111.95 -10.45 13.96 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.537 -0.727 . . . . 2.94 109.356 -179.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -123.21 148.0 46.29 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.744 -0.597 . . . . 1.52 109.775 -179.522 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.33 138.91 58.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.449 -0.782 . . . . 1.58 109.164 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.5 m -152.59 166.65 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.658 -0.652 . . . . 1.32 109.804 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.416 HD12 HG21 ' A' ' 157' ' ' ILE . 92.9 mt -96.51 146.07 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 106.191 -1.781 . . . . 1.27 106.191 176.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.1 tp -96.69 118.33 32.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.891 -1.13 . . . . 1.41 110.94 -177.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.0 t -119.6 123.25 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 109.015 -0.735 . . . . 1.23 109.015 179.095 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -153.06 159.97 42.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 1.32 109.012 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.27 -31.35 64.02 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.346 -1.472 . . . . 1.49 108.956 179.287 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 46.2 t0 -169.97 140.51 2.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.415 -0.803 . . . . 2.25 108.933 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.488 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 26.5 mt -114.77 131.55 56.75 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.371 -0.831 . . . . 1.35 109.031 -179.582 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.9 p -95.07 148.6 34.95 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.132 -0.98 . . . . 1.56 110.128 -179.526 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -37.32 -39.06 0.56 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.652 2.235 . . . . 0.87 112.56 179.19 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.3 m -57.58 -39.87 77.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.282 -0.886 . . . . 1.36 108.93 -179.052 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -69.9 -39.9 75.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.169 -0.957 . . . . 1.61 109.666 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 45.7 p -56.57 -24.01 44.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.033 -1.042 . . . . 1.21 110.51 -178.23 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.39 -55.78 4.96 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.967 -1.083 . . . . 1.21 109.358 179.432 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -83.84 40.78 0.76 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.98 -1.119 . . . . 2.11 107.98 179.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 35.1 tp -103.37 130.14 50.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.739 -0.601 . . . . 1.29 109.611 179.501 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.489 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 10.6 p-10 -86.15 97.92 10.61 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.954 -1.128 . . . . 2.81 107.954 178.243 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 56.3 mt -67.5 -41.49 84.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 2.09 111.119 -178.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -69.91 -26.83 64.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.658 -1.276 . . . . 2.86 112.222 -177.747 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -92.0 -5.94 52.1 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.556 -1.34 . . . . 2.39 109.513 -178.793 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.466 ' CG1' ' O ' ' A' ' 178' ' ' GLY . 60.9 t -107.28 119.66 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.688 -1.227 . . . . 1.27 107.688 178.168 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.1 mt -84.7 7.21 21.24 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.379 -0.825 . . . . 2.17 110.675 -177.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.466 ' O ' ' CG1' ' A' ' 176' ' ' VAL . . . 163.53 178.11 36.94 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.192 -1.563 . . . . 0.52 109.192 179.781 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -134.46 130.43 36.72 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.393 -1.063 . . . . 0.55 109.038 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 91.5 mt -130.63 125.2 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.204 -1.035 . . . . 1.27 108.204 178.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 65.6 p -149.69 160.32 43.62 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.845 -1.159 . . . . 1.39 110.682 -179.073 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.413 ' OD1' ' C ' ' A' ' 182' ' ' ASP . 4.1 p30 -108.69 27.19 9.68 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.513 -0.921 . . . . 2.46 108.513 179.283 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.25 -164.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.122 -0.986 . . . . 1.51 112.079 -177.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.63 -79.89 0.09 OUTLIER Glycine 0 N--CA 1.492 2.387 0 CA-C-N 115.793 -0.64 . . . . 2.23 111.579 -178.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.13 -151.64 6.07 Favored Glycine 0 N--CA 1.494 2.553 0 O-C-N 120.711 -1.464 . . . . 2.23 111.17 -178.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.436 ' O ' ' OG ' ' A' ' 191' ' ' SER . 47.6 ttt180 -79.73 -9.97 59.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.828 -0.807 . . . . 6.44 110.553 -178.448 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.9 p -84.55 3.12 38.09 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.101 -1.0 . . . . 4.09 110.856 -178.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.3 t -72.02 143.07 49.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.827 -1.17 . . . . 2.2 110.18 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -49.55 -50.21 43.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.235 -0.916 . . . . 1.15 110.128 -179.302 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.3 m -59.86 -40.23 87.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.368 -0.832 . . . . 2.01 110.32 -178.642 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 186' ' ' ARG . 52.2 p -59.93 -40.17 87.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.933 -1.104 . . . . 1.93 110.453 -178.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.0 -38.92 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.935 . . . . 2.2 109.526 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.5 mtp -60.25 -39.89 88.36 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.858 . . . . 1.32 110.207 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.12 -45.71 83.25 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.834 -1.166 . . . . 1.3 109.725 -179.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.36 -49.79 76.19 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.077 -1.049 . . . . 3.38 110.298 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 30.6 m -69.94 -34.7 73.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.715 -1.24 . . . . 1.15 110.525 -179.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 84.4 mt -72.67 -21.59 61.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.009 -1.057 . . . . 1.28 108.973 179.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 62.15 50.79 3.8 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.395 0.617 . . . . 1.5 110.886 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 96.5 mt -126.35 149.96 68.8 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 107.468 -1.308 . . . . 1.37 107.468 178.355 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.3 135.5 50.55 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 122.25 1.967 . . . . 0.76 111.845 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.99 149.97 3.72 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.595 -1.242 . . . . 1.19 111.941 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 202' ' ' ILE . 97.0 mt -126.54 146.03 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.787 -1.19 . . . . 1.31 107.787 179.147 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.48 -9.25 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 120.86 -1.15 . . . . 1.38 111.547 -179.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.58 23.83 23.45 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 110.048 -1.221 . . . . 1.03 110.048 -179.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.9 p -45.55 -45.98 13.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.189 -1.183 . . . . 1.38 109.987 -179.644 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 93.47 -54.77 2.39 Favored Glycine 0 N--CA 1.503 3.119 0 O-C-N 121.017 -1.052 . . . . 1.17 112.025 178.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 93.3 p -152.76 29.58 0.52 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.551 -1.558 . . . . 2.07 111.248 -179.042 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 76.2 t -76.26 -34.95 26.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.948 -1.095 . . . . 1.35 108.957 178.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.6 p -57.46 -30.44 65.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.461 -0.774 . . . . 1.49 110.291 -179.124 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 57.5 p -83.77 -15.18 49.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.783 -1.198 . . . . 2.16 110.06 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -96.21 -12.75 24.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.09 -1.006 . . . . 2.89 109.953 -179.587 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 73.9 t -103.73 136.65 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.363 -0.836 . . . . 1.33 110.38 -178.479 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -110.1 150.1 29.08 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.748 -1.204 . . . . 2.73 107.748 178.803 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.67 ' N ' HD21 ' A' ' 214' ' ' ASN . 0.0 OUTLIER -58.6 137.08 57.71 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.902 -1.124 . . . . 2.7 110.053 -179.355 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.4 m-20 85.64 0.04 0.73 Allowed 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.2 0.524 . . . . 2.38 110.025 179.722 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 60.1 t0 -70.67 144.1 51.16 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.193 -0.942 . . . . 2.09 109.246 179.416 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.402 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 40.9 t80 -93.77 120.27 33.82 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.383 -0.969 . . . . 1.45 108.383 178.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.4 mt -129.39 150.81 50.58 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.458 -0.776 . . . . 1.31 110.766 -178.696 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.5 mt -115.28 127.88 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.143 -1.429 . . . . 1.29 107.143 177.362 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 61.8 tp -100.54 118.95 37.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.972 -1.08 . . . . 1.31 108.469 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.43 ' C ' ' N ' ' A' ' 223' ' ' VAL . 18.8 t0 -81.33 -41.23 22.38 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.846 -1.168 . . . . 2.31 107.846 179.403 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 48.21 18.76 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.013 -0.736 . . . . 1.19 109.013 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.43 ' N ' ' C ' ' A' ' 221' ' ' ASP . 39.2 t -128.45 -42.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.114 -1.439 . . . . 1.45 107.114 178.507 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -104.78 8.11 34.81 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.509 -1.293 . . . . 3.13 107.509 178.062 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.689 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.9 OUTLIER 59.62 49.45 8.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.878 -0.514 . . . . 2.2 110.245 179.703 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.52 ' CD ' ' HH ' ' A' ' 228' ' ' TYR . 2.9 pt20 -147.94 149.9 33.05 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.817 -1.177 . . . . 2.32 110.766 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.45 122.05 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.304 -0.998 . . . . 1.4 108.304 179.035 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . 0.52 ' HH ' ' CD ' ' A' ' 226' ' ' GLN . 91.9 m-85 -87.67 128.98 35.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.626 -1.296 . . . . 1.29 109.218 -179.491 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 33.1 t -104.06 119.55 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.421 -0.8 . . . . 1.38 110.197 -179.014 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 57.02 69.4 1.7 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.058 -1.026 . . . . 2.33 109.598 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -91.3 135.64 1.81 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.525 2.817 . . . . 0.95 112.8 -179.689 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 55.8 m -65.87 159.76 24.78 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.212 -0.93 . . . . 2.31 108.791 179.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -59.71 -38.06 80.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 3.45 108.939 -179.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.23 -39.33 86.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.361 -0.837 . . . . 2.89 109.533 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 88.1 t -61.28 -41.35 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.34 -0.85 . . . . 1.73 109.459 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.1 mt . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 1.57 109.865 -179.956 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 8.1 ttt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -150.7 149.05 29.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.796 . . . . 0.0 109.243 179.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -149.36 160.99 42.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.078 -1.014 . . . . 0.0 110.116 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -153.42 149.75 28.1 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.796 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -111.62 131.38 55.31 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.23 -0.919 . . . . 0.0 109.815 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.17 122.71 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-O 122.287 1.041 . . . . 0.0 112.491 -176.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 95.5 m -75.59 103.9 5.9 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.849 0.833 . . . . 0.0 110.148 -178.647 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.6 mt -51.95 124.42 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 122.176 0.989 . . . . 0.0 109.977 -178.218 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 75.0 p -105.81 22.1 16.16 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.845 -178.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -80.58 149.32 67.92 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.61 -72.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.259 0 CA-C-N 119.455 0.841 . . . . 0.0 112.062 -179.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -86.29 23.87 1.48 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.123 -0.986 . . . . 0.0 110.819 -177.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 82.62 -163.14 42.11 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.542 -1.313 . . . . 0.0 109.841 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.413 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.0 tp -90.31 93.65 9.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.354 -1.086 . . . . 0.0 109.79 -178.094 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . 0.431 ' C ' HH21 ' A' ' 126' ' ' ARG . 10.4 p80 -94.39 -160.25 0.76 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.728 -1.232 . . . . 0.0 109.304 178.628 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.6 m -58.31 -45.16 88.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.83 -1.168 . . . . 0.0 112.752 -176.094 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.511 ' NE ' ' NE2' ' B' ' 321' ' ' GLN . 3.8 tpt180 -59.46 -64.51 2.9 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.111 -1.618 . . . . 0.0 111.375 -177.911 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -55.08 -34.11 86.16 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 CA-C-N 120.176 1.099 . . . . 0.0 112.047 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.2 -52.36 65.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.001 -1.062 . . . . 0.0 109.402 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.48 -41.05 63.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.217 -0.927 . . . . 0.0 109.633 -178.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . 0.511 ' NE2' ' NE ' ' B' ' 317' ' ' ARG . 44.6 mt-30 -70.81 -40.87 72.24 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.824 -1.172 . . . . 0.0 108.924 179.152 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -60.14 -50.5 73.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.298 -0.876 . . . . 0.0 110.854 -179.242 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 74.0 t -69.89 -31.16 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.753 -1.217 . . . . 0.0 109.792 -178.628 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . 0.518 ' HZ3' ' CD ' ' A' ' 74' ' ' GLU . 26.1 ttmt -59.76 -47.99 83.49 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.229 -0.92 . . . . 0.0 109.859 -179.56 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -67.08 -40.05 86.93 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 111.078 -178.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . 0.431 ' C ' ' H ' ' B' ' 328' ' ' GLY . . . -63.46 -53.22 55.56 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.998 -1.064 . . . . 0.0 111.393 -178.934 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -56.12 -10.2 0.79 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.015 -1.053 . . . . 0.0 109.526 -179.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' B' ' 326' ' ' ALA . . . -69.79 -30.26 70.59 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 178.892 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -102.67 141.73 35.0 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.594 -0.945 . . . . 0.0 109.172 179.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 44.5 m -89.78 -11.32 42.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.154 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 61.8 p -59.34 156.68 12.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.374 -0.829 . . . . 0.0 110.034 -179.5 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -72.9 127.93 33.99 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.351 -0.843 . . . . 0.0 108.956 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.7 mt -134.52 133.54 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 87.9 m -132.85 155.88 48.18 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.508 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 58.3 t -117.2 140.68 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.427 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 64.9 m -129.05 123.17 31.6 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.447 -0.783 . . . . 0.0 109.134 179.763 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 66.9 p -139.45 117.41 11.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.353 -0.842 . . . . 0.0 110.418 -179.725 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 59.8 t30 45.6 56.53 5.72 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 177.208 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.02 -13.29 26.32 Favored Glycine 0 N--CA 1.501 3.004 0 O-C-N 120.055 -1.653 . . . . 0.0 112.924 176.438 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -111.75 122.93 49.12 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-N 119.037 1.418 . . . . 0.0 109.52 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.1 m -118.53 143.53 46.69 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.769 0.795 . . . . 0.0 110.544 -178.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -139.87 161.0 38.62 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.822 0.82 . . . . 0.0 110.174 -179.441 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 15.5 t -89.59 140.0 29.99 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.619 -0.675 . . . . 0.0 109.446 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.418 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -76.78 -12.63 60.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.085 -1.009 . . . . 0.0 109.785 -179.137 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.42 19.87 4.21 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.649 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.418 ' H ' ' C ' ' B' ' 344' ' ' ALA . 16.3 t -149.37 96.91 2.58 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.912 -179.224 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 28.8 tp -59.97 -32.04 70.45 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -58.09 -52.34 65.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 109.915 -179.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.434 ' O ' ' OG1' ' B' ' 352' ' ' THR . 33.8 mtmm -69.93 -39.92 75.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.692 -1.255 . . . . 0.0 110.163 -178.292 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' B' ' 352' ' ' THR . 39.6 mt -50.63 -58.24 6.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.775 -1.203 . . . . 0.0 108.024 179.219 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.637 HE21 ' N ' ' B' ' 351' ' ' GLN . 0.0 OUTLIER -38.28 -27.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.871 -0.518 . . . . 0.0 111.127 -178.361 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.464 ' N ' ' O ' ' B' ' 350' ' ' LEU . 51.0 p -77.75 -11.48 59.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.091 -1.006 . . . . 0.0 110.388 -178.855 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 24.8 mt -92.78 115.41 28.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.888 -1.133 . . . . 0.0 109.195 179.221 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.1 92.75 0.75 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.919 -1.673 . . . . 0.0 108.919 179.504 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 44.3 mt -100.61 91.62 4.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.24 -1.153 . . . . 0.0 108.913 179.529 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 81.0 p -91.86 177.9 6.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.956 -1.09 . . . . 0.0 110.512 -178.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' B' ' 359' ' ' THR . 61.8 tt0 -46.48 155.68 0.22 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.664 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 39.46 25.23 0.05 OUTLIER Glycine 0 N--CA 1.495 2.595 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 177.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 359' ' ' THR . . . . . 0.465 ' N ' ' O ' ' B' ' 357' ' ' GLN . 9.2 m -82.47 112.44 19.41 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.708 -1.466 . . . . 0.0 109.283 179.423 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 16.4 t -77.37 115.8 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 122.214 1.007 . . . . 0.0 110.358 -176.882 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.3 m -110.34 176.85 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 30.8 m -132.19 129.81 40.24 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.4 mt -105.84 122.09 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.402 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 52.7 p -120.82 132.19 54.87 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.639 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.93 151.87 37.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.905 -1.122 . . . . 0.0 110.955 -178.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -144.87 124.49 13.25 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.691 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 160.16 -162.73 33.41 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 118.981 -1.58 . . . . 0.0 111.367 179.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -59.96 -55.64 31.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 122.258 -0.554 . . . . 0.0 111.759 -178.425 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' B' ' 370' ' ' GLU . 94.5 m-20 -104.93 7.48 34.24 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.996 -1.065 . . . . 0.0 111.105 -177.314 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' B' ' 369' ' ' ASP . 1.3 pp20? -42.91 -32.12 0.59 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.244 -0.91 . . . . 0.0 110.507 -179.12 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -70.08 -43.7 70.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 109.996 -179.293 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -64.7 -48.99 72.63 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.199 -0.938 . . . . 0.0 109.332 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.9 -75.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.425 -0.797 . . . . 0.0 110.705 -178.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . 0.44 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 45.4 t -44.5 -38.77 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.099 -1.001 . . . . 0.0 110.895 -177.564 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -64.86 -47.23 78.68 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.624 -1.298 . . . . 0.0 110.513 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -82.75 -41.72 18.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.919 -1.113 . . . . 0.0 110.445 -179.454 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.9 -39.23 77.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.904 -1.122 . . . . 0.0 108.284 -179.617 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 48.1 t -62.38 -40.24 87.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.213 179.13 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' B' ' 383' ' ' GLU . 20.8 mtpp -68.54 -55.78 10.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.595 -1.315 . . . . 0.0 108.824 178.604 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 56.1 tp -57.78 -35.85 71.36 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.762 -1.211 . . . . 0.0 109.734 -178.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 28.8 ttm -70.66 -40.05 73.22 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.257 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.31 -9.99 59.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.528 -0.733 . . . . 0.0 110.968 179.164 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' B' ' 379' ' ' LYS . 93.9 mt-10 -110.03 0.83 18.62 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.042 -1.036 . . . . 0.0 111.549 -178.191 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 13.2 mt -82.38 125.89 31.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.178 -1.576 . . . . 0.0 109.224 179.136 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.318 -179.978 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.422 ' H3 ' ' H ' ' A' ' 2' ' ' ILE . 85.7 mmm . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.255 -0.646 . . . . 3.19 109.255 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.422 ' H ' ' H3 ' ' A' ' 1' ' ' MET . 96.7 mt -110.0 130.03 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.611 -0.681 . . . . 1.71 109.164 179.671 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.5 m -120.92 144.28 48.52 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.579 -0.701 . . . . 1.66 109.747 -179.707 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -121.67 -162.82 11.75 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 108.894 -1.682 . . . . 1.05 108.894 179.751 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 6' ' ' LEU . 91.4 mt -89.28 -13.97 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.9 -1.353 . . . . 1.59 110.176 -179.218 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.9 tp 53.74 102.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.224 -0.922 . . . . 1.47 109.062 -179.883 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.64 -29.43 12.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.262 -0.899 . . . . 1.39 109.153 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 30.8 m -129.44 116.02 18.47 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 109.024 -0.732 . . . . 2.09 109.024 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.25 146.72 20.02 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.76 1.64 . . . . 0.91 112.079 -179.74 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 152.61 -154.4 25.5 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.462 -1.455 . . . . 0.92 109.462 -179.85 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.0 mt -148.36 150.33 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.36 -1.082 . . . . 1.35 108.587 178.947 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.84 156.32 34.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.939 -1.101 . . . . 1.14 110.752 179.663 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.2 m-85 -137.41 128.51 27.66 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.895 -1.15 . . . . 0.7 107.895 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.67 174.29 46.92 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 118.736 -1.697 . . . . 0.58 110.743 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -76.52 158.87 30.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.769 -0.842 . . . . 2.63 109.26 -179.735 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.99 126.11 46.13 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.358 -0.839 . . . . 1.27 111.377 -178.351 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.7 tp -101.36 129.96 47.46 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.876 -1.527 . . . . 1.41 106.876 177.57 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.2 tp -114.02 121.64 44.47 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.308 -0.87 . . . . 1.49 110.021 -178.914 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.2 mt -85.87 100.09 11.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.49 -0.756 . . . . 1.52 109.051 179.358 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -84.42 142.0 30.43 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.27 -1.011 . . . . 3.17 108.27 179.532 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -130.76 135.65 47.98 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.023 -1.048 . . . . 3.0 109.106 179.392 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -94.78 156.4 16.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.322 -0.861 . . . . 2.77 109.55 -179.916 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -78.58 136.98 37.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 2.94 109.321 179.787 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.6 mt -79.79 130.17 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.258 -0.901 . . . . 1.46 108.728 179.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.8 t -93.27 125.76 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.18 -0.95 . . . . 1.7 109.684 -179.461 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.8 mt -105.97 138.06 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.517 -0.739 . . . . 1.54 109.12 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -96.23 120.06 35.84 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.159 -0.963 . . . . 1.81 109.974 -179.585 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.501 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.0 mmt-85 -90.02 -0.24 57.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.402 -0.812 . . . . 3.23 109.692 -179.795 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -69.9 135.5 49.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.069 -1.02 . . . . 3.29 109.164 -179.895 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -83.02 154.81 24.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.107 -0.996 . . . . 2.8 109.419 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.9 pt -98.92 166.41 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.207 -0.933 . . . . 1.43 109.609 179.568 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.2 p -93.41 174.81 7.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.3 -0.875 . . . . 1.54 108.658 178.437 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.07 -48.56 81.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 1.6 110.292 -179.425 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -55.51 -31.48 62.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.767 -1.208 . . . . 2.56 110.568 -179.057 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -81.59 -8.98 59.78 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.177 -0.952 . . . . 2.36 110.289 -179.357 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.9 t -60.06 -50.09 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.776 -1.203 . . . . 1.43 109.087 179.825 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -60.11 -39.91 87.87 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.369 -0.832 . . . . 1.77 109.078 -179.663 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -64.19 -42.02 96.83 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.546 -0.721 . . . . 3.32 110.916 -178.717 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -62.83 -41.84 99.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.68 -1.263 . . . . 1.51 110.422 -179.224 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.7 t -63.73 -47.04 92.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.675 -1.266 . . . . 1.41 108.987 -179.763 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -60.0 -46.2 90.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.055 -1.028 . . . . 1.81 108.957 179.863 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -59.98 -48.59 81.1 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.026 -1.07 . . . . 3.26 108.766 179.5 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.15 -44.61 94.84 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.162 -0.961 . . . . 0.81 108.879 178.659 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.1 tp -59.95 -47.34 86.21 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.827 -1.175 . . . . 1.59 107.827 179.427 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.6 t -63.53 -43.62 96.6 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.571 -0.852 . . . . 1.38 108.979 178.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.97 -48.24 87.28 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.986 -1.646 . . . . 0.87 108.986 179.34 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -63.2 -31.5 72.66 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.365 -1.08 . . . . 3.62 108.2 179.114 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.05 82.17 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.813 -0.81 . . . . 1.43 108.813 179.887 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 50' ' ' ALA . 6.8 ttpm? -65.73 -74.31 0.11 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.932 -1.136 . . . . 3.08 107.932 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.94 -40.54 0.47 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.366 -0.834 . . . . 1.33 111.758 -178.255 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 64.0 m -54.48 -53.7 50.74 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.465 -1.397 . . . . 1.85 108.982 -179.875 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.23 -41.18 77.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.226 -0.921 . . . . 1.35 110.819 -179.318 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -66.89 -39.97 87.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.908 -1.12 . . . . 2.34 109.989 -179.511 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.9 mt -61.03 -39.95 91.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.892 -1.13 . . . . 2.2 108.725 179.066 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -61.94 -35.08 77.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.477 -0.765 . . . . 1.35 109.573 179.482 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -64.3 -43.04 95.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.034 -1.041 . . . . 1.34 109.35 179.816 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.9 -39.63 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.855 . . . . 1.26 108.917 179.681 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -57.07 -50.43 72.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.442 -0.786 . . . . 1.7 109.971 -179.368 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -57.1 -31.62 65.46 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.319 -0.863 . . . . 1.35 110.377 -177.888 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -70.02 -38.14 75.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.05 -1.031 . . . . 2.08 109.436 -179.897 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.8 -45.91 76.91 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.615 -0.678 . . . . 1.21 110.641 -179.128 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.88 -50.87 63.04 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.755 -1.212 . . . . 0.75 110.424 -178.637 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -70.24 -43.8 69.85 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.934 -1.333 . . . . 1.59 110.18 -179.792 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.4 m -69.98 -57.8 4.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.067 -1.021 . . . . 1.41 111.698 -178.042 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -98.31 -54.36 3.08 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.138 -0.976 . . . . 0.79 111.483 -178.168 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.26 -164.58 26.88 Favored Glycine 0 N--CA 1.5 2.914 0 C-N-CA 119.676 -1.25 . . . . 1.22 110.931 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -71.4 -25.92 62.55 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.884 -0.774 . . . . 5.81 110.795 -179.409 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.4 -35.9 78.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.165 -0.959 . . . . 3.37 110.197 -179.255 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -100.01 -20.28 16.14 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.331 -0.856 . . . . 2.37 110.269 -179.222 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -69.92 -40.32 75.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.962 -1.087 . . . . 1.65 110.501 -178.826 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.621 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -67.36 -26.1 66.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.133 -0.979 . . . . 1.42 109.972 -179.058 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.73 -39.99 81.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 118.954 -1.099 . . . . 1.43 108.345 179.77 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -67.82 -39.99 83.84 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.055 -1.028 . . . . 1.08 110.311 179.885 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.511 ' CD ' ' HZ3' ' B' ' 324' ' ' LYS . 80.2 tt0 -59.91 -40.78 89.97 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.759 -1.213 . . . . 1.37 109.454 179.464 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.86 -48.98 76.55 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.029 -1.628 . . . . 0.67 109.029 179.518 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.5 m170 -63.05 -42.96 99.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.463 -1.022 . . . . 1.99 109.485 179.916 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.02 -45.1 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.235 -0.916 . . . . 1.22 109.784 -179.737 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.0 ttp -60.27 -40.11 89.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.891 -1.13 . . . . 2.11 109.121 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.1 tp -63.09 -39.34 94.41 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.683 -0.636 . . . . 1.33 109.956 179.626 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.2 tp -66.26 -38.3 87.53 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.523 -0.735 . . . . 1.29 110.248 -179.483 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -80.35 3.28 21.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.958 -1.089 . . . . 1.47 110.258 -179.045 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -49.75 130.03 20.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.0 -1.063 . . . . 1.47 109.642 -179.614 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.18 -17.73 58.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.534 -0.729 . . . . 1.78 110.629 -179.536 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -71.85 -35.05 69.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.975 -1.078 . . . . 2.53 108.713 178.767 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.8 mt -69.96 -40.36 75.47 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.492 0.663 . . . . 1.36 109.831 179.761 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.04 -45.37 93.04 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.329 -0.857 . . . . 1.42 109.917 -179.22 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -69.99 -40.0 75.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 2.27 110.334 -179.14 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.96 -40.05 75.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.288 -0.882 . . . . 1.57 110.912 -179.175 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.3 mt -68.37 -42.45 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.991 -1.068 . . . . 1.19 109.595 -179.588 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.01 -38.78 76.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.564 -0.71 . . . . 1.39 110.633 -179.533 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.45 77.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.102 -0.999 . . . . 1.39 111.247 -178.615 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.81 -47.54 84.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.769 -1.207 . . . . 1.5 110.419 -178.964 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.42 -49.9 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.114 -0.991 . . . . 1.29 109.183 179.957 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -70.27 -43.9 69.54 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.375 -0.53 . . . . 2.64 111.132 -179.721 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -80.98 -49.87 10.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.986 -1.072 . . . . 1.65 111.991 -177.813 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -90.12 -2.43 58.08 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.001 -1.062 . . . . 2.5 111.584 -177.372 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 56.43 35.12 25.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.859 -1.15 . . . . 1.88 109.435 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.0 mtt -88.4 169.26 11.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.472 -0.768 . . . . 1.71 109.907 -179.417 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.429 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 52.4 p -81.88 160.0 23.54 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.342 -0.849 . . . . 1.61 108.776 179.532 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.77 -39.88 88.0 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.22 -0.925 . . . . 1.33 110.258 -179.472 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 35.9 p-10 -67.02 -35.07 79.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.081 -1.012 . . . . 2.07 109.335 -179.735 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.507 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.96 -47.39 13.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.317 -0.865 . . . . 1.37 109.604 179.661 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.63 -48.32 81.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.385 -0.822 . . . . 1.14 110.007 -179.612 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.28 -36.24 79.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.935 . . . . 1.26 109.844 -179.891 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.415 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 80.3 t60 -60.03 -42.67 94.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.286 -0.884 . . . . 2.02 109.98 -178.761 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' A' ' 110' ' ' GLY . 41.3 tt0 -64.36 -40.01 94.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.164 -0.96 . . . . 1.33 110.242 -179.469 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.2 t -60.57 -56.09 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.352 -0.842 . . . . 1.3 111.446 -178.06 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.1 mm -69.93 -39.97 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.942 -1.099 . . . . 1.32 108.936 -179.789 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.415 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 88.8 tt0 -64.78 -38.87 92.44 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.567 -0.901 . . . . 2.44 108.567 178.639 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.02 -49.2 77.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.813 -0.915 . . . . 0.99 110.813 -179.066 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -68.79 -52.34 31.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.716 -1.461 . . . . 1.97 109.527 -179.521 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.62 -40.05 78.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.296 -0.877 . . . . 1.43 109.26 179.868 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.6 t -58.24 -41.4 84.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.175 -0.953 . . . . 2.12 108.963 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.81 -40.5 91.91 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.258 -0.901 . . . . 1.64 109.028 179.192 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.5 mt -61.4 -45.24 95.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.107 -0.996 . . . . 1.93 109.62 -179.682 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -57.25 -32.32 66.45 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.143 -0.973 . . . . 2.2 109.846 -178.48 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -58.11 -21.74 47.66 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.022 -1.049 . . . . 2.12 108.605 179.773 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 54.4 mt -62.37 139.95 58.54 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.264 -0.898 . . . . 2.34 108.577 179.636 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -90.09 10.08 25.71 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.114 -0.991 . . . . 3.23 110.86 -178.722 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -94.39 133.59 37.8 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.777 -1.202 . . . . 2.49 109.828 -179.75 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -69.92 -28.99 66.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.571 -0.706 . . . . 3.95 109.954 -179.861 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.484 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.7 t80 -69.24 -36.86 77.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.376 -0.827 . . . . 2.25 110.244 179.417 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.6 mt -77.49 -35.21 53.84 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.093 -1.004 . . . . 2.27 109.57 179.838 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -59.99 -45.33 93.08 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.229 -0.919 . . . . 3.31 109.678 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.55 -45.37 94.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -0.964 . . . . 2.73 109.296 -179.655 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -61.94 -39.88 93.62 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.117 -1.068 . . . . 3.2 108.117 179.101 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.79 -23.25 51.54 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.184 -1.043 . . . . 1.66 108.184 178.796 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.96 -40.09 75.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.814 -0.81 . . . . 1.67 108.814 178.954 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.54 -40.09 94.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.528 -0.733 . . . . 1.55 110.294 -179.497 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.93 -40.56 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.08 -1.013 . . . . 1.32 108.402 179.842 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -60.09 -38.69 83.68 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.964 -0.754 . . . . 3.58 108.964 178.474 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -59.53 -39.57 84.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.745 . . . . 1.46 109.986 -179.52 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.93 -40.78 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.052 -1.03 . . . . 1.22 109.686 -179.623 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.63 -41.42 96.01 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.979 -1.105 . . . . 0.61 110.769 -179.44 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -59.93 -47.07 87.3 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.964 -1.315 . . . . 3.1 111.279 -178.799 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.602 HH12 ' CB ' ' A' ' 166' ' ' SER . 98.6 mtt180 -69.97 -30.47 67.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.504 -1.372 . . . . 3.71 109.927 -179.622 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.0 -46.15 90.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 1.87 109.152 -179.968 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.5 mt -59.88 -40.04 87.35 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.396 -0.815 . . . . 1.29 109.464 179.236 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -69.16 -40.02 78.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.397 -0.814 . . . . 3.05 110.206 179.959 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -69.93 -20.91 63.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.337 -0.852 . . . . 1.26 112.383 -178.136 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.5 mt -68.68 -40.02 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.19 -1.569 . . . . 1.34 108.408 179.664 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.13 -29.32 21.9 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.436 -0.79 . . . . 1.6 109.621 -179.699 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.96 54.35 2.05 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 108.695 -1.762 . . . . 0.96 108.695 -178.958 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.0 tp -74.73 147.31 41.48 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.625 -0.926 . . . . 1.67 110.009 -179.168 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -60.19 141.42 55.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.342 -0.848 . . . . 4.96 109.867 -179.867 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.3 mt -119.96 127.06 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-O 122.01 0.91 . . . . 1.68 109.414 179.52 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.5 mt -60.11 -45.9 95.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 116.063 -0.517 . . . . 2.14 109.952 -178.504 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.4 t0 64.22 101.52 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.498 -0.751 . . . . 1.5 109.256 -179.57 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.1 mt -71.74 -5.27 32.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.368 -0.833 . . . . 1.39 109.868 -179.269 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.6 m -80.21 -18.57 49.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.056 -1.028 . . . . 1.83 109.56 179.758 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.1 24.04 0.81 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.271 -0.893 . . . . 1.46 111.777 -178.002 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 39.2 mm -90.97 115.98 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.496 -1.378 . . . . 1.42 108.64 179.19 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -100.04 -9.68 22.39 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.34 -0.85 . . . . 2.94 110.545 -178.748 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -119.92 149.48 42.04 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.188 -0.945 . . . . 1.52 110.336 -179.392 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.01 133.81 52.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.388 -0.82 . . . . 1.58 109.1 179.766 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -151.77 164.7 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.448 -0.783 . . . . 1.32 109.597 179.678 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.435 HD13 HG21 ' A' ' 157' ' ' ILE . 87.8 mt -93.69 147.32 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.038 -1.838 . . . . 1.27 106.038 177.0 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 60.9 tp -97.3 117.01 30.57 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.879 -1.138 . . . . 1.41 110.642 -177.952 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 35.5 t -122.12 127.74 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.197 -1.038 . . . . 1.23 108.197 179.228 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.07 160.65 39.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.987 -1.07 . . . . 1.32 108.711 -179.895 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.96 -34.7 73.74 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.261 -1.524 . . . . 1.49 108.16 178.977 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -160.14 170.69 20.69 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.806 -0.813 . . . . 2.25 108.806 179.935 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.6 mt -141.96 129.95 21.93 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.041 -1.037 . . . . 1.35 108.733 178.989 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 63.1 p -90.56 144.23 30.32 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.084 -1.01 . . . . 1.56 109.293 -179.741 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -40.1 -37.6 1.83 Allowed 'Trans proline' 0 N--CA 1.488 1.196 0 C-N-CA 122.116 1.877 . . . . 0.87 112.457 179.39 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.602 ' CB ' HH12 ' A' ' 136' ' ' ARG . 50.2 m -59.98 -40.95 90.9 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.352 -0.843 . . . . 1.36 109.591 -179.238 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -62.78 -43.24 99.32 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.261 -0.9 . . . . 1.61 110.195 -179.644 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 62.4 p -57.85 -28.71 64.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 1.21 110.531 -178.679 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.99 -57.5 4.93 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.015 -1.053 . . . . 1.21 109.775 179.7 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -83.5 35.39 0.5 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.102 -0.703 . . . . 2.11 109.102 -179.446 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.3 tp -100.66 139.04 36.9 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.347 -0.846 . . . . 1.29 109.345 179.588 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -85.43 103.73 14.59 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.267 -0.896 . . . . 2.81 108.763 179.545 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 63.1 mt -63.62 -45.36 90.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.476 -0.765 . . . . 2.09 110.273 -178.694 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -70.06 -20.39 63.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.024 -1.048 . . . . 2.86 112.572 -178.328 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -93.15 -10.12 36.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.471 -1.393 . . . . 2.39 109.26 -179.185 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 89.4 t -109.79 117.64 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.317 -0.864 . . . . 1.27 109.356 179.465 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 78.4 mt -88.77 5.49 43.25 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.348 -0.845 . . . . 2.17 110.676 -178.407 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.59 173.16 38.96 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.2 -1.56 . . . . 0.52 109.2 179.808 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -133.09 129.94 38.64 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.258 -1.142 . . . . 0.55 110.105 -179.598 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 58.9 mt -128.9 122.89 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.037 -1.097 . . . . 1.27 108.037 177.971 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 11.7 p -143.52 157.03 44.75 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.986 -1.072 . . . . 1.39 110.982 -179.202 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 183' ' ' ALA . 1.1 m-20 -96.19 21.35 9.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.436 -0.79 . . . . 2.46 109.631 -179.891 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -46.9 -173.93 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.977 -1.077 . . . . 1.51 112.723 -177.922 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -85.85 -49.75 4.19 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 111.377 -0.689 . . . . 2.23 111.377 -178.979 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -174.18 -154.46 10.86 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 118.525 -1.798 . . . . 2.23 111.71 -179.291 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.583 ' C ' ' H ' ' A' ' 188' ' ' SER . 8.7 mtt-85 -62.42 -33.99 75.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.782 -0.834 . . . . 6.44 111.151 -178.632 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 29.1 p -60.04 6.99 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.839 -1.163 . . . . 4.09 110.639 -178.302 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.583 ' H ' ' C ' ' A' ' 186' ' ' ARG . 92.7 p -90.85 130.76 36.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.871 -1.143 . . . . 2.2 109.941 179.717 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -47.62 -45.87 28.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.203 -0.935 . . . . 1.15 109.548 -179.849 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 93.3 m -58.41 -40.26 81.96 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 2.01 110.171 -178.317 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.479 ' H ' ' HG ' ' A' ' 188' ' ' SER . 81.1 p -63.29 -38.8 92.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.822 -1.174 . . . . 1.93 109.849 -179.881 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.52 ' CD1' HH22 ' A' ' 195' ' ' ARG . 41.9 mm -60.09 -45.81 95.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.299 -0.876 . . . . 2.2 109.09 -179.459 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.16 -46.45 89.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.415 -0.803 . . . . 1.32 110.639 -179.698 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.43 -48.73 76.38 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.805 -1.185 . . . . 1.3 111.219 -178.273 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.52 HH22 ' CD1' ' A' ' 192' ' ' ILE . 26.8 mtm-85 -60.88 -50.04 75.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.684 -1.26 . . . . 3.38 110.458 -178.903 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 48.7 m -71.29 -34.98 71.14 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.834 -1.166 . . . . 1.15 111.6 -178.506 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 99.0 mt -81.52 -11.13 59.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.696 -1.253 . . . . 1.28 110.796 -178.356 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 56.91 46.48 19.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.166 -0.959 . . . . 1.5 110.696 179.592 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 8' ' ' SER . 92.2 mt -116.31 121.26 33.75 Favored Pre-proline 0 N--CA 1.5 2.072 0 N-CA-C 108.341 -0.985 . . . . 1.37 108.341 179.055 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -42.35 129.61 4.76 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.83 1.687 . . . . 0.76 111.952 -179.42 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.01 152.17 4.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.982 -1.074 . . . . 1.19 111.649 -179.221 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.7 mt -126.87 144.0 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.654 -1.239 . . . . 1.31 107.654 178.607 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 20.5 m -124.05 -9.43 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 O-C-N 120.796 -1.19 . . . . 1.38 111.381 -178.446 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.46 23.69 24.0 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 110.875 -0.89 . . . . 1.03 110.875 -178.829 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.441 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 19.2 p -47.19 -42.86 20.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.833 -1.392 . . . . 1.38 110.105 -179.276 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.77 -52.26 4.18 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 120.039 -1.077 . . . . 1.17 111.924 178.833 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.5 t -155.36 35.1 0.37 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.37 -1.665 . . . . 2.07 111.819 -178.759 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 29.5 t -75.95 -38.01 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.857 -1.152 . . . . 1.35 109.195 178.422 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.2 p -60.03 -40.07 88.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.591 -0.693 . . . . 1.49 111.55 -177.985 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.7 p -78.47 -11.37 59.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.799 -1.188 . . . . 2.16 110.264 -178.74 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -96.97 -12.24 23.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.233 -0.917 . . . . 2.89 110.408 -179.698 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 91.8 t -116.34 156.2 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.321 -0.862 . . . . 1.33 110.592 -179.344 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -114.71 154.12 29.04 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.207 -1.035 . . . . 2.73 108.207 179.687 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 39.0 p-10 -59.73 135.96 57.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.868 -1.145 . . . . 2.7 110.095 -179.404 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.7 OUTLIER 94.5 -1.72 0.08 Allowed 'General case' 0 N--CA 1.511 2.614 0 CA-C-O 121.581 0.705 . . . . 2.38 109.988 179.502 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 48.8 t0 -70.08 151.2 45.76 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.434 -0.792 . . . . 2.09 109.792 -179.961 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 51.0 t80 -95.37 120.13 35.07 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.371 -0.831 . . . . 1.45 108.804 179.602 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 90.2 mt -123.34 138.34 54.63 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.386 -0.821 . . . . 1.31 110.657 -179.297 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.9 mt -112.35 130.0 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 106.436 -1.69 . . . . 1.29 106.436 176.317 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 57.0 tp -100.32 115.01 28.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.115 -0.991 . . . . 1.31 109.542 -178.303 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' A' ' 223' ' ' VAL . 55.8 m-20 -70.6 -46.92 62.51 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.924 -1.139 . . . . 2.31 107.924 178.996 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 52.12 9.15 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.917 -0.771 . . . . 1.19 108.917 -179.644 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.535 ' H ' ' C ' ' A' ' 221' ' ' ASP . 75.5 t -125.9 -38.89 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 107.094 -1.447 . . . . 1.45 107.094 178.797 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -104.32 0.01 28.71 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.928 -1.138 . . . . 3.13 107.928 178.243 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 60.08 45.9 11.35 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.156 -0.683 . . . . 2.2 109.156 -179.524 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -136.41 156.26 48.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.398 -0.814 . . . . 2.32 109.599 -179.752 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.5 t -124.37 129.98 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 108.798 -0.816 . . . . 1.4 108.798 178.957 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -105.22 125.86 51.45 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.513 -0.921 . . . . 1.29 108.513 179.192 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.9 t -103.89 113.99 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.202 -0.936 . . . . 1.38 110.404 -179.406 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.528 HD21 ' C ' ' A' ' 230' ' ' ASN . 0.3 OUTLIER 49.48 62.67 11.61 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.099 -1.001 . . . . 2.33 110.707 178.916 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -85.35 156.16 10.87 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.832 2.355 . . . . 0.95 112.173 179.319 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.0 m -65.92 159.28 25.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.342 -0.849 . . . . 2.31 109.637 -179.423 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.735 ' ND2' ' H ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -61.61 -38.58 88.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.257 -0.902 . . . . 3.45 111.006 -178.916 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.735 ' H ' ' ND2' ' A' ' 233' ' ' ASN . 16.8 pt-20 -65.62 -30.83 71.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.79 -1.194 . . . . 2.89 109.708 -179.492 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.6 -43.15 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 1.73 108.564 179.286 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.536 -0.728 . . . . 1.57 109.963 179.885 . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 3.0 ttt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.509 0.671 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -151.98 150.07 29.59 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.995 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -148.34 159.17 44.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.007 -1.058 . . . . 0.0 110.14 -179.275 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -152.98 150.06 28.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.631 -0.668 . . . . 0.0 109.344 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . 0.481 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 1.6 pm0 -114.87 134.69 54.94 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.313 -0.867 . . . . 0.0 109.969 179.43 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 1.3 p -135.63 124.92 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 CA-C-O 122.029 0.919 . . . . 0.0 112.44 -177.212 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 88.7 m -77.72 106.35 9.47 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.93 0.871 . . . . 0.0 109.969 -179.385 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 92.3 mt -50.78 124.16 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 122.449 1.118 . . . . 0.0 110.274 -177.407 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 74.8 p -108.06 19.93 19.35 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.54 -178.955 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.57 118.21 68.27 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.907 . . . . 0.0 108.606 179.308 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -61.18 -13.4 27.96 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 CA-C-N 120.477 1.206 . . . . 0.0 112.288 -179.815 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -117.5 9.52 13.26 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.524 -0.735 . . . . 0.0 110.422 -178.581 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.96 172.08 16.78 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.311 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.484 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -82.34 87.92 6.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.951 -1.323 . . . . 0.0 109.557 -178.285 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . 0.424 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 3.5 p80 -90.56 -163.39 1.02 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.796 -1.19 . . . . 0.0 109.713 178.76 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.1 m -58.1 -41.29 83.21 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.806 -1.184 . . . . 0.0 112.595 -175.775 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.621 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 16.3 tpt180 -59.35 -59.58 13.38 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 120.379 -1.451 . . . . 0.0 111.658 -179.49 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . 0.424 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 14.9 Cg_endo -60.43 -34.86 92.71 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 CA-C-N 120.522 1.222 . . . . 0.0 111.693 -179.653 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.98 -51.97 67.4 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.318 -0.864 . . . . 0.0 108.978 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -54.27 -41.8 69.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.687 -178.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -70.08 -41.13 74.49 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.982 -1.074 . . . . 0.0 108.669 178.772 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -60.73 -51.67 68.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.548 -0.72 . . . . 0.0 111.247 -179.362 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 86.1 t -67.76 -27.04 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.565 -1.334 . . . . 0.0 109.259 -179.125 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . 0.511 ' HZ3' ' CD ' ' A' ' 74' ' ' GLU . 31.1 ttmt -60.04 -47.52 85.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.552 -0.718 . . . . 0.0 109.645 179.741 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -64.39 -45.22 88.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 110.557 -179.255 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.09 -52.79 63.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.854 -1.154 . . . . 0.0 110.751 -178.792 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -55.22 -16.63 3.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.174 -0.954 . . . . 0.0 109.808 179.706 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.96 -30.64 69.97 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.462 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.29 140.47 39.17 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.465 -1.02 . . . . 0.0 109.27 179.844 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 19.8 m -89.94 -10.71 44.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.124 -0.985 . . . . 0.0 109.607 -179.97 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 331' ' ' SER . . . . . 0.495 ' OG ' ' N ' ' B' ' 368' ' ' GLU . 72.9 m -57.74 146.55 30.82 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.051 -1.03 . . . . 0.0 108.679 179.451 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.7 132.66 50.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.186 -0.946 . . . . 0.0 109.499 -179.326 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.8 mt -132.34 131.8 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.471 -0.768 . . . . 0.0 108.964 179.694 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 52.1 m -128.73 153.48 47.31 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.778 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 98.9 t -118.51 140.03 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.504 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 34.3 m -128.04 123.51 34.82 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 179.225 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 86.9 p -138.54 114.98 10.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.261 -0.899 . . . . 0.0 110.87 -179.191 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 28.9 m120 45.17 50.04 9.63 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 176.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.92 -14.21 62.5 Favored Glycine 0 N--CA 1.501 3.028 0 O-C-N 120.077 -1.639 . . . . 0.0 112.947 176.873 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -116.02 126.69 54.15 Favored 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 119.225 1.512 . . . . 0.0 109.699 179.834 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 52.9 m -118.43 144.6 45.84 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.731 0.777 . . . . 0.0 110.648 -178.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -143.18 162.11 36.46 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.571 0.7 . . . . 0.0 110.005 -179.765 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 41.4 t -87.94 132.5 34.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.669 -0.644 . . . . 0.0 110.745 -178.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.423 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -68.96 -16.75 63.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 108.689 179.358 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -88.73 19.4 4.03 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 178.737 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.621 ' CB ' ' HZ2' ' B' ' 349' ' ' LYS . 53.9 p -146.62 94.99 2.52 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.774 0.797 . . . . 0.0 112.406 -179.428 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . 0.518 ' CD1' HE22 ' B' ' 351' ' ' GLN . 52.9 tp -60.0 -36.51 77.34 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.728 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -56.51 -53.52 56.5 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.324 -0.86 . . . . 0.0 110.708 -179.181 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.621 ' HZ2' ' CB ' ' B' ' 346' ' ' SER . 33.6 mtmm -70.04 -38.78 75.94 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.875 -1.141 . . . . 0.0 109.609 -178.846 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' B' ' 352' ' ' THR . 35.7 mt -48.2 -59.51 3.36 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.946 -1.096 . . . . 0.0 108.496 179.415 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' B' ' 351' ' ' GLN . 0.9 OUTLIER -39.14 -25.92 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.695 -0.628 . . . . 0.0 111.124 -179.088 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.46 ' N ' ' O ' ' B' ' 350' ' ' LEU . 66.3 p -79.45 -9.94 59.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.344 -1.472 . . . . 0.0 110.198 -178.295 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 61.1 mt -92.54 114.43 26.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.018 -1.051 . . . . 0.0 108.644 178.6 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.77 90.04 0.66 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 179.575 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 22.7 mt -100.62 93.54 5.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.316 -1.108 . . . . 0.0 108.674 179.426 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 356' ' ' THR . . . . . 0.669 ' H ' ' HG1' ' B' ' 359' ' ' THR . 70.9 p -93.36 167.34 11.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.135 -0.978 . . . . 0.0 110.625 -179.053 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 13.3 tm0? -57.84 113.01 1.67 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.782 -0.574 . . . . 0.0 110.693 -179.32 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.78 9.25 38.05 Favored Glycine 0 N--CA 1.498 2.821 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.737 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 359' ' ' THR . . . . . 0.669 ' HG1' ' H ' ' B' ' 356' ' ' THR . 54.6 m -87.19 110.65 20.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.388 -1.066 . . . . 0.0 111.415 -179.113 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 5.0 t -77.03 115.43 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 122.165 0.983 . . . . 0.0 109.703 -177.775 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 18.3 m -113.31 177.18 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.855 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 93.3 m -132.15 132.58 43.34 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.052 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 59.3 mt -107.94 126.07 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.194 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 54.0 m -125.36 133.51 52.53 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.447 -0.783 . . . . 0.0 109.17 -179.491 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -148.53 155.62 41.38 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.94 -1.1 . . . . 0.0 111.001 -178.812 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -149.55 128.68 12.76 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.824 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.461 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 156.65 -152.16 23.54 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.155 -1.498 . . . . 0.0 111.726 179.548 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . 0.495 ' N ' ' OG ' ' B' ' 331' ' ' SER . 54.5 tp10 -58.64 -52.1 67.13 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 122.099 -0.647 . . . . 0.0 112.376 -177.15 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' B' ' 370' ' ' GLU . 89.2 m-20 -114.98 15.63 17.23 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.011 -1.056 . . . . 0.0 111.416 -177.11 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.54 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.0 OUTLIER -41.25 -37.3 0.92 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.255 -0.903 . . . . 0.0 111.718 -178.488 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . 0.516 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 72.7 mm-40 -68.05 -44.53 76.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.602 -1.311 . . . . 0.0 110.376 -178.083 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -68.29 -51.56 43.51 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.094 -1.004 . . . . 0.0 109.033 179.806 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -46.32 -38.08 8.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.698 -0.626 . . . . 0.0 111.665 -178.87 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 70.4 t -73.02 -39.47 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.624 -1.297 . . . . 0.0 109.332 179.505 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.98 -58.67 7.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 0.0 111.507 -178.807 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -68.96 -40.45 78.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.525 -1.359 . . . . 0.0 111.791 -177.956 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.02 -41.87 93.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.715 -1.241 . . . . 0.0 108.853 -178.871 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 52.6 t -61.07 -44.58 98.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.221 -0.925 . . . . 0.0 109.624 179.367 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' B' ' 383' ' ' GLU . 45.7 mtpt -69.26 -55.3 10.93 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.108 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 48.7 tp -54.87 -35.9 64.55 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.317 -0.864 . . . . 0.0 109.393 -178.271 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 38.3 ttm -70.77 -40.02 72.88 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.623 -1.298 . . . . 0.0 108.689 177.829 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.86 -4.28 58.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.625 -0.672 . . . . 0.0 110.533 179.728 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' B' ' 379' ' ' LYS . 98.4 mt-10 -112.11 -4.79 14.34 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.087 -1.008 . . . . 0.0 110.986 -179.701 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 16.5 mt -80.27 132.86 35.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.455 -1.403 . . . . 0.0 108.483 178.579 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.284 -179.904 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mmm . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.197 0.522 . . . . 3.19 109.777 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.4 mt -99.69 122.9 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.267 -0.895 . . . . 1.71 109.042 179.505 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.3 m -139.03 119.39 13.75 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.302 -0.874 . . . . 1.66 109.683 -179.482 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.08 -163.01 29.72 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.108 -1.597 . . . . 1.05 109.108 179.648 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.2 mt -90.6 -7.77 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.118 -1.224 . . . . 1.59 110.684 -179.048 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.2 tp 54.85 96.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.969 -1.082 . . . . 1.47 109.246 -179.829 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.45 -25.77 26.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.142 -0.974 . . . . 1.39 109.375 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 t -150.93 131.21 7.0 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.152 -0.967 . . . . 2.09 109.101 179.659 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.11 140.31 15.66 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.954 1.769 . . . . 0.91 111.836 179.608 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 166.61 -164.59 37.82 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.382 -1.487 . . . . 0.92 109.382 -179.583 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.3 mt -147.24 147.27 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.897 -1.355 . . . . 1.35 108.589 179.37 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.06 157.67 37.91 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.924 -1.11 . . . . 1.14 110.07 179.755 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -139.02 128.13 23.89 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.01 -1.107 . . . . 0.7 108.01 179.312 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.52 178.78 47.4 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.473 -1.822 . . . . 0.58 110.792 179.714 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -77.43 158.15 30.17 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.761 -0.847 . . . . 2.63 109.431 -179.658 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.36 132.3 45.81 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.315 -0.866 . . . . 1.27 111.515 -178.563 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.3 tp -101.58 133.3 46.47 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.468 -1.308 . . . . 1.41 107.468 178.004 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.0 tp -116.35 123.13 46.85 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.853 0.835 . . . . 1.49 110.19 -178.798 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.3 mt -92.75 102.29 14.69 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.206 0.527 . . . . 1.52 110.586 -179.022 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mtmt -105.15 136.0 45.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.369 -0.832 . . . . 3.17 109.482 179.713 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -130.64 139.49 50.37 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.44 -0.787 . . . . 3.0 109.354 179.437 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -87.5 152.63 22.06 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.147 -0.971 . . . . 2.77 109.493 179.547 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -70.07 140.64 52.8 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.103 -0.998 . . . . 2.94 110.383 -179.781 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.6 mt -81.88 136.65 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.476 -0.935 . . . . 1.46 108.476 179.124 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.6 t -103.66 127.68 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.231 -0.918 . . . . 1.7 110.776 -178.82 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -102.96 136.69 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.791 -0.818 . . . . 1.54 108.791 179.481 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.13 124.55 34.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.987 -1.07 . . . . 1.81 109.238 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -88.99 1.12 55.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -0.873 . . . . 3.23 109.526 -179.762 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -61.85 140.33 58.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 3.29 110.129 179.859 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -85.58 141.73 29.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.612 -0.884 . . . . 2.8 108.612 179.452 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.7 pt -90.12 164.99 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.823 -1.173 . . . . 1.43 110.944 -179.12 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.3 p -97.07 172.46 7.82 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.551 -0.907 . . . . 1.54 108.551 178.566 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.02 -48.69 80.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.02 -1.05 . . . . 1.6 109.819 -179.473 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 40.1 t0 -55.5 -30.05 59.93 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.822 -1.174 . . . . 2.56 109.367 -179.889 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.86 -10.04 59.42 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.446 -0.784 . . . . 2.36 110.272 -179.756 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.5 t -64.08 -53.28 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.497 -1.377 . . . . 1.43 108.995 179.578 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.25 -40.04 96.3 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.436 -0.79 . . . . 1.77 110.121 -179.906 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -69.89 -40.25 75.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.095 -1.003 . . . . 3.32 110.497 -178.934 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -65.81 -40.04 91.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.846 -1.159 . . . . 1.51 109.955 -179.988 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.88 -46.48 96.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.963 -1.086 . . . . 1.41 108.514 178.919 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -60.26 -40.43 90.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.19 -0.944 . . . . 1.81 109.315 179.561 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -60.07 -44.14 94.96 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.097 -1.075 . . . . 3.26 108.097 179.099 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.33 -48.63 80.46 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.231 -0.918 . . . . 0.81 109.046 178.114 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.5 tp -59.81 -45.24 92.97 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.217 -1.031 . . . . 1.59 108.217 -179.472 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.2 t -60.34 -40.02 89.21 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.156 -0.965 . . . . 1.38 108.548 178.538 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.9 -48.87 80.89 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.641 -1.784 . . . . 0.87 108.641 179.32 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -60.33 -39.02 85.57 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.821 -1.177 . . . . 3.62 107.821 178.28 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.06 -40.79 59.14 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.582 -0.896 . . . . 1.43 108.582 179.887 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 50' ' ' ALA . 14.5 ttmm -66.91 -73.78 0.13 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.386 -1.338 . . . . 3.08 107.386 178.417 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.83 -38.7 0.19 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.659 -0.65 . . . . 1.33 111.139 -178.557 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.2 m -53.75 -55.25 27.97 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.513 -1.367 . . . . 1.85 108.184 179.206 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.91 -46.96 66.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.521 -0.737 . . . . 1.35 111.027 -179.63 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -62.47 -43.54 98.56 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.885 -1.134 . . . . 2.34 110.5 -179.058 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.6 mt -60.12 -40.07 88.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.06 -1.025 . . . . 2.2 108.924 179.694 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -62.71 -34.39 77.06 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.429 -0.794 . . . . 1.35 109.618 179.507 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -64.6 -44.15 91.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.991 -1.068 . . . . 1.34 109.744 179.881 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.9 mt -60.23 -39.86 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 1.26 109.343 179.822 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.9 ttpp -54.08 -50.19 67.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.492 -0.755 . . . . 1.7 109.7 -179.076 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.7 m -58.13 -37.98 75.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -0.939 . . . . 1.35 110.667 -177.884 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.411 ' O ' ' OG1' ' A' ' 64' ' ' THR . 97.6 mttt -64.85 -38.92 92.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.878 -1.139 . . . . 2.08 109.768 -179.696 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.65 -46.8 77.81 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.541 -0.724 . . . . 1.21 109.865 -179.613 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.13 -52.21 52.79 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.913 -1.275 . . . . 0.75 109.913 -179.124 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -70.08 -47.56 61.39 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.146 -1.208 . . . . 1.59 109.996 -179.728 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 49.0 m -63.63 -65.45 0.68 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.299 -0.876 . . . . 1.41 112.744 -177.569 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -95.58 -45.03 7.22 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.609 -1.307 . . . . 0.79 111.151 -177.944 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.17 -169.98 24.79 Favored Glycine 0 N--CA 1.5 2.91 0 O-C-N 120.672 -1.268 . . . . 1.22 110.863 179.67 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.0 -24.36 63.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.93 -0.747 . . . . 5.81 109.652 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -60.0 -34.01 72.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -0.802 . . . . 3.37 110.195 -179.682 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -100.33 -17.46 17.25 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.316 -0.865 . . . . 2.37 110.006 179.683 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -68.8 -46.44 68.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.262 -0.899 . . . . 1.65 110.284 -179.342 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.47 -28.2 69.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.412 -0.805 . . . . 1.42 109.945 -178.802 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 93.0 mt -60.06 -41.14 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.917 -1.114 . . . . 1.43 109.389 -179.621 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -68.19 -38.16 81.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.961 -1.087 . . . . 1.08 110.279 -179.567 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.441 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 74.4 tt0 -59.94 -39.95 87.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.922 -1.111 . . . . 1.37 109.485 179.676 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.1 -41.69 99.7 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.11 -1.596 . . . . 0.67 109.11 179.522 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.4 m170 -64.02 -40.97 97.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.398 -1.06 . . . . 1.99 109.502 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -68.91 -47.2 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.174 -0.954 . . . . 1.22 109.022 179.488 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -60.61 -40.24 91.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.095 -1.003 . . . . 2.11 110.472 -179.457 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.402 ' CD1' ' CE2' ' B' ' 348' ' ' PHE . 27.2 tp -67.48 -40.0 85.26 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.079 -1.013 . . . . 1.33 109.3 179.72 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.63 -39.98 92.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.468 -0.77 . . . . 1.29 110.368 -179.503 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -80.26 5.05 15.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.995 -1.066 . . . . 1.47 110.262 -178.706 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 61.9 t0 -51.57 130.03 27.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.059 -1.026 . . . . 1.47 109.618 -179.855 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.404 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.7 mt-10 -61.21 -15.18 31.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.48 -0.763 . . . . 1.78 110.173 -179.337 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -72.55 -36.86 68.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.106 -0.996 . . . . 2.53 108.673 178.758 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.04 -40.06 75.35 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.574 0.702 . . . . 1.36 109.41 -179.915 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.12 -49.16 78.75 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.259 -0.9 . . . . 1.42 109.597 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -69.99 -40.29 75.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.377 -0.827 . . . . 2.27 111.316 -179.008 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.07 -39.92 75.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.881 -1.137 . . . . 1.57 110.997 -178.678 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.3 mt -70.0 -41.97 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.02 -1.05 . . . . 1.19 109.585 -179.744 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.7 mt -68.53 -37.79 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.444 -0.785 . . . . 1.39 109.633 179.39 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.96 -47.28 86.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 1.39 110.818 -178.701 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 96' ' ' LYS . 97.8 mt -60.09 -45.99 91.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.81 -1.181 . . . . 1.5 109.393 -179.284 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.2 mt -61.68 -49.43 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.297 -0.877 . . . . 1.29 109.097 179.479 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -69.86 -40.0 76.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.306 -0.872 . . . . 2.64 110.67 179.805 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 91' ' ' ALA . 61.9 t0 -83.64 -52.86 6.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.037 -1.039 . . . . 1.65 112.057 -177.948 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 92' ' ' LEU . 7.1 mtpm? -93.4 -3.22 53.63 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.078 -1.014 . . . . 2.5 112.295 -177.123 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.2 m170 59.21 39.98 22.13 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.839 -1.163 . . . . 1.88 109.573 -179.585 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.5 mtp -91.27 164.97 13.69 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.459 -0.775 . . . . 1.71 110.112 -179.834 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 65.4 p -79.99 163.62 24.1 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.514 -0.741 . . . . 1.61 109.197 179.732 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.09 -41.23 82.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 1.33 110.458 -179.305 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -67.48 -37.69 83.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 2.07 109.577 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.29 -41.15 34.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.293 -0.879 . . . . 1.37 110.169 179.967 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.1 -47.02 63.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.895 . . . . 1.14 110.452 -179.25 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.45 -40.4 90.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.974 -1.079 . . . . 1.26 110.18 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.45 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 84.8 t60 -59.91 -40.12 87.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.251 -0.905 . . . . 2.02 110.17 -178.564 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -64.52 -40.12 95.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.057 -1.027 . . . . 1.33 110.795 -178.931 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.08 -51.85 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.072 -1.017 . . . . 1.3 111.06 -178.093 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mm -69.66 -39.97 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.777 -1.202 . . . . 1.32 108.574 -179.837 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.45 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 88.2 tt0 -62.78 -39.35 93.93 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.622 -0.881 . . . . 2.44 108.622 178.825 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.94 -50.61 65.8 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.199 -1.161 . . . . 0.99 110.199 -179.545 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -66.24 -48.11 71.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.79 -1.418 . . . . 1.97 109.112 179.955 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.05 93.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.139 -0.976 . . . . 1.43 108.673 179.431 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.1 t -58.19 -39.94 80.25 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.71 -0.848 . . . . 2.12 108.71 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.92 -40.0 94.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.403 -0.811 . . . . 1.64 109.631 179.485 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.04 -41.19 91.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.976 -1.078 . . . . 1.93 109.604 -179.431 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.83 -33.81 72.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.57 -1.331 . . . . 2.2 109.452 -179.246 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -54.5 -22.18 12.16 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.418 -0.956 . . . . 2.12 108.418 179.437 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 61.7 mt -64.09 144.84 56.8 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.378 -0.826 . . . . 2.34 109.319 179.912 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -100.63 46.67 0.94 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.248 -0.907 . . . . 3.23 110.489 -179.727 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 64.6 t0 -131.51 138.02 48.77 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.14 -0.975 . . . . 2.49 109.943 179.964 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.541 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 47.5 mt-10 -69.94 -32.0 70.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.599 -0.688 . . . . 3.95 110.504 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.465 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.3 t80 -72.18 -39.95 68.29 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.309 -0.87 . . . . 2.25 110.536 179.582 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.621 ' CD2' HH21 ' A' ' 126' ' ' ARG . 80.9 mt -70.54 -37.31 74.05 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.094 -1.004 . . . . 2.27 108.825 -179.855 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -60.41 -39.83 88.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 3.31 109.792 179.333 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -59.46 -48.94 79.7 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.112 -0.992 . . . . 2.73 109.692 -179.232 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.621 HH21 ' CD2' ' A' ' 123' ' ' LEU . 77.4 mtm180 -63.88 -38.52 91.39 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.134 -1.026 . . . . 3.2 108.672 179.105 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.67 -26.63 56.91 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.951 -1.129 . . . . 1.66 107.951 178.888 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.08 -38.08 72.45 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.403 -0.962 . . . . 1.67 108.403 178.347 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -64.98 -40.1 94.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.581 -0.699 . . . . 1.55 109.658 -179.527 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.2 t -68.84 -43.02 82.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.26 -0.9 . . . . 1.32 109.233 179.811 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 131' ' ' ARG . 28.6 ttt-85 -60.6 -39.68 89.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 3.58 108.842 179.14 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -60.0 -39.98 87.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.557 -0.714 . . . . 1.46 110.422 -179.447 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 94.3 mt -60.04 -43.91 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.887 -1.133 . . . . 1.22 109.997 -179.261 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.98 -34.43 70.92 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.894 -1.283 . . . . 0.61 109.894 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -60.0 -49.97 75.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -1.177 . . . . 3.1 109.673 -179.219 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -69.85 -30.85 68.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.851 -1.156 . . . . 3.71 110.04 -179.936 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.04 -43.24 95.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.07 -1.018 . . . . 1.87 109.083 -179.586 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.6 mt -60.39 -39.9 88.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.304 -0.873 . . . . 1.29 109.352 179.208 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -69.64 -38.17 77.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 3.05 108.485 179.072 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.453 HD21 ' N ' ' A' ' 140' ' ' ASN . 1.4 m120 -60.16 -36.71 78.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.819 -0.551 . . . . 1.26 110.626 -179.136 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.3 mt -70.07 -42.98 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.782 -1.199 . . . . 1.34 109.512 -179.767 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.8 mt -81.08 -38.03 28.0 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.402 -0.812 . . . . 1.6 110.021 -179.89 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.89 45.87 4.08 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 108.758 -1.737 . . . . 0.96 108.758 -178.941 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.4 tp -74.18 149.87 40.68 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.482 -1.01 . . . . 1.67 109.777 -179.273 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 142.56 53.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 4.96 109.655 -179.61 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.05 123.19 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-O 121.611 0.72 . . . . 1.68 109.214 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 147' ' ' ILE . 23.9 mm -49.18 -52.91 9.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.583 -0.698 . . . . 2.14 109.384 -178.943 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.6 t0 66.41 100.08 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.494 0.664 . . . . 1.5 109.527 -179.893 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.467 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 67.8 mt -70.91 -9.0 56.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.507 -0.746 . . . . 1.39 109.945 -179.337 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.416 ' HA ' HD22 ' A' ' 172' ' ' ASN . 22.9 p -74.99 -17.28 60.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.066 -1.021 . . . . 1.83 109.592 179.778 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.94 28.74 0.67 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.455 -0.778 . . . . 1.46 111.316 -177.716 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.467 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 49.9 mt -90.02 116.87 32.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.848 -1.157 . . . . 1.42 109.37 -179.434 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -98.97 -14.27 19.58 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.357 -0.84 . . . . 2.94 110.087 -178.982 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -127.17 149.91 49.75 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.193 -0.942 . . . . 1.52 110.23 -179.173 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -63.75 139.73 58.8 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.621 -0.881 . . . . 1.58 108.621 179.814 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.7 m -153.09 164.95 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 1.32 109.699 -179.693 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.1 mt -93.51 149.15 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 105.834 -1.913 . . . . 1.27 105.834 176.533 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 43.4 tp -97.37 113.91 25.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.934 -1.104 . . . . 1.41 110.481 -177.725 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 62.6 t -121.18 129.98 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 108.255 -1.017 . . . . 1.23 108.255 179.067 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.25 169.22 19.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 1.32 108.872 179.888 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.17 -35.37 68.98 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.696 -1.253 . . . . 1.49 108.023 178.375 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -167.46 175.52 7.14 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.812 -1.181 . . . . 2.25 107.812 179.961 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 58.0 mt -135.59 145.64 47.12 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.076 -1.015 . . . . 1.35 109.09 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 40.0 p -97.37 127.9 36.63 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.242 -1.021 . . . . 1.56 108.242 179.166 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -37.0 -35.9 0.25 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.985 1.79 . . . . 0.87 112.616 -179.407 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.3 m -60.01 -39.87 87.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.075 -1.016 . . . . 1.36 109.016 -179.722 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -67.88 -40.16 83.59 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.171 -0.955 . . . . 1.61 110.138 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 55.8 p -56.46 -33.79 66.25 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.145 -0.972 . . . . 1.21 111.382 -177.991 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.76 -45.08 65.43 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.676 -1.265 . . . . 1.21 109.71 -179.871 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -90.73 35.63 0.89 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.374 -0.972 . . . . 2.11 108.374 179.68 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.4 tp -106.71 130.73 54.39 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.12 -1.067 . . . . 1.29 108.12 178.577 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . 0.416 HD22 ' HA ' ' A' ' 150' ' ' SER . 4.1 m-20 -82.05 103.86 11.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.171 -0.956 . . . . 2.81 109.177 -179.75 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.25 -41.06 96.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.046 -1.033 . . . . 2.09 110.234 -179.471 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.52 -27.22 68.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 2.86 111.359 -178.049 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -92.75 -10.43 37.05 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.603 -1.31 . . . . 2.39 109.933 -178.867 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 58.1 t -103.23 112.83 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.15 -0.969 . . . . 1.27 108.698 179.031 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.9 mt -87.29 3.99 44.56 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.27 -0.894 . . . . 2.17 110.719 -178.336 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 176.31 168.91 37.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.112 -1.595 . . . . 0.52 109.112 179.719 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -130.91 127.12 37.84 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.386 -1.067 . . . . 0.55 109.277 -179.945 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 95.8 mt -130.48 123.58 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.449 -1.315 . . . . 1.27 107.449 177.915 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.3 p -141.88 159.15 42.8 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.204 1.002 . . . . 1.39 111.068 -178.824 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 183' ' ' ALA . 59.2 t0 -96.88 18.34 14.81 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.685 -0.634 . . . . 2.46 109.737 -179.8 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -44.28 -178.87 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.91 -1.119 . . . . 1.51 112.653 -178.032 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.71 -54.31 4.63 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 111.23 -0.748 . . . . 2.23 111.23 -179.355 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.1 -163.82 13.63 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.06 -1.543 . . . . 2.23 111.285 -178.835 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.429 HH11 ' HG2' ' A' ' 186' ' ' ARG . 12.6 ptt-85 -72.39 -10.54 59.92 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.794 -0.827 . . . . 6.44 110.738 -179.116 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.6 p -80.9 7.42 10.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.955 -1.091 . . . . 4.09 109.898 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 95.1 p -84.92 142.69 29.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 2.2 110.481 -179.69 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -48.27 -44.53 33.63 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.867 -0.79 . . . . 1.15 108.867 179.601 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.528 ' HG1' ' N ' ' A' ' 191' ' ' SER . 3.2 p -56.08 -40.08 73.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.626 -0.671 . . . . 2.01 109.806 -179.475 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.528 ' N ' ' HG1' ' A' ' 190' ' ' THR . 48.3 t -61.67 -40.28 94.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -0.93 . . . . 1.93 111.03 -179.241 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.9 mm -62.18 -41.52 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.084 -1.01 . . . . 2.2 110.115 -178.813 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.9 mtp -60.02 -45.62 92.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.039 -1.038 . . . . 1.32 110.683 -178.38 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.97 -42.68 94.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.688 -1.257 . . . . 1.3 109.708 -179.308 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 -60.04 -51.23 70.53 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.272 -0.892 . . . . 3.38 110.618 -178.919 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 52.6 m -77.74 -32.44 52.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.923 -1.111 . . . . 1.15 111.866 -178.336 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.7 mt -70.4 -20.31 62.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.634 -1.292 . . . . 1.28 109.459 -179.425 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 64.17 49.94 2.53 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.309 0.576 . . . . 1.5 110.546 -179.733 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 83.2 mt -130.35 151.0 77.77 Favored Pre-proline 0 N--CA 1.5 2.058 0 N-CA-C 108.163 -1.051 . . . . 1.37 108.163 178.679 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.65 139.43 69.56 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.002 1.801 . . . . 0.76 111.043 179.599 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -171.55 153.98 3.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.763 -1.21 . . . . 1.19 111.525 -179.721 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.64 152.32 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.053 -1.091 . . . . 1.31 108.053 179.362 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.2 m -131.88 -13.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 121.064 -1.023 . . . . 1.38 111.295 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -111.36 26.47 12.02 Favored Glycine 0 N--CA 1.502 3.088 0 N-CA-C 110.645 -0.982 . . . . 1.03 110.645 -178.826 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 204' ' ' GLY . 3.2 p -43.38 -45.06 5.97 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.23 -1.159 . . . . 1.38 109.962 -179.622 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.465 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 93.89 -53.95 2.26 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 120.204 -0.998 . . . . 1.17 111.2 179.128 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 64.3 m -154.4 31.49 0.43 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.321 -1.694 . . . . 2.07 111.449 -179.024 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.02 -40.08 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.85 -1.156 . . . . 1.35 108.885 178.581 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 75.0 p -53.29 -29.52 33.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.424 -0.798 . . . . 1.49 110.563 -179.219 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.0 t -83.7 -15.13 49.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.973 -1.08 . . . . 2.16 110.428 -178.855 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -100.09 -15.92 18.03 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.226 -0.921 . . . . 2.89 110.955 -179.009 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 88.5 t -105.29 139.72 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.136 -0.978 . . . . 1.33 111.001 -178.16 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.455 ' HZ1' ' CB ' ' A' ' 213' ' ' LYS . 0.0 OUTLIER -114.13 152.59 30.88 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.585 -1.265 . . . . 2.73 107.585 178.473 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 5.6 t-20 -58.27 139.16 55.62 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.948 -1.095 . . . . 2.7 110.283 -179.255 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 12.5 t0 87.74 8.61 0.17 Allowed 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 121.335 0.588 . . . . 2.38 109.796 179.633 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 56.2 t0 -79.07 140.5 37.87 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.326 -0.859 . . . . 2.09 109.317 179.551 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.531 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 55.3 t80 -91.78 118.39 30.64 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.346 -1.353 . . . . 1.45 107.346 178.476 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 82.7 mt -126.52 147.36 49.86 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.325 -0.86 . . . . 1.31 110.69 -178.631 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 81.6 mt -118.57 126.71 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.819 -1.548 . . . . 1.29 106.819 176.875 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 48.6 tp -102.02 124.84 48.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.241 -0.912 . . . . 1.31 108.645 -179.268 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.595 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 27.9 p-10 -87.94 -35.62 17.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.203 -0.935 . . . . 2.31 108.607 179.686 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.445 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 44.52 18.59 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.826 -0.805 . . . . 1.19 108.826 -179.224 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 221' ' ' ASP . 16.6 t -125.82 -46.89 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.127 -1.434 . . . . 1.45 107.127 179.579 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -100.75 -1.03 36.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.873 -1.529 . . . . 3.13 106.873 177.745 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 61.76 50.39 4.37 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.439 0.638 . . . . 2.2 109.587 179.996 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.595 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 95.6 mt-30 -138.77 151.16 46.85 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.522 -0.736 . . . . 2.32 109.311 179.76 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 84.2 t -119.41 127.73 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.421 -0.955 . . . . 1.4 108.421 178.882 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -102.26 123.98 47.03 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.331 -0.989 . . . . 1.29 108.331 179.443 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.21 115.0 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.492 -0.755 . . . . 1.38 110.369 -178.911 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 60.4 t30 53.61 69.55 2.19 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.912 . . . . 2.33 110.341 179.718 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -90.91 148.58 3.89 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 123.408 2.739 . . . . 0.95 112.478 179.541 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.7 m -69.99 160.88 31.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 2.31 109.701 -179.431 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.55 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 38.2 p30 -60.02 -39.94 87.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 3.45 111.481 -178.669 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.55 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 13.1 pt-20 -60.04 -31.22 69.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.58 -1.325 . . . . 2.89 109.641 -179.352 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 83.2 t -70.03 -42.41 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.033 -1.042 . . . . 1.73 109.282 179.115 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.499 1.986 0 O-C-N 121.313 -0.867 . . . . 1.57 110.396 -179.762 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 10.4 ttt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . 0.504 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 22.8 t80 -154.84 154.07 32.15 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.312 -0.868 . . . . 0.0 110.05 179.542 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . 0.504 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 2.9 pm0 -146.98 156.62 43.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.183 -0.948 . . . . 0.0 110.661 -179.621 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 0.4 OUTLIER -152.15 147.31 26.28 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.454 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . 0.517 ' N ' ' OE1' ' B' ' 304' ' ' GLN . 98.9 mt-10 -107.21 131.32 54.3 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.959 -1.088 . . . . 0.0 109.694 179.102 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.26 120.61 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 CA-C-O 122.045 0.926 . . . . 0.0 112.544 -177.745 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 8.8 m -76.91 107.11 9.01 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.874 0.845 . . . . 0.0 111.359 -177.711 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.6 mt -52.23 118.13 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 122.098 0.951 . . . . 0.0 109.717 -178.944 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 309' ' ' THR . . . . . 0.565 ' C ' HE22 ' B' ' 357' ' ' GLN . 67.4 p -107.3 19.95 19.61 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.714 -178.249 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . 0.522 ' N ' ' OE1' ' B' ' 357' ' ' GLN . . . -81.2 114.52 49.74 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.192 -0.943 . . . . 0.0 109.845 179.686 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -50.4 -9.72 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.733 0 CA-C-N 120.199 1.107 . . . . 0.0 113.308 -179.332 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' B' ' 310' ' ' ALA . 97.8 m-20 -120.5 4.04 10.7 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.437 -0.789 . . . . 0.0 109.265 179.829 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 74.0 -178.75 43.0 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.428 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.465 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.5 tp -83.64 89.82 7.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.05 -1.265 . . . . 0.0 109.027 -179.193 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -92.8 -162.2 0.91 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.924 -1.11 . . . . 0.0 109.989 179.18 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.8 m -58.07 -42.3 85.25 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.041 -1.037 . . . . 0.0 112.873 -175.932 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.454 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.4 tpt180 -59.87 -61.52 7.73 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 120.327 -1.483 . . . . 0.0 111.523 -178.571 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -58.11 -33.63 97.6 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.231 1.118 . . . . 0.0 111.473 179.975 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.29 74.53 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.515 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.2 -44.02 74.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.662 -0.649 . . . . 0.0 109.338 -179.905 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -70.01 -42.01 73.59 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.598 179.061 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -59.99 -50.41 73.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.635 -0.666 . . . . 0.0 110.543 -179.371 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.44 -30.25 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.591 -1.318 . . . . 0.0 109.172 -179.485 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . 0.441 ' NZ ' ' OE1' ' A' ' 74' ' ' GLU . 19.9 ttmt -60.01 -47.14 87.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.413 -0.804 . . . . 0.0 109.199 179.535 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -67.56 -48.89 65.64 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.184 -0.948 . . . . 0.0 110.896 -179.227 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -66.08 -52.72 46.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.798 -1.189 . . . . 0.0 110.709 -178.748 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -54.78 -14.5 1.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.088 -179.02 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -74.59 -20.95 79.37 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.358 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -103.79 146.96 27.86 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.439 -1.036 . . . . 0.0 108.719 179.686 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 13.9 t -91.2 -13.65 32.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.767 -1.208 . . . . 0.0 109.653 -179.898 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 63.7 p -60.13 147.58 39.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 -179.863 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' B' ' 332' ' ' GLU . 58.2 mp0 -68.87 134.49 49.7 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.104 -0.998 . . . . 0.0 108.636 179.758 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.1 mt -133.17 133.63 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.497 -0.752 . . . . 0.0 109.688 -179.222 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 82.4 m -129.05 149.81 50.71 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.478 -0.764 . . . . 0.0 109.288 179.409 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 53.9 t -122.84 114.07 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.338 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 96.5 m -104.97 134.18 48.51 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.212 -0.93 . . . . 0.0 109.394 -178.411 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 24.7 p -139.46 111.67 7.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.336 -0.853 . . . . 0.0 110.944 -179.48 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 48.89 50.81 17.06 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 176.685 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 90.04 -14.84 60.96 Favored Glycine 0 N--CA 1.501 2.998 0 O-C-N 119.941 -1.724 . . . . 0.0 112.503 177.104 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -118.64 131.44 56.18 Favored 'General case' 0 N--CA 1.508 2.447 0 CA-C-N 119.019 1.41 . . . . 0.0 109.69 -179.809 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 79.6 p -132.51 151.8 51.78 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.933 0.873 . . . . 0.0 110.681 -178.872 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -143.26 167.2 22.7 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -179.758 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 15.2 m -87.56 138.16 31.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.47 -0.769 . . . . 0.0 110.255 -179.273 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.447 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -77.13 -14.59 59.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.959 -1.088 . . . . 0.0 109.997 -179.394 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -89.59 20.46 3.98 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.126 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.447 ' H ' ' C ' ' B' ' 344' ' ' ALA . 9.0 t -145.74 94.44 2.49 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.535 -179.649 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . 0.529 ' CD1' HE22 ' B' ' 351' ' ' GLN . 58.5 tp -59.97 -36.32 76.86 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.069 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . 0.402 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 51.0 m-85 -54.54 -50.42 67.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 0.0 110.699 -179.376 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.419 ' NZ ' ' CB ' ' B' ' 346' ' ' SER . 35.9 mtmm -69.95 -40.02 75.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.911 -1.118 . . . . 0.0 111.237 -177.975 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' B' ' 352' ' ' THR . 88.2 mt -49.28 -56.99 7.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.875 -1.14 . . . . 0.0 109.443 -178.933 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.529 HE22 ' CD1' ' B' ' 347' ' ' LEU . 1.2 mp0 -42.23 -14.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.414 -0.804 . . . . 0.0 111.342 -178.101 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.55 ' N ' ' O ' ' B' ' 350' ' ' LEU . 59.3 p -88.72 -11.48 45.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.287 -1.508 . . . . 0.0 110.185 -179.132 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 79.3 mt -91.58 117.52 29.79 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.84 -1.162 . . . . 0.0 108.807 178.646 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -69.79 89.2 0.3 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 58.0 mt -98.73 86.81 3.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -1.162 . . . . 0.0 108.456 179.03 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 67.2 p -89.26 168.97 11.84 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.041 -1.037 . . . . 0.0 110.063 -178.926 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . 0.565 HE22 ' C ' ' B' ' 309' ' ' THR . 15.8 tp60 -62.99 114.94 3.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.631 -0.668 . . . . 0.0 110.61 -179.031 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.24 8.72 40.71 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.713 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 31.6 m -87.2 111.7 21.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.261 -1.14 . . . . 0.0 111.394 -178.986 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 48.5 t -76.98 118.09 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 122.267 1.032 . . . . 0.0 109.548 -177.914 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.0 m -112.9 177.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -177.952 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 48.9 m -130.71 128.79 41.56 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.45 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . 0.408 HG22 HD11 ' B' ' 363' ' ' ILE . 86.6 mt -103.06 117.58 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.154 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 72.7 m -120.99 132.09 54.7 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.289 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.24 153.34 40.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.069 -1.019 . . . . 0.0 110.489 -179.296 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . 0.441 ' OE1' ' OE1' ' B' ' 370' ' ' GLU . 17.1 tp10 -144.47 122.32 11.97 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.082 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.48 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 159.8 -157.11 28.34 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.954 -1.593 . . . . 0.0 111.595 -179.97 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -59.99 -51.88 67.77 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.338 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -109.15 12.5 25.0 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.754 -1.216 . . . . 0.0 111.176 -177.256 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.48 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 11.8 pt-20 -42.33 -38.17 1.75 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.157 -0.965 . . . . 0.0 111.807 -178.816 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -69.89 -40.51 75.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.638 -1.289 . . . . 0.0 110.249 -178.341 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -68.75 -51.39 41.85 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.171 -0.956 . . . . 0.0 109.482 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -49.64 -34.28 17.85 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.634 -0.666 . . . . 0.0 112.228 -178.413 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 56.2 t -74.82 -39.21 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.657 -1.277 . . . . 0.0 109.766 179.567 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -68.23 -40.01 82.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.168 -0.957 . . . . 0.0 112.37 -177.785 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -84.61 -43.07 14.78 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.193 -1.567 . . . . 0.0 110.901 -179.363 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.93 -40.09 87.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.998 -1.064 . . . . 0.0 108.843 -179.196 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.02 -45.98 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.217 -0.927 . . . . 0.0 109.412 179.42 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' B' ' 383' ' ' GLU . 62.3 mttp -68.62 -54.75 14.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.788 -1.195 . . . . 0.0 107.86 178.503 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 52.8 tp -55.8 -36.25 67.21 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.308 -0.87 . . . . 0.0 109.182 -178.29 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 23.8 ttm -70.65 -40.08 73.25 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.698 -1.251 . . . . 0.0 108.335 177.792 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.21 -4.93 58.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.526 -0.734 . . . . 0.0 110.606 179.585 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' B' ' 379' ' ' LYS . 96.8 mt-10 -112.16 -3.67 14.61 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.17 -0.956 . . . . 0.0 111.106 -179.46 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.2 mt -79.88 136.55 36.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.464 -1.397 . . . . 0.0 109.47 179.011 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 N--CA 1.497 1.918 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.368 -179.901 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.9 mtp . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.506 -0.553 . . . . 3.19 109.506 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.407 HG23 HD12 ' A' ' 2' ' ' ILE . 85.4 mt -110.18 129.98 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.417 -0.802 . . . . 1.71 109.71 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.2 m -132.67 149.84 52.24 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.402 -0.811 . . . . 1.66 109.408 179.686 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.7 -169.92 11.91 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.041 -1.624 . . . . 1.05 109.041 179.757 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.9 mt -85.48 -19.08 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.879 -1.365 . . . . 1.59 110.432 -178.831 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.7 tp 52.92 102.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.176 -0.952 . . . . 1.47 109.03 -179.732 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.11 -26.99 13.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.101 -0.999 . . . . 1.39 109.645 -179.881 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -134.77 117.97 13.17 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.469 -0.769 . . . . 2.09 109.004 -179.843 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.19 148.12 21.19 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.766 1.644 . . . . 0.91 112.562 -179.631 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 155.05 -155.41 26.21 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.754 -1.738 . . . . 0.92 108.754 -179.818 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.426 HG23 HD12 ' A' ' 11' ' ' ILE . 92.5 mt -149.6 151.18 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 120.909 -1.347 . . . . 1.35 108.715 179.041 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.47 150.85 30.06 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.901 -1.125 . . . . 1.14 110.719 179.772 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.8 m-85 -133.9 127.12 31.85 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 107.923 -1.14 . . . . 0.7 107.923 178.616 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.92 -176.69 46.39 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 118.37 -1.872 . . . . 0.58 111.203 179.713 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -79.23 155.64 28.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.985 -0.715 . . . . 2.63 109.841 -179.693 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.82 124.36 49.3 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.579 -0.7 . . . . 1.27 109.978 179.892 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.0 tp -94.22 135.19 35.88 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.472 -1.307 . . . . 1.41 107.472 178.582 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.9 tp -116.01 122.66 45.86 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.22 -0.925 . . . . 1.49 109.946 -179.08 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.7 mt -84.98 100.74 11.85 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.586 0.708 . . . . 1.52 109.955 -179.63 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -100.04 124.79 45.8 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.533 -0.914 . . . . 3.17 108.533 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -132.03 141.82 49.37 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.237 -0.915 . . . . 3.0 109.462 -179.954 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.543 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 9.9 p-10 -77.73 149.19 34.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.385 -0.822 . . . . 2.77 109.558 179.649 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -70.15 149.61 47.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.166 -0.959 . . . . 2.94 109.595 -179.741 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.429 HG21 HD11 ' A' ' 24' ' ' ILE . 84.7 mt -82.34 126.51 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.186 -0.946 . . . . 1.46 110.154 -179.604 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.67 123.63 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.278 -0.889 . . . . 1.7 108.744 179.074 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -100.55 145.23 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.333 -0.855 . . . . 1.54 109.363 -179.555 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -98.51 113.42 25.43 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.172 -0.955 . . . . 1.81 109.519 -179.879 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.451 HH11 ' HG2' ' A' ' 28' ' ' ARG . 7.4 mmt-85 -86.32 -2.13 58.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 3.23 109.449 -179.855 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -66.12 142.8 57.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.934 . . . . 3.29 109.225 179.714 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -83.43 149.6 26.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 2.8 109.544 -179.749 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.4 pt -93.2 165.02 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.032 -1.042 . . . . 1.43 109.091 179.311 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.9 p -94.72 169.53 10.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.948 -1.095 . . . . 1.54 108.485 178.963 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.68 -12.83 60.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 1.6 109.561 -179.967 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -88.32 -28.86 20.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.111 -0.993 . . . . 2.56 108.406 178.787 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -81.65 -8.91 59.76 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.748 -0.834 . . . . 2.36 108.748 178.963 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.3 t -62.46 -53.59 45.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.083 -1.01 . . . . 1.43 108.912 179.815 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -60.04 -40.05 88.06 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.171 -0.956 . . . . 1.77 109.928 -179.87 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -69.94 -40.2 75.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.948 -1.095 . . . . 3.32 110.899 -179.37 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -65.27 -40.07 93.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.674 -1.266 . . . . 1.51 110.199 -179.895 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -61.64 -47.8 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.639 -1.288 . . . . 1.41 108.537 179.083 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.03 -45.9 91.29 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.175 -0.953 . . . . 1.81 109.538 179.677 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -60.04 -42.94 95.49 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.688 -1.226 . . . . 3.26 107.688 179.146 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -61.2 -49.93 75.16 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.645 -0.659 . . . . 0.81 109.491 178.927 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.91 -45.48 94.49 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.457 -0.777 . . . . 1.59 109.721 -179.718 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.9 t -66.46 -45.68 78.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.027 -1.045 . . . . 1.38 109.332 179.682 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.85 -44.56 97.69 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.026 -2.029 . . . . 0.87 108.026 178.9 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 80' ' ' LEU . 69.2 ttt180 -62.98 -35.31 79.75 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.357 -0.979 . . . . 3.62 108.357 178.638 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.442 ' O ' ' OG ' ' A' ' 51' ' ' SER . . . -55.87 -39.93 72.22 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.834 -0.802 . . . . 1.43 108.834 179.801 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 50' ' ' ALA . 18.9 ttmt -63.32 -74.63 0.09 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.088 -1.078 . . . . 3.08 108.088 179.531 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.38 -31.82 0.06 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.363 -0.836 . . . . 1.33 111.682 -177.978 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 48' ' ' ALA . 75.6 p -60.1 -54.17 49.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.562 -1.336 . . . . 1.85 108.669 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.99 -42.44 73.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.339 -0.851 . . . . 1.35 111.055 -179.298 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.45 -40.5 97.3 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.826 -1.171 . . . . 2.34 110.552 -178.805 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.27 -39.66 92.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.874 -1.141 . . . . 2.2 108.993 179.603 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -59.95 -37.85 80.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.35 -0.844 . . . . 1.35 109.515 179.379 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -64.7 -41.2 96.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 1.34 110.46 -179.67 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.405 HG22 HD13 ' A' ' 57' ' ' ILE . 96.5 mt -64.62 -39.83 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.108 -0.995 . . . . 1.26 109.373 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.449 ' NZ ' ' OE2' ' A' ' 70' ' ' GLU . 13.2 ttpp -59.35 -49.98 75.73 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.275 -0.89 . . . . 1.7 109.121 -179.858 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.401 ' H ' ' HG1' ' A' ' 59' ' ' THR . 4.1 m -61.13 -40.03 92.26 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.211 -0.931 . . . . 1.35 110.493 -178.795 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -63.7 -38.86 92.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.096 -1.003 . . . . 2.08 109.155 179.692 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.14 -41.56 94.66 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.582 -0.699 . . . . 1.21 109.746 179.574 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.65 -50.39 66.7 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 110.24 -1.144 . . . . 0.75 110.24 -179.488 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.89 -43.0 72.67 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.881 -1.364 . . . . 1.59 109.654 -179.65 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.9 m -71.27 -59.84 2.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.035 -1.041 . . . . 1.41 112.06 -178.476 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -91.18 -54.16 4.05 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.678 -1.264 . . . . 0.79 110.603 -178.801 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.58 -169.32 25.21 Favored Glycine 0 N--CA 1.5 2.916 0 C-N-CA 120.071 -1.062 . . . . 1.22 111.224 179.748 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -70.01 -24.14 63.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.951 -0.735 . . . . 5.81 109.958 -179.954 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.507 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.8 tp10 -60.45 -38.04 82.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.888 . . . . 3.37 109.899 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -99.44 -19.43 16.96 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.395 -0.815 . . . . 2.37 110.604 -179.317 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.449 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 61.8 tt0 -68.1 -39.99 82.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.902 -1.124 . . . . 1.65 109.837 -179.528 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.28 -33.78 76.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.411 -0.806 . . . . 1.42 110.384 -178.886 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.07 -42.37 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.752 -1.217 . . . . 1.43 109.222 -179.849 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -72.59 -34.8 67.68 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.39 -0.819 . . . . 1.08 110.487 -179.213 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.503 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 72.6 tt0 -59.97 -40.07 87.81 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.838 -1.164 . . . . 1.37 109.198 179.035 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.98 -41.2 97.8 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.41 -1.876 . . . . 0.67 108.41 179.081 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -61.78 -48.53 80.25 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.341 -1.093 . . . . 1.99 108.785 179.365 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.3 -50.56 79.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.563 -0.711 . . . . 1.22 109.851 -179.776 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.6 ttp -60.98 -44.2 97.7 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.009 -1.057 . . . . 2.11 109.238 -179.639 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 tp -60.05 -39.91 87.59 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.579 -0.701 . . . . 1.33 109.114 179.214 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.52 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 58.6 tp -69.66 -35.06 74.83 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.604 -0.685 . . . . 1.29 109.968 -179.387 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -85.43 0.43 52.28 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.92 -1.112 . . . . 1.47 110.002 -179.276 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -46.3 130.07 10.5 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.201 -0.937 . . . . 1.47 109.879 -179.221 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -61.36 -22.33 64.84 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.458 -0.776 . . . . 1.78 111.011 -179.124 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.99 -31.76 69.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.874 -1.141 . . . . 2.53 109.417 179.15 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.2 mt -71.98 -40.02 68.87 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.673 0.749 . . . . 1.36 109.368 179.093 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.03 -49.25 78.38 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.724 -0.61 . . . . 1.42 110.827 -178.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -70.0 -42.01 73.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.17 -0.957 . . . . 2.27 111.061 -178.498 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.94 -39.94 75.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.964 . . . . 1.57 111.491 -178.824 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.7 mt -68.0 -45.22 84.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 120.973 -1.08 . . . . 1.19 109.782 -179.517 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -69.76 -38.79 76.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.322 -0.861 . . . . 1.39 110.089 179.831 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.66 -45.23 93.77 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 1.39 111.593 -178.913 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 99.3 mt -60.07 -44.22 94.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.83 -1.169 . . . . 1.5 109.533 -178.633 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.3 mt -61.19 -50.11 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.166 -0.959 . . . . 1.29 109.291 179.406 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -67.51 -40.01 85.13 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 120.22 -0.592 . . . . 2.64 111.436 -179.318 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -83.66 -52.14 6.69 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.752 -1.218 . . . . 1.65 112.025 -178.557 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -90.01 -0.05 57.37 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.119 -0.988 . . . . 2.5 112.026 -177.218 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 80.7 m80 55.1 33.81 21.21 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.834 -1.166 . . . . 1.88 109.486 -179.812 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 75.2 mtp -84.9 166.4 16.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.55 -0.719 . . . . 1.71 109.599 -179.625 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.499 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 76.8 p -78.64 154.85 29.88 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.171 -1.048 . . . . 1.61 108.171 179.187 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.0 -39.26 75.97 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.062 -1.024 . . . . 1.33 110.015 -179.707 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -63.23 -40.19 96.75 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.101 -1.0 . . . . 2.07 109.621 -179.695 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.499 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -82.05 -46.12 14.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.104 -0.997 . . . . 1.37 109.655 179.463 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.98 -46.15 90.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.454 -0.779 . . . . 1.14 109.71 -179.539 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.96 75.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.149 -0.97 . . . . 1.26 109.478 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -59.98 -34.79 73.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.861 . . . . 2.02 110.042 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -60.0 -41.27 91.71 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.176 -0.952 . . . . 1.33 109.103 -179.653 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.8 t -64.78 -49.96 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 1.3 110.072 -179.46 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.1 mm -69.05 -40.28 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.047 -1.033 . . . . 1.32 109.027 179.622 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -64.92 -40.01 94.4 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.722 -0.844 . . . . 2.44 108.722 179.362 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.97 -49.26 80.5 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.244 -1.142 . . . . 0.99 110.244 -179.76 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -66.4 -51.81 53.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.929 -1.336 . . . . 1.97 109.11 -179.493 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.97 93.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 1.43 109.718 179.583 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.8 p -58.38 -39.69 80.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 2.12 108.8 -179.701 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.96 -35.6 75.32 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.34 -0.85 . . . . 1.64 109.214 179.664 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.5 mt -66.2 -42.88 88.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.974 -1.079 . . . . 1.93 109.485 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -56.99 -32.71 66.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.072 -1.018 . . . . 2.2 109.327 -179.091 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.03 -28.43 67.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -0.889 . . . . 2.12 108.966 179.859 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 59.6 mt -64.23 148.29 50.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.366 -0.834 . . . . 2.34 109.199 -179.927 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -100.07 57.1 0.96 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.175 -0.953 . . . . 3.23 109.448 179.802 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 58.8 t0 -136.0 135.23 39.32 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.247 -0.908 . . . . 2.49 110.514 -179.681 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.465 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 38.7 mt-10 -70.0 -32.46 70.64 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.338 -0.851 . . . . 3.95 109.903 179.313 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.48 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.4 t80 -69.6 -36.4 76.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.45 -0.781 . . . . 2.25 110.815 -179.805 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.2 mt -80.73 -34.66 34.27 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.754 -1.216 . . . . 2.27 109.47 179.866 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -60.49 -44.46 95.92 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.121 -0.987 . . . . 3.31 109.235 179.447 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -69.53 -40.09 77.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 2.73 109.516 -179.912 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -60.64 -40.07 90.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.229 -0.92 . . . . 3.2 108.565 179.408 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 128' ' ' ALA . . . -59.44 -45.59 91.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.137 -0.977 . . . . 1.66 108.459 179.689 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 127' ' ' ALA . . . -44.3 -43.89 7.71 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.097 -0.705 . . . . 1.67 109.097 179.992 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -61.9 -45.85 91.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.389 -0.82 . . . . 1.55 109.868 179.389 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.14 -39.98 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.21 -0.931 . . . . 1.32 108.918 -179.896 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.672 ' HE ' ' NZ ' ' A' ' 135' ' ' LYS . 69.4 ttt180 -60.0 -39.41 85.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 3.58 109.147 179.528 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -60.02 -37.8 80.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.228 -0.92 . . . . 1.46 109.934 -179.749 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.03 -44.32 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.048 -1.032 . . . . 1.22 109.657 -179.205 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.95 -33.83 59.42 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.709 -1.234 . . . . 0.61 110.172 179.882 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.672 ' NZ ' ' HE ' ' A' ' 131' ' ' ARG . 37.5 mmtm -59.99 -46.88 88.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.151 -1.205 . . . . 3.1 110.061 -179.011 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -65.93 -34.21 77.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.802 -1.186 . . . . 3.71 109.452 179.86 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.0 tp -57.24 -42.01 80.65 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.655 -0.868 . . . . 1.87 108.655 -179.252 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.5 mt -60.88 -40.12 91.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 1.29 109.296 178.377 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.444 HH11 ' HG2' ' A' ' 139' ' ' ARG . 47.2 mtt-85 -69.68 -40.11 76.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 3.05 109.52 -179.915 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -66.93 -37.96 85.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.584 -0.698 . . . . 1.26 111.757 -178.827 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.418 HD12 HG22 ' A' ' 141' ' ' ILE . 96.8 mt -71.22 -40.01 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.411 -1.43 . . . . 1.34 109.43 179.61 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 60.8 mt -75.48 -12.25 60.2 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.618 -0.676 . . . . 1.6 110.819 -178.344 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.98 35.43 57.93 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.636 -1.785 . . . . 0.96 108.636 -179.286 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.0 tp -73.4 142.43 46.96 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.485 -1.009 . . . . 1.67 109.275 -179.19 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -72.37 140.77 48.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.38 -0.825 . . . . 4.96 110.441 -179.062 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.427 HG22 HD12 ' A' ' 146' ' ' ILE . 85.4 mt -112.58 129.96 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-O 122.007 0.908 . . . . 1.68 109.289 179.468 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.3 mt -62.07 -43.21 97.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.912 -0.585 . . . . 2.14 110.783 -178.588 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.9 t0 66.58 122.35 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.529 -0.732 . . . . 1.5 109.079 -179.016 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.5 mt -92.69 0.67 57.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.394 -0.816 . . . . 1.39 110.637 -179.034 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.7 p -83.61 -15.3 49.56 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.745 -1.222 . . . . 1.83 110.413 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.99 29.97 0.33 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.115 -0.991 . . . . 1.46 112.199 -177.997 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.3 mm -83.77 125.17 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.379 -1.45 . . . . 1.42 109.188 179.623 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -104.32 -12.74 16.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.4 -0.813 . . . . 2.94 109.755 -179.826 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -137.83 156.96 47.38 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.237 -0.914 . . . . 1.52 110.213 -179.107 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.66 135.11 56.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.282 -0.886 . . . . 1.58 109.226 -179.64 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.7 m -153.05 168.14 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.398 -0.813 . . . . 1.32 110.146 179.403 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 80.6 mt -98.79 143.89 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 105.772 -1.936 . . . . 1.27 105.772 177.212 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 47.4 tp -97.68 120.1 37.45 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.772 -1.205 . . . . 1.41 109.993 -178.464 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.0 t -119.79 127.9 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.059 -0.719 . . . . 1.23 109.059 179.833 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.86 161.5 34.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.899 . . . . 1.32 108.888 179.87 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.82 -32.72 67.86 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.438 -1.414 . . . . 1.49 108.077 178.579 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -170.35 143.49 2.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.493 -0.754 . . . . 2.25 109.564 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 54.9 mt -116.53 141.03 48.71 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.44 -0.788 . . . . 1.35 109.554 -179.499 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 48.4 p -95.29 145.82 30.22 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.14 -0.975 . . . . 1.56 110.226 -179.429 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -40.6 -36.78 1.95 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.512 2.141 . . . . 0.87 112.802 179.029 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 63.9 m -59.03 -39.87 83.26 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.317 -0.864 . . . . 1.36 109.183 -179.076 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.58 -40.05 84.85 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.295 -0.878 . . . . 1.61 109.91 -179.709 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.7 p -58.17 -23.29 54.9 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.956 -1.09 . . . . 1.21 110.408 -178.863 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.78 -56.44 4.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.092 -1.005 . . . . 1.21 109.562 179.694 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -84.17 42.24 0.87 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.805 -1.183 . . . . 2.11 107.805 179.611 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.5 tp -101.81 140.99 35.36 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.207 -0.664 . . . . 1.29 109.207 179.472 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -89.95 103.02 15.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.155 -0.965 . . . . 2.81 108.681 179.293 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 70.5 mt -67.19 -44.09 80.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.418 -0.801 . . . . 2.09 111.914 -178.072 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -69.98 -25.47 63.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.759 -1.213 . . . . 2.86 112.512 -177.525 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -93.4 -5.5 49.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.621 -1.299 . . . . 2.39 110.722 -178.328 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -86.13 139.99 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.834 -1.167 . . . . 1.27 110.496 -179.845 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.0 mt -103.91 -12.37 16.91 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 109.593 -0.521 . . . . 2.17 109.593 178.587 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 162.6 179.51 37.23 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.247 -1.541 . . . . 0.52 109.247 179.986 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -130.51 129.37 42.79 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.221 -1.164 . . . . 0.55 110.158 -179.95 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 66.5 mt -128.65 120.55 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.383 -0.969 . . . . 1.27 108.383 177.756 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 61.0 p -148.78 160.81 42.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.742 -1.224 . . . . 1.39 110.555 -179.654 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -110.08 30.29 6.86 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.123 -0.695 . . . . 2.46 109.123 179.321 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -74.66 -158.3 0.07 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.67 -1.269 . . . . 1.51 112.339 -177.499 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -54.56 -80.95 0.07 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.676 -0.97 . . . . 2.23 110.676 -179.403 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . 0.544 ' H ' ' HG ' ' A' ' 188' ' ' SER . . . 163.02 -115.88 0.68 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.369 -1.396 . . . . 2.23 110.405 -179.836 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.49 HH11 ' HG2' ' A' ' 186' ' ' ARG . 0.5 OUTLIER -68.49 -30.2 68.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.469 -1.018 . . . . 6.44 111.002 -178.856 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.0 p -79.97 7.42 9.01 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.006 -1.059 . . . . 4.09 110.544 -178.62 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.544 ' HG ' ' H ' ' A' ' 185' ' ' GLY . 61.0 m -90.95 128.6 36.85 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.821 -1.174 . . . . 2.2 110.702 -179.528 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -47.27 -48.62 24.69 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.381 -0.824 . . . . 1.15 109.493 179.929 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.2 m -60.04 -39.92 87.6 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 2.01 109.961 -179.153 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 62.1 m -60.01 -39.95 87.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.985 -1.072 . . . . 1.93 109.335 -179.38 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.5 mm -66.31 -40.28 86.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.278 -0.889 . . . . 2.2 109.235 -179.92 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 92.9 mtp -64.63 -39.99 94.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.123 -0.986 . . . . 1.32 111.254 -179.538 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.61 -43.27 93.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.313 -1.492 . . . . 1.3 108.978 -179.644 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -59.93 -49.92 75.79 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.244 -0.91 . . . . 3.38 109.786 -179.566 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.5 m -70.03 -34.21 72.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.039 -1.038 . . . . 1.15 110.631 -179.226 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.0 mt -76.07 -21.68 56.48 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.08 -1.012 . . . . 1.28 109.533 -179.413 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 61.28 47.7 6.76 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.543 -0.723 . . . . 1.5 110.633 -179.646 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 63.4 mt -121.52 135.58 25.22 Favored Pre-proline 0 N--CA 1.501 2.124 0 N-CA-C 108.514 -0.921 . . . . 1.37 108.514 178.662 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -43.64 128.93 6.83 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.021 1.814 . . . . 0.76 112.124 -179.947 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -166.42 144.32 5.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.597 -1.315 . . . . 1.19 112.151 -179.79 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.409 HD11 HG23 ' A' ' 202' ' ' ILE . 94.9 mt -124.55 144.53 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 106.763 -1.569 . . . . 1.31 106.763 177.656 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.48 -10.56 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 120.78 -1.2 . . . . 1.38 111.554 -178.372 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -103.6 23.76 31.83 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.592 -1.403 . . . . 1.03 109.592 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.6 p -45.98 -42.44 13.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -1.125 . . . . 1.38 109.971 -179.194 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 89.94 -49.1 3.29 Favored Glycine 0 N--CA 1.498 2.767 0 O-C-N 120.963 -1.086 . . . . 1.17 111.113 179.336 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.422 ' O ' ' OG ' ' A' ' 207' ' ' SER . 13.8 t -165.92 40.41 0.06 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.714 -1.463 . . . . 2.07 110.731 -179.612 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 49.2 t -79.45 -37.71 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.081 -1.081 . . . . 1.35 108.081 177.865 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.8 p -52.56 -27.22 15.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.663 -0.648 . . . . 1.49 109.703 -179.906 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 69.8 m -78.94 -26.5 43.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 2.16 109.856 -179.629 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -92.3 -8.3 45.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.043 -1.036 . . . . 2.89 109.856 -179.672 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 64.8 t -105.17 133.77 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.436 -0.79 . . . . 1.33 110.272 -178.955 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.482 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 70.2 mmtt -113.39 154.0 27.66 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 106.976 -1.49 . . . . 2.73 106.976 178.309 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 55.7 t-20 -59.95 138.98 57.7 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.955 -1.091 . . . . 2.7 110.238 -178.622 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 84.85 -1.69 0.9 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 121.116 0.484 . . . . 2.38 110.801 179.115 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.482 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 92.7 m-20 -70.38 148.1 48.79 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.13 -0.981 . . . . 2.09 109.107 178.978 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -96.9 119.98 36.39 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.913 -1.144 . . . . 1.45 107.913 179.16 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 87.1 mt -126.72 147.26 49.98 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.369 -0.832 . . . . 1.31 110.237 -178.876 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 99.9 mt -117.79 127.21 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.152 -1.425 . . . . 1.29 107.152 177.291 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 17.7 tp -100.94 120.6 40.41 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.257 -0.902 . . . . 1.31 109.584 -178.657 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 223' ' ' VAL . 7.1 t70 -76.01 -41.45 51.02 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.025 -1.102 . . . . 2.31 108.025 179.42 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 49.01 9.94 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.722 -0.611 . . . . 1.19 109.83 179.788 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.537 ' H ' ' C ' ' A' ' 221' ' ' ASP . 60.4 t -126.73 -35.12 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.619 -1.252 . . . . 1.45 107.619 178.66 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.492 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 98.6 m-20 -108.39 3.58 23.48 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.297 -1.001 . . . . 3.13 108.297 178.686 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 38.7 t30 59.86 45.52 12.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.64 -0.662 . . . . 2.2 110.352 179.981 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -138.92 144.55 39.13 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.168 -0.957 . . . . 2.32 109.792 179.392 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.2 t -115.35 130.13 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.66 -0.867 . . . . 1.4 108.66 179.381 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -104.63 126.13 51.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.444 -0.785 . . . . 1.29 108.98 179.5 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.1 t -100.03 106.99 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.272 -0.893 . . . . 1.38 109.954 -179.55 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 39.3 t30 49.92 61.0 14.46 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.189 -0.945 . . . . 2.33 111.422 178.002 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.83 158.39 27.74 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.494 2.13 . . . . 0.95 111.538 178.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.2 m -68.42 159.68 31.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.044 -1.035 . . . . 2.31 110.354 -178.923 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -59.95 -40.0 87.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.549 -0.719 . . . . 3.45 109.732 -179.619 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.05 -39.25 85.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 2.89 109.389 -179.985 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.9 t -67.5 -39.96 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.312 -0.868 . . . . 1.73 108.91 179.359 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.9 mt . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.319 -0.863 . . . . 1.57 109.247 179.32 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 45.5 ttm . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.408 0.623 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -151.02 148.17 28.02 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.153 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -152.19 161.6 42.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.935 -1.103 . . . . 0.0 111.039 -178.989 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -156.23 155.06 31.75 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.91 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -110.45 135.71 50.72 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.295 -0.878 . . . . 0.0 111.102 -179.055 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . 0.445 ' CG2' ' N ' ' B' ' 307' ' ' THR . 2.7 p -120.06 165.27 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.94 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 307' ' ' THR . . . . . 0.445 ' N ' ' CG2' ' B' ' 306' ' ' VAL . 70.9 m -119.11 115.96 25.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.101 -1.0 . . . . 0.0 108.328 178.526 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 60.2 mt -56.22 120.9 3.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-O 122.366 1.079 . . . . 0.0 110.893 -178.434 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 65.2 p -109.47 24.34 13.21 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.863 -179.945 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -85.17 116.65 66.38 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 108.725 179.618 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -68.33 -7.42 20.04 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 CA-C-N 120.201 1.108 . . . . 0.0 111.477 -179.948 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -119.12 6.61 11.27 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.634 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.52 175.76 43.86 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.366 -1.893 . . . . 0.0 108.366 -179.039 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.48 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -83.65 95.51 8.38 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.008 -1.289 . . . . 0.0 108.952 -178.874 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -96.66 -160.48 0.8 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.835 -1.165 . . . . 0.0 109.805 179.15 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 4.0 m -59.97 -43.46 95.06 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.942 -1.099 . . . . 0.0 112.278 -176.287 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.507 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 2.6 tpt180 -54.82 -62.06 4.78 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.44 -1.412 . . . . 0.0 111.299 -178.65 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -58.73 -36.42 97.14 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 CA-C-N 120.221 1.115 . . . . 0.0 111.181 179.787 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.71 72.65 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.503 -0.748 . . . . 0.0 108.989 179.77 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -56.84 -44.07 81.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.774 -179.182 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -69.91 -42.29 73.56 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.013 -1.055 . . . . 0.0 108.48 179.353 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -59.87 -50.04 75.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.673 -0.642 . . . . 0.0 111.192 -179.204 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 72.7 t -70.94 -28.65 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.556 -1.34 . . . . 0.0 109.875 -179.175 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . 0.503 ' NZ ' ' OE1' ' A' ' 74' ' ' GLU . 22.7 ttmt -60.05 -47.69 84.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.2 -0.938 . . . . 0.0 109.905 -179.203 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -65.31 -40.02 93.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.087 -1.008 . . . . 0.0 110.239 -179.292 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.67 -52.94 62.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.913 -1.117 . . . . 0.0 111.129 -179.025 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -60.58 -13.02 11.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.874 -1.141 . . . . 0.0 109.708 -179.515 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -67.46 -30.4 75.07 Favored Glycine 0 N--CA 1.485 1.967 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 178.608 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -106.11 144.15 33.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.654 -0.909 . . . . 0.0 108.942 179.587 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 25.3 p -90.34 -12.35 37.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.989 -1.069 . . . . 0.0 109.626 -179.993 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.7 t -58.49 147.98 29.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 109.117 179.768 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -66.71 131.89 46.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.247 -0.908 . . . . 0.0 109.201 -179.813 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 79.3 mt -130.92 130.33 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.492 -0.755 . . . . 0.0 109.293 179.938 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 28.6 m -131.46 153.8 49.38 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.569 -0.707 . . . . 0.0 109.433 179.568 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 68.7 t -116.09 139.27 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.081 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.7 m -129.49 121.99 28.37 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.177 -0.952 . . . . 0.0 108.995 179.771 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 42.0 p -138.72 119.37 14.03 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.013 0.911 . . . . 0.0 111.052 -179.272 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 57.5 t30 41.78 59.01 2.63 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 177.265 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 82.0 -14.6 31.64 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 120.369 -1.457 . . . . 0.0 113.087 176.316 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -115.94 128.68 55.95 Favored 'General case' 0 N--CA 1.506 2.34 0 CA-C-N 119.264 1.532 . . . . 0.0 109.425 179.978 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 81.0 p -129.55 150.82 50.72 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.807 0.813 . . . . 0.0 110.172 -179.089 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -143.54 166.49 24.66 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.682 0.753 . . . . 0.0 110.185 -179.223 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 343' ' ' SER . . . . . 0.419 ' OG ' ' NZ ' ' B' ' 345' ' ' LYS . 4.6 t -91.27 142.41 27.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.662 -0.648 . . . . 0.0 109.643 -179.587 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -80.02 -12.42 59.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 109.984 -179.508 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . 0.419 ' NZ ' ' OG ' ' B' ' 343' ' ' SER . 23.3 pttm -91.16 18.96 6.24 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.427 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.665 ' HG ' ' HZ3' ' B' ' 349' ' ' LYS . 19.7 m -146.05 95.92 2.71 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.279 -179.09 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 8.3 tp -59.96 -32.29 70.67 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.663 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -59.87 -54.53 45.07 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.524 -0.735 . . . . 0.0 110.636 -178.858 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.665 ' HZ3' ' HG ' ' B' ' 346' ' ' SER . 34.2 mtmm -67.0 -40.09 87.25 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.56 -1.337 . . . . 0.0 109.387 -178.633 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' B' ' 352' ' ' THR . 32.8 mt -50.19 -57.08 8.55 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.122 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -41.02 -17.66 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.864 -0.523 . . . . 0.0 111.099 -178.833 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.539 ' N ' ' O ' ' B' ' 350' ' ' LEU . 82.0 p -90.61 -5.98 55.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.183 -1.573 . . . . 0.0 110.567 -179.135 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 83.6 mt -92.96 108.63 20.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.945 -1.097 . . . . 0.0 109.639 179.434 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -68.25 84.67 0.18 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 107.81 -2.116 . . . . 0.0 107.81 178.774 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 71.0 mt -99.16 95.97 7.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.326 -1.103 . . . . 0.0 108.326 179.483 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 44.8 p -98.32 176.6 5.65 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.255 -0.903 . . . . 0.0 110.461 -178.604 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -44.62 159.15 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.355 1.074 . . . . 0.0 111.413 -179.327 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 41.09 23.3 0.08 OUTLIER Glycine 0 N--CA 1.497 2.701 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.601 177.608 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 4.5 m -87.4 108.04 18.82 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.459 -1.612 . . . . 0.0 109.501 179.595 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 57.8 t -77.28 123.2 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.784 -177.36 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.6 m -122.43 175.77 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -178.477 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 94.0 m -125.07 132.32 53.19 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.726 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 96.8 mt -100.73 121.78 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.484 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 54.0 p -124.09 133.92 53.5 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.524 -0.735 . . . . 0.0 109.471 -179.054 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.53 152.18 39.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.425 -0.797 . . . . 0.0 109.368 -179.489 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -141.97 119.77 11.89 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.529 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.527 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 159.68 -154.51 25.56 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.76 -1.686 . . . . 0.0 112.046 -179.935 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -58.05 -54.72 43.71 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -177.271 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' B' ' 370' ' ' GLU . 83.4 m-20 -112.39 14.42 20.37 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.028 -1.045 . . . . 0.0 111.177 -177.644 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.527 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.1 pt-20 -39.19 -37.52 0.41 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.621 -0.674 . . . . 0.0 110.926 -179.437 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -69.42 -46.18 67.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.022 -1.049 . . . . 0.0 111.064 -178.025 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.86 -49.48 65.54 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.864 -1.148 . . . . 0.0 110.374 -179.12 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -55.23 -35.15 64.63 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.082 -1.011 . . . . 0.0 111.477 -178.048 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 72.8 t -69.94 -41.04 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.458 -1.401 . . . . 0.0 108.264 178.996 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -63.86 -59.45 4.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.522 -0.736 . . . . 0.0 111.916 -178.737 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -67.84 -40.11 83.75 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.63 -1.294 . . . . 0.0 111.963 -177.306 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.4 -38.01 73.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.553 -1.342 . . . . 0.0 108.757 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 51.5 t -60.01 -42.04 88.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.255 -0.903 . . . . 0.0 109.285 179.499 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . 0.441 ' O ' ' OE2' ' B' ' 383' ' ' GLU . 19.1 mmmt -69.43 -55.02 11.5 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.082 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 64.3 tp -54.22 -38.65 65.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.786 -0.571 . . . . 0.0 110.604 -177.377 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 381' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' B' ' 381' ' ' MET . 0.0 OUTLIER -73.34 -40.01 64.76 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.619 -1.232 . . . . 0.0 108.607 178.238 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.08 -3.4 48.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.095 -1.003 . . . . 0.0 109.775 179.411 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.441 ' OE2' ' O ' ' B' ' 379' ' ' LYS . 0.0 OUTLIER -111.65 -3.02 15.18 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.378 -0.827 . . . . 0.0 111.026 -179.331 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.03 128.9 40.65 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.499 -1.376 . . . . 0.0 109.688 179.411 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 118.103 -0.951 . . . . 0.0 109.218 179.524 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.7 mtt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.471 -0.566 . . . . 3.19 109.471 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 87.5 mt -106.85 120.09 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.525 -0.734 . . . . 1.71 109.095 179.937 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.7 m -132.85 133.34 43.2 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.468 -0.77 . . . . 1.66 109.228 179.829 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.775 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -115.27 -162.38 13.54 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 108.44 -1.864 . . . . 1.05 108.44 179.496 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 6' ' ' LEU . 79.5 mt -91.6 -12.9 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.95 -1.324 . . . . 1.59 109.648 -179.478 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.0 tp 53.75 99.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.145 -0.972 . . . . 1.47 108.822 -179.569 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.15 -40.18 74.9 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.687 -0.857 . . . . 1.39 108.687 179.315 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.5 m -149.05 147.95 25.49 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.431 -0.793 . . . . 2.09 109.744 179.574 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.73 146.99 17.02 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.671 2.248 . . . . 0.91 113.272 -179.925 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 165.19 -164.04 36.89 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 109.105 -1.598 . . . . 0.92 109.105 179.756 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.1 mt -149.84 149.88 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 120.914 -1.344 . . . . 1.35 109.124 179.208 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.38 156.22 33.5 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.037 -1.04 . . . . 1.14 110.552 179.214 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.4 m-85 -137.02 129.14 29.47 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 107.85 -1.167 . . . . 0.7 107.85 178.597 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.22 -179.13 44.83 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 118.652 -1.737 . . . . 0.58 110.996 179.847 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -79.89 155.21 27.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.747 -0.854 . . . . 2.63 109.533 -179.972 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -101.89 129.99 48.26 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.45 -0.781 . . . . 1.27 110.563 -179.3 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.0 tp -96.31 135.17 38.51 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.205 -1.406 . . . . 1.41 107.205 178.42 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.4 tp -113.48 118.29 34.07 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.219 -0.925 . . . . 1.49 109.773 -179.532 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 51.0 mt -85.98 102.88 14.17 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.432 0.635 . . . . 1.52 109.502 -179.947 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -97.56 137.33 36.65 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.376 -0.828 . . . . 3.17 109.971 -179.39 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -130.5 132.99 45.92 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.72 -0.844 . . . . 3.0 108.72 179.492 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -78.69 138.34 38.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.967 -1.083 . . . . 2.77 109.053 179.748 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.81 139.97 57.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 2.94 108.762 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.7 mt -85.22 132.76 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 1.46 109.416 -179.264 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.6 t -106.96 129.69 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.25 -0.906 . . . . 1.7 109.762 -179.748 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.3 mt -99.21 141.14 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.36 -0.838 . . . . 1.54 109.074 179.734 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -98.96 118.94 36.88 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.162 -0.961 . . . . 1.81 109.441 -179.961 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -90.11 3.07 54.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.465 -0.772 . . . . 3.23 109.887 -179.275 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -59.97 144.18 49.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.043 -1.036 . . . . 3.29 109.67 -179.895 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -92.0 143.5 26.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.208 -0.932 . . . . 2.8 108.963 179.654 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 pt -93.55 165.79 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.131 -0.981 . . . . 1.43 110.438 -179.346 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.2 p -88.96 170.42 10.7 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.02 -1.104 . . . . 1.54 108.02 178.281 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.19 -18.47 63.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.879 -1.138 . . . . 1.6 110.176 -179.799 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 53.7 t0 -83.55 -26.75 29.84 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.893 -1.129 . . . . 2.56 108.605 179.14 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -82.18 -7.64 59.63 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.983 -0.747 . . . . 2.36 108.983 179.036 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.3 t -60.49 -53.14 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.254 -0.904 . . . . 1.43 109.253 179.77 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.81 -39.96 90.89 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.321 -0.862 . . . . 1.77 109.969 -179.447 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -63.46 -40.21 96.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.246 -0.909 . . . . 3.32 110.997 -179.298 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -65.94 -40.03 91.02 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.742 -1.224 . . . . 1.51 110.593 -179.395 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.01 -46.9 93.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 118.163 -1.415 . . . . 1.41 108.379 -179.614 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.03 -41.57 92.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.839 -1.163 . . . . 1.81 109.703 179.806 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -59.95 -44.82 94.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.805 -1.185 . . . . 3.26 108.576 179.131 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -63.18 -47.44 82.59 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.456 -0.778 . . . . 0.81 109.523 178.886 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.0 tp -59.96 -49.08 79.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.294 -0.879 . . . . 1.59 109.075 -179.069 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.8 t -64.27 -42.25 96.55 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.965 -1.084 . . . . 1.38 108.874 179.452 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.25 -48.86 84.04 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.544 -1.823 . . . . 0.87 108.544 179.117 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -60.64 -38.69 85.64 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.436 -1.038 . . . . 3.62 108.434 178.594 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.41 -40.06 70.96 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.096 -0.705 . . . . 1.43 109.096 -179.855 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 51' ' ' SER . 24.1 ttmt -61.16 -74.48 0.08 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.439 -1.319 . . . . 3.08 107.439 179.46 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.68 -30.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.39 -0.819 . . . . 1.33 111.427 -178.254 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 49' ' ' LYS . 18.3 t -60.0 -54.59 44.2 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.771 -1.172 . . . . 1.85 108.587 179.673 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.69 -42.81 77.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.611 -0.68 . . . . 1.35 111.161 -179.016 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.85 -45.68 93.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.801 -1.187 . . . . 2.34 110.675 -179.046 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.99 -40.18 94.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.927 -1.108 . . . . 2.2 109.477 -179.406 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -60.87 -39.77 90.43 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.252 -0.905 . . . . 1.35 110.031 179.861 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -65.41 -43.34 90.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.934 -1.104 . . . . 1.34 109.269 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.549 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.8 mt -61.68 -39.87 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 1.26 108.922 179.537 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -54.98 -50.38 69.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.752 . . . . 1.7 109.657 -179.469 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -57.33 -33.87 68.17 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.321 -0.862 . . . . 1.35 110.492 -178.088 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.417 ' O ' ' OG1' ' A' ' 64' ' ' THR . 97.6 mttt -69.83 -37.46 76.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 2.08 109.45 179.622 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.86 -46.07 79.82 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.677 -0.639 . . . . 1.21 110.192 -179.67 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.19 -52.81 44.71 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 110.159 -1.176 . . . . 0.75 110.159 -179.011 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -70.04 -43.92 70.3 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.997 -1.296 . . . . 1.59 110.255 -179.513 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 35.4 m -65.28 -65.25 0.7 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.092 -1.005 . . . . 1.41 112.987 -177.453 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -97.83 -42.59 7.5 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.812 -1.18 . . . . 0.79 111.667 -177.621 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.25 -168.98 25.22 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.752 -1.218 . . . . 1.22 111.014 179.499 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -73.77 -23.69 59.75 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.04 -0.682 . . . . 5.81 110.246 -179.966 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -62.46 -33.58 75.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 3.37 110.462 -179.077 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -99.06 -20.03 16.92 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.274 -0.891 . . . . 2.37 109.61 -179.801 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -69.92 -40.24 75.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.312 -0.868 . . . . 1.65 110.531 -178.845 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.643 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -69.15 -27.31 65.43 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.183 -0.948 . . . . 1.42 109.879 -179.002 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 94.2 mt -60.01 -40.4 83.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.793 -1.188 . . . . 1.43 107.793 179.894 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -62.1 -41.91 98.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -0.888 . . . . 1.08 108.906 179.281 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.521 ' CD ' ' HZ1' ' B' ' 324' ' ' LYS . 65.2 tt0 -60.86 -39.91 90.93 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.633 -0.827 . . . . 1.37 109.345 179.15 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.44 -47.82 88.51 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.881 -1.687 . . . . 0.67 108.881 179.531 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -64.06 -40.12 95.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.496 -1.002 . . . . 1.99 109.032 179.582 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.2 mt -69.4 -45.73 78.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.342 -0.849 . . . . 1.22 109.451 179.717 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.4 ttp -63.61 -40.07 95.99 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.04 -1.038 . . . . 2.11 110.16 -178.69 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.95 -40.03 90.98 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.396 -0.815 . . . . 1.33 109.959 -179.961 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.7 tp -65.5 -39.94 92.46 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.684 -0.635 . . . . 1.29 110.207 -178.775 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -84.68 4.72 31.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.896 -1.127 . . . . 1.47 110.039 -178.897 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.1 t0 -49.18 134.55 17.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.175 -0.953 . . . . 1.47 109.765 -179.666 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.46 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.6 mt-10 -60.69 -20.02 59.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.612 -0.68 . . . . 1.78 110.798 -178.728 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -71.36 -33.39 69.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.055 -1.028 . . . . 2.53 110.171 179.569 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.9 mt -75.02 -41.09 60.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.477 -0.764 . . . . 1.36 110.146 179.864 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.05 -50.05 75.24 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.227 -0.921 . . . . 1.42 110.732 -178.92 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.03 -40.74 74.98 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.05 -1.031 . . . . 2.27 111.665 -178.802 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -69.98 -39.16 76.11 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.031 -1.043 . . . . 1.57 111.354 -178.818 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.8 mt -67.67 -42.05 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.93 . . . . 1.19 109.116 -179.757 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.7 mt -65.82 -39.21 84.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.51 -0.744 . . . . 1.39 109.622 179.38 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.09 -49.45 77.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 1.39 111.451 -178.629 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.8 mt -60.99 -46.4 90.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.711 -1.243 . . . . 1.5 109.821 -178.866 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.03 -50.01 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 122.115 0.96 . . . . 1.29 109.075 179.729 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -70.43 -40.21 73.94 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 120.091 -0.644 . . . . 2.64 110.834 -179.762 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -81.13 -62.48 1.65 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.036 -1.04 . . . . 1.65 112.078 -178.135 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -82.55 -0.97 49.21 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.043 -1.036 . . . . 2.5 111.999 -177.025 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 73.3 m80 57.57 38.19 27.81 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.92 -1.112 . . . . 1.88 109.927 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.1 mtp -92.67 169.07 10.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.484 -0.76 . . . . 1.71 109.595 -179.937 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 99' ' ' THR . . . . . 0.48 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 44.7 p -81.55 160.23 23.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.28 -0.887 . . . . 1.61 109.559 -179.692 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.4 -39.72 77.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.33 -0.856 . . . . 1.33 109.937 -179.772 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -67.01 -40.04 87.19 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -0.888 . . . . 2.07 109.498 179.817 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.48 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -78.65 -43.86 25.15 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.43 -0.794 . . . . 1.37 109.868 179.618 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.99 -42.92 72.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.339 -0.851 . . . . 1.14 110.568 -179.222 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.05 -44.12 96.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.166 -0.959 . . . . 1.26 109.819 -179.495 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -59.98 -38.71 83.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.321 -0.862 . . . . 2.02 110.386 -179.202 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.98 -40.28 88.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.012 . . . . 1.33 110.379 -179.172 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.1 t -64.74 -49.09 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.838 -1.164 . . . . 1.3 110.055 -179.38 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.5 mm -67.58 -40.09 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.069 -1.019 . . . . 1.32 109.214 -179.802 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.46 -38.87 88.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 2.44 108.808 179.336 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.96 -45.69 95.45 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 120.313 -0.946 . . . . 0.99 110.749 -179.487 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . 0.626 HE21 ' CB ' ' B' ' 348' ' ' PHE . 17.9 mm100 -70.04 -52.56 23.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.7 -1.471 . . . . 1.97 110.039 -179.118 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.2 88.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.855 . . . . 1.43 109.811 -179.497 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.2 t -57.88 -39.64 78.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.174 -0.954 . . . . 2.12 109.559 -179.287 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.16 -39.45 94.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 1.64 109.562 179.63 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.3 mt -61.94 -39.97 93.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.105 -0.997 . . . . 1.93 109.671 -179.202 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.438 ' CD ' ' NH2' ' A' ' 131' ' ' ARG . 36.3 mt-10 -58.91 -33.27 70.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.608 -1.307 . . . . 2.2 109.705 -179.141 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -56.33 -21.57 25.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.873 -1.142 . . . . 2.12 108.713 179.264 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.54 140.4 58.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 2.34 108.939 179.687 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -90.63 21.66 3.9 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.208 -0.932 . . . . 3.23 110.126 -179.426 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 51.9 t0 -112.86 141.28 46.86 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.402 -0.811 . . . . 2.49 109.569 -179.737 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 124' ' ' LYS . 92.8 mt-10 -72.54 -63.2 1.21 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.265 -1.013 . . . . 3.95 108.265 178.631 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.46 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.8 t80 -38.65 -41.42 0.69 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.031 -0.418 . . . . 2.25 110.932 -178.935 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.2 mt -69.85 -39.92 76.1 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.63 -1.293 . . . . 2.27 108.239 179.549 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 121' ' ' GLU . 63.1 tttp -60.77 -40.07 91.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 3.31 110.022 179.718 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.02 -45.01 94.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.017 -1.052 . . . . 2.73 109.77 -179.28 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.814 ' HE ' HE22 ' B' ' 351' ' ' GLN . 65.6 mtp180 -60.54 -39.94 89.7 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.167 -0.958 . . . . 3.2 108.505 179.214 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.76 -27.35 67.9 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.556 -0.905 . . . . 1.66 108.556 179.027 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.18 -40.05 95.29 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.135 -1.061 . . . . 1.67 108.135 178.792 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -64.16 -40.09 95.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.518 -0.739 . . . . 1.55 109.21 179.653 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.89 -42.73 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -0.864 . . . . 1.32 108.733 179.945 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.438 ' NH2' ' CD ' ' A' ' 116' ' ' GLU . 44.1 ttm180 -60.33 -36.72 78.62 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.522 0.677 . . . . 3.58 109.203 179.361 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -58.45 -39.61 80.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.438 -0.789 . . . . 1.46 109.036 -179.671 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.87 -45.45 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.209 -0.932 . . . . 1.22 108.838 179.843 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.18 -41.34 99.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.771 -1.332 . . . . 0.61 109.771 179.689 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -59.99 -50.04 75.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.188 -1.184 . . . . 3.1 110.274 -179.927 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.549 HH22 ' CD1' ' A' ' 57' ' ' ILE . 62.1 mtp180 -69.64 -32.37 71.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.807 -1.183 . . . . 3.71 109.72 -179.631 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -57.3 -47.86 80.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 1.87 108.772 -179.139 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.9 mt -61.13 -39.69 90.98 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.254 -0.904 . . . . 1.29 108.955 178.407 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.504 HH11 ' CD2' ' A' ' 144' ' ' LEU . 50.0 mtt-85 -67.61 -40.05 84.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.89 . . . . 3.05 109.259 179.542 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -66.53 -39.88 88.83 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.629 -0.669 . . . . 1.26 110.456 -179.012 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.434 HD13 HG23 ' A' ' 141' ' ' ILE . 96.9 mt -71.78 -43.1 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 120.478 -1.389 . . . . 1.34 108.303 178.822 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.0 -32.25 70.35 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.74 -0.6 . . . . 1.6 109.733 179.944 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 139' ' ' ARG . . . 83.86 44.38 6.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.178 -1.569 . . . . 0.96 109.178 -179.373 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.504 ' CD2' HH11 ' A' ' 139' ' ' ARG . 12.3 tp -74.85 148.45 40.22 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.414 -1.05 . . . . 1.67 109.376 -179.44 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -70.45 143.16 51.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.24 -0.913 . . . . 4.96 109.896 -179.48 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.7 mt -115.22 129.98 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.984 0.897 . . . . 1.68 108.915 179.373 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 10.5 mt -66.85 -39.95 84.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 115.869 -0.605 . . . . 2.14 110.717 -178.23 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.6 t0 67.5 97.29 0.06 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.745 -0.835 . . . . 1.5 108.745 -179.329 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.2 mt -68.1 -1.13 5.37 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.443 -0.786 . . . . 1.39 110.939 -178.575 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 80.8 p -82.97 -14.0 54.9 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.695 -1.253 . . . . 1.83 110.111 -179.723 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.92 33.34 0.33 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.284 -0.885 . . . . 1.46 111.96 -177.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 45.1 mm -85.94 120.22 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.421 -1.425 . . . . 1.42 108.96 179.491 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . 0.414 ' O ' ' OD1' ' A' ' 154' ' ' ASP . 50.6 tt0 -99.85 -12.14 20.12 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.33 -0.856 . . . . 2.94 109.93 -179.364 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 153' ' ' GLN . 95.7 m-20 -139.26 157.89 45.12 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.944 -1.098 . . . . 1.52 110.285 -179.398 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.95 137.03 57.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.45 -0.782 . . . . 1.58 109.63 -179.62 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.5 m -153.3 167.9 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.462 -0.774 . . . . 1.32 109.982 179.609 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 81.5 mt -97.16 144.74 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.727 -1.583 . . . . 1.27 106.727 177.689 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.9 tp -94.2 117.08 29.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.911 -1.118 . . . . 1.41 110.367 -178.222 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 44.6 t -123.12 129.41 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 108.667 -0.864 . . . . 1.23 108.667 179.199 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.14 165.31 29.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.119 -0.988 . . . . 1.32 109.354 -179.627 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.42 -30.63 61.99 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.261 -1.524 . . . . 1.49 108.378 178.823 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -165.51 168.41 16.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.913 -0.773 . . . . 2.25 108.913 -179.61 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.1 mt -139.6 133.19 30.36 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.169 -0.957 . . . . 1.35 108.869 179.286 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 69.3 p -99.13 149.35 35.7 Favored Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.318 -0.864 . . . . 1.56 109.769 -179.717 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -40.62 -37.77 2.32 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.541 2.16 . . . . 0.87 113.263 179.515 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 65.1 m -59.99 -39.99 87.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 1.36 109.677 -178.794 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -69.08 -44.21 72.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.287 -0.883 . . . . 1.61 110.503 -179.445 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.0 p -54.9 -30.17 57.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.043 -1.036 . . . . 1.21 111.717 -177.458 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.79 -48.58 24.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.7 -1.25 . . . . 1.21 109.901 -179.522 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -86.43 40.12 0.87 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.899 -1.149 . . . . 2.11 107.899 179.636 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.3 tp -111.26 136.14 50.78 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.36 -0.978 . . . . 1.29 108.36 178.485 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -90.43 108.42 19.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.966 -1.084 . . . . 2.81 110.096 -179.728 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 71.9 mt -64.91 -40.43 95.06 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.458 -0.776 . . . . 2.09 111.071 -178.906 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -70.05 -25.04 63.37 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.87 -1.144 . . . . 2.86 111.708 -178.131 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -93.62 -8.99 39.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.784 -1.198 . . . . 2.39 110.373 -178.632 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.4 t -103.27 117.85 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.194 -0.941 . . . . 1.27 108.948 179.434 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 81.6 mt -86.73 6.42 31.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.456 -0.778 . . . . 2.17 110.571 -177.875 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 165.66 175.4 36.15 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.305 -1.518 . . . . 0.52 109.305 179.806 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -132.18 130.67 41.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.477 -1.013 . . . . 0.55 109.198 -179.877 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 98.2 mt -132.93 124.85 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.483 -0.76 . . . . 1.27 108.963 178.869 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 47.5 p -148.02 160.61 42.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.97 -1.081 . . . . 1.39 110.917 -179.622 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.443 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 0.8 OUTLIER -99.65 20.13 14.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.558 -0.714 . . . . 2.46 109.717 179.969 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.17 -163.32 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.812 -1.18 . . . . 1.51 111.607 -178.295 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -85.56 -46.92 5.32 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 111.224 -0.751 . . . . 2.23 111.224 -178.603 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 165.66 -136.44 4.18 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.963 -1.589 . . . . 2.23 110.612 -179.598 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.406 HH11 ' HG2' ' A' ' 186' ' ' ARG . 24.2 mmt-85 -70.21 -10.43 58.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.481 -1.011 . . . . 6.44 109.739 -179.219 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 78.1 p -76.08 -7.15 54.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.114 -0.992 . . . . 4.09 109.732 -179.471 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.482 ' H ' ' HG ' ' A' ' 188' ' ' SER . 5.2 p -91.39 131.87 36.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.134 -0.979 . . . . 2.2 109.889 179.819 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -49.69 -47.59 50.22 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.426 -0.796 . . . . 1.15 109.843 -179.559 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.96 -39.62 74.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.381 -0.824 . . . . 2.01 110.576 -178.949 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.4 t -60.03 -41.23 91.79 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.888 -1.132 . . . . 1.93 110.753 -179.267 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.7 mm -60.21 -40.01 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.135 -0.978 . . . . 2.2 109.338 -179.5 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.7 mtp -60.04 -40.13 88.31 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.27 -0.894 . . . . 1.32 110.055 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.48 -44.38 72.56 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.734 -1.228 . . . . 1.3 108.931 179.986 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -60.06 -52.42 65.46 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.346 -0.942 . . . . 3.38 110.518 -179.703 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 56.4 m -69.88 -34.68 73.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.025 -1.047 . . . . 1.15 110.79 -178.465 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.97 -29.68 66.85 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.955 -1.128 . . . . 1.28 107.955 179.593 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 65.09 47.34 2.51 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.454 0.645 . . . . 1.5 110.153 -179.629 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 93.6 mt -124.85 150.52 66.19 Favored Pre-proline 0 N--CA 1.5 2.05 0 N-CA-C 108.439 -0.948 . . . . 1.37 108.439 178.891 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -56.15 138.59 83.51 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.858 1.705 . . . . 0.76 111.135 179.841 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.94 151.03 3.22 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.744 -1.182 . . . . 1.19 111.778 -179.647 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.1 mt -127.23 143.89 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.069 -1.086 . . . . 1.31 108.069 179.116 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.9 m -130.0 -11.45 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 O-C-N 120.837 -1.165 . . . . 1.38 111.315 -178.825 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.51 25.85 18.25 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 110.064 -1.214 . . . . 1.03 110.064 -179.506 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.443 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 4.6 p -45.3 -45.59 12.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -1.158 . . . . 1.38 109.814 -179.562 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.8 -52.79 2.62 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.216 -0.993 . . . . 1.17 111.181 179.287 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.5 t -155.02 29.04 0.41 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.585 -1.538 . . . . 2.07 111.451 -179.032 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 56.0 t -70.18 -40.08 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.947 -1.095 . . . . 1.35 109.131 178.309 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 63.2 p -60.0 -26.53 66.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.423 -0.798 . . . . 1.49 110.621 -179.131 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 79.3 p -81.7 -20.69 38.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.921 -1.112 . . . . 2.16 110.181 -179.361 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -101.01 -9.1 21.76 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.344 -0.848 . . . . 2.89 109.967 -179.688 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.2 t -103.32 138.23 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.38 -0.825 . . . . 1.33 110.18 -179.053 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.87 155.34 26.99 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.606 -1.257 . . . . 2.73 107.606 178.938 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 55.3 t30 -59.56 139.43 57.16 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.872 -1.143 . . . . 2.7 109.738 -179.603 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.5 m-20 82.07 5.06 1.17 Allowed 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 121.144 0.497 . . . . 2.38 110.018 179.884 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 63.1 t0 -73.1 136.91 44.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 2.09 108.912 179.077 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.515 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 34.9 t80 -88.93 114.8 25.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.931 -1.105 . . . . 1.45 108.42 179.471 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 72.2 mt -124.67 146.15 49.28 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.52 -0.738 . . . . 1.31 110.343 -178.897 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.9 mt -112.87 128.7 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 107.741 -1.207 . . . . 1.29 107.741 178.187 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 49.5 tp -101.22 116.42 32.76 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.922 -1.111 . . . . 1.31 108.992 -179.523 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.503 ' OD2' ' ND2' ' A' ' 224' ' ' ASN . 38.5 t0 -80.7 -41.93 22.84 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.173 -1.047 . . . . 2.31 108.173 178.948 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 47.83 19.61 0.18 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.967 -0.753 . . . . 1.19 108.967 -179.401 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.434 ' N ' ' C ' ' A' ' 221' ' ' ASP . 47.3 t -128.61 -39.72 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.097 -1.445 . . . . 1.45 107.097 178.539 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.503 ' ND2' ' OD2' ' A' ' 221' ' ' ASP . 86.1 m-20 -108.85 4.78 23.89 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.836 -1.172 . . . . 3.13 107.836 178.072 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.775 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.5 OUTLIER 60.06 47.66 9.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.721 -0.612 . . . . 2.2 110.059 -179.884 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -140.84 140.29 34.62 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.134 -0.979 . . . . 2.32 110.252 179.889 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -118.31 120.14 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 108.533 -0.914 . . . . 1.4 108.533 179.104 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -88.57 130.02 35.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.978 -1.076 . . . . 1.29 109.366 -179.479 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.2 t -103.34 115.1 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.6 -0.688 . . . . 1.38 110.027 -179.056 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.6 t30 48.44 66.73 5.3 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.311 -0.868 . . . . 2.33 111.058 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -90.1 154.04 4.76 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.809 2.339 . . . . 0.95 111.687 178.851 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.8 t -77.98 168.88 19.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.03 -1.044 . . . . 2.31 110.257 -179.162 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -59.99 -38.97 84.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.696 -0.628 . . . . 3.45 111.321 -179.114 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -59.97 -39.98 87.5 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.936 -1.103 . . . . 2.89 110.137 -178.109 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.51 -39.9 79.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.089 -1.007 . . . . 1.73 109.306 179.572 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 1.57 110.309 -179.617 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 55.6 ttm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -149.48 146.87 27.63 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.011 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -150.35 159.86 44.15 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.943 -1.098 . . . . 0.0 110.423 -179.101 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -158.44 154.63 27.18 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.614 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . 0.462 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 54.6 mp0 -115.15 130.77 57.01 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.074 -1.016 . . . . 0.0 109.787 179.575 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.35 126.3 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 CA-C-O 122.181 0.991 . . . . 0.0 112.297 -177.526 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 35.5 m -79.04 102.68 8.5 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.072 0.939 . . . . 0.0 110.936 -178.403 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.7 mt -51.28 126.02 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 122.29 1.043 . . . . 0.0 110.742 -177.839 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 72.6 p -110.06 19.27 19.16 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.147 -179.103 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -76.71 126.28 86.12 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.902 -1.124 . . . . 0.0 108.134 178.942 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -65.7 -11.48 30.86 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 CA-C-N 120.312 1.147 . . . . 0.0 112.75 -178.866 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -119.98 10.06 11.4 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.464 -0.773 . . . . 0.0 109.589 -179.844 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.74 179.99 33.12 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -179.132 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.519 ' O ' ' NH1' ' A' ' 126' ' ' ARG . 3.2 tp -84.38 87.9 7.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.918 -1.342 . . . . 0.0 109.062 -178.801 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . 0.438 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 3.7 p80 -90.38 -163.12 0.97 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.862 -1.149 . . . . 0.0 109.997 179.187 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.0 m -55.88 -44.64 78.32 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.186 -0.946 . . . . 0.0 112.917 -176.054 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.643 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 12.7 tpt180 -60.02 -60.0 12.04 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 120.576 -1.327 . . . . 0.0 112.087 -178.991 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . 0.438 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 11.5 Cg_endo -59.5 -34.5 97.05 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 CA-C-N 120.634 1.262 . . . . 0.0 111.873 -179.147 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.0 75.46 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.421 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.46 -44.52 76.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.512 -0.743 . . . . 0.0 110.159 -179.221 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -70.02 -41.06 74.81 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.746 -1.221 . . . . 0.0 108.537 178.898 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -62.1 -52.88 62.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.455 -0.778 . . . . 0.0 110.151 -179.776 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 95.3 t -66.17 -25.35 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.823 -1.173 . . . . 0.0 109.974 -178.975 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . 0.521 ' HZ1' ' CD ' ' A' ' 74' ' ' GLU . 27.8 ttmt -60.0 -44.51 94.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.135 -0.978 . . . . 0.0 108.574 179.948 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.18 -52.56 46.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.461 -0.774 . . . . 0.0 110.991 -179.228 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . 0.428 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -53.13 -56.89 12.77 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.618 -1.301 . . . . 0.0 111.474 -178.444 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -50.06 -16.2 0.28 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.032 -1.042 . . . . 0.0 109.359 -179.912 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . 0.428 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -81.68 -17.05 71.57 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.361 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -106.22 141.39 37.66 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.607 -0.937 . . . . 0.0 109.257 179.571 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.2 p -92.14 -14.28 29.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.905 -1.122 . . . . 0.0 110.21 -179.998 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 47.4 t -59.99 143.85 50.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.073 -1.017 . . . . 0.0 109.404 -179.78 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -66.58 137.9 57.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.424 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 93.5 mt -134.11 134.18 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.469 -0.769 . . . . 0.0 110.327 -179.149 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 99.7 m -129.07 149.62 50.81 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.798 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 74.8 t -115.63 141.47 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.325 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 59.1 m -131.61 121.94 25.2 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.155 -0.966 . . . . 0.0 109.359 179.547 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.3 t -139.2 120.22 14.55 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.086 0.946 . . . . 0.0 110.737 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 42.47 50.08 4.73 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 177.365 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.28 -14.65 57.14 Favored Glycine 0 N--CA 1.503 3.16 0 O-C-N 120.186 -1.571 . . . . 0.0 113.351 176.391 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -112.65 121.65 45.38 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 119.368 1.584 . . . . 0.0 109.906 -179.532 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 53.2 m -106.23 154.03 21.31 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.968 0.89 . . . . 0.0 111.069 -178.668 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -150.75 150.18 30.7 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.374 0.606 . . . . 0.0 109.573 179.452 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 68.0 m -87.69 135.2 33.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.334 -0.854 . . . . 0.0 110.136 -179.56 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -69.31 -20.2 63.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.075 -1.015 . . . . 0.0 108.49 179.366 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -84.29 20.44 1.63 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.841 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.693 ' HG ' ' HZ2' ' B' ' 349' ' ' LYS . 2.6 m -149.1 91.71 1.88 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.014 -179.762 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 59.5 tp -56.54 -37.55 70.67 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.383 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . 0.626 ' CB ' HE21 ' A' ' 111' ' ' GLN . 62.3 m-85 -54.54 -50.09 68.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.354 -0.841 . . . . 0.0 111.039 -179.273 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.693 ' HZ2' ' HG ' ' B' ' 346' ' ' SER . 35.1 mtmm -69.97 -39.89 75.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.675 -1.265 . . . . 0.0 110.645 -178.525 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' B' ' 352' ' ' THR . 96.7 mt -46.63 -56.8 5.53 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.979 -1.076 . . . . 0.0 108.879 -179.494 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.814 HE22 ' HE ' ' A' ' 126' ' ' ARG . 56.9 mm-40 -39.49 -26.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.847 -0.533 . . . . 0.0 111.208 -178.571 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.445 ' N ' ' O ' ' B' ' 350' ' ' LEU . 67.8 p -79.3 -11.15 59.94 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.498 -1.376 . . . . 0.0 110.56 -178.078 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 24.3 mt -96.34 120.01 35.86 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.922 -1.111 . . . . 0.0 109.54 178.72 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.35 92.1 1.06 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.135 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.2 mt -98.41 92.01 5.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.301 -1.117 . . . . 0.0 109.331 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 70.1 p -92.89 175.79 6.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.133 -0.979 . . . . 0.0 111.352 -178.516 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -65.22 110.82 2.7 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.447 -179.543 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 102.65 12.93 31.38 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.688 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 50.1 m -88.36 110.09 20.51 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -1.137 . . . . 0.0 111.343 -179.092 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 31.0 t -77.45 113.83 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 122.119 0.962 . . . . 0.0 109.826 -177.752 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.5 m -109.78 176.6 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -177.875 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 29.8 m -131.58 127.57 37.41 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.477 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.0 mt -104.21 115.86 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.435 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 50.2 p -120.37 133.35 55.46 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.513 -0.742 . . . . 0.0 109.042 -179.664 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.61 150.05 36.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.114 -0.991 . . . . 0.0 110.086 -179.024 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -139.29 120.5 14.77 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.65 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.548 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 165.04 -167.07 38.53 Favored Glycine 0 N--CA 1.485 1.909 0 C-N-CA 119.119 -1.515 . . . . 0.0 111.117 -179.492 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -58.09 -47.03 84.47 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.359 -0.495 . . . . 0.0 111.707 -177.785 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -107.98 10.46 28.35 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.878 -1.139 . . . . 0.0 111.373 -177.681 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -43.92 -32.02 1.01 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.408 -0.808 . . . . 0.0 110.963 -178.96 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -69.46 -45.16 69.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.137 -0.977 . . . . 0.0 110.045 -178.481 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -67.5 -47.98 68.41 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.176 -0.953 . . . . 0.0 108.847 -179.632 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.15 -78.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.399 -0.813 . . . . 0.0 110.67 -179.471 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . 0.451 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 38.7 t -46.34 -35.75 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.042 -1.036 . . . . 0.0 110.633 -177.458 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -64.9 -49.84 68.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.528 -1.357 . . . . 0.0 110.591 -179.963 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -80.49 -41.78 23.69 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.956 -1.09 . . . . 0.0 110.493 -179.667 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 97.0 mt -59.94 -37.19 78.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 109.08 -179.133 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 50.2 t -65.46 -40.04 87.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.312 -0.867 . . . . 0.0 109.574 179.265 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -69.71 -57.03 5.63 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.772 -1.205 . . . . 0.0 108.408 179.213 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 57.3 tp -55.17 -26.73 40.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 0.0 110.403 -178.216 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 33.7 ttm -74.72 -38.13 62.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.691 -1.256 . . . . 0.0 109.027 177.857 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.89 -4.41 58.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.512 -0.742 . . . . 0.0 110.509 179.588 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -110.48 -6.66 14.87 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.122 -0.986 . . . . 0.0 111.245 -178.739 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.6 mt -78.56 132.37 37.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.3 -1.5 . . . . 0.0 109.029 179.141 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.366 -179.705 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.436 ' H2 ' ' H ' ' A' ' 2' ' ' ILE . 94.2 mmm . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.332 -0.618 . . . . 3.19 109.332 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.436 ' H ' ' H2 ' ' A' ' 1' ' ' MET . 97.0 mt -111.13 126.99 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.578 -0.701 . . . . 1.71 109.828 179.809 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.8 m -140.51 150.18 43.42 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.371 -0.83 . . . . 1.66 109.778 -179.832 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.7 -163.81 9.68 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.858 -1.697 . . . . 1.05 108.858 179.274 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 6' ' ' LEU . 97.4 mt -93.3 -16.82 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.95 -1.324 . . . . 1.59 110.125 -179.118 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.1 tp 54.55 105.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.397 -0.815 . . . . 1.47 109.407 179.906 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.31 -35.25 11.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.561 -0.903 . . . . 1.39 108.561 179.064 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 7.6 m -129.26 129.28 23.29 Favored Pre-proline 0 N--CA 1.502 2.136 0 N-CA-C 109.362 -0.607 . . . . 2.09 109.362 179.848 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.15 146.1 15.69 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.272 1.981 . . . . 0.91 112.807 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 160.53 -160.35 31.74 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 109.827 -1.309 . . . . 0.92 109.827 179.594 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.0 mt -149.98 149.64 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.268 -1.136 . . . . 1.35 108.195 179.215 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.04 149.82 25.07 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.568 -1.333 . . . . 1.14 111.128 179.628 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 4.0 m-85 -131.06 129.79 42.4 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 108.917 -0.771 . . . . 0.7 108.917 179.23 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.93 -173.79 46.03 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 118.509 -1.805 . . . . 0.58 110.948 179.3 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -82.55 155.46 24.49 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.949 -0.736 . . . . 2.63 110.026 -179.513 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.35 129.51 48.82 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.383 -0.823 . . . . 1.27 110.853 -179.532 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.3 tp -99.38 133.52 43.58 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.109 -1.441 . . . . 1.41 107.109 178.412 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.4 tp -118.72 125.41 49.6 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.235 -0.916 . . . . 1.49 109.652 -179.697 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.5 mt -87.36 103.73 15.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.583 -0.698 . . . . 1.52 109.578 179.627 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.98 132.15 43.79 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.557 -0.905 . . . . 3.17 108.557 179.367 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -131.26 130.32 42.71 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.972 -1.08 . . . . 3.0 109.003 179.03 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -79.46 154.1 29.16 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.166 -0.959 . . . . 2.77 108.777 179.448 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -67.74 141.18 56.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.043 -1.035 . . . . 2.94 109.838 -179.915 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.4 mt -79.44 135.45 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.241 -1.022 . . . . 1.46 108.241 179.532 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.1 t -103.39 124.33 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.175 -0.953 . . . . 1.7 109.998 -179.294 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.9 mt -99.03 140.77 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.849 -0.797 . . . . 1.54 108.849 179.803 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -92.15 121.39 33.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.063 -1.023 . . . . 1.81 109.359 -179.699 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -94.86 5.47 51.8 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.495 -0.928 . . . . 3.23 108.495 179.701 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -65.78 142.13 58.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.484 -0.76 . . . . 3.29 109.52 -179.783 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -88.53 140.32 29.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.226 -0.921 . . . . 2.8 109.119 -179.906 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 pt -94.39 164.43 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.885 -1.134 . . . . 1.43 109.746 -179.819 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.0 p -95.42 169.86 9.76 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.412 -0.958 . . . . 1.54 108.412 178.918 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.34 -13.24 49.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.952 -1.092 . . . . 1.6 110.085 -179.769 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -88.59 -30.33 19.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.868 -1.145 . . . . 2.56 108.977 179.576 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -82.64 -7.73 59.63 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.758 -0.83 . . . . 2.36 108.758 179.556 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 t -59.98 -51.96 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.24 -0.913 . . . . 1.43 108.832 179.613 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -60.01 -39.03 84.38 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.29 -0.882 . . . . 1.77 109.292 179.612 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -67.26 -41.8 84.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.053 -1.029 . . . . 3.32 110.915 -178.816 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -64.47 -40.08 95.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.597 -1.315 . . . . 1.51 110.181 -179.435 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.13 -47.02 93.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 120.622 -1.299 . . . . 1.41 108.449 179.242 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -59.89 -40.16 87.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 1.81 109.538 -179.777 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -60.02 -43.34 95.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.749 -1.219 . . . . 3.26 108.268 178.523 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -60.13 -49.31 78.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.344 -0.848 . . . . 0.81 108.907 178.59 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 21.0 tp -59.98 -49.04 79.23 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.762 -0.586 . . . . 1.59 109.453 -179.825 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 t -63.27 -46.13 88.24 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.43 -0.908 . . . . 1.38 109.033 179.121 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.19 -48.1 87.61 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.415 -1.874 . . . . 0.87 108.415 179.443 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 -60.61 -38.1 83.58 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.302 -0.999 . . . . 3.62 108.302 178.689 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.35 -42.16 52.61 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.382 -0.599 . . . . 1.43 109.382 -179.527 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.434 ' O ' ' C ' ' A' ' 50' ' ' ALA . 19.8 ttmt -66.99 -73.73 0.13 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.869 -1.16 . . . . 3.08 107.869 178.952 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.31 -39.91 0.48 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.516 -0.74 . . . . 1.33 111.01 -178.825 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.8 t -51.77 -61.72 2.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.769 -1.207 . . . . 1.85 109.368 179.797 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.87 82.94 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.391 -0.818 . . . . 1.35 111.41 -178.56 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -62.73 -40.69 97.99 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.854 -1.154 . . . . 2.34 110.063 -178.716 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.41 -40.05 95.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.113 -0.992 . . . . 2.2 109.695 -179.839 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -62.2 -37.64 86.09 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.341 -0.85 . . . . 1.35 109.285 -179.773 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.6 m -65.15 -42.7 93.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 1.34 109.174 -179.918 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.26 -39.91 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.21 -0.931 . . . . 1.26 109.334 179.876 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -58.87 -49.95 75.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.166 -0.959 . . . . 1.7 109.958 -179.06 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.8 m -56.65 -35.63 68.6 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.021 -1.049 . . . . 1.35 110.018 -178.198 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.427 ' O ' ' OG1' ' A' ' 64' ' ' THR . 68.2 mttm -65.7 -37.05 85.38 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.199 -0.938 . . . . 2.08 108.896 -179.844 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.87 -49.03 64.37 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.349 0.595 . . . . 1.21 110.215 179.82 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.97 -51.83 54.89 Favored Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.837 -1.173 . . . . 0.75 110.319 -178.937 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -70.13 -40.74 74.64 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.167 -1.196 . . . . 1.59 110.322 -179.44 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 89.9 m -69.95 -61.39 1.8 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.028 -1.045 . . . . 1.41 112.38 -177.532 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -93.74 -47.52 6.74 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.831 -1.168 . . . . 0.79 111.036 -177.752 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.73 -168.72 25.48 Favored Glycine 0 N--CA 1.5 2.934 0 C-N-CA 119.848 -1.167 . . . . 1.22 111.238 179.612 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -68.6 -26.41 65.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.824 -0.81 . . . . 5.81 110.359 -179.586 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -60.54 -35.22 75.49 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.331 -0.855 . . . . 3.37 110.484 -179.598 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.5 ' HZ2' ' HG1' ' A' ' 168' ' ' THR . 15.7 mmmt -96.07 -19.07 19.71 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.105 -0.997 . . . . 2.37 110.117 -179.743 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -69.27 -40.94 77.5 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.704 -1.248 . . . . 1.65 109.665 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.56 ' CB ' HH11 ' B' ' 317' ' ' ARG . . . -67.07 -36.46 82.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.44 -0.788 . . . . 1.42 110.67 -178.597 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 77.2 mt -60.69 -43.66 95.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.697 -1.252 . . . . 1.43 109.006 179.643 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -70.29 -33.31 71.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 1.08 109.581 179.776 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -63.98 -40.03 95.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.023 -1.048 . . . . 1.37 109.731 179.475 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.29 -39.86 91.99 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.013 -1.635 . . . . 0.67 109.013 179.426 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -60.19 -48.85 80.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.431 -1.041 . . . . 1.99 109.38 -179.908 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -66.52 -45.28 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 1.22 109.764 179.929 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.1 ttp -60.35 -40.16 89.75 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.099 -1.001 . . . . 2.11 109.27 -178.918 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.404 ' CD1' ' CE2' ' B' ' 348' ' ' PHE . 25.1 tp -61.13 -35.9 78.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 1.33 108.689 178.709 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.8 tp -67.96 -30.26 69.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.496 -0.753 . . . . 1.29 109.514 179.968 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -83.43 4.64 26.77 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.21 -0.932 . . . . 1.47 110.336 -179.483 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 57.1 t0 -56.83 130.57 46.26 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.974 -1.079 . . . . 1.47 111.212 -178.651 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.423 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 47.7 mt-10 -61.07 -18.59 58.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.929 -0.482 . . . . 1.78 111.179 -179.223 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -72.71 -34.33 67.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.625 -1.297 . . . . 2.53 108.813 178.877 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.1 mt -69.77 -43.1 72.87 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.353 0.597 . . . . 1.36 111.002 -179.252 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -62.74 -42.06 99.48 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.348 -0.845 . . . . 1.42 111.17 -178.032 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -70.12 -42.58 72.44 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.833 -1.167 . . . . 2.27 111.619 -178.289 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -68.16 -38.29 81.93 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.196 -0.94 . . . . 1.57 111.855 -177.87 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.8 mt -66.53 -42.29 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.67 -1.269 . . . . 1.19 109.445 -179.759 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.436 HD13 HG22 ' A' ' 90' ' ' ILE . 85.3 mt -70.04 -39.93 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 1.39 110.616 179.606 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.95 -43.06 96.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.25 -0.906 . . . . 1.39 111.748 -178.104 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.3 mt -63.68 -46.56 84.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.585 -1.322 . . . . 1.5 109.632 -179.357 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -59.84 -49.53 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 122.038 0.923 . . . . 1.29 109.434 179.531 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -70.04 -40.23 75.28 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 120.079 -0.649 . . . . 2.64 111.099 -179.635 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -81.86 -55.79 4.38 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.753 -1.217 . . . . 1.65 112.278 -178.346 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -90.04 -1.26 57.93 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.91 -1.119 . . . . 2.5 112.425 -177.03 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 59.57 40.07 20.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.842 -1.162 . . . . 1.88 110.082 179.377 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 79.1 mtp -95.27 167.21 11.49 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.31 -0.868 . . . . 1.71 109.656 -179.72 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 56.6 p -81.5 160.15 24.01 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.276 -0.89 . . . . 1.61 109.04 179.635 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.82 -39.79 94.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.895 . . . . 1.33 110.268 -179.639 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -69.3 -33.42 73.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.027 -1.046 . . . . 2.07 109.278 -179.619 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.73 -41.06 24.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -0.963 . . . . 1.37 109.377 179.442 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.47 -45.7 61.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.311 -0.868 . . . . 1.14 110.197 -179.813 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.37 -33.4 75.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.125 -0.985 . . . . 1.26 109.355 179.979 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -59.82 -44.94 93.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.568 -0.707 . . . . 2.02 109.958 -179.822 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -60.19 -40.29 89.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 1.33 110.966 -179.2 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.04 -65.95 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.239 -0.913 . . . . 1.3 112.38 -177.413 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.2 mm -68.78 -41.0 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.788 -1.195 . . . . 1.32 110.236 -178.446 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -67.79 -31.57 71.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.213 -0.93 . . . . 2.44 108.651 179.731 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.8 -46.61 66.32 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.917 -1.273 . . . . 0.99 109.917 -179.761 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -60.29 -50.33 74.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.929 -1.336 . . . . 1.97 110.048 -179.292 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.89 -36.08 74.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.371 -0.831 . . . . 1.43 109.84 179.839 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.2 t -59.72 -42.39 92.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.955 -1.091 . . . . 2.12 108.518 -179.893 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.4 94.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -0.838 . . . . 1.64 109.024 179.249 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.5 mt -62.07 -41.22 97.93 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.407 -0.808 . . . . 1.93 109.617 -179.495 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.93 -31.91 67.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.069 -1.019 . . . . 2.2 109.657 -179.387 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -60.16 -26.22 66.14 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.212 -0.93 . . . . 2.12 108.947 179.684 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 31.6 mt -61.72 144.8 54.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.142 -0.974 . . . . 2.34 108.913 -179.56 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -98.36 51.59 1.01 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.027 -1.046 . . . . 3.23 109.538 179.668 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 61.7 t0 -134.27 132.83 40.09 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.445 -0.784 . . . . 2.49 109.321 179.89 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.404 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 83.9 tt0 -69.95 -31.94 69.94 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.475 -0.766 . . . . 3.95 109.865 -179.836 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.454 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.3 t80 -70.09 -36.88 75.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.535 -0.728 . . . . 2.25 111.075 -179.679 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 79.7 mt -78.56 -37.81 41.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.047 -1.033 . . . . 2.27 109.701 -179.703 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -60.14 -48.99 79.39 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.109 -0.994 . . . . 3.31 109.957 179.849 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.76 -39.78 92.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.085 -1.009 . . . . 2.73 109.091 179.956 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -60.13 -40.04 88.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 3.2 108.711 179.824 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' VAL . . . -59.54 -47.93 83.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.932 -1.105 . . . . 1.66 108.543 179.496 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 127' ' ' ALA . . . -43.65 -39.12 3.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.669 -0.645 . . . . 1.67 109.299 179.89 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -66.11 -42.72 88.83 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.213 -0.93 . . . . 1.55 108.604 179.197 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 127' ' ' ALA . 55.4 t -69.9 -40.32 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.34 -0.85 . . . . 1.32 108.926 178.776 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -59.97 -39.13 84.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.378 -0.826 . . . . 3.58 109.033 179.25 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -59.98 -39.8 86.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.516 -0.74 . . . . 1.46 110.377 -179.559 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.8 mt -59.64 -41.25 84.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.907 -1.121 . . . . 1.22 108.98 -179.234 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.24 -37.65 91.19 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.931 -1.267 . . . . 0.61 109.931 179.516 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.63 -49.02 78.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.181 -1.188 . . . . 3.1 111.027 -178.872 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -66.62 -29.48 69.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.897 -1.127 . . . . 3.71 109.423 -179.445 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.8 tp -59.59 -41.76 90.99 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.72 -0.844 . . . . 1.87 108.72 -178.967 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.36 -39.9 94.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 1.29 108.55 179.226 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -68.75 -39.6 80.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.361 -0.837 . . . . 3.05 109.329 178.704 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -65.65 -34.46 78.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.452 -0.78 . . . . 1.26 110.84 -179.42 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 91.1 mt -70.44 -42.6 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 120.737 -1.227 . . . . 1.34 108.092 179.071 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.36 -33.74 71.8 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.005 -0.739 . . . . 1.6 109.005 179.118 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.24 43.63 5.55 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 108.129 -1.988 . . . . 0.96 108.129 -178.901 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.4 tp -75.15 150.84 38.63 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.644 -0.915 . . . . 1.67 110.263 -178.866 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.423 ' HD3' ' N ' ' A' ' 146' ' ' ILE . 9.6 tmtm? -69.61 149.31 48.28 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.722 -0.844 . . . . 4.96 108.722 179.464 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.423 ' N ' ' HD3' ' A' ' 145' ' ' LYS . 86.8 mt -119.81 125.14 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 121.933 0.873 . . . . 1.68 109.036 178.881 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.3 mm -49.42 -54.76 5.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.624 -0.673 . . . . 2.14 109.762 -178.485 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.8 t0 69.39 104.23 0.06 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.547 -0.72 . . . . 1.5 110.59 -179.903 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.439 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 95.9 mt -74.44 -7.18 52.11 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.524 -0.735 . . . . 1.39 109.977 179.84 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.0 t -81.45 -16.83 50.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.148 -0.97 . . . . 1.83 109.485 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.16 23.43 0.58 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.533 -0.729 . . . . 1.46 110.196 -178.543 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.439 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 63.9 mt -92.2 115.24 30.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.133 -0.979 . . . . 1.42 109.738 -179.085 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -100.66 -15.24 17.81 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.251 -0.906 . . . . 2.94 109.63 -179.83 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -118.19 145.86 44.64 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.498 -0.556 . . . . 1.52 109.498 -178.988 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.08 136.48 57.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 1.58 109.346 -179.739 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 26.9 m -151.6 163.3 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 109.328 -0.619 . . . . 1.32 109.328 179.99 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.402 HG22 HD11 ' A' ' 157' ' ' ILE . 82.3 mt -91.78 146.71 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 106.177 -1.786 . . . . 1.27 106.177 177.266 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.2 tp -99.01 118.96 36.96 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.022 -1.049 . . . . 1.41 110.423 -178.194 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.5 t -123.31 129.98 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.489 -0.93 . . . . 1.23 108.489 179.727 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.0 159.37 40.28 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.136 -0.977 . . . . 1.32 108.551 -179.839 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.45 -33.43 64.9 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.23 -1.544 . . . . 1.49 107.932 178.523 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -168.3 136.87 2.29 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.329 -0.989 . . . . 2.25 108.329 179.959 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 62.9 mt -106.8 138.68 42.53 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.247 -0.908 . . . . 1.35 109.565 -179.496 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.9 p -94.05 153.56 40.77 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.47 -0.769 . . . . 1.56 109.02 -179.838 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.04 -34.84 9.61 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.635 1.557 . . . . 0.87 111.952 179.222 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.1 m -58.65 -40.25 82.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 1.36 110.305 -178.306 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -68.04 -42.58 80.33 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.282 -0.886 . . . . 1.61 110.716 -179.302 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.5 ' HG1' ' HZ2' ' A' ' 69' ' ' LYS . 18.5 p -53.88 -31.74 50.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.047 -1.033 . . . . 1.21 110.546 -178.264 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.52 -54.58 8.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.951 -1.093 . . . . 1.21 109.682 179.689 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -85.4 40.74 0.85 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.999 -1.112 . . . . 2.11 107.999 179.81 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.84 133.0 47.3 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.888 -0.782 . . . . 1.29 108.888 179.083 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -89.69 102.14 14.83 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.334 -0.987 . . . . 2.81 108.334 179.348 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.94 -44.78 88.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.461 -0.775 . . . . 2.09 110.908 -178.294 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -70.18 -22.61 62.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.868 -1.145 . . . . 2.86 111.88 -178.337 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -93.56 -10.37 34.98 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.55 -1.344 . . . . 2.39 110.274 -178.465 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 94.3 t -106.76 117.22 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.232 -0.918 . . . . 1.27 109.274 179.568 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 51.4 mt -83.55 4.31 28.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.43 -0.794 . . . . 2.17 110.985 -177.817 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.72 172.12 36.71 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.561 -1.416 . . . . 0.52 109.561 -179.806 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -132.56 129.15 38.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.508 -0.995 . . . . 0.55 108.75 179.901 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.0 mt -129.98 126.05 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.687 -1.227 . . . . 1.27 107.687 178.426 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.4 p -143.51 157.37 44.49 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.379 1.085 . . . . 1.39 111.397 -179.007 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 64.4 t0 -94.61 18.06 12.16 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.783 -0.644 . . . . 2.46 109.265 179.878 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -54.3 -164.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.529 -1.357 . . . . 1.51 111.701 -178.025 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.37 -42.39 5.53 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.607 -0.806 . . . . 2.23 111.306 -178.395 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 175.83 -149.77 10.26 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 118.429 -1.843 . . . . 2.23 111.242 -179.539 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.428 ' N ' ' CD ' ' A' ' 186' ' ' ARG . 0.2 OUTLIER -70.11 -18.3 63.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.813 -0.816 . . . . 6.44 110.558 -178.956 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 82.5 p -69.97 -1.82 10.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.02 -1.05 . . . . 4.09 110.003 -179.177 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.3 m -84.92 130.72 34.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 2.2 110.419 -179.157 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -44.93 -55.38 5.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.524 -0.735 . . . . 1.15 110.224 -179.748 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 8.8 t -58.07 -39.67 79.1 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.411 -0.806 . . . . 2.01 110.721 -178.992 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.3 t -61.55 -40.53 95.03 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.953 -1.092 . . . . 1.93 110.797 -179.298 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.88 -40.01 81.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.235 -0.915 . . . . 2.2 109.614 -179.521 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.2 -40.22 89.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.856 . . . . 1.32 110.197 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.53 88.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.455 -1.403 . . . . 1.3 109.12 -179.735 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -59.92 -50.18 74.77 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.073 -1.051 . . . . 3.38 109.396 -179.297 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 37.1 m -70.41 -35.42 73.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.158 -0.964 . . . . 1.15 110.98 -178.989 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 74.1 mt -70.27 -24.74 63.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.922 -1.111 . . . . 1.28 109.185 179.996 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 66.45 49.89 1.34 Allowed 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.273 0.559 . . . . 1.5 110.828 -179.323 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.4 ' O ' ' CB ' ' A' ' 8' ' ' SER . 78.6 mt -127.23 149.71 70.37 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 107.504 -1.295 . . . . 1.37 107.504 178.18 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.97 139.12 71.91 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.17 1.914 . . . . 0.76 112.091 -179.7 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.17 147.23 3.12 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.955 -1.091 . . . . 1.19 110.995 -179.749 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.424 HG23 HD12 ' A' ' 202' ' ' ILE . 90.5 mt -120.04 139.1 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 106.842 -1.54 . . . . 1.31 106.842 178.223 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.05 -12.22 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 120.602 -1.311 . . . . 1.38 111.427 -178.238 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.74 26.13 16.92 Favored Glycine 0 N--CA 1.502 3.052 0 N-CA-C 110.898 -0.881 . . . . 1.03 110.898 -179.121 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.8 p -44.25 -38.36 3.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.972 -1.311 . . . . 1.38 110.573 -179.179 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.455 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 88.09 -50.47 3.9 Favored Glycine 0 N--CA 1.502 3.064 0 C-N-CA 120.201 -1.0 . . . . 1.17 111.302 179.337 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.2 m -162.67 41.48 0.12 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.491 -1.594 . . . . 2.07 111.157 -179.381 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.5 t -80.24 -37.81 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.988 -1.07 . . . . 1.35 109.085 178.42 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.5 p -58.92 -33.09 70.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.571 -0.706 . . . . 1.49 110.048 -178.862 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.1 m -76.59 -18.42 58.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.332 -0.855 . . . . 2.16 110.157 -178.977 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -102.84 -9.66 19.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.324 -0.86 . . . . 2.89 110.241 -179.144 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 55.2 t -102.01 140.32 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.003 -1.061 . . . . 1.33 110.545 -179.122 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -109.29 150.07 28.52 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.704 -1.221 . . . . 2.73 107.704 178.988 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 19.2 p30 -60.61 138.89 58.0 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.86 -1.15 . . . . 2.7 109.947 -179.52 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.481 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.5 t0 81.17 9.61 0.98 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.303 0.573 . . . . 2.38 109.615 179.466 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.2 t0 -79.06 141.78 37.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.377 -0.827 . . . . 2.09 108.936 179.11 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.519 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 47.3 t80 -88.0 121.75 30.78 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.152 -0.967 . . . . 1.45 108.873 -179.992 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 85.9 mt -130.01 150.19 51.4 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.37 -0.832 . . . . 1.31 110.886 -179.021 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 73.1 mt -117.4 128.73 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.379 -1.711 . . . . 1.29 106.379 176.951 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 44.1 tp -101.05 116.65 33.35 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.977 -1.077 . . . . 1.31 109.438 -178.731 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 223' ' ' VAL . 85.9 m-20 -74.45 -44.8 50.02 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.447 -0.946 . . . . 2.31 108.447 179.092 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 50.92 11.41 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.808 -0.812 . . . . 1.19 108.808 -179.656 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.521 ' H ' ' C ' ' A' ' 221' ' ' ASP . 54.7 t -126.95 -43.11 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 106.859 -1.534 . . . . 1.45 106.859 178.702 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -100.42 -0.01 38.94 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.728 -1.212 . . . . 3.13 107.728 178.611 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 60.56 42.0 14.74 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.3 -0.63 . . . . 2.2 109.3 -179.442 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -138.14 142.9 40.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.287 -0.883 . . . . 2.32 109.238 179.735 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 80.3 t -118.57 120.87 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 108.925 -0.769 . . . . 1.4 108.925 179.57 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -88.69 128.94 35.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.153 -0.967 . . . . 1.29 109.351 -179.438 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.45 114.06 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.735 -0.603 . . . . 1.38 110.244 -179.111 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 45.4 t30 50.97 63.75 9.3 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.33 -0.856 . . . . 2.33 111.509 179.064 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -85.83 148.39 9.58 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.38 2.053 . . . . 0.95 112.103 178.958 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 39.5 m -67.98 158.17 33.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.288 -0.883 . . . . 2.31 110.077 -179.473 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 47.7 p-10 -59.97 -37.9 80.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.312 -0.867 . . . . 3.45 110.679 -178.991 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . 0.534 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 99.0 mt-10 -59.82 -37.03 78.04 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.791 -1.193 . . . . 2.89 107.859 -179.998 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.9 t -70.04 -39.9 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.546 -0.721 . . . . 1.73 109.45 179.095 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.1 mt . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.109 -0.994 . . . . 1.57 108.966 179.533 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 57.1 ttm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -149.05 147.71 28.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -0.922 . . . . 0.0 108.962 179.501 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -150.86 160.06 44.14 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.98 -1.075 . . . . 0.0 111.124 -178.366 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -154.66 152.48 30.02 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.566 -0.708 . . . . 0.0 109.199 178.861 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . 0.428 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 58.1 mp0 -113.89 131.01 56.44 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.311 -0.868 . . . . 0.0 110.266 179.842 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.0 p -131.95 126.78 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 CA-C-O 122.522 1.153 . . . . 0.0 112.995 -177.899 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 32.2 m -79.27 102.43 8.58 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 122.023 0.916 . . . . 0.0 110.772 -178.724 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.5 mt -51.37 125.0 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 122.552 1.168 . . . . 0.0 110.853 -177.878 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 33.2 p -109.73 20.09 18.45 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.602 -179.249 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . 0.409 ' O ' ' CD ' ' B' ' 357' ' ' GLN . . . -67.47 149.11 98.52 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.11 -0.994 . . . . 0.0 108.582 179.366 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . 0.449 ' CD ' ' O ' ' B' ' 385' ' ' GLU . 28.9 Cg_endo -72.28 -30.38 12.99 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.112 1.208 . . . . 0.0 113.138 -179.622 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -120.26 23.16 11.07 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.778 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.59 -177.58 52.74 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.266 -1.933 . . . . 0.0 108.266 -179.028 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.454 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -84.38 93.32 8.24 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.96 -1.317 . . . . 0.0 109.484 -179.013 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -98.01 -159.52 0.74 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.044 -1.035 . . . . 0.0 109.536 178.971 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 316' ' ' THR . . . . . 0.412 ' H ' ' HG1' ' B' ' 316' ' ' THR . 3.5 m -60.06 -49.97 75.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.559 -1.338 . . . . 0.0 112.16 -176.459 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.56 HH11 ' CB ' ' A' ' 71' ' ' ALA . 11.9 tpt180 -47.35 -60.31 4.24 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.653 -1.279 . . . . 0.0 111.133 -179.104 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -61.56 -31.35 87.2 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 CA-C-N 120.559 1.235 . . . . 0.0 111.02 179.022 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.02 -53.79 53.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.399 -0.813 . . . . 0.0 109.485 -179.737 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.86 -42.67 62.8 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.074 -178.951 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.79 -39.94 76.29 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.024 -1.047 . . . . 0.0 108.784 179.243 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -65.71 -55.75 15.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 109.936 -179.485 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . 0.567 ' CG1' ' HZ2' ' B' ' 327' ' ' LYS . 41.3 t -64.13 -30.95 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.585 -1.322 . . . . 0.0 110.278 -178.704 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -60.44 -46.29 90.57 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.994 -1.066 . . . . 0.0 109.763 179.9 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -61.89 -44.35 96.97 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.326 -0.859 . . . . 0.0 111.072 -178.569 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' B' ' 329' ' ' PHE . . . -66.03 -52.17 51.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.988 -1.07 . . . . 0.0 111.691 -178.412 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . 0.567 ' HZ2' ' CG1' ' B' ' 323' ' ' VAL . 32.2 mttp -49.29 -18.07 0.32 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.007 -1.058 . . . . 0.0 110.744 -178.789 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -80.13 -16.57 76.31 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 178.882 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . 0.406 ' N ' ' O ' ' B' ' 326' ' ' ALA . 59.8 m-85 -104.02 136.72 43.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.693 -0.886 . . . . 0.0 109.532 179.825 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 76.8 p -91.49 -13.42 32.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.398 -0.814 . . . . 0.0 109.939 179.727 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 331' ' ' SER . . . . . 0.621 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 69.3 m -60.94 150.25 33.89 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.268 -0.895 . . . . 0.0 109.848 -179.982 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -69.33 136.21 51.48 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.682 179.389 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 80.7 mt -133.63 132.43 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.315 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 81.5 m -130.34 151.15 51.15 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.296 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 67.3 t -115.73 142.07 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.535 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 50.5 m -130.84 122.86 27.84 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.264 -0.897 . . . . 0.0 109.662 179.37 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 337' ' ' SER . . . . . 0.4 ' O ' ' OD1' ' B' ' 338' ' ' ASN . 2.6 t -137.16 118.63 14.78 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.031 0.919 . . . . 0.0 109.698 179.536 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' B' ' 338' ' ' ASN . 8.2 p-10 38.0 62.97 0.87 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.079 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 77.25 -14.18 8.91 Favored Glycine 0 N--CA 1.503 3.143 0 O-C-N 120.83 -1.169 . . . . 0.0 113.521 175.873 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -110.29 121.72 45.96 Favored 'General case' 0 N--CA 1.507 2.376 0 CA-C-N 119.056 1.428 . . . . 0.0 110.277 -179.733 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 83.3 p -109.06 157.65 18.5 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.774 0.797 . . . . 0.0 110.924 -179.082 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -152.54 151.93 31.27 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.821 -0.549 . . . . 0.0 109.925 179.58 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 16.1 m -87.64 136.21 33.04 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.303 -0.873 . . . . 0.0 109.61 -179.96 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -76.91 -14.67 59.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.951 -1.093 . . . . 0.0 110.095 -179.445 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -88.77 20.79 3.31 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 178.441 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.475 ' H ' ' C ' ' B' ' 344' ' ' ALA . 74.0 m -147.36 91.4 1.97 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.727 179.797 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 57.8 tp -57.04 -35.28 69.12 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.584 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . 0.404 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 70.8 m-85 -56.18 -53.95 51.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.922 . . . . 0.0 109.88 179.787 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -70.17 -21.31 63.07 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.577 -0.702 . . . . 0.0 111.045 -177.64 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' B' ' 352' ' ' THR . 77.9 mt -67.48 -50.82 57.31 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 118.314 -1.354 . . . . 0.0 108.648 178.526 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -46.07 -12.83 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.424 -0.798 . . . . 0.0 111.47 -177.741 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.487 ' N ' ' O ' ' B' ' 350' ' ' LEU . 67.3 p -85.73 -16.51 38.71 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 119.912 -1.743 . . . . 0.0 111.466 -178.509 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 29.4 mt -92.05 122.23 34.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.737 -1.227 . . . . 0.0 108.834 178.707 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.99 92.52 0.93 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 179.423 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 16.7 mt -101.26 93.72 5.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.417 -1.049 . . . . 0.0 108.755 179.949 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 71.0 p -92.79 177.05 6.21 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.939 -1.101 . . . . 0.0 111.316 -178.844 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . 0.409 ' CD ' ' O ' ' B' ' 310' ' ' ALA . 40.0 tt0 -65.49 113.23 4.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.81 -0.556 . . . . 0.0 110.787 -179.703 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 99.18 9.63 50.9 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.419 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 24.0 m -85.88 113.1 21.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.335 -1.097 . . . . 0.0 110.313 -179.79 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 11.0 t -78.07 114.45 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 122.307 1.051 . . . . 0.0 109.961 -177.073 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 14.0 m -110.49 177.16 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.91 -177.856 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 40.8 m -130.98 126.89 37.21 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.232 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 83.7 mt -103.63 118.03 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.487 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 49.0 m -122.93 133.65 54.38 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.552 -0.717 . . . . 0.0 109.249 -178.88 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.49 151.61 38.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.095 -1.003 . . . . 0.0 110.496 -178.738 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -140.64 120.72 13.73 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.414 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 164.08 -164.55 36.62 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 118.57 -1.776 . . . . 0.0 111.778 179.455 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -56.53 -50.03 73.02 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.939 -0.631 . . . . 0.0 111.743 -177.889 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.621 ' N ' ' OG ' ' B' ' 331' ' ' SER . 99.6 m-20 -109.87 11.8 24.11 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.033 -1.042 . . . . 0.0 111.574 -177.857 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -42.23 -31.96 0.44 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.946 -1.096 . . . . 0.0 111.212 -178.877 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -70.06 -43.04 72.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.816 -1.178 . . . . 0.0 110.347 -178.81 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -67.7 -47.97 67.89 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.78 -1.2 . . . . 0.0 108.666 -179.905 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.44 -77.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 110.113 -179.914 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . 0.485 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 51.2 t -45.18 -38.79 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.213 -0.93 . . . . 0.0 109.751 -178.19 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -67.63 -42.44 82.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.65 -1.281 . . . . 0.0 110.099 179.221 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -82.18 -45.41 15.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.121 -0.987 . . . . 0.0 110.481 -179.83 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 97.8 mt -59.91 -36.51 77.15 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.11 -0.994 . . . . 0.0 109.303 -179.054 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 53.5 t -69.95 -39.58 77.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 121.524 -0.735 . . . . 0.0 109.907 -179.989 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -79.18 -22.47 44.93 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.009 -1.057 . . . . 0.0 110.859 179.945 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 55.9 tp -82.25 -20.8 36.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.204 -1.56 . . . . 0.0 108.697 178.561 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.0 ttm -81.1 -30.75 34.56 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.161 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -84.34 -9.63 58.29 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.637 -0.665 . . . . 0.0 109.521 178.59 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -106.32 -2.01 22.76 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.316 -0.865 . . . . 0.0 110.919 -179.188 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 22.1 mt -91.53 124.9 36.05 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.949 -1.095 . . . . 0.0 110.636 -179.338 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . 0.449 ' O ' ' CD ' ' B' ' 311' ' ' PRO . 19.1 pt-20 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 118.017 -0.992 . . . . 0.0 108.755 178.675 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.519 -0.549 . . . . 3.19 109.519 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.575 ' CD1' HE22 ' A' ' 211' ' ' GLN . 85.9 mt -110.04 127.65 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.479 -0.934 . . . . 1.71 108.479 179.553 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.3 m -128.57 126.43 40.3 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.551 -0.718 . . . . 1.66 109.512 -179.343 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.79 -161.97 34.65 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.311 -1.516 . . . . 1.05 109.311 179.6 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.5 mt -88.75 -14.42 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -1.195 . . . . 1.59 110.316 -179.367 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.6 tp 52.67 100.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.07 -1.019 . . . . 1.47 109.07 -179.794 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.09 -28.33 12.76 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.113 -0.992 . . . . 1.39 109.267 179.388 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.9 m -132.08 115.31 15.27 Favored Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 109.111 -0.7 . . . . 2.09 109.111 -179.659 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.38 147.98 18.35 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.018 1.812 . . . . 0.91 112.964 -179.685 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 154.33 -156.04 26.59 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.606 -1.797 . . . . 0.92 108.606 -179.51 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.4 mt -149.0 151.06 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 120.904 -1.351 . . . . 1.35 108.866 178.68 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.58 156.62 36.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.048 -1.033 . . . . 1.14 110.241 179.397 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.2 m-85 -137.87 127.37 24.94 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.762 -1.199 . . . . 0.7 107.762 179.1 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.98 178.86 48.74 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 118.591 -1.766 . . . . 0.58 110.913 179.947 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -78.39 156.42 29.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.979 -0.719 . . . . 2.63 109.898 -179.525 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.32 129.98 46.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.43 -0.794 . . . . 1.27 110.844 -179.11 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.2 tp -105.98 134.59 48.86 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.469 -1.308 . . . . 1.41 107.469 178.286 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.9 tp -115.77 123.81 49.18 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.381 -0.824 . . . . 1.49 110.091 -179.419 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.5 mt -81.96 100.57 9.75 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 120.035 -0.666 . . . . 1.52 109.421 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -94.55 138.26 32.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.259 -0.901 . . . . 3.17 109.706 -179.667 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 58.0 mp0 -130.37 136.79 49.45 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.478 -0.764 . . . . 3.0 109.136 179.206 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -84.31 147.32 27.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 2.77 109.494 179.664 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.89 145.51 55.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.9 . . . . 2.94 109.671 -179.811 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.2 mt -98.41 132.73 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.396 -0.815 . . . . 1.46 109.372 179.888 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.6 t -106.81 128.25 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.427 -0.796 . . . . 1.7 109.84 -179.475 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.1 mt -98.36 142.42 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.494 -0.754 . . . . 1.54 109.134 179.976 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -83.6 123.77 30.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.985 -1.072 . . . . 1.81 109.056 179.834 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -93.47 -6.91 45.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.249 -0.907 . . . . 3.23 109.479 -179.64 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.71 138.55 52.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 3.29 109.594 -179.727 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -83.75 155.31 23.13 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.202 -1.036 . . . . 2.8 108.202 179.136 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 pt -99.04 165.66 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.071 -1.018 . . . . 1.43 109.936 -179.947 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.4 p -91.76 173.55 7.81 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.603 -0.888 . . . . 1.54 108.603 178.712 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.62 -15.47 63.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.134 -0.979 . . . . 1.6 110.696 -179.479 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 60.0 t0 -83.69 -30.67 26.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.822 -1.173 . . . . 2.56 108.842 179.47 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -82.65 -6.84 59.59 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.42 -0.585 . . . . 2.36 109.42 179.992 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 t -60.01 -51.81 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.182 -0.949 . . . . 1.43 109.254 179.949 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -60.14 -39.84 87.73 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.231 -0.918 . . . . 1.77 108.78 179.832 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -63.68 -40.23 96.3 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.308 -0.87 . . . . 3.32 110.133 -179.723 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.433 ' OE2' ' NH1' ' A' ' 42' ' ' ARG . 71.0 mm-40 -64.39 -41.55 96.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.847 -1.158 . . . . 1.51 110.28 -179.778 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.8 t -59.99 -45.7 95.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 120.671 -1.268 . . . . 1.41 108.085 179.996 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -59.89 -42.43 93.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.368 -0.833 . . . . 1.81 108.934 -179.78 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.433 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 96.6 mtt180 -60.04 -47.56 85.35 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.846 -1.168 . . . . 3.26 107.846 178.49 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -60.02 -45.22 93.51 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.202 -0.666 . . . . 0.81 109.202 178.897 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.92 -50.07 75.19 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.311 -0.996 . . . . 1.59 108.311 179.661 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -60.45 -42.71 96.7 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.277 -0.889 . . . . 1.38 108.997 179.081 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.18 -47.71 89.6 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.549 -1.421 . . . . 0.87 109.549 179.99 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -69.73 -31.66 69.78 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.284 -1.127 . . . . 3.62 108.402 179.337 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.65 89.71 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.566 -0.709 . . . . 1.43 109.12 -179.988 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.4 ttpt -67.25 -73.77 0.13 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.196 -0.94 . . . . 3.08 108.787 179.333 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.29 -41.81 0.65 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.325 -0.86 . . . . 1.33 111.265 -178.356 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.8 m -52.2 -57.87 8.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.587 -1.321 . . . . 1.85 109.106 179.873 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.64 -40.97 84.57 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.218 -0.926 . . . . 1.35 110.836 -179.267 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -68.14 -40.33 82.47 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.982 -1.074 . . . . 2.34 109.763 -179.693 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.6 mt -61.66 -40.19 94.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.892 -1.13 . . . . 2.2 109.092 179.108 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -64.37 -35.54 81.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 1.35 109.152 179.487 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -62.04 -41.85 98.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.27 -0.894 . . . . 1.34 109.161 179.536 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.517 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.5 mt -64.17 -39.84 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.432 -0.792 . . . . 1.26 109.43 179.622 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -54.35 -51.17 65.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.864 . . . . 1.7 109.826 -178.96 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.3 m -59.94 -37.27 79.04 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.238 -0.914 . . . . 1.35 110.837 -178.317 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.448 ' NZ ' ' HG ' ' A' ' 150' ' ' SER . 28.8 mtpt -64.14 -39.77 94.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.892 -1.13 . . . . 2.08 109.479 -179.559 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.52 -42.99 86.46 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.762 -0.586 . . . . 1.21 110.125 -179.392 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.38 -51.08 60.98 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.161 -1.176 . . . . 0.75 110.161 -179.174 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.0 -44.81 68.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.114 -1.227 . . . . 1.59 110.043 -179.855 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.0 m -69.91 -59.13 3.12 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 1.41 111.768 -178.248 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -97.3 -54.4 3.16 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.021 -1.049 . . . . 0.79 111.357 -178.056 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.83 -163.41 26.95 Favored Glycine 0 N--CA 1.501 3.006 0 C-N-CA 119.697 -1.239 . . . . 1.22 111.156 179.676 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.25 -23.96 62.99 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.912 -0.758 . . . . 5.81 110.841 -179.385 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -62.03 -39.6 92.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.959 -1.088 . . . . 3.37 110.361 -179.545 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -96.29 -18.85 19.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.228 -0.92 . . . . 2.37 110.434 -179.258 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -72.14 -40.77 67.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.043 -1.036 . . . . 1.65 110.466 -179.118 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.63 -30.89 70.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 1.42 109.984 -178.953 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.1 -40.27 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 118.82 -1.152 . . . . 1.43 108.822 -179.588 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -64.76 -40.07 94.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.047 -1.033 . . . . 1.08 109.885 -179.899 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -60.38 -40.89 92.49 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.89 -1.131 . . . . 1.37 109.863 179.519 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.9 -40.81 99.73 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.881 -1.688 . . . . 0.67 108.881 179.535 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.7 m170 -70.01 -40.06 75.47 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.396 -1.061 . . . . 1.99 109.208 179.767 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.9 mt -70.9 -46.47 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.383 -0.823 . . . . 1.22 109.986 179.828 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.7 ttp -60.35 -43.65 96.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 2.11 110.563 -178.452 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.8 tp -64.77 -39.44 93.61 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.293 -0.879 . . . . 1.33 109.938 -179.947 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.7 tp -63.81 -40.1 95.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.437 -0.79 . . . . 1.29 109.789 -179.72 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -78.87 4.07 15.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 1.47 110.099 -178.795 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 63.5 t0 -52.32 129.87 29.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.167 -0.958 . . . . 1.47 110.38 -179.37 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.423 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.8 mt-10 -60.16 -15.19 21.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.566 -0.709 . . . . 1.78 110.124 -179.982 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.02 -37.03 75.51 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.156 -0.965 . . . . 2.53 108.517 178.578 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.1 mt -69.98 -40.09 75.56 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.37 0.605 . . . . 1.36 109.876 179.426 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.07 -50.05 75.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.46 -0.775 . . . . 1.42 110.265 -178.975 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -74.36 -40.62 62.02 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.393 -0.817 . . . . 2.27 111.224 -178.801 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.92 -41.03 75.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.013 -1.054 . . . . 1.57 111.487 -178.675 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.9 mt -70.15 -46.12 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.857 -1.152 . . . . 1.19 109.445 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.8 mt -65.72 -37.45 79.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.625 -0.672 . . . . 1.39 110.121 -179.841 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.07 90.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.048 -1.033 . . . . 1.39 110.507 -178.829 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.3 mt -62.21 -45.49 93.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.947 -1.095 . . . . 1.5 109.579 -179.781 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.1 mt -62.05 -50.0 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 1.29 109.596 -179.907 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -71.21 -42.18 69.26 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.681 -0.808 . . . . 2.64 111.385 179.826 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -83.25 -50.42 8.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.952 -1.092 . . . . 1.65 112.197 -177.648 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -90.19 -2.61 58.07 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.871 -1.143 . . . . 2.5 111.474 -177.497 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 56.19 39.02 30.39 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.797 -1.189 . . . . 1.88 109.521 -179.413 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 54.7 mtt -92.04 169.33 10.73 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.44 -0.788 . . . . 1.71 109.652 -179.723 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.9 p -83.82 159.65 21.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.942 . . . . 1.61 108.956 179.514 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.76 -36.8 78.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 1.33 109.801 -179.635 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -68.66 -39.68 80.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -0.97 . . . . 2.07 110.203 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.59 -44.89 18.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.026 -1.046 . . . . 1.37 109.61 179.855 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.75 -50.25 67.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.449 -0.782 . . . . 1.14 110.211 -179.487 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.23 -37.3 79.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.074 -1.017 . . . . 1.26 109.445 179.917 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -59.91 -42.65 94.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.476 -0.765 . . . . 2.02 110.266 -179.013 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 110' ' ' GLY . 88.9 tt0 -64.9 -40.2 94.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.007 -1.058 . . . . 1.33 109.983 -179.634 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 70.1 t -61.74 -53.22 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.21 -0.931 . . . . 1.3 110.53 -178.509 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.1 mm -69.99 -39.98 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.136 -0.978 . . . . 1.32 109.197 179.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -68.95 -36.75 78.28 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.486 -0.931 . . . . 2.44 108.486 179.015 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.45 -49.82 72.87 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.061 -1.215 . . . . 0.99 110.061 -179.573 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -68.73 -48.53 63.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.749 -1.442 . . . . 1.97 109.41 -179.874 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.87 92.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 1.43 109.382 179.902 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.5 t -57.43 -39.34 76.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 2.12 109.025 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.04 94.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.313 -0.867 . . . . 1.64 109.393 179.437 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.3 mt -64.26 -42.47 96.45 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.153 -0.967 . . . . 1.93 109.827 -179.06 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.424 ' C ' ' N ' ' A' ' 118' ' ' LEU . 78.6 tt0 -59.87 -38.66 82.79 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.661 -1.274 . . . . 2.2 109.522 -178.659 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -50.08 -17.69 0.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.902 -1.124 . . . . 2.12 109.147 179.671 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.424 ' N ' ' C ' ' A' ' 116' ' ' GLU . 79.4 mt -63.36 146.77 52.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 2.34 108.542 179.585 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -95.83 10.81 35.86 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.086 -1.009 . . . . 3.23 111.439 -178.459 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 57.2 t0 -103.07 148.76 25.32 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.953 -1.092 . . . . 2.49 109.583 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 36.4 tt0 -72.04 -65.75 0.73 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.417 -0.957 . . . . 3.95 108.417 179.096 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.481 ' OH ' ' CZ ' ' A' ' 126' ' ' ARG . 11.2 t80 -39.19 -40.26 0.71 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.783 -0.573 . . . . 2.25 110.442 -179.127 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.1 mt -70.31 -39.57 74.74 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.86 -1.15 . . . . 2.27 108.95 178.897 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 121' ' ' GLU . 64.4 tttp -60.03 -40.0 87.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.389 -0.819 . . . . 3.31 109.586 -179.882 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -60.02 -39.43 85.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.859 . . . . 2.73 108.828 179.953 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.64 ' NE ' HE22 ' B' ' 351' ' ' GLN . 8.3 mtt180 -59.86 -39.79 86.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.17 -0.956 . . . . 3.2 108.793 179.314 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.38 -25.57 64.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 1.66 108.82 179.313 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.02 -40.03 75.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 1.67 109.39 179.378 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -66.74 -43.08 85.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.985 . . . . 1.55 109.838 179.925 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.5 t -69.9 -40.46 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.977 -1.077 . . . . 1.32 108.616 179.464 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -65.45 -35.67 81.61 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.501 -0.75 . . . . 3.58 109.443 179.51 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -59.97 -40.1 87.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 1.46 109.653 -179.747 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.36 -43.01 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.024 . . . . 1.22 109.187 179.805 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.8 -40.01 98.24 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.735 -1.346 . . . . 0.61 109.735 179.73 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -60.14 -49.96 75.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.397 -1.061 . . . . 3.1 109.705 -179.122 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.517 HH22 ' CD1' ' A' ' 57' ' ' ILE . 58.6 mtp180 -67.03 -32.61 73.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.125 -0.984 . . . . 3.71 110.255 -179.147 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 64.8 tp -60.04 -41.22 91.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.064 -1.023 . . . . 1.87 108.445 -179.539 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 94.5 mt -60.5 -39.99 89.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.367 -0.833 . . . . 1.29 109.265 179.323 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -69.16 -39.93 78.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.267 -0.895 . . . . 3.05 109.036 179.712 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -62.2 -39.97 94.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.606 -0.684 . . . . 1.26 111.343 -179.024 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.5 mt -73.74 -45.44 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 120.429 -1.419 . . . . 1.34 109.399 179.891 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.6 mt -69.97 -31.53 69.28 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.65 -0.656 . . . . 1.6 110.084 -179.273 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.38 36.58 10.61 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.45 -1.46 . . . . 0.96 109.45 -179.565 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.85 141.07 47.96 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.21 -1.171 . . . . 1.67 108.779 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -60.68 140.05 57.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.31 -0.869 . . . . 4.96 109.477 -179.433 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.6 mt -108.07 128.88 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 108.835 -0.802 . . . . 1.68 108.835 179.668 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 27.4 mm -58.04 -50.02 79.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.724 -0.61 . . . . 2.14 110.801 -177.432 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 33.9 t0 65.89 102.72 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.883 -0.784 . . . . 1.5 108.883 -178.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.474 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 59.5 mt -73.07 -3.72 28.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.483 -0.761 . . . . 1.39 110.034 -179.207 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.448 ' HG ' ' NZ ' ' A' ' 60' ' ' LYS . 31.9 t -83.11 -13.7 55.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.012 -1.055 . . . . 1.83 109.066 179.22 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.72 24.61 0.47 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.564 -0.71 . . . . 1.46 109.947 -178.695 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.474 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 63.7 mt -91.42 122.07 42.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.328 -0.858 . . . . 1.42 108.74 -179.423 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -110.33 -9.22 14.64 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.461 -0.775 . . . . 2.94 110.455 -179.008 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -126.43 151.33 47.86 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.276 -0.89 . . . . 1.52 110.488 -178.583 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.01 133.55 51.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 1.58 108.621 179.224 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 19.9 m -153.24 165.93 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.438 -0.789 . . . . 1.32 109.542 179.64 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.0 mt -94.2 149.1 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 105.896 -1.89 . . . . 1.27 105.896 176.749 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.9 tp -98.39 117.19 32.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.939 -1.1 . . . . 1.41 110.893 -177.486 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.3 t -121.44 127.81 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 108.804 -0.813 . . . . 1.23 108.804 179.495 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.84 160.68 37.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.084 -1.01 . . . . 1.32 108.688 -179.979 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.04 -33.3 71.79 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.116 -1.615 . . . . 1.49 108.449 178.801 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -160.27 171.46 19.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.456 -0.777 . . . . 2.25 108.931 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.6 mt -141.69 133.92 27.87 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.875 -1.141 . . . . 1.35 109.168 179.74 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 66.7 p -100.46 149.67 36.29 Favored Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 121.173 -0.955 . . . . 1.56 110.262 -179.65 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -43.04 -38.47 7.26 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.561 2.174 . . . . 0.87 113.466 179.203 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.1 m -59.84 -40.04 87.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.974 -1.079 . . . . 1.36 109.801 -178.084 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.92 -40.83 83.31 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.151 -0.968 . . . . 1.61 110.421 -179.746 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.2 p -58.03 -30.77 66.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.112 -0.993 . . . . 1.21 111.092 -178.218 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.15 -46.72 55.36 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.699 -1.25 . . . . 1.21 110.03 179.935 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -90.25 37.28 0.89 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.31 -0.996 . . . . 2.11 108.31 -179.88 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.5 tp -107.76 132.54 53.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.616 -0.678 . . . . 1.29 109.616 179.777 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -86.51 103.64 15.22 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.318 -0.864 . . . . 2.81 108.725 178.992 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 59.0 mt -64.09 -41.59 97.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 2.09 110.363 -179.294 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -66.03 -26.05 67.34 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.841 -1.162 . . . . 2.86 112.01 -177.591 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -92.41 -8.08 45.82 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.655 -1.278 . . . . 2.39 109.976 -178.656 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 80.1 t -107.69 118.48 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.337 -0.852 . . . . 1.27 109.108 179.031 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.5 mt -85.41 4.06 37.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.345 -0.847 . . . . 2.17 111.114 -178.026 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 169.66 173.03 36.83 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.342 -1.408 . . . . 0.52 109.748 179.877 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -131.52 127.55 37.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.456 -1.026 . . . . 0.55 109.027 179.812 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 77.4 mt -129.04 123.22 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.616 -0.883 . . . . 1.27 108.616 179.059 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 63.7 p -145.49 158.32 43.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.139 -0.976 . . . . 1.39 111.109 -179.436 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -103.68 25.89 9.22 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.779 -0.823 . . . . 2.46 108.779 179.724 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.13 -159.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.006 -1.059 . . . . 1.51 111.229 -178.195 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.33 -51.56 12.84 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.029 -1.229 . . . . 2.23 110.029 -179.613 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.74 -108.97 0.39 Allowed Glycine 0 N--CA 1.493 2.441 0 O-C-N 121.084 -1.245 . . . . 2.23 110.207 -179.988 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.442 ' CB ' HH11 ' A' ' 186' ' ' ARG . 0.0 OUTLIER -79.91 -10.12 59.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.289 -1.124 . . . . 6.44 110.393 -179.29 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 78.5 p -83.89 0.77 46.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.125 -0.984 . . . . 4.09 110.324 -178.708 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.6 t -90.76 118.86 30.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.003 -1.061 . . . . 2.2 109.655 179.73 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -42.23 -52.73 4.34 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.602 -0.686 . . . . 1.15 109.7 -179.826 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.2 m -54.15 -30.67 50.0 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.34 -0.85 . . . . 2.01 110.759 -179.388 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 16.3 t -60.03 -44.75 94.41 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.601 -1.312 . . . . 1.93 109.746 -179.502 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.427 HG21 HD12 ' A' ' 192' ' ' ILE . 43.0 mm -60.09 -39.69 81.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.611 -0.885 . . . . 2.2 108.611 179.749 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.3 mtp -60.05 -39.89 87.52 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.456 -0.777 . . . . 1.32 110.002 -179.586 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.04 -44.36 94.71 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.654 -1.279 . . . . 1.3 109.504 -179.665 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.411 HH22 ' HG2' ' A' ' 186' ' ' ARG . 95.1 mtt180 -62.39 -57.78 10.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.111 -0.993 . . . . 3.38 109.981 -179.313 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 66.8 m -60.91 -40.01 91.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.857 . . . . 1.15 111.993 -178.684 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 91.6 mt -79.94 -10.93 59.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.766 -1.208 . . . . 1.28 110.876 -177.846 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 59.14 49.96 8.64 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.136 -0.977 . . . . 1.5 110.28 179.881 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 66.7 mt -121.91 126.2 26.43 Favored Pre-proline 0 N--CA 1.501 2.106 0 N-CA-C 108.955 -0.757 . . . . 1.37 108.955 179.517 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -43.09 129.44 5.82 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.842 1.695 . . . . 0.76 112.077 179.497 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.26 145.47 6.99 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.452 -1.299 . . . . 1.19 112.102 -179.512 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.6 mt -124.3 144.72 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.533 -1.284 . . . . 1.31 107.533 178.336 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.7 m -129.29 -6.69 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 120.695 -1.253 . . . . 1.38 111.031 -178.87 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.9 20.87 26.13 Favored Glycine 0 N--CA 1.5 2.958 0 N-CA-C 110.963 -0.855 . . . . 1.03 110.963 -179.406 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.445 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 2.9 p -46.61 -41.36 14.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.711 -1.464 . . . . 1.38 109.725 -179.483 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . 0.493 ' C ' ' HG ' ' A' ' 207' ' ' SER . . . 90.61 -50.38 3.22 Favored Glycine 0 N--CA 1.498 2.823 0 C-N-CA 120.034 -1.079 . . . . 1.17 111.767 178.477 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.493 ' HG ' ' C ' ' A' ' 206' ' ' GLY . 74.2 m -161.88 42.26 0.14 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.596 -1.532 . . . . 2.07 111.334 -179.177 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 23.5 t -78.89 -38.14 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.932 -1.105 . . . . 1.35 108.666 178.348 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 4.3 p -55.3 -35.62 65.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.459 -0.776 . . . . 1.49 110.611 -179.062 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 63.4 m -84.29 -9.8 58.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.963 -1.086 . . . . 2.16 110.142 -179.374 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . 0.575 HE22 ' CD1' ' A' ' 2' ' ' ILE . 27.2 mt-30 -96.16 -16.5 21.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.065 -1.022 . . . . 2.89 110.485 -179.39 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.66 162.92 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.403 -0.81 . . . . 1.33 109.714 -179.596 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.495 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 0.5 OUTLIER -121.89 160.02 25.62 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.597 -0.89 . . . . 2.73 108.597 -179.615 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.458 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 39.8 p-10 -60.4 145.28 48.59 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.394 -0.816 . . . . 2.7 111.168 -179.02 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 84.29 -1.44 1.0 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.519 0.676 . . . . 2.38 110.326 178.594 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.495 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 96.5 m-20 -72.54 155.09 40.43 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.623 -0.831 . . . . 2.09 108.838 179.269 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -97.64 119.31 35.98 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.445 -0.946 . . . . 1.45 108.445 179.852 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 96.1 mt -122.83 142.24 50.97 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.439 -0.788 . . . . 1.31 110.504 -179.077 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 83.2 mt -114.82 128.37 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 106.299 -1.741 . . . . 1.29 106.299 176.365 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 56.7 tp -97.89 116.58 30.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.932 -1.105 . . . . 1.31 108.505 -179.358 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 223' ' ' VAL . 21.3 t0 -74.1 -44.66 53.07 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.466 -1.309 . . . . 2.31 107.466 179.553 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 51.82 8.49 0.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.834 -0.541 . . . . 1.19 109.654 179.073 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.518 ' H ' ' C ' ' A' ' 221' ' ' ASP . 95.2 t -126.75 -39.17 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 107.384 -1.339 . . . . 1.45 107.384 178.262 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -102.77 -0.41 31.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.878 -1.156 . . . . 3.13 107.878 178.637 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 61.94 45.77 7.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.817 -0.552 . . . . 2.2 109.839 -179.814 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -139.6 150.66 45.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.293 -0.879 . . . . 2.32 109.891 179.575 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 90.5 t -119.0 128.07 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.423 -0.955 . . . . 1.4 108.423 178.989 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -102.67 123.56 46.6 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.596 -0.89 . . . . 1.29 108.596 179.461 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.3 t -100.02 110.01 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.38 -0.825 . . . . 1.38 110.607 -178.865 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 230' ' ' ASN . 21.3 t30 50.94 60.65 14.45 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.44 -0.788 . . . . 2.33 111.516 179.047 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.51 153.04 23.47 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.703 2.268 . . . . 0.95 111.277 178.386 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.8 m -64.7 159.92 21.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 2.31 110.135 -179.25 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.18 -40.08 92.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.39 -0.818 . . . . 3.45 110.342 -179.632 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.01 -36.07 76.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.081 -1.012 . . . . 2.89 109.265 179.794 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.97 -39.93 78.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.564 -0.902 . . . . 1.73 108.564 179.261 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . 0.429 HG23 HD12 ' A' ' 236' ' ' ILE . 91.8 mt . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.444 -0.785 . . . . 1.57 110.001 179.931 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -155.19 153.65 31.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.267 -0.896 . . . . 0.0 109.499 179.485 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -145.56 155.48 43.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.214 -0.929 . . . . 0.0 109.55 -179.83 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . 0.522 HE22 ' C ' ' B' ' 305' ' ' GLU . 0.7 OUTLIER -154.49 150.02 27.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.515 -0.741 . . . . 0.0 109.015 -179.587 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . 0.522 ' C ' HE22 ' B' ' 304' ' ' GLN . 95.0 mt-10 -109.85 131.72 54.8 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.3 -0.875 . . . . 0.0 110.162 179.388 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 6.9 p -132.9 121.02 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 CA-C-O 122.121 0.962 . . . . 0.0 112.134 -178.136 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 87.8 m -80.0 103.01 9.6 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.696 0.76 . . . . 0.0 110.384 -178.93 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.5 mt -51.51 117.52 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.446 1.117 . . . . 0.0 109.971 -178.079 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 62.2 p -104.69 19.01 21.19 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.414 -177.954 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.46 115.98 44.73 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.327 -0.858 . . . . 0.0 109.098 179.507 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -53.05 -15.47 4.98 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 CA-C-N 120.306 1.145 . . . . 0.0 112.923 -179.704 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -115.27 4.98 14.59 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.506 -0.746 . . . . 0.0 109.036 -179.888 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.26 174.46 19.12 Favored Glycine 0 N--CA 1.481 1.692 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 -179.042 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.442 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.0 tp -85.84 95.59 9.48 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.163 -1.198 . . . . 0.0 108.696 -179.066 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -95.25 -162.55 0.96 Allowed 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.161 -0.962 . . . . 0.0 110.411 179.737 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 7.9 m -59.63 -39.96 86.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.056 -1.027 . . . . 0.0 112.581 -175.776 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.482 HH11 ' HG2' ' B' ' 317' ' ' ARG . 0.8 OUTLIER -60.15 -60.82 9.38 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.33 -1.481 . . . . 0.0 111.27 -179.257 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -59.4 -32.4 96.48 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.14 1.086 . . . . 0.0 111.628 -179.9 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.88 67.67 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.398 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -50.37 -40.02 48.28 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.819 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -69.99 -41.47 74.37 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 108.923 178.369 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -61.2 -52.78 63.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.83 . . . . 0.0 110.946 -179.365 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 87.9 t -65.41 -27.67 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.639 -1.288 . . . . 0.0 109.761 -178.957 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -45.16 93.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.404 -0.81 . . . . 0.0 109.411 179.581 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -66.52 -44.89 81.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.418 -0.801 . . . . 0.0 111.2 -178.437 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . 0.42 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -61.55 -53.87 50.61 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.724 -1.235 . . . . 0.0 111.144 -178.646 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -52.66 -13.43 0.39 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.724 -1.235 . . . . 0.0 109.317 179.673 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -72.6 -28.73 66.85 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.69 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -106.03 146.78 29.67 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.443 -1.033 . . . . 0.0 109.942 -179.676 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 51.6 p -91.11 -11.79 37.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.925 . . . . 0.0 110.134 179.997 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 56.4 p -65.3 157.87 27.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.196 -0.94 . . . . 0.0 110.323 -179.165 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -72.62 131.55 42.59 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.377 -0.827 . . . . 0.0 108.922 179.375 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 80.2 mt -132.33 132.69 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.873 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 62.7 m -131.6 155.89 46.74 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.48 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.1 140.49 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.318 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 26.7 m -128.9 123.89 33.78 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.128 -0.982 . . . . 0.0 108.561 179.95 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 93.0 p -137.93 116.61 12.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.966 -1.084 . . . . 0.0 110.82 -179.387 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 22.9 m120 45.14 53.43 7.86 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.318 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.74 -11.59 66.08 Favored Glycine 0 N--CA 1.502 3.07 0 O-C-N 120.06 -1.65 . . . . 0.0 113.052 176.264 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -120.92 132.35 54.9 Favored 'General case' 0 N--CA 1.506 2.37 0 CA-C-N 119.285 1.542 . . . . 0.0 109.512 -179.655 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 77.4 p -127.88 151.39 49.13 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.928 0.87 . . . . 0.0 110.886 -178.834 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.48 164.47 30.79 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.64 0.734 . . . . 0.0 110.423 -178.94 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 48.0 t -87.56 133.21 33.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.806 -0.559 . . . . 0.0 110.359 -179.353 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.486 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -70.13 -20.27 63.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.944 . . . . 0.0 108.911 179.289 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -84.61 17.36 2.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.494 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.486 ' H ' ' C ' ' B' ' 344' ' ' ALA . 3.0 m -146.45 95.43 2.6 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.773 0.797 . . . . 0.0 112.421 -179.368 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.98 -39.05 84.36 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.415 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -51.31 -51.15 56.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.979 -1.076 . . . . 0.0 110.459 -179.569 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.45 ' O ' ' OG1' ' B' ' 352' ' ' THR . 33.6 mtmm -71.66 -39.72 70.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.955 -1.09 . . . . 0.0 111.277 -178.2 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' B' ' 352' ' ' THR . 20.6 mt -47.81 -59.95 2.94 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.718 -1.239 . . . . 0.0 109.754 -179.153 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.64 HE22 ' NE ' ' A' ' 126' ' ' ARG . 7.6 mm100 -42.07 -20.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.399 -0.813 . . . . 0.0 111.192 -177.724 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.493 ' N ' ' O ' ' B' ' 350' ' ' LEU . 69.5 p -79.25 -12.76 59.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.081 -1.637 . . . . 0.0 109.53 -179.294 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 32.0 mt -94.09 122.7 36.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.114 -0.991 . . . . 0.0 108.993 178.383 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -72.03 96.89 0.71 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.718 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.5 mt -100.07 80.29 2.27 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.265 -1.138 . . . . 0.0 109.06 179.282 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 356' ' ' THR . . . . . 0.401 ' OG1' ' OG1' ' B' ' 359' ' ' THR . 75.1 p -91.13 166.28 13.05 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.967 -1.083 . . . . 0.0 111.055 -178.83 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -59.92 111.58 1.53 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.132 0.491 . . . . 0.0 110.642 -179.591 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 103.01 5.57 46.88 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.762 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 359' ' ' THR . . . . . 0.401 ' OG1' ' OG1' ' B' ' 356' ' ' THR . 52.4 m -80.14 109.78 14.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.051 -1.264 . . . . 0.0 110.855 -179.468 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 11.9 t -78.54 112.71 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.108 0.956 . . . . 0.0 109.943 -177.907 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 36.0 m -113.31 176.85 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 -178.735 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 57.4 m -126.64 130.02 49.63 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 176.648 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.5 mt -106.43 124.52 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.357 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 63.2 m -131.53 138.85 49.1 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.5 -0.75 . . . . 0.0 109.771 -178.979 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.41 155.24 42.44 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.217 -0.927 . . . . 0.0 109.763 -179.507 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -146.51 123.34 11.28 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.409 -0.807 . . . . 0.0 109.171 179.848 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.545 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.89 -153.47 24.73 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.248 -1.453 . . . . 0.0 111.548 179.868 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -59.97 -51.69 68.58 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.222 -0.575 . . . . 0.0 112.503 -177.292 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' B' ' 370' ' ' GLU . 62.5 m-20 -111.91 11.06 20.67 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.892 -1.13 . . . . 0.0 111.434 -177.267 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.545 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 11.1 pt-20 -39.14 -34.5 0.18 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.452 -0.78 . . . . 0.0 111.657 -179.16 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -69.99 -41.0 74.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.036 -1.04 . . . . 0.0 110.667 -178.148 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -69.68 -49.89 49.16 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.223 -179.609 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' B' ' 377' ' ' LEU . . . -45.77 -79.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 110.417 -179.653 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . 0.488 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 15.1 t -45.24 -38.38 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.154 -0.966 . . . . 0.0 110.367 -177.696 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -69.86 -40.25 75.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.535 -1.353 . . . . 0.0 110.111 179.738 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -83.32 -45.54 13.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.974 -1.079 . . . . 0.0 109.707 179.499 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' B' ' 373' ' ' ALA . 86.0 mt -60.08 -35.51 75.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 109.673 -179.211 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 54.4 t -68.88 -40.06 80.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.123 -0.986 . . . . 0.0 109.758 179.819 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -79.98 -10.0 59.73 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.705 -1.247 . . . . 0.0 108.611 178.251 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 44.1 tp -82.08 -26.81 33.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.997 -1.064 . . . . 0.0 108.697 178.377 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 38.7 mtt -83.36 -21.02 33.21 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 176.813 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -85.97 -11.3 53.38 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.583 -0.698 . . . . 0.0 109.451 178.789 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -109.98 -4.72 15.74 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.387 -0.821 . . . . 0.0 110.868 -178.998 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 31.1 mt -89.77 123.97 34.23 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.681 -1.262 . . . . 0.0 109.859 -179.79 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.406 -179.82 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 mmt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.457 -0.572 . . . . 3.19 109.457 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.3 mt -107.31 121.38 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.644 -0.873 . . . . 1.71 108.644 179.745 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 m -133.62 120.09 20.25 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.424 -0.798 . . . . 1.66 109.178 179.981 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.64 -161.7 37.72 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.422 -1.471 . . . . 1.05 109.422 179.917 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.7 mt -93.03 -10.13 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.038 -1.272 . . . . 1.59 110.005 -179.392 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' ILE . 55.2 tp 53.21 101.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -0.963 . . . . 1.47 109.548 -179.959 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.13 -26.24 20.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 1.39 109.631 179.928 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 12.1 t -144.6 130.18 9.58 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.213 -0.929 . . . . 2.09 109.433 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.94 143.43 16.31 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.175 1.916 . . . . 0.91 112.806 -179.926 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 163.74 -162.14 34.8 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.033 -1.627 . . . . 0.92 109.033 179.881 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.8 mt -149.52 149.8 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.922 -1.34 . . . . 1.35 108.466 178.841 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.5 158.4 37.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.749 -1.22 . . . . 1.14 110.794 179.83 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -139.97 129.19 23.82 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.897 -1.149 . . . . 0.7 107.897 178.817 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.93 -178.91 46.53 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 118.869 -1.634 . . . . 0.58 110.442 179.911 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -79.93 156.63 27.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.544 -0.974 . . . . 2.63 109.886 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -105.4 127.5 53.01 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.478 0.656 . . . . 1.27 110.925 -179.434 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.8 tp -101.25 140.08 36.04 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.772 -1.195 . . . . 1.41 107.772 178.537 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.7 tp -118.35 125.59 50.34 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.374 -0.829 . . . . 1.49 109.951 -179.442 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.8 mt -84.04 104.41 14.09 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.531 0.682 . . . . 1.52 109.963 -179.795 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -99.29 128.58 45.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.455 -0.778 . . . . 3.17 109.354 -179.789 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -130.06 127.94 40.92 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.41 -0.806 . . . . 3.0 109.072 179.256 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -76.74 147.31 37.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.282 -0.886 . . . . 2.77 109.418 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -63.61 141.55 58.72 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.23 -0.919 . . . . 2.94 108.995 -179.983 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.9 mt -76.97 131.88 33.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.229 -0.919 . . . . 1.46 109.162 -179.516 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.7 t -93.88 124.1 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.287 -0.883 . . . . 1.7 109.813 -179.621 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.403 HG23 HD12 ' A' ' 26' ' ' ILE . 88.6 mt -109.8 138.11 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.611 -0.681 . . . . 1.54 109.929 -179.462 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -97.45 116.93 30.58 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.13 -0.981 . . . . 1.81 109.441 179.834 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 28' ' ' ARG . 2.3 mmt-85 -85.67 -0.95 56.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.393 -0.817 . . . . 3.23 109.62 -179.431 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -60.54 144.11 52.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.935 . . . . 3.29 109.632 -179.712 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -87.71 147.88 25.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.192 -0.942 . . . . 2.8 109.046 -179.928 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 pt -94.66 164.82 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.997 -1.064 . . . . 1.43 109.823 179.924 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.43 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 53.9 p -90.23 175.64 7.05 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.477 -0.935 . . . . 1.54 108.477 178.576 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.06 -20.34 63.23 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.937 -1.102 . . . . 1.6 111.266 -178.95 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.43 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 7.5 p-10 -85.97 -23.19 27.0 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.501 -1.375 . . . . 2.56 108.553 179.001 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -81.84 -9.41 59.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.592 -0.892 . . . . 2.36 108.592 178.818 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 t -62.09 -53.66 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.487 -0.758 . . . . 1.43 109.309 179.711 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -62.17 -40.06 94.76 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.339 -0.851 . . . . 1.77 109.349 179.691 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -61.91 -42.2 98.81 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.422 -0.799 . . . . 3.32 110.598 -178.766 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -66.15 -39.96 90.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.711 -1.243 . . . . 1.51 110.376 -179.036 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.14 -47.88 90.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.708 -1.245 . . . . 1.41 108.681 179.586 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -61.46 -44.21 97.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.062 . . . . 1.81 109.652 179.846 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.441 HH11 ' HG2' ' A' ' 42' ' ' ARG . 25.8 mtt-85 -60.02 -41.13 91.53 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.937 -1.135 . . . . 3.26 107.937 179.139 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -62.31 -45.78 91.69 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.958 -1.127 . . . . 0.81 107.958 177.545 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.02 -47.63 85.03 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.828 -0.804 . . . . 1.59 108.828 179.694 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.1 t -62.39 -42.95 99.82 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.394 -0.922 . . . . 1.38 109.009 179.355 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.44 -48.58 84.22 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.866 -1.694 . . . . 0.87 108.866 179.477 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -62.27 -34.9 77.44 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.33 -1.1 . . . . 3.62 108.197 178.694 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.59 -43.81 80.46 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.613 -0.679 . . . . 1.43 109.285 -179.911 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.3 ttpt -65.78 -74.24 0.11 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.17 -1.418 . . . . 3.08 107.17 179.301 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.25 -31.35 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.318 -0.864 . . . . 1.33 111.118 -179.238 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 49' ' ' LYS . 34.4 t -57.06 -56.07 26.46 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.547 -1.346 . . . . 1.85 108.473 179.801 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.45 -40.03 81.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.433 -0.792 . . . . 1.35 111.204 -179.182 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -67.14 -40.03 86.68 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.699 -1.251 . . . . 2.34 110.42 -179.1 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.43 -39.95 94.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.886 -1.134 . . . . 2.2 109.504 179.815 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -62.24 -33.99 75.65 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.174 -0.954 . . . . 1.35 109.448 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.62 -41.39 98.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.955 . . . . 1.34 109.832 -179.986 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.36 -39.95 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.193 -0.942 . . . . 1.26 109.55 -180.0 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -56.69 -50.6 71.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 1.7 109.921 -178.962 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -59.41 -36.63 76.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.371 -0.83 . . . . 1.35 110.968 -177.472 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -64.29 -38.26 90.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.895 -1.128 . . . . 2.08 109.573 179.891 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.31 -43.43 97.83 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.467 -0.771 . . . . 1.21 109.732 -179.926 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.15 -50.85 63.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.498 -1.441 . . . . 0.75 109.498 -179.335 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.26 -50.1 56.09 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.139 -1.212 . . . . 1.59 109.5 179.628 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.1 m -63.03 -64.76 0.82 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 1.41 112.32 -177.893 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -97.65 -48.3 5.29 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.868 -1.145 . . . . 0.79 111.825 -178.079 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.91 -169.77 25.15 Favored Glycine 0 N--CA 1.5 2.943 0 O-C-N 120.662 -1.274 . . . . 1.22 110.943 179.889 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.03 -26.87 64.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.897 -0.767 . . . . 5.81 110.287 -179.705 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -61.04 -33.15 72.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.447 -0.783 . . . . 3.37 110.087 -179.67 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -100.33 -22.59 15.03 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.341 -0.849 . . . . 2.37 109.891 179.995 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -64.95 -40.76 95.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.132 -0.98 . . . . 1.65 110.02 -179.311 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.599 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -67.1 -25.82 66.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.401 -0.812 . . . . 1.42 110.431 -178.913 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.99 -40.53 83.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.969 -1.082 . . . . 1.43 108.499 -179.706 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -69.96 -35.76 74.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.144 -0.973 . . . . 1.08 110.107 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -60.01 -40.06 87.94 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.762 -1.211 . . . . 1.37 109.312 179.831 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.99 -42.62 94.63 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.463 -1.855 . . . . 0.67 108.463 179.09 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -61.06 -44.56 97.2 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.468 -1.019 . . . . 1.99 108.612 179.334 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.98 -43.53 79.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.674 -0.641 . . . . 1.22 109.799 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -64.11 -40.02 95.29 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.906 -1.121 . . . . 2.11 109.827 -179.356 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.9 tp -65.47 -39.97 92.61 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.237 -0.914 . . . . 1.33 109.44 179.536 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.5 tp -65.71 -37.09 85.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.557 -0.714 . . . . 1.29 109.177 -179.493 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -82.66 1.66 37.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 1.47 110.086 -179.372 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -48.56 130.01 16.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.965 -1.084 . . . . 1.47 109.672 -179.405 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.46 -18.4 51.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.542 -0.723 . . . . 1.78 110.354 -179.259 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.47 -35.1 73.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.005 -1.059 . . . . 2.53 108.739 178.353 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.3 mt -70.15 -42.12 72.93 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.521 0.677 . . . . 1.36 109.909 179.506 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -60.15 -48.81 80.18 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.36 -0.837 . . . . 1.42 110.028 -179.126 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -69.95 -41.31 74.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 2.27 110.705 -179.451 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.98 -40.04 75.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.16 -0.963 . . . . 1.57 111.735 -178.629 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 91.8 mt -69.47 -42.04 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.905 -1.122 . . . . 1.19 109.178 -179.571 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.7 mt -69.98 -39.62 77.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.638 -0.664 . . . . 1.39 109.943 179.329 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.99 -47.77 84.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -0.863 . . . . 1.39 110.81 -179.244 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 96' ' ' LYS . 93.2 mt -61.48 -47.51 85.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.994 -1.067 . . . . 1.5 109.921 -179.44 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.33 -49.63 83.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.296 -0.877 . . . . 1.29 109.185 179.632 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -70.09 -43.03 71.93 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.901 -0.719 . . . . 2.64 110.667 179.636 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -80.69 -47.39 14.09 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.103 -0.998 . . . . 1.65 111.79 -178.349 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 92' ' ' LEU . 65.8 mmtt -91.81 -2.3 56.96 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.973 -1.079 . . . . 2.5 111.659 -177.679 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 56.05 34.68 24.22 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.797 -1.189 . . . . 1.88 109.489 -179.845 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 59.0 mtt -91.63 169.84 10.41 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.518 -0.739 . . . . 1.71 110.03 -179.39 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.5 p -82.32 162.34 22.29 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.42 -0.8 . . . . 1.61 109.408 179.986 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.03 -39.71 75.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.417 -0.802 . . . . 1.33 109.892 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.94 -40.04 83.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 2.07 110.011 -179.753 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.49 -44.08 19.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.018 -1.051 . . . . 1.37 110.283 -179.506 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.63 -47.68 68.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 1.14 110.2 -179.306 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.03 87.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.178 -0.951 . . . . 1.26 109.659 -179.862 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -59.99 -40.87 90.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.43 -0.794 . . . . 2.02 110.01 -178.559 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -63.21 -40.02 96.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.913 . . . . 1.33 110.131 -179.596 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.3 -52.59 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.111 -0.993 . . . . 1.3 110.528 -178.721 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -70.02 -40.02 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.973 -1.079 . . . . 1.32 109.328 -179.752 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.61 -39.19 91.27 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.644 -0.872 . . . . 2.44 108.644 179.327 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.33 -47.86 87.12 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.74 -1.344 . . . . 0.99 109.74 -179.668 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -67.53 -51.65 48.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.942 -1.328 . . . . 1.97 109.197 -179.992 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.85 -42.5 89.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.375 -0.828 . . . . 1.43 109.591 -179.748 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.4 t -57.56 -39.5 76.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.059 -1.026 . . . . 2.12 109.056 -179.851 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.95 -39.93 90.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.935 . . . . 1.64 109.656 179.424 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.1 mt -64.66 -42.01 95.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.022 -1.049 . . . . 1.93 109.999 -178.827 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.95 -37.58 79.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.746 -1.222 . . . . 2.2 109.335 -179.596 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -53.45 -20.25 4.5 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.202 -0.936 . . . . 2.12 109.265 179.827 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 65.7 mt -62.46 139.99 58.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.044 -1.035 . . . . 2.34 108.798 179.861 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -90.99 48.23 1.5 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.04 -1.037 . . . . 3.23 109.393 179.894 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.42 ' OD1' ' OE2' ' A' ' 121' ' ' GLU . 58.3 t0 -135.18 130.13 34.85 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.368 -0.833 . . . . 2.49 109.282 -179.713 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.2 pm0 -69.35 -28.87 66.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.532 -0.73 . . . . 3.95 110.071 -179.677 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.545 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 2.4 t80 -73.2 -41.03 64.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.259 -0.901 . . . . 2.25 110.599 179.586 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.595 ' CD2' HH22 ' A' ' 126' ' ' ARG . 41.3 mt -74.92 -29.71 61.04 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.044 -1.035 . . . . 2.27 108.344 179.31 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -68.51 -39.1 81.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.5 -0.75 . . . . 3.31 110.1 179.523 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -59.98 -44.02 94.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.987 -1.071 . . . . 2.73 110.063 -178.905 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.709 ' HE ' ' NE2' ' B' ' 351' ' ' GLN . 22.2 mtm-85 -69.96 -28.91 65.94 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.315 -1.354 . . . . 3.2 108.797 179.805 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.75 -26.64 65.84 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.865 -1.161 . . . . 1.66 107.865 178.741 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.56 -39.98 64.28 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.088 -0.708 . . . . 1.67 109.088 178.795 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -65.85 -39.99 91.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.358 -0.838 . . . . 1.55 110.53 -179.442 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.5 t -65.11 -41.02 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.877 -1.139 . . . . 1.32 109.065 179.999 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -59.98 -37.86 80.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.092 -1.005 . . . . 3.58 108.522 178.868 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 57.2 t0 -60.03 -38.96 84.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.578 -0.701 . . . . 1.46 109.985 -179.614 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 94.5 mt -60.08 -42.5 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.92 -1.113 . . . . 1.22 110.101 -178.89 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.76 -29.3 59.56 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.647 -1.381 . . . . 0.61 109.647 179.867 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt -59.93 -49.04 79.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.299 -1.118 . . . . 3.1 109.464 -179.515 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.445 HH11 ' HG2' ' A' ' 136' ' ' ARG . 27.1 mtt-85 -65.16 -36.7 85.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.083 -1.011 . . . . 3.71 109.596 179.861 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.2 tp -57.08 -40.92 77.86 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.355 -0.84 . . . . 1.87 109.018 -178.652 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.16 -41.35 98.21 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.193 -0.942 . . . . 1.29 109.762 179.405 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -70.09 -39.94 75.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.23 -0.919 . . . . 3.05 109.014 179.384 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -63.87 -35.66 81.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.675 -0.641 . . . . 1.26 111.093 -179.31 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.444 HD11 HG22 ' A' ' 141' ' ' ILE . 83.6 mt -71.13 -45.9 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.487 -1.383 . . . . 1.34 108.75 179.522 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 77.2 mt -70.03 -34.96 73.93 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.51 -0.744 . . . . 1.6 109.518 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.91 43.74 5.31 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.188 -1.565 . . . . 0.96 109.188 -179.479 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 tp -74.29 149.83 40.5 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.324 -1.103 . . . . 1.67 109.012 -179.854 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -67.1 141.72 57.36 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.178 -0.951 . . . . 4.96 109.678 -179.553 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 89.1 mt -115.63 126.6 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 122.269 1.033 . . . . 1.68 109.269 179.635 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 148' ' ' ASP . 7.5 mt -70.01 -40.0 78.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 115.594 -0.73 . . . . 2.14 110.743 -178.219 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 147' ' ' ILE . 25.8 t0 63.49 131.29 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.642 -0.873 . . . . 1.5 108.642 -178.918 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.9 mt -89.89 -0.62 57.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.047 -1.033 . . . . 1.39 109.646 -179.324 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.7 m -84.83 -8.88 58.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 1.83 109.21 179.566 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.03 27.33 0.78 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.446 -0.784 . . . . 1.46 110.683 -178.207 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.539 ' O ' ' NZ ' ' A' ' 175' ' ' LYS . 54.4 mt -89.88 120.03 37.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 O-C-N 121.117 -0.99 . . . . 1.42 109.395 -179.16 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . 0.42 ' O ' ' OD1' ' A' ' 154' ' ' ASP . 72.2 mt-30 -97.07 -9.67 27.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.298 -0.876 . . . . 2.94 111.083 -178.765 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 153' ' ' GLN . 96.4 m-20 -139.7 157.89 45.02 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.898 -1.126 . . . . 1.52 110.815 -178.763 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -62.7 138.22 58.45 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.735 -0.839 . . . . 1.58 108.735 179.606 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.1 m -153.13 165.71 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 1.32 109.767 179.88 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.5 mt -95.48 148.84 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.414 -1.698 . . . . 1.27 106.414 176.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.3 tp -98.61 117.66 33.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.084 -1.01 . . . . 1.41 111.049 -177.684 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.0 t -122.42 130.04 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.622 -0.881 . . . . 1.23 108.622 178.416 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.63 161.24 38.64 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.584 -0.895 . . . . 1.32 108.584 179.996 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.485 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -72.09 -32.88 67.44 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.201 -1.562 . . . . 1.49 107.687 178.699 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 20.2 t0 -162.27 167.73 23.47 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.142 -1.059 . . . . 2.25 108.142 179.8 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.498 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 86.5 mt -141.67 130.61 23.12 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.907 -1.12 . . . . 1.35 109.586 179.689 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 63.8 p -93.05 144.62 28.66 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 108.543 -0.91 . . . . 1.56 108.543 179.363 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -42.11 -29.86 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.846 1.697 . . . . 0.87 112.65 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.3 m -59.71 -39.98 86.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.017 . . . . 1.36 109.711 -178.405 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -70.06 -42.11 73.29 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.12 -0.988 . . . . 1.61 110.354 -179.662 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 77.9 p -53.93 -29.97 44.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.228 -0.92 . . . . 1.21 111.356 -177.994 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.14 -56.6 5.3 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.945 -1.097 . . . . 1.21 110.53 -179.7 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -84.05 37.34 0.6 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.451 -0.78 . . . . 2.11 108.939 -179.599 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.9 tp -109.76 129.47 55.62 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.457 -0.942 . . . . 1.29 108.457 178.494 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -79.97 105.15 11.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.082 -1.011 . . . . 2.81 109.27 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 77.0 mt -66.84 -40.26 87.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.426 -0.796 . . . . 2.09 111.229 -178.564 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -70.0 -23.62 63.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.939 -1.1 . . . . 2.86 110.852 -178.029 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' A' ' 152' ' ' ILE . 41.4 mtpt -93.97 -6.44 45.42 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.032 -1.043 . . . . 2.39 109.861 -178.657 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.1 t -107.92 121.4 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.179 -0.95 . . . . 1.27 108.605 179.069 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 42.1 mt -85.66 7.12 24.59 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.391 -0.818 . . . . 2.17 111.777 -177.07 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 164.11 177.55 36.93 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.17 -1.49 . . . . 0.52 109.662 179.914 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -134.78 130.27 35.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.453 -1.028 . . . . 0.55 109.26 -179.695 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.419 HD12 HG22 ' A' ' 180' ' ' ILE . 91.0 mt -133.17 128.29 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.025 -0.731 . . . . 1.27 109.025 179.191 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 33.8 p -149.87 159.42 44.38 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.043 -1.035 . . . . 1.39 109.763 179.741 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 53.8 p-10 -106.27 27.55 8.59 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.519 -0.919 . . . . 2.46 108.519 178.847 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.5 -157.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.056 0.931 . . . . 1.51 111.972 -178.172 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.6 -80.48 0.08 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.875 -0.89 . . . . 2.23 110.875 -179.179 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.68 -130.57 1.37 Allowed Glycine 0 N--CA 1.49 2.288 0 O-C-N 120.892 -1.358 . . . . 2.23 110.112 -179.491 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -79.42 -9.31 59.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.305 -1.115 . . . . 6.44 111.031 -179.138 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.2 p -87.43 9.13 21.77 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.947 -1.096 . . . . 4.09 110.238 -179.085 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.7 m -90.19 139.32 30.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.941 -1.1 . . . . 2.2 110.358 -179.602 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -45.12 -53.38 8.08 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.473 -0.767 . . . . 1.15 109.99 -179.744 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.4 m -56.6 -39.01 72.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.401 -0.812 . . . . 2.01 110.164 -178.903 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.629 ' HG ' ' N ' ' A' ' 192' ' ' ILE . 27.8 p -60.0 -37.67 80.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.858 -1.151 . . . . 1.93 110.003 -179.554 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.629 ' N ' ' HG ' ' A' ' 191' ' ' SER . 82.5 mt -60.03 -39.91 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.115 -0.991 . . . . 2.2 108.935 179.985 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 90.7 mtp -60.04 -43.01 95.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.429 -0.795 . . . . 1.32 110.33 -179.038 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.39 -44.25 88.88 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.583 -1.323 . . . . 1.3 109.36 -179.341 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -62.55 -58.64 6.84 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.107 -1.037 . . . . 3.38 109.925 -179.606 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.6 m -61.96 -39.97 93.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.122 -0.986 . . . . 1.15 112.022 -178.548 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.0 mt -74.91 -20.53 59.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.753 -1.217 . . . . 1.28 110.338 -178.697 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 68.81 52.21 0.55 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.678 -0.639 . . . . 1.5 110.456 -179.762 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . 0.416 ' O ' ' OG ' ' A' ' 8' ' ' SER . 79.5 mt -129.68 149.93 74.33 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 108.072 -1.084 . . . . 1.37 108.072 178.794 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.52 143.55 63.38 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.063 1.842 . . . . 0.76 112.088 -179.654 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -172.63 150.74 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.083 -1.01 . . . . 1.19 111.286 -179.897 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.8 mt -121.51 146.68 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 107.664 -1.236 . . . . 1.31 107.664 178.432 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.8 m -128.35 -12.39 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 O-C-N 120.878 -1.139 . . . . 1.38 110.528 -179.051 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.05 25.25 16.79 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 110.824 -0.91 . . . . 1.03 110.824 -179.233 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.8 p -46.28 -40.62 11.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.913 -1.345 . . . . 1.38 109.803 -179.459 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.29 -51.42 3.39 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 120.127 -1.035 . . . . 1.17 110.85 179.385 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.6 m -161.94 34.97 0.12 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.621 -1.517 . . . . 2.07 111.204 -179.471 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.12 -40.15 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.923 -1.111 . . . . 1.35 108.621 177.999 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.2 p -56.23 -34.08 65.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.699 -0.625 . . . . 1.49 110.004 -179.088 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 39.8 t -86.5 -12.97 47.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.069 -1.019 . . . . 2.16 110.467 -179.169 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -94.0 -12.93 27.62 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.889 -1.132 . . . . 2.89 110.837 -179.538 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 44.6 t -123.75 165.1 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 O-C-N 121.185 -0.947 . . . . 1.33 110.267 -179.483 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.513 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 18.4 mmmt -118.14 156.45 28.67 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.558 -0.904 . . . . 2.73 108.558 -179.363 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 5.5 p30 -60.99 140.36 57.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 2.7 110.711 -179.474 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 6.5 t0 86.48 2.47 0.52 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.108 0.48 . . . . 2.38 110.204 179.102 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 89.9 m-20 -77.71 159.19 29.27 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.15 -0.969 . . . . 2.09 108.581 178.877 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -97.27 120.31 37.4 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.215 -0.928 . . . . 1.45 109.288 -179.351 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 88.8 mt -126.08 140.88 52.23 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.361 -0.837 . . . . 1.31 110.342 -179.812 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.7 mt -113.47 129.88 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.053 -1.462 . . . . 1.29 107.053 176.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 24.6 tp -103.12 120.13 40.12 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.215 -0.928 . . . . 1.31 109.255 -179.106 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.645 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 30.4 p-10 -80.77 -39.64 26.49 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.056 -1.027 . . . . 2.31 108.5 179.055 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 46.79 17.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.851 -0.796 . . . . 1.19 108.851 -179.003 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.5 t -130.25 -40.73 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.235 -1.394 . . . . 1.45 107.235 178.593 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -103.68 -0.69 29.18 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.139 -1.43 . . . . 3.13 107.139 177.905 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.539 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 47.7 t-20 60.03 48.74 8.28 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.354 0.597 . . . . 2.2 110.231 179.812 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.645 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 96.5 mt-30 -140.03 153.04 46.7 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.403 -0.81 . . . . 2.32 109.401 179.577 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 66.5 t -119.55 129.94 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.942 -0.762 . . . . 1.4 108.942 179.494 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -103.76 124.87 49.68 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.541 -0.911 . . . . 1.29 108.541 179.247 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 40.6 t -100.74 108.05 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.456 -0.777 . . . . 1.38 110.347 -178.978 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 49.39 66.71 5.3 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.199 -0.938 . . . . 2.33 110.367 179.012 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -85.57 156.23 10.56 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.875 2.383 . . . . 0.95 111.716 179.469 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 42.3 p -72.89 162.6 29.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.207 -0.933 . . . . 2.31 109.673 -179.558 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -59.86 -39.68 86.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.444 -0.785 . . . . 3.45 110.228 -179.537 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -58.03 -39.37 78.2 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.234 -0.916 . . . . 2.89 109.461 -179.037 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 77.1 t -68.96 -41.65 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.019 -1.051 . . . . 1.73 109.369 179.653 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.495 1.788 0 O-C-N 121.145 -0.972 . . . . 1.57 109.881 -179.889 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' B' B ' 301' ' ' MET . . . . . 0.426 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 40.7 ttp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.613 0.72 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . 0.426 ' N ' ' CG ' ' B' ' 301' ' ' MET . 15.7 t80 -149.81 146.57 27.22 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.451 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . 0.473 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 0.2 OUTLIER -150.25 159.98 44.04 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.882 -1.136 . . . . 0.0 110.551 -179.312 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -157.78 154.71 28.56 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.021 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -115.14 133.33 56.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.258 -0.901 . . . . 0.0 109.951 179.6 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 4.2 p -128.95 124.55 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-O 122.279 1.037 . . . . 0.0 112.364 -176.881 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 91.6 m -77.81 102.49 7.23 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.825 0.821 . . . . 0.0 110.898 -178.245 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' B' ' 358' ' ' GLY . 97.4 mt -52.92 123.28 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 122.403 1.097 . . . . 0.0 110.813 -178.201 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 77.6 p -109.99 20.02 18.4 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.768 -178.368 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -83.13 115.47 59.13 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.1 -1.0 . . . . 0.0 109.854 179.894 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -54.03 -7.2 0.61 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 CA-C-N 120.174 1.098 . . . . 0.0 112.973 179.809 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -117.42 3.53 12.5 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.301 -0.874 . . . . 0.0 109.451 -179.987 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 68.09 -178.9 20.33 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -178.764 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.476 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -83.0 83.29 7.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.686 -1.479 . . . . 0.0 109.593 -178.444 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . 0.429 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 2.6 p80 -91.89 -160.02 0.7 Allowed 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.132 -0.98 . . . . 0.0 109.769 178.403 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.2 m -56.76 -47.7 79.5 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.806 -1.184 . . . . 0.0 112.984 -175.852 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.599 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 11.3 tpt180 -56.35 -59.72 11.19 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 120.388 -1.445 . . . . 0.0 111.919 -179.23 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . 0.429 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 12.0 Cg_endo -58.83 -34.63 99.13 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 CA-C-N 120.369 1.168 . . . . 0.0 111.521 -179.525 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.68 72.8 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.986 179.914 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.78 -44.09 77.41 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.48 -179.078 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -70.01 -41.67 74.03 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.964 -1.095 . . . . 0.0 108.528 179.347 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -63.04 -53.96 45.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.448 -0.783 . . . . 0.0 110.346 -179.733 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 84.2 t -61.77 -28.23 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.528 -1.357 . . . . 0.0 109.768 -179.006 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -64.56 -42.56 95.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.063 -1.023 . . . . 0.0 109.48 -179.92 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -69.77 -42.04 74.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.321 -0.862 . . . . 0.0 111.429 -178.509 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . 0.453 ' C ' ' H ' ' B' ' 328' ' ' GLY . . . -61.65 -54.66 39.74 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.498 -1.376 . . . . 0.0 111.244 -178.591 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -54.15 -10.21 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.894 -1.129 . . . . 0.0 109.633 -179.672 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' B' ' 326' ' ' ALA . . . -71.96 -28.8 67.99 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.249 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -104.59 144.08 32.18 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.335 -1.097 . . . . 0.0 109.458 -179.661 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 91.5 m -90.56 -11.46 40.0 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.137 -0.977 . . . . 0.0 109.742 179.877 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 331' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 58.9 m -65.58 153.73 40.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.998 . . . . 0.0 109.45 179.999 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.44 134.98 49.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.078 -1.014 . . . . 0.0 109.164 -179.74 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.1 mt -131.89 132.81 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.519 -0.738 . . . . 0.0 109.453 -179.718 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 24.6 m -129.12 149.89 50.74 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.462 -0.774 . . . . 0.0 109.618 -179.814 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 90.8 t -123.66 115.4 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.404 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 94.0 m -113.73 122.8 48.21 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.09 -1.007 . . . . 0.0 110.928 -177.903 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 337' ' ' SER . . . . . 0.487 ' C ' ' H ' ' B' ' 339' ' ' GLY . 16.8 t -121.98 127.84 50.79 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.414 0.626 . . . . 0.0 109.312 178.873 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 35.6 m120 57.77 6.37 0.44 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.601 0.715 . . . . 0.0 109.481 -178.777 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' B' ' 337' ' ' SER . . . 101.19 13.16 34.23 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.23 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -104.57 121.15 42.91 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.616 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 58.2 p -100.16 151.54 21.31 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.259 1.028 . . . . 0.0 112.54 -177.026 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -149.76 148.72 29.56 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.35 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 1.8 t -89.27 130.01 35.74 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.991 -1.068 . . . . 0.0 110.777 -178.725 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.542 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -70.16 -19.91 63.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.267 -0.896 . . . . 0.0 110.311 -179.663 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -84.19 21.71 1.34 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.8 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.542 ' H ' ' C ' ' B' ' 344' ' ' ALA . 14.6 p -152.08 98.14 2.4 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.877 0.846 . . . . 0.0 111.21 179.583 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 45.9 tp -59.69 -32.74 70.78 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.832 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -52.93 -51.88 59.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.329 -0.857 . . . . 0.0 111.386 -179.625 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.531 ' NZ ' ' OG ' ' B' ' 346' ' ' SER . 33.6 mtmm -70.01 -40.0 75.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.727 -1.233 . . . . 0.0 111.108 -178.324 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' B' ' 352' ' ' THR . 88.7 mt -49.08 -57.09 7.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.798 -1.189 . . . . 0.0 109.931 -178.832 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.709 ' NE2' ' HE ' ' A' ' 126' ' ' ARG . 4.0 mm100 -44.86 -10.84 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.053 -1.029 . . . . 0.0 111.15 -177.697 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.565 ' N ' ' O ' ' B' ' 350' ' ' LEU . 72.5 p -87.24 -13.34 44.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 119.895 -1.753 . . . . 0.0 110.258 -178.978 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 53.0 mt -94.77 122.41 37.36 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.931 -1.106 . . . . 0.0 109.499 179.001 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.1 92.14 1.04 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 179.368 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 25.8 mt -101.83 95.37 6.36 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.424 -1.045 . . . . 0.0 109.176 179.817 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 75.0 p -93.64 -179.74 5.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.222 -0.924 . . . . 0.0 111.048 -178.954 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -69.27 114.16 7.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.711 -0.618 . . . . 0.0 110.51 -179.508 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 99.99 10.17 46.73 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.759 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 53.2 m -87.18 111.39 20.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -1.094 . . . . 0.0 110.195 -179.822 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 68.0 t -77.08 114.61 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.024 0.916 . . . . 0.0 109.61 -177.384 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 11.8 m -108.26 176.7 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -178.936 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 43.3 m -131.61 126.62 35.19 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.597 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.3 mt -103.49 117.79 49.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.398 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 64.8 m -118.72 130.82 56.03 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.108 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.41 150.8 39.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.267 -178.995 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -145.49 124.36 12.7 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.268 -0.895 . . . . 0.0 109.059 179.579 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.537 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.6 -154.49 25.57 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.403 -1.38 . . . . 0.0 111.072 -179.602 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -59.98 -50.63 73.01 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.468 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.419 ' N ' ' OG ' ' B' ' 331' ' ' SER . 85.1 m-20 -110.03 11.03 24.06 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.838 -1.163 . . . . 0.0 111.192 -177.193 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -40.84 -36.21 0.6 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.334 -0.853 . . . . 0.0 111.79 -178.992 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -69.13 -41.32 77.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.65 -1.281 . . . . 0.0 110.007 -178.526 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -72.97 -54.93 7.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.001 -1.062 . . . . 0.0 110.062 179.763 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -42.33 -34.33 0.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.545 -0.722 . . . . 0.0 111.238 -178.766 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . 0.432 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 93.3 t -80.0 -35.47 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.758 -1.214 . . . . 0.0 109.55 179.289 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -69.95 -39.99 75.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 112.303 -179.112 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -80.08 -46.61 16.21 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.383 -1.448 . . . . 0.0 110.432 -179.465 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' B' ' 381' ' ' MET . 87.9 mt -60.0 -38.03 81.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.889 . . . . 0.0 108.995 -179.637 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 26.9 t -61.5 -48.22 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.277 -0.889 . . . . 0.0 109.718 179.381 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.02 -56.51 6.77 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.625 -1.297 . . . . 0.0 107.613 178.785 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . 0.449 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 46.6 tp -52.51 -32.19 39.12 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.364 -0.835 . . . . 0.0 109.201 -179.176 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 381' ' ' MET . . . . . 0.401 ' N ' ' O ' ' B' ' 377' ' ' LEU . 34.3 ttm -76.07 -39.63 54.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 0.0 108.63 177.74 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.12 -5.06 50.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.58 -0.7 . . . . 0.0 109.873 179.614 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -108.26 3.74 23.89 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.29 -0.881 . . . . 0.0 110.499 -179.364 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . 0.449 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 27.6 mt -74.84 125.4 28.73 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.453 -1.404 . . . . 0.0 109.543 179.708 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.323 179.715 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtt . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.449 -0.575 . . . . 3.19 109.449 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.1 mt -109.9 129.23 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.504 -0.748 . . . . 1.71 109.201 179.808 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.6 m -140.64 122.33 15.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.306 -0.871 . . . . 1.66 109.607 -179.903 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.44 -161.47 31.4 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 108.962 -1.655 . . . . 1.05 108.962 179.319 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 6' ' ' LEU . 97.3 mt -90.22 -9.96 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.114 -1.227 . . . . 1.59 110.42 -179.028 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.6 tp 52.55 99.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.974 -1.079 . . . . 1.47 109.441 179.884 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.27 -27.31 15.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.118 -0.989 . . . . 1.39 109.535 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.0 t -136.4 121.14 12.91 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.385 -0.822 . . . . 2.09 109.22 179.944 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.08 144.77 24.02 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.788 1.659 . . . . 0.91 111.989 -179.949 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 159.72 -159.88 30.99 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.117 -1.593 . . . . 0.92 109.117 -179.576 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.434 HD11 HG21 ' A' ' 11' ' ' ILE . 86.8 mt -149.94 151.64 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 121.248 -1.148 . . . . 1.35 108.587 179.041 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.78 156.49 34.87 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.735 -1.228 . . . . 1.14 110.561 179.261 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -138.27 128.4 25.74 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.375 -1.343 . . . . 0.7 107.375 178.752 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.85 -179.84 47.61 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 118.666 -1.73 . . . . 0.58 110.823 -179.819 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -80.07 159.38 26.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.757 -0.849 . . . . 2.63 109.35 -179.832 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.09 131.51 54.02 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.408 -0.807 . . . . 1.27 111.011 -179.076 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.7 tp -98.7 139.54 34.25 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.245 -1.391 . . . . 1.41 107.245 178.161 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 34.2 tp -117.06 121.32 40.98 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.288 -0.883 . . . . 1.49 110.305 -178.971 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.4 mt -96.41 107.74 20.17 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.384 0.611 . . . . 1.52 110.036 179.905 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.601 ' H ' ' HZ3' ' A' ' 20' ' ' LYS . 1.5 mtmp? -101.87 139.61 37.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.462 -0.774 . . . . 3.17 109.044 179.493 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -128.27 121.75 30.04 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.407 -0.808 . . . . 3.0 108.829 179.419 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 59.3 t0 -75.79 146.53 39.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.084 -1.01 . . . . 2.77 109.598 179.859 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.5 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 84.9 tt0 -61.63 140.19 58.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.406 -0.809 . . . . 2.94 109.823 -179.793 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.4 mt -78.89 132.93 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 1.46 108.872 179.954 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -94.81 122.33 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.022 -1.049 . . . . 1.7 109.961 -179.389 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.05 138.54 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.083 -0.71 . . . . 1.54 109.083 179.979 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -89.43 123.47 33.6 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.059 -1.026 . . . . 1.81 110.255 -179.347 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.507 HH11 ' HG2' ' A' ' 28' ' ' ARG . 0.8 OUTLIER -93.96 3.81 54.82 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.379 -0.826 . . . . 3.23 109.651 -179.962 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -72.92 151.34 41.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.272 -0.892 . . . . 3.29 111.17 -178.753 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -93.24 145.61 24.31 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.581 -0.896 . . . . 2.8 108.581 179.092 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -98.46 167.02 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.071 -1.018 . . . . 1.43 110.297 -179.907 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.2 p -93.74 171.79 8.66 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.492 -0.929 . . . . 1.54 108.492 178.658 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.07 -47.21 86.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.044 -1.035 . . . . 1.6 109.45 -179.915 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -55.86 -31.9 63.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.951 -1.093 . . . . 2.56 109.834 -179.26 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -81.5 -10.23 59.52 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.347 -0.845 . . . . 2.36 110.608 -179.091 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.4 t -60.09 -49.98 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.977 -1.077 . . . . 1.43 109.132 -179.96 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.96 -40.02 91.76 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.341 -0.85 . . . . 1.77 109.614 179.799 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.58 -46.0 87.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.245 -0.909 . . . . 3.32 111.551 -178.837 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -61.39 -42.53 98.88 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.599 -1.313 . . . . 1.51 110.457 -179.085 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.04 -46.58 94.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.55 -1.344 . . . . 1.41 108.184 179.92 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -61.6 -43.9 98.0 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.257 -0.902 . . . . 1.81 109.786 179.34 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -59.99 -41.15 91.43 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.745 -1.222 . . . . 3.26 107.764 179.557 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -63.3 -44.61 94.52 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.708 -0.849 . . . . 0.81 108.708 178.246 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.08 -47.84 84.19 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.57 -0.706 . . . . 1.59 109.222 179.971 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.1 t -63.96 -44.98 91.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.065 -1.022 . . . . 1.38 108.908 179.362 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.56 -39.95 98.04 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.763 -2.135 . . . . 0.87 107.763 178.554 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -67.16 -35.81 80.47 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.572 -0.899 . . . . 3.62 108.572 178.63 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.97 87.62 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.554 -0.716 . . . . 1.43 109.621 -179.611 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.9 ttpt -64.91 -73.77 0.12 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.883 -1.136 . . . . 3.08 108.372 179.491 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.67 -38.57 0.28 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.38 -0.825 . . . . 1.33 111.203 -178.165 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.1 m -54.04 -56.85 14.1 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.718 -1.239 . . . . 1.85 108.939 179.732 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.92 88.3 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.22 -0.925 . . . . 1.35 111.123 -179.163 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -68.46 -40.07 81.17 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.956 -1.09 . . . . 2.34 109.978 -179.2 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.6 mt -65.54 -40.01 92.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.077 -1.014 . . . . 2.2 109.975 179.897 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.539 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 69.3 mm-40 -61.53 -39.96 92.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.084 -1.01 . . . . 1.35 109.869 -179.815 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -62.84 -40.03 96.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.021 -1.049 . . . . 1.34 109.967 -179.931 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.05 -39.85 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.179 -0.95 . . . . 1.26 108.911 179.669 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.539 ' NZ ' ' OE1' ' A' ' 55' ' ' GLU . 5.2 ttpm? -55.92 -49.98 71.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.92 . . . . 1.7 109.081 179.74 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -57.51 -33.54 68.15 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.374 -0.829 . . . . 1.35 110.512 -178.318 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -69.97 -38.86 76.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.897 -1.127 . . . . 2.08 110.005 179.965 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.23 -45.51 76.54 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.401 -0.812 . . . . 1.21 110.487 -179.241 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.66 -50.03 72.15 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.917 -1.135 . . . . 0.75 110.45 -178.68 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.95 -42.88 72.62 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.076 -1.25 . . . . 1.59 110.325 -179.563 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.9 m -70.13 -61.37 1.8 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.206 -0.934 . . . . 1.41 112.744 -177.678 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -93.3 -49.36 5.99 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.679 -1.263 . . . . 0.79 110.711 -178.437 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.76 -167.89 25.77 Favored Glycine 0 N--CA 1.5 2.918 0 C-N-CA 119.936 -1.125 . . . . 1.22 110.849 179.65 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -68.55 -22.12 64.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.805 -0.821 . . . . 5.81 109.859 -179.889 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -60.04 -36.22 76.82 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.654 -0.653 . . . . 3.37 110.371 -179.531 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -101.19 -15.43 17.35 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.352 -0.843 . . . . 2.37 110.322 -179.449 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -69.97 -40.2 75.51 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.933 -1.104 . . . . 1.65 110.585 -179.311 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.8 -28.65 65.91 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.611 -0.836 . . . . 1.42 109.91 -178.564 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.7 mt -60.06 -41.92 88.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.022 -1.071 . . . . 1.43 109.143 -179.903 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -65.88 -40.01 91.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.954 -1.091 . . . . 1.08 109.921 179.99 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -60.15 -40.41 89.77 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.9 -1.125 . . . . 1.37 109.254 179.834 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.86 -41.48 98.76 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.064 -2.014 . . . . 0.67 108.064 178.9 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.3 m170 -70.09 -43.69 70.56 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.618 -0.931 . . . . 1.99 108.595 179.169 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.9 mt -70.04 -46.63 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.367 -0.833 . . . . 1.22 109.369 179.433 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.5 ttp -60.68 -44.8 96.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.057 -1.027 . . . . 2.11 109.687 -179.61 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.411 ' CD1' ' CE2' ' B' ' 348' ' ' PHE . 50.8 tp -60.0 -40.06 87.91 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.802 -0.814 . . . . 1.33 108.802 179.142 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.7 tp -62.94 -39.95 96.16 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.671 -0.643 . . . . 1.29 109.537 179.614 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -79.44 5.2 13.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -0.861 . . . . 1.47 110.127 -179.14 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -56.08 128.99 38.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 1.47 110.291 -179.309 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -63.04 -14.08 43.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.591 -0.693 . . . . 1.78 110.059 -179.985 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -70.08 -37.08 75.37 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.231 -1.025 . . . . 2.53 108.231 178.505 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.03 -39.98 75.46 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.658 0.742 . . . . 1.36 109.757 179.407 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -60.05 -45.48 92.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.59 -0.694 . . . . 1.42 110.895 -178.417 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -70.78 -48.55 53.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.257 -0.902 . . . . 2.27 111.667 -178.584 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -64.16 -39.9 95.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.352 -0.842 . . . . 1.57 111.734 -177.409 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -66.27 -47.77 83.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 120.838 -1.164 . . . . 1.19 109.857 -179.541 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.413 HD12 HG23 ' A' ' 90' ' ' ILE . 96.9 mt -70.01 -39.04 76.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.415 -0.803 . . . . 1.39 110.671 -179.674 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.97 -48.86 79.95 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.173 -0.954 . . . . 1.39 111.045 -178.917 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 96' ' ' LYS . 75.7 mt -60.01 -44.9 94.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.917 -1.115 . . . . 1.5 109.501 -178.955 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.8 mt -60.23 -50.0 81.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.76 -1.2 . . . . 1.29 107.76 178.86 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -65.07 -40.05 94.14 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 120.024 -0.67 . . . . 2.64 110.243 179.359 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 91' ' ' ALA . 56.7 t0 -84.26 -55.11 4.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.995 -1.066 . . . . 1.65 112.277 -178.241 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 92' ' ' LEU . 99.0 mttt -90.04 -1.98 58.05 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.812 -1.18 . . . . 2.5 112.145 -177.348 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 57.85 37.54 26.99 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.846 -1.159 . . . . 1.88 109.379 -179.534 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.9 mtt -93.04 166.38 12.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.497 -0.752 . . . . 1.71 109.879 -179.758 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.4 p -79.95 160.0 26.11 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.034 -0.728 . . . . 1.61 109.034 179.678 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.05 77.59 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.321 -0.862 . . . . 1.33 109.755 -179.999 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -65.51 -40.03 92.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.084 -1.01 . . . . 2.07 109.521 179.665 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.6 -43.12 23.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 1.37 110.352 -179.684 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.05 -41.69 73.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 1.14 110.278 -179.442 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.95 -39.68 95.39 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.122 -0.986 . . . . 1.26 109.474 179.956 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.546 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 81.1 t60 -59.62 -40.07 86.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.551 -0.718 . . . . 2.02 109.578 -178.804 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 110' ' ' GLY . 87.2 tt0 -64.61 -40.02 94.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.305 -0.872 . . . . 1.33 110.55 -179.655 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.3 t -63.86 -60.61 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.148 -0.97 . . . . 1.3 111.478 -178.308 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.0 mm -65.06 -39.96 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.855 -1.153 . . . . 1.32 109.268 -179.459 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.546 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 85.3 tt0 -67.04 -39.98 87.08 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.076 -1.083 . . . . 2.44 108.076 178.275 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -56.82 -52.14 52.67 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.23 -1.148 . . . . 0.99 110.23 -179.27 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -65.07 -48.14 74.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.785 -1.421 . . . . 1.97 109.197 -179.848 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.08 85.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 1.43 109.03 179.676 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.5 m -59.57 -39.87 85.5 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.468 -0.77 . . . . 2.12 109.018 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.44 -40.03 92.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 1.64 109.015 179.02 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.2 mt -64.2 -41.87 96.88 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.273 -0.892 . . . . 1.93 109.784 -179.247 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.02 -33.78 72.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.822 -1.174 . . . . 2.2 109.783 -179.272 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -56.92 -20.52 23.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.108 -0.995 . . . . 2.12 108.927 179.949 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.0 mt -62.63 138.66 58.54 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.188 -1.041 . . . . 2.34 108.188 179.469 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 57.9 t0 -94.69 54.97 1.84 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.931 -1.105 . . . . 3.23 110.086 -179.611 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 58.9 t0 -136.1 136.7 40.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.345 -0.847 . . . . 2.49 108.938 179.23 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.461 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 98.9 mt-10 -70.02 -31.61 69.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.42 -0.8 . . . . 3.95 109.964 -179.537 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.509 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.4 t80 -72.64 -38.86 67.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.871 . . . . 2.25 110.728 179.886 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 70.7 mt -74.12 -36.26 64.18 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.975 -1.078 . . . . 2.27 109.745 -179.369 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -60.04 -40.0 87.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.015 -1.053 . . . . 3.31 109.357 179.601 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -60.0 -47.31 86.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 2.73 109.482 179.957 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.527 HH21 ' NE2' ' B' ' 351' ' ' GLN . 62.0 mtp180 -60.18 -39.98 88.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.963 . . . . 3.2 108.663 179.201 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.53 -36.12 77.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.82 . . . . 1.66 108.846 178.972 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.89 -40.02 96.26 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.081 -0.711 . . . . 1.67 109.081 179.684 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -64.22 -40.93 97.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 1.55 110.111 -179.352 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.55 -41.88 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 1.32 109.616 -179.889 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -60.01 -38.1 81.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.141 -0.974 . . . . 3.58 109.4 179.48 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -59.92 -40.88 90.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 1.46 110.361 -178.948 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.19 -45.01 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.894 -1.129 . . . . 1.22 109.581 179.815 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.97 -37.91 93.64 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.713 -1.355 . . . . 0.61 109.713 179.995 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -60.03 -47.6 85.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -1.111 . . . . 3.1 109.56 -179.378 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -68.76 -33.16 73.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.238 -0.914 . . . . 3.71 109.637 -179.772 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.7 tp -57.28 -43.7 83.37 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.355 -0.841 . . . . 1.87 108.995 -179.788 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.66 -39.96 95.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.13 -0.982 . . . . 1.29 108.654 179.145 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.6 mtp180 -66.89 -39.97 87.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.912 -0.773 . . . . 3.05 108.912 179.465 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -69.44 -31.7 70.18 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.554 -0.716 . . . . 1.26 110.941 -179.31 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.0 mt -70.04 -43.29 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.401 -1.437 . . . . 1.34 108.193 178.728 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 88.9 mt -71.56 -29.99 65.36 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.792 -0.568 . . . . 1.6 109.901 -179.708 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.69 40.33 8.31 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.983 -1.647 . . . . 0.96 108.983 -179.28 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 18.5 tp -73.99 146.36 43.88 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.386 -1.067 . . . . 1.67 109.14 -179.479 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -65.08 147.92 52.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -0.894 . . . . 4.96 110.002 -178.892 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 98.6 mt -118.89 125.63 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 122.093 0.949 . . . . 1.68 109.325 179.49 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 148' ' ' ASP . 5.5 mt -62.38 -43.58 98.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.87 -0.605 . . . . 2.14 110.219 -178.859 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 147' ' ' ILE . 32.2 t0 62.01 125.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.968 -0.753 . . . . 1.5 108.968 -179.126 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.4 mt -87.08 -2.09 58.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.256 -0.903 . . . . 1.39 109.639 -179.274 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 93.8 p -82.26 -9.96 59.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.916 -1.115 . . . . 1.83 108.752 178.951 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -88.71 18.54 4.61 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.666 . . . . 1.46 110.925 -177.818 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 65.2 mt -91.74 116.92 33.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.871 -1.143 . . . . 1.42 109.15 179.621 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -103.03 -12.03 17.72 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.251 -0.905 . . . . 2.94 110.206 -179.268 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -116.01 145.72 42.74 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.318 -0.864 . . . . 1.52 110.347 -178.805 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.81 131.97 50.63 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.496 -0.928 . . . . 1.58 108.496 179.584 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.7 m -152.57 165.23 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 1.32 109.954 -179.947 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.5 mt -93.31 148.8 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 105.215 -2.142 . . . . 1.27 105.215 176.776 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 39.9 tp -99.35 120.01 38.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.838 -1.164 . . . . 1.41 110.609 -177.836 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 49.6 t -123.59 130.08 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 108.752 -0.833 . . . . 1.23 108.752 179.343 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -156.72 162.69 39.78 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.4 -0.963 . . . . 1.32 108.4 179.837 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.95 -35.83 74.8 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.185 -1.572 . . . . 1.49 107.315 178.547 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 20.8 p-10 -171.21 144.69 2.09 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.582 -0.895 . . . . 2.25 108.582 179.287 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.2 mt -111.78 139.83 46.93 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.253 -0.905 . . . . 1.35 109.863 -179.438 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.1 p -93.19 145.28 29.77 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.392 -0.818 . . . . 1.56 109.501 -179.929 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -39.36 -36.94 1.03 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.405 2.07 . . . . 0.87 113.273 179.458 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 68.5 m -60.01 -39.97 87.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.026 -1.046 . . . . 1.36 109.776 -178.661 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.03 -42.0 90.19 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.023 -1.048 . . . . 1.61 110.217 -179.506 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 67.8 p -54.96 -30.61 59.41 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.136 -0.977 . . . . 1.21 110.598 -178.4 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.36 -54.27 11.33 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.028 -1.045 . . . . 1.21 109.879 179.77 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -87.32 39.15 0.85 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.183 -1.043 . . . . 2.11 108.183 179.88 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 33.7 tp -100.22 130.62 46.37 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.622 -0.674 . . . . 1.29 109.307 179.472 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -82.12 98.5 8.71 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.185 -1.043 . . . . 2.81 108.185 179.307 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 73.6 mt -67.16 -40.52 86.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.378 -0.826 . . . . 2.09 110.872 -178.592 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.39 -30.32 71.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.651 -1.281 . . . . 2.86 112.094 -177.714 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.65 -5.86 50.57 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.712 -1.243 . . . . 2.39 110.061 -178.734 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 84.0 t -106.24 116.62 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.134 -0.979 . . . . 1.27 109.307 179.652 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 78.1 mt -88.04 9.96 20.71 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.475 -0.765 . . . . 2.17 110.997 -177.786 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 165.64 176.59 37.22 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.62 -1.392 . . . . 0.52 109.62 179.858 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -137.64 131.21 31.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.456 -1.026 . . . . 0.55 108.853 -179.82 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 97.4 mt -133.46 130.0 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.772 -0.825 . . . . 1.27 108.772 179.002 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 72.1 p -148.4 160.0 43.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.965 -1.084 . . . . 1.39 110.855 -179.82 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -109.03 31.18 5.9 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.192 -1.04 . . . . 2.46 108.192 178.966 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.35 -160.44 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.919 -1.113 . . . . 1.51 111.516 -177.605 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.4 -67.68 1.99 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.34 -1.104 . . . . 2.23 110.34 -179.092 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 178.39 -130.98 1.65 Allowed Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.974 -1.584 . . . . 2.23 110.981 -179.802 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -79.46 -10.01 59.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.634 -0.921 . . . . 6.44 111.025 -178.504 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 42.9 p -81.8 4.87 20.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.968 -1.083 . . . . 4.09 109.687 -179.253 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.48 ' HG ' ' H ' ' A' ' 191' ' ' SER . 23.4 p -90.43 137.54 32.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.134 -0.979 . . . . 2.2 110.593 -179.522 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -48.34 -47.86 36.7 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.475 -0.766 . . . . 1.15 109.673 179.977 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 98.5 m -57.4 -37.79 73.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.455 -0.778 . . . . 2.01 110.717 -178.992 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.48 ' H ' ' HG ' ' A' ' 188' ' ' SER . 52.8 m -60.03 -39.9 87.49 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.854 -1.154 . . . . 1.93 110.354 -178.97 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 45.1 mm -64.85 -40.05 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 2.2 110.128 -179.599 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.3 mtp -60.1 -46.87 88.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.091 -1.006 . . . . 1.32 110.701 -179.765 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.71 -45.58 77.86 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.537 -1.352 . . . . 1.3 109.378 -179.589 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -60.1 -54.98 39.57 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.0 -1.062 . . . . 3.38 109.468 179.67 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 69.3 m -63.09 -40.05 96.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 1.15 110.966 -179.3 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.16 -29.17 64.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.985 -1.072 . . . . 1.28 108.468 179.73 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.97 50.03 1.09 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.285 0.564 . . . . 1.5 110.277 -179.842 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 32.7 mt -124.95 145.97 51.89 Favored Pre-proline 0 N--CA 1.503 2.212 0 N-CA-C 108.497 -0.927 . . . . 1.37 108.497 178.91 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.27 125.29 7.04 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.094 1.862 . . . . 0.76 112.555 179.737 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.26 141.23 7.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.489 -1.382 . . . . 1.19 112.154 179.866 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 202' ' ' ILE . 96.9 mt -124.84 147.14 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 107.173 -1.417 . . . . 1.31 107.173 177.811 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 17.3 m -130.78 -7.53 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 120.833 -1.167 . . . . 1.38 111.177 -178.991 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.99 23.05 24.37 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.454 -1.058 . . . . 1.03 110.454 -179.497 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.436 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 2.4 p -45.38 -44.18 11.67 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.93 -1.335 . . . . 1.38 109.88 -179.602 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 93.5 -51.65 2.38 Favored Glycine 0 N--CA 1.5 2.93 0 C-N-CA 120.129 -1.034 . . . . 1.17 111.742 178.692 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.3 t -161.9 36.23 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.577 -1.543 . . . . 2.07 110.676 -179.354 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 52.6 t -74.32 -40.83 50.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.215 -0.928 . . . . 1.35 108.934 178.409 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 209' ' ' THR . . . . . 0.436 ' HG1' ' N ' ' A' ' 210' ' ' SER . 1.5 p -53.1 -31.93 44.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.403 -0.811 . . . . 1.49 110.063 -179.147 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.436 ' N ' ' HG1' ' A' ' 209' ' ' THR . 39.8 t -71.11 -33.35 70.05 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.168 -0.957 . . . . 2.16 109.741 -179.741 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -89.46 -9.95 48.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 2.89 110.274 -178.995 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 69.6 t -101.52 132.85 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.254 -0.904 . . . . 1.33 110.463 -178.887 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -114.15 153.52 29.4 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.549 -1.278 . . . . 2.73 107.549 178.834 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 8.9 t-20 -58.8 138.7 57.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.946 -1.097 . . . . 2.7 110.345 -178.605 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 11.6 t0 83.78 5.28 0.76 Allowed 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.113 0.482 . . . . 2.38 109.998 179.699 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.4 t0 -75.72 140.86 42.68 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.071 -1.018 . . . . 2.09 108.862 179.146 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.498 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 51.3 t80 -93.29 117.06 29.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.146 -0.971 . . . . 1.45 108.41 179.155 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 57.4 mt -126.42 147.35 49.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.526 -0.734 . . . . 1.31 110.379 -178.929 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.8 mt -114.34 130.02 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 107.664 -1.236 . . . . 1.29 107.664 177.554 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 32.7 tp -100.17 118.18 35.96 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.938 -1.101 . . . . 1.31 109.571 -179.096 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.593 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 26.4 p-10 -77.64 -42.84 33.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.068 -1.02 . . . . 2.31 108.591 179.231 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . 0.493 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 52.1 17.27 0.66 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.796 -1.187 . . . . 1.19 107.796 -178.905 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.436 ' N ' ' C ' ' A' ' 221' ' ' ASP . 45.6 t -130.86 -43.66 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.708 -1.219 . . . . 1.45 107.708 179.362 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -99.14 -0.52 41.5 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.805 -1.554 . . . . 3.13 106.805 177.942 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.521 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 40.4 t-20 60.06 46.72 10.43 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.423 -0.584 . . . . 2.2 109.423 -179.933 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.593 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 95.3 mt-30 -140.46 157.23 45.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.385 -0.822 . . . . 2.32 109.647 -179.945 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 69.5 t -119.96 130.58 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 109.085 -0.709 . . . . 1.4 109.085 179.437 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -99.33 122.74 42.89 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.576 -0.898 . . . . 1.29 108.576 179.001 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 59.4 t -105.61 120.0 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.568 -0.707 . . . . 1.38 109.445 -179.242 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 62.96 66.76 1.17 Allowed Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.372 -0.83 . . . . 2.33 109.53 -179.731 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -89.16 127.78 1.79 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 123.142 2.561 . . . . 0.95 112.517 -179.664 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 26.0 p -75.33 170.47 16.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 2.31 109.623 -179.753 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -60.03 -39.44 85.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 3.45 109.088 179.67 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.08 -39.97 87.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.409 -0.807 . . . . 2.89 109.634 -179.382 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.6 t -67.24 -41.7 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.062 -1.024 . . . . 1.73 109.152 179.96 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 87.7 mt . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.193 -0.942 . . . . 1.57 109.921 -179.628 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 43.9 ttm . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.581 0.705 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -151.16 149.4 29.43 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.121 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -146.19 154.98 42.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.063 -1.023 . . . . 0.0 110.393 -179.226 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -150.36 146.72 26.89 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.598 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 56.8 mp0 -110.21 127.82 55.16 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.249 -0.907 . . . . 0.0 109.623 179.334 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.35 122.8 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 CA-C-O 122.295 1.045 . . . . 0.0 112.807 -176.849 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 58.8 m -77.95 101.52 6.9 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.997 0.903 . . . . 0.0 110.268 -178.987 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.9 mt -50.81 118.45 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 122.204 1.002 . . . . 0.0 109.923 -177.874 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 19.1 p -100.35 22.14 12.04 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.676 -178.776 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -86.82 114.24 57.16 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.97 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -68.82 -4.86 14.17 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 CA-C-N 120.227 1.117 . . . . 0.0 112.456 -179.283 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -108.76 4.81 24.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.518 -0.738 . . . . 0.0 109.101 179.741 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.6 169.77 8.65 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 -179.051 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.509 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -86.14 92.05 8.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.3 . . . . 0.0 108.846 -179.138 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -95.23 -159.94 0.75 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.085 -1.009 . . . . 0.0 109.98 179.029 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.3 m -58.92 -44.67 91.36 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.931 -1.106 . . . . 0.0 112.611 -175.995 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.615 ' NH2' ' NE2' ' B' ' 321' ' ' GLN . 1.6 tpt180 -59.88 -60.59 10.09 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 120.487 -1.383 . . . . 0.0 112.027 -178.257 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -59.94 -32.04 94.55 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 CA-C-N 120.362 1.165 . . . . 0.0 111.338 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.28 70.32 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.431 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.78 -40.09 65.99 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.601 -179.079 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . 0.615 ' NE2' ' NH2' ' B' ' 317' ' ' ARG . 50.0 mt-30 -69.87 -41.0 75.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.985 -1.072 . . . . 0.0 108.662 179.061 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -60.05 -51.26 70.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.72 -0.612 . . . . 0.0 110.343 -179.223 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 71.1 t -69.68 -35.75 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.946 -1.096 . . . . 0.0 109.743 -179.134 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -50.05 -49.89 49.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.387 -0.821 . . . . 0.0 109.122 -179.792 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -60.07 -49.9 75.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.269 -0.895 . . . . 0.0 109.339 -179.387 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -63.14 -47.11 84.11 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.157 -0.964 . . . . 0.0 109.765 179.765 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -48.4 -26.64 2.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.531 -0.73 . . . . 0.0 109.678 -179.339 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -82.59 -15.74 72.7 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.655 -179.181 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -105.72 135.0 47.92 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.26 -1.141 . . . . 0.0 109.434 179.736 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 16.9 m -90.6 -13.36 34.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.977 -1.077 . . . . 0.0 109.246 179.651 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 331' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 52.0 p -55.05 148.77 13.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.228 -0.92 . . . . 0.0 108.848 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -68.35 128.72 37.61 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.002 -1.061 . . . . 0.0 108.567 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 95.3 mt -132.34 132.32 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.675 -0.641 . . . . 0.0 109.352 -179.809 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 27.1 m -130.63 152.36 50.08 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.449 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 46.0 t -114.73 140.16 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 178.521 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 94.2 m -130.13 122.69 28.72 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.196 -0.94 . . . . 0.0 108.646 179.604 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 2.8 t -140.53 118.14 11.59 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.936 0.875 . . . . 0.0 112.065 -178.906 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 50.05 50.5 18.42 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 175.806 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.95 -10.77 72.77 Favored Glycine 0 N--CA 1.502 3.089 0 O-C-N 119.802 -1.811 . . . . 0.0 113.85 176.11 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . 0.473 ' NZ ' ' OG1' ' B' ' 352' ' ' THR . 62.2 tttm -128.26 140.31 51.96 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 120.022 1.911 . . . . 0.0 109.514 -179.642 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.7 m -126.74 147.79 49.95 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.818 0.818 . . . . 0.0 111.377 -178.266 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.3 164.58 29.86 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.309 0.576 . . . . 0.0 109.694 179.98 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 27.3 m -88.63 138.01 31.8 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.319 -0.863 . . . . 0.0 110.03 -179.326 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.43 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -78.9 -12.0 60.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.896 -1.127 . . . . 0.0 109.86 -179.479 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -91.87 20.15 5.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 178.042 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.43 ' H ' ' C ' ' B' ' 344' ' ' ALA . 42.6 t -145.89 94.44 2.48 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.013 -179.699 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . 0.512 ' CD1' HE22 ' B' ' 351' ' ' GLN . 60.8 tp -59.88 -33.85 72.38 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.829 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . 0.411 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 58.9 m-85 -57.25 -53.68 55.38 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.32 -0.863 . . . . 0.0 110.76 -179.337 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.41 ' O ' ' OG1' ' B' ' 352' ' ' THR . 33.1 mtmm -70.01 -29.63 66.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.868 -1.145 . . . . 0.0 110.951 -177.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' B' ' 352' ' ' THR . 84.8 mt -60.06 -52.86 63.55 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.157 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' B' ' 351' ' ' GLN . 0.7 OUTLIER -42.42 -21.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.436 -0.79 . . . . 0.0 110.674 -178.009 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.473 ' OG1' ' NZ ' ' B' ' 340' ' ' LYS . 68.1 p -81.74 -12.25 58.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.406 -1.434 . . . . 0.0 109.964 -179.112 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 31.4 mt -95.39 120.08 35.0 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.95 -1.094 . . . . 0.0 109.082 178.409 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -80.89 92.5 1.45 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.364 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 22.9 mt -98.42 93.07 5.98 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.111 -1.229 . . . . 0.0 108.139 178.695 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 53.6 p -95.17 -179.96 4.99 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.084 -1.01 . . . . 0.0 111.279 -178.249 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' B' ' 359' ' ' THR . 7.2 tt0 -46.86 154.65 0.31 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.175 0.988 . . . . 0.0 111.035 -179.546 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.98 26.88 0.05 OUTLIER Glycine 0 N--CA 1.497 2.743 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.157 177.754 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 359' ' ' THR . . . . . 0.447 ' N ' ' O ' ' B' ' 357' ' ' GLN . 23.8 m -84.61 111.27 19.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.798 -1.413 . . . . 0.0 109.744 179.922 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 12.6 t -78.16 113.06 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 122.297 1.046 . . . . 0.0 109.774 -177.587 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 16.0 m -110.09 178.51 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.173 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 25.5 m -131.48 127.13 36.71 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.176 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 60.4 mt -103.43 118.9 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.96 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 58.3 p -121.19 133.23 55.17 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.401 -0.812 . . . . 0.0 109.283 -179.459 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.79 148.25 35.31 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.048 -1.032 . . . . 0.0 110.527 -179.046 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -140.03 121.19 14.78 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.275 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.548 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.38 -163.52 33.99 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.048 -1.549 . . . . 0.0 111.53 -179.758 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -59.97 -52.76 64.0 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 122.162 -0.61 . . . . 0.0 111.998 -177.896 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.4 ' H ' ' HB3' ' B' ' 331' ' ' SER . 96.0 m-20 -105.2 10.1 33.86 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.974 -1.079 . . . . 0.0 111.128 -177.407 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -42.18 -36.2 1.14 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.222 -0.924 . . . . 0.0 111.392 -179.155 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -70.0 -40.04 75.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.921 -1.112 . . . . 0.0 109.899 -179.012 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -66.51 -48.41 69.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.021 -1.049 . . . . 0.0 109.394 -179.441 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.07 -75.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 110.686 -179.098 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 37.4 t -44.64 -38.26 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.235 -0.915 . . . . 0.0 110.881 -177.519 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.03 -51.37 64.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.576 -1.328 . . . . 0.0 110.887 -179.597 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -74.54 -40.67 61.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.88 -1.138 . . . . 0.0 109.976 -179.668 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.01 -39.79 87.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.897 . . . . 0.0 110.095 -179.502 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 55.4 t -62.18 -43.39 97.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.211 -0.931 . . . . 0.0 109.968 -179.867 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -68.56 -54.59 15.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.615 -1.303 . . . . 0.0 108.617 178.687 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 50.1 tp -58.56 -34.72 71.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.23 -0.919 . . . . 0.0 109.937 -178.126 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 32.0 ttm -70.59 -40.05 73.46 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.408 -1.317 . . . . 0.0 108.42 177.927 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.24 -7.17 59.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.456 -0.777 . . . . 0.0 110.716 179.57 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -110.84 -1.74 16.41 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.077 -1.015 . . . . 0.0 111.54 -178.804 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.7 mt -81.89 130.25 35.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.297 -1.502 . . . . 0.0 109.197 178.823 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.328 179.937 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtt . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.61 -0.515 . . . . 3.19 109.61 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.432 HG22 HD13 ' A' ' 2' ' ' ILE . 96.7 mt -101.39 127.74 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.297 -0.877 . . . . 1.71 109.491 -179.736 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.0 m -139.61 152.45 46.82 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.923 -0.769 . . . . 1.66 108.923 -179.929 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.89 -164.05 10.36 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 108.759 -1.736 . . . . 1.05 108.759 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.7 mt -88.57 -16.29 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.895 -1.356 . . . . 1.59 110.306 -179.133 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.1 tp 51.06 103.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.282 -0.886 . . . . 1.47 109.51 179.932 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.9 -25.38 14.63 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.06 -1.025 . . . . 1.39 109.523 179.604 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.5 m -134.83 121.19 14.69 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.511 -0.743 . . . . 2.09 109.432 -179.875 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -81.09 151.42 18.23 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.163 1.909 . . . . 0.91 112.81 179.947 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 142.35 177.82 17.77 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 109.248 -1.541 . . . . 0.92 109.248 179.597 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.6 mt -128.17 131.36 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 120.847 -1.384 . . . . 1.35 110.07 -179.555 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.4 155.98 49.35 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.252 -0.905 . . . . 1.14 109.888 -179.785 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.5 m-85 -129.44 129.63 44.9 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.655 -0.869 . . . . 0.7 108.655 179.879 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.79 171.7 44.29 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.979 -1.582 . . . . 0.58 110.583 179.841 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 157' ' ' ILE . 96.0 mttt -77.39 158.42 30.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.682 -0.893 . . . . 2.63 109.294 -179.895 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -101.89 129.63 48.18 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.385 -0.822 . . . . 1.27 111.775 -178.247 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.7 tp -100.17 132.26 45.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.179 -1.415 . . . . 1.41 107.179 177.928 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.0 tp -115.89 123.73 48.85 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.186 -0.946 . . . . 1.49 110.265 -179.218 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.2 mt -89.78 102.21 14.9 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.277 0.56 . . . . 1.52 110.541 -179.202 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -94.08 135.14 35.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.383 -0.823 . . . . 3.17 108.931 179.378 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -131.43 134.0 45.77 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.148 -0.97 . . . . 3.0 108.858 179.108 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -83.95 139.78 32.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 2.77 109.246 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.45 140.25 58.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.905 . . . . 2.94 109.42 -179.822 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.2 mt -82.83 133.69 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.878 . . . . 1.46 108.864 179.916 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.67 129.97 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.329 -0.857 . . . . 1.7 109.356 -179.666 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.0 mt -102.22 141.39 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.487 -0.758 . . . . 1.54 109.383 -179.84 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -96.13 120.48 36.49 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.153 -0.967 . . . . 1.81 109.721 -179.655 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.466 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.5 mmt-85 -87.48 -0.67 57.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.523 -0.735 . . . . 3.23 109.712 -179.627 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -67.9 136.55 54.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 3.29 109.235 179.991 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -81.3 150.73 28.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.105 -0.997 . . . . 2.8 109.117 179.718 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 pt -93.15 166.67 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.191 -0.943 . . . . 1.43 109.798 -179.933 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.9 p -96.75 171.67 8.38 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.499 -0.926 . . . . 1.54 108.499 178.705 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -48.81 80.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.121 -0.987 . . . . 1.6 109.868 -179.492 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 4.8 p-10 -57.14 -26.07 59.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.738 -1.226 . . . . 2.56 109.437 -179.639 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -82.76 -10.09 59.05 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.262 -0.899 . . . . 2.36 109.826 179.833 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -64.06 -52.48 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.964 -1.085 . . . . 1.43 109.368 -179.731 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.24 -40.05 94.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.335 -0.853 . . . . 1.77 109.478 179.817 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -67.66 -42.79 81.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.161 -0.962 . . . . 3.32 110.98 -178.926 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.485 ' OE2' ' NH1' ' A' ' 42' ' ' ARG . 72.6 mm-40 -66.67 -40.02 88.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.747 -1.221 . . . . 1.51 110.182 -179.504 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -59.97 -45.49 95.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 120.739 -1.226 . . . . 1.41 108.025 178.938 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -60.03 -39.95 87.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.35 -0.844 . . . . 1.81 109.319 179.649 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.485 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 99.0 mtt180 -60.02 -43.99 94.88 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.782 -1.192 . . . . 3.26 107.782 178.838 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -60.84 -47.06 88.08 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.743 -0.836 . . . . 0.81 108.743 178.076 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.3 tp -60.01 -48.71 80.57 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.516 -0.92 . . . . 1.59 108.516 -179.857 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.6 t -61.4 -42.28 98.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 1.38 108.86 179.255 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.39 -46.5 94.26 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.735 -1.746 . . . . 0.87 108.735 179.273 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.402 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 38.1 ttt-85 -62.89 -32.74 74.07 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.168 -1.049 . . . . 3.62 108.168 178.422 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.55 -43.83 93.43 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.237 -0.653 . . . . 1.43 109.237 -179.516 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 50' ' ' ALA . 26.5 ttpp -68.81 -74.25 0.13 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.854 -1.154 . . . . 3.08 108.331 179.473 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.22 -35.3 0.11 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.335 -0.853 . . . . 1.33 111.378 -178.366 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.7 t -58.44 -53.32 59.64 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.317 -1.353 . . . . 1.85 108.301 179.559 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.35 -39.99 81.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -0.857 . . . . 1.35 111.088 -179.232 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -67.57 -40.11 84.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.745 -1.222 . . . . 2.34 109.968 -179.598 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.6 mt -63.84 -40.01 95.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.978 -1.077 . . . . 2.2 108.819 179.842 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -63.93 -37.92 89.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.354 -0.841 . . . . 1.35 109.52 179.252 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -62.87 -43.5 98.62 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.098 -1.001 . . . . 1.34 108.548 179.175 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.411 HD13 HG23 ' A' ' 57' ' ' ILE . 87.2 mt -62.46 -39.98 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 109.022 -0.733 . . . . 1.26 109.022 179.498 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 ttpp -56.98 -51.84 67.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.165 -0.959 . . . . 1.7 109.876 -179.781 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -58.78 -30.8 67.84 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.431 -0.793 . . . . 1.35 110.29 -178.083 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -69.64 -38.86 77.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.092 -1.005 . . . . 2.08 109.071 -179.826 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.2 -42.91 93.07 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.692 -0.63 . . . . 1.21 109.72 -179.8 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.37 -52.37 52.09 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.839 -1.305 . . . . 0.75 109.839 -179.318 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.2 -47.53 61.12 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.08 -1.247 . . . . 1.59 110.122 -179.962 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.4 m -66.49 -62.7 1.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.966 . . . . 1.41 112.399 -177.449 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -95.34 -48.48 5.86 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.761 -1.212 . . . . 0.79 111.105 -178.218 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.31 -169.68 24.96 Favored Glycine 0 N--CA 1.5 2.917 0 C-N-CA 119.801 -1.19 . . . . 1.22 111.045 179.608 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -69.95 -23.83 63.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.819 -0.812 . . . . 5.81 109.547 179.881 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -61.93 -35.92 79.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.734 -0.603 . . . . 3.37 110.947 -179.27 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -99.4 -17.53 17.94 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.208 -0.932 . . . . 2.37 109.315 -179.934 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -69.2 -40.08 78.25 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.404 -0.81 . . . . 1.65 109.968 -179.187 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.566 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -69.18 -26.8 65.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.288 -0.883 . . . . 1.42 109.991 -179.137 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.9 mt -59.95 -42.12 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.098 -1.001 . . . . 1.43 108.608 -179.973 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -66.2 -40.03 90.08 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.392 -0.923 . . . . 1.08 109.706 179.845 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -59.96 -41.17 91.31 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.939 -1.101 . . . . 1.37 109.294 179.503 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.28 -44.87 97.05 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.69 -1.764 . . . . 0.67 108.69 179.353 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.9 m170 -66.86 -49.95 64.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.417 -1.049 . . . . 1.99 109.134 179.563 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.98 -50.01 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.329 -0.857 . . . . 1.22 109.322 179.719 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.3 ttp -60.12 -39.88 87.78 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.12 -0.987 . . . . 2.11 109.774 -179.265 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.5 tp -67.52 -40.0 85.1 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.403 -0.81 . . . . 1.33 109.946 179.7 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.1 tp -63.63 -39.87 95.46 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.576 -0.703 . . . . 1.29 109.611 -179.488 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -83.25 6.42 19.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.935 . . . . 1.47 109.758 -179.101 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 60.9 t0 -49.88 134.12 21.4 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.318 -0.864 . . . . 1.47 110.648 -179.074 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.481 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.9 mt-10 -59.98 -25.06 64.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.724 -0.61 . . . . 1.78 111.148 -179.464 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -70.95 -33.81 70.85 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.068 -1.02 . . . . 2.53 109.346 179.629 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.94 -40.21 75.6 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.571 0.7 . . . . 1.36 109.846 179.743 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.03 -47.1 87.23 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.373 -0.829 . . . . 1.42 110.594 -178.921 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -69.96 -41.28 74.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 2.27 111.184 -178.706 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.07 -39.91 75.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.03 -1.044 . . . . 1.57 111.697 -178.63 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.82 -47.19 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.033 -1.042 . . . . 1.19 109.94 -179.233 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.43 -39.56 82.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.538 -0.727 . . . . 1.39 109.999 -179.949 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.42 85.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.164 -0.96 . . . . 1.39 110.844 -179.195 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.09 -46.85 88.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.026 -1.046 . . . . 1.5 109.859 -179.238 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.8 mt -61.64 -49.93 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 1.29 109.015 179.681 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -67.29 -41.48 85.36 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.649 -0.657 . . . . 2.64 110.89 -179.247 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -83.87 -50.51 8.0 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.84 -1.162 . . . . 1.65 112.013 -178.642 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -90.16 -3.74 57.69 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.985 -1.072 . . . . 2.5 111.699 -177.337 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.3 m80 56.77 37.56 28.89 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.782 -1.199 . . . . 1.88 109.457 -179.518 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 54.8 mtt -90.04 168.82 11.7 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.574 -0.704 . . . . 1.71 109.733 -179.683 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 63.4 p -80.38 160.03 25.52 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.33 -0.856 . . . . 1.61 108.722 179.315 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.8 -37.75 76.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.064 -1.023 . . . . 1.33 110.422 -179.271 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 38.0 p-10 -69.96 -36.74 75.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.898 -1.127 . . . . 2.07 109.799 -179.566 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.515 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.86 -42.89 20.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 1.37 109.624 179.569 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.55 -47.96 74.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.41 -0.806 . . . . 1.14 109.992 -179.514 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.97 -38.56 82.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.084 -1.01 . . . . 1.26 109.746 -179.776 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -59.94 -39.97 87.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.395 -0.816 . . . . 2.02 110.275 -178.561 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -63.8 -39.97 95.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.01 . . . . 1.33 110.809 -178.779 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.3 t -62.17 -50.07 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.034 -1.041 . . . . 1.3 111.037 -178.401 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.9 mm -69.56 -40.0 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.963 -1.086 . . . . 1.32 108.988 -179.862 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -60.03 -38.62 83.26 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.103 -0.703 . . . . 2.44 109.103 179.056 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.03 -49.95 72.8 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 120.562 -0.828 . . . . 0.99 111.219 -179.111 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -66.64 -50.02 64.31 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.77 -1.43 . . . . 1.97 110.442 -178.528 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.2 88.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.905 -1.122 . . . . 1.43 109.231 -179.704 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.0 t -60.07 -40.72 90.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.306 -0.871 . . . . 2.12 109.074 -179.557 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.98 92.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.27 -0.894 . . . . 1.64 109.12 179.291 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.6 mt -65.98 -42.3 90.0 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.117 -0.989 . . . . 1.93 109.397 -179.634 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.95 -37.91 80.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.663 -1.273 . . . . 2.2 109.302 -179.473 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -52.42 -21.46 3.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.024 -1.048 . . . . 2.12 108.681 179.539 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 59.2 mt -63.64 152.31 39.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.145 -0.972 . . . . 2.34 108.877 179.612 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -98.66 41.06 1.15 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.08 -1.012 . . . . 3.23 110.363 -179.568 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.73 149.71 49.29 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.129 -0.982 . . . . 2.49 110.227 -179.798 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 58.5 mp0 -74.96 -67.08 0.68 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.742 0.782 . . . . 3.95 109.514 178.956 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.501 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.1 t80 -39.48 -38.65 0.6 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.8 -0.562 . . . . 2.25 111.236 -178.732 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.454 ' CD2' HH21 ' A' ' 126' ' ' ARG . 88.7 mt -68.31 -39.92 81.85 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.714 -1.241 . . . . 2.27 108.844 -179.335 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 121' ' ' GLU . 7.7 ttpm? -67.14 -31.08 71.27 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.361 -0.837 . . . . 3.31 109.477 179.311 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -46.12 90.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.287 -0.883 . . . . 2.73 109.759 -179.405 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . 0.454 HH21 ' CD2' ' A' ' 123' ' ' LEU . 83.8 mtm180 -65.51 -37.27 86.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.978 -1.076 . . . . 3.2 108.373 178.754 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.94 -29.05 68.13 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.284 -1.006 . . . . 1.66 108.284 178.544 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.12 -40.3 78.38 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.598 -0.89 . . . . 1.67 108.598 179.108 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.43 -40.0 96.01 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.244 -1.021 . . . . 1.55 108.244 178.976 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.6 t -66.01 -40.01 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 108.535 -0.913 . . . . 1.32 108.535 178.939 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 -60.01 -39.42 85.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.45 -0.781 . . . . 3.58 109.169 179.1 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 60.5 t0 -59.94 -39.56 85.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.384 -0.823 . . . . 1.46 109.934 -179.724 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.88 -46.6 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.108 -0.995 . . . . 1.22 110.303 -178.76 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.77 -34.32 66.38 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.519 -1.432 . . . . 0.61 109.519 179.735 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -60.0 -50.16 74.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.421 -1.046 . . . . 3.1 110.368 -179.221 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -69.98 -31.47 69.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.946 -1.096 . . . . 3.71 110.02 -179.574 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.06 -41.71 92.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.315 -0.866 . . . . 1.87 108.963 -179.153 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.43 -40.08 95.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.14 -0.975 . . . . 1.29 109.2 179.408 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.2 mtm180 -69.24 -40.0 78.15 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.309 -0.869 . . . . 3.05 108.798 179.465 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . 0.567 HD21 ' N ' ' A' ' 140' ' ' ASN . 1.3 m120 -64.41 -35.39 80.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.67 -0.644 . . . . 1.26 111.456 -178.853 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.4 mt -71.09 -44.63 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.52 -1.362 . . . . 1.34 109.152 179.81 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.05 -29.01 65.92 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.663 -0.648 . . . . 1.6 109.616 -179.678 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.57 40.01 11.52 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.614 -1.795 . . . . 0.96 108.614 -179.01 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 56.5 tp -73.76 147.49 43.43 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.524 -0.986 . . . . 1.67 109.192 -179.445 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -61.06 139.58 58.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 4.96 109.63 -179.273 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.48 130.11 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-O 121.957 0.884 . . . . 1.68 109.279 179.496 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.8 mt -60.1 -47.35 92.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 115.994 -0.548 . . . . 2.14 110.76 -177.833 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.6 t0 66.11 99.7 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.44 -0.948 . . . . 1.5 108.44 -179.045 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.1 mt -70.9 -2.04 13.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.327 -0.858 . . . . 1.39 110.73 -178.653 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.9 p -84.32 -13.53 52.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.737 -1.227 . . . . 1.83 109.744 179.999 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.51 29.45 0.24 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.226 -0.921 . . . . 1.46 112.004 -177.913 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 39.5 mm -87.64 120.29 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.467 -1.396 . . . . 1.42 109.691 -179.86 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -100.38 -9.96 21.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.396 -0.815 . . . . 2.94 110.3 -179.736 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -139.39 158.09 44.74 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.986 -1.071 . . . . 1.52 110.219 -179.395 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.84 136.95 57.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.141 -0.975 . . . . 1.58 109.307 179.944 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 26.9 m -152.84 165.64 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.564 -0.71 . . . . 1.32 109.371 179.381 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 15' ' ' LYS . 85.3 mt -95.55 148.0 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 105.662 -1.977 . . . . 1.27 105.662 177.208 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 60.2 tp -98.37 116.14 29.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.053 -1.029 . . . . 1.41 111.003 -177.365 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.5 t -119.98 128.24 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.493 -0.928 . . . . 1.23 108.493 178.811 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.6 160.26 37.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.111 -0.993 . . . . 1.32 108.725 -179.982 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -70.32 -33.71 71.84 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.205 -1.559 . . . . 1.49 107.848 178.669 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 162' ' ' ASP . 20.2 p-10 -161.95 170.92 18.51 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.993 -0.743 . . . . 2.25 108.993 179.859 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.3 mt -142.86 129.99 20.81 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.058 -1.026 . . . . 1.35 108.841 179.189 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 61.8 p -88.49 146.1 36.85 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.073 -1.017 . . . . 1.56 109.202 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -41.83 -35.56 2.98 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.949 1.766 . . . . 0.87 112.513 179.277 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 57.0 m -60.05 -39.98 87.85 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.066 -1.021 . . . . 1.36 109.142 -179.364 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.75 -42.85 97.77 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.377 -0.827 . . . . 1.61 109.816 179.984 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.3 p -56.53 -30.33 62.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.28 -0.887 . . . . 1.21 111.529 -178.094 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.447 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -73.19 -56.78 4.63 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.65 -1.281 . . . . 1.21 109.937 -179.974 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -79.39 36.59 0.31 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.327 -0.99 . . . . 2.11 108.327 -179.896 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 169' ' ' ALA . 15.6 tp -103.2 134.33 46.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 1.29 109.593 179.466 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -86.35 101.02 12.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.882 -1.155 . . . . 2.81 107.882 178.436 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 76.3 mt -65.16 -40.97 95.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 2.09 110.947 -178.483 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -69.87 -21.77 63.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.763 -1.211 . . . . 2.86 111.086 -178.087 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -93.89 -10.69 33.07 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.796 -1.19 . . . . 2.39 109.693 -179.533 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . 0.457 ' CG1' ' O ' ' A' ' 178' ' ' GLY . 71.5 t -105.59 116.57 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.397 -0.964 . . . . 1.27 108.397 178.599 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.9 mt -85.41 5.45 30.9 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.216 -0.928 . . . . 2.17 110.235 -178.215 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.457 ' O ' ' CG1' ' A' ' 176' ' ' VAL . . . 169.4 174.44 37.82 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.4 -1.48 . . . . 0.52 109.4 179.71 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -132.69 128.77 37.68 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.487 -1.008 . . . . 0.55 108.817 179.974 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.04 126.07 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.82 -0.807 . . . . 1.27 108.82 178.958 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.1 p -149.43 160.02 43.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.122 -0.986 . . . . 1.39 110.459 -179.208 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 182' ' ' ASP . 42.8 p-10 -108.23 28.85 7.89 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.764 -0.828 . . . . 2.46 108.764 179.256 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.39 -158.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.971 0.891 . . . . 1.51 112.227 -177.702 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.13 -71.4 0.8 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.959 -0.857 . . . . 2.23 110.959 -178.804 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 161.93 -131.82 2.66 Favored Glycine 0 N--CA 1.492 2.406 0 O-C-N 120.764 -1.433 . . . . 2.23 110.631 -179.658 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.751 ' HE ' HH12 ' A' ' 195' ' ' ARG . 33.2 ttt-85 -61.38 -39.99 92.7 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.586 -0.949 . . . . 6.44 111.506 -178.702 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 18.0 p -64.8 5.33 0.33 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.829 -1.169 . . . . 4.09 110.602 -178.532 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.476 ' H ' ' C ' ' A' ' 186' ' ' ARG . 48.0 t -90.87 130.07 36.86 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.953 -1.092 . . . . 2.2 110.702 -179.591 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -49.33 -44.81 44.77 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.423 -0.798 . . . . 1.15 109.255 179.509 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 88.8 m -60.01 -39.43 85.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.615 -0.678 . . . . 2.01 109.73 -179.26 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.5 t -58.66 -42.81 89.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.892 -1.13 . . . . 1.93 110.214 -179.225 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . 0.404 HD12 HG22 ' A' ' 192' ' ' ILE . 93.9 mt -60.8 -38.82 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 2.2 109.844 -179.991 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.7 mtp -59.97 -46.01 90.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 1.32 110.539 -179.246 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.99 -44.43 94.52 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.825 -1.172 . . . . 1.3 110.097 -179.381 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.751 HH12 ' HE ' ' A' ' 186' ' ' ARG . 51.7 mtp180 -60.03 -50.06 75.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.133 -0.979 . . . . 3.38 110.71 -179.01 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.6 m -73.41 -33.59 65.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.001 -1.062 . . . . 1.15 111.553 -178.665 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 86.8 mt -80.55 -11.07 59.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.735 -1.228 . . . . 1.28 110.475 -178.435 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 58.56 49.94 9.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.307 -0.871 . . . . 1.5 110.706 179.384 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 86.5 mt -123.84 122.98 26.29 Favored Pre-proline 0 N--CA 1.502 2.135 0 N-CA-C 108.456 -0.942 . . . . 1.37 108.456 179.0 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -43.28 133.48 6.56 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.037 1.825 . . . . 0.76 112.582 -179.845 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.58 150.01 3.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.846 -1.159 . . . . 1.19 111.375 179.819 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.0 mt -125.0 142.82 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 107.924 -1.139 . . . . 1.31 107.924 178.879 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.5 m -123.17 -8.57 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 O-C-N 120.85 -1.156 . . . . 1.38 111.057 -178.842 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.3 23.73 15.42 Favored Glycine 0 N--CA 1.5 2.962 0 O-C-N 121.381 -0.824 . . . . 1.03 111.203 -179.03 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 10.4 p -45.49 -44.36 12.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.776 -1.426 . . . . 1.38 109.751 -179.357 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 95.15 -51.28 1.89 Allowed Glycine 0 N--CA 1.499 2.88 0 C-N-CA 120.178 -1.01 . . . . 1.17 111.354 178.763 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 69.4 m -160.0 39.5 0.18 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.498 -1.59 . . . . 2.07 111.566 -179.242 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 30.9 t -79.96 -33.06 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.827 -1.171 . . . . 1.35 108.589 178.355 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.1 p -60.11 -40.01 88.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.608 -0.683 . . . . 1.49 111.095 -179.134 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 56.4 m -81.3 -13.56 58.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.971 -1.081 . . . . 2.16 110.563 -178.507 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -93.71 -11.91 30.43 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.073 -1.017 . . . . 2.89 110.755 -179.416 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 46.4 t -121.27 161.78 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 O-C-N 121.19 -0.944 . . . . 1.33 110.601 -179.56 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.58 158.02 28.24 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.714 -0.847 . . . . 2.73 108.714 -179.441 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 215' ' ' ASP . 57.6 t-20 -59.71 139.93 56.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 2.7 110.461 -179.384 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 3.1 t70 86.33 2.59 0.53 Allowed 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.15 0.5 . . . . 2.38 110.205 179.373 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 47.2 t0 -74.86 151.95 38.95 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.133 -0.979 . . . . 2.09 108.56 178.96 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.543 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 47.9 t80 -96.56 120.19 36.43 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.421 -0.955 . . . . 1.45 108.421 179.52 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 91.9 mt -124.8 141.68 51.94 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.426 -0.796 . . . . 1.31 110.754 -179.224 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . 0.427 HD13 HG22 ' A' ' 219' ' ' ILE . 88.6 mt -109.93 129.34 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.417 -1.697 . . . . 1.29 106.417 176.32 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 45.0 tp -101.28 117.67 35.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.027 -1.045 . . . . 1.31 109.024 -178.799 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 224' ' ' ASN . 8.5 t70 -76.96 -47.46 20.79 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.158 -0.964 . . . . 2.31 108.578 179.653 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 52.77 18.38 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.21 -0.663 . . . . 1.19 109.21 -179.958 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 72.8 t -132.67 -41.94 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.069 -1.456 . . . . 1.45 107.069 178.556 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.51 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 35.3 m120 -106.52 1.83 25.73 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.168 -1.419 . . . . 3.13 107.168 177.828 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.01 47.34 9.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.84 -0.538 . . . . 2.2 110.128 -179.868 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -136.97 148.51 46.96 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.314 -0.866 . . . . 2.32 109.614 179.235 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 86.1 t -123.88 125.5 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.294 -0.632 . . . . 1.4 109.294 179.659 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -91.83 122.45 34.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.135 -0.978 . . . . 1.29 108.588 179.651 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 37.0 t -102.23 118.46 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.423 -0.798 . . . . 1.38 109.478 -179.401 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.6 t30 67.57 68.77 0.52 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.441 -0.787 . . . . 2.33 108.923 -179.479 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -89.12 124.88 1.49 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.207 2.605 . . . . 0.95 112.761 -179.39 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.3 m -63.29 162.77 11.57 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -0.895 . . . . 2.31 108.881 179.684 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -60.11 -39.91 87.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.064 -1.022 . . . . 3.45 108.751 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -60.03 -38.88 84.04 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.4 -0.813 . . . . 2.89 109.193 179.534 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.64 -42.09 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.299 -0.876 . . . . 1.73 109.751 -179.75 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.121 -0.987 . . . . 1.57 109.471 -179.994 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' B' B ' 301' ' ' MET . . . . . 0.404 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 32.2 ttp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.493 0.663 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . 0.404 ' N ' ' CG ' ' B' ' 301' ' ' MET . 32.7 t80 -153.75 150.26 28.32 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.34 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . 0.444 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 3.9 pm0 -150.87 160.97 43.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.848 -1.158 . . . . 0.0 111.133 -179.398 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -152.19 148.89 28.14 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.554 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -114.03 132.13 56.11 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.218 -0.927 . . . . 0.0 109.827 179.282 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.21 127.97 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 CA-C-O 122.397 1.094 . . . . 0.0 112.61 -177.374 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 30.0 m -77.07 106.94 9.08 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.973 0.892 . . . . 0.0 110.603 -178.361 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . 0.435 HD12 HG21 ' B' ' 308' ' ' ILE . 87.1 mt -52.2 124.05 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.408 1.099 . . . . 0.0 110.508 -177.927 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 82.5 p -109.61 20.04 18.56 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.144 -178.697 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -79.13 115.71 54.74 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.28 -0.888 . . . . 0.0 109.005 179.291 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.38 -10.95 9.65 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 CA-C-N 120.376 1.17 . . . . 0.0 113.487 -179.348 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -114.83 9.94 16.37 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.227 -0.921 . . . . 0.0 110.396 -178.898 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 68.63 172.41 7.45 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -179.036 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.501 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -85.13 92.11 8.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.867 -1.372 . . . . 0.0 109.967 -178.298 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . 0.418 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 4.7 p80 -96.68 -159.29 0.72 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.008 -1.057 . . . . 0.0 109.62 178.163 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 4.4 m -59.4 -47.47 85.31 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.783 -1.198 . . . . 0.0 112.764 -176.182 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.566 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 10.9 tpt180 -55.74 -58.97 12.84 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 120.506 -1.372 . . . . 0.0 111.734 -179.102 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . 0.418 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 14.3 Cg_endo -61.81 -32.5 85.8 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 120.559 1.235 . . . . 0.0 111.388 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.67 -51.23 66.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.455 -0.778 . . . . 0.0 109.27 179.491 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.37 -39.99 64.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 109.373 -179.268 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . 0.408 HE21 ' CB ' ' A' ' 71' ' ' ALA . 96.5 mm-40 -68.7 -42.4 77.8 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.917 -1.114 . . . . 0.0 108.57 178.995 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -59.91 -50.4 73.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.526 -0.734 . . . . 0.0 110.298 -179.03 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 86.3 t -69.14 -29.15 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.722 -1.236 . . . . 0.0 110.207 -179.03 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -59.13 -49.26 78.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.112 -0.992 . . . . 0.0 109.7 -178.83 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -66.42 -40.95 89.86 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.024 -1.047 . . . . 0.0 111.102 -179.179 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.04 -54.61 43.95 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.516 -1.365 . . . . 0.0 110.993 -178.855 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -55.16 -15.91 2.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.073 -1.017 . . . . 0.0 109.007 179.702 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -70.35 -29.65 69.94 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 178.729 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -105.78 146.82 29.36 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.602 -0.94 . . . . 0.0 109.553 -179.916 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 32.0 p -90.57 -12.1 38.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.084 -1.01 . . . . 0.0 109.907 179.966 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 331' ' ' SER . . . . . 0.502 ' HG ' ' CA ' ' B' ' 367' ' ' GLY . 47.6 t -61.47 144.69 53.78 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.282 -0.886 . . . . 0.0 109.507 179.928 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -67.57 136.63 54.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.134 -0.979 . . . . 0.0 108.644 179.623 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . 0.406 HD13 HG22 ' B' ' 333' ' ' ILE . 85.9 mt -130.73 131.02 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.5 -0.75 . . . . 0.0 110.002 -179.728 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 91.8 m -128.14 147.01 50.53 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.276 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.65 115.57 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.658 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 89.0 m -102.82 128.8 49.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.124 -0.985 . . . . 0.0 109.041 -178.566 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 90.8 p -139.23 114.31 9.51 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.892 0.853 . . . . 0.0 111.136 -179.217 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 27.5 m120 49.43 49.99 18.9 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 176.45 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.81 -13.86 59.93 Favored Glycine 0 N--CA 1.501 2.994 0 O-C-N 119.804 -1.81 . . . . 0.0 112.289 176.946 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -117.01 129.0 55.73 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.999 -1.295 . . . . 0.0 109.419 -179.871 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 48.4 p -126.57 147.92 49.81 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.884 0.85 . . . . 0.0 110.754 -178.962 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.45 168.03 21.07 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.505 0.669 . . . . 0.0 109.825 -179.666 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 28.2 t -90.94 136.09 33.3 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.567 -0.708 . . . . 0.0 110.835 -178.775 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.414 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -71.42 -17.52 62.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.347 -0.845 . . . . 0.0 108.795 179.159 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -88.34 16.67 6.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.599 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.414 ' H ' ' C ' ' B' ' 344' ' ' ALA . 10.9 t -143.94 92.12 2.3 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.732 0.777 . . . . 0.0 111.287 -179.345 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 58.9 tp -58.74 -36.86 75.01 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.379 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -55.55 -50.06 71.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.854 . . . . 0.0 111.07 -179.14 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.426 ' O ' ' OG1' ' B' ' 352' ' ' THR . 25.2 mtmm -69.94 -40.03 75.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.722 -1.236 . . . . 0.0 110.721 -177.915 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' B' ' 352' ' ' THR . 87.9 mt -46.87 -55.69 7.57 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.995 -1.066 . . . . 0.0 109.106 -179.407 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.676 HE21 ' N ' ' B' ' 351' ' ' GLN . 0.0 OUTLIER -39.38 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.569 -0.707 . . . . 0.0 111.169 -178.76 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.483 ' N ' ' O ' ' B' ' 350' ' ' LEU . 75.6 p -81.27 -10.15 59.64 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.127 -1.608 . . . . 0.0 109.995 -179.096 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 32.9 mt -95.29 114.99 26.83 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.062 -1.024 . . . . 0.0 109.11 178.612 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.65 94.46 0.86 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 179.307 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 34.4 mt -101.77 89.56 3.72 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.366 -1.079 . . . . 0.0 109.279 179.721 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 46.9 p -94.16 177.02 6.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.102 -0.998 . . . . 0.0 110.934 -179.129 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -67.6 113.51 5.47 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.643 -0.661 . . . . 0.0 110.135 -179.918 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.93 9.41 34.66 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.974 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 66.3 m -90.85 107.64 19.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -1.139 . . . . 0.0 110.91 -179.536 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 14.5 t -76.89 118.15 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.201 1.0 . . . . 0.0 109.152 -177.641 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.0 m -113.42 178.14 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.968 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 58.1 m -130.86 128.27 40.27 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.287 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 93.9 mt -100.6 112.51 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.639 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 60.6 m -117.79 130.82 56.52 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.621 -0.675 . . . . 0.0 109.346 -179.217 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.79 151.99 39.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.815 . . . . 0.0 109.245 -179.493 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -145.83 125.51 13.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.4 -0.812 . . . . 0.0 108.867 179.666 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.518 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.11 -155.77 26.65 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.14 -1.505 . . . . 0.0 111.455 -179.984 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.73 -51.6 69.08 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 122.224 -0.574 . . . . 0.0 112.333 -177.508 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -110.01 13.17 23.44 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.829 -1.17 . . . . 0.0 111.221 -177.399 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -41.55 -34.33 0.56 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.292 -0.88 . . . . 0.0 111.507 -178.866 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -69.05 -41.15 78.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.589 -1.319 . . . . 0.0 109.994 -178.266 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -69.47 -50.1 48.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.842 -179.629 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -54.34 -36.22 63.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.86 . . . . 0.0 111.885 -178.077 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 71.1 t -74.31 -39.96 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.134 -1.604 . . . . 0.0 109.191 179.294 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.89 -56.01 14.04 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.331 -0.855 . . . . 0.0 111.923 -178.25 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -69.98 -39.97 75.62 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.31 -1.494 . . . . 0.0 111.905 -178.377 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 89.1 mt -57.99 -37.16 73.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.607 -1.308 . . . . 0.0 108.676 -179.286 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 48.9 t -60.03 -47.61 91.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.196 -0.94 . . . . 0.0 109.402 179.163 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' B' ' 383' ' ' GLU . 4.3 mptp? -69.98 -56.38 7.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.643 -1.285 . . . . 0.0 108.079 178.493 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . 0.48 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 62.8 tp -50.99 -36.39 38.92 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.187 -0.946 . . . . 0.0 108.787 -178.648 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 40.9 tpp -73.01 -39.92 65.61 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.421 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.09 -4.2 46.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.74 -0.6 . . . . 0.0 109.959 179.463 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' B' ' 379' ' ' LYS . 95.5 mt-10 -108.05 3.54 24.08 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.249 -0.907 . . . . 0.0 110.234 179.909 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . 0.48 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 15.1 mt -79.34 114.21 18.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.369 -1.457 . . . . 0.0 107.753 178.184 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.459 -179.777 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.187 -0.671 . . . . 3.19 109.187 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.7 mt -109.99 129.99 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.365 -0.834 . . . . 1.71 109.241 179.863 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.1 m -129.34 151.09 50.36 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.713 -0.617 . . . . 1.66 109.846 -179.379 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.493 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -135.22 -162.15 9.62 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.01 -1.636 . . . . 1.05 109.01 179.869 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.8 mt -90.11 -18.88 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.867 -1.373 . . . . 1.59 109.561 -179.535 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.5 tp 55.71 107.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.491 -0.755 . . . . 1.47 109.189 -179.507 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.32 -26.97 13.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.406 -0.809 . . . . 1.39 108.99 179.529 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.1 m -137.59 120.93 11.55 Favored Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.499 -0.751 . . . . 2.09 109.215 179.555 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.59 151.09 19.42 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.121 1.881 . . . . 0.91 112.825 179.928 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 146.79 173.01 17.65 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 109.469 -1.452 . . . . 0.92 109.469 179.705 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.43 HG23 HD11 ' A' ' 11' ' ' ILE . 87.7 mt -125.77 130.88 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 120.964 -1.315 . . . . 1.35 109.223 -179.74 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.89 150.65 48.37 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.169 -0.957 . . . . 1.14 110.048 -179.265 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 9.3 m-85 -123.22 129.94 52.07 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.267 -1.012 . . . . 0.7 108.267 179.765 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.59 172.76 45.14 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 118.81 -1.662 . . . . 0.58 110.69 179.988 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -78.66 158.82 28.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.609 -0.936 . . . . 2.63 108.906 179.655 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.05 131.62 51.12 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.325 -0.859 . . . . 1.27 111.107 -178.684 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.2 tp -101.52 135.01 43.74 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.167 -1.42 . . . . 1.41 107.167 178.161 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.3 tp -116.72 126.48 53.2 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.295 -0.878 . . . . 1.49 109.87 -179.06 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.4 mt -89.32 102.01 14.68 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.365 0.602 . . . . 1.52 110.214 -179.515 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -92.52 136.37 33.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.445 -0.784 . . . . 3.17 109.003 179.619 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -131.15 117.44 19.08 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.3 -0.875 . . . . 3.0 109.629 179.743 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 54.1 t0 -71.55 144.5 49.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.889 -1.132 . . . . 2.77 109.45 179.772 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.51 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 88.8 tt0 -63.52 139.95 58.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 2.94 109.526 -179.878 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.5 mt -83.89 134.5 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.791 -0.818 . . . . 1.46 108.791 -179.773 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.4 t -101.99 127.04 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.29 -0.881 . . . . 1.7 110.279 -179.11 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.9 mt -105.7 137.85 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.794 -0.817 . . . . 1.54 108.794 179.304 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -97.52 113.59 25.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.994 -1.066 . . . . 1.81 109.318 179.71 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -84.83 5.24 29.53 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.536 -0.913 . . . . 3.23 108.536 179.9 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -60.56 146.35 45.46 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.544 -0.722 . . . . 3.29 109.36 179.916 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -88.88 141.69 28.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 2.8 108.963 179.616 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 pt -94.47 165.73 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.1 -1.0 . . . . 1.43 109.383 179.773 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.0 p -97.91 174.21 6.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.004 -1.06 . . . . 1.54 108.72 178.856 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.83 84.18 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.362 -0.935 . . . . 1.6 109.297 -179.631 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 52.2 t0 -56.71 -30.39 63.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.773 -1.204 . . . . 2.56 109.923 -179.94 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -81.82 -10.56 59.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.235 -0.916 . . . . 2.36 110.02 -179.645 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -62.98 -51.67 68.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.908 -1.12 . . . . 1.43 108.68 179.713 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -61.7 -40.07 93.71 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.454 -0.779 . . . . 1.77 109.887 -179.588 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -68.84 -40.32 79.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 3.32 111.295 -178.492 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -66.14 -40.18 90.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.399 -1.438 . . . . 1.51 110.351 -179.528 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.95 -47.97 91.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.706 -1.246 . . . . 1.41 109.195 179.444 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -61.89 -44.13 97.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.005 -1.059 . . . . 1.81 109.935 179.977 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -60.06 -44.03 95.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.862 -1.149 . . . . 3.26 108.117 179.803 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -63.0 -46.98 85.12 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.196 -0.668 . . . . 0.81 109.196 179.062 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 48' ' ' ALA . 64.5 tp -59.87 -46.19 90.08 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.608 -0.886 . . . . 1.59 108.608 179.933 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.9 t -65.76 -43.74 87.97 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.265 -0.974 . . . . 1.38 108.861 179.276 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.21 -44.23 97.39 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.83 -2.108 . . . . 0.87 107.83 178.703 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.421 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 25.5 ttt-85 -65.39 -34.67 78.86 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.34 -0.985 . . . . 3.62 108.34 178.228 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -59.77 -40.0 86.76 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.732 -0.84 . . . . 1.43 108.732 -179.862 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 50' ' ' ALA . 1.2 ttmp? -61.47 -73.95 0.09 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.043 -1.095 . . . . 3.08 108.043 179.111 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.07 -34.94 0.09 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.253 -0.905 . . . . 1.33 111.904 -177.775 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.0 t -59.67 -50.37 74.14 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.344 -1.342 . . . . 1.85 108.291 179.846 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.05 92.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.501 -0.749 . . . . 1.35 110.504 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.9 -40.19 91.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.805 -1.184 . . . . 2.34 110.188 -179.118 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.07 -39.88 91.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.975 -1.078 . . . . 2.2 109.199 179.633 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -60.27 -39.93 88.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.541 -0.724 . . . . 1.35 110.136 179.853 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -62.83 -43.87 97.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.019 -1.051 . . . . 1.34 109.459 179.724 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.603 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.9 mt -61.35 -39.68 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.48 -0.763 . . . . 1.26 109.588 -179.919 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -57.43 -51.86 67.73 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.175 -0.953 . . . . 1.7 110.403 -179.43 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -58.88 -35.38 72.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.357 -0.839 . . . . 1.35 110.832 -177.396 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.3 mttp -66.02 -38.16 87.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.056 -1.028 . . . . 2.08 109.332 179.841 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.81 -45.86 80.77 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.74 -0.6 . . . . 1.21 110.2 -179.529 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.4 -53.38 45.39 Favored Glycine 0 N--CA 1.485 1.93 0 C-N-CA 120.09 -1.052 . . . . 0.75 110.61 -178.548 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.07 -41.78 73.68 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.938 -1.331 . . . . 1.59 110.382 -179.06 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.0 m -70.03 -60.05 2.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.92 -1.113 . . . . 1.41 111.981 -177.838 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.428 ' CE1' ' O ' ' A' ' 168' ' ' THR . 76.7 m-85 -95.94 -50.56 4.82 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.862 -1.149 . . . . 0.79 111.243 -178.178 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.75 -166.87 26.1 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 119.899 -1.143 . . . . 1.22 110.683 -179.974 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -69.98 -24.97 63.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.78 -0.836 . . . . 5.81 110.353 -179.479 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.418 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 48.5 tp10 -60.36 -34.91 74.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.38 -0.825 . . . . 3.37 110.294 -179.366 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -100.28 -17.51 17.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.295 -0.878 . . . . 2.37 110.291 -179.318 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -69.98 -44.51 69.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.067 -1.02 . . . . 1.65 110.667 -179.248 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.69 -25.64 65.78 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.386 -0.822 . . . . 1.42 109.885 -178.393 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 80.9 mt -59.91 -41.18 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.0 -1.062 . . . . 1.43 108.764 -179.886 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -69.99 -36.6 75.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.077 -1.014 . . . . 1.08 110.805 -179.789 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.52 ' CD ' ' HZ2' ' B' ' 324' ' ' LYS . 50.2 tt0 -59.93 -40.1 87.76 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.92 -1.112 . . . . 1.37 109.434 -179.495 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.79 -43.54 93.84 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.587 -1.805 . . . . 0.67 108.587 178.742 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 57.4 m170 -60.0 -46.14 90.44 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.357 -1.084 . . . . 1.99 108.761 179.703 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.67 -45.16 96.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.226 -0.921 . . . . 1.22 108.677 179.147 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.3 ttp -60.89 -43.05 99.0 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.309 -0.869 . . . . 2.11 110.036 -179.864 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.5 tp -61.21 -41.9 97.65 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.715 -0.846 . . . . 1.33 108.715 179.869 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.16 -38.14 89.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.636 -0.665 . . . . 1.29 109.917 -179.636 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -85.39 4.4 35.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.067 -1.02 . . . . 1.47 110.206 -179.101 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -50.1 131.4 23.32 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.964 -1.085 . . . . 1.47 110.44 -179.124 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -58.46 -20.65 46.96 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.67 -0.644 . . . . 1.78 110.14 -179.403 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.89 -33.08 71.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.118 -0.989 . . . . 2.53 108.735 179.477 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.0 mt -71.98 -40.1 68.82 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.352 0.596 . . . . 1.36 109.876 179.348 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -60.18 -50.02 75.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.477 -0.765 . . . . 1.42 110.374 -179.0 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -70.96 -40.81 71.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.051 -1.031 . . . . 2.27 111.099 -178.961 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.11 -39.97 75.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.117 -0.99 . . . . 1.57 111.573 -178.544 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.72 -46.19 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.026 . . . . 1.19 109.547 -179.309 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.85 -39.63 80.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.645 -0.66 . . . . 1.39 109.969 -179.822 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.33 -48.67 80.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 1.39 111.256 -179.033 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 96' ' ' LYS . 93.9 mt -63.04 -46.88 85.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.885 -1.134 . . . . 1.5 110.194 -178.927 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.1 mt -60.25 -49.48 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 122.18 0.991 . . . . 1.29 108.57 179.555 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -70.1 -40.46 74.93 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.785 -0.643 . . . . 2.64 110.578 -179.428 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -83.44 -49.7 9.04 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.901 -1.124 . . . . 1.65 111.718 -178.521 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 92' ' ' LEU . 71.0 mmtt -90.97 -1.83 57.78 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.102 -0.999 . . . . 2.5 111.73 -177.396 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 54.28 32.17 15.69 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.699 -1.251 . . . . 1.88 109.604 179.944 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.5 mtt -90.36 167.5 12.59 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.003 -0.74 . . . . 1.71 109.003 -179.848 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 68.5 p -75.42 155.14 36.65 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.844 -1.169 . . . . 1.61 107.844 178.956 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.8 -39.59 76.48 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.955 -1.09 . . . . 1.33 110.237 -179.065 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 34.4 p-10 -63.23 -38.65 91.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.855 -1.153 . . . . 2.07 109.387 179.552 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.504 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -78.29 -47.28 18.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.957 . . . . 1.37 109.44 179.509 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.85 -47.32 86.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.475 -0.766 . . . . 1.14 109.714 -179.925 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.5 -35.37 79.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 1.26 109.458 179.646 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -59.87 -44.25 94.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 2.02 108.746 -179.319 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 110' ' ' GLY . 85.8 tt0 -61.15 -40.02 92.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.265 -0.897 . . . . 1.33 109.462 179.298 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.76 -53.81 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.897 . . . . 1.3 110.475 -178.972 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.0 mm -69.87 -40.14 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.992 -1.068 . . . . 1.32 109.303 179.634 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -68.07 -38.76 82.76 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.57 -0.9 . . . . 2.44 108.57 179.045 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -59.74 -47.92 88.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.494 -1.042 . . . . 0.99 110.494 -179.182 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -67.97 -54.37 19.09 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.769 -1.43 . . . . 1.97 109.721 -179.685 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.89 -40.02 69.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 1.43 109.616 -179.925 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 54.3 m -59.95 -39.98 87.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.094 -1.004 . . . . 2.12 108.796 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.25 89.01 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.204 -0.935 . . . . 1.64 108.676 178.829 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.431 ' CD1' ' OE1' ' B' ' 351' ' ' GLN . 25.5 mt -65.57 -39.96 92.25 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.124 -0.985 . . . . 1.93 109.399 -179.643 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -57.75 -31.62 66.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.736 -1.228 . . . . 2.2 109.189 -179.264 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -59.38 -23.54 62.67 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.175 -1.046 . . . . 2.12 108.175 179.388 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 52.7 mt -62.17 139.93 58.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.23 -0.919 . . . . 2.34 108.617 -179.823 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -94.49 26.08 3.61 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.172 -0.955 . . . . 3.23 109.835 -179.699 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -110.76 129.99 55.7 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.367 -0.833 . . . . 2.49 109.729 -179.712 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -69.66 -29.36 66.79 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.48 0.657 . . . . 3.95 109.233 179.91 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.48 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.4 t80 -69.95 -39.97 75.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.702 -0.624 . . . . 2.25 110.845 -179.99 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.9 mt -76.41 -32.47 58.53 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.844 -1.16 . . . . 2.27 109.582 179.918 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -60.1 -40.56 90.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.054 -1.029 . . . . 3.31 108.684 179.318 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.93 -42.92 95.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.247 -0.908 . . . . 2.73 108.964 179.615 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -61.92 -40.05 94.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 3.2 108.57 178.97 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.52 -30.81 71.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.89 . . . . 1.66 108.716 179.021 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.19 -39.57 86.99 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.827 -0.805 . . . . 1.67 108.827 179.607 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -68.25 -39.85 82.13 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.349 -0.845 . . . . 1.55 109.279 -179.919 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.74 -39.97 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.421 -0.8 . . . . 1.32 109.057 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -65.18 -40.04 93.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.174 -0.954 . . . . 3.58 109.963 179.629 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 1.46 110.551 -178.938 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.12 -41.22 85.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.99 -1.069 . . . . 1.22 109.667 -179.7 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.97 -46.02 94.87 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.009 -1.237 . . . . 0.61 110.009 -179.761 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -59.87 -46.92 87.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.104 -1.233 . . . . 3.1 111.324 -179.511 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.603 HH22 ' CD1' ' A' ' 57' ' ' ILE . 60.4 mtp180 -63.85 -37.08 86.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.835 -1.166 . . . . 3.71 110.407 -179.385 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.6 tp -58.43 -42.88 88.27 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.353 -0.842 . . . . 1.87 110.132 -178.753 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.83 -39.96 93.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.001 -1.062 . . . . 1.29 108.961 179.628 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -65.72 -39.51 91.24 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.789 -0.819 . . . . 3.05 108.789 178.791 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -64.38 -36.96 85.83 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.649 -0.657 . . . . 1.26 110.951 -179.63 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.405 HG23 HD12 ' A' ' 141' ' ' ILE . 93.3 mt -70.54 -42.06 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.521 -1.362 . . . . 1.34 108.44 179.002 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.63 -38.75 73.94 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.609 0.718 . . . . 1.6 109.063 179.684 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.56 43.85 4.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.276 -1.93 . . . . 0.96 108.276 -178.767 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.3 tp -74.51 142.86 44.77 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.484 -1.009 . . . . 1.67 109.46 -179.183 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -62.3 137.87 58.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.423 -0.798 . . . . 4.96 109.795 -179.325 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.422 HG21 HD13 ' A' ' 146' ' ' ILE . 92.8 mt -113.94 129.97 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.217 1.008 . . . . 1.68 109.583 179.396 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.7 mt -64.44 -41.51 92.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.802 -0.635 . . . . 2.14 110.968 -178.145 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 47.4 t0 61.26 105.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.323 -0.861 . . . . 1.5 109.581 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 58.8 mt -68.75 -6.69 28.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.474 -0.766 . . . . 1.39 110.12 -179.357 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.5 t -83.37 -13.77 54.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.13 -0.981 . . . . 1.83 108.922 179.314 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.34 18.51 2.64 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.608 -0.683 . . . . 1.46 110.239 -178.442 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 66.1 mt -90.31 111.21 23.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.028 -1.045 . . . . 1.42 108.845 -179.778 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -97.31 -9.71 27.03 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.285 -0.884 . . . . 2.94 110.836 -178.559 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -120.47 149.12 42.89 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.214 -0.929 . . . . 1.52 110.175 -178.987 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -64.89 131.22 46.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.422 -0.799 . . . . 1.58 109.216 -179.9 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -151.95 163.77 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.511 -0.743 . . . . 1.32 109.343 179.614 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 83.3 mt -92.76 151.08 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 105.939 -1.875 . . . . 1.27 105.939 177.156 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 56.4 tp -102.07 118.73 37.51 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.121 -0.987 . . . . 1.41 110.798 -177.961 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.2 t -126.22 132.08 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 108.538 -0.912 . . . . 1.23 108.538 179.543 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.6 168.73 24.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.179 -0.951 . . . . 1.32 109.05 179.797 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.0 -37.78 75.78 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.489 -1.382 . . . . 1.49 108.287 178.735 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -170.66 148.51 3.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.58 -0.7 . . . . 2.25 109.189 179.737 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.4 mt -116.1 134.43 54.94 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.49 -0.757 . . . . 1.35 109.553 -179.641 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 77.7 p -94.15 149.96 37.64 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.428 -0.795 . . . . 1.56 109.038 179.501 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.402 ' O ' ' OG1' ' A' ' 168' ' ' THR . 71.8 Cg_exo -39.63 -34.75 0.8 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.334 2.023 . . . . 0.87 113.005 179.562 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 59.6 m -58.04 -42.51 85.54 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.217 -0.993 . . . . 1.36 109.353 -178.503 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -70.07 -39.96 75.31 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.163 -0.961 . . . . 1.61 109.792 179.456 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.428 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 68.8 p -52.79 -26.62 14.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -0.905 . . . . 1.21 111.112 -178.051 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -82.06 -55.88 4.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.874 -1.141 . . . . 1.21 109.963 179.624 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -80.25 40.14 0.48 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.677 -1.231 . . . . 2.11 107.677 179.775 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.474 ' H ' ' C ' ' A' ' 169' ' ' ALA . 17.7 tp -97.91 124.55 42.39 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.98 -0.748 . . . . 1.29 108.98 179.858 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -81.61 97.8 8.04 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.112 -1.07 . . . . 2.81 108.112 179.189 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.54 -44.85 95.33 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.565 -0.709 . . . . 2.09 110.62 -178.591 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -62.38 -32.02 72.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.1 -1.0 . . . . 2.86 112.47 -177.394 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -93.29 -10.27 36.07 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.684 -1.26 . . . . 2.39 110.787 -177.862 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.4 t -102.36 113.11 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.048 -1.032 . . . . 1.27 108.749 178.986 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 39.6 mt -85.75 5.14 33.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.188 -0.945 . . . . 2.17 110.687 -178.31 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.09 168.62 35.92 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.309 -1.424 . . . . 0.52 109.82 179.531 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -130.52 127.93 40.13 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.494 -1.003 . . . . 0.55 108.745 179.787 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 62.2 mt -130.56 124.19 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.332 -0.988 . . . . 1.27 108.332 178.725 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 36.0 p -139.53 152.0 46.57 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.343 -0.848 . . . . 1.39 110.642 -179.247 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . 0.543 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.7 OUTLIER -100.62 26.71 6.47 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.75 -0.833 . . . . 2.46 108.75 179.356 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.37 -161.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.103 -0.998 . . . . 1.51 111.574 -177.819 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.9 -57.34 6.42 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.974 -0.85 . . . . 2.23 110.974 -178.874 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.51 -132.69 2.04 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 118.887 -1.625 . . . . 2.23 111.2 -179.33 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 186' ' ' ARG . . . . . 0.513 ' NH2' ' NH1' ' A' ' 195' ' ' ARG . 10.7 mtp-105 -80.18 -10.11 59.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.474 -1.015 . . . . 6.44 110.533 -178.663 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 71.5 p -81.49 5.99 16.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.008 -1.058 . . . . 4.09 109.906 -179.231 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.5 t -88.34 134.15 33.89 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.048 -1.033 . . . . 2.2 110.191 -179.63 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -48.21 -43.2 31.82 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.237 -0.914 . . . . 1.15 108.681 179.645 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 93.5 m -59.4 -39.91 84.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.831 -0.543 . . . . 2.01 109.83 -179.517 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 55.8 p -59.9 -38.32 81.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.999 -1.063 . . . . 1.93 110.264 -179.397 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.6 mm -59.95 -40.0 81.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.322 -0.862 . . . . 2.2 109.371 -179.782 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.5 mtp -58.78 -49.93 75.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.269 -0.894 . . . . 1.32 110.55 -178.971 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -50.59 -44.3 56.88 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.855 -1.153 . . . . 1.3 109.524 -178.98 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 195' ' ' ARG . . . . . 0.513 ' NH1' ' NH2' ' A' ' 186' ' ' ARG . 65.4 mtp180 -59.94 -51.53 69.28 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.62 -0.832 . . . . 3.38 110.349 -178.709 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.7 m -76.07 -32.03 59.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.945 -1.097 . . . . 1.15 111.711 -178.152 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.3 -20.33 48.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.737 -1.227 . . . . 1.28 110.017 -179.197 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 60.41 46.81 9.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.205 -0.934 . . . . 1.5 110.223 -179.36 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 97.4 mt -121.09 129.18 25.39 Favored Pre-proline 0 N--CA 1.501 2.115 0 N-CA-C 108.375 -0.972 . . . . 1.37 108.375 178.715 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -43.52 131.2 7.17 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.975 1.783 . . . . 0.76 112.753 -179.571 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -168.91 146.54 3.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.703 -1.248 . . . . 1.19 111.607 179.962 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.3 mt -122.42 144.35 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 106.966 -1.494 . . . . 1.31 106.966 178.011 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 13.6 m -123.56 -13.2 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 O-C-N 120.854 -1.154 . . . . 1.38 111.454 -178.223 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.12 26.24 19.59 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.498 -1.041 . . . . 1.03 110.498 -179.172 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 205' ' ' THR . . . . . 0.456 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 7.7 p -47.23 -39.44 14.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.837 -1.39 . . . . 1.38 110.047 -179.117 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.81 -51.68 4.34 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 119.913 -1.137 . . . . 1.17 111.851 178.671 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 49.9 m -158.33 40.99 0.26 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.474 -1.603 . . . . 2.07 111.489 -178.766 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 18.5 t -79.52 -33.39 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.88 -1.138 . . . . 1.35 108.106 178.192 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.0 p -54.44 -31.61 55.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.657 -0.652 . . . . 1.49 110.92 -179.139 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 35.3 m -80.66 -10.91 59.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.99 -1.069 . . . . 2.16 110.304 -179.108 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -104.85 -13.98 15.65 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.274 -0.891 . . . . 2.89 110.788 -179.224 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.4 t -108.01 138.71 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.141 -0.974 . . . . 1.33 110.824 -178.497 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 213' ' ' LYS . . . . . 0.455 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 0.1 OUTLIER -118.31 150.6 39.2 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.38 -1.341 . . . . 2.73 107.38 178.434 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 17.9 p30 -51.81 138.58 23.58 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.065 -1.022 . . . . 2.7 111.001 -178.488 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.6 m-20 80.01 5.27 1.88 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 116.424 -0.353 . . . . 2.38 111.332 178.789 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.455 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 91.8 m-20 -73.7 140.4 46.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.648 -1.283 . . . . 2.09 109.025 178.977 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.03 116.85 24.5 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.358 -0.979 . . . . 1.45 108.358 179.508 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 86.3 mt -126.66 146.17 50.29 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.382 -0.824 . . . . 1.31 110.784 -178.92 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 78.6 mt -113.32 127.29 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.081 -1.822 . . . . 1.29 106.081 177.206 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 54.7 tp -101.21 119.23 38.45 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.865 -1.147 . . . . 1.31 108.51 -179.112 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.491 ' C ' ' N ' ' A' ' 223' ' ' VAL . 92.6 m-20 -77.07 -45.27 27.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.131 -0.98 . . . . 2.31 109.378 179.893 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 49.78 14.23 0.12 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.355 -0.979 . . . . 1.19 108.355 -178.996 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . 0.491 ' N ' ' C ' ' A' ' 221' ' ' ASP . 49.0 t -130.65 -45.3 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 106.601 -1.629 . . . . 1.45 106.601 178.542 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 224' ' ' ASN . . . . . 0.518 ' OD1' ' NE2' ' A' ' 226' ' ' GLN . 20.0 t-20 -99.67 -2.71 34.76 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.416 -1.327 . . . . 3.13 107.416 178.064 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 225' ' ' ASN . . . . . 0.493 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 62.56 40.0 10.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.917 -0.489 . . . . 2.2 110.194 179.837 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 226' ' ' GLN . . . . . 0.518 ' NE2' ' OD1' ' A' ' 224' ' ' ASN . 78.1 mt-30 -136.99 148.25 46.77 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.248 -0.907 . . . . 2.32 109.751 178.939 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.7 t -119.85 121.17 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.792 -0.568 . . . . 1.4 109.675 179.946 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -90.25 128.02 36.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.003 -1.06 . . . . 1.29 109.442 -179.887 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.8 t -100.73 111.51 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.469 -0.769 . . . . 1.38 110.205 -179.256 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 43.1 t30 50.01 65.74 6.51 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.193 -0.942 . . . . 2.33 111.482 178.899 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -90.05 156.49 4.83 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.969 2.446 . . . . 0.95 112.232 178.822 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.3 m -66.16 156.37 34.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.231 -0.918 . . . . 2.31 110.334 -179.237 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -60.01 -38.3 82.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.514 -0.741 . . . . 3.45 109.414 179.99 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -59.74 -36.05 75.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.117 -0.989 . . . . 2.89 108.903 -179.925 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.4 t -68.33 -40.11 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 1.73 108.718 178.913 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.6 mt . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.424 -0.798 . . . . 1.57 109.29 179.255 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 58.1 ttp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.694 0.759 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -153.87 150.67 28.64 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.831 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -152.32 160.91 43.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.024 -1.047 . . . . 0.0 110.719 -179.099 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -156.62 154.16 29.73 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.081 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 55.2 mp0 -110.31 129.53 55.72 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.252 -0.905 . . . . 0.0 109.709 179.577 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.41 121.95 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 CA-C-O 121.942 0.877 . . . . 0.0 112.157 -177.247 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 48.7 m -78.87 105.7 10.37 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 122.163 0.982 . . . . 0.0 111.444 -177.915 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.9 mt -53.08 123.52 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 122.438 1.113 . . . . 0.0 111.151 -177.863 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 76.0 p -111.42 19.88 17.79 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.895 -179.61 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.91 129.12 87.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.905 -1.122 . . . . 0.0 109.403 -179.932 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -51.17 -23.84 13.76 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 CA-C-N 119.983 1.03 . . . . 0.0 113.364 -179.506 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -122.16 11.42 10.16 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.348 -0.845 . . . . 0.0 109.203 -179.94 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.7 -171.25 55.15 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -178.481 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.48 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.7 tp -88.81 93.93 9.75 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.857 -1.378 . . . . 0.0 108.791 -179.618 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . 0.401 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 4.3 p80 -98.21 -159.02 0.71 Allowed 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.357 -0.839 . . . . 0.0 110.853 179.793 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 7.7 m -57.38 -47.01 82.8 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.246 -0.909 . . . . 0.0 112.699 -176.299 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.507 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.2 tpt180 -58.88 -60.25 11.12 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 120.434 -1.416 . . . . 0.0 112.217 -178.072 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . 0.401 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 10.3 Cg_endo -60.3 -30.71 91.66 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 CA-C-N 120.449 1.196 . . . . 0.0 111.45 -179.679 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.04 75.31 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.147 -0.971 . . . . 0.0 108.413 179.527 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.85 -43.52 77.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.444 -0.785 . . . . 0.0 109.673 -179.492 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -71.47 -41.76 68.97 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.913 -1.117 . . . . 0.0 108.792 178.763 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.58 -52.82 61.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.331 -0.856 . . . . 0.0 110.54 -179.76 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 74.9 t -67.19 -27.85 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.719 -1.238 . . . . 0.0 110.12 -178.781 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . 0.52 ' HZ2' ' CD ' ' A' ' 74' ' ' GLU . 30.6 ttpt -60.25 -42.75 95.98 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.642 179.514 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -65.53 -55.59 16.94 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.9 -1.125 . . . . 0.0 109.794 -179.778 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.93 71.81 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.923 -1.111 . . . . 0.0 110.469 -179.447 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -48.92 -22.48 0.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 108.99 -179.278 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -82.59 -13.05 79.16 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.778 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -104.95 141.84 35.83 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.363 -1.08 . . . . 0.0 108.894 179.416 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 38.9 p -90.9 -13.6 33.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.785 -1.197 . . . . 0.0 110.014 -179.832 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 331' ' ' SER . . . . . 0.404 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 67.5 p -59.98 142.77 53.23 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.039 -1.038 . . . . 0.0 109.181 179.909 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . 0.409 ' OE1' ' N ' ' B' ' 332' ' ' GLU . 40.2 mp0 -65.58 132.84 49.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.999 -1.063 . . . . 0.0 108.54 179.619 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . 0.402 HD12 HG23 ' B' ' 333' ' ' ILE . 95.8 mt -130.92 132.42 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.447 -0.783 . . . . 0.0 109.712 -179.859 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 27.1 m -129.93 147.09 51.65 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.514 -0.742 . . . . 0.0 109.33 179.492 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 59.9 t -120.76 116.73 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.386 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 71.9 m -104.93 121.51 43.87 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.164 -0.96 . . . . 0.0 109.712 -178.66 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 94.5 p -133.92 121.89 22.34 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.901 0.857 . . . . 0.0 111.233 -179.616 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 58.9 t30 47.51 54.5 9.59 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 176.938 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.92 -11.54 41.18 Favored Glycine 0 N--CA 1.499 2.868 0 O-C-N 120.009 -1.682 . . . . 0.0 112.843 176.481 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -121.88 134.65 54.87 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 119.087 1.444 . . . . 0.0 108.776 -179.712 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 59.7 p -133.63 152.77 51.96 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.371 -0.831 . . . . 0.0 110.947 -178.231 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -147.18 169.95 18.25 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.382 0.61 . . . . 0.0 109.842 -179.859 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 72.3 m -88.16 140.94 28.97 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.472 -0.768 . . . . 0.0 110.403 -179.38 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -81.91 -15.39 54.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.043 -1.035 . . . . 0.0 109.442 179.677 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -86.4 16.33 4.6 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.52 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 346' ' ' SER . . . . . 0.512 ' H ' ' C ' ' B' ' 344' ' ' ALA . 13.5 p -147.97 93.38 2.18 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.278 -179.362 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 21.8 tp -60.76 -32.93 72.22 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.746 -0.596 . . . . 0.0 109.704 178.97 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -53.22 -51.92 60.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.68 -1.263 . . . . 0.0 110.064 -179.558 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . 0.432 ' O ' ' OG1' ' B' ' 352' ' ' THR . 2.6 mppt? -70.69 -39.91 73.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 0.0 110.831 -179.408 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' B' ' 352' ' ' THR . 86.1 mt -48.05 -54.44 13.07 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.771 -1.206 . . . . 0.0 109.293 -179.311 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.431 ' OE1' ' CD1' ' A' ' 115' ' ' LEU . 37.7 mt-30 -40.99 -15.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.592 -0.693 . . . . 0.0 110.931 -178.726 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 352' ' ' THR . . . . . 0.587 ' N ' ' O ' ' B' ' 350' ' ' LEU . 62.0 p -87.72 -10.22 51.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.456 -1.402 . . . . 0.0 110.247 -179.424 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 60.3 mt -95.01 116.77 29.12 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.93 -1.106 . . . . 0.0 109.454 179.0 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.88 94.17 1.08 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.081 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 25.5 mt -100.64 92.04 4.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.297 -1.119 . . . . 0.0 109.507 -179.632 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 44.6 p -90.03 172.41 8.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.93 -1.106 . . . . 0.0 111.197 -178.862 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -66.84 116.9 8.23 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.359 0.599 . . . . 0.0 110.491 -179.856 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 99.61 8.92 51.37 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.7 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 45.6 m -87.61 111.3 21.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.404 -1.056 . . . . 0.0 110.404 -179.604 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 22.0 t -77.48 116.34 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 122.202 1.001 . . . . 0.0 109.448 -177.662 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 18.4 m -110.98 177.2 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.025 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 42.6 m -130.88 126.98 37.59 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.491 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.3 111.75 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.923 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 61.7 p -118.24 132.87 56.28 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.796 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.3 150.66 37.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.91 . . . . 0.0 109.974 -178.974 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . 0.402 ' O ' ' OE1' ' B' ' 332' ' ' GLU . 18.4 tp10 -141.61 122.42 14.4 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.505 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . 0.463 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 160.36 -160.61 31.91 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.053 -1.546 . . . . 0.0 111.477 -179.886 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -59.81 -50.14 74.97 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.979 -0.718 . . . . 0.0 112.42 -177.245 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . 0.404 ' H ' ' HB3' ' B' ' 331' ' ' SER . 70.7 m-20 -109.95 13.65 23.35 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.035 -1.041 . . . . 0.0 111.22 -177.223 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . 0.564 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -45.44 -34.96 3.43 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.081 -1.012 . . . . 0.0 111.852 -178.876 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . 0.506 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 27.1 mt-30 -70.94 -41.4 71.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.809 -1.182 . . . . 0.0 110.098 -179.001 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -66.41 -43.26 86.24 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.338 -0.852 . . . . 0.0 109.725 -178.869 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -53.95 -71.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 110.977 -178.965 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . 0.414 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 60.0 t -46.86 -37.69 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.914 -1.116 . . . . 0.0 110.204 -177.682 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -63.74 -50.0 70.8 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.75 -1.219 . . . . 0.0 110.345 179.518 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -78.5 -42.83 28.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.065 -1.022 . . . . 0.0 110.157 -179.894 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.95 -37.46 79.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.25 -0.906 . . . . 0.0 109.631 -179.306 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . 0.414 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 46.7 t -63.68 -40.2 88.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.209 -0.932 . . . . 0.0 109.325 179.836 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -70.59 -57.46 4.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.616 -1.303 . . . . 0.0 107.929 178.134 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 54.4 tp -57.41 -34.65 69.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.513 -0.742 . . . . 0.0 110.348 -178.151 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.9 ttm -70.51 -40.02 73.77 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.424 -1.423 . . . . 0.0 108.199 177.831 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.69 -7.25 59.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.811 -0.555 . . . . 0.0 110.794 179.324 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . 0.406 ' O ' ' OE2' ' B' ' 385' ' ' GLU . 96.7 mt-10 -111.73 -0.22 16.05 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.978 -1.076 . . . . 0.0 111.585 -179.388 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.1 mt -83.21 130.48 35.09 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.421 -1.424 . . . . 0.0 109.684 179.456 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . 0.428 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 35.4 mp0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.177 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.722 0 CA-C-O 121.191 0.519 . . . . 3.19 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 94.9 mt -109.41 124.72 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.914 -0.773 . . . . 1.71 108.914 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.6 m -130.07 130.31 44.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.978 -0.749 . . . . 1.66 108.978 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.704 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -115.49 -166.93 15.05 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 108.754 -1.738 . . . . 1.05 108.754 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.4 ' O ' ' O ' ' A' ' 6' ' ' LEU . 72.5 mt -91.06 -10.48 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.033 -1.275 . . . . 1.59 110.562 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 5' ' ' ILE . 57.5 tp 53.3 98.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.684 -1.26 . . . . 1.47 109.8 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.97 -38.7 44.57 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.848 -0.797 . . . . 1.39 108.848 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 m -141.27 140.2 20.43 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.498 -0.751 . . . . 2.09 109.595 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -80.48 140.33 13.38 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.529 2.153 . . . . 0.91 112.821 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 165.99 -163.68 36.94 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.05 -1.62 . . . . 0.92 109.05 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 11' ' ' ILE . 85.2 mt -148.64 149.63 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.208 -1.172 . . . . 1.35 108.156 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.38 155.58 33.88 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.572 -1.33 . . . . 1.14 110.721 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -137.89 129.68 28.43 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.072 -1.084 . . . . 0.7 108.072 178.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.43 -178.13 46.35 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 118.699 -1.715 . . . . 0.58 110.905 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -80.07 156.51 27.05 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.811 -0.817 . . . . 2.63 109.519 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.11 129.75 51.81 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.449 -0.782 . . . . 1.27 110.934 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.3 tp -100.09 135.83 40.93 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.307 -1.368 . . . . 1.41 107.307 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.2 tp -117.77 127.45 53.92 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.262 -0.899 . . . . 1.49 109.951 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.4 mt -88.28 101.22 13.64 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 120.115 -0.634 . . . . 1.52 109.352 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.31 137.58 32.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 3.17 108.701 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -130.48 133.33 46.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.217 -0.927 . . . . 3.0 108.998 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -81.42 149.84 28.63 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.105 -0.997 . . . . 2.77 108.94 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -66.75 146.84 54.02 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.0 -1.062 . . . . 2.94 108.893 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.8 mt -94.45 130.91 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.283 -0.886 . . . . 1.46 108.633 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.3 t -101.61 129.66 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.271 -0.893 . . . . 1.7 110.752 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -108.34 132.1 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.585 -0.894 . . . . 1.54 108.585 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -87.36 120.59 28.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.79 -1.194 . . . . 1.81 109.495 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -88.71 0.1 56.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.388 -0.82 . . . . 3.23 108.879 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -68.83 146.49 52.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 3.29 109.252 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -89.22 150.07 22.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 2.8 109.335 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.5 pt -93.92 166.18 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.321 -0.862 . . . . 1.43 109.793 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.5 p -97.59 171.12 8.56 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.224 -1.028 . . . . 1.54 108.224 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.69 -49.39 77.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.948 -1.095 . . . . 1.6 108.94 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -53.89 -29.94 43.84 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.81 -1.181 . . . . 2.56 109.516 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -82.84 -10.0 59.05 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.395 -0.816 . . . . 2.36 110.413 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.57 -53.84 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.831 -1.168 . . . . 1.43 108.691 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.21 -40.07 88.83 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.481 -0.762 . . . . 1.77 109.677 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.23 -41.96 93.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -0.901 . . . . 3.32 110.891 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -65.76 -39.98 91.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 1.51 110.419 -179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.0 -46.17 94.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.701 -1.249 . . . . 1.41 108.491 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -59.98 -40.63 89.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.01 -1.056 . . . . 1.81 109.192 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -60.07 -43.03 95.73 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.901 -1.125 . . . . 3.26 108.438 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -66.39 -42.97 87.09 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.842 -0.799 . . . . 0.81 108.842 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.91 -50.63 73.01 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.282 -1.007 . . . . 1.59 108.282 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.8 t -63.86 -42.76 97.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.371 -0.932 . . . . 1.38 108.872 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.33 -42.51 98.85 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.575 -1.81 . . . . 0.87 108.575 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.419 HH11 ' HG2' ' A' ' 47' ' ' ARG . 21.4 ttt-85 -64.95 -35.12 80.16 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.184 -1.043 . . . . 3.62 108.184 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.76 -39.94 65.77 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.773 -0.825 . . . . 1.43 108.773 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 50' ' ' ALA . 7.0 ttpm? -72.46 -73.7 0.19 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.89 -1.152 . . . . 3.08 107.89 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.02 -41.11 0.33 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.334 -0.854 . . . . 1.33 112.084 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.2 p -57.93 -55.07 39.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.591 -1.318 . . . . 1.85 108.816 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.06 95.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.446 -0.784 . . . . 1.35 110.85 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -62.16 -46.05 90.71 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.997 -1.064 . . . . 2.34 110.685 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.74 -40.21 94.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.13 -0.981 . . . . 2.2 109.418 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -62.84 -40.02 96.15 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.306 -0.871 . . . . 1.35 109.603 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.9 m -65.87 -41.5 91.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.021 -1.05 . . . . 1.34 109.983 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.416 HG22 HD11 ' A' ' 57' ' ' ILE . 88.1 mt -61.64 -40.0 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.112 -0.992 . . . . 1.26 108.793 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -55.44 -50.87 68.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.471 -0.768 . . . . 1.7 109.771 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -58.82 -37.51 76.56 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.329 -0.857 . . . . 1.35 110.254 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -61.7 -38.74 88.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.073 -1.017 . . . . 2.08 109.39 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.98 -46.9 73.19 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.745 -0.597 . . . . 1.21 110.162 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.84 -53.27 37.41 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.829 -1.308 . . . . 0.75 109.829 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.54 -44.82 66.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.05 -1.265 . . . . 1.59 110.462 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.5 m -66.53 -64.04 0.94 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.124 -0.985 . . . . 1.41 112.74 -177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -95.8 -45.25 7.06 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.747 -1.221 . . . . 0.79 111.002 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.4 -167.47 25.5 Favored Glycine 0 N--CA 1.498 2.786 0 C-N-CA 119.771 -1.204 . . . . 1.22 110.792 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.21 -24.18 63.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 122.032 -0.687 . . . . 5.81 109.819 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.516 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.4 tp10 -60.96 -35.83 77.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.407 -0.808 . . . . 3.37 110.786 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -97.62 -19.46 18.29 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.133 -0.979 . . . . 2.37 109.764 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -68.89 -40.22 79.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.248 -0.908 . . . . 1.65 110.402 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.48 -32.65 74.14 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.393 -0.817 . . . . 1.42 110.144 -178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.06 -40.41 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 118.836 -1.145 . . . . 1.43 108.672 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -64.43 -40.14 95.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.104 -0.998 . . . . 1.08 109.15 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -60.08 -41.93 93.5 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.299 -0.876 . . . . 1.37 109.438 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.05 -43.73 97.95 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.173 -1.571 . . . . 0.67 109.173 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.4 m170 -70.0 -40.02 75.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -1.117 . . . . 1.99 109.167 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.0 -47.22 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.101 -0.999 . . . . 1.22 109.019 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.1 ttp -60.08 -40.49 89.75 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.992 -1.068 . . . . 2.11 109.836 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.414 ' CD1' ' CE2' ' B' ' 348' ' ' PHE . 32.2 tp -68.53 -39.93 80.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.444 -0.785 . . . . 1.33 109.289 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.34 -39.97 94.83 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.424 -0.798 . . . . 1.29 109.481 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -79.42 1.72 24.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.319 -0.863 . . . . 1.47 110.171 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -49.42 128.19 16.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.831 -1.168 . . . . 1.47 109.953 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -62.41 -16.82 57.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.55 -0.719 . . . . 1.78 110.566 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.67 -32.71 66.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.788 -1.195 . . . . 2.53 108.813 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.8 mt -70.74 -43.58 68.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.69 -0.631 . . . . 1.36 110.442 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -60.03 -43.31 95.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.046 -1.034 . . . . 1.42 110.47 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.96 -42.87 72.6 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.05 -1.031 . . . . 2.27 110.812 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.14 -39.97 75.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.959 -1.088 . . . . 1.57 111.333 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.6 mt -64.05 -50.03 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 1.19 109.985 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.5 mt -69.34 -35.36 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.448 -0.783 . . . . 1.39 110.173 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.63 -45.85 92.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 1.39 110.847 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.56 -47.53 85.77 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.911 -1.118 . . . . 1.5 109.982 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.9 mt -60.24 -49.67 83.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 122.093 0.949 . . . . 1.29 108.932 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -69.8 -39.94 76.28 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.15 -0.62 . . . . 2.64 111.175 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -84.83 -57.99 2.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.769 -1.207 . . . . 1.65 112.345 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -83.61 -0.94 52.69 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.964 -1.085 . . . . 2.5 111.419 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 57.34 36.63 27.44 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.117 -0.99 . . . . 1.88 109.854 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.5 mtt -90.27 167.96 12.28 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.568 -0.707 . . . . 1.71 109.976 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.444 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 73.9 p -80.88 160.58 24.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.473 -0.767 . . . . 1.61 109.339 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.56 -40.86 80.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.102 -0.999 . . . . 1.33 110.069 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.444 ' OD1' ' OG1' ' A' ' 99' ' ' THR . 31.4 p-10 -64.36 -36.78 85.24 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.252 -0.905 . . . . 2.07 109.221 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.431 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.96 -48.61 12.05 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.036 -1.04 . . . . 1.37 109.844 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.65 -48.95 79.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.527 -0.733 . . . . 1.14 110.952 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.09 93.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.032 -1.043 . . . . 1.26 110.296 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.417 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 81.6 t60 -59.08 -38.27 79.06 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.055 -1.028 . . . . 2.02 110.397 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.71 -41.12 97.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.874 -1.141 . . . . 1.33 110.968 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.05 -52.19 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.013 -1.055 . . . . 1.3 110.715 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.0 mm -66.96 -39.96 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.063 -1.023 . . . . 1.32 108.402 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.417 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 89.2 tt0 -66.22 -38.2 87.37 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.737 -0.838 . . . . 2.44 108.737 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.88 -47.36 90.92 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.312 -1.115 . . . . 0.99 110.312 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -68.33 -53.48 23.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.688 -1.478 . . . . 1.97 108.677 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.89 -39.95 59.86 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.096 -1.002 . . . . 1.43 109.106 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 46.2 t -60.06 -42.74 95.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.099 -1.001 . . . . 2.12 108.544 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.89 87.37 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.394 -0.816 . . . . 1.64 109.188 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.6 mt -67.44 -41.6 84.48 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.909 -1.119 . . . . 1.93 108.986 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -53.65 -31.42 47.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.071 -1.018 . . . . 2.2 109.164 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.6 -24.88 65.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.275 -0.89 . . . . 2.12 108.717 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 61.0 mt -62.79 143.55 57.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 2.34 109.272 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -99.33 48.98 0.95 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.325 -0.86 . . . . 3.23 109.257 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 56.9 t0 -134.61 132.89 39.55 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.296 -0.878 . . . . 2.49 109.795 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.441 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 18.4 pt-20 -70.25 -29.01 65.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.568 -0.707 . . . . 3.95 109.898 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.478 ' OH ' ' NH1' ' A' ' 126' ' ' ARG . 3.5 t80 -71.1 -39.92 71.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.38 -0.825 . . . . 2.25 110.383 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 88.9 mt -79.63 -40.05 30.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.99 . . . . 2.27 109.775 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -60.15 -49.91 75.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.982 -1.074 . . . . 3.31 109.706 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.82 -40.17 94.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 2.73 108.862 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.652 ' CG ' HE22 ' B' ' 351' ' ' GLN . 31.6 ttt180 -60.03 -40.07 88.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.857 -1.164 . . . . 3.2 107.857 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.66 -23.51 66.81 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.261 -1.015 . . . . 1.66 108.261 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.46 -40.03 93.05 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.58 -1.267 . . . . 1.67 107.58 178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -61.54 -41.44 97.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.515 -0.741 . . . . 1.55 109.082 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 73.1 t -63.65 -40.08 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.273 -1.01 . . . . 1.32 108.273 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -62.7 -33.52 75.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.608 -0.683 . . . . 3.58 109.476 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -59.95 -41.58 92.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 1.46 109.487 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.1 mt -60.09 -45.58 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.163 -0.961 . . . . 1.22 109.863 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.66 -43.31 99.17 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.397 -0.906 . . . . 0.61 111.014 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -59.99 -47.87 84.05 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.011 -1.288 . . . . 3.1 110.901 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.575 HH12 ' CB ' ' A' ' 166' ' ' SER . 99.0 mtt180 -69.32 -29.02 66.77 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.832 -1.167 . . . . 3.71 109.903 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 57.6 tp -59.52 -41.57 90.25 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.555 -0.906 . . . . 1.87 108.555 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.6 mt -61.89 -40.12 94.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.141 -0.974 . . . . 1.29 109.317 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.87 -39.97 83.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.488 -0.757 . . . . 3.05 108.978 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.516 HD21 ' N ' ' A' ' 140' ' ' ASN . 1.9 m120 -60.09 -39.11 84.98 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.583 -0.698 . . . . 1.26 111.279 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.1 mt -73.46 -41.2 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.764 -1.21 . . . . 1.34 109.675 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.2 mt -70.43 -31.79 69.13 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.55 -0.719 . . . . 1.6 109.434 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.12 37.94 6.98 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.215 -1.554 . . . . 0.96 109.215 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.0 tp -73.63 142.56 46.51 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.263 -1.139 . . . . 1.67 108.644 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -69.16 142.72 54.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.207 -0.933 . . . . 4.96 110.668 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.02 129.99 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-O 122.063 0.935 . . . . 1.68 109.343 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.2 mt -61.48 -43.91 97.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.865 -0.607 . . . . 2.14 110.691 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.411 ' OD1' ' OG ' ' A' ' 150' ' ' SER . 24.6 t0 63.76 103.36 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.38 -0.825 . . . . 1.5 109.094 -179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.5 mt -70.53 -6.04 33.39 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.522 -0.736 . . . . 1.39 110.184 -179.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.411 ' OG ' ' OD1' ' A' ' 148' ' ' ASP . 93.7 p -85.09 -14.0 48.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.128 -0.983 . . . . 1.83 108.681 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.87 14.65 2.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.687 -0.633 . . . . 1.46 111.176 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.5 mp -89.4 134.34 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.603 -1.31 . . . . 1.42 108.188 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -117.53 -9.02 10.9 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.736 -0.602 . . . . 2.94 109.741 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -119.03 149.98 40.75 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.21 -0.932 . . . . 1.52 110.473 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -63.65 130.97 46.48 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.689 -0.856 . . . . 1.58 108.689 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.4 m -152.07 163.59 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.883 . . . . 1.32 109.518 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.0 mt -94.42 147.85 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 106.036 -1.839 . . . . 1.27 106.036 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.2 tp -97.31 117.4 31.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.086 -1.009 . . . . 1.41 110.905 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.91 126.42 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.215 -1.031 . . . . 1.23 108.215 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.88 161.26 40.61 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.094 -1.004 . . . . 1.32 109.201 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.42 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.35 -31.45 69.89 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.133 -1.604 . . . . 1.49 107.847 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -167.59 173.92 8.2 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.559 -0.904 . . . . 2.25 108.559 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 89.9 mt -141.22 130.04 22.99 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.076 -1.015 . . . . 1.35 108.823 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.8 p -87.89 147.91 42.17 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.03 -1.044 . . . . 1.56 109.23 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -43.38 -36.43 6.55 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.817 1.678 . . . . 0.87 112.125 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.575 ' CB ' HH12 ' A' ' 136' ' ' ARG . 50.3 m -60.04 -39.94 87.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.371 -0.831 . . . . 1.36 109.875 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.1 -40.87 78.12 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.155 -0.966 . . . . 1.61 109.751 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.8 p -55.64 -29.75 59.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.96 -1.087 . . . . 1.21 110.605 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.79 -51.21 23.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.879 -1.138 . . . . 1.21 109.573 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -85.02 38.52 0.72 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.417 -0.957 . . . . 2.11 108.417 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.8 tp -102.92 130.6 50.02 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.693 -0.63 . . . . 1.29 109.303 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -83.75 103.65 13.22 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.868 -0.789 . . . . 2.81 108.868 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 77.6 mt -64.86 -43.65 92.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.416 -0.803 . . . . 2.09 111.344 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -69.83 -25.24 63.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.893 -1.13 . . . . 2.86 112.417 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -93.18 -10.12 36.89 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.615 -1.303 . . . . 2.39 110.517 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 62.3 t -109.18 119.94 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.137 -1.06 . . . . 1.27 108.137 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.1 mt -90.94 8.09 36.9 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.184 -0.947 . . . . 2.17 111.09 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.96 172.64 37.4 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.153 -1.499 . . . . 0.52 109.87 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -133.7 128.51 35.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.656 -0.908 . . . . 0.55 108.594 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 97.3 mt -132.67 127.2 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.778 . . . . 1.27 109.204 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 50.4 p -150.02 162.0 41.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.904 -1.123 . . . . 1.39 110.516 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 38.1 p-10 -104.0 23.27 13.19 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.186 -0.672 . . . . 2.46 109.186 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.44 -159.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.057 -1.027 . . . . 1.51 111.644 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.66 -54.22 6.09 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.906 -0.877 . . . . 2.23 110.906 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 160.7 -131.46 2.63 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.147 -1.501 . . . . 2.23 110.732 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.484 HH11 ' HG2' ' A' ' 186' ' ' ARG . 12.5 mtt-85 -69.91 -20.78 63.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.67 -0.9 . . . . 6.44 111.065 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 25.1 p -73.04 -0.17 13.13 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.938 -1.101 . . . . 4.09 110.322 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.9 m -91.09 132.36 36.09 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.067 -1.021 . . . . 2.2 110.064 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -49.89 -48.19 51.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.334 -0.854 . . . . 1.15 109.526 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.75 -39.83 74.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.33 -0.856 . . . . 2.01 110.085 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 19.7 t -60.09 -43.04 95.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.928 -1.108 . . . . 1.93 109.907 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.33 -41.34 91.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.181 -0.95 . . . . 2.2 109.798 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 86.6 mtp -63.31 -39.98 96.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.168 -0.957 . . . . 1.32 110.175 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.74 -42.89 76.05 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.561 -1.337 . . . . 1.3 108.821 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -59.89 -50.1 75.11 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.455 -0.778 . . . . 3.38 110.041 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.0 m -70.32 -33.95 72.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.093 -1.004 . . . . 1.15 110.711 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 81.8 mt -70.0 -21.36 63.23 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.107 -0.996 . . . . 1.28 109.264 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 60.74 48.89 6.67 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.239 0.542 . . . . 1.5 110.751 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.8 mt -126.42 149.57 67.9 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.218 -1.401 . . . . 1.37 107.218 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.44 137.71 66.59 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.84 1.693 . . . . 0.76 111.593 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.17 151.0 3.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.876 -1.14 . . . . 1.19 111.478 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 202' ' ' ILE . 89.8 mt -126.87 143.62 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.964 -1.124 . . . . 1.31 107.964 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.8 m -128.49 -8.8 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 O-C-N 120.736 -1.227 . . . . 1.38 110.864 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.58 21.53 25.77 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 110.397 -1.081 . . . . 1.03 110.397 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 23.0 p -44.46 -44.17 8.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.114 -1.227 . . . . 1.38 110.048 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 93.94 -51.86 2.25 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 120.328 -0.939 . . . . 1.17 111.03 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.9 p -157.34 35.01 0.28 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.516 -1.579 . . . . 2.07 111.444 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.0 t -73.37 -39.86 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.969 -1.082 . . . . 1.35 108.907 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.504 ' HG1' ' N ' ' A' ' 210' ' ' SER . 3.0 p -56.14 -34.01 65.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.761 . . . . 1.49 110.666 -178.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.504 ' N ' ' HG1' ' A' ' 209' ' ' THR . 23.0 t -71.19 -31.64 67.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.136 -0.977 . . . . 2.16 109.794 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -89.84 -8.22 52.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.838 . . . . 2.89 110.728 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 75.0 t -102.79 131.99 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.011 -1.056 . . . . 1.33 110.528 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -111.33 145.08 39.46 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.066 -1.457 . . . . 2.73 107.066 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.477 ' O ' ' OD1' ' A' ' 215' ' ' ASP . 44.4 p-10 -54.25 137.8 40.29 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.201 -0.937 . . . . 2.7 111.051 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER 89.3 -2.53 0.38 Allowed 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.321 0.581 . . . . 2.38 110.768 178.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -71.36 150.51 45.0 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.336 -0.853 . . . . 2.09 109.497 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -99.09 120.0 38.76 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.234 -1.024 . . . . 1.45 108.234 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 73.8 mt -126.64 149.78 49.31 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.565 -0.709 . . . . 1.31 109.861 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.9 mt -119.26 129.95 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.301 -1.37 . . . . 1.29 107.301 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 23.9 tp -102.25 119.95 39.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.23 -0.919 . . . . 1.31 109.437 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 223' ' ' VAL . 29.0 t70 -80.1 -41.86 24.71 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.303 -0.873 . . . . 2.31 108.769 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 46.76 11.67 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.691 -0.63 . . . . 1.19 109.96 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 221' ' ' ASP . 46.7 t -118.84 -35.22 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 106.693 -1.595 . . . . 1.45 106.693 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.452 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 19.9 m120 -112.85 4.6 17.01 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.375 -1.343 . . . . 3.13 107.375 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.704 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.9 OUTLIER 57.58 50.61 10.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.855 -0.528 . . . . 2.2 110.235 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -136.95 147.5 46.38 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.216 -0.927 . . . . 2.32 109.548 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 76.0 t -115.02 129.3 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.545 -0.909 . . . . 1.4 108.545 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -104.48 121.06 42.67 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.768 -0.827 . . . . 1.29 108.768 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 43.1 t -100.08 110.95 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.593 -0.692 . . . . 1.38 109.805 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.47 HD21 ' C ' ' A' ' 230' ' ' ASN . 0.4 OUTLIER 51.69 69.94 2.22 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.41 -0.806 . . . . 2.33 110.911 179.486 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -90.67 147.64 4.06 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.33 2.687 . . . . 0.95 112.245 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 11.0 m -71.02 165.38 23.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.057 -1.027 . . . . 2.31 109.932 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -59.98 -39.92 87.33 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.318 -0.864 . . . . 3.45 109.88 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -60.02 -39.86 87.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.984 . . . . 2.89 109.64 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.32 -44.21 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.155 -0.965 . . . . 1.73 109.049 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.43 HD11 HG22 ' A' ' 236' ' ' ILE . 96.9 mt -63.18 -40.04 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 1.57 109.655 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.32 -40.12 85.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.895 -1.128 . . . . 2.43 108.542 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -65.33 -42.3 93.05 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.557 -0.905 . . . . 3.18 108.557 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 89.0 mtp -69.88 -33.73 72.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 1.59 109.88 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -65.59 -39.26 91.39 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.12 -0.987 . . . . 3.11 109.158 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.69 -42.88 93.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.469 -0.77 . . . . 2.17 109.946 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 53.4 t -60.07 -40.89 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.884 -1.135 . . . . 2.51 108.596 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -59.99 -40.18 88.27 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.297 -0.877 . . . . 3.82 109.292 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.61 -40.21 94.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 1.78 109.162 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -60.82 -40.46 92.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 2.77 108.824 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 79.4 t -63.44 -40.3 88.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.639 -0.663 . . . . 2.25 109.223 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.99 -42.21 93.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.272 -0.893 . . . . 2.54 109.555 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.0 t -65.01 -40.06 94.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.362 -0.836 . . . . 3.03 108.841 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -63.17 -33.71 76.06 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.575 -0.703 . . . . 3.34 109.522 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -59.95 -40.64 89.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.065 -1.022 . . . . 4.18 109.166 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.94 88.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.988 -1.07 . . . . 4.43 109.25 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 60.37 19.95 9.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.445 -0.784 . . . . 5.42 109.771 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 255' ' ' LYS . 88.0 mt -69.44 -25.02 63.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.166 -0.959 . . . . 6.11 109.391 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -42.42 -21.64 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.489 -0.757 . . . . 7.37 110.595 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 253' ' ' LEU . 57.6 mttp -72.48 162.27 29.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.001 -1.062 . . . . 8.3 109.5 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 9.9 mp -58.77 -35.94 73.59 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.23 -0.919 . . . . 9.05 108.61 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -149.95 148.82 29.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.297 -0.877 . . . . 10.56 109.466 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -130.53 43.12 3.16 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.49 -0.756 . . . . 11.32 109.292 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.024 -0.989 . . . . 12.74 109.438 179.869 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 21.8 ttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -153.95 150.84 28.73 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.36 -0.838 . . . . 0.0 108.965 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -148.66 160.05 43.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.98 -1.075 . . . . 0.0 110.171 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -152.12 149.24 28.58 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -109.82 130.24 55.54 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.39 -0.818 . . . . 0.0 109.673 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 1.5 p -131.95 121.51 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 122.167 0.984 . . . . 0.0 112.021 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 50.6 m -75.74 106.1 7.13 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.828 0.823 . . . . 0.0 110.524 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 77.9 mt -52.16 123.17 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 122.476 1.131 . . . . 0.0 110.296 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 77.7 p -104.0 23.2 13.3 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.776 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -82.66 119.47 74.63 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.142 -0.974 . . . . 0.0 109.262 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -66.3 -7.91 18.92 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 120.362 1.165 . . . . 0.0 111.884 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -117.39 6.44 12.64 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.69 176.93 34.25 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.229 -1.949 . . . . 0.0 108.229 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.465 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.3 tp -86.74 96.18 10.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.946 -1.326 . . . . 0.0 108.723 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -97.69 -159.97 0.77 Allowed 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.29 -0.881 . . . . 0.0 110.71 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 24.5 m -59.82 -43.03 94.73 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.033 -1.042 . . . . 0.0 112.303 -175.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.516 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 1.5 tpt180 -59.74 -64.33 3.14 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 120.356 -1.465 . . . . 0.0 111.428 -178.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -55.37 -33.78 86.66 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 CA-C-N 120.281 1.136 . . . . 0.0 111.782 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.95 71.72 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.46 -40.88 62.8 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.247 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -70.43 -40.06 74.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.031 -1.043 . . . . 0.0 108.674 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -61.44 -53.04 61.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.437 -0.789 . . . . 0.0 110.432 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 77.7 t -68.93 -35.12 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.766 -1.208 . . . . 0.0 109.756 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -59.97 -47.06 87.38 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.869 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -66.34 -40.05 89.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.096 -1.002 . . . . 0.0 109.999 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' B' ' 328' ' ' GLY . . . -64.65 -52.33 57.91 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.019 -1.051 . . . . 0.0 110.789 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -54.49 -10.21 0.39 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.021 -1.049 . . . . 0.0 109.555 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . 0.465 ' H ' ' C ' ' B' ' 326' ' ' ALA . . . -71.94 -26.19 73.12 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -101.99 144.99 29.91 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.39 -1.065 . . . . 0.0 109.272 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 8.8 m -90.87 -13.73 33.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.907 -1.121 . . . . 0.0 108.996 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.0 t -62.61 149.88 42.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 109.04 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -67.61 134.62 51.51 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.256 -0.903 . . . . 0.0 109.171 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . 0.429 HG22 HD11 ' B' ' 333' ' ' ILE . 90.3 mt -131.12 130.45 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.711 -0.618 . . . . 0.0 109.654 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 98.3 m -129.62 152.36 49.22 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.594 -0.691 . . . . 0.0 109.187 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 61.6 t -116.94 140.47 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 70.4 m -130.36 126.12 36.31 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.211 -0.931 . . . . 0.0 109.497 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 10.8 t -138.65 111.75 7.93 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.232 -0.917 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 46.39 56.38 6.42 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 84.56 -16.2 36.87 Favored Glycine 0 N--CA 1.499 2.873 0 O-C-N 120.223 -1.548 . . . . 0.0 112.299 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -110.65 121.61 45.74 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.922 -1.34 . . . . 0.0 109.482 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 88.4 p -128.25 148.19 50.63 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.811 0.815 . . . . 0.0 109.855 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.84 170.38 16.23 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.662 0.744 . . . . 0.0 110.11 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 70.4 m -88.53 140.47 29.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.605 -0.684 . . . . 0.0 109.582 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.429 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -83.13 -12.45 57.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.024 -1.048 . . . . 0.0 110.248 -179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -88.93 20.56 3.51 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.429 ' H ' ' C ' ' B' ' 344' ' ' ALA . 56.1 m -147.81 98.06 2.9 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.734 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 29.1 tp -60.0 -34.68 73.66 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . 0.414 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 55.7 m-85 -57.65 -53.53 57.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.709 -1.244 . . . . 0.0 109.942 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -70.05 -21.4 63.18 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.09 -1.006 . . . . 0.0 111.17 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' B' ' 352' ' ' THR . 21.4 mt -69.42 -52.68 24.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.771 -1.206 . . . . 0.0 108.165 178.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.652 HE22 ' CG ' ' A' ' 126' ' ' ARG . 10.3 mm100 -38.33 -22.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.293 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.533 ' N ' ' O ' ' B' ' 350' ' ' LEU . 58.5 p -82.08 -10.2 59.29 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.962 -1.086 . . . . 0.0 110.215 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 70.6 mt -95.5 116.24 28.55 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.066 -1.021 . . . . 0.0 109.076 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -80.27 94.43 1.49 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 27.8 mt -99.82 92.64 5.4 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.237 -1.155 . . . . 0.0 108.556 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 68.4 p -94.6 179.82 5.13 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.07 -1.019 . . . . 0.0 110.632 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' B' ' 359' ' ' THR . 62.2 tt0 -48.62 157.44 0.37 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.232 1.015 . . . . 0.0 111.236 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.61 23.98 0.02 OUTLIER Glycine 0 N--CA 1.497 2.708 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.499 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 359' ' ' THR . . . . . 0.5 ' N ' ' O ' ' B' ' 357' ' ' GLN . 19.1 m -84.4 111.58 19.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.732 -1.452 . . . . 0.0 109.448 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 23.4 t -76.27 115.68 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 122.318 1.056 . . . . 0.0 109.629 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 19.0 m -112.66 176.6 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 45.9 m -130.74 129.49 42.58 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 84.3 mt -102.96 118.24 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 22.1 m -123.67 134.0 53.81 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.322 -0.861 . . . . 0.0 109.232 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.29 150.55 38.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.179 -0.951 . . . . 0.0 109.74 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -140.09 119.81 13.34 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.541 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.74 -160.93 32.37 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 118.855 -1.641 . . . . 0.0 111.691 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -59.95 -51.65 68.78 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 122.371 -0.487 . . . . 0.0 112.311 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -105.52 9.36 33.49 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.857 -1.152 . . . . 0.0 110.939 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.9 pt-20 -42.7 -34.08 0.84 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.151 -0.968 . . . . 0.0 111.088 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -70.11 -41.31 74.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.963 . . . . 0.0 110.135 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -68.12 -49.89 58.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.2 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.27 -76.03 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.382 -0.824 . . . . 0.0 110.997 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 82.0 t -45.3 -36.49 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.98 -1.075 . . . . 0.0 111.033 -177.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -64.53 -52.57 57.11 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.427 -1.421 . . . . 0.0 110.637 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -76.81 -40.18 48.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.665 -1.272 . . . . 0.0 110.588 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 87.7 mt -59.62 -39.28 83.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.014 . . . . 0.0 109.088 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 50.6 t -60.98 -41.1 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.104 -0.998 . . . . 0.0 109.283 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' B' ' 383' ' ' GLU . 7.7 mtmp? -69.05 -55.2 11.5 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.567 -1.333 . . . . 0.0 108.62 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 63.3 tp -55.97 -35.07 66.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.946 -1.096 . . . . 0.0 109.783 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 6.0 ttm -70.29 -39.99 74.53 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.661 -1.275 . . . . 0.0 107.759 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.27 -7.02 58.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.766 -0.584 . . . . 0.0 110.782 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' B' ' 379' ' ' LYS . 49.3 mt-10 -111.34 1.77 17.26 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.953 -1.092 . . . . 0.0 110.989 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 17.8 mt -87.1 126.62 34.89 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.283 -1.511 . . . . 0.0 109.224 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.302 -179.775 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.028 -0.731 . . . . 3.19 109.028 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 95.2 mt -110.02 128.49 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.542 -0.724 . . . . 1.71 109.306 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.7 m -140.06 150.08 43.92 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.398 -0.813 . . . . 1.66 109.654 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.402 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -136.99 -162.94 9.55 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.297 -1.921 . . . . 1.05 108.297 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' LEU . 93.7 mt -90.4 -17.45 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.745 -1.444 . . . . 1.59 109.875 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.9 tp 51.51 103.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.365 -0.834 . . . . 1.47 109.304 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.7 -29.09 12.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.099 -1.0 . . . . 1.39 109.008 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.1 m -130.84 115.11 16.7 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.636 -0.665 . . . . 2.09 109.276 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -80.15 151.02 20.59 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 121.924 1.749 . . . . 0.91 112.627 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 150.18 169.18 16.01 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.704 -1.759 . . . . 0.92 108.704 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.9 mt -120.04 129.99 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 O-C-N 121.046 -1.267 . . . . 1.35 109.839 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.33 150.38 50.94 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.083 -1.01 . . . . 1.14 110.455 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.5 m-85 -126.87 128.46 46.53 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 107.924 -1.139 . . . . 0.7 107.924 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.56 178.55 48.47 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.583 -1.77 . . . . 0.58 110.977 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -79.98 158.81 26.48 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.892 -0.77 . . . . 2.63 109.244 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.92 129.71 54.7 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.331 -0.855 . . . . 1.27 110.92 -179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.7 tp -100.34 133.12 45.24 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.11 -1.441 . . . . 1.41 107.11 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.4 tp -114.83 127.32 55.65 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.258 -0.901 . . . . 1.49 109.536 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.4 mt -89.45 102.08 14.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.473 -0.767 . . . . 1.52 110.368 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -103.0 131.82 49.7 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.132 -0.692 . . . . 3.17 109.132 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -130.52 133.82 46.55 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.323 -0.861 . . . . 3.0 109.389 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -73.48 153.49 40.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.063 -1.023 . . . . 2.77 109.521 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -67.63 143.16 56.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 2.94 109.766 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.2 mt -83.13 128.15 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.895 . . . . 1.46 109.342 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.1 t -93.57 131.53 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.234 -0.916 . . . . 1.7 110.652 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.6 mt -107.97 133.57 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.861 -0.792 . . . . 1.54 108.861 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -92.29 119.25 31.69 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.04 -1.038 . . . . 1.81 109.317 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -90.7 -2.51 57.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.299 -0.875 . . . . 3.23 109.506 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -69.17 139.59 54.61 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.16 -0.963 . . . . 3.29 109.218 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -86.05 153.51 22.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.178 -0.951 . . . . 2.8 109.059 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.5 pt -98.29 166.19 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.223 -0.923 . . . . 1.43 109.711 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 81.3 p -90.08 171.66 9.38 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.299 -0.876 . . . . 1.54 109.041 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.53 -17.06 64.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.056 -1.027 . . . . 1.6 110.611 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -86.5 -26.64 24.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.863 -1.148 . . . . 2.56 108.012 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -82.31 -8.43 59.64 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.769 -0.826 . . . . 2.36 108.769 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 t -58.4 -50.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.351 -0.981 . . . . 1.43 108.351 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.98 -40.01 87.66 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.208 -0.933 . . . . 1.77 108.707 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -61.48 -46.55 89.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.404 -0.81 . . . . 3.32 110.926 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -60.16 -44.07 95.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.727 -1.233 . . . . 1.51 109.961 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.05 -46.15 94.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 120.918 -1.114 . . . . 1.41 108.737 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -60.03 -41.25 91.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 1.81 109.193 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -60.01 -45.99 90.96 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.914 -1.116 . . . . 3.26 108.092 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -60.52 -48.23 82.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.531 -0.731 . . . . 0.81 109.075 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.04 -49.93 75.73 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.873 -0.788 . . . . 1.59 108.873 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.6 t -61.47 -44.58 96.84 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.175 -0.953 . . . . 1.38 108.515 178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.52 -42.84 99.85 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.454 -1.859 . . . . 0.87 108.454 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.0 ttt-85 -66.08 -31.08 71.73 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.324 -0.991 . . . . 3.62 108.324 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.59 -40.02 82.01 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.175 -0.676 . . . . 1.43 109.175 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.7 ttmt -72.33 -73.43 0.19 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.979 -1.076 . . . . 3.08 108.178 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.53 -34.7 0.15 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.339 -0.851 . . . . 1.33 110.736 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.0 m -57.14 -61.29 2.56 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.65 -1.281 . . . . 1.85 108.54 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.0 82.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 1.35 111.248 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -66.28 -42.63 88.12 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.77 -1.206 . . . . 2.34 110.374 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.98 -39.99 96.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.837 -1.165 . . . . 2.2 108.899 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.25 -35.18 79.75 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.324 -0.86 . . . . 1.35 108.822 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -63.66 -41.68 98.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 1.34 109.779 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.22 -40.05 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.124 -0.985 . . . . 1.26 108.917 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -54.75 -49.93 69.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.46 -0.775 . . . . 1.7 109.712 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -58.38 -37.33 75.03 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.344 -0.848 . . . . 1.35 109.868 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -68.18 -37.52 81.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.001 -1.062 . . . . 2.08 109.277 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.65 -46.56 75.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.657 -0.652 . . . . 1.21 109.862 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.96 -50.02 72.26 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.57 -1.012 . . . . 0.75 110.57 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -70.0 -40.66 75.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.944 -1.327 . . . . 1.59 110.103 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.4 m -69.98 -58.26 4.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.061 -1.025 . . . . 1.41 111.474 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.416 ' CE1' ' O ' ' A' ' 168' ' ' THR . 89.2 m-85 -96.3 -51.39 4.4 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.031 -1.043 . . . . 0.79 111.189 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.86 -167.66 25.88 Favored Glycine 0 N--CA 1.503 3.167 0 C-N-CA 119.555 -1.307 . . . . 1.22 111.339 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -66.9 -25.12 66.22 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.866 -0.785 . . . . 5.81 109.991 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.442 ' OE2' ' NH1' ' B' ' 317' ' ' ARG . 23.3 tp10 -60.06 -34.86 74.0 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.604 -0.685 . . . . 3.37 110.81 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -98.12 -19.54 17.87 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.175 -0.953 . . . . 2.37 110.529 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -69.36 -40.01 77.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.785 -1.197 . . . . 1.65 110.029 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.22 -33.98 76.66 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.367 -0.833 . . . . 1.42 109.695 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.8 mt -60.0 -42.88 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.077 -1.015 . . . . 1.43 109.813 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -63.34 -38.67 92.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.911 -1.118 . . . . 1.08 110.327 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -59.96 -39.99 87.49 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.859 -1.151 . . . . 1.37 109.038 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.53 -54.57 34.79 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.424 -1.47 . . . . 0.67 109.424 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -61.31 -48.21 82.43 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.167 -1.196 . . . . 1.99 109.256 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.6 mt -61.79 -50.01 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.257 -0.902 . . . . 1.22 109.18 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.0 ttp -59.98 -40.79 90.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.073 -1.017 . . . . 2.11 110.173 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.0 tp -66.54 -39.89 88.79 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.31 -0.868 . . . . 1.33 109.343 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -64.03 -38.76 92.25 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.528 -0.733 . . . . 1.29 109.329 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -80.22 2.54 23.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 1.47 110.06 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -49.17 130.5 19.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.136 -0.978 . . . . 1.47 109.689 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -63.01 -19.07 64.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.696 -0.627 . . . . 1.78 111.411 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -71.98 -32.38 67.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.656 -1.277 . . . . 2.53 108.611 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.1 mt -71.13 -41.39 70.55 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.541 0.686 . . . . 1.36 109.957 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -60.04 -45.66 92.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.868 . . . . 1.42 110.277 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.97 -41.9 73.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.895 . . . . 2.27 110.734 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.97 -39.96 75.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.157 -0.965 . . . . 1.57 111.746 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 89' ' ' ILE . 93.8 mt -65.4 -49.09 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.977 -1.077 . . . . 1.19 109.652 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -68.25 -37.71 78.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.619 -0.676 . . . . 1.39 110.877 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -60.03 -47.97 83.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.057 -1.027 . . . . 1.39 111.054 -179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.548 ' O ' ' N ' ' A' ' 96' ' ' LYS . 78.5 mt -61.89 -46.21 90.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.908 -1.12 . . . . 1.5 110.28 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.0 mt -60.02 -49.77 82.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.084 -1.01 . . . . 1.29 108.655 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -69.95 -40.15 75.63 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.907 -0.588 . . . . 2.64 110.67 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.465 ' N ' ' O ' ' A' ' 91' ' ' ALA . 47.2 t0 -84.02 -46.96 11.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.016 -1.053 . . . . 1.65 111.72 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.548 ' N ' ' O ' ' A' ' 92' ' ' LEU . 30.9 mmtp -94.64 -2.22 51.74 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.014 -1.053 . . . . 2.5 111.952 -177.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 56.26 35.82 26.43 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.788 -1.195 . . . . 1.88 109.638 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.7 mtp -91.64 167.92 11.86 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.461 -0.774 . . . . 1.71 109.54 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.1 p -82.58 160.23 22.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.145 -0.972 . . . . 1.61 109.407 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.5 -39.92 85.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.237 -0.915 . . . . 1.33 110.195 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -65.06 -37.98 89.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.123 -0.986 . . . . 2.07 109.679 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.13 -48.98 11.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.319 -0.863 . . . . 1.37 110.034 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.91 -49.56 74.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.403 -0.81 . . . . 1.14 110.532 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.06 -43.01 95.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -0.967 . . . . 1.26 109.72 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 78.0 t60 -59.99 -40.0 87.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 2.02 110.531 -178.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.06 -39.98 91.91 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.962 -1.086 . . . . 1.33 109.902 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.5 t -62.2 -53.48 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.232 -0.917 . . . . 1.3 110.991 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.4 mm -69.95 -39.98 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.983 -1.073 . . . . 1.32 109.409 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.21 -39.85 94.13 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.393 -0.966 . . . . 2.44 108.393 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.06 -52.78 50.76 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.712 -0.955 . . . . 0.99 110.712 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -69.28 -44.79 71.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.762 -1.434 . . . . 1.97 109.861 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.88 -44.49 91.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.881 -1.137 . . . . 1.43 108.55 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 88.7 p -59.96 -36.74 77.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 2.12 109.066 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.99 94.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 1.64 109.067 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.4 mt -65.8 -42.27 90.9 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.12 -0.988 . . . . 1.93 109.508 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.43 ' C ' ' N ' ' A' ' 118' ' ' LEU . 85.5 tt0 -59.97 -39.59 86.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.909 -1.119 . . . . 2.2 110.082 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -49.26 -17.92 0.3 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.941 -1.1 . . . . 2.12 109.168 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.43 ' N ' ' C ' ' A' ' 116' ' ' GLU . 68.0 mt -62.65 140.4 58.69 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.526 -0.916 . . . . 2.34 108.526 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 49.8 t0 -93.94 44.15 1.12 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.006 -1.059 . . . . 3.23 111.124 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -137.44 150.9 47.96 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.971 -1.08 . . . . 2.49 109.575 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 124' ' ' LYS . 71.8 mm-40 -72.63 -65.82 0.74 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.144 -0.972 . . . . 3.95 109.13 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.638 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 4.0 t80 -39.11 -42.16 0.89 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.836 -0.54 . . . . 2.25 110.404 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.558 ' CD2' HH22 ' A' ' 126' ' ' ARG . 87.6 mt -70.58 -39.95 73.57 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.845 -1.159 . . . . 2.27 108.03 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 121' ' ' GLU . 32.8 ttmt -62.07 -38.34 88.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.673 -0.642 . . . . 3.31 110.256 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -60.06 -47.32 86.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.082 -1.011 . . . . 2.73 110.633 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.638 ' NH1' ' CE1' ' A' ' 122' ' ' TYR . 21.8 mtm-85 -70.08 -30.16 67.33 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.888 -1.133 . . . . 3.2 108.964 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.99 -27.95 67.28 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.428 -1.323 . . . . 1.66 107.428 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.17 -38.94 72.14 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.49 -0.93 . . . . 1.67 108.49 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -62.27 -42.4 99.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.583 -0.698 . . . . 1.55 110.504 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.75 -40.39 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.058 -1.026 . . . . 1.32 109.112 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.504 ' CG ' HH11 ' A' ' 131' ' ' ARG . 2.4 ttt-85 -60.62 -38.63 85.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.907 . . . . 3.58 109.356 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.02 -40.03 87.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.35 -0.844 . . . . 1.46 110.563 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.0 mt -59.94 -45.21 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.796 -1.19 . . . . 1.22 109.446 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.19 -39.98 96.48 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.928 -1.269 . . . . 0.61 109.928 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -59.98 -49.95 75.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.255 -1.144 . . . . 3.1 110.028 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 59.8 mtp180 -68.42 -32.15 71.98 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.017 -1.052 . . . . 3.71 110.062 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.5 tp -60.0 -40.58 89.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.098 -1.001 . . . . 1.87 108.758 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.03 -40.55 89.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.173 -0.954 . . . . 1.29 109.26 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -69.97 -40.08 75.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.476 -0.765 . . . . 3.05 109.72 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -62.72 -35.86 81.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.478 -0.764 . . . . 1.26 111.249 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.0 mt -72.92 -41.39 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.617 -1.302 . . . . 1.34 109.273 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.04 -26.32 63.98 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.668 -0.645 . . . . 1.6 109.462 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.27 35.53 20.33 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.688 -1.765 . . . . 0.96 108.688 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 tp -73.27 144.77 46.53 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.484 -1.009 . . . . 1.67 108.831 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -67.06 140.32 57.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -0.914 . . . . 4.96 110.427 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 89.5 mt -110.03 128.6 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.443 -0.947 . . . . 1.68 108.443 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 14.0 mm -60.21 -44.44 95.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.775 -0.578 . . . . 2.14 110.58 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 42.2 t0 62.62 113.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.438 -0.789 . . . . 1.5 108.951 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.12 -1.93 42.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.366 -0.834 . . . . 1.39 110.079 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.2 m -89.02 -17.18 29.91 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.932 -1.105 . . . . 1.83 110.543 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.27 17.75 0.34 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.107 -0.996 . . . . 1.46 111.721 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.408 HD11 HG22 ' A' ' 152' ' ' ILE . 32.7 mm -80.21 132.26 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.469 -1.395 . . . . 1.42 109.978 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -110.43 -11.32 14.51 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.685 -0.634 . . . . 2.94 109.525 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -129.96 152.13 49.77 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.578 -0.701 . . . . 1.52 110.012 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -65.36 136.51 56.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.089 -1.007 . . . . 1.58 109.514 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.8 m -153.36 166.69 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.411 -0.806 . . . . 1.32 109.838 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 157' ' ' ILE . 85.4 mt -95.84 149.59 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.026 -1.842 . . . . 1.27 106.026 176.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.1 tp -104.31 119.38 38.82 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.969 -1.082 . . . . 1.41 110.815 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 4.2 t -123.32 132.12 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.663 -0.865 . . . . 1.23 108.663 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -158.46 163.99 36.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.843 -1.161 . . . . 1.32 109.605 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.04 -35.44 71.96 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.3 -1.5 . . . . 1.49 108.485 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 62.8 t0 -169.56 142.76 2.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.133 -0.692 . . . . 2.25 109.133 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.466 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 90.7 mt -111.62 139.52 47.0 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.397 -0.815 . . . . 1.35 109.651 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 64.2 p -94.62 142.88 25.36 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.337 -0.852 . . . . 1.56 109.409 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -40.28 -38.31 2.23 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.195 1.93 . . . . 0.87 112.751 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.5 m -56.77 -40.08 75.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.044 -1.035 . . . . 1.36 108.514 -179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -66.31 -40.66 90.12 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.392 -0.817 . . . . 1.61 109.901 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.416 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 75.6 p -55.66 -24.23 32.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.996 -1.065 . . . . 1.21 110.083 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.74 -58.2 3.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.112 -0.993 . . . . 1.21 109.784 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -82.27 39.75 0.6 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.558 -0.904 . . . . 2.11 108.558 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.5 tp -104.43 133.48 49.24 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.794 -0.817 . . . . 1.29 108.794 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -93.26 103.51 15.76 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.142 -0.974 . . . . 2.81 108.752 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.37 -45.76 89.64 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.26 -0.9 . . . . 2.09 110.084 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -63.79 -28.48 69.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.967 -1.083 . . . . 2.86 112.207 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -92.51 -10.27 38.36 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.521 -1.362 . . . . 2.39 109.825 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 63.1 t -109.64 119.91 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.76 -1.2 . . . . 1.27 107.76 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 89.5 mt -89.26 4.92 47.15 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.201 -0.937 . . . . 2.17 111.422 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 171.26 173.65 38.43 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.134 -1.508 . . . . 0.52 109.679 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -137.4 129.99 29.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.372 -1.076 . . . . 0.55 108.84 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.3 mt -127.98 125.72 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.463 -0.94 . . . . 1.27 108.463 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 19.7 p -145.54 156.86 43.97 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.746 -1.221 . . . . 1.39 111.113 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 183' ' ' ALA . 0.7 OUTLIER -101.04 26.54 6.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.624 -0.673 . . . . 2.46 109.371 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -47.85 -172.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.364 1.078 . . . . 1.51 112.417 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.14 -55.17 4.89 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 111.062 -0.815 . . . . 2.23 111.062 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -160.5 -156.52 8.23 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 118.876 -1.63 . . . . 2.23 111.129 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 86.3 mtm180 -79.94 -10.06 59.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.696 -0.885 . . . . 6.44 109.918 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 60.6 p -74.6 3.14 8.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.153 -0.967 . . . . 4.09 109.477 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.9 t -76.85 133.37 39.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.859 . . . . 2.2 110.049 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -48.26 -50.68 28.82 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.3 -0.875 . . . . 1.15 110.026 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.7 t -58.26 -38.62 77.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.274 -0.891 . . . . 2.01 110.584 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 25.8 t -60.0 -40.16 88.26 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.0 -1.063 . . . . 1.93 110.288 -179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.17 -39.91 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 2.2 109.753 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.3 mtp -60.51 -41.58 94.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 1.32 110.901 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.1 95.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.547 -1.346 . . . . 1.3 109.673 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 66.9 mtt-85 -59.97 -47.54 85.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.108 -0.995 . . . . 3.38 109.952 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.5 m -76.57 -32.44 58.16 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.998 -1.063 . . . . 1.15 111.792 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 96.1 mt -79.98 -12.14 59.74 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.641 -1.287 . . . . 1.28 110.364 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 58.33 51.75 8.0 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.38 -0.825 . . . . 1.5 110.917 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.0 mt -127.44 131.94 24.09 Favored Pre-proline 0 N--CA 1.502 2.127 0 N-CA-C 108.892 -0.781 . . . . 1.37 108.892 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -43.45 123.53 3.65 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.937 1.758 . . . . 0.76 112.112 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.96 140.29 9.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.694 -1.254 . . . . 1.19 111.587 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.4 mt -122.84 141.74 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 107.155 -1.424 . . . . 1.31 107.155 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.7 m -124.88 -8.4 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 120.956 -1.09 . . . . 1.38 111.273 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.05 21.24 25.19 Favored Glycine 0 N--CA 1.501 3.024 0 N-CA-C 110.866 -0.894 . . . . 1.03 110.866 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.436 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.0 p -45.28 -43.79 10.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.891 -1.358 . . . . 1.38 110.048 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 93.01 -51.28 2.52 Favored Glycine 0 N--CA 1.5 2.935 0 C-N-CA 120.076 -1.059 . . . . 1.17 111.726 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.428 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 3.6 m -156.92 38.36 0.31 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.528 -1.571 . . . . 2.07 111.209 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.7 t -80.01 -31.26 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.024 -1.048 . . . . 1.35 108.518 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 55.6 p -58.79 -30.78 67.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.43 -0.794 . . . . 1.49 110.576 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 20.9 t -78.81 -17.94 54.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.926 -1.109 . . . . 2.16 109.731 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -98.64 -8.85 25.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.238 -0.914 . . . . 2.89 110.377 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 55.1 t -104.83 130.25 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.282 -0.886 . . . . 1.33 110.869 -178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -108.31 148.79 29.54 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.371 -1.344 . . . . 2.73 107.371 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.439 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 30.0 p-10 -59.97 136.99 58.18 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.101 -1.0 . . . . 2.7 110.901 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.9 m-20 82.59 -0.03 1.3 Allowed 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 116.187 -0.461 . . . . 2.38 111.547 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -74.04 158.54 34.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.418 -1.426 . . . . 2.09 108.385 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -99.29 119.56 38.12 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.385 -0.969 . . . . 1.45 108.385 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 80.7 mt -125.85 148.73 49.08 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.479 -0.763 . . . . 1.31 109.99 -179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 78.8 mt -116.16 129.97 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 107.086 -1.449 . . . . 1.29 107.086 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 40.6 tp -105.88 124.33 49.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.029 -1.045 . . . . 1.31 109.11 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.617 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 29.6 p-10 -87.95 -37.47 16.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.043 -1.036 . . . . 2.31 109.866 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.466 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 45.71 16.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.968 -0.752 . . . . 1.19 108.968 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.5 t -126.06 -41.19 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.497 -1.297 . . . . 1.45 107.497 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -106.53 -0.15 24.16 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.831 -1.174 . . . . 3.13 107.831 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.445 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 0.4 OUTLIER 61.69 49.66 4.83 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.401 0.619 . . . . 2.2 109.771 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.617 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 43.9 mt-30 -139.97 150.31 44.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.452 -0.78 . . . . 2.32 109.502 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.1 t -122.68 129.99 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.194 -1.039 . . . . 1.4 108.194 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -101.11 116.66 33.36 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.251 -0.906 . . . . 1.29 109.208 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 36.0 t -98.33 117.09 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.49 -0.756 . . . . 1.38 109.251 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 68.55 70.17 0.42 Allowed Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.27 -0.894 . . . . 2.33 109.408 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -89.79 118.27 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 123.376 2.717 . . . . 0.95 112.744 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.435 ' CG2' ' N ' ' A' ' 233' ' ' ASN . 96.4 m -67.97 170.52 8.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.174 -0.954 . . . . 2.31 108.989 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.435 ' N ' ' CG2' ' A' ' 232' ' ' THR . 11.9 m120 -59.84 -40.12 87.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.0 -1.062 . . . . 3.45 109.238 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.58 -39.91 92.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.838 . . . . 2.89 109.197 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.54 -42.74 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 1.73 109.882 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.7 -40.6 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.194 -0.941 . . . . 1.57 109.577 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 237' ' ' ASP . 50.0 t0 -60.01 -42.38 94.17 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.852 -1.155 . . . . 2.43 108.721 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -62.77 -45.72 91.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.89 . . . . 3.18 109.376 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 87.8 mtp -66.72 -31.98 72.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 1.59 109.652 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -68.85 -32.93 72.97 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.059 -1.026 . . . . 3.11 108.325 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.03 87.92 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.23 -0.919 . . . . 2.17 108.726 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 70.4 t -61.09 -40.93 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.887 -1.133 . . . . 2.51 108.106 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -60.05 -39.68 86.83 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.484 -0.932 . . . . 3.82 108.484 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.93 -31.7 70.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 1.78 109.02 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -59.98 -39.2 84.88 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.693 -1.225 . . . . 2.77 107.693 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 91.4 t -60.0 -40.0 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 107.92 -1.141 . . . . 2.25 107.92 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.97 -31.71 70.14 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.659 -0.867 . . . . 2.54 108.659 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 8.7 t -60.11 -39.2 85.39 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.619 -0.882 . . . . 3.03 108.619 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.97 -37.63 80.16 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.17 -1.418 . . . . 3.34 107.17 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -85.8 42.55 0.98 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.211 -1.403 . . . . 4.18 107.211 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -91.92 -0.69 57.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.964 -0.754 . . . . 4.43 108.964 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 56.97 25.91 11.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.79 -0.569 . . . . 5.42 109.892 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 98.2 mt -96.73 -18.13 19.84 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.123 -0.986 . . . . 6.11 109.435 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -88.37 -48.06 7.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 7.37 108.67 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 52.59 21.86 1.98 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.542 -0.724 . . . . 8.3 109.823 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 257' ' ' LYS . 40.7 mt 50.01 28.48 2.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.116 -0.99 . . . . 9.05 108.751 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 256' ' ' LEU . 52.1 mtpt 45.94 -172.23 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.43 0.634 . . . . 10.56 109.712 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -150.72 -123.05 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.281 -1.007 . . . . 11.32 108.281 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . 0.427 HH11 ' HG2' ' A' ' 259' ' ' ARG . 24.9 ttt-85 . . . . . 0 C--N 1.3 -1.57 0 CA-C-O 117.986 -1.007 . . . . 12.74 109.49 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 49.7 ttp . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.448 0.642 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -150.11 147.35 27.67 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -147.7 157.13 43.4 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.865 -1.147 . . . . 0.0 110.817 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -153.51 148.92 27.14 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -112.59 131.05 55.8 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.142 -0.974 . . . . 0.0 109.656 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.407 ' CG1' ' SD ' ' B' ' 381' ' ' MET . 1.9 p -132.79 125.15 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-O 122.146 0.974 . . . . 0.0 112.073 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 21.1 m -77.21 104.8 7.93 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.046 0.927 . . . . 0.0 110.766 -178.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' B' ' 358' ' ' GLY . 97.0 mt -52.81 124.64 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 122.429 1.109 . . . . 0.0 111.026 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 62.4 p -112.5 20.19 16.86 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.682 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -66.15 118.68 55.12 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.988 -1.07 . . . . 0.0 108.891 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -49.58 -26.07 12.05 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 CA-C-N 120.354 1.162 . . . . 0.0 112.718 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -120.52 17.58 12.09 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.642 -0.661 . . . . 0.0 109.352 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.76 179.75 32.74 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.469 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -87.86 94.8 9.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -1.223 . . . . 0.0 109.309 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -96.08 -160.43 0.79 Allowed 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.948 -1.095 . . . . 0.0 110.09 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 15.5 m -58.87 -42.79 90.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.076 -1.015 . . . . 0.0 112.546 -175.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.448 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.5 tpt180 -61.13 -61.41 8.02 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 120.452 -1.405 . . . . 0.0 112.119 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -59.3 -33.67 97.82 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 CA-C-N 120.394 1.176 . . . . 0.0 111.656 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.98 75.53 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.13 -41.4 65.01 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.474 -0.766 . . . . 0.0 109.801 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -69.97 -40.03 75.62 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.971 -1.08 . . . . 0.0 108.24 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -61.2 -52.47 64.65 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.2 -0.937 . . . . 0.0 110.432 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 94.7 t -62.79 -28.92 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.659 -1.275 . . . . 0.0 109.587 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -59.95 -44.6 94.3 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.537 -0.727 . . . . 0.0 109.041 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -67.65 -42.71 81.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.89 . . . . 0.0 111.378 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . 0.406 ' C ' ' H ' ' B' ' 328' ' ' GLY . . . -59.9 -53.89 52.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.556 -1.34 . . . . 0.0 110.97 -178.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 32.3 mttp -52.82 -12.57 0.32 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 109.768 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' B' ' 326' ' ' ALA . . . -77.74 -24.14 65.49 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -105.82 140.09 39.38 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.558 -0.966 . . . . 0.0 109.087 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 26.1 p -90.43 -10.93 41.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.109 -0.994 . . . . 0.0 109.926 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 79.7 p -67.49 152.36 45.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -0.939 . . . . 0.0 109.502 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.9 137.71 51.84 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.138 -0.976 . . . . 0.0 108.559 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 76.8 mt -131.85 132.68 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.666 -0.646 . . . . 0.0 109.293 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 24.0 m -129.52 148.67 51.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.552 -0.718 . . . . 0.0 109.089 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 70.0 t -123.19 116.16 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 45.9 m -105.57 130.35 53.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.304 -0.872 . . . . 0.0 109.337 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 43.2 t -139.32 119.07 13.17 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.028 0.918 . . . . 0.0 111.272 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 43.92 50.1 7.11 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.13 -14.41 60.78 Favored Glycine 0 N--CA 1.501 3.03 0 O-C-N 120.15 -1.594 . . . . 0.0 112.786 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -117.24 128.45 55.1 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-N 119.208 1.504 . . . . 0.0 110.082 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 80.3 p -126.33 148.33 49.57 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.774 0.797 . . . . 0.0 110.453 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -142.91 166.01 25.79 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 121.534 0.683 . . . . 0.0 110.145 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 25.1 m -87.25 133.62 33.65 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.473 -0.767 . . . . 0.0 110.377 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -72.63 -17.37 61.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.073 -1.017 . . . . 0.0 109.911 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -87.21 20.94 2.55 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.465 ' H ' ' C ' ' B' ' 344' ' ' ALA . 7.3 m -149.08 96.02 2.48 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.836 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 61.6 tp -58.16 -36.2 72.66 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -54.68 -54.01 47.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.796 -1.19 . . . . 0.0 110.193 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -71.3 -19.56 62.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.923 . . . . 0.0 111.699 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' B' ' 352' ' ' THR . 73.6 mt -71.01 -57.96 4.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.453 -1.404 . . . . 0.0 110.318 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.571 ' NE2' ' HE ' ' A' ' 126' ' ' ARG . 9.2 mm100 -43.16 -12.56 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.681 -0.637 . . . . 0.0 111.348 -176.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.571 ' N ' ' O ' ' B' ' 350' ' ' LEU . 77.1 p -86.01 -10.89 54.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.328 -1.483 . . . . 0.0 110.104 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 59.1 mt -92.74 117.98 30.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.03 -1.044 . . . . 0.0 109.021 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -71.96 90.24 0.49 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 23.7 mt -100.4 90.13 4.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.353 -1.086 . . . . 0.0 109.043 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 31.7 p -92.65 154.59 18.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.906 -1.121 . . . . 0.0 110.436 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -50.87 119.34 3.82 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.611 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 102.09 3.07 51.62 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 44.2 m -87.72 114.92 24.79 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.219 -1.165 . . . . 0.0 111.852 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.99 115.16 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 122.171 0.986 . . . . 0.0 109.939 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 14.5 m -110.49 177.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 22.5 m -130.53 129.3 42.68 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 48.5 mt -102.64 112.95 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 69.2 p -118.62 131.05 56.18 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.157 -0.964 . . . . 0.0 109.287 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.15 151.28 39.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.201 -0.937 . . . . 0.0 109.627 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -146.45 125.93 13.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.346 -0.846 . . . . 0.0 109.394 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.534 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.05 -156.24 26.92 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.496 -1.335 . . . . 0.0 111.182 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.03 -50.71 72.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.109 -0.642 . . . . 0.0 112.271 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -106.42 11.36 30.91 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.868 -1.145 . . . . 0.0 111.336 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.9 pt-20 -44.75 -35.7 2.83 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.986 -1.071 . . . . 0.0 111.117 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -70.53 -42.67 70.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.926 -1.109 . . . . 0.0 110.026 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.95 -48.97 66.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.397 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -46.61 -75.13 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.432 -0.792 . . . . 0.0 110.882 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 32.6 t -44.66 -34.81 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.068 -1.02 . . . . 0.0 110.942 -177.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -66.47 -46.09 77.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.421 -1.424 . . . . 0.0 110.301 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -80.37 -42.31 23.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.766 -1.209 . . . . 0.0 109.742 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 109.485 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 44.0 t -61.95 -42.0 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.003 -1.061 . . . . 0.0 109.51 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -69.89 -55.1 10.61 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.451 -1.3 . . . . 0.0 107.909 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 48.8 tp -57.56 -35.07 69.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.231 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 381' ' ' MET . . . . . 0.407 ' SD ' ' CG1' ' B' ' 306' ' ' VAL . 39.6 ttm -70.46 -39.94 74.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.217 -1.552 . . . . 0.0 108.359 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.49 -4.83 58.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.586 -0.696 . . . . 0.0 110.335 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -113.6 -3.39 13.63 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.034 -1.041 . . . . 0.0 111.072 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 13.7 mt -79.29 135.36 36.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.331 -1.481 . . . . 0.0 109.437 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.497 -179.572 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 mmt . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.466 -0.568 . . . . 3.19 109.466 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.415 HD11 HG22 ' A' ' 2' ' ' ILE . 85.5 mt -110.18 129.69 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.689 -0.856 . . . . 1.71 108.689 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.9 m -138.37 119.49 14.52 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.288 -0.883 . . . . 1.66 109.05 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.81 -162.02 36.64 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.123 -1.591 . . . . 1.05 109.123 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 5' ' ' ILE . 97.2 mt -93.5 -9.91 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.046 -1.267 . . . . 1.59 110.058 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.8 tp 54.94 96.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.18 -0.95 . . . . 1.47 109.184 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.66 -40.15 73.17 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.665 -0.865 . . . . 1.39 108.665 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 3.4 p -145.9 143.22 19.05 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.482 -0.761 . . . . 2.09 109.049 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.52 143.17 16.89 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.21 1.94 . . . . 0.91 112.705 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 165.45 -163.88 36.88 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.299 -1.52 . . . . 0.92 109.299 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.1 mt -149.34 149.69 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.051 -1.264 . . . . 1.35 108.332 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.88 151.62 31.52 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.954 -1.091 . . . . 1.14 110.183 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.5 m-85 -134.88 125.27 26.43 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.391 -0.966 . . . . 0.7 108.391 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.75 179.32 47.11 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 118.87 -1.633 . . . . 0.58 110.607 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -76.96 154.73 33.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.759 -0.848 . . . . 2.63 109.006 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.02 136.52 39.8 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.336 -0.852 . . . . 1.27 111.052 -178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.1 tp -104.99 133.28 50.05 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.533 -1.284 . . . . 1.41 107.533 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 64.4 tp -115.14 122.27 45.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.252 -0.905 . . . . 1.49 110.222 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.7 mt -88.71 100.51 13.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.677 -0.639 . . . . 1.52 109.761 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -86.84 139.51 30.6 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.072 -1.084 . . . . 3.17 108.072 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -130.93 136.6 48.73 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.025 -1.047 . . . . 3.0 109.41 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -91.77 137.89 31.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.11 -0.994 . . . . 2.77 109.147 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.03 139.97 57.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 2.94 109.857 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.5 mt -82.51 130.11 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.449 -0.782 . . . . 1.46 109.597 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.5 t -97.21 128.16 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.231 -0.918 . . . . 1.7 110.066 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -109.98 130.05 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.746 -0.835 . . . . 1.54 108.746 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -82.03 127.03 32.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.091 -1.005 . . . . 1.81 110.355 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -89.96 -1.64 58.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.384 -0.823 . . . . 3.23 109.149 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.37 142.18 52.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 3.29 109.681 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -85.19 150.1 25.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.279 -0.888 . . . . 2.8 109.275 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.5 pt -91.09 164.56 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.162 -0.961 . . . . 1.43 110.072 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.2 p -89.55 170.59 10.37 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.425 -0.954 . . . . 1.54 108.425 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.32 -19.8 63.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.848 -1.158 . . . . 1.6 110.402 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -82.74 -24.02 33.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.776 -1.203 . . . . 2.56 107.925 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -81.88 -8.75 59.7 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.889 -0.782 . . . . 2.36 108.889 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.68 -53.85 39.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.089 -1.007 . . . . 1.43 108.646 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -62.79 -40.15 96.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 1.77 109.644 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -69.96 -40.07 75.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.079 -1.013 . . . . 3.32 109.976 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -67.09 -40.0 86.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.067 -1.021 . . . . 1.51 109.689 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.31 -46.44 96.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.92 -1.113 . . . . 1.41 108.34 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -60.07 -40.88 91.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.918 . . . . 1.81 108.941 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.413 HH11 ' HG2' ' A' ' 42' ' ' ARG . 52.1 mtt-85 -60.08 -45.98 91.09 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.897 -1.149 . . . . 3.26 107.897 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -60.07 -49.2 78.57 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.442 -0.786 . . . . 0.81 108.944 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.04 -47.72 84.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.287 -0.883 . . . . 1.59 108.7 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.7 t -61.8 -41.38 97.68 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.228 -1.027 . . . . 1.38 108.228 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.54 -49.77 73.39 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.819 -1.712 . . . . 0.87 108.819 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -65.38 -35.47 81.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.343 -1.093 . . . . 3.62 108.468 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.53 -47.71 72.83 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.356 -0.84 . . . . 1.43 109.097 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 50' ' ' ALA . 32.5 ttpt -63.5 -72.97 0.12 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.889 -1.124 . . . . 3.08 107.972 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.88 -34.0 0.1 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.298 -0.876 . . . . 1.33 111.34 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.5 t -57.22 -52.85 63.67 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.616 -1.303 . . . . 1.85 108.526 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.14 -40.07 78.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 1.35 110.914 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -64.65 -40.13 94.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.081 -1.012 . . . . 2.34 109.974 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.6 -40.02 95.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.854 -1.154 . . . . 2.2 108.487 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -62.1 -34.36 76.18 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.657 -0.868 . . . . 1.35 108.657 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -65.32 -42.96 92.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 1.34 109.086 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.07 -39.94 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.302 -0.873 . . . . 1.26 108.815 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -55.17 -49.71 71.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.618 -0.677 . . . . 1.7 109.38 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.1 m -56.86 -33.47 66.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.337 -0.852 . . . . 1.35 110.747 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -68.17 -38.63 82.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.891 -1.131 . . . . 2.08 109.869 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.07 -47.22 68.9 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.606 -0.684 . . . . 1.21 110.915 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.03 -52.15 50.98 Favored Glycine 0 N--CA 1.486 1.983 0 C-N-CA 119.79 -1.195 . . . . 0.75 110.283 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.03 -42.91 72.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.838 -1.389 . . . . 1.59 110.592 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.0 m -69.96 -58.43 3.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.129 -0.982 . . . . 1.41 112.232 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -95.62 -54.58 3.32 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.978 -1.076 . . . . 0.79 111.159 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.01 -160.49 26.72 Favored Glycine 0 N--CA 1.501 3.033 0 O-C-N 120.849 -1.157 . . . . 1.22 110.415 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -70.01 -22.94 63.06 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.481 -1.011 . . . . 5.81 110.311 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -59.9 -37.66 80.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 3.37 110.296 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.3 mmtt -98.59 -18.48 18.1 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.33 -0.856 . . . . 2.37 110.829 -179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -70.0 -42.79 72.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.575 -1.328 . . . . 1.65 110.542 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.52 -30.35 71.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 1.42 109.672 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.03 -43.64 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.104 -0.997 . . . . 1.43 109.943 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -66.03 -39.97 90.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.949 -1.094 . . . . 1.08 110.531 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -60.07 -39.98 87.93 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.808 -1.182 . . . . 1.37 108.949 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.06 -49.77 64.95 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.929 -1.669 . . . . 0.67 108.929 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -64.72 -41.22 96.14 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.368 -1.078 . . . . 1.99 108.852 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.431 HD11 HG22 ' A' ' 77' ' ' ILE . 82.8 mt -69.96 -42.58 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.114 -0.991 . . . . 1.22 109.214 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.31 -39.98 88.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.985 -1.072 . . . . 2.11 109.737 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.455 ' CD1' ' CZ ' ' B' ' 348' ' ' PHE . 59.1 tp -66.56 -40.03 88.83 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.503 -0.748 . . . . 1.33 109.806 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.4 tp -60.05 -40.09 88.22 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.638 -0.825 . . . . 1.29 109.155 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -82.64 10.03 8.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.272 -0.893 . . . . 1.47 109.55 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 55.8 t0 -59.94 133.27 55.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.892 . . . . 1.47 110.421 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.468 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 96.7 mt-10 -59.91 -16.04 26.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.699 -0.625 . . . . 1.78 110.445 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -70.05 -37.46 75.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.969 -1.082 . . . . 2.53 108.859 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -73.69 -43.66 58.72 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.461 0.648 . . . . 1.36 110.642 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -59.95 -50.0 75.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.935 . . . . 1.42 110.851 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.51 -42.15 71.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.082 -1.011 . . . . 2.27 111.11 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.88 -39.97 72.54 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.058 -1.026 . . . . 1.57 112.273 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.04 -42.26 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.813 -1.179 . . . . 1.19 109.86 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.03 -39.29 77.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.584 -0.698 . . . . 1.39 110.303 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.93 -50.0 75.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.122 -0.986 . . . . 1.39 111.723 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.94 -44.3 94.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.661 -1.275 . . . . 1.5 109.641 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.6 mt -61.77 -46.66 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -0.866 . . . . 1.29 108.883 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -70.02 -40.98 74.88 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.924 -0.71 . . . . 2.64 110.74 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -82.24 -51.88 7.5 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.071 -1.018 . . . . 1.65 112.151 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.07 -3.16 58.1 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.961 -1.087 . . . . 2.5 111.684 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.2 m170 57.62 38.58 27.8 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.954 -1.091 . . . . 1.88 109.78 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.0 mtp -89.3 169.94 11.0 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.476 -0.765 . . . . 1.71 110.015 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 72.7 p -79.9 159.73 26.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.921 . . . . 1.61 109.664 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.03 -40.04 75.4 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.46 -0.775 . . . . 1.33 109.99 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 31.4 p-10 -69.49 -38.82 77.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.14 -0.975 . . . . 2.07 110.229 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.02 -40.67 23.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.972 -1.08 . . . . 1.37 109.933 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.11 -47.43 61.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 1.14 110.623 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.87 92.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.003 -1.061 . . . . 1.26 110.008 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -59.94 -38.6 82.88 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.289 -0.882 . . . . 2.02 110.406 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.0 -39.95 93.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.017 -1.052 . . . . 1.33 110.682 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.7 t -64.76 -50.14 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.938 -1.101 . . . . 1.3 110.815 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.17 -39.92 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.873 -1.142 . . . . 1.32 108.599 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -66.36 -37.42 85.26 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.718 -0.845 . . . . 2.44 108.718 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.44 ' O ' ' OG ' ' A' ' 113' ' ' SER . . . -60.07 -49.9 73.5 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 120.547 -0.835 . . . . 0.99 111.019 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -66.0 -50.43 64.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.503 -1.586 . . . . 1.97 109.746 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.15 84.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.844 . . . . 1.43 109.693 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 110' ' ' GLY . 85.0 p -55.56 -39.75 71.03 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.062 -1.024 . . . . 2.12 109.0 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.43 ' N ' ' HG ' ' A' ' 113' ' ' SER . . . -69.91 -31.36 69.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.913 . . . . 1.64 109.883 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.4 mt -69.93 -41.15 74.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.784 -1.197 . . . . 1.93 110.235 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -69.33 -22.57 63.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.131 -1.606 . . . . 2.2 109.367 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -59.85 -20.58 57.9 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.387 -1.338 . . . . 2.12 107.387 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 35.0 mt -62.94 140.06 58.81 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.106 -1.072 . . . . 2.34 108.106 178.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -85.76 41.51 0.91 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.952 -1.093 . . . . 3.23 109.134 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 53.3 t0 -131.96 142.46 49.63 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.575 -0.703 . . . . 2.49 109.707 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.499 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 81.6 mm-40 -73.87 -65.33 0.85 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.799 0.809 . . . . 3.95 108.835 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.633 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 4.1 t80 -39.28 -42.33 1.0 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.937 -0.477 . . . . 2.25 111.082 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.482 ' CD2' HH22 ' A' ' 126' ' ' ARG . 66.1 mt -70.56 -40.04 73.58 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.561 -1.337 . . . . 2.27 108.225 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 121' ' ' GLU . 62.8 tttp -68.67 -33.69 74.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.545 -0.722 . . . . 3.31 109.491 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 187' ' ' THR . 69.1 mm-40 -59.99 -44.9 94.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.806 -1.184 . . . . 2.73 109.629 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.633 ' NH1' ' CE1' ' A' ' 122' ' ' TYR . 20.5 mtm-85 -69.97 -30.36 67.7 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.895 -1.128 . . . . 3.2 108.592 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.89 -28.08 67.26 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.888 -1.153 . . . . 1.66 107.888 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.91 -38.88 69.85 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.158 -1.053 . . . . 1.67 108.158 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.85 -40.08 94.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 1.55 110.229 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.01 -40.0 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.993 -1.067 . . . . 1.32 108.446 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -60.01 -38.68 83.37 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.48 -0.933 . . . . 3.58 108.48 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -59.98 -37.43 79.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.567 -0.708 . . . . 1.46 109.545 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.98 -41.84 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 1.22 110.253 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.35 -31.75 53.74 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.574 -1.298 . . . . 0.61 110.354 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -60.05 -49.9 75.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.121 -1.223 . . . . 3.1 110.129 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -65.41 -31.99 73.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.912 -1.117 . . . . 3.71 109.829 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.89 -40.03 87.33 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.674 -0.862 . . . . 1.87 108.674 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.6 mt -61.03 -40.06 92.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 1.29 109.287 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.428 HH11 ' HG2' ' A' ' 139' ' ' ARG . 46.8 mtt-85 -65.44 -39.76 92.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 3.05 108.908 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -67.0 -33.38 75.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.606 -0.684 . . . . 1.26 111.759 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.03 -39.91 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.29 -1.507 . . . . 1.34 109.409 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.1 mt -77.26 -21.05 54.28 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.774 -0.77 . . . . 1.6 110.275 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.9 37.15 13.55 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.343 -1.903 . . . . 0.96 108.343 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 tp -73.1 140.83 47.42 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.591 -0.947 . . . . 1.67 108.761 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -73.92 138.38 44.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 4.96 109.613 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.1 mt -107.0 135.01 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-O 122.262 1.03 . . . . 1.68 110.065 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 148' ' ' ASP . 11.4 mt -69.52 -39.92 79.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.396 -0.82 . . . . 2.14 110.651 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 147' ' ' ILE . 48.9 t0 60.17 125.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.565 -0.709 . . . . 1.5 109.651 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.447 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 43.0 mt -83.84 -3.41 57.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.24 -0.912 . . . . 1.39 109.783 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.6 m -81.79 -12.9 58.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.135 -0.978 . . . . 1.83 109.188 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.72 27.97 0.28 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.575 -0.703 . . . . 1.46 110.418 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.447 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 57.9 mt -91.29 119.88 39.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.123 -0.986 . . . . 1.42 109.739 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -101.38 -9.49 21.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.297 -0.877 . . . . 2.94 109.997 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -139.17 158.38 44.28 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.072 -1.018 . . . . 1.52 110.207 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.73 138.59 58.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.864 . . . . 1.58 109.026 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 24.6 m -153.12 166.24 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.439 -0.788 . . . . 1.32 109.772 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.7 mt -96.63 146.15 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 105.415 -2.069 . . . . 1.27 105.415 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 45.7 tp -95.94 116.81 29.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.907 -1.12 . . . . 1.41 110.461 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.9 t -120.03 127.92 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.684 -1.228 . . . . 1.23 107.684 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -158.97 164.5 35.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.997 -1.064 . . . . 1.32 108.903 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.29 -35.11 68.6 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.405 -1.434 . . . . 1.49 108.806 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 58.5 t0 -170.51 146.48 2.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.366 -0.834 . . . . 2.25 109.586 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.515 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 39.3 mt -118.36 140.03 50.45 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.274 -0.891 . . . . 1.35 109.75 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.6 p -101.91 151.59 38.01 Favored Pre-proline 0 N--CA 1.5 2.075 0 O-C-N 121.351 -0.843 . . . . 1.56 109.785 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -40.26 -40.11 2.84 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.652 2.235 . . . . 0.87 113.233 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.8 m -59.96 -40.01 87.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 1.36 109.7 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.31 -40.6 86.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.125 -0.984 . . . . 1.61 110.375 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 67.3 p -58.73 -32.79 69.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.107 -0.995 . . . . 1.21 111.311 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.64 -49.63 51.95 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.693 -1.254 . . . . 1.21 109.966 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -86.99 38.08 0.79 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.919 -1.141 . . . . 2.11 107.919 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.9 tp -106.28 130.3 54.16 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.002 -0.74 . . . . 1.29 109.002 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -84.06 105.39 14.89 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.482 -0.933 . . . . 2.81 108.482 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.49 -40.53 93.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.808 . . . . 2.09 110.816 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -69.81 -23.1 63.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.779 -1.201 . . . . 2.86 111.836 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -93.31 -8.64 41.48 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.669 -1.27 . . . . 2.39 110.003 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 90.1 t -110.03 119.97 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.541 -0.911 . . . . 1.27 108.541 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 65.9 mt -90.65 6.61 43.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.294 -0.879 . . . . 2.17 110.476 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.58 170.39 36.3 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.279 -1.528 . . . . 0.52 109.279 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -129.98 129.09 43.3 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.508 -0.995 . . . . 0.55 108.834 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 72.7 mt -131.05 121.85 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.546 -0.909 . . . . 1.27 108.546 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.3 p -142.5 156.68 45.17 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.332 -0.855 . . . . 1.39 111.197 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.464 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 94.3 m-20 -90.09 18.61 5.69 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.596 -0.69 . . . . 2.46 109.266 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.37 -162.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.872 -1.143 . . . . 1.51 111.355 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -102.51 -33.99 4.3 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.527 -1.029 . . . . 2.23 110.527 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 157.24 -143.1 9.2 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 118.822 -1.656 . . . . 2.23 111.235 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -59.96 -28.39 67.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.826 -0.808 . . . . 6.44 110.692 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' THR . . . . . 0.431 ' O ' ' OE1' ' A' ' 125' ' ' GLU . 61.4 p -59.99 -10.27 3.98 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.991 -1.068 . . . . 4.09 109.145 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.5 t -91.64 124.66 35.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 2.2 109.41 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 62.0 t60 -48.05 -49.76 30.26 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.034 -1.041 . . . . 1.15 109.868 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.19 -40.48 64.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.32 -0.863 . . . . 2.01 110.358 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 56.1 m -60.04 -40.0 87.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.958 -1.089 . . . . 1.93 110.529 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.6 mm -61.12 -43.58 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.288 -0.882 . . . . 2.2 110.115 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.4 mtp -62.87 -40.06 96.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 1.32 110.681 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.92 78.11 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.58 -1.325 . . . . 1.3 109.054 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -60.03 -49.92 75.78 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.413 -0.805 . . . . 3.38 110.089 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.0 m -72.75 -33.44 66.35 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.086 -1.009 . . . . 1.15 110.534 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.7 mt -71.55 -26.82 62.79 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.144 -0.973 . . . . 1.28 108.384 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 61.45 50.57 4.57 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.978 -0.451 . . . . 1.5 110.833 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.44 ' O ' ' OG ' ' A' ' 8' ' ' SER . 73.4 mt -124.36 146.88 53.38 Favored Pre-proline 0 N--CA 1.505 2.307 0 N-CA-C 108.792 -0.818 . . . . 1.37 108.792 178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -45.06 121.83 3.9 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.829 1.686 . . . . 0.76 111.715 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -158.18 136.78 11.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.382 -1.449 . . . . 1.19 111.966 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 61.6 mt -121.03 145.32 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 106.691 -1.596 . . . . 1.31 106.691 177.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.5 -7.19 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.731 -1.231 . . . . 1.38 111.287 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -106.4 22.61 30.42 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.874 -1.29 . . . . 1.03 109.874 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.464 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 2.0 p -51.16 -41.41 60.13 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.051 -1.264 . . . . 1.38 110.333 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.407 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 84.67 -77.15 2.14 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.667 -1.254 . . . . 1.17 111.781 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 79.5 p -125.13 27.68 6.59 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 121.253 -1.145 . . . . 2.07 112.882 -177.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.96 -40.89 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.295 -1.503 . . . . 1.35 109.123 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 12.4 p -52.64 -26.75 14.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.878 . . . . 1.49 110.222 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.2 m -80.42 -15.83 55.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.016 -1.053 . . . . 2.16 109.931 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -103.78 -9.54 18.98 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.364 -0.835 . . . . 2.89 110.257 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 63.3 t -110.4 134.61 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.404 -0.81 . . . . 1.33 111.645 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -113.87 150.69 33.26 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.362 -1.348 . . . . 2.73 107.362 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 8.8 p30 -54.51 139.49 37.64 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.815 -1.178 . . . . 2.7 109.983 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.8 m-20 83.53 10.72 0.48 Allowed 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 121.19 0.519 . . . . 2.38 110.188 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.8 t0 -80.06 139.88 36.73 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.334 -0.853 . . . . 2.09 109.407 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.54 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 28.0 t80 -88.98 115.26 26.4 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.32 -0.993 . . . . 1.45 108.32 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 83.0 mt -127.78 149.23 50.35 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.49 -0.756 . . . . 1.31 110.505 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 85.6 mt -115.24 129.06 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 106.859 -1.534 . . . . 1.29 106.859 177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 26.1 tp -99.89 119.31 38.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.063 -1.023 . . . . 1.31 110.044 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.496 ' C ' ' N ' ' A' ' 223' ' ' VAL . 84.1 m-20 -76.47 -44.46 35.43 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.233 -0.917 . . . . 2.31 108.569 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 48.89 15.8 0.1 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.35 -0.982 . . . . 1.19 108.35 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.496 ' N ' ' C ' ' A' ' 221' ' ' ASP . 41.6 t -132.19 -46.12 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.293 -1.373 . . . . 1.45 107.293 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -97.8 0.51 46.95 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.469 -1.308 . . . . 3.13 107.469 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 60.07 45.35 12.01 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.036 -0.728 . . . . 2.2 109.036 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -138.68 150.07 45.81 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.402 -0.811 . . . . 2.32 109.83 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.0 t -121.08 130.01 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.615 -0.883 . . . . 1.4 108.615 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -98.1 119.91 37.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.317 -0.864 . . . . 1.29 108.955 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.9 t -100.35 113.52 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.632 -0.667 . . . . 1.38 109.981 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 8.1 t30 69.25 69.92 0.4 Allowed Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.439 -0.788 . . . . 2.33 109.425 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -90.8 126.39 1.17 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 123.588 2.858 . . . . 0.95 112.73 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 35.0 p -70.97 166.55 21.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.16 -0.963 . . . . 2.31 109.48 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -59.96 -40.0 87.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.27 -0.894 . . . . 3.45 110.558 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -59.94 -40.03 87.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 2.89 110.337 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.21 -40.01 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.985 -1.072 . . . . 1.73 109.49 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.84 -40.03 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.191 -0.943 . . . . 1.57 110.017 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -60.02 -47.19 86.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.102 -0.999 . . . . 2.43 108.596 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -60.39 -43.25 96.81 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.62 -0.675 . . . . 3.18 109.199 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 94.2 mtp -70.07 -33.57 72.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.858 . . . . 1.59 109.801 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -64.06 -40.07 95.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.107 -0.996 . . . . 3.11 109.665 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.35 78.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.15 -0.969 . . . . 2.17 109.426 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.01 -39.97 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.251 -0.905 . . . . 2.51 109.275 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.05 -41.7 92.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.274 -0.891 . . . . 3.82 110.539 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.88 -40.04 91.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.924 -1.11 . . . . 1.78 109.965 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -61.96 -40.03 94.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.192 -0.943 . . . . 2.77 109.516 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 86.2 t -63.81 -41.58 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.461 -0.775 . . . . 2.25 109.632 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.07 -38.74 83.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.361 -0.837 . . . . 2.54 109.314 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.8 t -60.02 -38.78 83.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.515 -0.741 . . . . 3.03 109.939 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -59.99 -40.03 87.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 3.34 109.743 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.477 ' O ' ' CD2' ' A' ' 253' ' ' LEU . 68.1 mttm -75.12 0.24 16.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.044 -1.035 . . . . 4.18 109.674 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.428 ' O ' ' OE2' ' A' ' 252' ' ' GLU . . . -101.29 8.1 42.57 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.223 -0.923 . . . . 4.43 110.524 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 251' ' ' ALA . 40.3 mm-40 -129.05 40.07 3.69 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.145 -0.972 . . . . 5.42 109.654 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 255' ' ' LYS . 0.1 OUTLIER -67.79 -40.25 83.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.246 -0.909 . . . . 6.11 109.35 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.54 ' C ' ' H ' ' A' ' 256' ' ' LEU . . . 48.39 6.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.395 -0.816 . . . . 7.37 110.58 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.557 ' H ' ' C ' ' A' ' 253' ' ' LEU . 8.0 mtmp? 49.52 8.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.874 -1.141 . . . . 8.3 109.965 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.54 ' H ' ' C ' ' A' ' 254' ' ' ALA . 34.4 tp -101.54 -42.69 6.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.116 -0.99 . . . . 9.05 109.417 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -80.44 147.54 30.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.469 -0.769 . . . . 10.56 109.329 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 34.8 t0 57.76 67.1 1.0 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.147 -0.971 . . . . 11.32 108.956 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.963 -1.018 . . . . 12.74 109.649 179.996 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 10.9 ttt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.471 0.653 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -152.38 151.99 31.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 109.512 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -147.84 158.84 44.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.128 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . 0.43 ' NE2' ' OE2' ' B' ' 305' ' ' GLU . 54.3 tp60 -152.51 148.32 27.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . 0.486 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 1.4 pm0 -114.9 133.49 55.94 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.266 -0.896 . . . . 0.0 110.103 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.31 123.69 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 CA-C-O 122.006 0.907 . . . . 0.0 112.22 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 35.9 m -78.01 105.47 9.23 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.972 0.892 . . . . 0.0 110.343 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.0 mt -51.66 122.15 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 122.434 1.111 . . . . 0.0 110.505 -177.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 19.3 p -107.36 18.87 21.05 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.226 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . 0.478 ' O ' ' CG ' ' B' ' 357' ' ' GLN . . . -74.94 133.21 76.12 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.048 -1.032 . . . . 0.0 108.329 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -69.99 -13.13 33.7 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 CA-C-N 120.161 1.093 . . . . 0.0 112.298 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -120.67 8.94 10.68 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.436 -0.79 . . . . 0.0 109.619 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.55 179.95 32.39 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.483 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.6 tp -86.92 93.12 9.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.079 -1.248 . . . . 0.0 109.641 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -96.54 -159.78 0.75 Allowed 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.138 -0.976 . . . . 0.0 110.204 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.2 m -57.12 -45.11 83.74 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.17 -0.956 . . . . 0.0 112.816 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.452 HH11 ' HG2' ' B' ' 317' ' ' ARG . 3.1 tpt180 -61.59 -61.46 7.8 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 120.571 -1.33 . . . . 0.0 112.166 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -59.69 -31.91 94.95 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 120.335 1.155 . . . . 0.0 111.797 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.03 -50.29 74.32 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -50.81 -40.89 56.68 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.432 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . 0.436 ' NE2' ' NE ' ' B' ' 317' ' ' ARG . 56.8 mt-30 -69.95 -40.19 75.59 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.16 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -61.99 -52.61 63.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.466 -0.771 . . . . 0.0 110.483 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 86.4 t -69.21 -32.35 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.729 -1.232 . . . . 0.0 110.005 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -59.98 -47.55 85.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.226 -0.921 . . . . 0.0 110.038 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.99 -42.36 73.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.077 -1.014 . . . . 0.0 110.819 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.71 -54.02 11.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.746 -1.222 . . . . 0.0 110.011 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -49.96 -17.34 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.573 -0.704 . . . . 0.0 109.619 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.16 -17.88 79.72 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -106.09 147.2 29.21 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.289 -1.124 . . . . 0.0 109.067 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 3.6 t -90.49 -13.05 35.5 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.065 -1.022 . . . . 0.0 109.831 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 331' ' ' SER . . . . . 0.649 ' HG ' ' N ' ' B' ' 369' ' ' ASP . 52.8 m -58.04 144.09 41.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 0.0 109.673 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -67.7 131.59 45.86 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.6 mt -132.61 132.68 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.47 -0.769 . . . . 0.0 109.645 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 50.7 m -128.93 148.88 50.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.448 -0.782 . . . . 0.0 109.328 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.96 114.99 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 55.2 m -103.15 123.53 46.87 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.246 -0.909 . . . . 0.0 108.818 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 47.8 t -136.58 120.29 17.3 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.003 0.906 . . . . 0.0 111.639 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 49.45 49.2 20.25 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 86.05 -11.13 63.46 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 119.863 -1.773 . . . . 0.0 112.438 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -122.59 133.45 54.55 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.008 -1.289 . . . . 0.0 109.503 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 14.8 m -128.46 150.24 50.23 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.973 0.892 . . . . 0.0 110.713 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -145.69 168.02 21.7 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.539 0.685 . . . . 0.0 109.825 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 28.6 m -89.06 139.6 30.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.518 -0.739 . . . . 0.0 110.136 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -77.64 -15.87 58.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 108.985 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -87.19 17.19 4.46 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.467 ' H ' ' C ' ' B' ' 344' ' ' ALA . 49.8 m -145.71 95.34 2.63 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.045 -179.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 59.5 tp -60.03 -38.29 82.3 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . 0.455 ' CZ ' ' CD1' ' A' ' 79' ' ' LEU . 59.9 m-85 -55.22 -51.65 65.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.076 -1.015 . . . . 0.0 110.849 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.447 ' O ' ' OG1' ' B' ' 352' ' ' THR . 19.2 mtmm -69.11 -39.92 78.67 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.767 -1.208 . . . . 0.0 109.799 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' B' ' 352' ' ' THR . 36.8 mt -48.18 -58.28 4.75 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.836 -1.165 . . . . 0.0 109.35 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.604 HE22 ' HE ' ' A' ' 126' ' ' ARG . 73.9 mm-40 -38.37 -23.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.523 -0.736 . . . . 0.0 111.355 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.522 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.6 p -80.09 -13.14 59.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.753 -1.217 . . . . 0.0 110.876 -178.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 27.5 mt -93.25 119.29 32.25 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.682 -1.262 . . . . 0.0 109.32 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.23 94.0 1.12 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 21.0 mt -101.67 92.05 4.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.336 -1.096 . . . . 0.0 108.835 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 74.3 p -92.22 175.22 6.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.217 -0.927 . . . . 0.0 110.608 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . 0.478 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 15.2 tm0? -63.92 111.32 2.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.742 -0.599 . . . . 0.0 110.926 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 102.12 9.97 40.73 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 51.9 m -84.74 111.79 19.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.225 -1.162 . . . . 0.0 110.514 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 20.1 t -76.74 115.32 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.277 1.037 . . . . 0.0 109.732 -177.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 10.8 m -111.9 176.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 56.0 m -131.9 129.19 40.01 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.5 mt -103.41 117.41 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 61.4 p -120.3 132.92 55.51 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.26 151.92 38.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.006 -1.059 . . . . 0.0 110.589 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -144.82 122.84 12.07 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.456 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 159.55 -158.61 29.77 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.02 -1.562 . . . . 0.0 111.596 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.07 -51.7 68.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.049 -0.677 . . . . 0.0 112.524 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.649 ' N ' ' HG ' ' B' ' 331' ' ' SER . 91.7 m-20 -109.65 13.59 23.76 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.796 -1.19 . . . . 0.0 111.047 -177.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -44.39 -36.68 2.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.033 -1.042 . . . . 0.0 111.278 -178.679 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . 0.533 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 78.1 mt-30 -70.02 -41.7 73.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.855 -1.153 . . . . 0.0 109.816 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -68.06 -49.52 60.85 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.685 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' B' ' 374' ' ' VAL . . . -50.18 -74.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.325 -0.86 . . . . 0.0 110.95 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . 0.4 ' C ' ' O ' ' B' ' 373' ' ' ALA . 38.9 t -44.1 -40.01 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -65.46 -45.76 82.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.793 -1.192 . . . . 0.0 110.171 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -80.41 -43.42 21.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.945 -1.097 . . . . 0.0 110.132 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 98.6 mt -59.99 -37.77 80.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.081 -1.012 . . . . 0.0 108.872 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 30.7 t -61.32 -40.96 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.088 -1.008 . . . . 0.0 108.8 178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' B' ' 383' ' ' GLU . 62.0 mttp -67.92 -55.32 13.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.849 -1.157 . . . . 0.0 108.21 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 59.6 tp -57.82 -36.26 72.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.008 -1.057 . . . . 0.0 109.285 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 38.1 ttm -74.56 -41.53 60.38 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.99 -10.0 59.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.27 -0.894 . . . . 0.0 109.415 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' B' ' 379' ' ' LYS . 71.3 mm-40 -108.19 10.43 27.92 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.512 -0.742 . . . . 0.0 110.966 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 16.6 mt -66.19 109.55 2.67 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.416 -1.428 . . . . 0.0 109.181 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.499 1.98 0 CA-C-O 118.003 -0.999 . . . . 0.0 108.927 179.524 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.136 -0.69 . . . . 3.19 109.136 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.7 mt -110.07 126.82 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.481 -0.762 . . . . 1.71 109.125 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.3 m -130.01 138.6 50.88 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.092 -0.707 . . . . 1.66 109.092 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.49 -161.92 19.43 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.221 -1.552 . . . . 1.05 109.221 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.7 mt -89.54 -18.55 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -1.211 . . . . 1.59 109.877 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 5' ' ' ILE . 62.6 tp 51.02 103.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.348 -0.845 . . . . 1.47 109.69 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.94 -29.39 12.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.254 -0.904 . . . . 1.39 109.037 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 64.8 m -119.67 115.87 33.5 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.513 -0.742 . . . . 2.09 109.47 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.64 146.46 16.89 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.029 1.819 . . . . 0.91 112.249 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.501 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 151.18 -152.13 23.98 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.878 -1.689 . . . . 0.92 108.878 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.5 mt -150.31 151.52 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 120.768 -1.43 . . . . 1.35 108.801 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.1 150.83 32.25 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.908 -1.12 . . . . 1.14 110.545 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -133.74 125.32 28.31 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.821 -1.178 . . . . 0.7 107.821 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.52 177.39 47.15 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 118.476 -1.821 . . . . 0.58 110.999 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 157' ' ' ILE . 85.2 mttt -79.87 160.02 26.21 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.831 -0.805 . . . . 2.63 108.905 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -105.44 134.89 47.81 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.355 -0.841 . . . . 1.27 111.527 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.1 tp -101.48 138.72 38.12 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.352 -1.351 . . . . 1.41 107.352 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.8 tp -118.64 124.9 48.53 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.156 -0.965 . . . . 1.49 110.199 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.8 mt -93.14 103.45 15.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.8 -0.563 . . . . 1.52 110.189 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.422 ' HZ1' ' CB ' ' A' ' 20' ' ' LYS . 9.3 mtpm? -98.66 133.06 43.52 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.388 -0.967 . . . . 3.17 108.388 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -130.07 128.23 41.5 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.62 -0.882 . . . . 3.0 108.62 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -75.46 149.83 38.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 2.77 109.901 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -69.13 143.12 54.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.486 -0.758 . . . . 2.94 108.992 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.2 mt -80.13 131.28 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 1.46 109.387 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 56.0 t -97.27 125.08 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.25 -0.906 . . . . 1.7 109.542 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.0 mt -107.9 135.32 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.434 -0.791 . . . . 1.54 108.921 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -93.87 121.13 35.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.12 -0.988 . . . . 1.81 109.699 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.473 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.8 mmt-85 -89.1 2.12 54.58 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.512 -0.742 . . . . 3.23 110.228 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -67.48 149.5 50.11 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.93 -1.106 . . . . 3.29 109.356 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -93.01 149.77 20.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.164 -0.96 . . . . 2.8 109.596 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.0 pt -96.44 167.7 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.213 -0.929 . . . . 1.43 110.246 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 61.8 p -100.66 176.2 5.39 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.484 -0.932 . . . . 1.54 108.484 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.85 76.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.156 -0.965 . . . . 1.6 110.695 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -58.05 -27.92 64.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.687 -1.258 . . . . 2.56 109.697 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -81.68 -11.01 59.25 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.34 -0.85 . . . . 2.36 109.808 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.5 t -62.91 -51.89 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.003 -1.061 . . . . 1.43 108.95 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.91 -40.11 96.59 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.247 -0.908 . . . . 1.77 110.113 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -66.28 -40.08 89.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.005 -1.059 . . . . 3.32 110.579 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -67.91 -40.07 83.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.778 -1.201 . . . . 1.51 110.302 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.04 -45.26 95.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 120.648 -1.283 . . . . 1.41 108.297 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -58.28 -39.9 80.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.997 -1.064 . . . . 1.81 108.594 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.433 HH11 ' HG2' ' A' ' 42' ' ' ARG . 44.5 mtt-85 -59.93 -43.68 94.81 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.287 -1.375 . . . . 3.26 107.287 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -63.5 -45.78 89.09 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.522 -0.736 . . . . 0.81 109.254 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.05 -50.08 75.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 1.59 108.567 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.7 t -63.45 -44.1 95.5 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.483 -0.887 . . . . 1.38 108.852 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.08 -43.33 99.57 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.859 -1.696 . . . . 0.87 108.859 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -67.44 -32.7 73.73 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.427 -1.043 . . . . 3.62 108.323 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.416 ' O ' ' OG ' ' A' ' 51' ' ' SER . . . -59.55 -40.99 89.06 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.508 -0.745 . . . . 1.43 109.348 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 34.6 ttpt -68.91 -74.73 0.12 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.953 -1.092 . . . . 3.08 108.447 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.1 -35.08 0.14 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.346 -0.846 . . . . 1.33 111.504 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 48' ' ' ALA . 95.5 p -57.46 -56.63 19.33 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.55 -1.26 . . . . 1.85 108.586 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.03 -40.74 75.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.419 -0.8 . . . . 1.35 111.413 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.41 -40.04 95.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.633 -1.292 . . . . 2.34 110.889 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.18 -40.01 93.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.848 -1.158 . . . . 2.2 109.367 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -60.01 -37.46 79.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 1.35 109.834 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.24 -40.55 96.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.078 -1.014 . . . . 1.34 110.198 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.407 HD12 HH22 ' A' ' 136' ' ' ARG . 96.8 mt -62.11 -39.94 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.25 -0.906 . . . . 1.26 109.58 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -59.5 -50.0 75.63 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.457 -0.777 . . . . 1.7 109.577 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.3 m -59.37 -39.5 83.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.99 -1.069 . . . . 1.35 110.097 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -64.35 -38.37 90.8 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.09 -1.006 . . . . 2.08 109.247 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.46 -43.98 92.52 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.594 -0.691 . . . . 1.21 109.915 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.24 -50.04 66.08 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.836 -1.173 . . . . 0.75 110.174 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.13 -45.54 80.71 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.228 -1.16 . . . . 1.59 109.708 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.9 m -72.56 -57.9 3.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.327 -0.858 . . . . 1.41 112.306 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -94.81 -54.35 3.51 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.8 -1.187 . . . . 0.79 111.09 -177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.35 -169.18 25.54 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 119.692 -1.242 . . . . 1.22 111.464 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.07 -28.78 66.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 122.043 -0.681 . . . . 5.81 111.145 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.448 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 50.8 tp10 -61.47 -34.86 76.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.066 -1.021 . . . . 3.37 110.516 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -99.46 -21.01 16.15 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.202 -0.936 . . . . 2.37 110.22 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -66.84 -42.61 85.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.115 -0.991 . . . . 1.65 110.314 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.21 -32.21 73.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.514 -0.741 . . . . 1.42 110.53 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.1 -42.49 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.996 -1.065 . . . . 1.43 109.987 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -71.56 -34.19 69.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.977 -1.077 . . . . 1.08 109.951 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -59.94 -39.81 86.8 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.228 -0.92 . . . . 1.37 109.284 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.45 -42.31 97.64 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.209 -1.557 . . . . 0.67 109.209 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -60.25 -41.42 93.15 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.357 -1.084 . . . . 1.99 108.893 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.8 mt -70.03 -45.44 76.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.239 -0.913 . . . . 1.22 109.45 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.6 ttp -60.25 -40.6 90.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.111 -0.993 . . . . 2.11 109.935 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.2 tp -67.26 -39.3 86.09 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.256 -0.902 . . . . 1.33 109.198 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.41 -39.94 92.57 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.039 -0.726 . . . . 1.29 109.039 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -83.07 5.81 21.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.316 -0.865 . . . . 1.47 109.585 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -49.83 130.36 21.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.219 -0.926 . . . . 1.47 109.428 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.16 -21.32 61.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.381 -0.824 . . . . 1.78 111.699 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.13 -33.02 69.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.623 -1.298 . . . . 2.53 108.878 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.7 mt -70.42 -40.74 73.65 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.488 0.661 . . . . 1.36 109.827 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.13 -49.66 76.76 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.449 -0.782 . . . . 1.42 109.827 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -69.97 -41.16 74.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.407 -0.808 . . . . 2.27 111.243 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.05 -39.97 75.39 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.934 -1.104 . . . . 1.57 111.682 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.08 -44.37 81.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 120.831 -1.168 . . . . 1.19 109.767 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.03 -38.6 75.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.403 -0.811 . . . . 1.39 110.131 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.5 -45.06 88.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.272 -0.892 . . . . 1.39 111.672 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 66.3 mt -61.57 -45.97 91.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.706 -1.247 . . . . 1.5 109.56 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 57.1 mt -61.36 -47.66 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.906 0.86 . . . . 1.29 109.082 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -70.04 -40.0 75.41 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.039 -0.664 . . . . 2.64 110.652 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -81.46 -61.55 1.9 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.039 -1.038 . . . . 1.65 112.116 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -82.2 0.54 40.67 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.097 -1.002 . . . . 2.5 111.68 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 57.17 37.8 28.59 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.132 -0.98 . . . . 1.88 109.923 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 79.7 mtp -90.85 166.97 12.79 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.63 -0.668 . . . . 1.71 109.499 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.2 p -80.89 161.88 24.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.948 . . . . 1.61 109.274 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.31 -39.93 85.95 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.256 -0.902 . . . . 1.33 109.581 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -68.45 -37.38 80.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.268 -0.895 . . . . 2.07 109.42 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.56 -45.56 21.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 1.37 109.445 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.43 -48.89 75.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.486 -0.759 . . . . 1.14 109.766 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.08 -36.0 76.42 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 1.26 109.284 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.544 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 84.5 t60 -59.96 -40.71 89.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.381 -0.824 . . . . 2.02 109.511 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -65.04 -40.53 94.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.334 -0.854 . . . . 1.33 111.149 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.34 -57.19 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.085 -1.01 . . . . 1.3 111.767 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.5 mm -66.92 -40.04 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.82 -1.175 . . . . 1.32 109.01 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.544 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 88.0 tt0 -63.11 -40.09 96.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 2.44 108.678 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.28 -52.61 50.54 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.504 -0.855 . . . . 0.99 110.987 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -62.8 -48.95 76.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.803 -1.41 . . . . 1.97 109.375 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.35 88.79 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.16 -0.962 . . . . 1.43 109.014 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.2 m -59.97 -40.26 88.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.1 -1.0 . . . . 2.12 108.876 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.85 87.26 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.255 -0.903 . . . . 1.64 109.116 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.8 mt -64.84 -39.97 94.43 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.873 -1.142 . . . . 1.93 108.774 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -59.23 -30.92 68.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.054 -1.029 . . . . 2.2 109.306 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.0 -27.54 66.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.105 -0.997 . . . . 2.12 108.514 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 28.4 mt -62.32 143.76 56.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 2.34 109.283 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -97.42 52.57 1.12 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.154 -0.966 . . . . 3.23 109.531 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -136.12 133.05 36.86 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.252 -0.905 . . . . 2.49 109.811 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.533 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 45.1 mp0 -70.04 -30.72 68.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.367 -0.833 . . . . 3.95 110.061 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.459 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.9 t80 -69.9 -38.06 76.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.195 -0.941 . . . . 2.25 110.091 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 65.1 mt -77.57 -39.81 44.47 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.094 -1.004 . . . . 2.27 109.788 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -61.58 -43.72 98.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.96 . . . . 3.31 110.445 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -67.12 -41.09 86.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.92 -1.112 . . . . 2.73 109.755 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.577 ' CD ' HE22 ' B' ' 351' ' ' GLN . 27.4 ttp180 -60.08 -40.03 88.12 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.779 -1.193 . . . . 3.2 107.779 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.81 -23.14 67.12 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.418 -0.956 . . . . 1.66 108.418 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.9 -40.02 87.35 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.606 -1.257 . . . . 1.67 107.606 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -66.75 -40.42 88.28 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.008 -0.677 . . . . 1.55 109.916 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 59.5 t -62.4 -40.0 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.933 -1.104 . . . . 1.32 108.437 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.472 HH11 ' HG2' ' A' ' 131' ' ' ARG . 9.1 ttt-85 -63.37 -36.22 82.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.414 -0.804 . . . . 3.58 109.931 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.36 -40.15 85.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.224 -0.922 . . . . 1.46 109.59 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.94 -43.18 91.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.038 -1.039 . . . . 1.22 108.805 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.43 -45.37 96.53 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.678 -0.969 . . . . 0.61 110.678 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -60.03 -44.68 94.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -1.23 . . . . 3.1 110.831 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.407 HH22 HD12 ' A' ' 57' ' ' ILE . 60.2 mtp180 -69.22 -34.88 75.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.482 -1.386 . . . . 3.71 110.157 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.7 tp -59.8 -45.25 92.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.149 -0.969 . . . . 1.87 109.731 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.57 -39.84 92.59 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.119 -0.988 . . . . 1.29 108.87 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -67.2 -39.8 86.4 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.62 -0.675 . . . . 3.05 110.238 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -68.62 -25.54 64.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.137 -0.977 . . . . 1.26 111.383 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.72 -43.64 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.334 -1.479 . . . . 1.34 108.36 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.5 mt -69.94 -31.16 68.76 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.752 -0.592 . . . . 1.6 109.918 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.53 36.95 7.18 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.074 -1.61 . . . . 0.96 109.074 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 56.7 tp -73.2 143.0 47.35 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.432 -1.04 . . . . 1.67 109.229 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -60.7 144.98 51.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.369 -0.832 . . . . 4.96 109.877 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.2 mt -114.88 121.31 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.29 -1.004 . . . . 1.68 108.29 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.425 HG22 HD11 ' A' ' 147' ' ' ILE . 16.9 mm -52.98 -52.17 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.568 -0.707 . . . . 2.14 110.409 -177.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.8 t0 66.01 102.46 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.779 -0.822 . . . . 1.5 108.779 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.1 mt -73.34 -1.77 19.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.538 -0.726 . . . . 1.39 110.45 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.3 p -80.01 -11.54 59.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.899 -1.126 . . . . 1.83 109.343 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -88.37 21.05 3.01 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.615 -0.678 . . . . 1.46 111.448 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 48.9 mt -92.74 111.72 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.771 -1.205 . . . . 1.42 108.734 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -100.11 -8.45 23.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.195 -0.94 . . . . 2.94 111.165 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -117.22 147.43 42.51 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.152 -0.967 . . . . 1.52 110.176 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.38 131.35 46.95 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.979 -0.749 . . . . 1.58 108.979 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -152.42 164.72 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.506 -0.746 . . . . 1.32 109.515 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.435 ' N ' ' O ' ' A' ' 15' ' ' LYS . 97.0 mt -92.62 152.37 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 105.384 -2.08 . . . . 1.27 105.384 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.9 tp -101.23 120.07 39.69 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.976 -1.077 . . . . 1.41 111.131 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.51 129.93 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.898 -0.779 . . . . 1.23 108.898 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.03 163.44 36.37 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.37 -0.974 . . . . 1.32 108.37 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.07 -36.69 75.14 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.416 -1.427 . . . . 1.49 108.223 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -170.54 146.35 2.74 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.889 -0.782 . . . . 2.25 108.889 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.7 mt -115.09 131.18 57.01 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.309 -0.869 . . . . 1.35 110.382 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.4 p -93.4 151.75 40.49 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.467 -0.771 . . . . 1.56 109.226 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -39.76 -36.43 1.23 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 122.118 1.878 . . . . 0.87 112.52 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.3 m -58.12 -45.16 87.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 1.36 109.221 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -69.94 -42.6 73.02 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.096 -1.003 . . . . 1.61 109.991 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 27.5 p -57.42 -16.1 8.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.198 -0.939 . . . . 1.21 110.731 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -90.66 -51.8 5.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.827 -1.171 . . . . 1.21 110.043 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -85.39 42.18 0.94 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.001 -1.111 . . . . 2.11 108.001 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.7 tp -109.99 132.8 53.83 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.704 -0.851 . . . . 1.29 108.704 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.445 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 0.8 OUTLIER -91.23 108.52 19.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.226 -0.921 . . . . 2.81 109.285 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.75 -43.63 98.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.469 -0.77 . . . . 2.09 110.99 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -64.53 -23.58 67.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.924 -1.11 . . . . 2.86 111.957 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -93.58 -11.11 32.56 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.689 -1.257 . . . . 2.39 109.794 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 98.8 t -110.05 118.89 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.186 -0.946 . . . . 1.27 109.413 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.1 mt -89.87 6.38 42.13 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.142 -0.973 . . . . 2.17 111.248 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.22 170.11 37.8 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.169 -1.572 . . . . 0.52 109.169 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -132.67 128.88 37.96 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.269 -1.136 . . . . 0.55 109.901 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 98.4 mt -132.17 125.11 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.727 -0.842 . . . . 1.27 108.727 178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.1 p -143.21 157.94 44.06 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.22 -0.925 . . . . 1.39 110.625 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 183' ' ' ALA . 1.1 m-20 -99.2 22.69 10.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.557 -0.715 . . . . 2.46 109.803 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.513 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -45.41 -175.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.41 1.1 . . . . 1.51 112.586 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.71 -54.59 4.89 Favored Glycine 0 N--CA 1.492 2.412 0 O-C-N 121.527 -0.733 . . . . 2.23 111.315 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -149.97 -161.84 10.11 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 120.631 -1.511 . . . . 2.23 111.278 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.425 ' O ' ' OG ' ' A' ' 191' ' ' SER . 41.1 ttp180 -80.01 -9.87 59.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.789 -0.83 . . . . 6.44 110.205 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 64.0 p -79.94 4.85 15.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.97 . . . . 4.09 109.85 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.432 ' O ' ' OG ' ' A' ' 191' ' ' SER . 47.7 t -71.57 134.46 46.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.265 -0.897 . . . . 2.2 110.81 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -41.3 -60.84 1.15 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.528 0.68 . . . . 1.15 110.758 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.7 t -51.12 -33.65 27.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.189 -0.944 . . . . 2.01 110.452 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 188' ' ' SER . 28.0 p -60.0 -40.12 88.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.973 -1.08 . . . . 1.93 109.689 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.5 -40.09 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.823 . . . . 2.2 110.176 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 35.1 mtm -59.89 -49.27 78.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.808 -1.182 . . . . 1.32 110.494 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.08 -44.17 94.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.753 -1.217 . . . . 1.3 110.626 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -60.03 -52.07 66.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 3.38 110.459 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.2 m -70.94 -33.58 70.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.125 -0.984 . . . . 1.15 110.723 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.04 -22.99 59.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.018 -1.051 . . . . 1.28 109.652 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 66.45 52.37 1.07 Allowed 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.576 0.703 . . . . 1.5 110.543 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.414 ' O ' ' CB ' ' A' ' 8' ' ' SER . 62.9 mt -127.28 132.31 24.26 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 107.722 -1.214 . . . . 1.37 107.722 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -43.45 134.35 6.83 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.805 1.67 . . . . 0.76 112.317 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -166.85 145.35 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.71 -1.196 . . . . 1.19 111.824 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.5 mt -123.16 145.67 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.403 -1.332 . . . . 1.31 107.403 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.1 m -129.7 -12.24 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 120.795 -1.191 . . . . 1.38 111.143 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.72 24.86 22.72 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 110.06 -1.216 . . . . 1.03 110.06 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.427 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 6.3 p -46.32 -42.29 14.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.059 -1.259 . . . . 1.38 110.04 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.78 -57.36 4.66 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.947 -1.121 . . . . 1.17 111.308 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 24.5 m -150.8 32.78 0.61 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.56 -1.553 . . . . 2.07 111.786 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.0 t -70.15 -44.63 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.796 -1.19 . . . . 1.35 109.134 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.0 p -50.59 -29.96 12.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.54 -0.725 . . . . 1.49 111.33 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 29.6 t -69.97 -27.13 64.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.723 -1.236 . . . . 2.16 109.844 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -96.94 -7.02 34.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.151 -0.968 . . . . 2.89 110.53 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 73.8 t -105.93 132.15 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.249 -0.907 . . . . 1.33 110.912 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.439 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 9.9 mtpt -120.12 149.54 42.05 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.621 -1.252 . . . . 2.73 107.621 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.469 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 23.6 p-10 -50.07 138.65 15.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.11 -0.994 . . . . 2.7 111.326 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.469 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 8.3 t0 82.3 5.44 1.07 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 116.165 -0.47 . . . . 2.38 110.538 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 91.9 m-20 -77.56 143.49 38.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.965 -1.084 . . . . 2.09 108.877 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -92.28 119.93 32.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.183 -0.948 . . . . 1.45 108.587 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 86.4 mt -127.21 146.6 50.35 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.41 -0.806 . . . . 1.31 110.636 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.2 mt -118.75 129.28 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 107.193 -1.41 . . . . 1.29 107.193 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.6 tp -104.1 119.93 40.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.107 -0.995 . . . . 1.31 108.787 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.597 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 21.6 p-10 -79.78 -39.09 31.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.214 -0.929 . . . . 2.31 109.114 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 47.69 16.61 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.782 -0.822 . . . . 1.19 108.782 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 221' ' ' ASP . 47.6 t -126.28 -38.76 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.526 -1.287 . . . . 1.45 107.526 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -109.81 -1.1 18.08 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.797 -1.186 . . . . 3.13 107.797 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 61.45 49.97 4.92 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.369 0.604 . . . . 2.2 109.935 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.597 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 27.4 mt-30 -137.64 153.34 49.88 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.573 -0.705 . . . . 2.32 109.305 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.93 128.87 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.144 -0.687 . . . . 1.4 109.144 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -103.05 122.44 44.65 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.784 -1.191 . . . . 1.29 107.784 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.8 t -101.04 111.86 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.429 -0.794 . . . . 1.38 110.89 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 42.8 t30 49.96 63.5 10.02 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.318 -0.864 . . . . 2.33 110.318 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.4 150.2 15.1 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.705 2.27 . . . . 0.95 111.9 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 68.1 p -67.47 163.74 20.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.142 -0.974 . . . . 2.31 110.131 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -60.18 -40.2 89.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.5 -0.75 . . . . 3.45 110.19 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -62.05 -34.57 76.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -0.917 . . . . 2.89 109.997 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.78 -39.99 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.343 -0.848 . . . . 1.73 109.299 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 236' ' ' ILE . 89.7 mt -65.52 -39.91 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 1.57 109.404 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.91 -40.04 87.47 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.14 -0.975 . . . . 2.43 109.106 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -67.3 -40.29 86.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.032 -1.043 . . . . 3.18 109.101 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 94.9 mtp -70.09 -30.23 67.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 1.59 109.148 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.464 HH11 ' NE2' ' A' ' 243' ' ' GLN . 15.8 mmm180 -69.97 -38.03 75.94 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.359 -0.838 . . . . 3.11 109.378 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.85 -45.07 86.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.269 -0.894 . . . . 2.17 108.618 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.5 -40.15 87.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.654 -0.869 . . . . 2.51 108.654 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.464 ' NE2' HH11 ' A' ' 240' ' ' ARG . 12.8 tt0 -62.41 -39.53 93.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.499 -0.75 . . . . 3.82 110.482 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -57.86 -39.81 78.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.918 -1.114 . . . . 1.78 109.138 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -68.19 -41.22 81.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.151 -0.968 . . . . 2.77 108.861 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 73.4 t -68.03 -39.97 82.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.815 -0.809 . . . . 2.25 108.815 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 251' ' ' ALA . . . -59.99 -36.03 76.28 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.526 -0.734 . . . . 2.54 109.478 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 70.4 m -59.92 -40.41 88.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.099 -1.0 . . . . 3.03 108.965 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -60.84 -40.03 91.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.377 -0.827 . . . . 3.34 108.833 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.458 ' C ' ' H ' ' A' ' 252' ' ' GLU . 52.7 mtpt -124.84 53.78 1.46 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.758 -0.83 . . . . 4.18 108.758 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 247' ' ' ALA . . . -54.57 -7.16 0.14 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.625 -0.672 . . . . 4.43 110.482 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.458 ' H ' ' C ' ' A' ' 250' ' ' LYS . 56.0 tt0 63.04 3.06 1.15 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.319 -0.863 . . . . 5.42 109.857 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 93.3 mt -80.11 -69.6 0.58 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.722 -1.236 . . . . 6.11 107.768 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -138.79 -76.67 0.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.298 -1.001 . . . . 7.37 108.298 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -172.91 -2.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.398 -0.814 . . . . 8.3 110.963 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 13.2 tp 58.36 104.2 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.936 -1.103 . . . . 9.05 109.231 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -159.38 160.0 34.45 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.661 -0.65 . . . . 10.56 109.285 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 259' ' ' ARG . 35.4 p-10 -70.5 -37.61 74.22 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.979 -1.119 . . . . 11.32 107.979 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . 0.521 ' N ' ' OD1' ' A' ' 258' ' ' ASP . 19.7 mmt180 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.07 -0.966 . . . . 12.74 109.196 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 44.4 ttp . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.407 0.622 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -154.6 151.8 29.26 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -146.8 158.52 43.93 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.042 -1.036 . . . . 0.0 110.354 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . 0.495 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 7.4 tm0? -149.53 145.22 26.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.461 -0.774 . . . . 0.0 108.977 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . 0.495 ' N ' ' CD ' ' B' ' 304' ' ' GLN . 93.4 mt-10 -111.69 131.13 55.5 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.16 -0.963 . . . . 0.0 110.09 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 1.2 p -130.17 120.84 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.799 0.809 . . . . 0.0 111.31 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 86.3 m -73.88 113.88 11.55 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.217 1.008 . . . . 0.0 110.563 -178.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 60.9 mt -57.95 115.78 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 122.623 1.201 . . . . 0.0 111.317 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 67.5 p -111.72 19.95 17.54 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.643 -179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.95 124.4 90.67 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.888 -1.132 . . . . 0.0 109.206 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -55.27 -18.38 18.27 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 CA-C-N 120.154 1.091 . . . . 0.0 112.921 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -121.32 10.1 10.51 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.293 -0.879 . . . . 0.0 110.027 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.85 -178.21 40.31 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.459 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -87.11 93.65 9.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.151 -1.205 . . . . 0.0 110.301 -178.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -96.37 -160.63 0.81 Allowed 'General case' 0 N--CA 1.509 2.496 0 O-C-N 120.662 -1.274 . . . . 0.0 110.134 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 13.6 m -58.73 -45.05 90.48 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.93 -1.106 . . . . 0.0 112.064 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.464 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.4 tpt180 -53.13 -62.43 3.49 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 120.564 -1.335 . . . . 0.0 111.127 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -57.25 -32.7 94.38 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 CA-C-N 120.135 1.084 . . . . 0.0 112.184 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.85 76.07 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.488 -0.885 . . . . 0.0 108.901 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.46 -45.49 76.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.459 -0.775 . . . . 0.0 110.474 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . 0.644 HE22 ' NZ ' ' B' ' 324' ' ' LYS . 94.0 mm-40 -70.13 -40.04 75.08 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.879 -1.138 . . . . 0.0 108.641 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -61.07 -51.81 67.57 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.596 -0.69 . . . . 0.0 110.643 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . 0.555 ' CG1' ' HZ1' ' B' ' 327' ' ' LYS . 75.4 t -70.21 -33.1 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.775 -1.203 . . . . 0.0 110.017 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . 0.644 ' NZ ' HE22 ' B' ' 321' ' ' GLN . 32.3 ttpt -60.04 -46.36 89.78 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 108.878 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -62.32 -45.33 93.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.169 -0.957 . . . . 0.0 109.819 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.91 -50.93 71.84 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.207 -0.933 . . . . 0.0 110.742 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.555 ' HZ1' ' CG1' ' B' ' 323' ' ' VAL . 42.4 mttp -55.96 -14.37 2.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.981 -1.074 . . . . 0.0 109.456 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -68.99 -30.04 72.31 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -104.67 145.06 30.87 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.333 -1.098 . . . . 0.0 109.096 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 37.9 p -90.63 -11.8 38.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.017 -1.052 . . . . 0.0 109.547 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 331' ' ' SER . . . . . 0.404 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 81.1 p -60.01 153.4 21.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -0.844 . . . . 0.0 109.568 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -71.12 132.94 45.8 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.178 -0.951 . . . . 0.0 108.701 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.6 mt -129.78 129.95 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.669 -0.644 . . . . 0.0 109.458 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 30.6 m -126.61 150.05 49.13 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 92.1 t -115.15 137.47 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 56.7 m -130.07 122.57 28.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.281 -0.887 . . . . 0.0 109.157 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 83.1 p -136.1 119.5 16.86 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.805 0.812 . . . . 0.0 110.215 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 36.27 61.08 0.82 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.76 -15.34 20.69 Favored Glycine 0 N--CA 1.499 2.834 0 O-C-N 120.608 -1.307 . . . . 0.0 113.129 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -108.28 119.57 39.86 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 119.463 1.631 . . . . 0.0 109.642 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 66.1 m -118.74 142.24 47.88 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.812 0.815 . . . . 0.0 110.168 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.19 163.21 33.57 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.572 0.701 . . . . 0.0 109.779 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 4.7 t -87.97 140.01 29.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.475 -0.766 . . . . 0.0 109.318 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.449 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -82.35 -10.0 59.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.937 -1.102 . . . . 0.0 110.157 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -90.26 22.18 3.45 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.449 ' H ' ' C ' ' B' ' 344' ' ' ALA . 48.1 t -149.72 99.51 2.87 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.611 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.83 -31.89 70.15 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -59.87 -54.54 44.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.009 -1.057 . . . . 0.0 110.031 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -68.98 -24.1 64.19 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.079 -1.013 . . . . 0.0 111.717 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' B' ' 352' ' ' THR . 82.6 mt -68.01 -51.76 43.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.386 -1.446 . . . . 0.0 108.191 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.577 HE22 ' CD ' ' A' ' 126' ' ' ARG . 61.8 mm-40 -39.06 -26.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.65 -178.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.43 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.9 p -79.88 -7.07 58.52 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.69 -1.256 . . . . 0.0 110.717 -177.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 60.5 mt -92.52 109.33 20.73 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.956 -1.09 . . . . 0.0 109.308 178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.53 88.82 0.62 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.7 mt -97.24 90.13 5.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.219 -1.166 . . . . 0.0 109.165 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 28.9 p -96.4 142.81 28.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.096 -1.002 . . . . 0.0 110.076 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -44.99 119.98 2.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.695 -0.628 . . . . 0.0 110.187 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 114.44 -3.95 23.39 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 52.4 m -99.17 129.75 45.44 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.424 -1.044 . . . . 0.0 109.084 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 13.8 t -92.44 134.79 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 119.773 -1.829 . . . . 0.0 109.109 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 29.8 m -112.07 174.98 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 30.3 m -131.13 127.88 38.98 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 84.2 mt -100.91 114.26 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 88.3 p -119.89 132.81 55.66 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.521 -0.737 . . . . 0.0 109.035 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.28 154.45 41.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.352 -0.842 . . . . 0.0 109.494 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -146.64 124.49 11.95 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 159.52 -158.58 29.74 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 118.798 -1.668 . . . . 0.0 111.59 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -60.04 -53.67 55.05 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.404 ' H ' ' HB3' ' B' ' 331' ' ' SER . 95.8 m-20 -110.51 9.98 23.17 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.98 -1.075 . . . . 0.0 110.897 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -42.08 -32.29 0.45 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.234 -0.916 . . . . 0.0 111.634 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -69.98 -39.77 75.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.737 -1.227 . . . . 0.0 109.849 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -68.75 -52.26 32.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.959 . . . . 0.0 109.326 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.8 -32.94 6.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.394 -0.816 . . . . 0.0 111.248 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 84.2 t -75.74 -39.33 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.611 -1.305 . . . . 0.0 109.615 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.59 -49.86 75.83 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.346 -0.846 . . . . 0.0 111.804 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -77.46 -41.37 39.9 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.888 -1.132 . . . . 0.0 111.514 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' B' ' 381' ' ' MET . 87.9 mt -60.09 -41.43 92.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.724 -1.235 . . . . 0.0 108.543 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.46 -46.12 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.285 -0.884 . . . . 0.0 109.22 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' B' ' 383' ' ' GLU . 65.6 mttm -69.99 -55.81 8.61 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 58.7 tp -57.64 -35.85 71.05 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.527 -0.733 . . . . 0.0 109.645 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 381' ' ' MET . . . . . 0.429 ' N ' ' O ' ' B' ' 377' ' ' LEU . 34.7 ttm -71.25 -40.04 71.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.387 -1.446 . . . . 0.0 108.016 177.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -79.07 -7.66 58.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.705 -0.622 . . . . 0.0 110.613 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' B' ' 379' ' ' LYS . 76.8 mm-40 -111.88 2.96 17.27 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.063 -1.023 . . . . 0.0 111.269 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 22.5 mt -96.19 126.6 41.53 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.667 -1.27 . . . . 0.0 109.508 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.896 -1.05 . . . . 0.0 109.246 179.471 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.179 0.514 . . . . 3.19 109.805 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 225' ' ' ASN . 88.1 mt -110.05 130.01 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.429 -0.794 . . . . 1.71 109.26 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.1 m -127.47 129.34 47.28 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.584 -0.697 . . . . 1.66 109.629 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.624 ' N ' HD22 ' A' ' 225' ' ' ASN . . . -113.93 -160.48 13.66 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 108.814 -1.714 . . . . 1.05 108.814 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.5 mt -88.85 -17.26 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.985 -1.303 . . . . 1.59 109.943 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.3 tp 55.4 105.46 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.291 -0.881 . . . . 1.47 108.828 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.64 -24.82 16.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.141 -0.974 . . . . 1.39 109.672 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.8 t -142.52 127.46 10.14 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.283 -0.886 . . . . 2.09 109.853 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.92 143.13 17.99 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.908 1.739 . . . . 0.91 111.624 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 167.64 -168.89 40.9 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.312 -1.515 . . . . 0.92 109.312 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.408 HD12 HG22 ' A' ' 11' ' ' ILE . 79.6 mt -149.14 126.77 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.352 -1.087 . . . . 1.35 108.222 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.99 149.76 43.63 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.958 -1.089 . . . . 1.14 111.025 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 3.0 m-85 -124.66 129.94 51.49 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.733 -1.21 . . . . 0.7 107.733 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.81 177.32 47.88 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 118.695 -1.717 . . . . 0.58 111.02 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -78.48 157.94 28.76 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.707 -0.878 . . . . 2.63 109.289 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.34 126.09 51.8 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.336 -0.852 . . . . 1.27 110.873 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.4 tp -97.27 138.02 35.4 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.378 -1.341 . . . . 1.41 107.378 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 39.5 tp -116.6 123.31 47.02 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.247 -0.908 . . . . 1.49 109.448 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.2 mt -88.06 106.66 18.3 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.556 0.693 . . . . 1.52 110.55 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -98.77 133.66 42.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.485 -0.759 . . . . 3.17 109.281 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -128.86 128.24 43.46 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.275 -0.891 . . . . 3.0 108.853 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -79.01 153.68 30.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.969 . . . . 2.77 110.067 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -73.78 140.91 46.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.282 -0.886 . . . . 2.94 108.769 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.7 mt -80.02 132.48 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.958 . . . . 1.46 108.83 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.9 t -95.65 122.35 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.321 -0.862 . . . . 1.7 108.995 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.9 mt -105.3 138.68 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.538 -0.726 . . . . 1.54 109.09 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -87.82 123.4 32.56 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.163 -0.961 . . . . 1.81 109.712 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -93.04 2.79 56.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.886 . . . . 3.23 109.833 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -69.98 149.77 47.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.059 -1.026 . . . . 3.29 110.077 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -87.93 144.03 26.78 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.384 -0.969 . . . . 2.8 108.384 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 pt -90.36 164.33 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.845 -1.159 . . . . 1.43 109.947 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.0 p -93.64 170.83 9.29 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.993 -1.114 . . . . 1.54 107.993 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.94 -48.27 82.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.764 -1.21 . . . . 1.6 109.222 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 62.8 t0 -54.13 -30.16 47.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.997 -1.064 . . . . 2.56 109.68 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -81.26 -9.09 59.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.358 -0.838 . . . . 2.36 110.362 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -65.6 -55.18 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.543 -1.348 . . . . 1.43 109.042 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -39.93 87.64 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.352 -0.843 . . . . 1.77 109.81 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.38 -41.78 76.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 3.32 111.033 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -64.25 -40.14 95.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.693 -1.255 . . . . 1.51 110.179 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.09 -44.66 95.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.79 -1.194 . . . . 1.41 107.993 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -59.97 -40.1 87.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 1.81 108.321 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.454 HH11 ' HG2' ' A' ' 42' ' ' ARG . 20.6 mtt-85 -59.96 -44.33 94.49 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.489 -1.3 . . . . 3.26 107.489 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -60.88 -47.62 85.53 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.601 -0.889 . . . . 0.81 108.601 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.01 -47.15 87.01 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.247 -1.02 . . . . 1.59 108.247 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.7 t -59.95 -41.44 91.88 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.322 -0.992 . . . . 1.38 108.322 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.61 -42.9 99.84 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.363 -1.895 . . . . 0.87 108.363 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -65.54 -38.81 90.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.121 -1.066 . . . . 3.62 108.121 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.02 -42.8 77.05 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.885 -0.51 . . . . 1.43 109.734 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.3 ttpt -71.19 -74.4 0.15 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.999 -1.111 . . . . 3.08 107.999 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.27 -38.78 0.37 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.267 -0.896 . . . . 1.33 111.443 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.0 t -55.71 -54.92 38.42 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.393 -1.442 . . . . 1.85 108.494 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.99 -41.75 73.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.377 -0.827 . . . . 1.35 111.356 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -66.87 -40.26 87.78 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.758 -1.213 . . . . 2.34 110.521 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.3 mt -60.37 -39.96 89.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.812 -1.18 . . . . 2.2 109.067 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -61.84 -32.05 72.35 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.348 -0.845 . . . . 1.35 109.724 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.4 m -67.87 -44.75 76.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.795 -1.191 . . . . 1.34 110.124 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.5 mt -59.98 -37.98 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.127 -0.983 . . . . 1.26 108.573 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -56.6 -50.03 73.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.708 -0.62 . . . . 1.7 109.376 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 m -56.62 -31.95 64.82 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.23 -0.919 . . . . 1.35 110.332 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -69.86 -39.8 76.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 2.08 110.192 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.09 -48.33 65.81 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.526 -0.734 . . . . 1.21 109.662 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -51.51 -56.57 14.83 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 110.209 -1.157 . . . . 0.75 110.209 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.06 -42.0 73.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.127 -1.219 . . . . 1.59 111.061 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.6 m -66.09 -62.39 1.51 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.844 -1.16 . . . . 1.41 111.996 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -94.56 -45.88 7.21 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.864 -1.148 . . . . 0.79 111.239 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.73 -167.93 25.43 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.908 -1.139 . . . . 1.22 110.819 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -70.16 -23.93 63.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.863 -0.786 . . . . 5.81 110.261 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.494 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.8 tp10 -59.93 -33.39 71.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.465 -0.772 . . . . 3.37 110.086 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -98.76 -18.91 17.74 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.252 -0.905 . . . . 2.37 110.469 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -67.71 -40.06 84.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.893 -1.129 . . . . 1.65 109.83 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.49 -32.82 74.38 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.414 -0.804 . . . . 1.42 110.218 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.7 mt -59.94 -41.83 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.902 -1.124 . . . . 1.43 109.594 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -64.57 -39.84 94.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.129 -0.982 . . . . 1.08 110.881 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -60.07 -40.0 88.0 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.916 -1.115 . . . . 1.37 109.458 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.81 -47.07 92.55 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.07 -1.612 . . . . 0.67 109.07 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -61.17 -47.88 84.15 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.408 -1.054 . . . . 1.99 109.326 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 77' ' ' ILE . 96.7 mt -64.15 -48.79 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.303 -0.873 . . . . 1.22 109.788 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.4 ttp -59.97 -41.52 92.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.964 -1.085 . . . . 2.11 110.588 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.4 ' CD1' ' CE2' ' B' ' 348' ' ' PHE . 57.9 tp -65.89 -39.94 91.11 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.358 -0.839 . . . . 1.33 109.928 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.46 -40.07 95.03 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.562 -0.711 . . . . 1.29 109.663 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -82.14 5.84 18.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.057 -1.027 . . . . 1.47 110.228 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -50.03 133.21 23.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.0 . . . . 1.47 110.423 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.49 -22.58 63.69 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.606 -0.684 . . . . 1.78 110.919 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.58 -34.12 71.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.928 -1.108 . . . . 2.53 109.1 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.0 -42.11 73.49 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.388 0.613 . . . . 1.36 110.257 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.03 -50.03 75.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 1.42 110.191 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -70.28 -42.53 71.95 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.352 -0.843 . . . . 2.27 110.983 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.07 -40.11 75.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.043 -1.035 . . . . 1.57 111.068 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 84.5 mt -67.47 -49.07 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.043 -1.036 . . . . 1.19 109.451 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.4 HG21 ' HZ1' ' A' ' 94' ' ' LYS . 88.1 mt -66.25 -36.76 78.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.608 -0.683 . . . . 1.39 110.248 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.27 82.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.174 -0.954 . . . . 1.39 110.988 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 96' ' ' LYS . 93.5 mt -59.95 -45.81 91.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.051 -1.031 . . . . 1.5 110.3 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.0 mt -60.39 -49.91 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.029 -1.044 . . . . 1.29 108.833 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.4 ' HZ1' HG21 ' A' ' 90' ' ' ILE . 31.9 mttp -65.79 -45.83 80.98 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.992 -0.683 . . . . 2.64 110.525 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -79.01 -48.83 13.71 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.044 -1.035 . . . . 1.65 112.103 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 92' ' ' LEU . 96.5 mttt -92.79 -3.03 55.43 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 120.719 -1.238 . . . . 2.5 112.48 -177.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 57.32 39.73 28.22 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.788 -1.195 . . . . 1.88 109.945 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 95.2 mtp -93.5 168.1 11.26 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.61 -0.681 . . . . 1.71 110.291 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.1 p -82.67 161.12 22.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.433 -0.792 . . . . 1.61 109.663 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.72 -40.04 88.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.344 -0.848 . . . . 1.33 109.491 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.414 ' C ' ' OD1' ' A' ' 101' ' ' ASP . 39.5 t0 -63.24 -40.07 96.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.149 -0.97 . . . . 2.07 109.541 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.48 -51.21 9.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.431 -0.793 . . . . 1.37 110.35 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.02 75.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.362 -0.836 . . . . 1.14 110.444 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.03 -41.83 93.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.023 -1.048 . . . . 1.26 109.81 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -59.8 -40.19 87.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.352 -0.843 . . . . 2.02 110.141 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 110' ' ' GLY . 88.7 tt0 -64.93 -40.11 94.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 1.33 111.077 -178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 86.1 t -64.79 -50.46 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.001 -1.062 . . . . 1.3 110.689 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.3 mm -70.05 -40.03 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.879 -1.138 . . . . 1.32 108.387 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -65.34 -38.54 90.44 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.257 -1.016 . . . . 2.44 108.257 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -60.69 -52.91 49.53 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.106 -1.198 . . . . 0.99 110.106 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -60.73 -49.93 75.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.902 -1.352 . . . . 1.97 108.987 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.13 -39.95 88.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.372 -0.83 . . . . 1.43 109.498 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.1 m -59.94 -40.09 87.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.11 -0.994 . . . . 2.12 109.119 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.4 -39.62 87.99 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.237 -0.914 . . . . 1.64 108.876 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.0 mt -62.47 -42.8 99.74 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.273 -0.892 . . . . 1.93 109.514 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -53.99 -31.34 50.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.99 -1.069 . . . . 2.2 109.676 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.97 -24.52 64.48 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.169 -0.957 . . . . 2.12 108.526 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 54.1 mt -62.74 139.98 58.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.931 . . . . 2.34 109.235 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -96.39 45.66 1.06 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.139 -0.975 . . . . 3.23 109.737 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 41.1 t0 -133.33 143.59 49.1 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.333 -0.855 . . . . 2.49 109.182 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.495 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 77.8 mm-40 -71.56 -64.86 0.84 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.195 -1.039 . . . . 3.95 108.195 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.616 ' HH ' HH12 ' A' ' 126' ' ' ARG . 2.7 t80 -39.11 -39.97 0.64 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.023 -0.423 . . . . 2.25 110.904 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.2 mt -79.98 -40.04 28.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.61 -1.306 . . . . 2.27 108.884 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.99 -40.57 96.09 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.502 -0.925 . . . . 3.31 108.502 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.89 -34.05 73.04 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.2 -1.037 . . . . 2.73 108.2 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.616 HH12 ' HH ' ' A' ' 122' ' ' TYR . 1.9 tpt180 -59.92 -39.42 85.37 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.389 -1.337 . . . . 3.2 107.389 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.55 -25.49 66.68 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.456 0.646 . . . . 1.66 109.285 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.11 94.3 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.037 -1.098 . . . . 1.67 108.037 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.5 -40.07 85.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.759 . . . . 1.55 109.613 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.88 -40.07 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.047 -1.033 . . . . 1.32 108.904 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -60.09 -40.6 90.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.149 -0.969 . . . . 3.58 108.985 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.09 -39.05 84.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.65 -0.656 . . . . 1.46 110.832 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.9 mt -59.96 -42.87 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.919 -1.113 . . . . 1.22 110.248 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.19 -27.47 71.78 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.407 -1.477 . . . . 0.61 109.407 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -59.91 -50.0 75.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.389 -1.065 . . . . 3.1 110.301 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.447 HH11 ' HG2' ' A' ' 136' ' ' ARG . 22.2 mtt-85 -65.71 -37.89 87.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.855 -1.153 . . . . 3.71 109.98 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.5 tp -55.22 -44.25 75.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -0.915 . . . . 1.87 109.323 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 89.3 mt -60.38 -39.98 89.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.24 -0.912 . . . . 1.29 109.511 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.406 HH11 ' HG2' ' A' ' 139' ' ' ARG . 51.9 mtt-85 -69.43 -39.83 77.6 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.28 -0.887 . . . . 3.05 108.831 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -64.5 -34.16 77.58 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.704 -0.623 . . . . 1.26 111.104 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.92 -45.74 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.18 -1.575 . . . . 1.34 107.788 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 99.4 mt -70.06 -37.42 75.5 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.392 0.615 . . . . 1.6 109.488 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.89 45.73 7.05 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.116 -1.993 . . . . 0.96 108.116 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.8 tp -76.51 160.05 29.82 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.532 -0.981 . . . . 1.67 109.498 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -68.54 143.83 54.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.447 -0.783 . . . . 4.96 109.823 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.421 HG22 HD11 ' A' ' 146' ' ' ILE . 86.6 mt -120.0 125.1 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 122.004 0.907 . . . . 1.68 109.188 179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 148' ' ' ASP . 5.3 mt -64.86 -41.98 93.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 115.962 -0.563 . . . . 2.14 110.225 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 147' ' ' ILE . 23.4 t0 63.73 125.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.213 -1.032 . . . . 1.5 108.213 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.462 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 40.7 mt -86.17 0.47 53.55 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.105 -0.997 . . . . 1.39 110.019 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.7 p -87.29 -8.55 56.6 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.178 -0.951 . . . . 1.83 109.397 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.96 21.82 1.26 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.353 -0.842 . . . . 1.46 111.255 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 152' ' ' ILE . 32.2 mm -88.4 119.97 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.614 -1.304 . . . . 1.42 108.796 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -100.33 -9.36 22.37 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.453 -0.779 . . . . 2.94 110.687 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -130.14 152.86 49.11 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.232 -0.918 . . . . 1.52 110.499 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -63.52 133.87 54.6 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.369 -0.832 . . . . 1.58 109.218 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.1 m -152.49 164.23 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.911 -0.774 . . . . 1.32 108.911 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.1 mt -92.59 151.53 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 106.029 -1.841 . . . . 1.27 106.029 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 33.7 tp -102.56 118.89 37.83 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.992 -1.068 . . . . 1.41 110.231 -177.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 12.3 t -125.72 134.34 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.805 -0.813 . . . . 1.23 108.805 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.31 166.13 28.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.931 . . . . 1.32 108.981 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.401 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -70.08 -38.74 75.81 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.34 -1.475 . . . . 1.49 107.306 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -171.17 144.15 2.02 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.961 -0.755 . . . . 2.25 108.961 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 40.9 mt -109.79 137.08 48.1 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.267 -0.896 . . . . 1.35 109.268 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 58.7 p -87.54 149.1 45.74 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 120.993 -1.067 . . . . 1.56 108.979 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -41.71 -36.97 3.59 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.128 1.885 . . . . 0.87 112.827 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.9 m -59.94 -47.18 86.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 1.36 109.661 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.66 -43.81 97.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.915 . . . . 1.61 110.024 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 30.6 p -55.22 -26.67 41.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.266 -0.896 . . . . 1.21 111.702 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -83.19 -43.9 15.62 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.555 -1.34 . . . . 1.21 110.099 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -89.28 36.93 0.84 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.028 -1.101 . . . . 2.11 108.028 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.1 tp -103.24 133.55 48.14 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.454 0.645 . . . . 1.29 109.697 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.645 ' ND2' ' NZ ' ' A' ' 175' ' ' LYS . 2.9 p30 -82.9 99.26 9.65 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.332 -0.988 . . . . 2.81 108.332 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 90.9 mt -65.07 -42.28 94.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 2.09 110.975 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -62.68 -32.36 73.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.988 -1.07 . . . . 2.86 112.678 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.645 ' NZ ' ' ND2' ' A' ' 172' ' ' ASN . 9.4 mtmp? -92.04 -5.09 53.56 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.64 -1.287 . . . . 2.39 110.341 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 72.3 t -104.68 116.46 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.067 -1.086 . . . . 1.27 108.067 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.6 mt -85.93 7.23 25.03 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.17 -0.957 . . . . 2.17 111.326 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.45 172.86 37.24 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.128 -1.511 . . . . 0.52 109.82 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -134.3 129.34 35.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.501 -0.999 . . . . 0.55 108.87 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 93.9 mt -134.72 130.33 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.329 -0.857 . . . . 1.27 108.973 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.7 p -151.6 162.17 41.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.956 -1.09 . . . . 1.39 110.531 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 183' ' ' ALA . 38.3 p-10 -109.63 26.73 10.31 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.905 -0.776 . . . . 2.46 108.905 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -54.31 -164.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.987 -1.071 . . . . 1.51 111.64 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.07 -59.33 5.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.562 -1.015 . . . . 2.23 110.562 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -174.07 -156.8 14.2 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 118.748 -1.691 . . . . 2.23 111.22 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.519 ' C ' ' H ' ' A' ' 188' ' ' SER . 46.8 ttp180 -62.33 -30.05 70.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.923 -0.751 . . . . 6.44 110.614 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 30.6 p -61.85 5.17 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.819 -1.176 . . . . 4.09 110.692 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.782 ' HG ' ' HG ' ' A' ' 191' ' ' SER . 50.2 p -90.87 140.18 30.05 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.871 -1.143 . . . . 2.2 110.419 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -50.0 -43.47 50.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.423 -0.798 . . . . 1.15 109.672 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.8 m -56.97 -40.49 76.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.625 -0.672 . . . . 2.01 109.633 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.782 ' HG ' ' HG ' ' A' ' 188' ' ' SER . 69.9 m -60.14 -39.9 87.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.208 -0.933 . . . . 1.93 110.116 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.8 mt -60.04 -45.12 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.463 -0.773 . . . . 2.2 110.504 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 30.1 mtm -59.94 -47.61 85.08 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.88 -1.137 . . . . 1.32 110.496 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.71 -45.74 63.67 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.681 -1.262 . . . . 1.3 109.897 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -59.93 -50.33 74.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.926 -1.109 . . . . 3.38 110.994 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.1 m -77.02 -30.19 55.68 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.612 -1.305 . . . . 1.15 111.104 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.0 -29.41 66.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.741 -1.224 . . . . 1.28 108.449 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 68.49 47.98 0.87 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.277 0.561 . . . . 1.5 110.317 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 89.4 mt -128.7 149.93 73.43 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 107.865 -1.161 . . . . 1.37 107.865 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.73 138.76 85.05 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 121.925 1.75 . . . . 0.76 111.69 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -172.7 149.17 2.0 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.147 -1.021 . . . . 1.19 110.891 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.5 mt -124.99 150.41 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.173 -1.417 . . . . 1.31 107.173 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.0 -12.11 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.464 0 O-C-N 120.931 -1.106 . . . . 1.38 111.869 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -114.68 25.98 9.84 Favored Glycine 0 N--CA 1.502 3.063 0 N-CA-C 110.076 -1.21 . . . . 1.03 110.076 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 58.3 p -44.26 -47.29 9.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -1.165 . . . . 1.38 110.469 -179.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 106.73 -51.39 0.74 Allowed Glycine 0 N--CA 1.5 2.941 0 N-CA-C 111.018 -0.833 . . . . 1.17 111.018 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 81.1 p -162.82 44.66 0.13 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.473 -1.604 . . . . 2.07 111.962 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 14.8 t -71.38 -41.02 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.685 -1.26 . . . . 1.35 108.513 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.3 p -50.66 -29.94 12.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.841 . . . . 1.49 109.512 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.1 m -81.92 -12.4 58.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 2.16 109.346 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -115.53 15.16 16.68 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.63 -0.669 . . . . 2.89 109.798 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 42.7 t -138.05 134.55 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.407 -0.808 . . . . 1.33 110.394 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.455 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 10.8 mptt -117.42 153.0 33.82 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.368 -1.345 . . . . 2.73 107.368 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.462 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 11.2 p30 -55.51 140.84 39.16 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.995 -1.066 . . . . 2.7 110.367 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.0 m-20 83.06 2.43 1.05 Allowed 'General case' 0 N--CA 1.502 2.147 0 CA-C-N 116.27 -0.423 . . . . 2.38 110.747 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.455 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 94.1 m-20 -74.82 141.58 44.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.743 -1.223 . . . . 2.09 109.153 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -90.69 116.42 28.55 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.933 -1.136 . . . . 1.45 107.933 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 79.9 mt -125.56 147.55 49.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.441 -0.787 . . . . 1.31 110.365 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.5 mt -115.86 129.83 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 106.627 -1.62 . . . . 1.29 106.627 177.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 61.0 tp -102.59 119.84 39.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.875 -1.141 . . . . 1.31 109.528 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.601 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 23.2 p-10 -76.22 -40.03 53.14 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.148 -1.056 . . . . 2.31 108.148 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.426 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 48.46 18.42 0.17 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.769 -0.826 . . . . 1.19 108.769 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.45 ' N ' ' C ' ' A' ' 221' ' ' ASP . 53.9 t -129.18 -36.66 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.953 -1.129 . . . . 1.45 107.953 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -110.07 -2.81 16.79 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.135 -1.431 . . . . 3.13 107.135 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.624 HD22 ' N ' ' A' ' 4' ' ' GLY . 27.8 t-20 63.66 51.4 2.48 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.498 0.666 . . . . 2.2 109.689 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.601 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 42.4 mt-30 -137.31 152.72 50.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.499 -0.751 . . . . 2.32 109.213 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.86 130.01 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.426 -0.953 . . . . 1.4 108.426 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -102.52 120.82 41.19 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.776 -0.824 . . . . 1.29 108.776 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.6 t -100.95 113.23 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.506 -0.746 . . . . 1.38 110.149 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 50.02 66.75 5.16 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.187 -0.946 . . . . 2.33 111.127 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -89.17 148.07 5.48 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 123.186 2.591 . . . . 0.95 112.339 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 24.8 p -70.72 166.17 21.44 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.18 -0.95 . . . . 2.31 110.744 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.666 -0.646 . . . . 3.45 109.773 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.02 -37.73 80.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.249 -0.907 . . . . 2.89 109.611 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.02 -41.84 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.169 -0.957 . . . . 1.73 109.056 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.4 mt -64.99 -40.69 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 1.57 109.932 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -60.04 -42.35 94.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.856 -1.152 . . . . 2.43 108.586 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -60.93 -43.13 99.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.43 -0.794 . . . . 3.18 109.104 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 95.2 mtp -70.02 -33.52 72.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.515 -0.741 . . . . 1.59 109.983 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -65.35 -39.79 92.78 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.136 -0.977 . . . . 3.11 109.15 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.02 87.77 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.332 -0.855 . . . . 2.17 108.93 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 74.6 t -62.52 -39.58 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.37 -0.832 . . . . 2.51 109.174 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -59.52 -39.82 85.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.421 -0.8 . . . . 3.82 109.609 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.89 -40.03 87.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.977 -1.077 . . . . 1.78 108.65 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -63.65 -39.54 94.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 2.77 108.682 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 66.1 t -60.04 -40.01 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 109.083 -0.71 . . . . 2.25 109.083 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.6 -41.79 70.36 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.074 -1.016 . . . . 2.54 108.307 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 48.1 t -65.41 -38.81 91.06 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.526 -0.734 . . . . 3.03 109.154 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -60.05 -45.09 93.99 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.228 -0.92 . . . . 3.34 109.422 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -61.53 -40.32 94.22 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.946 -1.096 . . . . 4.18 108.47 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 52.76 56.95 6.9 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.568 -0.707 . . . . 4.43 109.622 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -52.28 -29.52 23.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 5.42 108.563 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 81.2 mt -79.25 -64.59 1.15 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.192 -1.04 . . . . 6.11 108.192 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 66.49 16.23 10.35 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.542 -0.724 . . . . 7.37 110.159 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.573 ' O ' ' N ' ' A' ' 257' ' ' LYS . 62.7 tttm -85.83 -96.18 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.983 -1.073 . . . . 8.3 109.024 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 49.5 mt 42.72 15.75 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.142 -0.974 . . . . 9.05 110.796 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 255' ' ' LYS . 61.3 mttp 55.31 51.08 13.63 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.351 -0.843 . . . . 10.56 109.398 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 255' ' ' LYS . 38.0 p-10 -142.47 93.39 2.52 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.355 -0.98 . . . . 11.32 108.355 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 118.001 -0.999 . . . . 12.74 109.446 -179.131 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 56.9 ttm . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -149.55 146.89 27.6 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.41 162.32 41.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.004 -1.06 . . . . 0.0 110.375 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -156.03 153.9 30.18 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -114.93 134.57 55.05 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.077 -1.014 . . . . 0.0 110.056 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 p -131.82 124.0 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 CA-C-O 122.173 0.987 . . . . 0.0 112.751 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 89.0 m -77.25 104.29 7.67 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.935 0.874 . . . . 0.0 110.673 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . 0.434 HD11 HG22 ' B' ' 308' ' ' ILE . 92.7 mt -52.15 124.94 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.368 1.08 . . . . 0.0 110.657 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 71.2 p -110.03 20.05 18.34 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.027 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . 0.404 ' O ' ' CG ' ' B' ' 357' ' ' GLN . . . -74.8 118.5 70.79 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.944 -1.098 . . . . 0.0 109.233 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -53.4 -16.05 6.8 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 CA-C-N 120.251 1.125 . . . . 0.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -120.28 10.08 11.2 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.558 -0.714 . . . . 0.0 109.268 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 69.29 -176.75 30.37 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.714 -1.755 . . . . 0.0 108.714 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.457 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.4 tp -85.45 89.59 7.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.055 -1.262 . . . . 0.0 110.129 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . 0.494 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 4.3 p80 -94.94 -159.97 0.75 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.981 -1.074 . . . . 0.0 109.641 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.8 m -59.73 -47.43 85.68 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.859 -1.151 . . . . 0.0 112.916 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.494 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 1.4 tpt180 -57.98 -55.89 40.43 Favored Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 120.44 -1.412 . . . . 0.0 112.223 -178.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . 0.494 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 18.1 Cg_endo -64.84 -30.21 58.41 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 CA-C-N 120.583 1.244 . . . . 0.0 111.37 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.03 75.35 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.14 -41.83 72.27 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.569 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -69.97 -43.13 72.12 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.026 -1.046 . . . . 0.0 108.615 178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -60.41 -50.96 71.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.414 -0.804 . . . . 0.0 110.556 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 58.4 t -66.49 -26.52 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.722 -1.236 . . . . 0.0 109.889 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.33 -45.69 93.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.398 -0.814 . . . . 0.0 110.219 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -69.75 -41.6 75.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.229 -0.919 . . . . 0.0 112.205 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.24 -51.76 68.2 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.455 -1.403 . . . . 0.0 110.954 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -57.71 -11.91 2.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.044 -1.035 . . . . 0.0 109.415 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -70.33 -28.59 71.12 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -105.68 144.66 32.11 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.661 -0.905 . . . . 0.0 109.325 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 18.2 p -91.03 -11.74 37.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.138 -0.976 . . . . 0.0 110.055 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 90.6 p -58.03 153.64 14.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.164 -0.96 . . . . 0.0 110.135 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.11 130.81 42.47 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 79.8 mt -132.45 131.13 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.465 -0.772 . . . . 0.0 109.646 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 29.3 m -128.12 154.11 46.11 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 76.3 t -118.36 139.56 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 54.6 m -130.5 121.29 25.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.387 -0.82 . . . . 0.0 109.213 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 337' ' ' SER . . . . . 0.524 ' O ' ' ND2' ' B' ' 338' ' ' ASN . 29.3 t -136.61 117.7 14.39 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.906 0.86 . . . . 0.0 110.921 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' B' ' 337' ' ' SER . 7.3 p30 42.22 52.26 4.51 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 88.52 -13.39 62.41 Favored Glycine 0 N--CA 1.501 3.015 0 O-C-N 120.31 -1.494 . . . . 0.0 113.507 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -113.84 122.12 46.09 Favored 'General case' 0 N--CA 1.508 2.469 0 CA-C-N 119.602 1.701 . . . . 0.0 110.457 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 77.8 p -103.53 154.97 18.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.421 -0.799 . . . . 0.0 110.701 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -154.18 154.31 33.29 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.765 -0.584 . . . . 0.0 109.916 179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 4.6 t -91.05 138.09 31.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.346 -0.846 . . . . 0.0 109.971 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.48 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -78.09 -14.87 59.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.987 -1.071 . . . . 0.0 110.624 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -87.74 21.12 2.71 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.48 ' H ' ' C ' ' B' ' 344' ' ' ALA . 12.3 t -149.17 97.03 2.62 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.856 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 19.6 tp -59.55 -32.12 70.04 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . 0.4 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 61.0 m-85 -57.63 -51.64 68.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.375 -0.828 . . . . 0.0 110.529 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.45 ' O ' ' OG1' ' B' ' 352' ' ' THR . 36.2 mtmm -69.59 -40.01 76.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.572 -1.33 . . . . 0.0 110.002 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.612 ' O ' ' N ' ' B' ' 352' ' ' THR . 86.3 mt -50.62 -55.81 14.65 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.743 -1.223 . . . . 0.0 108.117 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -38.51 -16.07 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.039 -0.413 . . . . 0.0 111.294 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.612 ' N ' ' O ' ' B' ' 350' ' ' LEU . 75.4 p -91.68 -12.02 35.28 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.813 -1.18 . . . . 0.0 110.952 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 55.8 mt -92.56 119.41 31.99 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.896 -1.128 . . . . 0.0 109.179 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.8 91.63 0.99 Allowed Glycine 0 N--CA 1.485 1.958 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 66.2 mt -100.85 94.91 6.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.412 -1.052 . . . . 0.0 108.521 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 75.2 p -91.68 178.79 5.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.349 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . 0.404 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 16.1 tm0? -69.16 113.97 7.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.69 -0.631 . . . . 0.0 110.246 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 102.08 9.49 42.13 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 25.5 m -86.45 111.98 21.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.187 -1.184 . . . . 0.0 110.593 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 42.0 t -77.36 116.24 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 122.018 0.913 . . . . 0.0 110.325 -177.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.7 m -110.74 176.6 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 36.8 m -131.43 130.65 42.78 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 76.3 mt -103.93 115.67 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 77.4 p -118.11 131.66 56.41 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.351 -0.843 . . . . 0.0 109.3 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.27 151.55 38.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.105 -0.997 . . . . 0.0 110.187 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . 0.438 ' OE2' ' OE2' ' B' ' 370' ' ' GLU . 11.7 tp10 -141.98 119.76 11.87 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.443 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 164.19 -163.89 36.28 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 118.323 -1.894 . . . . 0.0 111.963 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 55.1 tp10 -59.85 -50.73 72.66 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.022 -0.589 . . . . 0.0 111.379 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -103.97 8.57 36.76 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.854 -1.154 . . . . 0.0 111.456 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.1 pt-20 -42.04 -32.96 0.5 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.117 -0.99 . . . . 0.0 111.355 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -66.15 -46.92 75.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.674 -1.266 . . . . 0.0 109.801 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -69.98 -52.07 27.38 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.176 -0.952 . . . . 0.0 109.601 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -42.16 -38.05 1.61 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.548 -0.72 . . . . 0.0 111.676 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 62.9 t -79.06 -34.84 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.502 -1.374 . . . . 0.0 110.012 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -65.66 -49.98 66.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.13 -0.981 . . . . 0.0 112.766 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -77.11 -40.37 46.08 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.267 -1.52 . . . . 0.0 110.869 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.9 mt -60.04 -40.46 89.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.875 -1.141 . . . . 0.0 108.99 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 54.5 t -62.27 -45.17 99.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.112 -0.993 . . . . 0.0 109.613 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.8 mttt -69.76 -55.97 8.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 38.7 tp -53.56 -35.71 61.06 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 11.1 tpt -69.97 -39.73 75.81 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.06 -5.78 56.46 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.665 -0.647 . . . . 0.0 110.594 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' B' ' 379' ' ' LYS . 99.2 mt-10 -114.42 -0.54 13.75 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.888 -1.132 . . . . 0.0 111.045 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 10.8 mt -81.14 131.88 35.32 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.406 -1.434 . . . . 0.0 109.746 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 56.4 mp0 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.961 -1.019 . . . . 0.0 108.996 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.349 -0.611 . . . . 3.19 109.349 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.0 mt -110.0 129.92 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.506 -0.746 . . . . 1.71 109.566 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.5 m -130.16 134.95 47.67 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.044 -0.725 . . . . 1.66 109.044 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.72 -163.99 23.32 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.585 -1.806 . . . . 1.05 108.585 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.9 mt -92.18 -11.08 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.91 -1.347 . . . . 1.59 109.539 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' A' ' 5' ' ' ILE . 52.6 tp 53.55 103.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.293 -0.879 . . . . 1.47 109.533 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.23 -21.15 21.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.239 -0.913 . . . . 1.39 109.99 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.4 m -148.67 135.7 10.57 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 120.895 -1.128 . . . . 2.09 109.596 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.73 142.45 14.24 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.707 2.271 . . . . 0.91 113.489 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.503 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 157.53 -158.44 29.0 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.206 -1.558 . . . . 0.92 109.206 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -149.28 150.5 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 107.851 -1.166 . . . . 1.35 107.851 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.67 141.5 21.06 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.808 -1.183 . . . . 1.14 110.712 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.636 ' CE2' ' NH1' ' A' ' 240' ' ' ARG . 17.0 m-85 -125.76 126.44 44.57 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.884 -1.154 . . . . 0.7 107.884 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.06 178.29 48.16 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 118.482 -1.818 . . . . 0.58 110.879 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -78.32 158.89 28.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.853 -0.792 . . . . 2.63 109.227 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -101.42 128.77 47.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.407 -0.808 . . . . 1.27 110.663 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.8 tp -99.11 134.94 41.23 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 106.865 -1.532 . . . . 1.41 106.865 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -117.39 118.27 31.77 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.408 -0.808 . . . . 1.49 110.121 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.4 mt -84.88 103.46 13.97 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.316 -0.624 . . . . 1.52 109.316 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -100.2 135.39 41.7 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.372 -0.83 . . . . 3.17 110.008 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -130.61 133.94 46.57 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.522 -0.736 . . . . 3.0 109.118 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -79.14 158.05 27.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.969 -1.082 . . . . 2.77 109.14 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -71.88 149.99 44.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.278 -0.889 . . . . 2.94 110.176 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.4 mt -95.48 130.34 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.214 -0.929 . . . . 1.46 108.938 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.17 129.71 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.121 -0.987 . . . . 1.7 110.115 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.7 mt -107.58 137.1 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 108.617 -0.882 . . . . 1.54 108.617 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -94.86 119.89 34.17 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.94 -1.1 . . . . 1.81 110.265 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.464 HH11 ' HG2' ' A' ' 28' ' ' ARG . 5.0 mmt-85 -88.71 0.05 56.83 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.53 -0.731 . . . . 3.23 109.79 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -70.35 141.43 52.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 3.29 109.921 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -82.41 150.55 27.04 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.204 -0.935 . . . . 2.8 109.301 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.5 pt -95.1 166.2 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.244 -0.91 . . . . 1.43 109.657 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.4 p -96.41 172.95 7.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.178 -0.951 . . . . 1.54 108.767 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.02 -49.29 78.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.047 -1.033 . . . . 1.6 109.335 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -54.86 -30.05 56.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.863 -1.148 . . . . 2.56 109.471 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -82.44 -10.75 58.91 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.407 -0.808 . . . . 2.36 110.265 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.27 -51.84 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.865 -1.147 . . . . 1.43 108.766 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.96 -39.98 93.99 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.364 -0.835 . . . . 1.77 110.055 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -68.38 -39.97 81.54 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.139 -0.976 . . . . 3.32 111.248 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -67.96 -39.96 83.29 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.8 -1.188 . . . . 1.51 110.184 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -62.98 -47.8 91.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 120.861 -1.149 . . . . 1.41 108.771 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -61.89 -41.6 98.08 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.104 -0.998 . . . . 1.81 109.347 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.18 -40.47 90.09 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.827 -1.149 . . . . 3.26 108.217 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -67.3 -42.02 84.4 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.55 -0.907 . . . . 0.81 108.55 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.92 -48.26 82.44 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.914 -1.143 . . . . 1.59 107.914 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.7 t -63.93 -44.02 94.15 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.756 -0.831 . . . . 1.38 108.756 178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.14 -45.45 96.51 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.282 -1.927 . . . . 0.87 108.282 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.546 ' NH2' ' O ' ' A' ' 80' ' ' LEU . 8.5 ttt180 -63.75 -34.11 77.15 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.681 -1.229 . . . . 3.62 107.681 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.04 -40.96 91.19 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.303 -0.628 . . . . 1.43 109.303 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 23.5 ttmt -63.64 -74.39 0.1 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.836 -1.172 . . . . 3.08 107.836 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.17 -39.6 0.43 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.45 -0.782 . . . . 1.33 111.316 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.2 m -53.01 -53.98 42.04 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.517 -1.365 . . . . 1.85 108.527 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.02 -39.96 75.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.469 -0.769 . . . . 1.35 111.501 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -68.89 -39.97 79.48 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.739 -1.225 . . . . 2.34 110.194 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 79.1 mt -63.11 -40.07 96.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.139 -0.976 . . . . 2.2 109.377 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -60.73 -35.26 75.9 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.248 -0.908 . . . . 1.35 109.432 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -62.58 -41.85 99.2 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.159 -0.963 . . . . 1.34 109.402 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.8 mt -62.77 -40.04 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.3 -0.875 . . . . 1.26 109.039 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -56.02 -50.03 72.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.11 -0.994 . . . . 1.7 109.197 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -56.02 -35.4 66.8 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.318 -0.864 . . . . 1.35 109.816 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -69.95 -37.91 75.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 2.08 109.815 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.13 -46.16 85.35 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.491 -0.756 . . . . 1.21 110.183 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.54 -50.03 72.13 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.497 -1.441 . . . . 0.75 109.497 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -68.23 -49.67 59.19 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.204 -1.174 . . . . 1.59 109.502 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.6 m -65.05 -63.8 1.02 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 1.41 112.332 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -95.27 -51.74 4.48 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.879 -1.138 . . . . 0.79 111.288 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.71 -167.99 25.72 Favored Glycine 0 N--CA 1.502 3.073 0 C-N-CA 119.706 -1.235 . . . . 1.22 111.128 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -70.22 -27.01 64.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 122.007 -0.702 . . . . 5.81 110.461 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -60.88 -35.72 77.35 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.3 -0.875 . . . . 3.37 110.571 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -101.04 -20.83 15.21 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.338 -0.851 . . . . 2.37 110.159 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -65.94 -40.06 91.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.026 -1.046 . . . . 1.65 110.002 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.545 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -64.75 -26.77 68.5 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.279 -0.888 . . . . 1.42 109.997 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.04 -39.96 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 118.717 -1.193 . . . . 1.43 108.531 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -66.42 -42.11 88.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.032 . . . . 1.08 110.282 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -60.13 -40.2 88.97 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.853 -1.155 . . . . 1.37 108.939 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.44 -49.95 66.07 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.945 -1.662 . . . . 0.67 108.945 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.5 m170 -62.9 -47.2 84.32 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.328 -1.101 . . . . 1.99 109.181 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.4 mt -65.69 -46.8 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.293 -0.879 . . . . 1.22 108.885 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.9 ttp -59.99 -40.12 88.11 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.01 -1.056 . . . . 2.11 109.048 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.4 tp -64.43 -39.99 94.89 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.457 0.646 . . . . 1.33 109.443 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.546 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 62.8 tp -63.18 -39.99 96.24 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.575 -0.703 . . . . 1.29 110.157 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -84.74 7.23 21.3 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.049 -1.032 . . . . 1.47 110.261 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 61.4 t0 -50.14 134.23 22.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.12 -0.987 . . . . 1.47 109.979 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.485 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 93.6 mt-10 -60.12 -23.51 63.93 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.634 -0.667 . . . . 1.78 110.941 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -70.81 -34.24 71.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.971 -1.08 . . . . 2.53 109.415 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.9 mt -71.02 -40.51 71.72 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.573 0.701 . . . . 1.36 109.692 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -59.98 -46.56 89.04 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.115 -0.991 . . . . 1.42 110.231 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -69.97 -42.24 73.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.211 -0.93 . . . . 2.27 111.594 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -69.99 -39.97 75.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.039 -1.038 . . . . 1.57 112.095 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.07 -48.14 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.142 -0.974 . . . . 1.19 109.625 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.412 HD11 HG22 ' A' ' 90' ' ' ILE . 96.7 mt -68.92 -39.62 80.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 121.262 0.553 . . . . 1.39 110.179 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.17 -47.69 84.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 1.39 110.768 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.4 mt -60.0 -48.35 82.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.989 -1.07 . . . . 1.5 109.941 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.2 mt -61.61 -48.59 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 121.957 0.884 . . . . 1.29 108.878 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -67.76 -40.16 84.11 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 120.203 -0.599 . . . . 2.64 110.857 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -86.57 -50.66 6.67 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.915 -1.115 . . . . 1.65 112.356 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -90.14 -2.9 58.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.984 -1.072 . . . . 2.5 111.71 -177.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.9 m170 57.94 35.81 25.65 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.893 -1.129 . . . . 1.88 109.474 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.8 mtp -90.33 163.88 14.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.47 -0.769 . . . . 1.71 109.752 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.6 p -76.06 158.36 31.92 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.29 -0.881 . . . . 1.61 108.648 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.55 -39.97 77.11 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.137 -0.977 . . . . 1.33 110.078 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.84 -39.86 95.66 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.225 -0.922 . . . . 2.07 109.678 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.35 -44.49 19.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 1.37 109.942 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.37 -49.29 76.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.328 -0.857 . . . . 1.14 110.191 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.21 90.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.127 -0.983 . . . . 1.26 110.025 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -60.05 -40.01 87.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 2.02 109.858 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -61.34 -40.12 93.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.063 -1.023 . . . . 1.33 110.395 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.0 t -62.81 -50.62 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.169 -0.957 . . . . 1.3 110.509 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.9 mm -69.99 -39.99 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.103 -0.998 . . . . 1.32 109.674 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -66.47 -39.21 88.67 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.29 -0.881 . . . . 2.44 108.699 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.27 -49.28 80.27 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.564 -1.014 . . . . 0.99 110.564 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -63.9 -47.51 80.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.938 -1.33 . . . . 1.97 110.135 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.43 -39.35 83.24 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.238 -0.914 . . . . 1.43 109.153 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.2 m -59.9 -40.07 87.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.142 -0.974 . . . . 2.12 108.997 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.94 87.67 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.231 -1.026 . . . . 1.64 108.231 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.3 mt -65.18 -41.74 94.3 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.313 -0.955 . . . . 1.93 108.55 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -57.8 -32.29 67.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.117 -0.989 . . . . 2.2 109.688 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.21 -26.71 61.12 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.084 -1.01 . . . . 2.12 108.466 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 25.3 mt -63.2 144.07 57.24 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.451 -0.944 . . . . 2.34 108.451 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -92.8 13.43 20.33 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.189 -0.944 . . . . 3.23 110.757 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 19.2 t0 -102.67 148.7 25.26 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.053 -1.029 . . . . 2.49 110.085 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 98.0 mt-10 -73.8 -65.05 0.88 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.483 -0.761 . . . . 3.95 109.34 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.623 ' HH ' ' CZ ' ' A' ' 126' ' ' ARG . 4.1 t80 -39.33 -35.43 0.26 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.893 -0.504 . . . . 2.25 110.616 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 78.6 mt -78.39 -40.04 37.3 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.834 -1.166 . . . . 2.27 109.342 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 121' ' ' GLU . 87.9 tttt -69.93 -42.6 73.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.189 -0.944 . . . . 3.31 110.807 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -63.35 -43.08 98.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.106 -0.997 . . . . 2.73 109.9 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.623 ' CZ ' ' HH ' ' A' ' 122' ' ' TYR . 26.8 ttp180 -59.99 -38.5 82.77 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.212 -0.93 . . . . 3.2 108.984 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.26 -43.64 92.45 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.141 -1.059 . . . . 1.66 108.141 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -44.7 -41.75 7.03 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.948 -0.76 . . . . 1.67 108.948 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.32 -39.93 94.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 1.55 109.708 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.36 -43.17 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.02 -1.05 . . . . 1.32 108.96 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -60.0 -39.92 87.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.109 -0.994 . . . . 3.58 109.372 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -57.17 -37.92 72.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.888 . . . . 1.46 109.742 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.94 -41.66 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.146 -0.971 . . . . 1.22 109.116 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.24 -30.72 58.37 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.769 -1.332 . . . . 0.61 109.769 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -59.98 -47.47 85.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.148 -1.207 . . . . 3.1 109.799 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -68.15 -31.14 70.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.814 -1.179 . . . . 3.71 109.63 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.09 -41.55 92.74 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.167 -0.958 . . . . 1.87 109.364 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.02 -40.05 87.93 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.209 -1.034 . . . . 1.29 108.209 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 62.3 mtt-85 -68.21 -38.04 81.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.662 -0.649 . . . . 3.05 109.305 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -68.6 -34.8 76.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 1.26 111.668 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.9 mt -70.4 -42.51 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.275 -1.516 . . . . 1.34 108.97 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.1 -25.4 63.49 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.636 -0.665 . . . . 1.6 109.591 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.78 36.24 19.79 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.378 -1.889 . . . . 0.96 108.378 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.1 tp -73.89 145.46 44.81 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.668 -0.901 . . . . 1.67 109.259 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -68.94 140.09 55.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -0.855 . . . . 4.96 109.924 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.5 mt -106.52 130.05 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-O 121.694 0.759 . . . . 1.68 109.21 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.401 HG22 HD11 ' A' ' 147' ' ' ILE . 16.8 mm -56.27 -49.12 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.682 -0.637 . . . . 2.14 110.367 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.6 t0 70.87 95.12 0.07 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.603 -0.686 . . . . 1.5 109.245 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.406 ' O ' ' OD1' ' A' ' 172' ' ' ASN . 33.4 mt -73.02 -4.08 30.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.352 -0.843 . . . . 1.39 110.968 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 81.2 p -82.85 -14.63 53.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.754 -1.216 . . . . 1.83 109.361 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.21 18.19 2.71 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.329 -0.857 . . . . 1.46 112.605 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.3 mp -91.33 115.82 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.121 -1.612 . . . . 1.42 108.02 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -100.17 -8.52 23.52 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.293 -0.88 . . . . 2.94 109.952 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -108.14 144.96 34.83 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.352 -0.843 . . . . 1.52 110.163 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -66.35 130.82 44.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.339 -0.851 . . . . 1.58 109.028 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.7 m -153.11 167.24 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.472 -0.768 . . . . 1.32 109.565 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -93.77 148.24 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 106.318 -1.734 . . . . 1.27 106.318 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 47.1 tp -96.89 117.45 31.13 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.872 -1.143 . . . . 1.41 111.066 -177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 8.5 t -121.41 127.97 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 108.516 -0.92 . . . . 1.23 108.516 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.04 162.06 36.61 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.213 -0.929 . . . . 1.32 108.74 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.475 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.94 -33.73 72.52 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.405 -1.434 . . . . 1.49 107.756 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.5 p-10 -166.8 175.33 7.86 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.318 -0.993 . . . . 2.25 108.318 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 51.6 mt -140.23 125.73 19.05 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.118 -1.067 . . . . 1.35 108.118 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 36.1 p -87.11 146.97 41.54 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.032 -1.043 . . . . 1.56 108.768 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -36.54 -38.13 0.32 Allowed 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.365 2.043 . . . . 0.87 112.295 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.2 m -60.04 -40.03 87.99 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.361 -0.837 . . . . 1.36 109.778 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.01 -44.42 69.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.105 -0.997 . . . . 1.61 110.192 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.8 p -55.53 -20.44 13.1 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.265 -0.897 . . . . 1.21 111.116 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.51 -47.57 12.03 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.868 -1.145 . . . . 1.21 109.871 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -90.24 38.41 0.93 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.221 -1.029 . . . . 2.11 108.221 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 9.3 tp -100.25 135.96 40.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 1.29 108.811 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.406 ' OD1' ' O ' ' A' ' 149' ' ' LEU . 30.7 m120 -86.67 102.12 13.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.194 -0.941 . . . . 2.81 109.307 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 80.9 mt -64.83 -41.67 95.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 2.09 110.799 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -69.12 -28.04 66.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.939 -1.101 . . . . 2.86 111.911 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -92.84 -11.43 33.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.748 -1.22 . . . . 2.39 109.159 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.9 t -99.07 108.16 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.611 -1.255 . . . . 1.27 107.611 178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.8 4.07 30.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.269 -0.894 . . . . 2.17 110.265 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.08 171.04 38.09 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.679 -1.768 . . . . 0.52 108.679 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -129.49 128.6 43.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.348 -1.089 . . . . 0.55 108.834 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 91.3 mt -131.44 123.2 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.595 -0.891 . . . . 1.27 108.595 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 203' ' ' VAL . 41.0 p -147.1 158.91 44.09 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.008 -1.057 . . . . 1.39 110.252 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 50.1 p30 -108.51 25.2 11.97 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.208 -0.664 . . . . 2.46 109.208 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.77 -162.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.029 -1.044 . . . . 1.51 111.358 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -64.22 -64.74 3.42 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.198 -1.161 . . . . 2.23 110.198 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.79 -131.45 1.66 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.19 -1.481 . . . . 2.23 110.8 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -79.95 -9.78 59.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.62 -0.929 . . . . 6.44 110.563 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 52.2 p -84.7 0.92 48.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.985 -1.072 . . . . 4.09 110.708 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 81.0 p -88.36 144.23 26.52 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.907 -1.121 . . . . 2.2 110.298 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -53.18 -41.06 64.86 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.344 -0.847 . . . . 1.15 108.844 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -53.38 -36.39 61.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.628 -0.67 . . . . 2.01 109.462 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 53.5 m -60.0 -40.02 87.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.194 -0.942 . . . . 1.93 109.981 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.6 mt -60.01 -40.09 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.926 . . . . 2.2 109.597 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 90.5 mtp -57.39 -48.83 78.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.082 -1.012 . . . . 1.32 110.435 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.94 -42.82 94.83 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.727 -1.233 . . . . 1.3 109.768 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -61.98 -59.25 5.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.131 -0.981 . . . . 3.38 110.389 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 61.5 m -67.11 -39.39 86.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.139 -0.975 . . . . 1.15 112.421 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 91.2 mt -70.22 -26.64 63.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.616 -1.303 . . . . 1.28 109.306 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 68.08 45.19 1.34 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.21 0.528 . . . . 1.5 110.535 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 93.6 mt -120.74 149.93 51.56 Favored Pre-proline 0 N--CA 1.503 2.202 0 N-CA-C 107.64 -1.245 . . . . 1.37 107.64 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.11 141.69 94.64 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.927 1.751 . . . . 0.76 111.301 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -171.49 152.41 3.23 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.523 -1.271 . . . . 1.19 111.898 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 202' ' ' ILE . 89.6 mt -121.84 146.4 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.695 -1.224 . . . . 1.31 107.695 178.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 181' ' ' THR . 21.4 m -127.66 -15.43 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 O-C-N 121.149 -0.97 . . . . 1.38 110.694 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.0 27.4 14.56 Favored Glycine 0 N--CA 1.504 3.193 0 O-C-N 121.389 -0.819 . . . . 1.03 111.098 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.0 p -49.14 -33.42 12.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.741 -1.446 . . . . 1.38 110.164 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 84.68 -87.31 1.55 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.708 -1.357 . . . . 1.17 109.708 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' A' ' 207' ' ' SER . 27.5 t -125.31 39.16 4.03 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.558 -0.966 . . . . 2.07 112.571 -177.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.15 -40.62 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.444 -1.41 . . . . 1.35 109.036 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.493 ' HG1' ' N ' ' A' ' 210' ' ' SER . 1.4 p -56.36 -31.41 63.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.263 -0.898 . . . . 1.49 109.94 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.493 ' N ' ' HG1' ' A' ' 209' ' ' THR . 23.0 t -71.71 -28.96 64.05 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.168 -0.957 . . . . 2.16 109.338 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -94.92 -9.57 33.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.283 -0.885 . . . . 2.89 111.176 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 63.6 t -102.61 137.14 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.95 -1.093 . . . . 1.33 110.632 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -114.11 155.04 26.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.751 -1.203 . . . . 2.73 107.751 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 57.5 t-20 -59.89 139.89 57.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.004 -1.06 . . . . 2.7 109.92 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.0 t0 84.55 6.44 0.57 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.407 0.622 . . . . 2.38 109.434 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 54.8 t0 -76.01 136.81 39.97 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.374 -0.829 . . . . 2.09 108.959 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.508 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 35.5 t80 -89.84 117.47 28.7 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.674 -1.232 . . . . 1.45 107.674 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 86.6 mt -125.97 145.01 50.47 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.287 -0.883 . . . . 1.31 110.808 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.1 mt -115.27 129.95 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.102 -1.073 . . . . 1.29 108.102 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 35.5 tp -103.95 117.66 34.85 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.14 -0.975 . . . . 1.31 109.133 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.525 ' C ' ' H ' ' A' ' 223' ' ' VAL . 92.4 m-20 -74.85 -43.48 54.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.069 -1.019 . . . . 2.31 108.962 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 51.24 9.84 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.255 -0.646 . . . . 1.19 109.255 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.525 ' H ' ' C ' ' A' ' 221' ' ' ASP . 47.0 t -129.82 -40.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 107.5 -1.296 . . . . 1.45 107.5 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -101.97 1.81 37.12 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.771 -0.825 . . . . 3.13 108.771 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 59.99 41.95 16.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.604 -0.685 . . . . 2.2 109.698 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -136.6 146.22 45.81 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.316 -0.865 . . . . 2.32 110.079 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.32 130.01 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.266 -1.013 . . . . 1.4 108.266 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -100.68 123.68 45.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.367 -0.833 . . . . 1.29 108.879 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.0 t -99.1 110.84 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.373 -0.829 . . . . 1.38 110.93 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 34.5 t30 49.68 59.93 16.05 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.503 -0.748 . . . . 2.33 111.047 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.67 151.93 19.57 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.694 2.263 . . . . 0.95 111.925 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 41.7 p -68.39 161.27 27.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.117 -0.99 . . . . 2.31 109.761 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.03 -38.28 82.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 3.45 108.972 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -59.87 -40.08 87.47 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.682 -0.859 . . . . 2.89 108.682 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.33 -39.87 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 1.73 109.36 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.4 HG22 HD11 ' A' ' 236' ' ' ILE . 91.6 mt -69.22 -40.01 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.186 -0.946 . . . . 1.57 109.147 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.96 -39.93 87.32 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.358 -0.839 . . . . 2.43 108.841 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -60.1 -40.81 90.94 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.934 -1.136 . . . . 3.18 107.934 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.541 ' O ' ' N ' ' A' ' 242' ' ' VAL . 98.1 mtp -68.05 -79.03 0.06 Allowed 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.186 -1.783 . . . . 1.59 106.186 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.636 ' NH1' ' CE2' ' A' ' 13' ' ' PHE . 15.3 mmt-85 -23.23 -43.83 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 N-CA-C 112.061 0.393 . . . . 3.11 112.061 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 239' ' ' MET . . . -59.97 -50.04 75.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.777 -1.202 . . . . 2.17 108.833 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 239' ' ' MET . 55.0 t -60.2 -39.96 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.074 -1.016 . . . . 2.51 108.56 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -60.07 -39.78 87.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.388 -0.82 . . . . 3.82 109.782 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -55.13 -38.49 68.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.0 -1.062 . . . . 1.78 109.072 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -60.01 -39.95 87.58 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.976 -1.12 . . . . 2.77 107.976 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 91.7 t -67.98 -38.12 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.839 -0.8 . . . . 2.25 108.839 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.16 -39.76 72.84 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.918 -0.771 . . . . 2.54 108.918 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 46.4 m -71.52 -39.39 70.8 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.107 -0.996 . . . . 3.03 109.811 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -63.05 -40.08 96.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.285 -0.884 . . . . 3.34 111.772 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -70.01 -19.08 63.34 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.568 -1.332 . . . . 4.18 110.558 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -60.04 -43.26 95.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.854 -1.153 . . . . 4.43 108.856 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 50.01 40.08 20.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.414 -0.803 . . . . 5.42 110.615 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 86.4 mt -100.43 7.61 44.11 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.829 -1.17 . . . . 6.11 108.731 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -100.09 -79.48 0.49 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.759 -0.83 . . . . 7.37 108.759 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -137.44 162.82 32.62 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.627 -0.879 . . . . 8.3 108.627 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.435 ' CD1' ' N ' ' A' ' 256' ' ' LEU . 8.8 mp -59.92 -38.68 83.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.184 -0.948 . . . . 9.05 110.11 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -148.34 159.95 43.49 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.952 -1.093 . . . . 10.56 109.725 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.557 ' CG ' ' H ' ' A' ' 259' ' ' ARG . 27.5 p-10 -157.3 -115.07 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.147 -0.97 . . . . 11.32 108.946 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . 0.557 ' H ' ' CG ' ' A' ' 258' ' ' ASP . 38.1 ttm-85 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.016 -0.992 . . . . 12.74 109.35 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 301' ' ' MET . . . . . 0.418 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 27.5 ttp . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.451 0.643 . . . . 0.0 109.573 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . 0.418 ' N ' ' CG ' ' B' ' 301' ' ' MET . 16.3 t80 -152.7 149.91 28.9 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . 0.408 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 14.6 pt20 -149.34 159.75 44.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.988 -1.07 . . . . 0.0 110.413 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -153.16 149.4 27.99 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -111.47 134.86 52.75 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.075 -1.016 . . . . 0.0 109.94 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.86 121.29 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 122.333 1.063 . . . . 0.0 112.735 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 16.9 m -75.92 105.35 6.91 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.941 0.877 . . . . 0.0 109.538 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.0 mt -53.13 123.64 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 122.469 1.128 . . . . 0.0 111.104 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 44.4 p -107.48 23.65 14.11 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.079 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -86.38 114.26 56.66 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.376 -0.828 . . . . 0.0 109.384 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -65.89 -6.9 15.27 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 120.289 1.139 . . . . 0.0 112.17 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -113.31 2.67 15.6 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.28 176.07 18.48 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.483 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -84.18 87.4 7.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.761 -1.435 . . . . 0.0 108.812 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . 0.459 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 3.6 p80 -92.65 -160.26 0.73 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.193 -0.942 . . . . 0.0 109.696 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 5.5 m -57.89 -49.7 75.83 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.912 -1.117 . . . . 0.0 112.168 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.545 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 11.4 tpt180 -52.35 -59.04 9.41 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 120.63 -1.294 . . . . 0.0 112.024 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . 0.459 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 17.8 Cg_endo -63.36 -35.03 64.28 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 CA-C-N 120.613 1.255 . . . . 0.0 111.483 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.35 78.01 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -57.57 -44.86 85.62 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.313 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -69.1 -44.53 72.27 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.626 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -60.01 -50.05 75.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.694 -0.629 . . . . 0.0 111.004 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.52 -29.18 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.529 -1.357 . . . . 0.0 109.206 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -59.93 -46.6 88.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.53 -0.731 . . . . 0.0 109.833 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -69.26 -40.6 77.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 0.0 111.426 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.19 -51.48 69.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.55 -1.344 . . . . 0.0 109.997 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -58.97 -13.33 6.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 109.307 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.6 -30.85 70.67 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -105.54 141.8 36.39 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.54 -0.977 . . . . 0.0 108.534 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 35.2 m -90.2 -11.43 41.04 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.841 -1.162 . . . . 0.0 109.539 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 93.8 p -57.99 151.2 18.96 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.139 -0.976 . . . . 0.0 108.784 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -68.06 130.48 43.09 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.213 -0.929 . . . . 0.0 108.813 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 80.1 mt -130.65 130.48 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.5 -0.75 . . . . 0.0 109.143 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 45.3 m -127.85 152.13 48.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.478 -0.764 . . . . 0.0 108.996 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 75.5 t -119.12 138.43 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 98.8 m -132.21 129.31 39.55 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.262 -0.899 . . . . 0.0 110.204 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 337' ' ' SER . . . . . 0.545 ' C ' ' H ' ' B' ' 339' ' ' GLY . 80.2 p -136.91 126.77 25.72 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.466 -0.771 . . . . 0.0 109.791 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 56.8 t30 57.09 5.58 0.26 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.59 0.71 . . . . 0.0 109.505 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . 0.545 ' H ' ' C ' ' B' ' 337' ' ' SER . . . 101.91 10.16 40.85 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -100.56 119.27 38.28 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 32.4 m -99.06 149.75 22.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.182 -0.949 . . . . 0.0 111.908 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -149.69 149.54 30.76 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 8.8 t -90.55 131.43 36.28 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.119 -0.988 . . . . 0.0 110.297 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -70.06 -16.63 63.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.152 -0.967 . . . . 0.0 110.047 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . 0.48 ' NZ ' ' CB ' ' B' ' 345' ' ' LYS . 0.1 OUTLIER -89.52 19.59 4.46 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 28.4 t -147.99 99.0 3.02 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.057 0.932 . . . . 0.0 111.572 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 58.9 tp -58.98 -36.2 74.48 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -55.17 -53.05 60.94 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.312 -0.868 . . . . 0.0 111.363 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -70.04 -29.75 66.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 0.0 109.74 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 55.7 mt -59.75 -39.4 84.64 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.414 -0.804 . . . . 0.0 111.196 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.546 ' NE2' ' CZ ' ' A' ' 126' ' ' ARG . 3.0 mm100 -65.78 -14.75 61.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.187 -1.571 . . . . 0.0 111.673 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 40.5 p -77.53 -10.89 59.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.13 -1.607 . . . . 0.0 110.156 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 52.8 mt -93.44 115.08 27.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.113 -0.992 . . . . 0.0 109.043 178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -72.24 93.97 0.62 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 107.772 -2.131 . . . . 0.0 107.772 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 80.6 mt -100.21 88.08 3.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.241 -1.152 . . . . 0.0 110.341 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 44.7 p -92.31 -179.99 5.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.977 -1.077 . . . . 0.0 110.651 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -71.23 114.07 8.92 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.597 -0.689 . . . . 0.0 110.605 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.77 10.65 32.33 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 25.6 m -90.99 108.17 19.68 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.353 -1.086 . . . . 0.0 110.578 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 99.8 t -76.99 118.17 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 122.181 0.991 . . . . 0.0 109.366 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 14.9 m -111.92 178.19 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 28.2 m -131.74 129.42 40.62 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 78.6 mt -105.33 120.63 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 75.6 p -120.32 132.32 55.25 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.548 -0.72 . . . . 0.0 109.184 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.21 149.56 36.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 109.799 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -147.0 125.84 12.69 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 158.72 -158.9 29.78 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 118.913 -1.613 . . . . 0.0 111.401 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -59.94 -52.53 65.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 122.178 -0.601 . . . . 0.0 111.794 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.411 ' O ' ' C ' ' B' ' 370' ' ' GLU . 70.9 m-20 -107.59 11.75 28.32 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.973 -1.079 . . . . 0.0 111.384 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 369' ' ' ASP . 12.9 pt-20 -37.78 -33.59 0.08 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.402 -0.812 . . . . 0.0 111.578 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -66.7 -51.17 59.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.906 -1.121 . . . . 0.0 110.925 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -64.08 -48.9 74.38 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.908 -1.12 . . . . 0.0 108.915 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.31 -40.75 3.7 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.53 -0.731 . . . . 0.0 111.594 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 94.7 t -76.13 -35.86 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.615 -1.303 . . . . 0.0 109.708 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.7 -59.07 5.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.103 -0.998 . . . . 0.0 111.832 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -70.02 -40.79 74.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.762 -1.211 . . . . 0.0 111.867 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.98 -41.14 91.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.676 -1.265 . . . . 0.0 109.422 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.63 -44.6 99.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.897 -1.127 . . . . 0.0 109.732 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' B' ' 383' ' ' GLU . 57.7 mtpt -68.97 -55.99 9.2 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 53.8 tp -54.49 -37.71 65.59 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.732 -0.605 . . . . 0.0 109.404 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 6.4 tpp -72.79 -40.0 66.26 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.602 -1.311 . . . . 0.0 108.441 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -79.97 -5.27 55.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.545 -0.722 . . . . 0.0 110.19 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' B' ' 379' ' ' LYS . 53.7 mm-40 -110.61 0.97 17.76 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.19 -0.944 . . . . 0.0 111.069 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 17.4 mt -90.8 124.59 35.26 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.518 -1.364 . . . . 0.0 109.107 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 . . . . . 0 N--CA 1.499 1.986 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.376 179.828 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.7 mtm . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.356 -0.609 . . . . 3.19 109.356 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.427 HG22 HD11 ' A' ' 2' ' ' ILE . 85.3 mt -110.36 129.0 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.533 -0.73 . . . . 1.71 109.311 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.7 m -140.79 120.55 13.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.375 -0.828 . . . . 1.66 109.23 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.7 -164.98 39.18 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.743 -1.343 . . . . 1.05 109.743 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.1 mt -86.44 -1.54 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.172 -1.193 . . . . 1.59 110.583 -178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.2 tp 52.53 88.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.799 -1.188 . . . . 1.47 109.07 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.74 -38.0 64.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.254 -0.904 . . . . 1.39 109.509 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.0 t -149.71 135.52 10.12 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.375 -0.828 . . . . 2.09 109.427 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -80.43 145.56 16.78 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.23 1.954 . . . . 0.91 113.772 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.441 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 159.84 -159.37 30.59 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.189 -1.564 . . . . 0.92 109.189 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.2 mt -149.54 150.01 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.047 -1.266 . . . . 1.35 108.955 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.44 150.37 26.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.054 -1.029 . . . . 1.14 110.53 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -130.25 126.22 36.77 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 107.969 -1.123 . . . . 0.7 107.969 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.8 178.04 48.4 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.429 -1.843 . . . . 0.58 111.096 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -80.01 159.61 26.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.89 -0.771 . . . . 2.63 109.679 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.38 132.04 45.97 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.376 -0.828 . . . . 1.27 111.582 -178.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.0 tp -105.27 133.42 50.07 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.717 -1.586 . . . . 1.41 106.717 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.8 tp -117.11 123.51 46.96 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.138 -0.976 . . . . 1.49 110.747 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 48.7 mt -92.43 104.13 16.49 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.755 -0.59 . . . . 1.52 110.473 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.66 137.56 32.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.318 -0.864 . . . . 3.17 109.341 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -131.12 134.14 46.27 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.241 -0.912 . . . . 3.0 109.492 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -88.21 139.96 29.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.116 -0.99 . . . . 2.77 109.074 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -62.31 140.78 58.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.034 -1.041 . . . . 2.94 109.268 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.3 mt -79.18 132.3 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 1.46 108.766 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.2 t -104.64 126.66 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.426 -0.797 . . . . 1.7 109.897 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -100.27 138.61 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.789 -0.819 . . . . 1.54 108.789 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -90.61 125.65 35.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.997 -1.064 . . . . 1.81 109.204 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -89.94 1.43 56.25 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.692 -0.855 . . . . 3.23 108.692 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.95 139.93 57.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.42 -0.8 . . . . 3.29 109.747 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -88.04 137.92 31.9 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.305 -0.872 . . . . 2.8 109.24 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.8 pt -90.57 159.98 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.994 -1.067 . . . . 1.43 109.442 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.4 p -94.65 171.78 8.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.061 -1.024 . . . . 1.54 108.687 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.58 -46.69 83.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 1.6 108.997 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 25.6 t0 -55.84 -32.7 63.84 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.758 -1.214 . . . . 2.56 109.516 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -81.51 -9.98 59.58 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.12 -0.988 . . . . 2.36 110.425 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 t -64.15 -53.02 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.6 -1.312 . . . . 1.43 108.8 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -61.72 -39.99 93.47 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.439 -0.788 . . . . 1.77 110.027 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.2 mm100 -67.96 -41.87 81.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 3.32 110.492 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -65.42 -39.98 92.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.065 -1.022 . . . . 1.51 110.575 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.98 -46.17 94.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.688 -1.258 . . . . 1.41 108.79 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -60.03 -40.01 87.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.846 -1.159 . . . . 1.81 108.94 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.476 HH11 ' HG2' ' A' ' 42' ' ' ARG . 17.9 mtt-85 -60.01 -43.28 95.35 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.973 -1.121 . . . . 3.26 107.973 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 28.6 t80 -60.84 -50.05 74.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.475 -0.766 . . . . 0.81 109.064 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.6 tp -61.87 -44.66 96.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.414 -0.804 . . . . 1.59 109.035 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.6 t -65.47 -43.74 89.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -0.943 . . . . 1.38 109.176 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.98 -45.71 95.43 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.684 -2.166 . . . . 0.87 107.684 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -60.66 -39.28 87.76 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.389 -0.967 . . . . 3.62 108.389 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.26 -40.18 64.42 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.286 -0.635 . . . . 1.43 109.286 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 50' ' ' ALA . 22.3 ttmt -65.81 -73.58 0.13 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.168 -1.419 . . . . 3.08 107.168 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.91 -38.99 0.34 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.35 -0.844 . . . . 1.33 111.222 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 t -51.93 -56.03 16.64 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.603 -1.311 . . . . 1.85 108.816 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.81 -40.72 79.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.86 . . . . 1.35 111.15 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -69.95 -40.05 75.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.748 -1.22 . . . . 2.34 110.008 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.04 -40.05 94.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.996 -1.065 . . . . 2.2 108.964 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -64.26 -33.93 76.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.26 -0.9 . . . . 1.35 109.361 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.5 m -64.87 -42.5 94.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.035 -1.041 . . . . 1.34 109.784 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.575 ' CD1' HH22 ' A' ' 136' ' ' ARG . 97.9 mt -62.27 -40.07 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 1.26 109.086 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -51.92 -49.99 61.99 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.447 -0.783 . . . . 1.7 109.426 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.6 m -59.44 -40.0 85.36 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.124 -0.985 . . . . 1.35 110.878 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -63.5 -37.88 88.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.745 -1.222 . . . . 2.08 109.835 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.32 -46.59 79.7 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.62 -0.675 . . . . 1.21 110.097 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.98 -49.57 77.08 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.274 -1.13 . . . . 0.75 110.274 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.97 -44.95 71.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.857 -1.378 . . . . 1.59 110.161 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.1 m -69.66 -57.23 5.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 1.41 111.54 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -97.11 -57.34 2.29 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.026 -1.046 . . . . 0.79 110.948 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.0 -163.75 26.94 Favored Glycine 0 N--CA 1.503 3.133 0 C-N-CA 119.802 -1.19 . . . . 1.22 111.041 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -67.92 -26.2 65.86 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.712 -0.875 . . . . 5.81 110.605 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -60.0 -36.36 77.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 3.37 110.211 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -100.5 -18.71 16.53 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.471 -0.768 . . . . 2.37 110.729 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -70.27 -43.1 71.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.779 -1.201 . . . . 1.65 110.838 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.41 -32.29 73.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.301 -0.874 . . . . 1.42 110.226 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.08 -39.92 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.854 -1.153 . . . . 1.43 109.307 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -64.48 -40.04 94.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.753 -1.217 . . . . 1.08 109.687 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.51 -40.37 91.2 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.105 -0.997 . . . . 1.37 109.614 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.98 -49.2 63.82 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.76 -1.736 . . . . 0.67 108.76 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.2 m170 -59.98 -43.35 95.18 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.374 -1.074 . . . . 1.99 108.687 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.81 -48.98 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.122 -0.986 . . . . 1.22 109.1 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.0 ttp -60.1 -42.7 95.26 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.043 -1.035 . . . . 2.11 109.491 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.408 ' CD1' ' CE2' ' B' ' 348' ' ' PHE . 46.8 tp -61.96 -39.36 91.88 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.37 -0.831 . . . . 1.33 108.772 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.05 -39.97 87.8 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.501 -0.749 . . . . 1.29 109.328 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -83.73 9.9 10.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.348 -0.845 . . . . 1.47 109.804 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 62.5 t0 -53.37 133.23 40.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.946 . . . . 1.47 109.984 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.469 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 99.2 mt-10 -59.06 -24.04 62.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.684 -0.635 . . . . 1.78 111.496 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -71.09 -34.65 71.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.896 -1.128 . . . . 2.53 109.871 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.9 mt -70.2 -40.02 74.85 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.585 0.707 . . . . 1.36 109.858 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.96 -48.9 79.81 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.364 -0.835 . . . . 1.42 110.31 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -70.13 -42.96 71.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.369 -0.832 . . . . 2.27 111.57 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.01 -40.02 75.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.082 -1.011 . . . . 1.57 112.119 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.75 -47.73 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.852 -1.155 . . . . 1.19 109.842 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.5 mt -66.51 -38.57 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.796 . . . . 1.39 109.904 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.9 88.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.178 -0.951 . . . . 1.39 111.26 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.1 mt -60.0 -46.61 88.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.773 -1.205 . . . . 1.5 109.945 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.1 mt -59.96 -46.14 94.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.751 -1.203 . . . . 1.29 107.751 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -67.99 -40.36 83.1 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.925 -0.71 . . . . 2.64 110.238 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -80.74 -55.9 4.51 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.035 -1.041 . . . . 1.65 112.437 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.01 -3.25 58.09 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.973 -1.08 . . . . 2.5 111.971 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 74.9 m80 57.13 41.12 27.71 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.885 -1.134 . . . . 1.88 109.236 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 68.0 mtp -95.62 169.18 10.21 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.445 0.641 . . . . 1.71 110.103 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 68.2 p -78.58 160.36 27.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.386 -0.821 . . . . 1.61 109.576 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.0 -39.12 87.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 1.33 110.155 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 18.2 p-10 -70.04 -34.06 72.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.013 -1.054 . . . . 2.07 109.349 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.08 -44.08 22.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 1.37 109.776 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.04 -43.12 71.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.448 -0.783 . . . . 1.14 110.229 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.93 87.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.99 -1.069 . . . . 1.26 109.72 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.466 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 82.4 t60 -60.05 -40.01 87.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.394 -0.816 . . . . 2.02 110.574 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.32 -41.87 93.54 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.044 -1.035 . . . . 1.33 110.74 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.89 -50.73 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.002 -1.061 . . . . 1.3 110.851 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.8 mm -69.9 -40.08 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.918 -1.114 . . . . 1.32 109.01 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.466 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.0 tt0 -63.82 -37.83 88.83 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.36 -0.978 . . . . 2.44 108.36 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.96 -54.1 40.25 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.598 -1.001 . . . . 0.99 110.598 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -64.77 -49.87 69.05 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.756 -1.438 . . . . 1.97 109.219 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.89 -41.93 88.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 1.43 109.085 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.9 t -58.84 -39.97 82.83 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.349 -0.844 . . . . 2.12 108.95 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.05 96.25 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.354 -0.841 . . . . 1.64 109.366 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.5 mt -63.58 -40.64 97.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.049 -1.032 . . . . 1.93 109.892 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.86 -36.54 77.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.846 -1.159 . . . . 2.2 109.508 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -53.85 -21.93 8.7 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.247 -0.908 . . . . 2.12 108.89 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 35.5 mt -62.95 142.6 58.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 2.34 109.349 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -91.11 12.78 18.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.406 -0.809 . . . . 3.23 109.425 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -100.4 126.5 46.79 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.261 -0.899 . . . . 2.49 110.147 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.402 ' O ' ' CD ' ' A' ' 121' ' ' GLU . 5.0 tm-20 -69.92 -29.96 67.26 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.686 0.755 . . . . 3.95 109.014 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.426 ' OH ' ' C ' ' B' ' 314' ' ' LEU . 19.3 t80 -62.83 -42.84 99.9 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 122.007 0.908 . . . . 2.25 110.109 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.429 ' CD2' ' O ' ' B' ' 351' ' ' GLN . 79.2 mt -76.16 -31.24 58.46 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.771 -0.825 . . . . 2.27 108.771 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -60.07 -40.85 90.94 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.475 -0.765 . . . . 3.31 108.985 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.11 -44.24 95.01 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.574 -0.899 . . . . 2.73 108.574 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.671 HH21 ' NE2' ' B' ' 351' ' ' GLN . 62.5 mtp180 -62.07 -39.67 93.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 3.2 109.138 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.98 -32.57 70.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.448 -0.782 . . . . 1.66 109.449 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.06 94.29 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.656 -0.868 . . . . 1.67 108.656 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -62.61 -40.08 95.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.421 -0.799 . . . . 1.55 110.192 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.06 -43.04 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 1.32 109.924 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -60.01 -40.0 87.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.081 -1.012 . . . . 3.58 109.538 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.03 -38.23 82.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.348 -0.845 . . . . 1.46 109.931 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.97 -43.31 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.122 -0.986 . . . . 1.22 110.358 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.2 -32.62 62.67 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.673 -1.251 . . . . 0.61 110.114 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -59.96 -49.97 75.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.107 -1.231 . . . . 3.1 109.283 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.575 HH22 ' CD1' ' A' ' 57' ' ' ILE . 59.5 mtp180 -65.61 -34.99 79.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 3.71 109.994 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.0 tp -59.96 -43.46 95.05 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.224 -0.922 . . . . 1.87 109.48 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.14 -39.96 94.36 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.087 -1.008 . . . . 1.29 108.815 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.407 ' NH1' ' CD2' ' A' ' 144' ' ' LEU . 58.6 mtt-85 -70.11 -39.9 75.22 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.461 -0.94 . . . . 3.05 108.461 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -62.04 -37.05 83.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.811 -0.556 . . . . 1.26 111.165 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.06 -43.56 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.698 -1.251 . . . . 1.34 108.221 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.98 -38.03 75.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.695 -0.628 . . . . 1.6 109.579 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.49 45.45 5.24 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.255 -1.938 . . . . 0.96 108.255 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.407 ' CD2' ' NH1' ' A' ' 139' ' ' ARG . 12.0 tp -74.58 150.02 39.88 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.499 -1.001 . . . . 1.67 109.548 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -63.02 142.84 58.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.341 -0.85 . . . . 4.96 110.428 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.2 mt -119.9 126.72 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.565 -0.902 . . . . 1.68 108.565 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.4 mt -59.97 -44.89 95.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.826 -0.546 . . . . 2.14 110.298 -178.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.4 t0 67.72 94.63 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.83 -0.804 . . . . 1.5 108.83 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.448 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 34.7 mt -67.07 -8.1 27.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.457 -0.777 . . . . 1.39 109.951 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.8 t -79.94 -13.8 59.09 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.993 -1.067 . . . . 1.83 108.286 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.12 24.76 0.76 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.786 -0.571 . . . . 1.46 110.395 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.448 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 42.6 mt -92.97 118.1 37.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.021 -1.05 . . . . 1.42 108.688 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -104.83 -11.22 16.88 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.222 -0.924 . . . . 2.94 110.391 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -119.71 147.31 44.73 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.615 -0.678 . . . . 1.52 110.12 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -64.11 136.52 57.33 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.408 -0.96 . . . . 1.58 108.408 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.2 m -153.52 168.54 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.233 -0.917 . . . . 1.32 109.99 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 74.0 mt -95.94 144.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 105.883 -1.895 . . . . 1.27 105.883 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 22.1 tp -92.99 115.86 28.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.905 -1.122 . . . . 1.41 110.48 -177.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 45.7 t -123.38 129.94 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 108.76 -0.829 . . . . 1.23 108.76 179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -162.16 164.67 27.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.905 . . . . 1.32 108.795 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.44 -35.35 70.89 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.257 -1.527 . . . . 1.49 107.781 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -164.56 173.87 11.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.411 -0.959 . . . . 2.25 108.411 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.4 mt -136.48 143.1 43.64 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.115 -0.991 . . . . 1.35 109.201 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 74.7 p -95.27 141.99 23.99 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.241 -0.912 . . . . 1.56 109.342 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -39.99 -39.88 2.48 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.278 1.985 . . . . 0.87 112.514 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 68.9 m -60.04 -39.97 87.78 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.26 -0.9 . . . . 1.36 109.097 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.5 -43.69 96.47 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.27 -0.894 . . . . 1.61 110.108 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.9 p -53.87 -25.85 21.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.187 -0.946 . . . . 1.21 110.823 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.55 -54.76 5.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.82 -1.175 . . . . 1.21 109.817 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -83.76 39.85 0.71 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.698 -0.853 . . . . 2.11 108.698 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.0 tp -105.2 135.66 46.14 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.709 -0.849 . . . . 1.29 108.709 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -84.96 103.41 13.98 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.194 -0.941 . . . . 2.81 108.93 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 36.3 mt -67.14 -40.53 86.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.511 -0.743 . . . . 2.09 110.881 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -69.97 -24.15 63.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.757 -1.215 . . . . 2.86 111.433 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -92.78 -6.79 48.2 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.802 -1.186 . . . . 2.39 109.853 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 178' ' ' GLY . 84.0 t -106.56 116.67 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.329 -0.857 . . . . 1.27 108.702 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 71.3 mt -89.99 7.24 38.52 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.283 -0.886 . . . . 2.17 110.243 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.411 ' O ' ' CG1' ' A' ' 176' ' ' VAL . . . 171.89 171.88 37.32 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.176 -1.57 . . . . 0.52 109.176 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -132.37 129.66 39.69 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.321 -1.105 . . . . 0.55 109.207 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 94.7 mt -134.07 127.51 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.525 -0.917 . . . . 1.27 108.525 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.1 p -149.94 162.75 39.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.938 -1.101 . . . . 1.39 110.681 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.481 ' O ' ' O ' ' A' ' 183' ' ' ALA . 0.9 OUTLIER -100.24 20.31 14.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.506 -0.747 . . . . 2.46 109.726 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -46.69 -174.7 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 122.322 1.058 . . . . 1.51 112.823 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.36 -56.69 3.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 111.396 -0.682 . . . . 2.23 111.396 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -167.36 -159.09 12.34 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 118.484 -1.817 . . . . 2.23 111.416 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.419 ' C ' ' H ' ' A' ' 188' ' ' SER . 17.8 ptt-85 -72.29 -15.93 61.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.749 -0.854 . . . . 6.44 110.849 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 71.5 p -71.23 3.42 3.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.831 -1.168 . . . . 4.09 109.271 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.419 ' H ' ' C ' ' A' ' 186' ' ' ARG . 40.7 t -83.4 134.29 34.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 2.2 110.275 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -49.88 -38.96 37.91 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.169 -1.049 . . . . 1.15 108.169 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.6 p -59.94 -41.49 91.93 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.928 -0.578 . . . . 2.01 110.493 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 41.2 t -62.06 -38.61 89.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.113 -0.992 . . . . 1.93 110.669 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.3 mm -60.0 -39.35 80.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.236 -0.915 . . . . 2.2 109.19 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.1 mtp -59.5 -44.43 93.11 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.245 -0.909 . . . . 1.32 110.102 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.36 -44.48 80.15 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.647 -1.283 . . . . 1.3 109.712 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -62.96 -57.81 9.49 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.142 -1.023 . . . . 3.38 110.778 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.1 m -62.7 -39.97 95.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.997 -1.064 . . . . 1.15 112.111 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.9 mt -69.95 -15.7 63.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.864 -1.147 . . . . 1.28 110.25 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 62.13 49.67 4.35 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.626 -0.671 . . . . 1.5 110.175 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 78.5 mt -130.39 149.91 74.73 Favored Pre-proline 0 N--CA 1.499 1.999 0 N-CA-C 107.682 -1.229 . . . . 1.37 107.682 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.79 147.5 62.82 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.316 2.01 . . . . 0.76 111.846 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -173.88 158.76 3.27 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.922 -1.111 . . . . 1.19 112.035 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.8 mt -130.96 144.75 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.281 -1.007 . . . . 1.31 108.281 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 28.0 m -128.98 -7.53 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.99 -1.069 . . . . 1.38 111.064 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.75 24.48 13.17 Favored Glycine 0 N--CA 1.501 3.032 0 N-CA-C 110.799 -0.92 . . . . 1.03 110.799 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.429 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.1 p -46.77 -44.14 18.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.876 -1.367 . . . . 1.38 109.748 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.57 -55.5 2.71 Favored Glycine 0 N--CA 1.498 2.803 0 C-N-CA 120.166 -1.016 . . . . 1.17 111.825 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 34.3 p -149.82 25.92 0.83 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.6 -1.53 . . . . 2.07 111.646 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.97 -39.62 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.773 -1.205 . . . . 1.35 108.964 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.474 ' HG1' ' N ' ' A' ' 210' ' ' SER . 50.4 p -58.0 -36.65 72.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.498 -0.751 . . . . 1.49 110.173 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.474 ' N ' ' HG1' ' A' ' 209' ' ' THR . 80.9 p -84.99 -11.74 54.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.013 -1.054 . . . . 2.16 110.25 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -95.87 -14.93 22.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.054 -1.029 . . . . 2.89 110.305 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.79 154.37 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.275 -0.891 . . . . 1.33 110.469 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.457 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 11.1 mptt -117.2 156.45 27.67 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.701 -1.222 . . . . 2.73 107.701 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 27.5 p30 -60.02 142.68 53.53 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.053 -1.029 . . . . 2.7 110.431 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 11.0 t0 86.62 0.83 0.56 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 120.919 0.39 . . . . 2.38 110.359 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.457 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 91.8 m-20 -75.05 153.78 38.25 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.938 -1.101 . . . . 2.09 108.814 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -96.44 131.27 43.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.226 -1.027 . . . . 1.45 108.226 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 82.6 mt -129.52 149.65 51.2 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.192 -0.943 . . . . 1.31 110.994 -178.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 219' ' ' ILE . 85.5 mt -120.59 122.64 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.816 -1.549 . . . . 1.29 106.816 175.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 57.2 tp -98.73 115.51 28.89 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.733 -1.23 . . . . 1.31 109.223 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 223' ' ' VAL . 96.0 m-20 -75.57 -44.61 42.36 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.031 -1.043 . . . . 2.31 108.29 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 46.95 17.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.978 0.894 . . . . 1.19 108.62 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.1 t -132.08 -45.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 106.654 -1.609 . . . . 1.45 106.654 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -100.33 1.93 42.04 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.685 -1.228 . . . . 3.13 107.685 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 60.53 44.15 12.1 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.79 -0.569 . . . . 2.2 109.824 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -139.65 141.84 37.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.323 -0.86 . . . . 2.32 109.525 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 97.2 t -119.98 120.85 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 109.112 -0.699 . . . . 1.4 109.112 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -89.04 131.67 35.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.981 -1.074 . . . . 1.29 108.715 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 64.2 t -109.33 122.92 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.709 -0.619 . . . . 1.38 109.64 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 62.49 69.15 0.94 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.524 -0.735 . . . . 2.33 109.745 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -90.18 127.85 1.48 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 123.417 2.744 . . . . 0.95 112.276 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.0 167.18 12.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.095 -1.003 . . . . 2.31 109.341 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -59.94 -40.0 87.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 3.45 110.07 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.438 ' O ' ' OD2' ' A' ' 237' ' ' ASP . 58.3 mp0 -60.0 -39.98 87.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -0.945 . . . . 2.89 110.085 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.32 -39.4 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 1.73 110.049 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.9 mt -66.77 -39.93 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 1.57 110.903 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 238' ' ' LYS . 1.0 OUTLIER -60.0 -41.49 92.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.607 -1.308 . . . . 2.43 108.969 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.492 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 8.3 ttpm? -60.14 -46.52 89.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.595 -0.69 . . . . 3.18 110.227 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 78.3 mtp -72.4 -23.26 61.07 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.288 -0.882 . . . . 1.59 110.058 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 15.4 mmm-85 -70.27 -40.14 74.51 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.022 -1.049 . . . . 3.11 109.105 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.18 -43.08 96.15 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.345 -0.847 . . . . 2.17 109.01 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.2 t -59.99 -45.95 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.392 -0.818 . . . . 2.51 108.889 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -60.18 -40.0 88.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.849 . . . . 3.82 109.962 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -61.46 -40.19 93.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.035 -1.041 . . . . 1.78 109.736 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -61.38 -39.95 92.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 2.77 109.985 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.04 -45.5 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.14 -0.975 . . . . 2.25 108.947 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.13 -50.13 74.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.399 -0.813 . . . . 2.54 109.685 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 252' ' ' GLU . 66.3 m -60.07 -40.0 88.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.303 -0.873 . . . . 3.03 109.616 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -63.92 -39.91 95.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.386 -0.821 . . . . 3.34 109.067 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -91.53 -0.06 57.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.587 -0.696 . . . . 4.18 110.395 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -130.78 -45.76 1.05 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.445 -1.409 . . . . 4.43 110.606 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 248' ' ' SER . 86.3 tt0 -167.42 109.41 0.64 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.946 -1.097 . . . . 5.42 109.006 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 21.4 mt -65.5 -27.13 68.26 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.21 -1.033 . . . . 6.11 108.21 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 255' ' ' LYS . . . 60.27 12.98 3.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.868 -0.52 . . . . 7.37 109.691 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.518 ' C ' ' H ' ' A' ' 257' ' ' LYS . 51.6 tttm 39.97 -129.97 0.34 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.702 -0.624 . . . . 8.3 110.171 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 257' ' ' LYS . 0.5 OUTLIER 67.61 -6.24 0.69 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.22 -0.925 . . . . 9.05 109.045 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.518 ' H ' ' C ' ' A' ' 255' ' ' LYS . 31.8 ttmt 55.8 155.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.544 0.688 . . . . 10.56 110.214 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -164.37 -89.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.023 -1.048 . . . . 11.32 109.675 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 117.949 -1.024 . . . . 12.74 109.447 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 301' ' ' MET . . . . . 0.485 ' N ' ' OE1' ' B' ' 366' ' ' GLU . 21.6 ttt . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 22.3 t80 -156.08 154.55 31.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 109.48 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . 0.506 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 20.6 pt20 -148.5 160.03 43.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.288 -0.883 . . . . 0.0 109.674 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -151.81 149.97 29.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.309 -0.869 . . . . 0.0 109.596 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 56.5 mp0 -105.94 130.63 53.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.382 -0.824 . . . . 0.0 109.742 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 10.2 p -130.58 117.73 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-O 122.25 1.024 . . . . 0.0 113.071 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 86.7 m -78.24 105.21 9.32 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.057 0.932 . . . . 0.0 110.53 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.7 mt -53.13 125.96 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 122.429 1.109 . . . . 0.0 111.264 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 22.6 p -112.04 19.94 17.37 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.557 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.71 120.65 82.31 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.746 -1.221 . . . . 0.0 109.402 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -50.96 -18.9 4.86 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 CA-C-N 120.205 1.109 . . . . 0.0 113.463 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -119.43 14.29 12.81 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.233 -0.917 . . . . 0.0 109.603 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.61 179.45 35.25 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.426 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 3.9 tp -85.38 95.41 9.23 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.05 -1.265 . . . . 0.0 109.477 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . 0.401 ' CA ' ' OH ' ' A' ' 122' ' ' TYR . 3.7 p80 -97.96 -160.72 0.82 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.934 -1.104 . . . . 0.0 110.108 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 7.9 m -59.92 -41.94 92.83 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.095 -1.003 . . . . 0.0 112.295 -176.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.639 HH21 ' NE2' ' B' ' 321' ' ' GLN . 1.0 OUTLIER -55.33 -62.13 4.89 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.538 -1.351 . . . . 0.0 111.224 -178.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.05 -33.23 97.05 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 120.242 1.122 . . . . 0.0 111.765 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.95 -50.79 72.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.254 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.46 -43.12 75.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.464 -0.772 . . . . 0.0 110.736 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . 0.639 ' NE2' HH21 ' B' ' 317' ' ' ARG . 27.7 mt-30 -73.49 -40.08 64.36 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.037 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -60.09 -50.26 74.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 0.0 110.431 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.45 -40.02 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.566 -1.334 . . . . 0.0 108.981 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -59.9 -45.77 91.48 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -62.49 -45.88 91.0 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.103 -0.998 . . . . 0.0 108.437 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . 0.409 ' C ' ' H ' ' B' ' 328' ' ' GLY . . . -60.09 -51.21 70.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.617 -0.677 . . . . 0.0 110.308 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -57.72 -10.46 1.63 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.913 -1.117 . . . . 0.0 109.082 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . 0.409 ' H ' ' C ' ' B' ' 326' ' ' ALA . . . -69.91 -29.89 70.57 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -103.36 144.89 30.78 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.561 -0.964 . . . . 0.0 108.915 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 16.6 p -91.39 -13.19 32.85 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.789 -1.195 . . . . 0.0 109.916 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 83.9 p -58.97 151.34 22.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.983 -1.073 . . . . 0.0 108.905 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.1 133.36 47.96 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.006 -1.059 . . . . 0.0 108.579 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.1 mt -131.88 131.05 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.753 -0.592 . . . . 0.0 109.802 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 89.2 m -129.82 153.51 48.19 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 84.9 t -116.11 138.27 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 77.6 m -130.03 125.4 35.2 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.119 -0.988 . . . . 0.0 109.133 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 51.6 p -139.58 117.0 11.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.197 -0.939 . . . . 0.0 110.906 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 34.4 m120 42.75 57.75 3.43 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 83.98 -14.26 44.53 Favored Glycine 0 N--CA 1.499 2.858 0 O-C-N 120.303 -1.498 . . . . 0.0 112.806 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -115.58 126.88 54.78 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-N 119.108 1.454 . . . . 0.0 109.974 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 80.0 p -127.27 148.92 50.22 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.929 0.871 . . . . 0.0 110.28 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -140.97 164.28 30.69 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.508 0.67 . . . . 0.0 109.903 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 23.2 t -87.35 137.23 32.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.493 -0.754 . . . . 0.0 109.202 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.438 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -76.73 -13.39 60.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.979 -1.076 . . . . 0.0 109.858 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.07 20.67 4.13 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.438 ' H ' ' C ' ' B' ' 344' ' ' ALA . 67.4 m -146.25 94.25 2.43 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.714 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . 0.484 ' CD1' HE22 ' B' ' 351' ' ' GLN . 56.9 tp -59.92 -33.34 71.74 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . 0.408 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 54.9 m-85 -56.75 -52.79 63.65 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.396 -0.815 . . . . 0.0 110.616 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.436 ' O ' ' OG1' ' B' ' 352' ' ' THR . 47.6 mtmt -69.33 -39.79 77.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.632 -1.292 . . . . 0.0 110.089 -178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' B' ' 352' ' ' THR . 20.9 mt -48.59 -58.49 4.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.062 -1.024 . . . . 0.0 109.07 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.671 ' NE2' HH21 ' A' ' 126' ' ' ARG . 1.3 mp0 -41.6 -14.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.555 -0.716 . . . . 0.0 111.19 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.574 ' N ' ' O ' ' B' ' 350' ' ' LEU . 50.2 p -87.65 -7.62 57.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.039 -1.663 . . . . 0.0 109.966 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 66.5 mt -97.42 116.14 29.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.129 -0.982 . . . . 0.0 109.493 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.67 93.06 1.02 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 21.8 mt -103.31 96.27 6.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.35 -1.088 . . . . 0.0 108.9 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 19.2 p -94.67 170.55 9.38 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.147 -0.971 . . . . 0.0 110.774 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.44 115.83 3.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.831 -0.543 . . . . 0.0 111.035 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 100.62 7.36 51.31 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 53.4 m -85.03 111.5 19.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.205 -1.173 . . . . 0.0 110.827 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 7.6 t -78.03 116.25 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 122.222 1.01 . . . . 0.0 109.503 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.1 m -113.64 178.62 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 86.6 m -130.45 130.86 44.79 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . 0.438 HD11 HG22 ' B' ' 363' ' ' ILE . 85.4 mt -106.86 126.26 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 177.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 71.1 m -129.96 137.17 50.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.554 -0.716 . . . . 0.0 109.48 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.32 156.54 43.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.337 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . 0.485 ' OE1' ' N ' ' B' ' 301' ' ' MET . 8.8 tp10 -145.96 122.84 11.31 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 157.42 -152.88 24.16 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 118.853 -1.641 . . . . 0.0 111.715 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -60.0 -52.96 63.15 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 122.268 -0.548 . . . . 0.0 112.357 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -110.2 11.26 23.66 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.838 -1.164 . . . . 0.0 111.224 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -42.58 -38.0 1.85 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.073 -1.017 . . . . 0.0 111.817 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -69.32 -44.17 72.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.531 -1.356 . . . . 0.0 110.158 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -70.83 -54.28 12.17 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.016 -1.053 . . . . 0.0 109.242 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.62 -35.95 1.95 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.627 -0.671 . . . . 0.0 110.771 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 53.2 t -70.04 -40.02 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.799 -1.188 . . . . 0.0 109.283 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.39 -65.38 0.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.985 -1.072 . . . . 0.0 111.668 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -59.96 -42.05 93.24 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.626 -1.296 . . . . 0.0 111.57 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 93.3 mt -59.92 -42.04 93.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.652 -1.28 . . . . 0.0 108.311 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 53.8 t -63.03 -42.36 96.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.297 -0.877 . . . . 0.0 109.684 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.4 mttt -69.99 -56.17 7.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.708 -1.245 . . . . 0.0 107.915 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 54.3 tp -54.51 -36.09 63.85 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 28.2 ttm -70.52 -40.25 73.58 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.391 -1.324 . . . . 0.0 108.413 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.46 -5.56 58.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.654 -0.654 . . . . 0.0 110.682 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' B' ' 379' ' ' LYS . 67.9 mt-10 -112.24 -1.96 15.03 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.052 -1.03 . . . . 0.0 110.708 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.3 mt -83.68 136.94 34.01 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.427 -1.42 . . . . 0.0 109.066 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.405 -179.639 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.7 mmm . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.448 -0.575 . . . . 3.19 109.448 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.4 mt -110.06 129.95 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.54 -0.911 . . . . 1.71 108.54 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.6 m -135.85 150.1 49.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.39 -0.819 . . . . 1.66 110.405 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.596 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -132.93 -164.62 10.94 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 108.081 -2.008 . . . . 1.05 108.081 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.6 mt -89.2 -14.46 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.632 -1.511 . . . . 1.59 110.353 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.0 tp 55.27 102.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.148 -0.97 . . . . 1.47 108.53 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.04 -22.86 19.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.994 -1.066 . . . . 1.39 109.633 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.5 m -149.99 133.4 8.62 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.097 -1.002 . . . . 2.09 109.677 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -80.37 141.01 13.98 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.4 2.067 . . . . 0.91 112.15 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 166.0 -165.58 38.19 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.712 -1.355 . . . . 0.92 109.712 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 11' ' ' ILE . 76.6 mt -147.54 148.01 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.22 -1.164 . . . . 1.35 108.52 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.17 156.55 34.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.939 -1.101 . . . . 1.14 110.487 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -137.01 129.64 30.26 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.315 -1.365 . . . . 0.7 107.315 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.38 -174.81 47.23 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 118.37 -1.871 . . . . 0.58 110.986 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -80.04 156.7 27.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.942 -0.74 . . . . 2.63 109.95 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.5 117.73 34.86 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.436 -0.79 . . . . 1.27 110.118 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.4 tp -89.99 131.55 35.82 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.507 -1.294 . . . . 1.41 107.507 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.5 tp -113.55 120.0 39.46 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.329 -0.857 . . . . 1.49 109.243 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.2 mt -82.74 102.76 11.75 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.515 0.674 . . . . 1.52 109.656 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -103.0 129.39 49.74 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.751 -0.833 . . . . 3.17 108.751 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.456 ' OE2' ' NZ ' ' A' ' 135' ' ' LYS . 87.0 tt0 -130.36 140.76 50.6 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.223 -0.923 . . . . 3.0 109.372 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -80.16 142.99 34.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.351 -0.843 . . . . 2.77 109.501 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -61.7 143.53 56.03 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.129 -0.982 . . . . 2.94 108.801 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.6 mt -78.16 129.16 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.084 -1.01 . . . . 1.46 109.119 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.7 t -94.14 127.59 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.223 -0.923 . . . . 1.7 109.998 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.6 mt -110.02 134.33 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.637 -0.664 . . . . 1.54 109.229 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -93.84 123.08 36.95 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.169 -0.957 . . . . 1.81 110.249 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.7 mmm-85 -90.0 -0.2 57.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.446 -0.784 . . . . 3.23 109.182 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -67.32 145.37 55.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.264 -0.897 . . . . 3.29 109.92 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -92.01 149.28 21.62 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.239 -0.913 . . . . 2.8 109.253 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.0 pt -95.7 165.81 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.998 -1.064 . . . . 1.43 109.046 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.2 p -93.11 173.93 7.48 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.419 -0.956 . . . . 1.54 108.419 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.26 78.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.898 -1.126 . . . . 1.6 109.669 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 51.8 t0 -54.93 -30.68 59.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.93 -1.106 . . . . 2.56 110.162 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -82.17 -8.67 59.66 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.177 -0.952 . . . . 2.36 110.249 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.98 -50.31 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.763 -1.21 . . . . 1.43 108.578 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -60.41 -39.96 89.26 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.359 -0.838 . . . . 1.77 108.926 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -62.25 -40.99 98.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.494 -0.753 . . . . 3.32 110.598 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -64.36 -41.63 96.62 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.813 -1.179 . . . . 1.51 110.166 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.07 -46.7 93.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.909 -1.119 . . . . 1.41 109.069 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -60.05 -40.79 90.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.055 -1.028 . . . . 1.81 109.551 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -60.06 -44.56 94.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.9 -1.125 . . . . 3.26 108.458 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -60.09 -49.16 78.76 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.313 -0.995 . . . . 0.81 108.313 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.1 -46.63 88.96 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.402 -0.962 . . . . 1.59 108.402 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.2 t -60.56 -44.47 96.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 1.38 108.875 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.02 -40.01 96.44 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.247 -1.941 . . . . 0.87 108.247 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.492 ' NH1' ' CG ' ' A' ' 47' ' ' ARG . 1.4 ttt-85 -69.11 -22.61 63.96 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.562 -0.964 . . . . 3.62 108.64 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.07 -46.37 88.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.259 -0.901 . . . . 1.43 109.155 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.598 ' CG ' ' H ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -78.15 -68.96 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.554 -1.258 . . . . 3.08 108.585 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.598 ' H ' ' CG ' ' A' ' 49' ' ' LYS . . . -37.84 -35.79 0.16 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 120.058 1.299 . . . . 1.33 110.462 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.3 t -57.97 -64.43 0.91 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.907 -1.121 . . . . 1.85 108.666 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.97 -40.07 79.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.475 -0.765 . . . . 1.35 110.832 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -63.11 -40.96 99.16 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.812 -1.18 . . . . 2.34 110.361 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 57.5 mt -62.94 -39.86 95.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.881 -1.137 . . . . 2.2 109.216 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -60.11 -38.95 84.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 1.35 110.014 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.6 m -61.24 -41.96 97.78 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.075 -1.015 . . . . 1.34 109.9 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.654 ' CD1' HH22 ' A' ' 136' ' ' ARG . 82.2 mt -61.2 -39.91 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -0.837 . . . . 1.26 109.522 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -59.97 -50.43 73.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.083 -1.011 . . . . 1.7 109.659 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -59.96 -39.14 84.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.281 -0.887 . . . . 1.35 110.125 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -66.03 -37.75 86.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.989 -1.07 . . . . 2.08 109.14 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.79 -45.53 85.91 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.599 -0.688 . . . . 1.21 109.89 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.41 -50.03 71.06 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.626 -1.39 . . . . 0.75 109.626 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -67.3 -45.87 75.24 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.294 -1.121 . . . . 1.59 109.871 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.9 m -65.23 -64.16 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.363 -0.836 . . . . 1.41 112.347 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.42 -47.91 6.65 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.723 -1.236 . . . . 0.79 111.188 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.35 -169.83 24.92 Favored Glycine 0 N--CA 1.501 3.016 0 C-N-CA 119.824 -1.179 . . . . 1.22 111.467 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.65 -27.3 64.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 122.01 -0.7 . . . . 5.81 110.41 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.514 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.3 tp10 -59.95 -32.92 71.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.275 -0.89 . . . . 3.37 110.258 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.578 ' NZ ' ' NE2' ' A' ' 189' ' ' HIS . 14.5 mmmt -98.99 -22.46 15.73 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.226 -0.921 . . . . 2.37 110.259 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.94 -40.07 94.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.954 -1.091 . . . . 1.65 109.893 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.82 -37.57 79.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.87 . . . . 1.42 110.309 -178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.01 -40.6 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.782 -1.199 . . . . 1.43 109.87 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -70.02 -34.11 72.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.858 -1.151 . . . . 1.08 109.609 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -61.18 -39.98 92.21 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.875 -1.141 . . . . 1.37 109.221 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.91 -41.84 95.2 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.547 -1.421 . . . . 0.67 109.547 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 60.9 m170 -60.16 -43.42 95.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -1.122 . . . . 1.99 109.582 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.3 mt -69.91 -43.55 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.116 -0.99 . . . . 1.22 109.491 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.2 ttp -59.96 -44.92 94.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.845 -1.159 . . . . 2.11 110.309 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.414 ' CD1' ' CE2' ' B' ' 348' ' ' PHE . 53.9 tp -62.02 -39.82 93.59 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.358 -0.839 . . . . 1.33 109.987 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.5 tp -62.16 -39.57 93.09 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.44 -0.788 . . . . 1.29 110.157 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -82.02 8.66 10.08 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.996 -1.065 . . . . 1.47 110.204 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 59.7 t0 -56.71 130.51 45.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.976 -1.077 . . . . 1.47 109.977 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.407 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.8 mt-10 -59.69 -18.43 42.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.482 -0.761 . . . . 1.78 111.019 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.89 -36.92 72.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.723 -1.235 . . . . 2.53 108.592 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.6 mt -69.99 -40.05 75.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.594 -0.691 . . . . 1.36 110.177 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.02 -49.99 75.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 1.42 110.483 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.13 -39.94 75.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.174 -0.954 . . . . 2.27 111.269 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.97 -40.18 75.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.835 -1.166 . . . . 1.57 111.66 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.2 mt -69.99 -44.15 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.739 -1.225 . . . . 1.19 109.917 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.9 mt -70.02 -37.83 73.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.616 -0.678 . . . . 1.39 110.374 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.68 84.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.988 . . . . 1.39 110.796 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 96' ' ' LYS . 84.8 mt -60.22 -47.06 87.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.082 -1.012 . . . . 1.5 109.986 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.2 mt -60.66 -50.04 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.309 -0.869 . . . . 1.29 109.447 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -70.08 -42.32 72.94 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.727 -0.789 . . . . 2.64 110.576 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -80.09 -52.79 7.36 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.188 -0.945 . . . . 1.65 112.417 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 92' ' ' LEU . 31.6 mtpt -90.12 -3.05 58.14 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.973 -1.08 . . . . 2.5 111.675 -177.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.1 m80 59.69 37.5 22.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.959 -1.088 . . . . 1.88 109.467 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 53.2 mtt -93.87 166.24 12.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.443 -0.786 . . . . 1.71 109.782 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.43 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 33.7 p -80.55 162.32 24.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.381 -0.824 . . . . 1.61 109.28 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.51 -37.61 85.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 1.33 110.102 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.43 ' OD1' ' OG1' ' A' ' 99' ' ' THR . 27.4 p-10 -69.87 -35.71 74.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 2.07 109.458 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.85 -41.05 27.09 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.296 -0.878 . . . . 1.37 109.56 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.2 -48.17 53.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.345 -0.847 . . . . 1.14 110.339 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.6 91.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 1.26 109.612 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.53 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 78.5 t60 -60.12 -40.0 88.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 2.02 109.617 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.54 -41.3 98.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.893 . . . . 1.33 110.81 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.28 -53.18 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.012 -1.055 . . . . 1.3 111.313 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.6 mm -70.0 -39.93 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.817 -1.177 . . . . 1.32 109.36 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.53 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 88.4 tt0 -64.65 -38.62 91.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.118 -0.989 . . . . 2.44 108.877 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.95 -43.7 97.86 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.479 -1.049 . . . . 0.99 110.479 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -69.94 -55.26 10.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.922 -1.34 . . . . 1.97 109.531 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.73 -40.31 69.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.183 -0.948 . . . . 1.43 109.343 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 33.8 t -57.77 -40.06 78.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.063 -1.023 . . . . 2.12 108.29 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.81 -39.56 87.77 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.743 -0.836 . . . . 1.64 108.743 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.9 mt -61.78 -42.48 99.04 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.119 -0.988 . . . . 1.93 109.673 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.43 -33.37 72.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.665 -1.272 . . . . 2.2 109.684 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.37 -23.17 35.98 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.984 -1.072 . . . . 2.12 108.506 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 21.9 mt -61.83 139.49 58.35 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.226 -1.027 . . . . 2.34 108.226 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -92.65 46.25 1.23 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.056 -1.027 . . . . 3.23 108.983 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -132.11 129.61 40.12 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.688 0.756 . . . . 2.49 109.664 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -70.05 -29.98 67.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.735 -0.603 . . . . 3.95 109.946 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.448 ' OH ' ' CA ' ' B' ' 315' ' ' HIS . 17.1 t80 -66.97 -42.97 84.24 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.958 0.885 . . . . 2.25 110.802 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.603 ' CD2' HH21 ' A' ' 126' ' ' ARG . 91.4 mt -70.67 -32.79 70.19 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.569 -0.707 . . . . 2.27 109.774 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -60.07 -39.98 87.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.312 -0.868 . . . . 3.31 108.86 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 125' ' ' GLU . 0.4 OUTLIER -59.51 -49.1 79.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.191 -0.943 . . . . 2.73 109.493 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.603 HH21 ' CD2' ' A' ' 123' ' ' LEU . 59.4 mtm180 -60.21 -39.6 87.18 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.569 -1.252 . . . . 3.2 108.418 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.44 -28.32 66.85 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.472 -0.936 . . . . 1.66 108.472 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.05 -46.75 88.52 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.407 -0.808 . . . . 1.67 108.978 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -61.29 -41.3 96.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 1.55 109.703 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.72 -44.39 98.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.299 -0.875 . . . . 1.32 109.445 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -63.6 -40.04 95.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.127 -0.983 . . . . 3.58 109.914 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -60.01 -41.09 91.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 1.46 110.341 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.96 -46.8 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.916 -1.115 . . . . 1.22 109.85 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.3 -40.34 98.89 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.756 -1.338 . . . . 0.61 109.756 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.456 ' NZ ' ' OE2' ' A' ' 21' ' ' GLU . 57.6 tttm -59.97 -49.78 76.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -1.081 . . . . 3.1 110.472 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.654 HH22 ' CD1' ' A' ' 57' ' ' ILE . 63.1 mtp180 -63.12 -39.37 94.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.123 -0.985 . . . . 3.71 110.952 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.81 -40.11 87.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 1.87 110.111 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 23.9 mt -62.35 -40.0 94.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.776 -1.203 . . . . 1.29 109.109 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -68.97 -38.74 79.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -0.846 . . . . 3.05 109.782 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -69.99 -31.22 68.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.45 -0.781 . . . . 1.26 111.887 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.56 -46.07 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.136 -1.603 . . . . 1.34 108.484 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.1 -31.23 68.7 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.634 -0.666 . . . . 1.6 109.561 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.61 45.93 4.46 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.507 -1.437 . . . . 0.96 109.507 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 tp -74.32 145.63 43.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.39 -1.065 . . . . 1.67 108.939 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -69.89 139.1 52.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.012 -1.055 . . . . 4.96 109.245 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.4 mt -111.75 129.96 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.936 0.874 . . . . 1.68 109.26 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.6 mt -59.89 -44.17 93.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.873 -0.517 . . . . 2.14 109.955 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.2 t0 66.37 99.03 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.516 0.674 . . . . 1.5 109.23 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.5 mt -66.46 -7.28 18.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.518 -0.739 . . . . 1.39 109.208 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -84.78 -16.82 40.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.463 -0.773 . . . . 1.83 109.208 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.31 13.08 3.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.436 -0.79 . . . . 1.46 111.162 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.539 ' N ' ' CD1' ' A' ' 152' ' ' ILE . 1.4 mp -90.28 126.21 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.58 -1.325 . . . . 1.42 108.804 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -104.09 -7.47 20.21 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.547 -0.721 . . . . 2.94 110.213 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -119.94 147.8 44.3 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.444 -0.785 . . . . 1.52 110.481 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.67 136.9 57.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.438 -0.789 . . . . 1.58 109.442 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.8 m -152.11 163.22 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -0.781 . . . . 1.32 109.334 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 79.5 mt -91.15 148.96 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 106.008 -1.849 . . . . 1.27 106.008 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 35.3 tp -96.38 113.98 25.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.869 -1.145 . . . . 1.41 110.39 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 50.4 t -121.76 129.92 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.83 -0.804 . . . . 1.23 108.83 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.96 162.26 34.35 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.243 -1.021 . . . . 1.32 108.243 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.9 -34.78 71.9 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.26 -1.525 . . . . 1.49 108.03 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -159.93 171.38 19.5 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.442 -0.947 . . . . 2.25 108.442 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.7 mt -139.76 140.04 36.62 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.063 -1.023 . . . . 1.35 109.592 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.3 p -100.19 135.43 20.33 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.415 -0.803 . . . . 1.56 109.501 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -38.61 -35.61 0.51 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.358 2.039 . . . . 0.87 113.437 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.5 m -59.9 -40.01 87.35 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.921 -1.112 . . . . 1.36 109.205 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.23 -40.98 90.63 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.308 -0.87 . . . . 1.61 109.948 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 67.3 p -57.21 -29.8 64.03 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.204 -0.935 . . . . 1.21 111.271 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.82 -53.91 13.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.682 -1.261 . . . . 1.21 109.768 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -86.98 36.36 0.72 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.022 -0.733 . . . . 2.11 109.022 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.4 tp -101.19 139.42 36.9 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.866 -0.79 . . . . 1.29 108.866 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -85.83 101.96 13.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.984 . . . . 2.81 108.954 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.09 -40.04 94.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.33 -0.856 . . . . 2.09 110.821 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -69.56 -25.46 64.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.966 -1.084 . . . . 2.86 111.458 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -93.15 -9.37 39.64 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.848 -1.157 . . . . 2.39 110.548 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 70.8 t -101.44 111.19 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.185 -1.043 . . . . 1.27 108.185 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.2 mt -83.52 3.27 33.03 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.228 -0.92 . . . . 2.17 110.577 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.29 170.49 37.62 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.147 -1.581 . . . . 0.52 109.147 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -131.31 128.62 40.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.454 -1.027 . . . . 0.55 109.374 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 84.9 mt -132.4 126.25 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.485 -0.931 . . . . 1.27 108.485 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 23.6 p -148.67 161.5 41.61 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.024 -1.048 . . . . 1.39 110.876 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.476 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 55.8 t0 -105.78 24.54 12.13 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.426 -0.583 . . . . 2.46 109.426 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.93 -161.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.241 -1.537 . . . . 1.51 111.195 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.02 -50.61 7.57 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.097 -1.201 . . . . 2.23 110.097 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 161.79 -133.68 3.23 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.27 -1.443 . . . . 2.23 110.909 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.533 ' C ' ' H ' ' A' ' 188' ' ' SER . 41.5 ttt-85 -60.02 -39.98 87.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.563 -0.963 . . . . 6.44 111.415 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 67.2 p -59.7 2.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.616 -1.302 . . . . 4.09 110.385 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 186' ' ' ARG . 24.8 t -92.0 127.96 37.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.969 -1.082 . . . . 2.2 109.898 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.578 ' NE2' ' NZ ' ' A' ' 69' ' ' LYS . 56.9 t60 -43.9 -48.52 8.47 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.356 -0.84 . . . . 1.15 109.458 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 61.6 m -55.04 -36.83 65.95 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.763 -0.585 . . . . 2.01 110.949 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.3 m -59.96 -39.99 87.53 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.679 -1.263 . . . . 1.93 110.441 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.8 mm -64.52 -39.91 87.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.134 -0.979 . . . . 2.2 109.122 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.0 mtp -59.94 -45.0 94.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.275 -0.891 . . . . 1.32 110.532 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.45 -45.52 84.65 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.381 -1.449 . . . . 1.3 109.956 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -62.4 -57.21 12.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.975 -1.078 . . . . 3.38 110.737 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.3 m -63.36 -40.02 96.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.002 -1.061 . . . . 1.15 111.997 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.34 -25.36 61.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.821 -1.175 . . . . 1.28 109.744 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 70.2 47.33 0.56 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.3 0.571 . . . . 1.5 110.218 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 62.7 mt -124.21 149.78 61.72 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 107.8 -1.185 . . . . 1.37 107.8 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.67 138.62 59.68 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 122.268 1.979 . . . . 0.76 111.832 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -171.77 152.01 2.97 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.605 -1.238 . . . . 1.19 111.713 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.8 mt -125.98 147.69 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.473 -1.306 . . . . 1.31 107.473 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.8 m -128.55 -9.92 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 O-C-N 120.932 -1.105 . . . . 1.38 110.812 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -114.73 24.58 10.91 Favored Glycine 0 N--CA 1.502 3.063 0 N-CA-C 110.435 -1.066 . . . . 1.03 110.435 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 204' ' ' GLY . 3.1 p -42.73 -47.17 5.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.262 -1.14 . . . . 1.38 110.192 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.443 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 98.71 -56.69 0.98 Allowed Glycine 0 N--CA 1.503 3.13 0 C-N-CA 120.221 -0.99 . . . . 1.17 111.549 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 26.1 p -148.99 26.62 0.88 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.445 -1.621 . . . . 2.07 111.103 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.23 -40.04 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.989 -1.069 . . . . 1.35 109.395 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.458 ' HG1' ' N ' ' A' ' 210' ' ' SER . 31.7 p -62.06 -29.27 70.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.169 -0.957 . . . . 1.49 109.765 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.458 ' N ' ' HG1' ' A' ' 209' ' ' THR . 94.9 p -79.94 -20.99 44.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.209 -0.932 . . . . 2.16 109.561 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -96.5 -8.34 32.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.25 -0.906 . . . . 2.89 109.534 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.94 138.72 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-O 121.622 0.725 . . . . 1.33 110.853 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.492 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 2.1 mptp? -112.59 154.72 25.57 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.655 -1.239 . . . . 2.73 107.655 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.466 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 17.9 p-10 -59.85 139.8 57.08 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.025 -1.047 . . . . 2.7 110.113 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.4 m-20 83.82 4.32 0.81 Allowed 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.121 0.486 . . . . 2.38 110.162 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.492 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 86.2 m-20 -73.57 138.16 44.76 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.136 -0.978 . . . . 2.09 109.231 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -90.09 117.91 29.23 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.501 -1.296 . . . . 1.45 107.501 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 74.5 mt -127.18 150.82 49.34 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.519 -0.738 . . . . 1.31 110.927 -178.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.2 mt -117.61 129.99 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.147 -1.427 . . . . 1.29 107.147 177.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 22.2 tp -102.38 120.19 40.08 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.001 -1.062 . . . . 1.31 109.701 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.614 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 25.1 p-10 -80.05 -39.9 28.84 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.082 -1.011 . . . . 2.31 108.863 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.411 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 48.04 19.68 0.2 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.338 -0.986 . . . . 1.19 108.338 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.451 ' N ' ' C ' ' A' ' 221' ' ' ASP . 21.4 t -133.12 -44.3 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.339 -1.356 . . . . 1.45 107.339 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -100.1 0.02 39.91 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.747 -1.205 . . . . 3.13 107.747 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.596 HD22 ' H ' ' A' ' 4' ' ' GLY . 38.6 t30 60.02 46.88 10.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.714 -0.616 . . . . 2.2 109.57 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.614 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 76.9 mt-30 -140.04 151.82 45.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.43 -0.794 . . . . 2.32 109.622 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 83.1 t -119.12 129.96 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.419 -0.956 . . . . 1.4 108.419 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -99.95 118.79 37.11 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.477 -0.934 . . . . 1.29 108.477 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.4 t -99.98 115.13 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.544 -0.722 . . . . 1.38 110.503 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 52.45 63.09 9.39 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 2.33 111.164 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -88.99 148.46 5.67 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.557 2.172 . . . . 0.95 111.871 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 58.9 p -68.78 161.38 28.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 2.31 109.576 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -60.03 -39.97 87.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.843 . . . . 3.45 110.519 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -60.32 -32.96 71.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.932 -1.105 . . . . 2.89 109.816 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.33 -39.98 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -0.985 . . . . 1.73 109.141 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.3 mt -61.6 -40.18 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.883 . . . . 1.57 109.284 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -59.97 -41.87 92.89 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.129 -0.982 . . . . 2.43 109.06 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -64.15 -42.62 96.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 3.18 108.752 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 93.6 mtp -64.75 -38.68 91.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.49 -0.756 . . . . 1.59 109.376 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -68.66 -40.05 80.36 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.256 -0.903 . . . . 3.11 109.438 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.84 95.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.128 -0.982 . . . . 2.17 108.786 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.53 -39.97 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.61 -0.681 . . . . 2.51 109.292 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.25 -41.68 84.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.017 -1.052 . . . . 3.82 108.851 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -61.03 -40.08 92.22 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.984 -1.117 . . . . 1.78 107.984 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -66.58 -36.6 83.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.662 -0.649 . . . . 2.77 109.419 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.99 -40.75 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.359 -0.838 . . . . 2.25 109.351 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.07 -40.87 90.98 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.295 -0.878 . . . . 2.54 109.165 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 18.9 t -65.15 -40.06 93.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 3.03 109.649 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -60.16 -39.98 88.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 3.34 109.309 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.404 ' C ' ' H ' ' A' ' 252' ' ' GLU . 6.7 ttpm? -65.76 -10.64 39.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.455 -0.778 . . . . 4.18 110.119 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.526 ' O ' ' NZ ' ' A' ' 255' ' ' LYS . . . -79.29 27.21 0.26 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.157 -0.965 . . . . 4.43 110.058 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 250' ' ' LYS . 6.5 pt-20 -140.04 27.83 2.15 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.103 -0.998 . . . . 5.42 109.694 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 60.1 mt -58.54 -50.02 75.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.06 -1.025 . . . . 6.11 109.535 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -161.41 58.27 0.28 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.804 -1.185 . . . . 7.37 110.405 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.526 ' NZ ' ' O ' ' A' ' 251' ' ' ALA . 45.1 mmtm -68.85 -44.98 72.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.119 -0.988 . . . . 8.3 109.663 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 23.5 tp -117.06 -51.38 2.55 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.55 -0.907 . . . . 9.05 108.55 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -149.99 157.68 43.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.454 -0.779 . . . . 10.56 109.407 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -58.45 -59.19 5.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.292 -0.88 . . . . 11.32 109.723 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.946 -1.026 . . . . 12.74 109.413 -179.433 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 40.7 ttp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.46 0.648 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 30.1 t80 -155.78 155.37 32.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.482 -0.761 . . . . 0.0 109.1 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . 0.539 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 12.9 pt20 -146.75 157.03 43.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.166 -0.959 . . . . 0.0 109.939 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -152.94 150.07 28.88 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -114.99 135.2 54.49 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.169 -0.957 . . . . 0.0 110.638 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.0 p -134.89 123.45 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 CA-C-O 122.033 0.92 . . . . 0.0 112.277 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 89.8 m -80.19 107.19 12.79 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.957 0.884 . . . . 0.0 111.201 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . 0.417 HD11 HG22 ' B' ' 308' ' ' ILE . 96.0 mt -51.65 121.21 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 122.329 1.062 . . . . 0.0 110.438 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 23.7 p -108.61 16.86 22.58 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.786 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.7 129.06 84.37 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 120.743 -1.223 . . . . 0.0 108.175 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -64.34 -10.99 25.98 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 CA-C-N 120.154 1.091 . . . . 0.0 112.752 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -115.78 8.6 14.9 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.364 -0.835 . . . . 0.0 109.782 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.59 173.91 14.8 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.422 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 3.2 tp -81.66 90.24 6.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.895 -1.356 . . . . 0.0 109.693 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . 0.448 ' CA ' ' OH ' ' A' ' 122' ' ' TYR . 4.4 p80 -95.13 -161.37 0.85 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.84 -1.162 . . . . 0.0 109.939 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.0 m -58.01 -40.4 80.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.007 -1.058 . . . . 0.0 112.31 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.553 HH21 ' NE2' ' B' ' 321' ' ' GLN . 2.2 tpt180 -59.58 -61.94 6.87 Favored Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 120.402 -1.436 . . . . 0.0 111.591 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.07 -32.79 87.82 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 CA-C-N 120.028 1.046 . . . . 0.0 111.832 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.95 -51.6 68.96 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.416 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.61 64.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.227 -0.92 . . . . 0.0 110.006 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . 0.553 ' NE2' HH21 ' B' ' 317' ' ' ARG . 86.9 mt-30 -70.82 -39.95 72.74 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.829 -1.17 . . . . 0.0 109.062 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -62.73 -54.79 33.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.364 -0.835 . . . . 0.0 110.463 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 60.1 t -63.6 -38.51 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.666 -1.271 . . . . 0.0 108.806 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -59.98 -47.1 87.2 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.217 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -62.58 -49.76 73.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.359 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.16 -51.56 52.29 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.256 -0.903 . . . . 0.0 110.883 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -52.04 -14.42 0.41 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.118 -0.989 . . . . 0.0 109.897 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -79.92 -17.23 75.31 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -106.01 140.55 38.83 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.319 -1.106 . . . . 0.0 108.758 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 5.3 p -91.42 -13.79 31.73 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.792 -1.192 . . . . 0.0 110.158 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 29.5 p -57.28 150.46 17.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.938 -1.101 . . . . 0.0 108.474 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.05 132.46 46.66 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.855 -1.153 . . . . 0.0 108.627 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.8 mt -133.4 133.64 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.615 -0.678 . . . . 0.0 109.531 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.7 m -130.04 152.28 49.66 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.481 -0.762 . . . . 0.0 109.117 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 72.0 t -123.88 114.68 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 87.0 m -105.22 130.45 53.37 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.144 -0.972 . . . . 0.0 109.177 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 97.0 p -136.47 114.01 10.97 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.92 0.867 . . . . 0.0 110.777 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 45.35 51.85 9.22 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.98 -13.82 63.63 Favored Glycine 0 N--CA 1.503 3.135 0 O-C-N 120.102 -1.624 . . . . 0.0 112.935 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -118.67 130.37 55.81 Favored 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 119.414 1.607 . . . . 0.0 109.367 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 82.2 p -128.51 150.75 50.03 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.968 0.889 . . . . 0.0 110.845 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -145.24 166.64 24.9 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.573 0.701 . . . . 0.0 110.126 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.8 m -88.99 139.94 29.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.449 -0.782 . . . . 0.0 110.052 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.457 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -78.78 -14.35 59.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.916 -1.115 . . . . 0.0 110.071 -179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -89.98 20.3 4.32 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.457 ' H ' ' C ' ' B' ' 344' ' ' ALA . 90.5 p -145.8 92.14 2.18 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.407 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . 0.558 ' CD1' HE22 ' B' ' 351' ' ' GLN . 57.1 tp -59.98 -34.54 73.44 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . 0.414 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 64.2 m-85 -56.33 -53.48 56.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.169 -0.957 . . . . 0.0 110.393 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.407 ' O ' ' OG1' ' B' ' 352' ' ' THR . 47.2 mtpt -69.43 -39.81 77.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 110.387 -177.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' B' ' 352' ' ' THR . 23.2 mt -47.67 -59.66 3.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.158 -0.964 . . . . 0.0 108.978 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.558 HE22 ' CD1' ' B' ' 347' ' ' LEU . 1.5 mp0 -39.27 -21.12 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.721 -0.612 . . . . 0.0 111.298 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.528 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.1 p -78.03 -10.1 59.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.102 -1.624 . . . . 0.0 110.216 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 49.9 mt -96.09 118.32 32.45 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.134 -0.979 . . . . 0.0 109.14 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.35 96.74 0.92 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 32.2 mt -106.77 95.29 5.63 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.447 -1.031 . . . . 0.0 109.582 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 356' ' ' THR . . . . . 0.406 ' H ' ' HG1' ' B' ' 356' ' ' THR . 17.8 p -98.31 176.42 5.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.217 -0.927 . . . . 0.0 110.462 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -63.93 111.89 2.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.806 -0.559 . . . . 0.0 110.586 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.76 7.7 38.49 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 46.9 m -84.83 110.23 18.67 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.087 -1.243 . . . . 0.0 111.067 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 4.9 t -78.12 115.62 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 122.113 0.959 . . . . 0.0 110.167 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 29.1 m -112.65 177.52 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 86.6 m -131.11 130.31 42.97 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 82.3 mt -105.34 120.35 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 58.7 m -121.38 132.56 54.83 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.25 153.9 41.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 110.034 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -146.77 122.91 10.83 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.455 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 159.53 -155.29 26.38 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 118.586 -1.768 . . . . 0.0 111.932 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.93 -53.36 58.78 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -107.31 11.61 28.97 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.898 -1.126 . . . . 0.0 111.383 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.455 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.3 pt-20 -40.23 -37.54 0.65 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.431 -0.793 . . . . 0.0 111.581 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.04 -44.31 72.92 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.73 -1.231 . . . . 0.0 110.787 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -69.79 -51.78 30.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.782 -1.199 . . . . 0.0 109.167 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -45.81 -37.22 5.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.646 -0.659 . . . . 0.0 111.278 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 81.8 t -69.98 -39.98 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.698 -1.251 . . . . 0.0 109.151 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.99 -64.45 0.86 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 111.163 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -60.06 -45.82 91.59 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.683 -1.261 . . . . 0.0 111.771 -177.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.9 mt -59.98 -41.39 91.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.623 -1.298 . . . . 0.0 108.813 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 54.7 t -65.88 -42.05 91.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.158 -0.964 . . . . 0.0 109.742 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -71.29 -57.96 3.98 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.742 -1.224 . . . . 0.0 107.85 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . 0.411 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 60.2 tp -56.22 -32.48 64.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.397 -0.814 . . . . 0.0 109.839 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 45.2 ttm -74.44 -40.02 62.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.007 -1.058 . . . . 0.0 108.813 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.67 -4.45 46.18 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.682 -0.636 . . . . 0.0 110.121 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -110.84 3.36 18.9 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.319 -0.863 . . . . 0.0 110.963 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . 0.411 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 32.3 mt -69.87 130.03 41.13 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.397 -1.439 . . . . 0.0 109.764 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.079 179.45 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.301 -0.629 . . . . 3.19 109.301 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.5 mt -108.88 128.69 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.644 -0.873 . . . . 1.71 108.644 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.1 m -118.85 154.04 33.54 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.081 -0.711 . . . . 1.66 109.081 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.752 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -141.75 179.05 20.12 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.359 -1.897 . . . . 1.05 108.359 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.5 mt -85.21 -4.69 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.88 -1.365 . . . . 1.59 110.607 -178.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.5 tp 52.31 93.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.64 -1.288 . . . . 1.47 109.362 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.22 -40.03 78.2 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.219 -1.03 . . . . 1.39 108.219 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 2.6 p -154.08 146.88 17.73 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 108.943 -0.762 . . . . 2.09 108.943 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -80.32 144.2 16.12 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.74 2.293 . . . . 0.91 113.5 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.67 164.51 13.27 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.544 -1.422 . . . . 0.92 109.544 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -117.42 152.82 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.13 -1.218 . . . . 1.35 110.072 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.91 155.98 35.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.228 -0.92 . . . . 1.14 109.83 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.9 OUTLIER -137.71 128.07 26.35 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.604 -0.888 . . . . 0.7 108.604 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.91 179.32 47.25 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 118.902 -1.618 . . . . 0.58 110.534 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -78.94 157.08 28.27 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.629 -0.924 . . . . 2.63 109.064 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.31 134.28 45.85 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.376 -0.827 . . . . 1.27 110.701 -179.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.9 tp -106.93 139.39 41.41 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.346 -1.353 . . . . 1.41 107.346 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.0 tp -119.06 121.03 38.91 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.309 -0.87 . . . . 1.49 110.146 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.8 mt -81.91 102.89 11.18 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.003 -0.679 . . . . 1.52 109.809 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -95.5 131.48 41.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.413 -0.804 . . . . 3.17 109.543 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -126.12 137.83 53.63 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.714 -0.847 . . . . 3.0 108.714 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 47.5 t0 -87.24 147.86 25.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.07 -1.019 . . . . 2.77 109.557 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.461 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 88.3 tt0 -64.18 149.88 46.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.906 . . . . 2.94 109.335 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.9 mt -91.87 127.46 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.374 -0.829 . . . . 1.46 108.897 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.6 t -93.62 124.07 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.159 -0.963 . . . . 1.7 109.738 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -106.74 135.66 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.796 -0.816 . . . . 1.54 108.796 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -95.04 117.04 29.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.001 -1.062 . . . . 1.81 109.328 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -89.83 2.11 55.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.431 -0.793 . . . . 3.23 109.097 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -58.81 146.13 38.27 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.291 -0.881 . . . . 3.29 109.583 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -84.76 137.6 33.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.423 -0.798 . . . . 2.8 109.035 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.0 pt -91.73 163.25 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.966 -1.084 . . . . 1.43 109.92 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.3 p -97.18 174.93 6.48 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.925 . . . . 1.54 108.761 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.05 83.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 1.6 109.689 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -57.35 -30.22 64.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.741 -1.224 . . . . 2.56 109.433 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -81.45 -10.2 59.55 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.185 -0.947 . . . . 2.36 109.891 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.9 -53.42 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.705 -1.247 . . . . 1.43 108.519 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.14 -40.01 94.52 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.59 -0.694 . . . . 1.77 110.14 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -69.87 -41.2 75.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.024 -1.047 . . . . 3.32 110.436 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -64.91 -40.02 94.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.832 -1.168 . . . . 1.51 110.069 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.3 t -62.84 -47.0 94.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.905 -1.122 . . . . 1.41 108.937 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -64.59 -42.8 95.35 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.047 -1.033 . . . . 1.81 110.063 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -60.07 -42.19 94.02 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.425 -1.324 . . . . 3.26 107.425 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -61.16 -50.04 74.8 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.151 -0.685 . . . . 0.81 109.151 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.9 tp -59.99 -42.32 93.95 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.444 -0.947 . . . . 1.59 108.444 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.8 t -63.6 -39.98 95.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 1.38 109.325 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.56 -48.98 77.69 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.702 -1.759 . . . . 0.87 108.702 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -61.1 -39.99 92.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.337 -1.096 . . . . 3.62 108.256 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.64 -43.27 17.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.558 -0.714 . . . . 1.43 109.14 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 50' ' ' ALA . 24.7 ttmt -66.07 -72.83 0.15 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.678 -1.23 . . . . 3.08 107.678 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.92 -42.45 0.62 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.359 -0.838 . . . . 1.33 111.37 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.2 t -51.37 -56.36 13.54 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.59 -1.319 . . . . 1.85 109.177 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.71 -41.95 74.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.195 -0.94 . . . . 1.35 110.794 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.7 -40.06 88.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.932 -1.105 . . . . 2.34 109.794 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.7 mt -60.62 -40.05 90.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.99 -1.069 . . . . 2.2 108.713 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -60.85 -33.54 73.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.455 -0.778 . . . . 1.35 109.429 179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -65.15 -44.09 89.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.039 -1.038 . . . . 1.34 109.427 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.05 -38.98 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.884 -0.784 . . . . 1.26 108.884 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -59.45 -49.97 75.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.468 -0.77 . . . . 1.7 109.67 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -59.58 -37.45 78.55 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.273 -0.892 . . . . 1.35 110.223 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -63.93 -38.91 92.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.96 -1.087 . . . . 2.08 109.595 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.26 -42.27 99.12 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.373 -0.829 . . . . 1.21 109.15 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.44 -51.4 58.97 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.101 -1.2 . . . . 0.75 110.101 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.39 -46.72 66.24 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.928 -1.337 . . . . 1.59 110.02 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.1 m -67.25 -63.08 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 1.41 112.442 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.474 ' CE2' ' O ' ' A' ' 168' ' ' THR . 95.4 m-85 -92.9 -50.5 5.52 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.749 -1.219 . . . . 0.79 110.917 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.46 -169.9 24.93 Favored Glycine 0 N--CA 1.499 2.894 0 C-N-CA 119.954 -1.117 . . . . 1.22 110.939 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -69.74 -24.19 63.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.894 -0.768 . . . . 5.81 109.714 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -60.04 -35.55 75.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.569 -0.707 . . . . 3.37 110.175 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -100.37 -18.5 16.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.329 -0.857 . . . . 2.37 110.415 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -70.05 -40.01 75.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.778 -1.202 . . . . 1.65 110.643 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.51 -30.58 70.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.217 -0.927 . . . . 1.42 110.22 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.9 mt -59.94 -40.63 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.051 -1.031 . . . . 1.43 109.291 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -70.04 -38.18 75.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 1.08 110.947 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -60.05 -39.93 87.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.859 -1.151 . . . . 1.37 109.8 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.97 -43.36 99.01 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.306 -1.518 . . . . 0.67 109.306 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -61.98 -42.93 99.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.388 -1.066 . . . . 1.99 109.705 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 98.7 mt -70.05 -43.34 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.225 -0.922 . . . . 1.22 109.741 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.8 ttp -59.97 -40.09 87.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.841 -1.162 . . . . 2.11 109.512 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.405 ' CD1' ' CE2' ' B' ' 348' ' ' PHE . 31.7 tp -65.21 -38.03 89.16 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.471 -0.768 . . . . 1.33 109.699 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.9 -40.09 95.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.455 -0.778 . . . . 1.29 109.964 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -81.0 6.29 13.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.238 -0.914 . . . . 1.47 110.219 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -52.75 133.47 36.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.073 -1.017 . . . . 1.47 110.473 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.44 -19.45 63.5 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.556 -0.715 . . . . 1.78 110.658 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.07 -33.87 72.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.92 -1.113 . . . . 2.53 108.887 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.0 mt -70.13 -41.46 73.89 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.41 0.624 . . . . 1.36 110.055 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -60.05 -48.79 80.25 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.3 -0.875 . . . . 1.42 110.943 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -70.0 -40.93 74.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.07 -1.019 . . . . 2.27 111.323 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -69.97 -40.02 75.63 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.031 -1.043 . . . . 1.57 111.485 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 84.2 mt -65.88 -49.87 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.975 -1.078 . . . . 1.19 109.69 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.7 mt -65.1 -37.15 79.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.686 -0.634 . . . . 1.39 110.401 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.03 -49.63 76.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.103 -0.998 . . . . 1.39 110.763 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.43 -45.89 91.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.83 -1.169 . . . . 1.5 109.748 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.7 mt -61.51 -49.96 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.981 0.896 . . . . 1.29 109.159 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -67.93 -44.92 75.72 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 120.163 -0.615 . . . . 2.64 111.144 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -80.19 -51.18 9.26 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.878 -1.138 . . . . 1.65 112.152 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -90.1 -3.38 57.95 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.91 -1.119 . . . . 2.5 112.13 -177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 39.0 m80 57.76 34.82 24.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.892 -1.13 . . . . 1.88 110.605 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 71.0 mtm -90.81 169.91 10.55 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.013 -1.054 . . . . 1.71 109.38 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.6 p -75.3 154.28 37.47 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.093 -1.005 . . . . 1.61 108.465 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.95 -36.87 75.59 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.1 -1.0 . . . . 1.33 110.541 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 38.2 p-10 -65.62 -38.71 90.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.99 -1.069 . . . . 2.07 109.766 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.522 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.53 -44.4 19.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.142 -0.974 . . . . 1.37 109.318 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.88 92.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.396 -0.815 . . . . 1.14 109.44 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.06 94.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.87 . . . . 1.26 109.557 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -59.49 -39.97 85.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.822 . . . . 2.02 109.573 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 110' ' ' GLY . 86.1 tt0 -63.12 -40.02 96.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.117 -0.989 . . . . 1.33 109.28 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.5 t -61.61 -52.27 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.471 -0.768 . . . . 1.3 110.731 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.5 mm -70.08 -39.98 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.916 -1.115 . . . . 1.32 108.934 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -67.24 -38.29 84.96 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.231 -1.026 . . . . 2.44 108.231 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.24 -50.0 70.59 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.33 -1.108 . . . . 0.99 110.33 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.402 HE21 ' CB ' ' B' ' 348' ' ' PHE . 14.8 mm100 -66.84 -52.22 46.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.654 -1.497 . . . . 1.97 109.06 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.85 -39.98 75.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 1.43 108.964 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.1 t -55.74 -39.46 71.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.238 -0.914 . . . . 2.12 108.708 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.05 -37.55 75.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.162 -0.961 . . . . 1.64 109.784 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.3 mt -67.47 -48.59 66.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.117 -0.989 . . . . 1.93 110.704 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -60.49 -21.96 62.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.391 -1.443 . . . . 2.2 110.194 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -67.97 -16.0 63.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.814 -1.179 . . . . 2.12 108.783 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 28.4 mt -63.05 145.61 55.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.296 -0.877 . . . . 2.34 108.95 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -90.53 28.81 1.4 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.248 -0.908 . . . . 3.23 110.458 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 55.5 t0 -117.36 131.89 56.7 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.333 -0.854 . . . . 2.49 109.78 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.418 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 47.1 mt-10 -69.97 -28.94 65.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.515 -0.74 . . . . 3.95 109.934 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.68 ' HH ' HH12 ' A' ' 126' ' ' ARG . 2.7 t80 -69.89 -37.87 76.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 2.25 109.999 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 72.4 mt -77.14 -31.32 55.59 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.08 -1.013 . . . . 2.27 109.036 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -60.02 -40.06 87.98 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.195 -0.941 . . . . 3.31 108.645 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -47.01 87.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -0.811 . . . . 2.73 109.305 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.68 HH12 ' HH ' ' A' ' 122' ' ' TYR . 4.2 mmm-85 -60.02 -40.05 87.95 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.282 -0.887 . . . . 3.2 109.898 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.37 76.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.035 -1.04 . . . . 1.66 108.656 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.08 95.65 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.067 -0.716 . . . . 1.67 109.067 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -66.59 -42.43 86.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.369 -0.832 . . . . 1.55 109.453 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.94 -40.38 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.287 -0.883 . . . . 1.32 108.625 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -60.24 -41.31 92.88 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.465 -0.772 . . . . 3.58 109.101 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -59.92 -40.01 87.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.514 -0.741 . . . . 1.46 110.726 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.9 mt -60.07 -41.28 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 1.22 110.304 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.53 -40.44 94.25 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.646 -1.264 . . . . 0.61 110.02 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -60.01 -45.27 93.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.292 -1.122 . . . . 3.1 110.314 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -65.96 -35.88 81.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.589 -1.319 . . . . 3.71 110.038 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.94 -41.6 92.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.107 -0.995 . . . . 1.87 109.441 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.01 -40.01 87.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.108 -0.995 . . . . 1.29 108.908 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -65.77 -39.98 91.55 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.749 -0.834 . . . . 3.05 108.749 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -69.73 -29.03 66.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.628 -0.67 . . . . 1.26 111.85 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.3 mt -70.02 -40.77 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.255 -1.528 . . . . 1.34 108.624 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.7 -29.66 59.07 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.676 -0.64 . . . . 1.6 109.747 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.19 45.82 4.62 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 108.954 -1.658 . . . . 0.96 108.954 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.6 tp -74.81 149.99 39.46 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.457 -1.025 . . . . 1.67 109.503 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -70.21 143.77 52.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.206 -0.934 . . . . 4.96 109.881 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.6 mt -114.91 128.8 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 122.037 0.922 . . . . 1.68 109.274 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.8 mt -69.93 -40.12 78.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.873 -0.603 . . . . 2.14 110.654 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.1 t0 63.39 103.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.27 -0.894 . . . . 1.5 109.223 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 57.7 mt -68.45 -1.25 6.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.395 -0.816 . . . . 1.39 109.88 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.6 p -81.67 -14.61 56.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.02 -1.05 . . . . 1.83 109.878 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.8 26.42 0.83 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.239 -0.913 . . . . 1.46 112.225 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 36.1 mm -90.8 122.49 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 120.367 -1.458 . . . . 1.42 109.122 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -104.39 -12.52 16.52 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.428 -0.795 . . . . 2.94 110.415 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -122.3 147.78 45.82 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.286 -0.884 . . . . 1.52 110.182 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.92 135.76 56.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.82 . . . . 1.58 109.487 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.0 m -152.8 166.63 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.608 -0.682 . . . . 1.32 109.799 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 86.3 mt -94.74 148.9 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.485 -1.672 . . . . 1.27 106.485 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 14.9 tp -97.78 118.19 33.76 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.867 -1.146 . . . . 1.41 110.383 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.8 t -123.12 130.01 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.808 -0.812 . . . . 1.23 108.808 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -156.66 160.67 39.58 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.385 -0.968 . . . . 1.32 108.385 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.84 -31.83 65.04 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.266 -1.521 . . . . 1.49 107.588 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -157.94 165.62 34.7 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.853 -0.795 . . . . 2.25 108.853 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 78.0 mt -136.95 132.16 34.01 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.162 -0.961 . . . . 1.35 108.964 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.1 p -102.44 148.99 36.27 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.389 -0.82 . . . . 1.56 108.975 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -41.59 -34.13 2.02 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.97 1.78 . . . . 0.87 112.211 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 43.7 m -57.46 -43.37 83.95 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.354 -0.841 . . . . 1.36 109.961 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.94 -40.96 75.19 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.126 -0.984 . . . . 1.61 110.252 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.474 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 72.0 p -58.03 -19.9 34.88 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.166 -0.959 . . . . 1.21 111.581 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.69 -43.18 13.62 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.634 -1.291 . . . . 1.21 109.773 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -96.98 41.53 1.11 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.39 -0.967 . . . . 2.11 108.39 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 58.9 tp -105.29 131.51 52.66 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.588 -0.893 . . . . 1.29 108.588 179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -84.03 103.33 13.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.008 -1.058 . . . . 2.81 108.847 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.77 -40.8 95.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.854 . . . . 2.09 110.814 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -65.59 -27.39 68.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.82 -1.175 . . . . 2.86 111.286 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.454 ' N ' ' CD ' ' A' ' 175' ' ' LYS . 1.1 mptm? -93.32 -11.83 31.48 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.895 -1.128 . . . . 2.39 109.723 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 178' ' ' GLY . 87.6 t -100.01 110.03 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.138 -0.977 . . . . 1.27 108.908 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 89.9 mt -83.76 7.32 18.16 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.229 -0.919 . . . . 2.17 110.377 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.407 ' O ' ' CG1' ' A' ' 176' ' ' VAL . . . 167.94 176.26 38.35 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.247 -1.541 . . . . 0.52 109.247 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -133.24 129.9 38.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.353 -1.087 . . . . 0.55 108.658 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.2 mt -132.93 126.51 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.309 -0.869 . . . . 1.27 109.28 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.4 p -145.35 158.03 43.92 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.034 -1.041 . . . . 1.39 111.189 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.529 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -103.14 26.84 7.77 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.789 -0.819 . . . . 2.46 108.789 179.124 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -67.42 -158.96 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.055 -1.028 . . . . 1.51 112.028 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.14 -50.55 10.23 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.07 -1.212 . . . . 2.23 110.07 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.85 -120.05 1.1 Allowed Glycine 0 N--CA 1.493 2.459 0 O-C-N 120.868 -1.372 . . . . 2.23 110.766 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.547 ' NE ' HH22 ' A' ' 195' ' ' ARG . 58.4 mtp180 -60.96 -37.6 82.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.774 -0.839 . . . . 6.44 111.627 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 32.7 p -67.31 3.02 1.36 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.9 -1.125 . . . . 4.09 110.909 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.8 t -90.39 118.89 30.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.746 -1.222 . . . . 2.2 109.952 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -43.11 -52.63 5.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.355 -0.841 . . . . 1.15 109.636 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.33 -33.16 41.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.352 -0.842 . . . . 2.01 110.706 -179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.1 t -59.99 -42.03 93.35 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.727 -1.233 . . . . 1.93 110.225 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.3 mm -60.37 -39.95 82.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.357 -0.84 . . . . 2.2 109.005 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.6 mtp -60.01 -40.56 89.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.495 -0.753 . . . . 1.32 110.919 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.36 95.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.673 -1.267 . . . . 1.3 109.149 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.547 HH22 ' NE ' ' A' ' 186' ' ' ARG . 98.4 mtt180 -59.96 -53.34 59.04 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.221 -0.924 . . . . 3.38 110.375 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.3 m -69.73 -35.66 75.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.067 -1.021 . . . . 1.15 111.267 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.03 -28.6 65.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.865 -1.147 . . . . 1.28 108.906 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 70.24 45.73 0.65 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.506 0.669 . . . . 1.5 109.644 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.471 ' O ' ' OG ' ' A' ' 8' ' ' SER . 88.2 mt -122.73 150.04 57.47 Favored Pre-proline 0 N--CA 1.498 1.963 0 N-CA-C 107.84 -1.171 . . . . 1.37 107.84 178.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.79 142.68 70.78 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.002 1.801 . . . . 0.76 111.536 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.01 151.15 3.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.983 -1.073 . . . . 1.19 111.388 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.402 HG22 HD11 ' A' ' 202' ' ' ILE . 85.7 mt -123.47 143.47 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.783 -1.191 . . . . 1.31 107.783 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 5.8 m -126.67 -10.08 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 120.694 -1.254 . . . . 1.38 110.54 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.1 23.14 26.01 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 110.323 -1.111 . . . . 1.03 110.323 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.43 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.5 p -46.02 -43.24 14.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.089 -1.242 . . . . 1.38 109.715 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.88 -52.6 3.92 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 120.144 -1.027 . . . . 1.17 111.532 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.9 m -157.38 33.76 0.28 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.54 -1.565 . . . . 2.07 111.425 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 56.1 t -72.77 -40.1 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.908 -1.12 . . . . 1.35 109.111 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.4 p -54.82 -32.36 60.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.431 -0.793 . . . . 1.49 110.578 -178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 84.9 p -76.43 -16.29 59.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.985 -1.072 . . . . 2.16 109.421 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -101.64 -13.73 17.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.498 -0.751 . . . . 2.89 109.95 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 55.9 t -104.77 137.92 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.359 -0.838 . . . . 1.33 110.555 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -112.79 151.7 30.03 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.686 -1.227 . . . . 2.73 107.686 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 30.5 p-10 -57.92 137.03 57.11 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.016 -1.053 . . . . 2.7 110.251 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.8 OUTLIER 82.79 8.69 0.72 Allowed 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.14 0.495 . . . . 2.38 110.432 179.281 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 60.5 t0 -77.8 143.57 37.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.12 -0.987 . . . . 2.09 109.131 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.527 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 33.9 t80 -88.32 118.24 27.8 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.025 -1.047 . . . . 1.45 109.041 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 91.7 mt -130.63 149.42 52.29 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.515 -0.741 . . . . 1.31 110.544 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.7 mt -118.28 128.56 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 106.85 -1.537 . . . . 1.29 106.85 177.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.7 tp -100.61 122.5 43.38 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.961 -1.087 . . . . 1.31 109.466 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.419 ' C ' ' N ' ' A' ' 223' ' ' VAL . 19.3 m-20 -87.53 -42.77 12.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.982 -1.074 . . . . 2.31 109.884 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 47.15 22.81 0.25 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.674 -0.861 . . . . 1.19 108.674 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.419 ' N ' ' C ' ' A' ' 221' ' ' ASP . 18.0 t -127.25 -42.82 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.903 -1.517 . . . . 1.45 106.903 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -109.84 7.39 24.04 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.0 -1.111 . . . . 3.13 108.0 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.752 HD22 ' H ' ' A' ' 4' ' ' GLY . 36.6 t-20 60.04 52.12 5.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.794 -0.566 . . . . 2.2 110.532 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -147.17 158.56 43.99 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.784 -1.198 . . . . 2.32 110.463 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.6 t -126.81 130.04 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.496 -0.927 . . . . 1.4 108.496 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -98.43 122.93 42.22 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.426 -0.796 . . . . 1.29 109.212 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 18.2 t -100.79 111.28 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.551 -0.718 . . . . 1.38 110.083 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 54.98 63.14 7.17 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.235 -0.916 . . . . 2.33 111.244 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -86.87 150.07 8.43 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.571 2.181 . . . . 0.95 112.246 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 39.8 p -74.43 165.02 25.9 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.318 -0.864 . . . . 2.31 109.437 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -60.0 -34.43 73.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.426 -0.796 . . . . 3.45 110.592 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -59.94 -39.29 85.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.053 -1.029 . . . . 2.89 109.756 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 76.1 t -70.02 -40.27 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.031 -1.043 . . . . 1.73 109.18 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.527 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 99.4 mt -64.39 -40.05 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.342 -0.849 . . . . 1.57 109.658 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.08 -41.51 92.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.911 -1.118 . . . . 2.43 109.088 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -66.2 -39.97 90.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.275 -0.891 . . . . 3.18 108.627 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 96.8 mtp -69.11 -36.63 77.74 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.568 -0.708 . . . . 1.59 109.176 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.527 ' NH1' ' CG2' ' A' ' 236' ' ' ILE . 1.8 mmt-85 -60.99 -40.1 92.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 3.11 109.904 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.68 -42.6 97.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.102 -0.999 . . . . 2.17 109.042 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.5 t -61.62 -40.03 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.5 -0.75 . . . . 2.51 109.178 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -59.82 -39.88 86.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.369 -0.832 . . . . 3.82 109.456 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -41.23 91.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.085 -1.009 . . . . 1.78 109.641 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -66.2 -40.09 90.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.039 -1.038 . . . . 2.77 108.884 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 71.2 t -66.0 -40.0 86.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.898 -0.779 . . . . 2.25 108.898 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.83 -38.83 83.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.512 -0.743 . . . . 2.54 109.409 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 67.5 m -60.01 -40.0 87.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.974 . . . . 3.03 109.234 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.17 -39.97 86.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.436 -0.79 . . . . 3.34 109.827 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.57 ' C ' ' H ' ' A' ' 252' ' ' GLU . 32.8 mmtp -90.0 5.99 44.19 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.321 -0.862 . . . . 4.18 109.951 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -66.1 28.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.998 -1.063 . . . . 4.43 110.461 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.57 ' H ' ' C ' ' A' ' 250' ' ' LYS . 63.9 mm-40 54.15 79.62 0.13 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.004 -1.06 . . . . 5.42 109.193 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 66.9 mt -56.89 -33.42 66.87 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.253 -1.388 . . . . 6.11 107.253 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -111.26 -84.91 0.56 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.534 -0.913 . . . . 7.37 108.534 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -176.47 -36.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.644 -1.613 . . . . 8.3 106.644 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 3.1 pp -151.7 160.58 43.55 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.077 -1.083 . . . . 9.05 108.077 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -143.52 156.28 44.57 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.306 -0.998 . . . . 10.56 108.306 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -140.98 82.48 1.84 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.978 -1.077 . . . . 11.32 109.693 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 118.222 -0.894 . . . . 12.74 109.389 -179.768 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 7.5 ttt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -151.69 149.54 29.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.368 -0.832 . . . . 0.0 109.099 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -148.91 159.96 43.71 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.053 -1.029 . . . . 0.0 110.655 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -152.7 148.74 27.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.475 -0.766 . . . . 0.0 109.314 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -107.03 131.11 54.45 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.135 -0.978 . . . . 0.0 109.646 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.59 119.06 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 122.186 0.993 . . . . 0.0 112.782 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 94.6 m -78.34 104.75 9.13 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.919 0.866 . . . . 0.0 110.004 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' B' ' 358' ' ' GLY . 70.4 mt -51.74 118.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 122.317 1.056 . . . . 0.0 110.295 -177.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 51.6 p -108.1 17.08 22.73 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.24 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . 0.405 ' O ' ' CG ' ' B' ' 357' ' ' GLN . . . -71.92 117.14 55.29 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.063 -1.023 . . . . 0.0 108.54 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -51.92 -16.07 3.86 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 CA-C-N 120.35 1.161 . . . . 0.0 113.594 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -120.47 10.57 11.19 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.329 -0.857 . . . . 0.0 109.357 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.14 -179.79 31.4 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.495 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -88.66 93.98 9.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.351 -1.088 . . . . 0.0 109.353 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -96.58 -160.01 0.77 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.897 -1.127 . . . . 0.0 110.564 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 316' ' ' THR . . . . . 0.403 ' H ' ' HG1' ' B' ' 316' ' ' THR . 2.2 m -57.33 -44.03 83.89 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.005 -1.059 . . . . 0.0 112.367 -175.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.556 HH21 ' NE2' ' B' ' 321' ' ' GLN . 2.1 tpt180 -59.92 -60.57 10.17 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 120.651 -1.28 . . . . 0.0 112.233 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -58.73 -29.82 90.72 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 CA-C-N 120.444 1.194 . . . . 0.0 111.595 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.92 -52.01 67.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 108.861 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.65 -41.49 61.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.944 . . . . 0.0 109.4 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . 0.556 ' NE2' HH21 ' B' ' 317' ' ' ARG . 89.5 mt-30 -69.96 -40.04 75.64 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.15 -0.969 . . . . 0.0 108.753 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -60.86 -52.88 63.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.519 -0.738 . . . . 0.0 110.989 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 71.9 t -67.74 -29.34 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.646 -1.284 . . . . 0.0 109.997 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -61.16 -45.53 94.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.942 . . . . 0.0 109.3 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -64.02 -45.04 90.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.332 -0.855 . . . . 0.0 110.178 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -61.44 -53.66 53.59 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.016 -1.053 . . . . 0.0 111.41 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -57.51 -13.26 3.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.868 -1.145 . . . . 0.0 109.496 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -68.24 -29.74 73.37 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -103.85 147.22 27.57 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.503 -0.998 . . . . 0.0 109.253 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 17.6 p -91.06 -11.88 37.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.975 -1.078 . . . . 0.0 109.85 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 80.8 p -64.09 158.01 23.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.342 -0.849 . . . . 0.0 110.478 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -74.85 132.96 41.92 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.0 mt -132.32 133.01 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.617 -0.677 . . . . 0.0 109.209 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 69.4 m -127.92 151.04 49.58 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.48 -0.763 . . . . 0.0 109.491 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 60.8 t -117.04 137.83 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 87.6 m -128.96 125.12 36.76 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.184 -0.948 . . . . 0.0 109.083 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 12.2 t -138.67 119.12 13.8 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.959 0.885 . . . . 0.0 110.798 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' B' ' 338' ' ' ASN . 8.1 p-10 39.01 65.13 0.7 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 79.3 -12.36 26.35 Favored Glycine 0 N--CA 1.5 2.947 0 O-C-N 120.833 -1.167 . . . . 0.0 113.668 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -120.67 133.09 55.38 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-N 119.564 1.682 . . . . 0.0 109.963 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 78.7 p -129.91 150.4 51.21 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.8 0.809 . . . . 0.0 110.513 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.23 167.33 22.68 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.528 0.68 . . . . 0.0 110.11 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 12.2 m -88.93 138.94 30.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.504 -0.748 . . . . 0.0 109.808 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -76.8 -13.03 60.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.907 -1.121 . . . . 0.0 108.974 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -89.69 16.58 7.66 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 67.3 m -145.61 94.79 2.55 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.607 0.717 . . . . 0.0 111.068 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . 0.57 ' O ' ' NE2' ' B' ' 351' ' ' GLN . 52.9 tp -59.89 -33.96 72.54 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . 0.405 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 54.2 m-85 -55.79 -52.84 62.59 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.928 -1.108 . . . . 0.0 109.852 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -69.99 -20.77 63.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -0.898 . . . . 0.0 111.889 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.97 -46.76 64.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.428 -1.42 . . . . 0.0 110.817 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.57 ' NE2' ' O ' ' B' ' 347' ' ' LEU . 0.7 OUTLIER -47.92 -21.11 0.38 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.894 -1.129 . . . . 0.0 111.695 -177.371 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 71.3 p -77.31 -12.97 60.01 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.168 -1.582 . . . . 0.0 109.974 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 30.0 mt -96.21 119.68 35.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.107 -0.995 . . . . 0.0 109.431 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.13 97.3 0.93 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 90.5 mt -98.64 81.56 2.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.327 -1.102 . . . . 0.0 109.399 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 46.5 p -89.77 176.48 6.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.149 -0.969 . . . . 0.0 110.964 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . 0.405 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 21.9 tm0? -70.64 112.19 6.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.694 -0.629 . . . . 0.0 110.379 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 104.26 8.74 37.87 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 19.2 m -86.55 109.2 18.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.122 -1.223 . . . . 0.0 110.357 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 7.9 t -77.6 115.49 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 122.329 1.061 . . . . 0.0 109.556 -177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 33.2 m -113.01 178.41 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -178.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 34.6 m -130.5 128.87 42.06 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 38.6 mt -104.69 121.55 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 68.8 p -126.46 136.12 52.23 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.71 153.25 40.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.208 -0.932 . . . . 0.0 109.923 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -146.16 125.82 13.38 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 158.98 -158.76 29.73 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.116 -1.516 . . . . 0.0 111.256 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.81 -51.99 67.36 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 122.077 -0.661 . . . . 0.0 112.177 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -111.27 11.92 21.7 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.998 -1.064 . . . . 0.0 111.023 -177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -43.53 -31.85 0.81 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.231 -0.918 . . . . 0.0 110.746 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . 0.402 ' HG3' ' H ' ' B' ' 372' ' ' LYS . 3.2 pt20 -65.13 -47.31 77.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.881 -1.137 . . . . 0.0 109.532 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . 0.402 ' H ' ' HG3' ' B' ' 371' ' ' GLN . 99.9 mttt -65.84 -49.28 68.75 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 109.209 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.49 -37.04 3.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.661 -0.649 . . . . 0.0 112.041 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 99.5 t -80.51 -35.38 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.479 -1.388 . . . . 0.0 109.964 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -67.04 -39.97 87.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.898 -1.126 . . . . 0.0 111.072 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -80.5 -46.64 15.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.759 -1.213 . . . . 0.0 110.57 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . 0.416 ' O ' ' N ' ' B' ' 381' ' ' MET . 89.8 mt -61.69 -39.95 93.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.194 -0.941 . . . . 0.0 109.865 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 54.8 t -60.19 -49.16 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.041 -1.037 . . . . 0.0 109.624 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' B' ' 383' ' ' GLU . 10.6 mtpm? -68.07 -54.2 20.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.703 -1.199 . . . . 0.0 107.993 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 50.1 tp -56.83 -34.97 68.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 110.182 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 381' ' ' MET . . . . . 0.416 ' N ' ' O ' ' B' ' 377' ' ' LEU . 0.8 OUTLIER -72.09 -40.31 68.31 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 118.286 -1.366 . . . . 0.0 108.805 178.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.07 -6.45 59.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.525 -0.734 . . . . 0.0 110.533 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' B' ' 379' ' ' LYS . 74.2 mm-40 -110.28 -2.42 16.77 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.129 -0.982 . . . . 0.0 111.377 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 12.7 mt -80.98 129.99 34.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.276 -1.515 . . . . 0.0 108.722 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.381 -179.783 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.6 mtp . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.143 -0.688 . . . . 3.19 109.143 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.9 mt -96.39 135.78 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.336 -0.853 . . . . 1.71 109.31 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.6 m -119.34 149.83 41.16 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.775 0.798 . . . . 1.66 109.895 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.781 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -139.79 -173.43 13.21 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.9 -1.68 . . . . 1.05 108.9 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.427 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.5 mt -85.48 -7.18 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.896 -1.355 . . . . 1.59 110.087 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.4 tp 50.42 95.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.91 -1.119 . . . . 1.47 109.453 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.11 -35.06 16.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 1.39 109.378 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 2.8 p -134.67 130.84 19.95 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.495 -0.753 . . . . 2.09 109.364 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.36 141.14 14.07 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.206 1.937 . . . . 0.91 112.779 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 162.94 -162.72 34.87 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.978 -1.249 . . . . 0.92 109.978 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.2 mt -146.28 147.09 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.265 -1.138 . . . . 1.35 108.376 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.69 141.45 18.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.524 -1.36 . . . . 1.14 111.455 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -122.14 126.15 47.7 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 107.773 -1.195 . . . . 0.7 107.773 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.08 178.52 48.53 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 118.551 -1.785 . . . . 0.58 111.188 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -79.13 160.95 26.79 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.863 -0.786 . . . . 2.63 110.135 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -102.44 127.28 49.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.549 -0.719 . . . . 1.27 111.256 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.3 tp -106.87 134.56 49.84 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.618 -1.623 . . . . 1.41 106.618 177.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.6 tp -117.66 123.09 45.29 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.243 -0.911 . . . . 1.49 110.523 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.8 mt -86.0 103.3 14.57 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.358 0.599 . . . . 1.52 109.644 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -93.98 135.21 35.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -0.896 . . . . 3.17 108.75 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -130.14 132.48 46.1 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.555 -0.906 . . . . 3.0 108.555 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -80.97 148.08 29.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.094 -1.004 . . . . 2.77 110.006 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -62.65 149.47 43.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.38 -0.825 . . . . 2.94 109.263 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 42.0 mt -90.67 125.5 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.223 -0.923 . . . . 1.46 108.89 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.5 t -92.1 125.82 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.096 -1.002 . . . . 1.7 109.989 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.54 130.59 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.028 -1.101 . . . . 1.54 108.028 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -90.68 123.06 33.99 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.824 -1.173 . . . . 1.81 110.245 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -86.63 -1.32 57.58 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.57 -0.9 . . . . 3.23 108.57 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -65.1 140.07 58.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.417 -0.802 . . . . 3.29 109.974 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -87.9 151.31 22.92 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.085 -1.079 . . . . 2.8 108.085 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.9 pt -101.48 166.91 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.918 -1.114 . . . . 1.43 109.882 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.0 p -97.96 178.83 4.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.259 -0.901 . . . . 1.54 109.407 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.15 -49.39 77.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.362 -0.836 . . . . 1.6 110.469 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -56.37 -31.5 63.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.616 -1.302 . . . . 2.56 110.248 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -81.8 -9.34 59.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.307 -0.871 . . . . 2.36 110.448 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.0 t -59.97 -50.09 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.937 -1.102 . . . . 1.43 108.75 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -62.61 -40.05 95.72 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.278 -0.889 . . . . 1.77 109.152 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -60.58 -46.03 91.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.296 -0.877 . . . . 3.32 110.488 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -60.72 -44.35 96.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.825 -1.172 . . . . 1.51 109.851 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.3 t -60.06 -46.37 94.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.95 -1.094 . . . . 1.41 108.743 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -58.75 -40.06 82.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.38 -0.825 . . . . 1.81 109.099 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -60.91 -44.5 97.09 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.007 -1.108 . . . . 3.26 108.007 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -60.12 -49.48 77.46 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.95 -0.759 . . . . 0.81 108.95 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.0 -47.38 86.06 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.281 -1.007 . . . . 1.59 108.281 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.7 t -60.85 -43.82 97.81 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.353 -0.939 . . . . 1.38 108.869 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.99 -45.16 96.39 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.551 -1.819 . . . . 0.87 108.551 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.0 ttt-85 -60.06 -36.34 77.11 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.132 -1.062 . . . . 3.62 108.132 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.04 -40.39 63.9 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.939 -0.763 . . . . 1.43 108.939 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.1 ttmt -75.08 -74.08 0.22 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.614 -1.254 . . . . 3.08 107.614 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.53 -39.64 0.33 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.533 -0.729 . . . . 1.33 111.222 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.705 ' HG ' ' H ' ' A' ' 52' ' ' ALA . 72.6 p -56.64 -59.09 5.52 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.658 -1.276 . . . . 1.85 108.895 179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.705 ' H ' ' HG ' ' A' ' 51' ' ' SER . . . -64.76 -39.97 94.5 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.347 -0.846 . . . . 1.35 110.939 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -67.73 -39.96 84.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.812 -1.18 . . . . 2.34 110.202 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.6 mt -65.64 -40.06 92.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.062 -1.024 . . . . 2.2 109.614 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.425 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 74.9 mm-40 -62.63 -39.95 95.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.089 -1.007 . . . . 1.35 109.846 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -64.14 -41.85 97.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.059 -1.026 . . . . 1.34 110.012 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.8 mt -61.41 -40.0 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.912 . . . . 1.26 109.858 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.425 ' NZ ' ' OE1' ' A' ' 55' ' ' GLU . 5.1 ttpm? -58.16 -49.92 75.32 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.194 -0.941 . . . . 1.7 109.876 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.4 m -58.55 -36.09 73.35 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.364 -0.835 . . . . 1.35 110.886 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -65.83 -38.72 89.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.971 -1.08 . . . . 2.08 109.644 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.97 92.32 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.531 -0.73 . . . . 1.21 110.256 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.08 -50.0 72.2 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.362 -1.495 . . . . 0.75 109.362 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -66.91 -49.5 65.38 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.269 -1.136 . . . . 1.59 109.579 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.8 m -69.74 -61.61 1.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.492 -0.755 . . . . 1.41 112.694 -177.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -93.63 -51.82 4.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.763 -1.21 . . . . 0.79 110.949 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.24 -173.01 23.55 Favored Glycine 0 N--CA 1.501 3.019 0 C-N-CA 119.767 -1.206 . . . . 1.22 111.444 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -71.13 -27.75 63.79 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.356 0.598 . . . . 5.81 110.495 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -63.58 -33.99 76.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.372 -0.83 . . . . 3.37 110.8 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -100.73 -24.99 14.29 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.104 -0.997 . . . . 2.37 109.843 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -62.83 -40.02 96.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 1.65 109.935 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.512 ' CB ' HH11 ' B' ' 317' ' ' ARG . . . -59.8 -29.88 68.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.398 -0.814 . . . . 1.42 109.732 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.7 mt -59.98 -40.09 82.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.453 -1.314 . . . . 1.43 107.453 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -70.99 -40.06 72.11 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.605 -0.685 . . . . 1.08 111.005 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -64.12 -42.04 97.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.601 -1.312 . . . . 1.37 109.712 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.88 -40.59 96.99 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.586 -1.806 . . . . 0.67 108.586 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.8 m170 -64.55 -43.15 94.85 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.387 -1.067 . . . . 1.99 109.332 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.1 mt -67.32 -47.59 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 1.22 109.983 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.9 ttp -60.1 -40.62 90.28 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.941 -1.099 . . . . 2.11 110.235 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.5 tp -66.29 -36.81 83.93 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.539 -0.726 . . . . 1.33 109.639 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.49 -39.34 91.79 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.528 -0.733 . . . . 1.29 109.84 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -78.65 6.88 7.81 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.959 -1.088 . . . . 1.47 110.082 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 57.4 t0 -53.46 132.6 40.14 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.215 -0.928 . . . . 1.47 110.93 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.437 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 93.6 mt-10 -63.34 -18.71 63.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.725 -0.609 . . . . 1.78 110.602 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.02 -34.97 69.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 2.53 108.919 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.48 -39.56 81.29 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.694 0.759 . . . . 1.36 109.241 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.9 -44.47 94.23 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.646 -0.659 . . . . 1.42 110.527 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -70.07 -43.15 71.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.157 -0.964 . . . . 2.27 111.628 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -69.95 -40.07 75.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.001 -1.062 . . . . 1.57 112.476 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.63 -44.53 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.75 -1.219 . . . . 1.19 109.938 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.63 -38.59 76.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.487 -0.758 . . . . 1.39 110.168 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.07 -50.11 74.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.159 -0.963 . . . . 1.39 111.501 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.1 mt -60.97 -45.87 93.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.849 -1.157 . . . . 1.5 109.882 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.1 mt -60.86 -50.03 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.182 -0.948 . . . . 1.29 109.025 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -70.0 -40.59 75.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.65 -0.656 . . . . 2.64 110.857 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -81.16 -62.5 1.64 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.197 -0.939 . . . . 1.65 112.189 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -83.59 -1.0 52.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.122 -0.987 . . . . 2.5 111.934 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 58.98 39.08 23.98 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.929 -1.107 . . . . 1.88 109.741 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.6 mtp -92.36 167.43 12.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.482 -0.761 . . . . 1.71 109.645 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.0 p -84.2 163.44 19.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 1.61 109.945 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.57 -39.75 80.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.397 -0.814 . . . . 1.33 109.242 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -62.24 -42.45 99.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.306 -0.871 . . . . 2.07 110.231 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.87 -42.85 18.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.327 -0.858 . . . . 1.37 110.701 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.69 -47.32 66.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.16 -0.962 . . . . 1.14 110.791 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.6 -38.98 93.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.017 -1.052 . . . . 1.26 109.346 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.459 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 77.2 t60 -59.28 -40.85 87.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.519 -0.738 . . . . 2.02 109.808 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 110' ' ' GLY . 87.0 tt0 -64.32 -39.94 94.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 1.33 110.373 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.8 t -62.19 -55.51 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.148 -0.97 . . . . 1.3 111.132 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 45.6 mm -69.15 -40.04 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.804 -1.185 . . . . 1.32 108.82 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.459 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.4 tt0 -64.89 -39.88 94.22 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.832 -1.173 . . . . 2.44 107.832 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.02 -49.17 77.56 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.882 -1.287 . . . . 0.99 109.882 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -69.52 -51.66 33.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.948 -1.325 . . . . 1.97 109.222 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.91 -42.75 85.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.915 . . . . 1.43 109.282 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 40.5 t -58.36 -38.64 77.63 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.352 -0.842 . . . . 2.12 109.164 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.76 89.52 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.2 -0.938 . . . . 1.64 108.893 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.2 mt -63.05 -42.74 99.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.905 -1.122 . . . . 1.93 109.646 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.99 -33.08 71.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.871 -1.143 . . . . 2.2 109.468 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.57 -20.96 51.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 2.12 109.075 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 29.5 mt -61.59 142.35 57.18 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.97 -1.081 . . . . 2.34 108.293 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -92.37 28.58 1.9 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.03 -1.044 . . . . 3.23 110.883 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -116.89 128.5 55.3 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.189 -0.944 . . . . 2.49 109.733 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -67.86 -28.04 67.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.557 -0.714 . . . . 3.95 109.522 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.584 ' HH ' ' C ' ' B' ' 314' ' ' LEU . 16.3 t80 -63.96 -41.81 97.45 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.237 1.018 . . . . 2.25 109.133 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.427 HD22 HH21 ' A' ' 126' ' ' ARG . 91.7 mt -75.93 -33.03 59.84 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.208 -0.664 . . . . 2.27 109.208 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -60.06 -40.56 89.88 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.861 -0.792 . . . . 3.31 108.861 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -60.0 -48.36 82.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 2.73 109.163 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.749 ' NE ' HE22 ' B' ' 351' ' ' GLN . 61.1 mtm180 -69.33 -30.38 68.41 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.136 -1.026 . . . . 3.2 108.608 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.56 -27.0 68.87 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.39 -0.967 . . . . 1.66 108.39 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.0 -39.93 72.12 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.89 -0.782 . . . . 1.67 108.89 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -60.05 -44.44 94.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.416 -0.802 . . . . 1.55 110.567 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.06 -39.97 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.003 -1.061 . . . . 1.32 108.772 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -61.38 -39.95 92.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.299 -0.875 . . . . 3.58 109.894 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.95 -40.0 87.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 1.46 110.566 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 93.7 mt -60.04 -43.41 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.038 -1.039 . . . . 1.22 109.669 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.05 -43.93 97.75 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.894 -1.283 . . . . 0.61 109.894 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.09 -45.73 91.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -1.188 . . . . 3.1 110.561 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -64.82 -34.95 79.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.831 -1.168 . . . . 3.71 109.641 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.1 tp -59.97 -42.08 93.35 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.315 -0.866 . . . . 1.87 109.333 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 59.3 mt -60.18 -41.83 93.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.088 -1.007 . . . . 1.29 109.703 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 64.4 mtm-85 -70.79 -40.04 72.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.111 -0.993 . . . . 3.05 109.802 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -61.02 -37.18 81.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 1.26 111.048 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.2 mt -69.99 -42.62 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.562 -1.336 . . . . 1.34 108.854 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.6 mt -70.03 -26.96 64.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.248 -0.649 . . . . 1.6 109.248 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.2 41.28 8.07 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.958 -1.657 . . . . 0.96 108.958 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.64 143.85 46.12 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.34 -1.094 . . . . 1.67 108.351 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -69.97 144.64 52.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.244 -0.91 . . . . 4.96 110.163 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.8 mt -109.88 127.93 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 122.176 0.989 . . . . 1.68 108.76 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.7 mt -69.99 -40.03 78.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-N 115.582 -0.736 . . . . 2.14 110.272 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 31.4 t0 64.22 123.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.514 -0.741 . . . . 1.5 109.442 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 mt -89.9 0.01 57.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.592 -0.692 . . . . 1.39 109.569 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.3 m -88.18 -18.46 28.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.234 -0.916 . . . . 1.83 110.716 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.69 16.52 2.16 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.072 -1.017 . . . . 1.46 112.008 -177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.12 119.19 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.427 -1.421 . . . . 1.42 108.72 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -99.38 -9.51 23.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.183 -0.948 . . . . 2.94 110.806 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -110.19 144.82 38.29 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.405 -0.809 . . . . 1.52 110.052 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -65.61 135.61 55.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 1.58 108.993 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.4 m -152.86 166.47 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.571 -0.706 . . . . 1.32 109.419 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.435 HD11 HG22 ' A' ' 157' ' ' ILE . 83.7 mt -94.75 144.65 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 105.563 -2.014 . . . . 1.27 105.563 176.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 12.2 tp -96.58 117.45 30.98 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.812 -1.18 . . . . 1.41 110.48 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.3 t -122.37 130.03 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.595 -0.891 . . . . 1.23 108.595 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.27 164.2 35.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.095 -1.003 . . . . 1.32 109.074 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.46 ' O ' ' OD1' ' A' ' 162' ' ' ASP . . . -75.3 -30.61 60.41 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.317 -1.489 . . . . 1.49 108.681 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 66.6 m-20 -159.54 167.87 27.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.52 -0.738 . . . . 2.25 109.398 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 86.7 mt -141.68 125.83 17.4 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.175 -0.953 . . . . 1.35 108.473 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 70.3 p -93.23 148.49 35.74 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.083 -1.01 . . . . 1.56 109.827 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.423 ' O ' ' OG1' ' A' ' 168' ' ' THR . 93.5 Cg_exo -39.64 -37.87 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.243 1.962 . . . . 0.87 112.389 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 73.8 m -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.207 -0.933 . . . . 1.36 109.673 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.8 -41.6 97.87 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.194 -0.941 . . . . 1.61 109.497 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 165' ' ' PRO . 59.5 p -55.6 -31.63 62.4 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.178 -0.951 . . . . 1.21 111.389 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -71.82 -55.01 8.36 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.578 -1.326 . . . . 1.21 109.446 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -82.43 40.35 0.65 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.8 -1.185 . . . . 2.11 107.8 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.421 ' H ' ' C ' ' A' ' 169' ' ' ALA . 62.3 tp -105.31 130.92 53.33 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.316 -0.994 . . . . 1.29 108.316 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -88.63 105.43 17.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.024 -1.048 . . . . 2.81 109.104 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 93.4 mt -63.69 -44.12 94.61 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.291 -0.881 . . . . 2.09 110.788 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.428 ' HZ1' ' CB ' ' A' ' 174' ' ' LYS . 9.2 mtmp? -72.4 -22.29 61.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.854 -1.153 . . . . 2.86 112.528 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -93.45 -9.99 36.63 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.527 -1.358 . . . . 2.39 109.663 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' A' ' 178' ' ' GLY . 99.2 t -107.99 119.05 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.306 -0.871 . . . . 1.27 109.254 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 70.1 mt -85.74 4.92 34.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.403 -0.811 . . . . 2.17 110.525 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.427 ' O ' ' CG1' ' A' ' 176' ' ' VAL . . . 168.03 175.22 37.58 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.296 -1.522 . . . . 0.52 109.296 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -133.61 130.48 38.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.402 -1.058 . . . . 0.55 109.144 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 79.4 mt -130.66 122.21 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.568 -0.901 . . . . 1.27 108.568 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 59.0 p -144.7 159.77 42.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.111 -0.993 . . . . 1.39 111.279 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 53.3 t0 -103.02 25.87 8.87 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.353 -0.61 . . . . 2.46 109.353 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.7 -161.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.178 -1.576 . . . . 1.51 111.747 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.61 -54.87 6.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.588 -1.005 . . . . 2.23 110.588 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.96 -114.37 0.65 Allowed Glycine 0 N--CA 1.495 2.61 0 O-C-N 120.778 -1.424 . . . . 2.23 111.263 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -69.98 -24.14 63.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.677 -0.896 . . . . 6.44 111.648 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 75.7 p -82.85 3.15 30.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.597 -1.314 . . . . 4.09 110.664 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 34.3 t -91.61 126.86 36.84 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.918 -1.114 . . . . 2.2 111.08 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -55.98 -46.37 78.68 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.277 -0.89 . . . . 1.15 110.32 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.19 -39.99 67.14 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.14 -0.975 . . . . 2.01 110.238 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 24.8 p -60.36 -39.6 87.75 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.003 -1.061 . . . . 1.93 110.454 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.9 -41.1 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.966 . . . . 2.2 110.188 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 91.6 mtp -62.57 -40.06 95.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.035 -1.04 . . . . 1.32 110.666 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.99 -40.45 73.34 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.613 -1.304 . . . . 1.3 108.594 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -59.62 -49.67 76.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 3.38 109.699 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 62.9 m -76.12 -31.24 58.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.18 -0.95 . . . . 1.15 110.798 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.82 -21.93 60.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.954 -1.091 . . . . 1.28 109.547 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 64.39 43.93 4.42 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.93 -0.481 . . . . 1.5 111.514 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.456 ' O ' ' OG ' ' A' ' 8' ' ' SER . 46.5 mt -121.08 142.1 34.17 Favored Pre-proline 0 N--CA 1.503 2.219 0 N-CA-C 107.601 -1.259 . . . . 1.37 107.601 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.72 143.84 99.46 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.508 1.472 . . . . 0.76 111.441 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.96 152.22 3.5 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.935 -1.106 . . . . 1.19 111.49 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 202' ' ' ILE . 89.9 mt -124.27 143.46 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.739 -1.208 . . . . 1.31 107.739 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.5 m -125.49 -10.77 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.996 -1.065 . . . . 1.38 111.19 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -113.11 25.97 10.91 Favored Glycine 0 N--CA 1.501 3.012 0 N-CA-C 111.063 -0.815 . . . . 1.03 111.063 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.409 ' C ' ' O ' ' A' ' 204' ' ' GLY . 11.4 p -43.56 -43.75 5.76 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.001 -1.294 . . . . 1.38 109.757 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.434 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 96.01 -50.7 1.71 Allowed Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.439 -0.886 . . . . 1.17 111.418 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.2 m -160.08 40.0 0.18 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.53 -1.571 . . . . 2.07 111.457 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 12.1 t -77.54 -32.02 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.889 -1.132 . . . . 1.35 108.775 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 31.9 p -60.0 -39.89 87.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.558 -0.714 . . . . 1.49 110.829 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 81.8 p -82.47 -10.7 58.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.973 -1.079 . . . . 2.16 110.731 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -98.53 -16.82 19.01 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.21 -0.931 . . . . 2.89 110.724 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 44.8 t -116.56 154.73 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 O-C-N 121.265 -0.897 . . . . 1.33 111.025 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.515 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 2.8 mptp? -116.01 154.83 29.18 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.558 -1.275 . . . . 2.73 107.558 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 20.9 p30 -59.74 140.11 56.76 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.956 -1.09 . . . . 2.7 110.474 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.4 t0 88.97 5.7 0.16 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.049 0.452 . . . . 2.38 110.368 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.515 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 59.4 m-20 -79.78 153.71 28.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.049 -1.032 . . . . 2.09 109.706 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -95.01 129.93 41.88 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.416 -0.802 . . . . 1.45 108.868 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 84.6 mt -130.72 151.18 51.45 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.136 -0.977 . . . . 1.31 110.769 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 219' ' ' ILE . 84.9 mt -120.13 122.03 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 107.235 -1.394 . . . . 1.29 107.235 176.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 45.2 tp -103.33 120.02 39.98 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.823 -1.173 . . . . 1.31 108.73 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 10' ' ' GLY . 32.3 t0 -87.24 -37.36 17.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.936 -1.102 . . . . 2.31 108.918 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 45.52 24.49 0.18 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.594 -0.691 . . . . 1.19 109.363 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 45.0 t -137.28 -44.63 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 106.965 -1.494 . . . . 1.45 106.965 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -99.94 2.69 43.88 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.131 -1.433 . . . . 3.13 107.131 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.781 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.8 OUTLIER 59.94 45.11 12.68 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 116.101 -0.5 . . . . 2.2 110.03 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -139.48 138.38 36.35 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.137 -0.977 . . . . 2.32 109.828 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 97.1 t -120.01 122.38 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.807 -0.812 . . . . 1.4 108.807 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.49 ' CD2' ' SD ' ' A' ' 239' ' ' MET . 99.2 m-85 -90.61 130.71 36.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.87 -1.144 . . . . 1.29 108.499 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 62.9 t -107.69 123.19 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.58 -0.7 . . . . 1.38 109.709 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 66.6 t30 56.65 67.34 2.72 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.284 -0.885 . . . . 2.33 109.271 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -88.53 130.87 2.37 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 123.144 2.563 . . . . 0.95 112.827 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.46 ' CG2' ' N ' ' A' ' 233' ' ' ASN . 95.1 m -73.2 173.23 9.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.368 -0.832 . . . . 2.31 109.082 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.46 ' N ' ' CG2' ' A' ' 232' ' ' THR . 70.3 m-80 -60.0 -40.0 87.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.168 -0.957 . . . . 3.45 109.886 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.48 -39.99 92.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 2.89 109.944 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.2 t -68.29 -39.95 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.093 -1.004 . . . . 1.73 109.544 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.4 mt -65.66 -42.27 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.076 -1.015 . . . . 1.57 108.672 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -61.31 -39.53 90.81 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.031 -0.729 . . . . 2.43 109.031 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -59.95 -49.67 76.77 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.522 -0.918 . . . . 3.18 108.522 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.546 ' O ' ' N ' ' A' ' 242' ' ' VAL . 96.2 mtp -62.66 -75.12 0.08 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.728 -1.582 . . . . 1.59 106.728 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.528 ' C ' ' O ' ' A' ' 239' ' ' MET . 13.1 mmm-85 -18.31 -55.73 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 112.112 0.412 . . . . 3.11 112.112 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 239' ' ' MET . . . -59.99 -50.61 73.08 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.894 -1.129 . . . . 2.17 109.82 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 239' ' ' MET . 54.5 t -62.84 -39.9 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.368 -0.832 . . . . 2.51 109.364 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.0 tm0? -59.73 -39.08 83.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.905 . . . . 3.82 109.555 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -39.97 87.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.715 -1.24 . . . . 1.78 108.859 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -61.29 -40.04 92.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.243 -0.911 . . . . 2.77 108.802 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 62.4 t -60.82 -39.95 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 109.034 -0.728 . . . . 2.25 109.034 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.92 82.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.37 -0.831 . . . . 2.54 109.617 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 58.1 m -60.09 -39.96 87.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.082 -1.011 . . . . 3.03 109.201 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 251' ' ' ALA . 46.9 tp10 -60.1 -40.02 88.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 3.34 109.191 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -50.81 -13.47 0.15 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.231 -0.918 . . . . 4.18 108.885 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 249' ' ' GLU . . . -60.05 -46.71 88.65 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.491 -0.756 . . . . 4.43 109.275 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -151.5 75.37 1.17 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.212 -0.93 . . . . 5.42 109.682 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.55 5.85 49.36 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.115 -0.991 . . . . 6.11 109.07 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -69.96 -26.47 64.12 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.276 -0.89 . . . . 7.37 109.432 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -60.02 -49.9 75.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 8.3 110.226 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.19 -40.08 93.75 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.003 -1.061 . . . . 9.05 109.514 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -80.87 158.29 25.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.334 -0.854 . . . . 10.56 109.92 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -97.08 11.94 34.4 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.329 -0.857 . . . . 11.32 109.54 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 12.74 109.589 -179.952 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 31.7 ttp . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.414 0.626 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -154.86 152.43 29.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.057 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -150.04 162.8 39.68 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.061 -1.025 . . . . 0.0 109.958 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -154.3 151.64 29.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 0.0 109.255 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -108.99 130.98 55.48 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.302 -0.874 . . . . 0.0 110.059 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.86 121.75 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-O 122.235 1.017 . . . . 0.0 112.512 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 18.1 m -76.7 106.72 8.53 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.944 0.878 . . . . 0.0 111.086 -177.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 97.1 mt -53.18 121.36 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 122.191 0.996 . . . . 0.0 110.566 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 81.8 p -110.76 19.98 18.06 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.232 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.92 118.02 59.33 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 120.928 -1.108 . . . . 0.0 108.826 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -49.65 -20.34 4.29 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 CA-C-N 120.216 1.113 . . . . 0.0 112.945 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -116.15 15.3 16.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.371 -0.831 . . . . 0.0 109.714 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.53 174.35 20.01 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.175 -1.97 . . . . 0.0 108.175 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.584 ' C ' ' HH ' ' A' ' 122' ' ' TYR . 3.5 tp -83.52 94.27 8.0 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.981 -1.305 . . . . 0.0 109.459 -178.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 3.6 p80 -99.94 -158.81 0.7 Allowed 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.085 -1.01 . . . . 0.0 109.978 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.7 m -59.95 -43.84 94.77 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.968 -1.083 . . . . 0.0 112.572 -175.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.527 HH12 ' NE2' ' B' ' 321' ' ' GLN . 11.9 tpt180 -54.1 -59.19 10.59 Favored Pre-proline 0 N--CA 1.499 2.025 0 O-C-N 120.335 -1.478 . . . . 0.0 111.271 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -60.59 -34.51 92.34 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 CA-C-N 120.531 1.225 . . . . 0.0 111.503 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.08 -50.88 71.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.364 -0.835 . . . . 0.0 109.034 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.71 -43.0 76.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.785 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . 0.527 ' NE2' HH12 ' B' ' 317' ' ' ARG . 83.0 mm-40 -70.02 -41.47 74.24 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.807 -1.183 . . . . 0.0 108.898 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -62.01 -52.91 62.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.548 -0.72 . . . . 0.0 110.554 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 87.0 t -65.73 -28.01 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.909 -1.119 . . . . 0.0 109.844 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -60.13 -46.66 88.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.123 -0.986 . . . . 0.0 110.057 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -66.1 -47.7 73.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.13 -0.981 . . . . 0.0 111.284 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.9 -53.4 58.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.64 -1.288 . . . . 0.0 111.34 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -57.16 -15.48 5.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.924 -1.11 . . . . 0.0 109.702 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -74.86 -30.07 60.06 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -101.71 146.23 28.03 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.318 -1.107 . . . . 0.0 108.594 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 24.3 p -89.79 -12.83 38.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.916 -1.115 . . . . 0.0 110.218 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 331' ' ' SER . . . . . 0.405 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 23.2 t -55.2 148.2 14.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.122 -0.986 . . . . 0.0 109.577 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -70.24 128.87 37.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.223 -0.923 . . . . 0.0 108.523 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.7 mt -131.48 131.15 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.568 -0.708 . . . . 0.0 109.817 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 89.4 m -130.39 154.48 47.65 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.548 -0.72 . . . . 0.0 109.531 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 56.1 t -116.44 137.87 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 178.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 91.3 m -129.11 126.42 39.3 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.107 -0.995 . . . . 0.0 108.898 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 49.4 p -139.94 114.4 9.24 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.128 -0.983 . . . . 0.0 111.678 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 46.76 52.95 10.79 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 176.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.94 -13.92 63.31 Favored Glycine 0 N--CA 1.502 3.094 0 O-C-N 119.992 -1.692 . . . . 0.0 112.776 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -119.89 131.42 55.24 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-N 119.13 1.465 . . . . 0.0 109.86 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 89.4 p -132.0 151.5 51.7 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.776 0.798 . . . . 0.0 110.332 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.3 169.84 17.13 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.479 0.657 . . . . 0.0 109.929 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 3.6 t -91.63 140.11 30.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.342 -0.849 . . . . 0.0 110.707 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -79.47 -16.01 56.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 0.0 109.798 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -84.05 16.02 3.13 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.491 ' H ' ' C ' ' B' ' 344' ' ' ALA . 93.4 p -149.99 95.7 2.33 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.048 0.928 . . . . 0.0 111.835 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 47.6 tp -60.17 -32.72 71.32 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -54.61 -52.88 60.83 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.902 -1.124 . . . . 0.0 109.817 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.448 ' O ' ' OG1' ' B' ' 352' ' ' THR . 40.0 mtpt -70.01 -39.89 75.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.246 -0.909 . . . . 0.0 110.549 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' B' ' 352' ' ' THR . 88.9 mt -49.93 -59.69 3.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.888 -1.132 . . . . 0.0 109.578 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.749 HE22 ' NE ' ' A' ' 126' ' ' ARG . 17.7 mm100 -42.21 -10.23 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.779 -0.575 . . . . 0.0 112.074 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.603 ' N ' ' O ' ' B' ' 350' ' ' LEU . 60.1 p -88.04 -5.07 58.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.336 -1.477 . . . . 0.0 109.48 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 91.4 mt -96.83 116.76 29.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.344 -0.848 . . . . 0.0 109.074 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.63 96.11 1.14 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 31.1 mt -106.17 96.81 6.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.342 -1.093 . . . . 0.0 109.634 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 21.4 p -97.55 159.64 14.8 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.942 -1.099 . . . . 0.0 110.687 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -52.81 119.29 4.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.691 -0.631 . . . . 0.0 110.66 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 101.51 4.07 52.86 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 63.2 m -87.52 111.25 21.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.454 -1.027 . . . . 0.0 111.093 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 45.2 t -77.12 117.74 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 122.291 1.044 . . . . 0.0 109.448 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 30.3 m -112.11 177.14 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 42.0 m -130.76 129.01 41.92 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 88.5 mt -104.7 122.36 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 69.6 m -126.95 135.98 51.65 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.63 156.21 42.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.199 -0.938 . . . . 0.0 109.527 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -147.95 124.57 11.1 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 159.15 -157.09 28.18 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.629 -1.748 . . . . 0.0 111.848 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -59.95 -55.06 38.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 122.249 -0.56 . . . . 0.0 111.995 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.405 ' H ' ' HB2' ' B' ' 331' ' ' SER . 95.9 m-20 -108.8 10.16 26.71 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.037 -1.039 . . . . 0.0 111.416 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.487 ' OE2' ' NE2' ' B' ' 371' ' ' GLN . 0.6 OUTLIER -43.97 -30.6 0.74 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.979 -1.075 . . . . 0.0 110.618 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . 0.487 ' NE2' ' OE2' ' B' ' 370' ' ' GLU . 92.1 mm-40 -70.04 -41.0 74.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.053 -1.029 . . . . 0.0 109.541 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -67.98 -49.45 61.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.128 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.78 -76.75 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.448 -0.783 . . . . 0.0 111.258 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . 0.42 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 46.3 t -45.31 -37.32 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 120.923 -1.111 . . . . 0.0 110.763 -177.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.73 -43.15 80.63 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.505 -1.372 . . . . 0.0 109.974 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -85.34 -43.18 13.91 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.751 -1.218 . . . . 0.0 110.09 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 84.9 mt -57.22 -38.17 73.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.95 -1.094 . . . . 0.0 108.919 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 54.5 t -66.78 -40.04 85.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.671 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -80.47 -10.08 59.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.67 -1.269 . . . . 0.0 109.727 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 57.2 tp -83.6 -26.78 29.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.654 -1.279 . . . . 0.0 108.08 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 18.3 tpp -80.64 -24.66 38.84 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -85.21 -9.57 57.63 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.767 -0.583 . . . . 0.0 109.736 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -110.6 -2.19 16.5 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.29 -0.881 . . . . 0.0 110.496 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 25.0 mt -91.45 119.63 31.59 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.82 -1.175 . . . . 0.0 109.334 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.498 1.94 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.019 179.751 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.616 -0.512 . . . . 3.19 109.616 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.42 HD11 HG22 ' A' ' 2' ' ' ILE . 85.5 mt -110.0 129.02 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.806 -0.813 . . . . 1.71 108.806 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -132.5 134.84 45.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.444 -0.785 . . . . 1.66 108.985 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.67 -163.11 19.57 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 108.723 -1.751 . . . . 1.05 108.723 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.436 ' CG2' ' HE ' ' A' ' 186' ' ' ARG . 96.9 mt -90.93 -10.38 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.033 -1.275 . . . . 1.59 109.891 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.4 tp 54.92 98.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.076 -1.015 . . . . 1.47 109.194 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.85 -36.65 62.35 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.565 -0.71 . . . . 1.39 109.5 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -149.75 144.46 17.77 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.135 -0.978 . . . . 2.09 109.949 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -80.05 140.93 14.48 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.693 2.262 . . . . 0.91 113.145 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 164.94 -163.93 36.72 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 109.468 -1.453 . . . . 0.92 109.468 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -149.98 150.0 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 121.12 -1.224 . . . . 1.35 108.784 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.73 155.74 33.65 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.813 -1.179 . . . . 1.14 110.682 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.8 m-85 -137.5 128.53 27.5 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.407 -0.96 . . . . 0.7 108.407 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.09 -179.92 46.92 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 118.814 -1.66 . . . . 0.58 110.769 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -79.9 157.33 26.95 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.734 -0.863 . . . . 2.63 108.97 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -101.02 129.49 46.87 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.434 -0.791 . . . . 1.27 111.157 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.5 tp -97.31 134.29 40.8 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 106.951 -1.5 . . . . 1.41 106.951 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.9 tp -118.71 122.17 41.85 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.333 -0.855 . . . . 1.49 110.836 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.9 mt -100.37 110.36 22.57 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.832 -0.543 . . . . 1.52 110.886 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -114.57 143.84 44.35 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.525 -0.734 . . . . 3.17 109.272 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.434 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 49.9 mp0 -127.93 130.72 48.94 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.34 -0.85 . . . . 3.0 108.99 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -72.47 144.3 48.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 2.77 109.492 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -61.74 140.36 58.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.304 -0.872 . . . . 2.94 108.972 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.4 mt -79.6 131.95 33.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.224 -0.922 . . . . 1.46 108.786 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.93 123.7 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.25 -0.906 . . . . 1.7 109.485 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -105.67 136.44 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.642 -0.874 . . . . 1.54 108.642 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -90.97 128.36 36.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.033 -1.042 . . . . 1.81 110.552 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.409 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.0 mmm-85 -92.57 7.37 43.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.639 -0.663 . . . . 3.23 109.316 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.55 145.27 54.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 3.29 109.744 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -87.86 139.45 30.5 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.386 -0.821 . . . . 2.8 109.267 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -90.59 163.62 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.896 -1.128 . . . . 1.43 109.899 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.7 p -94.52 169.15 10.4 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.244 -0.91 . . . . 1.54 108.939 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.75 -17.91 63.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.278 -0.889 . . . . 1.6 110.603 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -84.33 -28.45 27.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.688 -1.258 . . . . 2.56 108.094 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -82.07 -8.97 59.68 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.094 -0.706 . . . . 2.36 109.094 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.2 t -65.51 -54.73 25.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 120.916 -1.115 . . . . 1.43 108.571 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -59.97 -40.0 87.6 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.286 -0.884 . . . . 1.77 109.655 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -69.25 -41.84 76.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.228 -0.92 . . . . 3.32 110.684 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -63.33 -40.05 96.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.892 -1.13 . . . . 1.51 110.165 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.23 -46.82 95.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.785 -1.197 . . . . 1.41 108.153 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.26 -44.69 95.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.374 -0.829 . . . . 1.81 109.586 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.01 -43.15 95.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.942 -1.099 . . . . 3.26 108.281 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -64.05 -46.06 86.07 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.345 -0.847 . . . . 0.81 108.902 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.04 -48.34 82.11 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.562 -0.903 . . . . 1.59 108.562 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -64.85 -42.79 94.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.183 -0.948 . . . . 1.38 108.551 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.88 -47.46 88.69 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.478 -1.849 . . . . 0.87 108.478 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -63.79 -37.97 89.35 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.076 -1.083 . . . . 3.62 108.076 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.14 -39.99 70.08 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.562 -0.903 . . . . 1.43 108.562 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 50' ' ' ALA . 31.9 ttpt -61.17 -74.06 0.09 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.655 -1.239 . . . . 3.08 107.655 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.18 -33.18 0.05 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.304 -0.872 . . . . 1.33 111.912 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.2 m -60.02 -50.3 74.29 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.385 -1.447 . . . . 1.85 108.603 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.15 75.85 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.412 -0.805 . . . . 1.35 110.943 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -66.6 -40.0 88.66 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.802 -1.186 . . . . 2.34 110.442 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.87 -40.11 95.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.951 -1.093 . . . . 2.2 109.595 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -60.04 -36.13 76.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 1.35 109.557 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.0 -42.28 98.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -0.977 . . . . 1.34 109.678 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.31 -39.99 87.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.401 -0.812 . . . . 1.26 109.714 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -54.64 -51.59 64.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.264 -0.897 . . . . 1.7 110.123 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -59.7 -34.57 73.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 1.35 110.791 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.408 ' O ' ' OG1' ' A' ' 64' ' ' THR . 62.0 mttm -67.13 -39.58 86.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.087 -1.008 . . . . 2.08 109.877 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.18 -42.42 96.71 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.607 -0.683 . . . . 1.21 109.527 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.21 -55.64 29.57 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.926 -1.269 . . . . 0.75 109.926 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.75 -48.09 70.21 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.885 -1.362 . . . . 1.59 109.656 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 21.6 m -62.84 -65.08 0.74 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 1.41 112.17 -178.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -96.45 -48.74 5.44 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.717 -1.24 . . . . 0.79 111.357 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.76 -168.67 25.51 Favored Glycine 0 N--CA 1.502 3.075 0 C-N-CA 119.536 -1.316 . . . . 1.22 111.436 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -70.04 -26.29 63.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.993 -0.71 . . . . 5.81 110.695 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.486 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 52.8 tp10 -61.4 -35.25 76.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.309 -0.869 . . . . 3.37 110.679 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.9 mmtm -98.95 -20.8 16.59 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.175 -0.953 . . . . 2.37 109.984 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -70.03 -40.25 75.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.149 -0.97 . . . . 1.65 110.589 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.54 -31.71 72.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 1.42 109.788 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.7 mt -59.97 -40.65 83.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.17 -0.956 . . . . 1.43 109.07 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -62.67 -40.91 98.55 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.131 -0.981 . . . . 1.08 109.503 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.534 ' CD ' ' HZ3' ' B' ' 324' ' ' LYS . 66.5 tt0 -63.32 -39.88 95.79 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.715 -0.794 . . . . 1.37 109.834 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.78 98.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.757 -1.737 . . . . 0.67 108.757 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -67.73 -42.26 82.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.386 -1.067 . . . . 1.99 109.4 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.1 mt -66.86 -46.37 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.209 -0.932 . . . . 1.22 109.106 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.8 ttp -60.09 -44.26 94.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.144 -0.973 . . . . 2.11 110.129 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 tp -59.95 -40.13 87.96 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.172 -0.955 . . . . 1.33 108.909 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.6 -39.23 93.35 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.868 -0.52 . . . . 1.29 110.231 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -81.86 2.39 30.55 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.073 -1.017 . . . . 1.47 111.082 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -48.81 125.96 11.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.777 -1.202 . . . . 1.47 109.056 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.1 -15.33 22.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.259 -0.901 . . . . 1.78 110.259 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -72.0 -35.03 69.32 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.987 -1.07 . . . . 2.53 108.61 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.03 -40.79 74.98 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.363 0.602 . . . . 1.36 110.05 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.28 -43.76 95.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 1.42 109.774 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -70.05 -41.62 73.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.547 -0.721 . . . . 2.27 111.17 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.02 -40.11 75.42 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.905 -1.122 . . . . 1.57 111.301 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 72.5 mt -64.9 -49.41 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.113 -0.992 . . . . 1.19 109.561 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.506 ' CG2' ' HZ1' ' A' ' 94' ' ' LYS . 85.5 mt -69.41 -39.49 78.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.798 -0.564 . . . . 1.39 110.572 -179.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.81 84.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.016 . . . . 1.39 110.821 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.07 -45.16 93.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.973 -1.079 . . . . 1.5 109.707 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.8 mt -61.37 -49.94 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.092 -1.005 . . . . 1.29 108.599 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.506 ' HZ1' ' CG2' ' A' ' 90' ' ' ILE . 33.5 mttp -64.58 -41.41 96.3 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 120.067 -0.653 . . . . 2.64 110.157 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -80.14 -56.3 4.32 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.992 -1.068 . . . . 1.65 112.177 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -90.54 -2.47 57.9 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.103 -0.998 . . . . 2.5 112.677 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 57.5 39.65 27.73 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.693 -1.254 . . . . 1.88 109.585 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.7 mtp -92.11 169.22 10.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.545 -0.722 . . . . 1.71 109.82 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.513 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 42.9 p -83.37 160.63 21.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.362 -0.836 . . . . 1.61 109.412 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.56 88.55 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.499 -0.751 . . . . 1.33 110.335 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 32.7 p-10 -69.8 -35.91 75.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.189 -0.944 . . . . 2.07 109.627 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.513 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -80.5 -44.09 19.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 1.37 110.124 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.43 -44.97 70.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -0.963 . . . . 1.14 109.974 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.1 -39.39 85.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.134 -0.979 . . . . 1.26 109.655 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.525 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 85.5 t60 -59.93 -41.33 91.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.315 -0.866 . . . . 2.02 110.037 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.17 -39.92 86.53 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.142 -0.974 . . . . 1.33 111.214 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.3 t -58.24 -58.08 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.03 -1.044 . . . . 1.3 111.218 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.2 mm -70.1 -40.0 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.946 -1.097 . . . . 1.32 109.417 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.525 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 87.7 tt0 -60.41 -39.98 89.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 2.44 109.144 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.09 -50.13 71.05 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.432 -1.067 . . . . 0.99 110.432 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -61.12 -50.63 72.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.911 -1.347 . . . . 1.97 109.826 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.6 83.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.323 -0.861 . . . . 1.43 110.521 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.8 m -59.66 -39.97 86.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.892 -1.13 . . . . 2.12 108.781 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.66 -40.0 93.37 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.227 -0.92 . . . . 1.64 108.94 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.7 mt -61.19 -42.67 98.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.977 . . . . 1.93 109.47 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -55.15 -32.45 62.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.046 -1.034 . . . . 2.2 109.433 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -59.99 -23.61 63.79 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.192 -0.943 . . . . 2.12 108.93 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 58.2 mt -62.08 140.02 58.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.97 . . . . 2.34 109.02 -179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.7 p-10 -91.4 41.43 1.07 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.194 -0.941 . . . . 3.23 110.404 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 40.6 t0 -134.88 145.28 48.12 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.208 -0.932 . . . . 2.49 109.565 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.524 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 97.5 mt-10 -72.99 -64.7 0.92 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.439 -0.788 . . . . 3.95 109.045 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.453 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 4.1 t80 -38.55 -40.13 0.54 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.905 -0.497 . . . . 2.25 110.684 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.1 mt -72.44 -39.97 67.42 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.78 -1.2 . . . . 2.27 108.427 179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 121' ' ' GLU . 19.9 ttpp -64.98 -40.87 95.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.485 -0.76 . . . . 3.31 109.058 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -62.53 -42.55 99.59 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.172 -1.047 . . . . 2.73 108.172 179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.516 ' NH2' ' CB ' ' B' ' 319' ' ' ALA . 57.7 ttt180 -60.13 -40.02 88.33 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.923 -1.139 . . . . 3.2 107.923 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.73 -25.85 68.39 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.727 -0.842 . . . . 1.66 108.727 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.75 -41.07 94.67 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.168 -1.049 . . . . 1.67 108.168 179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.18 -40.1 90.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.49 -0.756 . . . . 1.55 109.637 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.416 ' CG2' ' NE2' ' B' ' 351' ' ' GLN . 56.0 t -63.0 -41.37 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.132 -0.98 . . . . 1.32 109.469 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -63.06 -39.83 95.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.152 -0.967 . . . . 3.58 109.398 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -60.19 -40.55 90.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.363 -0.836 . . . . 1.46 110.393 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 98.3 mt -60.01 -45.77 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.098 -1.001 . . . . 1.22 110.382 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.94 -34.89 55.13 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.826 -1.31 . . . . 0.61 109.826 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.451 ' NZ ' HH21 ' A' ' 139' ' ' ARG . 24.8 tptp -59.99 -49.54 77.29 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.4 -1.059 . . . . 3.1 109.658 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -64.74 -33.57 76.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.917 -1.114 . . . . 3.71 109.793 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.2 tp -59.98 -41.02 91.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.363 -0.836 . . . . 1.87 109.094 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.44 -39.99 89.49 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.258 -0.901 . . . . 1.29 108.698 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.451 HH21 ' NZ ' ' A' ' 135' ' ' LYS . 98.8 mtt180 -67.06 -39.93 87.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.491 -0.756 . . . . 3.05 109.429 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -70.2 -25.68 63.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.45 -0.781 . . . . 1.26 111.64 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.3 mt -70.28 -40.09 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.211 -1.556 . . . . 1.34 109.008 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.6 mt -82.34 -26.83 32.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.459 -0.775 . . . . 1.6 110.202 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.95 47.61 5.22 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.034 -1.626 . . . . 0.96 109.034 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.1 tp -74.29 145.48 43.95 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.381 -1.07 . . . . 1.67 109.448 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.24 137.19 58.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 4.96 109.584 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 146' ' ' ILE . 86.0 mt -113.97 130.03 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-O 121.975 0.893 . . . . 1.68 109.283 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.51 -42.2 94.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.769 -0.582 . . . . 2.14 110.366 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.6 t0 68.22 91.97 0.09 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.49 -0.756 . . . . 1.5 109.011 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.7 mt -64.08 -6.64 6.77 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.515 -0.741 . . . . 1.39 111.231 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.5 m -82.82 -14.74 53.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.651 -1.281 . . . . 1.83 110.069 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.41 30.91 0.4 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.108 -0.995 . . . . 1.46 112.133 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 41.9 mm -90.31 121.19 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 120.485 -1.384 . . . . 1.42 109.205 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -103.06 -12.54 17.34 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.337 -0.852 . . . . 2.94 110.537 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -128.37 152.09 48.58 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.077 -1.015 . . . . 1.52 110.46 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.32 137.0 57.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.497 -0.752 . . . . 1.58 109.402 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.5 m -152.54 164.38 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.943 -0.762 . . . . 1.32 108.943 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -93.77 146.49 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.486 -1.672 . . . . 1.27 106.486 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.5 tp -94.56 114.59 26.58 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.18 -0.95 . . . . 1.41 110.679 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 49.6 t -120.03 127.12 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 108.042 -1.095 . . . . 1.23 108.042 178.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.05 160.0 40.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.168 -0.958 . . . . 1.32 108.999 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.462 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -76.43 -30.09 57.26 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.266 -1.521 . . . . 1.49 107.872 178.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 57.2 t0 -170.05 134.09 1.23 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.334 -0.854 . . . . 2.25 108.894 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.445 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 81.8 mt -111.22 125.02 53.37 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.217 -0.927 . . . . 1.35 108.905 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 51.9 p -83.83 146.6 49.66 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 1.56 109.292 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -39.91 -37.15 1.52 Allowed 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.298 1.998 . . . . 0.87 113.235 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.6 m -59.99 -41.04 91.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.069 -1.019 . . . . 1.36 109.699 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.13 -40.66 71.27 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.222 -0.924 . . . . 1.61 110.342 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.1 p -53.12 -29.88 33.41 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.015 -1.053 . . . . 1.21 111.447 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.515 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -76.46 -56.82 4.28 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.754 -1.216 . . . . 1.21 110.327 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -77.12 37.04 0.19 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.36 -0.978 . . . . 2.11 108.36 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.515 ' H ' ' C ' ' A' ' 169' ' ' ALA . 58.6 tp -102.06 137.32 40.5 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.369 -0.604 . . . . 1.29 109.369 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -82.76 101.08 10.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.163 -0.96 . . . . 2.81 109.239 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 99.5 mt -66.19 -41.98 89.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.167 -0.958 . . . . 2.09 110.719 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -65.92 -28.82 69.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.857 -1.152 . . . . 2.86 111.568 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -92.52 -8.26 45.01 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.778 -1.201 . . . . 2.39 110.133 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 94.3 t -101.8 112.18 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.28 -1.008 . . . . 1.27 108.28 178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.03 5.15 30.62 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.28 -0.888 . . . . 2.17 110.709 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.97 173.38 38.04 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.309 -1.517 . . . . 0.52 109.309 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 -132.08 129.61 40.19 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.467 -1.02 . . . . 0.55 109.186 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.2 mt -134.12 127.09 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.372 -0.83 . . . . 1.27 108.943 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.5 p -149.78 160.26 43.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.982 -1.074 . . . . 1.39 110.387 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 20.1 p-10 -102.41 23.02 12.44 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.411 -0.806 . . . . 2.46 109.458 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -52.68 -165.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.081 -1.012 . . . . 1.51 111.951 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -75.52 -54.31 5.57 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.869 -0.892 . . . . 2.23 110.869 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 173.61 -140.28 5.47 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.053 -1.546 . . . . 2.23 110.824 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.534 ' C ' ' H ' ' A' ' 188' ' ' SER . 0.6 OUTLIER -65.55 -34.14 77.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.634 -0.921 . . . . 6.44 111.159 -178.854 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 12.9 p -59.95 4.24 0.05 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.942 -1.099 . . . . 4.09 110.879 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.534 ' H ' ' C ' ' A' ' 186' ' ' ARG . 17.1 m -91.93 131.66 37.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.771 -1.205 . . . . 2.2 110.29 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -47.26 -37.58 10.86 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.827 -1.175 . . . . 1.15 107.827 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.4 p -57.7 -41.85 82.51 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.546 -0.752 . . . . 2.01 110.368 -179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 75.4 m -61.38 -40.08 93.04 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.158 -0.964 . . . . 1.93 111.518 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.91 -40.48 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.114 -0.991 . . . . 2.2 109.548 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 76.9 mtp -58.89 -49.53 77.43 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.353 -0.842 . . . . 1.32 109.94 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.33 -47.05 62.8 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.961 -1.087 . . . . 1.3 110.024 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -62.53 -57.97 9.24 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 118.565 -1.254 . . . . 3.38 109.957 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.1 m -61.24 -40.01 92.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.048 -1.033 . . . . 1.15 111.657 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.96 -23.69 62.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.887 -1.133 . . . . 1.28 109.824 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 64.9 47.81 2.53 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.444 0.64 . . . . 1.5 109.547 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 86.0 mt -126.95 150.05 70.79 Favored Pre-proline 0 N--CA 1.501 2.103 0 N-CA-C 108.568 -0.901 . . . . 1.37 108.568 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.56 141.58 74.03 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.213 1.942 . . . . 0.76 111.67 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -171.58 153.82 3.56 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.797 -1.161 . . . . 1.19 111.518 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.8 mt -128.08 139.47 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.818 -1.179 . . . . 1.31 107.818 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.5 m -121.83 -11.31 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 120.959 -1.088 . . . . 1.38 111.362 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.1 26.42 15.32 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 110.465 -1.054 . . . . 1.03 110.465 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.8 p -46.42 -42.21 14.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.102 -1.234 . . . . 1.38 109.841 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.59 -54.04 4.1 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 120.125 -1.036 . . . . 1.17 111.104 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 84.9 p -152.58 28.41 0.55 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.556 -1.555 . . . . 2.07 111.567 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 73.0 t -74.03 -40.71 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.666 -1.271 . . . . 1.35 109.136 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.492 ' HG1' ' N ' ' A' ' 210' ' ' SER . 7.7 p -60.95 -30.87 70.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.102 -0.999 . . . . 1.49 110.5 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.492 ' N ' ' HG1' ' A' ' 209' ' ' THR . 79.3 p -79.97 -10.94 59.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.981 -1.074 . . . . 2.16 109.363 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -105.14 -10.92 16.82 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.569 -0.707 . . . . 2.89 109.948 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 79.8 t -101.64 139.99 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.407 -0.808 . . . . 1.33 109.957 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.406 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 0.1 OUTLIER -111.68 145.89 38.45 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.393 -1.336 . . . . 2.73 107.393 178.795 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.476 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 10.4 p30 -54.78 138.2 42.9 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.016 -1.053 . . . . 2.7 110.42 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.3 m-20 86.81 3.66 0.43 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 120.988 0.423 . . . . 2.38 110.434 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.406 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 96.5 m-20 -76.26 150.39 37.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.015 -1.053 . . . . 2.09 109.156 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -99.43 119.84 38.64 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.261 -1.015 . . . . 1.45 108.261 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 67.8 mt -126.57 148.51 49.74 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.398 -0.814 . . . . 1.31 110.782 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.8 mt -115.59 128.3 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 107.502 -1.296 . . . . 1.29 107.502 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.0 tp -100.7 118.19 36.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.122 -0.986 . . . . 1.31 109.432 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 10' ' ' GLY . 94.7 m-20 -77.15 -43.2 34.83 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.213 -0.929 . . . . 2.31 108.557 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 51.89 17.64 0.67 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.857 -1.164 . . . . 1.19 107.857 -178.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.441 ' N ' ' C ' ' A' ' 221' ' ' ASP . 56.4 t -136.05 -36.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.942 -1.133 . . . . 1.45 107.942 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -105.51 3.44 29.43 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.845 -1.169 . . . . 3.13 107.845 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 60.54 43.67 12.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.822 -0.549 . . . . 2.2 111.259 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.415 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 11.9 pt20 -150.0 152.78 35.45 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.723 -1.236 . . . . 2.32 110.314 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 91.1 t -119.94 123.38 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 109.043 -0.725 . . . . 1.4 109.043 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.415 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 74.0 m-85 -84.62 128.19 34.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.011 -1.055 . . . . 1.29 109.221 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.18 116.62 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.472 -0.768 . . . . 1.38 109.152 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 62.32 67.48 1.2 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 2.33 109.989 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -87.05 131.1 3.08 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 123.048 2.498 . . . . 0.95 112.375 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.3 m -68.56 163.85 22.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 2.31 109.59 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -59.93 -42.1 93.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.293 -0.879 . . . . 3.45 110.681 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.42 -33.6 72.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.818 -1.176 . . . . 2.89 109.335 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.77 -40.34 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.252 -0.905 . . . . 1.73 109.361 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.8 mt -65.36 -42.68 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.231 -0.918 . . . . 1.57 109.863 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -60.1 -42.09 93.95 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.111 -0.993 . . . . 2.43 109.564 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -64.16 -42.04 96.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.372 -0.83 . . . . 3.18 109.341 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 99.4 mtp -70.02 -32.6 70.84 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.393 -0.817 . . . . 1.59 109.772 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -67.4 -40.09 85.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.129 -0.982 . . . . 3.11 109.136 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.04 -40.83 82.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.341 -0.849 . . . . 2.17 109.469 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.22 -38.11 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 2.51 109.239 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -59.64 -40.06 86.38 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.351 -0.843 . . . . 3.82 109.372 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.84 -40.07 96.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.853 -1.154 . . . . 1.78 109.165 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -61.12 -36.04 78.68 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.482 -0.761 . . . . 2.77 109.552 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 79.1 t -60.02 -41.65 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.945 . . . . 2.25 109.055 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.93 88.84 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.295 -0.878 . . . . 2.54 108.896 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 7.0 p -81.62 -35.27 30.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 3.03 110.214 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -59.99 -44.74 94.31 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.204 -0.935 . . . . 3.34 111.13 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 252' ' ' GLU . 51.9 pttt -59.99 -42.69 94.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.809 -1.182 . . . . 4.18 109.716 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.416 ' N ' ' CG ' ' A' ' 250' ' ' LYS . . . 40.04 17.63 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.656 -0.652 . . . . 4.43 110.856 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 250' ' ' LYS . 87.6 tt0 -75.09 -25.04 58.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 5.42 110.064 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 90.7 mt -52.75 -59.98 3.83 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.179 -0.951 . . . . 6.11 109.703 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 175.17 78.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -0.858 . . . . 7.37 109.097 -179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -60.06 139.37 57.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.09 -1.006 . . . . 8.3 109.214 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 256' ' ' LEU . 8.6 mp -84.75 -1.93 56.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.9 . . . . 9.05 109.308 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -67.35 -55.47 13.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.03 -1.044 . . . . 10.56 109.38 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -156.79 92.27 1.27 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.327 -0.858 . . . . 11.32 109.364 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 118.033 -0.984 . . . . 12.74 109.918 179.895 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 43.3 ttm . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.468 0.652 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -149.23 144.97 26.87 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -150.76 160.0 44.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.874 -1.141 . . . . 0.0 110.787 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -154.64 149.57 26.75 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -117.66 134.68 54.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.252 -0.905 . . . . 0.0 109.629 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.8 129.97 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 CA-C-O 122.192 0.996 . . . . 0.0 112.356 -177.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 57.3 m -76.24 108.06 8.92 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.31 1.052 . . . . 0.0 110.958 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 90.5 mt -53.82 120.93 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 122.413 1.102 . . . . 0.0 111.278 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 60.3 p -109.82 19.97 18.54 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.005 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.0 136.09 87.32 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.964 -1.085 . . . . 0.0 108.429 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -65.9 -21.82 56.79 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 CA-C-N 119.929 1.01 . . . . 0.0 112.609 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -121.99 15.24 10.78 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.417 -0.802 . . . . 0.0 108.931 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.19 -175.76 52.3 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.453 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -85.85 91.97 8.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.05 -1.265 . . . . 0.0 109.063 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -92.43 -162.8 0.96 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.831 -1.168 . . . . 0.0 109.969 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 16.0 m -58.56 -43.35 89.33 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.888 -1.133 . . . . 0.0 112.47 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.68 HH21 ' NE2' ' B' ' 321' ' ' GLN . 1.9 tpt180 -55.58 -61.07 6.82 Favored Pre-proline 0 N--CA 1.5 2.025 0 O-C-N 120.517 -1.364 . . . . 0.0 111.46 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -60.22 -36.79 86.92 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 CA-C-N 120.229 1.118 . . . . 0.0 111.939 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . 0.516 ' CB ' ' NH2' ' A' ' 126' ' ' ARG . . . -63.26 -16.82 61.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 0.0 109.357 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -82.46 -44.47 15.98 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . 0.68 ' NE2' HH21 ' B' ' 317' ' ' ARG . 95.4 mt-30 -72.48 -39.13 67.93 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -62.08 -54.55 39.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 110.302 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 52.7 t -63.82 -28.58 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.706 -1.246 . . . . 0.0 110.001 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . 0.534 ' HZ3' ' CD ' ' A' ' 74' ' ' GLU . 11.7 ttmm -60.33 -45.69 92.55 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 109.818 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -62.33 -49.55 75.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.52 -0.738 . . . . 0.0 110.375 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.02 -54.03 50.88 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.054 -1.029 . . . . 0.0 111.468 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -53.86 -16.17 1.67 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.788 -1.195 . . . . 0.0 109.904 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.7 -25.16 75.84 Favored Glycine 0 N--CA 1.487 2.033 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -105.97 141.69 36.94 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.518 -0.989 . . . . 0.0 109.726 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 54.3 m -89.04 -10.04 48.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.237 -0.914 . . . . 0.0 109.242 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 331' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 26.8 m -62.36 150.96 38.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.084 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.86 133.47 49.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.061 -1.025 . . . . 0.0 109.086 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 87.1 mt -129.9 130.12 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.557 -0.714 . . . . 0.0 109.167 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 78.2 m -126.85 148.75 49.96 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.502 0.668 . . . . 0.0 109.287 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 48.3 t -114.07 139.55 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 28.7 m -130.18 121.28 25.94 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.173 -0.954 . . . . 0.0 109.046 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 31.0 t -138.5 115.11 10.58 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.888 0.851 . . . . 0.0 110.525 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 47.56 51.92 13.16 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.04 -14.55 48.63 Favored Glycine 0 N--CA 1.5 2.952 0 O-C-N 119.971 -1.705 . . . . 0.0 112.629 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -111.67 121.73 45.9 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 119.104 1.452 . . . . 0.0 110.222 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 39.1 m -106.57 156.31 18.72 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.719 0.771 . . . . 0.0 110.796 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -152.47 152.66 32.22 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.427 0.632 . . . . 0.0 110.036 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 8.6 t -87.99 131.42 34.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.303 -0.873 . . . . 0.0 109.686 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.485 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -70.83 -16.21 62.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.093 -1.005 . . . . 0.0 109.771 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -86.83 21.08 2.35 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.485 ' H ' ' C ' ' B' ' 344' ' ' ALA . 10.7 t -150.8 98.53 2.62 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.18 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 19.3 tp -60.06 -30.6 69.31 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -58.09 -54.36 47.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.414 -0.804 . . . . 0.0 110.718 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.468 ' HZ2' ' CB ' ' B' ' 346' ' ' SER . 35.6 mtmm -68.28 -40.06 81.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.885 -1.134 . . . . 0.0 109.509 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.59 ' O ' ' N ' ' B' ' 352' ' ' THR . 30.9 mt -49.87 -56.99 8.37 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.934 -1.104 . . . . 0.0 108.102 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.416 ' NE2' ' CG2' ' A' ' 130' ' ' VAL . 28.6 mt-30 -40.23 -13.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.044 -0.41 . . . . 0.0 111.799 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.59 ' N ' ' O ' ' B' ' 350' ' ' LEU . 77.0 p -93.99 -13.21 27.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.451 -1.406 . . . . 0.0 110.613 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 63.3 mt -90.54 118.89 30.35 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.847 -1.158 . . . . 0.0 109.077 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.8 90.95 0.67 Allowed Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 20.8 mt -96.77 84.69 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -1.168 . . . . 0.0 108.265 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 30.7 p -88.29 174.3 8.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.431 -0.793 . . . . 0.0 110.566 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -69.16 114.71 7.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.532 -0.73 . . . . 0.0 110.891 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.98 8.94 38.25 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 28.7 m -93.58 111.08 22.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -1.167 . . . . 0.0 110.921 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 11.2 t -77.25 120.23 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 122.141 0.972 . . . . 0.0 109.773 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 18.3 m -112.51 177.32 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 62.0 m -131.37 129.57 41.53 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 77.0 mt -104.53 117.46 50.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 96.8 p -126.27 136.75 53.16 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.426 -0.796 . . . . 0.0 109.593 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.23 154.02 40.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.395 -0.816 . . . . 0.0 109.886 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -142.99 122.47 13.17 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.494 ' O ' ' OE1' ' B' ' 370' ' ' GLU . . . 162.23 -160.24 32.39 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 118.689 -1.72 . . . . 0.0 111.81 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . 0.471 ' N ' ' OG ' ' B' ' 331' ' ' SER . 52.2 tp10 -59.97 -50.08 75.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.145 -0.621 . . . . 0.0 112.322 -177.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.491 ' N ' ' OG ' ' B' ' 331' ' ' SER . 49.5 m-20 -113.3 12.8 18.98 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.869 -1.144 . . . . 0.0 111.592 -177.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.584 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 1.1 pm0 -43.09 -27.86 0.24 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.177 -0.952 . . . . 0.0 110.351 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . 0.489 ' N ' ' CD ' ' B' ' 370' ' ' GLU . 4.4 pt20 -70.08 -42.37 72.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 0.0 109.84 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -65.17 -48.38 73.7 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.203 -0.936 . . . . 0.0 108.918 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.23 -76.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.401 -0.812 . . . . 0.0 110.859 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 59.6 t -46.0 -37.41 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.0 -1.062 . . . . 0.0 110.817 -177.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.34 -49.28 74.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.595 -1.316 . . . . 0.0 110.446 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -77.55 -43.59 31.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.004 -1.06 . . . . 0.0 110.521 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 44.5 mt -60.63 -39.73 89.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -0.893 . . . . 0.0 110.197 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 54.7 t -64.34 -39.99 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.958 -1.089 . . . . 0.0 109.291 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -70.01 -56.55 6.68 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.768 -1.208 . . . . 0.0 107.859 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 64.5 tp -58.01 -28.38 64.38 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.449 -0.782 . . . . 0.0 111.33 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 381' ' ' MET . . . . . 0.517 ' SD ' ' O ' ' B' ' 381' ' ' MET . 0.0 OUTLIER -73.67 -38.13 65.03 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.104 -1.623 . . . . 0.0 108.382 178.24 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.7 -4.52 54.69 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 110.321 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -111.37 -1.91 15.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.158 -0.964 . . . . 0.0 111.075 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . 0.427 ' CD2' ' OE1' ' B' ' 321' ' ' GLN . 23.8 mt -89.16 127.4 35.73 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.332 -1.48 . . . . 0.0 110.179 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 117.974 -1.012 . . . . 0.0 108.75 179.049 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.088 0.471 . . . . 3.19 109.884 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.423 HG22 HD11 ' A' ' 2' ' ' ILE . 94.5 mt -106.94 120.02 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.442 -0.786 . . . . 1.71 109.108 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.8 m -132.42 134.97 45.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.503 -0.748 . . . . 1.66 109.392 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.721 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -119.34 -162.01 11.84 Favored Glycine 0 N--CA 1.501 2.99 0 N-CA-C 108.872 -1.691 . . . . 1.05 108.872 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.468 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.5 mt -89.4 -18.46 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.938 -1.331 . . . . 1.59 110.249 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 5' ' ' ILE . 62.7 tp 54.68 105.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.369 -0.832 . . . . 1.47 108.849 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.15 -24.1 14.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.132 -0.98 . . . . 1.39 109.338 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 19.5 t -138.33 124.74 12.91 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.446 -0.784 . . . . 2.09 109.81 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.65 145.18 16.12 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.974 1.783 . . . . 0.91 112.122 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.479 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 158.03 -158.83 29.49 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.481 -1.448 . . . . 0.92 109.481 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.7 mt -149.68 150.81 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.169 -1.194 . . . . 1.35 108.661 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.44 155.47 33.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.073 -1.017 . . . . 1.14 110.168 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.2 m-85 -136.58 129.56 31.02 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.679 -1.23 . . . . 0.7 107.679 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.29 -178.76 47.62 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 118.349 -1.881 . . . . 0.58 110.951 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -79.96 157.09 26.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.814 -0.815 . . . . 2.63 109.53 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.82 129.19 49.4 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.363 -0.836 . . . . 1.27 111.108 -178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.0 tp -99.66 131.05 45.9 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.629 -1.249 . . . . 1.41 107.629 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.5 tp -111.21 120.09 41.11 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.08 -1.012 . . . . 1.49 109.5 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 35.7 mt -85.51 104.04 14.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.55 -0.718 . . . . 1.52 109.467 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -93.19 135.48 34.34 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.7 -0.852 . . . . 3.17 108.7 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.01 118.45 20.62 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.686 -0.857 . . . . 3.0 108.686 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -76.7 141.64 40.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.102 -0.998 . . . . 2.77 109.448 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -60.06 140.07 57.07 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.325 -0.859 . . . . 2.94 108.774 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 84.8 mt -77.76 135.24 26.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.556 -0.905 . . . . 1.46 108.556 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.7 t -100.6 122.63 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.271 -0.893 . . . . 1.7 109.878 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.1 mt -95.43 141.86 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.969 -0.752 . . . . 1.54 108.969 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -97.67 119.44 36.24 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.171 -0.956 . . . . 1.81 109.491 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -94.47 3.24 55.4 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.282 -0.886 . . . . 3.23 109.467 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -59.97 139.98 57.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.419 -0.801 . . . . 3.29 109.908 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -93.07 144.94 24.78 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.158 -0.963 . . . . 2.8 108.597 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 pt -103.17 166.92 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.121 -0.987 . . . . 1.43 110.863 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.9 p -96.9 177.63 5.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.349 -0.844 . . . . 1.54 109.332 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.08 -49.9 75.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.452 -0.78 . . . . 1.6 110.877 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -58.06 -29.81 65.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.525 -1.359 . . . . 2.56 109.991 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -81.56 -11.44 59.16 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.147 -0.97 . . . . 2.36 110.242 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.7 t -60.04 -50.03 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.861 -1.149 . . . . 1.43 108.729 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -61.22 -39.96 92.21 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.479 -0.763 . . . . 1.77 109.347 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -64.14 -43.45 95.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.411 -0.806 . . . . 3.32 111.274 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -63.56 -41.11 98.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.74 -1.225 . . . . 1.51 110.168 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.04 -46.08 94.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 118.709 -1.196 . . . . 1.41 108.794 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -60.03 -42.33 94.15 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.068 -1.02 . . . . 1.81 109.382 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.449 HH11 ' HG2' ' A' ' 42' ' ' ARG . 25.1 mtt-85 -60.06 -44.66 94.56 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.937 -1.134 . . . . 3.26 107.937 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -60.18 -45.76 92.03 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.393 -0.966 . . . . 0.81 108.393 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.98 -49.82 76.15 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.801 -0.815 . . . . 1.59 108.801 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.8 t -60.05 -42.2 93.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.048 -1.032 . . . . 1.38 109.174 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.0 -42.55 98.41 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.191 -1.964 . . . . 0.87 108.191 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.1 ttm-85 -60.07 -32.97 71.43 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.225 -1.028 . . . . 3.62 108.225 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.9 -40.09 83.44 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.743 -0.598 . . . . 1.43 109.631 -179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 50' ' ' ALA . 12.1 ttmt -75.16 -74.82 0.19 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.55 -1.26 . . . . 3.08 108.384 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -39.0 -39.32 0.53 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.16 -0.963 . . . . 1.33 111.459 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.9 p -55.95 -59.11 5.36 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.704 -1.247 . . . . 1.85 109.252 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.21 -40.01 82.23 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.249 -0.907 . . . . 1.35 111.331 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -63.39 -40.63 97.74 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.772 -1.205 . . . . 2.34 110.975 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.5 -40.07 96.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.758 -1.213 . . . . 2.2 109.078 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -59.92 -38.57 82.72 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.41 -0.806 . . . . 1.35 109.995 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -64.62 -43.68 92.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.915 -1.116 . . . . 1.34 109.226 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.423 ' CD1' HH22 ' A' ' 136' ' ' ARG . 87.9 mt -60.01 -40.01 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 1.26 108.936 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -55.58 -50.03 71.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.39 -0.818 . . . . 1.7 109.958 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -59.41 -36.32 75.64 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.316 -0.865 . . . . 1.35 111.002 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -62.37 -39.64 93.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.914 -1.116 . . . . 2.08 109.534 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.35 -45.25 80.82 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.629 -0.669 . . . . 1.21 110.218 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.63 -52.25 51.6 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.705 -1.358 . . . . 0.75 109.705 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.08 -46.5 64.78 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.135 -1.215 . . . . 1.59 110.214 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.7 m -67.27 -63.45 1.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.195 -0.94 . . . . 1.41 112.697 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -96.23 -45.08 6.99 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.786 -1.196 . . . . 0.79 111.29 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.64 -174.04 23.22 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 119.644 -1.265 . . . . 1.22 111.309 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -70.05 -26.68 64.13 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.395 0.617 . . . . 5.81 110.348 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -60.98 -32.76 72.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.447 -0.783 . . . . 3.37 110.703 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -100.44 -20.51 15.75 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.37 -0.831 . . . . 2.37 109.374 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -66.24 -40.09 89.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 1.65 110.329 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.35 -26.92 67.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 1.42 109.718 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.0 mt -60.03 -41.81 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.952 -1.092 . . . . 1.43 109.174 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -66.56 -39.84 88.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.264 -0.898 . . . . 1.08 110.089 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.537 ' CD ' ' HZ3' ' B' ' 324' ' ' LYS . 61.6 tt0 -60.06 -39.95 87.8 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.232 -0.917 . . . . 1.37 109.387 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.89 -46.06 95.3 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.308 -1.517 . . . . 0.67 109.308 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.4 m170 -60.09 -42.05 93.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.201 -1.176 . . . . 1.99 109.459 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.1 mt -68.43 -45.9 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.342 -0.849 . . . . 1.22 109.526 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.2 ttp -59.98 -44.12 94.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.83 -1.168 . . . . 2.11 110.074 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 26.5 tp -64.53 -39.94 94.7 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.202 -0.937 . . . . 1.33 109.248 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.2 tp -62.78 -39.87 95.53 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.567 -0.708 . . . . 1.29 109.589 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -84.69 4.15 33.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.215 -0.928 . . . . 1.47 110.152 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.6 t0 -50.02 133.06 23.16 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.127 -0.983 . . . . 1.47 110.867 -178.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.45 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 95.4 mt-10 -61.46 -20.31 62.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.571 -0.706 . . . . 1.78 110.005 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -68.22 -32.73 73.14 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.902 -1.147 . . . . 2.53 107.902 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.0 mt -75.97 -40.0 54.79 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.509 0.671 . . . . 1.36 110.28 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -60.06 -49.98 75.52 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.269 -0.894 . . . . 1.42 110.282 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -70.7 -41.64 71.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.114 -0.991 . . . . 2.27 110.656 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.08 -39.92 75.33 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.21 -0.931 . . . . 1.57 111.822 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.04 -43.9 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.765 -1.21 . . . . 1.19 109.35 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.7 mt -70.04 -39.34 77.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.574 -0.704 . . . . 1.39 110.101 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.424 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -60.05 -48.3 82.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.249 -0.907 . . . . 1.39 111.248 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.484 ' O ' ' N ' ' A' ' 96' ' ' LYS . 92.5 mt -60.1 -44.96 94.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.855 -1.153 . . . . 1.5 109.862 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.96 -49.19 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.343 -0.984 . . . . 1.29 108.343 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -69.33 -41.79 76.21 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.123 -0.631 . . . . 2.64 110.759 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 91' ' ' ALA . 53.6 t0 -81.34 -50.33 9.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.002 -1.061 . . . . 1.65 112.043 -178.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 92' ' ' LEU . 68.2 mmtt -92.46 -1.85 56.69 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.041 -1.037 . . . . 2.5 111.838 -177.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 55.72 33.84 22.15 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.785 -1.197 . . . . 1.88 109.562 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 93.9 mtp -89.56 168.95 11.76 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.526 -0.734 . . . . 1.71 110.047 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.592 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 43.3 p -81.11 160.01 24.55 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.74 -0.837 . . . . 1.61 108.74 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.41 -38.9 91.33 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.054 -1.029 . . . . 1.33 109.282 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -66.68 -39.3 88.07 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.281 -0.887 . . . . 2.07 109.532 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.592 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -76.76 -44.2 33.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 1.37 110.113 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.13 -45.35 73.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.893 . . . . 1.14 109.895 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.67 83.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.117 -0.989 . . . . 1.26 109.547 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -59.88 -44.63 94.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.351 -0.843 . . . . 2.02 110.266 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.463 ' O ' ' N ' ' A' ' 110' ' ' GLY . 88.6 tt0 -62.6 -40.69 97.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.898 . . . . 1.33 110.441 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.74 -55.74 21.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.229 -0.919 . . . . 1.3 110.84 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.1 mm -70.54 -40.04 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.784 -1.197 . . . . 1.32 109.491 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.438 ' OE2' ' OG ' ' A' ' 113' ' ' SER . 12.2 tm-20 -68.3 -39.97 81.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 2.44 108.8 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -60.57 -45.85 95.52 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.04 -1.224 . . . . 0.99 110.04 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.45 HE21 ' CB ' ' B' ' 348' ' ' PHE . 16.5 mm100 -69.95 -53.06 19.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.989 -1.301 . . . . 1.97 109.749 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.93 -40.04 69.49 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.088 -1.008 . . . . 1.43 109.229 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.438 ' OG ' ' OE2' ' A' ' 109' ' ' GLU . 59.1 m -60.0 -40.07 87.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.959 . . . . 2.12 109.275 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.09 -33.53 75.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 1.64 109.128 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.2 mt -69.06 -39.97 78.78 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.075 -1.016 . . . . 1.93 109.66 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.02 -27.94 67.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.858 -1.151 . . . . 2.2 109.194 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -59.94 -23.49 63.6 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.364 -0.976 . . . . 2.12 108.364 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 24.6 mt -62.15 151.54 35.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 2.34 109.115 -179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -99.49 30.05 3.75 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.214 -0.929 . . . . 3.23 110.16 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -118.07 131.27 56.46 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.19 -0.944 . . . . 2.49 110.637 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -70.07 -29.77 66.85 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.11 -0.7 . . . . 3.95 109.11 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.469 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.4 t80 -69.72 -38.93 77.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.603 -0.686 . . . . 2.25 110.38 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 88.2 mt -73.15 -32.94 65.19 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.069 -1.019 . . . . 2.27 109.262 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -60.02 -40.06 88.0 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.271 -0.893 . . . . 3.31 108.646 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -59.95 -46.15 90.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.888 . . . . 2.73 109.017 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.476 ' HE ' ' NE2' ' B' ' 351' ' ' GLN . 15.3 mmm-85 -60.11 -39.96 88.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.127 -0.983 . . . . 3.2 108.885 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.13 -34.93 75.77 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.469 -0.937 . . . . 1.66 108.469 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.18 -39.97 92.15 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.394 -0.965 . . . . 1.67 108.394 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -68.57 -39.94 80.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.402 -0.811 . . . . 1.55 109.172 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.44 -39.92 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.11 -1.07 . . . . 1.32 108.11 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.473 HH11 ' HG2' ' A' ' 131' ' ' ARG . 7.2 ttt-85 -67.25 -34.42 77.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.449 -0.782 . . . . 3.58 109.44 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.03 -41.22 91.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 1.46 109.587 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.3 mt -61.06 -44.01 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 1.22 109.272 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.13 -45.0 96.79 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.155 -1.178 . . . . 0.61 110.155 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -59.97 -45.4 92.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.158 -1.201 . . . . 3.1 109.561 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.423 HH22 ' CD1' ' A' ' 57' ' ' ILE . 60.3 mtp180 -67.32 -36.05 80.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.042 -1.036 . . . . 3.71 110.112 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.0 -43.31 95.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 1.87 109.513 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.34 -40.49 97.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.121 -0.987 . . . . 1.29 109.433 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -69.88 -38.09 76.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.188 -0.945 . . . . 3.05 108.672 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -59.97 -38.82 83.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.829 -0.545 . . . . 1.26 110.565 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -73.74 -44.18 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.829 -1.169 . . . . 1.34 108.917 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.96 -40.01 75.68 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.47 -0.769 . . . . 1.6 109.853 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.74 47.06 4.36 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.186 -1.566 . . . . 0.96 109.186 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.7 tp -73.66 148.76 42.47 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.439 -1.036 . . . . 1.67 109.396 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -66.89 140.67 57.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 4.96 109.391 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.3 mt -119.77 129.93 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 CA-C-O 121.77 0.795 . . . . 1.68 109.728 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 148' ' ' ASP . 1.4 mp -66.66 -39.94 84.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.786 -0.571 . . . . 2.14 110.323 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 147' ' ' ILE . 29.1 t0 62.27 127.03 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.822 -0.807 . . . . 1.5 108.822 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.1 mt -85.06 -4.51 59.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.054 -1.029 . . . . 1.39 109.366 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.4 t -86.75 -14.39 42.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.457 -0.777 . . . . 1.83 109.69 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.88 17.02 1.26 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -0.909 . . . . 1.46 110.473 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 38.3 mm -88.86 124.24 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.872 -1.142 . . . . 1.42 109.203 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -105.76 -9.78 17.07 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.423 -0.798 . . . . 2.94 109.833 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -124.05 149.62 45.9 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.319 -0.863 . . . . 1.52 110.311 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.21 134.62 55.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.351 -0.843 . . . . 1.58 109.595 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -151.95 164.64 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.492 -0.755 . . . . 1.32 109.525 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.7 mt -91.67 150.65 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 106.137 -1.801 . . . . 1.27 106.137 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 51.2 tp -99.98 115.9 30.78 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.936 -1.103 . . . . 1.41 110.611 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.62 130.04 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 109.028 -0.73 . . . . 1.23 109.028 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.78 163.35 34.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.184 -0.948 . . . . 1.32 108.647 179.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.36 -35.42 73.53 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.426 -1.421 . . . . 1.49 107.68 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -160.99 173.46 15.23 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.983 -0.747 . . . . 2.25 108.983 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.7 mt -138.91 139.19 37.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.18 -0.95 . . . . 1.35 109.037 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.4 p -96.09 140.29 22.19 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.168 -0.957 . . . . 1.56 109.141 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -40.25 -34.75 1.12 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.901 1.734 . . . . 0.87 112.216 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 59.3 m -59.94 -42.85 94.88 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.883 . . . . 1.36 109.787 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -69.56 -41.3 76.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.249 -0.907 . . . . 1.61 109.844 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.8 p -54.28 -23.85 16.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 1.21 111.528 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.438 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -86.01 -50.12 7.3 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.407 -1.433 . . . . 1.21 109.867 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -81.49 35.87 0.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.479 -0.934 . . . . 2.11 108.479 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 169' ' ' ALA . 59.1 tp -101.38 132.4 46.98 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.257 -0.645 . . . . 1.29 109.257 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -83.41 101.77 11.59 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.164 -0.96 . . . . 2.81 108.716 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.34 -40.18 96.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 2.09 111.111 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -67.7 -26.11 66.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.837 -1.164 . . . . 2.86 111.915 -177.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -93.74 -11.43 31.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.62 -1.3 . . . . 2.39 110.231 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 63.3 t -101.59 111.53 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.148 -0.97 . . . . 1.27 108.468 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.37 2.93 33.96 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.226 -0.921 . . . . 2.17 111.263 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.8 171.09 37.94 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.37 -1.492 . . . . 0.52 109.37 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.412 ' O ' ' CB ' ' A' ' 201' ' ' ALA . 14.5 m-85 -132.04 128.43 38.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.498 -1.001 . . . . 0.55 109.491 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.95 126.19 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.101 -1.074 . . . . 1.27 108.101 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 203' ' ' VAL . 16.6 p -146.21 158.62 43.89 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.013 -1.055 . . . . 1.39 110.842 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 59.5 t0 -106.15 28.13 7.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.748 -0.595 . . . . 2.46 109.452 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -52.99 -168.52 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.448 -1.408 . . . . 1.51 111.369 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.13 -54.93 6.0 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.49 -1.044 . . . . 2.23 110.49 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -166.51 -156.04 9.3 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.037 -1.554 . . . . 2.23 111.01 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 186' ' ' ARG . 16.6 ptt-85 -70.05 -18.0 63.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.8 -0.823 . . . . 6.44 111.327 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 69.5 p -73.13 5.25 3.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.768 -1.207 . . . . 4.09 110.305 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.7 p -82.11 137.8 34.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.93 -1.106 . . . . 2.2 109.991 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -49.3 -49.93 41.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.321 -0.862 . . . . 1.15 110.152 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -37.62 71.48 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.362 -0.836 . . . . 2.01 110.965 -178.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.9 t -60.03 -39.97 87.7 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.752 -1.217 . . . . 1.93 110.371 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.86 -39.74 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.855 . . . . 2.2 110.17 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.5 mtm -59.93 -45.0 94.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.966 -1.084 . . . . 1.32 110.42 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.99 -45.45 71.42 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.799 -1.188 . . . . 1.3 109.46 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -60.01 -53.44 57.85 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.998 -1.081 . . . . 3.38 110.445 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.4 m -68.21 -37.8 81.26 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.068 -1.02 . . . . 1.15 111.973 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.38 -22.95 62.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.698 -1.251 . . . . 1.28 109.906 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 66.56 49.3 1.35 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.322 0.582 . . . . 1.5 110.079 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.47 ' O ' ' CB ' ' A' ' 8' ' ' SER . 97.0 mt -129.53 148.98 71.54 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 108.027 -1.101 . . . . 1.37 108.027 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.54 138.31 69.59 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.276 1.984 . . . . 0.76 112.194 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 179' ' ' PHE . . . -171.01 149.73 2.97 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.076 -1.05 . . . . 1.19 111.354 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.408 HG22 HD11 ' A' ' 202' ' ' ILE . 96.5 mt -122.99 144.09 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 107.21 -1.404 . . . . 1.31 107.21 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 181' ' ' THR . 17.9 m -122.34 -12.81 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.006 -1.059 . . . . 1.38 111.127 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -112.65 26.77 10.48 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.88 -0.888 . . . . 1.03 110.88 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 204' ' ' GLY . 14.0 p -41.96 -46.57 4.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.15 -1.206 . . . . 1.38 110.12 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.454 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 94.74 -54.18 1.96 Allowed Glycine 0 N--CA 1.5 2.951 0 C-N-CA 120.332 -0.937 . . . . 1.17 111.587 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 207' ' ' SER . 7.4 t -150.01 29.94 0.72 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.329 -1.689 . . . . 2.07 111.024 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 41.8 t -75.25 -36.87 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.709 -1.244 . . . . 1.35 109.249 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.4 p -60.05 -33.73 72.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.922 . . . . 1.49 111.117 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.2 t -78.37 -22.44 47.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.935 -1.103 . . . . 2.16 110.306 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -94.7 -8.35 38.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.185 -0.947 . . . . 2.89 110.499 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 86.4 t -108.02 140.02 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.28 -0.888 . . . . 1.33 110.729 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.497 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 65.2 mmtt -117.15 156.87 26.91 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.895 -1.521 . . . . 2.73 106.895 177.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 29.9 p-10 -60.04 142.53 53.84 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.802 -1.186 . . . . 2.7 111.115 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.438 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.7 m-20 82.11 3.2 1.28 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 116.061 -0.518 . . . . 2.38 110.832 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.497 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 88.9 m-20 -74.95 145.01 42.93 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.889 -1.132 . . . . 2.09 109.301 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -94.59 120.0 34.13 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.231 -0.918 . . . . 1.45 108.847 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 59.6 mt -126.86 147.49 50.04 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.414 -0.804 . . . . 1.31 110.433 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 85.7 mt -114.11 128.28 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 106.906 -1.516 . . . . 1.29 106.906 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.1 tp -100.83 117.07 34.19 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.866 -1.146 . . . . 1.31 109.595 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.513 ' C ' ' H ' ' A' ' 223' ' ' VAL . 96.1 m-20 -74.03 -43.9 56.26 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.242 -0.911 . . . . 2.31 108.728 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 50.35 11.74 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.846 -0.798 . . . . 1.19 108.846 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.513 ' H ' ' C ' ' A' ' 221' ' ' ASP . 73.5 t -131.05 -44.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.817 -1.179 . . . . 1.45 107.817 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -100.04 3.23 44.0 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.61 -1.255 . . . . 3.13 107.61 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.721 HD22 ' H ' ' A' ' 4' ' ' GLY . 1.0 OUTLIER 59.61 43.67 15.51 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 116.246 -0.433 . . . . 2.2 110.192 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -140.09 144.46 36.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.122 -0.986 . . . . 2.32 110.042 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 87.8 t -120.03 125.68 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.926 -0.768 . . . . 1.4 108.926 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -90.99 118.15 30.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.85 -1.156 . . . . 1.29 109.679 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.76 116.69 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.475 -0.766 . . . . 1.38 109.529 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 68.22 67.67 0.52 Allowed Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.468 -0.77 . . . . 2.33 109.947 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -91.02 121.35 0.71 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 123.426 2.751 . . . . 0.95 112.955 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 233' ' ' ASN . 93.9 m -67.03 169.77 7.85 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.256 -0.903 . . . . 2.31 109.685 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.467 ' N ' ' CG2' ' A' ' 232' ' ' THR . 7.3 m120 -60.06 -40.0 87.97 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.307 -0.871 . . . . 3.45 109.544 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.91 -38.63 82.86 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.189 -0.945 . . . . 2.89 108.753 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.72 -40.06 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 1.73 109.559 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.426 HD11 HG22 ' A' ' 236' ' ' ILE . 96.7 mt -68.43 -40.93 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.291 -0.881 . . . . 1.57 109.86 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -59.96 -47.0 87.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.996 -1.065 . . . . 2.43 109.061 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -60.08 -43.93 95.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.486 -0.758 . . . . 3.18 109.67 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 94.5 mtp -72.67 -24.8 61.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.359 -0.838 . . . . 1.59 110.511 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 -73.34 -39.96 64.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.796 -1.19 . . . . 3.11 110.008 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.75 97.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 2.17 109.459 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.65 -41.36 91.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.315 -0.866 . . . . 2.51 109.542 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -60.64 -41.83 95.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.038 -1.039 . . . . 3.82 109.607 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -60.09 -40.0 88.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.144 -0.972 . . . . 1.78 108.96 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -60.95 -37.53 82.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.668 -0.645 . . . . 2.77 109.652 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.7 t -59.99 -43.69 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 2.25 109.516 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.32 -42.63 99.01 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.291 -0.881 . . . . 2.54 109.89 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 27.4 t -70.0 -40.41 75.31 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.194 -0.941 . . . . 3.03 111.05 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -62.57 -39.94 95.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.095 -1.003 . . . . 3.34 110.791 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -82.32 3.41 27.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.02 -1.05 . . . . 4.18 110.718 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -121.92 -45.3 2.27 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.049 -1.032 . . . . 4.43 109.942 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -62.07 -44.44 96.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.106 -0.996 . . . . 5.42 110.816 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 1.5 mp -119.68 -24.54 6.18 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.527 -0.733 . . . . 6.11 109.542 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 53.02 35.99 20.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 7.37 109.815 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -147.83 139.64 23.99 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.979 -1.119 . . . . 8.3 107.979 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 8.4 mp -87.13 105.71 17.37 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.006 -1.059 . . . . 9.05 108.985 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -52.2 146.47 9.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 10.56 109.62 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 258' ' ' ASP . 16.8 p-10 -150.84 40.44 0.73 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.336 -0.853 . . . . 11.32 109.603 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 117.977 -1.011 . . . . 12.74 109.487 -179.845 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 38.1 ttp . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.497 0.665 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -155.84 153.44 29.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.494 -0.754 . . . . 0.0 109.136 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -150.9 161.9 41.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.08 -1.012 . . . . 0.0 110.399 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -153.38 149.95 28.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.644 -0.66 . . . . 0.0 109.389 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.17 128.56 55.54 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -131.66 124.59 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 CA-C-O 122.192 0.996 . . . . 0.0 112.388 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 91.4 m -77.84 103.87 8.04 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.03 0.919 . . . . 0.0 110.869 -178.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . 0.431 HD11 HG22 ' B' ' 308' ' ' ILE . 88.8 mt -51.71 124.75 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 122.467 1.127 . . . . 0.0 110.464 -178.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 75.7 p -110.02 19.33 19.12 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.206 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . 0.404 ' O ' ' CD ' ' B' ' 357' ' ' GLN . . . -69.33 147.21 97.07 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.94 -1.1 . . . . 0.0 108.578 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -72.82 -24.69 17.69 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 120.892 1.061 . . . . 0.0 112.672 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -121.05 17.61 11.66 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.17 -173.37 53.97 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.989 -2.045 . . . . 0.0 107.989 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.469 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.5 tp -86.3 90.42 8.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.889 -1.359 . . . . 0.0 108.88 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -93.14 -161.42 0.84 Allowed 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.033 -1.042 . . . . 0.0 111.102 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.1 m -55.79 -45.32 78.24 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.569 -0.707 . . . . 0.0 112.71 -175.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.458 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.5 tpt180 -61.22 -58.58 17.98 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 120.526 -1.359 . . . . 0.0 112.176 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 11.5 Cg_endo -59.37 -32.03 95.91 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 120.307 1.145 . . . . 0.0 111.907 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.96 75.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.11 -0.994 . . . . 0.0 108.515 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.73 -42.76 68.45 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.248 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -69.95 -42.96 72.51 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.129 -0.982 . . . . 0.0 108.944 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.26 -52.55 64.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.462 -0.774 . . . . 0.0 110.622 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 92.5 t -64.66 -30.84 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.757 -1.214 . . . . 0.0 109.521 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . 0.537 ' HZ3' ' CD ' ' A' ' 74' ' ' GLU . 12.0 ttmm -60.03 -48.11 83.07 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.392 -0.818 . . . . 0.0 110.102 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -67.64 -44.45 77.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 111.239 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.04 -52.43 65.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.587 -1.32 . . . . 0.0 110.465 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -56.42 -14.1 2.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.009 . . . . 0.0 109.376 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -71.94 -21.53 79.02 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -105.8 143.68 33.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.669 -0.9 . . . . 0.0 108.721 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 15.3 t -91.02 -13.16 33.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.027 -1.046 . . . . 0.0 109.279 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 52.8 p -62.72 146.9 51.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.481 -0.762 . . . . 0.0 109.119 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.63 137.04 57.07 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.148 -0.97 . . . . 0.0 108.98 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 94.3 mt -132.94 133.21 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.604 -0.685 . . . . 0.0 109.679 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 46.5 m -130.34 152.42 49.77 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 62.3 t -117.41 139.51 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 97.9 m -130.7 126.09 35.62 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.105 -0.997 . . . . 0.0 109.714 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 73.5 p -140.16 118.19 11.88 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.863 0.84 . . . . 0.0 110.574 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 9.3 m120 42.09 54.45 4.09 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.2 -15.7 43.0 Favored Glycine 0 N--CA 1.502 3.067 0 O-C-N 120.206 -1.559 . . . . 0.0 113.138 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -112.44 124.22 52.03 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 119.327 1.563 . . . . 0.0 109.371 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 85.8 p -122.07 147.59 45.91 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.941 0.876 . . . . 0.0 111.044 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.24 159.78 41.49 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.671 0.748 . . . . 0.0 109.849 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 22.1 m -88.74 136.74 32.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.473 -0.767 . . . . 0.0 110.463 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.468 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -73.93 -16.78 61.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.051 -1.031 . . . . 0.0 109.876 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -87.36 19.9 3.06 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.468 ' H ' ' C ' ' B' ' 344' ' ' ALA . 25.1 t -149.75 94.83 2.23 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.733 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 36.0 tp -59.96 -32.72 71.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . 0.45 ' CB ' HE21 ' A' ' 111' ' ' GLN . 60.4 m-85 -54.75 -53.55 53.64 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.031 -1.043 . . . . 0.0 110.175 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.452 ' O ' ' OG1' ' B' ' 352' ' ' THR . 34.1 mtmm -70.07 -35.89 74.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 0.0 110.273 -178.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 81.8 mt -53.92 -50.1 67.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.878 -1.139 . . . . 0.0 110.232 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.476 ' NE2' ' HE ' ' A' ' 126' ' ' ARG . 3.6 mt-30 -49.99 -17.59 0.41 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.668 -1.27 . . . . 0.0 111.337 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' B' ' 349' ' ' LYS . 82.1 p -79.81 -14.55 58.61 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.275 -1.516 . . . . 0.0 110.972 -178.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 30.9 mt -91.82 118.66 30.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.749 -1.22 . . . . 0.0 109.201 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.35 92.81 0.77 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 20.9 mt -100.47 89.72 4.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.37 -1.077 . . . . 0.0 109.309 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 38.2 p -90.01 177.87 6.35 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.095 -1.003 . . . . 0.0 110.449 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . 0.404 ' CD ' ' O ' ' B' ' 310' ' ' ALA . 48.5 tt0 -69.87 115.14 8.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.632 -0.667 . . . . 0.0 110.926 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 100.2 9.54 47.79 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 52.1 m -87.21 114.12 23.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.228 -1.16 . . . . 0.0 110.888 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.97 115.15 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 122.116 0.96 . . . . 0.0 109.785 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 32.8 m -110.99 176.38 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 33.0 m -130.64 127.64 39.34 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 72.9 mt -102.88 116.64 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 84.1 p -119.98 131.6 55.22 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.304 -0.872 . . . . 0.0 109.47 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.69 151.55 39.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.19 -0.944 . . . . 0.0 109.587 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -144.07 122.99 12.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.406 -0.809 . . . . 0.0 108.889 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.534 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.06 -158.06 29.37 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.062 -1.542 . . . . 0.0 111.481 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -59.85 -50.02 75.44 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -108.99 13.4 24.7 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.819 -1.176 . . . . 0.0 110.963 -177.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.2 pt-20 -44.95 -36.25 3.28 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.077 -1.014 . . . . 0.0 110.89 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.14 -46.25 68.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.95 -1.094 . . . . 0.0 110.226 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -66.39 -48.15 71.03 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.154 -0.966 . . . . 0.0 109.727 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.12 -75.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 110.501 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 68.8 t -45.96 -38.82 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.097 -1.002 . . . . 0.0 110.557 -177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -63.72 -49.96 71.01 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.598 -1.314 . . . . 0.0 110.475 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . 0.401 ' N ' ' HD1' ' B' ' 376' ' ' HIS . 0.3 OUTLIER -78.11 -40.66 37.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.978 -1.076 . . . . 0.0 110.062 -179.933 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 82.4 mt -59.99 -38.66 83.22 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.111 -0.993 . . . . 0.0 109.296 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 39.8 t -61.44 -39.96 84.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.28 -0.887 . . . . 0.0 108.647 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.72 -55.55 12.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.963 -1.086 . . . . 0.0 108.218 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 57.6 tp -58.21 -32.25 68.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.127 -0.983 . . . . 0.0 109.932 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.8 tpp -71.78 -40.77 69.04 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.354 -1.338 . . . . 0.0 108.875 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.6 -5.84 59.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -0.775 . . . . 0.0 110.349 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -110.13 -3.86 16.13 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.223 -0.923 . . . . 0.0 111.237 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 12.4 mt -76.48 129.99 37.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.303 -1.498 . . . . 0.0 108.957 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.161 -179.868 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.34 -0.615 . . . . 3.19 109.34 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.0 mt -110.06 129.96 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.579 -0.701 . . . . 1.71 109.251 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.0 m -119.48 152.34 37.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.629 -0.669 . . . . 1.66 109.244 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.57 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -135.66 -165.22 10.61 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 108.441 -1.864 . . . . 1.05 108.441 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 6' ' ' LEU . 97.0 mt -89.49 -18.82 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.69 -1.476 . . . . 1.59 110.571 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' ILE . 37.1 tp 54.79 104.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.174 -0.954 . . . . 1.47 109.17 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.88 -27.02 13.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.258 -0.901 . . . . 1.39 109.238 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.8 t -133.69 118.39 14.52 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.575 -0.703 . . . . 2.09 109.17 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.27 148.58 18.96 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.964 1.776 . . . . 0.91 112.542 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 154.47 -156.77 27.09 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 108.897 -1.681 . . . . 0.92 108.897 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.2 mt -147.66 150.64 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.021 -1.281 . . . . 1.35 108.318 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.8 155.02 35.06 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.776 -1.203 . . . . 1.14 110.807 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.9 OUTLIER -139.01 129.5 25.79 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.551 -1.277 . . . . 0.7 107.551 178.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.08 -178.07 48.23 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.482 -1.818 . . . . 0.58 111.039 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -79.69 159.16 26.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.833 -0.804 . . . . 2.63 109.165 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -109.5 132.1 54.45 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.479 -0.763 . . . . 1.27 110.859 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.6 tp -102.99 139.39 38.62 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.102 -1.073 . . . . 1.41 108.102 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.9 tp -117.69 122.3 43.15 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.346 -0.846 . . . . 1.49 109.674 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 54.8 mt -87.98 104.28 16.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.538 -0.726 . . . . 1.52 109.834 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -101.07 132.74 46.37 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.783 -0.821 . . . . 3.17 108.783 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -124.82 136.19 53.6 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.757 -0.831 . . . . 3.0 108.757 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.21 142.98 34.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.093 -1.004 . . . . 2.77 109.641 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.49 140.02 58.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.875 . . . . 2.94 108.824 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.4 mt -81.6 130.53 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.211 -0.93 . . . . 1.46 109.627 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 t -96.43 128.47 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.217 -0.927 . . . . 1.7 110.181 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 26' ' ' ILE . 96.8 mt -109.0 135.41 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.178 -0.675 . . . . 1.54 109.178 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -91.53 121.36 33.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.124 -0.985 . . . . 1.81 109.794 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.419 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.1 mmm-85 -90.02 -0.04 57.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.378 -0.826 . . . . 3.23 109.888 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.54 146.1 54.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.043 -1.035 . . . . 3.29 109.468 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -88.45 147.27 24.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.296 -0.878 . . . . 2.8 109.282 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 pt -94.15 164.02 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.012 -1.055 . . . . 1.43 109.413 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -94.07 168.29 11.04 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.144 -0.972 . . . . 1.54 108.886 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.05 -15.52 59.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.067 -1.021 . . . . 1.6 109.943 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -87.41 -27.96 22.43 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.85 -1.167 . . . . 2.56 107.85 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -81.74 -9.24 59.69 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.723 -0.843 . . . . 2.36 108.723 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.8 t -62.87 -53.88 40.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.124 -0.985 . . . . 1.43 108.572 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -61.94 -39.97 93.91 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.33 -0.856 . . . . 1.77 110.123 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -69.84 -40.12 76.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.132 -0.98 . . . . 3.32 110.563 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -67.62 -39.83 84.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.925 -1.109 . . . . 1.51 110.029 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.14 -46.69 94.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 120.756 -1.215 . . . . 1.41 108.624 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -60.15 -42.18 94.34 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.147 -0.971 . . . . 1.81 109.495 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.02 -45.32 93.19 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.901 -1.119 . . . . 3.26 108.38 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -60.43 -46.13 91.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.326 -0.858 . . . . 0.81 108.764 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.2 tp -60.1 -47.98 83.63 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.616 -0.883 . . . . 1.59 108.616 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.4 t -61.82 -42.29 98.84 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.413 -0.915 . . . . 1.38 108.761 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.13 -45.83 95.3 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.346 -1.902 . . . . 0.87 108.346 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.431 ' NH1' ' HG3' ' A' ' 47' ' ' ARG . 31.9 ttm-85 -62.32 -32.92 73.74 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.433 -1.04 . . . . 3.62 108.307 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.81 -40.01 69.07 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.888 -0.782 . . . . 1.43 108.888 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.8 ttmt -72.44 -73.14 0.21 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.927 -1.138 . . . . 3.08 107.927 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.48 -37.93 0.14 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.362 -0.836 . . . . 1.33 111.844 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 m -59.99 -52.52 65.02 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.433 -1.417 . . . . 1.85 108.517 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.34 -40.0 93.12 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.866 . . . . 1.35 110.809 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -66.63 -40.07 88.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.036 -1.04 . . . . 2.34 110.766 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.87 -39.99 94.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.829 -1.169 . . . . 2.2 108.976 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -65.17 -35.83 82.31 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.274 -0.892 . . . . 1.35 108.926 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -64.52 -43.3 94.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 1.34 109.902 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.16 -39.88 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.987 . . . . 1.26 108.819 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -53.18 -52.48 58.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 1.7 110.064 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -57.01 -33.74 67.47 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.26 -0.9 . . . . 1.35 110.309 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.4 ' O ' ' OG1' ' A' ' 64' ' ' THR . 97.6 mttt -69.32 -37.25 77.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.909 -1.119 . . . . 2.08 109.435 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.99 -45.9 76.23 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.548 -0.72 . . . . 1.21 110.074 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.03 -51.95 55.78 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.333 -1.107 . . . . 0.75 110.333 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.75 -41.11 79.39 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.986 -1.302 . . . . 1.59 110.185 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.4 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 89.6 m -70.11 -62.48 1.37 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.053 -1.029 . . . . 1.41 112.739 -177.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -96.52 -45.88 6.57 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.787 -1.195 . . . . 0.79 111.573 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.08 -166.74 25.91 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 119.705 -1.236 . . . . 1.22 110.977 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -71.26 -24.01 62.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.914 -0.757 . . . . 5.81 110.663 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -62.7 -36.12 81.92 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.278 -0.889 . . . . 3.37 111.502 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -98.42 -18.43 18.26 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.034 -1.041 . . . . 2.37 109.548 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -67.23 -40.07 86.31 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.281 -0.887 . . . . 1.65 110.104 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.584 ' CB ' HH11 ' B' ' 317' ' ' ARG . . . -64.94 -28.37 69.48 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.287 -0.883 . . . . 1.42 109.974 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.84 -41.39 85.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 118.951 -1.1 . . . . 1.43 108.704 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -66.43 -42.51 87.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 1.08 110.493 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -63.11 -40.82 98.73 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.804 -1.185 . . . . 1.37 109.154 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.65 -40.71 98.34 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.344 -1.902 . . . . 0.67 108.344 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -70.05 -41.83 73.69 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.516 -0.991 . . . . 1.99 109.209 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.0 mt -69.71 -45.62 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.396 -0.815 . . . . 1.22 109.655 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.3 ttp -60.13 -46.52 89.35 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.916 -1.115 . . . . 2.11 109.802 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.7 tp -60.79 -40.54 93.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.314 -0.866 . . . . 1.33 109.328 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.411 ' HG ' HH12 ' A' ' 47' ' ' ARG . 63.9 tp -62.23 -40.01 94.73 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.538 -0.726 . . . . 1.29 109.931 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -82.12 8.81 9.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.173 -0.954 . . . . 1.47 110.152 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.7 t0 -54.58 132.98 46.23 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.186 -0.946 . . . . 1.47 110.258 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.415 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 39.9 mt-10 -60.38 -19.65 56.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.613 -0.679 . . . . 1.78 111.301 -178.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.4 -35.06 73.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.665 -1.272 . . . . 2.53 108.799 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.01 -43.58 71.09 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.491 0.663 . . . . 1.36 110.385 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.11 -48.76 80.39 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.967 -1.083 . . . . 1.42 110.55 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -70.0 -40.26 75.38 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.369 -0.832 . . . . 2.27 111.083 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.0 -40.04 75.52 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.906 -1.121 . . . . 1.57 111.61 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.8 mt -67.47 -45.21 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.946 -1.097 . . . . 1.19 109.756 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.92 -39.82 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.604 -0.685 . . . . 1.39 110.053 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.44 -46.91 88.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 1.39 110.579 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 96' ' ' LYS . 85.3 mt -60.12 -47.51 85.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.857 -1.152 . . . . 1.5 109.693 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.0 mt -63.22 -48.97 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.943 0.878 . . . . 1.29 108.926 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -69.84 -40.21 75.98 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.494 -0.754 . . . . 2.64 110.588 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -85.51 -51.55 6.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.04 -1.037 . . . . 1.65 111.952 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 92' ' ' LEU . 65.4 mmtt -89.76 -1.7 58.06 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.013 -1.054 . . . . 2.5 111.603 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 55.73 32.32 19.2 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.869 -1.145 . . . . 1.88 109.962 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.2 mtt -83.8 166.94 17.56 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.361 -0.837 . . . . 1.71 109.721 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 19.3 p -78.17 155.15 30.58 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.529 -0.915 . . . . 1.61 108.529 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.35 93.0 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.134 -0.979 . . . . 1.33 109.445 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -62.86 -39.83 95.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.546 -0.721 . . . . 2.07 109.985 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.66 -45.95 20.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.103 -0.998 . . . . 1.37 110.181 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.01 -50.68 72.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.403 -0.811 . . . . 1.14 110.56 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.72 86.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.004 -1.06 . . . . 1.26 109.919 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.509 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 78.1 t60 -59.97 -41.03 91.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 2.02 110.082 -178.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -63.54 -39.98 95.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.288 -0.882 . . . . 1.33 111.419 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.8 t -62.9 -53.98 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.76 -1.213 . . . . 1.3 112.018 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.3 mm -69.99 -39.94 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.578 -1.326 . . . . 1.32 108.68 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.509 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 87.5 tt0 -60.89 -39.95 91.21 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.736 -0.838 . . . . 2.44 108.736 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.27 94.53 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 120.512 -0.851 . . . . 0.99 111.018 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -70.02 -60.03 2.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.659 -1.495 . . . . 1.97 110.203 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.05 -41.28 25.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.113 -0.992 . . . . 1.43 110.051 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 78.6 p -59.81 -39.87 86.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.058 -1.026 . . . . 2.12 108.719 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.53 -38.85 81.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.248 -0.908 . . . . 1.64 109.293 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.8 mt -65.97 -40.99 91.75 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.12 -0.988 . . . . 1.93 110.155 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -59.92 -34.83 73.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.719 -1.238 . . . . 2.2 109.625 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -57.47 -19.31 23.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.155 -0.965 . . . . 2.12 109.912 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 40.7 mt -62.65 149.76 42.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.859 -1.15 . . . . 2.34 109.203 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -89.98 10.59 23.44 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.312 -0.868 . . . . 3.23 110.254 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -101.42 128.98 47.37 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.198 -0.939 . . . . 2.49 110.331 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.01 -29.18 66.19 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.581 0.705 . . . . 3.95 109.437 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.581 ' HH ' ' CZ ' ' A' ' 126' ' ' ARG . 6.7 t80 -70.22 -39.28 75.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.587 -0.695 . . . . 2.25 110.342 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.5 mt -69.97 -35.39 74.42 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.02 -1.05 . . . . 2.27 108.416 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -59.99 -39.07 84.46 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.072 -0.714 . . . . 3.31 109.072 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -58.24 -43.56 87.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 2.73 109.198 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.599 ' NH2' ' O ' ' B' ' 314' ' ' LEU . 89.9 mtt180 -62.23 -39.93 94.47 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.176 -1.01 . . . . 3.2 109.22 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.82 80.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 1.66 109.621 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.07 -48.76 80.36 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.363 -0.835 . . . . 1.67 109.416 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -63.5 -40.07 96.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 1.55 109.628 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.42 -40.12 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.085 -1.009 . . . . 1.32 108.471 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.498 HH11 ' HG2' ' A' ' 131' ' ' ARG . 3.8 ttt-85 -60.32 -38.62 84.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.517 -0.739 . . . . 3.58 109.233 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -59.94 -40.08 87.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.425 -0.797 . . . . 1.46 110.363 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.08 -45.99 94.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.905 -1.122 . . . . 1.22 109.377 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.88 -41.06 93.66 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 120.291 -0.957 . . . . 0.61 110.942 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -60.07 -46.33 89.92 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.906 -1.349 . . . . 3.1 109.954 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.611 HH12 ' CB ' ' A' ' 166' ' ' SER . 98.2 mtt180 -68.88 -29.91 68.29 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.932 -1.105 . . . . 3.71 109.48 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.1 tp -60.05 -43.13 95.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.948 . . . . 1.87 109.071 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.9 mt -61.02 -39.82 91.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.281 -0.887 . . . . 1.29 109.89 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -67.39 -39.94 85.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 3.05 108.933 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -61.34 -36.18 79.44 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.623 -0.673 . . . . 1.26 111.217 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.2 mt -70.7 -43.24 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.444 -1.41 . . . . 1.34 109.05 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.1 mt -71.04 -30.15 66.26 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.435 -0.79 . . . . 1.6 109.489 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.18 43.47 6.27 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.862 -1.695 . . . . 0.96 108.862 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.7 tp -74.44 149.47 40.37 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.427 -1.043 . . . . 1.67 109.241 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -72.11 142.29 49.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 4.96 109.58 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 93.9 mt -113.06 128.94 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-O 122.203 1.002 . . . . 1.68 109.927 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.5 mt -64.21 -43.77 97.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 115.485 -0.779 . . . . 2.14 110.87 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.3 t0 65.21 102.66 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.395 -0.816 . . . . 1.5 108.969 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.5 mt -69.02 -1.02 6.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.265 -0.897 . . . . 1.39 110.625 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 74.0 m -87.92 -10.88 49.23 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.852 -1.155 . . . . 1.83 109.395 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.84 15.97 2.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.336 -0.852 . . . . 1.46 112.588 -177.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.1 mp -90.32 119.98 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 120.213 -1.554 . . . . 1.42 109.215 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -100.45 -9.26 22.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.467 -0.771 . . . . 2.94 110.217 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -116.92 148.21 41.55 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.291 -0.881 . . . . 1.52 110.442 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -65.06 132.59 49.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.541 -0.724 . . . . 1.58 109.588 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.0 m -152.35 164.66 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.473 -0.767 . . . . 1.32 109.538 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.5 mt -91.84 149.53 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.023 -1.843 . . . . 1.27 106.023 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 52.3 tp -99.3 117.11 33.03 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.967 -1.083 . . . . 1.41 110.035 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 19.4 t -123.48 129.98 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.481 -0.933 . . . . 1.23 108.481 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.29 164.74 34.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.058 -1.026 . . . . 1.32 108.924 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.17 -38.07 69.22 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.379 -1.451 . . . . 1.49 108.378 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -171.07 142.83 1.87 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.825 -0.806 . . . . 2.25 108.825 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 19.9 mt -117.4 137.49 52.45 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.324 -0.86 . . . . 1.35 109.504 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.4 p -83.08 147.23 53.51 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.94 . . . . 1.56 108.722 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.403 ' O ' ' OG1' ' A' ' 168' ' ' THR . 86.5 Cg_exo -43.52 -31.83 3.34 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.567 1.511 . . . . 0.87 111.814 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.611 ' CB ' HH12 ' A' ' 136' ' ' ARG . 38.5 m -59.96 -40.16 88.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.907 . . . . 1.36 108.975 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.58 -43.21 85.55 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.441 -0.787 . . . . 1.61 109.658 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 165' ' ' PRO . 54.2 p -52.68 -29.08 24.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.13 -0.981 . . . . 1.21 110.092 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.29 -57.74 3.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 1.21 110.063 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -81.83 36.03 0.44 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.066 -0.716 . . . . 2.11 109.066 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.2 tp -97.96 138.21 35.62 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.494 -0.754 . . . . 1.29 109.006 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -86.27 102.92 14.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.08 -1.013 . . . . 2.81 109.196 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 66.2 mt -62.21 -45.64 92.47 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.265 -0.897 . . . . 2.09 110.209 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -66.42 -28.93 69.0 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.058 -1.027 . . . . 2.86 112.715 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -93.17 -13.03 28.92 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.46 -1.4 . . . . 2.39 109.95 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 178' ' ' GLY . 87.2 t -101.41 109.27 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.179 -0.95 . . . . 1.27 108.727 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.2 mt -82.76 6.53 17.82 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.897 . . . . 2.17 110.274 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.416 ' O ' ' CG1' ' A' ' 176' ' ' VAL . . . 169.09 175.85 38.71 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.312 -1.515 . . . . 0.52 109.312 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -135.76 130.16 33.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.394 -1.062 . . . . 0.55 109.299 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 94.5 mt -131.13 126.97 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.736 -0.839 . . . . 1.27 108.736 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.1 p -145.7 157.29 43.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.033 -1.042 . . . . 1.39 110.7 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.52 ' OD2' ' N ' ' A' ' 206' ' ' GLY . 7.2 m-20 -105.52 27.04 8.76 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.462 -0.94 . . . . 2.46 108.462 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.57 -157.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.201 -0.937 . . . . 1.51 112.225 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.84 -71.2 0.85 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 111.258 -0.737 . . . . 2.23 111.258 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 167.11 -133.66 2.99 Favored Glycine 0 N--CA 1.491 2.342 0 O-C-N 120.705 -1.468 . . . . 2.23 110.563 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.508 ' C ' ' H ' ' A' ' 188' ' ' SER . 28.0 mtm-85 -60.08 -40.04 88.19 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.427 -1.043 . . . . 6.44 111.01 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.4 p -65.78 8.88 0.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.066 -1.021 . . . . 4.09 110.471 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.508 ' H ' ' C ' ' A' ' 186' ' ' ARG . 29.1 t -90.79 129.59 36.85 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.015 -1.053 . . . . 2.2 110.255 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -42.79 -52.0 5.19 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.783 0.801 . . . . 1.15 109.38 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 9.5 p -55.38 -36.69 66.66 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.768 -0.582 . . . . 2.01 111.175 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.7 t -59.94 -40.03 87.57 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.846 -1.159 . . . . 1.93 110.903 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 192' ' ' ILE . 87.6 mt -65.7 -40.02 86.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.123 -0.985 . . . . 2.2 110.109 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.7 mtp -60.05 -45.31 93.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.846 . . . . 1.32 111.06 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.3 -43.8 92.58 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.927 -1.108 . . . . 1.3 109.59 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 51.4 mtt-85 -59.96 -51.61 68.92 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.901 -1.12 . . . . 3.38 109.361 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.5 m -70.11 -35.03 73.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 1.15 110.76 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.0 mt -76.12 -21.44 56.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 1.28 109.66 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 62.15 50.04 4.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.605 -0.684 . . . . 1.5 109.86 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.48 130.59 23.85 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 108.821 -0.807 . . . . 1.37 108.821 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -43.88 130.31 7.78 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.905 1.737 . . . . 0.76 112.343 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -168.84 145.67 3.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.736 -1.227 . . . . 1.19 111.661 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 91.2 mt -124.88 148.87 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 107.168 -1.419 . . . . 1.31 107.168 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 6.9 m -129.98 -9.83 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 O-C-N 120.819 -1.176 . . . . 1.38 110.894 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.68 22.38 26.26 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 110.228 -1.149 . . . . 1.03 110.228 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.44 ' OG1' ' OD2' ' A' ' 182' ' ' ASP . 3.3 p -47.14 -40.0 14.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.894 -1.356 . . . . 1.38 109.836 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.52 ' N ' ' OD2' ' A' ' 182' ' ' ASP . . . 89.11 -52.07 3.81 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 120.914 -1.116 . . . . 1.17 111.342 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.48 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 15.1 m -156.17 37.97 0.34 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.523 -1.575 . . . . 2.07 111.819 -178.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 12.8 t -77.05 -34.88 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.754 -1.216 . . . . 1.35 108.045 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 53.8 p -59.72 -34.26 72.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.571 -0.706 . . . . 1.49 110.284 -179.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.4 t -77.16 -16.97 58.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.046 -1.034 . . . . 2.16 109.962 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -99.27 -11.86 20.89 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.245 -0.909 . . . . 2.89 110.319 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.5 t -102.33 135.3 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.24 -0.913 . . . . 1.33 111.08 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.506 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 43.5 mmtm -110.38 150.48 28.73 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.518 -1.66 . . . . 2.73 106.518 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.489 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 13.1 p-10 -59.91 141.04 56.22 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.789 -1.194 . . . . 2.7 110.85 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.3 t0 85.24 1.04 0.74 Allowed 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.071 0.463 . . . . 2.38 110.012 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.506 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 98.1 m-20 -73.99 147.0 43.37 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.146 -0.971 . . . . 2.09 109.252 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -97.34 119.88 36.67 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.614 -1.254 . . . . 1.45 107.614 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 66.4 mt -126.98 148.99 50.07 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.475 -0.766 . . . . 1.31 110.489 -178.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.0 mt -116.18 129.91 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 107.675 -1.231 . . . . 1.29 107.675 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 35.2 tp -102.28 119.33 38.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.883 -1.136 . . . . 1.31 108.075 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.552 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 6.6 p30 -78.47 -40.13 36.41 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.886 -1.134 . . . . 2.31 108.751 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.456 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 51.35 13.64 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.439 -0.948 . . . . 1.19 108.439 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.484 ' H ' ' C ' ' A' ' 221' ' ' ASP . 24.9 t -127.65 -40.64 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.457 -1.312 . . . . 1.45 107.457 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -102.5 0.39 33.56 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.976 -1.12 . . . . 3.13 107.976 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.57 HD22 ' H ' ' A' ' 4' ' ' GLY . 48.8 t-20 59.78 44.96 13.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.834 -0.542 . . . . 2.2 110.297 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.552 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 80.5 mt-30 -140.22 158.38 44.13 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.174 -0.954 . . . . 2.32 109.709 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 81.3 t -120.14 130.05 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.032 -0.729 . . . . 1.4 109.032 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -101.61 120.98 41.16 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.383 -0.823 . . . . 1.29 108.918 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 49.0 t -103.36 119.23 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.548 -0.72 . . . . 1.38 109.759 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 63.79 66.9 1.03 Allowed Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.186 -0.946 . . . . 2.33 109.931 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -91.34 128.34 1.17 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 123.255 2.636 . . . . 0.95 112.661 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 30.4 p -69.01 169.37 11.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 2.31 109.422 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -60.07 -39.4 85.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 3.45 108.942 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.02 -38.22 82.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.344 -0.848 . . . . 2.89 110.083 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.61 -40.22 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.841 -1.162 . . . . 1.73 108.836 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 94.3 mt -66.64 -40.89 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.047 -1.033 . . . . 1.57 109.374 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -62.93 -40.1 96.62 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.138 -0.976 . . . . 2.43 109.048 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -67.66 -42.1 82.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 3.18 108.748 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 94.7 mtp -69.98 -30.68 68.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.591 -0.693 . . . . 1.59 109.816 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -69.2 -39.91 78.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.953 -1.092 . . . . 3.11 109.503 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.42 -40.1 89.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.359 -0.838 . . . . 2.17 109.57 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 69.7 t -62.84 -41.31 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 2.51 109.476 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -60.09 -42.14 93.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.331 -0.855 . . . . 3.82 109.79 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -62.46 -39.85 94.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.131 -0.981 . . . . 1.78 108.977 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -60.98 -37.02 80.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.5 -0.75 . . . . 2.77 109.298 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 69.6 t -59.96 -40.04 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -0.9 . . . . 2.25 109.009 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.02 -46.4 89.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.297 -0.877 . . . . 2.54 109.464 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 68.9 m -76.97 -22.12 53.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.183 -0.948 . . . . 3.03 109.357 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -60.03 -39.97 87.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.458 -0.776 . . . . 3.34 111.087 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' A' ' 252' ' ' GLU . 17.5 pttp -56.65 -34.42 67.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.794 -1.191 . . . . 4.18 109.63 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.498 ' C ' ' H ' ' A' ' 253' ' ' LEU . . . -71.2 51.93 0.17 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.891 -1.131 . . . . 4.43 108.826 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 250' ' ' LYS . 25.4 tp10 -62.83 0.29 0.56 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.388 -0.82 . . . . 5.42 109.228 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.498 ' H ' ' C ' ' A' ' 251' ' ' ALA . 54.7 mt -60.97 -40.06 91.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.141 -0.974 . . . . 6.11 109.477 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 55.57 50.1 15.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.122 -0.986 . . . . 7.37 109.432 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -60.07 -43.03 95.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 8.3 109.414 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 58.5 mt -80.08 -69.93 0.55 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.995 -1.065 . . . . 9.05 108.572 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? 177.17 115.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.944 -0.761 . . . . 10.56 108.944 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.47 ' CG ' ' H ' ' A' ' 259' ' ' ARG . 25.7 p-10 -92.61 -56.56 2.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.032 -1.042 . . . . 11.32 108.676 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . 0.47 ' H ' ' CG ' ' A' ' 258' ' ' ASP . 61.4 mtp180 . . . . . 0 C--N 1.303 -1.455 0 CA-C-O 118.051 -0.976 . . . . 12.74 109.497 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 33.1 ttp . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.513 0.673 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -150.96 148.53 28.5 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -150.02 159.36 44.46 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.087 -1.008 . . . . 0.0 110.397 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -157.56 154.02 27.85 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 -111.69 131.57 55.2 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.115 -0.99 . . . . 0.0 110.203 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.27 121.77 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-O 122.348 1.071 . . . . 0.0 112.307 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 56.7 m -80.4 101.2 8.87 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.804 0.811 . . . . 0.0 110.799 -178.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' B' ' 358' ' ' GLY . 97.5 mt -50.71 116.73 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.258 1.028 . . . . 0.0 109.673 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 25.1 p -106.59 14.1 27.44 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.946 -177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.42 116.67 42.37 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.994 -1.066 . . . . 0.0 108.445 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -51.85 -17.08 4.79 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 CA-C-N 120.216 1.113 . . . . 0.0 113.725 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -111.0 11.3 22.14 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.257 -0.902 . . . . 0.0 109.991 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 69.47 169.78 6.93 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.599 ' O ' ' NH2' ' A' ' 126' ' ' ARG . 3.1 tp -84.6 93.27 8.34 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.087 -1.243 . . . . 0.0 109.333 -178.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . 0.559 ' C ' HH21 ' A' ' 126' ' ' ARG . 3.8 p80 -96.48 -161.48 0.87 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 120.885 -1.134 . . . . 0.0 109.902 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 4.0 m -58.06 -41.58 83.63 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.884 -1.135 . . . . 0.0 112.726 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.584 HH11 ' CB ' ' A' ' 71' ' ' ALA . 14.7 tpt180 -57.31 -59.44 12.8 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 120.308 -1.495 . . . . 0.0 111.068 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.92 -42.9 17.56 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 CA-C-N 120.485 1.209 . . . . 0.0 111.606 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.89 -17.28 35.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.178 -0.951 . . . . 0.0 110.392 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -82.16 -38.55 24.53 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -72.16 -34.81 68.76 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -64.65 -58.28 6.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.39 -0.819 . . . . 0.0 109.796 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.68 -32.91 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.82 -1.175 . . . . 0.0 109.085 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -59.93 -46.65 88.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.422 -0.799 . . . . 0.0 109.112 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.29 -44.06 84.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 110.422 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . 0.46 ' C ' ' H ' ' B' ' 328' ' ' GLY . . . -60.03 -53.41 58.19 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.855 -1.153 . . . . 0.0 111.248 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -51.72 -10.45 0.11 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.883 -1.135 . . . . 0.0 110.136 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' B' ' 326' ' ' ALA . . . -75.9 -24.75 68.64 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -105.23 139.14 40.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.41 -1.053 . . . . 0.0 109.248 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 8.8 p -90.61 -9.8 45.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.275 -0.89 . . . . 0.0 110.115 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 14.0 t -64.47 155.21 33.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.101 -1.0 . . . . 0.0 109.963 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.6 131.73 45.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.907 . . . . 0.0 108.792 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 82.9 mt -132.44 132.95 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.392 -0.818 . . . . 0.0 109.938 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.4 m -131.56 149.94 52.33 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.484 -0.76 . . . . 0.0 109.128 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 66.6 t -122.43 117.41 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 94.7 m -107.5 133.43 52.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.228 -0.92 . . . . 0.0 109.697 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 4.8 p -139.85 115.94 10.41 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.766 0.793 . . . . 0.0 110.631 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 45.22 50.02 9.77 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.641 -0.662 . . . . 0.0 112.744 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.32 -16.41 48.92 Favored Glycine 0 N--CA 1.5 2.957 0 O-C-N 120.058 -1.651 . . . . 0.0 112.242 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -110.69 121.32 45.03 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 118.87 1.335 . . . . 0.0 109.69 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 86.4 p -126.76 148.33 49.91 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.815 0.816 . . . . 0.0 110.151 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -145.23 170.57 16.02 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.563 0.697 . . . . 0.0 110.093 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 17.3 m -89.04 134.73 33.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.519 -0.738 . . . . 0.0 110.518 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.518 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -75.91 -16.38 60.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.053 -1.03 . . . . 0.0 109.504 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -84.7 20.87 1.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.518 ' H ' ' C ' ' B' ' 344' ' ' ALA . 93.8 p -151.61 96.91 2.31 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.43 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . 0.46 ' O ' ' NE2' ' B' ' 351' ' ' GLN . 51.7 tp -60.05 -33.76 72.48 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -56.27 -52.95 62.6 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.931 -1.106 . . . . 0.0 110.034 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -69.82 -28.67 65.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 110.421 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.415 ' O ' ' N ' ' B' ' 352' ' ' THR . 80.8 mt -59.96 -50.01 75.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.101 -0.999 . . . . 0.0 109.728 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.46 ' NE2' ' O ' ' B' ' 347' ' ' LEU . 1.2 mp0 -45.07 -20.22 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.017 -1.052 . . . . 0.0 111.189 -178.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.415 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.3 p -80.3 -10.61 59.76 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.19 -1.568 . . . . 0.0 109.444 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 45.9 mt -95.79 115.29 27.21 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.176 -0.953 . . . . 0.0 108.77 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.84 95.21 1.24 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 22.8 mt -103.9 94.25 5.31 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.416 -1.05 . . . . 0.0 109.286 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 79.0 p -100.72 153.57 19.33 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.233 -0.917 . . . . 0.0 111.234 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -41.95 111.9 0.28 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.202 0.525 . . . . 0.0 110.664 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 103.14 6.09 45.78 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 91.7 m -83.69 111.24 18.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.157 . . . . 0.0 111.22 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 8.6 t -78.47 111.99 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 122.15 0.976 . . . . 0.0 109.801 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 12.3 m -110.08 177.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 40.4 m -130.26 126.9 38.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 64.0 mt -103.82 117.44 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 53.6 m -121.13 132.33 54.79 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.79 148.31 38.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.279 -0.888 . . . . 0.0 109.572 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -142.38 121.85 13.24 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.512 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.91 -158.39 29.07 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 119.192 -1.48 . . . . 0.0 111.159 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -59.9 -51.08 71.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 122.293 -0.534 . . . . 0.0 112.219 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -108.27 10.78 27.68 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 120.86 -1.15 . . . . 0.0 111.249 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.4 pt-20 -39.9 -34.12 0.25 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.338 -0.852 . . . . 0.0 112.232 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -68.3 -42.64 79.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.535 -1.353 . . . . 0.0 110.432 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -71.1 -52.56 18.66 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.991 -1.068 . . . . 0.0 109.653 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.69 -36.78 2.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.333 -0.854 . . . . 0.0 111.519 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . 0.413 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 58.9 t -81.14 -36.02 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.521 -1.362 . . . . 0.0 109.502 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -69.98 -40.01 75.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.375 -0.828 . . . . 0.0 111.921 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -77.59 -46.78 21.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.612 -1.305 . . . . 0.0 110.151 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.35 -36.38 80.02 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.294 -0.879 . . . . 0.0 109.116 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 53.8 t -73.68 -37.45 49.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -74.83 -17.01 60.67 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' B' ' 383' ' ' GLU . 41.9 tp -78.87 -68.07 0.69 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 57.3 mtt -54.3 -19.5 5.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.01 -1.056 . . . . 0.0 109.136 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.2 -23.72 51.44 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' B' ' 380' ' ' LEU . 97.5 mt-10 -108.62 4.37 23.88 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.626 -0.671 . . . . 0.0 110.962 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 69.0 mt -82.67 122.31 27.98 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.578 -1.326 . . . . 0.0 110.129 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.041 -0.98 . . . . 0.0 108.933 179.231 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.188 0.518 . . . . 3.19 109.691 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 87.7 mt -110.03 127.94 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.73 -0.841 . . . . 1.71 108.73 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.2 m -140.04 150.73 44.75 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.296 -0.877 . . . . 1.66 109.258 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.86 -163.89 9.7 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 108.465 -1.854 . . . . 1.05 108.465 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 6' ' ' LEU . 89.9 mt -90.37 -17.37 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.747 -1.443 . . . . 1.59 109.575 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.4 tp 55.1 106.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.496 -0.752 . . . . 1.47 109.184 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.26 -29.12 12.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.333 -0.855 . . . . 1.39 109.065 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 14.8 m -127.62 116.62 21.09 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 109.356 -0.609 . . . . 2.09 109.356 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.85 148.05 19.61 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 121.991 1.794 . . . . 0.91 112.453 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 143.36 178.78 19.47 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 108.853 -1.699 . . . . 0.92 108.853 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.7 mt -122.13 156.36 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.231 -1.158 . . . . 1.35 109.436 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.55 156.56 35.36 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.965 -1.084 . . . . 1.14 110.625 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.4 m-85 -137.69 128.99 27.85 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.03 -1.1 . . . . 0.7 108.03 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.43 178.38 47.77 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 118.505 -1.807 . . . . 0.58 110.842 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -78.86 156.7 28.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.786 -0.832 . . . . 2.63 109.14 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.62 133.03 52.65 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.392 -0.817 . . . . 1.27 110.923 -178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.3 tp -107.45 137.85 44.73 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 107.997 -1.112 . . . . 1.41 107.997 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 66.2 tp -115.76 122.66 46.12 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.526 -0.734 . . . . 1.49 109.561 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.9 mt -82.26 103.21 11.68 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.414 -0.804 . . . . 1.52 109.416 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -94.25 136.56 34.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.296 -0.878 . . . . 3.17 109.496 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 58.2 mp0 -131.02 134.84 47.05 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.361 -0.837 . . . . 3.0 109.086 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.17 150.76 28.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.133 -0.98 . . . . 2.77 109.133 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -65.96 149.22 50.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.943 -1.098 . . . . 2.94 109.245 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.523 ' CG1' HH12 ' A' ' 139' ' ' ARG . 88.2 mt -89.78 124.83 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 1.46 109.22 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.63 122.87 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.236 -0.915 . . . . 1.7 109.477 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.9 mt -108.09 133.22 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.802 -0.814 . . . . 1.54 108.802 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -86.97 118.27 26.24 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.792 -1.192 . . . . 1.81 109.58 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -87.51 -1.0 57.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 3.23 109.613 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.81 136.86 49.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.112 -0.993 . . . . 3.29 109.184 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -80.99 159.51 24.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.952 -1.092 . . . . 2.8 109.488 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.9 pt -102.57 167.67 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.303 -0.873 . . . . 1.43 109.883 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.3 p -94.1 175.27 6.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.229 -0.92 . . . . 1.54 109.093 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.74 -50.97 71.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.089 -1.007 . . . . 1.6 110.746 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 55.8 t0 -54.71 -29.41 53.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.561 -1.337 . . . . 2.56 109.681 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -82.02 -10.04 59.36 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.316 -0.865 . . . . 2.36 110.386 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.0 t -60.22 -50.3 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.824 -1.172 . . . . 1.43 109.068 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.67 -39.9 93.04 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.404 -0.81 . . . . 1.77 109.54 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -62.68 -43.79 97.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.903 . . . . 3.32 110.981 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -61.89 -40.19 94.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.84 -1.162 . . . . 1.51 110.171 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 66.4 t -59.87 -46.23 94.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 C-N-CA 118.722 -1.191 . . . . 1.41 108.86 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -59.93 -42.58 94.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.881 -1.137 . . . . 1.81 109.434 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.26 -41.52 93.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.807 -1.183 . . . . 3.26 108.222 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -64.01 -46.9 82.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.355 -0.841 . . . . 0.81 109.143 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.1 tp -59.96 -48.81 80.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.28 -0.887 . . . . 1.59 108.672 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.0 t -63.26 -41.95 99.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.075 -1.015 . . . . 1.38 109.543 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.62 -46.21 92.73 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.154 -1.578 . . . . 0.87 109.154 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -63.3 -33.56 75.78 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.261 -1.141 . . . . 3.62 108.739 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.424 ' O ' ' OG ' ' A' ' 51' ' ' SER . . . -58.25 -42.85 87.33 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.369 -0.832 . . . . 1.43 109.283 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 50' ' ' ALA . 1.2 ttmp? -63.68 -73.62 0.11 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.792 -1.193 . . . . 3.08 107.915 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.19 -41.14 0.37 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.415 -0.803 . . . . 1.33 111.411 -178.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 48' ' ' ALA . 93.2 p -54.22 -54.77 35.42 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.42 -1.425 . . . . 1.85 108.699 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.99 -39.97 83.17 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.462 -0.774 . . . . 1.35 111.301 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -68.37 -39.95 81.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.77 -1.206 . . . . 2.34 110.668 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.13 -39.97 96.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.979 -1.076 . . . . 2.2 108.736 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -63.91 -34.14 77.29 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.454 -0.779 . . . . 1.35 109.087 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.6 m -65.89 -44.13 86.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 1.34 108.883 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.9 mt -60.14 -37.75 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.675 -0.861 . . . . 1.26 108.675 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -59.8 -51.06 71.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.473 -0.767 . . . . 1.7 110.204 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 m -55.78 -33.28 64.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.051 -1.03 . . . . 1.35 110.042 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -69.92 -37.96 76.11 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.422 -0.798 . . . . 2.08 109.555 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.78 -47.67 65.6 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.204 0.526 . . . . 1.21 111.227 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.68 -50.97 61.81 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 110.004 -1.239 . . . . 0.75 110.004 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.96 -42.11 73.63 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.005 -1.291 . . . . 1.59 110.562 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.5 m -69.28 -60.69 2.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.088 -1.007 . . . . 1.41 112.111 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -96.52 -50.93 4.54 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.935 -1.103 . . . . 0.79 111.422 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.15 -163.86 26.98 Favored Glycine 0 N--CA 1.501 2.974 0 O-C-N 120.731 -1.231 . . . . 1.22 111.048 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.02 -25.15 63.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.772 -0.84 . . . . 5.81 110.65 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -60.33 -36.76 78.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.902 . . . . 3.37 110.197 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.479 ' NZ ' ' CE1' ' A' ' 189' ' ' HIS . 69.3 mmtt -97.78 -19.85 17.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.251 -0.905 . . . . 2.37 110.352 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.1 -46.13 68.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.909 -1.119 . . . . 1.65 110.224 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.7 -32.91 74.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.643 -0.661 . . . . 1.42 110.116 -178.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.09 -40.83 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.867 -1.146 . . . . 1.43 109.045 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -65.11 -39.83 93.67 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.14 -0.975 . . . . 1.08 109.776 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -60.09 -39.98 88.02 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.085 -1.009 . . . . 1.37 109.528 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.14 -49.3 72.55 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.623 -1.791 . . . . 0.67 108.623 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -60.91 -43.61 98.32 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.344 -1.091 . . . . 1.99 108.837 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.1 mt -68.94 -47.71 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.254 -0.903 . . . . 1.22 109.09 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.8 ttp -60.25 -42.94 96.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.899 -1.126 . . . . 2.11 109.792 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.4 tp -64.81 -40.0 94.5 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.376 -0.828 . . . . 1.33 109.772 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.7 tp -64.52 -40.05 94.9 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.292 -0.88 . . . . 1.29 110.189 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -81.55 4.86 19.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.974 -1.078 . . . . 1.47 109.844 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 51.7 t0 -50.26 132.02 24.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 1.47 110.07 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 97.7 mt-10 -62.02 -18.96 62.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.637 -0.664 . . . . 1.78 110.754 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -72.42 -36.05 68.5 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.853 -1.154 . . . . 2.53 108.935 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.17 -40.38 78.18 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.974 -0.75 . . . . 1.36 108.974 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.04 -49.87 75.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.566 -0.709 . . . . 1.42 110.023 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.13 -41.42 73.96 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.329 -0.857 . . . . 2.27 111.284 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.64 -40.35 73.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.947 -1.096 . . . . 1.57 111.512 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 89' ' ' ILE . 96.9 mt -68.8 -49.34 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.88 -1.137 . . . . 1.19 109.591 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.4 mt -65.29 -37.64 80.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.634 -0.666 . . . . 1.39 110.275 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.29 98.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 1.39 110.365 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 96' ' ' LYS . 81.5 mt -61.67 -46.38 89.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.885 -1.134 . . . . 1.5 109.085 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.2 mt -61.06 -50.2 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.963 0.887 . . . . 1.29 109.261 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.02 -40.95 74.9 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 120.008 -0.677 . . . . 2.64 110.451 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -82.34 -49.5 9.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.308 -0.87 . . . . 1.65 111.805 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 92' ' ' LEU . 65.7 mmtt -92.24 -2.05 56.73 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.033 -1.042 . . . . 2.5 111.788 -177.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 38.4 m170 55.51 32.77 19.7 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.844 -1.16 . . . . 1.88 109.082 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 93.5 mtp -90.18 166.72 13.21 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.707 -0.621 . . . . 1.71 109.826 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.2 p -78.39 158.62 28.69 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.451 -0.944 . . . . 1.61 108.451 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.99 -35.73 74.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.985 -1.072 . . . . 1.33 109.901 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -67.14 -40.01 86.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 2.07 109.437 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.41 -41.88 21.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.395 -0.816 . . . . 1.37 109.698 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.68 -50.5 66.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.418 -0.802 . . . . 1.14 110.417 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.07 88.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.164 -0.96 . . . . 1.26 109.836 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -58.34 -39.93 80.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 2.02 109.761 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.79 -40.13 96.39 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.217 -0.927 . . . . 1.33 110.034 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.3 t -66.51 -52.53 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.213 -0.929 . . . . 1.3 111.56 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.9 mm -69.34 -39.91 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.824 -1.173 . . . . 1.32 108.772 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.41 -34.85 76.75 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.615 -0.883 . . . . 2.44 108.615 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.32 -47.49 90.58 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 120.645 -0.788 . . . . 0.99 111.135 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -66.17 -48.12 71.78 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.614 -1.521 . . . . 1.97 109.602 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.74 78.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.895 . . . . 1.43 109.505 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 84.1 p -57.69 -40.2 78.91 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.091 -1.005 . . . . 2.12 108.748 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.8 89.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 1.64 109.614 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.4 mt -63.53 -43.35 97.39 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.798 -1.189 . . . . 1.93 110.274 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.18 -30.47 69.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.681 -1.262 . . . . 2.2 109.739 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.95 -23.72 63.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.991 -1.068 . . . . 2.12 108.598 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.4 147.73 47.59 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.291 -0.881 . . . . 2.34 109.128 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -94.95 49.16 1.21 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.085 -1.009 . . . . 3.23 109.734 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -136.25 130.27 32.8 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.198 -0.939 . . . . 2.49 109.888 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.06 -30.32 67.55 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.445 -0.784 . . . . 3.95 110.248 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.53 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.1 t80 -72.11 -38.24 69.34 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.287 -0.883 . . . . 2.25 110.716 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 89.4 mt -70.0 -32.28 70.39 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.045 -1.034 . . . . 2.27 108.249 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -60.24 -39.21 85.9 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.601 -0.888 . . . . 3.31 108.601 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -59.75 -48.35 82.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.331 -0.856 . . . . 2.73 110.108 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.576 HH21 ' C ' ' B' ' 315' ' ' HIS . 84.5 mtt180 -60.12 -39.68 87.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.679 -1.263 . . . . 3.2 108.495 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.51 -32.32 68.72 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.294 -0.879 . . . . 1.66 108.65 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.8 -40.22 88.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 1.67 109.588 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -65.55 -40.12 92.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 1.55 109.515 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.49 -41.85 86.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.45 -0.781 . . . . 1.32 109.292 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -62.03 -36.31 81.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 3.58 109.5 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -60.0 -40.01 87.76 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.263 -0.898 . . . . 1.46 110.077 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.26 -44.16 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.151 -0.968 . . . . 1.22 109.791 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.37 -39.72 98.13 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.474 -1.051 . . . . 0.61 110.474 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -58.94 -45.78 89.61 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.893 -1.357 . . . . 3.1 109.624 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.471 HH11 ' HG2' ' A' ' 136' ' ' ARG . 24.3 mtt-85 -63.22 -36.33 83.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.874 -1.141 . . . . 3.71 110.339 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.6 tp -56.19 -44.59 79.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.309 -0.869 . . . . 1.87 109.974 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.96 -40.07 91.96 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.032 -1.043 . . . . 1.29 108.791 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.582 HH11 ' HG2' ' A' ' 139' ' ' ARG . 11.5 mtt-85 -67.73 -39.94 84.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.348 -0.845 . . . . 3.05 109.339 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -68.06 -38.03 81.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.632 -0.667 . . . . 1.26 111.668 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.3 mt -73.73 -45.55 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.227 -1.546 . . . . 1.34 108.571 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.7 mt -70.0 -33.7 72.37 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.614 -0.679 . . . . 1.6 109.493 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.78 40.2 7.27 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.193 -1.563 . . . . 0.96 109.193 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.2 tp -74.94 150.39 39.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.521 -0.987 . . . . 1.67 110.17 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -68.4 141.29 55.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.322 -0.861 . . . . 4.96 110.174 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.9 mt -116.48 129.95 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 121.785 0.802 . . . . 1.68 109.474 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 15.0 mm -56.79 -50.17 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.794 -0.566 . . . . 2.14 111.137 -177.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.0 t0 67.09 104.31 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.266 -0.896 . . . . 1.5 109.5 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.4 mt -81.06 -7.58 59.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.275 -0.89 . . . . 1.39 110.799 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.7 p -80.13 -17.32 52.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.65 -1.281 . . . . 1.83 109.355 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.8 17.62 3.31 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.509 -0.745 . . . . 1.46 111.825 -177.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 50.1 mt -91.04 114.57 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.727 -1.233 . . . . 1.42 109.145 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -101.34 -11.01 19.76 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.385 -0.822 . . . . 2.94 110.604 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -110.53 146.6 35.75 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.16 -0.962 . . . . 1.52 109.442 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.94 130.58 43.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.148 -0.97 . . . . 1.58 109.407 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.1 m -152.27 163.71 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.939 -0.763 . . . . 1.32 108.939 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.414 HD11 HG22 ' A' ' 157' ' ' ILE . 85.1 mt -93.14 149.75 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 106.028 -1.842 . . . . 1.27 106.028 177.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 52.5 tp -100.44 117.81 35.37 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.996 -1.065 . . . . 1.41 110.908 -177.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.1 t -121.94 129.92 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 N-CA-C 108.694 -0.854 . . . . 1.23 108.694 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.22 164.49 35.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.976 -1.077 . . . . 1.32 109.153 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.433 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.86 -35.69 74.9 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.362 -1.461 . . . . 1.49 108.775 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 52.3 t0 -170.6 143.81 2.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.441 -0.948 . . . . 2.25 108.441 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.545 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 26.1 mt -112.71 129.72 56.31 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.52 -0.919 . . . . 1.35 108.52 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.3 p -83.63 145.42 47.57 Favored Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.239 -0.913 . . . . 1.56 109.004 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -38.01 -36.28 0.46 Allowed 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.031 1.821 . . . . 0.87 111.581 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.4 m -59.87 -40.0 87.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.407 -0.808 . . . . 1.36 109.656 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.5 -40.19 77.14 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.13 -0.982 . . . . 1.61 109.713 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 68.5 p -56.1 -28.14 56.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.067 -1.021 . . . . 1.21 110.739 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.49 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -74.58 -56.35 4.92 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.821 -1.174 . . . . 1.21 109.711 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -78.88 39.58 0.37 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.532 -1.285 . . . . 2.11 107.532 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.49 ' H ' ' C ' ' A' ' 169' ' ' ALA . 15.3 tp -99.93 131.86 45.63 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.695 -0.628 . . . . 1.29 109.522 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -88.05 100.27 12.8 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.144 -1.058 . . . . 2.81 108.144 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 65.9 mt -64.66 -42.98 95.03 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.323 -0.861 . . . . 2.09 110.791 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -69.89 -24.24 63.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.66 -1.275 . . . . 2.86 111.569 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -94.39 -13.51 26.23 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.6 -1.312 . . . . 2.39 109.767 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 69.6 t -104.85 116.17 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.238 -0.914 . . . . 1.27 108.541 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.7 mt -83.25 2.19 37.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.936 . . . . 2.17 111.007 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 171.86 172.33 37.73 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.231 -1.461 . . . . 0.52 109.735 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -130.63 126.67 37.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.516 -0.991 . . . . 0.55 108.846 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.02 126.25 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.2 -0.938 . . . . 1.27 108.623 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 80.6 p -147.94 158.43 44.04 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.903 -1.123 . . . . 1.39 110.771 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 44.1 p30 -103.92 24.67 10.96 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.956 -0.757 . . . . 2.46 108.956 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -57.78 -159.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.993 -1.067 . . . . 1.51 110.794 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.87 -54.38 9.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.155 -1.178 . . . . 2.23 110.155 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 156.69 -129.94 2.55 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 120.937 -1.331 . . . . 2.23 110.502 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 188' ' ' SER . 30.2 ttt-85 -63.2 -39.87 95.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.486 -1.008 . . . . 6.44 110.49 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 37.4 p -62.0 1.88 0.26 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.161 -0.962 . . . . 4.09 110.231 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.501 ' H ' ' C ' ' A' ' 186' ' ' ARG . 47.5 t -91.52 130.0 37.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.03 -1.044 . . . . 2.2 109.716 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . 0.479 ' CE1' ' NZ ' ' A' ' 69' ' ' LYS . 84.8 t60 -48.28 -44.15 33.38 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.897 0.856 . . . . 1.15 108.967 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 4.1 p -51.95 -36.33 49.0 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 116.116 -0.493 . . . . 2.01 110.869 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 49.6 m -65.96 -40.83 91.62 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.947 -1.096 . . . . 1.93 111.843 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.2 mm -63.88 -43.2 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.976 -1.077 . . . . 2.2 110.668 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.2 mtp -66.02 -39.95 90.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.249 -0.907 . . . . 1.32 111.036 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.14 -43.34 82.37 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.468 -1.395 . . . . 1.3 109.083 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -59.93 -48.85 80.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.125 -0.984 . . . . 3.38 110.086 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.2 m -68.09 -35.11 77.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.043 -1.036 . . . . 1.15 110.084 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 30.2 mt -71.56 -26.22 62.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.182 -0.949 . . . . 1.28 108.543 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 62.01 51.54 3.64 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.428 0.632 . . . . 1.5 110.494 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 8' ' ' SER . 72.0 mt -129.59 133.07 24.66 Favored Pre-proline 0 N--CA 1.501 2.125 0 N-CA-C 108.541 -0.911 . . . . 1.37 108.541 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -42.16 130.73 4.64 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.0 1.8 . . . . 0.76 112.427 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.31 148.8 3.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.93 -1.106 . . . . 1.19 111.326 -179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 78.8 mt -127.82 146.2 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 N-CA-C 107.985 -1.117 . . . . 1.31 107.985 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.0 m -126.0 -10.55 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 O-C-N 120.734 -1.229 . . . . 1.38 111.51 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.0 22.52 27.41 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 110.323 -1.111 . . . . 1.03 110.323 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.8 p -43.99 -42.99 6.36 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.317 -1.108 . . . . 1.38 109.834 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.73 -50.96 3.23 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.204 -0.998 . . . . 1.17 111.068 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 29.1 p -159.25 39.27 0.21 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.547 -1.56 . . . . 2.07 111.299 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.2 -35.76 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.952 -1.093 . . . . 1.35 108.378 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 6.4 p -55.72 -32.14 63.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.506 -0.746 . . . . 1.49 110.301 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 72.4 p -80.04 -15.65 56.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.951 -1.093 . . . . 2.16 109.84 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -99.76 -13.07 19.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.412 -0.805 . . . . 2.89 110.041 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 52.7 t -106.72 138.07 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 CA-C-O 121.773 0.797 . . . . 1.33 110.713 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.499 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -114.83 153.67 30.01 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.216 -1.402 . . . . 2.73 107.216 178.339 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.459 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 17.5 p-10 -57.63 138.91 54.83 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.914 -1.116 . . . . 2.7 110.546 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.5 m-20 84.36 5.09 0.67 Allowed 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 120.984 0.421 . . . . 2.38 110.758 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.499 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 74.8 m-20 -74.62 137.88 42.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.935 -1.103 . . . . 2.09 109.638 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -88.1 118.12 27.45 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.504 -1.295 . . . . 1.45 107.504 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 60.6 mt -128.95 150.36 50.41 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.493 -0.754 . . . . 1.31 110.611 -178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.9 mt -117.67 128.14 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.317 -1.734 . . . . 1.29 106.317 177.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.3 tp -101.08 120.88 40.85 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.043 -1.036 . . . . 1.31 109.385 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 223' ' ' VAL . 95.3 m-20 -76.32 -44.79 35.26 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.951 -1.093 . . . . 2.31 109.491 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 46.25 16.6 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.463 -0.94 . . . . 1.19 108.463 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 221' ' ' ASP . 45.9 t -135.48 -42.97 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.549 -1.278 . . . . 1.45 107.549 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -99.79 2.74 44.33 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.014 -1.106 . . . . 3.13 108.014 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 60.24 42.42 15.19 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.806 -0.559 . . . . 2.2 109.697 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -141.96 155.46 45.47 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.173 -0.955 . . . . 2.32 110.119 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.0 t -124.8 131.39 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.594 -0.891 . . . . 1.4 108.594 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -102.48 121.74 42.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.326 -0.859 . . . . 1.29 109.325 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 43.9 t -100.59 113.93 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.455 -0.778 . . . . 1.38 110.13 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 25.5 t30 53.48 61.96 10.04 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.237 -0.914 . . . . 2.33 111.59 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -87.35 149.27 7.77 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.976 2.451 . . . . 0.95 112.865 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 42.8 p -70.32 162.62 28.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.444 -0.785 . . . . 2.31 110.271 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -59.66 -35.19 73.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.489 -0.757 . . . . 3.45 109.304 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -59.96 -40.12 87.98 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.359 -0.838 . . . . 2.89 109.953 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.5 -39.53 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.0 -1.063 . . . . 1.73 109.328 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.545 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 85.5 mt -63.93 -39.63 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.108 -0.995 . . . . 1.57 109.445 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.13 -40.15 88.77 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.08 -1.012 . . . . 2.43 108.47 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -67.04 -40.03 87.07 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.369 -0.832 . . . . 3.18 108.974 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 98.1 mtp -69.81 -29.87 67.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.331 -0.856 . . . . 1.59 108.692 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.57 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -69.77 -36.87 76.12 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.526 -0.916 . . . . 3.11 108.526 178.53 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.78 -39.18 84.05 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.994 -0.743 . . . . 2.17 108.994 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 58.4 t -59.94 -41.43 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.281 -0.887 . . . . 2.51 108.844 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -61.33 -40.21 93.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.185 -0.947 . . . . 3.82 109.702 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.88 -39.18 88.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.239 -0.913 . . . . 1.78 109.858 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -59.98 -38.84 83.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.941 . . . . 2.77 109.498 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 54.1 t -59.92 -43.49 92.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.389 -0.819 . . . . 2.25 109.382 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.68 -44.24 94.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.163 -0.96 . . . . 2.54 109.123 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.8 t -70.83 -26.68 63.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -0.849 . . . . 3.03 109.734 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -60.17 -46.56 89.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.084 -1.01 . . . . 3.34 109.113 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.563 ' C ' ' H ' ' A' ' 252' ' ' GLU . 67.2 mttm -80.27 -71.85 0.44 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.034 -1.041 . . . . 4.18 108.968 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 63.83 -40.42 0.22 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.316 0.579 . . . . 4.43 109.725 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.563 ' H ' ' C ' ' A' ' 250' ' ' LYS . 54.0 tp10 -150.49 88.42 1.5 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.39 -0.967 . . . . 5.42 108.39 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.535 ' C ' ' H ' ' A' ' 255' ' ' LYS . 3.0 mp -41.31 -32.78 0.32 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.608 -0.683 . . . . 6.11 109.769 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 68.99 -17.13 0.21 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.667 -0.646 . . . . 7.37 109.856 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.535 ' H ' ' C ' ' A' ' 253' ' ' LEU . 26.5 mtpp -143.37 124.45 14.45 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.111 -0.993 . . . . 8.3 109.214 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 9.6 mp -62.43 -25.9 68.21 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.114 -0.992 . . . . 9.05 108.43 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -67.85 -52.35 37.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.502 -0.749 . . . . 10.56 110.368 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 50.9 t0 50.57 62.88 2.46 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.55 -0.908 . . . . 11.32 108.55 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . 0.483 HH11 ' HG2' ' A' ' 259' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.981 0 CA-C-O 117.937 -1.03 . . . . 12.74 108.821 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 45.0 ttp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 42.1 t80 -153.64 152.31 30.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.446 -0.784 . . . . 0.0 109.194 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . 0.443 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 14.0 pt20 -148.75 158.46 44.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.993 -1.067 . . . . 0.0 110.876 -178.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -152.84 149.88 28.75 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -111.93 131.26 55.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.313 -0.867 . . . . 0.0 110.051 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.4 ' CG1' ' SD ' ' B' ' 381' ' ' MET . 7.4 p -131.16 123.1 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 CA-C-O 122.474 1.131 . . . . 0.0 112.987 -177.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 61.2 m -79.38 103.91 9.63 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.805 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.6 mt -50.8 122.68 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 122.346 1.069 . . . . 0.0 110.296 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 34.6 p -108.43 15.71 23.69 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.697 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.77 116.33 48.91 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.919 -1.113 . . . . 0.0 108.716 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -53.53 -15.26 5.94 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 CA-C-N 120.308 1.146 . . . . 0.0 113.879 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -114.65 12.93 17.3 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.229 -0.919 . . . . 0.0 109.375 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 68.03 174.8 8.51 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.56 ' O ' ' NH2' ' A' ' 126' ' ' ARG . 4.0 tp -84.4 92.39 8.03 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.234 -1.156 . . . . 0.0 110.281 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . 0.576 ' C ' HH21 ' A' ' 126' ' ' ARG . 5.1 p80 -95.94 -162.23 0.93 Allowed 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.778 -1.201 . . . . 0.0 110.06 179.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 22.6 m -58.33 -40.1 81.22 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.93 -1.107 . . . . 0.0 112.661 -175.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.468 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.0 OUTLIER -60.82 -62.79 5.26 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 120.17 -1.581 . . . . 0.0 111.395 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -54.56 -34.37 82.35 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 CA-C-N 120.034 1.048 . . . . 0.0 111.812 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.92 -53.35 59.21 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.337 -0.945 . . . . 0.0 108.948 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.72 -40.66 66.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 0.0 109.387 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -69.96 -41.57 74.31 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 108.878 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.07 -50.97 71.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.557 -0.715 . . . . 0.0 110.535 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 89.4 t -70.23 -28.83 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.982 -1.074 . . . . 0.0 110.011 -179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -60.03 -45.82 91.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.142 -0.973 . . . . 0.0 108.472 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -60.6 -49.31 78.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.397 -0.815 . . . . 0.0 109.745 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . 0.413 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -63.02 -50.91 68.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.302 -0.874 . . . . 0.0 110.85 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt -49.72 -16.65 0.26 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.085 -1.009 . . . . 0.0 109.671 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . 0.413 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -79.3 -23.55 62.89 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.828 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -104.18 139.93 38.53 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.115 -1.227 . . . . 0.0 109.559 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 89.2 m -91.63 -13.32 32.05 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.13 -0.981 . . . . 0.0 110.388 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 331' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 64.6 p -58.85 154.84 14.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.948 -1.095 . . . . 0.0 109.388 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.98 130.87 42.69 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.119 -1.032 . . . . 0.0 108.406 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . 0.425 HD11 HG22 ' B' ' 333' ' ' ILE . 83.9 mt -132.33 133.32 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.603 -0.686 . . . . 0.0 109.583 -179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.6 m -130.09 151.56 50.5 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.515 -0.741 . . . . 0.0 109.578 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 97.2 t -115.86 139.2 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 336' ' ' THR . . . . . 0.45 ' HG1' ' HG ' ' B' ' 341' ' ' SER . 91.3 m -129.77 123.95 32.23 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.165 -0.959 . . . . 0.0 109.101 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 11.3 p -138.79 118.22 12.87 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.97 0.891 . . . . 0.0 110.768 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 61.6 t30 42.86 58.05 3.37 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.06 -13.53 31.5 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 120.31 -1.494 . . . . 0.0 113.069 176.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -115.61 127.24 55.07 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 119.336 1.568 . . . . 0.0 109.443 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 341' ' ' SER . . . . . 0.45 ' HG ' ' HG1' ' B' ' 336' ' ' THR . 74.6 m -123.98 146.56 48.43 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.882 0.849 . . . . 0.0 110.531 -178.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -140.97 163.1 33.87 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.468 0.651 . . . . 0.0 109.624 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 3.4 t -87.05 137.02 32.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.558 -0.714 . . . . 0.0 109.638 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -76.73 -13.78 60.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.881 -1.137 . . . . 0.0 109.8 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . 0.454 ' C ' ' HG ' ' B' ' 346' ' ' SER . 21.3 pttp -91.12 19.8 5.51 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.454 ' HG ' ' C ' ' B' ' 345' ' ' LYS . 4.6 m -144.28 95.23 2.68 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.269 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . 0.551 ' O ' ' NE2' ' B' ' 351' ' ' GLN . 43.0 tp -59.88 -36.75 77.58 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -56.15 -52.21 65.18 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.092 -1.005 . . . . 0.0 110.964 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -73.77 -23.6 59.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.783 -1.198 . . . . 0.0 110.866 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 29.9 mt -60.08 -45.61 92.34 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.322 -1.351 . . . . 0.0 108.734 179.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.588 ' N ' ' NE2' ' B' ' 351' ' ' GLN . 0.1 OUTLIER -50.78 -26.57 5.81 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.123 -0.986 . . . . 0.0 111.892 -178.416 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 44.2 p -72.8 -10.08 59.39 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 119.93 -1.731 . . . . 0.0 109.864 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 39.8 mt -97.46 116.17 29.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.212 -0.93 . . . . 0.0 109.398 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.69 96.34 1.16 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 19.3 mt -103.04 92.17 4.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.355 -1.085 . . . . 0.0 109.105 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 64.9 p -93.5 167.08 11.93 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.959 -1.088 . . . . 0.0 110.946 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -57.02 114.74 2.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.705 -0.622 . . . . 0.0 110.699 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 100.09 7.53 52.33 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 52.2 m -83.8 112.59 20.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -1.107 . . . . 0.0 110.634 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 13.5 t -78.03 114.36 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 122.263 1.03 . . . . 0.0 109.625 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 11.8 m -110.81 177.46 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 62.4 m -131.25 129.3 41.41 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 89.3 mt -104.11 118.4 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 37.3 p -121.64 133.65 54.98 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.11 154.07 40.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.087 -1.008 . . . . 0.0 110.239 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -144.61 122.39 11.91 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 160.28 -159.29 30.67 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 118.972 -1.585 . . . . 0.0 111.596 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -59.98 -51.8 68.13 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.169 -0.606 . . . . 0.0 112.295 -177.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.41 ' H ' ' HB3' ' B' ' 331' ' ' SER . 75.2 m-20 -109.31 10.37 25.62 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.775 -1.203 . . . . 0.0 111.059 -177.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.414 ' C ' ' OE1' ' B' ' 370' ' ' GLU . 0.7 OUTLIER -43.64 -34.9 1.58 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.096 -1.003 . . . . 0.0 111.718 -178.352 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -70.06 -42.69 72.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.378 -1.451 . . . . 0.0 110.866 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -69.23 -50.61 45.68 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.902 -1.124 . . . . 0.0 109.562 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -51.45 -31.29 22.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 111.381 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 70.3 t -71.74 -39.92 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.545 -1.347 . . . . 0.0 108.845 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -64.48 -62.4 1.62 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.24 -0.913 . . . . 0.0 110.908 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -60.68 -43.69 97.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.392 -1.443 . . . . 0.0 111.416 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.03 -40.12 88.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.437 -1.414 . . . . 0.0 108.359 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 52.3 t -66.67 -40.22 85.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.535 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -70.94 -58.5 3.52 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . 0.453 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 55.6 tp -54.41 -34.06 60.58 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.8 -0.563 . . . . 0.0 109.952 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 381' ' ' MET . . . . . 0.4 ' SD ' ' CG1' ' B' ' 306' ' ' VAL . 2.8 ttt -73.83 -40.03 63.62 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 108.819 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -79.19 -4.89 52.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.572 -0.705 . . . . 0.0 109.904 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -109.03 0.47 19.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.294 -0.879 . . . . 0.0 111.313 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . 0.453 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 20.4 mt -69.79 131.1 43.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.179 -1.576 . . . . 0.0 108.508 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.593 -179.334 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.7 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.424 -0.584 . . . . 3.19 109.424 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.43 HD11 HG23 ' A' ' 2' ' ' ILE . 85.2 mt -109.97 129.92 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.523 -0.736 . . . . 1.71 109.12 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.6 m -130.3 143.08 50.56 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.46 -0.775 . . . . 1.66 109.558 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.418 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -112.85 -160.0 14.29 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 108.944 -1.662 . . . . 1.05 108.944 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.469 ' O ' ' O ' ' A' ' 6' ' ' LEU . 92.0 mt -94.21 -15.5 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.997 -1.296 . . . . 1.59 110.086 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.9 tp 50.85 103.0 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.248 -0.908 . . . . 1.47 109.505 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.14 -25.79 14.42 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.988 -1.07 . . . . 1.39 109.273 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 35.0 m -133.73 119.67 15.08 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.427 -0.796 . . . . 2.09 109.573 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.91 147.29 16.79 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.08 1.854 . . . . 0.91 112.683 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 159.46 -159.33 30.41 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.082 -1.607 . . . . 0.92 109.082 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.4 mt -149.21 150.14 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.167 -1.196 . . . . 1.35 108.669 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.55 157.84 37.47 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.968 -1.083 . . . . 1.14 110.756 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -139.5 128.7 23.91 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.021 -1.103 . . . . 0.7 108.021 178.817 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.0 -177.29 47.09 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 118.758 -1.687 . . . . 0.58 110.92 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 157' ' ' ILE . 98.1 mttt -79.8 159.67 26.44 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.589 -0.948 . . . . 2.63 110.099 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.6 137.38 44.72 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.596 -0.69 . . . . 1.27 110.131 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.5 tp -104.05 131.12 51.63 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.882 -1.155 . . . . 1.41 107.882 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.3 tp -113.04 124.33 52.37 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.195 -0.941 . . . . 1.49 110.022 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.3 mt -95.42 103.64 15.51 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.667 -0.646 . . . . 1.52 111.005 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -107.22 136.93 46.22 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.541 -0.724 . . . . 3.17 109.925 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -130.15 138.2 50.52 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.356 -0.84 . . . . 3.0 109.377 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -78.04 158.77 29.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.067 -1.021 . . . . 2.77 109.944 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -72.32 144.21 48.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.424 -0.798 . . . . 2.94 108.905 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.8 mt -84.5 129.61 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.104 -0.998 . . . . 1.46 109.464 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.5 t -94.14 124.73 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.341 -0.849 . . . . 1.7 110.684 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.4 mt -110.37 134.28 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.52 -0.738 . . . . 1.54 109.355 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -93.66 116.45 28.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.978 -1.076 . . . . 1.81 109.141 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -83.72 -1.41 54.06 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.153 -0.967 . . . . 3.23 109.407 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.14 139.99 58.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 3.29 109.655 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -83.13 151.2 25.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.089 -1.007 . . . . 2.8 108.999 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -94.57 166.73 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.864 . . . . 1.43 110.149 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 83.9 p -96.78 173.43 7.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -0.947 . . . . 1.54 108.666 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.79 -49.69 76.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.072 -1.018 . . . . 1.6 109.512 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -53.57 -30.99 44.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.096 -1.003 . . . . 2.56 109.29 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -83.32 -9.92 58.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.58 -0.7 . . . . 2.36 110.669 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.97 -54.0 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.652 -1.28 . . . . 1.43 109.288 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -64.56 -40.14 95.03 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.31 -0.869 . . . . 1.77 110.036 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.475 HE21 HH21 ' A' ' 42' ' ' ARG . 27.3 mt-30 -65.99 -43.63 87.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.976 -1.078 . . . . 3.32 110.351 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -63.9 -40.04 95.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.86 -1.15 . . . . 1.51 110.168 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.0 -48.16 90.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.778 -1.201 . . . . 1.41 108.647 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -62.25 -43.96 97.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.157 -0.965 . . . . 1.81 109.505 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.475 HH21 HE21 ' A' ' 38' ' ' GLN . 21.8 mtt-85 -60.05 -43.15 95.57 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.857 -1.164 . . . . 3.26 107.857 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -60.73 -49.98 75.32 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.454 -0.943 . . . . 0.81 108.454 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.6 tp -60.06 -43.71 95.23 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.69 -0.856 . . . . 1.59 108.69 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.0 t -66.56 -41.96 87.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 1.38 109.292 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.29 -44.3 66.34 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.214 -1.954 . . . . 0.87 108.214 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.2 ttt-85 -62.77 -36.6 83.62 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.14 -1.059 . . . . 3.62 108.14 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.432 ' O ' ' OG ' ' A' ' 51' ' ' SER . . . -58.03 -39.39 78.25 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.581 -0.896 . . . . 1.43 108.581 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.2 ttpt -59.5 -73.66 0.08 Allowed 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.355 -1.35 . . . . 3.08 107.355 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.61 -37.73 0.23 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.439 -0.788 . . . . 1.33 111.153 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.432 ' OG ' ' O ' ' A' ' 48' ' ' ALA . 21.7 p -53.25 -53.61 48.2 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.578 -1.326 . . . . 1.85 108.478 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.402 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . -67.85 -40.86 83.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -0.899 . . . . 1.35 110.884 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -70.01 -39.96 75.52 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.796 -1.19 . . . . 2.34 109.746 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.13 -40.05 96.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.053 -1.029 . . . . 2.2 109.11 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.37 -38.58 84.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.383 -0.823 . . . . 1.35 109.831 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -61.34 -40.47 94.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 1.34 110.048 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.3 mt -61.58 -39.98 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.374 -0.829 . . . . 1.26 109.188 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -56.58 -50.82 70.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 1.7 109.949 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -60.0 -31.76 70.23 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.376 -0.827 . . . . 1.35 110.729 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -67.87 -39.48 83.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.044 -1.035 . . . . 2.08 109.302 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.7 -41.48 95.99 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.663 -0.648 . . . . 1.21 110.026 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.83 -50.25 69.74 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.493 -1.443 . . . . 0.75 109.493 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.17 -51.55 24.2 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.929 -1.336 . . . . 1.59 109.929 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.7 m -60.11 -65.7 0.64 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 1.41 112.202 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -94.22 -50.15 5.4 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.802 -1.186 . . . . 0.79 111.439 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.65 -168.24 25.61 Favored Glycine 0 N--CA 1.502 3.071 0 C-N-CA 119.732 -1.223 . . . . 1.22 111.198 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.0 -26.78 64.24 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.939 -0.742 . . . . 5.81 110.21 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.508 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.0 tp10 -60.1 -34.29 73.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.378 -0.826 . . . . 3.37 110.629 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -100.0 -18.01 17.24 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.079 -1.013 . . . . 2.37 109.799 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -69.26 -39.99 78.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.103 -0.998 . . . . 1.65 109.974 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.25 -31.5 72.67 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.308 -0.87 . . . . 1.42 109.47 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.0 mt -60.12 -42.21 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -0.985 . . . . 1.43 109.656 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -65.02 -39.88 94.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.994 -1.066 . . . . 1.08 110.317 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -59.79 -40.12 87.23 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.954 -1.091 . . . . 1.37 108.771 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.47 -46.34 94.01 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.649 -1.781 . . . . 0.67 108.649 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -65.34 -45.06 85.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -1.133 . . . . 1.99 109.646 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.7 mt -69.08 -45.0 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.078 -1.049 . . . . 1.22 109.09 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.3 ttp -61.1 -39.9 91.71 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.936 -1.102 . . . . 2.11 109.436 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 46.0 tp -63.15 -39.13 93.78 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.495 -0.753 . . . . 1.33 109.506 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 34.6 tp -66.1 -30.27 70.74 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.404 -0.81 . . . . 1.29 109.027 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -87.2 6.86 30.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.137 -0.977 . . . . 1.47 110.009 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 63.1 t0 -55.86 130.0 41.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.963 -1.085 . . . . 1.47 109.887 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.407 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 99.8 mt-10 -60.5 -19.43 56.88 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.528 -0.732 . . . . 1.78 111.058 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.96 -33.53 72.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.759 -1.213 . . . . 2.53 108.337 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 76.9 mt -71.94 -41.99 67.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.64 -0.663 . . . . 1.36 110.08 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -60.15 -50.12 74.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.02 -1.05 . . . . 1.42 111.056 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -70.12 -40.09 75.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.107 -0.996 . . . . 2.27 110.876 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.88 -39.99 75.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.22 -0.925 . . . . 1.57 111.01 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.2 -49.99 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.997 -1.064 . . . . 1.19 109.676 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.02 -39.11 80.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.538 -0.726 . . . . 1.39 110.436 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.11 -44.03 95.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 1.39 110.631 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.2 mt -62.47 -46.96 86.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.796 -1.19 . . . . 1.5 109.719 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.8 -50.06 81.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-O 121.911 0.862 . . . . 1.29 108.939 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -67.66 -42.54 82.02 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.456 -0.777 . . . . 2.64 110.758 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -80.33 -54.11 6.01 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.965 -1.085 . . . . 1.65 111.956 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -90.06 -1.94 58.03 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.111 -0.993 . . . . 2.5 112.35 -177.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.9 m80 58.32 35.06 24.6 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.837 -1.164 . . . . 1.88 109.776 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.6 mtp -86.56 165.17 16.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.409 -0.807 . . . . 1.71 110.17 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.5 p -79.22 161.37 26.42 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.0 -0.741 . . . . 1.61 109.0 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.29 -42.0 84.51 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.174 -0.954 . . . . 1.33 109.613 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -62.15 -40.04 94.61 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.192 -0.943 . . . . 2.07 109.445 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.27 -41.44 22.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 1.37 110.111 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.26 -52.02 60.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.333 -0.855 . . . . 1.14 110.402 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.99 87.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.109 -0.994 . . . . 1.26 109.785 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.526 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 82.7 t60 -60.02 -40.22 88.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 2.02 110.048 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.01 -40.05 92.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.145 -0.972 . . . . 1.33 110.671 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.23 -59.95 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.094 -1.004 . . . . 1.3 111.439 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.3 mm -62.28 -42.96 97.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.974 -1.079 . . . . 1.32 109.075 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.526 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 88.7 tt0 -61.47 -40.04 93.1 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.565 -0.902 . . . . 2.44 108.565 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.16 -51.03 61.36 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.367 -1.093 . . . . 0.99 110.367 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -62.15 -49.96 73.75 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.889 -1.36 . . . . 1.97 109.126 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.07 -40.06 88.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 1.43 109.636 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 56.6 m -60.04 -39.97 87.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.116 -0.99 . . . . 2.12 109.213 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.06 82.21 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.023 -1.048 . . . . 1.64 108.407 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 118' ' ' LEU . 51.8 mt -62.0 -46.47 89.08 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.111 -0.993 . . . . 1.93 108.662 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -47.76 -30.82 4.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.897 -1.127 . . . . 2.2 109.689 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.41 -27.12 68.79 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.013 -1.054 . . . . 2.12 108.354 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.478 ' N ' ' O ' ' A' ' 115' ' ' LEU . 74.4 mt -63.32 140.6 58.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.862 . . . . 2.34 108.952 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -94.23 10.12 35.27 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.075 -1.016 . . . . 3.23 110.42 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -98.3 147.0 25.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.005 -1.06 . . . . 2.49 109.891 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.488 ' O ' ' N ' ' A' ' 124' ' ' LYS . 98.9 mt-10 -72.98 -65.53 0.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.52 -0.738 . . . . 3.95 109.159 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.434 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 4.7 t80 -39.37 -40.05 0.74 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.867 -0.52 . . . . 2.25 110.602 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.606 ' CD2' HH21 ' A' ' 126' ' ' ARG . 81.0 mt -70.83 -40.0 72.67 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.744 -1.223 . . . . 2.27 108.551 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 121' ' ' GLU . 82.1 tttt -68.3 -34.52 76.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.553 -0.717 . . . . 3.31 109.579 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -60.08 -40.02 88.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.262 -0.899 . . . . 2.73 110.19 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.606 HH21 ' CD2' ' A' ' 123' ' ' LEU . 76.2 mtm180 -68.06 -33.44 74.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.934 -1.104 . . . . 3.2 109.258 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.88 78.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.11 -0.994 . . . . 1.66 108.621 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.27 96.86 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.797 -1.186 . . . . 1.67 107.797 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -69.96 -40.0 75.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.611 -0.681 . . . . 1.55 109.478 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.64 -39.99 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.197 -1.038 . . . . 1.32 108.197 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -65.49 -35.65 81.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.31 -0.868 . . . . 3.58 109.099 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -59.91 -40.12 87.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.252 -0.905 . . . . 1.46 109.541 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.06 -43.09 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.371 -0.83 . . . . 1.22 109.827 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.18 -36.69 50.38 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 120.197 -1.001 . . . . 0.61 110.659 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -59.55 -42.55 92.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.069 -1.254 . . . . 3.1 109.649 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -68.7 -34.37 75.53 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.707 -1.245 . . . . 3.71 109.46 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.6 tp -59.95 -43.07 95.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 1.87 109.478 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.09 -40.17 94.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.003 -1.06 . . . . 1.29 109.146 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -70.11 -36.84 75.13 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 3.05 109.488 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -69.87 -25.58 63.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.353 -0.842 . . . . 1.26 111.24 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.91 -43.76 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.472 -1.393 . . . . 1.34 108.931 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.59 -28.45 58.93 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.494 -0.754 . . . . 1.6 110.079 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.34 5.61 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.112 -1.995 . . . . 0.96 108.112 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.7 tp -73.59 146.87 44.36 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.632 -0.922 . . . . 1.67 109.229 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -60.81 144.12 53.24 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.24 -0.913 . . . . 4.96 109.515 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 97.2 mt -114.49 120.61 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.583 -0.895 . . . . 1.68 108.583 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 10.7 mm -52.6 -53.23 21.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.651 -0.656 . . . . 2.14 110.384 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.2 t0 66.37 103.32 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.548 -0.72 . . . . 1.5 109.285 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 17.1 mt -74.82 -3.08 29.66 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.673 -0.642 . . . . 1.39 110.374 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 53.1 m -86.83 -15.68 38.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.171 -0.955 . . . . 1.83 109.573 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.99 15.83 1.03 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.362 -0.836 . . . . 1.46 111.458 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.534 ' N ' ' CD1' ' A' ' 152' ' ' ILE . 1.3 mp -90.4 124.71 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.541 -1.349 . . . . 1.42 109.068 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -103.67 -7.09 20.96 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.386 -0.822 . . . . 2.94 110.101 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -119.36 149.43 41.84 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.477 -0.764 . . . . 1.52 110.496 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.35 135.42 54.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.419 -0.8 . . . . 1.58 109.161 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.0 m -152.07 166.02 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.428 -0.795 . . . . 1.32 109.538 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.448 ' N ' ' O ' ' A' ' 15' ' ' LYS . 86.3 mt -93.47 149.3 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 105.823 -1.918 . . . . 1.27 105.823 176.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.2 tp -97.06 115.26 27.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.942 -1.099 . . . . 1.41 110.799 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 64.2 t -120.11 124.69 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.679 -0.638 . . . . 1.23 109.436 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.45 162.66 35.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.168 -0.958 . . . . 1.32 108.481 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.02 -36.42 75.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.508 -1.37 . . . . 1.49 108.444 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 20.4 p-10 -170.77 146.79 2.67 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.21 -0.663 . . . . 2.25 109.21 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 44.8 mt -112.98 137.54 51.22 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.362 -0.836 . . . . 1.35 109.906 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 70.9 p -92.82 146.42 32.11 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.157 -0.964 . . . . 1.56 108.483 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -40.2 -37.81 1.98 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.02 1.814 . . . . 0.87 112.731 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.9 m -59.99 -40.76 90.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.912 . . . . 1.36 110.146 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.94 -40.63 75.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.05 -1.031 . . . . 1.61 109.824 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 66.5 p -59.14 -20.33 52.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.364 -0.835 . . . . 1.21 111.833 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.5 -47.45 9.9 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.471 -1.393 . . . . 1.21 109.739 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -85.62 36.29 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.581 -0.896 . . . . 2.11 108.581 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.0 tp -107.91 139.9 41.84 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.932 -0.766 . . . . 1.29 108.932 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.401 ' OD1' ' O ' ' A' ' 172' ' ' ASN . 6.2 p30 -89.37 106.39 18.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.045 -1.034 . . . . 2.81 108.912 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 59.6 mt -67.39 -40.16 85.65 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.576 -0.703 . . . . 2.09 111.678 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -68.75 -21.83 64.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.646 -1.284 . . . . 2.86 111.17 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -94.29 -8.37 39.26 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.89 -1.131 . . . . 2.39 109.96 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 84.4 t -101.0 112.42 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.216 -0.927 . . . . 1.27 108.719 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.52 1.49 29.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -0.91 . . . . 2.17 110.7 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.26 173.33 37.5 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.33 -1.508 . . . . 0.52 109.33 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -127.98 125.07 38.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.562 -0.963 . . . . 0.55 108.713 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 93.4 mt -130.85 125.38 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.399 -0.963 . . . . 1.27 108.399 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 31.6 p -151.42 163.43 38.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.885 -1.134 . . . . 1.39 111.172 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.501 ' O ' ' O ' ' A' ' 183' ' ' ALA . 57.4 t0 -100.84 27.35 6.03 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.993 -0.549 . . . . 2.46 109.675 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -46.96 -177.24 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.001 -1.687 . . . . 1.51 111.862 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.29 -54.39 6.92 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.254 -1.138 . . . . 2.23 110.254 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -161.4 -156.12 8.17 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.416 -1.373 . . . . 2.23 110.357 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.755 ' HE ' HH21 ' A' ' 195' ' ' ARG . 66.6 mtp180 -78.4 -9.48 59.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.633 -0.922 . . . . 6.44 109.354 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 39.6 p -77.75 2.78 15.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 4.09 110.067 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.435 ' OG ' ' OG ' ' A' ' 191' ' ' SER . 78.0 p -82.31 139.61 34.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.954 -1.091 . . . . 2.2 109.655 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -49.18 -50.05 39.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.986 -1.071 . . . . 1.15 109.918 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.6 t -53.64 -36.17 61.78 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.214 -0.929 . . . . 2.01 110.394 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.435 ' OG ' ' OG ' ' A' ' 188' ' ' SER . 66.7 m -59.92 -40.07 87.63 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.804 -1.185 . . . . 1.93 110.155 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.3 mt -61.02 -39.99 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 2.2 109.567 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 76.6 mtp -56.92 -41.39 78.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.251 -0.906 . . . . 1.32 109.978 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.08 -40.8 90.82 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.996 -1.065 . . . . 1.3 108.769 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.755 HH21 ' HE ' ' A' ' 186' ' ' ARG . 95.0 mtt180 -62.62 -59.98 4.16 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.346 -0.942 . . . . 3.38 110.281 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.4 m -63.42 -39.99 95.99 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.213 -0.929 . . . . 1.15 112.101 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.1 -22.42 63.03 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.854 -1.154 . . . . 1.28 109.307 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 61.35 47.02 7.19 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.694 -0.629 . . . . 1.5 109.782 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 8' ' ' SER . 97.5 mt -122.19 148.6 52.43 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 107.757 -1.201 . . . . 1.37 107.757 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.45 138.12 68.96 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.975 1.783 . . . . 0.76 111.39 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.01 150.96 3.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.942 -1.099 . . . . 1.19 111.588 -178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.6 mt -124.4 141.16 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 107.211 -1.403 . . . . 1.31 107.211 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.8 m -124.22 -9.22 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.52 0 O-C-N 120.522 -1.361 . . . . 1.38 111.406 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -111.36 23.34 18.45 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 110.607 -0.997 . . . . 1.03 110.607 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.412 ' C ' ' O ' ' A' ' 204' ' ' GLY . 2.9 p -43.07 -46.89 5.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.222 -1.163 . . . . 1.38 110.108 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.438 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 95.69 -54.0 1.7 Allowed Glycine 0 N--CA 1.501 2.973 0 C-N-CA 120.163 -1.018 . . . . 1.17 111.587 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 78.7 p -149.03 29.62 0.8 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.49 -1.594 . . . . 2.07 111.505 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 41.7 t -74.34 -36.35 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.691 -1.256 . . . . 1.35 109.299 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 53.5 p -58.96 -26.01 64.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.92 -1.112 . . . . 1.49 109.796 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.7 m -84.2 -15.27 47.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.105 -0.997 . . . . 2.16 109.892 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -102.46 -6.75 22.58 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.268 -0.895 . . . . 2.89 109.868 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 78.6 t -110.19 133.44 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.514 -0.742 . . . . 1.33 110.819 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -115.16 151.08 35.02 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.149 -1.426 . . . . 2.73 107.149 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.454 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 61.7 t30 -54.89 139.76 39.18 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.02 -1.05 . . . . 2.7 110.79 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.454 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.1 m-20 83.18 2.47 1.02 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-N 116.322 -0.399 . . . . 2.38 110.632 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -74.3 145.12 44.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.895 -1.128 . . . . 2.09 109.489 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -95.51 118.85 32.98 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.997 -1.112 . . . . 1.45 107.997 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 58.1 mt -128.04 151.22 49.42 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.559 -0.713 . . . . 1.31 110.151 -178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 83.0 mt -116.89 130.02 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.224 -1.398 . . . . 1.29 107.224 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 63.5 tp -97.95 115.19 27.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.967 -1.083 . . . . 1.31 109.069 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.556 ' C ' ' H ' ' A' ' 223' ' ' VAL . 20.2 t0 -72.93 -47.15 48.1 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.597 -1.261 . . . . 2.31 107.597 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 52.7 5.52 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.814 -0.554 . . . . 1.19 109.791 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.556 ' H ' ' C ' ' A' ' 221' ' ' ASP . 69.5 t -116.59 -40.21 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 107.473 -1.306 . . . . 1.45 107.473 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -108.43 5.39 25.3 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.976 -1.12 . . . . 3.13 107.976 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.418 HD22 ' H ' ' A' ' 4' ' ' GLY . 1.4 t-20 59.37 49.37 8.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.85 -0.531 . . . . 2.2 110.011 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -138.49 150.9 46.89 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.382 -0.824 . . . . 2.32 109.444 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 49.7 t -119.25 129.77 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.066 -1.087 . . . . 1.4 108.066 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -99.75 119.13 37.66 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.063 -1.088 . . . . 1.29 108.063 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 56.1 t -101.39 116.44 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.505 -0.747 . . . . 1.38 110.595 -178.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 230' ' ' ASN . 16.9 t30 49.98 60.13 15.62 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 2.33 110.836 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -85.69 149.68 9.93 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.571 2.181 . . . . 0.95 112.119 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 68.5 p -67.93 164.11 20.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.288 -0.882 . . . . 2.31 110.568 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -60.1 -38.74 83.84 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.84 -0.8 . . . . 3.45 108.84 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.97 -39.64 86.34 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.55 -0.719 . . . . 2.89 109.473 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.68 -40.09 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.019 -1.05 . . . . 1.73 109.968 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.09 -39.99 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.996 -1.065 . . . . 1.57 109.157 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -59.95 -39.74 86.61 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.879 -1.156 . . . . 2.43 107.879 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -59.9 -41.07 90.86 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.003 -1.11 . . . . 3.18 108.003 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.562 ' O ' ' N ' ' A' ' 242' ' ' VAL . 94.4 mtp -69.86 -78.51 0.07 Allowed 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.694 -1.595 . . . . 1.59 106.694 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.497 ' C ' ' O ' ' A' ' 239' ' ' MET . 28.4 mmt180 -21.77 -47.64 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 120.855 0.36 . . . . 3.11 111.901 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 239' ' ' MET . . . -59.83 -50.93 71.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.866 -1.146 . . . . 2.17 109.151 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.562 ' N ' ' O ' ' A' ' 239' ' ' MET . 69.6 t -61.73 -37.34 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.466 -0.771 . . . . 2.51 109.079 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -59.9 -39.97 87.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.402 -0.811 . . . . 3.82 109.71 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -59.92 -39.52 85.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.993 -1.067 . . . . 1.78 108.762 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.12 -38.69 83.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.396 -0.815 . . . . 2.77 109.444 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 80.0 t -59.96 -41.79 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.369 -0.832 . . . . 2.25 109.72 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.84 -44.76 96.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.082 -1.011 . . . . 2.54 109.263 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.9 t -63.88 -38.56 91.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.817 . . . . 3.03 109.374 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -60.01 -31.64 70.12 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.564 -0.71 . . . . 3.34 109.979 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.01 -40.14 88.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.135 -0.978 . . . . 4.18 109.672 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -90.04 4.58 49.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.69 -1.256 . . . . 4.43 110.309 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -94.85 15.55 18.27 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.012 -1.055 . . . . 5.42 108.769 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 89.1 mt -73.54 -10.38 59.65 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.851 -1.156 . . . . 6.11 108.779 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -67.39 -39.95 85.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.472 -0.768 . . . . 7.37 109.03 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.458 ' C ' ' H ' ' A' ' 257' ' ' LYS . 62.3 mttp -78.15 -156.22 0.09 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.372 -0.83 . . . . 8.3 109.765 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 71.8 mt -67.09 6.65 0.5 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.418 -0.801 . . . . 9.05 110.521 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.458 ' H ' ' C ' ' A' ' 255' ' ' LYS . 45.4 mtpt 66.56 26.61 9.83 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.815 -0.553 . . . . 10.56 109.515 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 257' ' ' LYS . 7.6 p-10 40.13 69.94 0.28 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.636 -0.665 . . . . 11.32 110.424 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.989 -1.005 . . . . 12.74 109.11 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 3.3 ttt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.532 0.682 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -151.56 148.48 28.05 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.11 161.06 43.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.796 -1.19 . . . . 0.0 111.037 -178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -154.01 151.13 29.01 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -106.96 132.71 52.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 109.248 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.3 122.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 CA-C-O 122.387 1.089 . . . . 0.0 112.74 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 29.4 m -79.27 106.84 11.59 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.671 -178.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' B' ' 358' ' ' GLY . 81.7 mt -51.97 117.14 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 122.135 0.969 . . . . 0.0 110.007 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 77.4 p -106.91 18.68 21.5 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.462 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -75.39 116.69 57.06 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.067 -1.02 . . . . 0.0 108.949 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -51.96 -13.11 1.59 Allowed 'Trans proline' 0 N--CA 1.499 1.823 0 CA-C-N 120.261 1.129 . . . . 0.0 113.442 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -118.13 6.77 12.05 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.307 -0.871 . . . . 0.0 109.449 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.85 174.92 27.27 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.434 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.0 tp -85.05 96.07 9.3 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.03 -1.276 . . . . 0.0 108.59 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -97.79 -160.18 0.79 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.082 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 9.2 m -59.0 -41.84 88.64 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.032 -1.042 . . . . 0.0 112.439 -176.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.508 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 1.4 tpt180 -60.4 -62.18 6.45 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 120.429 -1.42 . . . . 0.0 111.794 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -57.9 -32.02 94.06 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.199 1.107 . . . . 0.0 111.461 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.83 72.22 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.64 -41.6 63.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.441 -0.787 . . . . 0.0 109.25 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -69.98 -41.3 74.6 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.167 -1.013 . . . . 0.0 108.7 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -60.97 -51.96 67.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.471 -0.768 . . . . 0.0 110.435 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 70.0 t -68.36 -30.82 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.653 -1.279 . . . . 0.0 109.841 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -59.99 -44.32 94.6 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.231 -0.988 . . . . 0.0 108.608 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -69.41 -40.72 77.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 110.646 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.1 -52.08 66.89 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.516 -1.365 . . . . 0.0 109.343 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -57.33 -15.23 5.81 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.598 -0.689 . . . . 0.0 109.193 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.96 -29.78 70.55 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -104.83 147.23 27.95 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.455 -1.027 . . . . 0.0 109.109 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 22.6 p -91.36 -12.93 33.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.841 -1.162 . . . . 0.0 109.585 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 331' ' ' SER . . . . . 0.522 ' HG ' ' N ' ' B' ' 368' ' ' GLU . 5.8 m -59.46 152.52 21.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.297 -0.877 . . . . 0.0 109.663 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -70.78 134.1 47.11 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.165 -0.96 . . . . 0.0 108.681 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 86.2 mt -132.91 131.24 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.537 -0.727 . . . . 0.0 110.292 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 39.4 m -130.63 153.48 48.88 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 72.4 t -118.61 139.69 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 96.9 m -126.97 123.64 37.59 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.271 -0.893 . . . . 0.0 108.904 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 40.1 p -135.91 116.71 14.07 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.12 -0.988 . . . . 0.0 109.832 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' B' ' 338' ' ' ASN . 9.2 p30 39.95 69.05 0.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 72.31 -11.92 3.66 Favored Glycine 0 N--CA 1.5 2.966 0 O-C-N 120.762 -1.211 . . . . 0.0 113.411 176.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -115.4 129.13 56.48 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-N 119.473 1.637 . . . . 0.0 109.39 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 83.0 p -129.35 151.1 50.36 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.777 0.798 . . . . 0.0 110.699 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -146.14 166.53 25.89 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.595 0.712 . . . . 0.0 110.299 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 34.3 t -89.38 140.09 29.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.554 -0.717 . . . . 0.0 110.061 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.463 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -77.57 -14.66 59.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.015 -1.053 . . . . 0.0 109.613 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -86.98 18.52 3.5 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.463 ' H ' ' C ' ' B' ' 344' ' ' ALA . 88.2 p -146.12 96.54 2.81 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.403 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 11.9 tp -60.01 -34.56 73.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 -59.74 -54.94 40.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.536 -0.727 . . . . 0.0 110.6 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.421 ' O ' ' OG1' ' B' ' 352' ' ' THR . 52.9 mtpt -63.64 -40.07 95.94 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.705 -1.247 . . . . 0.0 109.007 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.594 ' O ' ' N ' ' B' ' 352' ' ' THR . 60.0 mt -52.18 -56.49 14.24 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.526 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -39.44 -14.55 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.872 -0.517 . . . . 0.0 111.758 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.594 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.1 p -93.24 -9.99 37.2 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.516 -1.365 . . . . 0.0 110.792 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 47.0 mt -94.36 119.94 33.85 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.854 -1.154 . . . . 0.0 109.914 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -71.02 94.23 0.52 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 85.0 mt -99.98 83.6 2.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.35 -1.088 . . . . 0.0 109.271 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 82.3 p -93.5 169.89 10.01 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.054 -1.029 . . . . 0.0 110.998 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.55 112.55 2.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.868 -0.52 . . . . 0.0 110.339 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 105.48 6.04 38.96 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.0 m -84.81 108.16 17.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -1.204 . . . . 0.0 111.062 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 17.0 t -77.7 115.03 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 122.236 1.017 . . . . 0.0 109.491 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.23 178.45 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 81.6 m -128.87 131.28 47.63 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.9 mt -102.85 120.28 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 41.6 m -120.69 130.06 53.93 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.534 -0.729 . . . . 0.0 109.474 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.16 151.21 40.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.396 -0.815 . . . . 0.0 109.498 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -147.16 122.34 10.18 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.461 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 160.23 -153.56 24.51 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 118.767 -1.683 . . . . 0.0 111.827 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . 0.522 ' N ' ' HG ' ' B' ' 331' ' ' SER . 85.5 tt0 -60.04 -50.42 73.78 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 122.203 -0.587 . . . . 0.0 112.22 -177.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.439 ' N ' ' OG ' ' B' ' 331' ' ' SER . 85.8 m-20 -112.59 12.3 19.82 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 120.924 -1.11 . . . . 0.0 111.628 -177.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.0 OUTLIER -39.65 -33.65 0.19 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.179 -0.951 . . . . 0.0 111.653 -178.494 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . 0.475 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 12.2 pt20 -65.7 -54.03 32.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.763 -1.211 . . . . 0.0 110.404 -178.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -64.43 -49.38 71.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.622 -1.299 . . . . 0.0 108.619 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -41.48 -42.27 2.3 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.724 -0.61 . . . . 0.0 111.186 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 76.3 t -74.71 -36.89 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.546 -1.346 . . . . 0.0 109.574 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -63.19 -64.93 0.77 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.01 -1.056 . . . . 0.0 110.498 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . 0.449 ' O ' ' N ' ' B' ' 380' ' ' LEU . 34.4 m170 -59.97 -45.31 93.11 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.776 -1.202 . . . . 0.0 112.07 -177.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.4 mt -60.0 -40.22 88.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.394 -1.441 . . . . 0.0 108.568 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 46.0 t -64.81 -49.54 79.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 110.164 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -80.17 -9.68 59.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.817 -1.177 . . . . 0.0 110.407 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . 0.449 ' N ' ' O ' ' B' ' 376' ' ' HIS . 56.7 tp -83.34 -27.92 29.38 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 41.6 ttm -80.46 -30.07 37.5 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.065 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -84.82 -7.66 59.1 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.54 -0.725 . . . . 0.0 109.837 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -110.21 -2.96 16.56 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.253 -0.904 . . . . 0.0 110.029 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 22.0 mt -90.98 125.63 35.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.011 -1.056 . . . . 0.0 109.091 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 117.917 -1.039 . . . . 0.0 109.597 -179.862 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.424 0.63 . . . . 3.19 109.777 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.5 mt -110.1 130.12 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.229 -0.656 . . . . 1.71 109.229 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.431 ' CB ' ' OD1' ' A' ' 225' ' ' ASN . 61.9 m -137.13 153.54 50.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.379 -0.825 . . . . 1.66 109.681 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.85 -158.17 8.1 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 108.47 -1.852 . . . . 1.05 108.47 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.418 ' O ' ' O ' ' A' ' 6' ' ' LEU . 82.3 mt -90.43 -18.56 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.751 -1.44 . . . . 1.59 109.568 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.1 tp 44.01 93.65 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.167 -0.958 . . . . 1.47 110.366 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.41 -22.66 18.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.954 -1.091 . . . . 1.39 109.267 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 70.7 m -121.06 112.4 33.37 Favored Pre-proline 0 N--CA 1.504 2.244 0 O-C-N 121.463 -0.773 . . . . 2.09 109.53 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -80.94 151.35 18.57 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.027 1.818 . . . . 0.91 112.408 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 145.92 175.84 19.3 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.959 -1.656 . . . . 0.92 108.959 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.0 mt -120.72 155.7 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 O-C-N 121.427 -1.043 . . . . 1.35 109.609 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.19 155.26 34.96 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.057 -1.027 . . . . 1.14 110.326 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 5.3 m-85 -135.28 126.37 27.92 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.012 -1.107 . . . . 0.7 108.012 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.29 -179.21 48.18 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 118.642 -1.742 . . . . 0.58 110.907 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -79.97 158.09 26.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.985 -0.715 . . . . 2.63 109.822 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.44 125.51 51.1 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.531 -0.731 . . . . 1.27 110.469 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.5 tp -97.53 136.76 37.49 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.03 -1.1 . . . . 1.41 108.03 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.9 tp -120.39 128.02 52.83 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.486 -0.759 . . . . 1.49 109.385 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.86 107.51 19.15 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.485 -0.76 . . . . 1.52 110.278 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -100.12 129.87 46.2 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.145 -1.057 . . . . 3.17 108.145 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -130.95 139.76 50.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.185 -0.947 . . . . 3.0 109.712 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 52.9 t0 -81.85 143.89 31.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 2.77 109.088 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.482 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 86.9 tt0 -64.88 140.41 58.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -0.972 . . . . 2.94 109.493 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.7 mt -81.68 135.3 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.331 -0.855 . . . . 1.46 108.818 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.2 t -110.75 128.89 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.368 -0.832 . . . . 1.7 110.093 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.0 mt -98.06 143.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.483 -0.932 . . . . 1.54 108.483 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -94.85 121.43 36.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.865 -1.147 . . . . 1.81 109.738 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.419 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.8 mmm-85 -88.02 -0.31 56.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.583 -0.698 . . . . 3.23 109.553 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.52 139.65 58.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.071 -1.018 . . . . 3.29 108.761 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -85.26 149.99 25.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 2.8 109.376 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.4 pt -91.48 165.15 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 1.43 109.494 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.2 p -97.2 172.56 7.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.15 -0.968 . . . . 1.54 108.464 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.56 77.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.952 -1.093 . . . . 1.6 109.355 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.05 -29.64 57.91 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.71 -1.243 . . . . 2.56 109.311 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -81.87 -9.62 59.54 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.256 -0.902 . . . . 2.36 109.971 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.9 t -65.37 -54.54 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.695 -1.253 . . . . 1.43 109.157 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.05 -39.98 87.83 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.294 -0.879 . . . . 1.77 109.56 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -67.82 -44.91 76.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.177 -0.952 . . . . 3.32 110.347 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -61.28 -41.02 96.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.915 -1.116 . . . . 1.51 110.44 -179.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.37 -47.16 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.66 -1.275 . . . . 1.41 107.957 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -62.11 -47.57 84.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.552 -0.717 . . . . 1.81 109.697 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -60.1 -41.42 92.47 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.621 -1.252 . . . . 3.26 107.621 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -64.53 -46.34 83.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.69 -0.631 . . . . 0.81 109.341 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 48' ' ' ALA . 63.6 tp -59.86 -44.84 93.92 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.508 -0.923 . . . . 1.59 108.508 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.5 t -65.03 -44.02 90.47 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.441 -0.904 . . . . 1.38 109.007 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.39 -43.13 95.47 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.282 -1.927 . . . . 0.87 108.282 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.493 ' NH2' ' O ' ' A' ' 80' ' ' LEU . 68.1 ttt180 -66.4 -37.0 84.24 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.01 -1.107 . . . . 3.62 108.01 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -60.0 -39.76 86.88 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.921 -0.77 . . . . 1.43 108.921 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 50' ' ' ALA . 18.0 ttpp -60.06 -73.64 0.09 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.108 -0.995 . . . . 3.08 108.486 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.67 -33.95 0.09 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.163 -0.961 . . . . 1.33 111.944 -177.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.0 m -60.0 -49.79 76.3 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.361 -1.462 . . . . 1.85 108.586 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.82 -40.06 79.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.853 . . . . 1.35 110.725 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -65.86 -40.09 91.34 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.897 -1.127 . . . . 2.34 110.021 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.0 mt -60.73 -39.95 90.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.093 -1.004 . . . . 2.2 108.687 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -59.98 -39.71 86.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.618 -0.676 . . . . 1.35 110.168 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.9 m -63.93 -43.38 96.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.72 -1.237 . . . . 1.34 108.609 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.514 ' CD1' HH22 ' A' ' 136' ' ' ARG . 82.3 mt -61.18 -39.94 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.464 -0.772 . . . . 1.26 109.027 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -56.63 -49.99 73.36 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.475 -0.935 . . . . 1.7 108.475 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -59.91 -35.21 74.38 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.675 -0.641 . . . . 1.35 110.464 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -68.16 -39.92 82.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.858 -1.151 . . . . 2.08 109.627 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.98 82.68 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.574 -0.704 . . . . 1.21 110.097 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.01 -51.11 60.91 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 119.905 -1.14 . . . . 0.75 110.394 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.09 -44.72 68.49 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.09 -1.241 . . . . 1.59 109.966 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.9 m -67.17 -62.46 1.42 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.936 . . . . 1.41 112.178 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -94.65 -49.13 5.77 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.905 -1.122 . . . . 0.79 111.058 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.79 -169.6 25.17 Favored Glycine 0 N--CA 1.502 3.043 0 C-N-CA 119.702 -1.237 . . . . 1.22 111.445 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -66.71 -26.32 66.96 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.939 -0.742 . . . . 5.81 110.109 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.12 -36.19 76.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.292 -0.88 . . . . 3.37 110.36 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt -97.23 -17.51 19.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.234 -0.916 . . . . 2.37 109.961 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -71.34 -42.79 68.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.054 -1.029 . . . . 1.65 110.264 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.5 -28.41 69.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.542 -0.724 . . . . 1.42 109.756 -179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.06 -40.76 84.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.095 -1.003 . . . . 1.43 108.9 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -69.99 -37.14 75.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 1.08 111.248 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -60.01 -40.37 89.03 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.626 -1.296 . . . . 1.37 109.63 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.63 -43.2 96.78 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.932 -1.667 . . . . 0.67 108.932 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -60.74 -45.19 95.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.306 -1.114 . . . . 1.99 109.14 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.2 mt -68.75 -47.19 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 1.22 109.786 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.7 ttp -60.0 -43.35 95.27 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.964 -1.085 . . . . 2.11 110.031 -178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 34.1 tp -60.25 -39.94 88.56 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.445 -0.785 . . . . 1.33 109.565 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.493 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 58.8 tp -61.67 -39.89 93.0 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.726 -0.608 . . . . 1.29 110.074 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.16 9.93 7.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.166 -0.959 . . . . 1.47 110.913 -178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -53.88 130.85 38.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.66 -1.275 . . . . 1.47 109.704 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -57.73 -21.02 38.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.498 -0.751 . . . . 1.78 110.395 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -70.49 -34.43 72.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.004 -1.06 . . . . 2.53 108.991 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 44.9 mt -69.99 -40.51 75.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.634 -0.666 . . . . 1.36 109.827 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.15 -47.14 87.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.151 -0.968 . . . . 1.42 110.45 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -69.91 -42.8 72.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.121 -0.987 . . . . 2.27 111.323 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -70.1 -39.98 75.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.992 -1.068 . . . . 1.57 111.171 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 91.4 mt -66.6 -49.57 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.976 -1.077 . . . . 1.19 109.668 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.503 ' CG2' ' HZ2' ' A' ' 94' ' ' LYS . 84.8 mt -69.66 -39.96 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.587 -0.696 . . . . 1.39 110.521 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.0 -47.86 84.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.081 -1.012 . . . . 1.39 110.888 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.06 -46.84 88.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.987 -1.071 . . . . 1.5 109.897 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.48 -49.54 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 1.29 109.711 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.503 ' HZ2' ' CG2' ' A' ' 90' ' ' ILE . 54.2 mttp -69.91 -45.84 66.69 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.419 -0.801 . . . . 2.64 111.173 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -80.16 -49.55 11.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.998 -1.063 . . . . 1.65 112.148 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -91.13 -3.62 56.92 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.938 -1.101 . . . . 2.5 111.944 -177.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 54.73 36.23 25.8 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.752 -1.217 . . . . 1.88 109.209 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 51.3 mtt -87.24 169.77 12.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.541 -0.725 . . . . 1.71 109.399 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 65.6 p -80.53 156.76 26.35 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.187 -0.946 . . . . 1.61 108.915 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.97 75.64 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.229 -0.919 . . . . 1.33 109.344 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -63.16 -40.08 96.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.897 . . . . 2.07 109.82 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.44 -49.32 10.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 1.37 109.87 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.49 -41.34 96.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.477 -0.764 . . . . 1.14 110.555 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.09 -54.02 36.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.927 -1.108 . . . . 1.26 110.349 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -63.15 -27.75 69.59 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.037 -1.039 . . . . 2.02 109.344 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.12 -40.12 88.59 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.286 -0.883 . . . . 1.33 109.39 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.26 -46.64 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.969 -1.082 . . . . 1.3 109.407 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.9 mm -61.15 -41.89 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.31 -0.869 . . . . 1.32 109.187 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -68.99 -34.3 75.08 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.153 -1.055 . . . . 2.44 108.153 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.48 -45.17 95.97 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.301 -1.12 . . . . 0.99 110.301 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -69.98 -46.85 64.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.755 -1.438 . . . . 1.97 109.807 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.01 86.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 1.43 109.909 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 58.0 m -60.01 -40.09 88.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.052 -1.03 . . . . 2.12 109.441 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.72 91.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 1.64 109.3 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.1 mt -63.75 -40.08 95.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.072 -1.018 . . . . 1.93 109.581 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -58.35 -31.21 67.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.81 -1.181 . . . . 2.2 109.542 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -58.66 -25.59 62.92 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.339 -0.986 . . . . 2.12 108.339 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 44.0 mt -62.71 144.71 56.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.878 . . . . 2.34 108.805 179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -96.54 45.4 1.06 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.089 -1.007 . . . . 3.23 109.92 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 51.4 t0 -136.05 146.14 46.78 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.253 -0.904 . . . . 2.49 109.604 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.538 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -73.9 -63.6 1.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.569 -0.9 . . . . 3.95 108.569 178.319 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.496 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.0 t80 -39.23 -41.73 0.9 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.905 -0.497 . . . . 2.25 111.187 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 91.4 mt -70.02 -40.01 75.45 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.64 -1.287 . . . . 2.27 108.651 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 121' ' ' GLU . 33.4 ttmt -62.38 -39.87 94.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.451 -0.781 . . . . 3.31 109.836 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.07 -40.91 91.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.236 -0.915 . . . . 2.73 110.225 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -62.09 -39.97 94.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.971 -1.081 . . . . 3.2 108.816 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.22 -28.47 70.06 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.507 -0.923 . . . . 1.66 108.507 179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.04 93.46 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.323 -0.992 . . . . 1.67 108.323 179.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.59 -40.01 95.86 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.586 -0.894 . . . . 1.55 108.586 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.8 t -66.26 -40.06 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.884 -0.784 . . . . 1.32 108.884 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.3 ttt-85 -60.56 -37.35 80.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.334 -0.854 . . . . 3.58 108.963 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -60.01 -42.74 94.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.419 -0.801 . . . . 1.46 109.992 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.0 -47.63 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.822 -1.174 . . . . 1.22 109.322 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.94 -41.06 97.67 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.302 -1.519 . . . . 0.61 109.302 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -60.15 -49.86 75.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.352 -1.087 . . . . 3.1 109.671 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.514 HH22 ' CD1' ' A' ' 57' ' ' ILE . 63.3 mtp180 -64.59 -36.04 82.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 3.71 110.333 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.94 -44.39 94.39 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.419 -0.8 . . . . 1.87 109.371 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.25 -42.59 95.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -0.954 . . . . 1.29 110.095 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -72.63 -35.85 67.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.052 -1.03 . . . . 3.05 109.288 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -60.06 -39.84 87.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.609 -0.682 . . . . 1.26 110.845 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.0 mt -74.98 -42.59 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.844 -1.16 . . . . 1.34 109.736 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.99 -29.95 67.17 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.574 -0.704 . . . . 1.6 109.934 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.46 40.6 10.89 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.74 -1.744 . . . . 0.96 108.74 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.3 tp -73.02 148.45 44.14 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.474 -1.015 . . . . 1.67 109.004 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -68.47 148.45 50.59 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.189 -0.944 . . . . 4.96 110.426 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.42 HG23 HD11 ' A' ' 146' ' ' ILE . 95.8 mt -119.98 122.67 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.989 0.899 . . . . 1.68 109.709 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.9 mt -61.0 -42.5 93.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 109.28 -0.637 . . . . 2.14 109.28 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.9 t0 62.47 123.92 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.779 -0.576 . . . . 1.5 110.125 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.4 mt -78.13 -5.78 52.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 1.39 108.68 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.8 t -81.84 -10.07 59.42 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.683 -0.858 . . . . 1.83 108.683 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.74 19.71 1.28 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.754 -0.591 . . . . 1.46 110.109 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 56.3 mt -91.58 120.69 41.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 121.253 -0.905 . . . . 1.42 109.161 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -108.01 -8.53 15.85 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.356 -0.84 . . . . 2.94 109.874 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -129.57 152.07 49.49 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.413 -0.805 . . . . 1.52 109.884 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.15 133.51 53.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -0.91 . . . . 1.58 108.872 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.5 m -152.83 166.35 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.402 -0.812 . . . . 1.32 109.757 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.3 mt -93.06 147.94 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 106.015 -1.846 . . . . 1.27 106.015 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.9 tp -102.13 117.61 35.14 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.052 -1.03 . . . . 1.41 109.9 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.7 t -125.02 134.31 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.36 -0.978 . . . . 1.23 108.36 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.81 168.63 22.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.113 -0.992 . . . . 1.32 109.14 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.91 -38.26 69.93 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.318 -1.489 . . . . 1.49 107.941 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -171.17 145.58 2.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.599 -0.688 . . . . 2.25 109.486 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.2 mt -115.91 137.46 52.08 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.415 -0.803 . . . . 1.35 109.615 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.2 p -91.22 149.97 40.71 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.233 -0.917 . . . . 1.56 109.512 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -42.36 -36.99 4.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.488 2.126 . . . . 0.87 113.564 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 72.3 m -59.99 -40.05 87.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.881 -1.137 . . . . 1.36 109.314 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.75 -43.09 89.99 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.148 -0.97 . . . . 1.61 109.432 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 79.1 p -59.1 -19.57 45.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.39 -0.819 . . . . 1.21 111.555 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -83.86 -46.72 11.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.769 -1.207 . . . . 1.21 110.26 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -90.73 39.32 0.98 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.312 -0.996 . . . . 2.11 108.312 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 56.6 tp -105.6 137.1 44.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.567 -0.708 . . . . 1.29 110.231 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -89.91 101.57 14.27 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.285 -0.884 . . . . 2.81 108.872 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.32 -39.99 94.84 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.385 -0.822 . . . . 2.09 111.109 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -66.54 -24.22 66.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.115 -0.991 . . . . 2.86 111.543 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -93.74 -10.96 32.52 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.706 -1.246 . . . . 2.39 110.358 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 80.4 t -102.76 112.77 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.099 -1.001 . . . . 1.27 109.355 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.7 mt -83.62 3.8 31.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.252 -0.905 . . . . 2.17 110.354 -178.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.38 169.91 36.33 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.554 -1.418 . . . . 0.52 109.554 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -134.47 130.23 36.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.395 -1.062 . . . . 0.55 108.517 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 67.2 mt -130.45 125.48 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.567 -0.901 . . . . 1.27 108.567 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 7.7 p -143.07 154.33 43.84 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.21 -0.931 . . . . 1.39 111.046 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -106.28 27.88 8.27 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.797 -0.816 . . . . 2.46 108.797 179.279 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.04 -157.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.825 -1.172 . . . . 1.51 111.908 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -53.4 -80.98 0.06 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.863 -1.295 . . . . 2.23 109.863 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.45 ' O ' ' OG ' ' A' ' 191' ' ' SER . . . -178.3 -131.97 1.64 Allowed Glycine 0 N--CA 1.488 2.1 0 C-N-CA 119.424 -1.369 . . . . 2.23 110.286 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -73.28 -10.53 59.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.628 -0.925 . . . . 6.44 111.122 -178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 51.7 p -92.83 7.84 42.08 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.804 -1.185 . . . . 4.09 110.984 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.414 ' OG ' ' OG ' ' A' ' 191' ' ' SER . 78.7 p -89.08 143.43 26.85 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.733 -1.23 . . . . 2.2 110.124 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -47.37 -47.48 26.08 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.383 -0.823 . . . . 1.15 109.338 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.0 m -56.53 -39.64 73.72 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.742 -0.599 . . . . 2.01 109.857 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 185' ' ' GLY . 53.7 m -59.89 -40.04 87.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.98 -1.075 . . . . 1.93 110.923 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.426 HD12 HG22 ' A' ' 192' ' ' ILE . 89.1 mt -60.06 -41.26 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.0 . . . . 2.2 110.161 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.8 mtp -60.07 -50.37 73.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.093 -1.005 . . . . 1.32 111.116 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -50.94 -45.41 60.6 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.908 -1.12 . . . . 1.3 109.646 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -60.03 -51.65 68.75 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.07 -1.052 . . . . 3.38 109.733 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.8 m -71.99 -35.06 69.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.075 -1.016 . . . . 1.15 110.86 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.46 -30.02 65.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.645 -1.284 . . . . 1.28 108.318 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 66.4 49.8 1.37 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.357 0.598 . . . . 1.5 110.138 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.445 ' O ' ' CB ' ' A' ' 8' ' ' SER . 86.1 mt -127.77 141.39 40.94 Favored Pre-proline 0 N--CA 1.503 2.215 0 N-CA-C 108.677 -0.86 . . . . 1.37 108.677 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -44.37 128.42 8.01 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.94 1.76 . . . . 0.76 112.039 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.8 141.51 6.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.875 -1.141 . . . . 1.19 111.471 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.2 mt -123.76 142.3 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.069 -1.456 . . . . 1.31 107.069 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 18.2 m -126.01 -12.03 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 120.952 -1.092 . . . . 1.38 111.382 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -106.11 23.06 29.95 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.014 -1.234 . . . . 1.03 110.014 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.441 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 2.8 p -44.91 -43.58 9.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -1.129 . . . . 1.38 110.083 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.76 -55.38 4.11 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 119.964 -1.112 . . . . 1.17 111.881 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 35.1 m -153.04 36.08 0.48 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.56 -1.553 . . . . 2.07 111.479 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.5 t -72.39 -40.15 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.914 -1.116 . . . . 1.35 108.53 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 38.3 p -52.98 -25.49 12.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.57 -0.706 . . . . 1.49 110.233 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.7 m -77.45 -30.91 53.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.037 -1.039 . . . . 2.16 110.551 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -93.33 -9.29 39.4 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.969 -1.082 . . . . 2.89 111.127 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.8 t -105.88 134.77 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.13 -0.981 . . . . 1.33 111.077 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -111.2 154.89 23.75 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.146 -1.427 . . . . 2.73 107.146 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 57.8 t-20 -59.87 138.9 57.69 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.781 -1.199 . . . . 2.7 109.728 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 7.7 t0 80.76 6.47 1.43 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.015 0.436 . . . . 2.38 110.172 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -71.97 128.96 37.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.029 -1.045 . . . . 2.09 109.059 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -79.45 114.78 18.65 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.914 -1.143 . . . . 1.45 107.914 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 75.1 mt -127.04 150.56 49.39 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.526 -0.734 . . . . 1.31 110.508 -178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.3 mt -116.35 128.94 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 106.043 -1.836 . . . . 1.29 106.043 177.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 31.5 tp -99.98 118.85 37.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.794 -1.191 . . . . 1.31 108.194 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 223' ' ' VAL . 20.7 t0 -80.66 -39.94 26.41 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.889 -1.132 . . . . 2.31 108.275 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 43.13 19.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.533 0.682 . . . . 1.19 109.377 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.4 t -134.32 -42.99 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.356 -1.35 . . . . 1.45 107.356 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -100.03 2.99 43.89 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.293 -1.373 . . . . 3.13 107.293 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.431 ' OD1' ' CB ' ' A' ' 3' ' ' SER . 9.8 t-20 59.96 48.5 8.69 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.506 -0.553 . . . . 2.2 109.506 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -142.0 150.37 41.24 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.158 -0.964 . . . . 2.32 110.29 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.4 t -119.96 128.75 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.84 -1.17 . . . . 1.4 107.84 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -104.96 120.05 40.5 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.285 -0.884 . . . . 1.29 108.913 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 46.4 t -100.28 114.7 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.503 -0.748 . . . . 1.38 110.194 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 50.96 69.11 2.78 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.272 -0.892 . . . . 2.33 110.819 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -90.43 144.16 3.87 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.298 2.665 . . . . 0.95 112.135 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 5.2 m -68.59 164.16 22.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 2.31 110.14 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -59.96 -36.74 77.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.532 -0.73 . . . . 3.45 110.051 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.03 -39.56 86.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 2.89 109.466 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.8 t -70.67 -36.09 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.014 -1.054 . . . . 1.73 109.451 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.464 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 96.8 mt -70.09 -40.03 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.117 -0.989 . . . . 1.57 109.774 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -60.05 -40.42 89.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.03 -1.044 . . . . 2.43 108.209 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -62.55 -39.16 92.76 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.311 0.577 . . . . 3.18 109.774 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 98.1 mtp -82.49 -19.31 39.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.137 -0.977 . . . . 1.59 110.48 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.471 HH11 ' HG2' ' A' ' 240' ' ' ARG . 0.6 OUTLIER -70.8 -39.97 72.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.784 -1.197 . . . . 3.11 109.125 179.127 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.15 -40.16 82.44 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.255 -1.017 . . . . 2.17 108.255 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.14 -38.72 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.397 -0.964 . . . . 2.51 108.397 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -60.0 -40.59 89.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.35 -0.844 . . . . 3.82 109.206 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -40.03 87.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.065 -1.022 . . . . 1.78 108.381 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -64.86 -39.87 94.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.506 -0.746 . . . . 2.77 109.216 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 54.8 t -59.97 -40.47 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.501 -0.749 . . . . 2.25 109.897 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.98 90.95 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.209 -0.932 . . . . 2.54 109.188 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 66.9 m -60.03 -40.1 88.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.38 -0.825 . . . . 3.03 109.715 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.06 -40.0 87.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 3.34 109.607 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.454 ' O ' ' CD2' ' A' ' 253' ' ' LEU . 68.3 mttm -72.42 0.71 9.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 4.18 109.5 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -108.36 18.32 21.15 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.675 -0.641 . . . . 4.43 109.336 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -127.28 28.08 5.78 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.565 -0.709 . . . . 5.42 109.741 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.454 ' CD2' ' O ' ' A' ' 250' ' ' LYS . 0.0 OUTLIER -63.46 -47.57 81.28 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.995 -1.066 . . . . 6.11 109.306 -179.769 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 42.59 25.26 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.446 -0.784 . . . . 7.37 110.324 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 253' ' ' LEU . 35.6 ttpt -172.61 -21.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.096 -1.002 . . . . 8.3 110.07 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 4.0 tt -81.25 88.46 6.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.152 -0.968 . . . . 9.05 109.808 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -109.32 5.17 23.37 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.195 -1.409 . . . . 10.56 107.195 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -62.41 -64.32 0.96 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.853 -0.795 . . . . 11.32 108.853 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 118.036 -0.983 . . . . 12.74 109.349 -179.808 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.564 0.697 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 19.0 t80 -152.64 151.4 30.55 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . 0.466 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 12.9 pt20 -145.58 155.04 42.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.995 -1.065 . . . . 0.0 110.708 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' B' ' 305' ' ' GLU . 12.5 tm0? -149.58 145.34 26.75 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . 0.506 ' O ' ' NE2' ' B' ' 304' ' ' GLN . 39.2 mp0 -109.09 131.8 54.72 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.067 -1.02 . . . . 0.0 110.46 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.07 119.12 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-O 122.077 0.941 . . . . 0.0 112.452 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 35.6 m -77.3 104.65 7.93 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.99 0.9 . . . . 0.0 111.024 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.8 mt -53.03 123.87 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.318 1.056 . . . . 0.0 110.729 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 71.9 p -111.37 20.11 17.59 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.257 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.14 120.39 80.01 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.831 -1.168 . . . . 0.0 109.682 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -49.57 -21.5 5.34 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 CA-C-N 120.137 1.084 . . . . 0.0 113.069 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -120.74 13.7 11.6 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.46 -0.775 . . . . 0.0 109.775 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.34 -178.6 37.83 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.496 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -84.42 91.06 7.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.111 -1.229 . . . . 0.0 110.191 -178.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -95.35 -160.35 0.78 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.673 -1.267 . . . . 0.0 109.995 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 5.3 m -59.61 -40.6 88.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.847 -1.158 . . . . 0.0 112.492 -175.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.468 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.2 tpt180 -62.75 -61.74 6.96 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 120.329 -1.482 . . . . 0.0 112.069 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.05 -30.32 93.0 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 CA-C-N 120.151 1.09 . . . . 0.0 111.824 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.05 -50.53 73.36 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.55 -39.32 61.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.344 -0.848 . . . . 0.0 109.431 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -68.99 -43.83 74.09 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.998 -1.064 . . . . 0.0 108.342 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -60.04 -52.27 66.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.439 -0.788 . . . . 0.0 110.984 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 72.1 t -68.42 -28.92 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.728 -1.232 . . . . 0.0 110.7 -178.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 24.7 ttmt -61.77 -45.8 92.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.109 -0.994 . . . . 0.0 110.252 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -69.97 -40.05 75.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.987 -1.07 . . . . 0.0 111.417 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . 0.44 ' C ' ' H ' ' B' ' 328' ' ' GLY . . . -61.53 -52.8 62.97 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.469 -1.394 . . . . 0.0 110.26 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -53.34 -11.23 0.28 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.169 -0.957 . . . . 0.0 109.648 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . 0.44 ' H ' ' C ' ' B' ' 326' ' ' ALA . . . -75.93 -25.62 66.49 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -105.05 141.1 37.21 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.629 -0.924 . . . . 0.0 108.798 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 89.7 m -89.94 -10.51 44.84 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.941 -1.099 . . . . 0.0 109.871 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 331' ' ' SER . . . . . 0.611 ' HG ' ' H ' ' B' ' 369' ' ' ASP . 75.6 m -61.49 149.62 38.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.705 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -67.67 132.77 48.11 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.0 mt -133.33 134.17 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.653 -0.654 . . . . 0.0 109.564 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 51.5 m -131.68 155.04 48.33 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 75.9 t -117.41 140.02 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 70.2 m -130.47 122.25 27.34 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.217 -0.927 . . . . 0.0 109.22 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 1.8 m -140.21 120.22 13.65 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 122.054 0.93 . . . . 0.0 110.657 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 47.56 57.8 5.56 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 75.28 -11.55 8.58 Favored Glycine 0 N--CA 1.498 2.787 0 O-C-N 120.19 -1.569 . . . . 0.0 112.52 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -114.43 125.1 53.45 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 118.923 1.361 . . . . 0.0 109.289 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 51.8 m -126.56 148.32 49.76 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.616 0.722 . . . . 0.0 110.196 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.77 167.44 22.58 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.515 0.674 . . . . 0.0 109.955 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 343' ' ' SER . . . . . 0.459 ' HG ' ' HZ2' ' B' ' 349' ' ' LYS . 19.8 m -87.09 139.05 30.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.43 -0.794 . . . . 0.0 109.595 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.461 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -78.7 -14.27 59.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.001 -1.062 . . . . 0.0 109.195 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -86.81 18.19 3.6 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.461 ' H ' ' C ' ' B' ' 344' ' ' ALA . 61.2 m -145.27 93.23 2.35 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.601 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . 0.507 ' O ' ' NE2' ' B' ' 351' ' ' GLN . 13.4 tp -55.74 -36.66 67.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -58.69 -52.52 65.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 110.165 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.459 ' HZ2' ' HG ' ' B' ' 343' ' ' SER . 56.4 mtpt -68.68 -21.11 64.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.992 -1.067 . . . . 0.0 110.987 -177.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' B' ' 352' ' ' THR . 90.2 mt -69.94 -52.16 26.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.532 -1.355 . . . . 0.0 108.523 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' B' ' 347' ' ' LEU . 0.1 OUTLIER -39.21 -18.85 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.817 -0.552 . . . . 0.0 111.07 -178.301 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.564 ' N ' ' O ' ' B' ' 350' ' ' LEU . 71.1 p -85.92 -11.12 53.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.225 -1.547 . . . . 0.0 110.647 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 42.3 mt -94.82 116.95 29.36 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.931 -1.106 . . . . 0.0 109.247 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.94 94.23 0.98 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 24.1 mt -103.31 94.58 5.58 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.453 -1.028 . . . . 0.0 108.947 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 43.3 p -93.3 161.01 14.57 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.101 -0.999 . . . . 0.0 110.427 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -54.22 119.36 5.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.551 -0.718 . . . . 0.0 110.225 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 98.74 4.65 56.89 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.036 -1.625 . . . . 0.0 109.036 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.9 m -84.2 112.64 20.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.406 -1.055 . . . . 0.0 110.574 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 19.3 t -78.44 116.62 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 122.081 0.943 . . . . 0.0 109.939 -177.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 17.3 m -110.38 177.5 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -178.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 58.5 m -131.35 130.01 42.12 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 78.3 mt -102.82 115.39 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 73.3 m -117.28 130.79 56.78 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.558 -0.714 . . . . 0.0 109.13 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.89 152.27 39.98 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.171 -0.956 . . . . 0.0 110.363 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . 0.436 ' OE2' ' OE2' ' B' ' 370' ' ' GLU . 9.9 tp10 -143.02 120.25 11.51 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.16 -163.88 36.78 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.466 -1.826 . . . . 0.0 111.947 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -59.2 -49.95 75.88 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 115.029 -0.586 . . . . 0.0 112.006 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.611 ' H ' ' HG ' ' B' ' 331' ' ' SER . 92.0 m-20 -105.77 10.74 32.58 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.979 -1.076 . . . . 0.0 111.066 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.436 ' OE2' ' OE2' ' B' ' 366' ' ' GLU . 14.7 pt-20 -40.98 -30.6 0.14 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.167 -0.958 . . . . 0.0 110.88 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -69.58 -40.46 76.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.06 -1.025 . . . . 0.0 109.204 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -72.16 -55.11 7.83 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 108.983 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -41.83 -35.63 0.87 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.694 -0.629 . . . . 0.0 111.771 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 62.2 t -79.93 -32.44 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.541 -1.35 . . . . 0.0 109.68 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.3 -60.05 3.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.978 -1.076 . . . . 0.0 111.939 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -73.31 -40.85 64.17 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.483 -1.386 . . . . 0.0 112.66 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.99 -40.05 87.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.528 -1.357 . . . . 0.0 109.042 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 54.5 t -61.08 -47.65 92.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.132 -0.98 . . . . 0.0 109.831 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -69.54 -55.75 9.27 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.728 -1.232 . . . . 0.0 108.154 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . 0.476 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 60.7 tp -53.04 -34.08 54.83 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.504 -0.747 . . . . 0.0 109.7 -178.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 39.5 ttm -75.44 -38.54 59.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.945 -1.097 . . . . 0.0 108.55 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.17 -5.42 51.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.685 -0.634 . . . . 0.0 110.496 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -110.45 4.54 20.62 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.085 -1.009 . . . . 0.0 110.812 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . 0.476 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 26.3 mt -72.2 121.97 20.25 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.34 -1.475 . . . . 0.0 109.947 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.989 -1.005 . . . . 0.0 108.942 179.152 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.6 mtm . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.076 -0.712 . . . . 3.19 109.076 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.7 mt -110.45 122.32 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.414 -0.804 . . . . 1.71 108.958 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.6 m -139.26 146.64 40.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.416 -0.802 . . . . 1.66 109.104 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.68 -162.79 9.25 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 108.719 -1.752 . . . . 1.05 108.719 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.6 mt -89.81 -13.71 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.863 -1.375 . . . . 1.59 110.302 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.3 tp 55.8 102.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 1.47 108.88 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.83 -23.12 17.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.0 . . . . 1.39 109.593 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 16.0 t -147.78 130.55 7.89 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.069 -1.019 . . . . 2.09 109.739 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.34 144.42 16.24 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.13 1.887 . . . . 0.91 112.902 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.28 167.27 16.05 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.745 -1.342 . . . . 0.92 109.745 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.0 mt -123.66 130.42 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.088 -1.243 . . . . 1.35 109.601 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.9 150.07 49.2 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.202 -0.936 . . . . 1.14 110.619 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.1 m-85 -126.29 129.97 49.94 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.793 -1.188 . . . . 0.7 107.793 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.04 178.94 48.59 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 118.354 -1.879 . . . . 0.58 110.969 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -78.87 158.46 28.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.764 -0.845 . . . . 2.63 109.195 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.17 131.55 53.29 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.559 -0.713 . . . . 1.27 110.485 -179.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.8 tp -99.75 136.31 39.86 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.593 -1.262 . . . . 1.41 107.593 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.4 tp -115.84 119.96 37.7 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.309 -0.869 . . . . 1.49 109.613 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.8 mt -90.69 105.79 18.06 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.767 -0.583 . . . . 1.52 109.803 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -101.48 136.61 41.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.368 -0.833 . . . . 3.17 109.252 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -127.34 122.19 33.08 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.799 -0.815 . . . . 3.0 108.799 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -71.19 148.25 47.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 2.77 109.904 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -65.18 141.86 58.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 2.94 109.489 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -82.02 130.12 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 1.46 109.176 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.6 t -93.9 124.06 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.255 -0.903 . . . . 1.7 109.868 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.5 mt -103.74 138.46 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.436 -0.79 . . . . 1.54 109.119 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -97.22 117.73 32.09 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.152 -0.967 . . . . 1.81 109.208 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -86.92 -2.3 58.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.367 -0.833 . . . . 3.23 109.372 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -64.34 141.3 58.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 3.29 109.68 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -87.73 150.14 23.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.913 . . . . 2.8 108.997 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -92.95 165.64 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.365 -0.834 . . . . 1.43 110.475 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.4 p -99.15 171.22 8.15 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.349 -0.982 . . . . 1.54 108.349 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.19 -47.93 80.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 1.6 109.089 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -55.63 -32.3 63.04 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.0 -1.062 . . . . 2.56 109.656 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -82.16 -9.91 59.35 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.287 -0.883 . . . . 2.36 110.246 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.63 -53.31 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.506 -1.371 . . . . 1.43 109.499 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.78 -40.05 95.73 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.023 -1.048 . . . . 1.77 110.006 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -69.98 -39.96 75.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.036 -1.04 . . . . 3.32 110.463 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -67.11 -40.05 86.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.006 -1.058 . . . . 1.51 110.069 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.99 -43.19 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.712 -1.242 . . . . 1.41 108.361 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -59.55 -37.1 77.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 1.81 108.895 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -60.04 -43.14 95.55 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.908 -1.145 . . . . 3.26 107.908 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -62.24 -49.78 74.34 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.449 -0.782 . . . . 0.81 109.409 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.5 tp -59.91 -48.4 81.87 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.397 -0.814 . . . . 1.59 109.024 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.5 t -62.21 -43.32 99.1 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.995 -1.065 . . . . 1.38 108.735 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.29 -45.42 96.02 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.732 -1.747 . . . . 0.87 108.732 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -67.48 -32.67 73.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.396 -1.061 . . . . 3.62 108.423 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.424 ' O ' ' OG ' ' A' ' 51' ' ' SER . . . -59.29 -40.03 84.88 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.643 -0.873 . . . . 1.43 108.643 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 50' ' ' ALA . 27.9 ttpt -67.25 -74.58 0.11 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.417 -0.956 . . . . 3.08 108.417 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.05 -33.22 0.08 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.203 -0.936 . . . . 1.33 111.489 -178.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.702 ' HG ' ' H ' ' A' ' 52' ' ' ALA . 83.3 p -60.06 -54.53 44.89 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.563 -1.336 . . . . 1.85 108.697 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.702 ' H ' ' HG ' ' A' ' 51' ' ' SER . . . -70.02 -40.2 75.36 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.372 -0.83 . . . . 1.35 111.157 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -65.16 -40.13 93.89 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.73 -1.231 . . . . 2.34 110.735 -178.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.28 -39.97 93.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.857 -1.152 . . . . 2.2 109.018 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -60.35 -37.13 79.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.385 -0.822 . . . . 1.35 109.419 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.5 m -65.41 -43.23 91.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.831 -1.168 . . . . 1.34 109.007 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.648 ' CD1' HH22 ' A' ' 136' ' ' ARG . 78.9 mt -62.04 -40.01 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.504 -0.925 . . . . 1.26 108.504 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -55.57 -50.22 70.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.4 -0.813 . . . . 1.7 109.527 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.416 ' H ' ' HG1' ' A' ' 59' ' ' THR . 4.0 m -57.99 -33.0 68.44 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.159 -0.963 . . . . 1.35 110.19 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -68.79 -37.87 79.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 2.08 109.145 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.45 -45.29 76.43 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.702 -0.624 . . . . 1.21 110.393 -179.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.72 -50.78 64.06 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.861 -1.162 . . . . 0.75 110.272 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.07 -42.09 73.25 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.12 -1.223 . . . . 1.59 110.379 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.2 m -69.96 -59.11 3.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.03 -1.043 . . . . 1.41 111.729 -178.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -97.07 -52.25 3.92 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.959 -1.088 . . . . 0.79 111.103 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.67 -165.38 26.49 Favored Glycine 0 N--CA 1.5 2.905 0 C-N-CA 119.706 -1.235 . . . . 1.22 110.955 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -70.75 -22.62 62.39 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.89 -0.771 . . . . 5.81 110.354 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.458 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.1 tp10 -62.05 -37.64 85.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 3.37 110.904 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -99.67 -18.02 17.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.184 -0.947 . . . . 2.37 110.12 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -69.76 -39.93 76.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.119 -0.988 . . . . 1.65 110.423 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.04 -30.92 71.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.382 -0.824 . . . . 1.42 109.834 -179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.0 -41.46 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.036 -1.04 . . . . 1.43 109.085 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -62.61 -40.45 96.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.065 -1.022 . . . . 1.08 109.966 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -60.78 -39.92 90.63 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.188 -1.005 . . . . 1.37 109.335 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.18 -41.26 98.43 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.671 -1.772 . . . . 0.67 108.671 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.7 m170 -69.77 -42.44 73.82 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.376 -1.073 . . . . 1.99 108.935 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.4 mt -70.14 -46.19 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.285 -0.884 . . . . 1.22 109.359 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.1 ttp -61.16 -40.93 95.71 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.087 -1.008 . . . . 2.11 110.05 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.418 ' CD1' ' CE2' ' B' ' 348' ' ' PHE . 59.0 tp -66.47 -40.05 89.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.164 -0.96 . . . . 1.33 109.444 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.2 tp -66.53 -39.88 88.83 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.502 -0.749 . . . . 1.29 110.012 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -79.99 -1.56 40.15 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.186 -0.946 . . . . 1.47 110.192 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -47.88 130.26 14.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.032 . . . . 1.47 109.904 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.28 -16.38 60.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.662 -0.649 . . . . 1.78 110.198 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.26 -35.18 73.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.941 -1.099 . . . . 2.53 108.512 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.12 -40.01 68.44 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.462 0.649 . . . . 1.36 109.275 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.04 -49.96 75.61 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.559 -0.713 . . . . 1.42 109.993 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -70.65 -40.31 73.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.257 -0.902 . . . . 2.27 110.839 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -69.74 -40.02 76.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.059 -1.025 . . . . 1.57 110.567 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.8 mt -68.6 -45.8 81.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.112 -0.992 . . . . 1.19 108.944 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.26 -39.1 80.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.528 -0.733 . . . . 1.39 109.963 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.07 -47.15 87.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.195 -0.94 . . . . 1.39 110.452 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 96' ' ' LYS . 85.7 mt -62.64 -45.77 91.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.896 -1.127 . . . . 1.5 109.43 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.79 -50.05 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 1.29 109.135 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -70.03 -40.56 75.11 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.707 -0.797 . . . . 2.64 110.338 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -81.3 -50.16 9.85 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.997 -1.064 . . . . 1.65 111.716 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 92' ' ' LEU . 19.7 mmmt -90.38 -1.83 57.93 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.933 -1.104 . . . . 2.5 111.64 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.3 m80 55.88 35.3 25.19 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.889 -1.132 . . . . 1.88 109.529 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.5 mtt -89.38 168.57 12.12 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.629 -0.669 . . . . 1.71 110.147 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.9 p -80.72 158.51 25.52 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.42 -0.8 . . . . 1.61 109.26 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.89 -40.06 87.64 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.243 -0.91 . . . . 1.33 109.662 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -67.87 -39.9 83.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.277 -0.89 . . . . 2.07 109.616 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.99 -42.52 21.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 1.37 109.897 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.53 -50.46 71.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 1.14 109.571 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.42 -33.41 72.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.228 -0.92 . . . . 1.26 109.509 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.546 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 86.2 t60 -60.06 -46.12 90.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.264 -0.897 . . . . 2.02 109.734 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -60.36 -40.0 89.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.353 -0.842 . . . . 1.33 111.007 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 41.9 t -63.28 -62.84 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.959 -1.088 . . . . 1.3 111.435 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.5 mm -63.9 -41.67 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.875 -1.141 . . . . 1.32 109.419 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.546 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 80.8 tt0 -63.53 -38.7 92.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 2.44 108.927 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.04 -46.44 94.18 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.712 -0.955 . . . . 0.99 110.712 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 28.6 mm100 -68.54 -44.04 75.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.746 -1.443 . . . . 1.97 109.67 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.43 78.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.092 -1.005 . . . . 1.43 109.055 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 29.5 t -60.02 -40.42 89.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.182 -0.949 . . . . 2.12 109.144 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.48 97.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 1.64 109.094 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.6 mt -67.82 -41.87 82.38 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.151 -0.968 . . . . 1.93 109.044 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.58 -33.62 70.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.781 -1.199 . . . . 2.2 109.774 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -57.81 -22.15 45.88 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.025 -1.047 . . . . 2.12 108.765 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 48.8 mt -63.28 139.91 58.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 2.34 108.787 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -84.41 -16.8 41.42 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.142 -0.974 . . . . 3.23 110.195 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -66.4 130.02 41.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.169 -0.957 . . . . 2.49 110.124 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 8.0 pm0 -70.13 -30.04 67.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.454 -0.779 . . . . 3.95 110.245 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.491 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.8 t80 -67.58 -34.16 76.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.406 -0.809 . . . . 2.25 110.194 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 86.4 mt -80.15 -26.67 39.26 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.103 -0.998 . . . . 2.27 108.882 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -61.95 -47.05 86.62 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.212 -0.93 . . . . 3.31 108.604 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 121' ' ' GLU . 7.6 mp0 -65.66 -36.69 84.39 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.264 -0.897 . . . . 2.73 108.77 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.552 ' CZ ' ' NE2' ' B' ' 351' ' ' GLN . 0.2 OUTLIER -59.69 -40.03 86.51 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.855 -1.165 . . . . 3.2 107.855 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.27 -23.4 67.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.425 -0.797 . . . . 1.66 109.008 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.44 -39.96 89.18 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.655 -0.869 . . . . 1.67 108.655 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -64.18 -40.67 96.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.385 -0.822 . . . . 1.55 109.233 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 77.3 t -69.89 -40.15 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.487 -0.931 . . . . 1.32 108.487 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.477 HH11 ' HG2' ' A' ' 131' ' ' ARG . 11.6 ttt-85 -59.98 -40.03 87.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.397 -0.814 . . . . 3.58 108.94 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -60.44 -39.93 89.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.534 -0.729 . . . . 1.46 110.06 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.99 -43.33 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.266 -0.896 . . . . 1.22 110.861 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.71 -33.86 71.82 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.754 -1.212 . . . . 0.61 110.168 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -59.98 -48.6 81.05 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -1.174 . . . . 3.1 110.022 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.648 HH22 ' CD1' ' A' ' 57' ' ' ILE . 67.0 mtp180 -68.32 -32.22 72.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.906 -1.121 . . . . 3.71 109.602 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.88 -45.54 92.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.26 -0.9 . . . . 1.87 108.647 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.54 -40.26 90.91 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.395 -0.816 . . . . 1.29 109.062 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.456 HH11 ' HG2' ' A' ' 139' ' ' ARG . 43.4 mtt-85 -69.91 -40.09 75.8 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.426 -0.953 . . . . 3.05 108.426 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -60.5 -40.04 89.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.848 -0.533 . . . . 1.26 110.759 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.404 HD11 HG23 ' A' ' 141' ' ' ILE . 96.9 mt -73.15 -42.09 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.788 -1.195 . . . . 1.34 108.313 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.8 mt -70.06 -38.4 75.75 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.235 0.541 . . . . 1.6 109.807 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.16 43.78 8.5 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.963 -1.655 . . . . 0.96 108.963 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 tp -75.68 152.78 37.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.58 -0.953 . . . . 1.67 109.652 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -63.91 140.97 58.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 4.96 109.265 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.4 mt -119.83 130.08 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 122.151 0.977 . . . . 1.68 109.77 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.1 mt -59.39 -47.63 89.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 115.657 -0.702 . . . . 2.14 110.922 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 31.2 t0 66.2 99.25 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.652 -0.87 . . . . 1.5 108.652 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 25.1 mt -68.83 -3.78 13.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 1.39 109.709 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 59.3 m -83.45 -13.4 54.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.096 -1.003 . . . . 1.83 108.891 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.17 20.28 1.98 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.459 -0.776 . . . . 1.46 111.08 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 40.9 mm -90.05 121.18 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.598 -1.313 . . . . 1.42 108.708 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -101.32 -9.0 21.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.263 -0.898 . . . . 2.94 110.473 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -125.45 149.78 47.91 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.34 -0.85 . . . . 1.52 110.434 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.87 135.36 56.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.346 -0.847 . . . . 1.58 109.14 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.5 m -152.34 166.37 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.576 -0.703 . . . . 1.32 109.872 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 94.1 mt -95.16 149.57 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.293 -1.743 . . . . 1.27 106.293 177.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 38.3 tp -100.01 117.88 35.21 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.985 -1.072 . . . . 1.41 110.854 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 84.3 t -121.54 129.44 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.408 -0.96 . . . . 1.23 108.408 178.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.09 165.02 32.57 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.109 -0.994 . . . . 1.32 109.091 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.45 -38.28 74.46 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.178 -1.576 . . . . 1.49 107.841 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -170.68 145.28 2.47 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.76 -0.83 . . . . 2.25 108.76 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.4 mt -112.17 140.22 47.05 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.248 -0.907 . . . . 1.35 109.818 -179.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.0 p -92.18 141.59 25.27 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.279 -0.888 . . . . 1.56 109.121 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -39.64 -36.5 1.15 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.208 1.938 . . . . 0.87 113.194 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.5 m -60.38 -40.03 89.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.033 -1.042 . . . . 1.36 110.242 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.59 -41.52 92.75 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.006 -1.058 . . . . 1.61 109.799 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.9 p -57.54 -32.92 67.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.192 -0.943 . . . . 1.21 111.293 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.14 -43.92 69.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.669 -1.27 . . . . 1.21 109.732 -179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -94.88 34.94 1.29 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.625 -0.879 . . . . 2.11 108.625 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.7 tp -107.48 138.98 42.71 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.814 -0.81 . . . . 1.29 108.814 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -86.47 103.87 15.41 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.141 -0.974 . . . . 2.81 109.539 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.85 -39.99 95.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.477 -0.764 . . . . 2.09 110.812 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -67.96 -25.92 65.68 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.994 -1.066 . . . . 2.86 111.76 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -93.37 -8.81 40.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.588 -1.32 . . . . 2.39 109.895 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.451 ' CG1' ' O ' ' A' ' 178' ' ' GLY . 81.8 t -97.04 110.38 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.101 -0.999 . . . . 1.27 108.792 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.0 mt -77.77 2.91 15.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.222 -0.924 . . . . 2.17 110.334 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.451 ' O ' ' CG1' ' A' ' 176' ' ' VAL . . . 165.6 177.04 37.6 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.198 -1.561 . . . . 0.52 109.198 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -132.96 129.98 38.96 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.425 -1.044 . . . . 0.55 108.521 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.6 mt -134.47 127.7 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.21 -0.931 . . . . 1.27 109.348 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 29.1 p -149.74 160.02 43.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 1.39 110.401 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' A' ' 182' ' ' ASP . 35.1 p-10 -109.16 27.57 9.38 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.684 -0.858 . . . . 2.46 108.684 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.04 -157.18 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.197 -0.939 . . . . 1.51 111.929 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.3 -80.83 0.06 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.087 -1.205 . . . . 2.23 110.087 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.55 -134.2 2.73 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.839 -1.305 . . . . 2.23 109.839 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.456 ' C ' ' H ' ' A' ' 188' ' ' SER . 14.6 tpp180 -60.01 -40.01 87.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.404 -1.056 . . . . 6.44 110.63 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.1 p -64.97 7.79 0.15 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.065 -1.022 . . . . 4.09 111.258 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 186' ' ' ARG . 15.9 m -90.72 135.32 33.79 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.66 -1.275 . . . . 2.2 110.827 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -46.12 -52.55 11.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.448 -0.783 . . . . 1.15 109.761 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -53.99 -37.1 63.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.492 -0.755 . . . . 2.01 110.247 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.3 t -60.05 -45.24 93.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.111 -0.993 . . . . 1.93 111.03 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 192' ' ' ILE . 96.4 mt -60.01 -40.49 83.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.321 -0.862 . . . . 2.2 110.406 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.2 mtp -60.14 -45.78 91.9 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.069 -1.019 . . . . 1.32 110.164 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.19 -45.97 65.38 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.549 -1.344 . . . . 1.3 109.484 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -63.48 -58.06 8.23 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.057 -1.057 . . . . 3.38 110.327 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.4 m -60.27 -39.93 88.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.897 -1.127 . . . . 1.15 111.655 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.35 -22.36 62.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.834 -1.167 . . . . 1.28 109.498 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 69.99 47.82 0.57 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.38 0.609 . . . . 1.5 110.31 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.438 ' O ' ' CB ' ' A' ' 8' ' ' SER . 68.6 mt -129.16 149.96 74.09 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 107.994 -1.113 . . . . 1.37 107.994 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.07 146.14 75.85 Favored 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 122.459 2.106 . . . . 0.76 112.05 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -177.0 154.12 1.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.106 -0.996 . . . . 1.19 111.004 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.0 mt -125.67 151.11 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.45 -1.315 . . . . 1.31 107.45 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.2 m -131.06 -12.03 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 120.866 -1.146 . . . . 1.38 111.04 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.01 25.02 17.47 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.09 -1.204 . . . . 1.03 110.09 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 22.4 p -45.32 -42.83 10.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.125 -1.221 . . . . 1.38 109.903 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 94.01 -52.52 2.23 Favored Glycine 0 N--CA 1.497 2.748 0 O-C-N 121.139 -0.976 . . . . 1.17 111.447 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 80.6 p -156.78 34.7 0.3 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.579 -1.542 . . . . 2.07 111.332 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 23.0 t -75.76 -39.42 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.061 -1.024 . . . . 1.35 108.904 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 72.7 p -56.72 -27.2 58.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 1.49 110.674 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.3 m -80.25 -24.62 39.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.835 -1.166 . . . . 2.16 110.308 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -95.55 -8.66 34.47 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.152 -0.967 . . . . 2.89 110.444 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 56.0 t -102.35 136.17 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.226 -0.921 . . . . 1.33 109.943 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.48 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 2.2 mptp? -116.28 152.92 32.87 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.567 -1.271 . . . . 2.73 107.567 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.455 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 16.6 p-10 -56.29 139.46 48.15 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.999 -1.063 . . . . 2.7 110.618 -178.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.0 m-20 82.02 8.74 0.88 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.028 0.442 . . . . 2.38 110.376 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.48 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 90.6 m-20 -79.32 139.82 37.7 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.025 -1.047 . . . . 2.09 109.346 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -91.65 115.04 27.71 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.031 -1.099 . . . . 1.45 108.031 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 59.6 mt -125.42 150.27 47.43 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.651 -0.655 . . . . 1.31 110.627 -178.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.3 mt -115.38 127.67 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.281 -1.377 . . . . 1.29 107.281 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 54.7 tp -100.7 119.99 39.41 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.936 -1.102 . . . . 1.31 108.702 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 223' ' ' VAL . 83.0 m-20 -78.88 -43.1 25.68 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.067 -1.02 . . . . 2.31 109.373 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 47.01 15.34 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.4 -0.963 . . . . 1.19 108.4 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 221' ' ' ASP . 53.2 t -131.5 -38.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.287 -1.375 . . . . 1.45 107.287 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -105.69 0.54 26.39 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.682 -1.229 . . . . 3.13 107.682 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 60.19 44.28 12.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.814 -0.554 . . . . 2.2 110.357 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -141.81 151.37 42.73 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.07 -1.019 . . . . 2.32 109.762 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.5 t -119.48 130.08 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.519 -0.919 . . . . 1.4 108.519 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -101.7 124.01 46.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.52 -0.737 . . . . 1.29 109.25 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 18.0 t -101.05 113.9 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.637 -0.665 . . . . 1.38 109.903 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 50.64 67.66 4.13 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.194 -0.941 . . . . 2.33 111.208 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -90.12 148.68 4.63 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 123.048 2.499 . . . . 0.95 112.346 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 71.5 p -72.45 166.26 22.95 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.099 -1.001 . . . . 2.31 109.897 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -59.94 -35.47 74.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 3.45 109.736 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.95 -39.99 87.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 2.89 109.686 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.85 -39.97 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.142 -0.974 . . . . 1.73 109.144 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.4 -40.0 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 1.57 109.693 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -60.02 -41.38 92.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.859 -1.151 . . . . 2.43 109.114 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -67.08 -40.04 86.93 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.665 -0.865 . . . . 3.18 108.665 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 95.8 mtp -70.76 -32.73 69.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.547 -0.721 . . . . 1.59 109.221 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.534 ' NH2' ' OE1' ' A' ' 243' ' ' GLN . 2.2 mmp_? -61.35 -40.17 93.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.218 -0.926 . . . . 3.11 109.17 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -64.81 -37.98 89.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.41 -0.806 . . . . 2.17 109.039 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 56.0 t -60.03 -41.37 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.457 -0.777 . . . . 2.51 109.524 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.534 ' OE1' ' NH2' ' A' ' 240' ' ' ARG . 60.2 tt0 -60.07 -40.39 89.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.956 . . . . 3.82 109.812 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -59.95 -39.72 86.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.924 -1.11 . . . . 1.78 108.89 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -59.88 -40.16 87.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.529 -0.732 . . . . 2.77 109.047 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 76.2 t -59.92 -40.52 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.389 -0.819 . . . . 2.25 110.11 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.26 -40.66 96.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.08 -1.013 . . . . 2.54 109.383 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 42.1 t -65.52 -34.19 77.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.355 -0.84 . . . . 3.03 109.288 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.97 -40.1 87.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.465 -0.772 . . . . 3.34 109.333 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -60.41 -40.34 90.62 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.421 -0.799 . . . . 4.18 110.507 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -85.86 0.44 53.04 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.236 -0.915 . . . . 4.43 109.374 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -77.89 -8.72 58.46 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.566 -0.709 . . . . 5.42 109.842 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 87.8 mt 49.97 73.27 0.27 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.904 -1.122 . . . . 6.11 108.264 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -71.6 -8.75 55.99 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.787 -0.571 . . . . 7.37 110.432 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -94.3 131.87 39.47 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.015 -1.053 . . . . 8.3 109.512 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 5.6 tp 55.35 39.99 31.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.092 -1.005 . . . . 9.05 108.804 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.435 ' O ' ' OD1' ' A' ' 258' ' ' ASP . 31.9 mtmm -49.42 -60.06 3.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.703 -0.623 . . . . 10.56 109.858 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 257' ' ' LYS . 85.9 m-20 -143.7 16.0 1.79 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 11.32 109.86 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.065 . . . . 12.74 109.469 -179.773 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 6.1 ttt . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.367 0.604 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -153.99 151.56 29.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.411 -0.806 . . . . 0.0 109.17 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -149.56 159.93 43.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.076 -1.015 . . . . 0.0 110.479 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -154.72 150.97 28.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . 0.486 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 2.0 pm0 -116.45 133.89 55.49 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.22 -0.925 . . . . 0.0 110.325 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.48 128.11 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 CA-C-O 122.351 1.072 . . . . 0.0 112.546 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 86.4 m -78.1 103.31 7.96 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.877 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 88.4 mt -51.19 122.65 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 122.446 1.117 . . . . 0.0 109.815 -178.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 54.2 p -103.23 21.09 16.48 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.202 -178.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -86.6 115.29 61.74 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.062 -1.024 . . . . 0.0 108.938 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -68.13 -3.29 10.42 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 CA-C-N 120.309 1.146 . . . . 0.0 111.511 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -111.31 -0.64 16.32 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.91 172.82 26.91 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 107.684 -2.167 . . . . 0.0 107.684 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.491 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -85.58 94.93 9.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.862 -1.375 . . . . 0.0 108.241 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -93.75 -162.79 0.97 Allowed 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.991 -1.068 . . . . 0.0 110.698 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.0 m -56.78 -42.5 79.56 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.098 -1.001 . . . . 0.0 112.514 -176.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.484 HH11 ' HG2' ' B' ' 317' ' ' ARG . 0.9 OUTLIER -61.37 -60.0 11.86 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 120.639 -1.288 . . . . 0.0 112.241 -178.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -60.78 -32.04 92.49 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 120.295 1.141 . . . . 0.0 111.811 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.44 73.74 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.25 -40.65 61.97 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.443 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -70.19 -40.73 74.46 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.043 -1.036 . . . . 0.0 108.768 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -60.26 -51.78 68.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.425 -0.797 . . . . 0.0 110.452 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 87.2 t -69.91 -30.63 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.758 -1.214 . . . . 0.0 110.35 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -60.08 -45.6 92.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 108.999 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -67.19 -40.05 86.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.84 . . . . 0.0 110.528 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . 0.437 ' C ' ' H ' ' B' ' 328' ' ' GLY . . . -64.91 -53.61 43.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.77 -1.206 . . . . 0.0 111.033 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -52.96 -10.05 0.16 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.121 -0.987 . . . . 0.0 110.458 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' B' ' 326' ' ' ALA . . . -79.23 -21.06 68.27 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -106.23 140.18 39.57 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.55 -0.971 . . . . 0.0 109.26 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 17.2 m -90.89 -11.08 40.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.045 -1.034 . . . . 0.0 110.342 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 331' ' ' SER . . . . . 0.404 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 84.4 p -62.93 153.66 32.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.907 -1.12 . . . . 0.0 109.712 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -69.44 133.14 47.39 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.5 mt -134.47 133.77 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.674 -0.641 . . . . 0.0 109.99 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 85.9 m -131.17 152.01 50.88 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 67.3 t -123.56 117.62 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 49.5 m -106.32 132.72 52.03 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.088 -1.007 . . . . 0.0 109.333 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 82.1 p -140.01 115.46 9.98 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.924 0.869 . . . . 0.0 110.798 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 24.0 m120 46.96 49.8 14.37 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 176.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.97 -12.96 65.92 Favored Glycine 0 N--CA 1.505 3.244 0 O-C-N 120.155 -1.59 . . . . 0.0 113.327 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -118.5 130.06 55.72 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-N 119.579 1.689 . . . . 0.0 109.503 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 38.9 m -128.75 150.4 50.3 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.871 0.843 . . . . 0.0 110.954 -178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -146.45 169.28 19.23 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.646 0.736 . . . . 0.0 110.293 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 60.8 m -88.17 139.57 30.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.637 -0.665 . . . . 0.0 109.903 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.52 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -79.78 -15.8 56.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.938 -1.101 . . . . 0.0 109.852 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -85.38 20.61 1.96 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.559 ' CB ' ' HZ3' ' B' ' 349' ' ' LYS . 17.3 t -147.97 95.95 2.57 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.31 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 61.2 tp -59.92 -34.7 73.57 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . 0.418 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 59.7 m-85 -54.56 -51.85 63.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.63 -0.669 . . . . 0.0 110.994 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.559 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 34.1 mtmm -80.89 -12.73 59.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.731 -1.23 . . . . 0.0 111.207 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 27.4 mt -69.48 -49.78 51.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.48 -1.387 . . . . 0.0 109.214 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.552 ' NE2' ' CZ ' ' A' ' 126' ' ' ARG . 2.0 mm100 -50.0 -20.1 0.86 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.144 -0.972 . . . . 0.0 111.451 -177.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 74.6 p -76.05 -10.02 59.08 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.233 -1.542 . . . . 0.0 109.242 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 53.0 mt -95.43 118.08 31.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.353 -0.842 . . . . 0.0 109.323 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.49 93.07 1.0 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 38.4 mt -97.51 85.49 3.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.232 -1.158 . . . . 0.0 108.344 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 356' ' ' THR . . . . . 0.414 ' C ' ' HG1' ' B' ' 359' ' ' THR . 31.9 p -93.64 179.96 5.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.195 -0.941 . . . . 0.0 110.81 -178.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . 0.52 ' O ' ' N ' ' B' ' 359' ' ' THR . 62.0 tt0 -49.5 156.91 0.57 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 122.371 1.081 . . . . 0.0 111.412 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.23 23.62 0.02 OUTLIER Glycine 0 N--CA 1.496 2.65 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.226 177.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 359' ' ' THR . . . . . 0.52 ' N ' ' O ' ' B' ' 357' ' ' GLN . 27.6 m -83.75 110.04 18.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.803 -1.41 . . . . 0.0 109.858 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 6.8 t -77.28 113.73 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 122.296 1.046 . . . . 0.0 109.833 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.2 m -109.67 176.19 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 56.2 m -131.96 129.95 40.87 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.5 mt -107.84 121.74 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 24.2 p -122.02 133.19 54.8 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.05 149.85 38.77 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.084 -1.01 . . . . 0.0 109.83 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -144.51 121.96 11.69 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.435 -0.79 . . . . 0.0 109.094 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.527 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.05 -152.95 24.28 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.125 -1.512 . . . . 0.0 111.724 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -58.82 -52.82 64.1 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.404 ' H ' ' HB3' ' B' ' 331' ' ' SER . 70.7 m-20 -109.96 12.71 23.65 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.015 -1.053 . . . . 0.0 111.32 -177.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.527 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.8 pt-20 -41.95 -35.56 0.89 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.286 -0.883 . . . . 0.0 111.362 -178.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -69.55 -41.0 76.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.574 -1.329 . . . . 0.0 109.991 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -71.76 -54.3 10.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.966 -1.084 . . . . 0.0 109.413 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.39 -35.27 1.5 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.6 -0.687 . . . . 0.0 111.934 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . 0.457 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 58.7 t -80.19 -33.21 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.492 -1.38 . . . . 0.0 109.297 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -70.0 -40.65 75.16 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.224 -0.922 . . . . 0.0 112.495 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -84.7 -44.65 13.19 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.438 -1.413 . . . . 0.0 110.687 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 90.9 mt -59.92 -39.34 85.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.099 -1.0 . . . . 0.0 109.159 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 49.3 t -64.36 -43.74 97.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.28 -0.888 . . . . 0.0 109.784 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -79.93 -9.86 59.72 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.054 -1.029 . . . . 0.0 109.457 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 43.0 tp -82.34 -24.88 34.32 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.1 tpp -82.79 -25.01 33.14 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -85.03 -11.11 56.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.687 -0.633 . . . . 0.0 110.202 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -107.33 -0.29 22.57 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.233 -0.917 . . . . 0.0 110.835 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 34.4 mt -94.95 119.3 33.24 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.76 -1.212 . . . . 0.0 110.084 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 1.3 pm0 . . . . . 0 N--CA 1.499 2.0 0 CA-C-O 117.94 -1.028 . . . . 0.0 109.479 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.9 mtm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.465 -0.569 . . . . 3.19 109.465 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 94.4 mt -110.06 126.37 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.479 -0.763 . . . . 1.71 109.625 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.5 m -136.75 134.06 36.7 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.893 -0.78 . . . . 1.66 108.893 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.461 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -105.92 -158.59 22.4 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 108.888 -1.685 . . . . 1.05 108.888 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.408 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.8 mt -91.65 -9.95 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.995 -1.297 . . . . 1.59 110.448 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.4 tp 55.01 98.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.956 -1.09 . . . . 1.47 108.773 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.75 -34.1 40.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.626 -0.672 . . . . 1.39 109.515 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 m -150.02 141.6 15.02 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.275 -0.89 . . . . 2.09 109.618 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.91 143.67 16.52 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.459 2.106 . . . . 0.91 112.488 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 165.91 -165.95 38.36 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.472 -1.451 . . . . 0.92 109.472 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.1 mt -149.2 149.97 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.169 -1.194 . . . . 1.35 108.506 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.27 144.2 19.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.945 -1.097 . . . . 1.14 110.363 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 16.3 m-85 -125.23 128.59 48.54 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.21 -1.033 . . . . 0.7 108.21 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.78 -178.84 44.63 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.717 -1.706 . . . . 0.58 110.816 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -80.19 158.14 26.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.774 -0.839 . . . . 2.63 109.542 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -105.04 131.24 52.8 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.434 -0.791 . . . . 1.27 110.671 -179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.6 tp -97.89 136.4 38.24 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.206 -1.405 . . . . 1.41 107.206 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 tp -120.29 124.61 46.04 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.337 -0.852 . . . . 1.49 109.407 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.8 mt -88.18 106.6 18.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.492 -0.755 . . . . 1.52 109.895 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.458 ' NZ ' ' CB ' ' A' ' 20' ' ' LYS . 7.4 mtpm? -102.23 128.78 48.61 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.744 -0.835 . . . . 3.17 108.744 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.531 ' OE1' ' NH2' ' A' ' 139' ' ' ARG . 98.6 mt-10 -126.19 137.95 53.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.312 -0.867 . . . . 3.0 109.135 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -79.15 143.56 35.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.22 -0.925 . . . . 2.77 109.035 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -61.23 140.01 58.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 2.94 109.547 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.6 mt -81.3 131.17 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.409 -0.807 . . . . 1.46 109.192 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.0 t -101.12 123.24 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.302 -0.874 . . . . 1.7 109.58 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.7 mt -98.13 142.94 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.398 -0.814 . . . . 1.54 108.938 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -91.09 122.16 33.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.019 -1.051 . . . . 1.81 109.48 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.492 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.6 mmt-85 -91.12 0.08 57.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 3.23 109.223 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.67 141.67 53.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -0.851 . . . . 3.29 109.654 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -85.78 146.8 26.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.195 -0.941 . . . . 2.8 109.281 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 pt -90.79 164.69 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 1.43 110.216 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.8 p -97.06 174.14 6.91 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.568 -0.901 . . . . 1.54 108.568 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.96 -48.58 81.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.151 -0.968 . . . . 1.6 110.032 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -54.51 -31.47 56.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.764 -1.21 . . . . 2.56 109.441 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -82.3 -9.05 59.62 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.466 -0.772 . . . . 2.36 110.276 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.2 t -68.05 -56.46 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.436 -1.415 . . . . 1.43 109.146 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.16 -39.97 88.28 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.384 -0.822 . . . . 1.77 109.739 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -67.14 -41.88 85.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.082 -1.011 . . . . 3.32 110.356 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -62.98 -40.08 96.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.904 -1.122 . . . . 1.51 110.405 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 44' ' ' LEU . 54.8 t -64.15 -48.67 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.749 -1.22 . . . . 1.41 109.197 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -61.73 -47.81 83.55 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.184 -0.947 . . . . 1.81 109.861 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.404 HH11 ' HG2' ' A' ' 42' ' ' ARG . 49.6 mtt-85 -60.11 -41.91 93.61 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.078 -1.082 . . . . 3.26 108.078 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -70.07 -39.94 75.32 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.513 -0.742 . . . . 0.81 109.344 178.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.404 ' N ' ' O ' ' A' ' 40' ' ' VAL . 48.5 tp -60.05 -48.53 81.34 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.28 -1.378 . . . . 1.59 107.28 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -63.69 -39.98 95.65 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.288 -1.004 . . . . 1.38 108.288 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.26 -50.02 72.17 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 108.491 -1.844 . . . . 0.87 108.491 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.4 ttt-85 -61.35 -39.78 91.85 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.709 -1.219 . . . . 3.62 107.709 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.96 87.84 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.971 -0.751 . . . . 1.43 108.971 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 33.6 ttpt -58.03 -74.99 0.05 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.021 -1.072 . . . . 3.08 108.21 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.61 -33.01 0.09 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.15 -0.969 . . . . 1.33 111.715 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.6 m -57.58 -47.54 81.82 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.138 -1.425 . . . . 1.85 108.365 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.8 -41.66 74.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.115 -0.991 . . . . 1.35 110.863 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -67.31 -39.97 85.95 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.806 -1.184 . . . . 2.34 110.163 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.47 -39.38 87.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.943 -1.098 . . . . 2.2 109.222 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -59.99 -36.54 77.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 1.35 109.942 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -63.96 -42.83 97.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.827 -1.171 . . . . 1.34 109.109 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.4 mt -61.68 -37.09 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 1.26 109.134 179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -58.19 -49.98 75.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.861 . . . . 1.7 109.178 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -59.59 -34.18 72.4 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.372 -0.83 . . . . 1.35 110.709 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -69.22 -39.37 78.61 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.847 -1.158 . . . . 2.08 109.598 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.95 -42.06 99.7 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.591 -0.693 . . . . 1.21 109.971 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.1 -50.53 66.67 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.576 -1.41 . . . . 0.75 109.576 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.28 -51.77 34.12 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.011 -1.287 . . . . 1.59 109.515 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.7 m -60.45 -65.68 0.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.355 -0.841 . . . . 1.41 112.179 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.507 ' CE1' ' O ' ' A' ' 168' ' ' THR . 84.3 m-85 -96.12 -49.31 5.3 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.757 -1.215 . . . . 0.79 111.519 -177.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.03 -169.54 25.28 Favored Glycine 0 N--CA 1.503 3.142 0 C-N-CA 119.659 -1.258 . . . . 1.22 111.298 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.05 -25.23 63.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.877 -0.778 . . . . 5.81 109.991 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.517 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.1 tp10 -59.99 -34.57 73.5 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.52 -0.737 . . . . 3.37 110.267 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -100.8 -16.34 17.33 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.366 -0.833 . . . . 2.37 109.91 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -70.35 -42.03 72.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 1.65 110.501 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.68 -28.47 69.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.898 . . . . 1.42 109.846 -178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 83.7 mt -60.12 -40.06 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.129 -1.029 . . . . 1.43 108.877 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -66.56 -41.72 88.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.035 . . . . 1.08 110.498 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -60.52 -40.03 89.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.888 -1.132 . . . . 1.37 109.832 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.43 99.41 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.24 -1.544 . . . . 0.67 109.24 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 60.2 m170 -66.99 -41.1 87.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -1.158 . . . . 1.99 109.384 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.63 -46.52 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.923 . . . . 1.22 109.826 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.7 ttp -60.08 -43.95 95.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.03 -1.044 . . . . 2.11 110.207 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.4 tp -62.62 -40.03 95.67 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.256 -0.903 . . . . 1.33 109.893 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.5 tp -62.65 -39.95 95.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.27 -0.894 . . . . 1.29 110.215 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -82.75 9.47 9.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.119 -0.988 . . . . 1.47 110.069 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 48.3 t0 -54.88 133.1 47.79 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.118 -0.989 . . . . 1.47 110.445 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 95.5 mt-10 -60.26 -21.07 61.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.64 -0.662 . . . . 1.78 110.734 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.54 -34.72 72.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.667 -1.271 . . . . 2.53 109.355 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.3 mt -70.05 -39.9 75.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 1.36 109.312 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -60.08 -49.95 75.64 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.446 -0.784 . . . . 1.42 109.804 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -70.14 -41.13 74.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 2.27 110.597 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.72 -40.45 69.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.007 -1.058 . . . . 1.57 111.646 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.1 mt -69.98 -40.32 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.981 -1.074 . . . . 1.19 109.885 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.3 mt -68.99 -36.81 75.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.505 -0.747 . . . . 1.39 109.96 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.76 -49.98 75.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 1.39 111.183 -178.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.9 mt -60.55 -46.16 91.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.638 -1.289 . . . . 1.5 109.808 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.93 -50.07 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.926 . . . . 1.29 109.461 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -74.13 -42.41 60.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.645 -0.66 . . . . 2.64 111.393 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 91' ' ' ALA . 54.9 t0 -79.92 -50.06 10.99 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.901 -1.124 . . . . 1.65 112.052 -177.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -91.03 -4.18 56.59 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.964 -1.085 . . . . 2.5 111.497 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 m80 56.02 36.43 27.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.911 -1.118 . . . . 1.88 109.072 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 53.7 mtt -90.87 169.98 10.46 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.661 -0.65 . . . . 1.71 109.639 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 82.1 p -77.79 153.72 32.57 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.928 -1.138 . . . . 1.61 107.928 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.59 -36.64 73.67 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.944 -1.098 . . . . 1.33 111.028 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -68.57 -39.42 81.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.93 -1.106 . . . . 2.07 109.797 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.5 -41.48 32.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 1.37 109.806 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.38 -42.88 67.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.283 -0.886 . . . . 1.14 110.272 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.68 -40.11 96.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.103 -0.998 . . . . 1.26 109.587 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -59.9 -40.05 87.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.5 -0.75 . . . . 2.02 110.3 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.522 ' O ' ' N ' ' A' ' 110' ' ' GLY . 86.3 tt0 -60.74 -39.97 90.66 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.138 -0.976 . . . . 1.33 109.994 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.61 -52.15 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.297 -0.877 . . . . 1.3 110.657 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.2 mm -70.06 -40.01 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.989 -1.069 . . . . 1.32 108.327 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -68.15 -32.94 73.56 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.452 -0.944 . . . . 2.44 108.452 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -65.22 -51.3 51.04 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.174 -1.17 . . . . 0.99 110.174 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -60.04 -49.3 78.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.967 -1.314 . . . . 1.97 109.248 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.67 81.4 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.311 -0.868 . . . . 1.43 109.691 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.9 p -59.3 -39.94 84.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.041 -1.037 . . . . 2.12 109.287 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.21 -40.06 94.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 1.64 108.823 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.0 mt -63.4 -42.68 98.79 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.123 -0.986 . . . . 1.93 109.096 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -56.82 -34.38 67.65 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.019 -1.051 . . . . 2.2 109.291 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.11 -23.15 65.29 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.245 -0.91 . . . . 2.12 109.267 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 55.4 mt -62.14 140.75 58.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.04 -1.037 . . . . 2.34 108.519 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -93.84 49.09 1.31 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.911 -1.118 . . . . 3.23 110.836 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -135.35 137.9 42.83 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.129 -0.982 . . . . 2.49 109.835 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 52.0 mp0 -70.12 -31.62 69.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.605 -0.684 . . . . 3.95 110.308 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.62 ' CZ ' ' NH1' ' A' ' 126' ' ' ARG . 3.5 t80 -73.8 -40.11 63.63 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.109 -0.994 . . . . 2.25 110.916 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.596 ' CD2' HH22 ' A' ' 126' ' ' ARG . 60.7 mt -69.44 -36.56 76.76 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.109 -0.995 . . . . 2.27 108.604 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.19 -36.99 85.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 3.31 110.004 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -59.82 -45.19 93.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.948 -1.095 . . . . 2.73 110.796 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.62 ' NH1' ' CZ ' ' A' ' 122' ' ' TYR . 25.6 mtm-85 -66.06 -34.51 78.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.599 -1.313 . . . . 3.2 108.756 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.27 -35.47 73.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 1.66 108.519 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.95 92.93 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.345 -0.983 . . . . 1.67 108.345 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -68.42 -39.94 81.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.407 -0.808 . . . . 1.55 109.856 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 43.7 t -69.38 -40.03 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.004 -1.06 . . . . 1.32 108.749 179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -60.07 -38.91 84.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 3.58 108.42 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -59.97 -38.82 83.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.541 -0.724 . . . . 1.46 109.916 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.9 -42.83 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.046 -1.034 . . . . 1.22 109.679 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.87 -35.27 72.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.724 -1.35 . . . . 0.61 109.724 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.98 -48.9 79.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -1.207 . . . . 3.1 110.185 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 59.1 mtp180 -67.07 -27.89 67.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.615 -1.303 . . . . 3.71 109.914 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.8 tp -59.54 -42.03 91.4 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.232 -1.025 . . . . 1.87 108.232 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.6 -40.05 95.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 1.29 109.414 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.531 ' NH2' ' OE1' ' A' ' 21' ' ' GLU . 99.0 mtt180 -67.58 -39.94 84.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.305 -0.872 . . . . 3.05 109.965 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -69.86 -31.6 69.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 1.26 112.062 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.1 mt -68.91 -51.62 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.087 -1.633 . . . . 1.34 108.226 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 98.5 mt -70.04 -39.94 75.43 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.068 -0.653 . . . . 1.6 109.348 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.16 52.59 2.35 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.497 -1.441 . . . . 0.96 109.497 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 tp -73.84 150.03 41.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.235 -1.156 . . . . 1.67 108.493 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.65 139.56 53.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.03 -1.044 . . . . 4.96 110.051 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.2 mt -110.01 129.96 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 122.046 0.927 . . . . 1.68 109.297 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.0 mt -69.8 -40.0 78.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 115.778 -0.646 . . . . 2.14 110.166 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 39.8 t0 63.29 131.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.451 0.643 . . . . 1.5 109.361 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.3 mt -85.44 -2.62 58.31 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.706 -0.85 . . . . 1.39 108.706 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.5 p -83.95 -9.6 58.57 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.82 -0.807 . . . . 1.83 108.82 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -86.04 22.72 1.65 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.531 -0.731 . . . . 1.46 109.798 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 66.0 mt -90.48 120.99 40.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.337 -0.852 . . . . 1.42 109.045 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -102.74 -13.98 16.84 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.269 -0.895 . . . . 2.94 110.123 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -130.23 151.61 50.56 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.59 -0.693 . . . . 1.52 110.11 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.28 137.15 58.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 1.58 108.768 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.8 m -153.14 168.05 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.519 -0.738 . . . . 1.32 110.067 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -95.11 146.16 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 106.564 -1.643 . . . . 1.27 106.564 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 49.6 tp -96.83 120.21 36.75 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.106 -0.996 . . . . 1.41 110.8 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.2 t -126.41 130.03 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 108.981 -0.748 . . . . 1.23 108.981 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.8 168.57 24.48 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.197 -0.939 . . . . 1.32 109.043 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.78 -37.92 73.36 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.364 -1.46 . . . . 1.49 108.006 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -170.59 145.36 2.53 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.743 -0.836 . . . . 2.25 108.743 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 48.1 mt -112.87 134.67 54.27 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.324 -0.86 . . . . 1.35 109.443 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 11.6 p -90.76 148.84 39.3 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.198 -0.939 . . . . 1.56 109.122 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.35 -32.98 5.73 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.949 1.766 . . . . 0.87 112.485 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 66.7 m -55.88 -45.56 78.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.085 -1.009 . . . . 1.36 109.444 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -69.96 -40.08 75.63 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.372 -0.83 . . . . 1.61 109.539 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.507 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 44.0 p -55.3 -18.37 6.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.233 -0.917 . . . . 1.21 110.935 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -88.46 -46.93 8.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.793 -1.192 . . . . 1.21 109.643 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -90.11 41.2 1.04 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.926 -1.138 . . . . 2.11 107.926 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.1 tp -105.0 131.19 52.84 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.733 -0.604 . . . . 1.29 109.591 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -85.43 97.51 10.06 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.175 -1.046 . . . . 2.81 108.175 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.28 -39.87 95.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.435 -0.791 . . . . 2.09 110.804 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -64.86 -25.51 67.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.082 -1.011 . . . . 2.86 111.033 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -93.96 -10.16 34.61 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.746 -1.221 . . . . 2.39 110.164 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 62.6 t -107.12 119.91 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.225 -0.922 . . . . 1.27 108.678 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.1 mt -94.45 11.58 30.23 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.399 -0.813 . . . . 2.17 111.051 -177.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 171.17 170.27 35.11 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.267 -1.533 . . . . 0.52 109.267 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -136.75 133.56 36.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.365 -1.079 . . . . 0.55 109.118 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 75.6 mt -135.41 128.4 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.751 -0.833 . . . . 1.27 108.751 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' A' ' 205' ' ' THR . 34.3 p -144.98 158.64 43.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 1.39 110.626 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 183' ' ' ALA . 86.2 m-20 -94.05 17.23 12.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.602 -0.686 . . . . 2.46 109.778 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -44.32 -179.51 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.496 1.141 . . . . 1.51 113.029 -177.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.8 -52.99 5.57 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.281 -1.127 . . . . 2.23 110.281 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -168.33 -159.88 14.91 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 118.558 -1.782 . . . . 2.23 111.46 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.424 ' O ' ' OG ' ' A' ' 191' ' ' SER . 11.3 ptt180 -69.98 -13.88 62.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 122.18 -0.6 . . . . 6.44 111.129 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 41.2 p -74.32 5.22 4.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.882 -1.136 . . . . 4.09 109.036 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 91.7 p -87.63 141.23 28.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.368 -0.832 . . . . 2.2 110.39 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -54.88 -38.66 67.82 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.293 -0.879 . . . . 1.15 108.997 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.2 p -59.85 -39.95 86.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.682 -0.637 . . . . 2.01 109.941 -179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.531 ' HG ' ' N ' ' A' ' 192' ' ' ILE . 93.9 p -61.31 -38.24 86.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 1.93 110.113 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.531 ' N ' ' HG ' ' A' ' 191' ' ' SER . 41.2 mm -60.01 -39.92 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 2.2 109.074 -179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.0 mtp -56.14 -49.69 73.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.094 -1.004 . . . . 1.32 109.967 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.96 -44.71 78.74 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.093 -1.004 . . . . 1.3 109.915 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -61.64 -58.96 6.01 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.293 -0.963 . . . . 3.38 110.601 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.2 m -63.12 -39.67 95.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.204 -0.935 . . . . 1.15 111.554 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.7 mt -70.04 -30.05 67.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.831 -1.168 . . . . 1.28 109.402 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 70.52 49.56 0.41 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.342 0.592 . . . . 1.5 109.671 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 55.9 mt -130.1 150.03 74.89 Favored Pre-proline 0 N--CA 1.503 2.193 0 N-CA-C 108.256 -1.016 . . . . 1.37 108.256 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.74 138.18 84.82 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 122.204 1.936 . . . . 0.76 112.051 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.43 151.13 3.63 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.402 -0.919 . . . . 1.19 111.139 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 75.7 mt -127.67 139.77 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 107.208 -1.405 . . . . 1.31 107.208 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 32.4 m -123.05 -14.41 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.204 -0.935 . . . . 1.38 111.424 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -106.04 26.94 19.11 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.489 -1.444 . . . . 1.03 109.489 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.468 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 1.7 p -52.64 -37.2 58.12 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.234 -1.156 . . . . 1.38 110.41 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.63 -80.54 1.68 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.488 -1.339 . . . . 1.17 110.668 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.424 ' O ' ' OG ' ' A' ' 207' ' ' SER . 21.9 t -129.81 31.89 4.66 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 121.426 -1.044 . . . . 2.07 112.333 -177.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 55.7 t -69.83 -40.22 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.408 -1.432 . . . . 1.35 107.931 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 72.3 p -53.88 -28.91 39.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.644 -0.66 . . . . 1.49 109.898 -179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.421 ' OG ' ' OG ' ' A' ' 207' ' ' SER . 28.1 p -80.56 -19.4 45.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.021 -1.05 . . . . 2.16 110.135 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -96.62 -13.56 22.78 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.165 -0.96 . . . . 2.89 110.148 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.2 t -102.53 136.5 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.271 -0.893 . . . . 1.33 110.635 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -115.24 157.04 24.29 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.46 -1.311 . . . . 2.73 107.46 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 46.9 p-10 -60.03 139.99 57.1 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.814 -1.179 . . . . 2.7 110.265 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.7 m-20 80.87 4.29 1.59 Allowed 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.109 0.48 . . . . 2.38 110.028 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -71.13 130.03 40.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.197 -0.939 . . . . 2.09 109.022 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -84.63 112.92 20.88 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.111 -1.07 . . . . 1.45 108.111 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 54.8 mt -123.77 147.26 47.68 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.595 -0.69 . . . . 1.31 110.87 -178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 75.8 mt -114.38 127.68 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.813 -1.551 . . . . 1.29 106.813 177.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.4 tp -100.4 118.14 36.03 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.826 -1.171 . . . . 1.31 109.622 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.552 ' C ' ' H ' ' A' ' 223' ' ' VAL . 96.0 m-20 -75.7 -43.4 47.36 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.096 -1.002 . . . . 2.31 108.407 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 50.04 10.55 0.05 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.948 -0.76 . . . . 1.19 108.948 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.552 ' H ' ' C ' ' A' ' 221' ' ' ASP . 52.9 t -130.31 -37.31 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 106.985 -1.487 . . . . 1.45 106.985 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -102.07 -2.9 28.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.388 -1.338 . . . . 3.13 107.388 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.461 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 62.67 40.11 10.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.902 -0.499 . . . . 2.2 110.578 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -140.95 147.18 38.39 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.112 -0.993 . . . . 2.32 109.923 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.96 123.04 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.492 -0.755 . . . . 1.4 109.388 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -91.26 134.3 34.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.026 -1.046 . . . . 1.29 109.156 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 44.1 t -105.17 115.32 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.545 -0.722 . . . . 1.38 110.115 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 50.12 61.12 14.15 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.145 -0.972 . . . . 2.33 111.712 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -83.17 153.05 14.21 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.745 2.296 . . . . 0.95 111.875 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 82.1 p -70.32 162.3 28.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.145 -0.972 . . . . 2.31 110.697 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.404 ' ND2' ' H ' ' A' ' 233' ' ' ASN . 2.6 p30 -60.13 -36.1 76.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.639 -0.663 . . . . 3.45 110.029 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -60.05 -38.29 82.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.197 -0.939 . . . . 2.89 108.858 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.6 t -69.71 -40.0 78.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.319 -0.863 . . . . 1.73 109.223 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.6 mt -68.45 -39.95 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 1.57 110.299 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -60.03 -41.27 91.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.844 -1.16 . . . . 2.43 108.47 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -65.29 -40.01 93.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.482 -0.761 . . . . 3.18 109.141 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 93.8 mtp -71.25 -30.31 66.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.407 -0.808 . . . . 1.59 109.882 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.475 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.1 OUTLIER -68.23 -41.35 81.37 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.183 -0.948 . . . . 3.11 109.344 179.537 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.93 92.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.178 -0.951 . . . . 2.17 108.474 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.4 t -62.19 -42.34 94.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.951 -0.759 . . . . 2.51 108.951 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -60.27 -40.16 89.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.431 -0.793 . . . . 3.82 108.963 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.06 -40.09 88.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.361 -0.837 . . . . 1.78 109.424 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -63.97 -40.05 95.52 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.353 -0.98 . . . . 2.77 108.353 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.25 -40.41 88.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.809 -0.811 . . . . 2.25 108.809 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.54 -37.52 87.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.517 -0.74 . . . . 2.54 109.343 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 63.0 m -59.99 -40.18 88.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 3.03 109.434 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -63.71 -31.94 73.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.449 -0.782 . . . . 3.34 109.665 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -59.9 -37.82 80.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.326 -0.859 . . . . 4.18 110.04 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.42 -37.77 76.04 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.214 -0.929 . . . . 4.43 110.418 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 252' ' ' GLU . 31.2 mp0 -54.99 -17.93 4.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.054 -1.029 . . . . 5.42 109.835 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 98.3 mt -69.25 -39.17 78.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.026 -1.047 . . . . 6.11 109.265 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 255' ' ' LYS . . . -76.15 -9.07 58.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.249 -0.907 . . . . 7.37 109.221 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.556 ' C ' ' H ' ' A' ' 257' ' ' LYS . 44.1 pttt 30.08 -121.26 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 120.811 0.338 . . . . 8.3 111.698 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 88.5 mt 55.79 4.33 0.11 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.278 -0.889 . . . . 9.05 109.111 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.556 ' H ' ' C ' ' A' ' 255' ' ' LYS . 61.4 tttp -163.84 145.99 9.33 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.609 -0.886 . . . . 10.56 108.609 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 257' ' ' LYS . 58.3 m-20 -157.79 90.76 1.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.988 -1.07 . . . . 11.32 109.274 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.013 -0.994 . . . . 12.74 109.254 179.926 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 301' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' B' ' 302' ' ' PHE . 13.1 tmm? . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.641 0.734 . . . . 0.0 109.649 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . 0.591 ' N ' ' SD ' ' B' ' 301' ' ' MET . 24.5 t80 -152.69 150.1 29.1 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -146.55 155.31 42.41 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.139 -0.976 . . . . 0.0 110.501 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -152.26 147.94 26.96 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -108.88 127.61 54.19 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.0 p -128.43 123.91 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 CA-C-O 122.407 1.099 . . . . 0.0 111.94 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 27.1 m -77.5 103.58 7.52 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.066 0.936 . . . . 0.0 110.926 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 89.5 mt -52.23 122.0 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 122.449 1.118 . . . . 0.0 110.049 -178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 71.2 p -103.02 23.4 12.36 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.708 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -83.38 116.72 65.9 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.95 . . . . 0.0 109.052 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -66.52 -6.95 16.42 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 CA-C-N 120.23 1.118 . . . . 0.0 111.504 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -118.09 5.96 12.05 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.48 177.47 34.55 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.469 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -87.28 94.34 9.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.153 -1.204 . . . . 0.0 108.824 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -96.88 -159.53 0.74 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.172 -0.955 . . . . 0.0 110.181 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 16.9 m -58.18 -46.84 85.07 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.971 -1.08 . . . . 0.0 112.637 -176.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.624 ' NH2' ' NE2' ' B' ' 321' ' ' GLN . 1.8 tpt180 -58.86 -61.45 7.74 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 120.425 -1.422 . . . . 0.0 112.09 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -58.8 -32.31 96.89 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 CA-C-N 120.373 1.169 . . . . 0.0 111.579 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.31 70.19 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.961 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.89 -41.0 67.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.882 . . . . 0.0 109.815 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . 0.624 ' NE2' ' NH2' ' B' ' 317' ' ' ARG . 40.3 mt-30 -69.97 -42.76 72.73 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.948 -1.095 . . . . 0.0 108.896 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -61.02 -51.67 68.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 110.348 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 73.8 t -67.72 -30.12 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.625 -1.297 . . . . 0.0 109.981 -179.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -60.05 -45.69 92.02 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.335 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -60.16 -49.95 75.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.037 -1.039 . . . . 0.0 109.225 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.97 74.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.305 -0.872 . . . . 0.0 110.657 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -49.65 -20.05 0.72 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.287 -0.883 . . . . 0.0 109.37 -178.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -81.6 -17.05 71.75 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -106.15 140.55 38.94 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.322 -1.105 . . . . 0.0 109.771 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 51.3 m -90.72 -12.98 34.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.109 -0.994 . . . . 0.0 109.34 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 331' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 58.5 m -61.24 144.74 53.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.335 -0.853 . . . . 0.0 109.587 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -67.32 135.98 54.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.059 -1.026 . . . . 0.0 109.298 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 88.8 mt -133.98 134.14 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.615 -0.678 . . . . 0.0 109.983 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 85.5 m -129.26 148.44 51.19 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.504 -0.747 . . . . 0.0 109.152 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 63.3 t -120.5 114.78 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 98.0 m -106.52 130.39 54.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.169 -0.957 . . . . 0.0 109.477 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 25.2 p -139.4 119.36 13.43 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.778 0.799 . . . . 0.0 110.787 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 41.71 52.87 4.01 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 177.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 84.06 -16.26 33.97 Favored Glycine 0 N--CA 1.5 2.938 0 O-C-N 120.293 -1.504 . . . . 0.0 112.507 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -110.56 122.63 48.22 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.796 -1.414 . . . . 0.0 109.472 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 56.7 p -129.84 150.62 51.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.741 0.782 . . . . 0.0 110.431 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -146.46 170.01 17.73 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.644 0.735 . . . . 0.0 110.204 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 16.5 m -88.62 139.04 30.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.575 -0.703 . . . . 0.0 110.011 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -80.49 -13.88 58.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.958 -1.089 . . . . 0.0 110.321 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -88.52 20.29 3.46 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.495 ' H ' ' C ' ' B' ' 344' ' ' ALA . 45.0 t -148.37 95.74 2.5 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.699 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 59.0 tp -60.35 -34.62 74.11 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -55.67 -52.49 63.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.134 -0.979 . . . . 0.0 109.891 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.431 ' O ' ' OG1' ' B' ' 352' ' ' THR . 53.9 mtpt -69.58 -40.13 76.91 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.264 -0.898 . . . . 0.0 110.226 -178.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' B' ' 352' ' ' THR . 80.5 mt -50.88 -54.68 21.9 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.984 -1.073 . . . . 0.0 108.608 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -40.15 -12.43 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.855 -0.528 . . . . 0.0 111.647 -178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.626 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.5 p -93.64 -10.78 33.39 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.589 -1.319 . . . . 0.0 110.627 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 64.0 mt -93.38 119.79 32.9 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.764 -1.21 . . . . 0.0 109.837 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.06 91.01 1.0 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 29.4 mt -96.56 86.83 4.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -1.127 . . . . 0.0 108.199 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 356' ' ' THR . . . . . 0.515 ' C ' ' HG1' ' B' ' 359' ' ' THR . 65.9 p -92.5 -179.72 5.28 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.19 -0.944 . . . . 0.0 111.257 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' B' ' 359' ' ' THR . 7.4 tt0 -49.53 153.99 1.03 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.331 1.062 . . . . 0.0 111.303 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.73 26.88 0.05 OUTLIER Glycine 0 N--CA 1.495 2.58 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.906 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 359' ' ' THR . . . . . 0.515 ' HG1' ' C ' ' B' ' 356' ' ' THR . 24.1 m -84.87 110.42 18.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.884 -1.363 . . . . 0.0 109.449 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 23.3 t -77.33 114.58 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 122.333 1.063 . . . . 0.0 109.698 -177.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 15.1 m -109.98 177.91 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 27.8 m -130.31 126.9 38.33 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 65.7 mt -102.36 112.65 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 44.8 p -115.5 130.05 56.75 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.2 149.5 38.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.296 -0.877 . . . . 0.0 109.618 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -143.88 123.94 13.63 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.412 ' H ' ' HG2' ' B' ' 370' ' ' GLU . . . 160.82 -161.85 33.09 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.157 -1.497 . . . . 0.0 111.577 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.85 -50.5 73.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 122.211 -0.582 . . . . 0.0 112.296 -177.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.528 ' N ' ' OG ' ' B' ' 331' ' ' SER . 95.8 m-20 -111.08 10.65 22.02 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.919 -1.113 . . . . 0.0 110.837 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.412 ' HG2' ' H ' ' B' ' 367' ' ' GLY . 0.7 OUTLIER -45.59 -32.87 2.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.036 -1.04 . . . . 0.0 111.334 -178.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -71.81 -40.06 69.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.857 -1.152 . . . . 0.0 109.87 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -68.46 -40.38 81.08 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 110.802 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.53 -64.01 0.98 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.58 -1.325 . . . . 0.0 111.088 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 45.2 t -45.33 -39.56 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.015 -1.053 . . . . 0.0 109.988 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -61.37 -51.56 68.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.917 -1.114 . . . . 0.0 110.341 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -75.15 -39.93 60.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.015 -1.053 . . . . 0.0 111.094 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.22 -37.27 77.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.11 -0.994 . . . . 0.0 108.827 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.48 -43.44 98.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.209 -0.932 . . . . 0.0 109.607 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' B' ' 383' ' ' GLU . 0.5 OUTLIER -70.02 -55.72 8.83 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.615 -1.303 . . . . 0.0 107.735 178.525 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 60.4 tp -56.52 -35.92 68.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 109.935 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 33.7 ttm -71.72 -40.6 69.33 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.704 -1.248 . . . . 0.0 109.011 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.39 -5.38 57.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.652 -0.655 . . . . 0.0 110.139 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' B' ' 379' ' ' LYS . 64.3 mm-40 -110.66 -1.07 16.92 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.228 -0.92 . . . . 0.0 110.833 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.9 mt -87.24 128.5 35.15 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.546 -1.346 . . . . 0.0 108.783 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.44 -179.629 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mpp? . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.266 0.555 . . . . 3.19 109.816 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -111.18 130.02 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.608 -0.683 . . . . 1.71 109.346 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.2 m -132.24 121.13 23.16 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.233 -0.917 . . . . 1.66 108.712 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.18 -166.75 32.78 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.611 -1.395 . . . . 1.05 109.611 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 88.9 mt -87.42 -6.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.03 -1.276 . . . . 1.59 109.758 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 23.7 tp 57.35 89.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.394 -0.816 . . . . 1.47 109.359 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.73 83.14 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.866 -1.161 . . . . 1.39 107.866 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 1.5 p -150.54 146.26 19.49 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 109.006 -0.739 . . . . 2.09 109.006 179.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.56 143.75 15.37 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.587 2.191 . . . . 0.91 113.272 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 165.88 -163.35 36.68 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.221 -1.552 . . . . 0.92 109.221 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.9 mt -148.58 147.54 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.971 -1.311 . . . . 1.35 108.933 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.88 147.84 28.42 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.875 -1.141 . . . . 1.14 110.537 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -128.5 120.71 27.32 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.818 -1.179 . . . . 0.7 107.818 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.82 -179.91 45.82 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 117.943 -2.075 . . . . 0.58 111.228 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -80.28 160.05 25.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.913 -0.757 . . . . 2.63 110.174 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.59 130.51 49.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.686 -0.634 . . . . 1.27 110.931 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.4 tp -100.38 135.42 41.85 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 107.486 -1.302 . . . . 1.41 107.486 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.1 tp -121.4 124.23 44.01 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.226 -0.921 . . . . 1.49 110.027 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 65.7 mt -81.66 103.31 11.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 1.52 109.758 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -96.88 121.69 39.02 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.267 -1.012 . . . . 3.17 108.267 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -130.36 133.68 46.6 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.27 -0.894 . . . . 3.0 110.153 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 42.5 t0 -69.7 141.76 53.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 2.77 109.505 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.496 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 86.3 tt0 -63.58 142.63 58.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.932 . . . . 2.94 109.232 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 80.4 mt -79.73 128.73 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.145 -0.972 . . . . 1.46 108.898 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.5 t -102.56 128.78 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.26 -0.9 . . . . 1.7 109.646 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.55 139.42 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.352 -0.843 . . . . 1.54 109.319 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -91.38 123.63 34.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.083 -1.011 . . . . 1.81 108.955 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.441 HH11 ' HG2' ' A' ' 28' ' ' ARG . 5.4 mmt-85 -89.96 -0.89 57.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.442 -0.786 . . . . 3.23 109.15 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -68.56 139.78 55.59 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.42 -0.8 . . . . 3.29 109.707 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -86.13 146.17 26.71 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.556 -0.905 . . . . 2.8 108.556 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.6 pt -92.66 165.98 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 1.43 109.95 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.3 p -99.71 173.87 6.5 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.488 -0.93 . . . . 1.54 108.488 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.01 -48.13 82.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.947 . . . . 1.6 109.3 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -57.37 -29.08 63.74 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.677 -1.264 . . . . 2.56 109.599 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -82.41 -10.52 59.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 2.36 110.257 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.3 t -62.15 -52.21 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.951 -1.093 . . . . 1.43 108.568 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.89 -40.24 96.94 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.407 -0.808 . . . . 1.77 110.156 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -70.9 -40.14 72.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.132 -0.98 . . . . 3.32 110.542 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -66.06 -40.11 90.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.113 -0.992 . . . . 1.51 110.161 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.2 t -61.68 -43.35 96.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.082 -1.011 . . . . 1.41 108.444 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -59.97 -39.71 86.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 1.81 108.984 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -60.06 -40.93 91.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.935 -1.103 . . . . 3.26 108.228 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -63.92 -47.87 78.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 0.81 108.612 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.5 -49.56 77.07 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.435 -0.58 . . . . 1.59 109.435 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.2 t -60.74 -43.3 98.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.113 -0.992 . . . . 1.38 108.81 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.81 -45.66 96.04 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.714 -1.754 . . . . 0.87 108.714 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -65.36 -32.81 74.64 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.954 -1.128 . . . . 3.62 107.954 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.65 -39.16 76.37 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.578 -0.701 . . . . 1.43 109.255 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.7 ttmt -72.78 -72.98 0.22 Allowed 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.768 -1.197 . . . . 3.08 107.768 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.76 -35.7 0.15 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.449 -0.782 . . . . 1.33 111.068 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.729 ' HG ' ' H ' ' A' ' 52' ' ' ALA . 78.3 p -59.86 -56.29 23.61 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.451 -1.406 . . . . 1.85 108.627 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.729 ' H ' ' HG ' ' A' ' 51' ' ' SER . . . -67.67 -42.68 81.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.144 -0.973 . . . . 1.35 110.644 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -65.24 -39.99 93.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.063 -1.023 . . . . 2.34 110.621 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.9 mt -66.63 -40.2 88.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.743 -1.223 . . . . 2.2 109.818 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -62.04 -36.33 81.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.991 -1.068 . . . . 1.35 109.554 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.9 m -64.04 -40.38 96.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.189 -0.944 . . . . 1.34 110.311 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.54 -38.81 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.131 -0.981 . . . . 1.26 109.45 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -55.62 -50.43 70.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.392 -0.817 . . . . 1.7 110.612 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -59.67 -39.92 86.09 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.199 -0.938 . . . . 1.35 110.224 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -66.22 -35.65 80.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 2.08 109.513 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.1 -43.11 99.39 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.498 -0.751 . . . . 1.21 109.942 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.38 -50.69 42.5 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.942 -1.263 . . . . 0.75 109.942 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.41 -45.97 92.12 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.202 -1.175 . . . . 1.59 108.642 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.5 m -68.52 -58.64 4.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.457 -0.777 . . . . 1.41 111.663 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -97.96 -54.17 3.17 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.002 -1.061 . . . . 0.79 111.265 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.35 -169.31 25.49 Favored Glycine 0 N--CA 1.504 3.191 0 O-C-N 120.694 -1.254 . . . . 1.22 111.573 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -68.59 -27.79 66.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.913 -0.757 . . . . 5.81 111.001 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -62.56 -36.31 82.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 3.37 110.089 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -98.51 -22.37 16.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.397 -0.814 . . . . 2.37 110.228 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -67.92 -40.14 83.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.0 -1.062 . . . . 1.65 110.457 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.571 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -69.34 -26.09 64.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 1.42 110.08 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.4 mt -59.88 -40.65 83.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 120.872 -1.142 . . . . 1.43 108.068 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -69.98 -37.61 75.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.428 -0.795 . . . . 1.08 110.139 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.516 ' OE2' ' NZ ' ' B' ' 324' ' ' LYS . 65.6 tt0 -60.65 -40.11 90.81 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.081 -1.012 . . . . 1.37 109.696 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.46 -45.91 81.72 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.381 -1.488 . . . . 0.67 109.381 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -60.43 -42.57 96.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -1.147 . . . . 1.99 109.539 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.1 mt -69.82 -41.09 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.124 -0.985 . . . . 1.22 109.531 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.8 ttp -62.57 -40.2 96.09 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.947 -1.096 . . . . 2.11 109.536 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 54.1 tp -64.89 -38.55 91.35 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.454 -0.779 . . . . 1.33 109.855 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.5 tp -62.08 -40.14 94.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.438 -0.789 . . . . 1.29 110.305 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -84.29 5.84 25.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.011 -1.055 . . . . 1.47 110.287 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 61.5 t0 -49.29 133.36 19.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.007 -1.058 . . . . 1.47 110.114 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.475 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 45.7 mt-10 -59.15 -21.22 59.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.809 -0.557 . . . . 1.78 110.507 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -71.03 -34.31 71.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.939 -1.101 . . . . 2.53 109.309 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.4 mt -71.07 -41.03 71.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.566 -0.709 . . . . 1.36 110.111 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -60.48 -47.69 85.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.533 -0.729 . . . . 1.42 110.653 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -69.82 -40.61 75.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.06 -1.025 . . . . 2.27 110.227 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.63 -39.9 70.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 1.57 111.875 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.55 -47.82 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.758 -1.213 . . . . 1.19 109.83 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.7 mt -69.66 -38.48 76.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.243 -0.911 . . . . 1.39 109.99 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.81 93.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.011 -1.056 . . . . 1.39 109.964 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.4 -45.98 88.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.839 -1.163 . . . . 1.5 109.406 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.66 -46.8 93.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.303 -0.873 . . . . 1.29 108.88 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -69.82 -42.36 73.77 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.334 -0.854 . . . . 2.64 111.602 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -86.08 -51.64 6.2 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.78 -1.2 . . . . 1.65 112.596 -177.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -88.8 -2.6 58.67 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.941 -1.099 . . . . 2.5 111.479 -177.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 56.8 37.98 29.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.908 -1.12 . . . . 1.88 109.709 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.1 mtt -87.44 169.21 12.43 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.548 -0.72 . . . . 1.71 110.043 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.1 p -84.37 160.3 20.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.875 . . . . 1.61 108.85 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.75 -38.94 87.62 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.05 -1.032 . . . . 1.33 110.032 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 38.6 p-10 -69.66 -36.8 76.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.983 -1.073 . . . . 2.07 110.168 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.48 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -81.57 -47.47 13.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.958 -1.088 . . . . 1.37 110.065 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.19 -49.76 76.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -0.875 . . . . 1.14 109.845 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.38 85.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.1 -1.0 . . . . 1.26 109.561 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.53 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 78.7 t60 -60.19 -41.99 94.1 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 2.02 110.263 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -62.34 -40.03 95.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.077 -1.014 . . . . 1.33 110.804 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.31 -56.33 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.948 -1.095 . . . . 1.3 111.613 -177.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.1 mm -69.24 -39.95 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.654 -1.279 . . . . 1.32 109.627 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.53 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.7 tt0 -60.31 -40.05 89.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.083 -1.011 . . . . 2.44 109.413 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.78 -49.37 79.33 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.405 -1.078 . . . . 0.99 110.405 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -67.97 -56.34 9.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.974 -1.31 . . . . 1.97 109.607 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.22 -42.7 63.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.726 -1.234 . . . . 1.43 109.041 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.4 t -59.84 -40.16 87.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.029 -1.045 . . . . 2.12 108.723 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.29 93.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.34 -0.85 . . . . 1.64 109.206 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.9 mt -66.47 -40.09 89.18 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.239 -0.913 . . . . 1.93 109.385 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.07 -33.52 72.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.986 -1.071 . . . . 2.2 109.941 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -58.74 -21.02 54.25 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.983 -1.073 . . . . 2.12 108.768 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.2 mt -62.77 139.64 58.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.232 -0.918 . . . . 2.34 109.247 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -92.46 46.1 1.23 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.981 -1.075 . . . . 3.23 108.929 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -132.12 130.74 41.57 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.4 -0.812 . . . . 2.49 110.033 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -69.9 -33.83 72.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.534 -0.729 . . . . 3.95 110.641 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.487 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.2 t80 -70.24 -40.21 74.6 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.121 -0.987 . . . . 2.25 110.566 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.569 ' CD2' HH21 ' A' ' 126' ' ' ARG . 82.4 mt -70.05 -35.96 74.64 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.954 -1.091 . . . . 2.27 108.747 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -59.93 -40.0 87.42 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.658 -0.651 . . . . 3.31 109.285 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -59.79 -46.5 89.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.857 -1.152 . . . . 2.73 110.011 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.569 HH21 ' CD2' ' A' ' 123' ' ' LEU . 74.0 mtm180 -62.62 -35.81 80.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.634 -1.291 . . . . 3.2 108.766 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.9 -32.29 70.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.368 -0.833 . . . . 1.66 108.813 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.64 -40.05 94.77 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.803 -0.814 . . . . 1.67 108.803 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -68.07 -40.54 82.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.442 -0.787 . . . . 1.55 110.039 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.436 HG21 HE22 ' B' ' 351' ' ' GLN . 49.9 t -70.22 -40.31 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.049 -1.032 . . . . 1.32 109.263 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -60.9 -40.34 92.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.955 -1.09 . . . . 3.58 108.449 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -60.03 -38.97 84.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.579 -0.701 . . . . 1.46 110.181 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.4 mt -59.75 -42.48 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.199 -0.938 . . . . 1.22 111.262 -178.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.94 -32.34 58.91 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.395 -1.384 . . . . 0.61 110.566 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -59.99 -48.57 81.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.037 -1.273 . . . . 3.1 110.408 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -69.33 -29.98 67.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.761 -1.212 . . . . 3.71 110.219 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.6 -40.08 86.3 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.043 -1.036 . . . . 1.87 108.277 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.89 -39.89 93.55 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.192 -1.04 . . . . 1.29 108.192 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -68.65 -39.87 80.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.322 -0.862 . . . . 3.05 109.582 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -64.98 -33.77 76.85 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.401 -0.812 . . . . 1.26 111.16 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 141' ' ' ILE . 96.6 mt -73.19 -45.83 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.571 -1.33 . . . . 1.34 109.615 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.2 mt -69.98 -30.08 67.33 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.681 -0.808 . . . . 1.6 108.989 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.34 40.61 6.02 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.811 -1.716 . . . . 0.96 108.811 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 24.3 tp -74.31 147.52 42.22 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.408 -1.054 . . . . 1.67 109.026 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -65.87 147.31 53.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.309 -0.869 . . . . 4.96 110.217 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.4 mt -115.63 123.17 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 108.524 -0.917 . . . . 1.68 108.524 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.41 HD11 HG23 ' A' ' 147' ' ' ILE . 20.6 mm -59.54 -49.01 85.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.765 -0.585 . . . . 2.14 110.574 -177.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.2 t0 67.72 101.42 0.05 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.51 -0.744 . . . . 1.5 109.085 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.452 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 91.2 mt -72.68 -1.97 18.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -0.867 . . . . 1.39 110.195 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.5 t -81.85 -10.84 59.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 1.83 108.402 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.03 26.25 0.63 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.739 -0.6 . . . . 1.46 110.496 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.452 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 50.3 mt -91.69 123.66 43.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.209 -0.932 . . . . 1.42 109.425 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -105.86 -10.95 16.41 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.213 -0.93 . . . . 2.94 109.975 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -134.02 155.07 50.65 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.137 -0.977 . . . . 1.52 110.512 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.31 134.51 56.59 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.695 0.76 . . . . 1.58 109.53 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.1 m -151.85 164.16 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.729 -0.841 . . . . 1.32 108.729 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.5 mt -94.96 144.72 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.766 -1.568 . . . . 1.27 106.766 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -92.64 117.63 30.18 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.814 -1.178 . . . . 1.41 110.131 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 3.5 t -126.44 132.99 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.619 -0.882 . . . . 1.23 108.619 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.64 165.46 30.59 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.344 -0.847 . . . . 1.32 108.912 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.0 -34.53 71.44 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.452 -1.405 . . . . 1.49 107.464 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 12.9 t70 -162.34 167.37 23.91 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.366 -0.976 . . . . 2.25 108.366 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.421 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 92.8 mt -140.55 132.48 27.67 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.215 -0.928 . . . . 1.35 108.746 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 5.6 p -98.95 153.99 37.55 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.302 -0.874 . . . . 1.56 109.606 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -45.37 -33.62 9.22 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.861 1.708 . . . . 0.87 112.327 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.7 m -53.27 -50.08 65.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.945 . . . . 1.36 109.941 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.65 -40.03 94.73 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.444 -0.785 . . . . 1.61 110.703 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 44.7 p -58.13 -18.67 26.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 1.21 111.749 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -86.08 -45.95 10.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.814 -1.179 . . . . 1.21 109.034 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -91.69 41.8 1.08 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.762 -1.199 . . . . 2.11 107.762 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.7 tp -108.74 138.79 44.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.639 -0.663 . . . . 1.29 109.513 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -93.38 99.54 12.03 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.291 -0.881 . . . . 2.81 108.78 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 25.1 mt -65.22 -40.36 94.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.195 -0.94 . . . . 2.09 109.679 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -62.48 -29.57 70.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.067 -1.021 . . . . 2.86 110.792 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.17 -9.2 37.13 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.826 -1.171 . . . . 2.39 110.721 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 77.5 t -104.14 118.18 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.036 -1.04 . . . . 1.27 108.578 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.96 9.41 25.12 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.473 -0.767 . . . . 2.17 111.266 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 166.58 175.41 36.79 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.31 -1.516 . . . . 0.52 109.31 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -134.14 131.27 38.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.46 -1.023 . . . . 0.55 108.835 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 98.0 mt -132.05 124.26 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.723 -0.843 . . . . 1.27 108.723 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 17.6 p -145.4 159.6 42.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.901 -1.124 . . . . 1.39 110.947 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -100.35 19.98 15.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.51 -0.744 . . . . 2.46 109.844 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.23 -162.01 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.695 -1.253 . . . . 1.51 111.379 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -87.26 -45.83 5.19 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 111.305 -0.718 . . . . 2.23 111.305 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 166.83 -145.66 10.11 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 118.43 -1.843 . . . . 2.23 111.245 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -60.69 -9.97 4.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.675 -0.897 . . . . 6.44 110.749 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 82.1 p -78.36 -1.09 31.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.862 -1.148 . . . . 4.09 109.868 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.8 t -91.83 129.78 37.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.178 -0.951 . . . . 2.2 109.927 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -46.26 -48.02 18.01 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.149 -0.97 . . . . 1.15 109.617 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 89.7 m -59.71 -38.51 81.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.61 -0.681 . . . . 2.01 110.866 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 96.6 p -59.81 -39.84 86.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.691 -1.255 . . . . 1.93 110.346 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.4 mm -62.61 -37.9 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 2.2 109.199 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.7 mtp -60.15 -43.79 95.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.37 -0.831 . . . . 1.32 110.162 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.28 -42.88 82.49 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.605 -1.309 . . . . 1.3 108.609 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -60.05 -54.12 49.73 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.619 -0.832 . . . . 3.38 110.425 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.4 m -71.26 -34.36 70.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.133 -0.979 . . . . 1.15 111.199 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.36 -29.74 66.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.01 -1.056 . . . . 1.28 108.724 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 69.99 49.87 0.48 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.236 0.541 . . . . 1.5 110.696 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.477 ' O ' ' OG ' ' A' ' 8' ' ' SER . 43.8 mt -128.27 149.28 70.93 Favored Pre-proline 0 N--CA 1.505 2.311 0 N-CA-C 107.799 -1.185 . . . . 1.37 107.799 178.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.14 143.53 99.74 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 122.21 1.94 . . . . 0.76 112.157 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -172.46 153.37 2.88 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.232 -0.987 . . . . 1.19 111.161 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.2 mt -128.0 143.55 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.847 -1.168 . . . . 1.31 107.847 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 28.3 m -128.78 -11.52 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 O-C-N 120.819 -1.176 . . . . 1.38 111.037 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.64 26.59 17.49 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.413 -1.075 . . . . 1.03 110.413 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.447 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.6 p -45.99 -42.2 12.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.105 -1.232 . . . . 1.38 109.542 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.34 -51.44 4.2 Favored Glycine 0 N--CA 1.494 2.547 0 C-N-CA 120.143 -1.027 . . . . 1.17 111.641 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 14.1 t -158.7 35.42 0.22 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.483 -1.598 . . . . 2.07 111.478 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.82 -40.04 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.128 -0.983 . . . . 1.35 108.747 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 47.2 p -54.77 -27.41 41.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.711 -0.618 . . . . 1.49 110.404 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.8 t -85.75 -12.13 51.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.16 -0.962 . . . . 2.16 110.624 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -104.19 -14.59 15.79 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.168 -0.957 . . . . 2.89 110.673 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 18.7 t -110.79 146.12 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.15 -0.969 . . . . 1.33 111.208 -177.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -113.36 150.11 33.08 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.747 -1.575 . . . . 2.73 106.747 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 56.6 t30 -55.82 139.96 43.83 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.944 -1.097 . . . . 2.7 110.014 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.7 t70 88.92 11.86 0.08 Allowed 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.27 0.557 . . . . 2.38 109.988 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 52.7 t0 -83.41 141.86 31.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.2 -0.938 . . . . 2.09 109.31 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.553 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 51.3 t80 -89.97 117.5 28.82 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.982 -1.118 . . . . 1.45 107.982 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.42 142.17 51.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.57 -0.706 . . . . 1.31 109.749 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.41 HD13 HG23 ' A' ' 219' ' ' ILE . 88.7 mt -110.2 124.75 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.968 -1.493 . . . . 1.29 106.968 177.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 21.4 tp -98.36 115.9 29.43 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.901 -1.124 . . . . 1.31 108.064 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 223' ' ' VAL . 15.0 m-20 -79.43 -44.25 21.74 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.524 -0.917 . . . . 2.31 108.524 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 46.96 14.75 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.043 -0.725 . . . . 1.19 109.043 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' A' ' 221' ' ' ASP . 47.0 t -124.71 -36.29 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.629 -1.619 . . . . 1.45 106.629 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.415 ' OD1' ' NE2' ' A' ' 226' ' ' GLN . 15.6 t-20 -108.61 0.06 20.52 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.864 -1.162 . . . . 3.13 107.864 178.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 65.07 46.22 2.84 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.905 -0.497 . . . . 2.2 111.324 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.415 ' NE2' ' OD1' ' A' ' 224' ' ' ASN . 23.0 pt20 -150.07 150.21 31.4 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.751 -1.218 . . . . 2.32 109.631 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.88 123.84 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.557 -0.905 . . . . 1.4 108.557 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -85.92 129.09 34.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.934 -1.104 . . . . 1.29 109.283 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.59 118.41 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.541 -0.724 . . . . 1.38 109.641 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 60.68 69.8 1.07 Allowed Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.112 -0.993 . . . . 2.33 110.294 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -90.45 132.07 1.73 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 123.532 2.821 . . . . 0.95 112.63 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.8 m -63.96 161.9 14.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.284 -0.885 . . . . 2.31 110.032 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.23 -42.49 95.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.209 -0.932 . . . . 3.45 110.479 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -60.81 -33.0 72.34 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.975 -1.078 . . . . 2.89 109.43 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.17 -40.07 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 1.73 109.3 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.1 mt -64.37 -41.38 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -0.914 . . . . 1.57 109.464 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -60.32 -42.46 95.66 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.993 -1.067 . . . . 2.43 108.789 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -62.59 -44.09 97.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.377 -0.827 . . . . 3.18 109.054 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 84.5 mtp -71.29 -30.62 66.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.492 -0.755 . . . . 1.59 110.68 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -65.04 -44.26 89.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.766 -1.209 . . . . 3.11 109.601 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.55 90.8 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.53 -0.915 . . . . 2.17 108.53 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.84 -39.94 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.803 -0.814 . . . . 2.51 108.803 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -60.08 -42.91 95.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.366 -0.834 . . . . 3.82 108.822 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.82 -36.87 75.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.376 -0.828 . . . . 1.78 109.184 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -60.56 -40.26 90.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 2.77 109.86 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.5 -45.63 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.133 -0.979 . . . . 2.25 109.08 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.1 93.21 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.559 -0.713 . . . . 2.54 109.597 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 252' ' ' GLU . 4.0 t -67.28 -41.84 84.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.377 -0.827 . . . . 3.03 110.589 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -60.3 -39.61 87.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.226 -0.921 . . . . 3.34 109.604 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -59.97 -39.32 85.23 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.824 -0.548 . . . . 4.18 111.664 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -126.35 -34.77 2.46 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.917 -1.114 . . . . 4.43 111.674 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 248' ' ' SER . 92.9 mt-10 -90.1 69.95 7.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.739 -1.226 . . . . 5.42 109.82 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 31.3 mt -84.85 -2.59 57.96 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.023 -1.103 . . . . 6.11 108.023 178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -68.5 -31.49 70.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.593 -0.692 . . . . 7.37 110.386 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -61.01 -15.63 34.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.882 -1.136 . . . . 8.3 109.938 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 258' ' ' ASP . 55.1 tp -59.74 -43.19 94.35 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.243 -0.91 . . . . 9.05 108.71 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -55.82 86.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.392 -0.817 . . . . 10.56 110.161 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.522 ' CG ' ' H ' ' A' ' 259' ' ' ARG . 9.4 p-10 -58.03 -62.94 1.45 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.942 -0.703 . . . . 11.32 109.378 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . 0.522 ' H ' ' CG ' ' A' ' 258' ' ' ASP . 18.9 ttt-85 . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 118.075 -0.964 . . . . 12.74 109.6 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 41.5 ttp . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.444 0.64 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -153.31 150.05 28.52 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -150.93 159.7 44.39 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.866 -1.146 . . . . 0.0 111.064 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -157.6 155.53 30.28 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.696 -0.628 . . . . 0.0 109.331 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -115.28 133.48 55.99 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.147 -0.971 . . . . 0.0 110.559 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.2 p -133.59 124.31 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 CA-C-O 122.11 0.957 . . . . 0.0 112.139 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 25.8 m -78.02 107.08 10.32 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.026 0.917 . . . . 0.0 111.195 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.7 mt -52.92 120.21 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 122.477 1.132 . . . . 0.0 110.451 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 30.6 p -108.45 18.68 20.7 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.967 -178.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . 0.457 ' O ' ' CG ' ' B' ' 357' ' ' GLN . . . -73.01 128.47 87.85 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -63.02 -14.63 42.76 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 CA-C-N 120.309 1.146 . . . . 0.0 112.859 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -120.4 10.32 11.17 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.78 -179.13 49.9 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.487 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 2.8 tp -82.28 87.45 6.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.765 -1.432 . . . . 0.0 109.033 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -92.54 -160.89 0.78 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.918 -1.114 . . . . 0.0 109.865 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.8 m -56.87 -45.66 82.36 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.986 -1.071 . . . . 0.0 112.789 -176.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.571 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 11.9 tpt180 -56.14 -59.1 12.8 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 120.613 -1.305 . . . . 0.0 111.933 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.04 -36.62 69.67 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 120.369 1.167 . . . . 0.0 111.921 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.71 84.74 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.26 -46.23 76.11 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.567 -0.708 . . . . 0.0 109.756 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -70.03 -39.88 75.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.824 -1.172 . . . . 0.0 108.355 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -61.57 -54.97 36.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.406 -0.809 . . . . 0.0 110.603 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.91 -30.63 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.667 -1.271 . . . . 0.0 110.091 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . 0.516 ' NZ ' ' OE2' ' A' ' 74' ' ' GLU . 29.7 ttmt -60.01 -45.41 92.87 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.173 -0.954 . . . . 0.0 109.076 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -68.31 -54.87 14.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 111.029 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -65.0 -54.91 23.04 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.848 -1.158 . . . . 0.0 112.284 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -52.97 -17.25 1.33 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.797 -1.189 . . . . 0.0 109.636 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -73.79 -16.85 79.17 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -105.48 150.54 25.22 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.15 -1.206 . . . . 0.0 109.248 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 14.6 t -89.76 -12.85 38.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.062 -1.024 . . . . 0.0 110.261 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 43.7 t -60.22 142.61 54.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -0.957 . . . . 0.0 109.496 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -67.59 136.08 53.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 108.656 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 79.1 mt -135.46 135.82 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.499 -0.751 . . . . 0.0 109.346 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 96.4 m -130.6 149.69 52.14 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 58.8 t -120.29 114.73 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 55.4 m -104.27 123.58 47.61 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.216 -0.927 . . . . 0.0 109.365 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 56.7 p -130.77 115.25 16.37 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.789 0.804 . . . . 0.0 110.489 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 44.67 59.18 3.49 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 177.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.12 -15.04 18.21 Favored Glycine 0 N--CA 1.498 2.805 0 O-C-N 120.321 -1.487 . . . . 0.0 112.688 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -115.98 127.4 54.91 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-N 118.833 1.317 . . . . 0.0 109.285 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 53.9 p -129.61 150.18 51.05 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.844 0.831 . . . . 0.0 110.369 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.83 168.17 20.39 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 5.6 m -87.82 130.0 35.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.388 -0.82 . . . . 0.0 111.086 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.545 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -68.23 -20.27 64.8 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.395 -0.815 . . . . 0.0 109.322 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.02 21.16 1.09 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.545 ' H ' ' C ' ' B' ' 344' ' ' ALA . 16.7 m -151.39 96.29 2.26 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.756 0.789 . . . . 0.0 111.981 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.94 -33.75 72.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -54.62 -52.46 62.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.391 -0.818 . . . . 0.0 110.716 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.426 ' O ' ' OG1' ' B' ' 352' ' ' THR . 34.1 mtmm -70.34 -40.1 74.3 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.05 -1.032 . . . . 0.0 110.255 -178.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.604 ' O ' ' N ' ' B' ' 352' ' ' THR . 79.3 mt -49.76 -55.16 15.06 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.826 -1.171 . . . . 0.0 108.69 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.436 HE22 HG21 ' A' ' 130' ' ' VAL . 32.3 mt-30 -41.42 -13.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.792 -0.568 . . . . 0.0 110.955 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.604 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.0 p -93.33 -10.41 35.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.286 -1.509 . . . . 0.0 110.158 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 70.2 mt -92.07 117.94 30.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.106 -0.996 . . . . 0.0 108.838 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -71.02 88.96 0.39 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.8 mt -98.33 88.51 4.17 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.224 -1.162 . . . . 0.0 109.189 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 34.3 p -89.95 175.82 7.04 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.943 -1.098 . . . . 0.0 110.96 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . 0.457 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 20.5 tm0? -68.97 113.02 5.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.638 -0.664 . . . . 0.0 110.227 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.97 9.14 37.84 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 45.2 m -87.64 112.05 21.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.165 -1.197 . . . . 0.0 110.847 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 39.0 t -76.5 116.98 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 122.137 0.97 . . . . 0.0 109.861 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 27.3 m -112.57 176.03 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 70.5 m -131.52 128.38 39.21 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 88.2 mt -101.16 113.46 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 51.1 m -116.72 130.57 56.81 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.21 152.72 39.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.126 -0.984 . . . . 0.0 110.654 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -143.77 122.99 12.97 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.546 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.62 -156.55 27.24 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.153 -1.499 . . . . 0.0 111.369 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -59.89 -53.8 53.64 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -103.3 11.37 36.84 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.107 -0.995 . . . . 0.0 111.434 -176.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.546 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 10.6 pt-20 -48.02 -41.62 26.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.102 -0.999 . . . . 0.0 111.779 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . 0.415 ' N ' ' CG ' ' B' ' 370' ' ' GLU . 97.7 mt-30 -69.97 -48.52 57.95 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.636 -1.29 . . . . 0.0 110.335 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -66.11 -45.37 81.37 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.463 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -49.74 -74.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.042 -1.036 . . . . 0.0 110.647 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 39.3 t -45.3 -38.62 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.004 -1.06 . . . . 0.0 110.42 -177.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -63.77 -48.15 78.12 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.828 -1.17 . . . . 0.0 109.861 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -79.52 -42.58 24.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.0 -1.063 . . . . 0.0 110.571 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.9 mt -59.4 -37.14 77.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.924 -1.11 . . . . 0.0 109.079 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 43.1 t -63.15 -40.23 88.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 119.204 -0.998 . . . . 0.0 109.309 179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.5 mttt -69.45 -55.61 9.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.694 -1.254 . . . . 0.0 108.476 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 58.0 tp -57.09 -32.75 66.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 109.452 -178.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 4.6 tpp -71.29 -40.01 71.13 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.543 -1.263 . . . . 0.0 107.885 177.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.4 -7.97 59.66 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.659 -0.651 . . . . 0.0 110.818 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.449 ' O ' ' OE2' ' B' ' 385' ' ' GLU . 96.5 mt-10 -110.33 -0.27 17.71 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 120.822 -1.173 . . . . 0.0 111.317 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.1 mt -82.31 132.36 35.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.394 -1.441 . . . . 0.0 110.238 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 56.4 mp0 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 118.148 -0.929 . . . . 0.0 108.926 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.104 -0.702 . . . . 3.19 109.104 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.418 HD11 HG21 ' A' ' 2' ' ' ILE . 85.4 mt -110.0 130.04 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.398 -0.814 . . . . 1.71 109.822 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.5 m -133.8 147.86 51.28 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.466 -0.771 . . . . 1.66 109.401 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.493 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -127.42 -162.32 11.09 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 108.766 -1.734 . . . . 1.05 108.766 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.8 mt -92.83 -14.64 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.844 -1.386 . . . . 1.59 109.775 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.8 tp 55.21 103.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.528 -0.916 . . . . 1.47 108.528 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.01 -30.08 17.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 1.39 109.104 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.0 t -141.57 126.89 10.8 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.454 -0.779 . . . . 2.09 109.457 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.55 142.82 18.66 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.738 1.625 . . . . 0.91 111.599 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.464 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 165.2 -164.16 36.97 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.35 -1.5 . . . . 0.92 109.35 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -147.32 148.62 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.009 -1.289 . . . . 1.35 109.005 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.33 152.45 32.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.094 -1.004 . . . . 1.14 110.105 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -135.09 124.85 25.35 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.122 -1.066 . . . . 0.7 108.122 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.71 -175.95 47.39 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 118.739 -1.696 . . . . 0.58 110.701 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -79.57 155.63 28.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.868 -0.784 . . . . 2.63 109.534 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -103.04 130.17 50.08 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.48 -0.763 . . . . 1.27 110.461 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.2 tp -98.36 135.51 39.85 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.024 -1.102 . . . . 1.41 108.024 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.9 tp -117.88 124.44 48.31 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.743 0.783 . . . . 1.49 109.756 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.2 mt -99.97 109.97 22.3 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.742 -0.598 . . . . 1.52 110.916 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -110.66 140.84 44.65 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.559 -0.713 . . . . 3.17 109.191 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -126.78 130.86 51.11 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.31 -0.869 . . . . 3.0 108.782 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.2 p-10 -77.58 155.33 31.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.05 -1.032 . . . . 2.77 109.104 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -72.05 141.26 49.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 2.94 109.511 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -82.44 136.4 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.286 -0.884 . . . . 1.46 108.632 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -95.23 129.42 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.098 -1.001 . . . . 1.7 110.071 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.01 135.87 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.598 -0.688 . . . . 1.54 109.303 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -90.93 123.54 34.51 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.995 -1.066 . . . . 1.81 110.242 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -90.04 -3.91 57.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.591 -0.693 . . . . 3.23 110.469 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -70.33 142.79 52.15 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.004 -1.06 . . . . 3.29 110.6 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp -84.3 153.17 23.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.217 -0.927 . . . . 2.8 108.91 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.6 pt -95.05 165.83 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.161 -0.962 . . . . 1.43 109.835 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -93.74 170.75 9.34 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.144 -1.058 . . . . 1.54 108.144 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.41 77.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.812 -1.18 . . . . 1.6 109.722 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -55.49 -28.73 56.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.744 -1.222 . . . . 2.56 109.303 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -81.52 -11.28 59.24 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.39 -0.818 . . . . 2.36 110.069 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -63.34 -51.71 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.751 -1.218 . . . . 1.43 108.94 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -61.47 -39.99 92.9 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.32 -0.862 . . . . 1.77 109.758 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -69.14 -41.33 77.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.896 . . . . 3.32 110.781 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -65.0 -40.05 94.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.831 -1.168 . . . . 1.51 110.015 -179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.6 -45.18 97.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.503 -1.295 . . . . 1.41 107.503 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -60.09 -42.7 95.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 1.81 109.125 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -60.05 -40.16 88.44 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.657 -1.238 . . . . 3.26 107.657 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -66.39 -43.95 84.43 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.421 -0.955 . . . . 0.81 108.421 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.08 -50.01 75.4 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.448 -0.945 . . . . 1.59 108.448 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.7 t -62.34 -43.52 98.64 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.542 -0.863 . . . . 1.38 108.731 179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.76 -44.22 98.22 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.266 -1.934 . . . . 0.87 108.266 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.403 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 32.8 ttt-85 -64.1 -36.03 82.69 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.35 -0.981 . . . . 3.62 108.35 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.77 -40.04 68.99 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.852 -0.795 . . . . 1.43 108.852 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 50' ' ' ALA . 17.1 ttmt -67.96 -74.79 0.11 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.166 -1.05 . . . . 3.08 108.166 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.27 -31.86 0.06 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.529 -0.732 . . . . 1.33 111.028 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 49' ' ' LYS . 47.4 t -59.57 -58.79 7.05 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.706 -1.246 . . . . 1.85 108.634 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.24 -44.51 71.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.275 -0.891 . . . . 1.35 111.261 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -61.05 -44.43 97.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.89 -1.131 . . . . 2.34 110.879 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.52 -40.01 93.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.947 -1.096 . . . . 2.2 110.066 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -60.01 -35.58 75.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.054 -1.029 . . . . 1.35 109.875 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -64.31 -41.42 96.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.04 -1.037 . . . . 1.34 110.145 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.8 mt -60.15 -39.94 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.099 -1.001 . . . . 1.26 109.455 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -59.74 -50.15 74.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 1.7 109.638 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -60.55 -40.02 90.04 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.453 -0.779 . . . . 1.35 110.804 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.57 -39.62 94.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.831 -1.168 . . . . 2.08 109.493 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.86 -42.8 89.95 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.583 -0.698 . . . . 1.21 110.064 -179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.06 -50.17 65.65 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.986 -1.102 . . . . 0.75 110.358 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.78 -42.94 76.69 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.949 -1.324 . . . . 1.59 109.658 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -70.25 -59.12 3.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 1.41 111.944 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 168' ' ' THR . 95.8 m-85 -95.09 -53.39 3.83 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.975 -1.078 . . . . 0.79 111.358 -177.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.14 -167.58 26.0 Favored Glycine 0 N--CA 1.502 3.043 0 C-N-CA 119.773 -1.203 . . . . 1.22 111.474 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -73.29 -26.51 61.11 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.97 -0.724 . . . . 5.81 111.251 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -61.97 -34.69 76.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.006 -1.059 . . . . 3.37 110.245 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -98.83 -24.12 15.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.13 -0.981 . . . . 2.37 110.27 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.61 -40.19 92.35 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.983 -1.073 . . . . 1.65 110.913 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.11 -32.02 70.6 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.213 -0.929 . . . . 1.42 109.747 -178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.97 -41.67 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.11 -0.994 . . . . 1.43 109.313 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -70.13 -38.14 75.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.299 -0.876 . . . . 1.08 111.229 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -59.93 -40.05 87.62 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.723 -1.235 . . . . 1.37 109.683 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.49 -43.94 97.4 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.941 -1.664 . . . . 0.67 108.941 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 59.7 m170 -61.96 -43.03 99.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.457 -1.025 . . . . 1.99 109.403 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.0 mt -68.89 -45.22 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 1.22 109.697 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.0 ttp -59.99 -40.22 88.41 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.024 -1.048 . . . . 2.11 109.902 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.1 tp -65.23 -38.07 89.23 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.493 -0.755 . . . . 1.33 109.912 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.3 tp -66.28 -40.03 89.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.471 -0.768 . . . . 1.29 110.354 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -81.8 4.67 21.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.893 -1.129 . . . . 1.47 109.711 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -50.48 131.86 24.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.364 -0.835 . . . . 1.47 110.183 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -62.34 -17.63 59.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.508 -0.745 . . . . 1.78 110.483 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.95 -35.2 74.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.94 -1.1 . . . . 2.53 108.362 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.07 -40.02 75.29 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.468 0.651 . . . . 1.36 109.83 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.1 -49.99 75.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.508 -0.745 . . . . 1.42 110.12 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -71.9 -41.74 67.57 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.277 -0.89 . . . . 2.27 110.63 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.04 -40.74 74.95 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.054 -1.029 . . . . 1.57 111.596 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.9 mt -68.62 -45.74 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.835 -1.166 . . . . 1.19 109.79 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -69.61 -35.09 64.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.378 -0.826 . . . . 1.39 110.048 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.79 99.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 1.39 110.653 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.75 -48.09 83.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.913 -1.117 . . . . 1.5 109.579 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 55.8 mt -60.13 -48.15 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 121.981 0.896 . . . . 1.29 108.862 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -69.93 -40.05 75.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.759 -0.588 . . . . 2.64 111.187 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -83.54 -52.35 6.56 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.984 -1.073 . . . . 1.65 112.041 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -90.08 -2.27 58.08 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.073 -1.017 . . . . 2.5 111.679 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 56.9 34.68 25.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.918 -1.114 . . . . 1.88 109.305 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.4 mtp -90.31 166.63 13.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.432 -0.793 . . . . 1.71 110.158 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 67.2 p -77.63 160.41 28.54 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.457 -0.777 . . . . 1.61 109.279 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.61 -40.04 84.71 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.182 -0.949 . . . . 1.33 110.114 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 34.1 p-10 -68.37 -37.13 80.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.07 -1.019 . . . . 2.07 109.309 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.469 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -78.99 -39.96 32.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.041 -1.037 . . . . 1.37 109.593 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.46 -46.72 63.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.862 . . . . 1.14 110.498 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.04 93.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.092 -1.005 . . . . 1.26 109.652 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.528 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 85.3 t60 -59.91 -39.91 87.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.839 . . . . 2.02 109.717 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.13 -43.05 95.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.21 -0.931 . . . . 1.33 110.221 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.86 -59.45 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.185 -0.947 . . . . 1.3 110.83 -178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.1 mm -63.57 -40.02 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.891 -1.131 . . . . 1.32 108.974 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.528 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 86.7 tt0 -64.01 -40.13 95.65 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.73 -1.211 . . . . 2.44 107.73 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.07 -48.6 85.31 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.952 -1.259 . . . . 0.99 109.952 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -68.03 -50.73 53.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.933 -1.333 . . . . 1.97 109.188 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.33 88.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 1.43 108.606 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 30.3 t -59.91 -40.8 90.05 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.437 -0.949 . . . . 2.12 108.437 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.22 96.31 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.33 -0.856 . . . . 1.64 108.781 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.8 mt -66.37 -42.13 88.42 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.305 -0.958 . . . . 1.93 109.248 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -60.05 -40.01 87.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.737 -1.227 . . . . 2.2 109.444 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -50.22 -20.17 0.97 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.991 -1.068 . . . . 2.12 109.02 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 54.1 mt -64.19 144.46 57.11 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.141 -0.975 . . . . 2.34 108.611 179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 -100.23 52.5 0.89 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.119 -0.988 . . . . 3.23 110.271 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 57.5 t0 -135.58 130.47 34.54 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.134 -0.979 . . . . 2.49 109.627 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 67.0 mt-10 -61.95 -32.97 73.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.741 . . . . 3.95 109.837 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.598 ' HH ' ' NH1' ' A' ' 126' ' ' ARG . 3.0 t80 -70.05 -38.53 75.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 2.25 110.421 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.6 mt -80.42 -32.77 37.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.927 -1.108 . . . . 2.27 109.51 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -60.01 -40.48 89.4 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.905 -1.122 . . . . 3.31 108.177 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.1 -40.07 94.06 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.511 -0.922 . . . . 2.73 108.511 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.598 ' NH1' ' HH ' ' A' ' 122' ' ' TYR . 0.0 OUTLIER -61.11 -39.95 91.94 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.643 -0.873 . . . . 3.2 108.643 179.416 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.18 -22.56 66.95 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.929 -0.767 . . . . 1.66 108.929 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.56 -42.59 70.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.645 -0.659 . . . . 1.67 109.78 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -63.88 -40.01 95.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 1.55 110.204 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.24 -41.68 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.106 -0.996 . . . . 1.32 109.427 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.4 ' HG2' HH11 ' A' ' 131' ' ' ARG . 30.3 ttt-85 -60.55 -37.34 80.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 3.58 109.221 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -59.99 -39.82 87.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.631 -0.668 . . . . 1.46 109.387 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.93 -42.04 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.01 -1.056 . . . . 1.22 109.46 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.41 -32.36 68.2 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.785 -1.326 . . . . 0.61 109.785 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.72 ' HZ3' ' HE ' ' A' ' 139' ' ' ARG . 50.3 tttm -59.92 -48.32 82.2 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.133 -1.216 . . . . 3.1 109.028 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.438 HH21 ' HB3' ' A' ' 166' ' ' SER . 1.8 mtt-85 -61.88 -35.34 78.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.993 . . . . 3.71 109.657 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.57 -44.18 93.39 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.507 -0.745 . . . . 1.87 110.275 -177.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 49.6 mt -65.12 -40.14 94.06 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.875 -1.141 . . . . 1.29 109.95 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.72 ' HE ' ' HZ3' ' A' ' 135' ' ' LYS . 59.2 mtt-85 -68.84 -38.96 80.18 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.485 -0.932 . . . . 3.05 108.485 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.486 HD21 ' N ' ' A' ' 140' ' ' ASN . 1.4 m120 -65.07 -38.53 91.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.749 -0.594 . . . . 1.26 110.98 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.6 mt -70.0 -43.16 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.548 -1.345 . . . . 1.34 108.946 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.03 -31.0 68.42 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.623 -0.673 . . . . 1.6 109.727 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.33 39.12 13.04 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.759 -1.737 . . . . 0.96 108.759 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.8 tp -73.96 149.55 41.3 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.469 -1.019 . . . . 1.67 109.623 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -61.42 146.74 47.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.509 -0.745 . . . . 4.96 110.127 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.51 121.93 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-O 122.077 0.941 . . . . 1.68 108.503 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 148' ' ' ASP . 6.0 mt -62.77 -44.32 99.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.839 -0.619 . . . . 2.14 110.823 -178.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 147' ' ' ILE . 50.7 t0 61.87 121.33 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.6 -0.688 . . . . 1.5 109.199 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 59.9 mt -87.97 0.85 55.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.406 -0.808 . . . . 1.39 109.999 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 62.1 m -82.67 -18.8 39.74 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.878 -1.139 . . . . 1.83 110.716 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.52 29.99 0.43 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.965 -1.085 . . . . 1.46 111.642 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 45.7 mm -90.55 119.19 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.682 -1.261 . . . . 1.42 108.38 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -100.15 -9.9 22.02 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.355 -0.841 . . . . 2.94 110.454 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -126.46 150.94 48.38 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.1 -1.0 . . . . 1.52 110.35 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.64 137.2 58.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.835 . . . . 1.58 109.413 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.6 m -152.18 163.5 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.992 -0.744 . . . . 1.32 108.992 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.3 mt -93.42 148.49 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 106.351 -1.722 . . . . 1.27 106.351 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 38.3 tp -96.8 114.28 25.9 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.862 -1.148 . . . . 1.41 110.299 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.51 130.08 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.525 -0.917 . . . . 1.23 108.525 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.08 162.05 39.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.169 -0.957 . . . . 1.32 108.899 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.94 -32.23 65.14 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.209 -1.557 . . . . 1.49 108.713 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 60.1 t0 -167.24 137.8 3.01 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.628 -0.879 . . . . 2.25 108.628 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.514 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 69.3 mt -112.89 131.41 55.74 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.347 -0.845 . . . . 1.35 109.926 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.5 p -100.56 148.92 35.63 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.419 -0.801 . . . . 1.56 108.906 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -38.22 -36.98 0.58 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.274 1.983 . . . . 0.87 112.717 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.438 ' HB3' HH21 ' A' ' 136' ' ' ARG . 4.2 m -50.34 -58.13 6.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 1.36 109.979 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -60.61 -39.85 89.7 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.38 -0.825 . . . . 1.61 110.755 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.445 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 64.4 p -60.03 -19.59 53.53 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.788 -1.195 . . . . 1.21 110.916 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -83.42 -38.6 21.7 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.852 -1.155 . . . . 1.21 109.556 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -104.66 39.3 1.71 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.663 -0.866 . . . . 2.11 108.663 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.6 tp -106.15 140.08 39.67 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.608 -0.886 . . . . 1.29 108.608 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -85.15 106.85 16.9 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.054 -1.029 . . . . 2.81 109.375 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 94.5 mt -62.84 -41.9 99.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.368 -0.833 . . . . 2.09 111.157 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -70.06 -24.49 63.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.155 -0.966 . . . . 2.86 111.859 -177.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -93.69 -10.52 34.14 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.654 -1.279 . . . . 2.39 109.711 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 68.8 t -98.62 107.02 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.154 -0.967 . . . . 1.27 108.6 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.3 mt -81.92 3.83 24.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.227 -0.92 . . . . 2.17 110.062 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 169.95 173.58 37.48 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.866 -1.294 . . . . 0.52 109.866 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 179' ' ' PHE . 7.8 m-85 -129.31 126.93 40.07 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.411 -1.052 . . . . 0.55 109.24 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 75.5 mt -128.45 123.69 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.815 -1.18 . . . . 1.27 107.815 177.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 35.1 p -147.05 160.61 42.18 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.806 -1.184 . . . . 1.39 111.504 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 61.6 t0 -103.93 25.95 9.28 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.233 -0.654 . . . . 2.46 109.233 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.42 -162.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.317 -1.49 . . . . 1.51 111.562 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.69 -58.16 4.63 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 111.162 -0.775 . . . . 2.23 111.162 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -168.84 -149.79 6.37 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 118.506 -1.807 . . . . 2.23 111.515 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.461 ' O ' ' OG ' ' A' ' 191' ' ' SER . 33.8 ptt180 -77.93 -9.01 58.87 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.817 -0.814 . . . . 6.44 111.013 -178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 74.5 p -83.13 4.62 25.71 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.814 -1.179 . . . . 4.09 110.557 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 191' ' ' SER . 22.7 p -82.14 143.3 31.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.887 -1.133 . . . . 2.2 110.394 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -46.65 -52.45 13.72 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.335 -0.853 . . . . 1.15 110.096 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -56.11 -38.0 70.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.361 -0.837 . . . . 2.01 110.725 -178.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.642 ' HG ' ' N ' ' A' ' 192' ' ' ILE . 80.5 p -61.69 -40.54 95.35 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.891 -1.131 . . . . 1.93 111.029 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.642 ' N ' ' HG ' ' A' ' 191' ' ' SER . 97.9 mt -60.09 -39.71 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.014 . . . . 2.2 109.123 -179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.0 mtp -59.98 -45.3 93.15 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.556 -0.715 . . . . 1.32 110.214 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.72 91.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.601 -1.312 . . . . 1.3 110.292 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -61.1 -52.04 66.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.853 -1.154 . . . . 3.38 110.607 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 62.1 m -70.4 -34.73 72.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.001 -1.062 . . . . 1.15 111.759 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.23 -9.98 59.05 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.702 -1.249 . . . . 1.28 110.543 -178.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 61.91 50.21 4.31 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.482 -0.761 . . . . 1.5 111.423 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 20.9 mt -128.36 149.48 71.61 Favored Pre-proline 0 N--CA 1.5 2.048 0 N-CA-C 107.664 -1.235 . . . . 1.37 107.664 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.06 139.5 46.96 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 122.245 1.963 . . . . 0.76 111.718 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.5 150.56 4.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.845 -1.159 . . . . 1.19 111.725 -179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 91.9 mt -126.86 142.12 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.792 -1.188 . . . . 1.31 107.792 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 18.2 m -123.03 -8.99 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 120.827 -1.17 . . . . 1.38 111.542 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -113.14 24.29 12.86 Favored Glycine 0 N--CA 1.502 3.07 0 N-CA-C 110.677 -0.969 . . . . 1.03 110.677 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.411 ' C ' ' O ' ' A' ' 204' ' ' GLY . 17.5 p -43.41 -47.91 7.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.121 -1.223 . . . . 1.38 110.074 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.433 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 97.03 -55.04 1.33 Allowed Glycine 0 N--CA 1.499 2.897 0 C-N-CA 120.341 -0.933 . . . . 1.17 111.611 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 85.6 p -148.52 28.59 0.87 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.397 -1.649 . . . . 2.07 111.584 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 18.3 t -70.03 -36.74 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.717 -1.24 . . . . 1.35 108.839 178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.3 p -58.02 -30.66 66.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 1.49 110.964 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.1 t -83.02 -19.4 37.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.803 -1.186 . . . . 2.16 110.389 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -96.98 -11.93 23.97 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.089 -1.007 . . . . 2.89 110.471 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.2 t -107.93 137.41 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.256 -0.902 . . . . 1.33 110.628 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -114.89 149.71 36.76 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.48 -1.304 . . . . 2.73 107.48 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 8.2 t-20 -56.25 138.58 50.12 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.083 -1.011 . . . . 2.7 110.955 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.0 m-20 83.88 7.42 0.62 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.138 0.494 . . . . 2.38 110.229 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -77.91 145.9 35.89 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.207 -0.933 . . . . 2.09 108.871 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -95.34 117.12 29.76 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.273 -1.01 . . . . 1.45 108.273 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 72.0 mt -126.75 150.7 48.94 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.578 -0.701 . . . . 1.31 110.278 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.7 mt -115.93 128.55 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 106.846 -1.539 . . . . 1.29 106.846 177.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 60.9 tp -99.98 120.09 39.27 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.947 -1.096 . . . . 1.31 109.186 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 223' ' ' VAL . 12.2 t70 -80.18 -41.13 25.87 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.281 -1.007 . . . . 2.31 108.281 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 47.27 12.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.775 -0.578 . . . . 1.19 109.55 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 221' ' ' ASP . 42.8 t -124.85 -35.44 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.283 -1.377 . . . . 1.45 107.283 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.519 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 71.9 m-80 -111.76 2.61 17.23 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.99 -1.115 . . . . 3.13 107.99 178.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.493 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.6 OUTLIER 59.63 47.77 10.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.776 -0.578 . . . . 2.2 110.376 179.715 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -135.5 148.22 49.11 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.147 -0.97 . . . . 2.32 109.864 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.7 t -117.84 125.72 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.545 -0.909 . . . . 1.4 108.545 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -101.13 121.87 42.6 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.405 -0.809 . . . . 1.29 109.177 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 32.1 t -101.85 113.16 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.462 -0.774 . . . . 1.38 110.897 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 52.02 60.75 13.2 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.052 -1.03 . . . . 2.33 111.3 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -86.67 152.64 8.83 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.653 2.236 . . . . 0.95 111.822 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.4 p -74.2 168.44 19.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.097 -1.002 . . . . 2.31 110.526 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -59.99 -37.94 81.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.663 -0.648 . . . . 3.45 110.265 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.57 -38.9 82.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 2.89 109.846 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.95 -41.35 79.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.218 -0.927 . . . . 1.73 109.236 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.58 -39.97 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.221 -0.924 . . . . 1.57 109.569 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.14 -39.95 88.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.91 -1.119 . . . . 2.43 108.495 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -66.9 -40.74 87.79 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.481 -0.762 . . . . 3.18 109.343 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 97.0 mtp -69.87 -38.19 76.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.266 -0.896 . . . . 1.59 109.793 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -61.04 -39.95 91.77 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.366 -0.834 . . . . 3.11 109.61 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.72 95.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 2.17 110.075 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.34 -40.09 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.941 . . . . 2.51 109.392 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -59.97 -40.98 90.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 3.82 109.035 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.19 -39.83 94.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 1.78 109.023 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.99 -39.97 87.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.543 -0.723 . . . . 2.77 109.249 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 66.1 t -60.09 -40.25 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.434 -0.791 . . . . 2.25 109.348 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.17 94.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 2.54 109.524 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 83.1 p -62.57 -40.02 95.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -0.947 . . . . 3.03 109.326 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.42 -38.68 91.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.449 -0.782 . . . . 3.34 109.397 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 252' ' ' GLU . 54.7 tttm -59.93 -39.99 87.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.485 -0.759 . . . . 4.18 110.038 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -46.39 -17.92 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.096 -1.003 . . . . 4.43 109.686 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 250' ' ' LYS . 81.1 mm-40 -69.95 -28.72 65.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.37 -0.831 . . . . 5.42 109.228 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 9.5 mt 42.17 27.72 0.08 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.506 -0.746 . . . . 6.11 110.157 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 252' ' ' GLU . . . -110.01 21.85 16.32 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.474 -0.766 . . . . 7.37 109.619 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.506 ' C ' ' H ' ' A' ' 257' ' ' LYS . 34.8 mtmm 52.02 36.33 18.39 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.499 -0.926 . . . . 8.3 108.499 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.501 ' O ' ' CB ' ' A' ' 257' ' ' LYS . 1.7 tt -74.07 42.5 0.15 Allowed 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.751 -0.833 . . . . 9.05 108.751 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.506 ' H ' ' C ' ' A' ' 255' ' ' LYS . 42.6 tttp 86.01 157.94 0.09 Allowed 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.122 -0.695 . . . . 10.56 109.122 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 257' ' ' LYS . 78.9 m-20 -148.96 -29.49 0.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.416 -0.802 . . . . 11.32 109.398 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . 0.431 HH11 ' HG2' ' A' ' 259' ' ' ARG . 28.2 mtt-85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.062 -0.97 . . . . 12.74 109.632 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -151.3 149.15 29.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -0.837 . . . . 0.0 108.83 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . 0.491 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 0.4 OUTLIER -146.15 154.65 42.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.199 -0.938 . . . . 0.0 110.171 -178.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -152.73 149.38 28.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.535 -0.728 . . . . 0.0 109.113 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -112.52 131.78 55.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.287 -0.883 . . . . 0.0 109.101 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.0 123.59 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-O 122.284 1.04 . . . . 0.0 112.476 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 29.3 m -77.84 104.05 8.15 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.999 0.904 . . . . 0.0 110.126 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 90.1 mt -51.59 119.58 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 122.487 1.137 . . . . 0.0 110.366 -177.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 23.7 p -99.9 24.63 8.23 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.587 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -88.28 113.62 55.98 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -70.99 -5.24 16.54 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 CA-C-N 120.215 1.113 . . . . 0.0 111.864 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -110.45 0.65 17.9 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 74.26 172.17 26.91 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.496 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.5 tp -86.05 93.81 9.08 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.956 -1.32 . . . . 0.0 108.333 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -93.47 -161.58 0.86 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.205 -0.935 . . . . 0.0 110.418 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.9 m -59.3 -44.59 92.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.126 -0.984 . . . . 0.0 112.416 -176.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.473 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.3 tpt180 -57.11 -62.52 5.03 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 120.436 -1.415 . . . . 0.0 111.532 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.75 -30.68 85.44 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 120.2 1.107 . . . . 0.0 111.539 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.11 -50.62 72.96 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.371 -0.931 . . . . 0.0 108.83 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -54.88 -43.17 72.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 109.874 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -70.1 -41.32 74.18 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.809 -1.156 . . . . 0.0 108.826 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -60.08 -50.19 74.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.455 -0.778 . . . . 0.0 110.356 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 80.4 t -68.93 -27.72 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.713 -1.242 . . . . 0.0 109.74 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -60.02 -49.14 78.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.881 . . . . 0.0 110.332 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -68.52 -40.15 80.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.075 -1.015 . . . . 0.0 111.326 -178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.87 -53.3 58.99 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.561 -1.337 . . . . 0.0 111.108 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -57.69 -11.61 2.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.095 -1.003 . . . . 0.0 109.426 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -68.07 -29.98 73.72 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -104.98 144.21 32.11 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.451 -1.029 . . . . 0.0 109.159 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 7.7 m -90.22 -11.28 41.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.062 -1.024 . . . . 0.0 109.443 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 331' ' ' SER . . . . . 0.633 ' HG ' ' N ' ' B' ' 369' ' ' ASP . 33.8 m -57.99 149.02 24.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 109.846 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.91 132.9 48.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.905 . . . . 0.0 109.236 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.9 mt -133.4 132.28 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.307 -0.871 . . . . 0.0 110.041 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 52.7 m -128.17 153.15 47.2 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 84.0 t -119.85 139.87 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 96.8 m -130.33 123.03 29.04 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.275 -0.891 . . . . 0.0 108.739 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 59.8 p -140.11 121.86 15.4 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.081 0.943 . . . . 0.0 111.314 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 57.4 t30 43.49 52.68 5.95 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.35 -12.27 59.0 Favored Glycine 0 N--CA 1.5 2.941 0 O-C-N 120.182 -1.574 . . . . 0.0 112.904 176.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -118.94 129.45 55.18 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-N 119.268 1.534 . . . . 0.0 109.925 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 69.7 m -122.32 146.13 47.6 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.763 0.792 . . . . 0.0 110.078 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -140.42 161.05 38.63 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.472 0.653 . . . . 0.0 109.805 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.8 t -86.09 136.29 33.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.517 -0.739 . . . . 0.0 109.246 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -79.11 -14.12 59.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.978 -1.076 . . . . 0.0 110.418 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -87.36 21.47 2.45 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.487 ' H ' ' C ' ' B' ' 344' ' ' ALA . 69.2 m -149.62 99.39 2.87 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.795 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 58.0 tp -60.11 -35.28 74.89 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -55.38 -54.43 43.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.956 -1.09 . . . . 0.0 109.786 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -69.93 -20.57 63.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.29 -0.881 . . . . 0.0 111.29 -177.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' B' ' 352' ' ' THR . 32.8 mt -70.32 -57.91 4.34 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.716 -1.24 . . . . 0.0 110.666 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.455 ' NE2' ' NE ' ' A' ' 126' ' ' ARG . 2.9 mm100 -44.92 -14.77 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.093 -1.005 . . . . 0.0 111.409 -176.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.511 ' N ' ' O ' ' B' ' 350' ' ' LEU . 70.4 p -80.3 -13.44 59.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.196 -1.565 . . . . 0.0 110.278 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 34.9 mt -93.03 119.26 32.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.098 -1.002 . . . . 0.0 108.778 178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.14 91.22 0.91 Allowed Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 18.9 mt -96.5 87.31 4.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.327 -1.102 . . . . 0.0 108.527 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 64.3 p -92.2 -179.48 5.26 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.802 0.81 . . . . 0.0 110.668 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . 0.424 ' O ' ' N ' ' B' ' 359' ' ' THR . 65.8 tt0 -49.41 155.57 0.72 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 122.268 1.033 . . . . 0.0 111.109 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.88 27.58 0.06 OUTLIER Glycine 0 N--CA 1.497 2.729 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.56 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 359' ' ' THR . . . . . 0.424 ' N ' ' O ' ' B' ' 357' ' ' GLN . 11.8 m -86.57 109.95 19.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.767 -1.431 . . . . 0.0 109.864 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.25 114.77 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.343 1.068 . . . . 0.0 110.147 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 9.9 m -111.93 177.52 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 49.7 m -130.95 130.1 43.0 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 81.9 mt -106.36 122.28 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 77.3 p -125.05 134.67 52.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.22 152.2 38.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.142 -0.973 . . . . 0.0 110.119 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -142.18 121.73 13.31 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 164.43 -163.28 36.04 Favored Glycine 0 N--CA 1.485 1.923 0 C-N-CA 118.636 -1.745 . . . . 0.0 111.536 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -59.57 -50.07 75.32 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.01 -0.595 . . . . 0.0 111.673 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.633 ' N ' ' HG ' ' B' ' 331' ' ' SER . 85.2 m-20 -111.6 10.3 21.15 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.974 -1.079 . . . . 0.0 110.936 -177.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.548 ' H ' ' HG ' ' B' ' 331' ' ' SER . 0.7 OUTLIER -44.02 -33.78 1.54 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.113 -0.992 . . . . 0.0 111.596 -178.61 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -69.89 -40.36 75.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.619 -1.301 . . . . 0.0 109.594 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -68.29 -48.15 65.75 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.173 -0.954 . . . . 0.0 109.862 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -50.44 -74.38 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.149 -0.97 . . . . 0.0 110.91 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 67.6 t -44.11 -40.75 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.254 -0.904 . . . . 0.0 110.697 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.86 -50.16 72.03 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.526 -1.358 . . . . 0.0 110.481 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -75.81 -40.03 55.72 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.802 -1.186 . . . . 0.0 110.669 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 98.9 mt -59.0 -37.51 77.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.011 -1.056 . . . . 0.0 108.606 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 47.1 t -60.74 -40.21 84.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.279 -0.888 . . . . 0.0 109.093 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' B' ' 383' ' ' GLU . 20.3 mmmt -67.97 -55.04 14.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.705 -1.247 . . . . 0.0 107.939 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 63.6 tp -56.36 -35.57 67.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.358 -0.839 . . . . 0.0 110.241 -178.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 34.7 ttm -72.45 -41.06 66.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.727 -1.233 . . . . 0.0 109.107 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.59 -5.69 58.27 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.346 -0.846 . . . . 0.0 110.215 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' B' ' 379' ' ' LYS . 96.2 mt-10 -109.72 -2.78 17.19 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.132 -0.98 . . . . 0.0 111.37 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.4 mt -83.7 130.02 34.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.285 -1.509 . . . . 0.0 109.027 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 N--CA 1.499 1.984 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.629 -179.656 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.251 0.548 . . . . 3.19 109.679 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.0 mt -110.18 129.88 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.47 -0.769 . . . . 1.71 109.114 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.8 m -130.81 148.78 52.62 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.514 -0.741 . . . . 1.66 109.173 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.41 ' H ' ' CG ' ' A' ' 225' ' ' ASN . . . -130.95 -163.54 10.99 Favored Glycine 0 N--CA 1.499 2.861 0 N-CA-C 108.142 -1.983 . . . . 1.05 108.142 179.323 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.451 ' O ' ' O ' ' A' ' 6' ' ' LEU . 95.7 mt -89.16 -14.79 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.659 -1.495 . . . . 1.59 110.068 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.0 tp 54.18 103.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.311 -0.868 . . . . 1.47 109.038 -179.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.94 -27.28 14.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.186 -0.946 . . . . 1.39 109.424 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 m -140.57 124.8 10.65 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.426 -0.796 . . . . 2.09 109.465 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.77 150.08 18.48 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.456 2.104 . . . . 0.91 112.904 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 146.93 171.78 16.53 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 109.811 -1.316 . . . . 0.92 109.811 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.429 HG23 HD13 ' A' ' 11' ' ' ILE . 89.7 mt -122.85 130.01 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 O-C-N 121.026 -1.279 . . . . 1.35 110.518 -179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.74 149.32 51.47 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.354 -0.842 . . . . 1.14 110.046 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.4 m-85 -126.52 129.1 47.96 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.726 -1.213 . . . . 0.7 107.726 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.12 176.39 46.85 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 118.732 -1.699 . . . . 0.58 110.998 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -79.94 158.75 26.55 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.443 -1.033 . . . . 2.63 109.438 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.59 137.04 43.02 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.522 -0.737 . . . . 1.27 111.015 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.1 tp -106.64 133.36 51.42 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 106.936 -1.505 . . . . 1.41 106.936 177.729 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.0 tp -113.55 122.14 46.33 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.169 -0.957 . . . . 1.49 109.687 -179.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.1 mt -85.17 100.78 11.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.617 -0.677 . . . . 1.52 109.399 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -99.37 133.23 43.97 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.441 -0.787 . . . . 3.17 109.463 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -130.19 134.88 47.6 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.462 -0.774 . . . . 3.0 108.938 179.307 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -79.69 158.21 27.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.294 -0.879 . . . . 2.77 109.995 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -70.45 145.78 50.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.351 -0.843 . . . . 2.94 109.225 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.8 mt -89.64 129.09 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.094 -1.003 . . . . 1.46 108.967 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t -93.78 125.47 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.181 -0.949 . . . . 1.7 110.38 -179.108 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.06 133.72 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.521 -0.918 . . . . 1.54 108.521 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -94.34 117.94 30.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.008 -1.058 . . . . 1.81 109.847 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.467 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.2 mmt-85 -89.89 3.8 51.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.294 -0.879 . . . . 3.23 109.415 -179.556 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -62.95 149.42 44.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.943 . . . . 3.29 109.647 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -91.77 141.91 28.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.364 -0.835 . . . . 2.8 109.217 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 pt -93.77 164.39 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.852 -1.155 . . . . 1.43 109.995 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.6 p -92.42 171.53 8.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.22 -0.925 . . . . 1.54 108.664 178.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.27 -15.53 63.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.106 -0.996 . . . . 1.6 110.285 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -85.6 -28.61 24.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.874 -1.141 . . . . 2.56 108.447 178.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -81.58 -8.41 59.71 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.14 -0.689 . . . . 2.36 109.14 179.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.0 t -63.72 -54.91 26.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.115 -0.991 . . . . 1.43 109.129 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.45 -39.72 88.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.077 -1.014 . . . . 1.77 109.355 179.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -65.7 -42.63 90.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 3.32 110.156 -179.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.59 -40.15 95.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.901 -1.124 . . . . 1.51 110.66 -179.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.63 -46.59 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.576 -1.328 . . . . 1.41 108.182 179.206 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -60.14 -44.32 95.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.175 -0.953 . . . . 1.81 109.389 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -59.98 -43.41 95.13 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.908 -1.145 . . . . 3.26 107.908 179.217 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -64.45 -40.02 94.92 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.451 -0.944 . . . . 0.81 108.451 179.008 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.21 -49.95 75.58 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.354 -0.98 . . . . 1.59 108.354 179.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.3 t -63.21 -43.5 97.95 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.22 -0.992 . . . . 1.38 108.92 179.086 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.64 -40.02 95.71 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.347 -1.901 . . . . 0.87 108.347 179.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.557 ' NH2' ' O ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER -66.65 -39.4 88.21 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.871 -1.159 . . . . 3.62 107.871 178.396 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.0 75.15 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.278 -0.638 . . . . 1.43 109.278 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ALA . 22.2 ttmt -60.72 -74.77 0.07 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.102 -1.073 . . . . 3.08 108.102 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.73 -34.12 0.1 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.435 -0.791 . . . . 1.33 111.471 -177.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.6 m -60.27 -54.68 42.84 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.536 -1.352 . . . . 1.85 108.674 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.82 -41.22 75.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.339 -0.851 . . . . 1.35 111.161 -178.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.33 -39.92 95.87 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.783 -1.198 . . . . 2.34 110.218 -179.289 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.1 mt -66.33 -39.79 89.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.0 -1.063 . . . . 2.2 109.963 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -59.97 -38.95 84.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.143 -0.973 . . . . 1.35 109.592 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -61.87 -41.18 97.55 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.059 -1.025 . . . . 1.34 110.095 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.34 -37.19 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.255 -0.903 . . . . 1.26 109.6 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -57.29 -51.16 70.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.432 -0.792 . . . . 1.7 110.665 -178.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -60.62 -37.2 80.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.017 . . . . 1.35 111.672 -177.327 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.1 -39.85 94.95 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.869 -1.145 . . . . 2.08 110.267 -179.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.13 -42.3 96.88 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.533 -0.729 . . . . 1.21 109.936 -179.59 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.84 -52.16 54.11 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.703 -1.359 . . . . 0.75 109.703 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.63 -48.04 73.55 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.167 -1.196 . . . . 1.59 109.806 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.7 m -70.07 -58.74 3.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.344 -0.848 . . . . 1.41 112.144 -177.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -96.85 -53.68 3.45 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.912 -1.117 . . . . 0.79 111.292 -178.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.51 -167.42 25.84 Favored Glycine 0 N--CA 1.5 2.96 0 C-N-CA 119.678 -1.248 . . . . 1.22 111.31 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -70.01 -25.51 63.63 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.799 -0.824 . . . . 5.81 110.685 -179.397 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -61.6 -35.59 78.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -0.954 . . . . 3.37 110.46 -179.461 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -100.38 -19.83 16.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.31 -0.868 . . . . 2.37 110.282 -179.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -69.94 -39.97 75.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.98 -1.075 . . . . 1.65 110.263 -179.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.85 -27.99 68.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.351 -0.843 . . . . 1.42 109.486 -179.174 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 85.3 mt -60.08 -40.49 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.18 -0.95 . . . . 1.43 108.928 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -69.74 -36.84 76.16 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.193 -0.942 . . . . 1.08 110.705 -179.506 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -59.88 -40.04 87.34 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.919 -1.113 . . . . 1.37 109.289 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.04 -43.82 95.23 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.523 -1.431 . . . . 0.67 109.523 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -62.62 -41.56 99.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -1.113 . . . . 1.99 109.043 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.7 mt -68.67 -46.46 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.766 -0.828 . . . . 1.22 108.766 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.1 ttp -60.25 -42.95 96.4 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.222 -0.924 . . . . 2.11 109.786 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.2 tp -63.91 -40.71 97.12 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.416 -0.803 . . . . 1.33 109.44 179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.557 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 61.8 tp -64.99 -39.81 94.02 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.63 -0.669 . . . . 1.29 109.827 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -79.68 2.14 23.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 1.47 110.677 -178.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -48.95 128.01 15.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.843 -1.16 . . . . 1.47 109.777 -179.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.15 -17.17 51.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.595 -0.69 . . . . 1.78 110.211 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -74.09 -32.95 63.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.074 -1.016 . . . . 2.53 109.43 178.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.07 -41.16 74.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.472 -0.767 . . . . 1.36 109.345 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -60.76 -46.22 91.31 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.383 -0.823 . . . . 1.42 110.159 -179.428 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -70.05 -41.93 73.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.344 -0.847 . . . . 2.27 110.44 -178.978 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.07 -39.9 75.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.912 . . . . 1.57 110.096 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.7 mt -66.68 -47.06 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.259 -0.901 . . . . 1.19 109.592 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.9 -37.57 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 1.39 110.111 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.04 -48.31 82.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.183 -0.948 . . . . 1.39 110.913 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.2 mt -60.3 -46.99 87.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.074 -1.016 . . . . 1.5 110.191 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.0 mt -61.13 -49.94 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 1.29 108.674 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -65.22 -43.28 92.0 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.107 -0.637 . . . . 2.64 110.491 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -80.02 -53.04 7.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.957 -1.09 . . . . 1.65 111.992 -178.421 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -90.48 -2.43 57.92 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.957 -1.089 . . . . 2.5 112.37 -177.195 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.3 m80 57.12 36.55 27.73 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.785 -1.197 . . . . 1.88 109.729 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 77.2 mtp -88.22 165.55 14.97 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.293 -0.879 . . . . 1.71 109.34 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.425 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 33.6 p -76.56 159.48 30.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.064 -1.022 . . . . 1.61 108.49 179.348 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.79 -39.96 91.47 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.285 -0.966 . . . . 1.33 110.047 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 24.1 p-10 -66.58 -34.87 78.86 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.122 -0.986 . . . . 2.07 109.312 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.17 -42.2 23.87 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.282 -0.886 . . . . 1.37 109.708 179.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.12 -48.4 68.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 1.14 109.9 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.7 92.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 1.26 109.845 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -60.0 -40.67 90.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 2.02 110.204 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.03 -40.26 95.09 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.305 -0.872 . . . . 1.33 110.342 -179.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.4 -53.16 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.076 -1.015 . . . . 1.3 111.028 -178.377 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.88 -40.05 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.861 -1.149 . . . . 1.32 109.307 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -64.64 -36.1 83.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 2.44 108.901 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.437 ' O ' ' OG ' ' A' ' 113' ' ' SER . . . -63.51 -49.93 65.99 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.805 -0.712 . . . . 0.99 111.688 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.589 HE21 ' CB ' ' B' ' 348' ' ' PHE . 19.4 mm100 -64.05 -47.01 81.83 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.55 -1.559 . . . . 1.97 110.01 -178.616 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.87 -39.49 85.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.067 -1.021 . . . . 1.43 109.512 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 110' ' ' GLY . 91.2 p -59.79 -40.05 86.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.946 . . . . 2.12 109.746 -179.444 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.82 -39.86 86.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.858 -1.151 . . . . 1.64 108.929 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 35.3 mt -61.27 -42.89 99.41 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.832 -1.167 . . . . 1.93 108.912 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.541 ' OE2' ' NH2' ' A' ' 131' ' ' ARG . 98.3 mt-10 -50.18 -26.08 4.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.092 -1.005 . . . . 2.2 109.567 -179.387 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -65.53 -26.49 67.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.084 -1.01 . . . . 2.12 108.716 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 59.6 mt -63.09 144.09 57.21 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.382 -0.824 . . . . 2.34 109.521 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -97.04 14.45 25.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.153 -0.967 . . . . 3.23 109.945 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 58.0 t0 -102.98 143.3 32.73 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.174 -0.954 . . . . 2.49 109.788 -179.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.542 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 66.6 mm-40 -71.57 -63.94 1.02 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.979 -1.119 . . . . 3.95 107.979 178.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.733 ' HH ' ' HE ' ' A' ' 126' ' ' ARG . 1.8 t80 -38.49 -40.0 0.52 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 116.032 -0.531 . . . . 2.25 110.818 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.85 -40.09 72.55 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.724 -1.235 . . . . 2.27 109.189 179.417 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 121' ' ' GLU . 61.4 tttp -60.73 -38.95 86.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.244 -0.91 . . . . 3.31 109.836 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -59.78 -39.78 86.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.371 -0.831 . . . . 2.73 109.258 -179.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.733 ' HE ' ' HH ' ' A' ' 122' ' ' TYR . 1.1 mtt-85 -60.11 -39.96 88.01 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.106 -0.996 . . . . 3.2 109.019 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.92 -31.15 71.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.25 -0.906 . . . . 1.66 109.505 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.52 -40.54 95.0 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.384 -0.926 . . . . 1.67 108.565 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -67.28 -40.17 86.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.435 -0.791 . . . . 1.55 109.681 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.04 -40.54 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.353 -0.98 . . . . 1.32 108.353 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.541 ' NH2' ' OE2' ' A' ' 116' ' ' GLU . 39.6 ttm180 -62.29 -37.48 85.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.619 -0.676 . . . . 3.58 109.472 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -59.74 -40.56 88.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.211 -0.931 . . . . 1.46 109.457 -178.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.09 -43.44 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.092 -1.005 . . . . 1.22 109.313 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.22 -44.61 97.9 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.098 -1.201 . . . . 0.61 110.098 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -60.82 -49.67 76.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.166 -1.196 . . . . 3.1 111.148 -179.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -64.88 -35.92 82.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.81 -1.181 . . . . 3.71 110.246 -178.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 64.9 tp -60.08 -40.6 90.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 1.87 109.04 -179.244 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 89.7 mt -62.36 -39.93 94.75 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.32 -0.863 . . . . 1.29 109.264 179.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -69.66 -34.63 74.26 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.673 -0.862 . . . . 3.05 108.673 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -66.69 -36.1 81.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.537 -0.727 . . . . 1.26 110.849 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.4 mt -70.66 -40.96 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 120.571 -1.331 . . . . 1.34 108.754 179.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.17 -35.2 68.93 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.569 -0.707 . . . . 1.6 109.73 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.49 34.94 8.19 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.043 -1.623 . . . . 0.96 109.043 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 29.1 tp -73.57 144.67 45.96 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.35 -1.088 . . . . 1.67 109.626 -179.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -61.15 143.76 54.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.449 -0.782 . . . . 4.96 110.486 -179.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.4 mt -111.67 127.27 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.362 -0.977 . . . . 1.68 108.362 178.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 148' ' ' ASP . 14.5 mm -59.94 -48.14 88.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.468 -0.77 . . . . 2.14 110.505 -177.718 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 147' ' ' ILE . 31.2 t0 62.46 118.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.344 -0.848 . . . . 1.5 109.007 -179.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.0 mt -84.91 -1.73 56.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.699 -0.626 . . . . 1.39 110.39 -178.784 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 92.4 p -83.38 -10.32 58.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.802 -1.186 . . . . 1.83 108.608 178.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.6 17.61 2.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.728 -0.607 . . . . 1.46 110.955 -177.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 52.2 mt -90.88 122.9 42.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.894 -1.129 . . . . 1.42 108.981 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -104.74 -7.35 19.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.496 -0.752 . . . . 2.94 110.613 -178.505 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -126.96 150.66 49.27 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.425 -0.797 . . . . 1.52 110.064 -179.067 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.4 136.35 57.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.224 -0.923 . . . . 1.58 108.827 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.8 m -153.08 167.88 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.477 -0.764 . . . . 1.32 109.975 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 76.4 mt -94.8 148.27 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 105.85 -1.907 . . . . 1.27 105.85 176.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 33.6 tp -97.15 118.31 33.29 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.732 -1.23 . . . . 1.41 110.71 -177.638 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.2 t -120.79 126.39 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.675 -0.64 . . . . 1.23 109.551 179.77 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.74 160.71 34.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.12 -0.987 . . . . 1.32 108.986 179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.92 -33.12 70.22 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.362 -1.461 . . . . 1.49 108.672 178.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 25.1 p-10 -171.09 142.03 1.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.576 -0.703 . . . . 2.25 109.119 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.9 mt -114.53 131.28 56.7 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.35 -0.844 . . . . 1.35 108.899 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.8 p -88.67 149.41 43.95 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.967 -1.083 . . . . 1.56 108.786 179.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -40.73 -34.39 1.28 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.942 1.761 . . . . 0.87 112.039 179.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 72.5 m -59.03 -40.14 84.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.189 -0.945 . . . . 1.36 109.194 -178.892 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -70.25 -40.52 74.37 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.305 -0.958 . . . . 1.61 109.615 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.5 p -57.24 -22.6 42.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.354 -0.841 . . . . 1.21 111.87 -177.545 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.407 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -85.09 -49.49 8.22 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.539 -1.351 . . . . 1.21 109.925 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -83.92 38.05 0.63 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.924 -1.139 . . . . 2.11 107.924 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.407 ' H ' ' C ' ' A' ' 169' ' ' ALA . 57.6 tp -107.6 130.99 54.84 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.303 -0.629 . . . . 1.29 109.303 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -86.44 103.52 15.06 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.109 -1.071 . . . . 2.81 108.109 178.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.19 -40.98 94.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.407 -0.808 . . . . 2.09 111.23 -178.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -63.54 -26.07 68.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.701 -1.249 . . . . 2.86 111.541 -177.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -93.57 -9.44 38.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.753 -1.217 . . . . 2.39 110.045 -178.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.1 t -104.71 115.23 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.346 -0.846 . . . . 1.27 108.792 179.044 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.4 mt -85.74 7.71 22.58 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.129 -0.982 . . . . 2.17 110.626 -178.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 166.91 174.66 36.35 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.725 -1.35 . . . . 0.52 109.725 179.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -130.98 129.11 41.68 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.393 -1.063 . . . . 0.55 109.069 179.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 89.6 mt -131.7 125.53 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.413 -0.804 . . . . 1.27 109.246 178.826 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 42.0 p -152.51 162.18 41.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.057 -1.027 . . . . 1.39 110.478 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 182' ' ' ASP . 36.7 p30 -107.85 26.89 9.79 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.658 -0.651 . . . . 2.46 109.358 179.354 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.69 -159.39 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.903 -1.123 . . . . 1.51 111.687 -178.285 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.44 -64.01 3.44 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 111.205 -0.758 . . . . 2.23 111.205 -178.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.12 -135.48 3.91 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.021 -1.562 . . . . 2.23 110.84 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.406 HH11 ' HG2' ' A' ' 186' ' ' ARG . 44.8 mtt-85 -61.1 -32.42 72.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.506 -0.996 . . . . 6.44 110.862 -178.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 11.3 p -71.53 1.73 6.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.963 -1.086 . . . . 4.09 110.275 -178.591 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.9 t -90.95 131.28 36.66 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.995 -1.066 . . . . 2.2 110.49 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -46.16 -44.94 16.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.346 -0.846 . . . . 1.15 108.965 179.285 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.4 p -56.37 -42.79 78.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.809 -0.557 . . . . 2.01 111.001 -178.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.4 m -60.22 -40.08 88.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.922 -1.111 . . . . 1.93 110.919 -178.865 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.404 HD12 HG23 ' A' ' 192' ' ' ILE . 91.2 mt -61.9 -40.9 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.084 -1.01 . . . . 2.2 110.157 -178.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 86.9 mtp -60.12 -43.35 95.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.103 -0.998 . . . . 1.32 110.141 -179.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.2 94.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.77 -1.206 . . . . 1.3 110.279 -179.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -60.26 -51.78 68.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 3.38 111.228 -178.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 69.1 m -72.6 -34.44 67.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.914 -1.116 . . . . 1.15 111.93 -178.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.6 -14.05 58.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.71 -1.244 . . . . 1.28 110.378 -178.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 57.97 48.37 13.44 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.355 -0.841 . . . . 1.5 110.349 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 94.8 mt -118.01 122.21 30.71 Favored Pre-proline 0 N--CA 1.501 2.107 0 N-CA-C 108.182 -1.044 . . . . 1.37 108.182 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -42.02 130.3 4.39 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.809 1.673 . . . . 0.76 112.377 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -171.46 152.43 3.25 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.012 -1.075 . . . . 1.19 111.483 -179.551 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.0 mt -126.91 141.8 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 107.729 -1.212 . . . . 1.31 107.729 178.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.7 m -124.92 -8.86 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 O-C-N 120.731 -1.23 . . . . 1.38 110.983 -178.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.48 22.89 23.64 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.254 -1.139 . . . . 1.03 110.254 -179.636 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 11.6 p -44.92 -42.56 8.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.163 -1.198 . . . . 1.38 109.835 -179.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.79 -51.24 2.91 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 120.149 -1.024 . . . . 1.17 111.006 179.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.9 m -157.9 37.36 0.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.523 -1.575 . . . . 2.07 111.427 -178.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 35.4 t -79.52 -32.04 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.789 -1.194 . . . . 1.35 108.749 178.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 74.3 p -59.93 -35.02 74.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.503 -0.748 . . . . 1.49 111.143 -178.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 85.2 p -80.14 -12.13 59.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.916 -1.115 . . . . 2.16 110.413 -179.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -100.06 -12.51 19.63 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.24 -0.913 . . . . 2.89 110.465 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 91.9 t -106.31 140.12 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.295 -0.878 . . . . 1.33 111.053 -178.227 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.476 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 2.0 mptp? -113.7 152.9 29.84 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.306 -1.368 . . . . 2.73 107.306 178.022 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.494 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 28.9 p-10 -57.86 137.59 56.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.011 -1.056 . . . . 2.7 110.561 -178.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 6.2 t0 85.29 2.1 0.69 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 122.117 -0.364 . . . . 2.38 110.734 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.476 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 91.8 m-20 -70.98 143.84 50.69 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.867 -1.146 . . . . 2.09 108.713 179.036 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -93.16 113.72 26.03 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.081 -1.081 . . . . 1.45 108.081 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 61.0 mt -123.29 145.55 48.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.607 -0.683 . . . . 1.31 110.349 -179.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.407 HG23 HD12 ' A' ' 219' ' ' ILE . 79.9 mt -111.36 129.87 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 106.21 -1.774 . . . . 1.29 106.21 176.615 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 51.4 tp -100.35 118.93 37.63 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.889 -1.132 . . . . 1.31 108.534 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 10' ' ' GLY . 38.5 t0 -77.84 -45.97 22.82 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.189 -0.944 . . . . 2.31 108.819 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 51.75 16.59 0.5 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.991 -1.115 . . . . 1.19 107.991 -178.847 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.456 ' N ' ' C ' ' A' ' 221' ' ' ASP . 42.0 t -126.17 -46.14 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 106.74 -1.578 . . . . 1.45 106.74 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.509 ' CG ' HE21 ' A' ' 226' ' ' GLN . 55.3 t-20 -102.25 2.92 37.66 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.44 -1.319 . . . . 3.13 107.44 178.129 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.41 ' CG ' ' H ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 59.84 46.24 11.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.976 -0.452 . . . . 2.2 110.048 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.509 HE21 ' CG ' ' A' ' 224' ' ' ASN . 42.9 mt-30 -140.42 154.07 46.53 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.214 -0.929 . . . . 2.32 109.898 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 88.5 t -119.97 131.5 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.079 -0.712 . . . . 1.4 109.079 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -94.99 119.06 32.86 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.177 -0.952 . . . . 1.29 108.487 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 91.6 t -99.69 115.24 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.323 -0.861 . . . . 1.38 109.618 -179.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 67.09 71.07 0.44 Allowed Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.58 -0.7 . . . . 2.33 109.634 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -90.19 124.9 1.18 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.337 2.692 . . . . 0.95 112.6 -179.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 63.6 m -67.01 159.68 28.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.413 -0.804 . . . . 2.31 109.261 -179.73 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -60.08 -38.74 83.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.087 -1.008 . . . . 3.45 109.972 -179.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -60.12 -40.16 88.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.106 -0.996 . . . . 2.89 109.599 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.61 -39.97 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.218 -0.926 . . . . 1.73 109.919 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.2 mt -61.86 -38.05 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.021 -1.05 . . . . 1.57 109.436 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.92 -40.06 87.61 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.014 -1.054 . . . . 2.43 108.394 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -64.83 -44.84 88.54 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.574 -0.899 . . . . 3.18 108.574 178.571 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 93.9 mtp -70.01 -26.13 63.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.693 -0.63 . . . . 1.59 110.078 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.47 ' NH2' ' OE1' ' A' ' 243' ' ' GLN . 0.0 OUTLIER -64.59 -41.37 96.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.059 -1.026 . . . . 3.11 108.964 179.339 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.86 91.34 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.248 -1.019 . . . . 2.17 108.248 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 77.0 t -59.96 -42.36 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.922 -0.77 . . . . 2.51 108.922 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . 0.47 ' OE1' ' NH2' ' A' ' 240' ' ' ARG . 63.6 tt0 -60.18 -40.19 89.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.115 -0.99 . . . . 3.82 108.922 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -62.21 -40.03 94.72 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.097 -1.002 . . . . 1.78 109.002 179.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -65.43 -39.99 92.77 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.934 -0.765 . . . . 2.77 108.934 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 71.7 t -62.27 -39.9 85.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.456 -0.942 . . . . 2.25 108.456 179.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 251' ' ' ALA . . . -53.4 -48.89 68.29 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.503 -0.748 . . . . 2.54 109.103 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 72.3 m -60.16 -41.3 92.5 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.991 -1.084 . . . . 3.03 108.13 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -61.99 -40.22 94.87 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.244 -1.391 . . . . 3.34 107.244 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -69.97 -32.02 70.03 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.469 -0.937 . . . . 4.18 108.469 178.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 247' ' ' ALA . . . 62.98 63.25 0.96 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.516 0.674 . . . . 4.43 111.404 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -130.06 30.01 4.86 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.37 -1.344 . . . . 5.42 107.37 177.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.526 ' O ' ' CB ' ' A' ' 254' ' ' ALA . 78.6 mt -119.0 -33.5 4.16 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.088 -0.708 . . . . 6.11 109.088 179.646 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 253' ' ' LEU . . . 156.92 72.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.216 -0.661 . . . . 7.37 109.216 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp -141.82 170.19 16.19 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.076 -1.015 . . . . 8.3 109.807 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 65.0 mt -69.07 70.85 0.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.324 -0.86 . . . . 9.05 110.551 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 57.5 mttp 46.09 -134.54 0.87 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.688 -0.633 . . . . 10.56 109.794 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -79.38 68.59 5.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.189 -0.945 . . . . 11.32 109.252 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.985 -1.007 . . . . 12.74 109.46 179.611 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 301' ' ' MET . . . . . 0.402 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 50.4 ttp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.485 0.66 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 23.7 t80 -151.58 149.65 29.41 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . 0.418 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 19.2 pt20 -149.65 159.68 44.14 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.876 -1.14 . . . . 0.0 110.521 -178.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -152.48 148.58 27.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.68 -0.638 . . . . 0.0 109.456 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -110.58 131.49 55.01 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.09 -1.006 . . . . 0.0 109.803 179.212 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.74 122.84 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-O 122.262 1.03 . . . . 0.0 112.294 -177.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 46.2 m -77.48 106.77 9.46 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.062 0.934 . . . . 0.0 110.184 -178.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . 0.409 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.7 mt -52.44 121.85 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 122.361 1.077 . . . . 0.0 110.651 -177.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 30.0 p -109.97 19.14 19.35 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.38 -178.562 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.86 129.04 77.47 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.795 -1.19 . . . . 0.0 108.525 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -62.66 -10.7 20.48 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 CA-C-N 120.356 1.163 . . . . 0.0 112.981 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -120.96 5.94 10.39 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.294 -0.879 . . . . 0.0 109.418 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.68 -175.39 37.64 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.461 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.5 tp -83.11 85.62 7.16 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.123 -1.222 . . . . 0.0 109.932 -178.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -91.84 -161.98 0.88 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.864 -1.148 . . . . 0.0 109.914 178.722 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 10.0 m -58.22 -43.82 87.89 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.864 -1.147 . . . . 0.0 112.831 -175.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.491 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.2 tpt180 -60.08 -61.35 8.09 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 120.42 -1.425 . . . . 0.0 112.29 -178.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -57.7 -29.41 85.5 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 CA-C-N 120.288 1.138 . . . . 0.0 111.655 -179.573 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.93 -51.78 68.21 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.351 -0.939 . . . . 0.0 108.524 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.18 -42.44 66.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.431 -0.793 . . . . 0.0 109.269 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -70.22 -40.07 74.76 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.929 -1.107 . . . . 0.0 108.719 177.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -63.92 -55.46 22.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.734 -0.604 . . . . 0.0 109.795 -179.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 54.2 t -68.05 -36.71 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.816 -1.178 . . . . 0.0 109.682 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -60.0 -44.62 94.42 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.755 -179.286 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -66.79 -40.07 88.0 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.955 -1.091 . . . . 0.0 109.872 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -64.67 -51.7 61.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.125 -0.984 . . . . 0.0 110.132 -179.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -57.55 -11.54 2.1 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.083 -1.01 . . . . 0.0 109.131 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -67.9 -30.45 74.3 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.716 -1.753 . . . . 0.0 108.716 179.182 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -105.31 143.28 33.7 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.598 -0.942 . . . . 0.0 109.15 179.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 27.9 m -89.95 -11.8 40.65 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.978 -1.076 . . . . 0.0 109.845 -179.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 60.1 p -60.02 153.8 20.63 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.049 -1.032 . . . . 0.0 108.764 179.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.75 129.5 40.12 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.181 -0.949 . . . . 0.0 109.558 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.3 mt -129.15 129.95 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.626 -0.671 . . . . 0.0 109.35 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.9 m -128.06 152.57 47.81 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.509 -0.744 . . . . 0.0 109.626 179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 63.5 t -118.03 137.47 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 336' ' ' THR . . . . . 0.453 ' HG1' ' HG ' ' B' ' 341' ' ' SER . 55.0 m -129.98 122.24 28.09 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.215 -0.928 . . . . 0.0 108.999 179.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 91.4 p -137.36 118.49 14.45 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.014 0.912 . . . . 0.0 111.102 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 44.38 57.41 4.38 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 177.298 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 83.16 -12.5 49.87 Favored Glycine 0 N--CA 1.5 2.956 0 O-C-N 120.164 -1.585 . . . . 0.0 113.388 176.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -119.11 131.27 55.9 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-N 119.367 1.584 . . . . 0.0 110.067 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 341' ' ' SER . . . . . 0.453 ' HG ' ' HG1' ' B' ' 336' ' ' THR . 70.6 m -124.86 146.71 49.15 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.903 0.859 . . . . 0.0 110.599 -179.113 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -138.81 161.81 36.32 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.634 0.73 . . . . 0.0 109.596 -179.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 51.0 m -86.08 131.87 34.17 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.558 -0.713 . . . . 0.0 109.994 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.436 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -69.86 -17.51 63.37 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.075 -1.016 . . . . 0.0 109.141 179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . 0.481 ' C ' ' HG ' ' B' ' 346' ' ' SER . 45.2 pttt -89.26 20.93 3.49 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.481 ' HG ' ' C ' ' B' ' 345' ' ' LYS . 5.7 m -145.41 92.34 2.23 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.451 -179.344 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . 0.537 ' O ' ' NE2' ' B' ' 351' ' ' GLN . 58.7 tp -59.95 -37.22 78.92 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.274 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . 0.589 ' CB ' HE21 ' A' ' 111' ' ' GLN . 59.1 m-85 -54.61 -51.34 65.66 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.25 -0.906 . . . . 0.0 111.138 -179.287 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.45 ' O ' ' OG1' ' B' ' 352' ' ' THR . 34.0 mtmm -69.25 -39.98 78.14 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.91 -1.118 . . . . 0.0 109.781 -178.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' B' ' 352' ' ' THR . 18.2 mt -47.16 -57.21 5.37 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.12 -0.988 . . . . 0.0 108.671 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' B' ' 347' ' ' LEU . 1.4 mp0 -39.33 -22.56 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.525 -0.734 . . . . 0.0 111.088 -179.009 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.52 ' N ' ' O ' ' B' ' 350' ' ' LEU . 72.4 p -82.88 -10.89 58.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.348 -1.47 . . . . 0.0 110.796 -178.155 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 49.6 mt -94.89 117.84 30.8 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.816 -1.178 . . . . 0.0 109.513 178.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.05 92.24 0.83 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.3 mt -99.57 91.35 4.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.233 -1.157 . . . . 0.0 109.279 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 33.4 p -89.71 168.29 12.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.812 -1.18 . . . . 0.0 111.046 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -63.13 115.94 4.94 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.228 0.537 . . . . 0.0 110.763 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 100.75 7.39 50.94 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 24.1 m -86.82 114.68 23.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.485 -1.009 . . . . 0.0 111.066 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 14.9 t -76.43 116.56 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.322 1.058 . . . . 0.0 109.865 -177.54 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.1 m -111.45 176.95 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.749 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 29.7 m -130.53 129.44 42.84 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 83.0 mt -104.98 118.97 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 178.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 74.1 m -123.59 133.47 53.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.506 -0.746 . . . . 0.0 109.43 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.44 152.46 40.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.302 -179.454 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -146.36 123.13 11.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 108.953 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.511 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.96 -156.22 27.15 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 118.987 -1.578 . . . . 0.0 111.342 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.97 -52.82 63.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 122.319 -0.518 . . . . 0.0 112.008 -177.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.418 ' O ' ' C ' ' B' ' 370' ' ' GLU . 80.1 m-20 -106.93 9.5 30.74 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.782 -1.199 . . . . 0.0 111.567 -177.31 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.2 pt-20 -38.76 -33.29 0.1 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.398 -0.814 . . . . 0.0 111.232 -179.039 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -67.24 -42.3 84.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.889 -1.132 . . . . 0.0 109.618 -178.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -69.98 -52.9 20.49 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.453 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -42.06 -38.55 1.69 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.51 -0.744 . . . . 0.0 111.39 -178.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . 0.408 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 92.0 t -80.05 -34.87 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.687 -1.258 . . . . 0.0 109.928 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.51 -40.06 77.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.945 -1.097 . . . . 0.0 111.702 -178.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -81.63 -45.62 15.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.398 -1.439 . . . . 0.0 110.126 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.9 mt -60.18 -40.33 89.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 109.209 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 53.3 t -61.92 -47.16 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.101 -0.999 . . . . 0.0 109.803 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' B' ' 383' ' ' GLU . 60.9 mttp -68.27 -54.7 15.79 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.515 -1.274 . . . . 0.0 107.762 178.597 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 59.8 tp -55.24 -33.86 63.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 110.088 -178.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 9.0 tpt -72.4 -40.19 67.4 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.378 -1.451 . . . . 0.0 109.013 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.93 -4.67 58.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 110.168 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' B' ' 379' ' ' LYS . 95.6 mt-10 -110.56 -3.47 15.95 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.07 -1.019 . . . . 0.0 111.178 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.1 mt -79.51 130.63 35.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.427 -1.421 . . . . 0.0 109.547 179.415 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . 0.471 ' CD ' ' N ' ' B' ' 385' ' ' GLU . 2.3 pm0 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.271 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.561 -0.533 . . . . 3.19 109.561 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.7 mt -110.19 129.4 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.433 -0.792 . . . . 1.71 109.321 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.1 m -140.05 151.71 45.63 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.382 -0.824 . . . . 1.66 109.122 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -136.34 -166.12 10.79 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 108.495 -1.842 . . . . 1.05 108.495 179.251 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.8 mt -93.8 -9.91 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.78 -1.424 . . . . 1.59 110.334 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.3 tp 53.36 101.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.134 -0.979 . . . . 1.47 109.41 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.57 -24.67 20.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.055 -1.028 . . . . 1.39 109.867 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.4 m -146.16 134.82 10.98 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.036 -1.04 . . . . 2.09 109.723 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -80.62 139.63 12.74 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.287 1.991 . . . . 0.91 112.634 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 164.79 -165.4 37.52 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.359 -1.496 . . . . 0.92 109.359 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.6 mt -147.81 149.8 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.091 -1.24 . . . . 1.35 108.196 178.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.77 156.91 38.6 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.867 -1.146 . . . . 1.14 110.543 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -139.63 124.89 18.93 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.013 -1.106 . . . . 0.7 108.013 179.194 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.43 -179.75 48.55 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 118.776 -1.678 . . . . 0.58 110.559 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -79.29 158.62 27.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.743 -0.857 . . . . 2.63 109.462 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -101.45 129.73 47.55 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.37 -0.831 . . . . 1.27 110.923 -178.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.9 tp -98.22 132.17 43.94 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.189 -1.411 . . . . 1.41 107.189 178.369 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.45 ' H ' HD21 ' A' ' 214' ' ' ASN . 36.8 tp -118.34 122.65 43.38 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.25 -0.906 . . . . 1.49 109.592 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.1 mt -87.35 103.4 15.44 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.599 0.714 . . . . 1.52 110.167 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -93.01 135.32 34.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.447 -0.783 . . . . 3.17 109.233 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 57.3 mp0 -130.94 136.89 48.98 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.349 -0.844 . . . . 3.0 109.485 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 63.0 t0 -86.55 140.74 29.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.109 -0.995 . . . . 2.77 108.889 179.048 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 85.4 tt0 -60.33 139.99 57.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 2.94 109.548 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.5 mt -86.4 134.37 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.31 -0.869 . . . . 1.46 109.172 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.8 t -98.8 129.12 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.253 -0.905 . . . . 1.7 110.459 -179.004 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.8 mt -105.95 137.42 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.618 -0.882 . . . . 1.54 108.618 179.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -88.54 121.81 31.32 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.95 -1.094 . . . . 1.81 109.949 -179.379 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -90.63 -6.22 54.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 3.23 109.717 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -71.03 137.87 49.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.98 -1.075 . . . . 3.29 109.63 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -81.66 158.1 24.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 2.8 108.967 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.9 pt -100.43 166.28 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.139 -0.976 . . . . 1.43 109.495 179.653 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.0 p -90.46 174.77 7.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.162 -0.961 . . . . 1.54 108.765 178.764 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.85 -16.78 63.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.091 -1.006 . . . . 1.6 110.758 -179.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.3 -27.45 25.94 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.892 -1.13 . . . . 2.56 108.456 179.195 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -82.69 -7.36 59.65 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.195 -0.668 . . . . 2.36 109.195 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.8 t -59.95 -51.53 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.153 -0.967 . . . . 1.43 108.475 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.91 -40.04 87.48 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.385 -0.822 . . . . 1.77 109.084 179.111 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -63.3 -40.52 97.58 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.337 -0.852 . . . . 3.32 110.277 -178.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.473 ' OE2' ' NH2' ' A' ' 42' ' ' ARG . 60.5 mm-40 -62.93 -44.71 95.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.749 -1.219 . . . . 1.51 109.865 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.5 -49.81 81.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.041 -1.037 . . . . 1.41 109.718 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -60.66 -48.2 82.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.976 -1.077 . . . . 1.81 109.518 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.473 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 86.5 mtm180 -60.03 -40.13 88.28 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.853 -1.154 . . . . 3.26 108.407 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -65.09 -47.52 76.95 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.348 -0.845 . . . . 0.81 109.075 178.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.06 -44.6 94.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 1.59 109.151 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 t -65.36 -43.16 91.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.047 . . . . 1.38 109.315 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.52 -42.54 97.44 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.014 -2.034 . . . . 0.87 108.014 178.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 36.9 ttt-85 -63.51 -38.52 91.43 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.731 -0.864 . . . . 3.62 108.808 178.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.76 -40.61 72.81 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.505 -0.747 . . . . 1.43 109.083 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 50' ' ' ALA . 6.5 ttpm? -62.52 -73.44 0.11 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.737 -1.209 . . . . 3.08 107.737 178.934 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.71 -35.64 0.09 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.429 -0.794 . . . . 1.33 112.164 -177.818 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 98.2 p -59.42 -49.98 75.72 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.318 -1.489 . . . . 1.85 108.335 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.46 -39.85 92.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.47 -0.769 . . . . 1.35 110.646 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -65.99 -40.1 90.88 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.819 -1.176 . . . . 2.34 110.2 -179.159 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 71.4 mt -62.64 -40.05 95.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.146 -0.971 . . . . 2.2 109.689 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -62.56 -39.76 94.67 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.252 -0.905 . . . . 1.35 110.161 -179.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -64.82 -43.84 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.06 -1.025 . . . . 1.34 110.018 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.8 mt -59.93 -39.34 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 1.26 109.222 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -57.51 -51.41 69.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.367 -0.833 . . . . 1.7 110.411 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -56.62 -29.16 61.87 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.447 -0.783 . . . . 1.35 110.556 -177.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -69.75 -39.09 76.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.969 -1.082 . . . . 2.08 110.376 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.6 -46.98 74.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.304 -0.872 . . . . 1.21 110.096 -179.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.21 -50.02 53.74 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 109.743 -1.343 . . . . 0.75 109.743 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.24 -46.34 42.24 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.334 -1.098 . . . . 1.59 111.026 -179.349 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.4 m -67.57 -62.63 1.32 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.091 -1.005 . . . . 1.41 112.806 -177.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.448 ' CE1' ' O ' ' A' ' 168' ' ' THR . 77.6 m-85 -93.54 -45.77 7.6 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.684 -1.26 . . . . 0.79 110.87 -178.277 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.29 -170.6 24.59 Favored Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.011 -1.09 . . . . 1.22 110.737 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -70.02 -25.39 63.56 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.844 -0.798 . . . . 5.81 109.878 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.493 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 51.0 tp10 -60.0 -31.34 69.83 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.518 -0.739 . . . . 3.37 109.747 -179.354 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -98.98 -19.67 17.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.306 -0.871 . . . . 2.37 110.065 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -69.89 -40.02 75.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.012 -1.055 . . . . 1.65 109.977 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.55 -31.38 72.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.391 -0.818 . . . . 1.42 109.742 -179.556 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 88.8 mt -60.04 -40.99 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.108 -0.995 . . . . 1.43 109.116 -179.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -65.57 -39.7 91.96 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.222 -0.924 . . . . 1.08 110.699 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -59.95 -40.04 87.63 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.817 -1.177 . . . . 1.37 108.834 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.61 -47.0 93.32 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.971 -2.052 . . . . 0.67 107.971 178.188 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -61.58 -49.44 76.65 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.398 -1.06 . . . . 1.99 109.102 179.222 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 77' ' ' ILE . 96.5 mt -63.05 -48.98 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.276 -0.89 . . . . 1.22 109.542 179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.7 ttp -60.06 -43.03 95.71 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.108 -0.995 . . . . 2.11 110.063 -178.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.424 ' CD1' ' CE2' ' B' ' 348' ' ' PHE . 56.4 tp -63.29 -40.01 96.16 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.318 -0.864 . . . . 1.33 109.425 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.45 -39.9 89.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.78 -0.822 . . . . 1.29 108.78 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -83.28 8.15 14.31 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.229 -0.919 . . . . 1.47 110.485 -179.928 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -56.64 130.89 47.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.785 -1.197 . . . . 1.47 109.529 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.51 -18.47 52.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.468 -0.77 . . . . 1.78 110.467 -179.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -70.14 -36.28 74.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.823 -1.173 . . . . 2.53 109.109 178.531 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.2 mt -70.2 -41.77 73.26 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.411 -0.806 . . . . 1.36 110.031 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -60.03 -48.67 80.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 1.42 110.372 -178.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -70.05 -40.83 74.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 2.27 110.726 -179.009 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.07 -40.02 75.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.194 -0.941 . . . . 1.57 111.516 -178.743 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.99 -43.87 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.03 -1.043 . . . . 1.19 109.616 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.5 mt -70.06 -40.0 77.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.379 -0.826 . . . . 1.39 110.309 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.01 75.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.105 -0.997 . . . . 1.39 111.307 -178.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 96' ' ' LYS . 17.6 mt -60.9 -45.73 93.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.089 -1.007 . . . . 1.5 109.703 -178.776 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.44 -49.89 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 1.29 109.134 179.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -70.38 -41.18 73.41 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.876 -0.73 . . . . 2.64 110.916 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -82.52 -53.68 5.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.998 -1.064 . . . . 1.65 112.1 -178.229 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 92' ' ' LEU . 90.6 mttt -90.06 -1.39 57.95 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.048 -1.032 . . . . 2.5 112.124 -177.172 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 57.05 35.7 26.72 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.746 -1.221 . . . . 1.88 109.196 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 38.4 mtt -83.8 164.96 19.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.513 -0.742 . . . . 1.71 109.823 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.431 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 43.7 p -79.58 158.73 27.07 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.496 -0.927 . . . . 1.61 108.496 179.147 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.0 -40.08 75.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.994 -1.066 . . . . 1.33 109.702 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.94 -39.94 95.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.975 . . . . 2.07 109.79 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.431 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -81.57 -46.47 14.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.125 -0.984 . . . . 1.37 109.434 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.05 -49.67 76.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.442 -0.786 . . . . 1.14 109.89 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.57 85.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.171 -0.956 . . . . 1.26 109.634 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.534 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 80.7 t60 -59.99 -39.0 84.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.327 -0.858 . . . . 2.02 109.858 -179.207 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 110' ' ' GLY . 41.3 tt0 -60.36 -41.57 93.96 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.106 -0.996 . . . . 1.33 109.541 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.7 t -65.91 -50.87 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.1 -1.0 . . . . 1.3 110.198 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.5 mm -69.31 -40.12 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.044 -1.035 . . . . 1.32 108.581 179.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.534 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 89.1 tt0 -67.09 -37.21 83.55 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.405 -0.961 . . . . 2.44 108.405 178.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -60.02 -47.32 91.61 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.74 -1.344 . . . . 0.99 109.74 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -69.34 -55.8 9.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.052 -1.263 . . . . 1.97 109.004 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.83 -42.83 65.52 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.976 . . . . 1.43 108.937 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 110' ' ' GLY . 63.8 p -59.98 -40.02 87.69 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.192 -0.942 . . . . 2.12 108.67 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.98 -40.06 91.99 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.33 -0.856 . . . . 1.64 108.697 179.066 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.0 mt -65.23 -42.0 93.84 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.134 -0.979 . . . . 1.93 108.914 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -56.75 -32.88 66.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.731 -1.23 . . . . 2.2 109.414 -179.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -59.19 -22.54 61.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.023 -1.048 . . . . 2.12 108.309 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 60.3 mt -62.97 148.05 48.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.342 -0.849 . . . . 2.34 108.861 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -100.21 37.1 1.72 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.242 -0.911 . . . . 3.23 109.955 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 56.8 t0 -125.25 134.64 52.24 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.382 -0.824 . . . . 2.49 110.438 -179.315 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.487 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 12.4 pt-20 -70.44 -30.12 66.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.783 -0.573 . . . . 3.95 110.58 179.529 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.651 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 3.0 t80 -71.87 -40.01 69.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.057 -1.027 . . . . 2.25 110.65 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.476 HD22 HH22 ' A' ' 126' ' ' ARG . 60.1 mt -71.77 -31.76 66.96 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.256 -0.902 . . . . 2.27 108.584 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -66.0 -39.97 90.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.605 -0.685 . . . . 3.31 110.018 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.0 -46.34 89.8 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.21 -0.931 . . . . 2.73 110.824 -178.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.757 ' HE ' HE22 ' B' ' 351' ' ' GLN . 21.3 mtm-85 -70.01 -27.1 64.41 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.755 -1.178 . . . . 3.2 108.863 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.91 -26.07 66.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.902 -1.147 . . . . 1.66 107.902 178.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.97 -40.16 75.56 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.481 -0.933 . . . . 1.67 108.481 178.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -62.23 -44.29 96.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.574 -0.704 . . . . 1.55 109.18 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.6 t -61.48 -40.26 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.654 -0.869 . . . . 1.32 108.654 179.28 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -60.49 -37.34 80.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.49 -0.756 . . . . 3.58 109.713 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -60.0 -41.0 91.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.173 -0.954 . . . . 1.46 109.996 -178.862 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.02 -49.55 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.97 -1.081 . . . . 1.22 109.176 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.21 -42.87 98.83 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.682 -1.367 . . . . 0.61 109.682 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -60.05 -49.96 75.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.147 -1.207 . . . . 3.1 110.27 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.536 HH12 ' CB ' ' A' ' 166' ' ' SER . 98.9 mtt180 -68.88 -27.18 65.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.774 -1.204 . . . . 3.71 109.838 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.95 -43.43 95.0 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.184 -0.947 . . . . 1.87 108.587 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.69 -40.03 93.56 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.397 -0.814 . . . . 1.29 109.083 178.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -63.54 -39.95 95.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.311 -0.868 . . . . 3.05 108.665 179.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -67.13 -39.95 86.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.711 -0.618 . . . . 1.26 111.258 -179.294 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.97 -43.05 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.438 -1.414 . . . . 1.34 108.061 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.01 -30.07 67.29 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.256 -0.646 . . . . 1.6 109.256 179.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.01 40.28 9.46 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.832 -1.707 . . . . 0.96 108.832 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 tp -74.68 149.97 39.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.374 -1.074 . . . . 1.67 109.341 -179.481 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -71.1 147.97 47.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.341 -0.849 . . . . 4.96 109.725 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.409 HG22 HD13 ' A' ' 146' ' ' ILE . 85.4 mt -118.82 129.47 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 122.041 0.924 . . . . 1.68 109.313 179.271 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 11.1 mt -67.05 -40.07 84.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.807 -0.633 . . . . 2.14 110.506 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 41.6 t0 60.89 105.07 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.669 -0.863 . . . . 1.5 108.669 -178.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 55.2 mt -67.76 -0.12 3.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.305 -0.872 . . . . 1.39 110.128 -178.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.2 m -83.2 -11.8 57.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.92 -1.113 . . . . 1.83 109.511 179.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.15 25.57 0.83 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.152 -0.967 . . . . 1.46 111.179 -178.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 40.5 mm -90.97 117.18 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.59 -1.319 . . . . 1.42 108.729 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -99.92 -9.35 22.92 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.258 -0.901 . . . . 2.94 110.481 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -129.18 152.11 49.12 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.296 -0.878 . . . . 1.52 110.057 -179.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.52 136.78 57.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.504 -0.748 . . . . 1.58 109.273 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.5 m -151.92 164.8 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.328 -0.858 . . . . 1.32 109.671 179.51 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.3 mt -92.1 146.52 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 105.954 -1.869 . . . . 1.27 105.954 177.028 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.6 tp -94.23 115.83 28.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.795 -1.191 . . . . 1.41 110.495 -178.149 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.2 t -123.2 129.94 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.512 -0.921 . . . . 1.23 108.512 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.24 162.24 36.15 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.275 -1.009 . . . . 1.32 108.275 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.6 -35.25 72.91 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.214 -1.553 . . . . 1.49 108.048 178.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -170.48 140.91 1.86 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.186 -1.042 . . . . 2.25 108.186 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.7 mt -113.48 134.61 54.58 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.231 -0.918 . . . . 1.35 109.955 -179.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 18.0 p -87.27 147.19 41.74 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.305 -0.872 . . . . 1.56 108.783 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -43.24 -33.07 3.53 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.12 1.88 . . . . 0.87 113.319 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.536 ' CB ' HH12 ' A' ' 136' ' ' ARG . 13.8 m -59.95 -48.55 81.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.808 -1.183 . . . . 1.36 108.928 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.04 -44.92 94.33 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.386 -0.822 . . . . 1.61 109.438 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.448 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 67.9 p -56.72 -18.87 14.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.877 . . . . 1.21 110.537 -178.67 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.36 -48.76 8.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.949 -1.095 . . . . 1.21 109.378 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -90.82 38.64 0.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.537 -0.912 . . . . 2.11 108.537 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.5 tp -104.85 134.39 48.05 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.92 -0.77 . . . . 1.29 108.92 179.382 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -80.86 101.72 9.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 2.81 108.79 179.706 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 97.2 mt -62.93 -39.96 96.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.269 -0.894 . . . . 2.09 110.337 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -67.02 -24.25 66.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.081 -1.012 . . . . 2.86 110.883 -178.121 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -93.92 -11.46 30.93 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.737 -1.227 . . . . 2.39 109.478 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 72.4 t -101.17 110.14 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.197 -0.94 . . . . 1.27 108.737 179.064 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.16 5.99 31.42 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.204 -0.935 . . . . 2.17 110.57 -178.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.18 170.41 37.44 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.991 -1.644 . . . . 0.52 108.991 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -130.86 128.93 41.61 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.334 -1.097 . . . . 0.55 109.288 -179.806 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 90.0 mt -132.55 125.38 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.484 -0.932 . . . . 1.27 108.484 178.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.3 p -145.94 160.04 42.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.062 -1.023 . . . . 1.39 110.84 -179.236 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 59.6 t0 -101.82 23.13 11.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.599 -0.688 . . . . 2.46 109.885 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.41 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -58.19 -161.17 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.287 -1.508 . . . . 1.51 110.792 -178.498 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -83.75 -44.34 6.86 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.607 -0.997 . . . . 2.23 110.607 -179.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.405 ' O ' ' OG ' ' A' ' 191' ' ' SER . . . 147.57 -115.25 0.75 Allowed Glycine 0 N--CA 1.497 2.724 0 O-C-N 120.83 -1.394 . . . . 2.23 110.32 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -59.92 -38.06 81.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.49 -1.006 . . . . 6.44 110.927 -179.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 73.4 p -70.25 0.09 7.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.914 -1.116 . . . . 4.09 110.432 -178.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 39.8 t -92.32 117.27 29.73 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.972 -1.08 . . . . 2.2 110.712 -179.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -47.71 -42.3 24.74 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.197 -0.939 . . . . 1.15 108.541 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 23.4 p -52.18 -34.66 46.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.801 -0.562 . . . . 2.01 109.96 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.405 ' OG ' ' O ' ' A' ' 185' ' ' GLY . 74.9 m -60.01 -40.06 87.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.011 -1.056 . . . . 1.93 110.472 -179.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.2 mm -63.98 -40.35 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.17 -0.956 . . . . 2.2 110.112 -178.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 82.9 mtp -59.99 -49.04 79.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.956 -1.09 . . . . 1.32 110.969 -178.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.52 -44.17 89.43 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.705 -1.247 . . . . 1.3 109.968 -178.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -61.75 -54.93 35.81 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.29 -0.964 . . . . 3.38 110.503 -179.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.3 m -70.0 -35.89 74.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.027 -1.046 . . . . 1.15 112.148 -178.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.55 -12.35 60.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.604 -1.31 . . . . 1.28 110.585 -178.114 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 62.14 49.56 4.39 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.495 -0.753 . . . . 1.5 111.055 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 96.4 mt -130.62 150.03 75.22 Favored Pre-proline 0 N--CA 1.499 2.002 0 N-CA-C 107.641 -1.244 . . . . 1.37 107.641 178.004 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.11 143.85 73.26 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.035 1.823 . . . . 0.76 111.418 179.867 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.91 151.74 4.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.746 -1.221 . . . . 1.19 111.889 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.6 mt -125.81 139.67 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.025 -1.102 . . . . 1.31 108.025 178.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.1 m -122.77 -12.67 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 120.985 -1.072 . . . . 1.38 110.968 -178.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.98 26.56 13.63 Favored Glycine 0 N--CA 1.501 2.978 0 N-CA-C 110.897 -0.881 . . . . 1.03 110.897 -178.838 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.7 p -43.2 -44.82 5.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.066 -1.255 . . . . 1.38 110.096 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.447 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 93.01 -52.12 2.54 Favored Glycine 0 N--CA 1.498 2.795 0 C-N-CA 120.224 -0.988 . . . . 1.17 110.741 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.2 t -158.91 33.64 0.21 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.617 -1.519 . . . . 2.07 111.186 -179.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.6 -40.05 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.985 -1.072 . . . . 1.35 109.082 178.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.0 p -54.54 -30.0 52.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.431 -0.793 . . . . 1.49 110.108 -179.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.5 t -80.89 -21.1 40.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.061 -1.024 . . . . 2.16 110.161 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -96.96 -13.41 22.39 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.128 -0.982 . . . . 2.89 110.125 -179.416 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.8 t -102.05 136.62 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.361 -0.837 . . . . 1.33 110.216 -178.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -112.23 154.54 25.43 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.04 -1.467 . . . . 2.73 107.04 178.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.497 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 15.5 t-20 -60.04 139.02 57.73 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.839 -1.163 . . . . 2.7 110.169 -179.145 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 9.6 t0 84.91 7.24 0.48 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.16 0.505 . . . . 2.38 110.019 179.49 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 55.3 t0 -76.87 142.07 40.35 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.204 -0.935 . . . . 2.09 109.096 179.232 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.493 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 49.3 t80 -92.81 117.98 30.61 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.977 -1.12 . . . . 1.45 107.977 178.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 69.9 mt -127.16 147.47 50.19 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.503 -0.748 . . . . 1.31 110.55 -178.554 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 80.5 mt -118.39 129.59 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 107.469 -1.308 . . . . 1.29 107.469 177.461 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 34.3 tp -104.22 123.65 47.71 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.668 -0.864 . . . . 1.31 108.668 -179.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 10' ' ' GLY . 29.1 t0 -85.75 -35.76 20.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.107 -0.995 . . . . 2.31 108.38 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.412 ' HB2' ' H ' ' A' ' 10' ' ' GLY . . . 45.71 21.41 0.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.742 0.782 . . . . 1.19 108.919 -179.319 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 221' ' ' ASP . 42.1 t -133.41 -44.07 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.121 -1.437 . . . . 1.45 107.121 178.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.465 ' ND2' ' OD2' ' A' ' 221' ' ' ASP . 84.3 m-20 -102.25 2.1 36.66 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.057 -1.09 . . . . 3.13 108.057 178.606 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 59.98 43.91 14.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.805 -0.559 . . . . 2.2 110.307 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -136.41 149.37 48.25 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.216 -0.928 . . . . 2.32 110.112 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.6 129.96 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.454 -0.943 . . . . 1.4 108.454 178.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -100.87 123.03 44.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.423 -0.798 . . . . 1.29 109.303 179.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 19.4 t -100.03 110.52 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.373 -0.83 . . . . 1.38 109.98 -179.312 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 230' ' ' ASN . 3.9 t30 56.61 67.43 2.69 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.325 -0.859 . . . . 2.33 111.368 179.221 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -91.05 150.02 3.82 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.266 2.644 . . . . 0.95 112.568 178.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.0 m -70.07 160.03 32.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.345 -0.847 . . . . 2.31 110.29 -179.23 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -59.99 -36.84 78.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.392 -0.817 . . . . 3.45 109.608 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -60.03 -38.43 82.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 2.89 109.221 -179.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.36 -40.05 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.096 -1.003 . . . . 1.73 109.405 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.429 HD12 HG21 ' A' ' 236' ' ' ILE . 96.6 mt -64.34 -40.11 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.164 -0.96 . . . . 1.57 110.104 -179.856 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -59.92 -43.83 94.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.806 -1.183 . . . . 2.43 109.117 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -62.01 -43.94 97.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.374 -0.829 . . . . 3.18 110.047 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 96.2 mtp -69.92 -34.72 73.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.325 -0.859 . . . . 1.59 110.324 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -62.04 -40.01 94.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.159 -0.963 . . . . 3.11 110.166 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -64.18 -43.29 95.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.995 -1.066 . . . . 2.17 109.756 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 56.7 t -60.81 -40.16 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.249 -0.907 . . . . 2.51 109.229 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -59.93 -40.16 87.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.306 -0.872 . . . . 3.82 109.62 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -59.97 -41.39 91.86 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.243 -0.911 . . . . 1.78 109.385 -179.6 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -70.0 -40.01 75.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 2.77 109.641 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.27 -45.11 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.462 -0.773 . . . . 2.25 109.603 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.03 -49.98 75.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 2.54 109.429 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 70.5 m -61.68 -39.93 93.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -0.87 . . . . 3.03 109.527 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -64.13 -40.04 95.33 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.567 -0.708 . . . . 3.34 110.206 -179.134 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -171.55 80.07 0.07 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.144 -0.973 . . . . 4.18 108.59 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.437 ' O ' ' CB ' ' A' ' 252' ' ' GLU . . . -80.9 -6.85 59.18 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.27 -0.894 . . . . 4.43 109.077 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' A' ' 251' ' ' ALA . 2.6 tm-20 75.56 -41.44 0.44 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.521 -0.737 . . . . 5.42 109.388 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.435 ' H ' ' C ' ' A' ' 251' ' ' ALA . 0.1 OUTLIER -100.16 46.2 0.96 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.075 -1.083 . . . . 6.11 108.075 179.27 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -152.71 -0.54 0.27 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.307 -0.871 . . . . 7.37 111.005 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 256' ' ' LEU . 55.6 tttp -145.93 6.14 1.03 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.68 -1.263 . . . . 8.3 109.404 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 255' ' ' LYS . 54.1 mt 56.52 114.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.244 -0.91 . . . . 9.05 109.825 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -123.87 14.83 9.3 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.271 -1.011 . . . . 10.56 108.271 179.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 258' ' ' ASP . 22.0 p-10 -84.73 36.35 0.6 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.732 -1.23 . . . . 11.32 109.657 -179.646 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 117.976 -1.012 . . . . 12.74 109.125 179.624 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 50.5 ttp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.573 0.701 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 36.2 t80 -154.92 152.83 30.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.706 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . 0.463 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 13.8 pt20 -149.78 159.99 43.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.937 -1.102 . . . . 0.0 110.474 -179.436 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -153.94 150.44 28.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -112.49 134.08 54.21 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.225 -0.922 . . . . 0.0 110.583 -179.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -129.71 121.52 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-O 122.251 1.024 . . . . 0.0 112.546 -177.485 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 25.4 m -76.45 105.1 7.31 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.79 0.805 . . . . 0.0 110.42 -178.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 98.9 mt -53.26 121.62 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 122.318 1.056 . . . . 0.0 110.375 -178.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 78.1 p -110.11 19.95 18.42 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.36 -178.622 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.14 126.14 91.97 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.901 -1.124 . . . . 0.0 109.168 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.65 -18.72 27.38 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 CA-C-N 120.404 1.18 . . . . 0.0 112.327 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -120.45 10.16 11.1 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 75.33 -176.98 49.47 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.098 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.515 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -83.45 87.54 6.99 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.088 -1.242 . . . . 0.0 108.988 -178.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -90.29 -162.92 0.94 Allowed 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.825 -1.172 . . . . 0.0 110.123 179.09 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 9.6 m -57.09 -41.78 79.49 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.852 -1.155 . . . . 0.0 112.486 -175.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.493 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 0.7 OUTLIER -60.02 -60.88 9.17 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 120.62 -1.3 . . . . 0.0 111.855 -178.835 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -59.38 -34.33 97.56 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 CA-C-N 120.139 1.085 . . . . 0.0 111.801 -179.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.52 73.42 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.74 -41.96 67.66 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.02 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . 0.505 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 27.3 mm100 -70.0 -41.4 74.42 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 108.692 178.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . 0.486 ' CE1' ' SD ' ' B' ' 381' ' ' MET . 55.1 t80 -61.93 -52.23 64.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.583 -0.698 . . . . 0.0 110.813 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . 0.517 ' CG1' ' HZ2' ' B' ' 327' ' ' LYS . 93.8 t -65.51 -29.23 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.596 -1.315 . . . . 0.0 109.299 -179.288 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . 0.505 ' NZ ' ' OE1' ' B' ' 321' ' ' GLN . 0.2 OUTLIER -60.13 -46.25 90.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.406 -0.809 . . . . 0.0 109.636 179.495 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -67.19 -45.62 76.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.346 -0.846 . . . . 0.0 110.893 -178.54 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.0 -53.0 62.97 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.706 -1.246 . . . . 0.0 110.833 -178.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.517 ' HZ2' ' CG1' ' B' ' 323' ' ' VAL . 28.5 mttp -54.12 -12.64 0.65 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.067 -1.021 . . . . 0.0 109.452 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.1 -20.14 73.42 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -106.03 146.66 29.82 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.387 -1.066 . . . . 0.0 108.599 179.531 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 70.0 p -91.51 -14.29 30.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.86 -1.15 . . . . 0.0 109.435 179.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 77.9 p -64.52 149.18 49.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.665 -179.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -69.85 138.25 52.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.129 -0.982 . . . . 0.0 108.795 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.6 mt -134.14 134.6 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.603 -0.686 . . . . 0.0 109.56 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 48.4 m -128.62 149.82 50.49 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.451 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 76.5 t -121.99 113.15 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.35 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 44.3 m -105.29 133.16 50.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.951 . . . . 0.0 109.28 -178.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 34.1 p -137.83 110.67 7.66 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.758 0.789 . . . . 0.0 110.248 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 22.4 m120 45.97 53.48 9.02 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 177.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.96 -15.45 59.35 Favored Glycine 0 N--CA 1.504 3.169 0 O-C-N 120.246 -1.534 . . . . 0.0 113.207 176.413 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . 0.528 ' NZ ' ' O ' ' B' ' 352' ' ' THR . 9.7 mtpm? -116.06 127.92 55.27 Favored 'General case' 0 N--CA 1.507 2.423 0 CA-C-N 119.338 1.569 . . . . 0.0 109.614 -179.517 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 67.2 m -127.2 148.58 50.19 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.968 0.889 . . . . 0.0 111.15 -178.395 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.94 164.69 29.49 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.348 0.594 . . . . 0.0 109.712 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 47.4 t -88.58 132.41 34.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.474 -0.766 . . . . 0.0 110.922 -178.735 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -69.86 -21.63 63.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.888 . . . . 0.0 108.871 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' B' ' 345' ' ' LYS . 24.0 ttpp -83.12 18.0 1.82 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.61 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.516 ' H ' ' C ' ' B' ' 344' ' ' ALA . 11.2 t -147.12 95.33 2.54 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.14 -179.489 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 60.8 tp -59.91 -39.7 86.28 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.542 -0.724 . . . . 0.0 109.132 179.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . 0.424 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 60.9 m-85 -54.02 -52.49 60.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.104 -0.998 . . . . 0.0 110.771 -179.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.446 ' O ' ' OG1' ' B' ' 352' ' ' THR . 49.9 mtpt -65.89 -39.99 91.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.152 -0.968 . . . . 0.0 109.704 -178.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' B' ' 352' ' ' THR . 17.6 mt -49.71 -58.35 5.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.193 -0.942 . . . . 0.0 109.915 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.757 HE22 ' HE ' ' A' ' 126' ' ' ARG . 8.2 mm100 -42.58 -13.19 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.239 -0.913 . . . . 0.0 111.869 -177.077 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.569 ' N ' ' O ' ' B' ' 350' ' ' LEU . 81.6 p -85.02 -15.01 45.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 119.95 -1.719 . . . . 0.0 110.275 -179.152 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 43.3 mt -91.32 119.96 31.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.999 -1.063 . . . . 0.0 109.431 179.335 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.26 93.91 0.7 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.175 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 52.0 mt -100.59 88.01 3.51 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.245 -1.15 . . . . 0.0 109.187 179.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 60.0 p -91.53 166.12 13.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.958 -1.089 . . . . 0.0 110.744 -178.974 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -59.41 116.64 4.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.774 -0.579 . . . . 0.0 111.077 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 101.02 7.11 50.91 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 47.7 m -86.74 110.89 20.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -1.136 . . . . 0.0 110.795 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 46.7 t -77.78 117.52 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 122.169 0.985 . . . . 0.0 109.48 -177.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 25.4 m -110.22 177.67 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 91.1 m -131.35 128.74 40.29 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.174 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 69.6 mt -103.0 116.33 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.647 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 67.2 m -116.06 129.99 56.6 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.88 151.8 39.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.353 -0.842 . . . . 0.0 109.724 -178.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -145.01 121.5 11.03 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.459 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.81 -155.38 26.54 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 118.765 -1.683 . . . . 0.0 111.844 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -59.94 -50.9 71.93 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.173 -0.514 . . . . 0.0 112.224 -177.151 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' B' ' 370' ' ' GLU . 97.0 m-20 -110.27 13.47 22.99 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.777 -1.202 . . . . 0.0 111.137 -177.584 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.7 pt-20 -42.23 -36.42 1.21 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.206 -0.934 . . . . 0.0 110.655 -179.246 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -69.26 -47.06 65.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.043 -1.036 . . . . 0.0 110.162 -179.148 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -69.98 -54.44 13.25 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.003 -1.06 . . . . 0.0 109.51 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.46 -34.18 1.26 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.365 -0.834 . . . . 0.0 111.179 -179.022 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 73.4 t -76.09 -35.66 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.603 -1.311 . . . . 0.0 109.399 179.327 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -65.41 -59.4 4.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 111.853 -178.15 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -69.77 -39.99 76.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.384 -1.448 . . . . 0.0 111.707 -178.269 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 88.0 mt -58.46 -39.99 81.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.526 -1.359 . . . . 0.0 108.696 -178.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 55.3 t -62.38 -42.72 96.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.103 -0.998 . . . . 0.0 109.596 179.401 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.6 mttt -71.25 -57.54 4.39 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.794 -1.191 . . . . 0.0 108.209 178.853 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 53.9 tp -53.32 -35.99 60.77 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.173 -0.954 . . . . 0.0 109.015 -178.346 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 381' ' ' MET . . . . . 0.486 ' SD ' ' CE1' ' B' ' 322' ' ' PHE . 0.9 OUTLIER -72.14 -40.0 68.38 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.621 -1.299 . . . . 0.0 108.437 177.648 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.62 -4.87 58.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.595 -0.691 . . . . 0.0 110.601 179.374 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' B' ' 379' ' ' LYS . 94.6 mt-10 -111.43 -3.11 15.34 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.125 -0.985 . . . . 0.0 110.807 -179.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.6 mt -82.98 131.14 35.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.637 -1.289 . . . . 0.0 109.099 179.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.091 179.615 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.358 -0.608 . . . . 3.19 109.358 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.431 ' CD1' ' OE1' ' A' ' 211' ' ' GLN . 97.4 mt -108.37 123.71 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.438 -0.788 . . . . 1.71 109.602 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.8 m -135.98 141.14 44.39 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.72 -0.844 . . . . 1.66 108.72 179.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.731 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -109.0 -160.13 19.45 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.113 -1.595 . . . . 1.05 109.113 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.1 mt -95.23 -15.01 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.118 -1.225 . . . . 1.59 109.589 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.4 tp 51.99 104.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.798 . . . . 1.47 109.666 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.82 -23.57 17.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.079 -1.013 . . . . 1.39 109.302 179.51 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.459 ' OG ' ' N ' ' A' ' 201' ' ' ALA . 12.5 p -137.42 119.24 11.01 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.405 -0.81 . . . . 2.09 109.06 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.99 150.13 20.51 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.904 1.736 . . . . 0.91 112.375 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 154.35 -155.09 25.96 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.08 -1.608 . . . . 0.92 109.08 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.429 HD11 HG21 ' A' ' 11' ' ' ILE . 71.7 mt -149.08 150.59 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.016 -1.285 . . . . 1.35 109.112 179.045 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.12 146.12 22.59 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.022 -1.049 . . . . 1.14 110.315 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -127.62 127.92 44.64 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.161 -1.051 . . . . 0.7 108.161 178.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.1 176.08 46.6 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.734 -1.698 . . . . 0.58 110.588 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -77.76 156.31 30.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.699 -0.883 . . . . 2.63 109.022 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.59 128.33 49.29 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.416 -0.802 . . . . 1.27 111.025 -178.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.8 tp -100.13 135.33 41.73 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.069 -1.456 . . . . 1.41 107.069 178.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.0 tp -115.3 121.6 43.37 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.3 -0.875 . . . . 1.49 110.099 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.1 mt -86.69 103.01 14.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.526 -0.734 . . . . 1.52 109.73 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -90.96 142.31 27.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.395 -0.815 . . . . 3.17 109.244 179.713 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -130.1 133.34 46.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.426 -0.953 . . . . 3.0 108.426 179.222 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -84.07 150.69 25.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.044 -1.035 . . . . 2.77 109.429 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -66.66 147.89 52.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.932 . . . . 2.94 109.301 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 86.5 mt -96.44 126.68 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.187 -0.946 . . . . 1.46 109.05 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.1 t -94.73 126.12 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.133 -0.979 . . . . 1.7 109.997 -179.298 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.5 mt -112.37 131.93 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 109.016 -0.735 . . . . 1.54 109.016 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.01 118.35 28.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.873 -1.142 . . . . 1.81 110.335 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -85.08 -1.06 56.42 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.715 -0.846 . . . . 3.23 108.715 179.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -69.9 140.37 53.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.469 -0.769 . . . . 3.29 110.024 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -80.03 153.3 28.91 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.194 -0.941 . . . . 2.8 109.409 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.0 pt -94.6 167.48 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.179 -0.95 . . . . 1.43 109.711 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.445 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 58.4 p -96.28 173.04 7.59 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.147 -1.057 . . . . 1.54 108.147 178.22 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.99 75.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.913 -1.117 . . . . 1.6 110.501 -179.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.445 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 11.9 p-10 -57.3 -26.45 60.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.703 -1.248 . . . . 2.56 109.513 -179.275 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -82.26 -9.83 59.34 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.302 -0.874 . . . . 2.36 109.762 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.3 t -66.49 -54.59 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.925 -1.11 . . . . 1.43 109.641 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.04 -40.08 88.14 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.269 -0.895 . . . . 1.77 109.102 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -62.87 -42.19 99.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.419 -0.801 . . . . 3.32 110.707 -179.295 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -62.62 -42.55 99.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.615 -1.303 . . . . 1.51 110.221 -179.498 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.98 -47.39 91.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 120.594 -1.316 . . . . 1.41 108.64 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -59.94 -45.15 93.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -0.942 . . . . 1.81 109.318 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.472 HH11 ' HG2' ' A' ' 42' ' ' ARG . 22.2 mtt-85 -60.08 -43.56 95.39 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.069 -1.086 . . . . 3.26 108.069 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -62.0 -47.2 85.85 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.737 -0.838 . . . . 0.81 108.737 178.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.2 tp -59.94 -48.92 79.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 1.59 108.837 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.4 t -63.04 -43.73 97.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.975 -1.078 . . . . 1.38 108.963 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.06 -47.51 90.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.57 -1.812 . . . . 0.87 108.57 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -61.56 -36.18 79.9 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.006 -1.109 . . . . 3.62 108.006 178.599 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.32 -40.01 70.64 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.317 -0.623 . . . . 1.43 109.317 -179.618 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ALA . 26.4 ttpp -66.34 -73.73 0.13 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.652 -1.24 . . . . 3.08 107.652 179.153 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.09 -36.34 0.2 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.46 -0.775 . . . . 1.33 111.346 -178.544 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 t -57.41 -55.94 28.34 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.508 -1.37 . . . . 1.85 108.612 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.08 -40.0 86.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.253 -0.904 . . . . 1.35 111.074 -179.49 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -67.96 -40.24 83.23 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.841 -1.162 . . . . 2.34 110.322 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.2 mt -62.03 -39.97 94.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.009 -1.057 . . . . 2.2 108.72 179.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -61.21 -38.49 86.79 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.426 -0.796 . . . . 1.35 109.713 179.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -64.27 -43.69 94.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.194 -0.941 . . . . 1.34 110.268 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.64 ' CD1' HH22 ' A' ' 136' ' ' ARG . 85.7 mt -63.04 -38.1 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 1.26 108.969 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -56.15 -50.59 70.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 1.7 109.896 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -59.94 -36.44 77.08 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.43 -0.794 . . . . 1.35 110.367 -177.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -63.79 -39.48 94.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.963 -1.086 . . . . 2.08 109.211 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.54 -45.48 75.54 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.564 -0.71 . . . . 1.21 110.033 -179.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.14 -51.16 60.07 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 110.268 -1.133 . . . . 0.75 110.268 -179.036 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -69.96 -41.88 73.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.037 -1.272 . . . . 1.59 110.309 -179.446 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.3 m -69.92 -60.4 2.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.912 . . . . 1.41 112.2 -177.546 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -95.49 -50.77 4.84 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.964 -1.085 . . . . 0.79 111.093 -178.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.42 -163.7 26.75 Favored Glycine 0 N--CA 1.499 2.837 0 O-C-N 120.747 -1.221 . . . . 1.22 110.726 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -70.0 -23.24 63.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.751 -0.852 . . . . 5.81 110.364 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.425 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 52.7 tp10 -60.13 -37.76 81.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 3.37 110.272 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -97.4 -19.02 18.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.293 -0.88 . . . . 2.37 110.388 -178.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -70.09 -40.12 75.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.855 -1.153 . . . . 1.65 110.496 -179.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.82 -29.9 69.17 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.399 -0.813 . . . . 1.42 109.585 -178.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.02 -42.57 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.248 -0.981 . . . . 1.43 109.112 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -64.5 -40.08 94.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.112 -0.993 . . . . 1.08 110.742 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -59.98 -40.02 87.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.831 -1.168 . . . . 1.37 108.833 -179.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.01 -43.53 98.73 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 107.98 -2.048 . . . . 0.67 107.98 178.514 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -65.21 -48.43 73.41 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.459 -1.024 . . . . 1.99 108.608 179.253 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.9 mt -64.36 -49.39 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.397 -0.815 . . . . 1.22 109.18 179.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.2 ttp -60.41 -42.73 96.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.167 -0.958 . . . . 2.11 110.37 -179.075 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.0 tp -66.04 -41.57 90.7 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.335 -0.853 . . . . 1.33 109.983 -179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.4 tp -63.31 -40.11 96.44 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.292 -0.88 . . . . 1.29 110.168 -179.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -82.57 8.03 12.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.188 -0.945 . . . . 1.47 110.08 -179.355 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -50.78 131.91 26.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 1.47 109.352 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.44 -20.66 60.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.701 -0.624 . . . . 1.78 111.027 -178.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.71 -34.32 67.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.901 -1.125 . . . . 2.53 109.552 179.54 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.6 mt -70.08 -40.1 75.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.538 -0.726 . . . . 1.36 109.321 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -60.08 -46.04 90.91 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.389 -0.82 . . . . 1.42 109.613 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -69.99 -40.48 75.29 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.406 -0.809 . . . . 2.27 110.244 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.02 -40.02 75.46 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.051 -1.03 . . . . 1.57 111.14 -179.417 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.0 mt -67.95 -48.88 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.919 -1.113 . . . . 1.19 109.461 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.97 -39.7 84.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.506 -0.746 . . . . 1.39 109.51 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.96 -48.89 79.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 1.39 110.532 -179.246 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 96' ' ' LYS . 84.3 mt -60.22 -47.73 84.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.928 -1.108 . . . . 1.5 109.878 -179.638 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.81 -50.05 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.89 . . . . 1.29 109.198 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -70.0 -40.49 75.25 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.857 -0.737 . . . . 2.64 110.814 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 91' ' ' ALA . 10.2 t70 -84.17 -50.9 7.49 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.041 -1.037 . . . . 1.65 112.058 -178.147 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.479 ' N ' ' O ' ' A' ' 92' ' ' LEU . 67.2 mmtt -90.19 -2.6 58.07 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.885 -1.135 . . . . 2.5 111.606 -177.491 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.7 m80 57.6 36.71 27.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.075 -1.016 . . . . 1.88 109.478 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 79.6 mtp -93.56 164.14 13.29 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.651 -0.655 . . . . 1.71 110.343 -179.361 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.6 p -77.9 161.82 27.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.608 -0.683 . . . . 1.61 109.177 179.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.89 81.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.102 -0.999 . . . . 1.33 109.783 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -64.29 -39.97 95.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.144 -0.972 . . . . 2.07 109.399 179.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.29 -46.76 19.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.836 . . . . 1.37 109.756 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.55 -50.01 75.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.308 -0.87 . . . . 1.14 109.838 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.57 -37.45 81.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 1.26 109.417 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -60.05 -46.91 87.97 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.514 -0.741 . . . . 2.02 110.109 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -62.65 -40.08 95.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -0.879 . . . . 1.33 110.946 -179.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.4 -56.29 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.005 -1.059 . . . . 1.3 111.039 -178.055 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.5 mm -68.78 -39.97 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.918 -1.114 . . . . 1.32 108.967 -179.326 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -63.63 -40.04 95.89 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.245 -1.02 . . . . 2.44 108.245 178.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.418 ' O ' ' OG ' ' A' ' 113' ' ' SER . . . -60.77 -50.43 67.67 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.057 -1.217 . . . . 0.99 110.057 -179.875 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -65.24 -49.49 69.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.956 -1.32 . . . . 1.97 109.262 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.56 -42.67 92.93 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.094 -1.004 . . . . 1.43 108.731 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 110' ' ' GLY . 88.6 p -60.11 -39.86 87.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.243 -0.91 . . . . 2.12 109.023 179.175 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.3 -39.92 80.62 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.056 -1.028 . . . . 1.64 108.629 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.9 mt -62.17 -39.97 94.43 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.138 -0.976 . . . . 1.93 109.047 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -53.85 -24.37 15.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.081 -1.012 . . . . 2.2 109.514 -179.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -59.91 -27.83 67.07 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.534 -1.284 . . . . 2.12 107.534 179.146 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 57.6 mt -62.99 140.38 58.86 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.712 -0.618 . . . . 2.34 109.511 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -100.12 48.92 0.92 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.232 -0.917 . . . . 3.23 109.538 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 51.1 t0 -136.34 148.53 47.94 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.311 -0.868 . . . . 2.49 109.424 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 71.4 mm-40 -73.28 -65.02 0.86 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.247 -0.908 . . . . 3.95 108.597 178.636 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -40.7 -39.85 1.17 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.83 -0.544 . . . . 2.25 110.948 -179.154 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.6 mt -76.33 -40.27 51.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.619 -1.301 . . . . 2.27 110.0 -179.455 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -68.64 -39.98 80.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.047 -1.033 . . . . 3.31 109.463 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -59.9 -43.57 94.74 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.135 -0.978 . . . . 2.73 108.527 -179.452 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.684 ' NE ' HE21 ' B' ' 351' ' ' GLN . 1.6 ttp180 -60.73 -40.02 90.81 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.364 -0.976 . . . . 3.2 108.364 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.04 -19.91 48.25 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.904 -1.147 . . . . 1.66 107.904 178.555 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.72 -40.04 76.5 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.585 -1.265 . . . . 1.67 107.585 178.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -65.02 -40.05 94.3 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.501 -0.749 . . . . 1.55 109.102 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.48 -40.09 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.306 -0.998 . . . . 1.32 108.306 178.997 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -62.33 -37.81 87.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.542 -0.723 . . . . 3.58 109.294 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -59.98 -40.56 89.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.374 -0.829 . . . . 1.46 110.034 -178.85 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.01 -47.81 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.129 -0.982 . . . . 1.22 109.45 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.16 -40.24 98.91 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.09 -1.204 . . . . 0.61 110.09 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -59.96 -48.0 83.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.378 -1.071 . . . . 3.1 109.774 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.64 HH22 ' CD1' ' A' ' 57' ' ' ILE . 57.4 mtp180 -65.77 -33.5 76.0 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.038 -1.039 . . . . 3.71 109.729 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.84 -43.15 94.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.41 -0.806 . . . . 1.87 109.374 -179.234 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.05 -40.06 88.12 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.19 -0.943 . . . . 1.29 109.238 179.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -69.94 -39.9 75.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 3.05 109.477 179.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -67.62 -34.66 77.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.478 -0.763 . . . . 1.26 112.096 -178.576 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.06 -41.46 79.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.256 -1.527 . . . . 1.34 108.784 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 92.1 mt -73.45 -26.19 60.82 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.802 -0.814 . . . . 1.6 108.802 179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.32 43.41 8.02 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.374 -1.89 . . . . 0.96 108.374 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 tp -74.35 150.03 40.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.532 -0.981 . . . . 1.67 109.029 -179.129 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -64.58 142.51 58.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.29 -0.881 . . . . 4.96 110.396 -178.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.7 mt -116.86 127.6 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-O 121.89 0.852 . . . . 1.68 108.771 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.8 mt -65.43 -43.87 94.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.918 -0.489 . . . . 2.14 111.468 -177.644 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.0 t0 64.53 112.78 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.222 -0.924 . . . . 1.5 109.031 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 86.6 mt -79.05 -3.28 44.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.319 -0.863 . . . . 1.39 110.029 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.9 m -87.3 -15.3 38.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.275 -0.89 . . . . 1.83 109.808 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.31 14.47 2.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.281 -0.887 . . . . 1.46 111.334 -178.503 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.556 ' N ' ' CD1' ' A' ' 152' ' ' ILE . 1.5 mp -90.23 117.92 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.549 -1.344 . . . . 1.42 108.764 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -101.65 -11.87 18.85 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.303 -0.873 . . . . 2.94 110.196 -179.433 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -112.24 146.66 37.77 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.55 -0.719 . . . . 1.52 110.168 -179.212 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.06 132.2 47.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.484 -0.76 . . . . 1.58 109.435 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.9 m -152.81 165.05 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.457 -0.777 . . . . 1.32 109.369 179.334 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.4 mt -92.43 147.95 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 105.383 -2.081 . . . . 1.27 105.383 176.485 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -98.52 117.49 33.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.833 -1.167 . . . . 1.41 110.581 -177.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.2 t -121.61 129.43 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.662 -0.866 . . . . 1.23 108.662 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.91 164.77 33.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.104 -0.997 . . . . 1.32 108.928 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.457 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.12 -36.85 77.95 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.069 -1.644 . . . . 1.49 108.381 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 162' ' ' ASP . 33.9 p-10 -170.7 150.47 3.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.195 -0.941 . . . . 2.25 109.563 179.647 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.7 mt -118.91 136.38 54.09 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.561 -0.712 . . . . 1.35 109.629 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 22.9 p -92.94 148.37 35.71 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.262 -0.899 . . . . 1.56 109.146 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.417 ' O ' ' OG1' ' A' ' 168' ' ' THR . 92.8 Cg_exo -39.97 -36.6 1.42 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.044 1.829 . . . . 0.87 112.599 179.613 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.7 m -60.0 -40.07 87.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 1.36 109.156 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.01 -43.09 88.68 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.286 -0.884 . . . . 1.61 109.635 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 165' ' ' PRO . 22.8 p -55.8 -28.78 57.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.149 -0.969 . . . . 1.21 110.308 -178.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.56 -53.34 9.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.11 -0.994 . . . . 1.21 109.678 179.817 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -85.36 38.34 0.73 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.091 -1.077 . . . . 2.11 108.091 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.4 tp -100.87 129.1 46.69 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.788 -0.819 . . . . 1.29 108.788 179.26 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.663 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 0.1 OUTLIER -85.62 101.46 12.73 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.908 -1.145 . . . . 2.81 107.908 179.106 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 70.0 mt -64.67 -43.18 94.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.563 -0.71 . . . . 2.09 111.613 -178.043 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -71.23 -21.65 62.1 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.73 -1.231 . . . . 2.86 111.874 -177.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -93.22 -11.31 32.95 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.583 -1.323 . . . . 2.39 108.849 -179.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 67.9 t -110.02 120.06 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.647 -0.871 . . . . 1.27 108.647 179.231 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.9 mt -89.01 6.35 40.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.266 -0.896 . . . . 2.17 110.98 -177.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.58 172.92 37.39 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.378 -1.391 . . . . 0.52 109.808 179.76 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -134.15 129.17 35.48 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.271 -1.135 . . . . 0.55 109.079 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.21 127.05 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.322 -0.861 . . . . 1.27 109.158 179.13 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.6 p -148.79 159.84 43.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.849 -1.157 . . . . 1.39 110.771 -179.721 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 37.2 p-10 -104.07 27.06 8.02 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.595 -0.691 . . . . 2.46 109.333 179.49 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -56.03 -162.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.975 -1.078 . . . . 1.51 111.318 -178.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.2 -59.17 5.14 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.958 -0.857 . . . . 2.23 110.958 -178.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -178.64 -150.66 8.94 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 118.862 -1.637 . . . . 2.23 111.085 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.412 ' C ' ' H ' ' A' ' 188' ' ' SER . 98.5 mtt180 -69.92 -20.62 63.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.604 -0.939 . . . . 6.44 110.54 -178.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 21.4 p -68.85 4.17 1.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.04 -1.038 . . . . 4.09 109.992 -179.136 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 186' ' ' ARG . 46.7 p -88.48 142.51 27.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.151 -0.968 . . . . 2.2 110.638 -179.46 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -49.99 -47.1 53.08 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.549 -0.719 . . . . 1.15 109.782 -179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.4 m -56.32 -39.99 73.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.498 -0.751 . . . . 2.01 110.313 -178.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.4 t -60.8 -39.96 90.88 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.034 -1.041 . . . . 1.93 111.051 -179.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.02 -41.12 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.018 -1.051 . . . . 2.2 110.095 -178.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.0 mtp -65.16 -41.7 94.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.032 -1.043 . . . . 1.32 111.233 -179.214 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.6 92.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.108 -1.62 . . . . 1.3 110.188 -179.399 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.02 -49.3 78.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 3.38 110.586 -178.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.4 m -72.45 -33.73 67.25 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.237 -0.914 . . . . 1.15 111.817 -178.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.1 mt -84.08 -8.1 59.2 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.697 -1.252 . . . . 1.28 111.118 -178.211 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 59.2 49.22 9.41 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.271 -0.893 . . . . 1.5 110.841 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 80.6 mt -121.5 122.73 27.87 Favored Pre-proline 0 N--CA 1.501 2.099 0 N-CA-C 108.588 -0.893 . . . . 1.37 108.588 178.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.17 131.4 8.76 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.8 1.667 . . . . 0.76 112.004 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.459 ' N ' ' OG ' ' A' ' 8' ' ' SER . . . -167.89 146.95 4.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.738 -1.226 . . . . 1.19 111.501 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 90.0 mt -125.47 140.79 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 107.745 -1.205 . . . . 1.31 107.745 178.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.63 -8.85 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.031 -1.043 . . . . 1.38 110.99 -178.8 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.41 22.0 29.68 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.219 -1.152 . . . . 1.03 110.219 -179.596 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.3 p -45.74 -42.59 12.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.031 -1.276 . . . . 1.38 109.848 -179.248 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.56 -51.09 3.29 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 120.111 -1.042 . . . . 1.17 111.303 178.901 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.6 t -161.1 37.8 0.15 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.71 -1.465 . . . . 2.07 110.984 -179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.88 -39.95 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.124 -0.985 . . . . 1.35 108.473 177.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.404 ' HG1' ' N ' ' A' ' 210' ' ' SER . 2.9 p -54.18 -29.99 47.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.529 -0.732 . . . . 1.49 110.775 -179.237 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.404 ' N ' ' HG1' ' A' ' 209' ' ' THR . 52.3 m -80.06 -12.64 59.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.002 -1.061 . . . . 2.16 109.643 -179.293 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.431 ' OE1' ' CD1' ' A' ' 2' ' ' ILE . 94.8 mt-30 -104.99 -12.2 16.29 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.485 -0.76 . . . . 2.89 109.773 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 71.5 t -104.64 137.7 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.333 -0.855 . . . . 1.33 110.602 -178.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.483 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -113.16 153.25 28.58 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.564 -1.272 . . . . 2.73 107.564 179.01 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.68 ' N ' HD21 ' A' ' 214' ' ' ASN . 0.0 OUTLIER -59.49 136.49 57.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.073 -1.017 . . . . 2.7 110.744 -178.623 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 10.4 t0 84.49 5.89 0.6 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.99 -0.444 . . . . 2.38 110.715 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.483 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 92.1 m-20 -75.13 145.44 42.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.79 -1.194 . . . . 2.09 109.065 178.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -92.37 117.92 30.4 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.928 -1.138 . . . . 1.45 107.928 178.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 83.4 mt -127.12 146.73 50.28 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.486 -0.758 . . . . 1.31 110.454 -178.893 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.6 mt -112.25 129.27 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.272 -1.751 . . . . 1.29 106.272 176.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 30.6 tp -98.8 115.68 29.33 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.892 -1.13 . . . . 1.31 109.506 -178.223 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.567 ' C ' ' H ' ' A' ' 223' ' ' VAL . 65.1 m-20 -70.95 -46.34 62.57 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.935 -1.135 . . . . 2.31 107.935 178.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 52.08 7.89 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.761 -0.829 . . . . 1.19 108.761 -179.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.567 ' H ' ' C ' ' A' ' 221' ' ' ASP . 72.1 t -123.86 -42.78 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.192 -1.41 . . . . 1.45 107.192 179.11 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -102.58 0.03 32.78 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.658 -1.238 . . . . 3.13 107.658 178.267 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.731 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 59.84 42.74 16.04 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.772 -0.58 . . . . 2.2 109.737 -179.955 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -133.12 152.36 51.95 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.398 -0.814 . . . . 2.32 109.462 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.23 129.98 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.997 -0.742 . . . . 1.4 108.997 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -100.05 122.76 43.43 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.505 -0.924 . . . . 1.29 108.505 179.094 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.2 t -103.12 113.39 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.573 -0.704 . . . . 1.38 109.904 -179.368 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 66.1 t30 53.89 66.87 3.99 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.357 -0.839 . . . . 2.33 111.532 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -90.94 151.36 3.93 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.196 2.597 . . . . 0.95 112.405 178.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 37.9 p -70.01 162.21 28.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.15 -0.969 . . . . 2.31 110.305 -179.34 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.55 -40.05 90.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.483 -0.761 . . . . 3.45 109.958 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -60.11 -37.86 81.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.426 -0.796 . . . . 2.89 109.874 -179.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.3 t -65.86 -41.68 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 1.73 109.481 -179.82 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.562 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 91.9 mt -62.36 -42.81 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.102 -0.999 . . . . 1.57 110.08 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -59.96 -44.78 94.22 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.864 -1.148 . . . . 2.43 108.493 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -60.31 -47.28 86.71 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.321 -0.862 . . . . 3.18 108.845 179.069 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 95.0 mtp -60.65 -40.07 90.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 1.59 109.174 179.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.562 ' NH1' ' CG2' ' A' ' 236' ' ' ILE . 0.4 OUTLIER -60.2 -36.24 77.23 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.395 -0.816 . . . . 3.11 109.437 179.38 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.91 -41.85 88.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 2.17 108.805 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 96.4 t -60.04 -40.03 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.332 -0.988 . . . . 2.51 108.332 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -59.93 -38.67 83.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.574 -0.704 . . . . 3.82 109.307 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.97 -39.24 85.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.163 -0.961 . . . . 1.78 108.871 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -59.98 -39.93 87.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 2.77 108.857 179.556 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 87.4 t -59.98 -40.03 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.422 -0.799 . . . . 2.25 109.141 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.99 -47.15 87.03 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.208 -0.932 . . . . 2.54 108.566 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -40.9 90.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 3.03 109.039 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.503 ' OE2' ' N ' ' A' ' 254' ' ' ALA . 27.0 tp10 -69.74 -39.95 76.48 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.639 -0.875 . . . . 3.34 108.639 179.341 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -63.05 -35.07 79.02 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.12 -0.696 . . . . 4.18 109.12 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -43.05 -68.5 0.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.573 -0.704 . . . . 4.43 110.296 -179.126 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -174.58 22.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.374 -0.829 . . . . 5.42 110.138 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 16.7 mt -85.57 -71.55 0.53 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.331 -1.481 . . . . 6.11 109.832 -179.612 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.503 ' N ' ' OE2' ' A' ' 249' ' ' GLU . . . 45.75 29.68 0.72 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.314 -0.866 . . . . 7.37 109.446 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -61.05 -42.33 98.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.407 -0.808 . . . . 8.3 111.301 -179.219 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.411 ' N ' ' CD1' ' A' ' 256' ' ' LEU . 9.9 mp -63.86 -40.13 95.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.766 -1.208 . . . . 9.05 109.696 -179.548 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 80.9 tttt 50.12 63.74 2.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.092 -1.005 . . . . 10.56 109.062 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -68.22 -18.27 64.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 11.32 109.705 -179.302 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . 0.408 HH11 ' HG2' ' A' ' 259' ' ' ARG . 29.7 ttt-85 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.057 -1.027 . . . . 12.74 109.73 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 301' ' ' MET . . . . . 0.407 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 37.8 ttp . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.516 0.674 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . 0.407 ' N ' ' CG ' ' B' ' 301' ' ' MET . 28.7 t80 -153.27 150.26 28.77 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.045 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -150.91 161.52 42.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.013 -1.054 . . . . 0.0 110.28 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -157.38 154.22 28.54 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -114.37 130.89 56.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.216 -0.928 . . . . 0.0 110.162 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 4.0 p -129.99 124.09 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 CA-C-O 122.18 0.991 . . . . 0.0 111.362 -178.764 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 32.8 m -79.92 104.33 10.43 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.868 0.842 . . . . 0.0 110.71 -178.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' B' ' 358' ' ' GLY . 89.7 mt -50.72 116.38 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 122.313 1.054 . . . . 0.0 110.222 -177.558 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 70.0 p -107.28 13.04 27.56 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.746 -178.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.67 116.43 49.79 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.022 -1.049 . . . . 0.0 108.829 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -58.94 -12.01 13.96 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 CA-C-N 120.579 1.243 . . . . 0.0 112.617 -179.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -103.73 2.77 33.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.3 -0.875 . . . . 0.0 109.993 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 65.69 167.49 2.07 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -178.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 2.8 tp -88.72 96.28 10.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.784 -1.421 . . . . 0.0 110.227 -177.628 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -100.07 -159.59 0.75 Allowed 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.975 -1.078 . . . . 0.0 109.632 178.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 93.4 m -59.95 -42.39 93.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.687 -1.258 . . . . 0.0 112.482 -176.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.455 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.4 tpt180 -57.59 -61.41 7.31 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.536 -1.353 . . . . 0.0 111.367 -178.308 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.26 -33.18 94.88 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 120.305 1.145 . . . . 0.0 111.454 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.93 -50.15 74.89 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.203 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.23 -41.77 65.74 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -69.89 -43.04 72.59 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.704 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -60.32 -51.58 68.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.562 -0.711 . . . . 0.0 110.208 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.34 -28.87 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.864 -1.147 . . . . 0.0 109.962 -179.072 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -59.98 -45.09 93.83 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.171 -0.956 . . . . 0.0 108.894 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.66 -46.35 69.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.305 -0.872 . . . . 0.0 110.969 -178.968 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.21 -54.64 19.23 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.516 -1.365 . . . . 0.0 111.118 -179.06 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -50.63 -16.56 0.4 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.217 -0.927 . . . . 0.0 109.598 -179.285 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -75.65 -18.67 79.63 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -103.54 143.48 32.68 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.444 -1.033 . . . . 0.0 108.876 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 86.7 m -90.72 -11.09 40.71 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.041 -1.037 . . . . 0.0 110.779 -178.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 88.8 p -67.04 156.92 34.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.881 -1.137 . . . . 0.0 109.754 -179.639 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -71.93 133.57 45.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.212 -0.93 . . . . 0.0 109.168 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . 0.415 HG22 HD13 ' B' ' 333' ' ' ILE . 84.2 mt -130.63 131.22 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 84.8 m -129.27 148.14 51.17 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.558 -0.713 . . . . 0.0 109.533 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 96.6 t -122.33 115.84 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 92.6 m -104.53 125.12 50.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.152 -0.968 . . . . 0.0 109.573 -178.44 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 15.1 p -134.4 117.25 16.11 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.861 0.838 . . . . 0.0 110.339 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 42.93 55.02 4.58 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 177.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.96 -15.19 22.7 Favored Glycine 0 N--CA 1.497 2.74 0 O-C-N 120.349 -1.469 . . . . 0.0 112.44 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -108.45 118.98 38.18 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 119.069 1.434 . . . . 0.0 109.377 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 65.2 m -116.27 143.43 45.54 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.896 0.855 . . . . 0.0 111.151 -178.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.06 159.36 42.38 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.539 0.685 . . . . 0.0 109.668 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 15.9 t -87.04 135.17 33.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.496 -0.752 . . . . 0.0 109.799 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.537 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -72.5 -16.62 61.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.998 -1.064 . . . . 0.0 109.121 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -85.4 20.96 1.87 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.136 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.537 ' H ' ' C ' ' B' ' 344' ' ' ALA . 2.5 m -149.46 95.86 2.41 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.87 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 59.3 tp -59.36 -35.06 73.19 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -56.32 -53.19 60.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.333 -0.854 . . . . 0.0 110.321 -179.878 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.491 ' O ' ' OG1' ' B' ' 352' ' ' THR . 52.6 mtmt -69.98 -40.06 75.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.986 -1.071 . . . . 0.0 110.505 -178.254 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.559 ' O ' ' N ' ' B' ' 352' ' ' THR . 87.7 mt -52.86 -59.89 3.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.496 -1.378 . . . . 0.0 108.546 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.684 HE21 ' NE ' ' A' ' 126' ' ' ARG . 3.4 tp-100 -42.61 -11.89 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.674 -178.312 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.559 ' N ' ' O ' ' B' ' 350' ' ' LEU . 71.8 p -89.24 -9.96 48.77 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.577 -1.327 . . . . 0.0 109.607 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 54.1 mt -92.71 120.49 33.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.188 -0.945 . . . . 0.0 108.874 178.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.8 92.34 0.81 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 179.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.73 90.59 4.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.263 -1.14 . . . . 0.0 109.663 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 356' ' ' THR . . . . . 0.45 ' O ' ' C ' ' B' ' 357' ' ' GLN . 82.1 p -97.86 139.32 33.89 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.084 -1.01 . . . . 0.0 109.774 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . 0.45 ' C ' ' O ' ' B' ' 356' ' ' THR . 16.4 tm0? -34.68 118.46 0.41 Allowed 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.393 0.616 . . . . 0.0 110.976 -178.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 103.15 5.08 47.15 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 21.6 m -87.25 109.45 19.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.318 -1.107 . . . . 0.0 110.426 -179.784 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 20.8 t -77.12 114.04 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 122.169 0.985 . . . . 0.0 109.46 -177.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.25 176.59 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.444 -0.946 . . . . 0.0 108.444 -178.152 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 24.9 m -130.41 126.27 36.6 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.958 -1.126 . . . . 0.0 107.958 177.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 84.4 mt -102.06 113.89 39.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.667 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 84.5 p -119.88 132.79 55.66 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.604 -0.685 . . . . 0.0 109.339 -178.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.12 150.51 38.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 109.428 -179.43 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -144.9 125.04 13.64 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.507 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.55 -160.92 30.98 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.679 -179.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -59.98 -50.01 75.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 122.051 -0.676 . . . . 0.0 112.16 -177.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -104.94 9.89 34.44 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.733 -1.229 . . . . 0.0 111.216 -177.243 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.1 pt-20 -42.49 -33.52 0.69 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.211 -0.931 . . . . 0.0 111.56 -178.901 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -70.01 -40.19 75.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.689 -1.257 . . . . 0.0 109.92 -178.612 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -66.84 -48.68 68.11 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.074 -1.051 . . . . 0.0 109.321 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.39 -78.16 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.392 -0.818 . . . . 0.0 110.901 -179.1 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . 0.407 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 37.6 t -47.28 -37.89 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.057 -1.027 . . . . 0.0 110.336 -177.384 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -69.82 -41.46 74.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.812 -1.18 . . . . 0.0 109.819 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -80.16 -46.74 15.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.137 -0.977 . . . . 0.0 110.315 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.15 -33.52 73.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 110.164 -179.026 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 71.3 t -75.61 -34.18 28.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.493 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -72.85 -23.24 60.73 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 108.582 178.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' B' ' 383' ' ' GLU . 51.7 tp -79.95 -67.06 0.8 Allowed 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.113 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 50.8 tpp -50.16 -28.24 7.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.496 -0.752 . . . . 0.0 109.068 -178.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -76.14 -22.43 55.46 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.403 178.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' B' ' 380' ' ' LEU . 78.5 mm-40 -106.94 4.63 27.43 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.324 -0.86 . . . . 0.0 111.872 -178.501 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 89.7 mt -78.2 121.64 24.62 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.16 -1.587 . . . . 0.0 108.98 179.288 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.44 179.688 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.0 mmm . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.588 -0.523 . . . . 3.19 109.588 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.1 mt -105.62 125.75 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.777 -0.823 . . . . 1.71 108.777 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.2 m -129.66 138.05 50.98 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.52 -0.738 . . . . 1.66 109.13 -179.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.92 -160.17 19.55 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 109.139 -1.585 . . . . 1.05 109.139 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.7 mt -94.63 -10.87 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.116 -1.226 . . . . 1.59 110.251 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.2 tp 54.18 101.48 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.116 -0.99 . . . . 1.47 108.818 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.54 -28.48 18.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.214 -0.929 . . . . 1.39 109.775 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.6 t -143.14 131.09 11.11 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.289 -0.882 . . . . 2.09 109.646 -179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.32 142.68 15.12 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.302 2.001 . . . . 0.91 113.147 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 161.93 -161.7 33.55 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.291 -1.524 . . . . 0.92 109.291 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.7 mt -149.5 150.02 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 121.198 -1.178 . . . . 1.35 108.435 179.203 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.49 157.99 37.8 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.746 -1.221 . . . . 1.14 110.436 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 9.8 m-85 -139.02 128.11 23.87 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.393 -0.965 . . . . 0.7 108.393 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.04 -178.8 46.66 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 118.585 -1.769 . . . . 0.58 111.188 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -79.99 157.93 26.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.731 -0.864 . . . . 2.63 109.619 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.02 135.36 45.67 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.456 -0.777 . . . . 1.27 111.078 -179.127 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.0 tp -102.1 134.83 44.72 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 107.743 -1.206 . . . . 1.41 107.743 178.409 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.4 tp -115.2 121.37 42.74 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.314 -0.866 . . . . 1.49 110.362 -179.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.4 mt -89.3 102.11 14.77 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.846 -0.534 . . . . 1.52 110.182 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -101.3 136.04 41.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.347 -0.846 . . . . 3.17 109.463 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -130.28 132.72 46.04 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.442 -0.786 . . . . 3.0 109.232 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -74.64 150.08 39.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.099 -1.0 . . . . 2.77 109.248 179.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -63.74 145.67 55.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.146 -0.971 . . . . 2.94 109.193 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 58.9 mt -84.4 125.84 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.107 -0.996 . . . . 1.46 109.4 -179.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.3 t -93.22 122.6 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.232 -0.918 . . . . 1.7 109.766 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.5 mt -103.73 139.42 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.831 -0.803 . . . . 1.54 108.831 179.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -96.89 114.95 26.61 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.134 -0.979 . . . . 1.81 109.354 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.475 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.4 mmt-85 -90.08 0.13 57.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.249 -0.907 . . . . 3.23 109.695 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -66.28 147.43 53.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.199 -0.938 . . . . 3.29 109.205 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -87.69 147.21 25.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.039 -1.038 . . . . 2.8 109.556 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 pt -93.89 165.28 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 1.43 109.788 -179.964 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.6 p -96.22 171.25 8.71 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.048 -1.032 . . . . 1.54 108.922 179.163 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.5 -16.58 64.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.113 -0.992 . . . . 1.6 110.603 -179.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.67 -26.1 26.17 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.676 -1.231 . . . . 2.56 107.676 178.296 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -82.45 -9.7 59.33 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.875 -0.787 . . . . 2.36 108.875 179.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.6 t -63.73 -53.8 40.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 120.862 -1.149 . . . . 1.43 108.961 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.44 -40.15 93.42 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.246 -0.909 . . . . 1.77 110.102 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -70.03 -43.01 72.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.038 -1.039 . . . . 3.32 110.347 -179.263 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -63.55 -39.86 95.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.078 -1.014 . . . . 1.51 110.288 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.36 -46.01 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.833 -1.167 . . . . 1.41 108.816 179.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -60.0 -39.8 87.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.143 -0.973 . . . . 1.81 108.69 -179.723 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -60.0 -41.62 92.49 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.724 -1.213 . . . . 3.26 107.724 178.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -63.45 -49.35 74.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.362 -0.836 . . . . 0.81 109.032 178.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.94 -48.67 80.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.382 -0.823 . . . . 1.59 109.038 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.5 t -63.64 -44.21 94.54 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.01 -1.056 . . . . 1.38 108.741 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.94 -48.58 85.36 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.851 -1.699 . . . . 0.87 108.851 179.315 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -65.34 -32.52 74.21 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.327 -1.102 . . . . 3.62 108.451 179.158 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.36 -39.92 84.82 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.803 -0.814 . . . . 1.43 108.803 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 51' ' ' SER . 33.6 ttpt -65.36 -74.38 0.11 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.962 -1.125 . . . . 3.08 107.962 179.189 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.45 -30.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.51 -0.744 . . . . 1.33 111.26 -178.423 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 49' ' ' LYS . 44.0 t -59.98 -54.39 46.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.706 -1.246 . . . . 1.85 108.397 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.62 -40.09 84.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.835 . . . . 1.35 111.054 -179.139 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -61.9 -46.56 88.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.68 -1.263 . . . . 2.34 110.128 -179.316 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.11 -40.03 88.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.14 -0.975 . . . . 2.2 109.018 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -60.31 -40.04 89.13 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.38 -0.825 . . . . 1.35 109.174 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.4 m -64.45 -44.24 91.74 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.243 -0.91 . . . . 1.34 108.64 178.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.5 mt -61.31 -39.88 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.848 -0.797 . . . . 1.26 108.848 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -59.69 -50.34 74.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.955 . . . . 1.7 109.17 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.9 m -59.95 -36.53 77.27 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.396 -0.815 . . . . 1.35 110.025 -178.136 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -66.17 -38.48 88.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.976 -1.077 . . . . 2.08 109.161 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.71 -45.02 88.34 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.585 -0.697 . . . . 1.21 109.948 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.9 -51.57 58.17 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 120.025 -1.083 . . . . 0.75 110.435 -179.15 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.95 -45.67 66.92 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.096 -1.238 . . . . 1.59 109.809 -179.397 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.6 m -67.17 -61.26 2.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 1.41 111.709 -178.36 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.01 -52.7 3.76 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.135 -0.978 . . . . 0.79 111.473 -177.872 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.11 -165.18 26.7 Favored Glycine 0 N--CA 1.501 3.033 0 C-N-CA 119.615 -1.278 . . . . 1.22 111.152 179.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -70.05 -25.16 63.41 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.804 -0.821 . . . . 5.81 110.696 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -60.75 -37.35 81.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.998 . . . . 3.37 110.224 -179.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -99.59 -18.03 17.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.45 -0.781 . . . . 2.37 110.296 -179.444 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -70.01 -45.37 67.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.973 -1.079 . . . . 1.65 110.457 -179.298 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.14 -27.29 67.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.394 -0.816 . . . . 1.42 109.931 -178.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.7 mt -60.07 -41.49 86.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.038 -1.039 . . . . 1.43 109.14 -179.858 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -69.1 -37.16 78.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.035 -1.041 . . . . 1.08 109.959 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -60.0 -40.28 88.66 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.799 -1.188 . . . . 1.37 108.867 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.84 -49.52 75.1 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.36 -1.896 . . . . 0.67 108.36 178.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -60.12 -46.63 88.99 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.374 -1.074 . . . . 1.99 108.462 179.418 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.96 -50.02 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -0.797 . . . . 1.22 109.193 179.148 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.8 ttp -60.53 -39.97 89.77 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.156 -0.965 . . . . 2.11 109.811 -179.294 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.3 tp -66.9 -39.93 87.57 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.632 -0.668 . . . . 1.33 110.118 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.92 -39.78 94.95 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.637 -0.825 . . . . 1.29 109.68 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -82.54 7.64 13.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.087 -1.008 . . . . 1.47 109.598 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 63.5 t0 -49.87 134.72 20.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.179 -0.951 . . . . 1.47 110.279 -178.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.479 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 95.2 mt-10 -58.84 -26.7 64.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.784 -0.572 . . . . 1.78 111.637 -178.266 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.09 -31.0 62.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.899 -1.125 . . . . 2.53 110.096 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.4 mt -70.01 -42.53 72.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.337 -0.852 . . . . 1.36 110.095 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.08 -48.17 82.85 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.502 -0.749 . . . . 1.42 110.621 -178.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -69.93 -42.92 72.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.958 . . . . 2.27 111.285 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.39 -40.01 74.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.11 -0.994 . . . . 1.57 111.624 -178.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.37 -45.89 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.897 -1.127 . . . . 1.19 109.786 -179.164 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.6 mt -69.93 -38.29 75.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.433 -0.792 . . . . 1.39 110.294 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.43 -40.87 98.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.083 -1.011 . . . . 1.39 111.049 -179.076 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.42 ' O ' ' N ' ' A' ' 96' ' ' LYS . 27.3 mt -61.24 -45.56 94.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.828 -1.17 . . . . 1.5 109.348 -179.744 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.9 mt -61.92 -48.18 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 122.048 0.928 . . . . 1.29 109.206 179.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -70.02 -40.03 75.47 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.608 -0.682 . . . . 2.64 110.298 -179.23 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.73 -53.67 5.73 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.164 -0.96 . . . . 1.65 111.91 -178.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 92' ' ' LEU . 98.3 mttt -89.97 -0.83 57.79 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.011 -1.056 . . . . 2.5 112.035 -177.274 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 70.7 m80 57.24 36.56 27.53 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.035 -1.041 . . . . 1.88 110.179 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 99.6 mtp -92.07 166.99 12.39 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.519 -0.738 . . . . 1.71 109.375 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 35.0 p -80.75 162.81 23.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 1.61 109.747 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.45 -39.87 81.3 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.357 -0.84 . . . . 1.33 109.744 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -64.36 -39.05 93.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 2.07 109.55 179.319 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.91 -41.21 23.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.407 -0.808 . . . . 1.37 110.322 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.46 -48.0 65.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 1.14 110.19 -179.192 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.94 -45.75 91.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.997 -1.064 . . . . 1.26 109.447 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.488 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 84.9 t60 -60.01 -40.0 87.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.406 -0.809 . . . . 2.02 109.731 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.0 -41.97 93.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.264 -0.897 . . . . 1.33 110.048 -179.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.7 t -68.88 -51.31 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.068 -1.02 . . . . 1.3 110.422 -178.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.39 -40.92 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.035 -1.041 . . . . 1.32 108.512 179.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.488 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 86.3 tt0 -65.29 -40.0 93.28 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.443 -0.947 . . . . 2.44 108.443 178.731 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.13 -50.16 70.66 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.159 -1.176 . . . . 0.99 110.159 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -65.34 -51.15 62.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.931 -1.335 . . . . 1.97 109.421 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.49 -40.86 75.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.166 -0.959 . . . . 1.43 109.206 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.7 m -59.97 -40.04 87.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.089 -1.007 . . . . 2.12 108.443 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.97 -39.95 90.85 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.641 -0.874 . . . . 1.64 108.641 178.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 87.1 mt -65.71 -42.65 90.88 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.091 -1.005 . . . . 1.93 109.474 -179.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -59.88 -39.05 84.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.916 -1.115 . . . . 2.2 109.848 -178.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -49.98 -19.99 0.83 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.005 -1.059 . . . . 2.12 109.555 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 29.2 mt -62.72 140.02 58.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.012 -1.055 . . . . 2.34 109.043 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -93.16 40.41 1.06 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.176 -0.953 . . . . 3.23 110.289 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -126.13 134.2 51.39 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.266 -0.896 . . . . 2.49 109.518 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.53 -30.42 68.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.451 -0.78 . . . . 3.95 109.919 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.497 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.0 t80 -69.99 -39.02 76.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.347 -0.845 . . . . 2.25 110.32 179.327 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.5 mt -80.76 -31.94 35.7 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.06 -1.025 . . . . 2.27 109.248 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -60.94 -40.76 94.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 3.31 109.003 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -64.22 -40.0 95.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 2.73 109.015 178.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.48 ' NH1' ' CD ' ' B' ' 351' ' ' GLN . 0.1 OUTLIER -59.97 -39.99 87.56 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.295 -1.002 . . . . 3.2 108.295 179.436 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.3 -26.13 66.28 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.595 -0.891 . . . . 1.66 108.595 178.962 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -67.68 -39.94 84.45 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.947 -0.76 . . . . 1.67 108.947 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.86 -39.99 79.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 1.55 109.681 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.7 -44.38 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 1.32 108.563 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -60.49 -37.38 80.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 3.58 108.918 178.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -59.82 -39.66 85.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.493 -0.755 . . . . 1.46 109.664 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.96 -40.4 82.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.04 -1.037 . . . . 1.22 108.873 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.08 -35.99 64.31 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.048 -1.221 . . . . 0.61 110.048 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -60.05 -49.9 75.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.115 -1.226 . . . . 3.1 109.931 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 87.6 mtm180 -67.66 -33.34 74.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.021 -1.049 . . . . 3.71 109.501 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.04 -43.25 95.49 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.249 -0.907 . . . . 1.87 109.074 -179.567 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.04 -42.52 94.58 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.192 -0.943 . . . . 1.29 109.985 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 63.1 mtm-85 -71.39 -39.29 71.26 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.394 -0.816 . . . . 3.05 109.352 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -65.57 -34.37 78.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.726 . . . . 1.26 111.259 -179.197 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.408 HD12 HG22 ' A' ' 141' ' ' ILE . 93.3 mt -70.01 -45.35 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.416 -1.427 . . . . 1.34 108.037 179.317 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.7 mt -69.89 -30.79 68.31 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 120.137 -0.625 . . . . 1.6 109.454 179.135 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.89 41.73 8.02 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.034 -1.626 . . . . 0.96 109.034 -179.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 tp -74.88 157.23 35.41 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.468 -1.019 . . . . 1.67 109.411 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.21 146.62 53.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.886 . . . . 4.96 110.062 -179.449 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.408 HG22 HD12 ' A' ' 146' ' ' ILE . 85.7 mt -119.9 127.78 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 108.826 -0.805 . . . . 1.68 108.826 179.351 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.402 HG21 HD11 ' A' ' 147' ' ' ILE . 27.6 mm -55.4 -49.68 71.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.36 -0.837 . . . . 2.14 110.212 -178.251 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.4 t0 66.24 103.92 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.528 -0.732 . . . . 1.5 109.338 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.8 mt -79.61 -5.77 55.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.42 -0.8 . . . . 1.39 110.179 -178.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.3 t -81.67 -20.52 39.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.942 -1.099 . . . . 1.83 109.634 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.04 21.53 0.7 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.297 -0.877 . . . . 1.46 111.66 -178.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 39.5 mm -89.12 129.49 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.565 -1.334 . . . . 1.42 108.965 179.517 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -110.53 -11.31 14.48 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.586 -0.696 . . . . 2.94 110.059 -179.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -118.3 148.11 42.79 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.177 -0.952 . . . . 1.52 110.457 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.24 133.95 52.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 1.58 109.214 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.9 m -153.33 166.33 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.42 -0.8 . . . . 1.32 109.439 179.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.402 HD12 HG23 ' A' ' 157' ' ' ILE . 85.3 mt -94.06 147.42 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.545 -1.65 . . . . 1.27 106.545 177.608 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 49.7 tp -94.27 113.58 25.51 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.011 -1.055 . . . . 1.41 110.101 -177.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.7 t -118.68 125.22 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 108.663 -0.866 . . . . 1.23 108.663 179.478 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.68 160.65 40.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.991 -1.068 . . . . 1.32 109.465 -179.49 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.45 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -78.82 -29.08 44.57 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.487 -1.383 . . . . 1.49 109.02 179.199 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 161' ' ' ALA . 14.5 m-20 -167.36 133.41 2.14 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.31 -0.869 . . . . 2.25 109.169 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 57.7 mt -118.15 130.04 55.87 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 108.781 -0.822 . . . . 1.35 108.781 179.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 20.8 p -93.84 149.99 37.9 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.079 -1.013 . . . . 1.56 109.737 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -39.38 -36.58 0.98 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.64 2.227 . . . . 0.87 113.636 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.6 m -59.98 -40.05 87.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.894 -1.129 . . . . 1.36 110.028 -178.194 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.61 -39.82 80.69 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.256 -0.902 . . . . 1.61 110.249 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.427 ' CG2' ' HG1' ' A' ' 190' ' ' THR . 80.7 p -57.39 -38.08 73.71 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.059 -1.025 . . . . 1.21 112.036 -177.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.97 -47.8 70.46 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.521 -1.362 . . . . 1.21 110.027 -179.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -85.68 33.83 0.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.327 -0.99 . . . . 2.11 108.327 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.3 tp -102.78 137.5 40.9 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.788 -0.819 . . . . 1.29 108.788 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.671 ' ND2' ' H ' ' A' ' 175' ' ' LYS . 0.2 OUTLIER -86.96 104.72 16.55 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.476 -0.935 . . . . 2.81 108.476 179.575 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.55 -40.11 92.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.895 . . . . 2.09 111.598 -178.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -69.87 -25.5 63.75 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.746 -1.221 . . . . 2.86 111.744 -177.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.671 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 98.5 mttt -93.73 -10.04 35.66 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.706 -1.246 . . . . 2.39 110.242 -178.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 95.0 t -100.94 113.22 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.029 -1.044 . . . . 1.27 108.339 178.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.4 mt -80.76 2.1 27.6 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.238 -0.913 . . . . 2.17 110.853 -177.781 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 166.25 177.99 38.67 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.3 -1.52 . . . . 0.52 109.3 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -132.31 128.23 37.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.484 -1.009 . . . . 0.55 109.489 -179.387 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 93.8 mt -130.74 124.21 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.507 -0.746 . . . . 1.27 109.03 179.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' THR . . . . . 0.446 ' C ' ' HG1' ' A' ' 205' ' ' THR . 52.8 p -150.88 161.92 41.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.813 -1.18 . . . . 1.39 110.721 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 37.1 p-10 -103.56 25.17 10.02 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.564 -0.71 . . . . 2.46 109.456 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.43 -158.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.863 -1.148 . . . . 1.51 111.703 -178.259 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.14 -54.4 5.24 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.84 -0.695 . . . . 2.23 111.44 -178.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 165.23 -139.17 5.65 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 118.968 -1.587 . . . . 2.23 111.07 -179.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 186' ' ' ARG . 0.4 OUTLIER -69.93 -22.88 63.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.608 -0.937 . . . . 6.44 111.175 -178.761 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 66.7 p -70.27 1.25 5.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.848 -1.157 . . . . 4.09 109.546 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.0 t -90.89 133.83 34.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.267 -0.896 . . . . 2.2 110.482 -179.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -47.48 -53.22 14.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.497 -0.752 . . . . 1.15 110.21 -179.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.427 ' HG1' ' CG2' ' A' ' 168' ' ' THR . 94.7 m -60.11 -40.44 89.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.341 -0.849 . . . . 2.01 111.473 -178.772 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 17.3 t -60.0 -40.73 90.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.829 -1.169 . . . . 1.93 110.12 -179.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 85.7 mt -61.39 -37.93 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.874 . . . . 2.2 109.728 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.3 mtp -60.07 -39.96 87.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.842 . . . . 1.32 109.692 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.07 88.69 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.713 -1.242 . . . . 1.3 108.633 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -60.06 -51.06 71.24 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.714 -0.794 . . . . 3.38 110.319 -179.234 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.9 m -74.88 -34.25 62.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.083 -1.011 . . . . 1.15 112.022 -178.374 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.1 mt -73.55 -11.5 60.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.632 -1.293 . . . . 1.28 109.829 -178.477 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 60.1 50.08 6.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.573 -0.704 . . . . 1.5 110.975 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.2 mt -128.77 149.92 73.48 Favored Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 107.602 -1.258 . . . . 1.37 107.602 178.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.81 140.75 47.22 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 122.16 1.907 . . . . 0.76 112.158 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -171.04 151.52 3.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.965 -1.084 . . . . 1.19 111.418 -179.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.7 mt -123.45 138.15 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.521 -1.288 . . . . 1.31 107.521 178.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 17.3 m -121.83 -11.86 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 O-C-N 120.738 -1.226 . . . . 1.38 111.478 -178.195 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -105.97 23.88 28.08 Favored Glycine 0 N--CA 1.5 2.934 0 N-CA-C 110.309 -1.117 . . . . 1.03 110.309 -179.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.446 ' HG1' ' C ' ' A' ' 181' ' ' THR . 6.7 p -44.29 -41.15 5.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.202 -1.175 . . . . 1.38 109.928 -179.439 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.41 -50.48 4.23 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 120.211 -0.995 . . . . 1.17 110.982 179.17 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 30.5 t -159.12 38.05 0.21 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.611 -1.523 . . . . 2.07 111.402 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.82 -35.54 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.934 -1.104 . . . . 1.35 108.673 178.133 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 76.7 p -54.73 -30.1 55.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.844 . . . . 1.49 110.148 -179.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.0 p -81.92 -12.62 58.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.112 -0.992 . . . . 2.16 110.228 -179.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 30.2 mm100 -101.71 -10.24 20.15 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.339 -0.851 . . . . 2.89 109.674 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 92.5 t -107.37 134.82 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.303 -0.873 . . . . 1.33 111.47 -178.013 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -113.44 155.22 25.68 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.746 -1.576 . . . . 2.73 106.746 177.223 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.7 t-20 -59.98 138.3 57.88 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.935 -1.103 . . . . 2.7 110.572 -178.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 16.3 t0 85.9 0.06 0.69 Allowed 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 116.342 -0.39 . . . . 2.38 110.836 179.054 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -71.8 148.28 46.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.77 -1.206 . . . . 2.09 108.94 179.01 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -95.3 119.01 33.06 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.083 -1.08 . . . . 1.45 108.083 179.125 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 83.0 mt -125.59 145.14 50.26 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.411 -0.806 . . . . 1.31 110.456 -179.05 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.1 mt -113.88 128.4 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.463 -1.31 . . . . 1.29 107.463 177.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 20.6 tp -100.36 117.56 34.79 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.004 -1.06 . . . . 1.31 108.786 -179.415 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 10' ' ' GLY . 32.3 t0 -77.13 -44.3 30.88 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.151 -1.055 . . . . 2.31 108.151 179.638 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.405 ' HB1' ' H ' ' A' ' 10' ' ' GLY . . . 54.03 13.71 0.61 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.256 -0.646 . . . . 1.19 109.256 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 87.8 t -130.5 -42.94 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.146 -1.427 . . . . 1.45 107.146 177.95 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.45 ' ND2' ' OE1' ' A' ' 226' ' ' GLN . 47.9 t-20 -96.69 0.04 49.06 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.226 -1.398 . . . . 3.13 107.226 178.154 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 60.07 44.64 12.88 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.849 -0.532 . . . . 2.2 109.585 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.45 ' OE1' ' ND2' ' A' ' 224' ' ' ASN . 97.8 mt-30 -139.96 151.77 45.8 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.192 -0.943 . . . . 2.32 110.454 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.1 t -118.78 129.96 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.507 -0.923 . . . . 1.4 108.507 178.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -102.95 127.34 50.21 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.758 -0.831 . . . . 1.29 108.758 179.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.0 t -100.19 109.95 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.362 -0.836 . . . . 1.38 110.947 -178.495 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 41.2 t30 50.11 64.43 8.41 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.145 -0.972 . . . . 2.33 110.895 179.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -85.84 156.16 10.17 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.795 2.33 . . . . 0.95 111.986 179.166 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 82.4 p -70.44 160.42 32.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 2.31 110.078 -179.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -59.9 -34.69 73.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.435 -0.791 . . . . 3.45 108.873 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -59.93 -40.09 87.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.476 -0.765 . . . . 2.89 109.344 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.72 -40.02 83.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.194 -0.941 . . . . 1.73 109.276 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.34 -40.47 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.24 -0.913 . . . . 1.57 110.31 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -60.22 -40.04 88.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.001 -1.062 . . . . 2.43 109.325 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -68.76 -40.91 79.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.491 -0.755 . . . . 3.18 109.485 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 93.1 mtp -70.06 -33.42 71.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.574 -0.704 . . . . 1.59 110.159 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -65.19 -40.03 93.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.002 . . . . 3.11 110.433 -179.561 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -63.49 -40.62 97.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.888 -1.132 . . . . 2.17 108.935 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.92 -40.05 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.457 -0.777 . . . . 2.51 109.143 179.449 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 20.7 tm0? -57.19 -42.43 81.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 3.82 109.738 -179.076 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.39 -39.99 95.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.034 -1.042 . . . . 1.78 109.214 179.402 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . 0.422 ' O ' ' OG ' ' A' ' 248' ' ' SER . 97.1 mt-30 -64.61 -40.12 94.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.155 -0.965 . . . . 2.77 109.285 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.83 -40.0 85.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.406 -0.808 . . . . 2.25 109.343 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.17 -40.16 70.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.272 -0.892 . . . . 2.54 109.057 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.422 ' OG ' ' O ' ' A' ' 245' ' ' GLN . 66.1 p -61.06 -36.93 80.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 3.03 109.314 179.477 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.441 ' C ' ' H ' ' A' ' 251' ' ' ALA . 96.7 mt-10 -69.75 -18.1 63.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.378 -0.826 . . . . 3.34 110.666 -179.244 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -75.62 13.59 0.77 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.987 . . . . 4.18 109.486 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' A' ' 249' ' ' GLU . . . -72.62 -60.3 2.3 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.15 -1.056 . . . . 4.43 108.15 178.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 179.84 -61.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.978 -1.119 . . . . 5.42 107.978 179.146 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 32.3 mt 65.26 64.11 0.63 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.864 -1.161 . . . . 6.11 107.864 -178.003 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -133.11 9.64 4.12 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.239 -0.652 . . . . 7.37 109.239 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.464 ' NZ ' ' CB ' ' A' ' 255' ' ' LYS . 5.6 ttpm? -78.41 145.59 35.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 8.3 110.165 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 10.9 mp -82.88 27.95 0.52 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.454 -0.779 . . . . 9.05 109.121 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 255' ' ' LYS . 62.3 tttm -154.19 67.81 0.73 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.821 -0.807 . . . . 10.56 108.821 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -158.9 -32.92 0.07 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.368 -0.832 . . . . 11.32 109.71 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 9.0 tpm_? . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.052 -0.975 . . . . 12.74 109.109 -179.751 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 41.5 ttm . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.596 0.713 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -150.27 147.09 27.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.338 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -150.83 161.77 42.04 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.921 -1.112 . . . . 0.0 110.546 -179.203 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -153.37 150.01 28.41 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' B' ' 305' ' ' GLU . 0.6 OUTLIER -115.81 135.47 53.98 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.244 -0.91 . . . . 0.0 109.971 179.278 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -138.64 129.84 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 CA-C-O 122.523 1.154 . . . . 0.0 113.052 -177.184 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 90.9 m -76.69 106.36 8.3 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.467 -178.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 92.3 mt -52.45 126.07 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 122.412 1.101 . . . . 0.0 110.82 -177.749 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 22.3 p -109.99 20.07 18.34 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.372 -178.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -79.4 117.02 64.82 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.851 -1.156 . . . . 0.0 109.109 179.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.28 -11.68 6.53 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 CA-C-N 120.233 1.119 . . . . 0.0 113.212 -179.095 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -119.45 6.66 11.11 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 179.708 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.47 -179.4 40.24 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 107.961 -2.055 . . . . 0.0 107.961 -178.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.497 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -85.42 92.24 8.43 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.868 -1.372 . . . . 0.0 108.454 -179.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . 0.461 ' C ' ' NH2' ' A' ' 126' ' ' ARG . 5.2 p80 -94.29 -160.91 0.81 Allowed 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.179 -0.951 . . . . 0.0 110.642 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 316' ' ' THR . . . . . 0.473 ' H ' ' HG1' ' B' ' 316' ' ' THR . 2.9 m -57.35 -43.92 83.88 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.204 -0.935 . . . . 0.0 112.651 -175.813 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.454 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.0 OUTLIER -60.75 -61.74 7.37 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 120.443 -1.411 . . . . 0.0 112.139 -178.508 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -57.33 -31.55 91.31 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 CA-C-N 120.219 1.114 . . . . 0.0 111.781 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.07 -51.51 69.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 109.069 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.7 -41.12 63.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.17 -178.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -72.71 -40.1 66.44 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.882 179.065 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -60.81 -52.46 64.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -0.813 . . . . 0.0 110.869 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . 0.485 ' CG1' ' HZ2' ' B' ' 327' ' ' LYS . 53.6 t -68.28 -38.07 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.685 -1.259 . . . . 0.0 109.334 -178.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . 0.42 ' CB ' ' HZ2' ' B' ' 324' ' ' LYS . 4.1 ttpm? -59.98 -46.17 90.31 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.751 -179.133 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -63.33 -40.06 96.26 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.925 -1.11 . . . . 0.0 108.789 179.127 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -61.08 -51.31 69.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.422 -0.798 . . . . 0.0 110.312 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.485 ' HZ2' ' CG1' ' B' ' 323' ' ' VAL . 18.6 mttp -56.92 -11.95 1.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.373 179.974 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -73.25 -27.48 68.06 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -105.4 143.19 33.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 27.4 p -91.16 -12.59 34.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.902 -1.124 . . . . 0.0 110.16 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 67.8 p -60.13 147.64 38.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.075 -1.015 . . . . 0.0 109.418 -179.809 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -67.11 136.38 55.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.108 -0.995 . . . . 0.0 108.581 179.629 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 90.0 mt -131.41 130.15 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.653 -0.654 . . . . 0.0 109.803 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 54.1 m -124.23 148.76 47.09 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.109 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 92.3 t -115.87 136.91 51.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.2 m -128.85 122.62 30.8 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.148 -0.97 . . . . 0.0 109.038 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 91.8 p -138.18 116.71 12.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.306 -0.871 . . . . 0.0 110.386 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 33.2 m120 45.7 62.69 2.09 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 75.16 -11.96 7.59 Favored Glycine 0 N--CA 1.498 2.77 0 O-C-N 120.399 -1.438 . . . . 0.0 112.924 176.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -115.81 127.53 55.14 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 118.951 1.375 . . . . 0.0 109.818 -179.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 21.2 m -126.12 148.61 49.35 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.872 0.844 . . . . 0.0 110.399 -179.016 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -142.43 164.15 30.9 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.405 0.622 . . . . 0.0 109.929 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 58.6 m -86.96 136.59 32.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.606 -0.684 . . . . 0.0 109.934 -179.388 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -73.77 -13.49 60.96 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.04 -1.037 . . . . 0.0 109.693 -179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -90.82 21.68 3.99 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.41 ' H ' ' C ' ' B' ' 344' ' ' ALA . 68.0 m -144.84 93.36 2.39 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.944 -179.071 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 37.9 tp -59.12 -34.75 72.4 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -57.87 -56.38 22.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.508 -0.745 . . . . 0.0 109.79 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -70.04 -20.05 63.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.869 . . . . 0.0 111.008 -178.556 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.63 ' O ' ' N ' ' B' ' 352' ' ' THR . 50.2 mt -72.03 -58.32 3.54 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.669 -1.269 . . . . 0.0 108.233 178.073 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.48 ' CD ' ' NH1' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -40.28 -10.25 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.769 -178.279 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.63 ' N ' ' O ' ' B' ' 350' ' ' LEU . 81.0 p -91.93 -11.43 36.25 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.574 -1.329 . . . . 0.0 110.446 -179.224 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 66.0 mt -92.47 120.07 32.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.996 -1.065 . . . . 0.0 108.972 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.88 92.95 0.83 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 31.1 mt -103.25 93.81 5.18 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.396 -1.061 . . . . 0.0 109.343 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 57.8 p -95.72 179.98 4.93 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.046 -1.034 . . . . 0.0 110.548 -179.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -68.45 111.82 4.91 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.506 -0.747 . . . . 0.0 109.945 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 105.75 9.69 32.27 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 97.6 m -87.83 106.21 17.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -1.172 . . . . 0.0 110.302 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 3.9 t -77.01 117.84 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 122.296 1.046 . . . . 0.0 109.004 -177.563 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 19.6 m -113.68 177.73 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.832 -177.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 93.9 m -132.0 130.04 40.89 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 176.85 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . 0.412 HG22 HD11 ' B' ' 363' ' ' ILE . 96.5 mt -105.35 120.51 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.36 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 58.2 m -120.07 131.72 55.18 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.689 -0.632 . . . . 0.0 109.543 -178.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.71 153.76 41.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 109.715 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -146.33 123.02 11.18 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 160.91 -155.39 26.55 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 118.681 -1.723 . . . . 0.0 111.86 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -58.94 -50.46 73.97 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.154 -0.523 . . . . 0.0 112.394 -177.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' B' ' 370' ' ' GLU . 97.8 m-20 -110.29 15.28 22.41 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.926 -1.109 . . . . 0.0 111.275 -177.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' B' ' 369' ' ' ASP . 16.2 pt-20 -39.54 -38.28 0.58 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.421 -0.8 . . . . 0.0 111.453 -179.034 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -66.73 -48.15 70.07 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.723 -1.236 . . . . 0.0 110.622 -178.233 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -70.02 -52.52 23.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.977 -1.077 . . . . 0.0 109.899 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.01 -38.71 3.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.429 -0.794 . . . . 0.0 111.229 -178.661 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 77.2 t -70.05 -39.98 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.515 -1.366 . . . . 0.0 109.251 179.748 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.91 -66.83 0.5 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.971 . . . . 0.0 111.637 -178.025 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . 0.448 ' O ' ' N ' ' B' ' 380' ' ' LEU . 32.2 m170 -59.92 -45.2 93.33 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.652 -1.28 . . . . 0.0 112.103 -177.171 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 98.0 mt -59.98 -42.0 93.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.328 -1.483 . . . . 0.0 108.841 -179.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 53.4 t -68.7 -40.14 81.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -80.67 -10.94 59.7 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.969 -1.082 . . . . 0.0 109.831 178.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . 0.448 ' N ' ' O ' ' B' ' 376' ' ' HIS . 61.3 tp -82.39 -25.98 33.25 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.473 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 3.4 ttp -82.75 -25.68 32.61 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -84.37 -10.07 57.89 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.599 -0.688 . . . . 0.0 110.03 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -108.55 -0.86 20.1 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.309 -0.869 . . . . 0.0 110.344 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 44.4 mt -98.94 119.99 38.64 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.009 -1.057 . . . . 0.0 109.727 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 53.3 mp0 . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 117.967 -1.016 . . . . 0.0 108.978 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.6 mtp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.881 -0.415 . . . . 3.19 109.881 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.2 mt -94.76 121.28 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.066 -1.022 . . . . 1.71 109.814 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.7 m -138.75 149.07 44.63 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.716 -0.846 . . . . 1.66 108.716 179.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.02 -161.4 12.21 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 109.357 -1.497 . . . . 1.05 109.357 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' LEU . 97.8 mt -92.07 -12.89 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -1.189 . . . . 1.59 109.944 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' ILE . 63.0 tp 53.92 101.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.059 -1.025 . . . . 1.47 108.717 -179.515 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.06 -39.94 24.95 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.764 -0.828 . . . . 1.39 108.764 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 m -141.05 135.28 15.16 Favored Pre-proline 0 N--CA 1.5 2.025 0 O-C-N 121.583 -0.698 . . . . 2.09 109.524 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.17 147.4 20.71 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.391 2.061 . . . . 0.91 112.877 179.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 162.45 -162.2 34.21 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.9 -1.68 . . . . 0.92 108.9 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.5 mt -149.56 150.42 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.01 -1.288 . . . . 1.35 108.565 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.45 159.31 38.55 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.701 -1.249 . . . . 1.14 110.615 179.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -140.03 129.08 23.58 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.884 -1.154 . . . . 0.7 107.884 179.068 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.66 -177.95 47.33 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 118.782 -1.675 . . . . 0.58 110.893 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -79.39 159.53 27.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.762 -0.846 . . . . 2.63 109.298 -179.743 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.8 137.39 45.9 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.374 -0.829 . . . . 1.27 111.119 -179.022 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.5 tp -107.32 132.59 52.96 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 107.283 -1.377 . . . . 1.41 107.283 178.501 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.2 tp -111.83 121.17 44.32 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.23 -0.919 . . . . 1.49 109.699 -179.314 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 31.0 mt -85.79 100.19 11.87 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.415 -0.803 . . . . 1.52 109.907 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -88.78 135.98 33.24 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.47 -0.769 . . . . 3.17 109.327 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -132.74 122.87 25.21 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.026 -1.101 . . . . 3.0 108.026 178.392 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -83.06 150.3 26.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.878 -1.139 . . . . 2.77 109.426 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -62.6 140.04 58.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 2.94 109.81 -179.61 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.6 mt -81.67 132.06 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 1.46 108.862 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.53 126.31 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.263 -0.898 . . . . 1.7 110.181 -179.133 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.5 mt -110.01 130.06 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 107.954 -1.128 . . . . 1.54 107.954 179.321 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -88.79 120.33 30.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.836 -1.165 . . . . 1.81 110.102 -179.218 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -89.95 -4.49 57.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 3.23 108.708 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -69.98 137.99 51.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 3.29 109.255 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -82.91 155.45 24.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 2.8 109.815 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.9 pt -98.84 168.47 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.445 -0.785 . . . . 1.43 109.339 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.9 p -89.99 173.55 8.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.08 -1.012 . . . . 1.54 108.481 178.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.04 -17.04 63.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.009 -1.057 . . . . 1.6 110.994 -179.367 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -84.57 -26.03 28.26 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.659 -1.276 . . . . 2.56 108.42 178.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -82.15 -7.95 59.64 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.131 -0.692 . . . . 2.36 109.131 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.0 t -60.01 -52.82 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.251 -0.905 . . . . 1.43 108.615 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -60.04 -40.05 88.02 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.354 -0.841 . . . . 1.77 109.208 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -64.06 -40.12 95.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 3.32 110.281 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -63.46 -44.41 94.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.756 -1.215 . . . . 1.51 110.023 -179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -60.03 -47.16 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.865 -1.147 . . . . 1.41 108.665 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -60.03 -46.69 88.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.302 -0.874 . . . . 1.81 108.984 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -60.21 -42.75 95.8 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.919 -1.113 . . . . 3.26 108.17 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -63.44 -47.73 80.68 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.535 -0.913 . . . . 0.81 108.535 178.31 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.3 tp -60.01 -48.68 80.72 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.516 -0.92 . . . . 1.59 108.516 -179.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.7 t -63.04 -43.85 97.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 1.38 108.903 179.075 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.99 -46.8 93.51 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.309 -1.917 . . . . 0.87 108.309 179.212 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.405 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 43.1 ttt-85 -60.1 -39.94 87.9 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.347 -0.983 . . . . 3.62 108.347 178.303 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.1 -46.23 33.69 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.148 -0.686 . . . . 1.43 109.148 -179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 50' ' ' ALA . 6.4 ttpm? -64.06 -74.08 0.11 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.92 -1.141 . . . . 3.08 107.92 179.261 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.62 -35.83 0.21 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.532 -0.73 . . . . 1.33 111.143 -178.588 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.2 t -53.76 -60.62 3.08 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.619 -1.301 . . . . 1.85 108.716 179.557 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.6 -39.99 84.77 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.508 -0.745 . . . . 1.35 111.648 -178.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -66.77 -41.3 87.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.693 -1.254 . . . . 2.34 110.302 -178.939 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.54 -39.98 95.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.863 -1.148 . . . . 2.2 108.873 179.198 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -65.83 -38.64 89.44 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.522 -0.736 . . . . 1.35 109.723 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.63 -40.87 98.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.014 . . . . 1.34 109.535 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.497 ' CD1' HH22 ' A' ' 136' ' ' ARG . 82.8 mt -60.19 -40.0 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 1.26 109.218 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -58.94 -50.03 75.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.847 . . . . 1.7 109.579 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -58.14 -28.76 64.98 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.316 -0.865 . . . . 1.35 110.618 -178.064 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -70.05 -39.1 75.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.063 -1.023 . . . . 2.08 109.878 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.04 -46.92 76.1 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.596 -0.69 . . . . 1.21 109.9 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.78 -54.06 32.9 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.928 -1.269 . . . . 0.75 109.928 -179.197 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.02 -45.53 60.51 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.045 -1.268 . . . . 1.59 110.588 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.5 m -68.34 -63.05 1.14 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.952 -1.092 . . . . 1.41 112.717 -177.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -95.7 -46.97 6.39 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.849 -1.157 . . . . 0.79 111.089 -177.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.93 -167.31 25.69 Favored Glycine 0 N--CA 1.5 2.943 0 O-C-N 120.839 -1.163 . . . . 1.22 111.143 179.485 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -75.6 -22.54 56.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.925 -0.75 . . . . 5.81 110.078 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.425 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.5 tp10 -61.12 -36.22 79.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.88 . . . . 3.37 110.211 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -100.72 -20.14 15.73 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.275 -0.89 . . . . 2.37 110.226 -179.486 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -68.51 -39.92 81.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.047 -1.033 . . . . 1.65 110.34 -179.106 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.5 -26.57 67.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.213 -0.93 . . . . 1.42 109.431 -179.362 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.8 mt -60.05 -40.82 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.081 -1.012 . . . . 1.43 108.732 179.959 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -70.04 -37.97 75.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.188 -0.945 . . . . 1.08 110.638 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -60.0 -40.11 88.08 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.656 -1.277 . . . . 1.37 108.642 179.351 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.07 -43.01 97.9 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.957 -1.657 . . . . 0.67 108.957 179.156 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.2 m170 -66.63 -41.31 88.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.302 -1.117 . . . . 1.99 108.969 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.4 mt -69.95 -45.44 76.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.323 -0.861 . . . . 1.22 108.987 179.354 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.4 ttp -60.69 -40.21 91.32 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.099 -1.001 . . . . 2.11 109.536 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 tp -64.95 -40.06 94.45 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.525 -0.735 . . . . 1.33 109.579 179.663 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.1 tp -63.62 -38.0 89.46 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.627 -0.67 . . . . 1.29 109.411 -179.213 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -82.4 4.39 24.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.159 -0.963 . . . . 1.47 110.913 -178.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -49.98 130.06 21.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.761 -1.212 . . . . 1.47 109.42 -179.655 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -57.54 -18.88 21.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.487 -0.758 . . . . 1.78 110.933 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.72 -34.56 69.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.77 -1.207 . . . . 2.53 108.878 178.722 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.2 mt -72.33 -42.52 65.31 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.73 -0.606 . . . . 1.36 110.567 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -60.0 -48.75 80.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.147 -0.971 . . . . 1.42 110.468 -178.819 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -69.95 -40.09 75.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.207 -0.933 . . . . 2.27 110.904 -178.788 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.03 -39.96 75.46 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.042 -1.036 . . . . 1.57 111.413 -179.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.2 mt -66.59 -49.94 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.949 -1.094 . . . . 1.19 109.539 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.3 mt -69.79 -39.99 78.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.562 -0.711 . . . . 1.39 110.013 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.04 -48.77 80.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.12 -0.987 . . . . 1.39 110.783 -179.543 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 96' ' ' LYS . 55.8 mt -59.97 -46.36 89.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.046 -1.034 . . . . 1.5 110.146 -179.089 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.9 -49.81 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 1.29 108.826 179.451 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -69.99 -40.96 75.0 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 120.276 -0.57 . . . . 2.64 111.19 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -85.07 -49.97 7.83 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.861 -1.15 . . . . 1.65 112.012 -178.228 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 92' ' ' LEU . 32.8 mmtp -89.18 -0.45 57.46 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.111 -0.993 . . . . 2.5 111.164 -177.229 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.2 m80 55.81 32.6 19.87 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.937 -1.102 . . . . 1.88 109.595 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.0 mtt -89.65 168.82 11.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.358 -0.839 . . . . 1.71 109.428 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.7 p -83.45 158.16 22.17 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.19 -0.944 . . . . 1.61 109.051 179.736 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.61 -39.95 92.07 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.267 -0.896 . . . . 1.33 109.262 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' A' ' 101' ' ' ASP . 40.4 t0 -65.55 -40.02 92.4 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.419 -0.801 . . . . 2.07 109.764 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.45 -41.52 24.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 1.37 110.147 -179.51 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.88 -45.45 64.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -0.946 . . . . 1.14 110.63 -179.316 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.05 -43.31 95.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.039 -1.038 . . . . 1.26 110.122 -179.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -60.01 -39.95 87.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 2.02 110.193 -178.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -61.46 -41.81 97.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.995 -1.066 . . . . 1.33 110.517 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.4 t -60.05 -50.85 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.14 -0.975 . . . . 1.3 110.598 -178.653 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.8 mm -69.94 -39.99 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.116 -0.99 . . . . 1.32 109.252 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -62.11 -39.38 92.31 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.584 -0.895 . . . . 2.44 108.584 179.099 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.0 -52.19 54.38 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.812 -0.915 . . . . 0.99 110.812 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.493 ' NE2' ' CB ' ' B' ' 348' ' ' PHE . 15.5 mm100 -64.04 -49.76 71.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.7 -1.47 . . . . 1.97 109.697 -179.436 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.91 83.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.189 -0.944 . . . . 1.43 109.027 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.8 t -59.98 -42.24 93.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.921 . . . . 2.12 108.873 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.29 -40.0 94.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.858 . . . . 1.64 109.882 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.4 mt -65.42 -40.26 93.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.787 -1.196 . . . . 1.93 109.674 -178.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.06 -31.06 69.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.9 -1.125 . . . . 2.2 109.75 -179.656 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -55.81 -23.57 31.04 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.084 -1.01 . . . . 2.12 108.396 179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.1 mt -63.23 148.91 46.82 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.576 -0.898 . . . . 2.34 108.576 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -99.81 47.07 0.95 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.025 -1.047 . . . . 3.23 110.204 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 34.6 t0 -137.44 150.17 47.43 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.174 -0.954 . . . . 2.49 109.772 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 124' ' ' LYS . 98.4 mt-10 -74.44 -67.97 0.57 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.299 -0.876 . . . . 3.95 109.259 178.825 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.634 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 4.8 t80 -39.25 -39.5 0.63 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.863 -0.523 . . . . 2.25 111.153 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.561 ' CD2' HH22 ' A' ' 126' ' ' ARG . 88.9 mt -69.97 -36.59 75.33 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.745 -1.222 . . . . 2.27 108.508 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 121' ' ' GLU . 74.6 tttt -69.23 -35.98 76.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.446 -0.784 . . . . 3.31 110.309 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.536 ' N ' ' OE1' ' A' ' 125' ' ' GLU . 0.4 OUTLIER -60.05 -46.31 89.97 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.966 -1.084 . . . . 2.73 110.603 -178.485 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.634 ' NH1' ' CE1' ' A' ' 122' ' ' TYR . 27.8 mtm-85 -63.14 -39.67 95.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.504 -1.372 . . . . 3.2 108.593 179.413 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.0 -36.6 77.55 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.459 -0.941 . . . . 1.66 108.459 179.057 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.22 88.58 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.216 -1.031 . . . . 1.67 108.216 179.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.88 -40.02 87.67 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.927 -0.768 . . . . 1.55 108.927 179.15 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 51.2 t -59.95 -42.9 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 1.32 109.052 179.384 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -60.04 -39.92 87.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 3.58 109.485 179.16 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -59.91 -40.05 87.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.427 -0.796 . . . . 1.46 110.196 -179.617 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.99 -42.17 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.127 -0.983 . . . . 1.22 110.447 -178.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.45 -34.46 54.23 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.805 -1.188 . . . . 0.61 110.236 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -60.05 -46.22 90.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -1.183 . . . . 3.1 109.684 -179.13 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.497 HH22 ' CD1' ' A' ' 57' ' ' ILE . 62.4 mtp180 -65.24 -34.5 78.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.125 -0.984 . . . . 3.71 110.108 -179.316 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.036 -1.04 . . . . 1.87 109.015 -179.597 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.4 mt -60.53 -40.06 90.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 1.29 108.537 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -65.62 -39.93 92.02 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.825 -0.805 . . . . 3.05 108.825 179.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -69.47 -34.23 74.06 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.717 -0.614 . . . . 1.26 111.328 -179.245 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.26 -39.85 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.454 -1.404 . . . . 1.34 109.243 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.9 mt -73.84 -19.17 60.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.597 -0.689 . . . . 1.6 109.943 -179.263 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.64 39.33 14.54 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.721 -1.752 . . . . 0.96 108.721 -179.289 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.8 tp -73.89 147.05 43.57 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.489 -1.006 . . . . 1.67 110.004 -179.001 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.74 141.05 49.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.351 -0.843 . . . . 4.96 109.713 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 90.2 mt -113.35 130.01 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.825 0.821 . . . . 1.68 108.838 179.108 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.4 mt -68.29 -39.94 81.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.857 -0.527 . . . . 2.14 110.874 -177.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.43 ' CG ' ' HG ' ' A' ' 150' ' ' SER . 32.8 t0 63.92 102.83 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.396 -0.815 . . . . 1.5 109.267 -179.3 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.2 mt -72.95 -1.73 18.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.412 -0.805 . . . . 1.39 110.669 -179.069 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.43 ' HG ' ' CG ' ' A' ' 148' ' ' ASP . 79.2 p -85.24 -16.07 41.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.791 -1.193 . . . . 1.83 109.766 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.62 28.02 0.27 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.172 -0.955 . . . . 1.46 111.859 -177.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 40.9 mm -85.99 125.94 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.491 -1.381 . . . . 1.42 109.191 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -106.91 -13.95 15.09 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.496 -0.752 . . . . 2.94 109.665 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -126.68 150.97 48.7 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.341 -0.85 . . . . 1.52 110.034 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.69 136.62 57.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 1.58 109.0 179.496 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.2 m -152.82 165.96 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.324 -0.86 . . . . 1.32 109.835 179.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.4 mt -95.55 145.95 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 105.661 -1.978 . . . . 1.27 105.661 176.783 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 37.7 tp -100.23 119.67 38.73 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.907 -1.121 . . . . 1.41 110.54 -178.092 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.0 125.72 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.605 -0.684 . . . . 1.23 109.225 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -152.78 158.67 42.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.985 -1.072 . . . . 1.32 109.494 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.01 -32.12 70.13 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.395 -1.44 . . . . 1.49 108.294 179.076 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 56.2 t0 -169.86 142.15 2.37 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.451 -0.944 . . . . 2.25 108.451 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.528 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 81.4 mt -110.74 129.03 55.94 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.325 -0.859 . . . . 1.35 108.968 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 43.5 p -90.17 149.89 42.24 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.299 -0.876 . . . . 1.56 109.22 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -37.85 -38.92 0.75 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 122.241 1.961 . . . . 0.87 112.439 179.667 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.1 m -59.51 -39.98 85.6 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.251 -0.906 . . . . 1.36 109.9 -178.219 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.14 -40.05 86.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.086 -1.009 . . . . 1.61 110.356 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.7 p -57.21 -32.6 66.67 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.981 -1.074 . . . . 1.21 111.124 -178.229 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.3 -46.96 53.47 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.984 -1.073 . . . . 1.21 109.97 -179.794 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -89.95 40.06 0.99 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.788 -1.19 . . . . 2.11 107.788 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.8 tp -106.96 126.44 52.32 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 109.082 -0.711 . . . . 1.29 109.082 179.208 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -84.68 105.71 15.68 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.075 -1.083 . . . . 2.81 108.075 178.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.12 -44.53 84.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.37 -0.831 . . . . 2.09 111.39 -178.131 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -69.99 -21.76 63.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.76 -1.213 . . . . 2.86 111.809 -177.386 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -93.91 -9.27 37.7 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.699 -1.251 . . . . 2.39 110.214 -178.943 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 99.8 t -108.76 119.94 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.385 -0.822 . . . . 1.27 108.912 179.516 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 89.5 mt -85.12 3.73 37.62 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.558 -0.714 . . . . 2.17 110.845 -178.182 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 166.55 175.23 36.61 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 119.224 -1.465 . . . . 0.52 109.75 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -133.69 129.41 36.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.551 -0.97 . . . . 0.55 108.411 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 90.3 mt -128.98 123.72 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.552 -0.907 . . . . 1.27 108.552 179.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 69.9 p -149.96 162.38 40.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.654 -1.279 . . . . 1.39 110.9 -179.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 183' ' ' ALA . 7.2 p30 -101.9 22.54 12.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.757 -0.589 . . . . 2.46 109.522 179.64 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -54.32 -162.98 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.817 -1.177 . . . . 1.51 112.048 -178.204 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.99 -54.0 5.97 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.809 -0.917 . . . . 2.23 110.809 -179.034 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 164.42 -139.01 5.59 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 118.94 -1.6 . . . . 2.23 110.707 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -71.59 -9.99 59.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.931 . . . . 6.44 110.625 -178.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 53.5 p -78.99 1.52 23.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.928 -1.108 . . . . 4.09 109.672 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 12.2 t -90.94 130.8 36.84 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.081 -1.012 . . . . 2.2 110.076 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -47.06 -50.27 19.99 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.447 -0.783 . . . . 1.15 109.966 179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 14.5 t -57.48 -37.16 72.46 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.304 -0.873 . . . . 2.01 110.973 -178.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 82.6 p -59.99 -41.01 91.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.739 -1.226 . . . . 1.93 110.851 -179.087 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 88.7 mt -61.09 -38.93 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.125 -0.984 . . . . 2.2 109.399 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 92.7 mtp -60.59 -39.93 89.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.555 -0.716 . . . . 1.32 110.395 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.27 -43.49 87.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.737 -1.227 . . . . 1.3 109.388 -179.453 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.58 ' CG ' HH11 ' A' ' 195' ' ' ARG . 2.2 mtt-85 -60.02 -49.92 75.77 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.288 -0.965 . . . . 3.38 109.911 -179.29 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 72.1 m -69.96 -34.43 73.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.088 -1.008 . . . . 1.15 111.026 -179.224 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.5 mt -71.47 -18.24 62.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.921 -1.112 . . . . 1.28 109.499 -179.536 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 60.99 47.92 7.0 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.294 0.569 . . . . 1.5 110.536 -179.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 38.5 mt -126.99 149.48 69.36 Favored Pre-proline 0 N--CA 1.499 2.021 0 N-CA-C 107.724 -1.213 . . . . 1.37 107.724 178.549 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.79 139.98 49.58 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.122 1.881 . . . . 0.76 112.102 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.99 150.59 3.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.112 -0.992 . . . . 1.19 111.052 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 93.1 mt -125.22 142.32 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 108.399 -0.963 . . . . 1.31 108.399 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.3 m -127.04 -7.97 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 120.816 -1.178 . . . . 1.38 111.322 -178.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.9 21.31 29.92 Favored Glycine 0 N--CA 1.503 3.135 0 O-C-N 121.211 -0.931 . . . . 1.03 110.867 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 8.3 p -45.84 -43.99 13.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.951 -1.323 . . . . 1.38 110.165 -179.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.34 -49.46 2.67 Favored Glycine 0 N--CA 1.498 2.784 0 C-N-CA 120.017 -1.087 . . . . 1.17 111.034 179.445 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.7 m -160.77 37.74 0.16 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.651 -1.5 . . . . 2.07 111.246 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 42.4 t -80.74 -31.5 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.991 -1.068 . . . . 1.35 108.86 178.206 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.583 ' HG1' ' N ' ' A' ' 210' ' ' SER . 2.7 p -59.95 -33.52 72.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.45 -0.781 . . . . 1.49 110.062 -179.081 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.583 ' N ' ' HG1' ' A' ' 209' ' ' THR . 91.2 p -78.21 -10.06 59.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.994 -1.066 . . . . 2.16 109.412 -179.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -103.6 -11.1 17.92 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.491 -0.756 . . . . 2.89 110.228 -179.304 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.4 t -103.42 136.2 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.213 -0.93 . . . . 1.33 110.806 -178.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -112.32 151.0 30.22 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.462 -1.31 . . . . 2.73 107.462 178.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.444 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 11.3 p-10 -57.92 139.53 54.1 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.058 -1.026 . . . . 2.7 110.069 -179.143 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.7 m-20 81.15 3.02 1.59 Allowed 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.13 0.491 . . . . 2.38 110.007 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 56.7 t0 -72.01 138.61 48.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.156 -0.965 . . . . 2.09 108.803 178.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.489 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 41.3 t80 -89.85 118.63 29.58 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.074 -1.084 . . . . 1.45 108.074 179.078 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 61.5 mt -128.47 149.05 50.74 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.498 -0.751 . . . . 1.31 110.642 -178.629 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.9 mt -115.15 130.01 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 107.703 -1.221 . . . . 1.29 107.703 177.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 63.5 tp -99.97 115.92 30.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.08 -1.013 . . . . 1.31 109.314 -179.207 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.541 ' C ' ' H ' ' A' ' 223' ' ' VAL . 97.3 m-20 -74.22 -42.72 59.3 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.918 -1.142 . . . . 2.31 107.918 178.368 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 51.54 11.22 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.404 -0.961 . . . . 1.19 108.404 -179.108 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.541 ' H ' ' C ' ' A' ' 221' ' ' ASP . 57.2 t -128.33 -39.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.327 -1.36 . . . . 1.45 107.327 179.057 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.502 ' N ' HD21 ' A' ' 224' ' ' ASN . 1.3 m-80 -100.43 3.23 42.93 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.047 -1.094 . . . . 3.13 108.047 178.68 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 60.57 43.8 12.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.71 -0.619 . . . . 2.2 110.601 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.406 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 25.1 pt20 -149.18 156.79 42.7 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.885 -1.134 . . . . 2.32 109.976 179.204 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -122.92 124.93 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.685 -0.857 . . . . 1.4 108.685 179.158 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.406 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 84.7 m-85 -84.76 122.83 29.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.701 -1.249 . . . . 1.29 109.556 -179.23 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 62.5 t -98.96 116.3 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.474 -0.766 . . . . 1.38 109.481 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 65.08 68.96 0.69 Allowed Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.227 -0.92 . . . . 2.33 109.372 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -89.18 124.05 1.4 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.181 2.587 . . . . 0.95 112.255 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.2 p -70.41 171.75 9.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 2.31 109.725 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -59.97 -40.16 88.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.323 -0.86 . . . . 3.45 109.921 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -64.33 -34.61 78.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.033 -1.042 . . . . 2.89 109.217 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.79 -42.7 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.121 -0.987 . . . . 1.73 108.613 178.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.421 HD12 HG23 ' A' ' 236' ' ' ILE . 95.1 mt -67.1 -41.99 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.747 -0.834 . . . . 1.57 108.747 179.389 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -59.86 -40.06 87.33 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.596 -0.89 . . . . 2.43 108.596 178.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -59.51 -46.71 88.05 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.393 -0.965 . . . . 3.18 108.393 -179.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.541 ' O ' ' N ' ' A' ' 242' ' ' VAL . 93.3 mtp -65.69 -77.3 0.06 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.19 -1.411 . . . . 1.59 107.19 178.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.503 ' C ' ' O ' ' A' ' 239' ' ' MET . 29.6 mmt180 -23.19 -45.07 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 120.983 0.421 . . . . 3.11 111.889 -178.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 239' ' ' MET . . . -63.88 -50.01 70.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.943 -1.098 . . . . 2.17 109.612 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 239' ' ' MET . 74.8 t -60.06 -38.13 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.228 -0.92 . . . . 2.51 108.884 179.498 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.96 -40.08 87.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.498 -0.751 . . . . 3.82 109.063 -179.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.38 -40.03 89.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.146 -0.971 . . . . 1.78 108.968 179.136 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -66.74 -40.09 88.18 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.238 -0.914 . . . . 2.77 108.964 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 53.6 t -66.05 -40.17 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.332 -0.855 . . . . 2.25 109.073 179.739 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.82 -39.77 91.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.42 -0.8 . . . . 2.54 109.493 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 57.8 m -60.02 -39.96 87.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.253 -0.904 . . . . 3.03 109.576 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -65.86 -40.03 91.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.951 . . . . 3.34 109.549 179.802 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -82.76 -2.29 53.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.408 -0.807 . . . . 4.18 109.845 -179.051 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.532 ' O ' ' NZ ' ' A' ' 257' ' ' LYS . . . -65.73 -39.39 91.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.811 -1.181 . . . . 4.43 110.588 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -163.2 -17.57 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.591 -1.318 . . . . 5.42 110.973 -179.056 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.99 -40.03 75.54 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.565 -1.334 . . . . 6.11 109.565 179.463 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 255' ' ' LYS . . . -118.44 4.87 11.76 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.534 -0.728 . . . . 7.37 110.659 -179.269 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 254' ' ' ALA . 43.6 pttt 33.12 -117.04 0.07 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.577 -0.702 . . . . 8.3 110.91 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 59.94 19.54 8.57 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.862 -1.162 . . . . 9.05 107.862 -179.27 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.532 ' NZ ' ' O ' ' A' ' 251' ' ' ALA . 87.5 mttt -66.52 -46.15 77.13 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.631 -0.828 . . . . 10.56 109.554 178.652 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -147.79 25.88 1.03 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.37 -0.831 . . . . 11.32 109.423 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.081 -1.012 . . . . 12.74 109.036 -179.972 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 16.9 ttt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -149.49 147.98 28.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.26 -0.9 . . . . 0.0 109.267 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -149.67 159.63 44.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.066 -1.021 . . . . 0.0 110.618 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -153.66 150.41 28.56 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -109.84 132.25 54.32 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.373 -0.83 . . . . 0.0 109.781 179.628 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.49 121.63 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 122.371 1.081 . . . . 0.0 112.729 -177.4 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 56.0 m -78.19 104.01 8.49 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.924 0.868 . . . . 0.0 110.02 -178.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . 0.46 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.6 mt -52.64 125.62 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 122.635 1.207 . . . . 0.0 111.073 -177.562 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 67.1 p -109.97 20.9 17.46 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.978 -179.023 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . 0.449 ' O ' ' CG ' ' B' ' 357' ' ' GLN . . . -75.29 116.87 58.55 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.048 -1.032 . . . . 0.0 108.945 179.426 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -54.53 -16.22 10.29 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 CA-C-N 120.276 1.134 . . . . 0.0 113.249 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -120.17 11.41 11.61 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.383 -0.823 . . . . 0.0 109.621 -179.191 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.85 179.25 32.14 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 108.431 -1.867 . . . . 0.0 108.431 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.459 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -87.08 93.13 9.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.952 -1.322 . . . . 0.0 108.998 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -95.43 -160.0 0.76 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.945 -1.097 . . . . 0.0 109.811 179.054 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 9.6 m -58.39 -43.99 88.75 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.021 -1.05 . . . . 0.0 112.629 -176.071 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.473 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.1 tpt180 -61.97 -62.05 6.57 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.352 -1.467 . . . . 0.0 112.184 -178.236 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -58.02 -29.6 87.34 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 CA-C-N 120.136 1.084 . . . . 0.0 111.548 -179.196 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.34 -49.96 75.83 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.085 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.34 -41.18 65.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.464 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -70.02 -40.61 75.1 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.768 -1.207 . . . . 0.0 108.911 178.478 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -65.5 -55.46 17.74 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.521 -0.737 . . . . 0.0 109.951 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 88.3 t -67.83 -29.72 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.872 -1.142 . . . . 0.0 111.058 -178.482 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -64.05 -42.96 96.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.966 -1.084 . . . . 0.0 109.876 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -66.23 -40.41 90.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.107 -0.995 . . . . 0.0 110.499 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -65.75 -53.13 44.73 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.745 -1.222 . . . . 0.0 110.389 -179.608 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -51.94 -15.64 0.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 109.964 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -75.49 -23.93 71.91 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -105.59 141.32 37.26 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.404 -1.057 . . . . 0.0 108.945 179.669 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 26.5 m -89.8 -11.48 42.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.997 -1.064 . . . . 0.0 109.937 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 63.3 p -61.32 148.88 39.81 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.973 -1.079 . . . . 0.0 109.241 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -68.53 134.63 50.35 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.116 -0.99 . . . . 0.0 108.908 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.3 mt -133.01 133.22 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.642 -0.661 . . . . 0.0 109.787 -179.57 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 32.4 m -129.9 149.03 51.81 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.487 -0.758 . . . . 0.0 109.089 179.245 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 87.1 t -122.3 116.48 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.327 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 33.3 m -105.67 132.12 52.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 33.8 t -140.02 116.49 10.7 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.768 0.794 . . . . 0.0 111.105 -179.79 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 45.52 51.96 9.48 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.723 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 90.0 -14.03 63.09 Favored Glycine 0 N--CA 1.503 3.142 0 O-C-N 120.156 -1.59 . . . . 0.0 113.099 176.52 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -119.76 131.16 55.28 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 119.495 1.647 . . . . 0.0 110.06 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 18.1 m -129.99 150.23 51.36 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.83 0.824 . . . . 0.0 110.426 -179.412 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -146.52 171.86 14.44 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.511 0.672 . . . . 0.0 110.145 -179.229 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 9.6 m -89.68 139.95 30.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.533 -0.73 . . . . 0.0 109.725 -179.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -81.51 -12.47 58.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.0 -1.062 . . . . 0.0 109.018 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -86.62 21.26 2.23 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.5 -1.666 . . . . 0.0 106.5 178.602 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.51 ' H ' ' C ' ' B' ' 344' ' ' ALA . 52.7 m -149.96 98.67 2.75 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.226 -179.053 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . 0.44 ' O ' ' OE1' ' B' ' 351' ' ' GLN . 26.0 tp -59.91 -34.4 73.15 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . 0.493 ' CB ' ' NE2' ' A' ' 111' ' ' GLN . 58.0 m-85 -59.93 -55.56 32.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.265 -0.897 . . . . 0.0 110.11 -179.37 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -69.35 -22.4 63.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 111.178 -177.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' B' ' 352' ' ' THR . 65.1 mt -68.94 -52.78 25.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.645 -1.284 . . . . 0.0 108.09 177.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.552 ' OE1' ' N ' ' B' ' 351' ' ' GLN . 0.8 OUTLIER -40.85 -16.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.977 -178.22 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.545 ' N ' ' O ' ' B' ' 350' ' ' LEU . 63.5 p -87.44 -10.01 53.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.405 -1.435 . . . . 0.0 109.941 -179.167 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 67.8 mt -95.42 117.81 31.02 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.07 -1.019 . . . . 0.0 109.081 178.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.35 94.04 0.91 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 18.1 mt -101.42 88.73 3.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.282 -1.128 . . . . 0.0 108.86 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 77.2 p -90.33 169.99 10.63 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.01 -1.056 . . . . 0.0 110.785 -179.068 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . 0.449 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 1.1 tm0? -61.46 113.78 2.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.721 -0.612 . . . . 0.0 110.973 -179.079 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 100.32 8.07 50.68 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.751 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.1 m -83.31 111.52 19.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.339 -1.095 . . . . 0.0 110.513 -179.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 6.1 t -77.31 114.59 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 122.292 1.044 . . . . 0.0 109.257 -177.636 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 14.5 m -111.7 177.68 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 90.3 m -131.29 129.35 41.39 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 176.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 71.9 mt -102.63 116.42 46.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 56.8 p -120.01 132.3 55.43 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.35 153.14 40.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 0.0 109.873 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -144.88 124.41 13.18 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.289 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.464 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 159.88 -160.34 31.46 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 118.804 -1.665 . . . . 0.0 111.578 -179.773 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -60.06 -50.93 71.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 122.132 -0.628 . . . . 0.0 112.133 -177.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -109.93 10.93 24.27 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.903 -1.123 . . . . 0.0 111.643 -177.2 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.554 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -42.04 -34.88 0.78 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.988 -1.07 . . . . 0.0 111.848 -178.392 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 26.7 mt-30 -70.72 -38.65 73.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.745 -1.222 . . . . 0.0 110.034 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -65.38 -50.04 67.02 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.926 -1.108 . . . . 0.0 109.011 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.05 -76.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.584 -0.697 . . . . 0.0 111.069 -178.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 23.5 t -43.08 -38.13 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.343 -0.848 . . . . 0.0 110.973 -177.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.92 -42.39 85.48 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.351 -1.468 . . . . 0.0 110.32 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -81.03 -43.43 19.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.795 -1.191 . . . . 0.0 109.909 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.09 -39.41 86.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.223 -179.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 55.9 t -62.02 -43.23 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.057 -1.027 . . . . 0.0 109.342 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -70.02 -56.38 7.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.703 -1.248 . . . . 0.0 107.64 178.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 52.0 tp -56.2 -35.06 66.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.564 -0.71 . . . . 0.0 110.058 -177.861 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 1.5 tpt -71.49 -39.93 70.53 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.543 -1.348 . . . . 0.0 108.669 178.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.75 -4.44 57.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.473 -0.767 . . . . 0.0 110.574 179.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.428 ' O ' ' OE2' ' B' ' 385' ' ' GLU . 73.2 mm-40 -111.68 -2.61 15.3 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.105 -0.997 . . . . 0.0 110.995 -179.563 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 13.1 mt -80.01 133.02 36.12 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.379 -1.45 . . . . 0.0 109.493 179.129 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . 0.525 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 42.9 mp0 . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.211 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mtp . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.5 -0.556 . . . . 3.19 109.5 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.2 mt -109.97 129.94 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.51 -0.744 . . . . 1.71 109.692 -179.84 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 m -131.65 147.61 52.53 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.719 -0.613 . . . . 1.66 109.456 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.44 -164.99 10.13 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 108.834 -1.706 . . . . 1.05 108.834 179.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.6 mt -87.41 -18.33 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.016 -1.285 . . . . 1.59 109.704 -179.356 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.4 tp 54.86 103.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.668 -0.864 . . . . 1.47 108.668 -179.138 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.5 -24.57 16.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 1.39 108.675 179.509 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 13.4 t -141.77 123.43 8.96 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.574 -0.704 . . . . 2.09 110.011 -179.889 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.98 147.48 21.2 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.184 1.923 . . . . 0.91 112.531 179.284 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 150.29 172.64 19.78 Favored Glycine 0 N--CA 1.5 2.918 0 N-CA-C 108.918 -1.673 . . . . 0.92 108.918 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.9 mt -127.45 132.31 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.875 -1.367 . . . . 1.35 109.677 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.43 151.89 50.0 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.317 -0.864 . . . . 1.14 109.957 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -127.28 130.84 50.31 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.866 -1.161 . . . . 0.7 107.866 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.72 178.82 48.65 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 118.583 -1.77 . . . . 0.58 111.183 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -79.96 155.56 27.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.799 -0.824 . . . . 2.63 109.325 -179.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.52 125.78 51.43 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 121.794 0.807 . . . . 1.27 111.369 -178.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.0 tp -99.47 137.52 37.85 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.529 -1.286 . . . . 1.41 107.529 178.195 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.5 tp -119.53 128.65 54.14 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.476 -0.765 . . . . 1.49 109.692 -179.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.1 mt -91.62 105.91 18.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.694 -0.629 . . . . 1.52 110.275 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -106.1 131.79 52.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.162 -1.051 . . . . 3.17 108.162 178.605 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -129.23 148.58 51.17 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.383 -0.823 . . . . 3.0 109.381 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -83.15 142.42 31.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.455 -0.778 . . . . 2.77 109.33 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -60.2 142.52 54.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.126 -0.983 . . . . 2.94 109.133 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -75.97 126.58 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.977 . . . . 1.46 109.985 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.57 125.33 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.343 -0.848 . . . . 1.7 110.166 -179.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 84.8 mt -110.18 132.29 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.607 -0.886 . . . . 1.54 108.607 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -92.23 117.92 30.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.764 -1.21 . . . . 1.81 109.474 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.418 HH11 ' HG2' ' A' ' 28' ' ' ARG . 5.3 mmt-85 -87.11 -4.39 59.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.164 -0.96 . . . . 3.23 109.342 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -68.25 140.77 56.03 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.194 -0.941 . . . . 3.29 109.248 179.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -84.02 154.49 23.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.899 . . . . 2.8 109.849 -179.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 pt -96.5 167.17 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 1.43 109.467 179.725 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.7 p -90.31 172.76 8.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.04 -1.037 . . . . 1.54 108.363 178.574 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.08 -18.09 63.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.938 -1.102 . . . . 1.6 110.994 -179.285 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 64.8 t0 -86.37 -24.62 25.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.626 -1.296 . . . . 2.56 108.392 178.842 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -81.29 -9.97 59.66 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.786 -0.82 . . . . 2.36 108.786 179.1 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 t -60.94 -52.02 66.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.799 -0.815 . . . . 1.43 108.799 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -61.08 -39.88 91.57 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.377 -0.827 . . . . 1.77 110.273 -179.619 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -69.24 -40.91 77.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.078 -1.014 . . . . 3.32 111.022 -178.309 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -65.91 -39.86 90.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.0 -1.063 . . . . 1.51 110.854 -179.21 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.8 t -61.33 -45.04 99.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.484 -1.385 . . . . 1.41 108.45 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -60.01 -41.5 92.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.043 -1.036 . . . . 1.81 109.622 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -60.17 -45.25 93.71 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.967 -1.093 . . . . 3.26 108.069 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -60.36 -48.29 82.37 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.889 -0.782 . . . . 0.81 108.889 178.199 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.447 ' CD1' HH21 ' A' ' 47' ' ' ARG . 43.2 tp -60.2 -48.81 80.16 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.048 -0.723 . . . . 1.59 109.048 -179.567 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.4 t -63.56 -43.18 97.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.021 -1.05 . . . . 1.38 108.386 178.83 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.56 -47.42 91.25 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.537 -1.825 . . . . 0.87 108.537 179.059 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.447 HH21 ' CD1' ' A' ' 44' ' ' LEU . 44.2 ttp180 -60.18 -38.78 84.27 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.888 -1.153 . . . . 3.62 107.888 178.656 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.9 -46.49 68.02 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.952 -0.758 . . . . 1.43 108.952 179.803 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 50' ' ' ALA . 34.0 ttpt -59.92 -74.82 0.07 Allowed 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.548 -1.279 . . . . 3.08 107.548 179.257 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.35 -39.61 0.3 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.356 -0.84 . . . . 1.33 111.907 -178.148 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.0 m -59.34 -52.17 66.8 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.458 -1.401 . . . . 1.85 108.707 -179.749 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.52 -40.71 89.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.365 -0.834 . . . . 1.35 110.58 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -63.3 -42.17 99.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.0 -1.062 . . . . 2.34 109.878 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.6 mt -64.11 -40.46 96.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.021 -1.049 . . . . 2.2 109.538 179.553 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.7 -39.87 90.15 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.109 -0.995 . . . . 1.35 108.708 179.671 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 89.3 m -62.23 -43.49 98.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.361 -0.837 . . . . 1.34 109.711 179.097 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 81.7 mt -61.47 -39.85 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.325 -0.859 . . . . 1.26 109.598 179.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -57.56 -50.22 73.81 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.255 -0.903 . . . . 1.7 109.872 -179.041 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -58.44 -37.68 75.9 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.25 -0.906 . . . . 1.35 110.491 -177.751 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -68.47 -36.88 79.6 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.911 -1.118 . . . . 2.08 109.352 179.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.27 -47.34 70.97 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.57 -0.706 . . . . 1.21 109.979 -179.636 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -54.59 -52.8 42.89 Favored Glycine 0 N--CA 1.484 1.858 0 C-N-CA 119.993 -1.099 . . . . 0.75 110.452 -178.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.42 -41.84 72.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.032 -1.275 . . . . 1.59 111.083 -178.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.8 m -66.34 -61.93 1.74 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.025 -1.047 . . . . 1.41 112.181 -177.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -96.68 -44.47 7.1 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.827 -1.171 . . . . 0.79 111.439 -177.546 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.39 -168.08 25.58 Favored Glycine 0 N--CA 1.499 2.882 0 C-N-CA 119.822 -1.18 . . . . 1.22 110.925 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -69.95 -22.82 63.14 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.981 -0.717 . . . . 5.81 110.115 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.506 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 50.4 tp10 -59.99 -35.71 75.61 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.466 -0.771 . . . . 3.37 111.31 -179.14 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -96.51 -16.22 21.23 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.166 -0.959 . . . . 2.37 109.748 -179.699 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -71.6 -43.13 66.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.219 -0.926 . . . . 1.65 110.373 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.53 78.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.435 -0.79 . . . . 1.42 110.119 -178.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.86 -40.61 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.909 -1.119 . . . . 1.43 109.108 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -65.04 -39.52 93.47 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.986 -1.071 . . . . 1.08 110.314 -179.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -60.12 -40.06 88.42 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.979 -1.076 . . . . 1.37 109.342 -179.182 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.99 -44.75 95.49 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.181 -1.968 . . . . 0.67 108.181 178.376 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -63.36 -45.88 89.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.529 -0.983 . . . . 1.99 109.142 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 98.5 mt -70.08 -45.51 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.108 -0.995 . . . . 1.22 109.319 179.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.0 ttp -62.65 -41.49 99.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.847 -1.158 . . . . 2.11 110.09 -179.488 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 45.7 tp -65.07 -40.83 95.22 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.541 -0.724 . . . . 1.33 110.065 -179.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.7 tp -68.73 -39.52 80.33 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.636 -0.665 . . . . 1.29 110.311 -179.096 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -79.67 0.94 28.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.043 -1.036 . . . . 1.47 109.935 -179.062 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 53.3 t0 -47.28 133.83 11.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.086 -1.009 . . . . 1.47 109.736 -179.311 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.458 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 99.3 mt-10 -64.92 -18.66 65.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.683 -0.636 . . . . 1.78 110.899 -178.749 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -75.51 -33.31 60.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.779 -1.201 . . . . 2.53 109.035 178.68 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.9 mt -70.02 -39.99 75.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.479 -0.763 . . . . 1.36 109.371 179.5 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.91 -49.53 77.31 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.429 -0.794 . . . . 1.42 110.16 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.4 -39.41 81.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.855 . . . . 2.27 110.787 -179.226 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -68.87 -40.25 79.37 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.719 -1.238 . . . . 1.57 111.221 -179.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.44 -43.19 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.601 -1.312 . . . . 1.19 109.402 179.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.78 -39.17 77.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.552 -0.717 . . . . 1.39 110.749 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.78 95.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.117 -0.989 . . . . 1.39 110.098 -179.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 21.1 mt -63.65 -45.4 90.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.094 -1.004 . . . . 1.5 109.333 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.9 mt -64.15 -48.98 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.406 -0.809 . . . . 1.29 109.18 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.99 -40.77 75.11 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.733 -0.787 . . . . 2.64 110.576 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -84.82 -55.86 3.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.969 -1.082 . . . . 1.65 112.134 -178.142 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -87.1 -1.44 57.89 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.866 -1.146 . . . . 2.5 111.872 -177.321 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 44.3 m80 58.58 35.01 24.31 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.995 -1.066 . . . . 1.88 110.304 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.2 mtp -86.89 166.27 15.28 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.256 -0.903 . . . . 1.71 109.889 -179.474 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.433 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 64.4 p -79.62 161.9 25.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.206 -0.934 . . . . 1.61 108.864 179.536 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.06 -40.54 87.11 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.0 -1.062 . . . . 1.33 109.541 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 23.9 p-10 -69.94 -35.72 74.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 2.07 109.925 179.825 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.12 -40.09 39.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.094 -1.004 . . . . 1.37 109.333 179.279 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.76 -48.33 63.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.862 . . . . 1.14 110.361 -179.368 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.81 -32.54 73.75 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.81 -1.181 . . . . 1.26 109.757 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.525 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 86.3 t60 -60.53 -45.07 95.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 2.02 109.56 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -66.41 -39.96 89.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.792 . . . . 1.33 110.997 -178.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.1 t -62.3 -53.35 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.165 -0.96 . . . . 1.3 111.493 -177.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.8 mm -72.59 -37.12 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.751 -1.218 . . . . 1.32 110.004 -179.382 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.525 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 84.5 tt0 -67.35 -34.2 76.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.172 -0.955 . . . . 2.44 108.537 179.623 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.59 -49.07 82.66 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.357 -1.097 . . . . 0.99 110.357 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.651 HE21 ' CB ' ' B' ' 348' ' ' PHE . 16.3 mm100 -65.92 -50.71 63.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.802 -1.411 . . . . 1.97 109.192 -179.537 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.87 -40.43 80.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 1.43 109.097 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 109' ' ' GLU . 61.8 m -60.03 -40.18 88.48 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.114 -0.991 . . . . 2.12 108.436 179.733 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.26 -39.65 95.19 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.391 -0.818 . . . . 1.64 109.304 179.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.6 mt -67.82 -43.16 80.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.993 -1.083 . . . . 1.93 109.461 -179.468 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -55.5 -25.4 36.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.85 -1.156 . . . . 2.2 109.723 -179.31 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -66.2 -22.0 66.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.973 -1.079 . . . . 2.12 108.765 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 51.8 mt -63.25 143.94 57.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.314 -0.866 . . . . 2.34 109.882 -179.617 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -92.55 14.31 17.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.201 -0.937 . . . . 3.23 109.358 179.03 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -103.22 127.83 50.41 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.32 -0.862 . . . . 2.49 110.516 -178.944 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -70.62 -28.94 65.22 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.366 0.603 . . . . 3.95 110.234 179.239 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.535 ' OH ' ' N ' ' B' ' 315' ' ' HIS . 15.7 t80 -64.26 -40.58 96.28 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.209 -0.932 . . . . 2.25 110.212 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.43 ' CD2' ' O ' ' B' ' 351' ' ' GLN . 64.2 mt -77.38 -37.15 52.7 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.51 -0.744 . . . . 2.27 109.875 -178.934 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -59.98 -40.9 90.7 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.249 -0.907 . . . . 3.31 109.329 -179.752 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -61.28 -46.02 92.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.958 -1.089 . . . . 2.73 108.877 179.401 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.419 HH21 ' CD2' ' A' ' 123' ' ' LEU . 17.5 ttp180 -61.16 -39.96 92.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.899 . . . . 3.2 108.59 179.203 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.88 -28.9 70.36 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.766 -0.827 . . . . 1.66 108.766 179.011 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.03 87.58 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.087 -1.079 . . . . 1.67 108.087 179.571 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -62.07 -42.24 98.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.522 -0.736 . . . . 1.55 109.503 179.741 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.11 -41.4 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.197 -0.939 . . . . 1.32 108.571 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -60.13 -39.33 85.94 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.688 -0.633 . . . . 3.58 109.458 179.32 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -60.04 -41.85 93.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.38 -0.825 . . . . 1.46 110.676 -179.304 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.16 -46.19 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.056 -1.028 . . . . 1.22 110.055 -179.088 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.99 97.85 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.996 -1.242 . . . . 0.61 109.996 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -59.8 -49.72 76.63 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.326 -1.102 . . . . 3.1 110.142 -179.658 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -70.05 -32.08 70.02 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.101 -0.999 . . . . 3.71 110.501 -179.808 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.9 tp -57.81 -46.74 84.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.97 . . . . 1.87 108.925 -178.884 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.96 -39.64 86.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.138 -0.977 . . . . 1.29 108.565 179.116 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -68.22 -40.0 82.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.356 -0.84 . . . . 3.05 108.884 178.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -60.16 -38.49 83.3 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.862 -0.524 . . . . 1.26 110.999 -178.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.5 mt -72.8 -40.87 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.653 -1.28 . . . . 1.34 108.727 179.397 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.68 -25.58 61.31 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.62 -0.675 . . . . 1.6 109.848 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.6 37.16 27.66 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.96 -1.656 . . . . 0.96 108.96 -179.309 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 58.5 tp -73.14 141.59 47.47 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.497 -1.002 . . . . 1.67 109.381 -179.401 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -61.96 140.06 58.35 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.845 0.831 . . . . 4.96 111.12 -178.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.421 HD12 HG23 ' A' ' 146' ' ' ILE . 97.0 mt -115.66 132.25 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.716 -0.846 . . . . 1.68 108.716 178.604 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 24.7 mm -57.02 -43.74 81.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.455 -0.778 . . . . 2.14 109.924 -178.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 11.8 t0 70.18 94.31 0.08 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.063 -0.718 . . . . 1.5 109.063 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.8 mt -66.36 -6.52 14.54 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.382 -0.824 . . . . 1.39 110.841 -178.761 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.0 t -82.93 -16.85 45.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.716 -1.24 . . . . 1.83 110.534 -179.186 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.33 24.29 0.83 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.068 -1.02 . . . . 1.46 112.581 -177.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.423 HG23 HD11 ' A' ' 152' ' ' ILE . 42.0 mm -79.28 126.5 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.305 -1.497 . . . . 1.42 108.793 179.531 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.4 ' O ' ' OD1' ' A' ' 154' ' ' ASP . 77.5 mt-30 -102.8 -11.92 17.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.558 -0.714 . . . . 2.94 110.158 -179.247 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 153' ' ' GLN . 97.7 m-20 -136.85 156.09 48.94 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.117 -0.989 . . . . 1.52 110.39 -178.975 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.08 135.17 56.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.321 -0.862 . . . . 1.58 109.137 179.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.9 m -152.65 164.48 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.42 -0.8 . . . . 1.32 109.802 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.412 HD12 HG22 ' A' ' 157' ' ' ILE . 85.7 mt -92.5 147.15 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 105.752 -1.944 . . . . 1.27 105.752 176.651 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.4 tp -99.69 119.21 37.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.173 -0.954 . . . . 1.41 110.464 -178.246 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.1 t -125.13 130.3 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.196 -1.038 . . . . 1.23 108.196 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.84 167.21 28.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -0.991 . . . . 1.32 109.221 -179.768 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.26 -37.31 74.88 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.781 -1.199 . . . . 1.49 108.715 179.013 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.6 p-10 -170.42 149.01 3.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.57 -0.706 . . . . 2.25 109.602 -179.655 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.1 mt -119.36 133.72 55.58 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.453 -0.779 . . . . 1.35 109.663 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.4 p -93.35 143.89 27.41 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.013 . . . . 1.56 108.624 179.157 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.439 ' O ' ' OG1' ' A' ' 168' ' ' THR . 85.2 Cg_exo -41.47 -34.23 1.92 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.302 2.001 . . . . 0.87 113.159 -179.669 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.7 m -59.92 -40.12 87.8 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.768 -1.207 . . . . 1.36 109.294 -178.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.5 -40.24 80.94 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.012 -1.055 . . . . 1.61 109.308 179.474 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 165' ' ' PRO . 63.8 p -52.94 -30.02 32.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.064 -1.022 . . . . 1.21 110.57 -178.92 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.405 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -70.72 -57.47 4.64 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.816 -1.178 . . . . 1.21 109.701 179.565 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -80.36 34.83 0.32 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.13 -0.693 . . . . 2.11 109.13 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.405 ' H ' ' C ' ' A' ' 169' ' ' ALA . 54.4 tp -100.08 136.54 39.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.426 -0.796 . . . . 1.29 109.763 179.437 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -86.18 96.89 10.07 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.926 -1.139 . . . . 2.81 107.926 178.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.9 -41.72 97.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 2.09 110.87 -178.577 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -68.02 -25.34 65.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.993 -1.067 . . . . 2.86 111.812 -177.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -93.7 -8.74 39.99 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.727 -1.233 . . . . 2.39 110.541 -178.506 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 87.5 t -107.58 118.58 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.182 -1.044 . . . . 1.27 108.182 178.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 95.3 mt -89.85 6.48 41.66 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.446 -0.784 . . . . 2.17 111.051 -177.342 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.82 166.16 32.87 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.419 -1.472 . . . . 0.52 109.419 179.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -132.2 128.44 37.96 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.344 -0.984 . . . . 0.55 108.344 179.573 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 86.2 mt -130.47 124.04 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.612 -1.255 . . . . 1.27 107.612 178.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.4 p -140.79 156.81 46.08 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.205 1.002 . . . . 1.39 111.386 -178.189 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.491 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 65.6 t0 -102.97 26.03 8.65 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.914 -0.585 . . . . 2.46 110.101 -179.567 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.67 -164.12 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.233 -1.542 . . . . 1.51 111.551 -178.045 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.82 -54.0 8.93 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.261 -1.136 . . . . 2.23 110.261 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.65 -154.44 13.71 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.764 -1.684 . . . . 2.23 111.68 -179.635 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -64.37 -11.28 31.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.89 -0.771 . . . . 6.44 110.745 -178.759 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 59.6 p -79.94 5.38 14.07 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.119 -0.988 . . . . 4.09 109.699 -179.005 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.0 t -88.67 142.48 27.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 2.2 109.894 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -53.36 -39.15 63.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.385 -0.822 . . . . 1.15 108.919 -179.831 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 89.5 m -59.77 -42.23 92.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.69 -0.631 . . . . 2.01 110.908 -179.33 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.3 p -60.98 -40.08 92.05 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.846 -1.159 . . . . 1.93 110.962 -178.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.8 mm -61.42 -41.19 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.204 -0.935 . . . . 2.2 110.096 -178.558 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.5 mtp -61.32 -42.94 99.5 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.989 -1.069 . . . . 1.32 110.333 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.96 -47.0 71.78 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.522 -1.361 . . . . 1.3 109.92 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -60.21 -50.26 74.37 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.903 -1.119 . . . . 3.38 110.003 -179.687 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.7 m -69.14 -36.07 77.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.773 -1.204 . . . . 1.15 111.069 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.7 mt -72.06 -26.39 62.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.822 -1.174 . . . . 1.28 109.45 -179.771 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 68.42 45.26 1.19 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.098 0.475 . . . . 1.5 110.778 -179.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.479 ' O ' ' CB ' ' A' ' 8' ' ' SER . 62.3 mt -126.69 148.67 65.8 Favored Pre-proline 0 N--CA 1.501 2.116 0 N-CA-C 107.852 -1.166 . . . . 1.37 107.852 178.239 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.86 137.82 78.75 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.192 1.928 . . . . 0.76 112.111 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.31 147.49 3.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.03 -1.044 . . . . 1.19 111.319 -179.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.4 mt -125.34 144.27 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.371 -1.344 . . . . 1.31 107.371 178.434 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 23.9 m -126.77 -11.78 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 O-C-N 121.106 -0.996 . . . . 1.38 111.144 -178.602 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -109.97 24.61 18.55 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.734 -1.346 . . . . 1.03 109.734 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 204' ' ' GLY . 3.0 p -43.3 -46.68 6.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.333 -1.099 . . . . 1.38 109.897 -179.008 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.491 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 95.51 -50.95 1.81 Allowed Glycine 0 N--CA 1.498 2.813 0 C-N-CA 120.218 -0.991 . . . . 1.17 111.496 178.998 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 46.8 t -157.07 30.87 0.3 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.245 -1.738 . . . . 2.07 110.745 -178.665 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 40.7 t -72.11 -40.04 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.096 -1.002 . . . . 1.35 109.263 178.512 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 6.4 p -54.17 -29.39 45.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -0.927 . . . . 1.49 110.191 -179.301 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 47.5 t -79.78 -20.96 44.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.156 -0.965 . . . . 2.16 110.349 -178.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -96.08 -10.61 27.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.044 -1.035 . . . . 2.89 110.393 -179.287 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 56.2 t -106.63 136.75 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.281 -0.887 . . . . 1.33 111.538 -177.809 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -112.52 154.54 25.76 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.293 -1.373 . . . . 2.73 107.293 178.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 33.6 p-10 -60.5 139.63 57.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.694 -1.253 . . . . 2.7 110.389 -179.166 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.4 t0 81.03 7.66 1.2 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.586 -0.524 . . . . 2.38 109.586 179.688 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 58.2 t0 -76.59 132.95 39.76 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.298 -0.876 . . . . 2.09 109.215 179.457 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.411 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 33.7 t80 -84.05 119.95 25.56 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.012 -1.107 . . . . 1.45 108.012 179.412 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 86.5 mt -130.42 149.82 51.92 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.334 -0.854 . . . . 1.31 110.927 -178.429 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 63.8 mt -115.22 126.62 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 106.907 -1.516 . . . . 1.29 106.907 177.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 45.1 tp -101.24 120.18 39.86 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.09 -1.006 . . . . 1.31 109.031 -178.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.472 ' C ' ' N ' ' A' ' 223' ' ' VAL . 91.8 m-20 -78.11 -46.99 19.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.088 -1.007 . . . . 2.31 110.263 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 50.05 16.45 0.24 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.115 -1.069 . . . . 1.19 108.115 -178.537 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.472 ' N ' ' C ' ' A' ' 221' ' ' ASP . 38.5 t -131.21 -47.04 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.321 -1.363 . . . . 1.45 107.321 179.235 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -99.62 3.62 45.33 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.357 -1.349 . . . . 3.13 107.357 177.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 48.6 t30 60.55 44.28 11.89 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 116.117 -0.492 . . . . 2.2 110.259 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -144.37 156.75 44.37 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.869 -1.144 . . . . 2.32 110.273 179.603 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 79.7 t -125.96 129.94 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.269 -0.641 . . . . 1.4 109.269 179.791 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -95.97 122.69 39.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.042 -1.036 . . . . 1.29 108.784 179.354 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 39.0 t -98.92 116.24 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.361 -0.837 . . . . 1.38 109.99 -179.157 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 63.53 68.42 0.9 Allowed Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.488 -0.757 . . . . 2.33 110.509 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -91.1 130.3 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.492 2.795 . . . . 0.95 112.471 179.7 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 23.7 m -67.9 166.1 16.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.16 -0.962 . . . . 2.31 109.894 -179.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 -60.13 -40.0 88.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.248 -0.907 . . . . 3.45 110.338 -179.392 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -60.27 -37.21 79.73 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.09 -1.006 . . . . 2.89 108.972 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 70.2 t -64.73 -40.14 88.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.351 -0.843 . . . . 1.73 109.76 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.36 -39.75 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.111 -0.993 . . . . 1.57 110.017 -179.784 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -60.01 -39.83 87.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.064 -1.023 . . . . 2.43 108.376 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -66.39 -41.64 89.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.411 -0.806 . . . . 3.18 109.212 179.11 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 80.3 mtp -69.94 -31.22 68.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.423 -0.798 . . . . 1.59 109.259 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.457 HH11 ' HG2' ' A' ' 240' ' ' ARG . 1.6 mmt-85 -64.83 -38.5 91.17 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.33 -0.856 . . . . 3.11 109.209 179.179 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.71 -41.23 90.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 2.17 109.208 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.99 -39.86 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.185 -0.947 . . . . 2.51 109.53 179.47 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -60.12 -40.13 88.66 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.295 -0.878 . . . . 3.82 110.583 -179.88 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -60.17 -43.52 95.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.154 -0.966 . . . . 1.78 109.604 -179.169 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -67.44 -40.24 85.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.427 -0.796 . . . . 2.77 109.413 179.509 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.5 t -66.99 -40.32 85.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.49 -0.757 . . . . 2.25 109.234 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.96 85.74 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.644 -0.66 . . . . 2.54 109.658 -179.719 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 96.6 p -59.92 -40.27 88.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 3.03 109.755 -179.588 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.414 ' O ' ' OE2' ' A' ' 249' ' ' GLU . 3.7 tm-20 -66.05 -39.1 89.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.023 -1.048 . . . . 3.34 109.453 179.686 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -101.69 41.38 1.21 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.394 -0.816 . . . . 4.18 109.688 -179.086 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -152.32 25.44 0.61 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.362 -0.837 . . . . 4.43 111.004 179.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -80.05 -70.62 0.5 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.704 -1.248 . . . . 5.42 108.814 179.456 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 72.8 mt -137.78 -46.05 0.54 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.237 -1.023 . . . . 6.11 108.237 178.493 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -162.45 -63.04 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.574 -0.704 . . . . 7.37 110.039 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 17.7 tptp 57.25 23.05 8.3 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.291 -1.003 . . . . 8.3 108.291 -179.483 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 257' ' ' LYS . 3.5 tt -57.29 -39.1 75.03 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.376 -0.601 . . . . 9.05 109.376 -179.445 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 256' ' ' LEU . 4.6 tppt? -36.22 132.02 0.58 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.496 -0.753 . . . . 10.56 111.749 -178.837 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 256' ' ' LEU . 4.5 p30 161.31 113.44 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.043 -1.095 . . . . 11.32 108.043 179.083 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.982 -1.009 . . . . 12.74 109.391 179.975 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 3.6 ttt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -150.54 150.32 31.09 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.367 -0.833 . . . . 0.0 109.057 179.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . 0.484 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 3.4 pm0 -150.18 157.83 43.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.135 -0.978 . . . . 0.0 110.926 -179.047 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -155.47 150.89 27.1 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.048 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -113.4 129.45 56.54 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.113 -0.992 . . . . 0.0 109.833 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.59 126.85 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 CA-C-O 122.512 1.149 . . . . 0.0 112.458 -177.737 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 31.4 m -77.99 102.37 7.35 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.925 -178.257 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 87.1 mt -51.48 123.92 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 122.277 1.037 . . . . 0.0 110.053 -178.072 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 25.6 p -109.25 20.05 18.74 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.693 -178.713 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.6 116.64 55.34 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 108.719 179.554 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.24 -16.1 44.38 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 CA-C-N 120.362 1.165 . . . . 0.0 112.546 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -112.27 12.15 20.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.523 -0.736 . . . . 0.0 109.652 -179.115 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.25 172.21 5.53 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 -178.913 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.425 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 2.6 tp -84.53 88.51 7.32 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.871 -1.37 . . . . 0.0 108.427 -179.133 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . 0.535 ' N ' ' OH ' ' A' ' 122' ' ' TYR . 5.0 p80 -90.94 -161.92 0.86 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 120.74 -1.225 . . . . 0.0 109.412 178.965 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.2 m -56.82 -41.18 77.38 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.147 -0.971 . . . . 0.0 112.605 -176.223 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.534 ' NH2' ' OE1' ' B' ' 321' ' ' GLN . 2.4 tpt180 -62.5 -62.67 5.31 Favored Pre-proline 0 N--CA 1.501 2.124 0 O-C-N 120.478 -1.389 . . . . 0.0 112.159 -178.494 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.77 -31.5 92.42 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 CA-C-N 120.004 1.037 . . . . 0.0 111.975 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.88 -50.53 73.42 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.006 -1.059 . . . . 0.0 108.233 179.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.73 -40.04 59.51 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.904 -179.12 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . 0.534 ' OE1' ' NH2' ' B' ' 317' ' ' ARG . 42.3 mt-30 -69.88 -41.83 74.25 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.981 -1.075 . . . . 0.0 109.57 179.074 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -61.02 -52.69 63.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.33 -0.856 . . . . 0.0 110.101 -179.25 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.19 -30.79 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.798 -1.188 . . . . 0.0 110.014 -178.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -59.36 -47.59 84.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.061 -1.024 . . . . 0.0 109.569 -179.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.53 -50.74 64.09 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.001 -1.062 . . . . 0.0 109.868 -179.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . 0.417 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -60.32 -51.09 71.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.677 -1.264 . . . . 0.0 110.074 -179.622 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -48.31 -19.27 0.28 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.498 -0.751 . . . . 0.0 109.126 -179.091 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . 0.417 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -80.49 -16.11 76.62 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -105.54 141.07 37.65 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.178 -1.189 . . . . 0.0 109.694 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 46.0 m -90.43 -12.39 37.57 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.307 -0.87 . . . . 0.0 109.165 179.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 95.2 p -61.32 150.02 36.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.147 -0.97 . . . . 0.0 108.862 179.412 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -71.28 135.65 47.54 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.9 132.29 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.575 -0.703 . . . . 0.0 109.861 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 96.7 m -130.86 147.9 52.57 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 63.0 t -121.99 119.07 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.299 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 21.6 m -103.4 121.34 42.59 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.028 -1.045 . . . . 0.0 109.145 -178.969 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 18.4 t -134.81 119.67 18.43 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.895 0.855 . . . . 0.0 110.569 -179.669 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 30.3 m120 43.89 57.61 4.03 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 177.468 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 75.26 -12.81 6.64 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.578 -1.326 . . . . 0.0 112.155 177.208 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -111.96 121.13 44.16 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.955 -1.32 . . . . 0.0 109.959 -178.764 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 69.0 m -108.49 157.49 18.4 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.749 0.785 . . . . 0.0 110.945 -178.998 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -153.05 153.72 33.44 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.465 0.65 . . . . 0.0 109.984 179.214 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 17.7 m -91.82 136.57 33.05 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.422 -0.799 . . . . 0.0 110.598 -179.142 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.487 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -70.71 -20.95 62.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.903 . . . . 0.0 109.757 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -84.07 18.69 2.01 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.24 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.635 ' CB ' ' HZ3' ' B' ' 349' ' ' LYS . 13.2 m -148.49 93.14 2.1 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.72 0.771 . . . . 0.0 111.273 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 55.6 tp -56.29 -35.46 67.52 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.211 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . 0.651 ' CB ' HE21 ' A' ' 111' ' ' GLN . 50.0 m-85 -56.16 -50.02 72.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.54 -0.725 . . . . 0.0 110.575 -179.06 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.635 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 34.5 mtmm -69.85 -39.86 76.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.705 -1.247 . . . . 0.0 110.243 -178.601 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' B' ' 352' ' ' THR . 38.0 mt -50.04 -56.01 12.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.732 -1.23 . . . . 0.0 108.165 179.481 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.668 HE21 ' N ' ' B' ' 351' ' ' GLN . 0.0 OUTLIER -41.36 -17.05 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.535 -0.728 . . . . 0.0 110.747 -179.151 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.551 ' N ' ' O ' ' B' ' 350' ' ' LEU . 52.7 p -85.87 -13.69 47.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.037 -1.665 . . . . 0.0 110.281 -178.897 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 29.4 mt -95.04 122.5 37.76 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.106 -0.996 . . . . 0.0 109.057 178.666 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.21 96.3 1.1 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 178.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 46.2 mt -102.33 90.38 3.88 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.293 -1.122 . . . . 0.0 109.925 -179.37 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 21.1 p -97.6 -177.43 3.79 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.267 -0.896 . . . . 0.0 111.253 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -69.74 111.76 5.74 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.9 -179.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.2 10.84 35.51 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 179.267 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 28.5 m -87.12 108.58 18.96 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.059 -1.26 . . . . 0.0 110.791 -179.579 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 32.4 t -77.89 113.79 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 122.058 0.933 . . . . 0.0 109.521 -178.204 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 34.7 m -109.68 178.28 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.409 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 19.1 m -130.43 123.18 29.21 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.522 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.5 mt -97.69 111.57 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.834 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 52.2 p -116.3 130.48 56.8 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.212 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.45 150.51 37.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.92 . . . . 0.0 109.48 -178.82 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -142.07 123.61 14.97 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.413 -0.804 . . . . 0.0 108.891 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.569 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.31 -162.64 33.43 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.395 -1.383 . . . . 0.0 111.057 -179.845 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.91 -50.33 74.2 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.207 -0.584 . . . . 0.0 112.518 -177.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -106.38 10.61 31.5 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 120.668 -1.27 . . . . 0.0 110.92 -177.575 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.569 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.3 pt-20 -44.19 -34.87 2.0 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.29 -0.882 . . . . 0.0 111.45 -179.236 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -70.55 -41.19 72.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.876 -1.14 . . . . 0.0 110.017 -179.414 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -67.06 -47.14 72.19 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.341 -179.307 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.24 -74.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.341 -0.849 . . . . 0.0 110.848 -179.06 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . 0.448 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 64.3 t -45.87 -34.74 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.93 -1.106 . . . . 0.0 110.871 -177.434 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.17 -47.78 72.86 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.361 -1.462 . . . . 0.0 110.592 179.613 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -78.82 -44.11 23.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.969 -1.082 . . . . 0.0 110.628 -179.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.99 -36.26 76.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 0.0 109.383 -179.637 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . 0.448 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 39.8 t -63.05 -43.91 99.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.109 -0.994 . . . . 0.0 109.287 179.736 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -69.96 -56.84 5.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.605 -1.309 . . . . 0.0 108.248 178.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 36.1 tp -55.72 -32.21 63.15 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.435 -0.791 . . . . 0.0 109.682 -178.123 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 26.2 ttm -71.97 -40.49 68.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.57 -1.331 . . . . 0.0 109.319 178.236 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.14 -3.93 57.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.458 -0.776 . . . . 0.0 110.17 179.662 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -111.75 -4.39 14.68 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.196 -0.94 . . . . 0.0 110.917 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.7 mt -80.45 133.67 35.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.36 -1.463 . . . . 0.0 109.365 179.062 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.324 -179.964 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.5 mtt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.365 -0.606 . . . . 3.19 109.365 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.4 mt -109.89 129.92 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.447 -0.783 . . . . 1.71 109.366 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 m -138.83 118.78 13.32 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -0.888 . . . . 1.66 108.771 179.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.666 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -91.83 -161.0 36.61 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.572 -1.411 . . . . 1.05 109.572 -179.848 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.407 ' O ' ' O ' ' A' ' 6' ' ' LEU . 87.0 mt -94.95 -10.42 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.259 -1.142 . . . . 1.59 110.653 -178.953 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.1 tp 55.01 100.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.977 -1.077 . . . . 1.47 109.183 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.96 -34.23 24.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 1.39 108.936 179.56 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.0 t -139.14 133.4 16.21 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.497 -0.752 . . . . 2.09 109.231 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.27 143.74 15.91 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.193 1.929 . . . . 0.91 112.672 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 163.49 -162.03 34.59 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.792 -1.323 . . . . 0.92 109.792 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.6 mt -148.02 146.88 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.169 -1.195 . . . . 1.35 108.334 179.023 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.19 159.62 37.9 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.829 -1.169 . . . . 1.14 110.656 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.8 m-85 -137.93 127.45 24.97 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.547 -1.279 . . . . 0.7 107.547 178.859 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.59 177.22 48.31 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 118.452 -1.832 . . . . 0.58 110.965 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.46 ' O ' ' N ' ' A' ' 157' ' ' ILE . 68.4 mttm -78.74 159.5 27.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.782 -0.834 . . . . 2.63 110.107 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.94 123.46 45.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.719 . . . . 1.27 110.994 -179.028 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.2 tp -99.3 134.06 42.7 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 106.498 -1.667 . . . . 1.41 106.498 177.566 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.6 tp -117.63 122.81 44.59 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.146 -0.971 . . . . 1.49 109.908 -179.354 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.4 mt -87.32 104.54 16.51 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.476 0.655 . . . . 1.52 109.986 -179.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -92.47 136.0 33.58 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.681 -0.859 . . . . 3.17 108.681 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -130.57 139.05 50.43 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.323 -0.86 . . . . 3.0 109.623 179.76 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -93.47 140.79 29.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.243 -0.91 . . . . 2.77 109.122 179.656 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -59.94 139.97 57.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.166 -0.959 . . . . 2.94 109.634 -179.849 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -79.69 131.81 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.906 . . . . 1.46 108.757 179.889 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.5 t -93.91 124.88 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.132 -0.98 . . . . 1.7 110.053 -179.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.3 mt -101.0 139.97 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.403 -0.811 . . . . 1.54 109.036 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -98.5 115.76 29.27 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.08 -1.012 . . . . 1.81 109.88 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -90.98 0.07 57.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.213 -0.93 . . . . 3.23 108.969 179.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -62.67 143.46 57.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.441 -0.787 . . . . 3.29 109.695 -179.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -83.7 139.39 32.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.413 -0.805 . . . . 2.8 109.873 -179.671 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 pt -89.83 165.28 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 1.43 109.807 -179.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.8 p -89.71 170.59 10.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.235 -0.915 . . . . 1.54 108.812 178.783 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.36 -22.02 64.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.988 -1.07 . . . . 1.6 109.939 -179.852 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -82.13 -24.65 34.99 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.529 -1.286 . . . . 2.56 107.529 178.71 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -82.04 -9.8 59.43 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.547 -0.908 . . . . 2.36 108.547 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.3 t -62.94 -52.49 58.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.099 -1.001 . . . . 1.43 108.903 179.759 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -63.2 -39.89 95.93 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.259 -0.901 . . . . 1.77 109.466 179.661 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -67.32 -41.11 85.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.03 -1.044 . . . . 3.32 110.292 -178.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.534 ' OE2' ' NH1' ' A' ' 42' ' ' ARG . 61.9 mm-40 -66.51 -39.99 88.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.15 -0.968 . . . . 1.51 110.129 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.45 -44.51 96.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.766 -1.208 . . . . 1.41 108.186 178.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -59.94 -36.08 76.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.319 -0.863 . . . . 1.81 109.472 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.534 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 99.1 mtt180 -59.75 -40.32 87.72 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 118.71 -1.196 . . . . 3.26 108.114 179.522 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -63.83 -48.28 77.43 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.33 -0.856 . . . . 0.81 108.706 177.82 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.6 tp -60.09 -48.86 79.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.46 -0.775 . . . . 1.59 109.216 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.9 t -64.86 -45.11 87.42 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.218 -0.993 . . . . 1.38 108.993 179.557 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.47 -45.06 96.95 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.26 -1.936 . . . . 0.87 108.26 179.098 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -65.6 -31.63 72.77 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.389 -0.967 . . . . 3.62 108.389 178.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.0 87.45 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.451 -0.781 . . . . 1.43 109.019 179.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 51' ' ' SER . 11.9 ttmm -65.51 -73.8 0.12 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.752 -1.203 . . . . 3.08 107.752 179.025 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.72 -32.08 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.552 -0.718 . . . . 1.33 111.222 -178.42 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 49' ' ' LYS . 29.7 t -59.74 -54.65 43.9 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.771 -1.205 . . . . 1.85 108.109 179.141 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.53 -41.02 85.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.383 -0.823 . . . . 1.35 111.292 -179.126 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -67.55 -40.54 84.98 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.726 -1.234 . . . . 2.34 110.037 -179.135 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.3 mt -64.85 -40.14 94.69 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.894 -1.129 . . . . 2.2 108.41 179.661 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -61.36 -39.95 92.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.26 -0.9 . . . . 1.35 109.35 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.9 m -67.13 -44.06 80.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.113 -0.992 . . . . 1.34 109.645 -179.854 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.55 -39.99 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.158 -0.964 . . . . 1.26 108.86 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -53.88 -50.64 65.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.501 -0.75 . . . . 1.7 110.034 -179.368 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -60.0 -38.8 83.68 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.449 -0.782 . . . . 1.35 111.134 -177.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -63.55 -39.67 95.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.833 -1.167 . . . . 2.08 109.613 -179.621 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.21 -43.89 93.64 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.365 0.602 . . . . 1.21 109.769 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.43 -52.48 52.94 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 120.009 -1.091 . . . . 0.75 110.536 -179.066 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.87 -44.81 69.07 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.073 -1.251 . . . . 1.59 110.465 -179.169 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.4 m -66.23 -62.28 1.56 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.999 -1.063 . . . . 1.41 112.24 -178.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -95.61 -49.56 5.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.889 -1.132 . . . . 0.79 111.171 -178.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.22 -167.72 25.99 Favored Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.843 -1.17 . . . . 1.22 110.905 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.94 -23.74 63.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.802 -0.823 . . . . 5.81 110.461 -179.344 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.423 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.7 tp10 -60.07 -36.02 76.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.254 -0.904 . . . . 3.37 110.211 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -98.23 -19.39 17.88 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.177 -0.952 . . . . 2.37 110.225 -179.283 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -70.12 -45.46 66.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.96 -1.087 . . . . 1.65 110.55 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.95 -30.58 71.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.433 -0.792 . . . . 1.42 110.235 -178.626 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.5 mt -59.72 -40.29 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.963 -1.086 . . . . 1.43 108.871 -179.588 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -65.05 -39.96 94.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.031 -1.043 . . . . 1.08 109.987 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -60.21 -40.06 88.79 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.965 -1.085 . . . . 1.37 109.444 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.5 -41.84 99.64 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.16 -1.576 . . . . 0.67 109.16 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -67.66 -39.98 84.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.283 -1.128 . . . . 1.99 109.728 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.417 HG21 HD13 ' A' ' 77' ' ' ILE . 95.4 mt -69.1 -46.4 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.005 -1.06 . . . . 1.22 109.104 179.555 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.3 ttp -59.9 -45.93 90.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.041 -1.037 . . . . 2.11 110.425 -179.239 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.2 tp -60.93 -40.07 91.84 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.245 -0.91 . . . . 1.33 109.809 179.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.7 tp -63.14 -40.01 96.35 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.376 -0.828 . . . . 1.29 109.642 -179.047 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -82.46 9.18 9.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.37 -0.831 . . . . 1.47 109.901 -179.34 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -55.68 132.3 48.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.991 -1.068 . . . . 1.47 110.139 -179.246 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -59.94 -21.21 60.85 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.511 -0.743 . . . . 1.78 111.129 -178.562 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -72.03 -34.51 68.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.787 -1.196 . . . . 2.53 109.686 178.93 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.9 -40.77 75.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.539 -0.726 . . . . 1.36 109.76 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -60.11 -50.1 75.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.857 . . . . 1.42 110.413 -179.137 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -70.61 -40.1 73.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.187 -0.945 . . . . 2.27 111.439 -179.171 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -69.91 -40.12 75.79 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.94 -1.1 . . . . 1.57 111.489 -178.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.57 -41.97 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.076 -1.015 . . . . 1.19 109.422 -179.505 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.02 -37.84 73.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.432 -0.792 . . . . 1.39 110.602 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.461 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -60.0 -46.28 89.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 1.39 110.803 -178.592 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 96' ' ' LYS . 29.3 mt -63.27 -45.83 89.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.755 -1.216 . . . . 1.5 109.411 -179.741 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.08 -50.0 81.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.954 0.883 . . . . 1.29 108.796 179.523 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -70.2 -41.0 74.26 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.851 -0.74 . . . . 2.64 110.258 179.616 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 91' ' ' ALA . 58.7 t0 -80.38 -53.05 6.97 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.062 -1.024 . . . . 1.65 112.252 -177.877 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 92' ' ' LEU . 25.9 mtpp -89.96 -3.92 57.76 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.023 -1.048 . . . . 2.5 111.854 -177.395 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 25.9 m170 58.62 38.82 25.12 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.988 -1.07 . . . . 1.88 109.306 -179.362 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.0 mtp -97.87 165.81 11.76 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.592 -0.692 . . . . 1.71 109.959 -179.526 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.417 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 46.4 p -76.65 162.22 27.91 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.402 -0.811 . . . . 1.61 109.586 -179.906 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.82 -37.18 79.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.335 -0.853 . . . . 1.33 110.482 -179.479 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 35.2 p-10 -69.96 -36.94 75.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.86 -1.15 . . . . 2.07 109.633 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.498 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -77.04 -44.97 28.81 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.4 -0.813 . . . . 1.37 109.843 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.02 -41.65 74.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 1.14 109.523 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.16 -37.94 81.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.065 -1.022 . . . . 1.26 109.71 179.651 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -60.11 -41.01 91.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.436 -0.79 . . . . 2.02 109.938 -178.679 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 110' ' ' GLY . 88.7 tt0 -63.04 -40.12 96.78 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.271 -0.893 . . . . 1.33 110.383 -179.447 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.74 -55.77 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.108 -0.995 . . . . 1.3 111.542 -177.797 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.3 mm -70.08 -40.04 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.645 -1.284 . . . . 1.32 109.22 -178.903 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -69.95 -38.11 76.03 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.344 -0.984 . . . . 2.44 108.344 178.869 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -60.08 -46.77 93.61 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.82 -1.312 . . . . 0.99 109.82 -179.712 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -64.88 -49.04 72.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.894 -1.356 . . . . 1.97 108.866 179.577 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.87 -39.68 86.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.465 -0.772 . . . . 1.43 109.269 179.615 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.5 t -54.85 -40.0 69.18 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.326 -0.859 . . . . 2.12 109.035 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.81 -36.74 78.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 1.64 109.917 179.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.35 -46.17 81.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.09 -1.006 . . . . 1.93 110.558 -178.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -62.89 -22.06 66.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.495 -1.378 . . . . 2.2 110.268 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -67.43 -21.08 65.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.803 -1.185 . . . . 2.12 108.566 178.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 19.4 mt -63.88 142.51 58.38 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.158 -1.053 . . . . 2.34 108.158 179.245 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.473 ' N ' ' OD1' ' A' ' 119' ' ' ASP . 29.4 p-10 -90.78 53.24 2.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.873 -1.142 . . . . 3.23 110.516 -179.65 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 64.9 t0 -136.33 135.07 38.58 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.176 -0.953 . . . . 2.49 109.795 179.331 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.477 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 99.2 mt-10 -70.17 -32.54 70.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.297 -0.877 . . . . 3.95 110.447 -179.881 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.51 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.9 t80 -70.08 -37.22 75.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.257 -0.902 . . . . 2.25 110.46 179.538 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.476 ' CD2' HH21 ' A' ' 126' ' ' ARG . 77.1 mt -74.0 -39.95 63.26 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.236 -0.915 . . . . 2.27 109.256 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.8 -44.32 96.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.941 . . . . 3.31 109.964 179.538 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -60.1 -41.3 92.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.111 -0.993 . . . . 2.73 109.29 -179.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.476 HH21 ' CD2' ' A' ' 123' ' ' LEU . 9.9 ttp180 -66.73 -38.74 87.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.153 -1.054 . . . . 3.2 108.153 179.057 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.21 -26.22 64.66 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.077 -1.083 . . . . 1.66 108.077 178.62 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.79 -40.25 76.12 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.111 -1.07 . . . . 1.67 108.111 178.709 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -64.79 -40.15 94.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.405 -0.809 . . . . 1.55 109.206 179.693 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.53 -39.98 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.278 -1.008 . . . . 1.32 108.278 179.471 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -60.28 -39.88 88.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.479 -0.763 . . . . 3.58 109.125 179.267 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -58.14 -40.24 80.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 1.46 109.888 -179.269 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.01 -46.69 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.998 -1.064 . . . . 1.22 109.42 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.79 -31.54 70.25 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.791 -1.324 . . . . 0.61 109.791 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.69 -49.67 76.84 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.244 -1.151 . . . . 3.1 109.208 -179.477 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.48 HH11 ' HG2' ' A' ' 136' ' ' ARG . 17.6 mtt-85 -67.07 -36.01 81.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.08 -1.012 . . . . 3.71 109.67 179.672 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.8 tp -54.54 -49.01 71.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.476 -0.765 . . . . 1.87 109.801 -178.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.09 -40.07 88.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.369 -0.832 . . . . 1.29 109.565 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -72.78 -36.1 67.55 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.264 -0.897 . . . . 3.05 108.661 178.542 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.401 ' CG ' ' O ' ' A' ' 136' ' ' ARG . 6.2 m120 -60.15 -39.75 87.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.836 -0.54 . . . . 1.26 110.97 -179.227 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.8 mt -71.09 -45.13 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.758 -1.214 . . . . 1.34 108.65 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.6 mt -69.97 -40.07 75.61 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.523 -0.871 . . . . 1.6 108.949 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.68 51.57 3.04 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.072 -1.611 . . . . 0.96 109.072 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.6 tp -73.72 148.57 42.53 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.314 -1.109 . . . . 1.67 109.009 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -66.57 141.22 57.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 4.96 109.641 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.408 HG21 HD11 ' A' ' 146' ' ' ILE . 85.2 mt -113.53 130.0 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-O 121.762 0.791 . . . . 1.68 110.069 -179.578 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.3 mp -68.01 -40.09 82.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.746 -0.596 . . . . 2.14 110.309 -178.599 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.3 t0 63.29 123.25 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.396 -0.815 . . . . 1.5 108.947 -178.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.9 mt -90.13 -0.74 57.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 1.39 110.088 -179.06 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.5 t -86.08 -17.49 34.95 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.042 -1.036 . . . . 1.83 110.17 -179.553 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.98 24.8 0.73 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.139 -0.975 . . . . 1.46 110.734 -178.838 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 41.8 mm -90.82 120.69 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.77 -1.206 . . . . 1.42 109.276 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -101.23 -17.51 16.56 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.436 -0.79 . . . . 2.94 110.259 -179.379 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -115.34 145.97 41.99 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.637 -0.665 . . . . 1.52 110.874 -178.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -63.8 135.23 56.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.523 -0.736 . . . . 1.58 109.4 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.0 m -151.55 164.57 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.649 -0.657 . . . . 1.32 109.452 179.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.46 ' N ' ' O ' ' A' ' 15' ' ' LYS . 86.0 mt -94.96 147.2 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 105.999 -1.852 . . . . 1.27 105.999 177.474 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 51.9 tp -96.99 117.96 32.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.035 -1.04 . . . . 1.41 110.767 -177.374 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.3 t -121.75 127.47 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.451 -0.944 . . . . 1.23 108.451 178.846 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -156.91 161.53 39.65 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 1.32 108.717 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.93 -31.71 63.19 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.26 -1.525 . . . . 1.49 109.172 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 64.9 t0 -169.23 141.92 2.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.434 -0.791 . . . . 2.25 109.128 -179.706 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 24.6 mt -112.08 142.71 44.17 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.362 -0.837 . . . . 1.35 110.226 -179.24 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.0 p -99.56 146.8 32.42 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.466 -0.771 . . . . 1.56 109.247 179.449 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -43.56 -36.7 7.33 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.952 1.768 . . . . 0.87 112.691 179.215 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.6 m -60.0 -39.94 87.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.267 -0.896 . . . . 1.36 109.767 -178.72 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.46 -41.31 93.52 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.187 -0.945 . . . . 1.61 109.992 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 41.1 p -56.44 -33.94 66.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 1.21 110.959 -178.4 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.4 -53.9 20.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.91 -1.119 . . . . 1.21 109.58 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -86.47 36.34 0.69 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.604 -0.888 . . . . 2.11 108.604 179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.2 tp -100.46 130.6 46.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.817 . . . . 1.29 109.166 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.523 ' C ' HD21 ' A' ' 172' ' ' ASN . 0.2 OUTLIER -82.79 98.96 9.39 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.276 -1.009 . . . . 2.81 108.276 179.412 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 71.0 mt -65.13 -41.14 95.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.403 -0.811 . . . . 2.09 111.085 -178.569 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -66.61 -25.59 66.68 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.844 -1.16 . . . . 2.86 111.571 -177.752 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.41 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 42.8 mmtm -93.32 -8.2 42.68 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.768 -1.207 . . . . 2.39 110.479 -179.037 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 63.3 t -109.31 119.65 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.385 -0.968 . . . . 1.27 108.385 178.578 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.8 mt -91.42 7.1 42.78 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.262 -0.899 . . . . 2.17 110.947 -177.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.44 171.07 36.97 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.355 -1.402 . . . . 0.52 109.626 179.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -133.94 129.76 36.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.463 -1.022 . . . . 0.55 109.066 179.991 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.3 mt -132.1 127.28 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.235 -1.024 . . . . 1.27 108.235 178.428 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 43.1 p -147.44 159.93 43.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.879 -1.138 . . . . 1.39 110.406 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -104.27 21.74 16.04 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.914 -0.773 . . . . 2.46 108.914 179.813 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.14 -159.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.995 -1.066 . . . . 1.51 111.202 -178.094 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.46 -53.15 8.99 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.357 -1.097 . . . . 2.23 110.357 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 157.07 -124.27 1.41 Allowed Glycine 0 N--CA 1.494 2.558 0 O-C-N 120.897 -1.355 . . . . 2.23 110.64 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -69.69 -23.9 63.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.39 -1.065 . . . . 6.44 111.014 -178.815 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 59.8 p -70.53 0.12 7.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.928 -1.107 . . . . 4.09 109.756 -179.29 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 39.2 m -89.46 124.7 34.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.08 -1.013 . . . . 2.2 110.119 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -46.48 -50.87 16.36 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.436 -0.79 . . . . 1.15 109.924 -179.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.82 -35.59 61.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.402 -0.811 . . . . 2.01 110.549 -178.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.5 t -60.07 -45.6 92.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.929 -1.107 . . . . 1.93 110.73 -179.185 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.08 -40.64 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 2.2 109.735 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.0 mtp -61.44 -40.03 92.99 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.084 -1.01 . . . . 1.32 109.964 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.61 -42.71 67.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.737 -1.227 . . . . 1.3 108.915 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -59.57 -50.06 75.36 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.461 -0.895 . . . . 3.38 109.517 -179.02 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 67.1 m -72.4 -33.13 66.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.204 -0.935 . . . . 1.15 111.114 -179.221 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.05 -22.81 63.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.952 -1.093 . . . . 1.28 109.515 -179.5 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 63.71 48.78 3.17 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.437 0.636 . . . . 1.5 110.055 -178.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 60.1 mt -130.25 150.1 75.19 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 107.797 -1.186 . . . . 1.37 107.797 178.693 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.56 144.98 62.71 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.949 1.766 . . . . 0.76 111.567 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -173.36 153.56 2.43 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.064 -1.055 . . . . 1.19 111.102 179.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 92.7 mt -124.72 151.62 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 107.669 -1.234 . . . . 1.31 107.669 178.832 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.0 m -133.67 -11.44 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 120.844 -1.16 . . . . 1.38 111.249 -178.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -111.17 25.73 13.49 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.655 -0.978 . . . . 1.03 110.655 -179.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.448 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.3 p -47.46 -38.21 13.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.759 -1.436 . . . . 1.38 109.595 -179.206 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.18 -51.06 3.4 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 120.085 -1.055 . . . . 1.17 111.257 178.782 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.428 ' O ' ' OG ' ' A' ' 207' ' ' SER . 12.9 t -156.51 33.24 0.32 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.558 -1.554 . . . . 2.07 111.4 -178.83 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 22.8 t -74.52 -36.02 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.66 -1.275 . . . . 1.35 108.348 178.159 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.42 ' HG1' ' N ' ' A' ' 210' ' ' SER . 44.4 p -59.97 -38.37 82.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.449 -0.782 . . . . 1.49 110.159 -179.553 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.42 ' N ' ' HG1' ' A' ' 209' ' ' THR . 50.4 m -82.01 -11.06 59.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.995 -1.065 . . . . 2.16 110.308 -179.162 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -99.05 -13.23 19.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.043 -1.036 . . . . 2.89 110.601 -179.231 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 80.8 t -114.62 154.0 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.247 -0.908 . . . . 1.33 110.955 -178.74 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -113.17 154.56 26.47 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.261 -1.385 . . . . 2.73 107.261 178.658 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 24.8 p-10 -59.82 141.52 55.17 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.974 -1.078 . . . . 2.7 110.134 -179.461 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 m-20 85.67 6.36 0.43 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.213 0.53 . . . . 2.38 110.032 179.692 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 53.2 t0 -76.62 150.16 36.46 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.262 -0.898 . . . . 2.09 108.71 179.037 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.526 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 50.8 t80 -95.25 122.85 38.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.066 -1.021 . . . . 1.45 108.844 179.725 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.0 mt -126.88 138.5 53.32 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.299 -0.875 . . . . 1.31 110.702 -179.288 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 83.6 mt -110.19 128.25 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 106.453 -1.684 . . . . 1.29 106.453 176.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 42.9 tp -103.36 119.92 39.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.065 -1.022 . . . . 1.31 109.901 -178.302 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 10' ' ' GLY . 30.9 t0 -83.44 -41.75 17.73 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.631 -0.877 . . . . 2.31 108.631 179.259 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 47.84 25.35 0.72 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.927 -0.768 . . . . 1.19 108.927 -179.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 37.4 t -130.74 -42.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.329 -1.36 . . . . 1.45 107.329 178.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.528 ' ND2' ' OE1' ' A' ' 226' ' ' GLN . 50.7 p30 -111.34 1.66 17.2 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.04 -1.467 . . . . 3.13 107.04 178.228 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.666 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.5 OUTLIER 62.15 50.12 4.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.93 -0.577 . . . . 2.2 110.258 -179.794 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.528 ' OE1' ' ND2' ' A' ' 224' ' ' ASN . 52.5 mt-30 -132.12 145.0 51.1 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.308 -0.87 . . . . 2.32 109.426 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 66.5 t -118.36 129.08 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.345 -0.983 . . . . 1.4 108.345 179.013 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -104.29 124.56 49.39 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.385 -0.969 . . . . 1.29 108.385 179.446 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.7 t -101.25 110.69 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.471 -0.768 . . . . 1.38 110.005 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 230' ' ' ASN . 30.9 t-20 48.64 67.01 4.92 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.31 -0.868 . . . . 2.33 110.571 179.541 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -86.72 157.22 8.96 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.843 2.362 . . . . 0.95 111.96 179.304 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.4 m -69.86 161.63 29.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 2.31 110.216 -179.071 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -60.04 -39.2 85.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.381 -0.824 . . . . 3.45 109.733 -179.689 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -60.04 -37.02 78.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.208 -0.932 . . . . 2.89 109.56 -179.146 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.27 -40.75 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.017 -1.052 . . . . 1.73 109.123 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.3 mt -66.13 -40.0 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.44 -0.788 . . . . 1.57 109.764 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -59.87 -39.96 87.0 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.993 -1.067 . . . . 2.43 108.436 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -66.58 -40.42 88.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 3.18 108.818 178.795 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 94.0 mtp -69.69 -33.48 72.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.513 -0.742 . . . . 1.59 109.405 179.605 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -68.44 -40.01 81.3 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.246 -0.909 . . . . 3.11 109.323 179.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.08 89.96 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.605 -0.887 . . . . 2.17 108.605 179.223 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 70.0 t -66.99 -40.77 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.358 -0.839 . . . . 2.51 109.252 179.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -60.06 -40.5 89.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 3.82 109.272 179.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.01 -42.02 97.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 1.78 109.742 179.593 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -60.98 -40.01 91.82 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.255 -0.903 . . . . 2.77 108.92 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 77.8 t -59.87 -40.77 83.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.399 -0.813 . . . . 2.25 109.414 -179.557 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.95 -41.69 99.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.196 -0.94 . . . . 2.54 109.21 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.0 t -60.43 -40.18 90.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.267 -0.896 . . . . 3.03 109.158 179.663 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.99 -35.53 75.21 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.589 -0.694 . . . . 3.34 109.427 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.93 -40.07 87.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 4.18 109.558 -179.546 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -59.9 -44.72 94.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 4.43 109.309 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -60.22 -39.88 88.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.504 -0.748 . . . . 5.42 109.612 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 255' ' ' LYS . 83.1 mt -60.12 -46.97 87.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.43 -0.794 . . . . 6.11 109.113 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 255' ' ' LYS . . . 45.21 22.03 0.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.356 -0.84 . . . . 7.37 110.204 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.554 ' C ' ' H ' ' A' ' 257' ' ' LYS . 59.8 mttm 48.05 -176.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.137 -0.977 . . . . 8.3 109.733 179.625 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.4 ' CB ' ' O ' ' A' ' 255' ' ' LYS . 0.2 OUTLIER 70.62 -31.77 0.23 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.12 -0.987 . . . . 9.05 109.333 -179.865 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.554 ' H ' ' C ' ' A' ' 255' ' ' LYS . 16.0 mtpp 50.58 58.6 5.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.768 -1.208 . . . . 10.56 109.2 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 259' ' ' ARG . 29.8 p-10 -54.47 -47.5 72.89 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.101 -0.999 . . . . 11.32 109.245 -179.444 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . 0.491 ' N ' ' OD1' ' A' ' 258' ' ' ASP . 18.4 ptt-85 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.007 -0.997 . . . . 12.74 109.503 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 35.1 ttp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.391 0.615 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -153.13 149.01 27.62 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -149.33 160.03 43.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.845 -1.159 . . . . 0.0 110.506 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -152.41 149.69 28.86 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 57.4 mp0 -107.84 130.69 54.97 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.239 -0.913 . . . . 0.0 109.555 179.381 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.83 119.09 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 122.316 1.055 . . . . 0.0 112.503 -177.726 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 94.9 m -76.86 104.07 7.15 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.159 0.98 . . . . 0.0 110.115 -178.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . 0.42 ' O ' ' N ' ' B' ' 358' ' ' GLY . 66.0 mt -52.56 116.35 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 122.35 1.072 . . . . 0.0 110.61 -178.017 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 30.5 p -102.08 22.3 13.37 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.632 -178.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -81.41 123.21 81.34 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.093 179.463 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -70.09 -9.02 25.03 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 CA-C-N 120.203 1.108 . . . . 0.0 112.058 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -119.76 4.22 11.05 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 75.7 178.52 43.64 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.51 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -88.49 97.21 10.95 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.129 -1.218 . . . . 0.0 108.389 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -95.0 -160.62 0.8 Allowed 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.097 -1.002 . . . . 0.0 110.034 179.677 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 19.5 m -59.9 -42.05 92.99 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.017 -1.052 . . . . 0.0 112.681 -175.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.478 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.3 tpt180 -61.82 -64.2 3.36 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 120.229 -1.544 . . . . 0.0 111.396 -178.313 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -55.38 -32.46 81.75 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 CA-C-N 120.096 1.07 . . . . 0.0 111.929 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.88 -51.6 69.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 108.845 179.525 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.51 -40.07 65.11 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 0.0 109.652 -179.274 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . 0.526 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 73.1 tp60 -68.21 -45.19 74.01 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.958 -1.089 . . . . 0.0 108.961 179.258 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -60.0 -50.83 72.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.485 -0.759 . . . . 0.0 110.52 -179.245 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.55 -30.69 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.623 -1.298 . . . . 0.0 109.698 -179.166 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . 0.526 ' NZ ' ' OE1' ' B' ' 321' ' ' GLN . 0.4 OUTLIER -59.96 -45.38 92.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.868 . . . . 0.0 109.093 179.701 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -68.28 -40.06 81.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.392 -0.818 . . . . 0.0 110.951 -178.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' B' ' 328' ' ' GLY . . . -74.08 -53.97 8.82 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.752 -1.218 . . . . 0.0 111.252 -178.74 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -49.51 -14.6 0.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 110.336 -178.581 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' B' ' 326' ' ' ALA . . . -79.98 -16.27 77.24 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.0 -179.897 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -105.73 143.31 34.06 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.378 -1.072 . . . . 0.0 109.308 179.577 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 31.8 m -90.19 -12.46 38.05 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.984 -1.072 . . . . 0.0 110.301 -179.564 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 13.5 p -60.49 145.01 49.99 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.93 -1.106 . . . . 0.0 109.232 179.617 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -67.66 137.06 55.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.087 -1.008 . . . . 0.0 108.75 179.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.3 mt -134.04 134.02 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.535 -0.728 . . . . 0.0 110.137 -179.194 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 51.9 m -129.36 149.02 51.32 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.446 -0.784 . . . . 0.0 109.164 178.959 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 64.6 t -123.34 116.63 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.063 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 93.0 m -105.95 129.32 54.11 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.088 -1.007 . . . . 0.0 109.153 -179.143 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 1.4 m -136.03 115.37 12.6 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.756 0.789 . . . . 0.0 110.666 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 40.1 t30 46.03 52.57 9.94 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 177.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.15 -13.73 53.19 Favored Glycine 0 N--CA 1.5 2.908 0 O-C-N 120.222 -1.549 . . . . 0.0 112.65 176.778 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 13.1 tptm -115.46 125.82 53.57 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 118.959 1.379 . . . . 0.0 108.834 -179.517 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 82.6 p -127.42 149.98 49.84 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.92 0.867 . . . . 0.0 110.574 -178.685 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -145.58 167.75 22.29 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.434 0.635 . . . . 0.0 110.234 -178.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 49.0 m -88.92 138.89 31.0 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.609 -0.682 . . . . 0.0 110.434 -179.233 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.539 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -81.09 -15.55 55.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.024 -1.048 . . . . 0.0 110.456 -179.366 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -84.05 22.26 1.21 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 178.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.539 ' H ' ' C ' ' B' ' 344' ' ' ALA . 63.6 m -150.81 101.67 2.93 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.661 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . 0.521 ' O ' ' NE2' ' B' ' 351' ' ' GLN . 17.3 tp -59.86 -36.6 77.21 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.388 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 52.6 m-85 -57.95 -53.04 62.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.86 . . . . 0.0 110.299 -179.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -68.53 -21.74 64.55 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.272 -0.892 . . . . 0.0 111.241 -176.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' B' ' 352' ' ' THR . 76.8 mt -69.26 -52.61 25.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.395 -1.44 . . . . 0.0 108.886 178.442 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.521 ' NE2' ' O ' ' B' ' 347' ' ' LEU . 0.8 OUTLIER -39.4 -22.33 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.696 -0.627 . . . . 0.0 110.953 -178.156 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.519 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.1 p -80.12 -10.81 59.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.18 -1.575 . . . . 0.0 110.235 -179.13 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 44.4 mt -96.48 117.79 31.64 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.085 -1.009 . . . . 0.0 108.925 178.729 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.5 95.46 0.78 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.359 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 92.6 mt -95.68 78.62 3.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -1.185 . . . . 0.0 108.691 179.252 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 75.6 p -90.97 179.75 5.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.944 . . . . 0.0 110.549 -178.338 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' B' ' 359' ' ' THR . 12.1 tt0 -50.79 157.47 0.79 Allowed 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 122.188 0.994 . . . . 0.0 111.097 -179.494 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 38.39 26.55 0.04 OUTLIER Glycine 0 N--CA 1.498 2.804 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.336 177.691 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 359' ' ' THR . . . . . 0.465 ' N ' ' O ' ' B' ' 357' ' ' GLN . 13.6 m -84.83 106.77 16.61 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.612 -1.522 . . . . 0.0 110.131 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 11.7 t -78.27 113.52 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 122.248 1.023 . . . . 0.0 110.231 -177.556 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 34.4 m -111.58 179.06 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -178.973 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 37.2 m -130.16 128.28 41.45 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 176.869 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.17 116.31 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.573 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 24.9 p -120.23 132.92 55.54 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.417 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.79 153.93 40.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 0.0 109.917 -178.888 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -147.03 125.8 12.64 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.458 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 159.23 -158.45 29.52 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.086 -1.53 . . . . 0.0 111.335 -179.654 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.14 -49.86 75.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 122.017 -0.696 . . . . 0.0 112.485 -177.385 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -114.28 13.64 17.91 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.914 -1.116 . . . . 0.0 111.528 -177.039 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.551 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -42.91 -33.8 0.85 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.23 -0.919 . . . . 0.0 111.035 -179.1 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . 0.504 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 92.4 mm-40 -69.95 -44.2 70.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.059 -1.026 . . . . 0.0 110.412 -178.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -67.52 -47.63 69.36 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.544 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.67 -76.83 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.334 -0.854 . . . . 0.0 110.61 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 94.4 t -46.4 -35.36 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 110.969 -177.319 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -67.11 -46.16 75.03 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.221 -1.549 . . . . 0.0 110.238 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -77.61 -43.48 31.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.807 -1.183 . . . . 0.0 109.546 179.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.05 -39.59 86.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 0.0 109.968 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.06 -45.21 95.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.772 -1.171 . . . . 0.0 109.168 179.657 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' B' ' 383' ' ' GLU . 99.3 mttt -70.0 -56.59 6.59 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.655 -1.278 . . . . 0.0 108.114 178.565 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 42.3 tp -54.88 -35.35 63.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.402 -0.811 . . . . 0.0 109.709 -178.024 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 381' ' ' MET . . . . . 0.502 ' O ' ' CE ' ' B' ' 381' ' ' MET . 0.0 OUTLIER -73.47 -39.9 64.55 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.44 -1.304 . . . . 0.0 107.826 177.635 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.48 -4.75 50.09 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.184 -0.948 . . . . 0.0 110.205 179.534 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' B' ' 379' ' ' LYS . 69.6 mm-40 -111.81 1.08 16.42 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.198 -0.939 . . . . 0.0 110.723 179.86 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 16.1 mt -90.36 129.3 36.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.761 -1.212 . . . . 0.0 109.261 179.362 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.326 -179.501 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.8 mtp . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.232 -0.655 . . . . 3.19 109.232 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.401 HG23 HD11 ' A' ' 2' ' ' ILE . 86.1 mt -110.49 124.85 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.499 -0.75 . . . . 1.71 109.601 -179.804 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.5 m -133.28 145.6 50.62 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.563 -0.71 . . . . 1.66 109.154 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.546 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -129.37 -164.36 11.43 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 108.868 -1.693 . . . . 1.05 108.868 179.924 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.1 mt -88.23 -9.93 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.922 -1.34 . . . . 1.59 110.116 -179.098 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 54.6 tp 50.3 98.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.16 -0.963 . . . . 1.47 109.13 179.804 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.11 -31.13 12.27 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.164 -0.96 . . . . 1.39 109.201 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 12.1 t -131.46 119.49 17.44 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 108.947 -0.761 . . . . 2.09 108.947 179.697 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -81.51 148.85 16.39 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.104 1.869 . . . . 0.91 112.812 -179.764 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.422 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 143.76 176.83 18.15 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 108.829 -1.708 . . . . 0.92 108.829 179.755 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 88.4 mt -120.0 153.78 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.147 -1.207 . . . . 1.35 109.833 -179.351 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.11 152.15 29.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 1.14 109.773 179.761 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.3 m-85 -133.47 127.58 33.59 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.334 -0.987 . . . . 0.7 108.334 179.565 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.78 175.47 47.37 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 118.885 -1.626 . . . . 0.58 110.687 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -78.66 155.4 29.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.654 -0.91 . . . . 2.63 109.529 -179.523 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.12 131.48 48.59 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.376 -0.828 . . . . 1.27 111.121 -178.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.9 tp -100.23 134.86 42.54 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.681 -1.229 . . . . 1.41 107.681 178.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.2 tp -115.35 119.97 38.06 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.252 -0.905 . . . . 1.49 110.144 -179.458 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt -88.87 101.11 13.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.503 -0.748 . . . . 1.52 109.944 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -95.78 133.66 39.64 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.235 -1.024 . . . . 3.17 108.235 179.441 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.522 ' CG ' HH21 ' A' ' 139' ' ' ARG . 81.8 tt0 -131.54 141.08 49.64 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.242 -0.911 . . . . 3.0 109.696 -179.398 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -88.24 141.9 28.19 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.453 -0.779 . . . . 2.77 109.662 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.52 139.98 58.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.038 -1.039 . . . . 2.94 109.078 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.5 mt -83.03 136.64 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -0.943 . . . . 1.46 108.915 179.495 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.7 t -102.69 129.55 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.444 -0.785 . . . . 1.7 109.329 -179.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.6 mt -106.8 138.92 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.834 -0.802 . . . . 1.54 108.834 179.919 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -92.87 119.27 32.02 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.01 -1.056 . . . . 1.81 109.586 -179.59 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.413 HH11 ' HG3' ' A' ' 28' ' ' ARG . 23.8 mmm-85 -86.95 -2.96 59.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.563 -0.711 . . . . 3.23 109.557 -179.5 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.7 144.37 56.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.125 -0.984 . . . . 3.29 109.902 179.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -87.99 151.17 22.98 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.837 -0.801 . . . . 2.8 108.837 179.563 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.5 pt -98.12 166.73 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.076 -1.015 . . . . 1.43 110.46 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.8 p -90.45 174.5 7.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 1.54 108.762 178.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.89 -18.7 63.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.14 -0.975 . . . . 1.6 111.087 -179.332 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -83.27 -27.4 29.89 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.565 -1.334 . . . . 2.56 108.709 178.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -81.19 -8.42 59.75 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.242 -0.651 . . . . 2.36 109.242 179.45 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.5 t -61.54 -54.13 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.224 -0.923 . . . . 1.43 108.917 179.516 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -62.14 -39.89 94.12 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.42 -0.8 . . . . 1.77 109.829 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -63.93 -42.78 97.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.033 -1.042 . . . . 3.32 110.104 -179.36 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -64.15 -39.79 94.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.923 -1.111 . . . . 1.51 110.328 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.85 -47.52 91.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.665 -1.272 . . . . 1.41 108.458 -179.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -60.04 -41.12 91.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.949 -1.094 . . . . 1.81 108.855 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -60.04 -44.47 94.63 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.842 -1.17 . . . . 3.26 107.842 178.705 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -60.32 -47.58 85.41 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.744 -0.836 . . . . 0.81 108.744 178.129 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.4 tp -59.9 -49.33 78.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 1.59 109.224 179.869 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.0 t -62.42 -43.58 98.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.024 -1.047 . . . . 1.38 109.44 179.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.26 -46.39 94.02 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.132 -1.587 . . . . 0.87 109.132 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -67.24 -30.71 70.68 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.328 -1.101 . . . . 3.62 108.454 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.8 -45.75 91.36 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.458 -0.776 . . . . 1.43 109.244 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 50' ' ' ALA . 30.6 ttpt -61.4 -72.69 0.11 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.901 -1.148 . . . . 3.08 107.901 179.427 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.86 -33.68 0.06 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.477 -0.764 . . . . 1.33 111.725 -178.188 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 64.1 m -59.95 -50.65 72.92 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.064 -1.454 . . . . 1.85 107.95 179.452 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.62 -40.09 76.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.44 -0.788 . . . . 1.35 111.211 -179.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -66.45 -40.04 89.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.663 -1.273 . . . . 2.34 110.116 -179.427 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.1 mt -65.09 -40.0 93.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.925 . . . . 2.2 109.783 -179.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -61.85 -38.04 86.75 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.98 -1.075 . . . . 1.35 109.694 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -63.63 -41.62 98.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 1.34 109.774 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.3 -39.89 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.198 -0.939 . . . . 1.26 109.077 179.756 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -55.67 -50.05 71.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -0.842 . . . . 1.7 109.542 -179.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -57.34 -33.23 67.53 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.223 -0.923 . . . . 1.35 110.062 -178.457 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.431 ' O ' ' OG1' ' A' ' 64' ' ' THR . 98.4 mttt -69.82 -39.76 76.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.944 -1.097 . . . . 2.08 110.594 179.593 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.13 -44.36 80.07 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.232 -0.918 . . . . 1.21 110.218 -178.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.78 -50.89 62.83 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.931 -1.268 . . . . 0.75 109.931 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.9 -43.93 70.75 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.99 -1.3 . . . . 1.59 109.985 -179.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 47.0 m -66.43 -62.73 1.31 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.118 -0.989 . . . . 1.41 111.742 -178.09 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -95.43 -48.71 5.74 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.872 -1.143 . . . . 0.79 111.316 -178.071 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.83 -166.64 25.86 Favored Glycine 0 N--CA 1.504 3.173 0 C-N-CA 119.818 -1.182 . . . . 1.22 111.043 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.51 -23.42 64.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.673 -0.898 . . . . 5.81 109.618 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -60.73 -37.69 82.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.816 . . . . 3.37 110.872 -179.579 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -99.43 -15.01 18.88 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.007 -1.058 . . . . 2.37 109.858 -179.567 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -70.03 -39.99 75.42 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.081 -1.012 . . . . 1.65 109.085 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -65.68 -31.5 72.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.622 -0.674 . . . . 1.42 109.946 -179.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 80.8 mt -59.89 -41.2 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.828 -1.17 . . . . 1.43 108.538 179.836 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -65.3 -39.32 92.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.959 . . . . 1.08 110.501 179.707 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -60.01 -39.85 87.21 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.697 -1.252 . . . . 1.37 109.086 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.41 -48.96 68.36 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.462 -1.855 . . . . 0.67 108.462 178.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -62.02 -44.72 96.11 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.264 -1.139 . . . . 1.99 108.682 179.203 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 80.9 mt -68.7 -48.6 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.266 -0.896 . . . . 1.22 109.344 179.429 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 52.3 ttp -60.17 -40.83 91.3 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.939 -1.101 . . . . 2.11 109.764 -179.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.5 tp -64.97 -39.9 94.18 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.338 -0.851 . . . . 1.33 109.907 179.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.0 tp -64.27 -40.1 95.29 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.497 -0.752 . . . . 1.29 110.268 -179.137 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -81.06 7.85 9.95 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.904 -1.123 . . . . 1.47 110.557 -178.853 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -56.91 129.78 43.03 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.081 -1.012 . . . . 1.47 110.134 -178.974 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -60.33 -15.36 24.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.33 -0.857 . . . . 1.78 110.438 -179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -69.9 -35.98 75.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.956 -1.09 . . . . 2.53 108.675 178.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.2 mt -71.17 -42.84 68.56 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.49 0.662 . . . . 1.36 110.054 179.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.59 -47.77 84.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.907 . . . . 1.42 110.551 -179.138 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -70.74 -43.92 67.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.089 -1.007 . . . . 2.27 111.746 -178.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -70.41 -38.65 74.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.127 -0.983 . . . . 1.57 111.525 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.406 HG21 HD12 ' A' ' 89' ' ' ILE . 95.7 mt -69.53 -42.23 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.044 -1.035 . . . . 1.19 110.016 -179.062 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.81 -37.78 77.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.42 -0.8 . . . . 1.39 110.17 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.01 -46.45 89.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.137 -0.977 . . . . 1.39 111.13 -179.03 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 96' ' ' LYS . 89.2 mt -60.96 -45.55 94.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.734 -1.228 . . . . 1.5 109.992 -178.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.36 -50.02 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 1.29 109.42 -179.577 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.04 -40.91 74.85 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.833 -0.747 . . . . 2.64 110.487 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -81.54 -50.5 9.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.129 -0.982 . . . . 1.65 112.249 -178.185 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 92' ' ' LEU . 42.2 mmtm -93.04 -2.24 55.83 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.071 -1.018 . . . . 2.5 111.982 -176.976 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 57.4 35.97 26.57 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.059 -1.026 . . . . 1.88 109.793 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.5 mtt -90.39 168.04 12.18 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.45 -0.781 . . . . 1.71 110.128 -179.457 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.5 p -80.15 160.64 25.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.489 -0.757 . . . . 1.61 109.597 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.82 -39.72 76.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 1.33 110.381 -179.557 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 34.2 p-10 -66.31 -39.2 89.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.052 -1.03 . . . . 2.07 109.821 -179.626 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.484 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -78.93 -51.59 9.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 1.37 109.704 179.417 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.48 77.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.537 -0.727 . . . . 1.14 111.131 -179.002 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.04 -45.92 91.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.065 -1.022 . . . . 1.26 110.018 -179.059 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -58.39 -37.16 74.7 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.308 -0.87 . . . . 2.02 109.917 -179.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.92 -39.99 91.5 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.26 -0.9 . . . . 1.33 111.014 -179.127 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.85 -49.97 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.832 -1.168 . . . . 1.3 110.58 -178.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.7 mm -67.42 -40.24 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.992 -1.067 . . . . 1.32 108.237 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -66.92 -37.2 83.89 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.184 -1.043 . . . . 2.44 108.184 178.836 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.93 -49.0 83.34 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.009 -1.236 . . . . 0.99 110.009 -179.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -65.86 -48.05 72.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.853 -1.38 . . . . 1.97 109.123 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.383 -0.823 . . . . 1.43 109.222 -179.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 58.5 m -60.02 -40.1 88.15 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.267 -1.012 . . . . 2.12 108.267 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.35 -43.5 96.45 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.45 -0.944 . . . . 1.64 108.45 179.074 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.7 mt -64.04 -48.83 74.72 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.159 -1.052 . . . . 1.93 108.159 179.302 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -49.48 -31.86 10.91 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.321 -0.862 . . . . 2.2 109.998 -179.11 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.74 -20.28 55.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.892 -1.13 . . . . 2.12 108.668 179.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 74.1 mt -63.15 140.05 58.83 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.511 -0.922 . . . . 2.34 108.511 179.317 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -99.11 49.01 0.95 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.116 -0.99 . . . . 3.23 111.02 -178.531 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 24.7 t0 -137.38 153.22 50.23 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.145 -0.972 . . . . 2.49 109.119 178.993 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.457 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 99.5 mt-10 -72.44 -64.78 0.88 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.95 -1.13 . . . . 3.95 107.95 178.352 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.438 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 6.6 t80 -41.33 -43.74 2.56 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.91 -0.494 . . . . 2.25 110.895 -179.234 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.496 ' CD2' HH21 ' A' ' 126' ' ' ARG . 85.3 mt -69.88 -40.05 75.92 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.604 -1.31 . . . . 2.27 109.028 -179.836 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -65.33 -37.36 86.85 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.525 -0.735 . . . . 3.31 109.563 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -59.83 -42.15 92.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.391 -0.818 . . . . 2.73 110.268 -179.031 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.551 ' NH1' ' OE1' ' B' ' 351' ' ' GLN . 82.2 mtm180 -70.05 -32.72 70.98 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.924 -1.11 . . . . 3.2 108.812 179.621 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.22 -22.77 65.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.735 -1.209 . . . . 1.66 107.735 178.458 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.72 -40.04 63.85 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.511 -0.922 . . . . 1.67 108.511 178.609 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.99 -41.22 99.51 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.433 -0.792 . . . . 1.55 110.377 -179.587 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.8 t -68.67 -40.45 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.047 -1.033 . . . . 1.32 108.873 179.776 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 36.3 ttt-85 -60.19 -37.69 81.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 3.58 108.779 178.602 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 61.6 t0 -59.84 -38.97 83.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.527 -0.733 . . . . 1.46 109.68 -179.483 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.04 -40.65 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.083 -1.011 . . . . 1.22 109.563 -179.486 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.13 -26.85 67.53 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.848 -1.301 . . . . 0.61 109.848 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -60.1 -49.62 76.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -1.186 . . . . 3.1 109.575 -179.217 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -68.32 -32.96 73.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.786 -1.197 . . . . 3.71 110.559 179.545 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.6 tp -54.34 -43.96 71.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.936 -1.103 . . . . 1.87 108.795 -179.338 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.92 -39.98 93.91 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.124 -0.985 . . . . 1.29 109.037 178.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.522 HH21 ' CG ' ' A' ' 21' ' ' GLU . 3.2 mtt-85 -68.13 -40.02 82.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.856 . . . . 3.05 109.714 179.407 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -68.76 -38.27 79.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.458 -0.776 . . . . 1.26 112.265 -178.439 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.91 -40.09 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.321 -1.487 . . . . 1.34 108.791 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 92.2 mt -76.03 -28.69 57.8 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.509 -0.744 . . . . 1.6 110.167 -179.429 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.81 38.95 18.46 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.423 -1.471 . . . . 0.96 109.423 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 tp -73.89 147.18 43.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.259 -1.141 . . . . 1.67 108.619 -179.663 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -66.43 137.02 56.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.034 -1.041 . . . . 4.96 109.653 -179.153 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 83.2 mt -109.83 132.92 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 122.218 1.008 . . . . 1.68 108.512 179.548 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.3 mt -65.02 -39.97 87.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 115.637 -0.71 . . . . 2.14 110.768 -178.304 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 41.3 t0 63.21 102.23 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.412 -0.805 . . . . 1.5 108.861 -179.255 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.9 mt -70.02 -1.11 8.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.365 -0.834 . . . . 1.39 111.49 -178.023 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.7 t -84.66 -13.15 52.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.524 -1.36 . . . . 1.83 110.324 -179.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.93 31.64 0.2 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.092 -1.005 . . . . 1.46 112.052 -178.07 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.8 mm -86.04 120.0 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.234 -1.541 . . . . 1.42 109.087 179.546 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -101.41 -9.32 21.22 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.321 -0.862 . . . . 2.94 110.462 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -140.31 159.93 41.1 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.039 -1.038 . . . . 1.52 110.867 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.83 132.88 50.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.501 -0.75 . . . . 1.58 109.162 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.0 m -152.06 165.5 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.274 -0.891 . . . . 1.32 110.074 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.42 HD11 HG21 ' A' ' 157' ' ' ILE . 84.9 mt -97.09 145.29 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 105.522 -2.029 . . . . 1.27 105.522 176.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.3 tp -95.41 115.49 27.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.873 -1.142 . . . . 1.41 110.614 -177.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.0 t -120.28 128.07 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 N-CA-C 108.257 -1.016 . . . . 1.23 108.257 179.026 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.48 165.58 30.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.025 -1.047 . . . . 1.32 109.27 -179.582 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.77 -38.0 73.41 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.363 -1.461 . . . . 1.49 108.567 178.61 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 54.0 t0 -171.7 147.16 2.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.582 -0.699 . . . . 2.25 109.468 -179.667 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.412 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 17.6 mt -119.91 136.72 54.4 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.281 -0.887 . . . . 1.35 108.859 179.505 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.5 p -89.98 149.98 42.75 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.179 -0.951 . . . . 1.56 110.009 -179.424 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.418 ' O ' ' OG1' ' A' ' 168' ' ' THR . 77.8 Cg_exo -40.63 -39.39 2.95 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.563 2.175 . . . . 0.87 113.438 179.58 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 66.1 m -59.99 -39.96 87.51 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.966 -1.084 . . . . 1.36 109.253 -179.122 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.68 -40.08 94.78 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.346 -0.846 . . . . 1.61 110.129 -179.828 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 165' ' ' PRO . 51.7 p -57.97 -34.55 70.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.163 -0.96 . . . . 1.21 111.225 -177.973 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.4 -50.91 41.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.962 -1.086 . . . . 1.21 109.914 -179.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -85.7 36.67 0.67 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.421 -0.799 . . . . 2.11 108.9 -179.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.2 tp -99.97 140.01 34.8 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.451 -0.781 . . . . 1.29 109.491 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -84.4 104.63 14.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.021 -1.049 . . . . 2.81 108.62 179.185 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 63.2 mt -65.75 -40.97 92.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.442 -0.786 . . . . 2.09 111.612 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -81.25 -15.01 56.82 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.638 -1.289 . . . . 2.86 112.162 -177.172 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -95.33 -10.63 29.59 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.611 -1.305 . . . . 2.39 109.132 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 99.9 t -110.28 120.08 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.401 -0.812 . . . . 1.27 108.82 178.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -91.64 7.85 39.59 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.027 -1.045 . . . . 2.17 110.723 -178.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.27 172.37 38.04 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.543 -1.423 . . . . 0.52 109.543 179.752 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -132.94 129.89 38.88 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.326 -1.102 . . . . 0.55 109.403 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.2 mt -132.02 124.26 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.865 -0.791 . . . . 1.27 108.865 178.67 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 53.6 p -146.97 159.8 43.12 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.132 -0.98 . . . . 1.39 110.761 -179.615 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.8 OUTLIER -96.35 21.63 8.83 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.124 -0.695 . . . . 2.46 109.124 179.686 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.485 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -45.58 -176.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 122.341 1.067 . . . . 1.51 112.847 -177.898 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.93 -56.77 4.71 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 111.131 -0.788 . . . . 2.23 111.131 -179.119 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.46 -144.24 5.1 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.118 -1.515 . . . . 2.23 110.79 -179.34 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.51 ' C ' ' H ' ' A' ' 188' ' ' SER . 82.1 mtm180 -69.66 -28.14 65.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.54 -0.976 . . . . 6.44 110.302 -178.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 69.7 p -62.95 5.82 0.12 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.194 -0.942 . . . . 4.09 110.614 -178.756 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.51 ' H ' ' C ' ' A' ' 186' ' ' ARG . 40.4 t -90.67 128.35 36.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.987 -1.071 . . . . 2.2 109.894 -179.982 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -47.52 -44.17 25.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.316 -0.865 . . . . 1.15 108.825 179.687 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.442 ' HG1' ' N ' ' A' ' 191' ' ' SER . 45.3 p -57.8 -39.56 77.82 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.78 -0.575 . . . . 2.01 110.425 -179.058 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.442 ' N ' ' HG1' ' A' ' 190' ' ' THR . 58.5 m -59.94 -40.17 88.04 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.997 -1.064 . . . . 1.93 110.899 -178.868 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 2.2 mp -64.75 -40.07 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.951 -1.093 . . . . 2.2 110.295 -179.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.5 mtp -61.25 -41.14 96.39 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.843 -1.161 . . . . 1.32 110.615 -179.441 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.86 -44.1 94.32 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.505 -1.372 . . . . 1.3 109.541 -179.73 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.409 HH21 ' HG2' ' A' ' 186' ' ' ARG . 30.0 mtt-85 -60.23 -50.1 74.99 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.272 -0.893 . . . . 3.38 109.996 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 39.4 m -72.0 -35.72 69.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.11 -0.994 . . . . 1.15 111.823 -178.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.6 mt -76.67 -13.24 60.07 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.499 -1.376 . . . . 1.28 110.194 -178.702 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 59.81 46.08 11.87 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.533 -0.73 . . . . 1.5 110.547 179.392 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.409 ' O ' ' CB ' ' A' ' 8' ' ' SER . 90.6 mt -122.85 128.91 25.2 Favored Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 108.687 -0.857 . . . . 1.37 108.687 179.313 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -43.41 133.92 6.8 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.82 1.68 . . . . 0.76 112.073 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -167.27 147.17 5.32 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.575 -1.25 . . . . 1.19 111.89 -179.483 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.7 mt -125.58 141.07 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 107.772 -1.196 . . . . 1.31 107.772 178.362 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 11.2 m -126.71 -7.29 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 120.806 -1.184 . . . . 1.38 110.589 -179.067 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.15 22.06 25.84 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.544 -1.022 . . . . 1.03 110.544 -179.62 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.456 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 12.6 p -47.14 -44.58 21.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.834 -1.392 . . . . 1.38 109.782 -179.287 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.69 -53.96 4.07 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 120.022 -1.085 . . . . 1.17 112.036 178.688 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.434 ' O ' ' OG ' ' A' ' 207' ' ' SER . 13.0 t -150.03 28.27 0.76 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 120.485 -1.597 . . . . 2.07 111.905 -178.2 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 45.6 t -70.25 -40.07 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.74 -1.225 . . . . 1.35 109.126 178.314 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 75.9 p -53.79 -30.82 46.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.377 -0.827 . . . . 1.49 111.392 -178.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.7 m -81.28 -12.95 58.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.823 -1.173 . . . . 2.16 110.283 -179.132 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -102.57 -12.14 17.98 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.141 -0.974 . . . . 2.89 110.351 -179.612 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 85.0 t -107.86 139.24 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.177 -0.952 . . . . 1.33 111.675 -177.66 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -114.25 150.01 35.02 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.356 -1.35 . . . . 2.73 107.356 178.212 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.507 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 21.3 p-10 -57.1 140.45 49.28 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.735 -1.228 . . . . 2.7 109.9 -179.356 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.1 t0 87.15 4.07 0.37 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 109.525 -0.546 . . . . 2.38 109.525 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 64.8 t0 -74.7 139.41 43.44 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.204 -0.935 . . . . 2.09 109.561 179.512 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.469 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 48.4 t80 -91.94 116.56 29.02 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.524 -1.287 . . . . 1.45 107.524 178.456 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 76.4 mt -127.37 149.4 50.08 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.468 -0.77 . . . . 1.31 110.297 -178.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 63.1 mt -114.66 129.71 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 106.859 -1.534 . . . . 1.29 106.859 176.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 55.0 tp -100.14 119.17 37.92 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.078 -1.082 . . . . 1.31 108.078 -179.153 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.459 ' C ' ' N ' ' A' ' 223' ' ' VAL . 78.7 m-20 -81.4 -46.73 14.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.965 -1.084 . . . . 2.31 109.51 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 48.23 17.27 0.11 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.792 -0.818 . . . . 1.19 108.792 -179.251 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.459 ' N ' ' C ' ' A' ' 221' ' ' ASP . 55.3 t -127.19 -49.42 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.256 -1.387 . . . . 1.45 107.256 178.387 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -100.31 2.87 42.98 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.412 -1.329 . . . . 3.13 107.412 178.37 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.546 HD22 ' H ' ' A' ' 4' ' ' GLY . 1.1 t-20 59.82 49.18 8.24 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.04 -0.726 . . . . 2.2 109.04 -179.071 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -136.85 147.11 46.33 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.438 -0.789 . . . . 2.32 109.572 -179.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.5 t -119.89 126.84 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.269 -1.011 . . . . 1.4 108.269 179.474 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -100.1 117.56 34.61 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.185 -0.947 . . . . 1.29 108.934 179.854 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.3 t -98.8 111.52 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.734 -0.604 . . . . 1.38 109.914 -179.044 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 55.18 68.54 2.47 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.311 -0.868 . . . . 2.33 111.235 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -90.67 145.42 3.86 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 123.13 2.553 . . . . 0.95 112.122 178.944 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 61.2 p -69.95 163.98 24.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.039 -1.038 . . . . 2.31 109.646 -179.618 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -60.19 -40.38 89.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 3.45 110.071 -178.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -60.07 -39.98 87.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.057 -1.027 . . . . 2.89 109.522 -179.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.69 -40.4 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.052 -1.03 . . . . 1.73 109.299 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.456 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 93.0 mt -61.61 -39.78 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.266 -0.896 . . . . 1.57 109.085 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -59.94 -40.06 87.66 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.155 -0.965 . . . . 2.43 109.021 179.657 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -65.18 -42.63 93.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 3.18 109.116 179.39 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 91.1 mtp -67.79 -34.33 76.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.35 -0.844 . . . . 1.59 109.142 179.604 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.559 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -63.19 -39.98 96.21 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.374 -0.829 . . . . 3.11 109.663 179.38 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.15 87.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.015 -1.053 . . . . 2.17 108.879 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.86 -39.98 83.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.371 -0.83 . . . . 2.51 109.008 179.557 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -59.97 -40.88 90.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.092 -1.005 . . . . 3.82 109.364 179.586 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.63 -40.0 93.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 1.78 109.026 179.496 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -60.79 -39.69 89.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.444 -0.785 . . . . 2.77 109.639 179.558 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 73.9 t -59.58 -39.88 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.465 -0.772 . . . . 2.25 109.793 -178.901 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.3 85.05 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.156 -0.965 . . . . 2.54 108.866 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 54.3 p -68.84 -33.68 74.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.478 -0.764 . . . . 3.03 109.954 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -60.48 -33.68 72.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.069 -1.019 . . . . 3.34 109.555 -179.755 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -60.01 -39.56 86.21 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.493 -0.928 . . . . 4.18 108.493 -179.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.573 ' C ' ' H ' ' A' ' 253' ' ' LEU . . . -65.06 -59.95 3.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.291 -0.881 . . . . 4.43 108.816 179.137 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 54.49 1.08 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.407 -0.808 . . . . 5.42 110.13 179.406 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.573 ' H ' ' C ' ' A' ' 251' ' ' ALA . 38.5 mt 48.86 44.79 22.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.826 -1.171 . . . . 6.11 109.424 179.656 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.3 -35.92 74.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.944 . . . . 7.37 109.807 -179.577 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -60.07 -40.02 88.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.021 . . . . 8.3 108.776 -179.785 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 8.2 tp -97.26 30.64 2.73 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.786 -1.191 . . . . 9.05 107.786 179.08 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 253' ' ' LEU . 45.6 mmtm 56.33 -171.7 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.146 -1.057 . . . . 10.56 108.146 -179.021 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -153.18 88.27 1.3 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.775 -1.203 . . . . 11.32 110.172 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 32.2 ttt-85 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.981 . . . . 12.74 109.422 179.566 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' B' B ' 301' ' ' MET . . . . . 0.476 ' N ' ' OE1' ' B' ' 366' ' ' GLU . 11.0 ttt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.488 0.661 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -156.93 154.23 29.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.382 -0.824 . . . . 0.0 109.056 178.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -151.21 162.44 40.88 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.916 -1.115 . . . . 0.0 110.737 -178.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -154.96 152.16 29.37 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.611 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -113.0 133.93 54.74 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.094 -1.004 . . . . 0.0 110.346 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.1 p -134.45 125.61 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 CA-C-O 122.415 1.102 . . . . 0.0 112.475 -178.492 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 93.9 m -77.83 106.29 9.57 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.306 -177.875 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.9 mt -52.13 122.02 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 122.222 1.01 . . . . 0.0 110.413 -178.186 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 62.4 p -110.73 18.62 19.45 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.697 -178.579 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.25 115.98 53.69 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.083 -1.011 . . . . 0.0 109.584 179.642 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -49.5 -15.4 0.9 Allowed 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 121.114 1.209 . . . . 0.0 114.266 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -118.92 9.44 11.93 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.199 -0.938 . . . . 0.0 109.694 -179.42 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.2 177.74 26.64 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -179.118 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.438 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.0 tp -83.73 93.86 8.02 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.034 -1.274 . . . . 0.0 109.716 -178.32 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -95.92 -162.52 0.96 Allowed 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.661 -1.274 . . . . 0.0 110.391 179.274 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 25.8 m -55.9 -40.01 72.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.154 -0.967 . . . . 0.0 112.377 -176.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.498 HH21 ' CD ' ' B' ' 321' ' ' GLN . 1.7 tpt180 -62.9 -61.65 7.09 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 120.677 -1.265 . . . . 0.0 112.507 -178.37 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.98 -32.54 95.53 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 CA-C-N 120.275 1.134 . . . . 0.0 111.896 -179.24 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.94 -50.07 75.21 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.139 -1.024 . . . . 0.0 108.457 179.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.65 -40.61 60.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.71 -179.423 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . 0.498 ' CD ' HH21 ' B' ' 317' ' ' ARG . 27.2 mt-30 -72.8 -40.06 66.18 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.827 -1.149 . . . . 0.0 109.457 178.631 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -60.28 -51.5 69.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.18 -0.95 . . . . 0.0 109.996 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 92.4 t -69.01 -24.73 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.936 -1.103 . . . . 0.0 110.501 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.03 -42.49 94.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.859 -1.15 . . . . 0.0 108.823 179.9 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -69.5 -60.06 2.58 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.626 -0.671 . . . . 0.0 111.562 -178.185 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.1 -9.01 43.1 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.822 -1.174 . . . . 0.0 112.698 -177.512 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -83.67 -20.3 33.81 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.441 -1.412 . . . . 0.0 110.113 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -87.52 -10.97 69.56 Favored Glycine 0 N--CA 1.498 2.78 0 C-N-CA 120.084 -1.055 . . . . 0.0 111.158 -178.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -102.45 143.23 32.44 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.961 -1.317 . . . . 0.0 109.417 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 57.9 p -89.59 -13.84 36.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.034 -1.041 . . . . 0.0 110.06 -179.739 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 82.2 p -58.9 145.24 41.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.109 -0.994 . . . . 0.0 109.095 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . 0.531 ' OE1' ' N ' ' B' ' 332' ' ' GLU . 49.5 mp0 -68.26 130.1 41.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.187 -0.946 . . . . 0.0 109.069 -179.804 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 86.1 mt -132.18 132.55 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.589 -0.695 . . . . 0.0 110.21 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 95.3 m -131.06 151.3 51.56 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.5 -0.75 . . . . 0.0 109.725 179.393 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 96.3 t -125.12 120.05 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.765 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 95.1 m -116.84 130.09 56.49 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.037 -1.039 . . . . 0.0 110.329 -178.321 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 2.0 m -133.75 117.62 17.13 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.883 0.849 . . . . 0.0 110.037 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 48.3 t30 49.66 50.51 18.17 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 176.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.84 -12.01 65.03 Favored Glycine 0 N--CA 1.504 3.19 0 O-C-N 119.682 -1.886 . . . . 0.0 113.434 176.286 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -120.56 132.5 55.19 Favored 'General case' 0 N--CA 1.506 2.375 0 CA-C-N 119.292 1.546 . . . . 0.0 108.957 -179.498 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 95.7 p -135.78 156.15 49.26 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 121.94 0.876 . . . . 0.0 111.249 -178.317 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -145.65 167.36 23.29 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.583 0.706 . . . . 0.0 110.183 -179.401 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 3.7 t -85.38 133.54 34.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.614 -0.679 . . . . 0.0 110.212 -179.392 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -70.71 -19.11 62.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.126 -0.984 . . . . 0.0 110.687 -179.361 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -88.49 21.36 2.95 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.168 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.491 ' H ' ' C ' ' B' ' 344' ' ' ALA . 59.7 p -144.42 93.81 2.48 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.863 -179.037 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 44.4 tp -59.84 -38.97 83.6 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -54.16 -52.28 61.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.185 -0.947 . . . . 0.0 110.946 -179.22 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.47 ' O ' ' OG1' ' B' ' 352' ' ' THR . 48.3 mtmt -69.64 -39.24 77.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.432 -1.417 . . . . 0.0 110.102 -179.378 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' B' ' 352' ' ' THR . 23.7 mt -50.12 -59.78 3.59 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.73 -1.232 . . . . 0.0 109.534 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.551 ' OE1' ' NH1' ' A' ' 126' ' ' ARG . 13.1 mm-40 -43.29 -11.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.555 -0.716 . . . . 0.0 111.4 -177.499 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.586 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.3 p -89.47 -8.96 51.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.586 -1.321 . . . . 0.0 109.638 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 68.8 mt -93.44 120.0 33.2 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.011 -1.055 . . . . 0.0 108.664 178.58 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.04 94.81 0.81 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 44.2 mt -102.26 88.22 3.25 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.429 -1.041 . . . . 0.0 109.569 179.691 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 71.8 p -93.11 170.8 9.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.071 -1.018 . . . . 0.0 110.528 -179.566 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -64.45 116.39 6.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.758 -0.589 . . . . 0.0 110.99 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 102.26 4.83 50.14 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 49.7 m -85.67 110.83 19.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.37 -1.077 . . . . 0.0 110.84 -179.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 45.7 t -76.23 115.9 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.965 0.888 . . . . 0.0 109.206 -177.301 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 13.3 m -110.21 175.79 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -178.266 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 26.4 m -130.86 131.29 44.47 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 177.463 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 78.3 mt -108.71 120.84 60.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.432 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 78.3 p -127.2 136.81 52.56 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.021 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.53 155.21 41.64 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.88 -1.138 . . . . 0.0 110.66 -179.271 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . 0.476 ' OE1' ' N ' ' B' ' 301' ' ' MET . 12.6 tp10 -144.84 121.98 11.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.476 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.452 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 161.07 -158.71 30.37 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 118.474 -1.822 . . . . 0.0 112.08 179.573 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -59.98 -51.89 67.73 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.396 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -110.13 11.31 23.78 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.958 -1.089 . . . . 0.0 111.239 -177.086 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.55 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.0 OUTLIER -40.52 -31.66 0.16 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.279 -0.888 . . . . 0.0 112.469 -178.43 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . 0.502 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 63.9 mt-30 -66.81 -48.3 69.38 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.374 -1.454 . . . . 0.0 110.958 -177.861 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -66.86 -48.17 69.66 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.53 -1.268 . . . . 0.0 108.339 179.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -42.6 -40.85 2.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.702 -0.624 . . . . 0.0 111.697 -178.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . 0.416 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 62.4 t -80.05 -32.63 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.283 -1.511 . . . . 0.0 109.769 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.98 -41.64 74.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.823 . . . . 0.0 112.392 -177.682 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . 0.496 ' O ' ' N ' ' B' ' 380' ' ' LEU . 67.1 m80 -86.54 -42.38 13.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.398 -1.438 . . . . 0.0 110.382 -179.513 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.05 -40.01 83.79 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.956 -1.097 . . . . 0.0 108.285 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . 0.416 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 51.1 t -64.36 -46.38 93.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.595 179.129 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -80.09 -9.5 59.71 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.785 -1.197 . . . . 0.0 109.786 178.492 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' B' ' 376' ' ' HIS . 49.5 tp -83.54 -28.27 28.74 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 176.769 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 56.9 tpp -81.42 -29.56 33.82 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.121 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.21 -9.6 59.76 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.891 -0.506 . . . . 0.0 109.902 179.413 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -106.96 1.48 24.52 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.231 -0.918 . . . . 0.0 110.998 -179.652 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . 0.405 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 20.6 mt -78.59 117.89 20.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.275 -1.516 . . . . 0.0 110.002 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 117.912 -1.042 . . . . 0.0 108.736 178.715 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 mmt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.197 -0.668 . . . . 3.19 109.197 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.432 HD12 HG23 ' A' ' 2' ' ' ILE . 99.3 mt -109.77 126.42 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.407 -0.96 . . . . 1.71 108.407 179.202 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -125.13 121.6 34.71 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.604 -0.685 . . . . 1.66 110.018 -178.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.72 -164.97 32.99 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.186 -1.566 . . . . 1.05 109.186 179.166 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' LEU . 88.2 mt -88.68 -13.6 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.02 -1.283 . . . . 1.59 109.854 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 5' ' ' ILE . 56.2 tp 46.07 99.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.227 -0.921 . . . . 1.47 110.342 179.094 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.51 -29.48 12.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.031 -1.043 . . . . 1.39 108.963 179.063 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 40.9 t -119.22 116.46 33.86 Favored Pre-proline 0 N--CA 1.501 2.101 0 N-CA-C 109.039 -0.726 . . . . 2.09 109.039 179.46 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.22 142.83 17.19 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.618 1.545 . . . . 0.91 111.877 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 161.4 -159.72 31.51 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.218 -1.553 . . . . 0.92 109.218 -179.713 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.3 mt -148.51 148.37 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 120.808 -1.407 . . . . 1.35 109.09 179.638 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.18 153.12 30.24 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.899 -1.126 . . . . 1.14 111.291 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 8.7 m-85 -133.16 129.94 38.52 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.72 -1.585 . . . . 0.7 106.72 177.891 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.67 175.68 46.63 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 117.936 -2.078 . . . . 0.58 111.245 -179.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -77.47 160.02 28.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.889 -0.771 . . . . 2.63 109.11 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.45 127.15 46.87 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.312 -0.867 . . . . 1.27 110.927 -179.06 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.5 tp -100.79 134.35 43.89 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 106.972 -1.492 . . . . 1.41 106.972 178.011 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.2 tp -120.4 122.32 40.49 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.123 -0.985 . . . . 1.49 110.044 -179.564 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 62.0 mt -80.85 102.61 10.14 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.499 0.666 . . . . 1.52 109.678 -179.421 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -99.34 131.09 45.6 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.451 -0.781 . . . . 3.17 109.883 -179.219 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -127.39 139.11 53.07 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.969 -0.752 . . . . 3.0 108.969 -179.948 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 61.6 t0 -82.7 149.71 27.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.983 -1.073 . . . . 2.77 109.171 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.55 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 70.7 tt0 -68.08 147.31 52.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 2.94 109.269 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.3 mt -97.62 133.78 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.232 -0.918 . . . . 1.46 109.181 -179.747 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.3 t -103.43 127.86 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.249 -0.907 . . . . 1.7 110.164 -179.056 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 84.1 mt -99.2 142.48 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.477 -0.765 . . . . 1.54 109.293 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -97.11 117.32 31.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.065 -1.022 . . . . 1.81 109.449 -179.762 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -89.27 3.61 51.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.172 -0.955 . . . . 3.23 109.153 -179.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -67.22 140.1 57.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 3.29 110.283 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -84.8 141.93 30.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 2.8 109.333 179.631 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.8 pt -89.84 164.1 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 1.43 109.365 179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 100.0 p -95.86 171.63 8.52 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.042 -1.036 . . . . 1.54 108.77 179.338 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.38 -48.35 80.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.882 -1.136 . . . . 1.6 109.376 -179.443 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -55.91 -30.38 61.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.698 -1.251 . . . . 2.56 109.878 -179.855 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -80.94 -9.69 59.8 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.214 -0.929 . . . . 2.36 109.837 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.41 -50.17 80.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 120.781 -1.199 . . . . 1.43 108.796 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -65.49 -40.11 92.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.842 -1.161 . . . . 1.77 110.199 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -69.97 -40.12 75.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.11 -0.993 . . . . 3.32 109.895 -179.282 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.544 ' OE2' ' NH1' ' A' ' 42' ' ' ARG . 28.1 mm-40 -68.37 -40.07 81.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 1.51 110.301 -179.242 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.1 t -59.95 -41.21 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.608 -1.256 . . . . 1.41 107.608 179.173 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -58.38 -37.97 76.34 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.563 -0.71 . . . . 1.81 109.626 -179.873 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.544 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 99.3 mtt180 -58.7 -41.71 86.95 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.865 -1.134 . . . . 3.26 108.016 179.443 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -62.73 -47.88 81.65 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.409 -0.959 . . . . 0.81 108.409 178.243 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 65.8 tp -59.85 -49.06 79.17 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.901 -1.148 . . . . 1.59 107.901 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.1 t -60.58 -45.15 95.01 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.464 -0.939 . . . . 1.38 108.464 178.653 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.93 -43.89 97.66 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.151 -1.98 . . . . 0.87 108.151 178.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -63.26 -33.09 74.75 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.476 -1.014 . . . . 3.62 108.72 178.34 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.25 -39.94 84.39 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.553 -0.717 . . . . 1.43 109.57 -179.207 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 50' ' ' ALA . 26.1 ttmt -70.67 -74.03 0.15 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.258 -1.386 . . . . 3.08 107.258 178.999 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.59 -39.61 0.34 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.944 -0.472 . . . . 1.33 111.126 -178.763 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.4 t -56.25 -59.04 5.52 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.338 -1.477 . . . . 1.85 108.559 179.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.17 -39.98 90.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.367 -0.833 . . . . 1.35 111.105 -179.267 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -69.82 -40.7 75.74 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.837 -1.164 . . . . 2.34 110.471 -178.931 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.3 mt -62.49 -39.95 95.15 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.915 -1.116 . . . . 2.2 108.063 179.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -62.87 -38.43 90.85 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.375 -0.828 . . . . 1.35 109.194 178.762 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.7 m -64.01 -43.81 94.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 1.34 109.477 179.137 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.3 mt -61.69 -37.84 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 1.26 109.192 179.693 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -58.8 -50.21 74.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 1.7 109.56 -179.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -57.49 -33.69 68.28 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.494 -0.754 . . . . 1.35 110.676 -177.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.443 ' O ' ' OG1' ' A' ' 64' ' ' THR . 68.1 mttm -69.62 -37.96 77.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.225 -0.922 . . . . 2.08 109.366 -179.438 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.29 -48.6 69.87 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.34 -0.85 . . . . 1.21 109.762 -179.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.08 -55.67 22.88 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 120.169 -1.015 . . . . 0.75 110.572 -179.146 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -70.18 -43.59 70.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.085 -1.244 . . . . 1.59 111.016 -178.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 58.5 m -63.09 -62.81 1.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.0 -1.063 . . . . 1.41 111.617 -177.742 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -97.4 -43.53 7.25 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.954 -1.091 . . . . 0.79 111.541 -177.926 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.65 -171.4 24.4 Favored Glycine 0 N--CA 1.501 3.032 0 O-C-N 120.703 -1.248 . . . . 1.22 111.298 179.619 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -68.95 -23.02 64.09 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.816 -0.814 . . . . 5.81 109.59 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.512 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.9 tp10 -60.01 -34.3 73.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.807 -0.558 . . . . 3.37 110.741 -179.508 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -98.71 -18.86 17.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.199 -0.938 . . . . 2.37 109.62 -179.695 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -67.68 -39.44 84.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 1.65 109.916 -179.799 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.91 -34.21 76.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 1.42 110.304 -178.685 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 85.1 mt -59.77 -40.43 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.635 -1.291 . . . . 1.43 108.682 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -64.2 -38.74 92.14 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.1 -1.0 . . . . 1.08 110.175 179.068 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -59.06 -39.7 82.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.161 -0.962 . . . . 1.37 109.141 -179.602 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.0 -41.02 95.47 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.179 -1.568 . . . . 0.67 109.179 179.069 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -66.02 -49.65 66.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.998 -1.295 . . . . 1.99 108.472 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.2 mt -61.91 -49.32 84.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.577 -0.702 . . . . 1.22 109.372 179.279 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 40.5 ttp -59.93 -46.29 89.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.331 -0.855 . . . . 2.11 109.802 -179.698 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.41 ' CD1' ' CE2' ' B' ' 348' ' ' PHE . 57.1 tp -60.13 -41.49 92.77 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.353 -0.842 . . . . 1.33 109.347 179.698 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.2 -39.64 89.81 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.181 -0.608 . . . . 1.29 110.065 -178.677 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -79.12 2.76 19.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.188 -0.945 . . . . 1.47 109.37 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -51.14 129.41 24.17 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.296 -0.878 . . . . 1.47 110.415 -178.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.63 -16.54 39.68 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.8 -0.562 . . . . 1.78 110.138 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -74.13 -35.74 64.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.027 -1.045 . . . . 2.53 109.494 178.933 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.58 -41.06 72.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.453 -0.779 . . . . 1.36 110.754 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -60.01 -49.48 77.48 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.246 -0.909 . . . . 1.42 110.394 -178.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -69.77 -40.47 76.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 2.27 110.91 -178.916 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -67.9 -40.15 83.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.971 -1.081 . . . . 1.57 110.874 -178.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.93 -47.52 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.906 -1.121 . . . . 1.19 109.636 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -65.36 -38.57 82.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.618 -0.676 . . . . 1.39 110.263 179.974 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.63 85.09 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.221 -0.924 . . . . 1.39 111.244 -178.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.414 ' O ' ' N ' ' A' ' 96' ' ' LYS . 83.2 mt -59.87 -43.93 94.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.853 -1.154 . . . . 1.5 109.243 -179.043 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.8 mt -63.34 -48.49 87.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.437 -0.79 . . . . 1.29 109.501 179.424 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -68.57 -40.34 80.63 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.116 -0.99 . . . . 2.64 110.189 179.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.74 -52.43 7.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 1.65 111.604 -178.403 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 92' ' ' LEU . 98.5 mttt -91.15 -3.08 57.37 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.117 -0.99 . . . . 2.5 112.247 -177.805 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 80.0 m80 57.29 39.05 28.81 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.816 -1.177 . . . . 1.88 109.834 -179.421 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 94.2 mtp -89.2 170.04 10.94 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.37 -0.832 . . . . 1.71 110.079 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.0 p -80.46 156.52 26.55 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.954 -0.758 . . . . 1.61 108.954 179.586 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.91 -39.9 75.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.11 -0.994 . . . . 1.33 110.2 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.58 -42.57 96.97 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.062 -1.024 . . . . 2.07 110.459 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.71 -46.33 14.43 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.374 -0.829 . . . . 1.37 110.494 -179.253 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.06 -48.26 82.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.372 -0.83 . . . . 1.14 110.364 -179.157 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.97 -47.51 85.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.929 . . . . 1.26 110.522 -179.094 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -60.15 -35.21 74.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.997 -1.065 . . . . 2.02 110.392 -179.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.28 -39.91 88.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.012 -1.055 . . . . 1.33 110.559 -179.222 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.67 -50.09 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.803 -1.185 . . . . 1.3 110.973 -178.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.4 mm -68.96 -40.14 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 120.801 -1.187 . . . . 1.32 109.134 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -64.03 -38.32 90.65 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.799 -0.815 . . . . 2.44 108.799 178.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.97 -50.04 71.94 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 120.247 -0.977 . . . . 0.99 110.839 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -65.24 -53.43 44.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.866 -1.373 . . . . 1.97 110.484 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.54 -39.16 70.21 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.998 -1.064 . . . . 1.43 109.301 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.6 t -53.82 -40.66 66.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.295 -0.878 . . . . 2.12 108.663 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.84 70.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.505 -0.747 . . . . 1.64 109.483 179.025 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.0 mt -65.78 -43.84 87.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.026 -1.046 . . . . 1.93 109.818 -178.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.97 -38.5 82.71 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.499 -1.376 . . . . 2.2 108.912 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -54.74 -18.88 5.21 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.225 -0.922 . . . . 2.12 109.538 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 85.4 mt -61.57 139.98 58.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.085 -1.009 . . . . 2.34 109.479 -179.598 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -90.9 11.45 22.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.254 -0.904 . . . . 3.23 109.714 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -99.01 117.0 32.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.151 -0.968 . . . . 2.49 109.207 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -60.2 -30.59 69.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.272 -0.892 . . . . 3.95 109.363 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.451 ' OH ' ' CA ' ' B' ' 315' ' ' HIS . 19.8 t80 -61.02 -42.08 97.79 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.995 0.902 . . . . 2.25 109.161 179.274 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.412 ' CD2' ' O ' ' B' ' 351' ' ' GLN . 74.9 mt -80.4 -26.9 38.25 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.975 -0.75 . . . . 2.27 108.975 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -60.07 -43.94 95.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.47 -0.937 . . . . 3.31 108.47 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -60.61 -45.61 93.35 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.115 -1.068 . . . . 2.73 108.115 178.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -60.68 -39.43 88.43 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.748 -0.781 . . . . 3.2 109.08 178.403 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.17 -28.27 66.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.388 -0.82 . . . . 1.66 109.162 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.31 -38.78 71.72 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.225 -0.922 . . . . 1.67 109.677 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.5 -40.58 95.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.025 -1.047 . . . . 1.55 110.466 -179.368 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.414 HG23 HE22 ' B' ' 351' ' ' GLN . 38.1 t -69.82 -42.0 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.873 -1.142 . . . . 1.32 109.801 -179.912 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -60.59 -38.6 85.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.762 -1.211 . . . . 3.58 109.407 179.427 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -58.68 -39.74 81.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.395 -0.816 . . . . 1.46 110.011 -178.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.99 -41.45 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.091 -1.005 . . . . 1.22 109.921 -179.611 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.94 -35.75 92.48 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.919 -1.272 . . . . 0.61 109.919 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -60.05 -48.57 81.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.318 -1.107 . . . . 3.1 110.995 -178.717 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.402 HH22 ' CB ' ' A' ' 166' ' ' SER . 98.0 mtt180 -67.69 -30.89 70.53 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.571 -1.331 . . . . 3.71 110.383 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.9 tp -58.53 -44.96 89.75 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.268 -1.012 . . . . 1.87 108.268 -179.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 66.1 mt -61.43 -43.97 97.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 1.29 110.192 178.631 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -70.02 -40.21 75.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.89 . . . . 3.05 109.891 -179.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -65.79 -37.92 87.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.671 -0.643 . . . . 1.26 111.048 -178.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.4 mt -66.98 -46.79 84.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 120.638 -1.289 . . . . 1.34 108.165 179.583 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 92.3 mt -70.16 -31.71 69.33 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.644 -0.66 . . . . 1.6 109.675 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.87 42.41 6.79 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.017 -1.633 . . . . 0.96 109.017 -178.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 tp -74.52 152.96 39.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.466 -1.02 . . . . 1.67 109.095 -179.654 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -64.23 143.24 58.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.083 -1.01 . . . . 4.96 109.626 -179.487 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.8 mt -115.4 121.77 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 CA-C-O 122.434 1.112 . . . . 1.68 109.22 179.279 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.2 mt -60.13 -47.74 90.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-N 115.019 -0.991 . . . . 2.14 110.858 -178.659 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.5 t0 62.92 106.04 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.615 -0.883 . . . . 1.5 108.615 -178.818 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.5 mt -69.33 0.3 5.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.296 -0.877 . . . . 1.39 110.174 -178.58 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 83.1 p -83.66 -13.87 53.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.048 -1.032 . . . . 1.83 110.379 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.64 28.23 0.49 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.112 -0.992 . . . . 1.46 111.916 -178.374 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 32.3 mm -90.58 118.15 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.484 -1.385 . . . . 1.42 108.405 179.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -104.88 -10.59 17.22 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.391 -0.818 . . . . 2.94 110.337 -178.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -126.48 150.94 48.42 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.097 -1.002 . . . . 1.52 109.832 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -63.98 133.02 52.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.436 -0.79 . . . . 1.58 109.731 -179.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.4 m -152.66 166.43 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.425 -0.797 . . . . 1.32 110.321 179.729 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 76.3 mt -95.82 147.86 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 105.994 -1.854 . . . . 1.27 105.994 177.214 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 48.7 tp -100.04 119.22 37.94 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.714 -1.241 . . . . 1.41 110.626 -177.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.84 129.96 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 107.978 -1.119 . . . . 1.23 107.978 178.64 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.46 161.96 35.55 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.125 -0.984 . . . . 1.32 109.069 -179.157 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.94 -37.25 75.82 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.111 -1.618 . . . . 1.49 107.294 178.412 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 13.1 p-10 -171.15 147.0 2.49 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.385 -0.598 . . . . 2.25 109.385 178.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.7 mt -106.04 141.36 37.55 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.336 -0.853 . . . . 1.35 108.926 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 82.1 p -94.38 144.66 28.35 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.22 -0.925 . . . . 1.56 108.828 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -40.13 -40.54 2.85 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.887 1.724 . . . . 0.87 112.268 179.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.402 ' CB ' HH22 ' A' ' 136' ' ' ARG . 61.4 m -60.42 -40.0 89.45 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.391 -0.818 . . . . 1.36 110.218 -179.646 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.45 -43.47 85.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.145 -0.972 . . . . 1.61 110.147 -179.099 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 40.2 p -55.67 -31.87 62.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.067 -1.021 . . . . 1.21 111.007 -178.007 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.73 -50.78 40.26 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.064 -1.023 . . . . 1.21 110.106 -179.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -88.7 39.36 0.92 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.482 -0.933 . . . . 2.11 108.482 -179.954 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.5 tp -103.35 138.03 40.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.683 -0.636 . . . . 1.29 109.567 179.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -87.55 101.32 13.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.345 -0.847 . . . . 2.81 109.648 179.849 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 46.6 mt -64.23 -42.22 96.65 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.403 -0.811 . . . . 2.09 110.379 -179.34 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.53 -27.56 66.2 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.846 -1.158 . . . . 2.86 112.45 -177.737 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -92.69 -8.31 44.33 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.584 -1.322 . . . . 2.39 110.429 -178.657 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 68.9 t -107.7 119.83 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.198 -0.939 . . . . 1.27 108.959 179.112 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.1 mt -88.84 8.37 29.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.287 -0.883 . . . . 2.17 111.227 -177.706 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 167.58 175.14 37.23 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.535 -1.426 . . . . 0.52 109.535 179.346 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -134.79 130.04 35.5 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.365 -1.079 . . . . 0.55 108.62 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 95.7 mt -132.34 126.54 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.194 -0.941 . . . . 1.27 109.156 179.381 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 41.0 p -149.89 162.87 39.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.925 -1.109 . . . . 1.39 111.051 -179.696 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 183' ' ' ALA . 35.5 p-10 -106.19 23.23 14.4 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.787 -0.57 . . . . 2.46 109.505 -179.767 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -56.62 -161.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.778 -1.201 . . . . 1.51 111.588 -177.689 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.04 -56.54 5.71 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.772 -0.931 . . . . 2.23 110.772 -178.652 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 171.83 -142.37 6.89 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 118.612 -1.756 . . . . 2.23 111.349 -179.448 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.502 ' C ' ' H ' ' A' ' 188' ' ' SER . 97.3 mtt180 -69.66 -31.02 68.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.853 -0.793 . . . . 6.44 110.905 -178.535 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 82.5 p -62.62 2.17 0.31 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.0 -1.063 . . . . 4.09 109.803 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.502 ' H ' ' C ' ' A' ' 186' ' ' ARG . 78.4 p -91.71 139.71 30.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.937 -1.102 . . . . 2.2 110.552 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -55.5 -39.53 70.59 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.784 -0.821 . . . . 1.15 108.784 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.0 p -57.52 -41.42 80.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.613 -0.68 . . . . 2.01 109.543 -179.538 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 186' ' ' ARG . 82.8 p -69.28 -38.08 78.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.178 -0.951 . . . . 1.93 111.255 -179.402 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.12 -44.48 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.885 -1.134 . . . . 2.2 110.106 -178.375 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.1 mtp -61.41 -40.3 93.92 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.041 -1.037 . . . . 1.32 111.18 -179.374 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.82 -42.66 76.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.683 -1.26 . . . . 1.3 109.113 -179.776 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -59.99 -51.79 68.15 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.088 -1.007 . . . . 3.38 109.263 -179.267 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.0 m -68.5 -36.89 79.56 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.449 -0.782 . . . . 1.15 111.106 -179.128 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 87.6 mt -69.91 -27.89 65.16 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.984 -1.117 . . . . 1.28 107.984 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 63.54 50.0 2.93 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.147 0.499 . . . . 1.5 110.587 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.477 ' O ' ' CB ' ' A' ' 8' ' ' SER . 77.0 mt -130.64 147.86 67.77 Favored Pre-proline 0 N--CA 1.505 2.285 0 N-CA-C 108.401 -0.963 . . . . 1.37 108.401 178.501 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -44.82 126.23 7.21 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.163 1.909 . . . . 0.76 112.65 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.32 139.85 12.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.537 -1.352 . . . . 1.19 111.963 179.44 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.6 mt -125.28 146.05 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.287 -1.375 . . . . 1.31 107.287 178.147 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.4 -4.82 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 120.84 -1.163 . . . . 1.38 110.588 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.91 21.21 27.9 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 110.831 -0.908 . . . . 1.03 110.831 -179.08 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.1 p -45.01 -41.06 7.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.03 -1.277 . . . . 1.38 110.261 -179.516 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.83 -50.98 3.79 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.201 -0.999 . . . . 1.17 111.005 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.3 t -158.57 38.45 0.23 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.588 -1.536 . . . . 2.07 111.354 -179.093 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.9 t -76.65 -39.38 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.819 -1.175 . . . . 1.35 108.967 178.582 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.8 p -57.09 -39.79 75.71 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.648 -0.657 . . . . 1.49 111.174 -177.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.0 p -80.03 -13.41 59.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.014 -1.053 . . . . 2.16 110.129 -178.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -95.51 -14.58 23.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.119 -0.988 . . . . 2.89 109.882 -179.404 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 55.1 t -114.16 152.74 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.358 -0.839 . . . . 1.33 110.994 -178.845 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -122.12 158.57 29.02 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.875 -1.158 . . . . 2.73 107.875 179.179 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 13.0 t-20 -54.69 140.36 35.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.177 -0.952 . . . . 2.7 111.075 -179.04 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.7 t70 84.38 10.58 0.39 Allowed 'General case' 0 N--CA 1.504 2.249 0 CA-C-O 120.991 0.424 . . . . 2.38 110.88 179.105 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -80.1 139.75 36.73 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.923 -1.11 . . . . 2.09 109.049 179.211 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -87.44 128.07 35.22 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.034 -1.098 . . . . 1.45 108.034 179.154 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 58.3 mt -131.71 138.76 48.8 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.199 -0.938 . . . . 1.31 110.532 -178.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 219' ' ' ILE . 71.9 mt -111.61 125.48 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.484 -1.673 . . . . 1.29 106.484 176.802 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 29.8 tp -103.51 119.74 39.49 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.861 -1.149 . . . . 1.31 108.944 -179.234 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.56 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 23.2 p-10 -81.51 -37.13 28.35 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.048 -1.093 . . . . 2.31 108.048 178.966 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.448 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 46.86 17.93 0.06 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.732 -0.84 . . . . 1.19 108.732 -179.304 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 221' ' ' ASP . 55.3 t -135.96 -41.02 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.912 -1.144 . . . . 1.45 107.912 178.941 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -97.75 1.09 48.07 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.623 -1.251 . . . . 3.13 107.623 178.386 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.535 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 29.7 t-20 60.53 42.96 13.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.753 -0.592 . . . . 2.2 109.964 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.56 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 92.0 mt-30 -140.94 148.26 40.11 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.177 -0.952 . . . . 2.32 109.611 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -120.06 126.56 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.115 -1.068 . . . . 1.4 108.115 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -98.67 126.23 44.21 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.526 -1.287 . . . . 1.29 107.526 178.906 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.86 125.1 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.634 -0.666 . . . . 1.38 110.177 -177.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 53.78 68.4 2.86 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.135 -0.978 . . . . 2.33 108.839 -179.656 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -91.22 131.5 1.42 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 123.25 2.634 . . . . 0.95 112.588 -178.914 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 23.5 m -63.54 166.51 6.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.315 -0.866 . . . . 2.31 109.769 -179.232 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -60.04 -40.08 88.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.134 -0.979 . . . . 3.45 110.045 -179.311 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -64.55 -32.18 73.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.965 -1.084 . . . . 2.89 110.092 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.53 -39.61 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.058 -1.026 . . . . 1.73 108.532 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.8 mt -66.65 -40.09 85.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.377 -0.827 . . . . 1.57 109.022 179.219 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.56 -40.88 93.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.197 -0.939 . . . . 2.43 109.58 179.605 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -68.39 -40.18 81.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.091 -1.006 . . . . 3.18 109.517 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 86.2 mtp -71.89 -24.52 61.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.11 -0.993 . . . . 1.59 109.827 179.251 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -72.67 -40.09 66.56 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.015 -1.053 . . . . 3.11 109.378 178.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.84 94.7 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.269 -1.012 . . . . 2.17 108.269 179.498 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.95 -40.13 78.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.741 -0.837 . . . . 2.51 108.741 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -60.17 -42.55 95.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.44 -0.788 . . . . 3.82 109.844 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.01 -40.15 88.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -0.854 . . . . 1.78 109.369 -179.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -65.02 -40.08 94.35 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.957 -1.089 . . . . 2.77 108.664 179.803 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.55 -45.37 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.842 -0.799 . . . . 2.25 108.842 179.51 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.55 -42.1 98.39 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.563 -0.903 . . . . 2.54 108.563 179.443 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 94.7 p -64.69 -41.51 95.99 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.5 -0.75 . . . . 3.03 109.351 179.734 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.476 ' O ' ' N ' ' A' ' 253' ' ' LEU . 17.5 tp10 -64.31 -39.92 94.88 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.757 0.789 . . . . 3.34 108.969 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -60.4 -42.74 96.57 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.659 -0.651 . . . . 4.18 110.815 -179.521 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -73.67 -40.63 63.55 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.148 -0.97 . . . . 4.43 110.999 -179.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' A' ' 253' ' ' LEU . 67.8 mm-40 -90.96 -15.62 29.41 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.337 -0.852 . . . . 5.42 110.998 -178.27 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 249' ' ' GLU . 3.8 mp 44.26 34.68 1.07 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.098 -1.001 . . . . 6.11 109.907 -179.525 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 258' ' ' ASP . . . -87.64 35.39 0.72 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.431 -0.952 . . . . 7.37 108.431 179.692 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.426 ' N ' ' OE2' ' A' ' 249' ' ' GLU . 87.3 tttt -59.87 -49.03 79.29 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.374 -0.829 . . . . 8.3 110.0 -179.011 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 62.4 tp -69.22 -41.1 77.49 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.817 -1.177 . . . . 9.05 109.326 179.247 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -70.64 -60.08 2.46 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.431 -0.793 . . . . 10.56 109.83 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 254' ' ' ALA . 60.4 m-20 -105.91 75.5 1.12 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.502 -0.749 . . . . 11.32 109.093 -179.822 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 . . . . . 0 C--N 1.296 -1.752 0 CA-C-O 117.926 -1.035 . . . . 12.74 109.185 179.5 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' B' B ' 301' ' ' MET . . . . . 0.415 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 37.0 ttp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.407 0.622 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . 0.415 ' N ' ' CG ' ' B' ' 301' ' ' MET . 16.8 t80 -152.44 148.8 27.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.353 -0.842 . . . . 0.0 108.871 179.552 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -152.36 163.59 39.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.889 -1.132 . . . . 0.0 110.573 -179.317 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -156.81 153.57 28.5 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.618 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 56.4 mp0 -115.08 130.9 57.04 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.203 -0.936 . . . . 0.0 109.414 179.029 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.55 125.32 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.425 0 CA-C-O 122.371 1.082 . . . . 0.0 111.435 -178.13 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 36.6 m -81.07 103.65 11.02 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.913 0.863 . . . . 0.0 111.114 -178.02 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . 0.454 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.6 mt -52.22 121.5 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.456 1.122 . . . . 0.0 110.952 -177.627 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 74.1 p -106.33 18.01 22.6 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.066 -178.427 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.32 118.89 71.45 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.65 -1.281 . . . . 0.0 109.221 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -52.41 -15.01 3.42 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 CA-C-N 120.176 1.098 . . . . 0.0 112.569 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -118.91 8.52 11.71 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.54 177.89 31.98 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -179.298 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.435 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -85.93 93.19 8.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -1.184 . . . . 0.0 108.527 -179.192 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . 0.451 ' CA ' ' OH ' ' A' ' 122' ' ' TYR . 4.1 p80 -96.66 -160.15 0.78 Allowed 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.109 -0.994 . . . . 0.0 109.958 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.3 m -59.38 -43.12 92.96 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.831 -1.168 . . . . 0.0 112.146 -176.032 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.512 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 2.5 tpt180 -57.56 -61.82 6.51 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.453 -1.404 . . . . 0.0 111.703 -178.485 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . 0.405 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 13.8 Cg_endo -59.42 -32.99 97.4 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 CA-C-N 119.932 1.011 . . . . 0.0 111.516 -179.431 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.27 -51.53 69.14 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.162 -0.961 . . . . 0.0 109.072 179.74 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.2 -41.71 62.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -0.85 . . . . 0.0 109.587 -178.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -71.33 -40.03 71.0 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.911 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -61.95 -54.78 37.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.426 -0.796 . . . . 0.0 109.784 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 89.8 t -61.33 -26.56 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.957 -1.09 . . . . 0.0 110.173 -178.899 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -63.02 -44.24 96.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.426 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -69.89 -40.14 75.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.383 -0.823 . . . . 0.0 111.731 -178.027 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' B' ' 328' ' ' GLY . . . -65.53 -55.86 15.49 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.3 -1.5 . . . . 0.0 111.924 -178.354 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -48.21 -10.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.033 -1.042 . . . . 0.0 110.281 -178.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' B' ' 326' ' ' ALA . . . -81.63 -15.35 76.01 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.23 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -107.07 140.42 39.91 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.377 -1.072 . . . . 0.0 109.255 179.433 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 16.9 m -91.31 -11.64 37.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 110.238 -179.981 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 331' ' ' SER . . . . . 0.7 ' HG ' ' H ' ' B' ' 369' ' ' ASP . 35.9 m -64.77 155.11 34.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.759 -1.213 . . . . 0.0 109.591 179.656 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -70.76 133.83 46.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.89 -1.131 . . . . 0.0 108.315 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 90.2 mt -131.79 133.5 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-O 121.362 0.601 . . . . 0.0 109.954 -179.692 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.4 m -130.08 148.61 51.95 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.445 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 79.7 t -120.29 114.96 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 177.459 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 92.7 m -105.46 124.95 50.4 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.227 -0.92 . . . . 0.0 109.709 -178.289 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 48.4 t -134.35 120.5 19.97 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.139 0.971 . . . . 0.0 111.59 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 66.6 t30 45.37 50.99 9.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 176.717 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.7 -11.97 68.62 Favored Glycine 0 N--CA 1.501 3.031 0 O-C-N 120.155 -1.591 . . . . 0.0 113.15 176.472 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . 0.459 ' HB2' ' HZ1' ' B' ' 340' ' ' LYS . 3.0 ttmp? -126.44 138.87 53.58 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 119.389 1.594 . . . . 0.0 109.432 -179.809 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 60.2 p -130.58 152.69 49.67 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.118 0.961 . . . . 0.0 111.236 -178.512 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -143.31 163.59 32.59 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.494 0.664 . . . . 0.0 109.52 -179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 10.8 t -87.52 135.89 33.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.637 -0.665 . . . . 0.0 110.821 -178.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.551 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -68.06 -21.31 65.0 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.107 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -80.3 25.18 0.41 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.037 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.551 ' H ' ' C ' ' B' ' 344' ' ' ALA . 58.4 m -152.92 92.94 1.69 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.814 -1.154 . . . . 0.0 113.266 -178.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 57.8 tp -59.53 -34.26 72.41 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 177.225 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . 0.41 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 55.4 m-85 -58.81 -53.3 59.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.707 -0.621 . . . . 0.0 110.264 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -78.26 -16.45 57.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.771 -1.206 . . . . 0.0 110.619 -177.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.604 ' O ' ' N ' ' B' ' 352' ' ' THR . 26.4 mt -69.64 -56.16 8.02 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.146 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.414 HE22 HG23 ' A' ' 130' ' ' VAL . 30.3 mt-30 -40.82 -12.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.103 -178.62 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.604 ' N ' ' O ' ' B' ' 350' ' ' LEU . 59.2 p -90.82 -8.19 50.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.52 -1.362 . . . . 0.0 109.954 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 85.0 mt -96.74 121.1 38.22 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.092 -1.005 . . . . 0.0 109.384 179.371 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.5 90.53 0.94 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 20.2 mt -99.79 91.94 5.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.19 -1.182 . . . . 0.0 108.855 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 38.0 p -94.01 -179.19 4.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.276 -0.89 . . . . 0.0 110.545 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -69.84 110.1 4.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.849 -0.532 . . . . 0.0 110.118 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 104.16 9.72 35.94 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 28.4 m -84.76 110.77 19.04 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.156 -1.202 . . . . 0.0 110.888 -179.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 27.2 t -77.12 111.86 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 122.237 1.018 . . . . 0.0 109.747 -177.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 17.5 m -109.03 175.02 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 32.3 m -131.79 128.61 39.15 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.647 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 95.0 mt -103.33 115.41 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.521 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 77.3 p -120.13 132.65 55.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.393 -0.817 . . . . 0.0 109.128 -179.356 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.81 152.61 40.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.898 . . . . 0.0 108.949 -179.057 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -147.71 125.45 11.87 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.16 -0.963 . . . . 0.0 109.471 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.495 ' O ' ' OE1' ' B' ' 370' ' ' GLU . . . 154.02 -148.97 20.26 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.277 -1.44 . . . . 0.0 111.532 179.824 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -60.02 -51.69 68.56 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.7 ' H ' ' HG ' ' B' ' 331' ' ' SER . 89.1 m-20 -112.71 13.77 19.89 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 120.835 -1.165 . . . . 0.0 111.267 -177.681 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.584 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 1.0 OUTLIER -42.39 -32.57 0.54 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.271 -0.893 . . . . 0.0 111.477 -179.011 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . 0.553 ' H ' ' CD ' ' B' ' 370' ' ' GLU . 10.3 pt20 -70.94 -43.2 68.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.853 -1.154 . . . . 0.0 110.205 -178.745 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -69.43 -54.25 15.26 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.377 -0.827 . . . . 0.0 109.159 179.473 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.86 -34.51 8.93 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.621 -0.674 . . . . 0.0 112.252 -178.398 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 69.4 t -80.99 -36.29 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.468 -1.395 . . . . 0.0 108.926 178.756 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -70.89 -38.97 73.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.657 -0.652 . . . . 0.0 111.269 179.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -82.54 -48.98 10.39 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.798 -1.189 . . . . 0.0 111.694 -178.235 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.02 -30.68 69.33 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.164 -0.96 . . . . 0.0 109.464 -179.096 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 55.0 t -79.78 -31.62 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 0.0 109.416 179.25 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -77.35 -22.22 52.11 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.689 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 31.9 tp -78.25 -67.76 0.7 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 5.6 ttp -56.01 -22.99 30.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.925 . . . . 0.0 109.788 -178.619 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.83 -22.2 58.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.928 -1.108 . . . . 0.0 108.705 177.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -104.21 2.52 31.81 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.42 -0.8 . . . . 0.0 111.677 -178.362 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 85.0 mt -85.03 125.47 32.76 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.219 -1.551 . . . . 0.0 109.739 179.739 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.052 179.004 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.2 mtp . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.255 -0.646 . . . . 3.19 109.255 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.446 ' O ' ' O ' ' A' ' 225' ' ' ASN . 89.8 mt -107.58 129.02 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.613 -0.884 . . . . 1.71 108.613 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.9 m -130.76 141.45 50.36 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.606 -0.684 . . . . 1.66 109.744 -179.653 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.689 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -138.07 -165.04 10.2 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 108.291 -1.924 . . . . 1.05 108.291 179.122 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.435 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.8 mt -91.99 -10.83 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.888 -1.36 . . . . 1.59 110.377 -179.05 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 5' ' ' ILE . 34.9 tp 52.62 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.973 -1.08 . . . . 1.47 108.839 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.59 -34.25 23.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 1.39 109.042 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -143.4 132.33 11.45 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.416 -0.803 . . . . 2.09 108.881 179.509 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.92 147.19 18.91 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.193 1.929 . . . . 0.91 113.477 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.421 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 165.53 -164.66 37.43 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.576 -1.41 . . . . 0.92 109.576 179.474 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.42 HD12 HG21 ' A' ' 11' ' ' ILE . 65.5 mt -146.45 147.82 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.26 -1.141 . . . . 1.35 108.741 179.053 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.91 154.64 31.53 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.541 -1.35 . . . . 1.14 110.979 -179.618 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.5 m-85 -136.31 129.26 31.15 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 108.245 -1.02 . . . . 0.7 108.245 178.819 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.5 -179.7 45.65 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.577 -1.773 . . . . 0.58 110.802 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -80.4 152.85 28.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.613 -0.934 . . . . 2.63 108.95 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.24 132.0 44.87 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.093 -1.004 . . . . 1.27 110.906 -178.078 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.4 tp -100.37 133.61 44.54 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.389 -1.338 . . . . 1.41 107.389 178.084 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.1 tp -115.43 121.34 42.46 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.207 -0.933 . . . . 1.49 109.949 -179.025 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 66.8 mt -91.29 106.22 18.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.521 -0.737 . . . . 1.52 109.881 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.475 ' NZ ' ' CB ' ' A' ' 20' ' ' LYS . 7.8 mtpm? -101.87 137.69 39.83 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.89 -0.781 . . . . 3.17 108.89 179.234 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 55.4 mp0 -127.81 128.76 45.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.373 -0.829 . . . . 3.0 108.795 179.689 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -71.89 149.85 44.77 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.044 -1.035 . . . . 2.77 108.474 179.639 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -67.52 139.98 57.0 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.924 -1.11 . . . . 2.94 108.576 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.8 mt -80.17 130.27 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 1.46 109.172 -179.463 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.1 t -99.24 129.75 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.203 -0.936 . . . . 1.7 111.08 -178.413 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.0 mt -109.85 131.21 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.654 -0.869 . . . . 1.54 108.654 179.031 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -81.61 127.37 32.8 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.878 -1.139 . . . . 1.81 109.815 -179.449 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.483 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.6 mmt-85 -90.75 -5.72 55.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.514 -0.742 . . . . 3.23 109.221 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -70.76 139.95 51.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 3.29 109.548 -179.668 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -80.96 151.97 28.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 2.8 109.027 179.184 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.2 pt -93.68 165.08 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 1.43 109.884 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.8 p -98.22 168.72 10.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.997 -1.064 . . . . 1.54 108.952 178.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.15 -13.65 39.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.126 -0.984 . . . . 1.6 110.104 -179.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -86.1 -30.19 22.75 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.678 -1.23 . . . . 2.56 107.678 178.511 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -83.38 -7.58 59.54 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.515 -0.55 . . . . 2.36 109.515 179.082 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 t -64.97 -56.33 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.734 -1.229 . . . . 1.43 109.174 179.719 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.06 -39.91 87.62 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.236 -0.915 . . . . 1.77 109.472 179.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -70.22 -41.06 74.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 3.32 110.688 -179.254 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -65.3 -39.98 93.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.031 -1.043 . . . . 1.51 110.134 -179.442 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.94 -44.58 94.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.882 -1.136 . . . . 1.41 107.96 179.424 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -59.91 -38.96 83.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.14 -0.975 . . . . 1.81 108.978 179.641 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -59.87 -43.03 94.93 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.635 -1.246 . . . . 3.26 107.635 179.335 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.96 -49.28 78.29 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.229 -1.026 . . . . 0.81 108.229 178.053 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.6 tp -60.0 -47.99 83.53 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.954 -0.758 . . . . 1.59 108.954 179.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.5 t -60.75 -44.5 96.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.949 -1.094 . . . . 1.38 108.782 178.97 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.09 -41.29 98.0 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.723 -2.151 . . . . 0.87 107.723 178.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -64.35 -34.86 79.12 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.557 -0.967 . . . . 3.62 108.514 178.26 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.445 ' O ' ' OG ' ' A' ' 51' ' ' SER . . . -54.48 -42.72 71.03 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.482 -0.761 . . . . 1.43 109.523 -179.286 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.457 ' HZ3' ' CA ' ' A' ' 140' ' ' ASN . 19.7 ttpp -73.9 -73.06 0.24 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.629 -1.249 . . . . 3.08 107.629 179.368 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.57 -34.24 0.09 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.445 -0.784 . . . . 1.33 111.035 -178.852 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 48' ' ' ALA . 90.3 p -57.43 -57.4 12.82 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.576 -1.327 . . . . 1.85 107.699 179.17 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.83 80.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.604 -0.685 . . . . 1.35 111.604 -179.2 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -68.86 -40.28 79.41 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.562 -1.337 . . . . 2.34 110.314 -178.646 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.49 -40.13 89.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.01 -1.056 . . . . 2.2 108.801 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.485 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 65.3 mm-40 -62.87 -40.0 96.15 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.251 -0.906 . . . . 1.35 109.11 179.104 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.463 ' CG2' ' NZ ' ' A' ' 60' ' ' LYS . 94.8 m -63.08 -39.92 96.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 1.34 110.133 179.857 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.0 mt -61.15 -40.98 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.012 -1.055 . . . . 1.26 108.973 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.485 ' NZ ' ' OE1' ' A' ' 55' ' ' GLU . 5.4 ttpm? -59.91 -50.45 73.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.279 -0.888 . . . . 1.7 110.103 -179.641 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -60.14 -39.98 88.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 1.35 110.841 -177.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.463 ' NZ ' ' CG2' ' A' ' 56' ' ' THR . 24.3 mttp -62.82 -38.66 91.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -0.911 . . . . 2.08 109.442 179.684 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.24 -39.97 96.11 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.541 -0.724 . . . . 1.21 109.435 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.63 -55.99 23.98 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.309 -1.516 . . . . 0.75 109.309 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.07 -49.86 72.86 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.973 -1.31 . . . . 1.59 109.694 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.1 m -65.8 -61.36 2.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.067 -1.02 . . . . 1.41 111.679 -177.749 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -94.73 -56.24 2.85 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.996 -1.065 . . . . 0.79 111.256 -178.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.4 -165.21 26.79 Favored Glycine 0 N--CA 1.5 2.956 0 C-N-CA 119.811 -1.185 . . . . 1.22 111.131 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -70.01 -25.77 63.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.935 -0.744 . . . . 5.81 110.553 -179.115 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.43 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.6 tp10 -60.29 -37.45 80.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.039 -1.038 . . . . 3.37 110.162 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -100.22 -19.86 16.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.397 -0.814 . . . . 2.37 110.72 -179.179 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -69.92 -42.96 72.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.793 -1.192 . . . . 1.65 110.174 -179.427 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.22 -30.72 70.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.505 -0.747 . . . . 1.42 109.499 -179.315 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 80.0 mt -60.1 -43.18 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.107 -0.996 . . . . 1.43 109.872 -179.569 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -74.84 -30.61 61.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.242 -0.911 . . . . 1.08 110.579 -178.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.518 ' CD ' ' HZ3' ' B' ' 324' ' ' LYS . 64.8 tt0 -61.57 -39.93 92.92 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.814 -1.179 . . . . 1.37 109.522 178.674 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.23 -46.95 93.44 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.87 -1.692 . . . . 0.67 108.87 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -60.01 -44.44 94.58 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.343 -1.093 . . . . 1.99 108.515 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.4 mt -62.75 -50.02 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 109.053 -0.721 . . . . 1.22 109.053 179.35 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -60.01 -40.59 89.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 2.11 109.54 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 43.8 tp -63.86 -40.03 95.6 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.518 -0.739 . . . . 1.33 109.552 179.335 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -68.85 -38.42 79.76 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.768 -0.583 . . . . 1.29 110.437 -178.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.34 0.36 29.33 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.017 -1.052 . . . . 1.47 110.048 -179.292 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.7 t0 -47.78 130.86 14.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.201 -0.937 . . . . 1.47 110.38 -178.934 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.41 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 93.9 mt-10 -61.94 -18.54 60.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.659 . . . . 1.78 111.086 -179.192 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.88 -33.72 66.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.818 -1.176 . . . . 2.53 108.855 178.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.07 -41.01 74.68 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.099 -0.704 . . . . 1.36 109.099 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.88 -48.68 80.7 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.216 -0.928 . . . . 1.42 110.76 -179.13 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.23 -39.99 74.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.415 -0.803 . . . . 2.27 111.076 -178.579 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -69.81 -39.93 76.24 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.277 -0.89 . . . . 1.57 110.839 -178.581 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.9 mt -69.02 -41.57 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.28 -0.888 . . . . 1.19 109.398 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.416 HG23 ' HZ1' ' A' ' 94' ' ' LYS . 82.4 mt -69.73 -39.68 78.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.505 -0.747 . . . . 1.39 110.3 -179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.0 -42.88 99.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.222 -0.924 . . . . 1.39 111.208 -178.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 49.1 mt -60.81 -46.97 88.44 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.709 -1.245 . . . . 1.5 109.372 -179.694 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.3 mt -60.17 -49.2 85.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.851 0.834 . . . . 1.29 108.9 179.509 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.416 ' HZ1' HG23 ' A' ' 90' ' ' ILE . 40.5 mttp -69.98 -40.53 75.3 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.909 -0.495 . . . . 2.64 111.309 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -81.02 -57.0 3.73 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.952 -1.092 . . . . 1.65 112.099 -177.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -90.95 0.08 57.61 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.093 -1.004 . . . . 2.5 112.603 -176.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 54.6 m80 58.29 39.76 25.27 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.928 -1.108 . . . . 1.88 109.877 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.0 mtp -89.54 166.85 13.4 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.516 -0.74 . . . . 1.71 110.036 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.6 p -80.37 159.67 25.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.365 -0.835 . . . . 1.61 108.923 179.491 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.67 -40.06 80.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.113 -0.992 . . . . 1.33 109.965 -179.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 32.2 p-10 -68.0 -37.12 81.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 2.07 109.57 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.503 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -81.56 -41.38 21.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 1.37 109.824 179.216 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.03 -47.68 73.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.277 -0.889 . . . . 1.14 109.705 -179.686 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.86 87.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.115 -0.991 . . . . 1.26 109.543 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -59.89 -40.09 87.54 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.337 -0.852 . . . . 2.02 110.12 -179.244 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -60.92 -44.17 97.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.347 -0.846 . . . . 1.33 110.792 -179.365 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.6 t -61.54 -50.47 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.16 -0.963 . . . . 1.3 111.009 -177.847 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.5 mm -69.32 -39.88 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.021 -1.049 . . . . 1.32 108.637 179.493 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 41.3 tp10 -61.53 -40.0 93.07 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.869 -0.789 . . . . 2.44 108.869 179.198 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.56 -48.41 84.84 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.534 -0.841 . . . . 0.99 111.235 -178.8 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -69.15 -49.85 53.11 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.686 -1.479 . . . . 1.97 110.827 -178.335 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.98 87.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.916 -1.115 . . . . 1.43 109.559 -179.257 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 40.8 t -59.45 -40.08 85.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.019 -1.05 . . . . 2.12 108.995 179.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.56 -43.85 96.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.3 -0.875 . . . . 1.64 109.2 179.451 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.7 mt -61.7 -41.0 97.02 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.33 -0.856 . . . . 1.93 109.45 -178.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -59.99 -37.77 80.63 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.076 -1.015 . . . . 2.2 109.483 -179.291 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -52.06 -22.18 3.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.043 -1.036 . . . . 2.12 109.169 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 49.7 mt -62.32 140.1 58.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.051 -1.031 . . . . 2.34 109.01 -179.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -89.93 38.01 0.91 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.127 -0.983 . . . . 3.23 110.249 -178.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 57.9 t0 -129.8 145.95 51.56 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.344 -0.848 . . . . 2.49 109.228 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 124' ' ' LYS . 88.0 tt0 -72.71 -66.52 0.65 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.412 -0.805 . . . . 3.95 109.1 179.656 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 121' ' ' GLU . 3.5 t80 -38.71 -36.19 0.24 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.789 -0.569 . . . . 2.25 110.622 -178.874 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.0 mt -79.24 -34.76 42.42 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.736 -1.228 . . . . 2.27 108.569 179.192 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 121' ' ' GLU . 7.4 ttpm? -68.17 -39.99 82.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 3.31 109.546 179.473 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.89 -40.31 94.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 2.73 109.265 -179.615 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.524 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -60.84 -38.23 84.79 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.429 -0.952 . . . . 3.2 108.429 -179.892 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.33 -26.92 65.44 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.518 -0.919 . . . . 1.66 108.518 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.47 -39.99 81.18 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.447 -0.946 . . . . 1.67 108.447 178.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -66.84 -42.72 85.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.505 -0.747 . . . . 1.55 109.998 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.23 -41.25 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 1.32 108.922 179.448 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 37.6 ttm-85 -60.64 -39.92 90.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.072 -1.017 . . . . 3.58 108.817 178.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -60.15 -34.43 73.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.57 -0.706 . . . . 1.46 109.617 -179.72 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.1 -43.09 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.135 -0.978 . . . . 1.22 109.55 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.92 -27.61 62.24 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.838 -1.305 . . . . 0.61 109.838 -179.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -59.98 -50.19 74.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.981 -1.305 . . . . 3.1 110.094 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -67.75 -32.11 72.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.999 -1.063 . . . . 3.71 109.348 -179.619 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.39 -41.67 89.94 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.914 -0.773 . . . . 1.87 108.914 -179.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.3 -40.01 94.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.967 . . . . 1.29 109.182 179.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.6 mtp180 -70.04 -40.06 75.38 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.971 0.891 . . . . 3.05 108.729 179.104 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.476 HD21 ' N ' ' A' ' 140' ' ' ASN . 2.2 m120 -60.74 -38.23 84.47 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 116.002 -0.544 . . . . 1.26 111.466 -178.539 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 141' ' ' ILE . 97.3 mt -70.33 -39.94 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.811 -1.181 . . . . 1.34 109.811 -179.745 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 54.2 mt -71.85 -20.56 61.8 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.397 -0.814 . . . . 1.6 110.241 -178.555 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.9 40.84 13.5 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.044 -1.622 . . . . 0.96 109.044 -179.189 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.3 tp -75.24 149.98 38.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.362 -1.081 . . . . 1.67 109.859 -179.361 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -74.71 141.79 44.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.513 -0.742 . . . . 4.96 109.949 -179.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.428 HG23 HD11 ' A' ' 146' ' ' ILE . 96.7 mt -111.3 129.77 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 122.29 1.043 . . . . 1.68 108.84 178.802 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 15.0 mt -69.66 -39.96 78.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 115.411 -0.813 . . . . 2.14 110.398 -177.937 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.8 t0 68.18 127.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.741 -0.837 . . . . 1.5 108.741 -179.251 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 19.5 mt -92.03 0.04 57.47 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.316 -0.865 . . . . 1.39 110.266 -178.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 24.5 t -95.61 -11.79 26.7 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.041 -1.037 . . . . 1.83 110.185 -179.683 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.24 15.48 1.55 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.066 -1.021 . . . . 1.46 111.333 -178.581 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 2.8 mp -86.1 137.14 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.446 -1.409 . . . . 1.42 108.417 179.517 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -111.95 -10.45 13.96 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.537 -0.727 . . . . 2.94 109.356 -179.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -123.21 148.0 46.29 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.744 -0.597 . . . . 1.52 109.775 -179.522 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.33 138.91 58.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.449 -0.782 . . . . 1.58 109.164 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.5 m -152.59 166.65 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.658 -0.652 . . . . 1.32 109.804 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.416 HD12 HG21 ' A' ' 157' ' ' ILE . 92.9 mt -96.51 146.07 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 106.191 -1.781 . . . . 1.27 106.191 176.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.1 tp -96.69 118.33 32.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.891 -1.13 . . . . 1.41 110.94 -177.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.0 t -119.6 123.25 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 109.015 -0.735 . . . . 1.23 109.015 179.095 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -153.06 159.97 42.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 1.32 109.012 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.27 -31.35 64.02 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.346 -1.472 . . . . 1.49 108.956 179.287 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 46.2 t0 -169.97 140.51 2.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.415 -0.803 . . . . 2.25 108.933 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.488 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 26.5 mt -114.77 131.55 56.75 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.371 -0.831 . . . . 1.35 109.031 -179.582 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.9 p -95.07 148.6 34.95 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.132 -0.98 . . . . 1.56 110.128 -179.526 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -37.32 -39.06 0.56 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.652 2.235 . . . . 0.87 112.56 179.19 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.3 m -57.58 -39.87 77.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.282 -0.886 . . . . 1.36 108.93 -179.052 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -69.9 -39.9 75.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.169 -0.957 . . . . 1.61 109.666 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 45.7 p -56.57 -24.01 44.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.033 -1.042 . . . . 1.21 110.51 -178.23 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.39 -55.78 4.96 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.967 -1.083 . . . . 1.21 109.358 179.432 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -83.84 40.78 0.76 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.98 -1.119 . . . . 2.11 107.98 179.411 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 35.1 tp -103.37 130.14 50.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.739 -0.601 . . . . 1.29 109.611 179.501 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.489 ' N ' ' OD1' ' A' ' 172' ' ' ASN . 10.6 p-10 -86.15 97.92 10.61 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.954 -1.128 . . . . 2.81 107.954 178.243 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 56.3 mt -67.5 -41.49 84.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 2.09 111.119 -178.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -69.91 -26.83 64.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.658 -1.276 . . . . 2.86 112.222 -177.747 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -92.0 -5.94 52.1 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.556 -1.34 . . . . 2.39 109.513 -178.793 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.466 ' CG1' ' O ' ' A' ' 178' ' ' GLY . 60.9 t -107.28 119.66 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.688 -1.227 . . . . 1.27 107.688 178.168 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.1 mt -84.7 7.21 21.24 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.379 -0.825 . . . . 2.17 110.675 -177.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.466 ' O ' ' CG1' ' A' ' 176' ' ' VAL . . . 163.53 178.11 36.94 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.192 -1.563 . . . . 0.52 109.192 179.781 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -134.46 130.43 36.72 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.393 -1.063 . . . . 0.55 109.038 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 91.5 mt -130.63 125.2 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.204 -1.035 . . . . 1.27 108.204 178.844 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 65.6 p -149.69 160.32 43.62 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.845 -1.159 . . . . 1.39 110.682 -179.073 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.413 ' OD1' ' C ' ' A' ' 182' ' ' ASP . 4.1 p30 -108.69 27.19 9.68 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.513 -0.921 . . . . 2.46 108.513 179.283 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.25 -164.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.122 -0.986 . . . . 1.51 112.079 -177.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.63 -79.89 0.09 OUTLIER Glycine 0 N--CA 1.492 2.387 0 CA-C-N 115.793 -0.64 . . . . 2.23 111.579 -178.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.13 -151.64 6.07 Favored Glycine 0 N--CA 1.494 2.553 0 O-C-N 120.711 -1.464 . . . . 2.23 111.17 -178.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.436 ' O ' ' OG ' ' A' ' 191' ' ' SER . 47.6 ttt180 -79.73 -9.97 59.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.828 -0.807 . . . . 6.44 110.553 -178.448 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.9 p -84.55 3.12 38.09 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.101 -1.0 . . . . 4.09 110.856 -178.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.3 t -72.02 143.07 49.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.827 -1.17 . . . . 2.2 110.18 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -49.55 -50.21 43.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.235 -0.916 . . . . 1.15 110.128 -179.302 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.3 m -59.86 -40.23 87.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.368 -0.832 . . . . 2.01 110.32 -178.642 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.436 ' OG ' ' O ' ' A' ' 186' ' ' ARG . 52.2 p -59.93 -40.17 87.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.933 -1.104 . . . . 1.93 110.453 -178.941 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.0 -38.92 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.935 . . . . 2.2 109.526 -179.739 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.5 mtp -60.25 -39.89 88.36 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.858 . . . . 1.32 110.207 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.12 -45.71 83.25 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.834 -1.166 . . . . 1.3 109.725 -179.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.36 -49.79 76.19 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.077 -1.049 . . . . 3.38 110.298 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 30.6 m -69.94 -34.7 73.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.715 -1.24 . . . . 1.15 110.525 -179.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 84.4 mt -72.67 -21.59 61.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.009 -1.057 . . . . 1.28 108.973 179.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 62.15 50.79 3.8 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.395 0.617 . . . . 1.5 110.886 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 96.5 mt -126.35 149.96 68.8 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 107.468 -1.308 . . . . 1.37 107.468 178.355 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.3 135.5 50.55 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 122.25 1.967 . . . . 0.76 111.845 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.99 149.97 3.72 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.595 -1.242 . . . . 1.19 111.941 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 202' ' ' ILE . 97.0 mt -126.54 146.03 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.787 -1.19 . . . . 1.31 107.787 179.147 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.48 -9.25 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 120.86 -1.15 . . . . 1.38 111.547 -179.268 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.58 23.83 23.45 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 110.048 -1.221 . . . . 1.03 110.048 -179.584 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.9 p -45.55 -45.98 13.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.189 -1.183 . . . . 1.38 109.987 -179.644 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 93.47 -54.77 2.39 Favored Glycine 0 N--CA 1.503 3.119 0 O-C-N 121.017 -1.052 . . . . 1.17 112.025 178.811 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 93.3 p -152.76 29.58 0.52 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.551 -1.558 . . . . 2.07 111.248 -179.042 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 76.2 t -76.26 -34.95 26.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.948 -1.095 . . . . 1.35 108.957 178.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.6 p -57.46 -30.44 65.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.461 -0.774 . . . . 1.49 110.291 -179.124 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 57.5 p -83.77 -15.18 49.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.783 -1.198 . . . . 2.16 110.06 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -96.21 -12.75 24.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.09 -1.006 . . . . 2.89 109.953 -179.587 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 73.9 t -103.73 136.65 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.363 -0.836 . . . . 1.33 110.38 -178.479 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -110.1 150.1 29.08 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.748 -1.204 . . . . 2.73 107.748 178.803 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.67 ' N ' HD21 ' A' ' 214' ' ' ASN . 0.0 OUTLIER -58.6 137.08 57.71 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.902 -1.124 . . . . 2.7 110.053 -179.355 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.4 m-20 85.64 0.04 0.73 Allowed 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.2 0.524 . . . . 2.38 110.025 179.722 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 60.1 t0 -70.67 144.1 51.16 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.193 -0.942 . . . . 2.09 109.246 179.416 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.402 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 40.9 t80 -93.77 120.27 33.82 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.383 -0.969 . . . . 1.45 108.383 178.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.4 mt -129.39 150.81 50.58 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.458 -0.776 . . . . 1.31 110.766 -178.696 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.5 mt -115.28 127.88 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.143 -1.429 . . . . 1.29 107.143 177.362 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 61.8 tp -100.54 118.95 37.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.972 -1.08 . . . . 1.31 108.469 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.43 ' C ' ' N ' ' A' ' 223' ' ' VAL . 18.8 t0 -81.33 -41.23 22.38 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.846 -1.168 . . . . 2.31 107.846 179.403 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 48.21 18.76 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.013 -0.736 . . . . 1.19 109.013 -179.961 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.43 ' N ' ' C ' ' A' ' 221' ' ' ASP . 39.2 t -128.45 -42.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.114 -1.439 . . . . 1.45 107.114 178.507 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -104.78 8.11 34.81 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.509 -1.293 . . . . 3.13 107.509 178.062 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.689 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.9 OUTLIER 59.62 49.45 8.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.878 -0.514 . . . . 2.2 110.245 179.703 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.52 ' CD ' ' HH ' ' A' ' 228' ' ' TYR . 2.9 pt20 -147.94 149.9 33.05 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.817 -1.177 . . . . 2.32 110.766 179.885 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.45 122.05 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.304 -0.998 . . . . 1.4 108.304 179.035 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.52 ' HH ' ' CD ' ' A' ' 226' ' ' GLN . 91.9 m-85 -87.67 128.98 35.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.626 -1.296 . . . . 1.29 109.218 -179.491 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 33.1 t -104.06 119.55 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.421 -0.8 . . . . 1.38 110.197 -179.014 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 57.02 69.4 1.7 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.058 -1.026 . . . . 2.33 109.598 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -91.3 135.64 1.81 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.525 2.817 . . . . 0.95 112.8 -179.689 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 55.8 m -65.87 159.76 24.78 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.212 -0.93 . . . . 2.31 108.791 179.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -59.71 -38.06 80.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 3.45 108.939 -179.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.23 -39.33 86.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.361 -0.837 . . . . 2.89 109.533 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 88.1 t -61.28 -41.35 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.34 -0.85 . . . . 1.73 109.459 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.32 -40.0 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 1.57 109.865 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -59.82 -40.24 87.78 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.974 -1.079 . . . . 2.43 109.238 179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -63.84 -45.91 87.39 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.335 -0.853 . . . . 3.18 108.916 179.204 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 88.5 mtp -68.71 -32.8 72.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.514 -0.742 . . . . 1.59 109.917 179.808 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -63.07 -38.69 92.2 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.952 -1.093 . . . . 3.11 108.943 179.043 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.85 93.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 2.17 108.595 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 55.2 t -62.21 -40.44 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.907 . . . . 2.51 108.926 178.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -60.12 -38.57 83.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.484 -0.76 . . . . 3.82 109.479 -179.925 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -60.28 -40.72 91.42 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.135 -0.978 . . . . 1.78 109.182 -179.462 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -65.0 -39.63 93.75 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.904 -1.123 . . . . 2.77 108.283 179.271 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.9 t -61.71 -36.06 71.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.278 -1.008 . . . . 2.25 108.278 178.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.28 -38.04 79.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.525 -0.735 . . . . 2.54 109.24 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 64.0 m -60.0 -40.32 88.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.139 -0.976 . . . . 3.03 108.631 179.561 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -63.44 -35.76 81.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.612 -0.68 . . . . 3.34 109.744 178.938 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -57.61 -32.78 67.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.526 -0.734 . . . . 4.18 109.143 -179.464 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.548 ' C ' ' H ' ' A' ' 253' ' ' LEU . . . -63.18 -42.21 99.33 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.621 -0.881 . . . . 4.43 108.621 179.052 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 60.6 -38.28 0.09 Allowed 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.032 0.444 . . . . 5.42 111.12 179.534 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.603 ' C ' ' H ' ' A' ' 255' ' ' LYS . 57.5 mt -82.25 -60.36 2.24 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.915 -1.115 . . . . 6.11 110.101 -179.249 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 253' ' ' LEU . . . 70.79 -34.47 0.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.663 -0.866 . . . . 7.37 108.663 -179.0 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.603 ' H ' ' C ' ' A' ' 253' ' ' LEU . 68.2 mttm -149.75 162.85 39.45 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.714 -0.847 . . . . 8.3 108.714 -179.864 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.443 ' CD2' ' N ' ' A' ' 256' ' ' LEU . 4.0 mm? -79.71 99.15 7.28 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.922 -1.111 . . . . 9.05 109.357 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -135.13 -29.79 1.08 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.651 -0.656 . . . . 10.56 109.398 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -88.31 66.42 8.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.933 . . . . 11.32 108.894 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 . . . . . 0 C--N 1.3 -1.574 0 CA-C-O 117.92 -1.038 . . . . 12.74 109.848 -179.748 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 8.1 ttt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -150.7 149.05 29.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.796 . . . . 0.0 109.243 179.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -149.36 160.99 42.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.078 -1.014 . . . . 0.0 110.116 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -153.42 149.75 28.1 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.796 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -111.62 131.38 55.31 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.23 -0.919 . . . . 0.0 109.815 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.17 122.71 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-O 122.287 1.041 . . . . 0.0 112.491 -176.898 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 95.5 m -75.59 103.9 5.9 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.849 0.833 . . . . 0.0 110.148 -178.647 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.6 mt -51.95 124.42 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 122.176 0.989 . . . . 0.0 109.977 -178.218 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 75.0 p -105.81 22.1 16.16 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.845 -178.745 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -80.58 149.32 67.92 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.61 -72.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.259 0 CA-C-N 119.455 0.841 . . . . 0.0 112.062 -179.655 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -86.29 23.87 1.48 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.123 -0.986 . . . . 0.0 110.819 -177.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 82.62 -163.14 42.11 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.542 -1.313 . . . . 0.0 109.841 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.413 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.0 tp -90.31 93.65 9.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.354 -1.086 . . . . 0.0 109.79 -178.094 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . 0.431 ' C ' HH21 ' A' ' 126' ' ' ARG . 10.4 p80 -94.39 -160.25 0.76 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.728 -1.232 . . . . 0.0 109.304 178.628 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.6 m -58.31 -45.16 88.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.83 -1.168 . . . . 0.0 112.752 -176.094 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.511 ' NE ' ' NE2' ' B' ' 321' ' ' GLN . 3.8 tpt180 -59.46 -64.51 2.9 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.111 -1.618 . . . . 0.0 111.375 -177.911 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -55.08 -34.11 86.16 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 CA-C-N 120.176 1.099 . . . . 0.0 112.047 179.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.2 -52.36 65.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.001 -1.062 . . . . 0.0 109.402 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.48 -41.05 63.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.217 -0.927 . . . . 0.0 109.633 -178.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . 0.511 ' NE2' ' NE ' ' B' ' 317' ' ' ARG . 44.6 mt-30 -70.81 -40.87 72.24 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.824 -1.172 . . . . 0.0 108.924 179.152 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -60.14 -50.5 73.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.298 -0.876 . . . . 0.0 110.854 -179.242 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 74.0 t -69.89 -31.16 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.753 -1.217 . . . . 0.0 109.792 -178.628 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . 0.518 ' HZ3' ' CD ' ' A' ' 74' ' ' GLU . 26.1 ttmt -59.76 -47.99 83.49 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.229 -0.92 . . . . 0.0 109.859 -179.56 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -67.08 -40.05 86.93 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 111.078 -178.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . 0.431 ' C ' ' H ' ' B' ' 328' ' ' GLY . . . -63.46 -53.22 55.56 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.998 -1.064 . . . . 0.0 111.393 -178.934 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -56.12 -10.2 0.79 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.015 -1.053 . . . . 0.0 109.526 -179.381 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' B' ' 326' ' ' ALA . . . -69.79 -30.26 70.59 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 178.892 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -102.67 141.73 35.0 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.594 -0.945 . . . . 0.0 109.172 179.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 44.5 m -89.78 -11.32 42.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.154 179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 61.8 p -59.34 156.68 12.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.374 -0.829 . . . . 0.0 110.034 -179.5 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -72.9 127.93 33.99 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.351 -0.843 . . . . 0.0 108.956 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.7 mt -134.52 133.54 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 87.9 m -132.85 155.88 48.18 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.508 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 58.3 t -117.2 140.68 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.427 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 64.9 m -129.05 123.17 31.6 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.447 -0.783 . . . . 0.0 109.134 179.763 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 66.9 p -139.45 117.41 11.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.353 -0.842 . . . . 0.0 110.418 -179.725 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 59.8 t30 45.6 56.53 5.72 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 177.208 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.02 -13.29 26.32 Favored Glycine 0 N--CA 1.501 3.004 0 O-C-N 120.055 -1.653 . . . . 0.0 112.924 176.438 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -111.75 122.93 49.12 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-N 119.037 1.418 . . . . 0.0 109.52 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.1 m -118.53 143.53 46.69 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.769 0.795 . . . . 0.0 110.544 -178.953 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -139.87 161.0 38.62 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.822 0.82 . . . . 0.0 110.174 -179.441 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 15.5 t -89.59 140.0 29.99 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.619 -0.675 . . . . 0.0 109.446 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.418 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -76.78 -12.63 60.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.085 -1.009 . . . . 0.0 109.785 -179.137 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.42 19.87 4.21 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.649 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.418 ' H ' ' C ' ' B' ' 344' ' ' ALA . 16.3 t -149.37 96.91 2.58 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.912 -179.224 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 28.8 tp -59.97 -32.04 70.45 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -58.09 -52.34 65.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 109.915 -179.28 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.434 ' O ' ' OG1' ' B' ' 352' ' ' THR . 33.8 mtmm -69.93 -39.92 75.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.692 -1.255 . . . . 0.0 110.163 -178.292 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' B' ' 352' ' ' THR . 39.6 mt -50.63 -58.24 6.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.775 -1.203 . . . . 0.0 108.024 179.219 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.637 HE21 ' N ' ' B' ' 351' ' ' GLN . 0.0 OUTLIER -38.28 -27.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.871 -0.518 . . . . 0.0 111.127 -178.361 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.464 ' N ' ' O ' ' B' ' 350' ' ' LEU . 51.0 p -77.75 -11.48 59.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.091 -1.006 . . . . 0.0 110.388 -178.855 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 24.8 mt -92.78 115.41 28.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.888 -1.133 . . . . 0.0 109.195 179.221 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.1 92.75 0.75 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.919 -1.673 . . . . 0.0 108.919 179.504 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 44.3 mt -100.61 91.62 4.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.24 -1.153 . . . . 0.0 108.913 179.529 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 81.0 p -91.86 177.9 6.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.956 -1.09 . . . . 0.0 110.512 -178.502 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' B' ' 359' ' ' THR . 61.8 tt0 -46.48 155.68 0.22 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.664 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 39.46 25.23 0.05 OUTLIER Glycine 0 N--CA 1.495 2.595 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 177.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 359' ' ' THR . . . . . 0.465 ' N ' ' O ' ' B' ' 357' ' ' GLN . 9.2 m -82.47 112.44 19.41 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.708 -1.466 . . . . 0.0 109.283 179.423 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 16.4 t -77.37 115.8 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 122.214 1.007 . . . . 0.0 110.358 -176.882 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.3 m -110.34 176.85 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.386 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 30.8 m -132.19 129.81 40.24 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.943 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.4 mt -105.84 122.09 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.402 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 52.7 p -120.82 132.19 54.87 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.639 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.93 151.87 37.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.905 -1.122 . . . . 0.0 110.955 -178.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -144.87 124.49 13.25 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.691 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 160.16 -162.73 33.41 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 118.981 -1.58 . . . . 0.0 111.367 179.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -59.96 -55.64 31.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 122.258 -0.554 . . . . 0.0 111.759 -178.425 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' B' ' 370' ' ' GLU . 94.5 m-20 -104.93 7.48 34.24 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.996 -1.065 . . . . 0.0 111.105 -177.314 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' B' ' 369' ' ' ASP . 1.3 pp20? -42.91 -32.12 0.59 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.244 -0.91 . . . . 0.0 110.507 -179.12 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -70.08 -43.7 70.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 109.996 -179.293 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -64.7 -48.99 72.63 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.199 -0.938 . . . . 0.0 109.332 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.9 -75.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.425 -0.797 . . . . 0.0 110.705 -178.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . 0.44 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 45.4 t -44.5 -38.77 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.099 -1.001 . . . . 0.0 110.895 -177.564 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -64.86 -47.23 78.68 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.624 -1.298 . . . . 0.0 110.513 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -82.75 -41.72 18.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.919 -1.113 . . . . 0.0 110.445 -179.454 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.9 -39.23 77.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.904 -1.122 . . . . 0.0 108.284 -179.617 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . 0.44 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 48.1 t -62.38 -40.24 87.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.213 179.13 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' B' ' 383' ' ' GLU . 20.8 mtpp -68.54 -55.78 10.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.595 -1.315 . . . . 0.0 108.824 178.604 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 56.1 tp -57.78 -35.85 71.36 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.762 -1.211 . . . . 0.0 109.734 -178.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 28.8 ttm -70.66 -40.05 73.22 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.257 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.31 -9.99 59.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.528 -0.733 . . . . 0.0 110.968 179.164 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' B' ' 379' ' ' LYS . 93.9 mt-10 -110.03 0.83 18.62 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.042 -1.036 . . . . 0.0 111.549 -178.191 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 13.2 mt -82.38 125.89 31.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.178 -1.576 . . . . 0.0 109.224 179.136 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.318 -179.978 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.422 ' H3 ' ' H ' ' A' ' 2' ' ' ILE . 85.7 mmm . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.255 -0.646 . . . . 3.19 109.255 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.422 ' H ' ' H3 ' ' A' ' 1' ' ' MET . 96.7 mt -110.0 130.03 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.611 -0.681 . . . . 1.71 109.164 179.671 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.5 m -120.92 144.28 48.52 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.579 -0.701 . . . . 1.66 109.747 -179.707 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -121.67 -162.82 11.75 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 108.894 -1.682 . . . . 1.05 108.894 179.751 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 6' ' ' LEU . 91.4 mt -89.28 -13.97 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.9 -1.353 . . . . 1.59 110.176 -179.218 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.9 tp 53.74 102.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.224 -0.922 . . . . 1.47 109.062 -179.883 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.64 -29.43 12.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.262 -0.899 . . . . 1.39 109.153 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 30.8 m -129.44 116.02 18.47 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 109.024 -0.732 . . . . 2.09 109.024 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.25 146.72 20.02 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.76 1.64 . . . . 0.91 112.079 -179.74 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 152.61 -154.4 25.5 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.462 -1.455 . . . . 0.92 109.462 -179.85 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.0 mt -148.36 150.33 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.36 -1.082 . . . . 1.35 108.587 178.947 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.84 156.32 34.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.939 -1.101 . . . . 1.14 110.752 179.663 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.2 m-85 -137.41 128.51 27.66 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.895 -1.15 . . . . 0.7 107.895 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.67 174.29 46.92 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 118.736 -1.697 . . . . 0.58 110.743 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -76.52 158.87 30.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.769 -0.842 . . . . 2.63 109.26 -179.735 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.99 126.11 46.13 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.358 -0.839 . . . . 1.27 111.377 -178.351 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.7 tp -101.36 129.96 47.46 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.876 -1.527 . . . . 1.41 106.876 177.57 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.2 tp -114.02 121.64 44.47 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.308 -0.87 . . . . 1.49 110.021 -178.914 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.2 mt -85.87 100.09 11.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.49 -0.756 . . . . 1.52 109.051 179.358 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -84.42 142.0 30.43 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.27 -1.011 . . . . 3.17 108.27 179.532 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -130.76 135.65 47.98 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.023 -1.048 . . . . 3.0 109.106 179.392 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -94.78 156.4 16.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.322 -0.861 . . . . 2.77 109.55 -179.916 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -78.58 136.98 37.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 2.94 109.321 179.787 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.6 mt -79.79 130.17 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.258 -0.901 . . . . 1.46 108.728 179.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.8 t -93.27 125.76 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.18 -0.95 . . . . 1.7 109.684 -179.461 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.8 mt -105.97 138.06 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.517 -0.739 . . . . 1.54 109.12 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -96.23 120.06 35.84 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.159 -0.963 . . . . 1.81 109.974 -179.585 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.501 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.0 mmt-85 -90.02 -0.24 57.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.402 -0.812 . . . . 3.23 109.692 -179.795 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -69.9 135.5 49.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.069 -1.02 . . . . 3.29 109.164 -179.895 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -83.02 154.81 24.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.107 -0.996 . . . . 2.8 109.419 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.9 pt -98.92 166.41 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.207 -0.933 . . . . 1.43 109.609 179.568 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.2 p -93.41 174.81 7.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.3 -0.875 . . . . 1.54 108.658 178.437 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.07 -48.56 81.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 1.6 110.292 -179.425 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -55.51 -31.48 62.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.767 -1.208 . . . . 2.56 110.568 -179.057 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -81.59 -8.98 59.78 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.177 -0.952 . . . . 2.36 110.289 -179.357 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.9 t -60.06 -50.09 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.776 -1.203 . . . . 1.43 109.087 179.825 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -60.11 -39.91 87.87 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.369 -0.832 . . . . 1.77 109.078 -179.663 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -64.19 -42.02 96.83 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.546 -0.721 . . . . 3.32 110.916 -178.717 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -62.83 -41.84 99.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.68 -1.263 . . . . 1.51 110.422 -179.224 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.7 t -63.73 -47.04 92.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.675 -1.266 . . . . 1.41 108.987 -179.763 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -60.0 -46.2 90.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.055 -1.028 . . . . 1.81 108.957 179.863 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -59.98 -48.59 81.1 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.026 -1.07 . . . . 3.26 108.766 179.5 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.15 -44.61 94.84 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.162 -0.961 . . . . 0.81 108.879 178.659 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.1 tp -59.95 -47.34 86.21 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.827 -1.175 . . . . 1.59 107.827 179.427 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.6 t -63.53 -43.62 96.6 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.571 -0.852 . . . . 1.38 108.979 178.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.97 -48.24 87.28 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.986 -1.646 . . . . 0.87 108.986 179.34 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -63.2 -31.5 72.66 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.365 -1.08 . . . . 3.62 108.2 179.114 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.05 82.17 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.813 -0.81 . . . . 1.43 108.813 179.887 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 50' ' ' ALA . 6.8 ttpm? -65.73 -74.31 0.11 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.932 -1.136 . . . . 3.08 107.932 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.94 -40.54 0.47 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.366 -0.834 . . . . 1.33 111.758 -178.255 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 64.0 m -54.48 -53.7 50.74 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.465 -1.397 . . . . 1.85 108.982 -179.875 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.23 -41.18 77.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.226 -0.921 . . . . 1.35 110.819 -179.318 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -66.89 -39.97 87.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.908 -1.12 . . . . 2.34 109.989 -179.511 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.9 mt -61.03 -39.95 91.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.892 -1.13 . . . . 2.2 108.725 179.066 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -61.94 -35.08 77.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.477 -0.765 . . . . 1.35 109.573 179.482 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -64.3 -43.04 95.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.034 -1.041 . . . . 1.34 109.35 179.816 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.9 -39.63 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.855 . . . . 1.26 108.917 179.681 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -57.07 -50.43 72.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.442 -0.786 . . . . 1.7 109.971 -179.368 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -57.1 -31.62 65.46 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.319 -0.863 . . . . 1.35 110.377 -177.888 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -70.02 -38.14 75.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.05 -1.031 . . . . 2.08 109.436 -179.897 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.8 -45.91 76.91 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.615 -0.678 . . . . 1.21 110.641 -179.128 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.88 -50.87 63.04 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.755 -1.212 . . . . 0.75 110.424 -178.637 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -70.24 -43.8 69.85 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.934 -1.333 . . . . 1.59 110.18 -179.792 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.4 m -69.98 -57.8 4.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.067 -1.021 . . . . 1.41 111.698 -178.042 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -98.31 -54.36 3.08 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.138 -0.976 . . . . 0.79 111.483 -178.168 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.26 -164.58 26.88 Favored Glycine 0 N--CA 1.5 2.914 0 C-N-CA 119.676 -1.25 . . . . 1.22 110.931 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -71.4 -25.92 62.55 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.884 -0.774 . . . . 5.81 110.795 -179.409 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.4 -35.9 78.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.165 -0.959 . . . . 3.37 110.197 -179.255 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -100.01 -20.28 16.14 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.331 -0.856 . . . . 2.37 110.269 -179.222 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -69.92 -40.32 75.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.962 -1.087 . . . . 1.65 110.501 -178.826 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.621 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -67.36 -26.1 66.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.133 -0.979 . . . . 1.42 109.972 -179.058 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.73 -39.99 81.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 118.954 -1.099 . . . . 1.43 108.345 179.77 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -67.82 -39.99 83.84 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.055 -1.028 . . . . 1.08 110.311 179.885 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.511 ' CD ' ' HZ3' ' B' ' 324' ' ' LYS . 80.2 tt0 -59.91 -40.78 89.97 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.759 -1.213 . . . . 1.37 109.454 179.464 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.86 -48.98 76.55 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.029 -1.628 . . . . 0.67 109.029 179.518 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.5 m170 -63.05 -42.96 99.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.463 -1.022 . . . . 1.99 109.485 179.916 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.02 -45.1 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.235 -0.916 . . . . 1.22 109.784 -179.737 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.0 ttp -60.27 -40.11 89.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.891 -1.13 . . . . 2.11 109.121 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 48.1 tp -63.09 -39.34 94.41 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.683 -0.636 . . . . 1.33 109.956 179.626 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.2 tp -66.26 -38.3 87.53 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.523 -0.735 . . . . 1.29 110.248 -179.483 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -80.35 3.28 21.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.958 -1.089 . . . . 1.47 110.258 -179.045 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -49.75 130.03 20.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.0 -1.063 . . . . 1.47 109.642 -179.614 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.18 -17.73 58.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.534 -0.729 . . . . 1.78 110.629 -179.536 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -71.85 -35.05 69.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.975 -1.078 . . . . 2.53 108.713 178.767 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.8 mt -69.96 -40.36 75.47 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.492 0.663 . . . . 1.36 109.831 179.761 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.04 -45.37 93.04 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.329 -0.857 . . . . 1.42 109.917 -179.22 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -69.99 -40.0 75.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 2.27 110.334 -179.14 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.96 -40.05 75.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.288 -0.882 . . . . 1.57 110.912 -179.175 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.3 mt -68.37 -42.45 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.991 -1.068 . . . . 1.19 109.595 -179.588 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.01 -38.78 76.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.564 -0.71 . . . . 1.39 110.633 -179.533 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.45 77.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.102 -0.999 . . . . 1.39 111.247 -178.615 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.81 -47.54 84.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.769 -1.207 . . . . 1.5 110.419 -178.964 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.42 -49.9 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.114 -0.991 . . . . 1.29 109.183 179.957 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -70.27 -43.9 69.54 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.375 -0.53 . . . . 2.64 111.132 -179.721 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -80.98 -49.87 10.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.986 -1.072 . . . . 1.65 111.991 -177.813 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -90.12 -2.43 58.08 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.001 -1.062 . . . . 2.5 111.584 -177.372 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 56.43 35.12 25.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.859 -1.15 . . . . 1.88 109.435 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.0 mtt -88.4 169.26 11.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.472 -0.768 . . . . 1.71 109.907 -179.417 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.429 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 52.4 p -81.88 160.0 23.54 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.342 -0.849 . . . . 1.61 108.776 179.532 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.77 -39.88 88.0 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.22 -0.925 . . . . 1.33 110.258 -179.472 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 35.9 p-10 -67.02 -35.07 79.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.081 -1.012 . . . . 2.07 109.335 -179.735 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.507 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.96 -47.39 13.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.317 -0.865 . . . . 1.37 109.604 179.661 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.63 -48.32 81.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.385 -0.822 . . . . 1.14 110.007 -179.612 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.28 -36.24 79.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.935 . . . . 1.26 109.844 -179.891 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.415 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 80.3 t60 -60.03 -42.67 94.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.286 -0.884 . . . . 2.02 109.98 -178.761 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' A' ' 110' ' ' GLY . 41.3 tt0 -64.36 -40.01 94.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.164 -0.96 . . . . 1.33 110.242 -179.469 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.2 t -60.57 -56.09 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.352 -0.842 . . . . 1.3 111.446 -178.06 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.1 mm -69.93 -39.97 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.942 -1.099 . . . . 1.32 108.936 -179.789 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.415 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 88.8 tt0 -64.78 -38.87 92.44 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.567 -0.901 . . . . 2.44 108.567 178.639 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.02 -49.2 77.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.813 -0.915 . . . . 0.99 110.813 -179.066 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -68.79 -52.34 31.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.716 -1.461 . . . . 1.97 109.527 -179.521 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.62 -40.05 78.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.296 -0.877 . . . . 1.43 109.26 179.868 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.6 t -58.24 -41.4 84.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.175 -0.953 . . . . 2.12 108.963 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.81 -40.5 91.91 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.258 -0.901 . . . . 1.64 109.028 179.192 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 76.5 mt -61.4 -45.24 95.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.107 -0.996 . . . . 1.93 109.62 -179.682 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -57.25 -32.32 66.45 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.143 -0.973 . . . . 2.2 109.846 -178.48 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -58.11 -21.74 47.66 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.022 -1.049 . . . . 2.12 108.605 179.773 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 54.4 mt -62.37 139.95 58.54 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.264 -0.898 . . . . 2.34 108.577 179.636 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -90.09 10.08 25.71 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.114 -0.991 . . . . 3.23 110.86 -178.722 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -94.39 133.59 37.8 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.777 -1.202 . . . . 2.49 109.828 -179.75 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -69.92 -28.99 66.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.571 -0.706 . . . . 3.95 109.954 -179.861 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.484 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.7 t80 -69.24 -36.86 77.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.376 -0.827 . . . . 2.25 110.244 179.417 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 90.6 mt -77.49 -35.21 53.84 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.093 -1.004 . . . . 2.27 109.57 179.838 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -59.99 -45.33 93.08 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.229 -0.919 . . . . 3.31 109.678 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -60.55 -45.37 94.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -0.964 . . . . 2.73 109.296 -179.655 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -61.94 -39.88 93.62 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.117 -1.068 . . . . 3.2 108.117 179.101 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.79 -23.25 51.54 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.184 -1.043 . . . . 1.66 108.184 178.796 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.96 -40.09 75.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.814 -0.81 . . . . 1.67 108.814 178.954 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.54 -40.09 94.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.528 -0.733 . . . . 1.55 110.294 -179.497 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.93 -40.56 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.08 -1.013 . . . . 1.32 108.402 179.842 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -60.09 -38.69 83.68 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.964 -0.754 . . . . 3.58 108.964 178.474 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -59.53 -39.57 84.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.745 . . . . 1.46 109.986 -179.52 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.93 -40.78 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.052 -1.03 . . . . 1.22 109.686 -179.623 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.63 -41.42 96.01 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.979 -1.105 . . . . 0.61 110.769 -179.44 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -59.93 -47.07 87.3 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.964 -1.315 . . . . 3.1 111.279 -178.799 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.602 HH12 ' CB ' ' A' ' 166' ' ' SER . 98.6 mtt180 -69.97 -30.47 67.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.504 -1.372 . . . . 3.71 109.927 -179.622 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.0 -46.15 90.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 1.87 109.152 -179.968 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.5 mt -59.88 -40.04 87.35 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.396 -0.815 . . . . 1.29 109.464 179.236 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 53.5 mtp180 -69.16 -40.02 78.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.397 -0.814 . . . . 3.05 110.206 179.959 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -69.93 -20.91 63.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.337 -0.852 . . . . 1.26 112.383 -178.136 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.5 mt -68.68 -40.02 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.19 -1.569 . . . . 1.34 108.408 179.664 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.13 -29.32 21.9 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.436 -0.79 . . . . 1.6 109.621 -179.699 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.96 54.35 2.05 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 108.695 -1.762 . . . . 0.96 108.695 -178.958 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.0 tp -74.73 147.31 41.48 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.625 -0.926 . . . . 1.67 110.009 -179.168 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -60.19 141.42 55.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.342 -0.848 . . . . 4.96 109.867 -179.867 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.3 mt -119.96 127.06 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-O 122.01 0.91 . . . . 1.68 109.414 179.52 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.5 mt -60.11 -45.9 95.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 116.063 -0.517 . . . . 2.14 109.952 -178.504 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.4 t0 64.22 101.52 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.498 -0.751 . . . . 1.5 109.256 -179.57 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.1 mt -71.74 -5.27 32.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.368 -0.833 . . . . 1.39 109.868 -179.269 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.6 m -80.21 -18.57 49.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.056 -1.028 . . . . 1.83 109.56 179.758 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.1 24.04 0.81 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.271 -0.893 . . . . 1.46 111.777 -178.002 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 39.2 mm -90.97 115.98 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.496 -1.378 . . . . 1.42 108.64 179.19 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -100.04 -9.68 22.39 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.34 -0.85 . . . . 2.94 110.545 -178.748 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -119.92 149.48 42.04 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.188 -0.945 . . . . 1.52 110.336 -179.392 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.01 133.81 52.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.388 -0.82 . . . . 1.58 109.1 179.766 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -151.77 164.7 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.448 -0.783 . . . . 1.32 109.597 179.678 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.435 HD13 HG21 ' A' ' 157' ' ' ILE . 87.8 mt -93.69 147.32 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.038 -1.838 . . . . 1.27 106.038 177.0 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 60.9 tp -97.3 117.01 30.57 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.879 -1.138 . . . . 1.41 110.642 -177.952 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 35.5 t -122.12 127.74 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.197 -1.038 . . . . 1.23 108.197 179.228 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.07 160.65 39.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.987 -1.07 . . . . 1.32 108.711 -179.895 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.96 -34.7 73.74 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.261 -1.524 . . . . 1.49 108.16 178.977 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -160.14 170.69 20.69 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.806 -0.813 . . . . 2.25 108.806 179.935 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.6 mt -141.96 129.95 21.93 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.041 -1.037 . . . . 1.35 108.733 178.989 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 63.1 p -90.56 144.23 30.32 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.084 -1.01 . . . . 1.56 109.293 -179.741 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -40.1 -37.6 1.83 Allowed 'Trans proline' 0 N--CA 1.488 1.196 0 C-N-CA 122.116 1.877 . . . . 0.87 112.457 179.39 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.602 ' CB ' HH12 ' A' ' 136' ' ' ARG . 50.2 m -59.98 -40.95 90.9 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.352 -0.843 . . . . 1.36 109.591 -179.238 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -62.78 -43.24 99.32 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.261 -0.9 . . . . 1.61 110.195 -179.644 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 62.4 p -57.85 -28.71 64.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 1.21 110.531 -178.679 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.99 -57.5 4.93 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.015 -1.053 . . . . 1.21 109.775 179.7 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -83.5 35.39 0.5 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.102 -0.703 . . . . 2.11 109.102 -179.446 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.3 tp -100.66 139.04 36.9 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.347 -0.846 . . . . 1.29 109.345 179.588 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -85.43 103.73 14.59 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.267 -0.896 . . . . 2.81 108.763 179.545 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 63.1 mt -63.62 -45.36 90.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.476 -0.765 . . . . 2.09 110.273 -178.694 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -70.06 -20.39 63.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.024 -1.048 . . . . 2.86 112.572 -178.328 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -93.15 -10.12 36.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.471 -1.393 . . . . 2.39 109.26 -179.185 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 89.4 t -109.79 117.64 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.317 -0.864 . . . . 1.27 109.356 179.465 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 78.4 mt -88.77 5.49 43.25 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.348 -0.845 . . . . 2.17 110.676 -178.407 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 172.59 173.16 38.96 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.2 -1.56 . . . . 0.52 109.2 179.808 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -133.09 129.94 38.64 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.258 -1.142 . . . . 0.55 110.105 -179.598 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 58.9 mt -128.9 122.89 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.037 -1.097 . . . . 1.27 108.037 177.971 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 11.7 p -143.52 157.03 44.75 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.986 -1.072 . . . . 1.39 110.982 -179.202 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 183' ' ' ALA . 1.1 m-20 -96.19 21.35 9.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.436 -0.79 . . . . 2.46 109.631 -179.891 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -46.9 -173.93 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.977 -1.077 . . . . 1.51 112.723 -177.922 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -85.85 -49.75 4.19 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 111.377 -0.689 . . . . 2.23 111.377 -178.979 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -174.18 -154.46 10.86 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 118.525 -1.798 . . . . 2.23 111.71 -179.291 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.583 ' C ' ' H ' ' A' ' 188' ' ' SER . 8.7 mtt-85 -62.42 -33.99 75.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.782 -0.834 . . . . 6.44 111.151 -178.632 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 29.1 p -60.04 6.99 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.839 -1.163 . . . . 4.09 110.639 -178.302 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.583 ' H ' ' C ' ' A' ' 186' ' ' ARG . 92.7 p -90.85 130.76 36.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.871 -1.143 . . . . 2.2 109.941 179.717 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -47.62 -45.87 28.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.203 -0.935 . . . . 1.15 109.548 -179.849 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 93.3 m -58.41 -40.26 81.96 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 2.01 110.171 -178.317 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.479 ' H ' ' HG ' ' A' ' 188' ' ' SER . 81.1 p -63.29 -38.8 92.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.822 -1.174 . . . . 1.93 109.849 -179.881 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.52 ' CD1' HH22 ' A' ' 195' ' ' ARG . 41.9 mm -60.09 -45.81 95.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.299 -0.876 . . . . 2.2 109.09 -179.459 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.16 -46.45 89.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.415 -0.803 . . . . 1.32 110.639 -179.698 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.43 -48.73 76.38 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.805 -1.185 . . . . 1.3 111.219 -178.273 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.52 HH22 ' CD1' ' A' ' 192' ' ' ILE . 26.8 mtm-85 -60.88 -50.04 75.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.684 -1.26 . . . . 3.38 110.458 -178.903 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 48.7 m -71.29 -34.98 71.14 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.834 -1.166 . . . . 1.15 111.6 -178.506 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 99.0 mt -81.52 -11.13 59.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.696 -1.253 . . . . 1.28 110.796 -178.356 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 56.91 46.48 19.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.166 -0.959 . . . . 1.5 110.696 179.592 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 8' ' ' SER . 92.2 mt -116.31 121.26 33.75 Favored Pre-proline 0 N--CA 1.5 2.072 0 N-CA-C 108.341 -0.985 . . . . 1.37 108.341 179.055 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -42.35 129.61 4.76 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.83 1.687 . . . . 0.76 111.952 -179.42 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.01 152.17 4.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.982 -1.074 . . . . 1.19 111.649 -179.221 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.7 mt -126.87 144.0 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.654 -1.239 . . . . 1.31 107.654 178.607 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 20.5 m -124.05 -9.43 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 O-C-N 120.796 -1.19 . . . . 1.38 111.381 -178.446 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.46 23.69 24.0 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 110.875 -0.89 . . . . 1.03 110.875 -178.829 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.441 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 19.2 p -47.19 -42.86 20.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.833 -1.392 . . . . 1.38 110.105 -179.276 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.77 -52.26 4.18 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 120.039 -1.077 . . . . 1.17 111.924 178.833 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.5 t -155.36 35.1 0.37 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.37 -1.665 . . . . 2.07 111.819 -178.759 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 29.5 t -75.95 -38.01 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.857 -1.152 . . . . 1.35 109.195 178.422 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.2 p -60.03 -40.07 88.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.591 -0.693 . . . . 1.49 111.55 -177.985 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.7 p -78.47 -11.37 59.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.799 -1.188 . . . . 2.16 110.264 -178.74 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -96.97 -12.24 23.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.233 -0.917 . . . . 2.89 110.408 -179.698 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 91.8 t -116.34 156.2 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.321 -0.862 . . . . 1.33 110.592 -179.344 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -114.71 154.12 29.04 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.207 -1.035 . . . . 2.73 108.207 179.687 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 39.0 p-10 -59.73 135.96 57.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.868 -1.145 . . . . 2.7 110.095 -179.404 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.7 OUTLIER 94.5 -1.72 0.08 Allowed 'General case' 0 N--CA 1.511 2.614 0 CA-C-O 121.581 0.705 . . . . 2.38 109.988 179.502 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 48.8 t0 -70.08 151.2 45.76 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.434 -0.792 . . . . 2.09 109.792 -179.961 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 51.0 t80 -95.37 120.13 35.07 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.371 -0.831 . . . . 1.45 108.804 179.602 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 90.2 mt -123.34 138.34 54.63 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.386 -0.821 . . . . 1.31 110.657 -179.297 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.9 mt -112.35 130.0 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 106.436 -1.69 . . . . 1.29 106.436 176.317 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 57.0 tp -100.32 115.01 28.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.115 -0.991 . . . . 1.31 109.542 -178.303 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' A' ' 223' ' ' VAL . 55.8 m-20 -70.6 -46.92 62.51 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.924 -1.139 . . . . 2.31 107.924 178.996 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 52.12 9.15 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.917 -0.771 . . . . 1.19 108.917 -179.644 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.535 ' H ' ' C ' ' A' ' 221' ' ' ASP . 75.5 t -125.9 -38.89 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 107.094 -1.447 . . . . 1.45 107.094 178.797 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -104.32 0.01 28.71 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.928 -1.138 . . . . 3.13 107.928 178.243 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 60.08 45.9 11.35 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.156 -0.683 . . . . 2.2 109.156 -179.524 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -136.41 156.26 48.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.398 -0.814 . . . . 2.32 109.599 -179.752 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.5 t -124.37 129.98 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 108.798 -0.816 . . . . 1.4 108.798 178.957 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . 0.536 ' CE1' ' SD ' ' A' ' 239' ' ' MET . 62.4 m-85 -105.22 125.86 51.45 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.513 -0.921 . . . . 1.29 108.513 179.192 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.9 t -103.89 113.99 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.202 -0.936 . . . . 1.38 110.404 -179.406 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.528 HD21 ' C ' ' A' ' 230' ' ' ASN . 0.3 OUTLIER 49.48 62.67 11.61 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.099 -1.001 . . . . 2.33 110.707 178.916 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -85.35 156.16 10.87 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.832 2.355 . . . . 0.95 112.173 179.319 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.0 m -65.92 159.28 25.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.342 -0.849 . . . . 2.31 109.637 -179.423 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.735 ' ND2' ' H ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -61.61 -38.58 88.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.257 -0.902 . . . . 3.45 111.006 -178.916 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.735 ' H ' ' ND2' ' A' ' 233' ' ' ASN . 16.8 pt-20 -65.62 -30.83 71.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.79 -1.194 . . . . 2.89 109.708 -179.492 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.6 -43.15 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 1.73 108.564 179.286 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.89 -41.53 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.536 -0.728 . . . . 1.57 109.963 179.885 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -60.0 -41.9 93.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.037 -1.039 . . . . 2.43 109.409 -179.904 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -61.34 -46.23 91.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 3.18 110.347 -179.566 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 239' ' ' MET . . . . . 0.536 ' SD ' ' CE1' ' A' ' 228' ' ' TYR . 11.7 mtm -70.33 -29.46 66.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.139 -0.975 . . . . 1.59 109.695 -179.896 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 23.6 mmm-85 -69.91 -37.9 76.09 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.329 -0.857 . . . . 3.11 109.526 178.913 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.0 -43.5 95.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 2.17 109.327 -179.618 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 76.1 t -62.92 -38.0 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.175 -0.953 . . . . 2.51 108.526 179.127 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -59.7 -39.66 85.32 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.57 -0.9 . . . . 3.82 108.57 179.802 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.94 -40.03 87.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.179 -0.951 . . . . 1.78 108.821 179.455 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.29 -39.96 89.72 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.231 -1.026 . . . . 2.77 108.231 179.076 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 53.5 t -69.08 -40.07 80.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.281 -1.007 . . . . 2.25 108.281 178.948 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.63 -39.43 84.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.718 -0.614 . . . . 2.54 109.514 -179.849 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 63.2 m -59.97 -40.12 88.0 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.961 -1.087 . . . . 3.03 108.99 -179.968 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -62.22 -39.59 93.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.087 -1.008 . . . . 3.34 109.182 179.214 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -94.62 33.34 1.46 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.299 -0.876 . . . . 4.18 109.419 -179.838 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -151.55 26.24 0.67 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.14 -0.975 . . . . 4.43 111.07 -179.457 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -104.96 54.13 0.72 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.086 -1.009 . . . . 5.42 109.628 179.403 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.453 ' C ' ' H ' ' A' ' 255' ' ' LYS . 15.1 mt 60.38 20.06 9.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.433 -0.792 . . . . 6.11 109.104 -179.001 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -75.14 11.59 1.11 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.977 -0.749 . . . . 7.37 108.977 179.62 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.453 ' H ' ' C ' ' A' ' 253' ' ' LEU . 63.1 tttp -60.01 -50.31 74.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.464 -0.772 . . . . 8.3 109.517 -179.715 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 38.3 mt -148.63 -29.83 0.28 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.297 -0.877 . . . . 9.05 109.419 178.853 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 258' ' ' ASP . 46.7 mtmt -72.01 -9.41 58.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 10.56 110.431 -178.776 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.545 ' C ' ' O ' ' A' ' 257' ' ' LYS . 13.5 t0 14.09 67.09 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.676 0 CA-C-O 120.974 0.416 . . . . 11.32 111.861 178.566 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 117.93 -1.033 . . . . 12.74 109.177 -179.717 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 3.0 ttt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.509 0.671 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -151.98 150.07 29.59 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.995 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -148.34 159.17 44.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.007 -1.058 . . . . 0.0 110.14 -179.275 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -152.98 150.06 28.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.631 -0.668 . . . . 0.0 109.344 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . 0.481 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 1.6 pm0 -114.87 134.69 54.94 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.313 -0.867 . . . . 0.0 109.969 179.43 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 1.3 p -135.63 124.92 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 CA-C-O 122.029 0.919 . . . . 0.0 112.44 -177.212 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 88.7 m -77.72 106.35 9.47 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.93 0.871 . . . . 0.0 109.969 -179.385 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 92.3 mt -50.78 124.16 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 122.449 1.118 . . . . 0.0 110.274 -177.407 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 74.8 p -108.06 19.93 19.35 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.54 -178.955 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.57 118.21 68.27 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.907 . . . . 0.0 108.606 179.308 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -61.18 -13.4 27.96 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 CA-C-N 120.477 1.206 . . . . 0.0 112.288 -179.815 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -117.5 9.52 13.26 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.524 -0.735 . . . . 0.0 110.422 -178.581 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.96 172.08 16.78 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.311 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.484 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -82.34 87.92 6.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.951 -1.323 . . . . 0.0 109.557 -178.285 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . 0.424 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 3.5 p80 -90.56 -163.39 1.02 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.796 -1.19 . . . . 0.0 109.713 178.76 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.1 m -58.1 -41.29 83.21 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.806 -1.184 . . . . 0.0 112.595 -175.775 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.621 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 16.3 tpt180 -59.35 -59.58 13.38 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 120.379 -1.451 . . . . 0.0 111.658 -179.49 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . 0.424 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 14.9 Cg_endo -60.43 -34.86 92.71 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 CA-C-N 120.522 1.222 . . . . 0.0 111.693 -179.653 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.98 -51.97 67.4 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.318 -0.864 . . . . 0.0 108.978 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -54.27 -41.8 69.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.687 -178.934 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -70.08 -41.13 74.49 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.982 -1.074 . . . . 0.0 108.669 178.772 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -60.73 -51.67 68.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.548 -0.72 . . . . 0.0 111.247 -179.362 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 86.1 t -67.76 -27.04 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.565 -1.334 . . . . 0.0 109.259 -179.125 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . 0.511 ' HZ3' ' CD ' ' A' ' 74' ' ' GLU . 31.1 ttmt -60.04 -47.52 85.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.552 -0.718 . . . . 0.0 109.645 179.741 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -64.39 -45.22 88.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 110.557 -179.255 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.09 -52.79 63.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.854 -1.154 . . . . 0.0 110.751 -178.792 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -55.22 -16.63 3.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.174 -0.954 . . . . 0.0 109.808 179.706 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.96 -30.64 69.97 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.462 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.29 140.47 39.17 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.465 -1.02 . . . . 0.0 109.27 179.844 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 19.8 m -89.94 -10.71 44.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.124 -0.985 . . . . 0.0 109.607 -179.97 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 331' ' ' SER . . . . . 0.495 ' OG ' ' N ' ' B' ' 368' ' ' GLU . 72.9 m -57.74 146.55 30.82 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.051 -1.03 . . . . 0.0 108.679 179.451 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.7 132.66 50.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.186 -0.946 . . . . 0.0 109.499 -179.326 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.8 mt -132.34 131.8 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.471 -0.768 . . . . 0.0 108.964 179.694 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 52.1 m -128.73 153.48 47.31 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.778 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 98.9 t -118.51 140.03 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.504 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 34.3 m -128.04 123.51 34.82 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 179.225 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 86.9 p -138.54 114.98 10.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.261 -0.899 . . . . 0.0 110.87 -179.191 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 28.9 m120 45.17 50.04 9.63 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 176.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.92 -14.21 62.5 Favored Glycine 0 N--CA 1.501 3.028 0 O-C-N 120.077 -1.639 . . . . 0.0 112.947 176.873 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -116.02 126.69 54.15 Favored 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 119.225 1.512 . . . . 0.0 109.699 179.834 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 52.9 m -118.43 144.6 45.84 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.731 0.777 . . . . 0.0 110.648 -178.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -143.18 162.11 36.46 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.571 0.7 . . . . 0.0 110.005 -179.765 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 41.4 t -87.94 132.5 34.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.669 -0.644 . . . . 0.0 110.745 -178.906 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.423 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -68.96 -16.75 63.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 108.689 179.358 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -88.73 19.4 4.03 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 178.737 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.621 ' CB ' ' HZ2' ' B' ' 349' ' ' LYS . 53.9 p -146.62 94.99 2.52 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.774 0.797 . . . . 0.0 112.406 -179.428 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . 0.518 ' CD1' HE22 ' B' ' 351' ' ' GLN . 52.9 tp -60.0 -36.51 77.34 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.728 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -56.51 -53.52 56.5 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.324 -0.86 . . . . 0.0 110.708 -179.181 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.621 ' HZ2' ' CB ' ' B' ' 346' ' ' SER . 33.6 mtmm -70.04 -38.78 75.94 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.875 -1.141 . . . . 0.0 109.609 -178.846 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' B' ' 352' ' ' THR . 35.7 mt -48.2 -59.51 3.36 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.946 -1.096 . . . . 0.0 108.496 179.415 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.529 ' OE1' ' N ' ' B' ' 351' ' ' GLN . 0.9 OUTLIER -39.14 -25.92 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.695 -0.628 . . . . 0.0 111.124 -179.088 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.46 ' N ' ' O ' ' B' ' 350' ' ' LEU . 66.3 p -79.45 -9.94 59.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.344 -1.472 . . . . 0.0 110.198 -178.295 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 61.1 mt -92.54 114.43 26.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.018 -1.051 . . . . 0.0 108.644 178.6 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.77 90.04 0.66 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 179.575 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 22.7 mt -100.62 93.54 5.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.316 -1.108 . . . . 0.0 108.674 179.426 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 356' ' ' THR . . . . . 0.669 ' H ' ' HG1' ' B' ' 359' ' ' THR . 70.9 p -93.36 167.34 11.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.135 -0.978 . . . . 0.0 110.625 -179.053 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 13.3 tm0? -57.84 113.01 1.67 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.782 -0.574 . . . . 0.0 110.693 -179.32 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.78 9.25 38.05 Favored Glycine 0 N--CA 1.498 2.821 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.737 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 359' ' ' THR . . . . . 0.669 ' HG1' ' H ' ' B' ' 356' ' ' THR . 54.6 m -87.19 110.65 20.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.388 -1.066 . . . . 0.0 111.415 -179.113 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 5.0 t -77.03 115.43 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 122.165 0.983 . . . . 0.0 109.703 -177.775 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 18.3 m -113.31 177.18 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.855 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 93.3 m -132.15 132.58 43.34 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.052 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 59.3 mt -107.94 126.07 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.194 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 54.0 m -125.36 133.51 52.53 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.447 -0.783 . . . . 0.0 109.17 -179.491 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -148.53 155.62 41.38 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.94 -1.1 . . . . 0.0 111.001 -178.812 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -149.55 128.68 12.76 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.824 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.461 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 156.65 -152.16 23.54 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.155 -1.498 . . . . 0.0 111.726 179.548 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . 0.495 ' N ' ' OG ' ' B' ' 331' ' ' SER . 54.5 tp10 -58.64 -52.1 67.13 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 122.099 -0.647 . . . . 0.0 112.376 -177.15 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' B' ' 370' ' ' GLU . 89.2 m-20 -114.98 15.63 17.23 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.011 -1.056 . . . . 0.0 111.416 -177.11 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.54 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.0 OUTLIER -41.25 -37.3 0.92 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.255 -0.903 . . . . 0.0 111.718 -178.488 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . 0.516 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 72.7 mm-40 -68.05 -44.53 76.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.602 -1.311 . . . . 0.0 110.376 -178.083 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -68.29 -51.56 43.51 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.094 -1.004 . . . . 0.0 109.033 179.806 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -46.32 -38.08 8.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.698 -0.626 . . . . 0.0 111.665 -178.87 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 70.4 t -73.02 -39.47 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.624 -1.297 . . . . 0.0 109.332 179.505 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.98 -58.67 7.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 0.0 111.507 -178.807 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -68.96 -40.45 78.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.525 -1.359 . . . . 0.0 111.791 -177.956 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.02 -41.87 93.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.715 -1.241 . . . . 0.0 108.853 -178.871 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 52.6 t -61.07 -44.58 98.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.221 -0.925 . . . . 0.0 109.624 179.367 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' B' ' 383' ' ' GLU . 45.7 mtpt -69.26 -55.3 10.93 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.108 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 48.7 tp -54.87 -35.9 64.55 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.317 -0.864 . . . . 0.0 109.393 -178.271 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 38.3 ttm -70.77 -40.02 72.88 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.623 -1.298 . . . . 0.0 108.689 177.829 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.86 -4.28 58.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.625 -0.672 . . . . 0.0 110.533 179.728 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' B' ' 379' ' ' LYS . 98.4 mt-10 -112.11 -4.79 14.34 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.087 -1.008 . . . . 0.0 110.986 -179.701 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 16.5 mt -80.27 132.86 35.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.455 -1.403 . . . . 0.0 108.483 178.579 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.284 -179.904 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mmm . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.197 0.522 . . . . 3.19 109.777 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.4 mt -99.69 122.9 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.267 -0.895 . . . . 1.71 109.042 179.505 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.3 m -139.03 119.39 13.75 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.302 -0.874 . . . . 1.66 109.683 -179.482 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.08 -163.01 29.72 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.108 -1.597 . . . . 1.05 109.108 179.648 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.2 mt -90.6 -7.77 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.118 -1.224 . . . . 1.59 110.684 -179.048 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.2 tp 54.85 96.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.969 -1.082 . . . . 1.47 109.246 -179.829 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.45 -25.77 26.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.142 -0.974 . . . . 1.39 109.375 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 t -150.93 131.21 7.0 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.152 -0.967 . . . . 2.09 109.101 179.659 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.11 140.31 15.66 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.954 1.769 . . . . 0.91 111.836 179.608 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 166.61 -164.59 37.82 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.382 -1.487 . . . . 0.92 109.382 -179.583 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.3 mt -147.24 147.27 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.897 -1.355 . . . . 1.35 108.589 179.37 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.06 157.67 37.91 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.924 -1.11 . . . . 1.14 110.07 179.755 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -139.02 128.13 23.89 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.01 -1.107 . . . . 0.7 108.01 179.312 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.52 178.78 47.4 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.473 -1.822 . . . . 0.58 110.792 179.714 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -77.43 158.15 30.17 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.761 -0.847 . . . . 2.63 109.431 -179.658 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.36 132.3 45.81 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.315 -0.866 . . . . 1.27 111.515 -178.563 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.3 tp -101.58 133.3 46.47 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.468 -1.308 . . . . 1.41 107.468 178.004 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.0 tp -116.35 123.13 46.85 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.853 0.835 . . . . 1.49 110.19 -178.798 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.3 mt -92.75 102.29 14.69 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.206 0.527 . . . . 1.52 110.586 -179.022 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mtmt -105.15 136.0 45.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.369 -0.832 . . . . 3.17 109.482 179.713 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -130.64 139.49 50.37 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.44 -0.787 . . . . 3.0 109.354 179.437 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -87.5 152.63 22.06 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.147 -0.971 . . . . 2.77 109.493 179.547 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -70.07 140.64 52.8 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.103 -0.998 . . . . 2.94 110.383 -179.781 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.6 mt -81.88 136.65 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.476 -0.935 . . . . 1.46 108.476 179.124 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.6 t -103.66 127.68 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.231 -0.918 . . . . 1.7 110.776 -178.82 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -102.96 136.69 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.791 -0.818 . . . . 1.54 108.791 179.481 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.13 124.55 34.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.987 -1.07 . . . . 1.81 109.238 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -88.99 1.12 55.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -0.873 . . . . 3.23 109.526 -179.762 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -61.85 140.33 58.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 3.29 110.129 179.859 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -85.58 141.73 29.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.612 -0.884 . . . . 2.8 108.612 179.452 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 7.7 pt -90.12 164.99 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.823 -1.173 . . . . 1.43 110.944 -179.12 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.3 p -97.07 172.46 7.82 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.551 -0.907 . . . . 1.54 108.551 178.566 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.02 -48.69 80.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.02 -1.05 . . . . 1.6 109.819 -179.473 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 40.1 t0 -55.5 -30.05 59.93 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.822 -1.174 . . . . 2.56 109.367 -179.889 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.86 -10.04 59.42 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.446 -0.784 . . . . 2.36 110.272 -179.756 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.5 t -64.08 -53.28 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.497 -1.377 . . . . 1.43 108.995 179.578 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.25 -40.04 96.3 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.436 -0.79 . . . . 1.77 110.121 -179.906 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -69.89 -40.25 75.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.095 -1.003 . . . . 3.32 110.497 -178.934 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -65.81 -40.04 91.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.846 -1.159 . . . . 1.51 109.955 -179.988 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.88 -46.48 96.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.963 -1.086 . . . . 1.41 108.514 178.919 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -60.26 -40.43 90.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.19 -0.944 . . . . 1.81 109.315 179.561 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -60.07 -44.14 94.96 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.097 -1.075 . . . . 3.26 108.097 179.099 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.33 -48.63 80.46 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.231 -0.918 . . . . 0.81 109.046 178.114 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.5 tp -59.81 -45.24 92.97 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.217 -1.031 . . . . 1.59 108.217 -179.472 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.2 t -60.34 -40.02 89.21 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.156 -0.965 . . . . 1.38 108.548 178.538 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.9 -48.87 80.89 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.641 -1.784 . . . . 0.87 108.641 179.32 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -60.33 -39.02 85.57 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.821 -1.177 . . . . 3.62 107.821 178.28 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.06 -40.79 59.14 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.582 -0.896 . . . . 1.43 108.582 179.887 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 50' ' ' ALA . 14.5 ttmm -66.91 -73.78 0.13 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.386 -1.338 . . . . 3.08 107.386 178.417 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.83 -38.7 0.19 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.659 -0.65 . . . . 1.33 111.139 -178.557 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.2 m -53.75 -55.25 27.97 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.513 -1.367 . . . . 1.85 108.184 179.206 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.91 -46.96 66.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.521 -0.737 . . . . 1.35 111.027 -179.63 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -62.47 -43.54 98.56 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.885 -1.134 . . . . 2.34 110.5 -179.058 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.6 mt -60.12 -40.07 88.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.06 -1.025 . . . . 2.2 108.924 179.694 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -62.71 -34.39 77.06 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.429 -0.794 . . . . 1.35 109.618 179.507 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -64.6 -44.15 91.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.991 -1.068 . . . . 1.34 109.744 179.881 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.9 mt -60.23 -39.86 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 1.26 109.343 179.822 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.9 ttpp -54.08 -50.19 67.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.492 -0.755 . . . . 1.7 109.7 -179.076 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.7 m -58.13 -37.98 75.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -0.939 . . . . 1.35 110.667 -177.884 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.411 ' O ' ' OG1' ' A' ' 64' ' ' THR . 97.6 mttt -64.85 -38.92 92.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.878 -1.139 . . . . 2.08 109.768 -179.696 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.65 -46.8 77.81 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.541 -0.724 . . . . 1.21 109.865 -179.613 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.13 -52.21 52.79 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.913 -1.275 . . . . 0.75 109.913 -179.124 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -70.08 -47.56 61.39 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.146 -1.208 . . . . 1.59 109.996 -179.728 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 49.0 m -63.63 -65.45 0.68 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.299 -0.876 . . . . 1.41 112.744 -177.569 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -95.58 -45.03 7.22 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.609 -1.307 . . . . 0.79 111.151 -177.944 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.17 -169.98 24.79 Favored Glycine 0 N--CA 1.5 2.91 0 O-C-N 120.672 -1.268 . . . . 1.22 110.863 179.67 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.0 -24.36 63.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.93 -0.747 . . . . 5.81 109.652 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -60.0 -34.01 72.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -0.802 . . . . 3.37 110.195 -179.682 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -100.33 -17.46 17.25 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.316 -0.865 . . . . 2.37 110.006 179.683 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -68.8 -46.44 68.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.262 -0.899 . . . . 1.65 110.284 -179.342 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.47 -28.2 69.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.412 -0.805 . . . . 1.42 109.945 -178.802 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 93.0 mt -60.06 -41.14 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.917 -1.114 . . . . 1.43 109.389 -179.621 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -68.19 -38.16 81.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.961 -1.087 . . . . 1.08 110.279 -179.567 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.441 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 74.4 tt0 -59.94 -39.95 87.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.922 -1.111 . . . . 1.37 109.485 179.676 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.1 -41.69 99.7 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.11 -1.596 . . . . 0.67 109.11 179.522 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.4 m170 -64.02 -40.97 97.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.398 -1.06 . . . . 1.99 109.502 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -68.91 -47.2 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.174 -0.954 . . . . 1.22 109.022 179.488 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -60.61 -40.24 91.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.095 -1.003 . . . . 2.11 110.472 -179.457 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.402 ' CD1' ' CE2' ' B' ' 348' ' ' PHE . 27.2 tp -67.48 -40.0 85.26 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.079 -1.013 . . . . 1.33 109.3 179.72 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.63 -39.98 92.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.468 -0.77 . . . . 1.29 110.368 -179.503 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -80.26 5.05 15.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.995 -1.066 . . . . 1.47 110.262 -178.706 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 61.9 t0 -51.57 130.03 27.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.059 -1.026 . . . . 1.47 109.618 -179.855 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.404 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.7 mt-10 -61.21 -15.18 31.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.48 -0.763 . . . . 1.78 110.173 -179.337 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -72.55 -36.86 68.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.106 -0.996 . . . . 2.53 108.673 178.758 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.04 -40.06 75.35 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.574 0.702 . . . . 1.36 109.41 -179.915 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.12 -49.16 78.75 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.259 -0.9 . . . . 1.42 109.597 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -69.99 -40.29 75.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.377 -0.827 . . . . 2.27 111.316 -179.008 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.07 -39.92 75.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.881 -1.137 . . . . 1.57 110.997 -178.678 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.3 mt -70.0 -41.97 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.02 -1.05 . . . . 1.19 109.585 -179.744 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.7 mt -68.53 -37.79 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.444 -0.785 . . . . 1.39 109.633 179.39 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.425 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.96 -47.28 86.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 1.39 110.818 -178.701 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 96' ' ' LYS . 97.8 mt -60.09 -45.99 91.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.81 -1.181 . . . . 1.5 109.393 -179.284 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.2 mt -61.68 -49.43 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.297 -0.877 . . . . 1.29 109.097 179.479 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -69.86 -40.0 76.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.306 -0.872 . . . . 2.64 110.67 179.805 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 91' ' ' ALA . 61.9 t0 -83.64 -52.86 6.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.037 -1.039 . . . . 1.65 112.057 -177.948 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 92' ' ' LEU . 7.1 mtpm? -93.4 -3.22 53.63 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.078 -1.014 . . . . 2.5 112.295 -177.123 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.2 m170 59.21 39.98 22.13 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.839 -1.163 . . . . 1.88 109.573 -179.585 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.5 mtp -91.27 164.97 13.69 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.459 -0.775 . . . . 1.71 110.112 -179.834 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 65.4 p -79.99 163.62 24.1 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.514 -0.741 . . . . 1.61 109.197 179.732 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.09 -41.23 82.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 1.33 110.458 -179.305 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -67.48 -37.69 83.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 2.07 109.577 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.29 -41.15 34.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.293 -0.879 . . . . 1.37 110.169 179.967 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.1 -47.02 63.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.895 . . . . 1.14 110.452 -179.25 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.45 -40.4 90.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.974 -1.079 . . . . 1.26 110.18 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.45 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 84.8 t60 -59.91 -40.12 87.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.251 -0.905 . . . . 2.02 110.17 -178.564 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -64.52 -40.12 95.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.057 -1.027 . . . . 1.33 110.795 -178.931 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.08 -51.85 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.072 -1.017 . . . . 1.3 111.06 -178.093 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mm -69.66 -39.97 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.777 -1.202 . . . . 1.32 108.574 -179.837 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.45 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 88.2 tt0 -62.78 -39.35 93.93 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.622 -0.881 . . . . 2.44 108.622 178.825 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.94 -50.61 65.8 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.199 -1.161 . . . . 0.99 110.199 -179.545 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -66.24 -48.11 71.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.79 -1.418 . . . . 1.97 109.112 179.955 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.05 93.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.139 -0.976 . . . . 1.43 108.673 179.431 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.1 t -58.19 -39.94 80.25 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.71 -0.848 . . . . 2.12 108.71 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.92 -40.0 94.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.403 -0.811 . . . . 1.64 109.631 179.485 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.04 -41.19 91.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.976 -1.078 . . . . 1.93 109.604 -179.431 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.83 -33.81 72.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.57 -1.331 . . . . 2.2 109.452 -179.246 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -54.5 -22.18 12.16 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.418 -0.956 . . . . 2.12 108.418 179.437 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 61.7 mt -64.09 144.84 56.8 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.378 -0.826 . . . . 2.34 109.319 179.912 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -100.63 46.67 0.94 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.248 -0.907 . . . . 3.23 110.489 -179.727 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 64.6 t0 -131.51 138.02 48.77 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.14 -0.975 . . . . 2.49 109.943 179.964 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.541 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 47.5 mt-10 -69.94 -32.0 70.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.599 -0.688 . . . . 3.95 110.504 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.465 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.3 t80 -72.18 -39.95 68.29 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.309 -0.87 . . . . 2.25 110.536 179.582 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.621 ' CD2' HH21 ' A' ' 126' ' ' ARG . 80.9 mt -70.54 -37.31 74.05 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.094 -1.004 . . . . 2.27 108.825 -179.855 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -60.41 -39.83 88.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 3.31 109.792 179.333 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -59.46 -48.94 79.7 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.112 -0.992 . . . . 2.73 109.692 -179.232 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.621 HH21 ' CD2' ' A' ' 123' ' ' LEU . 77.4 mtm180 -63.88 -38.52 91.39 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.134 -1.026 . . . . 3.2 108.672 179.105 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.67 -26.63 56.91 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.951 -1.129 . . . . 1.66 107.951 178.888 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.08 -38.08 72.45 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.403 -0.962 . . . . 1.67 108.403 178.347 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -64.98 -40.1 94.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.581 -0.699 . . . . 1.55 109.658 -179.527 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.2 t -68.84 -43.02 82.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.26 -0.9 . . . . 1.32 109.233 179.811 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.412 HH11 ' HG2' ' A' ' 131' ' ' ARG . 28.6 ttt-85 -60.6 -39.68 89.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 3.58 108.842 179.14 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -60.0 -39.98 87.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.557 -0.714 . . . . 1.46 110.422 -179.447 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 94.3 mt -60.04 -43.91 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.887 -1.133 . . . . 1.22 109.997 -179.261 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.98 -34.43 70.92 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.894 -1.283 . . . . 0.61 109.894 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -60.0 -49.97 75.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -1.177 . . . . 3.1 109.673 -179.219 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -69.85 -30.85 68.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.851 -1.156 . . . . 3.71 110.04 -179.936 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.04 -43.24 95.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.07 -1.018 . . . . 1.87 109.083 -179.586 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.6 mt -60.39 -39.9 88.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.304 -0.873 . . . . 1.29 109.352 179.208 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -69.64 -38.17 77.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 3.05 108.485 179.072 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.453 HD21 ' N ' ' A' ' 140' ' ' ASN . 1.4 m120 -60.16 -36.71 78.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.819 -0.551 . . . . 1.26 110.626 -179.136 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.3 mt -70.07 -42.98 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.782 -1.199 . . . . 1.34 109.512 -179.767 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.8 mt -81.08 -38.03 28.0 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.402 -0.812 . . . . 1.6 110.021 -179.89 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.89 45.87 4.08 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 108.758 -1.737 . . . . 0.96 108.758 -178.941 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.4 tp -74.18 149.87 40.68 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.482 -1.01 . . . . 1.67 109.777 -179.273 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 142.56 53.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 4.96 109.655 -179.61 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.05 123.19 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-O 121.611 0.72 . . . . 1.68 109.214 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 147' ' ' ILE . 23.9 mm -49.18 -52.91 9.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.583 -0.698 . . . . 2.14 109.384 -178.943 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.6 t0 66.41 100.08 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.494 0.664 . . . . 1.5 109.527 -179.893 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.467 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 67.8 mt -70.91 -9.0 56.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.507 -0.746 . . . . 1.39 109.945 -179.337 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.416 ' HA ' HD22 ' A' ' 172' ' ' ASN . 22.9 p -74.99 -17.28 60.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.066 -1.021 . . . . 1.83 109.592 179.778 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.94 28.74 0.67 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.455 -0.778 . . . . 1.46 111.316 -177.716 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.467 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 49.9 mt -90.02 116.87 32.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.848 -1.157 . . . . 1.42 109.37 -179.434 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -98.97 -14.27 19.58 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.357 -0.84 . . . . 2.94 110.087 -178.982 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -127.17 149.91 49.75 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.193 -0.942 . . . . 1.52 110.23 -179.173 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -63.75 139.73 58.8 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.621 -0.881 . . . . 1.58 108.621 179.814 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.7 m -153.09 164.95 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 1.32 109.699 -179.693 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.1 mt -93.51 149.15 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 105.834 -1.913 . . . . 1.27 105.834 176.533 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 43.4 tp -97.37 113.91 25.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.934 -1.104 . . . . 1.41 110.481 -177.725 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 62.6 t -121.18 129.98 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 108.255 -1.017 . . . . 1.23 108.255 179.067 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -163.25 169.22 19.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 1.32 108.872 179.888 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.17 -35.37 68.98 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.696 -1.253 . . . . 1.49 108.023 178.375 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -167.46 175.52 7.14 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.812 -1.181 . . . . 2.25 107.812 179.961 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 58.0 mt -135.59 145.64 47.12 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.076 -1.015 . . . . 1.35 109.09 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 40.0 p -97.37 127.9 36.63 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.242 -1.021 . . . . 1.56 108.242 179.166 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -37.0 -35.9 0.25 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.985 1.79 . . . . 0.87 112.616 -179.407 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.3 m -60.01 -39.87 87.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.075 -1.016 . . . . 1.36 109.016 -179.722 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -67.88 -40.16 83.59 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.171 -0.955 . . . . 1.61 110.138 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 55.8 p -56.46 -33.79 66.25 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.145 -0.972 . . . . 1.21 111.382 -177.991 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.76 -45.08 65.43 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.676 -1.265 . . . . 1.21 109.71 -179.871 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -90.73 35.63 0.89 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.374 -0.972 . . . . 2.11 108.374 179.68 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.4 tp -106.71 130.73 54.39 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.12 -1.067 . . . . 1.29 108.12 178.577 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . 0.416 HD22 ' HA ' ' A' ' 150' ' ' SER . 4.1 m-20 -82.05 103.86 11.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.171 -0.956 . . . . 2.81 109.177 -179.75 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.25 -41.06 96.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.046 -1.033 . . . . 2.09 110.234 -179.471 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.52 -27.22 68.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 2.86 111.359 -178.049 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -92.75 -10.43 37.05 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.603 -1.31 . . . . 2.39 109.933 -178.867 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 58.1 t -103.23 112.83 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.15 -0.969 . . . . 1.27 108.698 179.031 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.9 mt -87.29 3.99 44.56 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.27 -0.894 . . . . 2.17 110.719 -178.336 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 176.31 168.91 37.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.112 -1.595 . . . . 0.52 109.112 179.719 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -130.91 127.12 37.84 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.386 -1.067 . . . . 0.55 109.277 -179.945 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 95.8 mt -130.48 123.58 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.449 -1.315 . . . . 1.27 107.449 177.915 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.3 p -141.88 159.15 42.8 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.204 1.002 . . . . 1.39 111.068 -178.824 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 183' ' ' ALA . 59.2 t0 -96.88 18.34 14.81 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.685 -0.634 . . . . 2.46 109.737 -179.8 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -44.28 -178.87 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.91 -1.119 . . . . 1.51 112.653 -178.032 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.71 -54.31 4.63 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 111.23 -0.748 . . . . 2.23 111.23 -179.355 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.1 -163.82 13.63 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.06 -1.543 . . . . 2.23 111.285 -178.835 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.429 HH11 ' HG2' ' A' ' 186' ' ' ARG . 12.6 ptt-85 -72.39 -10.54 59.92 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.794 -0.827 . . . . 6.44 110.738 -179.116 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.6 p -80.9 7.42 10.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.955 -1.091 . . . . 4.09 109.898 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 95.1 p -84.92 142.69 29.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 2.2 110.481 -179.69 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -48.27 -44.53 33.63 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.867 -0.79 . . . . 1.15 108.867 179.601 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.528 ' HG1' ' N ' ' A' ' 191' ' ' SER . 3.2 p -56.08 -40.08 73.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.626 -0.671 . . . . 2.01 109.806 -179.475 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.528 ' N ' ' HG1' ' A' ' 190' ' ' THR . 48.3 t -61.67 -40.28 94.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -0.93 . . . . 1.93 111.03 -179.241 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.9 mm -62.18 -41.52 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.084 -1.01 . . . . 2.2 110.115 -178.813 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.9 mtp -60.02 -45.62 92.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.039 -1.038 . . . . 1.32 110.683 -178.38 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.97 -42.68 94.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.688 -1.257 . . . . 1.3 109.708 -179.308 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 -60.04 -51.23 70.53 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.272 -0.892 . . . . 3.38 110.618 -178.919 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 52.6 m -77.74 -32.44 52.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.923 -1.111 . . . . 1.15 111.866 -178.336 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.7 mt -70.4 -20.31 62.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.634 -1.292 . . . . 1.28 109.459 -179.425 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 64.17 49.94 2.53 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.309 0.576 . . . . 1.5 110.546 -179.733 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 83.2 mt -130.35 151.0 77.77 Favored Pre-proline 0 N--CA 1.5 2.058 0 N-CA-C 108.163 -1.051 . . . . 1.37 108.163 178.679 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.65 139.43 69.56 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.002 1.801 . . . . 0.76 111.043 179.599 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -171.55 153.98 3.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.763 -1.21 . . . . 1.19 111.525 -179.721 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.64 152.32 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.053 -1.091 . . . . 1.31 108.053 179.362 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.2 m -131.88 -13.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 121.064 -1.023 . . . . 1.38 111.295 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -111.36 26.47 12.02 Favored Glycine 0 N--CA 1.502 3.088 0 N-CA-C 110.645 -0.982 . . . . 1.03 110.645 -178.826 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 204' ' ' GLY . 3.2 p -43.38 -45.06 5.97 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.23 -1.159 . . . . 1.38 109.962 -179.622 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.465 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 93.89 -53.95 2.26 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 120.204 -0.998 . . . . 1.17 111.2 179.128 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 64.3 m -154.4 31.49 0.43 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.321 -1.694 . . . . 2.07 111.449 -179.024 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.02 -40.08 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.85 -1.156 . . . . 1.35 108.885 178.581 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 75.0 p -53.29 -29.52 33.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.424 -0.798 . . . . 1.49 110.563 -179.219 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.0 t -83.7 -15.13 49.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.973 -1.08 . . . . 2.16 110.428 -178.855 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -100.09 -15.92 18.03 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.226 -0.921 . . . . 2.89 110.955 -179.009 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 88.5 t -105.29 139.72 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.136 -0.978 . . . . 1.33 111.001 -178.16 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.455 ' HZ1' ' CB ' ' A' ' 213' ' ' LYS . 0.0 OUTLIER -114.13 152.59 30.88 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.585 -1.265 . . . . 2.73 107.585 178.473 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 5.6 t-20 -58.27 139.16 55.62 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.948 -1.095 . . . . 2.7 110.283 -179.255 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 12.5 t0 87.74 8.61 0.17 Allowed 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 121.335 0.588 . . . . 2.38 109.796 179.633 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 56.2 t0 -79.07 140.5 37.87 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.326 -0.859 . . . . 2.09 109.317 179.551 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.531 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 55.3 t80 -91.78 118.39 30.64 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.346 -1.353 . . . . 1.45 107.346 178.476 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 82.7 mt -126.52 147.36 49.86 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.325 -0.86 . . . . 1.31 110.69 -178.631 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 81.6 mt -118.57 126.71 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.819 -1.548 . . . . 1.29 106.819 176.875 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 48.6 tp -102.02 124.84 48.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.241 -0.912 . . . . 1.31 108.645 -179.268 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.595 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 27.9 p-10 -87.94 -35.62 17.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.203 -0.935 . . . . 2.31 108.607 179.686 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.445 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 44.52 18.59 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.826 -0.805 . . . . 1.19 108.826 -179.224 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 221' ' ' ASP . 16.6 t -125.82 -46.89 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.127 -1.434 . . . . 1.45 107.127 179.579 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -100.75 -1.03 36.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.873 -1.529 . . . . 3.13 106.873 177.745 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 61.76 50.39 4.37 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.439 0.638 . . . . 2.2 109.587 179.996 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.595 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 95.6 mt-30 -138.77 151.16 46.85 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.522 -0.736 . . . . 2.32 109.311 179.76 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 84.2 t -119.41 127.73 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.421 -0.955 . . . . 1.4 108.421 178.882 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -102.26 123.98 47.03 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.331 -0.989 . . . . 1.29 108.331 179.443 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.5 t -104.21 115.0 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.492 -0.755 . . . . 1.38 110.369 -178.911 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 60.4 t30 53.61 69.55 2.19 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.912 . . . . 2.33 110.341 179.718 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -90.91 148.58 3.89 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 123.408 2.739 . . . . 0.95 112.478 179.541 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.7 m -69.99 160.88 31.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 2.31 109.701 -179.431 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.55 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 38.2 p30 -60.02 -39.94 87.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 3.45 111.481 -178.669 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.55 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 13.1 pt-20 -60.04 -31.22 69.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.58 -1.325 . . . . 2.89 109.641 -179.352 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 83.2 t -70.03 -42.41 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.033 -1.042 . . . . 1.73 109.282 179.115 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.07 -40.67 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.313 -0.867 . . . . 1.57 110.396 -179.762 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -59.94 -41.65 92.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.812 -1.18 . . . . 2.43 108.861 -179.614 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -65.97 -40.12 90.96 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.248 -0.908 . . . . 3.18 109.25 179.591 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 96.2 mtp -68.11 -37.38 81.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.446 -0.784 . . . . 1.59 109.645 179.615 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -66.55 -37.78 85.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.4 -0.813 . . . . 3.11 109.857 179.989 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.12 -40.97 91.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.217 -0.927 . . . . 2.17 109.716 -179.606 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.82 -41.39 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 2.51 109.789 -179.672 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 13.5 tm0? -60.08 -40.12 88.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.205 -0.935 . . . . 3.82 110.033 -179.397 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -60.53 -44.89 95.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 1.78 109.783 -179.725 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -60.22 -40.01 88.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 2.77 109.631 -179.876 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 92.5 t -59.95 -39.79 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 2.25 109.139 -179.205 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.98 -48.46 78.35 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.212 -0.93 . . . . 2.54 109.116 179.85 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 62.4 m -62.52 -39.9 95.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.116 -0.99 . . . . 3.03 110.216 179.838 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.414 ' C ' ' H ' ' A' ' 251' ' ' ALA . 96.8 mt-10 -61.15 -39.96 92.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.319 -0.863 . . . . 3.34 111.188 -178.503 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.98 23.46 0.35 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.756 -1.215 . . . . 4.18 109.863 -179.337 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 249' ' ' GLU . . . -51.25 -22.54 2.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.115 -0.99 . . . . 4.43 108.677 179.695 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.485 ' OE1' ' N ' ' A' ' 252' ' ' GLU . 57.1 mp0 -69.93 -31.54 69.36 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.812 -0.81 . . . . 5.42 108.812 179.475 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.463 ' CB ' ' O ' ' A' ' 252' ' ' GLU . 8.6 mt 95.17 -44.89 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 106.969 -1.493 . . . . 6.11 106.969 -178.321 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 60.04 20.19 9.35 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.724 -0.61 . . . . 7.37 109.647 179.595 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -135.97 139.1 42.94 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.437 -0.789 . . . . 8.3 109.031 179.777 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.542 ' CD2' ' N ' ' A' ' 256' ' ' LEU . 3.0 mm? -98.63 30.8 3.12 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.559 -0.713 . . . . 9.05 109.991 -179.047 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -155.9 -80.0 0.08 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.99 -1.069 . . . . 10.56 109.86 179.834 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 46.6 t0 60.15 71.38 0.57 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.519 -0.738 . . . . 11.32 109.741 -179.588 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . 0.435 HH11 ' HG2' ' A' ' 259' ' ' ARG . 43.0 mtt-85 . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 117.985 -1.007 . . . . 12.74 109.283 179.729 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 10.4 ttt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . 0.504 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 22.8 t80 -154.84 154.07 32.15 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.312 -0.868 . . . . 0.0 110.05 179.542 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . 0.504 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 2.9 pm0 -146.98 156.62 43.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.183 -0.948 . . . . 0.0 110.661 -179.621 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 0.4 OUTLIER -152.15 147.31 26.28 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.454 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . 0.517 ' N ' ' OE1' ' B' ' 304' ' ' GLN . 98.9 mt-10 -107.21 131.32 54.3 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.959 -1.088 . . . . 0.0 109.694 179.102 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.26 120.61 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 CA-C-O 122.045 0.926 . . . . 0.0 112.544 -177.745 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 8.8 m -76.91 107.11 9.01 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.874 0.845 . . . . 0.0 111.359 -177.711 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.6 mt -52.23 118.13 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 122.098 0.951 . . . . 0.0 109.717 -178.944 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 309' ' ' THR . . . . . 0.565 ' C ' HE22 ' B' ' 357' ' ' GLN . 67.4 p -107.3 19.95 19.61 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.714 -178.249 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . 0.522 ' N ' ' OE1' ' B' ' 357' ' ' GLN . . . -81.2 114.52 49.74 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.192 -0.943 . . . . 0.0 109.845 179.686 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -50.4 -9.72 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.733 0 CA-C-N 120.199 1.107 . . . . 0.0 113.308 -179.332 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' B' ' 310' ' ' ALA . 97.8 m-20 -120.5 4.04 10.7 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.437 -0.789 . . . . 0.0 109.265 179.829 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 74.0 -178.75 43.0 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.428 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.465 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.5 tp -83.64 89.82 7.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.05 -1.265 . . . . 0.0 109.027 -179.193 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -92.8 -162.2 0.91 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.924 -1.11 . . . . 0.0 109.989 179.18 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.8 m -58.07 -42.3 85.25 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.041 -1.037 . . . . 0.0 112.873 -175.932 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.454 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.4 tpt180 -59.87 -61.52 7.73 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 120.327 -1.483 . . . . 0.0 111.523 -178.571 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -58.11 -33.63 97.6 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.231 1.118 . . . . 0.0 111.473 179.975 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.29 74.53 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.515 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.2 -44.02 74.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.662 -0.649 . . . . 0.0 109.338 -179.905 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -70.01 -42.01 73.59 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.598 179.061 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -59.99 -50.41 73.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.635 -0.666 . . . . 0.0 110.543 -179.371 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.44 -30.25 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.591 -1.318 . . . . 0.0 109.172 -179.485 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . 0.441 ' NZ ' ' OE1' ' A' ' 74' ' ' GLU . 19.9 ttmt -60.01 -47.14 87.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.413 -0.804 . . . . 0.0 109.199 179.535 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -67.56 -48.89 65.64 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.184 -0.948 . . . . 0.0 110.896 -179.227 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -66.08 -52.72 46.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.798 -1.189 . . . . 0.0 110.709 -178.748 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -54.78 -14.5 1.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.088 -179.02 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -74.59 -20.95 79.37 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.358 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -103.79 146.96 27.86 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.439 -1.036 . . . . 0.0 108.719 179.686 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 13.9 t -91.2 -13.65 32.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.767 -1.208 . . . . 0.0 109.653 -179.898 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 63.7 p -60.13 147.58 39.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 -179.863 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' B' ' 332' ' ' GLU . 58.2 mp0 -68.87 134.49 49.7 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.104 -0.998 . . . . 0.0 108.636 179.758 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.1 mt -133.17 133.63 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.497 -0.752 . . . . 0.0 109.688 -179.222 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 82.4 m -129.05 149.81 50.71 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.478 -0.764 . . . . 0.0 109.288 179.409 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 53.9 t -122.84 114.07 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.338 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 96.5 m -104.97 134.18 48.51 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.212 -0.93 . . . . 0.0 109.394 -178.411 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 24.7 p -139.46 111.67 7.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.336 -0.853 . . . . 0.0 110.944 -179.48 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 48.89 50.81 17.06 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 176.685 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 90.04 -14.84 60.96 Favored Glycine 0 N--CA 1.501 2.998 0 O-C-N 119.941 -1.724 . . . . 0.0 112.503 177.104 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -118.64 131.44 56.18 Favored 'General case' 0 N--CA 1.508 2.447 0 CA-C-N 119.019 1.41 . . . . 0.0 109.69 -179.809 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 79.6 p -132.51 151.8 51.78 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.933 0.873 . . . . 0.0 110.681 -178.872 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -143.26 167.2 22.7 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -179.758 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 15.2 m -87.56 138.16 31.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.47 -0.769 . . . . 0.0 110.255 -179.273 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.447 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -77.13 -14.59 59.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.959 -1.088 . . . . 0.0 109.997 -179.394 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -89.59 20.46 3.98 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.126 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.447 ' H ' ' C ' ' B' ' 344' ' ' ALA . 9.0 t -145.74 94.44 2.49 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.535 -179.649 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . 0.529 ' CD1' HE22 ' B' ' 351' ' ' GLN . 58.5 tp -59.97 -36.32 76.86 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.069 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . 0.402 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 51.0 m-85 -54.54 -50.42 67.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 0.0 110.699 -179.376 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.419 ' NZ ' ' CB ' ' B' ' 346' ' ' SER . 35.9 mtmm -69.95 -40.02 75.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.911 -1.118 . . . . 0.0 111.237 -177.975 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' B' ' 352' ' ' THR . 88.2 mt -49.28 -56.99 7.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.875 -1.14 . . . . 0.0 109.443 -178.933 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.529 HE22 ' CD1' ' B' ' 347' ' ' LEU . 1.2 mp0 -42.23 -14.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.414 -0.804 . . . . 0.0 111.342 -178.101 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.55 ' N ' ' O ' ' B' ' 350' ' ' LEU . 59.3 p -88.72 -11.48 45.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.287 -1.508 . . . . 0.0 110.185 -179.132 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 79.3 mt -91.58 117.52 29.79 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.84 -1.162 . . . . 0.0 108.807 178.646 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -69.79 89.2 0.3 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 58.0 mt -98.73 86.81 3.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -1.162 . . . . 0.0 108.456 179.03 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 67.2 p -89.26 168.97 11.84 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.041 -1.037 . . . . 0.0 110.063 -178.926 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . 0.565 HE22 ' C ' ' B' ' 309' ' ' THR . 15.8 tp60 -62.99 114.94 3.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.631 -0.668 . . . . 0.0 110.61 -179.031 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.24 8.72 40.71 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.713 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 31.6 m -87.2 111.7 21.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.261 -1.14 . . . . 0.0 111.394 -178.986 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 48.5 t -76.98 118.09 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 122.267 1.032 . . . . 0.0 109.548 -177.914 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.0 m -112.9 177.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -177.952 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 48.9 m -130.71 128.79 41.56 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.45 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . 0.408 HG22 HD11 ' B' ' 363' ' ' ILE . 86.6 mt -103.06 117.58 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.154 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 72.7 m -120.99 132.09 54.7 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.289 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.24 153.34 40.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.069 -1.019 . . . . 0.0 110.489 -179.296 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . 0.441 ' OE1' ' OE1' ' B' ' 370' ' ' GLU . 17.1 tp10 -144.47 122.32 11.97 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.082 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.48 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 159.8 -157.11 28.34 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.954 -1.593 . . . . 0.0 111.595 -179.97 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -59.99 -51.88 67.77 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.338 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -109.15 12.5 25.0 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.754 -1.216 . . . . 0.0 111.176 -177.256 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.48 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 11.8 pt-20 -42.33 -38.17 1.75 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.157 -0.965 . . . . 0.0 111.807 -178.816 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -69.89 -40.51 75.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.638 -1.289 . . . . 0.0 110.249 -178.341 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -68.75 -51.39 41.85 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.171 -0.956 . . . . 0.0 109.482 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -49.64 -34.28 17.85 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.634 -0.666 . . . . 0.0 112.228 -178.413 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 56.2 t -74.82 -39.21 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.657 -1.277 . . . . 0.0 109.766 179.567 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -68.23 -40.01 82.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.168 -0.957 . . . . 0.0 112.37 -177.785 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -84.61 -43.07 14.78 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.193 -1.567 . . . . 0.0 110.901 -179.363 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.93 -40.09 87.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.998 -1.064 . . . . 0.0 108.843 -179.196 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.02 -45.98 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.217 -0.927 . . . . 0.0 109.412 179.42 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' B' ' 383' ' ' GLU . 62.3 mttp -68.62 -54.75 14.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.788 -1.195 . . . . 0.0 107.86 178.503 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 52.8 tp -55.8 -36.25 67.21 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.308 -0.87 . . . . 0.0 109.182 -178.29 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 23.8 ttm -70.65 -40.08 73.25 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.698 -1.251 . . . . 0.0 108.335 177.792 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.21 -4.93 58.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.526 -0.734 . . . . 0.0 110.606 179.585 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' B' ' 379' ' ' LYS . 96.8 mt-10 -112.16 -3.67 14.61 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.17 -0.956 . . . . 0.0 111.106 -179.46 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.2 mt -79.88 136.55 36.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.464 -1.397 . . . . 0.0 109.47 179.011 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 N--CA 1.497 1.918 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.368 -179.901 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.9 mtp . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.506 -0.553 . . . . 3.19 109.506 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.407 HG23 HD12 ' A' ' 2' ' ' ILE . 85.4 mt -110.18 129.98 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.417 -0.802 . . . . 1.71 109.71 -179.928 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.2 m -132.67 149.84 52.24 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.402 -0.811 . . . . 1.66 109.408 179.686 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.7 -169.92 11.91 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.041 -1.624 . . . . 1.05 109.041 179.757 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.9 mt -85.48 -19.08 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.879 -1.365 . . . . 1.59 110.432 -178.831 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.7 tp 52.92 102.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.176 -0.952 . . . . 1.47 109.03 -179.732 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.11 -26.99 13.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.101 -0.999 . . . . 1.39 109.645 -179.881 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -134.77 117.97 13.17 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.469 -0.769 . . . . 2.09 109.004 -179.843 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.19 148.12 21.19 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.766 1.644 . . . . 0.91 112.562 -179.631 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.486 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 155.05 -155.41 26.21 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.754 -1.738 . . . . 0.92 108.754 -179.818 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.426 HG23 HD12 ' A' ' 11' ' ' ILE . 92.5 mt -149.6 151.18 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 120.909 -1.347 . . . . 1.35 108.715 179.041 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.47 150.85 30.06 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.901 -1.125 . . . . 1.14 110.719 179.772 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.8 m-85 -133.9 127.12 31.85 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 107.923 -1.14 . . . . 0.7 107.923 178.616 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.92 -176.69 46.39 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 118.37 -1.872 . . . . 0.58 111.203 179.713 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -79.23 155.64 28.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.985 -0.715 . . . . 2.63 109.841 -179.693 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.82 124.36 49.3 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.579 -0.7 . . . . 1.27 109.978 179.892 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.0 tp -94.22 135.19 35.88 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.472 -1.307 . . . . 1.41 107.472 178.582 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.9 tp -116.01 122.66 45.86 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.22 -0.925 . . . . 1.49 109.946 -179.08 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.7 mt -84.98 100.74 11.85 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.586 0.708 . . . . 1.52 109.955 -179.63 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -100.04 124.79 45.8 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.533 -0.914 . . . . 3.17 108.533 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.9 tp10 -132.03 141.82 49.37 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.237 -0.915 . . . . 3.0 109.462 -179.954 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.543 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 9.9 p-10 -77.73 149.19 34.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.385 -0.822 . . . . 2.77 109.558 179.649 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -70.15 149.61 47.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.166 -0.959 . . . . 2.94 109.595 -179.741 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.429 HG21 HD11 ' A' ' 24' ' ' ILE . 84.7 mt -82.34 126.51 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.186 -0.946 . . . . 1.46 110.154 -179.604 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.67 123.63 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.278 -0.889 . . . . 1.7 108.744 179.074 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -100.55 145.23 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.333 -0.855 . . . . 1.54 109.363 -179.555 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -98.51 113.42 25.43 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.172 -0.955 . . . . 1.81 109.519 -179.879 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.451 HH11 ' HG2' ' A' ' 28' ' ' ARG . 7.4 mmt-85 -86.32 -2.13 58.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 3.23 109.449 -179.855 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -66.12 142.8 57.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.934 . . . . 3.29 109.225 179.714 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -83.43 149.6 26.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 2.8 109.544 -179.749 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.4 pt -93.2 165.02 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.032 -1.042 . . . . 1.43 109.091 179.311 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.9 p -94.72 169.53 10.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.948 -1.095 . . . . 1.54 108.485 178.963 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.68 -12.83 60.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 1.6 109.561 -179.967 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -88.32 -28.86 20.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.111 -0.993 . . . . 2.56 108.406 178.787 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -81.65 -8.91 59.76 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.748 -0.834 . . . . 2.36 108.748 178.963 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.3 t -62.46 -53.59 45.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.083 -1.01 . . . . 1.43 108.912 179.815 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -60.04 -40.05 88.06 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.171 -0.956 . . . . 1.77 109.928 -179.87 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -69.94 -40.2 75.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.948 -1.095 . . . . 3.32 110.899 -179.37 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 68.7 mm-40 -65.27 -40.07 93.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.674 -1.266 . . . . 1.51 110.199 -179.895 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -61.64 -47.8 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.639 -1.288 . . . . 1.41 108.537 179.083 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.03 -45.9 91.29 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.175 -0.953 . . . . 1.81 109.538 179.677 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -60.04 -42.94 95.49 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.688 -1.226 . . . . 3.26 107.688 179.146 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -61.2 -49.93 75.16 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.645 -0.659 . . . . 0.81 109.491 178.927 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.91 -45.48 94.49 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.457 -0.777 . . . . 1.59 109.721 -179.718 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 31.9 t -66.46 -45.68 78.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.027 -1.045 . . . . 1.38 109.332 179.682 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.85 -44.56 97.69 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.026 -2.029 . . . . 0.87 108.026 178.9 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 80' ' ' LEU . 69.2 ttt180 -62.98 -35.31 79.75 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.357 -0.979 . . . . 3.62 108.357 178.638 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.442 ' O ' ' OG ' ' A' ' 51' ' ' SER . . . -55.87 -39.93 72.22 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.834 -0.802 . . . . 1.43 108.834 179.801 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 50' ' ' ALA . 18.9 ttmt -63.32 -74.63 0.09 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.088 -1.078 . . . . 3.08 108.088 179.531 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.38 -31.82 0.06 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.363 -0.836 . . . . 1.33 111.682 -177.978 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 48' ' ' ALA . 75.6 p -60.1 -54.17 49.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.562 -1.336 . . . . 1.85 108.669 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.99 -42.44 73.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.339 -0.851 . . . . 1.35 111.055 -179.298 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.45 -40.5 97.3 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.826 -1.171 . . . . 2.34 110.552 -178.805 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.27 -39.66 92.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.874 -1.141 . . . . 2.2 108.993 179.603 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -59.95 -37.85 80.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.35 -0.844 . . . . 1.35 109.515 179.379 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -64.7 -41.2 96.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 1.34 110.46 -179.67 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.405 HG22 HD13 ' A' ' 57' ' ' ILE . 96.5 mt -64.62 -39.83 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.108 -0.995 . . . . 1.26 109.373 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.449 ' NZ ' ' OE2' ' A' ' 70' ' ' GLU . 13.2 ttpp -59.35 -49.98 75.73 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.275 -0.89 . . . . 1.7 109.121 -179.858 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.401 ' H ' ' HG1' ' A' ' 59' ' ' THR . 4.1 m -61.13 -40.03 92.26 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.211 -0.931 . . . . 1.35 110.493 -178.795 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -63.7 -38.86 92.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.096 -1.003 . . . . 2.08 109.155 179.692 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.14 -41.56 94.66 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.582 -0.699 . . . . 1.21 109.746 179.574 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.65 -50.39 66.7 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 110.24 -1.144 . . . . 0.75 110.24 -179.488 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.89 -43.0 72.67 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.881 -1.364 . . . . 1.59 109.654 -179.65 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.9 m -71.27 -59.84 2.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.035 -1.041 . . . . 1.41 112.06 -178.476 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -91.18 -54.16 4.05 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.678 -1.264 . . . . 0.79 110.603 -178.801 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.58 -169.32 25.21 Favored Glycine 0 N--CA 1.5 2.916 0 C-N-CA 120.071 -1.062 . . . . 1.22 111.224 179.748 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -70.01 -24.14 63.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.951 -0.735 . . . . 5.81 109.958 -179.954 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.507 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.8 tp10 -60.45 -38.04 82.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.888 . . . . 3.37 109.899 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -99.44 -19.43 16.96 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.395 -0.815 . . . . 2.37 110.604 -179.317 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.449 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 61.8 tt0 -68.1 -39.99 82.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.902 -1.124 . . . . 1.65 109.837 -179.528 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.28 -33.78 76.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.411 -0.806 . . . . 1.42 110.384 -178.886 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.07 -42.37 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.752 -1.217 . . . . 1.43 109.222 -179.849 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -72.59 -34.8 67.68 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.39 -0.819 . . . . 1.08 110.487 -179.213 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.503 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 72.6 tt0 -59.97 -40.07 87.81 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.838 -1.164 . . . . 1.37 109.198 179.035 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.98 -41.2 97.8 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.41 -1.876 . . . . 0.67 108.41 179.081 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -61.78 -48.53 80.25 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.341 -1.093 . . . . 1.99 108.785 179.365 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.3 -50.56 79.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.563 -0.711 . . . . 1.22 109.851 -179.776 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.6 ttp -60.98 -44.2 97.7 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.009 -1.057 . . . . 2.11 109.238 -179.639 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.9 tp -60.05 -39.91 87.59 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.579 -0.701 . . . . 1.33 109.114 179.214 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.52 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 58.6 tp -69.66 -35.06 74.83 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.604 -0.685 . . . . 1.29 109.968 -179.387 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -85.43 0.43 52.28 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.92 -1.112 . . . . 1.47 110.002 -179.276 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -46.3 130.07 10.5 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.201 -0.937 . . . . 1.47 109.879 -179.221 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -61.36 -22.33 64.84 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.458 -0.776 . . . . 1.78 111.011 -179.124 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.99 -31.76 69.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.874 -1.141 . . . . 2.53 109.417 179.15 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 91.2 mt -71.98 -40.02 68.87 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.673 0.749 . . . . 1.36 109.368 179.093 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.03 -49.25 78.38 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.724 -0.61 . . . . 1.42 110.827 -178.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -70.0 -42.01 73.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.17 -0.957 . . . . 2.27 111.061 -178.498 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.94 -39.94 75.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.964 . . . . 1.57 111.491 -178.824 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.7 mt -68.0 -45.22 84.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 120.973 -1.08 . . . . 1.19 109.782 -179.517 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -69.76 -38.79 76.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.322 -0.861 . . . . 1.39 110.089 179.831 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.66 -45.23 93.77 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 1.39 111.593 -178.913 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 99.3 mt -60.07 -44.22 94.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.83 -1.169 . . . . 1.5 109.533 -178.633 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.3 mt -61.19 -50.11 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.166 -0.959 . . . . 1.29 109.291 179.406 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -67.51 -40.01 85.13 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 120.22 -0.592 . . . . 2.64 111.436 -179.318 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -83.66 -52.14 6.69 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.752 -1.218 . . . . 1.65 112.025 -178.557 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -90.01 -0.05 57.37 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.119 -0.988 . . . . 2.5 112.026 -177.218 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 80.7 m80 55.1 33.81 21.21 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.834 -1.166 . . . . 1.88 109.486 -179.812 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 75.2 mtp -84.9 166.4 16.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.55 -0.719 . . . . 1.71 109.599 -179.625 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.499 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 76.8 p -78.64 154.85 29.88 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.171 -1.048 . . . . 1.61 108.171 179.187 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.0 -39.26 75.97 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.062 -1.024 . . . . 1.33 110.015 -179.707 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -63.23 -40.19 96.75 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.101 -1.0 . . . . 2.07 109.621 -179.695 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.499 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -82.05 -46.12 14.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.104 -0.997 . . . . 1.37 109.655 179.463 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.98 -46.15 90.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.454 -0.779 . . . . 1.14 109.71 -179.539 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.96 75.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.149 -0.97 . . . . 1.26 109.478 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -59.98 -34.79 73.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.861 . . . . 2.02 110.042 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -60.0 -41.27 91.71 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.176 -0.952 . . . . 1.33 109.103 -179.653 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.8 t -64.78 -49.96 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 1.3 110.072 -179.46 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.1 mm -69.05 -40.28 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.047 -1.033 . . . . 1.32 109.027 179.622 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -64.92 -40.01 94.4 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.722 -0.844 . . . . 2.44 108.722 179.362 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.97 -49.26 80.5 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.244 -1.142 . . . . 0.99 110.244 -179.76 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -66.4 -51.81 53.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.929 -1.336 . . . . 1.97 109.11 -179.493 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.97 93.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 1.43 109.718 179.583 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.8 p -58.38 -39.69 80.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 2.12 108.8 -179.701 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.96 -35.6 75.32 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.34 -0.85 . . . . 1.64 109.214 179.664 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.5 mt -66.2 -42.88 88.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.974 -1.079 . . . . 1.93 109.485 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -56.99 -32.71 66.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.072 -1.018 . . . . 2.2 109.327 -179.091 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.03 -28.43 67.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -0.889 . . . . 2.12 108.966 179.859 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 59.6 mt -64.23 148.29 50.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.366 -0.834 . . . . 2.34 109.199 -179.927 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -100.07 57.1 0.96 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.175 -0.953 . . . . 3.23 109.448 179.802 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 58.8 t0 -136.0 135.23 39.32 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.247 -0.908 . . . . 2.49 110.514 -179.681 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.465 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 38.7 mt-10 -70.0 -32.46 70.64 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.338 -0.851 . . . . 3.95 109.903 179.313 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.48 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.4 t80 -69.6 -36.4 76.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.45 -0.781 . . . . 2.25 110.815 -179.805 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 66.2 mt -80.73 -34.66 34.27 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.754 -1.216 . . . . 2.27 109.47 179.866 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -60.49 -44.46 95.92 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.121 -0.987 . . . . 3.31 109.235 179.447 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -69.53 -40.09 77.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 2.73 109.516 -179.912 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -60.64 -40.07 90.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.229 -0.92 . . . . 3.2 108.565 179.408 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 128' ' ' ALA . . . -59.44 -45.59 91.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.137 -0.977 . . . . 1.66 108.459 179.689 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 127' ' ' ALA . . . -44.3 -43.89 7.71 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.097 -0.705 . . . . 1.67 109.097 179.992 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -61.9 -45.85 91.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.389 -0.82 . . . . 1.55 109.868 179.389 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.14 -39.98 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.21 -0.931 . . . . 1.32 108.918 -179.896 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.672 ' HE ' ' NZ ' ' A' ' 135' ' ' LYS . 69.4 ttt180 -60.0 -39.41 85.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 3.58 109.147 179.528 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -60.02 -37.8 80.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.228 -0.92 . . . . 1.46 109.934 -179.749 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.03 -44.32 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.048 -1.032 . . . . 1.22 109.657 -179.205 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.95 -33.83 59.42 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.709 -1.234 . . . . 0.61 110.172 179.882 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.672 ' NZ ' ' HE ' ' A' ' 131' ' ' ARG . 37.5 mmtm -59.99 -46.88 88.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.151 -1.205 . . . . 3.1 110.061 -179.011 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 66.4 mtp180 -65.93 -34.21 77.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.802 -1.186 . . . . 3.71 109.452 179.86 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.0 tp -57.24 -42.01 80.65 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.655 -0.868 . . . . 1.87 108.655 -179.252 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.5 mt -60.88 -40.12 91.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 1.29 109.296 178.377 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.444 HH11 ' HG2' ' A' ' 139' ' ' ARG . 47.2 mtt-85 -69.68 -40.11 76.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 3.05 109.52 -179.915 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -66.93 -37.96 85.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.584 -0.698 . . . . 1.26 111.757 -178.827 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.418 HD12 HG22 ' A' ' 141' ' ' ILE . 96.8 mt -71.22 -40.01 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.411 -1.43 . . . . 1.34 109.43 179.61 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 60.8 mt -75.48 -12.25 60.2 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.618 -0.676 . . . . 1.6 110.819 -178.344 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.98 35.43 57.93 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.636 -1.785 . . . . 0.96 108.636 -179.286 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.0 tp -73.4 142.43 46.96 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.485 -1.009 . . . . 1.67 109.275 -179.19 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -72.37 140.77 48.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.38 -0.825 . . . . 4.96 110.441 -179.062 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.427 HG22 HD12 ' A' ' 146' ' ' ILE . 85.4 mt -112.58 129.96 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-O 122.007 0.908 . . . . 1.68 109.289 179.468 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.3 mt -62.07 -43.21 97.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.912 -0.585 . . . . 2.14 110.783 -178.588 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.9 t0 66.58 122.35 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.529 -0.732 . . . . 1.5 109.079 -179.016 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.5 mt -92.69 0.67 57.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.394 -0.816 . . . . 1.39 110.637 -179.034 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.7 p -83.61 -15.3 49.56 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.745 -1.222 . . . . 1.83 110.413 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.99 29.97 0.33 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.115 -0.991 . . . . 1.46 112.199 -177.997 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.3 mm -83.77 125.17 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.379 -1.45 . . . . 1.42 109.188 179.623 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -104.32 -12.74 16.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.4 -0.813 . . . . 2.94 109.755 -179.826 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -137.83 156.96 47.38 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.237 -0.914 . . . . 1.52 110.213 -179.107 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.66 135.11 56.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.282 -0.886 . . . . 1.58 109.226 -179.64 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.7 m -153.05 168.14 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.398 -0.813 . . . . 1.32 110.146 179.403 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 80.6 mt -98.79 143.89 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 105.772 -1.936 . . . . 1.27 105.772 177.212 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 47.4 tp -97.68 120.1 37.45 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.772 -1.205 . . . . 1.41 109.993 -178.464 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.0 t -119.79 127.9 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.059 -0.719 . . . . 1.23 109.059 179.833 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.86 161.5 34.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.899 . . . . 1.32 108.888 179.87 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.82 -32.72 67.86 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.438 -1.414 . . . . 1.49 108.077 178.579 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -170.35 143.49 2.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.493 -0.754 . . . . 2.25 109.564 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 54.9 mt -116.53 141.03 48.71 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.44 -0.788 . . . . 1.35 109.554 -179.499 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 48.4 p -95.29 145.82 30.22 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.14 -0.975 . . . . 1.56 110.226 -179.429 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -40.6 -36.78 1.95 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.512 2.141 . . . . 0.87 112.802 179.029 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 63.9 m -59.03 -39.87 83.26 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.317 -0.864 . . . . 1.36 109.183 -179.076 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.58 -40.05 84.85 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.295 -0.878 . . . . 1.61 109.91 -179.709 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.7 p -58.17 -23.29 54.9 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.956 -1.09 . . . . 1.21 110.408 -178.863 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.78 -56.44 4.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.092 -1.005 . . . . 1.21 109.562 179.694 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -84.17 42.24 0.87 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.805 -1.183 . . . . 2.11 107.805 179.611 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.5 tp -101.81 140.99 35.36 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.207 -0.664 . . . . 1.29 109.207 179.472 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -89.95 103.02 15.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.155 -0.965 . . . . 2.81 108.681 179.293 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 70.5 mt -67.19 -44.09 80.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.418 -0.801 . . . . 2.09 111.914 -178.072 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -69.98 -25.47 63.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.759 -1.213 . . . . 2.86 112.512 -177.525 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -93.4 -5.5 49.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.621 -1.299 . . . . 2.39 110.722 -178.328 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 23.0 t -86.13 139.99 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.834 -1.167 . . . . 1.27 110.496 -179.845 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.0 mt -103.91 -12.37 16.91 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 109.593 -0.521 . . . . 2.17 109.593 178.587 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 162.6 179.51 37.23 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.247 -1.541 . . . . 0.52 109.247 179.986 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -130.51 129.37 42.79 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.221 -1.164 . . . . 0.55 110.158 -179.95 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 66.5 mt -128.65 120.55 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.383 -0.969 . . . . 1.27 108.383 177.756 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 61.0 p -148.78 160.81 42.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.742 -1.224 . . . . 1.39 110.555 -179.654 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -110.08 30.29 6.86 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.123 -0.695 . . . . 2.46 109.123 179.321 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -74.66 -158.3 0.07 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.67 -1.269 . . . . 1.51 112.339 -177.499 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -54.56 -80.95 0.07 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.676 -0.97 . . . . 2.23 110.676 -179.403 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . 0.544 ' H ' ' HG ' ' A' ' 188' ' ' SER . . . 163.02 -115.88 0.68 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.369 -1.396 . . . . 2.23 110.405 -179.836 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.49 HH11 ' HG2' ' A' ' 186' ' ' ARG . 0.5 OUTLIER -68.49 -30.2 68.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.469 -1.018 . . . . 6.44 111.002 -178.856 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.0 p -79.97 7.42 9.01 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.006 -1.059 . . . . 4.09 110.544 -178.62 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.544 ' HG ' ' H ' ' A' ' 185' ' ' GLY . 61.0 m -90.95 128.6 36.85 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.821 -1.174 . . . . 2.2 110.702 -179.528 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -47.27 -48.62 24.69 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.381 -0.824 . . . . 1.15 109.493 179.929 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.2 m -60.04 -39.92 87.6 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 2.01 109.961 -179.153 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 62.1 m -60.01 -39.95 87.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.985 -1.072 . . . . 1.93 109.335 -179.38 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.5 mm -66.31 -40.28 86.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.278 -0.889 . . . . 2.2 109.235 -179.92 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 92.9 mtp -64.63 -39.99 94.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.123 -0.986 . . . . 1.32 111.254 -179.538 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.61 -43.27 93.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.313 -1.492 . . . . 1.3 108.978 -179.644 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -59.93 -49.92 75.79 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.244 -0.91 . . . . 3.38 109.786 -179.566 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.5 m -70.03 -34.21 72.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.039 -1.038 . . . . 1.15 110.631 -179.226 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.0 mt -76.07 -21.68 56.48 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.08 -1.012 . . . . 1.28 109.533 -179.413 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 61.28 47.7 6.76 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.543 -0.723 . . . . 1.5 110.633 -179.646 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 63.4 mt -121.52 135.58 25.22 Favored Pre-proline 0 N--CA 1.501 2.124 0 N-CA-C 108.514 -0.921 . . . . 1.37 108.514 178.662 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -43.64 128.93 6.83 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.021 1.814 . . . . 0.76 112.124 -179.947 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -166.42 144.32 5.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.597 -1.315 . . . . 1.19 112.151 -179.79 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.409 HD11 HG23 ' A' ' 202' ' ' ILE . 94.9 mt -124.55 144.53 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 106.763 -1.569 . . . . 1.31 106.763 177.656 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.48 -10.56 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 120.78 -1.2 . . . . 1.38 111.554 -178.372 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -103.6 23.76 31.83 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.592 -1.403 . . . . 1.03 109.592 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 7.6 p -45.98 -42.44 13.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -1.125 . . . . 1.38 109.971 -179.194 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 89.94 -49.1 3.29 Favored Glycine 0 N--CA 1.498 2.767 0 O-C-N 120.963 -1.086 . . . . 1.17 111.113 179.336 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.422 ' O ' ' OG ' ' A' ' 207' ' ' SER . 13.8 t -165.92 40.41 0.06 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.714 -1.463 . . . . 2.07 110.731 -179.612 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 49.2 t -79.45 -37.71 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.081 -1.081 . . . . 1.35 108.081 177.865 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.8 p -52.56 -27.22 15.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.663 -0.648 . . . . 1.49 109.703 -179.906 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 69.8 m -78.94 -26.5 43.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 2.16 109.856 -179.629 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -92.3 -8.3 45.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.043 -1.036 . . . . 2.89 109.856 -179.672 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 64.8 t -105.17 133.77 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.436 -0.79 . . . . 1.33 110.272 -178.955 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.482 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 70.2 mmtt -113.39 154.0 27.66 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 106.976 -1.49 . . . . 2.73 106.976 178.309 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 55.7 t-20 -59.95 138.98 57.7 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.955 -1.091 . . . . 2.7 110.238 -178.622 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 84.85 -1.69 0.9 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 121.116 0.484 . . . . 2.38 110.801 179.115 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.482 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 92.7 m-20 -70.38 148.1 48.79 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.13 -0.981 . . . . 2.09 109.107 178.978 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -96.9 119.98 36.39 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.913 -1.144 . . . . 1.45 107.913 179.16 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 87.1 mt -126.72 147.26 49.98 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.369 -0.832 . . . . 1.31 110.237 -178.876 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 99.9 mt -117.79 127.21 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.152 -1.425 . . . . 1.29 107.152 177.291 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 17.7 tp -100.94 120.6 40.41 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.257 -0.902 . . . . 1.31 109.584 -178.657 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.537 ' C ' ' H ' ' A' ' 223' ' ' VAL . 7.1 t70 -76.01 -41.45 51.02 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.025 -1.102 . . . . 2.31 108.025 179.42 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 49.01 9.94 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.722 -0.611 . . . . 1.19 109.83 179.788 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.537 ' H ' ' C ' ' A' ' 221' ' ' ASP . 60.4 t -126.73 -35.12 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.619 -1.252 . . . . 1.45 107.619 178.66 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.492 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 98.6 m-20 -108.39 3.58 23.48 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.297 -1.001 . . . . 3.13 108.297 178.686 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 38.7 t30 59.86 45.52 12.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.64 -0.662 . . . . 2.2 110.352 179.981 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -138.92 144.55 39.13 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.168 -0.957 . . . . 2.32 109.792 179.392 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.2 t -115.35 130.13 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.66 -0.867 . . . . 1.4 108.66 179.381 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -104.63 126.13 51.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.444 -0.785 . . . . 1.29 108.98 179.5 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.1 t -100.03 106.99 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.272 -0.893 . . . . 1.38 109.954 -179.55 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 39.3 t30 49.92 61.0 14.46 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.189 -0.945 . . . . 2.33 111.422 178.002 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.83 158.39 27.74 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.494 2.13 . . . . 0.95 111.538 178.964 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.2 m -68.42 159.68 31.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.044 -1.035 . . . . 2.31 110.354 -178.923 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -59.95 -40.0 87.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.549 -0.719 . . . . 3.45 109.732 -179.619 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.05 -39.25 85.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 2.89 109.389 -179.985 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.9 t -67.5 -39.96 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.312 -0.868 . . . . 1.73 108.91 179.359 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.9 mt -66.47 -39.88 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.319 -0.863 . . . . 1.57 109.247 179.32 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -59.2 -43.18 92.24 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.078 -1.014 . . . . 2.43 108.619 -179.713 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -64.88 -40.01 94.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.293 -0.879 . . . . 3.18 108.766 178.976 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 93.9 mtp -70.77 -30.16 66.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.39 -0.819 . . . . 1.59 109.241 179.019 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -64.91 -40.02 94.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.275 -0.891 . . . . 3.11 109.366 179.502 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -64.06 -40.22 95.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 2.17 108.849 179.701 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.16 -40.09 82.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.477 -0.765 . . . . 2.51 109.073 179.467 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -57.26 -44.51 83.98 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.171 -0.955 . . . . 3.82 108.99 -179.416 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.0 -40.85 95.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.152 -0.967 . . . . 1.78 109.244 179.632 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -70.03 -44.24 69.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.336 -0.853 . . . . 2.77 109.783 179.746 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.17 -40.79 84.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.29 -0.882 . . . . 2.25 109.027 -179.735 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.8 -50.04 75.06 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.375 -0.828 . . . . 2.54 109.412 179.502 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 30.6 t -71.92 -41.31 68.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 3.03 110.55 -179.565 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -64.93 -40.48 95.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.242 -0.911 . . . . 3.34 110.96 -178.667 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.559 ' O ' ' N ' ' A' ' 252' ' ' GLU . 29.5 ttmt -70.07 -59.98 2.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.926 -1.109 . . . . 4.18 110.719 -178.272 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.646 ' O ' ' N ' ' A' ' 253' ' ' LEU . . . 46.51 12.39 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.31 -0.869 . . . . 4.43 109.6 -179.715 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 250' ' ' LYS . 88.2 tt0 59.68 -58.99 0.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.851 0.834 . . . . 5.42 108.979 -179.327 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.646 ' N ' ' O ' ' A' ' 251' ' ' ALA . 64.3 mt -72.21 13.14 0.34 Allowed 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.781 -0.574 . . . . 6.11 110.085 -178.279 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 252' ' ' GLU . . . -59.97 -49.95 75.68 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.45 -1.315 . . . . 7.37 107.45 178.532 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -177.53 143.59 0.36 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.455 -1.313 . . . . 8.3 107.455 178.98 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.504 ' CD2' ' N ' ' A' ' 256' ' ' LEU . 3.5 mm? -59.98 -37.66 80.28 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.922 -1.111 . . . . 9.05 108.031 179.626 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -101.09 -172.11 2.11 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.446 -0.946 . . . . 10.56 108.446 179.378 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -140.52 -108.25 0.15 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.948 -1.095 . . . . 11.32 108.84 179.807 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 41.2 mtm-85 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.975 -1.012 . . . . 12.74 109.515 179.935 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 45.5 ttm . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.408 0.623 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -151.02 148.17 28.02 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.153 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -152.19 161.6 42.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.935 -1.103 . . . . 0.0 111.039 -178.989 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -156.23 155.06 31.75 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.91 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -110.45 135.71 50.72 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.295 -0.878 . . . . 0.0 111.102 -179.055 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . 0.445 ' CG2' ' N ' ' B' ' 307' ' ' THR . 2.7 p -120.06 165.27 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.94 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 307' ' ' THR . . . . . 0.445 ' N ' ' CG2' ' B' ' 306' ' ' VAL . 70.9 m -119.11 115.96 25.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.101 -1.0 . . . . 0.0 108.328 178.526 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 60.2 mt -56.22 120.9 3.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-O 122.366 1.079 . . . . 0.0 110.893 -178.434 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 65.2 p -109.47 24.34 13.21 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.863 -179.945 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -85.17 116.65 66.38 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 108.725 179.618 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -68.33 -7.42 20.04 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 CA-C-N 120.201 1.108 . . . . 0.0 111.477 -179.948 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -119.12 6.61 11.27 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.634 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.52 175.76 43.86 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.366 -1.893 . . . . 0.0 108.366 -179.039 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.48 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -83.65 95.51 8.38 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.008 -1.289 . . . . 0.0 108.952 -178.874 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -96.66 -160.48 0.8 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.835 -1.165 . . . . 0.0 109.805 179.15 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 4.0 m -59.97 -43.46 95.06 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.942 -1.099 . . . . 0.0 112.278 -176.287 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.507 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 2.6 tpt180 -54.82 -62.06 4.78 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.44 -1.412 . . . . 0.0 111.299 -178.65 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -58.73 -36.42 97.14 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 CA-C-N 120.221 1.115 . . . . 0.0 111.181 179.787 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.71 72.65 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.503 -0.748 . . . . 0.0 108.989 179.77 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -56.84 -44.07 81.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.774 -179.182 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -69.91 -42.29 73.56 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.013 -1.055 . . . . 0.0 108.48 179.353 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -59.87 -50.04 75.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.673 -0.642 . . . . 0.0 111.192 -179.204 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 72.7 t -70.94 -28.65 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.556 -1.34 . . . . 0.0 109.875 -179.175 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . 0.503 ' NZ ' ' OE1' ' A' ' 74' ' ' GLU . 22.7 ttmt -60.05 -47.69 84.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.2 -0.938 . . . . 0.0 109.905 -179.203 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -65.31 -40.02 93.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.087 -1.008 . . . . 0.0 110.239 -179.292 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.67 -52.94 62.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.913 -1.117 . . . . 0.0 111.129 -179.025 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -60.58 -13.02 11.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.874 -1.141 . . . . 0.0 109.708 -179.515 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -67.46 -30.4 75.07 Favored Glycine 0 N--CA 1.485 1.967 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 178.608 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -106.11 144.15 33.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.654 -0.909 . . . . 0.0 108.942 179.587 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 25.3 p -90.34 -12.35 37.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.989 -1.069 . . . . 0.0 109.626 -179.993 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.7 t -58.49 147.98 29.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 109.117 179.768 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -66.71 131.89 46.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.247 -0.908 . . . . 0.0 109.201 -179.813 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 79.3 mt -130.92 130.33 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.492 -0.755 . . . . 0.0 109.293 179.938 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 28.6 m -131.46 153.8 49.38 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.569 -0.707 . . . . 0.0 109.433 179.568 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 68.7 t -116.09 139.27 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.081 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.7 m -129.49 121.99 28.37 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.177 -0.952 . . . . 0.0 108.995 179.771 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 42.0 p -138.72 119.37 14.03 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.013 0.911 . . . . 0.0 111.052 -179.272 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 57.5 t30 41.78 59.01 2.63 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 177.265 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 82.0 -14.6 31.64 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 120.369 -1.457 . . . . 0.0 113.087 176.316 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -115.94 128.68 55.95 Favored 'General case' 0 N--CA 1.506 2.34 0 CA-C-N 119.264 1.532 . . . . 0.0 109.425 179.978 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 81.0 p -129.55 150.82 50.72 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.807 0.813 . . . . 0.0 110.172 -179.089 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -143.54 166.49 24.66 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.682 0.753 . . . . 0.0 110.185 -179.223 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 343' ' ' SER . . . . . 0.419 ' OG ' ' NZ ' ' B' ' 345' ' ' LYS . 4.6 t -91.27 142.41 27.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.662 -0.648 . . . . 0.0 109.643 -179.587 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -80.02 -12.42 59.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 109.984 -179.508 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . 0.419 ' NZ ' ' OG ' ' B' ' 343' ' ' SER . 23.3 pttm -91.16 18.96 6.24 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.427 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.665 ' HG ' ' HZ3' ' B' ' 349' ' ' LYS . 19.7 m -146.05 95.92 2.71 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.279 -179.09 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 8.3 tp -59.96 -32.29 70.67 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.663 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -59.87 -54.53 45.07 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.524 -0.735 . . . . 0.0 110.636 -178.858 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.665 ' HZ3' ' HG ' ' B' ' 346' ' ' SER . 34.2 mtmm -67.0 -40.09 87.25 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.56 -1.337 . . . . 0.0 109.387 -178.633 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' B' ' 352' ' ' THR . 32.8 mt -50.19 -57.08 8.55 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.122 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -41.02 -17.66 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.864 -0.523 . . . . 0.0 111.099 -178.833 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.539 ' N ' ' O ' ' B' ' 350' ' ' LEU . 82.0 p -90.61 -5.98 55.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.183 -1.573 . . . . 0.0 110.567 -179.135 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 83.6 mt -92.96 108.63 20.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.945 -1.097 . . . . 0.0 109.639 179.434 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -68.25 84.67 0.18 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 107.81 -2.116 . . . . 0.0 107.81 178.774 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 71.0 mt -99.16 95.97 7.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.326 -1.103 . . . . 0.0 108.326 179.483 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 44.8 p -98.32 176.6 5.65 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.255 -0.903 . . . . 0.0 110.461 -178.604 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -44.62 159.15 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.355 1.074 . . . . 0.0 111.413 -179.327 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 41.09 23.3 0.08 OUTLIER Glycine 0 N--CA 1.497 2.701 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.601 177.608 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 4.5 m -87.4 108.04 18.82 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.459 -1.612 . . . . 0.0 109.501 179.595 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 57.8 t -77.28 123.2 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.784 -177.36 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.6 m -122.43 175.77 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -178.477 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 94.0 m -125.07 132.32 53.19 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.726 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 96.8 mt -100.73 121.78 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.484 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 54.0 p -124.09 133.92 53.5 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.524 -0.735 . . . . 0.0 109.471 -179.054 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.53 152.18 39.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.425 -0.797 . . . . 0.0 109.368 -179.489 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -141.97 119.77 11.89 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.529 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.527 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 159.68 -154.51 25.56 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.76 -1.686 . . . . 0.0 112.046 -179.935 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -58.05 -54.72 43.71 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -177.271 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' B' ' 370' ' ' GLU . 83.4 m-20 -112.39 14.42 20.37 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.028 -1.045 . . . . 0.0 111.177 -177.644 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.527 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.1 pt-20 -39.19 -37.52 0.41 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.621 -0.674 . . . . 0.0 110.926 -179.437 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -69.42 -46.18 67.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.022 -1.049 . . . . 0.0 111.064 -178.025 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.86 -49.48 65.54 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.864 -1.148 . . . . 0.0 110.374 -179.12 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -55.23 -35.15 64.63 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.082 -1.011 . . . . 0.0 111.477 -178.048 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 72.8 t -69.94 -41.04 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.458 -1.401 . . . . 0.0 108.264 178.996 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -63.86 -59.45 4.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.522 -0.736 . . . . 0.0 111.916 -178.737 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -67.84 -40.11 83.75 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.63 -1.294 . . . . 0.0 111.963 -177.306 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.4 -38.01 73.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.553 -1.342 . . . . 0.0 108.757 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 51.5 t -60.01 -42.04 88.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.255 -0.903 . . . . 0.0 109.285 179.499 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.441 ' O ' ' OE2' ' B' ' 383' ' ' GLU . 19.1 mmmt -69.43 -55.02 11.5 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.082 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 64.3 tp -54.22 -38.65 65.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.786 -0.571 . . . . 0.0 110.604 -177.377 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 381' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' B' ' 381' ' ' MET . 0.0 OUTLIER -73.34 -40.01 64.76 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.619 -1.232 . . . . 0.0 108.607 178.238 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.08 -3.4 48.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.095 -1.003 . . . . 0.0 109.775 179.411 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.441 ' OE2' ' O ' ' B' ' 379' ' ' LYS . 0.0 OUTLIER -111.65 -3.02 15.18 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.378 -0.827 . . . . 0.0 111.026 -179.331 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.03 128.9 40.65 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.499 -1.376 . . . . 0.0 109.688 179.411 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 118.103 -0.951 . . . . 0.0 109.218 179.524 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.7 mtt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.471 -0.566 . . . . 3.19 109.471 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 87.5 mt -106.85 120.09 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.525 -0.734 . . . . 1.71 109.095 179.937 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.7 m -132.85 133.34 43.2 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.468 -0.77 . . . . 1.66 109.228 179.829 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.775 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -115.27 -162.38 13.54 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 108.44 -1.864 . . . . 1.05 108.44 179.496 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 6' ' ' LEU . 79.5 mt -91.6 -12.9 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.95 -1.324 . . . . 1.59 109.648 -179.478 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.421 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.0 tp 53.75 99.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.145 -0.972 . . . . 1.47 108.822 -179.569 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.15 -40.18 74.9 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.687 -0.857 . . . . 1.39 108.687 179.315 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 46.5 m -149.05 147.95 25.49 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.431 -0.793 . . . . 2.09 109.744 179.574 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.73 146.99 17.02 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.671 2.248 . . . . 0.91 113.272 -179.925 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 165.19 -164.04 36.89 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 109.105 -1.598 . . . . 0.92 109.105 179.756 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.1 mt -149.84 149.88 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 120.914 -1.344 . . . . 1.35 109.124 179.208 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.38 156.22 33.5 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.037 -1.04 . . . . 1.14 110.552 179.214 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.4 m-85 -137.02 129.14 29.47 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 107.85 -1.167 . . . . 0.7 107.85 178.597 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.22 -179.13 44.83 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 118.652 -1.737 . . . . 0.58 110.996 179.847 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -79.89 155.21 27.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.747 -0.854 . . . . 2.63 109.533 -179.972 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -101.89 129.99 48.26 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.45 -0.781 . . . . 1.27 110.563 -179.3 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.0 tp -96.31 135.17 38.51 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.205 -1.406 . . . . 1.41 107.205 178.42 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.4 tp -113.48 118.29 34.07 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.219 -0.925 . . . . 1.49 109.773 -179.532 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 51.0 mt -85.98 102.88 14.17 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.432 0.635 . . . . 1.52 109.502 -179.947 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -97.56 137.33 36.65 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.376 -0.828 . . . . 3.17 109.971 -179.39 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -130.5 132.99 45.92 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.72 -0.844 . . . . 3.0 108.72 179.492 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -78.69 138.34 38.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.967 -1.083 . . . . 2.77 109.053 179.748 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.81 139.97 57.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 2.94 108.762 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.7 mt -85.22 132.76 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 1.46 109.416 -179.264 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.6 t -106.96 129.69 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.25 -0.906 . . . . 1.7 109.762 -179.748 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.3 mt -99.21 141.14 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.36 -0.838 . . . . 1.54 109.074 179.734 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -98.96 118.94 36.88 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.162 -0.961 . . . . 1.81 109.441 -179.961 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -90.11 3.07 54.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.465 -0.772 . . . . 3.23 109.887 -179.275 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -59.97 144.18 49.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.043 -1.036 . . . . 3.29 109.67 -179.895 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -92.0 143.5 26.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.208 -0.932 . . . . 2.8 108.963 179.654 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 pt -93.55 165.79 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.131 -0.981 . . . . 1.43 110.438 -179.346 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.2 p -88.96 170.42 10.7 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.02 -1.104 . . . . 1.54 108.02 178.281 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.19 -18.47 63.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.879 -1.138 . . . . 1.6 110.176 -179.799 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 53.7 t0 -83.55 -26.75 29.84 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.893 -1.129 . . . . 2.56 108.605 179.14 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -82.18 -7.64 59.63 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.983 -0.747 . . . . 2.36 108.983 179.036 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.3 t -60.49 -53.14 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.254 -0.904 . . . . 1.43 109.253 179.77 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.81 -39.96 90.89 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.321 -0.862 . . . . 1.77 109.969 -179.447 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -63.46 -40.21 96.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.246 -0.909 . . . . 3.32 110.997 -179.298 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -65.94 -40.03 91.02 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.742 -1.224 . . . . 1.51 110.593 -179.395 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.01 -46.9 93.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 118.163 -1.415 . . . . 1.41 108.379 -179.614 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.03 -41.57 92.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.839 -1.163 . . . . 1.81 109.703 179.806 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 mtt-85 -59.95 -44.82 94.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.805 -1.185 . . . . 3.26 108.576 179.131 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -63.18 -47.44 82.59 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.456 -0.778 . . . . 0.81 109.523 178.886 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.0 tp -59.96 -49.08 79.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.294 -0.879 . . . . 1.59 109.075 -179.069 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.8 t -64.27 -42.25 96.55 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.965 -1.084 . . . . 1.38 108.874 179.452 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.25 -48.86 84.04 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.544 -1.823 . . . . 0.87 108.544 179.117 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -60.64 -38.69 85.64 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.436 -1.038 . . . . 3.62 108.434 178.594 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.41 -40.06 70.96 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.096 -0.705 . . . . 1.43 109.096 -179.855 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 51' ' ' SER . 24.1 ttmt -61.16 -74.48 0.08 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.439 -1.319 . . . . 3.08 107.439 179.46 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.68 -30.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.39 -0.819 . . . . 1.33 111.427 -178.254 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 49' ' ' LYS . 18.3 t -60.0 -54.59 44.2 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.771 -1.172 . . . . 1.85 108.587 179.673 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.69 -42.81 77.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.611 -0.68 . . . . 1.35 111.161 -179.016 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.85 -45.68 93.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.801 -1.187 . . . . 2.34 110.675 -179.046 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.99 -40.18 94.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.927 -1.108 . . . . 2.2 109.477 -179.406 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -60.87 -39.77 90.43 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.252 -0.905 . . . . 1.35 110.031 179.861 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -65.41 -43.34 90.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.934 -1.104 . . . . 1.34 109.269 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.549 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.8 mt -61.68 -39.87 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 1.26 108.922 179.537 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -54.98 -50.38 69.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.752 . . . . 1.7 109.657 -179.469 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -57.33 -33.87 68.17 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.321 -0.862 . . . . 1.35 110.492 -178.088 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.417 ' O ' ' OG1' ' A' ' 64' ' ' THR . 97.6 mttt -69.83 -37.46 76.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 2.08 109.45 179.622 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.86 -46.07 79.82 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.677 -0.639 . . . . 1.21 110.192 -179.67 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.19 -52.81 44.71 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 110.159 -1.176 . . . . 0.75 110.159 -179.011 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -70.04 -43.92 70.3 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.997 -1.296 . . . . 1.59 110.255 -179.513 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 35.4 m -65.28 -65.25 0.7 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.092 -1.005 . . . . 1.41 112.987 -177.453 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -97.83 -42.59 7.5 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.812 -1.18 . . . . 0.79 111.667 -177.621 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.25 -168.98 25.22 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.752 -1.218 . . . . 1.22 111.014 179.499 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -73.77 -23.69 59.75 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.04 -0.682 . . . . 5.81 110.246 -179.966 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -62.46 -33.58 75.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 3.37 110.462 -179.077 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.5 mmtm -99.06 -20.03 16.92 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.274 -0.891 . . . . 2.37 109.61 -179.801 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -69.92 -40.24 75.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.312 -0.868 . . . . 1.65 110.531 -178.845 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.643 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -69.15 -27.31 65.43 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.183 -0.948 . . . . 1.42 109.879 -179.002 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 94.2 mt -60.01 -40.4 83.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.793 -1.188 . . . . 1.43 107.793 179.894 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -62.1 -41.91 98.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -0.888 . . . . 1.08 108.906 179.281 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.521 ' CD ' ' HZ1' ' B' ' 324' ' ' LYS . 65.2 tt0 -60.86 -39.91 90.93 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.633 -0.827 . . . . 1.37 109.345 179.15 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.44 -47.82 88.51 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.881 -1.687 . . . . 0.67 108.881 179.531 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -64.06 -40.12 95.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.496 -1.002 . . . . 1.99 109.032 179.582 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.2 mt -69.4 -45.73 78.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.342 -0.849 . . . . 1.22 109.451 179.717 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.4 ttp -63.61 -40.07 95.99 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.04 -1.038 . . . . 2.11 110.16 -178.69 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 58.0 tp -65.95 -40.03 90.98 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.396 -0.815 . . . . 1.33 109.959 -179.961 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.7 tp -65.5 -39.94 92.46 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.684 -0.635 . . . . 1.29 110.207 -178.775 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -84.68 4.72 31.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.896 -1.127 . . . . 1.47 110.039 -178.897 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.1 t0 -49.18 134.55 17.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.175 -0.953 . . . . 1.47 109.765 -179.666 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.46 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.6 mt-10 -60.69 -20.02 59.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.612 -0.68 . . . . 1.78 110.798 -178.728 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -71.36 -33.39 69.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.055 -1.028 . . . . 2.53 110.171 179.569 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.9 mt -75.02 -41.09 60.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.477 -0.764 . . . . 1.36 110.146 179.864 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.05 -50.05 75.24 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.227 -0.921 . . . . 1.42 110.732 -178.92 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.03 -40.74 74.98 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.05 -1.031 . . . . 2.27 111.665 -178.802 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -69.98 -39.16 76.11 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.031 -1.043 . . . . 1.57 111.354 -178.818 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.8 mt -67.67 -42.05 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.93 . . . . 1.19 109.116 -179.757 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.7 mt -65.82 -39.21 84.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.51 -0.744 . . . . 1.39 109.622 179.38 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.09 -49.45 77.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 1.39 111.451 -178.629 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.8 mt -60.99 -46.4 90.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.711 -1.243 . . . . 1.5 109.821 -178.866 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.03 -50.01 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 122.115 0.96 . . . . 1.29 109.075 179.729 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -70.43 -40.21 73.94 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 120.091 -0.644 . . . . 2.64 110.834 -179.762 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -81.13 -62.48 1.65 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.036 -1.04 . . . . 1.65 112.078 -178.135 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -82.55 -0.97 49.21 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.043 -1.036 . . . . 2.5 111.999 -177.025 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 73.3 m80 57.57 38.19 27.81 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.92 -1.112 . . . . 1.88 109.927 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.1 mtp -92.67 169.07 10.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.484 -0.76 . . . . 1.71 109.595 -179.937 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' THR . . . . . 0.48 ' HG1' ' H ' ' A' ' 102' ' ' ALA . 44.7 p -81.55 160.23 23.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.28 -0.887 . . . . 1.61 109.559 -179.692 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.4 -39.72 77.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.33 -0.856 . . . . 1.33 109.937 -179.772 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -67.01 -40.04 87.19 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -0.888 . . . . 2.07 109.498 179.817 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.48 ' H ' ' HG1' ' A' ' 99' ' ' THR . . . -78.65 -43.86 25.15 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.43 -0.794 . . . . 1.37 109.868 179.618 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.99 -42.92 72.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.339 -0.851 . . . . 1.14 110.568 -179.222 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.05 -44.12 96.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.166 -0.959 . . . . 1.26 109.819 -179.495 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -59.98 -38.71 83.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.321 -0.862 . . . . 2.02 110.386 -179.202 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.98 -40.28 88.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.012 . . . . 1.33 110.379 -179.172 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.1 t -64.74 -49.09 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.838 -1.164 . . . . 1.3 110.055 -179.38 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.5 mm -67.58 -40.09 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.069 -1.019 . . . . 1.32 109.214 -179.802 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.46 -38.87 88.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 2.44 108.808 179.336 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.96 -45.69 95.45 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 120.313 -0.946 . . . . 0.99 110.749 -179.487 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . 0.626 HE21 ' CB ' ' B' ' 348' ' ' PHE . 17.9 mm100 -70.04 -52.56 23.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.7 -1.471 . . . . 1.97 110.039 -179.118 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.2 88.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.855 . . . . 1.43 109.811 -179.497 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.2 t -57.88 -39.64 78.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.174 -0.954 . . . . 2.12 109.559 -179.287 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.16 -39.45 94.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 1.64 109.562 179.63 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.3 mt -61.94 -39.97 93.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.105 -0.997 . . . . 1.93 109.671 -179.202 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.438 ' CD ' ' NH2' ' A' ' 131' ' ' ARG . 36.3 mt-10 -58.91 -33.27 70.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.608 -1.307 . . . . 2.2 109.705 -179.141 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -56.33 -21.57 25.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.873 -1.142 . . . . 2.12 108.713 179.264 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 74.8 mt -62.54 140.4 58.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 2.34 108.939 179.687 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -90.63 21.66 3.9 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.208 -0.932 . . . . 3.23 110.126 -179.426 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 51.9 t0 -112.86 141.28 46.86 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.402 -0.811 . . . . 2.49 109.569 -179.737 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 124' ' ' LYS . 92.8 mt-10 -72.54 -63.2 1.21 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.265 -1.013 . . . . 3.95 108.265 178.631 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.46 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.8 t80 -38.65 -41.42 0.69 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.031 -0.418 . . . . 2.25 110.932 -178.935 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 87.2 mt -69.85 -39.92 76.1 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.63 -1.293 . . . . 2.27 108.239 179.549 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 121' ' ' GLU . 63.1 tttp -60.77 -40.07 91.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 3.31 110.022 179.718 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.02 -45.01 94.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.017 -1.052 . . . . 2.73 109.77 -179.28 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.814 ' HE ' HE22 ' B' ' 351' ' ' GLN . 65.6 mtp180 -60.54 -39.94 89.7 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.167 -0.958 . . . . 3.2 108.505 179.214 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.76 -27.35 67.9 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.556 -0.905 . . . . 1.66 108.556 179.027 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.18 -40.05 95.29 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.135 -1.061 . . . . 1.67 108.135 178.792 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -64.16 -40.09 95.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.518 -0.739 . . . . 1.55 109.21 179.653 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.89 -42.73 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -0.864 . . . . 1.32 108.733 179.945 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.438 ' NH2' ' CD ' ' A' ' 116' ' ' GLU . 44.1 ttm180 -60.33 -36.72 78.62 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.522 0.677 . . . . 3.58 109.203 179.361 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -58.45 -39.61 80.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.438 -0.789 . . . . 1.46 109.036 -179.671 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.87 -45.45 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.209 -0.932 . . . . 1.22 108.838 179.843 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.18 -41.34 99.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.771 -1.332 . . . . 0.61 109.771 179.689 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -59.99 -50.04 75.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.188 -1.184 . . . . 3.1 110.274 -179.927 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.549 HH22 ' CD1' ' A' ' 57' ' ' ILE . 62.1 mtp180 -69.64 -32.37 71.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.807 -1.183 . . . . 3.71 109.72 -179.631 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -57.3 -47.86 80.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 1.87 108.772 -179.139 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.9 mt -61.13 -39.69 90.98 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.254 -0.904 . . . . 1.29 108.955 178.407 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.504 HH11 ' CD2' ' A' ' 144' ' ' LEU . 50.0 mtt-85 -67.61 -40.05 84.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.89 . . . . 3.05 109.259 179.542 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -66.53 -39.88 88.83 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.629 -0.669 . . . . 1.26 110.456 -179.012 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.434 HD13 HG23 ' A' ' 141' ' ' ILE . 96.9 mt -71.78 -43.1 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 120.478 -1.389 . . . . 1.34 108.303 178.822 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.0 -32.25 70.35 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.74 -0.6 . . . . 1.6 109.733 179.944 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 139' ' ' ARG . . . 83.86 44.38 6.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.178 -1.569 . . . . 0.96 109.178 -179.373 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.504 ' CD2' HH11 ' A' ' 139' ' ' ARG . 12.3 tp -74.85 148.45 40.22 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.414 -1.05 . . . . 1.67 109.376 -179.44 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -70.45 143.16 51.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.24 -0.913 . . . . 4.96 109.896 -179.48 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.7 mt -115.22 129.98 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.984 0.897 . . . . 1.68 108.915 179.373 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 10.5 mt -66.85 -39.95 84.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 115.869 -0.605 . . . . 2.14 110.717 -178.23 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.6 t0 67.5 97.29 0.06 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.745 -0.835 . . . . 1.5 108.745 -179.329 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.2 mt -68.1 -1.13 5.37 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.443 -0.786 . . . . 1.39 110.939 -178.575 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 80.8 p -82.97 -14.0 54.9 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.695 -1.253 . . . . 1.83 110.111 -179.723 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.92 33.34 0.33 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.284 -0.885 . . . . 1.46 111.96 -177.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 45.1 mm -85.94 120.22 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.421 -1.425 . . . . 1.42 108.96 179.491 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.414 ' O ' ' OD1' ' A' ' 154' ' ' ASP . 50.6 tt0 -99.85 -12.14 20.12 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.33 -0.856 . . . . 2.94 109.93 -179.364 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 153' ' ' GLN . 95.7 m-20 -139.26 157.89 45.12 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.944 -1.098 . . . . 1.52 110.285 -179.398 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.95 137.03 57.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.45 -0.782 . . . . 1.58 109.63 -179.62 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.5 m -153.3 167.9 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.462 -0.774 . . . . 1.32 109.982 179.609 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 81.5 mt -97.16 144.74 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.727 -1.583 . . . . 1.27 106.727 177.689 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 40.9 tp -94.2 117.08 29.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.911 -1.118 . . . . 1.41 110.367 -178.222 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 44.6 t -123.12 129.41 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 108.667 -0.864 . . . . 1.23 108.667 179.199 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.14 165.31 29.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.119 -0.988 . . . . 1.32 109.354 -179.627 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.42 -30.63 61.99 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.261 -1.524 . . . . 1.49 108.378 178.823 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -165.51 168.41 16.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.913 -0.773 . . . . 2.25 108.913 -179.61 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.1 mt -139.6 133.19 30.36 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.169 -0.957 . . . . 1.35 108.869 179.286 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 69.3 p -99.13 149.35 35.7 Favored Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.318 -0.864 . . . . 1.56 109.769 -179.717 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -40.62 -37.77 2.32 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.541 2.16 . . . . 0.87 113.263 179.515 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 65.1 m -59.99 -39.99 87.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 1.36 109.677 -178.794 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -69.08 -44.21 72.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.287 -0.883 . . . . 1.61 110.503 -179.445 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.0 p -54.9 -30.17 57.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.043 -1.036 . . . . 1.21 111.717 -177.458 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.79 -48.58 24.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.7 -1.25 . . . . 1.21 109.901 -179.522 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -86.43 40.12 0.87 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.899 -1.149 . . . . 2.11 107.899 179.636 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.3 tp -111.26 136.14 50.78 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.36 -0.978 . . . . 1.29 108.36 178.485 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -90.43 108.42 19.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.966 -1.084 . . . . 2.81 110.096 -179.728 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 71.9 mt -64.91 -40.43 95.06 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.458 -0.776 . . . . 2.09 111.071 -178.906 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -70.05 -25.04 63.37 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.87 -1.144 . . . . 2.86 111.708 -178.131 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -93.62 -8.99 39.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.784 -1.198 . . . . 2.39 110.373 -178.632 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 85.4 t -103.27 117.85 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.194 -0.941 . . . . 1.27 108.948 179.434 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 81.6 mt -86.73 6.42 31.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.456 -0.778 . . . . 2.17 110.571 -177.875 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 165.66 175.4 36.15 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.305 -1.518 . . . . 0.52 109.305 179.806 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -132.18 130.67 41.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.477 -1.013 . . . . 0.55 109.198 -179.877 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 98.2 mt -132.93 124.85 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.483 -0.76 . . . . 1.27 108.963 178.869 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 47.5 p -148.02 160.61 42.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.97 -1.081 . . . . 1.39 110.917 -179.622 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.443 ' OD1' ' OG1' ' A' ' 205' ' ' THR . 0.8 OUTLIER -99.65 20.13 14.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.558 -0.714 . . . . 2.46 109.717 179.969 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.17 -163.32 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.812 -1.18 . . . . 1.51 111.607 -178.295 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -85.56 -46.92 5.32 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 111.224 -0.751 . . . . 2.23 111.224 -178.603 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 165.66 -136.44 4.18 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.963 -1.589 . . . . 2.23 110.612 -179.598 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.406 HH11 ' HG2' ' A' ' 186' ' ' ARG . 24.2 mmt-85 -70.21 -10.43 58.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.481 -1.011 . . . . 6.44 109.739 -179.219 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 78.1 p -76.08 -7.15 54.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.114 -0.992 . . . . 4.09 109.732 -179.471 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.482 ' H ' ' HG ' ' A' ' 188' ' ' SER . 5.2 p -91.39 131.87 36.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.134 -0.979 . . . . 2.2 109.889 179.819 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -49.69 -47.59 50.22 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.426 -0.796 . . . . 1.15 109.843 -179.559 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.96 -39.62 74.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.381 -0.824 . . . . 2.01 110.576 -178.949 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.4 t -60.03 -41.23 91.79 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.888 -1.132 . . . . 1.93 110.753 -179.267 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.7 mm -60.21 -40.01 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.135 -0.978 . . . . 2.2 109.338 -179.5 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.7 mtp -60.04 -40.13 88.31 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.27 -0.894 . . . . 1.32 110.055 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.48 -44.38 72.56 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.734 -1.228 . . . . 1.3 108.931 179.986 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -60.06 -52.42 65.46 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.346 -0.942 . . . . 3.38 110.518 -179.703 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 56.4 m -69.88 -34.68 73.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.025 -1.047 . . . . 1.15 110.79 -178.465 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.97 -29.68 66.85 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.955 -1.128 . . . . 1.28 107.955 179.593 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 65.09 47.34 2.51 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.454 0.645 . . . . 1.5 110.153 -179.629 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 93.6 mt -124.85 150.52 66.19 Favored Pre-proline 0 N--CA 1.5 2.05 0 N-CA-C 108.439 -0.948 . . . . 1.37 108.439 178.891 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -56.15 138.59 83.51 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.858 1.705 . . . . 0.76 111.135 179.841 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.94 151.03 3.22 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.744 -1.182 . . . . 1.19 111.778 -179.647 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.1 mt -127.23 143.89 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.069 -1.086 . . . . 1.31 108.069 179.116 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.9 m -130.0 -11.45 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 O-C-N 120.837 -1.165 . . . . 1.38 111.315 -178.825 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.51 25.85 18.25 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 110.064 -1.214 . . . . 1.03 110.064 -179.506 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.443 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 4.6 p -45.3 -45.59 12.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -1.158 . . . . 1.38 109.814 -179.562 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.8 -52.79 2.62 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.216 -0.993 . . . . 1.17 111.181 179.287 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.5 t -155.02 29.04 0.41 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.585 -1.538 . . . . 2.07 111.451 -179.032 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 56.0 t -70.18 -40.08 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.947 -1.095 . . . . 1.35 109.131 178.309 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 63.2 p -60.0 -26.53 66.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.423 -0.798 . . . . 1.49 110.621 -179.131 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 79.3 p -81.7 -20.69 38.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.921 -1.112 . . . . 2.16 110.181 -179.361 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -101.01 -9.1 21.76 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.344 -0.848 . . . . 2.89 109.967 -179.688 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.2 t -103.32 138.23 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.38 -0.825 . . . . 1.33 110.18 -179.053 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.87 155.34 26.99 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.606 -1.257 . . . . 2.73 107.606 178.938 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 55.3 t30 -59.56 139.43 57.16 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.872 -1.143 . . . . 2.7 109.738 -179.603 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.5 m-20 82.07 5.06 1.17 Allowed 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 121.144 0.497 . . . . 2.38 110.018 179.884 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 63.1 t0 -73.1 136.91 44.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 2.09 108.912 179.077 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.515 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 34.9 t80 -88.93 114.8 25.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.931 -1.105 . . . . 1.45 108.42 179.471 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 72.2 mt -124.67 146.15 49.28 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.52 -0.738 . . . . 1.31 110.343 -178.897 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.9 mt -112.87 128.7 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 107.741 -1.207 . . . . 1.29 107.741 178.187 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 49.5 tp -101.22 116.42 32.76 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.922 -1.111 . . . . 1.31 108.992 -179.523 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.503 ' OD2' ' ND2' ' A' ' 224' ' ' ASN . 38.5 t0 -80.7 -41.93 22.84 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.173 -1.047 . . . . 2.31 108.173 178.948 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 47.83 19.61 0.18 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.967 -0.753 . . . . 1.19 108.967 -179.401 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.434 ' N ' ' C ' ' A' ' 221' ' ' ASP . 47.3 t -128.61 -39.72 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.097 -1.445 . . . . 1.45 107.097 178.539 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.503 ' ND2' ' OD2' ' A' ' 221' ' ' ASP . 86.1 m-20 -108.85 4.78 23.89 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.836 -1.172 . . . . 3.13 107.836 178.072 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.775 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.5 OUTLIER 60.06 47.66 9.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.721 -0.612 . . . . 2.2 110.059 -179.884 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -140.84 140.29 34.62 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.134 -0.979 . . . . 2.32 110.252 179.889 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -118.31 120.14 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 108.533 -0.914 . . . . 1.4 108.533 179.104 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -88.57 130.02 35.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.978 -1.076 . . . . 1.29 109.366 -179.479 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 58.2 t -103.34 115.1 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.6 -0.688 . . . . 1.38 110.027 -179.056 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.6 t30 48.44 66.73 5.3 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.311 -0.868 . . . . 2.33 111.058 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -90.1 154.04 4.76 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.809 2.339 . . . . 0.95 111.687 178.851 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 1.8 t -77.98 168.88 19.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.03 -1.044 . . . . 2.31 110.257 -179.162 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -59.99 -38.97 84.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.696 -0.628 . . . . 3.45 111.321 -179.114 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -59.97 -39.98 87.5 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.936 -1.103 . . . . 2.89 110.137 -178.109 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.51 -39.9 79.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.089 -1.007 . . . . 1.73 109.306 179.572 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.88 -40.16 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 1.57 110.309 -179.617 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -60.06 -41.73 93.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.779 -1.2 . . . . 2.43 109.588 -179.758 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -64.46 -42.09 96.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.451 -0.78 . . . . 3.18 109.65 179.754 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 93.6 mtp -70.04 -33.7 72.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.506 -0.747 . . . . 1.59 110.421 179.614 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -70.07 -39.68 75.48 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.243 -0.91 . . . . 3.11 109.834 -179.975 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -56.1 -44.87 79.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -0.918 . . . . 2.17 109.414 -179.26 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.02 -43.74 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.14 -0.975 . . . . 2.51 108.992 179.557 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -60.04 -41.28 91.92 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.381 -0.824 . . . . 3.82 110.018 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.08 -39.87 87.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.229 -0.919 . . . . 1.78 109.872 -179.631 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -61.66 -37.46 84.11 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.327 -0.858 . . . . 2.77 109.894 180.0 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 53.4 t -60.13 -49.36 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.42 -0.8 . . . . 2.25 109.999 -178.781 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.02 -39.93 83.04 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.009 -1.057 . . . . 2.54 109.636 -179.888 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 30.3 t -70.87 -41.52 71.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.377 -0.827 . . . . 3.03 111.775 -178.972 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -71.04 -27.59 63.76 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.759 -1.213 . . . . 3.34 110.672 -178.603 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -79.89 -3.76 49.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.249 -0.907 . . . . 4.18 111.006 -178.649 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -109.97 -3.09 16.74 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.949 -1.095 . . . . 4.43 110.254 -179.722 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.442 ' OE1' ' NZ ' ' A' ' 255' ' ' LYS . 98.9 mt-10 -60.09 -49.95 75.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.001 -1.062 . . . . 5.42 109.682 -179.631 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -175.82 33.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.284 -0.885 . . . . 6.11 109.401 179.518 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 52.98 33.78 15.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.441 -0.787 . . . . 7.37 109.294 -179.936 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.537 ' C ' ' H ' ' A' ' 257' ' ' LYS . 58.0 pttt -63.01 -39.68 95.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.389 -0.819 . . . . 8.3 109.383 179.637 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.401 ' N ' ' CG ' ' A' ' 255' ' ' LYS . 9.4 mp 53.57 5.42 0.06 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.962 -0.755 . . . . 9.05 108.962 -179.053 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.537 ' H ' ' C ' ' A' ' 255' ' ' LYS . 78.0 mttt -150.8 161.08 43.33 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.892 -1.13 . . . . 10.56 109.583 179.689 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 257' ' ' LYS . 80.4 m-20 -142.77 -132.98 0.09 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.143 -1.058 . . . . 11.32 108.143 179.203 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . 0.473 HH11 ' HG2' ' A' ' 259' ' ' ARG . 11.1 ttt-85 . . . . . 0 C--N 1.296 -1.735 0 CA-C-O 117.948 -1.025 . . . . 12.74 109.532 -179.508 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 55.6 ttm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -149.48 146.87 27.63 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.011 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -150.35 159.86 44.15 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.943 -1.098 . . . . 0.0 110.423 -179.101 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -158.44 154.63 27.18 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.614 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . 0.462 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 54.6 mp0 -115.15 130.77 57.01 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.074 -1.016 . . . . 0.0 109.787 179.575 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.35 126.3 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 CA-C-O 122.181 0.991 . . . . 0.0 112.297 -177.526 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 35.5 m -79.04 102.68 8.5 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.072 0.939 . . . . 0.0 110.936 -178.403 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.7 mt -51.28 126.02 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 122.29 1.043 . . . . 0.0 110.742 -177.839 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 72.6 p -110.06 19.27 19.16 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.147 -179.103 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -76.71 126.28 86.12 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.902 -1.124 . . . . 0.0 108.134 178.942 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -65.7 -11.48 30.86 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 CA-C-N 120.312 1.147 . . . . 0.0 112.75 -178.866 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -119.98 10.06 11.4 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.464 -0.773 . . . . 0.0 109.589 -179.844 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.74 179.99 33.12 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -179.132 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.519 ' O ' ' NH1' ' A' ' 126' ' ' ARG . 3.2 tp -84.38 87.9 7.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.918 -1.342 . . . . 0.0 109.062 -178.801 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . 0.438 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 3.7 p80 -90.38 -163.12 0.97 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.862 -1.149 . . . . 0.0 109.997 179.187 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.0 m -55.88 -44.64 78.32 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.186 -0.946 . . . . 0.0 112.917 -176.054 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.643 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 12.7 tpt180 -60.02 -60.0 12.04 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 120.576 -1.327 . . . . 0.0 112.087 -178.991 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . 0.438 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 11.5 Cg_endo -59.5 -34.5 97.05 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 CA-C-N 120.634 1.262 . . . . 0.0 111.873 -179.147 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.0 75.46 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.421 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.46 -44.52 76.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.512 -0.743 . . . . 0.0 110.159 -179.221 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -70.02 -41.06 74.81 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.746 -1.221 . . . . 0.0 108.537 178.898 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -62.1 -52.88 62.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.455 -0.778 . . . . 0.0 110.151 -179.776 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 95.3 t -66.17 -25.35 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.823 -1.173 . . . . 0.0 109.974 -178.975 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . 0.521 ' HZ1' ' CD ' ' A' ' 74' ' ' GLU . 27.8 ttmt -60.0 -44.51 94.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.135 -0.978 . . . . 0.0 108.574 179.948 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.18 -52.56 46.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.461 -0.774 . . . . 0.0 110.991 -179.228 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . 0.428 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -53.13 -56.89 12.77 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.618 -1.301 . . . . 0.0 111.474 -178.444 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -50.06 -16.2 0.28 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.032 -1.042 . . . . 0.0 109.359 -179.912 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . 0.428 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -81.68 -17.05 71.57 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.361 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -106.22 141.39 37.66 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.607 -0.937 . . . . 0.0 109.257 179.571 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.2 p -92.14 -14.28 29.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.905 -1.122 . . . . 0.0 110.21 -179.998 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 47.4 t -59.99 143.85 50.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.073 -1.017 . . . . 0.0 109.404 -179.78 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -66.58 137.9 57.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.424 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 93.5 mt -134.11 134.18 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.469 -0.769 . . . . 0.0 110.327 -179.149 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 99.7 m -129.07 149.62 50.81 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.798 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 74.8 t -115.63 141.47 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.325 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 59.1 m -131.61 121.94 25.2 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.155 -0.966 . . . . 0.0 109.359 179.547 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.3 t -139.2 120.22 14.55 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.086 0.946 . . . . 0.0 110.737 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 42.47 50.08 4.73 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 177.365 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.28 -14.65 57.14 Favored Glycine 0 N--CA 1.503 3.16 0 O-C-N 120.186 -1.571 . . . . 0.0 113.351 176.391 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -112.65 121.65 45.38 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 119.368 1.584 . . . . 0.0 109.906 -179.532 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 53.2 m -106.23 154.03 21.31 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.968 0.89 . . . . 0.0 111.069 -178.668 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -150.75 150.18 30.7 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.374 0.606 . . . . 0.0 109.573 179.452 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 68.0 m -87.69 135.2 33.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.334 -0.854 . . . . 0.0 110.136 -179.56 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -69.31 -20.2 63.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.075 -1.015 . . . . 0.0 108.49 179.366 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -84.29 20.44 1.63 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.841 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.693 ' HG ' ' HZ2' ' B' ' 349' ' ' LYS . 2.6 m -149.1 91.71 1.88 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.014 -179.762 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 59.5 tp -56.54 -37.55 70.67 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.383 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . 0.626 ' CB ' HE21 ' A' ' 111' ' ' GLN . 62.3 m-85 -54.54 -50.09 68.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.354 -0.841 . . . . 0.0 111.039 -179.273 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.693 ' HZ2' ' HG ' ' B' ' 346' ' ' SER . 35.1 mtmm -69.97 -39.89 75.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.675 -1.265 . . . . 0.0 110.645 -178.525 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' B' ' 352' ' ' THR . 96.7 mt -46.63 -56.8 5.53 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.979 -1.076 . . . . 0.0 108.879 -179.494 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.814 HE22 ' HE ' ' A' ' 126' ' ' ARG . 56.9 mm-40 -39.49 -26.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.847 -0.533 . . . . 0.0 111.208 -178.571 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.445 ' N ' ' O ' ' B' ' 350' ' ' LEU . 67.8 p -79.3 -11.15 59.94 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.498 -1.376 . . . . 0.0 110.56 -178.078 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 24.3 mt -96.34 120.01 35.86 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.922 -1.111 . . . . 0.0 109.54 178.72 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.35 92.1 1.06 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.135 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.2 mt -98.41 92.01 5.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.301 -1.117 . . . . 0.0 109.331 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 70.1 p -92.89 175.79 6.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.133 -0.979 . . . . 0.0 111.352 -178.516 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -65.22 110.82 2.7 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.447 -179.543 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 102.65 12.93 31.38 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.688 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 50.1 m -88.36 110.09 20.51 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -1.137 . . . . 0.0 111.343 -179.092 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 31.0 t -77.45 113.83 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 122.119 0.962 . . . . 0.0 109.826 -177.752 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.5 m -109.78 176.6 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -177.875 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 29.8 m -131.58 127.57 37.41 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.477 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.0 mt -104.21 115.86 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.435 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 50.2 p -120.37 133.35 55.46 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.513 -0.742 . . . . 0.0 109.042 -179.664 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.61 150.05 36.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.114 -0.991 . . . . 0.0 110.086 -179.024 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -139.29 120.5 14.77 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.65 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.548 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 165.04 -167.07 38.53 Favored Glycine 0 N--CA 1.485 1.909 0 C-N-CA 119.119 -1.515 . . . . 0.0 111.117 -179.492 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -58.09 -47.03 84.47 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.359 -0.495 . . . . 0.0 111.707 -177.785 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -107.98 10.46 28.35 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.878 -1.139 . . . . 0.0 111.373 -177.681 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -43.92 -32.02 1.01 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.408 -0.808 . . . . 0.0 110.963 -178.96 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -69.46 -45.16 69.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.137 -0.977 . . . . 0.0 110.045 -178.481 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -67.5 -47.98 68.41 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.176 -0.953 . . . . 0.0 108.847 -179.632 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.15 -78.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.399 -0.813 . . . . 0.0 110.67 -179.471 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . 0.451 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 38.7 t -46.34 -35.75 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.042 -1.036 . . . . 0.0 110.633 -177.458 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -64.9 -49.84 68.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.528 -1.357 . . . . 0.0 110.591 -179.963 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -80.49 -41.78 23.69 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.956 -1.09 . . . . 0.0 110.493 -179.667 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 97.0 mt -59.94 -37.19 78.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 109.08 -179.133 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . 0.451 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 50.2 t -65.46 -40.04 87.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.312 -0.867 . . . . 0.0 109.574 179.265 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -69.71 -57.03 5.63 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.772 -1.205 . . . . 0.0 108.408 179.213 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 57.3 tp -55.17 -26.73 40.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 0.0 110.403 -178.216 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 33.7 ttm -74.72 -38.13 62.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.691 -1.256 . . . . 0.0 109.027 177.857 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.89 -4.41 58.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.512 -0.742 . . . . 0.0 110.509 179.588 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -110.48 -6.66 14.87 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.122 -0.986 . . . . 0.0 111.245 -178.739 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.6 mt -78.56 132.37 37.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.3 -1.5 . . . . 0.0 109.029 179.141 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.366 -179.705 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.436 ' H2 ' ' H ' ' A' ' 2' ' ' ILE . 94.2 mmm . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.332 -0.618 . . . . 3.19 109.332 . . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.436 ' H ' ' H2 ' ' A' ' 1' ' ' MET . 97.0 mt -111.13 126.99 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.578 -0.701 . . . . 1.71 109.828 179.809 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.8 m -140.51 150.18 43.42 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.371 -0.83 . . . . 1.66 109.778 -179.832 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -138.7 -163.81 9.68 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.858 -1.697 . . . . 1.05 108.858 179.274 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 6' ' ' LEU . 97.4 mt -93.3 -16.82 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.95 -1.324 . . . . 1.59 110.125 -179.118 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.1 tp 54.55 105.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.397 -0.815 . . . . 1.47 109.407 179.906 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.31 -35.25 11.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.561 -0.903 . . . . 1.39 108.561 179.064 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 7.6 m -129.26 129.28 23.29 Favored Pre-proline 0 N--CA 1.502 2.136 0 N-CA-C 109.362 -0.607 . . . . 2.09 109.362 179.848 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.15 146.1 15.69 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.272 1.981 . . . . 0.91 112.807 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 160.53 -160.35 31.74 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 109.827 -1.309 . . . . 0.92 109.827 179.594 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.0 mt -149.98 149.64 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.268 -1.136 . . . . 1.35 108.195 179.215 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.04 149.82 25.07 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.568 -1.333 . . . . 1.14 111.128 179.628 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 4.0 m-85 -131.06 129.79 42.4 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 108.917 -0.771 . . . . 0.7 108.917 179.23 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.93 -173.79 46.03 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 118.509 -1.805 . . . . 0.58 110.948 179.3 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -82.55 155.46 24.49 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.949 -0.736 . . . . 2.63 110.026 -179.513 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.35 129.51 48.82 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.383 -0.823 . . . . 1.27 110.853 -179.532 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.3 tp -99.38 133.52 43.58 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.109 -1.441 . . . . 1.41 107.109 178.412 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.4 tp -118.72 125.41 49.6 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.235 -0.916 . . . . 1.49 109.652 -179.697 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 85.5 mt -87.36 103.73 15.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.583 -0.698 . . . . 1.52 109.578 179.627 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.98 132.15 43.79 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.557 -0.905 . . . . 3.17 108.557 179.367 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -131.26 130.32 42.71 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.972 -1.08 . . . . 3.0 109.003 179.03 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -79.46 154.1 29.16 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.166 -0.959 . . . . 2.77 108.777 179.448 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -67.74 141.18 56.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.043 -1.035 . . . . 2.94 109.838 -179.915 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.4 mt -79.44 135.45 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.241 -1.022 . . . . 1.46 108.241 179.532 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.1 t -103.39 124.33 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.175 -0.953 . . . . 1.7 109.998 -179.294 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.9 mt -99.03 140.77 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.849 -0.797 . . . . 1.54 108.849 179.803 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -92.15 121.39 33.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.063 -1.023 . . . . 1.81 109.359 -179.699 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -94.86 5.47 51.8 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.495 -0.928 . . . . 3.23 108.495 179.701 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -65.78 142.13 58.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.484 -0.76 . . . . 3.29 109.52 -179.783 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -88.53 140.32 29.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.226 -0.921 . . . . 2.8 109.119 -179.906 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.3 pt -94.39 164.43 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.885 -1.134 . . . . 1.43 109.746 -179.819 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.0 p -95.42 169.86 9.76 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.412 -0.958 . . . . 1.54 108.412 178.918 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.34 -13.24 49.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.952 -1.092 . . . . 1.6 110.085 -179.769 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -88.59 -30.33 19.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.868 -1.145 . . . . 2.56 108.977 179.576 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -82.64 -7.73 59.63 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.758 -0.83 . . . . 2.36 108.758 179.556 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 t -59.98 -51.96 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.24 -0.913 . . . . 1.43 108.832 179.613 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -60.01 -39.03 84.38 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.29 -0.882 . . . . 1.77 109.292 179.612 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -67.26 -41.8 84.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.053 -1.029 . . . . 3.32 110.915 -178.816 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -64.47 -40.08 95.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.597 -1.315 . . . . 1.51 110.181 -179.435 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.13 -47.02 93.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 120.622 -1.299 . . . . 1.41 108.449 179.242 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -59.89 -40.16 87.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 1.81 109.538 -179.777 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -60.02 -43.34 95.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.749 -1.219 . . . . 3.26 108.268 178.523 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -60.13 -49.31 78.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.344 -0.848 . . . . 0.81 108.907 178.59 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 21.0 tp -59.98 -49.04 79.23 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.762 -0.586 . . . . 1.59 109.453 -179.825 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.2 t -63.27 -46.13 88.24 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.43 -0.908 . . . . 1.38 109.033 179.121 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.19 -48.1 87.61 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.415 -1.874 . . . . 0.87 108.415 179.443 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 -60.61 -38.1 83.58 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.302 -0.999 . . . . 3.62 108.302 178.689 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -50.35 -42.16 52.61 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.382 -0.599 . . . . 1.43 109.382 -179.527 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.434 ' O ' ' C ' ' A' ' 50' ' ' ALA . 19.8 ttmt -66.99 -73.73 0.13 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.869 -1.16 . . . . 3.08 107.869 178.952 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.31 -39.91 0.48 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.516 -0.74 . . . . 1.33 111.01 -178.825 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.8 t -51.77 -61.72 2.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.769 -1.207 . . . . 1.85 109.368 179.797 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.87 82.94 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.391 -0.818 . . . . 1.35 111.41 -178.56 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -62.73 -40.69 97.99 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.854 -1.154 . . . . 2.34 110.063 -178.716 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.41 -40.05 95.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.113 -0.992 . . . . 2.2 109.695 -179.839 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -62.2 -37.64 86.09 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.341 -0.85 . . . . 1.35 109.285 -179.773 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.6 m -65.15 -42.7 93.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 1.34 109.174 -179.918 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.26 -39.91 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.21 -0.931 . . . . 1.26 109.334 179.876 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -58.87 -49.95 75.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.166 -0.959 . . . . 1.7 109.958 -179.06 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.8 m -56.65 -35.63 68.6 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.021 -1.049 . . . . 1.35 110.018 -178.198 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.427 ' O ' ' OG1' ' A' ' 64' ' ' THR . 68.2 mttm -65.7 -37.05 85.38 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.199 -0.938 . . . . 2.08 108.896 -179.844 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.87 -49.03 64.37 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.349 0.595 . . . . 1.21 110.215 179.82 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.97 -51.83 54.89 Favored Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.837 -1.173 . . . . 0.75 110.319 -178.937 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -70.13 -40.74 74.64 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.167 -1.196 . . . . 1.59 110.322 -179.44 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 60' ' ' LYS . 89.9 m -69.95 -61.39 1.8 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.028 -1.045 . . . . 1.41 112.38 -177.532 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -93.74 -47.52 6.74 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.831 -1.168 . . . . 0.79 111.036 -177.752 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.73 -168.72 25.48 Favored Glycine 0 N--CA 1.5 2.934 0 C-N-CA 119.848 -1.167 . . . . 1.22 111.238 179.612 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -68.6 -26.41 65.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.824 -0.81 . . . . 5.81 110.359 -179.586 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -60.54 -35.22 75.49 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.331 -0.855 . . . . 3.37 110.484 -179.598 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.5 ' HZ2' ' HG1' ' A' ' 168' ' ' THR . 15.7 mmmt -96.07 -19.07 19.71 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.105 -0.997 . . . . 2.37 110.117 -179.743 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -69.27 -40.94 77.5 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.704 -1.248 . . . . 1.65 109.665 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.56 ' CB ' HH11 ' B' ' 317' ' ' ARG . . . -67.07 -36.46 82.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.44 -0.788 . . . . 1.42 110.67 -178.597 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 77.2 mt -60.69 -43.66 95.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.697 -1.252 . . . . 1.43 109.006 179.643 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -70.29 -33.31 71.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 1.08 109.581 179.776 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -63.98 -40.03 95.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.023 -1.048 . . . . 1.37 109.731 179.475 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.29 -39.86 91.99 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.013 -1.635 . . . . 0.67 109.013 179.426 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -60.19 -48.85 80.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.431 -1.041 . . . . 1.99 109.38 -179.908 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -66.52 -45.28 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 1.22 109.764 179.929 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.1 ttp -60.35 -40.16 89.75 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.099 -1.001 . . . . 2.11 109.27 -178.918 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.404 ' CD1' ' CE2' ' B' ' 348' ' ' PHE . 25.1 tp -61.13 -35.9 78.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 1.33 108.689 178.709 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.8 tp -67.96 -30.26 69.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.496 -0.753 . . . . 1.29 109.514 179.968 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -83.43 4.64 26.77 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.21 -0.932 . . . . 1.47 110.336 -179.483 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 57.1 t0 -56.83 130.57 46.26 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.974 -1.079 . . . . 1.47 111.212 -178.651 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.423 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 47.7 mt-10 -61.07 -18.59 58.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.929 -0.482 . . . . 1.78 111.179 -179.223 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -72.71 -34.33 67.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.625 -1.297 . . . . 2.53 108.813 178.877 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.1 mt -69.77 -43.1 72.87 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.353 0.597 . . . . 1.36 111.002 -179.252 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -62.74 -42.06 99.48 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.348 -0.845 . . . . 1.42 111.17 -178.032 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -70.12 -42.58 72.44 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.833 -1.167 . . . . 2.27 111.619 -178.289 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -68.16 -38.29 81.93 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.196 -0.94 . . . . 1.57 111.855 -177.87 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.8 mt -66.53 -42.29 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.67 -1.269 . . . . 1.19 109.445 -179.759 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.436 HD13 HG22 ' A' ' 90' ' ' ILE . 85.3 mt -70.04 -39.93 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 1.39 110.616 179.606 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.95 -43.06 96.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.25 -0.906 . . . . 1.39 111.748 -178.104 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.3 mt -63.68 -46.56 84.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.585 -1.322 . . . . 1.5 109.632 -179.357 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -59.84 -49.53 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 122.038 0.923 . . . . 1.29 109.434 179.531 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -70.04 -40.23 75.28 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 120.079 -0.649 . . . . 2.64 111.099 -179.635 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -81.86 -55.79 4.38 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.753 -1.217 . . . . 1.65 112.278 -178.346 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -90.04 -1.26 57.93 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.91 -1.119 . . . . 2.5 112.425 -177.03 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 59.57 40.07 20.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.842 -1.162 . . . . 1.88 110.082 179.377 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 79.1 mtp -95.27 167.21 11.49 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.31 -0.868 . . . . 1.71 109.656 -179.72 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 56.6 p -81.5 160.15 24.01 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.276 -0.89 . . . . 1.61 109.04 179.635 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.82 -39.79 94.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.895 . . . . 1.33 110.268 -179.639 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -69.3 -33.42 73.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.027 -1.046 . . . . 2.07 109.278 -179.619 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.73 -41.06 24.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -0.963 . . . . 1.37 109.377 179.442 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.47 -45.7 61.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.311 -0.868 . . . . 1.14 110.197 -179.813 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.37 -33.4 75.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.125 -0.985 . . . . 1.26 109.355 179.979 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -59.82 -44.94 93.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.568 -0.707 . . . . 2.02 109.958 -179.822 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -60.19 -40.29 89.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 1.33 110.966 -179.2 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.04 -65.95 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.239 -0.913 . . . . 1.3 112.38 -177.413 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.2 mm -68.78 -41.0 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.788 -1.195 . . . . 1.32 110.236 -178.446 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -67.79 -31.57 71.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.213 -0.93 . . . . 2.44 108.651 179.731 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.8 -46.61 66.32 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.917 -1.273 . . . . 0.99 109.917 -179.761 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -60.29 -50.33 74.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.929 -1.336 . . . . 1.97 110.048 -179.292 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.89 -36.08 74.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.371 -0.831 . . . . 1.43 109.84 179.839 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.2 t -59.72 -42.39 92.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.955 -1.091 . . . . 2.12 108.518 -179.893 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.4 94.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -0.838 . . . . 1.64 109.024 179.249 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.5 mt -62.07 -41.22 97.93 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.407 -0.808 . . . . 1.93 109.617 -179.495 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.93 -31.91 67.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.069 -1.019 . . . . 2.2 109.657 -179.387 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -60.16 -26.22 66.14 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.212 -0.93 . . . . 2.12 108.947 179.684 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 31.6 mt -61.72 144.8 54.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.142 -0.974 . . . . 2.34 108.913 -179.56 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -98.36 51.59 1.01 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.027 -1.046 . . . . 3.23 109.538 179.668 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 61.7 t0 -134.27 132.83 40.09 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.445 -0.784 . . . . 2.49 109.321 179.89 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.404 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 83.9 tt0 -69.95 -31.94 69.94 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.475 -0.766 . . . . 3.95 109.865 -179.836 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.454 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.3 t80 -70.09 -36.88 75.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.535 -0.728 . . . . 2.25 111.075 -179.679 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 79.7 mt -78.56 -37.81 41.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.047 -1.033 . . . . 2.27 109.701 -179.703 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -60.14 -48.99 79.39 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.109 -0.994 . . . . 3.31 109.957 179.849 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.76 -39.78 92.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.085 -1.009 . . . . 2.73 109.091 179.956 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -60.13 -40.04 88.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 3.2 108.711 179.824 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' VAL . . . -59.54 -47.93 83.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.932 -1.105 . . . . 1.66 108.543 179.496 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 127' ' ' ALA . . . -43.65 -39.12 3.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.669 -0.645 . . . . 1.67 109.299 179.89 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -66.11 -42.72 88.83 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.213 -0.93 . . . . 1.55 108.604 179.197 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 127' ' ' ALA . 55.4 t -69.9 -40.32 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.34 -0.85 . . . . 1.32 108.926 178.776 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -59.97 -39.13 84.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.378 -0.826 . . . . 3.58 109.033 179.25 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -59.98 -39.8 86.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.516 -0.74 . . . . 1.46 110.377 -179.559 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.8 mt -59.64 -41.25 84.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.907 -1.121 . . . . 1.22 108.98 -179.234 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -67.24 -37.65 91.19 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.931 -1.267 . . . . 0.61 109.931 179.516 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.63 -49.02 78.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.181 -1.188 . . . . 3.1 111.027 -178.872 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -66.62 -29.48 69.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.897 -1.127 . . . . 3.71 109.423 -179.445 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.8 tp -59.59 -41.76 90.99 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.72 -0.844 . . . . 1.87 108.72 -178.967 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.36 -39.9 94.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 1.29 108.55 179.226 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -68.75 -39.6 80.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.361 -0.837 . . . . 3.05 109.329 178.704 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -65.65 -34.46 78.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.452 -0.78 . . . . 1.26 110.84 -179.42 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 91.1 mt -70.44 -42.6 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 120.737 -1.227 . . . . 1.34 108.092 179.071 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.36 -33.74 71.8 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.005 -0.739 . . . . 1.6 109.005 179.118 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.24 43.63 5.55 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 108.129 -1.988 . . . . 0.96 108.129 -178.901 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.4 tp -75.15 150.84 38.63 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.644 -0.915 . . . . 1.67 110.263 -178.866 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.423 ' HD3' ' N ' ' A' ' 146' ' ' ILE . 9.6 tmtm? -69.61 149.31 48.28 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.722 -0.844 . . . . 4.96 108.722 179.464 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.423 ' N ' ' HD3' ' A' ' 145' ' ' LYS . 86.8 mt -119.81 125.14 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 121.933 0.873 . . . . 1.68 109.036 178.881 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.3 mm -49.42 -54.76 5.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.624 -0.673 . . . . 2.14 109.762 -178.485 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.8 t0 69.39 104.23 0.06 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.547 -0.72 . . . . 1.5 110.59 -179.903 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.439 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 95.9 mt -74.44 -7.18 52.11 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.524 -0.735 . . . . 1.39 109.977 179.84 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.0 t -81.45 -16.83 50.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.148 -0.97 . . . . 1.83 109.485 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.16 23.43 0.58 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.533 -0.729 . . . . 1.46 110.196 -178.543 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.439 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 63.9 mt -92.2 115.24 30.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.133 -0.979 . . . . 1.42 109.738 -179.085 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -100.66 -15.24 17.81 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.251 -0.906 . . . . 2.94 109.63 -179.83 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -118.19 145.86 44.64 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.498 -0.556 . . . . 1.52 109.498 -178.988 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.08 136.48 57.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 1.58 109.346 -179.739 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 26.9 m -151.6 163.3 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 109.328 -0.619 . . . . 1.32 109.328 179.99 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.402 HG22 HD11 ' A' ' 157' ' ' ILE . 82.3 mt -91.78 146.71 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 106.177 -1.786 . . . . 1.27 106.177 177.266 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.2 tp -99.01 118.96 36.96 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.022 -1.049 . . . . 1.41 110.423 -178.194 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.5 t -123.31 129.98 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.489 -0.93 . . . . 1.23 108.489 179.727 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.0 159.37 40.28 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.136 -0.977 . . . . 1.32 108.551 -179.839 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.45 -33.43 64.9 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.23 -1.544 . . . . 1.49 107.932 178.523 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -168.3 136.87 2.29 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.329 -0.989 . . . . 2.25 108.329 179.959 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 62.9 mt -106.8 138.68 42.53 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.247 -0.908 . . . . 1.35 109.565 -179.496 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.9 p -94.05 153.56 40.77 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.47 -0.769 . . . . 1.56 109.02 -179.838 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.04 -34.84 9.61 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.635 1.557 . . . . 0.87 111.952 179.222 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.1 m -58.65 -40.25 82.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 1.36 110.305 -178.306 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -68.04 -42.58 80.33 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.282 -0.886 . . . . 1.61 110.716 -179.302 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.5 ' HG1' ' HZ2' ' A' ' 69' ' ' LYS . 18.5 p -53.88 -31.74 50.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.047 -1.033 . . . . 1.21 110.546 -178.264 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.52 -54.58 8.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.951 -1.093 . . . . 1.21 109.682 179.689 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -85.4 40.74 0.85 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.999 -1.112 . . . . 2.11 107.999 179.81 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.84 133.0 47.3 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.888 -0.782 . . . . 1.29 108.888 179.083 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -89.69 102.14 14.83 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.334 -0.987 . . . . 2.81 108.334 179.348 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.94 -44.78 88.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.461 -0.775 . . . . 2.09 110.908 -178.294 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -70.18 -22.61 62.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.868 -1.145 . . . . 2.86 111.88 -178.337 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -93.56 -10.37 34.98 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.55 -1.344 . . . . 2.39 110.274 -178.465 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 94.3 t -106.76 117.22 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.232 -0.918 . . . . 1.27 109.274 179.568 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 51.4 mt -83.55 4.31 28.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.43 -0.794 . . . . 2.17 110.985 -177.817 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 170.72 172.12 36.71 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.561 -1.416 . . . . 0.52 109.561 -179.806 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -132.56 129.15 38.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.508 -0.995 . . . . 0.55 108.75 179.901 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.0 mt -129.98 126.05 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.687 -1.227 . . . . 1.27 107.687 178.426 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.4 p -143.51 157.37 44.49 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.379 1.085 . . . . 1.39 111.397 -179.007 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 64.4 t0 -94.61 18.06 12.16 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.783 -0.644 . . . . 2.46 109.265 179.878 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -54.3 -164.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.529 -1.357 . . . . 1.51 111.701 -178.025 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.37 -42.39 5.53 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.607 -0.806 . . . . 2.23 111.306 -178.395 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 175.83 -149.77 10.26 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 118.429 -1.843 . . . . 2.23 111.242 -179.539 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.428 ' N ' ' CD ' ' A' ' 186' ' ' ARG . 0.2 OUTLIER -70.11 -18.3 63.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.813 -0.816 . . . . 6.44 110.558 -178.956 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 82.5 p -69.97 -1.82 10.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.02 -1.05 . . . . 4.09 110.003 -179.177 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.3 m -84.92 130.72 34.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 2.2 110.419 -179.157 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -44.93 -55.38 5.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.524 -0.735 . . . . 1.15 110.224 -179.748 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 8.8 t -58.07 -39.67 79.1 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.411 -0.806 . . . . 2.01 110.721 -178.992 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.3 t -61.55 -40.53 95.03 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.953 -1.092 . . . . 1.93 110.797 -179.298 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.88 -40.01 81.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.235 -0.915 . . . . 2.2 109.614 -179.521 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.2 -40.22 89.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.856 . . . . 1.32 110.197 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.53 88.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.455 -1.403 . . . . 1.3 109.12 -179.735 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -59.92 -50.18 74.77 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.073 -1.051 . . . . 3.38 109.396 -179.297 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 37.1 m -70.41 -35.42 73.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.158 -0.964 . . . . 1.15 110.98 -178.989 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 74.1 mt -70.27 -24.74 63.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.922 -1.111 . . . . 1.28 109.185 179.996 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 66.45 49.89 1.34 Allowed 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.273 0.559 . . . . 1.5 110.828 -179.323 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.4 ' O ' ' CB ' ' A' ' 8' ' ' SER . 78.6 mt -127.23 149.71 70.37 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 107.504 -1.295 . . . . 1.37 107.504 178.18 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.97 139.12 71.91 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.17 1.914 . . . . 0.76 112.091 -179.7 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.17 147.23 3.12 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.955 -1.091 . . . . 1.19 110.995 -179.749 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.424 HG23 HD12 ' A' ' 202' ' ' ILE . 90.5 mt -120.04 139.1 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 106.842 -1.54 . . . . 1.31 106.842 178.223 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.05 -12.22 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 120.602 -1.311 . . . . 1.38 111.427 -178.238 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.74 26.13 16.92 Favored Glycine 0 N--CA 1.502 3.052 0 N-CA-C 110.898 -0.881 . . . . 1.03 110.898 -179.121 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.8 p -44.25 -38.36 3.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.972 -1.311 . . . . 1.38 110.573 -179.179 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.455 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 88.09 -50.47 3.9 Favored Glycine 0 N--CA 1.502 3.064 0 C-N-CA 120.201 -1.0 . . . . 1.17 111.302 179.337 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.2 m -162.67 41.48 0.12 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.491 -1.594 . . . . 2.07 111.157 -179.381 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.5 t -80.24 -37.81 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.988 -1.07 . . . . 1.35 109.085 178.42 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.5 p -58.92 -33.09 70.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.571 -0.706 . . . . 1.49 110.048 -178.862 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.1 m -76.59 -18.42 58.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.332 -0.855 . . . . 2.16 110.157 -178.977 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -102.84 -9.66 19.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.324 -0.86 . . . . 2.89 110.241 -179.144 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 55.2 t -102.01 140.32 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.003 -1.061 . . . . 1.33 110.545 -179.122 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -109.29 150.07 28.52 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.704 -1.221 . . . . 2.73 107.704 178.988 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 19.2 p30 -60.61 138.89 58.0 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.86 -1.15 . . . . 2.7 109.947 -179.52 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.481 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.5 t0 81.17 9.61 0.98 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.303 0.573 . . . . 2.38 109.615 179.466 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.2 t0 -79.06 141.78 37.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.377 -0.827 . . . . 2.09 108.936 179.11 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.519 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 47.3 t80 -88.0 121.75 30.78 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.152 -0.967 . . . . 1.45 108.873 -179.992 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 85.9 mt -130.01 150.19 51.4 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.37 -0.832 . . . . 1.31 110.886 -179.021 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 73.1 mt -117.4 128.73 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.379 -1.711 . . . . 1.29 106.379 176.951 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 44.1 tp -101.05 116.65 33.35 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.977 -1.077 . . . . 1.31 109.438 -178.731 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.521 ' C ' ' H ' ' A' ' 223' ' ' VAL . 85.9 m-20 -74.45 -44.8 50.02 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.447 -0.946 . . . . 2.31 108.447 179.092 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 50.92 11.41 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.808 -0.812 . . . . 1.19 108.808 -179.656 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.521 ' H ' ' C ' ' A' ' 221' ' ' ASP . 54.7 t -126.95 -43.11 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 106.859 -1.534 . . . . 1.45 106.859 178.702 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -100.42 -0.01 38.94 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.728 -1.212 . . . . 3.13 107.728 178.611 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 60.56 42.0 14.74 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.3 -0.63 . . . . 2.2 109.3 -179.442 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -138.14 142.9 40.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.287 -0.883 . . . . 2.32 109.238 179.735 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 80.3 t -118.57 120.87 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 108.925 -0.769 . . . . 1.4 108.925 179.57 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -88.69 128.94 35.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.153 -0.967 . . . . 1.29 109.351 -179.438 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.45 114.06 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.735 -0.603 . . . . 1.38 110.244 -179.111 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 45.4 t30 50.97 63.75 9.3 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.33 -0.856 . . . . 2.33 111.509 179.064 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -85.83 148.39 9.58 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.38 2.053 . . . . 0.95 112.103 178.958 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 39.5 m -67.98 158.17 33.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.288 -0.883 . . . . 2.31 110.077 -179.473 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 47.7 p-10 -59.97 -37.9 80.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.312 -0.867 . . . . 3.45 110.679 -178.991 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . 0.534 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 99.0 mt-10 -59.82 -37.03 78.04 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.791 -1.193 . . . . 2.89 107.859 -179.998 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.9 t -70.04 -39.9 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.546 -0.721 . . . . 1.73 109.45 179.095 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.1 mt -64.77 -39.92 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.109 -0.994 . . . . 1.57 108.966 179.533 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -59.99 -40.12 88.05 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.159 -0.963 . . . . 2.43 108.67 -179.882 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -67.4 -40.21 85.61 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.481 -0.933 . . . . 3.18 108.481 179.22 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 89.5 mtp -70.01 -32.58 70.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.356 -0.84 . . . . 1.59 109.796 178.908 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -67.07 -39.92 86.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -0.945 . . . . 3.11 109.209 179.095 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.03 87.28 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.391 -0.966 . . . . 2.17 108.391 179.732 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.32 -39.17 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.549 -0.72 . . . . 2.51 109.146 179.12 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -57.83 -40.05 79.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.056 . . . . 3.82 109.306 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.31 -40.02 89.06 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.296 -0.877 . . . . 1.78 109.789 -179.782 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -67.07 -40.05 86.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.99 -1.069 . . . . 2.77 108.607 179.516 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.73 -40.24 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.803 -0.814 . . . . 2.25 108.803 179.743 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.77 -34.97 79.1 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.294 -0.879 . . . . 2.54 109.395 179.993 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 248' ' ' SER . . . . . 0.498 ' O ' ' N ' ' A' ' 252' ' ' GLU . 35.8 t -61.24 -49.04 78.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.275 -0.891 . . . . 3.03 110.254 -179.395 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -70.19 -28.96 65.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.102 -0.999 . . . . 3.34 110.048 -179.275 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -95.61 28.5 2.97 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.449 -0.945 . . . . 4.18 108.449 179.567 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -167.09 -49.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.083 -1.011 . . . . 4.43 111.032 179.943 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 248' ' ' SER . 95.5 mt-10 -140.56 105.75 5.02 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.122 -0.986 . . . . 5.42 108.918 -179.696 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 86.5 mt -62.41 -17.72 59.92 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.992 -1.484 . . . . 6.11 106.992 178.251 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 64.53 26.12 13.31 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.677 -0.692 . . . . 7.37 109.759 -179.771 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 96.7 mttt 57.5 20.7 6.33 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.693 -0.629 . . . . 8.3 109.842 179.473 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 8.1 tp 52.55 42.49 31.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 9.05 109.306 179.838 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 259' ' ' ARG . 58.9 tttp -52.72 -60.16 3.6 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.269 -0.973 . . . . 10.56 108.657 -179.746 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.545 ' C ' ' O ' ' A' ' 257' ' ' LYS . 94.8 m-20 -7.71 75.41 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.65 0 CA-C-O 121.606 0.717 . . . . 11.32 111.768 179.36 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . 0.547 ' N ' ' O ' ' A' ' 257' ' ' LYS . 86.6 mtm180 . . . . . 0 C--N 1.3 -1.56 0 CA-C-O 117.97 -1.014 . . . . 12.74 109.534 -179.868 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 57.1 ttm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -149.05 147.71 28.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -0.922 . . . . 0.0 108.962 179.501 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -150.86 160.06 44.14 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.98 -1.075 . . . . 0.0 111.124 -178.366 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -154.66 152.48 30.02 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.566 -0.708 . . . . 0.0 109.199 178.861 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . 0.428 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 58.1 mp0 -113.89 131.01 56.44 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.311 -0.868 . . . . 0.0 110.266 179.842 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.0 p -131.95 126.78 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 CA-C-O 122.522 1.153 . . . . 0.0 112.995 -177.899 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 32.2 m -79.27 102.43 8.58 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 122.023 0.916 . . . . 0.0 110.772 -178.724 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . 0.504 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.5 mt -51.37 125.0 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 122.552 1.168 . . . . 0.0 110.853 -177.878 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 33.2 p -109.73 20.09 18.45 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.602 -179.249 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . 0.409 ' O ' ' CD ' ' B' ' 357' ' ' GLN . . . -67.47 149.11 98.52 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.11 -0.994 . . . . 0.0 108.582 179.366 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . 0.449 ' CD ' ' O ' ' B' ' 385' ' ' GLU . 28.9 Cg_endo -72.28 -30.38 12.99 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.112 1.208 . . . . 0.0 113.138 -179.622 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -120.26 23.16 11.07 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.778 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.59 -177.58 52.74 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.266 -1.933 . . . . 0.0 108.266 -179.028 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.454 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -84.38 93.32 8.24 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.96 -1.317 . . . . 0.0 109.484 -179.013 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -98.01 -159.52 0.74 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.044 -1.035 . . . . 0.0 109.536 178.971 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 316' ' ' THR . . . . . 0.412 ' H ' ' HG1' ' B' ' 316' ' ' THR . 3.5 m -60.06 -49.97 75.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.559 -1.338 . . . . 0.0 112.16 -176.459 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.56 HH11 ' CB ' ' A' ' 71' ' ' ALA . 11.9 tpt180 -47.35 -60.31 4.24 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.653 -1.279 . . . . 0.0 111.133 -179.104 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -61.56 -31.35 87.2 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 CA-C-N 120.559 1.235 . . . . 0.0 111.02 179.022 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.02 -53.79 53.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.399 -0.813 . . . . 0.0 109.485 -179.737 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.86 -42.67 62.8 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.074 -178.951 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.79 -39.94 76.29 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.024 -1.047 . . . . 0.0 108.784 179.243 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -65.71 -55.75 15.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 109.936 -179.485 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . 0.567 ' CG1' ' HZ2' ' B' ' 327' ' ' LYS . 41.3 t -64.13 -30.95 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.585 -1.322 . . . . 0.0 110.278 -178.704 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -60.44 -46.29 90.57 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.994 -1.066 . . . . 0.0 109.763 179.9 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -61.89 -44.35 96.97 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.326 -0.859 . . . . 0.0 111.072 -178.569 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . 0.406 ' O ' ' N ' ' B' ' 329' ' ' PHE . . . -66.03 -52.17 51.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.988 -1.07 . . . . 0.0 111.691 -178.412 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . 0.567 ' HZ2' ' CG1' ' B' ' 323' ' ' VAL . 32.2 mttp -49.29 -18.07 0.32 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.007 -1.058 . . . . 0.0 110.744 -178.789 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -80.13 -16.57 76.31 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 178.882 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . 0.406 ' N ' ' O ' ' B' ' 326' ' ' ALA . 59.8 m-85 -104.02 136.72 43.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.693 -0.886 . . . . 0.0 109.532 179.825 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 76.8 p -91.49 -13.42 32.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.398 -0.814 . . . . 0.0 109.939 179.727 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 331' ' ' SER . . . . . 0.621 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 69.3 m -60.94 150.25 33.89 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.268 -0.895 . . . . 0.0 109.848 -179.982 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -69.33 136.21 51.48 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.682 179.389 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 80.7 mt -133.63 132.43 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.315 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 81.5 m -130.34 151.15 51.15 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.296 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 67.3 t -115.73 142.07 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.535 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 50.5 m -130.84 122.86 27.84 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.264 -0.897 . . . . 0.0 109.662 179.37 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 337' ' ' SER . . . . . 0.4 ' O ' ' OD1' ' B' ' 338' ' ' ASN . 2.6 t -137.16 118.63 14.78 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.031 0.919 . . . . 0.0 109.698 179.536 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' B' ' 338' ' ' ASN . 8.2 p-10 38.0 62.97 0.87 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.079 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 77.25 -14.18 8.91 Favored Glycine 0 N--CA 1.503 3.143 0 O-C-N 120.83 -1.169 . . . . 0.0 113.521 175.873 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -110.29 121.72 45.96 Favored 'General case' 0 N--CA 1.507 2.376 0 CA-C-N 119.056 1.428 . . . . 0.0 110.277 -179.733 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 83.3 p -109.06 157.65 18.5 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.774 0.797 . . . . 0.0 110.924 -179.082 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -152.54 151.93 31.27 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.821 -0.549 . . . . 0.0 109.925 179.58 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 16.1 m -87.64 136.21 33.04 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.303 -0.873 . . . . 0.0 109.61 -179.96 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.475 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -76.91 -14.67 59.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.951 -1.093 . . . . 0.0 110.095 -179.445 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -88.77 20.79 3.31 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 178.441 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.475 ' H ' ' C ' ' B' ' 344' ' ' ALA . 74.0 m -147.36 91.4 1.97 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.727 179.797 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 57.8 tp -57.04 -35.28 69.12 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.584 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . 0.404 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 70.8 m-85 -56.18 -53.95 51.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.922 . . . . 0.0 109.88 179.787 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -70.17 -21.31 63.07 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.577 -0.702 . . . . 0.0 111.045 -177.64 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' B' ' 352' ' ' THR . 77.9 mt -67.48 -50.82 57.31 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 118.314 -1.354 . . . . 0.0 108.648 178.526 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -46.07 -12.83 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.424 -0.798 . . . . 0.0 111.47 -177.741 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.487 ' N ' ' O ' ' B' ' 350' ' ' LEU . 67.3 p -85.73 -16.51 38.71 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 119.912 -1.743 . . . . 0.0 111.466 -178.509 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 29.4 mt -92.05 122.23 34.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.737 -1.227 . . . . 0.0 108.834 178.707 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.99 92.52 0.93 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 179.423 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 16.7 mt -101.26 93.72 5.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.417 -1.049 . . . . 0.0 108.755 179.949 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 71.0 p -92.79 177.05 6.21 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.939 -1.101 . . . . 0.0 111.316 -178.844 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . 0.409 ' CD ' ' O ' ' B' ' 310' ' ' ALA . 40.0 tt0 -65.49 113.23 4.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.81 -0.556 . . . . 0.0 110.787 -179.703 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 99.18 9.63 50.9 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.419 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 24.0 m -85.88 113.1 21.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.335 -1.097 . . . . 0.0 110.313 -179.79 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 11.0 t -78.07 114.45 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 122.307 1.051 . . . . 0.0 109.961 -177.073 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 14.0 m -110.49 177.16 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.91 -177.856 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 40.8 m -130.98 126.89 37.21 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.232 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 83.7 mt -103.63 118.03 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.487 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 49.0 m -122.93 133.65 54.38 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.552 -0.717 . . . . 0.0 109.249 -178.88 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.49 151.61 38.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.095 -1.003 . . . . 0.0 110.496 -178.738 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -140.64 120.72 13.73 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.414 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 164.08 -164.55 36.62 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 118.57 -1.776 . . . . 0.0 111.778 179.455 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -56.53 -50.03 73.02 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.939 -0.631 . . . . 0.0 111.743 -177.889 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.621 ' N ' ' OG ' ' B' ' 331' ' ' SER . 99.6 m-20 -109.87 11.8 24.11 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.033 -1.042 . . . . 0.0 111.574 -177.857 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -42.23 -31.96 0.44 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.946 -1.096 . . . . 0.0 111.212 -178.877 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -70.06 -43.04 72.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.816 -1.178 . . . . 0.0 110.347 -178.81 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -67.7 -47.97 67.89 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.78 -1.2 . . . . 0.0 108.666 -179.905 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.44 -77.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 110.113 -179.914 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . 0.485 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 51.2 t -45.18 -38.79 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.213 -0.93 . . . . 0.0 109.751 -178.19 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -67.63 -42.44 82.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.65 -1.281 . . . . 0.0 110.099 179.221 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -82.18 -45.41 15.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.121 -0.987 . . . . 0.0 110.481 -179.83 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 97.8 mt -59.91 -36.51 77.15 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.11 -0.994 . . . . 0.0 109.303 -179.054 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 53.5 t -69.95 -39.58 77.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 121.524 -0.735 . . . . 0.0 109.907 -179.989 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -79.18 -22.47 44.93 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.009 -1.057 . . . . 0.0 110.859 179.945 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 55.9 tp -82.25 -20.8 36.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.204 -1.56 . . . . 0.0 108.697 178.561 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.0 ttm -81.1 -30.75 34.56 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.161 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -84.34 -9.63 58.29 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.637 -0.665 . . . . 0.0 109.521 178.59 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -106.32 -2.01 22.76 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.316 -0.865 . . . . 0.0 110.919 -179.188 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 22.1 mt -91.53 124.9 36.05 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.949 -1.095 . . . . 0.0 110.636 -179.338 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . 0.449 ' O ' ' CD ' ' B' ' 311' ' ' PRO . 19.1 pt-20 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 118.017 -0.992 . . . . 0.0 108.755 178.675 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.519 -0.549 . . . . 3.19 109.519 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.575 ' CD1' HE22 ' A' ' 211' ' ' GLN . 85.9 mt -110.04 127.65 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.479 -0.934 . . . . 1.71 108.479 179.553 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.3 m -128.57 126.43 40.3 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.551 -0.718 . . . . 1.66 109.512 -179.343 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.79 -161.97 34.65 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.311 -1.516 . . . . 1.05 109.311 179.6 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.5 mt -88.75 -14.42 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -1.195 . . . . 1.59 110.316 -179.367 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.6 tp 52.67 100.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.07 -1.019 . . . . 1.47 109.07 -179.794 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.09 -28.33 12.76 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.113 -0.992 . . . . 1.39 109.267 179.388 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.9 m -132.08 115.31 15.27 Favored Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 109.111 -0.7 . . . . 2.09 109.111 -179.659 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.38 147.98 18.35 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.018 1.812 . . . . 0.91 112.964 -179.685 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 154.33 -156.04 26.59 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.606 -1.797 . . . . 0.92 108.606 -179.51 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.4 mt -149.0 151.06 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 120.904 -1.351 . . . . 1.35 108.866 178.68 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.58 156.62 36.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.048 -1.033 . . . . 1.14 110.241 179.397 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.2 m-85 -137.87 127.37 24.94 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.762 -1.199 . . . . 0.7 107.762 179.1 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.98 178.86 48.74 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 118.591 -1.766 . . . . 0.58 110.913 179.947 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -78.39 156.42 29.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.979 -0.719 . . . . 2.63 109.898 -179.525 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.32 129.98 46.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.43 -0.794 . . . . 1.27 110.844 -179.11 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.2 tp -105.98 134.59 48.86 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.469 -1.308 . . . . 1.41 107.469 178.286 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.9 tp -115.77 123.81 49.18 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.381 -0.824 . . . . 1.49 110.091 -179.419 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.5 mt -81.96 100.57 9.75 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 120.035 -0.666 . . . . 1.52 109.421 179.92 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -94.55 138.26 32.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.259 -0.901 . . . . 3.17 109.706 -179.667 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 58.0 mp0 -130.37 136.79 49.45 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.478 -0.764 . . . . 3.0 109.136 179.206 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -84.31 147.32 27.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 2.77 109.494 179.664 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.89 145.51 55.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.9 . . . . 2.94 109.671 -179.811 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.2 mt -98.41 132.73 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.396 -0.815 . . . . 1.46 109.372 179.888 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.6 t -106.81 128.25 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.427 -0.796 . . . . 1.7 109.84 -179.475 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.1 mt -98.36 142.42 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.494 -0.754 . . . . 1.54 109.134 179.976 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -83.6 123.77 30.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.985 -1.072 . . . . 1.81 109.056 179.834 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -93.47 -6.91 45.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.249 -0.907 . . . . 3.23 109.479 -179.64 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.71 138.55 52.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 3.29 109.594 -179.727 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -83.75 155.31 23.13 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.202 -1.036 . . . . 2.8 108.202 179.136 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.1 pt -99.04 165.66 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.071 -1.018 . . . . 1.43 109.936 -179.947 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.4 p -91.76 173.55 7.81 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.603 -0.888 . . . . 1.54 108.603 178.712 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.62 -15.47 63.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.134 -0.979 . . . . 1.6 110.696 -179.479 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 60.0 t0 -83.69 -30.67 26.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.822 -1.173 . . . . 2.56 108.842 179.47 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -82.65 -6.84 59.59 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.42 -0.585 . . . . 2.36 109.42 179.992 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 t -60.01 -51.81 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.182 -0.949 . . . . 1.43 109.254 179.949 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -60.14 -39.84 87.73 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.231 -0.918 . . . . 1.77 108.78 179.832 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -63.68 -40.23 96.3 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.308 -0.87 . . . . 3.32 110.133 -179.723 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.433 ' OE2' ' NH1' ' A' ' 42' ' ' ARG . 71.0 mm-40 -64.39 -41.55 96.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.847 -1.158 . . . . 1.51 110.28 -179.778 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.8 t -59.99 -45.7 95.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 120.671 -1.268 . . . . 1.41 108.085 179.996 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -59.89 -42.43 93.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.368 -0.833 . . . . 1.81 108.934 -179.78 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.433 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 96.6 mtt180 -60.04 -47.56 85.35 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.846 -1.168 . . . . 3.26 107.846 178.49 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -60.02 -45.22 93.51 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.202 -0.666 . . . . 0.81 109.202 178.897 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.92 -50.07 75.19 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.311 -0.996 . . . . 1.59 108.311 179.661 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -60.45 -42.71 96.7 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.277 -0.889 . . . . 1.38 108.997 179.081 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.18 -47.71 89.6 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.549 -1.421 . . . . 0.87 109.549 179.99 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -69.73 -31.66 69.78 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.284 -1.127 . . . . 3.62 108.402 179.337 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.65 89.71 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.566 -0.709 . . . . 1.43 109.12 -179.988 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.4 ttpt -67.25 -73.77 0.13 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.196 -0.94 . . . . 3.08 108.787 179.333 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.29 -41.81 0.65 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.325 -0.86 . . . . 1.33 111.265 -178.356 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.8 m -52.2 -57.87 8.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.587 -1.321 . . . . 1.85 109.106 179.873 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.64 -40.97 84.57 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.218 -0.926 . . . . 1.35 110.836 -179.267 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -68.14 -40.33 82.47 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.982 -1.074 . . . . 2.34 109.763 -179.693 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.6 mt -61.66 -40.19 94.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.892 -1.13 . . . . 2.2 109.092 179.108 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -64.37 -35.54 81.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 1.35 109.152 179.487 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -62.04 -41.85 98.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.27 -0.894 . . . . 1.34 109.161 179.536 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.517 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.5 mt -64.17 -39.84 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.432 -0.792 . . . . 1.26 109.43 179.622 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -54.35 -51.17 65.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.864 . . . . 1.7 109.826 -178.96 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.3 m -59.94 -37.27 79.04 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.238 -0.914 . . . . 1.35 110.837 -178.317 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.448 ' NZ ' ' HG ' ' A' ' 150' ' ' SER . 28.8 mtpt -64.14 -39.77 94.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.892 -1.13 . . . . 2.08 109.479 -179.559 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.52 -42.99 86.46 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.762 -0.586 . . . . 1.21 110.125 -179.392 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.38 -51.08 60.98 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.161 -1.176 . . . . 0.75 110.161 -179.174 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.0 -44.81 68.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.114 -1.227 . . . . 1.59 110.043 -179.855 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.0 m -69.91 -59.13 3.12 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 1.41 111.768 -178.248 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -97.3 -54.4 3.16 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.021 -1.049 . . . . 0.79 111.357 -178.056 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.83 -163.41 26.95 Favored Glycine 0 N--CA 1.501 3.006 0 C-N-CA 119.697 -1.239 . . . . 1.22 111.156 179.676 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.25 -23.96 62.99 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.912 -0.758 . . . . 5.81 110.841 -179.385 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -62.03 -39.6 92.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.959 -1.088 . . . . 3.37 110.361 -179.545 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -96.29 -18.85 19.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.228 -0.92 . . . . 2.37 110.434 -179.258 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -72.14 -40.77 67.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.043 -1.036 . . . . 1.65 110.466 -179.118 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.63 -30.89 70.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 1.42 109.984 -178.953 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.1 -40.27 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 118.82 -1.152 . . . . 1.43 108.822 -179.588 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -64.76 -40.07 94.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.047 -1.033 . . . . 1.08 109.885 -179.899 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -60.38 -40.89 92.49 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.89 -1.131 . . . . 1.37 109.863 179.519 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.9 -40.81 99.73 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.881 -1.688 . . . . 0.67 108.881 179.535 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.7 m170 -70.01 -40.06 75.47 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.396 -1.061 . . . . 1.99 109.208 179.767 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.9 mt -70.9 -46.47 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.383 -0.823 . . . . 1.22 109.986 179.828 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.7 ttp -60.35 -43.65 96.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 2.11 110.563 -178.452 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 44.8 tp -64.77 -39.44 93.61 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.293 -0.879 . . . . 1.33 109.938 -179.947 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.7 tp -63.81 -40.1 95.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.437 -0.79 . . . . 1.29 109.789 -179.72 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -78.87 4.07 15.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 1.47 110.099 -178.795 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 63.5 t0 -52.32 129.87 29.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.167 -0.958 . . . . 1.47 110.38 -179.37 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.423 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.8 mt-10 -60.16 -15.19 21.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.566 -0.709 . . . . 1.78 110.124 -179.982 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.02 -37.03 75.51 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.156 -0.965 . . . . 2.53 108.517 178.578 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.1 mt -69.98 -40.09 75.56 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.37 0.605 . . . . 1.36 109.876 179.426 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.07 -50.05 75.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.46 -0.775 . . . . 1.42 110.265 -178.975 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -74.36 -40.62 62.02 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.393 -0.817 . . . . 2.27 111.224 -178.801 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.92 -41.03 75.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.013 -1.054 . . . . 1.57 111.487 -178.675 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.9 mt -70.15 -46.12 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.857 -1.152 . . . . 1.19 109.445 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.8 mt -65.72 -37.45 79.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.625 -0.672 . . . . 1.39 110.121 -179.841 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.07 90.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.048 -1.033 . . . . 1.39 110.507 -178.829 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.3 mt -62.21 -45.49 93.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.947 -1.095 . . . . 1.5 109.579 -179.781 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.1 mt -62.05 -50.0 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 1.29 109.596 -179.907 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -71.21 -42.18 69.26 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.681 -0.808 . . . . 2.64 111.385 179.826 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -83.25 -50.42 8.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.952 -1.092 . . . . 1.65 112.197 -177.648 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -90.19 -2.61 58.07 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.871 -1.143 . . . . 2.5 111.474 -177.497 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 56.19 39.02 30.39 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.797 -1.189 . . . . 1.88 109.521 -179.413 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 54.7 mtt -92.04 169.33 10.73 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.44 -0.788 . . . . 1.71 109.652 -179.723 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.9 p -83.82 159.65 21.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.942 . . . . 1.61 108.956 179.514 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.76 -36.8 78.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 1.33 109.801 -179.635 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -68.66 -39.68 80.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -0.97 . . . . 2.07 110.203 179.983 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.59 -44.89 18.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.026 -1.046 . . . . 1.37 109.61 179.855 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.75 -50.25 67.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.449 -0.782 . . . . 1.14 110.211 -179.487 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.23 -37.3 79.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.074 -1.017 . . . . 1.26 109.445 179.917 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -59.91 -42.65 94.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.476 -0.765 . . . . 2.02 110.266 -179.013 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 110' ' ' GLY . 88.9 tt0 -64.9 -40.2 94.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.007 -1.058 . . . . 1.33 109.983 -179.634 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 70.1 t -61.74 -53.22 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.21 -0.931 . . . . 1.3 110.53 -178.509 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.1 mm -69.99 -39.98 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.136 -0.978 . . . . 1.32 109.197 179.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -68.95 -36.75 78.28 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.486 -0.931 . . . . 2.44 108.486 179.015 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.45 -49.82 72.87 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.061 -1.215 . . . . 0.99 110.061 -179.573 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -68.73 -48.53 63.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.749 -1.442 . . . . 1.97 109.41 -179.874 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.87 92.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 1.43 109.382 179.902 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.5 t -57.43 -39.34 76.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 2.12 109.025 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.04 94.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.313 -0.867 . . . . 1.64 109.393 179.437 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.3 mt -64.26 -42.47 96.45 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.153 -0.967 . . . . 1.93 109.827 -179.06 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.424 ' C ' ' N ' ' A' ' 118' ' ' LEU . 78.6 tt0 -59.87 -38.66 82.79 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.661 -1.274 . . . . 2.2 109.522 -178.659 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -50.08 -17.69 0.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.902 -1.124 . . . . 2.12 109.147 179.671 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.424 ' N ' ' C ' ' A' ' 116' ' ' GLU . 79.4 mt -63.36 146.77 52.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 2.34 108.542 179.585 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -95.83 10.81 35.86 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.086 -1.009 . . . . 3.23 111.439 -178.459 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 57.2 t0 -103.07 148.76 25.32 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.953 -1.092 . . . . 2.49 109.583 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 36.4 tt0 -72.04 -65.75 0.73 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.417 -0.957 . . . . 3.95 108.417 179.096 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.481 ' OH ' ' CZ ' ' A' ' 126' ' ' ARG . 11.2 t80 -39.19 -40.26 0.71 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.783 -0.573 . . . . 2.25 110.442 -179.127 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.1 mt -70.31 -39.57 74.74 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.86 -1.15 . . . . 2.27 108.95 178.897 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 121' ' ' GLU . 64.4 tttp -60.03 -40.0 87.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.389 -0.819 . . . . 3.31 109.586 -179.882 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -60.02 -39.43 85.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.859 . . . . 2.73 108.828 179.953 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.64 ' NE ' HE22 ' B' ' 351' ' ' GLN . 8.3 mtt180 -59.86 -39.79 86.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.17 -0.956 . . . . 3.2 108.793 179.314 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.38 -25.57 64.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 1.66 108.82 179.313 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.02 -40.03 75.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 1.67 109.39 179.378 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -66.74 -43.08 85.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.985 . . . . 1.55 109.838 179.925 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.5 t -69.9 -40.46 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.977 -1.077 . . . . 1.32 108.616 179.464 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -65.45 -35.67 81.61 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.501 -0.75 . . . . 3.58 109.443 179.51 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -59.97 -40.1 87.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 1.46 109.653 -179.747 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.36 -43.01 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.024 . . . . 1.22 109.187 179.805 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.8 -40.01 98.24 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.735 -1.346 . . . . 0.61 109.735 179.73 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -60.14 -49.96 75.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.397 -1.061 . . . . 3.1 109.705 -179.122 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.517 HH22 ' CD1' ' A' ' 57' ' ' ILE . 58.6 mtp180 -67.03 -32.61 73.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.125 -0.984 . . . . 3.71 110.255 -179.147 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 64.8 tp -60.04 -41.22 91.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.064 -1.023 . . . . 1.87 108.445 -179.539 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 94.5 mt -60.5 -39.99 89.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.367 -0.833 . . . . 1.29 109.265 179.323 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -69.16 -39.93 78.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.267 -0.895 . . . . 3.05 109.036 179.712 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -62.2 -39.97 94.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.606 -0.684 . . . . 1.26 111.343 -179.024 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.5 mt -73.74 -45.44 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 120.429 -1.419 . . . . 1.34 109.399 179.891 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.6 mt -69.97 -31.53 69.28 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.65 -0.656 . . . . 1.6 110.084 -179.273 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.38 36.58 10.61 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.45 -1.46 . . . . 0.96 109.45 -179.565 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.85 141.07 47.96 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.21 -1.171 . . . . 1.67 108.779 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -60.68 140.05 57.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.31 -0.869 . . . . 4.96 109.477 -179.433 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.6 mt -108.07 128.88 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 108.835 -0.802 . . . . 1.68 108.835 179.668 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 27.4 mm -58.04 -50.02 79.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.724 -0.61 . . . . 2.14 110.801 -177.432 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 33.9 t0 65.89 102.72 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.883 -0.784 . . . . 1.5 108.883 -178.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.474 ' O ' ' CD1' ' A' ' 152' ' ' ILE . 59.5 mt -73.07 -3.72 28.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.483 -0.761 . . . . 1.39 110.034 -179.207 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.448 ' HG ' ' NZ ' ' A' ' 60' ' ' LYS . 31.9 t -83.11 -13.7 55.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.012 -1.055 . . . . 1.83 109.066 179.22 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.72 24.61 0.47 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.564 -0.71 . . . . 1.46 109.947 -178.695 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.474 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 63.7 mt -91.42 122.07 42.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.328 -0.858 . . . . 1.42 108.74 -179.423 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -110.33 -9.22 14.64 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.461 -0.775 . . . . 2.94 110.455 -179.008 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -126.43 151.33 47.86 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.276 -0.89 . . . . 1.52 110.488 -178.583 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.01 133.55 51.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 1.58 108.621 179.224 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 19.9 m -153.24 165.93 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.438 -0.789 . . . . 1.32 109.542 179.64 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.0 mt -94.2 149.1 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 105.896 -1.89 . . . . 1.27 105.896 176.749 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.9 tp -98.39 117.19 32.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.939 -1.1 . . . . 1.41 110.893 -177.486 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.3 t -121.44 127.81 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 108.804 -0.813 . . . . 1.23 108.804 179.495 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.84 160.68 37.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.084 -1.01 . . . . 1.32 108.688 -179.979 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.04 -33.3 71.79 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.116 -1.615 . . . . 1.49 108.449 178.801 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -160.27 171.46 19.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.456 -0.777 . . . . 2.25 108.931 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.6 mt -141.69 133.92 27.87 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.875 -1.141 . . . . 1.35 109.168 179.74 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 66.7 p -100.46 149.67 36.29 Favored Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 121.173 -0.955 . . . . 1.56 110.262 -179.65 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -43.04 -38.47 7.26 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.561 2.174 . . . . 0.87 113.466 179.203 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.1 m -59.84 -40.04 87.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.974 -1.079 . . . . 1.36 109.801 -178.084 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.92 -40.83 83.31 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.151 -0.968 . . . . 1.61 110.421 -179.746 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.2 p -58.03 -30.77 66.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.112 -0.993 . . . . 1.21 111.092 -178.218 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.15 -46.72 55.36 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.699 -1.25 . . . . 1.21 110.03 179.935 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -90.25 37.28 0.89 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.31 -0.996 . . . . 2.11 108.31 -179.88 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.5 tp -107.76 132.54 53.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.616 -0.678 . . . . 1.29 109.616 179.777 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -86.51 103.64 15.22 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.318 -0.864 . . . . 2.81 108.725 178.992 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 59.0 mt -64.09 -41.59 97.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 2.09 110.363 -179.294 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -66.03 -26.05 67.34 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.841 -1.162 . . . . 2.86 112.01 -177.591 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -92.41 -8.08 45.82 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.655 -1.278 . . . . 2.39 109.976 -178.656 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 80.1 t -107.69 118.48 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.337 -0.852 . . . . 1.27 109.108 179.031 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.5 mt -85.41 4.06 37.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.345 -0.847 . . . . 2.17 111.114 -178.026 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 169.66 173.03 36.83 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.342 -1.408 . . . . 0.52 109.748 179.877 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -131.52 127.55 37.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.456 -1.026 . . . . 0.55 109.027 179.812 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 77.4 mt -129.04 123.22 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.616 -0.883 . . . . 1.27 108.616 179.059 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 63.7 p -145.49 158.32 43.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.139 -0.976 . . . . 1.39 111.109 -179.436 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -103.68 25.89 9.22 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.779 -0.823 . . . . 2.46 108.779 179.724 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.13 -159.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.006 -1.059 . . . . 1.51 111.229 -178.195 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.33 -51.56 12.84 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.029 -1.229 . . . . 2.23 110.029 -179.613 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.74 -108.97 0.39 Allowed Glycine 0 N--CA 1.493 2.441 0 O-C-N 121.084 -1.245 . . . . 2.23 110.207 -179.988 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.442 ' CB ' HH11 ' A' ' 186' ' ' ARG . 0.0 OUTLIER -79.91 -10.12 59.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.289 -1.124 . . . . 6.44 110.393 -179.29 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 78.5 p -83.89 0.77 46.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.125 -0.984 . . . . 4.09 110.324 -178.708 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.6 t -90.76 118.86 30.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.003 -1.061 . . . . 2.2 109.655 179.73 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -42.23 -52.73 4.34 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.602 -0.686 . . . . 1.15 109.7 -179.826 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.2 m -54.15 -30.67 50.0 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.34 -0.85 . . . . 2.01 110.759 -179.388 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 16.3 t -60.03 -44.75 94.41 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.601 -1.312 . . . . 1.93 109.746 -179.502 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.427 HG21 HD12 ' A' ' 192' ' ' ILE . 43.0 mm -60.09 -39.69 81.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.611 -0.885 . . . . 2.2 108.611 179.749 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.3 mtp -60.05 -39.89 87.52 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.456 -0.777 . . . . 1.32 110.002 -179.586 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.04 -44.36 94.71 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.654 -1.279 . . . . 1.3 109.504 -179.665 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.411 HH22 ' HG2' ' A' ' 186' ' ' ARG . 95.1 mtt180 -62.39 -57.78 10.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.111 -0.993 . . . . 3.38 109.981 -179.313 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 66.8 m -60.91 -40.01 91.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.857 . . . . 1.15 111.993 -178.684 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 91.6 mt -79.94 -10.93 59.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.766 -1.208 . . . . 1.28 110.876 -177.846 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 59.14 49.96 8.64 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.136 -0.977 . . . . 1.5 110.28 179.881 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 66.7 mt -121.91 126.2 26.43 Favored Pre-proline 0 N--CA 1.501 2.106 0 N-CA-C 108.955 -0.757 . . . . 1.37 108.955 179.517 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -43.09 129.44 5.82 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.842 1.695 . . . . 0.76 112.077 179.497 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.26 145.47 6.99 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.452 -1.299 . . . . 1.19 112.102 -179.512 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.6 mt -124.3 144.72 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.533 -1.284 . . . . 1.31 107.533 178.336 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.7 m -129.29 -6.69 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 120.695 -1.253 . . . . 1.38 111.031 -178.87 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.9 20.87 26.13 Favored Glycine 0 N--CA 1.5 2.958 0 N-CA-C 110.963 -0.855 . . . . 1.03 110.963 -179.406 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.445 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 2.9 p -46.61 -41.36 14.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.711 -1.464 . . . . 1.38 109.725 -179.483 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . 0.493 ' C ' ' HG ' ' A' ' 207' ' ' SER . . . 90.61 -50.38 3.22 Favored Glycine 0 N--CA 1.498 2.823 0 C-N-CA 120.034 -1.079 . . . . 1.17 111.767 178.477 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.493 ' HG ' ' C ' ' A' ' 206' ' ' GLY . 74.2 m -161.88 42.26 0.14 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.596 -1.532 . . . . 2.07 111.334 -179.177 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 23.5 t -78.89 -38.14 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.932 -1.105 . . . . 1.35 108.666 178.348 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 4.3 p -55.3 -35.62 65.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.459 -0.776 . . . . 1.49 110.611 -179.062 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 63.4 m -84.29 -9.8 58.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.963 -1.086 . . . . 2.16 110.142 -179.374 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.575 HE22 ' CD1' ' A' ' 2' ' ' ILE . 27.2 mt-30 -96.16 -16.5 21.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.065 -1.022 . . . . 2.89 110.485 -179.39 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.66 162.92 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.403 -0.81 . . . . 1.33 109.714 -179.596 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.495 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 0.5 OUTLIER -121.89 160.02 25.62 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.597 -0.89 . . . . 2.73 108.597 -179.615 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.458 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 39.8 p-10 -60.4 145.28 48.59 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.394 -0.816 . . . . 2.7 111.168 -179.02 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 84.29 -1.44 1.0 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.519 0.676 . . . . 2.38 110.326 178.594 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.495 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 96.5 m-20 -72.54 155.09 40.43 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.623 -0.831 . . . . 2.09 108.838 179.269 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -97.64 119.31 35.98 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.445 -0.946 . . . . 1.45 108.445 179.852 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 96.1 mt -122.83 142.24 50.97 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.439 -0.788 . . . . 1.31 110.504 -179.077 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 83.2 mt -114.82 128.37 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 106.299 -1.741 . . . . 1.29 106.299 176.365 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 56.7 tp -97.89 116.58 30.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.932 -1.105 . . . . 1.31 108.505 -179.358 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.518 ' C ' ' H ' ' A' ' 223' ' ' VAL . 21.3 t0 -74.1 -44.66 53.07 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.466 -1.309 . . . . 2.31 107.466 179.553 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 51.82 8.49 0.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.834 -0.541 . . . . 1.19 109.654 179.073 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.518 ' H ' ' C ' ' A' ' 221' ' ' ASP . 95.2 t -126.75 -39.17 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 107.384 -1.339 . . . . 1.45 107.384 178.262 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -102.77 -0.41 31.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.878 -1.156 . . . . 3.13 107.878 178.637 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 61.94 45.77 7.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.817 -0.552 . . . . 2.2 109.839 -179.814 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -139.6 150.66 45.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.293 -0.879 . . . . 2.32 109.891 179.575 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 90.5 t -119.0 128.07 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.423 -0.955 . . . . 1.4 108.423 178.989 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -102.67 123.56 46.6 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.596 -0.89 . . . . 1.29 108.596 179.461 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.3 t -100.02 110.01 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.38 -0.825 . . . . 1.38 110.607 -178.865 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 230' ' ' ASN . 21.3 t30 50.94 60.65 14.45 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.44 -0.788 . . . . 2.33 111.516 179.047 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -79.51 153.04 23.47 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.703 2.268 . . . . 0.95 111.277 178.386 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.8 m -64.7 159.92 21.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 2.31 110.135 -179.25 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -61.18 -40.08 92.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.39 -0.818 . . . . 3.45 110.342 -179.632 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.01 -36.07 76.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.081 -1.012 . . . . 2.89 109.265 179.794 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.97 -39.93 78.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.564 -0.902 . . . . 1.73 108.564 179.261 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . 0.483 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 91.8 mt -67.06 -40.07 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.444 -0.785 . . . . 1.57 110.001 179.931 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -59.91 -40.32 88.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.064 -1.022 . . . . 2.43 109.069 -179.598 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -67.33 -40.0 85.89 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.775 -0.824 . . . . 3.18 108.775 179.165 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 93.6 mtp -69.38 -34.83 75.13 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.462 -0.774 . . . . 1.59 108.928 178.823 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.483 ' NH1' ' CG2' ' A' ' 236' ' ' ILE . 0.1 OUTLIER -64.11 -35.47 80.87 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.308 -0.87 . . . . 3.11 108.975 178.889 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.43 -44.67 89.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.141 -0.974 . . . . 2.17 108.835 179.949 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.09 -40.77 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.144 -0.973 . . . . 2.51 108.415 179.051 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -60.29 -40.93 92.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.452 -0.78 . . . . 3.82 110.083 -179.83 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.82 -40.65 93.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.055 -1.028 . . . . 1.78 109.76 -179.667 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -60.73 -40.1 91.13 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.229 -0.919 . . . . 2.77 108.877 179.949 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.4 t -62.29 -40.63 88.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.596 -0.69 . . . . 2.25 109.585 -179.931 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.67 -40.22 96.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 2.54 109.885 -179.37 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 26.0 t -69.67 -39.86 76.77 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.298 -0.876 . . . . 3.03 109.808 -179.685 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -60.13 -43.38 95.73 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.249 -0.907 . . . . 3.34 110.211 -179.084 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -83.89 -7.85 59.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.022 -1.049 . . . . 4.18 110.565 -179.172 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -106.74 -15.67 14.69 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.769 -1.207 . . . . 4.43 109.694 179.895 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.495 ' C ' ' H ' ' A' ' 254' ' ' ALA . 86.6 mt-10 -84.09 60.82 6.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.022 -1.049 . . . . 5.42 109.358 -179.978 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 89.8 mt -49.6 -13.37 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.467 -0.771 . . . . 6.11 109.127 179.67 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.495 ' H ' ' C ' ' A' ' 252' ' ' GLU . . . -59.99 -36.23 76.73 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.525 -0.917 . . . . 7.37 108.525 179.402 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . 0.423 ' HG2' ' H ' ' A' ' 257' ' ' LYS . 61.3 tttp -134.89 131.46 37.36 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.384 -0.969 . . . . 8.3 108.384 179.595 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.43 ' CD1' ' N ' ' A' ' 256' ' ' LEU . 7.7 mp -86.83 -9.6 55.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.294 -0.879 . . . . 9.05 109.252 -179.459 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . 0.423 ' H ' ' HG2' ' A' ' 255' ' ' LYS . 60.3 tttm 53.17 72.22 0.44 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.589 -0.694 . . . . 10.56 109.159 -179.99 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.427 ' O ' ' O ' ' A' ' 259' ' ' ARG . 27.6 p-10 -141.83 56.16 1.49 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.99 -0.745 . . . . 11.32 108.99 179.933 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' A' ' 258' ' ' ASP . 13.6 ptm180 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.107 -0.949 . . . . 12.74 109.61 -179.907 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -155.19 153.65 31.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.267 -0.896 . . . . 0.0 109.499 179.485 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -145.56 155.48 43.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.214 -0.929 . . . . 0.0 109.55 -179.83 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . 0.522 HE22 ' C ' ' B' ' 305' ' ' GLU . 0.7 OUTLIER -154.49 150.02 27.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.515 -0.741 . . . . 0.0 109.015 -179.587 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . 0.522 ' C ' HE22 ' B' ' 304' ' ' GLN . 95.0 mt-10 -109.85 131.72 54.8 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.3 -0.875 . . . . 0.0 110.162 179.388 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 6.9 p -132.9 121.02 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 CA-C-O 122.121 0.962 . . . . 0.0 112.134 -178.136 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 87.8 m -80.0 103.01 9.6 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.696 0.76 . . . . 0.0 110.384 -178.93 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.5 mt -51.51 117.52 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.446 1.117 . . . . 0.0 109.971 -178.079 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 62.2 p -104.69 19.01 21.19 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.414 -177.954 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.46 115.98 44.73 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.327 -0.858 . . . . 0.0 109.098 179.507 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -53.05 -15.47 4.98 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 CA-C-N 120.306 1.145 . . . . 0.0 112.923 -179.704 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -115.27 4.98 14.59 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.506 -0.746 . . . . 0.0 109.036 -179.888 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.26 174.46 19.12 Favored Glycine 0 N--CA 1.481 1.692 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 -179.042 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.442 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.0 tp -85.84 95.59 9.48 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.163 -1.198 . . . . 0.0 108.696 -179.066 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -95.25 -162.55 0.96 Allowed 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.161 -0.962 . . . . 0.0 110.411 179.737 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 7.9 m -59.63 -39.96 86.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.056 -1.027 . . . . 0.0 112.581 -175.776 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.482 HH11 ' HG2' ' B' ' 317' ' ' ARG . 0.8 OUTLIER -60.15 -60.82 9.38 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.33 -1.481 . . . . 0.0 111.27 -179.257 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -59.4 -32.4 96.48 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.14 1.086 . . . . 0.0 111.628 -179.9 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.88 67.67 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.398 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -50.37 -40.02 48.28 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.819 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -69.99 -41.47 74.37 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 108.923 178.369 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -61.2 -52.78 63.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.83 . . . . 0.0 110.946 -179.365 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 87.9 t -65.41 -27.67 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.639 -1.288 . . . . 0.0 109.761 -178.957 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -45.16 93.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.404 -0.81 . . . . 0.0 109.411 179.581 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -66.52 -44.89 81.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.418 -0.801 . . . . 0.0 111.2 -178.437 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . 0.42 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -61.55 -53.87 50.61 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.724 -1.235 . . . . 0.0 111.144 -178.646 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -52.66 -13.43 0.39 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.724 -1.235 . . . . 0.0 109.317 179.673 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -72.6 -28.73 66.85 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.69 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -106.03 146.78 29.67 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.443 -1.033 . . . . 0.0 109.942 -179.676 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 51.6 p -91.11 -11.79 37.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.925 . . . . 0.0 110.134 179.997 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 56.4 p -65.3 157.87 27.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.196 -0.94 . . . . 0.0 110.323 -179.165 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -72.62 131.55 42.59 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.377 -0.827 . . . . 0.0 108.922 179.375 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 80.2 mt -132.33 132.69 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.873 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 62.7 m -131.6 155.89 46.74 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.48 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 61.9 t -119.1 140.49 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.318 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 26.7 m -128.9 123.89 33.78 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.128 -0.982 . . . . 0.0 108.561 179.95 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 93.0 p -137.93 116.61 12.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.966 -1.084 . . . . 0.0 110.82 -179.387 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 22.9 m120 45.14 53.43 7.86 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.318 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.74 -11.59 66.08 Favored Glycine 0 N--CA 1.502 3.07 0 O-C-N 120.06 -1.65 . . . . 0.0 113.052 176.264 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -120.92 132.35 54.9 Favored 'General case' 0 N--CA 1.506 2.37 0 CA-C-N 119.285 1.542 . . . . 0.0 109.512 -179.655 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 77.4 p -127.88 151.39 49.13 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.928 0.87 . . . . 0.0 110.886 -178.834 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.48 164.47 30.79 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.64 0.734 . . . . 0.0 110.423 -178.94 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 48.0 t -87.56 133.21 33.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.806 -0.559 . . . . 0.0 110.359 -179.353 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.486 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -70.13 -20.27 63.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.944 . . . . 0.0 108.911 179.289 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -84.61 17.36 2.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.494 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.486 ' H ' ' C ' ' B' ' 344' ' ' ALA . 3.0 m -146.45 95.43 2.6 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.773 0.797 . . . . 0.0 112.421 -179.368 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.98 -39.05 84.36 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.415 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -51.31 -51.15 56.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.979 -1.076 . . . . 0.0 110.459 -179.569 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.45 ' O ' ' OG1' ' B' ' 352' ' ' THR . 33.6 mtmm -71.66 -39.72 70.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.955 -1.09 . . . . 0.0 111.277 -178.2 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' B' ' 352' ' ' THR . 20.6 mt -47.81 -59.95 2.94 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.718 -1.239 . . . . 0.0 109.754 -179.153 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.64 HE22 ' NE ' ' A' ' 126' ' ' ARG . 7.6 mm100 -42.07 -20.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.399 -0.813 . . . . 0.0 111.192 -177.724 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.493 ' N ' ' O ' ' B' ' 350' ' ' LEU . 69.5 p -79.25 -12.76 59.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.081 -1.637 . . . . 0.0 109.53 -179.294 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 32.0 mt -94.09 122.7 36.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.114 -0.991 . . . . 0.0 108.993 178.383 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -72.03 96.89 0.71 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.718 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.5 mt -100.07 80.29 2.27 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.265 -1.138 . . . . 0.0 109.06 179.282 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 356' ' ' THR . . . . . 0.401 ' OG1' ' OG1' ' B' ' 359' ' ' THR . 75.1 p -91.13 166.28 13.05 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.967 -1.083 . . . . 0.0 111.055 -178.83 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -59.92 111.58 1.53 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.132 0.491 . . . . 0.0 110.642 -179.591 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 103.01 5.57 46.88 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.762 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 359' ' ' THR . . . . . 0.401 ' OG1' ' OG1' ' B' ' 356' ' ' THR . 52.4 m -80.14 109.78 14.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.051 -1.264 . . . . 0.0 110.855 -179.468 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 11.9 t -78.54 112.71 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.108 0.956 . . . . 0.0 109.943 -177.907 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 36.0 m -113.31 176.85 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 -178.735 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 57.4 m -126.64 130.02 49.63 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 176.648 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.5 mt -106.43 124.52 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.357 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 63.2 m -131.53 138.85 49.1 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.5 -0.75 . . . . 0.0 109.771 -178.979 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.41 155.24 42.44 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.217 -0.927 . . . . 0.0 109.763 -179.507 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -146.51 123.34 11.28 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.409 -0.807 . . . . 0.0 109.171 179.848 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.545 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.89 -153.47 24.73 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.248 -1.453 . . . . 0.0 111.548 179.868 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -59.97 -51.69 68.58 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.222 -0.575 . . . . 0.0 112.503 -177.292 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' B' ' 370' ' ' GLU . 62.5 m-20 -111.91 11.06 20.67 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.892 -1.13 . . . . 0.0 111.434 -177.267 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.545 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 11.1 pt-20 -39.14 -34.5 0.18 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.452 -0.78 . . . . 0.0 111.657 -179.16 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -69.99 -41.0 74.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.036 -1.04 . . . . 0.0 110.667 -178.148 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -69.68 -49.89 49.16 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.223 -179.609 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . 0.423 ' O ' ' N ' ' B' ' 377' ' ' LEU . . . -45.77 -79.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 110.417 -179.653 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . 0.488 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 15.1 t -45.24 -38.38 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.154 -0.966 . . . . 0.0 110.367 -177.696 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -69.86 -40.25 75.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.535 -1.353 . . . . 0.0 110.111 179.738 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -83.32 -45.54 13.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.974 -1.079 . . . . 0.0 109.707 179.499 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' B' ' 373' ' ' ALA . 86.0 mt -60.08 -35.51 75.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 109.673 -179.211 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 54.4 t -68.88 -40.06 80.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.123 -0.986 . . . . 0.0 109.758 179.819 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -79.98 -10.0 59.73 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.705 -1.247 . . . . 0.0 108.611 178.251 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 44.1 tp -82.08 -26.81 33.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.997 -1.064 . . . . 0.0 108.697 178.377 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 38.7 mtt -83.36 -21.02 33.21 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 176.813 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -85.97 -11.3 53.38 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.583 -0.698 . . . . 0.0 109.451 178.789 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -109.98 -4.72 15.74 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.387 -0.821 . . . . 0.0 110.868 -178.998 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 31.1 mt -89.77 123.97 34.23 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.681 -1.262 . . . . 0.0 109.859 -179.79 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.406 -179.82 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 mmt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.457 -0.572 . . . . 3.19 109.457 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.3 mt -107.31 121.38 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.644 -0.873 . . . . 1.71 108.644 179.745 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 m -133.62 120.09 20.25 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.424 -0.798 . . . . 1.66 109.178 179.981 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.64 -161.7 37.72 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.422 -1.471 . . . . 1.05 109.422 179.917 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.44 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.7 mt -93.03 -10.13 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.038 -1.272 . . . . 1.59 110.005 -179.392 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' ILE . 55.2 tp 53.21 101.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -0.963 . . . . 1.47 109.548 -179.959 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.13 -26.24 20.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 1.39 109.631 179.928 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 12.1 t -144.6 130.18 9.58 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.213 -0.929 . . . . 2.09 109.433 179.923 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.94 143.43 16.31 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.175 1.916 . . . . 0.91 112.806 -179.926 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.497 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 163.74 -162.14 34.8 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.033 -1.627 . . . . 0.92 109.033 179.881 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.8 mt -149.52 149.8 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.922 -1.34 . . . . 1.35 108.466 178.841 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.5 158.4 37.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.749 -1.22 . . . . 1.14 110.794 179.83 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -139.97 129.19 23.82 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.897 -1.149 . . . . 0.7 107.897 178.817 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.93 -178.91 46.53 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 118.869 -1.634 . . . . 0.58 110.442 179.911 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -79.93 156.63 27.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.544 -0.974 . . . . 2.63 109.886 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -105.4 127.5 53.01 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.478 0.656 . . . . 1.27 110.925 -179.434 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.8 tp -101.25 140.08 36.04 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.772 -1.195 . . . . 1.41 107.772 178.537 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.7 tp -118.35 125.59 50.34 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.374 -0.829 . . . . 1.49 109.951 -179.442 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.8 mt -84.04 104.41 14.09 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.531 0.682 . . . . 1.52 109.963 -179.795 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -99.29 128.58 45.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.455 -0.778 . . . . 3.17 109.354 -179.789 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -130.06 127.94 40.92 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.41 -0.806 . . . . 3.0 109.072 179.256 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -76.74 147.31 37.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.282 -0.886 . . . . 2.77 109.418 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -63.61 141.55 58.72 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.23 -0.919 . . . . 2.94 108.995 -179.983 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.9 mt -76.97 131.88 33.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.229 -0.919 . . . . 1.46 109.162 -179.516 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.7 t -93.88 124.1 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.287 -0.883 . . . . 1.7 109.813 -179.621 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.403 HG23 HD12 ' A' ' 26' ' ' ILE . 88.6 mt -109.8 138.11 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.611 -0.681 . . . . 1.54 109.929 -179.462 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -97.45 116.93 30.58 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.13 -0.981 . . . . 1.81 109.441 179.834 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.489 HH11 ' HG2' ' A' ' 28' ' ' ARG . 2.3 mmt-85 -85.67 -0.95 56.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.393 -0.817 . . . . 3.23 109.62 -179.431 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -60.54 144.11 52.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.935 . . . . 3.29 109.632 -179.712 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -87.71 147.88 25.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.192 -0.942 . . . . 2.8 109.046 -179.928 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 pt -94.66 164.82 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.997 -1.064 . . . . 1.43 109.823 179.924 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.43 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 53.9 p -90.23 175.64 7.05 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.477 -0.935 . . . . 1.54 108.477 178.576 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.06 -20.34 63.23 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.937 -1.102 . . . . 1.6 111.266 -178.95 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.43 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 7.5 p-10 -85.97 -23.19 27.0 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.501 -1.375 . . . . 2.56 108.553 179.001 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -81.84 -9.41 59.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.592 -0.892 . . . . 2.36 108.592 178.818 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 t -62.09 -53.66 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.487 -0.758 . . . . 1.43 109.309 179.711 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -62.17 -40.06 94.76 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.339 -0.851 . . . . 1.77 109.349 179.691 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -61.91 -42.2 98.81 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.422 -0.799 . . . . 3.32 110.598 -178.766 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -66.15 -39.96 90.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.711 -1.243 . . . . 1.51 110.376 -179.036 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.14 -47.88 90.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.708 -1.245 . . . . 1.41 108.681 179.586 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -61.46 -44.21 97.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.062 . . . . 1.81 109.652 179.846 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.441 HH11 ' HG2' ' A' ' 42' ' ' ARG . 25.8 mtt-85 -60.02 -41.13 91.53 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.937 -1.135 . . . . 3.26 107.937 179.139 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -62.31 -45.78 91.69 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.958 -1.127 . . . . 0.81 107.958 177.545 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.02 -47.63 85.03 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.828 -0.804 . . . . 1.59 108.828 179.694 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.1 t -62.39 -42.95 99.82 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.394 -0.922 . . . . 1.38 109.009 179.355 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.44 -48.58 84.22 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.866 -1.694 . . . . 0.87 108.866 179.477 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -62.27 -34.9 77.44 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.33 -1.1 . . . . 3.62 108.197 178.694 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.59 -43.81 80.46 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.613 -0.679 . . . . 1.43 109.285 -179.911 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.3 ttpt -65.78 -74.24 0.11 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.17 -1.418 . . . . 3.08 107.17 179.301 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.25 -31.35 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.318 -0.864 . . . . 1.33 111.118 -179.238 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 49' ' ' LYS . 34.4 t -57.06 -56.07 26.46 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.547 -1.346 . . . . 1.85 108.473 179.801 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.45 -40.03 81.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.433 -0.792 . . . . 1.35 111.204 -179.182 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -67.14 -40.03 86.68 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.699 -1.251 . . . . 2.34 110.42 -179.1 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.43 -39.95 94.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.886 -1.134 . . . . 2.2 109.504 179.815 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -62.24 -33.99 75.65 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.174 -0.954 . . . . 1.35 109.448 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.62 -41.39 98.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.955 . . . . 1.34 109.832 -179.986 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.36 -39.95 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.193 -0.942 . . . . 1.26 109.55 -180.0 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -56.69 -50.6 71.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 1.7 109.921 -178.962 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -59.41 -36.63 76.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.371 -0.83 . . . . 1.35 110.968 -177.472 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -64.29 -38.26 90.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.895 -1.128 . . . . 2.08 109.573 179.891 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.31 -43.43 97.83 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.467 -0.771 . . . . 1.21 109.732 -179.926 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.15 -50.85 63.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.498 -1.441 . . . . 0.75 109.498 -179.335 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.26 -50.1 56.09 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.139 -1.212 . . . . 1.59 109.5 179.628 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.1 m -63.03 -64.76 0.82 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 1.41 112.32 -177.893 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -97.65 -48.3 5.29 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.868 -1.145 . . . . 0.79 111.825 -178.079 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.91 -169.77 25.15 Favored Glycine 0 N--CA 1.5 2.943 0 O-C-N 120.662 -1.274 . . . . 1.22 110.943 179.889 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.03 -26.87 64.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.897 -0.767 . . . . 5.81 110.287 -179.705 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -61.04 -33.15 72.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.447 -0.783 . . . . 3.37 110.087 -179.67 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -100.33 -22.59 15.03 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.341 -0.849 . . . . 2.37 109.891 179.995 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -64.95 -40.76 95.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.132 -0.98 . . . . 1.65 110.02 -179.311 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.599 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -67.1 -25.82 66.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.401 -0.812 . . . . 1.42 110.431 -178.913 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.99 -40.53 83.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.969 -1.082 . . . . 1.43 108.499 -179.706 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -69.96 -35.76 74.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.144 -0.973 . . . . 1.08 110.107 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -60.01 -40.06 87.94 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.762 -1.211 . . . . 1.37 109.312 179.831 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.99 -42.62 94.63 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.463 -1.855 . . . . 0.67 108.463 179.09 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -61.06 -44.56 97.2 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.468 -1.019 . . . . 1.99 108.612 179.334 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.98 -43.53 79.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.674 -0.641 . . . . 1.22 109.799 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -64.11 -40.02 95.29 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.906 -1.121 . . . . 2.11 109.827 -179.356 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 35.9 tp -65.47 -39.97 92.61 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.237 -0.914 . . . . 1.33 109.44 179.536 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.5 tp -65.71 -37.09 85.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.557 -0.714 . . . . 1.29 109.177 -179.493 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -82.66 1.66 37.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 1.47 110.086 -179.372 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -48.56 130.01 16.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.965 -1.084 . . . . 1.47 109.672 -179.405 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.46 -18.4 51.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.542 -0.723 . . . . 1.78 110.354 -179.259 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.47 -35.1 73.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.005 -1.059 . . . . 2.53 108.739 178.353 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.3 mt -70.15 -42.12 72.93 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.521 0.677 . . . . 1.36 109.909 179.506 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -60.15 -48.81 80.18 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.36 -0.837 . . . . 1.42 110.028 -179.126 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -69.95 -41.31 74.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 2.27 110.705 -179.451 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.98 -40.04 75.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.16 -0.963 . . . . 1.57 111.735 -178.629 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 91.8 mt -69.47 -42.04 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.905 -1.122 . . . . 1.19 109.178 -179.571 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.7 mt -69.98 -39.62 77.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.638 -0.664 . . . . 1.39 109.943 179.329 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.99 -47.77 84.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -0.863 . . . . 1.39 110.81 -179.244 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 96' ' ' LYS . 93.2 mt -61.48 -47.51 85.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.994 -1.067 . . . . 1.5 109.921 -179.44 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.33 -49.63 83.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.296 -0.877 . . . . 1.29 109.185 179.632 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -70.09 -43.03 71.93 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.901 -0.719 . . . . 2.64 110.667 179.636 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -80.69 -47.39 14.09 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.103 -0.998 . . . . 1.65 111.79 -178.349 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 92' ' ' LEU . 65.8 mmtt -91.81 -2.3 56.96 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.973 -1.079 . . . . 2.5 111.659 -177.679 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 56.05 34.68 24.22 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.797 -1.189 . . . . 1.88 109.489 -179.845 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 59.0 mtt -91.63 169.84 10.41 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.518 -0.739 . . . . 1.71 110.03 -179.39 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.5 p -82.32 162.34 22.29 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.42 -0.8 . . . . 1.61 109.408 179.986 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.03 -39.71 75.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.417 -0.802 . . . . 1.33 109.892 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.94 -40.04 83.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 2.07 110.011 -179.753 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.49 -44.08 19.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.018 -1.051 . . . . 1.37 110.283 -179.506 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.63 -47.68 68.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 1.14 110.2 -179.306 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.03 87.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.178 -0.951 . . . . 1.26 109.659 -179.862 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -59.99 -40.87 90.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.43 -0.794 . . . . 2.02 110.01 -178.559 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -63.21 -40.02 96.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.913 . . . . 1.33 110.131 -179.596 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.3 -52.59 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.111 -0.993 . . . . 1.3 110.528 -178.721 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -70.02 -40.02 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.973 -1.079 . . . . 1.32 109.328 -179.752 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.61 -39.19 91.27 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.644 -0.872 . . . . 2.44 108.644 179.327 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.33 -47.86 87.12 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.74 -1.344 . . . . 0.99 109.74 -179.668 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -67.53 -51.65 48.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.942 -1.328 . . . . 1.97 109.197 -179.992 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.85 -42.5 89.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.375 -0.828 . . . . 1.43 109.591 -179.748 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.4 t -57.56 -39.5 76.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.059 -1.026 . . . . 2.12 109.056 -179.851 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.95 -39.93 90.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.935 . . . . 1.64 109.656 179.424 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.1 mt -64.66 -42.01 95.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.022 -1.049 . . . . 1.93 109.999 -178.827 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.95 -37.58 79.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.746 -1.222 . . . . 2.2 109.335 -179.596 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -53.45 -20.25 4.5 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.202 -0.936 . . . . 2.12 109.265 179.827 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 65.7 mt -62.46 139.99 58.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.044 -1.035 . . . . 2.34 108.798 179.861 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -90.99 48.23 1.5 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.04 -1.037 . . . . 3.23 109.393 179.894 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.42 ' OD1' ' OE2' ' A' ' 121' ' ' GLU . 58.3 t0 -135.18 130.13 34.85 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.368 -0.833 . . . . 2.49 109.282 -179.713 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.2 pm0 -69.35 -28.87 66.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.532 -0.73 . . . . 3.95 110.071 -179.677 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.545 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 2.4 t80 -73.2 -41.03 64.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.259 -0.901 . . . . 2.25 110.599 179.586 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.595 ' CD2' HH22 ' A' ' 126' ' ' ARG . 41.3 mt -74.92 -29.71 61.04 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.044 -1.035 . . . . 2.27 108.344 179.31 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -68.51 -39.1 81.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.5 -0.75 . . . . 3.31 110.1 179.523 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -59.98 -44.02 94.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.987 -1.071 . . . . 2.73 110.063 -178.905 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.709 ' HE ' ' NE2' ' B' ' 351' ' ' GLN . 22.2 mtm-85 -69.96 -28.91 65.94 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.315 -1.354 . . . . 3.2 108.797 179.805 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.75 -26.64 65.84 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.865 -1.161 . . . . 1.66 107.865 178.741 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.56 -39.98 64.28 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.088 -0.708 . . . . 1.67 109.088 178.795 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -65.85 -39.99 91.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.358 -0.838 . . . . 1.55 110.53 -179.442 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.5 t -65.11 -41.02 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.877 -1.139 . . . . 1.32 109.065 179.999 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -59.98 -37.86 80.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.092 -1.005 . . . . 3.58 108.522 178.868 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 57.2 t0 -60.03 -38.96 84.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.578 -0.701 . . . . 1.46 109.985 -179.614 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 94.5 mt -60.08 -42.5 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.92 -1.113 . . . . 1.22 110.101 -178.89 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.76 -29.3 59.56 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.647 -1.381 . . . . 0.61 109.647 179.867 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt -59.93 -49.04 79.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.299 -1.118 . . . . 3.1 109.464 -179.515 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.445 HH11 ' HG2' ' A' ' 136' ' ' ARG . 27.1 mtt-85 -65.16 -36.7 85.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.083 -1.011 . . . . 3.71 109.596 179.861 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.2 tp -57.08 -40.92 77.86 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.355 -0.84 . . . . 1.87 109.018 -178.652 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.16 -41.35 98.21 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.193 -0.942 . . . . 1.29 109.762 179.405 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -70.09 -39.94 75.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.23 -0.919 . . . . 3.05 109.014 179.384 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -63.87 -35.66 81.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.675 -0.641 . . . . 1.26 111.093 -179.31 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.444 HD11 HG22 ' A' ' 141' ' ' ILE . 83.6 mt -71.13 -45.9 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.487 -1.383 . . . . 1.34 108.75 179.522 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 77.2 mt -70.03 -34.96 73.93 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.51 -0.744 . . . . 1.6 109.518 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.91 43.74 5.31 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.188 -1.565 . . . . 0.96 109.188 -179.479 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 tp -74.29 149.83 40.5 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.324 -1.103 . . . . 1.67 109.012 -179.854 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -67.1 141.72 57.36 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.178 -0.951 . . . . 4.96 109.678 -179.553 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 89.1 mt -115.63 126.6 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 122.269 1.033 . . . . 1.68 109.269 179.635 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 148' ' ' ASP . 7.5 mt -70.01 -40.0 78.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 115.594 -0.73 . . . . 2.14 110.743 -178.219 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 147' ' ' ILE . 25.8 t0 63.49 131.29 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.642 -0.873 . . . . 1.5 108.642 -178.918 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.9 mt -89.89 -0.62 57.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.047 -1.033 . . . . 1.39 109.646 -179.324 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.7 m -84.83 -8.88 58.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 1.83 109.21 179.566 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.03 27.33 0.78 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.446 -0.784 . . . . 1.46 110.683 -178.207 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.539 ' O ' ' NZ ' ' A' ' 175' ' ' LYS . 54.4 mt -89.88 120.03 37.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 O-C-N 121.117 -0.99 . . . . 1.42 109.395 -179.16 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.42 ' O ' ' OD1' ' A' ' 154' ' ' ASP . 72.2 mt-30 -97.07 -9.67 27.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.298 -0.876 . . . . 2.94 111.083 -178.765 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 153' ' ' GLN . 96.4 m-20 -139.7 157.89 45.02 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.898 -1.126 . . . . 1.52 110.815 -178.763 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -62.7 138.22 58.45 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.735 -0.839 . . . . 1.58 108.735 179.606 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.1 m -153.13 165.71 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 1.32 109.767 179.88 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.5 mt -95.48 148.84 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.414 -1.698 . . . . 1.27 106.414 176.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.3 tp -98.61 117.66 33.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.084 -1.01 . . . . 1.41 111.049 -177.684 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.0 t -122.42 130.04 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.622 -0.881 . . . . 1.23 108.622 178.416 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.63 161.24 38.64 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.584 -0.895 . . . . 1.32 108.584 179.996 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.485 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -72.09 -32.88 67.44 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.201 -1.562 . . . . 1.49 107.687 178.699 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 20.2 t0 -162.27 167.73 23.47 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.142 -1.059 . . . . 2.25 108.142 179.8 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.498 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 86.5 mt -141.67 130.61 23.12 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.907 -1.12 . . . . 1.35 109.586 179.689 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 63.8 p -93.05 144.62 28.66 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 108.543 -0.91 . . . . 1.56 108.543 179.363 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -42.11 -29.86 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.846 1.697 . . . . 0.87 112.65 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.3 m -59.71 -39.98 86.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.017 . . . . 1.36 109.711 -178.405 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -70.06 -42.11 73.29 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.12 -0.988 . . . . 1.61 110.354 -179.662 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 77.9 p -53.93 -29.97 44.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.228 -0.92 . . . . 1.21 111.356 -177.994 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.14 -56.6 5.3 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.945 -1.097 . . . . 1.21 110.53 -179.7 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -84.05 37.34 0.6 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.451 -0.78 . . . . 2.11 108.939 -179.599 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.9 tp -109.76 129.47 55.62 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.457 -0.942 . . . . 1.29 108.457 178.494 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -79.97 105.15 11.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.082 -1.011 . . . . 2.81 109.27 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 77.0 mt -66.84 -40.26 87.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.426 -0.796 . . . . 2.09 111.229 -178.564 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -70.0 -23.62 63.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.939 -1.1 . . . . 2.86 110.852 -178.029 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . 0.539 ' NZ ' ' O ' ' A' ' 152' ' ' ILE . 41.4 mtpt -93.97 -6.44 45.42 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.032 -1.043 . . . . 2.39 109.861 -178.657 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 93.1 t -107.92 121.4 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.179 -0.95 . . . . 1.27 108.605 179.069 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 42.1 mt -85.66 7.12 24.59 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.391 -0.818 . . . . 2.17 111.777 -177.07 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 164.11 177.55 36.93 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.17 -1.49 . . . . 0.52 109.662 179.914 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -134.78 130.27 35.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.453 -1.028 . . . . 0.55 109.26 -179.695 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.419 HD12 HG22 ' A' ' 180' ' ' ILE . 91.0 mt -133.17 128.29 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.025 -0.731 . . . . 1.27 109.025 179.191 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 33.8 p -149.87 159.42 44.38 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.043 -1.035 . . . . 1.39 109.763 179.741 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 53.8 p-10 -106.27 27.55 8.59 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.519 -0.919 . . . . 2.46 108.519 178.847 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.5 -157.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.056 0.931 . . . . 1.51 111.972 -178.172 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.6 -80.48 0.08 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.875 -0.89 . . . . 2.23 110.875 -179.179 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.68 -130.57 1.37 Allowed Glycine 0 N--CA 1.49 2.288 0 O-C-N 120.892 -1.358 . . . . 2.23 110.112 -179.491 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -79.42 -9.31 59.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.305 -1.115 . . . . 6.44 111.031 -179.138 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.2 p -87.43 9.13 21.77 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.947 -1.096 . . . . 4.09 110.238 -179.085 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.7 m -90.19 139.32 30.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.941 -1.1 . . . . 2.2 110.358 -179.602 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -45.12 -53.38 8.08 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.473 -0.767 . . . . 1.15 109.99 -179.744 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.4 m -56.6 -39.01 72.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.401 -0.812 . . . . 2.01 110.164 -178.903 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.629 ' HG ' ' N ' ' A' ' 192' ' ' ILE . 27.8 p -60.0 -37.67 80.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.858 -1.151 . . . . 1.93 110.003 -179.554 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.629 ' N ' ' HG ' ' A' ' 191' ' ' SER . 82.5 mt -60.03 -39.91 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.115 -0.991 . . . . 2.2 108.935 179.985 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 90.7 mtp -60.04 -43.01 95.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.429 -0.795 . . . . 1.32 110.33 -179.038 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.39 -44.25 88.88 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.583 -1.323 . . . . 1.3 109.36 -179.341 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -62.55 -58.64 6.84 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.107 -1.037 . . . . 3.38 109.925 -179.606 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.6 m -61.96 -39.97 93.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.122 -0.986 . . . . 1.15 112.022 -178.548 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.0 mt -74.91 -20.53 59.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.753 -1.217 . . . . 1.28 110.338 -178.697 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 68.81 52.21 0.55 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.678 -0.639 . . . . 1.5 110.456 -179.762 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . 0.416 ' O ' ' OG ' ' A' ' 8' ' ' SER . 79.5 mt -129.68 149.93 74.33 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 108.072 -1.084 . . . . 1.37 108.072 178.794 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.52 143.55 63.38 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.063 1.842 . . . . 0.76 112.088 -179.654 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -172.63 150.74 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.083 -1.01 . . . . 1.19 111.286 -179.897 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.8 mt -121.51 146.68 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 107.664 -1.236 . . . . 1.31 107.664 178.432 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.8 m -128.35 -12.39 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 O-C-N 120.878 -1.139 . . . . 1.38 110.528 -179.051 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.05 25.25 16.79 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 110.824 -0.91 . . . . 1.03 110.824 -179.233 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.8 p -46.28 -40.62 11.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.913 -1.345 . . . . 1.38 109.803 -179.459 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.29 -51.42 3.39 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 120.127 -1.035 . . . . 1.17 110.85 179.385 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.6 m -161.94 34.97 0.12 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.621 -1.517 . . . . 2.07 111.204 -179.471 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.12 -40.15 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.923 -1.111 . . . . 1.35 108.621 177.999 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.2 p -56.23 -34.08 65.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.699 -0.625 . . . . 1.49 110.004 -179.088 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 39.8 t -86.5 -12.97 47.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.069 -1.019 . . . . 2.16 110.467 -179.169 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -94.0 -12.93 27.62 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.889 -1.132 . . . . 2.89 110.837 -179.538 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 44.6 t -123.75 165.1 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 O-C-N 121.185 -0.947 . . . . 1.33 110.267 -179.483 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.513 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 18.4 mmmt -118.14 156.45 28.67 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.558 -0.904 . . . . 2.73 108.558 -179.363 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 5.5 p30 -60.99 140.36 57.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 2.7 110.711 -179.474 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 6.5 t0 86.48 2.47 0.52 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.108 0.48 . . . . 2.38 110.204 179.102 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 89.9 m-20 -77.71 159.19 29.27 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.15 -0.969 . . . . 2.09 108.581 178.877 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -97.27 120.31 37.4 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.215 -0.928 . . . . 1.45 109.288 -179.351 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 88.8 mt -126.08 140.88 52.23 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.361 -0.837 . . . . 1.31 110.342 -179.812 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.7 mt -113.47 129.88 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.053 -1.462 . . . . 1.29 107.053 176.967 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 24.6 tp -103.12 120.13 40.12 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.215 -0.928 . . . . 1.31 109.255 -179.106 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.645 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 30.4 p-10 -80.77 -39.64 26.49 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.056 -1.027 . . . . 2.31 108.5 179.055 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.523 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 46.79 17.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.851 -0.796 . . . . 1.19 108.851 -179.003 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.5 t -130.25 -40.73 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.235 -1.394 . . . . 1.45 107.235 178.593 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -103.68 -0.69 29.18 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.139 -1.43 . . . . 3.13 107.139 177.905 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.539 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 47.7 t-20 60.03 48.74 8.28 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.354 0.597 . . . . 2.2 110.231 179.812 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.645 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 96.5 mt-30 -140.03 153.04 46.7 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.403 -0.81 . . . . 2.32 109.401 179.577 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 66.5 t -119.55 129.94 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.942 -0.762 . . . . 1.4 108.942 179.494 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -103.76 124.87 49.68 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.541 -0.911 . . . . 1.29 108.541 179.247 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 40.6 t -100.74 108.05 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.456 -0.777 . . . . 1.38 110.347 -178.978 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 49.39 66.71 5.3 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.199 -0.938 . . . . 2.33 110.367 179.012 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -85.57 156.23 10.56 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.875 2.383 . . . . 0.95 111.716 179.469 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 42.3 p -72.89 162.6 29.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.207 -0.933 . . . . 2.31 109.673 -179.558 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -59.86 -39.68 86.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.444 -0.785 . . . . 3.45 110.228 -179.537 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -58.03 -39.37 78.2 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.234 -0.916 . . . . 2.89 109.461 -179.037 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 77.1 t -68.96 -41.65 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.019 -1.051 . . . . 1.73 109.369 179.653 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.51 -39.96 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.145 -0.972 . . . . 1.57 109.881 -179.889 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.03 -39.98 87.76 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.796 -1.19 . . . . 2.43 108.706 179.813 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -65.05 -41.63 95.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.316 -0.865 . . . . 3.18 108.923 179.132 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 96.9 mtp -69.96 -34.31 73.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.495 -0.753 . . . . 1.59 109.527 179.891 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -66.56 -40.07 88.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.329 -0.857 . . . . 3.11 109.664 179.689 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.66 -44.07 96.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.141 -0.975 . . . . 2.17 109.532 179.949 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 88.0 t -60.14 -40.59 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.298 -0.876 . . . . 2.51 109.249 -179.982 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -59.97 -40.06 87.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 3.82 109.337 179.916 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.05 -40.02 87.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.924 . . . . 1.78 109.869 -179.65 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -68.77 -40.02 79.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.094 -1.004 . . . . 2.77 109.478 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 74.5 t -62.32 -40.52 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.327 -0.858 . . . . 2.25 109.26 -179.968 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.03 95.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 2.54 109.62 -179.915 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.0 t -60.32 -39.94 88.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 3.03 109.84 -179.802 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -60.31 -39.97 88.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.335 -0.853 . . . . 3.34 110.3 -179.679 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -97.94 24.97 6.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.236 -0.915 . . . . 4.18 109.872 -178.956 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -101.51 -27.21 13.24 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.252 -0.905 . . . . 4.43 109.904 -179.571 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -84.22 -95.18 0.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.027 -1.046 . . . . 5.42 109.842 -179.631 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 88.5 mt -79.96 -70.11 0.54 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 6.11 109.716 -179.142 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 175.15 -45.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.008 -1.057 . . . . 7.37 109.82 179.85 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -171.42 -154.2 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.111 -0.993 . . . . 8.3 109.969 -179.587 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.89 -40.03 87.38 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.189 -0.944 . . . . 9.05 109.234 -179.429 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -55.58 129.32 38.53 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.958 -1.089 . . . . 10.56 109.233 179.873 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -131.71 31.91 4.19 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.498 -0.751 . . . . 11.32 109.045 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.994 -1.003 . . . . 12.74 109.302 -179.964 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' B' B ' 301' ' ' MET . . . . . 0.426 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 40.7 ttp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.613 0.72 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . 0.426 ' N ' ' CG ' ' B' ' 301' ' ' MET . 15.7 t80 -149.81 146.57 27.22 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.451 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . 0.473 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 0.2 OUTLIER -150.25 159.98 44.04 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.882 -1.136 . . . . 0.0 110.551 -179.312 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -157.78 154.71 28.56 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.021 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -115.14 133.33 56.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.258 -0.901 . . . . 0.0 109.951 179.6 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 4.2 p -128.95 124.55 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-O 122.279 1.037 . . . . 0.0 112.364 -176.881 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 91.6 m -77.81 102.49 7.23 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.825 0.821 . . . . 0.0 110.898 -178.245 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . 0.418 ' O ' ' N ' ' B' ' 358' ' ' GLY . 97.4 mt -52.92 123.28 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 122.403 1.097 . . . . 0.0 110.813 -178.201 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 77.6 p -109.99 20.02 18.4 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.768 -178.368 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -83.13 115.47 59.13 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.1 -1.0 . . . . 0.0 109.854 179.894 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -54.03 -7.2 0.61 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 CA-C-N 120.174 1.098 . . . . 0.0 112.973 179.809 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -117.42 3.53 12.5 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.301 -0.874 . . . . 0.0 109.451 -179.987 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 68.09 -178.9 20.33 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -178.764 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.476 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -83.0 83.29 7.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.686 -1.479 . . . . 0.0 109.593 -178.444 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . 0.429 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 2.6 p80 -91.89 -160.02 0.7 Allowed 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.132 -0.98 . . . . 0.0 109.769 178.403 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.2 m -56.76 -47.7 79.5 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.806 -1.184 . . . . 0.0 112.984 -175.852 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.599 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 11.3 tpt180 -56.35 -59.72 11.19 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 120.388 -1.445 . . . . 0.0 111.919 -179.23 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . 0.429 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 12.0 Cg_endo -58.83 -34.63 99.13 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 CA-C-N 120.369 1.168 . . . . 0.0 111.521 -179.525 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.68 72.8 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.986 179.914 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.78 -44.09 77.41 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.48 -179.078 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -70.01 -41.67 74.03 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.964 -1.095 . . . . 0.0 108.528 179.347 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -63.04 -53.96 45.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.448 -0.783 . . . . 0.0 110.346 -179.733 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 84.2 t -61.77 -28.23 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.528 -1.357 . . . . 0.0 109.768 -179.006 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -64.56 -42.56 95.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.063 -1.023 . . . . 0.0 109.48 -179.92 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -69.77 -42.04 74.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.321 -0.862 . . . . 0.0 111.429 -178.509 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . 0.453 ' C ' ' H ' ' B' ' 328' ' ' GLY . . . -61.65 -54.66 39.74 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.498 -1.376 . . . . 0.0 111.244 -178.591 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -54.15 -10.21 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.894 -1.129 . . . . 0.0 109.633 -179.672 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . 0.453 ' H ' ' C ' ' B' ' 326' ' ' ALA . . . -71.96 -28.8 67.99 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.249 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -104.59 144.08 32.18 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.335 -1.097 . . . . 0.0 109.458 -179.661 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 91.5 m -90.56 -11.46 40.0 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.137 -0.977 . . . . 0.0 109.742 179.877 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 331' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 58.9 m -65.58 153.73 40.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.998 . . . . 0.0 109.45 179.999 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.44 134.98 49.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.078 -1.014 . . . . 0.0 109.164 -179.74 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.1 mt -131.89 132.81 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.519 -0.738 . . . . 0.0 109.453 -179.718 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 24.6 m -129.12 149.89 50.74 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.462 -0.774 . . . . 0.0 109.618 -179.814 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 90.8 t -123.66 115.4 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.404 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 94.0 m -113.73 122.8 48.21 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.09 -1.007 . . . . 0.0 110.928 -177.903 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 337' ' ' SER . . . . . 0.487 ' C ' ' H ' ' B' ' 339' ' ' GLY . 16.8 t -121.98 127.84 50.79 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.414 0.626 . . . . 0.0 109.312 178.873 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 35.6 m120 57.77 6.37 0.44 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.601 0.715 . . . . 0.0 109.481 -178.777 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . 0.487 ' H ' ' C ' ' B' ' 337' ' ' SER . . . 101.19 13.16 34.23 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.23 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -104.57 121.15 42.91 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.616 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 58.2 p -100.16 151.54 21.31 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.259 1.028 . . . . 0.0 112.54 -177.026 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -149.76 148.72 29.56 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.35 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 1.8 t -89.27 130.01 35.74 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.991 -1.068 . . . . 0.0 110.777 -178.725 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.542 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -70.16 -19.91 63.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.267 -0.896 . . . . 0.0 110.311 -179.663 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -84.19 21.71 1.34 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.8 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.542 ' H ' ' C ' ' B' ' 344' ' ' ALA . 14.6 p -152.08 98.14 2.4 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.877 0.846 . . . . 0.0 111.21 179.583 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 45.9 tp -59.69 -32.74 70.78 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.832 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -52.93 -51.88 59.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.329 -0.857 . . . . 0.0 111.386 -179.625 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.531 ' NZ ' ' OG ' ' B' ' 346' ' ' SER . 33.6 mtmm -70.01 -40.0 75.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.727 -1.233 . . . . 0.0 111.108 -178.324 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' B' ' 352' ' ' THR . 88.7 mt -49.08 -57.09 7.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.798 -1.189 . . . . 0.0 109.931 -178.832 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.709 ' NE2' ' HE ' ' A' ' 126' ' ' ARG . 4.0 mm100 -44.86 -10.84 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.053 -1.029 . . . . 0.0 111.15 -177.697 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.565 ' N ' ' O ' ' B' ' 350' ' ' LEU . 72.5 p -87.24 -13.34 44.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 119.895 -1.753 . . . . 0.0 110.258 -178.978 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 53.0 mt -94.77 122.41 37.36 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.931 -1.106 . . . . 0.0 109.499 179.001 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.1 92.14 1.04 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 179.368 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 25.8 mt -101.83 95.37 6.36 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.424 -1.045 . . . . 0.0 109.176 179.817 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 75.0 p -93.64 -179.74 5.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.222 -0.924 . . . . 0.0 111.048 -178.954 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -69.27 114.16 7.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.711 -0.618 . . . . 0.0 110.51 -179.508 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 99.99 10.17 46.73 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.759 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 53.2 m -87.18 111.39 20.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -1.094 . . . . 0.0 110.195 -179.822 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 68.0 t -77.08 114.61 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.024 0.916 . . . . 0.0 109.61 -177.384 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 11.8 m -108.26 176.7 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -178.936 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 43.3 m -131.61 126.62 35.19 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.597 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.3 mt -103.49 117.79 49.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.398 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 64.8 m -118.72 130.82 56.03 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.108 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.41 150.8 39.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.267 -178.995 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -145.49 124.36 12.7 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.268 -0.895 . . . . 0.0 109.059 179.579 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.537 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.6 -154.49 25.57 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.403 -1.38 . . . . 0.0 111.072 -179.602 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -59.98 -50.63 73.01 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.468 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.419 ' N ' ' OG ' ' B' ' 331' ' ' SER . 85.1 m-20 -110.03 11.03 24.06 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.838 -1.163 . . . . 0.0 111.192 -177.193 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -40.84 -36.21 0.6 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.334 -0.853 . . . . 0.0 111.79 -178.992 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -69.13 -41.32 77.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.65 -1.281 . . . . 0.0 110.007 -178.526 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -72.97 -54.93 7.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.001 -1.062 . . . . 0.0 110.062 179.763 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -42.33 -34.33 0.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.545 -0.722 . . . . 0.0 111.238 -178.766 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . 0.432 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 93.3 t -80.0 -35.47 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.758 -1.214 . . . . 0.0 109.55 179.289 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -69.95 -39.99 75.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 112.303 -179.112 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -80.08 -46.61 16.21 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.383 -1.448 . . . . 0.0 110.432 -179.465 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . 0.401 ' O ' ' N ' ' B' ' 381' ' ' MET . 87.9 mt -60.0 -38.03 81.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.889 . . . . 0.0 108.995 -179.637 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . 0.432 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 26.9 t -61.5 -48.22 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.277 -0.889 . . . . 0.0 109.718 179.381 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.02 -56.51 6.77 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.625 -1.297 . . . . 0.0 107.613 178.785 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . 0.449 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 46.6 tp -52.51 -32.19 39.12 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.364 -0.835 . . . . 0.0 109.201 -179.176 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 381' ' ' MET . . . . . 0.401 ' N ' ' O ' ' B' ' 377' ' ' LEU . 34.3 ttm -76.07 -39.63 54.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 0.0 108.63 177.74 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.12 -5.06 50.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.58 -0.7 . . . . 0.0 109.873 179.614 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -108.26 3.74 23.89 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.29 -0.881 . . . . 0.0 110.499 -179.364 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . 0.449 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 27.6 mt -74.84 125.4 28.73 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.453 -1.404 . . . . 0.0 109.543 179.708 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.323 179.715 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtt . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.449 -0.575 . . . . 3.19 109.449 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.1 mt -109.9 129.23 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.504 -0.748 . . . . 1.71 109.201 179.808 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.6 m -140.64 122.33 15.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.306 -0.871 . . . . 1.66 109.607 -179.903 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.44 -161.47 31.4 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 108.962 -1.655 . . . . 1.05 108.962 179.319 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.433 ' O ' ' O ' ' A' ' 6' ' ' LEU . 97.3 mt -90.22 -9.96 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.114 -1.227 . . . . 1.59 110.42 -179.028 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.6 tp 52.55 99.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.974 -1.079 . . . . 1.47 109.441 179.884 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.27 -27.31 15.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.118 -0.989 . . . . 1.39 109.535 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.0 t -136.4 121.14 12.91 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.385 -0.822 . . . . 2.09 109.22 179.944 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.08 144.77 24.02 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.788 1.659 . . . . 0.91 111.989 -179.949 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 159.72 -159.88 30.99 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.117 -1.593 . . . . 0.92 109.117 -179.576 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.434 HD11 HG21 ' A' ' 11' ' ' ILE . 86.8 mt -149.94 151.64 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 121.248 -1.148 . . . . 1.35 108.587 179.041 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.78 156.49 34.87 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.735 -1.228 . . . . 1.14 110.561 179.261 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -138.27 128.4 25.74 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.375 -1.343 . . . . 0.7 107.375 178.752 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.85 -179.84 47.61 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 118.666 -1.73 . . . . 0.58 110.823 -179.819 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -80.07 159.38 26.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.757 -0.849 . . . . 2.63 109.35 -179.832 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -107.09 131.51 54.02 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.408 -0.807 . . . . 1.27 111.011 -179.076 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.7 tp -98.7 139.54 34.25 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.245 -1.391 . . . . 1.41 107.245 178.161 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 34.2 tp -117.06 121.32 40.98 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.288 -0.883 . . . . 1.49 110.305 -178.971 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.4 mt -96.41 107.74 20.17 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.384 0.611 . . . . 1.52 110.036 179.905 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.601 ' H ' ' HZ3' ' A' ' 20' ' ' LYS . 1.5 mtmp? -101.87 139.61 37.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.462 -0.774 . . . . 3.17 109.044 179.493 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -128.27 121.75 30.04 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.407 -0.808 . . . . 3.0 108.829 179.419 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 59.3 t0 -75.79 146.53 39.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.084 -1.01 . . . . 2.77 109.598 179.859 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.5 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 84.9 tt0 -61.63 140.19 58.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.406 -0.809 . . . . 2.94 109.823 -179.793 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.4 mt -78.89 132.93 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 1.46 108.872 179.954 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -94.81 122.33 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.022 -1.049 . . . . 1.7 109.961 -179.389 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.05 138.54 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.083 -0.71 . . . . 1.54 109.083 179.979 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -89.43 123.47 33.6 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.059 -1.026 . . . . 1.81 110.255 -179.347 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.507 HH11 ' HG2' ' A' ' 28' ' ' ARG . 0.8 OUTLIER -93.96 3.81 54.82 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.379 -0.826 . . . . 3.23 109.651 -179.962 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -72.92 151.34 41.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.272 -0.892 . . . . 3.29 111.17 -178.753 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -93.24 145.61 24.31 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.581 -0.896 . . . . 2.8 108.581 179.092 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -98.46 167.02 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.071 -1.018 . . . . 1.43 110.297 -179.907 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.2 p -93.74 171.79 8.66 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.492 -0.929 . . . . 1.54 108.492 178.658 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.07 -47.21 86.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.044 -1.035 . . . . 1.6 109.45 -179.915 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -55.86 -31.9 63.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.951 -1.093 . . . . 2.56 109.834 -179.26 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -81.5 -10.23 59.52 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.347 -0.845 . . . . 2.36 110.608 -179.091 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.4 t -60.09 -49.98 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.977 -1.077 . . . . 1.43 109.132 -179.96 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.96 -40.02 91.76 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.341 -0.85 . . . . 1.77 109.614 179.799 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.58 -46.0 87.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.245 -0.909 . . . . 3.32 111.551 -178.837 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -61.39 -42.53 98.88 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.599 -1.313 . . . . 1.51 110.457 -179.085 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.04 -46.58 94.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.55 -1.344 . . . . 1.41 108.184 179.92 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -61.6 -43.9 98.0 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.257 -0.902 . . . . 1.81 109.786 179.34 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -59.99 -41.15 91.43 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.745 -1.222 . . . . 3.26 107.764 179.557 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -63.3 -44.61 94.52 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.708 -0.849 . . . . 0.81 108.708 178.246 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.08 -47.84 84.19 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.57 -0.706 . . . . 1.59 109.222 179.971 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.1 t -63.96 -44.98 91.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.065 -1.022 . . . . 1.38 108.908 179.362 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.56 -39.95 98.04 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.763 -2.135 . . . . 0.87 107.763 178.554 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 68.5 ttt180 -67.16 -35.81 80.47 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.572 -0.899 . . . . 3.62 108.572 178.63 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.97 87.62 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.554 -0.716 . . . . 1.43 109.621 -179.611 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.9 ttpt -64.91 -73.77 0.12 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.883 -1.136 . . . . 3.08 108.372 179.491 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.67 -38.57 0.28 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.38 -0.825 . . . . 1.33 111.203 -178.165 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.1 m -54.04 -56.85 14.1 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.718 -1.239 . . . . 1.85 108.939 179.732 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.92 88.3 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.22 -0.925 . . . . 1.35 111.123 -179.163 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -68.46 -40.07 81.17 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.956 -1.09 . . . . 2.34 109.978 -179.2 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.6 mt -65.54 -40.01 92.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.077 -1.014 . . . . 2.2 109.975 179.897 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.539 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 69.3 mm-40 -61.53 -39.96 92.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.084 -1.01 . . . . 1.35 109.869 -179.815 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -62.84 -40.03 96.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.021 -1.049 . . . . 1.34 109.967 -179.931 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.05 -39.85 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.179 -0.95 . . . . 1.26 108.911 179.669 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.539 ' NZ ' ' OE1' ' A' ' 55' ' ' GLU . 5.2 ttpm? -55.92 -49.98 71.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.92 . . . . 1.7 109.081 179.74 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -57.51 -33.54 68.15 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.374 -0.829 . . . . 1.35 110.512 -178.318 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -69.97 -38.86 76.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.897 -1.127 . . . . 2.08 110.005 179.965 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -67.23 -45.51 76.54 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.401 -0.812 . . . . 1.21 110.487 -179.241 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.66 -50.03 72.15 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.917 -1.135 . . . . 0.75 110.45 -178.68 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.95 -42.88 72.62 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.076 -1.25 . . . . 1.59 110.325 -179.563 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.9 m -70.13 -61.37 1.8 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.206 -0.934 . . . . 1.41 112.744 -177.678 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -93.3 -49.36 5.99 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.679 -1.263 . . . . 0.79 110.711 -178.437 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.76 -167.89 25.77 Favored Glycine 0 N--CA 1.5 2.918 0 C-N-CA 119.936 -1.125 . . . . 1.22 110.849 179.65 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -68.55 -22.12 64.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.805 -0.821 . . . . 5.81 109.859 -179.889 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -60.04 -36.22 76.82 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.654 -0.653 . . . . 3.37 110.371 -179.531 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -101.19 -15.43 17.35 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.352 -0.843 . . . . 2.37 110.322 -179.449 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -69.97 -40.2 75.51 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.933 -1.104 . . . . 1.65 110.585 -179.311 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.8 -28.65 65.91 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.611 -0.836 . . . . 1.42 109.91 -178.564 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.7 mt -60.06 -41.92 88.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.022 -1.071 . . . . 1.43 109.143 -179.903 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -65.88 -40.01 91.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.954 -1.091 . . . . 1.08 109.921 179.99 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -60.15 -40.41 89.77 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.9 -1.125 . . . . 1.37 109.254 179.834 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.86 -41.48 98.76 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.064 -2.014 . . . . 0.67 108.064 178.9 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.3 m170 -70.09 -43.69 70.56 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.618 -0.931 . . . . 1.99 108.595 179.169 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.9 mt -70.04 -46.63 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.367 -0.833 . . . . 1.22 109.369 179.433 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.5 ttp -60.68 -44.8 96.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.057 -1.027 . . . . 2.11 109.687 -179.61 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.411 ' CD1' ' CE2' ' B' ' 348' ' ' PHE . 50.8 tp -60.0 -40.06 87.91 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.802 -0.814 . . . . 1.33 108.802 179.142 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.7 tp -62.94 -39.95 96.16 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.671 -0.643 . . . . 1.29 109.537 179.614 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -79.44 5.2 13.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -0.861 . . . . 1.47 110.127 -179.14 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -56.08 128.99 38.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 1.47 110.291 -179.309 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -63.04 -14.08 43.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.591 -0.693 . . . . 1.78 110.059 -179.985 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -70.08 -37.08 75.37 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.231 -1.025 . . . . 2.53 108.231 178.505 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.03 -39.98 75.46 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.658 0.742 . . . . 1.36 109.757 179.407 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -60.05 -45.48 92.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.59 -0.694 . . . . 1.42 110.895 -178.417 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -70.78 -48.55 53.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.257 -0.902 . . . . 2.27 111.667 -178.584 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -64.16 -39.9 95.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.352 -0.842 . . . . 1.57 111.734 -177.409 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -66.27 -47.77 83.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 120.838 -1.164 . . . . 1.19 109.857 -179.541 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.413 HD12 HG23 ' A' ' 90' ' ' ILE . 96.9 mt -70.01 -39.04 76.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.415 -0.803 . . . . 1.39 110.671 -179.674 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.97 -48.86 79.95 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.173 -0.954 . . . . 1.39 111.045 -178.917 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 96' ' ' LYS . 75.7 mt -60.01 -44.9 94.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.917 -1.115 . . . . 1.5 109.501 -178.955 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.8 mt -60.23 -50.0 81.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.76 -1.2 . . . . 1.29 107.76 178.86 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -65.07 -40.05 94.14 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 120.024 -0.67 . . . . 2.64 110.243 179.359 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 91' ' ' ALA . 56.7 t0 -84.26 -55.11 4.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.995 -1.066 . . . . 1.65 112.277 -178.241 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 92' ' ' LEU . 99.0 mttt -90.04 -1.98 58.05 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.812 -1.18 . . . . 2.5 112.145 -177.348 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 57.85 37.54 26.99 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.846 -1.159 . . . . 1.88 109.379 -179.534 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.9 mtt -93.04 166.38 12.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.497 -0.752 . . . . 1.71 109.879 -179.758 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.4 p -79.95 160.0 26.11 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.034 -0.728 . . . . 1.61 109.034 179.678 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.05 77.59 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.321 -0.862 . . . . 1.33 109.755 -179.999 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -65.51 -40.03 92.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.084 -1.01 . . . . 2.07 109.521 179.665 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.6 -43.12 23.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 1.37 110.352 -179.684 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.05 -41.69 73.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 1.14 110.278 -179.442 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.95 -39.68 95.39 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.122 -0.986 . . . . 1.26 109.474 179.956 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.546 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 81.1 t60 -59.62 -40.07 86.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.551 -0.718 . . . . 2.02 109.578 -178.804 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.464 ' O ' ' N ' ' A' ' 110' ' ' GLY . 87.2 tt0 -64.61 -40.02 94.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.305 -0.872 . . . . 1.33 110.55 -179.655 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.3 t -63.86 -60.61 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.148 -0.97 . . . . 1.3 111.478 -178.308 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.0 mm -65.06 -39.96 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.855 -1.153 . . . . 1.32 109.268 -179.459 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.546 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 85.3 tt0 -67.04 -39.98 87.08 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.076 -1.083 . . . . 2.44 108.076 178.275 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -56.82 -52.14 52.67 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.23 -1.148 . . . . 0.99 110.23 -179.27 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 22.9 mm100 -65.07 -48.14 74.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.785 -1.421 . . . . 1.97 109.197 -179.848 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.08 85.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 1.43 109.03 179.676 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.5 m -59.57 -39.87 85.5 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.468 -0.77 . . . . 2.12 109.018 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.44 -40.03 92.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 1.64 109.015 179.02 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.2 mt -64.2 -41.87 96.88 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.273 -0.892 . . . . 1.93 109.784 -179.247 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.02 -33.78 72.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.822 -1.174 . . . . 2.2 109.783 -179.272 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -56.92 -20.52 23.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.108 -0.995 . . . . 2.12 108.927 179.949 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.0 mt -62.63 138.66 58.54 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.188 -1.041 . . . . 2.34 108.188 179.469 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 57.9 t0 -94.69 54.97 1.84 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.931 -1.105 . . . . 3.23 110.086 -179.611 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 58.9 t0 -136.1 136.7 40.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.345 -0.847 . . . . 2.49 108.938 179.23 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.461 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 98.9 mt-10 -70.02 -31.61 69.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.42 -0.8 . . . . 3.95 109.964 -179.537 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.509 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.4 t80 -72.64 -38.86 67.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.871 . . . . 2.25 110.728 179.886 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 70.7 mt -74.12 -36.26 64.18 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.975 -1.078 . . . . 2.27 109.745 -179.369 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -60.04 -40.0 87.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.015 -1.053 . . . . 3.31 109.357 179.601 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -60.0 -47.31 86.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 2.73 109.482 179.957 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.527 HH21 ' NE2' ' B' ' 351' ' ' GLN . 62.0 mtp180 -60.18 -39.98 88.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.963 . . . . 3.2 108.663 179.201 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.53 -36.12 77.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.82 . . . . 1.66 108.846 178.972 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.89 -40.02 96.26 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.081 -0.711 . . . . 1.67 109.081 179.684 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -64.22 -40.93 97.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 1.55 110.111 -179.352 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.55 -41.88 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 1.32 109.616 -179.889 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -60.01 -38.1 81.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.141 -0.974 . . . . 3.58 109.4 179.48 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -59.92 -40.88 90.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 1.46 110.361 -178.948 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.19 -45.01 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.894 -1.129 . . . . 1.22 109.581 179.815 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.97 -37.91 93.64 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.713 -1.355 . . . . 0.61 109.713 179.995 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -60.03 -47.6 85.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -1.111 . . . . 3.1 109.56 -179.378 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 61.0 mtp180 -68.76 -33.16 73.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.238 -0.914 . . . . 3.71 109.637 -179.772 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.7 tp -57.28 -43.7 83.37 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.355 -0.841 . . . . 1.87 108.995 -179.788 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.66 -39.96 95.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.13 -0.982 . . . . 1.29 108.654 179.145 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.6 mtp180 -66.89 -39.97 87.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.912 -0.773 . . . . 3.05 108.912 179.465 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -69.44 -31.7 70.18 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.554 -0.716 . . . . 1.26 110.941 -179.31 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.0 mt -70.04 -43.29 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.401 -1.437 . . . . 1.34 108.193 178.728 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 88.9 mt -71.56 -29.99 65.36 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.792 -0.568 . . . . 1.6 109.901 -179.708 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.69 40.33 8.31 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.983 -1.647 . . . . 0.96 108.983 -179.28 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 18.5 tp -73.99 146.36 43.88 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.386 -1.067 . . . . 1.67 109.14 -179.479 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -65.08 147.92 52.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -0.894 . . . . 4.96 110.002 -178.892 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 98.6 mt -118.89 125.63 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 122.093 0.949 . . . . 1.68 109.325 179.49 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 148' ' ' ASP . 5.5 mt -62.38 -43.58 98.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.87 -0.605 . . . . 2.14 110.219 -178.859 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 147' ' ' ILE . 32.2 t0 62.01 125.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.968 -0.753 . . . . 1.5 108.968 -179.126 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.4 mt -87.08 -2.09 58.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.256 -0.903 . . . . 1.39 109.639 -179.274 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 93.8 p -82.26 -9.96 59.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.916 -1.115 . . . . 1.83 108.752 178.951 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -88.71 18.54 4.61 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.666 . . . . 1.46 110.925 -177.818 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 65.2 mt -91.74 116.92 33.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.871 -1.143 . . . . 1.42 109.15 179.621 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -103.03 -12.03 17.72 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.251 -0.905 . . . . 2.94 110.206 -179.268 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -116.01 145.72 42.74 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.318 -0.864 . . . . 1.52 110.347 -178.805 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.81 131.97 50.63 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.496 -0.928 . . . . 1.58 108.496 179.584 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.7 m -152.57 165.23 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 1.32 109.954 -179.947 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.5 mt -93.31 148.8 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 105.215 -2.142 . . . . 1.27 105.215 176.776 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 39.9 tp -99.35 120.01 38.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.838 -1.164 . . . . 1.41 110.609 -177.836 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 49.6 t -123.59 130.08 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 108.752 -0.833 . . . . 1.23 108.752 179.343 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -156.72 162.69 39.78 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.4 -0.963 . . . . 1.32 108.4 179.837 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.95 -35.83 74.8 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.185 -1.572 . . . . 1.49 107.315 178.547 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 20.8 p-10 -171.21 144.69 2.09 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.582 -0.895 . . . . 2.25 108.582 179.287 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.2 mt -111.78 139.83 46.93 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.253 -0.905 . . . . 1.35 109.863 -179.438 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.1 p -93.19 145.28 29.77 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.392 -0.818 . . . . 1.56 109.501 -179.929 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -39.36 -36.94 1.03 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.405 2.07 . . . . 0.87 113.273 179.458 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 68.5 m -60.01 -39.97 87.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.026 -1.046 . . . . 1.36 109.776 -178.661 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.03 -42.0 90.19 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.023 -1.048 . . . . 1.61 110.217 -179.506 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 67.8 p -54.96 -30.61 59.41 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.136 -0.977 . . . . 1.21 110.598 -178.4 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -71.36 -54.27 11.33 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.028 -1.045 . . . . 1.21 109.879 179.77 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -87.32 39.15 0.85 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.183 -1.043 . . . . 2.11 108.183 179.88 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 33.7 tp -100.22 130.62 46.37 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.622 -0.674 . . . . 1.29 109.307 179.472 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -82.12 98.5 8.71 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.185 -1.043 . . . . 2.81 108.185 179.307 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 73.6 mt -67.16 -40.52 86.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.378 -0.826 . . . . 2.09 110.872 -178.592 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.39 -30.32 71.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.651 -1.281 . . . . 2.86 112.094 -177.714 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.65 -5.86 50.57 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.712 -1.243 . . . . 2.39 110.061 -178.734 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 84.0 t -106.24 116.62 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.134 -0.979 . . . . 1.27 109.307 179.652 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 78.1 mt -88.04 9.96 20.71 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.475 -0.765 . . . . 2.17 110.997 -177.786 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 165.64 176.59 37.22 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.62 -1.392 . . . . 0.52 109.62 179.858 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -137.64 131.21 31.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.456 -1.026 . . . . 0.55 108.853 -179.82 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 97.4 mt -133.46 130.0 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.772 -0.825 . . . . 1.27 108.772 179.002 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 72.1 p -148.4 160.0 43.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.965 -1.084 . . . . 1.39 110.855 -179.82 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -109.03 31.18 5.9 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.192 -1.04 . . . . 2.46 108.192 178.966 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.35 -160.44 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.919 -1.113 . . . . 1.51 111.516 -177.605 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.4 -67.68 1.99 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.34 -1.104 . . . . 2.23 110.34 -179.092 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 178.39 -130.98 1.65 Allowed Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.974 -1.584 . . . . 2.23 110.981 -179.802 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -79.46 -10.01 59.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.634 -0.921 . . . . 6.44 111.025 -178.504 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 42.9 p -81.8 4.87 20.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.968 -1.083 . . . . 4.09 109.687 -179.253 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.48 ' HG ' ' H ' ' A' ' 191' ' ' SER . 23.4 p -90.43 137.54 32.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.134 -0.979 . . . . 2.2 110.593 -179.522 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -48.34 -47.86 36.7 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.475 -0.766 . . . . 1.15 109.673 179.977 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 98.5 m -57.4 -37.79 73.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.455 -0.778 . . . . 2.01 110.717 -178.992 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.48 ' H ' ' HG ' ' A' ' 188' ' ' SER . 52.8 m -60.03 -39.9 87.49 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.854 -1.154 . . . . 1.93 110.354 -178.97 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 45.1 mm -64.85 -40.05 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 2.2 110.128 -179.599 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.3 mtp -60.1 -46.87 88.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.091 -1.006 . . . . 1.32 110.701 -179.765 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.71 -45.58 77.86 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.537 -1.352 . . . . 1.3 109.378 -179.589 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -60.1 -54.98 39.57 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.0 -1.062 . . . . 3.38 109.468 179.67 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 69.3 m -63.09 -40.05 96.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 1.15 110.966 -179.3 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.16 -29.17 64.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.985 -1.072 . . . . 1.28 108.468 179.73 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.97 50.03 1.09 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.285 0.564 . . . . 1.5 110.277 -179.842 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 32.7 mt -124.95 145.97 51.89 Favored Pre-proline 0 N--CA 1.503 2.212 0 N-CA-C 108.497 -0.927 . . . . 1.37 108.497 178.91 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.27 125.29 7.04 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.094 1.862 . . . . 0.76 112.555 179.737 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.26 141.23 7.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.489 -1.382 . . . . 1.19 112.154 179.866 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.423 HD11 HG22 ' A' ' 202' ' ' ILE . 96.9 mt -124.84 147.14 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 107.173 -1.417 . . . . 1.31 107.173 177.811 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 17.3 m -130.78 -7.53 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 120.833 -1.167 . . . . 1.38 111.177 -178.991 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.99 23.05 24.37 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.454 -1.058 . . . . 1.03 110.454 -179.497 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.436 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 2.4 p -45.38 -44.18 11.67 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.93 -1.335 . . . . 1.38 109.88 -179.602 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 93.5 -51.65 2.38 Favored Glycine 0 N--CA 1.5 2.93 0 C-N-CA 120.129 -1.034 . . . . 1.17 111.742 178.692 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.3 t -161.9 36.23 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.577 -1.543 . . . . 2.07 110.676 -179.354 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 52.6 t -74.32 -40.83 50.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.215 -0.928 . . . . 1.35 108.934 178.409 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 209' ' ' THR . . . . . 0.436 ' HG1' ' N ' ' A' ' 210' ' ' SER . 1.5 p -53.1 -31.93 44.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.403 -0.811 . . . . 1.49 110.063 -179.147 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.436 ' N ' ' HG1' ' A' ' 209' ' ' THR . 39.8 t -71.11 -33.35 70.05 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.168 -0.957 . . . . 2.16 109.741 -179.741 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -89.46 -9.95 48.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 2.89 110.274 -178.995 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 69.6 t -101.52 132.85 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.254 -0.904 . . . . 1.33 110.463 -178.887 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -114.15 153.52 29.4 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.549 -1.278 . . . . 2.73 107.549 178.834 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 8.9 t-20 -58.8 138.7 57.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.946 -1.097 . . . . 2.7 110.345 -178.605 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 11.6 t0 83.78 5.28 0.76 Allowed 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.113 0.482 . . . . 2.38 109.998 179.699 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.4 t0 -75.72 140.86 42.68 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.071 -1.018 . . . . 2.09 108.862 179.146 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.498 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 51.3 t80 -93.29 117.06 29.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.146 -0.971 . . . . 1.45 108.41 179.155 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 57.4 mt -126.42 147.35 49.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.526 -0.734 . . . . 1.31 110.379 -178.929 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.8 mt -114.34 130.02 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 107.664 -1.236 . . . . 1.29 107.664 177.554 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 32.7 tp -100.17 118.18 35.96 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.938 -1.101 . . . . 1.31 109.571 -179.096 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.593 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 26.4 p-10 -77.64 -42.84 33.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.068 -1.02 . . . . 2.31 108.591 179.231 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . 0.493 ' N ' ' OD1' ' A' ' 221' ' ' ASP . . . 52.1 17.27 0.66 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.796 -1.187 . . . . 1.19 107.796 -178.905 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.436 ' N ' ' C ' ' A' ' 221' ' ' ASP . 45.6 t -130.86 -43.66 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.708 -1.219 . . . . 1.45 107.708 179.362 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -99.14 -0.52 41.5 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.805 -1.554 . . . . 3.13 106.805 177.942 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.521 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 40.4 t-20 60.06 46.72 10.43 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.423 -0.584 . . . . 2.2 109.423 -179.933 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.593 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 95.3 mt-30 -140.46 157.23 45.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.385 -0.822 . . . . 2.32 109.647 -179.945 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 69.5 t -119.96 130.58 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 109.085 -0.709 . . . . 1.4 109.085 179.437 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -99.33 122.74 42.89 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.576 -0.898 . . . . 1.29 108.576 179.001 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 59.4 t -105.61 120.0 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.568 -0.707 . . . . 1.38 109.445 -179.242 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 62.96 66.76 1.17 Allowed Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.372 -0.83 . . . . 2.33 109.53 -179.731 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -89.16 127.78 1.79 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 123.142 2.561 . . . . 0.95 112.517 -179.664 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 26.0 p -75.33 170.47 16.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 2.31 109.623 -179.753 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -60.03 -39.44 85.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 3.45 109.088 179.67 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.08 -39.97 87.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.409 -0.807 . . . . 2.89 109.634 -179.382 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.6 t -67.24 -41.7 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.062 -1.024 . . . . 1.73 109.152 179.96 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 87.7 mt -64.97 -40.19 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.193 -0.942 . . . . 1.57 109.921 -179.628 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -60.09 -46.02 90.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.872 -1.142 . . . . 2.43 108.276 179.745 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 8.3 ttpm? -61.03 -43.38 98.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.3 -0.875 . . . . 3.18 108.853 179.013 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 92.6 mtp -67.93 -34.68 77.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.404 -0.81 . . . . 1.59 109.864 -179.94 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -62.98 -40.03 96.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.076 -1.015 . . . . 3.11 109.535 179.463 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.77 -39.3 84.4 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.175 -0.953 . . . . 2.17 108.532 179.781 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 89.9 t -59.93 -39.43 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.456 -0.942 . . . . 2.51 108.456 179.201 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -60.0 -39.9 87.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.411 -0.806 . . . . 3.82 109.601 -179.947 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -60.04 -40.03 87.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.082 -1.012 . . . . 1.78 109.344 -179.911 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -68.89 -40.03 79.42 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.106 -0.996 . . . . 2.77 108.565 179.291 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 68.2 t -68.03 -39.51 81.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.858 -0.793 . . . . 2.25 108.858 179.333 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.33 -39.96 84.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.51 -0.744 . . . . 2.54 109.715 -179.364 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 29.0 t -60.0 -43.51 95.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.852 -1.155 . . . . 3.03 108.676 179.434 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -70.03 -40.01 75.44 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.461 -0.774 . . . . 3.34 109.021 179.551 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -66.77 -34.3 77.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.833 . . . . 4.18 108.83 179.615 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -64.18 -52.83 57.06 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.225 -0.922 . . . . 4.43 109.885 -179.844 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -69.98 -40.09 75.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.295 -0.878 . . . . 5.42 111.076 -179.283 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 5.4 mt 49.91 55.49 9.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.97 -1.081 . . . . 6.11 108.158 -179.002 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -160.72 47.16 0.22 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.377 -0.827 . . . . 7.37 109.309 179.92 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -141.66 163.57 32.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.256 -0.903 . . . . 8.3 109.016 -179.777 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 35.8 mt -44.22 110.62 0.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.542 -0.724 . . . . 9.05 109.87 -179.509 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -86.03 7.43 24.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.301 -0.875 . . . . 10.56 108.809 179.54 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -60.02 -40.07 88.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.685 -1.259 . . . . 11.32 109.951 -179.743 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? . . . . . 0 N--CA 1.491 1.604 0 O-C-N 120.828 -1.17 . . . . 12.74 109.354 -179.979 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 43.9 ttm . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.581 0.705 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -151.16 149.4 29.43 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.121 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -146.19 154.98 42.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.063 -1.023 . . . . 0.0 110.393 -179.226 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -150.36 146.72 26.89 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.598 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 56.8 mp0 -110.21 127.82 55.16 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.249 -0.907 . . . . 0.0 109.623 179.334 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.35 122.8 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 CA-C-O 122.295 1.045 . . . . 0.0 112.807 -176.849 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 58.8 m -77.95 101.52 6.9 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.997 0.903 . . . . 0.0 110.268 -178.987 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.9 mt -50.81 118.45 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 122.204 1.002 . . . . 0.0 109.923 -177.874 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 19.1 p -100.35 22.14 12.04 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.676 -178.776 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -86.82 114.24 57.16 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.97 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -68.82 -4.86 14.17 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 CA-C-N 120.227 1.117 . . . . 0.0 112.456 -179.283 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -108.76 4.81 24.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.518 -0.738 . . . . 0.0 109.101 179.741 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.6 169.77 8.65 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 -179.051 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.509 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -86.14 92.05 8.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.3 . . . . 0.0 108.846 -179.138 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -95.23 -159.94 0.75 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.085 -1.009 . . . . 0.0 109.98 179.029 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.3 m -58.92 -44.67 91.36 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.931 -1.106 . . . . 0.0 112.611 -175.995 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.615 ' NH2' ' NE2' ' B' ' 321' ' ' GLN . 1.6 tpt180 -59.88 -60.59 10.09 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 120.487 -1.383 . . . . 0.0 112.027 -178.257 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -59.94 -32.04 94.55 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 CA-C-N 120.362 1.165 . . . . 0.0 111.338 -179.974 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.28 70.32 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.431 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.78 -40.09 65.99 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.601 -179.079 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . 0.615 ' NE2' ' NH2' ' B' ' 317' ' ' ARG . 50.0 mt-30 -69.87 -41.0 75.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.985 -1.072 . . . . 0.0 108.662 179.061 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -60.05 -51.26 70.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.72 -0.612 . . . . 0.0 110.343 -179.223 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 71.1 t -69.68 -35.75 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.946 -1.096 . . . . 0.0 109.743 -179.134 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -50.05 -49.89 49.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.387 -0.821 . . . . 0.0 109.122 -179.792 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -60.07 -49.9 75.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.269 -0.895 . . . . 0.0 109.339 -179.387 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -63.14 -47.11 84.11 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.157 -0.964 . . . . 0.0 109.765 179.765 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -48.4 -26.64 2.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.531 -0.73 . . . . 0.0 109.678 -179.339 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -82.59 -15.74 72.7 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.655 -179.181 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -105.72 135.0 47.92 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.26 -1.141 . . . . 0.0 109.434 179.736 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 16.9 m -90.6 -13.36 34.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.977 -1.077 . . . . 0.0 109.246 179.651 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 331' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 52.0 p -55.05 148.77 13.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.228 -0.92 . . . . 0.0 108.848 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -68.35 128.72 37.61 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.002 -1.061 . . . . 0.0 108.567 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 95.3 mt -132.34 132.32 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.675 -0.641 . . . . 0.0 109.352 -179.809 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 27.1 m -130.63 152.36 50.08 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.449 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 46.0 t -114.73 140.16 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 178.521 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 94.2 m -130.13 122.69 28.72 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.196 -0.94 . . . . 0.0 108.646 179.604 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 2.8 t -140.53 118.14 11.59 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.936 0.875 . . . . 0.0 112.065 -178.906 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 50.05 50.5 18.42 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 175.806 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.95 -10.77 72.77 Favored Glycine 0 N--CA 1.502 3.089 0 O-C-N 119.802 -1.811 . . . . 0.0 113.85 176.11 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . 0.473 ' NZ ' ' OG1' ' B' ' 352' ' ' THR . 62.2 tttm -128.26 140.31 51.96 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 120.022 1.911 . . . . 0.0 109.514 -179.642 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.7 m -126.74 147.79 49.95 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.818 0.818 . . . . 0.0 111.377 -178.266 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.3 164.58 29.86 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.309 0.576 . . . . 0.0 109.694 179.98 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 27.3 m -88.63 138.01 31.8 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.319 -0.863 . . . . 0.0 110.03 -179.326 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.43 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -78.9 -12.0 60.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.896 -1.127 . . . . 0.0 109.86 -179.479 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -91.87 20.15 5.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 178.042 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.43 ' H ' ' C ' ' B' ' 344' ' ' ALA . 42.6 t -145.89 94.44 2.48 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.013 -179.699 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . 0.512 ' CD1' HE22 ' B' ' 351' ' ' GLN . 60.8 tp -59.88 -33.85 72.38 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.829 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . 0.411 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 58.9 m-85 -57.25 -53.68 55.38 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.32 -0.863 . . . . 0.0 110.76 -179.337 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.41 ' O ' ' OG1' ' B' ' 352' ' ' THR . 33.1 mtmm -70.01 -29.63 66.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.868 -1.145 . . . . 0.0 110.951 -177.989 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' B' ' 352' ' ' THR . 84.8 mt -60.06 -52.86 63.55 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.157 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.549 ' OE1' ' N ' ' B' ' 351' ' ' GLN . 0.7 OUTLIER -42.42 -21.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.436 -0.79 . . . . 0.0 110.674 -178.009 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.473 ' OG1' ' NZ ' ' B' ' 340' ' ' LYS . 68.1 p -81.74 -12.25 58.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.406 -1.434 . . . . 0.0 109.964 -179.112 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 31.4 mt -95.39 120.08 35.0 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.95 -1.094 . . . . 0.0 109.082 178.409 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -80.89 92.5 1.45 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.364 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 22.9 mt -98.42 93.07 5.98 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.111 -1.229 . . . . 0.0 108.139 178.695 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 53.6 p -95.17 -179.96 4.99 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.084 -1.01 . . . . 0.0 111.279 -178.249 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' B' ' 359' ' ' THR . 7.2 tt0 -46.86 154.65 0.31 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.175 0.988 . . . . 0.0 111.035 -179.546 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.98 26.88 0.05 OUTLIER Glycine 0 N--CA 1.497 2.743 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.157 177.754 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 359' ' ' THR . . . . . 0.447 ' N ' ' O ' ' B' ' 357' ' ' GLN . 23.8 m -84.61 111.27 19.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.798 -1.413 . . . . 0.0 109.744 179.922 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 12.6 t -78.16 113.06 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 122.297 1.046 . . . . 0.0 109.774 -177.587 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 16.0 m -110.09 178.51 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.173 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 25.5 m -131.48 127.13 36.71 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.176 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 60.4 mt -103.43 118.9 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.96 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 58.3 p -121.19 133.23 55.17 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.401 -0.812 . . . . 0.0 109.283 -179.459 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.79 148.25 35.31 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.048 -1.032 . . . . 0.0 110.527 -179.046 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -140.03 121.19 14.78 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.275 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.548 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.38 -163.52 33.99 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.048 -1.549 . . . . 0.0 111.53 -179.758 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -59.97 -52.76 64.0 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 122.162 -0.61 . . . . 0.0 111.998 -177.896 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.4 ' H ' ' HB3' ' B' ' 331' ' ' SER . 96.0 m-20 -105.2 10.1 33.86 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.974 -1.079 . . . . 0.0 111.128 -177.407 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.548 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -42.18 -36.2 1.14 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.222 -0.924 . . . . 0.0 111.392 -179.155 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -70.0 -40.04 75.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.921 -1.112 . . . . 0.0 109.899 -179.012 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -66.51 -48.41 69.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.021 -1.049 . . . . 0.0 109.394 -179.441 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.07 -75.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 110.686 -179.098 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 37.4 t -44.64 -38.26 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.235 -0.915 . . . . 0.0 110.881 -177.519 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.03 -51.37 64.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.576 -1.328 . . . . 0.0 110.887 -179.597 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -74.54 -40.67 61.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.88 -1.138 . . . . 0.0 109.976 -179.668 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.01 -39.79 87.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.897 . . . . 0.0 110.095 -179.502 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 55.4 t -62.18 -43.39 97.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.211 -0.931 . . . . 0.0 109.968 -179.867 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -68.56 -54.59 15.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.615 -1.303 . . . . 0.0 108.617 178.687 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 50.1 tp -58.56 -34.72 71.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.23 -0.919 . . . . 0.0 109.937 -178.126 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 32.0 ttm -70.59 -40.05 73.46 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.408 -1.317 . . . . 0.0 108.42 177.927 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.24 -7.17 59.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.456 -0.777 . . . . 0.0 110.716 179.57 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -110.84 -1.74 16.41 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.077 -1.015 . . . . 0.0 111.54 -178.804 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.7 mt -81.89 130.25 35.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.297 -1.502 . . . . 0.0 109.197 178.823 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.328 179.937 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtt . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.61 -0.515 . . . . 3.19 109.61 . . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.432 HG22 HD13 ' A' ' 2' ' ' ILE . 96.7 mt -101.39 127.74 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.297 -0.877 . . . . 1.71 109.491 -179.736 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.0 m -139.61 152.45 46.82 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.923 -0.769 . . . . 1.66 108.923 -179.929 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.89 -164.05 10.36 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 108.759 -1.736 . . . . 1.05 108.759 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.7 mt -88.57 -16.29 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.895 -1.356 . . . . 1.59 110.306 -179.133 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.1 tp 51.06 103.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.282 -0.886 . . . . 1.47 109.51 179.932 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.9 -25.38 14.63 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.06 -1.025 . . . . 1.39 109.523 179.604 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.5 m -134.83 121.19 14.69 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.511 -0.743 . . . . 2.09 109.432 -179.875 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -81.09 151.42 18.23 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.163 1.909 . . . . 0.91 112.81 179.947 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 142.35 177.82 17.77 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 109.248 -1.541 . . . . 0.92 109.248 179.597 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.6 mt -128.17 131.36 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 120.847 -1.384 . . . . 1.35 110.07 -179.555 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.4 155.98 49.35 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.252 -0.905 . . . . 1.14 109.888 -179.785 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.5 m-85 -129.44 129.63 44.9 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.655 -0.869 . . . . 0.7 108.655 179.879 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.79 171.7 44.29 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.979 -1.582 . . . . 0.58 110.583 179.841 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 157' ' ' ILE . 96.0 mttt -77.39 158.42 30.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.682 -0.893 . . . . 2.63 109.294 -179.895 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -101.89 129.63 48.18 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.385 -0.822 . . . . 1.27 111.775 -178.247 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.7 tp -100.17 132.26 45.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.179 -1.415 . . . . 1.41 107.179 177.928 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.0 tp -115.89 123.73 48.85 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.186 -0.946 . . . . 1.49 110.265 -179.218 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.2 mt -89.78 102.21 14.9 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.277 0.56 . . . . 1.52 110.541 -179.202 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -94.08 135.14 35.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.383 -0.823 . . . . 3.17 108.931 179.378 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -131.43 134.0 45.77 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.148 -0.97 . . . . 3.0 108.858 179.108 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -83.95 139.78 32.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 2.77 109.246 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.45 140.25 58.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.905 . . . . 2.94 109.42 -179.822 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.2 mt -82.83 133.69 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.878 . . . . 1.46 108.864 179.916 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.67 129.97 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.329 -0.857 . . . . 1.7 109.356 -179.666 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.0 mt -102.22 141.39 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.487 -0.758 . . . . 1.54 109.383 -179.84 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -96.13 120.48 36.49 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.153 -0.967 . . . . 1.81 109.721 -179.655 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.466 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.5 mmt-85 -87.48 -0.67 57.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.523 -0.735 . . . . 3.23 109.712 -179.627 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -67.9 136.55 54.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 3.29 109.235 179.991 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -81.3 150.73 28.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.105 -0.997 . . . . 2.8 109.117 179.718 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 pt -93.15 166.67 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.191 -0.943 . . . . 1.43 109.798 -179.933 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.9 p -96.75 171.67 8.38 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.499 -0.926 . . . . 1.54 108.499 178.705 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -48.81 80.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.121 -0.987 . . . . 1.6 109.868 -179.492 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 4.8 p-10 -57.14 -26.07 59.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.738 -1.226 . . . . 2.56 109.437 -179.639 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -82.76 -10.09 59.05 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.262 -0.899 . . . . 2.36 109.826 179.833 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -64.06 -52.48 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.964 -1.085 . . . . 1.43 109.368 -179.731 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.24 -40.05 94.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.335 -0.853 . . . . 1.77 109.478 179.817 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -67.66 -42.79 81.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.161 -0.962 . . . . 3.32 110.98 -178.926 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.485 ' OE2' ' NH1' ' A' ' 42' ' ' ARG . 72.6 mm-40 -66.67 -40.02 88.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.747 -1.221 . . . . 1.51 110.182 -179.504 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -59.97 -45.49 95.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 120.739 -1.226 . . . . 1.41 108.025 178.938 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -60.03 -39.95 87.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.35 -0.844 . . . . 1.81 109.319 179.649 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.485 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 99.0 mtt180 -60.02 -43.99 94.88 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.782 -1.192 . . . . 3.26 107.782 178.838 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -60.84 -47.06 88.08 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.743 -0.836 . . . . 0.81 108.743 178.076 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.3 tp -60.01 -48.71 80.57 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.516 -0.92 . . . . 1.59 108.516 -179.857 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.6 t -61.4 -42.28 98.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 1.38 108.86 179.255 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.39 -46.5 94.26 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.735 -1.746 . . . . 0.87 108.735 179.273 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.402 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 38.1 ttt-85 -62.89 -32.74 74.07 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.168 -1.049 . . . . 3.62 108.168 178.422 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.55 -43.83 93.43 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.237 -0.653 . . . . 1.43 109.237 -179.516 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 50' ' ' ALA . 26.5 ttpp -68.81 -74.25 0.13 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.854 -1.154 . . . . 3.08 108.331 179.473 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.22 -35.3 0.11 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.335 -0.853 . . . . 1.33 111.378 -178.366 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.7 t -58.44 -53.32 59.64 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.317 -1.353 . . . . 1.85 108.301 179.559 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.35 -39.99 81.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -0.857 . . . . 1.35 111.088 -179.232 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -67.57 -40.11 84.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.745 -1.222 . . . . 2.34 109.968 -179.598 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.6 mt -63.84 -40.01 95.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.978 -1.077 . . . . 2.2 108.819 179.842 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -63.93 -37.92 89.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.354 -0.841 . . . . 1.35 109.52 179.252 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -62.87 -43.5 98.62 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.098 -1.001 . . . . 1.34 108.548 179.175 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.411 HD13 HG23 ' A' ' 57' ' ' ILE . 87.2 mt -62.46 -39.98 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 109.022 -0.733 . . . . 1.26 109.022 179.498 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 ttpp -56.98 -51.84 67.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.165 -0.959 . . . . 1.7 109.876 -179.781 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -58.78 -30.8 67.84 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.431 -0.793 . . . . 1.35 110.29 -178.083 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -69.64 -38.86 77.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.092 -1.005 . . . . 2.08 109.071 -179.826 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.2 -42.91 93.07 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.692 -0.63 . . . . 1.21 109.72 -179.8 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.37 -52.37 52.09 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.839 -1.305 . . . . 0.75 109.839 -179.318 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.2 -47.53 61.12 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.08 -1.247 . . . . 1.59 110.122 -179.962 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.4 m -66.49 -62.7 1.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.966 . . . . 1.41 112.399 -177.449 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -95.34 -48.48 5.86 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.761 -1.212 . . . . 0.79 111.105 -178.218 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.31 -169.68 24.96 Favored Glycine 0 N--CA 1.5 2.917 0 C-N-CA 119.801 -1.19 . . . . 1.22 111.045 179.608 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -69.95 -23.83 63.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.819 -0.812 . . . . 5.81 109.547 179.881 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -61.93 -35.92 79.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.734 -0.603 . . . . 3.37 110.947 -179.27 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.2 mmtt -99.4 -17.53 17.94 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.208 -0.932 . . . . 2.37 109.315 -179.934 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -69.2 -40.08 78.25 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.404 -0.81 . . . . 1.65 109.968 -179.187 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.566 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -69.18 -26.8 65.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.288 -0.883 . . . . 1.42 109.991 -179.137 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.9 mt -59.95 -42.12 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.098 -1.001 . . . . 1.43 108.608 -179.973 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -66.2 -40.03 90.08 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.392 -0.923 . . . . 1.08 109.706 179.845 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -59.96 -41.17 91.31 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.939 -1.101 . . . . 1.37 109.294 179.503 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.28 -44.87 97.05 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.69 -1.764 . . . . 0.67 108.69 179.353 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.9 m170 -66.86 -49.95 64.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.417 -1.049 . . . . 1.99 109.134 179.563 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.98 -50.01 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.329 -0.857 . . . . 1.22 109.322 179.719 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.3 ttp -60.12 -39.88 87.78 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.12 -0.987 . . . . 2.11 109.774 -179.265 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 55.5 tp -67.52 -40.0 85.1 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.403 -0.81 . . . . 1.33 109.946 179.7 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.1 tp -63.63 -39.87 95.46 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.576 -0.703 . . . . 1.29 109.611 -179.488 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -83.25 6.42 19.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.935 . . . . 1.47 109.758 -179.101 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 60.9 t0 -49.88 134.12 21.4 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.318 -0.864 . . . . 1.47 110.648 -179.074 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.481 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.9 mt-10 -59.98 -25.06 64.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.724 -0.61 . . . . 1.78 111.148 -179.464 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -70.95 -33.81 70.85 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.068 -1.02 . . . . 2.53 109.346 179.629 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.8 mt -69.94 -40.21 75.6 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.571 0.7 . . . . 1.36 109.846 179.743 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.03 -47.1 87.23 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.373 -0.829 . . . . 1.42 110.594 -178.921 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -69.96 -41.28 74.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 2.27 111.184 -178.706 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.07 -39.91 75.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.03 -1.044 . . . . 1.57 111.697 -178.63 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.82 -47.19 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.033 -1.042 . . . . 1.19 109.94 -179.233 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.43 -39.56 82.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.538 -0.727 . . . . 1.39 109.999 -179.949 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.42 85.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.164 -0.96 . . . . 1.39 110.844 -179.195 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.09 -46.85 88.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.026 -1.046 . . . . 1.5 109.859 -179.238 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.8 mt -61.64 -49.93 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 1.29 109.015 179.681 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -67.29 -41.48 85.36 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.649 -0.657 . . . . 2.64 110.89 -179.247 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -83.87 -50.51 8.0 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.84 -1.162 . . . . 1.65 112.013 -178.642 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -90.16 -3.74 57.69 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.985 -1.072 . . . . 2.5 111.699 -177.337 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.3 m80 56.77 37.56 28.89 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.782 -1.199 . . . . 1.88 109.457 -179.518 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 54.8 mtt -90.04 168.82 11.7 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.574 -0.704 . . . . 1.71 109.733 -179.683 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 63.4 p -80.38 160.03 25.52 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.33 -0.856 . . . . 1.61 108.722 179.315 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.8 -37.75 76.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.064 -1.023 . . . . 1.33 110.422 -179.271 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 38.0 p-10 -69.96 -36.74 75.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.898 -1.127 . . . . 2.07 109.799 -179.566 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.515 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.86 -42.89 20.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 1.37 109.624 179.569 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.55 -47.96 74.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.41 -0.806 . . . . 1.14 109.992 -179.514 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.97 -38.56 82.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.084 -1.01 . . . . 1.26 109.746 -179.776 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -59.94 -39.97 87.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.395 -0.816 . . . . 2.02 110.275 -178.561 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -63.8 -39.97 95.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.01 . . . . 1.33 110.809 -178.779 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.3 t -62.17 -50.07 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.034 -1.041 . . . . 1.3 111.037 -178.401 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.9 mm -69.56 -40.0 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.963 -1.086 . . . . 1.32 108.988 -179.862 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -60.03 -38.62 83.26 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.103 -0.703 . . . . 2.44 109.103 179.056 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.03 -49.95 72.8 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 120.562 -0.828 . . . . 0.99 111.219 -179.111 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -66.64 -50.02 64.31 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.77 -1.43 . . . . 1.97 110.442 -178.528 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.2 88.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.905 -1.122 . . . . 1.43 109.231 -179.704 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.0 t -60.07 -40.72 90.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.306 -0.871 . . . . 2.12 109.074 -179.557 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.98 92.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.27 -0.894 . . . . 1.64 109.12 179.291 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.6 mt -65.98 -42.3 90.0 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.117 -0.989 . . . . 1.93 109.397 -179.634 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.95 -37.91 80.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.663 -1.273 . . . . 2.2 109.302 -179.473 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -52.42 -21.46 3.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.024 -1.048 . . . . 2.12 108.681 179.539 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 59.2 mt -63.64 152.31 39.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.145 -0.972 . . . . 2.34 108.877 179.612 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -98.66 41.06 1.15 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.08 -1.012 . . . . 3.23 110.363 -179.568 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.73 149.71 49.29 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.129 -0.982 . . . . 2.49 110.227 -179.798 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 58.5 mp0 -74.96 -67.08 0.68 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.742 0.782 . . . . 3.95 109.514 178.956 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.501 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.1 t80 -39.48 -38.65 0.6 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.8 -0.562 . . . . 2.25 111.236 -178.732 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.454 ' CD2' HH21 ' A' ' 126' ' ' ARG . 88.7 mt -68.31 -39.92 81.85 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.714 -1.241 . . . . 2.27 108.844 -179.335 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 121' ' ' GLU . 7.7 ttpm? -67.14 -31.08 71.27 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.361 -0.837 . . . . 3.31 109.477 179.311 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -46.12 90.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.287 -0.883 . . . . 2.73 109.759 -179.405 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . 0.454 HH21 ' CD2' ' A' ' 123' ' ' LEU . 83.8 mtm180 -65.51 -37.27 86.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.978 -1.076 . . . . 3.2 108.373 178.754 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.94 -29.05 68.13 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.284 -1.006 . . . . 1.66 108.284 178.544 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.12 -40.3 78.38 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.598 -0.89 . . . . 1.67 108.598 179.108 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.43 -40.0 96.01 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.244 -1.021 . . . . 1.55 108.244 178.976 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.6 t -66.01 -40.01 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 108.535 -0.913 . . . . 1.32 108.535 178.939 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 -60.01 -39.42 85.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.45 -0.781 . . . . 3.58 109.169 179.1 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 60.5 t0 -59.94 -39.56 85.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.384 -0.823 . . . . 1.46 109.934 -179.724 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.88 -46.6 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.108 -0.995 . . . . 1.22 110.303 -178.76 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.77 -34.32 66.38 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.519 -1.432 . . . . 0.61 109.519 179.735 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -60.0 -50.16 74.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.421 -1.046 . . . . 3.1 110.368 -179.221 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -69.98 -31.47 69.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.946 -1.096 . . . . 3.71 110.02 -179.574 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.06 -41.71 92.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.315 -0.866 . . . . 1.87 108.963 -179.153 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.43 -40.08 95.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.14 -0.975 . . . . 1.29 109.2 179.408 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.2 mtm180 -69.24 -40.0 78.15 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.309 -0.869 . . . . 3.05 108.798 179.465 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . 0.567 HD21 ' N ' ' A' ' 140' ' ' ASN . 1.3 m120 -64.41 -35.39 80.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.67 -0.644 . . . . 1.26 111.456 -178.853 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.4 mt -71.09 -44.63 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.52 -1.362 . . . . 1.34 109.152 179.81 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.05 -29.01 65.92 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.663 -0.648 . . . . 1.6 109.616 -179.678 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.57 40.01 11.52 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.614 -1.795 . . . . 0.96 108.614 -179.01 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 56.5 tp -73.76 147.49 43.43 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.524 -0.986 . . . . 1.67 109.192 -179.445 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -61.06 139.58 58.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 4.96 109.63 -179.273 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.48 130.11 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-O 121.957 0.884 . . . . 1.68 109.279 179.496 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.8 mt -60.1 -47.35 92.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 115.994 -0.548 . . . . 2.14 110.76 -177.833 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.6 t0 66.11 99.7 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.44 -0.948 . . . . 1.5 108.44 -179.045 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.1 mt -70.9 -2.04 13.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.327 -0.858 . . . . 1.39 110.73 -178.653 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.9 p -84.32 -13.53 52.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.737 -1.227 . . . . 1.83 109.744 179.999 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.51 29.45 0.24 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.226 -0.921 . . . . 1.46 112.004 -177.913 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 39.5 mm -87.64 120.29 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.467 -1.396 . . . . 1.42 109.691 -179.86 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -100.38 -9.96 21.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.396 -0.815 . . . . 2.94 110.3 -179.736 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -139.39 158.09 44.74 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.986 -1.071 . . . . 1.52 110.219 -179.395 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.84 136.95 57.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.141 -0.975 . . . . 1.58 109.307 179.944 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 26.9 m -152.84 165.64 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.564 -0.71 . . . . 1.32 109.371 179.381 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . 0.47 ' N ' ' O ' ' A' ' 15' ' ' LYS . 85.3 mt -95.55 148.0 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 105.662 -1.977 . . . . 1.27 105.662 177.208 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 60.2 tp -98.37 116.14 29.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.053 -1.029 . . . . 1.41 111.003 -177.365 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.5 t -119.98 128.24 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.493 -0.928 . . . . 1.23 108.493 178.811 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.6 160.26 37.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.111 -0.993 . . . . 1.32 108.725 -179.982 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -70.32 -33.71 71.84 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.205 -1.559 . . . . 1.49 107.848 178.669 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 162' ' ' ASP . 20.2 p-10 -161.95 170.92 18.51 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.993 -0.743 . . . . 2.25 108.993 179.859 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.3 mt -142.86 129.99 20.81 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.058 -1.026 . . . . 1.35 108.841 179.189 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 61.8 p -88.49 146.1 36.85 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.073 -1.017 . . . . 1.56 109.202 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -41.83 -35.56 2.98 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.949 1.766 . . . . 0.87 112.513 179.277 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 57.0 m -60.05 -39.98 87.85 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.066 -1.021 . . . . 1.36 109.142 -179.364 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.75 -42.85 97.77 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.377 -0.827 . . . . 1.61 109.816 179.984 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.3 p -56.53 -30.33 62.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.28 -0.887 . . . . 1.21 111.529 -178.094 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.447 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -73.19 -56.78 4.63 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.65 -1.281 . . . . 1.21 109.937 -179.974 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -79.39 36.59 0.31 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.327 -0.99 . . . . 2.11 108.327 -179.896 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.447 ' H ' ' C ' ' A' ' 169' ' ' ALA . 15.6 tp -103.2 134.33 46.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 1.29 109.593 179.466 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -86.35 101.02 12.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.882 -1.155 . . . . 2.81 107.882 178.436 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 76.3 mt -65.16 -40.97 95.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 2.09 110.947 -178.483 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -69.87 -21.77 63.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.763 -1.211 . . . . 2.86 111.086 -178.087 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -93.89 -10.69 33.07 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.796 -1.19 . . . . 2.39 109.693 -179.533 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . 0.457 ' CG1' ' O ' ' A' ' 178' ' ' GLY . 71.5 t -105.59 116.57 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.397 -0.964 . . . . 1.27 108.397 178.599 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.9 mt -85.41 5.45 30.9 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.216 -0.928 . . . . 2.17 110.235 -178.215 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.457 ' O ' ' CG1' ' A' ' 176' ' ' VAL . . . 169.4 174.44 37.82 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.4 -1.48 . . . . 0.52 109.4 179.71 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -132.69 128.77 37.68 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.487 -1.008 . . . . 0.55 108.817 179.974 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.04 126.07 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.82 -0.807 . . . . 1.27 108.82 178.958 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.1 p -149.43 160.02 43.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.122 -0.986 . . . . 1.39 110.459 -179.208 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 182' ' ' ASP . 42.8 p-10 -108.23 28.85 7.89 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.764 -0.828 . . . . 2.46 108.764 179.256 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.39 -158.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.971 0.891 . . . . 1.51 112.227 -177.702 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.13 -71.4 0.8 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.959 -0.857 . . . . 2.23 110.959 -178.804 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 161.93 -131.82 2.66 Favored Glycine 0 N--CA 1.492 2.406 0 O-C-N 120.764 -1.433 . . . . 2.23 110.631 -179.658 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.751 ' HE ' HH12 ' A' ' 195' ' ' ARG . 33.2 ttt-85 -61.38 -39.99 92.7 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.586 -0.949 . . . . 6.44 111.506 -178.702 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 18.0 p -64.8 5.33 0.33 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.829 -1.169 . . . . 4.09 110.602 -178.532 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.476 ' H ' ' C ' ' A' ' 186' ' ' ARG . 48.0 t -90.87 130.07 36.86 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.953 -1.092 . . . . 2.2 110.702 -179.591 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -49.33 -44.81 44.77 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.423 -0.798 . . . . 1.15 109.255 179.509 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 88.8 m -60.01 -39.43 85.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.615 -0.678 . . . . 2.01 109.73 -179.26 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.5 t -58.66 -42.81 89.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.892 -1.13 . . . . 1.93 110.214 -179.225 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . 0.404 HD12 HG22 ' A' ' 192' ' ' ILE . 93.9 mt -60.8 -38.82 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 2.2 109.844 -179.991 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.7 mtp -59.97 -46.01 90.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 1.32 110.539 -179.246 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.99 -44.43 94.52 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.825 -1.172 . . . . 1.3 110.097 -179.381 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.751 HH12 ' HE ' ' A' ' 186' ' ' ARG . 51.7 mtp180 -60.03 -50.06 75.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.133 -0.979 . . . . 3.38 110.71 -179.01 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.6 m -73.41 -33.59 65.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.001 -1.062 . . . . 1.15 111.553 -178.665 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 86.8 mt -80.55 -11.07 59.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.735 -1.228 . . . . 1.28 110.475 -178.435 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 58.56 49.94 9.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.307 -0.871 . . . . 1.5 110.706 179.384 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 86.5 mt -123.84 122.98 26.29 Favored Pre-proline 0 N--CA 1.502 2.135 0 N-CA-C 108.456 -0.942 . . . . 1.37 108.456 179.0 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -43.28 133.48 6.56 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.037 1.825 . . . . 0.76 112.582 -179.845 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.58 150.01 3.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.846 -1.159 . . . . 1.19 111.375 179.819 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.0 mt -125.0 142.82 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 107.924 -1.139 . . . . 1.31 107.924 178.879 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.5 m -123.17 -8.57 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 O-C-N 120.85 -1.156 . . . . 1.38 111.057 -178.842 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.3 23.73 15.42 Favored Glycine 0 N--CA 1.5 2.962 0 O-C-N 121.381 -0.824 . . . . 1.03 111.203 -179.03 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 10.4 p -45.49 -44.36 12.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.776 -1.426 . . . . 1.38 109.751 -179.357 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 95.15 -51.28 1.89 Allowed Glycine 0 N--CA 1.499 2.88 0 C-N-CA 120.178 -1.01 . . . . 1.17 111.354 178.763 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 69.4 m -160.0 39.5 0.18 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.498 -1.59 . . . . 2.07 111.566 -179.242 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 30.9 t -79.96 -33.06 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.827 -1.171 . . . . 1.35 108.589 178.355 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.1 p -60.11 -40.01 88.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.608 -0.683 . . . . 1.49 111.095 -179.134 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 56.4 m -81.3 -13.56 58.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.971 -1.081 . . . . 2.16 110.563 -178.507 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -93.71 -11.91 30.43 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.073 -1.017 . . . . 2.89 110.755 -179.416 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 46.4 t -121.27 161.78 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 O-C-N 121.19 -0.944 . . . . 1.33 110.601 -179.56 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.58 158.02 28.24 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.714 -0.847 . . . . 2.73 108.714 -179.441 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 215' ' ' ASP . 57.6 t-20 -59.71 139.93 56.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 2.7 110.461 -179.384 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 3.1 t70 86.33 2.59 0.53 Allowed 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.15 0.5 . . . . 2.38 110.205 179.373 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 47.2 t0 -74.86 151.95 38.95 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.133 -0.979 . . . . 2.09 108.56 178.96 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.543 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 47.9 t80 -96.56 120.19 36.43 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.421 -0.955 . . . . 1.45 108.421 179.52 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 91.9 mt -124.8 141.68 51.94 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.426 -0.796 . . . . 1.31 110.754 -179.224 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . 0.427 HD13 HG22 ' A' ' 219' ' ' ILE . 88.6 mt -109.93 129.34 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.417 -1.697 . . . . 1.29 106.417 176.32 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 45.0 tp -101.28 117.67 35.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.027 -1.045 . . . . 1.31 109.024 -178.799 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 224' ' ' ASN . 8.5 t70 -76.96 -47.46 20.79 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.158 -0.964 . . . . 2.31 108.578 179.653 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 52.77 18.38 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.21 -0.663 . . . . 1.19 109.21 -179.958 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 72.8 t -132.67 -41.94 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.069 -1.456 . . . . 1.45 107.069 178.556 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.51 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 35.3 m120 -106.52 1.83 25.73 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.168 -1.419 . . . . 3.13 107.168 177.828 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.01 47.34 9.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.84 -0.538 . . . . 2.2 110.128 -179.868 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -136.97 148.51 46.96 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.314 -0.866 . . . . 2.32 109.614 179.235 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 86.1 t -123.88 125.5 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.294 -0.632 . . . . 1.4 109.294 179.659 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -91.83 122.45 34.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.135 -0.978 . . . . 1.29 108.588 179.651 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 37.0 t -102.23 118.46 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.423 -0.798 . . . . 1.38 109.478 -179.401 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.6 t30 67.57 68.77 0.52 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.441 -0.787 . . . . 2.33 108.923 -179.479 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -89.12 124.88 1.49 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.207 2.605 . . . . 0.95 112.761 -179.39 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.3 m -63.29 162.77 11.57 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -0.895 . . . . 2.31 108.881 179.684 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -60.11 -39.91 87.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.064 -1.022 . . . . 3.45 108.751 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -60.03 -38.88 84.04 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.4 -0.813 . . . . 2.89 109.193 179.534 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.64 -42.09 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.299 -0.876 . . . . 1.73 109.751 -179.75 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.85 -44.35 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.121 -0.987 . . . . 1.57 109.471 -179.994 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -59.99 -43.87 94.89 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.239 -0.913 . . . . 2.43 109.52 -179.596 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -61.39 -48.25 82.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 3.18 109.457 179.681 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 95.8 mtp -64.91 -32.75 74.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.348 -0.845 . . . . 1.59 109.886 -179.447 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -68.95 -40.06 79.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.081 -1.012 . . . . 3.11 109.127 179.161 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.01 81.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 2.17 109.066 179.623 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.86 -40.05 85.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.348 -0.845 . . . . 2.51 109.343 179.671 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -60.02 -39.96 87.64 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.179 -0.951 . . . . 3.82 108.962 -179.743 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.18 -40.02 88.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.116 -0.99 . . . . 1.78 108.73 179.216 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -65.69 -36.25 83.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.669 -0.644 . . . . 2.77 109.377 179.863 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.99 -41.47 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.335 -0.853 . . . . 2.25 109.215 -179.458 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.83 93.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.91 . . . . 2.54 108.842 179.548 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 60.2 p -70.0 -36.29 75.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.342 -0.849 . . . . 3.03 109.155 179.485 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -59.92 -40.03 87.47 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.034 -0.728 . . . . 3.34 109.034 179.963 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 251' ' ' ALA . 59.4 tttp -74.87 -3.63 33.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.427 -0.796 . . . . 4.18 109.36 -179.904 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 250' ' ' LYS . . . -36.7 -41.49 0.32 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.604 -0.685 . . . . 4.43 111.117 -179.598 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -162.79 36.83 0.1 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.883 -1.136 . . . . 5.42 110.742 179.913 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 95.6 mt -117.63 -9.6 10.74 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.328 -0.858 . . . . 6.11 110.239 179.673 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -155.57 -4.4 0.13 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.836 -1.165 . . . . 7.37 110.113 179.66 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -68.0 -31.12 70.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.975 . . . . 8.3 110.131 179.894 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.92 -40.16 87.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.108 -0.995 . . . . 9.05 110.36 -178.85 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -109.88 -156.27 0.58 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.12 -0.987 . . . . 10.56 109.713 -179.542 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 25.5 t0 72.66 -0.2 3.41 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.875 -0.516 . . . . 11.32 109.672 -179.416 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 117.975 -1.012 . . . . 12.74 109.268 -179.852 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' B' B ' 301' ' ' MET . . . . . 0.404 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 32.2 ttp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.493 0.663 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . 0.404 ' N ' ' CG ' ' B' ' 301' ' ' MET . 32.7 t80 -153.75 150.26 28.32 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.34 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . 0.444 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 3.9 pm0 -150.87 160.97 43.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.848 -1.158 . . . . 0.0 111.133 -179.398 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -152.19 148.89 28.14 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.554 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -114.03 132.13 56.11 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.218 -0.927 . . . . 0.0 109.827 179.282 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.21 127.97 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 CA-C-O 122.397 1.094 . . . . 0.0 112.61 -177.374 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 30.0 m -77.07 106.94 9.08 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.973 0.892 . . . . 0.0 110.603 -178.361 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . 0.435 HD12 HG21 ' B' ' 308' ' ' ILE . 87.1 mt -52.2 124.05 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.408 1.099 . . . . 0.0 110.508 -177.927 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 82.5 p -109.61 20.04 18.56 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.144 -178.697 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -79.13 115.71 54.74 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.28 -0.888 . . . . 0.0 109.005 179.291 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.38 -10.95 9.65 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 CA-C-N 120.376 1.17 . . . . 0.0 113.487 -179.348 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -114.83 9.94 16.37 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.227 -0.921 . . . . 0.0 110.396 -178.898 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 68.63 172.41 7.45 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -179.036 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.501 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -85.13 92.11 8.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.867 -1.372 . . . . 0.0 109.967 -178.298 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . 0.418 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 4.7 p80 -96.68 -159.29 0.72 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.008 -1.057 . . . . 0.0 109.62 178.163 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 4.4 m -59.4 -47.47 85.31 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.783 -1.198 . . . . 0.0 112.764 -176.182 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.566 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 10.9 tpt180 -55.74 -58.97 12.84 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 120.506 -1.372 . . . . 0.0 111.734 -179.102 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . 0.418 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 14.3 Cg_endo -61.81 -32.5 85.8 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 120.559 1.235 . . . . 0.0 111.388 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.67 -51.23 66.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.455 -0.778 . . . . 0.0 109.27 179.491 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.37 -39.99 64.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 109.373 -179.268 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . 0.408 HE21 ' CB ' ' A' ' 71' ' ' ALA . 96.5 mm-40 -68.7 -42.4 77.8 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.917 -1.114 . . . . 0.0 108.57 178.995 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -59.91 -50.4 73.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.526 -0.734 . . . . 0.0 110.298 -179.03 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 86.3 t -69.14 -29.15 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.722 -1.236 . . . . 0.0 110.207 -179.03 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -59.13 -49.26 78.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.112 -0.992 . . . . 0.0 109.7 -178.83 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -66.42 -40.95 89.86 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.024 -1.047 . . . . 0.0 111.102 -179.179 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.04 -54.61 43.95 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.516 -1.365 . . . . 0.0 110.993 -178.855 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -55.16 -15.91 2.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.073 -1.017 . . . . 0.0 109.007 179.702 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -70.35 -29.65 69.94 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 178.729 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -105.78 146.82 29.36 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.602 -0.94 . . . . 0.0 109.553 -179.916 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 32.0 p -90.57 -12.1 38.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.084 -1.01 . . . . 0.0 109.907 179.966 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 331' ' ' SER . . . . . 0.502 ' HG ' ' CA ' ' B' ' 367' ' ' GLY . 47.6 t -61.47 144.69 53.78 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.282 -0.886 . . . . 0.0 109.507 179.928 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -67.57 136.63 54.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.134 -0.979 . . . . 0.0 108.644 179.623 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . 0.406 HD13 HG22 ' B' ' 333' ' ' ILE . 85.9 mt -130.73 131.02 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.5 -0.75 . . . . 0.0 110.002 -179.728 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 91.8 m -128.14 147.01 50.53 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.276 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.65 115.57 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.658 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 89.0 m -102.82 128.8 49.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.124 -0.985 . . . . 0.0 109.041 -178.566 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 90.8 p -139.23 114.31 9.51 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.892 0.853 . . . . 0.0 111.136 -179.217 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 27.5 m120 49.43 49.99 18.9 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 176.45 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.81 -13.86 59.93 Favored Glycine 0 N--CA 1.501 2.994 0 O-C-N 119.804 -1.81 . . . . 0.0 112.289 176.946 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -117.01 129.0 55.73 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.999 -1.295 . . . . 0.0 109.419 -179.871 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 48.4 p -126.57 147.92 49.81 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.884 0.85 . . . . 0.0 110.754 -178.962 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.45 168.03 21.07 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.505 0.669 . . . . 0.0 109.825 -179.666 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 28.2 t -90.94 136.09 33.3 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.567 -0.708 . . . . 0.0 110.835 -178.775 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.414 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -71.42 -17.52 62.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.347 -0.845 . . . . 0.0 108.795 179.159 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -88.34 16.67 6.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.599 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.414 ' H ' ' C ' ' B' ' 344' ' ' ALA . 10.9 t -143.94 92.12 2.3 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.732 0.777 . . . . 0.0 111.287 -179.345 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 58.9 tp -58.74 -36.86 75.01 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.379 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -55.55 -50.06 71.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.854 . . . . 0.0 111.07 -179.14 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.426 ' O ' ' OG1' ' B' ' 352' ' ' THR . 25.2 mtmm -69.94 -40.03 75.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.722 -1.236 . . . . 0.0 110.721 -177.915 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' B' ' 352' ' ' THR . 87.9 mt -46.87 -55.69 7.57 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.995 -1.066 . . . . 0.0 109.106 -179.407 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.676 HE21 ' N ' ' B' ' 351' ' ' GLN . 0.0 OUTLIER -39.38 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.569 -0.707 . . . . 0.0 111.169 -178.76 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.483 ' N ' ' O ' ' B' ' 350' ' ' LEU . 75.6 p -81.27 -10.15 59.64 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.127 -1.608 . . . . 0.0 109.995 -179.096 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 32.9 mt -95.29 114.99 26.83 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.062 -1.024 . . . . 0.0 109.11 178.612 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.65 94.46 0.86 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 179.307 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 34.4 mt -101.77 89.56 3.72 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.366 -1.079 . . . . 0.0 109.279 179.721 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 46.9 p -94.16 177.02 6.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.102 -0.998 . . . . 0.0 110.934 -179.129 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -67.6 113.51 5.47 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.643 -0.661 . . . . 0.0 110.135 -179.918 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.93 9.41 34.66 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.974 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 66.3 m -90.85 107.64 19.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -1.139 . . . . 0.0 110.91 -179.536 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 14.5 t -76.89 118.15 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.201 1.0 . . . . 0.0 109.152 -177.641 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.0 m -113.42 178.14 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.968 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 58.1 m -130.86 128.27 40.27 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.287 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 93.9 mt -100.6 112.51 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.639 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 60.6 m -117.79 130.82 56.52 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.621 -0.675 . . . . 0.0 109.346 -179.217 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.79 151.99 39.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.815 . . . . 0.0 109.245 -179.493 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -145.83 125.51 13.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.4 -0.812 . . . . 0.0 108.867 179.666 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.518 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.11 -155.77 26.65 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.14 -1.505 . . . . 0.0 111.455 -179.984 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.73 -51.6 69.08 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 122.224 -0.574 . . . . 0.0 112.333 -177.508 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -110.01 13.17 23.44 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.829 -1.17 . . . . 0.0 111.221 -177.399 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.518 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -41.55 -34.33 0.56 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.292 -0.88 . . . . 0.0 111.507 -178.866 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -69.05 -41.15 78.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.589 -1.319 . . . . 0.0 109.994 -178.266 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -69.47 -50.1 48.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.842 -179.629 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -54.34 -36.22 63.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.86 . . . . 0.0 111.885 -178.077 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 71.1 t -74.31 -39.96 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.134 -1.604 . . . . 0.0 109.191 179.294 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.89 -56.01 14.04 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.331 -0.855 . . . . 0.0 111.923 -178.25 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -69.98 -39.97 75.62 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.31 -1.494 . . . . 0.0 111.905 -178.377 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 89.1 mt -57.99 -37.16 73.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.607 -1.308 . . . . 0.0 108.676 -179.286 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 48.9 t -60.03 -47.61 91.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.196 -0.94 . . . . 0.0 109.402 179.163 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' B' ' 383' ' ' GLU . 4.3 mptp? -69.98 -56.38 7.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.643 -1.285 . . . . 0.0 108.079 178.493 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . 0.48 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 62.8 tp -50.99 -36.39 38.92 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.187 -0.946 . . . . 0.0 108.787 -178.648 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 40.9 tpp -73.01 -39.92 65.61 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.421 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.09 -4.2 46.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.74 -0.6 . . . . 0.0 109.959 179.463 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' B' ' 379' ' ' LYS . 95.5 mt-10 -108.05 3.54 24.08 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.249 -0.907 . . . . 0.0 110.234 179.909 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . 0.48 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 15.1 mt -79.34 114.21 18.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.369 -1.457 . . . . 0.0 107.753 178.184 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.459 -179.777 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.187 -0.671 . . . . 3.19 109.187 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.7 mt -109.99 129.99 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.365 -0.834 . . . . 1.71 109.241 179.863 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.1 m -129.34 151.09 50.36 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.713 -0.617 . . . . 1.66 109.846 -179.379 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.493 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -135.22 -162.15 9.62 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.01 -1.636 . . . . 1.05 109.01 179.869 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.8 mt -90.11 -18.88 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.867 -1.373 . . . . 1.59 109.561 -179.535 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.5 tp 55.71 107.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.491 -0.755 . . . . 1.47 109.189 -179.507 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.32 -26.97 13.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.406 -0.809 . . . . 1.39 108.99 179.529 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.1 m -137.59 120.93 11.55 Favored Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.499 -0.751 . . . . 2.09 109.215 179.555 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.59 151.09 19.42 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.121 1.881 . . . . 0.91 112.825 179.928 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.45 ' O ' ' O ' ' A' ' 221' ' ' ASP . . . 146.79 173.01 17.65 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 109.469 -1.452 . . . . 0.92 109.469 179.705 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.43 HG23 HD11 ' A' ' 11' ' ' ILE . 87.7 mt -125.77 130.88 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 120.964 -1.315 . . . . 1.35 109.223 -179.74 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.89 150.65 48.37 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.169 -0.957 . . . . 1.14 110.048 -179.265 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 9.3 m-85 -123.22 129.94 52.07 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.267 -1.012 . . . . 0.7 108.267 179.765 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.59 172.76 45.14 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 118.81 -1.662 . . . . 0.58 110.69 179.988 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -78.66 158.82 28.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.609 -0.936 . . . . 2.63 108.906 179.655 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.05 131.62 51.12 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.325 -0.859 . . . . 1.27 111.107 -178.684 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.2 tp -101.52 135.01 43.74 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.167 -1.42 . . . . 1.41 107.167 178.161 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.3 tp -116.72 126.48 53.2 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.295 -0.878 . . . . 1.49 109.87 -179.06 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.4 mt -89.32 102.01 14.68 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.365 0.602 . . . . 1.52 110.214 -179.515 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -92.52 136.37 33.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.445 -0.784 . . . . 3.17 109.003 179.619 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -131.15 117.44 19.08 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.3 -0.875 . . . . 3.0 109.629 179.743 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 54.1 t0 -71.55 144.5 49.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.889 -1.132 . . . . 2.77 109.45 179.772 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.51 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 88.8 tt0 -63.52 139.95 58.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 2.94 109.526 -179.878 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.5 mt -83.89 134.5 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.791 -0.818 . . . . 1.46 108.791 -179.773 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.4 t -101.99 127.04 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.29 -0.881 . . . . 1.7 110.279 -179.11 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.9 mt -105.7 137.85 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.794 -0.817 . . . . 1.54 108.794 179.304 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -97.52 113.59 25.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.994 -1.066 . . . . 1.81 109.318 179.71 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -84.83 5.24 29.53 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.536 -0.913 . . . . 3.23 108.536 179.9 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -60.56 146.35 45.46 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.544 -0.722 . . . . 3.29 109.36 179.916 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -88.88 141.69 28.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 2.8 108.963 179.616 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 pt -94.47 165.73 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.1 -1.0 . . . . 1.43 109.383 179.773 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.0 p -97.91 174.21 6.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.004 -1.06 . . . . 1.54 108.72 178.856 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.83 84.18 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.362 -0.935 . . . . 1.6 109.297 -179.631 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 52.2 t0 -56.71 -30.39 63.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.773 -1.204 . . . . 2.56 109.923 -179.94 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -81.82 -10.56 59.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.235 -0.916 . . . . 2.36 110.02 -179.645 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -62.98 -51.67 68.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.908 -1.12 . . . . 1.43 108.68 179.713 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -61.7 -40.07 93.71 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.454 -0.779 . . . . 1.77 109.887 -179.588 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -68.84 -40.32 79.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 3.32 111.295 -178.492 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -66.14 -40.18 90.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.399 -1.438 . . . . 1.51 110.351 -179.528 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.95 -47.97 91.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.706 -1.246 . . . . 1.41 109.195 179.444 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -61.89 -44.13 97.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.005 -1.059 . . . . 1.81 109.935 179.977 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -60.06 -44.03 95.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.862 -1.149 . . . . 3.26 108.117 179.803 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -63.0 -46.98 85.12 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.196 -0.668 . . . . 0.81 109.196 179.062 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.428 ' O ' ' N ' ' A' ' 48' ' ' ALA . 64.5 tp -59.87 -46.19 90.08 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.608 -0.886 . . . . 1.59 108.608 179.933 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.9 t -65.76 -43.74 87.97 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.265 -0.974 . . . . 1.38 108.861 179.276 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.21 -44.23 97.39 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.83 -2.108 . . . . 0.87 107.83 178.703 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.421 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 25.5 ttt-85 -65.39 -34.67 78.86 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.34 -0.985 . . . . 3.62 108.34 178.228 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -59.77 -40.0 86.76 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.732 -0.84 . . . . 1.43 108.732 -179.862 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 50' ' ' ALA . 1.2 ttmp? -61.47 -73.95 0.09 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.043 -1.095 . . . . 3.08 108.043 179.111 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.07 -34.94 0.09 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.253 -0.905 . . . . 1.33 111.904 -177.775 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.0 t -59.67 -50.37 74.14 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.344 -1.342 . . . . 1.85 108.291 179.846 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.05 92.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.501 -0.749 . . . . 1.35 110.504 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.9 -40.19 91.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.805 -1.184 . . . . 2.34 110.188 -179.118 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.07 -39.88 91.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.975 -1.078 . . . . 2.2 109.199 179.633 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -60.27 -39.93 88.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.541 -0.724 . . . . 1.35 110.136 179.853 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -62.83 -43.87 97.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.019 -1.051 . . . . 1.34 109.459 179.724 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.603 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.9 mt -61.35 -39.68 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.48 -0.763 . . . . 1.26 109.588 -179.919 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -57.43 -51.86 67.73 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.175 -0.953 . . . . 1.7 110.403 -179.43 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -58.88 -35.38 72.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.357 -0.839 . . . . 1.35 110.832 -177.396 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 27.3 mttp -66.02 -38.16 87.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.056 -1.028 . . . . 2.08 109.332 179.841 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.81 -45.86 80.77 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.74 -0.6 . . . . 1.21 110.2 -179.529 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.4 -53.38 45.39 Favored Glycine 0 N--CA 1.485 1.93 0 C-N-CA 120.09 -1.052 . . . . 0.75 110.61 -178.548 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.07 -41.78 73.68 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.938 -1.331 . . . . 1.59 110.382 -179.06 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.0 m -70.03 -60.05 2.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.92 -1.113 . . . . 1.41 111.981 -177.838 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.428 ' CE1' ' O ' ' A' ' 168' ' ' THR . 76.7 m-85 -95.94 -50.56 4.82 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.862 -1.149 . . . . 0.79 111.243 -178.178 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.75 -166.87 26.1 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 119.899 -1.143 . . . . 1.22 110.683 -179.974 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -69.98 -24.97 63.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.78 -0.836 . . . . 5.81 110.353 -179.479 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.418 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 48.5 tp10 -60.36 -34.91 74.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.38 -0.825 . . . . 3.37 110.294 -179.366 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.9 mmtm -100.28 -17.51 17.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.295 -0.878 . . . . 2.37 110.291 -179.318 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -69.98 -44.51 69.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.067 -1.02 . . . . 1.65 110.667 -179.248 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.69 -25.64 65.78 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.386 -0.822 . . . . 1.42 109.885 -178.393 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 80.9 mt -59.91 -41.18 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.0 -1.062 . . . . 1.43 108.764 -179.886 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -69.99 -36.6 75.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.077 -1.014 . . . . 1.08 110.805 -179.789 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.52 ' CD ' ' HZ2' ' B' ' 324' ' ' LYS . 50.2 tt0 -59.93 -40.1 87.76 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.92 -1.112 . . . . 1.37 109.434 -179.495 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.79 -43.54 93.84 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.587 -1.805 . . . . 0.67 108.587 178.742 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 57.4 m170 -60.0 -46.14 90.44 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.357 -1.084 . . . . 1.99 108.761 179.703 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.67 -45.16 96.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.226 -0.921 . . . . 1.22 108.677 179.147 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.3 ttp -60.89 -43.05 99.0 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.309 -0.869 . . . . 2.11 110.036 -179.864 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 12.5 tp -61.21 -41.9 97.65 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.715 -0.846 . . . . 1.33 108.715 179.869 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.16 -38.14 89.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.636 -0.665 . . . . 1.29 109.917 -179.636 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -85.39 4.4 35.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.067 -1.02 . . . . 1.47 110.206 -179.101 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -50.1 131.4 23.32 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.964 -1.085 . . . . 1.47 110.44 -179.124 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -58.46 -20.65 46.96 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.67 -0.644 . . . . 1.78 110.14 -179.403 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.89 -33.08 71.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.118 -0.989 . . . . 2.53 108.735 179.477 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.0 mt -71.98 -40.1 68.82 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.352 0.596 . . . . 1.36 109.876 179.348 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -60.18 -50.02 75.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.477 -0.765 . . . . 1.42 110.374 -179.0 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -70.96 -40.81 71.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.051 -1.031 . . . . 2.27 111.099 -178.961 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.11 -39.97 75.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.117 -0.99 . . . . 1.57 111.573 -178.544 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.72 -46.19 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.026 . . . . 1.19 109.547 -179.309 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.85 -39.63 80.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.645 -0.66 . . . . 1.39 109.969 -179.822 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.33 -48.67 80.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 1.39 111.256 -179.033 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 96' ' ' LYS . 93.9 mt -63.04 -46.88 85.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.885 -1.134 . . . . 1.5 110.194 -178.927 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.1 mt -60.25 -49.48 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 122.18 0.991 . . . . 1.29 108.57 179.555 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -70.1 -40.46 74.93 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.785 -0.643 . . . . 2.64 110.578 -179.428 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -83.44 -49.7 9.04 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.901 -1.124 . . . . 1.65 111.718 -178.521 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.48 ' N ' ' O ' ' A' ' 92' ' ' LEU . 71.0 mmtt -90.97 -1.83 57.78 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.102 -0.999 . . . . 2.5 111.73 -177.396 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 54.28 32.17 15.69 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.699 -1.251 . . . . 1.88 109.604 179.944 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.5 mtt -90.36 167.5 12.59 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.003 -0.74 . . . . 1.71 109.003 -179.848 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 68.5 p -75.42 155.14 36.65 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.844 -1.169 . . . . 1.61 107.844 178.956 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.8 -39.59 76.48 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.955 -1.09 . . . . 1.33 110.237 -179.065 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 34.4 p-10 -63.23 -38.65 91.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.855 -1.153 . . . . 2.07 109.387 179.552 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.504 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -78.29 -47.28 18.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.957 . . . . 1.37 109.44 179.509 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.85 -47.32 86.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.475 -0.766 . . . . 1.14 109.714 -179.925 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.5 -35.37 79.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 1.26 109.458 179.646 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -59.87 -44.25 94.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 2.02 108.746 -179.319 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 110' ' ' GLY . 85.8 tt0 -61.15 -40.02 92.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.265 -0.897 . . . . 1.33 109.462 179.298 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.76 -53.81 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.897 . . . . 1.3 110.475 -178.972 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.0 mm -69.87 -40.14 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.992 -1.068 . . . . 1.32 109.303 179.634 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -68.07 -38.76 82.76 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.57 -0.9 . . . . 2.44 108.57 179.045 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -59.74 -47.92 88.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.494 -1.042 . . . . 0.99 110.494 -179.182 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -67.97 -54.37 19.09 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.769 -1.43 . . . . 1.97 109.721 -179.685 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.89 -40.02 69.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 1.43 109.616 -179.925 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 54.3 m -59.95 -39.98 87.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.094 -1.004 . . . . 2.12 108.796 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.25 89.01 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.204 -0.935 . . . . 1.64 108.676 178.829 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.431 ' CD1' ' OE1' ' B' ' 351' ' ' GLN . 25.5 mt -65.57 -39.96 92.25 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.124 -0.985 . . . . 1.93 109.399 -179.643 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -57.75 -31.62 66.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.736 -1.228 . . . . 2.2 109.189 -179.264 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -59.38 -23.54 62.67 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.175 -1.046 . . . . 2.12 108.175 179.388 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 52.7 mt -62.17 139.93 58.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.23 -0.919 . . . . 2.34 108.617 -179.823 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -94.49 26.08 3.61 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.172 -0.955 . . . . 3.23 109.835 -179.699 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -110.76 129.99 55.7 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.367 -0.833 . . . . 2.49 109.729 -179.712 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -69.66 -29.36 66.79 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.48 0.657 . . . . 3.95 109.233 179.91 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.48 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.4 t80 -69.95 -39.97 75.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.702 -0.624 . . . . 2.25 110.845 -179.99 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 96.9 mt -76.41 -32.47 58.53 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.844 -1.16 . . . . 2.27 109.582 179.918 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -60.1 -40.56 90.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.054 -1.029 . . . . 3.31 108.684 179.318 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.93 -42.92 95.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.247 -0.908 . . . . 2.73 108.964 179.615 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -61.92 -40.05 94.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 3.2 108.57 178.97 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.52 -30.81 71.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.89 . . . . 1.66 108.716 179.021 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.19 -39.57 86.99 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.827 -0.805 . . . . 1.67 108.827 179.607 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -68.25 -39.85 82.13 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.349 -0.845 . . . . 1.55 109.279 -179.919 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.74 -39.97 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.421 -0.8 . . . . 1.32 109.057 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -65.18 -40.04 93.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.174 -0.954 . . . . 3.58 109.963 179.629 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 1.46 110.551 -178.938 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.12 -41.22 85.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.99 -1.069 . . . . 1.22 109.667 -179.7 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.97 -46.02 94.87 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.009 -1.237 . . . . 0.61 110.009 -179.761 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -59.87 -46.92 87.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.104 -1.233 . . . . 3.1 111.324 -179.511 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.603 HH22 ' CD1' ' A' ' 57' ' ' ILE . 60.4 mtp180 -63.85 -37.08 86.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.835 -1.166 . . . . 3.71 110.407 -179.385 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.6 tp -58.43 -42.88 88.27 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.353 -0.842 . . . . 1.87 110.132 -178.753 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.83 -39.96 93.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.001 -1.062 . . . . 1.29 108.961 179.628 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -65.72 -39.51 91.24 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.789 -0.819 . . . . 3.05 108.789 178.791 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -64.38 -36.96 85.83 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.649 -0.657 . . . . 1.26 110.951 -179.63 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.405 HG23 HD12 ' A' ' 141' ' ' ILE . 93.3 mt -70.54 -42.06 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.521 -1.362 . . . . 1.34 108.44 179.002 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.63 -38.75 73.94 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.609 0.718 . . . . 1.6 109.063 179.684 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.56 43.85 4.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.276 -1.93 . . . . 0.96 108.276 -178.767 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.3 tp -74.51 142.86 44.77 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.484 -1.009 . . . . 1.67 109.46 -179.183 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -62.3 137.87 58.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.423 -0.798 . . . . 4.96 109.795 -179.325 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.422 HG21 HD13 ' A' ' 146' ' ' ILE . 92.8 mt -113.94 129.97 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.217 1.008 . . . . 1.68 109.583 179.396 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.7 mt -64.44 -41.51 92.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.802 -0.635 . . . . 2.14 110.968 -178.145 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 47.4 t0 61.26 105.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.323 -0.861 . . . . 1.5 109.581 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 58.8 mt -68.75 -6.69 28.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.474 -0.766 . . . . 1.39 110.12 -179.357 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.5 t -83.37 -13.77 54.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.13 -0.981 . . . . 1.83 108.922 179.314 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.34 18.51 2.64 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.608 -0.683 . . . . 1.46 110.239 -178.442 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 66.1 mt -90.31 111.21 23.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.028 -1.045 . . . . 1.42 108.845 -179.778 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -97.31 -9.71 27.03 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.285 -0.884 . . . . 2.94 110.836 -178.559 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -120.47 149.12 42.89 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.214 -0.929 . . . . 1.52 110.175 -178.987 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -64.89 131.22 46.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.422 -0.799 . . . . 1.58 109.216 -179.9 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -151.95 163.77 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.511 -0.743 . . . . 1.32 109.343 179.614 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 83.3 mt -92.76 151.08 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 105.939 -1.875 . . . . 1.27 105.939 177.156 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 56.4 tp -102.07 118.73 37.51 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.121 -0.987 . . . . 1.41 110.798 -177.961 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.2 t -126.22 132.08 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 108.538 -0.912 . . . . 1.23 108.538 179.543 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.6 168.73 24.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.179 -0.951 . . . . 1.32 109.05 179.797 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.0 -37.78 75.78 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.489 -1.382 . . . . 1.49 108.287 178.735 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -170.66 148.51 3.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.58 -0.7 . . . . 2.25 109.189 179.737 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.4 mt -116.1 134.43 54.94 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.49 -0.757 . . . . 1.35 109.553 -179.641 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 77.7 p -94.15 149.96 37.64 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.428 -0.795 . . . . 1.56 109.038 179.501 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.402 ' O ' ' OG1' ' A' ' 168' ' ' THR . 71.8 Cg_exo -39.63 -34.75 0.8 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.334 2.023 . . . . 0.87 113.005 179.562 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 59.6 m -58.04 -42.51 85.54 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.217 -0.993 . . . . 1.36 109.353 -178.503 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -70.07 -39.96 75.31 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.163 -0.961 . . . . 1.61 109.792 179.456 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.428 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 68.8 p -52.79 -26.62 14.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -0.905 . . . . 1.21 111.112 -178.051 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.474 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -82.06 -55.88 4.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.874 -1.141 . . . . 1.21 109.963 179.624 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -80.25 40.14 0.48 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.677 -1.231 . . . . 2.11 107.677 179.775 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.474 ' H ' ' C ' ' A' ' 169' ' ' ALA . 17.7 tp -97.91 124.55 42.39 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.98 -0.748 . . . . 1.29 108.98 179.858 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -81.61 97.8 8.04 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.112 -1.07 . . . . 2.81 108.112 179.189 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.54 -44.85 95.33 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.565 -0.709 . . . . 2.09 110.62 -178.591 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -62.38 -32.02 72.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.1 -1.0 . . . . 2.86 112.47 -177.394 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -93.29 -10.27 36.07 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.684 -1.26 . . . . 2.39 110.787 -177.862 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 91.4 t -102.36 113.11 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.048 -1.032 . . . . 1.27 108.749 178.986 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 39.6 mt -85.75 5.14 33.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.188 -0.945 . . . . 2.17 110.687 -178.31 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.09 168.62 35.92 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.309 -1.424 . . . . 0.52 109.82 179.531 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -130.52 127.93 40.13 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.494 -1.003 . . . . 0.55 108.745 179.787 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 62.2 mt -130.56 124.19 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.332 -0.988 . . . . 1.27 108.332 178.725 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 36.0 p -139.53 152.0 46.57 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.343 -0.848 . . . . 1.39 110.642 -179.247 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . 0.543 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.7 OUTLIER -100.62 26.71 6.47 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.75 -0.833 . . . . 2.46 108.75 179.356 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.37 -161.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.103 -0.998 . . . . 1.51 111.574 -177.819 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.9 -57.34 6.42 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.974 -0.85 . . . . 2.23 110.974 -178.874 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.51 -132.69 2.04 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 118.887 -1.625 . . . . 2.23 111.2 -179.33 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 186' ' ' ARG . . . . . 0.513 ' NH2' ' NH1' ' A' ' 195' ' ' ARG . 10.7 mtp-105 -80.18 -10.11 59.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.474 -1.015 . . . . 6.44 110.533 -178.663 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 71.5 p -81.49 5.99 16.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.008 -1.058 . . . . 4.09 109.906 -179.231 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.5 t -88.34 134.15 33.89 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.048 -1.033 . . . . 2.2 110.191 -179.63 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -48.21 -43.2 31.82 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.237 -0.914 . . . . 1.15 108.681 179.645 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 93.5 m -59.4 -39.91 84.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.831 -0.543 . . . . 2.01 109.83 -179.517 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 55.8 p -59.9 -38.32 81.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.999 -1.063 . . . . 1.93 110.264 -179.397 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.6 mm -59.95 -40.0 81.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.322 -0.862 . . . . 2.2 109.371 -179.782 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.5 mtp -58.78 -49.93 75.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.269 -0.894 . . . . 1.32 110.55 -178.971 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -50.59 -44.3 56.88 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.855 -1.153 . . . . 1.3 109.524 -178.98 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 195' ' ' ARG . . . . . 0.513 ' NH1' ' NH2' ' A' ' 186' ' ' ARG . 65.4 mtp180 -59.94 -51.53 69.28 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.62 -0.832 . . . . 3.38 110.349 -178.709 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.7 m -76.07 -32.03 59.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.945 -1.097 . . . . 1.15 111.711 -178.152 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.3 -20.33 48.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.737 -1.227 . . . . 1.28 110.017 -179.197 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 60.41 46.81 9.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.205 -0.934 . . . . 1.5 110.223 -179.36 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 97.4 mt -121.09 129.18 25.39 Favored Pre-proline 0 N--CA 1.501 2.115 0 N-CA-C 108.375 -0.972 . . . . 1.37 108.375 178.715 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -43.52 131.2 7.17 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.975 1.783 . . . . 0.76 112.753 -179.571 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -168.91 146.54 3.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.703 -1.248 . . . . 1.19 111.607 179.962 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.3 mt -122.42 144.35 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 106.966 -1.494 . . . . 1.31 106.966 178.011 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 13.6 m -123.56 -13.2 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 O-C-N 120.854 -1.154 . . . . 1.38 111.454 -178.223 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.12 26.24 19.59 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.498 -1.041 . . . . 1.03 110.498 -179.172 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 205' ' ' THR . . . . . 0.456 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 7.7 p -47.23 -39.44 14.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.837 -1.39 . . . . 1.38 110.047 -179.117 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.81 -51.68 4.34 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 119.913 -1.137 . . . . 1.17 111.851 178.671 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 49.9 m -158.33 40.99 0.26 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.474 -1.603 . . . . 2.07 111.489 -178.766 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 18.5 t -79.52 -33.39 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.88 -1.138 . . . . 1.35 108.106 178.192 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.0 p -54.44 -31.61 55.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.657 -0.652 . . . . 1.49 110.92 -179.139 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 35.3 m -80.66 -10.91 59.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.99 -1.069 . . . . 2.16 110.304 -179.108 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -104.85 -13.98 15.65 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.274 -0.891 . . . . 2.89 110.788 -179.224 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.4 t -108.01 138.71 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.141 -0.974 . . . . 1.33 110.824 -178.497 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 213' ' ' LYS . . . . . 0.455 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 0.1 OUTLIER -118.31 150.6 39.2 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.38 -1.341 . . . . 2.73 107.38 178.434 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 17.9 p30 -51.81 138.58 23.58 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.065 -1.022 . . . . 2.7 111.001 -178.488 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.6 m-20 80.01 5.27 1.88 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 116.424 -0.353 . . . . 2.38 111.332 178.789 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.455 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 91.8 m-20 -73.7 140.4 46.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.648 -1.283 . . . . 2.09 109.025 178.977 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.03 116.85 24.5 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.358 -0.979 . . . . 1.45 108.358 179.508 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 86.3 mt -126.66 146.17 50.29 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.382 -0.824 . . . . 1.31 110.784 -178.92 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 78.6 mt -113.32 127.29 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.081 -1.822 . . . . 1.29 106.081 177.206 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 54.7 tp -101.21 119.23 38.45 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.865 -1.147 . . . . 1.31 108.51 -179.112 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.491 ' C ' ' N ' ' A' ' 223' ' ' VAL . 92.6 m-20 -77.07 -45.27 27.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.131 -0.98 . . . . 2.31 109.378 179.893 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . 49.78 14.23 0.12 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.355 -0.979 . . . . 1.19 108.355 -178.996 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . 0.491 ' N ' ' C ' ' A' ' 221' ' ' ASP . 49.0 t -130.65 -45.3 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 106.601 -1.629 . . . . 1.45 106.601 178.542 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 224' ' ' ASN . . . . . 0.518 ' OD1' ' NE2' ' A' ' 226' ' ' GLN . 20.0 t-20 -99.67 -2.71 34.76 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.416 -1.327 . . . . 3.13 107.416 178.064 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.493 HD22 ' H ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 62.56 40.0 10.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.917 -0.489 . . . . 2.2 110.194 179.837 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 226' ' ' GLN . . . . . 0.518 ' NE2' ' OD1' ' A' ' 224' ' ' ASN . 78.1 mt-30 -136.99 148.25 46.77 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.248 -0.907 . . . . 2.32 109.751 178.939 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.7 t -119.85 121.17 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.792 -0.568 . . . . 1.4 109.675 179.946 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -90.25 128.02 36.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.003 -1.06 . . . . 1.29 109.442 -179.887 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.8 t -100.73 111.51 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.469 -0.769 . . . . 1.38 110.205 -179.256 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 43.1 t30 50.01 65.74 6.51 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.193 -0.942 . . . . 2.33 111.482 178.899 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -90.05 156.49 4.83 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.969 2.446 . . . . 0.95 112.232 178.822 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.3 m -66.16 156.37 34.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.231 -0.918 . . . . 2.31 110.334 -179.237 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -60.01 -38.3 82.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.514 -0.741 . . . . 3.45 109.414 179.99 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -59.74 -36.05 75.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.117 -0.989 . . . . 2.89 108.903 -179.925 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.4 t -68.33 -40.11 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 1.73 108.718 178.913 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.6 mt -65.43 -39.58 85.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.424 -0.798 . . . . 1.57 109.29 179.255 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.97 -40.09 87.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.95 -1.094 . . . . 2.43 109.112 -179.459 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -67.52 -40.07 85.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.115 -0.991 . . . . 3.18 109.345 179.177 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 94.8 mtp -70.08 -32.3 70.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.234 -0.916 . . . . 1.59 109.667 179.461 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -67.95 -40.16 83.28 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.244 -0.91 . . . . 3.11 109.583 179.929 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.78 -42.47 93.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.038 -1.039 . . . . 2.17 109.531 179.822 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 75.0 t -60.06 -40.13 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.319 -0.863 . . . . 2.51 109.341 179.916 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.94 -40.15 87.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.264 -0.898 . . . . 3.82 109.622 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.92 -43.3 94.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 1.78 109.47 -179.429 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -64.15 -38.82 92.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.327 -0.858 . . . . 2.77 109.315 179.576 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 67.5 t -60.01 -40.55 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.52 -0.737 . . . . 2.25 109.804 -179.231 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.59 97.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.066 -1.021 . . . . 2.54 109.09 179.866 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 79.2 p -62.63 -37.4 86.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.307 -0.87 . . . . 3.03 109.287 179.691 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.435 ' C ' ' H ' ' A' ' 251' ' ' ALA . 98.9 mt-10 -66.5 -37.54 85.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.492 -0.755 . . . . 3.34 109.967 -179.757 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -69.77 5.38 1.51 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.121 -0.987 . . . . 4.18 110.019 -179.56 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 249' ' ' GLU . . . -62.35 -22.34 66.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.432 -0.792 . . . . 4.43 109.792 -179.848 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . 0.559 ' C ' ' H ' ' A' ' 254' ' ' ALA . 96.9 mt-10 55.94 11.94 0.81 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.595 0.712 . . . . 5.42 109.165 -179.507 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' A' ' 251' ' ' ALA . 17.3 mt 54.09 -2.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.786 -0.571 . . . . 6.11 111.284 179.62 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . 0.559 ' H ' ' C ' ' A' ' 252' ' ' GLU . . . 60.53 19.89 9.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.697 -1.252 . . . . 7.37 110.327 179.792 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -62.43 -39.67 94.07 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.066 -1.022 . . . . 8.3 109.666 179.611 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 60.2 tp -69.95 -24.02 63.28 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.399 -0.813 . . . . 9.05 110.995 -178.9 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -67.48 -76.31 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.549 -1.345 . . . . 10.56 109.811 -179.411 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -172.3 -52.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 11.32 109.538 179.864 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 117.935 -1.031 . . . . 12.74 109.483 -179.899 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 58.1 ttp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.694 0.759 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -153.87 150.67 28.64 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.831 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -152.32 160.91 43.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.024 -1.047 . . . . 0.0 110.719 -179.099 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -156.62 154.16 29.73 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.081 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 55.2 mp0 -110.31 129.53 55.72 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.252 -0.905 . . . . 0.0 109.709 179.577 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.41 121.95 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 CA-C-O 121.942 0.877 . . . . 0.0 112.157 -177.247 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 48.7 m -78.87 105.7 10.37 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 122.163 0.982 . . . . 0.0 111.444 -177.915 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.9 mt -53.08 123.52 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 122.438 1.113 . . . . 0.0 111.151 -177.863 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 76.0 p -111.42 19.88 17.79 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.895 -179.61 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.91 129.12 87.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.905 -1.122 . . . . 0.0 109.403 -179.932 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -51.17 -23.84 13.76 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 CA-C-N 119.983 1.03 . . . . 0.0 113.364 -179.506 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -122.16 11.42 10.16 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.348 -0.845 . . . . 0.0 109.203 -179.94 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.7 -171.25 55.15 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -178.481 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.48 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.7 tp -88.81 93.93 9.75 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.857 -1.378 . . . . 0.0 108.791 -179.618 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . 0.401 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 4.3 p80 -98.21 -159.02 0.71 Allowed 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.357 -0.839 . . . . 0.0 110.853 179.793 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 7.7 m -57.38 -47.01 82.8 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.246 -0.909 . . . . 0.0 112.699 -176.299 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.507 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.2 tpt180 -58.88 -60.25 11.12 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 120.434 -1.416 . . . . 0.0 112.217 -178.072 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . 0.401 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 10.3 Cg_endo -60.3 -30.71 91.66 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 CA-C-N 120.449 1.196 . . . . 0.0 111.45 -179.679 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.04 75.31 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.147 -0.971 . . . . 0.0 108.413 179.527 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.85 -43.52 77.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.444 -0.785 . . . . 0.0 109.673 -179.492 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -71.47 -41.76 68.97 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.913 -1.117 . . . . 0.0 108.792 178.763 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.58 -52.82 61.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.331 -0.856 . . . . 0.0 110.54 -179.76 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 74.9 t -67.19 -27.85 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.719 -1.238 . . . . 0.0 110.12 -178.781 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . 0.52 ' HZ2' ' CD ' ' A' ' 74' ' ' GLU . 30.6 ttpt -60.25 -42.75 95.98 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.642 179.514 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -65.53 -55.59 16.94 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.9 -1.125 . . . . 0.0 109.794 -179.778 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.93 71.81 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.923 -1.111 . . . . 0.0 110.469 -179.447 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -48.92 -22.48 0.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 108.99 -179.278 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -82.59 -13.05 79.16 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.778 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -104.95 141.84 35.83 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.363 -1.08 . . . . 0.0 108.894 179.416 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 38.9 p -90.9 -13.6 33.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.785 -1.197 . . . . 0.0 110.014 -179.832 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 331' ' ' SER . . . . . 0.404 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 67.5 p -59.98 142.77 53.23 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.039 -1.038 . . . . 0.0 109.181 179.909 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . 0.409 ' OE1' ' N ' ' B' ' 332' ' ' GLU . 40.2 mp0 -65.58 132.84 49.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.999 -1.063 . . . . 0.0 108.54 179.619 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . 0.402 HD12 HG23 ' B' ' 333' ' ' ILE . 95.8 mt -130.92 132.42 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.447 -0.783 . . . . 0.0 109.712 -179.859 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 27.1 m -129.93 147.09 51.65 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.514 -0.742 . . . . 0.0 109.33 179.492 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 59.9 t -120.76 116.73 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.386 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 71.9 m -104.93 121.51 43.87 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.164 -0.96 . . . . 0.0 109.712 -178.66 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 94.5 p -133.92 121.89 22.34 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.901 0.857 . . . . 0.0 111.233 -179.616 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 58.9 t30 47.51 54.5 9.59 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 176.938 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.92 -11.54 41.18 Favored Glycine 0 N--CA 1.499 2.868 0 O-C-N 120.009 -1.682 . . . . 0.0 112.843 176.481 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -121.88 134.65 54.87 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 119.087 1.444 . . . . 0.0 108.776 -179.712 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 59.7 p -133.63 152.77 51.96 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.371 -0.831 . . . . 0.0 110.947 -178.231 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -147.18 169.95 18.25 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.382 0.61 . . . . 0.0 109.842 -179.859 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 72.3 m -88.16 140.94 28.97 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.472 -0.768 . . . . 0.0 110.403 -179.38 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . 0.512 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -81.91 -15.39 54.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.043 -1.035 . . . . 0.0 109.442 179.677 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -86.4 16.33 4.6 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.52 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 346' ' ' SER . . . . . 0.512 ' H ' ' C ' ' B' ' 344' ' ' ALA . 13.5 p -147.97 93.38 2.18 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.278 -179.362 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 21.8 tp -60.76 -32.93 72.22 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.746 -0.596 . . . . 0.0 109.704 178.97 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -53.22 -51.92 60.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.68 -1.263 . . . . 0.0 110.064 -179.558 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . 0.432 ' O ' ' OG1' ' B' ' 352' ' ' THR . 2.6 mppt? -70.69 -39.91 73.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 0.0 110.831 -179.408 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' B' ' 352' ' ' THR . 86.1 mt -48.05 -54.44 13.07 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.771 -1.206 . . . . 0.0 109.293 -179.311 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.431 ' OE1' ' CD1' ' A' ' 115' ' ' LEU . 37.7 mt-30 -40.99 -15.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.592 -0.693 . . . . 0.0 110.931 -178.726 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 352' ' ' THR . . . . . 0.587 ' N ' ' O ' ' B' ' 350' ' ' LEU . 62.0 p -87.72 -10.22 51.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.456 -1.402 . . . . 0.0 110.247 -179.424 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 60.3 mt -95.01 116.77 29.12 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.93 -1.106 . . . . 0.0 109.454 179.0 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.88 94.17 1.08 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.081 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 25.5 mt -100.64 92.04 4.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.297 -1.119 . . . . 0.0 109.507 -179.632 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 44.6 p -90.03 172.41 8.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.93 -1.106 . . . . 0.0 111.197 -178.862 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -66.84 116.9 8.23 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.359 0.599 . . . . 0.0 110.491 -179.856 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 99.61 8.92 51.37 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.7 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 45.6 m -87.61 111.3 21.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.404 -1.056 . . . . 0.0 110.404 -179.604 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 22.0 t -77.48 116.34 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 122.202 1.001 . . . . 0.0 109.448 -177.662 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 18.4 m -110.98 177.2 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.025 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 42.6 m -130.88 126.98 37.59 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.491 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.3 111.75 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.923 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 61.7 p -118.24 132.87 56.28 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.796 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.3 150.66 37.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.91 . . . . 0.0 109.974 -178.974 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . 0.402 ' O ' ' OE1' ' B' ' 332' ' ' GLU . 18.4 tp10 -141.61 122.42 14.4 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.505 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . 0.463 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 160.36 -160.61 31.91 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.053 -1.546 . . . . 0.0 111.477 -179.886 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -59.81 -50.14 74.97 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.979 -0.718 . . . . 0.0 112.42 -177.245 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . 0.404 ' H ' ' HB3' ' B' ' 331' ' ' SER . 70.7 m-20 -109.95 13.65 23.35 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.035 -1.041 . . . . 0.0 111.22 -177.223 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . 0.564 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -45.44 -34.96 3.43 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.081 -1.012 . . . . 0.0 111.852 -178.876 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . 0.506 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 27.1 mt-30 -70.94 -41.4 71.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.809 -1.182 . . . . 0.0 110.098 -179.001 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -66.41 -43.26 86.24 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.338 -0.852 . . . . 0.0 109.725 -178.869 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -53.95 -71.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 110.977 -178.965 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . 0.414 ' O ' ' CG2' ' B' ' 378' ' ' VAL . 60.0 t -46.86 -37.69 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.914 -1.116 . . . . 0.0 110.204 -177.682 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -63.74 -50.0 70.8 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.75 -1.219 . . . . 0.0 110.345 179.518 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -78.5 -42.83 28.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.065 -1.022 . . . . 0.0 110.157 -179.894 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.95 -37.46 79.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.25 -0.906 . . . . 0.0 109.631 -179.306 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . 0.414 ' CG2' ' O ' ' B' ' 374' ' ' VAL . 46.7 t -63.68 -40.2 88.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.209 -0.932 . . . . 0.0 109.325 179.836 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -70.59 -57.46 4.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.616 -1.303 . . . . 0.0 107.929 178.134 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 54.4 tp -57.41 -34.65 69.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.513 -0.742 . . . . 0.0 110.348 -178.151 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.9 ttm -70.51 -40.02 73.77 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.424 -1.423 . . . . 0.0 108.199 177.831 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.69 -7.25 59.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.811 -0.555 . . . . 0.0 110.794 179.324 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . 0.406 ' O ' ' OE2' ' B' ' 385' ' ' GLU . 96.7 mt-10 -111.73 -0.22 16.05 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.978 -1.076 . . . . 0.0 111.585 -179.388 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.1 mt -83.21 130.48 35.09 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.421 -1.424 . . . . 0.0 109.684 179.456 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . 0.428 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 35.4 mp0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.177 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.722 0 CA-C-O 121.191 0.519 . . . . 2.91 . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 94.9 mt -109.41 124.72 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.914 -0.773 . . . . 1.2 108.914 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.6 m -130.07 130.31 44.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.978 -0.749 . . . . 1.4 108.978 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.664 ' N ' HD22 ' A' ' 225' ' ' ASN . . . -115.49 -166.93 15.05 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 108.754 -1.738 . . . . 1.05 108.754 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 5' ' ' ILE . 72.5 mt -91.06 -10.48 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.033 -1.275 . . . . 1.15 110.562 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.485 HD11 ' O ' ' A' ' 8' ' ' SER . 57.5 tp 53.3 98.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.684 -1.26 . . . . 0.98 109.8 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.97 -38.7 44.57 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.848 -0.797 . . . . 0.88 108.848 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.485 ' O ' HD11 ' A' ' 6' ' ' LEU . 5.0 m -141.27 140.2 20.43 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.498 -0.751 . . . . 1.69 109.595 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -80.48 140.33 13.38 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.529 2.153 . . . . 0.85 112.821 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.748 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.99 -163.68 36.94 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.05 -1.62 . . . . 0.92 109.05 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.2 mt -148.64 149.63 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.208 -1.172 . . . . 0.81 108.156 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.38 155.58 33.88 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.572 -1.33 . . . . 0.51 110.721 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -137.89 129.68 28.43 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.072 -1.084 . . . . 0.62 108.072 178.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.43 -178.13 46.35 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 118.699 -1.715 . . . . 0.55 110.905 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -80.07 156.51 27.05 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.811 -0.817 . . . . 2.1 109.519 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.585 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.11 129.75 51.81 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.449 -0.782 . . . . 0.77 110.934 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.3 tp -100.09 135.83 40.93 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.307 -1.368 . . . . 0.91 107.307 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.2 tp -117.77 127.45 53.92 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.262 -0.899 . . . . 0.93 109.951 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.4 mt -88.28 101.22 13.64 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 120.115 -0.634 . . . . 0.93 109.352 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.31 137.58 32.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 2.75 108.701 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -130.48 133.33 46.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.217 -0.927 . . . . 3.0 108.998 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -81.42 149.84 28.63 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.105 -0.997 . . . . 2.77 108.94 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -66.75 146.84 54.02 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.0 -1.062 . . . . 2.94 108.893 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.8 mt -94.45 130.91 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.283 -0.886 . . . . 0.95 108.633 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.3 t -101.61 129.66 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.271 -0.893 . . . . 1.28 110.752 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -108.34 132.1 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.585 -0.894 . . . . 1.21 108.585 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -87.36 120.59 28.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.79 -1.194 . . . . 1.81 109.495 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -88.71 0.1 56.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.388 -0.82 . . . . 2.8 108.879 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -68.83 146.49 52.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 2.87 109.252 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -89.22 150.07 22.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 2.35 109.335 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.502 HG21 ' HG3' ' A' ' 39' ' ' GLU . 3.5 pt -93.92 166.18 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.321 -0.862 . . . . 0.97 109.793 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.5 p -97.59 171.12 8.56 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.224 -1.028 . . . . 1.17 108.224 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.69 -49.39 77.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.948 -1.095 . . . . 1.18 108.94 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -53.89 -29.94 43.84 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.81 -1.181 . . . . 2.56 109.516 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -82.84 -10.0 59.05 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.395 -0.816 . . . . 1.79 110.413 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.57 -53.84 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.831 -1.168 . . . . 1.0 108.691 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.21 -40.07 88.83 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.481 -0.762 . . . . 1.77 109.677 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.23 -41.96 93.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -0.901 . . . . 2.7 110.891 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.502 ' HG3' HG21 ' A' ' 31' ' ' ILE . 67.4 mm-40 -65.76 -39.98 91.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 1.51 110.419 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.0 -46.17 94.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.701 -1.249 . . . . 0.93 108.491 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -59.98 -40.63 89.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.01 -1.056 . . . . 1.81 109.192 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -60.07 -43.03 95.73 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.901 -1.125 . . . . 2.78 108.438 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -66.39 -42.97 87.09 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.842 -0.799 . . . . 0.78 108.842 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.91 -50.63 73.01 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.282 -1.007 . . . . 1.07 108.282 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 42.8 t -63.86 -42.76 97.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.371 -0.932 . . . . 1.12 108.872 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.33 -42.51 98.85 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.575 -1.81 . . . . 0.84 108.575 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.442 HH11 ' HG2' ' A' ' 47' ' ' ARG . 21.4 ttt-85 -64.95 -35.12 80.16 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.184 -1.043 . . . . 3.09 108.184 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -53.76 -39.94 65.77 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.773 -0.825 . . . . 0.88 108.773 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.565 ' HZ3' ' HB3' ' A' ' 49' ' ' LYS . 7.0 ttpm? -72.46 -73.7 0.19 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.89 -1.152 . . . . 2.59 107.89 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.439 ' HB2' ' OD1' ' A' ' 140' ' ' ASN . . . -37.02 -41.11 0.33 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.334 -0.854 . . . . 0.7 112.084 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.2 p -57.93 -55.07 39.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.591 -1.318 . . . . 1.4 108.816 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.06 95.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.446 -0.784 . . . . 0.67 110.85 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -62.16 -46.05 90.71 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.997 -1.064 . . . . 1.66 110.685 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.74 -40.21 94.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.13 -0.981 . . . . 1.58 109.418 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -62.84 -40.02 96.15 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.306 -0.871 . . . . 1.35 109.603 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.9 m -65.87 -41.5 91.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.021 -1.05 . . . . 0.77 109.983 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.1 mt -61.64 -40.0 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.112 -0.992 . . . . 0.63 108.793 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -55.44 -50.87 68.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.471 -0.768 . . . . 1.14 109.771 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -58.82 -37.51 76.56 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.329 -0.857 . . . . 0.79 110.254 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -61.7 -38.74 88.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.073 -1.017 . . . . 1.53 109.39 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.413 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -66.98 -46.9 73.19 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.745 -0.597 . . . . 0.57 110.162 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.84 -53.27 37.41 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.829 -1.308 . . . . 0.75 109.829 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.54 -44.82 66.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.05 -1.265 . . . . 1.59 110.462 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.5 m -66.53 -64.04 0.94 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.124 -0.985 . . . . 0.73 112.74 -177.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -95.8 -45.25 7.06 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.747 -1.221 . . . . 0.75 111.002 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.4 -167.47 25.5 Favored Glycine 0 N--CA 1.498 2.786 0 C-N-CA 119.771 -1.204 . . . . 1.22 110.792 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.21 -24.18 63.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 122.032 -0.687 . . . . 5.81 109.819 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.516 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.4 tp10 -60.96 -35.83 77.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.407 -0.808 . . . . 3.37 110.786 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -97.62 -19.46 18.29 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.133 -0.979 . . . . 1.77 109.764 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -68.89 -40.22 79.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.248 -0.908 . . . . 1.65 110.402 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.54 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -66.48 -32.65 74.14 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.393 -0.817 . . . . 0.77 110.144 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.06 -40.41 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 118.836 -1.145 . . . . 0.8 108.672 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -64.43 -40.14 95.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.104 -0.998 . . . . 0.88 109.15 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -60.08 -41.93 93.5 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.299 -0.876 . . . . 1.37 109.438 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.05 -43.73 97.95 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.173 -1.571 . . . . 0.62 109.173 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.4 m170 -70.0 -40.02 75.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -1.117 . . . . 1.5 109.167 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.0 -47.22 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.101 -0.999 . . . . 0.63 109.019 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.1 ttp -60.08 -40.49 89.75 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.992 -1.068 . . . . 1.51 109.836 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.882 HD11 ' CE2' ' B' ' 348' ' ' PHE . 32.2 tp -68.53 -39.93 80.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.444 -0.785 . . . . 0.77 109.289 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.34 -39.97 94.83 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.424 -0.798 . . . . 0.62 109.481 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -79.42 1.72 24.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.319 -0.863 . . . . 1.47 110.171 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -49.42 128.19 16.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.831 -1.168 . . . . 1.47 109.953 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -62.41 -16.82 57.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.55 -0.719 . . . . 1.78 110.566 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.67 -32.71 66.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.788 -1.195 . . . . 2.53 108.813 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.8 mt -70.74 -43.58 68.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.69 -0.631 . . . . 0.8 110.442 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -60.03 -43.31 95.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.046 -1.034 . . . . 1.42 110.47 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.96 -42.87 72.6 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.05 -1.031 . . . . 1.71 110.812 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.14 -39.97 75.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.959 -1.088 . . . . 1.57 111.333 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.6 mt -64.05 -50.03 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.65 109.985 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.5 mt -69.34 -35.36 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.448 -0.783 . . . . 0.82 110.173 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.63 -45.85 92.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 0.79 110.847 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.56 -47.53 85.77 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.911 -1.118 . . . . 0.95 109.982 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.9 mt -60.24 -49.67 83.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 122.093 0.949 . . . . 0.66 108.932 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -69.8 -39.94 76.28 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.15 -0.62 . . . . 2.2 111.175 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -84.83 -57.99 2.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.769 -1.207 . . . . 1.65 112.345 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -83.61 -0.94 52.69 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.964 -1.085 . . . . 2.03 111.419 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 57.34 36.63 27.44 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.117 -0.99 . . . . 1.42 109.854 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.5 mtt -90.27 167.96 12.28 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.568 -0.707 . . . . 1.18 109.976 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.9 p -80.88 160.58 24.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.473 -0.767 . . . . 0.98 109.339 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.56 -40.86 80.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.102 -0.999 . . . . 0.64 110.069 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 31.4 p-10 -64.36 -36.78 85.24 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.252 -0.905 . . . . 2.07 109.221 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.431 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.96 -48.61 12.05 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.036 -1.04 . . . . 0.73 109.844 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.65 -48.95 79.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.527 -0.733 . . . . 0.54 110.952 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.09 93.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.032 -1.043 . . . . 0.56 110.296 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.417 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 81.6 t60 -59.08 -38.27 79.06 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.055 -1.028 . . . . 1.54 110.397 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.71 -41.12 97.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.874 -1.141 . . . . 1.33 110.968 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.05 -52.19 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.013 -1.055 . . . . 0.72 110.715 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.0 mm -66.96 -39.96 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.063 -1.023 . . . . 0.85 108.402 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.417 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 89.2 tt0 -66.22 -38.2 87.37 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.737 -0.838 . . . . 2.44 108.737 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.88 -47.36 90.92 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.312 -1.115 . . . . 0.98 110.312 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -68.33 -53.48 23.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.688 -1.478 . . . . 1.41 108.677 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.89 -39.95 59.86 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.096 -1.002 . . . . 1.2 109.106 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 46.2 t -60.06 -42.74 95.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.099 -1.001 . . . . 1.7 108.544 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.89 87.37 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.394 -0.816 . . . . 1.47 109.188 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.6 mt -67.44 -41.6 84.48 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.909 -1.119 . . . . 1.56 108.986 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -53.65 -31.42 47.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.071 -1.018 . . . . 2.2 109.164 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.6 -24.88 65.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.275 -0.89 . . . . 2.12 108.717 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.42 HD13 HD13 ' A' ' 123' ' ' LEU . 61.0 mt -62.79 143.55 57.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 2.0 109.272 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -99.33 48.98 0.95 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.325 -0.86 . . . . 3.23 109.257 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 56.9 t0 -134.61 132.89 39.55 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.296 -0.878 . . . . 2.49 109.795 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.441 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 18.4 pt-20 -70.25 -29.01 65.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.568 -0.707 . . . . 3.95 109.898 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.478 ' OH ' ' NH1' ' A' ' 126' ' ' ARG . 3.5 t80 -71.1 -39.92 71.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.38 -0.825 . . . . 2.0 110.383 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.464 HD22 ' O ' ' B' ' 351' ' ' GLN . 88.9 mt -79.63 -40.05 30.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.99 . . . . 1.86 109.775 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -60.15 -49.91 75.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.982 -1.074 . . . . 2.84 109.706 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 96.6 mt-10 -61.82 -40.17 94.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 2.73 108.862 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.702 ' CG ' HE22 ' B' ' 351' ' ' GLN . 31.6 ttt180 -60.03 -40.07 88.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.857 -1.164 . . . . 2.77 107.857 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.66 -23.51 66.81 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.261 -1.015 . . . . 1.19 108.261 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -61.46 -40.03 93.05 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.58 -1.267 . . . . 1.2 107.58 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -61.54 -41.44 97.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.515 -0.741 . . . . 1.55 109.082 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 73.1 t -63.65 -40.08 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.273 -1.01 . . . . 0.8 108.273 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -62.7 -33.52 75.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.608 -0.683 . . . . 3.09 109.476 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -59.95 -41.58 92.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 1.46 109.487 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.1 mt -60.09 -45.58 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.163 -0.961 . . . . 0.71 109.863 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.66 -43.31 99.17 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.397 -0.906 . . . . 0.57 111.014 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -59.99 -47.87 84.05 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.011 -1.288 . . . . 2.59 110.901 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.594 HH12 ' CB ' ' A' ' 166' ' ' SER . 99.0 mtt180 -69.32 -29.02 66.77 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.832 -1.167 . . . . 2.83 109.903 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 57.6 tp -59.52 -41.57 90.25 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.555 -0.906 . . . . 1.25 108.555 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.6 mt -61.89 -40.12 94.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.141 -0.974 . . . . 0.7 109.317 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.87 -39.97 83.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.488 -0.757 . . . . 2.57 108.978 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.535 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.9 m120 -60.09 -39.11 84.98 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.583 -0.698 . . . . 1.23 111.279 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.1 mt -73.46 -41.2 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.764 -1.21 . . . . 0.81 109.675 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.2 mt -70.43 -31.79 69.13 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.55 -0.719 . . . . 1.0 109.434 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.12 37.94 6.98 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.215 -1.554 . . . . 0.89 109.215 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 144' ' ' LEU . 16.0 tp -73.63 142.56 46.51 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.263 -1.139 . . . . 1.14 108.644 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -69.16 142.72 54.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.207 -0.933 . . . . 4.6 110.668 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.02 129.99 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-O 122.063 0.935 . . . . 1.24 109.343 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.2 mt -61.48 -43.91 97.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.865 -0.607 . . . . 1.54 110.691 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.6 t0 63.76 103.36 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.38 -0.825 . . . . 1.5 109.094 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.492 ' O ' HD13 ' A' ' 152' ' ' ILE . 22.5 mt -70.53 -6.04 33.39 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.522 -0.736 . . . . 0.79 110.184 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 93.7 p -85.09 -14.0 48.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.128 -0.983 . . . . 1.4 108.681 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.87 14.65 2.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.687 -0.633 . . . . 0.92 111.176 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.492 HD13 ' O ' ' A' ' 149' ' ' LEU . 2.5 mp -89.4 134.34 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.603 -1.31 . . . . 0.88 108.188 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -117.53 -9.02 10.9 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.736 -0.602 . . . . 2.45 109.741 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -119.03 149.98 40.75 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.21 -0.932 . . . . 1.52 110.473 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -63.65 130.97 46.48 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.689 -0.856 . . . . 1.58 108.689 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.4 m -152.07 163.59 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.883 . . . . 0.69 109.518 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.0 mt -94.42 147.85 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 106.036 -1.839 . . . . 0.61 106.036 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.2 tp -97.31 117.4 31.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.086 -1.009 . . . . 0.87 110.905 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.91 126.42 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.215 -1.031 . . . . 0.71 108.215 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.88 161.26 40.61 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.094 -1.004 . . . . 0.81 109.201 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.42 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.35 -31.45 69.89 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.133 -1.604 . . . . 0.98 107.847 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -167.59 173.92 8.2 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.559 -0.904 . . . . 2.25 108.559 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 89.9 mt -141.22 130.04 22.99 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.076 -1.015 . . . . 0.78 108.823 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.8 p -87.89 147.91 42.17 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.03 -1.044 . . . . 0.98 109.23 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -43.38 -36.43 6.55 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.817 1.678 . . . . 0.81 112.125 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.594 ' CB ' HH12 ' A' ' 136' ' ' ARG . 50.3 m -60.04 -39.94 87.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.371 -0.831 . . . . 0.9 109.875 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.1 -40.87 78.12 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.155 -0.966 . . . . 1.61 109.751 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.8 p -55.64 -29.75 59.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.96 -1.087 . . . . 0.61 110.605 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -71.79 -51.21 23.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.879 -1.138 . . . . 0.6 109.573 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -85.02 38.52 0.72 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.417 -0.957 . . . . 1.4 108.417 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.401 HD11 HG21 ' A' ' 176' ' ' VAL . 61.8 tp -102.92 130.6 50.02 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.693 -0.63 . . . . 0.7 109.303 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -83.75 103.65 13.22 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.868 -0.789 . . . . 2.35 108.868 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 77.6 mt -64.86 -43.65 92.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.416 -0.803 . . . . 1.51 111.344 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -69.83 -25.24 63.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.893 -1.13 . . . . 2.33 112.417 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -93.18 -10.12 36.89 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.615 -1.303 . . . . 1.92 110.517 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 178' ' ' GLY . 62.3 t -109.18 119.94 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.137 -1.06 . . . . 0.67 108.137 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.1 mt -90.94 8.09 36.9 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.184 -0.947 . . . . 1.53 111.09 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.505 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.96 172.64 37.4 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.153 -1.499 . . . . 0.48 109.87 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -133.7 128.51 35.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.656 -0.908 . . . . 0.55 108.594 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 97.3 mt -132.67 127.2 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.778 . . . . 0.65 109.204 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 50.4 p -150.02 162.0 41.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.904 -1.123 . . . . 0.82 110.516 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 38.1 p-10 -104.0 23.27 13.19 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.186 -0.672 . . . . 2.46 109.186 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.44 -159.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.057 -1.027 . . . . 1.28 111.644 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.66 -54.22 6.09 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.906 -0.877 . . . . 2.19 110.906 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 160.7 -131.46 2.63 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.147 -1.501 . . . . 2.13 110.732 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.522 HH11 ' HG2' ' A' ' 186' ' ' ARG . 12.5 mtt-85 -69.91 -20.78 63.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.67 -0.9 . . . . 5.86 111.065 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 25.1 p -73.04 -0.17 13.13 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.938 -1.101 . . . . 3.72 110.322 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.9 m -91.09 132.36 36.09 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.067 -1.021 . . . . 1.74 110.064 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -49.89 -48.19 51.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.334 -0.854 . . . . 0.95 109.526 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.455 ' H ' HG22 ' A' ' 190' ' ' THR . 0.0 OUTLIER -56.75 -39.83 74.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.33 -0.856 . . . . 1.55 110.085 -179.286 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 19.7 t -60.09 -43.04 95.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.928 -1.108 . . . . 1.51 109.907 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.33 -41.34 91.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.181 -0.95 . . . . 1.67 109.798 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 86.6 mtp -63.31 -39.98 96.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.168 -0.957 . . . . 1.02 110.175 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.74 -42.89 76.05 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.561 -1.337 . . . . 0.68 108.821 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -59.89 -50.1 75.11 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.455 -0.778 . . . . 2.93 110.041 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.0 m -70.32 -33.95 72.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.093 -1.004 . . . . 0.86 110.711 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 81.8 mt -70.0 -21.36 63.23 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.107 -0.996 . . . . 0.67 109.264 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 60.74 48.89 6.67 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.239 0.542 . . . . 1.5 110.751 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.8 mt -126.42 149.57 67.9 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.218 -1.401 . . . . 0.72 107.218 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.44 137.71 66.59 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.84 1.693 . . . . 0.61 111.593 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.17 151.0 3.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.876 -1.14 . . . . 0.66 111.478 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.8 mt -126.87 143.62 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.964 -1.124 . . . . 0.79 107.964 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.8 m -128.49 -8.8 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 O-C-N 120.736 -1.227 . . . . 0.91 110.864 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.58 21.53 25.77 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 110.397 -1.081 . . . . 1.01 110.397 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 23.0 p -44.46 -44.17 8.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.114 -1.227 . . . . 0.99 110.048 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 93.94 -51.86 2.25 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 120.328 -0.939 . . . . 1.12 111.03 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.9 p -157.34 35.01 0.28 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.516 -1.579 . . . . 1.72 111.444 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.0 t -73.37 -39.86 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.969 -1.082 . . . . 0.89 108.907 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.0 p -56.14 -34.01 65.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.761 . . . . 1.03 110.666 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 23.0 t -71.19 -31.64 67.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.136 -0.977 . . . . 1.83 109.794 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -89.84 -8.22 52.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.838 . . . . 2.27 110.728 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 75.0 t -102.79 131.99 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.011 -1.056 . . . . 0.92 110.528 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -111.33 145.08 39.46 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.066 -1.457 . . . . 2.2 107.066 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.477 ' O ' ' OD1' ' A' ' 215' ' ' ASP . 44.4 p-10 -54.25 137.8 40.29 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.201 -0.937 . . . . 2.36 111.051 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER 89.3 -2.53 0.38 Allowed 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.321 0.581 . . . . 2.38 110.768 178.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -71.36 150.51 45.0 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.336 -0.853 . . . . 2.09 109.497 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -99.09 120.0 38.76 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.234 -1.024 . . . . 1.27 108.234 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 16' ' ' ALA . 73.8 mt -126.64 149.78 49.31 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.565 -0.709 . . . . 0.75 109.861 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.421 HG23 ' CD2' ' A' ' 13' ' ' PHE . 86.9 mt -119.26 129.95 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.301 -1.37 . . . . 0.63 107.301 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 23.9 tp -102.25 119.95 39.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.23 -0.919 . . . . 0.7 109.437 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 223' ' ' VAL . 29.0 t70 -80.1 -41.86 24.71 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.303 -0.873 . . . . 2.31 108.769 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.76 11.67 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.691 -0.63 . . . . 0.78 109.96 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 221' ' ' ASP . 46.7 t -118.84 -35.22 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 106.693 -1.595 . . . . 1.04 106.693 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.452 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 19.9 m120 -112.85 4.6 17.01 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.375 -1.343 . . . . 2.44 107.375 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.664 HD22 ' N ' ' A' ' 4' ' ' GLY . 48.4 t-20 57.58 50.61 10.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.855 -0.528 . . . . 1.55 110.235 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -136.95 147.5 46.38 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.216 -0.927 . . . . 1.99 109.548 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 76.0 t -115.02 129.3 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.545 -0.909 . . . . 0.77 108.545 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -104.48 121.06 42.67 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.768 -0.827 . . . . 0.98 108.768 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 43.1 t -100.08 110.95 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.593 -0.692 . . . . 0.85 109.805 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 51.69 69.94 2.22 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.41 -0.806 . . . . 1.66 110.911 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -90.67 147.64 4.06 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.33 2.687 . . . . 0.95 112.245 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 233' ' ' ASN . 11.0 m -71.02 165.38 23.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.057 -1.027 . . . . 1.84 109.932 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.434 ' N ' HG22 ' A' ' 232' ' ' THR . 41.5 t30 -59.98 -39.92 87.33 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.318 -0.864 . . . . 2.74 109.88 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -60.02 -39.86 87.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.984 . . . . 2.89 109.64 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.32 -44.21 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.155 -0.965 . . . . 1.3 109.049 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 1.09 109.655 -179.813 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 21.8 ttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -153.95 150.84 28.73 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.36 -0.838 . . . . 0.0 108.965 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -148.66 160.05 43.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.98 -1.075 . . . . 0.0 110.171 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -152.12 149.24 28.58 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -109.82 130.24 55.54 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.39 -0.818 . . . . 0.0 109.673 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 1.5 p -131.95 121.51 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 122.167 0.984 . . . . 0.0 112.021 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 50.6 m -75.74 106.1 7.13 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.828 0.823 . . . . 0.0 110.524 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.512 HG22 ' H ' ' B' ' 310' ' ' ALA . 77.9 mt -52.16 123.17 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 122.476 1.131 . . . . 0.0 110.296 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 77.7 p -104.0 23.2 13.3 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.776 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.512 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -82.66 119.47 74.63 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.142 -0.974 . . . . 0.0 109.262 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -66.3 -7.91 18.92 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 120.362 1.165 . . . . 0.0 111.884 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -117.39 6.44 12.64 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.69 176.93 34.25 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.229 -1.949 . . . . 0.0 108.229 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.465 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.3 tp -86.74 96.18 10.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.946 -1.326 . . . . 0.0 108.723 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -97.69 -159.97 0.77 Allowed 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.29 -0.881 . . . . 0.0 110.71 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 24.5 m -59.82 -43.03 94.73 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.033 -1.042 . . . . 0.0 112.303 -175.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.54 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.5 tpt180 -59.74 -64.33 3.14 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 120.356 -1.465 . . . . 0.0 111.428 -178.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -55.37 -33.78 86.66 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 CA-C-N 120.281 1.136 . . . . 0.0 111.782 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.95 71.72 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.46 -40.88 62.8 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.247 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -70.43 -40.06 74.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.031 -1.043 . . . . 0.0 108.674 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -61.44 -53.04 61.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.437 -0.789 . . . . 0.0 110.432 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 77.7 t -68.93 -35.12 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.766 -1.208 . . . . 0.0 109.756 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -59.97 -47.06 87.38 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.869 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -66.34 -40.05 89.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.096 -1.002 . . . . 0.0 109.999 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 326' ' ' ALA . . . . . 0.419 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -64.65 -52.33 57.91 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.019 -1.051 . . . . 0.0 110.789 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -54.49 -10.21 0.39 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.021 -1.049 . . . . 0.0 109.555 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 328' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -71.94 -26.19 73.12 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -101.99 144.99 29.91 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.39 -1.065 . . . . 0.0 109.272 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 8.8 m -90.87 -13.73 33.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.907 -1.121 . . . . 0.0 108.996 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.0 t -62.61 149.88 42.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 109.04 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -67.61 134.62 51.51 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.256 -0.903 . . . . 0.0 109.171 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 90.3 mt -131.12 130.45 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.711 -0.618 . . . . 0.0 109.654 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 98.3 m -129.62 152.36 49.22 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.594 -0.691 . . . . 0.0 109.187 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 61.6 t -116.94 140.47 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 70.4 m -130.36 126.12 36.31 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.211 -0.931 . . . . 0.0 109.497 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 10.8 t -138.65 111.75 7.93 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.232 -0.917 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 46.39 56.38 6.42 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 84.56 -16.2 36.87 Favored Glycine 0 N--CA 1.499 2.873 0 O-C-N 120.223 -1.548 . . . . 0.0 112.299 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -110.65 121.61 45.74 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.922 -1.34 . . . . 0.0 109.482 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 88.4 p -128.25 148.19 50.63 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.811 0.815 . . . . 0.0 109.855 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 342' ' ' ALA . . . . . 0.553 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -144.84 170.38 16.23 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.662 0.744 . . . . 0.0 110.11 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 70.4 m -88.53 140.47 29.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.605 -0.684 . . . . 0.0 109.582 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -83.13 -12.45 57.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.024 -1.048 . . . . 0.0 110.248 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -88.93 20.56 3.51 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 56.1 m -147.81 98.06 2.9 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.734 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.56 HD23 HD22 ' A' ' 79' ' ' LEU . 29.1 tp -60.0 -34.68 73.66 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.882 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.7 m-85 -57.65 -53.53 57.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.709 -1.244 . . . . 0.0 109.942 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -70.05 -21.4 63.18 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.09 -1.006 . . . . 0.0 111.17 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' B' ' 352' ' ' THR . 21.4 mt -69.42 -52.68 24.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.771 -1.206 . . . . 0.0 108.165 178.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.702 HE22 ' CG ' ' A' ' 126' ' ' ARG . 10.3 mm100 -38.33 -22.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.293 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.533 ' N ' ' O ' ' B' ' 350' ' ' LEU . 58.5 p -82.08 -10.2 59.29 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.962 -1.086 . . . . 0.0 110.215 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.553 HD11 ' HB3' ' B' ' 342' ' ' ALA . 70.6 mt -95.5 116.24 28.55 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.066 -1.021 . . . . 0.0 109.076 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -80.27 94.43 1.49 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 27.8 mt -99.82 92.64 5.4 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.237 -1.155 . . . . 0.0 108.556 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 68.4 p -94.6 179.82 5.13 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.07 -1.019 . . . . 0.0 110.632 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 357' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' B' ' 359' ' ' THR . 62.2 tt0 -48.62 157.44 0.37 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.232 1.015 . . . . 0.0 111.236 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.61 23.98 0.02 OUTLIER Glycine 0 N--CA 1.497 2.708 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.499 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 359' ' ' THR . . . . . 0.5 ' N ' ' O ' ' B' ' 357' ' ' GLN . 19.1 m -84.4 111.58 19.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.732 -1.452 . . . . 0.0 109.448 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 23.4 t -76.27 115.68 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 122.318 1.056 . . . . 0.0 109.629 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 19.0 m -112.66 176.6 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 45.9 m -130.74 129.49 42.58 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 84.3 mt -102.96 118.24 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 22.1 m -123.67 134.0 53.81 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.322 -0.861 . . . . 0.0 109.232 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.29 150.55 38.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.179 -0.951 . . . . 0.0 109.74 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -140.09 119.81 13.34 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.555 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.74 -160.93 32.37 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 118.855 -1.641 . . . . 0.0 111.691 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -59.95 -51.65 68.78 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 122.371 -0.487 . . . . 0.0 112.311 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -105.52 9.36 33.49 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.857 -1.152 . . . . 0.0 110.939 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.9 pt-20 -42.7 -34.08 0.84 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.151 -0.968 . . . . 0.0 111.088 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -70.11 -41.31 74.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.963 . . . . 0.0 110.135 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -68.12 -49.89 58.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.2 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.27 -76.03 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.382 -0.824 . . . . 0.0 110.997 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.577 ' O ' HG23 ' B' ' 378' ' ' VAL . 82.0 t -45.3 -36.49 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.98 -1.075 . . . . 0.0 111.033 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -64.53 -52.57 57.11 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.427 -1.421 . . . . 0.0 110.637 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -76.81 -40.18 48.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.665 -1.272 . . . . 0.0 110.588 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 87.7 mt -59.62 -39.28 83.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.014 . . . . 0.0 109.088 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.577 HG23 ' O ' ' B' ' 374' ' ' VAL . 50.6 t -60.98 -41.1 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.104 -0.998 . . . . 0.0 109.283 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 379' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' B' ' 383' ' ' GLU . 7.7 mtmp? -69.05 -55.2 11.5 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.567 -1.333 . . . . 0.0 108.62 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 63.3 tp -55.97 -35.07 66.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.946 -1.096 . . . . 0.0 109.783 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 6.0 ttm -70.29 -39.99 74.53 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.661 -1.275 . . . . 0.0 107.759 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.27 -7.02 58.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.766 -0.584 . . . . 0.0 110.782 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' B' ' 379' ' ' LYS . 49.3 mt-10 -111.34 1.77 17.26 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.953 -1.092 . . . . 0.0 110.989 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 17.8 mt -87.1 126.62 34.89 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.283 -1.511 . . . . 0.0 109.224 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.302 -179.775 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.028 -0.731 . . . . 2.91 109.028 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 95.2 mt -110.02 128.49 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.542 -0.724 . . . . 1.2 109.306 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.7 m -140.06 150.08 43.92 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.398 -0.813 . . . . 1.4 109.654 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.445 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -136.99 -162.94 9.55 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.297 -1.921 . . . . 1.05 108.297 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' LEU . 93.7 mt -90.4 -17.45 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.745 -1.444 . . . . 1.15 109.875 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.9 tp 51.51 103.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.365 -0.834 . . . . 0.98 109.304 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.7 -29.09 12.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.099 -1.0 . . . . 0.88 109.008 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.1 m -130.84 115.11 16.7 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.636 -0.665 . . . . 1.69 109.276 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -80.15 151.02 20.59 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 121.924 1.749 . . . . 0.85 112.627 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.887 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 150.18 169.18 16.01 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.704 -1.759 . . . . 0.92 108.704 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.9 mt -120.04 129.99 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 O-C-N 121.046 -1.267 . . . . 0.81 109.839 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.33 150.38 50.94 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.083 -1.01 . . . . 0.51 110.455 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.5 m-85 -126.87 128.46 46.53 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 107.924 -1.139 . . . . 0.62 107.924 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.56 178.55 48.47 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.583 -1.77 . . . . 0.55 110.977 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -79.98 158.81 26.48 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.892 -0.77 . . . . 2.1 109.244 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.844 ' HB3' ' OD1' ' A' ' 216' ' ' ASP . . . -106.92 129.71 54.7 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.331 -0.855 . . . . 0.77 110.92 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.7 tp -100.34 133.12 45.24 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.11 -1.441 . . . . 0.91 107.11 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.4 tp -114.83 127.32 55.65 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.258 -0.901 . . . . 0.93 109.536 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.4 mt -89.45 102.08 14.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.473 -0.767 . . . . 0.93 110.368 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -103.0 131.82 49.7 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.132 -0.692 . . . . 2.75 109.132 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -130.52 133.82 46.55 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.323 -0.861 . . . . 3.0 109.389 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -73.48 153.49 40.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.063 -1.023 . . . . 2.77 109.521 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -67.63 143.16 56.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 2.94 109.766 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.2 mt -83.13 128.15 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.895 . . . . 0.95 109.342 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.1 t -93.57 131.53 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.234 -0.916 . . . . 1.28 110.652 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.6 mt -107.97 133.57 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.861 -0.792 . . . . 1.21 108.861 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -92.29 119.25 31.69 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.04 -1.038 . . . . 1.81 109.317 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -90.7 -2.51 57.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.299 -0.875 . . . . 2.8 109.506 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -69.17 139.59 54.61 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.16 -0.963 . . . . 2.87 109.218 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -86.05 153.51 22.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.178 -0.951 . . . . 2.35 109.059 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.638 HD13 ' HG3' ' A' ' 39' ' ' GLU . 2.5 pt -98.29 166.19 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.223 -0.923 . . . . 0.97 109.711 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 81.3 p -90.08 171.66 9.38 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.299 -0.876 . . . . 1.17 109.041 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.53 -17.06 64.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.056 -1.027 . . . . 1.18 110.611 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -86.5 -26.64 24.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.863 -1.148 . . . . 2.56 108.012 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -82.31 -8.43 59.64 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.769 -0.826 . . . . 1.79 108.769 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 t -58.4 -50.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.98 -40.01 87.66 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.208 -0.933 . . . . 1.77 108.707 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -61.48 -46.55 89.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.404 -0.81 . . . . 2.7 110.926 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.638 ' HG3' HD13 ' A' ' 31' ' ' ILE . 64.5 mm-40 -60.16 -44.07 95.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.727 -1.233 . . . . 1.51 109.961 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.05 -46.15 94.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 120.918 -1.114 . . . . 0.93 108.737 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -60.03 -41.25 91.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 1.81 109.193 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -60.01 -45.99 90.96 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.914 -1.116 . . . . 2.78 108.092 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -60.52 -48.23 82.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.531 -0.731 . . . . 0.78 109.075 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.04 -49.93 75.73 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.873 -0.788 . . . . 1.07 108.873 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.457 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 47.6 t -61.47 -44.58 96.84 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.175 -0.953 . . . . 1.12 108.515 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.52 -42.84 99.85 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.454 -1.859 . . . . 0.84 108.454 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.401 ' NH1' ' HG2' ' A' ' 47' ' ' ARG . 41.0 ttt-85 -66.08 -31.08 71.73 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.324 -0.991 . . . . 3.09 108.324 178.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.59 -40.02 82.01 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.175 -0.676 . . . . 0.88 109.175 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.7 ttmt -72.33 -73.43 0.19 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.979 -1.076 . . . . 2.59 108.178 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.53 -34.7 0.15 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.339 -0.851 . . . . 0.7 110.736 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.0 m -57.14 -61.29 2.56 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.65 -1.281 . . . . 1.4 108.54 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.0 82.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 0.67 111.248 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -66.28 -42.63 88.12 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.77 -1.206 . . . . 1.66 110.374 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.98 -39.99 96.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.837 -1.165 . . . . 1.58 108.899 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.25 -35.18 79.75 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.324 -0.86 . . . . 1.35 108.822 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -63.66 -41.68 98.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 0.77 109.779 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.22 -40.05 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.124 -0.985 . . . . 0.63 108.917 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -54.75 -49.93 69.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.46 -0.775 . . . . 1.14 109.712 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -58.38 -37.33 75.03 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.344 -0.848 . . . . 0.79 109.868 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -68.18 -37.52 81.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.001 -1.062 . . . . 1.53 109.277 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.715 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -66.65 -46.56 75.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.657 -0.652 . . . . 0.57 109.862 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.96 -50.02 72.26 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.57 -1.012 . . . . 0.75 110.57 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -70.0 -40.66 75.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.944 -1.327 . . . . 1.59 110.103 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.4 m -69.98 -58.26 4.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.061 -1.025 . . . . 0.73 111.474 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.416 ' CE1' ' O ' ' A' ' 168' ' ' THR . 89.2 m-85 -96.3 -51.39 4.4 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.031 -1.043 . . . . 0.75 111.189 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.86 -167.66 25.88 Favored Glycine 0 N--CA 1.503 3.167 0 C-N-CA 119.555 -1.307 . . . . 1.22 111.339 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -66.9 -25.12 66.22 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.866 -0.785 . . . . 5.81 109.991 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.442 ' OE2' ' NH1' ' B' ' 317' ' ' ARG . 23.3 tp10 -60.06 -34.86 74.0 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.604 -0.685 . . . . 3.37 110.81 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -98.12 -19.54 17.87 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.175 -0.953 . . . . 1.77 110.529 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -69.36 -40.01 77.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.785 -1.197 . . . . 1.65 110.029 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.557 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -63.22 -33.98 76.66 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.367 -0.833 . . . . 0.77 109.695 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.8 mt -60.0 -42.88 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.077 -1.015 . . . . 0.8 109.813 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -63.34 -38.67 92.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.911 -1.118 . . . . 0.88 110.327 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -59.96 -39.99 87.49 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.859 -1.151 . . . . 1.37 109.038 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.53 -54.57 34.79 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.424 -1.47 . . . . 0.62 109.424 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -61.31 -48.21 82.43 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.167 -1.196 . . . . 1.5 109.256 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.6 mt -61.79 -50.01 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.257 -0.902 . . . . 0.63 109.18 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.0 ttp -59.98 -40.79 90.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.073 -1.017 . . . . 1.51 110.173 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.844 HD11 ' CE2' ' B' ' 348' ' ' PHE . 35.0 tp -66.54 -39.89 88.79 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.31 -0.868 . . . . 0.77 109.343 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -64.03 -38.76 92.25 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.528 -0.733 . . . . 0.62 109.329 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -80.22 2.54 23.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 1.47 110.06 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -49.17 130.5 19.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.136 -0.978 . . . . 1.47 109.689 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -63.01 -19.07 64.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.696 -0.627 . . . . 1.78 111.411 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -71.98 -32.38 67.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.656 -1.277 . . . . 2.53 108.611 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.1 mt -71.13 -41.39 70.55 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.541 0.686 . . . . 0.8 109.957 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -60.04 -45.66 92.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.868 . . . . 1.42 110.277 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.97 -41.9 73.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.895 . . . . 1.71 110.734 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.97 -39.96 75.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.157 -0.965 . . . . 1.57 111.746 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 93.8 mt -65.4 -49.09 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.977 -1.077 . . . . 0.65 109.652 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -68.25 -37.71 78.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.619 -0.676 . . . . 0.82 110.877 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.97 83.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.057 -1.027 . . . . 0.79 111.054 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 96' ' ' LYS . 78.5 mt -61.89 -46.21 90.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.908 -1.12 . . . . 0.95 110.28 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.0 mt -60.02 -49.77 82.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.084 -1.01 . . . . 0.66 108.655 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -69.95 -40.15 75.63 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.907 -0.588 . . . . 2.2 110.67 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -84.02 -46.96 11.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.016 -1.053 . . . . 1.65 111.72 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 92' ' ' LEU . 30.9 mmtp -94.64 -2.22 51.74 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.014 -1.053 . . . . 2.03 111.952 -177.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 56.26 35.82 26.43 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.788 -1.195 . . . . 1.42 109.638 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.7 mtp -91.64 167.92 11.86 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.461 -0.774 . . . . 1.18 109.54 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.1 p -82.58 160.23 22.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.145 -0.972 . . . . 0.98 109.407 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.5 -39.92 85.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.237 -0.915 . . . . 0.64 110.195 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -65.06 -37.98 89.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.123 -0.986 . . . . 2.07 109.679 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.13 -48.98 11.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.319 -0.863 . . . . 0.73 110.034 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.91 -49.56 74.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.403 -0.81 . . . . 0.54 110.532 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.06 -43.01 95.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -0.967 . . . . 0.56 109.72 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.465 ' HB2' HD21 ' A' ' 138' ' ' LEU . 78.0 t60 -59.99 -40.0 87.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 1.54 110.531 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.06 -39.98 91.91 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.962 -1.086 . . . . 1.33 109.902 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.5 t -62.2 -53.48 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.232 -0.917 . . . . 0.72 110.991 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.4 mm -69.95 -39.98 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.983 -1.073 . . . . 0.85 109.409 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.21 -39.85 94.13 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.393 -0.966 . . . . 2.44 108.393 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.06 -52.78 50.76 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.712 -0.955 . . . . 0.98 110.712 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -69.28 -44.79 71.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.762 -1.434 . . . . 1.41 109.861 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.88 -44.49 91.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.881 -1.137 . . . . 1.2 108.55 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 88.7 p -59.96 -36.74 77.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 1.7 109.066 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.99 94.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 1.47 109.067 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.4 mt -65.8 -42.27 90.9 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.12 -0.988 . . . . 1.56 109.508 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.43 ' C ' ' N ' ' A' ' 118' ' ' LEU . 85.5 tt0 -59.97 -39.59 86.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.909 -1.119 . . . . 2.2 110.082 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -49.26 -17.92 0.3 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.941 -1.1 . . . . 2.12 109.168 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.43 ' N ' ' C ' ' A' ' 116' ' ' GLU . 68.0 mt -62.65 140.4 58.69 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.526 -0.916 . . . . 2.0 108.526 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 49.8 t0 -93.94 44.15 1.12 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.006 -1.059 . . . . 3.23 111.124 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -137.44 150.9 47.96 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.971 -1.08 . . . . 2.49 109.575 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 124' ' ' LYS . 71.8 mm-40 -72.63 -65.82 0.74 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.144 -0.972 . . . . 3.95 109.13 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.638 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 4.0 t80 -39.11 -42.16 0.89 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.836 -0.54 . . . . 2.0 110.404 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.721 HD23 HH22 ' A' ' 126' ' ' ARG . 87.6 mt -70.58 -39.95 73.57 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.845 -1.159 . . . . 1.86 108.03 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 121' ' ' GLU . 32.8 ttmt -62.07 -38.34 88.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.673 -0.642 . . . . 2.84 110.256 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -60.06 -47.32 86.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.082 -1.011 . . . . 2.73 110.633 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.721 HH22 HD23 ' A' ' 123' ' ' LEU . 21.8 mtm-85 -70.08 -30.16 67.33 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.888 -1.133 . . . . 2.77 108.964 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.99 -27.95 67.28 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.428 -1.323 . . . . 1.19 107.428 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.17 -38.94 72.14 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.49 -0.93 . . . . 1.2 108.49 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -62.27 -42.4 99.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.583 -0.698 . . . . 1.55 110.504 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.75 -40.39 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.058 -1.026 . . . . 0.8 109.112 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.541 HH11 ' HG2' ' A' ' 131' ' ' ARG . 2.4 ttt-85 -60.62 -38.63 85.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.907 . . . . 3.09 109.356 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.02 -40.03 87.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.35 -0.844 . . . . 1.46 110.563 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.0 mt -59.94 -45.21 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.796 -1.19 . . . . 0.71 109.446 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.19 -39.98 96.48 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.928 -1.269 . . . . 0.57 109.928 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -59.98 -49.95 75.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.255 -1.144 . . . . 2.59 110.028 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.416 HH12 ' HB3' ' A' ' 166' ' ' SER . 59.8 mtp180 -68.42 -32.15 71.98 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.017 -1.052 . . . . 2.83 110.062 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.5 tp -60.0 -40.58 89.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.098 -1.001 . . . . 1.25 108.758 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.465 HD21 ' HB2' ' A' ' 105' ' ' HIS . 75.5 mt -60.03 -40.55 89.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.173 -0.954 . . . . 0.7 109.26 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -69.97 -40.08 75.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.476 -0.765 . . . . 2.57 109.72 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -62.72 -35.86 81.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.478 -0.764 . . . . 1.23 111.249 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.0 mt -72.92 -41.39 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.617 -1.302 . . . . 0.81 109.273 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.04 -26.32 63.98 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.668 -0.645 . . . . 1.0 109.462 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.27 35.53 20.33 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.688 -1.765 . . . . 0.89 108.688 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 tp -73.27 144.77 46.53 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.484 -1.009 . . . . 1.14 108.831 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -67.06 140.32 57.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -0.914 . . . . 4.6 110.427 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 89.5 mt -110.03 128.6 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.443 -0.947 . . . . 1.24 108.443 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 14.0 mm -60.21 -44.44 95.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.775 -0.578 . . . . 1.54 110.58 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 42.2 t0 62.62 113.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.438 -0.789 . . . . 1.5 108.951 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.12 -1.93 42.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.366 -0.834 . . . . 0.79 110.079 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.2 m -89.02 -17.18 29.91 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.932 -1.105 . . . . 1.4 110.543 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.27 17.75 0.34 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.107 -0.996 . . . . 0.92 111.721 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 32.7 mm -80.21 132.26 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.469 -1.395 . . . . 0.88 109.978 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -110.43 -11.32 14.51 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.685 -0.634 . . . . 2.45 109.525 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -129.96 152.13 49.77 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.578 -0.701 . . . . 1.52 110.012 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -65.36 136.51 56.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.089 -1.007 . . . . 1.58 109.514 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.8 m -153.36 166.69 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.411 -0.806 . . . . 0.69 109.838 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.4 mt -95.84 149.59 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.026 -1.842 . . . . 0.61 106.026 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.1 tp -104.31 119.38 38.82 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.969 -1.082 . . . . 0.87 110.815 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.417 HG12 HG22 ' A' ' 209' ' ' THR . 4.2 t -123.32 132.12 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.663 -0.865 . . . . 0.71 108.663 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -158.46 163.99 36.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.843 -1.161 . . . . 0.81 109.605 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.04 -35.44 71.96 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.3 -1.5 . . . . 0.98 108.485 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 62.8 t0 -169.56 142.76 2.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.133 -0.692 . . . . 2.25 109.133 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.466 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 90.7 mt -111.62 139.52 47.0 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.397 -0.815 . . . . 0.78 109.651 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 64.2 p -94.62 142.88 25.36 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.337 -0.852 . . . . 0.98 109.409 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -40.28 -38.31 2.23 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.195 1.93 . . . . 0.81 112.751 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.416 ' HB3' HH12 ' A' ' 136' ' ' ARG . 52.5 m -56.77 -40.08 75.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.044 -1.035 . . . . 0.9 108.514 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -66.31 -40.66 90.12 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.392 -0.817 . . . . 1.61 109.901 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.416 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 75.6 p -55.66 -24.23 32.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.996 -1.065 . . . . 0.61 110.083 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.715 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -76.74 -58.2 3.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.112 -0.993 . . . . 0.6 109.784 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -82.27 39.75 0.6 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.558 -0.904 . . . . 1.4 108.558 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.5 tp -104.43 133.48 49.24 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.794 -0.817 . . . . 0.7 108.794 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -93.26 103.51 15.76 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.142 -0.974 . . . . 2.35 108.752 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.37 -45.76 89.64 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.26 -0.9 . . . . 1.51 110.084 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -63.79 -28.48 69.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.967 -1.083 . . . . 2.33 112.207 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -92.51 -10.27 38.36 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.521 -1.362 . . . . 1.92 109.825 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 178' ' ' GLY . 63.1 t -109.64 119.91 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.76 -1.2 . . . . 0.67 107.76 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 89.5 mt -89.26 4.92 47.15 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.201 -0.937 . . . . 1.53 111.422 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.463 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 171.26 173.65 38.43 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.134 -1.508 . . . . 0.48 109.679 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -137.4 129.99 29.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.372 -1.076 . . . . 0.55 108.84 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.3 mt -127.98 125.72 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.463 -0.94 . . . . 0.65 108.463 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 19.7 p -145.54 156.86 43.97 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.746 -1.221 . . . . 0.82 111.113 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 183' ' ' ALA . 0.7 OUTLIER -101.04 26.54 6.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.624 -0.673 . . . . 2.46 109.371 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -47.85 -172.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.364 1.078 . . . . 1.28 112.417 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.14 -55.17 4.89 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 111.062 -0.815 . . . . 2.19 111.062 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -160.5 -156.52 8.23 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 118.876 -1.63 . . . . 2.13 111.129 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.411 ' HD2' HH21 ' A' ' 195' ' ' ARG . 86.3 mtm180 -79.94 -10.06 59.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.696 -0.885 . . . . 5.86 109.918 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 60.6 p -74.6 3.14 8.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.153 -0.967 . . . . 3.72 109.477 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.9 t -76.85 133.37 39.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.859 . . . . 1.74 110.049 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -48.26 -50.68 28.82 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.3 -0.875 . . . . 0.95 110.026 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.442 HG23 ' N ' ' A' ' 191' ' ' SER . 14.7 t -58.26 -38.62 77.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.274 -0.891 . . . . 1.55 110.584 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.442 ' N ' HG23 ' A' ' 190' ' ' THR . 25.8 t -60.0 -40.16 88.26 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.0 -1.063 . . . . 1.51 110.288 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.17 -39.91 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 1.67 109.753 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.3 mtp -60.51 -41.58 94.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 1.02 110.901 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.1 95.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.547 -1.346 . . . . 0.68 109.673 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.411 HH21 ' HD2' ' A' ' 186' ' ' ARG . 66.9 mtt-85 -59.97 -47.54 85.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.108 -0.995 . . . . 2.93 109.952 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.5 m -76.57 -32.44 58.16 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.998 -1.063 . . . . 0.86 111.792 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 96.1 mt -79.98 -12.14 59.74 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.641 -1.287 . . . . 0.67 110.364 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 58.33 51.75 8.0 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.38 -0.825 . . . . 1.5 110.917 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.0 mt -127.44 131.94 24.09 Favored Pre-proline 0 N--CA 1.502 2.127 0 N-CA-C 108.892 -0.781 . . . . 0.72 108.892 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -43.45 123.53 3.65 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.937 1.758 . . . . 0.61 112.112 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.96 140.29 9.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.694 -1.254 . . . . 0.66 111.587 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.4 mt -122.84 141.74 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 107.155 -1.424 . . . . 0.79 107.155 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.7 m -124.88 -8.4 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 120.956 -1.09 . . . . 0.91 111.273 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.05 21.24 25.19 Favored Glycine 0 N--CA 1.501 3.024 0 N-CA-C 110.866 -0.894 . . . . 1.01 110.866 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.436 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.0 p -45.28 -43.79 10.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.891 -1.358 . . . . 0.99 110.048 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 93.01 -51.28 2.52 Favored Glycine 0 N--CA 1.5 2.935 0 C-N-CA 120.076 -1.059 . . . . 1.12 111.726 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.428 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 3.6 m -156.92 38.36 0.31 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.528 -1.571 . . . . 1.72 111.209 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.7 t -80.01 -31.26 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.024 -1.048 . . . . 0.89 108.518 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.417 HG22 HG12 ' A' ' 159' ' ' VAL . 55.6 p -58.79 -30.78 67.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.43 -0.794 . . . . 1.03 110.576 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 20.9 t -78.81 -17.94 54.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.926 -1.109 . . . . 1.83 109.731 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -98.64 -8.85 25.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.238 -0.914 . . . . 2.27 110.377 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.415 HG22 HD11 ' A' ' 218' ' ' LEU . 55.1 t -104.83 130.25 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.282 -0.886 . . . . 0.92 110.869 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -108.31 148.79 29.54 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.371 -1.344 . . . . 2.2 107.371 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.439 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 30.0 p-10 -59.97 136.99 58.18 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.101 -1.0 . . . . 2.36 110.901 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.9 m-20 82.59 -0.03 1.3 Allowed 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 116.187 -0.461 . . . . 2.38 111.547 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.844 ' OD1' ' HB3' ' A' ' 16' ' ' ALA . 24.4 p-10 -74.04 158.54 34.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.418 -1.426 . . . . 2.09 108.385 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -99.29 119.56 38.12 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.385 -0.969 . . . . 1.27 108.385 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 16' ' ' ALA . 80.7 mt -125.85 148.73 49.08 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.479 -0.763 . . . . 0.75 109.99 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 78.8 mt -116.16 129.97 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 107.086 -1.449 . . . . 0.63 107.086 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 40.6 tp -105.88 124.33 49.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.029 -1.045 . . . . 0.7 109.11 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.673 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 29.6 p-10 -87.95 -37.47 16.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.043 -1.036 . . . . 2.31 109.866 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.887 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 45.71 16.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.968 -0.752 . . . . 0.78 108.968 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.5 t -126.06 -41.19 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.497 -1.297 . . . . 1.04 107.497 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -106.53 -0.15 24.16 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.831 -1.174 . . . . 2.44 107.831 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.445 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 0.4 OUTLIER 61.69 49.66 4.83 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.401 0.619 . . . . 1.55 109.771 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.673 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 64.5 mt-30 -139.97 150.31 44.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.452 -0.78 . . . . 1.99 109.502 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.1 t -122.68 129.99 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.194 -1.039 . . . . 0.77 108.194 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -101.11 116.66 33.36 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.251 -0.906 . . . . 0.98 109.208 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 36.0 t -98.33 117.09 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.49 -0.756 . . . . 0.85 109.251 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 68.55 70.17 0.42 Allowed Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.27 -0.894 . . . . 1.66 109.408 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -89.79 118.27 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 123.376 2.717 . . . . 0.95 112.744 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.615 HG22 ' N ' ' A' ' 233' ' ' ASN . 96.4 m -67.97 170.52 8.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.174 -0.954 . . . . 1.84 108.989 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.615 ' N ' HG22 ' A' ' 232' ' ' THR . 95.2 m-20 -59.84 -40.12 87.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.0 -1.062 . . . . 2.74 109.238 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.58 -39.91 92.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.838 . . . . 2.89 109.197 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.54 -42.74 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 1.3 109.882 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.194 -0.941 . . . . 1.09 109.577 -179.804 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 49.7 ttp . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.448 0.642 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -150.11 147.35 27.67 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -147.7 157.13 43.4 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.865 -1.147 . . . . 0.0 110.817 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -153.51 148.92 27.14 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -112.59 131.05 55.8 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.142 -0.974 . . . . 0.0 109.656 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.407 ' CG1' ' SD ' ' B' ' 381' ' ' MET . 1.9 p -132.79 125.15 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-O 122.146 0.974 . . . . 0.0 112.073 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 21.1 m -77.21 104.8 7.93 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.046 0.927 . . . . 0.0 110.766 -178.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' B' ' 358' ' ' GLY . 97.0 mt -52.81 124.64 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 122.429 1.109 . . . . 0.0 111.026 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 62.4 p -112.5 20.19 16.86 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.682 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.402 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -66.15 118.68 55.12 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.988 -1.07 . . . . 0.0 108.891 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -49.58 -26.07 12.05 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 CA-C-N 120.354 1.162 . . . . 0.0 112.718 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -120.52 17.58 12.09 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.642 -0.661 . . . . 0.0 109.352 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.76 179.75 32.74 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.468 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -87.86 94.8 9.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -1.223 . . . . 0.0 109.309 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -96.08 -160.43 0.79 Allowed 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.948 -1.095 . . . . 0.0 110.09 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 15.5 m -58.87 -42.79 90.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.076 -1.015 . . . . 0.0 112.546 -175.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.557 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.5 tpt180 -61.13 -61.41 8.02 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 120.452 -1.405 . . . . 0.0 112.119 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -59.3 -33.67 97.82 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 CA-C-N 120.394 1.176 . . . . 0.0 111.656 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.98 75.53 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.13 -41.4 65.01 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.474 -0.766 . . . . 0.0 109.801 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -69.97 -40.03 75.62 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.971 -1.08 . . . . 0.0 108.24 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -61.2 -52.47 64.65 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.2 -0.937 . . . . 0.0 110.432 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 94.7 t -62.79 -28.92 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.659 -1.275 . . . . 0.0 109.587 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -59.95 -44.6 94.3 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.537 -0.727 . . . . 0.0 109.041 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -67.65 -42.71 81.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.89 . . . . 0.0 111.378 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 326' ' ' ALA . . . . . 0.4 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -59.9 -53.89 52.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.556 -1.34 . . . . 0.0 110.97 -178.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 32.3 mttp -52.82 -12.57 0.32 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 109.768 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 328' ' ' GLY . . . . . 0.4 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -77.74 -24.14 65.49 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -105.82 140.09 39.38 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.558 -0.966 . . . . 0.0 109.087 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 26.1 p -90.43 -10.93 41.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.109 -0.994 . . . . 0.0 109.926 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.486 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 79.7 p -67.49 152.36 45.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -0.939 . . . . 0.0 109.502 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.9 137.71 51.84 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.138 -0.976 . . . . 0.0 108.559 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 76.8 mt -131.85 132.68 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.666 -0.646 . . . . 0.0 109.293 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 24.0 m -129.52 148.67 51.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.552 -0.718 . . . . 0.0 109.089 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 70.0 t -123.19 116.16 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 45.9 m -105.57 130.35 53.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.304 -0.872 . . . . 0.0 109.337 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 43.2 t -139.32 119.07 13.17 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.028 0.918 . . . . 0.0 111.272 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 43.92 50.1 7.11 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.13 -14.41 60.78 Favored Glycine 0 N--CA 1.501 3.03 0 O-C-N 120.15 -1.594 . . . . 0.0 112.786 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -117.24 128.45 55.1 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-N 119.208 1.504 . . . . 0.0 110.082 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 80.3 p -126.33 148.33 49.57 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.774 0.797 . . . . 0.0 110.453 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -142.91 166.01 25.79 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 121.534 0.683 . . . . 0.0 110.145 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 25.1 m -87.25 133.62 33.65 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.473 -0.767 . . . . 0.0 110.377 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -72.63 -17.37 61.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.073 -1.017 . . . . 0.0 109.911 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -87.21 20.94 2.55 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 7.3 m -149.08 96.02 2.48 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.836 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.715 HD23 HD22 ' A' ' 79' ' ' LEU . 61.6 tp -58.16 -36.2 72.66 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.844 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.8 m-85 -54.68 -54.01 47.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.796 -1.19 . . . . 0.0 110.193 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -71.3 -19.56 62.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.923 . . . . 0.0 111.699 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' B' ' 352' ' ' THR . 73.6 mt -71.01 -57.96 4.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.453 -1.404 . . . . 0.0 110.318 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.562 ' NE2' ' HE ' ' A' ' 126' ' ' ARG . 9.2 mm100 -43.16 -12.56 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.681 -0.637 . . . . 0.0 111.348 -176.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.571 ' N ' ' O ' ' B' ' 350' ' ' LEU . 77.1 p -86.01 -10.89 54.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.328 -1.483 . . . . 0.0 110.104 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 59.1 mt -92.74 117.98 30.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.03 -1.044 . . . . 0.0 109.021 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -71.96 90.24 0.49 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 23.7 mt -100.4 90.13 4.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.353 -1.086 . . . . 0.0 109.043 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 31.7 p -92.65 154.59 18.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.906 -1.121 . . . . 0.0 110.436 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -50.87 119.34 3.82 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.611 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 358' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 102.09 3.07 51.62 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 44.2 m -87.72 114.92 24.79 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.219 -1.165 . . . . 0.0 111.852 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.99 115.16 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 122.171 0.986 . . . . 0.0 109.939 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 14.5 m -110.49 177.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 22.5 m -130.53 129.3 42.68 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 48.5 mt -102.64 112.95 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 69.2 p -118.62 131.05 56.18 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.157 -0.964 . . . . 0.0 109.287 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.15 151.28 39.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.201 -0.937 . . . . 0.0 109.627 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -146.45 125.93 13.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.346 -0.846 . . . . 0.0 109.394 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.555 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.05 -156.24 26.92 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.496 -1.335 . . . . 0.0 111.182 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.03 -50.71 72.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.109 -0.642 . . . . 0.0 112.271 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.486 ' H ' ' HB3' ' B' ' 331' ' ' SER . 93.0 m-20 -106.42 11.36 30.91 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.868 -1.145 . . . . 0.0 111.336 -177.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.9 pt-20 -44.75 -35.7 2.83 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.986 -1.071 . . . . 0.0 111.117 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -70.53 -42.67 70.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.926 -1.109 . . . . 0.0 110.026 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.95 -48.97 66.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.397 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -46.61 -75.13 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.432 -0.792 . . . . 0.0 110.882 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.497 ' O ' HG23 ' B' ' 378' ' ' VAL . 32.6 t -44.66 -34.81 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.068 -1.02 . . . . 0.0 110.942 -177.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -66.47 -46.09 77.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.421 -1.424 . . . . 0.0 110.301 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -80.37 -42.31 23.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.766 -1.209 . . . . 0.0 109.742 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 109.485 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.497 HG23 ' O ' ' B' ' 374' ' ' VAL . 44.0 t -61.95 -42.0 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.003 -1.061 . . . . 0.0 109.51 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -69.89 -55.1 10.61 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.451 -1.3 . . . . 0.0 107.909 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 48.8 tp -57.56 -35.07 69.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.231 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 381' ' ' MET . . . . . 0.407 ' SD ' ' CG1' ' B' ' 306' ' ' VAL . 39.6 ttm -70.46 -39.94 74.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.217 -1.552 . . . . 0.0 108.359 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.49 -4.83 58.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.586 -0.696 . . . . 0.0 110.335 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -113.6 -3.39 13.63 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.034 -1.041 . . . . 0.0 111.072 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 13.7 mt -79.29 135.36 36.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.331 -1.481 . . . . 0.0 109.437 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.497 -179.572 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 mmt . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.466 -0.568 . . . . 2.91 109.466 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.5 mt -110.18 129.69 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.689 -0.856 . . . . 1.2 108.689 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.9 m -138.37 119.49 14.52 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.288 -0.883 . . . . 1.4 109.05 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.81 -162.02 36.64 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.123 -1.591 . . . . 1.05 109.123 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 5' ' ' ILE . 97.2 mt -93.5 -9.91 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.046 -1.267 . . . . 1.15 110.058 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.471 HD11 ' O ' ' A' ' 8' ' ' SER . 58.8 tp 54.94 96.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.18 -0.95 . . . . 0.98 109.184 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.66 -40.15 73.17 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.665 -0.865 . . . . 0.88 108.665 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.471 ' O ' HD11 ' A' ' 6' ' ' LEU . 3.4 p -145.9 143.22 19.05 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.482 -0.761 . . . . 1.69 109.049 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.52 143.17 16.89 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.21 1.94 . . . . 0.85 112.705 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.875 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.45 -163.88 36.88 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.299 -1.52 . . . . 0.92 109.299 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.1 mt -149.34 149.69 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.051 -1.264 . . . . 0.81 108.332 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.88 151.62 31.52 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.954 -1.091 . . . . 0.51 110.183 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.5 m-85 -134.88 125.27 26.43 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.391 -0.966 . . . . 0.62 108.391 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.75 179.32 47.11 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 118.87 -1.633 . . . . 0.55 110.607 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -76.96 154.73 33.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.759 -0.848 . . . . 2.1 109.006 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -100.02 136.52 39.8 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.336 -0.852 . . . . 0.77 111.052 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.1 tp -104.99 133.28 50.05 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.533 -1.284 . . . . 0.91 107.533 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 64.4 tp -115.14 122.27 45.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.252 -0.905 . . . . 0.93 110.222 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.7 mt -88.71 100.51 13.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.677 -0.639 . . . . 0.93 109.761 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -86.84 139.51 30.6 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.072 -1.084 . . . . 2.75 108.072 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -130.93 136.6 48.73 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.025 -1.047 . . . . 3.0 109.41 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -91.77 137.89 31.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.11 -0.994 . . . . 2.77 109.147 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.03 139.97 57.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 2.94 109.857 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.5 mt -82.51 130.11 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.449 -0.782 . . . . 0.95 109.597 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.5 t -97.21 128.16 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.231 -0.918 . . . . 1.28 110.066 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -109.98 130.05 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.746 -0.835 . . . . 1.21 108.746 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -82.03 127.03 32.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.091 -1.005 . . . . 1.81 110.355 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -89.96 -1.64 58.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.384 -0.823 . . . . 2.8 109.149 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.37 142.18 52.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 2.87 109.681 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -85.19 150.1 25.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.279 -0.888 . . . . 2.35 109.275 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.496 HG21 ' HG3' ' A' ' 39' ' ' GLU . 5.5 pt -91.09 164.56 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.162 -0.961 . . . . 0.97 110.072 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.2 p -89.55 170.59 10.37 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.425 -0.954 . . . . 1.17 108.425 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.32 -19.8 63.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.848 -1.158 . . . . 1.18 110.402 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -82.74 -24.02 33.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.776 -1.203 . . . . 2.56 107.925 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -81.88 -8.75 59.7 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.889 -0.782 . . . . 1.79 108.889 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.68 -53.85 39.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.089 -1.007 . . . . 1.0 108.646 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -62.79 -40.15 96.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 1.77 109.644 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -69.96 -40.07 75.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.079 -1.013 . . . . 2.7 109.976 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.496 ' HG3' HG21 ' A' ' 31' ' ' ILE . 51.3 mm-40 -67.09 -40.0 86.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.067 -1.021 . . . . 1.51 109.689 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.31 -46.44 96.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.92 -1.113 . . . . 0.93 108.34 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -60.07 -40.88 91.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.918 . . . . 1.81 108.941 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.428 HH11 ' HG2' ' A' ' 42' ' ' ARG . 52.1 mtt-85 -60.08 -45.98 91.09 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.897 -1.149 . . . . 2.78 107.897 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -60.07 -49.2 78.57 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.442 -0.786 . . . . 0.78 108.944 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.04 -47.72 84.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.287 -0.883 . . . . 1.07 108.7 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.7 t -61.8 -41.38 97.68 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.228 -1.027 . . . . 1.12 108.228 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.54 -49.77 73.39 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.819 -1.712 . . . . 0.84 108.819 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -65.38 -35.47 81.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.343 -1.093 . . . . 3.09 108.468 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.53 -47.71 72.83 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.356 -0.84 . . . . 0.88 109.097 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 50' ' ' ALA . 32.5 ttpt -63.5 -72.97 0.12 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.889 -1.124 . . . . 2.59 107.972 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.88 -34.0 0.1 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.298 -0.876 . . . . 0.7 111.34 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.5 t -57.22 -52.85 63.67 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.616 -1.303 . . . . 1.4 108.526 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.14 -40.07 78.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 0.67 110.914 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -64.65 -40.13 94.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.081 -1.012 . . . . 1.66 109.974 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.6 -40.02 95.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.854 -1.154 . . . . 1.58 108.487 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -62.1 -34.36 76.18 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.657 -0.868 . . . . 1.35 108.657 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -65.32 -42.96 92.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 0.77 109.086 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.07 -39.94 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.302 -0.873 . . . . 0.63 108.815 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -55.17 -49.71 71.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.618 -0.677 . . . . 1.14 109.38 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.1 m -56.86 -33.47 66.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.337 -0.852 . . . . 0.79 110.747 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -68.17 -38.63 82.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.891 -1.131 . . . . 1.53 109.869 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.52 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -68.07 -47.22 68.9 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.606 -0.684 . . . . 0.57 110.915 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.03 -52.15 50.98 Favored Glycine 0 N--CA 1.486 1.983 0 C-N-CA 119.79 -1.195 . . . . 0.75 110.283 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.03 -42.91 72.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.838 -1.389 . . . . 1.59 110.592 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.0 m -69.96 -58.43 3.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.129 -0.982 . . . . 0.73 112.232 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -95.62 -54.58 3.32 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.978 -1.076 . . . . 0.75 111.159 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.01 -160.49 26.72 Favored Glycine 0 N--CA 1.501 3.033 0 O-C-N 120.849 -1.157 . . . . 1.22 110.415 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -70.01 -22.94 63.06 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.481 -1.011 . . . . 5.81 110.311 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -59.9 -37.66 80.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 3.37 110.296 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.519 ' HA ' HD12 ' A' ' 72' ' ' ILE . 67.3 mmtt -98.59 -18.48 18.1 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.33 -0.856 . . . . 1.77 110.829 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -70.0 -42.79 72.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.575 -1.328 . . . . 1.65 110.542 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.511 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.52 -30.35 71.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 0.77 109.672 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 69' ' ' LYS . 81.6 mt -60.03 -43.64 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.104 -0.997 . . . . 0.8 109.943 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -66.03 -39.97 90.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.949 -1.094 . . . . 0.88 110.531 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -60.07 -39.98 87.93 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.808 -1.182 . . . . 1.37 108.949 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.06 -49.77 64.95 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.929 -1.669 . . . . 0.62 108.929 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -64.72 -41.22 96.14 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.368 -1.078 . . . . 1.5 108.852 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.8 mt -69.96 -42.58 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.114 -0.991 . . . . 0.63 109.214 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.31 -39.98 88.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.985 -1.072 . . . . 1.51 109.737 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.833 HD22 HD23 ' B' ' 347' ' ' LEU . 59.1 tp -66.56 -40.03 88.83 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.503 -0.748 . . . . 0.77 109.806 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.4 tp -60.05 -40.09 88.22 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.638 -0.825 . . . . 0.62 109.155 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -82.64 10.03 8.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.272 -0.893 . . . . 1.47 109.55 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 55.8 t0 -59.94 133.27 55.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.892 . . . . 1.47 110.421 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.468 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 96.7 mt-10 -59.91 -16.04 26.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.699 -0.625 . . . . 1.78 110.445 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -70.05 -37.46 75.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.969 -1.082 . . . . 2.53 108.859 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -73.69 -43.66 58.72 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.461 0.648 . . . . 0.8 110.642 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -59.95 -50.0 75.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.935 . . . . 1.42 110.851 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.51 -42.15 71.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.082 -1.011 . . . . 1.71 111.11 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.88 -39.97 72.54 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.058 -1.026 . . . . 1.57 112.273 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.04 -42.26 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.813 -1.179 . . . . 0.65 109.86 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.03 -39.29 77.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.584 -0.698 . . . . 0.82 110.303 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.93 -50.0 75.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.122 -0.986 . . . . 0.79 111.723 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.94 -44.3 94.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.661 -1.275 . . . . 0.95 109.641 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.6 mt -61.77 -46.66 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -0.866 . . . . 0.66 108.883 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -70.02 -40.98 74.88 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.924 -0.71 . . . . 2.2 110.74 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -82.24 -51.88 7.5 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.071 -1.018 . . . . 1.65 112.151 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.07 -3.16 58.1 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.961 -1.087 . . . . 2.03 111.684 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.2 m170 57.62 38.58 27.8 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.954 -1.091 . . . . 1.42 109.78 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.0 mtp -89.3 169.94 11.0 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.476 -0.765 . . . . 1.18 110.015 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 102' ' ' ALA . 72.7 p -79.9 159.73 26.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.921 . . . . 0.98 109.664 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.03 -40.04 75.4 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.46 -0.775 . . . . 0.64 109.99 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 31.4 p-10 -69.49 -38.82 77.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.14 -0.975 . . . . 2.07 110.229 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.436 ' HB3' ' OG1' ' A' ' 99' ' ' THR . . . -81.02 -40.67 23.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.972 -1.08 . . . . 0.73 109.933 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.11 -47.43 61.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.54 110.623 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.87 92.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.003 -1.061 . . . . 0.56 110.008 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -59.94 -38.6 82.88 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.289 -0.882 . . . . 1.54 110.406 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.0 -39.95 93.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.017 -1.052 . . . . 1.33 110.682 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.7 t -64.76 -50.14 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.938 -1.101 . . . . 0.72 110.815 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.17 -39.92 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.873 -1.142 . . . . 0.85 108.599 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -66.36 -37.42 85.26 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.718 -0.845 . . . . 2.44 108.718 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.439 ' O ' ' OG ' ' A' ' 113' ' ' SER . . . -60.07 -49.9 73.5 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 120.547 -0.835 . . . . 0.98 111.019 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -66.0 -50.43 64.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.503 -1.586 . . . . 1.41 109.746 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.15 84.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.844 . . . . 1.2 109.693 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 110' ' ' GLY . 85.0 p -55.56 -39.75 71.03 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.062 -1.024 . . . . 1.7 109.0 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.91 -31.36 69.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.913 . . . . 1.47 109.883 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.4 mt -69.93 -41.15 74.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.784 -1.197 . . . . 1.56 110.235 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -69.33 -22.57 63.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.131 -1.606 . . . . 2.2 109.367 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -59.85 -20.58 57.9 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.387 -1.338 . . . . 2.12 107.387 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 123' ' ' LEU . 35.0 mt -62.94 140.06 58.81 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.106 -1.072 . . . . 2.0 108.106 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -85.76 41.51 0.91 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.952 -1.093 . . . . 3.23 109.134 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 53.3 t0 -131.96 142.46 49.63 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.575 -0.703 . . . . 2.49 109.707 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.499 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 81.6 mm-40 -73.87 -65.33 0.85 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.799 0.809 . . . . 3.95 108.835 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.633 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 4.1 t80 -39.28 -42.33 1.0 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.937 -0.477 . . . . 2.0 111.082 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.531 HD23 HH22 ' A' ' 126' ' ' ARG . 66.1 mt -70.56 -40.04 73.58 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.561 -1.337 . . . . 1.86 108.225 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 121' ' ' GLU . 62.8 tttp -68.67 -33.69 74.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.545 -0.722 . . . . 2.84 109.491 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 187' ' ' THR . 69.1 mm-40 -59.99 -44.9 94.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.806 -1.184 . . . . 2.73 109.629 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.672 ' HE ' HE22 ' B' ' 351' ' ' GLN . 20.5 mtm-85 -69.97 -30.36 67.7 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.895 -1.128 . . . . 2.77 108.592 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.89 -28.08 67.26 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.888 -1.153 . . . . 1.19 107.888 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.91 -38.88 69.85 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.158 -1.053 . . . . 1.2 108.158 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.85 -40.08 94.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 1.55 110.229 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.01 -40.0 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.993 -1.067 . . . . 0.8 108.446 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -60.01 -38.68 83.37 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.48 -0.933 . . . . 3.09 108.48 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -59.98 -37.43 79.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.567 -0.708 . . . . 1.46 109.545 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.98 -41.84 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.71 110.253 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.35 -31.75 53.74 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.574 -1.298 . . . . 0.57 110.354 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -60.05 -49.9 75.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.121 -1.223 . . . . 2.59 110.129 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -65.41 -31.99 73.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.912 -1.117 . . . . 2.83 109.829 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.89 -40.03 87.33 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.674 -0.862 . . . . 1.25 108.674 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.6 mt -61.03 -40.06 92.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.7 109.287 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.448 HH11 ' HG2' ' A' ' 139' ' ' ARG . 46.8 mtt-85 -65.44 -39.76 92.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 2.57 108.908 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -67.0 -33.38 75.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.606 -0.684 . . . . 1.23 111.759 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.03 -39.91 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.29 -1.507 . . . . 0.81 109.409 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.1 mt -77.26 -21.05 54.28 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.774 -0.77 . . . . 1.0 110.275 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.9 37.15 13.55 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.343 -1.903 . . . . 0.89 108.343 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 tp -73.1 140.83 47.42 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.591 -0.947 . . . . 1.14 108.761 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -73.92 138.38 44.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 4.6 109.613 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.1 mt -107.0 135.01 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-O 122.262 1.03 . . . . 1.24 110.065 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 148' ' ' ASP . 11.4 mt -69.52 -39.92 79.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.396 -0.82 . . . . 1.54 110.651 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 147' ' ' ILE . 48.9 t0 60.17 125.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.565 -0.709 . . . . 1.5 109.651 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.51 ' O ' HD12 ' A' ' 152' ' ' ILE . 43.0 mt -83.84 -3.41 57.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.24 -0.912 . . . . 0.79 109.783 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.6 m -81.79 -12.9 58.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.135 -0.978 . . . . 1.4 109.188 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.72 27.97 0.28 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.575 -0.703 . . . . 0.92 110.418 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 149' ' ' LEU . 57.9 mt -91.29 119.88 39.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.123 -0.986 . . . . 0.88 109.739 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -101.38 -9.49 21.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.297 -0.877 . . . . 2.45 109.997 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -139.17 158.38 44.28 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.072 -1.018 . . . . 1.52 110.207 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.73 138.59 58.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.864 . . . . 1.58 109.026 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 24.6 m -153.12 166.24 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.439 -0.788 . . . . 0.69 109.772 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.7 mt -96.63 146.15 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 105.415 -2.069 . . . . 0.61 105.415 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 45.7 tp -95.94 116.81 29.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.907 -1.12 . . . . 0.87 110.461 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.9 t -120.03 127.92 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.684 -1.228 . . . . 0.71 107.684 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -158.97 164.5 35.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.997 -1.064 . . . . 0.81 108.903 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.29 -35.11 68.6 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.405 -1.434 . . . . 0.98 108.806 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 58.5 t0 -170.51 146.48 2.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.366 -0.834 . . . . 2.25 109.586 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.515 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 39.3 mt -118.36 140.03 50.45 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.274 -0.891 . . . . 0.78 109.75 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.6 p -101.91 151.59 38.01 Favored Pre-proline 0 N--CA 1.5 2.075 0 O-C-N 121.351 -0.843 . . . . 0.98 109.785 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -40.26 -40.11 2.84 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.652 2.235 . . . . 0.81 113.233 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.8 m -59.96 -40.01 87.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 0.9 109.7 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.31 -40.6 86.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.125 -0.984 . . . . 1.61 110.375 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 67.3 p -58.73 -32.79 69.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.107 -0.995 . . . . 0.61 111.311 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -69.64 -49.63 51.95 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.693 -1.254 . . . . 0.6 109.966 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -86.99 38.08 0.79 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.919 -1.141 . . . . 1.4 107.919 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.9 tp -106.28 130.3 54.16 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.002 -0.74 . . . . 0.7 109.002 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.412 ' N ' HD22 ' A' ' 172' ' ' ASN . 3.1 m120 -84.06 105.39 14.89 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.482 -0.933 . . . . 2.35 108.482 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.49 -40.53 93.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.808 . . . . 1.51 110.816 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -69.81 -23.1 63.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.779 -1.201 . . . . 2.33 111.836 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -93.31 -8.64 41.48 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.669 -1.27 . . . . 1.92 110.003 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.553 HG12 ' H ' ' A' ' 178' ' ' GLY . 90.1 t -110.03 119.97 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.541 -0.911 . . . . 0.67 108.541 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 65.9 mt -90.65 6.61 43.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.294 -0.879 . . . . 1.53 110.476 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.553 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.58 170.39 36.3 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.279 -1.528 . . . . 0.48 109.279 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.407 ' CE1' HG11 ' A' ' 176' ' ' VAL . 27.0 m-85 -129.98 129.09 43.3 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.508 -0.995 . . . . 0.55 108.834 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.437 ' CG2' HG21 ' A' ' 205' ' ' THR . 72.7 mt -131.05 121.85 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.546 -0.909 . . . . 0.65 108.546 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.3 p -142.5 156.68 45.17 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.332 -0.855 . . . . 0.82 111.197 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 183' ' ' ALA . 94.3 m-20 -90.09 18.61 5.69 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.596 -0.69 . . . . 2.46 109.266 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.37 -162.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.872 -1.143 . . . . 1.28 111.355 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -102.51 -33.99 4.3 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.527 -1.029 . . . . 2.19 110.527 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 157.24 -143.1 9.2 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 118.822 -1.656 . . . . 2.13 111.235 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -59.96 -28.39 67.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.826 -0.808 . . . . 5.86 110.692 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' THR . . . . . 0.431 ' O ' ' OE1' ' A' ' 125' ' ' GLU . 61.4 p -59.99 -10.27 3.98 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.991 -1.068 . . . . 3.72 109.145 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.5 t -91.64 124.66 35.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 1.74 109.41 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 62.0 t60 -48.05 -49.76 30.26 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.034 -1.041 . . . . 0.95 109.868 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.459 ' H ' HG22 ' A' ' 190' ' ' THR . 0.0 OUTLIER -53.19 -40.48 64.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.32 -0.863 . . . . 1.55 110.358 -179.009 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 56.1 m -60.04 -40.0 87.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.958 -1.089 . . . . 1.51 110.529 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.6 mm -61.12 -43.58 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.288 -0.882 . . . . 1.67 110.115 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.4 mtp -62.87 -40.06 96.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 1.02 110.681 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.92 78.11 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.58 -1.325 . . . . 0.68 109.054 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -60.03 -49.92 75.78 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.413 -0.805 . . . . 2.93 110.089 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.0 m -72.75 -33.44 66.35 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.086 -1.009 . . . . 0.86 110.534 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.7 mt -71.55 -26.82 62.79 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.144 -0.973 . . . . 0.67 108.384 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 61.45 50.57 4.57 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.978 -0.451 . . . . 1.5 110.833 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 73.4 mt -124.36 146.88 53.38 Favored Pre-proline 0 N--CA 1.505 2.307 0 N-CA-C 108.792 -0.818 . . . . 0.72 108.792 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -45.06 121.83 3.9 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.829 1.686 . . . . 0.61 111.715 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -158.18 136.78 11.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.382 -1.449 . . . . 0.66 111.966 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.519 ' CD1' HD11 ' A' ' 220' ' ' LEU . 61.6 mt -121.03 145.32 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 106.691 -1.596 . . . . 0.79 106.691 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.5 -7.19 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.731 -1.231 . . . . 0.91 111.287 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -106.4 22.61 30.42 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.874 -1.29 . . . . 1.01 109.874 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.437 HG21 ' CG2' ' A' ' 180' ' ' ILE . 2.0 p -51.16 -41.41 60.13 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.051 -1.264 . . . . 0.99 110.333 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.426 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 84.67 -77.15 2.14 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.667 -1.254 . . . . 1.12 111.781 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 79.5 p -125.13 27.68 6.59 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 121.253 -1.145 . . . . 1.72 112.882 -177.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.96 -40.89 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.295 -1.503 . . . . 0.89 109.123 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 209' ' ' THR . 12.4 p -52.64 -26.75 14.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.878 . . . . 1.03 110.222 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.2 m -80.42 -15.83 55.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.016 -1.053 . . . . 1.83 109.931 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -103.78 -9.54 18.98 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.364 -0.835 . . . . 2.27 110.257 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 63.3 t -110.4 134.61 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.404 -0.81 . . . . 0.92 111.645 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -113.87 150.69 33.26 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.362 -1.348 . . . . 2.2 107.362 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 8.8 p30 -54.51 139.49 37.64 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.815 -1.178 . . . . 2.36 109.983 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.8 m-20 83.53 10.72 0.48 Allowed 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 121.19 0.519 . . . . 2.38 110.188 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.8 t0 -80.06 139.88 36.73 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.334 -0.853 . . . . 2.09 109.407 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.54 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 28.0 t80 -88.98 115.26 26.4 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.32 -0.993 . . . . 1.27 108.32 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 83.0 mt -127.78 149.23 50.35 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.49 -0.756 . . . . 0.75 110.505 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.402 HG23 ' CD2' ' A' ' 13' ' ' PHE . 85.6 mt -115.24 129.06 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 106.859 -1.534 . . . . 0.63 106.859 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.519 HD11 ' CD1' ' A' ' 202' ' ' ILE . 26.1 tp -99.89 119.31 38.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.063 -1.023 . . . . 0.7 110.044 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.496 ' C ' ' N ' ' A' ' 223' ' ' VAL . 84.1 m-20 -76.47 -44.46 35.43 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.233 -0.917 . . . . 2.31 108.569 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.875 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 48.89 15.8 0.1 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.35 -0.982 . . . . 0.78 108.35 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.496 ' N ' ' C ' ' A' ' 221' ' ' ASP . 41.6 t -132.19 -46.12 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.293 -1.373 . . . . 1.04 107.293 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -97.8 0.51 46.95 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.469 -1.308 . . . . 2.44 107.469 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 60.07 45.35 12.01 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.036 -0.728 . . . . 1.55 109.036 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -138.68 150.07 45.81 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.402 -0.811 . . . . 1.99 109.83 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.0 t -121.08 130.01 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.615 -0.883 . . . . 0.77 108.615 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -98.1 119.91 37.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.317 -0.864 . . . . 0.98 108.955 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.9 t -100.35 113.52 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.632 -0.667 . . . . 0.85 109.981 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 8.1 t30 69.25 69.92 0.4 Allowed Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.439 -0.788 . . . . 1.66 109.425 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -90.8 126.39 1.17 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 123.588 2.858 . . . . 0.95 112.73 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 35.0 p -70.97 166.55 21.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.16 -0.963 . . . . 1.84 109.48 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -59.96 -40.0 87.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.27 -0.894 . . . . 2.74 110.558 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -59.94 -40.03 87.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 2.89 110.337 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.21 -40.01 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.985 -1.072 . . . . 1.3 109.49 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.191 -0.943 . . . . 1.09 110.017 -179.571 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 10.9 ttt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.471 0.653 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -152.38 151.99 31.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 109.512 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -147.84 158.84 44.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.128 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 304' ' ' GLN . . . . . 0.43 ' NE2' ' OE2' ' B' ' 305' ' ' GLU . 54.3 tp60 -152.51 148.32 27.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 305' ' ' GLU . . . . . 0.486 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 1.4 pm0 -114.9 133.49 55.94 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.266 -0.896 . . . . 0.0 110.103 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.31 123.69 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 CA-C-O 122.006 0.907 . . . . 0.0 112.22 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 35.9 m -78.01 105.47 9.23 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.972 0.892 . . . . 0.0 110.343 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.0 mt -51.66 122.15 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 122.434 1.111 . . . . 0.0 110.505 -177.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 19.3 p -107.36 18.87 21.05 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.226 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.478 ' O ' ' CG ' ' B' ' 357' ' ' GLN . . . -74.94 133.21 76.12 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.048 -1.032 . . . . 0.0 108.329 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -69.99 -13.13 33.7 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 CA-C-N 120.161 1.093 . . . . 0.0 112.298 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -120.67 8.94 10.68 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.436 -0.79 . . . . 0.0 109.619 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.55 179.95 32.39 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.483 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.6 tp -86.92 93.12 9.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.079 -1.248 . . . . 0.0 109.641 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -96.54 -159.78 0.75 Allowed 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.138 -0.976 . . . . 0.0 110.204 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.2 m -57.12 -45.11 83.74 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.17 -0.956 . . . . 0.0 112.816 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.511 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 3.1 tpt180 -61.59 -61.46 7.8 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 120.571 -1.33 . . . . 0.0 112.166 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -59.69 -31.91 94.95 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 120.335 1.155 . . . . 0.0 111.797 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.03 -50.29 74.32 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -50.81 -40.89 56.68 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.432 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -69.95 -40.19 75.59 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.16 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -61.99 -52.61 63.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.466 -0.771 . . . . 0.0 110.483 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 86.4 t -69.21 -32.35 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.729 -1.232 . . . . 0.0 110.005 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -59.98 -47.55 85.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.226 -0.921 . . . . 0.0 110.038 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.99 -42.36 73.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.077 -1.014 . . . . 0.0 110.819 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.71 -54.02 11.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.746 -1.222 . . . . 0.0 110.011 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -49.96 -17.34 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.573 -0.704 . . . . 0.0 109.619 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.16 -17.88 79.72 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -106.09 147.2 29.21 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.289 -1.124 . . . . 0.0 109.067 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 3.6 t -90.49 -13.05 35.5 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.065 -1.022 . . . . 0.0 109.831 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.548 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 52.8 m -58.04 144.09 41.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 0.0 109.673 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -67.7 131.59 45.86 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.6 mt -132.61 132.68 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.47 -0.769 . . . . 0.0 109.645 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 50.7 m -128.93 148.88 50.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.448 -0.782 . . . . 0.0 109.328 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.96 114.99 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 55.2 m -103.15 123.53 46.87 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.246 -0.909 . . . . 0.0 108.818 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 47.8 t -136.58 120.29 17.3 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.003 0.906 . . . . 0.0 111.639 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 26.9 m120 49.45 49.2 20.25 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 86.05 -11.13 63.46 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 119.863 -1.773 . . . . 0.0 112.438 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -122.59 133.45 54.55 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.008 -1.289 . . . . 0.0 109.503 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 14.8 m -128.46 150.24 50.23 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.973 0.892 . . . . 0.0 110.713 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -145.69 168.02 21.7 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.539 0.685 . . . . 0.0 109.825 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 28.6 m -89.06 139.6 30.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.518 -0.739 . . . . 0.0 110.136 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -77.64 -15.87 58.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 108.985 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -87.19 17.19 4.46 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 49.8 m -145.71 95.34 2.63 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.045 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.833 HD23 HD22 ' A' ' 79' ' ' LEU . 59.5 tp -60.03 -38.29 82.3 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.825 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 59.9 m-85 -55.22 -51.65 65.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.076 -1.015 . . . . 0.0 110.849 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -69.11 -39.92 78.67 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.767 -1.208 . . . . 0.0 109.799 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' B' ' 352' ' ' THR . 36.8 mt -48.18 -58.28 4.75 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.836 -1.165 . . . . 0.0 109.35 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.672 HE22 ' HE ' ' A' ' 126' ' ' ARG . 73.9 mm-40 -38.37 -23.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.523 -0.736 . . . . 0.0 111.355 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.522 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.6 p -80.09 -13.14 59.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.753 -1.217 . . . . 0.0 110.876 -178.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 27.5 mt -93.25 119.29 32.25 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.682 -1.262 . . . . 0.0 109.32 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.23 94.0 1.12 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 21.0 mt -101.67 92.05 4.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.336 -1.096 . . . . 0.0 108.835 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 74.3 p -92.22 175.22 6.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.217 -0.927 . . . . 0.0 110.608 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 357' ' ' GLN . . . . . 0.478 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 15.2 tm0? -63.92 111.32 2.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.742 -0.599 . . . . 0.0 110.926 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 358' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 102.12 9.97 40.73 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 51.9 m -84.74 111.79 19.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.225 -1.162 . . . . 0.0 110.514 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 20.1 t -76.74 115.32 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.277 1.037 . . . . 0.0 109.732 -177.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 10.8 m -111.9 176.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 56.0 m -131.9 129.19 40.01 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 363' ' ' ILE . . . . . 0.462 HD11 ' SD ' ' B' ' 381' ' ' MET . 85.5 mt -103.41 117.41 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 61.4 p -120.3 132.92 55.51 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.26 151.92 38.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.006 -1.059 . . . . 0.0 110.589 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -144.82 122.84 12.07 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.456 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 159.55 -158.61 29.77 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.02 -1.562 . . . . 0.0 111.596 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.07 -51.7 68.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.049 -0.677 . . . . 0.0 112.524 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.548 ' N ' ' OG ' ' B' ' 331' ' ' SER . 91.7 m-20 -109.65 13.59 23.76 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.796 -1.19 . . . . 0.0 111.047 -177.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -44.39 -36.68 2.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.033 -1.042 . . . . 0.0 111.278 -178.679 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 371' ' ' GLN . . . . . 0.533 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 78.1 mt-30 -70.02 -41.7 73.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.855 -1.153 . . . . 0.0 109.816 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -68.06 -49.52 60.85 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.685 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 373' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' B' ' 374' ' ' VAL . . . -50.18 -74.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.325 -0.86 . . . . 0.0 110.95 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.561 ' O ' HG23 ' B' ' 378' ' ' VAL . 38.9 t -44.1 -40.01 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -65.46 -45.76 82.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.793 -1.192 . . . . 0.0 110.171 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -80.41 -43.42 21.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.945 -1.097 . . . . 0.0 110.132 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 98.6 mt -59.99 -37.77 80.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.081 -1.012 . . . . 0.0 108.872 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.561 HG23 ' O ' ' B' ' 374' ' ' VAL . 30.7 t -61.32 -40.96 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.088 -1.008 . . . . 0.0 108.8 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 379' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' B' ' 383' ' ' GLU . 62.0 mttp -67.92 -55.32 13.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.849 -1.157 . . . . 0.0 108.21 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 59.6 tp -57.82 -36.26 72.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.008 -1.057 . . . . 0.0 109.285 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 381' ' ' MET . . . . . 0.462 ' SD ' HD11 ' B' ' 363' ' ' ILE . 38.1 ttm -74.56 -41.53 60.38 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.99 -10.0 59.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.27 -0.894 . . . . 0.0 109.415 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' B' ' 379' ' ' LYS . 71.3 mm-40 -108.19 10.43 27.92 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.512 -0.742 . . . . 0.0 110.966 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 16.6 mt -66.19 109.55 2.67 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.416 -1.428 . . . . 0.0 109.181 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.499 1.98 0 CA-C-O 118.003 -0.999 . . . . 0.0 108.927 179.524 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.136 -0.69 . . . . 2.91 109.136 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.7 mt -110.07 126.82 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.481 -0.762 . . . . 1.2 109.125 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.3 m -130.01 138.6 50.88 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.092 -0.707 . . . . 1.4 109.092 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.49 -161.92 19.43 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.221 -1.552 . . . . 1.05 109.221 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.7 mt -89.54 -18.55 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -1.211 . . . . 1.15 109.877 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 5' ' ' ILE . 62.6 tp 51.02 103.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.348 -0.845 . . . . 0.98 109.69 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.94 -29.39 12.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.254 -0.904 . . . . 0.88 109.037 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 64.8 m -119.67 115.87 33.5 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.513 -0.742 . . . . 1.69 109.47 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.64 146.46 16.89 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.029 1.819 . . . . 0.85 112.249 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.646 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.18 -152.13 23.98 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.878 -1.689 . . . . 0.92 108.878 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.5 mt -150.31 151.52 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 120.768 -1.43 . . . . 0.81 108.801 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.1 150.83 32.25 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.908 -1.12 . . . . 0.51 110.545 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -133.74 125.32 28.31 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.821 -1.178 . . . . 0.62 107.821 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.52 177.39 47.15 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 118.476 -1.821 . . . . 0.55 110.999 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 157' ' ' ILE . 85.2 mttt -79.87 160.02 26.21 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.831 -0.805 . . . . 2.1 108.905 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.589 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -105.44 134.89 47.81 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.355 -0.841 . . . . 0.77 111.527 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.1 tp -101.48 138.72 38.12 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.352 -1.351 . . . . 0.91 107.352 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.8 tp -118.64 124.9 48.53 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.156 -0.965 . . . . 0.93 110.199 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.8 mt -93.14 103.45 15.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.8 -0.563 . . . . 0.93 110.189 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -98.66 133.06 43.52 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.388 -0.967 . . . . 2.75 108.388 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -130.07 128.23 41.5 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.62 -0.882 . . . . 3.0 108.62 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -75.46 149.83 38.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 2.77 109.901 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -69.13 143.12 54.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.486 -0.758 . . . . 2.94 108.992 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.2 mt -80.13 131.28 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.95 109.387 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 56.0 t -97.27 125.08 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.25 -0.906 . . . . 1.28 109.542 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.0 mt -107.9 135.32 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.434 -0.791 . . . . 1.21 108.921 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -93.87 121.13 35.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.12 -0.988 . . . . 1.81 109.699 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.501 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.8 mmt-85 -89.1 2.12 54.58 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.512 -0.742 . . . . 2.8 110.228 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -67.48 149.5 50.11 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.93 -1.106 . . . . 2.87 109.356 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -93.01 149.77 20.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.164 -0.96 . . . . 2.35 109.596 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.48 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.0 pt -96.44 167.7 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.213 -0.929 . . . . 0.97 110.246 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 61.8 p -100.66 176.2 5.39 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.484 -0.932 . . . . 1.17 108.484 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.85 76.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.156 -0.965 . . . . 1.18 110.695 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -58.05 -27.92 64.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.687 -1.258 . . . . 2.56 109.697 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -81.68 -11.01 59.25 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.34 -0.85 . . . . 1.79 109.808 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.5 t -62.91 -51.89 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.003 -1.061 . . . . 1.0 108.95 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.91 -40.11 96.59 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.247 -0.908 . . . . 1.77 110.113 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -66.28 -40.08 89.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.005 -1.059 . . . . 2.7 110.579 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.48 ' HG3' HG21 ' A' ' 31' ' ' ILE . 75.1 mm-40 -67.91 -40.07 83.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.778 -1.201 . . . . 1.51 110.302 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.04 -45.26 95.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 120.648 -1.283 . . . . 0.93 108.297 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -58.28 -39.9 80.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.997 -1.064 . . . . 1.81 108.594 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.458 HH11 ' HG2' ' A' ' 42' ' ' ARG . 44.5 mtt-85 -59.93 -43.68 94.81 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.287 -1.375 . . . . 2.78 107.287 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -63.5 -45.78 89.09 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.522 -0.736 . . . . 0.78 109.254 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.05 -50.08 75.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 1.07 108.567 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.7 t -63.45 -44.1 95.5 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.483 -0.887 . . . . 1.12 108.852 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.08 -43.33 99.57 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.859 -1.696 . . . . 0.84 108.859 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -67.44 -32.7 73.73 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.427 -1.043 . . . . 3.09 108.323 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.55 -40.99 89.06 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.508 -0.745 . . . . 0.88 109.348 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 34.6 ttpt -68.91 -74.73 0.12 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.953 -1.092 . . . . 2.59 108.447 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.1 -35.08 0.14 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.346 -0.846 . . . . 0.7 111.504 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.5 p -57.46 -56.63 19.33 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.55 -1.26 . . . . 1.4 108.586 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.03 -40.74 75.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.419 -0.8 . . . . 0.67 111.413 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -64.41 -40.04 95.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.633 -1.292 . . . . 1.66 110.889 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.18 -40.01 93.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.848 -1.158 . . . . 1.58 109.367 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -60.01 -37.46 79.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 1.35 109.834 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.24 -40.55 96.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.078 -1.014 . . . . 0.77 110.198 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.723 HD11 HH22 ' A' ' 136' ' ' ARG . 96.8 mt -62.11 -39.94 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.25 -0.906 . . . . 0.63 109.58 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -59.5 -50.0 75.63 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.457 -0.777 . . . . 1.14 109.577 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.3 m -59.37 -39.5 83.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.99 -1.069 . . . . 0.79 110.097 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -64.35 -38.37 90.8 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.09 -1.006 . . . . 1.53 109.247 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.46 -43.98 92.52 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.594 -0.691 . . . . 0.57 109.915 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.24 -50.04 66.08 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.836 -1.173 . . . . 0.75 110.174 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.13 -45.54 80.71 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.228 -1.16 . . . . 1.59 109.708 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.9 m -72.56 -57.9 3.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.327 -0.858 . . . . 0.73 112.306 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -94.81 -54.35 3.51 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.8 -1.187 . . . . 0.75 111.09 -177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.35 -169.18 25.54 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 119.692 -1.242 . . . . 1.22 111.464 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.07 -28.78 66.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 122.043 -0.681 . . . . 5.81 111.145 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.448 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 50.8 tp10 -61.47 -34.86 76.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.066 -1.021 . . . . 3.37 110.516 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -99.46 -21.01 16.15 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.202 -0.936 . . . . 1.77 110.22 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -66.84 -42.61 85.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.115 -0.991 . . . . 1.65 110.314 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.464 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -66.21 -32.21 73.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.514 -0.741 . . . . 0.77 110.53 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.1 -42.49 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.996 -1.065 . . . . 0.8 109.987 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.562 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 69.4 m-85 -71.56 -34.19 69.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.977 -1.077 . . . . 0.88 109.951 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -59.94 -39.81 86.8 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.228 -0.92 . . . . 1.37 109.284 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.45 -42.31 97.64 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.209 -1.557 . . . . 0.62 109.209 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -60.25 -41.42 93.15 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.357 -1.084 . . . . 1.5 108.893 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.8 mt -70.03 -45.44 76.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.239 -0.913 . . . . 0.63 109.45 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.6 ttp -60.25 -40.6 90.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.111 -0.993 . . . . 1.51 109.935 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.86 HD11 ' CE2' ' B' ' 348' ' ' PHE . 33.2 tp -67.26 -39.3 86.09 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.256 -0.902 . . . . 0.77 109.198 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.41 -39.94 92.57 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.039 -0.726 . . . . 0.62 109.039 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -83.07 5.81 21.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.316 -0.865 . . . . 1.47 109.585 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -49.83 130.36 21.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.219 -0.926 . . . . 1.47 109.428 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.16 -21.32 61.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.381 -0.824 . . . . 1.78 111.699 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.13 -33.02 69.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.623 -1.298 . . . . 2.53 108.878 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.7 mt -70.42 -40.74 73.65 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.488 0.661 . . . . 0.8 109.827 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.13 -49.66 76.76 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.449 -0.782 . . . . 1.42 109.827 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -69.97 -41.16 74.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.407 -0.808 . . . . 1.71 111.243 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.05 -39.97 75.39 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.934 -1.104 . . . . 1.57 111.682 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.08 -44.37 81.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 120.831 -1.168 . . . . 0.65 109.767 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.03 -38.6 75.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.403 -0.811 . . . . 0.82 110.131 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.5 -45.06 88.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.272 -0.892 . . . . 0.79 111.672 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 66.3 mt -61.57 -45.97 91.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.706 -1.247 . . . . 0.95 109.56 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 57.1 mt -61.36 -47.66 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.906 0.86 . . . . 0.66 109.082 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -70.04 -40.0 75.41 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.039 -0.664 . . . . 2.2 110.652 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -81.46 -61.55 1.9 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.039 -1.038 . . . . 1.65 112.116 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -82.2 0.54 40.67 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.097 -1.002 . . . . 2.03 111.68 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 57.17 37.8 28.59 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.132 -0.98 . . . . 1.42 109.923 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 79.7 mtp -90.85 166.97 12.79 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.63 -0.668 . . . . 1.18 109.499 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.2 p -80.89 161.88 24.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.948 . . . . 0.98 109.274 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.31 -39.93 85.95 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.256 -0.902 . . . . 0.64 109.581 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -68.45 -37.38 80.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.268 -0.895 . . . . 2.07 109.42 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.56 -45.56 21.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.73 109.445 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.43 -48.89 75.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.486 -0.759 . . . . 0.54 109.766 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.08 -36.0 76.42 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 0.56 109.284 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.544 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 84.5 t60 -59.96 -40.71 89.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.381 -0.824 . . . . 1.54 109.511 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -65.04 -40.53 94.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.334 -0.854 . . . . 1.33 111.149 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.34 -57.19 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.085 -1.01 . . . . 0.72 111.767 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.5 mm -66.92 -40.04 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.82 -1.175 . . . . 0.85 109.01 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.544 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 88.0 tt0 -63.11 -40.09 96.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 2.44 108.678 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.28 -52.61 50.54 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.504 -0.855 . . . . 0.98 110.987 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -62.8 -48.95 76.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.803 -1.41 . . . . 1.41 109.375 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.35 88.79 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.16 -0.962 . . . . 1.2 109.014 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.2 m -59.97 -40.26 88.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.1 -1.0 . . . . 1.7 108.876 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.85 87.26 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.255 -0.903 . . . . 1.47 109.116 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.8 mt -64.84 -39.97 94.43 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.873 -1.142 . . . . 1.56 108.774 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -59.23 -30.92 68.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.054 -1.029 . . . . 2.2 109.306 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.0 -27.54 66.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.105 -0.997 . . . . 2.12 108.514 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.46 HD13 HD13 ' A' ' 123' ' ' LEU . 28.4 mt -62.32 143.76 56.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 2.0 109.283 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -97.42 52.57 1.12 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.154 -0.966 . . . . 3.23 109.531 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -136.12 133.05 36.86 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.252 -0.905 . . . . 2.49 109.811 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.48 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 45.1 mp0 -70.04 -30.72 68.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.367 -0.833 . . . . 3.95 110.061 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.459 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.9 t80 -69.9 -38.06 76.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.195 -0.941 . . . . 2.0 110.091 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.46 HD13 HD13 ' A' ' 118' ' ' LEU . 65.1 mt -77.57 -39.81 44.47 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.094 -1.004 . . . . 1.86 109.788 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -61.58 -43.72 98.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.96 . . . . 2.84 110.445 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 65.9 mm-40 -67.12 -41.09 86.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.92 -1.112 . . . . 2.73 109.755 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.612 ' CD ' HE22 ' B' ' 351' ' ' GLN . 27.4 ttp180 -60.08 -40.03 88.12 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.779 -1.193 . . . . 2.77 107.779 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.81 -23.14 67.12 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.418 -0.956 . . . . 1.19 108.418 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -59.9 -40.02 87.35 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.606 -1.257 . . . . 1.2 107.606 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -66.75 -40.42 88.28 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.008 -0.677 . . . . 1.55 109.916 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 59.5 t -62.4 -40.0 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.933 -1.104 . . . . 0.8 108.437 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.513 HH11 ' HG2' ' A' ' 131' ' ' ARG . 9.1 ttt-85 -63.37 -36.22 82.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.414 -0.804 . . . . 3.09 109.931 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.36 -40.15 85.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.224 -0.922 . . . . 1.46 109.59 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.94 -43.18 91.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.038 -1.039 . . . . 0.71 108.805 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.43 -45.37 96.53 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.678 -0.969 . . . . 0.57 110.678 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -60.03 -44.68 94.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -1.23 . . . . 2.59 110.831 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.723 HH22 HD11 ' A' ' 57' ' ' ILE . 60.2 mtp180 -69.22 -34.88 75.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.482 -1.386 . . . . 2.83 110.157 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.7 tp -59.8 -45.25 92.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.149 -0.969 . . . . 1.25 109.731 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.57 -39.84 92.59 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.119 -0.988 . . . . 0.7 108.87 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -67.2 -39.8 86.4 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.62 -0.675 . . . . 2.57 110.238 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -68.62 -25.54 64.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.137 -0.977 . . . . 1.23 111.383 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.72 -43.64 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.334 -1.479 . . . . 0.81 108.36 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.5 mt -69.94 -31.16 68.76 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.752 -0.592 . . . . 1.0 109.918 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.53 36.95 7.18 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.074 -1.61 . . . . 0.89 109.074 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 56.7 tp -73.2 143.0 47.35 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.432 -1.04 . . . . 1.14 109.229 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -60.7 144.98 51.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.369 -0.832 . . . . 4.6 109.877 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.2 mt -114.88 121.31 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.29 -1.004 . . . . 1.24 108.29 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 16.9 mm -52.98 -52.17 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.568 -0.707 . . . . 1.54 110.409 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.8 t0 66.01 102.46 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.779 -0.822 . . . . 1.5 108.779 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.1 mt -73.34 -1.77 19.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.538 -0.726 . . . . 0.79 110.45 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.3 p -80.01 -11.54 59.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.899 -1.126 . . . . 1.4 109.343 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -88.37 21.05 3.01 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.615 -0.678 . . . . 0.92 111.448 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.437 ' HB ' HD21 ' A' ' 172' ' ' ASN . 48.9 mt -92.74 111.72 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.771 -1.205 . . . . 0.88 108.734 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -100.11 -8.45 23.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.195 -0.94 . . . . 2.45 111.165 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -117.22 147.43 42.51 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.152 -0.967 . . . . 1.52 110.176 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.38 131.35 46.95 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.979 -0.749 . . . . 1.58 108.979 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -152.42 164.72 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.506 -0.746 . . . . 0.69 109.515 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.423 ' N ' ' O ' ' A' ' 15' ' ' LYS . 97.0 mt -92.62 152.37 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 105.384 -2.08 . . . . 0.61 105.384 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.9 tp -101.23 120.07 39.69 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.976 -1.077 . . . . 0.87 111.131 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.51 129.93 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.898 -0.779 . . . . 0.71 108.898 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.03 163.44 36.37 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.37 -0.974 . . . . 0.81 108.37 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.07 -36.69 75.14 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.416 -1.427 . . . . 0.98 108.223 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -170.54 146.35 2.74 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.889 -0.782 . . . . 2.25 108.889 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.7 mt -115.09 131.18 57.01 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.309 -0.869 . . . . 0.78 110.382 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.4 p -93.4 151.75 40.49 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.467 -0.771 . . . . 0.98 109.226 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -39.76 -36.43 1.23 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 122.118 1.878 . . . . 0.81 112.52 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.3 m -58.12 -45.16 87.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.9 109.221 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -69.94 -42.6 73.02 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.096 -1.003 . . . . 1.61 109.991 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 27.5 p -57.42 -16.1 8.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.198 -0.939 . . . . 0.61 110.731 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.562 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . . . -90.66 -51.8 5.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.827 -1.171 . . . . 0.6 110.043 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -85.39 42.18 0.94 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.001 -1.111 . . . . 1.4 108.001 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.7 tp -109.99 132.8 53.83 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.704 -0.851 . . . . 0.7 108.704 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.437 HD21 ' HB ' ' A' ' 152' ' ' ILE . 0.8 OUTLIER -91.23 108.52 19.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.226 -0.921 . . . . 2.35 109.285 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.75 -43.63 98.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.469 -0.77 . . . . 1.51 110.99 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -64.53 -23.58 67.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.924 -1.11 . . . . 2.33 111.957 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -93.58 -11.11 32.56 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.689 -1.257 . . . . 1.92 109.794 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 178' ' ' GLY . 98.8 t -110.05 118.89 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.186 -0.946 . . . . 0.67 109.413 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.1 mt -89.87 6.38 42.13 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.142 -0.973 . . . . 1.53 111.248 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.486 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 175.22 170.11 37.8 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.169 -1.572 . . . . 0.48 109.169 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -132.67 128.88 37.96 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.269 -1.136 . . . . 0.55 109.901 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.401 ' CG2' HG21 ' A' ' 205' ' ' THR . 98.4 mt -132.17 125.11 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.727 -0.842 . . . . 0.65 108.727 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.1 p -143.21 157.94 44.06 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.22 -0.925 . . . . 0.82 110.625 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 183' ' ' ALA . 1.1 m-20 -99.2 22.69 10.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.557 -0.715 . . . . 2.46 109.803 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.513 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -45.41 -175.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.41 1.1 . . . . 1.28 112.586 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.71 -54.59 4.89 Favored Glycine 0 N--CA 1.492 2.412 0 O-C-N 121.527 -0.733 . . . . 2.19 111.315 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -149.97 -161.84 10.11 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 120.631 -1.511 . . . . 2.13 111.278 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.425 ' O ' ' OG ' ' A' ' 191' ' ' SER . 41.1 ttp180 -80.01 -9.87 59.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.789 -0.83 . . . . 5.86 110.205 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 64.0 p -79.94 4.85 15.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.97 . . . . 3.72 109.85 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.7 t -71.57 134.46 46.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.265 -0.897 . . . . 1.74 110.81 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -41.3 -60.84 1.15 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.528 0.68 . . . . 0.95 110.758 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.7 t -51.12 -33.65 27.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.189 -0.944 . . . . 1.55 110.452 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 186' ' ' ARG . 28.0 p -60.0 -40.12 88.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.973 -1.08 . . . . 1.51 109.689 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.5 -40.09 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.823 . . . . 1.67 110.176 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 35.1 mtm -59.89 -49.27 78.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.808 -1.182 . . . . 1.02 110.494 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.08 -44.17 94.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.753 -1.217 . . . . 0.68 110.626 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -60.03 -52.07 66.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 2.93 110.459 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.2 m -70.94 -33.58 70.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.125 -0.984 . . . . 0.86 110.723 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.04 -22.99 59.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.018 -1.051 . . . . 0.67 109.652 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 66.45 52.37 1.07 Allowed 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.576 0.703 . . . . 1.5 110.543 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.414 ' O ' ' CB ' ' A' ' 8' ' ' SER . 62.9 mt -127.28 132.31 24.26 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 107.722 -1.214 . . . . 0.72 107.722 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -43.45 134.35 6.83 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.805 1.67 . . . . 0.61 112.317 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -166.85 145.35 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.71 -1.196 . . . . 0.66 111.824 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.5 mt -123.16 145.67 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.403 -1.332 . . . . 0.79 107.403 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.1 m -129.7 -12.24 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 120.795 -1.191 . . . . 0.91 111.143 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.72 24.86 22.72 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 110.06 -1.216 . . . . 1.01 110.06 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.427 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 6.3 p -46.32 -42.29 14.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.059 -1.259 . . . . 0.99 110.04 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.78 -57.36 4.66 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.947 -1.121 . . . . 1.12 111.308 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 24.5 m -150.8 32.78 0.61 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.56 -1.553 . . . . 1.72 111.786 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.0 t -70.15 -44.63 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.796 -1.19 . . . . 0.89 109.134 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.441 ' H ' HG23 ' A' ' 209' ' ' THR . 3.0 p -50.59 -29.96 12.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.54 -0.725 . . . . 1.03 111.33 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 29.6 t -69.97 -27.13 64.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.723 -1.236 . . . . 1.83 109.844 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -96.94 -7.02 34.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.151 -0.968 . . . . 2.27 110.53 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 73.8 t -105.93 132.15 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.249 -0.907 . . . . 0.92 110.912 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.439 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 9.9 mtpt -120.12 149.54 42.05 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.621 -1.252 . . . . 2.2 107.621 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.469 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 23.6 p-10 -50.07 138.65 15.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.11 -0.994 . . . . 2.36 111.326 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.469 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 8.3 t0 82.3 5.44 1.07 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 116.165 -0.47 . . . . 2.38 110.538 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 91.9 m-20 -77.56 143.49 38.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.965 -1.084 . . . . 2.09 108.877 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -92.28 119.93 32.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.183 -0.948 . . . . 1.27 108.587 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.589 HD12 ' HB2' ' A' ' 16' ' ' ALA . 86.4 mt -127.21 146.6 50.35 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.41 -0.806 . . . . 0.75 110.636 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.2 mt -118.75 129.28 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 107.193 -1.41 . . . . 0.63 107.193 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.6 tp -104.1 119.93 40.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.107 -0.995 . . . . 0.7 108.787 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.644 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 21.6 p-10 -79.78 -39.09 31.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.214 -0.929 . . . . 2.31 109.114 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.69 16.61 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.782 -0.822 . . . . 0.78 108.782 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 221' ' ' ASP . 47.6 t -126.28 -38.76 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.526 -1.287 . . . . 1.04 107.526 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -109.81 -1.1 18.08 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.797 -1.186 . . . . 2.44 107.797 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 61.45 49.97 4.92 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.369 0.604 . . . . 1.55 109.935 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.644 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 27.4 mt-30 -137.64 153.34 49.88 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.573 -0.705 . . . . 1.99 109.305 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.93 128.87 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.144 -0.687 . . . . 0.77 109.144 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -103.05 122.44 44.65 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.784 -1.191 . . . . 0.98 107.784 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.8 t -101.04 111.86 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.429 -0.794 . . . . 0.85 110.89 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 42.8 t30 49.96 63.5 10.02 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.318 -0.864 . . . . 1.66 110.318 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.4 150.2 15.1 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.705 2.27 . . . . 0.95 111.9 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.407 ' OG1' HG23 ' A' ' 235' ' ' VAL . 68.1 p -67.47 163.74 20.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.142 -0.974 . . . . 1.84 110.131 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -60.18 -40.2 89.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.5 -0.75 . . . . 2.74 110.19 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -62.05 -34.57 76.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -0.917 . . . . 2.89 109.997 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.407 HG23 ' OG1' ' A' ' 232' ' ' THR . 55.3 t -69.78 -39.99 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.343 -0.848 . . . . 1.3 109.299 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.7 mt . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 1.09 109.404 179.875 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 44.4 ttp . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.407 0.622 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -154.6 151.8 29.26 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -146.8 158.52 43.93 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.042 -1.036 . . . . 0.0 110.354 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 304' ' ' GLN . . . . . 0.495 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 7.4 tm0? -149.53 145.22 26.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.461 -0.774 . . . . 0.0 108.977 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 305' ' ' GLU . . . . . 0.495 ' N ' ' CD ' ' B' ' 304' ' ' GLN . 93.4 mt-10 -111.69 131.13 55.5 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.16 -0.963 . . . . 0.0 110.09 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 1.2 p -130.17 120.84 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.799 0.809 . . . . 0.0 111.31 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 307' ' ' THR . . . . . 0.438 ' O ' HG23 ' B' ' 309' ' ' THR . 86.3 m -73.88 113.88 11.55 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.217 1.008 . . . . 0.0 110.563 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 60.9 mt -57.95 115.78 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 122.623 1.201 . . . . 0.0 111.317 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 309' ' ' THR . . . . . 0.438 HG23 ' O ' ' B' ' 307' ' ' THR . 67.5 p -111.72 19.95 17.54 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.643 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.95 124.4 90.67 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.888 -1.132 . . . . 0.0 109.206 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -55.27 -18.38 18.27 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 CA-C-N 120.154 1.091 . . . . 0.0 112.921 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -121.32 10.1 10.51 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.293 -0.879 . . . . 0.0 110.027 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.85 -178.21 40.31 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.459 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -87.11 93.65 9.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.151 -1.205 . . . . 0.0 110.301 -178.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -96.37 -160.63 0.81 Allowed 'General case' 0 N--CA 1.509 2.496 0 O-C-N 120.662 -1.274 . . . . 0.0 110.134 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 13.6 m -58.73 -45.05 90.48 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.93 -1.106 . . . . 0.0 112.064 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.492 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.4 tpt180 -53.13 -62.43 3.49 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 120.564 -1.335 . . . . 0.0 111.127 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -57.25 -32.7 94.38 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 CA-C-N 120.135 1.084 . . . . 0.0 112.184 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.85 76.07 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.488 -0.885 . . . . 0.0 108.901 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.46 -45.49 76.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.459 -0.775 . . . . 0.0 110.474 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -70.13 -40.04 75.08 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.879 -1.138 . . . . 0.0 108.641 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -61.07 -51.81 67.57 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.596 -0.69 . . . . 0.0 110.643 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 323' ' ' VAL . . . . . 0.577 ' CG1' ' HZ2' ' B' ' 327' ' ' LYS . 75.4 t -70.21 -33.1 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.775 -1.203 . . . . 0.0 110.017 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -60.04 -46.36 89.78 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 108.878 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -62.32 -45.33 93.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.169 -0.957 . . . . 0.0 109.819 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.91 -50.93 71.84 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.207 -0.933 . . . . 0.0 110.742 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 327' ' ' LYS . . . . . 0.577 ' HZ2' ' CG1' ' B' ' 323' ' ' VAL . 42.4 mttp -55.96 -14.37 2.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.981 -1.074 . . . . 0.0 109.456 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -68.99 -30.04 72.31 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -104.67 145.06 30.87 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.333 -1.098 . . . . 0.0 109.096 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 37.9 p -90.63 -11.8 38.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.017 -1.052 . . . . 0.0 109.547 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.48 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 81.1 p -60.01 153.4 21.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -0.844 . . . . 0.0 109.568 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -71.12 132.94 45.8 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.178 -0.951 . . . . 0.0 108.701 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.6 mt -129.78 129.95 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.669 -0.644 . . . . 0.0 109.458 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 30.6 m -126.61 150.05 49.13 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 92.1 t -115.15 137.47 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 56.7 m -130.07 122.57 28.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.281 -0.887 . . . . 0.0 109.157 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 83.1 p -136.1 119.5 16.86 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.805 0.812 . . . . 0.0 110.215 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 36.27 61.08 0.82 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.76 -15.34 20.69 Favored Glycine 0 N--CA 1.499 2.834 0 O-C-N 120.608 -1.307 . . . . 0.0 113.129 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -108.28 119.57 39.86 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 119.463 1.631 . . . . 0.0 109.642 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 66.1 m -118.74 142.24 47.88 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.812 0.815 . . . . 0.0 110.168 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 342' ' ' ALA . . . . . 0.464 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -141.19 163.21 33.57 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.572 0.701 . . . . 0.0 109.779 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 4.7 t -87.97 140.01 29.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.475 -0.766 . . . . 0.0 109.318 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.42 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -82.35 -10.0 59.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.937 -1.102 . . . . 0.0 110.157 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -90.26 22.18 3.45 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 48.1 t -149.72 99.51 2.87 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.611 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.704 HD23 HD22 ' A' ' 79' ' ' LEU . 60.9 tp -59.83 -31.89 70.15 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.86 ' CE2' HD11 ' A' ' 79' ' ' LEU . 53.4 m-85 -59.87 -54.54 44.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.009 -1.057 . . . . 0.0 110.031 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -68.98 -24.1 64.19 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.079 -1.013 . . . . 0.0 111.717 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' B' ' 352' ' ' THR . 82.6 mt -68.01 -51.76 43.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.386 -1.446 . . . . 0.0 108.191 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.612 HE22 ' CD ' ' A' ' 126' ' ' ARG . 61.8 mm-40 -39.06 -26.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.65 -178.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.43 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.9 p -79.88 -7.07 58.52 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.69 -1.256 . . . . 0.0 110.717 -177.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' B' ' 342' ' ' ALA . 60.5 mt -92.52 109.33 20.73 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.956 -1.09 . . . . 0.0 109.308 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.53 88.82 0.62 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.7 mt -97.24 90.13 5.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.219 -1.166 . . . . 0.0 109.165 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 28.9 p -96.4 142.81 28.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.096 -1.002 . . . . 0.0 110.076 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -44.99 119.98 2.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.695 -0.628 . . . . 0.0 110.187 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 114.44 -3.95 23.39 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 52.4 m -99.17 129.75 45.44 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.424 -1.044 . . . . 0.0 109.084 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 13.8 t -92.44 134.79 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 119.773 -1.829 . . . . 0.0 109.109 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 29.8 m -112.07 174.98 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 30.3 m -131.13 127.88 38.98 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 84.2 mt -100.91 114.26 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 88.3 p -119.89 132.81 55.66 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.521 -0.737 . . . . 0.0 109.035 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.28 154.45 41.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.352 -0.842 . . . . 0.0 109.494 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -146.64 124.49 11.95 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 159.52 -158.58 29.74 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 118.798 -1.668 . . . . 0.0 111.59 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -60.04 -53.67 55.05 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.48 ' H ' ' HB3' ' B' ' 331' ' ' SER . 95.8 m-20 -110.51 9.98 23.17 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.98 -1.075 . . . . 0.0 110.897 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -42.08 -32.29 0.45 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.234 -0.916 . . . . 0.0 111.634 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -69.98 -39.77 75.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.737 -1.227 . . . . 0.0 109.849 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -68.75 -52.26 32.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.959 . . . . 0.0 109.326 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.8 -32.94 6.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.394 -0.816 . . . . 0.0 111.248 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.504 ' O ' HG23 ' B' ' 378' ' ' VAL . 84.2 t -75.74 -39.33 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.611 -1.305 . . . . 0.0 109.615 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.59 -49.86 75.83 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.346 -0.846 . . . . 0.0 111.804 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -77.46 -41.37 39.9 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.888 -1.132 . . . . 0.0 111.514 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.09 -41.43 92.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.724 -1.235 . . . . 0.0 108.543 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.6 t -61.46 -46.12 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.285 -0.884 . . . . 0.0 109.22 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 379' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' B' ' 383' ' ' GLU . 65.6 mttm -69.99 -55.81 8.61 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 58.7 tp -57.64 -35.85 71.05 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.527 -0.733 . . . . 0.0 109.645 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 34.7 ttm -71.25 -40.04 71.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.387 -1.446 . . . . 0.0 108.016 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -79.07 -7.66 58.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.705 -0.622 . . . . 0.0 110.613 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' B' ' 379' ' ' LYS . 76.8 mm-40 -111.88 2.96 17.27 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.063 -1.023 . . . . 0.0 111.269 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 22.5 mt -96.19 126.6 41.53 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.667 -1.27 . . . . 0.0 109.508 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.896 -1.05 . . . . 0.0 109.246 179.471 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.179 0.514 . . . . 2.91 109.805 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 225' ' ' ASN . 88.1 mt -110.05 130.01 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.429 -0.794 . . . . 1.2 109.26 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.1 m -127.47 129.34 47.28 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.584 -0.697 . . . . 1.4 109.629 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.645 ' N ' HD21 ' A' ' 225' ' ' ASN . . . -113.93 -160.48 13.66 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 108.814 -1.714 . . . . 1.05 108.814 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.5 mt -88.85 -17.26 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.985 -1.303 . . . . 1.15 109.943 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.3 tp 55.4 105.46 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.291 -0.881 . . . . 0.98 108.828 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.64 -24.82 16.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.141 -0.974 . . . . 0.88 109.672 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.8 t -142.52 127.46 10.14 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.283 -0.886 . . . . 1.69 109.853 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.92 143.13 17.99 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.908 1.739 . . . . 0.85 111.624 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.853 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 167.64 -168.89 40.9 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.312 -1.515 . . . . 0.92 109.312 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.6 mt -149.14 126.77 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.352 -1.087 . . . . 0.81 108.222 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.99 149.76 43.63 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.958 -1.089 . . . . 0.51 111.025 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 3.0 m-85 -124.66 129.94 51.49 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.733 -1.21 . . . . 0.62 107.733 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.81 177.32 47.88 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 118.695 -1.717 . . . . 0.55 111.02 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -78.48 157.94 28.76 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.707 -0.878 . . . . 2.1 109.289 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.626 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -106.34 126.09 51.8 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.336 -0.852 . . . . 0.77 110.873 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.4 tp -97.27 138.02 35.4 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.378 -1.341 . . . . 0.91 107.378 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 39.5 tp -116.6 123.31 47.02 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.247 -0.908 . . . . 0.93 109.448 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 160' ' ' ALA . 27.2 mt -88.06 106.66 18.3 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.556 0.693 . . . . 0.93 110.55 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -98.77 133.66 42.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.485 -0.759 . . . . 2.75 109.281 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -128.86 128.24 43.46 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.275 -0.891 . . . . 3.0 108.853 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -79.01 153.68 30.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.969 . . . . 2.77 110.067 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -73.78 140.91 46.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.282 -0.886 . . . . 2.94 108.769 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.7 mt -80.02 132.48 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.958 . . . . 0.95 108.83 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.9 t -95.65 122.35 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.321 -0.862 . . . . 1.28 108.995 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.9 mt -105.3 138.68 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.538 -0.726 . . . . 1.21 109.09 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -87.82 123.4 32.56 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.163 -0.961 . . . . 1.81 109.712 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -93.04 2.79 56.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.886 . . . . 2.8 109.833 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -69.98 149.77 47.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.059 -1.026 . . . . 2.87 110.077 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -87.93 144.03 26.78 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.384 -0.969 . . . . 2.35 108.384 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.406 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.1 pt -90.36 164.33 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.845 -1.159 . . . . 0.97 109.947 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.0 p -93.64 170.83 9.29 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.993 -1.114 . . . . 1.17 107.993 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.94 -48.27 82.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.764 -1.21 . . . . 1.18 109.222 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 62.8 t0 -54.13 -30.16 47.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.997 -1.064 . . . . 2.56 109.68 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -81.26 -9.09 59.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.358 -0.838 . . . . 1.79 110.362 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -65.6 -55.18 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.543 -1.348 . . . . 1.0 109.042 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -39.93 87.64 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.352 -0.843 . . . . 1.77 109.81 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.38 -41.78 76.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 2.7 111.033 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.406 ' HG3' HG21 ' A' ' 31' ' ' ILE . 69.7 mm-40 -64.25 -40.14 95.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.693 -1.255 . . . . 1.51 110.179 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.09 -44.66 95.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.79 -1.194 . . . . 0.93 107.993 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -59.97 -40.1 87.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 1.81 108.321 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.48 HH11 ' HG2' ' A' ' 42' ' ' ARG . 20.6 mtt-85 -59.96 -44.33 94.49 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.489 -1.3 . . . . 2.78 107.489 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -60.88 -47.62 85.53 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.601 -0.889 . . . . 0.78 108.601 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.01 -47.15 87.01 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.247 -1.02 . . . . 1.07 108.247 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.7 t -59.95 -41.44 91.88 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.322 -0.992 . . . . 1.12 108.322 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.61 -42.9 99.84 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.363 -1.895 . . . . 0.84 108.363 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -65.54 -38.81 90.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.121 -1.066 . . . . 3.09 108.121 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.02 -42.8 77.05 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.885 -0.51 . . . . 0.88 109.734 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.3 ttpt -71.19 -74.4 0.15 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.999 -1.111 . . . . 2.59 107.999 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.27 -38.78 0.37 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.267 -0.896 . . . . 0.7 111.443 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.0 t -55.71 -54.92 38.42 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.393 -1.442 . . . . 1.4 108.494 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.99 -41.75 73.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.377 -0.827 . . . . 0.67 111.356 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -66.87 -40.26 87.78 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.758 -1.213 . . . . 1.66 110.521 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.3 mt -60.37 -39.96 89.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.812 -1.18 . . . . 1.58 109.067 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -61.84 -32.05 72.35 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.348 -0.845 . . . . 1.35 109.724 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.4 m -67.87 -44.75 76.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.795 -1.191 . . . . 0.77 110.124 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.5 mt -59.98 -37.98 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.127 -0.983 . . . . 0.63 108.573 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -56.6 -50.03 73.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.708 -0.62 . . . . 1.14 109.376 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 m -56.62 -31.95 64.82 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.23 -0.919 . . . . 0.79 110.332 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -69.86 -39.8 76.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 1.53 110.192 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.503 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -68.09 -48.33 65.81 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.526 -0.734 . . . . 0.57 109.662 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -51.51 -56.57 14.83 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 110.209 -1.157 . . . . 0.75 110.209 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.06 -42.0 73.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.127 -1.219 . . . . 1.59 111.061 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.6 m -66.09 -62.39 1.51 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.844 -1.16 . . . . 0.73 111.996 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -94.56 -45.88 7.21 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.864 -1.148 . . . . 0.75 111.239 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.73 -167.93 25.43 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.908 -1.139 . . . . 1.22 110.819 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -70.16 -23.93 63.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.863 -0.786 . . . . 5.81 110.261 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.494 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.8 tp10 -59.93 -33.39 71.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.465 -0.772 . . . . 3.37 110.086 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -98.76 -18.91 17.74 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.252 -0.905 . . . . 1.77 110.469 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -67.71 -40.06 84.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.893 -1.129 . . . . 1.65 109.83 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.591 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -63.49 -32.82 74.38 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.414 -0.804 . . . . 0.77 110.218 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.7 mt -59.94 -41.83 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.902 -1.124 . . . . 0.8 109.594 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -64.57 -39.84 94.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.129 -0.982 . . . . 0.88 110.881 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -60.07 -40.0 88.0 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.916 -1.115 . . . . 1.37 109.458 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.81 -47.07 92.55 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.07 -1.612 . . . . 0.62 109.07 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -61.17 -47.88 84.15 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.408 -1.054 . . . . 1.5 109.326 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.15 -48.79 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.303 -0.873 . . . . 0.63 109.788 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.4 ttp -59.97 -41.52 92.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.964 -1.085 . . . . 1.51 110.588 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.948 HD22 HD23 ' B' ' 347' ' ' LEU . 57.9 tp -65.89 -39.94 91.11 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.358 -0.839 . . . . 0.77 109.928 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.46 -40.07 95.03 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.562 -0.711 . . . . 0.62 109.663 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -82.14 5.84 18.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.057 -1.027 . . . . 1.47 110.228 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -50.03 133.21 23.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.0 . . . . 1.47 110.423 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.49 -22.58 63.69 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.606 -0.684 . . . . 1.78 110.919 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.58 -34.12 71.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.928 -1.108 . . . . 2.53 109.1 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.0 -42.11 73.49 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.388 0.613 . . . . 0.8 110.257 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.03 -50.03 75.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 1.42 110.191 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -70.28 -42.53 71.95 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.352 -0.843 . . . . 1.71 110.983 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.07 -40.11 75.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.043 -1.035 . . . . 1.57 111.068 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 84.5 mt -67.47 -49.07 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.043 -1.036 . . . . 0.65 109.451 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 88.1 mt -66.25 -36.76 78.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.608 -0.683 . . . . 0.82 110.248 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.27 82.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.174 -0.954 . . . . 0.79 110.988 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 96' ' ' LYS . 93.5 mt -59.95 -45.81 91.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.051 -1.031 . . . . 0.95 110.3 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.0 mt -60.39 -49.91 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.029 -1.044 . . . . 0.66 108.833 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -65.79 -45.83 80.98 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.992 -0.683 . . . . 2.2 110.525 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -79.01 -48.83 13.71 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.044 -1.035 . . . . 1.65 112.103 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 92' ' ' LEU . 96.5 mttt -92.79 -3.03 55.43 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 120.719 -1.238 . . . . 2.03 112.48 -177.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 57.32 39.73 28.22 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.788 -1.195 . . . . 1.42 109.945 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 95.2 mtp -93.5 168.1 11.26 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.61 -0.681 . . . . 1.18 110.291 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.1 p -82.67 161.12 22.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.433 -0.792 . . . . 0.98 109.663 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.72 -40.04 88.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.344 -0.848 . . . . 0.64 109.491 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.573 ' OD1' HD22 ' A' ' 138' ' ' LEU . 39.5 t0 -63.24 -40.07 96.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.149 -0.97 . . . . 2.07 109.541 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.48 -51.21 9.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.431 -0.793 . . . . 0.73 110.35 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.02 75.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.362 -0.836 . . . . 0.54 110.444 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.03 -41.83 93.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.023 -1.048 . . . . 0.56 109.81 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -59.8 -40.19 87.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.352 -0.843 . . . . 1.54 110.141 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -64.93 -40.11 94.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 1.33 111.077 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 86.1 t -64.79 -50.46 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.001 -1.062 . . . . 0.72 110.689 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.3 mm -70.05 -40.03 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.879 -1.138 . . . . 0.85 108.387 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -65.34 -38.54 90.44 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.257 -1.016 . . . . 2.44 108.257 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.69 -52.91 49.53 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.106 -1.198 . . . . 0.98 110.106 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -60.73 -49.93 75.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.902 -1.352 . . . . 1.41 108.987 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.13 -39.95 88.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.372 -0.83 . . . . 1.2 109.498 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.1 m -59.94 -40.09 87.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.11 -0.994 . . . . 1.7 109.119 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.4 -39.62 87.99 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.237 -0.914 . . . . 1.47 108.876 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.0 mt -62.47 -42.8 99.74 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.273 -0.892 . . . . 1.56 109.514 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -53.99 -31.34 50.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.99 -1.069 . . . . 2.2 109.676 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.97 -24.52 64.48 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.169 -0.957 . . . . 2.12 108.526 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 54.1 mt -62.74 139.98 58.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.931 . . . . 2.0 109.235 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -96.39 45.66 1.06 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.139 -0.975 . . . . 3.23 109.737 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 41.1 t0 -133.33 143.59 49.1 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.333 -0.855 . . . . 2.49 109.182 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.495 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 77.8 mm-40 -71.56 -64.86 0.84 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.195 -1.039 . . . . 3.95 108.195 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.457 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.7 t80 -39.11 -39.97 0.64 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.023 -0.423 . . . . 2.0 110.904 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.2 mt -79.98 -40.04 28.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.61 -1.306 . . . . 1.86 108.884 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.99 -40.57 96.09 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.502 -0.925 . . . . 2.84 108.502 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.89 -34.05 73.04 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.2 -1.037 . . . . 2.73 108.2 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.424 ' NH1' ' OH ' ' A' ' 122' ' ' TYR . 1.9 tpt180 -59.92 -39.42 85.37 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.389 -1.337 . . . . 2.77 107.389 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.55 -25.49 66.68 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.456 0.646 . . . . 1.19 109.285 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.11 94.3 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.037 -1.098 . . . . 1.2 108.037 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.5 -40.07 85.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.759 . . . . 1.55 109.613 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.88 -40.07 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.047 -1.033 . . . . 0.8 108.904 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -60.09 -40.6 90.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.149 -0.969 . . . . 3.09 108.985 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.09 -39.05 84.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.65 -0.656 . . . . 1.46 110.832 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.9 mt -59.96 -42.87 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.919 -1.113 . . . . 0.71 110.248 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.19 -27.47 71.78 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.407 -1.477 . . . . 0.57 109.407 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -59.91 -50.0 75.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.389 -1.065 . . . . 2.59 110.301 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.475 HH11 ' HG2' ' A' ' 136' ' ' ARG . 22.2 mtt-85 -65.71 -37.89 87.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.855 -1.153 . . . . 2.83 109.98 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.5 tp -55.22 -44.25 75.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -0.915 . . . . 1.25 109.323 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.573 HD22 ' OD1' ' A' ' 101' ' ' ASP . 89.3 mt -60.38 -39.98 89.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.24 -0.912 . . . . 0.7 109.511 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 139' ' ' ARG . 51.9 mtt-85 -69.43 -39.83 77.6 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.28 -0.887 . . . . 2.57 108.831 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -64.5 -34.16 77.58 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.704 -0.623 . . . . 1.23 111.104 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.92 -45.74 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.18 -1.575 . . . . 0.81 107.788 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 99.4 mt -70.06 -37.42 75.5 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.392 0.615 . . . . 1.0 109.488 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.89 45.73 7.05 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.116 -1.993 . . . . 0.89 108.116 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.8 tp -76.51 160.05 29.82 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.532 -0.981 . . . . 1.14 109.498 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -68.54 143.83 54.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.447 -0.783 . . . . 4.6 109.823 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.6 mt -120.0 125.1 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 122.004 0.907 . . . . 1.24 109.188 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 148' ' ' ASP . 5.3 mt -64.86 -41.98 93.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 115.962 -0.563 . . . . 1.54 110.225 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 147' ' ' ILE . 23.4 t0 63.73 125.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.213 -1.032 . . . . 1.5 108.213 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.7 mt -86.17 0.47 53.55 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.105 -0.997 . . . . 0.79 110.019 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.7 p -87.29 -8.55 56.6 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.178 -0.951 . . . . 1.4 109.397 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.96 21.82 1.26 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.353 -0.842 . . . . 0.92 111.255 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 32.2 mm -88.4 119.97 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.614 -1.304 . . . . 0.88 108.796 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -100.33 -9.36 22.37 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.453 -0.779 . . . . 2.45 110.687 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -130.14 152.86 49.11 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.232 -0.918 . . . . 1.52 110.499 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -63.52 133.87 54.6 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.369 -0.832 . . . . 1.58 109.218 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.1 m -152.49 164.23 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.911 -0.774 . . . . 0.69 108.911 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.1 mt -92.59 151.53 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 106.029 -1.841 . . . . 0.61 106.029 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 33.7 tp -102.56 118.89 37.83 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.992 -1.068 . . . . 0.87 110.231 -177.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 12.3 t -125.72 134.34 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.805 -0.813 . . . . 0.71 108.805 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.411 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.31 166.13 28.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.931 . . . . 0.81 108.981 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.401 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -70.08 -38.74 75.81 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.34 -1.475 . . . . 0.98 107.306 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -171.17 144.15 2.02 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.961 -0.755 . . . . 2.25 108.961 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 40.9 mt -109.79 137.08 48.1 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.267 -0.896 . . . . 0.78 109.268 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 58.7 p -87.54 149.1 45.74 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 120.993 -1.067 . . . . 0.98 108.979 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -41.71 -36.97 3.59 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.128 1.885 . . . . 0.81 112.827 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.9 m -59.94 -47.18 86.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 0.9 109.661 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.66 -43.81 97.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.915 . . . . 1.61 110.024 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 30.6 p -55.22 -26.67 41.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.266 -0.896 . . . . 0.61 111.702 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -83.19 -43.9 15.62 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.555 -1.34 . . . . 0.6 110.099 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -89.28 36.93 0.84 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.028 -1.101 . . . . 1.4 108.028 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.1 tp -103.24 133.55 48.14 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.454 0.645 . . . . 0.7 109.697 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.495 ' OD1' ' NZ ' ' A' ' 175' ' ' LYS . 0.2 OUTLIER -82.9 99.26 9.65 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.332 -0.988 . . . . 2.35 108.332 179.247 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 90.9 mt -65.07 -42.28 94.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 1.51 110.975 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -62.68 -32.36 73.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.988 -1.07 . . . . 2.33 112.678 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.551 ' HZ2' ' HB2' ' A' ' 175' ' ' LYS . 9.4 mtmp? -92.04 -5.09 53.56 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.64 -1.287 . . . . 1.92 110.341 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.522 HG12 ' H ' ' A' ' 178' ' ' GLY . 72.3 t -104.68 116.46 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.067 -1.086 . . . . 0.67 108.067 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.6 mt -85.93 7.23 25.03 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.17 -0.957 . . . . 1.53 111.326 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.522 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.45 172.86 37.24 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.128 -1.511 . . . . 0.48 109.82 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.482 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 11.4 m-85 -134.3 129.34 35.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.501 -0.999 . . . . 0.55 108.87 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 93.9 mt -134.72 130.33 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.329 -0.857 . . . . 0.65 108.973 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.7 p -151.6 162.17 41.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.956 -1.09 . . . . 0.82 110.531 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 183' ' ' ALA . 38.3 p-10 -109.63 26.73 10.31 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.905 -0.776 . . . . 2.46 108.905 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -54.31 -164.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.987 -1.071 . . . . 1.28 111.64 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.07 -59.33 5.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.562 -1.015 . . . . 2.19 110.562 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -174.07 -156.8 14.2 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 118.748 -1.691 . . . . 2.13 111.22 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.469 ' C ' ' H ' ' A' ' 188' ' ' SER . 46.8 ttp180 -62.33 -30.05 70.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.923 -0.751 . . . . 5.86 110.614 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 30.6 p -61.85 5.17 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.819 -1.176 . . . . 3.72 110.692 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 186' ' ' ARG . 50.2 p -90.87 140.18 30.05 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.871 -1.143 . . . . 1.74 110.419 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -50.0 -43.47 50.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.423 -0.798 . . . . 0.95 109.672 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.8 m -56.97 -40.49 76.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.625 -0.672 . . . . 1.55 109.633 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.9 m -60.14 -39.9 87.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.208 -0.933 . . . . 1.51 110.116 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.8 mt -60.04 -45.12 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.463 -0.773 . . . . 1.67 110.504 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 30.1 mtm -59.94 -47.61 85.08 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.88 -1.137 . . . . 1.02 110.496 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.71 -45.74 63.67 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.681 -1.262 . . . . 0.68 109.897 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -59.93 -50.33 74.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.926 -1.109 . . . . 2.93 110.994 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.1 m -77.02 -30.19 55.68 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.612 -1.305 . . . . 0.86 111.104 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.0 -29.41 66.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.741 -1.224 . . . . 0.67 108.449 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 68.49 47.98 0.87 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.277 0.561 . . . . 1.5 110.317 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 89.4 mt -128.7 149.93 73.43 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 107.865 -1.161 . . . . 0.72 107.865 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.73 138.76 85.05 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 121.925 1.75 . . . . 0.61 111.69 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -172.7 149.17 2.0 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.147 -1.021 . . . . 0.66 110.891 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.5 mt -124.99 150.41 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.173 -1.417 . . . . 0.79 107.173 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.0 -12.11 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.464 0 O-C-N 120.931 -1.106 . . . . 0.91 111.869 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -114.68 25.98 9.84 Favored Glycine 0 N--CA 1.502 3.063 0 N-CA-C 110.076 -1.21 . . . . 1.01 110.076 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.457 ' HB ' HG23 ' A' ' 208' ' ' VAL . 58.3 p -44.26 -47.29 9.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -1.165 . . . . 0.99 110.469 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 106.73 -51.39 0.74 Allowed Glycine 0 N--CA 1.5 2.941 0 N-CA-C 111.018 -0.833 . . . . 1.12 111.018 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 81.1 p -162.82 44.66 0.13 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.473 -1.604 . . . . 1.72 111.962 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' VAL . . . . . 0.457 HG23 ' HB ' ' A' ' 205' ' ' THR . 14.8 t -71.38 -41.02 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.685 -1.26 . . . . 0.89 108.513 178.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.423 ' H ' HG23 ' A' ' 209' ' ' THR . 8.3 p -50.66 -29.94 12.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.841 . . . . 1.03 109.512 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.1 m -81.92 -12.4 58.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 1.83 109.346 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -115.53 15.16 16.68 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.63 -0.669 . . . . 2.27 109.798 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 42.7 t -138.05 134.55 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.407 -0.808 . . . . 0.92 110.394 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.453 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 10.8 mptt -117.42 153.0 33.82 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.368 -1.345 . . . . 2.2 107.368 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.462 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 11.2 p30 -55.51 140.84 39.16 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.995 -1.066 . . . . 2.36 110.367 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.0 m-20 83.06 2.43 1.05 Allowed 'General case' 0 N--CA 1.502 2.147 0 CA-C-N 116.27 -0.423 . . . . 2.38 110.747 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 94.1 m-20 -74.82 141.58 44.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.743 -1.223 . . . . 2.09 109.153 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -90.69 116.42 28.55 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.933 -1.136 . . . . 1.27 107.933 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 16' ' ' ALA . 79.9 mt -125.56 147.55 49.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.441 -0.787 . . . . 0.75 110.365 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.495 HG23 ' CD2' ' A' ' 13' ' ' PHE . 71.5 mt -115.86 129.83 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 106.627 -1.62 . . . . 0.63 106.627 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 61.0 tp -102.59 119.84 39.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.875 -1.141 . . . . 0.7 109.528 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.645 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 23.2 p-10 -76.22 -40.03 53.14 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.148 -1.056 . . . . 2.31 108.148 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.853 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 48.46 18.42 0.17 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.769 -0.826 . . . . 0.78 108.769 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.45 ' N ' ' C ' ' A' ' 221' ' ' ASP . 53.9 t -129.18 -36.66 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.953 -1.129 . . . . 1.04 107.953 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -110.07 -2.81 16.79 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.135 -1.431 . . . . 2.44 107.135 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.645 HD21 ' N ' ' A' ' 4' ' ' GLY . 27.8 t-20 63.66 51.4 2.48 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.498 0.666 . . . . 1.55 109.689 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.645 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 68.9 mt-30 -137.31 152.72 50.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.499 -0.751 . . . . 1.99 109.213 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.86 130.01 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.426 -0.953 . . . . 0.77 108.426 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -102.52 120.82 41.19 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.776 -0.824 . . . . 0.98 108.776 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.6 t -100.95 113.23 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.506 -0.746 . . . . 0.85 110.149 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 41.2 t30 50.02 66.75 5.16 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.187 -0.946 . . . . 1.66 111.127 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -89.17 148.07 5.48 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 123.186 2.591 . . . . 0.95 112.339 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 24.8 p -70.72 166.17 21.44 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.18 -0.95 . . . . 1.84 110.744 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.666 -0.646 . . . . 2.74 109.773 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.02 -37.73 80.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.249 -0.907 . . . . 2.89 109.611 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.02 -41.84 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.169 -0.957 . . . . 1.3 109.056 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 1.09 109.932 -179.664 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 56.9 ttm . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -149.55 146.89 27.6 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.41 162.32 41.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.004 -1.06 . . . . 0.0 110.375 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -156.03 153.9 30.18 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -114.93 134.57 55.05 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.077 -1.014 . . . . 0.0 110.056 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 p -131.82 124.0 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 CA-C-O 122.173 0.987 . . . . 0.0 112.751 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 89.0 m -77.25 104.29 7.67 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.935 0.874 . . . . 0.0 110.673 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.463 HG22 ' H ' ' B' ' 310' ' ' ALA . 92.7 mt -52.15 124.94 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.368 1.08 . . . . 0.0 110.657 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 71.2 p -110.03 20.05 18.34 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.027 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.463 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -74.8 118.5 70.79 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.944 -1.098 . . . . 0.0 109.233 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -53.4 -16.05 6.8 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 CA-C-N 120.251 1.125 . . . . 0.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -120.28 10.08 11.2 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.558 -0.714 . . . . 0.0 109.268 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 69.29 -176.75 30.37 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.714 -1.755 . . . . 0.0 108.714 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.457 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.4 tp -85.45 89.59 7.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.055 -1.262 . . . . 0.0 110.129 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.494 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 4.3 p80 -94.94 -159.97 0.75 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.981 -1.074 . . . . 0.0 109.641 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.8 m -59.73 -47.43 85.68 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.859 -1.151 . . . . 0.0 112.916 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.591 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.4 tpt180 -57.98 -55.89 40.43 Favored Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 120.44 -1.412 . . . . 0.0 112.223 -178.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.494 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 18.1 Cg_endo -64.84 -30.21 58.41 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 CA-C-N 120.583 1.244 . . . . 0.0 111.37 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.03 75.35 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.14 -41.83 72.27 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.569 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 321' ' ' GLN . . . . . 0.41 ' NE2' HH21 ' B' ' 317' ' ' ARG . 12.7 tt0 -69.97 -43.13 72.12 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.026 -1.046 . . . . 0.0 108.615 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -60.41 -50.96 71.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.414 -0.804 . . . . 0.0 110.556 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 58.4 t -66.49 -26.52 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.722 -1.236 . . . . 0.0 109.889 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.33 -45.69 93.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.398 -0.814 . . . . 0.0 110.219 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -69.75 -41.6 75.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.229 -0.919 . . . . 0.0 112.205 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.24 -51.76 68.2 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.455 -1.403 . . . . 0.0 110.954 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -57.71 -11.91 2.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.044 -1.035 . . . . 0.0 109.415 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -70.33 -28.59 71.12 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -105.68 144.66 32.11 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.661 -0.905 . . . . 0.0 109.325 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 18.2 p -91.03 -11.74 37.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.138 -0.976 . . . . 0.0 110.055 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.492 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 90.6 p -58.03 153.64 14.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.164 -0.96 . . . . 0.0 110.135 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.11 130.81 42.47 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 79.8 mt -132.45 131.13 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.465 -0.772 . . . . 0.0 109.646 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 29.3 m -128.12 154.11 46.11 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 76.3 t -118.36 139.56 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 54.6 m -130.5 121.29 25.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.387 -0.82 . . . . 0.0 109.213 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.3 t -136.61 117.7 14.39 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.906 0.86 . . . . 0.0 110.921 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 338' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' B' ' 338' ' ' ASN . 4.8 p-10 42.22 52.26 4.51 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 88.52 -13.39 62.41 Favored Glycine 0 N--CA 1.501 3.015 0 O-C-N 120.31 -1.494 . . . . 0.0 113.507 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -113.84 122.12 46.09 Favored 'General case' 0 N--CA 1.508 2.469 0 CA-C-N 119.602 1.701 . . . . 0.0 110.457 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 77.8 p -103.53 154.97 18.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.421 -0.799 . . . . 0.0 110.701 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 342' ' ' ALA . . . . . 0.424 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -154.18 154.31 33.29 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.765 -0.584 . . . . 0.0 109.916 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 343' ' ' SER . . . . . 0.415 ' H ' ' HE2' ' B' ' 349' ' ' LYS . 4.6 t -91.05 138.09 31.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.346 -0.846 . . . . 0.0 109.971 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.405 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -78.09 -14.87 59.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.987 -1.071 . . . . 0.0 110.624 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -87.74 21.12 2.71 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 346' ' ' SER . . . . . 0.432 ' CB ' ' HZ3' ' B' ' 349' ' ' LYS . 12.3 t -149.17 97.03 2.62 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.856 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.948 HD23 HD22 ' A' ' 79' ' ' LEU . 19.6 tp -59.55 -32.12 70.04 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.818 ' CE2' HD11 ' A' ' 79' ' ' LEU . 61.0 m-85 -57.63 -51.64 68.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.375 -0.828 . . . . 0.0 110.529 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 349' ' ' LYS . . . . . 0.432 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 36.2 mtmm -69.59 -40.01 76.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.572 -1.33 . . . . 0.0 110.002 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.612 ' O ' ' N ' ' B' ' 352' ' ' THR . 86.3 mt -50.62 -55.81 14.65 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.743 -1.223 . . . . 0.0 108.117 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -38.51 -16.07 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.039 -0.413 . . . . 0.0 111.294 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.612 ' N ' ' O ' ' B' ' 350' ' ' LEU . 75.4 p -91.68 -12.02 35.28 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.813 -1.18 . . . . 0.0 110.952 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.424 HD11 ' HB3' ' B' ' 342' ' ' ALA . 55.8 mt -92.56 119.41 31.99 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.896 -1.128 . . . . 0.0 109.179 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.8 91.63 0.99 Allowed Glycine 0 N--CA 1.485 1.958 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 66.2 mt -100.85 94.91 6.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.412 -1.052 . . . . 0.0 108.521 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 75.2 p -91.68 178.79 5.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.349 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 357' ' ' GLN . . . . . 0.404 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 16.1 tm0? -69.16 113.97 7.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.69 -0.631 . . . . 0.0 110.246 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 102.08 9.49 42.13 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 25.5 m -86.45 111.98 21.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.187 -1.184 . . . . 0.0 110.593 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 42.0 t -77.36 116.24 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 122.018 0.913 . . . . 0.0 110.325 -177.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.7 m -110.74 176.6 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 36.8 m -131.43 130.65 42.78 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 76.3 mt -103.93 115.67 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 77.4 p -118.11 131.66 56.41 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.351 -0.843 . . . . 0.0 109.3 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.27 151.55 38.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.105 -0.997 . . . . 0.0 110.187 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 366' ' ' GLU . . . . . 0.438 ' OE2' ' OE2' ' B' ' 370' ' ' GLU . 11.7 tp10 -141.98 119.76 11.87 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.467 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 164.19 -163.89 36.28 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 118.323 -1.894 . . . . 0.0 111.963 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 55.1 tp10 -59.85 -50.73 72.66 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.022 -0.589 . . . . 0.0 111.379 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.492 ' H ' ' HB3' ' B' ' 331' ' ' SER . 75.3 m-20 -103.97 8.57 36.76 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.854 -1.154 . . . . 0.0 111.456 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.1 pt-20 -42.04 -32.96 0.5 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.117 -0.99 . . . . 0.0 111.355 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -66.15 -46.92 75.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.674 -1.266 . . . . 0.0 109.801 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -69.98 -52.07 27.38 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.176 -0.952 . . . . 0.0 109.601 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 373' ' ' ALA . . . . . 0.407 ' O ' HD12 ' B' ' 377' ' ' LEU . . . -42.16 -38.05 1.61 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.548 -0.72 . . . . 0.0 111.676 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.566 ' O ' HG23 ' B' ' 378' ' ' VAL . 62.9 t -79.06 -34.84 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.502 -1.374 . . . . 0.0 110.012 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -65.66 -49.98 66.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.13 -0.981 . . . . 0.0 112.766 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -77.11 -40.37 46.08 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.267 -1.52 . . . . 0.0 110.869 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.407 HD12 ' O ' ' B' ' 373' ' ' ALA . 96.9 mt -60.04 -40.46 89.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.875 -1.141 . . . . 0.0 108.99 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.566 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.5 t -62.27 -45.17 99.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.112 -0.993 . . . . 0.0 109.613 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 379' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.8 mttt -69.76 -55.97 8.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 38.7 tp -53.56 -35.71 61.06 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 381' ' ' MET . . . . . 0.42 ' CE ' HD13 ' B' ' 314' ' ' LEU . 11.1 tpt -69.97 -39.73 75.81 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.06 -5.78 56.46 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.665 -0.647 . . . . 0.0 110.594 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' B' ' 379' ' ' LYS . 99.2 mt-10 -114.42 -0.54 13.75 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.888 -1.132 . . . . 0.0 111.045 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 10.8 mt -81.14 131.88 35.32 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.406 -1.434 . . . . 0.0 109.746 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 385' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 56.4 mp0 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.961 -1.019 . . . . 0.0 108.996 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.349 -0.611 . . . . 2.91 109.349 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.0 mt -110.0 129.92 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.506 -0.746 . . . . 1.2 109.566 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.5 m -130.16 134.95 47.67 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.044 -0.725 . . . . 1.4 109.044 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.72 -163.99 23.32 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.585 -1.806 . . . . 1.05 108.585 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.9 mt -92.18 -11.08 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.91 -1.347 . . . . 1.15 109.539 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.567 HD11 ' O ' ' A' ' 8' ' ' SER . 52.6 tp 53.55 103.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.293 -0.879 . . . . 0.98 109.533 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.23 -21.15 21.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.239 -0.913 . . . . 0.88 109.99 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.567 ' O ' HD11 ' A' ' 6' ' ' LEU . 21.4 m -148.67 135.7 10.57 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 120.895 -1.128 . . . . 1.69 109.596 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.73 142.45 14.24 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.707 2.271 . . . . 0.85 113.489 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.857 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 157.53 -158.44 29.0 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.206 -1.558 . . . . 0.92 109.206 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -149.28 150.5 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 107.851 -1.166 . . . . 0.81 107.851 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.67 141.5 21.06 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.808 -1.183 . . . . 0.51 110.712 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -125.76 126.44 44.57 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.884 -1.154 . . . . 0.62 107.884 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.06 178.29 48.16 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 118.482 -1.818 . . . . 0.55 110.879 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -78.32 158.89 28.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.853 -0.792 . . . . 2.1 109.227 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -101.42 128.77 47.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.407 -0.808 . . . . 0.77 110.663 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.8 tp -99.11 134.94 41.23 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 106.865 -1.532 . . . . 0.91 106.865 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -117.39 118.27 31.77 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.408 -0.808 . . . . 0.93 110.121 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.4 mt -84.88 103.46 13.97 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.316 -0.624 . . . . 0.93 109.316 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -100.2 135.39 41.7 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.372 -0.83 . . . . 2.75 110.008 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -130.61 133.94 46.57 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.522 -0.736 . . . . 3.0 109.118 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -79.14 158.05 27.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.969 -1.082 . . . . 2.77 109.14 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -71.88 149.99 44.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.278 -0.889 . . . . 2.94 110.176 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.4 mt -95.48 130.34 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.214 -0.929 . . . . 0.95 108.938 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.17 129.71 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.121 -0.987 . . . . 1.28 110.115 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.7 mt -107.58 137.1 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 108.617 -0.882 . . . . 1.21 108.617 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -94.86 119.89 34.17 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.94 -1.1 . . . . 1.81 110.265 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.494 HH11 ' HG2' ' A' ' 28' ' ' ARG . 5.0 mmt-85 -88.71 0.05 56.83 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.53 -0.731 . . . . 2.8 109.79 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -70.35 141.43 52.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 2.87 109.921 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -82.41 150.55 27.04 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.204 -0.935 . . . . 2.35 109.301 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.447 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.5 pt -95.1 166.2 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.244 -0.91 . . . . 0.97 109.657 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.4 p -96.41 172.95 7.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.178 -0.951 . . . . 1.17 108.767 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.02 -49.29 78.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.047 -1.033 . . . . 1.18 109.335 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -54.86 -30.05 56.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.863 -1.148 . . . . 2.56 109.471 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -82.44 -10.75 58.91 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.407 -0.808 . . . . 1.79 110.265 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.27 -51.84 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.865 -1.147 . . . . 1.0 108.766 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.96 -39.98 93.99 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.364 -0.835 . . . . 1.77 110.055 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -68.38 -39.97 81.54 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.139 -0.976 . . . . 2.7 111.248 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.447 ' HG3' HG21 ' A' ' 31' ' ' ILE . 71.4 mm-40 -67.96 -39.96 83.29 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.8 -1.188 . . . . 1.51 110.184 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -62.98 -47.8 91.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 120.861 -1.149 . . . . 0.93 108.771 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -61.89 -41.6 98.08 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.104 -0.998 . . . . 1.81 109.347 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.18 -40.47 90.09 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.827 -1.149 . . . . 2.78 108.217 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -67.3 -42.02 84.4 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.55 -0.907 . . . . 0.78 108.55 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.92 -48.26 82.44 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.914 -1.143 . . . . 1.07 107.914 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.425 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 35.7 t -63.93 -44.02 94.15 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.756 -0.831 . . . . 1.12 108.756 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.14 -45.45 96.51 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.282 -1.927 . . . . 0.84 108.282 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.546 ' NH2' ' O ' ' A' ' 80' ' ' LEU . 8.5 ttt180 -63.75 -34.11 77.15 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.681 -1.229 . . . . 3.09 107.681 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -60.04 -40.96 91.19 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.303 -0.628 . . . . 0.88 109.303 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 23.5 ttmt -63.64 -74.39 0.1 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.836 -1.172 . . . . 2.59 107.836 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.17 -39.6 0.43 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.45 -0.782 . . . . 0.7 111.316 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.2 m -53.01 -53.98 42.04 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.517 -1.365 . . . . 1.4 108.527 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.02 -39.96 75.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.469 -0.769 . . . . 0.67 111.501 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -68.89 -39.97 79.48 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.739 -1.225 . . . . 1.66 110.194 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 79.1 mt -63.11 -40.07 96.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.139 -0.976 . . . . 1.58 109.377 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -60.73 -35.26 75.9 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.248 -0.908 . . . . 1.35 109.432 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -62.58 -41.85 99.2 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.159 -0.963 . . . . 0.77 109.402 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.8 mt -62.77 -40.04 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.3 -0.875 . . . . 0.63 109.039 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -56.02 -50.03 72.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.11 -0.994 . . . . 1.14 109.197 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -56.02 -35.4 66.8 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.318 -0.864 . . . . 0.79 109.816 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -69.95 -37.91 75.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 1.53 109.815 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.13 -46.16 85.35 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.491 -0.756 . . . . 0.57 110.183 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.54 -50.03 72.13 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.497 -1.441 . . . . 0.75 109.497 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -68.23 -49.67 59.19 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.204 -1.174 . . . . 1.59 109.502 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.6 m -65.05 -63.8 1.02 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 0.73 112.332 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -95.27 -51.74 4.48 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.879 -1.138 . . . . 0.75 111.288 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.71 -167.99 25.72 Favored Glycine 0 N--CA 1.502 3.073 0 C-N-CA 119.706 -1.235 . . . . 1.22 111.128 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -70.22 -27.01 64.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 122.007 -0.702 . . . . 5.81 110.461 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -60.88 -35.72 77.35 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.3 -0.875 . . . . 3.37 110.571 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -101.04 -20.83 15.21 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.338 -0.851 . . . . 1.77 110.159 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -65.94 -40.06 91.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.026 -1.046 . . . . 1.65 110.002 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.545 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -64.75 -26.77 68.5 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.279 -0.888 . . . . 0.77 109.997 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.04 -39.96 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 118.717 -1.193 . . . . 0.8 108.531 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -66.42 -42.11 88.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.032 . . . . 0.88 110.282 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -60.13 -40.2 88.97 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.853 -1.155 . . . . 1.37 108.939 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.44 -49.95 66.07 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.945 -1.662 . . . . 0.62 108.945 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.503 ' CG ' HD11 ' A' ' 133' ' ' ILE . 38.5 m170 -62.9 -47.2 84.32 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.328 -1.101 . . . . 1.5 109.181 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.4 mt -65.69 -46.8 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.293 -0.879 . . . . 0.63 108.885 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.9 ttp -59.99 -40.12 88.11 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.01 -1.056 . . . . 1.51 109.048 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.018 HD22 HD23 ' B' ' 347' ' ' LEU . 44.4 tp -64.43 -39.99 94.89 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.457 0.646 . . . . 0.77 109.443 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.546 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 62.8 tp -63.18 -39.99 96.24 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.575 -0.703 . . . . 0.62 110.157 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -84.74 7.23 21.3 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.049 -1.032 . . . . 1.47 110.261 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 61.4 t0 -50.14 134.23 22.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.12 -0.987 . . . . 1.47 109.979 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.485 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 93.6 mt-10 -60.12 -23.51 63.93 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.634 -0.667 . . . . 1.78 110.941 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -70.81 -34.24 71.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.971 -1.08 . . . . 2.53 109.415 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.9 mt -71.02 -40.51 71.72 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.573 0.701 . . . . 0.8 109.692 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -59.98 -46.56 89.04 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.115 -0.991 . . . . 1.42 110.231 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -69.97 -42.24 73.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.211 -0.93 . . . . 1.71 111.594 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -69.99 -39.97 75.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.039 -1.038 . . . . 1.57 112.095 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.07 -48.14 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.142 -0.974 . . . . 0.65 109.625 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.92 -39.62 80.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 121.262 0.553 . . . . 0.82 110.179 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.17 -47.69 84.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.79 110.768 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.4 mt -60.0 -48.35 82.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.989 -1.07 . . . . 0.95 109.941 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.2 mt -61.61 -48.59 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 121.957 0.884 . . . . 0.66 108.878 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -67.76 -40.16 84.11 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 120.203 -0.599 . . . . 2.2 110.857 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -86.57 -50.66 6.67 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.915 -1.115 . . . . 1.65 112.356 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -90.14 -2.9 58.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.984 -1.072 . . . . 2.03 111.71 -177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.9 m170 57.94 35.81 25.65 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.893 -1.129 . . . . 1.42 109.474 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.8 mtp -90.33 163.88 14.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.47 -0.769 . . . . 1.18 109.752 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.6 p -76.06 158.36 31.92 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.29 -0.881 . . . . 0.98 108.648 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.55 -39.97 77.11 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.137 -0.977 . . . . 0.64 110.078 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.84 -39.86 95.66 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.225 -0.922 . . . . 2.07 109.678 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.35 -44.49 19.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.73 109.942 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.37 -49.29 76.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.328 -0.857 . . . . 0.54 110.191 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.21 90.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.127 -0.983 . . . . 0.56 110.025 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -60.05 -40.01 87.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 1.54 109.858 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -61.34 -40.12 93.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.063 -1.023 . . . . 1.33 110.395 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.0 t -62.81 -50.62 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.169 -0.957 . . . . 0.72 110.509 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.9 mm -69.99 -39.99 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.103 -0.998 . . . . 0.85 109.674 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -66.47 -39.21 88.67 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.29 -0.881 . . . . 2.44 108.699 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.27 -49.28 80.27 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.564 -1.014 . . . . 0.98 110.564 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -63.9 -47.51 80.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.938 -1.33 . . . . 1.41 110.135 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.43 -39.35 83.24 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.238 -0.914 . . . . 1.2 109.153 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.2 m -59.9 -40.07 87.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.142 -0.974 . . . . 1.7 108.997 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.94 87.67 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.231 -1.026 . . . . 1.47 108.231 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.3 mt -65.18 -41.74 94.3 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.313 -0.955 . . . . 1.56 108.55 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -57.8 -32.29 67.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.117 -0.989 . . . . 2.2 109.688 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.21 -26.71 61.12 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.084 -1.01 . . . . 2.12 108.466 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 25.3 mt -63.2 144.07 57.24 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.451 -0.944 . . . . 2.0 108.451 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -92.8 13.43 20.33 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.189 -0.944 . . . . 3.23 110.757 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 19.2 t0 -102.67 148.7 25.26 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.053 -1.029 . . . . 2.49 110.085 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 98.0 mt-10 -73.8 -65.05 0.88 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.483 -0.761 . . . . 3.95 109.34 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.483 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 4.1 t80 -39.33 -35.43 0.26 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.893 -0.504 . . . . 2.0 110.616 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 78.6 mt -78.39 -40.04 37.3 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.834 -1.166 . . . . 1.86 109.342 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 121' ' ' GLU . 87.9 tttt -69.93 -42.6 73.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.189 -0.944 . . . . 2.84 110.807 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -63.35 -43.08 98.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.106 -0.997 . . . . 2.73 109.9 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.546 ' CZ ' ' NE2' ' B' ' 351' ' ' GLN . 26.8 ttp180 -59.99 -38.5 82.77 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.212 -0.93 . . . . 2.77 108.984 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.26 -43.64 92.45 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.141 -1.059 . . . . 1.19 108.141 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -44.7 -41.75 7.03 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.948 -0.76 . . . . 1.2 108.948 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.32 -39.93 94.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 1.55 109.708 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.36 -43.17 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.02 -1.05 . . . . 0.8 108.96 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -60.0 -39.92 87.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.109 -0.994 . . . . 3.09 109.372 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -57.17 -37.92 72.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.888 . . . . 1.46 109.742 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.503 HD11 ' CG ' ' A' ' 76' ' ' HIS . 96.9 mt -59.94 -41.66 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.146 -0.971 . . . . 0.71 109.116 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.24 -30.72 58.37 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.769 -1.332 . . . . 0.57 109.769 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -59.98 -47.47 85.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.148 -1.207 . . . . 2.59 109.799 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -68.15 -31.14 70.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.814 -1.179 . . . . 2.83 109.63 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.09 -41.55 92.74 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.167 -0.958 . . . . 1.25 109.364 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.02 -40.05 87.93 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.209 -1.034 . . . . 0.7 108.209 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.404 HH11 ' CD2' ' A' ' 144' ' ' LEU . 62.3 mtt-85 -68.21 -38.04 81.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.662 -0.649 . . . . 2.57 109.305 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -68.6 -34.8 76.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 1.23 111.668 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.9 mt -70.4 -42.51 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.275 -1.516 . . . . 0.81 108.97 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.1 -25.4 63.49 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.636 -0.665 . . . . 1.0 109.591 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.78 36.24 19.79 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.378 -1.889 . . . . 0.89 108.378 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.404 ' CD2' HH11 ' A' ' 139' ' ' ARG . 5.1 tp -73.89 145.46 44.81 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.668 -0.901 . . . . 1.14 109.259 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -68.94 140.09 55.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -0.855 . . . . 4.6 109.924 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.5 mt -106.52 130.05 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-O 121.694 0.759 . . . . 1.24 109.21 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 16.8 mm -56.27 -49.12 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.682 -0.637 . . . . 1.54 110.367 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.6 t0 70.87 95.12 0.07 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.603 -0.686 . . . . 1.5 109.245 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.406 ' O ' ' OD1' ' A' ' 172' ' ' ASN . 33.4 mt -73.02 -4.08 30.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.352 -0.843 . . . . 0.79 110.968 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 81.2 p -82.85 -14.63 53.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.754 -1.216 . . . . 1.4 109.361 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.21 18.19 2.71 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.329 -0.857 . . . . 0.92 112.605 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.3 mp -91.33 115.82 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.121 -1.612 . . . . 0.88 108.02 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -100.17 -8.52 23.52 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.293 -0.88 . . . . 2.45 109.952 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -108.14 144.96 34.83 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.352 -0.843 . . . . 1.52 110.163 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -66.35 130.82 44.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.339 -0.851 . . . . 1.58 109.028 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.7 m -153.11 167.24 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.472 -0.768 . . . . 0.69 109.565 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -93.77 148.24 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 106.318 -1.734 . . . . 0.61 106.318 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 171' ' ' LEU . 47.1 tp -96.89 117.45 31.13 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.872 -1.143 . . . . 0.87 111.066 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 8.5 t -121.41 127.97 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 108.516 -0.92 . . . . 0.71 108.516 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.04 162.06 36.61 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.213 -0.929 . . . . 0.81 108.74 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.475 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.94 -33.73 72.52 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.405 -1.434 . . . . 0.98 107.756 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.5 p-10 -166.8 175.33 7.86 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.318 -0.993 . . . . 2.25 108.318 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 51.6 mt -140.23 125.73 19.05 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.118 -1.067 . . . . 0.78 108.118 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 36.1 p -87.11 146.97 41.54 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.032 -1.043 . . . . 0.98 108.768 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -36.54 -38.13 0.32 Allowed 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.365 2.043 . . . . 0.81 112.295 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.2 m -60.04 -40.03 87.99 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.361 -0.837 . . . . 0.9 109.778 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.01 -44.42 69.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.105 -0.997 . . . . 1.61 110.192 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.8 p -55.53 -20.44 13.1 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.265 -0.897 . . . . 0.61 111.116 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.51 -47.57 12.03 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.868 -1.145 . . . . 0.6 109.871 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -90.24 38.41 0.93 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.221 -1.029 . . . . 1.4 108.221 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.597 HD11 HD22 ' A' ' 158' ' ' LEU . 9.3 tp -100.25 135.96 40.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.7 108.811 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.578 ' O ' HG23 ' A' ' 176' ' ' VAL . 30.7 m120 -86.67 102.12 13.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.194 -0.941 . . . . 2.35 109.307 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 80.9 mt -64.83 -41.67 95.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 1.51 110.799 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -69.12 -28.04 66.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.939 -1.101 . . . . 2.33 111.911 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -92.84 -11.43 33.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.748 -1.22 . . . . 1.92 109.159 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.581 HG11 ' CE1' ' A' ' 179' ' ' PHE . 85.9 t -99.07 108.16 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.611 -1.255 . . . . 0.67 107.611 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.8 4.07 30.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.269 -0.894 . . . . 1.53 110.265 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.08 171.04 38.09 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.679 -1.768 . . . . 0.48 108.679 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.581 ' CE1' HG11 ' A' ' 176' ' ' VAL . 35.0 m-85 -129.49 128.6 43.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.348 -1.089 . . . . 0.55 108.834 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 91.3 mt -131.44 123.2 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.595 -0.891 . . . . 0.65 108.595 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 203' ' ' VAL . 41.0 p -147.1 158.91 44.09 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.008 -1.057 . . . . 0.82 110.252 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 50.1 p30 -108.51 25.2 11.97 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.208 -0.664 . . . . 2.46 109.208 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.77 -162.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.029 -1.044 . . . . 1.28 111.358 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -64.22 -64.74 3.42 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.198 -1.161 . . . . 2.19 110.198 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.79 -131.45 1.66 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.19 -1.481 . . . . 2.13 110.8 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -79.95 -9.78 59.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.62 -0.929 . . . . 5.86 110.563 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 52.2 p -84.7 0.92 48.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.985 -1.072 . . . . 3.72 110.708 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 81.0 p -88.36 144.23 26.52 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.907 -1.121 . . . . 1.74 110.298 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -53.18 -41.06 64.86 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.344 -0.847 . . . . 0.95 108.844 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 190' ' ' THR . 0.7 OUTLIER -53.38 -36.39 61.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.628 -0.67 . . . . 1.55 109.462 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 53.5 m -60.0 -40.02 87.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.194 -0.942 . . . . 1.51 109.981 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.6 mt -60.01 -40.09 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.926 . . . . 1.67 109.597 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 90.5 mtp -57.39 -48.83 78.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.082 -1.012 . . . . 1.02 110.435 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.94 -42.82 94.83 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.727 -1.233 . . . . 0.68 109.768 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -61.98 -59.25 5.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.131 -0.981 . . . . 2.93 110.389 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 61.5 m -67.11 -39.39 86.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.139 -0.975 . . . . 0.86 112.421 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 91.2 mt -70.22 -26.64 63.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.616 -1.303 . . . . 0.67 109.306 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 68.08 45.19 1.34 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.21 0.528 . . . . 1.5 110.535 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 93.6 mt -120.74 149.93 51.56 Favored Pre-proline 0 N--CA 1.503 2.202 0 N-CA-C 107.64 -1.245 . . . . 0.72 107.64 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.11 141.69 94.64 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.927 1.751 . . . . 0.61 111.301 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -171.49 152.41 3.23 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.523 -1.271 . . . . 0.66 111.898 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.6 mt -121.84 146.4 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.695 -1.224 . . . . 0.79 107.695 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 181' ' ' THR . 21.4 m -127.66 -15.43 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 O-C-N 121.149 -0.97 . . . . 0.91 110.694 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.0 27.4 14.56 Favored Glycine 0 N--CA 1.504 3.193 0 O-C-N 121.389 -0.819 . . . . 1.01 111.098 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.0 p -49.14 -33.42 12.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.741 -1.446 . . . . 0.99 110.164 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 84.68 -87.31 1.55 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.708 -1.357 . . . . 1.12 109.708 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 27.5 t -125.31 39.16 4.03 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.558 -0.966 . . . . 1.72 112.571 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.15 -40.62 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.444 -1.41 . . . . 0.89 109.036 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 209' ' ' THR . 1.4 p -56.36 -31.41 63.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.263 -0.898 . . . . 1.03 109.94 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 23.0 t -71.71 -28.96 64.05 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.168 -0.957 . . . . 1.83 109.338 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -94.92 -9.57 33.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.283 -0.885 . . . . 2.27 111.176 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 63.6 t -102.61 137.14 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.95 -1.093 . . . . 0.92 110.632 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -114.11 155.04 26.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.751 -1.203 . . . . 2.2 107.751 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 57.5 t-20 -59.89 139.89 57.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.004 -1.06 . . . . 2.36 109.92 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.0 t0 84.55 6.44 0.57 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.407 0.622 . . . . 2.38 109.434 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 54.8 t0 -76.01 136.81 39.97 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.374 -0.829 . . . . 2.09 108.959 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.508 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 35.5 t80 -89.84 117.47 28.7 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.674 -1.232 . . . . 1.27 107.674 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 86.6 mt -125.97 145.01 50.47 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.287 -0.883 . . . . 0.75 110.808 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.1 mt -115.27 129.95 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.102 -1.073 . . . . 0.63 108.102 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 35.5 tp -103.95 117.66 34.85 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.14 -0.975 . . . . 0.7 109.133 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 223' ' ' VAL . 92.4 m-20 -74.85 -43.48 54.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.069 -1.019 . . . . 2.31 108.962 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.857 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.24 9.84 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.255 -0.646 . . . . 0.78 109.255 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.51 ' H ' ' C ' ' A' ' 221' ' ' ASP . 47.0 t -129.82 -40.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 107.5 -1.296 . . . . 1.04 107.5 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -101.97 1.81 37.12 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.771 -0.825 . . . . 2.44 108.771 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 59.99 41.95 16.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.604 -0.685 . . . . 1.55 109.698 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -136.6 146.22 45.81 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.316 -0.865 . . . . 1.99 110.079 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.32 130.01 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.266 -1.013 . . . . 0.77 108.266 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -100.68 123.68 45.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.367 -0.833 . . . . 0.98 108.879 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.0 t -99.1 110.84 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.373 -0.829 . . . . 0.85 110.93 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 34.5 t30 49.68 59.93 16.05 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.503 -0.748 . . . . 1.66 111.047 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.67 151.93 19.57 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.694 2.263 . . . . 0.95 111.925 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.444 ' OG1' HG23 ' A' ' 235' ' ' VAL . 41.7 p -68.39 161.27 27.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.117 -0.99 . . . . 1.84 109.761 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.03 -38.28 82.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 2.74 108.972 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -59.87 -40.08 87.47 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.682 -0.859 . . . . 2.89 108.682 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.444 HG23 ' OG1' ' A' ' 232' ' ' THR . 54.5 t -67.33 -39.87 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 1.3 109.36 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 91.6 mt . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.186 -0.946 . . . . 1.09 109.147 179.554 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 301' ' ' MET . . . . . 0.418 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 27.5 ttp . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.451 0.643 . . . . 0.0 109.573 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 302' ' ' PHE . . . . . 0.418 ' N ' ' CG ' ' B' ' 301' ' ' MET . 16.3 t80 -152.7 149.91 28.9 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 303' ' ' GLN . . . . . 0.408 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 14.6 pt20 -149.34 159.75 44.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.988 -1.07 . . . . 0.0 110.413 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -153.16 149.4 27.99 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -111.47 134.86 52.75 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.075 -1.016 . . . . 0.0 109.94 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.86 121.29 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 122.333 1.063 . . . . 0.0 112.735 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 16.9 m -75.92 105.35 6.91 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.941 0.877 . . . . 0.0 109.538 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.549 HG22 ' H ' ' B' ' 310' ' ' ALA . 96.0 mt -53.13 123.64 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 122.469 1.128 . . . . 0.0 111.104 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 44.4 p -107.48 23.65 14.11 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.079 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.549 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -86.38 114.26 56.66 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.376 -0.828 . . . . 0.0 109.384 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -65.89 -6.9 15.27 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 120.289 1.139 . . . . 0.0 112.17 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -113.31 2.67 15.6 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.28 176.07 18.48 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.483 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -84.18 87.4 7.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.761 -1.435 . . . . 0.0 108.812 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.544 ' CE1' ' HB3' ' B' ' 317' ' ' ARG . 23.1 p-80 -92.65 -160.26 0.73 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.193 -0.942 . . . . 0.0 109.696 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 5.5 m -57.89 -49.7 75.83 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.912 -1.117 . . . . 0.0 112.168 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.545 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 11.4 tpt180 -52.35 -59.04 9.41 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 120.63 -1.294 . . . . 0.0 112.024 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.425 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 17.8 Cg_endo -63.36 -35.03 64.28 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 CA-C-N 120.613 1.255 . . . . 0.0 111.483 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.35 78.01 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -57.57 -44.86 85.62 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.313 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -69.1 -44.53 72.27 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.626 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -60.01 -50.05 75.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.694 -0.629 . . . . 0.0 111.004 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.52 -29.18 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.529 -1.357 . . . . 0.0 109.206 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -59.93 -46.6 88.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.53 -0.731 . . . . 0.0 109.833 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -69.26 -40.6 77.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 0.0 111.426 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.19 -51.48 69.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.55 -1.344 . . . . 0.0 109.997 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -58.97 -13.33 6.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 109.307 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.6 -30.85 70.67 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -105.54 141.8 36.39 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.54 -0.977 . . . . 0.0 108.534 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 35.2 m -90.2 -11.43 41.04 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.841 -1.162 . . . . 0.0 109.539 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.478 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 93.8 p -57.99 151.2 18.96 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.139 -0.976 . . . . 0.0 108.784 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -68.06 130.48 43.09 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.213 -0.929 . . . . 0.0 108.813 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 80.1 mt -130.65 130.48 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.5 -0.75 . . . . 0.0 109.143 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 45.3 m -127.85 152.13 48.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.478 -0.764 . . . . 0.0 108.996 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 75.5 t -119.12 138.43 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 98.8 m -132.21 129.31 39.55 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.262 -0.899 . . . . 0.0 110.204 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 337' ' ' SER . . . . . 0.454 ' C ' ' H ' ' B' ' 339' ' ' GLY . 80.2 p -136.91 126.77 25.72 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.466 -0.771 . . . . 0.0 109.791 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 56.8 t30 57.09 5.58 0.26 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.59 0.71 . . . . 0.0 109.505 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 339' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' B' ' 337' ' ' SER . . . 101.91 10.16 40.85 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -100.56 119.27 38.28 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 32.4 m -99.06 149.75 22.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.182 -0.949 . . . . 0.0 111.908 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 342' ' ' ALA . . . . . 0.492 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -149.69 149.54 30.76 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 343' ' ' SER . . . . . 0.434 ' H ' ' HE3' ' B' ' 349' ' ' LYS . 8.8 t -90.55 131.43 36.28 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.119 -0.988 . . . . 0.0 110.297 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -70.06 -16.63 63.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.152 -0.967 . . . . 0.0 110.047 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 345' ' ' LYS . . . . . 0.48 ' NZ ' ' CB ' ' B' ' 345' ' ' LYS . 0.1 OUTLIER -89.52 19.59 4.46 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 28.4 t -147.99 99.0 3.02 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.057 0.932 . . . . 0.0 111.572 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 1.018 HD23 HD22 ' A' ' 79' ' ' LEU . 58.9 tp -58.98 -36.2 74.48 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.739 ' CE2' HD11 ' A' ' 79' ' ' LEU . 58.2 m-85 -55.17 -53.05 60.94 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.312 -0.868 . . . . 0.0 111.363 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 349' ' ' LYS . . . . . 0.434 ' HE3' ' H ' ' B' ' 343' ' ' SER . 49.8 mtmt -70.04 -29.75 66.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 0.0 109.74 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' B' ' 347' ' ' LEU . 55.7 mt -59.75 -39.4 84.64 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.414 -0.804 . . . . 0.0 111.196 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.546 ' NE2' ' CZ ' ' A' ' 126' ' ' ARG . 3.0 mm100 -65.78 -14.75 61.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.187 -1.571 . . . . 0.0 111.673 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 40.5 p -77.53 -10.89 59.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.13 -1.607 . . . . 0.0 110.156 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.492 HD11 ' HB3' ' B' ' 342' ' ' ALA . 52.8 mt -93.44 115.08 27.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.113 -0.992 . . . . 0.0 109.043 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -72.24 93.97 0.62 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 107.772 -2.131 . . . . 0.0 107.772 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 355' ' ' LEU . . . . . 0.45 HD22 HG11 ' B' ' 361' ' ' VAL . 80.6 mt -100.21 88.08 3.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.241 -1.152 . . . . 0.0 110.341 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 44.7 p -92.31 -179.99 5.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.977 -1.077 . . . . 0.0 110.651 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -71.23 114.07 8.92 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.597 -0.689 . . . . 0.0 110.605 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.77 10.65 32.33 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 25.6 m -90.99 108.17 19.68 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.353 -1.086 . . . . 0.0 110.578 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 99.8 t -76.99 118.17 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 122.181 0.991 . . . . 0.0 109.366 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 361' ' ' VAL . . . . . 0.45 HG11 HD22 ' B' ' 355' ' ' LEU . 14.9 m -111.92 178.19 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 28.2 m -131.74 129.42 40.62 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 78.6 mt -105.33 120.63 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 75.6 p -120.32 132.32 55.25 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.548 -0.72 . . . . 0.0 109.184 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.21 149.56 36.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 109.799 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -147.0 125.84 12.69 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 158.72 -158.9 29.78 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 118.913 -1.613 . . . . 0.0 111.401 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -59.94 -52.53 65.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 122.178 -0.601 . . . . 0.0 111.794 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.478 ' H ' ' HB3' ' B' ' 331' ' ' SER . 70.9 m-20 -107.59 11.75 28.32 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.973 -1.079 . . . . 0.0 111.384 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 369' ' ' ASP . 12.9 pt-20 -37.78 -33.59 0.08 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.402 -0.812 . . . . 0.0 111.578 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -66.7 -51.17 59.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.906 -1.121 . . . . 0.0 110.925 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -64.08 -48.9 74.38 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.908 -1.12 . . . . 0.0 108.915 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.31 -40.75 3.7 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.53 -0.731 . . . . 0.0 111.594 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 94.7 t -76.13 -35.86 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.615 -1.303 . . . . 0.0 109.708 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.7 -59.07 5.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.103 -0.998 . . . . 0.0 111.832 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -70.02 -40.79 74.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.762 -1.211 . . . . 0.0 111.867 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.98 -41.14 91.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.676 -1.265 . . . . 0.0 109.422 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.63 -44.6 99.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.897 -1.127 . . . . 0.0 109.732 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 379' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' B' ' 383' ' ' GLU . 57.7 mtpt -68.97 -55.99 9.2 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 53.8 tp -54.49 -37.71 65.59 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.732 -0.605 . . . . 0.0 109.404 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 6.4 tpp -72.79 -40.0 66.26 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.602 -1.311 . . . . 0.0 108.441 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -79.97 -5.27 55.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.545 -0.722 . . . . 0.0 110.19 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' B' ' 379' ' ' LYS . 53.7 mm-40 -110.61 0.97 17.76 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.19 -0.944 . . . . 0.0 111.069 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 17.4 mt -90.8 124.59 35.26 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.518 -1.364 . . . . 0.0 109.107 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 385' ' ' GLU . . . . . 0.417 ' H ' ' HG2' ' B' ' 385' ' ' GLU . 15.1 pt-20 . . . . . 0 N--CA 1.499 1.986 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.376 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.7 mtm . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.356 -0.609 . . . . 2.91 109.356 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.3 mt -110.36 129.0 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.533 -0.73 . . . . 1.2 109.311 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.7 m -140.79 120.55 13.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.375 -0.828 . . . . 1.4 109.23 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.7 -164.98 39.18 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.743 -1.343 . . . . 1.05 109.743 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 5' ' ' ILE . 88.1 mt -86.44 -1.54 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.172 -1.193 . . . . 1.15 110.583 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.2 tp 52.53 88.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.799 -1.188 . . . . 0.98 109.07 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.74 -38.0 64.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.254 -0.904 . . . . 0.88 109.509 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.0 t -149.71 135.52 10.12 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.375 -0.828 . . . . 1.69 109.427 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -80.43 145.56 16.78 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.23 1.954 . . . . 0.85 113.772 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.689 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.84 -159.37 30.59 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.189 -1.564 . . . . 0.92 109.189 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.2 mt -149.54 150.01 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.047 -1.266 . . . . 0.81 108.955 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.44 150.37 26.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.054 -1.029 . . . . 0.51 110.53 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -130.25 126.22 36.77 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 107.969 -1.123 . . . . 0.62 107.969 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.8 178.04 48.4 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.429 -1.843 . . . . 0.55 111.096 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -80.01 159.61 26.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.89 -0.771 . . . . 2.1 109.679 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -100.38 132.04 45.97 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.376 -0.828 . . . . 0.77 111.582 -178.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.0 tp -105.27 133.42 50.07 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.717 -1.586 . . . . 0.91 106.717 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.8 tp -117.11 123.51 46.96 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.138 -0.976 . . . . 0.93 110.747 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' A' ' 160' ' ' ALA . 48.7 mt -92.43 104.13 16.49 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.755 -0.59 . . . . 0.93 110.473 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.66 137.56 32.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.318 -0.864 . . . . 2.75 109.341 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -131.12 134.14 46.27 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.241 -0.912 . . . . 3.0 109.492 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -88.21 139.96 29.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.116 -0.99 . . . . 2.77 109.074 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -62.31 140.78 58.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.034 -1.041 . . . . 2.94 109.268 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.3 mt -79.18 132.3 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.95 108.766 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.2 t -104.64 126.66 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.426 -0.797 . . . . 1.28 109.897 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -100.27 138.61 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.789 -0.819 . . . . 1.21 108.789 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -90.61 125.65 35.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.997 -1.064 . . . . 1.81 109.204 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -89.94 1.43 56.25 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.692 -0.855 . . . . 2.8 108.692 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.95 139.93 57.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.42 -0.8 . . . . 2.87 109.747 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -88.04 137.92 31.9 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.305 -0.872 . . . . 2.35 109.24 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.8 pt -90.57 159.98 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.994 -1.067 . . . . 0.97 109.442 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.4 p -94.65 171.78 8.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.061 -1.024 . . . . 1.17 108.687 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.58 -46.69 83.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 1.18 108.997 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 25.6 t0 -55.84 -32.7 63.84 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.758 -1.214 . . . . 2.56 109.516 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -81.51 -9.98 59.58 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.12 -0.988 . . . . 1.79 110.425 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 t -64.15 -53.02 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.6 -1.312 . . . . 1.0 108.8 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -61.72 -39.99 93.47 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.439 -0.788 . . . . 1.77 110.027 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -67.96 -41.87 81.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 2.7 110.492 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -65.42 -39.98 92.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.065 -1.022 . . . . 1.51 110.575 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.98 -46.17 94.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.688 -1.258 . . . . 0.93 108.79 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -60.03 -40.01 87.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.846 -1.159 . . . . 1.81 108.94 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.505 HH11 ' HG2' ' A' ' 42' ' ' ARG . 17.9 mtt-85 -60.01 -43.28 95.35 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.973 -1.121 . . . . 2.78 107.973 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 28.6 t80 -60.84 -50.05 74.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.475 -0.766 . . . . 0.78 109.064 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.6 tp -61.87 -44.66 96.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.414 -0.804 . . . . 1.07 109.035 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.6 t -65.47 -43.74 89.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -0.943 . . . . 1.12 109.176 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.98 -45.71 95.43 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.684 -2.166 . . . . 0.84 107.684 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -60.66 -39.28 87.76 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.389 -0.967 . . . . 3.09 108.389 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.26 -40.18 64.42 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.286 -0.635 . . . . 0.88 109.286 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 50' ' ' ALA . 22.3 ttmt -65.81 -73.58 0.13 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.168 -1.419 . . . . 2.59 107.168 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.91 -38.99 0.34 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.35 -0.844 . . . . 0.7 111.222 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 t -51.93 -56.03 16.64 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.603 -1.311 . . . . 1.4 108.816 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.81 -40.72 79.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.86 . . . . 0.67 111.15 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -69.95 -40.05 75.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.748 -1.22 . . . . 1.66 110.008 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.04 -40.05 94.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.996 -1.065 . . . . 1.58 108.964 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -64.26 -33.93 76.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.26 -0.9 . . . . 1.35 109.361 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.5 m -64.87 -42.5 94.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.035 -1.041 . . . . 0.77 109.784 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.595 ' CD1' HH22 ' A' ' 136' ' ' ARG . 97.9 mt -62.27 -40.07 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.63 109.086 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -51.92 -49.99 61.99 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.447 -0.783 . . . . 1.14 109.426 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.6 m -59.44 -40.0 85.36 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.124 -0.985 . . . . 0.79 110.878 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -63.5 -37.88 88.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.745 -1.222 . . . . 1.53 109.835 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.407 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -65.32 -46.59 79.7 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.62 -0.675 . . . . 0.57 110.097 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.98 -49.57 77.08 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.274 -1.13 . . . . 0.75 110.274 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.97 -44.95 71.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.857 -1.378 . . . . 1.59 110.161 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.1 m -69.66 -57.23 5.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.73 111.54 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -97.11 -57.34 2.29 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.026 -1.046 . . . . 0.75 110.948 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.0 -163.75 26.94 Favored Glycine 0 N--CA 1.503 3.133 0 C-N-CA 119.802 -1.19 . . . . 1.22 111.041 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -67.92 -26.2 65.86 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.712 -0.875 . . . . 5.81 110.605 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -60.0 -36.36 77.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 3.37 110.211 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -100.5 -18.71 16.53 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.471 -0.768 . . . . 1.77 110.729 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -70.27 -43.1 71.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.779 -1.201 . . . . 1.65 110.838 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.57 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -66.41 -32.29 73.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.301 -0.874 . . . . 0.77 110.226 -178.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.08 -39.92 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.854 -1.153 . . . . 0.8 109.307 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -64.48 -40.04 94.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.753 -1.217 . . . . 0.88 109.687 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.51 -40.37 91.2 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.105 -0.997 . . . . 1.37 109.614 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.98 -49.2 63.82 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.76 -1.736 . . . . 0.62 108.76 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.2 m170 -59.98 -43.35 95.18 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.374 -1.074 . . . . 1.5 108.687 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.81 -48.98 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.122 -0.986 . . . . 0.63 109.1 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.0 ttp -60.1 -42.7 95.26 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.043 -1.035 . . . . 1.51 109.491 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.852 HD11 ' CE2' ' B' ' 348' ' ' PHE . 46.8 tp -61.96 -39.36 91.88 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.37 -0.831 . . . . 0.77 108.772 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.05 -39.97 87.8 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.501 -0.749 . . . . 0.62 109.328 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -83.73 9.9 10.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.348 -0.845 . . . . 1.47 109.804 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 62.5 t0 -53.37 133.23 40.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.946 . . . . 1.47 109.984 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.469 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 99.2 mt-10 -59.06 -24.04 62.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.684 -0.635 . . . . 1.78 111.496 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -71.09 -34.65 71.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.896 -1.128 . . . . 2.53 109.871 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.9 mt -70.2 -40.02 74.85 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.585 0.707 . . . . 0.8 109.858 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.96 -48.9 79.81 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.364 -0.835 . . . . 1.42 110.31 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -70.13 -42.96 71.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.369 -0.832 . . . . 1.71 111.57 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.01 -40.02 75.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.082 -1.011 . . . . 1.57 112.119 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.75 -47.73 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.852 -1.155 . . . . 0.65 109.842 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.5 mt -66.51 -38.57 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.796 . . . . 0.82 109.904 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.9 88.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.178 -0.951 . . . . 0.79 111.26 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.1 mt -60.0 -46.61 88.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.773 -1.205 . . . . 0.95 109.945 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.1 mt -59.96 -46.14 94.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.751 -1.203 . . . . 0.66 107.751 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -67.99 -40.36 83.1 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.925 -0.71 . . . . 2.2 110.238 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -80.74 -55.9 4.51 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.035 -1.041 . . . . 1.65 112.437 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.01 -3.25 58.09 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.973 -1.08 . . . . 2.03 111.971 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 74.9 m80 57.13 41.12 27.71 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.885 -1.134 . . . . 1.42 109.236 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 68.0 mtp -95.62 169.18 10.21 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.445 0.641 . . . . 1.18 110.103 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 68.2 p -78.58 160.36 27.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.386 -0.821 . . . . 0.98 109.576 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.0 -39.12 87.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.64 110.155 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 18.2 p-10 -70.04 -34.06 72.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.013 -1.054 . . . . 2.07 109.349 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.08 -44.08 22.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.73 109.776 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.04 -43.12 71.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.448 -0.783 . . . . 0.54 110.229 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.93 87.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.99 -1.069 . . . . 0.56 109.72 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.466 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 82.4 t60 -60.05 -40.01 87.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.394 -0.816 . . . . 1.54 110.574 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.32 -41.87 93.54 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.044 -1.035 . . . . 1.33 110.74 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.89 -50.73 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.002 -1.061 . . . . 0.72 110.851 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.8 mm -69.9 -40.08 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.918 -1.114 . . . . 0.85 109.01 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.466 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.0 tt0 -63.82 -37.83 88.83 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.36 -0.978 . . . . 2.44 108.36 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.96 -54.1 40.25 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.598 -1.001 . . . . 0.98 110.598 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -64.77 -49.87 69.05 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.756 -1.438 . . . . 1.41 109.219 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.89 -41.93 88.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 1.2 109.085 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.9 t -58.84 -39.97 82.83 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.349 -0.844 . . . . 1.7 108.95 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.05 96.25 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.354 -0.841 . . . . 1.47 109.366 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.5 mt -63.58 -40.64 97.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.049 -1.032 . . . . 1.56 109.892 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.86 -36.54 77.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.846 -1.159 . . . . 2.2 109.508 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -53.85 -21.93 8.7 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.247 -0.908 . . . . 2.12 108.89 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 123' ' ' LEU . 35.5 mt -62.95 142.6 58.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 2.0 109.349 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -91.11 12.78 18.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.406 -0.809 . . . . 3.23 109.425 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -100.4 126.5 46.79 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.261 -0.899 . . . . 2.49 110.147 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.402 ' O ' ' CD ' ' A' ' 121' ' ' GLU . 5.0 tm-20 -69.92 -29.96 67.26 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.686 0.755 . . . . 3.95 109.014 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.426 ' OH ' ' C ' ' B' ' 314' ' ' LEU . 19.3 t80 -62.83 -42.84 99.9 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 122.007 0.908 . . . . 2.0 110.109 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.912 HD22 ' O ' ' B' ' 351' ' ' GLN . 79.2 mt -76.16 -31.24 58.46 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.771 -0.825 . . . . 1.86 108.771 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -60.07 -40.85 90.94 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.475 -0.765 . . . . 2.84 108.985 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.11 -44.24 95.01 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.574 -0.899 . . . . 2.73 108.574 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.69 HH21 ' NE2' ' B' ' 351' ' ' GLN . 62.5 mtp180 -62.07 -39.67 93.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 2.77 109.138 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.98 -32.57 70.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.448 -0.782 . . . . 1.19 109.449 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.06 94.29 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.656 -0.868 . . . . 1.2 108.656 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -62.61 -40.08 95.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.421 -0.799 . . . . 1.55 110.192 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.06 -43.04 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 0.8 109.924 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -60.01 -40.0 87.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.081 -1.012 . . . . 3.09 109.538 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.03 -38.23 82.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.348 -0.845 . . . . 1.46 109.931 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.97 -43.31 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.122 -0.986 . . . . 0.71 110.358 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.2 -32.62 62.67 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.673 -1.251 . . . . 0.57 110.114 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -59.96 -49.97 75.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.107 -1.231 . . . . 2.59 109.283 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.595 HH22 ' CD1' ' A' ' 57' ' ' ILE . 59.5 mtp180 -65.61 -34.99 79.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 2.83 109.994 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.0 tp -59.96 -43.46 95.05 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.224 -0.922 . . . . 1.25 109.48 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.14 -39.96 94.36 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.087 -1.008 . . . . 0.7 108.815 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.416 HH11 ' HG2' ' A' ' 139' ' ' ARG . 58.6 mtt-85 -70.11 -39.9 75.22 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.461 -0.94 . . . . 2.57 108.461 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -62.04 -37.05 83.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.811 -0.556 . . . . 1.23 111.165 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.06 -43.56 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.698 -1.251 . . . . 0.81 108.221 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.98 -38.03 75.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.695 -0.628 . . . . 1.0 109.579 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.49 45.45 5.24 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.255 -1.938 . . . . 0.89 108.255 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.407 ' CD2' ' NH1' ' A' ' 139' ' ' ARG . 12.0 tp -74.58 150.02 39.88 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.499 -1.001 . . . . 1.14 109.548 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -63.02 142.84 58.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.341 -0.85 . . . . 4.6 110.428 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.2 mt -119.9 126.72 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.565 -0.902 . . . . 1.24 108.565 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.4 mt -59.97 -44.89 95.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.826 -0.546 . . . . 1.54 110.298 -178.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.4 t0 67.72 94.63 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.83 -0.804 . . . . 1.5 108.83 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.553 ' O ' HD12 ' A' ' 152' ' ' ILE . 34.7 mt -67.07 -8.1 27.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.457 -0.777 . . . . 0.79 109.951 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.8 t -79.94 -13.8 59.09 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.993 -1.067 . . . . 1.4 108.286 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.12 24.76 0.76 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.786 -0.571 . . . . 0.92 110.395 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.553 HD12 ' O ' ' A' ' 149' ' ' LEU . 42.6 mt -92.97 118.1 37.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.021 -1.05 . . . . 0.88 108.688 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -104.83 -11.22 16.88 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.222 -0.924 . . . . 2.45 110.391 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -119.71 147.31 44.73 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.615 -0.678 . . . . 1.52 110.12 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -64.11 136.52 57.33 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.408 -0.96 . . . . 1.58 108.408 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.2 m -153.52 168.54 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.233 -0.917 . . . . 0.69 109.99 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 74.0 mt -95.94 144.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 105.883 -1.895 . . . . 0.61 105.883 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 22.1 tp -92.99 115.86 28.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.905 -1.122 . . . . 0.87 110.48 -177.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.544 HG12 HG22 ' A' ' 209' ' ' THR . 45.7 t -123.38 129.94 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 108.76 -0.829 . . . . 0.71 108.76 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.497 ' C ' HG21 ' A' ' 209' ' ' THR . . . -162.16 164.67 27.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.905 . . . . 0.81 108.795 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.44 -35.35 70.89 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.257 -1.527 . . . . 0.98 107.781 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -164.56 173.87 11.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.411 -0.959 . . . . 2.25 108.411 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.4 mt -136.48 143.1 43.64 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.115 -0.991 . . . . 0.78 109.201 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 74.7 p -95.27 141.99 23.99 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.241 -0.912 . . . . 0.98 109.342 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -39.99 -39.88 2.48 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.278 1.985 . . . . 0.81 112.514 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 68.9 m -60.04 -39.97 87.78 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.26 -0.9 . . . . 0.9 109.097 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.5 -43.69 96.47 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.27 -0.894 . . . . 1.61 110.108 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.9 p -53.87 -25.85 21.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.187 -0.946 . . . . 0.61 110.823 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -80.55 -54.76 5.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.82 -1.175 . . . . 0.6 109.817 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -83.76 39.85 0.71 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.698 -0.853 . . . . 1.4 108.698 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.0 tp -105.2 135.66 46.14 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.709 -0.849 . . . . 0.7 108.709 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.43 ' O ' HG23 ' A' ' 176' ' ' VAL . 86.1 m-20 -84.96 103.41 13.98 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.194 -0.941 . . . . 2.35 108.93 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 36.3 mt -67.14 -40.53 86.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.511 -0.743 . . . . 1.51 110.881 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -69.97 -24.15 63.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.757 -1.215 . . . . 2.33 111.433 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -92.78 -6.79 48.2 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.802 -1.186 . . . . 1.92 109.853 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 178' ' ' GLY . 84.0 t -106.56 116.67 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.329 -0.857 . . . . 0.67 108.702 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 71.3 mt -89.99 7.24 38.52 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.283 -0.886 . . . . 1.53 110.243 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.512 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 171.89 171.88 37.32 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.176 -1.57 . . . . 0.48 109.176 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.474 ' CE1' HG11 ' A' ' 176' ' ' VAL . 26.8 m-85 -132.37 129.66 39.69 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.321 -1.105 . . . . 0.55 109.207 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 94.7 mt -134.07 127.51 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.525 -0.917 . . . . 0.65 108.525 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.1 p -149.94 162.75 39.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.938 -1.101 . . . . 0.82 110.681 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.481 ' O ' ' O ' ' A' ' 183' ' ' ALA . 0.9 OUTLIER -100.24 20.31 14.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.506 -0.747 . . . . 2.46 109.726 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -46.69 -174.7 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 122.322 1.058 . . . . 1.28 112.823 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.36 -56.69 3.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 111.396 -0.682 . . . . 2.19 111.396 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -167.36 -159.09 12.34 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 118.484 -1.817 . . . . 2.13 111.416 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.425 HH11 ' HG2' ' A' ' 186' ' ' ARG . 17.8 ptt-85 -72.29 -15.93 61.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.749 -0.854 . . . . 5.86 110.849 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 71.5 p -71.23 3.42 3.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.831 -1.168 . . . . 3.72 109.271 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 40.7 t -83.4 134.29 34.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 1.74 110.275 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -49.88 -38.96 37.91 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.169 -1.049 . . . . 0.95 108.169 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.6 p -59.94 -41.49 91.93 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.928 -0.578 . . . . 1.55 110.493 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 41.2 t -62.06 -38.61 89.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.113 -0.992 . . . . 1.51 110.669 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.3 mm -60.0 -39.35 80.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.236 -0.915 . . . . 1.67 109.19 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.1 mtp -59.5 -44.43 93.11 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.245 -0.909 . . . . 1.02 110.102 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.36 -44.48 80.15 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.647 -1.283 . . . . 0.68 109.712 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.409 HH22 ' HD2' ' A' ' 186' ' ' ARG . 98.9 mtt180 -62.96 -57.81 9.49 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.142 -1.023 . . . . 2.93 110.778 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.1 m -62.7 -39.97 95.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.997 -1.064 . . . . 0.86 112.111 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.9 mt -69.95 -15.7 63.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.864 -1.147 . . . . 0.67 110.25 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 62.13 49.67 4.35 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.626 -0.671 . . . . 1.5 110.175 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 78.5 mt -130.39 149.91 74.73 Favored Pre-proline 0 N--CA 1.499 1.999 0 N-CA-C 107.682 -1.229 . . . . 0.72 107.682 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.79 147.5 62.82 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.316 2.01 . . . . 0.61 111.846 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -173.88 158.76 3.27 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.922 -1.111 . . . . 0.66 112.035 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.8 mt -130.96 144.75 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.281 -1.007 . . . . 0.79 108.281 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 28.0 m -128.98 -7.53 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.99 -1.069 . . . . 0.91 111.064 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.75 24.48 13.17 Favored Glycine 0 N--CA 1.501 3.032 0 N-CA-C 110.799 -0.92 . . . . 1.01 110.799 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.429 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.1 p -46.77 -44.14 18.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.876 -1.367 . . . . 0.99 109.748 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.57 -55.5 2.71 Favored Glycine 0 N--CA 1.498 2.803 0 C-N-CA 120.166 -1.016 . . . . 1.12 111.825 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 34.3 p -149.82 25.92 0.83 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.6 -1.53 . . . . 1.72 111.646 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.97 -39.62 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.773 -1.205 . . . . 0.89 108.964 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.544 HG22 HG12 ' A' ' 159' ' ' VAL . 50.4 p -58.0 -36.65 72.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.498 -0.751 . . . . 1.03 110.173 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 80.9 p -84.99 -11.74 54.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.013 -1.054 . . . . 1.83 110.25 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -95.87 -14.93 22.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.054 -1.029 . . . . 2.27 110.305 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 213' ' ' LYS . 21.7 t -114.79 154.37 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.275 -0.891 . . . . 0.92 110.469 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.44 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 11.1 mptt -117.2 156.45 27.67 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.701 -1.222 . . . . 2.2 107.701 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 27.5 p30 -60.02 142.68 53.53 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.053 -1.029 . . . . 2.36 110.431 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 11.0 t0 86.62 0.83 0.56 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 120.919 0.39 . . . . 2.38 110.359 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 91.8 m-20 -75.05 153.78 38.25 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.938 -1.101 . . . . 2.09 108.814 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -96.44 131.27 43.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.226 -1.027 . . . . 1.27 108.226 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 82.6 mt -129.52 149.65 51.2 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.192 -0.943 . . . . 0.75 110.994 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 85.5 mt -120.59 122.64 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.816 -1.549 . . . . 0.63 106.816 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 57.2 tp -98.73 115.51 28.89 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.733 -1.23 . . . . 0.7 109.223 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 223' ' ' VAL . 96.0 m-20 -75.57 -44.61 42.36 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.031 -1.043 . . . . 2.31 108.29 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.95 17.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.978 0.894 . . . . 0.78 108.62 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.1 t -132.08 -45.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 106.654 -1.609 . . . . 1.04 106.654 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -100.33 1.93 42.04 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.685 -1.228 . . . . 2.44 107.685 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 60.53 44.15 12.1 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.79 -0.569 . . . . 1.55 109.824 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -139.65 141.84 37.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.323 -0.86 . . . . 1.99 109.525 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 97.2 t -119.98 120.85 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 109.112 -0.699 . . . . 0.77 109.112 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -89.04 131.67 35.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.981 -1.074 . . . . 0.98 108.715 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 64.2 t -109.33 122.92 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.709 -0.619 . . . . 0.85 109.64 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 62.49 69.15 0.94 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.524 -0.735 . . . . 1.66 109.745 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -90.18 127.85 1.48 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 123.417 2.744 . . . . 0.95 112.276 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.0 167.18 12.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.095 -1.003 . . . . 1.84 109.341 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -59.94 -40.0 87.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 2.74 110.07 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.453 ' H ' ' CD ' ' A' ' 234' ' ' GLU . 58.3 mp0 -60.0 -39.98 87.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -0.945 . . . . 2.89 110.085 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.32 -39.4 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 1.3 110.049 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.9 mt . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 1.09 110.903 -179.234 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 301' ' ' MET . . . . . 0.485 ' N ' ' OE1' ' B' ' 366' ' ' GLU . 21.6 ttt . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 302' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 22.3 t80 -156.08 154.55 31.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 109.48 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 303' ' ' GLN . . . . . 0.506 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 20.6 pt20 -148.5 160.03 43.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.288 -0.883 . . . . 0.0 109.674 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 304' ' ' GLN . . . . . 0.437 ' NE2' HG11 ' B' ' 378' ' ' VAL . 60.9 tt0 -151.81 149.97 29.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.309 -0.869 . . . . 0.0 109.596 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 305' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 56.5 mp0 -105.94 130.63 53.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.382 -0.824 . . . . 0.0 109.742 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.491 ' O ' HG13 ' B' ' 306' ' ' VAL . 10.2 p -130.58 117.73 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-O 122.25 1.024 . . . . 0.0 113.071 -177.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 86.7 m -78.24 105.21 9.32 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.057 0.932 . . . . 0.0 110.53 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.7 mt -53.13 125.96 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 122.429 1.109 . . . . 0.0 111.264 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 22.6 p -112.04 19.94 17.37 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.557 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.71 120.65 82.31 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.746 -1.221 . . . . 0.0 109.402 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -50.96 -18.9 4.86 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 CA-C-N 120.205 1.109 . . . . 0.0 113.463 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -119.43 14.29 12.81 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.233 -0.917 . . . . 0.0 109.603 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.61 179.45 35.25 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.426 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 3.9 tp -85.38 95.41 9.23 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.05 -1.265 . . . . 0.0 109.477 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.401 ' CA ' ' OH ' ' A' ' 122' ' ' TYR . 3.7 p80 -97.96 -160.72 0.82 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.934 -1.104 . . . . 0.0 110.108 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 7.9 m -59.92 -41.94 92.83 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.095 -1.003 . . . . 0.0 112.295 -176.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.692 HH21 ' NE2' ' B' ' 321' ' ' GLN . 1.0 OUTLIER -55.33 -62.13 4.89 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.538 -1.351 . . . . 0.0 111.224 -178.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.05 -33.23 97.05 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 120.242 1.122 . . . . 0.0 111.765 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.95 -50.79 72.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.254 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.46 -43.12 75.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.464 -0.772 . . . . 0.0 110.736 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 321' ' ' GLN . . . . . 0.692 ' NE2' HH21 ' B' ' 317' ' ' ARG . 92.3 mt-30 -73.49 -40.08 64.36 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.037 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -60.09 -50.26 74.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 0.0 110.431 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 323' ' ' VAL . . . . . 0.462 HG13 ' O ' ' B' ' 344' ' ' ALA . 54.6 t -66.45 -40.02 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.566 -1.334 . . . . 0.0 108.981 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -59.9 -45.77 91.48 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -62.49 -45.88 91.0 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.103 -0.998 . . . . 0.0 108.437 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.09 -51.21 70.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.617 -0.677 . . . . 0.0 110.308 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -57.72 -10.46 1.63 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.913 -1.117 . . . . 0.0 109.082 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.91 -29.89 70.57 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -103.36 144.89 30.78 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.561 -0.964 . . . . 0.0 108.915 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 16.6 p -91.39 -13.19 32.85 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.789 -1.195 . . . . 0.0 109.916 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 83.9 p -58.97 151.34 22.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.983 -1.073 . . . . 0.0 108.905 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.1 133.36 47.96 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.006 -1.059 . . . . 0.0 108.579 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.1 mt -131.88 131.05 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.753 -0.592 . . . . 0.0 109.802 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 334' ' ' THR . . . . . 0.405 HG22 ' N ' ' B' ' 335' ' ' VAL . 89.2 m -129.82 153.51 48.19 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 335' ' ' VAL . . . . . 0.405 ' N ' HG22 ' B' ' 334' ' ' THR . 84.9 t -116.11 138.27 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 77.6 m -130.03 125.4 35.2 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.119 -0.988 . . . . 0.0 109.133 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 51.6 p -139.58 117.0 11.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.197 -0.939 . . . . 0.0 110.906 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 34.4 m120 42.75 57.75 3.43 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 83.98 -14.26 44.53 Favored Glycine 0 N--CA 1.499 2.858 0 O-C-N 120.303 -1.498 . . . . 0.0 112.806 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -115.58 126.88 54.78 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-N 119.108 1.454 . . . . 0.0 109.974 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 80.0 p -127.27 148.92 50.22 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.929 0.871 . . . . 0.0 110.28 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -140.97 164.28 30.69 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.508 0.67 . . . . 0.0 109.903 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 23.2 t -87.35 137.23 32.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.493 -0.754 . . . . 0.0 109.202 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.462 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -76.73 -13.39 60.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.979 -1.076 . . . . 0.0 109.858 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.07 20.67 4.13 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 67.4 m -146.25 94.25 2.43 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.714 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.815 HD23 HD22 ' A' ' 79' ' ' LEU . 56.9 tp -59.92 -33.34 71.74 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.852 ' CE2' HD11 ' A' ' 79' ' ' LEU . 54.9 m-85 -56.75 -52.79 63.65 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.396 -0.815 . . . . 0.0 110.616 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -69.33 -39.79 77.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.632 -1.292 . . . . 0.0 110.089 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' B' ' 352' ' ' THR . 20.9 mt -48.59 -58.49 4.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.062 -1.024 . . . . 0.0 109.07 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.912 ' O ' HD22 ' A' ' 123' ' ' LEU . 1.3 mp0 -41.6 -14.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.555 -0.716 . . . . 0.0 111.19 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.574 ' N ' ' O ' ' B' ' 350' ' ' LEU . 50.2 p -87.65 -7.62 57.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.039 -1.663 . . . . 0.0 109.966 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 66.5 mt -97.42 116.14 29.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.129 -0.982 . . . . 0.0 109.493 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.67 93.06 1.02 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 21.8 mt -103.31 96.27 6.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.35 -1.088 . . . . 0.0 108.9 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 19.2 p -94.67 170.55 9.38 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.147 -0.971 . . . . 0.0 110.774 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.44 115.83 3.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.831 -0.543 . . . . 0.0 111.035 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 100.62 7.36 51.31 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 53.4 m -85.03 111.5 19.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.205 -1.173 . . . . 0.0 110.827 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 7.6 t -78.03 116.25 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 122.222 1.01 . . . . 0.0 109.503 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.1 m -113.64 178.62 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 86.6 m -130.45 130.86 44.79 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.4 mt -106.86 126.26 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 71.1 m -129.96 137.17 50.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.554 -0.716 . . . . 0.0 109.48 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.32 156.54 43.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.337 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 366' ' ' GLU . . . . . 0.485 ' OE1' ' N ' ' B' ' 301' ' ' MET . 8.8 tp10 -145.96 122.84 11.31 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 157.42 -152.88 24.16 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 118.853 -1.641 . . . . 0.0 111.715 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -60.0 -52.96 63.15 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 122.268 -0.548 . . . . 0.0 112.357 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -110.2 11.26 23.66 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.838 -1.164 . . . . 0.0 111.224 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -42.58 -38.0 1.85 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.073 -1.017 . . . . 0.0 111.817 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -69.32 -44.17 72.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.531 -1.356 . . . . 0.0 110.158 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -70.83 -54.28 12.17 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.016 -1.053 . . . . 0.0 109.242 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.62 -35.95 1.95 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.627 -0.671 . . . . 0.0 110.771 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.562 ' O ' HG23 ' B' ' 378' ' ' VAL . 53.2 t -70.04 -40.02 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.799 -1.188 . . . . 0.0 109.283 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.39 -65.38 0.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.985 -1.072 . . . . 0.0 111.668 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -59.96 -42.05 93.24 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.626 -1.296 . . . . 0.0 111.57 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 93.3 mt -59.92 -42.04 93.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.652 -1.28 . . . . 0.0 108.311 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.562 HG23 ' O ' ' B' ' 374' ' ' VAL . 53.8 t -63.03 -42.36 96.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.297 -0.877 . . . . 0.0 109.684 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 379' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.4 mttt -69.99 -56.17 7.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.708 -1.245 . . . . 0.0 107.915 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 54.3 tp -54.51 -36.09 63.85 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 381' ' ' MET . . . . . 0.433 ' SD ' HG11 ' B' ' 306' ' ' VAL . 28.2 ttm -70.52 -40.25 73.58 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.391 -1.324 . . . . 0.0 108.413 177.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.46 -5.56 58.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.654 -0.654 . . . . 0.0 110.682 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' B' ' 379' ' ' LYS . 67.9 mt-10 -112.24 -1.96 15.03 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.052 -1.03 . . . . 0.0 110.708 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 384' ' ' LEU . . . . . 0.464 HD21 ' OE1' ' B' ' 321' ' ' GLN . 15.3 mt -83.68 136.94 34.01 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.427 -1.42 . . . . 0.0 109.066 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.405 -179.639 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.7 mmm . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.448 -0.575 . . . . 2.91 109.448 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.4 mt -110.06 129.95 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.54 -0.911 . . . . 1.2 108.54 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.6 m -135.85 150.1 49.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.39 -0.819 . . . . 1.4 110.405 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.614 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -132.93 -164.62 10.94 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 108.081 -2.008 . . . . 1.05 108.081 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.6 mt -89.2 -14.46 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.632 -1.511 . . . . 1.15 110.353 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.0 tp 55.27 102.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.148 -0.97 . . . . 0.98 108.53 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.04 -22.86 19.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.994 -1.066 . . . . 0.88 109.633 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.5 m -149.99 133.4 8.62 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.097 -1.002 . . . . 1.69 109.677 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -80.37 141.01 13.98 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.4 2.067 . . . . 0.85 112.15 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.712 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 166.0 -165.58 38.19 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.712 -1.355 . . . . 0.92 109.712 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -147.54 148.01 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.22 -1.164 . . . . 0.81 108.52 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.17 156.55 34.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.939 -1.101 . . . . 0.51 110.487 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -137.01 129.64 30.26 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.315 -1.365 . . . . 0.62 107.315 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.38 -174.81 47.23 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 118.37 -1.871 . . . . 0.55 110.986 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -80.04 156.7 27.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.942 -0.74 . . . . 2.1 109.95 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.564 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.5 117.73 34.86 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.436 -0.79 . . . . 0.77 110.118 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.4 tp -89.99 131.55 35.82 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.507 -1.294 . . . . 0.91 107.507 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.5 tp -113.55 120.0 39.46 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.329 -0.857 . . . . 0.93 109.243 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 160' ' ' ALA . 40.2 mt -82.74 102.76 11.75 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.515 0.674 . . . . 0.93 109.656 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -103.0 129.39 49.74 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.751 -0.833 . . . . 2.75 108.751 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.456 ' OE2' ' NZ ' ' A' ' 135' ' ' LYS . 87.0 tt0 -130.36 140.76 50.6 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.223 -0.923 . . . . 3.0 109.372 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -80.16 142.99 34.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.351 -0.843 . . . . 2.77 109.501 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -61.7 143.53 56.03 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.129 -0.982 . . . . 2.94 108.801 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.6 mt -78.16 129.16 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.084 -1.01 . . . . 0.95 109.119 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.7 t -94.14 127.59 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.223 -0.923 . . . . 1.28 109.998 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.6 mt -110.02 134.33 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.637 -0.664 . . . . 1.21 109.229 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -93.84 123.08 36.95 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.169 -0.957 . . . . 1.81 110.249 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.417 HH11 ' HG3' ' A' ' 28' ' ' ARG . 24.7 mmm-85 -90.0 -0.2 57.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.446 -0.784 . . . . 2.8 109.182 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -67.32 145.37 55.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.264 -0.897 . . . . 2.87 109.92 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -92.01 149.28 21.62 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.239 -0.913 . . . . 2.35 109.253 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.559 HD13 ' HG3' ' A' ' 39' ' ' GLU . 3.0 pt -95.7 165.81 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.998 -1.064 . . . . 0.97 109.046 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.2 p -93.11 173.93 7.48 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.419 -0.956 . . . . 1.17 108.419 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.26 78.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.898 -1.126 . . . . 1.18 109.669 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 51.8 t0 -54.93 -30.68 59.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.93 -1.106 . . . . 2.56 110.162 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -82.17 -8.67 59.66 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.177 -0.952 . . . . 1.79 110.249 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.98 -50.31 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.763 -1.21 . . . . 1.0 108.578 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -60.41 -39.96 89.26 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.359 -0.838 . . . . 1.77 108.926 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -62.25 -40.99 98.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.494 -0.753 . . . . 2.7 110.598 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.559 ' HG3' HD13 ' A' ' 31' ' ' ILE . 71.3 mm-40 -64.36 -41.63 96.62 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.813 -1.179 . . . . 1.51 110.166 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.07 -46.7 93.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.909 -1.119 . . . . 0.93 109.069 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -60.05 -40.79 90.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.055 -1.028 . . . . 1.81 109.551 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -60.06 -44.56 94.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.9 -1.125 . . . . 2.78 108.458 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -60.09 -49.16 78.76 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.313 -0.995 . . . . 0.78 108.313 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.1 -46.63 88.96 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.402 -0.962 . . . . 1.07 108.402 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 23.2 t -60.56 -44.47 96.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 1.12 108.875 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.02 -40.01 96.44 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.247 -1.941 . . . . 0.84 108.247 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.523 HH11 ' HG2' ' A' ' 47' ' ' ARG . 1.4 ttt-85 -69.11 -22.61 63.96 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.562 -0.964 . . . . 3.09 108.64 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.07 -46.37 88.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.259 -0.901 . . . . 0.88 109.155 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.555 ' CG ' ' H ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -78.15 -68.96 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.554 -1.258 . . . . 2.59 108.585 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.555 ' H ' ' CG ' ' A' ' 49' ' ' LYS . . . -37.84 -35.79 0.16 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 120.058 1.299 . . . . 0.7 110.462 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.3 t -57.97 -64.43 0.91 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.907 -1.121 . . . . 1.4 108.666 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.97 -40.07 79.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.475 -0.765 . . . . 0.67 110.832 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -63.11 -40.96 99.16 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.812 -1.18 . . . . 1.66 110.361 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 57.5 mt -62.94 -39.86 95.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.881 -1.137 . . . . 1.58 109.216 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -60.11 -38.95 84.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 1.35 110.014 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.6 m -61.24 -41.96 97.78 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.075 -1.015 . . . . 0.77 109.9 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.678 ' CD1' HH22 ' A' ' 136' ' ' ARG . 82.2 mt -61.2 -39.91 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -0.837 . . . . 0.63 109.522 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -59.97 -50.43 73.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.083 -1.011 . . . . 1.14 109.659 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -59.96 -39.14 84.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.281 -0.887 . . . . 0.79 110.125 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -66.03 -37.75 86.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.989 -1.07 . . . . 1.53 109.14 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.79 -45.53 85.91 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.599 -0.688 . . . . 0.57 109.89 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.41 -50.03 71.06 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.626 -1.39 . . . . 0.75 109.626 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -67.3 -45.87 75.24 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.294 -1.121 . . . . 1.59 109.871 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.9 m -65.23 -64.16 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.363 -0.836 . . . . 0.73 112.347 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.42 -47.91 6.65 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.723 -1.236 . . . . 0.75 111.188 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.35 -169.83 24.92 Favored Glycine 0 N--CA 1.501 3.016 0 C-N-CA 119.824 -1.179 . . . . 1.22 111.467 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.65 -27.3 64.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 122.01 -0.7 . . . . 5.81 110.41 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.514 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.3 tp10 -59.95 -32.92 71.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.275 -0.89 . . . . 3.37 110.258 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.5 ' NZ ' ' NE2' ' A' ' 189' ' ' HIS . 14.5 mmmt -98.99 -22.46 15.73 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.226 -0.921 . . . . 1.77 110.259 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.94 -40.07 94.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.954 -1.091 . . . . 1.65 109.893 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.505 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -59.82 -37.57 79.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.87 . . . . 0.77 110.309 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.01 -40.6 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.782 -1.199 . . . . 0.8 109.87 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -70.02 -34.11 72.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.858 -1.151 . . . . 0.88 109.609 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -61.18 -39.98 92.21 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.875 -1.141 . . . . 1.37 109.221 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.91 -41.84 95.2 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.547 -1.421 . . . . 0.62 109.547 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 60.9 m170 -60.16 -43.42 95.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -1.122 . . . . 1.5 109.582 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.3 mt -69.91 -43.55 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.116 -0.99 . . . . 0.63 109.491 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.2 ttp -59.96 -44.92 94.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.845 -1.159 . . . . 1.51 110.309 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.875 HD11 ' CE2' ' B' ' 348' ' ' PHE . 53.9 tp -62.02 -39.82 93.59 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.358 -0.839 . . . . 0.77 109.987 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.5 tp -62.16 -39.57 93.09 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.44 -0.788 . . . . 0.62 110.157 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -82.02 8.66 10.08 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.996 -1.065 . . . . 1.47 110.204 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 59.7 t0 -56.71 130.51 45.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.976 -1.077 . . . . 1.47 109.977 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.407 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.8 mt-10 -59.69 -18.43 42.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.482 -0.761 . . . . 1.78 111.019 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.89 -36.92 72.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.723 -1.235 . . . . 2.53 108.592 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.6 mt -69.99 -40.05 75.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.594 -0.691 . . . . 0.8 110.177 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.02 -49.99 75.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 1.42 110.483 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.13 -39.94 75.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.174 -0.954 . . . . 1.71 111.269 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.97 -40.18 75.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.835 -1.166 . . . . 1.57 111.66 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.2 mt -69.99 -44.15 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.739 -1.225 . . . . 0.65 109.917 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.9 mt -70.02 -37.83 73.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.616 -0.678 . . . . 0.82 110.374 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.68 84.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.988 . . . . 0.79 110.796 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.22 -47.06 87.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.082 -1.012 . . . . 0.95 109.986 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.2 mt -60.66 -50.04 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.309 -0.869 . . . . 0.66 109.447 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -70.08 -42.32 72.94 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.727 -0.789 . . . . 2.2 110.576 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -80.09 -52.79 7.36 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.188 -0.945 . . . . 1.65 112.417 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -90.12 -3.05 58.14 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.973 -1.08 . . . . 2.03 111.675 -177.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.1 m80 59.69 37.5 22.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.959 -1.088 . . . . 1.42 109.467 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 53.2 mtt -93.87 166.24 12.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.443 -0.786 . . . . 1.18 109.782 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.7 p -80.55 162.32 24.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.381 -0.824 . . . . 0.98 109.28 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.51 -37.61 85.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.64 110.102 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 27.4 p-10 -69.87 -35.71 74.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 2.07 109.458 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.85 -41.05 27.09 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.296 -0.878 . . . . 0.73 109.56 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.2 -48.17 53.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.345 -0.847 . . . . 0.54 110.339 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.6 91.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 0.56 109.612 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.53 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 78.5 t60 -60.12 -40.0 88.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 1.54 109.617 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.54 -41.3 98.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.893 . . . . 1.33 110.81 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.28 -53.18 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.012 -1.055 . . . . 0.72 111.313 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.6 mm -70.0 -39.93 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.817 -1.177 . . . . 0.85 109.36 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.53 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 88.4 tt0 -64.65 -38.62 91.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.118 -0.989 . . . . 2.44 108.877 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.95 -43.7 97.86 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.479 -1.049 . . . . 0.98 110.479 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -69.94 -55.26 10.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.922 -1.34 . . . . 1.41 109.531 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.73 -40.31 69.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.183 -0.948 . . . . 1.2 109.343 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 33.8 t -57.77 -40.06 78.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.063 -1.023 . . . . 1.7 108.29 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.81 -39.56 87.77 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.743 -0.836 . . . . 1.47 108.743 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.9 mt -61.78 -42.48 99.04 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.119 -0.988 . . . . 1.56 109.673 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.43 -33.37 72.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.665 -1.272 . . . . 2.2 109.684 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.37 -23.17 35.98 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.984 -1.072 . . . . 2.12 108.506 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.535 HD13 HD13 ' A' ' 123' ' ' LEU . 21.9 mt -61.83 139.49 58.35 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.226 -1.027 . . . . 2.0 108.226 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -92.65 46.25 1.23 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.056 -1.027 . . . . 3.23 108.983 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -132.11 129.61 40.12 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.688 0.756 . . . . 2.49 109.664 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -70.05 -29.98 67.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.735 -0.603 . . . . 3.95 109.946 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.448 ' OH ' ' CA ' ' B' ' 315' ' ' HIS . 17.1 t80 -66.97 -42.97 84.24 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.958 0.885 . . . . 2.0 110.802 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.826 HD22 ' O ' ' B' ' 351' ' ' GLN . 91.4 mt -70.67 -32.79 70.19 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.569 -0.707 . . . . 1.86 109.774 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -60.07 -39.98 87.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.312 -0.868 . . . . 2.84 108.86 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 125' ' ' GLU . 0.4 OUTLIER -59.51 -49.1 79.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.191 -0.943 . . . . 2.73 109.493 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.623 HH21 ' CD2' ' A' ' 123' ' ' LEU . 59.4 mtm180 -60.21 -39.6 87.18 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.569 -1.252 . . . . 2.77 108.418 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.44 -28.32 66.85 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.472 -0.936 . . . . 1.19 108.472 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -60.05 -46.75 88.52 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.407 -0.808 . . . . 1.2 108.978 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -61.29 -41.3 96.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 1.55 109.703 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.72 -44.39 98.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.299 -0.875 . . . . 0.8 109.445 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -63.6 -40.04 95.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.127 -0.983 . . . . 3.09 109.914 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -60.01 -41.09 91.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 1.46 110.341 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.96 -46.8 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.916 -1.115 . . . . 0.71 109.85 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.3 -40.34 98.89 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.756 -1.338 . . . . 0.57 109.756 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.456 ' NZ ' ' OE2' ' A' ' 21' ' ' GLU . 57.6 tttm -59.97 -49.78 76.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -1.081 . . . . 2.59 110.472 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.678 HH22 ' CD1' ' A' ' 57' ' ' ILE . 63.1 mtp180 -63.12 -39.37 94.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.123 -0.985 . . . . 2.83 110.952 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.81 -40.11 87.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 1.25 110.111 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' A' ' 105' ' ' HIS . 23.9 mt -62.35 -40.0 94.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.776 -1.203 . . . . 0.7 109.109 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -68.97 -38.74 79.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -0.846 . . . . 2.57 109.782 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -69.99 -31.22 68.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.45 -0.781 . . . . 1.23 111.887 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.56 -46.07 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.136 -1.603 . . . . 0.81 108.484 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.1 -31.23 68.7 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.634 -0.666 . . . . 1.0 109.561 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.61 45.93 4.46 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.507 -1.437 . . . . 0.89 109.507 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 tp -74.32 145.63 43.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.39 -1.065 . . . . 1.14 108.939 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -69.89 139.1 52.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.012 -1.055 . . . . 4.6 109.245 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.4 mt -111.75 129.96 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.936 0.874 . . . . 1.24 109.26 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.6 mt -59.89 -44.17 93.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.873 -0.517 . . . . 1.54 109.955 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.2 t0 66.37 99.03 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.516 0.674 . . . . 1.5 109.23 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.5 mt -66.46 -7.28 18.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.518 -0.739 . . . . 0.79 109.208 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -84.78 -16.82 40.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.463 -0.773 . . . . 1.4 109.208 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.31 13.08 3.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.436 -0.79 . . . . 0.92 111.162 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.593 HD12 ' N ' ' A' ' 152' ' ' ILE . 1.4 mp -90.28 126.21 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.58 -1.325 . . . . 0.88 108.804 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -104.09 -7.47 20.21 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.547 -0.721 . . . . 2.45 110.213 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -119.94 147.8 44.3 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.444 -0.785 . . . . 1.52 110.481 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.67 136.9 57.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.438 -0.789 . . . . 1.58 109.442 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.8 m -152.11 163.22 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -0.781 . . . . 0.69 109.334 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 79.5 mt -91.15 148.96 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 106.008 -1.849 . . . . 0.61 106.008 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 35.3 tp -96.38 113.98 25.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.869 -1.145 . . . . 0.87 110.39 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.581 HG12 HG22 ' A' ' 209' ' ' THR . 50.4 t -121.76 129.92 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.83 -0.804 . . . . 0.71 108.83 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.445 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -159.96 162.26 34.35 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.243 -1.021 . . . . 0.81 108.243 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.9 -34.78 71.9 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.26 -1.525 . . . . 0.98 108.03 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -159.93 171.38 19.5 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.442 -0.947 . . . . 2.25 108.442 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.7 mt -139.76 140.04 36.62 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.063 -1.023 . . . . 0.78 109.592 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.3 p -100.19 135.43 20.33 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.415 -0.803 . . . . 0.98 109.501 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -38.61 -35.61 0.51 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.358 2.039 . . . . 0.81 113.437 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.5 m -59.9 -40.01 87.35 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.921 -1.112 . . . . 0.9 109.205 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.23 -40.98 90.63 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.308 -0.87 . . . . 1.61 109.948 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 67.3 p -57.21 -29.8 64.03 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.204 -0.935 . . . . 0.61 111.271 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.82 -53.91 13.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.682 -1.261 . . . . 0.6 109.768 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -86.98 36.36 0.72 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.022 -0.733 . . . . 1.4 109.022 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.4 tp -101.19 139.42 36.9 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.866 -0.79 . . . . 0.7 108.866 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -85.83 101.96 13.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.984 . . . . 2.35 108.954 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.09 -40.04 94.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.33 -0.856 . . . . 1.51 110.821 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -69.56 -25.46 64.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.966 -1.084 . . . . 2.33 111.458 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -93.15 -9.37 39.64 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.848 -1.157 . . . . 1.92 110.548 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.578 HG11 ' CE1' ' A' ' 179' ' ' PHE . 70.8 t -101.44 111.19 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.185 -1.043 . . . . 0.67 108.185 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.2 mt -83.52 3.27 33.03 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.228 -0.92 . . . . 1.53 110.577 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.29 170.49 37.62 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.147 -1.581 . . . . 0.48 109.147 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.578 ' CE1' HG11 ' A' ' 176' ' ' VAL . 27.7 m-85 -131.31 128.62 40.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.454 -1.027 . . . . 0.55 109.374 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 84.9 mt -132.4 126.25 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.485 -0.931 . . . . 0.65 108.485 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 23.6 p -148.67 161.5 41.61 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.024 -1.048 . . . . 0.82 110.876 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.476 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 55.8 t0 -105.78 24.54 12.13 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.426 -0.583 . . . . 2.46 109.426 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.93 -161.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.241 -1.537 . . . . 1.28 111.195 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.02 -50.61 7.57 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.097 -1.201 . . . . 2.19 110.097 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 161.79 -133.68 3.23 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.27 -1.443 . . . . 2.13 110.909 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.494 ' C ' ' H ' ' A' ' 188' ' ' SER . 41.5 ttt-85 -60.02 -39.98 87.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.563 -0.963 . . . . 5.86 111.415 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 67.2 p -59.7 2.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.616 -1.302 . . . . 3.72 110.385 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 186' ' ' ARG . 24.8 t -92.0 127.96 37.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.969 -1.082 . . . . 1.74 109.898 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.5 ' NE2' ' NZ ' ' A' ' 69' ' ' LYS . 56.9 t60 -43.9 -48.52 8.47 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.356 -0.84 . . . . 0.95 109.458 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 61.6 m -55.04 -36.83 65.95 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.763 -0.585 . . . . 1.55 110.949 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.3 m -59.96 -39.99 87.53 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.679 -1.263 . . . . 1.51 110.441 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.8 mm -64.52 -39.91 87.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.134 -0.979 . . . . 1.67 109.122 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.0 mtp -59.94 -45.0 94.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.275 -0.891 . . . . 1.02 110.532 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.45 -45.52 84.65 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.381 -1.449 . . . . 0.68 109.956 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -62.4 -57.21 12.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.975 -1.078 . . . . 2.93 110.737 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.3 m -63.36 -40.02 96.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.002 -1.061 . . . . 0.86 111.997 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.34 -25.36 61.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.821 -1.175 . . . . 0.67 109.744 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 70.2 47.33 0.56 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.3 0.571 . . . . 1.5 110.218 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 62.7 mt -124.21 149.78 61.72 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 107.8 -1.185 . . . . 0.72 107.8 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.67 138.62 59.68 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 122.268 1.979 . . . . 0.61 111.832 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.77 152.01 2.97 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.605 -1.238 . . . . 0.66 111.713 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.8 mt -125.98 147.69 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.473 -1.306 . . . . 0.79 107.473 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.8 m -128.55 -9.92 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 O-C-N 120.932 -1.105 . . . . 0.91 110.812 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -114.73 24.58 10.91 Favored Glycine 0 N--CA 1.502 3.063 0 N-CA-C 110.435 -1.066 . . . . 1.01 110.435 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 204' ' ' GLY . 3.1 p -42.73 -47.17 5.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.262 -1.14 . . . . 0.99 110.192 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.443 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 98.71 -56.69 0.98 Allowed Glycine 0 N--CA 1.503 3.13 0 C-N-CA 120.221 -0.99 . . . . 1.12 111.549 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 26.1 p -148.99 26.62 0.88 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.445 -1.621 . . . . 1.72 111.103 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.23 -40.04 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.989 -1.069 . . . . 0.89 109.395 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.581 HG22 HG12 ' A' ' 159' ' ' VAL . 31.7 p -62.06 -29.27 70.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.169 -0.957 . . . . 1.03 109.765 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 94.9 p -79.94 -20.99 44.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.209 -0.932 . . . . 1.83 109.561 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -96.5 -8.34 32.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.25 -0.906 . . . . 2.27 109.534 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.94 138.72 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-O 121.622 0.725 . . . . 0.92 110.853 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.433 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 2.1 mptp? -112.59 154.72 25.57 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.655 -1.239 . . . . 2.2 107.655 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.466 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 17.9 p-10 -59.85 139.8 57.08 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.025 -1.047 . . . . 2.36 110.113 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.4 m-20 83.82 4.32 0.81 Allowed 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.121 0.486 . . . . 2.38 110.162 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 86.2 m-20 -73.57 138.16 44.76 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.136 -0.978 . . . . 2.09 109.231 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -90.09 117.91 29.23 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.501 -1.296 . . . . 1.27 107.501 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.564 HD12 ' HB2' ' A' ' 16' ' ' ALA . 74.5 mt -127.18 150.82 49.34 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.519 -0.738 . . . . 0.75 110.927 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.471 HG23 ' CD2' ' A' ' 13' ' ' PHE . 76.2 mt -117.61 129.99 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.147 -1.427 . . . . 0.63 107.147 177.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 22.2 tp -102.38 120.19 40.08 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.001 -1.062 . . . . 0.7 109.701 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.669 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 25.1 p-10 -80.05 -39.9 28.84 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.082 -1.011 . . . . 2.31 108.863 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 48.04 19.68 0.2 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.338 -0.986 . . . . 0.78 108.338 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.451 ' N ' ' C ' ' A' ' 221' ' ' ASP . 21.4 t -133.12 -44.3 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.339 -1.356 . . . . 1.04 107.339 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -100.1 0.02 39.91 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.747 -1.205 . . . . 2.44 107.747 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.614 HD21 ' H ' ' A' ' 4' ' ' GLY . 38.6 t30 60.02 46.88 10.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.714 -0.616 . . . . 1.55 109.57 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.669 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 76.9 mt-30 -140.04 151.82 45.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.43 -0.794 . . . . 1.99 109.622 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 83.1 t -119.12 129.96 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.419 -0.956 . . . . 0.77 108.419 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -99.95 118.79 37.11 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.477 -0.934 . . . . 0.98 108.477 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.4 t -99.98 115.13 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.544 -0.722 . . . . 0.85 110.503 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 35.2 t30 52.45 63.09 9.39 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 1.66 111.164 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -88.99 148.46 5.67 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.557 2.172 . . . . 0.95 111.871 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 58.9 p -68.78 161.38 28.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 1.84 109.576 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -60.03 -39.97 87.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.843 . . . . 2.74 110.519 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -60.32 -32.96 71.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.932 -1.105 . . . . 2.89 109.816 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.33 -39.98 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -0.985 . . . . 1.3 109.141 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.883 . . . . 1.09 109.284 179.433 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 40.7 ttp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.46 0.648 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 302' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 30.1 t80 -155.78 155.37 32.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.482 -0.761 . . . . 0.0 109.1 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 303' ' ' GLN . . . . . 0.539 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 12.9 pt20 -146.75 157.03 43.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.166 -0.959 . . . . 0.0 109.939 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -152.94 150.07 28.88 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -114.99 135.2 54.49 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.169 -0.957 . . . . 0.0 110.638 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.0 p -134.89 123.45 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 CA-C-O 122.033 0.92 . . . . 0.0 112.277 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 89.8 m -80.19 107.19 12.79 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.957 0.884 . . . . 0.0 111.201 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.0 mt -51.65 121.21 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 122.329 1.062 . . . . 0.0 110.438 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 23.7 p -108.61 16.86 22.58 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.786 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.7 129.06 84.37 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 120.743 -1.223 . . . . 0.0 108.175 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -64.34 -10.99 25.98 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 CA-C-N 120.154 1.091 . . . . 0.0 112.752 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -115.78 8.6 14.9 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.364 -0.835 . . . . 0.0 109.782 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.59 173.91 14.8 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.422 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 3.2 tp -81.66 90.24 6.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.895 -1.356 . . . . 0.0 109.693 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.448 ' CA ' ' OH ' ' A' ' 122' ' ' TYR . 4.4 p80 -95.13 -161.37 0.85 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.84 -1.162 . . . . 0.0 109.939 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.0 m -58.01 -40.4 80.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.007 -1.058 . . . . 0.0 112.31 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.573 HH21 ' NE2' ' B' ' 321' ' ' GLN . 2.2 tpt180 -59.58 -61.94 6.87 Favored Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 120.402 -1.436 . . . . 0.0 111.591 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.421 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 9.4 Cg_endo -56.07 -32.79 87.82 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 CA-C-N 120.028 1.046 . . . . 0.0 111.832 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.95 -51.6 68.96 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.416 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.61 64.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.227 -0.92 . . . . 0.0 110.006 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 321' ' ' GLN . . . . . 0.573 ' NE2' HH21 ' B' ' 317' ' ' ARG . 86.9 mt-30 -70.82 -39.95 72.74 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.829 -1.17 . . . . 0.0 109.062 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -62.73 -54.79 33.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.364 -0.835 . . . . 0.0 110.463 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 60.1 t -63.6 -38.51 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.666 -1.271 . . . . 0.0 108.806 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -59.98 -47.1 87.2 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.217 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -62.58 -49.76 73.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.359 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.16 -51.56 52.29 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.256 -0.903 . . . . 0.0 110.883 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -52.04 -14.42 0.41 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.118 -0.989 . . . . 0.0 109.897 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -79.92 -17.23 75.31 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -106.01 140.55 38.83 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.319 -1.106 . . . . 0.0 108.758 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 5.3 p -91.42 -13.79 31.73 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.792 -1.192 . . . . 0.0 110.158 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 29.5 p -57.28 150.46 17.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.938 -1.101 . . . . 0.0 108.474 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.05 132.46 46.66 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.855 -1.153 . . . . 0.0 108.627 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.8 mt -133.4 133.64 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.615 -0.678 . . . . 0.0 109.531 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.7 m -130.04 152.28 49.66 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.481 -0.762 . . . . 0.0 109.117 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 72.0 t -123.88 114.68 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 87.0 m -105.22 130.45 53.37 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.144 -0.972 . . . . 0.0 109.177 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 97.0 p -136.47 114.01 10.97 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.92 0.867 . . . . 0.0 110.777 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 45.35 51.85 9.22 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.98 -13.82 63.63 Favored Glycine 0 N--CA 1.503 3.135 0 O-C-N 120.102 -1.624 . . . . 0.0 112.935 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -118.67 130.37 55.81 Favored 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 119.414 1.607 . . . . 0.0 109.367 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 82.2 p -128.51 150.75 50.03 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.968 0.889 . . . . 0.0 110.845 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -145.24 166.64 24.9 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.573 0.701 . . . . 0.0 110.126 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.8 m -88.99 139.94 29.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.449 -0.782 . . . . 0.0 110.052 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -78.78 -14.35 59.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.916 -1.115 . . . . 0.0 110.071 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -89.98 20.3 4.32 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 90.5 p -145.8 92.14 2.18 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.407 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.77 HD23 HD22 ' A' ' 79' ' ' LEU . 57.1 tp -59.98 -34.54 73.44 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.875 ' CE2' HD11 ' A' ' 79' ' ' LEU . 64.2 m-85 -56.33 -53.48 56.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.169 -0.957 . . . . 0.0 110.393 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -69.43 -39.81 77.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 110.387 -177.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' B' ' 352' ' ' THR . 23.2 mt -47.67 -59.66 3.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.158 -0.964 . . . . 0.0 108.978 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.826 ' O ' HD22 ' A' ' 123' ' ' LEU . 1.5 mp0 -39.27 -21.12 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.721 -0.612 . . . . 0.0 111.298 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.528 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.1 p -78.03 -10.1 59.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.102 -1.624 . . . . 0.0 110.216 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 49.9 mt -96.09 118.32 32.45 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.134 -0.979 . . . . 0.0 109.14 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.35 96.74 0.92 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 32.2 mt -106.77 95.29 5.63 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.447 -1.031 . . . . 0.0 109.582 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 17.8 p -98.31 176.42 5.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.217 -0.927 . . . . 0.0 110.462 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -63.93 111.89 2.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.806 -0.559 . . . . 0.0 110.586 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.76 7.7 38.49 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 46.9 m -84.83 110.23 18.67 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.087 -1.243 . . . . 0.0 111.067 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 4.9 t -78.12 115.62 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 122.113 0.959 . . . . 0.0 110.167 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 29.1 m -112.65 177.52 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 86.6 m -131.11 130.31 42.97 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 82.3 mt -105.34 120.35 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 58.7 m -121.38 132.56 54.83 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.25 153.9 41.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 110.034 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -146.77 122.91 10.83 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.486 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 159.53 -155.29 26.38 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 118.586 -1.768 . . . . 0.0 111.932 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.93 -53.36 58.78 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -107.31 11.61 28.97 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.898 -1.126 . . . . 0.0 111.383 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.3 pt-20 -40.23 -37.54 0.65 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.431 -0.793 . . . . 0.0 111.581 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.04 -44.31 72.92 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.73 -1.231 . . . . 0.0 110.787 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -69.79 -51.78 30.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.782 -1.199 . . . . 0.0 109.167 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -45.81 -37.22 5.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.646 -0.659 . . . . 0.0 111.278 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.53 ' O ' HG23 ' B' ' 378' ' ' VAL . 81.8 t -69.98 -39.98 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.698 -1.251 . . . . 0.0 109.151 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.99 -64.45 0.86 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 111.163 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -60.06 -45.82 91.59 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.683 -1.261 . . . . 0.0 111.771 -177.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.9 mt -59.98 -41.39 91.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.623 -1.298 . . . . 0.0 108.813 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.53 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.7 t -65.88 -42.05 91.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.158 -0.964 . . . . 0.0 109.742 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -71.29 -57.96 3.98 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.742 -1.224 . . . . 0.0 107.85 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.411 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 60.2 tp -56.22 -32.48 64.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.397 -0.814 . . . . 0.0 109.839 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 45.2 ttm -74.44 -40.02 62.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.007 -1.058 . . . . 0.0 108.813 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.67 -4.45 46.18 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.682 -0.636 . . . . 0.0 110.121 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -110.84 3.36 18.9 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.319 -0.863 . . . . 0.0 110.963 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 384' ' ' LEU . . . . . 0.411 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 32.3 mt -69.87 130.03 41.13 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.397 -1.439 . . . . 0.0 109.764 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.079 179.45 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.301 -0.629 . . . . 2.91 109.301 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.5 mt -108.88 128.69 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.644 -0.873 . . . . 1.2 108.644 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.1 m -118.85 154.04 33.54 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.081 -0.711 . . . . 1.4 109.081 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.801 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -141.75 179.05 20.12 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.359 -1.897 . . . . 1.05 108.359 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.5 mt -85.21 -4.69 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.88 -1.365 . . . . 1.15 110.607 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.4 HD11 ' HB1' ' A' ' 222' ' ' ALA . 43.5 tp 52.31 93.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.64 -1.288 . . . . 0.98 109.362 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.22 -40.03 78.2 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.219 -1.03 . . . . 0.88 108.219 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 p -154.08 146.88 17.73 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 108.943 -0.762 . . . . 1.69 108.943 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -80.32 144.2 16.12 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.74 2.293 . . . . 0.85 113.5 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.883 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.67 164.51 13.27 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.544 -1.422 . . . . 0.92 109.544 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -117.42 152.82 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.13 -1.218 . . . . 0.81 110.072 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.91 155.98 35.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.228 -0.92 . . . . 0.51 109.83 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.9 OUTLIER -137.71 128.07 26.35 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.604 -0.888 . . . . 0.62 108.604 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.91 179.32 47.25 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 118.902 -1.618 . . . . 0.55 110.534 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -78.94 157.08 28.27 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.629 -0.924 . . . . 2.1 109.064 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.586 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -102.31 134.28 45.85 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.376 -0.827 . . . . 0.77 110.701 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.9 tp -106.93 139.39 41.41 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.346 -1.353 . . . . 0.91 107.346 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.0 tp -119.06 121.03 38.91 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.309 -0.87 . . . . 0.93 110.146 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.8 mt -81.91 102.89 11.18 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.003 -0.679 . . . . 0.93 109.809 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -95.5 131.48 41.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.413 -0.804 . . . . 2.75 109.543 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -126.12 137.83 53.63 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.714 -0.847 . . . . 3.0 108.714 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 47.5 t0 -87.24 147.86 25.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.07 -1.019 . . . . 2.77 109.557 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.461 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 88.3 tt0 -64.18 149.88 46.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.906 . . . . 2.94 109.335 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.9 mt -91.87 127.46 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.374 -0.829 . . . . 0.95 108.897 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.6 t -93.62 124.07 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.159 -0.963 . . . . 1.28 109.738 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -106.74 135.66 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.796 -0.816 . . . . 1.21 108.796 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -95.04 117.04 29.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.001 -1.062 . . . . 1.81 109.328 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -89.83 2.11 55.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.431 -0.793 . . . . 2.8 109.097 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -58.81 146.13 38.27 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.291 -0.881 . . . . 2.87 109.583 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -84.76 137.6 33.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.423 -0.798 . . . . 2.35 109.035 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.403 HG21 ' HG3' ' A' ' 39' ' ' GLU . 5.0 pt -91.73 163.25 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.966 -1.084 . . . . 0.97 109.92 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.3 p -97.18 174.93 6.48 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.925 . . . . 1.17 108.761 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.05 83.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 1.18 109.689 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -57.35 -30.22 64.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.741 -1.224 . . . . 2.56 109.433 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -81.45 -10.2 59.55 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.185 -0.947 . . . . 1.79 109.891 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.9 -53.42 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.705 -1.247 . . . . 1.0 108.519 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.14 -40.01 94.52 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.59 -0.694 . . . . 1.77 110.14 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -69.87 -41.2 75.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.024 -1.047 . . . . 2.7 110.436 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.403 ' HG3' HG21 ' A' ' 31' ' ' ILE . 69.4 mm-40 -64.91 -40.02 94.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.832 -1.168 . . . . 1.51 110.069 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.3 t -62.84 -47.0 94.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.905 -1.122 . . . . 0.93 108.937 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -64.59 -42.8 95.35 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.047 -1.033 . . . . 1.81 110.063 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -60.07 -42.19 94.02 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.425 -1.324 . . . . 2.78 107.425 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -61.16 -50.04 74.8 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.151 -0.685 . . . . 0.78 109.151 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.9 tp -59.99 -42.32 93.95 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.444 -0.947 . . . . 1.07 108.444 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 36.8 t -63.6 -39.98 95.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 1.12 109.325 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.56 -48.98 77.69 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.702 -1.759 . . . . 0.84 108.702 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -61.1 -39.99 92.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.337 -1.096 . . . . 3.09 108.256 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -46.64 -43.27 17.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.558 -0.714 . . . . 0.88 109.14 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 50' ' ' ALA . 24.7 ttmt -66.07 -72.83 0.15 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.678 -1.23 . . . . 2.59 107.678 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.92 -42.45 0.62 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.359 -0.838 . . . . 0.7 111.37 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.2 t -51.37 -56.36 13.54 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.59 -1.319 . . . . 1.4 109.177 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.71 -41.95 74.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.195 -0.94 . . . . 0.67 110.794 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.7 -40.06 88.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.932 -1.105 . . . . 1.66 109.794 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.7 mt -60.62 -40.05 90.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.99 -1.069 . . . . 1.58 108.713 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.412 ' OE2' HD13 ' A' ' 77' ' ' ILE . 51.4 mm-40 -60.85 -33.54 73.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.455 -0.778 . . . . 1.35 109.429 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -65.15 -44.09 89.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.039 -1.038 . . . . 0.77 109.427 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.05 -38.98 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.884 -0.784 . . . . 0.63 108.884 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -59.45 -49.97 75.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.468 -0.77 . . . . 1.14 109.67 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -59.58 -37.45 78.55 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.273 -0.892 . . . . 0.79 110.223 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -63.93 -38.91 92.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.96 -1.087 . . . . 1.53 109.595 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.541 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -63.26 -42.27 99.12 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.373 -0.829 . . . . 0.57 109.15 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.44 -51.4 58.97 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.101 -1.2 . . . . 0.75 110.101 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.39 -46.72 66.24 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.928 -1.337 . . . . 1.59 110.02 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.1 m -67.25 -63.08 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.73 112.442 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.474 ' CE2' ' O ' ' A' ' 168' ' ' THR . 95.4 m-85 -92.9 -50.5 5.52 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.749 -1.219 . . . . 0.75 110.917 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.46 -169.9 24.93 Favored Glycine 0 N--CA 1.499 2.894 0 C-N-CA 119.954 -1.117 . . . . 1.22 110.939 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -69.74 -24.19 63.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.894 -0.768 . . . . 5.81 109.714 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -60.04 -35.55 75.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.569 -0.707 . . . . 3.37 110.175 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -100.37 -18.5 16.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.329 -0.857 . . . . 1.77 110.415 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -70.05 -40.01 75.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.778 -1.202 . . . . 1.65 110.643 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.536 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.51 -30.58 70.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.217 -0.927 . . . . 0.77 110.22 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.9 mt -59.94 -40.63 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.051 -1.031 . . . . 0.8 109.291 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 16.9 m-85 -70.04 -38.18 75.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.88 110.947 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -60.05 -39.93 87.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.859 -1.151 . . . . 1.37 109.8 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.97 -43.36 99.01 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.306 -1.518 . . . . 0.62 109.306 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -61.98 -42.93 99.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.388 -1.066 . . . . 1.5 109.705 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.412 HD13 ' OE2' ' A' ' 55' ' ' GLU . 98.7 mt -70.05 -43.34 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.225 -0.922 . . . . 0.63 109.741 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.8 ttp -59.97 -40.09 87.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.841 -1.162 . . . . 1.51 109.512 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.856 HD11 ' CE2' ' B' ' 348' ' ' PHE . 31.7 tp -65.21 -38.03 89.16 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.471 -0.768 . . . . 0.77 109.699 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.9 -40.09 95.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.455 -0.778 . . . . 0.62 109.964 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -81.0 6.29 13.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.238 -0.914 . . . . 1.47 110.219 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -52.75 133.47 36.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.073 -1.017 . . . . 1.47 110.473 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.44 -19.45 63.5 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.556 -0.715 . . . . 1.78 110.658 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.07 -33.87 72.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.92 -1.113 . . . . 2.53 108.887 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.0 mt -70.13 -41.46 73.89 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.41 0.624 . . . . 0.8 110.055 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -60.05 -48.79 80.25 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.3 -0.875 . . . . 1.42 110.943 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -70.0 -40.93 74.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.07 -1.019 . . . . 1.71 111.323 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -69.97 -40.02 75.63 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.031 -1.043 . . . . 1.57 111.485 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 84.2 mt -65.88 -49.87 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.975 -1.078 . . . . 0.65 109.69 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.7 mt -65.1 -37.15 79.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.686 -0.634 . . . . 0.82 110.401 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.03 -49.63 76.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.103 -0.998 . . . . 0.79 110.763 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.43 -45.89 91.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.83 -1.169 . . . . 0.95 109.748 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.7 mt -61.51 -49.96 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.981 0.896 . . . . 0.66 109.159 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -67.93 -44.92 75.72 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 120.163 -0.615 . . . . 2.2 111.144 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -80.19 -51.18 9.26 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.878 -1.138 . . . . 1.65 112.152 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -90.1 -3.38 57.95 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.91 -1.119 . . . . 2.03 112.13 -177.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 39.0 m80 57.76 34.82 24.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.892 -1.13 . . . . 1.42 110.605 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 71.0 mtm -90.81 169.91 10.55 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.013 -1.054 . . . . 1.18 109.38 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.6 p -75.3 154.28 37.47 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.093 -1.005 . . . . 0.98 108.465 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.95 -36.87 75.59 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.1 -1.0 . . . . 0.64 110.541 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 38.2 p-10 -65.62 -38.71 90.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.99 -1.069 . . . . 2.07 109.766 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.522 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.53 -44.4 19.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.142 -0.974 . . . . 0.73 109.318 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.88 92.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.396 -0.815 . . . . 0.54 109.44 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.06 94.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.87 . . . . 0.56 109.557 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -59.49 -39.97 85.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.822 . . . . 1.54 109.573 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 110' ' ' GLY . 86.1 tt0 -63.12 -40.02 96.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.117 -0.989 . . . . 1.33 109.28 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.5 t -61.61 -52.27 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.471 -0.768 . . . . 0.72 110.731 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.5 mm -70.08 -39.98 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.916 -1.115 . . . . 0.85 108.934 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -67.24 -38.29 84.96 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.231 -1.026 . . . . 2.44 108.231 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.24 -50.0 70.59 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.33 -1.108 . . . . 0.98 110.33 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -66.84 -52.22 46.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.654 -1.497 . . . . 1.41 109.06 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.85 -39.98 75.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 1.2 108.964 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.1 t -55.74 -39.46 71.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.238 -0.914 . . . . 1.7 108.708 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.05 -37.55 75.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.162 -0.961 . . . . 1.47 109.784 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.3 mt -67.47 -48.59 66.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.117 -0.989 . . . . 1.56 110.704 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -60.49 -21.96 62.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.391 -1.443 . . . . 2.2 110.194 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -67.97 -16.0 63.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.814 -1.179 . . . . 2.12 108.783 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.494 HD13 HD13 ' A' ' 123' ' ' LEU . 28.4 mt -63.05 145.61 55.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.296 -0.877 . . . . 2.0 108.95 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -90.53 28.81 1.4 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.248 -0.908 . . . . 3.23 110.458 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 55.5 t0 -117.36 131.89 56.7 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.333 -0.854 . . . . 2.49 109.78 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.418 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 47.1 mt-10 -69.97 -28.94 65.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.515 -0.74 . . . . 3.95 109.934 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.514 ' OH ' ' NH1' ' A' ' 126' ' ' ARG . 2.7 t80 -69.89 -37.87 76.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 2.0 109.999 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.494 HD13 HD13 ' A' ' 118' ' ' LEU . 72.4 mt -77.14 -31.32 55.59 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.08 -1.013 . . . . 1.86 109.036 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -60.02 -40.06 87.98 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.195 -0.941 . . . . 2.84 108.645 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -47.01 87.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -0.811 . . . . 2.73 109.305 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.514 ' NH1' ' OH ' ' A' ' 122' ' ' TYR . 4.2 mmm-85 -60.02 -40.05 87.95 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.282 -0.887 . . . . 2.77 109.898 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.37 76.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.035 -1.04 . . . . 1.19 108.656 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.08 95.65 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.067 -0.716 . . . . 1.2 109.067 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -66.59 -42.43 86.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.369 -0.832 . . . . 1.55 109.453 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.94 -40.38 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.287 -0.883 . . . . 0.8 108.625 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -60.24 -41.31 92.88 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.465 -0.772 . . . . 3.09 109.101 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -59.92 -40.01 87.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.514 -0.741 . . . . 1.46 110.726 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.9 mt -60.07 -41.28 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 0.71 110.304 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.53 -40.44 94.25 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.646 -1.264 . . . . 0.57 110.02 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -60.01 -45.27 93.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.292 -1.122 . . . . 2.59 110.314 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -65.96 -35.88 81.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.589 -1.319 . . . . 2.83 110.038 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.94 -41.6 92.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.107 -0.995 . . . . 1.25 109.441 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.01 -40.01 87.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.108 -0.995 . . . . 0.7 108.908 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -65.77 -39.98 91.55 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.749 -0.834 . . . . 2.57 108.749 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -69.73 -29.03 66.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.628 -0.67 . . . . 1.23 111.85 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.3 mt -70.02 -40.77 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.255 -1.528 . . . . 0.81 108.624 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.7 -29.66 59.07 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.676 -0.64 . . . . 1.0 109.747 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.19 45.82 4.62 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 108.954 -1.658 . . . . 0.89 108.954 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.6 tp -74.81 149.99 39.46 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.457 -1.025 . . . . 1.14 109.503 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -70.21 143.77 52.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.206 -0.934 . . . . 4.6 109.881 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.6 mt -114.91 128.8 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 122.037 0.922 . . . . 1.24 109.274 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.8 mt -69.93 -40.12 78.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.873 -0.603 . . . . 1.54 110.654 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.1 t0 63.39 103.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.27 -0.894 . . . . 1.5 109.223 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 57.7 mt -68.45 -1.25 6.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.395 -0.816 . . . . 0.79 109.88 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.6 p -81.67 -14.61 56.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.02 -1.05 . . . . 1.4 109.878 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.8 26.42 0.83 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.239 -0.913 . . . . 0.92 112.225 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 36.1 mm -90.8 122.49 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 120.367 -1.458 . . . . 0.88 109.122 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -104.39 -12.52 16.52 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.428 -0.795 . . . . 2.45 110.415 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -122.3 147.78 45.82 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.286 -0.884 . . . . 1.52 110.182 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.92 135.76 56.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.82 . . . . 1.58 109.487 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.0 m -152.8 166.63 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.608 -0.682 . . . . 0.69 109.799 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 86.3 mt -94.74 148.9 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.485 -1.672 . . . . 0.61 106.485 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 14.9 tp -97.78 118.19 33.76 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.867 -1.146 . . . . 0.87 110.383 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.8 t -123.12 130.01 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.808 -0.812 . . . . 0.71 108.808 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -156.66 160.67 39.58 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.385 -0.968 . . . . 0.81 108.385 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.84 -31.83 65.04 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.266 -1.521 . . . . 0.98 107.588 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -157.94 165.62 34.7 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.853 -0.795 . . . . 2.25 108.853 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 78.0 mt -136.95 132.16 34.01 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.162 -0.961 . . . . 0.78 108.964 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.1 p -102.44 148.99 36.27 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.389 -0.82 . . . . 0.98 108.975 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -41.59 -34.13 2.02 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.97 1.78 . . . . 0.81 112.211 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 43.7 m -57.46 -43.37 83.95 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.354 -0.841 . . . . 0.9 109.961 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.94 -40.96 75.19 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.126 -0.984 . . . . 1.61 110.252 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.474 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 72.0 p -58.03 -19.9 34.88 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.166 -0.959 . . . . 0.61 111.581 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.541 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -85.69 -43.18 13.62 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.634 -1.291 . . . . 0.6 109.773 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -96.98 41.53 1.11 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.39 -0.967 . . . . 1.4 108.39 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.479 HD11 HG21 ' A' ' 176' ' ' VAL . 58.9 tp -105.29 131.51 52.66 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.588 -0.893 . . . . 0.7 108.588 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.431 ' O ' HG23 ' A' ' 176' ' ' VAL . 16.7 m120 -84.03 103.33 13.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.008 -1.058 . . . . 2.35 108.847 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.77 -40.8 95.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.854 . . . . 1.51 110.814 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -65.59 -27.39 68.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.82 -1.175 . . . . 2.33 111.286 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.454 ' N ' ' CD ' ' A' ' 175' ' ' LYS . 1.1 mptm? -93.32 -11.83 31.48 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.895 -1.128 . . . . 1.92 109.723 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.479 HG21 HD11 ' A' ' 171' ' ' LEU . 87.6 t -100.01 110.03 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.138 -0.977 . . . . 0.67 108.908 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 89.9 mt -83.76 7.32 18.16 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.229 -0.919 . . . . 1.53 110.377 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.462 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 167.94 176.26 38.35 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.247 -1.541 . . . . 0.48 109.247 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.475 ' CE1' HG11 ' A' ' 176' ' ' VAL . 11.9 m-85 -133.24 129.9 38.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.353 -1.087 . . . . 0.55 108.658 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.2 mt -132.93 126.51 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.309 -0.869 . . . . 0.65 109.28 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.4 p -145.35 158.03 43.92 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.034 -1.041 . . . . 0.82 111.189 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.529 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -103.14 26.84 7.77 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.789 -0.819 . . . . 2.46 108.789 179.124 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -67.42 -158.96 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.055 -1.028 . . . . 1.28 112.028 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.14 -50.55 10.23 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.07 -1.212 . . . . 2.19 110.07 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.85 -120.05 1.1 Allowed Glycine 0 N--CA 1.493 2.459 0 O-C-N 120.868 -1.372 . . . . 2.13 110.766 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.566 ' NE ' HH22 ' A' ' 195' ' ' ARG . 58.4 mtp180 -60.96 -37.6 82.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.774 -0.839 . . . . 5.86 111.627 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 32.7 p -67.31 3.02 1.36 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.9 -1.125 . . . . 3.72 110.909 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.8 t -90.39 118.89 30.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.746 -1.222 . . . . 1.74 109.952 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -43.11 -52.63 5.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.355 -0.841 . . . . 0.95 109.636 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -52.33 -33.16 41.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.352 -0.842 . . . . 1.55 110.706 -179.463 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.1 t -59.99 -42.03 93.35 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.727 -1.233 . . . . 1.51 110.225 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.3 mm -60.37 -39.95 82.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.357 -0.84 . . . . 1.67 109.005 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.6 mtp -60.01 -40.56 89.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.495 -0.753 . . . . 1.02 110.919 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.36 95.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.673 -1.267 . . . . 0.68 109.149 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.566 HH22 ' NE ' ' A' ' 186' ' ' ARG . 98.4 mtt180 -59.96 -53.34 59.04 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.221 -0.924 . . . . 2.93 110.375 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.3 m -69.73 -35.66 75.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.067 -1.021 . . . . 0.86 111.267 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.03 -28.6 65.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.865 -1.147 . . . . 0.67 108.906 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 70.24 45.73 0.65 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.506 0.669 . . . . 1.5 109.644 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 88.2 mt -122.73 150.04 57.47 Favored Pre-proline 0 N--CA 1.498 1.963 0 N-CA-C 107.84 -1.171 . . . . 0.72 107.84 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.79 142.68 70.78 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.002 1.801 . . . . 0.61 111.536 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -170.01 151.15 3.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.983 -1.073 . . . . 0.66 111.388 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.7 mt -123.47 143.47 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.783 -1.191 . . . . 0.79 107.783 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 5.8 m -126.67 -10.08 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 120.694 -1.254 . . . . 0.91 110.54 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.1 23.14 26.01 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 110.323 -1.111 . . . . 1.01 110.323 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.417 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.5 p -46.02 -43.24 14.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.089 -1.242 . . . . 0.99 109.715 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.88 -52.6 3.92 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 120.144 -1.027 . . . . 1.12 111.532 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.9 m -157.38 33.76 0.28 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.54 -1.565 . . . . 1.72 111.425 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 56.1 t -72.77 -40.1 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.908 -1.12 . . . . 0.89 109.111 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.432 ' H ' HG23 ' A' ' 209' ' ' THR . 1.4 p -54.82 -32.36 60.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.431 -0.793 . . . . 1.03 110.578 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 84.9 p -76.43 -16.29 59.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.985 -1.072 . . . . 1.83 109.421 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -101.64 -13.73 17.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.498 -0.751 . . . . 2.27 109.95 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 55.9 t -104.77 137.92 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.359 -0.838 . . . . 0.92 110.555 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -112.79 151.7 30.03 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.686 -1.227 . . . . 2.2 107.686 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 30.5 p-10 -57.92 137.03 57.11 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.016 -1.053 . . . . 2.36 110.251 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.8 OUTLIER 82.79 8.69 0.72 Allowed 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.14 0.495 . . . . 2.38 110.432 179.281 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 60.5 t0 -77.8 143.57 37.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.12 -0.987 . . . . 2.09 109.131 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.527 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 33.9 t80 -88.32 118.24 27.8 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.025 -1.047 . . . . 1.27 109.041 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.586 HD12 ' HB2' ' A' ' 16' ' ' ALA . 91.7 mt -130.63 149.42 52.29 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.515 -0.741 . . . . 0.75 110.544 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.7 mt -118.28 128.56 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 106.85 -1.537 . . . . 0.63 106.85 177.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.7 tp -100.61 122.5 43.38 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.961 -1.087 . . . . 0.7 109.466 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.419 ' C ' ' N ' ' A' ' 223' ' ' VAL . 19.3 m-20 -87.53 -42.77 12.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.982 -1.074 . . . . 2.31 109.884 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.883 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.15 22.81 0.25 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.674 -0.861 . . . . 0.78 108.674 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.419 ' N ' ' C ' ' A' ' 221' ' ' ASP . 18.0 t -127.25 -42.82 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.903 -1.517 . . . . 1.04 106.903 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -109.84 7.39 24.04 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.0 -1.111 . . . . 2.44 108.0 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.801 HD21 ' H ' ' A' ' 4' ' ' GLY . 36.6 t-20 60.04 52.12 5.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.794 -0.566 . . . . 1.55 110.532 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -147.17 158.56 43.99 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.784 -1.198 . . . . 1.99 110.463 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.6 t -126.81 130.04 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.496 -0.927 . . . . 0.77 108.496 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -98.43 122.93 42.22 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.426 -0.796 . . . . 0.98 109.212 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 18.2 t -100.79 111.28 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.551 -0.718 . . . . 0.85 110.083 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 54.98 63.14 7.17 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.235 -0.916 . . . . 1.66 111.244 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -86.87 150.07 8.43 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.571 2.181 . . . . 0.95 112.246 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 39.8 p -74.43 165.02 25.9 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.318 -0.864 . . . . 1.84 109.437 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -60.0 -34.43 73.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.426 -0.796 . . . . 2.74 110.592 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -59.94 -39.29 85.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.053 -1.029 . . . . 2.89 109.756 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 76.1 t -70.02 -40.27 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.031 -1.043 . . . . 1.3 109.18 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 99.4 mt . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.342 -0.849 . . . . 1.09 109.658 -179.715 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 7.5 ttt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -151.69 149.54 29.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.368 -0.832 . . . . 0.0 109.099 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -148.91 159.96 43.71 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.053 -1.029 . . . . 0.0 110.655 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -152.7 148.74 27.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.475 -0.766 . . . . 0.0 109.314 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -107.03 131.11 54.45 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.135 -0.978 . . . . 0.0 109.646 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.59 119.06 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 122.186 0.993 . . . . 0.0 112.782 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 307' ' ' THR . . . . . 0.472 ' O ' HG23 ' B' ' 309' ' ' THR . 94.6 m -78.34 104.75 9.13 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.919 0.866 . . . . 0.0 110.004 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' B' ' 358' ' ' GLY . 70.4 mt -51.74 118.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 122.317 1.056 . . . . 0.0 110.295 -177.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 309' ' ' THR . . . . . 0.472 HG23 ' O ' ' B' ' 307' ' ' THR . 51.6 p -108.1 17.08 22.73 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.24 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.405 ' O ' ' CG ' ' B' ' 357' ' ' GLN . . . -71.92 117.14 55.29 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.063 -1.023 . . . . 0.0 108.54 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -51.92 -16.07 3.86 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 CA-C-N 120.35 1.161 . . . . 0.0 113.594 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -120.47 10.57 11.19 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.329 -0.857 . . . . 0.0 109.357 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.14 -179.79 31.4 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.494 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -88.66 93.98 9.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.351 -1.088 . . . . 0.0 109.353 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.411 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 6.5 p80 -96.58 -160.01 0.77 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.897 -1.127 . . . . 0.0 110.564 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.2 m -57.33 -44.03 83.89 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.005 -1.059 . . . . 0.0 112.367 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.577 HH21 ' NE2' ' B' ' 321' ' ' GLN . 2.1 tpt180 -59.92 -60.57 10.17 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 120.651 -1.28 . . . . 0.0 112.233 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.411 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 10.9 Cg_endo -58.73 -29.82 90.72 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 CA-C-N 120.444 1.194 . . . . 0.0 111.595 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.92 -52.01 67.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 108.861 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.65 -41.49 61.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.944 . . . . 0.0 109.4 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 321' ' ' GLN . . . . . 0.577 ' NE2' HH21 ' B' ' 317' ' ' ARG . 89.5 mt-30 -69.96 -40.04 75.64 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.15 -0.969 . . . . 0.0 108.753 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -60.86 -52.88 63.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.519 -0.738 . . . . 0.0 110.989 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 71.9 t -67.74 -29.34 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.646 -1.284 . . . . 0.0 109.997 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -61.16 -45.53 94.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.942 . . . . 0.0 109.3 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -64.02 -45.04 90.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.332 -0.855 . . . . 0.0 110.178 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -61.44 -53.66 53.59 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.016 -1.053 . . . . 0.0 111.41 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -57.51 -13.26 3.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.868 -1.145 . . . . 0.0 109.496 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -68.24 -29.74 73.37 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -103.85 147.22 27.57 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.503 -0.998 . . . . 0.0 109.253 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 17.6 p -91.06 -11.88 37.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.975 -1.078 . . . . 0.0 109.85 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.417 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 80.8 p -64.09 158.01 23.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.342 -0.849 . . . . 0.0 110.478 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -74.85 132.96 41.92 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.0 mt -132.32 133.01 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.617 -0.677 . . . . 0.0 109.209 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 69.4 m -127.92 151.04 49.58 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.48 -0.763 . . . . 0.0 109.491 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 60.8 t -117.04 137.83 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 87.6 m -128.96 125.12 36.76 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.184 -0.948 . . . . 0.0 109.083 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 337' ' ' SER . . . . . 0.418 ' HB2' HG12 ' B' ' 361' ' ' VAL . 12.2 t -138.67 119.12 13.8 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.959 0.885 . . . . 0.0 110.798 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 338' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' B' ' 338' ' ' ASN . 8.1 p-10 39.01 65.13 0.7 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 79.3 -12.36 26.35 Favored Glycine 0 N--CA 1.5 2.947 0 O-C-N 120.833 -1.167 . . . . 0.0 113.668 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -120.67 133.09 55.38 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-N 119.564 1.682 . . . . 0.0 109.963 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 78.7 p -129.91 150.4 51.21 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.8 0.809 . . . . 0.0 110.513 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.23 167.33 22.68 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.528 0.68 . . . . 0.0 110.11 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 12.2 m -88.93 138.94 30.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.504 -0.748 . . . . 0.0 109.808 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -76.8 -13.03 60.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.907 -1.121 . . . . 0.0 108.974 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -89.69 16.58 7.66 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 67.3 m -145.61 94.79 2.55 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.607 0.717 . . . . 0.0 111.068 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.717 HD23 HD22 ' A' ' 79' ' ' LEU . 52.9 tp -59.89 -33.96 72.54 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.856 ' CE2' HD11 ' A' ' 79' ' ' LEU . 54.2 m-85 -55.79 -52.84 62.59 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.928 -1.108 . . . . 0.0 109.852 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -69.99 -20.77 63.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -0.898 . . . . 0.0 111.889 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.97 -46.76 64.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.428 -1.42 . . . . 0.0 110.817 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.584 ' NE2' ' O ' ' B' ' 347' ' ' LEU . 1.0 OUTLIER -47.92 -21.11 0.38 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.894 -1.129 . . . . 0.0 111.695 -177.371 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 71.3 p -77.31 -12.97 60.01 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.168 -1.582 . . . . 0.0 109.974 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 30.0 mt -96.21 119.68 35.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.107 -0.995 . . . . 0.0 109.431 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.13 97.3 0.93 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 90.5 mt -98.64 81.56 2.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.327 -1.102 . . . . 0.0 109.399 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 46.5 p -89.77 176.48 6.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.149 -0.969 . . . . 0.0 110.964 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 357' ' ' GLN . . . . . 0.405 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 21.9 tm0? -70.64 112.19 6.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.694 -0.629 . . . . 0.0 110.379 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 358' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 104.26 8.74 37.87 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 19.2 m -86.55 109.2 18.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.122 -1.223 . . . . 0.0 110.357 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 360' ' ' VAL . . . . . 0.416 HG22 ' OG1' ' B' ' 307' ' ' THR . 7.9 t -77.6 115.49 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 122.329 1.061 . . . . 0.0 109.556 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 361' ' ' VAL . . . . . 0.418 HG12 ' HB2' ' B' ' 337' ' ' SER . 33.2 m -113.01 178.41 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 34.6 m -130.5 128.87 42.06 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 38.6 mt -104.69 121.55 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 68.8 p -126.46 136.12 52.23 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.71 153.25 40.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.208 -0.932 . . . . 0.0 109.923 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -146.16 125.82 13.38 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 158.98 -158.76 29.73 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.116 -1.516 . . . . 0.0 111.256 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.81 -51.99 67.36 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 122.077 -0.661 . . . . 0.0 112.177 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' B' ' 331' ' ' SER . 97.2 m-20 -111.27 11.92 21.7 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.998 -1.064 . . . . 0.0 111.023 -177.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -43.53 -31.85 0.81 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.231 -0.918 . . . . 0.0 110.746 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 371' ' ' GLN . . . . . 0.403 ' HG2' ' H ' ' B' ' 371' ' ' GLN . 3.2 pt20 -65.13 -47.31 77.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.881 -1.137 . . . . 0.0 109.532 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -65.84 -49.28 68.75 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 109.209 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.49 -37.04 3.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.661 -0.649 . . . . 0.0 112.041 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.544 ' O ' HG23 ' B' ' 378' ' ' VAL . 99.5 t -80.51 -35.38 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.479 -1.388 . . . . 0.0 109.964 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -67.04 -39.97 87.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.898 -1.126 . . . . 0.0 111.072 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -80.5 -46.64 15.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.759 -1.213 . . . . 0.0 110.57 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 89.8 mt -61.69 -39.95 93.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.194 -0.941 . . . . 0.0 109.865 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.544 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.8 t -60.19 -49.16 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.041 -1.037 . . . . 0.0 109.624 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 379' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' B' ' 383' ' ' GLU . 10.6 mtpm? -68.07 -54.2 20.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.703 -1.199 . . . . 0.0 107.993 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 50.1 tp -56.83 -34.97 68.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 110.182 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -72.09 -40.31 68.31 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 118.286 -1.366 . . . . 0.0 108.805 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.07 -6.45 59.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.525 -0.734 . . . . 0.0 110.533 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' B' ' 379' ' ' LYS . 74.2 mm-40 -110.28 -2.42 16.77 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.129 -0.982 . . . . 0.0 111.377 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 12.7 mt -80.98 129.99 34.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.276 -1.515 . . . . 0.0 108.722 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.381 -179.783 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.6 mtp . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.143 -0.688 . . . . 2.91 109.143 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.9 mt -96.39 135.78 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.336 -0.853 . . . . 1.2 109.31 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.6 m -119.34 149.83 41.16 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.775 0.798 . . . . 1.4 109.895 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.79 -173.43 13.21 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.9 -1.68 . . . . 1.05 108.9 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.5 mt -85.48 -7.18 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.896 -1.355 . . . . 1.15 110.087 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.4 tp 50.42 95.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.91 -1.119 . . . . 0.98 109.453 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.11 -35.06 16.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.88 109.378 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 2.8 p -134.67 130.84 19.95 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.495 -0.753 . . . . 1.69 109.364 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.36 141.14 14.07 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.206 1.937 . . . . 0.85 112.779 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.698 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.94 -162.72 34.87 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.978 -1.249 . . . . 0.92 109.978 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.2 mt -146.28 147.09 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.265 -1.138 . . . . 0.81 108.376 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.69 141.45 18.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.524 -1.36 . . . . 0.51 111.455 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -122.14 126.15 47.7 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 107.773 -1.195 . . . . 0.62 107.773 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.08 178.52 48.53 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 118.551 -1.785 . . . . 0.55 111.188 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -79.13 160.95 26.79 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.863 -0.786 . . . . 2.1 110.135 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -102.44 127.28 49.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.549 -0.719 . . . . 0.77 111.256 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.3 tp -106.87 134.56 49.84 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.618 -1.623 . . . . 0.91 106.618 177.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.6 tp -117.66 123.09 45.29 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.243 -0.911 . . . . 0.93 110.523 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.415 HD12 ' HB2' ' A' ' 160' ' ' ALA . 36.8 mt -86.0 103.3 14.57 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.358 0.599 . . . . 0.93 109.644 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -93.98 135.21 35.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -0.896 . . . . 2.75 108.75 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -130.14 132.48 46.1 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.555 -0.906 . . . . 3.0 108.555 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -80.97 148.08 29.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.094 -1.004 . . . . 2.77 110.006 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -62.65 149.47 43.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.38 -0.825 . . . . 2.94 109.263 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.544 HD11 ' NH1' ' A' ' 139' ' ' ARG . 42.0 mt -90.67 125.5 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.223 -0.923 . . . . 0.95 108.89 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.5 t -92.1 125.82 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.096 -1.002 . . . . 1.28 109.989 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.54 130.59 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.028 -1.101 . . . . 1.21 108.028 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -90.68 123.06 33.99 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.824 -1.173 . . . . 1.81 110.245 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -86.63 -1.32 57.58 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.57 -0.9 . . . . 2.8 108.57 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -65.1 140.07 58.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.417 -0.802 . . . . 2.87 109.974 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -87.9 151.31 22.92 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.085 -1.079 . . . . 2.35 108.085 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.673 HD13 ' HG3' ' A' ' 39' ' ' GLU . 3.9 pt -101.48 166.91 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.918 -1.114 . . . . 0.97 109.882 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.0 p -97.96 178.83 4.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.259 -0.901 . . . . 1.17 109.407 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.15 -49.39 77.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.362 -0.836 . . . . 1.18 110.469 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -56.37 -31.5 63.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.616 -1.302 . . . . 2.56 110.248 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -81.8 -9.34 59.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.307 -0.871 . . . . 1.79 110.448 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.0 t -59.97 -50.09 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.937 -1.102 . . . . 1.0 108.75 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -62.61 -40.05 95.72 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.278 -0.889 . . . . 1.77 109.152 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -60.58 -46.03 91.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.296 -0.877 . . . . 2.7 110.488 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.673 ' HG3' HD13 ' A' ' 31' ' ' ILE . 74.9 mm-40 -60.72 -44.35 96.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.825 -1.172 . . . . 1.51 109.851 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.3 t -60.06 -46.37 94.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.95 -1.094 . . . . 0.93 108.743 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -58.75 -40.06 82.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.38 -0.825 . . . . 1.81 109.099 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -60.91 -44.5 97.09 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.007 -1.108 . . . . 2.78 108.007 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -60.12 -49.48 77.46 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.95 -0.759 . . . . 0.78 108.95 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.0 -47.38 86.06 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.281 -1.007 . . . . 1.07 108.281 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.523 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 29.7 t -60.85 -43.82 97.81 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.353 -0.939 . . . . 1.12 108.869 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.99 -45.16 96.39 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.551 -1.819 . . . . 0.84 108.551 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.0 ttt-85 -60.06 -36.34 77.11 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.132 -1.062 . . . . 3.09 108.132 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -53.04 -40.39 63.9 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.939 -0.763 . . . . 0.88 108.939 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.1 ttmt -75.08 -74.08 0.22 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.614 -1.254 . . . . 2.59 107.614 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.53 -39.64 0.33 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.533 -0.729 . . . . 0.7 111.222 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.6 p -56.64 -59.09 5.52 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.658 -1.276 . . . . 1.4 108.895 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.76 -39.97 94.5 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.347 -0.846 . . . . 0.67 110.939 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -67.73 -39.96 84.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.812 -1.18 . . . . 1.66 110.202 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.6 mt -65.64 -40.06 92.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.062 -1.024 . . . . 1.58 109.614 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.425 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 74.9 mm-40 -62.63 -39.95 95.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.089 -1.007 . . . . 1.35 109.846 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -64.14 -41.85 97.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.059 -1.026 . . . . 0.77 110.012 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.413 HD11 HH22 ' A' ' 136' ' ' ARG . 82.8 mt -61.41 -40.0 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.912 . . . . 0.63 109.858 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.425 ' NZ ' ' OE1' ' A' ' 55' ' ' GLU . 5.1 ttpm? -58.16 -49.92 75.32 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.194 -0.941 . . . . 1.14 109.876 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.4 m -58.55 -36.09 73.35 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.364 -0.835 . . . . 0.79 110.886 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -65.83 -38.72 89.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.971 -1.08 . . . . 1.53 109.644 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.97 92.32 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.531 -0.73 . . . . 0.57 110.256 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.08 -50.0 72.2 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.362 -1.495 . . . . 0.75 109.362 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -66.91 -49.5 65.38 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.269 -1.136 . . . . 1.59 109.579 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.8 m -69.74 -61.61 1.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.492 -0.755 . . . . 0.73 112.694 -177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -93.63 -51.82 4.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.763 -1.21 . . . . 0.75 110.949 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.24 -173.01 23.55 Favored Glycine 0 N--CA 1.501 3.019 0 C-N-CA 119.767 -1.206 . . . . 1.22 111.444 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -71.13 -27.75 63.79 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.356 0.598 . . . . 5.81 110.495 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -63.58 -33.99 76.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.372 -0.83 . . . . 3.37 110.8 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -100.73 -24.99 14.29 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.104 -0.997 . . . . 1.77 109.843 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -62.83 -40.02 96.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 1.65 109.935 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.522 ' HB2' ' NH1' ' B' ' 317' ' ' ARG . . . -59.8 -29.88 68.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.398 -0.814 . . . . 0.77 109.732 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.7 mt -59.98 -40.09 82.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.453 -1.314 . . . . 0.8 107.453 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 81.3 m-85 -70.99 -40.06 72.11 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.605 -0.685 . . . . 0.88 111.005 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -64.12 -42.04 97.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.601 -1.312 . . . . 1.37 109.712 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.88 -40.59 96.99 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.586 -1.806 . . . . 0.62 108.586 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.8 m170 -64.55 -43.15 94.85 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.387 -1.067 . . . . 1.5 109.332 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.1 mt -67.32 -47.59 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 0.63 109.983 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.9 ttp -60.1 -40.62 90.28 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.941 -1.099 . . . . 1.51 110.235 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.788 HD11 ' CE2' ' B' ' 348' ' ' PHE . 35.5 tp -66.29 -36.81 83.93 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.539 -0.726 . . . . 0.77 109.639 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.49 -39.34 91.79 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.528 -0.733 . . . . 0.62 109.84 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -78.65 6.88 7.81 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.959 -1.088 . . . . 1.47 110.082 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 57.4 t0 -53.46 132.6 40.14 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.215 -0.928 . . . . 1.47 110.93 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.437 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 93.6 mt-10 -63.34 -18.71 63.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.725 -0.609 . . . . 1.78 110.602 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.02 -34.97 69.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 2.53 108.919 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.48 -39.56 81.29 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.694 0.759 . . . . 0.8 109.241 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.9 -44.47 94.23 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.646 -0.659 . . . . 1.42 110.527 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -70.07 -43.15 71.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.157 -0.964 . . . . 1.71 111.628 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -69.95 -40.07 75.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.001 -1.062 . . . . 1.57 112.476 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.63 -44.53 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.75 -1.219 . . . . 0.65 109.938 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.63 -38.59 76.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.487 -0.758 . . . . 0.82 110.168 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.07 -50.11 74.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.159 -0.963 . . . . 0.79 111.501 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.1 mt -60.97 -45.87 93.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.849 -1.157 . . . . 0.95 109.882 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.1 mt -60.86 -50.03 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.182 -0.948 . . . . 0.66 109.025 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -70.0 -40.59 75.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.65 -0.656 . . . . 2.2 110.857 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -81.16 -62.5 1.64 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.197 -0.939 . . . . 1.65 112.189 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -83.59 -1.0 52.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.122 -0.987 . . . . 2.03 111.934 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 58.98 39.08 23.98 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.929 -1.107 . . . . 1.42 109.741 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.6 mtp -92.36 167.43 12.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.482 -0.761 . . . . 1.18 109.645 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.0 p -84.2 163.44 19.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.98 109.945 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.57 -39.75 80.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.397 -0.814 . . . . 0.64 109.242 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -62.24 -42.45 99.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.306 -0.871 . . . . 2.07 110.231 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.87 -42.85 18.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.327 -0.858 . . . . 0.73 110.701 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.69 -47.32 66.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.16 -0.962 . . . . 0.54 110.791 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.6 -38.98 93.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.017 -1.052 . . . . 0.56 109.346 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.589 ' HB2' HD21 ' A' ' 138' ' ' LEU . 77.2 t60 -59.28 -40.85 87.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.519 -0.738 . . . . 1.54 109.808 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 110' ' ' GLY . 87.0 tt0 -64.32 -39.94 94.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 1.33 110.373 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.8 t -62.19 -55.51 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.148 -0.97 . . . . 0.72 111.132 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.431 HG21 ' CA ' ' A' ' 134' ' ' GLY . 45.6 mm -69.15 -40.04 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.804 -1.185 . . . . 0.85 108.82 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.459 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.4 tt0 -64.89 -39.88 94.22 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.832 -1.173 . . . . 2.44 107.832 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.02 -49.17 77.56 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.882 -1.287 . . . . 0.98 109.882 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -69.52 -51.66 33.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.948 -1.325 . . . . 1.41 109.222 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.91 -42.75 85.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.915 . . . . 1.2 109.282 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 40.5 t -58.36 -38.64 77.63 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.352 -0.842 . . . . 1.7 109.164 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.76 89.52 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.2 -0.938 . . . . 1.47 108.893 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.2 mt -63.05 -42.74 99.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.905 -1.122 . . . . 1.56 109.646 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.99 -33.08 71.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.871 -1.143 . . . . 2.2 109.468 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.57 -20.96 51.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 2.12 109.075 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.615 HD13 HD13 ' A' ' 123' ' ' LEU . 29.5 mt -61.59 142.35 57.18 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.97 -1.081 . . . . 2.0 108.293 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -92.37 28.58 1.9 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.03 -1.044 . . . . 3.23 110.883 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -116.89 128.5 55.3 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.189 -0.944 . . . . 2.49 109.733 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -67.86 -28.04 67.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.557 -0.714 . . . . 3.95 109.522 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.96 -41.81 97.45 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.237 1.018 . . . . 2.0 109.133 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.772 HD22 ' O ' ' B' ' 351' ' ' GLN . 91.7 mt -75.93 -33.03 59.84 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.208 -0.664 . . . . 1.86 109.208 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -60.06 -40.56 89.88 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.861 -0.792 . . . . 2.84 108.861 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -60.0 -48.36 82.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 2.73 109.163 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.761 ' NH1' HE22 ' B' ' 351' ' ' GLN . 61.1 mtm180 -69.33 -30.38 68.41 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.136 -1.026 . . . . 2.77 108.608 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.56 -27.0 68.87 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.39 -0.967 . . . . 1.19 108.39 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.0 -39.93 72.12 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.89 -0.782 . . . . 1.2 108.89 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -60.05 -44.44 94.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.416 -0.802 . . . . 1.55 110.567 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.06 -39.97 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.003 -1.061 . . . . 0.8 108.772 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -61.38 -39.95 92.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.299 -0.875 . . . . 3.09 109.894 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.95 -40.0 87.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 1.46 110.566 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 93.7 mt -60.04 -43.41 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.038 -1.039 . . . . 0.71 109.669 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.431 ' CA ' HG21 ' A' ' 108' ' ' ILE . . . -60.05 -43.93 97.75 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.894 -1.283 . . . . 0.57 109.894 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.09 -45.73 91.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -1.188 . . . . 2.59 110.561 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.413 HH22 HD11 ' A' ' 57' ' ' ILE . 56.4 mtp180 -64.82 -34.95 79.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.831 -1.168 . . . . 2.83 109.641 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.1 tp -59.97 -42.08 93.35 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.315 -0.866 . . . . 1.25 109.333 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 105' ' ' HIS . 59.3 mt -60.18 -41.83 93.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.088 -1.007 . . . . 0.7 109.703 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.544 ' NH1' HD11 ' A' ' 24' ' ' ILE . 64.4 mtm-85 -70.79 -40.04 72.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.111 -0.993 . . . . 2.57 109.802 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -61.02 -37.18 81.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 1.23 111.048 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.2 mt -69.99 -42.62 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.562 -1.336 . . . . 0.81 108.854 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.6 mt -70.03 -26.96 64.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.248 -0.649 . . . . 1.0 109.248 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.2 41.28 8.07 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.958 -1.657 . . . . 0.89 108.958 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.64 143.85 46.12 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.34 -1.094 . . . . 1.14 108.351 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -69.97 144.64 52.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.244 -0.91 . . . . 4.6 110.163 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.8 mt -109.88 127.93 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 122.176 0.989 . . . . 1.24 108.76 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.7 mt -69.99 -40.03 78.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-N 115.582 -0.736 . . . . 1.54 110.272 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 31.4 t0 64.22 123.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.514 -0.741 . . . . 1.5 109.442 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 mt -89.9 0.01 57.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.592 -0.692 . . . . 0.79 109.569 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.3 m -88.18 -18.46 28.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.234 -0.916 . . . . 1.4 110.716 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.69 16.52 2.16 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.072 -1.017 . . . . 0.92 112.008 -177.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.12 119.19 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.427 -1.421 . . . . 0.88 108.72 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -99.38 -9.51 23.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.183 -0.948 . . . . 2.45 110.806 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -110.19 144.82 38.29 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.405 -0.809 . . . . 1.52 110.052 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -65.61 135.61 55.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 1.58 108.993 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.4 m -152.86 166.47 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.571 -0.706 . . . . 0.69 109.419 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 83.7 mt -94.75 144.65 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 105.563 -2.014 . . . . 0.61 105.563 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 12.2 tp -96.58 117.45 30.98 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.812 -1.18 . . . . 0.87 110.48 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.3 t -122.37 130.03 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.595 -0.891 . . . . 0.71 108.595 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.415 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -159.27 164.2 35.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.095 -1.003 . . . . 0.81 109.074 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.46 ' O ' ' OD1' ' A' ' 162' ' ' ASP . . . -75.3 -30.61 60.41 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.317 -1.489 . . . . 0.98 108.681 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 66.6 m-20 -159.54 167.87 27.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.52 -0.738 . . . . 2.25 109.398 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 86.7 mt -141.68 125.83 17.4 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.175 -0.953 . . . . 0.78 108.473 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 70.3 p -93.23 148.49 35.74 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.083 -1.01 . . . . 0.98 109.827 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -39.64 -37.87 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.243 1.962 . . . . 0.81 112.389 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 73.8 m -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.207 -0.933 . . . . 0.9 109.673 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.8 -41.6 97.87 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.194 -0.941 . . . . 1.61 109.497 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 59.5 p -55.6 -31.63 62.4 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.178 -0.951 . . . . 0.61 111.389 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . . . -71.82 -55.01 8.36 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.578 -1.326 . . . . 0.6 109.446 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -82.43 40.35 0.65 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.8 -1.185 . . . . 1.4 107.8 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.409 ' H ' ' C ' ' A' ' 169' ' ' ALA . 62.3 tp -105.31 130.92 53.33 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.316 -0.994 . . . . 0.7 108.316 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -88.63 105.43 17.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.024 -1.048 . . . . 2.35 109.104 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 93.4 mt -63.69 -44.12 94.61 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.291 -0.881 . . . . 1.51 110.788 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -72.4 -22.29 61.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.854 -1.153 . . . . 2.33 112.528 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -93.45 -9.99 36.63 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.527 -1.358 . . . . 1.92 109.663 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.6 HG12 ' H ' ' A' ' 178' ' ' GLY . 99.2 t -107.99 119.05 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.306 -0.871 . . . . 0.67 109.254 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 70.1 mt -85.74 4.92 34.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.403 -0.811 . . . . 1.53 110.525 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.6 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 168.03 175.22 37.58 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.296 -1.522 . . . . 0.48 109.296 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.492 ' CE1' HG11 ' A' ' 176' ' ' VAL . 16.3 m-85 -133.61 130.48 38.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.402 -1.058 . . . . 0.55 109.144 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.415 ' CG2' HG21 ' A' ' 205' ' ' THR . 79.4 mt -130.66 122.21 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.568 -0.901 . . . . 0.65 108.568 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 59.0 p -144.7 159.77 42.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.111 -0.993 . . . . 0.82 111.279 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 53.3 t0 -103.02 25.87 8.87 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.353 -0.61 . . . . 2.46 109.353 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.7 -161.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.178 -1.576 . . . . 1.28 111.747 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.61 -54.87 6.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.588 -1.005 . . . . 2.19 110.588 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.96 -114.37 0.65 Allowed Glycine 0 N--CA 1.495 2.61 0 O-C-N 120.778 -1.424 . . . . 2.13 111.263 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -69.98 -24.14 63.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.677 -0.896 . . . . 5.86 111.648 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 75.7 p -82.85 3.15 30.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.597 -1.314 . . . . 3.72 110.664 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 34.3 t -91.61 126.86 36.84 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.918 -1.114 . . . . 1.74 111.08 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -55.98 -46.37 78.68 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.277 -0.89 . . . . 0.95 110.32 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -54.19 -39.99 67.14 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.14 -0.975 . . . . 1.55 110.238 -179.055 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 24.8 p -60.36 -39.6 87.75 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.003 -1.061 . . . . 1.51 110.454 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.9 -41.1 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.966 . . . . 1.67 110.188 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 91.6 mtp -62.57 -40.06 95.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.035 -1.04 . . . . 1.02 110.666 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.99 -40.45 73.34 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.613 -1.304 . . . . 0.68 108.594 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -59.62 -49.67 76.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 2.93 109.699 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 62.9 m -76.12 -31.24 58.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.18 -0.95 . . . . 0.86 110.798 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.82 -21.93 60.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.954 -1.091 . . . . 0.67 109.547 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 64.39 43.93 4.42 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.93 -0.481 . . . . 1.5 111.514 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.453 ' O ' ' OG ' ' A' ' 8' ' ' SER . 46.5 mt -121.08 142.1 34.17 Favored Pre-proline 0 N--CA 1.503 2.219 0 N-CA-C 107.601 -1.259 . . . . 0.72 107.601 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.72 143.84 99.46 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.508 1.472 . . . . 0.61 111.441 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.96 152.22 3.5 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.935 -1.106 . . . . 0.66 111.49 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.9 mt -124.27 143.46 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.739 -1.208 . . . . 0.79 107.739 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.5 m -125.49 -10.77 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.996 -1.065 . . . . 0.91 111.19 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -113.11 25.97 10.91 Favored Glycine 0 N--CA 1.501 3.012 0 N-CA-C 111.063 -0.815 . . . . 1.01 111.063 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.415 HG21 ' CG2' ' A' ' 180' ' ' ILE . 11.4 p -43.56 -43.75 5.76 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.001 -1.294 . . . . 0.99 109.757 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.434 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 96.01 -50.7 1.71 Allowed Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.439 -0.886 . . . . 1.12 111.418 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.2 m -160.08 40.0 0.18 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.53 -1.571 . . . . 1.72 111.457 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 12.1 t -77.54 -32.02 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.889 -1.132 . . . . 0.89 108.775 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 31.9 p -60.0 -39.89 87.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.558 -0.714 . . . . 1.03 110.829 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 81.8 p -82.47 -10.7 58.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.973 -1.079 . . . . 1.83 110.731 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -98.53 -16.82 19.01 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.21 -0.931 . . . . 2.27 110.724 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 213' ' ' LYS . 44.8 t -116.56 154.73 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 O-C-N 121.265 -0.897 . . . . 0.92 111.025 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.452 ' N ' HG12 ' A' ' 212' ' ' VAL . 2.8 mptp? -116.01 154.83 29.18 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.558 -1.275 . . . . 2.2 107.558 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 20.9 p30 -59.74 140.11 56.76 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.956 -1.09 . . . . 2.36 110.474 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.4 t0 88.97 5.7 0.16 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.049 0.452 . . . . 2.38 110.368 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 16' ' ' ALA . 59.4 m-20 -79.78 153.71 28.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.049 -1.032 . . . . 2.09 109.706 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -95.01 129.93 41.88 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.416 -0.802 . . . . 1.27 108.868 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.6 mt -130.72 151.18 51.45 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.136 -0.977 . . . . 0.75 110.769 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.9 mt -120.13 122.03 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 107.235 -1.394 . . . . 0.63 107.235 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 45.2 tp -103.33 120.02 39.98 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.823 -1.173 . . . . 0.7 108.73 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.479 ' OD2' ' ND2' ' A' ' 224' ' ' ASN . 32.3 t0 -87.24 -37.36 17.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.936 -1.102 . . . . 2.31 108.918 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 45.52 24.49 0.18 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.594 -0.691 . . . . 0.78 109.363 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 45.0 t -137.28 -44.63 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 106.965 -1.494 . . . . 1.04 106.965 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.479 ' ND2' ' OD2' ' A' ' 221' ' ' ASP . 75.2 m-20 -99.94 2.69 43.88 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.131 -1.433 . . . . 2.44 107.131 177.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 59.94 45.11 12.68 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 116.101 -0.5 . . . . 1.55 110.03 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -139.48 138.38 36.35 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.137 -0.977 . . . . 1.99 109.828 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 97.1 t -120.01 122.38 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.807 -0.812 . . . . 0.77 108.807 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -90.61 130.71 36.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.87 -1.144 . . . . 0.98 108.499 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 62.9 t -107.69 123.19 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.58 -0.7 . . . . 0.85 109.709 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 66.6 t30 56.65 67.34 2.72 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.284 -0.885 . . . . 1.66 109.271 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -88.53 130.87 2.37 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 123.144 2.563 . . . . 0.95 112.827 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.654 HG22 ' N ' ' A' ' 233' ' ' ASN . 95.1 m -73.2 173.23 9.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.368 -0.832 . . . . 1.84 109.082 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.654 ' N ' HG22 ' A' ' 232' ' ' THR . 70.3 m-80 -60.0 -40.0 87.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.168 -0.957 . . . . 2.74 109.886 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.48 -39.99 92.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 2.89 109.944 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.2 t -68.29 -39.95 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.093 -1.004 . . . . 1.3 109.544 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.4 mt . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.076 -1.015 . . . . 1.09 108.672 179.508 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 31.7 ttp . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.414 0.626 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -154.86 152.43 29.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.057 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -150.04 162.8 39.68 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.061 -1.025 . . . . 0.0 109.958 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -154.3 151.64 29.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 0.0 109.255 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -108.99 130.98 55.48 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.302 -0.874 . . . . 0.0 110.059 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.433 ' O ' HG13 ' B' ' 306' ' ' VAL . 7.2 p -132.86 121.75 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-O 122.235 1.017 . . . . 0.0 112.512 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 307' ' ' THR . . . . . 0.465 ' O ' HG23 ' B' ' 309' ' ' THR . 18.1 m -76.7 106.72 8.53 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.944 0.878 . . . . 0.0 111.086 -177.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 97.1 mt -53.18 121.36 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 122.191 0.996 . . . . 0.0 110.566 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 309' ' ' THR . . . . . 0.465 HG23 ' O ' ' B' ' 307' ' ' THR . 81.8 p -110.76 19.98 18.06 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.232 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.92 118.02 59.33 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 120.928 -1.108 . . . . 0.0 108.826 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -49.65 -20.34 4.29 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 CA-C-N 120.216 1.113 . . . . 0.0 112.945 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -116.15 15.3 16.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.371 -0.831 . . . . 0.0 109.714 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.53 174.35 20.01 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.175 -1.97 . . . . 0.0 108.175 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 3.5 tp -83.52 94.27 8.0 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.981 -1.305 . . . . 0.0 109.459 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.413 ' NE2' ' HB3' ' B' ' 317' ' ' ARG . 3.6 p80 -99.94 -158.81 0.7 Allowed 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.085 -1.01 . . . . 0.0 109.978 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.7 m -59.95 -43.84 94.77 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.968 -1.083 . . . . 0.0 112.572 -175.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.522 ' NH1' ' HB2' ' A' ' 71' ' ' ALA . 11.9 tpt180 -54.1 -59.19 10.59 Favored Pre-proline 0 N--CA 1.499 2.025 0 O-C-N 120.335 -1.478 . . . . 0.0 111.271 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -60.59 -34.51 92.34 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 CA-C-N 120.531 1.225 . . . . 0.0 111.503 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.08 -50.88 71.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.364 -0.835 . . . . 0.0 109.034 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.71 -43.0 76.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.785 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 321' ' ' GLN . . . . . 0.504 ' CG ' ' NH1' ' B' ' 317' ' ' ARG . 14.1 mm100 -70.02 -41.47 74.24 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.807 -1.183 . . . . 0.0 108.898 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -62.01 -52.91 62.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.548 -0.72 . . . . 0.0 110.554 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 87.0 t -65.73 -28.01 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.909 -1.119 . . . . 0.0 109.844 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -60.13 -46.66 88.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.123 -0.986 . . . . 0.0 110.057 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 325' ' ' GLU . . . . . 0.485 ' OE1' HD22 ' B' ' 380' ' ' LEU . 86.8 tt0 -66.1 -47.7 73.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.13 -0.981 . . . . 0.0 111.284 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.9 -53.4 58.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.64 -1.288 . . . . 0.0 111.34 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -57.16 -15.48 5.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.924 -1.11 . . . . 0.0 109.702 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -74.86 -30.07 60.06 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -101.71 146.23 28.03 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.318 -1.107 . . . . 0.0 108.594 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 24.3 p -89.79 -12.83 38.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.916 -1.115 . . . . 0.0 110.218 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.493 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 23.2 t -55.2 148.2 14.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.122 -0.986 . . . . 0.0 109.577 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -70.24 128.87 37.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.223 -0.923 . . . . 0.0 108.523 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.7 mt -131.48 131.15 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.568 -0.708 . . . . 0.0 109.817 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 334' ' ' THR . . . . . 0.421 HG22 ' N ' ' B' ' 335' ' ' VAL . 89.4 m -130.39 154.48 47.65 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.548 -0.72 . . . . 0.0 109.531 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 335' ' ' VAL . . . . . 0.421 ' N ' HG22 ' B' ' 334' ' ' THR . 56.1 t -116.44 137.87 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 91.3 m -129.11 126.42 39.3 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.107 -0.995 . . . . 0.0 108.898 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 49.4 p -139.94 114.4 9.24 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.128 -0.983 . . . . 0.0 111.678 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 46.76 52.95 10.79 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 176.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.94 -13.92 63.31 Favored Glycine 0 N--CA 1.502 3.094 0 O-C-N 119.992 -1.692 . . . . 0.0 112.776 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -119.89 131.42 55.24 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-N 119.13 1.465 . . . . 0.0 109.86 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 89.4 p -132.0 151.5 51.7 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.776 0.798 . . . . 0.0 110.332 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.3 169.84 17.13 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.479 0.657 . . . . 0.0 109.929 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 3.6 t -91.63 140.11 30.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.342 -0.849 . . . . 0.0 110.707 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.47 ' HA ' HD11 ' B' ' 350' ' ' LEU . . . -79.47 -16.01 56.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 0.0 109.798 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -84.05 16.02 3.13 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 346' ' ' SER . . . . . 0.419 ' H ' ' C ' ' B' ' 344' ' ' ALA . 93.4 p -149.99 95.7 2.33 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.048 0.928 . . . . 0.0 111.835 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.829 HD11 HE21 ' B' ' 351' ' ' GLN . 47.6 tp -60.17 -32.72 71.32 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.788 ' CE2' HD11 ' A' ' 79' ' ' LEU . 53.3 m-85 -54.61 -52.88 60.83 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.902 -1.124 . . . . 0.0 109.817 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -70.01 -39.89 75.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.246 -0.909 . . . . 0.0 110.549 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' B' ' 352' ' ' THR . 88.9 mt -49.93 -59.69 3.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.888 -1.132 . . . . 0.0 109.578 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.829 HE21 HD11 ' B' ' 347' ' ' LEU . 87.5 mm-40 -42.21 -10.23 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.779 -0.575 . . . . 0.0 112.074 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.603 ' N ' ' O ' ' B' ' 350' ' ' LEU . 60.1 p -88.04 -5.07 58.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.336 -1.477 . . . . 0.0 109.48 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 91.4 mt -96.83 116.76 29.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.344 -0.848 . . . . 0.0 109.074 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.63 96.11 1.14 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 31.1 mt -106.17 96.81 6.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.342 -1.093 . . . . 0.0 109.634 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 21.4 p -97.55 159.64 14.8 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.942 -1.099 . . . . 0.0 110.687 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -52.81 119.29 4.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.691 -0.631 . . . . 0.0 110.66 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 101.51 4.07 52.86 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 63.2 m -87.52 111.25 21.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.454 -1.027 . . . . 0.0 111.093 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 45.2 t -77.12 117.74 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 122.291 1.044 . . . . 0.0 109.448 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 30.3 m -112.11 177.14 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 42.0 m -130.76 129.01 41.92 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 88.5 mt -104.7 122.36 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 69.6 m -126.95 135.98 51.65 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.63 156.21 42.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.199 -0.938 . . . . 0.0 109.527 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -147.95 124.57 11.1 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 159.15 -157.09 28.18 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.629 -1.748 . . . . 0.0 111.848 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -59.95 -55.06 38.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 122.249 -0.56 . . . . 0.0 111.995 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.493 ' H ' ' HB2' ' B' ' 331' ' ' SER . 95.9 m-20 -108.8 10.16 26.71 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.037 -1.039 . . . . 0.0 111.416 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.487 ' OE2' ' NE2' ' B' ' 371' ' ' GLN . 0.6 OUTLIER -43.97 -30.6 0.74 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.979 -1.075 . . . . 0.0 110.618 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 371' ' ' GLN . . . . . 0.487 ' NE2' ' OE2' ' B' ' 370' ' ' GLU . 92.1 mm-40 -70.04 -41.0 74.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.053 -1.029 . . . . 0.0 109.541 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -67.98 -49.45 61.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.128 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.78 -76.75 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.448 -0.783 . . . . 0.0 111.258 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.543 ' O ' HG23 ' B' ' 378' ' ' VAL . 46.3 t -45.31 -37.32 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 120.923 -1.111 . . . . 0.0 110.763 -177.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.73 -43.15 80.63 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.505 -1.372 . . . . 0.0 109.974 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -85.34 -43.18 13.91 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.751 -1.218 . . . . 0.0 110.09 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 84.9 mt -57.22 -38.17 73.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.95 -1.094 . . . . 0.0 108.919 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.543 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.5 t -66.78 -40.04 85.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.671 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -80.47 -10.08 59.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.67 -1.269 . . . . 0.0 109.727 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.485 HD22 ' OE1' ' B' ' 325' ' ' GLU . 57.2 tp -83.6 -26.78 29.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.654 -1.279 . . . . 0.0 108.08 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 18.3 tpp -80.64 -24.66 38.84 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -85.21 -9.57 57.63 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.767 -0.583 . . . . 0.0 109.736 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -110.6 -2.19 16.5 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.29 -0.881 . . . . 0.0 110.496 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 25.0 mt -91.45 119.63 31.59 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.82 -1.175 . . . . 0.0 109.334 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.498 1.94 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.019 179.751 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.616 -0.512 . . . . 2.91 109.616 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.5 mt -110.0 129.02 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.806 -0.813 . . . . 1.2 108.806 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -132.5 134.84 45.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.444 -0.785 . . . . 1.4 108.985 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.67 -163.11 19.57 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 108.723 -1.751 . . . . 1.05 108.723 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.498 ' CG2' ' HE ' ' A' ' 186' ' ' ARG . 96.9 mt -90.93 -10.38 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.033 -1.275 . . . . 1.15 109.891 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.4 tp 54.92 98.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.076 -1.015 . . . . 0.98 109.194 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.85 -36.65 62.35 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.565 -0.71 . . . . 0.88 109.5 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -149.75 144.46 17.77 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.135 -0.978 . . . . 1.69 109.949 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -80.05 140.93 14.48 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.693 2.262 . . . . 0.85 113.145 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.812 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 164.94 -163.93 36.72 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 109.468 -1.453 . . . . 0.92 109.468 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -149.98 150.0 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 121.12 -1.224 . . . . 0.81 108.784 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.73 155.74 33.65 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.813 -1.179 . . . . 0.51 110.682 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.8 m-85 -137.5 128.53 27.5 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.407 -0.96 . . . . 0.62 108.407 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.09 -179.92 46.92 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 118.814 -1.66 . . . . 0.55 110.769 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -79.9 157.33 26.95 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.734 -0.863 . . . . 2.1 108.97 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -101.02 129.49 46.87 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.434 -0.791 . . . . 0.77 111.157 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.5 tp -97.31 134.29 40.8 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 106.951 -1.5 . . . . 0.91 106.951 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.9 tp -118.71 122.17 41.85 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.333 -0.855 . . . . 0.93 110.836 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.9 mt -100.37 110.36 22.57 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.832 -0.543 . . . . 0.93 110.886 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -114.57 143.84 44.35 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.525 -0.734 . . . . 2.75 109.272 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.434 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 49.9 mp0 -127.93 130.72 48.94 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.34 -0.85 . . . . 3.0 108.99 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -72.47 144.3 48.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 2.77 109.492 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -61.74 140.36 58.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.304 -0.872 . . . . 2.94 108.972 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.4 mt -79.6 131.95 33.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.224 -0.922 . . . . 0.95 108.786 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.93 123.7 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.25 -0.906 . . . . 1.28 109.485 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -105.67 136.44 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.642 -0.874 . . . . 1.21 108.642 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -90.97 128.36 36.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.033 -1.042 . . . . 1.81 110.552 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.419 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.0 mmm-85 -92.57 7.37 43.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.639 -0.663 . . . . 2.8 109.316 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.55 145.27 54.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 2.87 109.744 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -87.86 139.45 30.5 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.386 -0.821 . . . . 2.35 109.267 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -90.59 163.62 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.896 -1.128 . . . . 0.97 109.899 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.7 p -94.52 169.15 10.4 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.244 -0.91 . . . . 1.17 108.939 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.75 -17.91 63.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.278 -0.889 . . . . 1.18 110.603 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -84.33 -28.45 27.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.688 -1.258 . . . . 2.56 108.094 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -82.07 -8.97 59.68 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.094 -0.706 . . . . 1.79 109.094 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.2 t -65.51 -54.73 25.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 120.916 -1.115 . . . . 1.0 108.571 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -59.97 -40.0 87.6 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.286 -0.884 . . . . 1.77 109.655 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -69.25 -41.84 76.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.228 -0.92 . . . . 2.7 110.684 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -63.33 -40.05 96.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.892 -1.13 . . . . 1.51 110.165 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.23 -46.82 95.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.785 -1.197 . . . . 0.93 108.153 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.26 -44.69 95.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.374 -0.829 . . . . 1.81 109.586 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.01 -43.15 95.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.942 -1.099 . . . . 2.78 108.281 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.422 ' CZ ' HD13 ' A' ' 89' ' ' ILE . 91.0 t80 -64.05 -46.06 86.07 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.345 -0.847 . . . . 0.78 108.902 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.04 -48.34 82.11 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.562 -0.903 . . . . 1.07 108.562 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -64.85 -42.79 94.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.183 -0.948 . . . . 1.12 108.551 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.88 -47.46 88.69 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.478 -1.849 . . . . 0.84 108.478 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -63.79 -37.97 89.35 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.076 -1.083 . . . . 3.09 108.076 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.14 -39.99 70.08 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.562 -0.903 . . . . 0.88 108.562 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 50' ' ' ALA . 31.9 ttpt -61.17 -74.06 0.09 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.655 -1.239 . . . . 2.59 107.655 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.18 -33.18 0.05 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.304 -0.872 . . . . 0.7 111.912 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.2 m -60.02 -50.3 74.29 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.385 -1.447 . . . . 1.4 108.603 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.15 75.85 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.412 -0.805 . . . . 0.67 110.943 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -66.6 -40.0 88.66 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.802 -1.186 . . . . 1.66 110.442 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.87 -40.11 95.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.951 -1.093 . . . . 1.58 109.595 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -60.04 -36.13 76.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 1.35 109.557 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.0 -42.28 98.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -0.977 . . . . 0.77 109.678 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.31 -39.99 87.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.401 -0.812 . . . . 0.63 109.714 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -54.64 -51.59 64.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.264 -0.897 . . . . 1.14 110.123 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -59.7 -34.57 73.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.79 110.791 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -67.13 -39.58 86.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.087 -1.008 . . . . 1.53 109.877 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.18 -42.42 96.71 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.607 -0.683 . . . . 0.57 109.527 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.21 -55.64 29.57 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.926 -1.269 . . . . 0.75 109.926 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.75 -48.09 70.21 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.885 -1.362 . . . . 1.59 109.656 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.6 m -62.84 -65.08 0.74 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 0.73 112.17 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -96.45 -48.74 5.44 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.717 -1.24 . . . . 0.75 111.357 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.76 -168.67 25.51 Favored Glycine 0 N--CA 1.502 3.075 0 C-N-CA 119.536 -1.316 . . . . 1.22 111.436 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -70.04 -26.29 63.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.993 -0.71 . . . . 5.81 110.695 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.486 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 52.8 tp10 -61.4 -35.25 76.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.309 -0.869 . . . . 3.37 110.679 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.45 ' HA ' HD12 ' A' ' 72' ' ' ILE . 40.9 mmtm -98.95 -20.8 16.59 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.175 -0.953 . . . . 1.77 109.984 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -70.03 -40.25 75.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.149 -0.97 . . . . 1.65 110.589 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.489 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.54 -31.71 72.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 0.77 109.788 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 69' ' ' LYS . 95.7 mt -59.97 -40.65 83.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.17 -0.956 . . . . 0.8 109.07 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -62.67 -40.91 98.55 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.131 -0.981 . . . . 0.88 109.503 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.518 ' CD ' ' NZ ' ' B' ' 324' ' ' LYS . 66.5 tt0 -63.32 -39.88 95.79 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.715 -0.794 . . . . 1.37 109.834 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.78 98.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.757 -1.737 . . . . 0.62 108.757 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -67.73 -42.26 82.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.386 -1.067 . . . . 1.5 109.4 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.1 mt -66.86 -46.37 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.209 -0.932 . . . . 0.63 109.106 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.8 ttp -60.09 -44.26 94.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.144 -0.973 . . . . 1.51 110.129 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.838 HD11 ' CE2' ' B' ' 348' ' ' PHE . 44.9 tp -59.95 -40.13 87.96 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.172 -0.955 . . . . 0.77 108.909 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.6 -39.23 93.35 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.868 -0.52 . . . . 0.62 110.231 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -81.86 2.39 30.55 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.073 -1.017 . . . . 1.47 111.082 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -48.81 125.96 11.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.777 -1.202 . . . . 1.47 109.056 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.1 -15.33 22.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.259 -0.901 . . . . 1.78 110.259 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -72.0 -35.03 69.32 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.987 -1.07 . . . . 2.53 108.61 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.03 -40.79 74.98 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.363 0.602 . . . . 0.8 110.05 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.28 -43.76 95.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 1.42 109.774 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -70.05 -41.62 73.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.547 -0.721 . . . . 1.71 111.17 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.02 -40.11 75.42 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.905 -1.122 . . . . 1.57 111.301 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.422 HD13 ' CZ ' ' A' ' 43' ' ' PHE . 72.5 mt -64.9 -49.41 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.113 -0.992 . . . . 0.65 109.561 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.41 -39.49 78.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.798 -0.564 . . . . 0.82 110.572 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.81 84.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.016 . . . . 0.79 110.821 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.07 -45.16 93.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.973 -1.079 . . . . 0.95 109.707 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.8 mt -61.37 -49.94 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.092 -1.005 . . . . 0.66 108.599 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -64.58 -41.41 96.3 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 120.067 -0.653 . . . . 2.2 110.157 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -80.14 -56.3 4.32 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.992 -1.068 . . . . 1.65 112.177 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -90.54 -2.47 57.9 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.103 -0.998 . . . . 2.03 112.677 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 57.5 39.65 27.73 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.693 -1.254 . . . . 1.42 109.585 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.7 mtp -92.11 169.22 10.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.545 -0.722 . . . . 1.18 109.82 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 42.9 p -83.37 160.63 21.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.362 -0.836 . . . . 0.98 109.412 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.56 88.55 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.499 -0.751 . . . . 0.64 110.335 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 32.7 p-10 -69.8 -35.91 75.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.189 -0.944 . . . . 2.07 109.627 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.432 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.5 -44.09 19.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.73 110.124 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.43 -44.97 70.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -0.963 . . . . 0.54 109.974 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.1 -39.39 85.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.134 -0.979 . . . . 0.56 109.655 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.525 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 85.5 t60 -59.93 -41.33 91.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.315 -0.866 . . . . 1.54 110.037 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.17 -39.92 86.53 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.142 -0.974 . . . . 1.33 111.214 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.3 t -58.24 -58.08 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.03 -1.044 . . . . 0.72 111.218 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.2 mm -70.1 -40.0 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.946 -1.097 . . . . 0.85 109.417 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.525 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 87.7 tt0 -60.41 -39.98 89.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 2.44 109.144 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.09 -50.13 71.05 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.432 -1.067 . . . . 0.98 110.432 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -61.12 -50.63 72.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.911 -1.347 . . . . 1.41 109.826 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.6 83.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.323 -0.861 . . . . 1.2 110.521 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.8 m -59.66 -39.97 86.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.892 -1.13 . . . . 1.7 108.781 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.66 -40.0 93.37 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.227 -0.92 . . . . 1.47 108.94 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.7 mt -61.19 -42.67 98.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.977 . . . . 1.56 109.47 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -55.15 -32.45 62.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.046 -1.034 . . . . 2.2 109.433 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -59.99 -23.61 63.79 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.192 -0.943 . . . . 2.12 108.93 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.414 HD13 HD13 ' A' ' 123' ' ' LEU . 58.2 mt -62.08 140.02 58.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.97 . . . . 2.0 109.02 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.7 p-10 -91.4 41.43 1.07 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.194 -0.941 . . . . 3.23 110.404 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 40.6 t0 -134.88 145.28 48.12 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.208 -0.932 . . . . 2.49 109.565 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.524 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 97.5 mt-10 -72.99 -64.7 0.92 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.439 -0.788 . . . . 3.95 109.045 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.453 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 4.1 t80 -38.55 -40.13 0.54 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.905 -0.497 . . . . 2.0 110.684 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.414 HD13 HD13 ' A' ' 118' ' ' LEU . 91.1 mt -72.44 -39.97 67.42 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.78 -1.2 . . . . 1.86 108.427 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 121' ' ' GLU . 19.9 ttpp -64.98 -40.87 95.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.485 -0.76 . . . . 2.84 109.058 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 94.8 mt-10 -62.53 -42.55 99.59 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.172 -1.047 . . . . 2.73 108.172 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.516 ' NH2' ' CB ' ' B' ' 319' ' ' ALA . 57.7 ttt180 -60.13 -40.02 88.33 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.923 -1.139 . . . . 2.77 107.923 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.73 -25.85 68.39 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.727 -0.842 . . . . 1.19 108.727 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -60.75 -41.07 94.67 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.168 -1.049 . . . . 1.2 108.168 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.18 -40.1 90.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.49 -0.756 . . . . 1.55 109.637 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.428 ' CG2' HE22 ' B' ' 351' ' ' GLN . 56.0 t -63.0 -41.37 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.132 -0.98 . . . . 0.8 109.469 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -63.06 -39.83 95.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.152 -0.967 . . . . 3.09 109.398 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -60.19 -40.55 90.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.363 -0.836 . . . . 1.46 110.393 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 98.3 mt -60.01 -45.77 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.098 -1.001 . . . . 0.71 110.382 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.94 -34.89 55.13 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.826 -1.31 . . . . 0.57 109.826 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.464 ' NZ ' HH21 ' A' ' 139' ' ' ARG . 24.8 tptp -59.99 -49.54 77.29 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.4 -1.059 . . . . 2.59 109.658 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -64.74 -33.57 76.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.917 -1.114 . . . . 2.83 109.793 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.2 tp -59.98 -41.02 91.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.363 -0.836 . . . . 1.25 109.094 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.44 -39.99 89.49 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.258 -0.901 . . . . 0.7 108.698 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.464 HH21 ' NZ ' ' A' ' 135' ' ' LYS . 98.8 mtt180 -67.06 -39.93 87.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.491 -0.756 . . . . 2.57 109.429 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -70.2 -25.68 63.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.45 -0.781 . . . . 1.23 111.64 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.3 mt -70.28 -40.09 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.211 -1.556 . . . . 0.81 109.008 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.6 mt -82.34 -26.83 32.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.459 -0.775 . . . . 1.0 110.202 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.95 47.61 5.22 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.034 -1.626 . . . . 0.89 109.034 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.1 tp -74.29 145.48 43.95 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.381 -1.07 . . . . 1.14 109.448 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.24 137.19 58.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 4.6 109.584 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.0 mt -113.97 130.03 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-O 121.975 0.893 . . . . 1.24 109.283 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.51 -42.2 94.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.769 -0.582 . . . . 1.54 110.366 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.6 t0 68.22 91.97 0.09 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.49 -0.756 . . . . 1.5 109.011 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.7 mt -64.08 -6.64 6.77 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.515 -0.741 . . . . 0.79 111.231 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.5 m -82.82 -14.74 53.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.651 -1.281 . . . . 1.4 110.069 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.41 30.91 0.4 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.108 -0.995 . . . . 0.92 112.133 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 41.9 mm -90.31 121.19 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 120.485 -1.384 . . . . 0.88 109.205 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -103.06 -12.54 17.34 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.337 -0.852 . . . . 2.45 110.537 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -128.37 152.09 48.58 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.077 -1.015 . . . . 1.52 110.46 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.32 137.0 57.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.497 -0.752 . . . . 1.58 109.402 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.5 m -152.54 164.38 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.943 -0.762 . . . . 0.69 108.943 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -93.77 146.49 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.486 -1.672 . . . . 0.61 106.486 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.5 tp -94.56 114.59 26.58 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.18 -0.95 . . . . 0.87 110.679 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.523 ' CG1' HG22 ' A' ' 209' ' ' THR . 49.6 t -120.03 127.12 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 108.042 -1.095 . . . . 0.71 108.042 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.05 160.0 40.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.168 -0.958 . . . . 0.81 108.999 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.462 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -76.43 -30.09 57.26 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.266 -1.521 . . . . 0.98 107.872 178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 57.2 t0 -170.05 134.09 1.23 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.334 -0.854 . . . . 2.25 108.894 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.445 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 81.8 mt -111.22 125.02 53.37 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.217 -0.927 . . . . 0.78 108.905 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 51.9 p -83.83 146.6 49.66 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.98 109.292 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -39.91 -37.15 1.52 Allowed 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.298 1.998 . . . . 0.81 113.235 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.6 m -59.99 -41.04 91.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.069 -1.019 . . . . 0.9 109.699 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.13 -40.66 71.27 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.222 -0.924 . . . . 1.61 110.342 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.1 p -53.12 -29.88 33.41 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.015 -1.053 . . . . 0.61 111.447 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -76.46 -56.82 4.28 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.754 -1.216 . . . . 0.6 110.327 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -77.12 37.04 0.19 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.36 -0.978 . . . . 1.4 108.36 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.491 ' H ' ' C ' ' A' ' 169' ' ' ALA . 58.6 tp -102.06 137.32 40.5 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.369 -0.604 . . . . 0.7 109.369 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.461 ' O ' HG23 ' A' ' 176' ' ' VAL . 18.2 m120 -82.76 101.08 10.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.163 -0.96 . . . . 2.35 109.239 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 99.5 mt -66.19 -41.98 89.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.167 -0.958 . . . . 1.51 110.719 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -65.92 -28.82 69.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.857 -1.152 . . . . 2.33 111.568 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -92.52 -8.26 45.01 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.778 -1.201 . . . . 1.92 110.133 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 172' ' ' ASN . 94.3 t -101.8 112.18 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.28 -1.008 . . . . 0.67 108.28 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.03 5.15 30.62 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.28 -0.888 . . . . 1.53 110.709 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.435 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.97 173.38 38.04 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.309 -1.517 . . . . 0.48 109.309 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.448 ' CE1' HG11 ' A' ' 176' ' ' VAL . 15.4 m-85 -132.08 129.61 40.19 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.467 -1.02 . . . . 0.55 109.186 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.2 mt -134.12 127.09 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.372 -0.83 . . . . 0.65 108.943 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.5 p -149.78 160.26 43.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.982 -1.074 . . . . 0.82 110.387 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 20.1 p-10 -102.41 23.02 12.44 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.411 -0.806 . . . . 2.46 109.458 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -52.68 -165.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.081 -1.012 . . . . 1.28 111.951 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -75.52 -54.31 5.57 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.869 -0.892 . . . . 2.19 110.869 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 173.61 -140.28 5.47 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.053 -1.546 . . . . 2.13 110.824 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.498 ' HE ' ' CG2' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -65.55 -34.14 77.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.634 -0.921 . . . . 5.86 111.159 -178.854 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 12.9 p -59.95 4.24 0.05 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.942 -1.099 . . . . 3.72 110.879 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.497 ' H ' ' C ' ' A' ' 186' ' ' ARG . 17.1 m -91.93 131.66 37.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.771 -1.205 . . . . 1.74 110.29 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -47.26 -37.58 10.86 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.827 -1.175 . . . . 0.95 107.827 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.412 ' H ' HG23 ' A' ' 190' ' ' THR . 7.4 p -57.7 -41.85 82.51 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.546 -0.752 . . . . 1.55 110.368 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 75.4 m -61.38 -40.08 93.04 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.158 -0.964 . . . . 1.51 111.518 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.91 -40.48 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.114 -0.991 . . . . 1.67 109.548 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 76.9 mtp -58.89 -49.53 77.43 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.353 -0.842 . . . . 1.02 109.94 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.33 -47.05 62.8 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.961 -1.087 . . . . 0.68 110.024 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -62.53 -57.97 9.24 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 118.565 -1.254 . . . . 2.93 109.957 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.1 m -61.24 -40.01 92.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.048 -1.033 . . . . 0.86 111.657 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.96 -23.69 62.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.887 -1.133 . . . . 0.67 109.824 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 64.9 47.81 2.53 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.444 0.64 . . . . 1.5 109.547 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 86.0 mt -126.95 150.05 70.79 Favored Pre-proline 0 N--CA 1.501 2.103 0 N-CA-C 108.568 -0.901 . . . . 0.72 108.568 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.56 141.58 74.03 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.213 1.942 . . . . 0.61 111.67 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.58 153.82 3.56 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.797 -1.161 . . . . 0.66 111.518 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.8 mt -128.08 139.47 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.818 -1.179 . . . . 0.79 107.818 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.5 m -121.83 -11.31 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 120.959 -1.088 . . . . 0.91 111.362 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.1 26.42 15.32 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 110.465 -1.054 . . . . 1.01 110.465 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.8 p -46.42 -42.21 14.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.102 -1.234 . . . . 0.99 109.841 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.59 -54.04 4.1 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 120.125 -1.036 . . . . 1.12 111.104 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 84.9 p -152.58 28.41 0.55 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.556 -1.555 . . . . 1.72 111.567 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 73.0 t -74.03 -40.71 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.666 -1.271 . . . . 0.89 109.136 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.523 HG22 ' CG1' ' A' ' 159' ' ' VAL . 7.7 p -60.95 -30.87 70.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.102 -0.999 . . . . 1.03 110.5 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 79.3 p -79.97 -10.94 59.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.981 -1.074 . . . . 1.83 109.363 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -105.14 -10.92 16.82 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.569 -0.707 . . . . 2.27 109.948 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 79.8 t -101.64 139.99 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.407 -0.808 . . . . 0.92 109.957 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.68 145.89 38.45 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.393 -1.336 . . . . 2.2 107.393 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.476 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 10.4 p30 -54.78 138.2 42.9 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.016 -1.053 . . . . 2.36 110.42 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.3 m-20 86.81 3.66 0.43 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 120.988 0.423 . . . . 2.38 110.434 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -76.26 150.39 37.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.015 -1.053 . . . . 2.09 109.156 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -99.43 119.84 38.64 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.261 -1.015 . . . . 1.27 108.261 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 67.8 mt -126.57 148.51 49.74 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.398 -0.814 . . . . 0.75 110.782 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.8 mt -115.59 128.3 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 107.502 -1.296 . . . . 0.63 107.502 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.0 tp -100.7 118.19 36.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.122 -0.986 . . . . 0.7 109.432 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 10' ' ' GLY . 94.7 m-20 -77.15 -43.2 34.83 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.213 -0.929 . . . . 2.31 108.557 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.89 17.64 0.67 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.857 -1.164 . . . . 0.78 107.857 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.441 ' N ' ' C ' ' A' ' 221' ' ' ASP . 56.4 t -136.05 -36.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.942 -1.133 . . . . 1.04 107.942 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -105.51 3.44 29.43 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.845 -1.169 . . . . 2.44 107.845 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 60.54 43.67 12.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.822 -0.549 . . . . 1.55 111.259 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -150.0 152.78 35.45 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.723 -1.236 . . . . 1.99 110.314 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 91.1 t -119.94 123.38 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 109.043 -0.725 . . . . 0.77 109.043 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -84.62 128.19 34.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.011 -1.055 . . . . 0.98 109.221 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.18 116.62 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.472 -0.768 . . . . 0.85 109.152 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 62.32 67.48 1.2 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 1.66 109.989 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -87.05 131.1 3.08 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 123.048 2.498 . . . . 0.95 112.375 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.464 HG22 ' N ' ' A' ' 233' ' ' ASN . 25.3 m -68.56 163.85 22.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 1.84 109.59 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.464 ' N ' HG22 ' A' ' 232' ' ' THR . 43.0 t30 -59.93 -42.1 93.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.293 -0.879 . . . . 2.74 110.681 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.42 -33.6 72.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.818 -1.176 . . . . 2.89 109.335 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.77 -40.34 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.252 -0.905 . . . . 1.3 109.361 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.8 mt . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.231 -0.918 . . . . 1.09 109.863 -179.872 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 43.3 ttm . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.468 0.652 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -149.23 144.97 26.87 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -150.76 160.0 44.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.874 -1.141 . . . . 0.0 110.787 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -154.64 149.57 26.75 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -117.66 134.68 54.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.252 -0.905 . . . . 0.0 109.629 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.8 129.97 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 CA-C-O 122.192 0.996 . . . . 0.0 112.356 -177.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 307' ' ' THR . . . . . 0.448 ' OG1' HG22 ' B' ' 360' ' ' VAL . 57.3 m -76.24 108.06 8.92 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.31 1.052 . . . . 0.0 110.958 -178.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 90.5 mt -53.82 120.93 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 122.413 1.102 . . . . 0.0 111.278 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 60.3 p -109.82 19.97 18.54 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.005 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.0 136.09 87.32 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.964 -1.085 . . . . 0.0 108.429 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -65.9 -21.82 56.79 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 CA-C-N 119.929 1.01 . . . . 0.0 112.609 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -121.99 15.24 10.78 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.417 -0.802 . . . . 0.0 108.931 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.19 -175.76 52.3 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.453 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -85.85 91.97 8.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.05 -1.265 . . . . 0.0 109.063 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -92.43 -162.8 0.96 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.831 -1.168 . . . . 0.0 109.969 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 16.0 m -58.56 -43.35 89.33 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.888 -1.133 . . . . 0.0 112.47 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.7 HH21 ' NE2' ' B' ' 321' ' ' GLN . 1.9 tpt180 -55.58 -61.07 6.82 Favored Pre-proline 0 N--CA 1.5 2.025 0 O-C-N 120.517 -1.364 . . . . 0.0 111.46 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -60.22 -36.79 86.92 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 CA-C-N 120.229 1.118 . . . . 0.0 111.939 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 319' ' ' ALA . . . . . 0.516 ' CB ' ' NH2' ' A' ' 126' ' ' ARG . . . -63.26 -16.82 61.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 0.0 109.357 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -82.46 -44.47 15.98 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 321' ' ' GLN . . . . . 0.7 ' NE2' HH21 ' B' ' 317' ' ' ARG . 95.4 mt-30 -72.48 -39.13 67.93 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -62.08 -54.55 39.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 110.302 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 323' ' ' VAL . . . . . 0.41 HG13 ' O ' ' B' ' 344' ' ' ALA . 52.7 t -63.82 -28.58 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.706 -1.246 . . . . 0.0 110.001 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 324' ' ' LYS . . . . . 0.518 ' NZ ' ' CD ' ' A' ' 74' ' ' GLU . 11.7 ttmm -60.33 -45.69 92.55 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 109.818 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -62.33 -49.55 75.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.52 -0.738 . . . . 0.0 110.375 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.02 -54.03 50.88 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.054 -1.029 . . . . 0.0 111.468 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -53.86 -16.17 1.67 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.788 -1.195 . . . . 0.0 109.904 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.7 -25.16 75.84 Favored Glycine 0 N--CA 1.487 2.033 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -105.97 141.69 36.94 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.518 -0.989 . . . . 0.0 109.726 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 330' ' ' THR . . . . . 0.454 HG22 ' O ' ' B' ' 330' ' ' THR . 54.3 m -89.04 -10.04 48.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.237 -0.914 . . . . 0.0 109.242 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 26.8 m -62.36 150.96 38.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.084 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.86 133.47 49.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.061 -1.025 . . . . 0.0 109.086 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 87.1 mt -129.9 130.12 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.557 -0.714 . . . . 0.0 109.167 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 78.2 m -126.85 148.75 49.96 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.502 0.668 . . . . 0.0 109.287 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 48.3 t -114.07 139.55 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 28.7 m -130.18 121.28 25.94 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.173 -0.954 . . . . 0.0 109.046 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 31.0 t -138.5 115.11 10.58 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.888 0.851 . . . . 0.0 110.525 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 47.56 51.92 13.16 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.04 -14.55 48.63 Favored Glycine 0 N--CA 1.5 2.952 0 O-C-N 119.971 -1.705 . . . . 0.0 112.629 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -111.67 121.73 45.9 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 119.104 1.452 . . . . 0.0 110.222 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 39.1 m -106.57 156.31 18.72 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.719 0.771 . . . . 0.0 110.796 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 342' ' ' ALA . . . . . 0.44 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -152.47 152.66 32.22 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.427 0.632 . . . . 0.0 110.036 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 8.6 t -87.99 131.42 34.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.303 -0.873 . . . . 0.0 109.686 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.41 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -70.83 -16.21 62.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.093 -1.005 . . . . 0.0 109.771 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 345' ' ' LYS . . . . . 0.422 ' HG2' ' H ' ' B' ' 345' ' ' LYS . 12.6 ptmt -86.83 21.08 2.35 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 10.7 t -150.8 98.53 2.62 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.18 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.828 HD23 HD22 ' A' ' 79' ' ' LEU . 19.3 tp -60.06 -30.6 69.31 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.838 ' CE2' HD11 ' A' ' 79' ' ' LEU . 63.2 m-85 -58.09 -54.36 47.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.414 -0.804 . . . . 0.0 110.718 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -68.28 -40.06 81.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.885 -1.134 . . . . 0.0 109.509 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.59 ' O ' ' N ' ' B' ' 352' ' ' THR . 30.9 mt -49.87 -56.99 8.37 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.934 -1.104 . . . . 0.0 108.102 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.428 HE22 ' CG2' ' A' ' 130' ' ' VAL . 28.6 mt-30 -40.23 -13.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.044 -0.41 . . . . 0.0 111.799 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.59 ' N ' ' O ' ' B' ' 350' ' ' LEU . 77.0 p -93.99 -13.21 27.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.451 -1.406 . . . . 0.0 110.613 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' B' ' 342' ' ' ALA . 63.3 mt -90.54 118.89 30.35 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.847 -1.158 . . . . 0.0 109.077 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.8 90.95 0.67 Allowed Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 20.8 mt -96.77 84.69 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -1.168 . . . . 0.0 108.265 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 30.7 p -88.29 174.3 8.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.431 -0.793 . . . . 0.0 110.566 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -69.16 114.71 7.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.532 -0.73 . . . . 0.0 110.891 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.98 8.94 38.25 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 28.7 m -93.58 111.08 22.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -1.167 . . . . 0.0 110.921 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 360' ' ' VAL . . . . . 0.448 HG22 ' OG1' ' B' ' 307' ' ' THR . 11.2 t -77.25 120.23 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 122.141 0.972 . . . . 0.0 109.773 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 18.3 m -112.51 177.32 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 62.0 m -131.37 129.57 41.53 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 77.0 mt -104.53 117.46 50.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 96.8 p -126.27 136.75 53.16 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.426 -0.796 . . . . 0.0 109.593 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.23 154.02 40.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.395 -0.816 . . . . 0.0 109.886 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -142.99 122.47 13.17 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.494 ' O ' ' OE1' ' B' ' 370' ' ' GLU . . . 162.23 -160.24 32.39 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 118.689 -1.72 . . . . 0.0 111.81 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 368' ' ' GLU . . . . . 0.471 ' N ' ' OG ' ' B' ' 331' ' ' SER . 52.2 tp10 -59.97 -50.08 75.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.145 -0.621 . . . . 0.0 112.322 -177.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.491 ' N ' ' OG ' ' B' ' 331' ' ' SER . 49.5 m-20 -113.3 12.8 18.98 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.869 -1.144 . . . . 0.0 111.592 -177.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.584 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 1.1 pm0 -43.09 -27.86 0.24 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.177 -0.952 . . . . 0.0 110.351 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 371' ' ' GLN . . . . . 0.489 ' N ' ' CD ' ' B' ' 370' ' ' GLU . 4.4 pt20 -70.08 -42.37 72.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 0.0 109.84 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -65.17 -48.38 73.7 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.203 -0.936 . . . . 0.0 108.918 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.23 -76.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.401 -0.812 . . . . 0.0 110.859 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.462 ' O ' HG23 ' B' ' 378' ' ' VAL . 59.6 t -46.0 -37.41 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.0 -1.062 . . . . 0.0 110.817 -177.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.34 -49.28 74.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.595 -1.316 . . . . 0.0 110.446 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -77.55 -43.59 31.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.004 -1.06 . . . . 0.0 110.521 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 44.5 mt -60.63 -39.73 89.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -0.893 . . . . 0.0 110.197 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.462 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.7 t -64.34 -39.99 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.958 -1.089 . . . . 0.0 109.291 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -70.01 -56.55 6.68 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.768 -1.208 . . . . 0.0 107.859 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 64.5 tp -58.01 -28.38 64.38 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.449 -0.782 . . . . 0.0 111.33 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 381' ' ' MET . . . . . 0.517 ' SD ' ' O ' ' B' ' 381' ' ' MET . 0.0 OUTLIER -73.67 -38.13 65.03 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.104 -1.623 . . . . 0.0 108.382 178.24 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.7 -4.52 54.69 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 110.321 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -111.37 -1.91 15.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.158 -0.964 . . . . 0.0 111.075 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 384' ' ' LEU . . . . . 0.427 ' CD2' ' OE1' ' B' ' 321' ' ' GLN . 23.8 mt -89.16 127.4 35.73 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.332 -1.48 . . . . 0.0 110.179 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 117.974 -1.012 . . . . 0.0 108.75 179.049 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.088 0.471 . . . . 2.91 109.884 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 94.5 mt -106.94 120.02 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.442 -0.786 . . . . 1.2 109.108 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.418 ' HB3' HD22 ' A' ' 225' ' ' ASN . 28.8 m -132.42 134.97 45.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.503 -0.748 . . . . 1.4 109.392 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.34 -162.01 11.84 Favored Glycine 0 N--CA 1.501 2.99 0 N-CA-C 108.872 -1.691 . . . . 1.05 108.872 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.468 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.5 mt -89.4 -18.46 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.938 -1.331 . . . . 1.15 110.249 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 5' ' ' ILE . 62.7 tp 54.68 105.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.369 -0.832 . . . . 0.98 108.849 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.15 -24.1 14.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.132 -0.98 . . . . 0.88 109.338 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 19.5 t -138.33 124.74 12.91 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.446 -0.784 . . . . 1.69 109.81 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.65 145.18 16.12 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.974 1.783 . . . . 0.85 112.122 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.805 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 158.03 -158.83 29.49 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.481 -1.448 . . . . 0.92 109.481 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.7 mt -149.68 150.81 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.169 -1.194 . . . . 0.81 108.661 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.44 155.47 33.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.073 -1.017 . . . . 0.51 110.168 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.2 m-85 -136.58 129.56 31.02 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.679 -1.23 . . . . 0.62 107.679 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.29 -178.76 47.62 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 118.349 -1.881 . . . . 0.55 110.951 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -79.96 157.09 26.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.814 -0.815 . . . . 2.1 109.53 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.434 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -102.82 129.19 49.4 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.363 -0.836 . . . . 0.77 111.108 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.0 tp -99.66 131.05 45.9 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.629 -1.249 . . . . 0.91 107.629 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.5 tp -111.21 120.09 41.11 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.08 -1.012 . . . . 0.93 109.5 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 160' ' ' ALA . 35.7 mt -85.51 104.04 14.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.55 -0.718 . . . . 0.93 109.467 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -93.19 135.48 34.34 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.7 -0.852 . . . . 2.75 108.7 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.01 118.45 20.62 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.686 -0.857 . . . . 3.0 108.686 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -76.7 141.64 40.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.102 -0.998 . . . . 2.77 109.448 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -60.06 140.07 57.07 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.325 -0.859 . . . . 2.94 108.774 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 84.8 mt -77.76 135.24 26.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.556 -0.905 . . . . 0.95 108.556 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.7 t -100.6 122.63 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.271 -0.893 . . . . 1.28 109.878 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.1 mt -95.43 141.86 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.969 -0.752 . . . . 1.21 108.969 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -97.67 119.44 36.24 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.171 -0.956 . . . . 1.81 109.491 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -94.47 3.24 55.4 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.282 -0.886 . . . . 2.8 109.467 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -59.97 139.98 57.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.419 -0.801 . . . . 2.87 109.908 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -93.07 144.94 24.78 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.158 -0.963 . . . . 2.35 108.597 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 pt -103.17 166.92 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.121 -0.987 . . . . 0.97 110.863 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.9 p -96.9 177.63 5.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.349 -0.844 . . . . 1.17 109.332 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.08 -49.9 75.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.452 -0.78 . . . . 1.18 110.877 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -58.06 -29.81 65.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.525 -1.359 . . . . 2.56 109.991 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -81.56 -11.44 59.16 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.147 -0.97 . . . . 1.79 110.242 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.7 t -60.04 -50.03 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.861 -1.149 . . . . 1.0 108.729 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -61.22 -39.96 92.21 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.479 -0.763 . . . . 1.77 109.347 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -64.14 -43.45 95.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.411 -0.806 . . . . 2.7 111.274 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -63.56 -41.11 98.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.74 -1.225 . . . . 1.51 110.168 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.04 -46.08 94.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 118.709 -1.196 . . . . 0.93 108.794 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -60.03 -42.33 94.15 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.068 -1.02 . . . . 1.81 109.382 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.484 HH11 ' HG2' ' A' ' 42' ' ' ARG . 25.1 mtt-85 -60.06 -44.66 94.56 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.937 -1.134 . . . . 2.78 107.937 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -60.18 -45.76 92.03 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.393 -0.966 . . . . 0.78 108.393 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.98 -49.82 76.15 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.801 -0.815 . . . . 1.07 108.801 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.505 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 28.8 t -60.05 -42.2 93.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.048 -1.032 . . . . 1.12 109.174 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.0 -42.55 98.41 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.191 -1.964 . . . . 0.84 108.191 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.1 ttm-85 -60.07 -32.97 71.43 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.225 -1.028 . . . . 3.09 108.225 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.9 -40.09 83.44 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.743 -0.598 . . . . 0.88 109.631 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 50' ' ' ALA . 12.1 ttmt -75.16 -74.82 0.19 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.55 -1.26 . . . . 2.59 108.384 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -39.0 -39.32 0.53 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.16 -0.963 . . . . 0.7 111.459 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.9 p -55.95 -59.11 5.36 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.704 -1.247 . . . . 1.4 109.252 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.21 -40.01 82.23 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.249 -0.907 . . . . 0.67 111.331 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -63.39 -40.63 97.74 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.772 -1.205 . . . . 1.66 110.975 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.5 -40.07 96.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.758 -1.213 . . . . 1.58 109.078 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -59.92 -38.57 82.72 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.41 -0.806 . . . . 1.35 109.995 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -64.62 -43.68 92.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.915 -1.116 . . . . 0.77 109.226 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.441 ' CD1' HH22 ' A' ' 136' ' ' ARG . 87.9 mt -60.01 -40.01 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 0.63 108.936 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -55.58 -50.03 71.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.39 -0.818 . . . . 1.14 109.958 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -59.41 -36.32 75.64 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.316 -0.865 . . . . 0.79 111.002 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -62.37 -39.64 93.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.914 -1.116 . . . . 1.53 109.534 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.35 -45.25 80.82 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.629 -0.669 . . . . 0.57 110.218 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.63 -52.25 51.6 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.705 -1.358 . . . . 0.75 109.705 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.08 -46.5 64.78 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.135 -1.215 . . . . 1.59 110.214 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.7 m -67.27 -63.45 1.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.195 -0.94 . . . . 0.73 112.697 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -96.23 -45.08 6.99 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.786 -1.196 . . . . 0.75 111.29 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.64 -174.04 23.22 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 119.644 -1.265 . . . . 1.22 111.309 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -70.05 -26.68 64.13 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.395 0.617 . . . . 5.81 110.348 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -60.98 -32.76 72.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.447 -0.783 . . . . 3.37 110.703 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -100.44 -20.51 15.75 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.37 -0.831 . . . . 1.77 109.374 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -66.24 -40.09 89.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 1.65 110.329 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.579 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -66.35 -26.92 67.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.77 109.718 -178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.0 mt -60.03 -41.81 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.952 -1.092 . . . . 0.8 109.174 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -66.56 -39.84 88.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.264 -0.898 . . . . 0.88 110.089 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.51 ' CD ' ' NZ ' ' B' ' 324' ' ' LYS . 61.6 tt0 -60.06 -39.95 87.8 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.232 -0.917 . . . . 1.37 109.387 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.89 -46.06 95.3 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.308 -1.517 . . . . 0.62 109.308 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.4 m170 -60.09 -42.05 93.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.201 -1.176 . . . . 1.5 109.459 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.1 mt -68.43 -45.9 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.342 -0.849 . . . . 0.63 109.526 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.2 ttp -59.98 -44.12 94.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.83 -1.168 . . . . 1.51 110.074 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.854 HD11 ' CE2' ' B' ' 348' ' ' PHE . 26.5 tp -64.53 -39.94 94.7 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.202 -0.937 . . . . 0.77 109.248 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.2 tp -62.78 -39.87 95.53 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.567 -0.708 . . . . 0.62 109.589 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -84.69 4.15 33.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.215 -0.928 . . . . 1.47 110.152 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.6 t0 -50.02 133.06 23.16 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.127 -0.983 . . . . 1.47 110.867 -178.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.45 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 95.4 mt-10 -61.46 -20.31 62.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.571 -0.706 . . . . 1.78 110.005 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -68.22 -32.73 73.14 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.902 -1.147 . . . . 2.53 107.902 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 79' ' ' LEU . 94.0 mt -75.97 -40.0 54.79 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.509 0.671 . . . . 0.8 110.28 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -60.06 -49.98 75.52 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.269 -0.894 . . . . 1.42 110.282 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -70.7 -41.64 71.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.114 -0.991 . . . . 1.71 110.656 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.08 -39.92 75.33 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.21 -0.931 . . . . 1.57 111.822 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.04 -43.9 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.765 -1.21 . . . . 0.65 109.35 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.7 mt -70.04 -39.34 77.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.574 -0.704 . . . . 0.82 110.101 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.05 -48.3 82.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.249 -0.907 . . . . 0.79 111.248 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 96' ' ' LYS . 92.5 mt -60.1 -44.96 94.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.855 -1.153 . . . . 0.95 109.862 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.96 -49.19 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.343 -0.984 . . . . 0.66 108.343 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -69.33 -41.79 76.21 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.123 -0.631 . . . . 2.2 110.759 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -81.34 -50.33 9.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.002 -1.061 . . . . 1.65 112.043 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 92' ' ' LEU . 68.2 mmtt -92.46 -1.85 56.69 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.041 -1.037 . . . . 2.03 111.838 -177.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 55.72 33.84 22.15 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.785 -1.197 . . . . 1.42 109.562 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 93.9 mtp -89.56 168.95 11.76 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.526 -0.734 . . . . 1.18 110.047 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.3 p -81.11 160.01 24.55 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.74 -0.837 . . . . 0.98 108.74 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.41 -38.9 91.33 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.054 -1.029 . . . . 0.64 109.282 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -66.68 -39.3 88.07 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.281 -0.887 . . . . 2.07 109.532 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.76 -44.2 33.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.73 110.113 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.13 -45.35 73.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.893 . . . . 0.54 109.895 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.67 83.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.117 -0.989 . . . . 0.56 109.547 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -59.88 -44.63 94.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.351 -0.843 . . . . 1.54 110.266 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 110' ' ' GLY . 88.6 tt0 -62.6 -40.69 97.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.898 . . . . 1.33 110.441 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.74 -55.74 21.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.229 -0.919 . . . . 0.72 110.84 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.476 HG21 ' HA3' ' A' ' 134' ' ' GLY . 43.1 mm -70.54 -40.04 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.784 -1.197 . . . . 0.85 109.491 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.438 ' OE2' ' OG ' ' A' ' 113' ' ' SER . 12.2 tm-20 -68.3 -39.97 81.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 2.44 108.8 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -60.57 -45.85 95.52 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.04 -1.224 . . . . 0.98 110.04 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -69.95 -53.06 19.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.989 -1.301 . . . . 1.41 109.749 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.93 -40.04 69.49 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.088 -1.008 . . . . 1.2 109.229 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.438 ' OG ' ' OE2' ' A' ' 109' ' ' GLU . 59.1 m -60.0 -40.07 87.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.959 . . . . 1.7 109.275 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.09 -33.53 75.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 1.47 109.128 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.2 mt -69.06 -39.97 78.78 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.075 -1.016 . . . . 1.56 109.66 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.02 -27.94 67.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.858 -1.151 . . . . 2.2 109.194 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -59.94 -23.49 63.6 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.364 -0.976 . . . . 2.12 108.364 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.464 HD13 HD13 ' A' ' 123' ' ' LEU . 24.6 mt -62.15 151.54 35.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 2.0 109.115 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -99.49 30.05 3.75 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.214 -0.929 . . . . 3.23 110.16 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -118.07 131.27 56.46 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.19 -0.944 . . . . 2.49 110.637 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -70.07 -29.77 66.85 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.11 -0.7 . . . . 3.95 109.11 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.469 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.4 t80 -69.72 -38.93 77.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.603 -0.686 . . . . 2.0 110.38 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.506 HD22 ' O ' ' B' ' 351' ' ' GLN . 88.2 mt -73.15 -32.94 65.19 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.069 -1.019 . . . . 1.86 109.262 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -60.02 -40.06 88.0 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.271 -0.893 . . . . 2.84 108.646 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -59.95 -46.15 90.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.888 . . . . 2.73 109.017 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.48 ' HE ' ' NE2' ' B' ' 351' ' ' GLN . 15.3 mmm-85 -60.11 -39.96 88.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.127 -0.983 . . . . 2.77 108.885 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.13 -34.93 75.77 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.469 -0.937 . . . . 1.19 108.469 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.18 -39.97 92.15 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.394 -0.965 . . . . 1.2 108.394 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -68.57 -39.94 80.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.402 -0.811 . . . . 1.55 109.172 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.44 -39.92 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.11 -1.07 . . . . 0.8 108.11 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.513 HH11 ' HG2' ' A' ' 131' ' ' ARG . 7.2 ttt-85 -67.25 -34.42 77.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.449 -0.782 . . . . 3.09 109.44 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.03 -41.22 91.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 1.46 109.587 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.3 mt -61.06 -44.01 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.71 109.272 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.476 ' HA3' HG21 ' A' ' 108' ' ' ILE . . . -60.13 -45.0 96.79 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.155 -1.178 . . . . 0.57 110.155 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -59.97 -45.4 92.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.158 -1.201 . . . . 2.59 109.561 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.441 HH22 ' CD1' ' A' ' 57' ' ' ILE . 60.3 mtp180 -67.32 -36.05 80.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.042 -1.036 . . . . 2.83 110.112 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.0 -43.31 95.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 1.25 109.513 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.34 -40.49 97.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.121 -0.987 . . . . 0.7 109.433 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -69.88 -38.09 76.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.188 -0.945 . . . . 2.57 108.672 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -59.97 -38.82 83.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.829 -0.545 . . . . 1.23 110.565 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -73.74 -44.18 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.829 -1.169 . . . . 0.81 108.917 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.96 -40.01 75.68 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.47 -0.769 . . . . 1.0 109.853 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.74 47.06 4.36 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.186 -1.566 . . . . 0.89 109.186 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.7 tp -73.66 148.76 42.47 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.439 -1.036 . . . . 1.14 109.396 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -66.89 140.67 57.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 4.6 109.391 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.3 mt -119.77 129.93 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 CA-C-O 121.77 0.795 . . . . 1.24 109.728 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 148' ' ' ASP . 1.4 mp -66.66 -39.94 84.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.786 -0.571 . . . . 1.54 110.323 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 147' ' ' ILE . 29.1 t0 62.27 127.03 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.822 -0.807 . . . . 1.5 108.822 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.1 mt -85.06 -4.51 59.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.054 -1.029 . . . . 0.79 109.366 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.4 t -86.75 -14.39 42.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.457 -0.777 . . . . 1.4 109.69 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.88 17.02 1.26 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -0.909 . . . . 0.92 110.473 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 38.3 mm -88.86 124.24 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.872 -1.142 . . . . 0.88 109.203 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -105.76 -9.78 17.07 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.423 -0.798 . . . . 2.45 109.833 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -124.05 149.62 45.9 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.319 -0.863 . . . . 1.52 110.311 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.21 134.62 55.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.351 -0.843 . . . . 1.58 109.595 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -151.95 164.64 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.492 -0.755 . . . . 0.69 109.525 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.7 mt -91.67 150.65 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 106.137 -1.801 . . . . 0.61 106.137 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 51.2 tp -99.98 115.9 30.78 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.936 -1.103 . . . . 0.87 110.611 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.62 130.04 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 109.028 -0.73 . . . . 0.71 109.028 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.503 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -159.78 163.35 34.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.184 -0.948 . . . . 0.81 108.647 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.36 -35.42 73.53 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.426 -1.421 . . . . 0.98 107.68 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -160.99 173.46 15.23 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.983 -0.747 . . . . 2.25 108.983 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.7 mt -138.91 139.19 37.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.18 -0.95 . . . . 0.78 109.037 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.4 p -96.09 140.29 22.19 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.168 -0.957 . . . . 0.98 109.141 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -40.25 -34.75 1.12 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.901 1.734 . . . . 0.81 112.216 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.419 ' HB3' HH12 ' A' ' 136' ' ' ARG . 59.3 m -59.94 -42.85 94.88 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.883 . . . . 0.9 109.787 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -69.56 -41.3 76.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.249 -0.907 . . . . 1.61 109.844 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.8 p -54.28 -23.85 16.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.61 111.528 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -86.01 -50.12 7.3 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.407 -1.433 . . . . 0.6 109.867 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -81.49 35.87 0.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.479 -0.934 . . . . 1.4 108.479 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.416 HD11 HG21 ' A' ' 176' ' ' VAL . 59.1 tp -101.38 132.4 46.98 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.257 -0.645 . . . . 0.7 109.257 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.418 ' O ' HG23 ' A' ' 176' ' ' VAL . 32.9 t-20 -83.41 101.77 11.59 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.164 -0.96 . . . . 2.35 108.716 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.34 -40.18 96.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 1.51 111.111 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -67.7 -26.11 66.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.837 -1.164 . . . . 2.33 111.915 -177.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -93.74 -11.43 31.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.62 -1.3 . . . . 1.92 110.231 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 172' ' ' ASN . 63.3 t -101.59 111.53 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.148 -0.97 . . . . 0.67 108.468 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.37 2.93 33.96 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.226 -0.921 . . . . 1.53 111.263 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.8 171.09 37.94 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.37 -1.492 . . . . 0.48 109.37 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.538 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 14.5 m-85 -132.04 128.43 38.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.498 -1.001 . . . . 0.55 109.491 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.95 126.19 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.101 -1.074 . . . . 0.65 108.101 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 203' ' ' VAL . 16.6 p -146.21 158.62 43.89 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.013 -1.055 . . . . 0.82 110.842 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 59.5 t0 -106.15 28.13 7.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.748 -0.595 . . . . 2.46 109.452 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -52.99 -168.52 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.448 -1.408 . . . . 1.28 111.369 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.13 -54.93 6.0 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.49 -1.044 . . . . 2.19 110.49 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -166.51 -156.04 9.3 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.037 -1.554 . . . . 2.13 111.01 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.435 HH11 ' HG2' ' A' ' 186' ' ' ARG . 16.6 ptt-85 -70.05 -18.0 63.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.8 -0.823 . . . . 5.86 111.327 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 69.5 p -73.13 5.25 3.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.768 -1.207 . . . . 3.72 110.305 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.7 p -82.11 137.8 34.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.93 -1.106 . . . . 1.74 109.991 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -49.3 -49.93 41.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.321 -0.862 . . . . 0.95 110.152 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -37.62 71.48 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.362 -0.836 . . . . 1.55 110.965 -178.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.9 t -60.03 -39.97 87.7 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.752 -1.217 . . . . 1.51 110.371 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.86 -39.74 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.855 . . . . 1.67 110.17 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.5 mtm -59.93 -45.0 94.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.966 -1.084 . . . . 1.02 110.42 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.99 -45.45 71.42 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.799 -1.188 . . . . 0.68 109.46 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -60.01 -53.44 57.85 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.998 -1.081 . . . . 2.93 110.445 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.4 m -68.21 -37.8 81.26 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.068 -1.02 . . . . 0.86 111.973 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.38 -22.95 62.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.698 -1.251 . . . . 0.67 109.906 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 66.56 49.3 1.35 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.322 0.582 . . . . 1.5 110.079 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.47 ' O ' ' CB ' ' A' ' 8' ' ' SER . 97.0 mt -129.53 148.98 71.54 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 108.027 -1.101 . . . . 0.72 108.027 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.54 138.31 69.59 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.276 1.984 . . . . 0.61 112.194 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.01 149.73 2.97 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.076 -1.05 . . . . 0.66 111.354 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.5 mt -122.99 144.09 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 107.21 -1.404 . . . . 0.79 107.21 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 181' ' ' THR . 17.9 m -122.34 -12.81 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.006 -1.059 . . . . 0.91 111.127 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -112.65 26.77 10.48 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.88 -0.888 . . . . 1.01 110.88 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 204' ' ' GLY . 14.0 p -41.96 -46.57 4.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.15 -1.206 . . . . 0.99 110.12 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.454 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 94.74 -54.18 1.96 Allowed Glycine 0 N--CA 1.5 2.951 0 C-N-CA 120.332 -0.937 . . . . 1.12 111.587 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 207' ' ' SER . 7.4 t -150.01 29.94 0.72 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.329 -1.689 . . . . 1.72 111.024 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 41.8 t -75.25 -36.87 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.709 -1.244 . . . . 0.89 109.249 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.456 ' H ' HG23 ' A' ' 209' ' ' THR . 8.4 p -60.05 -33.73 72.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.922 . . . . 1.03 111.117 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.2 t -78.37 -22.44 47.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.935 -1.103 . . . . 1.83 110.306 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -94.7 -8.35 38.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.185 -0.947 . . . . 2.27 110.499 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 86.4 t -108.02 140.02 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.28 -0.888 . . . . 0.92 110.729 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.497 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 65.2 mmtt -117.15 156.87 26.91 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.895 -1.521 . . . . 2.2 106.895 177.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 29.9 p-10 -60.04 142.53 53.84 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.802 -1.186 . . . . 2.36 111.115 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.438 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.7 m-20 82.11 3.2 1.28 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 116.061 -0.518 . . . . 2.38 110.832 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.497 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 88.9 m-20 -74.95 145.01 42.93 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.889 -1.132 . . . . 2.09 109.301 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -94.59 120.0 34.13 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.231 -0.918 . . . . 1.27 108.847 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.434 HD12 ' HB2' ' A' ' 16' ' ' ALA . 59.6 mt -126.86 147.49 50.04 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.414 -0.804 . . . . 0.75 110.433 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 85.7 mt -114.11 128.28 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 106.906 -1.516 . . . . 0.63 106.906 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.1 tp -100.83 117.07 34.19 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.866 -1.146 . . . . 0.7 109.595 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 223' ' ' VAL . 96.1 m-20 -74.03 -43.9 56.26 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.242 -0.911 . . . . 2.31 108.728 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.805 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 50.35 11.74 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.846 -0.798 . . . . 0.78 108.846 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.493 ' H ' ' C ' ' A' ' 221' ' ' ASP . 73.5 t -131.05 -44.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.817 -1.179 . . . . 1.04 107.817 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -100.04 3.23 44.0 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.61 -1.255 . . . . 2.44 107.61 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.418 HD22 ' HB3' ' A' ' 3' ' ' SER . 48.4 t30 59.61 43.67 15.51 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 116.246 -0.433 . . . . 1.55 110.192 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -140.09 144.46 36.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.122 -0.986 . . . . 1.99 110.042 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 87.8 t -120.03 125.68 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.926 -0.768 . . . . 0.77 108.926 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -90.99 118.15 30.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.85 -1.156 . . . . 0.98 109.679 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.76 116.69 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.475 -0.766 . . . . 0.85 109.529 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 68.22 67.67 0.52 Allowed Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.468 -0.77 . . . . 1.66 109.947 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -91.02 121.35 0.71 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 123.426 2.751 . . . . 0.95 112.955 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.626 HG22 ' N ' ' A' ' 233' ' ' ASN . 93.9 m -67.03 169.77 7.85 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.256 -0.903 . . . . 1.84 109.685 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.626 ' N ' HG22 ' A' ' 232' ' ' THR . 92.8 m-20 -60.06 -40.0 87.97 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.307 -0.871 . . . . 2.74 109.544 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.91 -38.63 82.86 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.189 -0.945 . . . . 2.89 108.753 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.72 -40.06 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 1.3 109.559 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.291 -0.881 . . . . 1.09 109.86 -179.844 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 38.1 ttp . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.497 0.665 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -155.84 153.44 29.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.494 -0.754 . . . . 0.0 109.136 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -150.9 161.9 41.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.08 -1.012 . . . . 0.0 110.399 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -153.38 149.95 28.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.644 -0.66 . . . . 0.0 109.389 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.17 128.56 55.54 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -131.66 124.59 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 CA-C-O 122.192 0.996 . . . . 0.0 112.388 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 91.4 m -77.84 103.87 8.04 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.03 0.919 . . . . 0.0 110.869 -178.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 88.8 mt -51.71 124.75 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 122.467 1.127 . . . . 0.0 110.464 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 75.7 p -110.02 19.33 19.12 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.206 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.404 ' O ' ' CD ' ' B' ' 357' ' ' GLN . . . -69.33 147.21 97.07 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.94 -1.1 . . . . 0.0 108.578 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -72.82 -24.69 17.69 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 120.892 1.061 . . . . 0.0 112.672 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -121.05 17.61 11.66 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.17 -173.37 53.97 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.989 -2.045 . . . . 0.0 107.989 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.469 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.5 tp -86.3 90.42 8.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.889 -1.359 . . . . 0.0 108.88 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.424 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 4.5 p80 -93.14 -161.42 0.84 Allowed 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.033 -1.042 . . . . 0.0 111.102 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.1 m -55.79 -45.32 78.24 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.569 -0.707 . . . . 0.0 112.71 -175.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.579 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.5 tpt180 -61.22 -58.58 17.98 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 120.526 -1.359 . . . . 0.0 112.176 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 11.5 Cg_endo -59.37 -32.03 95.91 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 120.307 1.145 . . . . 0.0 111.907 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.96 75.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.11 -0.994 . . . . 0.0 108.515 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.73 -42.76 68.45 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.248 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -69.95 -42.96 72.51 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.129 -0.982 . . . . 0.0 108.944 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.26 -52.55 64.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.462 -0.774 . . . . 0.0 110.622 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 323' ' ' VAL . . . . . 0.408 HG13 ' O ' ' B' ' 344' ' ' ALA . 92.5 t -64.66 -30.84 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.757 -1.214 . . . . 0.0 109.521 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 324' ' ' LYS . . . . . 0.51 ' NZ ' ' CD ' ' A' ' 74' ' ' GLU . 12.0 ttmm -60.03 -48.11 83.07 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.392 -0.818 . . . . 0.0 110.102 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 325' ' ' GLU . . . . . 0.517 ' OE1' HD22 ' B' ' 380' ' ' LEU . 84.9 tt0 -67.64 -44.45 77.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 111.239 -178.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.04 -52.43 65.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.587 -1.32 . . . . 0.0 110.465 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -56.42 -14.1 2.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.009 . . . . 0.0 109.376 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -71.94 -21.53 79.02 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -105.8 143.68 33.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.669 -0.9 . . . . 0.0 108.721 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 15.3 t -91.02 -13.16 33.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.027 -1.046 . . . . 0.0 109.279 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.42 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 52.8 p -62.72 146.9 51.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.481 -0.762 . . . . 0.0 109.119 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.63 137.04 57.07 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.148 -0.97 . . . . 0.0 108.98 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 94.3 mt -132.94 133.21 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.604 -0.685 . . . . 0.0 109.679 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 46.5 m -130.34 152.42 49.77 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 62.3 t -117.41 139.51 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 97.9 m -130.7 126.09 35.62 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.105 -0.997 . . . . 0.0 109.714 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 73.5 p -140.16 118.19 11.88 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.863 0.84 . . . . 0.0 110.574 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 42.09 54.45 4.09 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.2 -15.7 43.0 Favored Glycine 0 N--CA 1.502 3.067 0 O-C-N 120.206 -1.559 . . . . 0.0 113.138 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -112.44 124.22 52.03 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 119.327 1.563 . . . . 0.0 109.371 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 85.8 p -122.07 147.59 45.91 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.941 0.876 . . . . 0.0 111.044 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.24 159.78 41.49 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.671 0.748 . . . . 0.0 109.849 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 22.1 m -88.74 136.74 32.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.473 -0.767 . . . . 0.0 110.463 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.44 ' HA ' HD11 ' B' ' 350' ' ' LEU . . . -73.93 -16.78 61.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.051 -1.031 . . . . 0.0 109.876 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -87.36 19.9 3.06 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 25.1 t -149.75 94.83 2.23 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.733 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.544 ' HB3' HD13 ' A' ' 79' ' ' LEU . 36.0 tp -59.96 -32.72 71.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.854 ' CE2' HD11 ' A' ' 79' ' ' LEU . 60.4 m-85 -54.75 -53.55 53.64 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.031 -1.043 . . . . 0.0 110.175 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -70.07 -35.89 74.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 0.0 110.273 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' B' ' 347' ' ' LEU . 81.8 mt -53.92 -50.1 67.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.878 -1.139 . . . . 0.0 110.232 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.506 ' O ' HD22 ' A' ' 123' ' ' LEU . 3.6 mt-30 -49.99 -17.59 0.41 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.668 -1.27 . . . . 0.0 111.337 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 82.1 p -79.81 -14.55 58.61 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.275 -1.516 . . . . 0.0 110.972 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 30.9 mt -91.82 118.66 30.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.749 -1.22 . . . . 0.0 109.201 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.35 92.81 0.77 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 20.9 mt -100.47 89.72 4.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.37 -1.077 . . . . 0.0 109.309 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 38.2 p -90.01 177.87 6.35 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.095 -1.003 . . . . 0.0 110.449 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 357' ' ' GLN . . . . . 0.404 ' CD ' ' O ' ' B' ' 310' ' ' ALA . 48.5 tt0 -69.87 115.14 8.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.632 -0.667 . . . . 0.0 110.926 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 100.2 9.54 47.79 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 52.1 m -87.21 114.12 23.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.228 -1.16 . . . . 0.0 110.888 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.97 115.15 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 122.116 0.96 . . . . 0.0 109.785 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 32.8 m -110.99 176.38 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 33.0 m -130.64 127.64 39.34 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 72.9 mt -102.88 116.64 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 84.1 p -119.98 131.6 55.22 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.304 -0.872 . . . . 0.0 109.47 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.69 151.55 39.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.19 -0.944 . . . . 0.0 109.587 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -144.07 122.99 12.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.406 -0.809 . . . . 0.0 108.889 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.552 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.06 -158.06 29.37 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.062 -1.542 . . . . 0.0 111.481 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -59.85 -50.02 75.44 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.42 ' H ' ' HB3' ' B' ' 331' ' ' SER . 96.0 m-20 -108.99 13.4 24.7 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.819 -1.176 . . . . 0.0 110.963 -177.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.552 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.2 pt-20 -44.95 -36.25 3.28 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.077 -1.014 . . . . 0.0 110.89 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.14 -46.25 68.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.95 -1.094 . . . . 0.0 110.226 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -66.39 -48.15 71.03 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.154 -0.966 . . . . 0.0 109.727 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.12 -75.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 110.501 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.562 ' O ' HG23 ' B' ' 378' ' ' VAL . 68.8 t -45.96 -38.82 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.097 -1.002 . . . . 0.0 110.557 -177.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -63.72 -49.96 71.01 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.598 -1.314 . . . . 0.0 110.475 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.11 -40.66 37.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.978 -1.076 . . . . 0.0 110.062 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 82.4 mt -59.99 -38.66 83.22 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.111 -0.993 . . . . 0.0 109.296 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.562 HG23 ' O ' ' B' ' 374' ' ' VAL . 39.8 t -61.44 -39.96 84.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.28 -0.887 . . . . 0.0 108.647 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.72 -55.55 12.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.963 -1.086 . . . . 0.0 108.218 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.517 HD22 ' OE1' ' B' ' 325' ' ' GLU . 57.6 tp -58.21 -32.25 68.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.127 -0.983 . . . . 0.0 109.932 -178.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.8 tpp -71.78 -40.77 69.04 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.354 -1.338 . . . . 0.0 108.875 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.6 -5.84 59.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -0.775 . . . . 0.0 110.349 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -110.13 -3.86 16.13 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.223 -0.923 . . . . 0.0 111.237 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 12.4 mt -76.48 129.99 37.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.303 -1.498 . . . . 0.0 108.957 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.161 -179.868 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.34 -0.615 . . . . 2.91 109.34 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.0 mt -110.06 129.96 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.579 -0.701 . . . . 1.2 109.251 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.0 m -119.48 152.34 37.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.629 -0.669 . . . . 1.4 109.244 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.594 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -135.66 -165.22 10.61 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 108.441 -1.864 . . . . 1.05 108.441 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 6' ' ' LEU . 97.0 mt -89.49 -18.82 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.69 -1.476 . . . . 1.15 110.571 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' ILE . 37.1 tp 54.79 104.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.174 -0.954 . . . . 0.98 109.17 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.88 -27.02 13.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.258 -0.901 . . . . 0.88 109.238 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.8 t -133.69 118.39 14.52 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.575 -0.703 . . . . 1.69 109.17 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.27 148.58 18.96 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.964 1.776 . . . . 0.85 112.542 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.791 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.47 -156.77 27.09 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 108.897 -1.681 . . . . 0.92 108.897 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.2 mt -147.66 150.64 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.021 -1.281 . . . . 0.81 108.318 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.8 155.02 35.06 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.776 -1.203 . . . . 0.51 110.807 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.9 OUTLIER -139.01 129.5 25.79 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.551 -1.277 . . . . 0.62 107.551 178.785 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.08 -178.07 48.23 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.482 -1.818 . . . . 0.55 111.039 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -79.69 159.16 26.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.833 -0.804 . . . . 2.1 109.165 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.605 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -109.5 132.1 54.45 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.479 -0.763 . . . . 0.77 110.859 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.6 tp -102.99 139.39 38.62 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.102 -1.073 . . . . 0.91 108.102 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.9 tp -117.69 122.3 43.15 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.346 -0.846 . . . . 0.93 109.674 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' A' ' 160' ' ' ALA . 54.8 mt -87.98 104.28 16.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.538 -0.726 . . . . 0.93 109.834 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -101.07 132.74 46.37 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.783 -0.821 . . . . 2.75 108.783 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -124.82 136.19 53.6 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.757 -0.831 . . . . 3.0 108.757 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.21 142.98 34.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.093 -1.004 . . . . 2.77 109.641 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.49 140.02 58.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.875 . . . . 2.94 108.824 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.4 mt -81.6 130.53 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.211 -0.93 . . . . 0.95 109.627 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 t -96.43 128.47 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.217 -0.927 . . . . 1.28 110.181 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.8 mt -109.0 135.41 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.178 -0.675 . . . . 1.21 109.178 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -91.53 121.36 33.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.124 -0.985 . . . . 1.81 109.794 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.1 mmm-85 -90.02 -0.04 57.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.378 -0.826 . . . . 2.8 109.888 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.54 146.1 54.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.043 -1.035 . . . . 2.87 109.468 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -88.45 147.27 24.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.296 -0.878 . . . . 2.35 109.282 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.568 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.3 pt -94.15 164.02 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.012 -1.055 . . . . 0.97 109.413 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -94.07 168.29 11.04 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.144 -0.972 . . . . 1.17 108.886 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.05 -15.52 59.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.067 -1.021 . . . . 1.18 109.943 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -87.41 -27.96 22.43 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.85 -1.167 . . . . 2.56 107.85 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -81.74 -9.24 59.69 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.723 -0.843 . . . . 1.79 108.723 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.8 t -62.87 -53.88 40.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.124 -0.985 . . . . 1.0 108.572 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -61.94 -39.97 93.91 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.33 -0.856 . . . . 1.77 110.123 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -69.84 -40.12 76.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.132 -0.98 . . . . 2.7 110.563 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.568 ' HG3' HG21 ' A' ' 31' ' ' ILE . 69.3 mm-40 -67.62 -39.83 84.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.925 -1.109 . . . . 1.51 110.029 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.14 -46.69 94.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 120.756 -1.215 . . . . 0.93 108.624 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -60.15 -42.18 94.34 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.147 -0.971 . . . . 1.81 109.495 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.02 -45.32 93.19 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.901 -1.119 . . . . 2.78 108.38 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -60.43 -46.13 91.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.326 -0.858 . . . . 0.78 108.764 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.2 tp -60.1 -47.98 83.63 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.616 -0.883 . . . . 1.07 108.616 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 41.4 t -61.82 -42.29 98.84 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.413 -0.915 . . . . 1.12 108.761 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.13 -45.83 95.3 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.346 -1.902 . . . . 0.84 108.346 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.459 ' NH1' ' HG3' ' A' ' 47' ' ' ARG . 31.9 ttm-85 -62.32 -32.92 73.74 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.433 -1.04 . . . . 3.09 108.307 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -54.81 -40.01 69.07 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.888 -0.782 . . . . 0.88 108.888 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.8 ttmt -72.44 -73.14 0.21 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.927 -1.138 . . . . 2.59 107.927 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.48 -37.93 0.14 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.362 -0.836 . . . . 0.7 111.844 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 m -59.99 -52.52 65.02 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.433 -1.417 . . . . 1.4 108.517 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.34 -40.0 93.12 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.866 . . . . 0.67 110.809 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -66.63 -40.07 88.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.036 -1.04 . . . . 1.66 110.766 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.87 -39.99 94.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.829 -1.169 . . . . 1.58 108.976 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' OE2' HD13 ' A' ' 77' ' ' ILE . 79.1 mm-40 -65.17 -35.83 82.31 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.274 -0.892 . . . . 1.35 108.926 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -64.52 -43.3 94.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 0.77 109.902 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.16 -39.88 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.987 . . . . 0.63 108.819 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -53.18 -52.48 58.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 1.14 110.064 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -57.01 -33.74 67.47 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.26 -0.9 . . . . 0.79 110.309 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -69.32 -37.25 77.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.909 -1.119 . . . . 1.53 109.435 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.99 -45.9 76.23 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.548 -0.72 . . . . 0.57 110.074 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.03 -51.95 55.78 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.333 -1.107 . . . . 0.75 110.333 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.75 -41.11 79.39 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.986 -1.302 . . . . 1.59 110.185 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.6 m -70.11 -62.48 1.37 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.053 -1.029 . . . . 0.73 112.739 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -96.52 -45.88 6.57 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.787 -1.195 . . . . 0.75 111.573 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.08 -166.74 25.91 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 119.705 -1.236 . . . . 1.22 110.977 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -71.26 -24.01 62.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.914 -0.757 . . . . 5.81 110.663 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -62.7 -36.12 81.92 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.278 -0.889 . . . . 3.37 111.502 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -98.42 -18.43 18.26 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.034 -1.041 . . . . 1.77 109.548 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -67.23 -40.07 86.31 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.281 -0.887 . . . . 1.65 110.104 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB2' ' NH1' ' B' ' 317' ' ' ARG . . . -64.94 -28.37 69.48 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.287 -0.883 . . . . 0.77 109.974 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.84 -41.39 85.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 118.951 -1.1 . . . . 0.8 108.704 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -66.43 -42.51 87.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.88 110.493 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -63.11 -40.82 98.73 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.804 -1.185 . . . . 1.37 109.154 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.65 -40.71 98.34 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.344 -1.902 . . . . 0.62 108.344 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -70.05 -41.83 73.69 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.516 -0.991 . . . . 1.5 109.209 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.448 HD13 ' OE2' ' A' ' 55' ' ' GLU . 96.0 mt -69.71 -45.62 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.396 -0.815 . . . . 0.63 109.655 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.3 ttp -60.13 -46.52 89.35 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.916 -1.115 . . . . 1.51 109.802 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.831 HD11 ' CE2' ' B' ' 348' ' ' PHE . 32.7 tp -60.79 -40.54 93.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.314 -0.866 . . . . 0.77 109.328 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.436 ' HG ' HH12 ' A' ' 47' ' ' ARG . 63.9 tp -62.23 -40.01 94.73 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.538 -0.726 . . . . 0.62 109.931 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -82.12 8.81 9.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.173 -0.954 . . . . 1.47 110.152 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.7 t0 -54.58 132.98 46.23 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.186 -0.946 . . . . 1.47 110.258 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.415 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 39.9 mt-10 -60.38 -19.65 56.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.613 -0.679 . . . . 1.78 111.301 -178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.4 -35.06 73.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.665 -1.272 . . . . 2.53 108.799 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.01 -43.58 71.09 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.491 0.663 . . . . 0.8 110.385 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.11 -48.76 80.39 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.967 -1.083 . . . . 1.42 110.55 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -70.0 -40.26 75.38 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.369 -0.832 . . . . 1.71 111.083 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.0 -40.04 75.52 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.906 -1.121 . . . . 1.57 111.61 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.8 mt -67.47 -45.21 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.946 -1.097 . . . . 0.65 109.756 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.92 -39.82 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.604 -0.685 . . . . 0.82 110.053 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.44 -46.91 88.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 0.79 110.579 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 96' ' ' LYS . 85.3 mt -60.12 -47.51 85.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.857 -1.152 . . . . 0.95 109.693 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.0 mt -63.22 -48.97 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.943 0.878 . . . . 0.66 108.926 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -69.84 -40.21 75.98 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.494 -0.754 . . . . 2.2 110.588 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -85.51 -51.55 6.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.04 -1.037 . . . . 1.65 111.952 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 92' ' ' LEU . 65.4 mmtt -89.76 -1.7 58.06 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.013 -1.054 . . . . 2.03 111.603 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 55.73 32.32 19.2 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.869 -1.145 . . . . 1.42 109.962 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.2 mtt -83.8 166.94 17.56 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.361 -0.837 . . . . 1.18 109.721 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 19.3 p -78.17 155.15 30.58 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.529 -0.915 . . . . 0.98 108.529 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.35 93.0 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.134 -0.979 . . . . 0.64 109.445 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -62.86 -39.83 95.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.546 -0.721 . . . . 2.07 109.985 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.66 -45.95 20.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.103 -0.998 . . . . 0.73 110.181 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.01 -50.68 72.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.403 -0.811 . . . . 0.54 110.56 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.72 86.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.004 -1.06 . . . . 0.56 109.919 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.509 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 78.1 t60 -59.97 -41.03 91.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 1.54 110.082 -178.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -63.54 -39.98 95.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.288 -0.882 . . . . 1.33 111.419 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.8 t -62.9 -53.98 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.76 -1.213 . . . . 0.72 112.018 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.3 mm -69.99 -39.94 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.578 -1.326 . . . . 0.85 108.68 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.509 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 87.5 tt0 -60.89 -39.95 91.21 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.736 -0.838 . . . . 2.44 108.736 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.27 94.53 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 120.512 -0.851 . . . . 0.98 111.018 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -70.02 -60.03 2.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.659 -1.495 . . . . 1.41 110.203 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.05 -41.28 25.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.113 -0.992 . . . . 1.2 110.051 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 78.6 p -59.81 -39.87 86.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.058 -1.026 . . . . 1.7 108.719 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.53 -38.85 81.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.248 -0.908 . . . . 1.47 109.293 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.8 mt -65.97 -40.99 91.75 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.12 -0.988 . . . . 1.56 110.155 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -59.92 -34.83 73.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.719 -1.238 . . . . 2.2 109.625 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -57.47 -19.31 23.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.155 -0.965 . . . . 2.12 109.912 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.5 HD13 HD13 ' A' ' 123' ' ' LEU . 40.7 mt -62.65 149.76 42.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.859 -1.15 . . . . 2.0 109.203 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -89.98 10.59 23.44 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.312 -0.868 . . . . 3.23 110.254 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -101.42 128.98 47.37 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.198 -0.939 . . . . 2.49 110.331 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.01 -29.18 66.19 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.581 0.705 . . . . 3.95 109.437 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.462 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 6.7 t80 -70.22 -39.28 75.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.587 -0.695 . . . . 2.0 110.342 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.53 HD22 ' O ' ' B' ' 351' ' ' GLN . 90.5 mt -69.97 -35.39 74.42 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.02 -1.05 . . . . 1.86 108.416 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -59.99 -39.07 84.46 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.072 -0.714 . . . . 2.84 109.072 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -58.24 -43.56 87.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 2.73 109.198 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.599 ' NH2' ' O ' ' B' ' 314' ' ' LEU . 89.9 mtt180 -62.23 -39.93 94.47 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.176 -1.01 . . . . 2.77 109.22 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.82 80.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 1.19 109.621 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.07 -48.76 80.36 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.363 -0.835 . . . . 1.2 109.416 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -63.5 -40.07 96.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 1.55 109.628 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.42 -40.12 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.085 -1.009 . . . . 0.8 108.471 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.54 HH11 ' HG2' ' A' ' 131' ' ' ARG . 3.8 ttt-85 -60.32 -38.62 84.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.517 -0.739 . . . . 3.09 109.233 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -59.94 -40.08 87.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.425 -0.797 . . . . 1.46 110.363 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.08 -45.99 94.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.905 -1.122 . . . . 0.71 109.377 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.88 -41.06 93.66 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 120.291 -0.957 . . . . 0.57 110.942 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -60.07 -46.33 89.92 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.906 -1.349 . . . . 2.59 109.954 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.631 HH12 ' CB ' ' A' ' 166' ' ' SER . 98.2 mtt180 -68.88 -29.91 68.29 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.932 -1.105 . . . . 2.83 109.48 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.1 tp -60.05 -43.13 95.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.948 . . . . 1.25 109.071 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.9 mt -61.02 -39.82 91.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.281 -0.887 . . . . 0.7 109.89 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -67.39 -39.94 85.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 2.57 108.933 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -61.34 -36.18 79.44 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.623 -0.673 . . . . 1.23 111.217 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.2 mt -70.7 -43.24 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.444 -1.41 . . . . 0.81 109.05 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.1 mt -71.04 -30.15 66.26 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.435 -0.79 . . . . 1.0 109.489 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.18 43.47 6.27 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.862 -1.695 . . . . 0.89 108.862 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.7 tp -74.44 149.47 40.37 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.427 -1.043 . . . . 1.14 109.241 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -72.11 142.29 49.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 4.6 109.58 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 93.9 mt -113.06 128.94 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-O 122.203 1.002 . . . . 1.24 109.927 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.5 mt -64.21 -43.77 97.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 115.485 -0.779 . . . . 1.54 110.87 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.3 t0 65.21 102.66 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.395 -0.816 . . . . 1.5 108.969 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.5 mt -69.02 -1.02 6.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.265 -0.897 . . . . 0.79 110.625 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 74.0 m -87.92 -10.88 49.23 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.852 -1.155 . . . . 1.4 109.395 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.84 15.97 2.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.336 -0.852 . . . . 0.92 112.588 -177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.1 mp -90.32 119.98 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 120.213 -1.554 . . . . 0.88 109.215 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -100.45 -9.26 22.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.467 -0.771 . . . . 2.45 110.217 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -116.92 148.21 41.55 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.291 -0.881 . . . . 1.52 110.442 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -65.06 132.59 49.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.541 -0.724 . . . . 1.58 109.588 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.0 m -152.35 164.66 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.473 -0.767 . . . . 0.69 109.538 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.5 mt -91.84 149.53 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.023 -1.843 . . . . 0.61 106.023 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 52.3 tp -99.3 117.11 33.03 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.967 -1.083 . . . . 0.87 110.035 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.723 HG12 HG22 ' A' ' 209' ' ' THR . 19.4 t -123.48 129.98 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.481 -0.933 . . . . 0.71 108.481 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.488 ' C ' HG21 ' A' ' 209' ' ' THR . . . -159.29 164.74 34.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.058 -1.026 . . . . 0.81 108.924 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.17 -38.07 69.22 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.379 -1.451 . . . . 0.98 108.378 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -171.07 142.83 1.87 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.825 -0.806 . . . . 2.25 108.825 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 19.9 mt -117.4 137.49 52.45 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.324 -0.86 . . . . 0.78 109.504 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.4 p -83.08 147.23 53.51 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.94 . . . . 0.98 108.722 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -43.52 -31.83 3.34 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.567 1.511 . . . . 0.81 111.814 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.631 ' CB ' HH12 ' A' ' 136' ' ' ARG . 38.5 m -59.96 -40.16 88.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.907 . . . . 0.9 108.975 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.58 -43.21 85.55 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.441 -0.787 . . . . 1.61 109.658 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 54.2 p -52.68 -29.08 24.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.13 -0.981 . . . . 0.61 110.092 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.29 -57.74 3.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 0.6 110.063 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -81.83 36.03 0.44 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.066 -0.716 . . . . 1.4 109.066 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 171' ' ' LEU . 14.2 tp -97.96 138.21 35.62 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.494 -0.754 . . . . 0.7 109.006 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -86.27 102.92 14.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.08 -1.013 . . . . 2.35 109.196 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 66.2 mt -62.21 -45.64 92.47 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.265 -0.897 . . . . 1.51 110.209 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -66.42 -28.93 69.0 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.058 -1.027 . . . . 2.33 112.715 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -93.17 -13.03 28.92 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.46 -1.4 . . . . 1.92 109.95 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.542 HG11 ' CE1' ' A' ' 179' ' ' PHE . 87.2 t -101.41 109.27 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.179 -0.95 . . . . 0.67 108.727 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.2 mt -82.76 6.53 17.82 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.897 . . . . 1.53 110.274 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.457 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 169.09 175.85 38.71 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.312 -1.515 . . . . 0.48 109.312 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.542 ' CE1' HG11 ' A' ' 176' ' ' VAL . 10.8 m-85 -135.76 130.16 33.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.394 -1.062 . . . . 0.55 109.299 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.423 ' CG2' HG21 ' A' ' 205' ' ' THR . 94.5 mt -131.13 126.97 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.736 -0.839 . . . . 0.65 108.736 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.1 p -145.7 157.29 43.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.033 -1.042 . . . . 0.82 110.7 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.658 ' OD1' HG23 ' A' ' 209' ' ' THR . 7.2 m-20 -105.52 27.04 8.76 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.462 -0.94 . . . . 2.46 108.462 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.57 -157.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.201 -0.937 . . . . 1.28 112.225 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.84 -71.2 0.85 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 111.258 -0.737 . . . . 2.19 111.258 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 167.11 -133.66 2.99 Favored Glycine 0 N--CA 1.491 2.342 0 O-C-N 120.705 -1.468 . . . . 2.13 110.563 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 188' ' ' SER . 28.0 mtm-85 -60.08 -40.04 88.19 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.427 -1.043 . . . . 5.86 111.01 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.4 p -65.78 8.88 0.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.066 -1.021 . . . . 3.72 110.471 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 186' ' ' ARG . 29.1 t -90.79 129.59 36.85 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.015 -1.053 . . . . 1.74 110.255 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -42.79 -52.0 5.19 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.783 0.801 . . . . 0.95 109.38 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 190' ' ' THR . 9.5 p -55.38 -36.69 66.66 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.768 -0.582 . . . . 1.55 111.175 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.7 t -59.94 -40.03 87.57 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.846 -1.159 . . . . 1.51 110.903 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.6 mt -65.7 -40.02 86.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.123 -0.985 . . . . 1.67 110.109 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.7 mtp -60.05 -45.31 93.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.846 . . . . 1.02 111.06 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.3 -43.8 92.58 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.927 -1.108 . . . . 0.68 109.59 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' ' 195' ' ' ARG . 51.4 mtt-85 -59.96 -51.61 68.92 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.901 -1.12 . . . . 2.93 109.361 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.5 m -70.11 -35.03 73.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.86 110.76 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.0 mt -76.12 -21.44 56.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 0.67 109.66 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 62.15 50.04 4.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.605 -0.684 . . . . 1.5 109.86 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.48 130.59 23.85 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 108.821 -0.807 . . . . 0.72 108.821 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -43.88 130.31 7.78 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.905 1.737 . . . . 0.61 112.343 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -168.84 145.67 3.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.736 -1.227 . . . . 0.66 111.661 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 91.2 mt -124.88 148.87 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 107.168 -1.419 . . . . 0.79 107.168 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 6.9 m -129.98 -9.83 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 O-C-N 120.819 -1.176 . . . . 0.91 110.894 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.68 22.38 26.26 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 110.228 -1.149 . . . . 1.01 110.228 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.44 ' OG1' ' OD2' ' A' ' 182' ' ' ASP . 3.3 p -47.14 -40.0 14.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.894 -1.356 . . . . 0.99 109.836 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.52 ' N ' ' OD2' ' A' ' 182' ' ' ASP . . . 89.11 -52.07 3.81 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 120.914 -1.116 . . . . 1.12 111.342 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.48 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 15.1 m -156.17 37.97 0.34 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.523 -1.575 . . . . 1.72 111.819 -178.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 12.8 t -77.05 -34.88 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.754 -1.216 . . . . 0.89 108.045 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.723 HG22 HG12 ' A' ' 159' ' ' VAL . 53.8 p -59.72 -34.26 72.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.571 -0.706 . . . . 1.03 110.284 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.4 t -77.16 -16.97 58.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.046 -1.034 . . . . 1.83 109.962 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -99.27 -11.86 20.89 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.245 -0.909 . . . . 2.27 110.319 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.5 t -102.33 135.3 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.24 -0.913 . . . . 0.92 111.08 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.45 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 43.5 mmtm -110.38 150.48 28.73 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.518 -1.66 . . . . 2.2 106.518 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.489 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 13.1 p-10 -59.91 141.04 56.22 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.789 -1.194 . . . . 2.36 110.85 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.3 t0 85.24 1.04 0.74 Allowed 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.071 0.463 . . . . 2.38 110.012 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.45 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 98.1 m-20 -73.99 147.0 43.37 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.146 -0.971 . . . . 2.09 109.252 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -97.34 119.88 36.67 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.614 -1.254 . . . . 1.27 107.614 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 16' ' ' ALA . 66.4 mt -126.98 148.99 50.07 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.475 -0.766 . . . . 0.75 110.489 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.0 mt -116.18 129.91 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 107.675 -1.231 . . . . 0.63 107.675 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 35.2 tp -102.28 119.33 38.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.883 -1.136 . . . . 0.7 108.075 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.613 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 6.6 p30 -78.47 -40.13 36.41 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.886 -1.134 . . . . 2.31 108.751 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.791 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.35 13.64 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.439 -0.948 . . . . 0.78 108.439 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.472 ' N ' ' C ' ' A' ' 221' ' ' ASP . 24.9 t -127.65 -40.64 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.457 -1.312 . . . . 1.04 107.457 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -102.5 0.39 33.56 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.976 -1.12 . . . . 2.44 107.976 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.594 HD21 ' H ' ' A' ' 4' ' ' GLY . 48.8 t-20 59.78 44.96 13.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.834 -0.542 . . . . 1.55 110.297 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.613 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 80.5 mt-30 -140.22 158.38 44.13 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.174 -0.954 . . . . 1.99 109.709 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 81.3 t -120.14 130.05 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.032 -0.729 . . . . 0.77 109.032 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -101.61 120.98 41.16 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.383 -0.823 . . . . 0.98 108.918 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.445 HG22 HD22 ' A' ' 218' ' ' LEU . 49.0 t -103.36 119.23 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.548 -0.72 . . . . 0.85 109.759 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 63.79 66.9 1.03 Allowed Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.186 -0.946 . . . . 1.66 109.931 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -91.34 128.34 1.17 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 123.255 2.636 . . . . 0.95 112.661 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 30.4 p -69.01 169.37 11.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 1.84 109.422 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -60.07 -39.4 85.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 2.74 108.942 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.02 -38.22 82.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.344 -0.848 . . . . 2.89 110.083 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.61 -40.22 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.841 -1.162 . . . . 1.3 108.836 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 94.3 mt . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.047 -1.033 . . . . 1.09 109.374 179.909 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 33.1 ttp . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.513 0.673 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -150.96 148.53 28.5 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -150.02 159.36 44.46 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.087 -1.008 . . . . 0.0 110.397 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -157.56 154.02 27.85 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 -111.69 131.57 55.2 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.115 -0.99 . . . . 0.0 110.203 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.27 121.77 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-O 122.348 1.071 . . . . 0.0 112.307 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 307' ' ' THR . . . . . 0.533 ' O ' HG23 ' B' ' 309' ' ' THR . 56.7 m -80.4 101.2 8.87 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.804 0.811 . . . . 0.0 110.799 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' B' ' 358' ' ' GLY . 97.5 mt -50.71 116.73 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.258 1.028 . . . . 0.0 109.673 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 309' ' ' THR . . . . . 0.533 HG23 ' O ' ' B' ' 307' ' ' THR . 25.1 p -106.59 14.1 27.44 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.946 -177.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.42 116.67 42.37 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.994 -1.066 . . . . 0.0 108.445 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -51.85 -17.08 4.79 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 CA-C-N 120.216 1.113 . . . . 0.0 113.725 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -111.0 11.3 22.14 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.257 -0.902 . . . . 0.0 109.991 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 69.47 169.78 6.93 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.599 ' O ' ' NH2' ' A' ' 126' ' ' ARG . 3.1 tp -84.6 93.27 8.34 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.087 -1.243 . . . . 0.0 109.333 -178.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.58 ' C ' HH21 ' A' ' 126' ' ' ARG . 3.8 p80 -96.48 -161.48 0.87 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 120.885 -1.134 . . . . 0.0 109.902 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 4.0 m -58.06 -41.58 83.63 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.884 -1.135 . . . . 0.0 112.726 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.603 ' NH1' ' HB2' ' A' ' 71' ' ' ALA . 14.7 tpt180 -57.31 -59.44 12.8 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 120.308 -1.495 . . . . 0.0 111.068 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.92 -42.9 17.56 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 CA-C-N 120.485 1.209 . . . . 0.0 111.606 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.89 -17.28 35.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.178 -0.951 . . . . 0.0 110.392 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -82.16 -38.55 24.53 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -72.16 -34.81 68.76 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -64.65 -58.28 6.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.39 -0.819 . . . . 0.0 109.796 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.68 -32.91 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.82 -1.175 . . . . 0.0 109.085 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -59.93 -46.65 88.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.422 -0.799 . . . . 0.0 109.112 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.29 -44.06 84.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 110.422 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 326' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' B' ' 328' ' ' GLY . . . -60.03 -53.41 58.19 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.855 -1.153 . . . . 0.0 111.248 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -51.72 -10.45 0.11 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.883 -1.135 . . . . 0.0 110.136 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 328' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' B' ' 326' ' ' ALA . . . -75.9 -24.75 68.64 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -105.23 139.14 40.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.41 -1.053 . . . . 0.0 109.248 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 8.8 p -90.61 -9.8 45.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.275 -0.89 . . . . 0.0 110.115 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.479 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 14.0 t -64.47 155.21 33.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.101 -1.0 . . . . 0.0 109.963 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.6 131.73 45.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.907 . . . . 0.0 108.792 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 82.9 mt -132.44 132.95 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.392 -0.818 . . . . 0.0 109.938 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.4 m -131.56 149.94 52.33 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.484 -0.76 . . . . 0.0 109.128 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 66.6 t -122.43 117.41 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 94.7 m -107.5 133.43 52.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.228 -0.92 . . . . 0.0 109.697 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 4.8 p -139.85 115.94 10.41 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.766 0.793 . . . . 0.0 110.631 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 45.22 50.02 9.77 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.641 -0.662 . . . . 0.0 112.744 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.32 -16.41 48.92 Favored Glycine 0 N--CA 1.5 2.957 0 O-C-N 120.058 -1.651 . . . . 0.0 112.242 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -110.69 121.32 45.03 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 118.87 1.335 . . . . 0.0 109.69 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 86.4 p -126.76 148.33 49.91 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.815 0.816 . . . . 0.0 110.151 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 342' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -145.23 170.57 16.02 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.563 0.697 . . . . 0.0 110.093 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 17.3 m -89.04 134.73 33.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.519 -0.738 . . . . 0.0 110.518 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.451 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -75.91 -16.38 60.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.053 -1.03 . . . . 0.0 109.504 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -84.7 20.87 1.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 346' ' ' SER . . . . . 0.451 ' H ' ' C ' ' B' ' 344' ' ' ALA . 93.8 p -151.61 96.91 2.31 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.43 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.676 HD23 HD22 ' A' ' 79' ' ' LEU . 51.7 tp -60.05 -33.76 72.48 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.831 ' CE2' HD11 ' A' ' 79' ' ' LEU . 60.0 m-85 -56.27 -52.95 62.6 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.931 -1.106 . . . . 0.0 110.034 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -69.82 -28.67 65.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 110.421 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.576 HD12 ' HA ' ' B' ' 347' ' ' LEU . 80.8 mt -59.96 -50.01 75.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.101 -0.999 . . . . 0.0 109.728 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.53 ' O ' HD22 ' A' ' 123' ' ' LEU . 1.2 mp0 -45.07 -20.22 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.017 -1.052 . . . . 0.0 111.189 -178.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.415 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.3 p -80.3 -10.61 59.76 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.19 -1.568 . . . . 0.0 109.444 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.415 HD11 ' HB3' ' B' ' 342' ' ' ALA . 45.9 mt -95.79 115.29 27.21 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.176 -0.953 . . . . 0.0 108.77 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.84 95.21 1.24 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 22.8 mt -103.9 94.25 5.31 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.416 -1.05 . . . . 0.0 109.286 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 79.0 p -100.72 153.57 19.33 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.233 -0.917 . . . . 0.0 111.234 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 14.9 tm0? -41.95 111.9 0.28 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.202 0.525 . . . . 0.0 110.664 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 358' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 103.14 6.09 45.78 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 91.7 m -83.69 111.24 18.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.157 . . . . 0.0 111.22 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 8.6 t -78.47 111.99 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 122.15 0.976 . . . . 0.0 109.801 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 12.3 m -110.08 177.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 40.4 m -130.26 126.9 38.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 64.0 mt -103.82 117.44 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 53.6 m -121.13 132.33 54.79 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.79 148.31 38.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.279 -0.888 . . . . 0.0 109.572 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -142.38 121.85 13.24 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.532 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.91 -158.39 29.07 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 119.192 -1.48 . . . . 0.0 111.159 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -59.9 -51.08 71.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 122.293 -0.534 . . . . 0.0 112.219 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.479 ' H ' ' HB2' ' B' ' 331' ' ' SER . 85.1 m-20 -108.27 10.78 27.68 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 120.86 -1.15 . . . . 0.0 111.249 -177.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.4 pt-20 -39.9 -34.12 0.25 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.338 -0.852 . . . . 0.0 112.232 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -68.3 -42.64 79.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.535 -1.353 . . . . 0.0 110.432 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -71.1 -52.56 18.66 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.991 -1.068 . . . . 0.0 109.653 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.69 -36.78 2.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.333 -0.854 . . . . 0.0 111.519 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.513 ' O ' HG23 ' B' ' 378' ' ' VAL . 58.9 t -81.14 -36.02 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.521 -1.362 . . . . 0.0 109.502 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -69.98 -40.01 75.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.375 -0.828 . . . . 0.0 111.921 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -77.59 -46.78 21.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.612 -1.305 . . . . 0.0 110.151 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.35 -36.38 80.02 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.294 -0.879 . . . . 0.0 109.116 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.513 HG23 ' O ' ' B' ' 374' ' ' VAL . 53.8 t -73.68 -37.45 49.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -74.83 -17.01 60.67 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' B' ' 383' ' ' GLU . 41.9 tp -78.87 -68.07 0.69 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 57.3 mtt -54.3 -19.5 5.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.01 -1.056 . . . . 0.0 109.136 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.2 -23.72 51.44 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' B' ' 380' ' ' LEU . 97.5 mt-10 -108.62 4.37 23.88 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.626 -0.671 . . . . 0.0 110.962 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 69.0 mt -82.67 122.31 27.98 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.578 -1.326 . . . . 0.0 110.129 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.041 -0.98 . . . . 0.0 108.933 179.231 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.188 0.518 . . . . 2.91 109.691 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 87.7 mt -110.03 127.94 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.73 -0.841 . . . . 1.2 108.73 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.2 m -140.04 150.73 44.75 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.296 -0.877 . . . . 1.4 109.258 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.86 -163.89 9.7 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 108.465 -1.854 . . . . 1.05 108.465 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 6' ' ' LEU . 89.9 mt -90.37 -17.37 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.747 -1.443 . . . . 1.15 109.575 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.4 tp 55.1 106.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.496 -0.752 . . . . 0.98 109.184 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.26 -29.12 12.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.333 -0.855 . . . . 0.88 109.065 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 14.8 m -127.62 116.62 21.09 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 109.356 -0.609 . . . . 1.69 109.356 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.85 148.05 19.61 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 121.991 1.794 . . . . 0.85 112.453 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.91 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 143.36 178.78 19.47 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 108.853 -1.699 . . . . 0.92 108.853 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.412 HG22 ' N ' ' A' ' 12' ' ' ALA . 96.7 mt -122.13 156.36 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.231 -1.158 . . . . 0.81 109.436 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.412 ' N ' HG22 ' A' ' 11' ' ' ILE . . . -155.55 156.56 35.36 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.965 -1.084 . . . . 0.51 110.625 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.4 m-85 -137.69 128.99 27.85 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.03 -1.1 . . . . 0.62 108.03 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.43 178.38 47.77 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 118.505 -1.807 . . . . 0.55 110.842 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -78.86 156.7 28.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.786 -0.832 . . . . 2.1 109.14 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.593 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -107.62 133.03 52.65 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.392 -0.817 . . . . 0.77 110.923 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.3 tp -107.45 137.85 44.73 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 107.997 -1.112 . . . . 0.91 107.997 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 66.2 tp -115.76 122.66 46.12 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.526 -0.734 . . . . 0.93 109.561 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.9 mt -82.26 103.21 11.68 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.414 -0.804 . . . . 0.93 109.416 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -94.25 136.56 34.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.296 -0.878 . . . . 2.75 109.496 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 58.2 mp0 -131.02 134.84 47.05 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.361 -0.837 . . . . 3.0 109.086 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.17 150.76 28.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.133 -0.98 . . . . 2.77 109.133 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -65.96 149.22 50.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.943 -1.098 . . . . 2.94 109.245 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.527 ' CG1' HH12 ' A' ' 139' ' ' ARG . 88.2 mt -89.78 124.83 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 0.95 109.22 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.63 122.87 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.236 -0.915 . . . . 1.28 109.477 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.9 mt -108.09 133.22 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.802 -0.814 . . . . 1.21 108.802 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -86.97 118.27 26.24 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.792 -1.192 . . . . 1.81 109.58 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -87.51 -1.0 57.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 2.8 109.613 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.81 136.86 49.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.112 -0.993 . . . . 2.87 109.184 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -80.99 159.51 24.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.952 -1.092 . . . . 2.35 109.488 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.416 HD13 ' HG3' ' A' ' 39' ' ' GLU . 2.9 pt -102.57 167.67 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.303 -0.873 . . . . 0.97 109.883 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.3 p -94.1 175.27 6.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.229 -0.92 . . . . 1.17 109.093 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.74 -50.97 71.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.089 -1.007 . . . . 1.18 110.746 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 55.8 t0 -54.71 -29.41 53.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.561 -1.337 . . . . 2.56 109.681 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -82.02 -10.04 59.36 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.316 -0.865 . . . . 1.79 110.386 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.0 t -60.22 -50.3 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.824 -1.172 . . . . 1.0 109.068 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.67 -39.9 93.04 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.404 -0.81 . . . . 1.77 109.54 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -62.68 -43.79 97.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.903 . . . . 2.7 110.981 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.416 ' HG3' HD13 ' A' ' 31' ' ' ILE . 75.5 mm-40 -61.89 -40.19 94.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.84 -1.162 . . . . 1.51 110.171 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 66.4 t -59.87 -46.23 94.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 C-N-CA 118.722 -1.191 . . . . 0.93 108.86 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -59.93 -42.58 94.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.881 -1.137 . . . . 1.81 109.434 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.26 -41.52 93.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.807 -1.183 . . . . 2.78 108.222 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -64.01 -46.9 82.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.355 -0.841 . . . . 0.78 109.143 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.1 tp -59.96 -48.81 80.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.28 -0.887 . . . . 1.07 108.672 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.0 t -63.26 -41.95 99.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.075 -1.015 . . . . 1.12 109.543 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.62 -46.21 92.73 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.154 -1.578 . . . . 0.84 109.154 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -63.3 -33.56 75.78 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.261 -1.141 . . . . 3.09 108.739 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.25 -42.85 87.33 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.369 -0.832 . . . . 0.88 109.283 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 50' ' ' ALA . 1.2 ttmp? -63.68 -73.62 0.11 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.792 -1.193 . . . . 2.59 107.915 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.19 -41.14 0.37 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.415 -0.803 . . . . 0.7 111.411 -178.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.2 p -54.22 -54.77 35.42 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.42 -1.425 . . . . 1.4 108.699 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.99 -39.97 83.17 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.462 -0.774 . . . . 0.67 111.301 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -68.37 -39.95 81.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.77 -1.206 . . . . 1.66 110.668 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.13 -39.97 96.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.979 -1.076 . . . . 1.58 108.736 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -63.91 -34.14 77.29 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.454 -0.779 . . . . 1.35 109.087 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.6 m -65.89 -44.13 86.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 0.77 108.883 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.9 mt -60.14 -37.75 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.675 -0.861 . . . . 0.63 108.675 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -59.8 -51.06 71.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.473 -0.767 . . . . 1.14 110.204 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 m -55.78 -33.28 64.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.051 -1.03 . . . . 0.79 110.042 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -69.92 -37.96 76.11 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.422 -0.798 . . . . 1.53 109.555 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.413 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -68.78 -47.67 65.6 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.204 0.526 . . . . 0.57 111.227 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.68 -50.97 61.81 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 110.004 -1.239 . . . . 0.75 110.004 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.96 -42.11 73.63 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.005 -1.291 . . . . 1.59 110.562 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.5 m -69.28 -60.69 2.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.088 -1.007 . . . . 0.73 112.111 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -96.52 -50.93 4.54 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.935 -1.103 . . . . 0.75 111.422 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.15 -163.86 26.98 Favored Glycine 0 N--CA 1.501 2.974 0 O-C-N 120.731 -1.231 . . . . 1.22 111.048 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.02 -25.15 63.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.772 -0.84 . . . . 5.81 110.65 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -60.33 -36.76 78.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.902 . . . . 3.37 110.197 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.479 ' NZ ' ' CE1' ' A' ' 189' ' ' HIS . 69.3 mmtt -97.78 -19.85 17.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.251 -0.905 . . . . 1.77 110.352 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.1 -46.13 68.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.909 -1.119 . . . . 1.65 110.224 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.617 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -62.7 -32.91 74.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.643 -0.661 . . . . 0.77 110.116 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.09 -40.83 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.867 -1.146 . . . . 0.8 109.045 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -65.11 -39.83 93.67 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.14 -0.975 . . . . 0.88 109.776 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -60.09 -39.98 88.02 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.085 -1.009 . . . . 1.37 109.528 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.14 -49.3 72.55 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.623 -1.791 . . . . 0.62 108.623 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -60.91 -43.61 98.32 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.344 -1.091 . . . . 1.5 108.837 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.1 mt -68.94 -47.71 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.254 -0.903 . . . . 0.63 109.09 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.8 ttp -60.25 -42.94 96.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.899 -1.126 . . . . 1.51 109.792 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.841 HD11 ' CE2' ' B' ' 348' ' ' PHE . 63.4 tp -64.81 -40.0 94.5 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.376 -0.828 . . . . 0.77 109.772 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.7 tp -64.52 -40.05 94.9 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.292 -0.88 . . . . 0.62 110.189 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -81.55 4.86 19.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.974 -1.078 . . . . 1.47 109.844 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 51.7 t0 -50.26 132.02 24.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 1.47 110.07 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 97.7 mt-10 -62.02 -18.96 62.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.637 -0.664 . . . . 1.78 110.754 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -72.42 -36.05 68.5 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.853 -1.154 . . . . 2.53 108.935 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.17 -40.38 78.18 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.974 -0.75 . . . . 0.8 108.974 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.04 -49.87 75.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.566 -0.709 . . . . 1.42 110.023 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.13 -41.42 73.96 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.329 -0.857 . . . . 1.71 111.284 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.64 -40.35 73.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.947 -1.096 . . . . 1.57 111.512 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.8 -49.34 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.88 -1.137 . . . . 0.65 109.591 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.4 mt -65.29 -37.64 80.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.634 -0.666 . . . . 0.82 110.275 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.29 98.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 0.79 110.365 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 96' ' ' LYS . 81.5 mt -61.67 -46.38 89.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.885 -1.134 . . . . 0.95 109.085 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.2 mt -61.06 -50.2 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.963 0.887 . . . . 0.66 109.261 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.02 -40.95 74.9 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 120.008 -0.677 . . . . 2.2 110.451 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -82.34 -49.5 9.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.308 -0.87 . . . . 1.65 111.805 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 92' ' ' LEU . 65.7 mmtt -92.24 -2.05 56.73 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.033 -1.042 . . . . 2.03 111.788 -177.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 38.4 m170 55.51 32.77 19.7 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.844 -1.16 . . . . 1.42 109.082 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 93.5 mtp -90.18 166.72 13.21 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.707 -0.621 . . . . 1.18 109.826 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.2 p -78.39 158.62 28.69 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.451 -0.944 . . . . 0.98 108.451 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.99 -35.73 74.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.985 -1.072 . . . . 0.64 109.901 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -67.14 -40.01 86.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 2.07 109.437 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.41 -41.88 21.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.395 -0.816 . . . . 0.73 109.698 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.68 -50.5 66.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.418 -0.802 . . . . 0.54 110.417 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.07 88.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.164 -0.96 . . . . 0.56 109.836 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -58.34 -39.93 80.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 1.54 109.761 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.79 -40.13 96.39 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.217 -0.927 . . . . 1.33 110.034 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.3 t -66.51 -52.53 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.213 -0.929 . . . . 0.72 111.56 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.9 mm -69.34 -39.91 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.824 -1.173 . . . . 0.85 108.772 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.41 -34.85 76.75 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.615 -0.883 . . . . 2.44 108.615 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.32 -47.49 90.58 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 120.645 -0.788 . . . . 0.98 111.135 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -66.17 -48.12 71.78 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.614 -1.521 . . . . 1.41 109.602 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.74 78.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.895 . . . . 1.2 109.505 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 84.1 p -57.69 -40.2 78.91 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.091 -1.005 . . . . 1.7 108.748 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.8 89.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 1.47 109.614 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.4 mt -63.53 -43.35 97.39 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.798 -1.189 . . . . 1.56 110.274 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.18 -30.47 69.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.681 -1.262 . . . . 2.2 109.739 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.95 -23.72 63.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.991 -1.068 . . . . 2.12 108.598 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.48 HD13 HD13 ' A' ' 123' ' ' LEU . 26.0 mt -62.4 147.73 47.59 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.291 -0.881 . . . . 2.0 109.128 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -94.95 49.16 1.21 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.085 -1.009 . . . . 3.23 109.734 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -136.25 130.27 32.8 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.198 -0.939 . . . . 2.49 109.888 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.06 -30.32 67.55 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.445 -0.784 . . . . 3.95 110.248 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.512 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.1 t80 -72.11 -38.24 69.34 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.287 -0.883 . . . . 2.0 110.716 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.576 HD22 ' O ' ' B' ' 351' ' ' GLN . 89.4 mt -70.0 -32.28 70.39 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.045 -1.034 . . . . 1.86 108.249 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -60.24 -39.21 85.9 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.601 -0.888 . . . . 2.84 108.601 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -59.75 -48.35 82.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.331 -0.856 . . . . 2.73 110.108 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.6 HH21 ' C ' ' B' ' 315' ' ' HIS . 84.5 mtt180 -60.12 -39.68 87.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.679 -1.263 . . . . 2.77 108.495 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.51 -32.32 68.72 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.294 -0.879 . . . . 1.19 108.65 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.8 -40.22 88.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 1.2 109.588 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -65.55 -40.12 92.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 1.55 109.515 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.49 -41.85 86.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.45 -0.781 . . . . 0.8 109.292 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -62.03 -36.31 81.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 3.09 109.5 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -60.0 -40.01 87.76 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.263 -0.898 . . . . 1.46 110.077 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.26 -44.16 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.151 -0.968 . . . . 0.71 109.791 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.37 -39.72 98.13 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.474 -1.051 . . . . 0.57 110.474 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -58.94 -45.78 89.61 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.893 -1.357 . . . . 2.59 109.624 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.502 HH11 ' HG2' ' A' ' 136' ' ' ARG . 24.3 mtt-85 -63.22 -36.33 83.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.874 -1.141 . . . . 2.83 110.339 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.6 tp -56.19 -44.59 79.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.309 -0.869 . . . . 1.25 109.974 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.96 -40.07 91.96 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.032 -1.043 . . . . 0.7 108.791 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.634 HH11 ' HG2' ' A' ' 139' ' ' ARG . 11.5 mtt-85 -67.73 -39.94 84.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.348 -0.845 . . . . 2.57 109.339 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -68.06 -38.03 81.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.632 -0.667 . . . . 1.23 111.668 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.3 mt -73.73 -45.55 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.227 -1.546 . . . . 0.81 108.571 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.7 mt -70.0 -33.7 72.37 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.614 -0.679 . . . . 1.0 109.493 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.78 40.2 7.27 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.193 -1.563 . . . . 0.89 109.193 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.2 tp -74.94 150.39 39.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.521 -0.987 . . . . 1.14 110.17 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -68.4 141.29 55.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.322 -0.861 . . . . 4.6 110.174 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.9 mt -116.48 129.95 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 121.785 0.802 . . . . 1.24 109.474 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 15.0 mm -56.79 -50.17 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.794 -0.566 . . . . 1.54 111.137 -177.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.0 t0 67.09 104.31 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.266 -0.896 . . . . 1.5 109.5 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.4 mt -81.06 -7.58 59.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.275 -0.89 . . . . 0.79 110.799 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.7 p -80.13 -17.32 52.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.65 -1.281 . . . . 1.4 109.355 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.8 17.62 3.31 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.509 -0.745 . . . . 0.92 111.825 -177.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 50.1 mt -91.04 114.57 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.727 -1.233 . . . . 0.88 109.145 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -101.34 -11.01 19.76 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.385 -0.822 . . . . 2.45 110.604 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -110.53 146.6 35.75 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.16 -0.962 . . . . 1.52 109.442 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.94 130.58 43.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.148 -0.97 . . . . 1.58 109.407 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.1 m -152.27 163.71 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.939 -0.763 . . . . 0.69 108.939 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.1 mt -93.14 149.75 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 106.028 -1.842 . . . . 0.61 106.028 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.426 HD22 HD11 ' A' ' 171' ' ' LEU . 52.5 tp -100.44 117.81 35.37 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.996 -1.065 . . . . 0.87 110.908 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.1 t -121.94 129.92 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 N-CA-C 108.694 -0.854 . . . . 0.71 108.694 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.22 164.49 35.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.976 -1.077 . . . . 0.81 109.153 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.433 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.86 -35.69 74.9 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.362 -1.461 . . . . 0.98 108.775 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 52.3 t0 -170.6 143.81 2.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.441 -0.948 . . . . 2.25 108.441 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.545 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 26.1 mt -112.71 129.72 56.31 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.52 -0.919 . . . . 0.78 108.52 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.3 p -83.63 145.42 47.57 Favored Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.239 -0.913 . . . . 0.98 109.004 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -38.01 -36.28 0.46 Allowed 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.031 1.821 . . . . 0.81 111.581 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.4 m -59.87 -40.0 87.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.407 -0.808 . . . . 0.9 109.656 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.5 -40.19 77.14 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.13 -0.982 . . . . 1.61 109.713 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 68.5 p -56.1 -28.14 56.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.067 -1.021 . . . . 0.61 110.739 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -74.58 -56.35 4.92 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.821 -1.174 . . . . 0.6 109.711 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -78.88 39.58 0.37 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.532 -1.285 . . . . 1.4 107.532 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.466 ' H ' ' C ' ' A' ' 169' ' ' ALA . 15.3 tp -99.93 131.86 45.63 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.695 -0.628 . . . . 0.7 109.522 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -88.05 100.27 12.8 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.144 -1.058 . . . . 2.35 108.144 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 65.9 mt -64.66 -42.98 95.03 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.323 -0.861 . . . . 1.51 110.791 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -69.89 -24.24 63.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.66 -1.275 . . . . 2.33 111.569 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -94.39 -13.51 26.23 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.6 -1.312 . . . . 1.92 109.767 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 178' ' ' GLY . 69.6 t -104.85 116.17 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.238 -0.914 . . . . 0.67 108.541 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.7 mt -83.25 2.19 37.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.936 . . . . 1.53 111.007 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.493 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 171.86 172.33 37.73 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.231 -1.461 . . . . 0.48 109.735 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.429 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 14.2 m-85 -130.63 126.67 37.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.516 -0.991 . . . . 0.55 108.846 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.02 126.25 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.2 -0.938 . . . . 0.65 108.623 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.407 ' C ' ' HG1' ' A' ' 205' ' ' THR . 80.6 p -147.94 158.43 44.04 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.903 -1.123 . . . . 0.82 110.771 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 44.1 p30 -103.92 24.67 10.96 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.956 -0.757 . . . . 2.46 108.956 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -57.78 -159.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.993 -1.067 . . . . 1.28 110.794 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.87 -54.38 9.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.155 -1.178 . . . . 2.19 110.155 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 156.69 -129.94 2.55 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 120.937 -1.331 . . . . 2.13 110.502 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.462 ' C ' ' H ' ' A' ' 188' ' ' SER . 30.2 ttt-85 -63.2 -39.87 95.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.486 -1.008 . . . . 5.86 110.49 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 37.4 p -62.0 1.88 0.26 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.161 -0.962 . . . . 3.72 110.231 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 186' ' ' ARG . 47.5 t -91.52 130.0 37.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.03 -1.044 . . . . 1.74 109.716 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' HIS . . . . . 0.479 ' CE1' ' NZ ' ' A' ' 69' ' ' LYS . 84.8 t60 -48.28 -44.15 33.38 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.897 0.856 . . . . 0.95 108.967 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.409 ' H ' HG23 ' A' ' 190' ' ' THR . 4.1 p -51.95 -36.33 49.0 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 116.116 -0.493 . . . . 1.55 110.869 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 49.6 m -65.96 -40.83 91.62 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.947 -1.096 . . . . 1.51 111.843 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.2 mm -63.88 -43.2 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.976 -1.077 . . . . 1.67 110.668 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.2 mtp -66.02 -39.95 90.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.249 -0.907 . . . . 1.02 111.036 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.14 -43.34 82.37 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.468 -1.395 . . . . 0.68 109.083 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -59.93 -48.85 80.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.125 -0.984 . . . . 2.93 110.086 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.2 m -68.09 -35.11 77.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.043 -1.036 . . . . 0.86 110.084 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 30.2 mt -71.56 -26.22 62.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.182 -0.949 . . . . 0.67 108.543 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 62.01 51.54 3.64 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.428 0.632 . . . . 1.5 110.494 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 8' ' ' SER . 72.0 mt -129.59 133.07 24.66 Favored Pre-proline 0 N--CA 1.501 2.125 0 N-CA-C 108.541 -0.911 . . . . 0.72 108.541 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -42.16 130.73 4.64 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.0 1.8 . . . . 0.61 112.427 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -169.31 148.8 3.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.93 -1.106 . . . . 0.66 111.326 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 78.8 mt -127.82 146.2 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 N-CA-C 107.985 -1.117 . . . . 0.79 107.985 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.0 m -126.0 -10.55 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 O-C-N 120.734 -1.229 . . . . 0.91 111.51 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.0 22.52 27.41 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 110.323 -1.111 . . . . 1.01 110.323 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.407 ' HG1' ' C ' ' A' ' 181' ' ' THR . 2.8 p -43.99 -42.99 6.36 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.317 -1.108 . . . . 0.99 109.834 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.73 -50.96 3.23 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.204 -0.998 . . . . 1.12 111.068 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 29.1 p -159.25 39.27 0.21 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.547 -1.56 . . . . 1.72 111.299 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.2 -35.76 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.952 -1.093 . . . . 0.89 108.378 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.463 ' H ' HG23 ' A' ' 209' ' ' THR . 6.4 p -55.72 -32.14 63.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.506 -0.746 . . . . 1.03 110.301 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 72.4 p -80.04 -15.65 56.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.951 -1.093 . . . . 1.83 109.84 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -99.76 -13.07 19.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.412 -0.805 . . . . 2.27 110.041 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 52.7 t -106.72 138.07 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 CA-C-O 121.773 0.797 . . . . 0.92 110.713 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.423 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -114.83 153.67 30.01 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.216 -1.402 . . . . 2.2 107.216 178.339 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.459 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 17.5 p-10 -57.63 138.91 54.83 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.914 -1.116 . . . . 2.36 110.546 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.5 m-20 84.36 5.09 0.67 Allowed 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 120.984 0.421 . . . . 2.38 110.758 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 74.8 m-20 -74.62 137.88 42.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.935 -1.103 . . . . 2.09 109.638 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -88.1 118.12 27.45 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.504 -1.295 . . . . 1.27 107.504 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.593 HD12 ' HB2' ' A' ' 16' ' ' ALA . 60.6 mt -128.95 150.36 50.41 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.493 -0.754 . . . . 0.75 110.611 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.9 mt -117.67 128.14 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.317 -1.734 . . . . 0.63 106.317 177.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.3 tp -101.08 120.88 40.85 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.043 -1.036 . . . . 0.7 109.385 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 223' ' ' VAL . 95.3 m-20 -76.32 -44.79 35.26 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.951 -1.093 . . . . 2.31 109.491 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.91 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.25 16.6 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.463 -0.94 . . . . 0.78 108.463 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 221' ' ' ASP . 45.9 t -135.48 -42.97 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.549 -1.278 . . . . 1.04 107.549 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.433 ' H ' ' HB3' ' A' ' 221' ' ' ASP . 84.4 m-20 -99.79 2.74 44.33 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.014 -1.106 . . . . 2.44 108.014 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 60.24 42.42 15.19 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.806 -0.559 . . . . 1.55 109.697 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -141.96 155.46 45.47 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.173 -0.955 . . . . 1.99 110.119 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.0 t -124.8 131.39 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.594 -0.891 . . . . 0.77 108.594 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -102.48 121.74 42.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.326 -0.859 . . . . 0.98 109.325 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 43.9 t -100.59 113.93 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.455 -0.778 . . . . 0.85 110.13 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 53.48 61.96 10.04 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.237 -0.914 . . . . 1.66 111.59 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -87.35 149.27 7.77 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.976 2.451 . . . . 0.95 112.865 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 42.8 p -70.32 162.62 28.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.444 -0.785 . . . . 1.84 110.271 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -59.66 -35.19 73.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.489 -0.757 . . . . 2.74 109.304 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -59.96 -40.12 87.98 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.359 -0.838 . . . . 2.89 109.953 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.5 -39.53 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.0 -1.063 . . . . 1.3 109.328 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 85.5 mt . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.108 -0.995 . . . . 1.09 109.445 179.349 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 45.0 ttp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 302' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 42.1 t80 -153.64 152.31 30.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.446 -0.784 . . . . 0.0 109.194 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 303' ' ' GLN . . . . . 0.443 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 14.0 pt20 -148.75 158.46 44.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.993 -1.067 . . . . 0.0 110.876 -178.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -152.84 149.88 28.75 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -111.93 131.26 55.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.313 -0.867 . . . . 0.0 110.051 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.4 ' CG1' ' SD ' ' B' ' 381' ' ' MET . 7.4 p -131.16 123.1 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 CA-C-O 122.474 1.131 . . . . 0.0 112.987 -177.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 61.2 m -79.38 103.91 9.63 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.805 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.6 mt -50.8 122.68 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 122.346 1.069 . . . . 0.0 110.296 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 34.6 p -108.43 15.71 23.69 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.697 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.77 116.33 48.91 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.919 -1.113 . . . . 0.0 108.716 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -53.53 -15.26 5.94 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 CA-C-N 120.308 1.146 . . . . 0.0 113.879 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -114.65 12.93 17.3 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.229 -0.919 . . . . 0.0 109.375 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 68.03 174.8 8.51 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.56 ' O ' ' NH2' ' A' ' 126' ' ' ARG . 4.0 tp -84.4 92.39 8.03 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.234 -1.156 . . . . 0.0 110.281 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.6 ' C ' HH21 ' A' ' 126' ' ' ARG . 5.1 p80 -95.94 -162.23 0.93 Allowed 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.778 -1.201 . . . . 0.0 110.06 179.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 22.6 m -58.33 -40.1 81.22 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.93 -1.107 . . . . 0.0 112.661 -175.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.617 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -60.82 -62.79 5.26 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 120.17 -1.581 . . . . 0.0 111.395 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -54.56 -34.37 82.35 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 CA-C-N 120.034 1.048 . . . . 0.0 111.812 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.92 -53.35 59.21 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.337 -0.945 . . . . 0.0 108.948 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.72 -40.66 66.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 0.0 109.387 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -69.96 -41.57 74.31 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 108.878 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.07 -50.97 71.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.557 -0.715 . . . . 0.0 110.535 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 323' ' ' VAL . . . . . 0.417 HG13 ' O ' ' B' ' 344' ' ' ALA . 89.4 t -70.23 -28.83 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.982 -1.074 . . . . 0.0 110.011 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -60.03 -45.82 91.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.142 -0.973 . . . . 0.0 108.472 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -60.6 -49.31 78.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.397 -0.815 . . . . 0.0 109.745 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 326' ' ' ALA . . . . . 0.413 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -63.02 -50.91 68.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.302 -0.874 . . . . 0.0 110.85 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt -49.72 -16.65 0.26 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.085 -1.009 . . . . 0.0 109.671 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 328' ' ' GLY . . . . . 0.413 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -79.3 -23.55 62.89 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.828 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -104.18 139.93 38.53 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.115 -1.227 . . . . 0.0 109.559 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 89.2 m -91.63 -13.32 32.05 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.13 -0.981 . . . . 0.0 110.388 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.476 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 64.6 p -58.85 154.84 14.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.948 -1.095 . . . . 0.0 109.388 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.98 130.87 42.69 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.119 -1.032 . . . . 0.0 108.406 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.9 mt -132.33 133.32 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.603 -0.686 . . . . 0.0 109.583 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.6 m -130.09 151.56 50.5 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.515 -0.741 . . . . 0.0 109.578 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 97.2 t -115.86 139.2 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 91.3 m -129.77 123.95 32.23 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.165 -0.959 . . . . 0.0 109.101 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 11.3 p -138.79 118.22 12.87 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.97 0.891 . . . . 0.0 110.768 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 61.6 t30 42.86 58.05 3.37 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.06 -13.53 31.5 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 120.31 -1.494 . . . . 0.0 113.069 176.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -115.61 127.24 55.07 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 119.336 1.568 . . . . 0.0 109.443 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 74.6 m -123.98 146.56 48.43 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.882 0.849 . . . . 0.0 110.531 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -140.97 163.1 33.87 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.468 0.651 . . . . 0.0 109.624 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 3.4 t -87.05 137.02 32.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.558 -0.714 . . . . 0.0 109.638 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.417 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -76.73 -13.78 60.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.881 -1.137 . . . . 0.0 109.8 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -91.12 19.8 5.51 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 4.6 m -144.28 95.23 2.68 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.269 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.809 HD23 HD22 ' A' ' 79' ' ' LEU . 43.0 tp -59.88 -36.75 77.58 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.841 ' CE2' HD11 ' A' ' 79' ' ' LEU . 63.0 m-85 -56.15 -52.21 65.18 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.092 -1.005 . . . . 0.0 110.964 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -73.77 -23.6 59.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.783 -1.198 . . . . 0.0 110.866 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' B' ' 350' ' ' LEU . 29.9 mt -60.08 -45.61 92.34 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.322 -1.351 . . . . 0.0 108.734 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.588 ' N ' ' NE2' ' B' ' 351' ' ' GLN . 0.1 OUTLIER -50.78 -26.57 5.81 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.123 -0.986 . . . . 0.0 111.892 -178.416 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 44.2 p -72.8 -10.08 59.39 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 119.93 -1.731 . . . . 0.0 109.864 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 39.8 mt -97.46 116.17 29.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.212 -0.93 . . . . 0.0 109.398 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.69 96.34 1.16 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 19.3 mt -103.04 92.17 4.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.355 -1.085 . . . . 0.0 109.105 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 64.9 p -93.5 167.08 11.93 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.959 -1.088 . . . . 0.0 110.946 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -57.02 114.74 2.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.705 -0.622 . . . . 0.0 110.699 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 100.09 7.53 52.33 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 52.2 m -83.8 112.59 20.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -1.107 . . . . 0.0 110.634 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 13.5 t -78.03 114.36 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 122.263 1.03 . . . . 0.0 109.625 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 11.8 m -110.81 177.46 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 62.4 m -131.25 129.3 41.41 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 89.3 mt -104.11 118.4 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 37.3 p -121.64 133.65 54.98 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.11 154.07 40.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.087 -1.008 . . . . 0.0 110.239 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -144.61 122.39 11.91 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 160.28 -159.29 30.67 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 118.972 -1.585 . . . . 0.0 111.596 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -59.98 -51.8 68.13 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.169 -0.606 . . . . 0.0 112.295 -177.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.476 ' H ' ' HB3' ' B' ' 331' ' ' SER . 75.2 m-20 -109.31 10.37 25.62 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.775 -1.203 . . . . 0.0 111.059 -177.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.414 ' C ' ' OE1' ' B' ' 370' ' ' GLU . 0.7 OUTLIER -43.64 -34.9 1.58 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.096 -1.003 . . . . 0.0 111.718 -178.352 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -70.06 -42.69 72.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.378 -1.451 . . . . 0.0 110.866 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -69.23 -50.61 45.68 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.902 -1.124 . . . . 0.0 109.562 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -51.45 -31.29 22.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 111.381 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.518 ' O ' HG23 ' B' ' 378' ' ' VAL . 70.3 t -71.74 -39.92 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.545 -1.347 . . . . 0.0 108.845 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -64.48 -62.4 1.62 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.24 -0.913 . . . . 0.0 110.908 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -60.68 -43.69 97.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.392 -1.443 . . . . 0.0 111.416 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.03 -40.12 88.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.437 -1.414 . . . . 0.0 108.359 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.518 HG23 ' O ' ' B' ' 374' ' ' VAL . 52.3 t -66.67 -40.22 85.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.535 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -70.94 -58.5 3.52 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.453 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 55.6 tp -54.41 -34.06 60.58 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.8 -0.563 . . . . 0.0 109.952 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 381' ' ' MET . . . . . 0.4 ' SD ' ' CG1' ' B' ' 306' ' ' VAL . 2.8 ttt -73.83 -40.03 63.62 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 108.819 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -79.19 -4.89 52.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.572 -0.705 . . . . 0.0 109.904 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -109.03 0.47 19.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.294 -0.879 . . . . 0.0 111.313 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 384' ' ' LEU . . . . . 0.453 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 20.4 mt -69.79 131.1 43.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.179 -1.576 . . . . 0.0 108.508 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.593 -179.334 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.7 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.424 -0.584 . . . . 2.91 109.424 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.2 mt -109.97 129.92 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.523 -0.736 . . . . 1.2 109.12 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.6 m -130.3 143.08 50.56 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.46 -0.775 . . . . 1.4 109.558 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.505 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -112.85 -160.0 14.29 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 108.944 -1.662 . . . . 1.05 108.944 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.469 ' O ' ' O ' ' A' ' 6' ' ' LEU . 92.0 mt -94.21 -15.5 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.997 -1.296 . . . . 1.15 110.086 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.9 tp 50.85 103.0 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.248 -0.908 . . . . 0.98 109.505 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.14 -25.79 14.42 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.988 -1.07 . . . . 0.88 109.273 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 35.0 m -133.73 119.67 15.08 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.427 -0.796 . . . . 1.69 109.573 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.91 147.29 16.79 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.08 1.854 . . . . 0.85 112.683 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.819 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.46 -159.33 30.41 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.082 -1.607 . . . . 0.92 109.082 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.4 mt -149.21 150.14 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.167 -1.196 . . . . 0.81 108.669 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.55 157.84 37.47 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.968 -1.083 . . . . 0.51 110.756 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -139.5 128.7 23.91 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.021 -1.103 . . . . 0.62 108.021 178.817 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.0 -177.29 47.09 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 118.758 -1.687 . . . . 0.55 110.92 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 157' ' ' ILE . 98.1 mttt -79.8 159.67 26.44 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.589 -0.948 . . . . 2.1 110.099 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.568 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -106.6 137.38 44.72 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.596 -0.69 . . . . 0.77 110.131 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.5 tp -104.05 131.12 51.63 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.882 -1.155 . . . . 0.91 107.882 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.3 tp -113.04 124.33 52.37 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.195 -0.941 . . . . 0.93 110.022 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.404 HD12 ' HB2' ' A' ' 160' ' ' ALA . 26.3 mt -95.42 103.64 15.51 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.667 -0.646 . . . . 0.93 111.005 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -107.22 136.93 46.22 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.541 -0.724 . . . . 2.75 109.925 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -130.15 138.2 50.52 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.356 -0.84 . . . . 3.0 109.377 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -78.04 158.77 29.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.067 -1.021 . . . . 2.77 109.944 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -72.32 144.21 48.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.424 -0.798 . . . . 2.94 108.905 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.8 mt -84.5 129.61 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.104 -0.998 . . . . 0.95 109.464 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.5 t -94.14 124.73 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.341 -0.849 . . . . 1.28 110.684 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.4 mt -110.37 134.28 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.52 -0.738 . . . . 1.21 109.355 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -93.66 116.45 28.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.978 -1.076 . . . . 1.81 109.141 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -83.72 -1.41 54.06 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.153 -0.967 . . . . 2.8 109.407 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.14 139.99 58.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 2.87 109.655 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -83.13 151.2 25.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.089 -1.007 . . . . 2.35 108.999 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -94.57 166.73 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.864 . . . . 0.97 110.149 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 83.9 p -96.78 173.43 7.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -0.947 . . . . 1.17 108.666 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.79 -49.69 76.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.072 -1.018 . . . . 1.18 109.512 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -53.57 -30.99 44.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.096 -1.003 . . . . 2.56 109.29 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -83.32 -9.92 58.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.58 -0.7 . . . . 1.79 110.669 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.97 -54.0 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.652 -1.28 . . . . 1.0 109.288 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -64.56 -40.14 95.03 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.31 -0.869 . . . . 1.77 110.036 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -65.99 -43.63 87.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.976 -1.078 . . . . 2.7 110.351 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -63.9 -40.04 95.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.86 -1.15 . . . . 1.51 110.168 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.0 -48.16 90.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.778 -1.201 . . . . 0.93 108.647 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -62.25 -43.96 97.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.157 -0.965 . . . . 1.81 109.505 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' A' ' 42' ' ' ARG . 21.8 mtt-85 -60.05 -43.15 95.57 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.857 -1.164 . . . . 2.78 107.857 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -60.73 -49.98 75.32 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.454 -0.943 . . . . 0.78 108.454 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.6 tp -60.06 -43.71 95.23 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.69 -0.856 . . . . 1.07 108.69 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.0 t -66.56 -41.96 87.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 1.12 109.292 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.29 -44.3 66.34 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.214 -1.954 . . . . 0.84 108.214 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.435 HH22 ' HG2' ' A' ' 81' ' ' GLU . 41.2 ttt-85 -62.77 -36.6 83.62 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.14 -1.059 . . . . 3.09 108.14 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.03 -39.39 78.25 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.581 -0.896 . . . . 0.88 108.581 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.2 ttpt -59.5 -73.66 0.08 Allowed 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.355 -1.35 . . . . 2.59 107.355 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.61 -37.73 0.23 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.439 -0.788 . . . . 0.7 111.153 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 52' ' ' ALA . 21.7 p -53.25 -53.61 48.2 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.578 -1.326 . . . . 1.4 108.478 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.402 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . -67.85 -40.86 83.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -0.899 . . . . 0.67 110.884 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -70.01 -39.96 75.52 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.796 -1.19 . . . . 1.66 109.746 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.13 -40.05 96.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.053 -1.029 . . . . 1.58 109.11 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.37 -38.58 84.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.383 -0.823 . . . . 1.35 109.831 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -61.34 -40.47 94.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.77 110.048 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.3 mt -61.58 -39.98 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.374 -0.829 . . . . 0.63 109.188 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -56.58 -50.82 70.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 1.14 109.949 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -60.0 -31.76 70.23 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.376 -0.827 . . . . 0.79 110.729 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -67.87 -39.48 83.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.044 -1.035 . . . . 1.53 109.302 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.7 -41.48 95.99 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.663 -0.648 . . . . 0.57 110.026 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.83 -50.25 69.74 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.493 -1.443 . . . . 0.75 109.493 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.17 -51.55 24.2 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.929 -1.336 . . . . 1.59 109.929 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.7 m -60.11 -65.7 0.64 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.73 112.202 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -94.22 -50.15 5.4 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.802 -1.186 . . . . 0.75 111.439 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.65 -168.24 25.61 Favored Glycine 0 N--CA 1.502 3.071 0 C-N-CA 119.732 -1.223 . . . . 1.22 111.198 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.0 -26.78 64.24 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.939 -0.742 . . . . 5.81 110.21 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.508 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.0 tp10 -60.1 -34.29 73.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.378 -0.826 . . . . 3.37 110.629 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -100.0 -18.01 17.24 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.079 -1.013 . . . . 1.77 109.799 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -69.26 -39.99 78.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.103 -0.998 . . . . 1.65 109.974 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.495 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -63.25 -31.5 72.67 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.308 -0.87 . . . . 0.77 109.47 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.0 mt -60.12 -42.21 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -0.985 . . . . 0.8 109.656 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -65.02 -39.88 94.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.994 -1.066 . . . . 0.88 110.317 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -59.79 -40.12 87.23 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.954 -1.091 . . . . 1.37 108.771 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.47 -46.34 94.01 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.649 -1.781 . . . . 0.62 108.649 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -65.34 -45.06 85.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -1.133 . . . . 1.5 109.646 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.7 mt -69.08 -45.0 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.078 -1.049 . . . . 0.63 109.09 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.3 ttp -61.1 -39.9 91.71 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.936 -1.102 . . . . 1.51 109.436 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.891 HD22 HD23 ' B' ' 347' ' ' LEU . 46.0 tp -63.15 -39.13 93.78 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.495 -0.753 . . . . 0.77 109.506 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 34.6 tp -66.1 -30.27 70.74 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.404 -0.81 . . . . 0.62 109.027 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.435 ' HG2' HH22 ' A' ' 47' ' ' ARG . 96.4 mt-10 -87.2 6.86 30.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.137 -0.977 . . . . 1.47 110.009 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 63.1 t0 -55.86 130.0 41.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.963 -1.085 . . . . 1.47 109.887 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.407 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 99.8 mt-10 -60.5 -19.43 56.88 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.528 -0.732 . . . . 1.78 111.058 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.96 -33.53 72.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.759 -1.213 . . . . 2.53 108.337 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 76.9 mt -71.94 -41.99 67.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.64 -0.663 . . . . 0.8 110.08 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -60.15 -50.12 74.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.02 -1.05 . . . . 1.42 111.056 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -70.12 -40.09 75.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.107 -0.996 . . . . 1.71 110.876 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.88 -39.99 75.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.22 -0.925 . . . . 1.57 111.01 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.2 -49.99 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.997 -1.064 . . . . 0.65 109.676 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.02 -39.11 80.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.538 -0.726 . . . . 0.82 110.436 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.11 -44.03 95.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 0.79 110.631 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.2 mt -62.47 -46.96 86.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.796 -1.19 . . . . 0.95 109.719 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.8 -50.06 81.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-O 121.911 0.862 . . . . 0.66 108.939 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -67.66 -42.54 82.02 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.456 -0.777 . . . . 2.2 110.758 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -80.33 -54.11 6.01 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.965 -1.085 . . . . 1.65 111.956 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -90.06 -1.94 58.03 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.111 -0.993 . . . . 2.03 112.35 -177.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.9 m80 58.32 35.06 24.6 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.837 -1.164 . . . . 1.42 109.776 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.6 mtp -86.56 165.17 16.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.409 -0.807 . . . . 1.18 110.17 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.5 p -79.22 161.37 26.42 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.0 -0.741 . . . . 0.98 109.0 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.29 -42.0 84.51 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.174 -0.954 . . . . 0.64 109.613 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -62.15 -40.04 94.61 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.192 -0.943 . . . . 2.07 109.445 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.27 -41.44 22.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.73 110.111 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.26 -52.02 60.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.333 -0.855 . . . . 0.54 110.402 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.99 87.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.109 -0.994 . . . . 0.56 109.785 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.526 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 82.7 t60 -60.02 -40.22 88.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 1.54 110.048 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.01 -40.05 92.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.145 -0.972 . . . . 1.33 110.671 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.23 -59.95 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.094 -1.004 . . . . 0.72 111.439 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.3 mm -62.28 -42.96 97.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.974 -1.079 . . . . 0.85 109.075 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.526 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 88.7 tt0 -61.47 -40.04 93.1 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.565 -0.902 . . . . 2.44 108.565 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.16 -51.03 61.36 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.367 -1.093 . . . . 0.98 110.367 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -62.15 -49.96 73.75 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.889 -1.36 . . . . 1.41 109.126 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.07 -40.06 88.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 1.2 109.636 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 56.6 m -60.04 -39.97 87.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.116 -0.99 . . . . 1.7 109.213 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.06 82.21 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.023 -1.048 . . . . 1.47 108.407 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 118' ' ' LEU . 51.8 mt -62.0 -46.47 89.08 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.111 -0.993 . . . . 1.56 108.662 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -47.76 -30.82 4.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.897 -1.127 . . . . 2.2 109.689 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.41 -27.12 68.79 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.013 -1.054 . . . . 2.12 108.354 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 115' ' ' LEU . 74.4 mt -63.32 140.6 58.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.862 . . . . 2.0 108.952 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -94.23 10.12 35.27 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.075 -1.016 . . . . 3.23 110.42 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -98.3 147.0 25.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.005 -1.06 . . . . 2.49 109.891 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.488 ' O ' ' N ' ' A' ' 124' ' ' LYS . 98.9 mt-10 -72.98 -65.53 0.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.52 -0.738 . . . . 3.95 109.159 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.412 ' C ' ' O ' ' A' ' 121' ' ' GLU . 4.7 t80 -39.37 -40.05 0.74 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.867 -0.52 . . . . 2.0 110.602 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.627 ' CD2' HH21 ' A' ' 126' ' ' ARG . 81.0 mt -70.83 -40.0 72.67 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.744 -1.223 . . . . 1.86 108.551 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 121' ' ' GLU . 82.1 tttt -68.3 -34.52 76.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.553 -0.717 . . . . 2.84 109.579 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -60.08 -40.02 88.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.262 -0.899 . . . . 2.73 110.19 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.627 HH21 ' CD2' ' A' ' 123' ' ' LEU . 76.2 mtm180 -68.06 -33.44 74.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.934 -1.104 . . . . 2.77 109.258 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.88 78.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.11 -0.994 . . . . 1.19 108.621 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.27 96.86 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.797 -1.186 . . . . 1.2 107.797 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -69.96 -40.0 75.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.611 -0.681 . . . . 1.55 109.478 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.64 -39.99 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.197 -1.038 . . . . 0.8 108.197 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -65.49 -35.65 81.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.31 -0.868 . . . . 3.09 109.099 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -59.91 -40.12 87.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.252 -0.905 . . . . 1.46 109.541 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.06 -43.09 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.371 -0.83 . . . . 0.71 109.827 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.18 -36.69 50.38 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 120.197 -1.001 . . . . 0.57 110.659 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -59.55 -42.55 92.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.069 -1.254 . . . . 2.59 109.649 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -68.7 -34.37 75.53 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.707 -1.245 . . . . 2.83 109.46 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.6 tp -59.95 -43.07 95.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 1.25 109.478 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.09 -40.17 94.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.003 -1.06 . . . . 0.7 109.146 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -70.11 -36.84 75.13 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 2.57 109.488 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -69.87 -25.58 63.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.353 -0.842 . . . . 1.23 111.24 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.91 -43.76 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.472 -1.393 . . . . 0.81 108.931 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.59 -28.45 58.93 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.494 -0.754 . . . . 1.0 110.079 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.34 5.61 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.112 -1.995 . . . . 0.89 108.112 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.7 tp -73.59 146.87 44.36 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.632 -0.922 . . . . 1.14 109.229 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -60.81 144.12 53.24 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.24 -0.913 . . . . 4.6 109.515 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 97.2 mt -114.49 120.61 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.583 -0.895 . . . . 1.24 108.583 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 10.7 mm -52.6 -53.23 21.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.651 -0.656 . . . . 1.54 110.384 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.2 t0 66.37 103.32 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.548 -0.72 . . . . 1.5 109.285 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 17.1 mt -74.82 -3.08 29.66 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.673 -0.642 . . . . 0.79 110.374 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 53.1 m -86.83 -15.68 38.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.171 -0.955 . . . . 1.4 109.573 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.99 15.83 1.03 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.362 -0.836 . . . . 0.92 111.458 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.547 HD12 ' N ' ' A' ' 152' ' ' ILE . 1.3 mp -90.4 124.71 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.541 -1.349 . . . . 0.88 109.068 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -103.67 -7.09 20.96 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.386 -0.822 . . . . 2.45 110.101 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -119.36 149.43 41.84 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.477 -0.764 . . . . 1.52 110.496 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.35 135.42 54.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.419 -0.8 . . . . 1.58 109.161 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.0 m -152.07 166.02 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.428 -0.795 . . . . 0.69 109.538 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 15' ' ' LYS . 86.3 mt -93.47 149.3 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 105.823 -1.918 . . . . 0.61 105.823 176.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.2 tp -97.06 115.26 27.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.942 -1.099 . . . . 0.87 110.799 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 64.2 t -120.11 124.69 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.679 -0.638 . . . . 0.71 109.436 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.404 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -159.45 162.66 35.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.168 -0.958 . . . . 0.81 108.481 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.02 -36.42 75.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.508 -1.37 . . . . 0.98 108.444 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 20.4 p-10 -170.77 146.79 2.67 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.21 -0.663 . . . . 2.25 109.21 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 44.8 mt -112.98 137.54 51.22 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.362 -0.836 . . . . 0.78 109.906 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 70.9 p -92.82 146.42 32.11 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.157 -0.964 . . . . 0.98 108.483 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -40.2 -37.81 1.98 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.02 1.814 . . . . 0.81 112.731 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.9 m -59.99 -40.76 90.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.912 . . . . 0.9 110.146 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.94 -40.63 75.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.05 -1.031 . . . . 1.61 109.824 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 66.5 p -59.14 -20.33 52.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.364 -0.835 . . . . 0.61 111.833 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.5 -47.45 9.9 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.471 -1.393 . . . . 0.6 109.739 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -85.62 36.29 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.581 -0.896 . . . . 1.4 108.581 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.0 tp -107.91 139.9 41.84 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.932 -0.766 . . . . 0.7 108.932 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.428 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 0.4 OUTLIER -89.37 106.39 18.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.045 -1.034 . . . . 2.35 108.912 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 59.6 mt -67.39 -40.16 85.65 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.576 -0.703 . . . . 1.51 111.678 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -68.75 -21.83 64.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.646 -1.284 . . . . 2.33 111.17 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -94.29 -8.37 39.26 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.89 -1.131 . . . . 1.92 109.96 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 178' ' ' GLY . 84.4 t -101.0 112.42 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.216 -0.927 . . . . 0.67 108.719 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.52 1.49 29.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -0.91 . . . . 1.53 110.7 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.473 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.26 173.33 37.5 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.33 -1.508 . . . . 0.48 109.33 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.488 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 26.9 m-85 -127.98 125.07 38.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.562 -0.963 . . . . 0.55 108.713 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 93.4 mt -130.85 125.38 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.399 -0.963 . . . . 0.65 108.399 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 31.6 p -151.42 163.43 38.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.885 -1.134 . . . . 0.82 111.172 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.501 ' O ' ' O ' ' A' ' 183' ' ' ALA . 57.4 t0 -100.84 27.35 6.03 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.993 -0.549 . . . . 2.46 109.675 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -46.96 -177.24 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.001 -1.687 . . . . 1.28 111.862 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.29 -54.39 6.92 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.254 -1.138 . . . . 2.19 110.254 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -161.4 -156.12 8.17 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.416 -1.373 . . . . 2.13 110.357 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.803 ' HE ' HH21 ' A' ' 195' ' ' ARG . 66.6 mtp180 -78.4 -9.48 59.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.633 -0.922 . . . . 5.86 109.354 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 39.6 p -77.75 2.78 15.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 3.72 110.067 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 78.0 p -82.31 139.61 34.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.954 -1.091 . . . . 1.74 109.655 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -49.18 -50.05 39.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.986 -1.071 . . . . 0.95 109.918 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.6 t -53.64 -36.17 61.78 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.214 -0.929 . . . . 1.55 110.394 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 66.7 m -59.92 -40.07 87.63 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.804 -1.185 . . . . 1.51 110.155 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.3 mt -61.02 -39.99 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 1.67 109.567 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 76.6 mtp -56.92 -41.39 78.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.251 -0.906 . . . . 1.02 109.978 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.08 -40.8 90.82 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.996 -1.065 . . . . 0.68 108.769 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.803 HH21 ' HE ' ' A' ' 186' ' ' ARG . 95.0 mtt180 -62.62 -59.98 4.16 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.346 -0.942 . . . . 2.93 110.281 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.4 m -63.42 -39.99 95.99 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.213 -0.929 . . . . 0.86 112.101 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.1 -22.42 63.03 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.854 -1.154 . . . . 0.67 109.307 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 61.35 47.02 7.19 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.694 -0.629 . . . . 1.5 109.782 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 8' ' ' SER . 97.5 mt -122.19 148.6 52.43 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 107.757 -1.201 . . . . 0.72 107.757 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.45 138.12 68.96 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.975 1.783 . . . . 0.61 111.39 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.488 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -170.01 150.96 3.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.942 -1.099 . . . . 0.66 111.588 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.6 mt -124.4 141.16 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 107.211 -1.403 . . . . 0.79 107.211 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.8 m -124.22 -9.22 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.52 0 O-C-N 120.522 -1.361 . . . . 0.91 111.406 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -111.36 23.34 18.45 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 110.607 -0.997 . . . . 1.01 110.607 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.412 ' C ' ' O ' ' A' ' 204' ' ' GLY . 2.9 p -43.07 -46.89 5.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.222 -1.163 . . . . 0.99 110.108 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.438 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 95.69 -54.0 1.7 Allowed Glycine 0 N--CA 1.501 2.973 0 C-N-CA 120.163 -1.018 . . . . 1.12 111.587 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 78.7 p -149.03 29.62 0.8 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.49 -1.594 . . . . 1.72 111.505 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 41.7 t -74.34 -36.35 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.691 -1.256 . . . . 0.89 109.299 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 53.5 p -58.96 -26.01 64.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.92 -1.112 . . . . 1.03 109.796 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.7 m -84.2 -15.27 47.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.105 -0.997 . . . . 1.83 109.892 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -102.46 -6.75 22.58 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.268 -0.895 . . . . 2.27 109.868 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 78.6 t -110.19 133.44 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.514 -0.742 . . . . 0.92 110.819 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -115.16 151.08 35.02 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.149 -1.426 . . . . 2.2 107.149 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.454 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 61.7 t30 -54.89 139.76 39.18 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.02 -1.05 . . . . 2.36 110.79 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.454 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.1 m-20 83.18 2.47 1.02 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-N 116.322 -0.399 . . . . 2.38 110.632 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -74.3 145.12 44.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.895 -1.128 . . . . 2.09 109.489 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -95.51 118.85 32.98 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.997 -1.112 . . . . 1.27 107.997 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.568 HD12 ' HB2' ' A' ' 16' ' ' ALA . 58.1 mt -128.04 151.22 49.42 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.559 -0.713 . . . . 0.75 110.151 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 83.0 mt -116.89 130.02 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.224 -1.398 . . . . 0.63 107.224 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 63.5 tp -97.95 115.19 27.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.967 -1.083 . . . . 0.7 109.069 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.538 ' C ' ' H ' ' A' ' 223' ' ' VAL . 20.2 t0 -72.93 -47.15 48.1 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.597 -1.261 . . . . 2.31 107.597 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.819 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 52.7 5.52 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.814 -0.554 . . . . 0.78 109.791 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.538 ' H ' ' C ' ' A' ' 221' ' ' ASP . 69.5 t -116.59 -40.21 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 107.473 -1.306 . . . . 1.04 107.473 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -108.43 5.39 25.3 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.976 -1.12 . . . . 2.44 107.976 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.505 HD21 ' H ' ' A' ' 4' ' ' GLY . 1.4 t-20 59.37 49.37 8.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.85 -0.531 . . . . 1.55 110.011 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -138.49 150.9 46.89 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.382 -0.824 . . . . 1.99 109.444 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 49.7 t -119.25 129.77 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.066 -1.087 . . . . 0.77 108.066 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -99.75 119.13 37.66 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.063 -1.088 . . . . 0.98 108.063 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.476 HG22 HD22 ' A' ' 218' ' ' LEU . 56.1 t -101.39 116.44 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.505 -0.747 . . . . 0.85 110.595 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 49.98 60.13 15.62 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 1.66 110.836 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -85.69 149.68 9.93 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.571 2.181 . . . . 0.95 112.119 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 68.5 p -67.93 164.11 20.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.288 -0.882 . . . . 1.84 110.568 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -60.1 -38.74 83.84 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.84 -0.8 . . . . 2.74 108.84 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.97 -39.64 86.34 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.55 -0.719 . . . . 2.89 109.473 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.68 -40.09 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.019 -1.05 . . . . 1.3 109.968 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.493 1.724 0 O-C-N 120.996 -1.065 . . . . 1.09 109.157 179.363 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 3.3 ttt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.532 0.682 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -151.56 148.48 28.05 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.11 161.06 43.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.796 -1.19 . . . . 0.0 111.037 -178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -154.01 151.13 29.01 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -106.96 132.71 52.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 109.248 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.3 122.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 CA-C-O 122.387 1.089 . . . . 0.0 112.74 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 307' ' ' THR . . . . . 0.486 ' O ' HG23 ' B' ' 309' ' ' THR . 29.4 m -79.27 106.84 11.59 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.671 -178.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' B' ' 358' ' ' GLY . 81.7 mt -51.97 117.14 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 122.135 0.969 . . . . 0.0 110.007 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 309' ' ' THR . . . . . 0.486 HG23 ' O ' ' B' ' 307' ' ' THR . 77.4 p -106.91 18.68 21.5 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.462 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -75.39 116.69 57.06 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.067 -1.02 . . . . 0.0 108.949 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -51.96 -13.11 1.59 Allowed 'Trans proline' 0 N--CA 1.499 1.823 0 CA-C-N 120.261 1.129 . . . . 0.0 113.442 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -118.13 6.77 12.05 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.307 -0.871 . . . . 0.0 109.449 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.85 174.92 27.27 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 3.0 tp -85.05 96.07 9.3 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.03 -1.276 . . . . 0.0 108.59 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -97.79 -160.18 0.79 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.082 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 9.2 m -59.0 -41.84 88.64 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.032 -1.042 . . . . 0.0 112.439 -176.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.508 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 1.4 tpt180 -60.4 -62.18 6.45 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 120.429 -1.42 . . . . 0.0 111.794 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -57.9 -32.02 94.06 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.199 1.107 . . . . 0.0 111.461 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.83 72.22 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.64 -41.6 63.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.441 -0.787 . . . . 0.0 109.25 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -69.98 -41.3 74.6 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.167 -1.013 . . . . 0.0 108.7 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -60.97 -51.96 67.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.471 -0.768 . . . . 0.0 110.435 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 323' ' ' VAL . . . . . 0.431 HG13 ' O ' ' B' ' 344' ' ' ALA . 70.0 t -68.36 -30.82 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.653 -1.279 . . . . 0.0 109.841 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -59.99 -44.32 94.6 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.231 -0.988 . . . . 0.0 108.608 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -69.41 -40.72 77.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 110.646 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.1 -52.08 66.89 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.516 -1.365 . . . . 0.0 109.343 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -57.33 -15.23 5.81 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.598 -0.689 . . . . 0.0 109.193 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.96 -29.78 70.55 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -104.83 147.23 27.95 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.455 -1.027 . . . . 0.0 109.109 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 22.6 p -91.36 -12.93 33.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.841 -1.162 . . . . 0.0 109.585 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' B' ' 368' ' ' GLU . 5.8 m -59.46 152.52 21.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.297 -0.877 . . . . 0.0 109.663 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -70.78 134.1 47.11 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.165 -0.96 . . . . 0.0 108.681 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 86.2 mt -132.91 131.24 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.537 -0.727 . . . . 0.0 110.292 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 39.4 m -130.63 153.48 48.88 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 72.4 t -118.61 139.69 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 96.9 m -126.97 123.64 37.59 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.271 -0.893 . . . . 0.0 108.904 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 40.1 p -135.91 116.71 14.07 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.12 -0.988 . . . . 0.0 109.832 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 338' ' ' ASN . . . . . 0.599 ' ND2' ' O ' ' B' ' 338' ' ' ASN . 3.2 p-10 39.95 69.05 0.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 72.31 -11.92 3.66 Favored Glycine 0 N--CA 1.5 2.966 0 O-C-N 120.762 -1.211 . . . . 0.0 113.411 176.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -115.4 129.13 56.48 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-N 119.473 1.637 . . . . 0.0 109.39 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 83.0 p -129.35 151.1 50.36 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.777 0.798 . . . . 0.0 110.699 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -146.14 166.53 25.89 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.595 0.712 . . . . 0.0 110.299 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 34.3 t -89.38 140.09 29.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.554 -0.717 . . . . 0.0 110.061 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.431 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -77.57 -14.66 59.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.015 -1.053 . . . . 0.0 109.613 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 345' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' B' ' 345' ' ' LYS . 47.3 tttp -86.98 18.52 3.5 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 88.2 p -146.12 96.54 2.81 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.403 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.891 HD23 HD22 ' A' ' 79' ' ' LEU . 11.9 tp -60.01 -34.56 73.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.748 ' CE2' HD11 ' A' ' 79' ' ' LEU . 50.9 m-85 -59.74 -54.94 40.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.536 -0.727 . . . . 0.0 110.6 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -63.64 -40.07 95.94 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.705 -1.247 . . . . 0.0 109.007 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.594 ' O ' ' N ' ' B' ' 352' ' ' THR . 60.0 mt -52.18 -56.49 14.24 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.526 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -39.44 -14.55 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.872 -0.517 . . . . 0.0 111.758 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.594 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.1 p -93.24 -9.99 37.2 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.516 -1.365 . . . . 0.0 110.792 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 47.0 mt -94.36 119.94 33.85 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.854 -1.154 . . . . 0.0 109.914 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -71.02 94.23 0.52 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 85.0 mt -99.98 83.6 2.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.35 -1.088 . . . . 0.0 109.271 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 82.3 p -93.5 169.89 10.01 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.054 -1.029 . . . . 0.0 110.998 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.55 112.55 2.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.868 -0.52 . . . . 0.0 110.339 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 358' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 105.48 6.04 38.96 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.0 m -84.81 108.16 17.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -1.204 . . . . 0.0 111.062 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 17.0 t -77.7 115.03 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 122.236 1.017 . . . . 0.0 109.491 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.23 178.45 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 81.6 m -128.87 131.28 47.63 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.9 mt -102.85 120.28 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 41.6 m -120.69 130.06 53.93 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.534 -0.729 . . . . 0.0 109.474 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.16 151.21 40.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.396 -0.815 . . . . 0.0 109.498 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -147.16 122.34 10.18 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.461 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 160.23 -153.56 24.51 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 118.767 -1.683 . . . . 0.0 111.827 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 368' ' ' GLU . . . . . 0.517 ' N ' ' OG ' ' B' ' 331' ' ' SER . 85.5 tt0 -60.04 -50.42 73.78 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 122.203 -0.587 . . . . 0.0 112.22 -177.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.439 ' N ' ' OG ' ' B' ' 331' ' ' SER . 85.8 m-20 -112.59 12.3 19.82 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 120.924 -1.11 . . . . 0.0 111.628 -177.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.0 OUTLIER -39.65 -33.65 0.19 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.179 -0.951 . . . . 0.0 111.653 -178.494 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 371' ' ' GLN . . . . . 0.49 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 12.2 pt20 -65.7 -54.03 32.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.763 -1.211 . . . . 0.0 110.404 -178.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -64.43 -49.38 71.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.622 -1.299 . . . . 0.0 108.619 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -41.48 -42.27 2.3 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.724 -0.61 . . . . 0.0 111.186 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.535 ' O ' HG23 ' B' ' 378' ' ' VAL . 76.3 t -74.71 -36.89 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.546 -1.346 . . . . 0.0 109.574 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -63.19 -64.93 0.77 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.01 -1.056 . . . . 0.0 110.498 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 376' ' ' HIS . . . . . 0.438 ' O ' ' N ' ' B' ' 380' ' ' LEU . 34.4 m170 -59.97 -45.31 93.11 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.776 -1.202 . . . . 0.0 112.07 -177.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.4 mt -60.0 -40.22 88.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.394 -1.441 . . . . 0.0 108.568 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.535 HG23 ' O ' ' B' ' 374' ' ' VAL . 46.0 t -64.81 -49.54 79.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 110.164 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -80.17 -9.68 59.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.817 -1.177 . . . . 0.0 110.407 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' B' ' 376' ' ' HIS . 56.7 tp -83.34 -27.92 29.38 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 41.6 ttm -80.46 -30.07 37.5 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.065 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -84.82 -7.66 59.1 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.54 -0.725 . . . . 0.0 109.837 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -110.21 -2.96 16.56 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.253 -0.904 . . . . 0.0 110.029 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 22.0 mt -90.98 125.63 35.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.011 -1.056 . . . . 0.0 109.091 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 117.917 -1.039 . . . . 0.0 109.597 -179.862 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.424 0.63 . . . . 2.91 109.777 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.5 mt -110.1 130.12 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.229 -0.656 . . . . 1.2 109.229 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.431 ' CB ' ' OD1' ' A' ' 225' ' ' ASN . 61.9 m -137.13 153.54 50.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.379 -0.825 . . . . 1.4 109.681 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.85 -158.17 8.1 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 108.47 -1.852 . . . . 1.05 108.47 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.418 ' O ' ' O ' ' A' ' 6' ' ' LEU . 82.3 mt -90.43 -18.56 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.751 -1.44 . . . . 1.15 109.568 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.45 HD21 ' O ' ' A' ' 222' ' ' ALA . 59.1 tp 44.01 93.65 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.167 -0.958 . . . . 0.98 110.366 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.41 -22.66 18.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.954 -1.091 . . . . 0.88 109.267 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 70.7 m -121.06 112.4 33.37 Favored Pre-proline 0 N--CA 1.504 2.244 0 O-C-N 121.463 -0.773 . . . . 1.69 109.53 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -80.94 151.35 18.57 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.027 1.818 . . . . 0.85 112.408 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.828 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 145.92 175.84 19.3 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.959 -1.656 . . . . 0.92 108.959 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 12' ' ' ALA . 97.0 mt -120.72 155.7 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 O-C-N 121.427 -1.043 . . . . 0.81 109.609 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.413 ' N ' HG22 ' A' ' 11' ' ' ILE . . . -154.19 155.26 34.96 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.057 -1.027 . . . . 0.51 110.326 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 5.3 m-85 -135.28 126.37 27.92 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.012 -1.107 . . . . 0.62 108.012 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.29 -179.21 48.18 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 118.642 -1.742 . . . . 0.55 110.907 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -79.97 158.09 26.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.985 -0.715 . . . . 2.1 109.822 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.591 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -106.44 125.51 51.1 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.531 -0.731 . . . . 0.77 110.469 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.5 tp -97.53 136.76 37.49 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.03 -1.1 . . . . 0.91 108.03 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.9 tp -120.39 128.02 52.83 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.486 -0.759 . . . . 0.93 109.385 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.86 107.51 19.15 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.485 -0.76 . . . . 0.93 110.278 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -100.12 129.87 46.2 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.145 -1.057 . . . . 2.75 108.145 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -130.95 139.76 50.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.185 -0.947 . . . . 3.0 109.712 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 52.9 t0 -81.85 143.89 31.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 2.77 109.088 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.482 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 86.9 tt0 -64.88 140.41 58.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -0.972 . . . . 2.94 109.493 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.7 mt -81.68 135.3 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.331 -0.855 . . . . 0.95 108.818 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.2 t -110.75 128.89 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.368 -0.832 . . . . 1.28 110.093 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.0 mt -98.06 143.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.483 -0.932 . . . . 1.21 108.483 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -94.85 121.43 36.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.865 -1.147 . . . . 1.81 109.738 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.8 mmm-85 -88.02 -0.31 56.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.583 -0.698 . . . . 2.8 109.553 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.52 139.65 58.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.071 -1.018 . . . . 2.87 108.761 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -85.26 149.99 25.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 2.35 109.376 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.483 HG21 ' HG3' ' A' ' 39' ' ' GLU . 5.4 pt -91.48 165.15 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.97 109.494 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.2 p -97.2 172.56 7.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.15 -0.968 . . . . 1.17 108.464 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.56 77.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.952 -1.093 . . . . 1.18 109.355 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.05 -29.64 57.91 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.71 -1.243 . . . . 2.56 109.311 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -81.87 -9.62 59.54 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.256 -0.902 . . . . 1.79 109.971 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.9 t -65.37 -54.54 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.695 -1.253 . . . . 1.0 109.157 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.05 -39.98 87.83 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.294 -0.879 . . . . 1.77 109.56 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -67.82 -44.91 76.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.177 -0.952 . . . . 2.7 110.347 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.483 ' HG3' HG21 ' A' ' 31' ' ' ILE . 64.1 mm-40 -61.28 -41.02 96.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.915 -1.116 . . . . 1.51 110.44 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.37 -47.16 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.66 -1.275 . . . . 0.93 107.957 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -62.11 -47.57 84.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.552 -0.717 . . . . 1.81 109.697 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -60.1 -41.42 92.47 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.621 -1.252 . . . . 2.78 107.621 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -64.53 -46.34 83.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.69 -0.631 . . . . 0.78 109.341 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 48' ' ' ALA . 63.6 tp -59.86 -44.84 93.92 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.508 -0.923 . . . . 1.07 108.508 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.5 t -65.03 -44.02 90.47 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.441 -0.904 . . . . 1.12 109.007 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.39 -43.13 95.47 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.282 -1.927 . . . . 0.84 108.282 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.493 ' NH2' ' O ' ' A' ' 80' ' ' LEU . 68.1 ttt180 -66.4 -37.0 84.24 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.01 -1.107 . . . . 3.09 108.01 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -60.0 -39.76 86.88 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.921 -0.77 . . . . 0.88 108.921 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 50' ' ' ALA . 18.0 ttpp -60.06 -73.64 0.09 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.108 -0.995 . . . . 2.59 108.486 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.67 -33.95 0.09 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.163 -0.961 . . . . 0.7 111.944 -177.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.0 m -60.0 -49.79 76.3 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.361 -1.462 . . . . 1.4 108.586 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.82 -40.06 79.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.853 . . . . 0.67 110.725 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -65.86 -40.09 91.34 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.897 -1.127 . . . . 1.66 110.021 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.0 mt -60.73 -39.95 90.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.093 -1.004 . . . . 1.58 108.687 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -59.98 -39.71 86.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.618 -0.676 . . . . 1.35 110.168 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.9 m -63.93 -43.38 96.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.72 -1.237 . . . . 0.77 108.609 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.532 ' CD1' HH22 ' A' ' 136' ' ' ARG . 82.3 mt -61.18 -39.94 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.464 -0.772 . . . . 0.63 109.027 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -56.63 -49.99 73.36 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.475 -0.935 . . . . 1.14 108.475 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -59.91 -35.21 74.38 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.675 -0.641 . . . . 0.79 110.464 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -68.16 -39.92 82.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.858 -1.151 . . . . 1.53 109.627 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.98 82.68 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.574 -0.704 . . . . 0.57 110.097 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.01 -51.11 60.91 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 119.905 -1.14 . . . . 0.75 110.394 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.09 -44.72 68.49 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.09 -1.241 . . . . 1.59 109.966 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.9 m -67.17 -62.46 1.42 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.936 . . . . 0.73 112.178 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -94.65 -49.13 5.77 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.905 -1.122 . . . . 0.75 111.058 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.79 -169.6 25.17 Favored Glycine 0 N--CA 1.502 3.043 0 C-N-CA 119.702 -1.237 . . . . 1.22 111.445 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -66.71 -26.32 66.96 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.939 -0.742 . . . . 5.81 110.109 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.12 -36.19 76.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.292 -0.88 . . . . 3.37 110.36 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HA ' HD12 ' A' ' 72' ' ' ILE . 66.8 mmtt -97.23 -17.51 19.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.234 -0.916 . . . . 1.77 109.961 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -71.34 -42.79 68.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.054 -1.029 . . . . 1.65 110.264 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.5 -28.41 69.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.542 -0.724 . . . . 0.77 109.756 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 69' ' ' LYS . 81.9 mt -60.06 -40.76 84.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.095 -1.003 . . . . 0.8 108.9 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -69.99 -37.14 75.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 0.88 111.248 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.442 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 65.0 tt0 -60.01 -40.37 89.03 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.626 -1.296 . . . . 1.37 109.63 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.63 -43.2 96.78 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.932 -1.667 . . . . 0.62 108.932 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -60.74 -45.19 95.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.306 -1.114 . . . . 1.5 109.14 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.2 mt -68.75 -47.19 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.63 109.786 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.7 ttp -60.0 -43.35 95.27 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.964 -1.085 . . . . 1.51 110.031 -178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.907 HD22 HD23 ' B' ' 347' ' ' LEU . 34.1 tp -60.25 -39.94 88.56 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.445 -0.785 . . . . 0.77 109.565 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.493 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 58.8 tp -61.67 -39.89 93.0 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.726 -0.608 . . . . 0.62 110.074 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.16 9.93 7.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.166 -0.959 . . . . 1.47 110.913 -178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -53.88 130.85 38.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.66 -1.275 . . . . 1.47 109.704 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -57.73 -21.02 38.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.498 -0.751 . . . . 1.78 110.395 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -70.49 -34.43 72.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.004 -1.06 . . . . 2.53 108.991 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 44.9 mt -69.99 -40.51 75.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.634 -0.666 . . . . 0.8 109.827 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.15 -47.14 87.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.151 -0.968 . . . . 1.42 110.45 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -69.91 -42.8 72.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.121 -0.987 . . . . 1.71 111.323 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -70.1 -39.98 75.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.992 -1.068 . . . . 1.57 111.171 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 91.4 mt -66.6 -49.57 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.976 -1.077 . . . . 0.65 109.668 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.462 HG23 ' HZ2' ' A' ' 94' ' ' LYS . 84.8 mt -69.66 -39.96 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.587 -0.696 . . . . 0.82 110.521 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.0 -47.86 84.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.081 -1.012 . . . . 0.79 110.888 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.06 -46.84 88.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.987 -1.071 . . . . 0.95 109.897 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.48 -49.54 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.66 109.711 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.462 ' HZ2' HG23 ' A' ' 90' ' ' ILE . 54.2 mttp -69.91 -45.84 66.69 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.419 -0.801 . . . . 2.2 111.173 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -80.16 -49.55 11.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.998 -1.063 . . . . 1.65 112.148 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -91.13 -3.62 56.92 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.938 -1.101 . . . . 2.03 111.944 -177.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 54.73 36.23 25.8 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.752 -1.217 . . . . 1.42 109.209 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 51.3 mtt -87.24 169.77 12.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.541 -0.725 . . . . 1.18 109.399 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 65.6 p -80.53 156.76 26.35 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.187 -0.946 . . . . 0.98 108.915 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.97 75.64 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.229 -0.919 . . . . 0.64 109.344 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -63.16 -40.08 96.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.897 . . . . 2.07 109.82 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.44 -49.32 10.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.73 109.87 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.49 -41.34 96.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.477 -0.764 . . . . 0.54 110.555 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.09 -54.02 36.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.927 -1.108 . . . . 0.56 110.349 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -63.15 -27.75 69.59 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.037 -1.039 . . . . 1.54 109.344 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.12 -40.12 88.59 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.286 -0.883 . . . . 1.33 109.39 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.26 -46.64 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.969 -1.082 . . . . 0.72 109.407 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.9 mm -61.15 -41.89 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.31 -0.869 . . . . 0.85 109.187 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -68.99 -34.3 75.08 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.153 -1.055 . . . . 2.44 108.153 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.48 -45.17 95.97 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.301 -1.12 . . . . 0.98 110.301 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -69.98 -46.85 64.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.755 -1.438 . . . . 1.41 109.807 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.01 86.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 1.2 109.909 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 58.0 m -60.01 -40.09 88.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.052 -1.03 . . . . 1.7 109.441 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.72 91.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 1.47 109.3 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 127' ' ' ALA . 20.1 mt -63.75 -40.08 95.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.072 -1.018 . . . . 1.56 109.581 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -58.35 -31.21 67.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.81 -1.181 . . . . 2.2 109.542 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -58.66 -25.59 62.92 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.339 -0.986 . . . . 2.12 108.339 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.442 HD13 HD13 ' A' ' 123' ' ' LEU . 44.0 mt -62.71 144.71 56.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.878 . . . . 2.0 108.805 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -96.54 45.4 1.06 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.089 -1.007 . . . . 3.23 109.92 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 51.4 t0 -136.05 146.14 46.78 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.253 -0.904 . . . . 2.49 109.604 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.538 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -73.9 -63.6 1.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.569 -0.9 . . . . 3.95 108.569 178.319 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.496 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.0 t80 -39.23 -41.73 0.9 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.905 -0.497 . . . . 2.0 111.187 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.442 HD13 HD13 ' A' ' 118' ' ' LEU . 91.4 mt -70.02 -40.01 75.45 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.64 -1.287 . . . . 1.86 108.651 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 121' ' ' GLU . 33.4 ttmt -62.38 -39.87 94.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.451 -0.781 . . . . 2.84 109.836 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 98.9 mt-10 -60.07 -40.91 91.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.236 -0.915 . . . . 2.73 110.225 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -62.09 -39.97 94.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.971 -1.081 . . . . 2.77 108.816 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.45 ' HB2' HD12 ' A' ' 115' ' ' LEU . . . -63.22 -28.47 70.06 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.507 -0.923 . . . . 1.19 108.507 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -60.02 -42.04 93.46 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.323 -0.992 . . . . 1.2 108.323 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.59 -40.01 95.86 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.586 -0.894 . . . . 1.55 108.586 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.8 t -66.26 -40.06 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.884 -0.784 . . . . 0.8 108.884 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.415 HH11 ' HG2' ' A' ' 131' ' ' ARG . 36.3 ttt-85 -60.56 -37.35 80.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.334 -0.854 . . . . 3.09 108.963 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -60.01 -42.74 94.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.419 -0.801 . . . . 1.46 109.992 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.0 -47.63 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.822 -1.174 . . . . 0.71 109.322 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.94 -41.06 97.67 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.302 -1.519 . . . . 0.57 109.302 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -60.15 -49.86 75.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.352 -1.087 . . . . 2.59 109.671 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.532 HH22 ' CD1' ' A' ' 57' ' ' ILE . 63.3 mtp180 -64.59 -36.04 82.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 2.83 110.333 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.94 -44.39 94.39 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.419 -0.8 . . . . 1.25 109.371 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.25 -42.59 95.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -0.954 . . . . 0.7 110.095 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -72.63 -35.85 67.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.052 -1.03 . . . . 2.57 109.288 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -60.06 -39.84 87.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.609 -0.682 . . . . 1.23 110.845 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.0 mt -74.98 -42.59 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.844 -1.16 . . . . 0.81 109.736 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.99 -29.95 67.17 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.574 -0.704 . . . . 1.0 109.934 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.46 40.6 10.89 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.74 -1.744 . . . . 0.89 108.74 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.3 tp -73.02 148.45 44.14 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.474 -1.015 . . . . 1.14 109.004 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -68.47 148.45 50.59 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.189 -0.944 . . . . 4.6 110.426 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.8 mt -119.98 122.67 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.989 0.899 . . . . 1.24 109.709 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.9 mt -61.0 -42.5 93.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 109.28 -0.637 . . . . 1.54 109.28 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.9 t0 62.47 123.92 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.779 -0.576 . . . . 1.5 110.125 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.505 ' O ' HD12 ' A' ' 152' ' ' ILE . 83.4 mt -78.13 -5.78 52.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 0.79 108.68 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.8 t -81.84 -10.07 59.42 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.683 -0.858 . . . . 1.4 108.683 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.74 19.71 1.28 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.754 -0.591 . . . . 0.92 110.109 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.505 HD12 ' O ' ' A' ' 149' ' ' LEU . 56.3 mt -91.58 120.69 41.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 121.253 -0.905 . . . . 0.88 109.161 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -108.01 -8.53 15.85 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.356 -0.84 . . . . 2.45 109.874 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -129.57 152.07 49.49 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.413 -0.805 . . . . 1.52 109.884 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.15 133.51 53.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -0.91 . . . . 1.58 108.872 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.5 m -152.83 166.35 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.402 -0.812 . . . . 0.69 109.757 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.3 mt -93.06 147.94 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 106.015 -1.846 . . . . 0.61 106.015 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.9 tp -102.13 117.61 35.14 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.052 -1.03 . . . . 0.87 109.9 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.7 t -125.02 134.31 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.36 -0.978 . . . . 0.71 108.36 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.81 168.63 22.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.113 -0.992 . . . . 0.81 109.14 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.91 -38.26 69.93 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.318 -1.489 . . . . 0.98 107.941 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -171.17 145.58 2.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.599 -0.688 . . . . 2.25 109.486 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.2 mt -115.91 137.46 52.08 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.415 -0.803 . . . . 0.78 109.615 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.2 p -91.22 149.97 40.71 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.233 -0.917 . . . . 0.98 109.512 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -42.36 -36.99 4.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.488 2.126 . . . . 0.81 113.564 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 72.3 m -59.99 -40.05 87.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.881 -1.137 . . . . 0.9 109.314 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.75 -43.09 89.99 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.148 -0.97 . . . . 1.61 109.432 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 79.1 p -59.1 -19.57 45.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.39 -0.819 . . . . 0.61 111.555 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -83.86 -46.72 11.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.769 -1.207 . . . . 0.6 110.26 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -90.73 39.32 0.98 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.312 -0.996 . . . . 1.4 108.312 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.459 HD13 HD13 ' A' ' 149' ' ' LEU . 56.6 tp -105.6 137.1 44.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.567 -0.708 . . . . 0.7 110.231 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -89.91 101.57 14.27 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.285 -0.884 . . . . 2.35 108.872 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.32 -39.99 94.84 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.385 -0.822 . . . . 1.51 111.109 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -66.54 -24.22 66.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.115 -0.991 . . . . 2.33 111.543 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -93.74 -10.96 32.52 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.706 -1.246 . . . . 1.92 110.358 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.521 HG11 ' CE1' ' A' ' 179' ' ' PHE . 80.4 t -102.76 112.77 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.099 -1.001 . . . . 0.67 109.355 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.7 mt -83.62 3.8 31.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.252 -0.905 . . . . 1.53 110.354 -178.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.509 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 173.38 169.91 36.33 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.554 -1.418 . . . . 0.48 109.554 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.521 ' CE1' HG11 ' A' ' 176' ' ' VAL . 7.0 m-85 -134.47 130.23 36.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.395 -1.062 . . . . 0.55 108.517 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.423 ' CG2' HG21 ' A' ' 205' ' ' THR . 67.2 mt -130.45 125.48 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.567 -0.901 . . . . 0.65 108.567 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 7.7 p -143.07 154.33 43.84 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.21 -0.931 . . . . 0.82 111.046 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -106.28 27.88 8.27 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.797 -0.816 . . . . 2.46 108.797 179.279 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.04 -157.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.825 -1.172 . . . . 1.28 111.908 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -53.4 -80.98 0.06 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.863 -1.295 . . . . 2.19 109.863 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLY . . . . . 0.45 ' O ' ' OG ' ' A' ' 191' ' ' SER . . . -178.3 -131.97 1.64 Allowed Glycine 0 N--CA 1.488 2.1 0 C-N-CA 119.424 -1.369 . . . . 2.13 110.286 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.402 ' NH1' ' HG3' ' A' ' 186' ' ' ARG . 7.1 ptm180 -73.28 -10.53 59.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.628 -0.925 . . . . 5.86 111.122 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 51.7 p -92.83 7.84 42.08 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.804 -1.185 . . . . 3.72 110.984 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 78.7 p -89.08 143.43 26.85 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.733 -1.23 . . . . 1.74 110.124 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -47.37 -47.48 26.08 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.383 -0.823 . . . . 0.95 109.338 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.0 m -56.53 -39.64 73.72 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.742 -0.599 . . . . 1.55 109.857 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 185' ' ' GLY . 53.7 m -59.89 -40.04 87.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.98 -1.075 . . . . 1.51 110.923 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 89.1 mt -60.06 -41.26 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.0 . . . . 1.67 110.161 -178.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.8 mtp -60.07 -50.37 73.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.093 -1.005 . . . . 1.02 111.116 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -50.94 -45.41 60.6 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.908 -1.12 . . . . 0.68 109.646 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -60.03 -51.65 68.75 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.07 -1.052 . . . . 2.93 109.733 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.8 m -71.99 -35.06 69.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.075 -1.016 . . . . 0.86 110.86 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.46 -30.02 65.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.645 -1.284 . . . . 0.67 108.318 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 66.4 49.8 1.37 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.357 0.598 . . . . 1.5 110.138 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.445 ' O ' ' CB ' ' A' ' 8' ' ' SER . 86.1 mt -127.77 141.39 40.94 Favored Pre-proline 0 N--CA 1.503 2.215 0 N-CA-C 108.677 -0.86 . . . . 0.72 108.677 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -44.37 128.42 8.01 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.94 1.76 . . . . 0.61 112.039 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.8 141.51 6.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.875 -1.141 . . . . 0.66 111.471 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.2 mt -123.76 142.3 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.069 -1.456 . . . . 0.79 107.069 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 18.2 m -126.01 -12.03 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 120.952 -1.092 . . . . 0.91 111.382 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -106.11 23.06 29.95 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.014 -1.234 . . . . 1.01 110.014 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.435 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 2.8 p -44.91 -43.58 9.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -1.129 . . . . 0.99 110.083 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.76 -55.38 4.11 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 119.964 -1.112 . . . . 1.12 111.881 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 35.1 m -153.04 36.08 0.48 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.56 -1.553 . . . . 1.72 111.479 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.5 t -72.39 -40.15 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.914 -1.116 . . . . 0.89 108.53 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 38.3 p -52.98 -25.49 12.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.57 -0.706 . . . . 1.03 110.233 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.7 m -77.45 -30.91 53.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.037 -1.039 . . . . 1.83 110.551 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -93.33 -9.29 39.4 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.969 -1.082 . . . . 2.27 111.127 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.8 t -105.88 134.77 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.13 -0.981 . . . . 0.92 111.077 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -111.2 154.89 23.75 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.146 -1.427 . . . . 2.2 107.146 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 57.8 t-20 -59.87 138.9 57.69 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.781 -1.199 . . . . 2.36 109.728 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 7.7 t0 80.76 6.47 1.43 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.015 0.436 . . . . 2.38 110.172 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -71.97 128.96 37.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.029 -1.045 . . . . 2.09 109.059 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -79.45 114.78 18.65 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.914 -1.143 . . . . 1.27 107.914 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.591 HD12 ' HB2' ' A' ' 16' ' ' ALA . 75.1 mt -127.04 150.56 49.39 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.526 -0.734 . . . . 0.75 110.508 -178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.3 mt -116.35 128.94 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 106.043 -1.836 . . . . 0.63 106.043 177.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 31.5 tp -99.98 118.85 37.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.794 -1.191 . . . . 0.7 108.194 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 223' ' ' VAL . 20.7 t0 -80.66 -39.94 26.41 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.889 -1.132 . . . . 2.31 108.275 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 43.13 19.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.533 0.682 . . . . 0.78 109.377 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.4 t -134.32 -42.99 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.356 -1.35 . . . . 1.04 107.356 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -100.03 2.99 43.89 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.293 -1.373 . . . . 2.44 107.293 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.431 ' OD1' ' CB ' ' A' ' 3' ' ' SER . 9.8 t-20 59.96 48.5 8.69 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.506 -0.553 . . . . 1.55 109.506 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -142.0 150.37 41.24 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.158 -0.964 . . . . 1.99 110.29 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.4 t -119.96 128.75 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.84 -1.17 . . . . 0.77 107.84 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -104.96 120.05 40.5 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.285 -0.884 . . . . 0.98 108.913 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.423 HG22 HD22 ' A' ' 218' ' ' LEU . 46.4 t -100.28 114.7 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.503 -0.748 . . . . 0.85 110.194 -178.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 50.96 69.11 2.78 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.272 -0.892 . . . . 1.66 110.819 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -90.43 144.16 3.87 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.298 2.665 . . . . 0.95 112.135 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 5.2 m -68.59 164.16 22.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 1.84 110.14 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -59.96 -36.74 77.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.532 -0.73 . . . . 2.74 110.051 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.03 -39.56 86.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 2.89 109.466 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.8 t -70.67 -36.09 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.014 -1.054 . . . . 1.3 109.451 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.117 -0.989 . . . . 1.09 109.774 179.605 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.564 0.697 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 302' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 19.0 t80 -152.64 151.4 30.55 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 303' ' ' GLN . . . . . 0.466 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 12.9 pt20 -145.58 155.04 42.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.995 -1.065 . . . . 0.0 110.708 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 304' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' B' ' 305' ' ' GLU . 12.5 tm0? -149.58 145.34 26.75 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 305' ' ' GLU . . . . . 0.506 ' O ' ' NE2' ' B' ' 304' ' ' GLN . 39.2 mp0 -109.09 131.8 54.72 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.067 -1.02 . . . . 0.0 110.46 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.07 119.12 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-O 122.077 0.941 . . . . 0.0 112.452 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 35.6 m -77.3 104.65 7.93 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.99 0.9 . . . . 0.0 111.024 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.8 mt -53.03 123.87 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.318 1.056 . . . . 0.0 110.729 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 71.9 p -111.37 20.11 17.59 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.257 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.14 120.39 80.01 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.831 -1.168 . . . . 0.0 109.682 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -49.57 -21.5 5.34 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 CA-C-N 120.137 1.084 . . . . 0.0 113.069 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -120.74 13.7 11.6 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.46 -0.775 . . . . 0.0 109.775 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.34 -178.6 37.83 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.496 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -84.42 91.06 7.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.111 -1.229 . . . . 0.0 110.191 -178.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -95.35 -160.35 0.78 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.673 -1.267 . . . . 0.0 109.995 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 5.3 m -59.61 -40.6 88.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.847 -1.158 . . . . 0.0 112.492 -175.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.603 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.2 tpt180 -62.75 -61.74 6.96 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 120.329 -1.482 . . . . 0.0 112.069 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.05 -30.32 93.0 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 CA-C-N 120.151 1.09 . . . . 0.0 111.824 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.05 -50.53 73.36 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.55 -39.32 61.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.344 -0.848 . . . . 0.0 109.431 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -68.99 -43.83 74.09 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.998 -1.064 . . . . 0.0 108.342 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -60.04 -52.27 66.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.439 -0.788 . . . . 0.0 110.984 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 323' ' ' VAL . . . . . 0.43 HG13 ' O ' ' B' ' 344' ' ' ALA . 72.1 t -68.42 -28.92 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.728 -1.232 . . . . 0.0 110.7 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 324' ' ' LYS . . . . . 0.442 ' NZ ' ' OE1' ' A' ' 74' ' ' GLU . 24.7 ttmt -61.77 -45.8 92.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.109 -0.994 . . . . 0.0 110.252 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -69.97 -40.05 75.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.987 -1.07 . . . . 0.0 111.417 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -61.53 -52.8 62.97 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.469 -1.394 . . . . 0.0 110.26 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -53.34 -11.23 0.28 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.169 -0.957 . . . . 0.0 109.648 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -75.93 -25.62 66.49 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -105.05 141.1 37.21 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.629 -0.924 . . . . 0.0 108.798 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 330' ' ' THR . . . . . 0.421 HG22 ' O ' ' B' ' 330' ' ' THR . 89.7 m -89.94 -10.51 44.84 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.941 -1.099 . . . . 0.0 109.871 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.597 ' HG ' ' H ' ' B' ' 369' ' ' ASP . 75.6 m -61.49 149.62 38.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.705 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -67.67 132.77 48.11 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.0 mt -133.33 134.17 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.653 -0.654 . . . . 0.0 109.564 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 334' ' ' THR . . . . . 0.433 HG22 ' N ' ' B' ' 335' ' ' VAL . 51.5 m -131.68 155.04 48.33 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 335' ' ' VAL . . . . . 0.433 ' N ' HG22 ' B' ' 334' ' ' THR . 75.9 t -117.41 140.02 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 70.2 m -130.47 122.25 27.34 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.217 -0.927 . . . . 0.0 109.22 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 1.8 m -140.21 120.22 13.65 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 122.054 0.93 . . . . 0.0 110.657 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 47.56 57.8 5.56 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 75.28 -11.55 8.58 Favored Glycine 0 N--CA 1.498 2.787 0 O-C-N 120.19 -1.569 . . . . 0.0 112.52 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -114.43 125.1 53.45 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 118.923 1.361 . . . . 0.0 109.289 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 51.8 m -126.56 148.32 49.76 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.616 0.722 . . . . 0.0 110.196 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.77 167.44 22.58 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.515 0.674 . . . . 0.0 109.955 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 19.8 m -87.09 139.05 30.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.43 -0.794 . . . . 0.0 109.595 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.43 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -78.7 -14.27 59.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.001 -1.062 . . . . 0.0 109.195 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -86.81 18.19 3.6 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 61.2 m -145.27 93.23 2.35 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.601 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.907 HD23 HD22 ' A' ' 79' ' ' LEU . 13.4 tp -55.74 -36.66 67.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.746 ' CE2' HD11 ' A' ' 79' ' ' LEU . 47.1 m-85 -58.69 -52.52 65.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 110.165 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -68.68 -21.11 64.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.992 -1.067 . . . . 0.0 110.987 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' B' ' 352' ' ' THR . 90.2 mt -69.94 -52.16 26.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.532 -1.355 . . . . 0.0 108.523 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' B' ' 347' ' ' LEU . 0.1 OUTLIER -39.21 -18.85 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.817 -0.552 . . . . 0.0 111.07 -178.301 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.564 ' N ' ' O ' ' B' ' 350' ' ' LEU . 71.1 p -85.92 -11.12 53.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.225 -1.547 . . . . 0.0 110.647 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 42.3 mt -94.82 116.95 29.36 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.931 -1.106 . . . . 0.0 109.247 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.94 94.23 0.98 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 24.1 mt -103.31 94.58 5.58 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.453 -1.028 . . . . 0.0 108.947 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 43.3 p -93.3 161.01 14.57 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.101 -0.999 . . . . 0.0 110.427 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -54.22 119.36 5.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.551 -0.718 . . . . 0.0 110.225 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 358' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 98.74 4.65 56.89 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.036 -1.625 . . . . 0.0 109.036 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.9 m -84.2 112.64 20.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.406 -1.055 . . . . 0.0 110.574 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 19.3 t -78.44 116.62 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 122.081 0.943 . . . . 0.0 109.939 -177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 17.3 m -110.38 177.5 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -178.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 58.5 m -131.35 130.01 42.12 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 78.3 mt -102.82 115.39 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 73.3 m -117.28 130.79 56.78 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.558 -0.714 . . . . 0.0 109.13 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.89 152.27 39.98 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.171 -0.956 . . . . 0.0 110.363 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 366' ' ' GLU . . . . . 0.436 ' OE2' ' OE2' ' B' ' 370' ' ' GLU . 9.9 tp10 -143.02 120.25 11.51 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.16 -163.88 36.78 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.466 -1.826 . . . . 0.0 111.947 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -59.2 -49.95 75.88 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 115.029 -0.586 . . . . 0.0 112.006 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.597 ' H ' ' HG ' ' B' ' 331' ' ' SER . 92.0 m-20 -105.77 10.74 32.58 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.979 -1.076 . . . . 0.0 111.066 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.436 ' OE2' ' OE2' ' B' ' 366' ' ' GLU . 14.7 pt-20 -40.98 -30.6 0.14 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.167 -0.958 . . . . 0.0 110.88 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -69.58 -40.46 76.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.06 -1.025 . . . . 0.0 109.204 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -72.16 -55.11 7.83 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 108.983 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -41.83 -35.63 0.87 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.694 -0.629 . . . . 0.0 111.771 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.468 ' O ' HG23 ' B' ' 378' ' ' VAL . 62.2 t -79.93 -32.44 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.541 -1.35 . . . . 0.0 109.68 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.3 -60.05 3.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.978 -1.076 . . . . 0.0 111.939 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -73.31 -40.85 64.17 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.483 -1.386 . . . . 0.0 112.66 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.99 -40.05 87.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.528 -1.357 . . . . 0.0 109.042 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.5 t -61.08 -47.65 92.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.132 -0.98 . . . . 0.0 109.831 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -69.54 -55.75 9.27 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.728 -1.232 . . . . 0.0 108.154 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.476 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 60.7 tp -53.04 -34.08 54.83 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.504 -0.747 . . . . 0.0 109.7 -178.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 39.5 ttm -75.44 -38.54 59.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.945 -1.097 . . . . 0.0 108.55 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.17 -5.42 51.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.685 -0.634 . . . . 0.0 110.496 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -110.45 4.54 20.62 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.085 -1.009 . . . . 0.0 110.812 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 384' ' ' LEU . . . . . 0.476 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 26.3 mt -72.2 121.97 20.25 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.34 -1.475 . . . . 0.0 109.947 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.989 -1.005 . . . . 0.0 108.942 179.152 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.6 mtm . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.076 -0.712 . . . . 2.91 109.076 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.7 mt -110.45 122.32 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.414 -0.804 . . . . 1.2 108.958 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.6 m -139.26 146.64 40.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.416 -0.802 . . . . 1.4 109.104 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.68 -162.79 9.25 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 108.719 -1.752 . . . . 1.05 108.719 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.6 mt -89.81 -13.71 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.863 -1.375 . . . . 1.15 110.302 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.3 tp 55.8 102.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 0.98 108.88 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.83 -23.12 17.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.0 . . . . 0.88 109.593 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 16.0 t -147.78 130.55 7.89 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.069 -1.019 . . . . 1.69 109.739 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.34 144.42 16.24 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.13 1.887 . . . . 0.85 112.902 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.908 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.28 167.27 16.05 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.745 -1.342 . . . . 0.92 109.745 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.0 mt -123.66 130.42 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.088 -1.243 . . . . 0.81 109.601 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.9 150.07 49.2 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.202 -0.936 . . . . 0.51 110.619 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.1 m-85 -126.29 129.97 49.94 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.793 -1.188 . . . . 0.62 107.793 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.04 178.94 48.59 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 118.354 -1.879 . . . . 0.55 110.969 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -78.87 158.46 28.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.764 -0.845 . . . . 2.1 109.195 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -106.17 131.55 53.29 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.559 -0.713 . . . . 0.77 110.485 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.8 tp -99.75 136.31 39.86 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.593 -1.262 . . . . 0.91 107.593 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.4 tp -115.84 119.96 37.7 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.309 -0.869 . . . . 0.93 109.613 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.484 HD12 ' HB2' ' A' ' 160' ' ' ALA . 56.8 mt -90.69 105.79 18.06 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.767 -0.583 . . . . 0.93 109.803 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -101.48 136.61 41.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.368 -0.833 . . . . 2.75 109.252 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -127.34 122.19 33.08 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.799 -0.815 . . . . 3.0 108.799 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -71.19 148.25 47.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 2.77 109.904 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -65.18 141.86 58.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 2.94 109.489 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -82.02 130.12 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.95 109.176 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.6 t -93.9 124.06 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.255 -0.903 . . . . 1.28 109.868 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.5 mt -103.74 138.46 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.436 -0.79 . . . . 1.21 109.119 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -97.22 117.73 32.09 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.152 -0.967 . . . . 1.81 109.208 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -86.92 -2.3 58.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.367 -0.833 . . . . 2.8 109.372 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -64.34 141.3 58.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 2.87 109.68 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -87.73 150.14 23.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.913 . . . . 2.35 108.997 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.544 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.7 pt -92.95 165.64 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.365 -0.834 . . . . 0.97 110.475 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.4 p -99.15 171.22 8.15 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.349 -0.982 . . . . 1.17 108.349 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.19 -47.93 80.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 1.18 109.089 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -55.63 -32.3 63.04 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.0 -1.062 . . . . 2.56 109.656 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -82.16 -9.91 59.35 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.287 -0.883 . . . . 1.79 110.246 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.63 -53.31 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.506 -1.371 . . . . 1.0 109.499 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.78 -40.05 95.73 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.023 -1.048 . . . . 1.77 110.006 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -69.98 -39.96 75.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.036 -1.04 . . . . 2.7 110.463 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.544 ' HG3' HG21 ' A' ' 31' ' ' ILE . 66.1 mm-40 -67.11 -40.05 86.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.006 -1.058 . . . . 1.51 110.069 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.99 -43.19 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.712 -1.242 . . . . 0.93 108.361 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -59.55 -37.1 77.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 1.81 108.895 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -60.04 -43.14 95.55 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.908 -1.145 . . . . 2.78 107.908 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -62.24 -49.78 74.34 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.449 -0.782 . . . . 0.78 109.409 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.5 tp -59.91 -48.4 81.87 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.397 -0.814 . . . . 1.07 109.024 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.5 t -62.21 -43.32 99.1 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.995 -1.065 . . . . 1.12 108.735 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.29 -45.42 96.02 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.732 -1.747 . . . . 0.84 108.732 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -67.48 -32.67 73.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.396 -1.061 . . . . 3.09 108.423 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.29 -40.03 84.88 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.643 -0.873 . . . . 0.88 108.643 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 50' ' ' ALA . 27.9 ttpt -67.25 -74.58 0.11 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.417 -0.956 . . . . 2.59 108.417 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.05 -33.22 0.08 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.203 -0.936 . . . . 0.7 111.489 -178.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 83.3 p -60.06 -54.53 44.89 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.563 -1.336 . . . . 1.4 108.697 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.02 -40.2 75.36 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.372 -0.83 . . . . 0.67 111.157 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -65.16 -40.13 93.89 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.73 -1.231 . . . . 1.66 110.735 -178.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.28 -39.97 93.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.857 -1.152 . . . . 1.58 109.018 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -60.35 -37.13 79.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.385 -0.822 . . . . 1.35 109.419 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.5 m -65.41 -43.23 91.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.831 -1.168 . . . . 0.77 109.007 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.668 ' CD1' HH22 ' A' ' 136' ' ' ARG . 78.9 mt -62.04 -40.01 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.504 -0.925 . . . . 0.63 108.504 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -55.57 -50.22 70.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.4 -0.813 . . . . 1.14 109.527 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -57.99 -33.0 68.44 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.159 -0.963 . . . . 0.79 110.19 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -68.79 -37.87 79.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 1.53 109.145 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.464 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.45 -45.29 76.43 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.702 -0.624 . . . . 0.57 110.393 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.72 -50.78 64.06 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.861 -1.162 . . . . 0.75 110.272 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.07 -42.09 73.25 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.12 -1.223 . . . . 1.59 110.379 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.2 m -69.96 -59.11 3.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.03 -1.043 . . . . 0.73 111.729 -178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -97.07 -52.25 3.92 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.959 -1.088 . . . . 0.75 111.103 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.67 -165.38 26.49 Favored Glycine 0 N--CA 1.5 2.905 0 C-N-CA 119.706 -1.235 . . . . 1.22 110.955 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -70.75 -22.62 62.39 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.89 -0.771 . . . . 5.81 110.354 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.458 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.1 tp10 -62.05 -37.64 85.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 3.37 110.904 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -99.67 -18.02 17.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.184 -0.947 . . . . 1.77 110.12 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -69.76 -39.93 76.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.119 -0.988 . . . . 1.65 110.423 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.492 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.04 -30.92 71.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.382 -0.824 . . . . 0.77 109.834 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.0 -41.46 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.036 -1.04 . . . . 0.8 109.085 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -62.61 -40.45 96.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.065 -1.022 . . . . 0.88 109.966 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -60.78 -39.92 90.63 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.188 -1.005 . . . . 1.37 109.335 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.18 -41.26 98.43 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.671 -1.772 . . . . 0.62 108.671 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.7 m170 -69.77 -42.44 73.82 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.376 -1.073 . . . . 1.5 108.935 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.4 mt -70.14 -46.19 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.285 -0.884 . . . . 0.63 109.359 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.1 ttp -61.16 -40.93 95.71 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.087 -1.008 . . . . 1.51 110.05 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.863 HD11 ' CE2' ' B' ' 348' ' ' PHE . 59.0 tp -66.47 -40.05 89.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.164 -0.96 . . . . 0.77 109.444 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.2 tp -66.53 -39.88 88.83 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.502 -0.749 . . . . 0.62 110.012 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -79.99 -1.56 40.15 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.186 -0.946 . . . . 1.47 110.192 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -47.88 130.26 14.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.032 . . . . 1.47 109.904 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.28 -16.38 60.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.662 -0.649 . . . . 1.78 110.198 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.26 -35.18 73.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.941 -1.099 . . . . 2.53 108.512 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.12 -40.01 68.44 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.462 0.649 . . . . 0.8 109.275 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.04 -49.96 75.61 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.559 -0.713 . . . . 1.42 109.993 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -70.65 -40.31 73.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.257 -0.902 . . . . 1.71 110.839 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -69.74 -40.02 76.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.059 -1.025 . . . . 1.57 110.567 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.8 mt -68.6 -45.8 81.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.112 -0.992 . . . . 0.65 108.944 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.26 -39.1 80.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.528 -0.733 . . . . 0.82 109.963 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.07 -47.15 87.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.195 -0.94 . . . . 0.79 110.452 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 96' ' ' LYS . 85.7 mt -62.64 -45.77 91.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.896 -1.127 . . . . 0.95 109.43 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.79 -50.05 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 0.66 109.135 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -70.03 -40.56 75.11 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.707 -0.797 . . . . 2.2 110.338 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -81.3 -50.16 9.85 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.997 -1.064 . . . . 1.65 111.716 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 92' ' ' LEU . 19.7 mmmt -90.38 -1.83 57.93 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.933 -1.104 . . . . 2.03 111.64 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.3 m80 55.88 35.3 25.19 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.889 -1.132 . . . . 1.42 109.529 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.5 mtt -89.38 168.57 12.12 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.629 -0.669 . . . . 1.18 110.147 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 102' ' ' ALA . 32.9 p -80.72 158.51 25.52 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.42 -0.8 . . . . 0.98 109.26 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.89 -40.06 87.64 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.243 -0.91 . . . . 0.64 109.662 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -67.87 -39.9 83.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.277 -0.89 . . . . 2.07 109.616 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.405 ' HB3' ' OG1' ' A' ' 99' ' ' THR . . . -80.99 -42.52 21.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.73 109.897 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.53 -50.46 71.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.54 109.571 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.42 -33.41 72.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.228 -0.92 . . . . 0.56 109.509 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.546 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 86.2 t60 -60.06 -46.12 90.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.264 -0.897 . . . . 1.54 109.734 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -60.36 -40.0 89.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.353 -0.842 . . . . 1.33 111.007 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 41.9 t -63.28 -62.84 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.959 -1.088 . . . . 0.72 111.435 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.5 mm -63.9 -41.67 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.875 -1.141 . . . . 0.85 109.419 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.546 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 80.8 tt0 -63.53 -38.7 92.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 2.44 108.927 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.04 -46.44 94.18 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.712 -0.955 . . . . 0.98 110.712 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -68.54 -44.04 75.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.746 -1.443 . . . . 1.41 109.67 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.43 78.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.092 -1.005 . . . . 1.2 109.055 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 29.5 t -60.02 -40.42 89.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.182 -0.949 . . . . 1.7 109.144 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.48 97.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 1.47 109.094 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.6 mt -67.82 -41.87 82.38 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.151 -0.968 . . . . 1.56 109.044 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.58 -33.62 70.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.781 -1.199 . . . . 2.2 109.774 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -57.81 -22.15 45.88 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.025 -1.047 . . . . 2.12 108.765 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.47 HD13 HD13 ' A' ' 123' ' ' LEU . 48.8 mt -63.28 139.91 58.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 2.0 108.787 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -84.41 -16.8 41.42 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.142 -0.974 . . . . 3.23 110.195 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -66.4 130.02 41.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.169 -0.957 . . . . 2.49 110.124 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.616 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 8.0 pm0 -70.13 -30.04 67.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.454 -0.779 . . . . 3.95 110.245 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.491 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.8 t80 -67.58 -34.16 76.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.406 -0.809 . . . . 2.0 110.194 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.64 HD22 ' O ' ' B' ' 351' ' ' GLN . 86.4 mt -80.15 -26.67 39.26 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.103 -0.998 . . . . 1.86 108.882 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -61.95 -47.05 86.62 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.212 -0.93 . . . . 2.84 108.604 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 121' ' ' GLU . 7.6 mp0 -65.66 -36.69 84.39 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.264 -0.897 . . . . 2.73 108.77 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.552 ' CZ ' ' NE2' ' B' ' 351' ' ' GLN . 0.2 OUTLIER -59.69 -40.03 86.51 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.855 -1.165 . . . . 2.77 107.855 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.27 -23.4 67.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.425 -0.797 . . . . 1.19 109.008 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -66.44 -39.96 89.18 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.655 -0.869 . . . . 1.2 108.655 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -64.18 -40.67 96.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.385 -0.822 . . . . 1.55 109.233 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 77.3 t -69.89 -40.15 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.487 -0.931 . . . . 0.8 108.487 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.506 HH11 ' HG2' ' A' ' 131' ' ' ARG . 11.6 ttt-85 -59.98 -40.03 87.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.397 -0.814 . . . . 3.09 108.94 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -60.44 -39.93 89.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.534 -0.729 . . . . 1.46 110.06 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.99 -43.33 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.266 -0.896 . . . . 0.71 110.861 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.71 -33.86 71.82 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.754 -1.212 . . . . 0.57 110.168 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -59.98 -48.6 81.05 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -1.174 . . . . 2.59 110.022 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.668 HH22 ' CD1' ' A' ' 57' ' ' ILE . 67.0 mtp180 -68.32 -32.22 72.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.906 -1.121 . . . . 2.83 109.602 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.88 -45.54 92.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.26 -0.9 . . . . 1.25 108.647 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.54 -40.26 90.91 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.395 -0.816 . . . . 0.7 109.062 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.482 HH11 ' HG2' ' A' ' 139' ' ' ARG . 43.4 mtt-85 -69.91 -40.09 75.8 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.426 -0.953 . . . . 2.57 108.426 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.404 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 4.5 m120 -60.5 -40.04 89.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.848 -0.533 . . . . 1.23 110.759 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.9 mt -73.15 -42.09 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.788 -1.195 . . . . 0.81 108.313 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.8 mt -70.06 -38.4 75.75 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.235 0.541 . . . . 1.0 109.807 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.16 43.78 8.5 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.963 -1.655 . . . . 0.89 108.963 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 tp -75.68 152.78 37.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.58 -0.953 . . . . 1.14 109.652 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -63.91 140.97 58.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 4.6 109.265 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.4 mt -119.83 130.08 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 122.151 0.977 . . . . 1.24 109.77 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.1 mt -59.39 -47.63 89.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 115.657 -0.702 . . . . 1.54 110.922 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 31.2 t0 66.2 99.25 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.652 -0.87 . . . . 1.5 108.652 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 25.1 mt -68.83 -3.78 13.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.79 109.709 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 59.3 m -83.45 -13.4 54.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.096 -1.003 . . . . 1.4 108.891 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.17 20.28 1.98 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.459 -0.776 . . . . 0.92 111.08 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 40.9 mm -90.05 121.18 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.598 -1.313 . . . . 0.88 108.708 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -101.32 -9.0 21.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.263 -0.898 . . . . 2.45 110.473 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -125.45 149.78 47.91 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.34 -0.85 . . . . 1.52 110.434 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.87 135.36 56.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.346 -0.847 . . . . 1.58 109.14 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.5 m -152.34 166.37 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.576 -0.703 . . . . 0.69 109.872 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 94.1 mt -95.16 149.57 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.293 -1.743 . . . . 0.61 106.293 177.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.441 HD11 HD11 ' A' ' 19' ' ' LEU . 38.3 tp -100.01 117.88 35.21 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.985 -1.072 . . . . 0.87 110.854 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.555 HG12 HG22 ' A' ' 209' ' ' THR . 84.3 t -121.54 129.44 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.408 -0.96 . . . . 0.71 108.408 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.513 ' C ' HG21 ' A' ' 209' ' ' THR . . . -160.09 165.02 32.57 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.109 -0.994 . . . . 0.81 109.091 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.45 -38.28 74.46 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.178 -1.576 . . . . 0.98 107.841 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -170.68 145.28 2.47 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.76 -0.83 . . . . 2.25 108.76 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.4 mt -112.17 140.22 47.05 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.248 -0.907 . . . . 0.78 109.818 -179.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.0 p -92.18 141.59 25.27 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.279 -0.888 . . . . 0.98 109.121 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -39.64 -36.5 1.15 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.208 1.938 . . . . 0.81 113.194 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.5 m -60.38 -40.03 89.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.033 -1.042 . . . . 0.9 110.242 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.59 -41.52 92.75 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.006 -1.058 . . . . 1.61 109.799 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.9 p -57.54 -32.92 67.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.192 -0.943 . . . . 0.61 111.293 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.464 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -70.14 -43.92 69.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.669 -1.27 . . . . 0.6 109.732 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -94.88 34.94 1.29 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.625 -0.879 . . . . 1.4 108.625 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.7 tp -107.48 138.98 42.71 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.814 -0.81 . . . . 0.7 108.814 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.469 ' O ' HG23 ' A' ' 176' ' ' VAL . 94.2 m-20 -86.47 103.87 15.41 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.141 -0.974 . . . . 2.35 109.539 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.85 -39.99 95.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.477 -0.764 . . . . 1.51 110.812 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -67.96 -25.92 65.68 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.994 -1.066 . . . . 2.33 111.76 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -93.37 -8.81 40.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.588 -1.32 . . . . 1.92 109.895 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.515 HG11 ' CE1' ' A' ' 179' ' ' PHE . 81.8 t -97.04 110.38 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.101 -0.999 . . . . 0.67 108.792 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.0 mt -77.77 2.91 15.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.222 -0.924 . . . . 1.53 110.334 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.513 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 165.6 177.04 37.6 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.198 -1.561 . . . . 0.48 109.198 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.609 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 17.8 m-85 -132.96 129.98 38.96 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.425 -1.044 . . . . 0.55 108.521 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.6 mt -134.47 127.7 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.21 -0.931 . . . . 0.65 109.348 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 29.1 p -149.74 160.02 43.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.82 110.401 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' A' ' 182' ' ' ASP . 35.1 p-10 -109.16 27.57 9.38 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.684 -0.858 . . . . 2.46 108.684 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.04 -157.18 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.197 -0.939 . . . . 1.28 111.929 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.3 -80.83 0.06 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.087 -1.205 . . . . 2.19 110.087 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.55 -134.2 2.73 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.839 -1.305 . . . . 2.13 109.839 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.414 ' C ' ' H ' ' A' ' 188' ' ' SER . 14.6 tpp180 -60.01 -40.01 87.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.404 -1.056 . . . . 5.86 110.63 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.1 p -64.97 7.79 0.15 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.065 -1.022 . . . . 3.72 111.258 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.414 ' H ' ' C ' ' A' ' 186' ' ' ARG . 15.9 m -90.72 135.32 33.79 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.66 -1.275 . . . . 1.74 110.827 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -46.12 -52.55 11.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.448 -0.783 . . . . 0.95 109.761 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.418 ' H ' HG22 ' A' ' 190' ' ' THR . 0.1 OUTLIER -53.99 -37.1 63.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.492 -0.755 . . . . 1.55 110.247 -179.101 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.3 t -60.05 -45.24 93.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.111 -0.993 . . . . 1.51 111.03 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.01 -40.49 83.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.321 -0.862 . . . . 1.67 110.406 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.2 mtp -60.14 -45.78 91.9 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.069 -1.019 . . . . 1.02 110.164 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.19 -45.97 65.38 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.549 -1.344 . . . . 0.68 109.484 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -63.48 -58.06 8.23 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.057 -1.057 . . . . 2.93 110.327 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.4 m -60.27 -39.93 88.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.897 -1.127 . . . . 0.86 111.655 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.35 -22.36 62.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.834 -1.167 . . . . 0.67 109.498 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 69.99 47.82 0.57 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.38 0.609 . . . . 1.5 110.31 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.438 ' O ' ' CB ' ' A' ' 8' ' ' SER . 68.6 mt -129.16 149.96 74.09 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 107.994 -1.113 . . . . 0.72 107.994 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.07 146.14 75.85 Favored 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 122.459 2.106 . . . . 0.61 112.05 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.609 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -177.0 154.12 1.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.106 -0.996 . . . . 0.66 111.004 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.0 mt -125.67 151.11 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.45 -1.315 . . . . 0.79 107.45 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.2 m -131.06 -12.03 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 120.866 -1.146 . . . . 0.91 111.04 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.01 25.02 17.47 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.09 -1.204 . . . . 1.01 110.09 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 22.4 p -45.32 -42.83 10.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.125 -1.221 . . . . 0.99 109.903 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 94.01 -52.52 2.23 Favored Glycine 0 N--CA 1.497 2.748 0 O-C-N 121.139 -0.976 . . . . 1.12 111.447 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 80.6 p -156.78 34.7 0.3 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.579 -1.542 . . . . 1.72 111.332 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 23.0 t -75.76 -39.42 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.061 -1.024 . . . . 0.89 108.904 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.555 HG22 HG12 ' A' ' 159' ' ' VAL . 72.7 p -56.72 -27.2 58.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 1.03 110.674 -179.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.3 m -80.25 -24.62 39.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.835 -1.166 . . . . 1.83 110.308 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -95.55 -8.66 34.47 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.152 -0.967 . . . . 2.27 110.444 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 56.0 t -102.35 136.17 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.226 -0.921 . . . . 0.92 109.943 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.48 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 2.2 mptp? -116.28 152.92 32.87 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.567 -1.271 . . . . 2.2 107.567 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.455 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 16.6 p-10 -56.29 139.46 48.15 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.999 -1.063 . . . . 2.36 110.618 -178.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.0 m-20 82.02 8.74 0.88 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.028 0.442 . . . . 2.38 110.376 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.48 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 90.6 m-20 -79.32 139.82 37.7 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.025 -1.047 . . . . 2.09 109.346 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -91.65 115.04 27.71 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.031 -1.099 . . . . 1.27 108.031 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.502 HD12 ' HB2' ' A' ' 16' ' ' ALA . 59.6 mt -125.42 150.27 47.43 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.651 -0.655 . . . . 0.75 110.627 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.3 mt -115.38 127.67 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.281 -1.377 . . . . 0.63 107.281 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 54.7 tp -100.7 119.99 39.41 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.936 -1.102 . . . . 0.7 108.702 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 223' ' ' VAL . 83.0 m-20 -78.88 -43.1 25.68 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.067 -1.02 . . . . 2.31 109.373 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.908 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.01 15.34 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.4 -0.963 . . . . 0.78 108.4 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 221' ' ' ASP . 53.2 t -131.5 -38.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.287 -1.375 . . . . 1.04 107.287 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -105.69 0.54 26.39 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.682 -1.229 . . . . 2.44 107.682 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 60.19 44.28 12.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.814 -0.554 . . . . 1.55 110.357 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -141.81 151.37 42.73 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.07 -1.019 . . . . 1.99 109.762 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.5 t -119.48 130.08 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.519 -0.919 . . . . 0.77 108.519 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -101.7 124.01 46.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.52 -0.737 . . . . 0.98 109.25 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 18.0 t -101.05 113.9 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.637 -0.665 . . . . 0.85 109.903 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 50.64 67.66 4.13 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.194 -0.941 . . . . 1.66 111.208 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -90.12 148.68 4.63 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 123.048 2.499 . . . . 0.95 112.346 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 71.5 p -72.45 166.26 22.95 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.099 -1.001 . . . . 1.84 109.897 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -59.94 -35.47 74.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 2.74 109.736 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.95 -39.99 87.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 2.89 109.686 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.85 -39.97 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.142 -0.974 . . . . 1.3 109.144 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 1.09 109.693 179.985 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 6.1 ttt . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.367 0.604 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -153.99 151.56 29.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.411 -0.806 . . . . 0.0 109.17 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -149.56 159.93 43.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.076 -1.015 . . . . 0.0 110.479 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -154.72 150.97 28.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 305' ' ' GLU . . . . . 0.486 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 2.0 pm0 -116.45 133.89 55.49 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.22 -0.925 . . . . 0.0 110.325 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.48 128.11 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 CA-C-O 122.351 1.072 . . . . 0.0 112.546 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 86.4 m -78.1 103.31 7.96 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.877 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.505 HG22 ' H ' ' B' ' 310' ' ' ALA . 88.4 mt -51.19 122.65 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 122.446 1.117 . . . . 0.0 109.815 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 54.2 p -103.23 21.09 16.48 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.202 -178.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.505 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -86.6 115.29 61.74 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.062 -1.024 . . . . 0.0 108.938 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -68.13 -3.29 10.42 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 CA-C-N 120.309 1.146 . . . . 0.0 111.511 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -111.31 -0.64 16.32 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.91 172.82 26.91 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 107.684 -2.167 . . . . 0.0 107.684 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.491 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -85.58 94.93 9.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.862 -1.375 . . . . 0.0 108.241 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -93.75 -162.79 0.97 Allowed 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.991 -1.068 . . . . 0.0 110.698 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.0 m -56.78 -42.5 79.56 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.098 -1.001 . . . . 0.0 112.514 -176.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.516 HH11 ' HG2' ' B' ' 317' ' ' ARG . 0.9 OUTLIER -61.37 -60.0 11.86 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 120.639 -1.288 . . . . 0.0 112.241 -178.677 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -60.78 -32.04 92.49 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 120.295 1.141 . . . . 0.0 111.811 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.44 73.74 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.25 -40.65 61.97 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.443 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -70.19 -40.73 74.46 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.043 -1.036 . . . . 0.0 108.768 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -60.26 -51.78 68.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.425 -0.797 . . . . 0.0 110.452 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 87.2 t -69.91 -30.63 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.758 -1.214 . . . . 0.0 110.35 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -60.08 -45.6 92.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 108.999 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -67.19 -40.05 86.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.84 . . . . 0.0 110.528 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -64.91 -53.61 43.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.77 -1.206 . . . . 0.0 111.033 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -52.96 -10.05 0.16 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.121 -0.987 . . . . 0.0 110.458 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -79.23 -21.06 68.27 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -106.23 140.18 39.57 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.55 -0.971 . . . . 0.0 109.26 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 17.2 m -90.89 -11.08 40.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.045 -1.034 . . . . 0.0 110.342 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.495 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 84.4 p -62.93 153.66 32.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.907 -1.12 . . . . 0.0 109.712 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -69.44 133.14 47.39 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.5 mt -134.47 133.77 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.674 -0.641 . . . . 0.0 109.99 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 85.9 m -131.17 152.01 50.88 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 67.3 t -123.56 117.62 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 49.5 m -106.32 132.72 52.03 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.088 -1.007 . . . . 0.0 109.333 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 82.1 p -140.01 115.46 9.98 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.924 0.869 . . . . 0.0 110.798 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 24.0 m120 46.96 49.8 14.37 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 176.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.97 -12.96 65.92 Favored Glycine 0 N--CA 1.505 3.244 0 O-C-N 120.155 -1.59 . . . . 0.0 113.327 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -118.5 130.06 55.72 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-N 119.579 1.689 . . . . 0.0 109.503 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 38.9 m -128.75 150.4 50.3 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.871 0.843 . . . . 0.0 110.954 -178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 342' ' ' ALA . . . . . 0.542 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -146.45 169.28 19.23 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.646 0.736 . . . . 0.0 110.293 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 60.8 m -88.17 139.57 30.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.637 -0.665 . . . . 0.0 109.903 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.452 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -79.78 -15.8 56.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.938 -1.101 . . . . 0.0 109.852 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -85.38 20.61 1.96 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 346' ' ' SER . . . . . 0.452 ' H ' ' C ' ' B' ' 344' ' ' ALA . 17.3 t -147.97 95.95 2.57 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.31 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.854 HD23 HD22 ' A' ' 79' ' ' LEU . 61.2 tp -59.92 -34.7 73.57 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.863 ' CE2' HD11 ' A' ' 79' ' ' LEU . 59.7 m-85 -54.56 -51.85 63.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.63 -0.669 . . . . 0.0 110.994 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 349' ' ' LYS . . . . . 0.434 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 34.1 mtmm -80.89 -12.73 59.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.731 -1.23 . . . . 0.0 111.207 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 27.4 mt -69.48 -49.78 51.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.48 -1.387 . . . . 0.0 109.214 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.64 ' O ' HD22 ' A' ' 123' ' ' LEU . 2.0 mm100 -50.0 -20.1 0.86 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.144 -0.972 . . . . 0.0 111.451 -177.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 74.6 p -76.05 -10.02 59.08 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.233 -1.542 . . . . 0.0 109.242 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.542 HD11 ' HB3' ' B' ' 342' ' ' ALA . 53.0 mt -95.43 118.08 31.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.353 -0.842 . . . . 0.0 109.323 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.49 93.07 1.0 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 38.4 mt -97.51 85.49 3.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.232 -1.158 . . . . 0.0 108.344 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 31.9 p -93.64 179.96 5.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.195 -0.941 . . . . 0.0 110.81 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 357' ' ' GLN . . . . . 0.52 ' O ' ' N ' ' B' ' 359' ' ' THR . 62.0 tt0 -49.5 156.91 0.57 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 122.371 1.081 . . . . 0.0 111.412 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.23 23.62 0.02 OUTLIER Glycine 0 N--CA 1.496 2.65 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.226 177.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 359' ' ' THR . . . . . 0.52 ' N ' ' O ' ' B' ' 357' ' ' GLN . 27.6 m -83.75 110.04 18.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.803 -1.41 . . . . 0.0 109.858 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 6.8 t -77.28 113.73 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 122.296 1.046 . . . . 0.0 109.833 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.2 m -109.67 176.19 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 56.2 m -131.96 129.95 40.87 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.5 mt -107.84 121.74 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 24.2 p -122.02 133.19 54.8 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.05 149.85 38.77 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.084 -1.01 . . . . 0.0 109.83 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -144.51 121.96 11.69 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.435 -0.79 . . . . 0.0 109.094 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.544 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.05 -152.95 24.28 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.125 -1.512 . . . . 0.0 111.724 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -58.82 -52.82 64.1 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.495 ' H ' ' HB3' ' B' ' 331' ' ' SER . 70.7 m-20 -109.96 12.71 23.65 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.015 -1.053 . . . . 0.0 111.32 -177.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.8 pt-20 -41.95 -35.56 0.89 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.286 -0.883 . . . . 0.0 111.362 -178.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -69.55 -41.0 76.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.574 -1.329 . . . . 0.0 109.991 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -71.76 -54.3 10.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.966 -1.084 . . . . 0.0 109.413 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.39 -35.27 1.5 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.6 -0.687 . . . . 0.0 111.934 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.54 ' O ' HG23 ' B' ' 378' ' ' VAL . 58.7 t -80.19 -33.21 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.492 -1.38 . . . . 0.0 109.297 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -70.0 -40.65 75.16 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.224 -0.922 . . . . 0.0 112.495 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -84.7 -44.65 13.19 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.438 -1.413 . . . . 0.0 110.687 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 90.9 mt -59.92 -39.34 85.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.099 -1.0 . . . . 0.0 109.159 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.54 HG23 ' O ' ' B' ' 374' ' ' VAL . 49.3 t -64.36 -43.74 97.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.28 -0.888 . . . . 0.0 109.784 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -79.93 -9.86 59.72 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.054 -1.029 . . . . 0.0 109.457 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 43.0 tp -82.34 -24.88 34.32 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.1 tpp -82.79 -25.01 33.14 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -85.03 -11.11 56.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.687 -0.633 . . . . 0.0 110.202 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -107.33 -0.29 22.57 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.233 -0.917 . . . . 0.0 110.835 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 34.4 mt -94.95 119.3 33.24 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.76 -1.212 . . . . 0.0 110.084 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 385' ' ' GLU . . . . . 0.567 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 1.3 pm0 . . . . . 0 N--CA 1.499 2.0 0 CA-C-O 117.94 -1.028 . . . . 0.0 109.479 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.9 mtm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.465 -0.569 . . . . 2.91 109.465 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 94.4 mt -110.06 126.37 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.479 -0.763 . . . . 1.2 109.625 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.5 m -136.75 134.06 36.7 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.893 -0.78 . . . . 1.4 108.893 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.92 -158.59 22.4 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 108.888 -1.685 . . . . 1.05 108.888 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.8 mt -91.65 -9.95 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.995 -1.297 . . . . 1.15 110.448 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.4 tp 55.01 98.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.956 -1.09 . . . . 0.98 108.773 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.75 -34.1 40.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.626 -0.672 . . . . 0.88 109.515 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 m -150.02 141.6 15.02 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.275 -0.89 . . . . 1.69 109.618 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.91 143.67 16.52 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.459 2.106 . . . . 0.85 112.488 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.885 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.91 -165.95 38.36 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.472 -1.451 . . . . 0.92 109.472 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.1 mt -149.2 149.97 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.169 -1.194 . . . . 0.81 108.506 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.27 144.2 19.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.945 -1.097 . . . . 0.51 110.363 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 16.3 m-85 -125.23 128.59 48.54 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.21 -1.033 . . . . 0.62 108.21 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.78 -178.84 44.63 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.717 -1.706 . . . . 0.55 110.816 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -80.19 158.14 26.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.774 -0.839 . . . . 2.1 109.542 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.492 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -105.04 131.24 52.8 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.434 -0.791 . . . . 0.77 110.671 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.6 tp -97.89 136.4 38.24 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.206 -1.405 . . . . 0.91 107.206 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 tp -120.29 124.61 46.04 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.337 -0.852 . . . . 0.93 109.407 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.8 mt -88.18 106.6 18.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.492 -0.755 . . . . 0.93 109.895 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.458 ' NZ ' ' CB ' ' A' ' 20' ' ' LYS . 7.4 mtpm? -102.23 128.78 48.61 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.744 -0.835 . . . . 2.75 108.744 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.531 ' OE1' ' NH2' ' A' ' 139' ' ' ARG . 98.6 mt-10 -126.19 137.95 53.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.312 -0.867 . . . . 3.0 109.135 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -79.15 143.56 35.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.22 -0.925 . . . . 2.77 109.035 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -61.23 140.01 58.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 2.94 109.547 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.6 mt -81.3 131.17 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.409 -0.807 . . . . 0.95 109.192 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.0 t -101.12 123.24 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.302 -0.874 . . . . 1.28 109.58 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.7 mt -98.13 142.94 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.398 -0.814 . . . . 1.21 108.938 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -91.09 122.16 33.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.019 -1.051 . . . . 1.81 109.48 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.533 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.6 mmt-85 -91.12 0.08 57.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 2.8 109.223 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.67 141.67 53.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -0.851 . . . . 2.87 109.654 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -85.78 146.8 26.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.195 -0.941 . . . . 2.35 109.281 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 pt -90.79 164.69 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.97 110.216 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.8 p -97.06 174.14 6.91 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.568 -0.901 . . . . 1.17 108.568 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.96 -48.58 81.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.151 -0.968 . . . . 1.18 110.032 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -54.51 -31.47 56.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.764 -1.21 . . . . 2.56 109.441 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -82.3 -9.05 59.62 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.466 -0.772 . . . . 1.79 110.276 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.2 t -68.05 -56.46 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.436 -1.415 . . . . 1.0 109.146 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.16 -39.97 88.28 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.384 -0.822 . . . . 1.77 109.739 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -67.14 -41.88 85.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.082 -1.011 . . . . 2.7 110.356 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -62.98 -40.08 96.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.904 -1.122 . . . . 1.51 110.405 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.15 -48.67 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.749 -1.22 . . . . 0.93 109.197 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -61.73 -47.81 83.55 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.184 -0.947 . . . . 1.81 109.861 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.421 HH11 ' HG2' ' A' ' 42' ' ' ARG . 49.6 mtt-85 -60.11 -41.91 93.61 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.078 -1.082 . . . . 2.78 108.078 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.433 ' CD1' ' HB1' ' A' ' 100' ' ' ALA . 61.8 t80 -70.07 -39.94 75.32 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.513 -0.742 . . . . 0.78 109.344 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.5 tp -60.05 -48.53 81.34 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.28 -1.378 . . . . 1.07 107.28 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -63.69 -39.98 95.65 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.288 -1.004 . . . . 1.12 108.288 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.26 -50.02 72.17 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 108.491 -1.844 . . . . 0.84 108.491 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.409 HH11 ' HB3' ' A' ' 47' ' ' ARG . 1.4 ttt-85 -61.35 -39.78 91.85 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.709 -1.219 . . . . 3.09 107.709 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.96 87.84 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.971 -0.751 . . . . 0.88 108.971 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 33.6 ttpt -58.03 -74.99 0.05 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.021 -1.072 . . . . 2.59 108.21 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.61 -33.01 0.09 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.15 -0.969 . . . . 0.7 111.715 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.6 m -57.58 -47.54 81.82 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.138 -1.425 . . . . 1.4 108.365 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.8 -41.66 74.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.115 -0.991 . . . . 0.67 110.863 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -67.31 -39.97 85.95 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.806 -1.184 . . . . 1.66 110.163 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.47 -39.38 87.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.943 -1.098 . . . . 1.58 109.222 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -59.99 -36.54 77.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 1.35 109.942 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -63.96 -42.83 97.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.827 -1.171 . . . . 0.77 109.109 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.524 HD11 HH22 ' A' ' 136' ' ' ARG . 85.4 mt -61.68 -37.09 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.63 109.134 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -58.19 -49.98 75.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.861 . . . . 1.14 109.178 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -59.59 -34.18 72.4 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.372 -0.83 . . . . 0.79 110.709 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -69.22 -39.37 78.61 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.847 -1.158 . . . . 1.53 109.598 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.95 -42.06 99.7 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.591 -0.693 . . . . 0.57 109.971 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.1 -50.53 66.67 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.576 -1.41 . . . . 0.75 109.576 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.28 -51.77 34.12 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.011 -1.287 . . . . 1.59 109.515 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.7 m -60.45 -65.68 0.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.355 -0.841 . . . . 0.73 112.179 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.507 ' CE1' ' O ' ' A' ' 168' ' ' THR . 84.3 m-85 -96.12 -49.31 5.3 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.757 -1.215 . . . . 0.75 111.519 -177.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.03 -169.54 25.28 Favored Glycine 0 N--CA 1.503 3.142 0 C-N-CA 119.659 -1.258 . . . . 1.22 111.298 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.05 -25.23 63.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.877 -0.778 . . . . 5.81 109.991 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.517 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.1 tp10 -59.99 -34.57 73.5 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.52 -0.737 . . . . 3.37 110.267 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -100.8 -16.34 17.33 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.366 -0.833 . . . . 1.77 109.91 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -70.35 -42.03 72.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 1.65 110.501 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.521 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.68 -28.47 69.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.898 . . . . 0.77 109.846 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 83.7 mt -60.12 -40.06 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.129 -1.029 . . . . 0.8 108.877 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -66.56 -41.72 88.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.035 . . . . 0.88 110.498 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -60.52 -40.03 89.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.888 -1.132 . . . . 1.37 109.832 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.43 99.41 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.24 -1.544 . . . . 0.62 109.24 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -66.99 -41.1 87.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -1.158 . . . . 1.5 109.384 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.63 -46.52 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.923 . . . . 0.63 109.826 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.7 ttp -60.08 -43.95 95.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.03 -1.044 . . . . 1.51 110.207 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.828 HD11 ' CE2' ' B' ' 348' ' ' PHE . 41.4 tp -62.62 -40.03 95.67 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.256 -0.903 . . . . 0.77 109.893 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.5 tp -62.65 -39.95 95.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.27 -0.894 . . . . 0.62 110.215 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -82.75 9.47 9.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.119 -0.988 . . . . 1.47 110.069 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 48.3 t0 -54.88 133.1 47.79 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.118 -0.989 . . . . 1.47 110.445 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 95.5 mt-10 -60.26 -21.07 61.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.64 -0.662 . . . . 1.78 110.734 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.54 -34.72 72.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.667 -1.271 . . . . 2.53 109.355 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.3 mt -70.05 -39.9 75.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.8 109.312 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -60.08 -49.95 75.64 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.446 -0.784 . . . . 1.42 109.804 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -70.14 -41.13 74.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 1.71 110.597 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.72 -40.45 69.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.007 -1.058 . . . . 1.57 111.646 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.1 mt -69.98 -40.32 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.981 -1.074 . . . . 0.65 109.885 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.3 mt -68.99 -36.81 75.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.505 -0.747 . . . . 0.82 109.96 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.76 -49.98 75.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.79 111.183 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.9 mt -60.55 -46.16 91.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.638 -1.289 . . . . 0.95 109.808 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.93 -50.07 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.926 . . . . 0.66 109.461 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -74.13 -42.41 60.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.645 -0.66 . . . . 2.2 111.393 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -79.92 -50.06 10.99 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.901 -1.124 . . . . 1.65 112.052 -177.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -91.03 -4.18 56.59 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.964 -1.085 . . . . 2.03 111.497 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 m80 56.02 36.43 27.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.911 -1.118 . . . . 1.42 109.072 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 53.7 mtt -90.87 169.98 10.46 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.661 -0.65 . . . . 1.18 109.639 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 102' ' ' ALA . 82.1 p -77.79 153.72 32.57 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.928 -1.138 . . . . 0.98 107.928 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 43' ' ' PHE . . . -70.59 -36.64 73.67 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.944 -1.098 . . . . 0.64 111.028 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -68.57 -39.42 81.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.93 -1.106 . . . . 2.07 109.797 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.412 ' HB3' ' OG1' ' A' ' 99' ' ' THR . . . -78.5 -41.48 32.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.73 109.806 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.38 -42.88 67.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.283 -0.886 . . . . 0.54 110.272 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.68 -40.11 96.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.103 -0.998 . . . . 0.56 109.587 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -59.9 -40.05 87.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.5 -0.75 . . . . 1.54 110.3 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 110' ' ' GLY . 86.3 tt0 -60.74 -39.97 90.66 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.138 -0.976 . . . . 1.33 109.994 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.61 -52.15 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.297 -0.877 . . . . 0.72 110.657 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.2 mm -70.06 -40.01 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.989 -1.069 . . . . 0.85 108.327 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -68.15 -32.94 73.56 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.452 -0.944 . . . . 2.44 108.452 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -65.22 -51.3 51.04 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.174 -1.17 . . . . 0.98 110.174 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -60.04 -49.3 78.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.967 -1.314 . . . . 1.41 109.248 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.67 81.4 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.311 -0.868 . . . . 1.2 109.691 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.9 p -59.3 -39.94 84.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.041 -1.037 . . . . 1.7 109.287 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.21 -40.06 94.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 1.47 108.823 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.0 mt -63.4 -42.68 98.79 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.123 -0.986 . . . . 1.56 109.096 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -56.82 -34.38 67.65 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.019 -1.051 . . . . 2.2 109.291 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.11 -23.15 65.29 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.245 -0.91 . . . . 2.12 109.267 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 55.4 mt -62.14 140.75 58.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.04 -1.037 . . . . 2.0 108.519 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -93.84 49.09 1.31 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.911 -1.118 . . . . 3.23 110.836 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -135.35 137.9 42.83 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.129 -0.982 . . . . 2.49 109.835 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 52.0 mp0 -70.12 -31.62 69.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.605 -0.684 . . . . 3.95 110.308 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.62 ' CZ ' ' NH1' ' A' ' 126' ' ' ARG . 3.5 t80 -73.8 -40.11 63.63 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.109 -0.994 . . . . 2.0 110.916 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.685 HD23 HH22 ' A' ' 126' ' ' ARG . 60.7 mt -69.44 -36.56 76.76 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.109 -0.995 . . . . 1.86 108.604 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.19 -36.99 85.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 2.84 110.004 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -59.82 -45.19 93.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.948 -1.095 . . . . 2.73 110.796 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.685 HH22 HD23 ' A' ' 123' ' ' LEU . 25.6 mtm-85 -66.06 -34.51 78.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.599 -1.313 . . . . 2.77 108.756 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.27 -35.47 73.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 1.19 108.519 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.95 92.93 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.345 -0.983 . . . . 1.2 108.345 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -68.42 -39.94 81.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.407 -0.808 . . . . 1.55 109.856 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.417 HG21 HE22 ' B' ' 351' ' ' GLN . 43.7 t -69.38 -40.03 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.004 -1.06 . . . . 0.8 108.749 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -60.07 -38.91 84.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 3.09 108.42 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -59.97 -38.82 83.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.541 -0.724 . . . . 1.46 109.916 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.9 -42.83 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.046 -1.034 . . . . 0.71 109.679 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.87 -35.27 72.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.724 -1.35 . . . . 0.57 109.724 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.98 -48.9 79.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -1.207 . . . . 2.59 110.185 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.524 HH22 HD11 ' A' ' 57' ' ' ILE . 59.1 mtp180 -67.07 -27.89 67.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.615 -1.303 . . . . 2.83 109.914 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.8 tp -59.54 -42.03 91.4 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.232 -1.025 . . . . 1.25 108.232 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.6 -40.05 95.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.7 109.414 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.531 ' NH2' ' OE1' ' A' ' 21' ' ' GLU . 99.0 mtt180 -67.58 -39.94 84.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.305 -0.872 . . . . 2.57 109.965 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -69.86 -31.6 69.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 1.23 112.062 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.1 mt -68.91 -51.62 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.087 -1.633 . . . . 0.81 108.226 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 98.5 mt -70.04 -39.94 75.43 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.068 -0.653 . . . . 1.0 109.348 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.16 52.59 2.35 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.497 -1.441 . . . . 0.89 109.497 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 tp -73.84 150.03 41.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.235 -1.156 . . . . 1.14 108.493 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.65 139.56 53.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.03 -1.044 . . . . 4.6 110.051 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.2 mt -110.01 129.96 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 122.046 0.927 . . . . 1.24 109.297 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.0 mt -69.8 -40.0 78.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 115.778 -0.646 . . . . 1.54 110.166 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 39.8 t0 63.29 131.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.451 0.643 . . . . 1.5 109.361 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 152' ' ' ILE . 83.3 mt -85.44 -2.62 58.31 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.706 -0.85 . . . . 0.79 108.706 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.5 p -83.95 -9.6 58.57 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.82 -0.807 . . . . 1.4 108.82 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -86.04 22.72 1.65 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.531 -0.731 . . . . 0.92 109.798 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.503 HD12 ' O ' ' A' ' 149' ' ' LEU . 66.0 mt -90.48 120.99 40.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.337 -0.852 . . . . 0.88 109.045 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -102.74 -13.98 16.84 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.269 -0.895 . . . . 2.45 110.123 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -130.23 151.61 50.56 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.59 -0.693 . . . . 1.52 110.11 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.28 137.15 58.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 1.58 108.768 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.8 m -153.14 168.05 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.519 -0.738 . . . . 0.69 110.067 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -95.11 146.16 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 106.564 -1.643 . . . . 0.61 106.564 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 49.6 tp -96.83 120.21 36.75 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.106 -0.996 . . . . 0.87 110.8 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.431 HG12 HG22 ' A' ' 209' ' ' THR . 42.2 t -126.41 130.03 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 108.981 -0.748 . . . . 0.71 108.981 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.8 168.57 24.48 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.197 -0.939 . . . . 0.81 109.043 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.78 -37.92 73.36 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.364 -1.46 . . . . 0.98 108.006 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -170.59 145.36 2.53 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.743 -0.836 . . . . 2.25 108.743 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 48.1 mt -112.87 134.67 54.27 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.324 -0.86 . . . . 0.78 109.443 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 11.6 p -90.76 148.84 39.3 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.198 -0.939 . . . . 0.98 109.122 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.35 -32.98 5.73 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.949 1.766 . . . . 0.81 112.485 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 66.7 m -55.88 -45.56 78.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.085 -1.009 . . . . 0.9 109.444 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -69.96 -40.08 75.63 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.372 -0.83 . . . . 1.61 109.539 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.507 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 44.0 p -55.3 -18.37 6.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.233 -0.917 . . . . 0.61 110.935 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -88.46 -46.93 8.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.793 -1.192 . . . . 0.6 109.643 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -90.11 41.2 1.04 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.926 -1.138 . . . . 1.4 107.926 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.1 tp -105.0 131.19 52.84 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.733 -0.604 . . . . 0.7 109.591 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -85.43 97.51 10.06 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.175 -1.046 . . . . 2.35 108.175 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.28 -39.87 95.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.435 -0.791 . . . . 1.51 110.804 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -64.86 -25.51 67.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.082 -1.011 . . . . 2.33 111.033 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -93.96 -10.16 34.61 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.746 -1.221 . . . . 1.92 110.164 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.494 HG12 ' H ' ' A' ' 178' ' ' GLY . 62.6 t -107.12 119.91 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.225 -0.922 . . . . 0.67 108.678 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.1 mt -94.45 11.58 30.23 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.399 -0.813 . . . . 1.53 111.051 -177.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.494 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 171.17 170.27 35.11 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.267 -1.533 . . . . 0.48 109.267 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -136.75 133.56 36.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.365 -1.079 . . . . 0.55 109.118 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.41 ' CG2' HG21 ' A' ' 205' ' ' THR . 75.6 mt -135.41 128.4 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.751 -0.833 . . . . 0.65 108.751 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' A' ' 205' ' ' THR . 34.3 p -144.98 158.64 43.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 0.82 110.626 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 183' ' ' ALA . 86.2 m-20 -94.05 17.23 12.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.602 -0.686 . . . . 2.46 109.778 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -44.32 -179.51 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.496 1.141 . . . . 1.28 113.029 -177.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.8 -52.99 5.57 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.281 -1.127 . . . . 2.19 110.281 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -168.33 -159.88 14.91 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 118.558 -1.782 . . . . 2.13 111.46 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.424 ' O ' ' OG ' ' A' ' 191' ' ' SER . 11.3 ptt180 -69.98 -13.88 62.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 122.18 -0.6 . . . . 5.86 111.129 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 41.2 p -74.32 5.22 4.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.882 -1.136 . . . . 3.72 109.036 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 91.7 p -87.63 141.23 28.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.368 -0.832 . . . . 1.74 110.39 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -54.88 -38.66 67.82 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.293 -0.879 . . . . 0.95 108.997 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 190' ' ' THR . 14.2 p -59.85 -39.95 86.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.682 -0.637 . . . . 1.55 109.941 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 186' ' ' ARG . 93.9 p -61.31 -38.24 86.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 1.51 110.113 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.2 mm -60.01 -39.92 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 1.67 109.074 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.0 mtp -56.14 -49.69 73.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.094 -1.004 . . . . 1.02 109.967 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.96 -44.71 78.74 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.093 -1.004 . . . . 0.68 109.915 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -61.64 -58.96 6.01 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.293 -0.963 . . . . 2.93 110.601 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.2 m -63.12 -39.67 95.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.204 -0.935 . . . . 0.86 111.554 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.7 mt -70.04 -30.05 67.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.831 -1.168 . . . . 0.67 109.402 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 70.52 49.56 0.41 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.342 0.592 . . . . 1.5 109.671 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 55.9 mt -130.1 150.03 74.89 Favored Pre-proline 0 N--CA 1.503 2.193 0 N-CA-C 108.256 -1.016 . . . . 0.72 108.256 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.74 138.18 84.82 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 122.204 1.936 . . . . 0.61 112.051 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.43 151.13 3.63 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.402 -0.919 . . . . 0.66 111.139 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.41 ' CG2' HG23 ' A' ' 205' ' ' THR . 75.7 mt -127.67 139.77 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 107.208 -1.405 . . . . 0.79 107.208 178.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 32.4 m -123.05 -14.41 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.204 -0.935 . . . . 0.91 111.424 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -106.04 26.94 19.11 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.489 -1.444 . . . . 1.01 109.489 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 181' ' ' THR . 1.7 p -52.64 -37.2 58.12 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.234 -1.156 . . . . 0.99 110.41 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.63 -80.54 1.68 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.488 -1.339 . . . . 1.12 110.668 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 21.9 t -129.81 31.89 4.66 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 121.426 -1.044 . . . . 1.72 112.333 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 55.7 t -69.83 -40.22 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.408 -1.432 . . . . 0.89 107.931 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.431 HG22 HG12 ' A' ' 159' ' ' VAL . 72.3 p -53.88 -28.91 39.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.644 -0.66 . . . . 1.03 109.898 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.1 p -80.56 -19.4 45.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.021 -1.05 . . . . 1.83 110.135 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -96.62 -13.56 22.78 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.165 -0.96 . . . . 2.27 110.148 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.2 t -102.53 136.5 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.271 -0.893 . . . . 0.92 110.635 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -115.24 157.04 24.29 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.46 -1.311 . . . . 2.2 107.46 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 46.9 p-10 -60.03 139.99 57.1 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.814 -1.179 . . . . 2.36 110.265 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.7 m-20 80.87 4.29 1.59 Allowed 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.109 0.48 . . . . 2.38 110.028 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -71.13 130.03 40.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.197 -0.939 . . . . 2.09 109.022 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -84.63 112.92 20.88 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.111 -1.07 . . . . 1.27 108.111 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.492 HD12 ' HB2' ' A' ' 16' ' ' ALA . 54.8 mt -123.77 147.26 47.68 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.595 -0.69 . . . . 0.75 110.87 -178.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.409 HD12 ' HG3' ' A' ' 231' ' ' PRO . 75.8 mt -114.38 127.68 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.813 -1.551 . . . . 0.63 106.813 177.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.4 tp -100.4 118.14 36.03 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.826 -1.171 . . . . 0.7 109.622 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.536 ' C ' ' H ' ' A' ' 223' ' ' VAL . 96.0 m-20 -75.7 -43.4 47.36 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.096 -1.002 . . . . 2.31 108.407 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.885 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 50.04 10.55 0.05 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.948 -0.76 . . . . 0.78 108.948 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.536 ' H ' ' C ' ' A' ' 221' ' ' ASP . 52.9 t -130.31 -37.31 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 106.985 -1.487 . . . . 1.04 106.985 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -102.07 -2.9 28.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.388 -1.338 . . . . 2.44 107.388 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 62.67 40.11 10.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.902 -0.499 . . . . 1.55 110.578 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -140.95 147.18 38.39 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.112 -0.993 . . . . 1.99 109.923 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.96 123.04 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.492 -0.755 . . . . 0.77 109.388 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -91.26 134.3 34.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.026 -1.046 . . . . 0.98 109.156 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.457 HG22 HD22 ' A' ' 218' ' ' LEU . 44.1 t -105.17 115.32 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.545 -0.722 . . . . 0.85 110.115 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 50.12 61.12 14.15 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.145 -0.972 . . . . 1.66 111.712 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.409 ' HG3' HD12 ' A' ' 219' ' ' ILE . 92.7 Cg_endo -83.17 153.05 14.21 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.745 2.296 . . . . 0.95 111.875 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 82.1 p -70.32 162.3 28.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.145 -0.972 . . . . 1.84 110.697 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -60.13 -36.1 76.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.639 -0.663 . . . . 2.74 110.029 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -60.05 -38.29 82.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.197 -0.939 . . . . 2.89 108.858 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.6 t -69.71 -40.0 78.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.319 -0.863 . . . . 1.3 109.223 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.6 mt . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 1.09 110.299 -179.741 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 301' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' B' ' 302' ' ' PHE . 13.1 tmm? . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.641 0.734 . . . . 0.0 109.649 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 302' ' ' PHE . . . . . 0.591 ' N ' ' SD ' ' B' ' 301' ' ' MET . 24.5 t80 -152.69 150.1 29.1 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -146.55 155.31 42.41 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.139 -0.976 . . . . 0.0 110.501 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 304' ' ' GLN . . . . . 0.404 ' HG2' HG21 ' B' ' 378' ' ' VAL . 72.9 tp60 -152.26 147.94 26.96 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -108.88 127.61 54.19 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.0 p -128.43 123.91 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 CA-C-O 122.407 1.099 . . . . 0.0 111.94 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 27.1 m -77.5 103.58 7.52 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.066 0.936 . . . . 0.0 110.926 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.524 HG22 ' H ' ' B' ' 310' ' ' ALA . 89.5 mt -52.23 122.0 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 122.449 1.118 . . . . 0.0 110.049 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 71.2 p -103.02 23.4 12.36 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.708 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.524 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -83.38 116.72 65.9 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.95 . . . . 0.0 109.052 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -66.52 -6.95 16.42 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 CA-C-N 120.23 1.118 . . . . 0.0 111.504 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -118.09 5.96 12.05 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.48 177.47 34.55 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.468 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -87.28 94.34 9.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.153 -1.204 . . . . 0.0 108.824 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -96.88 -159.53 0.74 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.172 -0.955 . . . . 0.0 110.181 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 16.9 m -58.18 -46.84 85.07 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.971 -1.08 . . . . 0.0 112.637 -176.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.61 HH21 ' NE2' ' B' ' 321' ' ' GLN . 1.8 tpt180 -58.86 -61.45 7.74 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 120.425 -1.422 . . . . 0.0 112.09 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -58.8 -32.31 96.89 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 CA-C-N 120.373 1.169 . . . . 0.0 111.579 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.31 70.19 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.961 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.89 -41.0 67.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.882 . . . . 0.0 109.815 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 321' ' ' GLN . . . . . 0.61 ' NE2' HH21 ' B' ' 317' ' ' ARG . 72.1 mt-30 -69.97 -42.76 72.73 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.948 -1.095 . . . . 0.0 108.896 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -61.02 -51.67 68.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 110.348 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 73.8 t -67.72 -30.12 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.625 -1.297 . . . . 0.0 109.981 -179.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -60.05 -45.69 92.02 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.335 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -60.16 -49.95 75.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.037 -1.039 . . . . 0.0 109.225 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.97 74.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.305 -0.872 . . . . 0.0 110.657 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -49.65 -20.05 0.72 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.287 -0.883 . . . . 0.0 109.37 -178.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -81.6 -17.05 71.75 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -106.15 140.55 38.94 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.322 -1.105 . . . . 0.0 109.771 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 330' ' ' THR . . . . . 0.416 HG22 ' O ' ' B' ' 330' ' ' THR . 51.3 m -90.72 -12.98 34.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.109 -0.994 . . . . 0.0 109.34 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 58.5 m -61.24 144.74 53.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.335 -0.853 . . . . 0.0 109.587 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -67.32 135.98 54.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.059 -1.026 . . . . 0.0 109.298 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 88.8 mt -133.98 134.14 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.615 -0.678 . . . . 0.0 109.983 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 85.5 m -129.26 148.44 51.19 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.504 -0.747 . . . . 0.0 109.152 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 63.3 t -120.5 114.78 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 98.0 m -106.52 130.39 54.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.169 -0.957 . . . . 0.0 109.477 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 25.2 p -139.4 119.36 13.43 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.778 0.799 . . . . 0.0 110.787 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 41.71 52.87 4.01 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 177.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 84.06 -16.26 33.97 Favored Glycine 0 N--CA 1.5 2.938 0 O-C-N 120.293 -1.504 . . . . 0.0 112.507 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -110.56 122.63 48.22 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.796 -1.414 . . . . 0.0 109.472 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 56.7 p -129.84 150.62 51.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.741 0.782 . . . . 0.0 110.431 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -146.46 170.01 17.73 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.644 0.735 . . . . 0.0 110.204 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 16.5 m -88.62 139.04 30.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.575 -0.703 . . . . 0.0 110.011 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.494 ' HA ' HD11 ' B' ' 350' ' ' LEU . . . -80.49 -13.88 58.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.958 -1.089 . . . . 0.0 110.321 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -88.52 20.29 3.46 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 346' ' ' SER . . . . . 0.432 ' H ' ' C ' ' B' ' 344' ' ' ALA . 45.0 t -148.37 95.74 2.5 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.699 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.609 HD23 HD22 ' A' ' 79' ' ' LEU . 59.0 tp -60.35 -34.62 74.11 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.828 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.1 m-85 -55.67 -52.49 63.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.134 -0.979 . . . . 0.0 109.891 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -69.58 -40.13 76.91 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.264 -0.898 . . . . 0.0 110.226 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' B' ' 352' ' ' THR . 80.5 mt -50.88 -54.68 21.9 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.984 -1.073 . . . . 0.0 108.608 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.417 HE22 HG21 ' A' ' 130' ' ' VAL . 27.2 mt-30 -40.15 -12.43 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.855 -0.528 . . . . 0.0 111.647 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.626 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.5 p -93.64 -10.78 33.39 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.589 -1.319 . . . . 0.0 110.627 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 64.0 mt -93.38 119.79 32.9 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.764 -1.21 . . . . 0.0 109.837 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.06 91.01 1.0 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 29.4 mt -96.56 86.83 4.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -1.127 . . . . 0.0 108.199 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 65.9 p -92.5 -179.72 5.28 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.19 -0.944 . . . . 0.0 111.257 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 357' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' B' ' 359' ' ' THR . 62.6 tt0 -49.53 153.99 1.03 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.331 1.062 . . . . 0.0 111.303 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.73 26.88 0.05 OUTLIER Glycine 0 N--CA 1.495 2.58 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.906 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 359' ' ' THR . . . . . 0.459 ' N ' ' O ' ' B' ' 357' ' ' GLN . 24.1 m -84.87 110.42 18.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.884 -1.363 . . . . 0.0 109.449 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 23.3 t -77.33 114.58 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 122.333 1.063 . . . . 0.0 109.698 -177.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 15.1 m -109.98 177.91 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 27.8 m -130.31 126.9 38.33 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 65.7 mt -102.36 112.65 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 44.8 p -115.5 130.05 56.75 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.2 149.5 38.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.296 -0.877 . . . . 0.0 109.618 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -143.88 123.94 13.63 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.438 ' H ' ' HG2' ' B' ' 370' ' ' GLU . . . 160.82 -161.85 33.09 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.157 -1.497 . . . . 0.0 111.577 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.85 -50.5 73.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 122.211 -0.582 . . . . 0.0 112.296 -177.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.528 ' N ' ' OG ' ' B' ' 331' ' ' SER . 95.8 m-20 -111.08 10.65 22.02 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.919 -1.113 . . . . 0.0 110.837 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' B' ' 367' ' ' GLY . 0.7 OUTLIER -45.59 -32.87 2.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.036 -1.04 . . . . 0.0 111.334 -178.788 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -71.81 -40.06 69.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.857 -1.152 . . . . 0.0 109.87 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -68.46 -40.38 81.08 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 110.802 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.53 -64.01 0.98 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.58 -1.325 . . . . 0.0 111.088 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.586 ' O ' HG23 ' B' ' 378' ' ' VAL . 45.2 t -45.33 -39.56 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.015 -1.053 . . . . 0.0 109.988 -177.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -61.37 -51.56 68.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.917 -1.114 . . . . 0.0 110.341 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -75.15 -39.93 60.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.015 -1.053 . . . . 0.0 111.094 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.22 -37.27 77.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.11 -0.994 . . . . 0.0 108.827 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.586 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.9 t -62.48 -43.44 98.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.209 -0.932 . . . . 0.0 109.607 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 379' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' B' ' 383' ' ' GLU . 0.5 OUTLIER -70.02 -55.72 8.83 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.615 -1.303 . . . . 0.0 107.735 178.525 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 60.4 tp -56.52 -35.92 68.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 109.935 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 33.7 ttm -71.72 -40.6 69.33 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.704 -1.248 . . . . 0.0 109.011 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.39 -5.38 57.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.652 -0.655 . . . . 0.0 110.139 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' B' ' 379' ' ' LYS . 64.3 mm-40 -110.66 -1.07 16.92 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.228 -0.92 . . . . 0.0 110.833 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.9 mt -87.24 128.5 35.15 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.546 -1.346 . . . . 0.0 108.783 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.44 -179.629 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mpp? . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.266 0.555 . . . . 2.91 109.816 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -111.18 130.02 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.608 -0.683 . . . . 1.2 109.346 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.2 m -132.24 121.13 23.16 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.233 -0.917 . . . . 1.4 108.712 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.18 -166.75 32.78 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.611 -1.395 . . . . 1.05 109.611 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 5' ' ' ILE . 88.9 mt -87.42 -6.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.03 -1.276 . . . . 1.15 109.758 -179.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 23.7 tp 57.35 89.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.394 -0.816 . . . . 0.98 109.359 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.73 83.14 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.866 -1.161 . . . . 0.88 107.866 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 p -150.54 146.26 19.49 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 109.006 -0.739 . . . . 1.69 109.006 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.56 143.75 15.37 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.587 2.191 . . . . 0.85 113.272 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.7 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.88 -163.35 36.68 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.221 -1.552 . . . . 0.92 109.221 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.9 mt -148.58 147.54 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.971 -1.311 . . . . 0.81 108.933 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.88 147.84 28.42 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.875 -1.141 . . . . 0.51 110.537 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -128.5 120.71 27.32 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.818 -1.179 . . . . 0.62 107.818 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.82 -179.91 45.82 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 117.943 -2.075 . . . . 0.55 111.228 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -80.28 160.05 25.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.913 -0.757 . . . . 2.1 110.174 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.59 130.51 49.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.686 -0.634 . . . . 0.77 110.931 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.4 tp -100.38 135.42 41.85 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 107.486 -1.302 . . . . 0.91 107.486 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.1 tp -121.4 124.23 44.01 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.226 -0.921 . . . . 0.93 110.027 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.725 HD21 HD21 ' A' ' 149' ' ' LEU . 65.7 mt -81.66 103.31 11.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 0.93 109.758 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -96.88 121.69 39.02 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.267 -1.012 . . . . 2.75 108.267 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -130.36 133.68 46.6 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.27 -0.894 . . . . 3.0 110.153 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 42.5 t0 -69.7 141.76 53.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 2.77 109.505 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.496 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 86.3 tt0 -63.58 142.63 58.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.932 . . . . 2.94 109.232 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.422 HD11 ' HE ' ' A' ' 139' ' ' ARG . 80.4 mt -79.73 128.73 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.145 -0.972 . . . . 0.95 108.898 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.5 t -102.56 128.78 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.26 -0.9 . . . . 1.28 109.646 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.55 139.42 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.352 -0.843 . . . . 1.21 109.319 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -91.38 123.63 34.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.083 -1.011 . . . . 1.81 108.955 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.468 HH11 ' HG2' ' A' ' 28' ' ' ARG . 5.4 mmt-85 -89.96 -0.89 57.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.442 -0.786 . . . . 2.8 109.15 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -68.56 139.78 55.59 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.42 -0.8 . . . . 2.87 109.707 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -86.13 146.17 26.71 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.556 -0.905 . . . . 2.35 108.556 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.614 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.6 pt -92.66 165.98 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.97 109.95 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.3 p -99.71 173.87 6.5 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.488 -0.93 . . . . 1.17 108.488 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.01 -48.13 82.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.947 . . . . 1.18 109.3 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -57.37 -29.08 63.74 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.677 -1.264 . . . . 2.56 109.599 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -82.41 -10.52 59.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 1.79 110.257 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 40' ' ' VAL . 40.3 t -62.15 -52.21 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.951 -1.093 . . . . 1.0 108.568 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.89 -40.24 96.94 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.407 -0.808 . . . . 1.77 110.156 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -70.9 -40.14 72.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.132 -0.98 . . . . 2.7 110.542 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.614 ' HG3' HG21 ' A' ' 31' ' ' ILE . 62.4 mm-40 -66.06 -40.11 90.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.113 -0.992 . . . . 1.51 110.161 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 36' ' ' VAL . 77.2 t -61.68 -43.35 96.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.082 -1.011 . . . . 0.93 108.444 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -59.97 -39.71 86.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 1.81 108.984 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -60.06 -40.93 91.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.935 -1.103 . . . . 2.78 108.228 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -63.92 -47.87 78.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 0.78 108.612 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.5 -49.56 77.07 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.435 -0.58 . . . . 1.07 109.435 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 47.2 t -60.74 -43.3 98.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.113 -0.992 . . . . 1.12 108.81 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.81 -45.66 96.04 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.714 -1.754 . . . . 0.84 108.714 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -65.36 -32.81 74.64 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.954 -1.128 . . . . 3.09 107.954 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.65 -39.16 76.37 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.578 -0.701 . . . . 0.88 109.255 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.7 ttmt -72.78 -72.98 0.22 Allowed 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.768 -1.197 . . . . 2.59 107.768 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.76 -35.7 0.15 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.449 -0.782 . . . . 0.7 111.068 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.3 p -59.86 -56.29 23.61 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.451 -1.406 . . . . 1.4 108.627 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.67 -42.68 81.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.144 -0.973 . . . . 0.67 110.644 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -65.24 -39.99 93.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.063 -1.023 . . . . 1.66 110.621 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.9 mt -66.63 -40.2 88.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.743 -1.223 . . . . 1.58 109.818 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -62.04 -36.33 81.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.991 -1.068 . . . . 1.35 109.554 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.9 m -64.04 -40.38 96.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.189 -0.944 . . . . 0.77 110.311 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.54 -38.81 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.131 -0.981 . . . . 0.63 109.45 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -55.62 -50.43 70.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.392 -0.817 . . . . 1.14 110.612 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -59.67 -39.92 86.09 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.199 -0.938 . . . . 0.79 110.224 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -66.22 -35.65 80.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 1.53 109.513 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.661 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -63.1 -43.11 99.39 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.498 -0.751 . . . . 0.57 109.942 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.38 -50.69 42.5 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.942 -1.263 . . . . 0.75 109.942 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.41 -45.97 92.12 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.202 -1.175 . . . . 1.59 108.642 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.5 m -68.52 -58.64 4.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.457 -0.777 . . . . 0.73 111.663 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -97.96 -54.17 3.17 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.002 -1.061 . . . . 0.75 111.265 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.35 -169.31 25.49 Favored Glycine 0 N--CA 1.504 3.191 0 O-C-N 120.694 -1.254 . . . . 1.22 111.573 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -68.59 -27.79 66.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.913 -0.757 . . . . 5.81 111.001 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -62.56 -36.31 82.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 3.37 110.089 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -98.51 -22.37 16.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.397 -0.814 . . . . 1.77 110.228 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -67.92 -40.14 83.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.0 -1.062 . . . . 1.65 110.457 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.571 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -69.34 -26.09 64.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.77 110.08 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.4 mt -59.88 -40.65 83.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 120.872 -1.142 . . . . 0.8 108.068 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 20.5 m-85 -69.98 -37.61 75.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.428 -0.795 . . . . 0.88 110.139 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.498 ' OE2' ' NZ ' ' B' ' 324' ' ' LYS . 65.6 tt0 -60.65 -40.11 90.81 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.081 -1.012 . . . . 1.37 109.696 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.46 -45.91 81.72 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.381 -1.488 . . . . 0.62 109.381 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -60.43 -42.57 96.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -1.147 . . . . 1.5 109.539 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.1 mt -69.82 -41.09 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.124 -0.985 . . . . 0.63 109.531 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.8 ttp -62.57 -40.2 96.09 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.947 -1.096 . . . . 1.51 109.536 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.777 HD11 ' CE2' ' B' ' 348' ' ' PHE . 54.1 tp -64.89 -38.55 91.35 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.454 -0.779 . . . . 0.77 109.855 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.5 tp -62.08 -40.14 94.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.438 -0.789 . . . . 0.62 110.305 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -84.29 5.84 25.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.011 -1.055 . . . . 1.47 110.287 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 61.5 t0 -49.29 133.36 19.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.007 -1.058 . . . . 1.47 110.114 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.475 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 45.7 mt-10 -59.15 -21.22 59.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.809 -0.557 . . . . 1.78 110.507 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -71.03 -34.31 71.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.939 -1.101 . . . . 2.53 109.309 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.4 mt -71.07 -41.03 71.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.566 -0.709 . . . . 0.8 110.111 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -60.48 -47.69 85.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.533 -0.729 . . . . 1.42 110.653 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -69.82 -40.61 75.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.06 -1.025 . . . . 1.71 110.227 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.63 -39.9 70.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 1.57 111.875 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.55 -47.82 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.758 -1.213 . . . . 0.65 109.83 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.7 mt -69.66 -38.48 76.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.243 -0.911 . . . . 0.82 109.99 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.81 93.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.011 -1.056 . . . . 0.79 109.964 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.4 -45.98 88.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.839 -1.163 . . . . 0.95 109.406 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.66 -46.8 93.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.303 -0.873 . . . . 0.66 108.88 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -69.82 -42.36 73.77 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.334 -0.854 . . . . 2.2 111.602 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -86.08 -51.64 6.2 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.78 -1.2 . . . . 1.65 112.596 -177.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -88.8 -2.6 58.67 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.941 -1.099 . . . . 2.03 111.479 -177.235 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 56.8 37.98 29.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.908 -1.12 . . . . 1.42 109.709 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.1 mtt -87.44 169.21 12.43 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.548 -0.72 . . . . 1.18 110.043 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.1 p -84.37 160.3 20.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.875 . . . . 0.98 108.85 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.75 -38.94 87.62 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.05 -1.032 . . . . 0.64 110.032 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 38.6 p-10 -69.66 -36.8 76.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.983 -1.073 . . . . 2.07 110.168 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.48 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -81.57 -47.47 13.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.958 -1.088 . . . . 0.73 110.065 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.19 -49.76 76.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -0.875 . . . . 0.54 109.845 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.38 85.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.1 -1.0 . . . . 0.56 109.561 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.53 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 78.7 t60 -60.19 -41.99 94.1 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 1.54 110.263 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -62.34 -40.03 95.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.077 -1.014 . . . . 1.33 110.804 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.31 -56.33 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.948 -1.095 . . . . 0.72 111.613 -177.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.1 mm -69.24 -39.95 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.654 -1.279 . . . . 0.85 109.627 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.53 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.7 tt0 -60.31 -40.05 89.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.083 -1.011 . . . . 2.44 109.413 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.78 -49.37 79.33 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.405 -1.078 . . . . 0.98 110.405 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -67.97 -56.34 9.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.974 -1.31 . . . . 1.41 109.607 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.22 -42.7 63.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.726 -1.234 . . . . 1.2 109.041 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.4 t -59.84 -40.16 87.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.029 -1.045 . . . . 1.7 108.723 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.29 93.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.34 -0.85 . . . . 1.47 109.206 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.9 mt -66.47 -40.09 89.18 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.239 -0.913 . . . . 1.56 109.385 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.07 -33.52 72.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.986 -1.071 . . . . 2.2 109.941 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -58.74 -21.02 54.25 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.983 -1.073 . . . . 2.12 108.768 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.457 HD13 HD13 ' A' ' 123' ' ' LEU . 57.2 mt -62.77 139.64 58.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.232 -0.918 . . . . 2.0 109.247 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -92.46 46.1 1.23 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.981 -1.075 . . . . 3.23 108.929 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -132.12 130.74 41.57 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.4 -0.812 . . . . 2.49 110.033 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -69.9 -33.83 72.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.534 -0.729 . . . . 3.95 110.641 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.487 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.2 t80 -70.24 -40.21 74.6 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.121 -0.987 . . . . 2.0 110.566 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.589 ' CD2' HH21 ' A' ' 126' ' ' ARG . 82.4 mt -70.05 -35.96 74.64 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.954 -1.091 . . . . 1.86 108.747 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -59.93 -40.0 87.42 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.658 -0.651 . . . . 2.84 109.285 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -59.79 -46.5 89.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.857 -1.152 . . . . 2.73 110.011 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.589 HH21 ' CD2' ' A' ' 123' ' ' LEU . 74.0 mtm180 -62.62 -35.81 80.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.634 -1.291 . . . . 2.77 108.766 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.9 -32.29 70.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.368 -0.833 . . . . 1.19 108.813 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.64 -40.05 94.77 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.803 -0.814 . . . . 1.2 108.803 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -68.07 -40.54 82.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.442 -0.787 . . . . 1.55 110.039 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.49 HG21 HE22 ' B' ' 351' ' ' GLN . 49.9 t -70.22 -40.31 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.049 -1.032 . . . . 0.8 109.263 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -60.9 -40.34 92.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.955 -1.09 . . . . 3.09 108.449 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -60.03 -38.97 84.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.579 -0.701 . . . . 1.46 110.181 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.4 mt -59.75 -42.48 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.199 -0.938 . . . . 0.71 111.262 -178.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.94 -32.34 58.91 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.395 -1.384 . . . . 0.57 110.566 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -59.99 -48.57 81.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.037 -1.273 . . . . 2.59 110.408 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -69.33 -29.98 67.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.761 -1.212 . . . . 2.83 110.219 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.6 -40.08 86.3 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.043 -1.036 . . . . 1.25 108.277 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.89 -39.89 93.55 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.192 -1.04 . . . . 0.7 108.192 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.422 ' HE ' HD11 ' A' ' 24' ' ' ILE . 96.9 mtt180 -68.65 -39.87 80.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.322 -0.862 . . . . 2.57 109.582 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -64.98 -33.77 76.85 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.401 -0.812 . . . . 1.23 111.16 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -73.19 -45.83 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.571 -1.33 . . . . 0.81 109.615 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.2 mt -69.98 -30.08 67.33 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.681 -0.808 . . . . 1.0 108.989 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.34 40.61 6.02 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.811 -1.716 . . . . 0.89 108.811 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.421 ' HA ' HD12 ' A' ' 144' ' ' LEU . 24.3 tp -74.31 147.52 42.22 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.408 -1.054 . . . . 1.14 109.026 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -65.87 147.31 53.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.309 -0.869 . . . . 4.6 110.217 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.4 mt -115.63 123.17 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 108.524 -0.917 . . . . 1.24 108.524 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.54 -49.01 85.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.765 -0.585 . . . . 1.54 110.574 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.2 t0 67.72 101.42 0.05 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.51 -0.744 . . . . 1.5 109.085 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.725 HD21 HD21 ' A' ' 19' ' ' LEU . 91.2 mt -72.68 -1.97 18.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -0.867 . . . . 0.79 110.195 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.5 t -81.85 -10.84 59.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 1.4 108.402 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.03 26.25 0.63 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.739 -0.6 . . . . 0.92 110.496 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.452 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 50.3 mt -91.69 123.66 43.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.209 -0.932 . . . . 0.88 109.425 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -105.86 -10.95 16.41 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.213 -0.93 . . . . 2.45 109.975 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -134.02 155.07 50.65 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.137 -0.977 . . . . 1.52 110.512 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.31 134.51 56.59 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.695 0.76 . . . . 1.58 109.53 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.1 m -151.85 164.16 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.729 -0.841 . . . . 0.69 108.729 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.5 mt -94.96 144.72 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.766 -1.568 . . . . 0.61 106.766 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -92.64 117.63 30.18 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.814 -1.178 . . . . 0.87 110.131 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 3.5 t -126.44 132.99 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.619 -0.882 . . . . 0.71 108.619 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.64 165.46 30.59 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.344 -0.847 . . . . 0.81 108.912 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.0 -34.53 71.44 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.452 -1.405 . . . . 0.98 107.464 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 12.9 t70 -162.34 167.37 23.91 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.366 -0.976 . . . . 2.25 108.366 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.421 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 92.8 mt -140.55 132.48 27.67 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.215 -0.928 . . . . 0.78 108.746 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 5.6 p -98.95 153.99 37.55 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.302 -0.874 . . . . 0.98 109.606 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -45.37 -33.62 9.22 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.861 1.708 . . . . 0.81 112.327 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.7 m -53.27 -50.08 65.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.945 . . . . 0.9 109.941 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.65 -40.03 94.73 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.444 -0.785 . . . . 1.61 110.703 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 44.7 p -58.13 -18.67 26.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.61 111.749 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.661 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -86.08 -45.95 10.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.814 -1.179 . . . . 0.6 109.034 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -91.69 41.8 1.08 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.762 -1.199 . . . . 1.4 107.762 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.457 HD11 HG21 ' A' ' 176' ' ' VAL . 57.7 tp -108.74 138.79 44.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.639 -0.663 . . . . 0.7 109.513 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -93.38 99.54 12.03 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.291 -0.881 . . . . 2.35 108.78 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 25.1 mt -65.22 -40.36 94.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.195 -0.94 . . . . 1.51 109.679 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -62.48 -29.57 70.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.067 -1.021 . . . . 2.33 110.792 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.17 -9.2 37.13 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.826 -1.171 . . . . 1.92 110.721 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 178' ' ' GLY . 77.5 t -104.14 118.18 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.036 -1.04 . . . . 0.67 108.578 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.96 9.41 25.12 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.473 -0.767 . . . . 1.53 111.266 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 166.58 175.41 36.79 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.31 -1.516 . . . . 0.48 109.31 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.411 ' CE1' HG11 ' A' ' 176' ' ' VAL . 18.8 m-85 -134.14 131.27 38.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.46 -1.023 . . . . 0.55 108.835 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 98.0 mt -132.05 124.26 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.723 -0.843 . . . . 0.65 108.723 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 17.6 p -145.4 159.6 42.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.901 -1.124 . . . . 0.82 110.947 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -100.35 19.98 15.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.51 -0.744 . . . . 2.46 109.844 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.23 -162.01 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.695 -1.253 . . . . 1.28 111.379 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -87.26 -45.83 5.19 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 111.305 -0.718 . . . . 2.19 111.305 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 166.83 -145.66 10.11 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 118.43 -1.843 . . . . 2.13 111.245 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -60.69 -9.97 4.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.675 -0.897 . . . . 5.86 110.749 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 82.1 p -78.36 -1.09 31.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.862 -1.148 . . . . 3.72 109.868 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.8 t -91.83 129.78 37.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.178 -0.951 . . . . 1.74 109.927 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -46.26 -48.02 18.01 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.149 -0.97 . . . . 0.95 109.617 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 89.7 m -59.71 -38.51 81.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.61 -0.681 . . . . 1.55 110.866 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 96.6 p -59.81 -39.84 86.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.691 -1.255 . . . . 1.51 110.346 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.4 mm -62.61 -37.9 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 1.67 109.199 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.7 mtp -60.15 -43.79 95.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.37 -0.831 . . . . 1.02 110.162 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.28 -42.88 82.49 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.605 -1.309 . . . . 0.68 108.609 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -60.05 -54.12 49.73 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.619 -0.832 . . . . 2.93 110.425 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.4 m -71.26 -34.36 70.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.133 -0.979 . . . . 0.86 111.199 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.36 -29.74 66.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.01 -1.056 . . . . 0.67 108.724 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 69.99 49.87 0.48 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.236 0.541 . . . . 1.5 110.696 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 43.8 mt -128.27 149.28 70.93 Favored Pre-proline 0 N--CA 1.505 2.311 0 N-CA-C 107.799 -1.185 . . . . 0.72 107.799 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.14 143.53 99.74 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 122.21 1.94 . . . . 0.61 112.157 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -172.46 153.37 2.88 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.232 -0.987 . . . . 0.66 111.161 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.2 mt -128.0 143.55 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.847 -1.168 . . . . 0.79 107.847 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 28.3 m -128.78 -11.52 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 O-C-N 120.819 -1.176 . . . . 0.91 111.037 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.64 26.59 17.49 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.413 -1.075 . . . . 1.01 110.413 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.446 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.6 p -45.99 -42.2 12.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.105 -1.232 . . . . 0.99 109.542 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.34 -51.44 4.2 Favored Glycine 0 N--CA 1.494 2.547 0 C-N-CA 120.143 -1.027 . . . . 1.12 111.641 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 14.1 t -158.7 35.42 0.22 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.483 -1.598 . . . . 1.72 111.478 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.82 -40.04 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.128 -0.983 . . . . 0.89 108.747 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 47.2 p -54.77 -27.41 41.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.711 -0.618 . . . . 1.03 110.404 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.8 t -85.75 -12.13 51.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.16 -0.962 . . . . 1.83 110.624 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -104.19 -14.59 15.79 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.168 -0.957 . . . . 2.27 110.673 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.464 HG11 HD11 ' A' ' 218' ' ' LEU . 18.7 t -110.79 146.12 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.15 -0.969 . . . . 0.92 111.208 -177.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -113.36 150.11 33.08 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.747 -1.575 . . . . 2.2 106.747 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 56.6 t30 -55.82 139.96 43.83 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.944 -1.097 . . . . 2.36 110.014 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.7 t70 88.92 11.86 0.08 Allowed 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.27 0.557 . . . . 2.38 109.988 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 52.7 t0 -83.41 141.86 31.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.2 -0.938 . . . . 2.09 109.31 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.553 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 51.3 t80 -89.97 117.5 28.82 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.982 -1.118 . . . . 1.27 107.982 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.464 HD11 HG11 ' A' ' 212' ' ' VAL . 78.0 mt -124.42 142.17 51.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.57 -0.706 . . . . 0.75 109.749 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 88.7 mt -110.2 124.75 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.968 -1.493 . . . . 0.63 106.968 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 21.4 tp -98.36 115.9 29.43 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.901 -1.124 . . . . 0.7 108.064 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 223' ' ' VAL . 15.0 m-20 -79.43 -44.25 21.74 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.524 -0.917 . . . . 2.31 108.524 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.96 14.75 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.043 -0.725 . . . . 0.78 109.043 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 221' ' ' ASP . 47.0 t -124.71 -36.29 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.629 -1.619 . . . . 1.04 106.629 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -108.61 0.06 20.52 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.864 -1.162 . . . . 2.44 107.864 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 65.07 46.22 2.84 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.905 -0.497 . . . . 1.55 111.324 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -150.07 150.21 31.4 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.751 -1.218 . . . . 1.99 109.631 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.88 123.84 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.557 -0.905 . . . . 0.77 108.557 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -85.92 129.09 34.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.934 -1.104 . . . . 0.98 109.283 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.59 118.41 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.541 -0.724 . . . . 0.85 109.641 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 60.68 69.8 1.07 Allowed Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.112 -0.993 . . . . 1.66 110.294 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -90.45 132.07 1.73 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 123.532 2.821 . . . . 0.95 112.63 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.8 m -63.96 161.9 14.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.284 -0.885 . . . . 1.84 110.032 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.23 -42.49 95.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.209 -0.932 . . . . 2.74 110.479 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -60.81 -33.0 72.34 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.975 -1.078 . . . . 2.89 109.43 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.17 -40.07 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 1.3 109.3 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.1 mt . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.238 -0.914 . . . . 1.09 109.464 179.528 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 41.5 ttp . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.444 0.64 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -153.31 150.05 28.52 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -150.93 159.7 44.39 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.866 -1.146 . . . . 0.0 111.064 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -157.6 155.53 30.28 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.696 -0.628 . . . . 0.0 109.331 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -115.28 133.48 55.99 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.147 -0.971 . . . . 0.0 110.559 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.2 p -133.59 124.31 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 CA-C-O 122.11 0.957 . . . . 0.0 112.139 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 307' ' ' THR . . . . . 0.436 ' O ' HG23 ' B' ' 309' ' ' THR . 25.8 m -78.02 107.08 10.32 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.026 0.917 . . . . 0.0 111.195 -177.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.7 mt -52.92 120.21 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 122.477 1.132 . . . . 0.0 110.451 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 309' ' ' THR . . . . . 0.436 HG23 ' O ' ' B' ' 307' ' ' THR . 30.6 p -108.45 18.68 20.7 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.967 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.457 ' O ' ' CG ' ' B' ' 357' ' ' GLN . . . -73.01 128.47 87.85 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -63.02 -14.63 42.76 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 CA-C-N 120.309 1.146 . . . . 0.0 112.859 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -120.4 10.32 11.17 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.78 -179.13 49.9 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.487 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 2.8 tp -82.28 87.45 6.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.765 -1.432 . . . . 0.0 109.033 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.406 ' NE2' ' HB3' ' B' ' 317' ' ' ARG . 2.6 p80 -92.54 -160.89 0.78 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.918 -1.114 . . . . 0.0 109.865 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.8 m -56.87 -45.66 82.36 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.986 -1.071 . . . . 0.0 112.789 -176.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.571 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 11.9 tpt180 -56.14 -59.1 12.8 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 120.613 -1.305 . . . . 0.0 111.933 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.4 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 18.0 Cg_endo -62.04 -36.62 69.67 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 120.369 1.167 . . . . 0.0 111.921 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.71 84.74 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.26 -46.23 76.11 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.567 -0.708 . . . . 0.0 109.756 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -70.03 -39.88 75.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.824 -1.172 . . . . 0.0 108.355 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -61.57 -54.97 36.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.406 -0.809 . . . . 0.0 110.603 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.91 -30.63 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.667 -1.271 . . . . 0.0 110.091 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 324' ' ' LYS . . . . . 0.498 ' NZ ' ' OE2' ' A' ' 74' ' ' GLU . 29.7 ttmt -60.01 -45.41 92.87 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.173 -0.954 . . . . 0.0 109.076 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 325' ' ' GLU . . . . . 0.41 ' OE1' HD22 ' B' ' 380' ' ' LEU . 81.5 tt0 -68.31 -54.87 14.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 111.029 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -65.0 -54.91 23.04 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.848 -1.158 . . . . 0.0 112.284 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -52.97 -17.25 1.33 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.797 -1.189 . . . . 0.0 109.636 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -73.79 -16.85 79.17 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -105.48 150.54 25.22 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.15 -1.206 . . . . 0.0 109.248 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 14.6 t -89.76 -12.85 38.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.062 -1.024 . . . . 0.0 110.261 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.488 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 43.7 t -60.22 142.61 54.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -0.957 . . . . 0.0 109.496 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -67.59 136.08 53.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 108.656 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 79.1 mt -135.46 135.82 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.499 -0.751 . . . . 0.0 109.346 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 96.4 m -130.6 149.69 52.14 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 58.8 t -120.29 114.73 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 55.4 m -104.27 123.58 47.61 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.216 -0.927 . . . . 0.0 109.365 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 56.7 p -130.77 115.25 16.37 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.789 0.804 . . . . 0.0 110.489 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 48.1 t30 44.67 59.18 3.49 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.12 -15.04 18.21 Favored Glycine 0 N--CA 1.498 2.805 0 O-C-N 120.321 -1.487 . . . . 0.0 112.688 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -115.98 127.4 54.91 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-N 118.833 1.317 . . . . 0.0 109.285 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 53.9 p -129.61 150.18 51.05 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.844 0.831 . . . . 0.0 110.369 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.83 168.17 20.39 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 5.6 m -87.82 130.0 35.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.388 -0.82 . . . . 0.0 111.086 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -68.23 -20.27 64.8 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.395 -0.815 . . . . 0.0 109.322 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.02 21.16 1.09 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 346' ' ' SER . . . . . 0.465 ' H ' ' C ' ' B' ' 344' ' ' ALA . 16.7 m -151.39 96.29 2.26 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.756 0.789 . . . . 0.0 111.981 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.663 HD23 HD22 ' A' ' 79' ' ' LEU . 58.9 tp -59.94 -33.75 72.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.777 ' CE2' HD11 ' A' ' 79' ' ' LEU . 69.1 m-85 -54.62 -52.46 62.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.391 -0.818 . . . . 0.0 110.716 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -70.34 -40.1 74.3 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.05 -1.032 . . . . 0.0 110.255 -178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.604 ' O ' ' N ' ' B' ' 352' ' ' THR . 79.3 mt -49.76 -55.16 15.06 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.826 -1.171 . . . . 0.0 108.69 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.49 HE22 HG21 ' A' ' 130' ' ' VAL . 32.3 mt-30 -41.42 -13.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.792 -0.568 . . . . 0.0 110.955 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.604 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.0 p -93.33 -10.41 35.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.286 -1.509 . . . . 0.0 110.158 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 70.2 mt -92.07 117.94 30.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.106 -0.996 . . . . 0.0 108.838 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -71.02 88.96 0.39 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.8 mt -98.33 88.51 4.17 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.224 -1.162 . . . . 0.0 109.189 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 34.3 p -89.95 175.82 7.04 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.943 -1.098 . . . . 0.0 110.96 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 357' ' ' GLN . . . . . 0.457 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 20.5 tm0? -68.97 113.02 5.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.638 -0.664 . . . . 0.0 110.227 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.97 9.14 37.84 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 45.2 m -87.64 112.05 21.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.165 -1.197 . . . . 0.0 110.847 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 39.0 t -76.5 116.98 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 122.137 0.97 . . . . 0.0 109.861 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 27.3 m -112.57 176.03 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 70.5 m -131.52 128.38 39.21 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 88.2 mt -101.16 113.46 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 51.1 m -116.72 130.57 56.81 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.21 152.72 39.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.126 -0.984 . . . . 0.0 110.654 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -143.77 122.99 12.97 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.571 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.62 -156.55 27.24 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.153 -1.499 . . . . 0.0 111.369 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -59.89 -53.8 53.64 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.488 ' H ' ' HB2' ' B' ' 331' ' ' SER . 12.0 t70 -103.3 11.37 36.84 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.107 -0.995 . . . . 0.0 111.434 -176.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 10.6 pt-20 -48.02 -41.62 26.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.102 -0.999 . . . . 0.0 111.779 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 371' ' ' GLN . . . . . 0.415 ' N ' ' CG ' ' B' ' 370' ' ' GLU . 97.7 mt-30 -69.97 -48.52 57.95 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.636 -1.29 . . . . 0.0 110.335 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -66.11 -45.37 81.37 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.463 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -49.74 -74.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.042 -1.036 . . . . 0.0 110.647 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.575 ' O ' HG23 ' B' ' 378' ' ' VAL . 39.3 t -45.3 -38.62 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.004 -1.06 . . . . 0.0 110.42 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -63.77 -48.15 78.12 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.828 -1.17 . . . . 0.0 109.861 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -79.52 -42.58 24.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.0 -1.063 . . . . 0.0 110.571 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.9 mt -59.4 -37.14 77.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.924 -1.11 . . . . 0.0 109.079 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.575 HG23 ' O ' ' B' ' 374' ' ' VAL . 43.1 t -63.15 -40.23 88.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 119.204 -0.998 . . . . 0.0 109.309 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 379' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.5 mttt -69.45 -55.61 9.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.694 -1.254 . . . . 0.0 108.476 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.41 HD22 ' OE1' ' B' ' 325' ' ' GLU . 58.0 tp -57.09 -32.75 66.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 109.452 -178.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 4.6 tpp -71.29 -40.01 71.13 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.543 -1.263 . . . . 0.0 107.885 177.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.4 -7.97 59.66 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.659 -0.651 . . . . 0.0 110.818 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.449 ' O ' ' OE2' ' B' ' 385' ' ' GLU . 96.5 mt-10 -110.33 -0.27 17.71 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 120.822 -1.173 . . . . 0.0 111.317 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.1 mt -82.31 132.36 35.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.394 -1.441 . . . . 0.0 110.238 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 385' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 56.4 mp0 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 118.148 -0.929 . . . . 0.0 108.926 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.104 -0.702 . . . . 2.91 109.104 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.4 mt -110.0 130.04 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.398 -0.814 . . . . 1.2 109.822 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.5 m -133.8 147.86 51.28 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.466 -0.771 . . . . 1.4 109.401 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.52 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -127.42 -162.32 11.09 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 108.766 -1.734 . . . . 1.05 108.766 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.8 mt -92.83 -14.64 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.844 -1.386 . . . . 1.15 109.775 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.8 tp 55.21 103.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.528 -0.916 . . . . 0.98 108.528 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.01 -30.08 17.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 0.88 109.104 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.0 t -141.57 126.89 10.8 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.454 -0.779 . . . . 1.69 109.457 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.55 142.82 18.66 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.738 1.625 . . . . 0.85 111.599 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.784 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.2 -164.16 36.97 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.35 -1.5 . . . . 0.92 109.35 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -147.32 148.62 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.009 -1.289 . . . . 0.81 109.005 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.33 152.45 32.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.094 -1.004 . . . . 0.51 110.105 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -135.09 124.85 25.35 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.122 -1.066 . . . . 0.62 108.122 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.71 -175.95 47.39 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 118.739 -1.696 . . . . 0.55 110.701 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -79.57 155.63 28.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.868 -0.784 . . . . 2.1 109.534 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -103.04 130.17 50.08 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.48 -0.763 . . . . 0.77 110.461 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.2 tp -98.36 135.51 39.85 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.024 -1.102 . . . . 0.91 108.024 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.9 tp -117.88 124.44 48.31 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.743 0.783 . . . . 0.93 109.756 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.2 mt -99.97 109.97 22.3 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.742 -0.598 . . . . 0.93 110.916 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -110.66 140.84 44.65 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.559 -0.713 . . . . 2.75 109.191 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -126.78 130.86 51.11 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.31 -0.869 . . . . 3.0 108.782 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.2 p-10 -77.58 155.33 31.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.05 -1.032 . . . . 2.77 109.104 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -72.05 141.26 49.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 2.94 109.511 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -82.44 136.4 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.286 -0.884 . . . . 0.95 108.632 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -95.23 129.42 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.098 -1.001 . . . . 1.28 110.071 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.01 135.87 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.598 -0.688 . . . . 1.21 109.303 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -90.93 123.54 34.51 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.995 -1.066 . . . . 1.81 110.242 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -90.04 -3.91 57.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.591 -0.693 . . . . 2.8 110.469 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -70.33 142.79 52.15 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.004 -1.06 . . . . 2.87 110.6 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp -84.3 153.17 23.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.217 -0.927 . . . . 2.35 108.91 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.63 HG21 ' HG3' ' A' ' 39' ' ' GLU . 3.6 pt -95.05 165.83 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.161 -0.962 . . . . 0.97 109.835 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -93.74 170.75 9.34 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.144 -1.058 . . . . 1.17 108.144 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.41 77.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.812 -1.18 . . . . 1.18 109.722 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -55.49 -28.73 56.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.744 -1.222 . . . . 2.56 109.303 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -81.52 -11.28 59.24 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.39 -0.818 . . . . 1.79 110.069 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -63.34 -51.71 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.751 -1.218 . . . . 1.0 108.94 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -61.47 -39.99 92.9 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.32 -0.862 . . . . 1.77 109.758 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -69.14 -41.33 77.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.896 . . . . 2.7 110.781 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.63 ' HG3' HG21 ' A' ' 31' ' ' ILE . 74.9 mm-40 -65.0 -40.05 94.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.831 -1.168 . . . . 1.51 110.015 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.6 -45.18 97.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.503 -1.295 . . . . 0.93 107.503 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -60.09 -42.7 95.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 1.81 109.125 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -60.05 -40.16 88.44 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.657 -1.238 . . . . 2.78 107.657 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -66.39 -43.95 84.43 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.421 -0.955 . . . . 0.78 108.421 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.08 -50.01 75.4 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.448 -0.945 . . . . 1.07 108.448 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 22.7 t -62.34 -43.52 98.64 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.542 -0.863 . . . . 1.12 108.731 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.76 -44.22 98.22 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.266 -1.934 . . . . 0.84 108.266 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.407 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 32.8 ttt-85 -64.1 -36.03 82.69 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.35 -0.981 . . . . 3.09 108.35 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -54.77 -40.04 68.99 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.852 -0.795 . . . . 0.88 108.852 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 50' ' ' ALA . 17.1 ttmt -67.96 -74.79 0.11 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.166 -1.05 . . . . 2.59 108.166 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.27 -31.86 0.06 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.529 -0.732 . . . . 0.7 111.028 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 49' ' ' LYS . 47.4 t -59.57 -58.79 7.05 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.706 -1.246 . . . . 1.4 108.634 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.24 -44.51 71.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.275 -0.891 . . . . 0.67 111.261 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -61.05 -44.43 97.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.89 -1.131 . . . . 1.66 110.879 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.52 -40.01 93.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.947 -1.096 . . . . 1.58 110.066 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -60.01 -35.58 75.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.054 -1.029 . . . . 1.35 109.875 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -64.31 -41.42 96.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.04 -1.037 . . . . 0.77 110.145 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.8 mt -60.15 -39.94 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.099 -1.001 . . . . 0.63 109.455 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -59.74 -50.15 74.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 1.14 109.638 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -60.55 -40.02 90.04 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.453 -0.779 . . . . 0.79 110.804 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.57 -39.62 94.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.831 -1.168 . . . . 1.53 109.493 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.603 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -65.86 -42.8 89.95 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.583 -0.698 . . . . 0.57 110.064 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.06 -50.17 65.65 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.986 -1.102 . . . . 0.75 110.358 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.78 -42.94 76.69 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.949 -1.324 . . . . 1.59 109.658 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -70.25 -59.12 3.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.73 111.944 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 168' ' ' THR . 95.8 m-85 -95.09 -53.39 3.83 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.975 -1.078 . . . . 0.75 111.358 -177.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.14 -167.58 26.0 Favored Glycine 0 N--CA 1.502 3.043 0 C-N-CA 119.773 -1.203 . . . . 1.22 111.474 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -73.29 -26.51 61.11 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.97 -0.724 . . . . 5.81 111.251 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -61.97 -34.69 76.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.006 -1.059 . . . . 3.37 110.245 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -98.83 -24.12 15.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.13 -0.981 . . . . 1.77 110.27 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.61 -40.19 92.35 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.983 -1.073 . . . . 1.65 110.913 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.601 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -60.11 -32.02 70.6 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.213 -0.929 . . . . 0.77 109.747 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.97 -41.67 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.11 -0.994 . . . . 0.8 109.313 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -70.13 -38.14 75.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.299 -0.876 . . . . 0.88 111.229 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -59.93 -40.05 87.62 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.723 -1.235 . . . . 1.37 109.683 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.49 -43.94 97.4 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.941 -1.664 . . . . 0.62 108.941 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 59.7 m170 -61.96 -43.03 99.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.457 -1.025 . . . . 1.5 109.403 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.0 mt -68.89 -45.22 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.63 109.697 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.0 ttp -59.99 -40.22 88.41 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.024 -1.048 . . . . 1.51 109.902 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.855 HD11 ' CE2' ' B' ' 348' ' ' PHE . 33.1 tp -65.23 -38.07 89.23 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.493 -0.755 . . . . 0.77 109.912 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.3 tp -66.28 -40.03 89.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.471 -0.768 . . . . 0.62 110.354 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -81.8 4.67 21.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.893 -1.129 . . . . 1.47 109.711 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -50.48 131.86 24.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.364 -0.835 . . . . 1.47 110.183 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -62.34 -17.63 59.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.508 -0.745 . . . . 1.78 110.483 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.95 -35.2 74.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.94 -1.1 . . . . 2.53 108.362 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.07 -40.02 75.29 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.468 0.651 . . . . 0.8 109.83 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.1 -49.99 75.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.508 -0.745 . . . . 1.42 110.12 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -71.9 -41.74 67.57 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.277 -0.89 . . . . 1.71 110.63 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.04 -40.74 74.95 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.054 -1.029 . . . . 1.57 111.596 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.9 mt -68.62 -45.74 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.835 -1.166 . . . . 0.65 109.79 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -69.61 -35.09 64.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.378 -0.826 . . . . 0.82 110.048 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.79 99.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.79 110.653 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.75 -48.09 83.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.913 -1.117 . . . . 0.95 109.579 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 55.8 mt -60.13 -48.15 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 121.981 0.896 . . . . 0.66 108.862 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -69.93 -40.05 75.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.759 -0.588 . . . . 2.2 111.187 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -83.54 -52.35 6.56 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.984 -1.073 . . . . 1.65 112.041 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -90.08 -2.27 58.08 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.073 -1.017 . . . . 2.03 111.679 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 56.9 34.68 25.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.918 -1.114 . . . . 1.42 109.305 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.4 mtp -90.31 166.63 13.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.432 -0.793 . . . . 1.18 110.158 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.413 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 67.2 p -77.63 160.41 28.54 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.457 -0.777 . . . . 0.98 109.279 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.61 -40.04 84.71 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.182 -0.949 . . . . 0.64 110.114 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 34.1 p-10 -68.37 -37.13 80.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.07 -1.019 . . . . 2.07 109.309 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.469 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -78.99 -39.96 32.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.041 -1.037 . . . . 0.73 109.593 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.46 -46.72 63.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.862 . . . . 0.54 110.498 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.04 93.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.092 -1.005 . . . . 0.56 109.652 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.528 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 85.3 t60 -59.91 -39.91 87.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.839 . . . . 1.54 109.717 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.13 -43.05 95.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.21 -0.931 . . . . 1.33 110.221 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.86 -59.45 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.185 -0.947 . . . . 0.72 110.83 -178.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.1 mm -63.57 -40.02 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.891 -1.131 . . . . 0.85 108.974 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.528 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 86.7 tt0 -64.01 -40.13 95.65 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.73 -1.211 . . . . 2.44 107.73 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.07 -48.6 85.31 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.952 -1.259 . . . . 0.98 109.952 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -68.03 -50.73 53.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.933 -1.333 . . . . 1.41 109.188 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.33 88.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 1.2 108.606 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 30.3 t -59.91 -40.8 90.05 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.437 -0.949 . . . . 1.7 108.437 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.22 96.31 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.33 -0.856 . . . . 1.47 108.781 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.8 mt -66.37 -42.13 88.42 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.305 -0.958 . . . . 1.56 109.248 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -60.05 -40.01 87.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.737 -1.227 . . . . 2.2 109.444 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -50.22 -20.17 0.97 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.991 -1.068 . . . . 2.12 109.02 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.573 HD13 HD13 ' A' ' 123' ' ' LEU . 54.1 mt -64.19 144.46 57.11 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.141 -0.975 . . . . 2.0 108.611 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 -100.23 52.5 0.89 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.119 -0.988 . . . . 3.23 110.271 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 57.5 t0 -135.58 130.47 34.54 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.134 -0.979 . . . . 2.49 109.627 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 67.0 mt-10 -61.95 -32.97 73.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.741 . . . . 3.95 109.837 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.495 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.0 t80 -70.05 -38.53 75.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 2.0 110.421 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.573 HD13 HD13 ' A' ' 118' ' ' LEU . 87.6 mt -80.42 -32.77 37.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.927 -1.108 . . . . 1.86 109.51 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -60.01 -40.48 89.4 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.905 -1.122 . . . . 2.84 108.177 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 98.9 mt-10 -65.1 -40.07 94.06 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.511 -0.922 . . . . 2.73 108.511 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.455 ' NE ' ' NE2' ' B' ' 351' ' ' GLN . 0.0 OUTLIER -61.11 -39.95 91.94 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.643 -0.873 . . . . 2.77 108.643 179.416 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.18 -22.56 66.95 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.929 -0.767 . . . . 1.19 108.929 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -70.56 -42.59 70.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.645 -0.659 . . . . 1.2 109.78 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -63.88 -40.01 95.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 1.55 110.204 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.24 -41.68 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.106 -0.996 . . . . 0.8 109.427 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.424 HH11 ' HG2' ' A' ' 131' ' ' ARG . 30.3 ttt-85 -60.55 -37.34 80.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 3.09 109.221 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -59.99 -39.82 87.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.631 -0.668 . . . . 1.46 109.387 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.93 -42.04 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.01 -1.056 . . . . 0.71 109.46 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.41 -32.36 68.2 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.785 -1.326 . . . . 0.57 109.785 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.554 ' NZ ' ' HE ' ' A' ' 139' ' ' ARG . 50.3 tttm -59.92 -48.32 82.2 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.133 -1.216 . . . . 2.59 109.028 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.458 HH21 ' HB3' ' A' ' 166' ' ' SER . 1.8 mtt-85 -61.88 -35.34 78.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.993 . . . . 2.83 109.657 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.57 -44.18 93.39 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.507 -0.745 . . . . 1.25 110.275 -177.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 49.6 mt -65.12 -40.14 94.06 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.875 -1.141 . . . . 0.7 109.95 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.554 ' HE ' ' NZ ' ' A' ' 135' ' ' LYS . 59.2 mtt-85 -68.84 -38.96 80.18 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.485 -0.932 . . . . 2.57 108.485 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.505 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.4 m120 -65.07 -38.53 91.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.749 -0.594 . . . . 1.23 110.98 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.6 mt -70.0 -43.16 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.548 -1.345 . . . . 0.81 108.946 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.03 -31.0 68.42 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.623 -0.673 . . . . 1.0 109.727 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.33 39.12 13.04 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.759 -1.737 . . . . 0.89 108.759 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.8 tp -73.96 149.55 41.3 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.469 -1.019 . . . . 1.14 109.623 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -61.42 146.74 47.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.509 -0.745 . . . . 4.6 110.127 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.51 121.93 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-O 122.077 0.941 . . . . 1.24 108.503 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 148' ' ' ASP . 6.0 mt -62.77 -44.32 99.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.839 -0.619 . . . . 1.54 110.823 -178.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 147' ' ' ILE . 50.7 t0 61.87 121.33 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.6 -0.688 . . . . 1.5 109.199 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 59.9 mt -87.97 0.85 55.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.406 -0.808 . . . . 0.79 109.999 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 62.1 m -82.67 -18.8 39.74 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.878 -1.139 . . . . 1.4 110.716 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.52 29.99 0.43 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.965 -1.085 . . . . 0.92 111.642 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 45.7 mm -90.55 119.19 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.682 -1.261 . . . . 0.88 108.38 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -100.15 -9.9 22.02 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.355 -0.841 . . . . 2.45 110.454 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -126.46 150.94 48.38 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.1 -1.0 . . . . 1.52 110.35 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.64 137.2 58.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.835 . . . . 1.58 109.413 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.6 m -152.18 163.5 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.992 -0.744 . . . . 0.69 108.992 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.3 mt -93.42 148.49 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 106.351 -1.722 . . . . 0.61 106.351 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 38.3 tp -96.8 114.28 25.9 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.862 -1.148 . . . . 0.87 110.299 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.51 130.08 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.525 -0.917 . . . . 0.71 108.525 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.08 162.05 39.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.169 -0.957 . . . . 0.81 108.899 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.94 -32.23 65.14 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.209 -1.557 . . . . 0.98 108.713 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 60.1 t0 -167.24 137.8 3.01 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.628 -0.879 . . . . 2.25 108.628 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.514 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 69.3 mt -112.89 131.41 55.74 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.347 -0.845 . . . . 0.78 109.926 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.5 p -100.56 148.92 35.63 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.419 -0.801 . . . . 0.98 108.906 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -38.22 -36.98 0.58 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.274 1.983 . . . . 0.81 112.717 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.458 ' HB3' HH21 ' A' ' 136' ' ' ARG . 4.2 m -50.34 -58.13 6.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 0.9 109.979 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -60.61 -39.85 89.7 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.38 -0.825 . . . . 1.61 110.755 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.445 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 64.4 p -60.03 -19.59 53.53 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.788 -1.195 . . . . 0.61 110.916 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.603 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -83.42 -38.6 21.7 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.852 -1.155 . . . . 0.6 109.556 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -104.66 39.3 1.71 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.663 -0.866 . . . . 1.4 108.663 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.6 tp -106.15 140.08 39.67 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.608 -0.886 . . . . 0.7 108.608 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -85.15 106.85 16.9 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.054 -1.029 . . . . 2.35 109.375 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 94.5 mt -62.84 -41.9 99.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.368 -0.833 . . . . 1.51 111.157 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -70.06 -24.49 63.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.155 -0.966 . . . . 2.33 111.859 -177.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -93.69 -10.52 34.14 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.654 -1.279 . . . . 1.92 109.711 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 68.8 t -98.62 107.02 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.154 -0.967 . . . . 0.67 108.6 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.3 mt -81.92 3.83 24.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.227 -0.92 . . . . 1.53 110.062 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 169.95 173.58 37.48 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.866 -1.294 . . . . 0.48 109.866 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.492 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 7.8 m-85 -129.31 126.93 40.07 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.411 -1.052 . . . . 0.55 109.24 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.415 ' CG2' HG21 ' A' ' 205' ' ' THR . 75.5 mt -128.45 123.69 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.815 -1.18 . . . . 0.65 107.815 177.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 35.1 p -147.05 160.61 42.18 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.806 -1.184 . . . . 0.82 111.504 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 61.6 t0 -103.93 25.95 9.28 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.233 -0.654 . . . . 2.46 109.233 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.42 -162.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.317 -1.49 . . . . 1.28 111.562 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.69 -58.16 4.63 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 111.162 -0.775 . . . . 2.19 111.162 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -168.84 -149.79 6.37 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 118.506 -1.807 . . . . 2.13 111.515 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -77.93 -9.01 58.87 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.817 -0.814 . . . . 5.86 111.013 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 74.5 p -83.13 4.62 25.71 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.814 -1.179 . . . . 3.72 110.557 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 191' ' ' SER . 22.7 p -82.14 143.3 31.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.887 -1.133 . . . . 1.74 110.394 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -46.65 -52.45 13.72 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.335 -0.853 . . . . 0.95 110.096 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 190' ' ' THR . 0.1 OUTLIER -56.11 -38.0 70.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.361 -0.837 . . . . 1.55 110.725 -178.828 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 188' ' ' SER . 80.5 p -61.69 -40.54 95.35 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.891 -1.131 . . . . 1.51 111.029 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.9 mt -60.09 -39.71 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.014 . . . . 1.67 109.123 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.0 mtp -59.98 -45.3 93.15 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.556 -0.715 . . . . 1.02 110.214 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.72 91.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.601 -1.312 . . . . 0.68 110.292 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -61.1 -52.04 66.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.853 -1.154 . . . . 2.93 110.607 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 62.1 m -70.4 -34.73 72.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.001 -1.062 . . . . 0.86 111.759 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.23 -9.98 59.05 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.702 -1.249 . . . . 0.67 110.543 -178.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 61.91 50.21 4.31 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.482 -0.761 . . . . 1.5 111.423 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 20.9 mt -128.36 149.48 71.61 Favored Pre-proline 0 N--CA 1.5 2.048 0 N-CA-C 107.664 -1.235 . . . . 0.72 107.664 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.06 139.5 46.96 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 122.245 1.963 . . . . 0.61 111.718 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -169.5 150.56 4.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.845 -1.159 . . . . 0.66 111.725 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 91.9 mt -126.86 142.12 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.792 -1.188 . . . . 0.79 107.792 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 18.2 m -123.03 -8.99 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 120.827 -1.17 . . . . 0.91 111.542 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -113.14 24.29 12.86 Favored Glycine 0 N--CA 1.502 3.07 0 N-CA-C 110.677 -0.969 . . . . 1.01 110.677 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.415 HG21 ' CG2' ' A' ' 180' ' ' ILE . 17.5 p -43.41 -47.91 7.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.121 -1.223 . . . . 0.99 110.074 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.433 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 97.03 -55.04 1.33 Allowed Glycine 0 N--CA 1.499 2.897 0 C-N-CA 120.341 -0.933 . . . . 1.12 111.611 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 85.6 p -148.52 28.59 0.87 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.397 -1.649 . . . . 1.72 111.584 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 18.3 t -70.03 -36.74 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.717 -1.24 . . . . 0.89 108.839 178.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.3 p -58.02 -30.66 66.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 1.03 110.964 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.1 t -83.02 -19.4 37.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.803 -1.186 . . . . 1.83 110.389 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -96.98 -11.93 23.97 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.089 -1.007 . . . . 2.27 110.471 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.2 t -107.93 137.41 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.256 -0.902 . . . . 0.92 110.628 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -114.89 149.71 36.76 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.48 -1.304 . . . . 2.2 107.48 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 41.7 t30 -56.25 138.58 50.12 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.083 -1.011 . . . . 2.36 110.955 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.0 m-20 83.88 7.42 0.62 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.138 0.494 . . . . 2.38 110.229 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -77.91 145.9 35.89 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.207 -0.933 . . . . 2.09 108.871 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -95.34 117.12 29.76 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.273 -1.01 . . . . 1.27 108.273 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' A' ' 16' ' ' ALA . 72.0 mt -126.75 150.7 48.94 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.578 -0.701 . . . . 0.75 110.278 -179.01 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.7 mt -115.93 128.55 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 106.846 -1.539 . . . . 0.63 106.846 177.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 60.9 tp -99.98 120.09 39.27 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.947 -1.096 . . . . 0.7 109.186 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 223' ' ' VAL . 12.2 t70 -80.18 -41.13 25.87 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.281 -1.007 . . . . 2.31 108.281 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.784 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.27 12.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.775 -0.578 . . . . 0.78 109.55 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 221' ' ' ASP . 42.8 t -124.85 -35.44 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.283 -1.377 . . . . 1.04 107.283 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.519 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 71.9 m-80 -111.76 2.61 17.23 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.99 -1.115 . . . . 2.44 107.99 178.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.52 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.6 OUTLIER 59.63 47.77 10.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.776 -0.578 . . . . 1.55 110.376 179.715 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -135.5 148.22 49.11 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.147 -0.97 . . . . 1.99 109.864 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.7 t -117.84 125.72 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.545 -0.909 . . . . 0.77 108.545 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -101.13 121.87 42.6 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.405 -0.809 . . . . 0.98 109.177 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.4 HG22 HD22 ' A' ' 218' ' ' LEU . 32.1 t -101.85 113.16 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.462 -0.774 . . . . 0.85 110.897 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 35.0 t30 52.02 60.75 13.2 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.052 -1.03 . . . . 1.66 111.3 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -86.67 152.64 8.83 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.653 2.236 . . . . 0.95 111.822 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.4 p -74.2 168.44 19.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.097 -1.002 . . . . 1.84 110.526 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -59.99 -37.94 81.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.663 -0.648 . . . . 2.74 110.265 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.57 -38.9 82.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 2.89 109.846 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.95 -41.35 79.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.218 -0.927 . . . . 1.3 109.236 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.221 -0.924 . . . . 1.09 109.569 -179.999 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -151.3 149.15 29.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -0.837 . . . . 0.0 108.83 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 303' ' ' GLN . . . . . 0.491 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 0.4 OUTLIER -146.15 154.65 42.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.199 -0.938 . . . . 0.0 110.171 -178.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -152.73 149.38 28.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.535 -0.728 . . . . 0.0 109.113 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -112.52 131.78 55.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.287 -0.883 . . . . 0.0 109.101 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.0 123.59 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-O 122.284 1.04 . . . . 0.0 112.476 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 29.3 m -77.84 104.05 8.15 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.999 0.904 . . . . 0.0 110.126 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.543 HG22 ' H ' ' B' ' 310' ' ' ALA . 90.1 mt -51.59 119.58 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 122.487 1.137 . . . . 0.0 110.366 -177.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 23.7 p -99.9 24.63 8.23 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.587 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.543 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -88.28 113.62 55.98 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -70.99 -5.24 16.54 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 CA-C-N 120.215 1.113 . . . . 0.0 111.864 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -110.45 0.65 17.9 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 74.26 172.17 26.91 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.495 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.5 tp -86.05 93.81 9.08 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.956 -1.32 . . . . 0.0 108.333 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -93.47 -161.58 0.86 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.205 -0.935 . . . . 0.0 110.418 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 316' ' ' THR . . . . . 0.404 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 2.9 m -59.3 -44.59 92.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.126 -0.984 . . . . 0.0 112.416 -176.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.601 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.3 tpt180 -57.11 -62.52 5.03 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 120.436 -1.415 . . . . 0.0 111.532 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.75 -30.68 85.44 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 120.2 1.107 . . . . 0.0 111.539 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.11 -50.62 72.96 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.371 -0.931 . . . . 0.0 108.83 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -54.88 -43.17 72.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 109.874 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -70.1 -41.32 74.18 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.809 -1.156 . . . . 0.0 108.826 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -60.08 -50.19 74.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.455 -0.778 . . . . 0.0 110.356 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 80.4 t -68.93 -27.72 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.713 -1.242 . . . . 0.0 109.74 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -60.02 -49.14 78.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.881 . . . . 0.0 110.332 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 325' ' ' GLU . . . . . 0.475 ' OE1' HD22 ' B' ' 380' ' ' LEU . 86.4 tt0 -68.52 -40.15 80.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.075 -1.015 . . . . 0.0 111.326 -178.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.87 -53.3 58.99 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.561 -1.337 . . . . 0.0 111.108 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -57.69 -11.61 2.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.095 -1.003 . . . . 0.0 109.426 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -68.07 -29.98 73.72 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -104.98 144.21 32.11 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.451 -1.029 . . . . 0.0 109.159 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 7.7 m -90.22 -11.28 41.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.062 -1.024 . . . . 0.0 109.443 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.475 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 33.8 m -57.99 149.02 24.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 109.846 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.91 132.9 48.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.905 . . . . 0.0 109.236 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.9 mt -133.4 132.28 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.307 -0.871 . . . . 0.0 110.041 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 334' ' ' THR . . . . . 0.408 HG22 ' N ' ' B' ' 335' ' ' VAL . 52.7 m -128.17 153.15 47.2 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 335' ' ' VAL . . . . . 0.408 ' N ' HG22 ' B' ' 334' ' ' THR . 84.0 t -119.85 139.87 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 96.8 m -130.33 123.03 29.04 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.275 -0.891 . . . . 0.0 108.739 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 59.8 p -140.11 121.86 15.4 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.081 0.943 . . . . 0.0 111.314 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 57.4 t30 43.49 52.68 5.95 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.35 -12.27 59.0 Favored Glycine 0 N--CA 1.5 2.941 0 O-C-N 120.182 -1.574 . . . . 0.0 112.904 176.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -118.94 129.45 55.18 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-N 119.268 1.534 . . . . 0.0 109.925 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 69.7 m -122.32 146.13 47.6 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.763 0.792 . . . . 0.0 110.078 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -140.42 161.05 38.63 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.472 0.653 . . . . 0.0 109.805 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.8 t -86.09 136.29 33.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.517 -0.739 . . . . 0.0 109.246 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.424 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -79.11 -14.12 59.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.978 -1.076 . . . . 0.0 110.418 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 345' ' ' LYS . . . . . 0.404 ' H ' ' HG2' ' B' ' 345' ' ' LYS . 19.7 pttp -87.36 21.47 2.45 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 346' ' ' SER . . . . . 0.424 ' H ' ' C ' ' B' ' 344' ' ' ALA . 69.2 m -149.62 99.39 2.87 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.795 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.702 HD23 HD22 ' A' ' 79' ' ' LEU . 58.0 tp -60.11 -35.28 74.89 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.855 ' CE2' HD11 ' A' ' 79' ' ' LEU . 51.7 m-85 -55.38 -54.43 43.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.956 -1.09 . . . . 0.0 109.786 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -69.93 -20.57 63.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.29 -0.881 . . . . 0.0 111.29 -177.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' B' ' 352' ' ' THR . 32.8 mt -70.32 -57.91 4.34 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.716 -1.24 . . . . 0.0 110.666 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.552 ' O ' HD22 ' A' ' 123' ' ' LEU . 2.9 mm100 -44.92 -14.77 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.093 -1.005 . . . . 0.0 111.409 -176.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.511 ' N ' ' O ' ' B' ' 350' ' ' LEU . 70.4 p -80.3 -13.44 59.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.196 -1.565 . . . . 0.0 110.278 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 34.9 mt -93.03 119.26 32.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.098 -1.002 . . . . 0.0 108.778 178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.14 91.22 0.91 Allowed Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 18.9 mt -96.5 87.31 4.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.327 -1.102 . . . . 0.0 108.527 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 64.3 p -92.2 -179.48 5.26 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.802 0.81 . . . . 0.0 110.668 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 357' ' ' GLN . . . . . 0.424 ' O ' ' N ' ' B' ' 359' ' ' THR . 65.8 tt0 -49.41 155.57 0.72 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 122.268 1.033 . . . . 0.0 111.109 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.88 27.58 0.06 OUTLIER Glycine 0 N--CA 1.497 2.729 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.56 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 359' ' ' THR . . . . . 0.424 ' N ' ' O ' ' B' ' 357' ' ' GLN . 11.8 m -86.57 109.95 19.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.767 -1.431 . . . . 0.0 109.864 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.25 114.77 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.343 1.068 . . . . 0.0 110.147 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 9.9 m -111.93 177.52 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 49.7 m -130.95 130.1 43.0 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 81.9 mt -106.36 122.28 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 77.3 p -125.05 134.67 52.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.22 152.2 38.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.142 -0.973 . . . . 0.0 110.119 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -142.18 121.73 13.31 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.407 ' H ' ' HG2' ' B' ' 370' ' ' GLU . . . 164.43 -163.28 36.04 Favored Glycine 0 N--CA 1.485 1.923 0 C-N-CA 118.636 -1.745 . . . . 0.0 111.536 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -59.57 -50.07 75.32 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.01 -0.595 . . . . 0.0 111.673 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.475 ' N ' ' OG ' ' B' ' 331' ' ' SER . 85.2 m-20 -111.6 10.3 21.15 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.974 -1.079 . . . . 0.0 110.936 -177.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' B' ' 367' ' ' GLY . 0.7 OUTLIER -44.02 -33.78 1.54 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.113 -0.992 . . . . 0.0 111.596 -178.61 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -69.89 -40.36 75.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.619 -1.301 . . . . 0.0 109.594 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -68.29 -48.15 65.75 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.173 -0.954 . . . . 0.0 109.862 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -50.44 -74.38 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.149 -0.97 . . . . 0.0 110.91 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.586 ' O ' HG23 ' B' ' 378' ' ' VAL . 67.6 t -44.11 -40.75 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.254 -0.904 . . . . 0.0 110.697 -177.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.86 -50.16 72.03 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.526 -1.358 . . . . 0.0 110.481 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -75.81 -40.03 55.72 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.802 -1.186 . . . . 0.0 110.669 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 98.9 mt -59.0 -37.51 77.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.011 -1.056 . . . . 0.0 108.606 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.586 HG23 ' O ' ' B' ' 374' ' ' VAL . 47.1 t -60.74 -40.21 84.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.279 -0.888 . . . . 0.0 109.093 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 379' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' B' ' 383' ' ' GLU . 20.3 mmmt -67.97 -55.04 14.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.705 -1.247 . . . . 0.0 107.939 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.475 HD22 ' OE1' ' B' ' 325' ' ' GLU . 63.6 tp -56.36 -35.57 67.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.358 -0.839 . . . . 0.0 110.241 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 34.7 ttm -72.45 -41.06 66.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.727 -1.233 . . . . 0.0 109.107 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.59 -5.69 58.27 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.346 -0.846 . . . . 0.0 110.215 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' B' ' 379' ' ' LYS . 96.2 mt-10 -109.72 -2.78 17.19 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.132 -0.98 . . . . 0.0 111.37 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.4 mt -83.7 130.02 34.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.285 -1.509 . . . . 0.0 109.027 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 N--CA 1.499 1.984 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.629 -179.656 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.251 0.548 . . . . 2.91 109.679 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.0 mt -110.18 129.88 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.47 -0.769 . . . . 1.2 109.114 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.8 m -130.81 148.78 52.62 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.514 -0.741 . . . . 1.4 109.173 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.42 ' H ' ' ND2' ' A' ' 225' ' ' ASN . . . -130.95 -163.54 10.99 Favored Glycine 0 N--CA 1.499 2.861 0 N-CA-C 108.142 -1.983 . . . . 1.05 108.142 179.323 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.451 ' O ' ' O ' ' A' ' 6' ' ' LEU . 95.7 mt -89.16 -14.79 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.659 -1.495 . . . . 1.15 110.068 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.0 tp 54.18 103.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.311 -0.868 . . . . 0.98 109.038 -179.669 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.94 -27.28 14.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.186 -0.946 . . . . 0.88 109.424 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 m -140.57 124.8 10.65 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.426 -0.796 . . . . 1.69 109.465 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.77 150.08 18.48 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.456 2.104 . . . . 0.85 112.904 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.9 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 146.93 171.78 16.53 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 109.811 -1.316 . . . . 0.92 109.811 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.7 mt -122.85 130.01 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 O-C-N 121.026 -1.279 . . . . 0.81 110.518 -179.784 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.74 149.32 51.47 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.354 -0.842 . . . . 0.51 110.046 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.4 m-85 -126.52 129.1 47.96 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.726 -1.213 . . . . 0.62 107.726 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.12 176.39 46.85 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 118.732 -1.699 . . . . 0.55 110.998 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -79.94 158.75 26.55 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.443 -1.033 . . . . 2.1 109.438 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.59 137.04 43.02 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.522 -0.737 . . . . 0.77 111.015 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.1 tp -106.64 133.36 51.42 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 106.936 -1.505 . . . . 0.91 106.936 177.729 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.0 tp -113.55 122.14 46.33 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.169 -0.957 . . . . 0.93 109.687 -179.017 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.1 mt -85.17 100.78 11.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.617 -0.677 . . . . 0.93 109.399 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -99.37 133.23 43.97 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.441 -0.787 . . . . 2.75 109.463 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -130.19 134.88 47.6 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.462 -0.774 . . . . 3.0 108.938 179.307 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -79.69 158.21 27.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.294 -0.879 . . . . 2.77 109.995 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -70.45 145.78 50.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.351 -0.843 . . . . 2.94 109.225 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.8 mt -89.64 129.09 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.094 -1.003 . . . . 0.95 108.967 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t -93.78 125.47 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.181 -0.949 . . . . 1.28 110.38 -179.108 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.06 133.72 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.521 -0.918 . . . . 1.21 108.521 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -94.34 117.94 30.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.008 -1.058 . . . . 1.81 109.847 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.2 mmt-85 -89.89 3.8 51.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.294 -0.879 . . . . 2.8 109.415 -179.556 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -62.95 149.42 44.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.943 . . . . 2.87 109.647 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -91.77 141.91 28.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.364 -0.835 . . . . 2.35 109.217 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 pt -93.77 164.39 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.852 -1.155 . . . . 0.97 109.995 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.6 p -92.42 171.53 8.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.22 -0.925 . . . . 1.17 108.664 178.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.27 -15.53 63.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.106 -0.996 . . . . 1.18 110.285 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -85.6 -28.61 24.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.874 -1.141 . . . . 2.56 108.447 178.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -81.58 -8.41 59.71 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.14 -0.689 . . . . 1.79 109.14 179.193 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.0 t -63.72 -54.91 26.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.115 -0.991 . . . . 1.0 109.129 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.45 -39.72 88.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.077 -1.014 . . . . 1.77 109.355 179.765 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -65.7 -42.63 90.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 2.7 110.156 -179.196 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.59 -40.15 95.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.901 -1.124 . . . . 1.51 110.66 -179.149 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.63 -46.59 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.576 -1.328 . . . . 0.93 108.182 179.206 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -60.14 -44.32 95.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.175 -0.953 . . . . 1.81 109.389 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -59.98 -43.41 95.13 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.908 -1.145 . . . . 2.78 107.908 179.217 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -64.45 -40.02 94.92 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.451 -0.944 . . . . 0.78 108.451 179.008 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.21 -49.95 75.58 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.354 -0.98 . . . . 1.07 108.354 179.481 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.3 t -63.21 -43.5 97.95 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.22 -0.992 . . . . 1.12 108.92 179.086 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.64 -40.02 95.71 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.347 -1.901 . . . . 0.84 108.347 179.004 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.562 ' CG ' HH11 ' A' ' 47' ' ' ARG . 0.7 OUTLIER -66.65 -39.4 88.21 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.871 -1.159 . . . . 3.09 107.871 178.396 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.0 75.15 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.278 -0.638 . . . . 0.88 109.278 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ALA . 22.2 ttmt -60.72 -74.77 0.07 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.102 -1.073 . . . . 2.59 108.102 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.73 -34.12 0.1 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.435 -0.791 . . . . 0.7 111.471 -177.827 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.6 m -60.27 -54.68 42.84 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.536 -1.352 . . . . 1.4 108.674 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.82 -41.22 75.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.339 -0.851 . . . . 0.67 111.161 -178.863 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.33 -39.92 95.87 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.783 -1.198 . . . . 1.66 110.218 -179.289 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.1 mt -66.33 -39.79 89.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.0 -1.063 . . . . 1.58 109.963 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -59.97 -38.95 84.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.143 -0.973 . . . . 1.35 109.592 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -61.87 -41.18 97.55 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.059 -1.025 . . . . 0.77 110.095 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.34 -37.19 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.255 -0.903 . . . . 0.63 109.6 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -57.29 -51.16 70.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.432 -0.792 . . . . 1.14 110.665 -178.239 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -60.62 -37.2 80.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.017 . . . . 0.79 111.672 -177.327 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.1 -39.85 94.95 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.869 -1.145 . . . . 1.53 110.267 -179.042 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.426 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -64.13 -42.3 96.88 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.533 -0.729 . . . . 0.57 109.936 -179.59 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.84 -52.16 54.11 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.703 -1.359 . . . . 0.75 109.703 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.63 -48.04 73.55 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.167 -1.196 . . . . 1.59 109.806 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.7 m -70.07 -58.74 3.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.344 -0.848 . . . . 0.73 112.144 -177.656 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -96.85 -53.68 3.45 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.912 -1.117 . . . . 0.75 111.292 -178.311 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.51 -167.42 25.84 Favored Glycine 0 N--CA 1.5 2.96 0 C-N-CA 119.678 -1.248 . . . . 1.22 111.31 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -70.01 -25.51 63.63 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.799 -0.824 . . . . 5.81 110.685 -179.397 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -61.6 -35.59 78.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -0.954 . . . . 3.37 110.46 -179.461 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.418 ' HA ' HD12 ' A' ' 72' ' ' ILE . 43.9 mmtm -100.38 -19.83 16.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.31 -0.868 . . . . 1.77 110.282 -179.649 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -69.94 -39.97 75.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.98 -1.075 . . . . 1.65 110.263 -179.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.551 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.85 -27.99 68.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.351 -0.843 . . . . 0.77 109.486 -179.174 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 69' ' ' LYS . 85.3 mt -60.08 -40.49 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.18 -0.95 . . . . 0.8 108.928 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -69.74 -36.84 76.16 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.193 -0.942 . . . . 0.88 110.705 -179.506 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -59.88 -40.04 87.34 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.919 -1.113 . . . . 1.37 109.289 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.04 -43.82 95.23 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.523 -1.431 . . . . 0.62 109.523 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -62.62 -41.56 99.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -1.113 . . . . 1.5 109.043 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.7 mt -68.67 -46.46 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.766 -0.828 . . . . 0.63 108.766 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.1 ttp -60.25 -42.95 96.4 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.222 -0.924 . . . . 1.51 109.786 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.831 HD22 HD23 ' B' ' 347' ' ' LEU . 55.2 tp -63.91 -40.71 97.12 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.416 -0.803 . . . . 0.77 109.44 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.557 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 61.8 tp -64.99 -39.81 94.02 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.63 -0.669 . . . . 0.62 109.827 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -79.68 2.14 23.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 1.47 110.677 -178.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -48.95 128.01 15.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.843 -1.16 . . . . 1.47 109.777 -179.023 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.15 -17.17 51.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.595 -0.69 . . . . 1.78 110.211 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -74.09 -32.95 63.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.074 -1.016 . . . . 2.53 109.43 178.827 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.07 -41.16 74.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.472 -0.767 . . . . 0.8 109.345 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -60.76 -46.22 91.31 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.383 -0.823 . . . . 1.42 110.159 -179.428 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -70.05 -41.93 73.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.344 -0.847 . . . . 1.71 110.44 -178.978 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.07 -39.9 75.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.912 . . . . 1.57 110.096 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.7 mt -66.68 -47.06 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.259 -0.901 . . . . 0.65 109.592 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.9 -37.57 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.82 110.111 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.04 -48.31 82.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.183 -0.948 . . . . 0.79 110.913 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.2 mt -60.3 -46.99 87.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.074 -1.016 . . . . 0.95 110.191 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.0 mt -61.13 -49.94 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.66 108.674 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -65.22 -43.28 92.0 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.107 -0.637 . . . . 2.2 110.491 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -80.02 -53.04 7.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.957 -1.09 . . . . 1.65 111.992 -178.421 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -90.48 -2.43 57.92 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.957 -1.089 . . . . 2.03 112.37 -177.195 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.3 m80 57.12 36.55 27.73 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.785 -1.197 . . . . 1.42 109.729 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 77.2 mtp -88.22 165.55 14.97 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.293 -0.879 . . . . 1.18 109.34 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.401 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 33.6 p -76.56 159.48 30.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.064 -1.022 . . . . 0.98 108.49 179.348 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.79 -39.96 91.47 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.285 -0.966 . . . . 0.64 110.047 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 24.1 p-10 -66.58 -34.87 78.86 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.122 -0.986 . . . . 2.07 109.312 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.17 -42.2 23.87 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.282 -0.886 . . . . 0.73 109.708 179.668 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.12 -48.4 68.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.54 109.9 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.7 92.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.56 109.845 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -60.0 -40.67 90.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 1.54 110.204 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.03 -40.26 95.09 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.305 -0.872 . . . . 1.33 110.342 -179.074 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.4 -53.16 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.076 -1.015 . . . . 0.72 111.028 -178.377 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.88 -40.05 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.861 -1.149 . . . . 0.85 109.307 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -64.64 -36.1 83.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 2.44 108.901 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.51 -49.93 65.99 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.805 -0.712 . . . . 0.98 111.688 -179.114 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -64.05 -47.01 81.83 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.55 -1.559 . . . . 1.41 110.01 -178.616 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.87 -39.49 85.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.067 -1.021 . . . . 1.2 109.512 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 91.2 p -59.79 -40.05 86.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.946 . . . . 1.7 109.746 -179.444 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.82 -39.86 86.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.858 -1.151 . . . . 1.47 108.929 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 35.3 mt -61.27 -42.89 99.41 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.832 -1.167 . . . . 1.56 108.912 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.541 ' OE2' ' NH2' ' A' ' 131' ' ' ARG . 98.3 mt-10 -50.18 -26.08 4.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.092 -1.005 . . . . 2.2 109.567 -179.387 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -65.53 -26.49 67.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.084 -1.01 . . . . 2.12 108.716 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 59.6 mt -63.09 144.09 57.21 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.382 -0.824 . . . . 2.0 109.521 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -97.04 14.45 25.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.153 -0.967 . . . . 3.23 109.945 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 58.0 t0 -102.98 143.3 32.73 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.174 -0.954 . . . . 2.49 109.788 -179.599 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.542 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 66.6 mm-40 -71.57 -63.94 1.02 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.979 -1.119 . . . . 3.95 107.979 178.644 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.459 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.8 t80 -38.49 -40.0 0.52 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 116.032 -0.531 . . . . 2.0 110.818 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.442 HD22 ' O ' ' B' ' 351' ' ' GLN . 83.9 mt -70.85 -40.09 72.55 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.724 -1.235 . . . . 1.86 109.189 179.417 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 121' ' ' GLU . 61.4 tttp -60.73 -38.95 86.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.244 -0.91 . . . . 2.84 109.836 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -59.78 -39.78 86.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.371 -0.831 . . . . 2.73 109.258 -179.38 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.402 HH11 ' HG3' ' B' ' 351' ' ' GLN . 1.1 mtt-85 -60.11 -39.96 88.01 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.106 -0.996 . . . . 2.77 109.019 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.92 -31.15 71.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.25 -0.906 . . . . 1.19 109.505 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.52 -40.54 95.0 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.384 -0.926 . . . . 1.2 108.565 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -67.28 -40.17 86.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.435 -0.791 . . . . 1.55 109.681 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.04 -40.54 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.353 -0.98 . . . . 0.8 108.353 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.541 ' NH2' ' OE2' ' A' ' 116' ' ' GLU . 39.6 ttm180 -62.29 -37.48 85.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.619 -0.676 . . . . 3.09 109.472 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -59.74 -40.56 88.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.211 -0.931 . . . . 1.46 109.457 -178.784 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.09 -43.44 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.092 -1.005 . . . . 0.71 109.313 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.22 -44.61 97.9 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.098 -1.201 . . . . 0.57 110.098 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -60.82 -49.67 76.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.166 -1.196 . . . . 2.59 111.148 -179.265 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -64.88 -35.92 82.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.81 -1.181 . . . . 2.83 110.246 -178.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 64.9 tp -60.08 -40.6 90.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 1.25 109.04 -179.244 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 138' ' ' LEU . 89.7 mt -62.36 -39.93 94.75 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.32 -0.863 . . . . 0.7 109.264 179.607 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -69.66 -34.63 74.26 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.673 -0.862 . . . . 2.57 108.673 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -66.69 -36.1 81.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.537 -0.727 . . . . 1.23 110.849 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.4 mt -70.66 -40.96 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 120.571 -1.331 . . . . 0.81 108.754 179.315 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.17 -35.2 68.93 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.569 -0.707 . . . . 1.0 109.73 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.49 34.94 8.19 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.043 -1.623 . . . . 0.89 109.043 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 29.1 tp -73.57 144.67 45.96 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.35 -1.088 . . . . 1.14 109.626 -179.514 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -61.15 143.76 54.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.449 -0.782 . . . . 4.6 110.486 -179.527 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.4 mt -111.67 127.27 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.362 -0.977 . . . . 1.24 108.362 178.583 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 148' ' ' ASP . 14.5 mm -59.94 -48.14 88.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.468 -0.77 . . . . 1.54 110.505 -177.718 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 147' ' ' ILE . 31.2 t0 62.46 118.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.344 -0.848 . . . . 1.5 109.007 -179.394 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.0 mt -84.91 -1.73 56.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.699 -0.626 . . . . 0.79 110.39 -178.784 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 92.4 p -83.38 -10.32 58.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.802 -1.186 . . . . 1.4 108.608 178.803 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.6 17.61 2.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.728 -0.607 . . . . 0.92 110.955 -177.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 52.2 mt -90.88 122.9 42.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.894 -1.129 . . . . 0.88 108.981 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -104.74 -7.35 19.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.496 -0.752 . . . . 2.45 110.613 -178.505 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -126.96 150.66 49.27 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.425 -0.797 . . . . 1.52 110.064 -179.067 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.4 136.35 57.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.224 -0.923 . . . . 1.58 108.827 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.8 m -153.08 167.88 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.477 -0.764 . . . . 0.69 109.975 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 76.4 mt -94.8 148.27 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 105.85 -1.907 . . . . 0.61 105.85 176.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 33.6 tp -97.15 118.31 33.29 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.732 -1.23 . . . . 0.87 110.71 -177.638 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.522 HG12 HG22 ' A' ' 209' ' ' THR . 89.2 t -120.79 126.39 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.675 -0.64 . . . . 0.71 109.551 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.529 ' C ' HG21 ' A' ' 209' ' ' THR . . . -159.74 160.71 34.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.12 -0.987 . . . . 0.81 108.986 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.92 -33.12 70.22 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.362 -1.461 . . . . 0.98 108.672 178.653 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 25.1 p-10 -171.09 142.03 1.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.576 -0.703 . . . . 2.25 109.119 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.9 mt -114.53 131.28 56.7 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.35 -0.844 . . . . 0.78 108.899 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.8 p -88.67 149.41 43.95 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.967 -1.083 . . . . 0.98 108.786 179.557 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -40.73 -34.39 1.28 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.942 1.761 . . . . 0.81 112.039 179.601 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 72.5 m -59.03 -40.14 84.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.189 -0.945 . . . . 0.9 109.194 -178.892 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -70.25 -40.52 74.37 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.305 -0.958 . . . . 1.61 109.615 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.5 p -57.24 -22.6 42.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.354 -0.841 . . . . 0.61 111.87 -177.545 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -85.09 -49.49 8.22 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.539 -1.351 . . . . 0.6 109.925 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -83.92 38.05 0.63 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.924 -1.139 . . . . 1.4 107.924 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.426 HD11 HG21 ' A' ' 176' ' ' VAL . 57.6 tp -107.6 130.99 54.84 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.303 -0.629 . . . . 0.7 109.303 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -86.44 103.52 15.06 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.109 -1.071 . . . . 2.35 108.109 178.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.19 -40.98 94.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.407 -0.808 . . . . 1.51 111.23 -178.261 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -63.54 -26.07 68.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.701 -1.249 . . . . 2.33 111.541 -177.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -93.57 -9.44 38.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.753 -1.217 . . . . 1.92 110.045 -178.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 178' ' ' GLY . 93.1 t -104.71 115.23 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.346 -0.846 . . . . 0.67 108.792 179.044 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.4 mt -85.74 7.71 22.58 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.129 -0.982 . . . . 1.53 110.626 -178.403 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.53 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 166.91 174.66 36.35 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.725 -1.35 . . . . 0.48 109.725 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.517 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 12.1 m-85 -130.98 129.11 41.68 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.393 -1.063 . . . . 0.55 109.069 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.417 ' CG2' HG21 ' A' ' 205' ' ' THR . 89.6 mt -131.7 125.53 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.413 -0.804 . . . . 0.65 109.246 178.826 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 42.0 p -152.51 162.18 41.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.057 -1.027 . . . . 0.82 110.478 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 182' ' ' ASP . 36.7 p30 -107.85 26.89 9.79 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.658 -0.651 . . . . 2.46 109.358 179.354 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.69 -159.39 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.903 -1.123 . . . . 1.28 111.687 -178.285 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.44 -64.01 3.44 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 111.205 -0.758 . . . . 2.19 111.205 -178.518 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.12 -135.48 3.91 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.021 -1.562 . . . . 2.13 110.84 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.424 HH11 ' HG2' ' A' ' 186' ' ' ARG . 44.8 mtt-85 -61.1 -32.42 72.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.506 -0.996 . . . . 5.86 110.862 -178.744 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 11.3 p -71.53 1.73 6.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.963 -1.086 . . . . 3.72 110.275 -178.591 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.9 t -90.95 131.28 36.66 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.995 -1.066 . . . . 1.74 110.49 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -46.16 -44.94 16.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.346 -0.846 . . . . 0.95 108.965 179.285 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 190' ' ' THR . 2.4 p -56.37 -42.79 78.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.809 -0.557 . . . . 1.55 111.001 -178.744 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.4 m -60.22 -40.08 88.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.922 -1.111 . . . . 1.51 110.919 -178.865 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 91.2 mt -61.9 -40.9 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.084 -1.01 . . . . 1.67 110.157 -178.907 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 86.9 mtp -60.12 -43.35 95.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.103 -0.998 . . . . 1.02 110.141 -179.35 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.2 94.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.77 -1.206 . . . . 0.68 110.279 -179.376 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -60.26 -51.78 68.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 2.93 111.228 -178.838 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 69.1 m -72.6 -34.44 67.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.914 -1.116 . . . . 0.86 111.93 -178.019 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.6 -14.05 58.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.71 -1.244 . . . . 0.67 110.378 -178.507 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 57.97 48.37 13.44 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.355 -0.841 . . . . 1.5 110.349 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 94.8 mt -118.01 122.21 30.71 Favored Pre-proline 0 N--CA 1.501 2.107 0 N-CA-C 108.182 -1.044 . . . . 0.72 108.182 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -42.02 130.3 4.39 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.809 1.673 . . . . 0.61 112.377 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.517 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.46 152.43 3.25 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.012 -1.075 . . . . 0.66 111.483 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.0 mt -126.91 141.8 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 107.729 -1.212 . . . . 0.79 107.729 178.773 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.7 m -124.92 -8.86 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 O-C-N 120.731 -1.23 . . . . 0.91 110.983 -178.473 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.48 22.89 23.64 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.254 -1.139 . . . . 1.01 110.254 -179.636 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.417 HG21 ' CG2' ' A' ' 180' ' ' ILE . 11.6 p -44.92 -42.56 8.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.163 -1.198 . . . . 0.99 109.835 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.79 -51.24 2.91 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 120.149 -1.024 . . . . 1.12 111.006 179.081 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.9 m -157.9 37.36 0.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.523 -1.575 . . . . 1.72 111.427 -178.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 35.4 t -79.52 -32.04 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.789 -1.194 . . . . 0.89 108.749 178.55 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.529 HG21 ' C ' ' A' ' 160' ' ' ALA . 74.3 p -59.93 -35.02 74.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.503 -0.748 . . . . 1.03 111.143 -178.756 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 85.2 p -80.14 -12.13 59.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.916 -1.115 . . . . 1.83 110.413 -179.087 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -100.06 -12.51 19.63 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.24 -0.913 . . . . 2.27 110.465 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 91.9 t -106.31 140.12 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.295 -0.878 . . . . 0.92 111.053 -178.227 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -113.7 152.9 29.84 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.306 -1.368 . . . . 2.2 107.306 178.022 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.494 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 28.9 p-10 -57.86 137.59 56.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.011 -1.056 . . . . 2.36 110.561 -178.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 6.2 t0 85.29 2.1 0.69 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 122.117 -0.364 . . . . 2.38 110.734 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.98 143.84 50.69 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.867 -1.146 . . . . 2.09 108.713 179.036 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -93.16 113.72 26.03 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.081 -1.081 . . . . 1.27 108.081 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.479 HD22 HG22 ' A' ' 229' ' ' VAL . 61.0 mt -123.29 145.55 48.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.607 -0.683 . . . . 0.75 110.349 -179.119 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 79.9 mt -111.36 129.87 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 106.21 -1.774 . . . . 0.63 106.21 176.615 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 51.4 tp -100.35 118.93 37.63 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.889 -1.132 . . . . 0.7 108.534 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 10' ' ' GLY . 38.5 t0 -77.84 -45.97 22.82 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.189 -0.944 . . . . 2.31 108.819 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.75 16.59 0.5 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.991 -1.115 . . . . 0.78 107.991 -178.847 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.456 ' N ' ' C ' ' A' ' 221' ' ' ASP . 42.0 t -126.17 -46.14 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 106.74 -1.578 . . . . 1.04 106.74 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 224' ' ' ASN . 55.3 t-20 -102.25 2.92 37.66 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.44 -1.319 . . . . 2.44 107.44 178.129 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.42 ' ND2' ' H ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 59.84 46.24 11.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.976 -0.452 . . . . 1.55 110.048 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -140.42 154.07 46.53 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.214 -0.929 . . . . 1.99 109.898 179.593 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 88.5 t -119.97 131.5 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.079 -0.712 . . . . 0.77 109.079 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -94.99 119.06 32.86 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.177 -0.952 . . . . 0.98 108.487 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.479 HG22 HD22 ' A' ' 218' ' ' LEU . 91.6 t -99.69 115.24 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.323 -0.861 . . . . 0.85 109.618 -179.54 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 67.09 71.07 0.44 Allowed Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.58 -0.7 . . . . 1.66 109.634 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -90.19 124.9 1.18 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.337 2.692 . . . . 0.95 112.6 -179.679 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 233' ' ' ASN . 63.6 m -67.01 159.68 28.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.413 -0.804 . . . . 1.84 109.261 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.441 ' N ' HG22 ' A' ' 232' ' ' THR . 27.7 p-10 -60.08 -38.74 83.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.087 -1.008 . . . . 2.74 109.972 -179.342 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -60.12 -40.16 88.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.106 -0.996 . . . . 2.89 109.599 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.61 -39.97 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.218 -0.926 . . . . 1.3 109.919 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.2 mt . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.021 -1.05 . . . . 1.09 109.436 179.726 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 301' ' ' MET . . . . . 0.402 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 50.4 ttp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.485 0.66 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 302' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 23.7 t80 -151.58 149.65 29.41 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 303' ' ' GLN . . . . . 0.418 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 19.2 pt20 -149.65 159.68 44.14 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.876 -1.14 . . . . 0.0 110.521 -178.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -152.48 148.58 27.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.68 -0.638 . . . . 0.0 109.456 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -110.58 131.49 55.01 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.09 -1.006 . . . . 0.0 109.803 179.212 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.74 122.84 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-O 122.262 1.03 . . . . 0.0 112.294 -177.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 307' ' ' THR . . . . . 0.407 ' O ' HG23 ' B' ' 309' ' ' THR . 46.2 m -77.48 106.77 9.46 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.062 0.934 . . . . 0.0 110.184 -178.819 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.7 mt -52.44 121.85 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 122.361 1.077 . . . . 0.0 110.651 -177.957 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 309' ' ' THR . . . . . 0.407 HG23 ' O ' ' B' ' 307' ' ' THR . 30.0 p -109.97 19.14 19.35 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.38 -178.562 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.86 129.04 77.47 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.795 -1.19 . . . . 0.0 108.525 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -62.66 -10.7 20.48 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 CA-C-N 120.356 1.163 . . . . 0.0 112.981 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -120.96 5.94 10.39 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.294 -0.879 . . . . 0.0 109.418 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.68 -175.39 37.64 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.459 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.5 tp -83.11 85.62 7.16 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.123 -1.222 . . . . 0.0 109.932 -178.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.419 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 4.7 p80 -91.84 -161.98 0.88 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.864 -1.148 . . . . 0.0 109.914 178.722 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 10.0 m -58.22 -43.82 87.89 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.864 -1.147 . . . . 0.0 112.831 -175.616 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.551 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.2 tpt180 -60.08 -61.35 8.09 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 120.42 -1.425 . . . . 0.0 112.29 -178.827 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.419 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 9.3 Cg_endo -57.7 -29.41 85.5 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 CA-C-N 120.288 1.138 . . . . 0.0 111.655 -179.573 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.93 -51.78 68.21 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.351 -0.939 . . . . 0.0 108.524 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.18 -42.44 66.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.431 -0.793 . . . . 0.0 109.269 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -70.22 -40.07 74.76 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.929 -1.107 . . . . 0.0 108.719 177.8 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -63.92 -55.46 22.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.734 -0.604 . . . . 0.0 109.795 -179.292 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 54.2 t -68.05 -36.71 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.816 -1.178 . . . . 0.0 109.682 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -60.0 -44.62 94.42 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.755 -179.286 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -66.79 -40.07 88.0 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.955 -1.091 . . . . 0.0 109.872 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -64.67 -51.7 61.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.125 -0.984 . . . . 0.0 110.132 -179.537 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -57.55 -11.54 2.1 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.083 -1.01 . . . . 0.0 109.131 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -67.9 -30.45 74.3 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.716 -1.753 . . . . 0.0 108.716 179.182 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -105.31 143.28 33.7 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.598 -0.942 . . . . 0.0 109.15 179.768 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 27.9 m -89.95 -11.8 40.65 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.978 -1.076 . . . . 0.0 109.845 -179.621 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.442 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 60.1 p -60.02 153.8 20.63 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.049 -1.032 . . . . 0.0 108.764 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.75 129.5 40.12 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.181 -0.949 . . . . 0.0 109.558 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.3 mt -129.15 129.95 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.626 -0.671 . . . . 0.0 109.35 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 334' ' ' THR . . . . . 0.401 HG22 ' N ' ' B' ' 335' ' ' VAL . 93.9 m -128.06 152.57 47.81 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.509 -0.744 . . . . 0.0 109.626 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 335' ' ' VAL . . . . . 0.401 ' N ' HG22 ' B' ' 334' ' ' THR . 63.5 t -118.03 137.47 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 55.0 m -129.98 122.24 28.09 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.215 -0.928 . . . . 0.0 108.999 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 91.4 p -137.36 118.49 14.45 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.014 0.912 . . . . 0.0 111.102 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 65.4 t30 44.38 57.41 4.38 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 177.298 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 83.16 -12.5 49.87 Favored Glycine 0 N--CA 1.5 2.956 0 O-C-N 120.164 -1.585 . . . . 0.0 113.388 176.109 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -119.11 131.27 55.9 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-N 119.367 1.584 . . . . 0.0 110.067 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 70.6 m -124.86 146.71 49.15 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.903 0.859 . . . . 0.0 110.599 -179.113 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 342' ' ' ALA . . . . . 0.433 ' CB ' HD11 ' B' ' 353' ' ' LEU . . . -138.81 161.81 36.32 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.634 0.73 . . . . 0.0 109.596 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 51.0 m -86.08 131.87 34.17 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.558 -0.713 . . . . 0.0 109.994 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -69.86 -17.51 63.37 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.075 -1.016 . . . . 0.0 109.141 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -89.26 20.93 3.49 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 5.7 m -145.41 92.34 2.23 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.451 -179.344 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.831 HD23 HD22 ' A' ' 79' ' ' LEU . 58.7 tp -59.95 -37.22 78.92 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.274 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.773 ' CE2' HD11 ' A' ' 79' ' ' LEU . 59.1 m-85 -54.61 -51.34 65.66 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.25 -0.906 . . . . 0.0 111.138 -179.287 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 349' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' B' ' 350' ' ' LEU . 34.0 mtmm -69.25 -39.98 78.14 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.91 -1.118 . . . . 0.0 109.781 -178.546 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' B' ' 352' ' ' THR . 18.2 mt -47.16 -57.21 5.37 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.12 -0.988 . . . . 0.0 108.671 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' B' ' 347' ' ' LEU . 1.4 mp0 -39.33 -22.56 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.525 -0.734 . . . . 0.0 111.088 -179.009 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.52 ' N ' ' O ' ' B' ' 350' ' ' LEU . 72.4 p -82.88 -10.89 58.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.348 -1.47 . . . . 0.0 110.796 -178.155 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.433 HD11 ' CB ' ' B' ' 342' ' ' ALA . 49.6 mt -94.89 117.84 30.8 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.816 -1.178 . . . . 0.0 109.513 178.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.05 92.24 0.83 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.449 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.3 mt -99.57 91.35 4.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.233 -1.157 . . . . 0.0 109.279 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 33.4 p -89.71 168.29 12.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.812 -1.18 . . . . 0.0 111.046 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -63.13 115.94 4.94 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.228 0.537 . . . . 0.0 110.763 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 358' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 100.75 7.39 50.94 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 24.1 m -86.82 114.68 23.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.485 -1.009 . . . . 0.0 111.066 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 14.9 t -76.43 116.56 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.322 1.058 . . . . 0.0 109.865 -177.54 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.1 m -111.45 176.95 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.749 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 29.7 m -130.53 129.44 42.84 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 83.0 mt -104.98 118.97 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 178.472 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 74.1 m -123.59 133.47 53.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.506 -0.746 . . . . 0.0 109.43 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.44 152.46 40.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.302 -179.454 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -146.36 123.13 11.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 108.953 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.531 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.96 -156.22 27.15 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 118.987 -1.578 . . . . 0.0 111.342 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.97 -52.82 63.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 122.319 -0.518 . . . . 0.0 112.008 -177.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.442 ' H ' ' HB3' ' B' ' 331' ' ' SER . 80.1 m-20 -106.93 9.5 30.74 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.782 -1.199 . . . . 0.0 111.567 -177.31 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.2 pt-20 -38.76 -33.29 0.1 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.398 -0.814 . . . . 0.0 111.232 -179.039 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -67.24 -42.3 84.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.889 -1.132 . . . . 0.0 109.618 -178.474 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -69.98 -52.9 20.49 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.453 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -42.06 -38.55 1.69 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.51 -0.744 . . . . 0.0 111.39 -178.431 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.525 ' O ' HG23 ' B' ' 378' ' ' VAL . 92.0 t -80.05 -34.87 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.687 -1.258 . . . . 0.0 109.928 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.51 -40.06 77.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.945 -1.097 . . . . 0.0 111.702 -178.712 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -81.63 -45.62 15.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.398 -1.439 . . . . 0.0 110.126 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.9 mt -60.18 -40.33 89.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 109.209 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.525 HG23 ' O ' ' B' ' 374' ' ' VAL . 53.3 t -61.92 -47.16 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.101 -0.999 . . . . 0.0 109.803 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 379' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' B' ' 383' ' ' GLU . 60.9 mttp -68.27 -54.7 15.79 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.515 -1.274 . . . . 0.0 107.762 178.597 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 59.8 tp -55.24 -33.86 63.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 110.088 -178.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 9.0 tpt -72.4 -40.19 67.4 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.378 -1.451 . . . . 0.0 109.013 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.93 -4.67 58.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 110.168 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' B' ' 379' ' ' LYS . 95.6 mt-10 -110.56 -3.47 15.95 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.07 -1.019 . . . . 0.0 111.178 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.1 mt -79.51 130.63 35.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.427 -1.421 . . . . 0.0 109.547 179.415 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 385' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 2.3 pm0 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.271 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.561 -0.533 . . . . 2.91 109.561 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.7 mt -110.19 129.4 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.433 -0.792 . . . . 1.2 109.321 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.1 m -140.05 151.71 45.63 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.382 -0.824 . . . . 1.4 109.122 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.441 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -136.34 -166.12 10.79 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 108.495 -1.842 . . . . 1.05 108.495 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.8 mt -93.8 -9.91 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.78 -1.424 . . . . 1.15 110.334 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.3 tp 53.36 101.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.134 -0.979 . . . . 0.98 109.41 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.57 -24.67 20.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.055 -1.028 . . . . 0.88 109.867 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.4 m -146.16 134.82 10.98 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.036 -1.04 . . . . 1.69 109.723 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -80.62 139.63 12.74 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.287 1.991 . . . . 0.85 112.634 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.778 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 164.79 -165.4 37.52 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.359 -1.496 . . . . 0.92 109.359 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.6 mt -147.81 149.8 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.091 -1.24 . . . . 0.81 108.196 178.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.77 156.91 38.6 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.867 -1.146 . . . . 0.51 110.543 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -139.63 124.89 18.93 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.013 -1.106 . . . . 0.62 108.013 179.194 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.43 -179.75 48.55 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 118.776 -1.678 . . . . 0.55 110.559 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -79.29 158.62 27.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.743 -0.857 . . . . 2.1 109.462 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.545 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -101.45 129.73 47.55 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.37 -0.831 . . . . 0.77 110.923 -178.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.9 tp -98.22 132.17 43.94 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.189 -1.411 . . . . 0.91 107.189 178.369 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 36.8 tp -118.34 122.65 43.38 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.25 -0.906 . . . . 0.93 109.592 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.1 mt -87.35 103.4 15.44 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.599 0.714 . . . . 0.93 110.167 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -93.01 135.32 34.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.447 -0.783 . . . . 2.75 109.233 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 57.3 mp0 -130.94 136.89 48.98 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.349 -0.844 . . . . 3.0 109.485 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 63.0 t0 -86.55 140.74 29.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.109 -0.995 . . . . 2.77 108.889 179.048 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 85.4 tt0 -60.33 139.99 57.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 2.94 109.548 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.5 mt -86.4 134.37 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.31 -0.869 . . . . 0.95 109.172 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.8 t -98.8 129.12 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.253 -0.905 . . . . 1.28 110.459 -179.004 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.8 mt -105.95 137.42 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.618 -0.882 . . . . 1.21 108.618 179.205 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -88.54 121.81 31.32 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.95 -1.094 . . . . 1.81 109.949 -179.379 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -90.63 -6.22 54.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 2.8 109.717 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -71.03 137.87 49.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.98 -1.075 . . . . 2.87 109.63 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -81.66 158.1 24.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 2.35 108.967 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.68 HD13 ' HG3' ' A' ' 39' ' ' GLU . 2.9 pt -100.43 166.28 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.139 -0.976 . . . . 0.97 109.495 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.0 p -90.46 174.77 7.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.162 -0.961 . . . . 1.17 108.765 178.764 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.85 -16.78 63.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.091 -1.006 . . . . 1.18 110.758 -179.359 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.3 -27.45 25.94 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.892 -1.13 . . . . 2.56 108.456 179.195 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -82.69 -7.36 59.65 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.195 -0.668 . . . . 1.79 109.195 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.8 t -59.95 -51.53 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.153 -0.967 . . . . 1.0 108.475 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.91 -40.04 87.48 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.385 -0.822 . . . . 1.77 109.084 179.111 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -63.3 -40.52 97.58 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.337 -0.852 . . . . 2.7 110.277 -178.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.68 ' HG3' HD13 ' A' ' 31' ' ' ILE . 60.5 mm-40 -62.93 -44.71 95.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.749 -1.219 . . . . 1.51 109.865 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.5 -49.81 81.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.041 -1.037 . . . . 0.93 109.718 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -60.66 -48.2 82.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.976 -1.077 . . . . 1.81 109.518 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.473 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 86.5 mtm180 -60.03 -40.13 88.28 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.853 -1.154 . . . . 2.78 108.407 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -65.09 -47.52 76.95 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.348 -0.845 . . . . 0.78 109.075 178.694 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.06 -44.6 94.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 1.07 109.151 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 t -65.36 -43.16 91.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.047 . . . . 1.12 109.315 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.52 -42.54 97.44 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.014 -2.034 . . . . 0.84 108.014 178.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.448 HH22 ' HG2' ' A' ' 81' ' ' GLU . 36.9 ttt-85 -63.51 -38.52 91.43 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.731 -0.864 . . . . 3.09 108.808 178.756 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.76 -40.61 72.81 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.505 -0.747 . . . . 0.88 109.083 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 50' ' ' ALA . 6.5 ttpm? -62.52 -73.44 0.11 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.737 -1.209 . . . . 2.59 107.737 178.934 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.71 -35.64 0.09 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.429 -0.794 . . . . 0.7 112.164 -177.818 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 98.2 p -59.42 -49.98 75.72 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.318 -1.489 . . . . 1.4 108.335 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.46 -39.85 92.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.47 -0.769 . . . . 0.67 110.646 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -65.99 -40.1 90.88 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.819 -1.176 . . . . 1.66 110.2 -179.159 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 71.4 mt -62.64 -40.05 95.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.146 -0.971 . . . . 1.58 109.689 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -62.56 -39.76 94.67 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.252 -0.905 . . . . 1.35 110.161 -179.338 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -64.82 -43.84 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.06 -1.025 . . . . 0.77 110.018 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.8 mt -59.93 -39.34 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.63 109.222 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -57.51 -51.41 69.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.367 -0.833 . . . . 1.14 110.411 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -56.62 -29.16 61.87 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.447 -0.783 . . . . 0.79 110.556 -177.515 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -69.75 -39.09 76.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.969 -1.082 . . . . 1.53 110.376 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.6 -46.98 74.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.304 -0.872 . . . . 0.57 110.096 -179.478 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.21 -50.02 53.74 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 109.743 -1.343 . . . . 0.75 109.743 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.24 -46.34 42.24 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.334 -1.098 . . . . 1.59 111.026 -179.349 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.4 m -67.57 -62.63 1.32 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.091 -1.005 . . . . 0.73 112.806 -177.183 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.448 ' CE1' ' O ' ' A' ' 168' ' ' THR . 77.6 m-85 -93.54 -45.77 7.6 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.684 -1.26 . . . . 0.75 110.87 -178.277 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.29 -170.6 24.59 Favored Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.011 -1.09 . . . . 1.22 110.737 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -70.02 -25.39 63.56 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.844 -0.798 . . . . 5.81 109.878 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.493 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 51.0 tp10 -60.0 -31.34 69.83 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.518 -0.739 . . . . 3.37 109.747 -179.354 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -98.98 -19.67 17.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.306 -0.871 . . . . 1.77 110.065 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -69.89 -40.02 75.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.012 -1.055 . . . . 1.65 109.977 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.479 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -63.55 -31.38 72.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.391 -0.818 . . . . 0.77 109.742 -179.556 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 88.8 mt -60.04 -40.99 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.108 -0.995 . . . . 0.8 109.116 -179.436 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -65.57 -39.7 91.96 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.222 -0.924 . . . . 0.88 110.699 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -59.95 -40.04 87.63 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.817 -1.177 . . . . 1.37 108.834 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.61 -47.0 93.32 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.971 -2.052 . . . . 0.62 107.971 178.188 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -61.58 -49.44 76.65 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.398 -1.06 . . . . 1.5 109.102 179.222 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.05 -48.98 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.276 -0.89 . . . . 0.63 109.542 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.7 ttp -60.06 -43.03 95.71 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.108 -0.995 . . . . 1.51 110.063 -178.662 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.884 HD11 ' CE2' ' B' ' 348' ' ' PHE . 56.4 tp -63.29 -40.01 96.16 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.318 -0.864 . . . . 0.77 109.425 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.45 -39.9 89.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.78 -0.822 . . . . 0.62 108.78 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.448 ' HG2' HH22 ' A' ' 47' ' ' ARG . 42.0 mt-10 -83.28 8.15 14.31 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.229 -0.919 . . . . 1.47 110.485 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -56.64 130.89 47.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.785 -1.197 . . . . 1.47 109.529 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.51 -18.47 52.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.468 -0.77 . . . . 1.78 110.467 -179.014 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -70.14 -36.28 74.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.823 -1.173 . . . . 2.53 109.109 178.531 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.2 mt -70.2 -41.77 73.26 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.411 -0.806 . . . . 0.8 110.031 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -60.03 -48.67 80.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 1.42 110.372 -178.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -70.05 -40.83 74.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 1.71 110.726 -179.009 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.07 -40.02 75.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.194 -0.941 . . . . 1.57 111.516 -178.743 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.99 -43.87 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.03 -1.043 . . . . 0.65 109.616 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.5 mt -70.06 -40.0 77.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.379 -0.826 . . . . 0.82 110.309 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.01 75.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.105 -0.997 . . . . 0.79 111.307 -178.599 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 96' ' ' LYS . 17.6 mt -60.9 -45.73 93.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.089 -1.007 . . . . 0.95 109.703 -178.776 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.44 -49.89 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.66 109.134 179.694 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -70.38 -41.18 73.41 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.876 -0.73 . . . . 2.2 110.916 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -82.52 -53.68 5.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.998 -1.064 . . . . 1.65 112.1 -178.229 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 92' ' ' LEU . 90.6 mttt -90.06 -1.39 57.95 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.048 -1.032 . . . . 2.03 112.124 -177.172 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 57.05 35.7 26.72 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.746 -1.221 . . . . 1.42 109.196 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 38.4 mtt -83.8 164.96 19.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.513 -0.742 . . . . 1.18 109.823 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.7 p -79.58 158.73 27.07 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.496 -0.927 . . . . 0.98 108.496 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.0 -40.08 75.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.994 -1.066 . . . . 0.64 109.702 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.94 -39.94 95.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.975 . . . . 2.07 109.79 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.57 -46.47 14.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.125 -0.984 . . . . 0.73 109.434 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.05 -49.67 76.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.442 -0.786 . . . . 0.54 109.89 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.57 85.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.171 -0.956 . . . . 0.56 109.634 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.534 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 80.7 t60 -59.99 -39.0 84.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.327 -0.858 . . . . 1.54 109.858 -179.207 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 110' ' ' GLY . 41.3 tt0 -60.36 -41.57 93.96 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.106 -0.996 . . . . 1.33 109.541 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.7 t -65.91 -50.87 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.1 -1.0 . . . . 0.72 110.198 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.5 mm -69.31 -40.12 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.044 -1.035 . . . . 0.85 108.581 179.492 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.534 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 89.1 tt0 -67.09 -37.21 83.55 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.405 -0.961 . . . . 2.44 108.405 178.805 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -60.02 -47.32 91.61 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.74 -1.344 . . . . 0.98 109.74 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -69.34 -55.8 9.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.052 -1.263 . . . . 1.41 109.004 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.83 -42.83 65.52 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.976 . . . . 1.2 108.937 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 110' ' ' GLY . 63.8 p -59.98 -40.02 87.69 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.192 -0.942 . . . . 1.7 108.67 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.98 -40.06 91.99 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.33 -0.856 . . . . 1.47 108.697 179.066 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.0 mt -65.23 -42.0 93.84 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.134 -0.979 . . . . 1.56 108.914 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -56.75 -32.88 66.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.731 -1.23 . . . . 2.2 109.414 -179.508 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -59.19 -22.54 61.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.023 -1.048 . . . . 2.12 108.309 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 123' ' ' LEU . 60.3 mt -62.97 148.05 48.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.342 -0.849 . . . . 2.0 108.861 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -100.21 37.1 1.72 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.242 -0.911 . . . . 3.23 109.955 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 56.8 t0 -125.25 134.64 52.24 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.382 -0.824 . . . . 2.49 110.438 -179.315 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.487 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 12.4 pt-20 -70.44 -30.12 66.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.783 -0.573 . . . . 3.95 110.58 179.529 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.651 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 3.0 t80 -71.87 -40.01 69.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.057 -1.027 . . . . 2.0 110.65 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.496 ' CD2' HH22 ' A' ' 126' ' ' ARG . 60.1 mt -71.77 -31.76 66.96 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.256 -0.902 . . . . 1.86 108.584 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -66.0 -39.97 90.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.605 -0.685 . . . . 2.84 110.018 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.0 -46.34 89.8 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.21 -0.931 . . . . 2.73 110.824 -178.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.651 ' NH1' ' CE1' ' A' ' 122' ' ' TYR . 21.3 mtm-85 -70.01 -27.1 64.41 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.755 -1.178 . . . . 2.77 108.863 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.91 -26.07 66.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.902 -1.147 . . . . 1.19 107.902 178.378 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.97 -40.16 75.56 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.481 -0.933 . . . . 1.2 108.481 178.615 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -62.23 -44.29 96.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.574 -0.704 . . . . 1.55 109.18 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.6 t -61.48 -40.26 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.654 -0.869 . . . . 0.8 108.654 179.28 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -60.49 -37.34 80.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.49 -0.756 . . . . 3.09 109.713 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -60.0 -41.0 91.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.173 -0.954 . . . . 1.46 109.996 -178.862 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.02 -49.55 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.97 -1.081 . . . . 0.71 109.176 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.21 -42.87 98.83 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.682 -1.367 . . . . 0.57 109.682 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -60.05 -49.96 75.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.147 -1.207 . . . . 2.59 110.27 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.548 HH12 ' CB ' ' A' ' 166' ' ' SER . 98.9 mtt180 -68.88 -27.18 65.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.774 -1.204 . . . . 2.83 109.838 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.95 -43.43 95.0 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.184 -0.947 . . . . 1.25 108.587 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.69 -40.03 93.56 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.397 -0.814 . . . . 0.7 109.083 178.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -63.54 -39.95 95.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.311 -0.868 . . . . 2.57 108.665 179.405 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -67.13 -39.95 86.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.711 -0.618 . . . . 1.23 111.258 -179.294 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.97 -43.05 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.438 -1.414 . . . . 0.81 108.061 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.01 -30.07 67.29 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 179.41 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.01 40.28 9.46 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.832 -1.707 . . . . 0.89 108.832 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 tp -74.68 149.97 39.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.374 -1.074 . . . . 1.14 109.341 -179.481 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -71.1 147.97 47.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.341 -0.849 . . . . 4.6 109.725 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.4 mt -118.82 129.47 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 122.041 0.924 . . . . 1.24 109.313 179.271 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 11.1 mt -67.05 -40.07 84.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.807 -0.633 . . . . 1.54 110.506 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 41.6 t0 60.89 105.07 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.669 -0.863 . . . . 1.5 108.669 -178.958 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 55.2 mt -67.76 -0.12 3.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.305 -0.872 . . . . 0.79 110.128 -178.964 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.2 m -83.2 -11.8 57.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.92 -1.113 . . . . 1.4 109.511 179.591 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.15 25.57 0.83 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.152 -0.967 . . . . 0.92 111.179 -178.562 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 40.5 mm -90.97 117.18 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.59 -1.319 . . . . 0.88 108.729 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -99.92 -9.35 22.92 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.258 -0.901 . . . . 2.45 110.481 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -129.18 152.11 49.12 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.296 -0.878 . . . . 1.52 110.057 -179.2 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.52 136.78 57.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.504 -0.748 . . . . 1.58 109.273 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.5 m -151.92 164.8 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.328 -0.858 . . . . 0.69 109.671 179.51 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.3 mt -92.1 146.52 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 105.954 -1.869 . . . . 0.61 105.954 177.028 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.6 tp -94.23 115.83 28.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.795 -1.191 . . . . 0.87 110.495 -178.149 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.2 t -123.2 129.94 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.512 -0.921 . . . . 0.71 108.512 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.24 162.24 36.15 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.275 -1.009 . . . . 0.81 108.275 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.6 -35.25 72.91 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.214 -1.553 . . . . 0.98 108.048 178.672 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -170.48 140.91 1.86 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.186 -1.042 . . . . 2.25 108.186 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.7 mt -113.48 134.61 54.58 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.231 -0.918 . . . . 0.78 109.955 -179.218 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 18.0 p -87.27 147.19 41.74 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.305 -0.872 . . . . 0.98 108.783 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -43.24 -33.07 3.53 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.12 1.88 . . . . 0.81 113.319 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.548 ' CB ' HH12 ' A' ' 136' ' ' ARG . 13.8 m -59.95 -48.55 81.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.808 -1.183 . . . . 0.9 108.928 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.04 -44.92 94.33 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.386 -0.822 . . . . 1.61 109.438 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.448 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 67.9 p -56.72 -18.87 14.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.877 . . . . 0.61 110.537 -178.67 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.36 -48.76 8.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.949 -1.095 . . . . 0.6 109.378 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -90.82 38.64 0.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.537 -0.912 . . . . 1.4 108.537 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.5 tp -104.85 134.39 48.05 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.92 -0.77 . . . . 0.7 108.92 179.382 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 176' ' ' VAL . 86.3 m-20 -80.86 101.72 9.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 2.35 108.79 179.706 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 97.2 mt -62.93 -39.96 96.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.269 -0.894 . . . . 1.51 110.337 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -67.02 -24.25 66.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.081 -1.012 . . . . 2.33 110.883 -178.121 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -93.92 -11.46 30.93 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.737 -1.227 . . . . 1.92 109.478 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.463 HG11 ' CE1' ' A' ' 179' ' ' PHE . 72.4 t -101.17 110.14 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.197 -0.94 . . . . 0.67 108.737 179.064 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.16 5.99 31.42 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.204 -0.935 . . . . 1.53 110.57 -178.658 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.18 170.41 37.44 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.991 -1.644 . . . . 0.48 108.991 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.463 ' CE1' HG11 ' A' ' 176' ' ' VAL . 22.3 m-85 -130.86 128.93 41.61 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.334 -1.097 . . . . 0.55 109.288 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 90.0 mt -132.55 125.38 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.484 -0.932 . . . . 0.65 108.484 178.725 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.3 p -145.94 160.04 42.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.062 -1.023 . . . . 0.82 110.84 -179.236 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 59.6 t0 -101.82 23.13 11.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.599 -0.688 . . . . 2.46 109.885 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.41 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -58.19 -161.17 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.287 -1.508 . . . . 1.28 110.792 -178.498 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -83.75 -44.34 6.86 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.607 -0.997 . . . . 2.19 110.607 -179.181 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 147.57 -115.25 0.75 Allowed Glycine 0 N--CA 1.497 2.724 0 O-C-N 120.83 -1.394 . . . . 2.13 110.32 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.422 ' HG2' HH22 ' A' ' 195' ' ' ARG . 46.4 mtt-85 -59.92 -38.06 81.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.49 -1.006 . . . . 5.86 110.927 -179.306 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 73.4 p -70.25 0.09 7.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.914 -1.116 . . . . 3.72 110.432 -178.38 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 39.8 t -92.32 117.27 29.73 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.972 -1.08 . . . . 1.74 110.712 -179.654 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -47.71 -42.3 24.74 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.197 -0.939 . . . . 0.95 108.541 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.432 ' H ' HG23 ' A' ' 190' ' ' THR . 23.4 p -52.18 -34.66 46.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.801 -0.562 . . . . 1.55 109.96 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 74.9 m -60.01 -40.06 87.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.011 -1.056 . . . . 1.51 110.472 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.2 mm -63.98 -40.35 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.17 -0.956 . . . . 1.67 110.112 -178.922 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 82.9 mtp -59.99 -49.04 79.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.956 -1.09 . . . . 1.02 110.969 -178.774 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.52 -44.17 89.43 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.705 -1.247 . . . . 0.68 109.968 -178.391 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.422 HH22 ' HG2' ' A' ' 186' ' ' ARG . 98.2 mtt180 -61.75 -54.93 35.81 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.29 -0.964 . . . . 2.93 110.503 -179.183 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.3 m -70.0 -35.89 74.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.027 -1.046 . . . . 0.86 112.148 -178.472 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.55 -12.35 60.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.604 -1.31 . . . . 0.67 110.585 -178.114 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 62.14 49.56 4.39 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.495 -0.753 . . . . 1.5 111.055 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 96.4 mt -130.62 150.03 75.22 Favored Pre-proline 0 N--CA 1.499 2.002 0 N-CA-C 107.641 -1.244 . . . . 0.72 107.641 178.004 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.11 143.85 73.26 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.035 1.823 . . . . 0.61 111.418 179.867 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.91 151.74 4.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.746 -1.221 . . . . 0.66 111.889 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.6 mt -125.81 139.67 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.025 -1.102 . . . . 0.79 108.025 178.774 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.1 m -122.77 -12.67 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 120.985 -1.072 . . . . 0.91 110.968 -178.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.98 26.56 13.63 Favored Glycine 0 N--CA 1.501 2.978 0 N-CA-C 110.897 -0.881 . . . . 1.01 110.897 -178.838 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.7 p -43.2 -44.82 5.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.066 -1.255 . . . . 0.99 110.096 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.447 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 93.01 -52.12 2.54 Favored Glycine 0 N--CA 1.498 2.795 0 C-N-CA 120.224 -0.988 . . . . 1.12 110.741 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.2 t -158.91 33.64 0.21 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.617 -1.519 . . . . 1.72 111.186 -179.259 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.6 -40.05 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.985 -1.072 . . . . 0.89 109.082 178.45 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.452 ' H ' HG23 ' A' ' 209' ' ' THR . 7.0 p -54.54 -30.0 52.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.431 -0.793 . . . . 1.03 110.108 -179.08 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.5 t -80.89 -21.1 40.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.061 -1.024 . . . . 1.83 110.161 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -96.96 -13.41 22.39 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.128 -0.982 . . . . 2.27 110.125 -179.416 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.8 t -102.05 136.62 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.361 -0.837 . . . . 0.92 110.216 -178.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -112.23 154.54 25.43 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.04 -1.467 . . . . 2.2 107.04 178.77 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.497 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 32.6 t30 -60.04 139.02 57.73 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.839 -1.163 . . . . 2.36 110.169 -179.145 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 9.6 t0 84.91 7.24 0.48 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.16 0.505 . . . . 2.38 110.019 179.49 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 55.3 t0 -76.87 142.07 40.35 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.204 -0.935 . . . . 2.09 109.096 179.232 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.493 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 49.3 t80 -92.81 117.98 30.61 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.977 -1.12 . . . . 1.27 107.977 178.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.545 HD12 ' HB2' ' A' ' 16' ' ' ALA . 69.9 mt -127.16 147.47 50.19 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.503 -0.748 . . . . 0.75 110.55 -178.554 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.403 HD12 ' HG3' ' A' ' 231' ' ' PRO . 80.5 mt -118.39 129.59 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 107.469 -1.308 . . . . 0.63 107.469 177.461 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 34.3 tp -104.22 123.65 47.71 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.668 -0.864 . . . . 0.7 108.668 -179.193 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 10' ' ' GLY . 29.1 t0 -85.75 -35.76 20.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.107 -0.995 . . . . 2.31 108.38 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 45.71 21.41 0.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.742 0.782 . . . . 0.78 108.919 -179.319 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 221' ' ' ASP . 42.1 t -133.41 -44.07 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.121 -1.437 . . . . 1.04 107.121 178.937 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.465 ' ND2' ' OD2' ' A' ' 221' ' ' ASP . 84.3 m-20 -102.25 2.1 36.66 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.057 -1.09 . . . . 2.44 108.057 178.606 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.441 HD21 ' H ' ' A' ' 4' ' ' GLY . 10.1 t-20 59.98 43.91 14.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.805 -0.559 . . . . 1.55 110.307 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -136.41 149.37 48.25 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.216 -0.928 . . . . 1.99 110.112 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.6 129.96 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.454 -0.943 . . . . 0.77 108.454 178.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -100.87 123.03 44.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.423 -0.798 . . . . 0.98 109.303 179.329 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 19.4 t -100.03 110.52 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.373 -0.83 . . . . 0.85 109.98 -179.312 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 230' ' ' ASN . 3.9 t30 56.61 67.43 2.69 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.325 -0.859 . . . . 1.66 111.368 179.221 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.403 ' HG3' HD12 ' A' ' 219' ' ' ILE . 81.6 Cg_endo -91.05 150.02 3.82 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.266 2.644 . . . . 0.95 112.568 178.897 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.0 m -70.07 160.03 32.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.345 -0.847 . . . . 1.84 110.29 -179.23 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -59.99 -36.84 78.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.392 -0.817 . . . . 2.74 109.608 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -60.03 -38.43 82.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 2.89 109.221 -179.689 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.36 -40.05 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.096 -1.003 . . . . 1.3 109.405 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.496 1.859 0 O-C-N 121.164 -0.96 . . . . 1.09 110.104 -179.856 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 50.5 ttp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.573 0.701 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' B' B ' 302' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 36.2 t80 -154.92 152.83 30.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.706 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 303' ' ' GLN . . . . . 0.463 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 13.8 pt20 -149.78 159.99 43.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.937 -1.102 . . . . 0.0 110.474 -179.436 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -153.94 150.44 28.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.568 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -112.49 134.08 54.21 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.225 -0.922 . . . . 0.0 110.583 -179.504 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -129.71 121.52 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-O 122.251 1.024 . . . . 0.0 112.546 -177.485 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 307' ' ' THR . . . . . 0.462 ' O ' HG23 ' B' ' 309' ' ' THR . 25.4 m -76.45 105.1 7.31 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.79 0.805 . . . . 0.0 110.42 -178.437 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 98.9 mt -53.26 121.62 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 122.318 1.056 . . . . 0.0 110.375 -178.325 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 309' ' ' THR . . . . . 0.462 HG23 ' O ' ' B' ' 307' ' ' THR . 78.1 p -110.11 19.95 18.42 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.36 -178.622 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.14 126.14 91.97 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.901 -1.124 . . . . 0.0 109.168 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.65 -18.72 27.38 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 CA-C-N 120.404 1.18 . . . . 0.0 112.327 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -120.45 10.16 11.1 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 75.33 -176.98 49.47 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.098 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.515 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -83.45 87.54 6.99 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.088 -1.242 . . . . 0.0 108.988 -178.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.419 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 3.9 p80 -90.29 -162.92 0.94 Allowed 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.825 -1.172 . . . . 0.0 110.123 179.09 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 9.6 m -57.09 -41.78 79.49 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.852 -1.155 . . . . 0.0 112.486 -175.922 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.493 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 0.7 OUTLIER -60.02 -60.88 9.17 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 120.62 -1.3 . . . . 0.0 111.855 -178.835 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.419 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 13.1 Cg_endo -59.38 -34.33 97.56 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 CA-C-N 120.139 1.085 . . . . 0.0 111.801 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.52 73.42 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.74 -41.96 67.66 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.02 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 321' ' ' GLN . . . . . 0.582 ' HA ' ' HZ2' ' B' ' 324' ' ' LYS . 27.3 mm100 -70.0 -41.4 74.42 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 108.692 178.749 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 322' ' ' PHE . . . . . 0.486 ' CE1' ' SD ' ' B' ' 381' ' ' MET . 55.1 t80 -61.93 -52.23 64.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.583 -0.698 . . . . 0.0 110.813 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.51 -29.23 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.596 -1.315 . . . . 0.0 109.299 -179.288 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 324' ' ' LYS . . . . . 0.582 ' HZ2' ' HA ' ' B' ' 321' ' ' GLN . 0.2 OUTLIER -60.13 -46.25 90.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.406 -0.809 . . . . 0.0 109.636 179.495 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -67.19 -45.62 76.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.346 -0.846 . . . . 0.0 110.893 -178.54 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.0 -53.0 62.97 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.706 -1.246 . . . . 0.0 110.833 -178.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 327' ' ' LYS . . . . . 0.438 ' HZ2' ' HG3' ' B' ' 345' ' ' LYS . 28.5 mttp -54.12 -12.64 0.65 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.067 -1.021 . . . . 0.0 109.452 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.1 -20.14 73.42 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -106.03 146.66 29.82 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.387 -1.066 . . . . 0.0 108.599 179.531 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 70.0 p -91.51 -14.29 30.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.86 -1.15 . . . . 0.0 109.435 179.586 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.419 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 77.9 p -64.52 149.18 49.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.665 -179.535 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -69.85 138.25 52.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.129 -0.982 . . . . 0.0 108.795 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.6 mt -134.14 134.6 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.603 -0.686 . . . . 0.0 109.56 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 48.4 m -128.62 149.82 50.49 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.451 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 76.5 t -121.99 113.15 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.35 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 44.3 m -105.29 133.16 50.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.951 . . . . 0.0 109.28 -178.644 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 34.1 p -137.83 110.67 7.66 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.758 0.789 . . . . 0.0 110.248 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 22.4 m120 45.97 53.48 9.02 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 177.456 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.96 -15.45 59.35 Favored Glycine 0 N--CA 1.504 3.169 0 O-C-N 120.246 -1.534 . . . . 0.0 113.207 176.413 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 340' ' ' LYS . . . . . 0.528 ' NZ ' ' O ' ' B' ' 352' ' ' THR . 9.7 mtpm? -116.06 127.92 55.27 Favored 'General case' 0 N--CA 1.507 2.423 0 CA-C-N 119.338 1.569 . . . . 0.0 109.614 -179.517 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 67.2 m -127.2 148.58 50.19 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.968 0.889 . . . . 0.0 111.15 -178.395 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.94 164.69 29.49 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.348 0.594 . . . . 0.0 109.712 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 47.4 t -88.58 132.41 34.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.474 -0.766 . . . . 0.0 110.922 -178.735 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.443 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -69.86 -21.63 63.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.888 . . . . 0.0 108.871 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 345' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' B' ' 345' ' ' LYS . 24.0 ttpp -83.12 18.0 1.82 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.61 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 346' ' ' SER . . . . . 0.443 ' H ' ' C ' ' B' ' 344' ' ' ALA . 11.2 t -147.12 95.33 2.54 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.14 -179.489 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.804 HD23 HD22 ' A' ' 79' ' ' LEU . 60.8 tp -59.91 -39.7 86.28 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.542 -0.724 . . . . 0.0 109.132 179.02 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.884 ' CE2' HD11 ' A' ' 79' ' ' LEU . 60.9 m-85 -54.02 -52.49 60.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.104 -0.998 . . . . 0.0 110.771 -179.404 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -65.89 -39.99 91.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.152 -0.968 . . . . 0.0 109.704 -178.774 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' B' ' 352' ' ' THR . 17.6 mt -49.71 -58.35 5.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.193 -0.942 . . . . 0.0 109.915 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.445 ' OE1' ' NE ' ' A' ' 126' ' ' ARG . 2.6 mm-40 -42.58 -13.19 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.239 -0.913 . . . . 0.0 111.869 -177.077 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.569 ' N ' ' O ' ' B' ' 350' ' ' LEU . 81.6 p -85.02 -15.01 45.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 119.95 -1.719 . . . . 0.0 110.275 -179.152 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.442 HD23 ' HZ3' ' B' ' 340' ' ' LYS . 43.3 mt -91.32 119.96 31.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.999 -1.063 . . . . 0.0 109.431 179.335 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.26 93.91 0.7 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.175 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 355' ' ' LEU . . . . . 0.417 HD22 HG11 ' B' ' 361' ' ' VAL . 52.0 mt -100.59 88.01 3.51 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.245 -1.15 . . . . 0.0 109.187 179.656 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 60.0 p -91.53 166.12 13.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.958 -1.089 . . . . 0.0 110.744 -178.974 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -59.41 116.64 4.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.774 -0.579 . . . . 0.0 111.077 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 101.02 7.11 50.91 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 47.7 m -86.74 110.89 20.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -1.136 . . . . 0.0 110.795 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 46.7 t -77.78 117.52 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 122.169 0.985 . . . . 0.0 109.48 -177.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 361' ' ' VAL . . . . . 0.417 HG11 HD22 ' B' ' 355' ' ' LEU . 25.4 m -110.22 177.67 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 91.1 m -131.35 128.74 40.29 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.174 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 69.6 mt -103.0 116.33 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.647 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 67.2 m -116.06 129.99 56.6 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.88 151.8 39.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.353 -0.842 . . . . 0.0 109.724 -178.429 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -145.01 121.5 11.03 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.475 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.81 -155.38 26.54 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 118.765 -1.683 . . . . 0.0 111.844 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -59.94 -50.9 71.93 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.173 -0.514 . . . . 0.0 112.224 -177.151 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.419 ' H ' ' HB3' ' B' ' 331' ' ' SER . 97.0 m-20 -110.27 13.47 22.99 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.777 -1.202 . . . . 0.0 111.137 -177.584 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.7 pt-20 -42.23 -36.42 1.21 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.206 -0.934 . . . . 0.0 110.655 -179.246 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 371' ' ' GLN . . . . . 0.407 ' HG2' ' H ' ' B' ' 371' ' ' GLN . 2.3 pt20 -69.26 -47.06 65.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.043 -1.036 . . . . 0.0 110.162 -179.148 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -69.98 -54.44 13.25 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.003 -1.06 . . . . 0.0 109.51 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 373' ' ' ALA . . . . . 0.427 ' O ' HD12 ' B' ' 377' ' ' LEU . . . -43.46 -34.18 1.26 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.365 -0.834 . . . . 0.0 111.179 -179.022 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.525 ' O ' HG23 ' B' ' 378' ' ' VAL . 73.4 t -76.09 -35.66 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.603 -1.311 . . . . 0.0 109.399 179.327 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -65.41 -59.4 4.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 111.853 -178.15 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -69.77 -39.99 76.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.384 -1.448 . . . . 0.0 111.707 -178.269 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 377' ' ' LEU . . . . . 0.427 HD12 ' O ' ' B' ' 373' ' ' ALA . 88.0 mt -58.46 -39.99 81.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.526 -1.359 . . . . 0.0 108.696 -178.792 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.525 HG23 ' O ' ' B' ' 374' ' ' VAL . 55.3 t -62.38 -42.72 96.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.103 -0.998 . . . . 0.0 109.596 179.401 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 379' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.6 mttt -71.25 -57.54 4.39 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.794 -1.191 . . . . 0.0 108.209 178.853 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 53.9 tp -53.32 -35.99 60.77 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.173 -0.954 . . . . 0.0 109.015 -178.346 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 381' ' ' MET . . . . . 0.486 ' SD ' ' CE1' ' B' ' 322' ' ' PHE . 0.9 OUTLIER -72.14 -40.0 68.38 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.621 -1.299 . . . . 0.0 108.437 177.648 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.62 -4.87 58.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.595 -0.691 . . . . 0.0 110.601 179.374 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' B' ' 379' ' ' LYS . 94.6 mt-10 -111.43 -3.11 15.34 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.125 -0.985 . . . . 0.0 110.807 -179.725 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.6 mt -82.98 131.14 35.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.637 -1.289 . . . . 0.0 109.099 179.25 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.091 179.615 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.358 -0.608 . . . . 2.91 109.358 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.505 HD11 HE22 ' A' ' 211' ' ' GLN . 97.4 mt -108.37 123.71 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.438 -0.788 . . . . 1.2 109.602 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.8 m -135.98 141.14 44.39 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.72 -0.844 . . . . 1.4 108.72 179.578 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.509 ' N ' HD22 ' A' ' 225' ' ' ASN . . . -109.0 -160.13 19.45 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.113 -1.595 . . . . 1.05 109.113 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.1 mt -95.23 -15.01 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.118 -1.225 . . . . 1.15 109.589 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.4 tp 51.99 104.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.798 . . . . 0.98 109.666 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.82 -23.57 17.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.079 -1.013 . . . . 0.88 109.302 179.51 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.459 ' OG ' ' N ' ' A' ' 201' ' ' ALA . 12.5 p -137.42 119.24 11.01 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.405 -0.81 . . . . 1.69 109.06 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.99 150.13 20.51 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.904 1.736 . . . . 0.85 112.375 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.784 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.35 -155.09 25.96 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.08 -1.608 . . . . 0.92 109.08 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.7 mt -149.08 150.59 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.016 -1.285 . . . . 0.81 109.112 179.045 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.12 146.12 22.59 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.022 -1.049 . . . . 0.51 110.315 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -127.62 127.92 44.64 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.161 -1.051 . . . . 0.62 108.161 178.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.1 176.08 46.6 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.734 -1.698 . . . . 0.55 110.588 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -77.76 156.31 30.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.699 -0.883 . . . . 2.1 109.022 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -102.59 128.33 49.29 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.416 -0.802 . . . . 0.77 111.025 -178.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.8 tp -100.13 135.33 41.73 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.069 -1.456 . . . . 0.91 107.069 178.268 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.0 tp -115.3 121.6 43.37 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.3 -0.875 . . . . 0.93 110.099 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.1 mt -86.69 103.01 14.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.526 -0.734 . . . . 0.93 109.73 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -90.96 142.31 27.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.395 -0.815 . . . . 2.75 109.244 179.713 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -130.1 133.34 46.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.426 -0.953 . . . . 3.0 108.426 179.222 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -84.07 150.69 25.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.044 -1.035 . . . . 2.77 109.429 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -66.66 147.89 52.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.932 . . . . 2.94 109.301 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 86.5 mt -96.44 126.68 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.187 -0.946 . . . . 0.95 109.05 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.1 t -94.73 126.12 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.133 -0.979 . . . . 1.28 109.997 -179.298 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.5 mt -112.37 131.93 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 109.016 -0.735 . . . . 1.21 109.016 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.01 118.35 28.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.873 -1.142 . . . . 1.81 110.335 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -85.08 -1.06 56.42 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.715 -0.846 . . . . 2.8 108.715 179.761 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -69.9 140.37 53.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.469 -0.769 . . . . 2.87 110.024 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -80.03 153.3 28.91 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.194 -0.941 . . . . 2.35 109.409 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.0 pt -94.6 167.48 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.179 -0.95 . . . . 0.97 109.711 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.4 p -96.28 173.04 7.59 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.147 -1.057 . . . . 1.17 108.147 178.22 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.99 75.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.913 -1.117 . . . . 1.18 110.501 -179.335 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -57.3 -26.45 60.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.703 -1.248 . . . . 2.56 109.513 -179.275 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -82.26 -9.83 59.34 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.302 -0.874 . . . . 1.79 109.762 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.3 t -66.49 -54.59 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.925 -1.11 . . . . 1.0 109.641 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.04 -40.08 88.14 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.269 -0.895 . . . . 1.77 109.102 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -62.87 -42.19 99.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.419 -0.801 . . . . 2.7 110.707 -179.295 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -62.62 -42.55 99.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.615 -1.303 . . . . 1.51 110.221 -179.498 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.98 -47.39 91.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 120.594 -1.316 . . . . 0.93 108.64 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -59.94 -45.15 93.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -0.942 . . . . 1.81 109.318 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.501 HH11 ' HG2' ' A' ' 42' ' ' ARG . 22.2 mtt-85 -60.08 -43.56 95.39 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.069 -1.086 . . . . 2.78 108.069 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -62.0 -47.2 85.85 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.737 -0.838 . . . . 0.78 108.737 178.488 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.2 tp -59.94 -48.92 79.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 1.07 108.837 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.442 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 29.4 t -63.04 -43.73 97.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.975 -1.078 . . . . 1.12 108.963 178.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.06 -47.51 90.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.57 -1.812 . . . . 0.84 108.57 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -61.56 -36.18 79.9 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.006 -1.109 . . . . 3.09 108.006 178.599 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -55.32 -40.01 70.64 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.317 -0.623 . . . . 0.88 109.317 -179.618 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ALA . 26.4 ttpp -66.34 -73.73 0.13 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.652 -1.24 . . . . 2.59 107.652 179.153 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.09 -36.34 0.2 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.46 -0.775 . . . . 0.7 111.346 -178.544 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 t -57.41 -55.94 28.34 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.508 -1.37 . . . . 1.4 108.612 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.08 -40.0 86.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.253 -0.904 . . . . 0.67 111.074 -179.49 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -67.96 -40.24 83.23 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.841 -1.162 . . . . 1.66 110.322 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.2 mt -62.03 -39.97 94.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.009 -1.057 . . . . 1.58 108.72 179.219 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -61.21 -38.49 86.79 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.426 -0.796 . . . . 1.35 109.713 179.26 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -64.27 -43.69 94.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.194 -0.941 . . . . 0.77 110.268 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.657 ' CD1' HH22 ' A' ' 136' ' ' ARG . 85.7 mt -63.04 -38.1 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.63 108.969 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -56.15 -50.59 70.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 1.14 109.896 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -59.94 -36.44 77.08 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.43 -0.794 . . . . 0.79 110.367 -177.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -63.79 -39.48 94.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.963 -1.086 . . . . 1.53 109.211 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.68 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.54 -45.48 75.54 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.564 -0.71 . . . . 0.57 110.033 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.14 -51.16 60.07 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 110.268 -1.133 . . . . 0.75 110.268 -179.036 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -69.96 -41.88 73.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.037 -1.272 . . . . 1.59 110.309 -179.446 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.3 m -69.92 -60.4 2.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.912 . . . . 0.73 112.2 -177.546 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -95.49 -50.77 4.84 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.964 -1.085 . . . . 0.75 111.093 -178.255 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.42 -163.7 26.75 Favored Glycine 0 N--CA 1.499 2.837 0 O-C-N 120.747 -1.221 . . . . 1.22 110.726 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -70.0 -23.24 63.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.751 -0.852 . . . . 5.81 110.364 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.425 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 52.7 tp10 -60.13 -37.76 81.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 3.37 110.272 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -97.4 -19.02 18.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.293 -0.88 . . . . 1.77 110.388 -178.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -70.09 -40.12 75.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.855 -1.153 . . . . 1.65 110.496 -179.712 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.601 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.82 -29.9 69.17 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.399 -0.813 . . . . 0.77 109.585 -178.761 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.02 -42.57 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.248 -0.981 . . . . 0.8 109.112 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.451 ' CZ ' HG22 ' A' ' 57' ' ' ILE . 39.5 m-85 -64.5 -40.08 94.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.112 -0.993 . . . . 0.88 110.742 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -59.98 -40.02 87.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.831 -1.168 . . . . 1.37 108.833 -179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.01 -43.53 98.73 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 107.98 -2.048 . . . . 0.62 107.98 178.514 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -65.21 -48.43 73.41 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.459 -1.024 . . . . 1.5 108.608 179.253 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.9 mt -64.36 -49.39 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.397 -0.815 . . . . 0.63 109.18 179.432 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.2 ttp -60.41 -42.73 96.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.167 -0.958 . . . . 1.51 110.37 -179.075 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.833 HD11 ' CE2' ' B' ' 348' ' ' PHE . 42.0 tp -66.04 -41.57 90.7 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.335 -0.853 . . . . 0.77 109.983 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.4 tp -63.31 -40.11 96.44 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.292 -0.88 . . . . 0.62 110.168 -179.548 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -82.57 8.03 12.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.188 -0.945 . . . . 1.47 110.08 -179.355 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -50.78 131.91 26.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 1.47 109.352 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.44 -20.66 60.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.701 -0.624 . . . . 1.78 111.027 -178.758 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.71 -34.32 67.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.901 -1.125 . . . . 2.53 109.552 179.54 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.6 mt -70.08 -40.1 75.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.538 -0.726 . . . . 0.8 109.321 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -60.08 -46.04 90.91 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.389 -0.82 . . . . 1.42 109.613 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -69.99 -40.48 75.29 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.406 -0.809 . . . . 1.71 110.244 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.02 -40.02 75.46 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.051 -1.03 . . . . 1.57 111.14 -179.417 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.0 mt -67.95 -48.88 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.919 -1.113 . . . . 0.65 109.461 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.97 -39.7 84.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.506 -0.746 . . . . 0.82 109.51 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.96 -48.89 79.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 0.79 110.532 -179.246 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 96' ' ' LYS . 84.3 mt -60.22 -47.73 84.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.928 -1.108 . . . . 0.95 109.878 -179.638 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.81 -50.05 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.89 . . . . 0.66 109.198 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -70.0 -40.49 75.25 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.857 -0.737 . . . . 2.2 110.814 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 91' ' ' ALA . 10.2 t70 -84.17 -50.9 7.49 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.041 -1.037 . . . . 1.65 112.058 -178.147 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 92' ' ' LEU . 67.2 mmtt -90.19 -2.6 58.07 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.885 -1.135 . . . . 2.03 111.606 -177.491 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.7 m80 57.6 36.71 27.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.075 -1.016 . . . . 1.42 109.478 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 79.6 mtp -93.56 164.14 13.29 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.651 -0.655 . . . . 1.18 110.343 -179.361 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.6 p -77.9 161.82 27.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.608 -0.683 . . . . 0.98 109.177 179.777 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.89 81.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.102 -0.999 . . . . 0.64 109.783 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.489 ' OD2' HD21 ' A' ' 142' ' ' LEU . 96.9 m-20 -64.29 -39.97 95.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.144 -0.972 . . . . 2.07 109.399 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.29 -46.76 19.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.836 . . . . 0.73 109.756 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.55 -50.01 75.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.308 -0.87 . . . . 0.54 109.838 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.57 -37.45 81.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 0.56 109.417 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -60.05 -46.91 87.97 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.514 -0.741 . . . . 1.54 110.109 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -62.65 -40.08 95.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -0.879 . . . . 1.33 110.946 -179.041 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.4 -56.29 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.005 -1.059 . . . . 0.72 111.039 -178.055 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.5 mm -68.78 -39.97 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.918 -1.114 . . . . 0.85 108.967 -179.326 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -63.63 -40.04 95.89 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.245 -1.02 . . . . 2.44 108.245 178.668 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.77 -50.43 67.67 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.057 -1.217 . . . . 0.98 110.057 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -65.24 -49.49 69.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.956 -1.32 . . . . 1.41 109.262 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.56 -42.67 92.93 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.094 -1.004 . . . . 1.2 108.731 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 88.6 p -60.11 -39.86 87.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.243 -0.91 . . . . 1.7 109.023 179.175 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.3 -39.92 80.62 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.056 -1.028 . . . . 1.47 108.629 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.9 mt -62.17 -39.97 94.43 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.138 -0.976 . . . . 1.56 109.047 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -53.85 -24.37 15.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.081 -1.012 . . . . 2.2 109.514 -179.124 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -59.91 -27.83 67.07 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.534 -1.284 . . . . 2.12 107.534 179.146 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.429 HD11 ' HA ' ' B' ' 352' ' ' THR . 57.6 mt -62.99 140.38 58.86 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.712 -0.618 . . . . 2.0 109.511 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -100.12 48.92 0.92 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.232 -0.917 . . . . 3.23 109.538 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 51.1 t0 -136.34 148.53 47.94 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.311 -0.868 . . . . 2.49 109.424 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 71.4 mm-40 -73.28 -65.02 0.86 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.247 -0.908 . . . . 3.95 108.597 178.636 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -40.7 -39.85 1.17 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.83 -0.544 . . . . 2.0 110.948 -179.154 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.647 ' HA ' HE22 ' B' ' 351' ' ' GLN . 83.6 mt -76.33 -40.27 51.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.619 -1.301 . . . . 1.86 110.0 -179.455 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -68.64 -39.98 80.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.047 -1.033 . . . . 2.84 109.463 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.604 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 47.8 mt-10 -59.9 -43.57 94.74 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.135 -0.978 . . . . 2.73 108.527 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.495 ' NH2' HD11 ' B' ' 347' ' ' LEU . 1.6 ttp180 -60.73 -40.02 90.81 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.364 -0.976 . . . . 2.77 108.364 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.04 -19.91 48.25 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.904 -1.147 . . . . 1.19 107.904 178.555 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -69.72 -40.04 76.5 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.585 -1.265 . . . . 1.2 107.585 178.502 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -65.02 -40.05 94.3 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.501 -0.749 . . . . 1.55 109.102 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.48 -40.09 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.306 -0.998 . . . . 0.8 108.306 178.997 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -62.33 -37.81 87.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.542 -0.723 . . . . 3.09 109.294 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -59.98 -40.56 89.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.374 -0.829 . . . . 1.46 110.034 -178.85 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.01 -47.81 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.129 -0.982 . . . . 0.71 109.45 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.16 -40.24 98.91 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.09 -1.204 . . . . 0.57 110.09 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -59.96 -48.0 83.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.378 -1.071 . . . . 2.59 109.774 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.657 HH22 ' CD1' ' A' ' 57' ' ' ILE . 57.4 mtp180 -65.77 -33.5 76.0 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.038 -1.039 . . . . 2.83 109.729 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.84 -43.15 94.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.41 -0.806 . . . . 1.25 109.374 -179.234 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.05 -40.06 88.12 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.19 -0.943 . . . . 0.7 109.238 179.472 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.401 HH11 ' HG2' ' A' ' 139' ' ' ARG . 55.2 mtt-85 -69.94 -39.9 75.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 2.57 109.477 179.554 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -67.62 -34.66 77.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.478 -0.763 . . . . 1.23 112.096 -178.576 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.06 -41.46 79.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.256 -1.527 . . . . 0.81 108.784 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.489 HD21 ' OD2' ' A' ' 101' ' ' ASP . 92.1 mt -73.45 -26.19 60.82 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.32 43.41 8.02 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.374 -1.89 . . . . 0.89 108.374 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 tp -74.35 150.03 40.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.532 -0.981 . . . . 1.14 109.029 -179.129 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -64.58 142.51 58.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.29 -0.881 . . . . 4.6 110.396 -178.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.7 mt -116.86 127.6 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-O 121.89 0.852 . . . . 1.24 108.771 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.8 mt -65.43 -43.87 94.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.918 -0.489 . . . . 1.54 111.468 -177.644 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.0 t0 64.53 112.78 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.222 -0.924 . . . . 1.5 109.031 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.482 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 86.6 mt -79.05 -3.28 44.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.319 -0.863 . . . . 0.79 110.029 -179.244 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.9 m -87.3 -15.3 38.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.275 -0.89 . . . . 1.4 109.808 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.31 14.47 2.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.281 -0.887 . . . . 0.92 111.334 -178.503 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.645 HD12 ' N ' ' A' ' 152' ' ' ILE . 1.5 mp -90.23 117.92 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.549 -1.344 . . . . 0.88 108.764 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -101.65 -11.87 18.85 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.303 -0.873 . . . . 2.45 110.196 -179.433 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -112.24 146.66 37.77 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.55 -0.719 . . . . 1.52 110.168 -179.212 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.06 132.2 47.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.484 -0.76 . . . . 1.58 109.435 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.9 m -152.81 165.05 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.457 -0.777 . . . . 0.69 109.369 179.334 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.4 mt -92.43 147.95 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 105.383 -2.081 . . . . 0.61 105.383 176.485 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -98.52 117.49 33.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.833 -1.167 . . . . 0.87 110.581 -177.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.2 t -121.61 129.43 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.662 -0.866 . . . . 0.71 108.662 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.91 164.77 33.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.104 -0.997 . . . . 0.81 108.928 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.457 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.12 -36.85 77.95 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.069 -1.644 . . . . 0.98 108.381 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 162' ' ' ASP . 33.9 p-10 -170.7 150.47 3.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.195 -0.941 . . . . 2.25 109.563 179.647 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.7 mt -118.91 136.38 54.09 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.561 -0.712 . . . . 0.78 109.629 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 22.9 p -92.94 148.37 35.71 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.262 -0.899 . . . . 0.98 109.146 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -39.97 -36.6 1.42 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.044 1.829 . . . . 0.81 112.599 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.7 m -60.0 -40.07 87.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 0.9 109.156 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.01 -43.09 88.68 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.286 -0.884 . . . . 1.61 109.635 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 22.8 p -55.8 -28.78 57.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.149 -0.969 . . . . 0.61 110.308 -178.952 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.68 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -74.56 -53.34 9.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.11 -0.994 . . . . 0.6 109.678 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -85.36 38.34 0.73 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.091 -1.077 . . . . 1.4 108.091 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.4 tp -100.87 129.1 46.69 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.788 -0.819 . . . . 0.7 108.788 179.26 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 149' ' ' LEU . 1.4 p30 -85.62 101.46 12.73 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.908 -1.145 . . . . 2.35 107.908 179.106 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 70.0 mt -64.67 -43.18 94.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.563 -0.71 . . . . 1.51 111.613 -178.043 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -71.23 -21.65 62.1 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.73 -1.231 . . . . 2.33 111.874 -177.714 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -93.22 -11.31 32.95 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.583 -1.323 . . . . 1.92 108.849 -179.35 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 178' ' ' GLY . 67.9 t -110.02 120.06 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.647 -0.871 . . . . 0.67 108.647 179.231 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.9 mt -89.01 6.35 40.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.266 -0.896 . . . . 1.53 110.98 -177.791 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.528 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.58 172.92 37.39 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.378 -1.391 . . . . 0.48 109.808 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -134.15 129.17 35.48 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.271 -1.135 . . . . 0.55 109.079 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.21 127.05 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.322 -0.861 . . . . 0.65 109.158 179.13 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 181' ' ' THR . . . . . 0.429 ' C ' ' HG1' ' A' ' 205' ' ' THR . 25.6 p -148.79 159.84 43.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.849 -1.157 . . . . 0.82 110.771 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 37.2 p-10 -104.07 27.06 8.02 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.595 -0.691 . . . . 2.46 109.333 179.49 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -56.03 -162.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.975 -1.078 . . . . 1.28 111.318 -178.464 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.2 -59.17 5.14 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.958 -0.857 . . . . 2.19 110.958 -178.786 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -178.64 -150.66 8.94 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 118.862 -1.637 . . . . 2.13 111.085 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -69.92 -20.62 63.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.604 -0.939 . . . . 5.86 110.54 -178.75 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 21.4 p -68.85 4.17 1.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.04 -1.038 . . . . 3.72 109.992 -179.136 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.7 p -88.48 142.51 27.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.151 -0.968 . . . . 1.74 110.638 -179.46 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -49.99 -47.1 53.08 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.549 -0.719 . . . . 0.95 109.782 -179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.4 m -56.32 -39.99 73.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.498 -0.751 . . . . 1.55 110.313 -178.7 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.4 t -60.8 -39.96 90.88 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.034 -1.041 . . . . 1.51 111.051 -179.631 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.02 -41.12 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.018 -1.051 . . . . 1.67 110.095 -178.681 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.0 mtp -65.16 -41.7 94.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.032 -1.043 . . . . 1.02 111.233 -179.214 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.6 92.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.108 -1.62 . . . . 0.68 110.188 -179.399 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.02 -49.3 78.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 2.93 110.586 -178.744 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.4 m -72.45 -33.73 67.25 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.237 -0.914 . . . . 0.86 111.817 -178.554 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.1 mt -84.08 -8.1 59.2 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.697 -1.252 . . . . 0.67 111.118 -178.211 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 59.2 49.22 9.41 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.271 -0.893 . . . . 1.5 110.841 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 80.6 mt -121.5 122.73 27.87 Favored Pre-proline 0 N--CA 1.501 2.099 0 N-CA-C 108.588 -0.893 . . . . 0.72 108.588 178.899 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.17 131.4 8.76 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.8 1.667 . . . . 0.61 112.004 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.459 ' N ' ' OG ' ' A' ' 8' ' ' SER . . . -167.89 146.95 4.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.738 -1.226 . . . . 0.66 111.501 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 90.0 mt -125.47 140.79 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 107.745 -1.205 . . . . 0.79 107.745 178.888 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.63 -8.85 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.031 -1.043 . . . . 0.91 110.99 -178.8 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.41 22.0 29.68 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.219 -1.152 . . . . 1.01 110.219 -179.596 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.429 ' HG1' ' C ' ' A' ' 181' ' ' THR . 6.3 p -45.74 -42.59 12.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.031 -1.276 . . . . 0.99 109.848 -179.248 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.56 -51.09 3.29 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 120.111 -1.042 . . . . 1.12 111.303 178.901 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.6 t -161.1 37.8 0.15 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.71 -1.465 . . . . 1.72 110.984 -179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.88 -39.95 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.124 -0.985 . . . . 0.89 108.473 177.84 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.436 HG23 ' H ' ' A' ' 209' ' ' THR . 2.9 p -54.18 -29.99 47.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.529 -0.732 . . . . 1.03 110.775 -179.237 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 52.3 m -80.06 -12.64 59.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.002 -1.061 . . . . 1.83 109.643 -179.293 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 211' ' ' GLN . . . . . 0.505 HE22 HD11 ' A' ' 2' ' ' ILE . 94.8 mt-30 -104.99 -12.2 16.29 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.485 -0.76 . . . . 2.27 109.773 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 71.5 t -104.64 137.7 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.333 -0.855 . . . . 0.92 110.602 -178.824 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.45 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -113.16 153.25 28.58 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.564 -1.272 . . . . 2.2 107.564 179.01 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.499 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 41.4 p-10 -59.49 136.49 57.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.073 -1.017 . . . . 2.36 110.744 -178.623 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 10.4 t0 84.49 5.89 0.6 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.99 -0.444 . . . . 2.38 110.715 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.45 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 92.1 m-20 -75.13 145.44 42.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.79 -1.194 . . . . 2.09 109.065 178.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -92.37 117.92 30.4 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.928 -1.138 . . . . 1.27 107.928 178.609 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.525 HD12 ' HB2' ' A' ' 16' ' ' ALA . 83.4 mt -127.12 146.73 50.28 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.486 -0.758 . . . . 0.75 110.454 -178.893 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.6 mt -112.25 129.27 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.272 -1.751 . . . . 0.63 106.272 176.896 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 30.6 tp -98.8 115.68 29.33 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.892 -1.13 . . . . 0.7 109.506 -178.223 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' A' ' 223' ' ' VAL . 65.1 m-20 -70.95 -46.34 62.57 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.935 -1.135 . . . . 2.31 107.935 178.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.784 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 52.08 7.89 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.761 -0.829 . . . . 0.78 108.761 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.535 ' H ' ' C ' ' A' ' 221' ' ' ASP . 72.1 t -123.86 -42.78 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.192 -1.41 . . . . 1.04 107.192 179.11 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -102.58 0.03 32.78 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.658 -1.238 . . . . 2.44 107.658 178.267 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.509 HD22 ' N ' ' A' ' 4' ' ' GLY . 28.5 t-20 59.84 42.74 16.04 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.772 -0.58 . . . . 1.55 109.737 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -133.12 152.36 51.95 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.398 -0.814 . . . . 1.99 109.462 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.23 129.98 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.997 -0.742 . . . . 0.77 108.997 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -100.05 122.76 43.43 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.505 -0.924 . . . . 0.98 108.505 179.094 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.2 t -103.12 113.39 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.573 -0.704 . . . . 0.85 109.904 -179.368 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 66.1 t30 53.89 66.87 3.99 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.357 -0.839 . . . . 1.66 111.532 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -90.94 151.36 3.93 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.196 2.597 . . . . 0.95 112.405 178.829 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.412 ' OG1' HG23 ' A' ' 235' ' ' VAL . 37.9 p -70.01 162.21 28.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.15 -0.969 . . . . 1.84 110.305 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.55 -40.05 90.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.483 -0.761 . . . . 2.74 109.958 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -60.11 -37.86 81.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.426 -0.796 . . . . 2.89 109.874 -179.436 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.412 HG23 ' OG1' ' A' ' 232' ' ' THR . 54.3 t -65.86 -41.68 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 1.3 109.481 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 91.9 mt . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.102 -0.999 . . . . 1.09 110.08 -179.888 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' B' B ' 301' ' ' MET . . . . . 0.407 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 37.8 ttp . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.516 0.674 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 302' ' ' PHE . . . . . 0.407 ' N ' ' CG ' ' B' ' 301' ' ' MET . 28.7 t80 -153.27 150.26 28.77 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.045 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -150.91 161.52 42.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.013 -1.054 . . . . 0.0 110.28 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -157.38 154.22 28.54 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.259 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -114.37 130.89 56.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.216 -0.928 . . . . 0.0 110.162 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 4.0 p -129.99 124.09 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 CA-C-O 122.18 0.991 . . . . 0.0 111.362 -178.764 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 307' ' ' THR . . . . . 0.548 ' O ' HG23 ' B' ' 309' ' ' THR . 32.8 m -79.92 104.33 10.43 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.868 0.842 . . . . 0.0 110.71 -178.063 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' B' ' 358' ' ' GLY . 89.7 mt -50.72 116.38 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 122.313 1.054 . . . . 0.0 110.222 -177.558 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 309' ' ' THR . . . . . 0.548 HG23 ' O ' ' B' ' 307' ' ' THR . 70.0 p -107.28 13.04 27.56 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.746 -178.497 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.67 116.43 49.79 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.022 -1.049 . . . . 0.0 108.829 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -58.94 -12.01 13.96 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 CA-C-N 120.579 1.243 . . . . 0.0 112.617 -179.497 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -103.73 2.77 33.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.3 -0.875 . . . . 0.0 109.993 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 65.69 167.49 2.07 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -178.703 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 2.8 tp -88.72 96.28 10.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.784 -1.421 . . . . 0.0 110.227 -177.628 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -100.07 -159.59 0.75 Allowed 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.975 -1.078 . . . . 0.0 109.632 178.673 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 93.4 m -59.95 -42.39 93.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.687 -1.258 . . . . 0.0 112.482 -176.39 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.601 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.4 tpt180 -57.59 -61.41 7.31 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.536 -1.353 . . . . 0.0 111.367 -178.308 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.26 -33.18 94.88 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 120.305 1.145 . . . . 0.0 111.454 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.93 -50.15 74.89 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.203 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.23 -41.77 65.74 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -69.89 -43.04 72.59 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.704 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -60.32 -51.58 68.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.562 -0.711 . . . . 0.0 110.208 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.34 -28.87 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.864 -1.147 . . . . 0.0 109.962 -179.072 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -59.98 -45.09 93.83 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.171 -0.956 . . . . 0.0 108.894 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.66 -46.35 69.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.305 -0.872 . . . . 0.0 110.969 -178.968 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.21 -54.64 19.23 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.516 -1.365 . . . . 0.0 111.118 -179.06 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -50.63 -16.56 0.4 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.217 -0.927 . . . . 0.0 109.598 -179.285 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -75.65 -18.67 79.63 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -103.54 143.48 32.68 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.444 -1.033 . . . . 0.0 108.876 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 330' ' ' THR . . . . . 0.417 HG22 ' O ' ' B' ' 330' ' ' THR . 86.7 m -90.72 -11.09 40.71 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.041 -1.037 . . . . 0.0 110.779 -178.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.454 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 88.8 p -67.04 156.92 34.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.881 -1.137 . . . . 0.0 109.754 -179.639 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -71.93 133.57 45.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.212 -0.93 . . . . 0.0 109.168 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.2 mt -130.63 131.22 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 84.8 m -129.27 148.14 51.17 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.558 -0.713 . . . . 0.0 109.533 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 96.6 t -122.33 115.84 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.208 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 92.6 m -104.53 125.12 50.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.152 -0.968 . . . . 0.0 109.573 -178.44 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 15.1 p -134.4 117.25 16.11 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.861 0.838 . . . . 0.0 110.339 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 42.93 55.02 4.58 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 177.831 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.96 -15.19 22.7 Favored Glycine 0 N--CA 1.497 2.74 0 O-C-N 120.349 -1.469 . . . . 0.0 112.44 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -108.45 118.98 38.18 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 119.069 1.434 . . . . 0.0 109.377 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 65.2 m -116.27 143.43 45.54 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.896 0.855 . . . . 0.0 111.151 -178.445 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.06 159.36 42.38 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.539 0.685 . . . . 0.0 109.668 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 15.9 t -87.04 135.17 33.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.496 -0.752 . . . . 0.0 109.799 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.67 ' HA ' HD11 ' B' ' 350' ' ' LEU . . . -72.5 -16.62 61.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.998 -1.064 . . . . 0.0 109.121 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -85.4 20.96 1.87 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.136 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 346' ' ' SER . . . . . 0.464 ' H ' ' C ' ' B' ' 344' ' ' ALA . 2.5 m -149.46 95.86 2.41 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.87 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.813 HD23 HD22 ' A' ' 79' ' ' LEU . 59.3 tp -59.36 -35.06 73.19 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.828 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.833 ' CE2' HD11 ' A' ' 79' ' ' LEU . 51.2 m-85 -56.32 -53.19 60.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.333 -0.854 . . . . 0.0 110.321 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -69.98 -40.06 75.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.986 -1.071 . . . . 0.0 110.505 -178.254 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.67 HD11 ' HA ' ' B' ' 344' ' ' ALA . 87.7 mt -52.86 -59.89 3.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.496 -1.378 . . . . 0.0 108.546 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.647 HE22 ' HA ' ' A' ' 123' ' ' LEU . 27.4 tp60 -42.61 -11.89 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.674 -178.312 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.559 ' N ' ' O ' ' B' ' 350' ' ' LEU . 71.8 p -89.24 -9.96 48.77 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.577 -1.327 . . . . 0.0 109.607 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 54.1 mt -92.71 120.49 33.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.188 -0.945 . . . . 0.0 108.874 178.703 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.8 92.34 0.81 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 179.405 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.73 90.59 4.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.263 -1.14 . . . . 0.0 109.663 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 356' ' ' THR . . . . . 0.45 ' O ' ' C ' ' B' ' 357' ' ' GLN . 82.1 p -97.86 139.32 33.89 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.084 -1.01 . . . . 0.0 109.774 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 357' ' ' GLN . . . . . 0.45 ' C ' ' O ' ' B' ' 356' ' ' THR . 16.4 tm0? -34.68 118.46 0.41 Allowed 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.393 0.616 . . . . 0.0 110.976 -178.838 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 358' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 103.15 5.08 47.15 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 21.6 m -87.25 109.45 19.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.318 -1.107 . . . . 0.0 110.426 -179.784 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 20.8 t -77.12 114.04 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 122.169 0.985 . . . . 0.0 109.46 -177.461 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.25 176.59 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.444 -0.946 . . . . 0.0 108.444 -178.152 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 24.9 m -130.41 126.27 36.6 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.958 -1.126 . . . . 0.0 107.958 177.513 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 84.4 mt -102.06 113.89 39.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.667 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 84.5 p -119.88 132.79 55.66 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.604 -0.685 . . . . 0.0 109.339 -178.822 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.12 150.51 38.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 109.428 -179.43 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -144.9 125.04 13.64 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.529 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.55 -160.92 30.98 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.679 -179.807 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -59.98 -50.01 75.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 122.051 -0.676 . . . . 0.0 112.16 -177.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.454 ' H ' ' HB3' ' B' ' 331' ' ' SER . 92.3 m-20 -104.94 9.89 34.44 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.733 -1.229 . . . . 0.0 111.216 -177.243 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.1 pt-20 -42.49 -33.52 0.69 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.211 -0.931 . . . . 0.0 111.56 -178.901 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -70.01 -40.19 75.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.689 -1.257 . . . . 0.0 109.92 -178.612 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -66.84 -48.68 68.11 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.074 -1.051 . . . . 0.0 109.321 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.39 -78.16 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.392 -0.818 . . . . 0.0 110.901 -179.1 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.52 ' O ' HG23 ' B' ' 378' ' ' VAL . 37.6 t -47.28 -37.89 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.057 -1.027 . . . . 0.0 110.336 -177.384 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -69.82 -41.46 74.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.812 -1.18 . . . . 0.0 109.819 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -80.16 -46.74 15.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.137 -0.977 . . . . 0.0 110.315 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.15 -33.52 73.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 110.164 -179.026 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.52 HG23 ' O ' ' B' ' 374' ' ' VAL . 71.3 t -75.61 -34.18 28.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.493 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -72.85 -23.24 60.73 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 108.582 178.381 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' B' ' 383' ' ' GLU . 51.7 tp -79.95 -67.06 0.8 Allowed 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.113 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 50.8 tpp -50.16 -28.24 7.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.496 -0.752 . . . . 0.0 109.068 -178.776 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -76.14 -22.43 55.46 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.403 178.56 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' B' ' 380' ' ' LEU . 78.5 mm-40 -106.94 4.63 27.43 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.324 -0.86 . . . . 0.0 111.872 -178.501 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 89.7 mt -78.2 121.64 24.62 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.16 -1.587 . . . . 0.0 108.98 179.288 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.44 179.688 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.0 mmm . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.588 -0.523 . . . . 2.91 109.588 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.1 mt -105.62 125.75 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.777 -0.823 . . . . 1.2 108.777 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.2 m -129.66 138.05 50.98 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.52 -0.738 . . . . 1.4 109.13 -179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.92 -160.17 19.55 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 109.139 -1.585 . . . . 1.05 109.139 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.7 mt -94.63 -10.87 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.116 -1.226 . . . . 1.15 110.251 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.2 tp 54.18 101.48 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.116 -0.99 . . . . 0.98 108.818 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.54 -28.48 18.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.214 -0.929 . . . . 0.88 109.775 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.6 t -143.14 131.09 11.11 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.289 -0.882 . . . . 1.69 109.646 -179.794 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.32 142.68 15.12 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.302 2.001 . . . . 0.85 113.147 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.881 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 161.93 -161.7 33.55 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.291 -1.524 . . . . 0.92 109.291 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.7 mt -149.5 150.02 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 121.198 -1.178 . . . . 0.81 108.435 179.203 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.49 157.99 37.8 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.746 -1.221 . . . . 0.51 110.436 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 9.8 m-85 -139.02 128.11 23.87 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.393 -0.965 . . . . 0.62 108.393 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.04 -178.8 46.66 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 118.585 -1.769 . . . . 0.55 111.188 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -79.99 157.93 26.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.731 -0.864 . . . . 2.1 109.619 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.496 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.02 135.36 45.67 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.456 -0.777 . . . . 0.77 111.078 -179.127 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.0 tp -102.1 134.83 44.72 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 107.743 -1.206 . . . . 0.91 107.743 178.409 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.4 tp -115.2 121.37 42.74 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.314 -0.866 . . . . 0.93 110.362 -179.107 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.4 mt -89.3 102.11 14.77 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.846 -0.534 . . . . 0.93 110.182 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -101.3 136.04 41.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.347 -0.846 . . . . 2.75 109.463 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -130.28 132.72 46.04 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.442 -0.786 . . . . 3.0 109.232 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -74.64 150.08 39.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.099 -1.0 . . . . 2.77 109.248 179.399 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -63.74 145.67 55.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.146 -0.971 . . . . 2.94 109.193 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.609 HD11 HH11 ' A' ' 139' ' ' ARG . 58.9 mt -84.4 125.84 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.107 -0.996 . . . . 0.95 109.4 -179.532 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.3 t -93.22 122.6 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.232 -0.918 . . . . 1.28 109.766 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.5 mt -103.73 139.42 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.831 -0.803 . . . . 1.21 108.831 179.609 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -96.89 114.95 26.61 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.134 -0.979 . . . . 1.81 109.354 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.509 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.4 mmt-85 -90.08 0.13 57.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.249 -0.907 . . . . 2.8 109.695 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -66.28 147.43 53.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.199 -0.938 . . . . 2.87 109.205 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -87.69 147.21 25.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.039 -1.038 . . . . 2.35 109.556 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.4 HG21 ' HG3' ' A' ' 39' ' ' GLU . 5.1 pt -93.89 165.28 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 0.97 109.788 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.6 p -96.22 171.25 8.71 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.048 -1.032 . . . . 1.17 108.922 179.163 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.5 -16.58 64.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.113 -0.992 . . . . 1.18 110.603 -179.595 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.67 -26.1 26.17 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.676 -1.231 . . . . 2.56 107.676 178.296 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -82.45 -9.7 59.33 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.875 -0.787 . . . . 1.79 108.875 179.237 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.6 t -63.73 -53.8 40.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 120.862 -1.149 . . . . 1.0 108.961 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.44 -40.15 93.42 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.246 -0.909 . . . . 1.77 110.102 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -70.03 -43.01 72.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.038 -1.039 . . . . 2.7 110.347 -179.263 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.4 ' HG3' HG21 ' A' ' 31' ' ' ILE . 65.4 mm-40 -63.55 -39.86 95.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.078 -1.014 . . . . 1.51 110.288 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.36 -46.01 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.833 -1.167 . . . . 0.93 108.816 179.304 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -60.0 -39.8 87.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.143 -0.973 . . . . 1.81 108.69 -179.723 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -60.0 -41.62 92.49 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.724 -1.213 . . . . 2.78 107.724 178.915 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -63.45 -49.35 74.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.362 -0.836 . . . . 0.78 109.032 178.327 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.94 -48.67 80.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.382 -0.823 . . . . 1.07 109.038 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.5 t -63.64 -44.21 94.54 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.01 -1.056 . . . . 1.12 108.741 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.94 -48.58 85.36 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.851 -1.699 . . . . 0.84 108.851 179.315 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -65.34 -32.52 74.21 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.327 -1.102 . . . . 3.09 108.451 179.158 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.36 -39.92 84.82 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.803 -0.814 . . . . 0.88 108.803 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 51' ' ' SER . 33.6 ttpt -65.36 -74.38 0.11 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.962 -1.125 . . . . 2.59 107.962 179.189 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.45 -30.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.51 -0.744 . . . . 0.7 111.26 -178.423 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 49' ' ' LYS . 44.0 t -59.98 -54.39 46.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.706 -1.246 . . . . 1.4 108.397 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.62 -40.09 84.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.835 . . . . 0.67 111.054 -179.139 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -61.9 -46.56 88.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.68 -1.263 . . . . 1.66 110.128 -179.316 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.11 -40.03 88.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.14 -0.975 . . . . 1.58 109.018 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -60.31 -40.04 89.13 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.38 -0.825 . . . . 1.35 109.174 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.4 m -64.45 -44.24 91.74 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.243 -0.91 . . . . 0.77 108.64 178.783 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.5 mt -61.31 -39.88 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.848 -0.797 . . . . 0.63 108.848 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -59.69 -50.34 74.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.955 . . . . 1.14 109.17 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.9 m -59.95 -36.53 77.27 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.396 -0.815 . . . . 0.79 110.025 -178.136 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -66.17 -38.48 88.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.976 -1.077 . . . . 1.53 109.161 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.71 -45.02 88.34 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.585 -0.697 . . . . 0.57 109.948 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.9 -51.57 58.17 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 120.025 -1.083 . . . . 0.75 110.435 -179.15 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.95 -45.67 66.92 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.096 -1.238 . . . . 1.59 109.809 -179.397 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.6 m -67.17 -61.26 2.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.73 111.709 -178.36 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.01 -52.7 3.76 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.135 -0.978 . . . . 0.75 111.473 -177.872 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.11 -165.18 26.7 Favored Glycine 0 N--CA 1.501 3.033 0 C-N-CA 119.615 -1.278 . . . . 1.22 111.152 179.638 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -70.05 -25.16 63.41 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.804 -0.821 . . . . 5.81 110.696 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -60.75 -37.35 81.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.998 . . . . 3.37 110.224 -179.596 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.566 ' HA ' HD12 ' A' ' 72' ' ' ILE . 42.6 mmtm -99.59 -18.03 17.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.45 -0.781 . . . . 1.77 110.296 -179.444 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -70.01 -45.37 67.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.973 -1.079 . . . . 1.65 110.457 -179.298 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.5 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -66.14 -27.29 67.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.394 -0.816 . . . . 0.77 109.931 -178.571 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' A' ' 69' ' ' LYS . 81.7 mt -60.07 -41.49 86.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.038 -1.039 . . . . 0.8 109.14 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -69.1 -37.16 78.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.035 -1.041 . . . . 0.88 109.959 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -60.0 -40.28 88.66 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.799 -1.188 . . . . 1.37 108.867 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.84 -49.52 75.1 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.36 -1.896 . . . . 0.62 108.36 178.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -60.12 -46.63 88.99 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.374 -1.074 . . . . 1.5 108.462 179.418 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.96 -50.02 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -0.797 . . . . 0.63 109.193 179.148 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.8 ttp -60.53 -39.97 89.77 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.156 -0.965 . . . . 1.51 109.811 -179.294 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.091 HD22 HD23 ' B' ' 347' ' ' LEU . 53.3 tp -66.9 -39.93 87.57 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.632 -0.668 . . . . 0.77 110.118 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.92 -39.78 94.95 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.637 -0.825 . . . . 0.62 109.68 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -82.54 7.64 13.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.087 -1.008 . . . . 1.47 109.598 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 63.5 t0 -49.87 134.72 20.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.179 -0.951 . . . . 1.47 110.279 -178.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.479 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 95.2 mt-10 -58.84 -26.7 64.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.784 -0.572 . . . . 1.78 111.637 -178.266 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.09 -31.0 62.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.899 -1.125 . . . . 2.53 110.096 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 79' ' ' LEU . 86.4 mt -70.01 -42.53 72.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.337 -0.852 . . . . 0.8 110.095 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.08 -48.17 82.85 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.502 -0.749 . . . . 1.42 110.621 -178.365 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -69.93 -42.92 72.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.958 . . . . 1.71 111.285 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.39 -40.01 74.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.11 -0.994 . . . . 1.57 111.624 -178.66 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.37 -45.89 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.897 -1.127 . . . . 0.65 109.786 -179.164 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.6 mt -69.93 -38.29 75.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.433 -0.792 . . . . 0.82 110.294 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.43 -40.87 98.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.083 -1.011 . . . . 0.79 111.049 -179.076 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.3 mt -61.24 -45.56 94.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.828 -1.17 . . . . 0.95 109.348 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.9 mt -61.92 -48.18 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 122.048 0.928 . . . . 0.66 109.206 179.262 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -70.02 -40.03 75.47 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.608 -0.682 . . . . 2.2 110.298 -179.23 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.73 -53.67 5.73 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.164 -0.96 . . . . 1.65 111.91 -178.568 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -89.97 -0.83 57.79 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.011 -1.056 . . . . 2.03 112.035 -177.274 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 70.7 m80 57.24 36.56 27.53 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.035 -1.041 . . . . 1.42 110.179 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 99.6 mtp -92.07 166.99 12.39 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.519 -0.738 . . . . 1.18 109.375 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 35.0 p -80.75 162.81 23.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.98 109.747 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.45 -39.87 81.3 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.357 -0.84 . . . . 0.64 109.744 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -64.36 -39.05 93.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 2.07 109.55 179.319 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.91 -41.21 23.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.407 -0.808 . . . . 0.73 110.322 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.46 -48.0 65.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 0.54 110.19 -179.192 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.94 -45.75 91.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.997 -1.064 . . . . 0.56 109.447 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.488 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 84.9 t60 -60.01 -40.0 87.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.406 -0.809 . . . . 1.54 109.731 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.0 -41.97 93.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.264 -0.897 . . . . 1.33 110.048 -179.443 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.7 t -68.88 -51.31 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.068 -1.02 . . . . 0.72 110.422 -178.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.39 -40.92 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.035 -1.041 . . . . 0.85 108.512 179.609 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.488 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 86.3 tt0 -65.29 -40.0 93.28 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.443 -0.947 . . . . 2.44 108.443 178.731 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.13 -50.16 70.66 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.159 -1.176 . . . . 0.98 110.159 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -65.34 -51.15 62.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.931 -1.335 . . . . 1.41 109.421 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.49 -40.86 75.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.166 -0.959 . . . . 1.2 109.206 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.7 m -59.97 -40.04 87.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.089 -1.007 . . . . 1.7 108.443 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.97 -39.95 90.85 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.641 -0.874 . . . . 1.47 108.641 178.9 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.472 HD22 ' HB3' ' B' ' 351' ' ' GLN . 87.1 mt -65.71 -42.65 90.88 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.091 -1.005 . . . . 1.56 109.474 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -59.88 -39.05 84.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.916 -1.115 . . . . 2.2 109.848 -178.931 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -49.98 -19.99 0.83 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.005 -1.059 . . . . 2.12 109.555 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 29.2 mt -62.72 140.02 58.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.012 -1.055 . . . . 2.0 109.043 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -93.16 40.41 1.06 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.176 -0.953 . . . . 3.23 110.289 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -126.13 134.2 51.39 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.266 -0.896 . . . . 2.49 109.518 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.53 -30.42 68.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.451 -0.78 . . . . 3.95 109.919 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.497 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.0 t80 -69.99 -39.02 76.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.347 -0.845 . . . . 2.0 110.32 179.327 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.442 HD22 ' O ' ' B' ' 351' ' ' GLN . 84.5 mt -80.76 -31.94 35.7 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.06 -1.025 . . . . 1.86 109.248 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -60.94 -40.76 94.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 2.84 109.003 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 64.7 mm-40 -64.22 -40.0 95.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 2.73 109.015 178.954 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.48 ' NH1' ' CD ' ' B' ' 351' ' ' GLN . 0.1 OUTLIER -59.97 -39.99 87.56 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.295 -1.002 . . . . 2.77 108.295 179.436 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.3 -26.13 66.28 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.595 -0.891 . . . . 1.19 108.595 178.962 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -67.68 -39.94 84.45 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.947 -0.76 . . . . 1.2 108.947 179.435 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.86 -39.99 79.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 1.55 109.681 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.7 -44.38 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.8 108.563 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -60.49 -37.38 80.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 3.09 108.918 178.825 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -59.82 -39.66 85.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.493 -0.755 . . . . 1.46 109.664 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.96 -40.4 82.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.04 -1.037 . . . . 0.71 108.873 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.08 -35.99 64.31 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.048 -1.221 . . . . 0.57 110.048 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -60.05 -49.9 75.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.115 -1.226 . . . . 2.59 109.931 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.402 ' HG2' HH21 ' A' ' 139' ' ' ARG . 87.6 mtm180 -67.66 -33.34 74.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.021 -1.049 . . . . 2.83 109.501 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.04 -43.25 95.49 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.249 -0.907 . . . . 1.25 109.074 -179.567 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.04 -42.52 94.58 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.192 -0.943 . . . . 0.7 109.985 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.609 HH11 HD11 ' A' ' 24' ' ' ILE . 63.1 mtm-85 -71.39 -39.29 71.26 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.394 -0.816 . . . . 2.57 109.352 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -65.57 -34.37 78.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.726 . . . . 1.23 111.259 -179.197 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.3 mt -70.01 -45.35 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.416 -1.427 . . . . 0.81 108.037 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.7 mt -69.89 -30.79 68.31 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 120.137 -0.625 . . . . 1.0 109.454 179.135 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.89 41.73 8.02 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.034 -1.626 . . . . 0.89 109.034 -179.172 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 tp -74.88 157.23 35.41 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.468 -1.019 . . . . 1.14 109.411 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.21 146.62 53.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.886 . . . . 4.6 110.062 -179.449 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.7 mt -119.9 127.78 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 108.826 -0.805 . . . . 1.24 108.826 179.351 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 27.6 mm -55.4 -49.68 71.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.36 -0.837 . . . . 1.54 110.212 -178.251 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.4 t0 66.24 103.92 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.528 -0.732 . . . . 1.5 109.338 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.8 mt -79.61 -5.77 55.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.42 -0.8 . . . . 0.79 110.179 -178.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.3 t -81.67 -20.52 39.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.942 -1.099 . . . . 1.4 109.634 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.04 21.53 0.7 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.297 -0.877 . . . . 0.92 111.66 -178.285 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 39.5 mm -89.12 129.49 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.565 -1.334 . . . . 0.88 108.965 179.517 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -110.53 -11.31 14.48 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.586 -0.696 . . . . 2.45 110.059 -179.234 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -118.3 148.11 42.79 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.177 -0.952 . . . . 1.52 110.457 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.24 133.95 52.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 1.58 109.214 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.9 m -153.33 166.33 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.42 -0.8 . . . . 0.69 109.439 179.081 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.3 mt -94.06 147.42 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.545 -1.65 . . . . 0.61 106.545 177.608 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 49.7 tp -94.27 113.58 25.51 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.011 -1.055 . . . . 0.87 110.101 -177.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.42 HG12 HG22 ' A' ' 209' ' ' THR . 46.7 t -118.68 125.22 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 108.663 -0.866 . . . . 0.71 108.663 179.478 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.442 ' CB ' HD21 ' A' ' 163' ' ' LEU . . . -155.68 160.65 40.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.991 -1.068 . . . . 0.81 109.465 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.45 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -78.82 -29.08 44.57 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.487 -1.383 . . . . 0.98 109.02 179.199 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 161' ' ' ALA . 14.5 m-20 -167.36 133.41 2.14 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.31 -0.869 . . . . 2.25 109.169 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.442 HD21 ' CB ' ' A' ' 160' ' ' ALA . 57.7 mt -118.15 130.04 55.87 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 108.781 -0.822 . . . . 0.78 108.781 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 20.8 p -93.84 149.99 37.9 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.079 -1.013 . . . . 0.98 109.737 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -39.38 -36.58 0.98 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.64 2.227 . . . . 0.81 113.636 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.6 m -59.98 -40.05 87.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.894 -1.129 . . . . 0.9 110.028 -178.194 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.61 -39.82 80.69 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.256 -0.902 . . . . 1.61 110.249 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.7 p -57.39 -38.08 73.71 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.059 -1.025 . . . . 0.61 112.036 -177.852 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.97 -47.8 70.46 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.521 -1.362 . . . . 0.6 110.027 -179.239 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -85.68 33.83 0.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.327 -0.99 . . . . 1.4 108.327 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.3 tp -102.78 137.5 40.9 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.788 -0.819 . . . . 0.7 108.788 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -86.96 104.72 16.55 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.476 -0.935 . . . . 2.35 108.476 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.55 -40.11 92.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.895 . . . . 1.51 111.598 -178.186 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -69.87 -25.5 63.75 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.746 -1.221 . . . . 2.33 111.744 -177.553 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -93.73 -10.04 35.66 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.706 -1.246 . . . . 1.92 110.242 -178.719 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 178' ' ' GLY . 95.0 t -100.94 113.22 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.029 -1.044 . . . . 0.67 108.339 178.633 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.4 mt -80.76 2.1 27.6 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.238 -0.913 . . . . 1.53 110.853 -177.781 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.507 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 166.25 177.99 38.67 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.3 -1.52 . . . . 0.48 109.3 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.586 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 7.4 m-85 -132.31 128.23 37.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.484 -1.009 . . . . 0.55 109.489 -179.387 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 93.8 mt -130.74 124.21 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.507 -0.746 . . . . 0.65 109.03 179.096 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 52.8 p -150.88 161.92 41.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.813 -1.18 . . . . 0.82 110.721 -179.794 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 37.1 p-10 -103.56 25.17 10.02 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.564 -0.71 . . . . 2.46 109.456 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.43 -158.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.863 -1.148 . . . . 1.28 111.703 -178.259 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.14 -54.4 5.24 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.84 -0.695 . . . . 2.19 111.44 -178.412 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 165.23 -139.17 5.65 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 118.968 -1.587 . . . . 2.13 111.07 -179.608 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 186' ' ' ARG . 0.4 OUTLIER -69.93 -22.88 63.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.608 -0.937 . . . . 5.86 111.175 -178.761 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 66.7 p -70.27 1.25 5.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.848 -1.157 . . . . 3.72 109.546 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.0 t -90.89 133.83 34.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.267 -0.896 . . . . 1.74 110.482 -179.634 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -47.48 -53.22 14.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.497 -0.752 . . . . 0.95 110.21 -179.771 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.7 m -60.11 -40.44 89.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.341 -0.849 . . . . 1.55 111.473 -178.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 17.3 t -60.0 -40.73 90.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.829 -1.169 . . . . 1.51 110.12 -179.026 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 85.7 mt -61.39 -37.93 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.874 . . . . 1.67 109.728 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.3 mtp -60.07 -39.96 87.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.842 . . . . 1.02 109.692 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.07 88.69 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.713 -1.242 . . . . 0.68 108.633 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -60.06 -51.06 71.24 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.714 -0.794 . . . . 2.93 110.319 -179.234 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.9 m -74.88 -34.25 62.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.083 -1.011 . . . . 0.86 112.022 -178.374 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.1 mt -73.55 -11.5 60.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.632 -1.293 . . . . 0.67 109.829 -178.477 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 60.1 50.08 6.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.573 -0.704 . . . . 1.5 110.975 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.2 mt -128.77 149.92 73.48 Favored Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 107.602 -1.258 . . . . 0.72 107.602 178.504 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.81 140.75 47.22 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 122.16 1.907 . . . . 0.61 112.158 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.04 151.52 3.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.965 -1.084 . . . . 0.66 111.418 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.7 mt -123.45 138.15 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.521 -1.288 . . . . 0.79 107.521 178.731 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 17.3 m -121.83 -11.86 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 O-C-N 120.738 -1.226 . . . . 0.91 111.478 -178.195 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -105.97 23.88 28.08 Favored Glycine 0 N--CA 1.5 2.934 0 N-CA-C 110.309 -1.117 . . . . 1.01 110.309 -179.456 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.7 p -44.29 -41.15 5.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.202 -1.175 . . . . 0.99 109.928 -179.439 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.41 -50.48 4.23 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 120.211 -0.995 . . . . 1.12 110.982 179.17 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 30.5 t -159.12 38.05 0.21 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.611 -1.523 . . . . 1.72 111.402 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.82 -35.54 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.934 -1.104 . . . . 0.89 108.673 178.133 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.42 HG22 HG12 ' A' ' 159' ' ' VAL . 76.7 p -54.73 -30.1 55.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.844 . . . . 1.03 110.148 -179.479 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.0 p -81.92 -12.62 58.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.112 -0.992 . . . . 1.83 110.228 -179.459 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 30.2 mm100 -101.71 -10.24 20.15 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.339 -0.851 . . . . 2.27 109.674 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 92.5 t -107.37 134.82 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.303 -0.873 . . . . 0.92 111.47 -178.013 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -113.44 155.22 25.68 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.746 -1.576 . . . . 2.2 106.746 177.223 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 57.4 t30 -59.98 138.3 57.88 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.935 -1.103 . . . . 2.36 110.572 -178.829 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 16.3 t0 85.9 0.06 0.69 Allowed 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 116.342 -0.39 . . . . 2.38 110.836 179.054 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -71.8 148.28 46.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.77 -1.206 . . . . 2.09 108.94 179.01 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -95.3 119.01 33.06 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.083 -1.08 . . . . 1.27 108.083 179.125 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 16' ' ' ALA . 83.0 mt -125.59 145.14 50.26 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.411 -0.806 . . . . 0.75 110.456 -179.05 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.1 mt -113.88 128.4 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.463 -1.31 . . . . 0.63 107.463 177.502 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 20.6 tp -100.36 117.56 34.79 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.004 -1.06 . . . . 0.7 108.786 -179.415 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 10' ' ' GLY . 32.3 t0 -77.13 -44.3 30.88 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.151 -1.055 . . . . 2.31 108.151 179.638 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.881 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 54.03 13.71 0.61 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.256 -0.646 . . . . 0.78 109.256 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 87.8 t -130.5 -42.94 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.146 -1.427 . . . . 1.04 107.146 177.95 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.45 ' ND2' ' OE1' ' A' ' 226' ' ' GLN . 47.9 t-20 -96.69 0.04 49.06 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.226 -1.398 . . . . 2.44 107.226 178.154 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 60.07 44.64 12.88 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.849 -0.532 . . . . 1.55 109.585 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.45 ' OE1' ' ND2' ' A' ' 224' ' ' ASN . 97.8 mt-30 -139.96 151.77 45.8 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.192 -0.943 . . . . 1.99 110.454 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.1 t -118.78 129.96 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.507 -0.923 . . . . 0.77 108.507 178.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -102.95 127.34 50.21 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.758 -0.831 . . . . 0.98 108.758 179.293 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.0 t -100.19 109.95 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.362 -0.836 . . . . 0.85 110.947 -178.495 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 41.2 t30 50.11 64.43 8.41 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.145 -0.972 . . . . 1.66 110.895 179.443 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -85.84 156.16 10.17 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.795 2.33 . . . . 0.95 111.986 179.166 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 82.4 p -70.44 160.42 32.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 1.84 110.078 -179.504 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -59.9 -34.69 73.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.435 -0.791 . . . . 2.74 108.873 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -59.93 -40.09 87.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.476 -0.765 . . . . 2.89 109.344 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.72 -40.02 83.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.194 -0.941 . . . . 1.3 109.276 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.495 1.799 0 O-C-N 121.24 -0.913 . . . . 1.09 110.31 -179.669 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 41.5 ttm . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.596 0.713 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -150.27 147.09 27.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.338 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -150.83 161.77 42.04 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.921 -1.112 . . . . 0.0 110.546 -179.203 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 304' ' ' GLN . . . . . 0.477 ' NE2' HG11 ' B' ' 378' ' ' VAL . 56.8 tt0 -153.37 150.01 28.41 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.309 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 305' ' ' GLU . . . . . 0.567 ' CD ' ' H ' ' B' ' 305' ' ' GLU . 0.6 OUTLIER -115.81 135.47 53.98 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.244 -0.91 . . . . 0.0 109.971 179.278 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -138.64 129.84 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 CA-C-O 122.523 1.154 . . . . 0.0 113.052 -177.184 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 90.9 m -76.69 106.36 8.3 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.467 -178.602 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.463 HG22 ' H ' ' B' ' 310' ' ' ALA . 92.3 mt -52.45 126.07 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 122.412 1.101 . . . . 0.0 110.82 -177.749 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 22.3 p -109.99 20.07 18.34 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.372 -178.899 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.463 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -79.4 117.02 64.82 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.851 -1.156 . . . . 0.0 109.109 179.673 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.28 -11.68 6.53 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 CA-C-N 120.233 1.119 . . . . 0.0 113.212 -179.095 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -119.45 6.66 11.11 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 179.708 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.47 -179.4 40.24 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 107.961 -2.055 . . . . 0.0 107.961 -178.731 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.497 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -85.42 92.24 8.43 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.868 -1.372 . . . . 0.0 108.454 -179.525 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.461 ' C ' ' NH2' ' A' ' 126' ' ' ARG . 5.2 p80 -94.29 -160.91 0.81 Allowed 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.179 -0.951 . . . . 0.0 110.642 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.9 m -57.35 -43.92 83.88 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.204 -0.935 . . . . 0.0 112.651 -175.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.5 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -60.75 -61.74 7.37 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 120.443 -1.411 . . . . 0.0 112.139 -178.508 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -57.33 -31.55 91.31 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 CA-C-N 120.219 1.114 . . . . 0.0 111.781 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.07 -51.51 69.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 109.069 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.7 -41.12 63.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.17 -178.665 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -72.71 -40.1 66.44 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.882 179.065 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -60.81 -52.46 64.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -0.813 . . . . 0.0 110.869 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.28 -38.07 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.685 -1.259 . . . . 0.0 109.334 -178.923 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 324' ' ' LYS . . . . . 0.419 ' CB ' ' NZ ' ' B' ' 324' ' ' LYS . 4.1 ttpm? -59.98 -46.17 90.31 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.751 -179.133 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -63.33 -40.06 96.26 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.925 -1.11 . . . . 0.0 108.789 179.127 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -61.08 -51.31 69.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.422 -0.798 . . . . 0.0 110.312 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -56.92 -11.95 1.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.373 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -73.25 -27.48 68.06 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.239 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -105.4 143.19 33.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 27.4 p -91.16 -12.59 34.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.902 -1.124 . . . . 0.0 110.16 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.426 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 67.8 p -60.13 147.64 38.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.075 -1.015 . . . . 0.0 109.418 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -67.11 136.38 55.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.108 -0.995 . . . . 0.0 108.581 179.629 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 90.0 mt -131.41 130.15 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.653 -0.654 . . . . 0.0 109.803 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 54.1 m -124.23 148.76 47.09 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.109 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 92.3 t -115.87 136.91 51.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.2 m -128.85 122.62 30.8 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.148 -0.97 . . . . 0.0 109.038 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 91.8 p -138.18 116.71 12.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.306 -0.871 . . . . 0.0 110.386 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 33.2 m120 45.7 62.69 2.09 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.462 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 75.16 -11.96 7.59 Favored Glycine 0 N--CA 1.498 2.77 0 O-C-N 120.399 -1.438 . . . . 0.0 112.924 176.467 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -115.81 127.53 55.14 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 118.951 1.375 . . . . 0.0 109.818 -179.604 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 21.2 m -126.12 148.61 49.35 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.872 0.844 . . . . 0.0 110.399 -179.016 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -142.43 164.15 30.9 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.405 0.622 . . . . 0.0 109.929 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 58.6 m -86.96 136.59 32.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.606 -0.684 . . . . 0.0 109.934 -179.388 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -73.77 -13.49 60.96 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.04 -1.037 . . . . 0.0 109.693 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -90.82 21.68 3.99 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.399 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 68.0 m -144.84 93.36 2.39 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.944 -179.071 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 1.091 HD23 HD22 ' A' ' 79' ' ' LEU . 37.9 tp -59.12 -34.75 72.4 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.417 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.797 ' CE2' HD11 ' A' ' 79' ' ' LEU . 66.1 m-85 -57.87 -56.38 22.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.508 -0.745 . . . . 0.0 109.79 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -70.04 -20.05 63.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.869 . . . . 0.0 111.008 -178.556 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.63 ' O ' ' N ' ' B' ' 352' ' ' THR . 50.2 mt -72.03 -58.32 3.54 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.669 -1.269 . . . . 0.0 108.233 178.073 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.48 ' CD ' ' NH1' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -40.28 -10.25 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.769 -178.279 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.63 ' N ' ' O ' ' B' ' 350' ' ' LEU . 81.0 p -91.93 -11.43 36.25 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.574 -1.329 . . . . 0.0 110.446 -179.224 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 66.0 mt -92.47 120.07 32.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.996 -1.065 . . . . 0.0 108.972 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.88 92.95 0.83 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 31.1 mt -103.25 93.81 5.18 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.396 -1.061 . . . . 0.0 109.343 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 57.8 p -95.72 179.98 4.93 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.046 -1.034 . . . . 0.0 110.548 -179.518 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -68.45 111.82 4.91 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.506 -0.747 . . . . 0.0 109.945 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 105.75 9.69 32.27 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 97.6 m -87.83 106.21 17.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -1.172 . . . . 0.0 110.302 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 3.9 t -77.01 117.84 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 122.296 1.046 . . . . 0.0 109.004 -177.563 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 19.6 m -113.68 177.73 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.832 -177.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 93.9 m -132.0 130.04 40.89 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 176.85 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 96.5 mt -105.35 120.51 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.36 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 58.2 m -120.07 131.72 55.18 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.689 -0.632 . . . . 0.0 109.543 -178.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.71 153.76 41.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 109.715 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -146.33 123.02 11.18 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 160.91 -155.39 26.55 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 118.681 -1.723 . . . . 0.0 111.86 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -58.94 -50.46 73.97 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.154 -0.523 . . . . 0.0 112.394 -177.032 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.426 ' H ' ' HB3' ' B' ' 331' ' ' SER . 97.8 m-20 -110.29 15.28 22.41 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.926 -1.109 . . . . 0.0 111.275 -177.605 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' B' ' 369' ' ' ASP . 16.2 pt-20 -39.54 -38.28 0.58 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.421 -0.8 . . . . 0.0 111.453 -179.034 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -66.73 -48.15 70.07 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.723 -1.236 . . . . 0.0 110.622 -178.233 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -70.02 -52.52 23.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.977 -1.077 . . . . 0.0 109.899 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.01 -38.71 3.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.429 -0.794 . . . . 0.0 111.229 -178.661 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.457 ' O ' HG23 ' B' ' 378' ' ' VAL . 77.2 t -70.05 -39.98 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.515 -1.366 . . . . 0.0 109.251 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.91 -66.83 0.5 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.971 . . . . 0.0 111.637 -178.025 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 376' ' ' HIS . . . . . 0.442 ' O ' ' N ' ' B' ' 380' ' ' LEU . 32.2 m170 -59.92 -45.2 93.33 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.652 -1.28 . . . . 0.0 112.103 -177.171 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 98.0 mt -59.98 -42.0 93.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.328 -1.483 . . . . 0.0 108.841 -179.13 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.477 HG11 ' NE2' ' B' ' 304' ' ' GLN . 53.4 t -68.7 -40.14 81.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -80.67 -10.94 59.7 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.969 -1.082 . . . . 0.0 109.831 178.855 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' B' ' 376' ' ' HIS . 61.3 tp -82.39 -25.98 33.25 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.473 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 3.4 ttp -82.75 -25.68 32.61 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.467 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -84.37 -10.07 57.89 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.599 -0.688 . . . . 0.0 110.03 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -108.55 -0.86 20.1 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.309 -0.869 . . . . 0.0 110.344 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 44.4 mt -98.94 119.99 38.64 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.009 -1.057 . . . . 0.0 109.727 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 385' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 53.3 mp0 . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 117.967 -1.016 . . . . 0.0 108.978 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.6 mtp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.881 -0.415 . . . . 2.91 109.881 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.2 mt -94.76 121.28 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.066 -1.022 . . . . 1.2 109.814 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.7 m -138.75 149.07 44.63 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.716 -0.846 . . . . 1.4 108.716 179.578 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.02 -161.4 12.21 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 109.357 -1.497 . . . . 1.05 109.357 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' LEU . 97.8 mt -92.07 -12.89 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -1.189 . . . . 1.15 109.944 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' ILE . 63.0 tp 53.92 101.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.059 -1.025 . . . . 0.98 108.717 -179.515 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.06 -39.94 24.95 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.764 -0.828 . . . . 0.88 108.764 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 m -141.05 135.28 15.16 Favored Pre-proline 0 N--CA 1.5 2.025 0 O-C-N 121.583 -0.698 . . . . 1.69 109.524 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.17 147.4 20.71 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.391 2.061 . . . . 0.85 112.877 179.741 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.862 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.45 -162.2 34.21 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.9 -1.68 . . . . 0.92 108.9 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.5 mt -149.56 150.42 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.01 -1.288 . . . . 0.81 108.565 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.45 159.31 38.55 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.701 -1.249 . . . . 0.51 110.615 179.246 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -140.03 129.08 23.58 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.884 -1.154 . . . . 0.62 107.884 179.068 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.66 -177.95 47.33 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 118.782 -1.675 . . . . 0.55 110.893 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -79.39 159.53 27.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.762 -0.846 . . . . 2.1 109.298 -179.743 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.611 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -107.8 137.39 45.9 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.374 -0.829 . . . . 0.77 111.119 -179.022 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.5 tp -107.32 132.59 52.96 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 107.283 -1.377 . . . . 0.91 107.283 178.501 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.2 tp -111.83 121.17 44.32 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.23 -0.919 . . . . 0.93 109.699 -179.314 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 31.0 mt -85.79 100.19 11.87 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.415 -0.803 . . . . 0.93 109.907 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -88.78 135.98 33.24 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.47 -0.769 . . . . 2.75 109.327 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -132.74 122.87 25.21 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.026 -1.101 . . . . 3.0 108.026 178.392 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -83.06 150.3 26.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.878 -1.139 . . . . 2.77 109.426 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -62.6 140.04 58.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 2.94 109.81 -179.61 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.6 mt -81.67 132.06 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 0.95 108.862 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.53 126.31 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.263 -0.898 . . . . 1.28 110.181 -179.133 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.5 mt -110.01 130.06 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 107.954 -1.128 . . . . 1.21 107.954 179.321 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -88.79 120.33 30.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.836 -1.165 . . . . 1.81 110.102 -179.218 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -89.95 -4.49 57.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 2.8 108.708 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -69.98 137.99 51.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 2.87 109.255 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -82.91 155.45 24.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 2.35 109.815 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.683 HD13 ' HG3' ' A' ' 39' ' ' GLU . 2.9 pt -98.84 168.47 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.445 -0.785 . . . . 0.97 109.339 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.9 p -89.99 173.55 8.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.08 -1.012 . . . . 1.17 108.481 178.47 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.04 -17.04 63.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.009 -1.057 . . . . 1.18 110.994 -179.367 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -84.57 -26.03 28.26 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.659 -1.276 . . . . 2.56 108.42 178.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -82.15 -7.95 59.64 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.131 -0.692 . . . . 1.79 109.131 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.0 t -60.01 -52.82 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.251 -0.905 . . . . 1.0 108.615 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -60.04 -40.05 88.02 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.354 -0.841 . . . . 1.77 109.208 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -64.06 -40.12 95.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 2.7 110.281 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.683 ' HG3' HD13 ' A' ' 31' ' ' ILE . 71.1 mm-40 -63.46 -44.41 94.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.756 -1.215 . . . . 1.51 110.023 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -60.03 -47.16 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.865 -1.147 . . . . 0.93 108.665 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -60.03 -46.69 88.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.302 -0.874 . . . . 1.81 108.984 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -60.21 -42.75 95.8 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.919 -1.113 . . . . 2.78 108.17 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -63.44 -47.73 80.68 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.535 -0.913 . . . . 0.78 108.535 178.31 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.3 tp -60.01 -48.68 80.72 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.516 -0.92 . . . . 1.07 108.516 -179.514 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 46.7 t -63.04 -43.85 97.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 1.12 108.903 179.075 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.99 -46.8 93.51 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.309 -1.917 . . . . 0.84 108.309 179.212 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.419 HH21 ' HG2' ' A' ' 81' ' ' GLU . 43.1 ttt-85 -60.1 -39.94 87.9 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.347 -0.983 . . . . 3.09 108.347 178.303 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -48.1 -46.23 33.69 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.148 -0.686 . . . . 0.88 109.148 -179.699 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 50' ' ' ALA . 6.4 ttpm? -64.06 -74.08 0.11 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.92 -1.141 . . . . 2.59 107.92 179.261 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.62 -35.83 0.21 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.532 -0.73 . . . . 0.7 111.143 -178.588 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.2 t -53.76 -60.62 3.08 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.619 -1.301 . . . . 1.4 108.716 179.557 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.6 -39.99 84.77 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.508 -0.745 . . . . 0.67 111.648 -178.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -66.77 -41.3 87.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.693 -1.254 . . . . 1.66 110.302 -178.939 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.54 -39.98 95.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.863 -1.148 . . . . 1.58 108.873 179.198 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -65.83 -38.64 89.44 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.522 -0.736 . . . . 1.35 109.723 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.63 -40.87 98.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.014 . . . . 0.77 109.535 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.517 ' CD1' HH22 ' A' ' 136' ' ' ARG . 82.8 mt -60.19 -40.0 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.63 109.218 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -58.94 -50.03 75.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.847 . . . . 1.14 109.579 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -58.14 -28.76 64.98 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.316 -0.865 . . . . 0.79 110.618 -178.064 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -70.05 -39.1 75.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.063 -1.023 . . . . 1.53 109.878 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.04 -46.92 76.1 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.596 -0.69 . . . . 0.57 109.9 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.78 -54.06 32.9 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.928 -1.269 . . . . 0.75 109.928 -179.197 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.02 -45.53 60.51 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.045 -1.268 . . . . 1.59 110.588 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.5 m -68.34 -63.05 1.14 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.952 -1.092 . . . . 0.73 112.717 -177.386 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -95.7 -46.97 6.39 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.849 -1.157 . . . . 0.75 111.089 -177.68 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.93 -167.31 25.69 Favored Glycine 0 N--CA 1.5 2.943 0 O-C-N 120.839 -1.163 . . . . 1.22 111.143 179.485 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -75.6 -22.54 56.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.925 -0.75 . . . . 5.81 110.078 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.425 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.5 tp10 -61.12 -36.22 79.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.88 . . . . 3.37 110.211 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.422 ' HA ' HD12 ' A' ' 72' ' ' ILE . 32.3 mmtp -100.72 -20.14 15.73 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.275 -0.89 . . . . 1.77 110.226 -179.486 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -68.51 -39.92 81.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.047 -1.033 . . . . 1.65 110.34 -179.106 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.536 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.5 -26.57 67.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.213 -0.93 . . . . 0.77 109.431 -179.362 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 69' ' ' LYS . 81.8 mt -60.05 -40.82 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.081 -1.012 . . . . 0.8 108.732 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -70.04 -37.97 75.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.188 -0.945 . . . . 0.88 110.638 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -60.0 -40.11 88.08 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.656 -1.277 . . . . 1.37 108.642 179.351 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.07 -43.01 97.9 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.957 -1.657 . . . . 0.62 108.957 179.156 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.2 m170 -66.63 -41.31 88.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.302 -1.117 . . . . 1.5 108.969 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.4 mt -69.95 -45.44 76.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.323 -0.861 . . . . 0.63 108.987 179.354 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.4 ttp -60.69 -40.21 91.32 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.099 -1.001 . . . . 1.51 109.536 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.966 HD22 HD23 ' B' ' 347' ' ' LEU . 50.4 tp -64.95 -40.06 94.45 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.525 -0.735 . . . . 0.77 109.579 179.663 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.1 tp -63.62 -38.0 89.46 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.627 -0.67 . . . . 0.62 109.411 -179.213 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.419 ' HG2' HH21 ' A' ' 47' ' ' ARG . 100.0 mt-10 -82.4 4.39 24.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.159 -0.963 . . . . 1.47 110.913 -178.7 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -49.98 130.06 21.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.761 -1.212 . . . . 1.47 109.42 -179.655 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -57.54 -18.88 21.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.487 -0.758 . . . . 1.78 110.933 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.72 -34.56 69.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.77 -1.207 . . . . 2.53 108.878 178.722 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.2 mt -72.33 -42.52 65.31 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.73 -0.606 . . . . 0.8 110.567 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -60.0 -48.75 80.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.147 -0.971 . . . . 1.42 110.468 -178.819 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -69.95 -40.09 75.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.207 -0.933 . . . . 1.71 110.904 -178.788 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.03 -39.96 75.46 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.042 -1.036 . . . . 1.57 111.413 -179.219 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.2 mt -66.59 -49.94 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.949 -1.094 . . . . 0.65 109.539 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.3 mt -69.79 -39.99 78.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.562 -0.711 . . . . 0.82 110.013 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.04 -48.77 80.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.12 -0.987 . . . . 0.79 110.783 -179.543 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 96' ' ' LYS . 55.8 mt -59.97 -46.36 89.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.046 -1.034 . . . . 0.95 110.146 -179.089 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.9 -49.81 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.66 108.826 179.451 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -69.99 -40.96 75.0 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 120.276 -0.57 . . . . 2.2 111.19 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -85.07 -49.97 7.83 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.861 -1.15 . . . . 1.65 112.012 -178.228 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 92' ' ' LEU . 32.8 mmtp -89.18 -0.45 57.46 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.111 -0.993 . . . . 2.03 111.164 -177.229 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.2 m80 55.81 32.6 19.87 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.937 -1.102 . . . . 1.42 109.595 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.0 mtt -89.65 168.82 11.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.358 -0.839 . . . . 1.18 109.428 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.7 p -83.45 158.16 22.17 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.19 -0.944 . . . . 0.98 109.051 179.736 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.61 -39.95 92.07 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.267 -0.896 . . . . 0.64 109.262 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.481 ' OD1' HD22 ' A' ' 138' ' ' LEU . 40.4 t0 -65.55 -40.02 92.4 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.419 -0.801 . . . . 2.07 109.764 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.45 -41.52 24.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 0.73 110.147 -179.51 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.88 -45.45 64.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -0.946 . . . . 0.54 110.63 -179.316 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.05 -43.31 95.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.039 -1.038 . . . . 0.56 110.122 -179.45 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -60.01 -39.95 87.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 1.54 110.193 -178.686 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -61.46 -41.81 97.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.995 -1.066 . . . . 1.33 110.517 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.4 t -60.05 -50.85 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.14 -0.975 . . . . 0.72 110.598 -178.653 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.8 mm -69.94 -39.99 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.116 -0.99 . . . . 0.85 109.252 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -62.11 -39.38 92.31 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.584 -0.895 . . . . 2.44 108.584 179.099 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.0 -52.19 54.38 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.812 -0.915 . . . . 0.98 110.812 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' GLN . . . . . 0.493 ' NE2' ' CB ' ' B' ' 348' ' ' PHE . 15.5 mm100 -64.04 -49.76 71.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.7 -1.47 . . . . 1.41 109.697 -179.436 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.91 83.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.189 -0.944 . . . . 1.2 109.027 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.8 t -59.98 -42.24 93.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.921 . . . . 1.7 108.873 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.29 -40.0 94.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.858 . . . . 1.47 109.882 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.417 HD22 ' HB3' ' B' ' 351' ' ' GLN . 59.4 mt -65.42 -40.26 93.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.787 -1.196 . . . . 1.56 109.674 -178.941 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.06 -31.06 69.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.9 -1.125 . . . . 2.2 109.75 -179.656 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -55.81 -23.57 31.04 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.084 -1.01 . . . . 2.12 108.396 179.778 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.1 mt -63.23 148.91 46.82 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.576 -0.898 . . . . 2.0 108.576 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -99.81 47.07 0.95 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.025 -1.047 . . . . 3.23 110.204 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 34.6 t0 -137.44 150.17 47.43 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.174 -0.954 . . . . 2.49 109.772 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 124' ' ' LYS . 98.4 mt-10 -74.44 -67.97 0.57 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.299 -0.876 . . . . 3.95 109.259 178.825 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.634 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 4.8 t80 -39.25 -39.5 0.63 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.863 -0.523 . . . . 2.0 111.153 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.611 HD23 HH22 ' A' ' 126' ' ' ARG . 88.9 mt -69.97 -36.59 75.33 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.745 -1.222 . . . . 1.86 108.508 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 121' ' ' GLU . 74.6 tttt -69.23 -35.98 76.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.446 -0.784 . . . . 2.84 110.309 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.536 ' N ' ' OE1' ' A' ' 125' ' ' GLU . 0.4 OUTLIER -60.05 -46.31 89.97 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.966 -1.084 . . . . 2.73 110.603 -178.485 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.634 ' NH1' ' CE1' ' A' ' 122' ' ' TYR . 27.8 mtm-85 -63.14 -39.67 95.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.504 -1.372 . . . . 2.77 108.593 179.413 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.0 -36.6 77.55 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.459 -0.941 . . . . 1.19 108.459 179.057 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.22 88.58 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.216 -1.031 . . . . 1.2 108.216 179.098 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.88 -40.02 87.67 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.927 -0.768 . . . . 1.55 108.927 179.15 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 51.2 t -59.95 -42.9 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.8 109.052 179.384 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -60.04 -39.92 87.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 3.09 109.485 179.16 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -59.91 -40.05 87.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.427 -0.796 . . . . 1.46 110.196 -179.617 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.99 -42.17 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.127 -0.983 . . . . 0.71 110.447 -178.877 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.45 -34.46 54.23 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.805 -1.188 . . . . 0.57 110.236 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -60.05 -46.22 90.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -1.183 . . . . 2.59 109.684 -179.13 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.517 HH22 ' CD1' ' A' ' 57' ' ' ILE . 62.4 mtp180 -65.24 -34.5 78.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.125 -0.984 . . . . 2.83 110.108 -179.316 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.036 -1.04 . . . . 1.25 109.015 -179.597 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.481 HD22 ' OD1' ' A' ' 101' ' ' ASP . 90.4 mt -60.53 -40.06 90.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 0.7 108.537 178.923 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -65.62 -39.93 92.02 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.825 -0.805 . . . . 2.57 108.825 179.187 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -69.47 -34.23 74.06 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.717 -0.614 . . . . 1.23 111.328 -179.245 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.26 -39.85 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.454 -1.404 . . . . 0.81 109.243 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.9 mt -73.84 -19.17 60.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.597 -0.689 . . . . 1.0 109.943 -179.263 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.64 39.33 14.54 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.721 -1.752 . . . . 0.89 108.721 -179.289 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.8 tp -73.89 147.05 43.57 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.489 -1.006 . . . . 1.14 110.004 -179.001 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.74 141.05 49.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.351 -0.843 . . . . 4.6 109.713 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 90.2 mt -113.35 130.01 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.825 0.821 . . . . 1.24 108.838 179.108 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.4 mt -68.29 -39.94 81.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.857 -0.527 . . . . 1.54 110.874 -177.864 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.8 t0 63.92 102.83 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.396 -0.815 . . . . 1.5 109.267 -179.3 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.2 mt -72.95 -1.73 18.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.412 -0.805 . . . . 0.79 110.669 -179.069 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.2 p -85.24 -16.07 41.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.791 -1.193 . . . . 1.4 109.766 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.62 28.02 0.27 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.172 -0.955 . . . . 0.92 111.859 -177.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 40.9 mm -85.99 125.94 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.491 -1.381 . . . . 0.88 109.191 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -106.91 -13.95 15.09 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.496 -0.752 . . . . 2.45 109.665 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -126.68 150.97 48.7 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.341 -0.85 . . . . 1.52 110.034 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.69 136.62 57.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 1.58 109.0 179.496 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.2 m -152.82 165.96 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.324 -0.86 . . . . 0.69 109.835 179.634 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.4 mt -95.55 145.95 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 105.661 -1.978 . . . . 0.61 105.661 176.783 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 37.7 tp -100.23 119.67 38.73 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.907 -1.121 . . . . 0.87 110.54 -178.092 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.0 125.72 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.605 -0.684 . . . . 0.71 109.225 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -152.78 158.67 42.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.985 -1.072 . . . . 0.81 109.494 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.01 -32.12 70.13 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.395 -1.44 . . . . 0.98 108.294 179.076 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 56.2 t0 -169.86 142.15 2.37 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.451 -0.944 . . . . 2.25 108.451 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.528 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 81.4 mt -110.74 129.03 55.94 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.325 -0.859 . . . . 0.78 108.968 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 43.5 p -90.17 149.89 42.24 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.299 -0.876 . . . . 0.98 109.22 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -37.85 -38.92 0.75 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 122.241 1.961 . . . . 0.81 112.439 179.667 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.1 m -59.51 -39.98 85.6 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.251 -0.906 . . . . 0.9 109.9 -178.219 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.14 -40.05 86.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.086 -1.009 . . . . 1.61 110.356 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.7 p -57.21 -32.6 66.67 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.981 -1.074 . . . . 0.61 111.124 -178.229 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.3 -46.96 53.47 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.984 -1.073 . . . . 0.6 109.97 -179.794 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -89.95 40.06 0.99 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.788 -1.19 . . . . 1.4 107.788 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.8 tp -106.96 126.44 52.32 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 109.082 -0.711 . . . . 0.7 109.082 179.208 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -84.68 105.71 15.68 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.075 -1.083 . . . . 2.35 108.075 178.884 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.12 -44.53 84.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.37 -0.831 . . . . 1.51 111.39 -178.131 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -69.99 -21.76 63.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.76 -1.213 . . . . 2.33 111.809 -177.386 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -93.91 -9.27 37.7 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.699 -1.251 . . . . 1.92 110.214 -178.943 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.593 HG12 ' H ' ' A' ' 178' ' ' GLY . 99.8 t -108.76 119.94 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.385 -0.822 . . . . 0.67 108.912 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 89.5 mt -85.12 3.73 37.62 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.558 -0.714 . . . . 1.53 110.845 -178.182 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.593 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 166.55 175.23 36.61 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 119.224 -1.465 . . . . 0.48 109.75 179.637 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -133.69 129.41 36.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.551 -0.97 . . . . 0.55 108.411 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 90.3 mt -128.98 123.72 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.552 -0.907 . . . . 0.65 108.552 179.232 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 69.9 p -149.96 162.38 40.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.654 -1.279 . . . . 0.82 110.9 -179.706 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 183' ' ' ALA . 7.2 p30 -101.9 22.54 12.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.757 -0.589 . . . . 2.46 109.522 179.64 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -54.32 -162.98 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.817 -1.177 . . . . 1.28 112.048 -178.204 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.99 -54.0 5.97 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.809 -0.917 . . . . 2.19 110.809 -179.034 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 164.42 -139.01 5.59 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 118.94 -1.6 . . . . 2.13 110.707 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -71.59 -9.99 59.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.931 . . . . 5.86 110.625 -178.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 53.5 p -78.99 1.52 23.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.928 -1.108 . . . . 3.72 109.672 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 12.2 t -90.94 130.8 36.84 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.081 -1.012 . . . . 1.74 110.076 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -47.06 -50.27 19.99 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.447 -0.783 . . . . 0.95 109.966 179.998 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.41 HG23 ' N ' ' A' ' 191' ' ' SER . 14.5 t -57.48 -37.16 72.46 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.304 -0.873 . . . . 1.55 110.973 -178.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.41 ' N ' HG23 ' A' ' 190' ' ' THR . 82.6 p -59.99 -41.01 91.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.739 -1.226 . . . . 1.51 110.851 -179.087 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 88.7 mt -61.09 -38.93 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.125 -0.984 . . . . 1.67 109.399 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 92.7 mtp -60.59 -39.93 89.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.555 -0.716 . . . . 1.02 110.395 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.27 -43.49 87.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.737 -1.227 . . . . 0.68 109.388 -179.453 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' A' ' 195' ' ' ARG . 2.2 mtt-85 -60.02 -49.92 75.77 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.288 -0.965 . . . . 2.93 109.911 -179.29 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 72.1 m -69.96 -34.43 73.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.088 -1.008 . . . . 0.86 111.026 -179.224 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.5 mt -71.47 -18.24 62.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.921 -1.112 . . . . 0.67 109.499 -179.536 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 60.99 47.92 7.0 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.294 0.569 . . . . 1.5 110.536 -179.415 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 38.5 mt -126.99 149.48 69.36 Favored Pre-proline 0 N--CA 1.499 2.021 0 N-CA-C 107.724 -1.213 . . . . 0.72 107.724 178.549 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.79 139.98 49.58 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.122 1.881 . . . . 0.61 112.102 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.99 150.59 3.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.112 -0.992 . . . . 0.66 111.052 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 93.1 mt -125.22 142.32 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 108.399 -0.963 . . . . 0.79 108.399 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.3 m -127.04 -7.97 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 120.816 -1.178 . . . . 0.91 111.322 -178.673 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.9 21.31 29.92 Favored Glycine 0 N--CA 1.503 3.135 0 O-C-N 121.211 -0.931 . . . . 1.01 110.867 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 8.3 p -45.84 -43.99 13.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.951 -1.323 . . . . 0.99 110.165 -179.313 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.34 -49.46 2.67 Favored Glycine 0 N--CA 1.498 2.784 0 C-N-CA 120.017 -1.087 . . . . 1.12 111.034 179.445 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.7 m -160.77 37.74 0.16 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.651 -1.5 . . . . 1.72 111.246 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 42.4 t -80.74 -31.5 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.991 -1.068 . . . . 0.89 108.86 178.206 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.7 p -59.95 -33.52 72.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.45 -0.781 . . . . 1.03 110.062 -179.081 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 91.2 p -78.21 -10.06 59.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.994 -1.066 . . . . 1.83 109.412 -179.664 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -103.6 -11.1 17.92 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.491 -0.756 . . . . 2.27 110.228 -179.304 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.4 t -103.42 136.2 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.213 -0.93 . . . . 0.92 110.806 -178.693 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -112.32 151.0 30.22 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.462 -1.31 . . . . 2.2 107.462 178.507 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.444 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 11.3 p-10 -57.92 139.53 54.1 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.058 -1.026 . . . . 2.36 110.069 -179.143 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.7 m-20 81.15 3.02 1.59 Allowed 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.13 0.491 . . . . 2.38 110.007 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 56.7 t0 -72.01 138.61 48.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.156 -0.965 . . . . 2.09 108.803 178.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.489 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 41.3 t80 -89.85 118.63 29.58 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.074 -1.084 . . . . 1.27 108.074 179.078 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.611 HD12 ' HB2' ' A' ' 16' ' ' ALA . 61.5 mt -128.47 149.05 50.74 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.498 -0.751 . . . . 0.75 110.642 -178.629 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.9 mt -115.15 130.01 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 107.703 -1.221 . . . . 0.63 107.703 177.615 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 63.5 tp -99.97 115.92 30.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.08 -1.013 . . . . 0.7 109.314 -179.207 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 223' ' ' VAL . 97.3 m-20 -74.22 -42.72 59.3 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.918 -1.142 . . . . 2.31 107.918 178.368 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.862 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.54 11.22 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.404 -0.961 . . . . 0.78 108.404 -179.108 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.503 ' H ' ' C ' ' A' ' 221' ' ' ASP . 57.2 t -128.33 -39.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.327 -1.36 . . . . 1.04 107.327 179.057 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -100.43 3.23 42.93 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.047 -1.094 . . . . 2.44 108.047 178.68 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 60.57 43.8 12.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.71 -0.619 . . . . 1.55 110.601 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -149.18 156.79 42.7 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.885 -1.134 . . . . 1.99 109.976 179.204 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -122.92 124.93 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.685 -0.857 . . . . 0.77 108.685 179.158 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -84.76 122.83 29.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.701 -1.249 . . . . 0.98 109.556 -179.23 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.406 HG22 HD22 ' A' ' 218' ' ' LEU . 62.5 t -98.96 116.3 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.474 -0.766 . . . . 0.85 109.481 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 65.08 68.96 0.69 Allowed Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.227 -0.92 . . . . 1.66 109.372 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -89.18 124.05 1.4 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.181 2.587 . . . . 0.95 112.255 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.2 p -70.41 171.75 9.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 1.84 109.725 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -59.97 -40.16 88.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.323 -0.86 . . . . 2.74 109.921 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -64.33 -34.61 78.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.033 -1.042 . . . . 2.89 109.217 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.79 -42.7 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.121 -0.987 . . . . 1.3 108.613 178.87 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 95.1 mt . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.747 -0.834 . . . . 1.09 108.747 179.389 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 16.9 ttt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -149.49 147.98 28.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.26 -0.9 . . . . 0.0 109.267 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -149.67 159.63 44.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.066 -1.021 . . . . 0.0 110.618 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -153.66 150.41 28.56 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -109.84 132.25 54.32 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.373 -0.83 . . . . 0.0 109.781 179.628 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.49 121.63 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 122.371 1.081 . . . . 0.0 112.729 -177.4 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 56.0 m -78.19 104.01 8.49 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.924 0.868 . . . . 0.0 110.02 -178.874 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.476 HG22 ' H ' ' B' ' 310' ' ' ALA . 96.6 mt -52.64 125.62 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 122.635 1.207 . . . . 0.0 111.073 -177.562 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 67.1 p -109.97 20.9 17.46 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.978 -179.023 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.476 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -75.29 116.87 58.55 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.048 -1.032 . . . . 0.0 108.945 179.426 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -54.53 -16.22 10.29 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 CA-C-N 120.276 1.134 . . . . 0.0 113.249 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -120.17 11.41 11.61 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.383 -0.823 . . . . 0.0 109.621 -179.191 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.85 179.25 32.14 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 108.431 -1.867 . . . . 0.0 108.431 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.457 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -87.08 93.13 9.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.952 -1.322 . . . . 0.0 108.998 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.404 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 5.8 p80 -95.43 -160.0 0.76 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.945 -1.097 . . . . 0.0 109.811 179.054 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 9.6 m -58.39 -43.99 88.75 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.021 -1.05 . . . . 0.0 112.629 -176.071 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.536 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.1 tpt180 -61.97 -62.05 6.57 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.352 -1.467 . . . . 0.0 112.184 -178.236 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.404 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 11.0 Cg_endo -58.02 -29.6 87.34 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 CA-C-N 120.136 1.084 . . . . 0.0 111.548 -179.196 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.34 -49.96 75.83 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.085 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.34 -41.18 65.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.464 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -70.02 -40.61 75.1 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.768 -1.207 . . . . 0.0 108.911 178.478 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -65.5 -55.46 17.74 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.521 -0.737 . . . . 0.0 109.951 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 323' ' ' VAL . . . . . 0.431 HG13 ' O ' ' B' ' 344' ' ' ALA . 88.3 t -67.83 -29.72 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.872 -1.142 . . . . 0.0 111.058 -178.482 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -64.05 -42.96 96.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.966 -1.084 . . . . 0.0 109.876 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -66.23 -40.41 90.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.107 -0.995 . . . . 0.0 110.499 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -65.75 -53.13 44.73 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.745 -1.222 . . . . 0.0 110.389 -179.608 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -51.94 -15.64 0.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 109.964 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -75.49 -23.93 71.91 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -105.59 141.32 37.26 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.404 -1.057 . . . . 0.0 108.945 179.669 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 26.5 m -89.8 -11.48 42.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.997 -1.064 . . . . 0.0 109.937 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.434 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 63.3 p -61.32 148.88 39.81 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.973 -1.079 . . . . 0.0 109.241 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -68.53 134.63 50.35 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.116 -0.99 . . . . 0.0 108.908 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.3 mt -133.01 133.22 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.642 -0.661 . . . . 0.0 109.787 -179.57 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 32.4 m -129.9 149.03 51.81 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.487 -0.758 . . . . 0.0 109.089 179.245 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 87.1 t -122.3 116.48 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.327 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 33.3 m -105.67 132.12 52.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 33.8 t -140.02 116.49 10.7 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.768 0.794 . . . . 0.0 111.105 -179.79 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 45.52 51.96 9.48 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.723 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 90.0 -14.03 63.09 Favored Glycine 0 N--CA 1.503 3.142 0 O-C-N 120.156 -1.59 . . . . 0.0 113.099 176.52 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -119.76 131.16 55.28 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 119.495 1.647 . . . . 0.0 110.06 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 18.1 m -129.99 150.23 51.36 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.83 0.824 . . . . 0.0 110.426 -179.412 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 342' ' ' ALA . . . . . 0.423 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -146.52 171.86 14.44 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.511 0.672 . . . . 0.0 110.145 -179.229 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 9.6 m -89.68 139.95 30.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.533 -0.73 . . . . 0.0 109.725 -179.514 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.441 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -81.51 -12.47 58.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.0 -1.062 . . . . 0.0 109.018 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -86.62 21.26 2.23 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.5 -1.666 . . . . 0.0 106.5 178.602 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 346' ' ' SER . . . . . 0.441 ' H ' ' C ' ' B' ' 344' ' ' ALA . 52.7 m -149.96 98.67 2.75 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.226 -179.053 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.966 HD23 HD22 ' A' ' 79' ' ' LEU . 26.0 tp -59.91 -34.4 73.15 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.8 ' CE2' HD11 ' A' ' 79' ' ' LEU . 58.0 m-85 -59.93 -55.56 32.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.265 -0.897 . . . . 0.0 110.11 -179.37 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -69.35 -22.4 63.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 111.178 -177.214 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' B' ' 352' ' ' THR . 65.1 mt -68.94 -52.78 25.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.645 -1.284 . . . . 0.0 108.09 177.839 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.552 ' OE1' ' N ' ' B' ' 351' ' ' GLN . 0.8 OUTLIER -40.85 -16.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.977 -178.22 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.545 ' N ' ' O ' ' B' ' 350' ' ' LEU . 63.5 p -87.44 -10.01 53.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.405 -1.435 . . . . 0.0 109.941 -179.167 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.423 HD11 ' HB3' ' B' ' 342' ' ' ALA . 67.8 mt -95.42 117.81 31.02 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.07 -1.019 . . . . 0.0 109.081 178.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.35 94.04 0.91 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.742 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 18.1 mt -101.42 88.73 3.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.282 -1.128 . . . . 0.0 108.86 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 77.2 p -90.33 169.99 10.63 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.01 -1.056 . . . . 0.0 110.785 -179.068 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 357' ' ' GLN . . . . . 0.449 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 1.1 tm0? -61.46 113.78 2.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.721 -0.612 . . . . 0.0 110.973 -179.079 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 358' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 100.32 8.07 50.68 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.751 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.1 m -83.31 111.52 19.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.339 -1.095 . . . . 0.0 110.513 -179.683 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 6.1 t -77.31 114.59 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 122.292 1.044 . . . . 0.0 109.257 -177.636 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 14.5 m -111.7 177.68 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.458 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 90.3 m -131.29 129.35 41.39 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 176.845 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 71.9 mt -102.63 116.42 46.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 56.8 p -120.01 132.3 55.43 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.659 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.35 153.14 40.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 0.0 109.873 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -144.88 124.41 13.18 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.289 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.464 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 159.88 -160.34 31.46 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 118.804 -1.665 . . . . 0.0 111.578 -179.773 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -60.06 -50.93 71.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 122.132 -0.628 . . . . 0.0 112.133 -177.641 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.434 ' H ' ' HB3' ' B' ' 331' ' ' SER . 71.3 m-20 -109.93 10.93 24.27 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.903 -1.123 . . . . 0.0 111.643 -177.2 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.554 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -42.04 -34.88 0.78 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.988 -1.07 . . . . 0.0 111.848 -178.392 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 371' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 91.3 mt-30 -70.72 -38.65 73.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.745 -1.222 . . . . 0.0 110.034 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -65.38 -50.04 67.02 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.926 -1.108 . . . . 0.0 109.011 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.05 -76.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.584 -0.697 . . . . 0.0 111.069 -178.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.579 ' O ' HG23 ' B' ' 378' ' ' VAL . 23.5 t -43.08 -38.13 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.343 -0.848 . . . . 0.0 110.973 -177.471 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.92 -42.39 85.48 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.351 -1.468 . . . . 0.0 110.32 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -81.03 -43.43 19.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.795 -1.191 . . . . 0.0 109.909 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.09 -39.41 86.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.223 -179.405 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.579 HG23 ' O ' ' B' ' 374' ' ' VAL . 55.9 t -62.02 -43.23 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.057 -1.027 . . . . 0.0 109.342 179.542 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -70.02 -56.38 7.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.703 -1.248 . . . . 0.0 107.64 178.439 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 52.0 tp -56.2 -35.06 66.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.564 -0.71 . . . . 0.0 110.058 -177.861 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 1.5 tpt -71.49 -39.93 70.53 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.543 -1.348 . . . . 0.0 108.669 178.165 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.75 -4.44 57.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.473 -0.767 . . . . 0.0 110.574 179.672 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.428 ' O ' ' OE2' ' B' ' 385' ' ' GLU . 73.2 mm-40 -111.68 -2.61 15.3 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.105 -0.997 . . . . 0.0 110.995 -179.563 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 13.1 mt -80.01 133.02 36.12 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.379 -1.45 . . . . 0.0 109.493 179.129 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 385' ' ' GLU . . . . . 0.525 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 42.9 mp0 . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.211 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mtp . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.5 -0.556 . . . . 2.91 109.5 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.2 mt -109.97 129.94 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.51 -0.744 . . . . 1.2 109.692 -179.84 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 m -131.65 147.61 52.53 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.719 -0.613 . . . . 1.4 109.456 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.44 -164.99 10.13 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 108.834 -1.706 . . . . 1.05 108.834 179.522 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.6 mt -87.41 -18.33 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.016 -1.285 . . . . 1.15 109.704 -179.356 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.4 tp 54.86 103.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.668 -0.864 . . . . 0.98 108.668 -179.138 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.5 -24.57 16.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.88 108.675 179.509 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 13.4 t -141.77 123.43 8.96 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.574 -0.704 . . . . 1.69 110.011 -179.889 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.98 147.48 21.2 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.184 1.923 . . . . 0.85 112.531 179.284 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.909 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 150.29 172.64 19.78 Favored Glycine 0 N--CA 1.5 2.918 0 N-CA-C 108.918 -1.673 . . . . 0.92 108.918 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.9 mt -127.45 132.31 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.875 -1.367 . . . . 0.81 109.677 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.43 151.89 50.0 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.317 -0.864 . . . . 0.51 109.957 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -127.28 130.84 50.31 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.866 -1.161 . . . . 0.62 107.866 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.72 178.82 48.65 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 118.583 -1.77 . . . . 0.55 111.183 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -79.96 155.56 27.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.799 -0.824 . . . . 2.1 109.325 -179.899 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.6 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -106.52 125.78 51.43 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 121.794 0.807 . . . . 0.77 111.369 -178.967 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.0 tp -99.47 137.52 37.85 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.529 -1.286 . . . . 0.91 107.529 178.195 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.5 tp -119.53 128.65 54.14 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.476 -0.765 . . . . 0.93 109.692 -179.211 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.1 mt -91.62 105.91 18.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.694 -0.629 . . . . 0.93 110.275 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -106.1 131.79 52.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.162 -1.051 . . . . 2.75 108.162 178.605 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -129.23 148.58 51.17 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.383 -0.823 . . . . 3.0 109.381 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -83.15 142.42 31.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.455 -0.778 . . . . 2.77 109.33 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -60.2 142.52 54.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.126 -0.983 . . . . 2.94 109.133 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -75.97 126.58 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.977 . . . . 0.95 109.985 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.57 125.33 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.343 -0.848 . . . . 1.28 110.166 -179.522 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 84.8 mt -110.18 132.29 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.607 -0.886 . . . . 1.21 108.607 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -92.23 117.92 30.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.764 -1.21 . . . . 1.81 109.474 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.447 HH11 ' HG2' ' A' ' 28' ' ' ARG . 5.3 mmt-85 -87.11 -4.39 59.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.164 -0.96 . . . . 2.8 109.342 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -68.25 140.77 56.03 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.194 -0.941 . . . . 2.87 109.248 179.612 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -84.02 154.49 23.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.899 . . . . 2.35 109.849 -179.696 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.546 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.3 pt -96.5 167.17 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 0.97 109.467 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.7 p -90.31 172.76 8.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.04 -1.037 . . . . 1.17 108.363 178.574 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.08 -18.09 63.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.938 -1.102 . . . . 1.18 110.994 -179.285 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 64.8 t0 -86.37 -24.62 25.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.626 -1.296 . . . . 2.56 108.392 178.842 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -81.29 -9.97 59.66 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.786 -0.82 . . . . 1.79 108.786 179.1 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 t -60.94 -52.02 66.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -61.08 -39.88 91.57 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.377 -0.827 . . . . 1.77 110.273 -179.619 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -69.24 -40.91 77.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.078 -1.014 . . . . 2.7 111.022 -178.309 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HG3' HG21 ' A' ' 31' ' ' ILE . 68.7 mm-40 -65.91 -39.86 90.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.0 -1.063 . . . . 1.51 110.854 -179.21 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.8 t -61.33 -45.04 99.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.484 -1.385 . . . . 0.93 108.45 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -60.01 -41.5 92.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.043 -1.036 . . . . 1.81 109.622 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -60.17 -45.25 93.71 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.967 -1.093 . . . . 2.78 108.069 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -60.36 -48.29 82.37 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.889 -0.782 . . . . 0.78 108.889 178.199 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.465 ' CD1' HH21 ' A' ' 47' ' ' ARG . 43.2 tp -60.2 -48.81 80.16 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.048 -0.723 . . . . 1.07 109.048 -179.567 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.459 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 44.4 t -63.56 -43.18 97.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.021 -1.05 . . . . 1.12 108.386 178.83 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.56 -47.42 91.25 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.537 -1.825 . . . . 0.84 108.537 179.059 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.465 HH21 ' CD1' ' A' ' 44' ' ' LEU . 44.2 ttp180 -60.18 -38.78 84.27 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.888 -1.153 . . . . 3.09 107.888 178.656 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -52.9 -46.49 68.02 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.952 -0.758 . . . . 0.88 108.952 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 50' ' ' ALA . 34.0 ttpt -59.92 -74.82 0.07 Allowed 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.548 -1.279 . . . . 2.59 107.548 179.257 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.35 -39.61 0.3 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.356 -0.84 . . . . 0.7 111.907 -178.148 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.0 m -59.34 -52.17 66.8 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.458 -1.401 . . . . 1.4 108.707 -179.749 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.52 -40.71 89.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.365 -0.834 . . . . 0.67 110.58 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -63.3 -42.17 99.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.0 -1.062 . . . . 1.66 109.878 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.6 mt -64.11 -40.46 96.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.021 -1.049 . . . . 1.58 109.538 179.553 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.7 -39.87 90.15 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.109 -0.995 . . . . 1.35 108.708 179.671 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.418 HG22 ' HZ3' ' A' ' 60' ' ' LYS . 89.3 m -62.23 -43.49 98.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.361 -0.837 . . . . 0.77 109.711 179.097 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 81.7 mt -61.47 -39.85 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.325 -0.859 . . . . 0.63 109.598 179.612 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -57.56 -50.22 73.81 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.255 -0.903 . . . . 1.14 109.872 -179.041 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -58.44 -37.68 75.9 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.25 -0.906 . . . . 0.79 110.491 -177.751 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.418 ' HZ3' HG22 ' A' ' 56' ' ' THR . 59.0 mttp -68.47 -36.88 79.6 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.911 -1.118 . . . . 1.53 109.352 179.461 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.438 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.27 -47.34 70.97 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.57 -0.706 . . . . 0.57 109.979 -179.636 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -54.59 -52.8 42.89 Favored Glycine 0 N--CA 1.484 1.858 0 C-N-CA 119.993 -1.099 . . . . 0.75 110.452 -178.909 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.42 -41.84 72.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.032 -1.275 . . . . 1.59 111.083 -178.996 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.8 m -66.34 -61.93 1.74 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.025 -1.047 . . . . 0.73 112.181 -177.503 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -96.68 -44.47 7.1 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.827 -1.171 . . . . 0.75 111.439 -177.546 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.39 -168.08 25.58 Favored Glycine 0 N--CA 1.499 2.882 0 C-N-CA 119.822 -1.18 . . . . 1.22 110.925 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -69.95 -22.82 63.14 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.981 -0.717 . . . . 5.81 110.115 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.506 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 50.4 tp10 -59.99 -35.71 75.61 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.466 -0.771 . . . . 3.37 111.31 -179.14 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -96.51 -16.22 21.23 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.166 -0.959 . . . . 1.77 109.748 -179.699 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -71.6 -43.13 66.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.219 -0.926 . . . . 1.65 110.373 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.59 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -63.69 -34.53 78.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.435 -0.79 . . . . 0.77 110.119 -178.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.86 -40.61 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.909 -1.119 . . . . 0.8 109.108 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -65.04 -39.52 93.47 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.986 -1.071 . . . . 0.88 110.314 -179.78 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -60.12 -40.06 88.42 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.979 -1.076 . . . . 1.37 109.342 -179.182 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.99 -44.75 95.49 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.181 -1.968 . . . . 0.62 108.181 178.376 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -63.36 -45.88 89.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.529 -0.983 . . . . 1.5 109.142 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 98.5 mt -70.08 -45.51 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.108 -0.995 . . . . 0.63 109.319 179.575 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.0 ttp -62.65 -41.49 99.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.847 -1.158 . . . . 1.51 110.09 -179.488 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.005 HD22 HD23 ' B' ' 347' ' ' LEU . 45.7 tp -65.07 -40.83 95.22 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.541 -0.724 . . . . 0.77 110.065 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.7 tp -68.73 -39.52 80.33 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.636 -0.665 . . . . 0.62 110.311 -179.096 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -79.67 0.94 28.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.043 -1.036 . . . . 1.47 109.935 -179.062 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 53.3 t0 -47.28 133.83 11.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.086 -1.009 . . . . 1.47 109.736 -179.311 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.458 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 99.3 mt-10 -64.92 -18.66 65.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.683 -0.636 . . . . 1.78 110.899 -178.749 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -75.51 -33.31 60.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.779 -1.201 . . . . 2.53 109.035 178.68 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 79' ' ' LEU . 88.9 mt -70.02 -39.99 75.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.479 -0.763 . . . . 0.8 109.371 179.5 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.91 -49.53 77.31 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.429 -0.794 . . . . 1.42 110.16 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.4 -39.41 81.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.855 . . . . 1.71 110.787 -179.226 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -68.87 -40.25 79.37 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.719 -1.238 . . . . 1.57 111.221 -179.439 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.44 -43.19 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.601 -1.312 . . . . 0.65 109.402 179.529 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.78 -39.17 77.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.552 -0.717 . . . . 0.82 110.749 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.78 95.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.117 -0.989 . . . . 0.79 110.098 -179.114 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 21.1 mt -63.65 -45.4 90.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.094 -1.004 . . . . 0.95 109.333 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.9 mt -64.15 -48.98 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.406 -0.809 . . . . 0.66 109.18 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.99 -40.77 75.11 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.733 -0.787 . . . . 2.2 110.576 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -84.82 -55.86 3.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.969 -1.082 . . . . 1.65 112.134 -178.142 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -87.1 -1.44 57.89 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.866 -1.146 . . . . 2.03 111.872 -177.321 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 44.3 m80 58.58 35.01 24.31 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.995 -1.066 . . . . 1.42 110.304 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.2 mtp -86.89 166.27 15.28 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.256 -0.903 . . . . 1.18 109.889 -179.474 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.426 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 64.4 p -79.62 161.9 25.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.206 -0.934 . . . . 0.98 108.864 179.536 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.06 -40.54 87.11 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.0 -1.062 . . . . 0.64 109.541 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 23.9 p-10 -69.94 -35.72 74.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 2.07 109.925 179.825 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.12 -40.09 39.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.094 -1.004 . . . . 0.73 109.333 179.279 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.76 -48.33 63.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.862 . . . . 0.54 110.361 -179.368 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.81 -32.54 73.75 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.81 -1.181 . . . . 0.56 109.757 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.525 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 86.3 t60 -60.53 -45.07 95.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 1.54 109.56 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -66.41 -39.96 89.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.792 . . . . 1.33 110.997 -178.879 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.1 t -62.3 -53.35 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.165 -0.96 . . . . 0.72 111.493 -177.902 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.8 mm -72.59 -37.12 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.751 -1.218 . . . . 0.85 110.004 -179.382 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.525 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 84.5 tt0 -67.35 -34.2 76.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.172 -0.955 . . . . 2.44 108.537 179.623 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.59 -49.07 82.66 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.357 -1.097 . . . . 0.98 110.357 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.8 mm-40 -65.92 -50.71 63.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.802 -1.411 . . . . 1.41 109.192 -179.537 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.87 -40.43 80.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 1.2 109.097 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 61.8 m -60.03 -40.18 88.48 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.114 -0.991 . . . . 1.7 108.436 179.733 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.26 -39.65 95.19 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.391 -0.818 . . . . 1.47 109.304 179.662 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.6 mt -67.82 -43.16 80.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.993 -1.083 . . . . 1.56 109.461 -179.468 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -55.5 -25.4 36.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.85 -1.156 . . . . 2.2 109.723 -179.31 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -66.2 -22.0 66.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.973 -1.079 . . . . 2.12 108.765 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.441 HD13 HD13 ' A' ' 123' ' ' LEU . 51.8 mt -63.25 143.94 57.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.314 -0.866 . . . . 2.0 109.882 -179.617 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -92.55 14.31 17.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.201 -0.937 . . . . 3.23 109.358 179.03 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -103.22 127.83 50.41 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.32 -0.862 . . . . 2.49 110.516 -178.944 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -70.62 -28.94 65.22 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.366 0.603 . . . . 3.95 110.234 179.239 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.535 ' OH ' ' N ' ' B' ' 315' ' ' HIS . 15.7 t80 -64.26 -40.58 96.28 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.209 -0.932 . . . . 2.0 110.212 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.91 HD22 ' O ' ' B' ' 351' ' ' GLN . 64.2 mt -77.38 -37.15 52.7 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.51 -0.744 . . . . 1.86 109.875 -178.934 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -59.98 -40.9 90.7 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.249 -0.907 . . . . 2.84 109.329 -179.752 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 78.1 mm-40 -61.28 -46.02 92.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.958 -1.089 . . . . 2.73 108.877 179.401 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.44 HH21 ' CD2' ' A' ' 123' ' ' LEU . 17.5 ttp180 -61.16 -39.96 92.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.899 . . . . 2.77 108.59 179.203 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.88 -28.9 70.36 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.766 -0.827 . . . . 1.19 108.766 179.011 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -59.95 -40.03 87.58 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.087 -1.079 . . . . 1.2 108.087 179.571 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -62.07 -42.24 98.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.522 -0.736 . . . . 1.55 109.503 179.741 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.11 -41.4 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.197 -0.939 . . . . 0.8 108.571 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -60.13 -39.33 85.94 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.688 -0.633 . . . . 3.09 109.458 179.32 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -60.04 -41.85 93.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.38 -0.825 . . . . 1.46 110.676 -179.304 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.16 -46.19 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.056 -1.028 . . . . 0.71 110.055 -179.088 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.99 97.85 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.996 -1.242 . . . . 0.57 109.996 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -59.8 -49.72 76.63 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.326 -1.102 . . . . 2.59 110.142 -179.658 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -70.05 -32.08 70.02 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.101 -0.999 . . . . 2.83 110.501 -179.808 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.9 tp -57.81 -46.74 84.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.97 . . . . 1.25 108.925 -178.884 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.96 -39.64 86.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.138 -0.977 . . . . 0.7 108.565 179.116 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -68.22 -40.0 82.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.356 -0.84 . . . . 2.57 108.884 178.595 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -60.16 -38.49 83.3 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.862 -0.524 . . . . 1.23 110.999 -178.995 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.5 mt -72.8 -40.87 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.653 -1.28 . . . . 0.81 108.727 179.397 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.68 -25.58 61.31 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.62 -0.675 . . . . 1.0 109.848 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.6 37.16 27.66 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.96 -1.656 . . . . 0.89 108.96 -179.309 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 58.5 tp -73.14 141.59 47.47 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.497 -1.002 . . . . 1.14 109.381 -179.401 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -61.96 140.06 58.35 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.845 0.831 . . . . 4.6 111.12 -178.698 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 97.0 mt -115.66 132.25 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.716 -0.846 . . . . 1.24 108.716 178.604 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 24.7 mm -57.02 -43.74 81.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.455 -0.778 . . . . 1.54 109.924 -178.392 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 11.8 t0 70.18 94.31 0.08 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.063 -0.718 . . . . 1.5 109.063 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.8 mt -66.36 -6.52 14.54 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.382 -0.824 . . . . 0.79 110.841 -178.761 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.0 t -82.93 -16.85 45.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.716 -1.24 . . . . 1.4 110.534 -179.186 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.33 24.29 0.83 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.068 -1.02 . . . . 0.92 112.581 -177.529 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.0 mm -79.28 126.5 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.305 -1.497 . . . . 0.88 108.793 179.531 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.4 ' O ' ' OD1' ' A' ' 154' ' ' ASP . 77.5 mt-30 -102.8 -11.92 17.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.558 -0.714 . . . . 2.45 110.158 -179.247 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 153' ' ' GLN . 97.7 m-20 -136.85 156.09 48.94 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.117 -0.989 . . . . 1.52 110.39 -178.975 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.08 135.17 56.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.321 -0.862 . . . . 1.58 109.137 179.871 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.9 m -152.65 164.48 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.42 -0.8 . . . . 0.69 109.802 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.7 mt -92.5 147.15 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 105.752 -1.944 . . . . 0.61 105.752 176.651 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.4 tp -99.69 119.21 37.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.173 -0.954 . . . . 0.87 110.464 -178.246 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.1 t -125.13 130.3 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.196 -1.038 . . . . 0.71 108.196 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.84 167.21 28.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -0.991 . . . . 0.81 109.221 -179.768 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.26 -37.31 74.88 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.781 -1.199 . . . . 0.98 108.715 179.013 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.6 p-10 -170.42 149.01 3.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.57 -0.706 . . . . 2.25 109.602 -179.655 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.1 mt -119.36 133.72 55.58 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.453 -0.779 . . . . 0.78 109.663 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.4 p -93.35 143.89 27.41 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.013 . . . . 0.98 108.624 179.157 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -41.47 -34.23 1.92 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.302 2.001 . . . . 0.81 113.159 -179.669 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.7 m -59.92 -40.12 87.8 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.768 -1.207 . . . . 0.9 109.294 -178.97 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.5 -40.24 80.94 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.012 -1.055 . . . . 1.61 109.308 179.474 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 63.8 p -52.94 -30.02 32.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.064 -1.022 . . . . 0.61 110.57 -178.92 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -70.72 -57.47 4.64 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.816 -1.178 . . . . 0.6 109.701 179.565 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -80.36 34.83 0.32 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.13 -0.693 . . . . 1.4 109.13 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.4 tp -100.08 136.54 39.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.426 -0.796 . . . . 0.7 109.763 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -86.18 96.89 10.07 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.926 -1.139 . . . . 2.35 107.926 178.494 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.9 -41.72 97.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 1.51 110.87 -178.577 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -68.02 -25.34 65.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.993 -1.067 . . . . 2.33 111.812 -177.4 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -93.7 -8.74 39.99 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.727 -1.233 . . . . 1.92 110.541 -178.506 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.458 HG12 ' H ' ' A' ' 178' ' ' GLY . 87.5 t -107.58 118.58 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.182 -1.044 . . . . 0.67 108.182 178.613 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 95.3 mt -89.85 6.48 41.66 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.446 -0.784 . . . . 1.53 111.051 -177.342 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.458 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 175.82 166.16 32.87 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.419 -1.472 . . . . 0.48 109.419 179.511 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -132.2 128.44 37.96 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.344 -0.984 . . . . 0.55 108.344 179.573 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.416 ' CG2' HG21 ' A' ' 205' ' ' THR . 86.2 mt -130.47 124.04 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.612 -1.255 . . . . 0.65 107.612 178.489 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.4 p -140.79 156.81 46.08 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.205 1.002 . . . . 0.82 111.386 -178.189 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.491 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 65.6 t0 -102.97 26.03 8.65 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.914 -0.585 . . . . 2.46 110.101 -179.567 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.67 -164.12 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.233 -1.542 . . . . 1.28 111.551 -178.045 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.82 -54.0 8.93 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.261 -1.136 . . . . 2.19 110.261 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.65 -154.44 13.71 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.764 -1.684 . . . . 2.13 111.68 -179.635 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -64.37 -11.28 31.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.89 -0.771 . . . . 5.86 110.745 -178.759 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 59.6 p -79.94 5.38 14.07 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.119 -0.988 . . . . 3.72 109.699 -179.005 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.0 t -88.67 142.48 27.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 1.74 109.894 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -53.36 -39.15 63.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.385 -0.822 . . . . 0.95 108.919 -179.831 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 89.5 m -59.77 -42.23 92.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.69 -0.631 . . . . 1.55 110.908 -179.33 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.3 p -60.98 -40.08 92.05 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.846 -1.159 . . . . 1.51 110.962 -178.871 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.8 mm -61.42 -41.19 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.204 -0.935 . . . . 1.67 110.096 -178.558 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.5 mtp -61.32 -42.94 99.5 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.989 -1.069 . . . . 1.02 110.333 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.96 -47.0 71.78 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.522 -1.361 . . . . 0.68 109.92 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -60.21 -50.26 74.37 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.903 -1.119 . . . . 2.93 110.003 -179.687 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.7 m -69.14 -36.07 77.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.773 -1.204 . . . . 0.86 111.069 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 197' ' ' LEU . 94.7 mt -72.06 -26.39 62.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.822 -1.174 . . . . 0.67 109.45 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 68.42 45.26 1.19 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.098 0.475 . . . . 1.5 110.778 -179.593 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.479 ' O ' ' CB ' ' A' ' 8' ' ' SER . 62.3 mt -126.69 148.67 65.8 Favored Pre-proline 0 N--CA 1.501 2.116 0 N-CA-C 107.852 -1.166 . . . . 0.72 107.852 178.239 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.86 137.82 78.75 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.192 1.928 . . . . 0.61 112.111 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.31 147.49 3.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.03 -1.044 . . . . 0.66 111.319 -179.669 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.4 mt -125.34 144.27 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.371 -1.344 . . . . 0.79 107.371 178.434 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 23.9 m -126.77 -11.78 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 O-C-N 121.106 -0.996 . . . . 0.91 111.144 -178.602 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -109.97 24.61 18.55 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.734 -1.346 . . . . 1.01 109.734 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.416 HG21 ' CG2' ' A' ' 180' ' ' ILE . 3.0 p -43.3 -46.68 6.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.333 -1.099 . . . . 0.99 109.897 -179.008 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.491 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 95.51 -50.95 1.81 Allowed Glycine 0 N--CA 1.498 2.813 0 C-N-CA 120.218 -0.991 . . . . 1.12 111.496 178.998 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 46.8 t -157.07 30.87 0.3 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.245 -1.738 . . . . 1.72 110.745 -178.665 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 40.7 t -72.11 -40.04 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.096 -1.002 . . . . 0.89 109.263 178.512 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.437 ' H ' HG23 ' A' ' 209' ' ' THR . 6.4 p -54.17 -29.39 45.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -0.927 . . . . 1.03 110.191 -179.301 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 47.5 t -79.78 -20.96 44.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.156 -0.965 . . . . 1.83 110.349 -178.932 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -96.08 -10.61 27.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.044 -1.035 . . . . 2.27 110.393 -179.287 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 56.2 t -106.63 136.75 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.281 -0.887 . . . . 0.92 111.538 -177.809 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -112.52 154.54 25.76 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.293 -1.373 . . . . 2.2 107.293 178.86 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 33.6 p-10 -60.5 139.63 57.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.694 -1.253 . . . . 2.36 110.389 -179.166 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.4 t0 81.03 7.66 1.2 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.586 -0.524 . . . . 2.38 109.586 179.688 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 58.2 t0 -76.59 132.95 39.76 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.298 -0.876 . . . . 2.09 109.215 179.457 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.411 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 33.7 t80 -84.05 119.95 25.56 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.012 -1.107 . . . . 1.27 108.012 179.412 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.6 HD12 ' HB2' ' A' ' 16' ' ' ALA . 86.5 mt -130.42 149.82 51.92 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.334 -0.854 . . . . 0.75 110.927 -178.429 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 63.8 mt -115.22 126.62 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 106.907 -1.516 . . . . 0.63 106.907 177.091 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 45.1 tp -101.24 120.18 39.86 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.09 -1.006 . . . . 0.7 109.031 -178.832 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.472 ' C ' ' N ' ' A' ' 223' ' ' VAL . 91.8 m-20 -78.11 -46.99 19.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.088 -1.007 . . . . 2.31 110.263 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.909 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 50.05 16.45 0.24 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.115 -1.069 . . . . 0.78 108.115 -178.537 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.472 ' N ' ' C ' ' A' ' 221' ' ' ASP . 38.5 t -131.21 -47.04 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.321 -1.363 . . . . 1.04 107.321 179.235 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -99.62 3.62 45.33 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.357 -1.349 . . . . 2.44 107.357 177.88 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 48.6 t30 60.55 44.28 11.89 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 116.117 -0.492 . . . . 1.55 110.259 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -144.37 156.75 44.37 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.869 -1.144 . . . . 1.99 110.273 179.603 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 79.7 t -125.96 129.94 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.269 -0.641 . . . . 0.77 109.269 179.791 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -95.97 122.69 39.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.042 -1.036 . . . . 0.98 108.784 179.354 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 39.0 t -98.92 116.24 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.361 -0.837 . . . . 0.85 109.99 -179.157 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 63.53 68.42 0.9 Allowed Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.488 -0.757 . . . . 1.66 110.509 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -91.1 130.3 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.492 2.795 . . . . 0.95 112.471 179.7 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.483 HG22 ' N ' ' A' ' 233' ' ' ASN . 23.7 m -67.9 166.1 16.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.16 -0.962 . . . . 1.84 109.894 -179.461 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.483 ' N ' HG22 ' A' ' 232' ' ' THR . 69.6 m-20 -60.13 -40.0 88.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.248 -0.907 . . . . 2.74 110.338 -179.392 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -60.27 -37.21 79.73 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.09 -1.006 . . . . 2.89 108.972 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 70.2 t -64.73 -40.14 88.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.351 -0.843 . . . . 1.3 109.76 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.497 1.89 0 O-C-N 121.111 -0.993 . . . . 1.09 110.017 -179.784 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 3.6 ttt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -150.54 150.32 31.09 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.367 -0.833 . . . . 0.0 109.057 179.082 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 303' ' ' GLN . . . . . 0.484 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 3.4 pm0 -150.18 157.83 43.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.135 -0.978 . . . . 0.0 110.926 -179.047 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -155.47 150.89 27.1 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.048 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -113.4 129.45 56.54 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.113 -0.992 . . . . 0.0 109.833 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.59 126.85 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 CA-C-O 122.512 1.149 . . . . 0.0 112.458 -177.737 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 31.4 m -77.99 102.37 7.35 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.925 -178.257 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 87.1 mt -51.48 123.92 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 122.277 1.037 . . . . 0.0 110.053 -178.072 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 25.6 p -109.25 20.05 18.74 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.693 -178.713 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' B' ' 385' ' ' GLU . . . -74.6 116.64 55.34 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 108.719 179.554 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.24 -16.1 44.38 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 CA-C-N 120.362 1.165 . . . . 0.0 112.546 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -112.27 12.15 20.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.523 -0.736 . . . . 0.0 109.652 -179.115 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.25 172.21 5.53 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 -178.913 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.425 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 2.6 tp -84.53 88.51 7.32 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.871 -1.37 . . . . 0.0 108.427 -179.133 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.535 ' N ' ' OH ' ' A' ' 122' ' ' TYR . 5.0 p80 -90.94 -161.92 0.86 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 120.74 -1.225 . . . . 0.0 109.412 178.965 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.2 m -56.82 -41.18 77.38 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.147 -0.971 . . . . 0.0 112.605 -176.223 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.59 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 2.4 tpt180 -62.5 -62.67 5.31 Favored Pre-proline 0 N--CA 1.501 2.124 0 O-C-N 120.478 -1.389 . . . . 0.0 112.159 -178.494 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.434 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 12.3 Cg_endo -57.77 -31.5 92.42 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 CA-C-N 120.004 1.037 . . . . 0.0 111.975 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.88 -50.53 73.42 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.006 -1.059 . . . . 0.0 108.233 179.637 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.73 -40.04 59.51 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.904 -179.12 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 321' ' ' GLN . . . . . 0.534 ' OE1' ' NH2' ' B' ' 317' ' ' ARG . 42.3 mt-30 -69.88 -41.83 74.25 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.981 -1.075 . . . . 0.0 109.57 179.074 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -61.02 -52.69 63.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.33 -0.856 . . . . 0.0 110.101 -179.25 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.19 -30.79 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.798 -1.188 . . . . 0.0 110.014 -178.961 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -59.36 -47.59 84.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.061 -1.024 . . . . 0.0 109.569 -179.685 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.53 -50.74 64.09 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.001 -1.062 . . . . 0.0 109.868 -179.091 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 326' ' ' ALA . . . . . 0.417 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -60.32 -51.09 71.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.677 -1.264 . . . . 0.0 110.074 -179.622 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -48.31 -19.27 0.28 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.498 -0.751 . . . . 0.0 109.126 -179.091 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 328' ' ' GLY . . . . . 0.417 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -80.49 -16.11 76.62 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -105.54 141.07 37.65 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.178 -1.189 . . . . 0.0 109.694 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 330' ' ' THR . . . . . 0.409 ' O ' HG22 ' B' ' 330' ' ' THR . 46.0 m -90.43 -12.39 37.57 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.307 -0.87 . . . . 0.0 109.165 179.211 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 95.2 p -61.32 150.02 36.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.147 -0.97 . . . . 0.0 108.862 179.412 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -71.28 135.65 47.54 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.387 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.9 132.29 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.575 -0.703 . . . . 0.0 109.861 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 96.7 m -130.86 147.9 52.57 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 63.0 t -121.99 119.07 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.299 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 21.6 m -103.4 121.34 42.59 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.028 -1.045 . . . . 0.0 109.145 -178.969 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 18.4 t -134.81 119.67 18.43 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.895 0.855 . . . . 0.0 110.569 -179.669 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 30.3 m120 43.89 57.61 4.03 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 177.468 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 75.26 -12.81 6.64 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.578 -1.326 . . . . 0.0 112.155 177.208 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -111.96 121.13 44.16 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.955 -1.32 . . . . 0.0 109.959 -178.764 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 69.0 m -108.49 157.49 18.4 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.749 0.785 . . . . 0.0 110.945 -178.998 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -153.05 153.72 33.44 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.465 0.65 . . . . 0.0 109.984 179.214 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 17.7 m -91.82 136.57 33.05 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.422 -0.799 . . . . 0.0 110.598 -179.142 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.405 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -70.71 -20.95 62.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.903 . . . . 0.0 109.757 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -84.07 18.69 2.01 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.24 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 346' ' ' SER . . . . . 0.405 ' H ' ' C ' ' B' ' 344' ' ' ALA . 13.2 m -148.49 93.14 2.1 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.72 0.771 . . . . 0.0 111.273 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 1.005 HD23 HD22 ' A' ' 79' ' ' LEU . 55.6 tp -56.29 -35.46 67.52 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.211 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.759 ' CE2' HD11 ' A' ' 79' ' ' LEU . 50.0 m-85 -56.16 -50.02 72.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.54 -0.725 . . . . 0.0 110.575 -179.06 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -69.85 -39.86 76.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.705 -1.247 . . . . 0.0 110.243 -178.601 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' B' ' 352' ' ' THR . 38.0 mt -50.04 -56.01 12.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.732 -1.23 . . . . 0.0 108.165 179.481 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.91 ' O ' HD22 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -41.36 -17.05 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.535 -0.728 . . . . 0.0 110.747 -179.151 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.551 ' N ' ' O ' ' B' ' 350' ' ' LEU . 52.7 p -85.87 -13.69 47.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.037 -1.665 . . . . 0.0 110.281 -178.897 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 29.4 mt -95.04 122.5 37.76 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.106 -0.996 . . . . 0.0 109.057 178.666 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.21 96.3 1.1 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 178.94 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 46.2 mt -102.33 90.38 3.88 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.293 -1.122 . . . . 0.0 109.925 -179.37 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 21.1 p -97.6 -177.43 3.79 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.267 -0.896 . . . . 0.0 111.253 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -69.74 111.76 5.74 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.9 -179.315 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.2 10.84 35.51 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 179.267 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 28.5 m -87.12 108.58 18.96 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.059 -1.26 . . . . 0.0 110.791 -179.579 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 32.4 t -77.89 113.79 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 122.058 0.933 . . . . 0.0 109.521 -178.204 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 34.7 m -109.68 178.28 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.409 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 19.1 m -130.43 123.18 29.21 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.522 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.5 mt -97.69 111.57 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.834 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 52.2 p -116.3 130.48 56.8 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.212 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.45 150.51 37.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.92 . . . . 0.0 109.48 -178.82 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -142.07 123.61 14.97 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.413 -0.804 . . . . 0.0 108.891 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.591 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.31 -162.64 33.43 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.395 -1.383 . . . . 0.0 111.057 -179.845 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.91 -50.33 74.2 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.207 -0.584 . . . . 0.0 112.518 -177.78 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.435 ' H ' ' HB3' ' B' ' 331' ' ' SER . 71.8 m-20 -106.38 10.61 31.5 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 120.668 -1.27 . . . . 0.0 110.92 -177.575 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.591 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.3 pt-20 -44.19 -34.87 2.0 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.29 -0.882 . . . . 0.0 111.45 -179.236 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -70.55 -41.19 72.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.876 -1.14 . . . . 0.0 110.017 -179.414 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -67.06 -47.14 72.19 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.341 -179.307 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.24 -74.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.341 -0.849 . . . . 0.0 110.848 -179.06 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.598 ' O ' HG23 ' B' ' 378' ' ' VAL . 64.3 t -45.87 -34.74 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.93 -1.106 . . . . 0.0 110.871 -177.434 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.17 -47.78 72.86 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.361 -1.462 . . . . 0.0 110.592 179.613 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -78.82 -44.11 23.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.969 -1.082 . . . . 0.0 110.628 -179.495 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.99 -36.26 76.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 0.0 109.383 -179.637 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.598 HG23 ' O ' ' B' ' 374' ' ' VAL . 39.8 t -63.05 -43.91 99.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.109 -0.994 . . . . 0.0 109.287 179.736 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -69.96 -56.84 5.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.605 -1.309 . . . . 0.0 108.248 178.519 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 36.1 tp -55.72 -32.21 63.15 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.435 -0.791 . . . . 0.0 109.682 -178.123 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 26.2 ttm -71.97 -40.49 68.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.57 -1.331 . . . . 0.0 109.319 178.236 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.14 -3.93 57.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.458 -0.776 . . . . 0.0 110.17 179.662 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -111.75 -4.39 14.68 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.196 -0.94 . . . . 0.0 110.917 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.7 mt -80.45 133.67 35.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.36 -1.463 . . . . 0.0 109.365 179.062 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 385' ' ' GLU . . . . . 0.402 ' O ' ' HB1' ' B' ' 310' ' ' ALA . 45.3 mt-10 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.324 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.5 mtt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.365 -0.606 . . . . 2.91 109.365 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.4 mt -109.89 129.92 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.447 -0.783 . . . . 1.2 109.366 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 m -138.83 118.78 13.32 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -0.888 . . . . 1.4 108.771 179.799 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.587 ' N ' HD22 ' A' ' 225' ' ' ASN . . . -91.83 -161.0 36.61 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.572 -1.411 . . . . 1.05 109.572 -179.848 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 5' ' ' ILE . 87.0 mt -94.95 -10.42 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.259 -1.142 . . . . 1.15 110.653 -178.953 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.1 tp 55.01 100.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.977 -1.077 . . . . 0.98 109.183 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.96 -34.23 24.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.88 108.936 179.56 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.0 t -139.14 133.4 16.21 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.497 -0.752 . . . . 1.69 109.231 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.27 143.74 15.91 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.193 1.929 . . . . 0.85 112.672 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.708 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 163.49 -162.03 34.59 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.792 -1.323 . . . . 0.92 109.792 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.6 mt -148.02 146.88 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.169 -1.195 . . . . 0.81 108.334 179.023 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.19 159.62 37.9 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.829 -1.169 . . . . 0.51 110.656 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.8 m-85 -137.93 127.45 24.97 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.547 -1.279 . . . . 0.62 107.547 178.859 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.59 177.22 48.31 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 118.452 -1.832 . . . . 0.55 110.965 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -78.74 159.5 27.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.782 -0.834 . . . . 2.1 110.107 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.94 123.46 45.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.719 . . . . 0.77 110.994 -179.028 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.2 tp -99.3 134.06 42.7 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 106.498 -1.667 . . . . 0.91 106.498 177.566 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.6 tp -117.63 122.81 44.59 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.146 -0.971 . . . . 0.93 109.908 -179.354 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.4 mt -87.32 104.54 16.51 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.476 0.655 . . . . 0.93 109.986 -179.678 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -92.47 136.0 33.58 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.681 -0.859 . . . . 2.75 108.681 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -130.57 139.05 50.43 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.323 -0.86 . . . . 3.0 109.623 179.76 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -93.47 140.79 29.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.243 -0.91 . . . . 2.77 109.122 179.656 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -59.94 139.97 57.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.166 -0.959 . . . . 2.94 109.634 -179.849 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -79.69 131.81 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.906 . . . . 0.95 108.757 179.889 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.5 t -93.91 124.88 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.132 -0.98 . . . . 1.28 110.053 -179.236 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.3 mt -101.0 139.97 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.403 -0.811 . . . . 1.21 109.036 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -98.5 115.76 29.27 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.08 -1.012 . . . . 1.81 109.88 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -90.98 0.07 57.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.213 -0.93 . . . . 2.8 108.969 179.601 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -62.67 143.46 57.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.441 -0.787 . . . . 2.87 109.695 -179.434 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -83.7 139.39 32.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.413 -0.805 . . . . 2.35 109.873 -179.671 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.565 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.3 pt -89.83 165.28 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.97 109.807 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.8 p -89.71 170.59 10.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.235 -0.915 . . . . 1.17 108.812 178.783 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.36 -22.02 64.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.988 -1.07 . . . . 1.18 109.939 -179.852 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -82.13 -24.65 34.99 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.529 -1.286 . . . . 2.56 107.529 178.71 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -82.04 -9.8 59.43 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.547 -0.908 . . . . 1.79 108.547 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.3 t -62.94 -52.49 58.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.099 -1.001 . . . . 1.0 108.903 179.759 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -63.2 -39.89 95.93 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.259 -0.901 . . . . 1.77 109.466 179.661 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -67.32 -41.11 85.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.03 -1.044 . . . . 2.7 110.292 -178.992 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.565 ' HG3' HG21 ' A' ' 31' ' ' ILE . 61.9 mm-40 -66.51 -39.99 88.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.15 -0.968 . . . . 1.51 110.129 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.45 -44.51 96.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.766 -1.208 . . . . 0.93 108.186 178.706 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -59.94 -36.08 76.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.319 -0.863 . . . . 1.81 109.472 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.534 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 99.1 mtt180 -59.75 -40.32 87.72 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 118.71 -1.196 . . . . 2.78 108.114 179.522 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -63.83 -48.28 77.43 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.33 -0.856 . . . . 0.78 108.706 177.82 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.6 tp -60.09 -48.86 79.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.46 -0.775 . . . . 1.07 109.216 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.9 t -64.86 -45.11 87.42 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.218 -0.993 . . . . 1.12 108.993 179.557 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.47 -45.06 96.95 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.26 -1.936 . . . . 0.84 108.26 179.098 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -65.6 -31.63 72.77 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.389 -0.967 . . . . 3.09 108.389 178.971 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.0 87.45 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.451 -0.781 . . . . 0.88 109.019 179.99 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 51' ' ' SER . 11.9 ttmm -65.51 -73.8 0.12 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.752 -1.203 . . . . 2.59 107.752 179.025 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.72 -32.08 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.552 -0.718 . . . . 0.7 111.222 -178.42 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 49' ' ' LYS . 29.7 t -59.74 -54.65 43.9 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.771 -1.205 . . . . 1.4 108.109 179.141 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.53 -41.02 85.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.383 -0.823 . . . . 0.67 111.292 -179.126 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -67.55 -40.54 84.98 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.726 -1.234 . . . . 1.66 110.037 -179.135 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.3 mt -64.85 -40.14 94.69 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.894 -1.129 . . . . 1.58 108.41 179.661 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -61.36 -39.95 92.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.26 -0.9 . . . . 1.35 109.35 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.9 m -67.13 -44.06 80.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.113 -0.992 . . . . 0.77 109.645 -179.854 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.55 -39.99 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.158 -0.964 . . . . 0.63 108.86 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -53.88 -50.64 65.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.501 -0.75 . . . . 1.14 110.034 -179.368 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -60.0 -38.8 83.68 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.449 -0.782 . . . . 0.79 111.134 -177.668 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -63.55 -39.67 95.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.833 -1.167 . . . . 1.53 109.613 -179.621 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.21 -43.89 93.64 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.365 0.602 . . . . 0.57 109.769 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.43 -52.48 52.94 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 120.009 -1.091 . . . . 0.75 110.536 -179.066 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.87 -44.81 69.07 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.073 -1.251 . . . . 1.59 110.465 -179.169 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.4 m -66.23 -62.28 1.56 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.999 -1.063 . . . . 0.73 112.24 -178.165 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -95.61 -49.56 5.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.889 -1.132 . . . . 0.75 111.171 -178.33 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.22 -167.72 25.99 Favored Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.843 -1.17 . . . . 1.22 110.905 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.94 -23.74 63.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.802 -0.823 . . . . 5.81 110.461 -179.344 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.423 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.7 tp10 -60.07 -36.02 76.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.254 -0.904 . . . . 3.37 110.211 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -98.23 -19.39 17.88 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.177 -0.952 . . . . 1.77 110.225 -179.283 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -70.12 -45.46 66.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.96 -1.087 . . . . 1.65 110.55 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.592 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -62.95 -30.58 71.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.433 -0.792 . . . . 0.77 110.235 -178.626 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.5 mt -59.72 -40.29 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.963 -1.086 . . . . 0.8 108.871 -179.588 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -65.05 -39.96 94.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.031 -1.043 . . . . 0.88 109.987 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -60.21 -40.06 88.79 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.965 -1.085 . . . . 1.37 109.444 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.5 -41.84 99.64 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.16 -1.576 . . . . 0.62 109.16 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -67.66 -39.98 84.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.283 -1.128 . . . . 1.5 109.728 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.4 mt -69.1 -46.4 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.005 -1.06 . . . . 0.63 109.104 179.555 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.3 ttp -59.9 -45.93 90.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.041 -1.037 . . . . 1.51 110.425 -179.239 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.873 HD22 HD23 ' B' ' 347' ' ' LEU . 55.2 tp -60.93 -40.07 91.84 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.245 -0.91 . . . . 0.77 109.809 179.792 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.7 tp -63.14 -40.01 96.35 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.376 -0.828 . . . . 0.62 109.642 -179.047 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -82.46 9.18 9.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.37 -0.831 . . . . 1.47 109.901 -179.34 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -55.68 132.3 48.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.991 -1.068 . . . . 1.47 110.139 -179.246 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -59.94 -21.21 60.85 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.511 -0.743 . . . . 1.78 111.129 -178.562 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -72.03 -34.51 68.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.787 -1.196 . . . . 2.53 109.686 178.93 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.9 -40.77 75.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.539 -0.726 . . . . 0.8 109.76 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -60.11 -50.1 75.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.857 . . . . 1.42 110.413 -179.137 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -70.61 -40.1 73.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.187 -0.945 . . . . 1.71 111.439 -179.171 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -69.91 -40.12 75.79 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.94 -1.1 . . . . 1.57 111.489 -178.569 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.57 -41.97 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.076 -1.015 . . . . 0.65 109.422 -179.505 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.02 -37.84 73.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.432 -0.792 . . . . 0.82 110.602 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.0 -46.28 89.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.79 110.803 -178.592 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 96' ' ' LYS . 29.3 mt -63.27 -45.83 89.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.755 -1.216 . . . . 0.95 109.411 -179.741 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.08 -50.0 81.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.954 0.883 . . . . 0.66 108.796 179.523 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -70.2 -41.0 74.26 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.851 -0.74 . . . . 2.2 110.258 179.616 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -80.38 -53.05 6.97 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.062 -1.024 . . . . 1.65 112.252 -177.877 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 92' ' ' LEU . 25.9 mtpp -89.96 -3.92 57.76 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.023 -1.048 . . . . 2.03 111.854 -177.395 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 25.9 m170 58.62 38.82 25.12 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.988 -1.07 . . . . 1.42 109.306 -179.362 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.0 mtp -97.87 165.81 11.76 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.592 -0.692 . . . . 1.18 109.959 -179.526 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 46.4 p -76.65 162.22 27.91 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.402 -0.811 . . . . 0.98 109.586 -179.906 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.82 -37.18 79.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.335 -0.853 . . . . 0.64 110.482 -179.479 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 35.2 p-10 -69.96 -36.94 75.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.86 -1.15 . . . . 2.07 109.633 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.498 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -77.04 -44.97 28.81 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.4 -0.813 . . . . 0.73 109.843 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.02 -41.65 74.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.54 109.523 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.16 -37.94 81.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.065 -1.022 . . . . 0.56 109.71 179.651 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -60.11 -41.01 91.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.436 -0.79 . . . . 1.54 109.938 -178.679 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.04 -40.12 96.78 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.271 -0.893 . . . . 1.33 110.383 -179.447 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.74 -55.77 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.108 -0.995 . . . . 0.72 111.542 -177.797 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.417 HG21 ' HA3' ' A' ' 134' ' ' GLY . 47.3 mm -70.08 -40.04 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.645 -1.284 . . . . 0.85 109.22 -178.903 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -69.95 -38.11 76.03 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.344 -0.984 . . . . 2.44 108.344 178.869 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.08 -46.77 93.61 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.82 -1.312 . . . . 0.98 109.82 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -64.88 -49.04 72.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.894 -1.356 . . . . 1.41 108.866 179.577 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.87 -39.68 86.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.465 -0.772 . . . . 1.2 109.269 179.615 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.5 t -54.85 -40.0 69.18 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.326 -0.859 . . . . 1.7 109.035 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.81 -36.74 78.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 1.47 109.917 179.768 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.35 -46.17 81.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.09 -1.006 . . . . 1.56 110.558 -178.75 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -62.89 -22.06 66.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.495 -1.378 . . . . 2.2 110.268 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -67.43 -21.08 65.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.803 -1.185 . . . . 2.12 108.566 178.932 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 123' ' ' LEU . 19.4 mt -63.88 142.51 58.38 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.158 -1.053 . . . . 2.0 108.158 179.245 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 29.4 p-10 -90.78 53.24 2.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.873 -1.142 . . . . 3.23 110.516 -179.65 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 64.9 t0 -136.33 135.07 38.58 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.176 -0.953 . . . . 2.49 109.795 179.331 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.477 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 99.2 mt-10 -70.17 -32.54 70.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.297 -0.877 . . . . 3.95 110.447 -179.881 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.495 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.9 t80 -70.08 -37.22 75.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.257 -0.902 . . . . 2.0 110.46 179.538 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 118' ' ' LEU . 77.1 mt -74.0 -39.95 63.26 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.236 -0.915 . . . . 1.86 109.256 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.8 -44.32 96.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.941 . . . . 2.84 109.964 179.538 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 45.8 mt-10 -60.1 -41.3 92.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.111 -0.993 . . . . 2.73 109.29 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.55 HH21 HD23 ' A' ' 123' ' ' LEU . 9.9 ttp180 -66.73 -38.74 87.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.153 -1.054 . . . . 2.77 108.153 179.057 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.21 -26.22 64.66 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.077 -1.083 . . . . 1.19 108.077 178.62 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -69.79 -40.25 76.12 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.111 -1.07 . . . . 1.2 108.111 178.709 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -64.79 -40.15 94.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.405 -0.809 . . . . 1.55 109.206 179.693 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.53 -39.98 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.278 -1.008 . . . . 0.8 108.278 179.471 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -60.28 -39.88 88.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.479 -0.763 . . . . 3.09 109.125 179.267 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -58.14 -40.24 80.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 1.46 109.888 -179.269 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.01 -46.69 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.998 -1.064 . . . . 0.71 109.42 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.417 ' HA3' HG21 ' A' ' 108' ' ' ILE . . . -69.79 -31.54 70.25 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.791 -1.324 . . . . 0.57 109.791 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.69 -49.67 76.84 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.244 -1.151 . . . . 2.59 109.208 -179.477 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.521 HH11 ' HG2' ' A' ' 136' ' ' ARG . 17.6 mtt-85 -67.07 -36.01 81.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.08 -1.012 . . . . 2.83 109.67 179.672 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.8 tp -54.54 -49.01 71.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.476 -0.765 . . . . 1.25 109.801 -178.726 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.09 -40.07 88.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.369 -0.832 . . . . 0.7 109.565 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -72.78 -36.1 67.55 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.264 -0.897 . . . . 2.57 108.661 178.542 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.401 ' CG ' ' O ' ' A' ' 136' ' ' ARG . 68.5 m-20 -60.15 -39.75 87.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.836 -0.54 . . . . 1.23 110.97 -179.227 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.8 mt -71.09 -45.13 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.758 -1.214 . . . . 0.81 108.65 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.6 mt -69.97 -40.07 75.61 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.523 -0.871 . . . . 1.0 108.949 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.68 51.57 3.04 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.072 -1.611 . . . . 0.89 109.072 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.6 tp -73.72 148.57 42.53 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.314 -1.109 . . . . 1.14 109.009 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -66.57 141.22 57.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 4.6 109.641 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.2 mt -113.53 130.0 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-O 121.762 0.791 . . . . 1.24 110.069 -179.578 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.3 mp -68.01 -40.09 82.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.746 -0.596 . . . . 1.54 110.309 -178.599 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.3 t0 63.29 123.25 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.396 -0.815 . . . . 1.5 108.947 -178.776 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.9 mt -90.13 -0.74 57.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 0.79 110.088 -179.06 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.5 t -86.08 -17.49 34.95 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.042 -1.036 . . . . 1.4 110.17 -179.553 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.98 24.8 0.73 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.139 -0.975 . . . . 0.92 110.734 -178.838 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 41.8 mm -90.82 120.69 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.77 -1.206 . . . . 0.88 109.276 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -101.23 -17.51 16.56 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.436 -0.79 . . . . 2.45 110.259 -179.379 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -115.34 145.97 41.99 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.637 -0.665 . . . . 1.52 110.874 -178.846 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -63.8 135.23 56.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.523 -0.736 . . . . 1.58 109.4 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.0 m -151.55 164.57 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.649 -0.657 . . . . 0.69 109.452 179.39 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 86.0 mt -94.96 147.2 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 105.999 -1.852 . . . . 0.61 105.999 177.474 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 51.9 tp -96.99 117.96 32.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.035 -1.04 . . . . 0.87 110.767 -177.374 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.539 HG12 HG22 ' A' ' 209' ' ' THR . 42.3 t -121.75 127.47 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.451 -0.944 . . . . 0.71 108.451 178.846 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -156.91 161.53 39.65 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 0.81 108.717 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.93 -31.71 63.19 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.26 -1.525 . . . . 0.98 109.172 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 64.9 t0 -169.23 141.92 2.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.434 -0.791 . . . . 2.25 109.128 -179.706 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 24.6 mt -112.08 142.71 44.17 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.362 -0.837 . . . . 0.78 110.226 -179.24 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.0 p -99.56 146.8 32.42 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.466 -0.771 . . . . 0.98 109.247 179.449 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -43.56 -36.7 7.33 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.952 1.768 . . . . 0.81 112.691 179.215 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.6 m -60.0 -39.94 87.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.267 -0.896 . . . . 0.9 109.767 -178.72 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.46 -41.31 93.52 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.187 -0.945 . . . . 1.61 109.992 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 41.1 p -56.44 -33.94 66.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.61 110.959 -178.4 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.4 -53.9 20.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.91 -1.119 . . . . 0.6 109.58 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -86.47 36.34 0.69 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.604 -0.888 . . . . 1.4 108.604 179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.2 tp -100.46 130.6 46.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.817 . . . . 0.7 109.166 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -82.79 98.96 9.39 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.276 -1.009 . . . . 2.35 108.276 179.412 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 71.0 mt -65.13 -41.14 95.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.403 -0.811 . . . . 1.51 111.085 -178.569 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -66.61 -25.59 66.68 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.844 -1.16 . . . . 2.33 111.571 -177.752 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -93.32 -8.2 42.68 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.768 -1.207 . . . . 1.92 110.479 -179.037 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 178' ' ' GLY . 63.3 t -109.31 119.65 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.385 -0.968 . . . . 0.67 108.385 178.578 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.8 mt -91.42 7.1 42.78 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.262 -0.899 . . . . 1.53 110.947 -177.992 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.496 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.44 171.07 36.97 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.355 -1.402 . . . . 0.48 109.626 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.473 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 12.9 m-85 -133.94 129.76 36.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.463 -1.022 . . . . 0.55 109.066 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.3 mt -132.1 127.28 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.235 -1.024 . . . . 0.65 108.235 178.428 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 43.1 p -147.44 159.93 43.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.879 -1.138 . . . . 0.82 110.406 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -104.27 21.74 16.04 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.914 -0.773 . . . . 2.46 108.914 179.813 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.14 -159.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.995 -1.066 . . . . 1.28 111.202 -178.094 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.46 -53.15 8.99 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.357 -1.097 . . . . 2.19 110.357 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 157.07 -124.27 1.41 Allowed Glycine 0 N--CA 1.494 2.558 0 O-C-N 120.897 -1.355 . . . . 2.13 110.64 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -69.69 -23.9 63.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.39 -1.065 . . . . 5.86 111.014 -178.815 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 59.8 p -70.53 0.12 7.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.928 -1.107 . . . . 3.72 109.756 -179.29 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 39.2 m -89.46 124.7 34.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.08 -1.013 . . . . 1.74 110.119 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -46.48 -50.87 16.36 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.436 -0.79 . . . . 0.95 109.924 -179.549 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.82 -35.59 61.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.402 -0.811 . . . . 1.55 110.549 -178.812 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.5 t -60.07 -45.6 92.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.929 -1.107 . . . . 1.51 110.73 -179.185 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.08 -40.64 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 1.67 109.735 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.0 mtp -61.44 -40.03 92.99 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.084 -1.01 . . . . 1.02 109.964 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.61 -42.71 67.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.737 -1.227 . . . . 0.68 108.915 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -59.57 -50.06 75.36 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.461 -0.895 . . . . 2.93 109.517 -179.02 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 67.1 m -72.4 -33.13 66.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.204 -0.935 . . . . 0.86 111.114 -179.221 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.05 -22.81 63.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.952 -1.093 . . . . 0.67 109.515 -179.5 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 63.71 48.78 3.17 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.437 0.636 . . . . 1.5 110.055 -178.984 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 60.1 mt -130.25 150.1 75.19 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 107.797 -1.186 . . . . 0.72 107.797 178.693 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.56 144.98 62.71 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.949 1.766 . . . . 0.61 111.567 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -173.36 153.56 2.43 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.064 -1.055 . . . . 0.66 111.102 179.688 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 92.7 mt -124.72 151.62 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 107.669 -1.234 . . . . 0.79 107.669 178.832 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.0 m -133.67 -11.44 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 120.844 -1.16 . . . . 0.91 111.249 -178.988 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -111.17 25.73 13.49 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.655 -0.978 . . . . 1.01 110.655 -179.375 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.448 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.3 p -47.46 -38.21 13.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.759 -1.436 . . . . 0.99 109.595 -179.206 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.18 -51.06 3.4 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 120.085 -1.055 . . . . 1.12 111.257 178.782 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 207' ' ' SER . 12.9 t -156.51 33.24 0.32 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.558 -1.554 . . . . 1.72 111.4 -178.83 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 22.8 t -74.52 -36.02 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.66 -1.275 . . . . 0.89 108.348 178.159 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.539 HG22 HG12 ' A' ' 159' ' ' VAL . 44.4 p -59.97 -38.37 82.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.449 -0.782 . . . . 1.03 110.159 -179.553 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 50.4 m -82.01 -11.06 59.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.995 -1.065 . . . . 1.83 110.308 -179.162 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -99.05 -13.23 19.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.043 -1.036 . . . . 2.27 110.601 -179.231 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 213' ' ' LYS . 80.8 t -114.62 154.0 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.247 -0.908 . . . . 0.92 110.955 -178.74 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.482 ' N ' HG12 ' A' ' 212' ' ' VAL . 12.1 mptt -113.17 154.56 26.47 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.261 -1.385 . . . . 2.2 107.261 178.658 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 24.8 p-10 -59.82 141.52 55.17 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.974 -1.078 . . . . 2.36 110.134 -179.461 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 m-20 85.67 6.36 0.43 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.213 0.53 . . . . 2.38 110.032 179.692 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 53.2 t0 -76.62 150.16 36.46 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.262 -0.898 . . . . 2.09 108.71 179.037 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.526 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 50.8 t80 -95.25 122.85 38.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.066 -1.021 . . . . 1.27 108.844 179.725 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.0 mt -126.88 138.5 53.32 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.299 -0.875 . . . . 0.75 110.702 -179.288 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.4 HG23 ' CD2' ' A' ' 13' ' ' PHE . 83.6 mt -110.19 128.25 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 106.453 -1.684 . . . . 0.63 106.453 176.385 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 42.9 tp -103.36 119.92 39.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.065 -1.022 . . . . 0.7 109.901 -178.302 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 10' ' ' GLY . 30.9 t0 -83.44 -41.75 17.73 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.631 -0.877 . . . . 2.31 108.631 179.259 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.84 25.35 0.72 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.927 -0.768 . . . . 0.78 108.927 -179.574 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 37.4 t -130.74 -42.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.329 -1.36 . . . . 1.04 107.329 178.861 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.528 ' ND2' ' OE1' ' A' ' 226' ' ' GLN . 50.7 p30 -111.34 1.66 17.2 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.04 -1.467 . . . . 2.44 107.04 178.228 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.587 HD22 ' N ' ' A' ' 4' ' ' GLY . 32.8 t-20 62.15 50.12 4.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.93 -0.577 . . . . 1.55 110.258 -179.794 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.528 ' OE1' ' ND2' ' A' ' 224' ' ' ASN . 52.5 mt-30 -132.12 145.0 51.1 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.308 -0.87 . . . . 1.99 109.426 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 66.5 t -118.36 129.08 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.345 -0.983 . . . . 0.77 108.345 179.013 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -104.29 124.56 49.39 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.385 -0.969 . . . . 0.98 108.385 179.446 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.7 t -101.25 110.69 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.471 -0.768 . . . . 0.85 110.005 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 230' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 230' ' ' ASN . 30.9 t-20 48.64 67.01 4.92 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.31 -0.868 . . . . 1.66 110.571 179.541 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -86.72 157.22 8.96 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.843 2.362 . . . . 0.95 111.96 179.304 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.4 m -69.86 161.63 29.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 1.84 110.216 -179.071 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -60.04 -39.2 85.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.381 -0.824 . . . . 2.74 109.733 -179.689 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -60.04 -37.02 78.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.208 -0.932 . . . . 2.89 109.56 -179.146 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.27 -40.75 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.017 -1.052 . . . . 1.3 109.123 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.3 mt . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.44 -0.788 . . . . 1.09 109.764 179.873 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 35.1 ttp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.391 0.615 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -153.13 149.01 27.62 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.33 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -149.33 160.03 43.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.845 -1.159 . . . . 0.0 110.506 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -152.41 149.69 28.86 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 305' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 57.4 mp0 -107.84 130.69 54.97 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.239 -0.913 . . . . 0.0 109.555 179.381 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.83 119.09 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 122.316 1.055 . . . . 0.0 112.503 -177.726 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 94.9 m -76.86 104.07 7.15 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.159 0.98 . . . . 0.0 110.115 -178.907 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.542 HD12 ' HB ' ' B' ' 359' ' ' THR . 66.0 mt -52.56 116.35 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 122.35 1.072 . . . . 0.0 110.61 -178.017 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 30.5 p -102.08 22.3 13.37 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.632 -178.918 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.406 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -81.41 123.21 81.34 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.093 179.463 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -70.09 -9.02 25.03 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 CA-C-N 120.203 1.108 . . . . 0.0 112.058 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -119.76 4.22 11.05 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 75.7 178.52 43.64 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.495 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -88.49 97.21 10.95 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.129 -1.218 . . . . 0.0 108.389 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.447 ' CE1' ' H ' ' B' ' 317' ' ' ARG . 6.9 p80 -95.0 -160.62 0.8 Allowed 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.097 -1.002 . . . . 0.0 110.034 179.677 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 19.5 m -59.9 -42.05 92.99 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.017 -1.052 . . . . 0.0 112.681 -175.831 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.592 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.3 tpt180 -61.82 -64.2 3.36 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 120.229 -1.544 . . . . 0.0 111.396 -178.313 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -55.38 -32.46 81.75 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 CA-C-N 120.096 1.07 . . . . 0.0 111.929 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.88 -51.6 69.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 108.845 179.525 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.51 -40.07 65.11 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 0.0 109.652 -179.274 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 321' ' ' GLN . . . . . 0.526 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 73.1 tp60 -68.21 -45.19 74.01 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.958 -1.089 . . . . 0.0 108.961 179.258 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -60.0 -50.83 72.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.485 -0.759 . . . . 0.0 110.52 -179.245 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.55 -30.69 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.623 -1.298 . . . . 0.0 109.698 -179.166 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 324' ' ' LYS . . . . . 0.526 ' NZ ' ' OE1' ' B' ' 321' ' ' GLN . 0.4 OUTLIER -59.96 -45.38 92.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.868 . . . . 0.0 109.093 179.701 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -68.28 -40.06 81.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.392 -0.818 . . . . 0.0 110.951 -178.909 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 326' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' B' ' 328' ' ' GLY . . . -74.08 -53.97 8.82 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.752 -1.218 . . . . 0.0 111.252 -178.74 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -49.51 -14.6 0.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 110.336 -178.581 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 328' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' B' ' 326' ' ' ALA . . . -79.98 -16.27 77.24 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.0 -179.897 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -105.73 143.31 34.06 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.378 -1.072 . . . . 0.0 109.308 179.577 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 31.8 m -90.19 -12.46 38.05 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.984 -1.072 . . . . 0.0 110.301 -179.564 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.432 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 13.5 p -60.49 145.01 49.99 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.93 -1.106 . . . . 0.0 109.232 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -67.66 137.06 55.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.087 -1.008 . . . . 0.0 108.75 179.678 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.3 mt -134.04 134.02 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.535 -0.728 . . . . 0.0 110.137 -179.194 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 51.9 m -129.36 149.02 51.32 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.446 -0.784 . . . . 0.0 109.164 178.959 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 64.6 t -123.34 116.63 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.063 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 93.0 m -105.95 129.32 54.11 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.088 -1.007 . . . . 0.0 109.153 -179.143 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 1.4 m -136.03 115.37 12.6 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.756 0.789 . . . . 0.0 110.666 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 40.1 t30 46.03 52.57 9.94 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 177.492 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.15 -13.73 53.19 Favored Glycine 0 N--CA 1.5 2.908 0 O-C-N 120.222 -1.549 . . . . 0.0 112.65 176.778 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 13.1 tptm -115.46 125.82 53.57 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 118.959 1.379 . . . . 0.0 108.834 -179.517 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 82.6 p -127.42 149.98 49.84 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.92 0.867 . . . . 0.0 110.574 -178.685 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 342' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -145.58 167.75 22.29 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.434 0.635 . . . . 0.0 110.234 -178.653 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 49.0 m -88.92 138.89 31.0 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.609 -0.682 . . . . 0.0 110.434 -179.233 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.47 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -81.09 -15.55 55.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.024 -1.048 . . . . 0.0 110.456 -179.366 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -84.05 22.26 1.21 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 178.33 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 346' ' ' SER . . . . . 0.47 ' H ' ' C ' ' B' ' 344' ' ' ALA . 63.6 m -150.81 101.67 2.93 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.661 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.873 HD23 HD22 ' A' ' 79' ' ' LEU . 17.3 tp -59.86 -36.6 77.21 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.388 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.852 ' CE2' HD11 ' A' ' 79' ' ' LEU . 52.6 m-85 -57.95 -53.04 62.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.86 . . . . 0.0 110.299 -179.574 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -68.53 -21.74 64.55 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.272 -0.892 . . . . 0.0 111.241 -176.884 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' B' ' 352' ' ' THR . 76.8 mt -69.26 -52.61 25.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.395 -1.44 . . . . 0.0 108.886 178.442 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.539 ' O ' HD22 ' A' ' 123' ' ' LEU . 0.8 OUTLIER -39.4 -22.33 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.696 -0.627 . . . . 0.0 110.953 -178.156 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.519 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.1 p -80.12 -10.81 59.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.18 -1.575 . . . . 0.0 110.235 -179.13 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' B' ' 342' ' ' ALA . 44.4 mt -96.48 117.79 31.64 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.085 -1.009 . . . . 0.0 108.925 178.729 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.5 95.46 0.78 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.359 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 92.6 mt -95.68 78.62 3.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -1.185 . . . . 0.0 108.691 179.252 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 75.6 p -90.97 179.75 5.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.944 . . . . 0.0 110.549 -178.338 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 357' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' B' ' 359' ' ' THR . 12.1 tt0 -50.79 157.47 0.79 Allowed 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 122.188 0.994 . . . . 0.0 111.097 -179.494 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 358' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 38.39 26.55 0.04 OUTLIER Glycine 0 N--CA 1.498 2.804 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.336 177.691 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 359' ' ' THR . . . . . 0.542 ' HB ' HD12 ' B' ' 308' ' ' ILE . 13.6 m -84.83 106.77 16.61 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.612 -1.522 . . . . 0.0 110.131 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 11.7 t -78.27 113.52 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 122.248 1.023 . . . . 0.0 110.231 -177.556 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 34.4 m -111.58 179.06 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -178.973 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 37.2 m -130.16 128.28 41.45 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 176.869 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.17 116.31 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.573 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 24.9 p -120.23 132.92 55.54 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.417 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.79 153.93 40.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 0.0 109.917 -178.888 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -147.03 125.8 12.64 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.075 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.458 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 159.23 -158.45 29.52 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.086 -1.53 . . . . 0.0 111.335 -179.654 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.14 -49.86 75.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 122.017 -0.696 . . . . 0.0 112.485 -177.385 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.432 ' H ' ' HB3' ' B' ' 331' ' ' SER . 76.9 m-20 -114.28 13.64 17.91 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.914 -1.116 . . . . 0.0 111.528 -177.039 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.551 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -42.91 -33.8 0.85 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.23 -0.919 . . . . 0.0 111.035 -179.1 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 371' ' ' GLN . . . . . 0.532 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 92.4 mm-40 -69.95 -44.2 70.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.059 -1.026 . . . . 0.0 110.412 -178.896 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -67.52 -47.63 69.36 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.544 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.67 -76.83 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.334 -0.854 . . . . 0.0 110.61 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.61 ' O ' HG23 ' B' ' 378' ' ' VAL . 94.4 t -46.4 -35.36 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 110.969 -177.319 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -67.11 -46.16 75.03 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.221 -1.549 . . . . 0.0 110.238 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -77.61 -43.48 31.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.807 -1.183 . . . . 0.0 109.546 179.165 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.05 -39.59 86.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 0.0 109.968 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.61 HG23 ' O ' ' B' ' 374' ' ' VAL . 48.5 t -60.06 -45.21 95.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.772 -1.171 . . . . 0.0 109.168 179.657 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 379' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' B' ' 383' ' ' GLU . 99.3 mttt -70.0 -56.59 6.59 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.655 -1.278 . . . . 0.0 108.114 178.565 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 42.3 tp -54.88 -35.35 63.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.402 -0.811 . . . . 0.0 109.709 -178.024 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 381' ' ' MET . . . . . 0.502 ' O ' ' CE ' ' B' ' 381' ' ' MET . 0.0 OUTLIER -73.47 -39.9 64.55 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.44 -1.304 . . . . 0.0 107.826 177.635 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.48 -4.75 50.09 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.184 -0.948 . . . . 0.0 110.205 179.534 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' B' ' 379' ' ' LYS . 69.6 mm-40 -111.81 1.08 16.42 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.198 -0.939 . . . . 0.0 110.723 179.86 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 16.1 mt -90.36 129.3 36.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.761 -1.212 . . . . 0.0 109.261 179.362 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.326 -179.501 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.8 mtp . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.232 -0.655 . . . . 2.91 109.232 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.1 mt -110.49 124.85 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.499 -0.75 . . . . 1.2 109.601 -179.804 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.427 ' HB3' HD22 ' A' ' 225' ' ' ASN . 60.5 m -133.28 145.6 50.62 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.563 -0.71 . . . . 1.4 109.154 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -129.37 -164.36 11.43 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 108.868 -1.693 . . . . 1.05 108.868 179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.1 mt -88.23 -9.93 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.922 -1.34 . . . . 1.15 110.116 -179.098 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 54.6 tp 50.3 98.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.16 -0.963 . . . . 0.98 109.13 179.804 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.11 -31.13 12.27 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.164 -0.96 . . . . 0.88 109.201 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 12.1 t -131.46 119.49 17.44 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 108.947 -0.761 . . . . 1.69 108.947 179.697 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -81.51 148.85 16.39 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.104 1.869 . . . . 0.85 112.812 -179.764 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.93 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 143.76 176.83 18.15 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 108.829 -1.708 . . . . 0.92 108.829 179.755 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 88.4 mt -120.0 153.78 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.147 -1.207 . . . . 0.81 109.833 -179.351 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.11 152.15 29.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.51 109.773 179.761 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.3 m-85 -133.47 127.58 33.59 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.334 -0.987 . . . . 0.62 108.334 179.565 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.78 175.47 47.37 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 118.885 -1.626 . . . . 0.55 110.687 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -78.66 155.4 29.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.654 -0.91 . . . . 2.1 109.529 -179.523 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.518 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -102.12 131.48 48.59 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.376 -0.828 . . . . 0.77 111.121 -178.586 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.9 tp -100.23 134.86 42.54 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.681 -1.229 . . . . 0.91 107.681 178.31 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.2 tp -115.35 119.97 38.06 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.252 -0.905 . . . . 0.93 110.144 -179.458 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt -88.87 101.11 13.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.503 -0.748 . . . . 0.93 109.944 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -95.78 133.66 39.64 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.235 -1.024 . . . . 2.75 108.235 179.441 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.535 ' CG ' HH21 ' A' ' 139' ' ' ARG . 81.8 tt0 -131.54 141.08 49.64 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.242 -0.911 . . . . 3.0 109.696 -179.398 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -88.24 141.9 28.19 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.453 -0.779 . . . . 2.77 109.662 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.52 139.98 58.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.038 -1.039 . . . . 2.94 109.078 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.5 mt -83.03 136.64 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -0.943 . . . . 0.95 108.915 179.495 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.7 t -102.69 129.55 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.444 -0.785 . . . . 1.28 109.329 -179.612 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.6 mt -106.8 138.92 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.834 -0.802 . . . . 1.21 108.834 179.919 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -92.87 119.27 32.02 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.01 -1.056 . . . . 1.81 109.586 -179.59 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.428 HH11 ' HG3' ' A' ' 28' ' ' ARG . 23.8 mmm-85 -86.95 -2.96 59.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.563 -0.711 . . . . 2.8 109.557 -179.5 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.7 144.37 56.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.125 -0.984 . . . . 2.87 109.902 179.575 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -87.99 151.17 22.98 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.837 -0.801 . . . . 2.35 108.837 179.563 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.5 pt -98.12 166.73 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.076 -1.015 . . . . 0.97 110.46 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.8 p -90.45 174.5 7.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 1.17 108.762 178.834 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.89 -18.7 63.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.14 -0.975 . . . . 1.18 111.087 -179.332 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -83.27 -27.4 29.89 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.565 -1.334 . . . . 2.56 108.709 178.974 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -81.19 -8.42 59.75 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.242 -0.651 . . . . 1.79 109.242 179.45 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.5 t -61.54 -54.13 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.224 -0.923 . . . . 1.0 108.917 179.516 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -62.14 -39.89 94.12 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.42 -0.8 . . . . 1.77 109.829 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -63.93 -42.78 97.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.033 -1.042 . . . . 2.7 110.104 -179.36 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -64.15 -39.79 94.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.923 -1.111 . . . . 1.51 110.328 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.85 -47.52 91.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.665 -1.272 . . . . 0.93 108.458 -179.877 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -60.04 -41.12 91.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.949 -1.094 . . . . 1.81 108.855 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -60.04 -44.47 94.63 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.842 -1.17 . . . . 2.78 107.842 178.705 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -60.32 -47.58 85.41 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.744 -0.836 . . . . 0.78 108.744 178.129 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.4 tp -59.9 -49.33 78.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 1.07 109.224 179.869 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.0 t -62.42 -43.58 98.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.024 -1.047 . . . . 1.12 109.44 179.582 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.26 -46.39 94.02 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.132 -1.587 . . . . 0.84 109.132 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -67.24 -30.71 70.68 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.328 -1.101 . . . . 3.09 108.454 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.8 -45.75 91.36 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.458 -0.776 . . . . 0.88 109.244 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 50' ' ' ALA . 30.6 ttpt -61.4 -72.69 0.11 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.901 -1.148 . . . . 2.59 107.901 179.427 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.86 -33.68 0.06 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.477 -0.764 . . . . 0.7 111.725 -178.188 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 64.1 m -59.95 -50.65 72.92 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.064 -1.454 . . . . 1.4 107.95 179.452 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.62 -40.09 76.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.44 -0.788 . . . . 0.67 111.211 -179.215 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -66.45 -40.04 89.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.663 -1.273 . . . . 1.66 110.116 -179.427 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.1 mt -65.09 -40.0 93.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.925 . . . . 1.58 109.783 -179.464 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -61.85 -38.04 86.75 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.98 -1.075 . . . . 1.35 109.694 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -63.63 -41.62 98.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 0.77 109.774 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.3 -39.89 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.198 -0.939 . . . . 0.63 109.077 179.756 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -55.67 -50.05 71.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -0.842 . . . . 1.14 109.542 -179.586 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -57.34 -33.23 67.53 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.223 -0.923 . . . . 0.79 110.062 -178.457 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -69.82 -39.76 76.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.944 -1.097 . . . . 1.53 110.594 179.593 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.407 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.13 -44.36 80.07 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.232 -0.918 . . . . 0.57 110.218 -178.931 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.78 -50.89 62.83 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.931 -1.268 . . . . 0.75 109.931 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.9 -43.93 70.75 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.99 -1.3 . . . . 1.59 109.985 -179.783 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.0 m -66.43 -62.73 1.31 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.118 -0.989 . . . . 0.73 111.742 -178.09 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -95.43 -48.71 5.74 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.872 -1.143 . . . . 0.75 111.316 -178.071 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.83 -166.64 25.86 Favored Glycine 0 N--CA 1.504 3.173 0 C-N-CA 119.818 -1.182 . . . . 1.22 111.043 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.51 -23.42 64.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.673 -0.898 . . . . 5.81 109.618 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -60.73 -37.69 82.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.816 . . . . 3.37 110.872 -179.579 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -99.43 -15.01 18.88 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.007 -1.058 . . . . 1.77 109.858 -179.567 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -70.03 -39.99 75.42 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.081 -1.012 . . . . 1.65 109.085 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.496 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.68 -31.5 72.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.622 -0.674 . . . . 0.77 109.946 -179.466 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 80.8 mt -59.89 -41.2 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.828 -1.17 . . . . 0.8 108.538 179.836 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -65.3 -39.32 92.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.959 . . . . 0.88 110.501 179.707 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -60.01 -39.85 87.21 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.697 -1.252 . . . . 1.37 109.086 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.41 -48.96 68.36 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.462 -1.855 . . . . 0.62 108.462 178.677 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -62.02 -44.72 96.11 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.264 -1.139 . . . . 1.5 108.682 179.203 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 80.9 mt -68.7 -48.6 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.266 -0.896 . . . . 0.63 109.344 179.429 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 52.3 ttp -60.17 -40.83 91.3 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.939 -1.101 . . . . 1.51 109.764 -179.168 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.848 HD22 HD23 ' B' ' 347' ' ' LEU . 53.5 tp -64.97 -39.9 94.18 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.338 -0.851 . . . . 0.77 109.907 179.639 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.0 tp -64.27 -40.1 95.29 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.497 -0.752 . . . . 0.62 110.268 -179.137 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -81.06 7.85 9.95 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.904 -1.123 . . . . 1.47 110.557 -178.853 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -56.91 129.78 43.03 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.081 -1.012 . . . . 1.47 110.134 -178.974 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -60.33 -15.36 24.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.33 -0.857 . . . . 1.78 110.438 -179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -69.9 -35.98 75.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.956 -1.09 . . . . 2.53 108.675 178.677 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.2 mt -71.17 -42.84 68.56 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.49 0.662 . . . . 0.8 110.054 179.735 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.59 -47.77 84.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.907 . . . . 1.42 110.551 -179.138 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -70.74 -43.92 67.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.089 -1.007 . . . . 1.71 111.746 -178.737 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -70.41 -38.65 74.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.127 -0.983 . . . . 1.57 111.525 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.53 -42.23 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.044 -1.035 . . . . 0.65 110.016 -179.062 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.81 -37.78 77.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.42 -0.8 . . . . 0.82 110.17 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.01 -46.45 89.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.137 -0.977 . . . . 0.79 111.13 -179.03 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.2 mt -60.96 -45.55 94.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.734 -1.228 . . . . 0.95 109.992 -178.964 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.36 -50.02 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 0.66 109.42 -179.577 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.04 -40.91 74.85 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.833 -0.747 . . . . 2.2 110.487 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -81.54 -50.5 9.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.129 -0.982 . . . . 1.65 112.249 -178.185 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -93.04 -2.24 55.83 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.071 -1.018 . . . . 2.03 111.982 -176.976 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 57.4 35.97 26.57 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.059 -1.026 . . . . 1.42 109.793 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.5 mtt -90.39 168.04 12.18 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.45 -0.781 . . . . 1.18 110.128 -179.457 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.5 p -80.15 160.64 25.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.489 -0.757 . . . . 0.98 109.597 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.82 -39.72 76.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.64 110.381 -179.557 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 34.2 p-10 -66.31 -39.2 89.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.052 -1.03 . . . . 2.07 109.821 -179.626 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.484 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -78.93 -51.59 9.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.73 109.704 179.417 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.48 77.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.537 -0.727 . . . . 0.54 111.131 -179.002 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.04 -45.92 91.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.065 -1.022 . . . . 0.56 110.018 -179.059 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -58.39 -37.16 74.7 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.308 -0.87 . . . . 1.54 109.917 -179.706 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.92 -39.99 91.5 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.26 -0.9 . . . . 1.33 111.014 -179.127 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.85 -49.97 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.832 -1.168 . . . . 0.72 110.58 -178.631 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.7 mm -67.42 -40.24 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.992 -1.067 . . . . 0.85 108.237 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -66.92 -37.2 83.89 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.184 -1.043 . . . . 2.44 108.184 178.836 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.93 -49.0 83.34 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.009 -1.236 . . . . 0.98 110.009 -179.484 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -65.86 -48.05 72.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.853 -1.38 . . . . 1.41 109.123 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.383 -0.823 . . . . 1.2 109.222 -179.825 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 58.5 m -60.02 -40.1 88.15 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.267 -1.012 . . . . 1.7 108.267 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.35 -43.5 96.45 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.45 -0.944 . . . . 1.47 108.45 179.074 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.7 mt -64.04 -48.83 74.72 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.159 -1.052 . . . . 1.56 108.159 179.302 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -49.48 -31.86 10.91 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.321 -0.862 . . . . 2.2 109.998 -179.11 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.74 -20.28 55.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.892 -1.13 . . . . 2.12 108.668 179.555 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 74.1 mt -63.15 140.05 58.83 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.511 -0.922 . . . . 2.0 108.511 179.317 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -99.11 49.01 0.95 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.116 -0.99 . . . . 3.23 111.02 -178.531 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 24.7 t0 -137.38 153.22 50.23 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.145 -0.972 . . . . 2.49 109.119 178.993 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.457 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 99.5 mt-10 -72.44 -64.78 0.88 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.95 -1.13 . . . . 3.95 107.95 178.352 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.437 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 6.6 t80 -41.33 -43.74 2.56 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.91 -0.494 . . . . 2.0 110.895 -179.234 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.607 HD23 HH21 ' A' ' 126' ' ' ARG . 85.3 mt -69.88 -40.05 75.92 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.604 -1.31 . . . . 1.86 109.028 -179.836 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -65.33 -37.36 86.85 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.525 -0.735 . . . . 2.84 109.563 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 95.0 mt-10 -59.83 -42.15 92.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.391 -0.818 . . . . 2.73 110.268 -179.031 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.607 HH21 HD23 ' A' ' 123' ' ' LEU . 82.2 mtm180 -70.05 -32.72 70.98 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.924 -1.11 . . . . 2.77 108.812 179.621 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.22 -22.77 65.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.735 -1.209 . . . . 1.19 107.735 178.458 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -73.72 -40.04 63.85 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.511 -0.922 . . . . 1.2 108.511 178.609 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.99 -41.22 99.51 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.433 -0.792 . . . . 1.55 110.377 -179.587 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.8 t -68.67 -40.45 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.047 -1.033 . . . . 0.8 108.873 179.776 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.415 HH11 ' HG2' ' A' ' 131' ' ' ARG . 36.3 ttt-85 -60.19 -37.69 81.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 3.09 108.779 178.602 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 61.6 t0 -59.84 -38.97 83.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.527 -0.733 . . . . 1.46 109.68 -179.483 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.04 -40.65 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.083 -1.011 . . . . 0.71 109.563 -179.486 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.13 -26.85 67.53 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.848 -1.301 . . . . 0.57 109.848 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -60.1 -49.62 76.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -1.186 . . . . 2.59 109.575 -179.217 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.412 HH22 ' HB3' ' A' ' 166' ' ' SER . 98.5 mtt180 -68.32 -32.96 73.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.786 -1.197 . . . . 2.83 110.559 179.545 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.6 tp -54.34 -43.96 71.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.936 -1.103 . . . . 1.25 108.795 -179.338 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.92 -39.98 93.91 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.124 -0.985 . . . . 0.7 109.037 178.999 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.624 HH12 HD23 ' A' ' 144' ' ' LEU . 3.2 mtt-85 -68.13 -40.02 82.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.856 . . . . 2.57 109.714 179.407 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -68.76 -38.27 79.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.458 -0.776 . . . . 1.23 112.265 -178.439 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.91 -40.09 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.321 -1.487 . . . . 0.81 108.791 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 92.2 mt -76.03 -28.69 57.8 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.509 -0.744 . . . . 1.0 110.167 -179.429 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.81 38.95 18.46 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.423 -1.471 . . . . 0.89 109.423 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.624 HD23 HH12 ' A' ' 139' ' ' ARG . 3.3 tp -73.89 147.18 43.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.259 -1.141 . . . . 1.14 108.619 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -66.43 137.02 56.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.034 -1.041 . . . . 4.6 109.653 -179.153 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 83.2 mt -109.83 132.92 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 122.218 1.008 . . . . 1.24 108.512 179.548 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.3 mt -65.02 -39.97 87.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 115.637 -0.71 . . . . 1.54 110.768 -178.304 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 41.3 t0 63.21 102.23 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.412 -0.805 . . . . 1.5 108.861 -179.255 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.9 mt -70.02 -1.11 8.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.365 -0.834 . . . . 0.79 111.49 -178.023 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.7 t -84.66 -13.15 52.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.524 -1.36 . . . . 1.4 110.324 -179.734 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.93 31.64 0.2 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.092 -1.005 . . . . 0.92 112.052 -178.07 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.8 mm -86.04 120.0 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.234 -1.541 . . . . 0.88 109.087 179.546 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -101.41 -9.32 21.22 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.321 -0.862 . . . . 2.45 110.462 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -140.31 159.93 41.1 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.039 -1.038 . . . . 1.52 110.867 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.83 132.88 50.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.501 -0.75 . . . . 1.58 109.162 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.0 m -152.06 165.5 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.274 -0.891 . . . . 0.69 110.074 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.9 mt -97.09 145.29 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 105.522 -2.029 . . . . 0.61 105.522 176.958 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.3 tp -95.41 115.49 27.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.873 -1.142 . . . . 0.87 110.614 -177.967 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.526 HG12 HG22 ' A' ' 209' ' ' THR . 57.0 t -120.28 128.07 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 N-CA-C 108.257 -1.016 . . . . 0.71 108.257 179.026 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.48 165.58 30.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.025 -1.047 . . . . 0.81 109.27 -179.582 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.77 -38.0 73.41 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.363 -1.461 . . . . 0.98 108.567 178.61 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 54.0 t0 -171.7 147.16 2.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.582 -0.699 . . . . 2.25 109.468 -179.667 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.412 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 17.6 mt -119.91 136.72 54.4 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.281 -0.887 . . . . 0.78 108.859 179.505 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.5 p -89.98 149.98 42.75 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.179 -0.951 . . . . 0.98 110.009 -179.424 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -40.63 -39.39 2.95 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.563 2.175 . . . . 0.81 113.438 179.58 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.412 ' HB3' HH22 ' A' ' 136' ' ' ARG . 66.1 m -59.99 -39.96 87.51 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.966 -1.084 . . . . 0.9 109.253 -179.122 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.68 -40.08 94.78 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.346 -0.846 . . . . 1.61 110.129 -179.828 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 51.7 p -57.97 -34.55 70.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.163 -0.96 . . . . 0.61 111.225 -177.973 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -69.4 -50.91 41.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.962 -1.086 . . . . 0.6 109.914 -179.659 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -85.7 36.67 0.67 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.421 -0.799 . . . . 1.4 108.9 -179.612 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.2 tp -99.97 140.01 34.8 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.451 -0.781 . . . . 0.7 109.491 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -84.4 104.63 14.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.021 -1.049 . . . . 2.35 108.62 179.185 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 63.2 mt -65.75 -40.97 92.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.442 -0.786 . . . . 1.51 111.612 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -81.25 -15.01 56.82 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.638 -1.289 . . . . 2.33 112.162 -177.172 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -95.33 -10.63 29.59 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.611 -1.305 . . . . 1.92 109.132 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 178' ' ' GLY . 99.9 t -110.28 120.08 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.401 -0.812 . . . . 0.67 108.82 178.669 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -91.64 7.85 39.59 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.027 -1.045 . . . . 1.53 110.723 -178.794 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.27 172.37 38.04 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.543 -1.423 . . . . 0.48 109.543 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -132.94 129.89 38.88 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.326 -1.102 . . . . 0.55 109.403 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.439 ' CG2' HG21 ' A' ' 205' ' ' THR . 96.2 mt -132.02 124.26 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.865 -0.791 . . . . 0.65 108.865 178.67 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 53.6 p -146.97 159.8 43.12 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.132 -0.98 . . . . 0.82 110.761 -179.615 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.8 OUTLIER -96.35 21.63 8.83 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.124 -0.695 . . . . 2.46 109.124 179.686 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.485 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -45.58 -176.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 122.341 1.067 . . . . 1.28 112.847 -177.898 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.93 -56.77 4.71 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 111.131 -0.788 . . . . 2.19 111.131 -179.119 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.46 -144.24 5.1 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.118 -1.515 . . . . 2.13 110.79 -179.34 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 188' ' ' SER . 82.1 mtm180 -69.66 -28.14 65.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.54 -0.976 . . . . 5.86 110.302 -178.977 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 69.7 p -62.95 5.82 0.12 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.194 -0.942 . . . . 3.72 110.614 -178.756 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 186' ' ' ARG . 40.4 t -90.67 128.35 36.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.987 -1.071 . . . . 1.74 109.894 -179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -47.52 -44.17 25.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.316 -0.865 . . . . 0.95 108.825 179.687 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 45.3 p -57.8 -39.56 77.82 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.78 -0.575 . . . . 1.55 110.425 -179.058 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 58.5 m -59.94 -40.17 88.04 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.997 -1.064 . . . . 1.51 110.899 -178.868 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.555 HD12 ' N ' ' A' ' 192' ' ' ILE . 2.2 mp -64.75 -40.07 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.951 -1.093 . . . . 1.67 110.295 -179.035 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.5 mtp -61.25 -41.14 96.39 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.843 -1.161 . . . . 1.02 110.615 -179.441 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.86 -44.1 94.32 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.505 -1.372 . . . . 0.68 109.541 -179.73 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.43 HH11 ' HG2' ' A' ' 195' ' ' ARG . 30.0 mtt-85 -60.23 -50.1 74.99 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.272 -0.893 . . . . 2.93 109.996 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 39.4 m -72.0 -35.72 69.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.11 -0.994 . . . . 0.86 111.823 -178.985 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.6 mt -76.67 -13.24 60.07 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.499 -1.376 . . . . 0.67 110.194 -178.702 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 59.81 46.08 11.87 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.533 -0.73 . . . . 1.5 110.547 179.392 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.409 ' O ' ' CB ' ' A' ' 8' ' ' SER . 90.6 mt -122.85 128.91 25.2 Favored Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 108.687 -0.857 . . . . 0.72 108.687 179.313 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -43.41 133.92 6.8 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.82 1.68 . . . . 0.61 112.073 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -167.27 147.17 5.32 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.575 -1.25 . . . . 0.66 111.89 -179.483 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.7 mt -125.58 141.07 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 107.772 -1.196 . . . . 0.79 107.772 178.362 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 11.2 m -126.71 -7.29 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 120.806 -1.184 . . . . 0.91 110.589 -179.067 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.15 22.06 25.84 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.544 -1.022 . . . . 1.01 110.544 -179.62 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.456 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 12.6 p -47.14 -44.58 21.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.834 -1.392 . . . . 0.99 109.782 -179.287 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.69 -53.96 4.07 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 120.022 -1.085 . . . . 1.12 112.036 178.688 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.0 t -150.03 28.27 0.76 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 120.485 -1.597 . . . . 1.72 111.905 -178.2 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 45.6 t -70.25 -40.07 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.74 -1.225 . . . . 0.89 109.126 178.314 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.526 HG22 HG12 ' A' ' 159' ' ' VAL . 75.9 p -53.79 -30.82 46.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.377 -0.827 . . . . 1.03 111.392 -178.945 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.7 m -81.28 -12.95 58.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.823 -1.173 . . . . 1.83 110.283 -179.132 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -102.57 -12.14 17.98 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.141 -0.974 . . . . 2.27 110.351 -179.612 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 85.0 t -107.86 139.24 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.177 -0.952 . . . . 0.92 111.675 -177.66 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -114.25 150.01 35.02 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.356 -1.35 . . . . 2.2 107.356 178.212 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.507 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 21.3 p-10 -57.1 140.45 49.28 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.735 -1.228 . . . . 2.36 109.9 -179.356 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.1 t0 87.15 4.07 0.37 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 109.525 -0.546 . . . . 2.38 109.525 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 64.8 t0 -74.7 139.41 43.44 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.204 -0.935 . . . . 2.09 109.561 179.512 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.469 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 48.4 t80 -91.94 116.56 29.02 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.524 -1.287 . . . . 1.27 107.524 178.456 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.518 HD12 ' HB2' ' A' ' 16' ' ' ALA . 76.4 mt -127.37 149.4 50.08 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.468 -0.77 . . . . 0.75 110.297 -178.631 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 63.1 mt -114.66 129.71 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 106.859 -1.534 . . . . 0.63 106.859 176.905 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 55.0 tp -100.14 119.17 37.92 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.078 -1.082 . . . . 0.7 108.078 -179.153 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.459 ' C ' ' N ' ' A' ' 223' ' ' VAL . 78.7 m-20 -81.4 -46.73 14.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.965 -1.084 . . . . 2.31 109.51 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.93 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 48.23 17.27 0.11 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.792 -0.818 . . . . 0.78 108.792 -179.251 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.459 ' N ' ' C ' ' A' ' 221' ' ' ASP . 55.3 t -127.19 -49.42 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.256 -1.387 . . . . 1.04 107.256 178.387 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -100.31 2.87 42.98 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.412 -1.329 . . . . 2.44 107.412 178.37 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.427 HD22 ' HB3' ' A' ' 3' ' ' SER . 49.7 t30 59.82 49.18 8.24 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.04 -0.726 . . . . 1.55 109.04 -179.071 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -136.85 147.11 46.33 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.438 -0.789 . . . . 1.99 109.572 -179.642 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.5 t -119.89 126.84 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.269 -1.011 . . . . 0.77 108.269 179.474 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -100.1 117.56 34.61 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.185 -0.947 . . . . 0.98 108.934 179.854 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.3 t -98.8 111.52 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.734 -0.604 . . . . 0.85 109.914 -179.044 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 43.3 t30 55.18 68.54 2.47 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.311 -0.868 . . . . 1.66 111.235 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -90.67 145.42 3.86 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 123.13 2.553 . . . . 0.95 112.122 178.944 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 61.2 p -69.95 163.98 24.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.039 -1.038 . . . . 1.84 109.646 -179.618 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -60.19 -40.38 89.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 2.74 110.071 -178.945 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -60.07 -39.98 87.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.057 -1.027 . . . . 2.89 109.522 -179.785 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.69 -40.4 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.052 -1.03 . . . . 1.3 109.299 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.0 mt . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.266 -0.896 . . . . 1.09 109.085 179.72 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' B' B ' 301' ' ' MET . . . . . 0.482 ' N ' ' OE1' ' B' ' 366' ' ' GLU . 11.0 ttt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.488 0.661 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -156.93 154.23 29.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.382 -0.824 . . . . 0.0 109.056 178.98 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -151.21 162.44 40.88 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.916 -1.115 . . . . 0.0 110.737 -178.951 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 304' ' ' GLN . . . . . 0.418 ' NE2' HG11 ' B' ' 378' ' ' VAL . 49.0 tt0 -154.96 152.16 29.37 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.611 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -113.0 133.93 54.74 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.094 -1.004 . . . . 0.0 110.346 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.1 p -134.45 125.61 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 CA-C-O 122.415 1.102 . . . . 0.0 112.475 -178.492 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 307' ' ' THR . . . . . 0.487 ' O ' HG23 ' B' ' 309' ' ' THR . 93.9 m -77.83 106.29 9.57 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.306 -177.875 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.9 mt -52.13 122.02 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 122.222 1.01 . . . . 0.0 110.413 -178.186 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 309' ' ' THR . . . . . 0.487 HG23 ' O ' ' B' ' 307' ' ' THR . 62.4 p -110.73 18.62 19.45 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.697 -178.579 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.25 115.98 53.69 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.083 -1.011 . . . . 0.0 109.584 179.642 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -49.5 -15.4 0.9 Allowed 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 121.114 1.209 . . . . 0.0 114.266 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -118.92 9.44 11.93 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.199 -0.938 . . . . 0.0 109.694 -179.42 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.2 177.74 26.64 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -179.118 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.437 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.0 tp -83.73 93.86 8.02 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.034 -1.274 . . . . 0.0 109.716 -178.32 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -95.92 -162.52 0.96 Allowed 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.661 -1.274 . . . . 0.0 110.391 179.274 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 25.8 m -55.9 -40.01 72.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.154 -0.967 . . . . 0.0 112.377 -176.31 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.517 HH21 ' CD ' ' B' ' 321' ' ' GLN . 1.7 tpt180 -62.9 -61.65 7.09 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 120.677 -1.265 . . . . 0.0 112.507 -178.37 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.98 -32.54 95.53 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 CA-C-N 120.275 1.134 . . . . 0.0 111.896 -179.24 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.94 -50.07 75.21 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.139 -1.024 . . . . 0.0 108.457 179.363 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.65 -40.61 60.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.71 -179.423 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 321' ' ' GLN . . . . . 0.517 ' CD ' HH21 ' B' ' 317' ' ' ARG . 27.2 mt-30 -72.8 -40.06 66.18 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.827 -1.149 . . . . 0.0 109.457 178.631 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -60.28 -51.5 69.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.18 -0.95 . . . . 0.0 109.996 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 92.4 t -69.01 -24.73 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.936 -1.103 . . . . 0.0 110.501 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 324' ' ' LYS . . . . . 0.466 ' HZ1' ' HA ' ' B' ' 321' ' ' GLN . 0.9 OUTLIER -60.03 -42.49 94.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.859 -1.15 . . . . 0.0 108.823 179.9 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -69.5 -60.06 2.58 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.626 -0.671 . . . . 0.0 111.562 -178.185 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.1 -9.01 43.1 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.822 -1.174 . . . . 0.0 112.698 -177.512 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -83.67 -20.3 33.81 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.441 -1.412 . . . . 0.0 110.113 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -87.52 -10.97 69.56 Favored Glycine 0 N--CA 1.498 2.78 0 C-N-CA 120.084 -1.055 . . . . 0.0 111.158 -178.915 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -102.45 143.23 32.44 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.961 -1.317 . . . . 0.0 109.417 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 57.9 p -89.59 -13.84 36.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.034 -1.041 . . . . 0.0 110.06 -179.739 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 82.2 p -58.9 145.24 41.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.109 -0.994 . . . . 0.0 109.095 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 332' ' ' GLU . . . . . 0.462 ' OE1' ' N ' ' B' ' 332' ' ' GLU . 49.5 mp0 -68.26 130.1 41.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.187 -0.946 . . . . 0.0 109.069 -179.804 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 86.1 mt -132.18 132.55 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.589 -0.695 . . . . 0.0 110.21 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 95.3 m -131.06 151.3 51.56 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.5 -0.75 . . . . 0.0 109.725 179.393 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 96.3 t -125.12 120.05 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.765 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 95.1 m -116.84 130.09 56.49 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.037 -1.039 . . . . 0.0 110.329 -178.321 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 2.0 m -133.75 117.62 17.13 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.883 0.849 . . . . 0.0 110.037 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 48.3 t30 49.66 50.51 18.17 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 176.96 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.84 -12.01 65.03 Favored Glycine 0 N--CA 1.504 3.19 0 O-C-N 119.682 -1.886 . . . . 0.0 113.434 176.286 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -120.56 132.5 55.19 Favored 'General case' 0 N--CA 1.506 2.375 0 CA-C-N 119.292 1.546 . . . . 0.0 108.957 -179.498 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 95.7 p -135.78 156.15 49.26 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 121.94 0.876 . . . . 0.0 111.249 -178.317 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -145.65 167.36 23.29 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.583 0.706 . . . . 0.0 110.183 -179.401 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 3.7 t -85.38 133.54 34.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.614 -0.679 . . . . 0.0 110.212 -179.392 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -70.71 -19.11 62.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.126 -0.984 . . . . 0.0 110.687 -179.361 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -88.49 21.36 2.95 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.168 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 346' ' ' SER . . . . . 0.42 ' H ' ' C ' ' B' ' 344' ' ' ALA . 59.7 p -144.42 93.81 2.48 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.863 -179.037 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.848 HD23 HD22 ' A' ' 79' ' ' LEU . 44.4 tp -59.84 -38.97 83.6 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.669 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.715 ' CE2' HD11 ' A' ' 79' ' ' LEU . 57.5 m-85 -54.16 -52.28 61.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.185 -0.947 . . . . 0.0 110.946 -179.22 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -69.64 -39.24 77.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.432 -1.417 . . . . 0.0 110.102 -179.378 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' B' ' 352' ' ' THR . 23.7 mt -50.12 -59.78 3.59 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.73 -1.232 . . . . 0.0 109.534 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.551 ' OE1' ' NH1' ' A' ' 126' ' ' ARG . 13.1 mm-40 -43.29 -11.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.555 -0.716 . . . . 0.0 111.4 -177.499 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.586 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.3 p -89.47 -8.96 51.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.586 -1.321 . . . . 0.0 109.638 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 68.8 mt -93.44 120.0 33.2 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.011 -1.055 . . . . 0.0 108.664 178.58 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.04 94.81 0.81 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 44.2 mt -102.26 88.22 3.25 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.429 -1.041 . . . . 0.0 109.569 179.691 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 71.8 p -93.11 170.8 9.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.071 -1.018 . . . . 0.0 110.528 -179.566 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -64.45 116.39 6.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.758 -0.589 . . . . 0.0 110.99 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 102.26 4.83 50.14 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.511 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 49.7 m -85.67 110.83 19.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.37 -1.077 . . . . 0.0 110.84 -179.244 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 45.7 t -76.23 115.9 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.965 0.888 . . . . 0.0 109.206 -177.301 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 13.3 m -110.21 175.79 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -178.266 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 26.4 m -130.86 131.29 44.47 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 177.463 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 78.3 mt -108.71 120.84 60.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.432 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 78.3 p -127.2 136.81 52.56 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.021 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.53 155.21 41.64 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.88 -1.138 . . . . 0.0 110.66 -179.271 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 366' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' B' ' 301' ' ' MET . 12.6 tp10 -144.84 121.98 11.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.476 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.452 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 161.07 -158.71 30.37 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 118.474 -1.822 . . . . 0.0 112.08 179.573 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -59.98 -51.89 67.73 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.396 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -110.13 11.31 23.78 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.958 -1.089 . . . . 0.0 111.239 -177.086 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' B' ' 371' ' ' GLN . 0.0 OUTLIER -40.52 -31.66 0.16 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.279 -0.888 . . . . 0.0 112.469 -178.43 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' B' B ' 371' ' ' GLN . . . . . 0.553 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 63.9 mt-30 -66.81 -48.3 69.38 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.374 -1.454 . . . . 0.0 110.958 -177.861 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -66.86 -48.17 69.66 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.53 -1.268 . . . . 0.0 108.339 179.669 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -42.6 -40.85 2.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.702 -0.624 . . . . 0.0 111.697 -178.614 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.506 ' O ' HG23 ' B' ' 378' ' ' VAL . 62.4 t -80.05 -32.63 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.283 -1.511 . . . . 0.0 109.769 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.98 -41.64 74.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.823 . . . . 0.0 112.392 -177.682 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 376' ' ' HIS . . . . . 0.488 ' O ' ' N ' ' B' ' 380' ' ' LEU . 67.1 m80 -86.54 -42.38 13.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.398 -1.438 . . . . 0.0 110.382 -179.513 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.05 -40.01 83.79 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.956 -1.097 . . . . 0.0 108.285 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.506 HG23 ' O ' ' B' ' 374' ' ' VAL . 51.1 t -64.36 -46.38 93.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.595 179.129 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -80.09 -9.5 59.71 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.785 -1.197 . . . . 0.0 109.786 178.492 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' B' ' 376' ' ' HIS . 49.5 tp -83.54 -28.27 28.74 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 176.769 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 56.9 tpp -81.42 -29.56 33.82 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.121 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.21 -9.6 59.76 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.891 -0.506 . . . . 0.0 109.902 179.413 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -106.96 1.48 24.52 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.231 -0.918 . . . . 0.0 110.998 -179.652 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 384' ' ' LEU . . . . . 0.405 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 20.6 mt -78.59 117.89 20.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.275 -1.516 . . . . 0.0 110.002 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 117.912 -1.042 . . . . 0.0 108.736 178.715 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 mmt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.197 -0.668 . . . . 2.91 109.197 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 99.3 mt -109.77 126.42 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.407 -0.96 . . . . 1.2 108.407 179.202 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -125.13 121.6 34.71 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.604 -0.685 . . . . 1.4 110.018 -178.78 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.72 -164.97 32.99 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.186 -1.566 . . . . 1.05 109.186 179.166 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' LEU . 88.2 mt -88.68 -13.6 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.02 -1.283 . . . . 1.15 109.854 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 5' ' ' ILE . 56.2 tp 46.07 99.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.227 -0.921 . . . . 0.98 110.342 179.094 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.51 -29.48 12.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.031 -1.043 . . . . 0.88 108.963 179.063 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 40.9 t -119.22 116.46 33.86 Favored Pre-proline 0 N--CA 1.501 2.101 0 N-CA-C 109.039 -0.726 . . . . 1.69 109.039 179.46 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.22 142.83 17.19 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.618 1.545 . . . . 0.85 111.877 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.734 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 161.4 -159.72 31.51 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.218 -1.553 . . . . 0.92 109.218 -179.713 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.3 mt -148.51 148.37 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 120.808 -1.407 . . . . 0.81 109.09 179.638 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.18 153.12 30.24 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.899 -1.126 . . . . 0.51 111.291 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 8.7 m-85 -133.16 129.94 38.52 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.72 -1.585 . . . . 0.62 106.72 177.891 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.67 175.68 46.63 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 117.936 -2.078 . . . . 0.55 111.245 -179.725 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -77.47 160.02 28.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.889 -0.771 . . . . 2.1 109.11 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.447 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -100.45 127.15 46.87 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.312 -0.867 . . . . 0.77 110.927 -179.06 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.5 tp -100.79 134.35 43.89 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 106.972 -1.492 . . . . 0.91 106.972 178.011 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.2 tp -120.4 122.32 40.49 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.123 -0.985 . . . . 0.93 110.044 -179.564 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 62.0 mt -80.85 102.61 10.14 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.499 0.666 . . . . 0.93 109.678 -179.421 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -99.34 131.09 45.6 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.451 -0.781 . . . . 2.75 109.883 -179.219 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -127.39 139.11 53.07 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.969 -0.752 . . . . 3.0 108.969 -179.948 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 61.6 t0 -82.7 149.71 27.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.983 -1.073 . . . . 2.77 109.171 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.55 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 70.7 tt0 -68.08 147.31 52.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 2.94 109.269 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.3 mt -97.62 133.78 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.232 -0.918 . . . . 0.95 109.181 -179.747 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.3 t -103.43 127.86 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.249 -0.907 . . . . 1.28 110.164 -179.056 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 84.1 mt -99.2 142.48 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.477 -0.765 . . . . 1.21 109.293 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -97.11 117.32 31.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.065 -1.022 . . . . 1.81 109.449 -179.762 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -89.27 3.61 51.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.172 -0.955 . . . . 2.8 109.153 -179.644 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -67.22 140.1 57.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 2.87 110.283 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -84.8 141.93 30.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 2.35 109.333 179.631 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.431 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.8 pt -89.84 164.1 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.97 109.365 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 100.0 p -95.86 171.63 8.52 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.042 -1.036 . . . . 1.17 108.77 179.338 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.38 -48.35 80.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.882 -1.136 . . . . 1.18 109.376 -179.443 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -55.91 -30.38 61.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.698 -1.251 . . . . 2.56 109.878 -179.855 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -80.94 -9.69 59.8 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.214 -0.929 . . . . 1.79 109.837 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 40' ' ' VAL . 40.9 t -62.41 -50.17 80.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 120.781 -1.199 . . . . 1.0 108.796 179.758 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -65.49 -40.11 92.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.842 -1.161 . . . . 1.77 110.199 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -69.97 -40.12 75.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.11 -0.993 . . . . 2.7 109.895 -179.282 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.544 ' OE2' ' NH1' ' A' ' 42' ' ' ARG . 28.1 mm-40 -68.37 -40.07 81.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 1.51 110.301 -179.242 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 36' ' ' VAL . 53.1 t -59.95 -41.21 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.608 -1.256 . . . . 0.93 107.608 179.173 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -58.38 -37.97 76.34 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.563 -0.71 . . . . 1.81 109.626 -179.873 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.544 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 99.3 mtt180 -58.7 -41.71 86.95 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.865 -1.134 . . . . 2.78 108.016 179.443 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -62.73 -47.88 81.65 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.409 -0.959 . . . . 0.78 108.409 178.243 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 65.8 tp -59.85 -49.06 79.17 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.901 -1.148 . . . . 1.07 107.901 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.1 t -60.58 -45.15 95.01 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.464 -0.939 . . . . 1.12 108.464 178.653 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.93 -43.89 97.66 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.151 -1.98 . . . . 0.84 108.151 178.962 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -63.26 -33.09 74.75 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.476 -1.014 . . . . 3.09 108.72 178.34 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.25 -39.94 84.39 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.553 -0.717 . . . . 0.88 109.57 -179.207 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 50' ' ' ALA . 26.1 ttmt -70.67 -74.03 0.15 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.258 -1.386 . . . . 2.59 107.258 178.999 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.59 -39.61 0.34 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.944 -0.472 . . . . 0.7 111.126 -178.763 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.4 t -56.25 -59.04 5.52 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.338 -1.477 . . . . 1.4 108.559 179.598 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.17 -39.98 90.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.367 -0.833 . . . . 0.67 111.105 -179.267 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -69.82 -40.7 75.74 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.837 -1.164 . . . . 1.66 110.471 -178.931 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.3 mt -62.49 -39.95 95.15 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.915 -1.116 . . . . 1.58 108.063 179.408 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -62.87 -38.43 90.85 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.375 -0.828 . . . . 1.35 109.194 178.762 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.7 m -64.01 -43.81 94.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.77 109.477 179.137 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.3 mt -61.69 -37.84 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 0.63 109.192 179.693 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -58.8 -50.21 74.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 1.14 109.56 -179.422 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -57.49 -33.69 68.28 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.494 -0.754 . . . . 0.79 110.676 -177.737 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -69.62 -37.96 77.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.225 -0.922 . . . . 1.53 109.366 -179.438 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.41 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -66.29 -48.6 69.87 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.34 -0.85 . . . . 0.57 109.762 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.08 -55.67 22.88 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 120.169 -1.015 . . . . 0.75 110.572 -179.146 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -70.18 -43.59 70.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.085 -1.244 . . . . 1.59 111.016 -178.844 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.5 m -63.09 -62.81 1.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.0 -1.063 . . . . 0.73 111.617 -177.742 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -97.4 -43.53 7.25 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.954 -1.091 . . . . 0.75 111.541 -177.926 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.65 -171.4 24.4 Favored Glycine 0 N--CA 1.501 3.032 0 O-C-N 120.703 -1.248 . . . . 1.22 111.298 179.619 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -68.95 -23.02 64.09 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.816 -0.814 . . . . 5.81 109.59 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.512 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.9 tp10 -60.01 -34.3 73.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.807 -0.558 . . . . 3.37 110.741 -179.508 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -98.71 -18.86 17.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.199 -0.938 . . . . 1.77 109.62 -179.695 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -67.68 -39.44 84.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 1.65 109.916 -179.799 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.579 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.91 -34.21 76.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.77 110.304 -178.685 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 85.1 mt -59.77 -40.43 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.635 -1.291 . . . . 0.8 108.682 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -64.2 -38.74 92.14 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.1 -1.0 . . . . 0.88 110.175 179.068 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -59.06 -39.7 82.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.161 -0.962 . . . . 1.37 109.141 -179.602 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.0 -41.02 95.47 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.179 -1.568 . . . . 0.62 109.179 179.069 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -66.02 -49.65 66.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.998 -1.295 . . . . 1.5 108.472 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.2 mt -61.91 -49.32 84.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.577 -0.702 . . . . 0.63 109.372 179.279 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 40.5 ttp -59.93 -46.29 89.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.331 -0.855 . . . . 1.51 109.802 -179.698 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.871 HD11 ' CE2' ' B' ' 348' ' ' PHE . 57.1 tp -60.13 -41.49 92.77 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.353 -0.842 . . . . 0.77 109.347 179.698 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.2 -39.64 89.81 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.181 -0.608 . . . . 0.62 110.065 -178.677 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -79.12 2.76 19.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.188 -0.945 . . . . 1.47 109.37 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -51.14 129.41 24.17 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.296 -0.878 . . . . 1.47 110.415 -178.939 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.63 -16.54 39.68 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.8 -0.562 . . . . 1.78 110.138 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -74.13 -35.74 64.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.027 -1.045 . . . . 2.53 109.494 178.933 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.58 -41.06 72.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.453 -0.779 . . . . 0.8 110.754 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -60.01 -49.48 77.48 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.246 -0.909 . . . . 1.42 110.394 -178.644 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -69.77 -40.47 76.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 1.71 110.91 -178.916 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -67.9 -40.15 83.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.971 -1.081 . . . . 1.57 110.874 -178.975 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.93 -47.52 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.906 -1.121 . . . . 0.65 109.636 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -65.36 -38.57 82.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.618 -0.676 . . . . 0.82 110.263 179.974 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.63 85.09 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.221 -0.924 . . . . 0.79 111.244 -178.937 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.2 mt -59.87 -43.93 94.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.853 -1.154 . . . . 0.95 109.243 -179.043 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.8 mt -63.34 -48.49 87.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.437 -0.79 . . . . 0.66 109.501 179.424 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -68.57 -40.34 80.63 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.116 -0.99 . . . . 2.2 110.189 179.766 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.74 -52.43 7.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 1.65 111.604 -178.403 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -91.15 -3.08 57.37 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.117 -0.99 . . . . 2.03 112.247 -177.805 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 80.0 m80 57.29 39.05 28.81 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.816 -1.177 . . . . 1.42 109.834 -179.421 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 94.2 mtp -89.2 170.04 10.94 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.37 -0.832 . . . . 1.18 110.079 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.0 p -80.46 156.52 26.55 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.954 -0.758 . . . . 0.98 108.954 179.586 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.91 -39.9 75.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.11 -0.994 . . . . 0.64 110.2 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.58 -42.57 96.97 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.062 -1.024 . . . . 2.07 110.459 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.71 -46.33 14.43 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.374 -0.829 . . . . 0.73 110.494 -179.253 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.06 -48.26 82.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.372 -0.83 . . . . 0.54 110.364 -179.157 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.488 ' HB1' HD21 ' A' ' 137' ' ' LEU . . . -59.97 -47.51 85.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.929 . . . . 0.56 110.522 -179.094 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.655 ' HB2' HD21 ' A' ' 138' ' ' LEU . 85.0 t60 -60.15 -35.21 74.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.997 -1.065 . . . . 1.54 110.392 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.28 -39.91 88.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.012 -1.055 . . . . 1.33 110.559 -179.222 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.67 -50.09 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.803 -1.185 . . . . 0.72 110.973 -178.679 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.4 mm -68.96 -40.14 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 120.801 -1.187 . . . . 0.85 109.134 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -64.03 -38.32 90.65 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.799 -0.815 . . . . 2.44 108.799 178.771 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.97 -50.04 71.94 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 120.247 -0.977 . . . . 0.98 110.839 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -65.24 -53.43 44.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.866 -1.373 . . . . 1.41 110.484 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.54 -39.16 70.21 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.998 -1.064 . . . . 1.2 109.301 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.6 t -53.82 -40.66 66.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.295 -0.878 . . . . 1.7 108.663 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.84 70.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.505 -0.747 . . . . 1.47 109.483 179.025 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.0 mt -65.78 -43.84 87.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.026 -1.046 . . . . 1.56 109.818 -178.804 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.97 -38.5 82.71 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.499 -1.376 . . . . 2.2 108.912 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -54.74 -18.88 5.21 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.225 -0.922 . . . . 2.12 109.538 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.439 HD13 HD13 ' A' ' 123' ' ' LEU . 85.4 mt -61.57 139.98 58.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.085 -1.009 . . . . 2.0 109.479 -179.598 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -90.9 11.45 22.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.254 -0.904 . . . . 3.23 109.714 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -99.01 117.0 32.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.151 -0.968 . . . . 2.49 109.207 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -60.2 -30.59 69.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.272 -0.892 . . . . 3.95 109.363 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.451 ' OH ' ' CA ' ' B' ' 315' ' ' HIS . 19.8 t80 -61.02 -42.08 97.79 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.995 0.902 . . . . 2.0 109.161 179.274 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.893 HD22 ' O ' ' B' ' 351' ' ' GLN . 74.9 mt -80.4 -26.9 38.25 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.975 -0.75 . . . . 1.86 108.975 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -60.07 -43.94 95.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.47 -0.937 . . . . 2.84 108.47 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -60.61 -45.61 93.35 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.115 -1.068 . . . . 2.73 108.115 178.553 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -60.68 -39.43 88.43 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.748 -0.781 . . . . 2.77 109.08 178.403 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.17 -28.27 66.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.388 -0.82 . . . . 1.19 109.162 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.31 -38.78 71.72 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.225 -0.922 . . . . 1.2 109.677 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.5 -40.58 95.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.025 -1.047 . . . . 1.55 110.466 -179.368 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.435 HG21 HE22 ' B' ' 351' ' ' GLN . 38.1 t -69.82 -42.0 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.873 -1.142 . . . . 0.8 109.801 -179.912 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -60.59 -38.6 85.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.762 -1.211 . . . . 3.09 109.407 179.427 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -58.68 -39.74 81.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.395 -0.816 . . . . 1.46 110.011 -178.892 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.99 -41.45 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.091 -1.005 . . . . 0.71 109.921 -179.611 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.94 -35.75 92.48 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.919 -1.272 . . . . 0.57 109.919 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -60.05 -48.57 81.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.318 -1.107 . . . . 2.59 110.995 -178.717 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.417 HH22 ' CB ' ' A' ' 166' ' ' SER . 98.0 mtt180 -67.69 -30.89 70.53 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.571 -1.331 . . . . 2.83 110.383 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 137' ' ' LEU . . . . . 0.488 HD21 ' HB1' ' A' ' 104' ' ' ALA . 63.9 tp -58.53 -44.96 89.75 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.268 -1.012 . . . . 1.25 108.268 -179.175 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.655 HD21 ' HB2' ' A' ' 105' ' ' HIS . 66.1 mt -61.43 -43.97 97.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.7 110.192 178.631 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -70.02 -40.21 75.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.89 . . . . 2.57 109.891 -179.821 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -65.79 -37.92 87.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.671 -0.643 . . . . 1.23 111.048 -178.923 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.4 mt -66.98 -46.79 84.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 120.638 -1.289 . . . . 0.81 108.165 179.583 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 92.3 mt -70.16 -31.71 69.33 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.644 -0.66 . . . . 1.0 109.675 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.87 42.41 6.79 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.017 -1.633 . . . . 0.89 109.017 -178.908 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 tp -74.52 152.96 39.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.466 -1.02 . . . . 1.14 109.095 -179.654 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -64.23 143.24 58.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.083 -1.01 . . . . 4.6 109.626 -179.487 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.8 mt -115.4 121.77 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 CA-C-O 122.434 1.112 . . . . 1.24 109.22 179.279 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.2 mt -60.13 -47.74 90.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-N 115.019 -0.991 . . . . 1.54 110.858 -178.659 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.5 t0 62.92 106.04 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.615 -0.883 . . . . 1.5 108.615 -178.818 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.5 mt -69.33 0.3 5.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.296 -0.877 . . . . 0.79 110.174 -178.58 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 83.1 p -83.66 -13.87 53.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.048 -1.032 . . . . 1.4 110.379 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.64 28.23 0.49 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.112 -0.992 . . . . 0.92 111.916 -178.374 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 32.3 mm -90.58 118.15 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.484 -1.385 . . . . 0.88 108.405 179.184 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -104.88 -10.59 17.22 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.391 -0.818 . . . . 2.45 110.337 -178.863 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -126.48 150.94 48.42 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.097 -1.002 . . . . 1.52 109.832 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -63.98 133.02 52.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.436 -0.79 . . . . 1.58 109.731 -179.434 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.4 m -152.66 166.43 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.425 -0.797 . . . . 0.69 110.321 179.729 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 76.3 mt -95.82 147.86 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 105.994 -1.854 . . . . 0.61 105.994 177.214 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 48.7 tp -100.04 119.22 37.94 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.714 -1.241 . . . . 0.87 110.626 -177.989 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.84 129.96 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 107.978 -1.119 . . . . 0.71 107.978 178.64 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.46 161.96 35.55 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.125 -0.984 . . . . 0.81 109.069 -179.157 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.94 -37.25 75.82 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.111 -1.618 . . . . 0.98 107.294 178.412 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 13.1 p-10 -171.15 147.0 2.49 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.385 -0.598 . . . . 2.25 109.385 178.922 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.7 mt -106.04 141.36 37.55 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.336 -0.853 . . . . 0.78 108.926 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 82.1 p -94.38 144.66 28.35 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.22 -0.925 . . . . 0.98 108.828 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -40.13 -40.54 2.85 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.887 1.724 . . . . 0.81 112.268 179.724 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.417 ' CB ' HH22 ' A' ' 136' ' ' ARG . 61.4 m -60.42 -40.0 89.45 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.391 -0.818 . . . . 0.9 110.218 -179.646 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.45 -43.47 85.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.145 -0.972 . . . . 1.61 110.147 -179.099 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 40.2 p -55.67 -31.87 62.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.067 -1.021 . . . . 0.61 111.007 -178.007 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -69.73 -50.78 40.26 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.064 -1.023 . . . . 0.6 110.106 -179.547 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.41 ' H ' ' HG2' ' A' ' 170' ' ' GLN . 15.2 pt20 -88.7 39.36 0.92 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.482 -0.933 . . . . 1.4 108.482 -179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.5 tp -103.35 138.03 40.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.683 -0.636 . . . . 0.7 109.567 179.328 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -87.55 101.32 13.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.345 -0.847 . . . . 2.35 109.648 179.849 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 46.6 mt -64.23 -42.22 96.65 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.403 -0.811 . . . . 1.51 110.379 -179.34 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.53 -27.56 66.2 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.846 -1.158 . . . . 2.33 112.45 -177.737 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -92.69 -8.31 44.33 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.584 -1.322 . . . . 1.92 110.429 -178.657 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 178' ' ' GLY . 68.9 t -107.7 119.83 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.198 -0.939 . . . . 0.67 108.959 179.112 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.1 mt -88.84 8.37 29.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.287 -0.883 . . . . 1.53 111.227 -177.706 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.568 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 167.58 175.14 37.23 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.535 -1.426 . . . . 0.48 109.535 179.346 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -134.79 130.04 35.5 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.365 -1.079 . . . . 0.55 108.62 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.418 ' CG2' HG21 ' A' ' 205' ' ' THR . 95.7 mt -132.34 126.54 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.194 -0.941 . . . . 0.65 109.156 179.381 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 41.0 p -149.89 162.87 39.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.925 -1.109 . . . . 0.82 111.051 -179.696 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 183' ' ' ALA . 35.5 p-10 -106.19 23.23 14.4 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.787 -0.57 . . . . 2.46 109.505 -179.767 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -56.62 -161.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.778 -1.201 . . . . 1.28 111.588 -177.689 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.04 -56.54 5.71 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.772 -0.931 . . . . 2.19 110.772 -178.652 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 171.83 -142.37 6.89 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 118.612 -1.756 . . . . 2.13 111.349 -179.448 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.456 ' C ' ' H ' ' A' ' 188' ' ' SER . 97.3 mtt180 -69.66 -31.02 68.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.853 -0.793 . . . . 5.86 110.905 -178.535 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 82.5 p -62.62 2.17 0.31 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.0 -1.063 . . . . 3.72 109.803 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 186' ' ' ARG . 78.4 p -91.71 139.71 30.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.937 -1.102 . . . . 1.74 110.552 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -55.5 -39.53 70.59 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.784 -0.821 . . . . 0.95 108.784 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 190' ' ' THR . 2.0 p -57.52 -41.42 80.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.613 -0.68 . . . . 1.55 109.543 -179.538 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 186' ' ' ARG . 82.8 p -69.28 -38.08 78.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.178 -0.951 . . . . 1.51 111.255 -179.402 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.12 -44.48 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.885 -1.134 . . . . 1.67 110.106 -178.375 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.1 mtp -61.41 -40.3 93.92 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.041 -1.037 . . . . 1.02 111.18 -179.374 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.82 -42.66 76.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.683 -1.26 . . . . 0.68 109.113 -179.776 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -59.99 -51.79 68.15 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.088 -1.007 . . . . 2.93 109.263 -179.267 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.0 m -68.5 -36.89 79.56 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.449 -0.782 . . . . 0.86 111.106 -179.128 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 87.6 mt -69.91 -27.89 65.16 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.984 -1.117 . . . . 0.67 107.984 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 63.54 50.0 2.93 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.147 0.499 . . . . 1.5 110.587 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.477 ' O ' ' CB ' ' A' ' 8' ' ' SER . 77.0 mt -130.64 147.86 67.77 Favored Pre-proline 0 N--CA 1.505 2.285 0 N-CA-C 108.401 -0.963 . . . . 0.72 108.401 178.501 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -44.82 126.23 7.21 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.163 1.909 . . . . 0.61 112.65 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.32 139.85 12.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.537 -1.352 . . . . 0.66 111.963 179.44 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.6 mt -125.28 146.05 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.287 -1.375 . . . . 0.79 107.287 178.147 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.4 -4.82 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 120.84 -1.163 . . . . 0.91 110.588 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.91 21.21 27.9 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 110.831 -0.908 . . . . 1.01 110.831 -179.08 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.418 HG21 ' CG2' ' A' ' 180' ' ' ILE . 7.1 p -45.01 -41.06 7.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.03 -1.277 . . . . 0.99 110.261 -179.516 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.83 -50.98 3.79 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.201 -0.999 . . . . 1.12 111.005 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.3 t -158.57 38.45 0.23 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.588 -1.536 . . . . 1.72 111.354 -179.093 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.9 t -76.65 -39.38 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.819 -1.175 . . . . 0.89 108.967 178.582 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.438 HG23 ' H ' ' A' ' 209' ' ' THR . 2.8 p -57.09 -39.79 75.71 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.648 -0.657 . . . . 1.03 111.174 -177.877 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.0 p -80.03 -13.41 59.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.014 -1.053 . . . . 1.83 110.129 -178.894 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -95.51 -14.58 23.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.119 -0.988 . . . . 2.27 109.882 -179.404 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 213' ' ' LYS . 55.1 t -114.16 152.74 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.358 -0.839 . . . . 0.92 110.994 -178.845 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.447 ' N ' HG12 ' A' ' 212' ' ' VAL . 10.5 mptt -122.12 158.57 29.02 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.875 -1.158 . . . . 2.2 107.875 179.179 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 13.0 t-20 -54.69 140.36 35.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.177 -0.952 . . . . 2.36 111.075 -179.04 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.7 t70 84.38 10.58 0.39 Allowed 'General case' 0 N--CA 1.504 2.249 0 CA-C-O 120.991 0.424 . . . . 2.38 110.88 179.105 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -80.1 139.75 36.73 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.923 -1.11 . . . . 2.09 109.049 179.211 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -87.44 128.07 35.22 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.034 -1.098 . . . . 1.27 108.034 179.154 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.447 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 58.3 mt -131.71 138.76 48.8 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.199 -0.938 . . . . 0.75 110.532 -178.863 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.9 mt -111.61 125.48 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.484 -1.673 . . . . 0.63 106.484 176.802 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 29.8 tp -103.51 119.74 39.49 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.861 -1.149 . . . . 0.7 108.944 -179.234 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.626 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 23.2 p-10 -81.51 -37.13 28.35 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.048 -1.093 . . . . 2.31 108.048 178.966 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.86 17.93 0.06 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.732 -0.84 . . . . 0.78 108.732 -179.304 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 221' ' ' ASP . 55.3 t -135.96 -41.02 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.912 -1.144 . . . . 1.04 107.912 178.941 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -97.75 1.09 48.07 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.623 -1.251 . . . . 2.44 107.623 178.386 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.535 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 29.7 t-20 60.53 42.96 13.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.753 -0.592 . . . . 1.55 109.964 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.626 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 92.0 mt-30 -140.94 148.26 40.11 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.177 -0.952 . . . . 1.99 109.611 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -120.06 126.56 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.115 -1.068 . . . . 0.77 108.115 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -98.67 126.23 44.21 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.526 -1.287 . . . . 0.98 107.526 178.906 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.86 125.1 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.634 -0.666 . . . . 0.85 110.177 -177.958 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 53.78 68.4 2.86 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.135 -0.978 . . . . 1.66 108.839 -179.656 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -91.22 131.5 1.42 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 123.25 2.634 . . . . 0.95 112.588 -178.914 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 233' ' ' ASN . 23.5 m -63.54 166.51 6.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.315 -0.866 . . . . 1.84 109.769 -179.232 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.457 ' N ' HG22 ' A' ' 232' ' ' THR . 21.3 m120 -60.04 -40.08 88.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.134 -0.979 . . . . 2.74 110.045 -179.311 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -64.55 -32.18 73.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.965 -1.084 . . . . 2.89 110.092 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.53 -39.61 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.058 -1.026 . . . . 1.3 108.532 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.8 mt . . . . . 0 C--N 1.303 -1.424 0 O-C-N 121.377 -0.827 . . . . 1.09 109.022 179.219 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' B' B ' 301' ' ' MET . . . . . 0.415 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 37.0 ttp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.407 0.622 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 302' ' ' PHE . . . . . 0.415 ' N ' ' CG ' ' B' ' 301' ' ' MET . 16.8 t80 -152.44 148.8 27.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.353 -0.842 . . . . 0.0 108.871 179.552 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -152.36 163.59 39.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.889 -1.132 . . . . 0.0 110.573 -179.317 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -156.81 153.57 28.5 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.618 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 305' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 56.4 mp0 -115.08 130.9 57.04 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.203 -0.936 . . . . 0.0 109.414 179.029 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.55 125.32 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.425 0 CA-C-O 122.371 1.082 . . . . 0.0 111.435 -178.13 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 36.6 m -81.07 103.65 11.02 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.913 0.863 . . . . 0.0 111.114 -178.02 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.6 mt -52.22 121.5 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.456 1.122 . . . . 0.0 110.952 -177.627 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 74.1 p -106.33 18.01 22.6 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.066 -178.427 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.32 118.89 71.45 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.65 -1.281 . . . . 0.0 109.221 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -52.41 -15.01 3.42 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 CA-C-N 120.176 1.098 . . . . 0.0 112.569 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -118.91 8.52 11.71 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.54 177.89 31.98 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -179.298 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.435 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -85.93 93.19 8.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -1.184 . . . . 0.0 108.527 -179.192 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.483 ' CE1' ' HB3' ' B' ' 317' ' ' ARG . 24.1 p-80 -96.66 -160.15 0.78 Allowed 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.109 -0.994 . . . . 0.0 109.958 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.3 m -59.38 -43.12 92.96 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.831 -1.168 . . . . 0.0 112.146 -176.032 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.579 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 2.5 tpt180 -57.56 -61.82 6.51 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.453 -1.404 . . . . 0.0 111.703 -178.485 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.409 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 13.8 Cg_endo -59.42 -32.99 97.4 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 CA-C-N 119.932 1.011 . . . . 0.0 111.516 -179.431 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.27 -51.53 69.14 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.162 -0.961 . . . . 0.0 109.072 179.74 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.2 -41.71 62.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -0.85 . . . . 0.0 109.587 -178.791 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -71.33 -40.03 71.0 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.911 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -61.95 -54.78 37.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.426 -0.796 . . . . 0.0 109.784 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 89.8 t -61.33 -26.56 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.957 -1.09 . . . . 0.0 110.173 -178.899 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -63.02 -44.24 96.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.426 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -69.89 -40.14 75.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.383 -0.823 . . . . 0.0 111.731 -178.027 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 326' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' B' ' 328' ' ' GLY . . . -65.53 -55.86 15.49 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.3 -1.5 . . . . 0.0 111.924 -178.354 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -48.21 -10.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.033 -1.042 . . . . 0.0 110.281 -178.814 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 328' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' B' ' 326' ' ' ALA . . . -81.63 -15.35 76.01 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.23 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -107.07 140.42 39.91 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.377 -1.072 . . . . 0.0 109.255 179.433 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 16.9 m -91.31 -11.64 37.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 110.238 -179.981 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 35.9 m -64.77 155.11 34.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.759 -1.213 . . . . 0.0 109.591 179.656 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -70.76 133.83 46.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.89 -1.131 . . . . 0.0 108.315 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 90.2 mt -131.79 133.5 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-O 121.362 0.601 . . . . 0.0 109.954 -179.692 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.4 m -130.08 148.61 51.95 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.445 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 79.7 t -120.29 114.96 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 177.459 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 92.7 m -105.46 124.95 50.4 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.227 -0.92 . . . . 0.0 109.709 -178.289 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 48.4 t -134.35 120.5 19.97 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.139 0.971 . . . . 0.0 111.59 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 66.6 t30 45.37 50.99 9.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 176.717 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.7 -11.97 68.62 Favored Glycine 0 N--CA 1.501 3.031 0 O-C-N 120.155 -1.591 . . . . 0.0 113.15 176.472 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -126.44 138.87 53.58 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 119.389 1.594 . . . . 0.0 109.432 -179.809 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 60.2 p -130.58 152.69 49.67 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.118 0.961 . . . . 0.0 111.236 -178.512 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 342' ' ' ALA . . . . . 0.47 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -143.31 163.59 32.59 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.494 0.664 . . . . 0.0 109.52 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 10.8 t -87.52 135.89 33.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.637 -0.665 . . . . 0.0 110.821 -178.878 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.47 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -68.06 -21.31 65.0 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.107 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -80.3 25.18 0.41 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.037 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 346' ' ' SER . . . . . 0.47 ' H ' ' C ' ' B' ' 344' ' ' ALA . 58.4 m -152.92 92.94 1.69 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.814 -1.154 . . . . 0.0 113.266 -178.992 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.668 HD23 HD22 ' A' ' 79' ' ' LEU . 57.8 tp -59.53 -34.26 72.41 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 177.225 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.871 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.4 m-85 -58.81 -53.3 59.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.707 -0.621 . . . . 0.0 110.264 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -78.26 -16.45 57.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.771 -1.206 . . . . 0.0 110.619 -177.956 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.604 ' O ' ' N ' ' B' ' 352' ' ' THR . 26.4 mt -69.64 -56.16 8.02 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.146 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.893 ' O ' HD22 ' A' ' 123' ' ' LEU . 30.3 mt-30 -40.82 -12.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.103 -178.62 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.604 ' N ' ' O ' ' B' ' 350' ' ' LEU . 59.2 p -90.82 -8.19 50.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.52 -1.362 . . . . 0.0 109.954 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' B' ' 342' ' ' ALA . 85.0 mt -96.74 121.1 38.22 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.092 -1.005 . . . . 0.0 109.384 179.371 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.5 90.53 0.94 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.793 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 20.2 mt -99.79 91.94 5.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.19 -1.182 . . . . 0.0 108.855 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 38.0 p -94.01 -179.19 4.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.276 -0.89 . . . . 0.0 110.545 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -69.84 110.1 4.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.849 -0.532 . . . . 0.0 110.118 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 358' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 104.16 9.72 35.94 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 28.4 m -84.76 110.77 19.04 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.156 -1.202 . . . . 0.0 110.888 -179.482 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 27.2 t -77.12 111.86 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 122.237 1.018 . . . . 0.0 109.747 -177.328 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 17.5 m -109.03 175.02 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.296 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 32.3 m -131.79 128.61 39.15 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.647 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 95.0 mt -103.33 115.41 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.521 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 77.3 p -120.13 132.65 55.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.393 -0.817 . . . . 0.0 109.128 -179.356 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.81 152.61 40.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.898 . . . . 0.0 108.949 -179.057 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -147.71 125.45 11.87 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.16 -0.963 . . . . 0.0 109.471 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.495 ' O ' ' OE1' ' B' ' 370' ' ' GLU . . . 154.02 -148.97 20.26 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.277 -1.44 . . . . 0.0 111.532 179.824 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -60.02 -51.69 68.56 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.989 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.542 ' N ' ' OG ' ' B' ' 331' ' ' SER . 89.1 m-20 -112.71 13.77 19.89 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 120.835 -1.165 . . . . 0.0 111.267 -177.681 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.584 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 1.0 OUTLIER -42.39 -32.57 0.54 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.271 -0.893 . . . . 0.0 111.477 -179.011 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 371' ' ' GLN . . . . . 0.514 ' H ' ' CD ' ' B' ' 370' ' ' GLU . 10.3 pt20 -70.94 -43.2 68.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.853 -1.154 . . . . 0.0 110.205 -178.745 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -69.43 -54.25 15.26 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.377 -0.827 . . . . 0.0 109.159 179.473 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.86 -34.51 8.93 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.621 -0.674 . . . . 0.0 112.252 -178.398 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 69.4 t -80.99 -36.29 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.468 -1.395 . . . . 0.0 108.926 178.756 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -70.89 -38.97 73.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.657 -0.652 . . . . 0.0 111.269 179.815 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -82.54 -48.98 10.39 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.798 -1.189 . . . . 0.0 111.694 -178.235 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.02 -30.68 69.33 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.164 -0.96 . . . . 0.0 109.464 -179.096 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 55.0 t -79.78 -31.62 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 0.0 109.416 179.25 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -77.35 -22.22 52.11 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.689 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 31.9 tp -78.25 -67.76 0.7 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.492 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 5.6 ttp -56.01 -22.99 30.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.925 . . . . 0.0 109.788 -178.619 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.83 -22.2 58.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.928 -1.108 . . . . 0.0 108.705 177.87 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -104.21 2.52 31.81 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.42 -0.8 . . . . 0.0 111.677 -178.362 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 85.0 mt -85.03 125.47 32.76 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.219 -1.551 . . . . 0.0 109.739 179.739 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.052 179.004 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.2 mtp . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.255 -0.646 . . . . 2.91 109.255 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.446 ' O ' ' O ' ' A' ' 225' ' ' ASN . 89.8 mt -107.58 129.02 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.613 -0.884 . . . . 1.2 108.613 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.9 m -130.76 141.45 50.36 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.606 -0.684 . . . . 1.4 109.744 -179.653 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.679 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -138.07 -165.04 10.2 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 108.291 -1.924 . . . . 1.05 108.291 179.122 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.8 mt -91.99 -10.83 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.888 -1.36 . . . . 1.15 110.377 -179.05 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 5' ' ' ILE . 34.9 tp 52.62 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.973 -1.08 . . . . 0.98 108.839 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.59 -34.25 23.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 0.88 109.042 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -143.4 132.33 11.45 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.416 -0.803 . . . . 1.69 108.881 179.509 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.92 147.19 18.91 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.193 1.929 . . . . 0.85 113.477 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.782 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.53 -164.66 37.43 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.576 -1.41 . . . . 0.92 109.576 179.474 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.5 mt -146.45 147.82 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.26 -1.141 . . . . 0.81 108.741 179.053 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.91 154.64 31.53 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.541 -1.35 . . . . 0.51 110.979 -179.618 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.5 m-85 -136.31 129.26 31.15 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 108.245 -1.02 . . . . 0.62 108.245 178.819 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.5 -179.7 45.65 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.577 -1.773 . . . . 0.55 110.802 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -80.4 152.85 28.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.613 -0.934 . . . . 2.1 108.95 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.417 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -99.24 132.0 44.87 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.093 -1.004 . . . . 0.77 110.906 -178.078 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.4 tp -100.37 133.61 44.54 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.389 -1.338 . . . . 0.91 107.389 178.084 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.1 tp -115.43 121.34 42.46 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.207 -0.933 . . . . 0.93 109.949 -179.025 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 66.8 mt -91.29 106.22 18.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.521 -0.737 . . . . 0.93 109.881 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.475 ' NZ ' ' CB ' ' A' ' 20' ' ' LYS . 7.8 mtpm? -101.87 137.69 39.83 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.89 -0.781 . . . . 2.75 108.89 179.234 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 55.4 mp0 -127.81 128.76 45.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.373 -0.829 . . . . 3.0 108.795 179.689 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -71.89 149.85 44.77 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.044 -1.035 . . . . 2.77 108.474 179.639 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -67.52 139.98 57.0 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.924 -1.11 . . . . 2.94 108.576 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.8 mt -80.17 130.27 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.95 109.172 -179.463 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.1 t -99.24 129.75 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.203 -0.936 . . . . 1.28 111.08 -178.413 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.0 mt -109.85 131.21 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.654 -0.869 . . . . 1.21 108.654 179.031 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -81.61 127.37 32.8 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.878 -1.139 . . . . 1.81 109.815 -179.449 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.52 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.6 mmt-85 -90.75 -5.72 55.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.514 -0.742 . . . . 2.8 109.221 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -70.76 139.95 51.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 2.87 109.548 -179.668 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -80.96 151.97 28.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 2.35 109.027 179.184 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.462 HG21 ' HG3' ' A' ' 39' ' ' GLU . 5.2 pt -93.68 165.08 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.97 109.884 -179.932 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.8 p -98.22 168.72 10.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.997 -1.064 . . . . 1.17 108.952 178.989 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.15 -13.65 39.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.126 -0.984 . . . . 1.18 110.104 -179.675 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -86.1 -30.19 22.75 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.678 -1.23 . . . . 2.56 107.678 178.511 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -83.38 -7.58 59.54 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.515 -0.55 . . . . 1.79 109.515 179.082 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 t -64.97 -56.33 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.734 -1.229 . . . . 1.0 109.174 179.719 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.06 -39.91 87.62 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.236 -0.915 . . . . 1.77 109.472 179.718 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -70.22 -41.06 74.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 2.7 110.688 -179.254 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.462 ' HG3' HG21 ' A' ' 31' ' ' ILE . 63.2 mm-40 -65.3 -39.98 93.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.031 -1.043 . . . . 1.51 110.134 -179.442 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.94 -44.58 94.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.882 -1.136 . . . . 0.93 107.96 179.424 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -59.91 -38.96 83.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.14 -0.975 . . . . 1.81 108.978 179.641 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -59.87 -43.03 94.93 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.635 -1.246 . . . . 2.78 107.635 179.335 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.96 -49.28 78.29 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.229 -1.026 . . . . 0.78 108.229 178.053 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.6 tp -60.0 -47.99 83.53 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.954 -0.758 . . . . 1.07 108.954 179.334 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.444 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 46.5 t -60.75 -44.5 96.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.949 -1.094 . . . . 1.12 108.782 178.97 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.09 -41.29 98.0 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.723 -2.151 . . . . 0.84 107.723 178.965 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -64.35 -34.86 79.12 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.557 -0.967 . . . . 3.09 108.514 178.26 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -54.48 -42.72 71.03 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.482 -0.761 . . . . 0.88 109.523 -179.286 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.533 ' HZ1' ' CA ' ' A' ' 140' ' ' ASN . 19.7 ttpp -73.9 -73.06 0.24 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.629 -1.249 . . . . 2.59 107.629 179.368 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.57 -34.24 0.09 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.445 -0.784 . . . . 0.7 111.035 -178.852 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 48' ' ' ALA . 90.3 p -57.43 -57.4 12.82 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.576 -1.327 . . . . 1.4 107.699 179.17 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.83 80.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.604 -0.685 . . . . 0.67 111.604 -179.2 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -68.86 -40.28 79.41 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.562 -1.337 . . . . 1.66 110.314 -178.646 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.49 -40.13 89.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.01 -1.056 . . . . 1.58 108.801 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.485 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 65.3 mm-40 -62.87 -40.0 96.15 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.251 -0.906 . . . . 1.35 109.11 179.104 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.469 HG22 ' HZ3' ' A' ' 60' ' ' LYS . 94.8 m -63.08 -39.92 96.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.77 110.133 179.857 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.0 mt -61.15 -40.98 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.012 -1.055 . . . . 0.63 108.973 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.485 ' NZ ' ' OE1' ' A' ' 55' ' ' GLU . 5.4 ttpm? -59.91 -50.45 73.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.279 -0.888 . . . . 1.14 110.103 -179.641 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -60.14 -39.98 88.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.79 110.841 -177.979 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.469 ' HZ3' HG22 ' A' ' 56' ' ' THR . 24.3 mttp -62.82 -38.66 91.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -0.911 . . . . 1.53 109.442 179.684 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.24 -39.97 96.11 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.541 -0.724 . . . . 0.57 109.435 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.63 -55.99 23.98 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.309 -1.516 . . . . 0.75 109.309 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.07 -49.86 72.86 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.973 -1.31 . . . . 1.59 109.694 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.1 m -65.8 -61.36 2.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.067 -1.02 . . . . 0.73 111.679 -177.749 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -94.73 -56.24 2.85 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.996 -1.065 . . . . 0.75 111.256 -178.236 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.4 -165.21 26.79 Favored Glycine 0 N--CA 1.5 2.956 0 C-N-CA 119.811 -1.185 . . . . 1.22 111.131 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -70.01 -25.77 63.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.935 -0.744 . . . . 5.81 110.553 -179.115 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.43 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.6 tp10 -60.29 -37.45 80.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.039 -1.038 . . . . 3.37 110.162 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.436 ' HA ' HD12 ' A' ' 72' ' ' ILE . 32.2 mmtp -100.22 -19.86 16.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.397 -0.814 . . . . 1.77 110.72 -179.179 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -69.92 -42.96 72.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.793 -1.192 . . . . 1.65 110.174 -179.427 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.538 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.22 -30.72 70.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.505 -0.747 . . . . 0.77 109.499 -179.315 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 69' ' ' LYS . 80.0 mt -60.1 -43.18 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.107 -0.996 . . . . 0.8 109.872 -179.569 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -74.84 -30.61 61.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.242 -0.911 . . . . 0.88 110.579 -178.828 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -61.57 -39.93 92.92 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.814 -1.179 . . . . 1.37 109.522 178.674 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.23 -46.95 93.44 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.87 -1.692 . . . . 0.62 108.87 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -60.01 -44.44 94.58 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.343 -1.093 . . . . 1.5 108.515 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.4 mt -62.75 -50.02 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 109.053 -0.721 . . . . 0.63 109.053 179.35 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -60.01 -40.59 89.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 1.51 109.54 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.9 HD22 HD23 ' B' ' 347' ' ' LEU . 43.8 tp -63.86 -40.03 95.6 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.518 -0.739 . . . . 0.77 109.552 179.335 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -68.85 -38.42 79.76 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.768 -0.583 . . . . 0.62 110.437 -178.931 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.34 0.36 29.33 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.017 -1.052 . . . . 1.47 110.048 -179.292 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.7 t0 -47.78 130.86 14.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.201 -0.937 . . . . 1.47 110.38 -178.934 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.41 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 93.9 mt-10 -61.94 -18.54 60.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.659 . . . . 1.78 111.086 -179.192 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.88 -33.72 66.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.818 -1.176 . . . . 2.53 108.855 178.995 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.07 -41.01 74.68 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.099 -0.704 . . . . 0.8 109.099 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.88 -48.68 80.7 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.216 -0.928 . . . . 1.42 110.76 -179.13 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.23 -39.99 74.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.415 -0.803 . . . . 1.71 111.076 -178.579 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -69.81 -39.93 76.24 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.277 -0.89 . . . . 1.57 110.839 -178.581 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.9 mt -69.02 -41.57 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.28 -0.888 . . . . 0.65 109.398 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.4 mt -69.73 -39.68 78.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.505 -0.747 . . . . 0.82 110.3 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.0 -42.88 99.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.222 -0.924 . . . . 0.79 111.208 -178.992 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 49.1 mt -60.81 -46.97 88.44 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.709 -1.245 . . . . 0.95 109.372 -179.694 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.3 mt -60.17 -49.2 85.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.851 0.834 . . . . 0.66 108.9 179.509 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -69.98 -40.53 75.3 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.909 -0.495 . . . . 2.2 111.309 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -81.02 -57.0 3.73 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.952 -1.092 . . . . 1.65 112.099 -177.78 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -90.95 0.08 57.61 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.093 -1.004 . . . . 2.03 112.603 -176.858 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 54.6 m80 58.29 39.76 25.27 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.928 -1.108 . . . . 1.42 109.877 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.0 mtp -89.54 166.85 13.4 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.516 -0.74 . . . . 1.18 110.036 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.452 ' OG1' ' HB3' ' A' ' 102' ' ' ALA . 43.6 p -80.37 159.67 25.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.365 -0.835 . . . . 0.98 108.923 179.491 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.67 -40.06 80.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.113 -0.992 . . . . 0.64 109.965 -179.679 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 32.2 p-10 -68.0 -37.12 81.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 2.07 109.57 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.503 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -81.56 -41.38 21.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.73 109.824 179.216 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.03 -47.68 73.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.277 -0.889 . . . . 0.54 109.705 -179.686 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.86 87.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.115 -0.991 . . . . 0.56 109.543 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -59.89 -40.09 87.54 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.337 -0.852 . . . . 1.54 110.12 -179.244 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -60.92 -44.17 97.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.347 -0.846 . . . . 1.33 110.792 -179.365 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.6 t -61.54 -50.47 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.16 -0.963 . . . . 0.72 111.009 -177.847 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.5 mm -69.32 -39.88 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.021 -1.049 . . . . 0.85 108.637 179.493 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.401 ' CD ' HH12 ' A' ' 131' ' ' ARG . 41.3 tp10 -61.53 -40.0 93.07 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.869 -0.789 . . . . 2.44 108.869 179.198 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.56 -48.41 84.84 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.534 -0.841 . . . . 0.98 111.235 -178.8 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -69.15 -49.85 53.11 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.686 -1.479 . . . . 1.41 110.827 -178.335 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.98 87.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.916 -1.115 . . . . 1.2 109.559 -179.257 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 40.8 t -59.45 -40.08 85.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.019 -1.05 . . . . 1.7 108.995 179.962 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.56 -43.85 96.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.3 -0.875 . . . . 1.47 109.2 179.451 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' B' ' 351' ' ' GLN . 76.7 mt -61.7 -41.0 97.02 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.33 -0.856 . . . . 1.56 109.45 -178.993 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -59.99 -37.77 80.63 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.076 -1.015 . . . . 2.2 109.483 -179.291 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -52.06 -22.18 3.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.043 -1.036 . . . . 2.12 109.169 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 49.7 mt -62.32 140.1 58.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.051 -1.031 . . . . 2.0 109.01 -179.649 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -89.93 38.01 0.91 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.127 -0.983 . . . . 3.23 110.249 -178.977 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 57.9 t0 -129.8 145.95 51.56 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.344 -0.848 . . . . 2.49 109.228 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 124' ' ' LYS . 88.0 tt0 -72.71 -66.52 0.65 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.412 -0.805 . . . . 3.95 109.1 179.656 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 121' ' ' GLU . 3.5 t80 -38.71 -36.19 0.24 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.789 -0.569 . . . . 2.0 110.622 -178.874 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.0 mt -79.24 -34.76 42.42 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.736 -1.228 . . . . 1.86 108.569 179.192 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 121' ' ' GLU . 7.4 ttpm? -68.17 -39.99 82.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 2.84 109.546 179.473 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.89 -40.31 94.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 2.73 109.265 -179.615 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.536 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -60.84 -38.23 84.79 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.429 -0.952 . . . . 2.77 108.429 -179.892 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.33 -26.92 65.44 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.518 -0.919 . . . . 1.19 108.518 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.47 -39.99 81.18 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.447 -0.946 . . . . 1.2 108.447 178.627 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -66.84 -42.72 85.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.505 -0.747 . . . . 1.55 109.998 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.23 -41.25 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 0.8 108.922 179.448 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.401 HH12 ' CD ' ' A' ' 109' ' ' GLU . 37.6 ttm-85 -60.64 -39.92 90.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.072 -1.017 . . . . 3.09 108.817 178.93 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -60.15 -34.43 73.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.57 -0.706 . . . . 1.46 109.617 -179.72 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.1 -43.09 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.135 -0.978 . . . . 0.71 109.55 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.92 -27.61 62.24 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.838 -1.305 . . . . 0.57 109.838 -179.621 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -59.98 -50.19 74.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.981 -1.305 . . . . 2.59 110.094 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -67.75 -32.11 72.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.999 -1.063 . . . . 2.83 109.348 -179.619 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.39 -41.67 89.94 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.914 -0.773 . . . . 1.25 108.914 -179.486 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.3 -40.01 94.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.967 . . . . 0.7 109.182 179.386 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.405 HH21 HD23 ' A' ' 144' ' ' LEU . 58.6 mtp180 -70.04 -40.06 75.38 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.971 0.891 . . . . 2.57 108.729 179.104 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.533 ' CA ' ' HZ1' ' A' ' 49' ' ' LYS . 2.2 m120 -60.74 -38.23 84.47 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 116.002 -0.544 . . . . 1.23 111.466 -178.539 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.3 mt -70.33 -39.94 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.811 -1.181 . . . . 0.81 109.811 -179.745 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 54.2 mt -71.85 -20.56 61.8 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.397 -0.814 . . . . 1.0 110.241 -178.555 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.9 40.84 13.5 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.044 -1.622 . . . . 0.89 109.044 -179.189 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.405 HD23 HH21 ' A' ' 139' ' ' ARG . 3.3 tp -75.24 149.98 38.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.362 -1.081 . . . . 1.14 109.859 -179.361 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -74.71 141.79 44.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.513 -0.742 . . . . 4.6 109.949 -179.867 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.3 129.77 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 122.29 1.043 . . . . 1.24 108.84 178.802 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 15.0 mt -69.66 -39.96 78.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 115.411 -0.813 . . . . 1.54 110.398 -177.937 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.8 t0 68.18 127.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.741 -0.837 . . . . 1.5 108.741 -179.251 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.411 ' O ' HD13 ' A' ' 152' ' ' ILE . 19.5 mt -92.03 0.04 57.47 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.316 -0.865 . . . . 0.79 110.266 -178.95 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 24.5 t -95.61 -11.79 26.7 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.041 -1.037 . . . . 1.4 110.185 -179.683 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.24 15.48 1.55 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.066 -1.021 . . . . 0.92 111.333 -178.581 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.411 HD13 ' O ' ' A' ' 149' ' ' LEU . 2.8 mp -86.1 137.14 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.446 -1.409 . . . . 0.88 108.417 179.517 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -111.95 -10.45 13.96 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.537 -0.727 . . . . 2.45 109.356 -179.411 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -123.21 148.0 46.29 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.744 -0.597 . . . . 1.52 109.775 -179.522 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.33 138.91 58.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.449 -0.782 . . . . 1.58 109.164 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.5 m -152.59 166.65 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.658 -0.652 . . . . 0.69 109.804 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 92.9 mt -96.51 146.07 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 106.191 -1.781 . . . . 0.61 106.191 176.964 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.1 tp -96.69 118.33 32.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.891 -1.13 . . . . 0.87 110.94 -177.764 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.0 t -119.6 123.25 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 109.015 -0.735 . . . . 0.71 109.015 179.095 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -153.06 159.97 42.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.81 109.012 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.27 -31.35 64.02 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.346 -1.472 . . . . 0.98 108.956 179.287 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 46.2 t0 -169.97 140.51 2.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.415 -0.803 . . . . 2.25 108.933 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.488 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 26.5 mt -114.77 131.55 56.75 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.371 -0.831 . . . . 0.78 109.031 -179.582 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.9 p -95.07 148.6 34.95 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.132 -0.98 . . . . 0.98 110.128 -179.526 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -37.32 -39.06 0.56 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.652 2.235 . . . . 0.81 112.56 179.19 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.3 m -57.58 -39.87 77.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.282 -0.886 . . . . 0.9 108.93 -179.052 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -69.9 -39.9 75.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.169 -0.957 . . . . 1.61 109.666 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 45.7 p -56.57 -24.01 44.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.033 -1.042 . . . . 0.61 110.51 -178.23 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.39 -55.78 4.96 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.967 -1.083 . . . . 0.6 109.358 179.432 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -83.84 40.78 0.76 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.98 -1.119 . . . . 1.4 107.98 179.411 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 35.1 tp -103.37 130.14 50.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.739 -0.601 . . . . 0.7 109.611 179.501 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 172' ' ' ASN . 10.6 p-10 -86.15 97.92 10.61 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.954 -1.128 . . . . 2.35 107.954 178.243 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 56.3 mt -67.5 -41.49 84.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 1.51 111.119 -178.245 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -69.91 -26.83 64.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.658 -1.276 . . . . 2.33 112.222 -177.747 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -92.0 -5.94 52.1 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.556 -1.34 . . . . 1.92 109.513 -178.793 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.627 HG12 ' H ' ' A' ' 178' ' ' GLY . 60.9 t -107.28 119.66 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.688 -1.227 . . . . 0.67 107.688 178.168 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.1 mt -84.7 7.21 21.24 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.379 -0.825 . . . . 1.53 110.675 -177.861 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.627 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 163.53 178.11 36.94 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.192 -1.563 . . . . 0.48 109.192 179.781 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.462 ' CE1' HG11 ' A' ' 176' ' ' VAL . 13.2 m-85 -134.46 130.43 36.72 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.393 -1.063 . . . . 0.55 109.038 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.414 ' CG2' HG21 ' A' ' 205' ' ' THR . 91.5 mt -130.63 125.2 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.204 -1.035 . . . . 0.65 108.204 178.844 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 65.6 p -149.69 160.32 43.62 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.845 -1.159 . . . . 0.82 110.682 -179.073 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.457 ' CB ' ' H ' ' A' ' 206' ' ' GLY . 4.1 p30 -108.69 27.19 9.68 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.513 -0.921 . . . . 2.46 108.513 179.283 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.25 -164.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.122 -0.986 . . . . 1.28 112.079 -177.547 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.63 -79.89 0.09 OUTLIER Glycine 0 N--CA 1.492 2.387 0 CA-C-N 115.793 -0.64 . . . . 2.19 111.579 -178.593 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.13 -151.64 6.07 Favored Glycine 0 N--CA 1.494 2.553 0 O-C-N 120.711 -1.464 . . . . 2.13 111.17 -178.858 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -79.73 -9.97 59.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.828 -0.807 . . . . 5.86 110.553 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.9 p -84.55 3.12 38.09 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.101 -1.0 . . . . 3.72 110.856 -178.768 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.3 t -72.02 143.07 49.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.827 -1.17 . . . . 1.74 110.18 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -49.55 -50.21 43.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.235 -0.916 . . . . 0.95 110.128 -179.302 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.3 m -59.86 -40.23 87.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.368 -0.832 . . . . 1.55 110.32 -178.642 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 52.2 p -59.93 -40.17 87.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.933 -1.104 . . . . 1.51 110.453 -178.941 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.426 HG12 HH21 ' A' ' 195' ' ' ARG . 96.9 mt -60.0 -38.92 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.935 . . . . 1.67 109.526 -179.739 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.5 mtp -60.25 -39.89 88.36 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.858 . . . . 1.02 110.207 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.12 -45.71 83.25 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.834 -1.166 . . . . 0.68 109.725 -179.476 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.426 HH21 HG12 ' A' ' 192' ' ' ILE . 83.6 mtm180 -60.36 -49.79 76.19 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.077 -1.049 . . . . 2.93 110.298 -179.911 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 30.6 m -69.94 -34.7 73.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.715 -1.24 . . . . 0.86 110.525 -179.268 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 84.4 mt -72.67 -21.59 61.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.009 -1.057 . . . . 0.67 108.973 179.914 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 62.15 50.79 3.8 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.395 0.617 . . . . 1.5 110.886 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 96.5 mt -126.35 149.96 68.8 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 107.468 -1.308 . . . . 0.72 107.468 178.355 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.3 135.5 50.55 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 122.25 1.967 . . . . 0.61 111.845 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.99 149.97 3.72 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.595 -1.242 . . . . 0.66 111.941 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.0 mt -126.54 146.03 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.787 -1.19 . . . . 0.79 107.787 179.147 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.48 -9.25 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 120.86 -1.15 . . . . 0.91 111.547 -179.268 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.58 23.83 23.45 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 110.048 -1.221 . . . . 1.01 110.048 -179.584 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.414 HG21 ' CG2' ' A' ' 180' ' ' ILE . 7.9 p -45.55 -45.98 13.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.189 -1.183 . . . . 0.99 109.987 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.457 ' H ' ' CB ' ' A' ' 182' ' ' ASP . . . 93.47 -54.77 2.39 Favored Glycine 0 N--CA 1.503 3.119 0 O-C-N 121.017 -1.052 . . . . 1.12 112.025 178.811 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 93.3 p -152.76 29.58 0.52 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.551 -1.558 . . . . 1.72 111.248 -179.042 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 76.2 t -76.26 -34.95 26.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.948 -1.095 . . . . 0.89 108.957 178.838 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.6 p -57.46 -30.44 65.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.461 -0.774 . . . . 1.03 110.291 -179.124 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 57.5 p -83.77 -15.18 49.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.783 -1.198 . . . . 1.83 110.06 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -96.21 -12.75 24.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.09 -1.006 . . . . 2.27 109.953 -179.587 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 73.9 t -103.73 136.65 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.363 -0.836 . . . . 0.92 110.38 -178.479 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -110.1 150.1 29.08 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.748 -1.204 . . . . 2.2 107.748 178.803 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.479 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 40.8 p-10 -58.6 137.08 57.71 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.902 -1.124 . . . . 2.36 110.053 -179.355 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.4 m-20 85.64 0.04 0.73 Allowed 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.2 0.524 . . . . 2.38 110.025 179.722 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 60.1 t0 -70.67 144.1 51.16 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.193 -0.942 . . . . 2.09 109.246 179.416 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.402 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 40.9 t80 -93.77 120.27 33.82 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.383 -0.969 . . . . 1.27 108.383 178.951 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.417 HD12 ' HB2' ' A' ' 16' ' ' ALA . 89.4 mt -129.39 150.81 50.58 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.458 -0.776 . . . . 0.75 110.766 -178.696 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.5 mt -115.28 127.88 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.143 -1.429 . . . . 0.63 107.143 177.362 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 61.8 tp -100.54 118.95 37.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.972 -1.08 . . . . 0.7 108.469 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.43 ' C ' ' N ' ' A' ' 223' ' ' VAL . 18.8 t0 -81.33 -41.23 22.38 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.846 -1.168 . . . . 2.31 107.846 179.403 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.782 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 48.21 18.76 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.013 -0.736 . . . . 0.78 109.013 -179.961 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.43 ' N ' ' C ' ' A' ' 221' ' ' ASP . 39.2 t -128.45 -42.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.114 -1.439 . . . . 1.04 107.114 178.507 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -104.78 8.11 34.81 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.509 -1.293 . . . . 2.44 107.509 178.062 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.679 HD22 ' H ' ' A' ' 4' ' ' GLY . 45.1 t30 59.62 49.45 8.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.878 -0.514 . . . . 1.55 110.245 179.703 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -147.94 149.9 33.05 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.817 -1.177 . . . . 1.99 110.766 179.885 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.45 122.05 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.304 -0.998 . . . . 0.77 108.304 179.035 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -87.67 128.98 35.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.626 -1.296 . . . . 0.98 109.218 -179.491 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 33.1 t -104.06 119.55 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.421 -0.8 . . . . 0.85 110.197 -179.014 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 57.02 69.4 1.7 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.058 -1.026 . . . . 1.66 109.598 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -91.3 135.64 1.81 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.525 2.817 . . . . 0.95 112.8 -179.689 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 233' ' ' ASN . 55.8 m -65.87 159.76 24.78 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.212 -0.93 . . . . 1.84 108.791 179.626 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.431 ' N ' HG22 ' A' ' 232' ' ' THR . 34.6 m120 -59.71 -38.06 80.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 2.74 108.939 -179.486 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.23 -39.33 86.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.361 -0.837 . . . . 2.89 109.533 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 88.1 t -61.28 -41.35 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.34 -0.85 . . . . 1.3 109.459 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.1 mt . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 1.09 109.865 -179.956 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 8.1 ttt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -150.7 149.05 29.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.796 . . . . 0.0 109.243 179.334 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -149.36 160.99 42.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.078 -1.014 . . . . 0.0 110.116 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -153.42 149.75 28.1 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.796 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -111.62 131.38 55.31 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.23 -0.919 . . . . 0.0 109.815 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.17 122.71 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-O 122.287 1.041 . . . . 0.0 112.491 -176.898 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 95.5 m -75.59 103.9 5.9 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.849 0.833 . . . . 0.0 110.148 -178.647 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.58 HG22 ' H ' ' B' ' 310' ' ' ALA . 96.6 mt -51.95 124.42 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 122.176 0.989 . . . . 0.0 109.977 -178.218 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 75.0 p -105.81 22.1 16.16 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.845 -178.745 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.58 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -80.58 149.32 67.92 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.769 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.61 -72.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.259 0 CA-C-N 119.455 0.841 . . . . 0.0 112.062 -179.655 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -86.29 23.87 1.48 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.123 -0.986 . . . . 0.0 110.819 -177.834 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 82.62 -163.14 42.11 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.542 -1.313 . . . . 0.0 109.841 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.413 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.0 tp -90.31 93.65 9.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.354 -1.086 . . . . 0.0 109.79 -178.094 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.483 ' CE1' ' H ' ' B' ' 317' ' ' ARG . 10.4 p80 -94.39 -160.25 0.76 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.728 -1.232 . . . . 0.0 109.304 178.628 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.6 m -58.31 -45.16 88.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.83 -1.168 . . . . 0.0 112.752 -176.094 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.546 HH21 ' NE2' ' B' ' 321' ' ' GLN . 3.8 tpt180 -59.46 -64.51 2.9 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.111 -1.618 . . . . 0.0 111.375 -177.911 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.403 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 7.3 Cg_endo -55.08 -34.11 86.16 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 CA-C-N 120.176 1.099 . . . . 0.0 112.047 179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.2 -52.36 65.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.001 -1.062 . . . . 0.0 109.402 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.48 -41.05 63.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.217 -0.927 . . . . 0.0 109.633 -178.962 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 321' ' ' GLN . . . . . 0.546 ' NE2' HH21 ' B' ' 317' ' ' ARG . 62.3 mt-30 -70.81 -40.87 72.24 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.824 -1.172 . . . . 0.0 108.924 179.152 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -60.14 -50.5 73.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.298 -0.876 . . . . 0.0 110.854 -179.242 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 74.0 t -69.89 -31.16 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.753 -1.217 . . . . 0.0 109.792 -178.628 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -59.76 -47.99 83.49 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.229 -0.92 . . . . 0.0 109.859 -179.56 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -67.08 -40.05 86.93 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 111.078 -178.834 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 326' ' ' ALA . . . . . 0.406 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -63.46 -53.22 55.56 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.998 -1.064 . . . . 0.0 111.393 -178.934 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -56.12 -10.2 0.79 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.015 -1.053 . . . . 0.0 109.526 -179.381 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 328' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -69.79 -30.26 70.59 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 178.892 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -102.67 141.73 35.0 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.594 -0.945 . . . . 0.0 109.172 179.772 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 330' ' ' THR . . . . . 0.418 HG22 ' O ' ' B' ' 330' ' ' THR . 44.5 m -89.78 -11.32 42.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.154 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 61.8 p -59.34 156.68 12.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.374 -0.829 . . . . 0.0 110.034 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -72.9 127.93 33.99 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.351 -0.843 . . . . 0.0 108.956 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.7 mt -134.52 133.54 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 334' ' ' THR . . . . . 0.425 HG22 ' N ' ' B' ' 335' ' ' VAL . 87.9 m -132.85 155.88 48.18 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.508 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 335' ' ' VAL . . . . . 0.425 ' N ' HG22 ' B' ' 334' ' ' THR . 58.3 t -117.2 140.68 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.427 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 64.9 m -129.05 123.17 31.6 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.447 -0.783 . . . . 0.0 109.134 179.763 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 66.9 p -139.45 117.41 11.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.353 -0.842 . . . . 0.0 110.418 -179.725 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 59.8 t30 45.6 56.53 5.72 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 177.208 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.02 -13.29 26.32 Favored Glycine 0 N--CA 1.501 3.004 0 O-C-N 120.055 -1.653 . . . . 0.0 112.924 176.438 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -111.75 122.93 49.12 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-N 119.037 1.418 . . . . 0.0 109.52 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.1 m -118.53 143.53 46.69 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.769 0.795 . . . . 0.0 110.544 -178.953 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -139.87 161.0 38.62 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.822 0.82 . . . . 0.0 110.174 -179.441 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 15.5 t -89.59 140.0 29.99 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.619 -0.675 . . . . 0.0 109.446 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -76.78 -12.63 60.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.085 -1.009 . . . . 0.0 109.785 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.42 19.87 4.21 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.649 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 16.3 t -149.37 96.91 2.58 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.912 -179.224 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.9 HD23 HD22 ' A' ' 79' ' ' LEU . 28.8 tp -59.97 -32.04 70.45 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.933 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.721 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.9 m-85 -58.09 -52.34 65.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 109.915 -179.28 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 349' ' ' LYS . . . . . 0.432 ' O ' ' OG1' ' B' ' 352' ' ' THR . 33.8 mtmm -69.93 -39.92 75.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.692 -1.255 . . . . 0.0 110.163 -178.292 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' B' ' 352' ' ' THR . 39.6 mt -50.63 -58.24 6.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.775 -1.203 . . . . 0.0 108.024 179.219 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.47 ' HB3' HD22 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -38.28 -27.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.871 -0.518 . . . . 0.0 111.127 -178.361 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.464 ' N ' ' O ' ' B' ' 350' ' ' LEU . 51.0 p -77.75 -11.48 59.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.091 -1.006 . . . . 0.0 110.388 -178.855 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 24.8 mt -92.78 115.41 28.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.888 -1.133 . . . . 0.0 109.195 179.221 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.1 92.75 0.75 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.919 -1.673 . . . . 0.0 108.919 179.504 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 44.3 mt -100.61 91.62 4.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.24 -1.153 . . . . 0.0 108.913 179.529 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 81.0 p -91.86 177.9 6.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.956 -1.09 . . . . 0.0 110.512 -178.502 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 357' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' B' ' 359' ' ' THR . 61.8 tt0 -46.48 155.68 0.22 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.664 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 39.46 25.23 0.05 OUTLIER Glycine 0 N--CA 1.495 2.595 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 177.597 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 359' ' ' THR . . . . . 0.465 ' N ' ' O ' ' B' ' 357' ' ' GLN . 9.2 m -82.47 112.44 19.41 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.708 -1.466 . . . . 0.0 109.283 179.423 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 16.4 t -77.37 115.8 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 122.214 1.007 . . . . 0.0 110.358 -176.882 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.3 m -110.34 176.85 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.386 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 30.8 m -132.19 129.81 40.24 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.943 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.4 mt -105.84 122.09 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.402 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 52.7 p -120.82 132.19 54.87 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.639 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.93 151.87 37.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.905 -1.122 . . . . 0.0 110.955 -178.828 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -144.87 124.49 13.25 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.691 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 160.16 -162.73 33.41 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 118.981 -1.58 . . . . 0.0 111.367 179.823 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -59.96 -55.64 31.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 122.258 -0.554 . . . . 0.0 111.759 -178.425 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.41 ' H ' ' HB3' ' B' ' 331' ' ' SER . 94.5 m-20 -104.93 7.48 34.24 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.996 -1.065 . . . . 0.0 111.105 -177.314 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' B' ' 369' ' ' ASP . 1.3 pp20? -42.91 -32.12 0.59 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.244 -0.91 . . . . 0.0 110.507 -179.12 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -70.08 -43.7 70.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 109.996 -179.293 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -64.7 -48.99 72.63 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.199 -0.938 . . . . 0.0 109.332 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.9 -75.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.425 -0.797 . . . . 0.0 110.705 -178.834 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.566 ' O ' HG23 ' B' ' 378' ' ' VAL . 45.4 t -44.5 -38.77 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.099 -1.001 . . . . 0.0 110.895 -177.564 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -64.86 -47.23 78.68 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.624 -1.298 . . . . 0.0 110.513 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -82.75 -41.72 18.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.919 -1.113 . . . . 0.0 110.445 -179.454 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.9 -39.23 77.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.904 -1.122 . . . . 0.0 108.284 -179.617 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.566 HG23 ' O ' ' B' ' 374' ' ' VAL . 48.1 t -62.38 -40.24 87.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.213 179.13 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 379' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' B' ' 383' ' ' GLU . 20.8 mtpp -68.54 -55.78 10.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.595 -1.315 . . . . 0.0 108.824 178.604 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 56.1 tp -57.78 -35.85 71.36 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.762 -1.211 . . . . 0.0 109.734 -178.699 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 28.8 ttm -70.66 -40.05 73.22 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.257 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.31 -9.99 59.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.528 -0.733 . . . . 0.0 110.968 179.164 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' B' ' 379' ' ' LYS . 93.9 mt-10 -110.03 0.83 18.62 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.042 -1.036 . . . . 0.0 111.549 -178.191 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 13.2 mt -82.38 125.89 31.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.178 -1.576 . . . . 0.0 109.224 179.136 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.318 -179.978 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.7 mmm . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.255 -0.646 . . . . 2.91 109.255 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.7 mt -110.0 130.03 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.611 -0.681 . . . . 1.2 109.164 179.671 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.5 m -120.92 144.28 48.52 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.579 -0.701 . . . . 1.4 109.747 -179.707 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -121.67 -162.82 11.75 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 108.894 -1.682 . . . . 1.05 108.894 179.751 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 6' ' ' LEU . 91.4 mt -89.28 -13.97 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.9 -1.353 . . . . 1.15 110.176 -179.218 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.9 tp 53.74 102.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.224 -0.922 . . . . 0.98 109.062 -179.883 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.64 -29.43 12.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.262 -0.899 . . . . 0.88 109.153 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 30.8 m -129.44 116.02 18.47 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 109.024 -0.732 . . . . 1.69 109.024 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.25 146.72 20.02 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.76 1.64 . . . . 0.85 112.079 -179.74 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.808 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.61 -154.4 25.5 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.462 -1.455 . . . . 0.92 109.462 -179.85 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.0 mt -148.36 150.33 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.36 -1.082 . . . . 0.81 108.587 178.947 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.84 156.32 34.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.939 -1.101 . . . . 0.51 110.752 179.663 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.2 m-85 -137.41 128.51 27.66 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.895 -1.15 . . . . 0.62 107.895 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.67 174.29 46.92 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 118.736 -1.697 . . . . 0.55 110.743 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -76.52 158.87 30.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.769 -0.842 . . . . 2.1 109.26 -179.735 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.99 126.11 46.13 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.358 -0.839 . . . . 0.77 111.377 -178.351 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.7 tp -101.36 129.96 47.46 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.876 -1.527 . . . . 0.91 106.876 177.57 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.2 tp -114.02 121.64 44.47 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.308 -0.87 . . . . 0.93 110.021 -178.914 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.2 mt -85.87 100.09 11.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.49 -0.756 . . . . 0.93 109.051 179.358 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -84.42 142.0 30.43 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.27 -1.011 . . . . 2.75 108.27 179.532 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -130.76 135.65 47.98 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.023 -1.048 . . . . 3.0 109.106 179.392 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -94.78 156.4 16.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.322 -0.861 . . . . 2.77 109.55 -179.916 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -78.58 136.98 37.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 2.94 109.321 179.787 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.6 mt -79.79 130.17 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.258 -0.901 . . . . 0.95 108.728 179.931 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.8 t -93.27 125.76 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.18 -0.95 . . . . 1.28 109.684 -179.461 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.8 mt -105.97 138.06 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.517 -0.739 . . . . 1.21 109.12 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -96.23 120.06 35.84 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.159 -0.963 . . . . 1.81 109.974 -179.585 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.542 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.0 mmt-85 -90.02 -0.24 57.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.402 -0.812 . . . . 2.8 109.692 -179.795 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -69.9 135.5 49.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.069 -1.02 . . . . 2.87 109.164 -179.895 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -83.02 154.81 24.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.107 -0.996 . . . . 2.35 109.419 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.529 HD13 ' HG3' ' A' ' 39' ' ' GLU . 2.9 pt -98.92 166.41 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.207 -0.933 . . . . 0.97 109.609 179.568 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.2 p -93.41 174.81 7.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.3 -0.875 . . . . 1.17 108.658 178.437 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.07 -48.56 81.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 1.18 110.292 -179.425 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -55.51 -31.48 62.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.767 -1.208 . . . . 2.56 110.568 -179.057 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -81.59 -8.98 59.78 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.177 -0.952 . . . . 1.79 110.289 -179.357 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.9 t -60.06 -50.09 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.776 -1.203 . . . . 1.0 109.087 179.825 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -60.11 -39.91 87.87 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.369 -0.832 . . . . 1.77 109.078 -179.663 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -64.19 -42.02 96.83 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.546 -0.721 . . . . 2.7 110.916 -178.717 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.529 ' HG3' HD13 ' A' ' 31' ' ' ILE . 68.7 mm-40 -62.83 -41.84 99.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.68 -1.263 . . . . 1.51 110.422 -179.224 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.7 t -63.73 -47.04 92.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.675 -1.266 . . . . 0.93 108.987 -179.763 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -60.0 -46.2 90.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.055 -1.028 . . . . 1.81 108.957 179.863 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -59.98 -48.59 81.1 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.026 -1.07 . . . . 2.78 108.766 179.5 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.451 ' CZ ' HD13 ' A' ' 89' ' ' ILE . 88.1 t80 -60.15 -44.61 94.84 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.162 -0.961 . . . . 0.78 108.879 178.659 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.1 tp -59.95 -47.34 86.21 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.827 -1.175 . . . . 1.07 107.827 179.427 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 27.6 t -63.53 -43.62 96.6 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.571 -0.852 . . . . 1.12 108.979 178.963 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.97 -48.24 87.28 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.986 -1.646 . . . . 0.84 108.986 179.34 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -63.2 -31.5 72.66 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.365 -1.08 . . . . 3.09 108.2 179.114 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.61 -40.05 82.17 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.813 -0.81 . . . . 0.88 108.813 179.887 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.546 ' HZ3' ' HB3' ' A' ' 49' ' ' LYS . 6.8 ttpm? -65.73 -74.31 0.11 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.932 -1.136 . . . . 2.59 107.932 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.94 -40.54 0.47 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.366 -0.834 . . . . 0.7 111.758 -178.255 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 64.0 m -54.48 -53.7 50.74 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.465 -1.397 . . . . 1.4 108.982 -179.875 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.23 -41.18 77.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.226 -0.921 . . . . 0.67 110.819 -179.318 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -66.89 -39.97 87.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.908 -1.12 . . . . 1.66 109.989 -179.511 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.9 mt -61.03 -39.95 91.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.892 -1.13 . . . . 1.58 108.725 179.066 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -61.94 -35.08 77.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.477 -0.765 . . . . 1.35 109.573 179.482 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -64.3 -43.04 95.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.034 -1.041 . . . . 0.77 109.35 179.816 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.9 -39.63 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.855 . . . . 0.63 108.917 179.681 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -57.07 -50.43 72.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.442 -0.786 . . . . 1.14 109.971 -179.368 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -57.1 -31.62 65.46 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.319 -0.863 . . . . 0.79 110.377 -177.888 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -70.02 -38.14 75.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.05 -1.031 . . . . 1.53 109.436 -179.897 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.8 -45.91 76.91 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.615 -0.678 . . . . 0.57 110.641 -179.128 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.88 -50.87 63.04 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.755 -1.212 . . . . 0.75 110.424 -178.637 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -70.24 -43.8 69.85 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.934 -1.333 . . . . 1.59 110.18 -179.792 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.4 m -69.98 -57.8 4.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.067 -1.021 . . . . 0.73 111.698 -178.042 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -98.31 -54.36 3.08 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.138 -0.976 . . . . 0.75 111.483 -178.168 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.26 -164.58 26.88 Favored Glycine 0 N--CA 1.5 2.914 0 C-N-CA 119.676 -1.25 . . . . 1.22 110.931 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -71.4 -25.92 62.55 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.884 -0.774 . . . . 5.81 110.795 -179.409 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.4 -35.9 78.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.165 -0.959 . . . . 3.37 110.197 -179.255 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -100.01 -20.28 16.14 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.331 -0.856 . . . . 1.77 110.269 -179.222 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -69.92 -40.32 75.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.962 -1.087 . . . . 1.65 110.501 -178.826 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.621 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -67.36 -26.1 66.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.133 -0.979 . . . . 0.77 109.972 -179.058 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.73 -39.99 81.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 118.954 -1.099 . . . . 0.8 108.345 179.77 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -67.82 -39.99 83.84 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.055 -1.028 . . . . 0.88 110.311 179.885 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.419 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 80.2 tt0 -59.91 -40.78 89.97 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.759 -1.213 . . . . 1.37 109.454 179.464 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.86 -48.98 76.55 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.029 -1.628 . . . . 0.62 109.029 179.518 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.5 m170 -63.05 -42.96 99.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.463 -1.022 . . . . 1.5 109.485 179.916 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.02 -45.1 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.235 -0.916 . . . . 0.63 109.784 -179.737 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.0 ttp -60.27 -40.11 89.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.891 -1.13 . . . . 1.51 109.121 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.969 HD22 HD23 ' B' ' 347' ' ' LEU . 48.1 tp -63.09 -39.34 94.41 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.683 -0.636 . . . . 0.77 109.956 179.626 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.2 tp -66.26 -38.3 87.53 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.523 -0.735 . . . . 0.62 110.248 -179.483 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -80.35 3.28 21.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.958 -1.089 . . . . 1.47 110.258 -179.045 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -49.75 130.03 20.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.0 -1.063 . . . . 1.47 109.642 -179.614 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.18 -17.73 58.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.534 -0.729 . . . . 1.78 110.629 -179.536 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -71.85 -35.05 69.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.975 -1.078 . . . . 2.53 108.713 178.767 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.8 mt -69.96 -40.36 75.47 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.492 0.663 . . . . 0.8 109.831 179.761 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.04 -45.37 93.04 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.329 -0.857 . . . . 1.42 109.917 -179.22 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -69.99 -40.0 75.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 1.71 110.334 -179.14 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.96 -40.05 75.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.288 -0.882 . . . . 1.57 110.912 -179.175 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.451 HD13 ' CZ ' ' A' ' 43' ' ' PHE . 87.3 mt -68.37 -42.45 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.991 -1.068 . . . . 0.65 109.595 -179.588 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.01 -38.78 76.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.564 -0.71 . . . . 0.82 110.633 -179.533 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.45 77.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.102 -0.999 . . . . 0.79 111.247 -178.615 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.81 -47.54 84.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.769 -1.207 . . . . 0.95 110.419 -178.964 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.42 -49.9 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.114 -0.991 . . . . 0.66 109.183 179.957 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -70.27 -43.9 69.54 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.375 -0.53 . . . . 2.2 111.132 -179.721 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -80.98 -49.87 10.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.986 -1.072 . . . . 1.65 111.991 -177.813 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -90.12 -2.43 58.08 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.001 -1.062 . . . . 2.03 111.584 -177.372 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 56.43 35.12 25.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.859 -1.15 . . . . 1.42 109.435 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.0 mtt -88.4 169.26 11.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.472 -0.768 . . . . 1.18 109.907 -179.417 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.4 p -81.88 160.0 23.54 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.342 -0.849 . . . . 0.98 108.776 179.532 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.77 -39.88 88.0 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.22 -0.925 . . . . 0.64 110.258 -179.472 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 35.9 p-10 -67.02 -35.07 79.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.081 -1.012 . . . . 2.07 109.335 -179.735 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.507 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.96 -47.39 13.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.317 -0.865 . . . . 0.73 109.604 179.661 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.63 -48.32 81.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.385 -0.822 . . . . 0.54 110.007 -179.612 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.28 -36.24 79.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.935 . . . . 0.56 109.844 -179.891 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.415 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 80.3 t60 -60.03 -42.67 94.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.286 -0.884 . . . . 1.54 109.98 -178.761 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' A' ' 110' ' ' GLY . 41.3 tt0 -64.36 -40.01 94.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.164 -0.96 . . . . 1.33 110.242 -179.469 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.2 t -60.57 -56.09 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.352 -0.842 . . . . 0.72 111.446 -178.06 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.1 mm -69.93 -39.97 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.942 -1.099 . . . . 0.85 108.936 -179.789 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.415 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 88.8 tt0 -64.78 -38.87 92.44 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.567 -0.901 . . . . 2.44 108.567 178.639 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.02 -49.2 77.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.813 -0.915 . . . . 0.98 110.813 -179.066 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -68.79 -52.34 31.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.716 -1.461 . . . . 1.41 109.527 -179.521 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.62 -40.05 78.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.296 -0.877 . . . . 1.2 109.26 179.868 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.6 t -58.24 -41.4 84.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.175 -0.953 . . . . 1.7 108.963 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.81 -40.5 91.91 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.258 -0.901 . . . . 1.47 109.028 179.192 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.431 HD22 ' HB3' ' B' ' 351' ' ' GLN . 76.5 mt -61.4 -45.24 95.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.107 -0.996 . . . . 1.56 109.62 -179.682 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -57.25 -32.32 66.45 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.143 -0.973 . . . . 2.2 109.846 -178.48 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -58.11 -21.74 47.66 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.022 -1.049 . . . . 2.12 108.605 179.773 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 123' ' ' LEU . 54.4 mt -62.37 139.95 58.54 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.264 -0.898 . . . . 2.0 108.577 179.636 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -90.09 10.08 25.71 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.114 -0.991 . . . . 3.23 110.86 -178.722 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -94.39 133.59 37.8 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.777 -1.202 . . . . 2.49 109.828 -179.75 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -69.92 -28.99 66.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.571 -0.706 . . . . 3.95 109.954 -179.861 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.484 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.7 t80 -69.24 -36.86 77.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.376 -0.827 . . . . 2.0 110.244 179.417 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.654 HD22 ' O ' ' B' ' 351' ' ' GLN . 90.6 mt -77.49 -35.21 53.84 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.093 -1.004 . . . . 1.86 109.57 179.838 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -59.99 -45.33 93.08 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.229 -0.919 . . . . 2.84 109.678 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 77.6 mm-40 -60.55 -45.37 94.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -0.964 . . . . 2.73 109.296 -179.655 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -61.94 -39.88 93.62 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.117 -1.068 . . . . 2.77 108.117 179.101 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.79 -23.25 51.54 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.184 -1.043 . . . . 1.19 108.184 178.796 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -69.96 -40.09 75.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.814 -0.81 . . . . 1.2 108.814 178.954 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.54 -40.09 94.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.528 -0.733 . . . . 1.55 110.294 -179.497 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.93 -40.56 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.08 -1.013 . . . . 0.8 108.402 179.842 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -60.09 -38.69 83.68 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.964 -0.754 . . . . 3.09 108.964 178.474 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -59.53 -39.57 84.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.745 . . . . 1.46 109.986 -179.52 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.93 -40.78 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.052 -1.03 . . . . 0.71 109.686 -179.623 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.63 -41.42 96.01 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.979 -1.105 . . . . 0.57 110.769 -179.44 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -59.93 -47.07 87.3 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.964 -1.315 . . . . 2.59 111.279 -178.799 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.621 HH12 ' CB ' ' A' ' 166' ' ' SER . 98.6 mtt180 -69.97 -30.47 67.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.504 -1.372 . . . . 2.83 109.927 -179.622 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.0 -46.15 90.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 1.25 109.152 -179.968 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.5 mt -59.88 -40.04 87.35 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.396 -0.815 . . . . 0.7 109.464 179.236 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.414 ' NE ' HD23 ' A' ' 144' ' ' LEU . 53.5 mtp180 -69.16 -40.02 78.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.397 -0.814 . . . . 2.57 110.206 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -69.93 -20.91 63.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.337 -0.852 . . . . 1.23 112.383 -178.136 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.5 mt -68.68 -40.02 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.19 -1.569 . . . . 0.81 108.408 179.664 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.13 -29.32 21.9 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.436 -0.79 . . . . 1.0 109.621 -179.699 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.96 54.35 2.05 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 108.695 -1.762 . . . . 0.89 108.695 -178.958 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.414 HD23 ' NE ' ' A' ' 139' ' ' ARG . 19.0 tp -74.73 147.31 41.48 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.625 -0.926 . . . . 1.14 110.009 -179.168 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -60.19 141.42 55.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.342 -0.848 . . . . 4.6 109.867 -179.867 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.3 mt -119.96 127.06 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-O 122.01 0.91 . . . . 1.24 109.414 179.52 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.5 mt -60.11 -45.9 95.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 116.063 -0.517 . . . . 1.54 109.952 -178.504 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.4 t0 64.22 101.52 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.498 -0.751 . . . . 1.5 109.256 -179.57 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.1 mt -71.74 -5.27 32.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.368 -0.833 . . . . 0.79 109.868 -179.269 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.6 m -80.21 -18.57 49.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.056 -1.028 . . . . 1.4 109.56 179.758 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.1 24.04 0.81 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.271 -0.893 . . . . 0.92 111.777 -178.002 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 39.2 mm -90.97 115.98 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.496 -1.378 . . . . 0.88 108.64 179.19 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -100.04 -9.68 22.39 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.34 -0.85 . . . . 2.45 110.545 -178.748 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -119.92 149.48 42.04 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.188 -0.945 . . . . 1.52 110.336 -179.392 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.01 133.81 52.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.388 -0.82 . . . . 1.58 109.1 179.766 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -151.77 164.7 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.448 -0.783 . . . . 0.69 109.597 179.678 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.8 mt -93.69 147.32 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.038 -1.838 . . . . 0.61 106.038 177.0 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 60.9 tp -97.3 117.01 30.57 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.879 -1.138 . . . . 0.87 110.642 -177.952 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 35.5 t -122.12 127.74 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.197 -1.038 . . . . 0.71 108.197 179.228 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.07 160.65 39.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.987 -1.07 . . . . 0.81 108.711 -179.895 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.96 -34.7 73.74 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.261 -1.524 . . . . 0.98 108.16 178.977 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -160.14 170.69 20.69 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.806 -0.813 . . . . 2.25 108.806 179.935 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.6 mt -141.96 129.95 21.93 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.041 -1.037 . . . . 0.78 108.733 178.989 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 63.1 p -90.56 144.23 30.32 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.084 -1.01 . . . . 0.98 109.293 -179.741 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -40.1 -37.6 1.83 Allowed 'Trans proline' 0 N--CA 1.488 1.196 0 C-N-CA 122.116 1.877 . . . . 0.81 112.457 179.39 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.621 ' CB ' HH12 ' A' ' 136' ' ' ARG . 50.2 m -59.98 -40.95 90.9 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.352 -0.843 . . . . 0.9 109.591 -179.238 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -62.78 -43.24 99.32 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.261 -0.9 . . . . 1.61 110.195 -179.644 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 62.4 p -57.85 -28.71 64.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.61 110.531 -178.679 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.99 -57.5 4.93 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.015 -1.053 . . . . 0.6 109.775 179.7 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -83.5 35.39 0.5 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.102 -0.703 . . . . 1.4 109.102 -179.446 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.3 tp -100.66 139.04 36.9 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.347 -0.846 . . . . 0.7 109.345 179.588 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -85.43 103.73 14.59 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.267 -0.896 . . . . 2.35 108.763 179.545 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 63.1 mt -63.62 -45.36 90.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.476 -0.765 . . . . 1.51 110.273 -178.694 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -70.06 -20.39 63.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.024 -1.048 . . . . 2.33 112.572 -178.328 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -93.15 -10.12 36.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.471 -1.393 . . . . 1.92 109.26 -179.185 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 178' ' ' GLY . 89.4 t -109.79 117.64 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.317 -0.864 . . . . 0.67 109.356 179.465 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 78.4 mt -88.77 5.49 43.25 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.348 -0.845 . . . . 1.53 110.676 -178.407 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.514 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.59 173.16 38.96 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.2 -1.56 . . . . 0.48 109.2 179.808 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.432 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 22.6 m-85 -133.09 129.94 38.64 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.258 -1.142 . . . . 0.55 110.105 -179.598 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.555 ' CG2' HG21 ' A' ' 205' ' ' THR . 58.9 mt -128.9 122.89 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.037 -1.097 . . . . 0.65 108.037 177.971 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 11.7 p -143.52 157.03 44.75 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.986 -1.072 . . . . 0.82 110.982 -179.202 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 183' ' ' ALA . 1.1 m-20 -96.19 21.35 9.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.436 -0.79 . . . . 2.46 109.631 -179.891 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -46.9 -173.93 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.977 -1.077 . . . . 1.28 112.723 -177.922 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -85.85 -49.75 4.19 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 111.377 -0.689 . . . . 2.19 111.377 -178.979 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -174.18 -154.46 10.86 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 118.525 -1.798 . . . . 2.13 111.71 -179.291 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.543 ' C ' ' H ' ' A' ' 188' ' ' SER . 8.7 mtt-85 -62.42 -33.99 75.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.782 -0.834 . . . . 5.86 111.151 -178.632 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 29.1 p -60.04 6.99 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.839 -1.163 . . . . 3.72 110.639 -178.302 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.543 ' H ' ' C ' ' A' ' 186' ' ' ARG . 92.7 p -90.85 130.76 36.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.871 -1.143 . . . . 1.74 109.941 179.717 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -47.62 -45.87 28.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.203 -0.935 . . . . 0.95 109.548 -179.849 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 93.3 m -58.41 -40.26 81.96 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 1.55 110.171 -178.317 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 186' ' ' ARG . 81.1 p -63.29 -38.8 92.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.822 -1.174 . . . . 1.51 109.849 -179.881 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.591 HD13 HH22 ' A' ' 195' ' ' ARG . 41.9 mm -60.09 -45.81 95.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.299 -0.876 . . . . 1.67 109.09 -179.459 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.16 -46.45 89.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.415 -0.803 . . . . 1.02 110.639 -179.698 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.43 -48.73 76.38 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.805 -1.185 . . . . 0.68 111.219 -178.273 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.591 HH22 HD13 ' A' ' 192' ' ' ILE . 26.8 mtm-85 -60.88 -50.04 75.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.684 -1.26 . . . . 2.93 110.458 -178.903 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 48.7 m -71.29 -34.98 71.14 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.834 -1.166 . . . . 0.86 111.6 -178.506 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 99.0 mt -81.52 -11.13 59.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.696 -1.253 . . . . 0.67 110.796 -178.356 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 56.91 46.48 19.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.166 -0.959 . . . . 1.5 110.696 179.592 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 8' ' ' SER . 92.2 mt -116.31 121.26 33.75 Favored Pre-proline 0 N--CA 1.5 2.072 0 N-CA-C 108.341 -0.985 . . . . 0.72 108.341 179.055 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -42.35 129.61 4.76 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.83 1.687 . . . . 0.61 111.952 -179.42 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -170.01 152.17 4.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.982 -1.074 . . . . 0.66 111.649 -179.221 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.7 mt -126.87 144.0 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.654 -1.239 . . . . 0.79 107.654 178.607 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 20.5 m -124.05 -9.43 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 O-C-N 120.796 -1.19 . . . . 0.91 111.381 -178.446 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.46 23.69 24.0 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 110.875 -0.89 . . . . 1.01 110.875 -178.829 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.555 HG21 ' CG2' ' A' ' 180' ' ' ILE . 19.2 p -47.19 -42.86 20.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.833 -1.392 . . . . 0.99 110.105 -179.276 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.77 -52.26 4.18 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 120.039 -1.077 . . . . 1.12 111.924 178.833 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.5 t -155.36 35.1 0.37 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.37 -1.665 . . . . 1.72 111.819 -178.759 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 29.5 t -75.95 -38.01 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.857 -1.152 . . . . 0.89 109.195 178.422 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.441 HG23 ' H ' ' A' ' 209' ' ' THR . 2.2 p -60.03 -40.07 88.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.591 -0.693 . . . . 1.03 111.55 -177.985 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.7 p -78.47 -11.37 59.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.799 -1.188 . . . . 1.83 110.264 -178.74 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -96.97 -12.24 23.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.233 -0.917 . . . . 2.27 110.408 -179.698 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 213' ' ' LYS . 91.8 t -116.34 156.2 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.321 -0.862 . . . . 0.92 110.592 -179.344 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.505 ' N ' HG12 ' A' ' 212' ' ' VAL . 62.3 mmtt -114.71 154.12 29.04 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.207 -1.035 . . . . 2.2 108.207 179.687 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 39.0 p-10 -59.73 135.96 57.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.868 -1.145 . . . . 2.36 110.095 -179.404 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.7 OUTLIER 94.5 -1.72 0.08 Allowed 'General case' 0 N--CA 1.511 2.614 0 CA-C-O 121.581 0.705 . . . . 2.38 109.988 179.502 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 48.8 t0 -70.08 151.2 45.76 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.434 -0.792 . . . . 2.09 109.792 -179.961 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 51.0 t80 -95.37 120.13 35.07 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.371 -0.831 . . . . 1.27 108.804 179.602 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 90.2 mt -123.34 138.34 54.63 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.386 -0.821 . . . . 0.75 110.657 -179.297 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.9 mt -112.35 130.0 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 106.436 -1.69 . . . . 0.63 106.436 176.317 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 57.0 tp -100.32 115.01 28.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.115 -0.991 . . . . 0.7 109.542 -178.303 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 223' ' ' VAL . 55.8 m-20 -70.6 -46.92 62.51 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.924 -1.139 . . . . 2.31 107.924 178.996 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.808 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 52.12 9.15 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.917 -0.771 . . . . 0.78 108.917 -179.644 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' A' ' 221' ' ' ASP . 75.5 t -125.9 -38.89 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 107.094 -1.447 . . . . 1.04 107.094 178.797 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -104.32 0.01 28.71 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.928 -1.138 . . . . 2.44 107.928 178.243 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 60.08 45.9 11.35 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.156 -0.683 . . . . 1.55 109.156 -179.524 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -136.41 156.26 48.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.398 -0.814 . . . . 1.99 109.599 -179.752 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.5 t -124.37 129.98 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 108.798 -0.816 . . . . 0.77 108.798 178.957 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -105.22 125.86 51.45 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.513 -0.921 . . . . 0.98 108.513 179.192 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.9 t -103.89 113.99 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.202 -0.936 . . . . 0.85 110.404 -179.406 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 49.48 62.67 11.61 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.099 -1.001 . . . . 1.66 110.707 178.916 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -85.35 156.16 10.87 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.832 2.355 . . . . 0.95 112.173 179.319 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.0 m -65.92 159.28 25.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.342 -0.849 . . . . 1.84 109.637 -179.423 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 41.9 p-10 -61.61 -38.58 88.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.257 -0.902 . . . . 2.74 111.006 -178.916 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.462 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 16.8 pt-20 -65.62 -30.83 71.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.79 -1.194 . . . . 2.89 109.708 -179.492 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.6 -43.15 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 1.3 108.564 179.286 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.536 -0.728 . . . . 1.09 109.963 179.885 . . . . . . . . 0 0 . 1 . 031 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 3.0 ttt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.509 0.671 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -151.98 150.07 29.59 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.995 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -148.34 159.17 44.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.007 -1.058 . . . . 0.0 110.14 -179.275 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -152.98 150.06 28.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.631 -0.668 . . . . 0.0 109.344 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 305' ' ' GLU . . . . . 0.481 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 1.6 pm0 -114.87 134.69 54.94 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.313 -0.867 . . . . 0.0 109.969 179.43 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 1.3 p -135.63 124.92 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 CA-C-O 122.029 0.919 . . . . 0.0 112.44 -177.212 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 88.7 m -77.72 106.35 9.47 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.93 0.871 . . . . 0.0 109.969 -179.385 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.472 HG22 ' H ' ' B' ' 310' ' ' ALA . 92.3 mt -50.78 124.16 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 122.449 1.118 . . . . 0.0 110.274 -177.407 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 74.8 p -108.06 19.93 19.35 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.54 -178.955 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.472 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -74.57 118.21 68.27 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.907 . . . . 0.0 108.606 179.308 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -61.18 -13.4 27.96 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 CA-C-N 120.477 1.206 . . . . 0.0 112.288 -179.815 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -117.5 9.52 13.26 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.524 -0.735 . . . . 0.0 110.422 -178.581 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.96 172.08 16.78 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.311 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.484 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -82.34 87.92 6.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.951 -1.323 . . . . 0.0 109.557 -178.285 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.537 ' CE1' ' HB3' ' B' ' 317' ' ' ARG . 23.4 p-80 -90.56 -163.39 1.02 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.796 -1.19 . . . . 0.0 109.713 178.76 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.1 m -58.1 -41.29 83.21 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.806 -1.184 . . . . 0.0 112.595 -175.775 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.621 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 16.3 tpt180 -59.35 -59.58 13.38 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 120.379 -1.451 . . . . 0.0 111.658 -179.49 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.412 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 14.9 Cg_endo -60.43 -34.86 92.71 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 CA-C-N 120.522 1.222 . . . . 0.0 111.693 -179.653 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.98 -51.97 67.4 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.318 -0.864 . . . . 0.0 108.978 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -54.27 -41.8 69.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.687 -178.934 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -70.08 -41.13 74.49 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.982 -1.074 . . . . 0.0 108.669 178.772 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -60.73 -51.67 68.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.548 -0.72 . . . . 0.0 111.247 -179.362 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 323' ' ' VAL . . . . . 0.41 HG13 ' O ' ' B' ' 344' ' ' ALA . 86.1 t -67.76 -27.04 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.565 -1.334 . . . . 0.0 109.259 -179.125 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 324' ' ' LYS . . . . . 0.419 ' NZ ' ' OE1' ' A' ' 74' ' ' GLU . 31.1 ttmt -60.04 -47.52 85.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.552 -0.718 . . . . 0.0 109.645 179.741 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -64.39 -45.22 88.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 110.557 -179.255 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.09 -52.79 63.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.854 -1.154 . . . . 0.0 110.751 -178.792 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -55.22 -16.63 3.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.174 -0.954 . . . . 0.0 109.808 179.706 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.96 -30.64 69.97 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.462 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.29 140.47 39.17 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.465 -1.02 . . . . 0.0 109.27 179.844 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 19.8 m -89.94 -10.71 44.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.124 -0.985 . . . . 0.0 109.607 -179.97 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.495 ' OG ' ' N ' ' B' ' 368' ' ' GLU . 72.9 m -57.74 146.55 30.82 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.051 -1.03 . . . . 0.0 108.679 179.451 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.7 132.66 50.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.186 -0.946 . . . . 0.0 109.499 -179.326 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.8 mt -132.34 131.8 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.471 -0.768 . . . . 0.0 108.964 179.694 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 334' ' ' THR . . . . . 0.403 HG22 ' N ' ' B' ' 335' ' ' VAL . 52.1 m -128.73 153.48 47.31 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.778 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 335' ' ' VAL . . . . . 0.403 ' N ' HG22 ' B' ' 334' ' ' THR . 98.9 t -118.51 140.03 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.504 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 34.3 m -128.04 123.51 34.82 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 179.225 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 86.9 p -138.54 114.98 10.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.261 -0.899 . . . . 0.0 110.87 -179.191 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 28.9 m120 45.17 50.04 9.63 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 176.906 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.92 -14.21 62.5 Favored Glycine 0 N--CA 1.501 3.028 0 O-C-N 120.077 -1.639 . . . . 0.0 112.947 176.873 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -116.02 126.69 54.15 Favored 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 119.225 1.512 . . . . 0.0 109.699 179.834 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 52.9 m -118.43 144.6 45.84 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.731 0.777 . . . . 0.0 110.648 -178.943 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 342' ' ' ALA . . . . . 0.506 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -143.18 162.11 36.46 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.571 0.7 . . . . 0.0 110.005 -179.765 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 41.4 t -87.94 132.5 34.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.669 -0.644 . . . . 0.0 110.745 -178.906 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.41 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -68.96 -16.75 63.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 108.689 179.358 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -88.73 19.4 4.03 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 178.737 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 346' ' ' SER . . . . . 0.745 ' CB ' ' HZ3' ' B' ' 349' ' ' LYS . 53.9 p -146.62 94.99 2.52 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.774 0.797 . . . . 0.0 112.406 -179.428 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.969 HD23 HD22 ' A' ' 79' ' ' LEU . 52.9 tp -60.0 -36.51 77.34 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.728 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.763 ' CE2' HD11 ' A' ' 79' ' ' LEU . 58.3 m-85 -56.51 -53.52 56.5 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.324 -0.86 . . . . 0.0 110.708 -179.181 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 349' ' ' LYS . . . . . 0.745 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 33.6 mtmm -70.04 -38.78 75.94 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.875 -1.141 . . . . 0.0 109.609 -178.846 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' B' ' 352' ' ' THR . 35.7 mt -48.2 -59.51 3.36 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.946 -1.096 . . . . 0.0 108.496 179.415 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.654 ' O ' HD22 ' A' ' 123' ' ' LEU . 0.9 OUTLIER -39.14 -25.92 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.695 -0.628 . . . . 0.0 111.124 -179.088 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.46 ' N ' ' O ' ' B' ' 350' ' ' LEU . 66.3 p -79.45 -9.94 59.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.344 -1.472 . . . . 0.0 110.198 -178.295 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' B' ' 342' ' ' ALA . 61.1 mt -92.54 114.43 26.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.018 -1.051 . . . . 0.0 108.644 178.6 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.77 90.04 0.66 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 179.575 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 22.7 mt -100.62 93.54 5.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.316 -1.108 . . . . 0.0 108.674 179.426 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 70.9 p -93.36 167.34 11.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.135 -0.978 . . . . 0.0 110.625 -179.053 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 13.3 tm0? -57.84 113.01 1.67 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.782 -0.574 . . . . 0.0 110.693 -179.32 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.78 9.25 38.05 Favored Glycine 0 N--CA 1.498 2.821 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.737 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.6 m -87.19 110.65 20.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.388 -1.066 . . . . 0.0 111.415 -179.113 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 5.0 t -77.03 115.43 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 122.165 0.983 . . . . 0.0 109.703 -177.775 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 18.3 m -113.31 177.18 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.855 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 93.3 m -132.15 132.58 43.34 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.052 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 59.3 mt -107.94 126.07 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.194 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 54.0 m -125.36 133.51 52.53 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.447 -0.783 . . . . 0.0 109.17 -179.491 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -148.53 155.62 41.38 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.94 -1.1 . . . . 0.0 111.001 -178.812 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -149.55 128.68 12.76 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.824 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.461 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 156.65 -152.16 23.54 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.155 -1.498 . . . . 0.0 111.726 179.548 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 368' ' ' GLU . . . . . 0.495 ' N ' ' OG ' ' B' ' 331' ' ' SER . 54.5 tp10 -58.64 -52.1 67.13 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 122.099 -0.647 . . . . 0.0 112.376 -177.15 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' B' ' 370' ' ' GLU . 89.2 m-20 -114.98 15.63 17.23 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.011 -1.056 . . . . 0.0 111.416 -177.11 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.54 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.0 OUTLIER -41.25 -37.3 0.92 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.255 -0.903 . . . . 0.0 111.718 -178.488 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' B' B ' 371' ' ' GLN . . . . . 0.516 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 24.6 mm100 -68.05 -44.53 76.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.602 -1.311 . . . . 0.0 110.376 -178.083 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -68.29 -51.56 43.51 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.094 -1.004 . . . . 0.0 109.033 179.806 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -46.32 -38.08 8.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.698 -0.626 . . . . 0.0 111.665 -178.87 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.467 ' O ' HG23 ' B' ' 378' ' ' VAL . 70.4 t -73.02 -39.47 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.624 -1.297 . . . . 0.0 109.332 179.505 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.98 -58.67 7.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 0.0 111.507 -178.807 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -68.96 -40.45 78.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.525 -1.359 . . . . 0.0 111.791 -177.956 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.02 -41.87 93.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.715 -1.241 . . . . 0.0 108.853 -178.871 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.467 HG23 ' O ' ' B' ' 374' ' ' VAL . 52.6 t -61.07 -44.58 98.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.221 -0.925 . . . . 0.0 109.624 179.367 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 379' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' B' ' 383' ' ' GLU . 45.7 mtpt -69.26 -55.3 10.93 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.108 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 48.7 tp -54.87 -35.9 64.55 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.317 -0.864 . . . . 0.0 109.393 -178.271 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 38.3 ttm -70.77 -40.02 72.88 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.623 -1.298 . . . . 0.0 108.689 177.829 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.86 -4.28 58.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.625 -0.672 . . . . 0.0 110.533 179.728 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' B' ' 379' ' ' LYS . 98.4 mt-10 -112.11 -4.79 14.34 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.087 -1.008 . . . . 0.0 110.986 -179.701 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 16.5 mt -80.27 132.86 35.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.455 -1.403 . . . . 0.0 108.483 178.579 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.284 -179.904 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mmm . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.197 0.522 . . . . 2.91 109.777 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.4 mt -99.69 122.9 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.267 -0.895 . . . . 1.2 109.042 179.505 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.3 m -139.03 119.39 13.75 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.302 -0.874 . . . . 1.4 109.683 -179.482 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.08 -163.01 29.72 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.108 -1.597 . . . . 1.05 109.108 179.648 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.2 mt -90.6 -7.77 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.118 -1.224 . . . . 1.15 110.684 -179.048 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.2 tp 54.85 96.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.969 -1.082 . . . . 0.98 109.246 -179.829 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.45 -25.77 26.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.142 -0.974 . . . . 0.88 109.375 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 t -150.93 131.21 7.0 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.152 -0.967 . . . . 1.69 109.101 179.659 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.11 140.31 15.66 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.954 1.769 . . . . 0.85 111.836 179.608 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.691 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 166.61 -164.59 37.82 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.382 -1.487 . . . . 0.92 109.382 -179.583 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.3 mt -147.24 147.27 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.897 -1.355 . . . . 0.81 108.589 179.37 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.06 157.67 37.91 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.924 -1.11 . . . . 0.51 110.07 179.755 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -139.02 128.13 23.89 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.01 -1.107 . . . . 0.62 108.01 179.312 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.52 178.78 47.4 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.473 -1.822 . . . . 0.55 110.792 179.714 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -77.43 158.15 30.17 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.761 -0.847 . . . . 2.1 109.431 -179.658 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.36 132.3 45.81 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.315 -0.866 . . . . 0.77 111.515 -178.563 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.3 tp -101.58 133.3 46.47 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.468 -1.308 . . . . 0.91 107.468 178.004 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.0 tp -116.35 123.13 46.85 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.853 0.835 . . . . 0.93 110.19 -178.798 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.429 HD12 ' HB2' ' A' ' 160' ' ' ALA . 18.3 mt -92.75 102.29 14.69 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.206 0.527 . . . . 0.93 110.586 -179.022 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mtmt -105.15 136.0 45.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.369 -0.832 . . . . 2.75 109.482 179.713 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -130.64 139.49 50.37 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.44 -0.787 . . . . 3.0 109.354 179.437 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -87.5 152.63 22.06 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.147 -0.971 . . . . 2.77 109.493 179.547 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -70.07 140.64 52.8 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.103 -0.998 . . . . 2.94 110.383 -179.781 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.6 mt -81.88 136.65 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.476 -0.935 . . . . 0.95 108.476 179.124 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.6 t -103.66 127.68 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.231 -0.918 . . . . 1.28 110.776 -178.82 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -102.96 136.69 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.791 -0.818 . . . . 1.21 108.791 179.481 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.13 124.55 34.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.987 -1.07 . . . . 1.81 109.238 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -88.99 1.12 55.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -0.873 . . . . 2.8 109.526 -179.762 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -61.85 140.33 58.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 2.87 110.129 179.859 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -85.58 141.73 29.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.612 -0.884 . . . . 2.35 108.612 179.452 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.495 HG21 ' HG3' ' A' ' 39' ' ' GLU . 7.7 pt -90.12 164.99 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.823 -1.173 . . . . 0.97 110.944 -179.12 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.3 p -97.07 172.46 7.82 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.551 -0.907 . . . . 1.17 108.551 178.566 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.02 -48.69 80.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.02 -1.05 . . . . 1.18 109.819 -179.473 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 40.1 t0 -55.5 -30.05 59.93 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.822 -1.174 . . . . 2.56 109.367 -179.889 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.86 -10.04 59.42 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.446 -0.784 . . . . 1.79 110.272 -179.756 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.5 t -64.08 -53.28 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.497 -1.377 . . . . 1.0 108.995 179.578 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.25 -40.04 96.3 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.436 -0.79 . . . . 1.77 110.121 -179.906 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -69.89 -40.25 75.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.095 -1.003 . . . . 2.7 110.497 -178.934 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.495 ' HG3' HG21 ' A' ' 31' ' ' ILE . 66.4 mm-40 -65.81 -40.04 91.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.846 -1.159 . . . . 1.51 109.955 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.88 -46.48 96.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.963 -1.086 . . . . 0.93 108.514 178.919 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -60.26 -40.43 90.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.19 -0.944 . . . . 1.81 109.315 179.561 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -60.07 -44.14 94.96 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.097 -1.075 . . . . 2.78 108.097 179.099 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.33 -48.63 80.46 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.231 -0.918 . . . . 0.78 109.046 178.114 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.5 tp -59.81 -45.24 92.97 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.217 -1.031 . . . . 1.07 108.217 -179.472 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 41.2 t -60.34 -40.02 89.21 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.156 -0.965 . . . . 1.12 108.548 178.538 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.9 -48.87 80.89 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.641 -1.784 . . . . 0.84 108.641 179.32 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -60.33 -39.02 85.57 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.821 -1.177 . . . . 3.09 107.821 178.28 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -51.06 -40.79 59.14 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.582 -0.896 . . . . 0.88 108.582 179.887 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 50' ' ' ALA . 14.5 ttmm -66.91 -73.78 0.13 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.386 -1.338 . . . . 2.59 107.386 178.417 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.83 -38.7 0.19 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.659 -0.65 . . . . 0.7 111.139 -178.557 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.2 m -53.75 -55.25 27.97 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.513 -1.367 . . . . 1.4 108.184 179.206 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.91 -46.96 66.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.521 -0.737 . . . . 0.67 111.027 -179.63 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -62.47 -43.54 98.56 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.885 -1.134 . . . . 1.66 110.5 -179.058 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.6 mt -60.12 -40.07 88.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.06 -1.025 . . . . 1.58 108.924 179.694 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -62.71 -34.39 77.06 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.429 -0.794 . . . . 1.35 109.618 179.507 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -64.6 -44.15 91.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.991 -1.068 . . . . 0.77 109.744 179.881 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.9 mt -60.23 -39.86 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.63 109.343 179.822 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.9 ttpp -54.08 -50.19 67.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.492 -0.755 . . . . 1.14 109.7 -179.076 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.7 m -58.13 -37.98 75.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -0.939 . . . . 0.79 110.667 -177.884 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.85 -38.92 92.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.878 -1.139 . . . . 1.53 109.768 -179.696 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.65 -46.8 77.81 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.541 -0.724 . . . . 0.57 109.865 -179.613 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.13 -52.21 52.79 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.913 -1.275 . . . . 0.75 109.913 -179.124 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -70.08 -47.56 61.39 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.146 -1.208 . . . . 1.59 109.996 -179.728 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 49.0 m -63.63 -65.45 0.68 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.299 -0.876 . . . . 0.73 112.744 -177.569 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -95.58 -45.03 7.22 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.609 -1.307 . . . . 0.75 111.151 -177.944 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.17 -169.98 24.79 Favored Glycine 0 N--CA 1.5 2.91 0 O-C-N 120.672 -1.268 . . . . 1.22 110.863 179.67 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.0 -24.36 63.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.93 -0.747 . . . . 5.81 109.652 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -60.0 -34.01 72.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -0.802 . . . . 3.37 110.195 -179.682 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.417 ' HA ' HD12 ' A' ' 72' ' ' ILE . 29.5 mmtp -100.33 -17.46 17.25 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.316 -0.865 . . . . 1.77 110.006 179.683 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -68.8 -46.44 68.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.262 -0.899 . . . . 1.65 110.284 -179.342 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.553 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -62.47 -28.2 69.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.412 -0.805 . . . . 0.77 109.945 -178.802 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 69' ' ' LYS . 93.0 mt -60.06 -41.14 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.917 -1.114 . . . . 0.8 109.389 -179.621 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -68.19 -38.16 81.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.961 -1.087 . . . . 0.88 110.279 -179.567 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.401 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 74.4 tt0 -59.94 -39.95 87.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.922 -1.111 . . . . 1.37 109.485 179.676 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.1 -41.69 99.7 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.11 -1.596 . . . . 0.62 109.11 179.522 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.4 m170 -64.02 -40.97 97.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.398 -1.06 . . . . 1.5 109.502 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -68.91 -47.2 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.174 -0.954 . . . . 0.63 109.022 179.488 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -60.61 -40.24 91.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.095 -1.003 . . . . 1.51 110.472 -179.457 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.86 HD11 ' CE2' ' B' ' 348' ' ' PHE . 27.2 tp -67.48 -40.0 85.26 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.079 -1.013 . . . . 0.77 109.3 179.72 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.63 -39.98 92.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.468 -0.77 . . . . 0.62 110.368 -179.503 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -80.26 5.05 15.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.995 -1.066 . . . . 1.47 110.262 -178.706 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 61.9 t0 -51.57 130.03 27.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.059 -1.026 . . . . 1.47 109.618 -179.855 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.404 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.7 mt-10 -61.21 -15.18 31.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.48 -0.763 . . . . 1.78 110.173 -179.337 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -72.55 -36.86 68.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.106 -0.996 . . . . 2.53 108.673 178.758 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.04 -40.06 75.35 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.574 0.702 . . . . 0.8 109.41 -179.915 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.12 -49.16 78.75 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.259 -0.9 . . . . 1.42 109.597 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -69.99 -40.29 75.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.377 -0.827 . . . . 1.71 111.316 -179.008 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.07 -39.92 75.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.881 -1.137 . . . . 1.57 110.997 -178.678 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.3 mt -70.0 -41.97 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.02 -1.05 . . . . 0.65 109.585 -179.744 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.7 mt -68.53 -37.79 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.444 -0.785 . . . . 0.82 109.633 179.39 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.28 86.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.79 110.818 -178.701 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 96' ' ' LYS . 97.8 mt -60.09 -45.99 91.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.81 -1.181 . . . . 0.95 109.393 -179.284 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.2 mt -61.68 -49.43 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.297 -0.877 . . . . 0.66 109.097 179.479 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -69.86 -40.0 76.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.306 -0.872 . . . . 2.2 110.67 179.805 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -83.64 -52.86 6.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.037 -1.039 . . . . 1.65 112.057 -177.948 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 92' ' ' LEU . 7.1 mtpm? -93.4 -3.22 53.63 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.078 -1.014 . . . . 2.03 112.295 -177.123 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.2 m170 59.21 39.98 22.13 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.839 -1.163 . . . . 1.42 109.573 -179.585 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.5 mtp -91.27 164.97 13.69 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.459 -0.775 . . . . 1.18 110.112 -179.834 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 65.4 p -79.99 163.62 24.1 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.514 -0.741 . . . . 0.98 109.197 179.732 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.09 -41.23 82.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.64 110.458 -179.305 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -67.48 -37.69 83.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 2.07 109.577 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.29 -41.15 34.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.293 -0.879 . . . . 0.73 110.169 179.967 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.1 -47.02 63.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.895 . . . . 0.54 110.452 -179.25 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.45 -40.4 90.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.974 -1.079 . . . . 0.56 110.18 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.45 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 84.8 t60 -59.91 -40.12 87.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.251 -0.905 . . . . 1.54 110.17 -178.564 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -64.52 -40.12 95.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.057 -1.027 . . . . 1.33 110.795 -178.931 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.08 -51.85 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.072 -1.017 . . . . 0.72 111.06 -178.093 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mm -69.66 -39.97 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.777 -1.202 . . . . 0.85 108.574 -179.837 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.45 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 88.2 tt0 -62.78 -39.35 93.93 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.622 -0.881 . . . . 2.44 108.622 178.825 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.94 -50.61 65.8 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.199 -1.161 . . . . 0.98 110.199 -179.545 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -66.24 -48.11 71.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.79 -1.418 . . . . 1.41 109.112 179.955 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.05 93.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.139 -0.976 . . . . 1.2 108.673 179.431 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.1 t -58.19 -39.94 80.25 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.71 -0.848 . . . . 1.7 108.71 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.92 -40.0 94.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.403 -0.811 . . . . 1.47 109.631 179.485 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.04 -41.19 91.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.976 -1.078 . . . . 1.56 109.604 -179.431 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.83 -33.81 72.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.57 -1.331 . . . . 2.2 109.452 -179.246 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -54.5 -22.18 12.16 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.418 -0.956 . . . . 2.12 108.418 179.437 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.467 HD13 HD13 ' A' ' 123' ' ' LEU . 61.7 mt -64.09 144.84 56.8 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.378 -0.826 . . . . 2.0 109.319 179.912 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -100.63 46.67 0.94 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.248 -0.907 . . . . 3.23 110.489 -179.727 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 64.6 t0 -131.51 138.02 48.77 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.14 -0.975 . . . . 2.49 109.943 179.964 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.541 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 47.5 mt-10 -69.94 -32.0 70.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.599 -0.688 . . . . 3.95 110.504 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.463 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.3 t80 -72.18 -39.95 68.29 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.309 -0.87 . . . . 2.0 110.536 179.582 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.642 ' CD2' HH21 ' A' ' 126' ' ' ARG . 80.9 mt -70.54 -37.31 74.05 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.094 -1.004 . . . . 1.86 108.825 -179.855 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -60.41 -39.83 88.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 2.84 109.792 179.333 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 73.3 mm-40 -59.46 -48.94 79.7 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.112 -0.992 . . . . 2.73 109.692 -179.232 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.642 HH21 ' CD2' ' A' ' 123' ' ' LEU . 77.4 mtm180 -63.88 -38.52 91.39 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.134 -1.026 . . . . 2.77 108.672 179.105 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.67 -26.63 56.91 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.951 -1.129 . . . . 1.19 107.951 178.888 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -71.08 -38.08 72.45 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.403 -0.962 . . . . 1.2 108.403 178.347 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -64.98 -40.1 94.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.581 -0.699 . . . . 1.55 109.658 -179.527 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.2 t -68.84 -43.02 82.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.26 -0.9 . . . . 0.8 109.233 179.811 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.434 HH11 ' HG2' ' A' ' 131' ' ' ARG . 28.6 ttt-85 -60.6 -39.68 89.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 3.09 108.842 179.14 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -60.0 -39.98 87.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.557 -0.714 . . . . 1.46 110.422 -179.447 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 94.3 mt -60.04 -43.91 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.887 -1.133 . . . . 0.71 109.997 -179.261 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.98 -34.43 70.92 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.894 -1.283 . . . . 0.57 109.894 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -60.0 -49.97 75.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -1.177 . . . . 2.59 109.673 -179.219 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.405 ' HG2' HH21 ' A' ' 139' ' ' ARG . 86.1 mtm180 -69.85 -30.85 68.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.851 -1.156 . . . . 2.83 110.04 -179.936 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.04 -43.24 95.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.07 -1.018 . . . . 1.25 109.083 -179.586 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.6 mt -60.39 -39.9 88.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.304 -0.873 . . . . 0.7 109.352 179.208 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.405 HH21 ' HG2' ' A' ' 136' ' ' ARG . 57.0 mtm180 -69.64 -38.17 77.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 2.57 108.485 179.072 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.482 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.4 m120 -60.16 -36.71 78.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.819 -0.551 . . . . 1.23 110.626 -179.136 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.3 mt -70.07 -42.98 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.782 -1.199 . . . . 0.81 109.512 -179.767 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.8 mt -81.08 -38.03 28.0 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.402 -0.812 . . . . 1.0 110.021 -179.89 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.89 45.87 4.08 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 108.758 -1.737 . . . . 0.89 108.758 -178.941 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.4 tp -74.18 149.87 40.68 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.482 -1.01 . . . . 1.14 109.777 -179.273 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 142.56 53.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 4.6 109.655 -179.61 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.05 123.19 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-O 121.611 0.72 . . . . 1.24 109.214 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.414 HG12 ' H ' ' A' ' 147' ' ' ILE . 23.9 mm -49.18 -52.91 9.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.583 -0.698 . . . . 1.54 109.384 -178.943 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.6 t0 66.41 100.08 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.494 0.664 . . . . 1.5 109.527 -179.893 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.51 ' O ' HD12 ' A' ' 152' ' ' ILE . 67.8 mt -70.91 -9.0 56.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.507 -0.746 . . . . 0.79 109.945 -179.337 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.9 p -74.99 -17.28 60.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.066 -1.021 . . . . 1.4 109.592 179.778 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.94 28.74 0.67 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.455 -0.778 . . . . 0.92 111.316 -177.716 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 149' ' ' LEU . 49.9 mt -90.02 116.87 32.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.848 -1.157 . . . . 0.88 109.37 -179.434 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -98.97 -14.27 19.58 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.357 -0.84 . . . . 2.45 110.087 -178.982 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -127.17 149.91 49.75 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.193 -0.942 . . . . 1.52 110.23 -179.173 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -63.75 139.73 58.8 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.621 -0.881 . . . . 1.58 108.621 179.814 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.7 m -153.09 164.95 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 0.69 109.699 -179.693 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.1 mt -93.51 149.15 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 105.834 -1.913 . . . . 0.61 105.834 176.533 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.415 HD11 HD11 ' A' ' 19' ' ' LEU . 43.4 tp -97.37 113.91 25.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.934 -1.104 . . . . 0.87 110.481 -177.725 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 62.6 t -121.18 129.98 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 108.255 -1.017 . . . . 0.71 108.255 179.067 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.429 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -163.25 169.22 19.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 0.81 108.872 179.888 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.17 -35.37 68.98 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.696 -1.253 . . . . 0.98 108.023 178.375 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -167.46 175.52 7.14 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.812 -1.181 . . . . 2.25 107.812 179.961 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 58.0 mt -135.59 145.64 47.12 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.076 -1.015 . . . . 0.78 109.09 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 40.0 p -97.37 127.9 36.63 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.242 -1.021 . . . . 0.98 108.242 179.166 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -37.0 -35.9 0.25 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.985 1.79 . . . . 0.81 112.616 -179.407 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.3 m -60.01 -39.87 87.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.075 -1.016 . . . . 0.9 109.016 -179.722 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -67.88 -40.16 83.59 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.171 -0.955 . . . . 1.61 110.138 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 55.8 p -56.46 -33.79 66.25 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.145 -0.972 . . . . 0.61 111.382 -177.991 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.76 -45.08 65.43 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.676 -1.265 . . . . 0.6 109.71 -179.871 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.437 ' H ' ' HG2' ' A' ' 170' ' ' GLN . 14.5 pt20 -90.73 35.63 0.89 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.374 -0.972 . . . . 1.4 108.374 179.68 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.4 tp -106.71 130.73 54.39 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.12 -1.067 . . . . 0.7 108.12 178.577 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -82.05 103.86 11.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.171 -0.956 . . . . 2.35 109.177 -179.75 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.25 -41.06 96.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.046 -1.033 . . . . 1.51 110.234 -179.471 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.52 -27.22 68.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 2.33 111.359 -178.049 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -92.75 -10.43 37.05 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.603 -1.31 . . . . 1.92 109.933 -178.867 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.448 HG11 ' CE1' ' A' ' 179' ' ' PHE . 58.1 t -103.23 112.83 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.15 -0.969 . . . . 0.67 108.698 179.031 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.9 mt -87.29 3.99 44.56 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.27 -0.894 . . . . 1.53 110.719 -178.336 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.406 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 176.31 168.91 37.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.112 -1.595 . . . . 0.48 109.112 179.719 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.456 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 23.2 m-85 -130.91 127.12 37.84 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.386 -1.067 . . . . 0.55 109.277 -179.945 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 95.8 mt -130.48 123.58 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.449 -1.315 . . . . 0.65 107.449 177.915 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.3 p -141.88 159.15 42.8 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.204 1.002 . . . . 0.82 111.068 -178.824 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 183' ' ' ALA . 59.2 t0 -96.88 18.34 14.81 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.685 -0.634 . . . . 2.46 109.737 -179.8 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -44.28 -178.87 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.91 -1.119 . . . . 1.28 112.653 -178.032 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.71 -54.31 4.63 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 111.23 -0.748 . . . . 2.19 111.23 -179.355 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.1 -163.82 13.63 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.06 -1.543 . . . . 2.13 111.285 -178.835 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.452 HH11 ' HG2' ' A' ' 186' ' ' ARG . 12.6 ptt-85 -72.39 -10.54 59.92 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.794 -0.827 . . . . 5.86 110.738 -179.116 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.6 p -80.9 7.42 10.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.955 -1.091 . . . . 3.72 109.898 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 95.1 p -84.92 142.69 29.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 1.74 110.481 -179.69 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -48.27 -44.53 33.63 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.867 -0.79 . . . . 0.95 108.867 179.601 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.411 ' H ' HG23 ' A' ' 190' ' ' THR . 3.2 p -56.08 -40.08 73.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.626 -0.671 . . . . 1.55 109.806 -179.475 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 48.3 t -61.67 -40.28 94.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -0.93 . . . . 1.51 111.03 -179.241 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.9 mm -62.18 -41.52 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.084 -1.01 . . . . 1.67 110.115 -178.813 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.9 mtp -60.02 -45.62 92.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.039 -1.038 . . . . 1.02 110.683 -178.38 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.97 -42.68 94.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.688 -1.257 . . . . 0.68 109.708 -179.308 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 -60.04 -51.23 70.53 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.272 -0.892 . . . . 2.93 110.618 -178.919 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 52.6 m -77.74 -32.44 52.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.923 -1.111 . . . . 0.86 111.866 -178.336 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.7 mt -70.4 -20.31 62.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.634 -1.292 . . . . 0.67 109.459 -179.425 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 64.17 49.94 2.53 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.309 0.576 . . . . 1.5 110.546 -179.733 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 83.2 mt -130.35 151.0 77.77 Favored Pre-proline 0 N--CA 1.5 2.058 0 N-CA-C 108.163 -1.051 . . . . 0.72 108.163 178.679 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.65 139.43 69.56 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.002 1.801 . . . . 0.61 111.043 179.599 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.55 153.98 3.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.763 -1.21 . . . . 0.66 111.525 -179.721 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.64 152.32 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.053 -1.091 . . . . 0.79 108.053 179.362 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.2 m -131.88 -13.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 121.064 -1.023 . . . . 0.91 111.295 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 204' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -111.36 26.47 12.02 Favored Glycine 0 N--CA 1.502 3.088 0 N-CA-C 110.645 -0.982 . . . . 1.01 110.645 -178.826 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 204' ' ' GLY . 3.2 p -43.38 -45.06 5.97 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.23 -1.159 . . . . 0.99 109.962 -179.622 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.465 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 93.89 -53.95 2.26 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 120.204 -0.998 . . . . 1.12 111.2 179.128 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 64.3 m -154.4 31.49 0.43 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.321 -1.694 . . . . 1.72 111.449 -179.024 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.02 -40.08 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.85 -1.156 . . . . 0.89 108.885 178.581 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 75.0 p -53.29 -29.52 33.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.424 -0.798 . . . . 1.03 110.563 -179.219 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.0 t -83.7 -15.13 49.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.973 -1.08 . . . . 1.83 110.428 -178.855 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -100.09 -15.92 18.03 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.226 -0.921 . . . . 2.27 110.955 -179.009 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 88.5 t -105.29 139.72 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.136 -0.978 . . . . 0.92 111.001 -178.16 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.13 152.59 30.88 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.585 -1.265 . . . . 2.2 107.585 178.473 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 30.8 t30 -58.27 139.16 55.62 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.948 -1.095 . . . . 2.36 110.283 -179.255 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 12.5 t0 87.74 8.61 0.17 Allowed 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 121.335 0.588 . . . . 2.38 109.796 179.633 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 56.2 t0 -79.07 140.5 37.87 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.326 -0.859 . . . . 2.09 109.317 179.551 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.531 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 55.3 t80 -91.78 118.39 30.64 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.346 -1.353 . . . . 1.27 107.346 178.476 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.522 HD22 HG22 ' A' ' 229' ' ' VAL . 82.7 mt -126.52 147.36 49.86 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.325 -0.86 . . . . 0.75 110.69 -178.631 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.449 HD12 ' HG3' ' A' ' 231' ' ' PRO . 81.6 mt -118.57 126.71 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.819 -1.548 . . . . 0.63 106.819 176.875 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 48.6 tp -102.02 124.84 48.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.241 -0.912 . . . . 0.7 108.645 -179.268 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.658 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 27.9 p-10 -87.94 -35.62 17.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.203 -0.935 . . . . 2.31 108.607 179.686 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 44.52 18.59 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.826 -0.805 . . . . 0.78 108.826 -179.224 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 221' ' ' ASP . 16.6 t -125.82 -46.89 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.127 -1.434 . . . . 1.04 107.127 179.579 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -100.75 -1.03 36.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.873 -1.529 . . . . 2.44 106.873 177.745 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 61.76 50.39 4.37 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.439 0.638 . . . . 1.55 109.587 179.996 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.658 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 95.6 mt-30 -138.77 151.16 46.85 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.522 -0.736 . . . . 1.99 109.311 179.76 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 84.2 t -119.41 127.73 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.421 -0.955 . . . . 0.77 108.421 178.882 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -102.26 123.98 47.03 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.331 -0.989 . . . . 0.98 108.331 179.443 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.522 HG22 HD22 ' A' ' 218' ' ' LEU . 58.5 t -104.21 115.0 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.492 -0.755 . . . . 0.85 110.369 -178.911 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 60.4 t30 53.61 69.55 2.19 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.912 . . . . 1.66 110.341 179.718 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.449 ' HG3' HD12 ' A' ' 219' ' ' ILE . 98.2 Cg_endo -90.91 148.58 3.89 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 123.408 2.739 . . . . 0.95 112.478 179.541 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.7 m -69.99 160.88 31.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 1.84 109.701 -179.431 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.55 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 38.2 p30 -60.02 -39.94 87.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 2.74 111.481 -178.669 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.55 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 13.1 pt-20 -60.04 -31.22 69.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.58 -1.325 . . . . 2.89 109.641 -179.352 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 83.2 t -70.03 -42.41 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.033 -1.042 . . . . 1.3 109.282 179.115 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.499 1.986 0 O-C-N 121.313 -0.867 . . . . 1.09 110.396 -179.762 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 10.4 ttt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' B' B ' 302' ' ' PHE . . . . . 0.504 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 22.8 t80 -154.84 154.07 32.15 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.312 -0.868 . . . . 0.0 110.05 179.542 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 303' ' ' GLN . . . . . 0.504 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 2.9 pm0 -146.98 156.62 43.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.183 -0.948 . . . . 0.0 110.661 -179.621 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 304' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 0.4 OUTLIER -152.15 147.31 26.28 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.454 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' B' B ' 305' ' ' GLU . . . . . 0.517 ' N ' ' OE1' ' B' ' 304' ' ' GLN . 98.9 mt-10 -107.21 131.32 54.3 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.959 -1.088 . . . . 0.0 109.694 179.102 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.453 ' O ' HG13 ' B' ' 306' ' ' VAL . 7.4 p -131.26 120.61 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 CA-C-O 122.045 0.926 . . . . 0.0 112.544 -177.745 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 307' ' ' THR . . . . . 0.538 ' O ' HG23 ' B' ' 309' ' ' THR . 8.8 m -76.91 107.11 9.01 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.874 0.845 . . . . 0.0 111.359 -177.711 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.6 mt -52.23 118.13 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 122.098 0.951 . . . . 0.0 109.717 -178.944 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 309' ' ' THR . . . . . 0.599 ' C ' HE22 ' B' ' 357' ' ' GLN . 67.4 p -107.3 19.95 19.61 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.714 -178.249 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.522 ' N ' ' OE1' ' B' ' 357' ' ' GLN . . . -81.2 114.52 49.74 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.192 -0.943 . . . . 0.0 109.845 179.686 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -50.4 -9.72 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.733 0 CA-C-N 120.199 1.107 . . . . 0.0 113.308 -179.332 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 312' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' B' ' 310' ' ' ALA . 97.8 m-20 -120.5 4.04 10.7 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.437 -0.789 . . . . 0.0 109.265 179.829 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 74.0 -178.75 43.0 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.428 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.463 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.5 tp -83.64 89.82 7.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.05 -1.265 . . . . 0.0 109.027 -179.193 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.4 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 4.7 p80 -92.8 -162.2 0.91 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.924 -1.11 . . . . 0.0 109.989 179.18 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.8 m -58.07 -42.3 85.25 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.041 -1.037 . . . . 0.0 112.873 -175.932 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.553 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.4 tpt180 -59.87 -61.52 7.73 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 120.327 -1.483 . . . . 0.0 111.523 -178.571 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.4 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 9.9 Cg_endo -58.11 -33.63 97.6 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.231 1.118 . . . . 0.0 111.473 179.975 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.29 74.53 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.515 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.2 -44.02 74.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.662 -0.649 . . . . 0.0 109.338 -179.905 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -70.01 -42.01 73.59 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.598 179.061 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -59.99 -50.41 73.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.635 -0.666 . . . . 0.0 110.543 -179.371 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.44 -30.25 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.591 -1.318 . . . . 0.0 109.172 -179.485 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 324' ' ' LYS . . . . . 0.401 ' NZ ' ' OE1' ' A' ' 74' ' ' GLU . 19.9 ttmt -60.01 -47.14 87.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.413 -0.804 . . . . 0.0 109.199 179.535 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -67.56 -48.89 65.64 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.184 -0.948 . . . . 0.0 110.896 -179.227 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -66.08 -52.72 46.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.798 -1.189 . . . . 0.0 110.709 -178.748 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -54.78 -14.5 1.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.088 -179.02 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -74.59 -20.95 79.37 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.358 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -103.79 146.96 27.86 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.439 -1.036 . . . . 0.0 108.719 179.686 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 13.9 t -91.2 -13.65 32.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.767 -1.208 . . . . 0.0 109.653 -179.898 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.43 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 63.7 p -60.13 147.58 39.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 -179.863 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 332' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' B' ' 332' ' ' GLU . 58.2 mp0 -68.87 134.49 49.7 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.104 -0.998 . . . . 0.0 108.636 179.758 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.1 mt -133.17 133.63 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.497 -0.752 . . . . 0.0 109.688 -179.222 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 82.4 m -129.05 149.81 50.71 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.478 -0.764 . . . . 0.0 109.288 179.409 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 53.9 t -122.84 114.07 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.338 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 96.5 m -104.97 134.18 48.51 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.212 -0.93 . . . . 0.0 109.394 -178.411 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 24.7 p -139.46 111.67 7.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.336 -0.853 . . . . 0.0 110.944 -179.48 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 48.89 50.81 17.06 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 176.685 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 90.04 -14.84 60.96 Favored Glycine 0 N--CA 1.501 2.998 0 O-C-N 119.941 -1.724 . . . . 0.0 112.503 177.104 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -118.64 131.44 56.18 Favored 'General case' 0 N--CA 1.508 2.447 0 CA-C-N 119.019 1.41 . . . . 0.0 109.69 -179.809 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 79.6 p -132.51 151.8 51.78 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.933 0.873 . . . . 0.0 110.681 -178.872 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -143.26 167.2 22.7 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -179.758 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 15.2 m -87.56 138.16 31.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.47 -0.769 . . . . 0.0 110.255 -179.273 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -77.13 -14.59 59.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.959 -1.088 . . . . 0.0 109.997 -179.394 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -89.59 20.46 3.98 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.126 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 346' ' ' SER . . . . . 0.453 ' CB ' ' HZ3' ' B' ' 349' ' ' LYS . 9.0 t -145.74 94.44 2.49 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.535 -179.649 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.733 HD23 HD22 ' A' ' 79' ' ' LEU . 58.5 tp -59.97 -36.32 76.86 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.069 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.86 ' CE2' HD11 ' A' ' 79' ' ' LEU . 51.0 m-85 -54.54 -50.42 67.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 0.0 110.699 -179.376 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 349' ' ' LYS . . . . . 0.453 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 35.9 mtmm -69.95 -40.02 75.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.911 -1.118 . . . . 0.0 111.237 -177.975 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' B' ' 352' ' ' THR . 88.2 mt -49.28 -56.99 7.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.875 -1.14 . . . . 0.0 109.443 -178.933 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.567 HE22 ' CD1' ' B' ' 347' ' ' LEU . 1.2 mp0 -42.23 -14.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.414 -0.804 . . . . 0.0 111.342 -178.101 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.55 ' N ' ' O ' ' B' ' 350' ' ' LEU . 59.3 p -88.72 -11.48 45.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.287 -1.508 . . . . 0.0 110.185 -179.132 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 79.3 mt -91.58 117.52 29.79 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.84 -1.162 . . . . 0.0 108.807 178.646 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -69.79 89.2 0.3 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 58.0 mt -98.73 86.81 3.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -1.162 . . . . 0.0 108.456 179.03 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 67.2 p -89.26 168.97 11.84 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.041 -1.037 . . . . 0.0 110.063 -178.926 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 357' ' ' GLN . . . . . 0.599 HE22 ' C ' ' B' ' 309' ' ' THR . 15.8 tp60 -62.99 114.94 3.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.631 -0.668 . . . . 0.0 110.61 -179.031 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.24 8.72 40.71 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.713 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 31.6 m -87.2 111.7 21.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.261 -1.14 . . . . 0.0 111.394 -178.986 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 48.5 t -76.98 118.09 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 122.267 1.032 . . . . 0.0 109.548 -177.914 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.0 m -112.9 177.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -177.952 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 48.9 m -130.71 128.79 41.56 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.45 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.6 mt -103.06 117.58 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.154 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 72.7 m -120.99 132.09 54.7 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.289 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.24 153.34 40.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.069 -1.019 . . . . 0.0 110.489 -179.296 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 366' ' ' GLU . . . . . 0.441 ' OE1' ' OE1' ' B' ' 370' ' ' GLU . 17.1 tp10 -144.47 122.32 11.97 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.082 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.494 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 159.8 -157.11 28.34 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.954 -1.593 . . . . 0.0 111.595 -179.97 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -59.99 -51.88 67.77 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.338 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.43 ' H ' ' HB3' ' B' ' 331' ' ' SER . 42.6 m-20 -109.15 12.5 25.0 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.754 -1.216 . . . . 0.0 111.176 -177.256 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 11.8 pt-20 -42.33 -38.17 1.75 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.157 -0.965 . . . . 0.0 111.807 -178.816 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -69.89 -40.51 75.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.638 -1.289 . . . . 0.0 110.249 -178.341 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -68.75 -51.39 41.85 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.171 -0.956 . . . . 0.0 109.482 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -49.64 -34.28 17.85 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.634 -0.666 . . . . 0.0 112.228 -178.413 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.505 ' O ' HG23 ' B' ' 378' ' ' VAL . 56.2 t -74.82 -39.21 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.657 -1.277 . . . . 0.0 109.766 179.567 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -68.23 -40.01 82.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.168 -0.957 . . . . 0.0 112.37 -177.785 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -84.61 -43.07 14.78 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.193 -1.567 . . . . 0.0 110.901 -179.363 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.93 -40.09 87.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.998 -1.064 . . . . 0.0 108.843 -179.196 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.505 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.9 t -61.02 -45.98 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.217 -0.927 . . . . 0.0 109.412 179.42 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 379' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' B' ' 383' ' ' GLU . 62.3 mttp -68.62 -54.75 14.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.788 -1.195 . . . . 0.0 107.86 178.503 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 52.8 tp -55.8 -36.25 67.21 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.308 -0.87 . . . . 0.0 109.182 -178.29 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 23.8 ttm -70.65 -40.08 73.25 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.698 -1.251 . . . . 0.0 108.335 177.792 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.21 -4.93 58.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.526 -0.734 . . . . 0.0 110.606 179.585 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' B' ' 379' ' ' LYS . 96.8 mt-10 -112.16 -3.67 14.61 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.17 -0.956 . . . . 0.0 111.106 -179.46 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.2 mt -79.88 136.55 36.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.464 -1.397 . . . . 0.0 109.47 179.011 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 N--CA 1.497 1.918 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.368 -179.901 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.9 mtp . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.506 -0.553 . . . . 2.91 109.506 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.4 mt -110.18 129.98 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.417 -0.802 . . . . 1.2 109.71 -179.928 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.2 m -132.67 149.84 52.24 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.402 -0.811 . . . . 1.4 109.408 179.686 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.416 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -140.7 -169.92 11.91 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.041 -1.624 . . . . 1.05 109.041 179.757 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.9 mt -85.48 -19.08 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.879 -1.365 . . . . 1.15 110.432 -178.831 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.7 tp 52.92 102.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.176 -0.952 . . . . 0.98 109.03 -179.732 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.11 -26.99 13.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.101 -0.999 . . . . 0.88 109.645 -179.881 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -134.77 117.97 13.17 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.469 -0.769 . . . . 1.69 109.004 -179.843 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.19 148.12 21.19 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.766 1.644 . . . . 0.85 112.562 -179.631 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.721 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.05 -155.41 26.21 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.754 -1.738 . . . . 0.92 108.754 -179.818 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.5 mt -149.6 151.18 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 120.909 -1.347 . . . . 0.81 108.715 179.041 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.47 150.85 30.06 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.901 -1.125 . . . . 0.51 110.719 179.772 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.8 m-85 -133.9 127.12 31.85 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 107.923 -1.14 . . . . 0.62 107.923 178.616 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.92 -176.69 46.39 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 118.37 -1.872 . . . . 0.55 111.203 179.713 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -79.23 155.64 28.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.985 -0.715 . . . . 2.1 109.841 -179.693 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.82 124.36 49.3 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.579 -0.7 . . . . 0.77 109.978 179.892 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.0 tp -94.22 135.19 35.88 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.472 -1.307 . . . . 0.91 107.472 178.582 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.9 tp -116.01 122.66 45.86 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.22 -0.925 . . . . 0.93 109.946 -179.08 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.7 mt -84.98 100.74 11.85 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.586 0.708 . . . . 0.93 109.955 -179.63 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -100.04 124.79 45.8 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.533 -0.914 . . . . 2.75 108.533 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.461 ' OE1' HD11 ' A' ' 147' ' ' ILE . 36.9 tp10 -132.03 141.82 49.37 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.237 -0.915 . . . . 3.0 109.462 -179.954 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.59 ' OD2' HD11 ' A' ' 144' ' ' LEU . 9.9 p-10 -77.73 149.19 34.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.385 -0.822 . . . . 2.77 109.558 179.649 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -70.15 149.61 47.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.166 -0.959 . . . . 2.94 109.595 -179.741 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 84.7 mt -82.34 126.51 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.186 -0.946 . . . . 0.95 110.154 -179.604 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.67 123.63 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.278 -0.889 . . . . 1.28 108.744 179.074 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -100.55 145.23 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.333 -0.855 . . . . 1.21 109.363 -179.555 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -98.51 113.42 25.43 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.172 -0.955 . . . . 1.81 109.519 -179.879 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.479 HH11 ' HG2' ' A' ' 28' ' ' ARG . 7.4 mmt-85 -86.32 -2.13 58.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 2.8 109.449 -179.855 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -66.12 142.8 57.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.934 . . . . 2.87 109.225 179.714 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -83.43 149.6 26.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 2.35 109.544 -179.749 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.439 HG21 ' HG3' ' A' ' 39' ' ' GLU . 6.4 pt -93.2 165.02 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.032 -1.042 . . . . 0.97 109.091 179.311 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.9 p -94.72 169.53 10.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.948 -1.095 . . . . 1.17 108.485 178.963 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.68 -12.83 60.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 1.18 109.561 -179.967 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -88.32 -28.86 20.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.111 -0.993 . . . . 2.56 108.406 178.787 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -81.65 -8.91 59.76 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.748 -0.834 . . . . 1.79 108.748 178.963 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.3 t -62.46 -53.59 45.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.083 -1.01 . . . . 1.0 108.912 179.815 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -60.04 -40.05 88.06 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.171 -0.956 . . . . 1.77 109.928 -179.87 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -69.94 -40.2 75.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.948 -1.095 . . . . 2.7 110.899 -179.37 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.439 ' HG3' HG21 ' A' ' 31' ' ' ILE . 68.7 mm-40 -65.27 -40.07 93.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.674 -1.266 . . . . 1.51 110.199 -179.895 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -61.64 -47.8 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.639 -1.288 . . . . 0.93 108.537 179.083 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.03 -45.9 91.29 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.175 -0.953 . . . . 1.81 109.538 179.677 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -60.04 -42.94 95.49 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.688 -1.226 . . . . 2.78 107.688 179.146 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -61.2 -49.93 75.16 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.645 -0.659 . . . . 0.78 109.491 178.927 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.91 -45.48 94.49 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.457 -0.777 . . . . 1.07 109.721 -179.718 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 31.9 t -66.46 -45.68 78.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.027 -1.045 . . . . 1.12 109.332 179.682 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.85 -44.56 97.69 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.026 -2.029 . . . . 0.84 108.026 178.9 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 80' ' ' LEU . 69.2 ttt180 -62.98 -35.31 79.75 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.357 -0.979 . . . . 3.09 108.357 178.638 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -55.87 -39.93 72.22 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.834 -0.802 . . . . 0.88 108.834 179.801 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 50' ' ' ALA . 18.9 ttmt -63.32 -74.63 0.09 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.088 -1.078 . . . . 2.59 108.088 179.531 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.38 -31.82 0.06 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.363 -0.836 . . . . 0.7 111.682 -177.978 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.6 p -60.1 -54.17 49.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.562 -1.336 . . . . 1.4 108.669 179.988 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.99 -42.44 73.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.339 -0.851 . . . . 0.67 111.055 -179.298 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.45 -40.5 97.3 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.826 -1.171 . . . . 1.66 110.552 -178.805 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.27 -39.66 92.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.874 -1.141 . . . . 1.58 108.993 179.603 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -59.95 -37.85 80.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.35 -0.844 . . . . 1.35 109.515 179.379 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -64.7 -41.2 96.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.77 110.46 -179.67 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.411 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.5 mt -64.62 -39.83 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.108 -0.995 . . . . 0.63 109.373 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.444 ' NZ ' ' OE2' ' A' ' 70' ' ' GLU . 13.2 ttpp -59.35 -49.98 75.73 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.275 -0.89 . . . . 1.14 109.121 -179.858 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.1 m -61.13 -40.03 92.26 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.211 -0.931 . . . . 0.79 110.493 -178.795 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -63.7 -38.86 92.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.096 -1.003 . . . . 1.53 109.155 179.692 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.484 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -65.14 -41.56 94.66 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.582 -0.699 . . . . 0.57 109.746 179.574 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.65 -50.39 66.7 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 110.24 -1.144 . . . . 0.75 110.24 -179.488 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.89 -43.0 72.67 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.881 -1.364 . . . . 1.59 109.654 -179.65 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.9 m -71.27 -59.84 2.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.035 -1.041 . . . . 0.73 112.06 -178.476 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -91.18 -54.16 4.05 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.678 -1.264 . . . . 0.75 110.603 -178.801 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.58 -169.32 25.21 Favored Glycine 0 N--CA 1.5 2.916 0 C-N-CA 120.071 -1.062 . . . . 1.22 111.224 179.748 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -70.01 -24.14 63.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.951 -0.735 . . . . 5.81 109.958 -179.954 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.507 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.8 tp10 -60.45 -38.04 82.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.888 . . . . 3.37 109.899 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -99.44 -19.43 16.96 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.395 -0.815 . . . . 1.77 110.604 -179.317 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.444 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 61.8 tt0 -68.1 -39.99 82.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.902 -1.124 . . . . 1.65 109.837 -179.528 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.431 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.28 -33.78 76.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.411 -0.806 . . . . 0.77 110.384 -178.886 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.07 -42.37 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.752 -1.217 . . . . 0.8 109.222 -179.849 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 57.4 m-85 -72.59 -34.8 67.68 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.39 -0.819 . . . . 0.88 110.487 -179.213 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.465 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 72.6 tt0 -59.97 -40.07 87.81 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.838 -1.164 . . . . 1.37 109.198 179.035 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.98 -41.2 97.8 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.41 -1.876 . . . . 0.62 108.41 179.081 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -61.78 -48.53 80.25 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.341 -1.093 . . . . 1.5 108.785 179.365 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.3 -50.56 79.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.563 -0.711 . . . . 0.63 109.851 -179.776 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.6 ttp -60.98 -44.2 97.7 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.009 -1.057 . . . . 1.51 109.238 -179.639 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.811 HD22 HD23 ' B' ' 347' ' ' LEU . 44.9 tp -60.05 -39.91 87.59 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.579 -0.701 . . . . 0.77 109.114 179.214 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.52 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 58.6 tp -69.66 -35.06 74.83 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.604 -0.685 . . . . 0.62 109.968 -179.387 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -85.43 0.43 52.28 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.92 -1.112 . . . . 1.47 110.002 -179.276 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -46.3 130.07 10.5 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.201 -0.937 . . . . 1.47 109.879 -179.221 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -61.36 -22.33 64.84 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.458 -0.776 . . . . 1.78 111.011 -179.124 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.99 -31.76 69.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.874 -1.141 . . . . 2.53 109.417 179.15 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 79' ' ' LEU . 91.2 mt -71.98 -40.02 68.87 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.673 0.749 . . . . 0.8 109.368 179.093 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.03 -49.25 78.38 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.724 -0.61 . . . . 1.42 110.827 -178.964 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -70.0 -42.01 73.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.17 -0.957 . . . . 1.71 111.061 -178.498 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.94 -39.94 75.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.964 . . . . 1.57 111.491 -178.824 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.7 mt -68.0 -45.22 84.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 120.973 -1.08 . . . . 0.65 109.782 -179.517 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -69.76 -38.79 76.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.322 -0.861 . . . . 0.82 110.089 179.831 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.66 -45.23 93.77 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 0.79 111.593 -178.913 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 99.3 mt -60.07 -44.22 94.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.83 -1.169 . . . . 0.95 109.533 -178.633 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.3 mt -61.19 -50.11 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.166 -0.959 . . . . 0.66 109.291 179.406 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -67.51 -40.01 85.13 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 120.22 -0.592 . . . . 2.2 111.436 -179.318 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -83.66 -52.14 6.69 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.752 -1.218 . . . . 1.65 112.025 -178.557 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -90.01 -0.05 57.37 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.119 -0.988 . . . . 2.03 112.026 -177.218 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 80.7 m80 55.1 33.81 21.21 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.834 -1.166 . . . . 1.42 109.486 -179.812 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 75.2 mtp -84.9 166.4 16.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.55 -0.719 . . . . 1.18 109.599 -179.625 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 76.8 p -78.64 154.85 29.88 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.171 -1.048 . . . . 0.98 108.171 179.187 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.0 -39.26 75.97 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.062 -1.024 . . . . 0.64 110.015 -179.707 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.538 ' OD1' HG21 ' A' ' 141' ' ' ILE . 86.5 m-20 -63.23 -40.19 96.75 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.101 -1.0 . . . . 2.07 109.621 -179.695 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.05 -46.12 14.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.104 -0.997 . . . . 0.73 109.655 179.463 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.98 -46.15 90.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.454 -0.779 . . . . 0.54 109.71 -179.539 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.96 75.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.149 -0.97 . . . . 0.56 109.478 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -59.98 -34.79 73.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.861 . . . . 1.54 110.042 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -60.0 -41.27 91.71 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.176 -0.952 . . . . 1.33 109.103 -179.653 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.8 t -64.78 -49.96 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 0.72 110.072 -179.46 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.1 mm -69.05 -40.28 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.047 -1.033 . . . . 0.85 109.027 179.622 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -64.92 -40.01 94.4 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.722 -0.844 . . . . 2.44 108.722 179.362 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.97 -49.26 80.5 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.244 -1.142 . . . . 0.98 110.244 -179.76 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -66.4 -51.81 53.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.929 -1.336 . . . . 1.41 109.11 -179.493 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.97 93.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 1.2 109.718 179.583 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.8 p -58.38 -39.69 80.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 1.7 108.8 -179.701 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.96 -35.6 75.32 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.34 -0.85 . . . . 1.47 109.214 179.664 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.5 mt -66.2 -42.88 88.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.974 -1.079 . . . . 1.56 109.485 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -56.99 -32.71 66.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.072 -1.018 . . . . 2.2 109.327 -179.091 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.03 -28.43 67.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -0.889 . . . . 2.12 108.966 179.859 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.554 HD13 HD13 ' A' ' 123' ' ' LEU . 59.6 mt -64.23 148.29 50.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.366 -0.834 . . . . 2.0 109.199 -179.927 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -100.07 57.1 0.96 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.175 -0.953 . . . . 3.23 109.448 179.802 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 58.8 t0 -136.0 135.23 39.32 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.247 -0.908 . . . . 2.49 110.514 -179.681 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.465 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 38.7 mt-10 -70.0 -32.46 70.64 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.338 -0.851 . . . . 3.95 109.903 179.313 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -69.6 -36.4 76.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.45 -0.781 . . . . 2.0 110.815 -179.805 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.554 HD13 HD13 ' A' ' 118' ' ' LEU . 66.2 mt -80.73 -34.66 34.27 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.754 -1.216 . . . . 1.86 109.47 179.866 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -60.49 -44.46 95.92 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.121 -0.987 . . . . 2.84 109.235 179.447 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -69.53 -40.09 77.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 2.73 109.516 -179.912 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -60.64 -40.07 90.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.229 -0.92 . . . . 2.77 108.565 179.408 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 128' ' ' ALA . . . -59.44 -45.59 91.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.137 -0.977 . . . . 1.19 108.459 179.689 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 127' ' ' ALA . . . -44.3 -43.89 7.71 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.097 -0.705 . . . . 1.2 109.097 179.992 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -61.9 -45.85 91.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.389 -0.82 . . . . 1.55 109.868 179.389 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.14 -39.98 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.21 -0.931 . . . . 0.8 108.918 -179.896 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.712 ' HE ' ' NZ ' ' A' ' 135' ' ' LYS . 69.4 ttt180 -60.0 -39.41 85.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 3.09 109.147 179.528 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -60.02 -37.8 80.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.228 -0.92 . . . . 1.46 109.934 -179.749 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.03 -44.32 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.048 -1.032 . . . . 0.71 109.657 -179.205 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.95 -33.83 59.42 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.709 -1.234 . . . . 0.57 110.172 179.882 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.712 ' NZ ' ' HE ' ' A' ' 131' ' ' ARG . 37.5 mmtm -59.99 -46.88 88.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.151 -1.205 . . . . 2.59 110.061 -179.011 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.411 HH22 ' CD1' ' A' ' 57' ' ' ILE . 66.4 mtp180 -65.93 -34.21 77.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.802 -1.186 . . . . 2.83 109.452 179.86 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.0 tp -57.24 -42.01 80.65 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.655 -0.868 . . . . 1.25 108.655 -179.252 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.412 HD21 ' O ' ' A' ' 101' ' ' ASP . 83.5 mt -60.88 -40.12 91.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.7 109.296 178.377 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.473 HH11 ' HG2' ' A' ' 139' ' ' ARG . 47.2 mtt-85 -69.68 -40.11 76.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 2.57 109.52 -179.915 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -66.93 -37.96 85.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.584 -0.698 . . . . 1.23 111.757 -178.827 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.538 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.8 mt -71.22 -40.01 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.411 -1.43 . . . . 0.81 109.43 179.61 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 60.8 mt -75.48 -12.25 60.2 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.618 -0.676 . . . . 1.0 110.819 -178.344 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.98 35.43 57.93 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.636 -1.785 . . . . 0.89 108.636 -179.286 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.59 HD11 ' OD2' ' A' ' 22' ' ' ASP . 15.0 tp -73.4 142.43 46.96 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.485 -1.009 . . . . 1.14 109.275 -179.19 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -72.37 140.77 48.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.38 -0.825 . . . . 4.6 110.441 -179.062 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.4 mt -112.58 129.96 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-O 122.007 0.908 . . . . 1.24 109.289 179.468 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.461 HD11 ' OE1' ' A' ' 21' ' ' GLU . 6.3 mt -62.07 -43.21 97.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.912 -0.585 . . . . 1.54 110.783 -178.588 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.9 t0 66.58 122.35 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.529 -0.732 . . . . 1.5 109.079 -179.016 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.5 mt -92.69 0.67 57.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.394 -0.816 . . . . 0.79 110.637 -179.034 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.7 p -83.61 -15.3 49.56 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.745 -1.222 . . . . 1.4 110.413 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.99 29.97 0.33 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.115 -0.991 . . . . 0.92 112.199 -177.997 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.3 mm -83.77 125.17 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.379 -1.45 . . . . 0.88 109.188 179.623 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -104.32 -12.74 16.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.4 -0.813 . . . . 2.45 109.755 -179.826 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -137.83 156.96 47.38 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.237 -0.914 . . . . 1.52 110.213 -179.107 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.66 135.11 56.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.282 -0.886 . . . . 1.58 109.226 -179.64 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.7 m -153.05 168.14 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.398 -0.813 . . . . 0.69 110.146 179.403 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 80.6 mt -98.79 143.89 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 105.772 -1.936 . . . . 0.61 105.772 177.212 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 47.4 tp -97.68 120.1 37.45 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.772 -1.205 . . . . 0.87 109.993 -178.464 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.0 t -119.79 127.9 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.059 -0.719 . . . . 0.71 109.059 179.833 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.443 ' HB3' HD21 ' A' ' 163' ' ' LEU . . . -159.86 161.5 34.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.899 . . . . 0.81 108.888 179.87 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.82 -32.72 67.86 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.438 -1.414 . . . . 0.98 108.077 178.579 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -170.35 143.49 2.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.493 -0.754 . . . . 2.25 109.564 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.443 HD21 ' HB3' ' A' ' 160' ' ' ALA . 54.9 mt -116.53 141.03 48.71 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.44 -0.788 . . . . 0.78 109.554 -179.499 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 48.4 p -95.29 145.82 30.22 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.14 -0.975 . . . . 0.98 110.226 -179.429 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -40.6 -36.78 1.95 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.512 2.141 . . . . 0.81 112.802 179.029 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 63.9 m -59.03 -39.87 83.26 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.317 -0.864 . . . . 0.9 109.183 -179.076 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.58 -40.05 84.85 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.295 -0.878 . . . . 1.61 109.91 -179.709 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.7 p -58.17 -23.29 54.9 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.956 -1.09 . . . . 0.61 110.408 -178.863 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -75.78 -56.44 4.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.092 -1.005 . . . . 0.6 109.562 179.694 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -84.17 42.24 0.87 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.805 -1.183 . . . . 1.4 107.805 179.611 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.5 tp -101.81 140.99 35.36 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.207 -0.664 . . . . 0.7 109.207 179.472 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.512 ' O ' HG23 ' A' ' 176' ' ' VAL . 98.6 m-20 -89.95 103.02 15.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.155 -0.965 . . . . 2.35 108.681 179.293 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 70.5 mt -67.19 -44.09 80.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.418 -0.801 . . . . 1.51 111.914 -178.072 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -69.98 -25.47 63.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.759 -1.213 . . . . 2.33 112.512 -177.525 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -93.4 -5.5 49.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.621 -1.299 . . . . 1.92 110.722 -178.328 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 172' ' ' ASN . 23.0 t -86.13 139.99 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.834 -1.167 . . . . 0.67 110.496 -179.845 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.0 mt -103.91 -12.37 16.91 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 109.593 -0.521 . . . . 1.53 109.593 178.587 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 162.6 179.51 37.23 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.247 -1.541 . . . . 0.48 109.247 179.986 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -130.51 129.37 42.79 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.221 -1.164 . . . . 0.55 110.158 -179.95 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.416 ' CG2' HG21 ' A' ' 205' ' ' THR . 66.5 mt -128.65 120.55 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.383 -0.969 . . . . 0.65 108.383 177.756 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 61.0 p -148.78 160.81 42.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.742 -1.224 . . . . 0.82 110.555 -179.654 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -110.08 30.29 6.86 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.123 -0.695 . . . . 2.46 109.123 179.321 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -74.66 -158.3 0.07 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.67 -1.269 . . . . 1.28 112.339 -177.499 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -54.56 -80.95 0.07 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.676 -0.97 . . . . 2.19 110.676 -179.403 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 163.02 -115.88 0.68 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.369 -1.396 . . . . 2.13 110.405 -179.836 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.53 HH11 ' HG2' ' A' ' 186' ' ' ARG . 0.5 OUTLIER -68.49 -30.2 68.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.469 -1.018 . . . . 5.86 111.002 -178.856 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.0 p -79.97 7.42 9.01 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.006 -1.059 . . . . 3.72 110.544 -178.62 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 61.0 m -90.95 128.6 36.85 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.821 -1.174 . . . . 1.74 110.702 -179.528 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -47.27 -48.62 24.69 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.381 -0.824 . . . . 0.95 109.493 179.929 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.2 m -60.04 -39.92 87.6 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 1.55 109.961 -179.153 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 62.1 m -60.01 -39.95 87.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.985 -1.072 . . . . 1.51 109.335 -179.38 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.5 mm -66.31 -40.28 86.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.278 -0.889 . . . . 1.67 109.235 -179.92 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 92.9 mtp -64.63 -39.99 94.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.123 -0.986 . . . . 1.02 111.254 -179.538 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.61 -43.27 93.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.313 -1.492 . . . . 0.68 108.978 -179.644 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -59.93 -49.92 75.79 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.244 -0.91 . . . . 2.93 109.786 -179.566 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.5 m -70.03 -34.21 72.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.039 -1.038 . . . . 0.86 110.631 -179.226 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.0 mt -76.07 -21.68 56.48 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.08 -1.012 . . . . 0.67 109.533 -179.413 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 61.28 47.7 6.76 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.543 -0.723 . . . . 1.5 110.633 -179.646 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 63.4 mt -121.52 135.58 25.22 Favored Pre-proline 0 N--CA 1.501 2.124 0 N-CA-C 108.514 -0.921 . . . . 0.72 108.514 178.662 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -43.64 128.93 6.83 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.021 1.814 . . . . 0.61 112.124 -179.947 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -166.42 144.32 5.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.597 -1.315 . . . . 0.66 112.151 -179.79 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 94.9 mt -124.55 144.53 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 106.763 -1.569 . . . . 0.79 106.763 177.656 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.48 -10.56 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 120.78 -1.2 . . . . 0.91 111.554 -178.372 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -103.6 23.76 31.83 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.592 -1.403 . . . . 1.01 109.592 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.416 HG21 ' CG2' ' A' ' 180' ' ' ILE . 7.6 p -45.98 -42.44 13.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -1.125 . . . . 0.99 109.971 -179.194 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 89.94 -49.1 3.29 Favored Glycine 0 N--CA 1.498 2.767 0 O-C-N 120.963 -1.086 . . . . 1.12 111.113 179.336 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.8 t -165.92 40.41 0.06 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.714 -1.463 . . . . 1.72 110.731 -179.612 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 49.2 t -79.45 -37.71 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.081 -1.081 . . . . 0.89 108.081 177.865 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 209' ' ' THR . 2.8 p -52.56 -27.22 15.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.663 -0.648 . . . . 1.03 109.703 -179.906 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 69.8 m -78.94 -26.5 43.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 1.83 109.856 -179.629 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -92.3 -8.3 45.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.043 -1.036 . . . . 2.27 109.856 -179.672 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 64.8 t -105.17 133.77 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.436 -0.79 . . . . 0.92 110.272 -178.955 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.404 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 70.2 mmtt -113.39 154.0 27.66 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 106.976 -1.49 . . . . 2.2 106.976 178.309 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 55.7 t-20 -59.95 138.98 57.7 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.955 -1.091 . . . . 2.36 110.238 -178.622 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 84.85 -1.69 0.9 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 121.116 0.484 . . . . 2.38 110.801 179.115 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.404 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 92.7 m-20 -70.38 148.1 48.79 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.13 -0.981 . . . . 2.09 109.107 178.978 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -96.9 119.98 36.39 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.913 -1.144 . . . . 1.27 107.913 179.16 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 16' ' ' ALA . 87.1 mt -126.72 147.26 49.98 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.369 -0.832 . . . . 0.75 110.237 -178.876 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 99.9 mt -117.79 127.21 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.152 -1.425 . . . . 0.63 107.152 177.291 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 17.7 tp -100.94 120.6 40.41 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.257 -0.902 . . . . 0.7 109.584 -178.657 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 223' ' ' VAL . 7.1 t70 -76.01 -41.45 51.02 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.025 -1.102 . . . . 2.31 108.025 179.42 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 49.01 9.94 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.722 -0.611 . . . . 0.78 109.83 179.788 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.514 ' N ' ' O ' ' A' ' 221' ' ' ASP . 60.4 t -126.73 -35.12 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.619 -1.252 . . . . 1.04 107.619 178.66 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.486 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 98.6 m-20 -108.39 3.58 23.48 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.297 -1.001 . . . . 2.44 108.297 178.686 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.416 HD21 ' H ' ' A' ' 4' ' ' GLY . 38.7 t30 59.86 45.52 12.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.64 -0.662 . . . . 1.55 110.352 179.981 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -138.92 144.55 39.13 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.168 -0.957 . . . . 1.99 109.792 179.392 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.2 t -115.35 130.13 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.66 -0.867 . . . . 0.77 108.66 179.381 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -104.63 126.13 51.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.444 -0.785 . . . . 0.98 108.98 179.5 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.1 t -100.03 106.99 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.272 -0.893 . . . . 0.85 109.954 -179.55 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 39.3 t30 49.92 61.0 14.46 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.189 -0.945 . . . . 1.66 111.422 178.002 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.83 158.39 27.74 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.494 2.13 . . . . 0.95 111.538 178.964 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.2 m -68.42 159.68 31.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.044 -1.035 . . . . 1.84 110.354 -178.923 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -59.95 -40.0 87.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.549 -0.719 . . . . 2.74 109.732 -179.619 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.05 -39.25 85.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 2.89 109.389 -179.985 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.9 t -67.5 -39.96 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.312 -0.868 . . . . 1.3 108.91 179.359 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.9 mt . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.319 -0.863 . . . . 1.09 109.247 179.32 . . . . . . . . 0 0 . 1 . 033 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 45.5 ttm . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.408 0.623 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -151.02 148.17 28.02 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.153 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -152.19 161.6 42.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.935 -1.103 . . . . 0.0 111.039 -178.989 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -156.23 155.06 31.75 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.91 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -110.45 135.71 50.72 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.295 -0.878 . . . . 0.0 111.102 -179.055 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.548 HG22 ' N ' ' B' ' 307' ' ' THR . 2.7 p -120.06 165.27 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.94 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 307' ' ' THR . . . . . 0.548 ' N ' HG22 ' B' ' 306' ' ' VAL . 70.9 m -119.11 115.96 25.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.101 -1.0 . . . . 0.0 108.328 178.526 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.59 HD12 ' HB ' ' B' ' 359' ' ' THR . 60.2 mt -56.22 120.9 3.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-O 122.366 1.079 . . . . 0.0 110.893 -178.434 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 65.2 p -109.47 24.34 13.21 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.863 -179.945 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -85.17 116.65 66.38 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 108.725 179.618 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -68.33 -7.42 20.04 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 CA-C-N 120.201 1.108 . . . . 0.0 111.477 -179.948 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -119.12 6.61 11.27 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.634 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.52 175.76 43.86 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.366 -1.893 . . . . 0.0 108.366 -179.039 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 3.3 tp -83.65 95.51 8.38 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.008 -1.289 . . . . 0.0 108.952 -178.874 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -96.66 -160.48 0.8 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.835 -1.165 . . . . 0.0 109.805 179.15 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 4.0 m -59.97 -43.46 95.06 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.942 -1.099 . . . . 0.0 112.278 -176.287 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.507 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 2.6 tpt180 -54.82 -62.06 4.78 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.44 -1.412 . . . . 0.0 111.299 -178.65 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -58.73 -36.42 97.14 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 CA-C-N 120.221 1.115 . . . . 0.0 111.181 179.787 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.71 72.65 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.503 -0.748 . . . . 0.0 108.989 179.77 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -56.84 -44.07 81.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.774 -179.182 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -69.91 -42.29 73.56 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.013 -1.055 . . . . 0.0 108.48 179.353 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -59.87 -50.04 75.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.673 -0.642 . . . . 0.0 111.192 -179.204 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 72.7 t -70.94 -28.65 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.556 -1.34 . . . . 0.0 109.875 -179.175 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 324' ' ' LYS . . . . . 0.465 ' NZ ' ' OE1' ' A' ' 74' ' ' GLU . 22.7 ttmt -60.05 -47.69 84.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.2 -0.938 . . . . 0.0 109.905 -179.203 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 325' ' ' GLU . . . . . 0.481 ' OE1' HD22 ' B' ' 380' ' ' LEU . 85.3 tt0 -65.31 -40.02 93.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.087 -1.008 . . . . 0.0 110.239 -179.292 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.67 -52.94 62.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.913 -1.117 . . . . 0.0 111.129 -179.025 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -60.58 -13.02 11.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.874 -1.141 . . . . 0.0 109.708 -179.515 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -67.46 -30.4 75.07 Favored Glycine 0 N--CA 1.485 1.967 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 178.608 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -106.11 144.15 33.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.654 -0.909 . . . . 0.0 108.942 179.587 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 25.3 p -90.34 -12.35 37.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.989 -1.069 . . . . 0.0 109.626 -179.993 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.43 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 15.7 t -58.49 147.98 29.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 109.117 179.768 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -66.71 131.89 46.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.247 -0.908 . . . . 0.0 109.201 -179.813 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 79.3 mt -130.92 130.33 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.492 -0.755 . . . . 0.0 109.293 179.938 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 28.6 m -131.46 153.8 49.38 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.569 -0.707 . . . . 0.0 109.433 179.568 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 68.7 t -116.09 139.27 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.081 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.7 m -129.49 121.99 28.37 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.177 -0.952 . . . . 0.0 108.995 179.771 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 42.0 p -138.72 119.37 14.03 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.013 0.911 . . . . 0.0 111.052 -179.272 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 57.5 t30 41.78 59.01 2.63 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 177.265 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 82.0 -14.6 31.64 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 120.369 -1.457 . . . . 0.0 113.087 176.316 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -115.94 128.68 55.95 Favored 'General case' 0 N--CA 1.506 2.34 0 CA-C-N 119.264 1.532 . . . . 0.0 109.425 179.978 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 81.0 p -129.55 150.82 50.72 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.807 0.813 . . . . 0.0 110.172 -179.089 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 342' ' ' ALA . . . . . 0.453 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -143.54 166.49 24.66 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.682 0.753 . . . . 0.0 110.185 -179.223 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 4.6 t -91.27 142.41 27.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.662 -0.648 . . . . 0.0 109.643 -179.587 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -80.02 -12.42 59.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 109.984 -179.508 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -91.16 18.96 6.24 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.427 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 19.7 m -146.05 95.92 2.71 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.279 -179.09 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.811 HD23 HD22 ' A' ' 79' ' ' LEU . 8.3 tp -59.96 -32.29 70.67 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.663 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.609 ' CE2' HD11 ' A' ' 79' ' ' LEU . 60.0 m-85 -59.87 -54.53 45.07 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.524 -0.735 . . . . 0.0 110.636 -178.858 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -67.0 -40.09 87.25 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.56 -1.337 . . . . 0.0 109.387 -178.633 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' B' ' 352' ' ' THR . 32.8 mt -50.19 -57.08 8.55 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.122 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.516 ' O ' HD22 ' A' ' 123' ' ' LEU . 22.3 mt-30 -41.02 -17.66 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.864 -0.523 . . . . 0.0 111.099 -178.833 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.539 ' N ' ' O ' ' B' ' 350' ' ' LEU . 82.0 p -90.61 -5.98 55.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.183 -1.573 . . . . 0.0 110.567 -179.135 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.453 HD11 ' HB3' ' B' ' 342' ' ' ALA . 83.6 mt -92.96 108.63 20.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.945 -1.097 . . . . 0.0 109.639 179.434 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -68.25 84.67 0.18 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 107.81 -2.116 . . . . 0.0 107.81 178.774 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 71.0 mt -99.16 95.97 7.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.326 -1.103 . . . . 0.0 108.326 179.483 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 44.8 p -98.32 176.6 5.65 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.255 -0.903 . . . . 0.0 110.461 -178.604 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -44.62 159.15 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.355 1.074 . . . . 0.0 111.413 -179.327 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 41.09 23.3 0.08 OUTLIER Glycine 0 N--CA 1.497 2.701 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.601 177.608 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 359' ' ' THR . . . . . 0.59 ' HB ' HD12 ' B' ' 308' ' ' ILE . 4.5 m -87.4 108.04 18.82 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.459 -1.612 . . . . 0.0 109.501 179.595 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 57.8 t -77.28 123.2 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.784 -177.36 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.6 m -122.43 175.77 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -178.477 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 94.0 m -125.07 132.32 53.19 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.726 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 96.8 mt -100.73 121.78 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.484 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 54.0 p -124.09 133.92 53.5 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.524 -0.735 . . . . 0.0 109.471 -179.054 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.53 152.18 39.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.425 -0.797 . . . . 0.0 109.368 -179.489 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -141.97 119.77 11.89 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.529 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.539 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 159.68 -154.51 25.56 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.76 -1.686 . . . . 0.0 112.046 -179.935 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -58.05 -54.72 43.71 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -177.271 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.43 ' H ' ' HB2' ' B' ' 331' ' ' SER . 83.4 m-20 -112.39 14.42 20.37 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.028 -1.045 . . . . 0.0 111.177 -177.644 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.1 pt-20 -39.19 -37.52 0.41 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.621 -0.674 . . . . 0.0 110.926 -179.437 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -69.42 -46.18 67.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.022 -1.049 . . . . 0.0 111.064 -178.025 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.86 -49.48 65.54 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.864 -1.148 . . . . 0.0 110.374 -179.12 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -55.23 -35.15 64.63 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.082 -1.011 . . . . 0.0 111.477 -178.048 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.591 ' O ' HG23 ' B' ' 378' ' ' VAL . 72.8 t -69.94 -41.04 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.458 -1.401 . . . . 0.0 108.264 178.996 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -63.86 -59.45 4.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.522 -0.736 . . . . 0.0 111.916 -178.737 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -67.84 -40.11 83.75 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.63 -1.294 . . . . 0.0 111.963 -177.306 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.4 -38.01 73.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.553 -1.342 . . . . 0.0 108.757 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.591 HG23 ' O ' ' B' ' 374' ' ' VAL . 51.5 t -60.01 -42.04 88.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.255 -0.903 . . . . 0.0 109.285 179.499 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 379' ' ' LYS . . . . . 0.441 ' O ' ' OE2' ' B' ' 383' ' ' GLU . 19.1 mmmt -69.43 -55.02 11.5 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.082 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.481 HD22 ' OE1' ' B' ' 325' ' ' GLU . 64.3 tp -54.22 -38.65 65.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.786 -0.571 . . . . 0.0 110.604 -177.377 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 381' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' B' ' 381' ' ' MET . 0.0 OUTLIER -73.34 -40.01 64.76 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.619 -1.232 . . . . 0.0 108.607 178.238 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' B' B ' 382' ' ' ALA . . . . . 0.515 ' HB3' ' OE2' ' B' ' 383' ' ' GLU . . . -80.08 -3.4 48.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.095 -1.003 . . . . 0.0 109.775 179.411 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.515 ' OE2' ' HB3' ' B' ' 382' ' ' ALA . 0.0 OUTLIER -111.65 -3.02 15.18 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.378 -0.827 . . . . 0.0 111.026 -179.331 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.03 128.9 40.65 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.499 -1.376 . . . . 0.0 109.688 179.411 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 118.103 -0.951 . . . . 0.0 109.218 179.524 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.7 mtt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.471 -0.566 . . . . 2.91 109.471 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 87.5 mt -106.85 120.09 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.525 -0.734 . . . . 1.2 109.095 179.937 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.7 m -132.85 133.34 43.2 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.468 -0.77 . . . . 1.4 109.228 179.829 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.27 -162.38 13.54 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 108.44 -1.864 . . . . 1.05 108.44 179.496 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 6' ' ' LEU . 79.5 mt -91.6 -12.9 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.95 -1.324 . . . . 1.15 109.648 -179.478 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.468 HD11 ' O ' ' A' ' 8' ' ' SER . 60.0 tp 53.75 99.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.145 -0.972 . . . . 0.98 108.822 -179.569 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.15 -40.18 74.9 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.687 -0.857 . . . . 0.88 108.687 179.315 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.468 ' O ' HD11 ' A' ' 6' ' ' LEU . 46.5 m -149.05 147.95 25.49 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.431 -0.793 . . . . 1.69 109.744 179.574 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.73 146.99 17.02 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.671 2.248 . . . . 0.85 113.272 -179.925 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.677 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.19 -164.04 36.89 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 109.105 -1.598 . . . . 0.92 109.105 179.756 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.1 mt -149.84 149.88 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 120.914 -1.344 . . . . 0.81 109.124 179.208 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.38 156.22 33.5 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.037 -1.04 . . . . 0.51 110.552 179.214 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.4 m-85 -137.02 129.14 29.47 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 107.85 -1.167 . . . . 0.62 107.85 178.597 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.22 -179.13 44.83 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 118.652 -1.737 . . . . 0.55 110.996 179.847 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -79.89 155.21 27.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.747 -0.854 . . . . 2.1 109.533 -179.972 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.479 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -101.89 129.99 48.26 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.45 -0.781 . . . . 0.77 110.563 -179.3 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.0 tp -96.31 135.17 38.51 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.205 -1.406 . . . . 0.91 107.205 178.42 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.4 tp -113.48 118.29 34.07 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.219 -0.925 . . . . 0.93 109.773 -179.532 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.614 HD12 ' HB2' ' A' ' 160' ' ' ALA . 51.0 mt -85.98 102.88 14.17 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.432 0.635 . . . . 0.93 109.502 -179.947 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -97.56 137.33 36.65 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.376 -0.828 . . . . 2.75 109.971 -179.39 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -130.5 132.99 45.92 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.72 -0.844 . . . . 3.0 108.72 179.492 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -78.69 138.34 38.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.967 -1.083 . . . . 2.77 109.053 179.748 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.81 139.97 57.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 2.94 108.762 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.7 mt -85.22 132.76 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.95 109.416 -179.264 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.6 t -106.96 129.69 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.25 -0.906 . . . . 1.28 109.762 -179.748 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.3 mt -99.21 141.14 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.36 -0.838 . . . . 1.21 109.074 179.734 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -98.96 118.94 36.88 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.162 -0.961 . . . . 1.81 109.441 -179.961 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -90.11 3.07 54.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.465 -0.772 . . . . 2.8 109.887 -179.275 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -59.97 144.18 49.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.043 -1.036 . . . . 2.87 109.67 -179.895 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -92.0 143.5 26.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.208 -0.932 . . . . 2.35 108.963 179.654 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 pt -93.55 165.79 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.131 -0.981 . . . . 0.97 110.438 -179.346 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.2 p -88.96 170.42 10.7 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.02 -1.104 . . . . 1.17 108.02 178.281 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.19 -18.47 63.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.879 -1.138 . . . . 1.18 110.176 -179.799 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 53.7 t0 -83.55 -26.75 29.84 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.893 -1.129 . . . . 2.56 108.605 179.14 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -82.18 -7.64 59.63 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.983 -0.747 . . . . 1.79 108.983 179.036 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.3 t -60.49 -53.14 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.254 -0.904 . . . . 1.0 109.253 179.77 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.81 -39.96 90.89 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.321 -0.862 . . . . 1.77 109.969 -179.447 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -63.46 -40.21 96.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.246 -0.909 . . . . 2.7 110.997 -179.298 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -65.94 -40.03 91.02 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.742 -1.224 . . . . 1.51 110.593 -179.395 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.01 -46.9 93.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 118.163 -1.415 . . . . 0.93 108.379 -179.614 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.03 -41.57 92.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.839 -1.163 . . . . 1.81 109.703 179.806 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.402 ' HG2' HH11 ' A' ' 42' ' ' ARG . 57.2 mtt-85 -59.95 -44.82 94.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.805 -1.185 . . . . 2.78 108.576 179.131 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -63.18 -47.44 82.59 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.456 -0.778 . . . . 0.78 109.523 178.886 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.0 tp -59.96 -49.08 79.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.294 -0.879 . . . . 1.07 109.075 -179.069 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.8 t -64.27 -42.25 96.55 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.965 -1.084 . . . . 1.12 108.874 179.452 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.25 -48.86 84.04 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.544 -1.823 . . . . 0.84 108.544 179.117 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -60.64 -38.69 85.64 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.436 -1.038 . . . . 3.09 108.434 178.594 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.41 -40.06 70.96 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.096 -0.705 . . . . 0.88 109.096 -179.855 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 51' ' ' SER . 24.1 ttmt -61.16 -74.48 0.08 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.439 -1.319 . . . . 2.59 107.439 179.46 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.68 -30.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.39 -0.819 . . . . 0.7 111.427 -178.254 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 49' ' ' LYS . 18.3 t -60.0 -54.59 44.2 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.771 -1.172 . . . . 1.4 108.587 179.673 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.69 -42.81 77.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.611 -0.68 . . . . 0.67 111.161 -179.016 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.85 -45.68 93.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.801 -1.187 . . . . 1.66 110.675 -179.046 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.99 -40.18 94.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.927 -1.108 . . . . 1.58 109.477 -179.406 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -60.87 -39.77 90.43 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.252 -0.905 . . . . 1.35 110.031 179.861 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -65.41 -43.34 90.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.934 -1.104 . . . . 0.77 109.269 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.567 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.8 mt -61.68 -39.87 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.63 108.922 179.537 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -54.98 -50.38 69.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.752 . . . . 1.14 109.657 -179.469 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -57.33 -33.87 68.17 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.321 -0.862 . . . . 0.79 110.492 -178.088 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -69.83 -37.46 76.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 1.53 109.45 179.622 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.86 -46.07 79.82 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.677 -0.639 . . . . 0.57 110.192 -179.67 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.19 -52.81 44.71 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 110.159 -1.176 . . . . 0.75 110.159 -179.011 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -70.04 -43.92 70.3 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.997 -1.296 . . . . 1.59 110.255 -179.513 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.4 m -65.28 -65.25 0.7 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.092 -1.005 . . . . 0.73 112.987 -177.453 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -97.83 -42.59 7.5 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.812 -1.18 . . . . 0.75 111.667 -177.621 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.25 -168.98 25.22 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.752 -1.218 . . . . 1.22 111.014 179.499 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -73.77 -23.69 59.75 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.04 -0.682 . . . . 5.81 110.246 -179.966 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -62.46 -33.58 75.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 3.37 110.462 -179.077 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HA ' HD12 ' A' ' 72' ' ' ILE . 34.5 mmtm -99.06 -20.03 16.92 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.274 -0.891 . . . . 1.77 109.61 -179.801 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -69.92 -40.24 75.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.312 -0.868 . . . . 1.65 110.531 -178.845 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.643 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -69.15 -27.31 65.43 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.183 -0.948 . . . . 0.77 109.879 -179.002 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 69' ' ' LYS . 94.2 mt -60.01 -40.4 83.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.793 -1.188 . . . . 0.8 107.793 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -62.1 -41.91 98.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -0.888 . . . . 0.88 108.906 179.281 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -60.86 -39.91 90.93 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.633 -0.827 . . . . 1.37 109.345 179.15 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.44 -47.82 88.51 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.881 -1.687 . . . . 0.62 108.881 179.531 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -64.06 -40.12 95.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.496 -1.002 . . . . 1.5 109.032 179.582 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.2 mt -69.4 -45.73 78.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.342 -0.849 . . . . 0.63 109.451 179.717 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.4 ttp -63.61 -40.07 95.99 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.04 -1.038 . . . . 1.51 110.16 -178.69 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.887 HD22 HD23 ' B' ' 347' ' ' LEU . 58.0 tp -65.95 -40.03 90.98 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.396 -0.815 . . . . 0.77 109.959 -179.961 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.7 tp -65.5 -39.94 92.46 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.684 -0.635 . . . . 0.62 110.207 -178.775 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -84.68 4.72 31.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.896 -1.127 . . . . 1.47 110.039 -178.897 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.1 t0 -49.18 134.55 17.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.175 -0.953 . . . . 1.47 109.765 -179.666 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.46 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.6 mt-10 -60.69 -20.02 59.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.612 -0.68 . . . . 1.78 110.798 -178.728 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -71.36 -33.39 69.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.055 -1.028 . . . . 2.53 110.171 179.569 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.9 mt -75.02 -41.09 60.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.477 -0.764 . . . . 0.8 110.146 179.864 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.05 -50.05 75.24 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.227 -0.921 . . . . 1.42 110.732 -178.92 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.03 -40.74 74.98 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.05 -1.031 . . . . 1.71 111.665 -178.802 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -69.98 -39.16 76.11 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.031 -1.043 . . . . 1.57 111.354 -178.818 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.8 mt -67.67 -42.05 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.93 . . . . 0.65 109.116 -179.757 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.7 mt -65.82 -39.21 84.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.51 -0.744 . . . . 0.82 109.622 179.38 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.09 -49.45 77.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 0.79 111.451 -178.629 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.8 mt -60.99 -46.4 90.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.711 -1.243 . . . . 0.95 109.821 -178.866 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.03 -50.01 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 122.115 0.96 . . . . 0.66 109.075 179.729 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -70.43 -40.21 73.94 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 120.091 -0.644 . . . . 2.2 110.834 -179.762 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -81.13 -62.48 1.65 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.036 -1.04 . . . . 1.65 112.078 -178.135 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -82.55 -0.97 49.21 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.043 -1.036 . . . . 2.03 111.999 -177.025 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 73.3 m80 57.57 38.19 27.81 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.92 -1.112 . . . . 1.42 109.927 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.1 mtp -92.67 169.07 10.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.484 -0.76 . . . . 1.18 109.595 -179.937 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.7 p -81.55 160.23 23.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.28 -0.887 . . . . 0.98 109.559 -179.692 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.4 -39.72 77.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.33 -0.856 . . . . 0.64 109.937 -179.772 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -67.01 -40.04 87.19 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -0.888 . . . . 2.07 109.498 179.817 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.65 -43.86 25.15 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.43 -0.794 . . . . 0.73 109.868 179.618 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.99 -42.92 72.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.339 -0.851 . . . . 0.54 110.568 -179.222 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.05 -44.12 96.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.166 -0.959 . . . . 0.56 109.819 -179.495 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -59.98 -38.71 83.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.321 -0.862 . . . . 1.54 110.386 -179.202 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.98 -40.28 88.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.012 . . . . 1.33 110.379 -179.172 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.1 t -64.74 -49.09 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.838 -1.164 . . . . 0.72 110.055 -179.38 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.5 mm -67.58 -40.09 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.069 -1.019 . . . . 0.85 109.214 -179.802 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.46 -38.87 88.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 2.44 108.808 179.336 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.96 -45.69 95.45 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 120.313 -0.946 . . . . 0.98 110.749 -179.487 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.3 mm-40 -70.04 -52.56 23.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.7 -1.471 . . . . 1.41 110.039 -179.118 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.2 88.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.855 . . . . 1.2 109.811 -179.497 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.2 t -57.88 -39.64 78.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.174 -0.954 . . . . 1.7 109.559 -179.287 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.16 -39.45 94.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 1.47 109.562 179.63 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.3 mt -61.94 -39.97 93.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.105 -0.997 . . . . 1.56 109.671 -179.202 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.438 ' CD ' ' NH2' ' A' ' 131' ' ' ARG . 36.3 mt-10 -58.91 -33.27 70.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.608 -1.307 . . . . 2.2 109.705 -179.141 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -56.33 -21.57 25.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.873 -1.142 . . . . 2.12 108.713 179.264 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.432 HD13 HD13 ' A' ' 123' ' ' LEU . 74.8 mt -62.54 140.4 58.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 2.0 108.939 179.687 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -90.63 21.66 3.9 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.208 -0.932 . . . . 3.23 110.126 -179.426 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 51.9 t0 -112.86 141.28 46.86 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.402 -0.811 . . . . 2.49 109.569 -179.737 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 124' ' ' LYS . 92.8 mt-10 -72.54 -63.2 1.21 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.265 -1.013 . . . . 3.95 108.265 178.631 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.46 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.8 t80 -38.65 -41.42 0.69 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.031 -0.418 . . . . 2.0 110.932 -178.935 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.433 HD22 ' O ' ' B' ' 351' ' ' GLN . 87.2 mt -69.85 -39.92 76.1 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.63 -1.293 . . . . 1.86 108.239 179.549 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 121' ' ' GLU . 63.1 tttp -60.77 -40.07 91.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 2.84 110.022 179.718 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 41.3 mt-10 -60.02 -45.01 94.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.017 -1.052 . . . . 2.73 109.77 -179.28 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.872 ' HE ' HE22 ' B' ' 351' ' ' GLN . 65.6 mtp180 -60.54 -39.94 89.7 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.167 -0.958 . . . . 2.77 108.505 179.214 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.76 -27.35 67.9 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.556 -0.905 . . . . 1.19 108.556 179.027 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -64.18 -40.05 95.29 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.135 -1.061 . . . . 1.2 108.135 178.792 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -64.16 -40.09 95.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.518 -0.739 . . . . 1.55 109.21 179.653 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.89 -42.73 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -0.864 . . . . 0.8 108.733 179.945 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.438 ' NH2' ' CD ' ' A' ' 116' ' ' GLU . 44.1 ttm180 -60.33 -36.72 78.62 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.522 0.677 . . . . 3.09 109.203 179.361 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -58.45 -39.61 80.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.438 -0.789 . . . . 1.46 109.036 -179.671 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.87 -45.45 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.209 -0.932 . . . . 0.71 108.838 179.843 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.18 -41.34 99.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.771 -1.332 . . . . 0.57 109.771 179.689 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -59.99 -50.04 75.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.188 -1.184 . . . . 2.59 110.274 -179.927 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.567 HH22 ' CD1' ' A' ' 57' ' ' ILE . 62.1 mtp180 -69.64 -32.37 71.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.807 -1.183 . . . . 2.83 109.72 -179.631 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -57.3 -47.86 80.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 1.25 108.772 -179.139 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.9 mt -61.13 -39.69 90.98 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.254 -0.904 . . . . 0.7 108.955 178.407 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.512 HH11 ' CD2' ' A' ' 144' ' ' LEU . 50.0 mtt-85 -67.61 -40.05 84.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.89 . . . . 2.57 109.259 179.542 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -66.53 -39.88 88.83 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.629 -0.669 . . . . 1.23 110.456 -179.012 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.9 mt -71.78 -43.1 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 120.478 -1.389 . . . . 0.81 108.303 178.822 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.0 -32.25 70.35 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.74 -0.6 . . . . 1.0 109.733 179.944 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.86 44.38 6.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.178 -1.569 . . . . 0.89 109.178 -179.373 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.512 ' CD2' HH11 ' A' ' 139' ' ' ARG . 12.3 tp -74.85 148.45 40.22 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.414 -1.05 . . . . 1.14 109.376 -179.44 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -70.45 143.16 51.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.24 -0.913 . . . . 4.6 109.896 -179.48 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.7 mt -115.22 129.98 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.984 0.897 . . . . 1.24 108.915 179.373 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 10.5 mt -66.85 -39.95 84.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 115.869 -0.605 . . . . 1.54 110.717 -178.23 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.6 t0 67.5 97.29 0.06 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.745 -0.835 . . . . 1.5 108.745 -179.329 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.2 mt -68.1 -1.13 5.37 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.443 -0.786 . . . . 0.79 110.939 -178.575 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 80.8 p -82.97 -14.0 54.9 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.695 -1.253 . . . . 1.4 110.111 -179.723 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.92 33.34 0.33 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.284 -0.885 . . . . 0.92 111.96 -177.955 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 45.1 mm -85.94 120.22 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.421 -1.425 . . . . 0.88 108.96 179.491 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.414 ' O ' ' OD1' ' A' ' 154' ' ' ASP . 50.6 tt0 -99.85 -12.14 20.12 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.33 -0.856 . . . . 2.45 109.93 -179.364 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 153' ' ' GLN . 95.7 m-20 -139.26 157.89 45.12 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.944 -1.098 . . . . 1.52 110.285 -179.398 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.95 137.03 57.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.45 -0.782 . . . . 1.58 109.63 -179.62 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.5 m -153.3 167.9 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.462 -0.774 . . . . 0.69 109.982 179.609 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 81.5 mt -97.16 144.74 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.727 -1.583 . . . . 0.61 106.727 177.689 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.511 HD11 HD11 ' A' ' 19' ' ' LEU . 40.9 tp -94.2 117.08 29.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.911 -1.118 . . . . 0.87 110.367 -178.222 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.786 HG12 HG22 ' A' ' 209' ' ' THR . 44.6 t -123.12 129.41 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 108.667 -0.864 . . . . 0.71 108.667 179.199 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.614 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.14 165.31 29.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.119 -0.988 . . . . 0.81 109.354 -179.627 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.42 -30.63 61.99 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.261 -1.524 . . . . 0.98 108.378 178.823 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -165.51 168.41 16.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.913 -0.773 . . . . 2.25 108.913 -179.61 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.1 mt -139.6 133.19 30.36 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.169 -0.957 . . . . 0.78 108.869 179.286 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 69.3 p -99.13 149.35 35.7 Favored Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.318 -0.864 . . . . 0.98 109.769 -179.717 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -40.62 -37.77 2.32 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.541 2.16 . . . . 0.81 113.263 179.515 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 65.1 m -59.99 -39.99 87.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.9 109.677 -178.794 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -69.08 -44.21 72.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.287 -0.883 . . . . 1.61 110.503 -179.445 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.0 p -54.9 -30.17 57.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.043 -1.036 . . . . 0.61 111.717 -177.458 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.79 -48.58 24.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.7 -1.25 . . . . 0.6 109.901 -179.522 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 170' ' ' GLN . . . . . 0.421 ' H ' ' HG2' ' A' ' 170' ' ' GLN . 13.9 pt20 -86.43 40.12 0.87 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.899 -1.149 . . . . 1.4 107.899 179.636 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.3 tp -111.26 136.14 50.78 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.36 -0.978 . . . . 0.7 108.36 178.485 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.428 ' O ' HG23 ' A' ' 176' ' ' VAL . 87.2 m-20 -90.43 108.42 19.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.966 -1.084 . . . . 2.35 110.096 -179.728 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 71.9 mt -64.91 -40.43 95.06 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.458 -0.776 . . . . 1.51 111.071 -178.906 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -70.05 -25.04 63.37 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.87 -1.144 . . . . 2.33 111.708 -178.131 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -93.62 -8.99 39.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.784 -1.198 . . . . 1.92 110.373 -178.632 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.581 HG12 ' H ' ' A' ' 178' ' ' GLY . 85.4 t -103.27 117.85 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.194 -0.941 . . . . 0.67 108.948 179.434 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 81.6 mt -86.73 6.42 31.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.456 -0.778 . . . . 1.53 110.571 -177.875 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.581 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 165.66 175.4 36.15 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.305 -1.518 . . . . 0.48 109.305 179.806 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.443 ' CE1' HG11 ' A' ' 176' ' ' VAL . 21.8 m-85 -132.18 130.67 41.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.477 -1.013 . . . . 0.55 109.198 -179.877 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.417 ' CG2' HG21 ' A' ' 205' ' ' THR . 98.2 mt -132.93 124.85 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.483 -0.76 . . . . 0.65 108.963 178.869 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 47.5 p -148.02 160.61 42.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.97 -1.081 . . . . 0.82 110.917 -179.622 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 183' ' ' ALA . 0.8 OUTLIER -99.65 20.13 14.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.558 -0.714 . . . . 2.46 109.717 179.969 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.17 -163.32 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.812 -1.18 . . . . 1.28 111.607 -178.295 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -85.56 -46.92 5.32 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 111.224 -0.751 . . . . 2.19 111.224 -178.603 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 165.66 -136.44 4.18 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.963 -1.589 . . . . 2.13 110.612 -179.598 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' ' 186' ' ' ARG . 24.2 mmt-85 -70.21 -10.43 58.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.481 -1.011 . . . . 5.86 109.739 -179.219 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 78.1 p -76.08 -7.15 54.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.114 -0.992 . . . . 3.72 109.732 -179.471 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.2 p -91.39 131.87 36.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.134 -0.979 . . . . 1.74 109.889 179.819 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -49.69 -47.59 50.22 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.426 -0.796 . . . . 0.95 109.843 -179.559 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.414 ' H ' HG22 ' A' ' 190' ' ' THR . 0.6 OUTLIER -56.96 -39.62 74.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.381 -0.824 . . . . 1.55 110.576 -178.949 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.4 t -60.03 -41.23 91.79 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.888 -1.132 . . . . 1.51 110.753 -179.267 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.7 mm -60.21 -40.01 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.135 -0.978 . . . . 1.67 109.338 -179.5 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.7 mtp -60.04 -40.13 88.31 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.27 -0.894 . . . . 1.02 110.055 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.48 -44.38 72.56 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.734 -1.228 . . . . 0.68 108.931 179.986 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -60.06 -52.42 65.46 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.346 -0.942 . . . . 2.93 110.518 -179.703 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 56.4 m -69.88 -34.68 73.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.025 -1.047 . . . . 0.86 110.79 -178.465 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.97 -29.68 66.85 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.955 -1.128 . . . . 0.67 107.955 179.593 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 65.09 47.34 2.51 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.454 0.645 . . . . 1.5 110.153 -179.629 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 93.6 mt -124.85 150.52 66.19 Favored Pre-proline 0 N--CA 1.5 2.05 0 N-CA-C 108.439 -0.948 . . . . 0.72 108.439 178.891 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -56.15 138.59 83.51 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.858 1.705 . . . . 0.61 111.135 179.841 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.94 151.03 3.22 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.744 -1.182 . . . . 0.66 111.778 -179.647 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.1 mt -127.23 143.89 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.069 -1.086 . . . . 0.79 108.069 179.116 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.9 m -130.0 -11.45 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 O-C-N 120.837 -1.165 . . . . 0.91 111.315 -178.825 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.51 25.85 18.25 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 110.064 -1.214 . . . . 1.01 110.064 -179.506 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.417 HG21 ' CG2' ' A' ' 180' ' ' ILE . 4.6 p -45.3 -45.59 12.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -1.158 . . . . 0.99 109.814 -179.562 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.8 -52.79 2.62 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.216 -0.993 . . . . 1.12 111.181 179.287 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.5 t -155.02 29.04 0.41 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.585 -1.538 . . . . 1.72 111.451 -179.032 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 56.0 t -70.18 -40.08 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.947 -1.095 . . . . 0.89 109.131 178.309 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.786 HG22 HG12 ' A' ' 159' ' ' VAL . 63.2 p -60.0 -26.53 66.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.423 -0.798 . . . . 1.03 110.621 -179.131 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 79.3 p -81.7 -20.69 38.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.921 -1.112 . . . . 1.83 110.181 -179.361 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -101.01 -9.1 21.76 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.344 -0.848 . . . . 2.27 109.967 -179.688 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.2 t -103.32 138.23 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.38 -0.825 . . . . 0.92 110.18 -179.053 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.87 155.34 26.99 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.606 -1.257 . . . . 2.2 107.606 178.938 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 55.3 t30 -59.56 139.43 57.16 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.872 -1.143 . . . . 2.36 109.738 -179.603 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.5 m-20 82.07 5.06 1.17 Allowed 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 121.144 0.497 . . . . 2.38 110.018 179.884 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 63.1 t0 -73.1 136.91 44.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 2.09 108.912 179.077 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.515 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 34.9 t80 -88.93 114.8 25.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.931 -1.105 . . . . 1.27 108.42 179.471 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.479 HD12 ' HB2' ' A' ' 16' ' ' ALA . 72.2 mt -124.67 146.15 49.28 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.52 -0.738 . . . . 0.75 110.343 -178.897 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.9 mt -112.87 128.7 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 107.741 -1.207 . . . . 0.63 107.741 178.187 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 49.5 tp -101.22 116.42 32.76 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.922 -1.111 . . . . 0.7 108.992 -179.523 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.503 ' OD2' ' ND2' ' A' ' 224' ' ' ASN . 38.5 t0 -80.7 -41.93 22.84 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.173 -1.047 . . . . 2.31 108.173 178.948 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.83 19.61 0.18 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.967 -0.753 . . . . 0.78 108.967 -179.401 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.434 ' N ' ' C ' ' A' ' 221' ' ' ASP . 47.3 t -128.61 -39.72 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.097 -1.445 . . . . 1.04 107.097 178.539 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.503 ' ND2' ' OD2' ' A' ' 221' ' ' ASP . 86.1 m-20 -108.85 4.78 23.89 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.836 -1.172 . . . . 2.44 107.836 178.072 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 60.06 47.66 9.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.721 -0.612 . . . . 1.55 110.059 -179.884 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -140.84 140.29 34.62 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.134 -0.979 . . . . 1.99 110.252 179.889 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -118.31 120.14 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 108.533 -0.914 . . . . 0.77 108.533 179.104 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -88.57 130.02 35.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.978 -1.076 . . . . 0.98 109.366 -179.479 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.462 HG22 HD22 ' A' ' 218' ' ' LEU . 58.2 t -103.34 115.1 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.6 -0.688 . . . . 0.85 110.027 -179.056 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.6 t30 48.44 66.73 5.3 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.311 -0.868 . . . . 1.66 111.058 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -90.1 154.04 4.76 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.809 2.339 . . . . 0.95 111.687 178.851 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 232' ' ' THR . 1.8 t -77.98 168.88 19.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.03 -1.044 . . . . 1.84 110.257 -179.162 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -59.99 -38.97 84.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.696 -0.628 . . . . 2.74 111.321 -179.114 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -59.97 -39.98 87.5 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.936 -1.103 . . . . 2.89 110.137 -178.109 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.51 -39.9 79.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.089 -1.007 . . . . 1.3 109.306 179.572 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 1.09 110.309 -179.617 . . . . . . . . 0 0 . 1 . 034 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 55.6 ttm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -149.48 146.87 27.63 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.011 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.35 159.86 44.15 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.943 -1.098 . . . . 0.0 110.423 -179.101 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -158.44 154.63 27.18 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.614 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 305' ' ' GLU . . . . . 0.462 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 54.6 mp0 -115.15 130.77 57.01 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.074 -1.016 . . . . 0.0 109.787 179.575 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.35 126.3 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 CA-C-O 122.181 0.991 . . . . 0.0 112.297 -177.526 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 35.5 m -79.04 102.68 8.5 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.072 0.939 . . . . 0.0 110.936 -178.403 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.453 HG22 ' H ' ' B' ' 310' ' ' ALA . 96.7 mt -51.28 126.02 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 122.29 1.043 . . . . 0.0 110.742 -177.839 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 72.6 p -110.06 19.27 19.16 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.147 -179.103 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.453 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -76.71 126.28 86.12 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.902 -1.124 . . . . 0.0 108.134 178.942 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -65.7 -11.48 30.86 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 CA-C-N 120.312 1.147 . . . . 0.0 112.75 -178.866 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -119.98 10.06 11.4 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.464 -0.773 . . . . 0.0 109.589 -179.844 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.74 179.99 33.12 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -179.132 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.519 ' O ' ' NH1' ' A' ' 126' ' ' ARG . 3.2 tp -84.38 87.9 7.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.918 -1.342 . . . . 0.0 109.062 -178.801 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.438 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 3.7 p80 -90.38 -163.12 0.97 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.862 -1.149 . . . . 0.0 109.997 179.187 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.0 m -55.88 -44.64 78.32 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.186 -0.946 . . . . 0.0 112.917 -176.054 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.643 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 12.7 tpt180 -60.02 -60.0 12.04 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 120.576 -1.327 . . . . 0.0 112.087 -178.991 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.438 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 11.5 Cg_endo -59.5 -34.5 97.05 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 CA-C-N 120.634 1.262 . . . . 0.0 111.873 -179.147 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.0 75.46 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.421 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.46 -44.52 76.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.512 -0.743 . . . . 0.0 110.159 -179.221 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -70.02 -41.06 74.81 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.746 -1.221 . . . . 0.0 108.537 178.898 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -62.1 -52.88 62.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.455 -0.778 . . . . 0.0 110.151 -179.776 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 95.3 t -66.17 -25.35 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.823 -1.173 . . . . 0.0 109.974 -178.975 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -60.0 -44.51 94.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.135 -0.978 . . . . 0.0 108.574 179.948 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.18 -52.56 46.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.461 -0.774 . . . . 0.0 110.991 -179.228 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 326' ' ' ALA . . . . . 0.428 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -53.13 -56.89 12.77 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.618 -1.301 . . . . 0.0 111.474 -178.444 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -50.06 -16.2 0.28 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.032 -1.042 . . . . 0.0 109.359 -179.912 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 328' ' ' GLY . . . . . 0.428 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -81.68 -17.05 71.57 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.361 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -106.22 141.39 37.66 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.607 -0.937 . . . . 0.0 109.257 179.571 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.2 p -92.14 -14.28 29.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.905 -1.122 . . . . 0.0 110.21 -179.998 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.487 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 47.4 t -59.99 143.85 50.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.073 -1.017 . . . . 0.0 109.404 -179.78 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -66.58 137.9 57.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.424 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 93.5 mt -134.11 134.18 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.469 -0.769 . . . . 0.0 110.327 -179.149 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 99.7 m -129.07 149.62 50.81 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.798 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 74.8 t -115.63 141.47 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.325 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 59.1 m -131.61 121.94 25.2 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.155 -0.966 . . . . 0.0 109.359 179.547 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.3 t -139.2 120.22 14.55 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.086 0.946 . . . . 0.0 110.737 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 42.47 50.08 4.73 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 177.365 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.28 -14.65 57.14 Favored Glycine 0 N--CA 1.503 3.16 0 O-C-N 120.186 -1.571 . . . . 0.0 113.351 176.391 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -112.65 121.65 45.38 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 119.368 1.584 . . . . 0.0 109.906 -179.532 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 53.2 m -106.23 154.03 21.31 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.968 0.89 . . . . 0.0 111.069 -178.668 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -150.75 150.18 30.7 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.374 0.606 . . . . 0.0 109.573 179.452 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 68.0 m -87.69 135.2 33.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.334 -0.854 . . . . 0.0 110.136 -179.56 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.429 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -69.31 -20.2 63.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.075 -1.015 . . . . 0.0 108.49 179.366 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -84.29 20.44 1.63 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.841 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 346' ' ' SER . . . . . 0.429 ' H ' ' C ' ' B' ' 344' ' ' ALA . 2.6 m -149.1 91.71 1.88 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.014 -179.762 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.887 HD23 HD22 ' A' ' 79' ' ' LEU . 59.5 tp -56.54 -37.55 70.67 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.383 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.806 ' CE2' HD11 ' A' ' 79' ' ' LEU . 62.3 m-85 -54.54 -50.09 68.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.354 -0.841 . . . . 0.0 111.039 -179.273 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 349' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' B' ' 350' ' ' LEU . 35.1 mtmm -69.97 -39.89 75.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.675 -1.265 . . . . 0.0 110.645 -178.525 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' B' ' 352' ' ' THR . 96.7 mt -46.63 -56.8 5.53 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.979 -1.076 . . . . 0.0 108.879 -179.494 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.872 HE22 ' HE ' ' A' ' 126' ' ' ARG . 56.9 mm-40 -39.49 -26.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.847 -0.533 . . . . 0.0 111.208 -178.571 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.445 ' N ' ' O ' ' B' ' 350' ' ' LEU . 67.8 p -79.3 -11.15 59.94 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.498 -1.376 . . . . 0.0 110.56 -178.078 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 24.3 mt -96.34 120.01 35.86 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.922 -1.111 . . . . 0.0 109.54 178.72 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.35 92.1 1.06 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.135 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.2 mt -98.41 92.01 5.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.301 -1.117 . . . . 0.0 109.331 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 70.1 p -92.89 175.79 6.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.133 -0.979 . . . . 0.0 111.352 -178.516 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -65.22 110.82 2.7 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.447 -179.543 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 102.65 12.93 31.38 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.688 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 50.1 m -88.36 110.09 20.51 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -1.137 . . . . 0.0 111.343 -179.092 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 31.0 t -77.45 113.83 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 122.119 0.962 . . . . 0.0 109.826 -177.752 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.5 m -109.78 176.6 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -177.875 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 29.8 m -131.58 127.57 37.41 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.477 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.0 mt -104.21 115.86 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.435 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 50.2 p -120.37 133.35 55.46 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.513 -0.742 . . . . 0.0 109.042 -179.664 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.61 150.05 36.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.114 -0.991 . . . . 0.0 110.086 -179.024 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -139.29 120.5 14.77 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.65 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.574 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 165.04 -167.07 38.53 Favored Glycine 0 N--CA 1.485 1.909 0 C-N-CA 119.119 -1.515 . . . . 0.0 111.117 -179.492 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -58.09 -47.03 84.47 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.359 -0.495 . . . . 0.0 111.707 -177.785 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.487 ' H ' ' HB2' ' B' ' 331' ' ' SER . 2.7 p30 -107.98 10.46 28.35 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.878 -1.139 . . . . 0.0 111.373 -177.681 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -43.92 -32.02 1.01 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.408 -0.808 . . . . 0.0 110.963 -178.96 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -69.46 -45.16 69.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.137 -0.977 . . . . 0.0 110.045 -178.481 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -67.5 -47.98 68.41 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.176 -0.953 . . . . 0.0 108.847 -179.632 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.15 -78.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.399 -0.813 . . . . 0.0 110.67 -179.471 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.583 ' O ' HG23 ' B' ' 378' ' ' VAL . 38.7 t -46.34 -35.75 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.042 -1.036 . . . . 0.0 110.633 -177.458 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -64.9 -49.84 68.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.528 -1.357 . . . . 0.0 110.591 -179.963 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -80.49 -41.78 23.69 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.956 -1.09 . . . . 0.0 110.493 -179.667 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 97.0 mt -59.94 -37.19 78.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 109.08 -179.133 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.583 HG23 ' O ' ' B' ' 374' ' ' VAL . 50.2 t -65.46 -40.04 87.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.312 -0.867 . . . . 0.0 109.574 179.265 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -69.71 -57.03 5.63 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.772 -1.205 . . . . 0.0 108.408 179.213 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 57.3 tp -55.17 -26.73 40.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 0.0 110.403 -178.216 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 33.7 ttm -74.72 -38.13 62.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.691 -1.256 . . . . 0.0 109.027 177.857 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.89 -4.41 58.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.512 -0.742 . . . . 0.0 110.509 179.588 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -110.48 -6.66 14.87 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.122 -0.986 . . . . 0.0 111.245 -178.739 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.6 mt -78.56 132.37 37.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.3 -1.5 . . . . 0.0 109.029 179.141 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.366 -179.705 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.2 mmm . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.332 -0.618 . . . . 2.91 109.332 . . . . . . . . . 0 0 . 1 . 035 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.0 mt -111.13 126.99 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.578 -0.701 . . . . 1.2 109.828 179.809 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.8 m -140.51 150.18 43.42 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.371 -0.83 . . . . 1.4 109.778 -179.832 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.417 ' H ' ' CG ' ' A' ' 225' ' ' ASN . . . -138.7 -163.81 9.68 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.858 -1.697 . . . . 1.05 108.858 179.274 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 6' ' ' LEU . 97.4 mt -93.3 -16.82 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.95 -1.324 . . . . 1.15 110.125 -179.118 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.1 tp 54.55 105.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.397 -0.815 . . . . 0.98 109.407 179.906 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.31 -35.25 11.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.561 -0.903 . . . . 0.88 108.561 179.064 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 7.6 m -129.26 129.28 23.29 Favored Pre-proline 0 N--CA 1.502 2.136 0 N-CA-C 109.362 -0.607 . . . . 1.69 109.362 179.848 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.15 146.1 15.69 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.272 1.981 . . . . 0.85 112.807 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.807 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 160.53 -160.35 31.74 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 109.827 -1.309 . . . . 0.92 109.827 179.594 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.0 mt -149.98 149.64 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.268 -1.136 . . . . 0.81 108.195 179.215 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.04 149.82 25.07 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.568 -1.333 . . . . 0.51 111.128 179.628 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 4.0 m-85 -131.06 129.79 42.4 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 108.917 -0.771 . . . . 0.62 108.917 179.23 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.93 -173.79 46.03 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 118.509 -1.805 . . . . 0.55 110.948 179.3 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -82.55 155.46 24.49 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.949 -0.736 . . . . 2.1 110.026 -179.513 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.578 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -102.35 129.51 48.82 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.383 -0.823 . . . . 0.77 110.853 -179.532 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.3 tp -99.38 133.52 43.58 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.109 -1.441 . . . . 0.91 107.109 178.412 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.4 tp -118.72 125.41 49.6 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.235 -0.916 . . . . 0.93 109.652 -179.697 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.56 HD21 HD21 ' A' ' 149' ' ' LEU . 85.5 mt -87.36 103.73 15.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.583 -0.698 . . . . 0.93 109.578 179.627 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.98 132.15 43.79 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.557 -0.905 . . . . 2.75 108.557 179.367 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -131.26 130.32 42.71 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.972 -1.08 . . . . 3.0 109.003 179.03 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -79.46 154.1 29.16 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.166 -0.959 . . . . 2.77 108.777 179.448 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -67.74 141.18 56.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.043 -1.035 . . . . 2.94 109.838 -179.915 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.4 mt -79.44 135.45 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.241 -1.022 . . . . 0.95 108.241 179.532 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.1 t -103.39 124.33 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.175 -0.953 . . . . 1.28 109.998 -179.294 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.9 mt -99.03 140.77 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.849 -0.797 . . . . 1.21 108.849 179.803 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -92.15 121.39 33.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.063 -1.023 . . . . 1.81 109.359 -179.699 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -94.86 5.47 51.8 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.495 -0.928 . . . . 2.8 108.495 179.701 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -65.78 142.13 58.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.484 -0.76 . . . . 2.87 109.52 -179.783 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -88.53 140.32 29.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.226 -0.921 . . . . 2.35 109.119 -179.906 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.517 HG21 ' HG3' ' A' ' 39' ' ' GLU . 3.3 pt -94.39 164.43 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.885 -1.134 . . . . 0.97 109.746 -179.819 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.0 p -95.42 169.86 9.76 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.412 -0.958 . . . . 1.17 108.412 178.918 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.34 -13.24 49.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.952 -1.092 . . . . 1.18 110.085 -179.769 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -88.59 -30.33 19.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.868 -1.145 . . . . 2.56 108.977 179.576 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -82.64 -7.73 59.63 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.758 -0.83 . . . . 1.79 108.758 179.556 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 t -59.98 -51.96 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.24 -0.913 . . . . 1.0 108.832 179.613 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -60.01 -39.03 84.38 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.29 -0.882 . . . . 1.77 109.292 179.612 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -67.26 -41.8 84.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.053 -1.029 . . . . 2.7 110.915 -178.816 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.517 ' HG3' HG21 ' A' ' 31' ' ' ILE . 63.2 mm-40 -64.47 -40.08 95.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.597 -1.315 . . . . 1.51 110.181 -179.435 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.13 -47.02 93.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 120.622 -1.299 . . . . 0.93 108.449 179.242 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -59.89 -40.16 87.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 1.81 109.538 -179.777 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -60.02 -43.34 95.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.749 -1.219 . . . . 2.78 108.268 178.523 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.424 ' CE1' HD13 ' A' ' 89' ' ' ILE . 69.5 t80 -60.13 -49.31 78.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.344 -0.848 . . . . 0.78 108.907 178.59 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 21.0 tp -59.98 -49.04 79.23 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.762 -0.586 . . . . 1.07 109.453 -179.825 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 22.2 t -63.27 -46.13 88.24 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.43 -0.908 . . . . 1.12 109.033 179.121 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.19 -48.1 87.61 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.415 -1.874 . . . . 0.84 108.415 179.443 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 -60.61 -38.1 83.58 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.302 -0.999 . . . . 3.09 108.302 178.689 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -50.35 -42.16 52.61 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.382 -0.599 . . . . 0.88 109.382 -179.527 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.434 ' O ' ' C ' ' A' ' 50' ' ' ALA . 19.8 ttmt -66.99 -73.73 0.13 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.869 -1.16 . . . . 2.59 107.869 178.952 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.31 -39.91 0.48 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.516 -0.74 . . . . 0.7 111.01 -178.825 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.8 t -51.77 -61.72 2.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.769 -1.207 . . . . 1.4 109.368 179.797 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.87 82.94 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.391 -0.818 . . . . 0.67 111.41 -178.56 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -62.73 -40.69 97.99 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.854 -1.154 . . . . 1.66 110.063 -178.716 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.41 -40.05 95.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.113 -0.992 . . . . 1.58 109.695 -179.839 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -62.2 -37.64 86.09 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.341 -0.85 . . . . 1.35 109.285 -179.773 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.6 m -65.15 -42.7 93.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.77 109.174 -179.918 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.26 -39.91 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.21 -0.931 . . . . 0.63 109.334 179.876 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -58.87 -49.95 75.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.166 -0.959 . . . . 1.14 109.958 -179.06 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.8 m -56.65 -35.63 68.6 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.021 -1.049 . . . . 0.79 110.018 -178.198 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -65.7 -37.05 85.38 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.199 -0.938 . . . . 1.53 108.896 -179.844 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.433 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.87 -49.03 64.37 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.349 0.595 . . . . 0.57 110.215 179.82 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.97 -51.83 54.89 Favored Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.837 -1.173 . . . . 0.75 110.319 -178.937 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -70.13 -40.74 74.64 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.167 -1.196 . . . . 1.59 110.322 -179.44 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.9 m -69.95 -61.39 1.8 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.028 -1.045 . . . . 0.73 112.38 -177.532 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -93.74 -47.52 6.74 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.831 -1.168 . . . . 0.75 111.036 -177.752 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.73 -168.72 25.48 Favored Glycine 0 N--CA 1.5 2.934 0 C-N-CA 119.848 -1.167 . . . . 1.22 111.238 179.612 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -68.6 -26.41 65.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.824 -0.81 . . . . 5.81 110.359 -179.586 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -60.54 -35.22 75.49 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.331 -0.855 . . . . 3.37 110.484 -179.598 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -96.07 -19.07 19.71 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.105 -0.997 . . . . 1.77 110.117 -179.743 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -69.27 -40.94 77.5 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.704 -1.248 . . . . 1.65 109.665 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.566 ' CB ' HH11 ' B' ' 317' ' ' ARG . . . -67.07 -36.46 82.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.44 -0.788 . . . . 0.77 110.67 -178.597 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 77.2 mt -60.69 -43.66 95.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.697 -1.252 . . . . 0.8 109.006 179.643 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 10.8 m-85 -70.29 -33.31 71.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 0.88 109.581 179.776 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -63.98 -40.03 95.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.023 -1.048 . . . . 1.37 109.731 179.475 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.29 -39.86 91.99 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.013 -1.635 . . . . 0.62 109.013 179.426 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -60.19 -48.85 80.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.431 -1.041 . . . . 1.5 109.38 -179.908 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -66.52 -45.28 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 0.63 109.764 179.929 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.1 ttp -60.35 -40.16 89.75 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.099 -1.001 . . . . 1.51 109.27 -178.918 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.874 HD11 ' CE2' ' B' ' 348' ' ' PHE . 25.1 tp -61.13 -35.9 78.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.77 108.689 178.709 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.8 tp -67.96 -30.26 69.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.496 -0.753 . . . . 0.62 109.514 179.968 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -83.43 4.64 26.77 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.21 -0.932 . . . . 1.47 110.336 -179.483 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 57.1 t0 -56.83 130.57 46.26 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.974 -1.079 . . . . 1.47 111.212 -178.651 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.423 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 47.7 mt-10 -61.07 -18.59 58.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.929 -0.482 . . . . 1.78 111.179 -179.223 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -72.71 -34.33 67.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.625 -1.297 . . . . 2.53 108.813 178.877 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.1 mt -69.77 -43.1 72.87 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.353 0.597 . . . . 0.8 111.002 -179.252 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -62.74 -42.06 99.48 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.348 -0.845 . . . . 1.42 111.17 -178.032 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -70.12 -42.58 72.44 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.833 -1.167 . . . . 1.71 111.619 -178.289 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -68.16 -38.29 81.93 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.196 -0.94 . . . . 1.57 111.855 -177.87 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.424 HD13 ' CE1' ' A' ' 43' ' ' PHE . 96.8 mt -66.53 -42.29 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.67 -1.269 . . . . 0.65 109.445 -179.759 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.3 mt -70.04 -39.93 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 0.82 110.616 179.606 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.95 -43.06 96.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.25 -0.906 . . . . 0.79 111.748 -178.104 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.3 mt -63.68 -46.56 84.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.585 -1.322 . . . . 0.95 109.632 -179.357 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -59.84 -49.53 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 122.038 0.923 . . . . 0.66 109.434 179.531 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -70.04 -40.23 75.28 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 120.079 -0.649 . . . . 2.2 111.099 -179.635 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -81.86 -55.79 4.38 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.753 -1.217 . . . . 1.65 112.278 -178.346 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -90.04 -1.26 57.93 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.91 -1.119 . . . . 2.03 112.425 -177.03 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 59.57 40.07 20.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.842 -1.162 . . . . 1.42 110.082 179.377 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 79.1 mtp -95.27 167.21 11.49 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.31 -0.868 . . . . 1.18 109.656 -179.72 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 56.6 p -81.5 160.15 24.01 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.276 -0.89 . . . . 0.98 109.04 179.635 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.82 -39.79 94.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.895 . . . . 0.64 110.268 -179.639 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -69.3 -33.42 73.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.027 -1.046 . . . . 2.07 109.278 -179.619 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.73 -41.06 24.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -0.963 . . . . 0.73 109.377 179.442 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.47 -45.7 61.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.311 -0.868 . . . . 0.54 110.197 -179.813 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.37 -33.4 75.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.125 -0.985 . . . . 0.56 109.355 179.979 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -59.82 -44.94 93.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.568 -0.707 . . . . 1.54 109.958 -179.822 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -60.19 -40.29 89.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 1.33 110.966 -179.2 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.04 -65.95 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.239 -0.913 . . . . 0.72 112.38 -177.413 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.407 HG21 ' CA ' ' A' ' 134' ' ' GLY . 43.2 mm -68.78 -41.0 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.788 -1.195 . . . . 0.85 110.236 -178.446 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -67.79 -31.57 71.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.213 -0.93 . . . . 2.44 108.651 179.731 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.8 -46.61 66.32 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.917 -1.273 . . . . 0.98 109.917 -179.761 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -60.29 -50.33 74.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.929 -1.336 . . . . 1.41 110.048 -179.292 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.89 -36.08 74.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.371 -0.831 . . . . 1.2 109.84 179.839 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.2 t -59.72 -42.39 92.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.955 -1.091 . . . . 1.7 108.518 -179.893 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.4 94.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -0.838 . . . . 1.47 109.024 179.249 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.5 mt -62.07 -41.22 97.93 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.407 -0.808 . . . . 1.56 109.617 -179.495 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.93 -31.91 67.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.069 -1.019 . . . . 2.2 109.657 -179.387 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -60.16 -26.22 66.14 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.212 -0.93 . . . . 2.12 108.947 179.684 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.402 HD13 HD13 ' A' ' 123' ' ' LEU . 31.6 mt -61.72 144.8 54.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.142 -0.974 . . . . 2.0 108.913 -179.56 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -98.36 51.59 1.01 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.027 -1.046 . . . . 3.23 109.538 179.668 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 61.7 t0 -134.27 132.83 40.09 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.445 -0.784 . . . . 2.49 109.321 179.89 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.404 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 83.9 tt0 -69.95 -31.94 69.94 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.475 -0.766 . . . . 3.95 109.865 -179.836 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.454 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.3 t80 -70.09 -36.88 75.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.535 -0.728 . . . . 2.0 111.075 -179.679 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.464 HD22 ' O ' ' B' ' 351' ' ' GLN . 79.7 mt -78.56 -37.81 41.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.047 -1.033 . . . . 1.86 109.701 -179.703 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -60.14 -48.99 79.39 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.109 -0.994 . . . . 2.84 109.957 179.849 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.76 -39.78 92.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.085 -1.009 . . . . 2.73 109.091 179.956 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.619 HH21 HD11 ' B' ' 347' ' ' LEU . 65.8 ttt180 -60.13 -40.04 88.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 2.77 108.711 179.824 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' VAL . . . -59.54 -47.93 83.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.932 -1.105 . . . . 1.19 108.543 179.496 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 127' ' ' ALA . . . -43.65 -39.12 3.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.669 -0.645 . . . . 1.2 109.299 179.89 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -66.11 -42.72 88.83 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.213 -0.93 . . . . 1.55 108.604 179.197 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 127' ' ' ALA . 55.4 t -69.9 -40.32 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.34 -0.85 . . . . 0.8 108.926 178.776 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -59.97 -39.13 84.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.378 -0.826 . . . . 3.09 109.033 179.25 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -59.98 -39.8 86.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.516 -0.74 . . . . 1.46 110.377 -179.559 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.8 mt -59.64 -41.25 84.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.907 -1.121 . . . . 0.71 108.98 -179.234 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.407 ' CA ' HG21 ' A' ' 108' ' ' ILE . . . -67.24 -37.65 91.19 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.931 -1.267 . . . . 0.57 109.931 179.516 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.63 -49.02 78.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.181 -1.188 . . . . 2.59 111.027 -178.872 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -66.62 -29.48 69.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.897 -1.127 . . . . 2.83 109.423 -179.445 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.8 tp -59.59 -41.76 90.99 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.72 -0.844 . . . . 1.25 108.72 -178.967 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.36 -39.9 94.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 0.7 108.55 179.226 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -68.75 -39.6 80.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.361 -0.837 . . . . 2.57 109.329 178.704 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -65.65 -34.46 78.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.452 -0.78 . . . . 1.23 110.84 -179.42 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 91.1 mt -70.44 -42.6 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 120.737 -1.227 . . . . 0.81 108.092 179.071 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.36 -33.74 71.8 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.118 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.24 43.63 5.55 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 108.129 -1.988 . . . . 0.89 108.129 -178.901 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.4 tp -75.15 150.84 38.63 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.644 -0.915 . . . . 1.14 110.263 -178.866 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.435 ' HD3' ' N ' ' A' ' 146' ' ' ILE . 9.6 tmtm? -69.61 149.31 48.28 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.722 -0.844 . . . . 4.6 108.722 179.464 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.435 ' N ' ' HD3' ' A' ' 145' ' ' LYS . 86.8 mt -119.81 125.14 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 121.933 0.873 . . . . 1.24 109.036 178.881 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.445 HG12 ' H ' ' A' ' 147' ' ' ILE . 6.3 mm -49.42 -54.76 5.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.624 -0.673 . . . . 1.54 109.762 -178.485 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.8 t0 69.39 104.23 0.06 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.547 -0.72 . . . . 1.5 110.59 -179.903 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.562 ' O ' HD12 ' A' ' 152' ' ' ILE . 95.9 mt -74.44 -7.18 52.11 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.524 -0.735 . . . . 0.79 109.977 179.84 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.0 t -81.45 -16.83 50.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.148 -0.97 . . . . 1.4 109.485 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.16 23.43 0.58 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.533 -0.729 . . . . 0.92 110.196 -178.543 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 149' ' ' LEU . 63.9 mt -92.2 115.24 30.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.133 -0.979 . . . . 0.88 109.738 -179.085 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -100.66 -15.24 17.81 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.251 -0.906 . . . . 2.45 109.63 -179.83 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -118.19 145.86 44.64 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.498 -0.556 . . . . 1.52 109.498 -178.988 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.08 136.48 57.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 1.58 109.346 -179.739 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 26.9 m -151.6 163.3 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 109.328 -0.619 . . . . 0.69 109.328 179.99 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 82.3 mt -91.78 146.71 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 106.177 -1.786 . . . . 0.61 106.177 177.266 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.2 tp -99.01 118.96 36.96 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.022 -1.049 . . . . 0.87 110.423 -178.194 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.5 t -123.31 129.98 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.489 -0.93 . . . . 0.71 108.489 179.727 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.0 159.37 40.28 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.136 -0.977 . . . . 0.81 108.551 -179.839 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.45 -33.43 64.9 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.23 -1.544 . . . . 0.98 107.932 178.523 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -168.3 136.87 2.29 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.329 -0.989 . . . . 2.25 108.329 179.959 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 62.9 mt -106.8 138.68 42.53 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.247 -0.908 . . . . 0.78 109.565 -179.496 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.9 p -94.05 153.56 40.77 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.47 -0.769 . . . . 0.98 109.02 -179.838 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.04 -34.84 9.61 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.635 1.557 . . . . 0.81 111.952 179.222 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.1 m -58.65 -40.25 82.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.9 110.305 -178.306 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -68.04 -42.58 80.33 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.282 -0.886 . . . . 1.61 110.716 -179.302 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.5 p -53.88 -31.74 50.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.047 -1.033 . . . . 0.61 110.546 -178.264 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . . . -72.52 -54.58 8.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.951 -1.093 . . . . 0.6 109.682 179.689 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -85.4 40.74 0.85 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.999 -1.112 . . . . 1.4 107.999 179.81 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.84 133.0 47.3 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.888 -0.782 . . . . 0.7 108.888 179.083 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -89.69 102.14 14.83 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.334 -0.987 . . . . 2.35 108.334 179.348 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.94 -44.78 88.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.461 -0.775 . . . . 1.51 110.908 -178.294 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -70.18 -22.61 62.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.868 -1.145 . . . . 2.33 111.88 -178.337 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -93.56 -10.37 34.98 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.55 -1.344 . . . . 1.92 110.274 -178.465 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 178' ' ' GLY . 94.3 t -106.76 117.22 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.232 -0.918 . . . . 0.67 109.274 179.568 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 51.4 mt -83.55 4.31 28.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.43 -0.794 . . . . 1.53 110.985 -177.817 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.557 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.72 172.12 36.71 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.561 -1.416 . . . . 0.48 109.561 -179.806 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.51 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 25.3 m-85 -132.56 129.15 38.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.508 -0.995 . . . . 0.55 108.75 179.901 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.0 mt -129.98 126.05 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.687 -1.227 . . . . 0.65 107.687 178.426 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.4 p -143.51 157.37 44.49 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.379 1.085 . . . . 0.82 111.397 -179.007 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 64.4 t0 -94.61 18.06 12.16 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.783 -0.644 . . . . 2.46 109.265 179.878 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 183' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -54.3 -164.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.529 -1.357 . . . . 1.28 111.701 -178.025 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.37 -42.39 5.53 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.607 -0.806 . . . . 2.19 111.306 -178.395 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 175.83 -149.77 10.26 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 118.429 -1.843 . . . . 2.13 111.242 -179.539 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.428 ' N ' ' CD ' ' A' ' 186' ' ' ARG . 0.2 OUTLIER -70.11 -18.3 63.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.813 -0.816 . . . . 5.86 110.558 -178.956 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 82.5 p -69.97 -1.82 10.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.02 -1.05 . . . . 3.72 110.003 -179.177 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.3 m -84.92 130.72 34.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 1.74 110.419 -179.157 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -44.93 -55.38 5.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.524 -0.735 . . . . 0.95 110.224 -179.748 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 191' ' ' SER . 8.8 t -58.07 -39.67 79.1 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.411 -0.806 . . . . 1.55 110.721 -178.992 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.427 ' N ' HG23 ' A' ' 190' ' ' THR . 23.3 t -61.55 -40.53 95.03 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.953 -1.092 . . . . 1.51 110.797 -179.298 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.88 -40.01 81.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.235 -0.915 . . . . 1.67 109.614 -179.521 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.2 -40.22 89.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.856 . . . . 1.02 110.197 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.53 88.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.455 -1.403 . . . . 0.68 109.12 -179.735 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -59.92 -50.18 74.77 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.073 -1.051 . . . . 2.93 109.396 -179.297 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 37.1 m -70.41 -35.42 73.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.158 -0.964 . . . . 0.86 110.98 -178.989 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 74.1 mt -70.27 -24.74 63.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.922 -1.111 . . . . 0.67 109.185 179.996 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 66.45 49.89 1.34 Allowed 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.273 0.559 . . . . 1.5 110.828 -179.323 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 199' ' ' LEU . . . . . 0.4 ' O ' ' CB ' ' A' ' 8' ' ' SER . 78.6 mt -127.23 149.71 70.37 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 107.504 -1.295 . . . . 0.72 107.504 178.18 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.97 139.12 71.91 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.17 1.914 . . . . 0.61 112.091 -179.7 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.51 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -170.17 147.23 3.12 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.955 -1.091 . . . . 0.66 110.995 -179.749 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 90.5 mt -120.04 139.1 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 106.842 -1.54 . . . . 0.79 106.842 178.223 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.05 -12.22 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 120.602 -1.311 . . . . 0.91 111.427 -178.238 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.74 26.13 16.92 Favored Glycine 0 N--CA 1.502 3.052 0 N-CA-C 110.898 -0.881 . . . . 1.01 110.898 -179.121 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.8 p -44.25 -38.36 3.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.972 -1.311 . . . . 0.99 110.573 -179.179 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.455 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 88.09 -50.47 3.9 Favored Glycine 0 N--CA 1.502 3.064 0 C-N-CA 120.201 -1.0 . . . . 1.12 111.302 179.337 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.2 m -162.67 41.48 0.12 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.491 -1.594 . . . . 1.72 111.157 -179.381 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.5 t -80.24 -37.81 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.988 -1.07 . . . . 0.89 109.085 178.42 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.5 p -58.92 -33.09 70.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.571 -0.706 . . . . 1.03 110.048 -178.862 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.1 m -76.59 -18.42 58.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.332 -0.855 . . . . 1.83 110.157 -178.977 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -102.84 -9.66 19.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.324 -0.86 . . . . 2.27 110.241 -179.144 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 55.2 t -102.01 140.32 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.003 -1.061 . . . . 0.92 110.545 -179.122 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -109.29 150.07 28.52 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.704 -1.221 . . . . 2.2 107.704 178.988 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 19.2 p30 -60.61 138.89 58.0 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.86 -1.15 . . . . 2.36 109.947 -179.52 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.481 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.5 t0 81.17 9.61 0.98 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.303 0.573 . . . . 2.38 109.615 179.466 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.2 t0 -79.06 141.78 37.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.377 -0.827 . . . . 2.09 108.936 179.11 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.519 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 47.3 t80 -88.0 121.75 30.78 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.152 -0.967 . . . . 1.27 108.873 -179.992 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' A' ' 16' ' ' ALA . 85.9 mt -130.01 150.19 51.4 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.37 -0.832 . . . . 0.75 110.886 -179.021 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.49 HG23 ' CD2' ' A' ' 13' ' ' PHE . 73.1 mt -117.4 128.73 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.379 -1.711 . . . . 0.63 106.379 176.951 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 44.1 tp -101.05 116.65 33.35 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.977 -1.077 . . . . 0.7 109.438 -178.731 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.511 ' C ' ' H ' ' A' ' 223' ' ' VAL . 85.9 m-20 -74.45 -44.8 50.02 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.447 -0.946 . . . . 2.31 108.447 179.092 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 50.92 11.41 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.808 -0.812 . . . . 0.78 108.808 -179.656 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 221' ' ' ASP . 54.7 t -126.95 -43.11 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 106.859 -1.534 . . . . 1.04 106.859 178.702 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -100.42 -0.01 38.94 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.728 -1.212 . . . . 2.44 107.728 178.611 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.417 ' CG ' ' H ' ' A' ' 4' ' ' GLY . 6.1 t-20 60.56 42.0 14.74 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.3 -0.63 . . . . 1.55 109.3 -179.442 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -138.14 142.9 40.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.287 -0.883 . . . . 1.99 109.238 179.735 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 80.3 t -118.57 120.87 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 108.925 -0.769 . . . . 0.77 108.925 179.57 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -88.69 128.94 35.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.153 -0.967 . . . . 0.98 109.351 -179.438 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.45 114.06 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.735 -0.603 . . . . 0.85 110.244 -179.111 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 45.4 t30 50.97 63.75 9.3 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.33 -0.856 . . . . 1.66 111.509 179.064 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -85.83 148.39 9.58 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.38 2.053 . . . . 0.95 112.103 178.958 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 233' ' ' ASN . 39.5 m -67.98 158.17 33.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.288 -0.883 . . . . 1.84 110.077 -179.473 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 47.7 p-10 -59.97 -37.9 80.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.312 -0.867 . . . . 2.74 110.679 -178.991 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 234' ' ' GLU . . . . . 0.544 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 99.0 mt-10 -59.82 -37.03 78.04 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.791 -1.193 . . . . 2.89 107.859 -179.998 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.9 t -70.04 -39.9 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.546 -0.721 . . . . 1.3 109.45 179.095 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.1 mt . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.109 -0.994 . . . . 1.09 108.966 179.533 . . . . . . . . 0 0 . 1 . 035 nuclear build core ' B' B ' 301' ' ' MET . . . . . 0.405 ' HG2' ' N ' ' B' ' 302' ' ' PHE . 57.1 ttm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 302' ' ' PHE . . . . . 0.405 ' N ' ' HG2' ' B' ' 301' ' ' MET . 41.4 t80 -149.05 147.71 28.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -0.922 . . . . 0.0 108.962 179.501 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -150.86 160.06 44.14 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.98 -1.075 . . . . 0.0 111.124 -178.366 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -154.66 152.48 30.02 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.566 -0.708 . . . . 0.0 109.199 178.861 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 305' ' ' GLU . . . . . 0.428 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 58.1 mp0 -113.89 131.01 56.44 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.311 -0.868 . . . . 0.0 110.266 179.842 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.0 p -131.95 126.78 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 CA-C-O 122.522 1.153 . . . . 0.0 112.995 -177.899 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 32.2 m -79.27 102.43 8.58 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 122.023 0.916 . . . . 0.0 110.772 -178.724 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.5 mt -51.37 125.0 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 122.552 1.168 . . . . 0.0 110.853 -177.878 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 33.2 p -109.73 20.09 18.45 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.602 -179.249 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.434 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -67.47 149.11 98.52 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.11 -0.994 . . . . 0.0 108.582 179.366 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 311' ' ' PRO . . . . . 0.449 ' CD ' ' O ' ' B' ' 385' ' ' GLU . 28.9 Cg_endo -72.28 -30.38 12.99 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.112 1.208 . . . . 0.0 113.138 -179.622 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -120.26 23.16 11.07 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.778 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.59 -177.58 52.74 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.266 -1.933 . . . . 0.0 108.266 -179.028 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.454 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -84.38 93.32 8.24 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.96 -1.317 . . . . 0.0 109.484 -179.013 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -98.01 -159.52 0.74 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.044 -1.035 . . . . 0.0 109.536 178.971 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.5 m -60.06 -49.97 75.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.559 -1.338 . . . . 0.0 112.16 -176.459 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.566 HH11 ' CB ' ' A' ' 71' ' ' ALA . 11.9 tpt180 -47.35 -60.31 4.24 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.653 -1.279 . . . . 0.0 111.133 -179.104 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -61.56 -31.35 87.2 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 CA-C-N 120.559 1.235 . . . . 0.0 111.02 179.022 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.02 -53.79 53.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.399 -0.813 . . . . 0.0 109.485 -179.737 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.86 -42.67 62.8 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.074 -178.951 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.79 -39.94 76.29 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.024 -1.047 . . . . 0.0 108.784 179.243 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -65.71 -55.75 15.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 109.936 -179.485 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 323' ' ' VAL . . . . . 0.458 ' CG1' ' NZ ' ' B' ' 327' ' ' LYS . 41.3 t -64.13 -30.95 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.585 -1.322 . . . . 0.0 110.278 -178.704 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -60.44 -46.29 90.57 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.994 -1.066 . . . . 0.0 109.763 179.9 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -61.89 -44.35 96.97 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.326 -0.859 . . . . 0.0 111.072 -178.569 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -66.03 -52.17 51.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.988 -1.07 . . . . 0.0 111.691 -178.412 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 327' ' ' LYS . . . . . 0.458 ' NZ ' ' CG1' ' B' ' 323' ' ' VAL . 32.2 mttp -49.29 -18.07 0.32 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.007 -1.058 . . . . 0.0 110.744 -178.789 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -80.13 -16.57 76.31 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 178.882 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -104.02 136.72 43.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.693 -0.886 . . . . 0.0 109.532 179.825 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 76.8 p -91.49 -13.42 32.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.398 -0.814 . . . . 0.0 109.939 179.727 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.589 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 69.3 m -60.94 150.25 33.89 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.268 -0.895 . . . . 0.0 109.848 -179.982 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -69.33 136.21 51.48 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.682 179.389 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 80.7 mt -133.63 132.43 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.315 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 81.5 m -130.34 151.15 51.15 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.296 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 67.3 t -115.73 142.07 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.535 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 50.5 m -130.84 122.86 27.84 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.264 -0.897 . . . . 0.0 109.662 179.37 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 337' ' ' SER . . . . . 0.4 ' O ' ' OD1' ' B' ' 338' ' ' ASN . 2.6 t -137.16 118.63 14.78 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.031 0.919 . . . . 0.0 109.698 179.536 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 338' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' B' ' 338' ' ' ASN . 8.2 p-10 38.0 62.97 0.87 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.079 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 77.25 -14.18 8.91 Favored Glycine 0 N--CA 1.503 3.143 0 O-C-N 120.83 -1.169 . . . . 0.0 113.521 175.873 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -110.29 121.72 45.96 Favored 'General case' 0 N--CA 1.507 2.376 0 CA-C-N 119.056 1.428 . . . . 0.0 110.277 -179.733 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 83.3 p -109.06 157.65 18.5 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.774 0.797 . . . . 0.0 110.924 -179.082 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -152.54 151.93 31.27 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.821 -0.549 . . . . 0.0 109.925 179.58 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 16.1 m -87.64 136.21 33.04 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.303 -0.873 . . . . 0.0 109.61 -179.96 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -76.91 -14.67 59.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.951 -1.093 . . . . 0.0 110.095 -179.445 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -88.77 20.79 3.31 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 178.441 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 346' ' ' SER . . . . . 0.412 ' H ' ' C ' ' B' ' 344' ' ' ALA . 74.0 m -147.36 91.4 1.97 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.727 179.797 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.665 HD23 HD22 ' A' ' 79' ' ' LEU . 57.8 tp -57.04 -35.28 69.12 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.584 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.874 ' CE2' HD11 ' A' ' 79' ' ' LEU . 70.8 m-85 -56.18 -53.95 51.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.922 . . . . 0.0 109.88 179.787 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -70.17 -21.31 63.07 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.577 -0.702 . . . . 0.0 111.045 -177.64 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' B' ' 352' ' ' THR . 77.9 mt -67.48 -50.82 57.31 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 118.314 -1.354 . . . . 0.0 108.648 178.526 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.464 ' O ' HD22 ' A' ' 123' ' ' LEU . 17.5 mt-30 -46.07 -12.83 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.424 -0.798 . . . . 0.0 111.47 -177.741 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.487 ' N ' ' O ' ' B' ' 350' ' ' LEU . 67.3 p -85.73 -16.51 38.71 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 119.912 -1.743 . . . . 0.0 111.466 -178.509 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 29.4 mt -92.05 122.23 34.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.737 -1.227 . . . . 0.0 108.834 178.707 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.99 92.52 0.93 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 179.423 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 16.7 mt -101.26 93.72 5.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.417 -1.049 . . . . 0.0 108.755 179.949 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 71.0 p -92.79 177.05 6.21 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.939 -1.101 . . . . 0.0 111.316 -178.844 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 357' ' ' GLN . . . . . 0.409 ' CD ' ' O ' ' B' ' 310' ' ' ALA . 7.5 tt0 -65.49 113.23 4.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.81 -0.556 . . . . 0.0 110.787 -179.703 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 358' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 99.18 9.63 50.9 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.419 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 24.0 m -85.88 113.1 21.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.335 -1.097 . . . . 0.0 110.313 -179.79 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 11.0 t -78.07 114.45 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 122.307 1.051 . . . . 0.0 109.961 -177.073 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 14.0 m -110.49 177.16 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.91 -177.856 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 40.8 m -130.98 126.89 37.21 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.232 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 83.7 mt -103.63 118.03 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.487 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 49.0 m -122.93 133.65 54.38 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.552 -0.717 . . . . 0.0 109.249 -178.88 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.49 151.61 38.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.095 -1.003 . . . . 0.0 110.496 -178.738 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -140.64 120.72 13.73 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.414 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.412 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 164.08 -164.55 36.62 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 118.57 -1.776 . . . . 0.0 111.778 179.455 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -56.53 -50.03 73.02 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.939 -0.631 . . . . 0.0 111.743 -177.889 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.589 ' N ' ' OG ' ' B' ' 331' ' ' SER . 99.6 m-20 -109.87 11.8 24.11 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.033 -1.042 . . . . 0.0 111.574 -177.857 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 11.8 pt-20 -42.23 -31.96 0.44 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.946 -1.096 . . . . 0.0 111.212 -178.877 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -70.06 -43.04 72.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.816 -1.178 . . . . 0.0 110.347 -178.81 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -67.7 -47.97 67.89 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.78 -1.2 . . . . 0.0 108.666 -179.905 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.44 -77.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 110.113 -179.914 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.582 ' O ' HG23 ' B' ' 378' ' ' VAL . 51.2 t -45.18 -38.79 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.213 -0.93 . . . . 0.0 109.751 -178.19 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -67.63 -42.44 82.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.65 -1.281 . . . . 0.0 110.099 179.221 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -82.18 -45.41 15.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.121 -0.987 . . . . 0.0 110.481 -179.83 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 97.8 mt -59.91 -36.51 77.15 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.11 -0.994 . . . . 0.0 109.303 -179.054 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.582 HG23 ' O ' ' B' ' 374' ' ' VAL . 53.5 t -69.95 -39.58 77.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 121.524 -0.735 . . . . 0.0 109.907 -179.989 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -79.18 -22.47 44.93 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.009 -1.057 . . . . 0.0 110.859 179.945 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 55.9 tp -82.25 -20.8 36.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.204 -1.56 . . . . 0.0 108.697 178.561 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.0 ttm -81.1 -30.75 34.56 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.161 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -84.34 -9.63 58.29 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.637 -0.665 . . . . 0.0 109.521 178.59 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -106.32 -2.01 22.76 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.316 -0.865 . . . . 0.0 110.919 -179.188 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 22.1 mt -91.53 124.9 36.05 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.949 -1.095 . . . . 0.0 110.636 -179.338 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' B' B ' 385' ' ' GLU . . . . . 0.449 ' O ' ' CD ' ' B' ' 311' ' ' PRO . 19.1 pt-20 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 118.017 -0.992 . . . . 0.0 108.755 178.675 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.519 -0.549 . . . . 2.91 109.519 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.9 mt -110.04 127.65 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.479 -0.934 . . . . 1.2 108.479 179.553 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.3 m -128.57 126.43 40.3 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.551 -0.718 . . . . 1.4 109.512 -179.343 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.79 -161.97 34.65 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.311 -1.516 . . . . 1.05 109.311 179.6 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.5 mt -88.75 -14.42 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -1.195 . . . . 1.15 110.316 -179.367 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.6 tp 52.67 100.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.07 -1.019 . . . . 0.98 109.07 -179.794 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.09 -28.33 12.76 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.113 -0.992 . . . . 0.88 109.267 179.388 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.9 m -132.08 115.31 15.27 Favored Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 109.111 -0.7 . . . . 1.69 109.111 -179.659 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.38 147.98 18.35 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.018 1.812 . . . . 0.85 112.964 -179.685 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.862 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.33 -156.04 26.59 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.606 -1.797 . . . . 0.92 108.606 -179.51 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.4 mt -149.0 151.06 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 120.904 -1.351 . . . . 0.81 108.866 178.68 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.58 156.62 36.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.048 -1.033 . . . . 0.51 110.241 179.397 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.2 m-85 -137.87 127.37 24.94 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.762 -1.199 . . . . 0.62 107.762 179.1 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.98 178.86 48.74 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 118.591 -1.766 . . . . 0.55 110.913 179.947 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -78.39 156.42 29.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.979 -0.719 . . . . 2.1 109.898 -179.525 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.54 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -100.32 129.98 46.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.43 -0.794 . . . . 0.77 110.844 -179.11 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.2 tp -105.98 134.59 48.86 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.469 -1.308 . . . . 0.91 107.469 178.286 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.9 tp -115.77 123.81 49.18 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.381 -0.824 . . . . 0.93 110.091 -179.419 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 160' ' ' ALA . 25.5 mt -81.96 100.57 9.75 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 120.035 -0.666 . . . . 0.93 109.421 179.92 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -94.55 138.26 32.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.259 -0.901 . . . . 2.75 109.706 -179.667 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 58.0 mp0 -130.37 136.79 49.45 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.478 -0.764 . . . . 3.0 109.136 179.206 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -84.31 147.32 27.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 2.77 109.494 179.664 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.89 145.51 55.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.9 . . . . 2.94 109.671 -179.811 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.2 mt -98.41 132.73 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.396 -0.815 . . . . 0.95 109.372 179.888 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.6 t -106.81 128.25 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.427 -0.796 . . . . 1.28 109.84 -179.475 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.1 mt -98.36 142.42 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.494 -0.754 . . . . 1.21 109.134 179.976 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -83.6 123.77 30.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.985 -1.072 . . . . 1.81 109.056 179.834 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -93.47 -6.91 45.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.249 -0.907 . . . . 2.8 109.479 -179.64 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.71 138.55 52.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 2.87 109.594 -179.727 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -83.75 155.31 23.13 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.202 -1.036 . . . . 2.35 108.202 179.136 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.689 HD13 ' HG3' ' A' ' 39' ' ' GLU . 3.1 pt -99.04 165.66 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.071 -1.018 . . . . 0.97 109.936 -179.947 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.4 p -91.76 173.55 7.81 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.603 -0.888 . . . . 1.17 108.603 178.712 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.62 -15.47 63.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.134 -0.979 . . . . 1.18 110.696 -179.479 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 60.0 t0 -83.69 -30.67 26.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.822 -1.173 . . . . 2.56 108.842 179.47 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -82.65 -6.84 59.59 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.42 -0.585 . . . . 1.79 109.42 179.992 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 t -60.01 -51.81 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.182 -0.949 . . . . 1.0 109.254 179.949 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -60.14 -39.84 87.73 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.231 -0.918 . . . . 1.77 108.78 179.832 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -63.68 -40.23 96.3 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.308 -0.87 . . . . 2.7 110.133 -179.723 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.689 ' HG3' HD13 ' A' ' 31' ' ' ILE . 71.0 mm-40 -64.39 -41.55 96.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.847 -1.158 . . . . 1.51 110.28 -179.778 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.8 t -59.99 -45.7 95.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 120.671 -1.268 . . . . 0.93 108.085 179.996 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -59.89 -42.43 93.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.368 -0.833 . . . . 1.81 108.934 -179.78 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.433 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 96.6 mtt180 -60.04 -47.56 85.35 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.846 -1.168 . . . . 2.78 107.846 178.49 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -60.02 -45.22 93.51 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.202 -0.666 . . . . 0.78 109.202 178.897 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.92 -50.07 75.19 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.311 -0.996 . . . . 1.07 108.311 179.661 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -60.45 -42.71 96.7 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.277 -0.889 . . . . 1.12 108.997 179.081 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.18 -47.71 89.6 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.549 -1.421 . . . . 0.84 109.549 179.99 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -69.73 -31.66 69.78 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.284 -1.127 . . . . 3.09 108.402 179.337 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.65 89.71 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.566 -0.709 . . . . 0.88 109.12 -179.988 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.4 ttpt -67.25 -73.77 0.13 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.196 -0.94 . . . . 2.59 108.787 179.333 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.29 -41.81 0.65 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.325 -0.86 . . . . 0.7 111.265 -178.356 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.8 m -52.2 -57.87 8.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.587 -1.321 . . . . 1.4 109.106 179.873 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.64 -40.97 84.57 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.218 -0.926 . . . . 0.67 110.836 -179.267 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -68.14 -40.33 82.47 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.982 -1.074 . . . . 1.66 109.763 -179.693 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.6 mt -61.66 -40.19 94.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.892 -1.13 . . . . 1.58 109.092 179.108 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -64.37 -35.54 81.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 1.35 109.152 179.487 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -62.04 -41.85 98.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.27 -0.894 . . . . 0.77 109.161 179.536 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.533 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.5 mt -64.17 -39.84 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.432 -0.792 . . . . 0.63 109.43 179.622 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -54.35 -51.17 65.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.864 . . . . 1.14 109.826 -178.96 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.3 m -59.94 -37.27 79.04 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.238 -0.914 . . . . 0.79 110.837 -178.317 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -64.14 -39.77 94.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.892 -1.13 . . . . 1.53 109.479 -179.559 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.426 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -66.52 -42.99 86.46 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.762 -0.586 . . . . 0.57 110.125 -179.392 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.38 -51.08 60.98 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.161 -1.176 . . . . 0.75 110.161 -179.174 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.0 -44.81 68.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.114 -1.227 . . . . 1.59 110.043 -179.855 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.0 m -69.91 -59.13 3.12 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 0.73 111.768 -178.248 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -97.3 -54.4 3.16 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.021 -1.049 . . . . 0.75 111.357 -178.056 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.83 -163.41 26.95 Favored Glycine 0 N--CA 1.501 3.006 0 C-N-CA 119.697 -1.239 . . . . 1.22 111.156 179.676 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.25 -23.96 62.99 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.912 -0.758 . . . . 5.81 110.841 -179.385 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -62.03 -39.6 92.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.959 -1.088 . . . . 3.37 110.361 -179.545 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -96.29 -18.85 19.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.228 -0.92 . . . . 1.77 110.434 -179.258 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -72.14 -40.77 67.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.043 -1.036 . . . . 1.65 110.466 -179.118 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.601 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.63 -30.89 70.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 0.77 109.984 -178.953 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.1 -40.27 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 118.82 -1.152 . . . . 0.8 108.822 -179.588 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -64.76 -40.07 94.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.047 -1.033 . . . . 0.88 109.885 -179.899 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -60.38 -40.89 92.49 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.89 -1.131 . . . . 1.37 109.863 179.519 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.9 -40.81 99.73 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.881 -1.688 . . . . 0.62 108.881 179.535 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.7 m170 -70.01 -40.06 75.47 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.396 -1.061 . . . . 1.5 109.208 179.767 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.9 mt -70.9 -46.47 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.383 -0.823 . . . . 0.63 109.986 179.828 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.7 ttp -60.35 -43.65 96.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 1.51 110.563 -178.452 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.687 HD11 ' CE2' ' B' ' 348' ' ' PHE . 44.8 tp -64.77 -39.44 93.61 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.293 -0.879 . . . . 0.77 109.938 -179.947 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.7 tp -63.81 -40.1 95.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.437 -0.79 . . . . 0.62 109.789 -179.72 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -78.87 4.07 15.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 1.47 110.099 -178.795 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 63.5 t0 -52.32 129.87 29.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.167 -0.958 . . . . 1.47 110.38 -179.37 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.423 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.8 mt-10 -60.16 -15.19 21.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.566 -0.709 . . . . 1.78 110.124 -179.982 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.02 -37.03 75.51 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.156 -0.965 . . . . 2.53 108.517 178.578 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.1 mt -69.98 -40.09 75.56 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.37 0.605 . . . . 0.8 109.876 179.426 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.07 -50.05 75.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.46 -0.775 . . . . 1.42 110.265 -178.975 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -74.36 -40.62 62.02 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.393 -0.817 . . . . 1.71 111.224 -178.801 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.92 -41.03 75.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.013 -1.054 . . . . 1.57 111.487 -178.675 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.9 mt -70.15 -46.12 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.857 -1.152 . . . . 0.65 109.445 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.8 mt -65.72 -37.45 79.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.625 -0.672 . . . . 0.82 110.121 -179.841 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.07 90.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.048 -1.033 . . . . 0.79 110.507 -178.829 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.3 mt -62.21 -45.49 93.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.947 -1.095 . . . . 0.95 109.579 -179.781 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.1 mt -62.05 -50.0 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.66 109.596 -179.907 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -71.21 -42.18 69.26 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.681 -0.808 . . . . 2.2 111.385 179.826 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -83.25 -50.42 8.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.952 -1.092 . . . . 1.65 112.197 -177.648 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -90.19 -2.61 58.07 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.871 -1.143 . . . . 2.03 111.474 -177.497 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 56.19 39.02 30.39 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.797 -1.189 . . . . 1.42 109.521 -179.413 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 54.7 mtt -92.04 169.33 10.73 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.44 -0.788 . . . . 1.18 109.652 -179.723 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.9 p -83.82 159.65 21.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.942 . . . . 0.98 108.956 179.514 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.76 -36.8 78.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 0.64 109.801 -179.635 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.433 ' OD1' HG21 ' A' ' 141' ' ' ILE . 95.7 m-20 -68.66 -39.68 80.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -0.97 . . . . 2.07 110.203 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.59 -44.89 18.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.026 -1.046 . . . . 0.73 109.61 179.855 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.75 -50.25 67.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.449 -0.782 . . . . 0.54 110.211 -179.487 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.23 -37.3 79.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.074 -1.017 . . . . 0.56 109.445 179.917 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -59.91 -42.65 94.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.476 -0.765 . . . . 1.54 110.266 -179.013 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 110' ' ' GLY . 88.9 tt0 -64.9 -40.2 94.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.007 -1.058 . . . . 1.33 109.983 -179.634 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 70.1 t -61.74 -53.22 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.21 -0.931 . . . . 0.72 110.53 -178.509 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.1 mm -69.99 -39.98 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.136 -0.978 . . . . 0.85 109.197 179.857 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -68.95 -36.75 78.28 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.486 -0.931 . . . . 2.44 108.486 179.015 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.45 -49.82 72.87 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.061 -1.215 . . . . 0.98 110.061 -179.573 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -68.73 -48.53 63.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.749 -1.442 . . . . 1.41 109.41 -179.874 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.87 92.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 1.2 109.382 179.902 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.5 t -57.43 -39.34 76.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 1.7 109.025 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.04 94.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.313 -0.867 . . . . 1.47 109.393 179.437 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.3 mt -64.26 -42.47 96.45 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.153 -0.967 . . . . 1.56 109.827 -179.06 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.424 ' C ' ' N ' ' A' ' 118' ' ' LEU . 78.6 tt0 -59.87 -38.66 82.79 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.661 -1.274 . . . . 2.2 109.522 -178.659 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -50.08 -17.69 0.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.902 -1.124 . . . . 2.12 109.147 179.671 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.424 ' N ' ' C ' ' A' ' 116' ' ' GLU . 79.4 mt -63.36 146.77 52.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 2.0 108.542 179.585 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -95.83 10.81 35.86 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.086 -1.009 . . . . 3.23 111.439 -178.459 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 57.2 t0 -103.07 148.76 25.32 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.953 -1.092 . . . . 2.49 109.583 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 36.4 tt0 -72.04 -65.75 0.73 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.417 -0.957 . . . . 3.95 108.417 179.096 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.481 ' OH ' ' CZ ' ' A' ' 126' ' ' ARG . 11.2 t80 -39.19 -40.26 0.71 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.783 -0.573 . . . . 2.0 110.442 -179.127 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.537 HD22 ' O ' ' B' ' 351' ' ' GLN . 95.1 mt -70.31 -39.57 74.74 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.86 -1.15 . . . . 1.86 108.95 178.897 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 121' ' ' GLU . 64.4 tttp -60.03 -40.0 87.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.389 -0.819 . . . . 2.84 109.586 -179.882 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -60.02 -39.43 85.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.859 . . . . 2.73 108.828 179.953 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.643 ' NE ' HE22 ' B' ' 351' ' ' GLN . 8.3 mtt180 -59.86 -39.79 86.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.17 -0.956 . . . . 2.77 108.793 179.314 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.38 -25.57 64.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 1.19 108.82 179.313 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.02 -40.03 75.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 1.2 109.39 179.378 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -66.74 -43.08 85.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.985 . . . . 1.55 109.838 179.925 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.5 t -69.9 -40.46 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.977 -1.077 . . . . 0.8 108.616 179.464 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -65.45 -35.67 81.61 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.501 -0.75 . . . . 3.09 109.443 179.51 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -59.97 -40.1 87.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 1.46 109.653 -179.747 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.36 -43.01 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.024 . . . . 0.71 109.187 179.805 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.8 -40.01 98.24 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.735 -1.346 . . . . 0.57 109.735 179.73 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -60.14 -49.96 75.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.397 -1.061 . . . . 2.59 109.705 -179.122 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.533 HH22 ' CD1' ' A' ' 57' ' ' ILE . 58.6 mtp180 -67.03 -32.61 73.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.125 -0.984 . . . . 2.83 110.255 -179.147 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 64.8 tp -60.04 -41.22 91.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.064 -1.023 . . . . 1.25 108.445 -179.539 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 94.5 mt -60.5 -39.99 89.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.367 -0.833 . . . . 0.7 109.265 179.323 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -69.16 -39.93 78.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.267 -0.895 . . . . 2.57 109.036 179.712 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -62.2 -39.97 94.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.606 -0.684 . . . . 1.23 111.343 -179.024 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.433 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.5 mt -73.74 -45.44 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 120.429 -1.419 . . . . 0.81 109.399 179.891 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.6 mt -69.97 -31.53 69.28 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.65 -0.656 . . . . 1.0 110.084 -179.273 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.38 36.58 10.61 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.45 -1.46 . . . . 0.89 109.45 -179.565 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.85 141.07 47.96 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.21 -1.171 . . . . 1.14 108.779 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -60.68 140.05 57.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.31 -0.869 . . . . 4.6 109.477 -179.433 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.6 mt -108.07 128.88 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 108.835 -0.802 . . . . 1.24 108.835 179.668 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 27.4 mm -58.04 -50.02 79.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.724 -0.61 . . . . 1.54 110.801 -177.432 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 33.9 t0 65.89 102.72 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.883 -0.784 . . . . 1.5 108.883 -178.857 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.531 ' O ' HD12 ' A' ' 152' ' ' ILE . 59.5 mt -73.07 -3.72 28.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.483 -0.761 . . . . 0.79 110.034 -179.207 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.9 t -83.11 -13.7 55.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.012 -1.055 . . . . 1.4 109.066 179.22 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.72 24.61 0.47 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.564 -0.71 . . . . 0.92 109.947 -178.695 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.531 HD12 ' O ' ' A' ' 149' ' ' LEU . 63.7 mt -91.42 122.07 42.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.328 -0.858 . . . . 0.88 108.74 -179.423 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -110.33 -9.22 14.64 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.461 -0.775 . . . . 2.45 110.455 -179.008 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -126.43 151.33 47.86 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.276 -0.89 . . . . 1.52 110.488 -178.583 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.01 133.55 51.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 1.58 108.621 179.224 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 19.9 m -153.24 165.93 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.438 -0.789 . . . . 0.69 109.542 179.64 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.0 mt -94.2 149.1 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 105.896 -1.89 . . . . 0.61 105.896 176.749 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.9 tp -98.39 117.19 32.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.939 -1.1 . . . . 0.87 110.893 -177.486 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.3 t -121.44 127.81 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 108.804 -0.813 . . . . 0.71 108.804 179.495 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.438 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -157.84 160.68 37.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.084 -1.01 . . . . 0.81 108.688 -179.979 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.04 -33.3 71.79 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.116 -1.615 . . . . 0.98 108.449 178.801 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -160.27 171.46 19.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.456 -0.777 . . . . 2.25 108.931 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.6 mt -141.69 133.92 27.87 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.875 -1.141 . . . . 0.78 109.168 179.74 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 66.7 p -100.46 149.67 36.29 Favored Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 121.173 -0.955 . . . . 0.98 110.262 -179.65 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -43.04 -38.47 7.26 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.561 2.174 . . . . 0.81 113.466 179.203 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.1 m -59.84 -40.04 87.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.974 -1.079 . . . . 0.9 109.801 -178.084 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.92 -40.83 83.31 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.151 -0.968 . . . . 1.61 110.421 -179.746 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.2 p -58.03 -30.77 66.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.112 -0.993 . . . . 0.61 111.092 -178.218 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -72.15 -46.72 55.36 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.699 -1.25 . . . . 0.6 110.03 179.935 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -90.25 37.28 0.89 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.31 -0.996 . . . . 1.4 108.31 -179.88 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.5 tp -107.76 132.54 53.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.616 -0.678 . . . . 0.7 109.616 179.777 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -86.51 103.64 15.22 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.318 -0.864 . . . . 2.35 108.725 178.992 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 59.0 mt -64.09 -41.59 97.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 1.51 110.363 -179.294 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -66.03 -26.05 67.34 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.841 -1.162 . . . . 2.33 112.01 -177.591 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -92.41 -8.08 45.82 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.655 -1.278 . . . . 1.92 109.976 -178.656 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 178' ' ' GLY . 80.1 t -107.69 118.48 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.337 -0.852 . . . . 0.67 109.108 179.031 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.5 mt -85.41 4.06 37.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.345 -0.847 . . . . 1.53 111.114 -178.026 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.552 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 169.66 173.03 36.83 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.342 -1.408 . . . . 0.48 109.748 179.877 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -131.52 127.55 37.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.456 -1.026 . . . . 0.55 109.027 179.812 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 77.4 mt -129.04 123.22 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.616 -0.883 . . . . 0.65 108.616 179.059 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 63.7 p -145.49 158.32 43.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.139 -0.976 . . . . 0.82 111.109 -179.436 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -103.68 25.89 9.22 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.779 -0.823 . . . . 2.46 108.779 179.724 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.13 -159.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.006 -1.059 . . . . 1.28 111.229 -178.195 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.33 -51.56 12.84 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.029 -1.229 . . . . 2.19 110.029 -179.613 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.74 -108.97 0.39 Allowed Glycine 0 N--CA 1.493 2.441 0 O-C-N 121.084 -1.245 . . . . 2.13 110.207 -179.988 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.462 ' CB ' HH11 ' A' ' 186' ' ' ARG . 0.0 OUTLIER -79.91 -10.12 59.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.289 -1.124 . . . . 5.86 110.393 -179.29 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 78.5 p -83.89 0.77 46.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.125 -0.984 . . . . 3.72 110.324 -178.708 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.6 t -90.76 118.86 30.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.003 -1.061 . . . . 1.74 109.655 179.73 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -42.23 -52.73 4.34 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.602 -0.686 . . . . 0.95 109.7 -179.826 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.2 m -54.15 -30.67 50.0 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.34 -0.85 . . . . 1.55 110.759 -179.388 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 16.3 t -60.03 -44.75 94.41 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.601 -1.312 . . . . 1.51 109.746 -179.502 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.0 mm -60.09 -39.69 81.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.611 -0.885 . . . . 1.67 108.611 179.749 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.3 mtp -60.05 -39.89 87.52 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.456 -0.777 . . . . 1.02 110.002 -179.586 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.04 -44.36 94.71 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.654 -1.279 . . . . 0.68 109.504 -179.665 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.445 HH22 ' HG2' ' A' ' 186' ' ' ARG . 95.1 mtt180 -62.39 -57.78 10.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.111 -0.993 . . . . 2.93 109.981 -179.313 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 66.8 m -60.91 -40.01 91.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.857 . . . . 0.86 111.993 -178.684 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 91.6 mt -79.94 -10.93 59.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.766 -1.208 . . . . 0.67 110.876 -177.846 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 59.14 49.96 8.64 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.136 -0.977 . . . . 1.5 110.28 179.881 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 66.7 mt -121.91 126.2 26.43 Favored Pre-proline 0 N--CA 1.501 2.106 0 N-CA-C 108.955 -0.757 . . . . 0.72 108.955 179.517 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -43.09 129.44 5.82 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.842 1.695 . . . . 0.61 112.077 179.497 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.26 145.47 6.99 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.452 -1.299 . . . . 0.66 112.102 -179.512 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.6 mt -124.3 144.72 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.533 -1.284 . . . . 0.79 107.533 178.336 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.7 m -129.29 -6.69 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 120.695 -1.253 . . . . 0.91 111.031 -178.87 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.9 20.87 26.13 Favored Glycine 0 N--CA 1.5 2.958 0 N-CA-C 110.963 -0.855 . . . . 1.01 110.963 -179.406 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.44 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 2.9 p -46.61 -41.36 14.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.711 -1.464 . . . . 0.99 109.725 -179.483 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.61 -50.38 3.22 Favored Glycine 0 N--CA 1.498 2.823 0 C-N-CA 120.034 -1.079 . . . . 1.12 111.767 178.477 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 74.2 m -161.88 42.26 0.14 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.596 -1.532 . . . . 1.72 111.334 -179.177 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 23.5 t -78.89 -38.14 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.932 -1.105 . . . . 0.89 108.666 178.348 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.451 ' H ' HG23 ' A' ' 209' ' ' THR . 4.3 p -55.3 -35.62 65.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.459 -0.776 . . . . 1.03 110.611 -179.062 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 63.4 m -84.29 -9.8 58.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.963 -1.086 . . . . 1.83 110.142 -179.374 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -96.16 -16.5 21.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.065 -1.022 . . . . 2.27 110.485 -179.39 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 213' ' ' LYS . 18.2 t -123.66 162.92 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.403 -0.81 . . . . 0.92 109.714 -179.596 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.487 ' N ' HG12 ' A' ' 212' ' ' VAL . 0.5 OUTLIER -121.89 160.02 25.62 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.597 -0.89 . . . . 2.2 108.597 -179.615 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.458 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 39.8 p-10 -60.4 145.28 48.59 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.394 -0.816 . . . . 2.36 111.168 -179.02 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 84.29 -1.44 1.0 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.519 0.676 . . . . 2.38 110.326 178.594 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.46 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 96.5 m-20 -72.54 155.09 40.43 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.623 -0.831 . . . . 2.09 108.838 179.269 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -97.64 119.31 35.98 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.445 -0.946 . . . . 1.27 108.445 179.852 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.54 HD12 ' HB2' ' A' ' 16' ' ' ALA . 96.1 mt -122.83 142.24 50.97 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.439 -0.788 . . . . 0.75 110.504 -179.077 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.452 HD12 ' HG3' ' A' ' 231' ' ' PRO . 83.2 mt -114.82 128.37 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 106.299 -1.741 . . . . 0.63 106.299 176.365 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 56.7 tp -97.89 116.58 30.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.932 -1.105 . . . . 0.7 108.505 -179.358 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 223' ' ' VAL . 21.3 t0 -74.1 -44.66 53.07 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.466 -1.309 . . . . 2.31 107.466 179.553 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.862 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.82 8.49 0.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.834 -0.541 . . . . 0.78 109.654 179.073 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.508 ' H ' ' C ' ' A' ' 221' ' ' ASP . 95.2 t -126.75 -39.17 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 107.384 -1.339 . . . . 1.04 107.384 178.262 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -102.77 -0.41 31.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.878 -1.156 . . . . 2.44 107.878 178.637 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 61.94 45.77 7.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.817 -0.552 . . . . 1.55 109.839 -179.814 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -139.6 150.66 45.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.293 -0.879 . . . . 1.99 109.891 179.575 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 90.5 t -119.0 128.07 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.423 -0.955 . . . . 0.77 108.423 178.989 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -102.67 123.56 46.6 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.596 -0.89 . . . . 0.98 108.596 179.461 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.3 t -100.02 110.01 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.38 -0.825 . . . . 0.85 110.607 -178.865 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 50.94 60.65 14.45 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.44 -0.788 . . . . 1.66 111.516 179.047 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.452 ' HG3' HD12 ' A' ' 219' ' ' ILE . 90.7 Cg_endo -79.51 153.04 23.47 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.703 2.268 . . . . 0.95 111.277 178.386 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 232' ' ' THR . . . . . 0.435 HG22 ' N ' ' A' ' 233' ' ' ASN . 25.8 m -64.7 159.92 21.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 1.84 110.135 -179.25 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 233' ' ' ASN . . . . . 0.435 ' N ' HG22 ' A' ' 232' ' ' THR . 98.6 m-20 -61.18 -40.08 92.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.39 -0.818 . . . . 2.74 110.342 -179.632 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.01 -36.07 76.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.081 -1.012 . . . . 2.89 109.265 179.794 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.97 -39.93 78.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.564 -0.902 . . . . 1.3 108.564 179.261 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.444 -0.785 . . . . 1.09 110.001 179.931 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -155.19 153.65 31.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.267 -0.896 . . . . 0.0 109.499 179.485 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -145.56 155.48 43.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.214 -0.929 . . . . 0.0 109.55 -179.83 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 304' ' ' GLN . . . . . 0.583 ' NE2' ' O ' ' B' ' 305' ' ' GLU . 17.0 tm0? -154.49 150.02 27.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.515 -0.741 . . . . 0.0 109.015 -179.587 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 305' ' ' GLU . . . . . 0.583 ' O ' ' NE2' ' B' ' 304' ' ' GLN . 95.0 mt-10 -109.85 131.72 54.8 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.3 -0.875 . . . . 0.0 110.162 179.388 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 306' ' ' VAL . . . . . 0.409 ' O ' HG13 ' B' ' 306' ' ' VAL . 6.9 p -132.9 121.02 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 CA-C-O 122.121 0.962 . . . . 0.0 112.134 -178.136 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 307' ' ' THR . . . . . 0.477 ' O ' HG23 ' B' ' 309' ' ' THR . 87.8 m -80.0 103.01 9.6 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.696 0.76 . . . . 0.0 110.384 -178.93 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.5 mt -51.51 117.52 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.446 1.117 . . . . 0.0 109.971 -178.079 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 309' ' ' THR . . . . . 0.477 HG23 ' O ' ' B' ' 307' ' ' THR . 62.2 p -104.69 19.01 21.19 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.414 -177.954 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.46 115.98 44.73 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.327 -0.858 . . . . 0.0 109.098 179.507 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -53.05 -15.47 4.98 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 CA-C-N 120.306 1.145 . . . . 0.0 112.923 -179.704 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -115.27 4.98 14.59 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.506 -0.746 . . . . 0.0 109.036 -179.888 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.26 174.46 19.12 Favored Glycine 0 N--CA 1.481 1.692 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 -179.042 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.442 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.0 tp -85.84 95.59 9.48 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.163 -1.198 . . . . 0.0 108.696 -179.066 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -95.25 -162.55 0.96 Allowed 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.161 -0.962 . . . . 0.0 110.411 179.737 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 7.9 m -59.63 -39.96 86.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.056 -1.027 . . . . 0.0 112.581 -175.776 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.601 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -60.15 -60.82 9.38 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.33 -1.481 . . . . 0.0 111.27 -179.257 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -59.4 -32.4 96.48 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.14 1.086 . . . . 0.0 111.628 -179.9 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.88 67.67 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.398 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -50.37 -40.02 48.28 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.819 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 321' ' ' GLN . . . . . 0.423 HE21 HD11 ' B' ' 380' ' ' LEU . 61.8 tt0 -69.99 -41.47 74.37 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 108.923 178.369 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -61.2 -52.78 63.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.83 . . . . 0.0 110.946 -179.365 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 87.9 t -65.41 -27.67 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.639 -1.288 . . . . 0.0 109.761 -178.957 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -45.16 93.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.404 -0.81 . . . . 0.0 109.411 179.581 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -66.52 -44.89 81.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.418 -0.801 . . . . 0.0 111.2 -178.437 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 326' ' ' ALA . . . . . 0.42 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -61.55 -53.87 50.61 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.724 -1.235 . . . . 0.0 111.144 -178.646 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -52.66 -13.43 0.39 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.724 -1.235 . . . . 0.0 109.317 179.673 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 328' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -72.6 -28.73 66.85 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.69 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -106.03 146.78 29.67 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.443 -1.033 . . . . 0.0 109.942 -179.676 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 51.6 p -91.11 -11.79 37.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.925 . . . . 0.0 110.134 179.997 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.427 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 56.4 p -65.3 157.87 27.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.196 -0.94 . . . . 0.0 110.323 -179.165 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -72.62 131.55 42.59 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.377 -0.827 . . . . 0.0 108.922 179.375 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 80.2 mt -132.33 132.69 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.873 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 334' ' ' THR . . . . . 0.417 HG22 ' N ' ' B' ' 335' ' ' VAL . 62.7 m -131.6 155.89 46.74 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.48 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 335' ' ' VAL . . . . . 0.417 ' N ' HG22 ' B' ' 334' ' ' THR . 61.9 t -119.1 140.49 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.318 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 26.7 m -128.9 123.89 33.78 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.128 -0.982 . . . . 0.0 108.561 179.95 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 337' ' ' SER . . . . . 0.4 ' CB ' HG12 ' B' ' 361' ' ' VAL . 93.0 p -137.93 116.61 12.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.966 -1.084 . . . . 0.0 110.82 -179.387 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 22.9 m120 45.14 53.43 7.86 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.318 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.74 -11.59 66.08 Favored Glycine 0 N--CA 1.502 3.07 0 O-C-N 120.06 -1.65 . . . . 0.0 113.052 176.264 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -120.92 132.35 54.9 Favored 'General case' 0 N--CA 1.506 2.37 0 CA-C-N 119.285 1.542 . . . . 0.0 109.512 -179.655 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 77.4 p -127.88 151.39 49.13 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.928 0.87 . . . . 0.0 110.886 -178.834 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.48 164.47 30.79 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.64 0.734 . . . . 0.0 110.423 -178.94 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 48.0 t -87.56 133.21 33.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.806 -0.559 . . . . 0.0 110.359 -179.353 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -70.13 -20.27 63.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.944 . . . . 0.0 108.911 179.289 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -84.61 17.36 2.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.494 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 3.0 m -146.45 95.43 2.6 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.773 0.797 . . . . 0.0 112.421 -179.368 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.659 HD23 HD22 ' A' ' 79' ' ' LEU . 42.7 tp -59.98 -39.05 84.36 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.415 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.687 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.0 m-85 -51.31 -51.15 56.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.979 -1.076 . . . . 0.0 110.459 -179.569 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -71.66 -39.72 70.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.955 -1.09 . . . . 0.0 111.277 -178.2 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' B' ' 352' ' ' THR . 20.6 mt -47.81 -59.95 2.94 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.718 -1.239 . . . . 0.0 109.754 -179.153 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.643 HE22 ' NE ' ' A' ' 126' ' ' ARG . 7.6 mm100 -42.07 -20.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.399 -0.813 . . . . 0.0 111.192 -177.724 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.493 ' N ' ' O ' ' B' ' 350' ' ' LEU . 69.5 p -79.25 -12.76 59.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.081 -1.637 . . . . 0.0 109.53 -179.294 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 32.0 mt -94.09 122.7 36.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.114 -0.991 . . . . 0.0 108.993 178.383 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -72.03 96.89 0.71 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.718 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.5 mt -100.07 80.29 2.27 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.265 -1.138 . . . . 0.0 109.06 179.282 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 75.1 p -91.13 166.28 13.05 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.967 -1.083 . . . . 0.0 111.055 -178.83 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -59.92 111.58 1.53 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.132 0.491 . . . . 0.0 110.642 -179.591 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 358' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 103.01 5.57 46.88 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.762 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 52.4 m -80.14 109.78 14.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.051 -1.264 . . . . 0.0 110.855 -179.468 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 360' ' ' VAL . . . . . 0.439 HG22 ' OG1' ' B' ' 307' ' ' THR . 11.9 t -78.54 112.71 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.108 0.956 . . . . 0.0 109.943 -177.907 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 361' ' ' VAL . . . . . 0.4 HG12 ' CB ' ' B' ' 337' ' ' SER . 36.0 m -113.31 176.85 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 -178.735 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 57.4 m -126.64 130.02 49.63 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 176.648 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.5 mt -106.43 124.52 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.357 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 63.2 m -131.53 138.85 49.1 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.5 -0.75 . . . . 0.0 109.771 -178.979 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.41 155.24 42.44 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.217 -0.927 . . . . 0.0 109.763 -179.507 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -146.51 123.34 11.28 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.409 -0.807 . . . . 0.0 109.171 179.848 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.508 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.89 -153.47 24.73 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.248 -1.453 . . . . 0.0 111.548 179.868 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -59.97 -51.69 68.58 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.222 -0.575 . . . . 0.0 112.503 -177.292 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.427 ' H ' ' HB3' ' B' ' 331' ' ' SER . 62.5 m-20 -111.91 11.06 20.67 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.892 -1.13 . . . . 0.0 111.434 -177.267 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 11.1 pt-20 -39.14 -34.5 0.18 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.452 -0.78 . . . . 0.0 111.657 -179.16 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -69.99 -41.0 74.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.036 -1.04 . . . . 0.0 110.667 -178.148 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -69.68 -49.89 49.16 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.223 -179.609 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -45.77 -79.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 110.417 -179.653 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.607 ' O ' HG23 ' B' ' 378' ' ' VAL . 15.1 t -45.24 -38.38 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.154 -0.966 . . . . 0.0 110.367 -177.696 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -69.86 -40.25 75.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.535 -1.353 . . . . 0.0 110.111 179.738 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -83.32 -45.54 13.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.974 -1.079 . . . . 0.0 109.707 179.499 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.08 -35.51 75.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 109.673 -179.211 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.607 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.4 t -68.88 -40.06 80.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.123 -0.986 . . . . 0.0 109.758 179.819 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -79.98 -10.0 59.73 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.705 -1.247 . . . . 0.0 108.611 178.251 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.423 HD11 HE21 ' B' ' 321' ' ' GLN . 44.1 tp -82.08 -26.81 33.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.997 -1.064 . . . . 0.0 108.697 178.377 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 38.7 mtt -83.36 -21.02 33.21 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 176.813 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -85.97 -11.3 53.38 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.583 -0.698 . . . . 0.0 109.451 178.789 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -109.98 -4.72 15.74 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.387 -0.821 . . . . 0.0 110.868 -178.998 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 31.1 mt -89.77 123.97 34.23 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.681 -1.262 . . . . 0.0 109.859 -179.79 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.406 -179.82 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 mmt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.457 -0.572 . . . . 2.91 109.457 . . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.3 mt -107.31 121.38 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.644 -0.873 . . . . 1.2 108.644 179.745 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 m -133.62 120.09 20.25 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.424 -0.798 . . . . 1.4 109.178 179.981 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.64 -161.7 37.72 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.422 -1.471 . . . . 1.05 109.422 179.917 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.7 mt -93.03 -10.13 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.038 -1.272 . . . . 1.15 110.005 -179.392 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' ILE . 55.2 tp 53.21 101.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -0.963 . . . . 0.98 109.548 -179.959 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.13 -26.24 20.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 0.88 109.631 179.928 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.1 t -144.6 130.18 9.58 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.213 -0.929 . . . . 1.69 109.433 179.923 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.94 143.43 16.31 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.175 1.916 . . . . 0.85 112.806 -179.926 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.663 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 163.74 -162.14 34.8 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.033 -1.627 . . . . 0.92 109.033 179.881 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.8 mt -149.52 149.8 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.922 -1.34 . . . . 0.81 108.466 178.841 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.5 158.4 37.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.749 -1.22 . . . . 0.51 110.794 179.83 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -139.97 129.19 23.82 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.897 -1.149 . . . . 0.62 107.897 178.817 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.93 -178.91 46.53 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 118.869 -1.634 . . . . 0.55 110.442 179.911 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -79.93 156.63 27.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.544 -0.974 . . . . 2.1 109.886 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -105.4 127.5 53.01 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.478 0.656 . . . . 0.77 110.925 -179.434 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.8 tp -101.25 140.08 36.04 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.772 -1.195 . . . . 0.91 107.772 178.537 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.7 tp -118.35 125.59 50.34 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.374 -0.829 . . . . 0.93 109.951 -179.442 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.8 mt -84.04 104.41 14.09 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.531 0.682 . . . . 0.93 109.963 -179.795 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -99.29 128.58 45.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.455 -0.778 . . . . 2.75 109.354 -179.789 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -130.06 127.94 40.92 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.41 -0.806 . . . . 3.0 109.072 179.256 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -76.74 147.31 37.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.282 -0.886 . . . . 2.77 109.418 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -63.61 141.55 58.72 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.23 -0.919 . . . . 2.94 108.995 -179.983 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.9 mt -76.97 131.88 33.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.229 -0.919 . . . . 0.95 109.162 -179.516 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.7 t -93.88 124.1 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.287 -0.883 . . . . 1.28 109.813 -179.621 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.6 mt -109.8 138.11 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.611 -0.681 . . . . 1.21 109.929 -179.462 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -97.45 116.93 30.58 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.13 -0.981 . . . . 1.81 109.441 179.834 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.53 HH11 ' HG2' ' A' ' 28' ' ' ARG . 2.3 mmt-85 -85.67 -0.95 56.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.393 -0.817 . . . . 2.8 109.62 -179.431 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -60.54 144.11 52.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.935 . . . . 2.87 109.632 -179.712 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -87.71 147.88 25.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.192 -0.942 . . . . 2.35 109.046 -179.928 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 pt -94.66 164.82 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.997 -1.064 . . . . 0.97 109.823 179.924 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.418 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 53.9 p -90.23 175.64 7.05 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.477 -0.935 . . . . 1.17 108.477 178.576 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.06 -20.34 63.23 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.937 -1.102 . . . . 1.18 111.266 -178.95 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.418 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 7.5 p-10 -85.97 -23.19 27.0 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.501 -1.375 . . . . 2.56 108.553 179.001 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -81.84 -9.41 59.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.592 -0.892 . . . . 1.79 108.592 178.818 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 t -62.09 -53.66 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.487 -0.758 . . . . 1.0 109.309 179.711 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -62.17 -40.06 94.76 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.339 -0.851 . . . . 1.77 109.349 179.691 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -61.91 -42.2 98.81 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.422 -0.799 . . . . 2.7 110.598 -178.766 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -66.15 -39.96 90.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.711 -1.243 . . . . 1.51 110.376 -179.036 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.14 -47.88 90.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.708 -1.245 . . . . 0.93 108.681 179.586 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -61.46 -44.21 97.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.062 . . . . 1.81 109.652 179.846 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.463 HH11 ' HG2' ' A' ' 42' ' ' ARG . 25.8 mtt-85 -60.02 -41.13 91.53 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.937 -1.135 . . . . 2.78 107.937 179.139 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -62.31 -45.78 91.69 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.958 -1.127 . . . . 0.78 107.958 177.545 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.02 -47.63 85.03 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.828 -0.804 . . . . 1.07 108.828 179.694 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 18.1 t -62.39 -42.95 99.82 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.394 -0.922 . . . . 1.12 109.009 179.355 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.44 -48.58 84.22 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.866 -1.694 . . . . 0.84 108.866 179.477 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -62.27 -34.9 77.44 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.33 -1.1 . . . . 3.09 108.197 178.694 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.59 -43.81 80.46 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.613 -0.679 . . . . 0.88 109.285 -179.911 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.3 ttpt -65.78 -74.24 0.11 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.17 -1.418 . . . . 2.59 107.17 179.301 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.25 -31.35 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.318 -0.864 . . . . 0.7 111.118 -179.238 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 49' ' ' LYS . 34.4 t -57.06 -56.07 26.46 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.547 -1.346 . . . . 1.4 108.473 179.801 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.45 -40.03 81.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.433 -0.792 . . . . 0.67 111.204 -179.182 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -67.14 -40.03 86.68 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.699 -1.251 . . . . 1.66 110.42 -179.1 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.43 -39.95 94.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.886 -1.134 . . . . 1.58 109.504 179.815 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -62.24 -33.99 75.65 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.174 -0.954 . . . . 1.35 109.448 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.62 -41.39 98.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.955 . . . . 0.77 109.832 -179.986 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.36 -39.95 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.193 -0.942 . . . . 0.63 109.55 -180.0 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -56.69 -50.6 71.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 1.14 109.921 -178.962 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -59.41 -36.63 76.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.371 -0.83 . . . . 0.79 110.968 -177.472 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -64.29 -38.26 90.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.895 -1.128 . . . . 1.53 109.573 179.891 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.31 -43.43 97.83 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.467 -0.771 . . . . 0.57 109.732 -179.926 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.15 -50.85 63.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.498 -1.441 . . . . 0.75 109.498 -179.335 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.26 -50.1 56.09 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.139 -1.212 . . . . 1.59 109.5 179.628 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.1 m -63.03 -64.76 0.82 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 0.73 112.32 -177.893 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -97.65 -48.3 5.29 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.868 -1.145 . . . . 0.75 111.825 -178.079 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.91 -169.77 25.15 Favored Glycine 0 N--CA 1.5 2.943 0 O-C-N 120.662 -1.274 . . . . 1.22 110.943 179.889 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.03 -26.87 64.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.897 -0.767 . . . . 5.81 110.287 -179.705 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -61.04 -33.15 72.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.447 -0.783 . . . . 3.37 110.087 -179.67 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -100.33 -22.59 15.03 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.341 -0.849 . . . . 1.77 109.891 179.995 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -64.95 -40.76 95.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.132 -0.98 . . . . 1.65 110.02 -179.311 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.599 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -67.1 -25.82 66.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.401 -0.812 . . . . 0.77 110.431 -178.913 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.99 -40.53 83.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.969 -1.082 . . . . 0.8 108.499 -179.706 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -69.96 -35.76 74.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.144 -0.973 . . . . 0.88 110.107 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -60.01 -40.06 87.94 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.762 -1.211 . . . . 1.37 109.312 179.831 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.99 -42.62 94.63 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.463 -1.855 . . . . 0.62 108.463 179.09 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -61.06 -44.56 97.2 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.468 -1.019 . . . . 1.5 108.612 179.334 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.98 -43.53 79.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.674 -0.641 . . . . 0.63 109.799 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -64.11 -40.02 95.29 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.906 -1.121 . . . . 1.51 109.827 -179.356 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.801 HD11 ' CE2' ' B' ' 348' ' ' PHE . 35.9 tp -65.47 -39.97 92.61 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.237 -0.914 . . . . 0.77 109.44 179.536 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.5 tp -65.71 -37.09 85.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.557 -0.714 . . . . 0.62 109.177 -179.493 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -82.66 1.66 37.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 1.47 110.086 -179.372 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -48.56 130.01 16.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.965 -1.084 . . . . 1.47 109.672 -179.405 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.46 -18.4 51.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.542 -0.723 . . . . 1.78 110.354 -179.259 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.47 -35.1 73.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.005 -1.059 . . . . 2.53 108.739 178.353 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.3 mt -70.15 -42.12 72.93 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.521 0.677 . . . . 0.8 109.909 179.506 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -60.15 -48.81 80.18 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.36 -0.837 . . . . 1.42 110.028 -179.126 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -69.95 -41.31 74.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 1.71 110.705 -179.451 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.98 -40.04 75.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.16 -0.963 . . . . 1.57 111.735 -178.629 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 91.8 mt -69.47 -42.04 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.905 -1.122 . . . . 0.65 109.178 -179.571 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.7 mt -69.98 -39.62 77.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.638 -0.664 . . . . 0.82 109.943 179.329 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.99 -47.77 84.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -0.863 . . . . 0.79 110.81 -179.244 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 96' ' ' LYS . 93.2 mt -61.48 -47.51 85.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.994 -1.067 . . . . 0.95 109.921 -179.44 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.33 -49.63 83.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.296 -0.877 . . . . 0.66 109.185 179.632 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -70.09 -43.03 71.93 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.901 -0.719 . . . . 2.2 110.667 179.636 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -80.69 -47.39 14.09 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.103 -0.998 . . . . 1.65 111.79 -178.349 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 92' ' ' LEU . 65.8 mmtt -91.81 -2.3 56.96 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.973 -1.079 . . . . 2.03 111.659 -177.679 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 56.05 34.68 24.22 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.797 -1.189 . . . . 1.42 109.489 -179.845 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 59.0 mtt -91.63 169.84 10.41 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.518 -0.739 . . . . 1.18 110.03 -179.39 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.5 p -82.32 162.34 22.29 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.42 -0.8 . . . . 0.98 109.408 179.986 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.03 -39.71 75.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.417 -0.802 . . . . 0.64 109.892 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.94 -40.04 83.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 2.07 110.011 -179.753 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.49 -44.08 19.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.018 -1.051 . . . . 0.73 110.283 -179.506 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.63 -47.68 68.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.54 110.2 -179.306 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.03 87.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.178 -0.951 . . . . 0.56 109.659 -179.862 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -59.99 -40.87 90.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.43 -0.794 . . . . 1.54 110.01 -178.559 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -63.21 -40.02 96.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.913 . . . . 1.33 110.131 -179.596 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.3 -52.59 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.111 -0.993 . . . . 0.72 110.528 -178.721 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -70.02 -40.02 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.973 -1.079 . . . . 0.85 109.328 -179.752 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.61 -39.19 91.27 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.644 -0.872 . . . . 2.44 108.644 179.327 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.33 -47.86 87.12 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.74 -1.344 . . . . 0.98 109.74 -179.668 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -67.53 -51.65 48.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.942 -1.328 . . . . 1.41 109.197 -179.992 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.85 -42.5 89.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.375 -0.828 . . . . 1.2 109.591 -179.748 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.4 t -57.56 -39.5 76.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.059 -1.026 . . . . 1.7 109.056 -179.851 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.95 -39.93 90.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.935 . . . . 1.47 109.656 179.424 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.1 mt -64.66 -42.01 95.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.022 -1.049 . . . . 1.56 109.999 -178.827 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.95 -37.58 79.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.746 -1.222 . . . . 2.2 109.335 -179.596 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -53.45 -20.25 4.5 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.202 -0.936 . . . . 2.12 109.265 179.827 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 65.7 mt -62.46 139.99 58.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.044 -1.035 . . . . 2.0 108.798 179.861 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -90.99 48.23 1.5 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.04 -1.037 . . . . 3.23 109.393 179.894 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.42 ' OD1' ' OE2' ' A' ' 121' ' ' GLU . 58.3 t0 -135.18 130.13 34.85 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.368 -0.833 . . . . 2.49 109.282 -179.713 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.2 pm0 -69.35 -28.87 66.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.532 -0.73 . . . . 3.95 110.071 -179.677 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.545 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 2.4 t80 -73.2 -41.03 64.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.259 -0.901 . . . . 2.0 110.599 179.586 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.624 ' CD2' HH22 ' A' ' 126' ' ' ARG . 41.3 mt -74.92 -29.71 61.04 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.044 -1.035 . . . . 1.86 108.344 179.31 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -68.51 -39.1 81.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.5 -0.75 . . . . 2.84 110.1 179.523 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -59.98 -44.02 94.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.987 -1.071 . . . . 2.73 110.063 -178.905 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.714 ' HE ' ' NE2' ' B' ' 351' ' ' GLN . 22.2 mtm-85 -69.96 -28.91 65.94 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.315 -1.354 . . . . 2.77 108.797 179.805 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.75 -26.64 65.84 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.865 -1.161 . . . . 1.19 107.865 178.741 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.56 -39.98 64.28 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.088 -0.708 . . . . 1.2 109.088 178.795 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -65.85 -39.99 91.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.358 -0.838 . . . . 1.55 110.53 -179.442 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.5 t -65.11 -41.02 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.877 -1.139 . . . . 0.8 109.065 179.999 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -59.98 -37.86 80.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.092 -1.005 . . . . 3.09 108.522 178.868 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 57.2 t0 -60.03 -38.96 84.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.578 -0.701 . . . . 1.46 109.985 -179.614 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 94.5 mt -60.08 -42.5 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.92 -1.113 . . . . 0.71 110.101 -178.89 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.76 -29.3 59.56 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.647 -1.381 . . . . 0.57 109.647 179.867 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt -59.93 -49.04 79.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.299 -1.118 . . . . 2.59 109.464 -179.515 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.467 HH11 ' HG2' ' A' ' 136' ' ' ARG . 27.1 mtt-85 -65.16 -36.7 85.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.083 -1.011 . . . . 2.83 109.596 179.861 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.2 tp -57.08 -40.92 77.86 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.355 -0.84 . . . . 1.25 109.018 -178.652 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.16 -41.35 98.21 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.193 -0.942 . . . . 0.7 109.762 179.405 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -70.09 -39.94 75.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.23 -0.919 . . . . 2.57 109.014 179.384 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -63.87 -35.66 81.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.675 -0.641 . . . . 1.23 111.093 -179.31 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 83.6 mt -71.13 -45.9 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.487 -1.383 . . . . 0.81 108.75 179.522 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 77.2 mt -70.03 -34.96 73.93 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.51 -0.744 . . . . 1.0 109.518 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.91 43.74 5.31 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.188 -1.565 . . . . 0.89 109.188 -179.479 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 tp -74.29 149.83 40.5 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.324 -1.103 . . . . 1.14 109.012 -179.854 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -67.1 141.72 57.36 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.178 -0.951 . . . . 4.6 109.678 -179.553 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 89.1 mt -115.63 126.6 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 122.269 1.033 . . . . 1.24 109.269 179.635 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 148' ' ' ASP . 7.5 mt -70.01 -40.0 78.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 115.594 -0.73 . . . . 1.54 110.743 -178.219 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 147' ' ' ILE . 25.8 t0 63.49 131.29 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.642 -0.873 . . . . 1.5 108.642 -178.918 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 152' ' ' ILE . 38.9 mt -89.89 -0.62 57.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.047 -1.033 . . . . 0.79 109.646 -179.324 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.7 m -84.83 -8.88 58.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 1.4 109.21 179.566 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.03 27.33 0.78 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.446 -0.784 . . . . 0.92 110.683 -178.207 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.415 ' O ' ' NZ ' ' A' ' 175' ' ' LYS . 54.4 mt -89.88 120.03 37.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 O-C-N 121.117 -0.99 . . . . 0.88 109.395 -179.16 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.42 ' O ' ' OD1' ' A' ' 154' ' ' ASP . 72.2 mt-30 -97.07 -9.67 27.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.298 -0.876 . . . . 2.45 111.083 -178.765 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 153' ' ' GLN . 96.4 m-20 -139.7 157.89 45.02 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.898 -1.126 . . . . 1.52 110.815 -178.763 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -62.7 138.22 58.45 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.735 -0.839 . . . . 1.58 108.735 179.606 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.1 m -153.13 165.71 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.69 109.767 179.88 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.5 mt -95.48 148.84 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.414 -1.698 . . . . 0.61 106.414 176.967 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.3 tp -98.61 117.66 33.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.084 -1.01 . . . . 0.87 111.049 -177.684 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.0 t -122.42 130.04 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.622 -0.881 . . . . 0.71 108.622 178.416 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.63 161.24 38.64 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.584 -0.895 . . . . 0.81 108.584 179.996 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.485 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -72.09 -32.88 67.44 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.201 -1.562 . . . . 0.98 107.687 178.699 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 20.2 t0 -162.27 167.73 23.47 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.142 -1.059 . . . . 2.25 108.142 179.8 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.498 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 86.5 mt -141.67 130.61 23.12 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.907 -1.12 . . . . 0.78 109.586 179.689 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 63.8 p -93.05 144.62 28.66 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 108.543 -0.91 . . . . 0.98 108.543 179.363 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -42.11 -29.86 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.846 1.697 . . . . 0.81 112.65 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.3 m -59.71 -39.98 86.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.017 . . . . 0.9 109.711 -178.405 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -70.06 -42.11 73.29 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.12 -0.988 . . . . 1.61 110.354 -179.662 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 77.9 p -53.93 -29.97 44.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.228 -0.92 . . . . 0.61 111.356 -177.994 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.14 -56.6 5.3 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.945 -1.097 . . . . 0.6 110.53 -179.7 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -84.05 37.34 0.6 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.451 -0.78 . . . . 1.4 108.939 -179.599 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.9 tp -109.76 129.47 55.62 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.457 -0.942 . . . . 0.7 108.457 178.494 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -79.97 105.15 11.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.082 -1.011 . . . . 2.35 109.27 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 77.0 mt -66.84 -40.26 87.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.426 -0.796 . . . . 1.51 111.229 -178.564 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -70.0 -23.62 63.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.939 -1.1 . . . . 2.33 110.852 -178.029 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 175' ' ' LYS . . . . . 0.415 ' NZ ' ' O ' ' A' ' 152' ' ' ILE . 41.4 mtpt -93.97 -6.44 45.42 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.032 -1.043 . . . . 1.92 109.861 -178.657 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.585 HG12 ' H ' ' A' ' 178' ' ' GLY . 93.1 t -107.92 121.4 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.179 -0.95 . . . . 0.67 108.605 179.069 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 42.1 mt -85.66 7.12 24.59 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.391 -0.818 . . . . 1.53 111.777 -177.07 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.585 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 164.11 177.55 36.93 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.17 -1.49 . . . . 0.48 109.662 179.914 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.461 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 22.5 m-85 -134.78 130.27 35.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.453 -1.028 . . . . 0.55 109.26 -179.695 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 91.0 mt -133.17 128.29 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.025 -0.731 . . . . 0.65 109.025 179.191 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 33.8 p -149.87 159.42 44.38 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.043 -1.035 . . . . 0.82 109.763 179.741 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 53.8 p-10 -106.27 27.55 8.59 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.519 -0.919 . . . . 2.46 108.519 178.847 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.5 -157.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.056 0.931 . . . . 1.28 111.972 -178.172 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.6 -80.48 0.08 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.875 -0.89 . . . . 2.19 110.875 -179.179 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.68 -130.57 1.37 Allowed Glycine 0 N--CA 1.49 2.288 0 O-C-N 120.892 -1.358 . . . . 2.13 110.112 -179.491 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -79.42 -9.31 59.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.305 -1.115 . . . . 5.86 111.031 -179.138 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.2 p -87.43 9.13 21.77 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.947 -1.096 . . . . 3.72 110.238 -179.085 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.7 m -90.19 139.32 30.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.941 -1.1 . . . . 1.74 110.358 -179.602 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -45.12 -53.38 8.08 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.473 -0.767 . . . . 0.95 109.99 -179.744 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.4 m -56.6 -39.01 72.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.401 -0.812 . . . . 1.55 110.164 -178.903 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 27.8 p -60.0 -37.67 80.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.858 -1.151 . . . . 1.51 110.003 -179.554 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 192' ' ' ILE . . . . . 0.41 HG12 HH21 ' A' ' 195' ' ' ARG . 82.5 mt -60.03 -39.91 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.115 -0.991 . . . . 1.67 108.935 179.985 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 90.7 mtp -60.04 -43.01 95.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.429 -0.795 . . . . 1.02 110.33 -179.038 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.39 -44.25 88.88 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.583 -1.323 . . . . 0.68 109.36 -179.341 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.41 HH21 HG12 ' A' ' 192' ' ' ILE . 82.8 mtm180 -62.55 -58.64 6.84 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.107 -1.037 . . . . 2.93 109.925 -179.606 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.6 m -61.96 -39.97 93.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.122 -0.986 . . . . 0.86 112.022 -178.548 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.0 mt -74.91 -20.53 59.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.753 -1.217 . . . . 0.67 110.338 -178.697 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 68.81 52.21 0.55 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.678 -0.639 . . . . 1.5 110.456 -179.762 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.5 mt -129.68 149.93 74.33 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 108.072 -1.084 . . . . 0.72 108.072 178.794 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.52 143.55 63.38 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.063 1.842 . . . . 0.61 112.088 -179.654 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -172.63 150.74 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.083 -1.01 . . . . 0.66 111.286 -179.897 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.8 mt -121.51 146.68 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 107.664 -1.236 . . . . 0.79 107.664 178.432 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.8 m -128.35 -12.39 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 O-C-N 120.878 -1.139 . . . . 0.91 110.528 -179.051 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.05 25.25 16.79 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 110.824 -0.91 . . . . 1.01 110.824 -179.233 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.8 p -46.28 -40.62 11.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.913 -1.345 . . . . 0.99 109.803 -179.459 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.403 ' H ' ' HB2' ' A' ' 182' ' ' ASP . . . 90.29 -51.42 3.39 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 120.127 -1.035 . . . . 1.12 110.85 179.385 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.6 m -161.94 34.97 0.12 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.621 -1.517 . . . . 1.72 111.204 -179.471 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.12 -40.15 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.923 -1.111 . . . . 0.89 108.621 177.999 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.451 ' H ' HG23 ' A' ' 209' ' ' THR . 1.2 p -56.23 -34.08 65.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.699 -0.625 . . . . 1.03 110.004 -179.088 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 39.8 t -86.5 -12.97 47.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.069 -1.019 . . . . 1.83 110.467 -179.169 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -94.0 -12.93 27.62 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.889 -1.132 . . . . 2.27 110.837 -179.538 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 213' ' ' LYS . 44.6 t -123.75 165.1 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 O-C-N 121.185 -0.947 . . . . 0.92 110.267 -179.483 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.572 ' N ' HG12 ' A' ' 212' ' ' VAL . 18.4 mmmt -118.14 156.45 28.67 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.558 -0.904 . . . . 2.2 108.558 -179.363 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 5.5 p30 -60.99 140.36 57.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 2.36 110.711 -179.474 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 6.5 t0 86.48 2.47 0.52 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.108 0.48 . . . . 2.38 110.204 179.102 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.442 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 89.9 m-20 -77.71 159.19 29.27 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.15 -0.969 . . . . 2.09 108.581 178.877 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -97.27 120.31 37.4 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.215 -0.928 . . . . 1.27 109.288 -179.351 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.506 HD12 ' HB2' ' A' ' 16' ' ' ALA . 88.8 mt -126.08 140.88 52.23 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.361 -0.837 . . . . 0.75 110.342 -179.812 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.7 mt -113.47 129.88 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.053 -1.462 . . . . 0.63 107.053 176.967 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 24.6 tp -103.12 120.13 40.12 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.215 -0.928 . . . . 0.7 109.255 -179.106 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.694 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 30.4 p-10 -80.77 -39.64 26.49 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.056 -1.027 . . . . 2.31 108.5 179.055 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.79 17.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.851 -0.796 . . . . 0.78 108.851 -179.003 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.5 t -130.25 -40.73 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.235 -1.394 . . . . 1.04 107.235 178.593 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -103.68 -0.69 29.18 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.139 -1.43 . . . . 2.44 107.139 177.905 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.539 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 47.7 t-20 60.03 48.74 8.28 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.354 0.597 . . . . 1.55 110.231 179.812 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.694 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 96.5 mt-30 -140.03 153.04 46.7 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.403 -0.81 . . . . 1.99 109.401 179.577 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 66.5 t -119.55 129.94 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.942 -0.762 . . . . 0.77 108.942 179.494 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -103.76 124.87 49.68 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.541 -0.911 . . . . 0.98 108.541 179.247 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 40.6 t -100.74 108.05 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.456 -0.777 . . . . 0.85 110.347 -178.978 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 49.39 66.71 5.3 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.199 -0.938 . . . . 1.66 110.367 179.012 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -85.57 156.23 10.56 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.875 2.383 . . . . 0.95 111.716 179.469 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 42.3 p -72.89 162.6 29.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.207 -0.933 . . . . 1.84 109.673 -179.558 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -59.86 -39.68 86.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.444 -0.785 . . . . 2.74 110.228 -179.537 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -58.03 -39.37 78.2 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.234 -0.916 . . . . 2.89 109.461 -179.037 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 77.1 t -68.96 -41.65 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.019 -1.051 . . . . 1.3 109.369 179.653 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.495 1.788 0 O-C-N 121.145 -0.972 . . . . 1.09 109.881 -179.889 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' B' B ' 301' ' ' MET . . . . . 0.426 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 40.7 ttp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.613 0.72 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 302' ' ' PHE . . . . . 0.426 ' N ' ' CG ' ' B' ' 301' ' ' MET . 15.7 t80 -149.81 146.57 27.22 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.451 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 303' ' ' GLN . . . . . 0.473 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 0.2 OUTLIER -150.25 159.98 44.04 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.882 -1.136 . . . . 0.0 110.551 -179.312 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -157.78 154.71 28.56 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.021 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -115.14 133.33 56.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.258 -0.901 . . . . 0.0 109.951 179.6 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 4.2 p -128.95 124.55 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-O 122.279 1.037 . . . . 0.0 112.364 -176.881 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 307' ' ' THR . . . . . 0.415 ' O ' HG23 ' B' ' 309' ' ' THR . 91.6 m -77.81 102.49 7.23 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.825 0.821 . . . . 0.0 110.898 -178.245 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' B' ' 358' ' ' GLY . 97.4 mt -52.92 123.28 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 122.403 1.097 . . . . 0.0 110.813 -178.201 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 309' ' ' THR . . . . . 0.415 HG23 ' O ' ' B' ' 307' ' ' THR . 77.6 p -109.99 20.02 18.4 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.768 -178.368 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -83.13 115.47 59.13 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.1 -1.0 . . . . 0.0 109.854 179.894 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -54.03 -7.2 0.61 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 CA-C-N 120.174 1.098 . . . . 0.0 112.973 179.809 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -117.42 3.53 12.5 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.301 -0.874 . . . . 0.0 109.451 -179.987 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 68.09 -178.9 20.33 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -178.764 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.476 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -83.0 83.29 7.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.686 -1.479 . . . . 0.0 109.593 -178.444 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.472 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 2.6 p80 -91.89 -160.02 0.7 Allowed 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.132 -0.98 . . . . 0.0 109.769 178.403 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.2 m -56.76 -47.7 79.5 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.806 -1.184 . . . . 0.0 112.984 -175.852 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.599 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 11.3 tpt180 -56.35 -59.72 11.19 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 120.388 -1.445 . . . . 0.0 111.919 -179.23 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.472 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 12.0 Cg_endo -58.83 -34.63 99.13 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 CA-C-N 120.369 1.168 . . . . 0.0 111.521 -179.525 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.68 72.8 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.986 179.914 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.78 -44.09 77.41 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.48 -179.078 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -70.01 -41.67 74.03 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.964 -1.095 . . . . 0.0 108.528 179.347 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -63.04 -53.96 45.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.448 -0.783 . . . . 0.0 110.346 -179.733 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 84.2 t -61.77 -28.23 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.528 -1.357 . . . . 0.0 109.768 -179.006 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -64.56 -42.56 95.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.063 -1.023 . . . . 0.0 109.48 -179.92 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -69.77 -42.04 74.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.321 -0.862 . . . . 0.0 111.429 -178.509 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 326' ' ' ALA . . . . . 0.421 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -61.65 -54.66 39.74 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.498 -1.376 . . . . 0.0 111.244 -178.591 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -54.15 -10.21 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.894 -1.129 . . . . 0.0 109.633 -179.672 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 328' ' ' GLY . . . . . 0.421 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -71.96 -28.8 67.99 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.249 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -104.59 144.08 32.18 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.335 -1.097 . . . . 0.0 109.458 -179.661 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 330' ' ' THR . . . . . 0.403 HG22 ' O ' ' B' ' 330' ' ' THR . 91.5 m -90.56 -11.46 40.0 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.137 -0.977 . . . . 0.0 109.742 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 58.9 m -65.58 153.73 40.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.998 . . . . 0.0 109.45 179.999 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.44 134.98 49.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.078 -1.014 . . . . 0.0 109.164 -179.74 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.1 mt -131.89 132.81 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.519 -0.738 . . . . 0.0 109.453 -179.718 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 24.6 m -129.12 149.89 50.74 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.462 -0.774 . . . . 0.0 109.618 -179.814 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 90.8 t -123.66 115.4 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.404 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 94.0 m -113.73 122.8 48.21 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.09 -1.007 . . . . 0.0 110.928 -177.903 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 337' ' ' SER . . . . . 0.428 ' C ' ' H ' ' B' ' 339' ' ' GLY . 16.8 t -121.98 127.84 50.79 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.414 0.626 . . . . 0.0 109.312 178.873 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 35.6 m120 57.77 6.37 0.44 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.601 0.715 . . . . 0.0 109.481 -178.777 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 339' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' B' ' 337' ' ' SER . . . 101.19 13.16 34.23 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.23 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -104.57 121.15 42.91 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.616 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 58.2 p -100.16 151.54 21.31 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.259 1.028 . . . . 0.0 112.54 -177.026 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -149.76 148.72 29.56 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.35 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 343' ' ' SER . . . . . 0.414 ' H ' ' HE2' ' B' ' 349' ' ' LYS . 1.8 t -89.27 130.01 35.74 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.991 -1.068 . . . . 0.0 110.777 -178.725 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -70.16 -19.91 63.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.267 -0.896 . . . . 0.0 110.311 -179.663 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -84.19 21.71 1.34 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.8 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 346' ' ' SER . . . . . 0.589 ' CB ' ' HZ3' ' B' ' 349' ' ' LYS . 14.6 p -152.08 98.14 2.4 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.877 0.846 . . . . 0.0 111.21 179.583 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.65 HD23 HD22 ' A' ' 79' ' ' LEU . 45.9 tp -59.69 -32.74 70.78 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.832 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.801 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.9 m-85 -52.93 -51.88 59.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.329 -0.857 . . . . 0.0 111.386 -179.625 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 349' ' ' LYS . . . . . 0.589 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 33.6 mtmm -70.01 -40.0 75.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.727 -1.233 . . . . 0.0 111.108 -178.324 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' B' ' 352' ' ' THR . 88.7 mt -49.08 -57.09 7.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.798 -1.189 . . . . 0.0 109.931 -178.832 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.714 ' NE2' ' HE ' ' A' ' 126' ' ' ARG . 4.0 mm100 -44.86 -10.84 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.053 -1.029 . . . . 0.0 111.15 -177.697 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.565 ' N ' ' O ' ' B' ' 350' ' ' LEU . 72.5 p -87.24 -13.34 44.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 119.895 -1.753 . . . . 0.0 110.258 -178.978 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 53.0 mt -94.77 122.41 37.36 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.931 -1.106 . . . . 0.0 109.499 179.001 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.1 92.14 1.04 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 179.368 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 25.8 mt -101.83 95.37 6.36 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.424 -1.045 . . . . 0.0 109.176 179.817 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 75.0 p -93.64 -179.74 5.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.222 -0.924 . . . . 0.0 111.048 -178.954 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -69.27 114.16 7.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.711 -0.618 . . . . 0.0 110.51 -179.508 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 358' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 99.99 10.17 46.73 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.759 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 53.2 m -87.18 111.39 20.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -1.094 . . . . 0.0 110.195 -179.822 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 68.0 t -77.08 114.61 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.024 0.916 . . . . 0.0 109.61 -177.384 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 11.8 m -108.26 176.7 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -178.936 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 43.3 m -131.61 126.62 35.19 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.597 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.3 mt -103.49 117.79 49.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.398 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 64.8 m -118.72 130.82 56.03 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.108 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.41 150.8 39.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.267 -178.995 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -145.49 124.36 12.7 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.268 -0.895 . . . . 0.0 109.059 179.579 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.558 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.6 -154.49 25.57 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.403 -1.38 . . . . 0.0 111.072 -179.602 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -59.98 -50.63 73.01 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.468 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.419 ' N ' ' OG ' ' B' ' 331' ' ' SER . 85.1 m-20 -110.03 11.03 24.06 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.838 -1.163 . . . . 0.0 111.192 -177.193 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -40.84 -36.21 0.6 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.334 -0.853 . . . . 0.0 111.79 -178.992 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -69.13 -41.32 77.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.65 -1.281 . . . . 0.0 110.007 -178.526 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -72.97 -54.93 7.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.001 -1.062 . . . . 0.0 110.062 179.763 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -42.33 -34.33 0.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.545 -0.722 . . . . 0.0 111.238 -178.766 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.561 ' O ' HG23 ' B' ' 378' ' ' VAL . 93.3 t -80.0 -35.47 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.758 -1.214 . . . . 0.0 109.55 179.289 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -69.95 -39.99 75.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 112.303 -179.112 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -80.08 -46.61 16.21 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.383 -1.448 . . . . 0.0 110.432 -179.465 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.0 -38.03 81.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.889 . . . . 0.0 108.995 -179.637 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.561 HG23 ' O ' ' B' ' 374' ' ' VAL . 26.9 t -61.5 -48.22 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.277 -0.889 . . . . 0.0 109.718 179.381 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.02 -56.51 6.77 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.625 -1.297 . . . . 0.0 107.613 178.785 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.449 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 46.6 tp -52.51 -32.19 39.12 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.364 -0.835 . . . . 0.0 109.201 -179.176 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 34.3 ttm -76.07 -39.63 54.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 0.0 108.63 177.74 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.12 -5.06 50.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.58 -0.7 . . . . 0.0 109.873 179.614 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -108.26 3.74 23.89 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.29 -0.881 . . . . 0.0 110.499 -179.364 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' B' B ' 384' ' ' LEU . . . . . 0.449 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 27.6 mt -74.84 125.4 28.73 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.453 -1.404 . . . . 0.0 109.543 179.708 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.323 179.715 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtt . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.449 -0.575 . . . . 2.91 109.449 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.1 mt -109.9 129.23 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.504 -0.748 . . . . 1.2 109.201 179.808 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.6 m -140.64 122.33 15.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.306 -0.871 . . . . 1.4 109.607 -179.903 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.44 -161.47 31.4 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 108.962 -1.655 . . . . 1.05 108.962 179.319 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 5' ' ' ILE . 97.3 mt -90.22 -9.96 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.114 -1.227 . . . . 1.15 110.42 -179.028 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.6 tp 52.55 99.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.974 -1.079 . . . . 0.98 109.441 179.884 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.27 -27.31 15.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.118 -0.989 . . . . 0.88 109.535 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.0 t -136.4 121.14 12.91 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.385 -0.822 . . . . 1.69 109.22 179.944 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.08 144.77 24.02 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.788 1.659 . . . . 0.85 111.989 -179.949 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.885 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.72 -159.88 30.99 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.117 -1.593 . . . . 0.92 109.117 -179.576 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.8 mt -149.94 151.64 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 121.248 -1.148 . . . . 0.81 108.587 179.041 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.78 156.49 34.87 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.735 -1.228 . . . . 0.51 110.561 179.261 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -138.27 128.4 25.74 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.375 -1.343 . . . . 0.62 107.375 178.752 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.85 -179.84 47.61 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 118.666 -1.73 . . . . 0.55 110.823 -179.819 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -80.07 159.38 26.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.757 -0.849 . . . . 2.1 109.35 -179.832 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.524 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -107.09 131.51 54.02 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.408 -0.807 . . . . 0.77 111.011 -179.076 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.7 tp -98.7 139.54 34.25 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.245 -1.391 . . . . 0.91 107.245 178.161 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 34.2 tp -117.06 121.32 40.98 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.288 -0.883 . . . . 0.93 110.305 -178.971 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.422 HD12 ' HB2' ' A' ' 160' ' ' ALA . 45.4 mt -96.41 107.74 20.17 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.384 0.611 . . . . 0.93 110.036 179.905 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.623 ' HB2' ' HZ3' ' A' ' 20' ' ' LYS . 1.5 mtmp? -101.87 139.61 37.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.462 -0.774 . . . . 2.75 109.044 179.493 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -128.27 121.75 30.04 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.407 -0.808 . . . . 3.0 108.829 179.419 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 59.3 t0 -75.79 146.53 39.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.084 -1.01 . . . . 2.77 109.598 179.859 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.5 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 84.9 tt0 -61.63 140.19 58.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.406 -0.809 . . . . 2.94 109.823 -179.793 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.4 mt -78.89 132.93 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 0.95 108.872 179.954 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -94.81 122.33 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.022 -1.049 . . . . 1.28 109.961 -179.389 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.05 138.54 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.083 -0.71 . . . . 1.21 109.083 179.979 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -89.43 123.47 33.6 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.059 -1.026 . . . . 1.81 110.255 -179.347 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.547 HH11 ' HG2' ' A' ' 28' ' ' ARG . 0.8 OUTLIER -93.96 3.81 54.82 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.379 -0.826 . . . . 2.8 109.651 -179.962 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -72.92 151.34 41.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.272 -0.892 . . . . 2.87 111.17 -178.753 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -93.24 145.61 24.31 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.581 -0.896 . . . . 2.35 108.581 179.092 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -98.46 167.02 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.071 -1.018 . . . . 0.97 110.297 -179.907 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.2 p -93.74 171.79 8.66 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.492 -0.929 . . . . 1.17 108.492 178.658 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.07 -47.21 86.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.044 -1.035 . . . . 1.18 109.45 -179.915 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -55.86 -31.9 63.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.951 -1.093 . . . . 2.56 109.834 -179.26 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -81.5 -10.23 59.52 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.347 -0.845 . . . . 1.79 110.608 -179.091 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.4 t -60.09 -49.98 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.977 -1.077 . . . . 1.0 109.132 -179.96 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.96 -40.02 91.76 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.341 -0.85 . . . . 1.77 109.614 179.799 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.58 -46.0 87.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.245 -0.909 . . . . 2.7 111.551 -178.837 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -61.39 -42.53 98.88 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.599 -1.313 . . . . 1.51 110.457 -179.085 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.04 -46.58 94.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.55 -1.344 . . . . 0.93 108.184 179.92 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -61.6 -43.9 98.0 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.257 -0.902 . . . . 1.81 109.786 179.34 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -59.99 -41.15 91.43 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.745 -1.222 . . . . 2.78 107.764 179.557 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -63.3 -44.61 94.52 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.708 -0.849 . . . . 0.78 108.708 178.246 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.08 -47.84 84.19 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.57 -0.706 . . . . 1.07 109.222 179.971 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.1 t -63.96 -44.98 91.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.065 -1.022 . . . . 1.12 108.908 179.362 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.56 -39.95 98.04 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.763 -2.135 . . . . 0.84 107.763 178.554 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.421 HH21 ' HA ' ' A' ' 81' ' ' GLU . 68.5 ttt180 -67.16 -35.81 80.47 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.572 -0.899 . . . . 3.09 108.572 178.63 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.97 87.62 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.554 -0.716 . . . . 0.88 109.621 -179.611 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.9 ttpt -64.91 -73.77 0.12 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.883 -1.136 . . . . 2.59 108.372 179.491 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.67 -38.57 0.28 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.38 -0.825 . . . . 0.7 111.203 -178.165 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.1 m -54.04 -56.85 14.1 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.718 -1.239 . . . . 1.4 108.939 179.732 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.92 88.3 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.22 -0.925 . . . . 0.67 111.123 -179.163 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -68.46 -40.07 81.17 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.956 -1.09 . . . . 1.66 109.978 -179.2 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.6 mt -65.54 -40.01 92.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.077 -1.014 . . . . 1.58 109.975 179.897 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.539 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 69.3 mm-40 -61.53 -39.96 92.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.084 -1.01 . . . . 1.35 109.869 -179.815 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -62.84 -40.03 96.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.021 -1.049 . . . . 0.77 109.967 -179.931 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.05 -39.85 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.179 -0.95 . . . . 0.63 108.911 179.669 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.539 ' NZ ' ' OE1' ' A' ' 55' ' ' GLU . 5.2 ttpm? -55.92 -49.98 71.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.92 . . . . 1.14 109.081 179.74 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -57.51 -33.54 68.15 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.374 -0.829 . . . . 0.79 110.512 -178.318 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -69.97 -38.86 76.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.897 -1.127 . . . . 1.53 110.005 179.965 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.462 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.23 -45.51 76.54 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.401 -0.812 . . . . 0.57 110.487 -179.241 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.66 -50.03 72.15 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.917 -1.135 . . . . 0.75 110.45 -178.68 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.95 -42.88 72.62 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.076 -1.25 . . . . 1.59 110.325 -179.563 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.9 m -70.13 -61.37 1.8 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.206 -0.934 . . . . 0.73 112.744 -177.678 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -93.3 -49.36 5.99 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.679 -1.263 . . . . 0.75 110.711 -178.437 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.76 -167.89 25.77 Favored Glycine 0 N--CA 1.5 2.918 0 C-N-CA 119.936 -1.125 . . . . 1.22 110.849 179.65 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -68.55 -22.12 64.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.805 -0.821 . . . . 5.81 109.859 -179.889 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -60.04 -36.22 76.82 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.654 -0.653 . . . . 3.37 110.371 -179.531 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -101.19 -15.43 17.35 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.352 -0.843 . . . . 1.77 110.322 -179.449 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -69.97 -40.2 75.51 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.933 -1.104 . . . . 1.65 110.585 -179.311 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.563 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -69.8 -28.65 65.91 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.611 -0.836 . . . . 0.77 109.91 -178.564 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.7 mt -60.06 -41.92 88.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.022 -1.071 . . . . 0.8 109.143 -179.903 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -65.88 -40.01 91.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.954 -1.091 . . . . 0.88 109.921 179.99 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -60.15 -40.41 89.77 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.9 -1.125 . . . . 1.37 109.254 179.834 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.86 -41.48 98.76 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.064 -2.014 . . . . 0.62 108.064 178.9 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.3 m170 -70.09 -43.69 70.56 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.618 -0.931 . . . . 1.5 108.595 179.169 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.9 mt -70.04 -46.63 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.367 -0.833 . . . . 0.63 109.369 179.433 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.5 ttp -60.68 -44.8 96.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.057 -1.027 . . . . 1.51 109.687 -179.61 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.859 HD11 ' CE2' ' B' ' 348' ' ' PHE . 50.8 tp -60.0 -40.06 87.91 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.802 -0.814 . . . . 0.77 108.802 179.142 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.7 tp -62.94 -39.95 96.16 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.671 -0.643 . . . . 0.62 109.537 179.614 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.421 ' HA ' HH21 ' A' ' 47' ' ' ARG . 99.7 mt-10 -79.44 5.2 13.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -0.861 . . . . 1.47 110.127 -179.14 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -56.08 128.99 38.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 1.47 110.291 -179.309 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -63.04 -14.08 43.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.591 -0.693 . . . . 1.78 110.059 -179.985 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -70.08 -37.08 75.37 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.231 -1.025 . . . . 2.53 108.231 178.505 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.03 -39.98 75.46 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.658 0.742 . . . . 0.8 109.757 179.407 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -60.05 -45.48 92.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.59 -0.694 . . . . 1.42 110.895 -178.417 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -70.78 -48.55 53.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.257 -0.902 . . . . 1.71 111.667 -178.584 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -64.16 -39.9 95.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.352 -0.842 . . . . 1.57 111.734 -177.409 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -66.27 -47.77 83.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 120.838 -1.164 . . . . 0.65 109.857 -179.541 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -70.01 -39.04 76.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.415 -0.803 . . . . 0.82 110.671 -179.674 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.97 -48.86 79.95 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.173 -0.954 . . . . 0.79 111.045 -178.917 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 96' ' ' LYS . 75.7 mt -60.01 -44.9 94.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.917 -1.115 . . . . 0.95 109.501 -178.955 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.8 mt -60.23 -50.0 81.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.76 -1.2 . . . . 0.66 107.76 178.86 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -65.07 -40.05 94.14 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 120.024 -0.67 . . . . 2.2 110.243 179.359 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 91' ' ' ALA . 56.7 t0 -84.26 -55.11 4.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.995 -1.066 . . . . 1.65 112.277 -178.241 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 92' ' ' LEU . 99.0 mttt -90.04 -1.98 58.05 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.812 -1.18 . . . . 2.03 112.145 -177.348 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 57.85 37.54 26.99 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.846 -1.159 . . . . 1.42 109.379 -179.534 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.9 mtt -93.04 166.38 12.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.497 -0.752 . . . . 1.18 109.879 -179.758 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.4 p -79.95 160.0 26.11 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.034 -0.728 . . . . 0.98 109.034 179.678 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.05 77.59 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.321 -0.862 . . . . 0.64 109.755 -179.999 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.43 ' OD1' HD22 ' A' ' 138' ' ' LEU . 20.3 t0 -65.51 -40.03 92.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.084 -1.01 . . . . 2.07 109.521 179.665 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.6 -43.12 23.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.73 110.352 -179.684 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.05 -41.69 73.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 0.54 110.278 -179.442 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.95 -39.68 95.39 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.122 -0.986 . . . . 0.56 109.474 179.956 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.546 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 81.1 t60 -59.62 -40.07 86.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.551 -0.718 . . . . 1.54 109.578 -178.804 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.422 ' O ' ' N ' ' A' ' 110' ' ' GLY . 87.2 tt0 -64.61 -40.02 94.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.305 -0.872 . . . . 1.33 110.55 -179.655 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.3 t -63.86 -60.61 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.148 -0.97 . . . . 0.72 111.478 -178.308 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.0 mm -65.06 -39.96 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.855 -1.153 . . . . 0.85 109.268 -179.459 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.546 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 85.3 tt0 -67.04 -39.98 87.08 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.076 -1.083 . . . . 2.44 108.076 178.275 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -56.82 -52.14 52.67 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.23 -1.148 . . . . 0.98 110.23 -179.27 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -65.07 -48.14 74.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.785 -1.421 . . . . 1.41 109.197 -179.848 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.08 85.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 1.2 109.03 179.676 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.5 m -59.57 -39.87 85.5 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.468 -0.77 . . . . 1.7 109.018 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.44 -40.03 92.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 1.47 109.015 179.02 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.2 mt -64.2 -41.87 96.88 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.273 -0.892 . . . . 1.56 109.784 -179.247 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.02 -33.78 72.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.822 -1.174 . . . . 2.2 109.783 -179.272 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -56.92 -20.52 23.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.108 -0.995 . . . . 2.12 108.927 179.949 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.0 mt -62.63 138.66 58.54 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.188 -1.041 . . . . 2.0 108.188 179.469 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 57.9 t0 -94.69 54.97 1.84 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.931 -1.105 . . . . 3.23 110.086 -179.611 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 58.9 t0 -136.1 136.7 40.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.345 -0.847 . . . . 2.49 108.938 179.23 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.461 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 98.9 mt-10 -70.02 -31.61 69.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.42 -0.8 . . . . 3.95 109.964 -179.537 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.508 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.4 t80 -72.64 -38.86 67.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.871 . . . . 2.0 110.728 179.886 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.409 HD22 ' O ' ' B' ' 351' ' ' GLN . 70.7 mt -74.12 -36.26 64.18 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.975 -1.078 . . . . 1.86 109.745 -179.369 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -60.04 -40.0 87.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.015 -1.053 . . . . 2.84 109.357 179.601 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -60.0 -47.31 86.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 2.73 109.482 179.957 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.545 HH21 ' NE2' ' B' ' 351' ' ' GLN . 62.0 mtp180 -60.18 -39.98 88.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.963 . . . . 2.77 108.663 179.201 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.53 -36.12 77.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.82 . . . . 1.19 108.846 178.972 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.89 -40.02 96.26 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.081 -0.711 . . . . 1.2 109.081 179.684 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -64.22 -40.93 97.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 1.55 110.111 -179.352 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.55 -41.88 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.8 109.616 -179.889 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -60.01 -38.1 81.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.141 -0.974 . . . . 3.09 109.4 179.48 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -59.92 -40.88 90.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 1.46 110.361 -178.948 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.19 -45.01 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.894 -1.129 . . . . 0.71 109.581 179.815 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.97 -37.91 93.64 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.713 -1.355 . . . . 0.57 109.713 179.995 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -60.03 -47.6 85.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -1.111 . . . . 2.59 109.56 -179.378 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.418 HH12 ' HB3' ' A' ' 166' ' ' SER . 61.0 mtp180 -68.76 -33.16 73.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.238 -0.914 . . . . 2.83 109.637 -179.772 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.7 tp -57.28 -43.7 83.37 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.355 -0.841 . . . . 1.25 108.995 -179.788 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.43 HD22 ' OD1' ' A' ' 101' ' ' ASP . 84.1 mt -63.66 -39.96 95.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.13 -0.982 . . . . 0.7 108.654 179.145 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.6 mtp180 -66.89 -39.97 87.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.912 -0.773 . . . . 2.57 108.912 179.465 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -69.44 -31.7 70.18 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.554 -0.716 . . . . 1.23 110.941 -179.31 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.0 mt -70.04 -43.29 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.401 -1.437 . . . . 0.81 108.193 178.728 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 88.9 mt -71.56 -29.99 65.36 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.792 -0.568 . . . . 1.0 109.901 -179.708 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.69 40.33 8.31 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.983 -1.647 . . . . 0.89 108.983 -179.28 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.405 ' HA ' HD12 ' A' ' 144' ' ' LEU . 18.5 tp -73.99 146.36 43.88 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.386 -1.067 . . . . 1.14 109.14 -179.479 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -65.08 147.92 52.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -0.894 . . . . 4.6 110.002 -178.892 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 98.6 mt -118.89 125.63 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 122.093 0.949 . . . . 1.24 109.325 179.49 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 147' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 148' ' ' ASP . 5.5 mt -62.38 -43.58 98.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.87 -0.605 . . . . 1.54 110.219 -178.859 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 147' ' ' ILE . 32.2 t0 62.01 125.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.968 -0.753 . . . . 1.5 108.968 -179.126 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.4 mt -87.08 -2.09 58.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.256 -0.903 . . . . 0.79 109.639 -179.274 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 93.8 p -82.26 -9.96 59.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.916 -1.115 . . . . 1.4 108.752 178.951 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -88.71 18.54 4.61 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.666 . . . . 0.92 110.925 -177.818 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 65.2 mt -91.74 116.92 33.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.871 -1.143 . . . . 0.88 109.15 179.621 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -103.03 -12.03 17.72 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.251 -0.905 . . . . 2.45 110.206 -179.268 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -116.01 145.72 42.74 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.318 -0.864 . . . . 1.52 110.347 -178.805 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.81 131.97 50.63 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.496 -0.928 . . . . 1.58 108.496 179.584 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.7 m -152.57 165.23 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.69 109.954 -179.947 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.5 mt -93.31 148.8 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 105.215 -2.142 . . . . 0.61 105.215 176.776 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 39.9 tp -99.35 120.01 38.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.838 -1.164 . . . . 0.87 110.609 -177.836 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 49.6 t -123.59 130.08 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 108.752 -0.833 . . . . 0.71 108.752 179.343 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 160' ' ' ALA . . . . . 0.422 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -156.72 162.69 39.78 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.4 -0.963 . . . . 0.81 108.4 179.837 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.95 -35.83 74.8 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.185 -1.572 . . . . 0.98 107.315 178.547 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 20.8 p-10 -171.21 144.69 2.09 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.582 -0.895 . . . . 2.25 108.582 179.287 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.2 mt -111.78 139.83 46.93 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.253 -0.905 . . . . 0.78 109.863 -179.438 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.1 p -93.19 145.28 29.77 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.392 -0.818 . . . . 0.98 109.501 -179.929 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -39.36 -36.94 1.03 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.405 2.07 . . . . 0.81 113.273 179.458 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.418 ' HB3' HH12 ' A' ' 136' ' ' ARG . 68.5 m -60.01 -39.97 87.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.026 -1.046 . . . . 0.9 109.776 -178.661 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.03 -42.0 90.19 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.023 -1.048 . . . . 1.61 110.217 -179.506 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 67.8 p -54.96 -30.61 59.41 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.136 -0.977 . . . . 0.61 110.598 -178.4 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.462 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -71.36 -54.27 11.33 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.028 -1.045 . . . . 0.6 109.879 179.77 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -87.32 39.15 0.85 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.183 -1.043 . . . . 1.4 108.183 179.88 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 33.7 tp -100.22 130.62 46.37 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.622 -0.674 . . . . 0.7 109.307 179.472 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 172' ' ' ASN . . . . . 0.469 ' O ' HG23 ' A' ' 176' ' ' VAL . 77.8 m-20 -82.12 98.5 8.71 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.185 -1.043 . . . . 2.35 108.185 179.307 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 73.6 mt -67.16 -40.52 86.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.378 -0.826 . . . . 1.51 110.872 -178.592 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.39 -30.32 71.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.651 -1.281 . . . . 2.33 112.094 -177.714 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.65 -5.86 50.57 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.712 -1.243 . . . . 1.92 110.061 -178.734 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 178' ' ' GLY . 84.0 t -106.24 116.62 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.134 -0.979 . . . . 0.67 109.307 179.652 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 78.1 mt -88.04 9.96 20.71 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.475 -0.765 . . . . 1.53 110.997 -177.786 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.507 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 165.64 176.59 37.22 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.62 -1.392 . . . . 0.48 109.62 179.858 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -137.64 131.21 31.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.456 -1.026 . . . . 0.55 108.853 -179.82 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.402 ' CG2' HG21 ' A' ' 205' ' ' THR . 97.4 mt -133.46 130.0 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.772 -0.825 . . . . 0.65 108.772 179.002 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 72.1 p -148.4 160.0 43.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.965 -1.084 . . . . 0.82 110.855 -179.82 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -109.03 31.18 5.9 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.192 -1.04 . . . . 2.46 108.192 178.966 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.35 -160.44 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.919 -1.113 . . . . 1.28 111.516 -177.605 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.4 -67.68 1.99 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.34 -1.104 . . . . 2.19 110.34 -179.092 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 178.39 -130.98 1.65 Allowed Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.974 -1.584 . . . . 2.13 110.981 -179.802 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -79.46 -10.01 59.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.634 -0.921 . . . . 5.86 111.025 -178.504 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 42.9 p -81.8 4.87 20.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.968 -1.083 . . . . 3.72 109.687 -179.253 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.421 ' OG ' ' OG ' ' A' ' 191' ' ' SER . 23.4 p -90.43 137.54 32.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.134 -0.979 . . . . 1.74 110.593 -179.522 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -48.34 -47.86 36.7 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.475 -0.766 . . . . 0.95 109.673 179.977 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 98.5 m -57.4 -37.79 73.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.455 -0.778 . . . . 1.55 110.717 -178.992 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.421 ' OG ' ' OG ' ' A' ' 188' ' ' SER . 52.8 m -60.03 -39.9 87.49 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.854 -1.154 . . . . 1.51 110.354 -178.97 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 45.1 mm -64.85 -40.05 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 1.67 110.128 -179.599 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.3 mtp -60.1 -46.87 88.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.091 -1.006 . . . . 1.02 110.701 -179.765 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.71 -45.58 77.86 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.537 -1.352 . . . . 0.68 109.378 -179.589 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -60.1 -54.98 39.57 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.0 -1.062 . . . . 2.93 109.468 179.67 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 69.3 m -63.09 -40.05 96.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 0.86 110.966 -179.3 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.16 -29.17 64.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.985 -1.072 . . . . 0.67 108.468 179.73 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.97 50.03 1.09 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.285 0.564 . . . . 1.5 110.277 -179.842 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 32.7 mt -124.95 145.97 51.89 Favored Pre-proline 0 N--CA 1.503 2.212 0 N-CA-C 108.497 -0.927 . . . . 0.72 108.497 178.91 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.27 125.29 7.04 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.094 1.862 . . . . 0.61 112.555 179.737 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.26 141.23 7.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.489 -1.382 . . . . 0.66 112.154 179.866 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.84 147.14 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 107.173 -1.417 . . . . 0.79 107.173 177.811 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 17.3 m -130.78 -7.53 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 120.833 -1.167 . . . . 0.91 111.177 -178.991 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.99 23.05 24.37 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.454 -1.058 . . . . 1.01 110.454 -179.497 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.415 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 2.4 p -45.38 -44.18 11.67 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.93 -1.335 . . . . 0.99 109.88 -179.602 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 93.5 -51.65 2.38 Favored Glycine 0 N--CA 1.5 2.93 0 C-N-CA 120.129 -1.034 . . . . 1.12 111.742 178.692 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.3 t -161.9 36.23 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.577 -1.543 . . . . 1.72 110.676 -179.354 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 52.6 t -74.32 -40.83 50.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.215 -0.928 . . . . 0.89 108.934 178.409 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 209' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 209' ' ' THR . 1.5 p -53.1 -31.93 44.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.403 -0.811 . . . . 1.03 110.063 -179.147 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 39.8 t -71.11 -33.35 70.05 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.168 -0.957 . . . . 1.83 109.741 -179.741 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -89.46 -9.95 48.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 2.27 110.274 -178.995 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 69.6 t -101.52 132.85 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.254 -0.904 . . . . 0.92 110.463 -178.887 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -114.15 153.52 29.4 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.549 -1.278 . . . . 2.2 107.549 178.834 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 42.4 t30 -58.8 138.7 57.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.946 -1.097 . . . . 2.36 110.345 -178.605 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 11.6 t0 83.78 5.28 0.76 Allowed 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.113 0.482 . . . . 2.38 109.998 179.699 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.4 t0 -75.72 140.86 42.68 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.071 -1.018 . . . . 2.09 108.862 179.146 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.498 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 51.3 t80 -93.29 117.06 29.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.146 -0.971 . . . . 1.27 108.41 179.155 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.524 HD12 ' HB2' ' A' ' 16' ' ' ALA . 57.4 mt -126.42 147.35 49.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.526 -0.734 . . . . 0.75 110.379 -178.929 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 219' ' ' ILE . . . . . 0.413 HG23 ' CD2' ' A' ' 13' ' ' PHE . 86.8 mt -114.34 130.02 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 107.664 -1.236 . . . . 0.63 107.664 177.554 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 32.7 tp -100.17 118.18 35.96 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.938 -1.101 . . . . 0.7 109.571 -179.096 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.645 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 26.4 p-10 -77.64 -42.84 33.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.068 -1.02 . . . . 2.31 108.591 179.231 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.885 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 52.1 17.27 0.66 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.796 -1.187 . . . . 0.78 107.796 -178.905 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.436 ' N ' ' C ' ' A' ' 221' ' ' ASP . 45.6 t -130.86 -43.66 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.708 -1.219 . . . . 1.04 107.708 179.362 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -99.14 -0.52 41.5 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.805 -1.554 . . . . 2.44 106.805 177.942 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.521 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 40.4 t-20 60.06 46.72 10.43 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.423 -0.584 . . . . 1.55 109.423 -179.933 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 226' ' ' GLN . . . . . 0.645 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 95.3 mt-30 -140.46 157.23 45.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.385 -0.822 . . . . 1.99 109.647 -179.945 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 69.5 t -119.96 130.58 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 109.085 -0.709 . . . . 0.77 109.085 179.437 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -99.33 122.74 42.89 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.576 -0.898 . . . . 0.98 108.576 179.001 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 229' ' ' VAL . . . . . 0.502 HG22 HD22 ' A' ' 218' ' ' LEU . 59.4 t -105.61 120.0 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.568 -0.707 . . . . 0.85 109.445 -179.242 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 52.5 t30 62.96 66.76 1.17 Allowed Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.372 -0.83 . . . . 1.66 109.53 -179.731 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -89.16 127.78 1.79 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 123.142 2.561 . . . . 0.95 112.517 -179.664 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 26.0 p -75.33 170.47 16.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 1.84 109.623 -179.753 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -60.03 -39.44 85.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 2.74 109.088 179.67 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.08 -39.97 87.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.409 -0.807 . . . . 2.89 109.634 -179.382 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.6 t -67.24 -41.7 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.062 -1.024 . . . . 1.3 109.152 179.96 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 87.7 mt . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.193 -0.942 . . . . 1.09 109.921 -179.628 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 43.9 ttm . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.581 0.705 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 038 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -151.16 149.4 29.43 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.121 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -146.19 154.98 42.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.063 -1.023 . . . . 0.0 110.393 -179.226 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -150.36 146.72 26.89 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.598 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 305' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 56.8 mp0 -110.21 127.82 55.16 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.249 -0.907 . . . . 0.0 109.623 179.334 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.35 122.8 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 CA-C-O 122.295 1.045 . . . . 0.0 112.807 -176.849 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 58.8 m -77.95 101.52 6.9 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.997 0.903 . . . . 0.0 110.268 -178.987 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 308' ' ' ILE . . . . . 0.522 HG22 ' H ' ' B' ' 310' ' ' ALA . 96.9 mt -50.81 118.45 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 122.204 1.002 . . . . 0.0 109.923 -177.874 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 19.1 p -100.35 22.14 12.04 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.676 -178.776 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.522 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -86.82 114.24 57.16 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.97 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -68.82 -4.86 14.17 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 CA-C-N 120.227 1.117 . . . . 0.0 112.456 -179.283 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -108.76 4.81 24.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.518 -0.738 . . . . 0.0 109.101 179.741 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.6 169.77 8.65 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 -179.051 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.508 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -86.14 92.05 8.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.3 . . . . 0.0 108.846 -179.138 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.405 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 5.4 p80 -95.23 -159.94 0.75 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.085 -1.009 . . . . 0.0 109.98 179.029 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.3 m -58.92 -44.67 91.36 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.931 -1.106 . . . . 0.0 112.611 -175.995 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.629 HH21 ' NE2' ' B' ' 321' ' ' GLN . 1.6 tpt180 -59.88 -60.59 10.09 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 120.487 -1.383 . . . . 0.0 112.027 -178.257 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.405 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 12.0 Cg_endo -59.94 -32.04 94.55 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 CA-C-N 120.362 1.165 . . . . 0.0 111.338 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.28 70.32 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.431 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.78 -40.09 65.99 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.601 -179.079 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 321' ' ' GLN . . . . . 0.629 ' NE2' HH21 ' B' ' 317' ' ' ARG . 55.3 mt-30 -69.87 -41.0 75.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.985 -1.072 . . . . 0.0 108.662 179.061 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -60.05 -51.26 70.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.72 -0.612 . . . . 0.0 110.343 -179.223 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 323' ' ' VAL . . . . . 0.401 HG13 ' O ' ' B' ' 344' ' ' ALA . 71.1 t -69.68 -35.75 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.946 -1.096 . . . . 0.0 109.743 -179.134 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -50.05 -49.89 49.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.387 -0.821 . . . . 0.0 109.122 -179.792 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -60.07 -49.9 75.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.269 -0.895 . . . . 0.0 109.339 -179.387 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -63.14 -47.11 84.11 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.157 -0.964 . . . . 0.0 109.765 179.765 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -48.4 -26.64 2.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.531 -0.73 . . . . 0.0 109.678 -179.339 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -82.59 -15.74 72.7 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.655 -179.181 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -105.72 135.0 47.92 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.26 -1.141 . . . . 0.0 109.434 179.736 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 16.9 m -90.6 -13.36 34.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.977 -1.077 . . . . 0.0 109.246 179.651 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 52.0 p -55.05 148.77 13.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.228 -0.92 . . . . 0.0 108.848 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -68.35 128.72 37.61 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.002 -1.061 . . . . 0.0 108.567 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 95.3 mt -132.34 132.32 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.675 -0.641 . . . . 0.0 109.352 -179.809 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 27.1 m -130.63 152.36 50.08 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.449 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 46.0 t -114.73 140.16 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 178.521 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 94.2 m -130.13 122.69 28.72 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.196 -0.94 . . . . 0.0 108.646 179.604 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 2.8 t -140.53 118.14 11.59 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.936 0.875 . . . . 0.0 112.065 -178.906 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 64.1 t30 50.05 50.5 18.42 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 175.806 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.95 -10.77 72.77 Favored Glycine 0 N--CA 1.502 3.089 0 O-C-N 119.802 -1.811 . . . . 0.0 113.85 176.11 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -128.26 140.31 51.96 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 120.022 1.911 . . . . 0.0 109.514 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.7 m -126.74 147.79 49.95 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.818 0.818 . . . . 0.0 111.377 -178.266 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.3 164.58 29.86 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.309 0.576 . . . . 0.0 109.694 179.98 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 27.3 m -88.63 138.01 31.8 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.319 -0.863 . . . . 0.0 110.03 -179.326 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.401 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -78.9 -12.0 60.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.896 -1.127 . . . . 0.0 109.86 -179.479 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -91.87 20.15 5.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 178.042 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 42.6 t -145.89 94.44 2.48 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.013 -179.699 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.816 HD23 HD22 ' A' ' 79' ' ' LEU . 60.8 tp -59.88 -33.85 72.38 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.829 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 79' ' ' LEU . 58.9 m-85 -57.25 -53.68 55.38 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.32 -0.863 . . . . 0.0 110.76 -179.337 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -70.01 -29.63 66.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.868 -1.145 . . . . 0.0 110.951 -177.989 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' B' ' 352' ' ' THR . 84.8 mt -60.06 -52.86 63.55 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.157 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.61 HE22 HD11 ' B' ' 347' ' ' LEU . 0.7 OUTLIER -42.42 -21.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.436 -0.79 . . . . 0.0 110.674 -178.009 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.463 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.1 p -81.74 -12.25 58.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.406 -1.434 . . . . 0.0 109.964 -179.112 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 31.4 mt -95.39 120.08 35.0 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.95 -1.094 . . . . 0.0 109.082 178.409 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -80.89 92.5 1.45 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.364 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 22.9 mt -98.42 93.07 5.98 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.111 -1.229 . . . . 0.0 108.139 178.695 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 53.6 p -95.17 -179.96 4.99 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.084 -1.01 . . . . 0.0 111.279 -178.249 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 357' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' B' ' 359' ' ' THR . 61.3 tt0 -46.86 154.65 0.31 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.175 0.988 . . . . 0.0 111.035 -179.546 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.98 26.88 0.05 OUTLIER Glycine 0 N--CA 1.497 2.743 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.157 177.754 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 359' ' ' THR . . . . . 0.447 ' N ' ' O ' ' B' ' 357' ' ' GLN . 23.8 m -84.61 111.27 19.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.798 -1.413 . . . . 0.0 109.744 179.922 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 12.6 t -78.16 113.06 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 122.297 1.046 . . . . 0.0 109.774 -177.587 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 16.0 m -110.09 178.51 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.173 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 25.5 m -131.48 127.13 36.71 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.176 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 60.4 mt -103.43 118.9 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.96 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 58.3 p -121.19 133.23 55.17 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.401 -0.812 . . . . 0.0 109.283 -179.459 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.79 148.25 35.31 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.048 -1.032 . . . . 0.0 110.527 -179.046 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -140.03 121.19 14.78 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.275 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.561 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.38 -163.52 33.99 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.048 -1.549 . . . . 0.0 111.53 -179.758 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -59.97 -52.76 64.0 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 122.162 -0.61 . . . . 0.0 111.998 -177.896 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.507 ' H ' ' HB3' ' B' ' 331' ' ' SER . 96.0 m-20 -105.2 10.1 33.86 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.974 -1.079 . . . . 0.0 111.128 -177.407 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.561 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -42.18 -36.2 1.14 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.222 -0.924 . . . . 0.0 111.392 -179.155 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -70.0 -40.04 75.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.921 -1.112 . . . . 0.0 109.899 -179.012 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -66.51 -48.41 69.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.021 -1.049 . . . . 0.0 109.394 -179.441 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.07 -75.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 110.686 -179.098 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.64 ' O ' HG23 ' B' ' 378' ' ' VAL . 37.4 t -44.64 -38.26 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.235 -0.915 . . . . 0.0 110.881 -177.519 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.03 -51.37 64.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.576 -1.328 . . . . 0.0 110.887 -179.597 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -74.54 -40.67 61.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.88 -1.138 . . . . 0.0 109.976 -179.668 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.01 -39.79 87.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.897 . . . . 0.0 110.095 -179.502 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.64 HG23 ' O ' ' B' ' 374' ' ' VAL . 55.4 t -62.18 -43.39 97.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.211 -0.931 . . . . 0.0 109.968 -179.867 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -68.56 -54.59 15.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.615 -1.303 . . . . 0.0 108.617 178.687 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 50.1 tp -58.56 -34.72 71.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.23 -0.919 . . . . 0.0 109.937 -178.126 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 32.0 ttm -70.59 -40.05 73.46 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.408 -1.317 . . . . 0.0 108.42 177.927 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.24 -7.17 59.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.456 -0.777 . . . . 0.0 110.716 179.57 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -110.84 -1.74 16.41 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.077 -1.015 . . . . 0.0 111.54 -178.804 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.7 mt -81.89 130.25 35.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.297 -1.502 . . . . 0.0 109.197 178.823 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.328 179.937 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtt . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.61 -0.515 . . . . 2.91 109.61 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.39 127.74 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.297 -0.877 . . . . 1.2 109.491 -179.736 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.0 m -139.61 152.45 46.82 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.923 -0.769 . . . . 1.4 108.923 -179.929 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.89 -164.05 10.36 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 108.759 -1.736 . . . . 1.05 108.759 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.7 mt -88.57 -16.29 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.895 -1.356 . . . . 1.15 110.306 -179.133 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.1 tp 51.06 103.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.282 -0.886 . . . . 0.98 109.51 179.932 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.9 -25.38 14.63 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.06 -1.025 . . . . 0.88 109.523 179.604 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.5 m -134.83 121.19 14.69 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.511 -0.743 . . . . 1.69 109.432 -179.875 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -81.09 151.42 18.23 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.163 1.909 . . . . 0.85 112.81 179.947 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.926 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 142.35 177.82 17.77 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 109.248 -1.541 . . . . 0.92 109.248 179.597 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.6 mt -128.17 131.36 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 120.847 -1.384 . . . . 0.81 110.07 -179.555 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.4 155.98 49.35 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.252 -0.905 . . . . 0.51 109.888 -179.785 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.5 m-85 -129.44 129.63 44.9 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.655 -0.869 . . . . 0.62 108.655 179.879 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.79 171.7 44.29 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.979 -1.582 . . . . 0.55 110.583 179.841 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -77.39 158.42 30.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.682 -0.893 . . . . 2.1 109.294 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.451 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -101.89 129.63 48.18 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.385 -0.822 . . . . 0.77 111.775 -178.247 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.7 tp -100.17 132.26 45.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.179 -1.415 . . . . 0.91 107.179 177.928 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.0 tp -115.89 123.73 48.85 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.186 -0.946 . . . . 0.93 110.265 -179.218 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.2 mt -89.78 102.21 14.9 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.277 0.56 . . . . 0.93 110.541 -179.202 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -94.08 135.14 35.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.383 -0.823 . . . . 2.75 108.931 179.378 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -131.43 134.0 45.77 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.148 -0.97 . . . . 3.0 108.858 179.108 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -83.95 139.78 32.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 2.77 109.246 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.45 140.25 58.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.905 . . . . 2.94 109.42 -179.822 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.2 mt -82.83 133.69 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.878 . . . . 0.95 108.864 179.916 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.67 129.97 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.329 -0.857 . . . . 1.28 109.356 -179.666 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.0 mt -102.22 141.39 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.487 -0.758 . . . . 1.21 109.383 -179.84 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -96.13 120.48 36.49 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.153 -0.967 . . . . 1.81 109.721 -179.655 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.503 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.5 mmt-85 -87.48 -0.67 57.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.523 -0.735 . . . . 2.8 109.712 -179.627 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -67.9 136.55 54.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 2.87 109.235 179.991 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -81.3 150.73 28.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.105 -0.997 . . . . 2.35 109.117 179.718 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.459 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.1 pt -93.15 166.67 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.191 -0.943 . . . . 0.97 109.798 -179.933 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.9 p -96.75 171.67 8.38 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.499 -0.926 . . . . 1.17 108.499 178.705 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -48.81 80.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.121 -0.987 . . . . 1.18 109.868 -179.492 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 4.8 p-10 -57.14 -26.07 59.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.738 -1.226 . . . . 2.56 109.437 -179.639 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -82.76 -10.09 59.05 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.262 -0.899 . . . . 1.79 109.826 179.833 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -64.06 -52.48 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.964 -1.085 . . . . 1.0 109.368 -179.731 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.24 -40.05 94.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.335 -0.853 . . . . 1.77 109.478 179.817 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -67.66 -42.79 81.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.161 -0.962 . . . . 2.7 110.98 -178.926 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.485 ' OE2' ' NH1' ' A' ' 42' ' ' ARG . 72.6 mm-40 -66.67 -40.02 88.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.747 -1.221 . . . . 1.51 110.182 -179.504 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -59.97 -45.49 95.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 120.739 -1.226 . . . . 0.93 108.025 178.938 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -60.03 -39.95 87.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.35 -0.844 . . . . 1.81 109.319 179.649 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.485 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 99.0 mtt180 -60.02 -43.99 94.88 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.782 -1.192 . . . . 2.78 107.782 178.838 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -60.84 -47.06 88.08 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.743 -0.836 . . . . 0.78 108.743 178.076 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.3 tp -60.01 -48.71 80.57 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.516 -0.92 . . . . 1.07 108.516 -179.857 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 47.6 t -61.4 -42.28 98.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 1.12 108.86 179.255 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.39 -46.5 94.26 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.735 -1.746 . . . . 0.84 108.735 179.273 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.408 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 38.1 ttt-85 -62.89 -32.74 74.07 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.168 -1.049 . . . . 3.09 108.168 178.422 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.55 -43.83 93.43 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.237 -0.653 . . . . 0.88 109.237 -179.516 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 50' ' ' ALA . 26.5 ttpp -68.81 -74.25 0.13 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.854 -1.154 . . . . 2.59 108.331 179.473 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.22 -35.3 0.11 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.335 -0.853 . . . . 0.7 111.378 -178.366 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.7 t -58.44 -53.32 59.64 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.317 -1.353 . . . . 1.4 108.301 179.559 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.35 -39.99 81.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -0.857 . . . . 0.67 111.088 -179.232 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -67.57 -40.11 84.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.745 -1.222 . . . . 1.66 109.968 -179.598 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.6 mt -63.84 -40.01 95.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.978 -1.077 . . . . 1.58 108.819 179.842 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -63.93 -37.92 89.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.354 -0.841 . . . . 1.35 109.52 179.252 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -62.87 -43.5 98.62 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.098 -1.001 . . . . 0.77 108.548 179.175 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.46 -39.98 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 109.022 -0.733 . . . . 0.63 109.022 179.498 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 ttpp -56.98 -51.84 67.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.165 -0.959 . . . . 1.14 109.876 -179.781 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -58.78 -30.8 67.84 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.431 -0.793 . . . . 0.79 110.29 -178.083 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -69.64 -38.86 77.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.092 -1.005 . . . . 1.53 109.071 -179.826 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.2 -42.91 93.07 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.692 -0.63 . . . . 0.57 109.72 -179.8 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.37 -52.37 52.09 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.839 -1.305 . . . . 0.75 109.839 -179.318 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.2 -47.53 61.12 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.08 -1.247 . . . . 1.59 110.122 -179.962 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.4 m -66.49 -62.7 1.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.966 . . . . 0.73 112.399 -177.449 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -95.34 -48.48 5.86 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.761 -1.212 . . . . 0.75 111.105 -178.218 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.31 -169.68 24.96 Favored Glycine 0 N--CA 1.5 2.917 0 C-N-CA 119.801 -1.19 . . . . 1.22 111.045 179.608 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -69.95 -23.83 63.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.819 -0.812 . . . . 5.81 109.547 179.881 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -61.93 -35.92 79.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.734 -0.603 . . . . 3.37 110.947 -179.27 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.468 ' HA ' HD12 ' A' ' 72' ' ' ILE . 61.2 mmtt -99.4 -17.53 17.94 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.208 -0.932 . . . . 1.77 109.315 -179.934 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -69.2 -40.08 78.25 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.404 -0.81 . . . . 1.65 109.968 -179.187 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.566 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -69.18 -26.8 65.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.288 -0.883 . . . . 0.77 109.991 -179.137 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 69' ' ' LYS . 81.9 mt -59.95 -42.12 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.098 -1.001 . . . . 0.8 108.608 -179.973 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -66.2 -40.03 90.08 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.392 -0.923 . . . . 0.88 109.706 179.845 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -59.96 -41.17 91.31 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.939 -1.101 . . . . 1.37 109.294 179.503 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.28 -44.87 97.05 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.69 -1.764 . . . . 0.62 108.69 179.353 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.9 m170 -66.86 -49.95 64.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.417 -1.049 . . . . 1.5 109.134 179.563 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.98 -50.01 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.329 -0.857 . . . . 0.63 109.322 179.719 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.3 ttp -60.12 -39.88 87.78 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.12 -0.987 . . . . 1.51 109.774 -179.265 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.836 HD22 HD23 ' B' ' 347' ' ' LEU . 55.5 tp -67.52 -40.0 85.1 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.403 -0.81 . . . . 0.77 109.946 179.7 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.1 tp -63.63 -39.87 95.46 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.576 -0.703 . . . . 0.62 109.611 -179.488 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -83.25 6.42 19.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.935 . . . . 1.47 109.758 -179.101 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 60.9 t0 -49.88 134.12 21.4 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.318 -0.864 . . . . 1.47 110.648 -179.074 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.481 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.9 mt-10 -59.98 -25.06 64.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.724 -0.61 . . . . 1.78 111.148 -179.464 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -70.95 -33.81 70.85 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.068 -1.02 . . . . 2.53 109.346 179.629 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 79' ' ' LEU . 87.8 mt -69.94 -40.21 75.6 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.571 0.7 . . . . 0.8 109.846 179.743 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.03 -47.1 87.23 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.373 -0.829 . . . . 1.42 110.594 -178.921 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -69.96 -41.28 74.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 1.71 111.184 -178.706 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.07 -39.91 75.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.03 -1.044 . . . . 1.57 111.697 -178.63 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.82 -47.19 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.033 -1.042 . . . . 0.65 109.94 -179.233 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.43 -39.56 82.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.538 -0.727 . . . . 0.82 109.999 -179.949 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.42 85.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.164 -0.96 . . . . 0.79 110.844 -179.195 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.09 -46.85 88.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.026 -1.046 . . . . 0.95 109.859 -179.238 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.8 mt -61.64 -49.93 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 0.66 109.015 179.681 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -67.29 -41.48 85.36 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.649 -0.657 . . . . 2.2 110.89 -179.247 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -83.87 -50.51 8.0 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.84 -1.162 . . . . 1.65 112.013 -178.642 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -90.16 -3.74 57.69 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.985 -1.072 . . . . 2.03 111.699 -177.337 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.3 m80 56.77 37.56 28.89 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.782 -1.199 . . . . 1.42 109.457 -179.518 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 54.8 mtt -90.04 168.82 11.7 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.574 -0.704 . . . . 1.18 109.733 -179.683 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 63.4 p -80.38 160.03 25.52 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.33 -0.856 . . . . 0.98 108.722 179.315 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.8 -37.75 76.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.064 -1.023 . . . . 0.64 110.422 -179.271 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 38.0 p-10 -69.96 -36.74 75.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.898 -1.127 . . . . 2.07 109.799 -179.566 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.515 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.86 -42.89 20.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 0.73 109.624 179.569 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.55 -47.96 74.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.41 -0.806 . . . . 0.54 109.992 -179.514 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.97 -38.56 82.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.084 -1.01 . . . . 0.56 109.746 -179.776 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -59.94 -39.97 87.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.395 -0.816 . . . . 1.54 110.275 -178.561 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -63.8 -39.97 95.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.01 . . . . 1.33 110.809 -178.779 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.3 t -62.17 -50.07 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.034 -1.041 . . . . 0.72 111.037 -178.401 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.9 mm -69.56 -40.0 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.963 -1.086 . . . . 0.85 108.988 -179.862 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -60.03 -38.62 83.26 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.103 -0.703 . . . . 2.44 109.103 179.056 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.03 -49.95 72.8 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 120.562 -0.828 . . . . 0.98 111.219 -179.111 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -66.64 -50.02 64.31 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.77 -1.43 . . . . 1.41 110.442 -178.528 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.2 88.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.905 -1.122 . . . . 1.2 109.231 -179.704 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.0 t -60.07 -40.72 90.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.306 -0.871 . . . . 1.7 109.074 -179.557 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.98 92.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.27 -0.894 . . . . 1.47 109.12 179.291 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.6 mt -65.98 -42.3 90.0 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.117 -0.989 . . . . 1.56 109.397 -179.634 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.95 -37.91 80.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.663 -1.273 . . . . 2.2 109.302 -179.473 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -52.42 -21.46 3.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.024 -1.048 . . . . 2.12 108.681 179.539 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.515 HD13 HD13 ' A' ' 123' ' ' LEU . 59.2 mt -63.64 152.31 39.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.145 -0.972 . . . . 2.0 108.877 179.612 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -98.66 41.06 1.15 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.08 -1.012 . . . . 3.23 110.363 -179.568 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.73 149.71 49.29 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.129 -0.982 . . . . 2.49 110.227 -179.798 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 58.5 mp0 -74.96 -67.08 0.68 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.742 0.782 . . . . 3.95 109.514 178.956 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.5 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.1 t80 -39.48 -38.65 0.6 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.8 -0.562 . . . . 2.0 111.236 -178.732 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.515 HD13 HD13 ' A' ' 118' ' ' LEU . 88.7 mt -68.31 -39.92 81.85 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.714 -1.241 . . . . 1.86 108.844 -179.335 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 121' ' ' GLU . 7.7 ttpm? -67.14 -31.08 71.27 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.361 -0.837 . . . . 2.84 109.477 179.311 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -46.12 90.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.287 -0.883 . . . . 2.73 109.759 -179.405 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.472 HH21 ' CD2' ' A' ' 123' ' ' LEU . 83.8 mtm180 -65.51 -37.27 86.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.978 -1.076 . . . . 2.77 108.373 178.754 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.94 -29.05 68.13 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.284 -1.006 . . . . 1.19 108.284 178.544 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.12 -40.3 78.38 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.598 -0.89 . . . . 1.2 108.598 179.108 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.43 -40.0 96.01 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.244 -1.021 . . . . 1.55 108.244 178.976 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.6 t -66.01 -40.01 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 108.535 -0.913 . . . . 0.8 108.535 178.939 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 -60.01 -39.42 85.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.45 -0.781 . . . . 3.09 109.169 179.1 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 60.5 t0 -59.94 -39.56 85.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.384 -0.823 . . . . 1.46 109.934 -179.724 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.88 -46.6 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.108 -0.995 . . . . 0.71 110.303 -178.76 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.77 -34.32 66.38 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.519 -1.432 . . . . 0.57 109.519 179.735 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -60.0 -50.16 74.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.421 -1.046 . . . . 2.59 110.368 -179.221 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -69.98 -31.47 69.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.946 -1.096 . . . . 2.83 110.02 -179.574 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.06 -41.71 92.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.315 -0.866 . . . . 1.25 108.963 -179.153 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.43 -40.08 95.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.14 -0.975 . . . . 0.7 109.2 179.408 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.2 mtm180 -69.24 -40.0 78.15 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.309 -0.869 . . . . 2.57 108.798 179.465 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 140' ' ' ASN . . . . . 0.593 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.3 m120 -64.41 -35.39 80.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.67 -0.644 . . . . 1.23 111.456 -178.853 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.4 mt -71.09 -44.63 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.52 -1.362 . . . . 0.81 109.152 179.81 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.05 -29.01 65.92 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.663 -0.648 . . . . 1.0 109.616 -179.678 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.57 40.01 11.52 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.614 -1.795 . . . . 0.89 108.614 -179.01 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 56.5 tp -73.76 147.49 43.43 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.524 -0.986 . . . . 1.14 109.192 -179.445 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -61.06 139.58 58.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 4.6 109.63 -179.273 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.48 130.11 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-O 121.957 0.884 . . . . 1.24 109.279 179.496 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.8 mt -60.1 -47.35 92.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 115.994 -0.548 . . . . 1.54 110.76 -177.833 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.6 t0 66.11 99.7 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.44 -0.948 . . . . 1.5 108.44 -179.045 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.1 mt -70.9 -2.04 13.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.327 -0.858 . . . . 0.79 110.73 -178.653 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.9 p -84.32 -13.53 52.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.737 -1.227 . . . . 1.4 109.744 179.999 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.51 29.45 0.24 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.226 -0.921 . . . . 0.92 112.004 -177.913 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 39.5 mm -87.64 120.29 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.467 -1.396 . . . . 0.88 109.691 -179.86 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -100.38 -9.96 21.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.396 -0.815 . . . . 2.45 110.3 -179.736 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -139.39 158.09 44.74 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.986 -1.071 . . . . 1.52 110.219 -179.395 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.84 136.95 57.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.141 -0.975 . . . . 1.58 109.307 179.944 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 26.9 m -152.84 165.64 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.564 -0.71 . . . . 0.69 109.371 179.381 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.3 mt -95.55 148.0 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 105.662 -1.977 . . . . 0.61 105.662 177.208 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 60.2 tp -98.37 116.14 29.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.053 -1.029 . . . . 0.87 111.003 -177.365 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.5 t -119.98 128.24 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.493 -0.928 . . . . 0.71 108.493 178.811 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.6 160.26 37.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.111 -0.993 . . . . 0.81 108.725 -179.982 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -70.32 -33.71 71.84 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.205 -1.559 . . . . 0.98 107.848 178.669 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 162' ' ' ASP . 20.2 p-10 -161.95 170.92 18.51 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.993 -0.743 . . . . 2.25 108.993 179.859 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.3 mt -142.86 129.99 20.81 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.058 -1.026 . . . . 0.78 108.841 179.189 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 61.8 p -88.49 146.1 36.85 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.073 -1.017 . . . . 0.98 109.202 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -41.83 -35.56 2.98 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.949 1.766 . . . . 0.81 112.513 179.277 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 57.0 m -60.05 -39.98 87.85 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.066 -1.021 . . . . 0.9 109.142 -179.364 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.75 -42.85 97.77 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.377 -0.827 . . . . 1.61 109.816 179.984 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.3 p -56.53 -30.33 62.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.28 -0.887 . . . . 0.61 111.529 -178.094 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.43 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -73.19 -56.78 4.63 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.65 -1.281 . . . . 0.6 109.937 -179.974 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -79.39 36.59 0.31 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.327 -0.99 . . . . 1.4 108.327 -179.896 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.43 ' H ' ' C ' ' A' ' 169' ' ' ALA . 15.6 tp -103.2 134.33 46.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 0.7 109.593 179.466 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -86.35 101.02 12.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.882 -1.155 . . . . 2.35 107.882 178.436 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 76.3 mt -65.16 -40.97 95.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 1.51 110.947 -178.483 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -69.87 -21.77 63.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.763 -1.211 . . . . 2.33 111.086 -178.087 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -93.89 -10.69 33.07 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.796 -1.19 . . . . 1.92 109.693 -179.533 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 178' ' ' GLY . 71.5 t -105.59 116.57 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.397 -0.964 . . . . 0.67 108.397 178.599 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.9 mt -85.41 5.45 30.9 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.216 -0.928 . . . . 1.53 110.235 -178.215 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.562 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 169.4 174.44 37.82 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.4 -1.48 . . . . 0.48 109.4 179.71 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.477 ' CE1' HG11 ' A' ' 176' ' ' VAL . 18.0 m-85 -132.69 128.77 37.68 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.487 -1.008 . . . . 0.55 108.817 179.974 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.04 126.07 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.82 -0.807 . . . . 0.65 108.82 178.958 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.1 p -149.43 160.02 43.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.122 -0.986 . . . . 0.82 110.459 -179.208 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 182' ' ' ASP . 42.8 p-10 -108.23 28.85 7.89 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.764 -0.828 . . . . 2.46 108.764 179.256 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.39 -158.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.971 0.891 . . . . 1.28 112.227 -177.702 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.13 -71.4 0.8 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.959 -0.857 . . . . 2.19 110.959 -178.804 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 161.93 -131.82 2.66 Favored Glycine 0 N--CA 1.492 2.406 0 O-C-N 120.764 -1.433 . . . . 2.13 110.631 -179.658 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.764 ' HE ' HH12 ' A' ' 195' ' ' ARG . 33.2 ttt-85 -61.38 -39.99 92.7 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.586 -0.949 . . . . 5.86 111.506 -178.702 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 18.0 p -64.8 5.33 0.33 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.829 -1.169 . . . . 3.72 110.602 -178.532 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 186' ' ' ARG . 48.0 t -90.87 130.07 36.86 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.953 -1.092 . . . . 1.74 110.702 -179.591 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -49.33 -44.81 44.77 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.423 -0.798 . . . . 0.95 109.255 179.509 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 88.8 m -60.01 -39.43 85.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.615 -0.678 . . . . 1.55 109.73 -179.26 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.5 t -58.66 -42.81 89.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.892 -1.13 . . . . 1.51 110.214 -179.225 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 93.9 mt -60.8 -38.82 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 1.67 109.844 -179.991 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.7 mtp -59.97 -46.01 90.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 1.02 110.539 -179.246 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.99 -44.43 94.52 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.825 -1.172 . . . . 0.68 110.097 -179.381 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.764 HH12 ' HE ' ' A' ' 186' ' ' ARG . 51.7 mtp180 -60.03 -50.06 75.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.133 -0.979 . . . . 2.93 110.71 -179.01 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.6 m -73.41 -33.59 65.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.001 -1.062 . . . . 0.86 111.553 -178.665 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 86.8 mt -80.55 -11.07 59.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.735 -1.228 . . . . 0.67 110.475 -178.435 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 58.56 49.94 9.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.307 -0.871 . . . . 1.5 110.706 179.384 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 86.5 mt -123.84 122.98 26.29 Favored Pre-proline 0 N--CA 1.502 2.135 0 N-CA-C 108.456 -0.942 . . . . 0.72 108.456 179.0 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -43.28 133.48 6.56 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.037 1.825 . . . . 0.61 112.582 -179.845 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -170.58 150.01 3.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.846 -1.159 . . . . 0.66 111.375 179.819 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.0 mt -125.0 142.82 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 107.924 -1.139 . . . . 0.79 107.924 178.879 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.5 m -123.17 -8.57 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 O-C-N 120.85 -1.156 . . . . 0.91 111.057 -178.842 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.3 23.73 15.42 Favored Glycine 0 N--CA 1.5 2.962 0 O-C-N 121.381 -0.824 . . . . 1.01 111.203 -179.03 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 10.4 p -45.49 -44.36 12.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.776 -1.426 . . . . 0.99 109.751 -179.357 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 206' ' ' GLY . . . . . 0.417 ' H ' ' CB ' ' A' ' 182' ' ' ASP . . . 95.15 -51.28 1.89 Allowed Glycine 0 N--CA 1.499 2.88 0 C-N-CA 120.178 -1.01 . . . . 1.12 111.354 178.763 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 69.4 m -160.0 39.5 0.18 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.498 -1.59 . . . . 1.72 111.566 -179.242 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 30.9 t -79.96 -33.06 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.827 -1.171 . . . . 0.89 108.589 178.355 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.1 p -60.11 -40.01 88.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.608 -0.683 . . . . 1.03 111.095 -179.134 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 56.4 m -81.3 -13.56 58.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.971 -1.081 . . . . 1.83 110.563 -178.507 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -93.71 -11.91 30.43 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.073 -1.017 . . . . 2.27 110.755 -179.416 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 212' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 213' ' ' LYS . 46.4 t -121.27 161.78 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 O-C-N 121.19 -0.944 . . . . 0.92 110.601 -179.56 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.556 ' N ' HG12 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -120.58 158.02 28.24 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.714 -0.847 . . . . 2.2 108.714 -179.441 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 215' ' ' ASP . 57.6 t-20 -59.71 139.93 56.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 2.36 110.461 -179.384 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 3.1 t70 86.33 2.59 0.53 Allowed 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.15 0.5 . . . . 2.38 110.205 179.373 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 47.2 t0 -74.86 151.95 38.95 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.133 -0.979 . . . . 2.09 108.56 178.96 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.543 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 47.9 t80 -96.56 120.19 36.43 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.421 -0.955 . . . . 1.27 108.421 179.52 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.451 HD12 ' HB2' ' A' ' 16' ' ' ALA . 91.9 mt -124.8 141.68 51.94 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.426 -0.796 . . . . 0.75 110.754 -179.224 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 88.6 mt -109.93 129.34 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.417 -1.697 . . . . 0.63 106.417 176.32 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 45.0 tp -101.28 117.67 35.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.027 -1.045 . . . . 0.7 109.024 -178.799 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 224' ' ' ASN . 8.5 t70 -76.96 -47.46 20.79 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.158 -0.964 . . . . 2.31 108.578 179.653 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.926 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 52.77 18.38 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.21 -0.663 . . . . 0.78 109.21 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 72.8 t -132.67 -41.94 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.069 -1.456 . . . . 1.04 107.069 178.556 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.51 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 35.3 m120 -106.52 1.83 25.73 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.168 -1.419 . . . . 2.44 107.168 177.828 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.01 47.34 9.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.84 -0.538 . . . . 1.55 110.128 -179.868 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -136.97 148.51 46.96 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.314 -0.866 . . . . 1.99 109.614 179.235 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 86.1 t -123.88 125.5 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.294 -0.632 . . . . 0.77 109.294 179.659 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -91.83 122.45 34.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.135 -0.978 . . . . 0.98 108.588 179.651 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 37.0 t -102.23 118.46 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.423 -0.798 . . . . 0.85 109.478 -179.401 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.6 t30 67.57 68.77 0.52 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.441 -0.787 . . . . 1.66 108.923 -179.479 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -89.12 124.88 1.49 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.207 2.605 . . . . 0.95 112.761 -179.39 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.3 m -63.29 162.77 11.57 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -0.895 . . . . 1.84 108.881 179.684 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -60.11 -39.91 87.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.064 -1.022 . . . . 2.74 108.751 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -60.03 -38.88 84.04 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.4 -0.813 . . . . 2.89 109.193 179.534 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.64 -42.09 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.299 -0.876 . . . . 1.3 109.751 -179.75 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.121 -0.987 . . . . 1.09 109.471 -179.994 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' B' B ' 301' ' ' MET . . . . . 0.404 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 32.2 ttp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.493 0.663 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 302' ' ' PHE . . . . . 0.404 ' N ' ' CG ' ' B' ' 301' ' ' MET . 32.7 t80 -153.75 150.26 28.32 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.34 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 303' ' ' GLN . . . . . 0.444 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 3.9 pm0 -150.87 160.97 43.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.848 -1.158 . . . . 0.0 111.133 -179.398 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -152.19 148.89 28.14 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.554 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -114.03 132.13 56.11 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.218 -0.927 . . . . 0.0 109.827 179.282 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.21 127.97 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 CA-C-O 122.397 1.094 . . . . 0.0 112.61 -177.374 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 30.0 m -77.07 106.94 9.08 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.973 0.892 . . . . 0.0 110.603 -178.361 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 87.1 mt -52.2 124.05 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.408 1.099 . . . . 0.0 110.508 -177.927 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 82.5 p -109.61 20.04 18.56 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.144 -178.697 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -79.13 115.71 54.74 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.28 -0.888 . . . . 0.0 109.005 179.291 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.38 -10.95 9.65 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 CA-C-N 120.376 1.17 . . . . 0.0 113.487 -179.348 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -114.83 9.94 16.37 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.227 -0.921 . . . . 0.0 110.396 -178.898 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 68.63 172.41 7.45 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -179.036 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.5 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -85.13 92.11 8.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.867 -1.372 . . . . 0.0 109.967 -178.298 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.454 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 4.7 p80 -96.68 -159.29 0.72 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.008 -1.057 . . . . 0.0 109.62 178.163 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 4.4 m -59.4 -47.47 85.31 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.783 -1.198 . . . . 0.0 112.764 -176.182 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.566 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 10.9 tpt180 -55.74 -58.97 12.84 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 120.506 -1.372 . . . . 0.0 111.734 -179.102 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.454 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 14.3 Cg_endo -61.81 -32.5 85.8 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 120.559 1.235 . . . . 0.0 111.388 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.67 -51.23 66.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.455 -0.778 . . . . 0.0 109.27 179.491 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.37 -39.99 64.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 109.373 -179.268 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -68.7 -42.4 77.8 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.917 -1.114 . . . . 0.0 108.57 178.995 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -59.91 -50.4 73.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.526 -0.734 . . . . 0.0 110.298 -179.03 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 86.3 t -69.14 -29.15 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.722 -1.236 . . . . 0.0 110.207 -179.03 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -59.13 -49.26 78.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.112 -0.992 . . . . 0.0 109.7 -178.83 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -66.42 -40.95 89.86 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.024 -1.047 . . . . 0.0 111.102 -179.179 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.04 -54.61 43.95 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.516 -1.365 . . . . 0.0 110.993 -178.855 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -55.16 -15.91 2.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.073 -1.017 . . . . 0.0 109.007 179.702 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -70.35 -29.65 69.94 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 178.729 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -105.78 146.82 29.36 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.602 -0.94 . . . . 0.0 109.553 -179.916 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 32.0 p -90.57 -12.1 38.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.084 -1.01 . . . . 0.0 109.907 179.966 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.458 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 47.6 t -61.47 144.69 53.78 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.282 -0.886 . . . . 0.0 109.507 179.928 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -67.57 136.63 54.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.134 -0.979 . . . . 0.0 108.644 179.623 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.9 mt -130.73 131.02 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.5 -0.75 . . . . 0.0 110.002 -179.728 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 91.8 m -128.14 147.01 50.53 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.276 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.65 115.57 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.658 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 89.0 m -102.82 128.8 49.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.124 -0.985 . . . . 0.0 109.041 -178.566 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 90.8 p -139.23 114.31 9.51 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.892 0.853 . . . . 0.0 111.136 -179.217 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 27.5 m120 49.43 49.99 18.9 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 176.45 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.81 -13.86 59.93 Favored Glycine 0 N--CA 1.501 2.994 0 O-C-N 119.804 -1.81 . . . . 0.0 112.289 176.946 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -117.01 129.0 55.73 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.999 -1.295 . . . . 0.0 109.419 -179.871 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 48.4 p -126.57 147.92 49.81 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.884 0.85 . . . . 0.0 110.754 -178.962 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.45 168.03 21.07 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.505 0.669 . . . . 0.0 109.825 -179.666 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 28.2 t -90.94 136.09 33.3 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.567 -0.708 . . . . 0.0 110.835 -178.775 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -71.42 -17.52 62.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.347 -0.845 . . . . 0.0 108.795 179.159 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -88.34 16.67 6.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.599 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 10.9 t -143.94 92.12 2.3 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.732 0.777 . . . . 0.0 111.287 -179.345 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.836 HD23 HD22 ' A' ' 79' ' ' LEU . 58.9 tp -58.74 -36.86 75.01 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.379 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.805 ' CE2' HD11 ' A' ' 79' ' ' LEU . 61.1 m-85 -55.55 -50.06 71.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.854 . . . . 0.0 111.07 -179.14 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 349' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' B' ' 350' ' ' LEU . 25.2 mtmm -69.94 -40.03 75.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.722 -1.236 . . . . 0.0 110.721 -177.915 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' B' ' 352' ' ' THR . 87.9 mt -46.87 -55.69 7.57 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.995 -1.066 . . . . 0.0 109.106 -179.407 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.59 HE22 ' HG ' ' B' ' 347' ' ' LEU . 0.0 OUTLIER -39.38 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.569 -0.707 . . . . 0.0 111.169 -178.76 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.483 ' N ' ' O ' ' B' ' 350' ' ' LEU . 75.6 p -81.27 -10.15 59.64 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.127 -1.608 . . . . 0.0 109.995 -179.096 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 32.9 mt -95.29 114.99 26.83 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.062 -1.024 . . . . 0.0 109.11 178.612 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.65 94.46 0.86 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 179.307 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 34.4 mt -101.77 89.56 3.72 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.366 -1.079 . . . . 0.0 109.279 179.721 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 46.9 p -94.16 177.02 6.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.102 -0.998 . . . . 0.0 110.934 -179.129 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -67.6 113.51 5.47 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.643 -0.661 . . . . 0.0 110.135 -179.918 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.93 9.41 34.66 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.974 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 66.3 m -90.85 107.64 19.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -1.139 . . . . 0.0 110.91 -179.536 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 14.5 t -76.89 118.15 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.201 1.0 . . . . 0.0 109.152 -177.641 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.0 m -113.42 178.14 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.968 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 58.1 m -130.86 128.27 40.27 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.287 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 93.9 mt -100.6 112.51 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.639 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 60.6 m -117.79 130.82 56.52 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.621 -0.675 . . . . 0.0 109.346 -179.217 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.79 151.99 39.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.815 . . . . 0.0 109.245 -179.493 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -145.83 125.51 13.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.4 -0.812 . . . . 0.0 108.867 179.666 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.537 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.11 -155.77 26.65 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.14 -1.505 . . . . 0.0 111.455 -179.984 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.73 -51.6 69.08 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 122.224 -0.574 . . . . 0.0 112.333 -177.508 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.458 ' H ' ' HB2' ' B' ' 331' ' ' SER . 72.0 m-20 -110.01 13.17 23.44 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.829 -1.17 . . . . 0.0 111.221 -177.399 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -41.55 -34.33 0.56 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.292 -0.88 . . . . 0.0 111.507 -178.866 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -69.05 -41.15 78.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.589 -1.319 . . . . 0.0 109.994 -178.266 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -69.47 -50.1 48.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.842 -179.629 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -54.34 -36.22 63.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.86 . . . . 0.0 111.885 -178.077 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.574 ' O ' HG23 ' B' ' 378' ' ' VAL . 71.1 t -74.31 -39.96 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.134 -1.604 . . . . 0.0 109.191 179.294 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.89 -56.01 14.04 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.331 -0.855 . . . . 0.0 111.923 -178.25 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -69.98 -39.97 75.62 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.31 -1.494 . . . . 0.0 111.905 -178.377 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 89.1 mt -57.99 -37.16 73.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.607 -1.308 . . . . 0.0 108.676 -179.286 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.574 HG23 ' O ' ' B' ' 374' ' ' VAL . 48.9 t -60.03 -47.61 91.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.196 -0.94 . . . . 0.0 109.402 179.163 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 379' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' B' ' 383' ' ' GLU . 4.3 mptp? -69.98 -56.38 7.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.643 -1.285 . . . . 0.0 108.079 178.493 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.48 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 62.8 tp -50.99 -36.39 38.92 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.187 -0.946 . . . . 0.0 108.787 -178.648 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 40.9 tpp -73.01 -39.92 65.61 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.421 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.09 -4.2 46.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.74 -0.6 . . . . 0.0 109.959 179.463 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' B' ' 379' ' ' LYS . 95.5 mt-10 -108.05 3.54 24.08 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.249 -0.907 . . . . 0.0 110.234 179.909 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 384' ' ' LEU . . . . . 0.48 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 15.1 mt -79.34 114.21 18.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.369 -1.457 . . . . 0.0 107.753 178.184 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.459 -179.777 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.187 -0.671 . . . . 2.91 109.187 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.7 mt -109.99 129.99 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.365 -0.834 . . . . 1.2 109.241 179.863 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.1 m -129.34 151.09 50.36 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.713 -0.617 . . . . 1.4 109.846 -179.379 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.526 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -135.22 -162.15 9.62 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.01 -1.636 . . . . 1.05 109.01 179.869 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.8 mt -90.11 -18.88 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.867 -1.373 . . . . 1.15 109.561 -179.535 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.5 tp 55.71 107.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.491 -0.755 . . . . 0.98 109.189 -179.507 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.32 -26.97 13.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.406 -0.809 . . . . 0.88 108.99 179.529 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.1 m -137.59 120.93 11.55 Favored Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.499 -0.751 . . . . 1.69 109.215 179.555 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.59 151.09 19.42 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.121 1.881 . . . . 0.85 112.825 179.928 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.9 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 146.79 173.01 17.65 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 109.469 -1.452 . . . . 0.92 109.469 179.705 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.7 mt -125.77 130.88 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 120.964 -1.315 . . . . 0.81 109.223 -179.74 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.89 150.65 48.37 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.169 -0.957 . . . . 0.51 110.048 -179.265 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 13' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 9.3 m-85 -123.22 129.94 52.07 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.267 -1.012 . . . . 0.62 108.267 179.765 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.59 172.76 45.14 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 118.81 -1.662 . . . . 0.55 110.69 179.988 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -78.66 158.82 28.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.609 -0.936 . . . . 2.1 108.906 179.655 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.548 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.05 131.62 51.12 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.325 -0.859 . . . . 0.77 111.107 -178.684 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.2 tp -101.52 135.01 43.74 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.167 -1.42 . . . . 0.91 107.167 178.161 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.3 tp -116.72 126.48 53.2 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.295 -0.878 . . . . 0.93 109.87 -179.06 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.4 mt -89.32 102.01 14.68 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.365 0.602 . . . . 0.93 110.214 -179.515 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -92.52 136.37 33.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.445 -0.784 . . . . 2.75 109.003 179.619 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -131.15 117.44 19.08 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.3 -0.875 . . . . 3.0 109.629 179.743 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 54.1 t0 -71.55 144.5 49.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.889 -1.132 . . . . 2.77 109.45 179.772 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.51 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 88.8 tt0 -63.52 139.95 58.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 2.94 109.526 -179.878 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.5 mt -83.89 134.5 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.791 -0.818 . . . . 0.95 108.791 -179.773 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.4 t -101.99 127.04 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.29 -0.881 . . . . 1.28 110.279 -179.11 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.9 mt -105.7 137.85 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.794 -0.817 . . . . 1.21 108.794 179.304 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -97.52 113.59 25.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.994 -1.066 . . . . 1.81 109.318 179.71 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -84.83 5.24 29.53 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.536 -0.913 . . . . 2.8 108.536 179.9 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -60.56 146.35 45.46 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.544 -0.722 . . . . 2.87 109.36 179.916 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -88.88 141.69 28.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 2.35 108.963 179.616 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 pt -94.47 165.73 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.1 -1.0 . . . . 0.97 109.383 179.773 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.0 p -97.91 174.21 6.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.004 -1.06 . . . . 1.17 108.72 178.856 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.83 84.18 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.362 -0.935 . . . . 1.18 109.297 -179.631 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 52.2 t0 -56.71 -30.39 63.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.773 -1.204 . . . . 2.56 109.923 -179.94 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -81.82 -10.56 59.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.235 -0.916 . . . . 1.79 110.02 -179.645 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -62.98 -51.67 68.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.908 -1.12 . . . . 1.0 108.68 179.713 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -61.7 -40.07 93.71 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.454 -0.779 . . . . 1.77 109.887 -179.588 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -68.84 -40.32 79.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 2.7 111.295 -178.492 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -66.14 -40.18 90.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.399 -1.438 . . . . 1.51 110.351 -179.528 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.95 -47.97 91.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.706 -1.246 . . . . 0.93 109.195 179.444 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -61.89 -44.13 97.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.005 -1.059 . . . . 1.81 109.935 179.977 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -60.06 -44.03 95.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.862 -1.149 . . . . 2.78 108.117 179.803 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -63.0 -46.98 85.12 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.196 -0.668 . . . . 0.78 109.196 179.062 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.5 tp -59.87 -46.19 90.08 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.608 -0.886 . . . . 1.07 108.608 179.933 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.9 t -65.76 -43.74 87.97 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.265 -0.974 . . . . 1.12 108.861 179.276 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.21 -44.23 97.39 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.83 -2.108 . . . . 0.84 107.83 178.703 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.428 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 25.5 ttt-85 -65.39 -34.67 78.86 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.34 -0.985 . . . . 3.09 108.34 178.228 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.77 -40.0 86.76 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.732 -0.84 . . . . 0.88 108.732 -179.862 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 50' ' ' ALA . 1.2 ttmp? -61.47 -73.95 0.09 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.043 -1.095 . . . . 2.59 108.043 179.111 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.07 -34.94 0.09 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.253 -0.905 . . . . 0.7 111.904 -177.775 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.0 t -59.67 -50.37 74.14 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.344 -1.342 . . . . 1.4 108.291 179.846 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.05 92.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.501 -0.749 . . . . 0.67 110.504 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.9 -40.19 91.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.805 -1.184 . . . . 1.66 110.188 -179.118 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.07 -39.88 91.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.975 -1.078 . . . . 1.58 109.199 179.633 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -60.27 -39.93 88.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.541 -0.724 . . . . 1.35 110.136 179.853 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.466 HG22 ' HZ3' ' A' ' 60' ' ' LYS . 94.4 m -62.83 -43.87 97.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.019 -1.051 . . . . 0.77 109.459 179.724 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.621 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.9 mt -61.35 -39.68 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.48 -0.763 . . . . 0.63 109.588 -179.919 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -57.43 -51.86 67.73 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.175 -0.953 . . . . 1.14 110.403 -179.43 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -58.88 -35.38 72.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.357 -0.839 . . . . 0.79 110.832 -177.396 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.466 ' HZ3' HG22 ' A' ' 56' ' ' THR . 27.3 mttp -66.02 -38.16 87.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.056 -1.028 . . . . 1.53 109.332 179.841 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.443 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -65.81 -45.86 80.77 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.74 -0.6 . . . . 0.57 110.2 -179.529 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.4 -53.38 45.39 Favored Glycine 0 N--CA 1.485 1.93 0 C-N-CA 120.09 -1.052 . . . . 0.75 110.61 -178.548 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.07 -41.78 73.68 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.938 -1.331 . . . . 1.59 110.382 -179.06 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.0 m -70.03 -60.05 2.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.92 -1.113 . . . . 0.73 111.981 -177.838 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.428 ' CE1' ' O ' ' A' ' 168' ' ' THR . 76.7 m-85 -95.94 -50.56 4.82 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.862 -1.149 . . . . 0.75 111.243 -178.178 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.75 -166.87 26.1 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 119.899 -1.143 . . . . 1.22 110.683 -179.974 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -69.98 -24.97 63.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.78 -0.836 . . . . 5.81 110.353 -179.479 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.418 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 48.5 tp10 -60.36 -34.91 74.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.38 -0.825 . . . . 3.37 110.294 -179.366 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.483 ' HA ' HD12 ' A' ' 72' ' ' ILE . 43.9 mmtm -100.28 -17.51 17.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.295 -0.878 . . . . 1.77 110.291 -179.318 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -69.98 -44.51 69.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.067 -1.02 . . . . 1.65 110.667 -179.248 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.557 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.69 -25.64 65.78 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.386 -0.822 . . . . 0.77 109.885 -178.393 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 69' ' ' LYS . 80.9 mt -59.91 -41.18 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.0 -1.062 . . . . 0.8 108.764 -179.886 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -69.99 -36.6 75.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.077 -1.014 . . . . 0.88 110.805 -179.789 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -59.93 -40.1 87.76 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.92 -1.112 . . . . 1.37 109.434 -179.495 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.79 -43.54 93.84 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.587 -1.805 . . . . 0.62 108.587 178.742 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 57.4 m170 -60.0 -46.14 90.44 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.357 -1.084 . . . . 1.5 108.761 179.703 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.67 -45.16 96.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.226 -0.921 . . . . 0.63 108.677 179.147 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.3 ttp -60.89 -43.05 99.0 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.309 -0.869 . . . . 1.51 110.036 -179.864 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.457 HD13 HD23 ' B' ' 347' ' ' LEU . 12.5 tp -61.21 -41.9 97.65 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.715 -0.846 . . . . 0.77 108.715 179.869 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.16 -38.14 89.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.636 -0.665 . . . . 0.62 109.917 -179.636 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -85.39 4.4 35.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.067 -1.02 . . . . 1.47 110.206 -179.101 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -50.1 131.4 23.32 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.964 -1.085 . . . . 1.47 110.44 -179.124 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -58.46 -20.65 46.96 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.67 -0.644 . . . . 1.78 110.14 -179.403 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.89 -33.08 71.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.118 -0.989 . . . . 2.53 108.735 179.477 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.0 mt -71.98 -40.1 68.82 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.352 0.596 . . . . 0.8 109.876 179.348 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -60.18 -50.02 75.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.477 -0.765 . . . . 1.42 110.374 -179.0 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -70.96 -40.81 71.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.051 -1.031 . . . . 1.71 111.099 -178.961 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.11 -39.97 75.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.117 -0.99 . . . . 1.57 111.573 -178.544 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.72 -46.19 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.026 . . . . 0.65 109.547 -179.309 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.85 -39.63 80.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.645 -0.66 . . . . 0.82 109.969 -179.822 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.33 -48.67 80.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.79 111.256 -179.033 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 96' ' ' LYS . 93.9 mt -63.04 -46.88 85.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.885 -1.134 . . . . 0.95 110.194 -178.927 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.1 mt -60.25 -49.48 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 122.18 0.991 . . . . 0.66 108.57 179.555 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -70.1 -40.46 74.93 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.785 -0.643 . . . . 2.2 110.578 -179.428 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -83.44 -49.7 9.04 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.901 -1.124 . . . . 1.65 111.718 -178.521 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 92' ' ' LEU . 71.0 mmtt -90.97 -1.83 57.78 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.102 -0.999 . . . . 2.03 111.73 -177.396 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 54.28 32.17 15.69 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.699 -1.251 . . . . 1.42 109.604 179.944 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.5 mtt -90.36 167.5 12.59 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.003 -0.74 . . . . 1.18 109.003 -179.848 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 68.5 p -75.42 155.14 36.65 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.844 -1.169 . . . . 0.98 107.844 178.956 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.8 -39.59 76.48 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.955 -1.09 . . . . 0.64 110.237 -179.065 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 34.4 p-10 -63.23 -38.65 91.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.855 -1.153 . . . . 2.07 109.387 179.552 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.504 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -78.29 -47.28 18.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.957 . . . . 0.73 109.44 179.509 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.85 -47.32 86.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.475 -0.766 . . . . 0.54 109.714 -179.925 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.5 -35.37 79.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 0.56 109.458 179.646 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -59.87 -44.25 94.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 1.54 108.746 -179.319 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 110' ' ' GLY . 85.8 tt0 -61.15 -40.02 92.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.265 -0.897 . . . . 1.33 109.462 179.298 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.76 -53.81 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.897 . . . . 0.72 110.475 -178.972 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.453 HG21 ' HA3' ' A' ' 134' ' ' GLY . 47.0 mm -69.87 -40.14 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.992 -1.068 . . . . 0.85 109.303 179.634 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -68.07 -38.76 82.76 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.57 -0.9 . . . . 2.44 108.57 179.045 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -59.74 -47.92 88.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.494 -1.042 . . . . 0.98 110.494 -179.182 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -67.97 -54.37 19.09 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.769 -1.43 . . . . 1.41 109.721 -179.685 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.89 -40.02 69.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 1.2 109.616 -179.925 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 54.3 m -59.95 -39.98 87.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.094 -1.004 . . . . 1.7 108.796 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.25 89.01 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.204 -0.935 . . . . 1.47 108.676 178.829 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.431 ' CD1' ' OE1' ' B' ' 351' ' ' GLN . 25.5 mt -65.57 -39.96 92.25 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.124 -0.985 . . . . 1.56 109.399 -179.643 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -57.75 -31.62 66.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.736 -1.228 . . . . 2.2 109.189 -179.264 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -59.38 -23.54 62.67 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.175 -1.046 . . . . 2.12 108.175 179.388 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 52.7 mt -62.17 139.93 58.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.23 -0.919 . . . . 2.0 108.617 -179.823 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -94.49 26.08 3.61 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.172 -0.955 . . . . 3.23 109.835 -179.699 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -110.76 129.99 55.7 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.367 -0.833 . . . . 2.49 109.729 -179.712 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -69.66 -29.36 66.79 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.48 0.657 . . . . 3.95 109.233 179.91 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.48 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.4 t80 -69.95 -39.97 75.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.702 -0.624 . . . . 2.0 110.845 -179.99 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.53 HD22 ' O ' ' B' ' 351' ' ' GLN . 96.9 mt -76.41 -32.47 58.53 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.844 -1.16 . . . . 1.86 109.582 179.918 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -60.1 -40.56 90.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.054 -1.029 . . . . 2.84 108.684 179.318 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 98.9 mt-10 -59.93 -42.92 95.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.247 -0.908 . . . . 2.73 108.964 179.615 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -61.92 -40.05 94.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 2.77 108.57 178.97 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.52 -30.81 71.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.89 . . . . 1.19 108.716 179.021 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -60.19 -39.57 86.99 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.827 -0.805 . . . . 1.2 108.827 179.607 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -68.25 -39.85 82.13 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.349 -0.845 . . . . 1.55 109.279 -179.919 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.74 -39.97 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.421 -0.8 . . . . 0.8 109.057 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -65.18 -40.04 93.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.174 -0.954 . . . . 3.09 109.963 179.629 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 1.46 110.551 -178.938 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.12 -41.22 85.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.99 -1.069 . . . . 0.71 109.667 -179.7 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.453 ' HA3' HG21 ' A' ' 108' ' ' ILE . . . -59.97 -46.02 94.87 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.009 -1.237 . . . . 0.57 110.009 -179.761 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -59.87 -46.92 87.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.104 -1.233 . . . . 2.59 111.324 -179.511 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.621 HH22 ' CD1' ' A' ' 57' ' ' ILE . 60.4 mtp180 -63.85 -37.08 86.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.835 -1.166 . . . . 2.83 110.407 -179.385 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.6 tp -58.43 -42.88 88.27 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.353 -0.842 . . . . 1.25 110.132 -178.753 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.83 -39.96 93.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.001 -1.062 . . . . 0.7 108.961 179.628 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -65.72 -39.51 91.24 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.789 -0.819 . . . . 2.57 108.789 178.791 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -64.38 -36.96 85.83 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.649 -0.657 . . . . 1.23 110.951 -179.63 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.3 mt -70.54 -42.06 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.521 -1.362 . . . . 0.81 108.44 179.002 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.63 -38.75 73.94 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.609 0.718 . . . . 1.0 109.063 179.684 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.56 43.85 4.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.276 -1.93 . . . . 0.89 108.276 -178.767 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 144' ' ' LEU . 21.3 tp -74.51 142.86 44.77 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.484 -1.009 . . . . 1.14 109.46 -179.183 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -62.3 137.87 58.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.423 -0.798 . . . . 4.6 109.795 -179.325 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 92.8 mt -113.94 129.97 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.217 1.008 . . . . 1.24 109.583 179.396 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.7 mt -64.44 -41.51 92.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.802 -0.635 . . . . 1.54 110.968 -178.145 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 47.4 t0 61.26 105.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.323 -0.861 . . . . 1.5 109.581 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 152' ' ' ILE . 58.8 mt -68.75 -6.69 28.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.474 -0.766 . . . . 0.79 110.12 -179.357 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.5 t -83.37 -13.77 54.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.13 -0.981 . . . . 1.4 108.922 179.314 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.34 18.51 2.64 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.608 -0.683 . . . . 0.92 110.239 -178.442 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.415 HD12 ' O ' ' A' ' 149' ' ' LEU . 66.1 mt -90.31 111.21 23.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.028 -1.045 . . . . 0.88 108.845 -179.778 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -97.31 -9.71 27.03 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.285 -0.884 . . . . 2.45 110.836 -178.559 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -120.47 149.12 42.89 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.214 -0.929 . . . . 1.52 110.175 -178.987 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -64.89 131.22 46.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.422 -0.799 . . . . 1.58 109.216 -179.9 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -151.95 163.77 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.511 -0.743 . . . . 0.69 109.343 179.614 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 83.3 mt -92.76 151.08 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 105.939 -1.875 . . . . 0.61 105.939 177.156 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 56.4 tp -102.07 118.73 37.51 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.121 -0.987 . . . . 0.87 110.798 -177.961 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.2 t -126.22 132.08 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 108.538 -0.912 . . . . 0.71 108.538 179.543 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.6 168.73 24.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.179 -0.951 . . . . 0.81 109.05 179.797 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.0 -37.78 75.78 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.489 -1.382 . . . . 0.98 108.287 178.735 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -170.66 148.51 3.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.58 -0.7 . . . . 2.25 109.189 179.737 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.4 mt -116.1 134.43 54.94 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.49 -0.757 . . . . 0.78 109.553 -179.641 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 77.7 p -94.15 149.96 37.64 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.428 -0.795 . . . . 0.98 109.038 179.501 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -39.63 -34.75 0.8 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.334 2.023 . . . . 0.81 113.005 179.562 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 59.6 m -58.04 -42.51 85.54 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.217 -0.993 . . . . 0.9 109.353 -178.503 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -70.07 -39.96 75.31 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.163 -0.961 . . . . 1.61 109.792 179.456 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.428 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 68.8 p -52.79 -26.62 14.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -0.905 . . . . 0.61 111.112 -178.051 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -82.06 -55.88 4.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.874 -1.141 . . . . 0.6 109.963 179.624 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -80.25 40.14 0.48 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.677 -1.231 . . . . 1.4 107.677 179.775 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.458 ' H ' ' C ' ' A' ' 169' ' ' ALA . 17.7 tp -97.91 124.55 42.39 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.98 -0.748 . . . . 0.7 108.98 179.858 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -81.61 97.8 8.04 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.112 -1.07 . . . . 2.35 108.112 179.189 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.54 -44.85 95.33 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.565 -0.709 . . . . 1.51 110.62 -178.591 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -62.38 -32.02 72.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.1 -1.0 . . . . 2.33 112.47 -177.394 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -93.29 -10.27 36.07 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.684 -1.26 . . . . 1.92 110.787 -177.862 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 176' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 178' ' ' GLY . 91.4 t -102.36 113.11 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.048 -1.032 . . . . 0.67 108.749 178.986 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 39.6 mt -85.75 5.14 33.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.188 -0.945 . . . . 1.53 110.687 -178.31 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.463 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 175.09 168.62 35.92 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.309 -1.424 . . . . 0.48 109.82 179.531 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.441 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 23.0 m-85 -130.52 127.93 40.13 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.494 -1.003 . . . . 0.55 108.745 179.787 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.403 ' CG2' HG21 ' A' ' 205' ' ' THR . 62.2 mt -130.56 124.19 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.332 -0.988 . . . . 0.65 108.332 178.725 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 36.0 p -139.53 152.0 46.57 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.343 -0.848 . . . . 0.82 110.642 -179.247 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 182' ' ' ASP . . . . . 0.543 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.7 OUTLIER -100.62 26.71 6.47 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.75 -0.833 . . . . 2.46 108.75 179.356 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.37 -161.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.103 -0.998 . . . . 1.28 111.574 -177.819 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.9 -57.34 6.42 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.974 -0.85 . . . . 2.19 110.974 -178.874 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.51 -132.69 2.04 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 118.887 -1.625 . . . . 2.13 111.2 -179.33 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 186' ' ' ARG . . . . . 0.513 ' NH2' ' NH1' ' A' ' 195' ' ' ARG . 10.7 mtp-105 -80.18 -10.11 59.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.474 -1.015 . . . . 5.86 110.533 -178.663 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 71.5 p -81.49 5.99 16.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.008 -1.058 . . . . 3.72 109.906 -179.231 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.5 t -88.34 134.15 33.89 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.048 -1.033 . . . . 1.74 110.191 -179.63 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -48.21 -43.2 31.82 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.237 -0.914 . . . . 0.95 108.681 179.645 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 93.5 m -59.4 -39.91 84.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.831 -0.543 . . . . 1.55 109.83 -179.517 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 55.8 p -59.9 -38.32 81.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.999 -1.063 . . . . 1.51 110.264 -179.397 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.6 mm -59.95 -40.0 81.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.322 -0.862 . . . . 1.67 109.371 -179.782 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.5 mtp -58.78 -49.93 75.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.269 -0.894 . . . . 1.02 110.55 -178.971 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -50.59 -44.3 56.88 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.855 -1.153 . . . . 0.68 109.524 -178.98 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 195' ' ' ARG . . . . . 0.513 ' NH1' ' NH2' ' A' ' 186' ' ' ARG . 65.4 mtp180 -59.94 -51.53 69.28 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.62 -0.832 . . . . 2.93 110.349 -178.709 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.7 m -76.07 -32.03 59.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.945 -1.097 . . . . 0.86 111.711 -178.152 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.3 -20.33 48.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.737 -1.227 . . . . 0.67 110.017 -179.197 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 60.41 46.81 9.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.205 -0.934 . . . . 1.5 110.223 -179.36 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 97.4 mt -121.09 129.18 25.39 Favored Pre-proline 0 N--CA 1.501 2.115 0 N-CA-C 108.375 -0.972 . . . . 0.72 108.375 178.715 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -43.52 131.2 7.17 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.975 1.783 . . . . 0.61 112.753 -179.571 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -168.91 146.54 3.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.703 -1.248 . . . . 0.66 111.607 179.962 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.3 mt -122.42 144.35 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 106.966 -1.494 . . . . 0.79 106.966 178.011 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 13.6 m -123.56 -13.2 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 O-C-N 120.854 -1.154 . . . . 0.91 111.454 -178.223 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.12 26.24 19.59 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.498 -1.041 . . . . 1.01 110.498 -179.172 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.456 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 7.7 p -47.23 -39.44 14.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.837 -1.39 . . . . 0.99 110.047 -179.117 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.81 -51.68 4.34 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 119.913 -1.137 . . . . 1.12 111.851 178.671 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 49.9 m -158.33 40.99 0.26 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.474 -1.603 . . . . 1.72 111.489 -178.766 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 18.5 t -79.52 -33.39 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.88 -1.138 . . . . 0.89 108.106 178.192 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.0 p -54.44 -31.61 55.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.657 -0.652 . . . . 1.03 110.92 -179.139 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 35.3 m -80.66 -10.91 59.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.99 -1.069 . . . . 1.83 110.304 -179.108 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -104.85 -13.98 15.65 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.274 -0.891 . . . . 2.27 110.788 -179.224 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.4 t -108.01 138.71 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.141 -0.974 . . . . 0.92 110.824 -178.497 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 213' ' ' LYS . . . . . 0.455 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 0.1 OUTLIER -118.31 150.6 39.2 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.38 -1.341 . . . . 2.2 107.38 178.434 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 214' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 17.9 p30 -51.81 138.58 23.58 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.065 -1.022 . . . . 2.36 111.001 -178.488 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.6 m-20 80.01 5.27 1.88 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 116.424 -0.353 . . . . 2.38 111.332 178.789 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.455 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 91.8 m-20 -73.7 140.4 46.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.648 -1.283 . . . . 2.09 109.025 178.977 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.03 116.85 24.5 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.358 -0.979 . . . . 1.27 108.358 179.508 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' A' ' 16' ' ' ALA . 86.3 mt -126.66 146.17 50.29 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.382 -0.824 . . . . 0.75 110.784 -178.92 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 78.6 mt -113.32 127.29 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.081 -1.822 . . . . 0.63 106.081 177.206 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 54.7 tp -101.21 119.23 38.45 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.865 -1.147 . . . . 0.7 108.51 -179.112 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.491 ' C ' ' N ' ' A' ' 223' ' ' VAL . 92.6 m-20 -77.07 -45.27 27.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.131 -0.98 . . . . 2.31 109.378 179.893 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 222' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 49.78 14.23 0.12 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.355 -0.979 . . . . 0.78 108.355 -178.996 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 223' ' ' VAL . . . . . 0.491 ' N ' ' C ' ' A' ' 221' ' ' ASP . 49.0 t -130.65 -45.3 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 106.601 -1.629 . . . . 1.04 106.601 178.542 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 224' ' ' ASN . . . . . 0.426 ' H ' ' HB3' ' A' ' 221' ' ' ASP . 20.0 t-20 -99.67 -2.71 34.76 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.416 -1.327 . . . . 2.44 107.416 178.064 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 225' ' ' ASN . . . . . 0.526 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 62.56 40.0 10.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.917 -0.489 . . . . 1.55 110.194 179.837 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -136.99 148.25 46.77 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.248 -0.907 . . . . 1.99 109.751 178.939 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.7 t -119.85 121.17 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.792 -0.568 . . . . 0.77 109.675 179.946 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -90.25 128.02 36.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.003 -1.06 . . . . 0.98 109.442 -179.887 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.8 t -100.73 111.51 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.469 -0.769 . . . . 0.85 110.205 -179.256 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 43.1 t30 50.01 65.74 6.51 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.193 -0.942 . . . . 1.66 111.482 178.899 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -90.05 156.49 4.83 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.969 2.446 . . . . 0.95 112.232 178.822 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.3 m -66.16 156.37 34.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.231 -0.918 . . . . 1.84 110.334 -179.237 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -60.01 -38.3 82.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.514 -0.741 . . . . 2.74 109.414 179.99 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -59.74 -36.05 75.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.117 -0.989 . . . . 2.89 108.903 -179.925 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.4 t -68.33 -40.11 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 1.3 108.718 178.913 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.6 mt . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.424 -0.798 . . . . 1.09 109.29 179.255 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 58.1 ttp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.694 0.759 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -153.87 150.67 28.64 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.831 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -152.32 160.91 43.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.024 -1.047 . . . . 0.0 110.719 -179.099 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -156.62 154.16 29.73 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.081 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 305' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 55.2 mp0 -110.31 129.53 55.72 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.252 -0.905 . . . . 0.0 109.709 179.577 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.41 121.95 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 CA-C-O 121.942 0.877 . . . . 0.0 112.157 -177.247 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 48.7 m -78.87 105.7 10.37 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 122.163 0.982 . . . . 0.0 111.444 -177.915 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.9 mt -53.08 123.52 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 122.438 1.113 . . . . 0.0 111.151 -177.863 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 76.0 p -111.42 19.88 17.79 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.895 -179.61 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.91 129.12 87.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.905 -1.122 . . . . 0.0 109.403 -179.932 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -51.17 -23.84 13.76 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 CA-C-N 119.983 1.03 . . . . 0.0 113.364 -179.506 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -122.16 11.42 10.16 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.348 -0.845 . . . . 0.0 109.203 -179.94 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.7 -171.25 55.15 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -178.481 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.48 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.7 tp -88.81 93.93 9.75 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.857 -1.378 . . . . 0.0 108.791 -179.618 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.401 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 4.3 p80 -98.21 -159.02 0.71 Allowed 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.357 -0.839 . . . . 0.0 110.853 179.793 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 7.7 m -57.38 -47.01 82.8 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.246 -0.909 . . . . 0.0 112.699 -176.299 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.557 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.2 tpt180 -58.88 -60.25 11.12 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 120.434 -1.416 . . . . 0.0 112.217 -178.072 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.401 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 10.3 Cg_endo -60.3 -30.71 91.66 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 CA-C-N 120.449 1.196 . . . . 0.0 111.45 -179.679 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.04 75.31 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.147 -0.971 . . . . 0.0 108.413 179.527 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.85 -43.52 77.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.444 -0.785 . . . . 0.0 109.673 -179.492 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -71.47 -41.76 68.97 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.913 -1.117 . . . . 0.0 108.792 178.763 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.58 -52.82 61.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.331 -0.856 . . . . 0.0 110.54 -179.76 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 74.9 t -67.19 -27.85 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.719 -1.238 . . . . 0.0 110.12 -178.781 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -60.25 -42.75 95.98 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.642 179.514 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -65.53 -55.59 16.94 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.9 -1.125 . . . . 0.0 109.794 -179.778 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.93 71.81 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.923 -1.111 . . . . 0.0 110.469 -179.447 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -48.92 -22.48 0.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 108.99 -179.278 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -82.59 -13.05 79.16 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.778 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -104.95 141.84 35.83 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.363 -1.08 . . . . 0.0 108.894 179.416 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 38.9 p -90.9 -13.6 33.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.785 -1.197 . . . . 0.0 110.014 -179.832 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 331' ' ' SER . . . . . 0.49 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 67.5 p -59.98 142.77 53.23 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.039 -1.038 . . . . 0.0 109.181 179.909 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 332' ' ' GLU . . . . . 0.405 ' OE1' ' N ' ' B' ' 332' ' ' GLU . 40.2 mp0 -65.58 132.84 49.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.999 -1.063 . . . . 0.0 108.54 179.619 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 95.8 mt -130.92 132.42 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.447 -0.783 . . . . 0.0 109.712 -179.859 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 27.1 m -129.93 147.09 51.65 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.514 -0.742 . . . . 0.0 109.33 179.492 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 59.9 t -120.76 116.73 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.386 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 71.9 m -104.93 121.51 43.87 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.164 -0.96 . . . . 0.0 109.712 -178.66 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 94.5 p -133.92 121.89 22.34 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.901 0.857 . . . . 0.0 111.233 -179.616 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 58.9 t30 47.51 54.5 9.59 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 176.938 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.92 -11.54 41.18 Favored Glycine 0 N--CA 1.499 2.868 0 O-C-N 120.009 -1.682 . . . . 0.0 112.843 176.481 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -121.88 134.65 54.87 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 119.087 1.444 . . . . 0.0 108.776 -179.712 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 59.7 p -133.63 152.77 51.96 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.371 -0.831 . . . . 0.0 110.947 -178.231 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -147.18 169.95 18.25 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.382 0.61 . . . . 0.0 109.842 -179.859 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 72.3 m -88.16 140.94 28.97 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.472 -0.768 . . . . 0.0 110.403 -179.38 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.484 ' HA ' HD11 ' B' ' 350' ' ' LEU . . . -81.91 -15.39 54.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.043 -1.035 . . . . 0.0 109.442 179.677 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -86.4 16.33 4.6 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.52 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 346' ' ' SER . . . . . 0.426 ' H ' ' C ' ' B' ' 344' ' ' ALA . 13.5 p -147.97 93.38 2.18 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.278 -179.362 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 347' ' ' LEU . . . . . 0.506 ' HA ' HD12 ' B' ' 350' ' ' LEU . 21.8 tp -60.76 -32.93 72.22 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.746 -0.596 . . . . 0.0 109.704 178.97 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -53.22 -51.92 60.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.68 -1.263 . . . . 0.0 110.064 -179.558 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -70.69 -39.91 73.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 0.0 110.831 -179.408 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 350' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' B' ' 352' ' ' THR . 86.1 mt -48.05 -54.44 13.07 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.771 -1.206 . . . . 0.0 109.293 -179.311 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.53 ' O ' HD22 ' A' ' 123' ' ' LEU . 37.7 mt-30 -40.99 -15.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.592 -0.693 . . . . 0.0 110.931 -178.726 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 352' ' ' THR . . . . . 0.587 ' N ' ' O ' ' B' ' 350' ' ' LEU . 62.0 p -87.72 -10.22 51.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.456 -1.402 . . . . 0.0 110.247 -179.424 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 60.3 mt -95.01 116.77 29.12 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.93 -1.106 . . . . 0.0 109.454 179.0 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.88 94.17 1.08 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.081 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 25.5 mt -100.64 92.04 4.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.297 -1.119 . . . . 0.0 109.507 -179.632 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 44.6 p -90.03 172.41 8.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.93 -1.106 . . . . 0.0 111.197 -178.862 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -66.84 116.9 8.23 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.359 0.599 . . . . 0.0 110.491 -179.856 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 99.61 8.92 51.37 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.7 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 45.6 m -87.61 111.3 21.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.404 -1.056 . . . . 0.0 110.404 -179.604 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 22.0 t -77.48 116.34 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 122.202 1.001 . . . . 0.0 109.448 -177.662 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 18.4 m -110.98 177.2 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.025 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 42.6 m -130.88 126.98 37.59 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.491 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.3 111.75 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.923 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 61.7 p -118.24 132.87 56.28 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.796 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.3 150.66 37.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.91 . . . . 0.0 109.974 -178.974 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 366' ' ' GLU . . . . . 0.402 ' O ' ' OE1' ' B' ' 332' ' ' GLU . 18.4 tp10 -141.61 122.42 14.4 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.505 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 367' ' ' GLY . . . . . 0.463 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 160.36 -160.61 31.91 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.053 -1.546 . . . . 0.0 111.477 -179.886 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -59.81 -50.14 74.97 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.979 -0.718 . . . . 0.0 112.42 -177.245 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 369' ' ' ASP . . . . . 0.49 ' H ' ' HB3' ' B' ' 331' ' ' SER . 70.7 m-20 -109.95 13.65 23.35 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.035 -1.041 . . . . 0.0 111.22 -177.223 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 370' ' ' GLU . . . . . 0.564 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -45.44 -34.96 3.43 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.081 -1.012 . . . . 0.0 111.852 -178.876 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' B' B ' 371' ' ' GLN . . . . . 0.518 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 96.6 mt-30 -70.94 -41.4 71.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.809 -1.182 . . . . 0.0 110.098 -179.001 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -66.41 -43.26 86.24 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.338 -0.852 . . . . 0.0 109.725 -178.869 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -53.95 -71.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 110.977 -178.965 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 374' ' ' VAL . . . . . 0.588 ' O ' HG23 ' B' ' 378' ' ' VAL . 60.0 t -46.86 -37.69 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.914 -1.116 . . . . 0.0 110.204 -177.682 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -63.74 -50.0 70.8 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.75 -1.219 . . . . 0.0 110.345 179.518 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -78.5 -42.83 28.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.065 -1.022 . . . . 0.0 110.157 -179.894 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.95 -37.46 79.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.25 -0.906 . . . . 0.0 109.631 -179.306 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 378' ' ' VAL . . . . . 0.588 HG23 ' O ' ' B' ' 374' ' ' VAL . 46.7 t -63.68 -40.2 88.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.209 -0.932 . . . . 0.0 109.325 179.836 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -70.59 -57.46 4.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.616 -1.303 . . . . 0.0 107.929 178.134 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 54.4 tp -57.41 -34.65 69.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.513 -0.742 . . . . 0.0 110.348 -178.151 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.9 ttm -70.51 -40.02 73.77 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.424 -1.423 . . . . 0.0 108.199 177.831 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.69 -7.25 59.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.811 -0.555 . . . . 0.0 110.794 179.324 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 383' ' ' GLU . . . . . 0.406 ' O ' ' OE2' ' B' ' 385' ' ' GLU . 96.7 mt-10 -111.73 -0.22 16.05 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.978 -1.076 . . . . 0.0 111.585 -179.388 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.1 mt -83.21 130.48 35.09 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.421 -1.424 . . . . 0.0 109.684 179.456 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' B' B ' 385' ' ' GLU . . . . . 0.428 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 35.4 mp0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.177 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.722 0 CA-C-O 121.191 0.519 . . . . 2.91 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 94.9 mt -109.41 124.72 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.914 -0.773 . . . . 1.2 108.914 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.6 m -130.07 130.31 44.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.978 -0.749 . . . . 1.4 108.978 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.664 ' N ' HD22 ' A' ' 225' ' ' ASN . . . -115.49 -166.93 15.05 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 108.754 -1.738 . . . . 1.05 108.754 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 5' ' ' ILE . 72.5 mt -91.06 -10.48 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.033 -1.275 . . . . 1.15 110.562 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.485 HD11 ' O ' ' A' ' 8' ' ' SER . 57.5 tp 53.3 98.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.684 -1.26 . . . . 0.98 109.8 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.97 -38.7 44.57 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.848 -0.797 . . . . 0.88 108.848 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.485 ' O ' HD11 ' A' ' 6' ' ' LEU . 5.0 m -141.27 140.2 20.43 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.498 -0.751 . . . . 1.69 109.595 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -80.48 140.33 13.38 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.529 2.153 . . . . 0.85 112.821 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.748 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.99 -163.68 36.94 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.05 -1.62 . . . . 0.92 109.05 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.2 mt -148.64 149.63 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.208 -1.172 . . . . 0.81 108.156 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.38 155.58 33.88 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.572 -1.33 . . . . 0.51 110.721 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -137.89 129.68 28.43 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.072 -1.084 . . . . 0.62 108.072 178.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.43 -178.13 46.35 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 118.699 -1.715 . . . . 0.55 110.905 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -80.07 156.51 27.05 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.811 -0.817 . . . . 2.1 109.519 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.585 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.11 129.75 51.81 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.449 -0.782 . . . . 0.77 110.934 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.3 tp -100.09 135.83 40.93 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.307 -1.368 . . . . 0.91 107.307 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.2 tp -117.77 127.45 53.92 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.262 -0.899 . . . . 0.93 109.951 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.4 mt -88.28 101.22 13.64 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 120.115 -0.634 . . . . 0.93 109.352 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.31 137.58 32.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 2.75 108.701 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -130.48 133.33 46.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.217 -0.927 . . . . 3.0 108.998 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -81.42 149.84 28.63 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.105 -0.997 . . . . 2.77 108.94 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -66.75 146.84 54.02 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.0 -1.062 . . . . 2.94 108.893 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.8 mt -94.45 130.91 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.283 -0.886 . . . . 0.95 108.633 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.3 t -101.61 129.66 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.271 -0.893 . . . . 1.28 110.752 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -108.34 132.1 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.585 -0.894 . . . . 1.21 108.585 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -87.36 120.59 28.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.79 -1.194 . . . . 1.81 109.495 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -88.71 0.1 56.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.388 -0.82 . . . . 2.8 108.879 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -68.83 146.49 52.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 2.87 109.252 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -89.22 150.07 22.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 2.35 109.335 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.502 HG21 ' HG3' ' A' ' 39' ' ' GLU . 3.5 pt -93.92 166.18 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.321 -0.862 . . . . 0.97 109.793 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.5 p -97.59 171.12 8.56 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.224 -1.028 . . . . 1.17 108.224 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.69 -49.39 77.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.948 -1.095 . . . . 1.18 108.94 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -53.89 -29.94 43.84 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.81 -1.181 . . . . 2.56 109.516 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -82.84 -10.0 59.05 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.395 -0.816 . . . . 1.79 110.413 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.57 -53.84 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.831 -1.168 . . . . 1.0 108.691 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.21 -40.07 88.83 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.481 -0.762 . . . . 1.77 109.677 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.23 -41.96 93.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -0.901 . . . . 2.7 110.891 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.502 ' HG3' HG21 ' A' ' 31' ' ' ILE . 67.4 mm-40 -65.76 -39.98 91.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 1.51 110.419 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.0 -46.17 94.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.701 -1.249 . . . . 0.93 108.491 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -59.98 -40.63 89.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.01 -1.056 . . . . 1.81 109.192 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -60.07 -43.03 95.73 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.901 -1.125 . . . . 2.78 108.438 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -66.39 -42.97 87.09 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.842 -0.799 . . . . 0.78 108.842 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.91 -50.63 73.01 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.282 -1.007 . . . . 1.07 108.282 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 42.8 t -63.86 -42.76 97.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.371 -0.932 . . . . 1.12 108.872 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.33 -42.51 98.85 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.575 -1.81 . . . . 0.84 108.575 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.442 HH11 ' HG2' ' A' ' 47' ' ' ARG . 21.4 ttt-85 -64.95 -35.12 80.16 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.184 -1.043 . . . . 3.09 108.184 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -53.76 -39.94 65.77 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.773 -0.825 . . . . 0.88 108.773 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.565 ' HZ3' ' HB3' ' A' ' 49' ' ' LYS . 7.0 ttpm? -72.46 -73.7 0.19 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.89 -1.152 . . . . 2.59 107.89 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.439 ' HB2' ' OD1' ' A' ' 140' ' ' ASN . . . -37.02 -41.11 0.33 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.334 -0.854 . . . . 0.7 112.084 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.2 p -57.93 -55.07 39.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.591 -1.318 . . . . 1.4 108.816 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.06 95.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.446 -0.784 . . . . 0.67 110.85 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -62.16 -46.05 90.71 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.997 -1.064 . . . . 1.66 110.685 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.74 -40.21 94.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.13 -0.981 . . . . 1.58 109.418 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -62.84 -40.02 96.15 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.306 -0.871 . . . . 1.35 109.603 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.9 m -65.87 -41.5 91.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.021 -1.05 . . . . 0.77 109.983 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.1 mt -61.64 -40.0 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.112 -0.992 . . . . 0.63 108.793 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -55.44 -50.87 68.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.471 -0.768 . . . . 1.14 109.771 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -58.82 -37.51 76.56 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.329 -0.857 . . . . 0.79 110.254 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -61.7 -38.74 88.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.073 -1.017 . . . . 1.53 109.39 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.413 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -66.98 -46.9 73.19 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.745 -0.597 . . . . 0.57 110.162 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.84 -53.27 37.41 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.829 -1.308 . . . . 0.75 109.829 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.54 -44.82 66.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.05 -1.265 . . . . 1.59 110.462 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.5 m -66.53 -64.04 0.94 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.124 -0.985 . . . . 0.73 112.74 -177.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -95.8 -45.25 7.06 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.747 -1.221 . . . . 0.75 111.002 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.4 -167.47 25.5 Favored Glycine 0 N--CA 1.498 2.786 0 C-N-CA 119.771 -1.204 . . . . 1.22 110.792 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.21 -24.18 63.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 122.032 -0.687 . . . . 5.81 109.819 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.516 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.4 tp10 -60.96 -35.83 77.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.407 -0.808 . . . . 3.37 110.786 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -97.62 -19.46 18.29 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.133 -0.979 . . . . 1.77 109.764 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -68.89 -40.22 79.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.248 -0.908 . . . . 1.65 110.402 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.54 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -66.48 -32.65 74.14 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.393 -0.817 . . . . 0.77 110.144 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.06 -40.41 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 118.836 -1.145 . . . . 0.8 108.672 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -64.43 -40.14 95.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.104 -0.998 . . . . 0.88 109.15 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -60.08 -41.93 93.5 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.299 -0.876 . . . . 1.37 109.438 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.05 -43.73 97.95 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.173 -1.571 . . . . 0.62 109.173 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.4 m170 -70.0 -40.02 75.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -1.117 . . . . 1.5 109.167 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.0 -47.22 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.101 -0.999 . . . . 0.63 109.019 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.1 ttp -60.08 -40.49 89.75 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.992 -1.068 . . . . 1.51 109.836 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.882 HD11 ' CE2' ' B' ' 348' ' ' PHE . 32.2 tp -68.53 -39.93 80.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.444 -0.785 . . . . 0.77 109.289 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.34 -39.97 94.83 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.424 -0.798 . . . . 0.62 109.481 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -79.42 1.72 24.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.319 -0.863 . . . . 1.47 110.171 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -49.42 128.19 16.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.831 -1.168 . . . . 1.47 109.953 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -62.41 -16.82 57.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.55 -0.719 . . . . 1.78 110.566 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.67 -32.71 66.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.788 -1.195 . . . . 2.53 108.813 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.8 mt -70.74 -43.58 68.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.69 -0.631 . . . . 0.8 110.442 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -60.03 -43.31 95.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.046 -1.034 . . . . 1.42 110.47 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.96 -42.87 72.6 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.05 -1.031 . . . . 1.71 110.812 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.14 -39.97 75.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.959 -1.088 . . . . 1.57 111.333 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.6 mt -64.05 -50.03 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.65 109.985 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.5 mt -69.34 -35.36 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.448 -0.783 . . . . 0.82 110.173 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.63 -45.85 92.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 0.79 110.847 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.56 -47.53 85.77 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.911 -1.118 . . . . 0.95 109.982 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.9 mt -60.24 -49.67 83.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 122.093 0.949 . . . . 0.66 108.932 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -69.8 -39.94 76.28 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.15 -0.62 . . . . 2.2 111.175 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -84.83 -57.99 2.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.769 -1.207 . . . . 1.65 112.345 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -83.61 -0.94 52.69 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.964 -1.085 . . . . 2.03 111.419 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 57.34 36.63 27.44 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.117 -0.99 . . . . 1.42 109.854 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.5 mtt -90.27 167.96 12.28 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.568 -0.707 . . . . 1.18 109.976 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.9 p -80.88 160.58 24.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.473 -0.767 . . . . 0.98 109.339 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.56 -40.86 80.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.102 -0.999 . . . . 0.64 110.069 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 31.4 p-10 -64.36 -36.78 85.24 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.252 -0.905 . . . . 2.07 109.221 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.431 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.96 -48.61 12.05 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.036 -1.04 . . . . 0.73 109.844 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.65 -48.95 79.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.527 -0.733 . . . . 0.54 110.952 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.09 93.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.032 -1.043 . . . . 0.56 110.296 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.417 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 81.6 t60 -59.08 -38.27 79.06 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.055 -1.028 . . . . 1.54 110.397 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.71 -41.12 97.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.874 -1.141 . . . . 1.33 110.968 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.05 -52.19 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.013 -1.055 . . . . 0.72 110.715 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.0 mm -66.96 -39.96 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.063 -1.023 . . . . 0.85 108.402 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.417 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 89.2 tt0 -66.22 -38.2 87.37 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.737 -0.838 . . . . 2.44 108.737 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.88 -47.36 90.92 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.312 -1.115 . . . . 0.98 110.312 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -68.33 -53.48 23.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.688 -1.478 . . . . 1.41 108.677 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.89 -39.95 59.86 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.096 -1.002 . . . . 1.2 109.106 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 46.2 t -60.06 -42.74 95.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.099 -1.001 . . . . 1.7 108.544 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.89 87.37 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.394 -0.816 . . . . 1.47 109.188 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.6 mt -67.44 -41.6 84.48 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.909 -1.119 . . . . 1.56 108.986 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -53.65 -31.42 47.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.071 -1.018 . . . . 2.2 109.164 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.6 -24.88 65.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.275 -0.89 . . . . 2.12 108.717 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.42 HD13 HD13 ' A' ' 123' ' ' LEU . 61.0 mt -62.79 143.55 57.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 2.0 109.272 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -99.33 48.98 0.95 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.325 -0.86 . . . . 3.23 109.257 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 56.9 t0 -134.61 132.89 39.55 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.296 -0.878 . . . . 2.49 109.795 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.441 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 18.4 pt-20 -70.25 -29.01 65.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.568 -0.707 . . . . 3.95 109.898 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.478 ' OH ' ' NH1' ' A' ' 126' ' ' ARG . 3.5 t80 -71.1 -39.92 71.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.38 -0.825 . . . . 2.0 110.383 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.464 HD22 ' O ' ' B' ' 351' ' ' GLN . 88.9 mt -79.63 -40.05 30.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.99 . . . . 1.86 109.775 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -60.15 -49.91 75.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.982 -1.074 . . . . 2.84 109.706 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 96.6 mt-10 -61.82 -40.17 94.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 2.73 108.862 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.702 ' CG ' HE22 ' B' ' 351' ' ' GLN . 31.6 ttt180 -60.03 -40.07 88.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.857 -1.164 . . . . 2.77 107.857 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.66 -23.51 66.81 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.261 -1.015 . . . . 1.19 108.261 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -61.46 -40.03 93.05 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.58 -1.267 . . . . 1.2 107.58 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -61.54 -41.44 97.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.515 -0.741 . . . . 1.55 109.082 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 73.1 t -63.65 -40.08 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.273 -1.01 . . . . 0.8 108.273 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -62.7 -33.52 75.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.608 -0.683 . . . . 3.09 109.476 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -59.95 -41.58 92.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 1.46 109.487 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.1 mt -60.09 -45.58 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.163 -0.961 . . . . 0.71 109.863 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.66 -43.31 99.17 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.397 -0.906 . . . . 0.57 111.014 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -59.99 -47.87 84.05 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.011 -1.288 . . . . 2.59 110.901 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.594 HH12 ' CB ' ' A' ' 166' ' ' SER . 99.0 mtt180 -69.32 -29.02 66.77 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.832 -1.167 . . . . 2.83 109.903 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 57.6 tp -59.52 -41.57 90.25 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.555 -0.906 . . . . 1.25 108.555 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.6 mt -61.89 -40.12 94.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.141 -0.974 . . . . 0.7 109.317 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.87 -39.97 83.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.488 -0.757 . . . . 2.57 108.978 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.535 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.9 m120 -60.09 -39.11 84.98 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.583 -0.698 . . . . 1.23 111.279 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.1 mt -73.46 -41.2 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.764 -1.21 . . . . 0.81 109.675 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.2 mt -70.43 -31.79 69.13 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.55 -0.719 . . . . 1.0 109.434 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.12 37.94 6.98 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.215 -1.554 . . . . 0.89 109.215 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 144' ' ' LEU . 16.0 tp -73.63 142.56 46.51 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.263 -1.139 . . . . 1.14 108.644 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -69.16 142.72 54.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.207 -0.933 . . . . 4.6 110.668 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.02 129.99 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-O 122.063 0.935 . . . . 1.24 109.343 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.2 mt -61.48 -43.91 97.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.865 -0.607 . . . . 1.54 110.691 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.6 t0 63.76 103.36 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.38 -0.825 . . . . 1.5 109.094 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.492 ' O ' HD13 ' A' ' 152' ' ' ILE . 22.5 mt -70.53 -6.04 33.39 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.522 -0.736 . . . . 0.79 110.184 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 93.7 p -85.09 -14.0 48.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.128 -0.983 . . . . 1.4 108.681 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.87 14.65 2.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.687 -0.633 . . . . 0.92 111.176 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.492 HD13 ' O ' ' A' ' 149' ' ' LEU . 2.5 mp -89.4 134.34 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.603 -1.31 . . . . 0.88 108.188 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -117.53 -9.02 10.9 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.736 -0.602 . . . . 2.45 109.741 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -119.03 149.98 40.75 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.21 -0.932 . . . . 1.52 110.473 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -63.65 130.97 46.48 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.689 -0.856 . . . . 1.58 108.689 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.4 m -152.07 163.59 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.883 . . . . 0.69 109.518 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.0 mt -94.42 147.85 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 106.036 -1.839 . . . . 0.61 106.036 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.2 tp -97.31 117.4 31.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.086 -1.009 . . . . 0.87 110.905 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.91 126.42 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.215 -1.031 . . . . 0.71 108.215 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.88 161.26 40.61 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.094 -1.004 . . . . 0.81 109.201 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.42 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.35 -31.45 69.89 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.133 -1.604 . . . . 0.98 107.847 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -167.59 173.92 8.2 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.559 -0.904 . . . . 2.25 108.559 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 89.9 mt -141.22 130.04 22.99 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.076 -1.015 . . . . 0.78 108.823 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.8 p -87.89 147.91 42.17 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.03 -1.044 . . . . 0.98 109.23 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -43.38 -36.43 6.55 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.817 1.678 . . . . 0.81 112.125 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.594 ' CB ' HH12 ' A' ' 136' ' ' ARG . 50.3 m -60.04 -39.94 87.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.371 -0.831 . . . . 0.9 109.875 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.1 -40.87 78.12 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.155 -0.966 . . . . 1.61 109.751 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.8 p -55.64 -29.75 59.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.96 -1.087 . . . . 0.61 110.605 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -71.79 -51.21 23.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.879 -1.138 . . . . 0.6 109.573 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -85.02 38.52 0.72 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.417 -0.957 . . . . 1.4 108.417 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.401 HD11 HG21 ' A' ' 176' ' ' VAL . 61.8 tp -102.92 130.6 50.02 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.693 -0.63 . . . . 0.7 109.303 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -83.75 103.65 13.22 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.868 -0.789 . . . . 2.35 108.868 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 77.6 mt -64.86 -43.65 92.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.416 -0.803 . . . . 1.51 111.344 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -69.83 -25.24 63.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.893 -1.13 . . . . 2.33 112.417 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -93.18 -10.12 36.89 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.615 -1.303 . . . . 1.92 110.517 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 178' ' ' GLY . 62.3 t -109.18 119.94 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.137 -1.06 . . . . 0.67 108.137 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.1 mt -90.94 8.09 36.9 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.184 -0.947 . . . . 1.53 111.09 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.505 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.96 172.64 37.4 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.153 -1.499 . . . . 0.48 109.87 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -133.7 128.51 35.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.656 -0.908 . . . . 0.55 108.594 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 97.3 mt -132.67 127.2 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.778 . . . . 0.65 109.204 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 50.4 p -150.02 162.0 41.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.904 -1.123 . . . . 0.82 110.516 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 38.1 p-10 -104.0 23.27 13.19 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.186 -0.672 . . . . 2.46 109.186 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.44 -159.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.057 -1.027 . . . . 1.28 111.644 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.66 -54.22 6.09 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.906 -0.877 . . . . 2.19 110.906 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 160.7 -131.46 2.63 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.147 -1.501 . . . . 2.13 110.732 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.522 HH11 ' HG2' ' A' ' 186' ' ' ARG . 12.5 mtt-85 -69.91 -20.78 63.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.67 -0.9 . . . . 5.86 111.065 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 25.1 p -73.04 -0.17 13.13 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.938 -1.101 . . . . 3.72 110.322 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.9 m -91.09 132.36 36.09 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.067 -1.021 . . . . 1.74 110.064 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -49.89 -48.19 51.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.334 -0.854 . . . . 0.95 109.526 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.455 ' H ' HG22 ' A' ' 190' ' ' THR . 0.0 OUTLIER -56.75 -39.83 74.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.33 -0.856 . . . . 1.55 110.085 -179.286 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 19.7 t -60.09 -43.04 95.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.928 -1.108 . . . . 1.51 109.907 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.33 -41.34 91.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.181 -0.95 . . . . 1.67 109.798 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 86.6 mtp -63.31 -39.98 96.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.168 -0.957 . . . . 1.02 110.175 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.74 -42.89 76.05 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.561 -1.337 . . . . 0.68 108.821 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -59.89 -50.1 75.11 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.455 -0.778 . . . . 2.93 110.041 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.0 m -70.32 -33.95 72.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.093 -1.004 . . . . 0.86 110.711 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 81.8 mt -70.0 -21.36 63.23 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.107 -0.996 . . . . 0.67 109.264 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 60.74 48.89 6.67 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.239 0.542 . . . . 1.5 110.751 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.8 mt -126.42 149.57 67.9 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.218 -1.401 . . . . 0.72 107.218 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.44 137.71 66.59 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.84 1.693 . . . . 0.61 111.593 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.17 151.0 3.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.876 -1.14 . . . . 0.66 111.478 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.8 mt -126.87 143.62 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.964 -1.124 . . . . 0.79 107.964 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.8 m -128.49 -8.8 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 O-C-N 120.736 -1.227 . . . . 0.91 110.864 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.58 21.53 25.77 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 110.397 -1.081 . . . . 1.01 110.397 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 23.0 p -44.46 -44.17 8.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.114 -1.227 . . . . 0.99 110.048 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 93.94 -51.86 2.25 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 120.328 -0.939 . . . . 1.12 111.03 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.9 p -157.34 35.01 0.28 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.516 -1.579 . . . . 1.72 111.444 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.0 t -73.37 -39.86 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.969 -1.082 . . . . 0.89 108.907 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.0 p -56.14 -34.01 65.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.761 . . . . 1.03 110.666 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 23.0 t -71.19 -31.64 67.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.136 -0.977 . . . . 1.83 109.794 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -89.84 -8.22 52.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.838 . . . . 2.27 110.728 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 75.0 t -102.79 131.99 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.011 -1.056 . . . . 0.92 110.528 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -111.33 145.08 39.46 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.066 -1.457 . . . . 2.2 107.066 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.477 ' O ' ' OD1' ' A' ' 215' ' ' ASP . 44.4 p-10 -54.25 137.8 40.29 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.201 -0.937 . . . . 2.36 111.051 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER 89.3 -2.53 0.38 Allowed 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.321 0.581 . . . . 2.38 110.768 178.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -71.36 150.51 45.0 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.336 -0.853 . . . . 2.09 109.497 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -99.09 120.0 38.76 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.234 -1.024 . . . . 1.27 108.234 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 16' ' ' ALA . 73.8 mt -126.64 149.78 49.31 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.565 -0.709 . . . . 0.75 109.861 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.421 HG23 ' CD2' ' A' ' 13' ' ' PHE . 86.9 mt -119.26 129.95 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.301 -1.37 . . . . 0.63 107.301 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 23.9 tp -102.25 119.95 39.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.23 -0.919 . . . . 0.7 109.437 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 223' ' ' VAL . 29.0 t70 -80.1 -41.86 24.71 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.303 -0.873 . . . . 2.31 108.769 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.76 11.67 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.691 -0.63 . . . . 0.78 109.96 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 221' ' ' ASP . 46.7 t -118.84 -35.22 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 106.693 -1.595 . . . . 1.04 106.693 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.452 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 19.9 m120 -112.85 4.6 17.01 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.375 -1.343 . . . . 2.44 107.375 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.664 HD22 ' N ' ' A' ' 4' ' ' GLY . 48.4 t-20 57.58 50.61 10.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.855 -0.528 . . . . 1.55 110.235 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -136.95 147.5 46.38 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.216 -0.927 . . . . 1.99 109.548 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 76.0 t -115.02 129.3 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.545 -0.909 . . . . 0.77 108.545 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -104.48 121.06 42.67 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.768 -0.827 . . . . 0.98 108.768 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 43.1 t -100.08 110.95 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.593 -0.692 . . . . 0.85 109.805 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 51.69 69.94 2.22 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.41 -0.806 . . . . 1.66 110.911 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -90.67 147.64 4.06 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.33 2.687 . . . . 0.95 112.245 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 233' ' ' ASN . 11.0 m -71.02 165.38 23.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.057 -1.027 . . . . 1.84 109.932 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.434 ' N ' HG22 ' A' ' 232' ' ' THR . 41.5 t30 -59.98 -39.92 87.33 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.318 -0.864 . . . . 2.74 109.88 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -60.02 -39.86 87.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.984 . . . . 2.89 109.64 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.32 -44.21 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.155 -0.965 . . . . 1.3 109.049 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.18 -40.04 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 1.09 109.655 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.32 -40.12 85.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.895 -1.128 . . . . 2.43 108.542 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -65.33 -42.3 93.05 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.557 -0.905 . . . . 2.78 108.557 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 89.0 mtp -69.88 -33.73 72.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 1.25 109.88 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -65.59 -39.26 91.39 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.12 -0.987 . . . . 2.63 109.158 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.69 -42.88 93.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.469 -0.77 . . . . 1.8 109.946 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 53.4 t -60.07 -40.89 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.884 -1.135 . . . . 2.13 108.596 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -59.99 -40.18 88.27 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.297 -0.877 . . . . 3.17 109.292 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.61 -40.21 94.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 1.78 109.162 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -60.82 -40.46 92.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 2.47 108.824 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 79.4 t -63.44 -40.3 88.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.639 -0.663 . . . . 2.09 109.223 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.99 -42.21 93.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.272 -0.893 . . . . 2.54 109.555 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.0 t -65.01 -40.06 94.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.362 -0.836 . . . . 2.99 108.841 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -63.17 -33.71 76.06 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.575 -0.703 . . . . 3.34 109.522 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -59.95 -40.64 89.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.065 -1.022 . . . . 3.88 109.166 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.94 88.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.988 -1.07 . . . . 4.43 109.25 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 60.37 19.95 9.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.445 -0.784 . . . . 5.42 109.771 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 255' ' ' LYS . 88.0 mt -69.44 -25.02 63.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.166 -0.959 . . . . 6.1 109.391 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -42.42 -21.64 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.489 -0.757 . . . . 7.37 110.595 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 253' ' ' LEU . 57.6 mttp -72.48 162.27 29.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.001 -1.062 . . . . 8.01 109.5 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 256' ' ' LEU . 9.9 mp -58.77 -35.94 73.59 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.23 -0.919 . . . . 9.05 108.61 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -149.95 148.82 29.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.297 -0.877 . . . . 10.56 109.466 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -130.53 43.12 3.16 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.49 -0.756 . . . . 11.32 109.292 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.024 -0.989 . . . . 12.42 109.438 179.869 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 21.8 ttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -153.95 150.84 28.73 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.36 -0.838 . . . . 0.0 108.965 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -148.66 160.05 43.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.98 -1.075 . . . . 0.0 110.171 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -152.12 149.24 28.58 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -109.82 130.24 55.54 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.39 -0.818 . . . . 0.0 109.673 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 1.5 p -131.95 121.51 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 122.167 0.984 . . . . 0.0 112.021 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 50.6 m -75.74 106.1 7.13 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.828 0.823 . . . . 0.0 110.524 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.512 HG22 ' H ' ' B' ' 310' ' ' ALA . 77.9 mt -52.16 123.17 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 122.476 1.131 . . . . 0.0 110.296 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 77.7 p -104.0 23.2 13.3 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.776 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.512 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -82.66 119.47 74.63 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.142 -0.974 . . . . 0.0 109.262 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -66.3 -7.91 18.92 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 120.362 1.165 . . . . 0.0 111.884 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -117.39 6.44 12.64 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.69 176.93 34.25 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.229 -1.949 . . . . 0.0 108.229 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.465 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.3 tp -86.74 96.18 10.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.946 -1.326 . . . . 0.0 108.723 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -97.69 -159.97 0.77 Allowed 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.29 -0.881 . . . . 0.0 110.71 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 24.5 m -59.82 -43.03 94.73 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.033 -1.042 . . . . 0.0 112.303 -175.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.54 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.5 tpt180 -59.74 -64.33 3.14 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 120.356 -1.465 . . . . 0.0 111.428 -178.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -55.37 -33.78 86.66 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 CA-C-N 120.281 1.136 . . . . 0.0 111.782 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.95 71.72 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.46 -40.88 62.8 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.247 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -70.43 -40.06 74.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.031 -1.043 . . . . 0.0 108.674 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -61.44 -53.04 61.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.437 -0.789 . . . . 0.0 110.432 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 77.7 t -68.93 -35.12 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.766 -1.208 . . . . 0.0 109.756 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -59.97 -47.06 87.38 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.869 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -66.34 -40.05 89.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.096 -1.002 . . . . 0.0 109.999 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 326' ' ' ALA . . . . . 0.419 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -64.65 -52.33 57.91 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.019 -1.051 . . . . 0.0 110.789 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -54.49 -10.21 0.39 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.021 -1.049 . . . . 0.0 109.555 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 328' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -71.94 -26.19 73.12 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -101.99 144.99 29.91 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.39 -1.065 . . . . 0.0 109.272 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 8.8 m -90.87 -13.73 33.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.907 -1.121 . . . . 0.0 108.996 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.0 t -62.61 149.88 42.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 109.04 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -67.61 134.62 51.51 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.256 -0.903 . . . . 0.0 109.171 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 90.3 mt -131.12 130.45 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.711 -0.618 . . . . 0.0 109.654 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 98.3 m -129.62 152.36 49.22 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.594 -0.691 . . . . 0.0 109.187 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 61.6 t -116.94 140.47 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 70.4 m -130.36 126.12 36.31 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.211 -0.931 . . . . 0.0 109.497 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 10.8 t -138.65 111.75 7.93 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.232 -0.917 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 46.39 56.38 6.42 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 84.56 -16.2 36.87 Favored Glycine 0 N--CA 1.499 2.873 0 O-C-N 120.223 -1.548 . . . . 0.0 112.299 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -110.65 121.61 45.74 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.922 -1.34 . . . . 0.0 109.482 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 88.4 p -128.25 148.19 50.63 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.811 0.815 . . . . 0.0 109.855 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 342' ' ' ALA . . . . . 0.553 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -144.84 170.38 16.23 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.662 0.744 . . . . 0.0 110.11 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 70.4 m -88.53 140.47 29.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.605 -0.684 . . . . 0.0 109.582 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -83.13 -12.45 57.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.024 -1.048 . . . . 0.0 110.248 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -88.93 20.56 3.51 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 56.1 m -147.81 98.06 2.9 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.734 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.56 HD23 HD22 ' A' ' 79' ' ' LEU . 29.1 tp -60.0 -34.68 73.66 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.882 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.7 m-85 -57.65 -53.53 57.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.709 -1.244 . . . . 0.0 109.942 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -70.05 -21.4 63.18 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.09 -1.006 . . . . 0.0 111.17 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' B' ' 352' ' ' THR . 21.4 mt -69.42 -52.68 24.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.771 -1.206 . . . . 0.0 108.165 178.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.702 HE22 ' CG ' ' A' ' 126' ' ' ARG . 10.3 mm100 -38.33 -22.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.293 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.533 ' N ' ' O ' ' B' ' 350' ' ' LEU . 58.5 p -82.08 -10.2 59.29 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.962 -1.086 . . . . 0.0 110.215 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.553 HD11 ' HB3' ' B' ' 342' ' ' ALA . 70.6 mt -95.5 116.24 28.55 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.066 -1.021 . . . . 0.0 109.076 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -80.27 94.43 1.49 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 27.8 mt -99.82 92.64 5.4 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.237 -1.155 . . . . 0.0 108.556 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 68.4 p -94.6 179.82 5.13 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.07 -1.019 . . . . 0.0 110.632 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 357' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' B' ' 359' ' ' THR . 62.2 tt0 -48.62 157.44 0.37 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.232 1.015 . . . . 0.0 111.236 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.61 23.98 0.02 OUTLIER Glycine 0 N--CA 1.497 2.708 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.499 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 359' ' ' THR . . . . . 0.5 ' N ' ' O ' ' B' ' 357' ' ' GLN . 19.1 m -84.4 111.58 19.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.732 -1.452 . . . . 0.0 109.448 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 23.4 t -76.27 115.68 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 122.318 1.056 . . . . 0.0 109.629 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 19.0 m -112.66 176.6 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 45.9 m -130.74 129.49 42.58 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 84.3 mt -102.96 118.24 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 22.1 m -123.67 134.0 53.81 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.322 -0.861 . . . . 0.0 109.232 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.29 150.55 38.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.179 -0.951 . . . . 0.0 109.74 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -140.09 119.81 13.34 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.555 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.74 -160.93 32.37 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 118.855 -1.641 . . . . 0.0 111.691 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -59.95 -51.65 68.78 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 122.371 -0.487 . . . . 0.0 112.311 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -105.52 9.36 33.49 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.857 -1.152 . . . . 0.0 110.939 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.9 pt-20 -42.7 -34.08 0.84 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.151 -0.968 . . . . 0.0 111.088 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -70.11 -41.31 74.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.963 . . . . 0.0 110.135 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -68.12 -49.89 58.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.2 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.27 -76.03 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.382 -0.824 . . . . 0.0 110.997 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.577 ' O ' HG23 ' B' ' 378' ' ' VAL . 82.0 t -45.3 -36.49 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.98 -1.075 . . . . 0.0 111.033 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -64.53 -52.57 57.11 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.427 -1.421 . . . . 0.0 110.637 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -76.81 -40.18 48.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.665 -1.272 . . . . 0.0 110.588 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 87.7 mt -59.62 -39.28 83.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.014 . . . . 0.0 109.088 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.577 HG23 ' O ' ' B' ' 374' ' ' VAL . 50.6 t -60.98 -41.1 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.104 -0.998 . . . . 0.0 109.283 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' B' ' 383' ' ' GLU . 7.7 mtmp? -69.05 -55.2 11.5 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.567 -1.333 . . . . 0.0 108.62 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 63.3 tp -55.97 -35.07 66.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.946 -1.096 . . . . 0.0 109.783 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 6.0 ttm -70.29 -39.99 74.53 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.661 -1.275 . . . . 0.0 107.759 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.27 -7.02 58.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.766 -0.584 . . . . 0.0 110.782 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' B' ' 379' ' ' LYS . 49.3 mt-10 -111.34 1.77 17.26 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.953 -1.092 . . . . 0.0 110.989 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 17.8 mt -87.1 126.62 34.89 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.283 -1.511 . . . . 0.0 109.224 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.302 -179.775 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.028 -0.731 . . . . 2.91 109.028 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 95.2 mt -110.02 128.49 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.542 -0.724 . . . . 1.2 109.306 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.7 m -140.06 150.08 43.92 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.398 -0.813 . . . . 1.4 109.654 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.445 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -136.99 -162.94 9.55 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.297 -1.921 . . . . 1.05 108.297 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' LEU . 93.7 mt -90.4 -17.45 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.745 -1.444 . . . . 1.15 109.875 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.9 tp 51.51 103.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.365 -0.834 . . . . 0.98 109.304 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.7 -29.09 12.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.099 -1.0 . . . . 0.88 109.008 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.1 m -130.84 115.11 16.7 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.636 -0.665 . . . . 1.69 109.276 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -80.15 151.02 20.59 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 121.924 1.749 . . . . 0.85 112.627 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.887 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 150.18 169.18 16.01 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.704 -1.759 . . . . 0.92 108.704 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.9 mt -120.04 129.99 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 O-C-N 121.046 -1.267 . . . . 0.81 109.839 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.33 150.38 50.94 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.083 -1.01 . . . . 0.51 110.455 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.5 m-85 -126.87 128.46 46.53 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 107.924 -1.139 . . . . 0.62 107.924 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.56 178.55 48.47 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.583 -1.77 . . . . 0.55 110.977 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -79.98 158.81 26.48 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.892 -0.77 . . . . 2.1 109.244 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.844 ' HB3' ' OD1' ' A' ' 216' ' ' ASP . . . -106.92 129.71 54.7 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.331 -0.855 . . . . 0.77 110.92 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.7 tp -100.34 133.12 45.24 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.11 -1.441 . . . . 0.91 107.11 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.4 tp -114.83 127.32 55.65 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.258 -0.901 . . . . 0.93 109.536 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.4 mt -89.45 102.08 14.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.473 -0.767 . . . . 0.93 110.368 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -103.0 131.82 49.7 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.132 -0.692 . . . . 2.75 109.132 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -130.52 133.82 46.55 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.323 -0.861 . . . . 3.0 109.389 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -73.48 153.49 40.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.063 -1.023 . . . . 2.77 109.521 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -67.63 143.16 56.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 2.94 109.766 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.2 mt -83.13 128.15 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.895 . . . . 0.95 109.342 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.1 t -93.57 131.53 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.234 -0.916 . . . . 1.28 110.652 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.6 mt -107.97 133.57 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.861 -0.792 . . . . 1.21 108.861 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -92.29 119.25 31.69 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.04 -1.038 . . . . 1.81 109.317 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -90.7 -2.51 57.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.299 -0.875 . . . . 2.8 109.506 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -69.17 139.59 54.61 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.16 -0.963 . . . . 2.87 109.218 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -86.05 153.51 22.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.178 -0.951 . . . . 2.35 109.059 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.638 HD13 ' HG3' ' A' ' 39' ' ' GLU . 2.5 pt -98.29 166.19 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.223 -0.923 . . . . 0.97 109.711 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 81.3 p -90.08 171.66 9.38 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.299 -0.876 . . . . 1.17 109.041 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.53 -17.06 64.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.056 -1.027 . . . . 1.18 110.611 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -86.5 -26.64 24.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.863 -1.148 . . . . 2.56 108.012 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -82.31 -8.43 59.64 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.769 -0.826 . . . . 1.79 108.769 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 t -58.4 -50.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.98 -40.01 87.66 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.208 -0.933 . . . . 1.77 108.707 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -61.48 -46.55 89.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.404 -0.81 . . . . 2.7 110.926 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.638 ' HG3' HD13 ' A' ' 31' ' ' ILE . 64.5 mm-40 -60.16 -44.07 95.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.727 -1.233 . . . . 1.51 109.961 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.05 -46.15 94.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 120.918 -1.114 . . . . 0.93 108.737 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -60.03 -41.25 91.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 1.81 109.193 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -60.01 -45.99 90.96 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.914 -1.116 . . . . 2.78 108.092 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -60.52 -48.23 82.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.531 -0.731 . . . . 0.78 109.075 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.04 -49.93 75.73 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.873 -0.788 . . . . 1.07 108.873 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.457 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 47.6 t -61.47 -44.58 96.84 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.175 -0.953 . . . . 1.12 108.515 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.52 -42.84 99.85 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.454 -1.859 . . . . 0.84 108.454 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.401 ' NH1' ' HG2' ' A' ' 47' ' ' ARG . 41.0 ttt-85 -66.08 -31.08 71.73 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.324 -0.991 . . . . 3.09 108.324 178.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.59 -40.02 82.01 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.175 -0.676 . . . . 0.88 109.175 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.7 ttmt -72.33 -73.43 0.19 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.979 -1.076 . . . . 2.59 108.178 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.53 -34.7 0.15 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.339 -0.851 . . . . 0.7 110.736 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.0 m -57.14 -61.29 2.56 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.65 -1.281 . . . . 1.4 108.54 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.0 82.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 0.67 111.248 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -66.28 -42.63 88.12 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.77 -1.206 . . . . 1.66 110.374 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.98 -39.99 96.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.837 -1.165 . . . . 1.58 108.899 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.25 -35.18 79.75 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.324 -0.86 . . . . 1.35 108.822 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -63.66 -41.68 98.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 0.77 109.779 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.22 -40.05 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.124 -0.985 . . . . 0.63 108.917 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -54.75 -49.93 69.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.46 -0.775 . . . . 1.14 109.712 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -58.38 -37.33 75.03 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.344 -0.848 . . . . 0.79 109.868 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -68.18 -37.52 81.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.001 -1.062 . . . . 1.53 109.277 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.715 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -66.65 -46.56 75.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.657 -0.652 . . . . 0.57 109.862 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.96 -50.02 72.26 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.57 -1.012 . . . . 0.75 110.57 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -70.0 -40.66 75.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.944 -1.327 . . . . 1.59 110.103 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.4 m -69.98 -58.26 4.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.061 -1.025 . . . . 0.73 111.474 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.416 ' CE1' ' O ' ' A' ' 168' ' ' THR . 89.2 m-85 -96.3 -51.39 4.4 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.031 -1.043 . . . . 0.75 111.189 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.86 -167.66 25.88 Favored Glycine 0 N--CA 1.503 3.167 0 C-N-CA 119.555 -1.307 . . . . 1.22 111.339 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -66.9 -25.12 66.22 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.866 -0.785 . . . . 5.81 109.991 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.442 ' OE2' ' NH1' ' B' ' 317' ' ' ARG . 23.3 tp10 -60.06 -34.86 74.0 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.604 -0.685 . . . . 3.37 110.81 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -98.12 -19.54 17.87 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.175 -0.953 . . . . 1.77 110.529 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -69.36 -40.01 77.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.785 -1.197 . . . . 1.65 110.029 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.557 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -63.22 -33.98 76.66 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.367 -0.833 . . . . 0.77 109.695 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.8 mt -60.0 -42.88 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.077 -1.015 . . . . 0.8 109.813 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -63.34 -38.67 92.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.911 -1.118 . . . . 0.88 110.327 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -59.96 -39.99 87.49 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.859 -1.151 . . . . 1.37 109.038 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.53 -54.57 34.79 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.424 -1.47 . . . . 0.62 109.424 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -61.31 -48.21 82.43 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.167 -1.196 . . . . 1.5 109.256 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.6 mt -61.79 -50.01 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.257 -0.902 . . . . 0.63 109.18 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.0 ttp -59.98 -40.79 90.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.073 -1.017 . . . . 1.51 110.173 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.844 HD11 ' CE2' ' B' ' 348' ' ' PHE . 35.0 tp -66.54 -39.89 88.79 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.31 -0.868 . . . . 0.77 109.343 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -64.03 -38.76 92.25 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.528 -0.733 . . . . 0.62 109.329 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -80.22 2.54 23.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 1.47 110.06 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -49.17 130.5 19.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.136 -0.978 . . . . 1.47 109.689 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -63.01 -19.07 64.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.696 -0.627 . . . . 1.78 111.411 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -71.98 -32.38 67.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.656 -1.277 . . . . 2.53 108.611 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.1 mt -71.13 -41.39 70.55 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.541 0.686 . . . . 0.8 109.957 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -60.04 -45.66 92.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.868 . . . . 1.42 110.277 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.97 -41.9 73.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.895 . . . . 1.71 110.734 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.97 -39.96 75.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.157 -0.965 . . . . 1.57 111.746 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 93.8 mt -65.4 -49.09 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.977 -1.077 . . . . 0.65 109.652 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -68.25 -37.71 78.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.619 -0.676 . . . . 0.82 110.877 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.97 83.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.057 -1.027 . . . . 0.79 111.054 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 96' ' ' LYS . 78.5 mt -61.89 -46.21 90.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.908 -1.12 . . . . 0.95 110.28 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.0 mt -60.02 -49.77 82.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.084 -1.01 . . . . 0.66 108.655 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -69.95 -40.15 75.63 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.907 -0.588 . . . . 2.2 110.67 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -84.02 -46.96 11.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.016 -1.053 . . . . 1.65 111.72 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 92' ' ' LEU . 30.9 mmtp -94.64 -2.22 51.74 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.014 -1.053 . . . . 2.03 111.952 -177.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 56.26 35.82 26.43 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.788 -1.195 . . . . 1.42 109.638 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.7 mtp -91.64 167.92 11.86 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.461 -0.774 . . . . 1.18 109.54 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.1 p -82.58 160.23 22.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.145 -0.972 . . . . 0.98 109.407 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.5 -39.92 85.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.237 -0.915 . . . . 0.64 110.195 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -65.06 -37.98 89.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.123 -0.986 . . . . 2.07 109.679 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.13 -48.98 11.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.319 -0.863 . . . . 0.73 110.034 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.91 -49.56 74.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.403 -0.81 . . . . 0.54 110.532 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.06 -43.01 95.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -0.967 . . . . 0.56 109.72 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.465 ' HB2' HD21 ' A' ' 138' ' ' LEU . 78.0 t60 -59.99 -40.0 87.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 1.54 110.531 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.06 -39.98 91.91 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.962 -1.086 . . . . 1.33 109.902 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.5 t -62.2 -53.48 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.232 -0.917 . . . . 0.72 110.991 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.4 mm -69.95 -39.98 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.983 -1.073 . . . . 0.85 109.409 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.21 -39.85 94.13 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.393 -0.966 . . . . 2.44 108.393 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.06 -52.78 50.76 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.712 -0.955 . . . . 0.98 110.712 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 83.9 mm-40 -69.28 -44.79 71.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.762 -1.434 . . . . 1.41 109.861 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.88 -44.49 91.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.881 -1.137 . . . . 1.2 108.55 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 88.7 p -59.96 -36.74 77.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 1.7 109.066 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.99 94.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 1.47 109.067 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.4 mt -65.8 -42.27 90.9 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.12 -0.988 . . . . 1.56 109.508 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.43 ' C ' ' N ' ' A' ' 118' ' ' LEU . 85.5 tt0 -59.97 -39.59 86.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.909 -1.119 . . . . 2.2 110.082 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -49.26 -17.92 0.3 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.941 -1.1 . . . . 2.12 109.168 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.43 ' N ' ' C ' ' A' ' 116' ' ' GLU . 68.0 mt -62.65 140.4 58.69 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.526 -0.916 . . . . 2.0 108.526 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 49.8 t0 -93.94 44.15 1.12 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.006 -1.059 . . . . 3.23 111.124 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -137.44 150.9 47.96 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.971 -1.08 . . . . 2.49 109.575 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 124' ' ' LYS . 71.8 mm-40 -72.63 -65.82 0.74 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.144 -0.972 . . . . 3.95 109.13 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.638 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 4.0 t80 -39.11 -42.16 0.89 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.836 -0.54 . . . . 2.0 110.404 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.721 HD23 HH22 ' A' ' 126' ' ' ARG . 87.6 mt -70.58 -39.95 73.57 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.845 -1.159 . . . . 1.86 108.03 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 121' ' ' GLU . 32.8 ttmt -62.07 -38.34 88.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.673 -0.642 . . . . 2.84 110.256 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -60.06 -47.32 86.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.082 -1.011 . . . . 2.73 110.633 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.721 HH22 HD23 ' A' ' 123' ' ' LEU . 21.8 mtm-85 -70.08 -30.16 67.33 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.888 -1.133 . . . . 2.77 108.964 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.99 -27.95 67.28 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.428 -1.323 . . . . 1.19 107.428 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.17 -38.94 72.14 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.49 -0.93 . . . . 1.2 108.49 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -62.27 -42.4 99.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.583 -0.698 . . . . 1.55 110.504 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.75 -40.39 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.058 -1.026 . . . . 0.8 109.112 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.541 HH11 ' HG2' ' A' ' 131' ' ' ARG . 2.4 ttt-85 -60.62 -38.63 85.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.907 . . . . 3.09 109.356 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.02 -40.03 87.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.35 -0.844 . . . . 1.46 110.563 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.0 mt -59.94 -45.21 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.796 -1.19 . . . . 0.71 109.446 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.19 -39.98 96.48 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.928 -1.269 . . . . 0.57 109.928 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -59.98 -49.95 75.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.255 -1.144 . . . . 2.59 110.028 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.416 HH12 ' HB3' ' A' ' 166' ' ' SER . 59.8 mtp180 -68.42 -32.15 71.98 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.017 -1.052 . . . . 2.83 110.062 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.5 tp -60.0 -40.58 89.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.098 -1.001 . . . . 1.25 108.758 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.465 HD21 ' HB2' ' A' ' 105' ' ' HIS . 75.5 mt -60.03 -40.55 89.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.173 -0.954 . . . . 0.7 109.26 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -69.97 -40.08 75.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.476 -0.765 . . . . 2.57 109.72 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 26.5 m120 -62.72 -35.86 81.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.478 -0.764 . . . . 1.23 111.249 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.0 mt -72.92 -41.39 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.617 -1.302 . . . . 0.81 109.273 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.04 -26.32 63.98 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.668 -0.645 . . . . 1.0 109.462 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.27 35.53 20.33 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.688 -1.765 . . . . 0.89 108.688 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 tp -73.27 144.77 46.53 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.484 -1.009 . . . . 1.14 108.831 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -67.06 140.32 57.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -0.914 . . . . 4.6 110.427 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 89.5 mt -110.03 128.6 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.443 -0.947 . . . . 1.24 108.443 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 14.0 mm -60.21 -44.44 95.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.775 -0.578 . . . . 1.54 110.58 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 42.2 t0 62.62 113.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.438 -0.789 . . . . 1.5 108.951 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.12 -1.93 42.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.366 -0.834 . . . . 0.79 110.079 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.2 m -89.02 -17.18 29.91 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.932 -1.105 . . . . 1.4 110.543 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.27 17.75 0.34 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.107 -0.996 . . . . 0.92 111.721 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 32.7 mm -80.21 132.26 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.469 -1.395 . . . . 0.88 109.978 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -110.43 -11.32 14.51 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.685 -0.634 . . . . 2.45 109.525 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -129.96 152.13 49.77 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.578 -0.701 . . . . 1.52 110.012 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -65.36 136.51 56.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.089 -1.007 . . . . 1.58 109.514 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.8 m -153.36 166.69 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.411 -0.806 . . . . 0.69 109.838 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.4 mt -95.84 149.59 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.026 -1.842 . . . . 0.61 106.026 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.1 tp -104.31 119.38 38.82 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.969 -1.082 . . . . 0.87 110.815 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.417 HG12 HG22 ' A' ' 209' ' ' THR . 4.2 t -123.32 132.12 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.663 -0.865 . . . . 0.71 108.663 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -158.46 163.99 36.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.843 -1.161 . . . . 0.81 109.605 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.04 -35.44 71.96 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.3 -1.5 . . . . 0.98 108.485 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 62.8 t0 -169.56 142.76 2.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.133 -0.692 . . . . 2.25 109.133 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.466 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 90.7 mt -111.62 139.52 47.0 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.397 -0.815 . . . . 0.78 109.651 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 64.2 p -94.62 142.88 25.36 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.337 -0.852 . . . . 0.98 109.409 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -40.28 -38.31 2.23 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.195 1.93 . . . . 0.81 112.751 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.416 ' HB3' HH12 ' A' ' 136' ' ' ARG . 52.5 m -56.77 -40.08 75.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.044 -1.035 . . . . 0.9 108.514 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -66.31 -40.66 90.12 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.392 -0.817 . . . . 1.61 109.901 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.416 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 75.6 p -55.66 -24.23 32.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.996 -1.065 . . . . 0.61 110.083 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.715 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -76.74 -58.2 3.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.112 -0.993 . . . . 0.6 109.784 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -82.27 39.75 0.6 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.558 -0.904 . . . . 1.4 108.558 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.5 tp -104.43 133.48 49.24 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.794 -0.817 . . . . 0.7 108.794 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -93.26 103.51 15.76 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.142 -0.974 . . . . 2.35 108.752 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.37 -45.76 89.64 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.26 -0.9 . . . . 1.51 110.084 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -63.79 -28.48 69.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.967 -1.083 . . . . 2.33 112.207 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -92.51 -10.27 38.36 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.521 -1.362 . . . . 1.92 109.825 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 178' ' ' GLY . 63.1 t -109.64 119.91 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.76 -1.2 . . . . 0.67 107.76 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 89.5 mt -89.26 4.92 47.15 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.201 -0.937 . . . . 1.53 111.422 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.463 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 171.26 173.65 38.43 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.134 -1.508 . . . . 0.48 109.679 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -137.4 129.99 29.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.372 -1.076 . . . . 0.55 108.84 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.3 mt -127.98 125.72 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.463 -0.94 . . . . 0.65 108.463 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 19.7 p -145.54 156.86 43.97 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.746 -1.221 . . . . 0.82 111.113 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 183' ' ' ALA . 0.7 OUTLIER -101.04 26.54 6.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.624 -0.673 . . . . 2.46 109.371 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -47.85 -172.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.364 1.078 . . . . 1.28 112.417 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.14 -55.17 4.89 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 111.062 -0.815 . . . . 2.19 111.062 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -160.5 -156.52 8.23 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 118.876 -1.63 . . . . 2.13 111.129 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.411 ' HD2' HH21 ' A' ' 195' ' ' ARG . 86.3 mtm180 -79.94 -10.06 59.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.696 -0.885 . . . . 5.86 109.918 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 60.6 p -74.6 3.14 8.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.153 -0.967 . . . . 3.72 109.477 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.9 t -76.85 133.37 39.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.859 . . . . 1.74 110.049 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -48.26 -50.68 28.82 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.3 -0.875 . . . . 0.95 110.026 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.442 HG23 ' N ' ' A' ' 191' ' ' SER . 14.7 t -58.26 -38.62 77.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.274 -0.891 . . . . 1.55 110.584 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.442 ' N ' HG23 ' A' ' 190' ' ' THR . 25.8 t -60.0 -40.16 88.26 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.0 -1.063 . . . . 1.51 110.288 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.17 -39.91 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 1.67 109.753 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.3 mtp -60.51 -41.58 94.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 1.02 110.901 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.1 95.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.547 -1.346 . . . . 0.68 109.673 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.411 HH21 ' HD2' ' A' ' 186' ' ' ARG . 66.9 mtt-85 -59.97 -47.54 85.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.108 -0.995 . . . . 2.93 109.952 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.5 m -76.57 -32.44 58.16 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.998 -1.063 . . . . 0.86 111.792 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 96.1 mt -79.98 -12.14 59.74 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.641 -1.287 . . . . 0.67 110.364 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 58.33 51.75 8.0 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.38 -0.825 . . . . 1.5 110.917 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.0 mt -127.44 131.94 24.09 Favored Pre-proline 0 N--CA 1.502 2.127 0 N-CA-C 108.892 -0.781 . . . . 0.72 108.892 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -43.45 123.53 3.65 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.937 1.758 . . . . 0.61 112.112 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.96 140.29 9.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.694 -1.254 . . . . 0.66 111.587 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.4 mt -122.84 141.74 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 107.155 -1.424 . . . . 0.79 107.155 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.7 m -124.88 -8.4 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 120.956 -1.09 . . . . 0.91 111.273 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.05 21.24 25.19 Favored Glycine 0 N--CA 1.501 3.024 0 N-CA-C 110.866 -0.894 . . . . 1.01 110.866 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.436 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.0 p -45.28 -43.79 10.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.891 -1.358 . . . . 0.99 110.048 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 93.01 -51.28 2.52 Favored Glycine 0 N--CA 1.5 2.935 0 C-N-CA 120.076 -1.059 . . . . 1.12 111.726 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.428 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 3.6 m -156.92 38.36 0.31 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.528 -1.571 . . . . 1.72 111.209 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.7 t -80.01 -31.26 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.024 -1.048 . . . . 0.89 108.518 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.417 HG22 HG12 ' A' ' 159' ' ' VAL . 55.6 p -58.79 -30.78 67.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.43 -0.794 . . . . 1.03 110.576 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 20.9 t -78.81 -17.94 54.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.926 -1.109 . . . . 1.83 109.731 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -98.64 -8.85 25.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.238 -0.914 . . . . 2.27 110.377 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.415 HG22 HD11 ' A' ' 218' ' ' LEU . 55.1 t -104.83 130.25 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.282 -0.886 . . . . 0.92 110.869 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -108.31 148.79 29.54 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.371 -1.344 . . . . 2.2 107.371 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.439 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 30.0 p-10 -59.97 136.99 58.18 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.101 -1.0 . . . . 2.36 110.901 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.9 m-20 82.59 -0.03 1.3 Allowed 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 116.187 -0.461 . . . . 2.38 111.547 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.844 ' OD1' ' HB3' ' A' ' 16' ' ' ALA . 24.4 p-10 -74.04 158.54 34.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.418 -1.426 . . . . 2.09 108.385 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -99.29 119.56 38.12 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.385 -0.969 . . . . 1.27 108.385 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 16' ' ' ALA . 80.7 mt -125.85 148.73 49.08 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.479 -0.763 . . . . 0.75 109.99 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 78.8 mt -116.16 129.97 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 107.086 -1.449 . . . . 0.63 107.086 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 40.6 tp -105.88 124.33 49.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.029 -1.045 . . . . 0.7 109.11 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.673 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 29.6 p-10 -87.95 -37.47 16.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.043 -1.036 . . . . 2.31 109.866 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.887 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 45.71 16.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.968 -0.752 . . . . 0.78 108.968 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.5 t -126.06 -41.19 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.497 -1.297 . . . . 1.04 107.497 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -106.53 -0.15 24.16 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.831 -1.174 . . . . 2.44 107.831 178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.445 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 0.4 OUTLIER 61.69 49.66 4.83 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.401 0.619 . . . . 1.55 109.771 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.673 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 64.5 mt-30 -139.97 150.31 44.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.452 -0.78 . . . . 1.99 109.502 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.1 t -122.68 129.99 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.194 -1.039 . . . . 0.77 108.194 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -101.11 116.66 33.36 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.251 -0.906 . . . . 0.98 109.208 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 36.0 t -98.33 117.09 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.49 -0.756 . . . . 0.85 109.251 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 68.55 70.17 0.42 Allowed Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.27 -0.894 . . . . 1.66 109.408 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -89.79 118.27 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 123.376 2.717 . . . . 0.95 112.744 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.615 HG22 ' N ' ' A' ' 233' ' ' ASN . 96.4 m -67.97 170.52 8.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.174 -0.954 . . . . 1.84 108.989 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.615 ' N ' HG22 ' A' ' 232' ' ' THR . 95.2 m-20 -59.84 -40.12 87.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.0 -1.062 . . . . 2.74 109.238 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.58 -39.91 92.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.838 . . . . 2.89 109.197 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.54 -42.74 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 1.3 109.882 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.7 -40.6 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.194 -0.941 . . . . 1.09 109.577 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 237' ' ' ASP . 50.0 t0 -60.01 -42.38 94.17 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.852 -1.155 . . . . 2.43 108.721 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -62.77 -45.72 91.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.89 . . . . 2.78 109.376 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 87.8 mtp -66.72 -31.98 72.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 1.25 109.652 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -68.85 -32.93 72.97 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.059 -1.026 . . . . 2.63 108.325 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.03 87.92 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.23 -0.919 . . . . 1.8 108.726 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 70.4 t -61.09 -40.93 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.887 -1.133 . . . . 2.13 108.106 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -60.05 -39.68 86.83 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.484 -0.932 . . . . 3.17 108.484 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.93 -31.7 70.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 1.78 109.02 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -59.98 -39.2 84.88 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.693 -1.225 . . . . 2.47 107.693 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 91.4 t -60.0 -40.0 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 107.92 -1.141 . . . . 2.09 107.92 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.97 -31.71 70.14 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.659 -0.867 . . . . 2.54 108.659 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 251' ' ' ALA . 8.7 t -60.11 -39.2 85.39 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.619 -0.882 . . . . 2.99 108.619 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.97 -37.63 80.16 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.17 -1.418 . . . . 3.34 107.17 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -85.8 42.55 0.98 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.211 -1.403 . . . . 3.88 107.211 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 248' ' ' SER . . . -91.92 -0.69 57.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.964 -0.754 . . . . 4.43 108.964 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 56.97 25.91 11.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.79 -0.569 . . . . 5.42 109.892 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 98.2 mt -96.73 -18.13 19.84 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.123 -0.986 . . . . 6.1 109.435 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -88.37 -48.06 7.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 7.37 108.67 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 52.59 21.86 1.98 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.542 -0.724 . . . . 8.01 109.823 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 257' ' ' LYS . 40.7 mt 50.01 28.48 2.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.116 -0.99 . . . . 9.05 108.751 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 256' ' ' LEU . 52.1 mtpt 45.94 -172.23 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.43 0.634 . . . . 10.56 109.712 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -150.72 -123.05 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.281 -1.007 . . . . 11.32 108.281 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.454 HH11 ' HG2' ' A' ' 259' ' ' ARG . 24.9 ttt-85 . . . . . 0 C--N 1.3 -1.57 0 CA-C-O 117.986 -1.007 . . . . 12.42 109.49 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 49.7 ttp . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.448 0.642 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -150.11 147.35 27.67 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -147.7 157.13 43.4 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.865 -1.147 . . . . 0.0 110.817 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -153.51 148.92 27.14 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -112.59 131.05 55.8 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.142 -0.974 . . . . 0.0 109.656 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.407 ' CG1' ' SD ' ' B' ' 381' ' ' MET . 1.9 p -132.79 125.15 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-O 122.146 0.974 . . . . 0.0 112.073 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 21.1 m -77.21 104.8 7.93 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.046 0.927 . . . . 0.0 110.766 -178.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' B' ' 358' ' ' GLY . 97.0 mt -52.81 124.64 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 122.429 1.109 . . . . 0.0 111.026 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 62.4 p -112.5 20.19 16.86 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.682 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.402 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -66.15 118.68 55.12 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.988 -1.07 . . . . 0.0 108.891 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -49.58 -26.07 12.05 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 CA-C-N 120.354 1.162 . . . . 0.0 112.718 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -120.52 17.58 12.09 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.642 -0.661 . . . . 0.0 109.352 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.76 179.75 32.74 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.468 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -87.86 94.8 9.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -1.223 . . . . 0.0 109.309 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -96.08 -160.43 0.79 Allowed 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.948 -1.095 . . . . 0.0 110.09 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 15.5 m -58.87 -42.79 90.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.076 -1.015 . . . . 0.0 112.546 -175.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.557 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.5 tpt180 -61.13 -61.41 8.02 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 120.452 -1.405 . . . . 0.0 112.119 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -59.3 -33.67 97.82 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 CA-C-N 120.394 1.176 . . . . 0.0 111.656 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.98 75.53 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.13 -41.4 65.01 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.474 -0.766 . . . . 0.0 109.801 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -69.97 -40.03 75.62 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.971 -1.08 . . . . 0.0 108.24 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -61.2 -52.47 64.65 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.2 -0.937 . . . . 0.0 110.432 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 94.7 t -62.79 -28.92 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.659 -1.275 . . . . 0.0 109.587 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -59.95 -44.6 94.3 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.537 -0.727 . . . . 0.0 109.041 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -67.65 -42.71 81.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.89 . . . . 0.0 111.378 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 326' ' ' ALA . . . . . 0.4 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -59.9 -53.89 52.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.556 -1.34 . . . . 0.0 110.97 -178.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 32.3 mttp -52.82 -12.57 0.32 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 109.768 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 328' ' ' GLY . . . . . 0.4 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -77.74 -24.14 65.49 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -105.82 140.09 39.38 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.558 -0.966 . . . . 0.0 109.087 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 26.1 p -90.43 -10.93 41.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.109 -0.994 . . . . 0.0 109.926 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.486 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 79.7 p -67.49 152.36 45.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -0.939 . . . . 0.0 109.502 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.9 137.71 51.84 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.138 -0.976 . . . . 0.0 108.559 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 76.8 mt -131.85 132.68 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.666 -0.646 . . . . 0.0 109.293 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 24.0 m -129.52 148.67 51.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.552 -0.718 . . . . 0.0 109.089 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 70.0 t -123.19 116.16 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 45.9 m -105.57 130.35 53.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.304 -0.872 . . . . 0.0 109.337 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 43.2 t -139.32 119.07 13.17 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.028 0.918 . . . . 0.0 111.272 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 43.92 50.1 7.11 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.13 -14.41 60.78 Favored Glycine 0 N--CA 1.501 3.03 0 O-C-N 120.15 -1.594 . . . . 0.0 112.786 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -117.24 128.45 55.1 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-N 119.208 1.504 . . . . 0.0 110.082 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 80.3 p -126.33 148.33 49.57 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.774 0.797 . . . . 0.0 110.453 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -142.91 166.01 25.79 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 121.534 0.683 . . . . 0.0 110.145 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 25.1 m -87.25 133.62 33.65 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.473 -0.767 . . . . 0.0 110.377 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -72.63 -17.37 61.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.073 -1.017 . . . . 0.0 109.911 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -87.21 20.94 2.55 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 7.3 m -149.08 96.02 2.48 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.836 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.715 HD23 HD22 ' A' ' 79' ' ' LEU . 61.6 tp -58.16 -36.2 72.66 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.844 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.8 m-85 -54.68 -54.01 47.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.796 -1.19 . . . . 0.0 110.193 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -71.3 -19.56 62.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.923 . . . . 0.0 111.699 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' B' ' 352' ' ' THR . 73.6 mt -71.01 -57.96 4.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.453 -1.404 . . . . 0.0 110.318 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.562 ' NE2' ' HE ' ' A' ' 126' ' ' ARG . 9.2 mm100 -43.16 -12.56 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.681 -0.637 . . . . 0.0 111.348 -176.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.571 ' N ' ' O ' ' B' ' 350' ' ' LEU . 77.1 p -86.01 -10.89 54.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.328 -1.483 . . . . 0.0 110.104 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 59.1 mt -92.74 117.98 30.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.03 -1.044 . . . . 0.0 109.021 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -71.96 90.24 0.49 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 23.7 mt -100.4 90.13 4.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.353 -1.086 . . . . 0.0 109.043 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 31.7 p -92.65 154.59 18.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.906 -1.121 . . . . 0.0 110.436 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -50.87 119.34 3.82 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.611 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 358' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 102.09 3.07 51.62 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 44.2 m -87.72 114.92 24.79 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.219 -1.165 . . . . 0.0 111.852 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.99 115.16 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 122.171 0.986 . . . . 0.0 109.939 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 14.5 m -110.49 177.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 22.5 m -130.53 129.3 42.68 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 48.5 mt -102.64 112.95 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 69.2 p -118.62 131.05 56.18 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.157 -0.964 . . . . 0.0 109.287 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.15 151.28 39.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.201 -0.937 . . . . 0.0 109.627 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -146.45 125.93 13.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.346 -0.846 . . . . 0.0 109.394 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.555 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.05 -156.24 26.92 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.496 -1.335 . . . . 0.0 111.182 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.03 -50.71 72.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.109 -0.642 . . . . 0.0 112.271 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.486 ' H ' ' HB3' ' B' ' 331' ' ' SER . 93.0 m-20 -106.42 11.36 30.91 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.868 -1.145 . . . . 0.0 111.336 -177.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.9 pt-20 -44.75 -35.7 2.83 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.986 -1.071 . . . . 0.0 111.117 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -70.53 -42.67 70.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.926 -1.109 . . . . 0.0 110.026 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.95 -48.97 66.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.397 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -46.61 -75.13 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.432 -0.792 . . . . 0.0 110.882 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.497 ' O ' HG23 ' B' ' 378' ' ' VAL . 32.6 t -44.66 -34.81 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.068 -1.02 . . . . 0.0 110.942 -177.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -66.47 -46.09 77.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.421 -1.424 . . . . 0.0 110.301 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -80.37 -42.31 23.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.766 -1.209 . . . . 0.0 109.742 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 109.485 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.497 HG23 ' O ' ' B' ' 374' ' ' VAL . 44.0 t -61.95 -42.0 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.003 -1.061 . . . . 0.0 109.51 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -69.89 -55.1 10.61 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.451 -1.3 . . . . 0.0 107.909 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 48.8 tp -57.56 -35.07 69.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.231 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 381' ' ' MET . . . . . 0.407 ' SD ' ' CG1' ' B' ' 306' ' ' VAL . 39.6 ttm -70.46 -39.94 74.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.217 -1.552 . . . . 0.0 108.359 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.49 -4.83 58.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.586 -0.696 . . . . 0.0 110.335 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -113.6 -3.39 13.63 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.034 -1.041 . . . . 0.0 111.072 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 13.7 mt -79.29 135.36 36.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.331 -1.481 . . . . 0.0 109.437 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.497 -179.572 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 mmt . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.466 -0.568 . . . . 2.91 109.466 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.5 mt -110.18 129.69 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.689 -0.856 . . . . 1.2 108.689 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.9 m -138.37 119.49 14.52 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.288 -0.883 . . . . 1.4 109.05 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.81 -162.02 36.64 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.123 -1.591 . . . . 1.05 109.123 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 5' ' ' ILE . 97.2 mt -93.5 -9.91 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.046 -1.267 . . . . 1.15 110.058 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.471 HD11 ' O ' ' A' ' 8' ' ' SER . 58.8 tp 54.94 96.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.18 -0.95 . . . . 0.98 109.184 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.66 -40.15 73.17 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.665 -0.865 . . . . 0.88 108.665 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.471 ' O ' HD11 ' A' ' 6' ' ' LEU . 3.4 p -145.9 143.22 19.05 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.482 -0.761 . . . . 1.69 109.049 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.52 143.17 16.89 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.21 1.94 . . . . 0.85 112.705 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.875 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.45 -163.88 36.88 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.299 -1.52 . . . . 0.92 109.299 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.1 mt -149.34 149.69 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.051 -1.264 . . . . 0.81 108.332 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.88 151.62 31.52 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.954 -1.091 . . . . 0.51 110.183 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.5 m-85 -134.88 125.27 26.43 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.391 -0.966 . . . . 0.62 108.391 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.75 179.32 47.11 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 118.87 -1.633 . . . . 0.55 110.607 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -76.96 154.73 33.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.759 -0.848 . . . . 2.1 109.006 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -100.02 136.52 39.8 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.336 -0.852 . . . . 0.77 111.052 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.1 tp -104.99 133.28 50.05 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.533 -1.284 . . . . 0.91 107.533 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 64.4 tp -115.14 122.27 45.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.252 -0.905 . . . . 0.93 110.222 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.7 mt -88.71 100.51 13.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.677 -0.639 . . . . 0.93 109.761 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -86.84 139.51 30.6 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.072 -1.084 . . . . 2.75 108.072 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -130.93 136.6 48.73 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.025 -1.047 . . . . 3.0 109.41 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -91.77 137.89 31.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.11 -0.994 . . . . 2.77 109.147 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.03 139.97 57.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 2.94 109.857 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.5 mt -82.51 130.11 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.449 -0.782 . . . . 0.95 109.597 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.5 t -97.21 128.16 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.231 -0.918 . . . . 1.28 110.066 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -109.98 130.05 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.746 -0.835 . . . . 1.21 108.746 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -82.03 127.03 32.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.091 -1.005 . . . . 1.81 110.355 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -89.96 -1.64 58.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.384 -0.823 . . . . 2.8 109.149 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.37 142.18 52.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 2.87 109.681 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -85.19 150.1 25.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.279 -0.888 . . . . 2.35 109.275 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.496 HG21 ' HG3' ' A' ' 39' ' ' GLU . 5.5 pt -91.09 164.56 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.162 -0.961 . . . . 0.97 110.072 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.2 p -89.55 170.59 10.37 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.425 -0.954 . . . . 1.17 108.425 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.32 -19.8 63.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.848 -1.158 . . . . 1.18 110.402 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -82.74 -24.02 33.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.776 -1.203 . . . . 2.56 107.925 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -81.88 -8.75 59.7 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.889 -0.782 . . . . 1.79 108.889 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.68 -53.85 39.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.089 -1.007 . . . . 1.0 108.646 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -62.79 -40.15 96.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 1.77 109.644 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -69.96 -40.07 75.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.079 -1.013 . . . . 2.7 109.976 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.496 ' HG3' HG21 ' A' ' 31' ' ' ILE . 51.3 mm-40 -67.09 -40.0 86.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.067 -1.021 . . . . 1.51 109.689 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.31 -46.44 96.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.92 -1.113 . . . . 0.93 108.34 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -60.07 -40.88 91.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.918 . . . . 1.81 108.941 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.428 HH11 ' HG2' ' A' ' 42' ' ' ARG . 52.1 mtt-85 -60.08 -45.98 91.09 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.897 -1.149 . . . . 2.78 107.897 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -60.07 -49.2 78.57 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.442 -0.786 . . . . 0.78 108.944 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.04 -47.72 84.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.287 -0.883 . . . . 1.07 108.7 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.7 t -61.8 -41.38 97.68 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.228 -1.027 . . . . 1.12 108.228 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.54 -49.77 73.39 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.819 -1.712 . . . . 0.84 108.819 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -65.38 -35.47 81.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.343 -1.093 . . . . 3.09 108.468 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.53 -47.71 72.83 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.356 -0.84 . . . . 0.88 109.097 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 50' ' ' ALA . 32.5 ttpt -63.5 -72.97 0.12 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.889 -1.124 . . . . 2.59 107.972 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.88 -34.0 0.1 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.298 -0.876 . . . . 0.7 111.34 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.5 t -57.22 -52.85 63.67 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.616 -1.303 . . . . 1.4 108.526 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.14 -40.07 78.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 0.67 110.914 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -64.65 -40.13 94.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.081 -1.012 . . . . 1.66 109.974 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.6 -40.02 95.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.854 -1.154 . . . . 1.58 108.487 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -62.1 -34.36 76.18 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.657 -0.868 . . . . 1.35 108.657 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -65.32 -42.96 92.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 0.77 109.086 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.07 -39.94 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.302 -0.873 . . . . 0.63 108.815 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -55.17 -49.71 71.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.618 -0.677 . . . . 1.14 109.38 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.1 m -56.86 -33.47 66.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.337 -0.852 . . . . 0.79 110.747 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -68.17 -38.63 82.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.891 -1.131 . . . . 1.53 109.869 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.52 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -68.07 -47.22 68.9 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.606 -0.684 . . . . 0.57 110.915 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.03 -52.15 50.98 Favored Glycine 0 N--CA 1.486 1.983 0 C-N-CA 119.79 -1.195 . . . . 0.75 110.283 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.03 -42.91 72.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.838 -1.389 . . . . 1.59 110.592 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.0 m -69.96 -58.43 3.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.129 -0.982 . . . . 0.73 112.232 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -95.62 -54.58 3.32 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.978 -1.076 . . . . 0.75 111.159 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.01 -160.49 26.72 Favored Glycine 0 N--CA 1.501 3.033 0 O-C-N 120.849 -1.157 . . . . 1.22 110.415 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -70.01 -22.94 63.06 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.481 -1.011 . . . . 5.81 110.311 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -59.9 -37.66 80.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 3.37 110.296 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.519 ' HA ' HD12 ' A' ' 72' ' ' ILE . 67.3 mmtt -98.59 -18.48 18.1 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.33 -0.856 . . . . 1.77 110.829 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -70.0 -42.79 72.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.575 -1.328 . . . . 1.65 110.542 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.511 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.52 -30.35 71.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 0.77 109.672 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 69' ' ' LYS . 81.6 mt -60.03 -43.64 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.104 -0.997 . . . . 0.8 109.943 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -66.03 -39.97 90.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.949 -1.094 . . . . 0.88 110.531 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -60.07 -39.98 87.93 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.808 -1.182 . . . . 1.37 108.949 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.06 -49.77 64.95 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.929 -1.669 . . . . 0.62 108.929 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -64.72 -41.22 96.14 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.368 -1.078 . . . . 1.5 108.852 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.8 mt -69.96 -42.58 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.114 -0.991 . . . . 0.63 109.214 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.31 -39.98 88.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.985 -1.072 . . . . 1.51 109.737 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.833 HD22 HD23 ' B' ' 347' ' ' LEU . 59.1 tp -66.56 -40.03 88.83 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.503 -0.748 . . . . 0.77 109.806 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.4 tp -60.05 -40.09 88.22 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.638 -0.825 . . . . 0.62 109.155 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -82.64 10.03 8.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.272 -0.893 . . . . 1.47 109.55 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 55.8 t0 -59.94 133.27 55.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.892 . . . . 1.47 110.421 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.468 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 96.7 mt-10 -59.91 -16.04 26.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.699 -0.625 . . . . 1.78 110.445 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -70.05 -37.46 75.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.969 -1.082 . . . . 2.53 108.859 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -73.69 -43.66 58.72 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.461 0.648 . . . . 0.8 110.642 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -59.95 -50.0 75.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.935 . . . . 1.42 110.851 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.51 -42.15 71.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.082 -1.011 . . . . 1.71 111.11 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.88 -39.97 72.54 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.058 -1.026 . . . . 1.57 112.273 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.04 -42.26 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.813 -1.179 . . . . 0.65 109.86 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.03 -39.29 77.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.584 -0.698 . . . . 0.82 110.303 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.93 -50.0 75.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.122 -0.986 . . . . 0.79 111.723 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.94 -44.3 94.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.661 -1.275 . . . . 0.95 109.641 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.6 mt -61.77 -46.66 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -0.866 . . . . 0.66 108.883 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -70.02 -40.98 74.88 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.924 -0.71 . . . . 2.2 110.74 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -82.24 -51.88 7.5 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.071 -1.018 . . . . 1.65 112.151 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.07 -3.16 58.1 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.961 -1.087 . . . . 2.03 111.684 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.2 m170 57.62 38.58 27.8 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.954 -1.091 . . . . 1.42 109.78 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.0 mtp -89.3 169.94 11.0 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.476 -0.765 . . . . 1.18 110.015 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 102' ' ' ALA . 72.7 p -79.9 159.73 26.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.921 . . . . 0.98 109.664 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.03 -40.04 75.4 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.46 -0.775 . . . . 0.64 109.99 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 31.4 p-10 -69.49 -38.82 77.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.14 -0.975 . . . . 2.07 110.229 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.436 ' HB3' ' OG1' ' A' ' 99' ' ' THR . . . -81.02 -40.67 23.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.972 -1.08 . . . . 0.73 109.933 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.11 -47.43 61.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.54 110.623 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.87 92.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.003 -1.061 . . . . 0.56 110.008 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -59.94 -38.6 82.88 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.289 -0.882 . . . . 1.54 110.406 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.0 -39.95 93.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.017 -1.052 . . . . 1.33 110.682 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.7 t -64.76 -50.14 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.938 -1.101 . . . . 0.72 110.815 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.17 -39.92 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.873 -1.142 . . . . 0.85 108.599 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -66.36 -37.42 85.26 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.718 -0.845 . . . . 2.44 108.718 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.439 ' O ' ' OG ' ' A' ' 113' ' ' SER . . . -60.07 -49.9 73.5 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 120.547 -0.835 . . . . 0.98 111.019 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -66.0 -50.43 64.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.503 -1.586 . . . . 1.41 109.746 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.15 84.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.844 . . . . 1.2 109.693 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 110' ' ' GLY . 85.0 p -55.56 -39.75 71.03 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.062 -1.024 . . . . 1.7 109.0 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.91 -31.36 69.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.913 . . . . 1.47 109.883 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.4 mt -69.93 -41.15 74.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.784 -1.197 . . . . 1.56 110.235 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -69.33 -22.57 63.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.131 -1.606 . . . . 2.2 109.367 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -59.85 -20.58 57.9 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.387 -1.338 . . . . 2.12 107.387 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 123' ' ' LEU . 35.0 mt -62.94 140.06 58.81 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.106 -1.072 . . . . 2.0 108.106 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -85.76 41.51 0.91 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.952 -1.093 . . . . 3.23 109.134 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 53.3 t0 -131.96 142.46 49.63 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.575 -0.703 . . . . 2.49 109.707 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.499 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 81.6 mm-40 -73.87 -65.33 0.85 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.799 0.809 . . . . 3.95 108.835 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.633 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 4.1 t80 -39.28 -42.33 1.0 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.937 -0.477 . . . . 2.0 111.082 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.531 HD23 HH22 ' A' ' 126' ' ' ARG . 66.1 mt -70.56 -40.04 73.58 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.561 -1.337 . . . . 1.86 108.225 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 121' ' ' GLU . 62.8 tttp -68.67 -33.69 74.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.545 -0.722 . . . . 2.84 109.491 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 187' ' ' THR . 69.1 mm-40 -59.99 -44.9 94.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.806 -1.184 . . . . 2.73 109.629 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.672 ' HE ' HE22 ' B' ' 351' ' ' GLN . 20.5 mtm-85 -69.97 -30.36 67.7 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.895 -1.128 . . . . 2.77 108.592 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.89 -28.08 67.26 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.888 -1.153 . . . . 1.19 107.888 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.91 -38.88 69.85 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.158 -1.053 . . . . 1.2 108.158 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.85 -40.08 94.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 1.55 110.229 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.01 -40.0 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.993 -1.067 . . . . 0.8 108.446 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -60.01 -38.68 83.37 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.48 -0.933 . . . . 3.09 108.48 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -59.98 -37.43 79.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.567 -0.708 . . . . 1.46 109.545 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.98 -41.84 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.71 110.253 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.35 -31.75 53.74 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.574 -1.298 . . . . 0.57 110.354 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -60.05 -49.9 75.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.121 -1.223 . . . . 2.59 110.129 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -65.41 -31.99 73.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.912 -1.117 . . . . 2.83 109.829 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.89 -40.03 87.33 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.674 -0.862 . . . . 1.25 108.674 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.6 mt -61.03 -40.06 92.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.7 109.287 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.448 HH11 ' HG2' ' A' ' 139' ' ' ARG . 46.8 mtt-85 -65.44 -39.76 92.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 2.57 108.908 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -67.0 -33.38 75.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.606 -0.684 . . . . 1.23 111.759 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.03 -39.91 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.29 -1.507 . . . . 0.81 109.409 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.1 mt -77.26 -21.05 54.28 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.774 -0.77 . . . . 1.0 110.275 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.9 37.15 13.55 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.343 -1.903 . . . . 0.89 108.343 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 tp -73.1 140.83 47.42 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.591 -0.947 . . . . 1.14 108.761 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -73.92 138.38 44.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 4.6 109.613 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.1 mt -107.0 135.01 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-O 122.262 1.03 . . . . 1.24 110.065 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 148' ' ' ASP . 11.4 mt -69.52 -39.92 79.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.396 -0.82 . . . . 1.54 110.651 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 147' ' ' ILE . 48.9 t0 60.17 125.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.565 -0.709 . . . . 1.5 109.651 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.51 ' O ' HD12 ' A' ' 152' ' ' ILE . 43.0 mt -83.84 -3.41 57.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.24 -0.912 . . . . 0.79 109.783 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.6 m -81.79 -12.9 58.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.135 -0.978 . . . . 1.4 109.188 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.72 27.97 0.28 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.575 -0.703 . . . . 0.92 110.418 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 149' ' ' LEU . 57.9 mt -91.29 119.88 39.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.123 -0.986 . . . . 0.88 109.739 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -101.38 -9.49 21.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.297 -0.877 . . . . 2.45 109.997 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -139.17 158.38 44.28 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.072 -1.018 . . . . 1.52 110.207 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.73 138.59 58.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.864 . . . . 1.58 109.026 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 24.6 m -153.12 166.24 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.439 -0.788 . . . . 0.69 109.772 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.7 mt -96.63 146.15 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 105.415 -2.069 . . . . 0.61 105.415 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 45.7 tp -95.94 116.81 29.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.907 -1.12 . . . . 0.87 110.461 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.9 t -120.03 127.92 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.684 -1.228 . . . . 0.71 107.684 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -158.97 164.5 35.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.997 -1.064 . . . . 0.81 108.903 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.29 -35.11 68.6 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.405 -1.434 . . . . 0.98 108.806 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 58.5 t0 -170.51 146.48 2.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.366 -0.834 . . . . 2.25 109.586 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.515 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 39.3 mt -118.36 140.03 50.45 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.274 -0.891 . . . . 0.78 109.75 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.6 p -101.91 151.59 38.01 Favored Pre-proline 0 N--CA 1.5 2.075 0 O-C-N 121.351 -0.843 . . . . 0.98 109.785 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -40.26 -40.11 2.84 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.652 2.235 . . . . 0.81 113.233 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.8 m -59.96 -40.01 87.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 0.9 109.7 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.31 -40.6 86.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.125 -0.984 . . . . 1.61 110.375 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 67.3 p -58.73 -32.79 69.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.107 -0.995 . . . . 0.61 111.311 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -69.64 -49.63 51.95 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.693 -1.254 . . . . 0.6 109.966 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -86.99 38.08 0.79 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.919 -1.141 . . . . 1.4 107.919 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.9 tp -106.28 130.3 54.16 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.002 -0.74 . . . . 0.7 109.002 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.412 ' N ' HD22 ' A' ' 172' ' ' ASN . 3.1 m120 -84.06 105.39 14.89 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.482 -0.933 . . . . 2.35 108.482 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.49 -40.53 93.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.808 . . . . 1.51 110.816 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -69.81 -23.1 63.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.779 -1.201 . . . . 2.33 111.836 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -93.31 -8.64 41.48 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.669 -1.27 . . . . 1.92 110.003 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.553 HG12 ' H ' ' A' ' 178' ' ' GLY . 90.1 t -110.03 119.97 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.541 -0.911 . . . . 0.67 108.541 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 65.9 mt -90.65 6.61 43.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.294 -0.879 . . . . 1.53 110.476 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.553 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.58 170.39 36.3 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.279 -1.528 . . . . 0.48 109.279 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.407 ' CE1' HG11 ' A' ' 176' ' ' VAL . 27.0 m-85 -129.98 129.09 43.3 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.508 -0.995 . . . . 0.55 108.834 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.437 ' CG2' HG21 ' A' ' 205' ' ' THR . 72.7 mt -131.05 121.85 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.546 -0.909 . . . . 0.65 108.546 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.3 p -142.5 156.68 45.17 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.332 -0.855 . . . . 0.82 111.197 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 183' ' ' ALA . 94.3 m-20 -90.09 18.61 5.69 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.596 -0.69 . . . . 2.46 109.266 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.37 -162.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.872 -1.143 . . . . 1.28 111.355 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -102.51 -33.99 4.3 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.527 -1.029 . . . . 2.19 110.527 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 157.24 -143.1 9.2 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 118.822 -1.656 . . . . 2.13 111.235 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -59.96 -28.39 67.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.826 -0.808 . . . . 5.86 110.692 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.431 ' O ' ' OE1' ' A' ' 125' ' ' GLU . 61.4 p -59.99 -10.27 3.98 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.991 -1.068 . . . . 3.72 109.145 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.5 t -91.64 124.66 35.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 1.74 109.41 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 62.0 t60 -48.05 -49.76 30.26 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.034 -1.041 . . . . 0.95 109.868 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.459 ' H ' HG22 ' A' ' 190' ' ' THR . 0.0 OUTLIER -53.19 -40.48 64.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.32 -0.863 . . . . 1.55 110.358 -179.009 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 56.1 m -60.04 -40.0 87.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.958 -1.089 . . . . 1.51 110.529 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.6 mm -61.12 -43.58 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.288 -0.882 . . . . 1.67 110.115 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.4 mtp -62.87 -40.06 96.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 1.02 110.681 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.92 78.11 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.58 -1.325 . . . . 0.68 109.054 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -60.03 -49.92 75.78 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.413 -0.805 . . . . 2.93 110.089 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.0 m -72.75 -33.44 66.35 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.086 -1.009 . . . . 0.86 110.534 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.7 mt -71.55 -26.82 62.79 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.144 -0.973 . . . . 0.67 108.384 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 61.45 50.57 4.57 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.978 -0.451 . . . . 1.5 110.833 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 73.4 mt -124.36 146.88 53.38 Favored Pre-proline 0 N--CA 1.505 2.307 0 N-CA-C 108.792 -0.818 . . . . 0.72 108.792 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -45.06 121.83 3.9 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.829 1.686 . . . . 0.61 111.715 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -158.18 136.78 11.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.382 -1.449 . . . . 0.66 111.966 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.519 ' CD1' HD11 ' A' ' 220' ' ' LEU . 61.6 mt -121.03 145.32 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 106.691 -1.596 . . . . 0.79 106.691 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.5 -7.19 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.731 -1.231 . . . . 0.91 111.287 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -106.4 22.61 30.42 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.874 -1.29 . . . . 1.01 109.874 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.437 HG21 ' CG2' ' A' ' 180' ' ' ILE . 2.0 p -51.16 -41.41 60.13 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.051 -1.264 . . . . 0.99 110.333 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.426 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 84.67 -77.15 2.14 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.667 -1.254 . . . . 1.12 111.781 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 79.5 p -125.13 27.68 6.59 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 121.253 -1.145 . . . . 1.72 112.882 -177.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.96 -40.89 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.295 -1.503 . . . . 0.89 109.123 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 209' ' ' THR . 12.4 p -52.64 -26.75 14.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.878 . . . . 1.03 110.222 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.2 m -80.42 -15.83 55.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.016 -1.053 . . . . 1.83 109.931 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -103.78 -9.54 18.98 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.364 -0.835 . . . . 2.27 110.257 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 63.3 t -110.4 134.61 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.404 -0.81 . . . . 0.92 111.645 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -113.87 150.69 33.26 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.362 -1.348 . . . . 2.2 107.362 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 8.8 p30 -54.51 139.49 37.64 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.815 -1.178 . . . . 2.36 109.983 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.8 m-20 83.53 10.72 0.48 Allowed 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 121.19 0.519 . . . . 2.38 110.188 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.8 t0 -80.06 139.88 36.73 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.334 -0.853 . . . . 2.09 109.407 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.54 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 28.0 t80 -88.98 115.26 26.4 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.32 -0.993 . . . . 1.27 108.32 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 83.0 mt -127.78 149.23 50.35 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.49 -0.756 . . . . 0.75 110.505 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.402 HG23 ' CD2' ' A' ' 13' ' ' PHE . 85.6 mt -115.24 129.06 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 106.859 -1.534 . . . . 0.63 106.859 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.519 HD11 ' CD1' ' A' ' 202' ' ' ILE . 26.1 tp -99.89 119.31 38.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.063 -1.023 . . . . 0.7 110.044 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.496 ' C ' ' N ' ' A' ' 223' ' ' VAL . 84.1 m-20 -76.47 -44.46 35.43 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.233 -0.917 . . . . 2.31 108.569 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.875 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 48.89 15.8 0.1 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.35 -0.982 . . . . 0.78 108.35 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.496 ' N ' ' C ' ' A' ' 221' ' ' ASP . 41.6 t -132.19 -46.12 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.293 -1.373 . . . . 1.04 107.293 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -97.8 0.51 46.95 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.469 -1.308 . . . . 2.44 107.469 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 60.07 45.35 12.01 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.036 -0.728 . . . . 1.55 109.036 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -138.68 150.07 45.81 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.402 -0.811 . . . . 1.99 109.83 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.0 t -121.08 130.01 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.615 -0.883 . . . . 0.77 108.615 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -98.1 119.91 37.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.317 -0.864 . . . . 0.98 108.955 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.9 t -100.35 113.52 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.632 -0.667 . . . . 0.85 109.981 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 8.1 t30 69.25 69.92 0.4 Allowed Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.439 -0.788 . . . . 1.66 109.425 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -90.8 126.39 1.17 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 123.588 2.858 . . . . 0.95 112.73 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 35.0 p -70.97 166.55 21.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.16 -0.963 . . . . 1.84 109.48 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -59.96 -40.0 87.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.27 -0.894 . . . . 2.74 110.558 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -59.94 -40.03 87.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 2.89 110.337 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.21 -40.01 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.985 -1.072 . . . . 1.3 109.49 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.84 -40.03 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.191 -0.943 . . . . 1.09 110.017 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -60.02 -47.19 86.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.102 -0.999 . . . . 2.43 108.596 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -60.39 -43.25 96.81 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.62 -0.675 . . . . 2.78 109.199 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 94.2 mtp -70.07 -33.57 72.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.858 . . . . 1.25 109.801 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -64.06 -40.07 95.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.107 -0.996 . . . . 2.63 109.665 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.35 78.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.15 -0.969 . . . . 1.8 109.426 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.01 -39.97 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.251 -0.905 . . . . 2.13 109.275 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.05 -41.7 92.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.274 -0.891 . . . . 3.17 110.539 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.88 -40.04 91.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.924 -1.11 . . . . 1.78 109.965 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -61.96 -40.03 94.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.192 -0.943 . . . . 2.47 109.516 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 86.2 t -63.81 -41.58 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.461 -0.775 . . . . 2.09 109.632 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.07 -38.74 83.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.361 -0.837 . . . . 2.54 109.314 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.8 t -60.02 -38.78 83.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.515 -0.741 . . . . 2.99 109.939 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -59.99 -40.03 87.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 3.34 109.743 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.477 ' O ' ' CD2' ' A' ' 253' ' ' LEU . 68.1 mttm -75.12 0.24 16.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.044 -1.035 . . . . 3.88 109.674 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.428 ' O ' ' OE2' ' A' ' 252' ' ' GLU . . . -101.29 8.1 42.57 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.223 -0.923 . . . . 4.43 110.524 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 251' ' ' ALA . 40.3 mm-40 -129.05 40.07 3.69 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.145 -0.972 . . . . 5.42 109.654 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.724 HD23 ' H ' ' A' ' 253' ' ' LEU . 0.1 OUTLIER -67.79 -40.25 83.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.246 -0.909 . . . . 6.1 109.35 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 256' ' ' LEU . . . 48.39 6.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.395 -0.816 . . . . 7.37 110.58 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 253' ' ' LEU . 8.0 mtmp? 49.52 8.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.874 -1.141 . . . . 8.01 109.965 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' A' ' 254' ' ' ALA . 34.4 tp -101.54 -42.69 6.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.116 -0.99 . . . . 9.05 109.417 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -80.44 147.54 30.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.469 -0.769 . . . . 10.56 109.329 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 34.8 t0 57.76 67.1 1.0 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.147 -0.971 . . . . 11.32 108.956 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.963 -1.018 . . . . 12.42 109.649 179.996 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 10.9 ttt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.471 0.653 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -152.38 151.99 31.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 109.512 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -147.84 158.84 44.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.128 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 304' ' ' GLN . . . . . 0.43 ' NE2' ' OE2' ' B' ' 305' ' ' GLU . 54.3 tp60 -152.51 148.32 27.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 305' ' ' GLU . . . . . 0.486 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 1.4 pm0 -114.9 133.49 55.94 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.266 -0.896 . . . . 0.0 110.103 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.31 123.69 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 CA-C-O 122.006 0.907 . . . . 0.0 112.22 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 35.9 m -78.01 105.47 9.23 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.972 0.892 . . . . 0.0 110.343 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.0 mt -51.66 122.15 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 122.434 1.111 . . . . 0.0 110.505 -177.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 19.3 p -107.36 18.87 21.05 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.226 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.478 ' O ' ' CG ' ' B' ' 357' ' ' GLN . . . -74.94 133.21 76.12 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.048 -1.032 . . . . 0.0 108.329 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -69.99 -13.13 33.7 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 CA-C-N 120.161 1.093 . . . . 0.0 112.298 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -120.67 8.94 10.68 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.436 -0.79 . . . . 0.0 109.619 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.55 179.95 32.39 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.483 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.6 tp -86.92 93.12 9.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.079 -1.248 . . . . 0.0 109.641 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -96.54 -159.78 0.75 Allowed 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.138 -0.976 . . . . 0.0 110.204 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.2 m -57.12 -45.11 83.74 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.17 -0.956 . . . . 0.0 112.816 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.511 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 3.1 tpt180 -61.59 -61.46 7.8 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 120.571 -1.33 . . . . 0.0 112.166 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -59.69 -31.91 94.95 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 120.335 1.155 . . . . 0.0 111.797 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.03 -50.29 74.32 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -50.81 -40.89 56.68 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.432 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -69.95 -40.19 75.59 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.16 179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -61.99 -52.61 63.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.466 -0.771 . . . . 0.0 110.483 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 86.4 t -69.21 -32.35 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.729 -1.232 . . . . 0.0 110.005 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -59.98 -47.55 85.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.226 -0.921 . . . . 0.0 110.038 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.99 -42.36 73.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.077 -1.014 . . . . 0.0 110.819 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.71 -54.02 11.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.746 -1.222 . . . . 0.0 110.011 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -49.96 -17.34 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.573 -0.704 . . . . 0.0 109.619 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.16 -17.88 79.72 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -106.09 147.2 29.21 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.289 -1.124 . . . . 0.0 109.067 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 3.6 t -90.49 -13.05 35.5 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.065 -1.022 . . . . 0.0 109.831 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.548 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 52.8 m -58.04 144.09 41.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 0.0 109.673 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -67.7 131.59 45.86 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.6 mt -132.61 132.68 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.47 -0.769 . . . . 0.0 109.645 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 50.7 m -128.93 148.88 50.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.448 -0.782 . . . . 0.0 109.328 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.96 114.99 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 55.2 m -103.15 123.53 46.87 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.246 -0.909 . . . . 0.0 108.818 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 47.8 t -136.58 120.29 17.3 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.003 0.906 . . . . 0.0 111.639 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 26.9 m120 49.45 49.2 20.25 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 176.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 86.05 -11.13 63.46 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 119.863 -1.773 . . . . 0.0 112.438 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -122.59 133.45 54.55 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.008 -1.289 . . . . 0.0 109.503 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 14.8 m -128.46 150.24 50.23 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.973 0.892 . . . . 0.0 110.713 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -145.69 168.02 21.7 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.539 0.685 . . . . 0.0 109.825 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 28.6 m -89.06 139.6 30.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.518 -0.739 . . . . 0.0 110.136 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -77.64 -15.87 58.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 108.985 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -87.19 17.19 4.46 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 49.8 m -145.71 95.34 2.63 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.045 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.833 HD23 HD22 ' A' ' 79' ' ' LEU . 59.5 tp -60.03 -38.29 82.3 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.825 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 59.9 m-85 -55.22 -51.65 65.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.076 -1.015 . . . . 0.0 110.849 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -69.11 -39.92 78.67 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.767 -1.208 . . . . 0.0 109.799 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' B' ' 352' ' ' THR . 36.8 mt -48.18 -58.28 4.75 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.836 -1.165 . . . . 0.0 109.35 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.672 HE22 ' HE ' ' A' ' 126' ' ' ARG . 73.9 mm-40 -38.37 -23.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.523 -0.736 . . . . 0.0 111.355 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.522 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.6 p -80.09 -13.14 59.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.753 -1.217 . . . . 0.0 110.876 -178.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 27.5 mt -93.25 119.29 32.25 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.682 -1.262 . . . . 0.0 109.32 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.23 94.0 1.12 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 21.0 mt -101.67 92.05 4.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.336 -1.096 . . . . 0.0 108.835 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 74.3 p -92.22 175.22 6.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.217 -0.927 . . . . 0.0 110.608 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 357' ' ' GLN . . . . . 0.478 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 15.2 tm0? -63.92 111.32 2.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.742 -0.599 . . . . 0.0 110.926 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 358' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 102.12 9.97 40.73 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 51.9 m -84.74 111.79 19.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.225 -1.162 . . . . 0.0 110.514 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 20.1 t -76.74 115.32 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.277 1.037 . . . . 0.0 109.732 -177.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 10.8 m -111.9 176.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 56.0 m -131.9 129.19 40.01 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 363' ' ' ILE . . . . . 0.462 HD11 ' SD ' ' B' ' 381' ' ' MET . 85.5 mt -103.41 117.41 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 61.4 p -120.3 132.92 55.51 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.26 151.92 38.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.006 -1.059 . . . . 0.0 110.589 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -144.82 122.84 12.07 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.456 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 159.55 -158.61 29.77 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.02 -1.562 . . . . 0.0 111.596 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.07 -51.7 68.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.049 -0.677 . . . . 0.0 112.524 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.548 ' N ' ' OG ' ' B' ' 331' ' ' SER . 91.7 m-20 -109.65 13.59 23.76 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.796 -1.19 . . . . 0.0 111.047 -177.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -44.39 -36.68 2.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.033 -1.042 . . . . 0.0 111.278 -178.679 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 371' ' ' GLN . . . . . 0.533 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 78.1 mt-30 -70.02 -41.7 73.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.855 -1.153 . . . . 0.0 109.816 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -68.06 -49.52 60.85 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.685 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 373' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' B' ' 374' ' ' VAL . . . -50.18 -74.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.325 -0.86 . . . . 0.0 110.95 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.561 ' O ' HG23 ' B' ' 378' ' ' VAL . 38.9 t -44.1 -40.01 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -65.46 -45.76 82.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.793 -1.192 . . . . 0.0 110.171 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -80.41 -43.42 21.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.945 -1.097 . . . . 0.0 110.132 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 98.6 mt -59.99 -37.77 80.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.081 -1.012 . . . . 0.0 108.872 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.561 HG23 ' O ' ' B' ' 374' ' ' VAL . 30.7 t -61.32 -40.96 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.088 -1.008 . . . . 0.0 108.8 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' B' ' 383' ' ' GLU . 62.0 mttp -67.92 -55.32 13.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.849 -1.157 . . . . 0.0 108.21 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 59.6 tp -57.82 -36.26 72.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.008 -1.057 . . . . 0.0 109.285 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 381' ' ' MET . . . . . 0.462 ' SD ' HD11 ' B' ' 363' ' ' ILE . 38.1 ttm -74.56 -41.53 60.38 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.99 -10.0 59.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.27 -0.894 . . . . 0.0 109.415 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' B' ' 379' ' ' LYS . 71.3 mm-40 -108.19 10.43 27.92 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.512 -0.742 . . . . 0.0 110.966 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 16.6 mt -66.19 109.55 2.67 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.416 -1.428 . . . . 0.0 109.181 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.499 1.98 0 CA-C-O 118.003 -0.999 . . . . 0.0 108.927 179.524 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.136 -0.69 . . . . 2.91 109.136 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.7 mt -110.07 126.82 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.481 -0.762 . . . . 1.2 109.125 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.3 m -130.01 138.6 50.88 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.092 -0.707 . . . . 1.4 109.092 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.49 -161.92 19.43 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.221 -1.552 . . . . 1.05 109.221 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.7 mt -89.54 -18.55 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -1.211 . . . . 1.15 109.877 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 5' ' ' ILE . 62.6 tp 51.02 103.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.348 -0.845 . . . . 0.98 109.69 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.94 -29.39 12.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.254 -0.904 . . . . 0.88 109.037 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 64.8 m -119.67 115.87 33.5 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.513 -0.742 . . . . 1.69 109.47 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.64 146.46 16.89 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.029 1.819 . . . . 0.85 112.249 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.646 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.18 -152.13 23.98 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.878 -1.689 . . . . 0.92 108.878 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.5 mt -150.31 151.52 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 120.768 -1.43 . . . . 0.81 108.801 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.1 150.83 32.25 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.908 -1.12 . . . . 0.51 110.545 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -133.74 125.32 28.31 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.821 -1.178 . . . . 0.62 107.821 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.52 177.39 47.15 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 118.476 -1.821 . . . . 0.55 110.999 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 157' ' ' ILE . 85.2 mttt -79.87 160.02 26.21 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.831 -0.805 . . . . 2.1 108.905 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.589 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -105.44 134.89 47.81 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.355 -0.841 . . . . 0.77 111.527 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.1 tp -101.48 138.72 38.12 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.352 -1.351 . . . . 0.91 107.352 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.8 tp -118.64 124.9 48.53 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.156 -0.965 . . . . 0.93 110.199 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.8 mt -93.14 103.45 15.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.8 -0.563 . . . . 0.93 110.189 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -98.66 133.06 43.52 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.388 -0.967 . . . . 2.75 108.388 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -130.07 128.23 41.5 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.62 -0.882 . . . . 3.0 108.62 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -75.46 149.83 38.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 2.77 109.901 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -69.13 143.12 54.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.486 -0.758 . . . . 2.94 108.992 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.2 mt -80.13 131.28 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.95 109.387 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 56.0 t -97.27 125.08 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.25 -0.906 . . . . 1.28 109.542 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.0 mt -107.9 135.32 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.434 -0.791 . . . . 1.21 108.921 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -93.87 121.13 35.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.12 -0.988 . . . . 1.81 109.699 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.501 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.8 mmt-85 -89.1 2.12 54.58 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.512 -0.742 . . . . 2.8 110.228 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -67.48 149.5 50.11 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.93 -1.106 . . . . 2.87 109.356 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -93.01 149.77 20.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.164 -0.96 . . . . 2.35 109.596 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.48 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.0 pt -96.44 167.7 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.213 -0.929 . . . . 0.97 110.246 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 61.8 p -100.66 176.2 5.39 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.484 -0.932 . . . . 1.17 108.484 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.85 76.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.156 -0.965 . . . . 1.18 110.695 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -58.05 -27.92 64.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.687 -1.258 . . . . 2.56 109.697 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -81.68 -11.01 59.25 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.34 -0.85 . . . . 1.79 109.808 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.5 t -62.91 -51.89 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.003 -1.061 . . . . 1.0 108.95 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.91 -40.11 96.59 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.247 -0.908 . . . . 1.77 110.113 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -66.28 -40.08 89.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.005 -1.059 . . . . 2.7 110.579 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.48 ' HG3' HG21 ' A' ' 31' ' ' ILE . 75.1 mm-40 -67.91 -40.07 83.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.778 -1.201 . . . . 1.51 110.302 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.04 -45.26 95.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 120.648 -1.283 . . . . 0.93 108.297 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -58.28 -39.9 80.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.997 -1.064 . . . . 1.81 108.594 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.458 HH11 ' HG2' ' A' ' 42' ' ' ARG . 44.5 mtt-85 -59.93 -43.68 94.81 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.287 -1.375 . . . . 2.78 107.287 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -63.5 -45.78 89.09 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.522 -0.736 . . . . 0.78 109.254 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.05 -50.08 75.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 1.07 108.567 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.7 t -63.45 -44.1 95.5 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.483 -0.887 . . . . 1.12 108.852 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.08 -43.33 99.57 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.859 -1.696 . . . . 0.84 108.859 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -67.44 -32.7 73.73 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.427 -1.043 . . . . 3.09 108.323 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.55 -40.99 89.06 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.508 -0.745 . . . . 0.88 109.348 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 34.6 ttpt -68.91 -74.73 0.12 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.953 -1.092 . . . . 2.59 108.447 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.1 -35.08 0.14 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.346 -0.846 . . . . 0.7 111.504 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.5 p -57.46 -56.63 19.33 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.55 -1.26 . . . . 1.4 108.586 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.03 -40.74 75.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.419 -0.8 . . . . 0.67 111.413 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -64.41 -40.04 95.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.633 -1.292 . . . . 1.66 110.889 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.18 -40.01 93.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.848 -1.158 . . . . 1.58 109.367 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -60.01 -37.46 79.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 1.35 109.834 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.24 -40.55 96.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.078 -1.014 . . . . 0.77 110.198 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.723 HD11 HH22 ' A' ' 136' ' ' ARG . 96.8 mt -62.11 -39.94 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.25 -0.906 . . . . 0.63 109.58 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -59.5 -50.0 75.63 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.457 -0.777 . . . . 1.14 109.577 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.3 m -59.37 -39.5 83.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.99 -1.069 . . . . 0.79 110.097 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -64.35 -38.37 90.8 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.09 -1.006 . . . . 1.53 109.247 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.46 -43.98 92.52 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.594 -0.691 . . . . 0.57 109.915 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.24 -50.04 66.08 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.836 -1.173 . . . . 0.75 110.174 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.13 -45.54 80.71 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.228 -1.16 . . . . 1.59 109.708 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.9 m -72.56 -57.9 3.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.327 -0.858 . . . . 0.73 112.306 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -94.81 -54.35 3.51 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.8 -1.187 . . . . 0.75 111.09 -177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.35 -169.18 25.54 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 119.692 -1.242 . . . . 1.22 111.464 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.07 -28.78 66.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 122.043 -0.681 . . . . 5.81 111.145 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.448 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 50.8 tp10 -61.47 -34.86 76.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.066 -1.021 . . . . 3.37 110.516 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -99.46 -21.01 16.15 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.202 -0.936 . . . . 1.77 110.22 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -66.84 -42.61 85.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.115 -0.991 . . . . 1.65 110.314 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.464 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -66.21 -32.21 73.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.514 -0.741 . . . . 0.77 110.53 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.1 -42.49 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.996 -1.065 . . . . 0.8 109.987 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.562 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 69.4 m-85 -71.56 -34.19 69.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.977 -1.077 . . . . 0.88 109.951 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -59.94 -39.81 86.8 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.228 -0.92 . . . . 1.37 109.284 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.45 -42.31 97.64 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.209 -1.557 . . . . 0.62 109.209 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -60.25 -41.42 93.15 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.357 -1.084 . . . . 1.5 108.893 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.8 mt -70.03 -45.44 76.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.239 -0.913 . . . . 0.63 109.45 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.6 ttp -60.25 -40.6 90.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.111 -0.993 . . . . 1.51 109.935 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.86 HD11 ' CE2' ' B' ' 348' ' ' PHE . 33.2 tp -67.26 -39.3 86.09 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.256 -0.902 . . . . 0.77 109.198 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.41 -39.94 92.57 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.039 -0.726 . . . . 0.62 109.039 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -83.07 5.81 21.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.316 -0.865 . . . . 1.47 109.585 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -49.83 130.36 21.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.219 -0.926 . . . . 1.47 109.428 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.16 -21.32 61.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.381 -0.824 . . . . 1.78 111.699 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.13 -33.02 69.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.623 -1.298 . . . . 2.53 108.878 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.7 mt -70.42 -40.74 73.65 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.488 0.661 . . . . 0.8 109.827 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.13 -49.66 76.76 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.449 -0.782 . . . . 1.42 109.827 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -69.97 -41.16 74.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.407 -0.808 . . . . 1.71 111.243 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.05 -39.97 75.39 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.934 -1.104 . . . . 1.57 111.682 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.08 -44.37 81.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 120.831 -1.168 . . . . 0.65 109.767 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.03 -38.6 75.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.403 -0.811 . . . . 0.82 110.131 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.5 -45.06 88.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.272 -0.892 . . . . 0.79 111.672 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 66.3 mt -61.57 -45.97 91.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.706 -1.247 . . . . 0.95 109.56 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 57.1 mt -61.36 -47.66 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.906 0.86 . . . . 0.66 109.082 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -70.04 -40.0 75.41 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.039 -0.664 . . . . 2.2 110.652 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -81.46 -61.55 1.9 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.039 -1.038 . . . . 1.65 112.116 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -82.2 0.54 40.67 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.097 -1.002 . . . . 2.03 111.68 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 57.17 37.8 28.59 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.132 -0.98 . . . . 1.42 109.923 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 79.7 mtp -90.85 166.97 12.79 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.63 -0.668 . . . . 1.18 109.499 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.2 p -80.89 161.88 24.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.948 . . . . 0.98 109.274 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.31 -39.93 85.95 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.256 -0.902 . . . . 0.64 109.581 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -68.45 -37.38 80.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.268 -0.895 . . . . 2.07 109.42 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.56 -45.56 21.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.73 109.445 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.43 -48.89 75.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.486 -0.759 . . . . 0.54 109.766 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.08 -36.0 76.42 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 0.56 109.284 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.544 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 84.5 t60 -59.96 -40.71 89.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.381 -0.824 . . . . 1.54 109.511 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -65.04 -40.53 94.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.334 -0.854 . . . . 1.33 111.149 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.34 -57.19 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.085 -1.01 . . . . 0.72 111.767 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.5 mm -66.92 -40.04 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.82 -1.175 . . . . 0.85 109.01 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.544 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 88.0 tt0 -63.11 -40.09 96.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 2.44 108.678 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.28 -52.61 50.54 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.504 -0.855 . . . . 0.98 110.987 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -62.8 -48.95 76.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.803 -1.41 . . . . 1.41 109.375 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.35 88.79 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.16 -0.962 . . . . 1.2 109.014 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.2 m -59.97 -40.26 88.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.1 -1.0 . . . . 1.7 108.876 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.85 87.26 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.255 -0.903 . . . . 1.47 109.116 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.8 mt -64.84 -39.97 94.43 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.873 -1.142 . . . . 1.56 108.774 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -59.23 -30.92 68.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.054 -1.029 . . . . 2.2 109.306 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.0 -27.54 66.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.105 -0.997 . . . . 2.12 108.514 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.46 HD13 HD13 ' A' ' 123' ' ' LEU . 28.4 mt -62.32 143.76 56.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 2.0 109.283 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -97.42 52.57 1.12 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.154 -0.966 . . . . 3.23 109.531 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -136.12 133.05 36.86 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.252 -0.905 . . . . 2.49 109.811 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.48 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 45.1 mp0 -70.04 -30.72 68.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.367 -0.833 . . . . 3.95 110.061 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.459 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.9 t80 -69.9 -38.06 76.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.195 -0.941 . . . . 2.0 110.091 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.46 HD13 HD13 ' A' ' 118' ' ' LEU . 65.1 mt -77.57 -39.81 44.47 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.094 -1.004 . . . . 1.86 109.788 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -61.58 -43.72 98.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.96 . . . . 2.84 110.445 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 65.9 mm-40 -67.12 -41.09 86.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.92 -1.112 . . . . 2.73 109.755 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.612 ' CD ' HE22 ' B' ' 351' ' ' GLN . 27.4 ttp180 -60.08 -40.03 88.12 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.779 -1.193 . . . . 2.77 107.779 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.81 -23.14 67.12 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.418 -0.956 . . . . 1.19 108.418 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -59.9 -40.02 87.35 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.606 -1.257 . . . . 1.2 107.606 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -66.75 -40.42 88.28 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.008 -0.677 . . . . 1.55 109.916 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 59.5 t -62.4 -40.0 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.933 -1.104 . . . . 0.8 108.437 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.513 HH11 ' HG2' ' A' ' 131' ' ' ARG . 9.1 ttt-85 -63.37 -36.22 82.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.414 -0.804 . . . . 3.09 109.931 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.36 -40.15 85.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.224 -0.922 . . . . 1.46 109.59 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.94 -43.18 91.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.038 -1.039 . . . . 0.71 108.805 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.43 -45.37 96.53 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.678 -0.969 . . . . 0.57 110.678 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -60.03 -44.68 94.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -1.23 . . . . 2.59 110.831 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.723 HH22 HD11 ' A' ' 57' ' ' ILE . 60.2 mtp180 -69.22 -34.88 75.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.482 -1.386 . . . . 2.83 110.157 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.7 tp -59.8 -45.25 92.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.149 -0.969 . . . . 1.25 109.731 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.57 -39.84 92.59 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.119 -0.988 . . . . 0.7 108.87 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -67.2 -39.8 86.4 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.62 -0.675 . . . . 2.57 110.238 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -68.62 -25.54 64.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.137 -0.977 . . . . 1.23 111.383 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.72 -43.64 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.334 -1.479 . . . . 0.81 108.36 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.5 mt -69.94 -31.16 68.76 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.752 -0.592 . . . . 1.0 109.918 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.53 36.95 7.18 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.074 -1.61 . . . . 0.89 109.074 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 56.7 tp -73.2 143.0 47.35 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.432 -1.04 . . . . 1.14 109.229 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -60.7 144.98 51.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.369 -0.832 . . . . 4.6 109.877 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.2 mt -114.88 121.31 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.29 -1.004 . . . . 1.24 108.29 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 16.9 mm -52.98 -52.17 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.568 -0.707 . . . . 1.54 110.409 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.8 t0 66.01 102.46 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.779 -0.822 . . . . 1.5 108.779 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.1 mt -73.34 -1.77 19.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.538 -0.726 . . . . 0.79 110.45 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.3 p -80.01 -11.54 59.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.899 -1.126 . . . . 1.4 109.343 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -88.37 21.05 3.01 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.615 -0.678 . . . . 0.92 111.448 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.437 ' HB ' HD21 ' A' ' 172' ' ' ASN . 48.9 mt -92.74 111.72 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.771 -1.205 . . . . 0.88 108.734 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -100.11 -8.45 23.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.195 -0.94 . . . . 2.45 111.165 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -117.22 147.43 42.51 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.152 -0.967 . . . . 1.52 110.176 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.38 131.35 46.95 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.979 -0.749 . . . . 1.58 108.979 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -152.42 164.72 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.506 -0.746 . . . . 0.69 109.515 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.423 ' N ' ' O ' ' A' ' 15' ' ' LYS . 97.0 mt -92.62 152.37 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 105.384 -2.08 . . . . 0.61 105.384 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.9 tp -101.23 120.07 39.69 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.976 -1.077 . . . . 0.87 111.131 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.51 129.93 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.898 -0.779 . . . . 0.71 108.898 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.03 163.44 36.37 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.37 -0.974 . . . . 0.81 108.37 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.07 -36.69 75.14 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.416 -1.427 . . . . 0.98 108.223 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -170.54 146.35 2.74 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.889 -0.782 . . . . 2.25 108.889 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.7 mt -115.09 131.18 57.01 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.309 -0.869 . . . . 0.78 110.382 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.4 p -93.4 151.75 40.49 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.467 -0.771 . . . . 0.98 109.226 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -39.76 -36.43 1.23 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 122.118 1.878 . . . . 0.81 112.52 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.3 m -58.12 -45.16 87.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.9 109.221 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -69.94 -42.6 73.02 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.096 -1.003 . . . . 1.61 109.991 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 27.5 p -57.42 -16.1 8.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.198 -0.939 . . . . 0.61 110.731 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.562 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . . . -90.66 -51.8 5.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.827 -1.171 . . . . 0.6 110.043 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -85.39 42.18 0.94 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.001 -1.111 . . . . 1.4 108.001 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.7 tp -109.99 132.8 53.83 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.704 -0.851 . . . . 0.7 108.704 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.437 HD21 ' HB ' ' A' ' 152' ' ' ILE . 0.8 OUTLIER -91.23 108.52 19.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.226 -0.921 . . . . 2.35 109.285 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.75 -43.63 98.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.469 -0.77 . . . . 1.51 110.99 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -64.53 -23.58 67.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.924 -1.11 . . . . 2.33 111.957 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -93.58 -11.11 32.56 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.689 -1.257 . . . . 1.92 109.794 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 178' ' ' GLY . 98.8 t -110.05 118.89 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.186 -0.946 . . . . 0.67 109.413 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.1 mt -89.87 6.38 42.13 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.142 -0.973 . . . . 1.53 111.248 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.486 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 175.22 170.11 37.8 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.169 -1.572 . . . . 0.48 109.169 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -132.67 128.88 37.96 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.269 -1.136 . . . . 0.55 109.901 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.401 ' CG2' HG21 ' A' ' 205' ' ' THR . 98.4 mt -132.17 125.11 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.727 -0.842 . . . . 0.65 108.727 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.1 p -143.21 157.94 44.06 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.22 -0.925 . . . . 0.82 110.625 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 183' ' ' ALA . 1.1 m-20 -99.2 22.69 10.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.557 -0.715 . . . . 2.46 109.803 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.513 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -45.41 -175.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.41 1.1 . . . . 1.28 112.586 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.71 -54.59 4.89 Favored Glycine 0 N--CA 1.492 2.412 0 O-C-N 121.527 -0.733 . . . . 2.19 111.315 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -149.97 -161.84 10.11 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 120.631 -1.511 . . . . 2.13 111.278 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.425 ' O ' ' OG ' ' A' ' 191' ' ' SER . 41.1 ttp180 -80.01 -9.87 59.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.789 -0.83 . . . . 5.86 110.205 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 64.0 p -79.94 4.85 15.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.97 . . . . 3.72 109.85 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.7 t -71.57 134.46 46.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.265 -0.897 . . . . 1.74 110.81 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 -41.3 -60.84 1.15 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.528 0.68 . . . . 0.95 110.758 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.7 t -51.12 -33.65 27.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.189 -0.944 . . . . 1.55 110.452 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 186' ' ' ARG . 28.0 p -60.0 -40.12 88.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.973 -1.08 . . . . 1.51 109.689 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.5 -40.09 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.823 . . . . 1.67 110.176 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 35.1 mtm -59.89 -49.27 78.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.808 -1.182 . . . . 1.02 110.494 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.08 -44.17 94.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.753 -1.217 . . . . 0.68 110.626 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -60.03 -52.07 66.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 2.93 110.459 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.2 m -70.94 -33.58 70.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.125 -0.984 . . . . 0.86 110.723 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.04 -22.99 59.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.018 -1.051 . . . . 0.67 109.652 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 66.45 52.37 1.07 Allowed 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.576 0.703 . . . . 1.5 110.543 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.414 ' O ' ' CB ' ' A' ' 8' ' ' SER . 62.9 mt -127.28 132.31 24.26 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 107.722 -1.214 . . . . 0.72 107.722 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -43.45 134.35 6.83 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.805 1.67 . . . . 0.61 112.317 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -166.85 145.35 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.71 -1.196 . . . . 0.66 111.824 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.5 mt -123.16 145.67 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.403 -1.332 . . . . 0.79 107.403 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.1 m -129.7 -12.24 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 120.795 -1.191 . . . . 0.91 111.143 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.72 24.86 22.72 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 110.06 -1.216 . . . . 1.01 110.06 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.427 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 6.3 p -46.32 -42.29 14.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.059 -1.259 . . . . 0.99 110.04 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.78 -57.36 4.66 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.947 -1.121 . . . . 1.12 111.308 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 24.5 m -150.8 32.78 0.61 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.56 -1.553 . . . . 1.72 111.786 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.0 t -70.15 -44.63 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.796 -1.19 . . . . 0.89 109.134 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.441 ' H ' HG23 ' A' ' 209' ' ' THR . 3.0 p -50.59 -29.96 12.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.54 -0.725 . . . . 1.03 111.33 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 29.6 t -69.97 -27.13 64.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.723 -1.236 . . . . 1.83 109.844 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -96.94 -7.02 34.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.151 -0.968 . . . . 2.27 110.53 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 73.8 t -105.93 132.15 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.249 -0.907 . . . . 0.92 110.912 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.439 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 9.9 mtpt -120.12 149.54 42.05 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.621 -1.252 . . . . 2.2 107.621 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.469 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 23.6 p-10 -50.07 138.65 15.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.11 -0.994 . . . . 2.36 111.326 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.469 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 8.3 t0 82.3 5.44 1.07 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 116.165 -0.47 . . . . 2.38 110.538 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 91.9 m-20 -77.56 143.49 38.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.965 -1.084 . . . . 2.09 108.877 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -92.28 119.93 32.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.183 -0.948 . . . . 1.27 108.587 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.589 HD12 ' HB2' ' A' ' 16' ' ' ALA . 86.4 mt -127.21 146.6 50.35 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.41 -0.806 . . . . 0.75 110.636 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.2 mt -118.75 129.28 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 107.193 -1.41 . . . . 0.63 107.193 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.6 tp -104.1 119.93 40.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.107 -0.995 . . . . 0.7 108.787 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.644 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 21.6 p-10 -79.78 -39.09 31.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.214 -0.929 . . . . 2.31 109.114 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.69 16.61 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.782 -0.822 . . . . 0.78 108.782 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 221' ' ' ASP . 47.6 t -126.28 -38.76 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.526 -1.287 . . . . 1.04 107.526 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -109.81 -1.1 18.08 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.797 -1.186 . . . . 2.44 107.797 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 61.45 49.97 4.92 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.369 0.604 . . . . 1.55 109.935 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.644 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 27.4 mt-30 -137.64 153.34 49.88 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.573 -0.705 . . . . 1.99 109.305 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.93 128.87 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.144 -0.687 . . . . 0.77 109.144 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -103.05 122.44 44.65 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.784 -1.191 . . . . 0.98 107.784 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.8 t -101.04 111.86 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.429 -0.794 . . . . 0.85 110.89 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 42.8 t30 49.96 63.5 10.02 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.318 -0.864 . . . . 1.66 110.318 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.4 150.2 15.1 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.705 2.27 . . . . 0.95 111.9 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.407 ' OG1' HG23 ' A' ' 235' ' ' VAL . 68.1 p -67.47 163.74 20.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.142 -0.974 . . . . 1.84 110.131 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -60.18 -40.2 89.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.5 -0.75 . . . . 2.74 110.19 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -62.05 -34.57 76.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -0.917 . . . . 2.89 109.997 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.407 HG23 ' OG1' ' A' ' 232' ' ' THR . 55.3 t -69.78 -39.99 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.343 -0.848 . . . . 1.3 109.299 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.7 mt -65.52 -39.91 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 1.09 109.404 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.91 -40.04 87.47 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.14 -0.975 . . . . 2.43 109.106 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -67.3 -40.29 86.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.032 -1.043 . . . . 2.78 109.101 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 94.9 mtp -70.09 -30.23 67.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 1.25 109.148 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -69.97 -38.03 75.94 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.359 -0.838 . . . . 2.63 109.378 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.85 -45.07 86.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.269 -0.894 . . . . 1.8 108.618 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.5 -40.15 87.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.654 -0.869 . . . . 2.13 108.654 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -62.41 -39.53 93.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.499 -0.75 . . . . 3.17 110.482 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -57.86 -39.81 78.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.918 -1.114 . . . . 1.78 109.138 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -68.19 -41.22 81.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.151 -0.968 . . . . 2.47 108.861 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 73.4 t -68.03 -39.97 82.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.815 -0.809 . . . . 2.09 108.815 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 251' ' ' ALA . . . -59.99 -36.03 76.28 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.526 -0.734 . . . . 2.54 109.478 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 70.4 m -59.92 -40.41 88.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.099 -1.0 . . . . 2.99 108.965 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -60.84 -40.03 91.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.377 -0.827 . . . . 3.34 108.833 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.417 ' C ' ' H ' ' A' ' 252' ' ' GLU . 52.7 mtpt -124.84 53.78 1.46 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.758 -0.83 . . . . 3.88 108.758 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 247' ' ' ALA . . . -54.57 -7.16 0.14 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.625 -0.672 . . . . 4.43 110.482 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 250' ' ' LYS . 56.0 tt0 63.04 3.06 1.15 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.319 -0.863 . . . . 5.42 109.857 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 93.3 mt -80.11 -69.6 0.58 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.722 -1.236 . . . . 6.1 107.768 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -138.79 -76.67 0.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.298 -1.001 . . . . 7.37 108.298 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -172.91 -2.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.398 -0.814 . . . . 8.01 110.963 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 13.2 tp 58.36 104.2 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.936 -1.103 . . . . 9.05 109.231 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.403 ' HG2' ' H ' ' A' ' 259' ' ' ARG . 32.0 ttmt -159.38 160.0 34.45 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.661 -0.65 . . . . 10.56 109.285 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 259' ' ' ARG . 35.4 p-10 -70.5 -37.61 74.22 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.979 -1.119 . . . . 11.32 107.979 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.527 ' N ' ' OD1' ' A' ' 258' ' ' ASP . 19.7 mmt180 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.07 -0.966 . . . . 12.42 109.196 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 44.4 ttp . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.407 0.622 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -154.6 151.8 29.26 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -146.8 158.52 43.93 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.042 -1.036 . . . . 0.0 110.354 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 304' ' ' GLN . . . . . 0.495 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 7.4 tm0? -149.53 145.22 26.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.461 -0.774 . . . . 0.0 108.977 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 305' ' ' GLU . . . . . 0.495 ' N ' ' CD ' ' B' ' 304' ' ' GLN . 93.4 mt-10 -111.69 131.13 55.5 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.16 -0.963 . . . . 0.0 110.09 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 1.2 p -130.17 120.84 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.799 0.809 . . . . 0.0 111.31 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 307' ' ' THR . . . . . 0.438 ' O ' HG23 ' B' ' 309' ' ' THR . 86.3 m -73.88 113.88 11.55 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.217 1.008 . . . . 0.0 110.563 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 60.9 mt -57.95 115.78 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 122.623 1.201 . . . . 0.0 111.317 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 309' ' ' THR . . . . . 0.438 HG23 ' O ' ' B' ' 307' ' ' THR . 67.5 p -111.72 19.95 17.54 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.643 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.95 124.4 90.67 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.888 -1.132 . . . . 0.0 109.206 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -55.27 -18.38 18.27 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 CA-C-N 120.154 1.091 . . . . 0.0 112.921 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -121.32 10.1 10.51 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.293 -0.879 . . . . 0.0 110.027 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.85 -178.21 40.31 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.459 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -87.11 93.65 9.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.151 -1.205 . . . . 0.0 110.301 -178.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -96.37 -160.63 0.81 Allowed 'General case' 0 N--CA 1.509 2.496 0 O-C-N 120.662 -1.274 . . . . 0.0 110.134 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 13.6 m -58.73 -45.05 90.48 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.93 -1.106 . . . . 0.0 112.064 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.492 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.4 tpt180 -53.13 -62.43 3.49 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 120.564 -1.335 . . . . 0.0 111.127 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -57.25 -32.7 94.38 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 CA-C-N 120.135 1.084 . . . . 0.0 112.184 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.85 76.07 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.488 -0.885 . . . . 0.0 108.901 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.46 -45.49 76.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.459 -0.775 . . . . 0.0 110.474 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -70.13 -40.04 75.08 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.879 -1.138 . . . . 0.0 108.641 179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -61.07 -51.81 67.57 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.596 -0.69 . . . . 0.0 110.643 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 323' ' ' VAL . . . . . 0.577 ' CG1' ' HZ2' ' B' ' 327' ' ' LYS . 75.4 t -70.21 -33.1 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.775 -1.203 . . . . 0.0 110.017 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -60.04 -46.36 89.78 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 108.878 -179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -62.32 -45.33 93.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.169 -0.957 . . . . 0.0 109.819 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.91 -50.93 71.84 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.207 -0.933 . . . . 0.0 110.742 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.577 ' HZ2' ' CG1' ' B' ' 323' ' ' VAL . 42.4 mttp -55.96 -14.37 2.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.981 -1.074 . . . . 0.0 109.456 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -68.99 -30.04 72.31 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -104.67 145.06 30.87 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.333 -1.098 . . . . 0.0 109.096 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 37.9 p -90.63 -11.8 38.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.017 -1.052 . . . . 0.0 109.547 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.48 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 81.1 p -60.01 153.4 21.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -0.844 . . . . 0.0 109.568 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -71.12 132.94 45.8 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.178 -0.951 . . . . 0.0 108.701 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.6 mt -129.78 129.95 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.669 -0.644 . . . . 0.0 109.458 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 30.6 m -126.61 150.05 49.13 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 92.1 t -115.15 137.47 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 56.7 m -130.07 122.57 28.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.281 -0.887 . . . . 0.0 109.157 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 83.1 p -136.1 119.5 16.86 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.805 0.812 . . . . 0.0 110.215 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 36.27 61.08 0.82 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.76 -15.34 20.69 Favored Glycine 0 N--CA 1.499 2.834 0 O-C-N 120.608 -1.307 . . . . 0.0 113.129 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -108.28 119.57 39.86 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 119.463 1.631 . . . . 0.0 109.642 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 66.1 m -118.74 142.24 47.88 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.812 0.815 . . . . 0.0 110.168 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 342' ' ' ALA . . . . . 0.464 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -141.19 163.21 33.57 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.572 0.701 . . . . 0.0 109.779 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 4.7 t -87.97 140.01 29.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.475 -0.766 . . . . 0.0 109.318 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.42 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -82.35 -10.0 59.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.937 -1.102 . . . . 0.0 110.157 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -90.26 22.18 3.45 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 48.1 t -149.72 99.51 2.87 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.611 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.704 HD23 HD22 ' A' ' 79' ' ' LEU . 60.9 tp -59.83 -31.89 70.15 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.86 ' CE2' HD11 ' A' ' 79' ' ' LEU . 53.4 m-85 -59.87 -54.54 44.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.009 -1.057 . . . . 0.0 110.031 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -68.98 -24.1 64.19 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.079 -1.013 . . . . 0.0 111.717 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' B' ' 352' ' ' THR . 82.6 mt -68.01 -51.76 43.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.386 -1.446 . . . . 0.0 108.191 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.612 HE22 ' CD ' ' A' ' 126' ' ' ARG . 61.8 mm-40 -39.06 -26.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.65 -178.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.43 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.9 p -79.88 -7.07 58.52 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.69 -1.256 . . . . 0.0 110.717 -177.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' B' ' 342' ' ' ALA . 60.5 mt -92.52 109.33 20.73 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.956 -1.09 . . . . 0.0 109.308 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.53 88.82 0.62 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.7 mt -97.24 90.13 5.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.219 -1.166 . . . . 0.0 109.165 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 28.9 p -96.4 142.81 28.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.096 -1.002 . . . . 0.0 110.076 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -44.99 119.98 2.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.695 -0.628 . . . . 0.0 110.187 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 114.44 -3.95 23.39 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 52.4 m -99.17 129.75 45.44 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.424 -1.044 . . . . 0.0 109.084 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 13.8 t -92.44 134.79 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 119.773 -1.829 . . . . 0.0 109.109 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 29.8 m -112.07 174.98 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 30.3 m -131.13 127.88 38.98 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 84.2 mt -100.91 114.26 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 88.3 p -119.89 132.81 55.66 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.521 -0.737 . . . . 0.0 109.035 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.28 154.45 41.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.352 -0.842 . . . . 0.0 109.494 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -146.64 124.49 11.95 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 159.52 -158.58 29.74 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 118.798 -1.668 . . . . 0.0 111.59 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -60.04 -53.67 55.05 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.48 ' H ' ' HB3' ' B' ' 331' ' ' SER . 95.8 m-20 -110.51 9.98 23.17 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.98 -1.075 . . . . 0.0 110.897 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -42.08 -32.29 0.45 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.234 -0.916 . . . . 0.0 111.634 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -69.98 -39.77 75.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.737 -1.227 . . . . 0.0 109.849 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -68.75 -52.26 32.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.959 . . . . 0.0 109.326 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.8 -32.94 6.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.394 -0.816 . . . . 0.0 111.248 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.504 ' O ' HG23 ' B' ' 378' ' ' VAL . 84.2 t -75.74 -39.33 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.611 -1.305 . . . . 0.0 109.615 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.59 -49.86 75.83 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.346 -0.846 . . . . 0.0 111.804 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -77.46 -41.37 39.9 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.888 -1.132 . . . . 0.0 111.514 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.09 -41.43 92.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.724 -1.235 . . . . 0.0 108.543 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.6 t -61.46 -46.12 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.285 -0.884 . . . . 0.0 109.22 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' B' ' 383' ' ' GLU . 65.6 mttm -69.99 -55.81 8.61 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 58.7 tp -57.64 -35.85 71.05 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.527 -0.733 . . . . 0.0 109.645 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 34.7 ttm -71.25 -40.04 71.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.387 -1.446 . . . . 0.0 108.016 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -79.07 -7.66 58.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.705 -0.622 . . . . 0.0 110.613 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' B' ' 379' ' ' LYS . 76.8 mm-40 -111.88 2.96 17.27 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.063 -1.023 . . . . 0.0 111.269 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 22.5 mt -96.19 126.6 41.53 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.667 -1.27 . . . . 0.0 109.508 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.896 -1.05 . . . . 0.0 109.246 179.471 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.179 0.514 . . . . 2.91 109.805 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 225' ' ' ASN . 88.1 mt -110.05 130.01 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.429 -0.794 . . . . 1.2 109.26 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.1 m -127.47 129.34 47.28 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.584 -0.697 . . . . 1.4 109.629 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.645 ' N ' HD21 ' A' ' 225' ' ' ASN . . . -113.93 -160.48 13.66 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 108.814 -1.714 . . . . 1.05 108.814 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.5 mt -88.85 -17.26 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.985 -1.303 . . . . 1.15 109.943 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.3 tp 55.4 105.46 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.291 -0.881 . . . . 0.98 108.828 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.64 -24.82 16.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.141 -0.974 . . . . 0.88 109.672 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.8 t -142.52 127.46 10.14 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.283 -0.886 . . . . 1.69 109.853 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.92 143.13 17.99 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.908 1.739 . . . . 0.85 111.624 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.853 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 167.64 -168.89 40.9 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.312 -1.515 . . . . 0.92 109.312 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.6 mt -149.14 126.77 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.352 -1.087 . . . . 0.81 108.222 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.99 149.76 43.63 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.958 -1.089 . . . . 0.51 111.025 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 3.0 m-85 -124.66 129.94 51.49 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.733 -1.21 . . . . 0.62 107.733 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.81 177.32 47.88 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 118.695 -1.717 . . . . 0.55 111.02 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -78.48 157.94 28.76 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.707 -0.878 . . . . 2.1 109.289 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.626 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -106.34 126.09 51.8 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.336 -0.852 . . . . 0.77 110.873 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.4 tp -97.27 138.02 35.4 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.378 -1.341 . . . . 0.91 107.378 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 39.5 tp -116.6 123.31 47.02 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.247 -0.908 . . . . 0.93 109.448 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 160' ' ' ALA . 27.2 mt -88.06 106.66 18.3 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.556 0.693 . . . . 0.93 110.55 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -98.77 133.66 42.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.485 -0.759 . . . . 2.75 109.281 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -128.86 128.24 43.46 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.275 -0.891 . . . . 3.0 108.853 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -79.01 153.68 30.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.969 . . . . 2.77 110.067 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -73.78 140.91 46.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.282 -0.886 . . . . 2.94 108.769 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.7 mt -80.02 132.48 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.958 . . . . 0.95 108.83 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.9 t -95.65 122.35 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.321 -0.862 . . . . 1.28 108.995 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.9 mt -105.3 138.68 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.538 -0.726 . . . . 1.21 109.09 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -87.82 123.4 32.56 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.163 -0.961 . . . . 1.81 109.712 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -93.04 2.79 56.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.886 . . . . 2.8 109.833 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -69.98 149.77 47.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.059 -1.026 . . . . 2.87 110.077 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -87.93 144.03 26.78 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.384 -0.969 . . . . 2.35 108.384 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.406 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.1 pt -90.36 164.33 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.845 -1.159 . . . . 0.97 109.947 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.0 p -93.64 170.83 9.29 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.993 -1.114 . . . . 1.17 107.993 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.94 -48.27 82.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.764 -1.21 . . . . 1.18 109.222 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 62.8 t0 -54.13 -30.16 47.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.997 -1.064 . . . . 2.56 109.68 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -81.26 -9.09 59.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.358 -0.838 . . . . 1.79 110.362 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -65.6 -55.18 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.543 -1.348 . . . . 1.0 109.042 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -39.93 87.64 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.352 -0.843 . . . . 1.77 109.81 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.38 -41.78 76.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 2.7 111.033 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.406 ' HG3' HG21 ' A' ' 31' ' ' ILE . 69.7 mm-40 -64.25 -40.14 95.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.693 -1.255 . . . . 1.51 110.179 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.09 -44.66 95.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.79 -1.194 . . . . 0.93 107.993 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -59.97 -40.1 87.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 1.81 108.321 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.48 HH11 ' HG2' ' A' ' 42' ' ' ARG . 20.6 mtt-85 -59.96 -44.33 94.49 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.489 -1.3 . . . . 2.78 107.489 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -60.88 -47.62 85.53 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.601 -0.889 . . . . 0.78 108.601 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.01 -47.15 87.01 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.247 -1.02 . . . . 1.07 108.247 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.7 t -59.95 -41.44 91.88 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.322 -0.992 . . . . 1.12 108.322 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.61 -42.9 99.84 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.363 -1.895 . . . . 0.84 108.363 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -65.54 -38.81 90.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.121 -1.066 . . . . 3.09 108.121 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.02 -42.8 77.05 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.885 -0.51 . . . . 0.88 109.734 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.3 ttpt -71.19 -74.4 0.15 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.999 -1.111 . . . . 2.59 107.999 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.27 -38.78 0.37 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.267 -0.896 . . . . 0.7 111.443 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.0 t -55.71 -54.92 38.42 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.393 -1.442 . . . . 1.4 108.494 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.99 -41.75 73.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.377 -0.827 . . . . 0.67 111.356 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -66.87 -40.26 87.78 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.758 -1.213 . . . . 1.66 110.521 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.3 mt -60.37 -39.96 89.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.812 -1.18 . . . . 1.58 109.067 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -61.84 -32.05 72.35 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.348 -0.845 . . . . 1.35 109.724 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.4 m -67.87 -44.75 76.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.795 -1.191 . . . . 0.77 110.124 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.5 mt -59.98 -37.98 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.127 -0.983 . . . . 0.63 108.573 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -56.6 -50.03 73.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.708 -0.62 . . . . 1.14 109.376 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 m -56.62 -31.95 64.82 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.23 -0.919 . . . . 0.79 110.332 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -69.86 -39.8 76.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 1.53 110.192 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.503 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -68.09 -48.33 65.81 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.526 -0.734 . . . . 0.57 109.662 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -51.51 -56.57 14.83 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 110.209 -1.157 . . . . 0.75 110.209 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.06 -42.0 73.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.127 -1.219 . . . . 1.59 111.061 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.6 m -66.09 -62.39 1.51 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.844 -1.16 . . . . 0.73 111.996 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -94.56 -45.88 7.21 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.864 -1.148 . . . . 0.75 111.239 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.73 -167.93 25.43 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.908 -1.139 . . . . 1.22 110.819 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -70.16 -23.93 63.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.863 -0.786 . . . . 5.81 110.261 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.494 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.8 tp10 -59.93 -33.39 71.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.465 -0.772 . . . . 3.37 110.086 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -98.76 -18.91 17.74 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.252 -0.905 . . . . 1.77 110.469 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -67.71 -40.06 84.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.893 -1.129 . . . . 1.65 109.83 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.591 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -63.49 -32.82 74.38 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.414 -0.804 . . . . 0.77 110.218 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.7 mt -59.94 -41.83 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.902 -1.124 . . . . 0.8 109.594 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -64.57 -39.84 94.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.129 -0.982 . . . . 0.88 110.881 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -60.07 -40.0 88.0 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.916 -1.115 . . . . 1.37 109.458 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.81 -47.07 92.55 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.07 -1.612 . . . . 0.62 109.07 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -61.17 -47.88 84.15 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.408 -1.054 . . . . 1.5 109.326 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.15 -48.79 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.303 -0.873 . . . . 0.63 109.788 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.4 ttp -59.97 -41.52 92.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.964 -1.085 . . . . 1.51 110.588 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.948 HD22 HD23 ' B' ' 347' ' ' LEU . 57.9 tp -65.89 -39.94 91.11 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.358 -0.839 . . . . 0.77 109.928 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.46 -40.07 95.03 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.562 -0.711 . . . . 0.62 109.663 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -82.14 5.84 18.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.057 -1.027 . . . . 1.47 110.228 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -50.03 133.21 23.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.0 . . . . 1.47 110.423 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.49 -22.58 63.69 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.606 -0.684 . . . . 1.78 110.919 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.58 -34.12 71.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.928 -1.108 . . . . 2.53 109.1 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.0 -42.11 73.49 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.388 0.613 . . . . 0.8 110.257 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.03 -50.03 75.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 1.42 110.191 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -70.28 -42.53 71.95 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.352 -0.843 . . . . 1.71 110.983 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.07 -40.11 75.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.043 -1.035 . . . . 1.57 111.068 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 84.5 mt -67.47 -49.07 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.043 -1.036 . . . . 0.65 109.451 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 88.1 mt -66.25 -36.76 78.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.608 -0.683 . . . . 0.82 110.248 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.27 82.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.174 -0.954 . . . . 0.79 110.988 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 96' ' ' LYS . 93.5 mt -59.95 -45.81 91.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.051 -1.031 . . . . 0.95 110.3 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.0 mt -60.39 -49.91 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.029 -1.044 . . . . 0.66 108.833 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -65.79 -45.83 80.98 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.992 -0.683 . . . . 2.2 110.525 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -79.01 -48.83 13.71 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.044 -1.035 . . . . 1.65 112.103 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 92' ' ' LEU . 96.5 mttt -92.79 -3.03 55.43 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 120.719 -1.238 . . . . 2.03 112.48 -177.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 57.32 39.73 28.22 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.788 -1.195 . . . . 1.42 109.945 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 95.2 mtp -93.5 168.1 11.26 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.61 -0.681 . . . . 1.18 110.291 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.1 p -82.67 161.12 22.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.433 -0.792 . . . . 0.98 109.663 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.72 -40.04 88.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.344 -0.848 . . . . 0.64 109.491 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.573 ' OD1' HD22 ' A' ' 138' ' ' LEU . 39.5 t0 -63.24 -40.07 96.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.149 -0.97 . . . . 2.07 109.541 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.48 -51.21 9.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.431 -0.793 . . . . 0.73 110.35 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.02 75.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.362 -0.836 . . . . 0.54 110.444 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.03 -41.83 93.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.023 -1.048 . . . . 0.56 109.81 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -59.8 -40.19 87.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.352 -0.843 . . . . 1.54 110.141 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -64.93 -40.11 94.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 1.33 111.077 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 86.1 t -64.79 -50.46 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.001 -1.062 . . . . 0.72 110.689 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.3 mm -70.05 -40.03 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.879 -1.138 . . . . 0.85 108.387 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -65.34 -38.54 90.44 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.257 -1.016 . . . . 2.44 108.257 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.69 -52.91 49.53 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.106 -1.198 . . . . 0.98 110.106 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -60.73 -49.93 75.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.902 -1.352 . . . . 1.41 108.987 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.13 -39.95 88.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.372 -0.83 . . . . 1.2 109.498 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.1 m -59.94 -40.09 87.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.11 -0.994 . . . . 1.7 109.119 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.4 -39.62 87.99 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.237 -0.914 . . . . 1.47 108.876 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.0 mt -62.47 -42.8 99.74 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.273 -0.892 . . . . 1.56 109.514 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -53.99 -31.34 50.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.99 -1.069 . . . . 2.2 109.676 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.97 -24.52 64.48 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.169 -0.957 . . . . 2.12 108.526 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 54.1 mt -62.74 139.98 58.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.931 . . . . 2.0 109.235 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -96.39 45.66 1.06 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.139 -0.975 . . . . 3.23 109.737 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 41.1 t0 -133.33 143.59 49.1 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.333 -0.855 . . . . 2.49 109.182 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.495 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 77.8 mm-40 -71.56 -64.86 0.84 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.195 -1.039 . . . . 3.95 108.195 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.457 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.7 t80 -39.11 -39.97 0.64 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.023 -0.423 . . . . 2.0 110.904 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.2 mt -79.98 -40.04 28.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.61 -1.306 . . . . 1.86 108.884 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.99 -40.57 96.09 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.502 -0.925 . . . . 2.84 108.502 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.89 -34.05 73.04 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.2 -1.037 . . . . 2.73 108.2 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.424 ' NH1' ' OH ' ' A' ' 122' ' ' TYR . 1.9 tpt180 -59.92 -39.42 85.37 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.389 -1.337 . . . . 2.77 107.389 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.55 -25.49 66.68 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.456 0.646 . . . . 1.19 109.285 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.11 94.3 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.037 -1.098 . . . . 1.2 108.037 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.5 -40.07 85.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.759 . . . . 1.55 109.613 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.88 -40.07 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.047 -1.033 . . . . 0.8 108.904 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -60.09 -40.6 90.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.149 -0.969 . . . . 3.09 108.985 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.09 -39.05 84.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.65 -0.656 . . . . 1.46 110.832 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.9 mt -59.96 -42.87 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.919 -1.113 . . . . 0.71 110.248 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.19 -27.47 71.78 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.407 -1.477 . . . . 0.57 109.407 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -59.91 -50.0 75.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.389 -1.065 . . . . 2.59 110.301 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.475 HH11 ' HG2' ' A' ' 136' ' ' ARG . 22.2 mtt-85 -65.71 -37.89 87.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.855 -1.153 . . . . 2.83 109.98 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.5 tp -55.22 -44.25 75.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -0.915 . . . . 1.25 109.323 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.573 HD22 ' OD1' ' A' ' 101' ' ' ASP . 89.3 mt -60.38 -39.98 89.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.24 -0.912 . . . . 0.7 109.511 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 139' ' ' ARG . 51.9 mtt-85 -69.43 -39.83 77.6 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.28 -0.887 . . . . 2.57 108.831 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -64.5 -34.16 77.58 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.704 -0.623 . . . . 1.23 111.104 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.92 -45.74 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.18 -1.575 . . . . 0.81 107.788 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 99.4 mt -70.06 -37.42 75.5 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.392 0.615 . . . . 1.0 109.488 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.89 45.73 7.05 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.116 -1.993 . . . . 0.89 108.116 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.8 tp -76.51 160.05 29.82 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.532 -0.981 . . . . 1.14 109.498 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -68.54 143.83 54.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.447 -0.783 . . . . 4.6 109.823 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.6 mt -120.0 125.1 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 122.004 0.907 . . . . 1.24 109.188 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 148' ' ' ASP . 5.3 mt -64.86 -41.98 93.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 115.962 -0.563 . . . . 1.54 110.225 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 147' ' ' ILE . 23.4 t0 63.73 125.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.213 -1.032 . . . . 1.5 108.213 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.7 mt -86.17 0.47 53.55 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.105 -0.997 . . . . 0.79 110.019 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.7 p -87.29 -8.55 56.6 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.178 -0.951 . . . . 1.4 109.397 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.96 21.82 1.26 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.353 -0.842 . . . . 0.92 111.255 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 32.2 mm -88.4 119.97 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.614 -1.304 . . . . 0.88 108.796 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -100.33 -9.36 22.37 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.453 -0.779 . . . . 2.45 110.687 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -130.14 152.86 49.11 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.232 -0.918 . . . . 1.52 110.499 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -63.52 133.87 54.6 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.369 -0.832 . . . . 1.58 109.218 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.1 m -152.49 164.23 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.911 -0.774 . . . . 0.69 108.911 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.1 mt -92.59 151.53 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 106.029 -1.841 . . . . 0.61 106.029 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 33.7 tp -102.56 118.89 37.83 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.992 -1.068 . . . . 0.87 110.231 -177.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 12.3 t -125.72 134.34 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.805 -0.813 . . . . 0.71 108.805 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.411 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.31 166.13 28.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.931 . . . . 0.81 108.981 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.401 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -70.08 -38.74 75.81 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.34 -1.475 . . . . 0.98 107.306 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -171.17 144.15 2.02 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.961 -0.755 . . . . 2.25 108.961 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 40.9 mt -109.79 137.08 48.1 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.267 -0.896 . . . . 0.78 109.268 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 58.7 p -87.54 149.1 45.74 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 120.993 -1.067 . . . . 0.98 108.979 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -41.71 -36.97 3.59 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.128 1.885 . . . . 0.81 112.827 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.9 m -59.94 -47.18 86.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 0.9 109.661 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.66 -43.81 97.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.915 . . . . 1.61 110.024 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 30.6 p -55.22 -26.67 41.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.266 -0.896 . . . . 0.61 111.702 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -83.19 -43.9 15.62 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.555 -1.34 . . . . 0.6 110.099 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -89.28 36.93 0.84 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.028 -1.101 . . . . 1.4 108.028 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.1 tp -103.24 133.55 48.14 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.454 0.645 . . . . 0.7 109.697 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.495 ' OD1' ' NZ ' ' A' ' 175' ' ' LYS . 0.2 OUTLIER -82.9 99.26 9.65 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.332 -0.988 . . . . 2.35 108.332 179.247 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 90.9 mt -65.07 -42.28 94.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 1.51 110.975 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -62.68 -32.36 73.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.988 -1.07 . . . . 2.33 112.678 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.551 ' HZ2' ' HB2' ' A' ' 175' ' ' LYS . 9.4 mtmp? -92.04 -5.09 53.56 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.64 -1.287 . . . . 1.92 110.341 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.522 HG12 ' H ' ' A' ' 178' ' ' GLY . 72.3 t -104.68 116.46 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.067 -1.086 . . . . 0.67 108.067 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.6 mt -85.93 7.23 25.03 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.17 -0.957 . . . . 1.53 111.326 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.522 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.45 172.86 37.24 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.128 -1.511 . . . . 0.48 109.82 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.482 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 11.4 m-85 -134.3 129.34 35.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.501 -0.999 . . . . 0.55 108.87 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 93.9 mt -134.72 130.33 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.329 -0.857 . . . . 0.65 108.973 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.7 p -151.6 162.17 41.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.956 -1.09 . . . . 0.82 110.531 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 183' ' ' ALA . 38.3 p-10 -109.63 26.73 10.31 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.905 -0.776 . . . . 2.46 108.905 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -54.31 -164.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.987 -1.071 . . . . 1.28 111.64 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.07 -59.33 5.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.562 -1.015 . . . . 2.19 110.562 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -174.07 -156.8 14.2 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 118.748 -1.691 . . . . 2.13 111.22 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.469 ' C ' ' H ' ' A' ' 188' ' ' SER . 46.8 ttp180 -62.33 -30.05 70.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.923 -0.751 . . . . 5.86 110.614 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 30.6 p -61.85 5.17 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.819 -1.176 . . . . 3.72 110.692 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 186' ' ' ARG . 50.2 p -90.87 140.18 30.05 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.871 -1.143 . . . . 1.74 110.419 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -50.0 -43.47 50.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.423 -0.798 . . . . 0.95 109.672 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.8 m -56.97 -40.49 76.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.625 -0.672 . . . . 1.55 109.633 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.9 m -60.14 -39.9 87.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.208 -0.933 . . . . 1.51 110.116 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.8 mt -60.04 -45.12 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.463 -0.773 . . . . 1.67 110.504 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 30.1 mtm -59.94 -47.61 85.08 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.88 -1.137 . . . . 1.02 110.496 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.71 -45.74 63.67 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.681 -1.262 . . . . 0.68 109.897 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -59.93 -50.33 74.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.926 -1.109 . . . . 2.93 110.994 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.1 m -77.02 -30.19 55.68 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.612 -1.305 . . . . 0.86 111.104 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.0 -29.41 66.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.741 -1.224 . . . . 0.67 108.449 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 68.49 47.98 0.87 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.277 0.561 . . . . 1.5 110.317 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 89.4 mt -128.7 149.93 73.43 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 107.865 -1.161 . . . . 0.72 107.865 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.73 138.76 85.05 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 121.925 1.75 . . . . 0.61 111.69 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -172.7 149.17 2.0 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.147 -1.021 . . . . 0.66 110.891 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.5 mt -124.99 150.41 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.173 -1.417 . . . . 0.79 107.173 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.0 -12.11 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.464 0 O-C-N 120.931 -1.106 . . . . 0.91 111.869 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -114.68 25.98 9.84 Favored Glycine 0 N--CA 1.502 3.063 0 N-CA-C 110.076 -1.21 . . . . 1.01 110.076 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.457 ' HB ' HG23 ' A' ' 208' ' ' VAL . 58.3 p -44.26 -47.29 9.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -1.165 . . . . 0.99 110.469 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 106.73 -51.39 0.74 Allowed Glycine 0 N--CA 1.5 2.941 0 N-CA-C 111.018 -0.833 . . . . 1.12 111.018 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 81.1 p -162.82 44.66 0.13 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.473 -1.604 . . . . 1.72 111.962 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' VAL . . . . . 0.457 HG23 ' HB ' ' A' ' 205' ' ' THR . 14.8 t -71.38 -41.02 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.685 -1.26 . . . . 0.89 108.513 178.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.423 ' H ' HG23 ' A' ' 209' ' ' THR . 8.3 p -50.66 -29.94 12.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.841 . . . . 1.03 109.512 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.1 m -81.92 -12.4 58.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 1.83 109.346 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -115.53 15.16 16.68 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.63 -0.669 . . . . 2.27 109.798 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 42.7 t -138.05 134.55 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.407 -0.808 . . . . 0.92 110.394 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.453 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 10.8 mptt -117.42 153.0 33.82 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.368 -1.345 . . . . 2.2 107.368 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.462 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 11.2 p30 -55.51 140.84 39.16 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.995 -1.066 . . . . 2.36 110.367 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.0 m-20 83.06 2.43 1.05 Allowed 'General case' 0 N--CA 1.502 2.147 0 CA-C-N 116.27 -0.423 . . . . 2.38 110.747 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 94.1 m-20 -74.82 141.58 44.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.743 -1.223 . . . . 2.09 109.153 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -90.69 116.42 28.55 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.933 -1.136 . . . . 1.27 107.933 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 16' ' ' ALA . 79.9 mt -125.56 147.55 49.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.441 -0.787 . . . . 0.75 110.365 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.495 HG23 ' CD2' ' A' ' 13' ' ' PHE . 71.5 mt -115.86 129.83 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 106.627 -1.62 . . . . 0.63 106.627 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 61.0 tp -102.59 119.84 39.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.875 -1.141 . . . . 0.7 109.528 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.645 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 23.2 p-10 -76.22 -40.03 53.14 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.148 -1.056 . . . . 2.31 108.148 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.853 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 48.46 18.42 0.17 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.769 -0.826 . . . . 0.78 108.769 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.45 ' N ' ' C ' ' A' ' 221' ' ' ASP . 53.9 t -129.18 -36.66 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.953 -1.129 . . . . 1.04 107.953 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -110.07 -2.81 16.79 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.135 -1.431 . . . . 2.44 107.135 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.645 HD21 ' N ' ' A' ' 4' ' ' GLY . 27.8 t-20 63.66 51.4 2.48 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.498 0.666 . . . . 1.55 109.689 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.645 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 68.9 mt-30 -137.31 152.72 50.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.499 -0.751 . . . . 1.99 109.213 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.86 130.01 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.426 -0.953 . . . . 0.77 108.426 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -102.52 120.82 41.19 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.776 -0.824 . . . . 0.98 108.776 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.6 t -100.95 113.23 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.506 -0.746 . . . . 0.85 110.149 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 41.2 t30 50.02 66.75 5.16 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.187 -0.946 . . . . 1.66 111.127 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -89.17 148.07 5.48 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 123.186 2.591 . . . . 0.95 112.339 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 24.8 p -70.72 166.17 21.44 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.18 -0.95 . . . . 1.84 110.744 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.666 -0.646 . . . . 2.74 109.773 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.02 -37.73 80.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.249 -0.907 . . . . 2.89 109.611 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.02 -41.84 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.169 -0.957 . . . . 1.3 109.056 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.4 mt -64.99 -40.69 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 1.09 109.932 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -60.04 -42.35 94.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.856 -1.152 . . . . 2.43 108.586 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -60.93 -43.13 99.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.43 -0.794 . . . . 2.78 109.104 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 95.2 mtp -70.02 -33.52 72.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.515 -0.741 . . . . 1.25 109.983 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -65.35 -39.79 92.78 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.136 -0.977 . . . . 2.63 109.15 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.02 87.77 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.332 -0.855 . . . . 1.8 108.93 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 74.6 t -62.52 -39.58 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.37 -0.832 . . . . 2.13 109.174 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -59.52 -39.82 85.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.421 -0.8 . . . . 3.17 109.609 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.89 -40.03 87.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.977 -1.077 . . . . 1.78 108.65 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -63.65 -39.54 94.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 2.47 108.682 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 66.1 t -60.04 -40.01 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 109.083 -0.71 . . . . 2.09 109.083 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.6 -41.79 70.36 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.074 -1.016 . . . . 2.54 108.307 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 48.1 t -65.41 -38.81 91.06 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.526 -0.734 . . . . 2.99 109.154 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -60.05 -45.09 93.99 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.228 -0.92 . . . . 3.34 109.422 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -61.53 -40.32 94.22 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.946 -1.096 . . . . 3.88 108.47 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 52.76 56.95 6.9 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.568 -0.707 . . . . 4.43 109.622 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -52.28 -29.52 23.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 5.42 108.563 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.477 ' O ' ' HB3' ' A' ' 254' ' ' ALA . 81.2 mt -79.25 -64.59 1.15 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.192 -1.04 . . . . 6.1 108.192 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 253' ' ' LEU . . . 66.49 16.23 10.35 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.542 -0.724 . . . . 7.37 110.159 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.573 ' O ' ' N ' ' A' ' 257' ' ' LYS . 62.7 tttm -85.83 -96.18 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.983 -1.073 . . . . 8.01 109.024 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 49.5 mt 42.72 15.75 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.142 -0.974 . . . . 9.05 110.796 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 255' ' ' LYS . 61.3 mttp 55.31 51.08 13.63 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.351 -0.843 . . . . 10.56 109.398 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 255' ' ' LYS . 38.0 p-10 -142.47 93.39 2.52 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.355 -0.98 . . . . 11.32 108.355 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 118.001 -0.999 . . . . 12.42 109.446 -179.131 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 56.9 ttm . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -149.55 146.89 27.6 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.41 162.32 41.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.004 -1.06 . . . . 0.0 110.375 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -156.03 153.9 30.18 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -114.93 134.57 55.05 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.077 -1.014 . . . . 0.0 110.056 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 p -131.82 124.0 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 CA-C-O 122.173 0.987 . . . . 0.0 112.751 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 89.0 m -77.25 104.29 7.67 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.935 0.874 . . . . 0.0 110.673 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.463 HG22 ' H ' ' B' ' 310' ' ' ALA . 92.7 mt -52.15 124.94 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.368 1.08 . . . . 0.0 110.657 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 71.2 p -110.03 20.05 18.34 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.027 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.463 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -74.8 118.5 70.79 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.944 -1.098 . . . . 0.0 109.233 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -53.4 -16.05 6.8 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 CA-C-N 120.251 1.125 . . . . 0.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -120.28 10.08 11.2 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.558 -0.714 . . . . 0.0 109.268 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 69.29 -176.75 30.37 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.714 -1.755 . . . . 0.0 108.714 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.457 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.4 tp -85.45 89.59 7.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.055 -1.262 . . . . 0.0 110.129 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.494 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 4.3 p80 -94.94 -159.97 0.75 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.981 -1.074 . . . . 0.0 109.641 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.8 m -59.73 -47.43 85.68 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.859 -1.151 . . . . 0.0 112.916 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.591 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.4 tpt180 -57.98 -55.89 40.43 Favored Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 120.44 -1.412 . . . . 0.0 112.223 -178.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.494 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 18.1 Cg_endo -64.84 -30.21 58.41 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 CA-C-N 120.583 1.244 . . . . 0.0 111.37 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.03 75.35 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.14 -41.83 72.27 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.569 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 321' ' ' GLN . . . . . 0.41 ' NE2' HH21 ' B' ' 317' ' ' ARG . 12.7 tt0 -69.97 -43.13 72.12 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.026 -1.046 . . . . 0.0 108.615 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -60.41 -50.96 71.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.414 -0.804 . . . . 0.0 110.556 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 58.4 t -66.49 -26.52 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.722 -1.236 . . . . 0.0 109.889 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.33 -45.69 93.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.398 -0.814 . . . . 0.0 110.219 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -69.75 -41.6 75.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.229 -0.919 . . . . 0.0 112.205 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.24 -51.76 68.2 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.455 -1.403 . . . . 0.0 110.954 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -57.71 -11.91 2.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.044 -1.035 . . . . 0.0 109.415 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -70.33 -28.59 71.12 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -105.68 144.66 32.11 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.661 -0.905 . . . . 0.0 109.325 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 18.2 p -91.03 -11.74 37.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.138 -0.976 . . . . 0.0 110.055 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.492 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 90.6 p -58.03 153.64 14.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.164 -0.96 . . . . 0.0 110.135 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.11 130.81 42.47 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 79.8 mt -132.45 131.13 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.465 -0.772 . . . . 0.0 109.646 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 29.3 m -128.12 154.11 46.11 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 76.3 t -118.36 139.56 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 54.6 m -130.5 121.29 25.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.387 -0.82 . . . . 0.0 109.213 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.3 t -136.61 117.7 14.39 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.906 0.86 . . . . 0.0 110.921 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 338' ' ' ASN . . . . . 0.47 ' ND2' ' O ' ' B' ' 338' ' ' ASN . 4.8 p-10 42.22 52.26 4.51 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 88.52 -13.39 62.41 Favored Glycine 0 N--CA 1.501 3.015 0 O-C-N 120.31 -1.494 . . . . 0.0 113.507 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -113.84 122.12 46.09 Favored 'General case' 0 N--CA 1.508 2.469 0 CA-C-N 119.602 1.701 . . . . 0.0 110.457 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 77.8 p -103.53 154.97 18.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.421 -0.799 . . . . 0.0 110.701 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 342' ' ' ALA . . . . . 0.424 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -154.18 154.31 33.29 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.765 -0.584 . . . . 0.0 109.916 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 343' ' ' SER . . . . . 0.415 ' H ' ' HE2' ' B' ' 349' ' ' LYS . 4.6 t -91.05 138.09 31.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.346 -0.846 . . . . 0.0 109.971 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.405 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -78.09 -14.87 59.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.987 -1.071 . . . . 0.0 110.624 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -87.74 21.12 2.71 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 346' ' ' SER . . . . . 0.432 ' CB ' ' HZ3' ' B' ' 349' ' ' LYS . 12.3 t -149.17 97.03 2.62 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.856 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.948 HD23 HD22 ' A' ' 79' ' ' LEU . 19.6 tp -59.55 -32.12 70.04 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.818 ' CE2' HD11 ' A' ' 79' ' ' LEU . 61.0 m-85 -57.63 -51.64 68.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.375 -0.828 . . . . 0.0 110.529 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 349' ' ' LYS . . . . . 0.432 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 36.2 mtmm -69.59 -40.01 76.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.572 -1.33 . . . . 0.0 110.002 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.612 ' O ' ' N ' ' B' ' 352' ' ' THR . 86.3 mt -50.62 -55.81 14.65 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.743 -1.223 . . . . 0.0 108.117 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -38.51 -16.07 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.039 -0.413 . . . . 0.0 111.294 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.612 ' N ' ' O ' ' B' ' 350' ' ' LEU . 75.4 p -91.68 -12.02 35.28 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.813 -1.18 . . . . 0.0 110.952 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.424 HD11 ' HB3' ' B' ' 342' ' ' ALA . 55.8 mt -92.56 119.41 31.99 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.896 -1.128 . . . . 0.0 109.179 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.8 91.63 0.99 Allowed Glycine 0 N--CA 1.485 1.958 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 66.2 mt -100.85 94.91 6.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.412 -1.052 . . . . 0.0 108.521 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 75.2 p -91.68 178.79 5.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.349 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 357' ' ' GLN . . . . . 0.404 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 16.1 tm0? -69.16 113.97 7.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.69 -0.631 . . . . 0.0 110.246 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 102.08 9.49 42.13 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 25.5 m -86.45 111.98 21.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.187 -1.184 . . . . 0.0 110.593 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 42.0 t -77.36 116.24 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 122.018 0.913 . . . . 0.0 110.325 -177.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.7 m -110.74 176.6 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 36.8 m -131.43 130.65 42.78 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 76.3 mt -103.93 115.67 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 77.4 p -118.11 131.66 56.41 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.351 -0.843 . . . . 0.0 109.3 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.27 151.55 38.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.105 -0.997 . . . . 0.0 110.187 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 366' ' ' GLU . . . . . 0.438 ' OE2' ' OE2' ' B' ' 370' ' ' GLU . 11.7 tp10 -141.98 119.76 11.87 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.467 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 164.19 -163.89 36.28 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 118.323 -1.894 . . . . 0.0 111.963 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 55.1 tp10 -59.85 -50.73 72.66 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.022 -0.589 . . . . 0.0 111.379 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.492 ' H ' ' HB3' ' B' ' 331' ' ' SER . 75.3 m-20 -103.97 8.57 36.76 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.854 -1.154 . . . . 0.0 111.456 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.1 pt-20 -42.04 -32.96 0.5 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.117 -0.99 . . . . 0.0 111.355 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -66.15 -46.92 75.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.674 -1.266 . . . . 0.0 109.801 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -69.98 -52.07 27.38 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.176 -0.952 . . . . 0.0 109.601 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 373' ' ' ALA . . . . . 0.407 ' O ' HD12 ' B' ' 377' ' ' LEU . . . -42.16 -38.05 1.61 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.548 -0.72 . . . . 0.0 111.676 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.566 ' O ' HG23 ' B' ' 378' ' ' VAL . 62.9 t -79.06 -34.84 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.502 -1.374 . . . . 0.0 110.012 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -65.66 -49.98 66.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.13 -0.981 . . . . 0.0 112.766 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -77.11 -40.37 46.08 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.267 -1.52 . . . . 0.0 110.869 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.407 HD12 ' O ' ' B' ' 373' ' ' ALA . 96.9 mt -60.04 -40.46 89.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.875 -1.141 . . . . 0.0 108.99 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.566 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.5 t -62.27 -45.17 99.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.112 -0.993 . . . . 0.0 109.613 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.8 mttt -69.76 -55.97 8.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 38.7 tp -53.56 -35.71 61.06 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 381' ' ' MET . . . . . 0.42 ' CE ' HD13 ' B' ' 314' ' ' LEU . 11.1 tpt -69.97 -39.73 75.81 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.06 -5.78 56.46 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.665 -0.647 . . . . 0.0 110.594 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' B' ' 379' ' ' LYS . 99.2 mt-10 -114.42 -0.54 13.75 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.888 -1.132 . . . . 0.0 111.045 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 10.8 mt -81.14 131.88 35.32 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.406 -1.434 . . . . 0.0 109.746 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 385' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 56.4 mp0 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.961 -1.019 . . . . 0.0 108.996 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.349 -0.611 . . . . 2.91 109.349 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.0 mt -110.0 129.92 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.506 -0.746 . . . . 1.2 109.566 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.5 m -130.16 134.95 47.67 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.044 -0.725 . . . . 1.4 109.044 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.72 -163.99 23.32 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.585 -1.806 . . . . 1.05 108.585 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.9 mt -92.18 -11.08 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.91 -1.347 . . . . 1.15 109.539 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.567 HD11 ' O ' ' A' ' 8' ' ' SER . 52.6 tp 53.55 103.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.293 -0.879 . . . . 0.98 109.533 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.23 -21.15 21.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.239 -0.913 . . . . 0.88 109.99 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.567 ' O ' HD11 ' A' ' 6' ' ' LEU . 21.4 m -148.67 135.7 10.57 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 120.895 -1.128 . . . . 1.69 109.596 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.73 142.45 14.24 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.707 2.271 . . . . 0.85 113.489 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.857 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 157.53 -158.44 29.0 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.206 -1.558 . . . . 0.92 109.206 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -149.28 150.5 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 107.851 -1.166 . . . . 0.81 107.851 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.67 141.5 21.06 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.808 -1.183 . . . . 0.51 110.712 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.636 ' CE2' ' NH1' ' A' ' 240' ' ' ARG . 17.0 m-85 -125.76 126.44 44.57 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.884 -1.154 . . . . 0.62 107.884 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.06 178.29 48.16 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 118.482 -1.818 . . . . 0.55 110.879 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -78.32 158.89 28.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.853 -0.792 . . . . 2.1 109.227 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -101.42 128.77 47.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.407 -0.808 . . . . 0.77 110.663 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.8 tp -99.11 134.94 41.23 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 106.865 -1.532 . . . . 0.91 106.865 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -117.39 118.27 31.77 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.408 -0.808 . . . . 0.93 110.121 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.4 mt -84.88 103.46 13.97 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.316 -0.624 . . . . 0.93 109.316 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -100.2 135.39 41.7 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.372 -0.83 . . . . 2.75 110.008 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -130.61 133.94 46.57 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.522 -0.736 . . . . 3.0 109.118 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -79.14 158.05 27.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.969 -1.082 . . . . 2.77 109.14 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -71.88 149.99 44.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.278 -0.889 . . . . 2.94 110.176 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.4 mt -95.48 130.34 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.214 -0.929 . . . . 0.95 108.938 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.17 129.71 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.121 -0.987 . . . . 1.28 110.115 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.7 mt -107.58 137.1 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 108.617 -0.882 . . . . 1.21 108.617 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -94.86 119.89 34.17 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.94 -1.1 . . . . 1.81 110.265 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.494 HH11 ' HG2' ' A' ' 28' ' ' ARG . 5.0 mmt-85 -88.71 0.05 56.83 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.53 -0.731 . . . . 2.8 109.79 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -70.35 141.43 52.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 2.87 109.921 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -82.41 150.55 27.04 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.204 -0.935 . . . . 2.35 109.301 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.447 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.5 pt -95.1 166.2 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.244 -0.91 . . . . 0.97 109.657 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.4 p -96.41 172.95 7.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.178 -0.951 . . . . 1.17 108.767 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.02 -49.29 78.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.047 -1.033 . . . . 1.18 109.335 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -54.86 -30.05 56.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.863 -1.148 . . . . 2.56 109.471 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -82.44 -10.75 58.91 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.407 -0.808 . . . . 1.79 110.265 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.27 -51.84 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.865 -1.147 . . . . 1.0 108.766 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.96 -39.98 93.99 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.364 -0.835 . . . . 1.77 110.055 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -68.38 -39.97 81.54 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.139 -0.976 . . . . 2.7 111.248 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.447 ' HG3' HG21 ' A' ' 31' ' ' ILE . 71.4 mm-40 -67.96 -39.96 83.29 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.8 -1.188 . . . . 1.51 110.184 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -62.98 -47.8 91.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 120.861 -1.149 . . . . 0.93 108.771 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -61.89 -41.6 98.08 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.104 -0.998 . . . . 1.81 109.347 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.18 -40.47 90.09 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.827 -1.149 . . . . 2.78 108.217 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -67.3 -42.02 84.4 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.55 -0.907 . . . . 0.78 108.55 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.92 -48.26 82.44 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.914 -1.143 . . . . 1.07 107.914 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.425 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 35.7 t -63.93 -44.02 94.15 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.756 -0.831 . . . . 1.12 108.756 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.14 -45.45 96.51 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.282 -1.927 . . . . 0.84 108.282 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.546 ' NH2' ' O ' ' A' ' 80' ' ' LEU . 8.5 ttt180 -63.75 -34.11 77.15 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.681 -1.229 . . . . 3.09 107.681 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -60.04 -40.96 91.19 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.303 -0.628 . . . . 0.88 109.303 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 23.5 ttmt -63.64 -74.39 0.1 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.836 -1.172 . . . . 2.59 107.836 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.17 -39.6 0.43 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.45 -0.782 . . . . 0.7 111.316 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.2 m -53.01 -53.98 42.04 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.517 -1.365 . . . . 1.4 108.527 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.02 -39.96 75.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.469 -0.769 . . . . 0.67 111.501 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -68.89 -39.97 79.48 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.739 -1.225 . . . . 1.66 110.194 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 79.1 mt -63.11 -40.07 96.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.139 -0.976 . . . . 1.58 109.377 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -60.73 -35.26 75.9 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.248 -0.908 . . . . 1.35 109.432 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -62.58 -41.85 99.2 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.159 -0.963 . . . . 0.77 109.402 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.8 mt -62.77 -40.04 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.3 -0.875 . . . . 0.63 109.039 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -56.02 -50.03 72.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.11 -0.994 . . . . 1.14 109.197 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -56.02 -35.4 66.8 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.318 -0.864 . . . . 0.79 109.816 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -69.95 -37.91 75.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 1.53 109.815 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.13 -46.16 85.35 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.491 -0.756 . . . . 0.57 110.183 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.54 -50.03 72.13 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.497 -1.441 . . . . 0.75 109.497 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -68.23 -49.67 59.19 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.204 -1.174 . . . . 1.59 109.502 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.6 m -65.05 -63.8 1.02 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 0.73 112.332 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -95.27 -51.74 4.48 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.879 -1.138 . . . . 0.75 111.288 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.71 -167.99 25.72 Favored Glycine 0 N--CA 1.502 3.073 0 C-N-CA 119.706 -1.235 . . . . 1.22 111.128 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -70.22 -27.01 64.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 122.007 -0.702 . . . . 5.81 110.461 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -60.88 -35.72 77.35 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.3 -0.875 . . . . 3.37 110.571 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -101.04 -20.83 15.21 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.338 -0.851 . . . . 1.77 110.159 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -65.94 -40.06 91.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.026 -1.046 . . . . 1.65 110.002 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.545 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -64.75 -26.77 68.5 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.279 -0.888 . . . . 0.77 109.997 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.04 -39.96 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 118.717 -1.193 . . . . 0.8 108.531 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -66.42 -42.11 88.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.032 . . . . 0.88 110.282 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -60.13 -40.2 88.97 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.853 -1.155 . . . . 1.37 108.939 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.44 -49.95 66.07 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.945 -1.662 . . . . 0.62 108.945 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.503 ' CG ' HD11 ' A' ' 133' ' ' ILE . 38.5 m170 -62.9 -47.2 84.32 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.328 -1.101 . . . . 1.5 109.181 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.4 mt -65.69 -46.8 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.293 -0.879 . . . . 0.63 108.885 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.9 ttp -59.99 -40.12 88.11 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.01 -1.056 . . . . 1.51 109.048 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.018 HD22 HD23 ' B' ' 347' ' ' LEU . 44.4 tp -64.43 -39.99 94.89 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.457 0.646 . . . . 0.77 109.443 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.546 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 62.8 tp -63.18 -39.99 96.24 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.575 -0.703 . . . . 0.62 110.157 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -84.74 7.23 21.3 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.049 -1.032 . . . . 1.47 110.261 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 61.4 t0 -50.14 134.23 22.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.12 -0.987 . . . . 1.47 109.979 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.485 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 93.6 mt-10 -60.12 -23.51 63.93 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.634 -0.667 . . . . 1.78 110.941 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -70.81 -34.24 71.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.971 -1.08 . . . . 2.53 109.415 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.9 mt -71.02 -40.51 71.72 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.573 0.701 . . . . 0.8 109.692 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -59.98 -46.56 89.04 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.115 -0.991 . . . . 1.42 110.231 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -69.97 -42.24 73.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.211 -0.93 . . . . 1.71 111.594 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -69.99 -39.97 75.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.039 -1.038 . . . . 1.57 112.095 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.07 -48.14 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.142 -0.974 . . . . 0.65 109.625 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.92 -39.62 80.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 121.262 0.553 . . . . 0.82 110.179 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.17 -47.69 84.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.79 110.768 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.4 mt -60.0 -48.35 82.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.989 -1.07 . . . . 0.95 109.941 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.2 mt -61.61 -48.59 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 121.957 0.884 . . . . 0.66 108.878 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -67.76 -40.16 84.11 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 120.203 -0.599 . . . . 2.2 110.857 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -86.57 -50.66 6.67 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.915 -1.115 . . . . 1.65 112.356 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -90.14 -2.9 58.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.984 -1.072 . . . . 2.03 111.71 -177.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.9 m170 57.94 35.81 25.65 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.893 -1.129 . . . . 1.42 109.474 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.8 mtp -90.33 163.88 14.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.47 -0.769 . . . . 1.18 109.752 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.6 p -76.06 158.36 31.92 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.29 -0.881 . . . . 0.98 108.648 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.55 -39.97 77.11 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.137 -0.977 . . . . 0.64 110.078 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.84 -39.86 95.66 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.225 -0.922 . . . . 2.07 109.678 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.35 -44.49 19.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.73 109.942 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.37 -49.29 76.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.328 -0.857 . . . . 0.54 110.191 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.21 90.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.127 -0.983 . . . . 0.56 110.025 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -60.05 -40.01 87.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 1.54 109.858 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -61.34 -40.12 93.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.063 -1.023 . . . . 1.33 110.395 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.0 t -62.81 -50.62 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.169 -0.957 . . . . 0.72 110.509 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.9 mm -69.99 -39.99 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.103 -0.998 . . . . 0.85 109.674 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -66.47 -39.21 88.67 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.29 -0.881 . . . . 2.44 108.699 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.27 -49.28 80.27 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.564 -1.014 . . . . 0.98 110.564 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -63.9 -47.51 80.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.938 -1.33 . . . . 1.41 110.135 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.43 -39.35 83.24 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.238 -0.914 . . . . 1.2 109.153 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.2 m -59.9 -40.07 87.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.142 -0.974 . . . . 1.7 108.997 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.94 87.67 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.231 -1.026 . . . . 1.47 108.231 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.3 mt -65.18 -41.74 94.3 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.313 -0.955 . . . . 1.56 108.55 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -57.8 -32.29 67.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.117 -0.989 . . . . 2.2 109.688 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.21 -26.71 61.12 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.084 -1.01 . . . . 2.12 108.466 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 25.3 mt -63.2 144.07 57.24 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.451 -0.944 . . . . 2.0 108.451 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -92.8 13.43 20.33 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.189 -0.944 . . . . 3.23 110.757 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 19.2 t0 -102.67 148.7 25.26 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.053 -1.029 . . . . 2.49 110.085 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 98.0 mt-10 -73.8 -65.05 0.88 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.483 -0.761 . . . . 3.95 109.34 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.483 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 4.1 t80 -39.33 -35.43 0.26 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.893 -0.504 . . . . 2.0 110.616 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 78.6 mt -78.39 -40.04 37.3 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.834 -1.166 . . . . 1.86 109.342 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 121' ' ' GLU . 87.9 tttt -69.93 -42.6 73.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.189 -0.944 . . . . 2.84 110.807 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -63.35 -43.08 98.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.106 -0.997 . . . . 2.73 109.9 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.546 ' CZ ' ' NE2' ' B' ' 351' ' ' GLN . 26.8 ttp180 -59.99 -38.5 82.77 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.212 -0.93 . . . . 2.77 108.984 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.26 -43.64 92.45 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.141 -1.059 . . . . 1.19 108.141 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -44.7 -41.75 7.03 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.948 -0.76 . . . . 1.2 108.948 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.32 -39.93 94.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 1.55 109.708 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.36 -43.17 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.02 -1.05 . . . . 0.8 108.96 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -60.0 -39.92 87.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.109 -0.994 . . . . 3.09 109.372 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -57.17 -37.92 72.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.888 . . . . 1.46 109.742 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.503 HD11 ' CG ' ' A' ' 76' ' ' HIS . 96.9 mt -59.94 -41.66 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.146 -0.971 . . . . 0.71 109.116 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.24 -30.72 58.37 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.769 -1.332 . . . . 0.57 109.769 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -59.98 -47.47 85.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.148 -1.207 . . . . 2.59 109.799 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -68.15 -31.14 70.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.814 -1.179 . . . . 2.83 109.63 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.09 -41.55 92.74 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.167 -0.958 . . . . 1.25 109.364 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.02 -40.05 87.93 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.209 -1.034 . . . . 0.7 108.209 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.404 HH11 ' CD2' ' A' ' 144' ' ' LEU . 62.3 mtt-85 -68.21 -38.04 81.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.662 -0.649 . . . . 2.57 109.305 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -68.6 -34.8 76.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 1.23 111.668 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.9 mt -70.4 -42.51 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.275 -1.516 . . . . 0.81 108.97 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.1 -25.4 63.49 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.636 -0.665 . . . . 1.0 109.591 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.78 36.24 19.79 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.378 -1.889 . . . . 0.89 108.378 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.404 ' CD2' HH11 ' A' ' 139' ' ' ARG . 5.1 tp -73.89 145.46 44.81 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.668 -0.901 . . . . 1.14 109.259 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -68.94 140.09 55.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -0.855 . . . . 4.6 109.924 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.5 mt -106.52 130.05 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-O 121.694 0.759 . . . . 1.24 109.21 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 16.8 mm -56.27 -49.12 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.682 -0.637 . . . . 1.54 110.367 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.6 t0 70.87 95.12 0.07 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.603 -0.686 . . . . 1.5 109.245 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.406 ' O ' ' OD1' ' A' ' 172' ' ' ASN . 33.4 mt -73.02 -4.08 30.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.352 -0.843 . . . . 0.79 110.968 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 81.2 p -82.85 -14.63 53.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.754 -1.216 . . . . 1.4 109.361 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.21 18.19 2.71 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.329 -0.857 . . . . 0.92 112.605 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.3 mp -91.33 115.82 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.121 -1.612 . . . . 0.88 108.02 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -100.17 -8.52 23.52 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.293 -0.88 . . . . 2.45 109.952 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -108.14 144.96 34.83 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.352 -0.843 . . . . 1.52 110.163 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -66.35 130.82 44.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.339 -0.851 . . . . 1.58 109.028 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.7 m -153.11 167.24 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.472 -0.768 . . . . 0.69 109.565 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -93.77 148.24 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 106.318 -1.734 . . . . 0.61 106.318 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 171' ' ' LEU . 47.1 tp -96.89 117.45 31.13 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.872 -1.143 . . . . 0.87 111.066 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 8.5 t -121.41 127.97 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 108.516 -0.92 . . . . 0.71 108.516 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.04 162.06 36.61 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.213 -0.929 . . . . 0.81 108.74 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.475 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.94 -33.73 72.52 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.405 -1.434 . . . . 0.98 107.756 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.5 p-10 -166.8 175.33 7.86 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.318 -0.993 . . . . 2.25 108.318 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 51.6 mt -140.23 125.73 19.05 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.118 -1.067 . . . . 0.78 108.118 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 36.1 p -87.11 146.97 41.54 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.032 -1.043 . . . . 0.98 108.768 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -36.54 -38.13 0.32 Allowed 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.365 2.043 . . . . 0.81 112.295 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.2 m -60.04 -40.03 87.99 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.361 -0.837 . . . . 0.9 109.778 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.01 -44.42 69.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.105 -0.997 . . . . 1.61 110.192 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.8 p -55.53 -20.44 13.1 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.265 -0.897 . . . . 0.61 111.116 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.51 -47.57 12.03 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.868 -1.145 . . . . 0.6 109.871 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -90.24 38.41 0.93 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.221 -1.029 . . . . 1.4 108.221 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.597 HD11 HD22 ' A' ' 158' ' ' LEU . 9.3 tp -100.25 135.96 40.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.7 108.811 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.578 ' O ' HG23 ' A' ' 176' ' ' VAL . 30.7 m120 -86.67 102.12 13.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.194 -0.941 . . . . 2.35 109.307 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 80.9 mt -64.83 -41.67 95.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 1.51 110.799 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -69.12 -28.04 66.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.939 -1.101 . . . . 2.33 111.911 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -92.84 -11.43 33.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.748 -1.22 . . . . 1.92 109.159 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.581 HG11 ' CE1' ' A' ' 179' ' ' PHE . 85.9 t -99.07 108.16 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.611 -1.255 . . . . 0.67 107.611 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.8 4.07 30.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.269 -0.894 . . . . 1.53 110.265 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.08 171.04 38.09 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.679 -1.768 . . . . 0.48 108.679 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.581 ' CE1' HG11 ' A' ' 176' ' ' VAL . 35.0 m-85 -129.49 128.6 43.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.348 -1.089 . . . . 0.55 108.834 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 91.3 mt -131.44 123.2 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.595 -0.891 . . . . 0.65 108.595 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 203' ' ' VAL . 41.0 p -147.1 158.91 44.09 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.008 -1.057 . . . . 0.82 110.252 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 50.1 p30 -108.51 25.2 11.97 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.208 -0.664 . . . . 2.46 109.208 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.77 -162.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.029 -1.044 . . . . 1.28 111.358 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -64.22 -64.74 3.42 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.198 -1.161 . . . . 2.19 110.198 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.79 -131.45 1.66 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.19 -1.481 . . . . 2.13 110.8 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -79.95 -9.78 59.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.62 -0.929 . . . . 5.86 110.563 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 52.2 p -84.7 0.92 48.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.985 -1.072 . . . . 3.72 110.708 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 81.0 p -88.36 144.23 26.52 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.907 -1.121 . . . . 1.74 110.298 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -53.18 -41.06 64.86 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.344 -0.847 . . . . 0.95 108.844 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 190' ' ' THR . 0.7 OUTLIER -53.38 -36.39 61.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.628 -0.67 . . . . 1.55 109.462 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 53.5 m -60.0 -40.02 87.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.194 -0.942 . . . . 1.51 109.981 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.6 mt -60.01 -40.09 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.926 . . . . 1.67 109.597 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 90.5 mtp -57.39 -48.83 78.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.082 -1.012 . . . . 1.02 110.435 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.94 -42.82 94.83 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.727 -1.233 . . . . 0.68 109.768 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -61.98 -59.25 5.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.131 -0.981 . . . . 2.93 110.389 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 61.5 m -67.11 -39.39 86.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.139 -0.975 . . . . 0.86 112.421 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 91.2 mt -70.22 -26.64 63.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.616 -1.303 . . . . 0.67 109.306 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 68.08 45.19 1.34 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.21 0.528 . . . . 1.5 110.535 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 93.6 mt -120.74 149.93 51.56 Favored Pre-proline 0 N--CA 1.503 2.202 0 N-CA-C 107.64 -1.245 . . . . 0.72 107.64 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.11 141.69 94.64 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.927 1.751 . . . . 0.61 111.301 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -171.49 152.41 3.23 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.523 -1.271 . . . . 0.66 111.898 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.6 mt -121.84 146.4 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.695 -1.224 . . . . 0.79 107.695 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 181' ' ' THR . 21.4 m -127.66 -15.43 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 O-C-N 121.149 -0.97 . . . . 0.91 110.694 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.0 27.4 14.56 Favored Glycine 0 N--CA 1.504 3.193 0 O-C-N 121.389 -0.819 . . . . 1.01 111.098 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.0 p -49.14 -33.42 12.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.741 -1.446 . . . . 0.99 110.164 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 84.68 -87.31 1.55 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.708 -1.357 . . . . 1.12 109.708 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 27.5 t -125.31 39.16 4.03 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.558 -0.966 . . . . 1.72 112.571 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.15 -40.62 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.444 -1.41 . . . . 0.89 109.036 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 209' ' ' THR . 1.4 p -56.36 -31.41 63.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.263 -0.898 . . . . 1.03 109.94 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 23.0 t -71.71 -28.96 64.05 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.168 -0.957 . . . . 1.83 109.338 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -94.92 -9.57 33.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.283 -0.885 . . . . 2.27 111.176 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 63.6 t -102.61 137.14 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.95 -1.093 . . . . 0.92 110.632 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -114.11 155.04 26.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.751 -1.203 . . . . 2.2 107.751 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 57.5 t-20 -59.89 139.89 57.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.004 -1.06 . . . . 2.36 109.92 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.0 t0 84.55 6.44 0.57 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.407 0.622 . . . . 2.38 109.434 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 54.8 t0 -76.01 136.81 39.97 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.374 -0.829 . . . . 2.09 108.959 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.508 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 35.5 t80 -89.84 117.47 28.7 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.674 -1.232 . . . . 1.27 107.674 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 86.6 mt -125.97 145.01 50.47 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.287 -0.883 . . . . 0.75 110.808 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.1 mt -115.27 129.95 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.102 -1.073 . . . . 0.63 108.102 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 35.5 tp -103.95 117.66 34.85 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.14 -0.975 . . . . 0.7 109.133 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 223' ' ' VAL . 92.4 m-20 -74.85 -43.48 54.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.069 -1.019 . . . . 2.31 108.962 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.857 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.24 9.84 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.255 -0.646 . . . . 0.78 109.255 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.51 ' H ' ' C ' ' A' ' 221' ' ' ASP . 47.0 t -129.82 -40.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 107.5 -1.296 . . . . 1.04 107.5 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -101.97 1.81 37.12 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.771 -0.825 . . . . 2.44 108.771 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 59.99 41.95 16.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.604 -0.685 . . . . 1.55 109.698 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -136.6 146.22 45.81 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.316 -0.865 . . . . 1.99 110.079 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.32 130.01 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.266 -1.013 . . . . 0.77 108.266 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -100.68 123.68 45.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.367 -0.833 . . . . 0.98 108.879 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.0 t -99.1 110.84 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.373 -0.829 . . . . 0.85 110.93 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 34.5 t30 49.68 59.93 16.05 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.503 -0.748 . . . . 1.66 111.047 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.67 151.93 19.57 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.694 2.263 . . . . 0.95 111.925 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.444 ' OG1' HG23 ' A' ' 235' ' ' VAL . 41.7 p -68.39 161.27 27.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.117 -0.99 . . . . 1.84 109.761 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.03 -38.28 82.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 2.74 108.972 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -59.87 -40.08 87.47 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.682 -0.859 . . . . 2.89 108.682 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.444 HG23 ' OG1' ' A' ' 232' ' ' THR . 54.5 t -67.33 -39.87 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 1.3 109.36 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 91.6 mt -69.22 -40.01 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.186 -0.946 . . . . 1.09 109.147 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.96 -39.93 87.32 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.358 -0.839 . . . . 2.43 108.841 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -60.1 -40.81 90.94 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.934 -1.136 . . . . 2.78 107.934 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.541 ' O ' ' N ' ' A' ' 242' ' ' VAL . 98.1 mtp -68.05 -79.03 0.06 Allowed 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.186 -1.783 . . . . 1.25 106.186 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.636 ' NH1' ' CE2' ' A' ' 13' ' ' PHE . 15.3 mmt-85 -23.23 -43.83 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 N-CA-C 112.061 0.393 . . . . 2.63 112.061 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 239' ' ' MET . . . -59.97 -50.04 75.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.777 -1.202 . . . . 1.8 108.833 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 239' ' ' MET . 55.0 t -60.2 -39.96 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.074 -1.016 . . . . 2.13 108.56 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -60.07 -39.78 87.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.388 -0.82 . . . . 3.17 109.782 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -55.13 -38.49 68.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.0 -1.062 . . . . 1.78 109.072 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -60.01 -39.95 87.58 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.976 -1.12 . . . . 2.47 107.976 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 91.7 t -67.98 -38.12 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.839 -0.8 . . . . 2.09 108.839 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.16 -39.76 72.84 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.918 -0.771 . . . . 2.54 108.918 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 46.4 m -71.52 -39.39 70.8 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.107 -0.996 . . . . 2.99 109.811 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -63.05 -40.08 96.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.285 -0.884 . . . . 3.34 111.772 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -70.01 -19.08 63.34 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.568 -1.332 . . . . 3.88 110.558 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -60.04 -43.26 95.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.854 -1.153 . . . . 4.43 108.856 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 50.01 40.08 20.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.414 -0.803 . . . . 5.42 110.615 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 86.4 mt -100.43 7.61 44.11 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.829 -1.17 . . . . 6.1 108.731 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -100.09 -79.48 0.49 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.759 -0.83 . . . . 7.37 108.759 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -137.44 162.82 32.62 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.627 -0.879 . . . . 8.01 108.627 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.616 ' N ' HD12 ' A' ' 256' ' ' LEU . 8.8 mp -59.92 -38.68 83.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.184 -0.948 . . . . 9.05 110.11 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -148.34 159.95 43.49 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.952 -1.093 . . . . 10.56 109.725 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.524 ' CG ' ' H ' ' A' ' 259' ' ' ARG . 27.5 p-10 -157.3 -115.07 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.147 -0.97 . . . . 11.32 108.946 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.524 ' H ' ' CG ' ' A' ' 258' ' ' ASP . 38.1 ttm-85 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.016 -0.992 . . . . 12.42 109.35 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 301' ' ' MET . . . . . 0.418 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 27.5 ttp . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.451 0.643 . . . . 0.0 109.573 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 302' ' ' PHE . . . . . 0.418 ' N ' ' CG ' ' B' ' 301' ' ' MET . 16.3 t80 -152.7 149.91 28.9 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 303' ' ' GLN . . . . . 0.408 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 14.6 pt20 -149.34 159.75 44.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.988 -1.07 . . . . 0.0 110.413 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -153.16 149.4 27.99 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -111.47 134.86 52.75 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.075 -1.016 . . . . 0.0 109.94 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.86 121.29 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 122.333 1.063 . . . . 0.0 112.735 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 16.9 m -75.92 105.35 6.91 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.941 0.877 . . . . 0.0 109.538 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.549 HG22 ' H ' ' B' ' 310' ' ' ALA . 96.0 mt -53.13 123.64 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 122.469 1.128 . . . . 0.0 111.104 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 44.4 p -107.48 23.65 14.11 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.079 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.549 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -86.38 114.26 56.66 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.376 -0.828 . . . . 0.0 109.384 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -65.89 -6.9 15.27 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 120.289 1.139 . . . . 0.0 112.17 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -113.31 2.67 15.6 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.28 176.07 18.48 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.483 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -84.18 87.4 7.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.761 -1.435 . . . . 0.0 108.812 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.544 ' CE1' ' HB3' ' B' ' 317' ' ' ARG . 23.1 p-80 -92.65 -160.26 0.73 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.193 -0.942 . . . . 0.0 109.696 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 5.5 m -57.89 -49.7 75.83 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.912 -1.117 . . . . 0.0 112.168 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.545 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 11.4 tpt180 -52.35 -59.04 9.41 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 120.63 -1.294 . . . . 0.0 112.024 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.425 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 17.8 Cg_endo -63.36 -35.03 64.28 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 CA-C-N 120.613 1.255 . . . . 0.0 111.483 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.35 78.01 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -57.57 -44.86 85.62 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.313 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -69.1 -44.53 72.27 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.626 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -60.01 -50.05 75.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.694 -0.629 . . . . 0.0 111.004 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.52 -29.18 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.529 -1.357 . . . . 0.0 109.206 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -59.93 -46.6 88.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.53 -0.731 . . . . 0.0 109.833 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -69.26 -40.6 77.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 0.0 111.426 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.19 -51.48 69.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.55 -1.344 . . . . 0.0 109.997 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -58.97 -13.33 6.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 109.307 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.6 -30.85 70.67 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -105.54 141.8 36.39 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.54 -0.977 . . . . 0.0 108.534 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 35.2 m -90.2 -11.43 41.04 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.841 -1.162 . . . . 0.0 109.539 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.478 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 93.8 p -57.99 151.2 18.96 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.139 -0.976 . . . . 0.0 108.784 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -68.06 130.48 43.09 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.213 -0.929 . . . . 0.0 108.813 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 80.1 mt -130.65 130.48 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.5 -0.75 . . . . 0.0 109.143 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 45.3 m -127.85 152.13 48.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.478 -0.764 . . . . 0.0 108.996 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 75.5 t -119.12 138.43 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 98.8 m -132.21 129.31 39.55 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.262 -0.899 . . . . 0.0 110.204 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 337' ' ' SER . . . . . 0.454 ' C ' ' H ' ' B' ' 339' ' ' GLY . 80.2 p -136.91 126.77 25.72 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.466 -0.771 . . . . 0.0 109.791 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 56.8 t30 57.09 5.58 0.26 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.59 0.71 . . . . 0.0 109.505 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 339' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' B' ' 337' ' ' SER . . . 101.91 10.16 40.85 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -100.56 119.27 38.28 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 32.4 m -99.06 149.75 22.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.182 -0.949 . . . . 0.0 111.908 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 342' ' ' ALA . . . . . 0.492 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -149.69 149.54 30.76 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 343' ' ' SER . . . . . 0.434 ' H ' ' HE3' ' B' ' 349' ' ' LYS . 8.8 t -90.55 131.43 36.28 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.119 -0.988 . . . . 0.0 110.297 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -70.06 -16.63 63.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.152 -0.967 . . . . 0.0 110.047 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 345' ' ' LYS . . . . . 0.48 ' NZ ' ' CB ' ' B' ' 345' ' ' LYS . 0.1 OUTLIER -89.52 19.59 4.46 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 28.4 t -147.99 99.0 3.02 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.057 0.932 . . . . 0.0 111.572 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 1.018 HD23 HD22 ' A' ' 79' ' ' LEU . 58.9 tp -58.98 -36.2 74.48 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.739 ' CE2' HD11 ' A' ' 79' ' ' LEU . 58.2 m-85 -55.17 -53.05 60.94 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.312 -0.868 . . . . 0.0 111.363 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 349' ' ' LYS . . . . . 0.434 ' HE3' ' H ' ' B' ' 343' ' ' SER . 49.8 mtmt -70.04 -29.75 66.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 0.0 109.74 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' B' ' 347' ' ' LEU . 55.7 mt -59.75 -39.4 84.64 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.414 -0.804 . . . . 0.0 111.196 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.546 ' NE2' ' CZ ' ' A' ' 126' ' ' ARG . 3.0 mm100 -65.78 -14.75 61.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.187 -1.571 . . . . 0.0 111.673 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 40.5 p -77.53 -10.89 59.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.13 -1.607 . . . . 0.0 110.156 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.492 HD11 ' HB3' ' B' ' 342' ' ' ALA . 52.8 mt -93.44 115.08 27.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.113 -0.992 . . . . 0.0 109.043 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -72.24 93.97 0.62 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 107.772 -2.131 . . . . 0.0 107.772 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 355' ' ' LEU . . . . . 0.45 HD22 HG11 ' B' ' 361' ' ' VAL . 80.6 mt -100.21 88.08 3.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.241 -1.152 . . . . 0.0 110.341 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 44.7 p -92.31 -179.99 5.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.977 -1.077 . . . . 0.0 110.651 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -71.23 114.07 8.92 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.597 -0.689 . . . . 0.0 110.605 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.77 10.65 32.33 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 25.6 m -90.99 108.17 19.68 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.353 -1.086 . . . . 0.0 110.578 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 99.8 t -76.99 118.17 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 122.181 0.991 . . . . 0.0 109.366 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 361' ' ' VAL . . . . . 0.45 HG11 HD22 ' B' ' 355' ' ' LEU . 14.9 m -111.92 178.19 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 28.2 m -131.74 129.42 40.62 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 78.6 mt -105.33 120.63 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 75.6 p -120.32 132.32 55.25 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.548 -0.72 . . . . 0.0 109.184 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.21 149.56 36.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 109.799 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -147.0 125.84 12.69 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 158.72 -158.9 29.78 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 118.913 -1.613 . . . . 0.0 111.401 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -59.94 -52.53 65.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 122.178 -0.601 . . . . 0.0 111.794 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.478 ' H ' ' HB3' ' B' ' 331' ' ' SER . 70.9 m-20 -107.59 11.75 28.32 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.973 -1.079 . . . . 0.0 111.384 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 369' ' ' ASP . 12.9 pt-20 -37.78 -33.59 0.08 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.402 -0.812 . . . . 0.0 111.578 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -66.7 -51.17 59.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.906 -1.121 . . . . 0.0 110.925 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -64.08 -48.9 74.38 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.908 -1.12 . . . . 0.0 108.915 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.31 -40.75 3.7 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.53 -0.731 . . . . 0.0 111.594 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 94.7 t -76.13 -35.86 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.615 -1.303 . . . . 0.0 109.708 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.7 -59.07 5.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.103 -0.998 . . . . 0.0 111.832 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -70.02 -40.79 74.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.762 -1.211 . . . . 0.0 111.867 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.98 -41.14 91.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.676 -1.265 . . . . 0.0 109.422 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.63 -44.6 99.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.897 -1.127 . . . . 0.0 109.732 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' B' ' 383' ' ' GLU . 57.7 mtpt -68.97 -55.99 9.2 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 53.8 tp -54.49 -37.71 65.59 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.732 -0.605 . . . . 0.0 109.404 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 6.4 tpp -72.79 -40.0 66.26 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.602 -1.311 . . . . 0.0 108.441 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -79.97 -5.27 55.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.545 -0.722 . . . . 0.0 110.19 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' B' ' 379' ' ' LYS . 53.7 mm-40 -110.61 0.97 17.76 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.19 -0.944 . . . . 0.0 111.069 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 17.4 mt -90.8 124.59 35.26 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.518 -1.364 . . . . 0.0 109.107 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 385' ' ' GLU . . . . . 0.417 ' H ' ' HG2' ' B' ' 385' ' ' GLU . 15.1 pt-20 . . . . . 0 N--CA 1.499 1.986 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.376 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.7 mtm . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.356 -0.609 . . . . 2.91 109.356 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.3 mt -110.36 129.0 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.533 -0.73 . . . . 1.2 109.311 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.7 m -140.79 120.55 13.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.375 -0.828 . . . . 1.4 109.23 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.7 -164.98 39.18 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.743 -1.343 . . . . 1.05 109.743 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 5' ' ' ILE . 88.1 mt -86.44 -1.54 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.172 -1.193 . . . . 1.15 110.583 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.2 tp 52.53 88.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.799 -1.188 . . . . 0.98 109.07 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.74 -38.0 64.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.254 -0.904 . . . . 0.88 109.509 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.0 t -149.71 135.52 10.12 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.375 -0.828 . . . . 1.69 109.427 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -80.43 145.56 16.78 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.23 1.954 . . . . 0.85 113.772 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.689 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.84 -159.37 30.59 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.189 -1.564 . . . . 0.92 109.189 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.2 mt -149.54 150.01 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.047 -1.266 . . . . 0.81 108.955 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.44 150.37 26.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.054 -1.029 . . . . 0.51 110.53 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -130.25 126.22 36.77 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 107.969 -1.123 . . . . 0.62 107.969 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.8 178.04 48.4 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.429 -1.843 . . . . 0.55 111.096 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -80.01 159.61 26.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.89 -0.771 . . . . 2.1 109.679 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -100.38 132.04 45.97 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.376 -0.828 . . . . 0.77 111.582 -178.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.0 tp -105.27 133.42 50.07 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.717 -1.586 . . . . 0.91 106.717 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.8 tp -117.11 123.51 46.96 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.138 -0.976 . . . . 0.93 110.747 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' A' ' 160' ' ' ALA . 48.7 mt -92.43 104.13 16.49 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.755 -0.59 . . . . 0.93 110.473 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.66 137.56 32.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.318 -0.864 . . . . 2.75 109.341 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -131.12 134.14 46.27 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.241 -0.912 . . . . 3.0 109.492 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -88.21 139.96 29.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.116 -0.99 . . . . 2.77 109.074 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -62.31 140.78 58.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.034 -1.041 . . . . 2.94 109.268 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.3 mt -79.18 132.3 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.95 108.766 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.2 t -104.64 126.66 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.426 -0.797 . . . . 1.28 109.897 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -100.27 138.61 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.789 -0.819 . . . . 1.21 108.789 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -90.61 125.65 35.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.997 -1.064 . . . . 1.81 109.204 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -89.94 1.43 56.25 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.692 -0.855 . . . . 2.8 108.692 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.95 139.93 57.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.42 -0.8 . . . . 2.87 109.747 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -88.04 137.92 31.9 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.305 -0.872 . . . . 2.35 109.24 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.8 pt -90.57 159.98 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.994 -1.067 . . . . 0.97 109.442 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.4 p -94.65 171.78 8.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.061 -1.024 . . . . 1.17 108.687 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.58 -46.69 83.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 1.18 108.997 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 25.6 t0 -55.84 -32.7 63.84 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.758 -1.214 . . . . 2.56 109.516 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -81.51 -9.98 59.58 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.12 -0.988 . . . . 1.79 110.425 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 t -64.15 -53.02 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.6 -1.312 . . . . 1.0 108.8 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -61.72 -39.99 93.47 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.439 -0.788 . . . . 1.77 110.027 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -67.96 -41.87 81.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 2.7 110.492 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -65.42 -39.98 92.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.065 -1.022 . . . . 1.51 110.575 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.98 -46.17 94.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.688 -1.258 . . . . 0.93 108.79 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -60.03 -40.01 87.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.846 -1.159 . . . . 1.81 108.94 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.505 HH11 ' HG2' ' A' ' 42' ' ' ARG . 17.9 mtt-85 -60.01 -43.28 95.35 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.973 -1.121 . . . . 2.78 107.973 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 28.6 t80 -60.84 -50.05 74.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.475 -0.766 . . . . 0.78 109.064 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.6 tp -61.87 -44.66 96.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.414 -0.804 . . . . 1.07 109.035 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.6 t -65.47 -43.74 89.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -0.943 . . . . 1.12 109.176 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.98 -45.71 95.43 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.684 -2.166 . . . . 0.84 107.684 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -60.66 -39.28 87.76 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.389 -0.967 . . . . 3.09 108.389 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.26 -40.18 64.42 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.286 -0.635 . . . . 0.88 109.286 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 50' ' ' ALA . 22.3 ttmt -65.81 -73.58 0.13 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.168 -1.419 . . . . 2.59 107.168 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.91 -38.99 0.34 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.35 -0.844 . . . . 0.7 111.222 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 t -51.93 -56.03 16.64 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.603 -1.311 . . . . 1.4 108.816 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.81 -40.72 79.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.86 . . . . 0.67 111.15 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -69.95 -40.05 75.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.748 -1.22 . . . . 1.66 110.008 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.04 -40.05 94.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.996 -1.065 . . . . 1.58 108.964 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -64.26 -33.93 76.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.26 -0.9 . . . . 1.35 109.361 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.5 m -64.87 -42.5 94.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.035 -1.041 . . . . 0.77 109.784 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.595 ' CD1' HH22 ' A' ' 136' ' ' ARG . 97.9 mt -62.27 -40.07 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.63 109.086 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -51.92 -49.99 61.99 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.447 -0.783 . . . . 1.14 109.426 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.6 m -59.44 -40.0 85.36 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.124 -0.985 . . . . 0.79 110.878 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -63.5 -37.88 88.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.745 -1.222 . . . . 1.53 109.835 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.407 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -65.32 -46.59 79.7 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.62 -0.675 . . . . 0.57 110.097 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.98 -49.57 77.08 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.274 -1.13 . . . . 0.75 110.274 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.97 -44.95 71.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.857 -1.378 . . . . 1.59 110.161 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.1 m -69.66 -57.23 5.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.73 111.54 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -97.11 -57.34 2.29 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.026 -1.046 . . . . 0.75 110.948 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.0 -163.75 26.94 Favored Glycine 0 N--CA 1.503 3.133 0 C-N-CA 119.802 -1.19 . . . . 1.22 111.041 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -67.92 -26.2 65.86 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.712 -0.875 . . . . 5.81 110.605 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -60.0 -36.36 77.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 3.37 110.211 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -100.5 -18.71 16.53 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.471 -0.768 . . . . 1.77 110.729 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -70.27 -43.1 71.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.779 -1.201 . . . . 1.65 110.838 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.57 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -66.41 -32.29 73.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.301 -0.874 . . . . 0.77 110.226 -178.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.08 -39.92 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.854 -1.153 . . . . 0.8 109.307 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -64.48 -40.04 94.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.753 -1.217 . . . . 0.88 109.687 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.51 -40.37 91.2 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.105 -0.997 . . . . 1.37 109.614 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.98 -49.2 63.82 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.76 -1.736 . . . . 0.62 108.76 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.2 m170 -59.98 -43.35 95.18 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.374 -1.074 . . . . 1.5 108.687 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.81 -48.98 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.122 -0.986 . . . . 0.63 109.1 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.0 ttp -60.1 -42.7 95.26 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.043 -1.035 . . . . 1.51 109.491 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.852 HD11 ' CE2' ' B' ' 348' ' ' PHE . 46.8 tp -61.96 -39.36 91.88 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.37 -0.831 . . . . 0.77 108.772 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.05 -39.97 87.8 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.501 -0.749 . . . . 0.62 109.328 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -83.73 9.9 10.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.348 -0.845 . . . . 1.47 109.804 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 62.5 t0 -53.37 133.23 40.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.946 . . . . 1.47 109.984 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.469 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 99.2 mt-10 -59.06 -24.04 62.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.684 -0.635 . . . . 1.78 111.496 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -71.09 -34.65 71.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.896 -1.128 . . . . 2.53 109.871 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.9 mt -70.2 -40.02 74.85 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.585 0.707 . . . . 0.8 109.858 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.96 -48.9 79.81 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.364 -0.835 . . . . 1.42 110.31 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -70.13 -42.96 71.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.369 -0.832 . . . . 1.71 111.57 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.01 -40.02 75.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.082 -1.011 . . . . 1.57 112.119 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.75 -47.73 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.852 -1.155 . . . . 0.65 109.842 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.5 mt -66.51 -38.57 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.796 . . . . 0.82 109.904 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.9 88.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.178 -0.951 . . . . 0.79 111.26 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.1 mt -60.0 -46.61 88.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.773 -1.205 . . . . 0.95 109.945 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.1 mt -59.96 -46.14 94.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.751 -1.203 . . . . 0.66 107.751 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -67.99 -40.36 83.1 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.925 -0.71 . . . . 2.2 110.238 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -80.74 -55.9 4.51 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.035 -1.041 . . . . 1.65 112.437 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.01 -3.25 58.09 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.973 -1.08 . . . . 2.03 111.971 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 74.9 m80 57.13 41.12 27.71 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.885 -1.134 . . . . 1.42 109.236 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 68.0 mtp -95.62 169.18 10.21 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.445 0.641 . . . . 1.18 110.103 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 68.2 p -78.58 160.36 27.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.386 -0.821 . . . . 0.98 109.576 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.0 -39.12 87.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.64 110.155 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 18.2 p-10 -70.04 -34.06 72.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.013 -1.054 . . . . 2.07 109.349 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.08 -44.08 22.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.73 109.776 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.04 -43.12 71.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.448 -0.783 . . . . 0.54 110.229 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.93 87.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.99 -1.069 . . . . 0.56 109.72 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.466 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 82.4 t60 -60.05 -40.01 87.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.394 -0.816 . . . . 1.54 110.574 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.32 -41.87 93.54 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.044 -1.035 . . . . 1.33 110.74 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.89 -50.73 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.002 -1.061 . . . . 0.72 110.851 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.8 mm -69.9 -40.08 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.918 -1.114 . . . . 0.85 109.01 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.466 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.0 tt0 -63.82 -37.83 88.83 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.36 -0.978 . . . . 2.44 108.36 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.96 -54.1 40.25 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.598 -1.001 . . . . 0.98 110.598 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -64.77 -49.87 69.05 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.756 -1.438 . . . . 1.41 109.219 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.89 -41.93 88.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 1.2 109.085 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.9 t -58.84 -39.97 82.83 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.349 -0.844 . . . . 1.7 108.95 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.05 96.25 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.354 -0.841 . . . . 1.47 109.366 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.5 mt -63.58 -40.64 97.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.049 -1.032 . . . . 1.56 109.892 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.86 -36.54 77.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.846 -1.159 . . . . 2.2 109.508 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -53.85 -21.93 8.7 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.247 -0.908 . . . . 2.12 108.89 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 123' ' ' LEU . 35.5 mt -62.95 142.6 58.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 2.0 109.349 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -91.11 12.78 18.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.406 -0.809 . . . . 3.23 109.425 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -100.4 126.5 46.79 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.261 -0.899 . . . . 2.49 110.147 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.402 ' O ' ' CD ' ' A' ' 121' ' ' GLU . 5.0 tm-20 -69.92 -29.96 67.26 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.686 0.755 . . . . 3.95 109.014 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.426 ' OH ' ' C ' ' B' ' 314' ' ' LEU . 19.3 t80 -62.83 -42.84 99.9 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 122.007 0.908 . . . . 2.0 110.109 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.912 HD22 ' O ' ' B' ' 351' ' ' GLN . 79.2 mt -76.16 -31.24 58.46 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.771 -0.825 . . . . 1.86 108.771 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -60.07 -40.85 90.94 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.475 -0.765 . . . . 2.84 108.985 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.11 -44.24 95.01 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.574 -0.899 . . . . 2.73 108.574 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.69 HH21 ' NE2' ' B' ' 351' ' ' GLN . 62.5 mtp180 -62.07 -39.67 93.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 2.77 109.138 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.98 -32.57 70.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.448 -0.782 . . . . 1.19 109.449 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.06 94.29 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.656 -0.868 . . . . 1.2 108.656 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -62.61 -40.08 95.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.421 -0.799 . . . . 1.55 110.192 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.06 -43.04 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 0.8 109.924 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -60.01 -40.0 87.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.081 -1.012 . . . . 3.09 109.538 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.03 -38.23 82.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.348 -0.845 . . . . 1.46 109.931 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.97 -43.31 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.122 -0.986 . . . . 0.71 110.358 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.2 -32.62 62.67 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.673 -1.251 . . . . 0.57 110.114 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -59.96 -49.97 75.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.107 -1.231 . . . . 2.59 109.283 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.595 HH22 ' CD1' ' A' ' 57' ' ' ILE . 59.5 mtp180 -65.61 -34.99 79.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 2.83 109.994 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.0 tp -59.96 -43.46 95.05 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.224 -0.922 . . . . 1.25 109.48 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.14 -39.96 94.36 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.087 -1.008 . . . . 0.7 108.815 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.416 HH11 ' HG2' ' A' ' 139' ' ' ARG . 58.6 mtt-85 -70.11 -39.9 75.22 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.461 -0.94 . . . . 2.57 108.461 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 44.6 m-20 -62.04 -37.05 83.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.811 -0.556 . . . . 1.23 111.165 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.06 -43.56 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.698 -1.251 . . . . 0.81 108.221 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.98 -38.03 75.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.695 -0.628 . . . . 1.0 109.579 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.49 45.45 5.24 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.255 -1.938 . . . . 0.89 108.255 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.407 ' CD2' ' NH1' ' A' ' 139' ' ' ARG . 12.0 tp -74.58 150.02 39.88 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.499 -1.001 . . . . 1.14 109.548 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -63.02 142.84 58.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.341 -0.85 . . . . 4.6 110.428 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.2 mt -119.9 126.72 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.565 -0.902 . . . . 1.24 108.565 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.4 mt -59.97 -44.89 95.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.826 -0.546 . . . . 1.54 110.298 -178.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.4 t0 67.72 94.63 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.83 -0.804 . . . . 1.5 108.83 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.553 ' O ' HD12 ' A' ' 152' ' ' ILE . 34.7 mt -67.07 -8.1 27.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.457 -0.777 . . . . 0.79 109.951 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.8 t -79.94 -13.8 59.09 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.993 -1.067 . . . . 1.4 108.286 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.12 24.76 0.76 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.786 -0.571 . . . . 0.92 110.395 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.553 HD12 ' O ' ' A' ' 149' ' ' LEU . 42.6 mt -92.97 118.1 37.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.021 -1.05 . . . . 0.88 108.688 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -104.83 -11.22 16.88 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.222 -0.924 . . . . 2.45 110.391 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -119.71 147.31 44.73 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.615 -0.678 . . . . 1.52 110.12 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -64.11 136.52 57.33 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.408 -0.96 . . . . 1.58 108.408 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.2 m -153.52 168.54 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.233 -0.917 . . . . 0.69 109.99 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 74.0 mt -95.94 144.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 105.883 -1.895 . . . . 0.61 105.883 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 22.1 tp -92.99 115.86 28.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.905 -1.122 . . . . 0.87 110.48 -177.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.544 HG12 HG22 ' A' ' 209' ' ' THR . 45.7 t -123.38 129.94 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 108.76 -0.829 . . . . 0.71 108.76 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.497 ' C ' HG21 ' A' ' 209' ' ' THR . . . -162.16 164.67 27.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.905 . . . . 0.81 108.795 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.44 -35.35 70.89 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.257 -1.527 . . . . 0.98 107.781 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -164.56 173.87 11.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.411 -0.959 . . . . 2.25 108.411 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.4 mt -136.48 143.1 43.64 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.115 -0.991 . . . . 0.78 109.201 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 74.7 p -95.27 141.99 23.99 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.241 -0.912 . . . . 0.98 109.342 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -39.99 -39.88 2.48 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.278 1.985 . . . . 0.81 112.514 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 68.9 m -60.04 -39.97 87.78 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.26 -0.9 . . . . 0.9 109.097 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.5 -43.69 96.47 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.27 -0.894 . . . . 1.61 110.108 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.9 p -53.87 -25.85 21.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.187 -0.946 . . . . 0.61 110.823 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -80.55 -54.76 5.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.82 -1.175 . . . . 0.6 109.817 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -83.76 39.85 0.71 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.698 -0.853 . . . . 1.4 108.698 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.0 tp -105.2 135.66 46.14 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.709 -0.849 . . . . 0.7 108.709 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.43 ' O ' HG23 ' A' ' 176' ' ' VAL . 86.1 m-20 -84.96 103.41 13.98 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.194 -0.941 . . . . 2.35 108.93 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 36.3 mt -67.14 -40.53 86.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.511 -0.743 . . . . 1.51 110.881 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -69.97 -24.15 63.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.757 -1.215 . . . . 2.33 111.433 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -92.78 -6.79 48.2 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.802 -1.186 . . . . 1.92 109.853 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 178' ' ' GLY . 84.0 t -106.56 116.67 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.329 -0.857 . . . . 0.67 108.702 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 71.3 mt -89.99 7.24 38.52 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.283 -0.886 . . . . 1.53 110.243 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.512 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 171.89 171.88 37.32 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.176 -1.57 . . . . 0.48 109.176 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.474 ' CE1' HG11 ' A' ' 176' ' ' VAL . 26.8 m-85 -132.37 129.66 39.69 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.321 -1.105 . . . . 0.55 109.207 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 94.7 mt -134.07 127.51 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.525 -0.917 . . . . 0.65 108.525 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.1 p -149.94 162.75 39.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.938 -1.101 . . . . 0.82 110.681 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.481 ' O ' ' O ' ' A' ' 183' ' ' ALA . 0.9 OUTLIER -100.24 20.31 14.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.506 -0.747 . . . . 2.46 109.726 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -46.69 -174.7 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 122.322 1.058 . . . . 1.28 112.823 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.36 -56.69 3.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 111.396 -0.682 . . . . 2.19 111.396 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -167.36 -159.09 12.34 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 118.484 -1.817 . . . . 2.13 111.416 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.425 HH11 ' HG2' ' A' ' 186' ' ' ARG . 17.8 ptt-85 -72.29 -15.93 61.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.749 -0.854 . . . . 5.86 110.849 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 71.5 p -71.23 3.42 3.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.831 -1.168 . . . . 3.72 109.271 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 40.7 t -83.4 134.29 34.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 1.74 110.275 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -49.88 -38.96 37.91 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.169 -1.049 . . . . 0.95 108.169 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.6 p -59.94 -41.49 91.93 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.928 -0.578 . . . . 1.55 110.493 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 41.2 t -62.06 -38.61 89.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.113 -0.992 . . . . 1.51 110.669 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.3 mm -60.0 -39.35 80.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.236 -0.915 . . . . 1.67 109.19 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.1 mtp -59.5 -44.43 93.11 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.245 -0.909 . . . . 1.02 110.102 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.36 -44.48 80.15 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.647 -1.283 . . . . 0.68 109.712 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.409 HH22 ' HD2' ' A' ' 186' ' ' ARG . 98.9 mtt180 -62.96 -57.81 9.49 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.142 -1.023 . . . . 2.93 110.778 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.1 m -62.7 -39.97 95.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.997 -1.064 . . . . 0.86 112.111 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.9 mt -69.95 -15.7 63.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.864 -1.147 . . . . 0.67 110.25 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 62.13 49.67 4.35 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.626 -0.671 . . . . 1.5 110.175 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 78.5 mt -130.39 149.91 74.73 Favored Pre-proline 0 N--CA 1.499 1.999 0 N-CA-C 107.682 -1.229 . . . . 0.72 107.682 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.79 147.5 62.82 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.316 2.01 . . . . 0.61 111.846 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -173.88 158.76 3.27 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.922 -1.111 . . . . 0.66 112.035 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.8 mt -130.96 144.75 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.281 -1.007 . . . . 0.79 108.281 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 28.0 m -128.98 -7.53 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.99 -1.069 . . . . 0.91 111.064 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.75 24.48 13.17 Favored Glycine 0 N--CA 1.501 3.032 0 N-CA-C 110.799 -0.92 . . . . 1.01 110.799 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.429 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.1 p -46.77 -44.14 18.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.876 -1.367 . . . . 0.99 109.748 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.57 -55.5 2.71 Favored Glycine 0 N--CA 1.498 2.803 0 C-N-CA 120.166 -1.016 . . . . 1.12 111.825 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 34.3 p -149.82 25.92 0.83 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.6 -1.53 . . . . 1.72 111.646 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.97 -39.62 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.773 -1.205 . . . . 0.89 108.964 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.544 HG22 HG12 ' A' ' 159' ' ' VAL . 50.4 p -58.0 -36.65 72.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.498 -0.751 . . . . 1.03 110.173 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 80.9 p -84.99 -11.74 54.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.013 -1.054 . . . . 1.83 110.25 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -95.87 -14.93 22.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.054 -1.029 . . . . 2.27 110.305 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 213' ' ' LYS . 21.7 t -114.79 154.37 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.275 -0.891 . . . . 0.92 110.469 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.44 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 11.1 mptt -117.2 156.45 27.67 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.701 -1.222 . . . . 2.2 107.701 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 27.5 p30 -60.02 142.68 53.53 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.053 -1.029 . . . . 2.36 110.431 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 11.0 t0 86.62 0.83 0.56 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 120.919 0.39 . . . . 2.38 110.359 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 91.8 m-20 -75.05 153.78 38.25 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.938 -1.101 . . . . 2.09 108.814 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -96.44 131.27 43.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.226 -1.027 . . . . 1.27 108.226 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 82.6 mt -129.52 149.65 51.2 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.192 -0.943 . . . . 0.75 110.994 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 85.5 mt -120.59 122.64 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.816 -1.549 . . . . 0.63 106.816 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 57.2 tp -98.73 115.51 28.89 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.733 -1.23 . . . . 0.7 109.223 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 223' ' ' VAL . 96.0 m-20 -75.57 -44.61 42.36 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.031 -1.043 . . . . 2.31 108.29 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.95 17.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.978 0.894 . . . . 0.78 108.62 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.1 t -132.08 -45.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 106.654 -1.609 . . . . 1.04 106.654 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -100.33 1.93 42.04 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.685 -1.228 . . . . 2.44 107.685 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 60.53 44.15 12.1 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.79 -0.569 . . . . 1.55 109.824 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -139.65 141.84 37.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.323 -0.86 . . . . 1.99 109.525 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 97.2 t -119.98 120.85 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 109.112 -0.699 . . . . 0.77 109.112 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -89.04 131.67 35.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.981 -1.074 . . . . 0.98 108.715 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 64.2 t -109.33 122.92 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.709 -0.619 . . . . 0.85 109.64 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 62.49 69.15 0.94 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.524 -0.735 . . . . 1.66 109.745 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -90.18 127.85 1.48 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 123.417 2.744 . . . . 0.95 112.276 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.0 167.18 12.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.095 -1.003 . . . . 1.84 109.341 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -59.94 -40.0 87.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 2.74 110.07 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.453 ' H ' ' CD ' ' A' ' 234' ' ' GLU . 58.3 mp0 -60.0 -39.98 87.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -0.945 . . . . 2.89 110.085 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.32 -39.4 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 1.3 110.049 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.9 mt -66.77 -39.93 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 1.09 110.903 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 238' ' ' LYS . 1.0 OUTLIER -60.0 -41.49 92.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.607 -1.308 . . . . 2.43 108.969 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.492 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 8.3 ttpm? -60.14 -46.52 89.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.595 -0.69 . . . . 2.78 110.227 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 78.3 mtp -72.4 -23.26 61.07 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.288 -0.882 . . . . 1.25 110.058 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.404 HH11 ' HG3' ' A' ' 240' ' ' ARG . 15.4 mmm-85 -70.27 -40.14 74.51 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.022 -1.049 . . . . 2.63 109.105 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.18 -43.08 96.15 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.345 -0.847 . . . . 1.8 109.01 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.2 t -59.99 -45.95 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.392 -0.818 . . . . 2.13 108.889 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -60.18 -40.0 88.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.849 . . . . 3.17 109.962 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -61.46 -40.19 93.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.035 -1.041 . . . . 1.78 109.736 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -61.38 -39.95 92.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 2.47 109.985 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.04 -45.5 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.14 -0.975 . . . . 2.09 108.947 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.13 -50.13 74.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.399 -0.813 . . . . 2.54 109.685 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 252' ' ' GLU . 66.3 m -60.07 -40.0 88.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.303 -0.873 . . . . 2.99 109.616 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -63.92 -39.91 95.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.386 -0.821 . . . . 3.34 109.067 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -91.53 -0.06 57.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.587 -0.696 . . . . 3.88 110.395 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -130.78 -45.76 1.05 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.445 -1.409 . . . . 4.43 110.606 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 248' ' ' SER . 86.3 tt0 -167.42 109.41 0.64 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.946 -1.097 . . . . 5.42 109.006 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 21.4 mt -65.5 -27.13 68.26 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.21 -1.033 . . . . 6.1 108.21 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 255' ' ' LYS . . . 60.27 12.98 3.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.868 -0.52 . . . . 7.37 109.691 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.491 ' C ' ' H ' ' A' ' 257' ' ' LYS . 51.6 tttm 39.97 -129.97 0.34 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.702 -0.624 . . . . 8.01 110.171 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 257' ' ' LYS . 0.5 OUTLIER 67.61 -6.24 0.69 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.22 -0.925 . . . . 9.05 109.045 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.491 ' H ' ' C ' ' A' ' 255' ' ' LYS . 31.8 ttmt 55.8 155.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.544 0.688 . . . . 10.56 110.214 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -164.37 -89.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.023 -1.048 . . . . 11.32 109.675 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 117.949 -1.024 . . . . 12.42 109.447 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 301' ' ' MET . . . . . 0.485 ' N ' ' OE1' ' B' ' 366' ' ' GLU . 21.6 ttt . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 302' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 22.3 t80 -156.08 154.55 31.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 109.48 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 303' ' ' GLN . . . . . 0.506 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 20.6 pt20 -148.5 160.03 43.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.288 -0.883 . . . . 0.0 109.674 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 304' ' ' GLN . . . . . 0.437 ' NE2' HG11 ' B' ' 378' ' ' VAL . 60.9 tt0 -151.81 149.97 29.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.309 -0.869 . . . . 0.0 109.596 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 305' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 56.5 mp0 -105.94 130.63 53.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.382 -0.824 . . . . 0.0 109.742 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.491 ' O ' HG13 ' B' ' 306' ' ' VAL . 10.2 p -130.58 117.73 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-O 122.25 1.024 . . . . 0.0 113.071 -177.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 86.7 m -78.24 105.21 9.32 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.057 0.932 . . . . 0.0 110.53 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.7 mt -53.13 125.96 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 122.429 1.109 . . . . 0.0 111.264 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 22.6 p -112.04 19.94 17.37 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.557 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.71 120.65 82.31 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.746 -1.221 . . . . 0.0 109.402 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -50.96 -18.9 4.86 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 CA-C-N 120.205 1.109 . . . . 0.0 113.463 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -119.43 14.29 12.81 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.233 -0.917 . . . . 0.0 109.603 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.61 179.45 35.25 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.426 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 3.9 tp -85.38 95.41 9.23 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.05 -1.265 . . . . 0.0 109.477 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.401 ' CA ' ' OH ' ' A' ' 122' ' ' TYR . 3.7 p80 -97.96 -160.72 0.82 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.934 -1.104 . . . . 0.0 110.108 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 7.9 m -59.92 -41.94 92.83 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.095 -1.003 . . . . 0.0 112.295 -176.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.692 HH21 ' NE2' ' B' ' 321' ' ' GLN . 1.0 OUTLIER -55.33 -62.13 4.89 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.538 -1.351 . . . . 0.0 111.224 -178.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.05 -33.23 97.05 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 120.242 1.122 . . . . 0.0 111.765 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.95 -50.79 72.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.254 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.46 -43.12 75.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.464 -0.772 . . . . 0.0 110.736 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 321' ' ' GLN . . . . . 0.692 ' NE2' HH21 ' B' ' 317' ' ' ARG . 92.3 mt-30 -73.49 -40.08 64.36 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.037 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -60.09 -50.26 74.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 0.0 110.431 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 323' ' ' VAL . . . . . 0.462 HG13 ' O ' ' B' ' 344' ' ' ALA . 54.6 t -66.45 -40.02 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.566 -1.334 . . . . 0.0 108.981 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -59.9 -45.77 91.48 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -62.49 -45.88 91.0 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.103 -0.998 . . . . 0.0 108.437 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.09 -51.21 70.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.617 -0.677 . . . . 0.0 110.308 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -57.72 -10.46 1.63 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.913 -1.117 . . . . 0.0 109.082 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.91 -29.89 70.57 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -103.36 144.89 30.78 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.561 -0.964 . . . . 0.0 108.915 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 16.6 p -91.39 -13.19 32.85 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.789 -1.195 . . . . 0.0 109.916 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 83.9 p -58.97 151.34 22.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.983 -1.073 . . . . 0.0 108.905 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.1 133.36 47.96 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.006 -1.059 . . . . 0.0 108.579 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.1 mt -131.88 131.05 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.753 -0.592 . . . . 0.0 109.802 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 334' ' ' THR . . . . . 0.405 HG22 ' N ' ' B' ' 335' ' ' VAL . 89.2 m -129.82 153.51 48.19 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 335' ' ' VAL . . . . . 0.405 ' N ' HG22 ' B' ' 334' ' ' THR . 84.9 t -116.11 138.27 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 77.6 m -130.03 125.4 35.2 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.119 -0.988 . . . . 0.0 109.133 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 51.6 p -139.58 117.0 11.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.197 -0.939 . . . . 0.0 110.906 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 34.4 m120 42.75 57.75 3.43 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 83.98 -14.26 44.53 Favored Glycine 0 N--CA 1.499 2.858 0 O-C-N 120.303 -1.498 . . . . 0.0 112.806 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -115.58 126.88 54.78 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-N 119.108 1.454 . . . . 0.0 109.974 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 80.0 p -127.27 148.92 50.22 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.929 0.871 . . . . 0.0 110.28 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -140.97 164.28 30.69 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.508 0.67 . . . . 0.0 109.903 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 23.2 t -87.35 137.23 32.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.493 -0.754 . . . . 0.0 109.202 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.462 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -76.73 -13.39 60.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.979 -1.076 . . . . 0.0 109.858 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.07 20.67 4.13 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 67.4 m -146.25 94.25 2.43 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.714 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.815 HD23 HD22 ' A' ' 79' ' ' LEU . 56.9 tp -59.92 -33.34 71.74 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.852 ' CE2' HD11 ' A' ' 79' ' ' LEU . 54.9 m-85 -56.75 -52.79 63.65 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.396 -0.815 . . . . 0.0 110.616 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -69.33 -39.79 77.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.632 -1.292 . . . . 0.0 110.089 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' B' ' 352' ' ' THR . 20.9 mt -48.59 -58.49 4.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.062 -1.024 . . . . 0.0 109.07 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.912 ' O ' HD22 ' A' ' 123' ' ' LEU . 1.3 mp0 -41.6 -14.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.555 -0.716 . . . . 0.0 111.19 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.574 ' N ' ' O ' ' B' ' 350' ' ' LEU . 50.2 p -87.65 -7.62 57.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.039 -1.663 . . . . 0.0 109.966 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 66.5 mt -97.42 116.14 29.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.129 -0.982 . . . . 0.0 109.493 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.67 93.06 1.02 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 21.8 mt -103.31 96.27 6.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.35 -1.088 . . . . 0.0 108.9 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 19.2 p -94.67 170.55 9.38 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.147 -0.971 . . . . 0.0 110.774 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.44 115.83 3.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.831 -0.543 . . . . 0.0 111.035 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 100.62 7.36 51.31 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 53.4 m -85.03 111.5 19.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.205 -1.173 . . . . 0.0 110.827 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 7.6 t -78.03 116.25 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 122.222 1.01 . . . . 0.0 109.503 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.1 m -113.64 178.62 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 86.6 m -130.45 130.86 44.79 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.4 mt -106.86 126.26 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 71.1 m -129.96 137.17 50.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.554 -0.716 . . . . 0.0 109.48 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.32 156.54 43.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.337 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 366' ' ' GLU . . . . . 0.485 ' OE1' ' N ' ' B' ' 301' ' ' MET . 8.8 tp10 -145.96 122.84 11.31 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 157.42 -152.88 24.16 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 118.853 -1.641 . . . . 0.0 111.715 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -60.0 -52.96 63.15 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 122.268 -0.548 . . . . 0.0 112.357 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -110.2 11.26 23.66 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.838 -1.164 . . . . 0.0 111.224 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -42.58 -38.0 1.85 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.073 -1.017 . . . . 0.0 111.817 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -69.32 -44.17 72.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.531 -1.356 . . . . 0.0 110.158 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -70.83 -54.28 12.17 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.016 -1.053 . . . . 0.0 109.242 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.62 -35.95 1.95 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.627 -0.671 . . . . 0.0 110.771 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.562 ' O ' HG23 ' B' ' 378' ' ' VAL . 53.2 t -70.04 -40.02 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.799 -1.188 . . . . 0.0 109.283 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.39 -65.38 0.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.985 -1.072 . . . . 0.0 111.668 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -59.96 -42.05 93.24 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.626 -1.296 . . . . 0.0 111.57 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 93.3 mt -59.92 -42.04 93.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.652 -1.28 . . . . 0.0 108.311 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.562 HG23 ' O ' ' B' ' 374' ' ' VAL . 53.8 t -63.03 -42.36 96.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.297 -0.877 . . . . 0.0 109.684 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.4 mttt -69.99 -56.17 7.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.708 -1.245 . . . . 0.0 107.915 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 54.3 tp -54.51 -36.09 63.85 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 381' ' ' MET . . . . . 0.433 ' SD ' HG11 ' B' ' 306' ' ' VAL . 28.2 ttm -70.52 -40.25 73.58 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.391 -1.324 . . . . 0.0 108.413 177.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.46 -5.56 58.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.654 -0.654 . . . . 0.0 110.682 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' B' ' 379' ' ' LYS . 67.9 mt-10 -112.24 -1.96 15.03 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.052 -1.03 . . . . 0.0 110.708 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 384' ' ' LEU . . . . . 0.464 HD21 ' OE1' ' B' ' 321' ' ' GLN . 15.3 mt -83.68 136.94 34.01 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.427 -1.42 . . . . 0.0 109.066 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.405 -179.639 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.7 mmm . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.448 -0.575 . . . . 2.91 109.448 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.4 mt -110.06 129.95 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.54 -0.911 . . . . 1.2 108.54 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.6 m -135.85 150.1 49.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.39 -0.819 . . . . 1.4 110.405 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.614 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -132.93 -164.62 10.94 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 108.081 -2.008 . . . . 1.05 108.081 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.6 mt -89.2 -14.46 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.632 -1.511 . . . . 1.15 110.353 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.0 tp 55.27 102.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.148 -0.97 . . . . 0.98 108.53 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.04 -22.86 19.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.994 -1.066 . . . . 0.88 109.633 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.5 m -149.99 133.4 8.62 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.097 -1.002 . . . . 1.69 109.677 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -80.37 141.01 13.98 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.4 2.067 . . . . 0.85 112.15 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.712 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 166.0 -165.58 38.19 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.712 -1.355 . . . . 0.92 109.712 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -147.54 148.01 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.22 -1.164 . . . . 0.81 108.52 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.17 156.55 34.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.939 -1.101 . . . . 0.51 110.487 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -137.01 129.64 30.26 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.315 -1.365 . . . . 0.62 107.315 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.38 -174.81 47.23 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 118.37 -1.871 . . . . 0.55 110.986 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -80.04 156.7 27.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.942 -0.74 . . . . 2.1 109.95 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.564 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.5 117.73 34.86 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.436 -0.79 . . . . 0.77 110.118 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.4 tp -89.99 131.55 35.82 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.507 -1.294 . . . . 0.91 107.507 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.5 tp -113.55 120.0 39.46 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.329 -0.857 . . . . 0.93 109.243 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 160' ' ' ALA . 40.2 mt -82.74 102.76 11.75 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.515 0.674 . . . . 0.93 109.656 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -103.0 129.39 49.74 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.751 -0.833 . . . . 2.75 108.751 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.456 ' OE2' ' NZ ' ' A' ' 135' ' ' LYS . 87.0 tt0 -130.36 140.76 50.6 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.223 -0.923 . . . . 3.0 109.372 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -80.16 142.99 34.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.351 -0.843 . . . . 2.77 109.501 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -61.7 143.53 56.03 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.129 -0.982 . . . . 2.94 108.801 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.6 mt -78.16 129.16 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.084 -1.01 . . . . 0.95 109.119 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.7 t -94.14 127.59 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.223 -0.923 . . . . 1.28 109.998 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.6 mt -110.02 134.33 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.637 -0.664 . . . . 1.21 109.229 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -93.84 123.08 36.95 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.169 -0.957 . . . . 1.81 110.249 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.417 HH11 ' HG3' ' A' ' 28' ' ' ARG . 24.7 mmm-85 -90.0 -0.2 57.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.446 -0.784 . . . . 2.8 109.182 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -67.32 145.37 55.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.264 -0.897 . . . . 2.87 109.92 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -92.01 149.28 21.62 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.239 -0.913 . . . . 2.35 109.253 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.559 HD13 ' HG3' ' A' ' 39' ' ' GLU . 3.0 pt -95.7 165.81 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.998 -1.064 . . . . 0.97 109.046 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.2 p -93.11 173.93 7.48 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.419 -0.956 . . . . 1.17 108.419 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.26 78.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.898 -1.126 . . . . 1.18 109.669 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 51.8 t0 -54.93 -30.68 59.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.93 -1.106 . . . . 2.56 110.162 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -82.17 -8.67 59.66 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.177 -0.952 . . . . 1.79 110.249 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.98 -50.31 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.763 -1.21 . . . . 1.0 108.578 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -60.41 -39.96 89.26 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.359 -0.838 . . . . 1.77 108.926 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -62.25 -40.99 98.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.494 -0.753 . . . . 2.7 110.598 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.559 ' HG3' HD13 ' A' ' 31' ' ' ILE . 71.3 mm-40 -64.36 -41.63 96.62 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.813 -1.179 . . . . 1.51 110.166 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.07 -46.7 93.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.909 -1.119 . . . . 0.93 109.069 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -60.05 -40.79 90.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.055 -1.028 . . . . 1.81 109.551 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -60.06 -44.56 94.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.9 -1.125 . . . . 2.78 108.458 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -60.09 -49.16 78.76 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.313 -0.995 . . . . 0.78 108.313 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.1 -46.63 88.96 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.402 -0.962 . . . . 1.07 108.402 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 23.2 t -60.56 -44.47 96.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 1.12 108.875 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.02 -40.01 96.44 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.247 -1.941 . . . . 0.84 108.247 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.523 HH11 ' HG2' ' A' ' 47' ' ' ARG . 1.4 ttt-85 -69.11 -22.61 63.96 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.562 -0.964 . . . . 3.09 108.64 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.07 -46.37 88.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.259 -0.901 . . . . 0.88 109.155 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.555 ' CG ' ' H ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -78.15 -68.96 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.554 -1.258 . . . . 2.59 108.585 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.555 ' H ' ' CG ' ' A' ' 49' ' ' LYS . . . -37.84 -35.79 0.16 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 120.058 1.299 . . . . 0.7 110.462 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.3 t -57.97 -64.43 0.91 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.907 -1.121 . . . . 1.4 108.666 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.97 -40.07 79.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.475 -0.765 . . . . 0.67 110.832 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -63.11 -40.96 99.16 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.812 -1.18 . . . . 1.66 110.361 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 57.5 mt -62.94 -39.86 95.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.881 -1.137 . . . . 1.58 109.216 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -60.11 -38.95 84.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 1.35 110.014 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.6 m -61.24 -41.96 97.78 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.075 -1.015 . . . . 0.77 109.9 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.678 ' CD1' HH22 ' A' ' 136' ' ' ARG . 82.2 mt -61.2 -39.91 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -0.837 . . . . 0.63 109.522 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -59.97 -50.43 73.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.083 -1.011 . . . . 1.14 109.659 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -59.96 -39.14 84.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.281 -0.887 . . . . 0.79 110.125 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -66.03 -37.75 86.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.989 -1.07 . . . . 1.53 109.14 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.79 -45.53 85.91 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.599 -0.688 . . . . 0.57 109.89 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.41 -50.03 71.06 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.626 -1.39 . . . . 0.75 109.626 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -67.3 -45.87 75.24 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.294 -1.121 . . . . 1.59 109.871 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.9 m -65.23 -64.16 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.363 -0.836 . . . . 0.73 112.347 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.42 -47.91 6.65 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.723 -1.236 . . . . 0.75 111.188 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.35 -169.83 24.92 Favored Glycine 0 N--CA 1.501 3.016 0 C-N-CA 119.824 -1.179 . . . . 1.22 111.467 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.65 -27.3 64.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 122.01 -0.7 . . . . 5.81 110.41 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.514 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.3 tp10 -59.95 -32.92 71.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.275 -0.89 . . . . 3.37 110.258 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.5 ' NZ ' ' NE2' ' A' ' 189' ' ' HIS . 14.5 mmmt -98.99 -22.46 15.73 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.226 -0.921 . . . . 1.77 110.259 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.94 -40.07 94.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.954 -1.091 . . . . 1.65 109.893 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.505 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -59.82 -37.57 79.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.87 . . . . 0.77 110.309 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.01 -40.6 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.782 -1.199 . . . . 0.8 109.87 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -70.02 -34.11 72.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.858 -1.151 . . . . 0.88 109.609 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -61.18 -39.98 92.21 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.875 -1.141 . . . . 1.37 109.221 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.91 -41.84 95.2 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.547 -1.421 . . . . 0.62 109.547 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 60.9 m170 -60.16 -43.42 95.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -1.122 . . . . 1.5 109.582 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.3 mt -69.91 -43.55 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.116 -0.99 . . . . 0.63 109.491 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.2 ttp -59.96 -44.92 94.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.845 -1.159 . . . . 1.51 110.309 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.875 HD11 ' CE2' ' B' ' 348' ' ' PHE . 53.9 tp -62.02 -39.82 93.59 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.358 -0.839 . . . . 0.77 109.987 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.5 tp -62.16 -39.57 93.09 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.44 -0.788 . . . . 0.62 110.157 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -82.02 8.66 10.08 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.996 -1.065 . . . . 1.47 110.204 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 59.7 t0 -56.71 130.51 45.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.976 -1.077 . . . . 1.47 109.977 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.407 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.8 mt-10 -59.69 -18.43 42.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.482 -0.761 . . . . 1.78 111.019 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.89 -36.92 72.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.723 -1.235 . . . . 2.53 108.592 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.6 mt -69.99 -40.05 75.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.594 -0.691 . . . . 0.8 110.177 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.02 -49.99 75.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 1.42 110.483 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.13 -39.94 75.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.174 -0.954 . . . . 1.71 111.269 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.97 -40.18 75.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.835 -1.166 . . . . 1.57 111.66 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.2 mt -69.99 -44.15 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.739 -1.225 . . . . 0.65 109.917 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.9 mt -70.02 -37.83 73.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.616 -0.678 . . . . 0.82 110.374 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.68 84.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.988 . . . . 0.79 110.796 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.22 -47.06 87.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.082 -1.012 . . . . 0.95 109.986 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.2 mt -60.66 -50.04 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.309 -0.869 . . . . 0.66 109.447 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -70.08 -42.32 72.94 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.727 -0.789 . . . . 2.2 110.576 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -80.09 -52.79 7.36 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.188 -0.945 . . . . 1.65 112.417 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -90.12 -3.05 58.14 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.973 -1.08 . . . . 2.03 111.675 -177.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.1 m80 59.69 37.5 22.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.959 -1.088 . . . . 1.42 109.467 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 53.2 mtt -93.87 166.24 12.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.443 -0.786 . . . . 1.18 109.782 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.7 p -80.55 162.32 24.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.381 -0.824 . . . . 0.98 109.28 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.51 -37.61 85.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.64 110.102 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 27.4 p-10 -69.87 -35.71 74.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 2.07 109.458 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.85 -41.05 27.09 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.296 -0.878 . . . . 0.73 109.56 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.2 -48.17 53.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.345 -0.847 . . . . 0.54 110.339 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.6 91.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 0.56 109.612 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.53 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 78.5 t60 -60.12 -40.0 88.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 1.54 109.617 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.54 -41.3 98.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.893 . . . . 1.33 110.81 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.28 -53.18 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.012 -1.055 . . . . 0.72 111.313 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.6 mm -70.0 -39.93 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.817 -1.177 . . . . 0.85 109.36 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.53 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 88.4 tt0 -64.65 -38.62 91.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.118 -0.989 . . . . 2.44 108.877 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.95 -43.7 97.86 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.479 -1.049 . . . . 0.98 110.479 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -69.94 -55.26 10.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.922 -1.34 . . . . 1.41 109.531 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.73 -40.31 69.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.183 -0.948 . . . . 1.2 109.343 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 33.8 t -57.77 -40.06 78.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.063 -1.023 . . . . 1.7 108.29 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.81 -39.56 87.77 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.743 -0.836 . . . . 1.47 108.743 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.9 mt -61.78 -42.48 99.04 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.119 -0.988 . . . . 1.56 109.673 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.43 -33.37 72.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.665 -1.272 . . . . 2.2 109.684 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.37 -23.17 35.98 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.984 -1.072 . . . . 2.12 108.506 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.535 HD13 HD13 ' A' ' 123' ' ' LEU . 21.9 mt -61.83 139.49 58.35 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.226 -1.027 . . . . 2.0 108.226 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -92.65 46.25 1.23 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.056 -1.027 . . . . 3.23 108.983 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -132.11 129.61 40.12 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.688 0.756 . . . . 2.49 109.664 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -70.05 -29.98 67.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.735 -0.603 . . . . 3.95 109.946 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.448 ' OH ' ' CA ' ' B' ' 315' ' ' HIS . 17.1 t80 -66.97 -42.97 84.24 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.958 0.885 . . . . 2.0 110.802 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.826 HD22 ' O ' ' B' ' 351' ' ' GLN . 91.4 mt -70.67 -32.79 70.19 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.569 -0.707 . . . . 1.86 109.774 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -60.07 -39.98 87.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.312 -0.868 . . . . 2.84 108.86 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 125' ' ' GLU . 0.4 OUTLIER -59.51 -49.1 79.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.191 -0.943 . . . . 2.73 109.493 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.623 HH21 ' CD2' ' A' ' 123' ' ' LEU . 59.4 mtm180 -60.21 -39.6 87.18 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.569 -1.252 . . . . 2.77 108.418 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.44 -28.32 66.85 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.472 -0.936 . . . . 1.19 108.472 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -60.05 -46.75 88.52 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.407 -0.808 . . . . 1.2 108.978 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -61.29 -41.3 96.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 1.55 109.703 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.72 -44.39 98.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.299 -0.875 . . . . 0.8 109.445 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -63.6 -40.04 95.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.127 -0.983 . . . . 3.09 109.914 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -60.01 -41.09 91.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 1.46 110.341 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.96 -46.8 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.916 -1.115 . . . . 0.71 109.85 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.3 -40.34 98.89 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.756 -1.338 . . . . 0.57 109.756 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.456 ' NZ ' ' OE2' ' A' ' 21' ' ' GLU . 57.6 tttm -59.97 -49.78 76.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -1.081 . . . . 2.59 110.472 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.678 HH22 ' CD1' ' A' ' 57' ' ' ILE . 63.1 mtp180 -63.12 -39.37 94.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.123 -0.985 . . . . 2.83 110.952 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.81 -40.11 87.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 1.25 110.111 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' A' ' 105' ' ' HIS . 23.9 mt -62.35 -40.0 94.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.776 -1.203 . . . . 0.7 109.109 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -68.97 -38.74 79.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -0.846 . . . . 2.57 109.782 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -69.99 -31.22 68.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.45 -0.781 . . . . 1.23 111.887 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.56 -46.07 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.136 -1.603 . . . . 0.81 108.484 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.1 -31.23 68.7 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.634 -0.666 . . . . 1.0 109.561 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.61 45.93 4.46 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.507 -1.437 . . . . 0.89 109.507 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 tp -74.32 145.63 43.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.39 -1.065 . . . . 1.14 108.939 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -69.89 139.1 52.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.012 -1.055 . . . . 4.6 109.245 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.4 mt -111.75 129.96 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.936 0.874 . . . . 1.24 109.26 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.6 mt -59.89 -44.17 93.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.873 -0.517 . . . . 1.54 109.955 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.2 t0 66.37 99.03 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.516 0.674 . . . . 1.5 109.23 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.5 mt -66.46 -7.28 18.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.518 -0.739 . . . . 0.79 109.208 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -84.78 -16.82 40.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.463 -0.773 . . . . 1.4 109.208 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.31 13.08 3.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.436 -0.79 . . . . 0.92 111.162 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.593 HD12 ' N ' ' A' ' 152' ' ' ILE . 1.4 mp -90.28 126.21 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.58 -1.325 . . . . 0.88 108.804 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -104.09 -7.47 20.21 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.547 -0.721 . . . . 2.45 110.213 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -119.94 147.8 44.3 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.444 -0.785 . . . . 1.52 110.481 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.67 136.9 57.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.438 -0.789 . . . . 1.58 109.442 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.8 m -152.11 163.22 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -0.781 . . . . 0.69 109.334 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 79.5 mt -91.15 148.96 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 106.008 -1.849 . . . . 0.61 106.008 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 35.3 tp -96.38 113.98 25.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.869 -1.145 . . . . 0.87 110.39 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.581 HG12 HG22 ' A' ' 209' ' ' THR . 50.4 t -121.76 129.92 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.83 -0.804 . . . . 0.71 108.83 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.445 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -159.96 162.26 34.35 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.243 -1.021 . . . . 0.81 108.243 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.9 -34.78 71.9 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.26 -1.525 . . . . 0.98 108.03 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -159.93 171.38 19.5 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.442 -0.947 . . . . 2.25 108.442 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.7 mt -139.76 140.04 36.62 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.063 -1.023 . . . . 0.78 109.592 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.3 p -100.19 135.43 20.33 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.415 -0.803 . . . . 0.98 109.501 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -38.61 -35.61 0.51 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.358 2.039 . . . . 0.81 113.437 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.5 m -59.9 -40.01 87.35 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.921 -1.112 . . . . 0.9 109.205 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.23 -40.98 90.63 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.308 -0.87 . . . . 1.61 109.948 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 67.3 p -57.21 -29.8 64.03 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.204 -0.935 . . . . 0.61 111.271 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.82 -53.91 13.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.682 -1.261 . . . . 0.6 109.768 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -86.98 36.36 0.72 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.022 -0.733 . . . . 1.4 109.022 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.4 tp -101.19 139.42 36.9 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.866 -0.79 . . . . 0.7 108.866 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -85.83 101.96 13.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.984 . . . . 2.35 108.954 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.09 -40.04 94.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.33 -0.856 . . . . 1.51 110.821 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -69.56 -25.46 64.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.966 -1.084 . . . . 2.33 111.458 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -93.15 -9.37 39.64 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.848 -1.157 . . . . 1.92 110.548 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.578 HG11 ' CE1' ' A' ' 179' ' ' PHE . 70.8 t -101.44 111.19 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.185 -1.043 . . . . 0.67 108.185 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.2 mt -83.52 3.27 33.03 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.228 -0.92 . . . . 1.53 110.577 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.29 170.49 37.62 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.147 -1.581 . . . . 0.48 109.147 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.578 ' CE1' HG11 ' A' ' 176' ' ' VAL . 27.7 m-85 -131.31 128.62 40.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.454 -1.027 . . . . 0.55 109.374 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 84.9 mt -132.4 126.25 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.485 -0.931 . . . . 0.65 108.485 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 23.6 p -148.67 161.5 41.61 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.024 -1.048 . . . . 0.82 110.876 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.476 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 55.8 t0 -105.78 24.54 12.13 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.426 -0.583 . . . . 2.46 109.426 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.93 -161.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.241 -1.537 . . . . 1.28 111.195 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.02 -50.61 7.57 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.097 -1.201 . . . . 2.19 110.097 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 161.79 -133.68 3.23 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.27 -1.443 . . . . 2.13 110.909 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.494 ' C ' ' H ' ' A' ' 188' ' ' SER . 41.5 ttt-85 -60.02 -39.98 87.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.563 -0.963 . . . . 5.86 111.415 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 67.2 p -59.7 2.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.616 -1.302 . . . . 3.72 110.385 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 186' ' ' ARG . 24.8 t -92.0 127.96 37.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.969 -1.082 . . . . 1.74 109.898 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.5 ' NE2' ' NZ ' ' A' ' 69' ' ' LYS . 56.9 t60 -43.9 -48.52 8.47 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.356 -0.84 . . . . 0.95 109.458 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 61.6 m -55.04 -36.83 65.95 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.763 -0.585 . . . . 1.55 110.949 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.3 m -59.96 -39.99 87.53 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.679 -1.263 . . . . 1.51 110.441 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.8 mm -64.52 -39.91 87.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.134 -0.979 . . . . 1.67 109.122 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.0 mtp -59.94 -45.0 94.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.275 -0.891 . . . . 1.02 110.532 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.45 -45.52 84.65 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.381 -1.449 . . . . 0.68 109.956 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -62.4 -57.21 12.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.975 -1.078 . . . . 2.93 110.737 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.3 m -63.36 -40.02 96.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.002 -1.061 . . . . 0.86 111.997 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.34 -25.36 61.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.821 -1.175 . . . . 0.67 109.744 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 70.2 47.33 0.56 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.3 0.571 . . . . 1.5 110.218 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 62.7 mt -124.21 149.78 61.72 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 107.8 -1.185 . . . . 0.72 107.8 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.67 138.62 59.68 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 122.268 1.979 . . . . 0.61 111.832 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.77 152.01 2.97 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.605 -1.238 . . . . 0.66 111.713 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.8 mt -125.98 147.69 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.473 -1.306 . . . . 0.79 107.473 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.8 m -128.55 -9.92 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 O-C-N 120.932 -1.105 . . . . 0.91 110.812 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -114.73 24.58 10.91 Favored Glycine 0 N--CA 1.502 3.063 0 N-CA-C 110.435 -1.066 . . . . 1.01 110.435 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 204' ' ' GLY . 3.1 p -42.73 -47.17 5.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.262 -1.14 . . . . 0.99 110.192 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.443 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 98.71 -56.69 0.98 Allowed Glycine 0 N--CA 1.503 3.13 0 C-N-CA 120.221 -0.99 . . . . 1.12 111.549 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 26.1 p -148.99 26.62 0.88 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.445 -1.621 . . . . 1.72 111.103 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.23 -40.04 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.989 -1.069 . . . . 0.89 109.395 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.581 HG22 HG12 ' A' ' 159' ' ' VAL . 31.7 p -62.06 -29.27 70.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.169 -0.957 . . . . 1.03 109.765 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 94.9 p -79.94 -20.99 44.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.209 -0.932 . . . . 1.83 109.561 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -96.5 -8.34 32.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.25 -0.906 . . . . 2.27 109.534 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.94 138.72 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-O 121.622 0.725 . . . . 0.92 110.853 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.433 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 2.1 mptp? -112.59 154.72 25.57 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.655 -1.239 . . . . 2.2 107.655 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.466 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 17.9 p-10 -59.85 139.8 57.08 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.025 -1.047 . . . . 2.36 110.113 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.4 m-20 83.82 4.32 0.81 Allowed 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.121 0.486 . . . . 2.38 110.162 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 86.2 m-20 -73.57 138.16 44.76 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.136 -0.978 . . . . 2.09 109.231 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -90.09 117.91 29.23 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.501 -1.296 . . . . 1.27 107.501 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.564 HD12 ' HB2' ' A' ' 16' ' ' ALA . 74.5 mt -127.18 150.82 49.34 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.519 -0.738 . . . . 0.75 110.927 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.471 HG23 ' CD2' ' A' ' 13' ' ' PHE . 76.2 mt -117.61 129.99 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.147 -1.427 . . . . 0.63 107.147 177.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 22.2 tp -102.38 120.19 40.08 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.001 -1.062 . . . . 0.7 109.701 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.669 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 25.1 p-10 -80.05 -39.9 28.84 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.082 -1.011 . . . . 2.31 108.863 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 48.04 19.68 0.2 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.338 -0.986 . . . . 0.78 108.338 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.451 ' N ' ' C ' ' A' ' 221' ' ' ASP . 21.4 t -133.12 -44.3 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.339 -1.356 . . . . 1.04 107.339 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -100.1 0.02 39.91 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.747 -1.205 . . . . 2.44 107.747 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.614 HD21 ' H ' ' A' ' 4' ' ' GLY . 38.6 t30 60.02 46.88 10.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.714 -0.616 . . . . 1.55 109.57 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.669 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 76.9 mt-30 -140.04 151.82 45.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.43 -0.794 . . . . 1.99 109.622 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 83.1 t -119.12 129.96 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.419 -0.956 . . . . 0.77 108.419 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -99.95 118.79 37.11 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.477 -0.934 . . . . 0.98 108.477 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.4 t -99.98 115.13 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.544 -0.722 . . . . 0.85 110.503 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 35.2 t30 52.45 63.09 9.39 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 1.66 111.164 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -88.99 148.46 5.67 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.557 2.172 . . . . 0.95 111.871 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 58.9 p -68.78 161.38 28.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 1.84 109.576 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -60.03 -39.97 87.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.843 . . . . 2.74 110.519 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -60.32 -32.96 71.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.932 -1.105 . . . . 2.89 109.816 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.33 -39.98 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -0.985 . . . . 1.3 109.141 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.3 mt -61.6 -40.18 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.883 . . . . 1.09 109.284 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -59.97 -41.87 92.89 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.129 -0.982 . . . . 2.43 109.06 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -64.15 -42.62 96.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 2.78 108.752 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 93.6 mtp -64.75 -38.68 91.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.49 -0.756 . . . . 1.25 109.376 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -68.66 -40.05 80.36 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.256 -0.903 . . . . 2.63 109.438 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.84 95.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.128 -0.982 . . . . 1.8 108.786 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.53 -39.97 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.61 -0.681 . . . . 2.13 109.292 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.25 -41.68 84.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.017 -1.052 . . . . 3.17 108.851 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -61.03 -40.08 92.22 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.984 -1.117 . . . . 1.78 107.984 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -66.58 -36.6 83.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.662 -0.649 . . . . 2.47 109.419 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.99 -40.75 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.359 -0.838 . . . . 2.09 109.351 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.07 -40.87 90.98 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.295 -0.878 . . . . 2.54 109.165 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 18.9 t -65.15 -40.06 93.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 2.99 109.649 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -60.16 -39.98 88.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 3.34 109.309 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -65.76 -10.64 39.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.455 -0.778 . . . . 3.88 110.119 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.519 ' O ' ' NZ ' ' A' ' 255' ' ' LYS . . . -79.29 27.21 0.26 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.157 -0.965 . . . . 4.43 110.058 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -140.04 27.83 2.15 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.103 -0.998 . . . . 5.42 109.694 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 60.1 mt -58.54 -50.02 75.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.06 -1.025 . . . . 6.1 109.535 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -161.41 58.27 0.28 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.804 -1.185 . . . . 7.37 110.405 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.519 ' NZ ' ' O ' ' A' ' 251' ' ' ALA . 45.1 mmtm -68.85 -44.98 72.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.119 -0.988 . . . . 8.01 109.663 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 23.5 tp -117.06 -51.38 2.55 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.55 -0.907 . . . . 9.05 108.55 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -149.99 157.68 43.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.454 -0.779 . . . . 10.56 109.407 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -58.45 -59.19 5.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.292 -0.88 . . . . 11.32 109.723 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.405 ' HG2' HH11 ' A' ' 259' ' ' ARG . 39.3 ttt-85 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.946 -1.026 . . . . 12.42 109.413 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 40.7 ttp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.46 0.648 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 302' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 30.1 t80 -155.78 155.37 32.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.482 -0.761 . . . . 0.0 109.1 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 303' ' ' GLN . . . . . 0.539 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 12.9 pt20 -146.75 157.03 43.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.166 -0.959 . . . . 0.0 109.939 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -152.94 150.07 28.88 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -114.99 135.2 54.49 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.169 -0.957 . . . . 0.0 110.638 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.0 p -134.89 123.45 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 CA-C-O 122.033 0.92 . . . . 0.0 112.277 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 89.8 m -80.19 107.19 12.79 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.957 0.884 . . . . 0.0 111.201 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.0 mt -51.65 121.21 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 122.329 1.062 . . . . 0.0 110.438 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 23.7 p -108.61 16.86 22.58 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.786 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.7 129.06 84.37 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 120.743 -1.223 . . . . 0.0 108.175 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -64.34 -10.99 25.98 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 CA-C-N 120.154 1.091 . . . . 0.0 112.752 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -115.78 8.6 14.9 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.364 -0.835 . . . . 0.0 109.782 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.59 173.91 14.8 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.422 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 3.2 tp -81.66 90.24 6.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.895 -1.356 . . . . 0.0 109.693 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.448 ' CA ' ' OH ' ' A' ' 122' ' ' TYR . 4.4 p80 -95.13 -161.37 0.85 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.84 -1.162 . . . . 0.0 109.939 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.0 m -58.01 -40.4 80.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.007 -1.058 . . . . 0.0 112.31 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.573 HH21 ' NE2' ' B' ' 321' ' ' GLN . 2.2 tpt180 -59.58 -61.94 6.87 Favored Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 120.402 -1.436 . . . . 0.0 111.591 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.421 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 9.4 Cg_endo -56.07 -32.79 87.82 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 CA-C-N 120.028 1.046 . . . . 0.0 111.832 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.95 -51.6 68.96 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.416 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.61 64.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.227 -0.92 . . . . 0.0 110.006 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 321' ' ' GLN . . . . . 0.573 ' NE2' HH21 ' B' ' 317' ' ' ARG . 86.9 mt-30 -70.82 -39.95 72.74 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.829 -1.17 . . . . 0.0 109.062 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -62.73 -54.79 33.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.364 -0.835 . . . . 0.0 110.463 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 60.1 t -63.6 -38.51 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.666 -1.271 . . . . 0.0 108.806 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -59.98 -47.1 87.2 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.217 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -62.58 -49.76 73.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.359 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.16 -51.56 52.29 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.256 -0.903 . . . . 0.0 110.883 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -52.04 -14.42 0.41 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.118 -0.989 . . . . 0.0 109.897 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -79.92 -17.23 75.31 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -106.01 140.55 38.83 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.319 -1.106 . . . . 0.0 108.758 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 5.3 p -91.42 -13.79 31.73 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.792 -1.192 . . . . 0.0 110.158 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 29.5 p -57.28 150.46 17.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.938 -1.101 . . . . 0.0 108.474 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.05 132.46 46.66 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.855 -1.153 . . . . 0.0 108.627 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.8 mt -133.4 133.64 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.615 -0.678 . . . . 0.0 109.531 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.7 m -130.04 152.28 49.66 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.481 -0.762 . . . . 0.0 109.117 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 72.0 t -123.88 114.68 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 87.0 m -105.22 130.45 53.37 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.144 -0.972 . . . . 0.0 109.177 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 97.0 p -136.47 114.01 10.97 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.92 0.867 . . . . 0.0 110.777 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 45.35 51.85 9.22 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.98 -13.82 63.63 Favored Glycine 0 N--CA 1.503 3.135 0 O-C-N 120.102 -1.624 . . . . 0.0 112.935 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -118.67 130.37 55.81 Favored 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 119.414 1.607 . . . . 0.0 109.367 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 82.2 p -128.51 150.75 50.03 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.968 0.889 . . . . 0.0 110.845 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -145.24 166.64 24.9 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.573 0.701 . . . . 0.0 110.126 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.8 m -88.99 139.94 29.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.449 -0.782 . . . . 0.0 110.052 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -78.78 -14.35 59.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.916 -1.115 . . . . 0.0 110.071 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -89.98 20.3 4.32 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 90.5 p -145.8 92.14 2.18 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.407 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.77 HD23 HD22 ' A' ' 79' ' ' LEU . 57.1 tp -59.98 -34.54 73.44 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.875 ' CE2' HD11 ' A' ' 79' ' ' LEU . 64.2 m-85 -56.33 -53.48 56.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.169 -0.957 . . . . 0.0 110.393 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -69.43 -39.81 77.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 110.387 -177.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' B' ' 352' ' ' THR . 23.2 mt -47.67 -59.66 3.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.158 -0.964 . . . . 0.0 108.978 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.826 ' O ' HD22 ' A' ' 123' ' ' LEU . 1.5 mp0 -39.27 -21.12 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.721 -0.612 . . . . 0.0 111.298 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.528 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.1 p -78.03 -10.1 59.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.102 -1.624 . . . . 0.0 110.216 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 49.9 mt -96.09 118.32 32.45 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.134 -0.979 . . . . 0.0 109.14 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.35 96.74 0.92 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 32.2 mt -106.77 95.29 5.63 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.447 -1.031 . . . . 0.0 109.582 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 17.8 p -98.31 176.42 5.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.217 -0.927 . . . . 0.0 110.462 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -63.93 111.89 2.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.806 -0.559 . . . . 0.0 110.586 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.76 7.7 38.49 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 46.9 m -84.83 110.23 18.67 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.087 -1.243 . . . . 0.0 111.067 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 4.9 t -78.12 115.62 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 122.113 0.959 . . . . 0.0 110.167 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 29.1 m -112.65 177.52 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 86.6 m -131.11 130.31 42.97 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 82.3 mt -105.34 120.35 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 58.7 m -121.38 132.56 54.83 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.25 153.9 41.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 110.034 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -146.77 122.91 10.83 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.486 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 159.53 -155.29 26.38 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 118.586 -1.768 . . . . 0.0 111.932 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.93 -53.36 58.78 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -107.31 11.61 28.97 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.898 -1.126 . . . . 0.0 111.383 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.3 pt-20 -40.23 -37.54 0.65 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.431 -0.793 . . . . 0.0 111.581 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.04 -44.31 72.92 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.73 -1.231 . . . . 0.0 110.787 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -69.79 -51.78 30.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.782 -1.199 . . . . 0.0 109.167 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -45.81 -37.22 5.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.646 -0.659 . . . . 0.0 111.278 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.53 ' O ' HG23 ' B' ' 378' ' ' VAL . 81.8 t -69.98 -39.98 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.698 -1.251 . . . . 0.0 109.151 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.99 -64.45 0.86 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 111.163 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -60.06 -45.82 91.59 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.683 -1.261 . . . . 0.0 111.771 -177.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.9 mt -59.98 -41.39 91.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.623 -1.298 . . . . 0.0 108.813 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.53 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.7 t -65.88 -42.05 91.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.158 -0.964 . . . . 0.0 109.742 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -71.29 -57.96 3.98 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.742 -1.224 . . . . 0.0 107.85 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.411 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 60.2 tp -56.22 -32.48 64.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.397 -0.814 . . . . 0.0 109.839 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 45.2 ttm -74.44 -40.02 62.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.007 -1.058 . . . . 0.0 108.813 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.67 -4.45 46.18 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.682 -0.636 . . . . 0.0 110.121 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -110.84 3.36 18.9 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.319 -0.863 . . . . 0.0 110.963 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 384' ' ' LEU . . . . . 0.411 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 32.3 mt -69.87 130.03 41.13 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.397 -1.439 . . . . 0.0 109.764 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.079 179.45 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.301 -0.629 . . . . 2.91 109.301 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.5 mt -108.88 128.69 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.644 -0.873 . . . . 1.2 108.644 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.1 m -118.85 154.04 33.54 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.081 -0.711 . . . . 1.4 109.081 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.801 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -141.75 179.05 20.12 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.359 -1.897 . . . . 1.05 108.359 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.5 mt -85.21 -4.69 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.88 -1.365 . . . . 1.15 110.607 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.4 HD11 ' HB1' ' A' ' 222' ' ' ALA . 43.5 tp 52.31 93.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.64 -1.288 . . . . 0.98 109.362 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.22 -40.03 78.2 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.219 -1.03 . . . . 0.88 108.219 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 p -154.08 146.88 17.73 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 108.943 -0.762 . . . . 1.69 108.943 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -80.32 144.2 16.12 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.74 2.293 . . . . 0.85 113.5 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.883 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.67 164.51 13.27 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.544 -1.422 . . . . 0.92 109.544 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -117.42 152.82 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.13 -1.218 . . . . 0.81 110.072 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.91 155.98 35.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.228 -0.92 . . . . 0.51 109.83 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.9 OUTLIER -137.71 128.07 26.35 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.604 -0.888 . . . . 0.62 108.604 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.91 179.32 47.25 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 118.902 -1.618 . . . . 0.55 110.534 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -78.94 157.08 28.27 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.629 -0.924 . . . . 2.1 109.064 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.586 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -102.31 134.28 45.85 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.376 -0.827 . . . . 0.77 110.701 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.9 tp -106.93 139.39 41.41 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.346 -1.353 . . . . 0.91 107.346 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.0 tp -119.06 121.03 38.91 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.309 -0.87 . . . . 0.93 110.146 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.8 mt -81.91 102.89 11.18 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.003 -0.679 . . . . 0.93 109.809 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -95.5 131.48 41.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.413 -0.804 . . . . 2.75 109.543 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -126.12 137.83 53.63 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.714 -0.847 . . . . 3.0 108.714 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 47.5 t0 -87.24 147.86 25.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.07 -1.019 . . . . 2.77 109.557 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.461 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 88.3 tt0 -64.18 149.88 46.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.906 . . . . 2.94 109.335 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.9 mt -91.87 127.46 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.374 -0.829 . . . . 0.95 108.897 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.6 t -93.62 124.07 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.159 -0.963 . . . . 1.28 109.738 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -106.74 135.66 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.796 -0.816 . . . . 1.21 108.796 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -95.04 117.04 29.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.001 -1.062 . . . . 1.81 109.328 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -89.83 2.11 55.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.431 -0.793 . . . . 2.8 109.097 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -58.81 146.13 38.27 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.291 -0.881 . . . . 2.87 109.583 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -84.76 137.6 33.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.423 -0.798 . . . . 2.35 109.035 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.403 HG21 ' HG3' ' A' ' 39' ' ' GLU . 5.0 pt -91.73 163.25 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.966 -1.084 . . . . 0.97 109.92 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.3 p -97.18 174.93 6.48 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.925 . . . . 1.17 108.761 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.05 83.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 1.18 109.689 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -57.35 -30.22 64.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.741 -1.224 . . . . 2.56 109.433 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -81.45 -10.2 59.55 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.185 -0.947 . . . . 1.79 109.891 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.9 -53.42 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.705 -1.247 . . . . 1.0 108.519 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.14 -40.01 94.52 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.59 -0.694 . . . . 1.77 110.14 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -69.87 -41.2 75.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.024 -1.047 . . . . 2.7 110.436 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.403 ' HG3' HG21 ' A' ' 31' ' ' ILE . 69.4 mm-40 -64.91 -40.02 94.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.832 -1.168 . . . . 1.51 110.069 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.3 t -62.84 -47.0 94.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.905 -1.122 . . . . 0.93 108.937 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -64.59 -42.8 95.35 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.047 -1.033 . . . . 1.81 110.063 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -60.07 -42.19 94.02 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.425 -1.324 . . . . 2.78 107.425 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -61.16 -50.04 74.8 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.151 -0.685 . . . . 0.78 109.151 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.9 tp -59.99 -42.32 93.95 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.444 -0.947 . . . . 1.07 108.444 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 36.8 t -63.6 -39.98 95.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 1.12 109.325 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.56 -48.98 77.69 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.702 -1.759 . . . . 0.84 108.702 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -61.1 -39.99 92.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.337 -1.096 . . . . 3.09 108.256 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -46.64 -43.27 17.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.558 -0.714 . . . . 0.88 109.14 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 50' ' ' ALA . 24.7 ttmt -66.07 -72.83 0.15 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.678 -1.23 . . . . 2.59 107.678 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.92 -42.45 0.62 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.359 -0.838 . . . . 0.7 111.37 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.2 t -51.37 -56.36 13.54 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.59 -1.319 . . . . 1.4 109.177 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.71 -41.95 74.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.195 -0.94 . . . . 0.67 110.794 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.7 -40.06 88.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.932 -1.105 . . . . 1.66 109.794 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.7 mt -60.62 -40.05 90.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.99 -1.069 . . . . 1.58 108.713 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.412 ' OE2' HD13 ' A' ' 77' ' ' ILE . 51.4 mm-40 -60.85 -33.54 73.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.455 -0.778 . . . . 1.35 109.429 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -65.15 -44.09 89.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.039 -1.038 . . . . 0.77 109.427 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.05 -38.98 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.884 -0.784 . . . . 0.63 108.884 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -59.45 -49.97 75.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.468 -0.77 . . . . 1.14 109.67 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -59.58 -37.45 78.55 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.273 -0.892 . . . . 0.79 110.223 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -63.93 -38.91 92.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.96 -1.087 . . . . 1.53 109.595 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.541 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -63.26 -42.27 99.12 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.373 -0.829 . . . . 0.57 109.15 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.44 -51.4 58.97 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.101 -1.2 . . . . 0.75 110.101 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.39 -46.72 66.24 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.928 -1.337 . . . . 1.59 110.02 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.1 m -67.25 -63.08 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.73 112.442 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.474 ' CE2' ' O ' ' A' ' 168' ' ' THR . 95.4 m-85 -92.9 -50.5 5.52 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.749 -1.219 . . . . 0.75 110.917 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.46 -169.9 24.93 Favored Glycine 0 N--CA 1.499 2.894 0 C-N-CA 119.954 -1.117 . . . . 1.22 110.939 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -69.74 -24.19 63.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.894 -0.768 . . . . 5.81 109.714 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -60.04 -35.55 75.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.569 -0.707 . . . . 3.37 110.175 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -100.37 -18.5 16.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.329 -0.857 . . . . 1.77 110.415 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -70.05 -40.01 75.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.778 -1.202 . . . . 1.65 110.643 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.536 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.51 -30.58 70.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.217 -0.927 . . . . 0.77 110.22 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.9 mt -59.94 -40.63 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.051 -1.031 . . . . 0.8 109.291 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 16.9 m-85 -70.04 -38.18 75.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.88 110.947 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -60.05 -39.93 87.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.859 -1.151 . . . . 1.37 109.8 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.97 -43.36 99.01 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.306 -1.518 . . . . 0.62 109.306 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -61.98 -42.93 99.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.388 -1.066 . . . . 1.5 109.705 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.412 HD13 ' OE2' ' A' ' 55' ' ' GLU . 98.7 mt -70.05 -43.34 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.225 -0.922 . . . . 0.63 109.741 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.8 ttp -59.97 -40.09 87.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.841 -1.162 . . . . 1.51 109.512 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.856 HD11 ' CE2' ' B' ' 348' ' ' PHE . 31.7 tp -65.21 -38.03 89.16 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.471 -0.768 . . . . 0.77 109.699 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.9 -40.09 95.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.455 -0.778 . . . . 0.62 109.964 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -81.0 6.29 13.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.238 -0.914 . . . . 1.47 110.219 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -52.75 133.47 36.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.073 -1.017 . . . . 1.47 110.473 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.44 -19.45 63.5 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.556 -0.715 . . . . 1.78 110.658 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.07 -33.87 72.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.92 -1.113 . . . . 2.53 108.887 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.0 mt -70.13 -41.46 73.89 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.41 0.624 . . . . 0.8 110.055 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -60.05 -48.79 80.25 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.3 -0.875 . . . . 1.42 110.943 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -70.0 -40.93 74.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.07 -1.019 . . . . 1.71 111.323 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -69.97 -40.02 75.63 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.031 -1.043 . . . . 1.57 111.485 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 84.2 mt -65.88 -49.87 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.975 -1.078 . . . . 0.65 109.69 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.7 mt -65.1 -37.15 79.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.686 -0.634 . . . . 0.82 110.401 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.03 -49.63 76.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.103 -0.998 . . . . 0.79 110.763 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.43 -45.89 91.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.83 -1.169 . . . . 0.95 109.748 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.7 mt -61.51 -49.96 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.981 0.896 . . . . 0.66 109.159 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -67.93 -44.92 75.72 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 120.163 -0.615 . . . . 2.2 111.144 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -80.19 -51.18 9.26 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.878 -1.138 . . . . 1.65 112.152 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -90.1 -3.38 57.95 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.91 -1.119 . . . . 2.03 112.13 -177.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 39.0 m80 57.76 34.82 24.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.892 -1.13 . . . . 1.42 110.605 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 71.0 mtm -90.81 169.91 10.55 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.013 -1.054 . . . . 1.18 109.38 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.6 p -75.3 154.28 37.47 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.093 -1.005 . . . . 0.98 108.465 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.95 -36.87 75.59 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.1 -1.0 . . . . 0.64 110.541 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 38.2 p-10 -65.62 -38.71 90.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.99 -1.069 . . . . 2.07 109.766 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.522 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.53 -44.4 19.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.142 -0.974 . . . . 0.73 109.318 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.88 92.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.396 -0.815 . . . . 0.54 109.44 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.06 94.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.87 . . . . 0.56 109.557 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -59.49 -39.97 85.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.822 . . . . 1.54 109.573 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 110' ' ' GLY . 86.1 tt0 -63.12 -40.02 96.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.117 -0.989 . . . . 1.33 109.28 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.5 t -61.61 -52.27 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.471 -0.768 . . . . 0.72 110.731 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.5 mm -70.08 -39.98 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.916 -1.115 . . . . 0.85 108.934 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -67.24 -38.29 84.96 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.231 -1.026 . . . . 2.44 108.231 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.24 -50.0 70.59 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.33 -1.108 . . . . 0.98 110.33 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 17.3 mm-40 -66.84 -52.22 46.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.654 -1.497 . . . . 1.41 109.06 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.85 -39.98 75.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 1.2 108.964 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.1 t -55.74 -39.46 71.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.238 -0.914 . . . . 1.7 108.708 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.05 -37.55 75.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.162 -0.961 . . . . 1.47 109.784 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.3 mt -67.47 -48.59 66.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.117 -0.989 . . . . 1.56 110.704 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -60.49 -21.96 62.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.391 -1.443 . . . . 2.2 110.194 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -67.97 -16.0 63.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.814 -1.179 . . . . 2.12 108.783 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.494 HD13 HD13 ' A' ' 123' ' ' LEU . 28.4 mt -63.05 145.61 55.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.296 -0.877 . . . . 2.0 108.95 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -90.53 28.81 1.4 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.248 -0.908 . . . . 3.23 110.458 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 55.5 t0 -117.36 131.89 56.7 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.333 -0.854 . . . . 2.49 109.78 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.418 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 47.1 mt-10 -69.97 -28.94 65.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.515 -0.74 . . . . 3.95 109.934 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.514 ' OH ' ' NH1' ' A' ' 126' ' ' ARG . 2.7 t80 -69.89 -37.87 76.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 2.0 109.999 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.494 HD13 HD13 ' A' ' 118' ' ' LEU . 72.4 mt -77.14 -31.32 55.59 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.08 -1.013 . . . . 1.86 109.036 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -60.02 -40.06 87.98 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.195 -0.941 . . . . 2.84 108.645 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -47.01 87.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -0.811 . . . . 2.73 109.305 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.514 ' NH1' ' OH ' ' A' ' 122' ' ' TYR . 4.2 mmm-85 -60.02 -40.05 87.95 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.282 -0.887 . . . . 2.77 109.898 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.37 76.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.035 -1.04 . . . . 1.19 108.656 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.08 95.65 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.067 -0.716 . . . . 1.2 109.067 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -66.59 -42.43 86.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.369 -0.832 . . . . 1.55 109.453 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.94 -40.38 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.287 -0.883 . . . . 0.8 108.625 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -60.24 -41.31 92.88 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.465 -0.772 . . . . 3.09 109.101 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -59.92 -40.01 87.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.514 -0.741 . . . . 1.46 110.726 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.9 mt -60.07 -41.28 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 0.71 110.304 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.53 -40.44 94.25 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.646 -1.264 . . . . 0.57 110.02 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -60.01 -45.27 93.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.292 -1.122 . . . . 2.59 110.314 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -65.96 -35.88 81.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.589 -1.319 . . . . 2.83 110.038 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.94 -41.6 92.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.107 -0.995 . . . . 1.25 109.441 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.01 -40.01 87.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.108 -0.995 . . . . 0.7 108.908 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -65.77 -39.98 91.55 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.749 -0.834 . . . . 2.57 108.749 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -69.73 -29.03 66.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.628 -0.67 . . . . 1.23 111.85 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.3 mt -70.02 -40.77 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.255 -1.528 . . . . 0.81 108.624 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.7 -29.66 59.07 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.676 -0.64 . . . . 1.0 109.747 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.19 45.82 4.62 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 108.954 -1.658 . . . . 0.89 108.954 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.6 tp -74.81 149.99 39.46 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.457 -1.025 . . . . 1.14 109.503 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -70.21 143.77 52.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.206 -0.934 . . . . 4.6 109.881 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.6 mt -114.91 128.8 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 122.037 0.922 . . . . 1.24 109.274 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.8 mt -69.93 -40.12 78.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.873 -0.603 . . . . 1.54 110.654 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.1 t0 63.39 103.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.27 -0.894 . . . . 1.5 109.223 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 57.7 mt -68.45 -1.25 6.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.395 -0.816 . . . . 0.79 109.88 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.6 p -81.67 -14.61 56.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.02 -1.05 . . . . 1.4 109.878 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.8 26.42 0.83 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.239 -0.913 . . . . 0.92 112.225 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 36.1 mm -90.8 122.49 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 120.367 -1.458 . . . . 0.88 109.122 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -104.39 -12.52 16.52 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.428 -0.795 . . . . 2.45 110.415 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -122.3 147.78 45.82 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.286 -0.884 . . . . 1.52 110.182 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.92 135.76 56.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.82 . . . . 1.58 109.487 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.0 m -152.8 166.63 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.608 -0.682 . . . . 0.69 109.799 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 86.3 mt -94.74 148.9 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.485 -1.672 . . . . 0.61 106.485 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 14.9 tp -97.78 118.19 33.76 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.867 -1.146 . . . . 0.87 110.383 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.8 t -123.12 130.01 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.808 -0.812 . . . . 0.71 108.808 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -156.66 160.67 39.58 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.385 -0.968 . . . . 0.81 108.385 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.84 -31.83 65.04 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.266 -1.521 . . . . 0.98 107.588 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -157.94 165.62 34.7 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.853 -0.795 . . . . 2.25 108.853 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 78.0 mt -136.95 132.16 34.01 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.162 -0.961 . . . . 0.78 108.964 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.1 p -102.44 148.99 36.27 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.389 -0.82 . . . . 0.98 108.975 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -41.59 -34.13 2.02 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.97 1.78 . . . . 0.81 112.211 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 43.7 m -57.46 -43.37 83.95 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.354 -0.841 . . . . 0.9 109.961 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.94 -40.96 75.19 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.126 -0.984 . . . . 1.61 110.252 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.474 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 72.0 p -58.03 -19.9 34.88 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.166 -0.959 . . . . 0.61 111.581 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.541 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -85.69 -43.18 13.62 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.634 -1.291 . . . . 0.6 109.773 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -96.98 41.53 1.11 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.39 -0.967 . . . . 1.4 108.39 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.479 HD11 HG21 ' A' ' 176' ' ' VAL . 58.9 tp -105.29 131.51 52.66 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.588 -0.893 . . . . 0.7 108.588 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.431 ' O ' HG23 ' A' ' 176' ' ' VAL . 16.7 m120 -84.03 103.33 13.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.008 -1.058 . . . . 2.35 108.847 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.77 -40.8 95.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.854 . . . . 1.51 110.814 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -65.59 -27.39 68.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.82 -1.175 . . . . 2.33 111.286 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.454 ' N ' ' CD ' ' A' ' 175' ' ' LYS . 1.1 mptm? -93.32 -11.83 31.48 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.895 -1.128 . . . . 1.92 109.723 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.479 HG21 HD11 ' A' ' 171' ' ' LEU . 87.6 t -100.01 110.03 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.138 -0.977 . . . . 0.67 108.908 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 89.9 mt -83.76 7.32 18.16 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.229 -0.919 . . . . 1.53 110.377 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.462 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 167.94 176.26 38.35 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.247 -1.541 . . . . 0.48 109.247 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.475 ' CE1' HG11 ' A' ' 176' ' ' VAL . 11.9 m-85 -133.24 129.9 38.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.353 -1.087 . . . . 0.55 108.658 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.2 mt -132.93 126.51 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.309 -0.869 . . . . 0.65 109.28 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.4 p -145.35 158.03 43.92 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.034 -1.041 . . . . 0.82 111.189 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.529 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -103.14 26.84 7.77 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.789 -0.819 . . . . 2.46 108.789 179.124 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -67.42 -158.96 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.055 -1.028 . . . . 1.28 112.028 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.14 -50.55 10.23 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.07 -1.212 . . . . 2.19 110.07 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.85 -120.05 1.1 Allowed Glycine 0 N--CA 1.493 2.459 0 O-C-N 120.868 -1.372 . . . . 2.13 110.766 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.566 ' NE ' HH22 ' A' ' 195' ' ' ARG . 58.4 mtp180 -60.96 -37.6 82.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.774 -0.839 . . . . 5.86 111.627 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 32.7 p -67.31 3.02 1.36 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.9 -1.125 . . . . 3.72 110.909 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.8 t -90.39 118.89 30.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.746 -1.222 . . . . 1.74 109.952 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -43.11 -52.63 5.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.355 -0.841 . . . . 0.95 109.636 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -52.33 -33.16 41.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.352 -0.842 . . . . 1.55 110.706 -179.463 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.1 t -59.99 -42.03 93.35 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.727 -1.233 . . . . 1.51 110.225 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.3 mm -60.37 -39.95 82.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.357 -0.84 . . . . 1.67 109.005 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.6 mtp -60.01 -40.56 89.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.495 -0.753 . . . . 1.02 110.919 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.36 95.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.673 -1.267 . . . . 0.68 109.149 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.566 HH22 ' NE ' ' A' ' 186' ' ' ARG . 98.4 mtt180 -59.96 -53.34 59.04 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.221 -0.924 . . . . 2.93 110.375 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.3 m -69.73 -35.66 75.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.067 -1.021 . . . . 0.86 111.267 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.03 -28.6 65.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.865 -1.147 . . . . 0.67 108.906 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 70.24 45.73 0.65 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.506 0.669 . . . . 1.5 109.644 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 88.2 mt -122.73 150.04 57.47 Favored Pre-proline 0 N--CA 1.498 1.963 0 N-CA-C 107.84 -1.171 . . . . 0.72 107.84 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.79 142.68 70.78 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.002 1.801 . . . . 0.61 111.536 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -170.01 151.15 3.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.983 -1.073 . . . . 0.66 111.388 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.7 mt -123.47 143.47 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.783 -1.191 . . . . 0.79 107.783 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 5.8 m -126.67 -10.08 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 120.694 -1.254 . . . . 0.91 110.54 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.1 23.14 26.01 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 110.323 -1.111 . . . . 1.01 110.323 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.417 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.5 p -46.02 -43.24 14.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.089 -1.242 . . . . 0.99 109.715 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.88 -52.6 3.92 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 120.144 -1.027 . . . . 1.12 111.532 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.9 m -157.38 33.76 0.28 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.54 -1.565 . . . . 1.72 111.425 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 56.1 t -72.77 -40.1 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.908 -1.12 . . . . 0.89 109.111 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.432 ' H ' HG23 ' A' ' 209' ' ' THR . 1.4 p -54.82 -32.36 60.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.431 -0.793 . . . . 1.03 110.578 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 84.9 p -76.43 -16.29 59.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.985 -1.072 . . . . 1.83 109.421 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -101.64 -13.73 17.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.498 -0.751 . . . . 2.27 109.95 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 55.9 t -104.77 137.92 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.359 -0.838 . . . . 0.92 110.555 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -112.79 151.7 30.03 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.686 -1.227 . . . . 2.2 107.686 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 30.5 p-10 -57.92 137.03 57.11 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.016 -1.053 . . . . 2.36 110.251 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.8 OUTLIER 82.79 8.69 0.72 Allowed 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.14 0.495 . . . . 2.38 110.432 179.281 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 60.5 t0 -77.8 143.57 37.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.12 -0.987 . . . . 2.09 109.131 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.527 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 33.9 t80 -88.32 118.24 27.8 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.025 -1.047 . . . . 1.27 109.041 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.586 HD12 ' HB2' ' A' ' 16' ' ' ALA . 91.7 mt -130.63 149.42 52.29 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.515 -0.741 . . . . 0.75 110.544 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.7 mt -118.28 128.56 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 106.85 -1.537 . . . . 0.63 106.85 177.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.7 tp -100.61 122.5 43.38 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.961 -1.087 . . . . 0.7 109.466 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.419 ' C ' ' N ' ' A' ' 223' ' ' VAL . 19.3 m-20 -87.53 -42.77 12.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.982 -1.074 . . . . 2.31 109.884 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.883 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.15 22.81 0.25 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.674 -0.861 . . . . 0.78 108.674 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.419 ' N ' ' C ' ' A' ' 221' ' ' ASP . 18.0 t -127.25 -42.82 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.903 -1.517 . . . . 1.04 106.903 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -109.84 7.39 24.04 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.0 -1.111 . . . . 2.44 108.0 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.801 HD21 ' H ' ' A' ' 4' ' ' GLY . 36.6 t-20 60.04 52.12 5.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.794 -0.566 . . . . 1.55 110.532 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -147.17 158.56 43.99 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.784 -1.198 . . . . 1.99 110.463 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.6 t -126.81 130.04 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.496 -0.927 . . . . 0.77 108.496 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -98.43 122.93 42.22 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.426 -0.796 . . . . 0.98 109.212 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 18.2 t -100.79 111.28 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.551 -0.718 . . . . 0.85 110.083 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 54.98 63.14 7.17 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.235 -0.916 . . . . 1.66 111.244 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -86.87 150.07 8.43 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.571 2.181 . . . . 0.95 112.246 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 39.8 p -74.43 165.02 25.9 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.318 -0.864 . . . . 1.84 109.437 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -60.0 -34.43 73.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.426 -0.796 . . . . 2.74 110.592 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -59.94 -39.29 85.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.053 -1.029 . . . . 2.89 109.756 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 76.1 t -70.02 -40.27 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.031 -1.043 . . . . 1.3 109.18 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.527 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 99.4 mt -64.39 -40.05 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.342 -0.849 . . . . 1.09 109.658 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.08 -41.51 92.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.911 -1.118 . . . . 2.43 109.088 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -66.2 -39.97 90.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.275 -0.891 . . . . 2.78 108.627 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 96.8 mtp -69.11 -36.63 77.74 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.568 -0.708 . . . . 1.25 109.176 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.527 ' NH1' ' CG2' ' A' ' 236' ' ' ILE . 1.8 mmt-85 -60.99 -40.1 92.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 2.63 109.904 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.68 -42.6 97.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.102 -0.999 . . . . 1.8 109.042 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.5 t -61.62 -40.03 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.5 -0.75 . . . . 2.13 109.178 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -59.82 -39.88 86.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.369 -0.832 . . . . 3.17 109.456 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -41.23 91.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.085 -1.009 . . . . 1.78 109.641 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -66.2 -40.09 90.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.039 -1.038 . . . . 2.47 108.884 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 71.2 t -66.0 -40.0 86.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.898 -0.779 . . . . 2.09 108.898 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.83 -38.83 83.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.512 -0.743 . . . . 2.54 109.409 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 67.5 m -60.01 -40.0 87.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.974 . . . . 2.99 109.234 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.17 -39.97 86.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.436 -0.79 . . . . 3.34 109.827 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.54 ' C ' ' H ' ' A' ' 252' ' ' GLU . 32.8 mmtp -90.0 5.99 44.19 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.321 -0.862 . . . . 3.88 109.951 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -66.1 28.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.998 -1.063 . . . . 4.43 110.461 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' A' ' 250' ' ' LYS . 63.9 mm-40 54.15 79.62 0.13 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.004 -1.06 . . . . 5.42 109.193 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 66.9 mt -56.89 -33.42 66.87 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.253 -1.388 . . . . 6.1 107.253 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -111.26 -84.91 0.56 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.534 -0.913 . . . . 7.37 108.534 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -176.47 -36.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.644 -1.613 . . . . 8.01 106.644 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 3.1 pp -151.7 160.58 43.55 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.077 -1.083 . . . . 9.05 108.077 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -143.52 156.28 44.57 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.306 -0.998 . . . . 10.56 108.306 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -140.98 82.48 1.84 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.978 -1.077 . . . . 11.32 109.693 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 118.222 -0.894 . . . . 12.42 109.389 -179.768 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 7.5 ttt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -151.69 149.54 29.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.368 -0.832 . . . . 0.0 109.099 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -148.91 159.96 43.71 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.053 -1.029 . . . . 0.0 110.655 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -152.7 148.74 27.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.475 -0.766 . . . . 0.0 109.314 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -107.03 131.11 54.45 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.135 -0.978 . . . . 0.0 109.646 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.59 119.06 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 122.186 0.993 . . . . 0.0 112.782 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 307' ' ' THR . . . . . 0.472 ' O ' HG23 ' B' ' 309' ' ' THR . 94.6 m -78.34 104.75 9.13 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.919 0.866 . . . . 0.0 110.004 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' B' ' 358' ' ' GLY . 70.4 mt -51.74 118.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 122.317 1.056 . . . . 0.0 110.295 -177.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 309' ' ' THR . . . . . 0.472 HG23 ' O ' ' B' ' 307' ' ' THR . 51.6 p -108.1 17.08 22.73 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.24 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.405 ' O ' ' CG ' ' B' ' 357' ' ' GLN . . . -71.92 117.14 55.29 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.063 -1.023 . . . . 0.0 108.54 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -51.92 -16.07 3.86 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 CA-C-N 120.35 1.161 . . . . 0.0 113.594 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -120.47 10.57 11.19 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.329 -0.857 . . . . 0.0 109.357 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.14 -179.79 31.4 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.494 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -88.66 93.98 9.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.351 -1.088 . . . . 0.0 109.353 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.411 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 6.5 p80 -96.58 -160.01 0.77 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.897 -1.127 . . . . 0.0 110.564 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.2 m -57.33 -44.03 83.89 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.005 -1.059 . . . . 0.0 112.367 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.577 HH21 ' NE2' ' B' ' 321' ' ' GLN . 2.1 tpt180 -59.92 -60.57 10.17 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 120.651 -1.28 . . . . 0.0 112.233 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.411 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 10.9 Cg_endo -58.73 -29.82 90.72 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 CA-C-N 120.444 1.194 . . . . 0.0 111.595 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.92 -52.01 67.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 108.861 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.65 -41.49 61.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.944 . . . . 0.0 109.4 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 321' ' ' GLN . . . . . 0.577 ' NE2' HH21 ' B' ' 317' ' ' ARG . 89.5 mt-30 -69.96 -40.04 75.64 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.15 -0.969 . . . . 0.0 108.753 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -60.86 -52.88 63.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.519 -0.738 . . . . 0.0 110.989 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 71.9 t -67.74 -29.34 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.646 -1.284 . . . . 0.0 109.997 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -61.16 -45.53 94.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.942 . . . . 0.0 109.3 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -64.02 -45.04 90.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.332 -0.855 . . . . 0.0 110.178 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -61.44 -53.66 53.59 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.016 -1.053 . . . . 0.0 111.41 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -57.51 -13.26 3.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.868 -1.145 . . . . 0.0 109.496 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -68.24 -29.74 73.37 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -103.85 147.22 27.57 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.503 -0.998 . . . . 0.0 109.253 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 17.6 p -91.06 -11.88 37.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.975 -1.078 . . . . 0.0 109.85 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.417 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 80.8 p -64.09 158.01 23.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.342 -0.849 . . . . 0.0 110.478 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -74.85 132.96 41.92 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.0 mt -132.32 133.01 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.617 -0.677 . . . . 0.0 109.209 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 69.4 m -127.92 151.04 49.58 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.48 -0.763 . . . . 0.0 109.491 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 60.8 t -117.04 137.83 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 87.6 m -128.96 125.12 36.76 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.184 -0.948 . . . . 0.0 109.083 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 337' ' ' SER . . . . . 0.418 ' HB2' HG12 ' B' ' 361' ' ' VAL . 12.2 t -138.67 119.12 13.8 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.959 0.885 . . . . 0.0 110.798 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 338' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' B' ' 338' ' ' ASN . 8.1 p-10 39.01 65.13 0.7 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 79.3 -12.36 26.35 Favored Glycine 0 N--CA 1.5 2.947 0 O-C-N 120.833 -1.167 . . . . 0.0 113.668 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -120.67 133.09 55.38 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-N 119.564 1.682 . . . . 0.0 109.963 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 78.7 p -129.91 150.4 51.21 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.8 0.809 . . . . 0.0 110.513 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.23 167.33 22.68 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.528 0.68 . . . . 0.0 110.11 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 12.2 m -88.93 138.94 30.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.504 -0.748 . . . . 0.0 109.808 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -76.8 -13.03 60.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.907 -1.121 . . . . 0.0 108.974 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -89.69 16.58 7.66 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 67.3 m -145.61 94.79 2.55 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.607 0.717 . . . . 0.0 111.068 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.717 HD23 HD22 ' A' ' 79' ' ' LEU . 52.9 tp -59.89 -33.96 72.54 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.856 ' CE2' HD11 ' A' ' 79' ' ' LEU . 54.2 m-85 -55.79 -52.84 62.59 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.928 -1.108 . . . . 0.0 109.852 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -69.99 -20.77 63.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -0.898 . . . . 0.0 111.889 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.97 -46.76 64.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.428 -1.42 . . . . 0.0 110.817 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.584 ' NE2' ' O ' ' B' ' 347' ' ' LEU . 1.0 OUTLIER -47.92 -21.11 0.38 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.894 -1.129 . . . . 0.0 111.695 -177.371 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 71.3 p -77.31 -12.97 60.01 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.168 -1.582 . . . . 0.0 109.974 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 30.0 mt -96.21 119.68 35.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.107 -0.995 . . . . 0.0 109.431 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.13 97.3 0.93 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 90.5 mt -98.64 81.56 2.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.327 -1.102 . . . . 0.0 109.399 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 46.5 p -89.77 176.48 6.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.149 -0.969 . . . . 0.0 110.964 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 357' ' ' GLN . . . . . 0.405 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 21.9 tm0? -70.64 112.19 6.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.694 -0.629 . . . . 0.0 110.379 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 358' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 104.26 8.74 37.87 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 19.2 m -86.55 109.2 18.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.122 -1.223 . . . . 0.0 110.357 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 360' ' ' VAL . . . . . 0.416 HG22 ' OG1' ' B' ' 307' ' ' THR . 7.9 t -77.6 115.49 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 122.329 1.061 . . . . 0.0 109.556 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 361' ' ' VAL . . . . . 0.418 HG12 ' HB2' ' B' ' 337' ' ' SER . 33.2 m -113.01 178.41 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 34.6 m -130.5 128.87 42.06 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 38.6 mt -104.69 121.55 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 68.8 p -126.46 136.12 52.23 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.71 153.25 40.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.208 -0.932 . . . . 0.0 109.923 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -146.16 125.82 13.38 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 158.98 -158.76 29.73 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.116 -1.516 . . . . 0.0 111.256 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.81 -51.99 67.36 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 122.077 -0.661 . . . . 0.0 112.177 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' B' ' 331' ' ' SER . 97.2 m-20 -111.27 11.92 21.7 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.998 -1.064 . . . . 0.0 111.023 -177.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -43.53 -31.85 0.81 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.231 -0.918 . . . . 0.0 110.746 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 371' ' ' GLN . . . . . 0.403 ' HG2' ' H ' ' B' ' 371' ' ' GLN . 3.2 pt20 -65.13 -47.31 77.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.881 -1.137 . . . . 0.0 109.532 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -65.84 -49.28 68.75 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 109.209 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.49 -37.04 3.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.661 -0.649 . . . . 0.0 112.041 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.544 ' O ' HG23 ' B' ' 378' ' ' VAL . 99.5 t -80.51 -35.38 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.479 -1.388 . . . . 0.0 109.964 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -67.04 -39.97 87.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.898 -1.126 . . . . 0.0 111.072 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -80.5 -46.64 15.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.759 -1.213 . . . . 0.0 110.57 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 89.8 mt -61.69 -39.95 93.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.194 -0.941 . . . . 0.0 109.865 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.544 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.8 t -60.19 -49.16 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.041 -1.037 . . . . 0.0 109.624 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' B' ' 383' ' ' GLU . 10.6 mtpm? -68.07 -54.2 20.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.703 -1.199 . . . . 0.0 107.993 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 50.1 tp -56.83 -34.97 68.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 110.182 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -72.09 -40.31 68.31 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 118.286 -1.366 . . . . 0.0 108.805 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.07 -6.45 59.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.525 -0.734 . . . . 0.0 110.533 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' B' ' 379' ' ' LYS . 74.2 mm-40 -110.28 -2.42 16.77 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.129 -0.982 . . . . 0.0 111.377 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 12.7 mt -80.98 129.99 34.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.276 -1.515 . . . . 0.0 108.722 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.381 -179.783 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.6 mtp . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.143 -0.688 . . . . 2.91 109.143 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.9 mt -96.39 135.78 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.336 -0.853 . . . . 1.2 109.31 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.6 m -119.34 149.83 41.16 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.775 0.798 . . . . 1.4 109.895 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -139.79 -173.43 13.21 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.9 -1.68 . . . . 1.05 108.9 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.5 mt -85.48 -7.18 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.896 -1.355 . . . . 1.15 110.087 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.4 tp 50.42 95.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.91 -1.119 . . . . 0.98 109.453 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.11 -35.06 16.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.88 109.378 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 2.8 p -134.67 130.84 19.95 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.495 -0.753 . . . . 1.69 109.364 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.36 141.14 14.07 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.206 1.937 . . . . 0.85 112.779 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.698 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.94 -162.72 34.87 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.978 -1.249 . . . . 0.92 109.978 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.2 mt -146.28 147.09 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.265 -1.138 . . . . 0.81 108.376 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.69 141.45 18.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.524 -1.36 . . . . 0.51 111.455 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -122.14 126.15 47.7 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 107.773 -1.195 . . . . 0.62 107.773 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.08 178.52 48.53 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 118.551 -1.785 . . . . 0.55 111.188 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -79.13 160.95 26.79 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.863 -0.786 . . . . 2.1 110.135 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -102.44 127.28 49.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.549 -0.719 . . . . 0.77 111.256 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.3 tp -106.87 134.56 49.84 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.618 -1.623 . . . . 0.91 106.618 177.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.6 tp -117.66 123.09 45.29 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.243 -0.911 . . . . 0.93 110.523 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.415 HD12 ' HB2' ' A' ' 160' ' ' ALA . 36.8 mt -86.0 103.3 14.57 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.358 0.599 . . . . 0.93 109.644 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -93.98 135.21 35.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -0.896 . . . . 2.75 108.75 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -130.14 132.48 46.1 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.555 -0.906 . . . . 3.0 108.555 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -80.97 148.08 29.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.094 -1.004 . . . . 2.77 110.006 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -62.65 149.47 43.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.38 -0.825 . . . . 2.94 109.263 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.544 HD11 ' NH1' ' A' ' 139' ' ' ARG . 42.0 mt -90.67 125.5 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.223 -0.923 . . . . 0.95 108.89 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.5 t -92.1 125.82 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.096 -1.002 . . . . 1.28 109.989 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.54 130.59 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.028 -1.101 . . . . 1.21 108.028 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -90.68 123.06 33.99 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.824 -1.173 . . . . 1.81 110.245 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -86.63 -1.32 57.58 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.57 -0.9 . . . . 2.8 108.57 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -65.1 140.07 58.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.417 -0.802 . . . . 2.87 109.974 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -87.9 151.31 22.92 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.085 -1.079 . . . . 2.35 108.085 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.673 HD13 ' HG3' ' A' ' 39' ' ' GLU . 3.9 pt -101.48 166.91 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.918 -1.114 . . . . 0.97 109.882 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.0 p -97.96 178.83 4.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.259 -0.901 . . . . 1.17 109.407 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.15 -49.39 77.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.362 -0.836 . . . . 1.18 110.469 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -56.37 -31.5 63.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.616 -1.302 . . . . 2.56 110.248 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -81.8 -9.34 59.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.307 -0.871 . . . . 1.79 110.448 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.0 t -59.97 -50.09 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.937 -1.102 . . . . 1.0 108.75 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -62.61 -40.05 95.72 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.278 -0.889 . . . . 1.77 109.152 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -60.58 -46.03 91.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.296 -0.877 . . . . 2.7 110.488 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.673 ' HG3' HD13 ' A' ' 31' ' ' ILE . 74.9 mm-40 -60.72 -44.35 96.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.825 -1.172 . . . . 1.51 109.851 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.3 t -60.06 -46.37 94.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.95 -1.094 . . . . 0.93 108.743 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -58.75 -40.06 82.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.38 -0.825 . . . . 1.81 109.099 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -60.91 -44.5 97.09 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.007 -1.108 . . . . 2.78 108.007 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -60.12 -49.48 77.46 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.95 -0.759 . . . . 0.78 108.95 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.0 -47.38 86.06 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.281 -1.007 . . . . 1.07 108.281 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.523 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 29.7 t -60.85 -43.82 97.81 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.353 -0.939 . . . . 1.12 108.869 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.99 -45.16 96.39 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.551 -1.819 . . . . 0.84 108.551 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.0 ttt-85 -60.06 -36.34 77.11 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.132 -1.062 . . . . 3.09 108.132 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -53.04 -40.39 63.9 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.939 -0.763 . . . . 0.88 108.939 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.1 ttmt -75.08 -74.08 0.22 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.614 -1.254 . . . . 2.59 107.614 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.53 -39.64 0.33 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.533 -0.729 . . . . 0.7 111.222 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.6 p -56.64 -59.09 5.52 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.658 -1.276 . . . . 1.4 108.895 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.76 -39.97 94.5 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.347 -0.846 . . . . 0.67 110.939 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -67.73 -39.96 84.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.812 -1.18 . . . . 1.66 110.202 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.6 mt -65.64 -40.06 92.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.062 -1.024 . . . . 1.58 109.614 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.425 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 74.9 mm-40 -62.63 -39.95 95.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.089 -1.007 . . . . 1.35 109.846 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -64.14 -41.85 97.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.059 -1.026 . . . . 0.77 110.012 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.413 HD11 HH22 ' A' ' 136' ' ' ARG . 82.8 mt -61.41 -40.0 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.912 . . . . 0.63 109.858 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.425 ' NZ ' ' OE1' ' A' ' 55' ' ' GLU . 5.1 ttpm? -58.16 -49.92 75.32 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.194 -0.941 . . . . 1.14 109.876 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.4 m -58.55 -36.09 73.35 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.364 -0.835 . . . . 0.79 110.886 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -65.83 -38.72 89.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.971 -1.08 . . . . 1.53 109.644 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.97 92.32 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.531 -0.73 . . . . 0.57 110.256 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.08 -50.0 72.2 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.362 -1.495 . . . . 0.75 109.362 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -66.91 -49.5 65.38 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.269 -1.136 . . . . 1.59 109.579 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.8 m -69.74 -61.61 1.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.492 -0.755 . . . . 0.73 112.694 -177.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -93.63 -51.82 4.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.763 -1.21 . . . . 0.75 110.949 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.24 -173.01 23.55 Favored Glycine 0 N--CA 1.501 3.019 0 C-N-CA 119.767 -1.206 . . . . 1.22 111.444 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -71.13 -27.75 63.79 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.356 0.598 . . . . 5.81 110.495 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -63.58 -33.99 76.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.372 -0.83 . . . . 3.37 110.8 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -100.73 -24.99 14.29 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.104 -0.997 . . . . 1.77 109.843 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -62.83 -40.02 96.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 1.65 109.935 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.522 ' HB2' ' NH1' ' B' ' 317' ' ' ARG . . . -59.8 -29.88 68.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.398 -0.814 . . . . 0.77 109.732 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.7 mt -59.98 -40.09 82.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.453 -1.314 . . . . 0.8 107.453 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 81.3 m-85 -70.99 -40.06 72.11 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.605 -0.685 . . . . 0.88 111.005 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -64.12 -42.04 97.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.601 -1.312 . . . . 1.37 109.712 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.88 -40.59 96.99 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.586 -1.806 . . . . 0.62 108.586 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.8 m170 -64.55 -43.15 94.85 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.387 -1.067 . . . . 1.5 109.332 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.1 mt -67.32 -47.59 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 0.63 109.983 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.9 ttp -60.1 -40.62 90.28 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.941 -1.099 . . . . 1.51 110.235 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.788 HD11 ' CE2' ' B' ' 348' ' ' PHE . 35.5 tp -66.29 -36.81 83.93 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.539 -0.726 . . . . 0.77 109.639 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.49 -39.34 91.79 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.528 -0.733 . . . . 0.62 109.84 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -78.65 6.88 7.81 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.959 -1.088 . . . . 1.47 110.082 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 57.4 t0 -53.46 132.6 40.14 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.215 -0.928 . . . . 1.47 110.93 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.437 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 93.6 mt-10 -63.34 -18.71 63.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.725 -0.609 . . . . 1.78 110.602 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.02 -34.97 69.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 2.53 108.919 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.48 -39.56 81.29 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.694 0.759 . . . . 0.8 109.241 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.9 -44.47 94.23 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.646 -0.659 . . . . 1.42 110.527 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -70.07 -43.15 71.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.157 -0.964 . . . . 1.71 111.628 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -69.95 -40.07 75.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.001 -1.062 . . . . 1.57 112.476 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.63 -44.53 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.75 -1.219 . . . . 0.65 109.938 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.63 -38.59 76.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.487 -0.758 . . . . 0.82 110.168 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.07 -50.11 74.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.159 -0.963 . . . . 0.79 111.501 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.1 mt -60.97 -45.87 93.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.849 -1.157 . . . . 0.95 109.882 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.1 mt -60.86 -50.03 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.182 -0.948 . . . . 0.66 109.025 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -70.0 -40.59 75.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.65 -0.656 . . . . 2.2 110.857 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -81.16 -62.5 1.64 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.197 -0.939 . . . . 1.65 112.189 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -83.59 -1.0 52.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.122 -0.987 . . . . 2.03 111.934 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 58.98 39.08 23.98 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.929 -1.107 . . . . 1.42 109.741 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.6 mtp -92.36 167.43 12.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.482 -0.761 . . . . 1.18 109.645 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.0 p -84.2 163.44 19.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.98 109.945 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.57 -39.75 80.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.397 -0.814 . . . . 0.64 109.242 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -62.24 -42.45 99.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.306 -0.871 . . . . 2.07 110.231 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.87 -42.85 18.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.327 -0.858 . . . . 0.73 110.701 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.69 -47.32 66.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.16 -0.962 . . . . 0.54 110.791 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.6 -38.98 93.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.017 -1.052 . . . . 0.56 109.346 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.589 ' HB2' HD21 ' A' ' 138' ' ' LEU . 77.2 t60 -59.28 -40.85 87.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.519 -0.738 . . . . 1.54 109.808 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 110' ' ' GLY . 87.0 tt0 -64.32 -39.94 94.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 1.33 110.373 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.8 t -62.19 -55.51 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.148 -0.97 . . . . 0.72 111.132 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.431 HG21 ' CA ' ' A' ' 134' ' ' GLY . 45.6 mm -69.15 -40.04 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.804 -1.185 . . . . 0.85 108.82 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.459 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.4 tt0 -64.89 -39.88 94.22 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.832 -1.173 . . . . 2.44 107.832 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.02 -49.17 77.56 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.882 -1.287 . . . . 0.98 109.882 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -69.52 -51.66 33.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.948 -1.325 . . . . 1.41 109.222 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.91 -42.75 85.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.915 . . . . 1.2 109.282 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 40.5 t -58.36 -38.64 77.63 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.352 -0.842 . . . . 1.7 109.164 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.76 89.52 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.2 -0.938 . . . . 1.47 108.893 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.2 mt -63.05 -42.74 99.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.905 -1.122 . . . . 1.56 109.646 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.99 -33.08 71.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.871 -1.143 . . . . 2.2 109.468 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.57 -20.96 51.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 2.12 109.075 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.615 HD13 HD13 ' A' ' 123' ' ' LEU . 29.5 mt -61.59 142.35 57.18 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.97 -1.081 . . . . 2.0 108.293 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -92.37 28.58 1.9 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.03 -1.044 . . . . 3.23 110.883 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -116.89 128.5 55.3 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.189 -0.944 . . . . 2.49 109.733 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -67.86 -28.04 67.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.557 -0.714 . . . . 3.95 109.522 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.96 -41.81 97.45 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.237 1.018 . . . . 2.0 109.133 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.772 HD22 ' O ' ' B' ' 351' ' ' GLN . 91.7 mt -75.93 -33.03 59.84 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.208 -0.664 . . . . 1.86 109.208 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -60.06 -40.56 89.88 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.861 -0.792 . . . . 2.84 108.861 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -60.0 -48.36 82.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 2.73 109.163 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.761 ' NH1' HE22 ' B' ' 351' ' ' GLN . 61.1 mtm180 -69.33 -30.38 68.41 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.136 -1.026 . . . . 2.77 108.608 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.56 -27.0 68.87 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.39 -0.967 . . . . 1.19 108.39 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.0 -39.93 72.12 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.89 -0.782 . . . . 1.2 108.89 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -60.05 -44.44 94.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.416 -0.802 . . . . 1.55 110.567 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.06 -39.97 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.003 -1.061 . . . . 0.8 108.772 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -61.38 -39.95 92.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.299 -0.875 . . . . 3.09 109.894 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.95 -40.0 87.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 1.46 110.566 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 93.7 mt -60.04 -43.41 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.038 -1.039 . . . . 0.71 109.669 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.431 ' CA ' HG21 ' A' ' 108' ' ' ILE . . . -60.05 -43.93 97.75 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.894 -1.283 . . . . 0.57 109.894 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.09 -45.73 91.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -1.188 . . . . 2.59 110.561 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.413 HH22 HD11 ' A' ' 57' ' ' ILE . 56.4 mtp180 -64.82 -34.95 79.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.831 -1.168 . . . . 2.83 109.641 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.1 tp -59.97 -42.08 93.35 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.315 -0.866 . . . . 1.25 109.333 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 105' ' ' HIS . 59.3 mt -60.18 -41.83 93.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.088 -1.007 . . . . 0.7 109.703 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.544 ' NH1' HD11 ' A' ' 24' ' ' ILE . 64.4 mtm-85 -70.79 -40.04 72.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.111 -0.993 . . . . 2.57 109.802 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -61.02 -37.18 81.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 1.23 111.048 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.2 mt -69.99 -42.62 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.562 -1.336 . . . . 0.81 108.854 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.6 mt -70.03 -26.96 64.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.248 -0.649 . . . . 1.0 109.248 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.2 41.28 8.07 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.958 -1.657 . . . . 0.89 108.958 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.64 143.85 46.12 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.34 -1.094 . . . . 1.14 108.351 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -69.97 144.64 52.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.244 -0.91 . . . . 4.6 110.163 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.8 mt -109.88 127.93 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 122.176 0.989 . . . . 1.24 108.76 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.7 mt -69.99 -40.03 78.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-N 115.582 -0.736 . . . . 1.54 110.272 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 31.4 t0 64.22 123.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.514 -0.741 . . . . 1.5 109.442 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 mt -89.9 0.01 57.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.592 -0.692 . . . . 0.79 109.569 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.3 m -88.18 -18.46 28.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.234 -0.916 . . . . 1.4 110.716 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.69 16.52 2.16 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.072 -1.017 . . . . 0.92 112.008 -177.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.12 119.19 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.427 -1.421 . . . . 0.88 108.72 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -99.38 -9.51 23.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.183 -0.948 . . . . 2.45 110.806 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -110.19 144.82 38.29 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.405 -0.809 . . . . 1.52 110.052 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -65.61 135.61 55.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 1.58 108.993 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.4 m -152.86 166.47 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.571 -0.706 . . . . 0.69 109.419 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 83.7 mt -94.75 144.65 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 105.563 -2.014 . . . . 0.61 105.563 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 12.2 tp -96.58 117.45 30.98 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.812 -1.18 . . . . 0.87 110.48 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.3 t -122.37 130.03 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.595 -0.891 . . . . 0.71 108.595 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.415 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -159.27 164.2 35.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.095 -1.003 . . . . 0.81 109.074 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.46 ' O ' ' OD1' ' A' ' 162' ' ' ASP . . . -75.3 -30.61 60.41 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.317 -1.489 . . . . 0.98 108.681 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 66.6 m-20 -159.54 167.87 27.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.52 -0.738 . . . . 2.25 109.398 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 86.7 mt -141.68 125.83 17.4 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.175 -0.953 . . . . 0.78 108.473 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 70.3 p -93.23 148.49 35.74 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.083 -1.01 . . . . 0.98 109.827 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -39.64 -37.87 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.243 1.962 . . . . 0.81 112.389 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 73.8 m -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.207 -0.933 . . . . 0.9 109.673 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.8 -41.6 97.87 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.194 -0.941 . . . . 1.61 109.497 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 59.5 p -55.6 -31.63 62.4 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.178 -0.951 . . . . 0.61 111.389 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . . . -71.82 -55.01 8.36 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.578 -1.326 . . . . 0.6 109.446 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -82.43 40.35 0.65 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.8 -1.185 . . . . 1.4 107.8 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.409 ' H ' ' C ' ' A' ' 169' ' ' ALA . 62.3 tp -105.31 130.92 53.33 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.316 -0.994 . . . . 0.7 108.316 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -88.63 105.43 17.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.024 -1.048 . . . . 2.35 109.104 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 93.4 mt -63.69 -44.12 94.61 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.291 -0.881 . . . . 1.51 110.788 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -72.4 -22.29 61.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.854 -1.153 . . . . 2.33 112.528 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -93.45 -9.99 36.63 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.527 -1.358 . . . . 1.92 109.663 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.6 HG12 ' H ' ' A' ' 178' ' ' GLY . 99.2 t -107.99 119.05 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.306 -0.871 . . . . 0.67 109.254 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 70.1 mt -85.74 4.92 34.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.403 -0.811 . . . . 1.53 110.525 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.6 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 168.03 175.22 37.58 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.296 -1.522 . . . . 0.48 109.296 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.492 ' CE1' HG11 ' A' ' 176' ' ' VAL . 16.3 m-85 -133.61 130.48 38.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.402 -1.058 . . . . 0.55 109.144 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.415 ' CG2' HG21 ' A' ' 205' ' ' THR . 79.4 mt -130.66 122.21 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.568 -0.901 . . . . 0.65 108.568 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 59.0 p -144.7 159.77 42.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.111 -0.993 . . . . 0.82 111.279 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 53.3 t0 -103.02 25.87 8.87 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.353 -0.61 . . . . 2.46 109.353 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.7 -161.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.178 -1.576 . . . . 1.28 111.747 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.61 -54.87 6.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.588 -1.005 . . . . 2.19 110.588 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.96 -114.37 0.65 Allowed Glycine 0 N--CA 1.495 2.61 0 O-C-N 120.778 -1.424 . . . . 2.13 111.263 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -69.98 -24.14 63.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.677 -0.896 . . . . 5.86 111.648 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 75.7 p -82.85 3.15 30.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.597 -1.314 . . . . 3.72 110.664 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 34.3 t -91.61 126.86 36.84 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.918 -1.114 . . . . 1.74 111.08 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -55.98 -46.37 78.68 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.277 -0.89 . . . . 0.95 110.32 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -54.19 -39.99 67.14 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.14 -0.975 . . . . 1.55 110.238 -179.055 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 24.8 p -60.36 -39.6 87.75 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.003 -1.061 . . . . 1.51 110.454 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.9 -41.1 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.966 . . . . 1.67 110.188 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 91.6 mtp -62.57 -40.06 95.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.035 -1.04 . . . . 1.02 110.666 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.99 -40.45 73.34 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.613 -1.304 . . . . 0.68 108.594 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -59.62 -49.67 76.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 2.93 109.699 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 62.9 m -76.12 -31.24 58.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.18 -0.95 . . . . 0.86 110.798 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.82 -21.93 60.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.954 -1.091 . . . . 0.67 109.547 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 64.39 43.93 4.42 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.93 -0.481 . . . . 1.5 111.514 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.453 ' O ' ' OG ' ' A' ' 8' ' ' SER . 46.5 mt -121.08 142.1 34.17 Favored Pre-proline 0 N--CA 1.503 2.219 0 N-CA-C 107.601 -1.259 . . . . 0.72 107.601 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.72 143.84 99.46 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.508 1.472 . . . . 0.61 111.441 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.96 152.22 3.5 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.935 -1.106 . . . . 0.66 111.49 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.9 mt -124.27 143.46 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.739 -1.208 . . . . 0.79 107.739 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.5 m -125.49 -10.77 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.996 -1.065 . . . . 0.91 111.19 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -113.11 25.97 10.91 Favored Glycine 0 N--CA 1.501 3.012 0 N-CA-C 111.063 -0.815 . . . . 1.01 111.063 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.415 HG21 ' CG2' ' A' ' 180' ' ' ILE . 11.4 p -43.56 -43.75 5.76 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.001 -1.294 . . . . 0.99 109.757 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.434 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 96.01 -50.7 1.71 Allowed Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.439 -0.886 . . . . 1.12 111.418 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.2 m -160.08 40.0 0.18 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.53 -1.571 . . . . 1.72 111.457 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 12.1 t -77.54 -32.02 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.889 -1.132 . . . . 0.89 108.775 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 31.9 p -60.0 -39.89 87.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.558 -0.714 . . . . 1.03 110.829 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 81.8 p -82.47 -10.7 58.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.973 -1.079 . . . . 1.83 110.731 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -98.53 -16.82 19.01 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.21 -0.931 . . . . 2.27 110.724 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 213' ' ' LYS . 44.8 t -116.56 154.73 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 O-C-N 121.265 -0.897 . . . . 0.92 111.025 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.452 ' N ' HG12 ' A' ' 212' ' ' VAL . 2.8 mptp? -116.01 154.83 29.18 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.558 -1.275 . . . . 2.2 107.558 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 20.9 p30 -59.74 140.11 56.76 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.956 -1.09 . . . . 2.36 110.474 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.4 t0 88.97 5.7 0.16 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.049 0.452 . . . . 2.38 110.368 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 16' ' ' ALA . 59.4 m-20 -79.78 153.71 28.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.049 -1.032 . . . . 2.09 109.706 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -95.01 129.93 41.88 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.416 -0.802 . . . . 1.27 108.868 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.6 mt -130.72 151.18 51.45 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.136 -0.977 . . . . 0.75 110.769 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.9 mt -120.13 122.03 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 107.235 -1.394 . . . . 0.63 107.235 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 45.2 tp -103.33 120.02 39.98 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.823 -1.173 . . . . 0.7 108.73 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.479 ' OD2' ' ND2' ' A' ' 224' ' ' ASN . 32.3 t0 -87.24 -37.36 17.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.936 -1.102 . . . . 2.31 108.918 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 45.52 24.49 0.18 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.594 -0.691 . . . . 0.78 109.363 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 45.0 t -137.28 -44.63 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 106.965 -1.494 . . . . 1.04 106.965 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.479 ' ND2' ' OD2' ' A' ' 221' ' ' ASP . 75.2 m-20 -99.94 2.69 43.88 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.131 -1.433 . . . . 2.44 107.131 177.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 59.94 45.11 12.68 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 116.101 -0.5 . . . . 1.55 110.03 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -139.48 138.38 36.35 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.137 -0.977 . . . . 1.99 109.828 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 97.1 t -120.01 122.38 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.807 -0.812 . . . . 0.77 108.807 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.49 ' CD2' ' SD ' ' A' ' 239' ' ' MET . 99.2 m-85 -90.61 130.71 36.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.87 -1.144 . . . . 0.98 108.499 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 62.9 t -107.69 123.19 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.58 -0.7 . . . . 0.85 109.709 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 66.6 t30 56.65 67.34 2.72 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.284 -0.885 . . . . 1.66 109.271 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -88.53 130.87 2.37 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 123.144 2.563 . . . . 0.95 112.827 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.654 HG22 ' N ' ' A' ' 233' ' ' ASN . 95.1 m -73.2 173.23 9.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.368 -0.832 . . . . 1.84 109.082 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.654 ' N ' HG22 ' A' ' 232' ' ' THR . 70.3 m-80 -60.0 -40.0 87.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.168 -0.957 . . . . 2.74 109.886 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.48 -39.99 92.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 2.89 109.944 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.2 t -68.29 -39.95 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.093 -1.004 . . . . 1.3 109.544 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.4 mt -65.66 -42.27 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.076 -1.015 . . . . 1.09 108.672 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -61.31 -39.53 90.81 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.031 -0.729 . . . . 2.43 109.031 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -59.95 -49.67 76.77 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.522 -0.918 . . . . 2.78 108.522 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.546 ' O ' ' N ' ' A' ' 242' ' ' VAL . 96.2 mtp -62.66 -75.12 0.08 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.728 -1.582 . . . . 1.25 106.728 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.528 ' C ' ' O ' ' A' ' 239' ' ' MET . 13.1 mmm-85 -18.31 -55.73 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 112.112 0.412 . . . . 2.63 112.112 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 239' ' ' MET . . . -59.99 -50.61 73.08 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.894 -1.129 . . . . 1.8 109.82 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 239' ' ' MET . 54.5 t -62.84 -39.9 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.368 -0.832 . . . . 2.13 109.364 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.0 tm0? -59.73 -39.08 83.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.905 . . . . 3.17 109.555 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -39.97 87.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.715 -1.24 . . . . 1.78 108.859 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -61.29 -40.04 92.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.243 -0.911 . . . . 2.47 108.802 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 62.4 t -60.82 -39.95 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 109.034 -0.728 . . . . 2.09 109.034 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.92 82.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.37 -0.831 . . . . 2.54 109.617 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 58.1 m -60.09 -39.96 87.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.082 -1.011 . . . . 2.99 109.201 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.455 ' C ' ' N ' ' A' ' 251' ' ' ALA . 46.9 tp10 -60.1 -40.02 88.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 3.34 109.191 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -50.81 -13.47 0.15 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.231 -0.918 . . . . 3.88 108.885 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.455 ' N ' ' C ' ' A' ' 249' ' ' GLU . . . -60.05 -46.71 88.65 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.491 -0.756 . . . . 4.43 109.275 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -151.5 75.37 1.17 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.212 -0.93 . . . . 5.42 109.682 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 254' ' ' ALA . 0.3 OUTLIER -92.55 5.85 49.36 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.115 -0.991 . . . . 6.1 109.07 179.588 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.485 ' N ' HD12 ' A' ' 253' ' ' LEU . . . -69.96 -26.47 64.12 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.276 -0.89 . . . . 7.37 109.432 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -60.02 -49.9 75.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 8.01 110.226 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.19 -40.08 93.75 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.003 -1.061 . . . . 9.05 109.514 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -80.87 158.29 25.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.334 -0.854 . . . . 10.56 109.92 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -97.08 11.94 34.4 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.329 -0.857 . . . . 11.32 109.54 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 12.42 109.589 -179.952 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 31.7 ttp . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.414 0.626 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -154.86 152.43 29.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.057 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -150.04 162.8 39.68 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.061 -1.025 . . . . 0.0 109.958 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -154.3 151.64 29.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 0.0 109.255 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -108.99 130.98 55.48 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.302 -0.874 . . . . 0.0 110.059 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.433 ' O ' HG13 ' B' ' 306' ' ' VAL . 7.2 p -132.86 121.75 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-O 122.235 1.017 . . . . 0.0 112.512 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 307' ' ' THR . . . . . 0.465 ' O ' HG23 ' B' ' 309' ' ' THR . 18.1 m -76.7 106.72 8.53 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.944 0.878 . . . . 0.0 111.086 -177.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 97.1 mt -53.18 121.36 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 122.191 0.996 . . . . 0.0 110.566 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 309' ' ' THR . . . . . 0.465 HG23 ' O ' ' B' ' 307' ' ' THR . 81.8 p -110.76 19.98 18.06 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.232 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.92 118.02 59.33 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 120.928 -1.108 . . . . 0.0 108.826 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -49.65 -20.34 4.29 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 CA-C-N 120.216 1.113 . . . . 0.0 112.945 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -116.15 15.3 16.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.371 -0.831 . . . . 0.0 109.714 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.53 174.35 20.01 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.175 -1.97 . . . . 0.0 108.175 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 3.5 tp -83.52 94.27 8.0 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.981 -1.305 . . . . 0.0 109.459 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.413 ' NE2' ' HB3' ' B' ' 317' ' ' ARG . 3.6 p80 -99.94 -158.81 0.7 Allowed 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.085 -1.01 . . . . 0.0 109.978 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.7 m -59.95 -43.84 94.77 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.968 -1.083 . . . . 0.0 112.572 -175.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.522 ' NH1' ' HB2' ' A' ' 71' ' ' ALA . 11.9 tpt180 -54.1 -59.19 10.59 Favored Pre-proline 0 N--CA 1.499 2.025 0 O-C-N 120.335 -1.478 . . . . 0.0 111.271 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -60.59 -34.51 92.34 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 CA-C-N 120.531 1.225 . . . . 0.0 111.503 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.08 -50.88 71.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.364 -0.835 . . . . 0.0 109.034 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.71 -43.0 76.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.785 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 321' ' ' GLN . . . . . 0.504 ' CG ' ' NH1' ' B' ' 317' ' ' ARG . 14.1 mm100 -70.02 -41.47 74.24 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.807 -1.183 . . . . 0.0 108.898 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -62.01 -52.91 62.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.548 -0.72 . . . . 0.0 110.554 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 87.0 t -65.73 -28.01 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.909 -1.119 . . . . 0.0 109.844 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -60.13 -46.66 88.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.123 -0.986 . . . . 0.0 110.057 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 325' ' ' GLU . . . . . 0.485 ' OE1' HD22 ' B' ' 380' ' ' LEU . 86.8 tt0 -66.1 -47.7 73.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.13 -0.981 . . . . 0.0 111.284 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.9 -53.4 58.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.64 -1.288 . . . . 0.0 111.34 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -57.16 -15.48 5.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.924 -1.11 . . . . 0.0 109.702 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -74.86 -30.07 60.06 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -101.71 146.23 28.03 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.318 -1.107 . . . . 0.0 108.594 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 24.3 p -89.79 -12.83 38.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.916 -1.115 . . . . 0.0 110.218 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.493 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 23.2 t -55.2 148.2 14.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.122 -0.986 . . . . 0.0 109.577 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -70.24 128.87 37.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.223 -0.923 . . . . 0.0 108.523 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.7 mt -131.48 131.15 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.568 -0.708 . . . . 0.0 109.817 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 334' ' ' THR . . . . . 0.421 HG22 ' N ' ' B' ' 335' ' ' VAL . 89.4 m -130.39 154.48 47.65 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.548 -0.72 . . . . 0.0 109.531 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 335' ' ' VAL . . . . . 0.421 ' N ' HG22 ' B' ' 334' ' ' THR . 56.1 t -116.44 137.87 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 91.3 m -129.11 126.42 39.3 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.107 -0.995 . . . . 0.0 108.898 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 49.4 p -139.94 114.4 9.24 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.128 -0.983 . . . . 0.0 111.678 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 46.76 52.95 10.79 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 176.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.94 -13.92 63.31 Favored Glycine 0 N--CA 1.502 3.094 0 O-C-N 119.992 -1.692 . . . . 0.0 112.776 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -119.89 131.42 55.24 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-N 119.13 1.465 . . . . 0.0 109.86 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 89.4 p -132.0 151.5 51.7 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.776 0.798 . . . . 0.0 110.332 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.3 169.84 17.13 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.479 0.657 . . . . 0.0 109.929 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 3.6 t -91.63 140.11 30.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.342 -0.849 . . . . 0.0 110.707 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.47 ' HA ' HD11 ' B' ' 350' ' ' LEU . . . -79.47 -16.01 56.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 0.0 109.798 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -84.05 16.02 3.13 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 346' ' ' SER . . . . . 0.419 ' H ' ' C ' ' B' ' 344' ' ' ALA . 93.4 p -149.99 95.7 2.33 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.048 0.928 . . . . 0.0 111.835 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.829 HD11 HE21 ' B' ' 351' ' ' GLN . 47.6 tp -60.17 -32.72 71.32 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.788 ' CE2' HD11 ' A' ' 79' ' ' LEU . 53.3 m-85 -54.61 -52.88 60.83 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.902 -1.124 . . . . 0.0 109.817 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -70.01 -39.89 75.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.246 -0.909 . . . . 0.0 110.549 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' B' ' 352' ' ' THR . 88.9 mt -49.93 -59.69 3.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.888 -1.132 . . . . 0.0 109.578 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.829 HE21 HD11 ' B' ' 347' ' ' LEU . 87.5 mm-40 -42.21 -10.23 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.779 -0.575 . . . . 0.0 112.074 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.603 ' N ' ' O ' ' B' ' 350' ' ' LEU . 60.1 p -88.04 -5.07 58.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.336 -1.477 . . . . 0.0 109.48 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 91.4 mt -96.83 116.76 29.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.344 -0.848 . . . . 0.0 109.074 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.63 96.11 1.14 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 31.1 mt -106.17 96.81 6.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.342 -1.093 . . . . 0.0 109.634 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 21.4 p -97.55 159.64 14.8 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.942 -1.099 . . . . 0.0 110.687 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -52.81 119.29 4.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.691 -0.631 . . . . 0.0 110.66 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 101.51 4.07 52.86 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 63.2 m -87.52 111.25 21.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.454 -1.027 . . . . 0.0 111.093 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 45.2 t -77.12 117.74 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 122.291 1.044 . . . . 0.0 109.448 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 30.3 m -112.11 177.14 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 42.0 m -130.76 129.01 41.92 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 88.5 mt -104.7 122.36 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 69.6 m -126.95 135.98 51.65 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.63 156.21 42.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.199 -0.938 . . . . 0.0 109.527 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -147.95 124.57 11.1 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 159.15 -157.09 28.18 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.629 -1.748 . . . . 0.0 111.848 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -59.95 -55.06 38.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 122.249 -0.56 . . . . 0.0 111.995 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.493 ' H ' ' HB2' ' B' ' 331' ' ' SER . 95.9 m-20 -108.8 10.16 26.71 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.037 -1.039 . . . . 0.0 111.416 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.487 ' OE2' ' NE2' ' B' ' 371' ' ' GLN . 0.6 OUTLIER -43.97 -30.6 0.74 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.979 -1.075 . . . . 0.0 110.618 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 371' ' ' GLN . . . . . 0.487 ' NE2' ' OE2' ' B' ' 370' ' ' GLU . 92.1 mm-40 -70.04 -41.0 74.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.053 -1.029 . . . . 0.0 109.541 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -67.98 -49.45 61.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.128 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.78 -76.75 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.448 -0.783 . . . . 0.0 111.258 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.543 ' O ' HG23 ' B' ' 378' ' ' VAL . 46.3 t -45.31 -37.32 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 120.923 -1.111 . . . . 0.0 110.763 -177.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.73 -43.15 80.63 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.505 -1.372 . . . . 0.0 109.974 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -85.34 -43.18 13.91 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.751 -1.218 . . . . 0.0 110.09 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 84.9 mt -57.22 -38.17 73.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.95 -1.094 . . . . 0.0 108.919 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.543 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.5 t -66.78 -40.04 85.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.671 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -80.47 -10.08 59.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.67 -1.269 . . . . 0.0 109.727 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.485 HD22 ' OE1' ' B' ' 325' ' ' GLU . 57.2 tp -83.6 -26.78 29.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.654 -1.279 . . . . 0.0 108.08 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 18.3 tpp -80.64 -24.66 38.84 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -85.21 -9.57 57.63 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.767 -0.583 . . . . 0.0 109.736 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -110.6 -2.19 16.5 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.29 -0.881 . . . . 0.0 110.496 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 25.0 mt -91.45 119.63 31.59 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.82 -1.175 . . . . 0.0 109.334 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.498 1.94 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.019 179.751 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.616 -0.512 . . . . 2.91 109.616 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.5 mt -110.0 129.02 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.806 -0.813 . . . . 1.2 108.806 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -132.5 134.84 45.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.444 -0.785 . . . . 1.4 108.985 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.67 -163.11 19.57 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 108.723 -1.751 . . . . 1.05 108.723 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.498 ' CG2' ' HE ' ' A' ' 186' ' ' ARG . 96.9 mt -90.93 -10.38 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.033 -1.275 . . . . 1.15 109.891 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.4 tp 54.92 98.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.076 -1.015 . . . . 0.98 109.194 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.85 -36.65 62.35 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.565 -0.71 . . . . 0.88 109.5 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -149.75 144.46 17.77 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.135 -0.978 . . . . 1.69 109.949 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -80.05 140.93 14.48 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.693 2.262 . . . . 0.85 113.145 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.812 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 164.94 -163.93 36.72 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 109.468 -1.453 . . . . 0.92 109.468 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -149.98 150.0 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 121.12 -1.224 . . . . 0.81 108.784 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.73 155.74 33.65 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.813 -1.179 . . . . 0.51 110.682 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.8 m-85 -137.5 128.53 27.5 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.407 -0.96 . . . . 0.62 108.407 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.09 -179.92 46.92 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 118.814 -1.66 . . . . 0.55 110.769 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -79.9 157.33 26.95 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.734 -0.863 . . . . 2.1 108.97 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -101.02 129.49 46.87 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.434 -0.791 . . . . 0.77 111.157 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.5 tp -97.31 134.29 40.8 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 106.951 -1.5 . . . . 0.91 106.951 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.9 tp -118.71 122.17 41.85 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.333 -0.855 . . . . 0.93 110.836 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.9 mt -100.37 110.36 22.57 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.832 -0.543 . . . . 0.93 110.886 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -114.57 143.84 44.35 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.525 -0.734 . . . . 2.75 109.272 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.434 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 49.9 mp0 -127.93 130.72 48.94 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.34 -0.85 . . . . 3.0 108.99 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -72.47 144.3 48.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 2.77 109.492 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -61.74 140.36 58.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.304 -0.872 . . . . 2.94 108.972 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.4 mt -79.6 131.95 33.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.224 -0.922 . . . . 0.95 108.786 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.93 123.7 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.25 -0.906 . . . . 1.28 109.485 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -105.67 136.44 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.642 -0.874 . . . . 1.21 108.642 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -90.97 128.36 36.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.033 -1.042 . . . . 1.81 110.552 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.419 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.0 mmm-85 -92.57 7.37 43.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.639 -0.663 . . . . 2.8 109.316 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.55 145.27 54.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 2.87 109.744 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -87.86 139.45 30.5 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.386 -0.821 . . . . 2.35 109.267 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -90.59 163.62 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.896 -1.128 . . . . 0.97 109.899 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.7 p -94.52 169.15 10.4 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.244 -0.91 . . . . 1.17 108.939 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.75 -17.91 63.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.278 -0.889 . . . . 1.18 110.603 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -84.33 -28.45 27.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.688 -1.258 . . . . 2.56 108.094 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -82.07 -8.97 59.68 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.094 -0.706 . . . . 1.79 109.094 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.2 t -65.51 -54.73 25.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 120.916 -1.115 . . . . 1.0 108.571 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -59.97 -40.0 87.6 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.286 -0.884 . . . . 1.77 109.655 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -69.25 -41.84 76.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.228 -0.92 . . . . 2.7 110.684 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -63.33 -40.05 96.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.892 -1.13 . . . . 1.51 110.165 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.23 -46.82 95.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.785 -1.197 . . . . 0.93 108.153 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.26 -44.69 95.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.374 -0.829 . . . . 1.81 109.586 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.01 -43.15 95.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.942 -1.099 . . . . 2.78 108.281 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.422 ' CZ ' HD13 ' A' ' 89' ' ' ILE . 91.0 t80 -64.05 -46.06 86.07 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.345 -0.847 . . . . 0.78 108.902 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.04 -48.34 82.11 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.562 -0.903 . . . . 1.07 108.562 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -64.85 -42.79 94.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.183 -0.948 . . . . 1.12 108.551 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.88 -47.46 88.69 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.478 -1.849 . . . . 0.84 108.478 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -63.79 -37.97 89.35 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.076 -1.083 . . . . 3.09 108.076 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.14 -39.99 70.08 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.562 -0.903 . . . . 0.88 108.562 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 50' ' ' ALA . 31.9 ttpt -61.17 -74.06 0.09 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.655 -1.239 . . . . 2.59 107.655 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.18 -33.18 0.05 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.304 -0.872 . . . . 0.7 111.912 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.2 m -60.02 -50.3 74.29 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.385 -1.447 . . . . 1.4 108.603 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.15 75.85 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.412 -0.805 . . . . 0.67 110.943 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -66.6 -40.0 88.66 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.802 -1.186 . . . . 1.66 110.442 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.87 -40.11 95.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.951 -1.093 . . . . 1.58 109.595 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -60.04 -36.13 76.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 1.35 109.557 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.0 -42.28 98.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -0.977 . . . . 0.77 109.678 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.31 -39.99 87.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.401 -0.812 . . . . 0.63 109.714 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -54.64 -51.59 64.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.264 -0.897 . . . . 1.14 110.123 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -59.7 -34.57 73.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.79 110.791 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -67.13 -39.58 86.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.087 -1.008 . . . . 1.53 109.877 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.18 -42.42 96.71 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.607 -0.683 . . . . 0.57 109.527 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.21 -55.64 29.57 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.926 -1.269 . . . . 0.75 109.926 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.75 -48.09 70.21 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.885 -1.362 . . . . 1.59 109.656 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.6 m -62.84 -65.08 0.74 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 0.73 112.17 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -96.45 -48.74 5.44 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.717 -1.24 . . . . 0.75 111.357 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.76 -168.67 25.51 Favored Glycine 0 N--CA 1.502 3.075 0 C-N-CA 119.536 -1.316 . . . . 1.22 111.436 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -70.04 -26.29 63.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.993 -0.71 . . . . 5.81 110.695 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.486 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 52.8 tp10 -61.4 -35.25 76.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.309 -0.869 . . . . 3.37 110.679 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.45 ' HA ' HD12 ' A' ' 72' ' ' ILE . 40.9 mmtm -98.95 -20.8 16.59 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.175 -0.953 . . . . 1.77 109.984 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -70.03 -40.25 75.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.149 -0.97 . . . . 1.65 110.589 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.489 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.54 -31.71 72.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 0.77 109.788 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 69' ' ' LYS . 95.7 mt -59.97 -40.65 83.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.17 -0.956 . . . . 0.8 109.07 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -62.67 -40.91 98.55 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.131 -0.981 . . . . 0.88 109.503 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.518 ' CD ' ' NZ ' ' B' ' 324' ' ' LYS . 66.5 tt0 -63.32 -39.88 95.79 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.715 -0.794 . . . . 1.37 109.834 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.78 98.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.757 -1.737 . . . . 0.62 108.757 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -67.73 -42.26 82.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.386 -1.067 . . . . 1.5 109.4 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.1 mt -66.86 -46.37 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.209 -0.932 . . . . 0.63 109.106 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.8 ttp -60.09 -44.26 94.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.144 -0.973 . . . . 1.51 110.129 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.838 HD11 ' CE2' ' B' ' 348' ' ' PHE . 44.9 tp -59.95 -40.13 87.96 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.172 -0.955 . . . . 0.77 108.909 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.6 -39.23 93.35 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.868 -0.52 . . . . 0.62 110.231 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -81.86 2.39 30.55 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.073 -1.017 . . . . 1.47 111.082 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -48.81 125.96 11.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.777 -1.202 . . . . 1.47 109.056 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.1 -15.33 22.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.259 -0.901 . . . . 1.78 110.259 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -72.0 -35.03 69.32 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.987 -1.07 . . . . 2.53 108.61 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.03 -40.79 74.98 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.363 0.602 . . . . 0.8 110.05 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.28 -43.76 95.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 1.42 109.774 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -70.05 -41.62 73.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.547 -0.721 . . . . 1.71 111.17 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.02 -40.11 75.42 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.905 -1.122 . . . . 1.57 111.301 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.422 HD13 ' CZ ' ' A' ' 43' ' ' PHE . 72.5 mt -64.9 -49.41 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.113 -0.992 . . . . 0.65 109.561 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.41 -39.49 78.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.798 -0.564 . . . . 0.82 110.572 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.81 84.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.016 . . . . 0.79 110.821 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.07 -45.16 93.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.973 -1.079 . . . . 0.95 109.707 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.8 mt -61.37 -49.94 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.092 -1.005 . . . . 0.66 108.599 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -64.58 -41.41 96.3 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 120.067 -0.653 . . . . 2.2 110.157 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -80.14 -56.3 4.32 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.992 -1.068 . . . . 1.65 112.177 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -90.54 -2.47 57.9 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.103 -0.998 . . . . 2.03 112.677 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 57.5 39.65 27.73 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.693 -1.254 . . . . 1.42 109.585 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.7 mtp -92.11 169.22 10.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.545 -0.722 . . . . 1.18 109.82 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 42.9 p -83.37 160.63 21.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.362 -0.836 . . . . 0.98 109.412 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.56 88.55 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.499 -0.751 . . . . 0.64 110.335 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 32.7 p-10 -69.8 -35.91 75.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.189 -0.944 . . . . 2.07 109.627 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.432 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.5 -44.09 19.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.73 110.124 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.43 -44.97 70.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -0.963 . . . . 0.54 109.974 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.1 -39.39 85.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.134 -0.979 . . . . 0.56 109.655 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.525 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 85.5 t60 -59.93 -41.33 91.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.315 -0.866 . . . . 1.54 110.037 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.17 -39.92 86.53 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.142 -0.974 . . . . 1.33 111.214 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.3 t -58.24 -58.08 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.03 -1.044 . . . . 0.72 111.218 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.2 mm -70.1 -40.0 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.946 -1.097 . . . . 0.85 109.417 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.525 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 87.7 tt0 -60.41 -39.98 89.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 2.44 109.144 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.09 -50.13 71.05 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.432 -1.067 . . . . 0.98 110.432 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -61.12 -50.63 72.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.911 -1.347 . . . . 1.41 109.826 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.6 83.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.323 -0.861 . . . . 1.2 110.521 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.8 m -59.66 -39.97 86.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.892 -1.13 . . . . 1.7 108.781 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.66 -40.0 93.37 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.227 -0.92 . . . . 1.47 108.94 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.7 mt -61.19 -42.67 98.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.977 . . . . 1.56 109.47 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -55.15 -32.45 62.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.046 -1.034 . . . . 2.2 109.433 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -59.99 -23.61 63.79 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.192 -0.943 . . . . 2.12 108.93 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.414 HD13 HD13 ' A' ' 123' ' ' LEU . 58.2 mt -62.08 140.02 58.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.97 . . . . 2.0 109.02 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.7 p-10 -91.4 41.43 1.07 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.194 -0.941 . . . . 3.23 110.404 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 40.6 t0 -134.88 145.28 48.12 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.208 -0.932 . . . . 2.49 109.565 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.524 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 97.5 mt-10 -72.99 -64.7 0.92 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.439 -0.788 . . . . 3.95 109.045 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.453 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 4.1 t80 -38.55 -40.13 0.54 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.905 -0.497 . . . . 2.0 110.684 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.414 HD13 HD13 ' A' ' 118' ' ' LEU . 91.1 mt -72.44 -39.97 67.42 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.78 -1.2 . . . . 1.86 108.427 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 121' ' ' GLU . 19.9 ttpp -64.98 -40.87 95.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.485 -0.76 . . . . 2.84 109.058 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 94.8 mt-10 -62.53 -42.55 99.59 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.172 -1.047 . . . . 2.73 108.172 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.516 ' NH2' ' CB ' ' B' ' 319' ' ' ALA . 57.7 ttt180 -60.13 -40.02 88.33 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.923 -1.139 . . . . 2.77 107.923 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.73 -25.85 68.39 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.727 -0.842 . . . . 1.19 108.727 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -60.75 -41.07 94.67 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.168 -1.049 . . . . 1.2 108.168 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.18 -40.1 90.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.49 -0.756 . . . . 1.55 109.637 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.428 ' CG2' HE22 ' B' ' 351' ' ' GLN . 56.0 t -63.0 -41.37 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.132 -0.98 . . . . 0.8 109.469 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -63.06 -39.83 95.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.152 -0.967 . . . . 3.09 109.398 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -60.19 -40.55 90.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.363 -0.836 . . . . 1.46 110.393 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 98.3 mt -60.01 -45.77 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.098 -1.001 . . . . 0.71 110.382 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.94 -34.89 55.13 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.826 -1.31 . . . . 0.57 109.826 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.464 ' NZ ' HH21 ' A' ' 139' ' ' ARG . 24.8 tptp -59.99 -49.54 77.29 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.4 -1.059 . . . . 2.59 109.658 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -64.74 -33.57 76.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.917 -1.114 . . . . 2.83 109.793 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.2 tp -59.98 -41.02 91.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.363 -0.836 . . . . 1.25 109.094 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.44 -39.99 89.49 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.258 -0.901 . . . . 0.7 108.698 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.464 HH21 ' NZ ' ' A' ' 135' ' ' LYS . 98.8 mtt180 -67.06 -39.93 87.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.491 -0.756 . . . . 2.57 109.429 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -70.2 -25.68 63.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.45 -0.781 . . . . 1.23 111.64 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.3 mt -70.28 -40.09 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.211 -1.556 . . . . 0.81 109.008 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.6 mt -82.34 -26.83 32.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.459 -0.775 . . . . 1.0 110.202 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.95 47.61 5.22 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.034 -1.626 . . . . 0.89 109.034 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.1 tp -74.29 145.48 43.95 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.381 -1.07 . . . . 1.14 109.448 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.24 137.19 58.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 4.6 109.584 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.0 mt -113.97 130.03 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-O 121.975 0.893 . . . . 1.24 109.283 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.51 -42.2 94.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.769 -0.582 . . . . 1.54 110.366 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.6 t0 68.22 91.97 0.09 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.49 -0.756 . . . . 1.5 109.011 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.7 mt -64.08 -6.64 6.77 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.515 -0.741 . . . . 0.79 111.231 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.5 m -82.82 -14.74 53.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.651 -1.281 . . . . 1.4 110.069 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.41 30.91 0.4 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.108 -0.995 . . . . 0.92 112.133 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 41.9 mm -90.31 121.19 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 120.485 -1.384 . . . . 0.88 109.205 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -103.06 -12.54 17.34 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.337 -0.852 . . . . 2.45 110.537 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -128.37 152.09 48.58 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.077 -1.015 . . . . 1.52 110.46 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.32 137.0 57.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.497 -0.752 . . . . 1.58 109.402 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.5 m -152.54 164.38 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.943 -0.762 . . . . 0.69 108.943 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -93.77 146.49 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.486 -1.672 . . . . 0.61 106.486 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.5 tp -94.56 114.59 26.58 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.18 -0.95 . . . . 0.87 110.679 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.523 ' CG1' HG22 ' A' ' 209' ' ' THR . 49.6 t -120.03 127.12 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 108.042 -1.095 . . . . 0.71 108.042 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.05 160.0 40.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.168 -0.958 . . . . 0.81 108.999 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.462 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -76.43 -30.09 57.26 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.266 -1.521 . . . . 0.98 107.872 178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 57.2 t0 -170.05 134.09 1.23 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.334 -0.854 . . . . 2.25 108.894 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.445 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 81.8 mt -111.22 125.02 53.37 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.217 -0.927 . . . . 0.78 108.905 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 51.9 p -83.83 146.6 49.66 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.98 109.292 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -39.91 -37.15 1.52 Allowed 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.298 1.998 . . . . 0.81 113.235 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.6 m -59.99 -41.04 91.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.069 -1.019 . . . . 0.9 109.699 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.13 -40.66 71.27 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.222 -0.924 . . . . 1.61 110.342 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.1 p -53.12 -29.88 33.41 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.015 -1.053 . . . . 0.61 111.447 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -76.46 -56.82 4.28 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.754 -1.216 . . . . 0.6 110.327 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -77.12 37.04 0.19 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.36 -0.978 . . . . 1.4 108.36 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.491 ' H ' ' C ' ' A' ' 169' ' ' ALA . 58.6 tp -102.06 137.32 40.5 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.369 -0.604 . . . . 0.7 109.369 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.461 ' O ' HG23 ' A' ' 176' ' ' VAL . 18.2 m120 -82.76 101.08 10.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.163 -0.96 . . . . 2.35 109.239 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 99.5 mt -66.19 -41.98 89.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.167 -0.958 . . . . 1.51 110.719 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -65.92 -28.82 69.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.857 -1.152 . . . . 2.33 111.568 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -92.52 -8.26 45.01 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.778 -1.201 . . . . 1.92 110.133 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 172' ' ' ASN . 94.3 t -101.8 112.18 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.28 -1.008 . . . . 0.67 108.28 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.03 5.15 30.62 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.28 -0.888 . . . . 1.53 110.709 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.435 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.97 173.38 38.04 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.309 -1.517 . . . . 0.48 109.309 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.448 ' CE1' HG11 ' A' ' 176' ' ' VAL . 15.4 m-85 -132.08 129.61 40.19 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.467 -1.02 . . . . 0.55 109.186 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.2 mt -134.12 127.09 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.372 -0.83 . . . . 0.65 108.943 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.5 p -149.78 160.26 43.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.982 -1.074 . . . . 0.82 110.387 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 20.1 p-10 -102.41 23.02 12.44 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.411 -0.806 . . . . 2.46 109.458 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -52.68 -165.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.081 -1.012 . . . . 1.28 111.951 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -75.52 -54.31 5.57 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.869 -0.892 . . . . 2.19 110.869 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 173.61 -140.28 5.47 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.053 -1.546 . . . . 2.13 110.824 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.498 ' HE ' ' CG2' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -65.55 -34.14 77.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.634 -0.921 . . . . 5.86 111.159 -178.854 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 12.9 p -59.95 4.24 0.05 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.942 -1.099 . . . . 3.72 110.879 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.497 ' H ' ' C ' ' A' ' 186' ' ' ARG . 17.1 m -91.93 131.66 37.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.771 -1.205 . . . . 1.74 110.29 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -47.26 -37.58 10.86 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.827 -1.175 . . . . 0.95 107.827 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.412 ' H ' HG23 ' A' ' 190' ' ' THR . 7.4 p -57.7 -41.85 82.51 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.546 -0.752 . . . . 1.55 110.368 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 75.4 m -61.38 -40.08 93.04 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.158 -0.964 . . . . 1.51 111.518 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.91 -40.48 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.114 -0.991 . . . . 1.67 109.548 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 76.9 mtp -58.89 -49.53 77.43 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.353 -0.842 . . . . 1.02 109.94 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.33 -47.05 62.8 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.961 -1.087 . . . . 0.68 110.024 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -62.53 -57.97 9.24 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 118.565 -1.254 . . . . 2.93 109.957 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.1 m -61.24 -40.01 92.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.048 -1.033 . . . . 0.86 111.657 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.96 -23.69 62.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.887 -1.133 . . . . 0.67 109.824 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 64.9 47.81 2.53 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.444 0.64 . . . . 1.5 109.547 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 86.0 mt -126.95 150.05 70.79 Favored Pre-proline 0 N--CA 1.501 2.103 0 N-CA-C 108.568 -0.901 . . . . 0.72 108.568 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.56 141.58 74.03 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.213 1.942 . . . . 0.61 111.67 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.58 153.82 3.56 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.797 -1.161 . . . . 0.66 111.518 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.8 mt -128.08 139.47 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.818 -1.179 . . . . 0.79 107.818 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.5 m -121.83 -11.31 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 120.959 -1.088 . . . . 0.91 111.362 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.1 26.42 15.32 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 110.465 -1.054 . . . . 1.01 110.465 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.8 p -46.42 -42.21 14.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.102 -1.234 . . . . 0.99 109.841 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.59 -54.04 4.1 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 120.125 -1.036 . . . . 1.12 111.104 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 84.9 p -152.58 28.41 0.55 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.556 -1.555 . . . . 1.72 111.567 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 73.0 t -74.03 -40.71 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.666 -1.271 . . . . 0.89 109.136 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.523 HG22 ' CG1' ' A' ' 159' ' ' VAL . 7.7 p -60.95 -30.87 70.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.102 -0.999 . . . . 1.03 110.5 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 79.3 p -79.97 -10.94 59.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.981 -1.074 . . . . 1.83 109.363 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -105.14 -10.92 16.82 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.569 -0.707 . . . . 2.27 109.948 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 79.8 t -101.64 139.99 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.407 -0.808 . . . . 0.92 109.957 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.68 145.89 38.45 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.393 -1.336 . . . . 2.2 107.393 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.476 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 10.4 p30 -54.78 138.2 42.9 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.016 -1.053 . . . . 2.36 110.42 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.3 m-20 86.81 3.66 0.43 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 120.988 0.423 . . . . 2.38 110.434 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -76.26 150.39 37.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.015 -1.053 . . . . 2.09 109.156 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -99.43 119.84 38.64 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.261 -1.015 . . . . 1.27 108.261 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 67.8 mt -126.57 148.51 49.74 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.398 -0.814 . . . . 0.75 110.782 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.8 mt -115.59 128.3 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 107.502 -1.296 . . . . 0.63 107.502 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.0 tp -100.7 118.19 36.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.122 -0.986 . . . . 0.7 109.432 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 10' ' ' GLY . 94.7 m-20 -77.15 -43.2 34.83 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.213 -0.929 . . . . 2.31 108.557 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.89 17.64 0.67 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.857 -1.164 . . . . 0.78 107.857 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.441 ' N ' ' C ' ' A' ' 221' ' ' ASP . 56.4 t -136.05 -36.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.942 -1.133 . . . . 1.04 107.942 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -105.51 3.44 29.43 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.845 -1.169 . . . . 2.44 107.845 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 60.54 43.67 12.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.822 -0.549 . . . . 1.55 111.259 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -150.0 152.78 35.45 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.723 -1.236 . . . . 1.99 110.314 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 91.1 t -119.94 123.38 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 109.043 -0.725 . . . . 0.77 109.043 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -84.62 128.19 34.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.011 -1.055 . . . . 0.98 109.221 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.18 116.62 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.472 -0.768 . . . . 0.85 109.152 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 62.32 67.48 1.2 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 1.66 109.989 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -87.05 131.1 3.08 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 123.048 2.498 . . . . 0.95 112.375 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.464 HG22 ' N ' ' A' ' 233' ' ' ASN . 25.3 m -68.56 163.85 22.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 1.84 109.59 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.464 ' N ' HG22 ' A' ' 232' ' ' THR . 43.0 t30 -59.93 -42.1 93.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.293 -0.879 . . . . 2.74 110.681 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.42 -33.6 72.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.818 -1.176 . . . . 2.89 109.335 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.77 -40.34 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.252 -0.905 . . . . 1.3 109.361 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.8 mt -65.36 -42.68 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.231 -0.918 . . . . 1.09 109.863 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -60.1 -42.09 93.95 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.111 -0.993 . . . . 2.43 109.564 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -64.16 -42.04 96.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.372 -0.83 . . . . 2.78 109.341 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 99.4 mtp -70.02 -32.6 70.84 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.393 -0.817 . . . . 1.25 109.772 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -67.4 -40.09 85.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.129 -0.982 . . . . 2.63 109.136 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.04 -40.83 82.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.341 -0.849 . . . . 1.8 109.469 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.22 -38.11 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 2.13 109.239 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -59.64 -40.06 86.38 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.351 -0.843 . . . . 3.17 109.372 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.84 -40.07 96.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.853 -1.154 . . . . 1.78 109.165 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -61.12 -36.04 78.68 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.482 -0.761 . . . . 2.47 109.552 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 79.1 t -60.02 -41.65 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.945 . . . . 2.09 109.055 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.93 88.84 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.295 -0.878 . . . . 2.54 108.896 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 7.0 p -81.62 -35.27 30.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 2.99 110.214 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -59.99 -44.74 94.31 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.204 -0.935 . . . . 3.34 111.13 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 252' ' ' GLU . 51.9 pttt -59.99 -42.69 94.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.809 -1.182 . . . . 3.88 109.716 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.416 ' N ' ' CG ' ' A' ' 250' ' ' LYS . . . 40.04 17.63 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.656 -0.652 . . . . 4.43 110.856 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 250' ' ' LYS . 87.6 tt0 -75.09 -25.04 58.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 5.42 110.064 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 254' ' ' ALA . 90.7 mt -52.75 -59.98 3.83 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.179 -0.951 . . . . 6.1 109.703 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 253' ' ' LEU . . . 175.17 78.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -0.858 . . . . 7.37 109.097 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -60.06 139.37 57.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.09 -1.006 . . . . 8.01 109.214 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 256' ' ' LEU . 8.6 mp -84.75 -1.93 56.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.9 . . . . 9.05 109.308 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -67.35 -55.47 13.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.03 -1.044 . . . . 10.56 109.38 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -156.79 92.27 1.27 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.327 -0.858 . . . . 11.32 109.364 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 118.033 -0.984 . . . . 12.42 109.918 179.895 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 43.3 ttm . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.468 0.652 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -149.23 144.97 26.87 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -150.76 160.0 44.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.874 -1.141 . . . . 0.0 110.787 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -154.64 149.57 26.75 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -117.66 134.68 54.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.252 -0.905 . . . . 0.0 109.629 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.8 129.97 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 CA-C-O 122.192 0.996 . . . . 0.0 112.356 -177.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 307' ' ' THR . . . . . 0.448 ' OG1' HG22 ' B' ' 360' ' ' VAL . 57.3 m -76.24 108.06 8.92 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.31 1.052 . . . . 0.0 110.958 -178.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 90.5 mt -53.82 120.93 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 122.413 1.102 . . . . 0.0 111.278 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 60.3 p -109.82 19.97 18.54 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.005 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.0 136.09 87.32 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.964 -1.085 . . . . 0.0 108.429 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -65.9 -21.82 56.79 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 CA-C-N 119.929 1.01 . . . . 0.0 112.609 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -121.99 15.24 10.78 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.417 -0.802 . . . . 0.0 108.931 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.19 -175.76 52.3 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.453 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -85.85 91.97 8.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.05 -1.265 . . . . 0.0 109.063 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -92.43 -162.8 0.96 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.831 -1.168 . . . . 0.0 109.969 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 16.0 m -58.56 -43.35 89.33 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.888 -1.133 . . . . 0.0 112.47 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.7 HH21 ' NE2' ' B' ' 321' ' ' GLN . 1.9 tpt180 -55.58 -61.07 6.82 Favored Pre-proline 0 N--CA 1.5 2.025 0 O-C-N 120.517 -1.364 . . . . 0.0 111.46 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -60.22 -36.79 86.92 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 CA-C-N 120.229 1.118 . . . . 0.0 111.939 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 319' ' ' ALA . . . . . 0.516 ' CB ' ' NH2' ' A' ' 126' ' ' ARG . . . -63.26 -16.82 61.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 0.0 109.357 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -82.46 -44.47 15.98 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 321' ' ' GLN . . . . . 0.7 ' NE2' HH21 ' B' ' 317' ' ' ARG . 95.4 mt-30 -72.48 -39.13 67.93 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -62.08 -54.55 39.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 110.302 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 323' ' ' VAL . . . . . 0.41 HG13 ' O ' ' B' ' 344' ' ' ALA . 52.7 t -63.82 -28.58 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.706 -1.246 . . . . 0.0 110.001 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.518 ' NZ ' ' CD ' ' A' ' 74' ' ' GLU . 11.7 ttmm -60.33 -45.69 92.55 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 109.818 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -62.33 -49.55 75.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.52 -0.738 . . . . 0.0 110.375 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.02 -54.03 50.88 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.054 -1.029 . . . . 0.0 111.468 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -53.86 -16.17 1.67 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.788 -1.195 . . . . 0.0 109.904 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.7 -25.16 75.84 Favored Glycine 0 N--CA 1.487 2.033 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -105.97 141.69 36.94 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.518 -0.989 . . . . 0.0 109.726 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 330' ' ' THR . . . . . 0.454 HG22 ' O ' ' B' ' 330' ' ' THR . 54.3 m -89.04 -10.04 48.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.237 -0.914 . . . . 0.0 109.242 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 26.8 m -62.36 150.96 38.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.084 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.86 133.47 49.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.061 -1.025 . . . . 0.0 109.086 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 87.1 mt -129.9 130.12 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.557 -0.714 . . . . 0.0 109.167 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 78.2 m -126.85 148.75 49.96 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.502 0.668 . . . . 0.0 109.287 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 48.3 t -114.07 139.55 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 28.7 m -130.18 121.28 25.94 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.173 -0.954 . . . . 0.0 109.046 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 31.0 t -138.5 115.11 10.58 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.888 0.851 . . . . 0.0 110.525 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 47.56 51.92 13.16 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.04 -14.55 48.63 Favored Glycine 0 N--CA 1.5 2.952 0 O-C-N 119.971 -1.705 . . . . 0.0 112.629 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -111.67 121.73 45.9 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 119.104 1.452 . . . . 0.0 110.222 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 39.1 m -106.57 156.31 18.72 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.719 0.771 . . . . 0.0 110.796 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 342' ' ' ALA . . . . . 0.44 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -152.47 152.66 32.22 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.427 0.632 . . . . 0.0 110.036 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 8.6 t -87.99 131.42 34.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.303 -0.873 . . . . 0.0 109.686 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.41 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -70.83 -16.21 62.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.093 -1.005 . . . . 0.0 109.771 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 345' ' ' LYS . . . . . 0.422 ' HG2' ' H ' ' B' ' 345' ' ' LYS . 12.6 ptmt -86.83 21.08 2.35 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 10.7 t -150.8 98.53 2.62 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.18 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.828 HD23 HD22 ' A' ' 79' ' ' LEU . 19.3 tp -60.06 -30.6 69.31 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.838 ' CE2' HD11 ' A' ' 79' ' ' LEU . 63.2 m-85 -58.09 -54.36 47.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.414 -0.804 . . . . 0.0 110.718 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -68.28 -40.06 81.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.885 -1.134 . . . . 0.0 109.509 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.59 ' O ' ' N ' ' B' ' 352' ' ' THR . 30.9 mt -49.87 -56.99 8.37 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.934 -1.104 . . . . 0.0 108.102 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.428 HE22 ' CG2' ' A' ' 130' ' ' VAL . 28.6 mt-30 -40.23 -13.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.044 -0.41 . . . . 0.0 111.799 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.59 ' N ' ' O ' ' B' ' 350' ' ' LEU . 77.0 p -93.99 -13.21 27.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.451 -1.406 . . . . 0.0 110.613 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' B' ' 342' ' ' ALA . 63.3 mt -90.54 118.89 30.35 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.847 -1.158 . . . . 0.0 109.077 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.8 90.95 0.67 Allowed Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 20.8 mt -96.77 84.69 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -1.168 . . . . 0.0 108.265 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 30.7 p -88.29 174.3 8.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.431 -0.793 . . . . 0.0 110.566 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -69.16 114.71 7.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.532 -0.73 . . . . 0.0 110.891 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.98 8.94 38.25 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 28.7 m -93.58 111.08 22.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -1.167 . . . . 0.0 110.921 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 360' ' ' VAL . . . . . 0.448 HG22 ' OG1' ' B' ' 307' ' ' THR . 11.2 t -77.25 120.23 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 122.141 0.972 . . . . 0.0 109.773 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 18.3 m -112.51 177.32 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 62.0 m -131.37 129.57 41.53 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 77.0 mt -104.53 117.46 50.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 96.8 p -126.27 136.75 53.16 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.426 -0.796 . . . . 0.0 109.593 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.23 154.02 40.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.395 -0.816 . . . . 0.0 109.886 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -142.99 122.47 13.17 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.494 ' O ' ' OE1' ' B' ' 370' ' ' GLU . . . 162.23 -160.24 32.39 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 118.689 -1.72 . . . . 0.0 111.81 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 368' ' ' GLU . . . . . 0.471 ' N ' ' OG ' ' B' ' 331' ' ' SER . 52.2 tp10 -59.97 -50.08 75.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.145 -0.621 . . . . 0.0 112.322 -177.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.491 ' N ' ' OG ' ' B' ' 331' ' ' SER . 49.5 m-20 -113.3 12.8 18.98 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.869 -1.144 . . . . 0.0 111.592 -177.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.584 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 1.1 pm0 -43.09 -27.86 0.24 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.177 -0.952 . . . . 0.0 110.351 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 371' ' ' GLN . . . . . 0.489 ' N ' ' CD ' ' B' ' 370' ' ' GLU . 4.4 pt20 -70.08 -42.37 72.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 0.0 109.84 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -65.17 -48.38 73.7 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.203 -0.936 . . . . 0.0 108.918 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.23 -76.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.401 -0.812 . . . . 0.0 110.859 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.462 ' O ' HG23 ' B' ' 378' ' ' VAL . 59.6 t -46.0 -37.41 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.0 -1.062 . . . . 0.0 110.817 -177.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.34 -49.28 74.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.595 -1.316 . . . . 0.0 110.446 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -77.55 -43.59 31.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.004 -1.06 . . . . 0.0 110.521 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 44.5 mt -60.63 -39.73 89.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -0.893 . . . . 0.0 110.197 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.462 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.7 t -64.34 -39.99 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.958 -1.089 . . . . 0.0 109.291 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -70.01 -56.55 6.68 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.768 -1.208 . . . . 0.0 107.859 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 64.5 tp -58.01 -28.38 64.38 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.449 -0.782 . . . . 0.0 111.33 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 381' ' ' MET . . . . . 0.517 ' SD ' ' O ' ' B' ' 381' ' ' MET . 0.0 OUTLIER -73.67 -38.13 65.03 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.104 -1.623 . . . . 0.0 108.382 178.24 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.7 -4.52 54.69 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 110.321 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -111.37 -1.91 15.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.158 -0.964 . . . . 0.0 111.075 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 384' ' ' LEU . . . . . 0.427 ' CD2' ' OE1' ' B' ' 321' ' ' GLN . 23.8 mt -89.16 127.4 35.73 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.332 -1.48 . . . . 0.0 110.179 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 117.974 -1.012 . . . . 0.0 108.75 179.049 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.088 0.471 . . . . 2.91 109.884 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 94.5 mt -106.94 120.02 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.442 -0.786 . . . . 1.2 109.108 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.418 ' HB3' HD22 ' A' ' 225' ' ' ASN . 28.8 m -132.42 134.97 45.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.503 -0.748 . . . . 1.4 109.392 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.34 -162.01 11.84 Favored Glycine 0 N--CA 1.501 2.99 0 N-CA-C 108.872 -1.691 . . . . 1.05 108.872 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.468 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.5 mt -89.4 -18.46 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.938 -1.331 . . . . 1.15 110.249 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 5' ' ' ILE . 62.7 tp 54.68 105.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.369 -0.832 . . . . 0.98 108.849 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.15 -24.1 14.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.132 -0.98 . . . . 0.88 109.338 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 19.5 t -138.33 124.74 12.91 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.446 -0.784 . . . . 1.69 109.81 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.65 145.18 16.12 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.974 1.783 . . . . 0.85 112.122 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.805 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 158.03 -158.83 29.49 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.481 -1.448 . . . . 0.92 109.481 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.7 mt -149.68 150.81 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.169 -1.194 . . . . 0.81 108.661 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.44 155.47 33.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.073 -1.017 . . . . 0.51 110.168 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.2 m-85 -136.58 129.56 31.02 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.679 -1.23 . . . . 0.62 107.679 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.29 -178.76 47.62 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 118.349 -1.881 . . . . 0.55 110.951 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -79.96 157.09 26.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.814 -0.815 . . . . 2.1 109.53 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.434 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -102.82 129.19 49.4 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.363 -0.836 . . . . 0.77 111.108 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.0 tp -99.66 131.05 45.9 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.629 -1.249 . . . . 0.91 107.629 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.5 tp -111.21 120.09 41.11 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.08 -1.012 . . . . 0.93 109.5 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 160' ' ' ALA . 35.7 mt -85.51 104.04 14.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.55 -0.718 . . . . 0.93 109.467 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -93.19 135.48 34.34 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.7 -0.852 . . . . 2.75 108.7 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.01 118.45 20.62 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.686 -0.857 . . . . 3.0 108.686 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -76.7 141.64 40.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.102 -0.998 . . . . 2.77 109.448 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -60.06 140.07 57.07 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.325 -0.859 . . . . 2.94 108.774 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 84.8 mt -77.76 135.24 26.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.556 -0.905 . . . . 0.95 108.556 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.7 t -100.6 122.63 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.271 -0.893 . . . . 1.28 109.878 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.1 mt -95.43 141.86 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.969 -0.752 . . . . 1.21 108.969 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -97.67 119.44 36.24 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.171 -0.956 . . . . 1.81 109.491 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -94.47 3.24 55.4 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.282 -0.886 . . . . 2.8 109.467 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -59.97 139.98 57.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.419 -0.801 . . . . 2.87 109.908 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -93.07 144.94 24.78 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.158 -0.963 . . . . 2.35 108.597 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 pt -103.17 166.92 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.121 -0.987 . . . . 0.97 110.863 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.9 p -96.9 177.63 5.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.349 -0.844 . . . . 1.17 109.332 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.08 -49.9 75.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.452 -0.78 . . . . 1.18 110.877 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -58.06 -29.81 65.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.525 -1.359 . . . . 2.56 109.991 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -81.56 -11.44 59.16 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.147 -0.97 . . . . 1.79 110.242 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.7 t -60.04 -50.03 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.861 -1.149 . . . . 1.0 108.729 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -61.22 -39.96 92.21 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.479 -0.763 . . . . 1.77 109.347 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -64.14 -43.45 95.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.411 -0.806 . . . . 2.7 111.274 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -63.56 -41.11 98.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.74 -1.225 . . . . 1.51 110.168 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.04 -46.08 94.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 118.709 -1.196 . . . . 0.93 108.794 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -60.03 -42.33 94.15 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.068 -1.02 . . . . 1.81 109.382 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.484 HH11 ' HG2' ' A' ' 42' ' ' ARG . 25.1 mtt-85 -60.06 -44.66 94.56 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.937 -1.134 . . . . 2.78 107.937 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -60.18 -45.76 92.03 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.393 -0.966 . . . . 0.78 108.393 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.98 -49.82 76.15 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.801 -0.815 . . . . 1.07 108.801 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.505 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 28.8 t -60.05 -42.2 93.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.048 -1.032 . . . . 1.12 109.174 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.0 -42.55 98.41 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.191 -1.964 . . . . 0.84 108.191 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.1 ttm-85 -60.07 -32.97 71.43 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.225 -1.028 . . . . 3.09 108.225 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.9 -40.09 83.44 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.743 -0.598 . . . . 0.88 109.631 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 50' ' ' ALA . 12.1 ttmt -75.16 -74.82 0.19 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.55 -1.26 . . . . 2.59 108.384 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -39.0 -39.32 0.53 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.16 -0.963 . . . . 0.7 111.459 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.9 p -55.95 -59.11 5.36 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.704 -1.247 . . . . 1.4 109.252 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.21 -40.01 82.23 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.249 -0.907 . . . . 0.67 111.331 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -63.39 -40.63 97.74 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.772 -1.205 . . . . 1.66 110.975 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.5 -40.07 96.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.758 -1.213 . . . . 1.58 109.078 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -59.92 -38.57 82.72 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.41 -0.806 . . . . 1.35 109.995 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -64.62 -43.68 92.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.915 -1.116 . . . . 0.77 109.226 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.441 ' CD1' HH22 ' A' ' 136' ' ' ARG . 87.9 mt -60.01 -40.01 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 0.63 108.936 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -55.58 -50.03 71.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.39 -0.818 . . . . 1.14 109.958 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -59.41 -36.32 75.64 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.316 -0.865 . . . . 0.79 111.002 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -62.37 -39.64 93.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.914 -1.116 . . . . 1.53 109.534 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.35 -45.25 80.82 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.629 -0.669 . . . . 0.57 110.218 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.63 -52.25 51.6 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.705 -1.358 . . . . 0.75 109.705 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.08 -46.5 64.78 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.135 -1.215 . . . . 1.59 110.214 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.7 m -67.27 -63.45 1.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.195 -0.94 . . . . 0.73 112.697 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -96.23 -45.08 6.99 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.786 -1.196 . . . . 0.75 111.29 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.64 -174.04 23.22 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 119.644 -1.265 . . . . 1.22 111.309 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -70.05 -26.68 64.13 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.395 0.617 . . . . 5.81 110.348 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -60.98 -32.76 72.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.447 -0.783 . . . . 3.37 110.703 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -100.44 -20.51 15.75 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.37 -0.831 . . . . 1.77 109.374 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -66.24 -40.09 89.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 1.65 110.329 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.579 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -66.35 -26.92 67.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.77 109.718 -178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.0 mt -60.03 -41.81 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.952 -1.092 . . . . 0.8 109.174 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -66.56 -39.84 88.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.264 -0.898 . . . . 0.88 110.089 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.51 ' CD ' ' NZ ' ' B' ' 324' ' ' LYS . 61.6 tt0 -60.06 -39.95 87.8 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.232 -0.917 . . . . 1.37 109.387 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.89 -46.06 95.3 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.308 -1.517 . . . . 0.62 109.308 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.4 m170 -60.09 -42.05 93.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.201 -1.176 . . . . 1.5 109.459 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.1 mt -68.43 -45.9 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.342 -0.849 . . . . 0.63 109.526 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.2 ttp -59.98 -44.12 94.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.83 -1.168 . . . . 1.51 110.074 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.854 HD11 ' CE2' ' B' ' 348' ' ' PHE . 26.5 tp -64.53 -39.94 94.7 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.202 -0.937 . . . . 0.77 109.248 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.2 tp -62.78 -39.87 95.53 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.567 -0.708 . . . . 0.62 109.589 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -84.69 4.15 33.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.215 -0.928 . . . . 1.47 110.152 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.6 t0 -50.02 133.06 23.16 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.127 -0.983 . . . . 1.47 110.867 -178.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.45 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 95.4 mt-10 -61.46 -20.31 62.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.571 -0.706 . . . . 1.78 110.005 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -68.22 -32.73 73.14 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.902 -1.147 . . . . 2.53 107.902 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 79' ' ' LEU . 94.0 mt -75.97 -40.0 54.79 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.509 0.671 . . . . 0.8 110.28 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -60.06 -49.98 75.52 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.269 -0.894 . . . . 1.42 110.282 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -70.7 -41.64 71.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.114 -0.991 . . . . 1.71 110.656 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.08 -39.92 75.33 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.21 -0.931 . . . . 1.57 111.822 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.04 -43.9 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.765 -1.21 . . . . 0.65 109.35 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.7 mt -70.04 -39.34 77.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.574 -0.704 . . . . 0.82 110.101 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.05 -48.3 82.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.249 -0.907 . . . . 0.79 111.248 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 96' ' ' LYS . 92.5 mt -60.1 -44.96 94.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.855 -1.153 . . . . 0.95 109.862 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.96 -49.19 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.343 -0.984 . . . . 0.66 108.343 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -69.33 -41.79 76.21 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.123 -0.631 . . . . 2.2 110.759 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -81.34 -50.33 9.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.002 -1.061 . . . . 1.65 112.043 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 92' ' ' LEU . 68.2 mmtt -92.46 -1.85 56.69 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.041 -1.037 . . . . 2.03 111.838 -177.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 55.72 33.84 22.15 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.785 -1.197 . . . . 1.42 109.562 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 93.9 mtp -89.56 168.95 11.76 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.526 -0.734 . . . . 1.18 110.047 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.3 p -81.11 160.01 24.55 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.74 -0.837 . . . . 0.98 108.74 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.41 -38.9 91.33 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.054 -1.029 . . . . 0.64 109.282 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -66.68 -39.3 88.07 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.281 -0.887 . . . . 2.07 109.532 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.76 -44.2 33.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.73 110.113 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.13 -45.35 73.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.893 . . . . 0.54 109.895 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.67 83.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.117 -0.989 . . . . 0.56 109.547 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -59.88 -44.63 94.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.351 -0.843 . . . . 1.54 110.266 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 110' ' ' GLY . 88.6 tt0 -62.6 -40.69 97.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.898 . . . . 1.33 110.441 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.74 -55.74 21.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.229 -0.919 . . . . 0.72 110.84 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.476 HG21 ' HA3' ' A' ' 134' ' ' GLY . 43.1 mm -70.54 -40.04 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.784 -1.197 . . . . 0.85 109.491 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.438 ' OE2' ' OG ' ' A' ' 113' ' ' SER . 12.2 tm-20 -68.3 -39.97 81.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 2.44 108.8 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -60.57 -45.85 95.52 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.04 -1.224 . . . . 0.98 110.04 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -69.95 -53.06 19.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.989 -1.301 . . . . 1.41 109.749 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.93 -40.04 69.49 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.088 -1.008 . . . . 1.2 109.229 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.438 ' OG ' ' OE2' ' A' ' 109' ' ' GLU . 59.1 m -60.0 -40.07 87.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.959 . . . . 1.7 109.275 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.09 -33.53 75.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 1.47 109.128 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.2 mt -69.06 -39.97 78.78 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.075 -1.016 . . . . 1.56 109.66 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.02 -27.94 67.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.858 -1.151 . . . . 2.2 109.194 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -59.94 -23.49 63.6 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.364 -0.976 . . . . 2.12 108.364 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.464 HD13 HD13 ' A' ' 123' ' ' LEU . 24.6 mt -62.15 151.54 35.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 2.0 109.115 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -99.49 30.05 3.75 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.214 -0.929 . . . . 3.23 110.16 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -118.07 131.27 56.46 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.19 -0.944 . . . . 2.49 110.637 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -70.07 -29.77 66.85 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.11 -0.7 . . . . 3.95 109.11 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.469 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.4 t80 -69.72 -38.93 77.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.603 -0.686 . . . . 2.0 110.38 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.506 HD22 ' O ' ' B' ' 351' ' ' GLN . 88.2 mt -73.15 -32.94 65.19 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.069 -1.019 . . . . 1.86 109.262 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -60.02 -40.06 88.0 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.271 -0.893 . . . . 2.84 108.646 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -59.95 -46.15 90.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.888 . . . . 2.73 109.017 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.48 ' HE ' ' NE2' ' B' ' 351' ' ' GLN . 15.3 mmm-85 -60.11 -39.96 88.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.127 -0.983 . . . . 2.77 108.885 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.13 -34.93 75.77 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.469 -0.937 . . . . 1.19 108.469 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.18 -39.97 92.15 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.394 -0.965 . . . . 1.2 108.394 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -68.57 -39.94 80.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.402 -0.811 . . . . 1.55 109.172 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.44 -39.92 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.11 -1.07 . . . . 0.8 108.11 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.513 HH11 ' HG2' ' A' ' 131' ' ' ARG . 7.2 ttt-85 -67.25 -34.42 77.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.449 -0.782 . . . . 3.09 109.44 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.03 -41.22 91.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 1.46 109.587 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.3 mt -61.06 -44.01 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.71 109.272 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.476 ' HA3' HG21 ' A' ' 108' ' ' ILE . . . -60.13 -45.0 96.79 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.155 -1.178 . . . . 0.57 110.155 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -59.97 -45.4 92.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.158 -1.201 . . . . 2.59 109.561 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.441 HH22 ' CD1' ' A' ' 57' ' ' ILE . 60.3 mtp180 -67.32 -36.05 80.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.042 -1.036 . . . . 2.83 110.112 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.0 -43.31 95.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 1.25 109.513 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.34 -40.49 97.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.121 -0.987 . . . . 0.7 109.433 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -69.88 -38.09 76.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.188 -0.945 . . . . 2.57 108.672 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -59.97 -38.82 83.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.829 -0.545 . . . . 1.23 110.565 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -73.74 -44.18 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.829 -1.169 . . . . 0.81 108.917 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.96 -40.01 75.68 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.47 -0.769 . . . . 1.0 109.853 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.74 47.06 4.36 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.186 -1.566 . . . . 0.89 109.186 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.7 tp -73.66 148.76 42.47 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.439 -1.036 . . . . 1.14 109.396 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -66.89 140.67 57.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 4.6 109.391 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.3 mt -119.77 129.93 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 CA-C-O 121.77 0.795 . . . . 1.24 109.728 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 148' ' ' ASP . 1.4 mp -66.66 -39.94 84.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.786 -0.571 . . . . 1.54 110.323 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 147' ' ' ILE . 29.1 t0 62.27 127.03 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.822 -0.807 . . . . 1.5 108.822 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.1 mt -85.06 -4.51 59.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.054 -1.029 . . . . 0.79 109.366 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.4 t -86.75 -14.39 42.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.457 -0.777 . . . . 1.4 109.69 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.88 17.02 1.26 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -0.909 . . . . 0.92 110.473 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 38.3 mm -88.86 124.24 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.872 -1.142 . . . . 0.88 109.203 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -105.76 -9.78 17.07 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.423 -0.798 . . . . 2.45 109.833 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -124.05 149.62 45.9 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.319 -0.863 . . . . 1.52 110.311 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.21 134.62 55.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.351 -0.843 . . . . 1.58 109.595 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -151.95 164.64 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.492 -0.755 . . . . 0.69 109.525 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.7 mt -91.67 150.65 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 106.137 -1.801 . . . . 0.61 106.137 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 51.2 tp -99.98 115.9 30.78 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.936 -1.103 . . . . 0.87 110.611 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.62 130.04 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 109.028 -0.73 . . . . 0.71 109.028 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.503 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -159.78 163.35 34.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.184 -0.948 . . . . 0.81 108.647 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.36 -35.42 73.53 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.426 -1.421 . . . . 0.98 107.68 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -160.99 173.46 15.23 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.983 -0.747 . . . . 2.25 108.983 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.7 mt -138.91 139.19 37.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.18 -0.95 . . . . 0.78 109.037 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.4 p -96.09 140.29 22.19 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.168 -0.957 . . . . 0.98 109.141 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -40.25 -34.75 1.12 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.901 1.734 . . . . 0.81 112.216 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.419 ' HB3' HH12 ' A' ' 136' ' ' ARG . 59.3 m -59.94 -42.85 94.88 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.883 . . . . 0.9 109.787 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -69.56 -41.3 76.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.249 -0.907 . . . . 1.61 109.844 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.8 p -54.28 -23.85 16.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.61 111.528 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -86.01 -50.12 7.3 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.407 -1.433 . . . . 0.6 109.867 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -81.49 35.87 0.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.479 -0.934 . . . . 1.4 108.479 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.416 HD11 HG21 ' A' ' 176' ' ' VAL . 59.1 tp -101.38 132.4 46.98 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.257 -0.645 . . . . 0.7 109.257 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.418 ' O ' HG23 ' A' ' 176' ' ' VAL . 32.9 t-20 -83.41 101.77 11.59 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.164 -0.96 . . . . 2.35 108.716 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.34 -40.18 96.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 1.51 111.111 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -67.7 -26.11 66.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.837 -1.164 . . . . 2.33 111.915 -177.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -93.74 -11.43 31.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.62 -1.3 . . . . 1.92 110.231 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 172' ' ' ASN . 63.3 t -101.59 111.53 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.148 -0.97 . . . . 0.67 108.468 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.37 2.93 33.96 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.226 -0.921 . . . . 1.53 111.263 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.8 171.09 37.94 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.37 -1.492 . . . . 0.48 109.37 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.538 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 14.5 m-85 -132.04 128.43 38.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.498 -1.001 . . . . 0.55 109.491 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.95 126.19 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.101 -1.074 . . . . 0.65 108.101 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 203' ' ' VAL . 16.6 p -146.21 158.62 43.89 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.013 -1.055 . . . . 0.82 110.842 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 59.5 t0 -106.15 28.13 7.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.748 -0.595 . . . . 2.46 109.452 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -52.99 -168.52 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.448 -1.408 . . . . 1.28 111.369 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.13 -54.93 6.0 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.49 -1.044 . . . . 2.19 110.49 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -166.51 -156.04 9.3 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.037 -1.554 . . . . 2.13 111.01 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.435 HH11 ' HG2' ' A' ' 186' ' ' ARG . 16.6 ptt-85 -70.05 -18.0 63.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.8 -0.823 . . . . 5.86 111.327 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 69.5 p -73.13 5.25 3.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.768 -1.207 . . . . 3.72 110.305 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.7 p -82.11 137.8 34.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.93 -1.106 . . . . 1.74 109.991 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -49.3 -49.93 41.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.321 -0.862 . . . . 0.95 110.152 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -37.62 71.48 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.362 -0.836 . . . . 1.55 110.965 -178.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.9 t -60.03 -39.97 87.7 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.752 -1.217 . . . . 1.51 110.371 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.86 -39.74 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.855 . . . . 1.67 110.17 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.5 mtm -59.93 -45.0 94.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.966 -1.084 . . . . 1.02 110.42 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.99 -45.45 71.42 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.799 -1.188 . . . . 0.68 109.46 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -60.01 -53.44 57.85 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.998 -1.081 . . . . 2.93 110.445 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.4 m -68.21 -37.8 81.26 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.068 -1.02 . . . . 0.86 111.973 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.38 -22.95 62.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.698 -1.251 . . . . 0.67 109.906 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 66.56 49.3 1.35 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.322 0.582 . . . . 1.5 110.079 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.47 ' O ' ' CB ' ' A' ' 8' ' ' SER . 97.0 mt -129.53 148.98 71.54 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 108.027 -1.101 . . . . 0.72 108.027 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.54 138.31 69.59 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.276 1.984 . . . . 0.61 112.194 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.01 149.73 2.97 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.076 -1.05 . . . . 0.66 111.354 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.5 mt -122.99 144.09 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 107.21 -1.404 . . . . 0.79 107.21 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 181' ' ' THR . 17.9 m -122.34 -12.81 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.006 -1.059 . . . . 0.91 111.127 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -112.65 26.77 10.48 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.88 -0.888 . . . . 1.01 110.88 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 204' ' ' GLY . 14.0 p -41.96 -46.57 4.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.15 -1.206 . . . . 0.99 110.12 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.454 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 94.74 -54.18 1.96 Allowed Glycine 0 N--CA 1.5 2.951 0 C-N-CA 120.332 -0.937 . . . . 1.12 111.587 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 207' ' ' SER . 7.4 t -150.01 29.94 0.72 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.329 -1.689 . . . . 1.72 111.024 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 41.8 t -75.25 -36.87 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.709 -1.244 . . . . 0.89 109.249 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.456 ' H ' HG23 ' A' ' 209' ' ' THR . 8.4 p -60.05 -33.73 72.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.922 . . . . 1.03 111.117 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.2 t -78.37 -22.44 47.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.935 -1.103 . . . . 1.83 110.306 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -94.7 -8.35 38.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.185 -0.947 . . . . 2.27 110.499 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 86.4 t -108.02 140.02 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.28 -0.888 . . . . 0.92 110.729 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.497 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 65.2 mmtt -117.15 156.87 26.91 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.895 -1.521 . . . . 2.2 106.895 177.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 29.9 p-10 -60.04 142.53 53.84 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.802 -1.186 . . . . 2.36 111.115 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.438 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.7 m-20 82.11 3.2 1.28 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 116.061 -0.518 . . . . 2.38 110.832 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.497 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 88.9 m-20 -74.95 145.01 42.93 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.889 -1.132 . . . . 2.09 109.301 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -94.59 120.0 34.13 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.231 -0.918 . . . . 1.27 108.847 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.434 HD12 ' HB2' ' A' ' 16' ' ' ALA . 59.6 mt -126.86 147.49 50.04 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.414 -0.804 . . . . 0.75 110.433 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 85.7 mt -114.11 128.28 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 106.906 -1.516 . . . . 0.63 106.906 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.1 tp -100.83 117.07 34.19 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.866 -1.146 . . . . 0.7 109.595 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 223' ' ' VAL . 96.1 m-20 -74.03 -43.9 56.26 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.242 -0.911 . . . . 2.31 108.728 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.805 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 50.35 11.74 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.846 -0.798 . . . . 0.78 108.846 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.493 ' H ' ' C ' ' A' ' 221' ' ' ASP . 73.5 t -131.05 -44.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.817 -1.179 . . . . 1.04 107.817 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -100.04 3.23 44.0 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.61 -1.255 . . . . 2.44 107.61 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.418 HD22 ' HB3' ' A' ' 3' ' ' SER . 48.4 t30 59.61 43.67 15.51 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 116.246 -0.433 . . . . 1.55 110.192 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -140.09 144.46 36.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.122 -0.986 . . . . 1.99 110.042 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 87.8 t -120.03 125.68 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.926 -0.768 . . . . 0.77 108.926 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -90.99 118.15 30.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.85 -1.156 . . . . 0.98 109.679 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.76 116.69 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.475 -0.766 . . . . 0.85 109.529 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 68.22 67.67 0.52 Allowed Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.468 -0.77 . . . . 1.66 109.947 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -91.02 121.35 0.71 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 123.426 2.751 . . . . 0.95 112.955 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.626 HG22 ' N ' ' A' ' 233' ' ' ASN . 93.9 m -67.03 169.77 7.85 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.256 -0.903 . . . . 1.84 109.685 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.626 ' N ' HG22 ' A' ' 232' ' ' THR . 92.8 m-20 -60.06 -40.0 87.97 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.307 -0.871 . . . . 2.74 109.544 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.91 -38.63 82.86 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.189 -0.945 . . . . 2.89 108.753 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.72 -40.06 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 1.3 109.559 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.43 -40.93 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.291 -0.881 . . . . 1.09 109.86 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -59.96 -47.0 87.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.996 -1.065 . . . . 2.43 109.061 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -60.08 -43.93 95.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.486 -0.758 . . . . 2.78 109.67 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 94.5 mtp -72.67 -24.8 61.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.359 -0.838 . . . . 1.25 110.511 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 -73.34 -39.96 64.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.796 -1.19 . . . . 2.63 110.008 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.75 97.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 1.8 109.459 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.65 -41.36 91.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.315 -0.866 . . . . 2.13 109.542 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -60.64 -41.83 95.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.038 -1.039 . . . . 3.17 109.607 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -60.09 -40.0 88.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.144 -0.972 . . . . 1.78 108.96 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -60.95 -37.53 82.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.668 -0.645 . . . . 2.47 109.652 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.7 t -59.99 -43.69 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 2.09 109.516 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.32 -42.63 99.01 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.291 -0.881 . . . . 2.54 109.89 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 27.4 t -70.0 -40.41 75.31 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.194 -0.941 . . . . 2.99 111.05 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -62.57 -39.94 95.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.095 -1.003 . . . . 3.34 110.791 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -82.32 3.41 27.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.02 -1.05 . . . . 3.88 110.718 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -121.92 -45.3 2.27 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.049 -1.032 . . . . 4.43 109.942 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -62.07 -44.44 96.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.106 -0.996 . . . . 5.42 110.816 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 1.5 mp -119.68 -24.54 6.18 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.527 -0.733 . . . . 6.1 109.542 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 53.02 35.99 20.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 7.37 109.815 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -147.83 139.64 23.99 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.979 -1.119 . . . . 8.01 107.979 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.558 ' N ' HD12 ' A' ' 256' ' ' LEU . 8.4 mp -87.13 105.71 17.37 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.006 -1.059 . . . . 9.05 108.985 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -52.2 146.47 9.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 10.56 109.62 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 258' ' ' ASP . 16.8 p-10 -150.84 40.44 0.73 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.336 -0.853 . . . . 11.32 109.603 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 117.977 -1.011 . . . . 12.42 109.487 -179.845 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 38.1 ttp . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.497 0.665 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -155.84 153.44 29.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.494 -0.754 . . . . 0.0 109.136 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -150.9 161.9 41.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.08 -1.012 . . . . 0.0 110.399 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -153.38 149.95 28.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.644 -0.66 . . . . 0.0 109.389 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.17 128.56 55.54 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -131.66 124.59 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 CA-C-O 122.192 0.996 . . . . 0.0 112.388 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 91.4 m -77.84 103.87 8.04 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.03 0.919 . . . . 0.0 110.869 -178.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 88.8 mt -51.71 124.75 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 122.467 1.127 . . . . 0.0 110.464 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 75.7 p -110.02 19.33 19.12 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.206 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.404 ' O ' ' CD ' ' B' ' 357' ' ' GLN . . . -69.33 147.21 97.07 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.94 -1.1 . . . . 0.0 108.578 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -72.82 -24.69 17.69 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 120.892 1.061 . . . . 0.0 112.672 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -121.05 17.61 11.66 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.17 -173.37 53.97 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.989 -2.045 . . . . 0.0 107.989 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.469 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.5 tp -86.3 90.42 8.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.889 -1.359 . . . . 0.0 108.88 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.424 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 4.5 p80 -93.14 -161.42 0.84 Allowed 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.033 -1.042 . . . . 0.0 111.102 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.1 m -55.79 -45.32 78.24 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.569 -0.707 . . . . 0.0 112.71 -175.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.579 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.5 tpt180 -61.22 -58.58 17.98 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 120.526 -1.359 . . . . 0.0 112.176 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 11.5 Cg_endo -59.37 -32.03 95.91 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 120.307 1.145 . . . . 0.0 111.907 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.96 75.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.11 -0.994 . . . . 0.0 108.515 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.73 -42.76 68.45 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.248 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -69.95 -42.96 72.51 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.129 -0.982 . . . . 0.0 108.944 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.26 -52.55 64.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.462 -0.774 . . . . 0.0 110.622 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 323' ' ' VAL . . . . . 0.408 HG13 ' O ' ' B' ' 344' ' ' ALA . 92.5 t -64.66 -30.84 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.757 -1.214 . . . . 0.0 109.521 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.51 ' NZ ' ' CD ' ' A' ' 74' ' ' GLU . 12.0 ttmm -60.03 -48.11 83.07 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.392 -0.818 . . . . 0.0 110.102 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 325' ' ' GLU . . . . . 0.517 ' OE1' HD22 ' B' ' 380' ' ' LEU . 84.9 tt0 -67.64 -44.45 77.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 111.239 -178.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.04 -52.43 65.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.587 -1.32 . . . . 0.0 110.465 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -56.42 -14.1 2.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.009 . . . . 0.0 109.376 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -71.94 -21.53 79.02 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -105.8 143.68 33.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.669 -0.9 . . . . 0.0 108.721 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 15.3 t -91.02 -13.16 33.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.027 -1.046 . . . . 0.0 109.279 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.42 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 52.8 p -62.72 146.9 51.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.481 -0.762 . . . . 0.0 109.119 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.63 137.04 57.07 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.148 -0.97 . . . . 0.0 108.98 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 94.3 mt -132.94 133.21 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.604 -0.685 . . . . 0.0 109.679 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 46.5 m -130.34 152.42 49.77 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 62.3 t -117.41 139.51 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 97.9 m -130.7 126.09 35.62 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.105 -0.997 . . . . 0.0 109.714 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 73.5 p -140.16 118.19 11.88 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.863 0.84 . . . . 0.0 110.574 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 42.09 54.45 4.09 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.2 -15.7 43.0 Favored Glycine 0 N--CA 1.502 3.067 0 O-C-N 120.206 -1.559 . . . . 0.0 113.138 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -112.44 124.22 52.03 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 119.327 1.563 . . . . 0.0 109.371 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 85.8 p -122.07 147.59 45.91 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.941 0.876 . . . . 0.0 111.044 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.24 159.78 41.49 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.671 0.748 . . . . 0.0 109.849 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 22.1 m -88.74 136.74 32.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.473 -0.767 . . . . 0.0 110.463 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.44 ' HA ' HD11 ' B' ' 350' ' ' LEU . . . -73.93 -16.78 61.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.051 -1.031 . . . . 0.0 109.876 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -87.36 19.9 3.06 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 25.1 t -149.75 94.83 2.23 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.733 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.544 ' HB3' HD13 ' A' ' 79' ' ' LEU . 36.0 tp -59.96 -32.72 71.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.854 ' CE2' HD11 ' A' ' 79' ' ' LEU . 60.4 m-85 -54.75 -53.55 53.64 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.031 -1.043 . . . . 0.0 110.175 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -70.07 -35.89 74.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 0.0 110.273 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' B' ' 347' ' ' LEU . 81.8 mt -53.92 -50.1 67.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.878 -1.139 . . . . 0.0 110.232 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.506 ' O ' HD22 ' A' ' 123' ' ' LEU . 3.6 mt-30 -49.99 -17.59 0.41 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.668 -1.27 . . . . 0.0 111.337 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 82.1 p -79.81 -14.55 58.61 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.275 -1.516 . . . . 0.0 110.972 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 30.9 mt -91.82 118.66 30.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.749 -1.22 . . . . 0.0 109.201 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.35 92.81 0.77 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 20.9 mt -100.47 89.72 4.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.37 -1.077 . . . . 0.0 109.309 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 38.2 p -90.01 177.87 6.35 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.095 -1.003 . . . . 0.0 110.449 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 357' ' ' GLN . . . . . 0.404 ' CD ' ' O ' ' B' ' 310' ' ' ALA . 48.5 tt0 -69.87 115.14 8.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.632 -0.667 . . . . 0.0 110.926 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 100.2 9.54 47.79 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 52.1 m -87.21 114.12 23.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.228 -1.16 . . . . 0.0 110.888 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.97 115.15 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 122.116 0.96 . . . . 0.0 109.785 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 32.8 m -110.99 176.38 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 33.0 m -130.64 127.64 39.34 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 72.9 mt -102.88 116.64 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 84.1 p -119.98 131.6 55.22 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.304 -0.872 . . . . 0.0 109.47 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.69 151.55 39.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.19 -0.944 . . . . 0.0 109.587 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -144.07 122.99 12.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.406 -0.809 . . . . 0.0 108.889 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.552 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.06 -158.06 29.37 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.062 -1.542 . . . . 0.0 111.481 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -59.85 -50.02 75.44 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.42 ' H ' ' HB3' ' B' ' 331' ' ' SER . 96.0 m-20 -108.99 13.4 24.7 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.819 -1.176 . . . . 0.0 110.963 -177.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.552 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.2 pt-20 -44.95 -36.25 3.28 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.077 -1.014 . . . . 0.0 110.89 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.14 -46.25 68.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.95 -1.094 . . . . 0.0 110.226 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -66.39 -48.15 71.03 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.154 -0.966 . . . . 0.0 109.727 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.12 -75.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 110.501 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.562 ' O ' HG23 ' B' ' 378' ' ' VAL . 68.8 t -45.96 -38.82 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.097 -1.002 . . . . 0.0 110.557 -177.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -63.72 -49.96 71.01 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.598 -1.314 . . . . 0.0 110.475 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.11 -40.66 37.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.978 -1.076 . . . . 0.0 110.062 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 82.4 mt -59.99 -38.66 83.22 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.111 -0.993 . . . . 0.0 109.296 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.562 HG23 ' O ' ' B' ' 374' ' ' VAL . 39.8 t -61.44 -39.96 84.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.28 -0.887 . . . . 0.0 108.647 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.72 -55.55 12.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.963 -1.086 . . . . 0.0 108.218 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.517 HD22 ' OE1' ' B' ' 325' ' ' GLU . 57.6 tp -58.21 -32.25 68.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.127 -0.983 . . . . 0.0 109.932 -178.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.8 tpp -71.78 -40.77 69.04 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.354 -1.338 . . . . 0.0 108.875 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.6 -5.84 59.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -0.775 . . . . 0.0 110.349 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -110.13 -3.86 16.13 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.223 -0.923 . . . . 0.0 111.237 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 12.4 mt -76.48 129.99 37.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.303 -1.498 . . . . 0.0 108.957 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.161 -179.868 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.34 -0.615 . . . . 2.91 109.34 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.0 mt -110.06 129.96 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.579 -0.701 . . . . 1.2 109.251 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.0 m -119.48 152.34 37.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.629 -0.669 . . . . 1.4 109.244 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.594 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -135.66 -165.22 10.61 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 108.441 -1.864 . . . . 1.05 108.441 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 6' ' ' LEU . 97.0 mt -89.49 -18.82 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.69 -1.476 . . . . 1.15 110.571 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' ILE . 37.1 tp 54.79 104.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.174 -0.954 . . . . 0.98 109.17 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.88 -27.02 13.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.258 -0.901 . . . . 0.88 109.238 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.8 t -133.69 118.39 14.52 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.575 -0.703 . . . . 1.69 109.17 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.27 148.58 18.96 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.964 1.776 . . . . 0.85 112.542 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.791 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.47 -156.77 27.09 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 108.897 -1.681 . . . . 0.92 108.897 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.2 mt -147.66 150.64 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.021 -1.281 . . . . 0.81 108.318 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.8 155.02 35.06 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.776 -1.203 . . . . 0.51 110.807 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.9 OUTLIER -139.01 129.5 25.79 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.551 -1.277 . . . . 0.62 107.551 178.785 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.08 -178.07 48.23 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.482 -1.818 . . . . 0.55 111.039 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -79.69 159.16 26.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.833 -0.804 . . . . 2.1 109.165 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.605 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -109.5 132.1 54.45 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.479 -0.763 . . . . 0.77 110.859 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.6 tp -102.99 139.39 38.62 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.102 -1.073 . . . . 0.91 108.102 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.9 tp -117.69 122.3 43.15 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.346 -0.846 . . . . 0.93 109.674 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' A' ' 160' ' ' ALA . 54.8 mt -87.98 104.28 16.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.538 -0.726 . . . . 0.93 109.834 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -101.07 132.74 46.37 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.783 -0.821 . . . . 2.75 108.783 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -124.82 136.19 53.6 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.757 -0.831 . . . . 3.0 108.757 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.21 142.98 34.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.093 -1.004 . . . . 2.77 109.641 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.49 140.02 58.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.875 . . . . 2.94 108.824 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.4 mt -81.6 130.53 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.211 -0.93 . . . . 0.95 109.627 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 t -96.43 128.47 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.217 -0.927 . . . . 1.28 110.181 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.8 mt -109.0 135.41 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.178 -0.675 . . . . 1.21 109.178 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -91.53 121.36 33.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.124 -0.985 . . . . 1.81 109.794 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.1 mmm-85 -90.02 -0.04 57.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.378 -0.826 . . . . 2.8 109.888 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.54 146.1 54.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.043 -1.035 . . . . 2.87 109.468 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -88.45 147.27 24.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.296 -0.878 . . . . 2.35 109.282 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.568 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.3 pt -94.15 164.02 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.012 -1.055 . . . . 0.97 109.413 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -94.07 168.29 11.04 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.144 -0.972 . . . . 1.17 108.886 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.05 -15.52 59.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.067 -1.021 . . . . 1.18 109.943 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -87.41 -27.96 22.43 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.85 -1.167 . . . . 2.56 107.85 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -81.74 -9.24 59.69 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.723 -0.843 . . . . 1.79 108.723 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.8 t -62.87 -53.88 40.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.124 -0.985 . . . . 1.0 108.572 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -61.94 -39.97 93.91 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.33 -0.856 . . . . 1.77 110.123 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -69.84 -40.12 76.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.132 -0.98 . . . . 2.7 110.563 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.568 ' HG3' HG21 ' A' ' 31' ' ' ILE . 69.3 mm-40 -67.62 -39.83 84.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.925 -1.109 . . . . 1.51 110.029 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.14 -46.69 94.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 120.756 -1.215 . . . . 0.93 108.624 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -60.15 -42.18 94.34 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.147 -0.971 . . . . 1.81 109.495 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.02 -45.32 93.19 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.901 -1.119 . . . . 2.78 108.38 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -60.43 -46.13 91.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.326 -0.858 . . . . 0.78 108.764 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.2 tp -60.1 -47.98 83.63 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.616 -0.883 . . . . 1.07 108.616 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 41.4 t -61.82 -42.29 98.84 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.413 -0.915 . . . . 1.12 108.761 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.13 -45.83 95.3 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.346 -1.902 . . . . 0.84 108.346 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.459 ' NH1' ' HG3' ' A' ' 47' ' ' ARG . 31.9 ttm-85 -62.32 -32.92 73.74 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.433 -1.04 . . . . 3.09 108.307 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -54.81 -40.01 69.07 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.888 -0.782 . . . . 0.88 108.888 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.8 ttmt -72.44 -73.14 0.21 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.927 -1.138 . . . . 2.59 107.927 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.48 -37.93 0.14 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.362 -0.836 . . . . 0.7 111.844 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 m -59.99 -52.52 65.02 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.433 -1.417 . . . . 1.4 108.517 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.34 -40.0 93.12 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.866 . . . . 0.67 110.809 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -66.63 -40.07 88.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.036 -1.04 . . . . 1.66 110.766 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.87 -39.99 94.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.829 -1.169 . . . . 1.58 108.976 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' OE2' HD13 ' A' ' 77' ' ' ILE . 79.1 mm-40 -65.17 -35.83 82.31 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.274 -0.892 . . . . 1.35 108.926 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -64.52 -43.3 94.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 0.77 109.902 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.16 -39.88 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.987 . . . . 0.63 108.819 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -53.18 -52.48 58.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 1.14 110.064 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -57.01 -33.74 67.47 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.26 -0.9 . . . . 0.79 110.309 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -69.32 -37.25 77.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.909 -1.119 . . . . 1.53 109.435 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.99 -45.9 76.23 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.548 -0.72 . . . . 0.57 110.074 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.03 -51.95 55.78 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.333 -1.107 . . . . 0.75 110.333 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.75 -41.11 79.39 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.986 -1.302 . . . . 1.59 110.185 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.6 m -70.11 -62.48 1.37 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.053 -1.029 . . . . 0.73 112.739 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -96.52 -45.88 6.57 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.787 -1.195 . . . . 0.75 111.573 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.08 -166.74 25.91 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 119.705 -1.236 . . . . 1.22 110.977 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -71.26 -24.01 62.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.914 -0.757 . . . . 5.81 110.663 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -62.7 -36.12 81.92 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.278 -0.889 . . . . 3.37 111.502 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -98.42 -18.43 18.26 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.034 -1.041 . . . . 1.77 109.548 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -67.23 -40.07 86.31 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.281 -0.887 . . . . 1.65 110.104 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB2' ' NH1' ' B' ' 317' ' ' ARG . . . -64.94 -28.37 69.48 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.287 -0.883 . . . . 0.77 109.974 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.84 -41.39 85.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 118.951 -1.1 . . . . 0.8 108.704 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -66.43 -42.51 87.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.88 110.493 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -63.11 -40.82 98.73 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.804 -1.185 . . . . 1.37 109.154 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.65 -40.71 98.34 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.344 -1.902 . . . . 0.62 108.344 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.2 m-70 -70.05 -41.83 73.69 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.516 -0.991 . . . . 1.5 109.209 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.448 HD13 ' OE2' ' A' ' 55' ' ' GLU . 96.0 mt -69.71 -45.62 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.396 -0.815 . . . . 0.63 109.655 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.3 ttp -60.13 -46.52 89.35 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.916 -1.115 . . . . 1.51 109.802 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.831 HD11 ' CE2' ' B' ' 348' ' ' PHE . 32.7 tp -60.79 -40.54 93.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.314 -0.866 . . . . 0.77 109.328 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.436 ' HG ' HH12 ' A' ' 47' ' ' ARG . 63.9 tp -62.23 -40.01 94.73 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.538 -0.726 . . . . 0.62 109.931 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -82.12 8.81 9.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.173 -0.954 . . . . 1.47 110.152 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.7 t0 -54.58 132.98 46.23 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.186 -0.946 . . . . 1.47 110.258 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.415 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 39.9 mt-10 -60.38 -19.65 56.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.613 -0.679 . . . . 1.78 111.301 -178.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.4 -35.06 73.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.665 -1.272 . . . . 2.53 108.799 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.01 -43.58 71.09 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.491 0.663 . . . . 0.8 110.385 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.11 -48.76 80.39 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.967 -1.083 . . . . 1.42 110.55 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -70.0 -40.26 75.38 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.369 -0.832 . . . . 1.71 111.083 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.0 -40.04 75.52 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.906 -1.121 . . . . 1.57 111.61 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.8 mt -67.47 -45.21 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.946 -1.097 . . . . 0.65 109.756 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.92 -39.82 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.604 -0.685 . . . . 0.82 110.053 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.44 -46.91 88.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 0.79 110.579 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 96' ' ' LYS . 85.3 mt -60.12 -47.51 85.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.857 -1.152 . . . . 0.95 109.693 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.0 mt -63.22 -48.97 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.943 0.878 . . . . 0.66 108.926 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -69.84 -40.21 75.98 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.494 -0.754 . . . . 2.2 110.588 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -85.51 -51.55 6.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.04 -1.037 . . . . 1.65 111.952 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 92' ' ' LEU . 65.4 mmtt -89.76 -1.7 58.06 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.013 -1.054 . . . . 2.03 111.603 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 55.73 32.32 19.2 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.869 -1.145 . . . . 1.42 109.962 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.2 mtt -83.8 166.94 17.56 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.361 -0.837 . . . . 1.18 109.721 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 19.3 p -78.17 155.15 30.58 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.529 -0.915 . . . . 0.98 108.529 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.35 93.0 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.134 -0.979 . . . . 0.64 109.445 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -62.86 -39.83 95.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.546 -0.721 . . . . 2.07 109.985 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.66 -45.95 20.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.103 -0.998 . . . . 0.73 110.181 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.01 -50.68 72.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.403 -0.811 . . . . 0.54 110.56 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.72 86.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.004 -1.06 . . . . 0.56 109.919 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.509 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 78.1 t60 -59.97 -41.03 91.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 1.54 110.082 -178.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -63.54 -39.98 95.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.288 -0.882 . . . . 1.33 111.419 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.8 t -62.9 -53.98 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.76 -1.213 . . . . 0.72 112.018 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.3 mm -69.99 -39.94 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.578 -1.326 . . . . 0.85 108.68 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.509 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 87.5 tt0 -60.89 -39.95 91.21 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.736 -0.838 . . . . 2.44 108.736 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.27 94.53 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 120.512 -0.851 . . . . 0.98 111.018 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -70.02 -60.03 2.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.659 -1.495 . . . . 1.41 110.203 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.05 -41.28 25.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.113 -0.992 . . . . 1.2 110.051 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 78.6 p -59.81 -39.87 86.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.058 -1.026 . . . . 1.7 108.719 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.53 -38.85 81.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.248 -0.908 . . . . 1.47 109.293 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.8 mt -65.97 -40.99 91.75 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.12 -0.988 . . . . 1.56 110.155 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -59.92 -34.83 73.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.719 -1.238 . . . . 2.2 109.625 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -57.47 -19.31 23.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.155 -0.965 . . . . 2.12 109.912 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.5 HD13 HD13 ' A' ' 123' ' ' LEU . 40.7 mt -62.65 149.76 42.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.859 -1.15 . . . . 2.0 109.203 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -89.98 10.59 23.44 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.312 -0.868 . . . . 3.23 110.254 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -101.42 128.98 47.37 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.198 -0.939 . . . . 2.49 110.331 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.01 -29.18 66.19 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.581 0.705 . . . . 3.95 109.437 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.462 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 6.7 t80 -70.22 -39.28 75.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.587 -0.695 . . . . 2.0 110.342 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.53 HD22 ' O ' ' B' ' 351' ' ' GLN . 90.5 mt -69.97 -35.39 74.42 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.02 -1.05 . . . . 1.86 108.416 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -59.99 -39.07 84.46 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.072 -0.714 . . . . 2.84 109.072 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -58.24 -43.56 87.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 2.73 109.198 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.599 ' NH2' ' O ' ' B' ' 314' ' ' LEU . 89.9 mtt180 -62.23 -39.93 94.47 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.176 -1.01 . . . . 2.77 109.22 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.82 80.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 1.19 109.621 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.07 -48.76 80.36 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.363 -0.835 . . . . 1.2 109.416 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -63.5 -40.07 96.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 1.55 109.628 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.42 -40.12 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.085 -1.009 . . . . 0.8 108.471 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.54 HH11 ' HG2' ' A' ' 131' ' ' ARG . 3.8 ttt-85 -60.32 -38.62 84.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.517 -0.739 . . . . 3.09 109.233 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -59.94 -40.08 87.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.425 -0.797 . . . . 1.46 110.363 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.08 -45.99 94.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.905 -1.122 . . . . 0.71 109.377 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.88 -41.06 93.66 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 120.291 -0.957 . . . . 0.57 110.942 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -60.07 -46.33 89.92 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.906 -1.349 . . . . 2.59 109.954 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.631 HH12 ' CB ' ' A' ' 166' ' ' SER . 98.2 mtt180 -68.88 -29.91 68.29 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.932 -1.105 . . . . 2.83 109.48 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.1 tp -60.05 -43.13 95.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.948 . . . . 1.25 109.071 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.9 mt -61.02 -39.82 91.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.281 -0.887 . . . . 0.7 109.89 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -67.39 -39.94 85.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 2.57 108.933 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -61.34 -36.18 79.44 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.623 -0.673 . . . . 1.23 111.217 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.2 mt -70.7 -43.24 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.444 -1.41 . . . . 0.81 109.05 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.1 mt -71.04 -30.15 66.26 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.435 -0.79 . . . . 1.0 109.489 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.18 43.47 6.27 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.862 -1.695 . . . . 0.89 108.862 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.7 tp -74.44 149.47 40.37 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.427 -1.043 . . . . 1.14 109.241 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -72.11 142.29 49.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 4.6 109.58 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 93.9 mt -113.06 128.94 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-O 122.203 1.002 . . . . 1.24 109.927 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.5 mt -64.21 -43.77 97.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 115.485 -0.779 . . . . 1.54 110.87 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.3 t0 65.21 102.66 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.395 -0.816 . . . . 1.5 108.969 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.5 mt -69.02 -1.02 6.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.265 -0.897 . . . . 0.79 110.625 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 74.0 m -87.92 -10.88 49.23 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.852 -1.155 . . . . 1.4 109.395 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.84 15.97 2.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.336 -0.852 . . . . 0.92 112.588 -177.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.1 mp -90.32 119.98 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 120.213 -1.554 . . . . 0.88 109.215 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -100.45 -9.26 22.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.467 -0.771 . . . . 2.45 110.217 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -116.92 148.21 41.55 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.291 -0.881 . . . . 1.52 110.442 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -65.06 132.59 49.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.541 -0.724 . . . . 1.58 109.588 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.0 m -152.35 164.66 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.473 -0.767 . . . . 0.69 109.538 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.5 mt -91.84 149.53 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.023 -1.843 . . . . 0.61 106.023 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 52.3 tp -99.3 117.11 33.03 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.967 -1.083 . . . . 0.87 110.035 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.723 HG12 HG22 ' A' ' 209' ' ' THR . 19.4 t -123.48 129.98 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.481 -0.933 . . . . 0.71 108.481 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.488 ' C ' HG21 ' A' ' 209' ' ' THR . . . -159.29 164.74 34.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.058 -1.026 . . . . 0.81 108.924 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.17 -38.07 69.22 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.379 -1.451 . . . . 0.98 108.378 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -171.07 142.83 1.87 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.825 -0.806 . . . . 2.25 108.825 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 19.9 mt -117.4 137.49 52.45 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.324 -0.86 . . . . 0.78 109.504 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.4 p -83.08 147.23 53.51 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.94 . . . . 0.98 108.722 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -43.52 -31.83 3.34 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.567 1.511 . . . . 0.81 111.814 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.631 ' CB ' HH12 ' A' ' 136' ' ' ARG . 38.5 m -59.96 -40.16 88.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.907 . . . . 0.9 108.975 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.58 -43.21 85.55 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.441 -0.787 . . . . 1.61 109.658 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 54.2 p -52.68 -29.08 24.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.13 -0.981 . . . . 0.61 110.092 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.29 -57.74 3.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 0.6 110.063 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -81.83 36.03 0.44 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.066 -0.716 . . . . 1.4 109.066 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 171' ' ' LEU . 14.2 tp -97.96 138.21 35.62 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.494 -0.754 . . . . 0.7 109.006 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -86.27 102.92 14.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.08 -1.013 . . . . 2.35 109.196 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 66.2 mt -62.21 -45.64 92.47 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.265 -0.897 . . . . 1.51 110.209 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -66.42 -28.93 69.0 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.058 -1.027 . . . . 2.33 112.715 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -93.17 -13.03 28.92 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.46 -1.4 . . . . 1.92 109.95 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.542 HG11 ' CE1' ' A' ' 179' ' ' PHE . 87.2 t -101.41 109.27 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.179 -0.95 . . . . 0.67 108.727 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.2 mt -82.76 6.53 17.82 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.897 . . . . 1.53 110.274 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.457 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 169.09 175.85 38.71 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.312 -1.515 . . . . 0.48 109.312 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.542 ' CE1' HG11 ' A' ' 176' ' ' VAL . 10.8 m-85 -135.76 130.16 33.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.394 -1.062 . . . . 0.55 109.299 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.423 ' CG2' HG21 ' A' ' 205' ' ' THR . 94.5 mt -131.13 126.97 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.736 -0.839 . . . . 0.65 108.736 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.1 p -145.7 157.29 43.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.033 -1.042 . . . . 0.82 110.7 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.658 ' OD1' HG23 ' A' ' 209' ' ' THR . 7.2 m-20 -105.52 27.04 8.76 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.462 -0.94 . . . . 2.46 108.462 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.57 -157.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.201 -0.937 . . . . 1.28 112.225 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.84 -71.2 0.85 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 111.258 -0.737 . . . . 2.19 111.258 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 167.11 -133.66 2.99 Favored Glycine 0 N--CA 1.491 2.342 0 O-C-N 120.705 -1.468 . . . . 2.13 110.563 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 188' ' ' SER . 28.0 mtm-85 -60.08 -40.04 88.19 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.427 -1.043 . . . . 5.86 111.01 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.4 p -65.78 8.88 0.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.066 -1.021 . . . . 3.72 110.471 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 186' ' ' ARG . 29.1 t -90.79 129.59 36.85 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.015 -1.053 . . . . 1.74 110.255 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -42.79 -52.0 5.19 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.783 0.801 . . . . 0.95 109.38 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 190' ' ' THR . 9.5 p -55.38 -36.69 66.66 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.768 -0.582 . . . . 1.55 111.175 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.7 t -59.94 -40.03 87.57 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.846 -1.159 . . . . 1.51 110.903 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.6 mt -65.7 -40.02 86.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.123 -0.985 . . . . 1.67 110.109 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.7 mtp -60.05 -45.31 93.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.846 . . . . 1.02 111.06 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.3 -43.8 92.58 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.927 -1.108 . . . . 0.68 109.59 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' ' 195' ' ' ARG . 51.4 mtt-85 -59.96 -51.61 68.92 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.901 -1.12 . . . . 2.93 109.361 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.5 m -70.11 -35.03 73.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.86 110.76 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.0 mt -76.12 -21.44 56.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 0.67 109.66 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 62.15 50.04 4.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.605 -0.684 . . . . 1.5 109.86 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.48 130.59 23.85 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 108.821 -0.807 . . . . 0.72 108.821 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -43.88 130.31 7.78 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.905 1.737 . . . . 0.61 112.343 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -168.84 145.67 3.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.736 -1.227 . . . . 0.66 111.661 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 91.2 mt -124.88 148.87 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 107.168 -1.419 . . . . 0.79 107.168 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 6.9 m -129.98 -9.83 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 O-C-N 120.819 -1.176 . . . . 0.91 110.894 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.68 22.38 26.26 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 110.228 -1.149 . . . . 1.01 110.228 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.44 ' OG1' ' OD2' ' A' ' 182' ' ' ASP . 3.3 p -47.14 -40.0 14.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.894 -1.356 . . . . 0.99 109.836 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.52 ' N ' ' OD2' ' A' ' 182' ' ' ASP . . . 89.11 -52.07 3.81 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 120.914 -1.116 . . . . 1.12 111.342 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.48 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 15.1 m -156.17 37.97 0.34 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.523 -1.575 . . . . 1.72 111.819 -178.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 12.8 t -77.05 -34.88 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.754 -1.216 . . . . 0.89 108.045 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.723 HG22 HG12 ' A' ' 159' ' ' VAL . 53.8 p -59.72 -34.26 72.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.571 -0.706 . . . . 1.03 110.284 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.4 t -77.16 -16.97 58.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.046 -1.034 . . . . 1.83 109.962 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -99.27 -11.86 20.89 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.245 -0.909 . . . . 2.27 110.319 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.5 t -102.33 135.3 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.24 -0.913 . . . . 0.92 111.08 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.45 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 43.5 mmtm -110.38 150.48 28.73 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.518 -1.66 . . . . 2.2 106.518 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.489 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 13.1 p-10 -59.91 141.04 56.22 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.789 -1.194 . . . . 2.36 110.85 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.3 t0 85.24 1.04 0.74 Allowed 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.071 0.463 . . . . 2.38 110.012 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.45 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 98.1 m-20 -73.99 147.0 43.37 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.146 -0.971 . . . . 2.09 109.252 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -97.34 119.88 36.67 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.614 -1.254 . . . . 1.27 107.614 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 16' ' ' ALA . 66.4 mt -126.98 148.99 50.07 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.475 -0.766 . . . . 0.75 110.489 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.0 mt -116.18 129.91 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 107.675 -1.231 . . . . 0.63 107.675 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 35.2 tp -102.28 119.33 38.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.883 -1.136 . . . . 0.7 108.075 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.613 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 6.6 p30 -78.47 -40.13 36.41 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.886 -1.134 . . . . 2.31 108.751 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.791 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.35 13.64 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.439 -0.948 . . . . 0.78 108.439 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.472 ' N ' ' C ' ' A' ' 221' ' ' ASP . 24.9 t -127.65 -40.64 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.457 -1.312 . . . . 1.04 107.457 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -102.5 0.39 33.56 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.976 -1.12 . . . . 2.44 107.976 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.594 HD21 ' H ' ' A' ' 4' ' ' GLY . 48.8 t-20 59.78 44.96 13.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.834 -0.542 . . . . 1.55 110.297 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.613 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 80.5 mt-30 -140.22 158.38 44.13 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.174 -0.954 . . . . 1.99 109.709 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 81.3 t -120.14 130.05 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.032 -0.729 . . . . 0.77 109.032 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -101.61 120.98 41.16 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.383 -0.823 . . . . 0.98 108.918 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.445 HG22 HD22 ' A' ' 218' ' ' LEU . 49.0 t -103.36 119.23 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.548 -0.72 . . . . 0.85 109.759 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 63.79 66.9 1.03 Allowed Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.186 -0.946 . . . . 1.66 109.931 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -91.34 128.34 1.17 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 123.255 2.636 . . . . 0.95 112.661 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 30.4 p -69.01 169.37 11.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 1.84 109.422 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -60.07 -39.4 85.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 2.74 108.942 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.02 -38.22 82.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.344 -0.848 . . . . 2.89 110.083 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.61 -40.22 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.841 -1.162 . . . . 1.3 108.836 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 94.3 mt -66.64 -40.89 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.047 -1.033 . . . . 1.09 109.374 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -62.93 -40.1 96.62 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.138 -0.976 . . . . 2.43 109.048 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -67.66 -42.1 82.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 2.78 108.748 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 94.7 mtp -69.98 -30.68 68.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.591 -0.693 . . . . 1.25 109.816 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -69.2 -39.91 78.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.953 -1.092 . . . . 2.63 109.503 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.42 -40.1 89.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.359 -0.838 . . . . 1.8 109.57 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 69.7 t -62.84 -41.31 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 2.13 109.476 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -60.09 -42.14 93.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.331 -0.855 . . . . 3.17 109.79 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -62.46 -39.85 94.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.131 -0.981 . . . . 1.78 108.977 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -60.98 -37.02 80.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.5 -0.75 . . . . 2.47 109.298 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 69.6 t -59.96 -40.04 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -0.9 . . . . 2.09 109.009 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.02 -46.4 89.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.297 -0.877 . . . . 2.54 109.464 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 68.9 m -76.97 -22.12 53.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.183 -0.948 . . . . 2.99 109.357 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -60.03 -39.97 87.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.458 -0.776 . . . . 3.34 111.087 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' A' ' 252' ' ' GLU . 17.5 pttp -56.65 -34.42 67.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.794 -1.191 . . . . 3.88 109.63 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 253' ' ' LEU . . . -71.2 51.93 0.17 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.891 -1.131 . . . . 4.43 108.826 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 250' ' ' LYS . 25.4 tp10 -62.83 0.29 0.56 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.388 -0.82 . . . . 5.42 109.228 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.467 ' H ' ' C ' ' A' ' 251' ' ' ALA . 54.7 mt -60.97 -40.06 91.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.141 -0.974 . . . . 6.1 109.477 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 55.57 50.1 15.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.122 -0.986 . . . . 7.37 109.432 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -60.07 -43.03 95.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 8.01 109.414 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 58.5 mt -80.08 -69.93 0.55 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.995 -1.065 . . . . 9.05 108.572 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? 177.17 115.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.944 -0.761 . . . . 10.56 108.944 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 258' ' ' ASP . 25.7 p-10 -92.61 -56.56 2.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.032 -1.042 . . . . 11.32 108.676 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.454 ' N ' ' OD1' ' A' ' 258' ' ' ASP . 61.4 mtp180 . . . . . 0 C--N 1.303 -1.455 0 CA-C-O 118.051 -0.976 . . . . 12.42 109.497 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 33.1 ttp . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.513 0.673 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -150.96 148.53 28.5 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -150.02 159.36 44.46 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.087 -1.008 . . . . 0.0 110.397 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -157.56 154.02 27.85 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 -111.69 131.57 55.2 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.115 -0.99 . . . . 0.0 110.203 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.27 121.77 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-O 122.348 1.071 . . . . 0.0 112.307 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 307' ' ' THR . . . . . 0.533 ' O ' HG23 ' B' ' 309' ' ' THR . 56.7 m -80.4 101.2 8.87 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.804 0.811 . . . . 0.0 110.799 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' B' ' 358' ' ' GLY . 97.5 mt -50.71 116.73 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.258 1.028 . . . . 0.0 109.673 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 309' ' ' THR . . . . . 0.533 HG23 ' O ' ' B' ' 307' ' ' THR . 25.1 p -106.59 14.1 27.44 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.946 -177.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.42 116.67 42.37 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.994 -1.066 . . . . 0.0 108.445 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -51.85 -17.08 4.79 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 CA-C-N 120.216 1.113 . . . . 0.0 113.725 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -111.0 11.3 22.14 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.257 -0.902 . . . . 0.0 109.991 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 69.47 169.78 6.93 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.599 ' O ' ' NH2' ' A' ' 126' ' ' ARG . 3.1 tp -84.6 93.27 8.34 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.087 -1.243 . . . . 0.0 109.333 -178.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.58 ' C ' HH21 ' A' ' 126' ' ' ARG . 3.8 p80 -96.48 -161.48 0.87 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 120.885 -1.134 . . . . 0.0 109.902 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 4.0 m -58.06 -41.58 83.63 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.884 -1.135 . . . . 0.0 112.726 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.603 ' NH1' ' HB2' ' A' ' 71' ' ' ALA . 14.7 tpt180 -57.31 -59.44 12.8 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 120.308 -1.495 . . . . 0.0 111.068 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.92 -42.9 17.56 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 CA-C-N 120.485 1.209 . . . . 0.0 111.606 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.89 -17.28 35.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.178 -0.951 . . . . 0.0 110.392 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -82.16 -38.55 24.53 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -72.16 -34.81 68.76 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -64.65 -58.28 6.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.39 -0.819 . . . . 0.0 109.796 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.68 -32.91 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.82 -1.175 . . . . 0.0 109.085 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -59.93 -46.65 88.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.422 -0.799 . . . . 0.0 109.112 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.29 -44.06 84.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 110.422 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 326' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' B' ' 328' ' ' GLY . . . -60.03 -53.41 58.19 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.855 -1.153 . . . . 0.0 111.248 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -51.72 -10.45 0.11 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.883 -1.135 . . . . 0.0 110.136 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 328' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' B' ' 326' ' ' ALA . . . -75.9 -24.75 68.64 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -105.23 139.14 40.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.41 -1.053 . . . . 0.0 109.248 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 8.8 p -90.61 -9.8 45.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.275 -0.89 . . . . 0.0 110.115 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.479 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 14.0 t -64.47 155.21 33.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.101 -1.0 . . . . 0.0 109.963 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.6 131.73 45.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.907 . . . . 0.0 108.792 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 82.9 mt -132.44 132.95 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.392 -0.818 . . . . 0.0 109.938 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.4 m -131.56 149.94 52.33 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.484 -0.76 . . . . 0.0 109.128 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 66.6 t -122.43 117.41 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 94.7 m -107.5 133.43 52.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.228 -0.92 . . . . 0.0 109.697 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 4.8 p -139.85 115.94 10.41 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.766 0.793 . . . . 0.0 110.631 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 45.22 50.02 9.77 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.641 -0.662 . . . . 0.0 112.744 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.32 -16.41 48.92 Favored Glycine 0 N--CA 1.5 2.957 0 O-C-N 120.058 -1.651 . . . . 0.0 112.242 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -110.69 121.32 45.03 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 118.87 1.335 . . . . 0.0 109.69 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 86.4 p -126.76 148.33 49.91 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.815 0.816 . . . . 0.0 110.151 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 342' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -145.23 170.57 16.02 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.563 0.697 . . . . 0.0 110.093 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 17.3 m -89.04 134.73 33.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.519 -0.738 . . . . 0.0 110.518 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.451 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -75.91 -16.38 60.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.053 -1.03 . . . . 0.0 109.504 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -84.7 20.87 1.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 346' ' ' SER . . . . . 0.451 ' H ' ' C ' ' B' ' 344' ' ' ALA . 93.8 p -151.61 96.91 2.31 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.43 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.676 HD23 HD22 ' A' ' 79' ' ' LEU . 51.7 tp -60.05 -33.76 72.48 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.831 ' CE2' HD11 ' A' ' 79' ' ' LEU . 60.0 m-85 -56.27 -52.95 62.6 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.931 -1.106 . . . . 0.0 110.034 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -69.82 -28.67 65.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 110.421 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.576 HD12 ' HA ' ' B' ' 347' ' ' LEU . 80.8 mt -59.96 -50.01 75.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.101 -0.999 . . . . 0.0 109.728 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.53 ' O ' HD22 ' A' ' 123' ' ' LEU . 1.2 mp0 -45.07 -20.22 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.017 -1.052 . . . . 0.0 111.189 -178.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.415 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.3 p -80.3 -10.61 59.76 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.19 -1.568 . . . . 0.0 109.444 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.415 HD11 ' HB3' ' B' ' 342' ' ' ALA . 45.9 mt -95.79 115.29 27.21 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.176 -0.953 . . . . 0.0 108.77 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.84 95.21 1.24 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 22.8 mt -103.9 94.25 5.31 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.416 -1.05 . . . . 0.0 109.286 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 79.0 p -100.72 153.57 19.33 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.233 -0.917 . . . . 0.0 111.234 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 14.9 tm0? -41.95 111.9 0.28 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.202 0.525 . . . . 0.0 110.664 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 358' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 103.14 6.09 45.78 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 91.7 m -83.69 111.24 18.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.157 . . . . 0.0 111.22 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 8.6 t -78.47 111.99 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 122.15 0.976 . . . . 0.0 109.801 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 12.3 m -110.08 177.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 40.4 m -130.26 126.9 38.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 64.0 mt -103.82 117.44 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 53.6 m -121.13 132.33 54.79 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.79 148.31 38.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.279 -0.888 . . . . 0.0 109.572 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -142.38 121.85 13.24 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.532 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.91 -158.39 29.07 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 119.192 -1.48 . . . . 0.0 111.159 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -59.9 -51.08 71.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 122.293 -0.534 . . . . 0.0 112.219 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.479 ' H ' ' HB2' ' B' ' 331' ' ' SER . 85.1 m-20 -108.27 10.78 27.68 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 120.86 -1.15 . . . . 0.0 111.249 -177.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.4 pt-20 -39.9 -34.12 0.25 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.338 -0.852 . . . . 0.0 112.232 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -68.3 -42.64 79.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.535 -1.353 . . . . 0.0 110.432 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -71.1 -52.56 18.66 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.991 -1.068 . . . . 0.0 109.653 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.69 -36.78 2.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.333 -0.854 . . . . 0.0 111.519 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.513 ' O ' HG23 ' B' ' 378' ' ' VAL . 58.9 t -81.14 -36.02 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.521 -1.362 . . . . 0.0 109.502 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -69.98 -40.01 75.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.375 -0.828 . . . . 0.0 111.921 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -77.59 -46.78 21.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.612 -1.305 . . . . 0.0 110.151 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.35 -36.38 80.02 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.294 -0.879 . . . . 0.0 109.116 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.513 HG23 ' O ' ' B' ' 374' ' ' VAL . 53.8 t -73.68 -37.45 49.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -74.83 -17.01 60.67 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' B' ' 383' ' ' GLU . 41.9 tp -78.87 -68.07 0.69 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 57.3 mtt -54.3 -19.5 5.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.01 -1.056 . . . . 0.0 109.136 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.2 -23.72 51.44 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' B' ' 380' ' ' LEU . 97.5 mt-10 -108.62 4.37 23.88 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.626 -0.671 . . . . 0.0 110.962 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 69.0 mt -82.67 122.31 27.98 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.578 -1.326 . . . . 0.0 110.129 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.041 -0.98 . . . . 0.0 108.933 179.231 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.188 0.518 . . . . 2.91 109.691 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 87.7 mt -110.03 127.94 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.73 -0.841 . . . . 1.2 108.73 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.2 m -140.04 150.73 44.75 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.296 -0.877 . . . . 1.4 109.258 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.86 -163.89 9.7 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 108.465 -1.854 . . . . 1.05 108.465 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 6' ' ' LEU . 89.9 mt -90.37 -17.37 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.747 -1.443 . . . . 1.15 109.575 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.4 tp 55.1 106.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.496 -0.752 . . . . 0.98 109.184 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.26 -29.12 12.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.333 -0.855 . . . . 0.88 109.065 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 14.8 m -127.62 116.62 21.09 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 109.356 -0.609 . . . . 1.69 109.356 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.85 148.05 19.61 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 121.991 1.794 . . . . 0.85 112.453 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.91 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 143.36 178.78 19.47 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 108.853 -1.699 . . . . 0.92 108.853 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.412 HG22 ' N ' ' A' ' 12' ' ' ALA . 96.7 mt -122.13 156.36 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.231 -1.158 . . . . 0.81 109.436 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.412 ' N ' HG22 ' A' ' 11' ' ' ILE . . . -155.55 156.56 35.36 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.965 -1.084 . . . . 0.51 110.625 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.4 m-85 -137.69 128.99 27.85 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.03 -1.1 . . . . 0.62 108.03 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.43 178.38 47.77 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 118.505 -1.807 . . . . 0.55 110.842 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -78.86 156.7 28.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.786 -0.832 . . . . 2.1 109.14 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.593 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -107.62 133.03 52.65 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.392 -0.817 . . . . 0.77 110.923 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.3 tp -107.45 137.85 44.73 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 107.997 -1.112 . . . . 0.91 107.997 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 66.2 tp -115.76 122.66 46.12 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.526 -0.734 . . . . 0.93 109.561 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.9 mt -82.26 103.21 11.68 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.414 -0.804 . . . . 0.93 109.416 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -94.25 136.56 34.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.296 -0.878 . . . . 2.75 109.496 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 58.2 mp0 -131.02 134.84 47.05 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.361 -0.837 . . . . 3.0 109.086 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.17 150.76 28.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.133 -0.98 . . . . 2.77 109.133 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -65.96 149.22 50.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.943 -1.098 . . . . 2.94 109.245 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.527 ' CG1' HH12 ' A' ' 139' ' ' ARG . 88.2 mt -89.78 124.83 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 0.95 109.22 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.63 122.87 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.236 -0.915 . . . . 1.28 109.477 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.9 mt -108.09 133.22 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.802 -0.814 . . . . 1.21 108.802 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -86.97 118.27 26.24 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.792 -1.192 . . . . 1.81 109.58 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -87.51 -1.0 57.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 2.8 109.613 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.81 136.86 49.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.112 -0.993 . . . . 2.87 109.184 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -80.99 159.51 24.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.952 -1.092 . . . . 2.35 109.488 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.416 HD13 ' HG3' ' A' ' 39' ' ' GLU . 2.9 pt -102.57 167.67 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.303 -0.873 . . . . 0.97 109.883 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.3 p -94.1 175.27 6.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.229 -0.92 . . . . 1.17 109.093 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.74 -50.97 71.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.089 -1.007 . . . . 1.18 110.746 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 55.8 t0 -54.71 -29.41 53.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.561 -1.337 . . . . 2.56 109.681 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -82.02 -10.04 59.36 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.316 -0.865 . . . . 1.79 110.386 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.0 t -60.22 -50.3 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.824 -1.172 . . . . 1.0 109.068 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.67 -39.9 93.04 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.404 -0.81 . . . . 1.77 109.54 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -62.68 -43.79 97.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.903 . . . . 2.7 110.981 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.416 ' HG3' HD13 ' A' ' 31' ' ' ILE . 75.5 mm-40 -61.89 -40.19 94.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.84 -1.162 . . . . 1.51 110.171 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 66.4 t -59.87 -46.23 94.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 C-N-CA 118.722 -1.191 . . . . 0.93 108.86 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -59.93 -42.58 94.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.881 -1.137 . . . . 1.81 109.434 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.26 -41.52 93.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.807 -1.183 . . . . 2.78 108.222 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -64.01 -46.9 82.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.355 -0.841 . . . . 0.78 109.143 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.1 tp -59.96 -48.81 80.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.28 -0.887 . . . . 1.07 108.672 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.0 t -63.26 -41.95 99.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.075 -1.015 . . . . 1.12 109.543 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.62 -46.21 92.73 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.154 -1.578 . . . . 0.84 109.154 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -63.3 -33.56 75.78 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.261 -1.141 . . . . 3.09 108.739 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.25 -42.85 87.33 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.369 -0.832 . . . . 0.88 109.283 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 50' ' ' ALA . 1.2 ttmp? -63.68 -73.62 0.11 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.792 -1.193 . . . . 2.59 107.915 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.19 -41.14 0.37 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.415 -0.803 . . . . 0.7 111.411 -178.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.2 p -54.22 -54.77 35.42 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.42 -1.425 . . . . 1.4 108.699 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.99 -39.97 83.17 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.462 -0.774 . . . . 0.67 111.301 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -68.37 -39.95 81.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.77 -1.206 . . . . 1.66 110.668 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.13 -39.97 96.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.979 -1.076 . . . . 1.58 108.736 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -63.91 -34.14 77.29 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.454 -0.779 . . . . 1.35 109.087 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.6 m -65.89 -44.13 86.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 0.77 108.883 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.9 mt -60.14 -37.75 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.675 -0.861 . . . . 0.63 108.675 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -59.8 -51.06 71.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.473 -0.767 . . . . 1.14 110.204 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 m -55.78 -33.28 64.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.051 -1.03 . . . . 0.79 110.042 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -69.92 -37.96 76.11 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.422 -0.798 . . . . 1.53 109.555 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.413 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -68.78 -47.67 65.6 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.204 0.526 . . . . 0.57 111.227 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.68 -50.97 61.81 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 110.004 -1.239 . . . . 0.75 110.004 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.96 -42.11 73.63 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.005 -1.291 . . . . 1.59 110.562 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.5 m -69.28 -60.69 2.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.088 -1.007 . . . . 0.73 112.111 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -96.52 -50.93 4.54 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.935 -1.103 . . . . 0.75 111.422 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.15 -163.86 26.98 Favored Glycine 0 N--CA 1.501 2.974 0 O-C-N 120.731 -1.231 . . . . 1.22 111.048 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.02 -25.15 63.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.772 -0.84 . . . . 5.81 110.65 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -60.33 -36.76 78.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.902 . . . . 3.37 110.197 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.479 ' NZ ' ' CE1' ' A' ' 189' ' ' HIS . 69.3 mmtt -97.78 -19.85 17.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.251 -0.905 . . . . 1.77 110.352 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.1 -46.13 68.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.909 -1.119 . . . . 1.65 110.224 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.617 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -62.7 -32.91 74.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.643 -0.661 . . . . 0.77 110.116 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.09 -40.83 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.867 -1.146 . . . . 0.8 109.045 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -65.11 -39.83 93.67 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.14 -0.975 . . . . 0.88 109.776 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -60.09 -39.98 88.02 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.085 -1.009 . . . . 1.37 109.528 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.14 -49.3 72.55 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.623 -1.791 . . . . 0.62 108.623 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -60.91 -43.61 98.32 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.344 -1.091 . . . . 1.5 108.837 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.1 mt -68.94 -47.71 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.254 -0.903 . . . . 0.63 109.09 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.8 ttp -60.25 -42.94 96.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.899 -1.126 . . . . 1.51 109.792 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.841 HD11 ' CE2' ' B' ' 348' ' ' PHE . 63.4 tp -64.81 -40.0 94.5 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.376 -0.828 . . . . 0.77 109.772 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.7 tp -64.52 -40.05 94.9 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.292 -0.88 . . . . 0.62 110.189 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -81.55 4.86 19.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.974 -1.078 . . . . 1.47 109.844 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 51.7 t0 -50.26 132.02 24.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 1.47 110.07 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 97.7 mt-10 -62.02 -18.96 62.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.637 -0.664 . . . . 1.78 110.754 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -72.42 -36.05 68.5 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.853 -1.154 . . . . 2.53 108.935 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.17 -40.38 78.18 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.974 -0.75 . . . . 0.8 108.974 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.04 -49.87 75.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.566 -0.709 . . . . 1.42 110.023 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.13 -41.42 73.96 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.329 -0.857 . . . . 1.71 111.284 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.64 -40.35 73.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.947 -1.096 . . . . 1.57 111.512 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.8 -49.34 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.88 -1.137 . . . . 0.65 109.591 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.4 mt -65.29 -37.64 80.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.634 -0.666 . . . . 0.82 110.275 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.29 98.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 0.79 110.365 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 96' ' ' LYS . 81.5 mt -61.67 -46.38 89.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.885 -1.134 . . . . 0.95 109.085 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.2 mt -61.06 -50.2 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.963 0.887 . . . . 0.66 109.261 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.02 -40.95 74.9 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 120.008 -0.677 . . . . 2.2 110.451 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -82.34 -49.5 9.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.308 -0.87 . . . . 1.65 111.805 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 92' ' ' LEU . 65.7 mmtt -92.24 -2.05 56.73 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.033 -1.042 . . . . 2.03 111.788 -177.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 38.4 m170 55.51 32.77 19.7 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.844 -1.16 . . . . 1.42 109.082 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 93.5 mtp -90.18 166.72 13.21 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.707 -0.621 . . . . 1.18 109.826 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.2 p -78.39 158.62 28.69 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.451 -0.944 . . . . 0.98 108.451 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.99 -35.73 74.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.985 -1.072 . . . . 0.64 109.901 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -67.14 -40.01 86.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 2.07 109.437 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.41 -41.88 21.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.395 -0.816 . . . . 0.73 109.698 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.68 -50.5 66.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.418 -0.802 . . . . 0.54 110.417 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.07 88.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.164 -0.96 . . . . 0.56 109.836 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -58.34 -39.93 80.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 1.54 109.761 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.79 -40.13 96.39 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.217 -0.927 . . . . 1.33 110.034 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.3 t -66.51 -52.53 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.213 -0.929 . . . . 0.72 111.56 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.9 mm -69.34 -39.91 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.824 -1.173 . . . . 0.85 108.772 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.41 -34.85 76.75 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.615 -0.883 . . . . 2.44 108.615 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.32 -47.49 90.58 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 120.645 -0.788 . . . . 0.98 111.135 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -66.17 -48.12 71.78 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.614 -1.521 . . . . 1.41 109.602 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.74 78.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.895 . . . . 1.2 109.505 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 84.1 p -57.69 -40.2 78.91 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.091 -1.005 . . . . 1.7 108.748 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.8 89.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 1.47 109.614 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.4 mt -63.53 -43.35 97.39 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.798 -1.189 . . . . 1.56 110.274 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.18 -30.47 69.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.681 -1.262 . . . . 2.2 109.739 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.95 -23.72 63.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.991 -1.068 . . . . 2.12 108.598 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.48 HD13 HD13 ' A' ' 123' ' ' LEU . 26.0 mt -62.4 147.73 47.59 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.291 -0.881 . . . . 2.0 109.128 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -94.95 49.16 1.21 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.085 -1.009 . . . . 3.23 109.734 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -136.25 130.27 32.8 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.198 -0.939 . . . . 2.49 109.888 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.06 -30.32 67.55 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.445 -0.784 . . . . 3.95 110.248 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.512 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.1 t80 -72.11 -38.24 69.34 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.287 -0.883 . . . . 2.0 110.716 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.576 HD22 ' O ' ' B' ' 351' ' ' GLN . 89.4 mt -70.0 -32.28 70.39 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.045 -1.034 . . . . 1.86 108.249 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -60.24 -39.21 85.9 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.601 -0.888 . . . . 2.84 108.601 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -59.75 -48.35 82.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.331 -0.856 . . . . 2.73 110.108 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.6 HH21 ' C ' ' B' ' 315' ' ' HIS . 84.5 mtt180 -60.12 -39.68 87.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.679 -1.263 . . . . 2.77 108.495 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.51 -32.32 68.72 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.294 -0.879 . . . . 1.19 108.65 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.8 -40.22 88.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 1.2 109.588 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -65.55 -40.12 92.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 1.55 109.515 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.49 -41.85 86.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.45 -0.781 . . . . 0.8 109.292 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -62.03 -36.31 81.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 3.09 109.5 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -60.0 -40.01 87.76 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.263 -0.898 . . . . 1.46 110.077 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.26 -44.16 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.151 -0.968 . . . . 0.71 109.791 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.37 -39.72 98.13 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.474 -1.051 . . . . 0.57 110.474 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -58.94 -45.78 89.61 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.893 -1.357 . . . . 2.59 109.624 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.502 HH11 ' HG2' ' A' ' 136' ' ' ARG . 24.3 mtt-85 -63.22 -36.33 83.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.874 -1.141 . . . . 2.83 110.339 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.6 tp -56.19 -44.59 79.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.309 -0.869 . . . . 1.25 109.974 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.96 -40.07 91.96 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.032 -1.043 . . . . 0.7 108.791 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.634 HH11 ' HG2' ' A' ' 139' ' ' ARG . 11.5 mtt-85 -67.73 -39.94 84.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.348 -0.845 . . . . 2.57 109.339 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -68.06 -38.03 81.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.632 -0.667 . . . . 1.23 111.668 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.3 mt -73.73 -45.55 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.227 -1.546 . . . . 0.81 108.571 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.7 mt -70.0 -33.7 72.37 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.614 -0.679 . . . . 1.0 109.493 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.78 40.2 7.27 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.193 -1.563 . . . . 0.89 109.193 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.2 tp -74.94 150.39 39.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.521 -0.987 . . . . 1.14 110.17 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -68.4 141.29 55.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.322 -0.861 . . . . 4.6 110.174 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.9 mt -116.48 129.95 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 121.785 0.802 . . . . 1.24 109.474 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 15.0 mm -56.79 -50.17 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.794 -0.566 . . . . 1.54 111.137 -177.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.0 t0 67.09 104.31 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.266 -0.896 . . . . 1.5 109.5 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.4 mt -81.06 -7.58 59.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.275 -0.89 . . . . 0.79 110.799 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.7 p -80.13 -17.32 52.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.65 -1.281 . . . . 1.4 109.355 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.8 17.62 3.31 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.509 -0.745 . . . . 0.92 111.825 -177.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 50.1 mt -91.04 114.57 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.727 -1.233 . . . . 0.88 109.145 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -101.34 -11.01 19.76 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.385 -0.822 . . . . 2.45 110.604 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -110.53 146.6 35.75 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.16 -0.962 . . . . 1.52 109.442 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.94 130.58 43.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.148 -0.97 . . . . 1.58 109.407 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.1 m -152.27 163.71 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.939 -0.763 . . . . 0.69 108.939 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.1 mt -93.14 149.75 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 106.028 -1.842 . . . . 0.61 106.028 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.426 HD22 HD11 ' A' ' 171' ' ' LEU . 52.5 tp -100.44 117.81 35.37 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.996 -1.065 . . . . 0.87 110.908 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.1 t -121.94 129.92 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 N-CA-C 108.694 -0.854 . . . . 0.71 108.694 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.22 164.49 35.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.976 -1.077 . . . . 0.81 109.153 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.433 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.86 -35.69 74.9 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.362 -1.461 . . . . 0.98 108.775 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 52.3 t0 -170.6 143.81 2.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.441 -0.948 . . . . 2.25 108.441 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.545 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 26.1 mt -112.71 129.72 56.31 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.52 -0.919 . . . . 0.78 108.52 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.3 p -83.63 145.42 47.57 Favored Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.239 -0.913 . . . . 0.98 109.004 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -38.01 -36.28 0.46 Allowed 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.031 1.821 . . . . 0.81 111.581 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.4 m -59.87 -40.0 87.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.407 -0.808 . . . . 0.9 109.656 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.5 -40.19 77.14 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.13 -0.982 . . . . 1.61 109.713 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 68.5 p -56.1 -28.14 56.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.067 -1.021 . . . . 0.61 110.739 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -74.58 -56.35 4.92 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.821 -1.174 . . . . 0.6 109.711 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -78.88 39.58 0.37 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.532 -1.285 . . . . 1.4 107.532 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.466 ' H ' ' C ' ' A' ' 169' ' ' ALA . 15.3 tp -99.93 131.86 45.63 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.695 -0.628 . . . . 0.7 109.522 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -88.05 100.27 12.8 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.144 -1.058 . . . . 2.35 108.144 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 65.9 mt -64.66 -42.98 95.03 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.323 -0.861 . . . . 1.51 110.791 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -69.89 -24.24 63.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.66 -1.275 . . . . 2.33 111.569 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -94.39 -13.51 26.23 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.6 -1.312 . . . . 1.92 109.767 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 178' ' ' GLY . 69.6 t -104.85 116.17 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.238 -0.914 . . . . 0.67 108.541 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.7 mt -83.25 2.19 37.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.936 . . . . 1.53 111.007 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.493 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 171.86 172.33 37.73 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.231 -1.461 . . . . 0.48 109.735 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.429 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 14.2 m-85 -130.63 126.67 37.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.516 -0.991 . . . . 0.55 108.846 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.02 126.25 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.2 -0.938 . . . . 0.65 108.623 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.407 ' C ' ' HG1' ' A' ' 205' ' ' THR . 80.6 p -147.94 158.43 44.04 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.903 -1.123 . . . . 0.82 110.771 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 44.1 p30 -103.92 24.67 10.96 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.956 -0.757 . . . . 2.46 108.956 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -57.78 -159.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.993 -1.067 . . . . 1.28 110.794 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.87 -54.38 9.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.155 -1.178 . . . . 2.19 110.155 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 156.69 -129.94 2.55 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 120.937 -1.331 . . . . 2.13 110.502 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.462 ' C ' ' H ' ' A' ' 188' ' ' SER . 30.2 ttt-85 -63.2 -39.87 95.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.486 -1.008 . . . . 5.86 110.49 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 37.4 p -62.0 1.88 0.26 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.161 -0.962 . . . . 3.72 110.231 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 186' ' ' ARG . 47.5 t -91.52 130.0 37.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.03 -1.044 . . . . 1.74 109.716 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' HIS . . . . . 0.479 ' CE1' ' NZ ' ' A' ' 69' ' ' LYS . 84.8 t60 -48.28 -44.15 33.38 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.897 0.856 . . . . 0.95 108.967 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.409 ' H ' HG23 ' A' ' 190' ' ' THR . 4.1 p -51.95 -36.33 49.0 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 116.116 -0.493 . . . . 1.55 110.869 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 49.6 m -65.96 -40.83 91.62 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.947 -1.096 . . . . 1.51 111.843 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.2 mm -63.88 -43.2 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.976 -1.077 . . . . 1.67 110.668 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.2 mtp -66.02 -39.95 90.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.249 -0.907 . . . . 1.02 111.036 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.14 -43.34 82.37 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.468 -1.395 . . . . 0.68 109.083 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -59.93 -48.85 80.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.125 -0.984 . . . . 2.93 110.086 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.2 m -68.09 -35.11 77.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.043 -1.036 . . . . 0.86 110.084 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 30.2 mt -71.56 -26.22 62.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.182 -0.949 . . . . 0.67 108.543 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 62.01 51.54 3.64 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.428 0.632 . . . . 1.5 110.494 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 8' ' ' SER . 72.0 mt -129.59 133.07 24.66 Favored Pre-proline 0 N--CA 1.501 2.125 0 N-CA-C 108.541 -0.911 . . . . 0.72 108.541 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -42.16 130.73 4.64 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.0 1.8 . . . . 0.61 112.427 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -169.31 148.8 3.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.93 -1.106 . . . . 0.66 111.326 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 78.8 mt -127.82 146.2 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 N-CA-C 107.985 -1.117 . . . . 0.79 107.985 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.0 m -126.0 -10.55 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 O-C-N 120.734 -1.229 . . . . 0.91 111.51 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.0 22.52 27.41 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 110.323 -1.111 . . . . 1.01 110.323 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.407 ' HG1' ' C ' ' A' ' 181' ' ' THR . 2.8 p -43.99 -42.99 6.36 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.317 -1.108 . . . . 0.99 109.834 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.73 -50.96 3.23 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.204 -0.998 . . . . 1.12 111.068 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 29.1 p -159.25 39.27 0.21 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.547 -1.56 . . . . 1.72 111.299 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.2 -35.76 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.952 -1.093 . . . . 0.89 108.378 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.463 ' H ' HG23 ' A' ' 209' ' ' THR . 6.4 p -55.72 -32.14 63.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.506 -0.746 . . . . 1.03 110.301 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 72.4 p -80.04 -15.65 56.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.951 -1.093 . . . . 1.83 109.84 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -99.76 -13.07 19.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.412 -0.805 . . . . 2.27 110.041 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 52.7 t -106.72 138.07 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 CA-C-O 121.773 0.797 . . . . 0.92 110.713 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.423 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -114.83 153.67 30.01 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.216 -1.402 . . . . 2.2 107.216 178.339 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.459 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 17.5 p-10 -57.63 138.91 54.83 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.914 -1.116 . . . . 2.36 110.546 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.5 m-20 84.36 5.09 0.67 Allowed 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 120.984 0.421 . . . . 2.38 110.758 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 74.8 m-20 -74.62 137.88 42.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.935 -1.103 . . . . 2.09 109.638 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -88.1 118.12 27.45 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.504 -1.295 . . . . 1.27 107.504 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.593 HD12 ' HB2' ' A' ' 16' ' ' ALA . 60.6 mt -128.95 150.36 50.41 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.493 -0.754 . . . . 0.75 110.611 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.9 mt -117.67 128.14 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.317 -1.734 . . . . 0.63 106.317 177.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.3 tp -101.08 120.88 40.85 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.043 -1.036 . . . . 0.7 109.385 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 223' ' ' VAL . 95.3 m-20 -76.32 -44.79 35.26 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.951 -1.093 . . . . 2.31 109.491 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.91 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.25 16.6 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.463 -0.94 . . . . 0.78 108.463 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 221' ' ' ASP . 45.9 t -135.48 -42.97 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.549 -1.278 . . . . 1.04 107.549 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.433 ' H ' ' HB3' ' A' ' 221' ' ' ASP . 84.4 m-20 -99.79 2.74 44.33 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.014 -1.106 . . . . 2.44 108.014 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 60.24 42.42 15.19 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.806 -0.559 . . . . 1.55 109.697 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -141.96 155.46 45.47 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.173 -0.955 . . . . 1.99 110.119 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.0 t -124.8 131.39 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.594 -0.891 . . . . 0.77 108.594 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -102.48 121.74 42.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.326 -0.859 . . . . 0.98 109.325 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 43.9 t -100.59 113.93 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.455 -0.778 . . . . 0.85 110.13 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 53.48 61.96 10.04 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.237 -0.914 . . . . 1.66 111.59 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -87.35 149.27 7.77 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.976 2.451 . . . . 0.95 112.865 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 42.8 p -70.32 162.62 28.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.444 -0.785 . . . . 1.84 110.271 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -59.66 -35.19 73.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.489 -0.757 . . . . 2.74 109.304 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -59.96 -40.12 87.98 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.359 -0.838 . . . . 2.89 109.953 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.5 -39.53 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.0 -1.063 . . . . 1.3 109.328 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.545 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 85.5 mt -63.93 -39.63 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.108 -0.995 . . . . 1.09 109.445 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.13 -40.15 88.77 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.08 -1.012 . . . . 2.43 108.47 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -67.04 -40.03 87.07 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.369 -0.832 . . . . 2.78 108.974 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 98.1 mtp -69.81 -29.87 67.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.331 -0.856 . . . . 1.25 108.692 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.582 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -69.77 -36.87 76.12 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.526 -0.916 . . . . 2.63 108.526 178.53 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.78 -39.18 84.05 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.994 -0.743 . . . . 1.8 108.994 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 58.4 t -59.94 -41.43 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.281 -0.887 . . . . 2.13 108.844 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -61.33 -40.21 93.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.185 -0.947 . . . . 3.17 109.702 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.88 -39.18 88.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.239 -0.913 . . . . 1.78 109.858 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -59.98 -38.84 83.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.941 . . . . 2.47 109.498 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 54.1 t -59.92 -43.49 92.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.389 -0.819 . . . . 2.09 109.382 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.68 -44.24 94.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.163 -0.96 . . . . 2.54 109.123 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.8 t -70.83 -26.68 63.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -0.849 . . . . 2.99 109.734 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -60.17 -46.56 89.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.084 -1.01 . . . . 3.34 109.113 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.579 ' O ' ' N ' ' A' ' 252' ' ' GLU . 67.2 mttm -80.27 -71.85 0.44 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.034 -1.041 . . . . 3.88 108.968 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 63.83 -40.42 0.22 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.316 0.579 . . . . 4.43 109.725 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.579 ' N ' ' O ' ' A' ' 250' ' ' LYS . 54.0 tp10 -150.49 88.42 1.5 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.39 -0.967 . . . . 5.42 108.39 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.598 ' H ' HD12 ' A' ' 253' ' ' LEU . 3.0 mp -41.31 -32.78 0.32 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.608 -0.683 . . . . 6.1 109.769 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 253' ' ' LEU . . . 68.99 -17.13 0.21 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.667 -0.646 . . . . 7.37 109.856 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.515 ' H ' ' C ' ' A' ' 253' ' ' LEU . 26.5 mtpp -143.37 124.45 14.45 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.111 -0.993 . . . . 8.01 109.214 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 256' ' ' LEU . 9.6 mp -62.43 -25.9 68.21 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.114 -0.992 . . . . 9.05 108.43 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -67.85 -52.35 37.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.502 -0.749 . . . . 10.56 110.368 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 50.9 t0 50.57 62.88 2.46 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.55 -0.908 . . . . 11.32 108.55 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.52 HH11 ' HG2' ' A' ' 259' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.981 0 CA-C-O 117.937 -1.03 . . . . 12.42 108.821 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 45.0 ttp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 302' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 42.1 t80 -153.64 152.31 30.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.446 -0.784 . . . . 0.0 109.194 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 303' ' ' GLN . . . . . 0.443 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 14.0 pt20 -148.75 158.46 44.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.993 -1.067 . . . . 0.0 110.876 -178.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -152.84 149.88 28.75 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -111.93 131.26 55.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.313 -0.867 . . . . 0.0 110.051 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.4 ' CG1' ' SD ' ' B' ' 381' ' ' MET . 7.4 p -131.16 123.1 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 CA-C-O 122.474 1.131 . . . . 0.0 112.987 -177.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 61.2 m -79.38 103.91 9.63 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.805 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.6 mt -50.8 122.68 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 122.346 1.069 . . . . 0.0 110.296 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 34.6 p -108.43 15.71 23.69 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.697 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.77 116.33 48.91 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.919 -1.113 . . . . 0.0 108.716 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -53.53 -15.26 5.94 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 CA-C-N 120.308 1.146 . . . . 0.0 113.879 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -114.65 12.93 17.3 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.229 -0.919 . . . . 0.0 109.375 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 68.03 174.8 8.51 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.56 ' O ' ' NH2' ' A' ' 126' ' ' ARG . 4.0 tp -84.4 92.39 8.03 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.234 -1.156 . . . . 0.0 110.281 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.6 ' C ' HH21 ' A' ' 126' ' ' ARG . 5.1 p80 -95.94 -162.23 0.93 Allowed 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.778 -1.201 . . . . 0.0 110.06 179.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 22.6 m -58.33 -40.1 81.22 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.93 -1.107 . . . . 0.0 112.661 -175.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.617 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -60.82 -62.79 5.26 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 120.17 -1.581 . . . . 0.0 111.395 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -54.56 -34.37 82.35 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 CA-C-N 120.034 1.048 . . . . 0.0 111.812 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.92 -53.35 59.21 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.337 -0.945 . . . . 0.0 108.948 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.72 -40.66 66.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 0.0 109.387 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -69.96 -41.57 74.31 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 108.878 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.07 -50.97 71.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.557 -0.715 . . . . 0.0 110.535 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 323' ' ' VAL . . . . . 0.417 HG13 ' O ' ' B' ' 344' ' ' ALA . 89.4 t -70.23 -28.83 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.982 -1.074 . . . . 0.0 110.011 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -60.03 -45.82 91.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.142 -0.973 . . . . 0.0 108.472 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -60.6 -49.31 78.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.397 -0.815 . . . . 0.0 109.745 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 326' ' ' ALA . . . . . 0.413 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -63.02 -50.91 68.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.302 -0.874 . . . . 0.0 110.85 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt -49.72 -16.65 0.26 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.085 -1.009 . . . . 0.0 109.671 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 328' ' ' GLY . . . . . 0.413 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -79.3 -23.55 62.89 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.828 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -104.18 139.93 38.53 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.115 -1.227 . . . . 0.0 109.559 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 89.2 m -91.63 -13.32 32.05 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.13 -0.981 . . . . 0.0 110.388 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.476 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 64.6 p -58.85 154.84 14.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.948 -1.095 . . . . 0.0 109.388 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.98 130.87 42.69 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.119 -1.032 . . . . 0.0 108.406 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.9 mt -132.33 133.32 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.603 -0.686 . . . . 0.0 109.583 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.6 m -130.09 151.56 50.5 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.515 -0.741 . . . . 0.0 109.578 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 97.2 t -115.86 139.2 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 91.3 m -129.77 123.95 32.23 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.165 -0.959 . . . . 0.0 109.101 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 11.3 p -138.79 118.22 12.87 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.97 0.891 . . . . 0.0 110.768 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 61.6 t30 42.86 58.05 3.37 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.06 -13.53 31.5 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 120.31 -1.494 . . . . 0.0 113.069 176.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -115.61 127.24 55.07 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 119.336 1.568 . . . . 0.0 109.443 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 74.6 m -123.98 146.56 48.43 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.882 0.849 . . . . 0.0 110.531 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -140.97 163.1 33.87 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.468 0.651 . . . . 0.0 109.624 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 3.4 t -87.05 137.02 32.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.558 -0.714 . . . . 0.0 109.638 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.417 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -76.73 -13.78 60.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.881 -1.137 . . . . 0.0 109.8 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -91.12 19.8 5.51 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 4.6 m -144.28 95.23 2.68 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.269 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.809 HD23 HD22 ' A' ' 79' ' ' LEU . 43.0 tp -59.88 -36.75 77.58 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.841 ' CE2' HD11 ' A' ' 79' ' ' LEU . 63.0 m-85 -56.15 -52.21 65.18 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.092 -1.005 . . . . 0.0 110.964 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -73.77 -23.6 59.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.783 -1.198 . . . . 0.0 110.866 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' B' ' 350' ' ' LEU . 29.9 mt -60.08 -45.61 92.34 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.322 -1.351 . . . . 0.0 108.734 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.588 ' N ' ' NE2' ' B' ' 351' ' ' GLN . 0.1 OUTLIER -50.78 -26.57 5.81 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.123 -0.986 . . . . 0.0 111.892 -178.416 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 44.2 p -72.8 -10.08 59.39 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 119.93 -1.731 . . . . 0.0 109.864 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 39.8 mt -97.46 116.17 29.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.212 -0.93 . . . . 0.0 109.398 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.69 96.34 1.16 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 19.3 mt -103.04 92.17 4.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.355 -1.085 . . . . 0.0 109.105 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 64.9 p -93.5 167.08 11.93 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.959 -1.088 . . . . 0.0 110.946 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -57.02 114.74 2.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.705 -0.622 . . . . 0.0 110.699 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 100.09 7.53 52.33 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 52.2 m -83.8 112.59 20.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -1.107 . . . . 0.0 110.634 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 13.5 t -78.03 114.36 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 122.263 1.03 . . . . 0.0 109.625 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 11.8 m -110.81 177.46 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 62.4 m -131.25 129.3 41.41 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 89.3 mt -104.11 118.4 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 37.3 p -121.64 133.65 54.98 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.11 154.07 40.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.087 -1.008 . . . . 0.0 110.239 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -144.61 122.39 11.91 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 160.28 -159.29 30.67 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 118.972 -1.585 . . . . 0.0 111.596 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -59.98 -51.8 68.13 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.169 -0.606 . . . . 0.0 112.295 -177.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.476 ' H ' ' HB3' ' B' ' 331' ' ' SER . 75.2 m-20 -109.31 10.37 25.62 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.775 -1.203 . . . . 0.0 111.059 -177.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.414 ' C ' ' OE1' ' B' ' 370' ' ' GLU . 0.7 OUTLIER -43.64 -34.9 1.58 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.096 -1.003 . . . . 0.0 111.718 -178.352 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -70.06 -42.69 72.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.378 -1.451 . . . . 0.0 110.866 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -69.23 -50.61 45.68 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.902 -1.124 . . . . 0.0 109.562 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -51.45 -31.29 22.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 111.381 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.518 ' O ' HG23 ' B' ' 378' ' ' VAL . 70.3 t -71.74 -39.92 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.545 -1.347 . . . . 0.0 108.845 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -64.48 -62.4 1.62 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.24 -0.913 . . . . 0.0 110.908 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -60.68 -43.69 97.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.392 -1.443 . . . . 0.0 111.416 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.03 -40.12 88.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.437 -1.414 . . . . 0.0 108.359 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.518 HG23 ' O ' ' B' ' 374' ' ' VAL . 52.3 t -66.67 -40.22 85.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.535 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -70.94 -58.5 3.52 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.453 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 55.6 tp -54.41 -34.06 60.58 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.8 -0.563 . . . . 0.0 109.952 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 381' ' ' MET . . . . . 0.4 ' SD ' ' CG1' ' B' ' 306' ' ' VAL . 2.8 ttt -73.83 -40.03 63.62 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 108.819 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -79.19 -4.89 52.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.572 -0.705 . . . . 0.0 109.904 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -109.03 0.47 19.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.294 -0.879 . . . . 0.0 111.313 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 384' ' ' LEU . . . . . 0.453 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 20.4 mt -69.79 131.1 43.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.179 -1.576 . . . . 0.0 108.508 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.593 -179.334 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.7 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.424 -0.584 . . . . 2.91 109.424 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.2 mt -109.97 129.92 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.523 -0.736 . . . . 1.2 109.12 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.6 m -130.3 143.08 50.56 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.46 -0.775 . . . . 1.4 109.558 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.505 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -112.85 -160.0 14.29 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 108.944 -1.662 . . . . 1.05 108.944 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.469 ' O ' ' O ' ' A' ' 6' ' ' LEU . 92.0 mt -94.21 -15.5 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.997 -1.296 . . . . 1.15 110.086 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.9 tp 50.85 103.0 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.248 -0.908 . . . . 0.98 109.505 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.14 -25.79 14.42 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.988 -1.07 . . . . 0.88 109.273 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 35.0 m -133.73 119.67 15.08 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.427 -0.796 . . . . 1.69 109.573 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.91 147.29 16.79 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.08 1.854 . . . . 0.85 112.683 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.819 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.46 -159.33 30.41 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.082 -1.607 . . . . 0.92 109.082 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.4 mt -149.21 150.14 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.167 -1.196 . . . . 0.81 108.669 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.55 157.84 37.47 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.968 -1.083 . . . . 0.51 110.756 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -139.5 128.7 23.91 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.021 -1.103 . . . . 0.62 108.021 178.817 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.0 -177.29 47.09 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 118.758 -1.687 . . . . 0.55 110.92 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 157' ' ' ILE . 98.1 mttt -79.8 159.67 26.44 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.589 -0.948 . . . . 2.1 110.099 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.568 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -106.6 137.38 44.72 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.596 -0.69 . . . . 0.77 110.131 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.5 tp -104.05 131.12 51.63 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.882 -1.155 . . . . 0.91 107.882 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.3 tp -113.04 124.33 52.37 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.195 -0.941 . . . . 0.93 110.022 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.404 HD12 ' HB2' ' A' ' 160' ' ' ALA . 26.3 mt -95.42 103.64 15.51 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.667 -0.646 . . . . 0.93 111.005 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -107.22 136.93 46.22 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.541 -0.724 . . . . 2.75 109.925 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -130.15 138.2 50.52 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.356 -0.84 . . . . 3.0 109.377 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -78.04 158.77 29.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.067 -1.021 . . . . 2.77 109.944 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -72.32 144.21 48.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.424 -0.798 . . . . 2.94 108.905 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.8 mt -84.5 129.61 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.104 -0.998 . . . . 0.95 109.464 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.5 t -94.14 124.73 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.341 -0.849 . . . . 1.28 110.684 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.4 mt -110.37 134.28 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.52 -0.738 . . . . 1.21 109.355 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -93.66 116.45 28.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.978 -1.076 . . . . 1.81 109.141 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -83.72 -1.41 54.06 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.153 -0.967 . . . . 2.8 109.407 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.14 139.99 58.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 2.87 109.655 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -83.13 151.2 25.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.089 -1.007 . . . . 2.35 108.999 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -94.57 166.73 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.864 . . . . 0.97 110.149 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 83.9 p -96.78 173.43 7.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -0.947 . . . . 1.17 108.666 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.79 -49.69 76.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.072 -1.018 . . . . 1.18 109.512 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -53.57 -30.99 44.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.096 -1.003 . . . . 2.56 109.29 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -83.32 -9.92 58.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.58 -0.7 . . . . 1.79 110.669 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.97 -54.0 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.652 -1.28 . . . . 1.0 109.288 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -64.56 -40.14 95.03 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.31 -0.869 . . . . 1.77 110.036 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -65.99 -43.63 87.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.976 -1.078 . . . . 2.7 110.351 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -63.9 -40.04 95.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.86 -1.15 . . . . 1.51 110.168 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.0 -48.16 90.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.778 -1.201 . . . . 0.93 108.647 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -62.25 -43.96 97.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.157 -0.965 . . . . 1.81 109.505 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' A' ' 42' ' ' ARG . 21.8 mtt-85 -60.05 -43.15 95.57 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.857 -1.164 . . . . 2.78 107.857 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -60.73 -49.98 75.32 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.454 -0.943 . . . . 0.78 108.454 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.6 tp -60.06 -43.71 95.23 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.69 -0.856 . . . . 1.07 108.69 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.0 t -66.56 -41.96 87.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 1.12 109.292 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.29 -44.3 66.34 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.214 -1.954 . . . . 0.84 108.214 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.435 HH22 ' HG2' ' A' ' 81' ' ' GLU . 41.2 ttt-85 -62.77 -36.6 83.62 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.14 -1.059 . . . . 3.09 108.14 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.03 -39.39 78.25 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.581 -0.896 . . . . 0.88 108.581 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.2 ttpt -59.5 -73.66 0.08 Allowed 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.355 -1.35 . . . . 2.59 107.355 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.61 -37.73 0.23 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.439 -0.788 . . . . 0.7 111.153 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 52' ' ' ALA . 21.7 p -53.25 -53.61 48.2 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.578 -1.326 . . . . 1.4 108.478 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.402 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . -67.85 -40.86 83.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -0.899 . . . . 0.67 110.884 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -70.01 -39.96 75.52 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.796 -1.19 . . . . 1.66 109.746 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.13 -40.05 96.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.053 -1.029 . . . . 1.58 109.11 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.37 -38.58 84.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.383 -0.823 . . . . 1.35 109.831 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -61.34 -40.47 94.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.77 110.048 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.3 mt -61.58 -39.98 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.374 -0.829 . . . . 0.63 109.188 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -56.58 -50.82 70.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 1.14 109.949 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -60.0 -31.76 70.23 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.376 -0.827 . . . . 0.79 110.729 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -67.87 -39.48 83.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.044 -1.035 . . . . 1.53 109.302 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.7 -41.48 95.99 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.663 -0.648 . . . . 0.57 110.026 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.83 -50.25 69.74 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.493 -1.443 . . . . 0.75 109.493 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.17 -51.55 24.2 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.929 -1.336 . . . . 1.59 109.929 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.7 m -60.11 -65.7 0.64 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.73 112.202 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -94.22 -50.15 5.4 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.802 -1.186 . . . . 0.75 111.439 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.65 -168.24 25.61 Favored Glycine 0 N--CA 1.502 3.071 0 C-N-CA 119.732 -1.223 . . . . 1.22 111.198 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.0 -26.78 64.24 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.939 -0.742 . . . . 5.81 110.21 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.508 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.0 tp10 -60.1 -34.29 73.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.378 -0.826 . . . . 3.37 110.629 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -100.0 -18.01 17.24 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.079 -1.013 . . . . 1.77 109.799 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -69.26 -39.99 78.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.103 -0.998 . . . . 1.65 109.974 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.495 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -63.25 -31.5 72.67 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.308 -0.87 . . . . 0.77 109.47 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.0 mt -60.12 -42.21 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -0.985 . . . . 0.8 109.656 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -65.02 -39.88 94.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.994 -1.066 . . . . 0.88 110.317 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -59.79 -40.12 87.23 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.954 -1.091 . . . . 1.37 108.771 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.47 -46.34 94.01 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.649 -1.781 . . . . 0.62 108.649 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -65.34 -45.06 85.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -1.133 . . . . 1.5 109.646 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.7 mt -69.08 -45.0 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.078 -1.049 . . . . 0.63 109.09 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.3 ttp -61.1 -39.9 91.71 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.936 -1.102 . . . . 1.51 109.436 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.891 HD22 HD23 ' B' ' 347' ' ' LEU . 46.0 tp -63.15 -39.13 93.78 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.495 -0.753 . . . . 0.77 109.506 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 34.6 tp -66.1 -30.27 70.74 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.404 -0.81 . . . . 0.62 109.027 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.435 ' HG2' HH22 ' A' ' 47' ' ' ARG . 96.4 mt-10 -87.2 6.86 30.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.137 -0.977 . . . . 1.47 110.009 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 63.1 t0 -55.86 130.0 41.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.963 -1.085 . . . . 1.47 109.887 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.407 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 99.8 mt-10 -60.5 -19.43 56.88 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.528 -0.732 . . . . 1.78 111.058 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.96 -33.53 72.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.759 -1.213 . . . . 2.53 108.337 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 76.9 mt -71.94 -41.99 67.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.64 -0.663 . . . . 0.8 110.08 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -60.15 -50.12 74.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.02 -1.05 . . . . 1.42 111.056 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -70.12 -40.09 75.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.107 -0.996 . . . . 1.71 110.876 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.88 -39.99 75.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.22 -0.925 . . . . 1.57 111.01 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.2 -49.99 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.997 -1.064 . . . . 0.65 109.676 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.02 -39.11 80.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.538 -0.726 . . . . 0.82 110.436 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.11 -44.03 95.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 0.79 110.631 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.2 mt -62.47 -46.96 86.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.796 -1.19 . . . . 0.95 109.719 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.8 -50.06 81.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-O 121.911 0.862 . . . . 0.66 108.939 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -67.66 -42.54 82.02 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.456 -0.777 . . . . 2.2 110.758 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -80.33 -54.11 6.01 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.965 -1.085 . . . . 1.65 111.956 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -90.06 -1.94 58.03 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.111 -0.993 . . . . 2.03 112.35 -177.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.9 m80 58.32 35.06 24.6 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.837 -1.164 . . . . 1.42 109.776 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.6 mtp -86.56 165.17 16.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.409 -0.807 . . . . 1.18 110.17 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.5 p -79.22 161.37 26.42 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.0 -0.741 . . . . 0.98 109.0 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.29 -42.0 84.51 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.174 -0.954 . . . . 0.64 109.613 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -62.15 -40.04 94.61 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.192 -0.943 . . . . 2.07 109.445 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.27 -41.44 22.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.73 110.111 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.26 -52.02 60.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.333 -0.855 . . . . 0.54 110.402 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.99 87.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.109 -0.994 . . . . 0.56 109.785 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.526 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 82.7 t60 -60.02 -40.22 88.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 1.54 110.048 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.01 -40.05 92.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.145 -0.972 . . . . 1.33 110.671 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.23 -59.95 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.094 -1.004 . . . . 0.72 111.439 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.3 mm -62.28 -42.96 97.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.974 -1.079 . . . . 0.85 109.075 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.526 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 88.7 tt0 -61.47 -40.04 93.1 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.565 -0.902 . . . . 2.44 108.565 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.16 -51.03 61.36 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.367 -1.093 . . . . 0.98 110.367 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 -62.15 -49.96 73.75 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.889 -1.36 . . . . 1.41 109.126 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.07 -40.06 88.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 1.2 109.636 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 56.6 m -60.04 -39.97 87.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.116 -0.99 . . . . 1.7 109.213 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.06 82.21 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.023 -1.048 . . . . 1.47 108.407 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 118' ' ' LEU . 51.8 mt -62.0 -46.47 89.08 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.111 -0.993 . . . . 1.56 108.662 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -47.76 -30.82 4.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.897 -1.127 . . . . 2.2 109.689 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.41 -27.12 68.79 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.013 -1.054 . . . . 2.12 108.354 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 115' ' ' LEU . 74.4 mt -63.32 140.6 58.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.862 . . . . 2.0 108.952 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -94.23 10.12 35.27 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.075 -1.016 . . . . 3.23 110.42 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -98.3 147.0 25.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.005 -1.06 . . . . 2.49 109.891 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.488 ' O ' ' N ' ' A' ' 124' ' ' LYS . 98.9 mt-10 -72.98 -65.53 0.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.52 -0.738 . . . . 3.95 109.159 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.412 ' C ' ' O ' ' A' ' 121' ' ' GLU . 4.7 t80 -39.37 -40.05 0.74 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.867 -0.52 . . . . 2.0 110.602 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.627 ' CD2' HH21 ' A' ' 126' ' ' ARG . 81.0 mt -70.83 -40.0 72.67 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.744 -1.223 . . . . 1.86 108.551 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 121' ' ' GLU . 82.1 tttt -68.3 -34.52 76.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.553 -0.717 . . . . 2.84 109.579 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -60.08 -40.02 88.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.262 -0.899 . . . . 2.73 110.19 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.627 HH21 ' CD2' ' A' ' 123' ' ' LEU . 76.2 mtm180 -68.06 -33.44 74.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.934 -1.104 . . . . 2.77 109.258 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.88 78.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.11 -0.994 . . . . 1.19 108.621 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.27 96.86 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.797 -1.186 . . . . 1.2 107.797 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -69.96 -40.0 75.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.611 -0.681 . . . . 1.55 109.478 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.64 -39.99 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.197 -1.038 . . . . 0.8 108.197 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -65.49 -35.65 81.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.31 -0.868 . . . . 3.09 109.099 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -59.91 -40.12 87.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.252 -0.905 . . . . 1.46 109.541 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.06 -43.09 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.371 -0.83 . . . . 0.71 109.827 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.18 -36.69 50.38 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 120.197 -1.001 . . . . 0.57 110.659 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -59.55 -42.55 92.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.069 -1.254 . . . . 2.59 109.649 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -68.7 -34.37 75.53 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.707 -1.245 . . . . 2.83 109.46 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.6 tp -59.95 -43.07 95.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 1.25 109.478 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.09 -40.17 94.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.003 -1.06 . . . . 0.7 109.146 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -70.11 -36.84 75.13 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 2.57 109.488 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -69.87 -25.58 63.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.353 -0.842 . . . . 1.23 111.24 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.91 -43.76 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.472 -1.393 . . . . 0.81 108.931 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.59 -28.45 58.93 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.494 -0.754 . . . . 1.0 110.079 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.34 5.61 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.112 -1.995 . . . . 0.89 108.112 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.7 tp -73.59 146.87 44.36 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.632 -0.922 . . . . 1.14 109.229 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -60.81 144.12 53.24 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.24 -0.913 . . . . 4.6 109.515 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 97.2 mt -114.49 120.61 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.583 -0.895 . . . . 1.24 108.583 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 10.7 mm -52.6 -53.23 21.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.651 -0.656 . . . . 1.54 110.384 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.2 t0 66.37 103.32 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.548 -0.72 . . . . 1.5 109.285 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 17.1 mt -74.82 -3.08 29.66 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.673 -0.642 . . . . 0.79 110.374 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 53.1 m -86.83 -15.68 38.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.171 -0.955 . . . . 1.4 109.573 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.99 15.83 1.03 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.362 -0.836 . . . . 0.92 111.458 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.547 HD12 ' N ' ' A' ' 152' ' ' ILE . 1.3 mp -90.4 124.71 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.541 -1.349 . . . . 0.88 109.068 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -103.67 -7.09 20.96 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.386 -0.822 . . . . 2.45 110.101 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -119.36 149.43 41.84 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.477 -0.764 . . . . 1.52 110.496 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.35 135.42 54.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.419 -0.8 . . . . 1.58 109.161 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.0 m -152.07 166.02 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.428 -0.795 . . . . 0.69 109.538 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 15' ' ' LYS . 86.3 mt -93.47 149.3 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 105.823 -1.918 . . . . 0.61 105.823 176.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.2 tp -97.06 115.26 27.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.942 -1.099 . . . . 0.87 110.799 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 64.2 t -120.11 124.69 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.679 -0.638 . . . . 0.71 109.436 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.404 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -159.45 162.66 35.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.168 -0.958 . . . . 0.81 108.481 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.02 -36.42 75.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.508 -1.37 . . . . 0.98 108.444 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 20.4 p-10 -170.77 146.79 2.67 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.21 -0.663 . . . . 2.25 109.21 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 44.8 mt -112.98 137.54 51.22 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.362 -0.836 . . . . 0.78 109.906 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 70.9 p -92.82 146.42 32.11 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.157 -0.964 . . . . 0.98 108.483 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -40.2 -37.81 1.98 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.02 1.814 . . . . 0.81 112.731 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.9 m -59.99 -40.76 90.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.912 . . . . 0.9 110.146 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.94 -40.63 75.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.05 -1.031 . . . . 1.61 109.824 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 66.5 p -59.14 -20.33 52.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.364 -0.835 . . . . 0.61 111.833 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.5 -47.45 9.9 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.471 -1.393 . . . . 0.6 109.739 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -85.62 36.29 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.581 -0.896 . . . . 1.4 108.581 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.0 tp -107.91 139.9 41.84 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.932 -0.766 . . . . 0.7 108.932 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.428 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 0.4 OUTLIER -89.37 106.39 18.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.045 -1.034 . . . . 2.35 108.912 179.346 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 59.6 mt -67.39 -40.16 85.65 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.576 -0.703 . . . . 1.51 111.678 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -68.75 -21.83 64.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.646 -1.284 . . . . 2.33 111.17 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -94.29 -8.37 39.26 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.89 -1.131 . . . . 1.92 109.96 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 178' ' ' GLY . 84.4 t -101.0 112.42 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.216 -0.927 . . . . 0.67 108.719 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.52 1.49 29.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -0.91 . . . . 1.53 110.7 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.473 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.26 173.33 37.5 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.33 -1.508 . . . . 0.48 109.33 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.488 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 26.9 m-85 -127.98 125.07 38.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.562 -0.963 . . . . 0.55 108.713 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 93.4 mt -130.85 125.38 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.399 -0.963 . . . . 0.65 108.399 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 31.6 p -151.42 163.43 38.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.885 -1.134 . . . . 0.82 111.172 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.501 ' O ' ' O ' ' A' ' 183' ' ' ALA . 57.4 t0 -100.84 27.35 6.03 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.993 -0.549 . . . . 2.46 109.675 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -46.96 -177.24 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.001 -1.687 . . . . 1.28 111.862 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.29 -54.39 6.92 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.254 -1.138 . . . . 2.19 110.254 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -161.4 -156.12 8.17 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.416 -1.373 . . . . 2.13 110.357 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.803 ' HE ' HH21 ' A' ' 195' ' ' ARG . 66.6 mtp180 -78.4 -9.48 59.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.633 -0.922 . . . . 5.86 109.354 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 39.6 p -77.75 2.78 15.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 3.72 110.067 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 78.0 p -82.31 139.61 34.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.954 -1.091 . . . . 1.74 109.655 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -49.18 -50.05 39.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.986 -1.071 . . . . 0.95 109.918 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.6 t -53.64 -36.17 61.78 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.214 -0.929 . . . . 1.55 110.394 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 66.7 m -59.92 -40.07 87.63 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.804 -1.185 . . . . 1.51 110.155 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.3 mt -61.02 -39.99 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 1.67 109.567 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 76.6 mtp -56.92 -41.39 78.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.251 -0.906 . . . . 1.02 109.978 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.08 -40.8 90.82 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.996 -1.065 . . . . 0.68 108.769 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.803 HH21 ' HE ' ' A' ' 186' ' ' ARG . 95.0 mtt180 -62.62 -59.98 4.16 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.346 -0.942 . . . . 2.93 110.281 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.4 m -63.42 -39.99 95.99 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.213 -0.929 . . . . 0.86 112.101 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.1 -22.42 63.03 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.854 -1.154 . . . . 0.67 109.307 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 61.35 47.02 7.19 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.694 -0.629 . . . . 1.5 109.782 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 8' ' ' SER . 97.5 mt -122.19 148.6 52.43 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 107.757 -1.201 . . . . 0.72 107.757 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.45 138.12 68.96 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.975 1.783 . . . . 0.61 111.39 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.488 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -170.01 150.96 3.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.942 -1.099 . . . . 0.66 111.588 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.6 mt -124.4 141.16 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 107.211 -1.403 . . . . 0.79 107.211 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.8 m -124.22 -9.22 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.52 0 O-C-N 120.522 -1.361 . . . . 0.91 111.406 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -111.36 23.34 18.45 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 110.607 -0.997 . . . . 1.01 110.607 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.412 ' C ' ' O ' ' A' ' 204' ' ' GLY . 2.9 p -43.07 -46.89 5.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.222 -1.163 . . . . 0.99 110.108 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.438 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 95.69 -54.0 1.7 Allowed Glycine 0 N--CA 1.501 2.973 0 C-N-CA 120.163 -1.018 . . . . 1.12 111.587 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 78.7 p -149.03 29.62 0.8 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.49 -1.594 . . . . 1.72 111.505 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 41.7 t -74.34 -36.35 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.691 -1.256 . . . . 0.89 109.299 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 53.5 p -58.96 -26.01 64.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.92 -1.112 . . . . 1.03 109.796 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.7 m -84.2 -15.27 47.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.105 -0.997 . . . . 1.83 109.892 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -102.46 -6.75 22.58 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.268 -0.895 . . . . 2.27 109.868 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 78.6 t -110.19 133.44 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.514 -0.742 . . . . 0.92 110.819 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -115.16 151.08 35.02 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.149 -1.426 . . . . 2.2 107.149 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.454 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 61.7 t30 -54.89 139.76 39.18 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.02 -1.05 . . . . 2.36 110.79 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.454 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.1 m-20 83.18 2.47 1.02 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-N 116.322 -0.399 . . . . 2.38 110.632 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -74.3 145.12 44.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.895 -1.128 . . . . 2.09 109.489 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -95.51 118.85 32.98 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.997 -1.112 . . . . 1.27 107.997 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.568 HD12 ' HB2' ' A' ' 16' ' ' ALA . 58.1 mt -128.04 151.22 49.42 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.559 -0.713 . . . . 0.75 110.151 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 83.0 mt -116.89 130.02 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.224 -1.398 . . . . 0.63 107.224 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 63.5 tp -97.95 115.19 27.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.967 -1.083 . . . . 0.7 109.069 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.538 ' C ' ' H ' ' A' ' 223' ' ' VAL . 20.2 t0 -72.93 -47.15 48.1 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.597 -1.261 . . . . 2.31 107.597 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.819 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 52.7 5.52 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.814 -0.554 . . . . 0.78 109.791 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.538 ' H ' ' C ' ' A' ' 221' ' ' ASP . 69.5 t -116.59 -40.21 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 107.473 -1.306 . . . . 1.04 107.473 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -108.43 5.39 25.3 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.976 -1.12 . . . . 2.44 107.976 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.505 HD21 ' H ' ' A' ' 4' ' ' GLY . 1.4 t-20 59.37 49.37 8.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.85 -0.531 . . . . 1.55 110.011 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -138.49 150.9 46.89 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.382 -0.824 . . . . 1.99 109.444 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 49.7 t -119.25 129.77 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.066 -1.087 . . . . 0.77 108.066 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -99.75 119.13 37.66 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.063 -1.088 . . . . 0.98 108.063 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.476 HG22 HD22 ' A' ' 218' ' ' LEU . 56.1 t -101.39 116.44 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.505 -0.747 . . . . 0.85 110.595 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 49.98 60.13 15.62 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 1.66 110.836 179.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -85.69 149.68 9.93 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.571 2.181 . . . . 0.95 112.119 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 68.5 p -67.93 164.11 20.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.288 -0.882 . . . . 1.84 110.568 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -60.1 -38.74 83.84 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.84 -0.8 . . . . 2.74 108.84 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.97 -39.64 86.34 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.55 -0.719 . . . . 2.89 109.473 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.68 -40.09 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.019 -1.05 . . . . 1.3 109.968 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.09 -39.99 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.996 -1.065 . . . . 1.09 109.157 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -59.95 -39.74 86.61 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.879 -1.156 . . . . 2.43 107.879 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -59.9 -41.07 90.86 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.003 -1.11 . . . . 2.78 108.003 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.562 ' O ' ' N ' ' A' ' 242' ' ' VAL . 94.4 mtp -69.86 -78.51 0.07 Allowed 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.694 -1.595 . . . . 1.25 106.694 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.497 ' C ' ' O ' ' A' ' 239' ' ' MET . 28.4 mmt180 -21.77 -47.64 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 120.855 0.36 . . . . 2.63 111.901 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 239' ' ' MET . . . -59.83 -50.93 71.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.866 -1.146 . . . . 1.8 109.151 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.562 ' N ' ' O ' ' A' ' 239' ' ' MET . 69.6 t -61.73 -37.34 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.466 -0.771 . . . . 2.13 109.079 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -59.9 -39.97 87.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.402 -0.811 . . . . 3.17 109.71 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -59.92 -39.52 85.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.993 -1.067 . . . . 1.78 108.762 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.12 -38.69 83.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.396 -0.815 . . . . 2.47 109.444 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 80.0 t -59.96 -41.79 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.369 -0.832 . . . . 2.09 109.72 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.84 -44.76 96.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.082 -1.011 . . . . 2.54 109.263 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.9 t -63.88 -38.56 91.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.817 . . . . 2.99 109.374 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -60.01 -31.64 70.12 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.564 -0.71 . . . . 3.34 109.979 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.01 -40.14 88.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.135 -0.978 . . . . 3.88 109.672 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -90.04 4.58 49.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.69 -1.256 . . . . 4.43 110.309 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -94.85 15.55 18.27 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.012 -1.055 . . . . 5.42 108.769 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 89.1 mt -73.54 -10.38 59.65 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.851 -1.156 . . . . 6.1 108.779 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -67.39 -39.95 85.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.472 -0.768 . . . . 7.37 109.03 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.426 ' C ' ' H ' ' A' ' 257' ' ' LYS . 62.3 mttp -78.15 -156.22 0.09 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.372 -0.83 . . . . 8.01 109.765 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 71.8 mt -67.09 6.65 0.5 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.418 -0.801 . . . . 9.05 110.521 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 255' ' ' LYS . 45.4 mtpt 66.56 26.61 9.83 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.815 -0.553 . . . . 10.56 109.515 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 257' ' ' LYS . 7.6 p-10 40.13 69.94 0.28 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.636 -0.665 . . . . 11.32 110.424 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.989 -1.005 . . . . 12.42 109.11 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 3.3 ttt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.532 0.682 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -151.56 148.48 28.05 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.11 161.06 43.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.796 -1.19 . . . . 0.0 111.037 -178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -154.01 151.13 29.01 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -106.96 132.71 52.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 109.248 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.3 122.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 CA-C-O 122.387 1.089 . . . . 0.0 112.74 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 307' ' ' THR . . . . . 0.486 ' O ' HG23 ' B' ' 309' ' ' THR . 29.4 m -79.27 106.84 11.59 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.671 -178.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' B' ' 358' ' ' GLY . 81.7 mt -51.97 117.14 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 122.135 0.969 . . . . 0.0 110.007 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 309' ' ' THR . . . . . 0.486 HG23 ' O ' ' B' ' 307' ' ' THR . 77.4 p -106.91 18.68 21.5 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.462 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -75.39 116.69 57.06 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.067 -1.02 . . . . 0.0 108.949 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -51.96 -13.11 1.59 Allowed 'Trans proline' 0 N--CA 1.499 1.823 0 CA-C-N 120.261 1.129 . . . . 0.0 113.442 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -118.13 6.77 12.05 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.307 -0.871 . . . . 0.0 109.449 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.85 174.92 27.27 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 3.0 tp -85.05 96.07 9.3 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.03 -1.276 . . . . 0.0 108.59 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -97.79 -160.18 0.79 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.082 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 9.2 m -59.0 -41.84 88.64 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.032 -1.042 . . . . 0.0 112.439 -176.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.508 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 1.4 tpt180 -60.4 -62.18 6.45 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 120.429 -1.42 . . . . 0.0 111.794 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -57.9 -32.02 94.06 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.199 1.107 . . . . 0.0 111.461 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.83 72.22 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.64 -41.6 63.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.441 -0.787 . . . . 0.0 109.25 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -69.98 -41.3 74.6 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.167 -1.013 . . . . 0.0 108.7 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -60.97 -51.96 67.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.471 -0.768 . . . . 0.0 110.435 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 323' ' ' VAL . . . . . 0.431 HG13 ' O ' ' B' ' 344' ' ' ALA . 70.0 t -68.36 -30.82 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.653 -1.279 . . . . 0.0 109.841 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -59.99 -44.32 94.6 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.231 -0.988 . . . . 0.0 108.608 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -69.41 -40.72 77.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 110.646 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.1 -52.08 66.89 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.516 -1.365 . . . . 0.0 109.343 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -57.33 -15.23 5.81 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.598 -0.689 . . . . 0.0 109.193 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.96 -29.78 70.55 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -104.83 147.23 27.95 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.455 -1.027 . . . . 0.0 109.109 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 22.6 p -91.36 -12.93 33.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.841 -1.162 . . . . 0.0 109.585 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' B' ' 368' ' ' GLU . 5.8 m -59.46 152.52 21.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.297 -0.877 . . . . 0.0 109.663 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -70.78 134.1 47.11 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.165 -0.96 . . . . 0.0 108.681 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 86.2 mt -132.91 131.24 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.537 -0.727 . . . . 0.0 110.292 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 39.4 m -130.63 153.48 48.88 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 72.4 t -118.61 139.69 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 96.9 m -126.97 123.64 37.59 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.271 -0.893 . . . . 0.0 108.904 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 40.1 p -135.91 116.71 14.07 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.12 -0.988 . . . . 0.0 109.832 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 338' ' ' ASN . . . . . 0.599 ' ND2' ' O ' ' B' ' 338' ' ' ASN . 3.2 p-10 39.95 69.05 0.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 72.31 -11.92 3.66 Favored Glycine 0 N--CA 1.5 2.966 0 O-C-N 120.762 -1.211 . . . . 0.0 113.411 176.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -115.4 129.13 56.48 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-N 119.473 1.637 . . . . 0.0 109.39 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 83.0 p -129.35 151.1 50.36 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.777 0.798 . . . . 0.0 110.699 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -146.14 166.53 25.89 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.595 0.712 . . . . 0.0 110.299 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 34.3 t -89.38 140.09 29.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.554 -0.717 . . . . 0.0 110.061 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.431 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -77.57 -14.66 59.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.015 -1.053 . . . . 0.0 109.613 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 345' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' B' ' 345' ' ' LYS . 47.3 tttp -86.98 18.52 3.5 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 88.2 p -146.12 96.54 2.81 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.403 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.891 HD23 HD22 ' A' ' 79' ' ' LEU . 11.9 tp -60.01 -34.56 73.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.748 ' CE2' HD11 ' A' ' 79' ' ' LEU . 50.9 m-85 -59.74 -54.94 40.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.536 -0.727 . . . . 0.0 110.6 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -63.64 -40.07 95.94 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.705 -1.247 . . . . 0.0 109.007 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.594 ' O ' ' N ' ' B' ' 352' ' ' THR . 60.0 mt -52.18 -56.49 14.24 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.526 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -39.44 -14.55 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.872 -0.517 . . . . 0.0 111.758 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.594 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.1 p -93.24 -9.99 37.2 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.516 -1.365 . . . . 0.0 110.792 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 47.0 mt -94.36 119.94 33.85 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.854 -1.154 . . . . 0.0 109.914 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -71.02 94.23 0.52 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 85.0 mt -99.98 83.6 2.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.35 -1.088 . . . . 0.0 109.271 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 82.3 p -93.5 169.89 10.01 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.054 -1.029 . . . . 0.0 110.998 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.55 112.55 2.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.868 -0.52 . . . . 0.0 110.339 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 358' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 105.48 6.04 38.96 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.0 m -84.81 108.16 17.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -1.204 . . . . 0.0 111.062 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 17.0 t -77.7 115.03 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 122.236 1.017 . . . . 0.0 109.491 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.23 178.45 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 81.6 m -128.87 131.28 47.63 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.9 mt -102.85 120.28 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 41.6 m -120.69 130.06 53.93 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.534 -0.729 . . . . 0.0 109.474 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.16 151.21 40.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.396 -0.815 . . . . 0.0 109.498 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -147.16 122.34 10.18 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.461 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 160.23 -153.56 24.51 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 118.767 -1.683 . . . . 0.0 111.827 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 368' ' ' GLU . . . . . 0.517 ' N ' ' OG ' ' B' ' 331' ' ' SER . 85.5 tt0 -60.04 -50.42 73.78 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 122.203 -0.587 . . . . 0.0 112.22 -177.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.439 ' N ' ' OG ' ' B' ' 331' ' ' SER . 85.8 m-20 -112.59 12.3 19.82 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 120.924 -1.11 . . . . 0.0 111.628 -177.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.0 OUTLIER -39.65 -33.65 0.19 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.179 -0.951 . . . . 0.0 111.653 -178.494 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 371' ' ' GLN . . . . . 0.49 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 12.2 pt20 -65.7 -54.03 32.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.763 -1.211 . . . . 0.0 110.404 -178.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -64.43 -49.38 71.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.622 -1.299 . . . . 0.0 108.619 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -41.48 -42.27 2.3 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.724 -0.61 . . . . 0.0 111.186 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.535 ' O ' HG23 ' B' ' 378' ' ' VAL . 76.3 t -74.71 -36.89 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.546 -1.346 . . . . 0.0 109.574 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -63.19 -64.93 0.77 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.01 -1.056 . . . . 0.0 110.498 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 376' ' ' HIS . . . . . 0.438 ' O ' ' N ' ' B' ' 380' ' ' LEU . 34.4 m170 -59.97 -45.31 93.11 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.776 -1.202 . . . . 0.0 112.07 -177.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.4 mt -60.0 -40.22 88.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.394 -1.441 . . . . 0.0 108.568 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.535 HG23 ' O ' ' B' ' 374' ' ' VAL . 46.0 t -64.81 -49.54 79.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 110.164 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -80.17 -9.68 59.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.817 -1.177 . . . . 0.0 110.407 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' B' ' 376' ' ' HIS . 56.7 tp -83.34 -27.92 29.38 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 41.6 ttm -80.46 -30.07 37.5 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.065 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -84.82 -7.66 59.1 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.54 -0.725 . . . . 0.0 109.837 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -110.21 -2.96 16.56 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.253 -0.904 . . . . 0.0 110.029 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 22.0 mt -90.98 125.63 35.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.011 -1.056 . . . . 0.0 109.091 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 117.917 -1.039 . . . . 0.0 109.597 -179.862 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.424 0.63 . . . . 2.91 109.777 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.5 mt -110.1 130.12 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.229 -0.656 . . . . 1.2 109.229 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.431 ' CB ' ' OD1' ' A' ' 225' ' ' ASN . 61.9 m -137.13 153.54 50.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.379 -0.825 . . . . 1.4 109.681 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.85 -158.17 8.1 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 108.47 -1.852 . . . . 1.05 108.47 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.418 ' O ' ' O ' ' A' ' 6' ' ' LEU . 82.3 mt -90.43 -18.56 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.751 -1.44 . . . . 1.15 109.568 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.45 HD21 ' O ' ' A' ' 222' ' ' ALA . 59.1 tp 44.01 93.65 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.167 -0.958 . . . . 0.98 110.366 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.41 -22.66 18.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.954 -1.091 . . . . 0.88 109.267 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 70.7 m -121.06 112.4 33.37 Favored Pre-proline 0 N--CA 1.504 2.244 0 O-C-N 121.463 -0.773 . . . . 1.69 109.53 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -80.94 151.35 18.57 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.027 1.818 . . . . 0.85 112.408 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.828 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 145.92 175.84 19.3 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.959 -1.656 . . . . 0.92 108.959 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 12' ' ' ALA . 97.0 mt -120.72 155.7 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 O-C-N 121.427 -1.043 . . . . 0.81 109.609 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.413 ' N ' HG22 ' A' ' 11' ' ' ILE . . . -154.19 155.26 34.96 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.057 -1.027 . . . . 0.51 110.326 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 5.3 m-85 -135.28 126.37 27.92 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.012 -1.107 . . . . 0.62 108.012 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.29 -179.21 48.18 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 118.642 -1.742 . . . . 0.55 110.907 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -79.97 158.09 26.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.985 -0.715 . . . . 2.1 109.822 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.591 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -106.44 125.51 51.1 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.531 -0.731 . . . . 0.77 110.469 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.5 tp -97.53 136.76 37.49 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.03 -1.1 . . . . 0.91 108.03 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.9 tp -120.39 128.02 52.83 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.486 -0.759 . . . . 0.93 109.385 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.86 107.51 19.15 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.485 -0.76 . . . . 0.93 110.278 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -100.12 129.87 46.2 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.145 -1.057 . . . . 2.75 108.145 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -130.95 139.76 50.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.185 -0.947 . . . . 3.0 109.712 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 52.9 t0 -81.85 143.89 31.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 2.77 109.088 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.482 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 86.9 tt0 -64.88 140.41 58.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -0.972 . . . . 2.94 109.493 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.7 mt -81.68 135.3 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.331 -0.855 . . . . 0.95 108.818 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.2 t -110.75 128.89 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.368 -0.832 . . . . 1.28 110.093 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.0 mt -98.06 143.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.483 -0.932 . . . . 1.21 108.483 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -94.85 121.43 36.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.865 -1.147 . . . . 1.81 109.738 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.8 mmm-85 -88.02 -0.31 56.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.583 -0.698 . . . . 2.8 109.553 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.52 139.65 58.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.071 -1.018 . . . . 2.87 108.761 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -85.26 149.99 25.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 2.35 109.376 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.483 HG21 ' HG3' ' A' ' 39' ' ' GLU . 5.4 pt -91.48 165.15 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.97 109.494 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.2 p -97.2 172.56 7.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.15 -0.968 . . . . 1.17 108.464 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.56 77.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.952 -1.093 . . . . 1.18 109.355 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.05 -29.64 57.91 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.71 -1.243 . . . . 2.56 109.311 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -81.87 -9.62 59.54 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.256 -0.902 . . . . 1.79 109.971 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.9 t -65.37 -54.54 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.695 -1.253 . . . . 1.0 109.157 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.05 -39.98 87.83 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.294 -0.879 . . . . 1.77 109.56 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -67.82 -44.91 76.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.177 -0.952 . . . . 2.7 110.347 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.483 ' HG3' HG21 ' A' ' 31' ' ' ILE . 64.1 mm-40 -61.28 -41.02 96.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.915 -1.116 . . . . 1.51 110.44 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.37 -47.16 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.66 -1.275 . . . . 0.93 107.957 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -62.11 -47.57 84.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.552 -0.717 . . . . 1.81 109.697 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -60.1 -41.42 92.47 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.621 -1.252 . . . . 2.78 107.621 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -64.53 -46.34 83.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.69 -0.631 . . . . 0.78 109.341 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 48' ' ' ALA . 63.6 tp -59.86 -44.84 93.92 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.508 -0.923 . . . . 1.07 108.508 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.5 t -65.03 -44.02 90.47 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.441 -0.904 . . . . 1.12 109.007 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.39 -43.13 95.47 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.282 -1.927 . . . . 0.84 108.282 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.493 ' NH2' ' O ' ' A' ' 80' ' ' LEU . 68.1 ttt180 -66.4 -37.0 84.24 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.01 -1.107 . . . . 3.09 108.01 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -60.0 -39.76 86.88 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.921 -0.77 . . . . 0.88 108.921 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 50' ' ' ALA . 18.0 ttpp -60.06 -73.64 0.09 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.108 -0.995 . . . . 2.59 108.486 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.67 -33.95 0.09 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.163 -0.961 . . . . 0.7 111.944 -177.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.0 m -60.0 -49.79 76.3 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.361 -1.462 . . . . 1.4 108.586 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.82 -40.06 79.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.853 . . . . 0.67 110.725 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -65.86 -40.09 91.34 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.897 -1.127 . . . . 1.66 110.021 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.0 mt -60.73 -39.95 90.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.093 -1.004 . . . . 1.58 108.687 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -59.98 -39.71 86.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.618 -0.676 . . . . 1.35 110.168 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.9 m -63.93 -43.38 96.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.72 -1.237 . . . . 0.77 108.609 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.532 ' CD1' HH22 ' A' ' 136' ' ' ARG . 82.3 mt -61.18 -39.94 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.464 -0.772 . . . . 0.63 109.027 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -56.63 -49.99 73.36 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.475 -0.935 . . . . 1.14 108.475 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -59.91 -35.21 74.38 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.675 -0.641 . . . . 0.79 110.464 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -68.16 -39.92 82.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.858 -1.151 . . . . 1.53 109.627 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.98 82.68 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.574 -0.704 . . . . 0.57 110.097 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.01 -51.11 60.91 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 119.905 -1.14 . . . . 0.75 110.394 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.09 -44.72 68.49 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.09 -1.241 . . . . 1.59 109.966 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.9 m -67.17 -62.46 1.42 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.936 . . . . 0.73 112.178 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -94.65 -49.13 5.77 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.905 -1.122 . . . . 0.75 111.058 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.79 -169.6 25.17 Favored Glycine 0 N--CA 1.502 3.043 0 C-N-CA 119.702 -1.237 . . . . 1.22 111.445 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -66.71 -26.32 66.96 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.939 -0.742 . . . . 5.81 110.109 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.12 -36.19 76.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.292 -0.88 . . . . 3.37 110.36 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HA ' HD12 ' A' ' 72' ' ' ILE . 66.8 mmtt -97.23 -17.51 19.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.234 -0.916 . . . . 1.77 109.961 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -71.34 -42.79 68.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.054 -1.029 . . . . 1.65 110.264 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.5 -28.41 69.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.542 -0.724 . . . . 0.77 109.756 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 69' ' ' LYS . 81.9 mt -60.06 -40.76 84.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.095 -1.003 . . . . 0.8 108.9 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -69.99 -37.14 75.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 0.88 111.248 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.442 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 65.0 tt0 -60.01 -40.37 89.03 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.626 -1.296 . . . . 1.37 109.63 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.63 -43.2 96.78 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.932 -1.667 . . . . 0.62 108.932 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -60.74 -45.19 95.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.306 -1.114 . . . . 1.5 109.14 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.2 mt -68.75 -47.19 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.63 109.786 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.7 ttp -60.0 -43.35 95.27 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.964 -1.085 . . . . 1.51 110.031 -178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.907 HD22 HD23 ' B' ' 347' ' ' LEU . 34.1 tp -60.25 -39.94 88.56 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.445 -0.785 . . . . 0.77 109.565 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.493 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 58.8 tp -61.67 -39.89 93.0 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.726 -0.608 . . . . 0.62 110.074 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.16 9.93 7.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.166 -0.959 . . . . 1.47 110.913 -178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -53.88 130.85 38.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.66 -1.275 . . . . 1.47 109.704 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -57.73 -21.02 38.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.498 -0.751 . . . . 1.78 110.395 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -70.49 -34.43 72.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.004 -1.06 . . . . 2.53 108.991 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 44.9 mt -69.99 -40.51 75.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.634 -0.666 . . . . 0.8 109.827 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.15 -47.14 87.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.151 -0.968 . . . . 1.42 110.45 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -69.91 -42.8 72.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.121 -0.987 . . . . 1.71 111.323 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -70.1 -39.98 75.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.992 -1.068 . . . . 1.57 111.171 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 91.4 mt -66.6 -49.57 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.976 -1.077 . . . . 0.65 109.668 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.462 HG23 ' HZ2' ' A' ' 94' ' ' LYS . 84.8 mt -69.66 -39.96 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.587 -0.696 . . . . 0.82 110.521 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.0 -47.86 84.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.081 -1.012 . . . . 0.79 110.888 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.06 -46.84 88.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.987 -1.071 . . . . 0.95 109.897 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.48 -49.54 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.66 109.711 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.462 ' HZ2' HG23 ' A' ' 90' ' ' ILE . 54.2 mttp -69.91 -45.84 66.69 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.419 -0.801 . . . . 2.2 111.173 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -80.16 -49.55 11.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.998 -1.063 . . . . 1.65 112.148 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -91.13 -3.62 56.92 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.938 -1.101 . . . . 2.03 111.944 -177.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 54.73 36.23 25.8 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.752 -1.217 . . . . 1.42 109.209 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 51.3 mtt -87.24 169.77 12.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.541 -0.725 . . . . 1.18 109.399 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 65.6 p -80.53 156.76 26.35 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.187 -0.946 . . . . 0.98 108.915 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.97 75.64 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.229 -0.919 . . . . 0.64 109.344 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -63.16 -40.08 96.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.897 . . . . 2.07 109.82 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.44 -49.32 10.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.73 109.87 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.49 -41.34 96.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.477 -0.764 . . . . 0.54 110.555 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.09 -54.02 36.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.927 -1.108 . . . . 0.56 110.349 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -63.15 -27.75 69.59 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.037 -1.039 . . . . 1.54 109.344 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.12 -40.12 88.59 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.286 -0.883 . . . . 1.33 109.39 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.26 -46.64 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.969 -1.082 . . . . 0.72 109.407 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.9 mm -61.15 -41.89 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.31 -0.869 . . . . 0.85 109.187 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -68.99 -34.3 75.08 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.153 -1.055 . . . . 2.44 108.153 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.48 -45.17 95.97 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.301 -1.12 . . . . 0.98 110.301 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -69.98 -46.85 64.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.755 -1.438 . . . . 1.41 109.807 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.01 86.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 1.2 109.909 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 58.0 m -60.01 -40.09 88.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.052 -1.03 . . . . 1.7 109.441 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.72 91.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 1.47 109.3 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 127' ' ' ALA . 20.1 mt -63.75 -40.08 95.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.072 -1.018 . . . . 1.56 109.581 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -58.35 -31.21 67.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.81 -1.181 . . . . 2.2 109.542 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -58.66 -25.59 62.92 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.339 -0.986 . . . . 2.12 108.339 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.442 HD13 HD13 ' A' ' 123' ' ' LEU . 44.0 mt -62.71 144.71 56.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.878 . . . . 2.0 108.805 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -96.54 45.4 1.06 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.089 -1.007 . . . . 3.23 109.92 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 51.4 t0 -136.05 146.14 46.78 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.253 -0.904 . . . . 2.49 109.604 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.538 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -73.9 -63.6 1.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.569 -0.9 . . . . 3.95 108.569 178.319 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.496 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.0 t80 -39.23 -41.73 0.9 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.905 -0.497 . . . . 2.0 111.187 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.442 HD13 HD13 ' A' ' 118' ' ' LEU . 91.4 mt -70.02 -40.01 75.45 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.64 -1.287 . . . . 1.86 108.651 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 121' ' ' GLU . 33.4 ttmt -62.38 -39.87 94.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.451 -0.781 . . . . 2.84 109.836 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 98.9 mt-10 -60.07 -40.91 91.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.236 -0.915 . . . . 2.73 110.225 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -62.09 -39.97 94.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.971 -1.081 . . . . 2.77 108.816 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.45 ' HB2' HD12 ' A' ' 115' ' ' LEU . . . -63.22 -28.47 70.06 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.507 -0.923 . . . . 1.19 108.507 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -60.02 -42.04 93.46 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.323 -0.992 . . . . 1.2 108.323 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.59 -40.01 95.86 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.586 -0.894 . . . . 1.55 108.586 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.8 t -66.26 -40.06 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.884 -0.784 . . . . 0.8 108.884 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.415 HH11 ' HG2' ' A' ' 131' ' ' ARG . 36.3 ttt-85 -60.56 -37.35 80.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.334 -0.854 . . . . 3.09 108.963 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -60.01 -42.74 94.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.419 -0.801 . . . . 1.46 109.992 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.0 -47.63 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.822 -1.174 . . . . 0.71 109.322 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.94 -41.06 97.67 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.302 -1.519 . . . . 0.57 109.302 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -60.15 -49.86 75.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.352 -1.087 . . . . 2.59 109.671 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.532 HH22 ' CD1' ' A' ' 57' ' ' ILE . 63.3 mtp180 -64.59 -36.04 82.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 2.83 110.333 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.94 -44.39 94.39 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.419 -0.8 . . . . 1.25 109.371 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.25 -42.59 95.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -0.954 . . . . 0.7 110.095 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -72.63 -35.85 67.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.052 -1.03 . . . . 2.57 109.288 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -60.06 -39.84 87.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.609 -0.682 . . . . 1.23 110.845 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.0 mt -74.98 -42.59 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.844 -1.16 . . . . 0.81 109.736 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.99 -29.95 67.17 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.574 -0.704 . . . . 1.0 109.934 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.46 40.6 10.89 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.74 -1.744 . . . . 0.89 108.74 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.3 tp -73.02 148.45 44.14 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.474 -1.015 . . . . 1.14 109.004 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -68.47 148.45 50.59 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.189 -0.944 . . . . 4.6 110.426 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.8 mt -119.98 122.67 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.989 0.899 . . . . 1.24 109.709 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.9 mt -61.0 -42.5 93.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 109.28 -0.637 . . . . 1.54 109.28 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.9 t0 62.47 123.92 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.779 -0.576 . . . . 1.5 110.125 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.505 ' O ' HD12 ' A' ' 152' ' ' ILE . 83.4 mt -78.13 -5.78 52.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 0.79 108.68 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.8 t -81.84 -10.07 59.42 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.683 -0.858 . . . . 1.4 108.683 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.74 19.71 1.28 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.754 -0.591 . . . . 0.92 110.109 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.505 HD12 ' O ' ' A' ' 149' ' ' LEU . 56.3 mt -91.58 120.69 41.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 121.253 -0.905 . . . . 0.88 109.161 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -108.01 -8.53 15.85 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.356 -0.84 . . . . 2.45 109.874 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -129.57 152.07 49.49 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.413 -0.805 . . . . 1.52 109.884 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.15 133.51 53.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -0.91 . . . . 1.58 108.872 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.5 m -152.83 166.35 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.402 -0.812 . . . . 0.69 109.757 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.3 mt -93.06 147.94 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 106.015 -1.846 . . . . 0.61 106.015 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.9 tp -102.13 117.61 35.14 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.052 -1.03 . . . . 0.87 109.9 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.7 t -125.02 134.31 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.36 -0.978 . . . . 0.71 108.36 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.81 168.63 22.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.113 -0.992 . . . . 0.81 109.14 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.91 -38.26 69.93 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.318 -1.489 . . . . 0.98 107.941 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -171.17 145.58 2.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.599 -0.688 . . . . 2.25 109.486 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.2 mt -115.91 137.46 52.08 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.415 -0.803 . . . . 0.78 109.615 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.2 p -91.22 149.97 40.71 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.233 -0.917 . . . . 0.98 109.512 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -42.36 -36.99 4.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.488 2.126 . . . . 0.81 113.564 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 72.3 m -59.99 -40.05 87.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.881 -1.137 . . . . 0.9 109.314 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.75 -43.09 89.99 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.148 -0.97 . . . . 1.61 109.432 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 79.1 p -59.1 -19.57 45.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.39 -0.819 . . . . 0.61 111.555 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -83.86 -46.72 11.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.769 -1.207 . . . . 0.6 110.26 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -90.73 39.32 0.98 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.312 -0.996 . . . . 1.4 108.312 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.459 HD13 HD13 ' A' ' 149' ' ' LEU . 56.6 tp -105.6 137.1 44.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.567 -0.708 . . . . 0.7 110.231 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -89.91 101.57 14.27 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.285 -0.884 . . . . 2.35 108.872 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.32 -39.99 94.84 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.385 -0.822 . . . . 1.51 111.109 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -66.54 -24.22 66.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.115 -0.991 . . . . 2.33 111.543 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -93.74 -10.96 32.52 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.706 -1.246 . . . . 1.92 110.358 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.521 HG11 ' CE1' ' A' ' 179' ' ' PHE . 80.4 t -102.76 112.77 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.099 -1.001 . . . . 0.67 109.355 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.7 mt -83.62 3.8 31.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.252 -0.905 . . . . 1.53 110.354 -178.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.509 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 173.38 169.91 36.33 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.554 -1.418 . . . . 0.48 109.554 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.521 ' CE1' HG11 ' A' ' 176' ' ' VAL . 7.0 m-85 -134.47 130.23 36.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.395 -1.062 . . . . 0.55 108.517 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.423 ' CG2' HG21 ' A' ' 205' ' ' THR . 67.2 mt -130.45 125.48 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.567 -0.901 . . . . 0.65 108.567 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 7.7 p -143.07 154.33 43.84 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.21 -0.931 . . . . 0.82 111.046 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -106.28 27.88 8.27 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.797 -0.816 . . . . 2.46 108.797 179.279 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.04 -157.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.825 -1.172 . . . . 1.28 111.908 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -53.4 -80.98 0.06 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.863 -1.295 . . . . 2.19 109.863 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLY . . . . . 0.45 ' O ' ' OG ' ' A' ' 191' ' ' SER . . . -178.3 -131.97 1.64 Allowed Glycine 0 N--CA 1.488 2.1 0 C-N-CA 119.424 -1.369 . . . . 2.13 110.286 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.402 ' NH1' ' HG3' ' A' ' 186' ' ' ARG . 7.1 ptm180 -73.28 -10.53 59.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.628 -0.925 . . . . 5.86 111.122 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 51.7 p -92.83 7.84 42.08 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.804 -1.185 . . . . 3.72 110.984 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 78.7 p -89.08 143.43 26.85 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.733 -1.23 . . . . 1.74 110.124 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -47.37 -47.48 26.08 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.383 -0.823 . . . . 0.95 109.338 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.0 m -56.53 -39.64 73.72 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.742 -0.599 . . . . 1.55 109.857 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 185' ' ' GLY . 53.7 m -59.89 -40.04 87.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.98 -1.075 . . . . 1.51 110.923 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 89.1 mt -60.06 -41.26 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.0 . . . . 1.67 110.161 -178.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.8 mtp -60.07 -50.37 73.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.093 -1.005 . . . . 1.02 111.116 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -50.94 -45.41 60.6 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.908 -1.12 . . . . 0.68 109.646 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -60.03 -51.65 68.75 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.07 -1.052 . . . . 2.93 109.733 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.8 m -71.99 -35.06 69.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.075 -1.016 . . . . 0.86 110.86 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.46 -30.02 65.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.645 -1.284 . . . . 0.67 108.318 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 66.4 49.8 1.37 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.357 0.598 . . . . 1.5 110.138 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.445 ' O ' ' CB ' ' A' ' 8' ' ' SER . 86.1 mt -127.77 141.39 40.94 Favored Pre-proline 0 N--CA 1.503 2.215 0 N-CA-C 108.677 -0.86 . . . . 0.72 108.677 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -44.37 128.42 8.01 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.94 1.76 . . . . 0.61 112.039 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.8 141.51 6.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.875 -1.141 . . . . 0.66 111.471 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.2 mt -123.76 142.3 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.069 -1.456 . . . . 0.79 107.069 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 18.2 m -126.01 -12.03 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 120.952 -1.092 . . . . 0.91 111.382 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -106.11 23.06 29.95 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.014 -1.234 . . . . 1.01 110.014 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.435 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 2.8 p -44.91 -43.58 9.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -1.129 . . . . 0.99 110.083 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.76 -55.38 4.11 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 119.964 -1.112 . . . . 1.12 111.881 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 35.1 m -153.04 36.08 0.48 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.56 -1.553 . . . . 1.72 111.479 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.5 t -72.39 -40.15 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.914 -1.116 . . . . 0.89 108.53 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 38.3 p -52.98 -25.49 12.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.57 -0.706 . . . . 1.03 110.233 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.7 m -77.45 -30.91 53.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.037 -1.039 . . . . 1.83 110.551 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -93.33 -9.29 39.4 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.969 -1.082 . . . . 2.27 111.127 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.8 t -105.88 134.77 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.13 -0.981 . . . . 0.92 111.077 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -111.2 154.89 23.75 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.146 -1.427 . . . . 2.2 107.146 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 57.8 t-20 -59.87 138.9 57.69 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.781 -1.199 . . . . 2.36 109.728 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 7.7 t0 80.76 6.47 1.43 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.015 0.436 . . . . 2.38 110.172 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -71.97 128.96 37.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.029 -1.045 . . . . 2.09 109.059 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -79.45 114.78 18.65 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.914 -1.143 . . . . 1.27 107.914 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.591 HD12 ' HB2' ' A' ' 16' ' ' ALA . 75.1 mt -127.04 150.56 49.39 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.526 -0.734 . . . . 0.75 110.508 -178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.3 mt -116.35 128.94 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 106.043 -1.836 . . . . 0.63 106.043 177.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 31.5 tp -99.98 118.85 37.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.794 -1.191 . . . . 0.7 108.194 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 223' ' ' VAL . 20.7 t0 -80.66 -39.94 26.41 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.889 -1.132 . . . . 2.31 108.275 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 43.13 19.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.533 0.682 . . . . 0.78 109.377 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.4 t -134.32 -42.99 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.356 -1.35 . . . . 1.04 107.356 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -100.03 2.99 43.89 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.293 -1.373 . . . . 2.44 107.293 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.431 ' OD1' ' CB ' ' A' ' 3' ' ' SER . 9.8 t-20 59.96 48.5 8.69 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.506 -0.553 . . . . 1.55 109.506 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -142.0 150.37 41.24 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.158 -0.964 . . . . 1.99 110.29 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.4 t -119.96 128.75 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.84 -1.17 . . . . 0.77 107.84 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -104.96 120.05 40.5 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.285 -0.884 . . . . 0.98 108.913 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.423 HG22 HD22 ' A' ' 218' ' ' LEU . 46.4 t -100.28 114.7 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.503 -0.748 . . . . 0.85 110.194 -178.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 50.96 69.11 2.78 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.272 -0.892 . . . . 1.66 110.819 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -90.43 144.16 3.87 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.298 2.665 . . . . 0.95 112.135 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 5.2 m -68.59 164.16 22.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 1.84 110.14 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -59.96 -36.74 77.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.532 -0.73 . . . . 2.74 110.051 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.03 -39.56 86.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 2.89 109.466 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.8 t -70.67 -36.09 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.014 -1.054 . . . . 1.3 109.451 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.464 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 96.8 mt -70.09 -40.03 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.117 -0.989 . . . . 1.09 109.774 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -60.05 -40.42 89.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.03 -1.044 . . . . 2.43 108.209 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -62.55 -39.16 92.76 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.311 0.577 . . . . 2.78 109.774 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 98.1 mtp -82.49 -19.31 39.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.137 -0.977 . . . . 1.25 110.48 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.498 HH11 ' HG2' ' A' ' 240' ' ' ARG . 0.6 OUTLIER -70.8 -39.97 72.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.784 -1.197 . . . . 2.63 109.125 179.127 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.15 -40.16 82.44 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.255 -1.017 . . . . 1.8 108.255 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.14 -38.72 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.397 -0.964 . . . . 2.13 108.397 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 18.5 tm0? -60.0 -40.59 89.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.35 -0.844 . . . . 3.17 109.206 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -40.03 87.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.065 -1.022 . . . . 1.78 108.381 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -64.86 -39.87 94.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.506 -0.746 . . . . 2.47 109.216 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 54.8 t -59.97 -40.47 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.501 -0.749 . . . . 2.09 109.897 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.98 90.95 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.209 -0.932 . . . . 2.54 109.188 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 66.9 m -60.03 -40.1 88.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.38 -0.825 . . . . 2.99 109.715 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.06 -40.0 87.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 3.34 109.607 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.454 ' O ' ' CD2' ' A' ' 253' ' ' LEU . 68.3 mttm -72.42 0.71 9.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 3.88 109.5 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -108.36 18.32 21.15 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.675 -0.641 . . . . 4.43 109.336 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -127.28 28.08 5.78 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.565 -0.709 . . . . 5.42 109.741 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.544 HD23 ' H ' ' A' ' 253' ' ' LEU . 0.0 OUTLIER -63.46 -47.57 81.28 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.995 -1.066 . . . . 6.1 109.306 -179.769 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 42.59 25.26 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.446 -0.784 . . . . 7.37 110.324 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 253' ' ' LEU . 35.6 ttpt -172.61 -21.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.096 -1.002 . . . . 8.01 110.07 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.474 ' C ' HD23 ' A' ' 256' ' ' LEU . 4.0 tt -81.25 88.46 6.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.152 -0.968 . . . . 9.05 109.808 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -109.32 5.17 23.37 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.195 -1.409 . . . . 10.56 107.195 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -62.41 -64.32 0.96 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.853 -0.795 . . . . 11.32 108.853 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 118.036 -0.983 . . . . 12.42 109.349 -179.808 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.564 0.697 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 302' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 19.0 t80 -152.64 151.4 30.55 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 303' ' ' GLN . . . . . 0.466 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 12.9 pt20 -145.58 155.04 42.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.995 -1.065 . . . . 0.0 110.708 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 304' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' B' ' 305' ' ' GLU . 12.5 tm0? -149.58 145.34 26.75 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 305' ' ' GLU . . . . . 0.506 ' O ' ' NE2' ' B' ' 304' ' ' GLN . 39.2 mp0 -109.09 131.8 54.72 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.067 -1.02 . . . . 0.0 110.46 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.07 119.12 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-O 122.077 0.941 . . . . 0.0 112.452 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 35.6 m -77.3 104.65 7.93 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.99 0.9 . . . . 0.0 111.024 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.8 mt -53.03 123.87 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.318 1.056 . . . . 0.0 110.729 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 71.9 p -111.37 20.11 17.59 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.257 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.14 120.39 80.01 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.831 -1.168 . . . . 0.0 109.682 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -49.57 -21.5 5.34 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 CA-C-N 120.137 1.084 . . . . 0.0 113.069 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -120.74 13.7 11.6 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.46 -0.775 . . . . 0.0 109.775 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.34 -178.6 37.83 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.496 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -84.42 91.06 7.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.111 -1.229 . . . . 0.0 110.191 -178.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -95.35 -160.35 0.78 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.673 -1.267 . . . . 0.0 109.995 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 5.3 m -59.61 -40.6 88.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.847 -1.158 . . . . 0.0 112.492 -175.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.603 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.2 tpt180 -62.75 -61.74 6.96 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 120.329 -1.482 . . . . 0.0 112.069 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.05 -30.32 93.0 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 CA-C-N 120.151 1.09 . . . . 0.0 111.824 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.05 -50.53 73.36 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.55 -39.32 61.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.344 -0.848 . . . . 0.0 109.431 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -68.99 -43.83 74.09 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.998 -1.064 . . . . 0.0 108.342 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -60.04 -52.27 66.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.439 -0.788 . . . . 0.0 110.984 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 323' ' ' VAL . . . . . 0.43 HG13 ' O ' ' B' ' 344' ' ' ALA . 72.1 t -68.42 -28.92 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.728 -1.232 . . . . 0.0 110.7 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.442 ' NZ ' ' OE1' ' A' ' 74' ' ' GLU . 24.7 ttmt -61.77 -45.8 92.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.109 -0.994 . . . . 0.0 110.252 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -69.97 -40.05 75.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.987 -1.07 . . . . 0.0 111.417 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -61.53 -52.8 62.97 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.469 -1.394 . . . . 0.0 110.26 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -53.34 -11.23 0.28 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.169 -0.957 . . . . 0.0 109.648 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -75.93 -25.62 66.49 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -105.05 141.1 37.21 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.629 -0.924 . . . . 0.0 108.798 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 330' ' ' THR . . . . . 0.421 HG22 ' O ' ' B' ' 330' ' ' THR . 89.7 m -89.94 -10.51 44.84 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.941 -1.099 . . . . 0.0 109.871 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.597 ' HG ' ' H ' ' B' ' 369' ' ' ASP . 75.6 m -61.49 149.62 38.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.705 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -67.67 132.77 48.11 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.0 mt -133.33 134.17 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.653 -0.654 . . . . 0.0 109.564 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 334' ' ' THR . . . . . 0.433 HG22 ' N ' ' B' ' 335' ' ' VAL . 51.5 m -131.68 155.04 48.33 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 335' ' ' VAL . . . . . 0.433 ' N ' HG22 ' B' ' 334' ' ' THR . 75.9 t -117.41 140.02 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 70.2 m -130.47 122.25 27.34 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.217 -0.927 . . . . 0.0 109.22 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 1.8 m -140.21 120.22 13.65 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 122.054 0.93 . . . . 0.0 110.657 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 47.56 57.8 5.56 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 75.28 -11.55 8.58 Favored Glycine 0 N--CA 1.498 2.787 0 O-C-N 120.19 -1.569 . . . . 0.0 112.52 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -114.43 125.1 53.45 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 118.923 1.361 . . . . 0.0 109.289 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 51.8 m -126.56 148.32 49.76 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.616 0.722 . . . . 0.0 110.196 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.77 167.44 22.58 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.515 0.674 . . . . 0.0 109.955 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 19.8 m -87.09 139.05 30.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.43 -0.794 . . . . 0.0 109.595 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.43 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -78.7 -14.27 59.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.001 -1.062 . . . . 0.0 109.195 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -86.81 18.19 3.6 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 61.2 m -145.27 93.23 2.35 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.601 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.907 HD23 HD22 ' A' ' 79' ' ' LEU . 13.4 tp -55.74 -36.66 67.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.746 ' CE2' HD11 ' A' ' 79' ' ' LEU . 47.1 m-85 -58.69 -52.52 65.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 110.165 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -68.68 -21.11 64.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.992 -1.067 . . . . 0.0 110.987 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' B' ' 352' ' ' THR . 90.2 mt -69.94 -52.16 26.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.532 -1.355 . . . . 0.0 108.523 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' B' ' 347' ' ' LEU . 0.1 OUTLIER -39.21 -18.85 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.817 -0.552 . . . . 0.0 111.07 -178.301 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.564 ' N ' ' O ' ' B' ' 350' ' ' LEU . 71.1 p -85.92 -11.12 53.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.225 -1.547 . . . . 0.0 110.647 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 42.3 mt -94.82 116.95 29.36 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.931 -1.106 . . . . 0.0 109.247 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.94 94.23 0.98 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 24.1 mt -103.31 94.58 5.58 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.453 -1.028 . . . . 0.0 108.947 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 43.3 p -93.3 161.01 14.57 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.101 -0.999 . . . . 0.0 110.427 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -54.22 119.36 5.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.551 -0.718 . . . . 0.0 110.225 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 358' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 98.74 4.65 56.89 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.036 -1.625 . . . . 0.0 109.036 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.9 m -84.2 112.64 20.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.406 -1.055 . . . . 0.0 110.574 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 19.3 t -78.44 116.62 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 122.081 0.943 . . . . 0.0 109.939 -177.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 17.3 m -110.38 177.5 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -178.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 58.5 m -131.35 130.01 42.12 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 78.3 mt -102.82 115.39 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 73.3 m -117.28 130.79 56.78 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.558 -0.714 . . . . 0.0 109.13 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.89 152.27 39.98 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.171 -0.956 . . . . 0.0 110.363 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 366' ' ' GLU . . . . . 0.436 ' OE2' ' OE2' ' B' ' 370' ' ' GLU . 9.9 tp10 -143.02 120.25 11.51 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.16 -163.88 36.78 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.466 -1.826 . . . . 0.0 111.947 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -59.2 -49.95 75.88 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 115.029 -0.586 . . . . 0.0 112.006 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.597 ' H ' ' HG ' ' B' ' 331' ' ' SER . 92.0 m-20 -105.77 10.74 32.58 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.979 -1.076 . . . . 0.0 111.066 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.436 ' OE2' ' OE2' ' B' ' 366' ' ' GLU . 14.7 pt-20 -40.98 -30.6 0.14 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.167 -0.958 . . . . 0.0 110.88 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -69.58 -40.46 76.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.06 -1.025 . . . . 0.0 109.204 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -72.16 -55.11 7.83 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 108.983 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -41.83 -35.63 0.87 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.694 -0.629 . . . . 0.0 111.771 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.468 ' O ' HG23 ' B' ' 378' ' ' VAL . 62.2 t -79.93 -32.44 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.541 -1.35 . . . . 0.0 109.68 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.3 -60.05 3.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.978 -1.076 . . . . 0.0 111.939 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -73.31 -40.85 64.17 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.483 -1.386 . . . . 0.0 112.66 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.99 -40.05 87.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.528 -1.357 . . . . 0.0 109.042 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.5 t -61.08 -47.65 92.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.132 -0.98 . . . . 0.0 109.831 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -69.54 -55.75 9.27 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.728 -1.232 . . . . 0.0 108.154 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.476 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 60.7 tp -53.04 -34.08 54.83 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.504 -0.747 . . . . 0.0 109.7 -178.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 39.5 ttm -75.44 -38.54 59.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.945 -1.097 . . . . 0.0 108.55 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.17 -5.42 51.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.685 -0.634 . . . . 0.0 110.496 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -110.45 4.54 20.62 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.085 -1.009 . . . . 0.0 110.812 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 384' ' ' LEU . . . . . 0.476 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 26.3 mt -72.2 121.97 20.25 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.34 -1.475 . . . . 0.0 109.947 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.989 -1.005 . . . . 0.0 108.942 179.152 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.6 mtm . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.076 -0.712 . . . . 2.91 109.076 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.7 mt -110.45 122.32 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.414 -0.804 . . . . 1.2 108.958 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.6 m -139.26 146.64 40.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.416 -0.802 . . . . 1.4 109.104 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.68 -162.79 9.25 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 108.719 -1.752 . . . . 1.05 108.719 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.6 mt -89.81 -13.71 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.863 -1.375 . . . . 1.15 110.302 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.3 tp 55.8 102.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 0.98 108.88 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.83 -23.12 17.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.0 . . . . 0.88 109.593 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 16.0 t -147.78 130.55 7.89 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.069 -1.019 . . . . 1.69 109.739 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.34 144.42 16.24 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.13 1.887 . . . . 0.85 112.902 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.908 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.28 167.27 16.05 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.745 -1.342 . . . . 0.92 109.745 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.0 mt -123.66 130.42 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.088 -1.243 . . . . 0.81 109.601 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.9 150.07 49.2 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.202 -0.936 . . . . 0.51 110.619 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.1 m-85 -126.29 129.97 49.94 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.793 -1.188 . . . . 0.62 107.793 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.04 178.94 48.59 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 118.354 -1.879 . . . . 0.55 110.969 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -78.87 158.46 28.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.764 -0.845 . . . . 2.1 109.195 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -106.17 131.55 53.29 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.559 -0.713 . . . . 0.77 110.485 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.8 tp -99.75 136.31 39.86 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.593 -1.262 . . . . 0.91 107.593 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.4 tp -115.84 119.96 37.7 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.309 -0.869 . . . . 0.93 109.613 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.484 HD12 ' HB2' ' A' ' 160' ' ' ALA . 56.8 mt -90.69 105.79 18.06 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.767 -0.583 . . . . 0.93 109.803 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -101.48 136.61 41.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.368 -0.833 . . . . 2.75 109.252 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -127.34 122.19 33.08 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.799 -0.815 . . . . 3.0 108.799 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -71.19 148.25 47.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 2.77 109.904 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -65.18 141.86 58.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 2.94 109.489 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -82.02 130.12 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.95 109.176 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.6 t -93.9 124.06 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.255 -0.903 . . . . 1.28 109.868 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.5 mt -103.74 138.46 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.436 -0.79 . . . . 1.21 109.119 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -97.22 117.73 32.09 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.152 -0.967 . . . . 1.81 109.208 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -86.92 -2.3 58.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.367 -0.833 . . . . 2.8 109.372 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -64.34 141.3 58.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 2.87 109.68 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -87.73 150.14 23.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.913 . . . . 2.35 108.997 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.544 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.7 pt -92.95 165.64 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.365 -0.834 . . . . 0.97 110.475 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.4 p -99.15 171.22 8.15 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.349 -0.982 . . . . 1.17 108.349 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.19 -47.93 80.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 1.18 109.089 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -55.63 -32.3 63.04 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.0 -1.062 . . . . 2.56 109.656 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -82.16 -9.91 59.35 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.287 -0.883 . . . . 1.79 110.246 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.63 -53.31 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.506 -1.371 . . . . 1.0 109.499 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.78 -40.05 95.73 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.023 -1.048 . . . . 1.77 110.006 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -69.98 -39.96 75.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.036 -1.04 . . . . 2.7 110.463 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.544 ' HG3' HG21 ' A' ' 31' ' ' ILE . 66.1 mm-40 -67.11 -40.05 86.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.006 -1.058 . . . . 1.51 110.069 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.99 -43.19 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.712 -1.242 . . . . 0.93 108.361 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -59.55 -37.1 77.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 1.81 108.895 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -60.04 -43.14 95.55 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.908 -1.145 . . . . 2.78 107.908 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -62.24 -49.78 74.34 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.449 -0.782 . . . . 0.78 109.409 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.5 tp -59.91 -48.4 81.87 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.397 -0.814 . . . . 1.07 109.024 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.5 t -62.21 -43.32 99.1 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.995 -1.065 . . . . 1.12 108.735 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.29 -45.42 96.02 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.732 -1.747 . . . . 0.84 108.732 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -67.48 -32.67 73.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.396 -1.061 . . . . 3.09 108.423 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.29 -40.03 84.88 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.643 -0.873 . . . . 0.88 108.643 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 50' ' ' ALA . 27.9 ttpt -67.25 -74.58 0.11 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.417 -0.956 . . . . 2.59 108.417 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.05 -33.22 0.08 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.203 -0.936 . . . . 0.7 111.489 -178.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 83.3 p -60.06 -54.53 44.89 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.563 -1.336 . . . . 1.4 108.697 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.02 -40.2 75.36 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.372 -0.83 . . . . 0.67 111.157 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -65.16 -40.13 93.89 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.73 -1.231 . . . . 1.66 110.735 -178.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.28 -39.97 93.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.857 -1.152 . . . . 1.58 109.018 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -60.35 -37.13 79.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.385 -0.822 . . . . 1.35 109.419 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.5 m -65.41 -43.23 91.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.831 -1.168 . . . . 0.77 109.007 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.668 ' CD1' HH22 ' A' ' 136' ' ' ARG . 78.9 mt -62.04 -40.01 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.504 -0.925 . . . . 0.63 108.504 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -55.57 -50.22 70.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.4 -0.813 . . . . 1.14 109.527 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -57.99 -33.0 68.44 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.159 -0.963 . . . . 0.79 110.19 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -68.79 -37.87 79.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 1.53 109.145 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.464 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.45 -45.29 76.43 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.702 -0.624 . . . . 0.57 110.393 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.72 -50.78 64.06 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.861 -1.162 . . . . 0.75 110.272 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.07 -42.09 73.25 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.12 -1.223 . . . . 1.59 110.379 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.2 m -69.96 -59.11 3.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.03 -1.043 . . . . 0.73 111.729 -178.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -97.07 -52.25 3.92 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.959 -1.088 . . . . 0.75 111.103 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.67 -165.38 26.49 Favored Glycine 0 N--CA 1.5 2.905 0 C-N-CA 119.706 -1.235 . . . . 1.22 110.955 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -70.75 -22.62 62.39 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.89 -0.771 . . . . 5.81 110.354 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.458 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.1 tp10 -62.05 -37.64 85.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 3.37 110.904 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -99.67 -18.02 17.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.184 -0.947 . . . . 1.77 110.12 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -69.76 -39.93 76.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.119 -0.988 . . . . 1.65 110.423 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.492 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.04 -30.92 71.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.382 -0.824 . . . . 0.77 109.834 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.0 -41.46 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.036 -1.04 . . . . 0.8 109.085 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -62.61 -40.45 96.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.065 -1.022 . . . . 0.88 109.966 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -60.78 -39.92 90.63 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.188 -1.005 . . . . 1.37 109.335 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.18 -41.26 98.43 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.671 -1.772 . . . . 0.62 108.671 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.7 m170 -69.77 -42.44 73.82 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.376 -1.073 . . . . 1.5 108.935 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.4 mt -70.14 -46.19 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.285 -0.884 . . . . 0.63 109.359 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.1 ttp -61.16 -40.93 95.71 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.087 -1.008 . . . . 1.51 110.05 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.863 HD11 ' CE2' ' B' ' 348' ' ' PHE . 59.0 tp -66.47 -40.05 89.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.164 -0.96 . . . . 0.77 109.444 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.2 tp -66.53 -39.88 88.83 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.502 -0.749 . . . . 0.62 110.012 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -79.99 -1.56 40.15 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.186 -0.946 . . . . 1.47 110.192 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -47.88 130.26 14.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.032 . . . . 1.47 109.904 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.28 -16.38 60.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.662 -0.649 . . . . 1.78 110.198 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.26 -35.18 73.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.941 -1.099 . . . . 2.53 108.512 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.12 -40.01 68.44 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.462 0.649 . . . . 0.8 109.275 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.04 -49.96 75.61 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.559 -0.713 . . . . 1.42 109.993 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -70.65 -40.31 73.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.257 -0.902 . . . . 1.71 110.839 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -69.74 -40.02 76.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.059 -1.025 . . . . 1.57 110.567 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.8 mt -68.6 -45.8 81.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.112 -0.992 . . . . 0.65 108.944 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.26 -39.1 80.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.528 -0.733 . . . . 0.82 109.963 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.07 -47.15 87.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.195 -0.94 . . . . 0.79 110.452 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 96' ' ' LYS . 85.7 mt -62.64 -45.77 91.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.896 -1.127 . . . . 0.95 109.43 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.79 -50.05 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 0.66 109.135 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -70.03 -40.56 75.11 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.707 -0.797 . . . . 2.2 110.338 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -81.3 -50.16 9.85 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.997 -1.064 . . . . 1.65 111.716 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 92' ' ' LEU . 19.7 mmmt -90.38 -1.83 57.93 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.933 -1.104 . . . . 2.03 111.64 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.3 m80 55.88 35.3 25.19 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.889 -1.132 . . . . 1.42 109.529 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.5 mtt -89.38 168.57 12.12 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.629 -0.669 . . . . 1.18 110.147 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 102' ' ' ALA . 32.9 p -80.72 158.51 25.52 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.42 -0.8 . . . . 0.98 109.26 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.89 -40.06 87.64 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.243 -0.91 . . . . 0.64 109.662 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -67.87 -39.9 83.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.277 -0.89 . . . . 2.07 109.616 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.405 ' HB3' ' OG1' ' A' ' 99' ' ' THR . . . -80.99 -42.52 21.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.73 109.897 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.53 -50.46 71.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.54 109.571 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.42 -33.41 72.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.228 -0.92 . . . . 0.56 109.509 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.546 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 86.2 t60 -60.06 -46.12 90.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.264 -0.897 . . . . 1.54 109.734 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -60.36 -40.0 89.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.353 -0.842 . . . . 1.33 111.007 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 41.9 t -63.28 -62.84 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.959 -1.088 . . . . 0.72 111.435 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.5 mm -63.9 -41.67 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.875 -1.141 . . . . 0.85 109.419 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.546 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 80.8 tt0 -63.53 -38.7 92.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 2.44 108.927 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.04 -46.44 94.18 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.712 -0.955 . . . . 0.98 110.712 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -68.54 -44.04 75.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.746 -1.443 . . . . 1.41 109.67 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.43 78.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.092 -1.005 . . . . 1.2 109.055 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 29.5 t -60.02 -40.42 89.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.182 -0.949 . . . . 1.7 109.144 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.48 97.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 1.47 109.094 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.6 mt -67.82 -41.87 82.38 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.151 -0.968 . . . . 1.56 109.044 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.58 -33.62 70.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.781 -1.199 . . . . 2.2 109.774 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -57.81 -22.15 45.88 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.025 -1.047 . . . . 2.12 108.765 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.47 HD13 HD13 ' A' ' 123' ' ' LEU . 48.8 mt -63.28 139.91 58.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 2.0 108.787 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -84.41 -16.8 41.42 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.142 -0.974 . . . . 3.23 110.195 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -66.4 130.02 41.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.169 -0.957 . . . . 2.49 110.124 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.616 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 8.0 pm0 -70.13 -30.04 67.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.454 -0.779 . . . . 3.95 110.245 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.491 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.8 t80 -67.58 -34.16 76.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.406 -0.809 . . . . 2.0 110.194 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.64 HD22 ' O ' ' B' ' 351' ' ' GLN . 86.4 mt -80.15 -26.67 39.26 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.103 -0.998 . . . . 1.86 108.882 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -61.95 -47.05 86.62 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.212 -0.93 . . . . 2.84 108.604 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 121' ' ' GLU . 7.6 mp0 -65.66 -36.69 84.39 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.264 -0.897 . . . . 2.73 108.77 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.552 ' CZ ' ' NE2' ' B' ' 351' ' ' GLN . 0.2 OUTLIER -59.69 -40.03 86.51 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.855 -1.165 . . . . 2.77 107.855 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.27 -23.4 67.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.425 -0.797 . . . . 1.19 109.008 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -66.44 -39.96 89.18 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.655 -0.869 . . . . 1.2 108.655 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -64.18 -40.67 96.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.385 -0.822 . . . . 1.55 109.233 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 77.3 t -69.89 -40.15 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.487 -0.931 . . . . 0.8 108.487 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.506 HH11 ' HG2' ' A' ' 131' ' ' ARG . 11.6 ttt-85 -59.98 -40.03 87.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.397 -0.814 . . . . 3.09 108.94 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -60.44 -39.93 89.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.534 -0.729 . . . . 1.46 110.06 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.99 -43.33 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.266 -0.896 . . . . 0.71 110.861 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.71 -33.86 71.82 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.754 -1.212 . . . . 0.57 110.168 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -59.98 -48.6 81.05 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -1.174 . . . . 2.59 110.022 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.668 HH22 ' CD1' ' A' ' 57' ' ' ILE . 67.0 mtp180 -68.32 -32.22 72.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.906 -1.121 . . . . 2.83 109.602 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.88 -45.54 92.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.26 -0.9 . . . . 1.25 108.647 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.54 -40.26 90.91 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.395 -0.816 . . . . 0.7 109.062 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.482 HH11 ' HG2' ' A' ' 139' ' ' ARG . 43.4 mtt-85 -69.91 -40.09 75.8 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.426 -0.953 . . . . 2.57 108.426 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.404 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 4.5 m120 -60.5 -40.04 89.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.848 -0.533 . . . . 1.23 110.759 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.9 mt -73.15 -42.09 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.788 -1.195 . . . . 0.81 108.313 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.8 mt -70.06 -38.4 75.75 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.235 0.541 . . . . 1.0 109.807 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.16 43.78 8.5 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.963 -1.655 . . . . 0.89 108.963 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 tp -75.68 152.78 37.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.58 -0.953 . . . . 1.14 109.652 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -63.91 140.97 58.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 4.6 109.265 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.4 mt -119.83 130.08 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 122.151 0.977 . . . . 1.24 109.77 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.1 mt -59.39 -47.63 89.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 115.657 -0.702 . . . . 1.54 110.922 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 31.2 t0 66.2 99.25 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.652 -0.87 . . . . 1.5 108.652 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 25.1 mt -68.83 -3.78 13.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.79 109.709 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 59.3 m -83.45 -13.4 54.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.096 -1.003 . . . . 1.4 108.891 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.17 20.28 1.98 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.459 -0.776 . . . . 0.92 111.08 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 40.9 mm -90.05 121.18 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.598 -1.313 . . . . 0.88 108.708 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -101.32 -9.0 21.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.263 -0.898 . . . . 2.45 110.473 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -125.45 149.78 47.91 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.34 -0.85 . . . . 1.52 110.434 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.87 135.36 56.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.346 -0.847 . . . . 1.58 109.14 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.5 m -152.34 166.37 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.576 -0.703 . . . . 0.69 109.872 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 94.1 mt -95.16 149.57 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.293 -1.743 . . . . 0.61 106.293 177.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.441 HD11 HD11 ' A' ' 19' ' ' LEU . 38.3 tp -100.01 117.88 35.21 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.985 -1.072 . . . . 0.87 110.854 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.555 HG12 HG22 ' A' ' 209' ' ' THR . 84.3 t -121.54 129.44 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.408 -0.96 . . . . 0.71 108.408 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.513 ' C ' HG21 ' A' ' 209' ' ' THR . . . -160.09 165.02 32.57 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.109 -0.994 . . . . 0.81 109.091 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.45 -38.28 74.46 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.178 -1.576 . . . . 0.98 107.841 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -170.68 145.28 2.47 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.76 -0.83 . . . . 2.25 108.76 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.4 mt -112.17 140.22 47.05 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.248 -0.907 . . . . 0.78 109.818 -179.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.0 p -92.18 141.59 25.27 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.279 -0.888 . . . . 0.98 109.121 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -39.64 -36.5 1.15 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.208 1.938 . . . . 0.81 113.194 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.5 m -60.38 -40.03 89.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.033 -1.042 . . . . 0.9 110.242 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.59 -41.52 92.75 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.006 -1.058 . . . . 1.61 109.799 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.9 p -57.54 -32.92 67.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.192 -0.943 . . . . 0.61 111.293 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.464 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -70.14 -43.92 69.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.669 -1.27 . . . . 0.6 109.732 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -94.88 34.94 1.29 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.625 -0.879 . . . . 1.4 108.625 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.7 tp -107.48 138.98 42.71 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.814 -0.81 . . . . 0.7 108.814 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.469 ' O ' HG23 ' A' ' 176' ' ' VAL . 94.2 m-20 -86.47 103.87 15.41 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.141 -0.974 . . . . 2.35 109.539 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.85 -39.99 95.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.477 -0.764 . . . . 1.51 110.812 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -67.96 -25.92 65.68 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.994 -1.066 . . . . 2.33 111.76 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -93.37 -8.81 40.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.588 -1.32 . . . . 1.92 109.895 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.515 HG11 ' CE1' ' A' ' 179' ' ' PHE . 81.8 t -97.04 110.38 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.101 -0.999 . . . . 0.67 108.792 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.0 mt -77.77 2.91 15.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.222 -0.924 . . . . 1.53 110.334 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.513 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 165.6 177.04 37.6 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.198 -1.561 . . . . 0.48 109.198 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.609 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 17.8 m-85 -132.96 129.98 38.96 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.425 -1.044 . . . . 0.55 108.521 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.6 mt -134.47 127.7 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.21 -0.931 . . . . 0.65 109.348 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 29.1 p -149.74 160.02 43.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.82 110.401 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' A' ' 182' ' ' ASP . 35.1 p-10 -109.16 27.57 9.38 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.684 -0.858 . . . . 2.46 108.684 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.04 -157.18 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.197 -0.939 . . . . 1.28 111.929 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.3 -80.83 0.06 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.087 -1.205 . . . . 2.19 110.087 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.55 -134.2 2.73 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.839 -1.305 . . . . 2.13 109.839 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.414 ' C ' ' H ' ' A' ' 188' ' ' SER . 14.6 tpp180 -60.01 -40.01 87.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.404 -1.056 . . . . 5.86 110.63 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.1 p -64.97 7.79 0.15 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.065 -1.022 . . . . 3.72 111.258 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.414 ' H ' ' C ' ' A' ' 186' ' ' ARG . 15.9 m -90.72 135.32 33.79 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.66 -1.275 . . . . 1.74 110.827 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -46.12 -52.55 11.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.448 -0.783 . . . . 0.95 109.761 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.418 ' H ' HG22 ' A' ' 190' ' ' THR . 0.1 OUTLIER -53.99 -37.1 63.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.492 -0.755 . . . . 1.55 110.247 -179.101 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.3 t -60.05 -45.24 93.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.111 -0.993 . . . . 1.51 111.03 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.01 -40.49 83.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.321 -0.862 . . . . 1.67 110.406 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.2 mtp -60.14 -45.78 91.9 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.069 -1.019 . . . . 1.02 110.164 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.19 -45.97 65.38 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.549 -1.344 . . . . 0.68 109.484 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -63.48 -58.06 8.23 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.057 -1.057 . . . . 2.93 110.327 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.4 m -60.27 -39.93 88.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.897 -1.127 . . . . 0.86 111.655 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.35 -22.36 62.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.834 -1.167 . . . . 0.67 109.498 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 69.99 47.82 0.57 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.38 0.609 . . . . 1.5 110.31 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.438 ' O ' ' CB ' ' A' ' 8' ' ' SER . 68.6 mt -129.16 149.96 74.09 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 107.994 -1.113 . . . . 0.72 107.994 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.07 146.14 75.85 Favored 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 122.459 2.106 . . . . 0.61 112.05 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.609 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -177.0 154.12 1.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.106 -0.996 . . . . 0.66 111.004 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.0 mt -125.67 151.11 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.45 -1.315 . . . . 0.79 107.45 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.2 m -131.06 -12.03 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 120.866 -1.146 . . . . 0.91 111.04 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.01 25.02 17.47 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.09 -1.204 . . . . 1.01 110.09 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 22.4 p -45.32 -42.83 10.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.125 -1.221 . . . . 0.99 109.903 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 94.01 -52.52 2.23 Favored Glycine 0 N--CA 1.497 2.748 0 O-C-N 121.139 -0.976 . . . . 1.12 111.447 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 80.6 p -156.78 34.7 0.3 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.579 -1.542 . . . . 1.72 111.332 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 23.0 t -75.76 -39.42 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.061 -1.024 . . . . 0.89 108.904 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.555 HG22 HG12 ' A' ' 159' ' ' VAL . 72.7 p -56.72 -27.2 58.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 1.03 110.674 -179.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.3 m -80.25 -24.62 39.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.835 -1.166 . . . . 1.83 110.308 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -95.55 -8.66 34.47 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.152 -0.967 . . . . 2.27 110.444 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 56.0 t -102.35 136.17 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.226 -0.921 . . . . 0.92 109.943 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.48 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 2.2 mptp? -116.28 152.92 32.87 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.567 -1.271 . . . . 2.2 107.567 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.455 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 16.6 p-10 -56.29 139.46 48.15 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.999 -1.063 . . . . 2.36 110.618 -178.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.0 m-20 82.02 8.74 0.88 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.028 0.442 . . . . 2.38 110.376 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.48 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 90.6 m-20 -79.32 139.82 37.7 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.025 -1.047 . . . . 2.09 109.346 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -91.65 115.04 27.71 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.031 -1.099 . . . . 1.27 108.031 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.502 HD12 ' HB2' ' A' ' 16' ' ' ALA . 59.6 mt -125.42 150.27 47.43 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.651 -0.655 . . . . 0.75 110.627 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.3 mt -115.38 127.67 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.281 -1.377 . . . . 0.63 107.281 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 54.7 tp -100.7 119.99 39.41 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.936 -1.102 . . . . 0.7 108.702 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 223' ' ' VAL . 83.0 m-20 -78.88 -43.1 25.68 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.067 -1.02 . . . . 2.31 109.373 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.908 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.01 15.34 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.4 -0.963 . . . . 0.78 108.4 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 221' ' ' ASP . 53.2 t -131.5 -38.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.287 -1.375 . . . . 1.04 107.287 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -105.69 0.54 26.39 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.682 -1.229 . . . . 2.44 107.682 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 60.19 44.28 12.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.814 -0.554 . . . . 1.55 110.357 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -141.81 151.37 42.73 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.07 -1.019 . . . . 1.99 109.762 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.5 t -119.48 130.08 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.519 -0.919 . . . . 0.77 108.519 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -101.7 124.01 46.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.52 -0.737 . . . . 0.98 109.25 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 18.0 t -101.05 113.9 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.637 -0.665 . . . . 0.85 109.903 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 50.64 67.66 4.13 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.194 -0.941 . . . . 1.66 111.208 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -90.12 148.68 4.63 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 123.048 2.499 . . . . 0.95 112.346 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 71.5 p -72.45 166.26 22.95 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.099 -1.001 . . . . 1.84 109.897 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -59.94 -35.47 74.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 2.74 109.736 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.95 -39.99 87.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 2.89 109.686 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.85 -39.97 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.142 -0.974 . . . . 1.3 109.144 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.4 -40.0 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 1.09 109.693 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -60.02 -41.38 92.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.859 -1.151 . . . . 2.43 109.114 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -67.08 -40.04 86.93 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.665 -0.865 . . . . 2.78 108.665 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 95.8 mtp -70.76 -32.73 69.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.547 -0.721 . . . . 1.25 109.221 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.534 ' NH2' ' OE1' ' A' ' 243' ' ' GLN . 2.2 mmp_? -61.35 -40.17 93.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.218 -0.926 . . . . 2.63 109.17 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -64.81 -37.98 89.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.41 -0.806 . . . . 1.8 109.039 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 56.0 t -60.03 -41.37 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.457 -0.777 . . . . 2.13 109.524 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.534 ' OE1' ' NH2' ' A' ' 240' ' ' ARG . 60.2 tt0 -60.07 -40.39 89.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.956 . . . . 3.17 109.812 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -59.95 -39.72 86.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.924 -1.11 . . . . 1.78 108.89 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -59.88 -40.16 87.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.529 -0.732 . . . . 2.47 109.047 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 76.2 t -59.92 -40.52 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.389 -0.819 . . . . 2.09 110.11 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.26 -40.66 96.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.08 -1.013 . . . . 2.54 109.383 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 42.1 t -65.52 -34.19 77.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.355 -0.84 . . . . 2.99 109.288 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.97 -40.1 87.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.465 -0.772 . . . . 3.34 109.333 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -60.41 -40.34 90.62 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.421 -0.799 . . . . 3.88 110.507 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -85.86 0.44 53.04 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.236 -0.915 . . . . 4.43 109.374 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -77.89 -8.72 58.46 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.566 -0.709 . . . . 5.42 109.842 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 87.8 mt 49.97 73.27 0.27 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.904 -1.122 . . . . 6.1 108.264 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -71.6 -8.75 55.99 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.787 -0.571 . . . . 7.37 110.432 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -94.3 131.87 39.47 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.015 -1.053 . . . . 8.01 109.512 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 5.6 tp 55.35 39.99 31.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.092 -1.005 . . . . 9.05 108.804 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.435 ' O ' ' OD1' ' A' ' 258' ' ' ASP . 31.9 mtmm -49.42 -60.06 3.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.703 -0.623 . . . . 10.56 109.858 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 257' ' ' LYS . 85.9 m-20 -143.7 16.0 1.79 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 11.32 109.86 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.065 . . . . 12.42 109.469 -179.773 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 6.1 ttt . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.367 0.604 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -153.99 151.56 29.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.411 -0.806 . . . . 0.0 109.17 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -149.56 159.93 43.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.076 -1.015 . . . . 0.0 110.479 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -154.72 150.97 28.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 305' ' ' GLU . . . . . 0.486 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 2.0 pm0 -116.45 133.89 55.49 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.22 -0.925 . . . . 0.0 110.325 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.48 128.11 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 CA-C-O 122.351 1.072 . . . . 0.0 112.546 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 86.4 m -78.1 103.31 7.96 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.877 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.505 HG22 ' H ' ' B' ' 310' ' ' ALA . 88.4 mt -51.19 122.65 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 122.446 1.117 . . . . 0.0 109.815 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 54.2 p -103.23 21.09 16.48 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.202 -178.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.505 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -86.6 115.29 61.74 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.062 -1.024 . . . . 0.0 108.938 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -68.13 -3.29 10.42 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 CA-C-N 120.309 1.146 . . . . 0.0 111.511 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -111.31 -0.64 16.32 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.91 172.82 26.91 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 107.684 -2.167 . . . . 0.0 107.684 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.491 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -85.58 94.93 9.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.862 -1.375 . . . . 0.0 108.241 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -93.75 -162.79 0.97 Allowed 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.991 -1.068 . . . . 0.0 110.698 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.0 m -56.78 -42.5 79.56 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.098 -1.001 . . . . 0.0 112.514 -176.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.516 HH11 ' HG2' ' B' ' 317' ' ' ARG . 0.9 OUTLIER -61.37 -60.0 11.86 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 120.639 -1.288 . . . . 0.0 112.241 -178.677 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -60.78 -32.04 92.49 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 120.295 1.141 . . . . 0.0 111.811 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.44 73.74 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.25 -40.65 61.97 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.443 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -70.19 -40.73 74.46 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.043 -1.036 . . . . 0.0 108.768 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -60.26 -51.78 68.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.425 -0.797 . . . . 0.0 110.452 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 87.2 t -69.91 -30.63 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.758 -1.214 . . . . 0.0 110.35 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -60.08 -45.6 92.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 108.999 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -67.19 -40.05 86.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.84 . . . . 0.0 110.528 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -64.91 -53.61 43.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.77 -1.206 . . . . 0.0 111.033 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -52.96 -10.05 0.16 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.121 -0.987 . . . . 0.0 110.458 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -79.23 -21.06 68.27 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -106.23 140.18 39.57 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.55 -0.971 . . . . 0.0 109.26 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 17.2 m -90.89 -11.08 40.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.045 -1.034 . . . . 0.0 110.342 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.495 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 84.4 p -62.93 153.66 32.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.907 -1.12 . . . . 0.0 109.712 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -69.44 133.14 47.39 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.5 mt -134.47 133.77 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.674 -0.641 . . . . 0.0 109.99 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 85.9 m -131.17 152.01 50.88 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 67.3 t -123.56 117.62 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 49.5 m -106.32 132.72 52.03 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.088 -1.007 . . . . 0.0 109.333 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 82.1 p -140.01 115.46 9.98 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.924 0.869 . . . . 0.0 110.798 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 24.0 m120 46.96 49.8 14.37 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 176.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.97 -12.96 65.92 Favored Glycine 0 N--CA 1.505 3.244 0 O-C-N 120.155 -1.59 . . . . 0.0 113.327 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -118.5 130.06 55.72 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-N 119.579 1.689 . . . . 0.0 109.503 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 38.9 m -128.75 150.4 50.3 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.871 0.843 . . . . 0.0 110.954 -178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 342' ' ' ALA . . . . . 0.542 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -146.45 169.28 19.23 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.646 0.736 . . . . 0.0 110.293 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 60.8 m -88.17 139.57 30.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.637 -0.665 . . . . 0.0 109.903 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.452 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -79.78 -15.8 56.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.938 -1.101 . . . . 0.0 109.852 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -85.38 20.61 1.96 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 346' ' ' SER . . . . . 0.452 ' H ' ' C ' ' B' ' 344' ' ' ALA . 17.3 t -147.97 95.95 2.57 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.31 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.854 HD23 HD22 ' A' ' 79' ' ' LEU . 61.2 tp -59.92 -34.7 73.57 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.863 ' CE2' HD11 ' A' ' 79' ' ' LEU . 59.7 m-85 -54.56 -51.85 63.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.63 -0.669 . . . . 0.0 110.994 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 349' ' ' LYS . . . . . 0.434 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 34.1 mtmm -80.89 -12.73 59.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.731 -1.23 . . . . 0.0 111.207 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 27.4 mt -69.48 -49.78 51.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.48 -1.387 . . . . 0.0 109.214 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.64 ' O ' HD22 ' A' ' 123' ' ' LEU . 2.0 mm100 -50.0 -20.1 0.86 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.144 -0.972 . . . . 0.0 111.451 -177.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 74.6 p -76.05 -10.02 59.08 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.233 -1.542 . . . . 0.0 109.242 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.542 HD11 ' HB3' ' B' ' 342' ' ' ALA . 53.0 mt -95.43 118.08 31.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.353 -0.842 . . . . 0.0 109.323 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.49 93.07 1.0 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 38.4 mt -97.51 85.49 3.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.232 -1.158 . . . . 0.0 108.344 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 31.9 p -93.64 179.96 5.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.195 -0.941 . . . . 0.0 110.81 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 357' ' ' GLN . . . . . 0.52 ' O ' ' N ' ' B' ' 359' ' ' THR . 62.0 tt0 -49.5 156.91 0.57 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 122.371 1.081 . . . . 0.0 111.412 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.23 23.62 0.02 OUTLIER Glycine 0 N--CA 1.496 2.65 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.226 177.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 359' ' ' THR . . . . . 0.52 ' N ' ' O ' ' B' ' 357' ' ' GLN . 27.6 m -83.75 110.04 18.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.803 -1.41 . . . . 0.0 109.858 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 6.8 t -77.28 113.73 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 122.296 1.046 . . . . 0.0 109.833 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.2 m -109.67 176.19 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 56.2 m -131.96 129.95 40.87 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.5 mt -107.84 121.74 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 24.2 p -122.02 133.19 54.8 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.05 149.85 38.77 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.084 -1.01 . . . . 0.0 109.83 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -144.51 121.96 11.69 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.435 -0.79 . . . . 0.0 109.094 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.544 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.05 -152.95 24.28 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.125 -1.512 . . . . 0.0 111.724 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -58.82 -52.82 64.1 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.495 ' H ' ' HB3' ' B' ' 331' ' ' SER . 70.7 m-20 -109.96 12.71 23.65 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.015 -1.053 . . . . 0.0 111.32 -177.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.8 pt-20 -41.95 -35.56 0.89 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.286 -0.883 . . . . 0.0 111.362 -178.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -69.55 -41.0 76.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.574 -1.329 . . . . 0.0 109.991 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -71.76 -54.3 10.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.966 -1.084 . . . . 0.0 109.413 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.39 -35.27 1.5 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.6 -0.687 . . . . 0.0 111.934 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.54 ' O ' HG23 ' B' ' 378' ' ' VAL . 58.7 t -80.19 -33.21 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.492 -1.38 . . . . 0.0 109.297 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -70.0 -40.65 75.16 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.224 -0.922 . . . . 0.0 112.495 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -84.7 -44.65 13.19 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.438 -1.413 . . . . 0.0 110.687 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 90.9 mt -59.92 -39.34 85.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.099 -1.0 . . . . 0.0 109.159 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.54 HG23 ' O ' ' B' ' 374' ' ' VAL . 49.3 t -64.36 -43.74 97.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.28 -0.888 . . . . 0.0 109.784 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -79.93 -9.86 59.72 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.054 -1.029 . . . . 0.0 109.457 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 43.0 tp -82.34 -24.88 34.32 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.1 tpp -82.79 -25.01 33.14 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -85.03 -11.11 56.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.687 -0.633 . . . . 0.0 110.202 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -107.33 -0.29 22.57 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.233 -0.917 . . . . 0.0 110.835 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 34.4 mt -94.95 119.3 33.24 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.76 -1.212 . . . . 0.0 110.084 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 385' ' ' GLU . . . . . 0.567 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 1.3 pm0 . . . . . 0 N--CA 1.499 2.0 0 CA-C-O 117.94 -1.028 . . . . 0.0 109.479 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.9 mtm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.465 -0.569 . . . . 2.91 109.465 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 94.4 mt -110.06 126.37 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.479 -0.763 . . . . 1.2 109.625 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.5 m -136.75 134.06 36.7 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.893 -0.78 . . . . 1.4 108.893 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.92 -158.59 22.4 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 108.888 -1.685 . . . . 1.05 108.888 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.8 mt -91.65 -9.95 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.995 -1.297 . . . . 1.15 110.448 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.4 tp 55.01 98.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.956 -1.09 . . . . 0.98 108.773 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.75 -34.1 40.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.626 -0.672 . . . . 0.88 109.515 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 m -150.02 141.6 15.02 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.275 -0.89 . . . . 1.69 109.618 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.91 143.67 16.52 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.459 2.106 . . . . 0.85 112.488 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.885 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.91 -165.95 38.36 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.472 -1.451 . . . . 0.92 109.472 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.1 mt -149.2 149.97 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.169 -1.194 . . . . 0.81 108.506 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.27 144.2 19.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.945 -1.097 . . . . 0.51 110.363 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 16.3 m-85 -125.23 128.59 48.54 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.21 -1.033 . . . . 0.62 108.21 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.78 -178.84 44.63 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.717 -1.706 . . . . 0.55 110.816 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -80.19 158.14 26.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.774 -0.839 . . . . 2.1 109.542 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.492 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -105.04 131.24 52.8 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.434 -0.791 . . . . 0.77 110.671 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.6 tp -97.89 136.4 38.24 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.206 -1.405 . . . . 0.91 107.206 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 tp -120.29 124.61 46.04 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.337 -0.852 . . . . 0.93 109.407 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.8 mt -88.18 106.6 18.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.492 -0.755 . . . . 0.93 109.895 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.458 ' NZ ' ' CB ' ' A' ' 20' ' ' LYS . 7.4 mtpm? -102.23 128.78 48.61 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.744 -0.835 . . . . 2.75 108.744 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.531 ' OE1' ' NH2' ' A' ' 139' ' ' ARG . 98.6 mt-10 -126.19 137.95 53.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.312 -0.867 . . . . 3.0 109.135 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -79.15 143.56 35.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.22 -0.925 . . . . 2.77 109.035 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -61.23 140.01 58.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 2.94 109.547 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.6 mt -81.3 131.17 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.409 -0.807 . . . . 0.95 109.192 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.0 t -101.12 123.24 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.302 -0.874 . . . . 1.28 109.58 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.7 mt -98.13 142.94 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.398 -0.814 . . . . 1.21 108.938 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -91.09 122.16 33.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.019 -1.051 . . . . 1.81 109.48 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.533 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.6 mmt-85 -91.12 0.08 57.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 2.8 109.223 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.67 141.67 53.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -0.851 . . . . 2.87 109.654 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -85.78 146.8 26.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.195 -0.941 . . . . 2.35 109.281 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 pt -90.79 164.69 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.97 110.216 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.8 p -97.06 174.14 6.91 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.568 -0.901 . . . . 1.17 108.568 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.96 -48.58 81.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.151 -0.968 . . . . 1.18 110.032 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -54.51 -31.47 56.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.764 -1.21 . . . . 2.56 109.441 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -82.3 -9.05 59.62 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.466 -0.772 . . . . 1.79 110.276 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.2 t -68.05 -56.46 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.436 -1.415 . . . . 1.0 109.146 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.16 -39.97 88.28 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.384 -0.822 . . . . 1.77 109.739 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -67.14 -41.88 85.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.082 -1.011 . . . . 2.7 110.356 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -62.98 -40.08 96.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.904 -1.122 . . . . 1.51 110.405 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.15 -48.67 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.749 -1.22 . . . . 0.93 109.197 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -61.73 -47.81 83.55 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.184 -0.947 . . . . 1.81 109.861 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.421 HH11 ' HG2' ' A' ' 42' ' ' ARG . 49.6 mtt-85 -60.11 -41.91 93.61 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.078 -1.082 . . . . 2.78 108.078 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.433 ' CD1' ' HB1' ' A' ' 100' ' ' ALA . 61.8 t80 -70.07 -39.94 75.32 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.513 -0.742 . . . . 0.78 109.344 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.5 tp -60.05 -48.53 81.34 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.28 -1.378 . . . . 1.07 107.28 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -63.69 -39.98 95.65 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.288 -1.004 . . . . 1.12 108.288 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.26 -50.02 72.17 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 108.491 -1.844 . . . . 0.84 108.491 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.409 HH11 ' HB3' ' A' ' 47' ' ' ARG . 1.4 ttt-85 -61.35 -39.78 91.85 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.709 -1.219 . . . . 3.09 107.709 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.96 87.84 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.971 -0.751 . . . . 0.88 108.971 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 33.6 ttpt -58.03 -74.99 0.05 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.021 -1.072 . . . . 2.59 108.21 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.61 -33.01 0.09 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.15 -0.969 . . . . 0.7 111.715 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.6 m -57.58 -47.54 81.82 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.138 -1.425 . . . . 1.4 108.365 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.8 -41.66 74.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.115 -0.991 . . . . 0.67 110.863 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -67.31 -39.97 85.95 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.806 -1.184 . . . . 1.66 110.163 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.47 -39.38 87.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.943 -1.098 . . . . 1.58 109.222 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -59.99 -36.54 77.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 1.35 109.942 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -63.96 -42.83 97.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.827 -1.171 . . . . 0.77 109.109 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.524 HD11 HH22 ' A' ' 136' ' ' ARG . 85.4 mt -61.68 -37.09 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.63 109.134 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -58.19 -49.98 75.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.861 . . . . 1.14 109.178 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -59.59 -34.18 72.4 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.372 -0.83 . . . . 0.79 110.709 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -69.22 -39.37 78.61 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.847 -1.158 . . . . 1.53 109.598 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.95 -42.06 99.7 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.591 -0.693 . . . . 0.57 109.971 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.1 -50.53 66.67 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.576 -1.41 . . . . 0.75 109.576 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.28 -51.77 34.12 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.011 -1.287 . . . . 1.59 109.515 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.7 m -60.45 -65.68 0.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.355 -0.841 . . . . 0.73 112.179 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.507 ' CE1' ' O ' ' A' ' 168' ' ' THR . 84.3 m-85 -96.12 -49.31 5.3 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.757 -1.215 . . . . 0.75 111.519 -177.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.03 -169.54 25.28 Favored Glycine 0 N--CA 1.503 3.142 0 C-N-CA 119.659 -1.258 . . . . 1.22 111.298 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.05 -25.23 63.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.877 -0.778 . . . . 5.81 109.991 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.517 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.1 tp10 -59.99 -34.57 73.5 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.52 -0.737 . . . . 3.37 110.267 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -100.8 -16.34 17.33 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.366 -0.833 . . . . 1.77 109.91 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -70.35 -42.03 72.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 1.65 110.501 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.521 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.68 -28.47 69.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.898 . . . . 0.77 109.846 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 83.7 mt -60.12 -40.06 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.129 -1.029 . . . . 0.8 108.877 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -66.56 -41.72 88.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.035 . . . . 0.88 110.498 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -60.52 -40.03 89.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.888 -1.132 . . . . 1.37 109.832 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.43 99.41 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.24 -1.544 . . . . 0.62 109.24 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -66.99 -41.1 87.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -1.158 . . . . 1.5 109.384 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.63 -46.52 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.923 . . . . 0.63 109.826 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.7 ttp -60.08 -43.95 95.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.03 -1.044 . . . . 1.51 110.207 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.828 HD11 ' CE2' ' B' ' 348' ' ' PHE . 41.4 tp -62.62 -40.03 95.67 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.256 -0.903 . . . . 0.77 109.893 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.5 tp -62.65 -39.95 95.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.27 -0.894 . . . . 0.62 110.215 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -82.75 9.47 9.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.119 -0.988 . . . . 1.47 110.069 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 48.3 t0 -54.88 133.1 47.79 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.118 -0.989 . . . . 1.47 110.445 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 95.5 mt-10 -60.26 -21.07 61.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.64 -0.662 . . . . 1.78 110.734 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.54 -34.72 72.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.667 -1.271 . . . . 2.53 109.355 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.3 mt -70.05 -39.9 75.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.8 109.312 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -60.08 -49.95 75.64 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.446 -0.784 . . . . 1.42 109.804 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -70.14 -41.13 74.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 1.71 110.597 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.72 -40.45 69.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.007 -1.058 . . . . 1.57 111.646 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.1 mt -69.98 -40.32 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.981 -1.074 . . . . 0.65 109.885 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.3 mt -68.99 -36.81 75.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.505 -0.747 . . . . 0.82 109.96 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.76 -49.98 75.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.79 111.183 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.9 mt -60.55 -46.16 91.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.638 -1.289 . . . . 0.95 109.808 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.93 -50.07 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.926 . . . . 0.66 109.461 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -74.13 -42.41 60.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.645 -0.66 . . . . 2.2 111.393 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -79.92 -50.06 10.99 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.901 -1.124 . . . . 1.65 112.052 -177.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -91.03 -4.18 56.59 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.964 -1.085 . . . . 2.03 111.497 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 m80 56.02 36.43 27.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.911 -1.118 . . . . 1.42 109.072 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 53.7 mtt -90.87 169.98 10.46 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.661 -0.65 . . . . 1.18 109.639 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 102' ' ' ALA . 82.1 p -77.79 153.72 32.57 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.928 -1.138 . . . . 0.98 107.928 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 43' ' ' PHE . . . -70.59 -36.64 73.67 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.944 -1.098 . . . . 0.64 111.028 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -68.57 -39.42 81.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.93 -1.106 . . . . 2.07 109.797 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.412 ' HB3' ' OG1' ' A' ' 99' ' ' THR . . . -78.5 -41.48 32.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.73 109.806 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.38 -42.88 67.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.283 -0.886 . . . . 0.54 110.272 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.68 -40.11 96.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.103 -0.998 . . . . 0.56 109.587 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -59.9 -40.05 87.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.5 -0.75 . . . . 1.54 110.3 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 110' ' ' GLY . 86.3 tt0 -60.74 -39.97 90.66 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.138 -0.976 . . . . 1.33 109.994 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.61 -52.15 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.297 -0.877 . . . . 0.72 110.657 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.2 mm -70.06 -40.01 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.989 -1.069 . . . . 0.85 108.327 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -68.15 -32.94 73.56 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.452 -0.944 . . . . 2.44 108.452 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -65.22 -51.3 51.04 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.174 -1.17 . . . . 0.98 110.174 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -60.04 -49.3 78.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.967 -1.314 . . . . 1.41 109.248 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.67 81.4 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.311 -0.868 . . . . 1.2 109.691 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.9 p -59.3 -39.94 84.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.041 -1.037 . . . . 1.7 109.287 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.21 -40.06 94.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 1.47 108.823 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.0 mt -63.4 -42.68 98.79 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.123 -0.986 . . . . 1.56 109.096 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -56.82 -34.38 67.65 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.019 -1.051 . . . . 2.2 109.291 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.11 -23.15 65.29 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.245 -0.91 . . . . 2.12 109.267 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 55.4 mt -62.14 140.75 58.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.04 -1.037 . . . . 2.0 108.519 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -93.84 49.09 1.31 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.911 -1.118 . . . . 3.23 110.836 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -135.35 137.9 42.83 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.129 -0.982 . . . . 2.49 109.835 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 52.0 mp0 -70.12 -31.62 69.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.605 -0.684 . . . . 3.95 110.308 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.62 ' CZ ' ' NH1' ' A' ' 126' ' ' ARG . 3.5 t80 -73.8 -40.11 63.63 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.109 -0.994 . . . . 2.0 110.916 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.685 HD23 HH22 ' A' ' 126' ' ' ARG . 60.7 mt -69.44 -36.56 76.76 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.109 -0.995 . . . . 1.86 108.604 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.19 -36.99 85.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 2.84 110.004 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -59.82 -45.19 93.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.948 -1.095 . . . . 2.73 110.796 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.685 HH22 HD23 ' A' ' 123' ' ' LEU . 25.6 mtm-85 -66.06 -34.51 78.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.599 -1.313 . . . . 2.77 108.756 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.27 -35.47 73.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 1.19 108.519 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.95 92.93 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.345 -0.983 . . . . 1.2 108.345 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -68.42 -39.94 81.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.407 -0.808 . . . . 1.55 109.856 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.417 HG21 HE22 ' B' ' 351' ' ' GLN . 43.7 t -69.38 -40.03 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.004 -1.06 . . . . 0.8 108.749 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -60.07 -38.91 84.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 3.09 108.42 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -59.97 -38.82 83.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.541 -0.724 . . . . 1.46 109.916 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.9 -42.83 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.046 -1.034 . . . . 0.71 109.679 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.87 -35.27 72.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.724 -1.35 . . . . 0.57 109.724 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.98 -48.9 79.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -1.207 . . . . 2.59 110.185 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.524 HH22 HD11 ' A' ' 57' ' ' ILE . 59.1 mtp180 -67.07 -27.89 67.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.615 -1.303 . . . . 2.83 109.914 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.8 tp -59.54 -42.03 91.4 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.232 -1.025 . . . . 1.25 108.232 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.6 -40.05 95.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.7 109.414 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.531 ' NH2' ' OE1' ' A' ' 21' ' ' GLU . 99.0 mtt180 -67.58 -39.94 84.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.305 -0.872 . . . . 2.57 109.965 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -69.86 -31.6 69.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 1.23 112.062 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.1 mt -68.91 -51.62 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.087 -1.633 . . . . 0.81 108.226 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 98.5 mt -70.04 -39.94 75.43 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.068 -0.653 . . . . 1.0 109.348 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.16 52.59 2.35 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.497 -1.441 . . . . 0.89 109.497 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 tp -73.84 150.03 41.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.235 -1.156 . . . . 1.14 108.493 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.65 139.56 53.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.03 -1.044 . . . . 4.6 110.051 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.2 mt -110.01 129.96 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 122.046 0.927 . . . . 1.24 109.297 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.0 mt -69.8 -40.0 78.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 115.778 -0.646 . . . . 1.54 110.166 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 39.8 t0 63.29 131.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.451 0.643 . . . . 1.5 109.361 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 152' ' ' ILE . 83.3 mt -85.44 -2.62 58.31 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.706 -0.85 . . . . 0.79 108.706 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.5 p -83.95 -9.6 58.57 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.82 -0.807 . . . . 1.4 108.82 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -86.04 22.72 1.65 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.531 -0.731 . . . . 0.92 109.798 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.503 HD12 ' O ' ' A' ' 149' ' ' LEU . 66.0 mt -90.48 120.99 40.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.337 -0.852 . . . . 0.88 109.045 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -102.74 -13.98 16.84 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.269 -0.895 . . . . 2.45 110.123 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -130.23 151.61 50.56 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.59 -0.693 . . . . 1.52 110.11 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.28 137.15 58.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 1.58 108.768 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.8 m -153.14 168.05 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.519 -0.738 . . . . 0.69 110.067 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -95.11 146.16 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 106.564 -1.643 . . . . 0.61 106.564 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 49.6 tp -96.83 120.21 36.75 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.106 -0.996 . . . . 0.87 110.8 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.431 HG12 HG22 ' A' ' 209' ' ' THR . 42.2 t -126.41 130.03 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 108.981 -0.748 . . . . 0.71 108.981 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.8 168.57 24.48 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.197 -0.939 . . . . 0.81 109.043 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.78 -37.92 73.36 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.364 -1.46 . . . . 0.98 108.006 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -170.59 145.36 2.53 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.743 -0.836 . . . . 2.25 108.743 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 48.1 mt -112.87 134.67 54.27 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.324 -0.86 . . . . 0.78 109.443 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 11.6 p -90.76 148.84 39.3 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.198 -0.939 . . . . 0.98 109.122 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.35 -32.98 5.73 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.949 1.766 . . . . 0.81 112.485 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 66.7 m -55.88 -45.56 78.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.085 -1.009 . . . . 0.9 109.444 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -69.96 -40.08 75.63 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.372 -0.83 . . . . 1.61 109.539 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.507 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 44.0 p -55.3 -18.37 6.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.233 -0.917 . . . . 0.61 110.935 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -88.46 -46.93 8.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.793 -1.192 . . . . 0.6 109.643 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -90.11 41.2 1.04 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.926 -1.138 . . . . 1.4 107.926 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.1 tp -105.0 131.19 52.84 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.733 -0.604 . . . . 0.7 109.591 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -85.43 97.51 10.06 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.175 -1.046 . . . . 2.35 108.175 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.28 -39.87 95.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.435 -0.791 . . . . 1.51 110.804 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -64.86 -25.51 67.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.082 -1.011 . . . . 2.33 111.033 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -93.96 -10.16 34.61 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.746 -1.221 . . . . 1.92 110.164 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.494 HG12 ' H ' ' A' ' 178' ' ' GLY . 62.6 t -107.12 119.91 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.225 -0.922 . . . . 0.67 108.678 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.1 mt -94.45 11.58 30.23 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.399 -0.813 . . . . 1.53 111.051 -177.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.494 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 171.17 170.27 35.11 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.267 -1.533 . . . . 0.48 109.267 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -136.75 133.56 36.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.365 -1.079 . . . . 0.55 109.118 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.41 ' CG2' HG21 ' A' ' 205' ' ' THR . 75.6 mt -135.41 128.4 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.751 -0.833 . . . . 0.65 108.751 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' A' ' 205' ' ' THR . 34.3 p -144.98 158.64 43.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 0.82 110.626 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 183' ' ' ALA . 86.2 m-20 -94.05 17.23 12.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.602 -0.686 . . . . 2.46 109.778 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -44.32 -179.51 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.496 1.141 . . . . 1.28 113.029 -177.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.8 -52.99 5.57 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.281 -1.127 . . . . 2.19 110.281 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -168.33 -159.88 14.91 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 118.558 -1.782 . . . . 2.13 111.46 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.424 ' O ' ' OG ' ' A' ' 191' ' ' SER . 11.3 ptt180 -69.98 -13.88 62.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 122.18 -0.6 . . . . 5.86 111.129 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 41.2 p -74.32 5.22 4.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.882 -1.136 . . . . 3.72 109.036 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 91.7 p -87.63 141.23 28.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.368 -0.832 . . . . 1.74 110.39 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -54.88 -38.66 67.82 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.293 -0.879 . . . . 0.95 108.997 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 190' ' ' THR . 14.2 p -59.85 -39.95 86.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.682 -0.637 . . . . 1.55 109.941 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 186' ' ' ARG . 93.9 p -61.31 -38.24 86.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 1.51 110.113 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.2 mm -60.01 -39.92 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 1.67 109.074 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.0 mtp -56.14 -49.69 73.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.094 -1.004 . . . . 1.02 109.967 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.96 -44.71 78.74 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.093 -1.004 . . . . 0.68 109.915 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -61.64 -58.96 6.01 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.293 -0.963 . . . . 2.93 110.601 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.2 m -63.12 -39.67 95.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.204 -0.935 . . . . 0.86 111.554 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.7 mt -70.04 -30.05 67.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.831 -1.168 . . . . 0.67 109.402 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 70.52 49.56 0.41 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.342 0.592 . . . . 1.5 109.671 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 55.9 mt -130.1 150.03 74.89 Favored Pre-proline 0 N--CA 1.503 2.193 0 N-CA-C 108.256 -1.016 . . . . 0.72 108.256 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.74 138.18 84.82 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 122.204 1.936 . . . . 0.61 112.051 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.43 151.13 3.63 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.402 -0.919 . . . . 0.66 111.139 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.41 ' CG2' HG23 ' A' ' 205' ' ' THR . 75.7 mt -127.67 139.77 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 107.208 -1.405 . . . . 0.79 107.208 178.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 32.4 m -123.05 -14.41 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.204 -0.935 . . . . 0.91 111.424 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -106.04 26.94 19.11 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.489 -1.444 . . . . 1.01 109.489 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 181' ' ' THR . 1.7 p -52.64 -37.2 58.12 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.234 -1.156 . . . . 0.99 110.41 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.63 -80.54 1.68 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.488 -1.339 . . . . 1.12 110.668 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 21.9 t -129.81 31.89 4.66 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 121.426 -1.044 . . . . 1.72 112.333 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 55.7 t -69.83 -40.22 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.408 -1.432 . . . . 0.89 107.931 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.431 HG22 HG12 ' A' ' 159' ' ' VAL . 72.3 p -53.88 -28.91 39.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.644 -0.66 . . . . 1.03 109.898 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.1 p -80.56 -19.4 45.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.021 -1.05 . . . . 1.83 110.135 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -96.62 -13.56 22.78 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.165 -0.96 . . . . 2.27 110.148 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.2 t -102.53 136.5 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.271 -0.893 . . . . 0.92 110.635 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -115.24 157.04 24.29 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.46 -1.311 . . . . 2.2 107.46 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 46.9 p-10 -60.03 139.99 57.1 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.814 -1.179 . . . . 2.36 110.265 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.7 m-20 80.87 4.29 1.59 Allowed 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.109 0.48 . . . . 2.38 110.028 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -71.13 130.03 40.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.197 -0.939 . . . . 2.09 109.022 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -84.63 112.92 20.88 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.111 -1.07 . . . . 1.27 108.111 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.492 HD12 ' HB2' ' A' ' 16' ' ' ALA . 54.8 mt -123.77 147.26 47.68 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.595 -0.69 . . . . 0.75 110.87 -178.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.409 HD12 ' HG3' ' A' ' 231' ' ' PRO . 75.8 mt -114.38 127.68 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.813 -1.551 . . . . 0.63 106.813 177.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.4 tp -100.4 118.14 36.03 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.826 -1.171 . . . . 0.7 109.622 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.536 ' C ' ' H ' ' A' ' 223' ' ' VAL . 96.0 m-20 -75.7 -43.4 47.36 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.096 -1.002 . . . . 2.31 108.407 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.885 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 50.04 10.55 0.05 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.948 -0.76 . . . . 0.78 108.948 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.536 ' H ' ' C ' ' A' ' 221' ' ' ASP . 52.9 t -130.31 -37.31 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 106.985 -1.487 . . . . 1.04 106.985 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -102.07 -2.9 28.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.388 -1.338 . . . . 2.44 107.388 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 62.67 40.11 10.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.902 -0.499 . . . . 1.55 110.578 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -140.95 147.18 38.39 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.112 -0.993 . . . . 1.99 109.923 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.96 123.04 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.492 -0.755 . . . . 0.77 109.388 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -91.26 134.3 34.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.026 -1.046 . . . . 0.98 109.156 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.457 HG22 HD22 ' A' ' 218' ' ' LEU . 44.1 t -105.17 115.32 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.545 -0.722 . . . . 0.85 110.115 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 50.12 61.12 14.15 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.145 -0.972 . . . . 1.66 111.712 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.409 ' HG3' HD12 ' A' ' 219' ' ' ILE . 92.7 Cg_endo -83.17 153.05 14.21 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.745 2.296 . . . . 0.95 111.875 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 82.1 p -70.32 162.3 28.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.145 -0.972 . . . . 1.84 110.697 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -60.13 -36.1 76.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.639 -0.663 . . . . 2.74 110.029 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -60.05 -38.29 82.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.197 -0.939 . . . . 2.89 108.858 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.6 t -69.71 -40.0 78.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.319 -0.863 . . . . 1.3 109.223 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.6 mt -68.45 -39.95 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 1.09 110.299 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -60.03 -41.27 91.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.844 -1.16 . . . . 2.43 108.47 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -65.29 -40.01 93.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.482 -0.761 . . . . 2.78 109.141 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 93.8 mtp -71.25 -30.31 66.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.407 -0.808 . . . . 1.25 109.882 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.488 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.1 OUTLIER -68.23 -41.35 81.37 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.183 -0.948 . . . . 2.63 109.344 179.537 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.93 92.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.178 -0.951 . . . . 1.8 108.474 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.4 t -62.19 -42.34 94.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.951 -0.759 . . . . 2.13 108.951 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -60.27 -40.16 89.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.431 -0.793 . . . . 3.17 108.963 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.06 -40.09 88.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.361 -0.837 . . . . 1.78 109.424 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -63.97 -40.05 95.52 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.353 -0.98 . . . . 2.47 108.353 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.25 -40.41 88.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.809 -0.811 . . . . 2.09 108.809 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.54 -37.52 87.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.517 -0.74 . . . . 2.54 109.343 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 63.0 m -59.99 -40.18 88.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 2.99 109.434 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -63.71 -31.94 73.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.449 -0.782 . . . . 3.34 109.665 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -59.9 -37.82 80.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.326 -0.859 . . . . 3.88 110.04 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.42 -37.77 76.04 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.214 -0.929 . . . . 4.43 110.418 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 252' ' ' GLU . 31.2 mp0 -54.99 -17.93 4.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.054 -1.029 . . . . 5.42 109.835 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 98.3 mt -69.25 -39.17 78.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.026 -1.047 . . . . 6.1 109.265 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 255' ' ' LYS . . . -76.15 -9.07 58.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.249 -0.907 . . . . 7.37 109.221 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' A' ' 257' ' ' LYS . 44.1 pttt 30.08 -121.26 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 120.811 0.338 . . . . 8.01 111.698 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 88.5 mt 55.79 4.33 0.11 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.278 -0.889 . . . . 9.05 109.111 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.53 ' H ' ' C ' ' A' ' 255' ' ' LYS . 61.4 tttp -163.84 145.99 9.33 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.609 -0.886 . . . . 10.56 108.609 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 257' ' ' LYS . 58.3 m-20 -157.79 90.76 1.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.988 -1.07 . . . . 11.32 109.274 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.013 -0.994 . . . . 12.42 109.254 179.926 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 301' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' B' ' 302' ' ' PHE . 13.1 tmm? . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.641 0.734 . . . . 0.0 109.649 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 302' ' ' PHE . . . . . 0.591 ' N ' ' SD ' ' B' ' 301' ' ' MET . 24.5 t80 -152.69 150.1 29.1 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -146.55 155.31 42.41 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.139 -0.976 . . . . 0.0 110.501 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 304' ' ' GLN . . . . . 0.404 ' HG2' HG21 ' B' ' 378' ' ' VAL . 72.9 tp60 -152.26 147.94 26.96 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -108.88 127.61 54.19 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.0 p -128.43 123.91 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 CA-C-O 122.407 1.099 . . . . 0.0 111.94 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 27.1 m -77.5 103.58 7.52 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.066 0.936 . . . . 0.0 110.926 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.524 HG22 ' H ' ' B' ' 310' ' ' ALA . 89.5 mt -52.23 122.0 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 122.449 1.118 . . . . 0.0 110.049 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 71.2 p -103.02 23.4 12.36 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.708 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.524 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -83.38 116.72 65.9 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.95 . . . . 0.0 109.052 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -66.52 -6.95 16.42 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 CA-C-N 120.23 1.118 . . . . 0.0 111.504 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -118.09 5.96 12.05 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.48 177.47 34.55 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.468 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -87.28 94.34 9.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.153 -1.204 . . . . 0.0 108.824 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -96.88 -159.53 0.74 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.172 -0.955 . . . . 0.0 110.181 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 16.9 m -58.18 -46.84 85.07 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.971 -1.08 . . . . 0.0 112.637 -176.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.61 HH21 ' NE2' ' B' ' 321' ' ' GLN . 1.8 tpt180 -58.86 -61.45 7.74 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 120.425 -1.422 . . . . 0.0 112.09 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -58.8 -32.31 96.89 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 CA-C-N 120.373 1.169 . . . . 0.0 111.579 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.31 70.19 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.961 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.89 -41.0 67.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.882 . . . . 0.0 109.815 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 321' ' ' GLN . . . . . 0.61 ' NE2' HH21 ' B' ' 317' ' ' ARG . 72.1 mt-30 -69.97 -42.76 72.73 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.948 -1.095 . . . . 0.0 108.896 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -61.02 -51.67 68.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 110.348 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 73.8 t -67.72 -30.12 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.625 -1.297 . . . . 0.0 109.981 -179.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -60.05 -45.69 92.02 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.335 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -60.16 -49.95 75.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.037 -1.039 . . . . 0.0 109.225 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.97 74.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.305 -0.872 . . . . 0.0 110.657 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -49.65 -20.05 0.72 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.287 -0.883 . . . . 0.0 109.37 -178.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -81.6 -17.05 71.75 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -106.15 140.55 38.94 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.322 -1.105 . . . . 0.0 109.771 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 330' ' ' THR . . . . . 0.416 HG22 ' O ' ' B' ' 330' ' ' THR . 51.3 m -90.72 -12.98 34.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.109 -0.994 . . . . 0.0 109.34 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 58.5 m -61.24 144.74 53.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.335 -0.853 . . . . 0.0 109.587 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -67.32 135.98 54.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.059 -1.026 . . . . 0.0 109.298 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 88.8 mt -133.98 134.14 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.615 -0.678 . . . . 0.0 109.983 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 85.5 m -129.26 148.44 51.19 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.504 -0.747 . . . . 0.0 109.152 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 63.3 t -120.5 114.78 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 98.0 m -106.52 130.39 54.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.169 -0.957 . . . . 0.0 109.477 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 25.2 p -139.4 119.36 13.43 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.778 0.799 . . . . 0.0 110.787 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 41.71 52.87 4.01 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 177.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 84.06 -16.26 33.97 Favored Glycine 0 N--CA 1.5 2.938 0 O-C-N 120.293 -1.504 . . . . 0.0 112.507 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -110.56 122.63 48.22 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.796 -1.414 . . . . 0.0 109.472 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 56.7 p -129.84 150.62 51.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.741 0.782 . . . . 0.0 110.431 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -146.46 170.01 17.73 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.644 0.735 . . . . 0.0 110.204 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 16.5 m -88.62 139.04 30.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.575 -0.703 . . . . 0.0 110.011 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.494 ' HA ' HD11 ' B' ' 350' ' ' LEU . . . -80.49 -13.88 58.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.958 -1.089 . . . . 0.0 110.321 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -88.52 20.29 3.46 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 346' ' ' SER . . . . . 0.432 ' H ' ' C ' ' B' ' 344' ' ' ALA . 45.0 t -148.37 95.74 2.5 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.699 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.609 HD23 HD22 ' A' ' 79' ' ' LEU . 59.0 tp -60.35 -34.62 74.11 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.828 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.1 m-85 -55.67 -52.49 63.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.134 -0.979 . . . . 0.0 109.891 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -69.58 -40.13 76.91 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.264 -0.898 . . . . 0.0 110.226 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' B' ' 352' ' ' THR . 80.5 mt -50.88 -54.68 21.9 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.984 -1.073 . . . . 0.0 108.608 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.417 HE22 HG21 ' A' ' 130' ' ' VAL . 27.2 mt-30 -40.15 -12.43 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.855 -0.528 . . . . 0.0 111.647 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.626 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.5 p -93.64 -10.78 33.39 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.589 -1.319 . . . . 0.0 110.627 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 64.0 mt -93.38 119.79 32.9 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.764 -1.21 . . . . 0.0 109.837 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.06 91.01 1.0 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 29.4 mt -96.56 86.83 4.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -1.127 . . . . 0.0 108.199 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 65.9 p -92.5 -179.72 5.28 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.19 -0.944 . . . . 0.0 111.257 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 357' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' B' ' 359' ' ' THR . 62.6 tt0 -49.53 153.99 1.03 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.331 1.062 . . . . 0.0 111.303 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.73 26.88 0.05 OUTLIER Glycine 0 N--CA 1.495 2.58 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.906 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 359' ' ' THR . . . . . 0.459 ' N ' ' O ' ' B' ' 357' ' ' GLN . 24.1 m -84.87 110.42 18.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.884 -1.363 . . . . 0.0 109.449 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 23.3 t -77.33 114.58 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 122.333 1.063 . . . . 0.0 109.698 -177.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 15.1 m -109.98 177.91 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 27.8 m -130.31 126.9 38.33 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 65.7 mt -102.36 112.65 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 44.8 p -115.5 130.05 56.75 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.2 149.5 38.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.296 -0.877 . . . . 0.0 109.618 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -143.88 123.94 13.63 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.438 ' H ' ' HG2' ' B' ' 370' ' ' GLU . . . 160.82 -161.85 33.09 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.157 -1.497 . . . . 0.0 111.577 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.85 -50.5 73.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 122.211 -0.582 . . . . 0.0 112.296 -177.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.528 ' N ' ' OG ' ' B' ' 331' ' ' SER . 95.8 m-20 -111.08 10.65 22.02 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.919 -1.113 . . . . 0.0 110.837 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' B' ' 367' ' ' GLY . 0.7 OUTLIER -45.59 -32.87 2.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.036 -1.04 . . . . 0.0 111.334 -178.788 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -71.81 -40.06 69.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.857 -1.152 . . . . 0.0 109.87 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -68.46 -40.38 81.08 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 110.802 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.53 -64.01 0.98 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.58 -1.325 . . . . 0.0 111.088 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.586 ' O ' HG23 ' B' ' 378' ' ' VAL . 45.2 t -45.33 -39.56 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.015 -1.053 . . . . 0.0 109.988 -177.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -61.37 -51.56 68.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.917 -1.114 . . . . 0.0 110.341 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -75.15 -39.93 60.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.015 -1.053 . . . . 0.0 111.094 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.22 -37.27 77.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.11 -0.994 . . . . 0.0 108.827 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.586 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.9 t -62.48 -43.44 98.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.209 -0.932 . . . . 0.0 109.607 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' B' ' 383' ' ' GLU . 0.5 OUTLIER -70.02 -55.72 8.83 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.615 -1.303 . . . . 0.0 107.735 178.525 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 60.4 tp -56.52 -35.92 68.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 109.935 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 33.7 ttm -71.72 -40.6 69.33 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.704 -1.248 . . . . 0.0 109.011 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.39 -5.38 57.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.652 -0.655 . . . . 0.0 110.139 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' B' ' 379' ' ' LYS . 64.3 mm-40 -110.66 -1.07 16.92 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.228 -0.92 . . . . 0.0 110.833 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.9 mt -87.24 128.5 35.15 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.546 -1.346 . . . . 0.0 108.783 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.44 -179.629 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mpp? . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.266 0.555 . . . . 2.91 109.816 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -111.18 130.02 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.608 -0.683 . . . . 1.2 109.346 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.2 m -132.24 121.13 23.16 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.233 -0.917 . . . . 1.4 108.712 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.18 -166.75 32.78 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.611 -1.395 . . . . 1.05 109.611 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 5' ' ' ILE . 88.9 mt -87.42 -6.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.03 -1.276 . . . . 1.15 109.758 -179.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 23.7 tp 57.35 89.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.394 -0.816 . . . . 0.98 109.359 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.73 83.14 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.866 -1.161 . . . . 0.88 107.866 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 p -150.54 146.26 19.49 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 109.006 -0.739 . . . . 1.69 109.006 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.56 143.75 15.37 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.587 2.191 . . . . 0.85 113.272 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.7 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.88 -163.35 36.68 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.221 -1.552 . . . . 0.92 109.221 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.9 mt -148.58 147.54 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.971 -1.311 . . . . 0.81 108.933 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.88 147.84 28.42 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.875 -1.141 . . . . 0.51 110.537 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -128.5 120.71 27.32 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.818 -1.179 . . . . 0.62 107.818 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.82 -179.91 45.82 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 117.943 -2.075 . . . . 0.55 111.228 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -80.28 160.05 25.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.913 -0.757 . . . . 2.1 110.174 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.59 130.51 49.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.686 -0.634 . . . . 0.77 110.931 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.4 tp -100.38 135.42 41.85 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 107.486 -1.302 . . . . 0.91 107.486 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.1 tp -121.4 124.23 44.01 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.226 -0.921 . . . . 0.93 110.027 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.725 HD21 HD21 ' A' ' 149' ' ' LEU . 65.7 mt -81.66 103.31 11.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 0.93 109.758 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -96.88 121.69 39.02 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.267 -1.012 . . . . 2.75 108.267 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -130.36 133.68 46.6 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.27 -0.894 . . . . 3.0 110.153 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 42.5 t0 -69.7 141.76 53.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 2.77 109.505 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.496 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 86.3 tt0 -63.58 142.63 58.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.932 . . . . 2.94 109.232 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.422 HD11 ' HE ' ' A' ' 139' ' ' ARG . 80.4 mt -79.73 128.73 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.145 -0.972 . . . . 0.95 108.898 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.5 t -102.56 128.78 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.26 -0.9 . . . . 1.28 109.646 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.55 139.42 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.352 -0.843 . . . . 1.21 109.319 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -91.38 123.63 34.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.083 -1.011 . . . . 1.81 108.955 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.468 HH11 ' HG2' ' A' ' 28' ' ' ARG . 5.4 mmt-85 -89.96 -0.89 57.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.442 -0.786 . . . . 2.8 109.15 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -68.56 139.78 55.59 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.42 -0.8 . . . . 2.87 109.707 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -86.13 146.17 26.71 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.556 -0.905 . . . . 2.35 108.556 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.614 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.6 pt -92.66 165.98 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.97 109.95 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.3 p -99.71 173.87 6.5 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.488 -0.93 . . . . 1.17 108.488 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.01 -48.13 82.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.947 . . . . 1.18 109.3 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -57.37 -29.08 63.74 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.677 -1.264 . . . . 2.56 109.599 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -82.41 -10.52 59.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 1.79 110.257 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 40' ' ' VAL . 40.3 t -62.15 -52.21 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.951 -1.093 . . . . 1.0 108.568 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.89 -40.24 96.94 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.407 -0.808 . . . . 1.77 110.156 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -70.9 -40.14 72.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.132 -0.98 . . . . 2.7 110.542 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.614 ' HG3' HG21 ' A' ' 31' ' ' ILE . 62.4 mm-40 -66.06 -40.11 90.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.113 -0.992 . . . . 1.51 110.161 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 36' ' ' VAL . 77.2 t -61.68 -43.35 96.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.082 -1.011 . . . . 0.93 108.444 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -59.97 -39.71 86.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 1.81 108.984 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -60.06 -40.93 91.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.935 -1.103 . . . . 2.78 108.228 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -63.92 -47.87 78.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 0.78 108.612 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.5 -49.56 77.07 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.435 -0.58 . . . . 1.07 109.435 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 47.2 t -60.74 -43.3 98.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.113 -0.992 . . . . 1.12 108.81 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.81 -45.66 96.04 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.714 -1.754 . . . . 0.84 108.714 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -65.36 -32.81 74.64 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.954 -1.128 . . . . 3.09 107.954 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.65 -39.16 76.37 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.578 -0.701 . . . . 0.88 109.255 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.7 ttmt -72.78 -72.98 0.22 Allowed 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.768 -1.197 . . . . 2.59 107.768 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.76 -35.7 0.15 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.449 -0.782 . . . . 0.7 111.068 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.3 p -59.86 -56.29 23.61 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.451 -1.406 . . . . 1.4 108.627 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.67 -42.68 81.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.144 -0.973 . . . . 0.67 110.644 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -65.24 -39.99 93.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.063 -1.023 . . . . 1.66 110.621 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.9 mt -66.63 -40.2 88.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.743 -1.223 . . . . 1.58 109.818 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -62.04 -36.33 81.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.991 -1.068 . . . . 1.35 109.554 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.9 m -64.04 -40.38 96.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.189 -0.944 . . . . 0.77 110.311 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.54 -38.81 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.131 -0.981 . . . . 0.63 109.45 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -55.62 -50.43 70.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.392 -0.817 . . . . 1.14 110.612 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -59.67 -39.92 86.09 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.199 -0.938 . . . . 0.79 110.224 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -66.22 -35.65 80.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 1.53 109.513 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.661 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -63.1 -43.11 99.39 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.498 -0.751 . . . . 0.57 109.942 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.38 -50.69 42.5 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.942 -1.263 . . . . 0.75 109.942 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.41 -45.97 92.12 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.202 -1.175 . . . . 1.59 108.642 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.5 m -68.52 -58.64 4.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.457 -0.777 . . . . 0.73 111.663 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -97.96 -54.17 3.17 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.002 -1.061 . . . . 0.75 111.265 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.35 -169.31 25.49 Favored Glycine 0 N--CA 1.504 3.191 0 O-C-N 120.694 -1.254 . . . . 1.22 111.573 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -68.59 -27.79 66.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.913 -0.757 . . . . 5.81 111.001 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -62.56 -36.31 82.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 3.37 110.089 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -98.51 -22.37 16.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.397 -0.814 . . . . 1.77 110.228 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -67.92 -40.14 83.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.0 -1.062 . . . . 1.65 110.457 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.571 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -69.34 -26.09 64.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.77 110.08 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.4 mt -59.88 -40.65 83.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 120.872 -1.142 . . . . 0.8 108.068 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 20.5 m-85 -69.98 -37.61 75.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.428 -0.795 . . . . 0.88 110.139 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.498 ' OE2' ' NZ ' ' B' ' 324' ' ' LYS . 65.6 tt0 -60.65 -40.11 90.81 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.081 -1.012 . . . . 1.37 109.696 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.46 -45.91 81.72 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.381 -1.488 . . . . 0.62 109.381 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -60.43 -42.57 96.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -1.147 . . . . 1.5 109.539 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.1 mt -69.82 -41.09 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.124 -0.985 . . . . 0.63 109.531 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.8 ttp -62.57 -40.2 96.09 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.947 -1.096 . . . . 1.51 109.536 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.777 HD11 ' CE2' ' B' ' 348' ' ' PHE . 54.1 tp -64.89 -38.55 91.35 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.454 -0.779 . . . . 0.77 109.855 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.5 tp -62.08 -40.14 94.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.438 -0.789 . . . . 0.62 110.305 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -84.29 5.84 25.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.011 -1.055 . . . . 1.47 110.287 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 61.5 t0 -49.29 133.36 19.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.007 -1.058 . . . . 1.47 110.114 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.475 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 45.7 mt-10 -59.15 -21.22 59.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.809 -0.557 . . . . 1.78 110.507 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -71.03 -34.31 71.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.939 -1.101 . . . . 2.53 109.309 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.4 mt -71.07 -41.03 71.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.566 -0.709 . . . . 0.8 110.111 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -60.48 -47.69 85.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.533 -0.729 . . . . 1.42 110.653 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -69.82 -40.61 75.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.06 -1.025 . . . . 1.71 110.227 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.63 -39.9 70.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 1.57 111.875 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.55 -47.82 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.758 -1.213 . . . . 0.65 109.83 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.7 mt -69.66 -38.48 76.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.243 -0.911 . . . . 0.82 109.99 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.81 93.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.011 -1.056 . . . . 0.79 109.964 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.4 -45.98 88.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.839 -1.163 . . . . 0.95 109.406 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.66 -46.8 93.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.303 -0.873 . . . . 0.66 108.88 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -69.82 -42.36 73.77 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.334 -0.854 . . . . 2.2 111.602 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -86.08 -51.64 6.2 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.78 -1.2 . . . . 1.65 112.596 -177.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -88.8 -2.6 58.67 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.941 -1.099 . . . . 2.03 111.479 -177.235 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 56.8 37.98 29.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.908 -1.12 . . . . 1.42 109.709 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.1 mtt -87.44 169.21 12.43 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.548 -0.72 . . . . 1.18 110.043 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.1 p -84.37 160.3 20.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.875 . . . . 0.98 108.85 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.75 -38.94 87.62 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.05 -1.032 . . . . 0.64 110.032 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 38.6 p-10 -69.66 -36.8 76.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.983 -1.073 . . . . 2.07 110.168 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.48 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -81.57 -47.47 13.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.958 -1.088 . . . . 0.73 110.065 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.19 -49.76 76.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -0.875 . . . . 0.54 109.845 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.38 85.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.1 -1.0 . . . . 0.56 109.561 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.53 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 78.7 t60 -60.19 -41.99 94.1 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 1.54 110.263 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -62.34 -40.03 95.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.077 -1.014 . . . . 1.33 110.804 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.31 -56.33 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.948 -1.095 . . . . 0.72 111.613 -177.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.1 mm -69.24 -39.95 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.654 -1.279 . . . . 0.85 109.627 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.53 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.7 tt0 -60.31 -40.05 89.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.083 -1.011 . . . . 2.44 109.413 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.78 -49.37 79.33 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.405 -1.078 . . . . 0.98 110.405 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -67.97 -56.34 9.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.974 -1.31 . . . . 1.41 109.607 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.22 -42.7 63.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.726 -1.234 . . . . 1.2 109.041 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.4 t -59.84 -40.16 87.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.029 -1.045 . . . . 1.7 108.723 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.29 93.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.34 -0.85 . . . . 1.47 109.206 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.9 mt -66.47 -40.09 89.18 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.239 -0.913 . . . . 1.56 109.385 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.07 -33.52 72.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.986 -1.071 . . . . 2.2 109.941 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -58.74 -21.02 54.25 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.983 -1.073 . . . . 2.12 108.768 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.457 HD13 HD13 ' A' ' 123' ' ' LEU . 57.2 mt -62.77 139.64 58.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.232 -0.918 . . . . 2.0 109.247 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -92.46 46.1 1.23 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.981 -1.075 . . . . 3.23 108.929 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -132.12 130.74 41.57 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.4 -0.812 . . . . 2.49 110.033 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -69.9 -33.83 72.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.534 -0.729 . . . . 3.95 110.641 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.487 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.2 t80 -70.24 -40.21 74.6 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.121 -0.987 . . . . 2.0 110.566 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.589 ' CD2' HH21 ' A' ' 126' ' ' ARG . 82.4 mt -70.05 -35.96 74.64 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.954 -1.091 . . . . 1.86 108.747 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -59.93 -40.0 87.42 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.658 -0.651 . . . . 2.84 109.285 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -59.79 -46.5 89.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.857 -1.152 . . . . 2.73 110.011 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.589 HH21 ' CD2' ' A' ' 123' ' ' LEU . 74.0 mtm180 -62.62 -35.81 80.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.634 -1.291 . . . . 2.77 108.766 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.9 -32.29 70.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.368 -0.833 . . . . 1.19 108.813 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.64 -40.05 94.77 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.803 -0.814 . . . . 1.2 108.803 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -68.07 -40.54 82.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.442 -0.787 . . . . 1.55 110.039 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.49 HG21 HE22 ' B' ' 351' ' ' GLN . 49.9 t -70.22 -40.31 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.049 -1.032 . . . . 0.8 109.263 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -60.9 -40.34 92.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.955 -1.09 . . . . 3.09 108.449 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -60.03 -38.97 84.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.579 -0.701 . . . . 1.46 110.181 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.4 mt -59.75 -42.48 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.199 -0.938 . . . . 0.71 111.262 -178.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.94 -32.34 58.91 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.395 -1.384 . . . . 0.57 110.566 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -59.99 -48.57 81.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.037 -1.273 . . . . 2.59 110.408 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -69.33 -29.98 67.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.761 -1.212 . . . . 2.83 110.219 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.6 -40.08 86.3 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.043 -1.036 . . . . 1.25 108.277 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.89 -39.89 93.55 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.192 -1.04 . . . . 0.7 108.192 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.422 ' HE ' HD11 ' A' ' 24' ' ' ILE . 96.9 mtt180 -68.65 -39.87 80.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.322 -0.862 . . . . 2.57 109.582 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -64.98 -33.77 76.85 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.401 -0.812 . . . . 1.23 111.16 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -73.19 -45.83 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.571 -1.33 . . . . 0.81 109.615 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.2 mt -69.98 -30.08 67.33 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.681 -0.808 . . . . 1.0 108.989 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.34 40.61 6.02 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.811 -1.716 . . . . 0.89 108.811 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.421 ' HA ' HD12 ' A' ' 144' ' ' LEU . 24.3 tp -74.31 147.52 42.22 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.408 -1.054 . . . . 1.14 109.026 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -65.87 147.31 53.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.309 -0.869 . . . . 4.6 110.217 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.4 mt -115.63 123.17 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 108.524 -0.917 . . . . 1.24 108.524 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.54 -49.01 85.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.765 -0.585 . . . . 1.54 110.574 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.2 t0 67.72 101.42 0.05 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.51 -0.744 . . . . 1.5 109.085 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.725 HD21 HD21 ' A' ' 19' ' ' LEU . 91.2 mt -72.68 -1.97 18.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -0.867 . . . . 0.79 110.195 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.5 t -81.85 -10.84 59.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 1.4 108.402 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.03 26.25 0.63 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.739 -0.6 . . . . 0.92 110.496 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.452 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 50.3 mt -91.69 123.66 43.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.209 -0.932 . . . . 0.88 109.425 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -105.86 -10.95 16.41 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.213 -0.93 . . . . 2.45 109.975 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -134.02 155.07 50.65 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.137 -0.977 . . . . 1.52 110.512 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.31 134.51 56.59 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.695 0.76 . . . . 1.58 109.53 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.1 m -151.85 164.16 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.729 -0.841 . . . . 0.69 108.729 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.5 mt -94.96 144.72 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.766 -1.568 . . . . 0.61 106.766 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -92.64 117.63 30.18 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.814 -1.178 . . . . 0.87 110.131 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 3.5 t -126.44 132.99 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.619 -0.882 . . . . 0.71 108.619 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.64 165.46 30.59 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.344 -0.847 . . . . 0.81 108.912 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.0 -34.53 71.44 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.452 -1.405 . . . . 0.98 107.464 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 12.9 t70 -162.34 167.37 23.91 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.366 -0.976 . . . . 2.25 108.366 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.421 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 92.8 mt -140.55 132.48 27.67 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.215 -0.928 . . . . 0.78 108.746 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 5.6 p -98.95 153.99 37.55 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.302 -0.874 . . . . 0.98 109.606 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -45.37 -33.62 9.22 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.861 1.708 . . . . 0.81 112.327 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.7 m -53.27 -50.08 65.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.945 . . . . 0.9 109.941 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.65 -40.03 94.73 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.444 -0.785 . . . . 1.61 110.703 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 44.7 p -58.13 -18.67 26.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.61 111.749 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.661 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -86.08 -45.95 10.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.814 -1.179 . . . . 0.6 109.034 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -91.69 41.8 1.08 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.762 -1.199 . . . . 1.4 107.762 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.457 HD11 HG21 ' A' ' 176' ' ' VAL . 57.7 tp -108.74 138.79 44.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.639 -0.663 . . . . 0.7 109.513 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -93.38 99.54 12.03 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.291 -0.881 . . . . 2.35 108.78 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 25.1 mt -65.22 -40.36 94.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.195 -0.94 . . . . 1.51 109.679 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -62.48 -29.57 70.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.067 -1.021 . . . . 2.33 110.792 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.17 -9.2 37.13 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.826 -1.171 . . . . 1.92 110.721 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 178' ' ' GLY . 77.5 t -104.14 118.18 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.036 -1.04 . . . . 0.67 108.578 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.96 9.41 25.12 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.473 -0.767 . . . . 1.53 111.266 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 166.58 175.41 36.79 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.31 -1.516 . . . . 0.48 109.31 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.411 ' CE1' HG11 ' A' ' 176' ' ' VAL . 18.8 m-85 -134.14 131.27 38.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.46 -1.023 . . . . 0.55 108.835 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 98.0 mt -132.05 124.26 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.723 -0.843 . . . . 0.65 108.723 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 17.6 p -145.4 159.6 42.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.901 -1.124 . . . . 0.82 110.947 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -100.35 19.98 15.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.51 -0.744 . . . . 2.46 109.844 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.23 -162.01 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.695 -1.253 . . . . 1.28 111.379 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -87.26 -45.83 5.19 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 111.305 -0.718 . . . . 2.19 111.305 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 166.83 -145.66 10.11 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 118.43 -1.843 . . . . 2.13 111.245 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -60.69 -9.97 4.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.675 -0.897 . . . . 5.86 110.749 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 82.1 p -78.36 -1.09 31.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.862 -1.148 . . . . 3.72 109.868 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.8 t -91.83 129.78 37.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.178 -0.951 . . . . 1.74 109.927 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -46.26 -48.02 18.01 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.149 -0.97 . . . . 0.95 109.617 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 89.7 m -59.71 -38.51 81.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.61 -0.681 . . . . 1.55 110.866 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 96.6 p -59.81 -39.84 86.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.691 -1.255 . . . . 1.51 110.346 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.4 mm -62.61 -37.9 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 1.67 109.199 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.7 mtp -60.15 -43.79 95.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.37 -0.831 . . . . 1.02 110.162 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.28 -42.88 82.49 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.605 -1.309 . . . . 0.68 108.609 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -60.05 -54.12 49.73 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.619 -0.832 . . . . 2.93 110.425 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.4 m -71.26 -34.36 70.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.133 -0.979 . . . . 0.86 111.199 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.36 -29.74 66.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.01 -1.056 . . . . 0.67 108.724 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 69.99 49.87 0.48 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.236 0.541 . . . . 1.5 110.696 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 43.8 mt -128.27 149.28 70.93 Favored Pre-proline 0 N--CA 1.505 2.311 0 N-CA-C 107.799 -1.185 . . . . 0.72 107.799 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.14 143.53 99.74 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 122.21 1.94 . . . . 0.61 112.157 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -172.46 153.37 2.88 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.232 -0.987 . . . . 0.66 111.161 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.2 mt -128.0 143.55 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.847 -1.168 . . . . 0.79 107.847 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 28.3 m -128.78 -11.52 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 O-C-N 120.819 -1.176 . . . . 0.91 111.037 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.64 26.59 17.49 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.413 -1.075 . . . . 1.01 110.413 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.446 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.6 p -45.99 -42.2 12.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.105 -1.232 . . . . 0.99 109.542 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.34 -51.44 4.2 Favored Glycine 0 N--CA 1.494 2.547 0 C-N-CA 120.143 -1.027 . . . . 1.12 111.641 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 14.1 t -158.7 35.42 0.22 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.483 -1.598 . . . . 1.72 111.478 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.82 -40.04 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.128 -0.983 . . . . 0.89 108.747 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 47.2 p -54.77 -27.41 41.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.711 -0.618 . . . . 1.03 110.404 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.8 t -85.75 -12.13 51.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.16 -0.962 . . . . 1.83 110.624 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -104.19 -14.59 15.79 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.168 -0.957 . . . . 2.27 110.673 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.464 HG11 HD11 ' A' ' 218' ' ' LEU . 18.7 t -110.79 146.12 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.15 -0.969 . . . . 0.92 111.208 -177.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -113.36 150.11 33.08 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.747 -1.575 . . . . 2.2 106.747 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 56.6 t30 -55.82 139.96 43.83 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.944 -1.097 . . . . 2.36 110.014 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.7 t70 88.92 11.86 0.08 Allowed 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.27 0.557 . . . . 2.38 109.988 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 52.7 t0 -83.41 141.86 31.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.2 -0.938 . . . . 2.09 109.31 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.553 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 51.3 t80 -89.97 117.5 28.82 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.982 -1.118 . . . . 1.27 107.982 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.464 HD11 HG11 ' A' ' 212' ' ' VAL . 78.0 mt -124.42 142.17 51.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.57 -0.706 . . . . 0.75 109.749 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 88.7 mt -110.2 124.75 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.968 -1.493 . . . . 0.63 106.968 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 21.4 tp -98.36 115.9 29.43 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.901 -1.124 . . . . 0.7 108.064 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 223' ' ' VAL . 15.0 m-20 -79.43 -44.25 21.74 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.524 -0.917 . . . . 2.31 108.524 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.96 14.75 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.043 -0.725 . . . . 0.78 109.043 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 221' ' ' ASP . 47.0 t -124.71 -36.29 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.629 -1.619 . . . . 1.04 106.629 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -108.61 0.06 20.52 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.864 -1.162 . . . . 2.44 107.864 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 65.07 46.22 2.84 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.905 -0.497 . . . . 1.55 111.324 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -150.07 150.21 31.4 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.751 -1.218 . . . . 1.99 109.631 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.88 123.84 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.557 -0.905 . . . . 0.77 108.557 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -85.92 129.09 34.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.934 -1.104 . . . . 0.98 109.283 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.59 118.41 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.541 -0.724 . . . . 0.85 109.641 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 60.68 69.8 1.07 Allowed Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.112 -0.993 . . . . 1.66 110.294 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -90.45 132.07 1.73 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 123.532 2.821 . . . . 0.95 112.63 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.8 m -63.96 161.9 14.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.284 -0.885 . . . . 1.84 110.032 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.23 -42.49 95.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.209 -0.932 . . . . 2.74 110.479 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -60.81 -33.0 72.34 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.975 -1.078 . . . . 2.89 109.43 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.17 -40.07 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 1.3 109.3 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.1 mt -64.37 -41.38 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -0.914 . . . . 1.09 109.464 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -60.32 -42.46 95.66 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.993 -1.067 . . . . 2.43 108.789 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -62.59 -44.09 97.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.377 -0.827 . . . . 2.78 109.054 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 84.5 mtp -71.29 -30.62 66.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.492 -0.755 . . . . 1.25 110.68 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -65.04 -44.26 89.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.766 -1.209 . . . . 2.63 109.601 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.55 90.8 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.53 -0.915 . . . . 1.8 108.53 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.84 -39.94 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.803 -0.814 . . . . 2.13 108.803 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -60.08 -42.91 95.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.366 -0.834 . . . . 3.17 108.822 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.82 -36.87 75.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.376 -0.828 . . . . 1.78 109.184 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -60.56 -40.26 90.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 2.47 109.86 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.5 -45.63 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.133 -0.979 . . . . 2.09 109.08 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.1 93.21 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.559 -0.713 . . . . 2.54 109.597 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 252' ' ' GLU . 4.0 t -67.28 -41.84 84.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.377 -0.827 . . . . 2.99 110.589 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -60.3 -39.61 87.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.226 -0.921 . . . . 3.34 109.604 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -59.97 -39.32 85.23 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.824 -0.548 . . . . 3.88 111.664 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -126.35 -34.77 2.46 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.917 -1.114 . . . . 4.43 111.674 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 248' ' ' SER . 92.9 mt-10 -90.1 69.95 7.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.739 -1.226 . . . . 5.42 109.82 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 31.3 mt -84.85 -2.59 57.96 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.023 -1.103 . . . . 6.1 108.023 178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -68.5 -31.49 70.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.593 -0.692 . . . . 7.37 110.386 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -61.01 -15.63 34.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.882 -1.136 . . . . 8.01 109.938 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 258' ' ' ASP . 55.1 tp -59.74 -43.19 94.35 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.243 -0.91 . . . . 9.05 108.71 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -55.82 86.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.392 -0.817 . . . . 10.56 110.161 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 256' ' ' LEU . 9.4 p-10 -58.03 -62.94 1.45 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.942 -0.703 . . . . 11.32 109.378 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.49 ' H ' ' CG ' ' A' ' 258' ' ' ASP . 18.9 ttt-85 . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 118.075 -0.964 . . . . 12.42 109.6 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 41.5 ttp . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.444 0.64 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -153.31 150.05 28.52 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -150.93 159.7 44.39 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.866 -1.146 . . . . 0.0 111.064 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -157.6 155.53 30.28 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.696 -0.628 . . . . 0.0 109.331 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -115.28 133.48 55.99 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.147 -0.971 . . . . 0.0 110.559 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.2 p -133.59 124.31 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 CA-C-O 122.11 0.957 . . . . 0.0 112.139 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 307' ' ' THR . . . . . 0.436 ' O ' HG23 ' B' ' 309' ' ' THR . 25.8 m -78.02 107.08 10.32 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.026 0.917 . . . . 0.0 111.195 -177.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.7 mt -52.92 120.21 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 122.477 1.132 . . . . 0.0 110.451 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 309' ' ' THR . . . . . 0.436 HG23 ' O ' ' B' ' 307' ' ' THR . 30.6 p -108.45 18.68 20.7 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.967 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.457 ' O ' ' CG ' ' B' ' 357' ' ' GLN . . . -73.01 128.47 87.85 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -63.02 -14.63 42.76 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 CA-C-N 120.309 1.146 . . . . 0.0 112.859 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -120.4 10.32 11.17 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.78 -179.13 49.9 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.487 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 2.8 tp -82.28 87.45 6.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.765 -1.432 . . . . 0.0 109.033 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.406 ' NE2' ' HB3' ' B' ' 317' ' ' ARG . 2.6 p80 -92.54 -160.89 0.78 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.918 -1.114 . . . . 0.0 109.865 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.8 m -56.87 -45.66 82.36 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.986 -1.071 . . . . 0.0 112.789 -176.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.571 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 11.9 tpt180 -56.14 -59.1 12.8 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 120.613 -1.305 . . . . 0.0 111.933 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.4 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 18.0 Cg_endo -62.04 -36.62 69.67 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 120.369 1.167 . . . . 0.0 111.921 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.71 84.74 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.26 -46.23 76.11 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.567 -0.708 . . . . 0.0 109.756 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -70.03 -39.88 75.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.824 -1.172 . . . . 0.0 108.355 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -61.57 -54.97 36.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.406 -0.809 . . . . 0.0 110.603 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.91 -30.63 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.667 -1.271 . . . . 0.0 110.091 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.498 ' NZ ' ' OE2' ' A' ' 74' ' ' GLU . 29.7 ttmt -60.01 -45.41 92.87 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.173 -0.954 . . . . 0.0 109.076 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 325' ' ' GLU . . . . . 0.41 ' OE1' HD22 ' B' ' 380' ' ' LEU . 81.5 tt0 -68.31 -54.87 14.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 111.029 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -65.0 -54.91 23.04 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.848 -1.158 . . . . 0.0 112.284 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -52.97 -17.25 1.33 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.797 -1.189 . . . . 0.0 109.636 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -73.79 -16.85 79.17 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -105.48 150.54 25.22 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.15 -1.206 . . . . 0.0 109.248 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 14.6 t -89.76 -12.85 38.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.062 -1.024 . . . . 0.0 110.261 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.488 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 43.7 t -60.22 142.61 54.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -0.957 . . . . 0.0 109.496 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -67.59 136.08 53.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 108.656 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 79.1 mt -135.46 135.82 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.499 -0.751 . . . . 0.0 109.346 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 96.4 m -130.6 149.69 52.14 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 58.8 t -120.29 114.73 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 55.4 m -104.27 123.58 47.61 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.216 -0.927 . . . . 0.0 109.365 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 56.7 p -130.77 115.25 16.37 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.789 0.804 . . . . 0.0 110.489 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 48.1 t30 44.67 59.18 3.49 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.12 -15.04 18.21 Favored Glycine 0 N--CA 1.498 2.805 0 O-C-N 120.321 -1.487 . . . . 0.0 112.688 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -115.98 127.4 54.91 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-N 118.833 1.317 . . . . 0.0 109.285 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 53.9 p -129.61 150.18 51.05 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.844 0.831 . . . . 0.0 110.369 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.83 168.17 20.39 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 5.6 m -87.82 130.0 35.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.388 -0.82 . . . . 0.0 111.086 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -68.23 -20.27 64.8 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.395 -0.815 . . . . 0.0 109.322 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.02 21.16 1.09 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 346' ' ' SER . . . . . 0.465 ' H ' ' C ' ' B' ' 344' ' ' ALA . 16.7 m -151.39 96.29 2.26 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.756 0.789 . . . . 0.0 111.981 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.663 HD23 HD22 ' A' ' 79' ' ' LEU . 58.9 tp -59.94 -33.75 72.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.777 ' CE2' HD11 ' A' ' 79' ' ' LEU . 69.1 m-85 -54.62 -52.46 62.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.391 -0.818 . . . . 0.0 110.716 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -70.34 -40.1 74.3 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.05 -1.032 . . . . 0.0 110.255 -178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.604 ' O ' ' N ' ' B' ' 352' ' ' THR . 79.3 mt -49.76 -55.16 15.06 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.826 -1.171 . . . . 0.0 108.69 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.49 HE22 HG21 ' A' ' 130' ' ' VAL . 32.3 mt-30 -41.42 -13.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.792 -0.568 . . . . 0.0 110.955 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.604 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.0 p -93.33 -10.41 35.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.286 -1.509 . . . . 0.0 110.158 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 70.2 mt -92.07 117.94 30.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.106 -0.996 . . . . 0.0 108.838 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -71.02 88.96 0.39 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.8 mt -98.33 88.51 4.17 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.224 -1.162 . . . . 0.0 109.189 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 34.3 p -89.95 175.82 7.04 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.943 -1.098 . . . . 0.0 110.96 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 357' ' ' GLN . . . . . 0.457 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 20.5 tm0? -68.97 113.02 5.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.638 -0.664 . . . . 0.0 110.227 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.97 9.14 37.84 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 45.2 m -87.64 112.05 21.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.165 -1.197 . . . . 0.0 110.847 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 39.0 t -76.5 116.98 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 122.137 0.97 . . . . 0.0 109.861 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 27.3 m -112.57 176.03 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 70.5 m -131.52 128.38 39.21 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 88.2 mt -101.16 113.46 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 51.1 m -116.72 130.57 56.81 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.21 152.72 39.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.126 -0.984 . . . . 0.0 110.654 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -143.77 122.99 12.97 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.571 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.62 -156.55 27.24 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.153 -1.499 . . . . 0.0 111.369 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -59.89 -53.8 53.64 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.488 ' H ' ' HB2' ' B' ' 331' ' ' SER . 12.0 t70 -103.3 11.37 36.84 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.107 -0.995 . . . . 0.0 111.434 -176.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 10.6 pt-20 -48.02 -41.62 26.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.102 -0.999 . . . . 0.0 111.779 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 371' ' ' GLN . . . . . 0.415 ' N ' ' CG ' ' B' ' 370' ' ' GLU . 97.7 mt-30 -69.97 -48.52 57.95 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.636 -1.29 . . . . 0.0 110.335 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -66.11 -45.37 81.37 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.463 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -49.74 -74.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.042 -1.036 . . . . 0.0 110.647 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.575 ' O ' HG23 ' B' ' 378' ' ' VAL . 39.3 t -45.3 -38.62 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.004 -1.06 . . . . 0.0 110.42 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -63.77 -48.15 78.12 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.828 -1.17 . . . . 0.0 109.861 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -79.52 -42.58 24.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.0 -1.063 . . . . 0.0 110.571 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.9 mt -59.4 -37.14 77.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.924 -1.11 . . . . 0.0 109.079 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.575 HG23 ' O ' ' B' ' 374' ' ' VAL . 43.1 t -63.15 -40.23 88.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 119.204 -0.998 . . . . 0.0 109.309 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.5 mttt -69.45 -55.61 9.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.694 -1.254 . . . . 0.0 108.476 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.41 HD22 ' OE1' ' B' ' 325' ' ' GLU . 58.0 tp -57.09 -32.75 66.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 109.452 -178.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 4.6 tpp -71.29 -40.01 71.13 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.543 -1.263 . . . . 0.0 107.885 177.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.4 -7.97 59.66 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.659 -0.651 . . . . 0.0 110.818 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.449 ' O ' ' OE2' ' B' ' 385' ' ' GLU . 96.5 mt-10 -110.33 -0.27 17.71 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 120.822 -1.173 . . . . 0.0 111.317 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.1 mt -82.31 132.36 35.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.394 -1.441 . . . . 0.0 110.238 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 385' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 56.4 mp0 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 118.148 -0.929 . . . . 0.0 108.926 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.104 -0.702 . . . . 2.91 109.104 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.4 mt -110.0 130.04 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.398 -0.814 . . . . 1.2 109.822 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.5 m -133.8 147.86 51.28 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.466 -0.771 . . . . 1.4 109.401 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.52 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -127.42 -162.32 11.09 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 108.766 -1.734 . . . . 1.05 108.766 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.8 mt -92.83 -14.64 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.844 -1.386 . . . . 1.15 109.775 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.8 tp 55.21 103.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.528 -0.916 . . . . 0.98 108.528 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.01 -30.08 17.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 0.88 109.104 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.0 t -141.57 126.89 10.8 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.454 -0.779 . . . . 1.69 109.457 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.55 142.82 18.66 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.738 1.625 . . . . 0.85 111.599 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.784 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.2 -164.16 36.97 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.35 -1.5 . . . . 0.92 109.35 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -147.32 148.62 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.009 -1.289 . . . . 0.81 109.005 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.33 152.45 32.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.094 -1.004 . . . . 0.51 110.105 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -135.09 124.85 25.35 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.122 -1.066 . . . . 0.62 108.122 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.71 -175.95 47.39 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 118.739 -1.696 . . . . 0.55 110.701 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -79.57 155.63 28.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.868 -0.784 . . . . 2.1 109.534 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -103.04 130.17 50.08 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.48 -0.763 . . . . 0.77 110.461 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.2 tp -98.36 135.51 39.85 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.024 -1.102 . . . . 0.91 108.024 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.9 tp -117.88 124.44 48.31 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.743 0.783 . . . . 0.93 109.756 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.2 mt -99.97 109.97 22.3 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.742 -0.598 . . . . 0.93 110.916 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -110.66 140.84 44.65 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.559 -0.713 . . . . 2.75 109.191 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -126.78 130.86 51.11 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.31 -0.869 . . . . 3.0 108.782 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.2 p-10 -77.58 155.33 31.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.05 -1.032 . . . . 2.77 109.104 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -72.05 141.26 49.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 2.94 109.511 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -82.44 136.4 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.286 -0.884 . . . . 0.95 108.632 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -95.23 129.42 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.098 -1.001 . . . . 1.28 110.071 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.01 135.87 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.598 -0.688 . . . . 1.21 109.303 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -90.93 123.54 34.51 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.995 -1.066 . . . . 1.81 110.242 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -90.04 -3.91 57.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.591 -0.693 . . . . 2.8 110.469 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -70.33 142.79 52.15 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.004 -1.06 . . . . 2.87 110.6 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp -84.3 153.17 23.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.217 -0.927 . . . . 2.35 108.91 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.63 HG21 ' HG3' ' A' ' 39' ' ' GLU . 3.6 pt -95.05 165.83 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.161 -0.962 . . . . 0.97 109.835 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -93.74 170.75 9.34 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.144 -1.058 . . . . 1.17 108.144 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.41 77.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.812 -1.18 . . . . 1.18 109.722 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -55.49 -28.73 56.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.744 -1.222 . . . . 2.56 109.303 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -81.52 -11.28 59.24 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.39 -0.818 . . . . 1.79 110.069 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -63.34 -51.71 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.751 -1.218 . . . . 1.0 108.94 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -61.47 -39.99 92.9 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.32 -0.862 . . . . 1.77 109.758 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -69.14 -41.33 77.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.896 . . . . 2.7 110.781 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.63 ' HG3' HG21 ' A' ' 31' ' ' ILE . 74.9 mm-40 -65.0 -40.05 94.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.831 -1.168 . . . . 1.51 110.015 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.6 -45.18 97.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.503 -1.295 . . . . 0.93 107.503 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -60.09 -42.7 95.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 1.81 109.125 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -60.05 -40.16 88.44 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.657 -1.238 . . . . 2.78 107.657 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -66.39 -43.95 84.43 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.421 -0.955 . . . . 0.78 108.421 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.08 -50.01 75.4 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.448 -0.945 . . . . 1.07 108.448 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 22.7 t -62.34 -43.52 98.64 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.542 -0.863 . . . . 1.12 108.731 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.76 -44.22 98.22 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.266 -1.934 . . . . 0.84 108.266 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.407 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 32.8 ttt-85 -64.1 -36.03 82.69 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.35 -0.981 . . . . 3.09 108.35 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -54.77 -40.04 68.99 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.852 -0.795 . . . . 0.88 108.852 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 50' ' ' ALA . 17.1 ttmt -67.96 -74.79 0.11 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.166 -1.05 . . . . 2.59 108.166 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.27 -31.86 0.06 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.529 -0.732 . . . . 0.7 111.028 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 49' ' ' LYS . 47.4 t -59.57 -58.79 7.05 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.706 -1.246 . . . . 1.4 108.634 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.24 -44.51 71.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.275 -0.891 . . . . 0.67 111.261 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -61.05 -44.43 97.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.89 -1.131 . . . . 1.66 110.879 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.52 -40.01 93.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.947 -1.096 . . . . 1.58 110.066 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -60.01 -35.58 75.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.054 -1.029 . . . . 1.35 109.875 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -64.31 -41.42 96.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.04 -1.037 . . . . 0.77 110.145 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.8 mt -60.15 -39.94 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.099 -1.001 . . . . 0.63 109.455 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -59.74 -50.15 74.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 1.14 109.638 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -60.55 -40.02 90.04 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.453 -0.779 . . . . 0.79 110.804 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.57 -39.62 94.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.831 -1.168 . . . . 1.53 109.493 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.603 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -65.86 -42.8 89.95 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.583 -0.698 . . . . 0.57 110.064 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.06 -50.17 65.65 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.986 -1.102 . . . . 0.75 110.358 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.78 -42.94 76.69 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.949 -1.324 . . . . 1.59 109.658 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -70.25 -59.12 3.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.73 111.944 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 168' ' ' THR . 95.8 m-85 -95.09 -53.39 3.83 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.975 -1.078 . . . . 0.75 111.358 -177.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.14 -167.58 26.0 Favored Glycine 0 N--CA 1.502 3.043 0 C-N-CA 119.773 -1.203 . . . . 1.22 111.474 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -73.29 -26.51 61.11 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.97 -0.724 . . . . 5.81 111.251 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -61.97 -34.69 76.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.006 -1.059 . . . . 3.37 110.245 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -98.83 -24.12 15.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.13 -0.981 . . . . 1.77 110.27 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.61 -40.19 92.35 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.983 -1.073 . . . . 1.65 110.913 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.601 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -60.11 -32.02 70.6 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.213 -0.929 . . . . 0.77 109.747 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.97 -41.67 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.11 -0.994 . . . . 0.8 109.313 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -70.13 -38.14 75.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.299 -0.876 . . . . 0.88 111.229 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -59.93 -40.05 87.62 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.723 -1.235 . . . . 1.37 109.683 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.49 -43.94 97.4 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.941 -1.664 . . . . 0.62 108.941 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 59.7 m170 -61.96 -43.03 99.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.457 -1.025 . . . . 1.5 109.403 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.0 mt -68.89 -45.22 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.63 109.697 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.0 ttp -59.99 -40.22 88.41 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.024 -1.048 . . . . 1.51 109.902 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.855 HD11 ' CE2' ' B' ' 348' ' ' PHE . 33.1 tp -65.23 -38.07 89.23 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.493 -0.755 . . . . 0.77 109.912 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.3 tp -66.28 -40.03 89.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.471 -0.768 . . . . 0.62 110.354 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -81.8 4.67 21.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.893 -1.129 . . . . 1.47 109.711 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -50.48 131.86 24.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.364 -0.835 . . . . 1.47 110.183 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -62.34 -17.63 59.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.508 -0.745 . . . . 1.78 110.483 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.95 -35.2 74.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.94 -1.1 . . . . 2.53 108.362 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.07 -40.02 75.29 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.468 0.651 . . . . 0.8 109.83 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.1 -49.99 75.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.508 -0.745 . . . . 1.42 110.12 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -71.9 -41.74 67.57 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.277 -0.89 . . . . 1.71 110.63 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.04 -40.74 74.95 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.054 -1.029 . . . . 1.57 111.596 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.9 mt -68.62 -45.74 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.835 -1.166 . . . . 0.65 109.79 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -69.61 -35.09 64.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.378 -0.826 . . . . 0.82 110.048 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.79 99.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.79 110.653 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.75 -48.09 83.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.913 -1.117 . . . . 0.95 109.579 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 55.8 mt -60.13 -48.15 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 121.981 0.896 . . . . 0.66 108.862 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -69.93 -40.05 75.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.759 -0.588 . . . . 2.2 111.187 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -83.54 -52.35 6.56 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.984 -1.073 . . . . 1.65 112.041 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -90.08 -2.27 58.08 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.073 -1.017 . . . . 2.03 111.679 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 56.9 34.68 25.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.918 -1.114 . . . . 1.42 109.305 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.4 mtp -90.31 166.63 13.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.432 -0.793 . . . . 1.18 110.158 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.413 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 67.2 p -77.63 160.41 28.54 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.457 -0.777 . . . . 0.98 109.279 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.61 -40.04 84.71 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.182 -0.949 . . . . 0.64 110.114 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 34.1 p-10 -68.37 -37.13 80.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.07 -1.019 . . . . 2.07 109.309 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.469 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -78.99 -39.96 32.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.041 -1.037 . . . . 0.73 109.593 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.46 -46.72 63.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.862 . . . . 0.54 110.498 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.04 93.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.092 -1.005 . . . . 0.56 109.652 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.528 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 85.3 t60 -59.91 -39.91 87.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.839 . . . . 1.54 109.717 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.13 -43.05 95.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.21 -0.931 . . . . 1.33 110.221 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.86 -59.45 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.185 -0.947 . . . . 0.72 110.83 -178.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.1 mm -63.57 -40.02 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.891 -1.131 . . . . 0.85 108.974 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.528 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 86.7 tt0 -64.01 -40.13 95.65 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.73 -1.211 . . . . 2.44 107.73 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.07 -48.6 85.31 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.952 -1.259 . . . . 0.98 109.952 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -68.03 -50.73 53.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.933 -1.333 . . . . 1.41 109.188 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.33 88.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 1.2 108.606 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 30.3 t -59.91 -40.8 90.05 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.437 -0.949 . . . . 1.7 108.437 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.22 96.31 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.33 -0.856 . . . . 1.47 108.781 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.8 mt -66.37 -42.13 88.42 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.305 -0.958 . . . . 1.56 109.248 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -60.05 -40.01 87.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.737 -1.227 . . . . 2.2 109.444 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -50.22 -20.17 0.97 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.991 -1.068 . . . . 2.12 109.02 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.573 HD13 HD13 ' A' ' 123' ' ' LEU . 54.1 mt -64.19 144.46 57.11 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.141 -0.975 . . . . 2.0 108.611 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 -100.23 52.5 0.89 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.119 -0.988 . . . . 3.23 110.271 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 57.5 t0 -135.58 130.47 34.54 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.134 -0.979 . . . . 2.49 109.627 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 67.0 mt-10 -61.95 -32.97 73.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.741 . . . . 3.95 109.837 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.495 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.0 t80 -70.05 -38.53 75.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 2.0 110.421 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.573 HD13 HD13 ' A' ' 118' ' ' LEU . 87.6 mt -80.42 -32.77 37.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.927 -1.108 . . . . 1.86 109.51 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -60.01 -40.48 89.4 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.905 -1.122 . . . . 2.84 108.177 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 98.9 mt-10 -65.1 -40.07 94.06 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.511 -0.922 . . . . 2.73 108.511 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.455 ' NE ' ' NE2' ' B' ' 351' ' ' GLN . 0.0 OUTLIER -61.11 -39.95 91.94 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.643 -0.873 . . . . 2.77 108.643 179.416 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.18 -22.56 66.95 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.929 -0.767 . . . . 1.19 108.929 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -70.56 -42.59 70.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.645 -0.659 . . . . 1.2 109.78 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -63.88 -40.01 95.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 1.55 110.204 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.24 -41.68 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.106 -0.996 . . . . 0.8 109.427 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.424 HH11 ' HG2' ' A' ' 131' ' ' ARG . 30.3 ttt-85 -60.55 -37.34 80.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 3.09 109.221 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -59.99 -39.82 87.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.631 -0.668 . . . . 1.46 109.387 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.93 -42.04 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.01 -1.056 . . . . 0.71 109.46 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.41 -32.36 68.2 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.785 -1.326 . . . . 0.57 109.785 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.554 ' NZ ' ' HE ' ' A' ' 139' ' ' ARG . 50.3 tttm -59.92 -48.32 82.2 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.133 -1.216 . . . . 2.59 109.028 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.458 HH21 ' HB3' ' A' ' 166' ' ' SER . 1.8 mtt-85 -61.88 -35.34 78.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.993 . . . . 2.83 109.657 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.57 -44.18 93.39 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.507 -0.745 . . . . 1.25 110.275 -177.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 49.6 mt -65.12 -40.14 94.06 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.875 -1.141 . . . . 0.7 109.95 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.554 ' HE ' ' NZ ' ' A' ' 135' ' ' LYS . 59.2 mtt-85 -68.84 -38.96 80.18 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.485 -0.932 . . . . 2.57 108.485 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.505 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.4 m120 -65.07 -38.53 91.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.749 -0.594 . . . . 1.23 110.98 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.6 mt -70.0 -43.16 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.548 -1.345 . . . . 0.81 108.946 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.03 -31.0 68.42 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.623 -0.673 . . . . 1.0 109.727 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.33 39.12 13.04 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.759 -1.737 . . . . 0.89 108.759 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.8 tp -73.96 149.55 41.3 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.469 -1.019 . . . . 1.14 109.623 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -61.42 146.74 47.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.509 -0.745 . . . . 4.6 110.127 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.51 121.93 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-O 122.077 0.941 . . . . 1.24 108.503 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 148' ' ' ASP . 6.0 mt -62.77 -44.32 99.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.839 -0.619 . . . . 1.54 110.823 -178.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 147' ' ' ILE . 50.7 t0 61.87 121.33 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.6 -0.688 . . . . 1.5 109.199 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 59.9 mt -87.97 0.85 55.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.406 -0.808 . . . . 0.79 109.999 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 62.1 m -82.67 -18.8 39.74 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.878 -1.139 . . . . 1.4 110.716 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.52 29.99 0.43 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.965 -1.085 . . . . 0.92 111.642 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 45.7 mm -90.55 119.19 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.682 -1.261 . . . . 0.88 108.38 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -100.15 -9.9 22.02 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.355 -0.841 . . . . 2.45 110.454 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -126.46 150.94 48.38 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.1 -1.0 . . . . 1.52 110.35 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.64 137.2 58.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.835 . . . . 1.58 109.413 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.6 m -152.18 163.5 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.992 -0.744 . . . . 0.69 108.992 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.3 mt -93.42 148.49 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 106.351 -1.722 . . . . 0.61 106.351 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 38.3 tp -96.8 114.28 25.9 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.862 -1.148 . . . . 0.87 110.299 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.51 130.08 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.525 -0.917 . . . . 0.71 108.525 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.08 162.05 39.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.169 -0.957 . . . . 0.81 108.899 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.94 -32.23 65.14 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.209 -1.557 . . . . 0.98 108.713 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 60.1 t0 -167.24 137.8 3.01 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.628 -0.879 . . . . 2.25 108.628 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.514 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 69.3 mt -112.89 131.41 55.74 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.347 -0.845 . . . . 0.78 109.926 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.5 p -100.56 148.92 35.63 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.419 -0.801 . . . . 0.98 108.906 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -38.22 -36.98 0.58 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.274 1.983 . . . . 0.81 112.717 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.458 ' HB3' HH21 ' A' ' 136' ' ' ARG . 4.2 m -50.34 -58.13 6.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 0.9 109.979 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -60.61 -39.85 89.7 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.38 -0.825 . . . . 1.61 110.755 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.445 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 64.4 p -60.03 -19.59 53.53 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.788 -1.195 . . . . 0.61 110.916 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.603 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -83.42 -38.6 21.7 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.852 -1.155 . . . . 0.6 109.556 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -104.66 39.3 1.71 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.663 -0.866 . . . . 1.4 108.663 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.6 tp -106.15 140.08 39.67 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.608 -0.886 . . . . 0.7 108.608 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -85.15 106.85 16.9 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.054 -1.029 . . . . 2.35 109.375 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 94.5 mt -62.84 -41.9 99.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.368 -0.833 . . . . 1.51 111.157 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -70.06 -24.49 63.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.155 -0.966 . . . . 2.33 111.859 -177.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -93.69 -10.52 34.14 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.654 -1.279 . . . . 1.92 109.711 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 68.8 t -98.62 107.02 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.154 -0.967 . . . . 0.67 108.6 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.3 mt -81.92 3.83 24.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.227 -0.92 . . . . 1.53 110.062 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 169.95 173.58 37.48 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.866 -1.294 . . . . 0.48 109.866 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.492 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 7.8 m-85 -129.31 126.93 40.07 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.411 -1.052 . . . . 0.55 109.24 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.415 ' CG2' HG21 ' A' ' 205' ' ' THR . 75.5 mt -128.45 123.69 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.815 -1.18 . . . . 0.65 107.815 177.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 35.1 p -147.05 160.61 42.18 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.806 -1.184 . . . . 0.82 111.504 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 61.6 t0 -103.93 25.95 9.28 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.233 -0.654 . . . . 2.46 109.233 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.42 -162.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.317 -1.49 . . . . 1.28 111.562 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.69 -58.16 4.63 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 111.162 -0.775 . . . . 2.19 111.162 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -168.84 -149.79 6.37 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 118.506 -1.807 . . . . 2.13 111.515 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -77.93 -9.01 58.87 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.817 -0.814 . . . . 5.86 111.013 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 74.5 p -83.13 4.62 25.71 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.814 -1.179 . . . . 3.72 110.557 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 191' ' ' SER . 22.7 p -82.14 143.3 31.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.887 -1.133 . . . . 1.74 110.394 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -46.65 -52.45 13.72 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.335 -0.853 . . . . 0.95 110.096 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 190' ' ' THR . 0.1 OUTLIER -56.11 -38.0 70.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.361 -0.837 . . . . 1.55 110.725 -178.828 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 188' ' ' SER . 80.5 p -61.69 -40.54 95.35 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.891 -1.131 . . . . 1.51 111.029 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.9 mt -60.09 -39.71 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.014 . . . . 1.67 109.123 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.0 mtp -59.98 -45.3 93.15 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.556 -0.715 . . . . 1.02 110.214 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.72 91.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.601 -1.312 . . . . 0.68 110.292 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -61.1 -52.04 66.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.853 -1.154 . . . . 2.93 110.607 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 62.1 m -70.4 -34.73 72.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.001 -1.062 . . . . 0.86 111.759 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.23 -9.98 59.05 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.702 -1.249 . . . . 0.67 110.543 -178.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 61.91 50.21 4.31 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.482 -0.761 . . . . 1.5 111.423 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 20.9 mt -128.36 149.48 71.61 Favored Pre-proline 0 N--CA 1.5 2.048 0 N-CA-C 107.664 -1.235 . . . . 0.72 107.664 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.06 139.5 46.96 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 122.245 1.963 . . . . 0.61 111.718 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -169.5 150.56 4.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.845 -1.159 . . . . 0.66 111.725 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 91.9 mt -126.86 142.12 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.792 -1.188 . . . . 0.79 107.792 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 18.2 m -123.03 -8.99 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 120.827 -1.17 . . . . 0.91 111.542 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -113.14 24.29 12.86 Favored Glycine 0 N--CA 1.502 3.07 0 N-CA-C 110.677 -0.969 . . . . 1.01 110.677 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.415 HG21 ' CG2' ' A' ' 180' ' ' ILE . 17.5 p -43.41 -47.91 7.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.121 -1.223 . . . . 0.99 110.074 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.433 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 97.03 -55.04 1.33 Allowed Glycine 0 N--CA 1.499 2.897 0 C-N-CA 120.341 -0.933 . . . . 1.12 111.611 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 85.6 p -148.52 28.59 0.87 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.397 -1.649 . . . . 1.72 111.584 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 18.3 t -70.03 -36.74 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.717 -1.24 . . . . 0.89 108.839 178.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.3 p -58.02 -30.66 66.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 1.03 110.964 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.1 t -83.02 -19.4 37.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.803 -1.186 . . . . 1.83 110.389 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -96.98 -11.93 23.97 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.089 -1.007 . . . . 2.27 110.471 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.2 t -107.93 137.41 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.256 -0.902 . . . . 0.92 110.628 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -114.89 149.71 36.76 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.48 -1.304 . . . . 2.2 107.48 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 41.7 t30 -56.25 138.58 50.12 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.083 -1.011 . . . . 2.36 110.955 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.0 m-20 83.88 7.42 0.62 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.138 0.494 . . . . 2.38 110.229 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -77.91 145.9 35.89 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.207 -0.933 . . . . 2.09 108.871 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -95.34 117.12 29.76 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.273 -1.01 . . . . 1.27 108.273 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' A' ' 16' ' ' ALA . 72.0 mt -126.75 150.7 48.94 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.578 -0.701 . . . . 0.75 110.278 -179.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.7 mt -115.93 128.55 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 106.846 -1.539 . . . . 0.63 106.846 177.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 60.9 tp -99.98 120.09 39.27 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.947 -1.096 . . . . 0.7 109.186 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 223' ' ' VAL . 12.2 t70 -80.18 -41.13 25.87 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.281 -1.007 . . . . 2.31 108.281 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.784 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.27 12.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.775 -0.578 . . . . 0.78 109.55 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 221' ' ' ASP . 42.8 t -124.85 -35.44 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.283 -1.377 . . . . 1.04 107.283 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.519 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 71.9 m-80 -111.76 2.61 17.23 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.99 -1.115 . . . . 2.44 107.99 178.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.52 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.6 OUTLIER 59.63 47.77 10.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.776 -0.578 . . . . 1.55 110.376 179.715 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -135.5 148.22 49.11 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.147 -0.97 . . . . 1.99 109.864 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.7 t -117.84 125.72 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.545 -0.909 . . . . 0.77 108.545 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -101.13 121.87 42.6 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.405 -0.809 . . . . 0.98 109.177 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.4 HG22 HD22 ' A' ' 218' ' ' LEU . 32.1 t -101.85 113.16 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.462 -0.774 . . . . 0.85 110.897 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 35.0 t30 52.02 60.75 13.2 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.052 -1.03 . . . . 1.66 111.3 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -86.67 152.64 8.83 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.653 2.236 . . . . 0.95 111.822 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.4 p -74.2 168.44 19.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.097 -1.002 . . . . 1.84 110.526 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -59.99 -37.94 81.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.663 -0.648 . . . . 2.74 110.265 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.57 -38.9 82.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 2.89 109.846 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.95 -41.35 79.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.218 -0.927 . . . . 1.3 109.236 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.58 -39.97 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.221 -0.924 . . . . 1.09 109.569 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.14 -39.95 88.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.91 -1.119 . . . . 2.43 108.495 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -66.9 -40.74 87.79 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.481 -0.762 . . . . 2.78 109.343 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 97.0 mtp -69.87 -38.19 76.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.266 -0.896 . . . . 1.25 109.793 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -61.04 -39.95 91.77 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.366 -0.834 . . . . 2.63 109.61 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.72 95.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 1.8 110.075 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.34 -40.09 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.941 . . . . 2.13 109.392 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -59.97 -40.98 90.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 3.17 109.035 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.19 -39.83 94.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 1.78 109.023 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.99 -39.97 87.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.543 -0.723 . . . . 2.47 109.249 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 66.1 t -60.09 -40.25 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.434 -0.791 . . . . 2.09 109.348 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.17 94.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 2.54 109.524 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 83.1 p -62.57 -40.02 95.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -0.947 . . . . 2.99 109.326 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.42 -38.68 91.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.449 -0.782 . . . . 3.34 109.397 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 252' ' ' GLU . 54.7 tttm -59.93 -39.99 87.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.485 -0.759 . . . . 3.88 110.038 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -46.39 -17.92 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.096 -1.003 . . . . 4.43 109.686 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 250' ' ' LYS . 81.1 mm-40 -69.95 -28.72 65.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.37 -0.831 . . . . 5.42 109.228 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 9.5 mt 42.17 27.72 0.08 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.506 -0.746 . . . . 6.1 110.157 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 252' ' ' GLU . . . -110.01 21.85 16.32 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.474 -0.766 . . . . 7.37 109.619 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.465 ' C ' ' H ' ' A' ' 257' ' ' LYS . 34.8 mtmm 52.02 36.33 18.39 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.499 -0.926 . . . . 8.01 108.499 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.501 ' O ' ' CB ' ' A' ' 257' ' ' LYS . 1.7 tt -74.07 42.5 0.15 Allowed 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.751 -0.833 . . . . 9.05 108.751 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 256' ' ' LEU . 42.6 tttp 86.01 157.94 0.09 Allowed 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.122 -0.695 . . . . 10.56 109.122 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 257' ' ' LYS . 78.9 m-20 -148.96 -29.49 0.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.416 -0.802 . . . . 11.32 109.398 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.465 HH11 ' HG2' ' A' ' 259' ' ' ARG . 28.2 mtt-85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.062 -0.97 . . . . 12.42 109.632 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -151.3 149.15 29.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -0.837 . . . . 0.0 108.83 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 303' ' ' GLN . . . . . 0.491 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 0.4 OUTLIER -146.15 154.65 42.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.199 -0.938 . . . . 0.0 110.171 -178.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -152.73 149.38 28.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.535 -0.728 . . . . 0.0 109.113 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -112.52 131.78 55.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.287 -0.883 . . . . 0.0 109.101 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.0 123.59 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-O 122.284 1.04 . . . . 0.0 112.476 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 29.3 m -77.84 104.05 8.15 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.999 0.904 . . . . 0.0 110.126 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.543 HG22 ' H ' ' B' ' 310' ' ' ALA . 90.1 mt -51.59 119.58 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 122.487 1.137 . . . . 0.0 110.366 -177.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 23.7 p -99.9 24.63 8.23 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.587 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.543 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -88.28 113.62 55.98 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -70.99 -5.24 16.54 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 CA-C-N 120.215 1.113 . . . . 0.0 111.864 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -110.45 0.65 17.9 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 74.26 172.17 26.91 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.495 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.5 tp -86.05 93.81 9.08 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.956 -1.32 . . . . 0.0 108.333 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -93.47 -161.58 0.86 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.205 -0.935 . . . . 0.0 110.418 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 316' ' ' THR . . . . . 0.404 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 2.9 m -59.3 -44.59 92.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.126 -0.984 . . . . 0.0 112.416 -176.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.601 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.3 tpt180 -57.11 -62.52 5.03 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 120.436 -1.415 . . . . 0.0 111.532 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.75 -30.68 85.44 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 120.2 1.107 . . . . 0.0 111.539 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.11 -50.62 72.96 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.371 -0.931 . . . . 0.0 108.83 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -54.88 -43.17 72.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 109.874 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -70.1 -41.32 74.18 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.809 -1.156 . . . . 0.0 108.826 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -60.08 -50.19 74.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.455 -0.778 . . . . 0.0 110.356 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 80.4 t -68.93 -27.72 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.713 -1.242 . . . . 0.0 109.74 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -60.02 -49.14 78.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.881 . . . . 0.0 110.332 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 325' ' ' GLU . . . . . 0.475 ' OE1' HD22 ' B' ' 380' ' ' LEU . 86.4 tt0 -68.52 -40.15 80.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.075 -1.015 . . . . 0.0 111.326 -178.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.87 -53.3 58.99 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.561 -1.337 . . . . 0.0 111.108 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -57.69 -11.61 2.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.095 -1.003 . . . . 0.0 109.426 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -68.07 -29.98 73.72 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -104.98 144.21 32.11 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.451 -1.029 . . . . 0.0 109.159 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 7.7 m -90.22 -11.28 41.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.062 -1.024 . . . . 0.0 109.443 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.475 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 33.8 m -57.99 149.02 24.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 109.846 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.91 132.9 48.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.905 . . . . 0.0 109.236 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.9 mt -133.4 132.28 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.307 -0.871 . . . . 0.0 110.041 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 334' ' ' THR . . . . . 0.408 HG22 ' N ' ' B' ' 335' ' ' VAL . 52.7 m -128.17 153.15 47.2 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 335' ' ' VAL . . . . . 0.408 ' N ' HG22 ' B' ' 334' ' ' THR . 84.0 t -119.85 139.87 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 96.8 m -130.33 123.03 29.04 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.275 -0.891 . . . . 0.0 108.739 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 59.8 p -140.11 121.86 15.4 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.081 0.943 . . . . 0.0 111.314 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 57.4 t30 43.49 52.68 5.95 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.35 -12.27 59.0 Favored Glycine 0 N--CA 1.5 2.941 0 O-C-N 120.182 -1.574 . . . . 0.0 112.904 176.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -118.94 129.45 55.18 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-N 119.268 1.534 . . . . 0.0 109.925 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 69.7 m -122.32 146.13 47.6 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.763 0.792 . . . . 0.0 110.078 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -140.42 161.05 38.63 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.472 0.653 . . . . 0.0 109.805 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.8 t -86.09 136.29 33.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.517 -0.739 . . . . 0.0 109.246 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.424 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -79.11 -14.12 59.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.978 -1.076 . . . . 0.0 110.418 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 345' ' ' LYS . . . . . 0.404 ' H ' ' HG2' ' B' ' 345' ' ' LYS . 19.7 pttp -87.36 21.47 2.45 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 346' ' ' SER . . . . . 0.424 ' H ' ' C ' ' B' ' 344' ' ' ALA . 69.2 m -149.62 99.39 2.87 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.795 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.702 HD23 HD22 ' A' ' 79' ' ' LEU . 58.0 tp -60.11 -35.28 74.89 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.855 ' CE2' HD11 ' A' ' 79' ' ' LEU . 51.7 m-85 -55.38 -54.43 43.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.956 -1.09 . . . . 0.0 109.786 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -69.93 -20.57 63.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.29 -0.881 . . . . 0.0 111.29 -177.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' B' ' 352' ' ' THR . 32.8 mt -70.32 -57.91 4.34 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.716 -1.24 . . . . 0.0 110.666 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.552 ' O ' HD22 ' A' ' 123' ' ' LEU . 2.9 mm100 -44.92 -14.77 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.093 -1.005 . . . . 0.0 111.409 -176.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.511 ' N ' ' O ' ' B' ' 350' ' ' LEU . 70.4 p -80.3 -13.44 59.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.196 -1.565 . . . . 0.0 110.278 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 34.9 mt -93.03 119.26 32.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.098 -1.002 . . . . 0.0 108.778 178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.14 91.22 0.91 Allowed Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 18.9 mt -96.5 87.31 4.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.327 -1.102 . . . . 0.0 108.527 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 64.3 p -92.2 -179.48 5.26 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.802 0.81 . . . . 0.0 110.668 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 357' ' ' GLN . . . . . 0.424 ' O ' ' N ' ' B' ' 359' ' ' THR . 65.8 tt0 -49.41 155.57 0.72 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 122.268 1.033 . . . . 0.0 111.109 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.88 27.58 0.06 OUTLIER Glycine 0 N--CA 1.497 2.729 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.56 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 359' ' ' THR . . . . . 0.424 ' N ' ' O ' ' B' ' 357' ' ' GLN . 11.8 m -86.57 109.95 19.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.767 -1.431 . . . . 0.0 109.864 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.25 114.77 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.343 1.068 . . . . 0.0 110.147 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 9.9 m -111.93 177.52 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 49.7 m -130.95 130.1 43.0 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 81.9 mt -106.36 122.28 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 77.3 p -125.05 134.67 52.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.22 152.2 38.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.142 -0.973 . . . . 0.0 110.119 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -142.18 121.73 13.31 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.407 ' H ' ' HG2' ' B' ' 370' ' ' GLU . . . 164.43 -163.28 36.04 Favored Glycine 0 N--CA 1.485 1.923 0 C-N-CA 118.636 -1.745 . . . . 0.0 111.536 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -59.57 -50.07 75.32 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.01 -0.595 . . . . 0.0 111.673 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.475 ' N ' ' OG ' ' B' ' 331' ' ' SER . 85.2 m-20 -111.6 10.3 21.15 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.974 -1.079 . . . . 0.0 110.936 -177.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' B' ' 367' ' ' GLY . 0.7 OUTLIER -44.02 -33.78 1.54 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.113 -0.992 . . . . 0.0 111.596 -178.61 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -69.89 -40.36 75.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.619 -1.301 . . . . 0.0 109.594 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -68.29 -48.15 65.75 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.173 -0.954 . . . . 0.0 109.862 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -50.44 -74.38 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.149 -0.97 . . . . 0.0 110.91 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.586 ' O ' HG23 ' B' ' 378' ' ' VAL . 67.6 t -44.11 -40.75 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.254 -0.904 . . . . 0.0 110.697 -177.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.86 -50.16 72.03 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.526 -1.358 . . . . 0.0 110.481 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -75.81 -40.03 55.72 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.802 -1.186 . . . . 0.0 110.669 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 98.9 mt -59.0 -37.51 77.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.011 -1.056 . . . . 0.0 108.606 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.586 HG23 ' O ' ' B' ' 374' ' ' VAL . 47.1 t -60.74 -40.21 84.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.279 -0.888 . . . . 0.0 109.093 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' B' ' 383' ' ' GLU . 20.3 mmmt -67.97 -55.04 14.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.705 -1.247 . . . . 0.0 107.939 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.475 HD22 ' OE1' ' B' ' 325' ' ' GLU . 63.6 tp -56.36 -35.57 67.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.358 -0.839 . . . . 0.0 110.241 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 34.7 ttm -72.45 -41.06 66.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.727 -1.233 . . . . 0.0 109.107 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.59 -5.69 58.27 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.346 -0.846 . . . . 0.0 110.215 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' B' ' 379' ' ' LYS . 96.2 mt-10 -109.72 -2.78 17.19 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.132 -0.98 . . . . 0.0 111.37 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.4 mt -83.7 130.02 34.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.285 -1.509 . . . . 0.0 109.027 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 N--CA 1.499 1.984 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.629 -179.656 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.251 0.548 . . . . 2.91 109.679 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.0 mt -110.18 129.88 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.47 -0.769 . . . . 1.2 109.114 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.8 m -130.81 148.78 52.62 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.514 -0.741 . . . . 1.4 109.173 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.42 ' H ' ' ND2' ' A' ' 225' ' ' ASN . . . -130.95 -163.54 10.99 Favored Glycine 0 N--CA 1.499 2.861 0 N-CA-C 108.142 -1.983 . . . . 1.05 108.142 179.323 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.451 ' O ' ' O ' ' A' ' 6' ' ' LEU . 95.7 mt -89.16 -14.79 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.659 -1.495 . . . . 1.15 110.068 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.0 tp 54.18 103.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.311 -0.868 . . . . 0.98 109.038 -179.669 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.94 -27.28 14.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.186 -0.946 . . . . 0.88 109.424 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 m -140.57 124.8 10.65 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.426 -0.796 . . . . 1.69 109.465 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.77 150.08 18.48 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.456 2.104 . . . . 0.85 112.904 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.9 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 146.93 171.78 16.53 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 109.811 -1.316 . . . . 0.92 109.811 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.7 mt -122.85 130.01 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 O-C-N 121.026 -1.279 . . . . 0.81 110.518 -179.784 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.74 149.32 51.47 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.354 -0.842 . . . . 0.51 110.046 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.4 m-85 -126.52 129.1 47.96 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.726 -1.213 . . . . 0.62 107.726 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.12 176.39 46.85 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 118.732 -1.699 . . . . 0.55 110.998 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -79.94 158.75 26.55 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.443 -1.033 . . . . 2.1 109.438 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.59 137.04 43.02 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.522 -0.737 . . . . 0.77 111.015 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.1 tp -106.64 133.36 51.42 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 106.936 -1.505 . . . . 0.91 106.936 177.729 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.0 tp -113.55 122.14 46.33 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.169 -0.957 . . . . 0.93 109.687 -179.017 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.1 mt -85.17 100.78 11.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.617 -0.677 . . . . 0.93 109.399 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -99.37 133.23 43.97 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.441 -0.787 . . . . 2.75 109.463 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -130.19 134.88 47.6 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.462 -0.774 . . . . 3.0 108.938 179.307 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -79.69 158.21 27.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.294 -0.879 . . . . 2.77 109.995 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -70.45 145.78 50.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.351 -0.843 . . . . 2.94 109.225 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.8 mt -89.64 129.09 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.094 -1.003 . . . . 0.95 108.967 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t -93.78 125.47 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.181 -0.949 . . . . 1.28 110.38 -179.108 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.06 133.72 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.521 -0.918 . . . . 1.21 108.521 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -94.34 117.94 30.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.008 -1.058 . . . . 1.81 109.847 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.2 mmt-85 -89.89 3.8 51.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.294 -0.879 . . . . 2.8 109.415 -179.556 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -62.95 149.42 44.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.943 . . . . 2.87 109.647 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -91.77 141.91 28.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.364 -0.835 . . . . 2.35 109.217 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 pt -93.77 164.39 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.852 -1.155 . . . . 0.97 109.995 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.6 p -92.42 171.53 8.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.22 -0.925 . . . . 1.17 108.664 178.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.27 -15.53 63.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.106 -0.996 . . . . 1.18 110.285 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -85.6 -28.61 24.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.874 -1.141 . . . . 2.56 108.447 178.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -81.58 -8.41 59.71 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.14 -0.689 . . . . 1.79 109.14 179.193 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.0 t -63.72 -54.91 26.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.115 -0.991 . . . . 1.0 109.129 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.45 -39.72 88.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.077 -1.014 . . . . 1.77 109.355 179.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -65.7 -42.63 90.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 2.7 110.156 -179.196 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.59 -40.15 95.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.901 -1.124 . . . . 1.51 110.66 -179.149 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.63 -46.59 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.576 -1.328 . . . . 0.93 108.182 179.206 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -60.14 -44.32 95.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.175 -0.953 . . . . 1.81 109.389 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -59.98 -43.41 95.13 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.908 -1.145 . . . . 2.78 107.908 179.217 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -64.45 -40.02 94.92 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.451 -0.944 . . . . 0.78 108.451 179.008 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.21 -49.95 75.58 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.354 -0.98 . . . . 1.07 108.354 179.481 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.3 t -63.21 -43.5 97.95 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.22 -0.992 . . . . 1.12 108.92 179.086 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.64 -40.02 95.71 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.347 -1.901 . . . . 0.84 108.347 179.004 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.562 ' CG ' HH11 ' A' ' 47' ' ' ARG . 0.7 OUTLIER -66.65 -39.4 88.21 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.871 -1.159 . . . . 3.09 107.871 178.396 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.0 75.15 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.278 -0.638 . . . . 0.88 109.278 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ALA . 22.2 ttmt -60.72 -74.77 0.07 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.102 -1.073 . . . . 2.59 108.102 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.73 -34.12 0.1 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.435 -0.791 . . . . 0.7 111.471 -177.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.6 m -60.27 -54.68 42.84 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.536 -1.352 . . . . 1.4 108.674 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.82 -41.22 75.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.339 -0.851 . . . . 0.67 111.161 -178.863 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.33 -39.92 95.87 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.783 -1.198 . . . . 1.66 110.218 -179.289 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.1 mt -66.33 -39.79 89.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.0 -1.063 . . . . 1.58 109.963 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -59.97 -38.95 84.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.143 -0.973 . . . . 1.35 109.592 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -61.87 -41.18 97.55 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.059 -1.025 . . . . 0.77 110.095 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.34 -37.19 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.255 -0.903 . . . . 0.63 109.6 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -57.29 -51.16 70.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.432 -0.792 . . . . 1.14 110.665 -178.239 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -60.62 -37.2 80.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.017 . . . . 0.79 111.672 -177.327 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.1 -39.85 94.95 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.869 -1.145 . . . . 1.53 110.267 -179.042 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.426 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -64.13 -42.3 96.88 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.533 -0.729 . . . . 0.57 109.936 -179.59 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.84 -52.16 54.11 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.703 -1.359 . . . . 0.75 109.703 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.63 -48.04 73.55 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.167 -1.196 . . . . 1.59 109.806 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.7 m -70.07 -58.74 3.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.344 -0.848 . . . . 0.73 112.144 -177.656 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -96.85 -53.68 3.45 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.912 -1.117 . . . . 0.75 111.292 -178.311 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.51 -167.42 25.84 Favored Glycine 0 N--CA 1.5 2.96 0 C-N-CA 119.678 -1.248 . . . . 1.22 111.31 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -70.01 -25.51 63.63 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.799 -0.824 . . . . 5.81 110.685 -179.397 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -61.6 -35.59 78.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -0.954 . . . . 3.37 110.46 -179.461 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.418 ' HA ' HD12 ' A' ' 72' ' ' ILE . 43.9 mmtm -100.38 -19.83 16.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.31 -0.868 . . . . 1.77 110.282 -179.649 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -69.94 -39.97 75.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.98 -1.075 . . . . 1.65 110.263 -179.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.551 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.85 -27.99 68.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.351 -0.843 . . . . 0.77 109.486 -179.174 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 69' ' ' LYS . 85.3 mt -60.08 -40.49 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.18 -0.95 . . . . 0.8 108.928 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -69.74 -36.84 76.16 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.193 -0.942 . . . . 0.88 110.705 -179.506 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -59.88 -40.04 87.34 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.919 -1.113 . . . . 1.37 109.289 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.04 -43.82 95.23 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.523 -1.431 . . . . 0.62 109.523 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -62.62 -41.56 99.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -1.113 . . . . 1.5 109.043 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.7 mt -68.67 -46.46 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.766 -0.828 . . . . 0.63 108.766 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.1 ttp -60.25 -42.95 96.4 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.222 -0.924 . . . . 1.51 109.786 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.831 HD22 HD23 ' B' ' 347' ' ' LEU . 55.2 tp -63.91 -40.71 97.12 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.416 -0.803 . . . . 0.77 109.44 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.557 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 61.8 tp -64.99 -39.81 94.02 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.63 -0.669 . . . . 0.62 109.827 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -79.68 2.14 23.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 1.47 110.677 -178.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -48.95 128.01 15.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.843 -1.16 . . . . 1.47 109.777 -179.023 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.15 -17.17 51.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.595 -0.69 . . . . 1.78 110.211 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -74.09 -32.95 63.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.074 -1.016 . . . . 2.53 109.43 178.827 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.07 -41.16 74.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.472 -0.767 . . . . 0.8 109.345 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -60.76 -46.22 91.31 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.383 -0.823 . . . . 1.42 110.159 -179.428 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -70.05 -41.93 73.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.344 -0.847 . . . . 1.71 110.44 -178.978 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.07 -39.9 75.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.912 . . . . 1.57 110.096 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.7 mt -66.68 -47.06 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.259 -0.901 . . . . 0.65 109.592 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.9 -37.57 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.82 110.111 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.04 -48.31 82.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.183 -0.948 . . . . 0.79 110.913 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.2 mt -60.3 -46.99 87.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.074 -1.016 . . . . 0.95 110.191 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.0 mt -61.13 -49.94 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.66 108.674 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -65.22 -43.28 92.0 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.107 -0.637 . . . . 2.2 110.491 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -80.02 -53.04 7.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.957 -1.09 . . . . 1.65 111.992 -178.421 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -90.48 -2.43 57.92 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.957 -1.089 . . . . 2.03 112.37 -177.195 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.3 m80 57.12 36.55 27.73 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.785 -1.197 . . . . 1.42 109.729 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 77.2 mtp -88.22 165.55 14.97 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.293 -0.879 . . . . 1.18 109.34 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.401 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 33.6 p -76.56 159.48 30.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.064 -1.022 . . . . 0.98 108.49 179.348 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.79 -39.96 91.47 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.285 -0.966 . . . . 0.64 110.047 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 24.1 p-10 -66.58 -34.87 78.86 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.122 -0.986 . . . . 2.07 109.312 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.17 -42.2 23.87 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.282 -0.886 . . . . 0.73 109.708 179.668 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.12 -48.4 68.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.54 109.9 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.7 92.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.56 109.845 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -60.0 -40.67 90.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 1.54 110.204 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.03 -40.26 95.09 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.305 -0.872 . . . . 1.33 110.342 -179.074 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.4 -53.16 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.076 -1.015 . . . . 0.72 111.028 -178.377 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.88 -40.05 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.861 -1.149 . . . . 0.85 109.307 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -64.64 -36.1 83.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 2.44 108.901 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.51 -49.93 65.99 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.805 -0.712 . . . . 0.98 111.688 -179.114 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -64.05 -47.01 81.83 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.55 -1.559 . . . . 1.41 110.01 -178.616 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.87 -39.49 85.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.067 -1.021 . . . . 1.2 109.512 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 91.2 p -59.79 -40.05 86.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.946 . . . . 1.7 109.746 -179.444 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.82 -39.86 86.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.858 -1.151 . . . . 1.47 108.929 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 35.3 mt -61.27 -42.89 99.41 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.832 -1.167 . . . . 1.56 108.912 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.541 ' OE2' ' NH2' ' A' ' 131' ' ' ARG . 98.3 mt-10 -50.18 -26.08 4.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.092 -1.005 . . . . 2.2 109.567 -179.387 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -65.53 -26.49 67.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.084 -1.01 . . . . 2.12 108.716 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 59.6 mt -63.09 144.09 57.21 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.382 -0.824 . . . . 2.0 109.521 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -97.04 14.45 25.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.153 -0.967 . . . . 3.23 109.945 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 58.0 t0 -102.98 143.3 32.73 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.174 -0.954 . . . . 2.49 109.788 -179.599 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.542 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 66.6 mm-40 -71.57 -63.94 1.02 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.979 -1.119 . . . . 3.95 107.979 178.644 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.459 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.8 t80 -38.49 -40.0 0.52 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 116.032 -0.531 . . . . 2.0 110.818 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.442 HD22 ' O ' ' B' ' 351' ' ' GLN . 83.9 mt -70.85 -40.09 72.55 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.724 -1.235 . . . . 1.86 109.189 179.417 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 121' ' ' GLU . 61.4 tttp -60.73 -38.95 86.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.244 -0.91 . . . . 2.84 109.836 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -59.78 -39.78 86.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.371 -0.831 . . . . 2.73 109.258 -179.38 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.402 HH11 ' HG3' ' B' ' 351' ' ' GLN . 1.1 mtt-85 -60.11 -39.96 88.01 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.106 -0.996 . . . . 2.77 109.019 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.92 -31.15 71.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.25 -0.906 . . . . 1.19 109.505 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.52 -40.54 95.0 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.384 -0.926 . . . . 1.2 108.565 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -67.28 -40.17 86.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.435 -0.791 . . . . 1.55 109.681 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.04 -40.54 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.353 -0.98 . . . . 0.8 108.353 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.541 ' NH2' ' OE2' ' A' ' 116' ' ' GLU . 39.6 ttm180 -62.29 -37.48 85.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.619 -0.676 . . . . 3.09 109.472 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -59.74 -40.56 88.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.211 -0.931 . . . . 1.46 109.457 -178.784 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.09 -43.44 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.092 -1.005 . . . . 0.71 109.313 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.22 -44.61 97.9 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.098 -1.201 . . . . 0.57 110.098 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -60.82 -49.67 76.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.166 -1.196 . . . . 2.59 111.148 -179.265 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -64.88 -35.92 82.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.81 -1.181 . . . . 2.83 110.246 -178.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 64.9 tp -60.08 -40.6 90.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 1.25 109.04 -179.244 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 138' ' ' LEU . 89.7 mt -62.36 -39.93 94.75 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.32 -0.863 . . . . 0.7 109.264 179.607 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -69.66 -34.63 74.26 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.673 -0.862 . . . . 2.57 108.673 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -66.69 -36.1 81.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.537 -0.727 . . . . 1.23 110.849 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.4 mt -70.66 -40.96 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 120.571 -1.331 . . . . 0.81 108.754 179.315 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.17 -35.2 68.93 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.569 -0.707 . . . . 1.0 109.73 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.49 34.94 8.19 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.043 -1.623 . . . . 0.89 109.043 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 29.1 tp -73.57 144.67 45.96 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.35 -1.088 . . . . 1.14 109.626 -179.514 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -61.15 143.76 54.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.449 -0.782 . . . . 4.6 110.486 -179.527 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.4 mt -111.67 127.27 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.362 -0.977 . . . . 1.24 108.362 178.583 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 148' ' ' ASP . 14.5 mm -59.94 -48.14 88.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.468 -0.77 . . . . 1.54 110.505 -177.718 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 147' ' ' ILE . 31.2 t0 62.46 118.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.344 -0.848 . . . . 1.5 109.007 -179.394 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.0 mt -84.91 -1.73 56.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.699 -0.626 . . . . 0.79 110.39 -178.784 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 92.4 p -83.38 -10.32 58.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.802 -1.186 . . . . 1.4 108.608 178.803 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.6 17.61 2.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.728 -0.607 . . . . 0.92 110.955 -177.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 52.2 mt -90.88 122.9 42.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.894 -1.129 . . . . 0.88 108.981 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -104.74 -7.35 19.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.496 -0.752 . . . . 2.45 110.613 -178.505 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -126.96 150.66 49.27 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.425 -0.797 . . . . 1.52 110.064 -179.067 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.4 136.35 57.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.224 -0.923 . . . . 1.58 108.827 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.8 m -153.08 167.88 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.477 -0.764 . . . . 0.69 109.975 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 76.4 mt -94.8 148.27 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 105.85 -1.907 . . . . 0.61 105.85 176.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 33.6 tp -97.15 118.31 33.29 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.732 -1.23 . . . . 0.87 110.71 -177.638 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.522 HG12 HG22 ' A' ' 209' ' ' THR . 89.2 t -120.79 126.39 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.675 -0.64 . . . . 0.71 109.551 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.529 ' C ' HG21 ' A' ' 209' ' ' THR . . . -159.74 160.71 34.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.12 -0.987 . . . . 0.81 108.986 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.92 -33.12 70.22 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.362 -1.461 . . . . 0.98 108.672 178.653 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 25.1 p-10 -171.09 142.03 1.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.576 -0.703 . . . . 2.25 109.119 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.9 mt -114.53 131.28 56.7 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.35 -0.844 . . . . 0.78 108.899 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.8 p -88.67 149.41 43.95 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.967 -1.083 . . . . 0.98 108.786 179.557 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -40.73 -34.39 1.28 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.942 1.761 . . . . 0.81 112.039 179.601 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 72.5 m -59.03 -40.14 84.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.189 -0.945 . . . . 0.9 109.194 -178.892 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -70.25 -40.52 74.37 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.305 -0.958 . . . . 1.61 109.615 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.5 p -57.24 -22.6 42.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.354 -0.841 . . . . 0.61 111.87 -177.545 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -85.09 -49.49 8.22 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.539 -1.351 . . . . 0.6 109.925 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -83.92 38.05 0.63 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.924 -1.139 . . . . 1.4 107.924 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.426 HD11 HG21 ' A' ' 176' ' ' VAL . 57.6 tp -107.6 130.99 54.84 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.303 -0.629 . . . . 0.7 109.303 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -86.44 103.52 15.06 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.109 -1.071 . . . . 2.35 108.109 178.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.19 -40.98 94.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.407 -0.808 . . . . 1.51 111.23 -178.261 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -63.54 -26.07 68.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.701 -1.249 . . . . 2.33 111.541 -177.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -93.57 -9.44 38.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.753 -1.217 . . . . 1.92 110.045 -178.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 178' ' ' GLY . 93.1 t -104.71 115.23 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.346 -0.846 . . . . 0.67 108.792 179.044 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.4 mt -85.74 7.71 22.58 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.129 -0.982 . . . . 1.53 110.626 -178.403 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.53 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 166.91 174.66 36.35 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.725 -1.35 . . . . 0.48 109.725 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.517 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 12.1 m-85 -130.98 129.11 41.68 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.393 -1.063 . . . . 0.55 109.069 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.417 ' CG2' HG21 ' A' ' 205' ' ' THR . 89.6 mt -131.7 125.53 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.413 -0.804 . . . . 0.65 109.246 178.826 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 42.0 p -152.51 162.18 41.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.057 -1.027 . . . . 0.82 110.478 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 182' ' ' ASP . 36.7 p30 -107.85 26.89 9.79 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.658 -0.651 . . . . 2.46 109.358 179.354 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.69 -159.39 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.903 -1.123 . . . . 1.28 111.687 -178.285 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.44 -64.01 3.44 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 111.205 -0.758 . . . . 2.19 111.205 -178.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.12 -135.48 3.91 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.021 -1.562 . . . . 2.13 110.84 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.424 HH11 ' HG2' ' A' ' 186' ' ' ARG . 44.8 mtt-85 -61.1 -32.42 72.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.506 -0.996 . . . . 5.86 110.862 -178.744 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 11.3 p -71.53 1.73 6.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.963 -1.086 . . . . 3.72 110.275 -178.591 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.9 t -90.95 131.28 36.66 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.995 -1.066 . . . . 1.74 110.49 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -46.16 -44.94 16.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.346 -0.846 . . . . 0.95 108.965 179.285 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 190' ' ' THR . 2.4 p -56.37 -42.79 78.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.809 -0.557 . . . . 1.55 111.001 -178.744 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.4 m -60.22 -40.08 88.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.922 -1.111 . . . . 1.51 110.919 -178.865 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 91.2 mt -61.9 -40.9 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.084 -1.01 . . . . 1.67 110.157 -178.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 86.9 mtp -60.12 -43.35 95.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.103 -0.998 . . . . 1.02 110.141 -179.35 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.2 94.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.77 -1.206 . . . . 0.68 110.279 -179.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -60.26 -51.78 68.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 2.93 111.228 -178.838 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 69.1 m -72.6 -34.44 67.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.914 -1.116 . . . . 0.86 111.93 -178.019 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.6 -14.05 58.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.71 -1.244 . . . . 0.67 110.378 -178.507 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 57.97 48.37 13.44 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.355 -0.841 . . . . 1.5 110.349 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 94.8 mt -118.01 122.21 30.71 Favored Pre-proline 0 N--CA 1.501 2.107 0 N-CA-C 108.182 -1.044 . . . . 0.72 108.182 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -42.02 130.3 4.39 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.809 1.673 . . . . 0.61 112.377 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.517 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.46 152.43 3.25 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.012 -1.075 . . . . 0.66 111.483 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.0 mt -126.91 141.8 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 107.729 -1.212 . . . . 0.79 107.729 178.773 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.7 m -124.92 -8.86 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 O-C-N 120.731 -1.23 . . . . 0.91 110.983 -178.473 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.48 22.89 23.64 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.254 -1.139 . . . . 1.01 110.254 -179.636 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.417 HG21 ' CG2' ' A' ' 180' ' ' ILE . 11.6 p -44.92 -42.56 8.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.163 -1.198 . . . . 0.99 109.835 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.79 -51.24 2.91 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 120.149 -1.024 . . . . 1.12 111.006 179.081 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.9 m -157.9 37.36 0.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.523 -1.575 . . . . 1.72 111.427 -178.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 35.4 t -79.52 -32.04 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.789 -1.194 . . . . 0.89 108.749 178.55 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.529 HG21 ' C ' ' A' ' 160' ' ' ALA . 74.3 p -59.93 -35.02 74.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.503 -0.748 . . . . 1.03 111.143 -178.756 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 85.2 p -80.14 -12.13 59.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.916 -1.115 . . . . 1.83 110.413 -179.087 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -100.06 -12.51 19.63 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.24 -0.913 . . . . 2.27 110.465 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 91.9 t -106.31 140.12 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.295 -0.878 . . . . 0.92 111.053 -178.227 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -113.7 152.9 29.84 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.306 -1.368 . . . . 2.2 107.306 178.022 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.494 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 28.9 p-10 -57.86 137.59 56.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.011 -1.056 . . . . 2.36 110.561 -178.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 6.2 t0 85.29 2.1 0.69 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 122.117 -0.364 . . . . 2.38 110.734 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.98 143.84 50.69 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.867 -1.146 . . . . 2.09 108.713 179.036 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -93.16 113.72 26.03 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.081 -1.081 . . . . 1.27 108.081 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.479 HD22 HG22 ' A' ' 229' ' ' VAL . 61.0 mt -123.29 145.55 48.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.607 -0.683 . . . . 0.75 110.349 -179.119 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 79.9 mt -111.36 129.87 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 106.21 -1.774 . . . . 0.63 106.21 176.615 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 51.4 tp -100.35 118.93 37.63 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.889 -1.132 . . . . 0.7 108.534 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 10' ' ' GLY . 38.5 t0 -77.84 -45.97 22.82 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.189 -0.944 . . . . 2.31 108.819 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.75 16.59 0.5 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.991 -1.115 . . . . 0.78 107.991 -178.847 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.456 ' N ' ' C ' ' A' ' 221' ' ' ASP . 42.0 t -126.17 -46.14 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 106.74 -1.578 . . . . 1.04 106.74 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.414 ' O ' ' OD1' ' A' ' 224' ' ' ASN . 55.3 t-20 -102.25 2.92 37.66 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.44 -1.319 . . . . 2.44 107.44 178.129 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.42 ' ND2' ' H ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 59.84 46.24 11.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.976 -0.452 . . . . 1.55 110.048 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -140.42 154.07 46.53 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.214 -0.929 . . . . 1.99 109.898 179.593 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 88.5 t -119.97 131.5 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.079 -0.712 . . . . 0.77 109.079 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -94.99 119.06 32.86 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.177 -0.952 . . . . 0.98 108.487 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.479 HG22 HD22 ' A' ' 218' ' ' LEU . 91.6 t -99.69 115.24 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.323 -0.861 . . . . 0.85 109.618 -179.54 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 67.09 71.07 0.44 Allowed Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.58 -0.7 . . . . 1.66 109.634 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -90.19 124.9 1.18 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.337 2.692 . . . . 0.95 112.6 -179.679 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 233' ' ' ASN . 63.6 m -67.01 159.68 28.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.413 -0.804 . . . . 1.84 109.261 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.441 ' N ' HG22 ' A' ' 232' ' ' THR . 27.7 p-10 -60.08 -38.74 83.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.087 -1.008 . . . . 2.74 109.972 -179.342 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -60.12 -40.16 88.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.106 -0.996 . . . . 2.89 109.599 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.61 -39.97 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.218 -0.926 . . . . 1.3 109.919 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.2 mt -61.86 -38.05 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.021 -1.05 . . . . 1.09 109.436 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.92 -40.06 87.61 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.014 -1.054 . . . . 2.43 108.394 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -64.83 -44.84 88.54 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.574 -0.899 . . . . 2.78 108.574 178.571 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 93.9 mtp -70.01 -26.13 63.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.693 -0.63 . . . . 1.25 110.078 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.47 ' HE ' ' CA ' ' A' ' 240' ' ' ARG . 0.0 OUTLIER -64.59 -41.37 96.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.059 -1.026 . . . . 2.63 108.964 179.339 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.86 91.34 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.248 -1.019 . . . . 1.8 108.248 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 77.0 t -59.96 -42.36 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.922 -0.77 . . . . 2.13 108.922 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.47 ' OE1' ' NH2' ' A' ' 240' ' ' ARG . 63.6 tt0 -60.18 -40.19 89.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.115 -0.99 . . . . 3.17 108.922 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -62.21 -40.03 94.72 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.097 -1.002 . . . . 1.78 109.002 179.38 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -65.43 -39.99 92.77 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.934 -0.765 . . . . 2.47 108.934 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 71.7 t -62.27 -39.9 85.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.456 -0.942 . . . . 2.09 108.456 179.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 251' ' ' ALA . . . -53.4 -48.89 68.29 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.503 -0.748 . . . . 2.54 109.103 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 72.3 m -60.16 -41.3 92.5 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.991 -1.084 . . . . 2.99 108.13 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -61.99 -40.22 94.87 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.244 -1.391 . . . . 3.34 107.244 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -69.97 -32.02 70.03 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.469 -0.937 . . . . 3.88 108.469 178.366 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 247' ' ' ALA . . . 62.98 63.25 0.96 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.516 0.674 . . . . 4.43 111.404 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -130.06 30.01 4.86 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.37 -1.344 . . . . 5.42 107.37 177.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.659 ' O ' ' HB2' ' A' ' 254' ' ' ALA . 78.6 mt -119.0 -33.5 4.16 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.088 -0.708 . . . . 6.1 109.088 179.646 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' A' ' 253' ' ' LEU . . . 156.92 72.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.216 -0.661 . . . . 7.37 109.216 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp -141.82 170.19 16.19 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.076 -1.015 . . . . 8.01 109.807 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 65.0 mt -69.07 70.85 0.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.324 -0.86 . . . . 9.05 110.551 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 57.5 mttp 46.09 -134.54 0.87 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.688 -0.633 . . . . 10.56 109.794 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -79.38 68.59 5.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.189 -0.945 . . . . 11.32 109.252 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.985 -1.007 . . . . 12.42 109.46 179.611 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 301' ' ' MET . . . . . 0.402 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 50.4 ttp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.485 0.66 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 302' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 23.7 t80 -151.58 149.65 29.41 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 303' ' ' GLN . . . . . 0.418 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 19.2 pt20 -149.65 159.68 44.14 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.876 -1.14 . . . . 0.0 110.521 -178.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -152.48 148.58 27.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.68 -0.638 . . . . 0.0 109.456 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -110.58 131.49 55.01 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.09 -1.006 . . . . 0.0 109.803 179.212 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.74 122.84 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-O 122.262 1.03 . . . . 0.0 112.294 -177.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 307' ' ' THR . . . . . 0.407 ' O ' HG23 ' B' ' 309' ' ' THR . 46.2 m -77.48 106.77 9.46 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.062 0.934 . . . . 0.0 110.184 -178.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.7 mt -52.44 121.85 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 122.361 1.077 . . . . 0.0 110.651 -177.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 309' ' ' THR . . . . . 0.407 HG23 ' O ' ' B' ' 307' ' ' THR . 30.0 p -109.97 19.14 19.35 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.38 -178.562 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.86 129.04 77.47 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.795 -1.19 . . . . 0.0 108.525 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -62.66 -10.7 20.48 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 CA-C-N 120.356 1.163 . . . . 0.0 112.981 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -120.96 5.94 10.39 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.294 -0.879 . . . . 0.0 109.418 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.68 -175.39 37.64 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.459 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.5 tp -83.11 85.62 7.16 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.123 -1.222 . . . . 0.0 109.932 -178.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.419 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 4.7 p80 -91.84 -161.98 0.88 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.864 -1.148 . . . . 0.0 109.914 178.722 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 10.0 m -58.22 -43.82 87.89 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.864 -1.147 . . . . 0.0 112.831 -175.616 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.551 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.2 tpt180 -60.08 -61.35 8.09 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 120.42 -1.425 . . . . 0.0 112.29 -178.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.419 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 9.3 Cg_endo -57.7 -29.41 85.5 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 CA-C-N 120.288 1.138 . . . . 0.0 111.655 -179.573 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.93 -51.78 68.21 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.351 -0.939 . . . . 0.0 108.524 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.18 -42.44 66.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.431 -0.793 . . . . 0.0 109.269 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -70.22 -40.07 74.76 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.929 -1.107 . . . . 0.0 108.719 177.8 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -63.92 -55.46 22.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.734 -0.604 . . . . 0.0 109.795 -179.292 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 54.2 t -68.05 -36.71 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.816 -1.178 . . . . 0.0 109.682 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -60.0 -44.62 94.42 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.755 -179.286 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -66.79 -40.07 88.0 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.955 -1.091 . . . . 0.0 109.872 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -64.67 -51.7 61.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.125 -0.984 . . . . 0.0 110.132 -179.537 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -57.55 -11.54 2.1 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.083 -1.01 . . . . 0.0 109.131 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -67.9 -30.45 74.3 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.716 -1.753 . . . . 0.0 108.716 179.182 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -105.31 143.28 33.7 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.598 -0.942 . . . . 0.0 109.15 179.768 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 27.9 m -89.95 -11.8 40.65 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.978 -1.076 . . . . 0.0 109.845 -179.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.442 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 60.1 p -60.02 153.8 20.63 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.049 -1.032 . . . . 0.0 108.764 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.75 129.5 40.12 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.181 -0.949 . . . . 0.0 109.558 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.3 mt -129.15 129.95 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.626 -0.671 . . . . 0.0 109.35 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 334' ' ' THR . . . . . 0.401 HG22 ' N ' ' B' ' 335' ' ' VAL . 93.9 m -128.06 152.57 47.81 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.509 -0.744 . . . . 0.0 109.626 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 335' ' ' VAL . . . . . 0.401 ' N ' HG22 ' B' ' 334' ' ' THR . 63.5 t -118.03 137.47 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 55.0 m -129.98 122.24 28.09 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.215 -0.928 . . . . 0.0 108.999 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 91.4 p -137.36 118.49 14.45 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.014 0.912 . . . . 0.0 111.102 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 65.4 t30 44.38 57.41 4.38 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 177.298 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 83.16 -12.5 49.87 Favored Glycine 0 N--CA 1.5 2.956 0 O-C-N 120.164 -1.585 . . . . 0.0 113.388 176.109 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -119.11 131.27 55.9 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-N 119.367 1.584 . . . . 0.0 110.067 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 70.6 m -124.86 146.71 49.15 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.903 0.859 . . . . 0.0 110.599 -179.113 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 342' ' ' ALA . . . . . 0.433 ' CB ' HD11 ' B' ' 353' ' ' LEU . . . -138.81 161.81 36.32 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.634 0.73 . . . . 0.0 109.596 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 51.0 m -86.08 131.87 34.17 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.558 -0.713 . . . . 0.0 109.994 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -69.86 -17.51 63.37 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.075 -1.016 . . . . 0.0 109.141 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -89.26 20.93 3.49 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 5.7 m -145.41 92.34 2.23 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.451 -179.344 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.831 HD23 HD22 ' A' ' 79' ' ' LEU . 58.7 tp -59.95 -37.22 78.92 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.274 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.773 ' CE2' HD11 ' A' ' 79' ' ' LEU . 59.1 m-85 -54.61 -51.34 65.66 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.25 -0.906 . . . . 0.0 111.138 -179.287 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 349' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' B' ' 350' ' ' LEU . 34.0 mtmm -69.25 -39.98 78.14 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.91 -1.118 . . . . 0.0 109.781 -178.546 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' B' ' 352' ' ' THR . 18.2 mt -47.16 -57.21 5.37 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.12 -0.988 . . . . 0.0 108.671 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' B' ' 347' ' ' LEU . 1.4 mp0 -39.33 -22.56 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.525 -0.734 . . . . 0.0 111.088 -179.009 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.52 ' N ' ' O ' ' B' ' 350' ' ' LEU . 72.4 p -82.88 -10.89 58.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.348 -1.47 . . . . 0.0 110.796 -178.155 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.433 HD11 ' CB ' ' B' ' 342' ' ' ALA . 49.6 mt -94.89 117.84 30.8 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.816 -1.178 . . . . 0.0 109.513 178.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.05 92.24 0.83 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.449 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.3 mt -99.57 91.35 4.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.233 -1.157 . . . . 0.0 109.279 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 33.4 p -89.71 168.29 12.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.812 -1.18 . . . . 0.0 111.046 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -63.13 115.94 4.94 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.228 0.537 . . . . 0.0 110.763 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 358' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 100.75 7.39 50.94 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 24.1 m -86.82 114.68 23.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.485 -1.009 . . . . 0.0 111.066 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 14.9 t -76.43 116.56 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.322 1.058 . . . . 0.0 109.865 -177.54 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.1 m -111.45 176.95 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.749 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 29.7 m -130.53 129.44 42.84 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 83.0 mt -104.98 118.97 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 178.472 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 74.1 m -123.59 133.47 53.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.506 -0.746 . . . . 0.0 109.43 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.44 152.46 40.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.302 -179.454 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -146.36 123.13 11.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 108.953 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.531 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.96 -156.22 27.15 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 118.987 -1.578 . . . . 0.0 111.342 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.97 -52.82 63.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 122.319 -0.518 . . . . 0.0 112.008 -177.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.442 ' H ' ' HB3' ' B' ' 331' ' ' SER . 80.1 m-20 -106.93 9.5 30.74 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.782 -1.199 . . . . 0.0 111.567 -177.31 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.2 pt-20 -38.76 -33.29 0.1 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.398 -0.814 . . . . 0.0 111.232 -179.039 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -67.24 -42.3 84.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.889 -1.132 . . . . 0.0 109.618 -178.474 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -69.98 -52.9 20.49 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.453 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -42.06 -38.55 1.69 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.51 -0.744 . . . . 0.0 111.39 -178.431 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.525 ' O ' HG23 ' B' ' 378' ' ' VAL . 92.0 t -80.05 -34.87 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.687 -1.258 . . . . 0.0 109.928 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.51 -40.06 77.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.945 -1.097 . . . . 0.0 111.702 -178.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -81.63 -45.62 15.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.398 -1.439 . . . . 0.0 110.126 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.9 mt -60.18 -40.33 89.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 109.209 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.525 HG23 ' O ' ' B' ' 374' ' ' VAL . 53.3 t -61.92 -47.16 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.101 -0.999 . . . . 0.0 109.803 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' B' ' 383' ' ' GLU . 60.9 mttp -68.27 -54.7 15.79 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.515 -1.274 . . . . 0.0 107.762 178.597 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 59.8 tp -55.24 -33.86 63.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 110.088 -178.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 9.0 tpt -72.4 -40.19 67.4 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.378 -1.451 . . . . 0.0 109.013 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.93 -4.67 58.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 110.168 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' B' ' 379' ' ' LYS . 95.6 mt-10 -110.56 -3.47 15.95 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.07 -1.019 . . . . 0.0 111.178 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.1 mt -79.51 130.63 35.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.427 -1.421 . . . . 0.0 109.547 179.415 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 385' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 2.3 pm0 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.271 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.561 -0.533 . . . . 2.91 109.561 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.7 mt -110.19 129.4 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.433 -0.792 . . . . 1.2 109.321 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.1 m -140.05 151.71 45.63 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.382 -0.824 . . . . 1.4 109.122 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.441 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -136.34 -166.12 10.79 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 108.495 -1.842 . . . . 1.05 108.495 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.8 mt -93.8 -9.91 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.78 -1.424 . . . . 1.15 110.334 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.3 tp 53.36 101.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.134 -0.979 . . . . 0.98 109.41 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.57 -24.67 20.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.055 -1.028 . . . . 0.88 109.867 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.4 m -146.16 134.82 10.98 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.036 -1.04 . . . . 1.69 109.723 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -80.62 139.63 12.74 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.287 1.991 . . . . 0.85 112.634 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.778 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 164.79 -165.4 37.52 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.359 -1.496 . . . . 0.92 109.359 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.6 mt -147.81 149.8 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.091 -1.24 . . . . 0.81 108.196 178.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.77 156.91 38.6 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.867 -1.146 . . . . 0.51 110.543 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -139.63 124.89 18.93 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.013 -1.106 . . . . 0.62 108.013 179.194 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.43 -179.75 48.55 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 118.776 -1.678 . . . . 0.55 110.559 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -79.29 158.62 27.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.743 -0.857 . . . . 2.1 109.462 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.545 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -101.45 129.73 47.55 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.37 -0.831 . . . . 0.77 110.923 -178.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 53.9 tp -98.22 132.17 43.94 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.189 -1.411 . . . . 0.91 107.189 178.369 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 36.8 tp -118.34 122.65 43.38 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.25 -0.906 . . . . 0.93 109.592 -179.667 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.1 mt -87.35 103.4 15.44 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.599 0.714 . . . . 0.93 110.167 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -93.01 135.32 34.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.447 -0.783 . . . . 2.75 109.233 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 57.3 mp0 -130.94 136.89 48.98 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.349 -0.844 . . . . 3.0 109.485 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 63.0 t0 -86.55 140.74 29.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.109 -0.995 . . . . 2.77 108.889 179.048 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 85.4 tt0 -60.33 139.99 57.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 2.94 109.548 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.5 mt -86.4 134.37 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.31 -0.869 . . . . 0.95 109.172 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.8 t -98.8 129.12 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.253 -0.905 . . . . 1.28 110.459 -179.004 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.8 mt -105.95 137.42 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.618 -0.882 . . . . 1.21 108.618 179.205 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -88.54 121.81 31.32 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.95 -1.094 . . . . 1.81 109.949 -179.379 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -90.63 -6.22 54.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 2.8 109.717 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -71.03 137.87 49.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.98 -1.075 . . . . 2.87 109.63 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -81.66 158.1 24.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 2.35 108.967 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.68 HD13 ' HG3' ' A' ' 39' ' ' GLU . 2.9 pt -100.43 166.28 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.139 -0.976 . . . . 0.97 109.495 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.0 p -90.46 174.77 7.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.162 -0.961 . . . . 1.17 108.765 178.764 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.85 -16.78 63.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.091 -1.006 . . . . 1.18 110.758 -179.359 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.3 -27.45 25.94 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.892 -1.13 . . . . 2.56 108.456 179.195 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -82.69 -7.36 59.65 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.195 -0.668 . . . . 1.79 109.195 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.8 t -59.95 -51.53 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.153 -0.967 . . . . 1.0 108.475 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.91 -40.04 87.48 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.385 -0.822 . . . . 1.77 109.084 179.111 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -63.3 -40.52 97.58 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.337 -0.852 . . . . 2.7 110.277 -178.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.68 ' HG3' HD13 ' A' ' 31' ' ' ILE . 60.5 mm-40 -62.93 -44.71 95.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.749 -1.219 . . . . 1.51 109.865 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.5 -49.81 81.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.041 -1.037 . . . . 0.93 109.718 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -60.66 -48.2 82.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.976 -1.077 . . . . 1.81 109.518 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.473 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 86.5 mtm180 -60.03 -40.13 88.28 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.853 -1.154 . . . . 2.78 108.407 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -65.09 -47.52 76.95 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.348 -0.845 . . . . 0.78 109.075 178.694 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.06 -44.6 94.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 1.07 109.151 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 t -65.36 -43.16 91.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.047 . . . . 1.12 109.315 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.52 -42.54 97.44 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.014 -2.034 . . . . 0.84 108.014 178.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.448 HH22 ' HG2' ' A' ' 81' ' ' GLU . 36.9 ttt-85 -63.51 -38.52 91.43 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.731 -0.864 . . . . 3.09 108.808 178.756 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.76 -40.61 72.81 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.505 -0.747 . . . . 0.88 109.083 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 50' ' ' ALA . 6.5 ttpm? -62.52 -73.44 0.11 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.737 -1.209 . . . . 2.59 107.737 178.934 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.71 -35.64 0.09 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.429 -0.794 . . . . 0.7 112.164 -177.818 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 98.2 p -59.42 -49.98 75.72 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.318 -1.489 . . . . 1.4 108.335 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.46 -39.85 92.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.47 -0.769 . . . . 0.67 110.646 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -65.99 -40.1 90.88 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.819 -1.176 . . . . 1.66 110.2 -179.159 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 71.4 mt -62.64 -40.05 95.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.146 -0.971 . . . . 1.58 109.689 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -62.56 -39.76 94.67 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.252 -0.905 . . . . 1.35 110.161 -179.338 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -64.82 -43.84 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.06 -1.025 . . . . 0.77 110.018 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.8 mt -59.93 -39.34 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.63 109.222 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -57.51 -51.41 69.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.367 -0.833 . . . . 1.14 110.411 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -56.62 -29.16 61.87 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.447 -0.783 . . . . 0.79 110.556 -177.515 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -69.75 -39.09 76.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.969 -1.082 . . . . 1.53 110.376 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.6 -46.98 74.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.304 -0.872 . . . . 0.57 110.096 -179.478 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.21 -50.02 53.74 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 109.743 -1.343 . . . . 0.75 109.743 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.24 -46.34 42.24 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.334 -1.098 . . . . 1.59 111.026 -179.349 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.4 m -67.57 -62.63 1.32 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.091 -1.005 . . . . 0.73 112.806 -177.183 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.448 ' CE1' ' O ' ' A' ' 168' ' ' THR . 77.6 m-85 -93.54 -45.77 7.6 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.684 -1.26 . . . . 0.75 110.87 -178.277 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.29 -170.6 24.59 Favored Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.011 -1.09 . . . . 1.22 110.737 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -70.02 -25.39 63.56 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.844 -0.798 . . . . 5.81 109.878 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.493 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 51.0 tp10 -60.0 -31.34 69.83 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.518 -0.739 . . . . 3.37 109.747 -179.354 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -98.98 -19.67 17.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.306 -0.871 . . . . 1.77 110.065 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -69.89 -40.02 75.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.012 -1.055 . . . . 1.65 109.977 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.479 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -63.55 -31.38 72.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.391 -0.818 . . . . 0.77 109.742 -179.556 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 88.8 mt -60.04 -40.99 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.108 -0.995 . . . . 0.8 109.116 -179.436 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -65.57 -39.7 91.96 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.222 -0.924 . . . . 0.88 110.699 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -59.95 -40.04 87.63 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.817 -1.177 . . . . 1.37 108.834 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.61 -47.0 93.32 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.971 -2.052 . . . . 0.62 107.971 178.188 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -61.58 -49.44 76.65 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.398 -1.06 . . . . 1.5 109.102 179.222 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.05 -48.98 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.276 -0.89 . . . . 0.63 109.542 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.7 ttp -60.06 -43.03 95.71 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.108 -0.995 . . . . 1.51 110.063 -178.662 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.884 HD11 ' CE2' ' B' ' 348' ' ' PHE . 56.4 tp -63.29 -40.01 96.16 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.318 -0.864 . . . . 0.77 109.425 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.45 -39.9 89.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.78 -0.822 . . . . 0.62 108.78 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.448 ' HG2' HH22 ' A' ' 47' ' ' ARG . 42.0 mt-10 -83.28 8.15 14.31 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.229 -0.919 . . . . 1.47 110.485 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -56.64 130.89 47.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.785 -1.197 . . . . 1.47 109.529 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.51 -18.47 52.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.468 -0.77 . . . . 1.78 110.467 -179.014 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -70.14 -36.28 74.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.823 -1.173 . . . . 2.53 109.109 178.531 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.2 mt -70.2 -41.77 73.26 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.411 -0.806 . . . . 0.8 110.031 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -60.03 -48.67 80.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 1.42 110.372 -178.945 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -70.05 -40.83 74.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 1.71 110.726 -179.009 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.07 -40.02 75.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.194 -0.941 . . . . 1.57 111.516 -178.743 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.99 -43.87 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.03 -1.043 . . . . 0.65 109.616 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.5 mt -70.06 -40.0 77.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.379 -0.826 . . . . 0.82 110.309 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.01 75.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.105 -0.997 . . . . 0.79 111.307 -178.599 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 96' ' ' LYS . 17.6 mt -60.9 -45.73 93.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.089 -1.007 . . . . 0.95 109.703 -178.776 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.44 -49.89 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.66 109.134 179.694 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -70.38 -41.18 73.41 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.876 -0.73 . . . . 2.2 110.916 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -82.52 -53.68 5.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.998 -1.064 . . . . 1.65 112.1 -178.229 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 92' ' ' LEU . 90.6 mttt -90.06 -1.39 57.95 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.048 -1.032 . . . . 2.03 112.124 -177.172 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 57.05 35.7 26.72 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.746 -1.221 . . . . 1.42 109.196 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 38.4 mtt -83.8 164.96 19.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.513 -0.742 . . . . 1.18 109.823 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.7 p -79.58 158.73 27.07 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.496 -0.927 . . . . 0.98 108.496 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.0 -40.08 75.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.994 -1.066 . . . . 0.64 109.702 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.94 -39.94 95.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.975 . . . . 2.07 109.79 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.57 -46.47 14.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.125 -0.984 . . . . 0.73 109.434 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.05 -49.67 76.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.442 -0.786 . . . . 0.54 109.89 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.57 85.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.171 -0.956 . . . . 0.56 109.634 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.534 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 80.7 t60 -59.99 -39.0 84.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.327 -0.858 . . . . 1.54 109.858 -179.207 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 110' ' ' GLY . 41.3 tt0 -60.36 -41.57 93.96 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.106 -0.996 . . . . 1.33 109.541 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.7 t -65.91 -50.87 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.1 -1.0 . . . . 0.72 110.198 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.5 mm -69.31 -40.12 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.044 -1.035 . . . . 0.85 108.581 179.492 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.534 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 89.1 tt0 -67.09 -37.21 83.55 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.405 -0.961 . . . . 2.44 108.405 178.805 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -60.02 -47.32 91.61 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.74 -1.344 . . . . 0.98 109.74 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -69.34 -55.8 9.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.052 -1.263 . . . . 1.41 109.004 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.83 -42.83 65.52 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.976 . . . . 1.2 108.937 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 110' ' ' GLY . 63.8 p -59.98 -40.02 87.69 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.192 -0.942 . . . . 1.7 108.67 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.98 -40.06 91.99 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.33 -0.856 . . . . 1.47 108.697 179.066 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.0 mt -65.23 -42.0 93.84 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.134 -0.979 . . . . 1.56 108.914 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -56.75 -32.88 66.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.731 -1.23 . . . . 2.2 109.414 -179.508 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -59.19 -22.54 61.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.023 -1.048 . . . . 2.12 108.309 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 123' ' ' LEU . 60.3 mt -62.97 148.05 48.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.342 -0.849 . . . . 2.0 108.861 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -100.21 37.1 1.72 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.242 -0.911 . . . . 3.23 109.955 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 56.8 t0 -125.25 134.64 52.24 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.382 -0.824 . . . . 2.49 110.438 -179.315 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.487 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 12.4 pt-20 -70.44 -30.12 66.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.783 -0.573 . . . . 3.95 110.58 179.529 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.651 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 3.0 t80 -71.87 -40.01 69.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.057 -1.027 . . . . 2.0 110.65 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.496 ' CD2' HH22 ' A' ' 126' ' ' ARG . 60.1 mt -71.77 -31.76 66.96 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.256 -0.902 . . . . 1.86 108.584 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -66.0 -39.97 90.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.605 -0.685 . . . . 2.84 110.018 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.0 -46.34 89.8 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.21 -0.931 . . . . 2.73 110.824 -178.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.651 ' NH1' ' CE1' ' A' ' 122' ' ' TYR . 21.3 mtm-85 -70.01 -27.1 64.41 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.755 -1.178 . . . . 2.77 108.863 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.91 -26.07 66.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.902 -1.147 . . . . 1.19 107.902 178.378 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.97 -40.16 75.56 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.481 -0.933 . . . . 1.2 108.481 178.615 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -62.23 -44.29 96.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.574 -0.704 . . . . 1.55 109.18 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.6 t -61.48 -40.26 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.654 -0.869 . . . . 0.8 108.654 179.28 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -60.49 -37.34 80.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.49 -0.756 . . . . 3.09 109.713 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -60.0 -41.0 91.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.173 -0.954 . . . . 1.46 109.996 -178.862 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.02 -49.55 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.97 -1.081 . . . . 0.71 109.176 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.21 -42.87 98.83 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.682 -1.367 . . . . 0.57 109.682 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -60.05 -49.96 75.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.147 -1.207 . . . . 2.59 110.27 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.548 HH12 ' CB ' ' A' ' 166' ' ' SER . 98.9 mtt180 -68.88 -27.18 65.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.774 -1.204 . . . . 2.83 109.838 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.95 -43.43 95.0 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.184 -0.947 . . . . 1.25 108.587 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.69 -40.03 93.56 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.397 -0.814 . . . . 0.7 109.083 178.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -63.54 -39.95 95.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.311 -0.868 . . . . 2.57 108.665 179.405 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -67.13 -39.95 86.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.711 -0.618 . . . . 1.23 111.258 -179.294 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.97 -43.05 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.438 -1.414 . . . . 0.81 108.061 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.01 -30.07 67.29 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 179.41 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.01 40.28 9.46 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.832 -1.707 . . . . 0.89 108.832 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 tp -74.68 149.97 39.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.374 -1.074 . . . . 1.14 109.341 -179.481 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -71.1 147.97 47.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.341 -0.849 . . . . 4.6 109.725 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.4 mt -118.82 129.47 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 122.041 0.924 . . . . 1.24 109.313 179.271 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 11.1 mt -67.05 -40.07 84.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.807 -0.633 . . . . 1.54 110.506 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 41.6 t0 60.89 105.07 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.669 -0.863 . . . . 1.5 108.669 -178.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 55.2 mt -67.76 -0.12 3.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.305 -0.872 . . . . 0.79 110.128 -178.964 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.2 m -83.2 -11.8 57.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.92 -1.113 . . . . 1.4 109.511 179.591 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.15 25.57 0.83 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.152 -0.967 . . . . 0.92 111.179 -178.562 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 40.5 mm -90.97 117.18 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.59 -1.319 . . . . 0.88 108.729 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -99.92 -9.35 22.92 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.258 -0.901 . . . . 2.45 110.481 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -129.18 152.11 49.12 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.296 -0.878 . . . . 1.52 110.057 -179.2 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.52 136.78 57.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.504 -0.748 . . . . 1.58 109.273 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.5 m -151.92 164.8 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.328 -0.858 . . . . 0.69 109.671 179.51 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.3 mt -92.1 146.52 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 105.954 -1.869 . . . . 0.61 105.954 177.028 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.6 tp -94.23 115.83 28.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.795 -1.191 . . . . 0.87 110.495 -178.149 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.2 t -123.2 129.94 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.512 -0.921 . . . . 0.71 108.512 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.24 162.24 36.15 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.275 -1.009 . . . . 0.81 108.275 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.6 -35.25 72.91 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.214 -1.553 . . . . 0.98 108.048 178.672 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -170.48 140.91 1.86 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.186 -1.042 . . . . 2.25 108.186 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.7 mt -113.48 134.61 54.58 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.231 -0.918 . . . . 0.78 109.955 -179.218 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 18.0 p -87.27 147.19 41.74 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.305 -0.872 . . . . 0.98 108.783 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -43.24 -33.07 3.53 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.12 1.88 . . . . 0.81 113.319 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.548 ' CB ' HH12 ' A' ' 136' ' ' ARG . 13.8 m -59.95 -48.55 81.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.808 -1.183 . . . . 0.9 108.928 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.04 -44.92 94.33 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.386 -0.822 . . . . 1.61 109.438 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.448 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 67.9 p -56.72 -18.87 14.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.877 . . . . 0.61 110.537 -178.67 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.36 -48.76 8.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.949 -1.095 . . . . 0.6 109.378 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -90.82 38.64 0.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.537 -0.912 . . . . 1.4 108.537 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.5 tp -104.85 134.39 48.05 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.92 -0.77 . . . . 0.7 108.92 179.382 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 176' ' ' VAL . 86.3 m-20 -80.86 101.72 9.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 2.35 108.79 179.706 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 97.2 mt -62.93 -39.96 96.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.269 -0.894 . . . . 1.51 110.337 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -67.02 -24.25 66.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.081 -1.012 . . . . 2.33 110.883 -178.121 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -93.92 -11.46 30.93 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.737 -1.227 . . . . 1.92 109.478 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.463 HG11 ' CE1' ' A' ' 179' ' ' PHE . 72.4 t -101.17 110.14 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.197 -0.94 . . . . 0.67 108.737 179.064 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.16 5.99 31.42 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.204 -0.935 . . . . 1.53 110.57 -178.658 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.18 170.41 37.44 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.991 -1.644 . . . . 0.48 108.991 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.463 ' CE1' HG11 ' A' ' 176' ' ' VAL . 22.3 m-85 -130.86 128.93 41.61 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.334 -1.097 . . . . 0.55 109.288 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 90.0 mt -132.55 125.38 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.484 -0.932 . . . . 0.65 108.484 178.725 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.3 p -145.94 160.04 42.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.062 -1.023 . . . . 0.82 110.84 -179.236 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 59.6 t0 -101.82 23.13 11.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.599 -0.688 . . . . 2.46 109.885 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.41 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -58.19 -161.17 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.287 -1.508 . . . . 1.28 110.792 -178.498 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -83.75 -44.34 6.86 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.607 -0.997 . . . . 2.19 110.607 -179.181 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 147.57 -115.25 0.75 Allowed Glycine 0 N--CA 1.497 2.724 0 O-C-N 120.83 -1.394 . . . . 2.13 110.32 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.422 ' HG2' HH22 ' A' ' 195' ' ' ARG . 46.4 mtt-85 -59.92 -38.06 81.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.49 -1.006 . . . . 5.86 110.927 -179.306 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 73.4 p -70.25 0.09 7.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.914 -1.116 . . . . 3.72 110.432 -178.38 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 39.8 t -92.32 117.27 29.73 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.972 -1.08 . . . . 1.74 110.712 -179.654 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -47.71 -42.3 24.74 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.197 -0.939 . . . . 0.95 108.541 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.432 ' H ' HG23 ' A' ' 190' ' ' THR . 23.4 p -52.18 -34.66 46.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.801 -0.562 . . . . 1.55 109.96 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 74.9 m -60.01 -40.06 87.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.011 -1.056 . . . . 1.51 110.472 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.2 mm -63.98 -40.35 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.17 -0.956 . . . . 1.67 110.112 -178.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 82.9 mtp -59.99 -49.04 79.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.956 -1.09 . . . . 1.02 110.969 -178.774 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.52 -44.17 89.43 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.705 -1.247 . . . . 0.68 109.968 -178.391 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.422 HH22 ' HG2' ' A' ' 186' ' ' ARG . 98.2 mtt180 -61.75 -54.93 35.81 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.29 -0.964 . . . . 2.93 110.503 -179.183 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.3 m -70.0 -35.89 74.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.027 -1.046 . . . . 0.86 112.148 -178.472 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.55 -12.35 60.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.604 -1.31 . . . . 0.67 110.585 -178.114 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 62.14 49.56 4.39 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.495 -0.753 . . . . 1.5 111.055 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 96.4 mt -130.62 150.03 75.22 Favored Pre-proline 0 N--CA 1.499 2.002 0 N-CA-C 107.641 -1.244 . . . . 0.72 107.641 178.004 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.11 143.85 73.26 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.035 1.823 . . . . 0.61 111.418 179.867 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.91 151.74 4.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.746 -1.221 . . . . 0.66 111.889 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.6 mt -125.81 139.67 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.025 -1.102 . . . . 0.79 108.025 178.774 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.1 m -122.77 -12.67 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 120.985 -1.072 . . . . 0.91 110.968 -178.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.98 26.56 13.63 Favored Glycine 0 N--CA 1.501 2.978 0 N-CA-C 110.897 -0.881 . . . . 1.01 110.897 -178.838 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.7 p -43.2 -44.82 5.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.066 -1.255 . . . . 0.99 110.096 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.447 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 93.01 -52.12 2.54 Favored Glycine 0 N--CA 1.498 2.795 0 C-N-CA 120.224 -0.988 . . . . 1.12 110.741 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.2 t -158.91 33.64 0.21 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.617 -1.519 . . . . 1.72 111.186 -179.259 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.6 -40.05 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.985 -1.072 . . . . 0.89 109.082 178.45 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.452 ' H ' HG23 ' A' ' 209' ' ' THR . 7.0 p -54.54 -30.0 52.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.431 -0.793 . . . . 1.03 110.108 -179.08 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.5 t -80.89 -21.1 40.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.061 -1.024 . . . . 1.83 110.161 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -96.96 -13.41 22.39 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.128 -0.982 . . . . 2.27 110.125 -179.416 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.8 t -102.05 136.62 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.361 -0.837 . . . . 0.92 110.216 -178.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -112.23 154.54 25.43 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.04 -1.467 . . . . 2.2 107.04 178.77 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.497 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 32.6 t30 -60.04 139.02 57.73 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.839 -1.163 . . . . 2.36 110.169 -179.145 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 9.6 t0 84.91 7.24 0.48 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.16 0.505 . . . . 2.38 110.019 179.49 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 55.3 t0 -76.87 142.07 40.35 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.204 -0.935 . . . . 2.09 109.096 179.232 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.493 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 49.3 t80 -92.81 117.98 30.61 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.977 -1.12 . . . . 1.27 107.977 178.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.545 HD12 ' HB2' ' A' ' 16' ' ' ALA . 69.9 mt -127.16 147.47 50.19 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.503 -0.748 . . . . 0.75 110.55 -178.554 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.403 HD12 ' HG3' ' A' ' 231' ' ' PRO . 80.5 mt -118.39 129.59 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 107.469 -1.308 . . . . 0.63 107.469 177.461 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 34.3 tp -104.22 123.65 47.71 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.668 -0.864 . . . . 0.7 108.668 -179.193 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 10' ' ' GLY . 29.1 t0 -85.75 -35.76 20.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.107 -0.995 . . . . 2.31 108.38 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 45.71 21.41 0.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.742 0.782 . . . . 0.78 108.919 -179.319 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 221' ' ' ASP . 42.1 t -133.41 -44.07 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.121 -1.437 . . . . 1.04 107.121 178.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.465 ' ND2' ' OD2' ' A' ' 221' ' ' ASP . 84.3 m-20 -102.25 2.1 36.66 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.057 -1.09 . . . . 2.44 108.057 178.606 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.441 HD21 ' H ' ' A' ' 4' ' ' GLY . 10.1 t-20 59.98 43.91 14.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.805 -0.559 . . . . 1.55 110.307 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -136.41 149.37 48.25 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.216 -0.928 . . . . 1.99 110.112 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.6 129.96 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.454 -0.943 . . . . 0.77 108.454 178.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -100.87 123.03 44.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.423 -0.798 . . . . 0.98 109.303 179.329 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 19.4 t -100.03 110.52 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.373 -0.83 . . . . 0.85 109.98 -179.312 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 230' ' ' ASN . 3.9 t30 56.61 67.43 2.69 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.325 -0.859 . . . . 1.66 111.368 179.221 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.403 ' HG3' HD12 ' A' ' 219' ' ' ILE . 81.6 Cg_endo -91.05 150.02 3.82 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.266 2.644 . . . . 0.95 112.568 178.897 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.0 m -70.07 160.03 32.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.345 -0.847 . . . . 1.84 110.29 -179.23 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -59.99 -36.84 78.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.392 -0.817 . . . . 2.74 109.608 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -60.03 -38.43 82.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 2.89 109.221 -179.689 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.36 -40.05 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.096 -1.003 . . . . 1.3 109.405 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.34 -40.11 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.164 -0.96 . . . . 1.09 110.104 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -59.92 -43.83 94.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.806 -1.183 . . . . 2.43 109.117 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -62.01 -43.94 97.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.374 -0.829 . . . . 2.78 110.047 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 96.2 mtp -69.92 -34.72 73.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.325 -0.859 . . . . 1.25 110.324 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -62.04 -40.01 94.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.159 -0.963 . . . . 2.63 110.166 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -64.18 -43.29 95.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.995 -1.066 . . . . 1.8 109.756 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 56.7 t -60.81 -40.16 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.249 -0.907 . . . . 2.13 109.229 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -59.93 -40.16 87.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.306 -0.872 . . . . 3.17 109.62 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -59.97 -41.39 91.86 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.243 -0.911 . . . . 1.78 109.385 -179.6 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -70.0 -40.01 75.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 2.47 109.641 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.27 -45.11 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.462 -0.773 . . . . 2.09 109.603 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.03 -49.98 75.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 2.54 109.429 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 70.5 m -61.68 -39.93 93.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -0.87 . . . . 2.99 109.527 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -64.13 -40.04 95.33 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.567 -0.708 . . . . 3.34 110.206 -179.134 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -171.55 80.07 0.07 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.144 -0.973 . . . . 3.88 108.59 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.462 ' O ' HD23 ' A' ' 253' ' ' LEU . . . -80.9 -6.85 59.18 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.27 -0.894 . . . . 4.43 109.077 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' A' ' 251' ' ' ALA . 2.6 tm-20 75.56 -41.44 0.44 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.521 -0.737 . . . . 5.42 109.388 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 251' ' ' ALA . 0.1 OUTLIER -100.16 46.2 0.96 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.075 -1.083 . . . . 6.1 108.075 179.27 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -152.71 -0.54 0.27 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.307 -0.871 . . . . 7.37 111.005 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 256' ' ' LEU . 55.6 tttp -145.93 6.14 1.03 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.68 -1.263 . . . . 8.01 109.404 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 255' ' ' LYS . 54.1 mt 56.52 114.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.244 -0.91 . . . . 9.05 109.825 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -123.87 14.83 9.3 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.271 -1.011 . . . . 10.56 108.271 179.042 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 258' ' ' ASP . 22.0 p-10 -84.73 36.35 0.6 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.732 -1.23 . . . . 11.32 109.657 -179.646 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 117.976 -1.012 . . . . 12.42 109.125 179.624 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 50.5 ttp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.573 0.701 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 302' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 36.2 t80 -154.92 152.83 30.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.706 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 303' ' ' GLN . . . . . 0.463 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 13.8 pt20 -149.78 159.99 43.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.937 -1.102 . . . . 0.0 110.474 -179.436 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -153.94 150.44 28.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.568 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -112.49 134.08 54.21 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.225 -0.922 . . . . 0.0 110.583 -179.504 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -129.71 121.52 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-O 122.251 1.024 . . . . 0.0 112.546 -177.485 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 307' ' ' THR . . . . . 0.462 ' O ' HG23 ' B' ' 309' ' ' THR . 25.4 m -76.45 105.1 7.31 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.79 0.805 . . . . 0.0 110.42 -178.437 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 98.9 mt -53.26 121.62 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 122.318 1.056 . . . . 0.0 110.375 -178.325 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 309' ' ' THR . . . . . 0.462 HG23 ' O ' ' B' ' 307' ' ' THR . 78.1 p -110.11 19.95 18.42 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.36 -178.622 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.14 126.14 91.97 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.901 -1.124 . . . . 0.0 109.168 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.65 -18.72 27.38 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 CA-C-N 120.404 1.18 . . . . 0.0 112.327 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -120.45 10.16 11.1 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 75.33 -176.98 49.47 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.098 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.515 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -83.45 87.54 6.99 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.088 -1.242 . . . . 0.0 108.988 -178.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.419 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 3.9 p80 -90.29 -162.92 0.94 Allowed 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.825 -1.172 . . . . 0.0 110.123 179.09 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 9.6 m -57.09 -41.78 79.49 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.852 -1.155 . . . . 0.0 112.486 -175.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.493 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 0.7 OUTLIER -60.02 -60.88 9.17 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 120.62 -1.3 . . . . 0.0 111.855 -178.835 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.419 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 13.1 Cg_endo -59.38 -34.33 97.56 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 CA-C-N 120.139 1.085 . . . . 0.0 111.801 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.52 73.42 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.74 -41.96 67.66 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.02 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 321' ' ' GLN . . . . . 0.582 ' HA ' ' HZ2' ' B' ' 324' ' ' LYS . 27.3 mm100 -70.0 -41.4 74.42 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 108.692 178.749 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 322' ' ' PHE . . . . . 0.486 ' CE1' ' SD ' ' B' ' 381' ' ' MET . 55.1 t80 -61.93 -52.23 64.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.583 -0.698 . . . . 0.0 110.813 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.51 -29.23 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.596 -1.315 . . . . 0.0 109.299 -179.288 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.582 ' HZ2' ' HA ' ' B' ' 321' ' ' GLN . 0.2 OUTLIER -60.13 -46.25 90.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.406 -0.809 . . . . 0.0 109.636 179.495 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -67.19 -45.62 76.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.346 -0.846 . . . . 0.0 110.893 -178.54 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.0 -53.0 62.97 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.706 -1.246 . . . . 0.0 110.833 -178.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.438 ' HZ2' ' HG3' ' B' ' 345' ' ' LYS . 28.5 mttp -54.12 -12.64 0.65 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.067 -1.021 . . . . 0.0 109.452 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.1 -20.14 73.42 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -106.03 146.66 29.82 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.387 -1.066 . . . . 0.0 108.599 179.531 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 70.0 p -91.51 -14.29 30.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.86 -1.15 . . . . 0.0 109.435 179.586 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.419 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 77.9 p -64.52 149.18 49.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.665 -179.535 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -69.85 138.25 52.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.129 -0.982 . . . . 0.0 108.795 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.6 mt -134.14 134.6 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.603 -0.686 . . . . 0.0 109.56 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 48.4 m -128.62 149.82 50.49 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.451 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 76.5 t -121.99 113.15 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.35 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 44.3 m -105.29 133.16 50.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.951 . . . . 0.0 109.28 -178.644 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 34.1 p -137.83 110.67 7.66 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.758 0.789 . . . . 0.0 110.248 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 22.4 m120 45.97 53.48 9.02 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 177.456 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.96 -15.45 59.35 Favored Glycine 0 N--CA 1.504 3.169 0 O-C-N 120.246 -1.534 . . . . 0.0 113.207 176.413 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 340' ' ' LYS . . . . . 0.528 ' NZ ' ' O ' ' B' ' 352' ' ' THR . 9.7 mtpm? -116.06 127.92 55.27 Favored 'General case' 0 N--CA 1.507 2.423 0 CA-C-N 119.338 1.569 . . . . 0.0 109.614 -179.517 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 67.2 m -127.2 148.58 50.19 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.968 0.889 . . . . 0.0 111.15 -178.395 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.94 164.69 29.49 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.348 0.594 . . . . 0.0 109.712 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 47.4 t -88.58 132.41 34.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.474 -0.766 . . . . 0.0 110.922 -178.735 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.443 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -69.86 -21.63 63.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.888 . . . . 0.0 108.871 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 345' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' B' ' 345' ' ' LYS . 24.0 ttpp -83.12 18.0 1.82 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.61 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 346' ' ' SER . . . . . 0.443 ' H ' ' C ' ' B' ' 344' ' ' ALA . 11.2 t -147.12 95.33 2.54 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.14 -179.489 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.804 HD23 HD22 ' A' ' 79' ' ' LEU . 60.8 tp -59.91 -39.7 86.28 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.542 -0.724 . . . . 0.0 109.132 179.02 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.884 ' CE2' HD11 ' A' ' 79' ' ' LEU . 60.9 m-85 -54.02 -52.49 60.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.104 -0.998 . . . . 0.0 110.771 -179.404 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -65.89 -39.99 91.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.152 -0.968 . . . . 0.0 109.704 -178.774 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' B' ' 352' ' ' THR . 17.6 mt -49.71 -58.35 5.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.193 -0.942 . . . . 0.0 109.915 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.445 ' OE1' ' NE ' ' A' ' 126' ' ' ARG . 2.6 mm-40 -42.58 -13.19 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.239 -0.913 . . . . 0.0 111.869 -177.077 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.569 ' N ' ' O ' ' B' ' 350' ' ' LEU . 81.6 p -85.02 -15.01 45.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 119.95 -1.719 . . . . 0.0 110.275 -179.152 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.442 HD23 ' HZ3' ' B' ' 340' ' ' LYS . 43.3 mt -91.32 119.96 31.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.999 -1.063 . . . . 0.0 109.431 179.335 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.26 93.91 0.7 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.175 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 355' ' ' LEU . . . . . 0.417 HD22 HG11 ' B' ' 361' ' ' VAL . 52.0 mt -100.59 88.01 3.51 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.245 -1.15 . . . . 0.0 109.187 179.656 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 60.0 p -91.53 166.12 13.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.958 -1.089 . . . . 0.0 110.744 -178.974 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -59.41 116.64 4.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.774 -0.579 . . . . 0.0 111.077 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 101.02 7.11 50.91 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 47.7 m -86.74 110.89 20.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -1.136 . . . . 0.0 110.795 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 46.7 t -77.78 117.52 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 122.169 0.985 . . . . 0.0 109.48 -177.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 361' ' ' VAL . . . . . 0.417 HG11 HD22 ' B' ' 355' ' ' LEU . 25.4 m -110.22 177.67 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 91.1 m -131.35 128.74 40.29 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.174 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 69.6 mt -103.0 116.33 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.647 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 67.2 m -116.06 129.99 56.6 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.88 151.8 39.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.353 -0.842 . . . . 0.0 109.724 -178.429 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -145.01 121.5 11.03 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.475 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.81 -155.38 26.54 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 118.765 -1.683 . . . . 0.0 111.844 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -59.94 -50.9 71.93 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.173 -0.514 . . . . 0.0 112.224 -177.151 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.419 ' H ' ' HB3' ' B' ' 331' ' ' SER . 97.0 m-20 -110.27 13.47 22.99 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.777 -1.202 . . . . 0.0 111.137 -177.584 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.7 pt-20 -42.23 -36.42 1.21 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.206 -0.934 . . . . 0.0 110.655 -179.246 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 371' ' ' GLN . . . . . 0.407 ' HG2' ' H ' ' B' ' 371' ' ' GLN . 2.3 pt20 -69.26 -47.06 65.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.043 -1.036 . . . . 0.0 110.162 -179.148 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -69.98 -54.44 13.25 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.003 -1.06 . . . . 0.0 109.51 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 373' ' ' ALA . . . . . 0.427 ' O ' HD12 ' B' ' 377' ' ' LEU . . . -43.46 -34.18 1.26 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.365 -0.834 . . . . 0.0 111.179 -179.022 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.525 ' O ' HG23 ' B' ' 378' ' ' VAL . 73.4 t -76.09 -35.66 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.603 -1.311 . . . . 0.0 109.399 179.327 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -65.41 -59.4 4.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 111.853 -178.15 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -69.77 -39.99 76.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.384 -1.448 . . . . 0.0 111.707 -178.269 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 377' ' ' LEU . . . . . 0.427 HD12 ' O ' ' B' ' 373' ' ' ALA . 88.0 mt -58.46 -39.99 81.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.526 -1.359 . . . . 0.0 108.696 -178.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.525 HG23 ' O ' ' B' ' 374' ' ' VAL . 55.3 t -62.38 -42.72 96.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.103 -0.998 . . . . 0.0 109.596 179.401 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.6 mttt -71.25 -57.54 4.39 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.794 -1.191 . . . . 0.0 108.209 178.853 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 53.9 tp -53.32 -35.99 60.77 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.173 -0.954 . . . . 0.0 109.015 -178.346 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 381' ' ' MET . . . . . 0.486 ' SD ' ' CE1' ' B' ' 322' ' ' PHE . 0.9 OUTLIER -72.14 -40.0 68.38 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.621 -1.299 . . . . 0.0 108.437 177.648 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.62 -4.87 58.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.595 -0.691 . . . . 0.0 110.601 179.374 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' B' ' 379' ' ' LYS . 94.6 mt-10 -111.43 -3.11 15.34 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.125 -0.985 . . . . 0.0 110.807 -179.725 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.6 mt -82.98 131.14 35.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.637 -1.289 . . . . 0.0 109.099 179.25 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.091 179.615 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.358 -0.608 . . . . 2.91 109.358 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.505 HD11 HE22 ' A' ' 211' ' ' GLN . 97.4 mt -108.37 123.71 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.438 -0.788 . . . . 1.2 109.602 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.8 m -135.98 141.14 44.39 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.72 -0.844 . . . . 1.4 108.72 179.578 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.509 ' N ' HD22 ' A' ' 225' ' ' ASN . . . -109.0 -160.13 19.45 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.113 -1.595 . . . . 1.05 109.113 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.1 mt -95.23 -15.01 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.118 -1.225 . . . . 1.15 109.589 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.4 tp 51.99 104.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.798 . . . . 0.98 109.666 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.82 -23.57 17.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.079 -1.013 . . . . 0.88 109.302 179.51 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.459 ' OG ' ' N ' ' A' ' 201' ' ' ALA . 12.5 p -137.42 119.24 11.01 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.405 -0.81 . . . . 1.69 109.06 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.99 150.13 20.51 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.904 1.736 . . . . 0.85 112.375 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.784 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.35 -155.09 25.96 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.08 -1.608 . . . . 0.92 109.08 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.7 mt -149.08 150.59 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.016 -1.285 . . . . 0.81 109.112 179.045 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.12 146.12 22.59 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.022 -1.049 . . . . 0.51 110.315 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -127.62 127.92 44.64 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.161 -1.051 . . . . 0.62 108.161 178.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.1 176.08 46.6 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.734 -1.698 . . . . 0.55 110.588 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -77.76 156.31 30.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.699 -0.883 . . . . 2.1 109.022 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -102.59 128.33 49.29 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.416 -0.802 . . . . 0.77 111.025 -178.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.8 tp -100.13 135.33 41.73 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.069 -1.456 . . . . 0.91 107.069 178.268 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.0 tp -115.3 121.6 43.37 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.3 -0.875 . . . . 0.93 110.099 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.1 mt -86.69 103.01 14.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.526 -0.734 . . . . 0.93 109.73 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -90.96 142.31 27.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.395 -0.815 . . . . 2.75 109.244 179.713 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -130.1 133.34 46.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.426 -0.953 . . . . 3.0 108.426 179.222 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -84.07 150.69 25.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.044 -1.035 . . . . 2.77 109.429 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -66.66 147.89 52.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.932 . . . . 2.94 109.301 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 86.5 mt -96.44 126.68 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.187 -0.946 . . . . 0.95 109.05 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.1 t -94.73 126.12 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.133 -0.979 . . . . 1.28 109.997 -179.298 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.5 mt -112.37 131.93 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 109.016 -0.735 . . . . 1.21 109.016 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.01 118.35 28.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.873 -1.142 . . . . 1.81 110.335 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -85.08 -1.06 56.42 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.715 -0.846 . . . . 2.8 108.715 179.761 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -69.9 140.37 53.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.469 -0.769 . . . . 2.87 110.024 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -80.03 153.3 28.91 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.194 -0.941 . . . . 2.35 109.409 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.0 pt -94.6 167.48 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.179 -0.95 . . . . 0.97 109.711 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.4 p -96.28 173.04 7.59 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.147 -1.057 . . . . 1.17 108.147 178.22 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.99 75.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.913 -1.117 . . . . 1.18 110.501 -179.335 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -57.3 -26.45 60.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.703 -1.248 . . . . 2.56 109.513 -179.275 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -82.26 -9.83 59.34 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.302 -0.874 . . . . 1.79 109.762 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.3 t -66.49 -54.59 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.925 -1.11 . . . . 1.0 109.641 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.04 -40.08 88.14 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.269 -0.895 . . . . 1.77 109.102 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -62.87 -42.19 99.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.419 -0.801 . . . . 2.7 110.707 -179.295 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -62.62 -42.55 99.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.615 -1.303 . . . . 1.51 110.221 -179.498 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.98 -47.39 91.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 120.594 -1.316 . . . . 0.93 108.64 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -59.94 -45.15 93.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -0.942 . . . . 1.81 109.318 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.501 HH11 ' HG2' ' A' ' 42' ' ' ARG . 22.2 mtt-85 -60.08 -43.56 95.39 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.069 -1.086 . . . . 2.78 108.069 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -62.0 -47.2 85.85 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.737 -0.838 . . . . 0.78 108.737 178.488 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.2 tp -59.94 -48.92 79.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 1.07 108.837 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.442 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 29.4 t -63.04 -43.73 97.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.975 -1.078 . . . . 1.12 108.963 178.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.06 -47.51 90.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.57 -1.812 . . . . 0.84 108.57 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -61.56 -36.18 79.9 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.006 -1.109 . . . . 3.09 108.006 178.599 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -55.32 -40.01 70.64 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.317 -0.623 . . . . 0.88 109.317 -179.618 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ALA . 26.4 ttpp -66.34 -73.73 0.13 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.652 -1.24 . . . . 2.59 107.652 179.153 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.09 -36.34 0.2 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.46 -0.775 . . . . 0.7 111.346 -178.544 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 t -57.41 -55.94 28.34 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.508 -1.37 . . . . 1.4 108.612 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.08 -40.0 86.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.253 -0.904 . . . . 0.67 111.074 -179.49 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -67.96 -40.24 83.23 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.841 -1.162 . . . . 1.66 110.322 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.2 mt -62.03 -39.97 94.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.009 -1.057 . . . . 1.58 108.72 179.219 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -61.21 -38.49 86.79 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.426 -0.796 . . . . 1.35 109.713 179.26 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -64.27 -43.69 94.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.194 -0.941 . . . . 0.77 110.268 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.657 ' CD1' HH22 ' A' ' 136' ' ' ARG . 85.7 mt -63.04 -38.1 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.63 108.969 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -56.15 -50.59 70.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 1.14 109.896 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -59.94 -36.44 77.08 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.43 -0.794 . . . . 0.79 110.367 -177.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -63.79 -39.48 94.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.963 -1.086 . . . . 1.53 109.211 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.68 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.54 -45.48 75.54 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.564 -0.71 . . . . 0.57 110.033 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.14 -51.16 60.07 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 110.268 -1.133 . . . . 0.75 110.268 -179.036 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -69.96 -41.88 73.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.037 -1.272 . . . . 1.59 110.309 -179.446 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.3 m -69.92 -60.4 2.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.912 . . . . 0.73 112.2 -177.546 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -95.49 -50.77 4.84 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.964 -1.085 . . . . 0.75 111.093 -178.255 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.42 -163.7 26.75 Favored Glycine 0 N--CA 1.499 2.837 0 O-C-N 120.747 -1.221 . . . . 1.22 110.726 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -70.0 -23.24 63.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.751 -0.852 . . . . 5.81 110.364 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.425 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 52.7 tp10 -60.13 -37.76 81.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 3.37 110.272 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -97.4 -19.02 18.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.293 -0.88 . . . . 1.77 110.388 -178.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -70.09 -40.12 75.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.855 -1.153 . . . . 1.65 110.496 -179.712 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.601 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.82 -29.9 69.17 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.399 -0.813 . . . . 0.77 109.585 -178.761 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.02 -42.57 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.248 -0.981 . . . . 0.8 109.112 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.451 ' CZ ' HG22 ' A' ' 57' ' ' ILE . 39.5 m-85 -64.5 -40.08 94.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.112 -0.993 . . . . 0.88 110.742 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -59.98 -40.02 87.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.831 -1.168 . . . . 1.37 108.833 -179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.01 -43.53 98.73 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 107.98 -2.048 . . . . 0.62 107.98 178.514 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -65.21 -48.43 73.41 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.459 -1.024 . . . . 1.5 108.608 179.253 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.9 mt -64.36 -49.39 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.397 -0.815 . . . . 0.63 109.18 179.432 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.2 ttp -60.41 -42.73 96.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.167 -0.958 . . . . 1.51 110.37 -179.075 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.833 HD11 ' CE2' ' B' ' 348' ' ' PHE . 42.0 tp -66.04 -41.57 90.7 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.335 -0.853 . . . . 0.77 109.983 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.4 tp -63.31 -40.11 96.44 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.292 -0.88 . . . . 0.62 110.168 -179.548 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -82.57 8.03 12.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.188 -0.945 . . . . 1.47 110.08 -179.355 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -50.78 131.91 26.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 1.47 109.352 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.44 -20.66 60.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.701 -0.624 . . . . 1.78 111.027 -178.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.71 -34.32 67.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.901 -1.125 . . . . 2.53 109.552 179.54 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.6 mt -70.08 -40.1 75.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.538 -0.726 . . . . 0.8 109.321 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -60.08 -46.04 90.91 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.389 -0.82 . . . . 1.42 109.613 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -69.99 -40.48 75.29 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.406 -0.809 . . . . 1.71 110.244 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.02 -40.02 75.46 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.051 -1.03 . . . . 1.57 111.14 -179.417 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.0 mt -67.95 -48.88 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.919 -1.113 . . . . 0.65 109.461 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.97 -39.7 84.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.506 -0.746 . . . . 0.82 109.51 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.96 -48.89 79.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 0.79 110.532 -179.246 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 96' ' ' LYS . 84.3 mt -60.22 -47.73 84.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.928 -1.108 . . . . 0.95 109.878 -179.638 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.81 -50.05 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.89 . . . . 0.66 109.198 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -70.0 -40.49 75.25 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.857 -0.737 . . . . 2.2 110.814 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 91' ' ' ALA . 10.2 t70 -84.17 -50.9 7.49 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.041 -1.037 . . . . 1.65 112.058 -178.147 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 92' ' ' LEU . 67.2 mmtt -90.19 -2.6 58.07 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.885 -1.135 . . . . 2.03 111.606 -177.491 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.7 m80 57.6 36.71 27.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.075 -1.016 . . . . 1.42 109.478 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 79.6 mtp -93.56 164.14 13.29 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.651 -0.655 . . . . 1.18 110.343 -179.361 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.6 p -77.9 161.82 27.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.608 -0.683 . . . . 0.98 109.177 179.777 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.89 81.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.102 -0.999 . . . . 0.64 109.783 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.489 ' OD2' HD21 ' A' ' 142' ' ' LEU . 96.9 m-20 -64.29 -39.97 95.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.144 -0.972 . . . . 2.07 109.399 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.29 -46.76 19.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.836 . . . . 0.73 109.756 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.55 -50.01 75.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.308 -0.87 . . . . 0.54 109.838 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.57 -37.45 81.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 0.56 109.417 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -60.05 -46.91 87.97 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.514 -0.741 . . . . 1.54 110.109 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -62.65 -40.08 95.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -0.879 . . . . 1.33 110.946 -179.041 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.4 -56.29 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.005 -1.059 . . . . 0.72 111.039 -178.055 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.5 mm -68.78 -39.97 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.918 -1.114 . . . . 0.85 108.967 -179.326 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -63.63 -40.04 95.89 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.245 -1.02 . . . . 2.44 108.245 178.668 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.77 -50.43 67.67 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.057 -1.217 . . . . 0.98 110.057 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -65.24 -49.49 69.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.956 -1.32 . . . . 1.41 109.262 -179.801 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.56 -42.67 92.93 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.094 -1.004 . . . . 1.2 108.731 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 88.6 p -60.11 -39.86 87.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.243 -0.91 . . . . 1.7 109.023 179.175 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.3 -39.92 80.62 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.056 -1.028 . . . . 1.47 108.629 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.9 mt -62.17 -39.97 94.43 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.138 -0.976 . . . . 1.56 109.047 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -53.85 -24.37 15.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.081 -1.012 . . . . 2.2 109.514 -179.124 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -59.91 -27.83 67.07 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.534 -1.284 . . . . 2.12 107.534 179.146 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.429 HD11 ' HA ' ' B' ' 352' ' ' THR . 57.6 mt -62.99 140.38 58.86 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.712 -0.618 . . . . 2.0 109.511 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -100.12 48.92 0.92 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.232 -0.917 . . . . 3.23 109.538 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 51.1 t0 -136.34 148.53 47.94 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.311 -0.868 . . . . 2.49 109.424 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 71.4 mm-40 -73.28 -65.02 0.86 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.247 -0.908 . . . . 3.95 108.597 178.636 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -40.7 -39.85 1.17 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.83 -0.544 . . . . 2.0 110.948 -179.154 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.647 ' HA ' HE22 ' B' ' 351' ' ' GLN . 83.6 mt -76.33 -40.27 51.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.619 -1.301 . . . . 1.86 110.0 -179.455 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -68.64 -39.98 80.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.047 -1.033 . . . . 2.84 109.463 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.604 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 47.8 mt-10 -59.9 -43.57 94.74 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.135 -0.978 . . . . 2.73 108.527 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.495 ' NH2' HD11 ' B' ' 347' ' ' LEU . 1.6 ttp180 -60.73 -40.02 90.81 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.364 -0.976 . . . . 2.77 108.364 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.04 -19.91 48.25 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.904 -1.147 . . . . 1.19 107.904 178.555 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -69.72 -40.04 76.5 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.585 -1.265 . . . . 1.2 107.585 178.502 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -65.02 -40.05 94.3 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.501 -0.749 . . . . 1.55 109.102 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.48 -40.09 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.306 -0.998 . . . . 0.8 108.306 178.997 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -62.33 -37.81 87.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.542 -0.723 . . . . 3.09 109.294 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -59.98 -40.56 89.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.374 -0.829 . . . . 1.46 110.034 -178.85 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.01 -47.81 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.129 -0.982 . . . . 0.71 109.45 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.16 -40.24 98.91 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.09 -1.204 . . . . 0.57 110.09 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -59.96 -48.0 83.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.378 -1.071 . . . . 2.59 109.774 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.657 HH22 ' CD1' ' A' ' 57' ' ' ILE . 57.4 mtp180 -65.77 -33.5 76.0 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.038 -1.039 . . . . 2.83 109.729 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.84 -43.15 94.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.41 -0.806 . . . . 1.25 109.374 -179.234 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.05 -40.06 88.12 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.19 -0.943 . . . . 0.7 109.238 179.472 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.401 HH11 ' HG2' ' A' ' 139' ' ' ARG . 55.2 mtt-85 -69.94 -39.9 75.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 2.57 109.477 179.554 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -67.62 -34.66 77.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.478 -0.763 . . . . 1.23 112.096 -178.576 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.06 -41.46 79.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.256 -1.527 . . . . 0.81 108.784 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.489 HD21 ' OD2' ' A' ' 101' ' ' ASP . 92.1 mt -73.45 -26.19 60.82 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.32 43.41 8.02 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.374 -1.89 . . . . 0.89 108.374 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 tp -74.35 150.03 40.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.532 -0.981 . . . . 1.14 109.029 -179.129 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -64.58 142.51 58.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.29 -0.881 . . . . 4.6 110.396 -178.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.7 mt -116.86 127.6 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-O 121.89 0.852 . . . . 1.24 108.771 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.8 mt -65.43 -43.87 94.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.918 -0.489 . . . . 1.54 111.468 -177.644 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.0 t0 64.53 112.78 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.222 -0.924 . . . . 1.5 109.031 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.482 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 86.6 mt -79.05 -3.28 44.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.319 -0.863 . . . . 0.79 110.029 -179.244 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.9 m -87.3 -15.3 38.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.275 -0.89 . . . . 1.4 109.808 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.31 14.47 2.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.281 -0.887 . . . . 0.92 111.334 -178.503 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.645 HD12 ' N ' ' A' ' 152' ' ' ILE . 1.5 mp -90.23 117.92 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.549 -1.344 . . . . 0.88 108.764 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -101.65 -11.87 18.85 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.303 -0.873 . . . . 2.45 110.196 -179.433 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -112.24 146.66 37.77 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.55 -0.719 . . . . 1.52 110.168 -179.212 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.06 132.2 47.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.484 -0.76 . . . . 1.58 109.435 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.9 m -152.81 165.05 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.457 -0.777 . . . . 0.69 109.369 179.334 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.4 mt -92.43 147.95 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 105.383 -2.081 . . . . 0.61 105.383 176.485 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -98.52 117.49 33.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.833 -1.167 . . . . 0.87 110.581 -177.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.2 t -121.61 129.43 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.662 -0.866 . . . . 0.71 108.662 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.91 164.77 33.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.104 -0.997 . . . . 0.81 108.928 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.457 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.12 -36.85 77.95 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.069 -1.644 . . . . 0.98 108.381 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 162' ' ' ASP . 33.9 p-10 -170.7 150.47 3.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.195 -0.941 . . . . 2.25 109.563 179.647 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.7 mt -118.91 136.38 54.09 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.561 -0.712 . . . . 0.78 109.629 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 22.9 p -92.94 148.37 35.71 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.262 -0.899 . . . . 0.98 109.146 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -39.97 -36.6 1.42 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.044 1.829 . . . . 0.81 112.599 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.7 m -60.0 -40.07 87.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 0.9 109.156 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.01 -43.09 88.68 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.286 -0.884 . . . . 1.61 109.635 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 22.8 p -55.8 -28.78 57.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.149 -0.969 . . . . 0.61 110.308 -178.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.68 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -74.56 -53.34 9.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.11 -0.994 . . . . 0.6 109.678 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -85.36 38.34 0.73 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.091 -1.077 . . . . 1.4 108.091 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.4 tp -100.87 129.1 46.69 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.788 -0.819 . . . . 0.7 108.788 179.26 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.482 ' ND2' ' O ' ' A' ' 149' ' ' LEU . 1.4 p30 -85.62 101.46 12.73 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.908 -1.145 . . . . 2.35 107.908 179.106 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 70.0 mt -64.67 -43.18 94.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.563 -0.71 . . . . 1.51 111.613 -178.043 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -71.23 -21.65 62.1 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.73 -1.231 . . . . 2.33 111.874 -177.714 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -93.22 -11.31 32.95 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.583 -1.323 . . . . 1.92 108.849 -179.35 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 178' ' ' GLY . 67.9 t -110.02 120.06 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.647 -0.871 . . . . 0.67 108.647 179.231 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.9 mt -89.01 6.35 40.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.266 -0.896 . . . . 1.53 110.98 -177.791 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.528 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.58 172.92 37.39 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.378 -1.391 . . . . 0.48 109.808 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -134.15 129.17 35.48 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.271 -1.135 . . . . 0.55 109.079 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.21 127.05 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.322 -0.861 . . . . 0.65 109.158 179.13 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 181' ' ' THR . . . . . 0.429 ' C ' ' HG1' ' A' ' 205' ' ' THR . 25.6 p -148.79 159.84 43.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.849 -1.157 . . . . 0.82 110.771 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 37.2 p-10 -104.07 27.06 8.02 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.595 -0.691 . . . . 2.46 109.333 179.49 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -56.03 -162.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.975 -1.078 . . . . 1.28 111.318 -178.464 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.2 -59.17 5.14 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.958 -0.857 . . . . 2.19 110.958 -178.786 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -178.64 -150.66 8.94 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 118.862 -1.637 . . . . 2.13 111.085 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -69.92 -20.62 63.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.604 -0.939 . . . . 5.86 110.54 -178.75 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 21.4 p -68.85 4.17 1.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.04 -1.038 . . . . 3.72 109.992 -179.136 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.7 p -88.48 142.51 27.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.151 -0.968 . . . . 1.74 110.638 -179.46 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -49.99 -47.1 53.08 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.549 -0.719 . . . . 0.95 109.782 -179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.4 m -56.32 -39.99 73.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.498 -0.751 . . . . 1.55 110.313 -178.7 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.4 t -60.8 -39.96 90.88 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.034 -1.041 . . . . 1.51 111.051 -179.631 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.02 -41.12 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.018 -1.051 . . . . 1.67 110.095 -178.681 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.0 mtp -65.16 -41.7 94.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.032 -1.043 . . . . 1.02 111.233 -179.214 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.6 92.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.108 -1.62 . . . . 0.68 110.188 -179.399 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.02 -49.3 78.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 2.93 110.586 -178.744 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.4 m -72.45 -33.73 67.25 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.237 -0.914 . . . . 0.86 111.817 -178.554 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.1 mt -84.08 -8.1 59.2 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.697 -1.252 . . . . 0.67 111.118 -178.211 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 59.2 49.22 9.41 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.271 -0.893 . . . . 1.5 110.841 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 80.6 mt -121.5 122.73 27.87 Favored Pre-proline 0 N--CA 1.501 2.099 0 N-CA-C 108.588 -0.893 . . . . 0.72 108.588 178.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.17 131.4 8.76 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.8 1.667 . . . . 0.61 112.004 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.459 ' N ' ' OG ' ' A' ' 8' ' ' SER . . . -167.89 146.95 4.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.738 -1.226 . . . . 0.66 111.501 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 90.0 mt -125.47 140.79 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 107.745 -1.205 . . . . 0.79 107.745 178.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.63 -8.85 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.031 -1.043 . . . . 0.91 110.99 -178.8 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.41 22.0 29.68 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.219 -1.152 . . . . 1.01 110.219 -179.596 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.429 ' HG1' ' C ' ' A' ' 181' ' ' THR . 6.3 p -45.74 -42.59 12.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.031 -1.276 . . . . 0.99 109.848 -179.248 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.56 -51.09 3.29 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 120.111 -1.042 . . . . 1.12 111.303 178.901 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.6 t -161.1 37.8 0.15 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.71 -1.465 . . . . 1.72 110.984 -179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.88 -39.95 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.124 -0.985 . . . . 0.89 108.473 177.84 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.436 HG23 ' H ' ' A' ' 209' ' ' THR . 2.9 p -54.18 -29.99 47.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.529 -0.732 . . . . 1.03 110.775 -179.237 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 52.3 m -80.06 -12.64 59.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.002 -1.061 . . . . 1.83 109.643 -179.293 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.505 HE22 HD11 ' A' ' 2' ' ' ILE . 94.8 mt-30 -104.99 -12.2 16.29 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.485 -0.76 . . . . 2.27 109.773 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 71.5 t -104.64 137.7 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.333 -0.855 . . . . 0.92 110.602 -178.824 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.45 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -113.16 153.25 28.58 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.564 -1.272 . . . . 2.2 107.564 179.01 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.499 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 41.4 p-10 -59.49 136.49 57.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.073 -1.017 . . . . 2.36 110.744 -178.623 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 10.4 t0 84.49 5.89 0.6 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.99 -0.444 . . . . 2.38 110.715 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.45 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 92.1 m-20 -75.13 145.44 42.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.79 -1.194 . . . . 2.09 109.065 178.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -92.37 117.92 30.4 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.928 -1.138 . . . . 1.27 107.928 178.609 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.525 HD12 ' HB2' ' A' ' 16' ' ' ALA . 83.4 mt -127.12 146.73 50.28 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.486 -0.758 . . . . 0.75 110.454 -178.893 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.6 mt -112.25 129.27 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.272 -1.751 . . . . 0.63 106.272 176.896 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 30.6 tp -98.8 115.68 29.33 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.892 -1.13 . . . . 0.7 109.506 -178.223 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' A' ' 223' ' ' VAL . 65.1 m-20 -70.95 -46.34 62.57 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.935 -1.135 . . . . 2.31 107.935 178.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.784 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 52.08 7.89 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.761 -0.829 . . . . 0.78 108.761 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.535 ' H ' ' C ' ' A' ' 221' ' ' ASP . 72.1 t -123.86 -42.78 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.192 -1.41 . . . . 1.04 107.192 179.11 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -102.58 0.03 32.78 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.658 -1.238 . . . . 2.44 107.658 178.267 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.509 HD22 ' N ' ' A' ' 4' ' ' GLY . 28.5 t-20 59.84 42.74 16.04 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.772 -0.58 . . . . 1.55 109.737 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -133.12 152.36 51.95 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.398 -0.814 . . . . 1.99 109.462 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.23 129.98 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.997 -0.742 . . . . 0.77 108.997 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -100.05 122.76 43.43 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.505 -0.924 . . . . 0.98 108.505 179.094 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.2 t -103.12 113.39 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.573 -0.704 . . . . 0.85 109.904 -179.368 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 66.1 t30 53.89 66.87 3.99 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.357 -0.839 . . . . 1.66 111.532 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -90.94 151.36 3.93 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.196 2.597 . . . . 0.95 112.405 178.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.412 ' OG1' HG23 ' A' ' 235' ' ' VAL . 37.9 p -70.01 162.21 28.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.15 -0.969 . . . . 1.84 110.305 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.55 -40.05 90.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.483 -0.761 . . . . 2.74 109.958 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -60.11 -37.86 81.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.426 -0.796 . . . . 2.89 109.874 -179.436 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.412 HG23 ' OG1' ' A' ' 232' ' ' THR . 54.3 t -65.86 -41.68 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 1.3 109.481 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.562 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 91.9 mt -62.36 -42.81 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.102 -0.999 . . . . 1.09 110.08 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -59.96 -44.78 94.22 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.864 -1.148 . . . . 2.43 108.493 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -60.31 -47.28 86.71 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.321 -0.862 . . . . 2.78 108.845 179.069 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 95.0 mtp -60.65 -40.07 90.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 1.25 109.174 179.243 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.562 ' NH1' ' CG2' ' A' ' 236' ' ' ILE . 0.4 OUTLIER -60.2 -36.24 77.23 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.395 -0.816 . . . . 2.63 109.437 179.38 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.91 -41.85 88.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 1.8 108.805 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 96.4 t -60.04 -40.03 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.332 -0.988 . . . . 2.13 108.332 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -59.93 -38.67 83.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.574 -0.704 . . . . 3.17 109.307 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.97 -39.24 85.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.163 -0.961 . . . . 1.78 108.871 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -59.98 -39.93 87.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 2.47 108.857 179.556 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 87.4 t -59.98 -40.03 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.422 -0.799 . . . . 2.09 109.141 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.99 -47.15 87.03 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.208 -0.932 . . . . 2.54 108.566 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -40.9 90.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 2.99 109.039 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.503 ' OE2' ' N ' ' A' ' 254' ' ' ALA . 27.0 tp10 -69.74 -39.95 76.48 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.639 -0.875 . . . . 3.34 108.639 179.341 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -63.05 -35.07 79.02 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.12 -0.696 . . . . 3.88 109.12 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -43.05 -68.5 0.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.573 -0.704 . . . . 4.43 110.296 -179.126 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -174.58 22.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.374 -0.829 . . . . 5.42 110.138 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 16.7 mt -85.57 -71.55 0.53 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.331 -1.481 . . . . 6.1 109.832 -179.612 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.503 ' N ' ' OE2' ' A' ' 249' ' ' GLU . . . 45.75 29.68 0.72 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.314 -0.866 . . . . 7.37 109.446 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -61.05 -42.33 98.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.407 -0.808 . . . . 8.01 111.301 -179.219 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 256' ' ' LEU . 9.9 mp -63.86 -40.13 95.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.766 -1.208 . . . . 9.05 109.696 -179.548 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 80.9 tttt 50.12 63.74 2.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.092 -1.005 . . . . 10.56 109.062 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -68.22 -18.27 64.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 11.32 109.705 -179.302 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.425 HH11 ' HG2' ' A' ' 259' ' ' ARG . 29.7 ttt-85 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.057 -1.027 . . . . 12.42 109.73 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 301' ' ' MET . . . . . 0.407 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 37.8 ttp . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.516 0.674 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 302' ' ' PHE . . . . . 0.407 ' N ' ' CG ' ' B' ' 301' ' ' MET . 28.7 t80 -153.27 150.26 28.77 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.045 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -150.91 161.52 42.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.013 -1.054 . . . . 0.0 110.28 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -157.38 154.22 28.54 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.259 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -114.37 130.89 56.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.216 -0.928 . . . . 0.0 110.162 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 4.0 p -129.99 124.09 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 CA-C-O 122.18 0.991 . . . . 0.0 111.362 -178.764 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 307' ' ' THR . . . . . 0.548 ' O ' HG23 ' B' ' 309' ' ' THR . 32.8 m -79.92 104.33 10.43 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.868 0.842 . . . . 0.0 110.71 -178.063 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' B' ' 358' ' ' GLY . 89.7 mt -50.72 116.38 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 122.313 1.054 . . . . 0.0 110.222 -177.558 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 309' ' ' THR . . . . . 0.548 HG23 ' O ' ' B' ' 307' ' ' THR . 70.0 p -107.28 13.04 27.56 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.746 -178.497 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.67 116.43 49.79 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.022 -1.049 . . . . 0.0 108.829 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -58.94 -12.01 13.96 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 CA-C-N 120.579 1.243 . . . . 0.0 112.617 -179.497 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -103.73 2.77 33.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.3 -0.875 . . . . 0.0 109.993 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 65.69 167.49 2.07 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -178.703 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 2.8 tp -88.72 96.28 10.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.784 -1.421 . . . . 0.0 110.227 -177.628 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -100.07 -159.59 0.75 Allowed 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.975 -1.078 . . . . 0.0 109.632 178.673 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 93.4 m -59.95 -42.39 93.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.687 -1.258 . . . . 0.0 112.482 -176.39 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.601 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.4 tpt180 -57.59 -61.41 7.31 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.536 -1.353 . . . . 0.0 111.367 -178.308 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.26 -33.18 94.88 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 120.305 1.145 . . . . 0.0 111.454 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.93 -50.15 74.89 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.203 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.23 -41.77 65.74 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -69.89 -43.04 72.59 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.704 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -60.32 -51.58 68.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.562 -0.711 . . . . 0.0 110.208 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.34 -28.87 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.864 -1.147 . . . . 0.0 109.962 -179.072 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -59.98 -45.09 93.83 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.171 -0.956 . . . . 0.0 108.894 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.66 -46.35 69.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.305 -0.872 . . . . 0.0 110.969 -178.968 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.21 -54.64 19.23 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.516 -1.365 . . . . 0.0 111.118 -179.06 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -50.63 -16.56 0.4 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.217 -0.927 . . . . 0.0 109.598 -179.285 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -75.65 -18.67 79.63 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -103.54 143.48 32.68 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.444 -1.033 . . . . 0.0 108.876 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 330' ' ' THR . . . . . 0.417 HG22 ' O ' ' B' ' 330' ' ' THR . 86.7 m -90.72 -11.09 40.71 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.041 -1.037 . . . . 0.0 110.779 -178.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.454 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 88.8 p -67.04 156.92 34.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.881 -1.137 . . . . 0.0 109.754 -179.639 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -71.93 133.57 45.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.212 -0.93 . . . . 0.0 109.168 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.2 mt -130.63 131.22 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 84.8 m -129.27 148.14 51.17 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.558 -0.713 . . . . 0.0 109.533 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 96.6 t -122.33 115.84 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.208 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 92.6 m -104.53 125.12 50.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.152 -0.968 . . . . 0.0 109.573 -178.44 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 15.1 p -134.4 117.25 16.11 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.861 0.838 . . . . 0.0 110.339 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 42.93 55.02 4.58 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 177.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.96 -15.19 22.7 Favored Glycine 0 N--CA 1.497 2.74 0 O-C-N 120.349 -1.469 . . . . 0.0 112.44 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -108.45 118.98 38.18 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 119.069 1.434 . . . . 0.0 109.377 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 65.2 m -116.27 143.43 45.54 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.896 0.855 . . . . 0.0 111.151 -178.445 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.06 159.36 42.38 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.539 0.685 . . . . 0.0 109.668 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 15.9 t -87.04 135.17 33.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.496 -0.752 . . . . 0.0 109.799 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.67 ' HA ' HD11 ' B' ' 350' ' ' LEU . . . -72.5 -16.62 61.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.998 -1.064 . . . . 0.0 109.121 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -85.4 20.96 1.87 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.136 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 346' ' ' SER . . . . . 0.464 ' H ' ' C ' ' B' ' 344' ' ' ALA . 2.5 m -149.46 95.86 2.41 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.87 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.813 HD23 HD22 ' A' ' 79' ' ' LEU . 59.3 tp -59.36 -35.06 73.19 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.828 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.833 ' CE2' HD11 ' A' ' 79' ' ' LEU . 51.2 m-85 -56.32 -53.19 60.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.333 -0.854 . . . . 0.0 110.321 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -69.98 -40.06 75.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.986 -1.071 . . . . 0.0 110.505 -178.254 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.67 HD11 ' HA ' ' B' ' 344' ' ' ALA . 87.7 mt -52.86 -59.89 3.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.496 -1.378 . . . . 0.0 108.546 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.647 HE22 ' HA ' ' A' ' 123' ' ' LEU . 27.4 tp60 -42.61 -11.89 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.674 -178.312 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.559 ' N ' ' O ' ' B' ' 350' ' ' LEU . 71.8 p -89.24 -9.96 48.77 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.577 -1.327 . . . . 0.0 109.607 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 54.1 mt -92.71 120.49 33.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.188 -0.945 . . . . 0.0 108.874 178.703 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.8 92.34 0.81 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 179.405 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.73 90.59 4.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.263 -1.14 . . . . 0.0 109.663 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 356' ' ' THR . . . . . 0.45 ' O ' ' C ' ' B' ' 357' ' ' GLN . 82.1 p -97.86 139.32 33.89 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.084 -1.01 . . . . 0.0 109.774 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 357' ' ' GLN . . . . . 0.45 ' C ' ' O ' ' B' ' 356' ' ' THR . 16.4 tm0? -34.68 118.46 0.41 Allowed 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.393 0.616 . . . . 0.0 110.976 -178.838 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 358' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 103.15 5.08 47.15 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 21.6 m -87.25 109.45 19.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.318 -1.107 . . . . 0.0 110.426 -179.784 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 20.8 t -77.12 114.04 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 122.169 0.985 . . . . 0.0 109.46 -177.461 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.25 176.59 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.444 -0.946 . . . . 0.0 108.444 -178.152 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 24.9 m -130.41 126.27 36.6 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.958 -1.126 . . . . 0.0 107.958 177.513 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 84.4 mt -102.06 113.89 39.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.667 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 84.5 p -119.88 132.79 55.66 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.604 -0.685 . . . . 0.0 109.339 -178.822 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.12 150.51 38.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 109.428 -179.43 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -144.9 125.04 13.64 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.529 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.55 -160.92 30.98 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.679 -179.807 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -59.98 -50.01 75.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 122.051 -0.676 . . . . 0.0 112.16 -177.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.454 ' H ' ' HB3' ' B' ' 331' ' ' SER . 92.3 m-20 -104.94 9.89 34.44 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.733 -1.229 . . . . 0.0 111.216 -177.243 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.1 pt-20 -42.49 -33.52 0.69 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.211 -0.931 . . . . 0.0 111.56 -178.901 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -70.01 -40.19 75.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.689 -1.257 . . . . 0.0 109.92 -178.612 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -66.84 -48.68 68.11 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.074 -1.051 . . . . 0.0 109.321 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.39 -78.16 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.392 -0.818 . . . . 0.0 110.901 -179.1 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.52 ' O ' HG23 ' B' ' 378' ' ' VAL . 37.6 t -47.28 -37.89 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.057 -1.027 . . . . 0.0 110.336 -177.384 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -69.82 -41.46 74.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.812 -1.18 . . . . 0.0 109.819 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -80.16 -46.74 15.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.137 -0.977 . . . . 0.0 110.315 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.15 -33.52 73.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 110.164 -179.026 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.52 HG23 ' O ' ' B' ' 374' ' ' VAL . 71.3 t -75.61 -34.18 28.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.493 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -72.85 -23.24 60.73 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 108.582 178.381 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' B' ' 383' ' ' GLU . 51.7 tp -79.95 -67.06 0.8 Allowed 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.113 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 50.8 tpp -50.16 -28.24 7.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.496 -0.752 . . . . 0.0 109.068 -178.776 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -76.14 -22.43 55.46 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.403 178.56 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' B' ' 380' ' ' LEU . 78.5 mm-40 -106.94 4.63 27.43 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.324 -0.86 . . . . 0.0 111.872 -178.501 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 89.7 mt -78.2 121.64 24.62 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.16 -1.587 . . . . 0.0 108.98 179.288 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.44 179.688 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.0 mmm . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.588 -0.523 . . . . 2.91 109.588 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.1 mt -105.62 125.75 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.777 -0.823 . . . . 1.2 108.777 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.2 m -129.66 138.05 50.98 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.52 -0.738 . . . . 1.4 109.13 -179.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.92 -160.17 19.55 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 109.139 -1.585 . . . . 1.05 109.139 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.7 mt -94.63 -10.87 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.116 -1.226 . . . . 1.15 110.251 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.2 tp 54.18 101.48 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.116 -0.99 . . . . 0.98 108.818 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.54 -28.48 18.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.214 -0.929 . . . . 0.88 109.775 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.6 t -143.14 131.09 11.11 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.289 -0.882 . . . . 1.69 109.646 -179.794 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.32 142.68 15.12 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.302 2.001 . . . . 0.85 113.147 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.881 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 161.93 -161.7 33.55 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.291 -1.524 . . . . 0.92 109.291 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.7 mt -149.5 150.02 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 121.198 -1.178 . . . . 0.81 108.435 179.203 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.49 157.99 37.8 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.746 -1.221 . . . . 0.51 110.436 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 9.8 m-85 -139.02 128.11 23.87 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.393 -0.965 . . . . 0.62 108.393 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.04 -178.8 46.66 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 118.585 -1.769 . . . . 0.55 111.188 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -79.99 157.93 26.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.731 -0.864 . . . . 2.1 109.619 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.496 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.02 135.36 45.67 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.456 -0.777 . . . . 0.77 111.078 -179.127 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.0 tp -102.1 134.83 44.72 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 107.743 -1.206 . . . . 0.91 107.743 178.409 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.4 tp -115.2 121.37 42.74 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.314 -0.866 . . . . 0.93 110.362 -179.107 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.4 mt -89.3 102.11 14.77 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.846 -0.534 . . . . 0.93 110.182 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -101.3 136.04 41.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.347 -0.846 . . . . 2.75 109.463 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -130.28 132.72 46.04 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.442 -0.786 . . . . 3.0 109.232 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -74.64 150.08 39.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.099 -1.0 . . . . 2.77 109.248 179.399 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -63.74 145.67 55.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.146 -0.971 . . . . 2.94 109.193 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.609 HD11 HH11 ' A' ' 139' ' ' ARG . 58.9 mt -84.4 125.84 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.107 -0.996 . . . . 0.95 109.4 -179.532 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.3 t -93.22 122.6 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.232 -0.918 . . . . 1.28 109.766 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.5 mt -103.73 139.42 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.831 -0.803 . . . . 1.21 108.831 179.609 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -96.89 114.95 26.61 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.134 -0.979 . . . . 1.81 109.354 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.509 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.4 mmt-85 -90.08 0.13 57.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.249 -0.907 . . . . 2.8 109.695 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -66.28 147.43 53.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.199 -0.938 . . . . 2.87 109.205 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -87.69 147.21 25.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.039 -1.038 . . . . 2.35 109.556 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.4 HG21 ' HG3' ' A' ' 39' ' ' GLU . 5.1 pt -93.89 165.28 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 0.97 109.788 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.6 p -96.22 171.25 8.71 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.048 -1.032 . . . . 1.17 108.922 179.163 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.5 -16.58 64.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.113 -0.992 . . . . 1.18 110.603 -179.595 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.67 -26.1 26.17 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.676 -1.231 . . . . 2.56 107.676 178.296 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -82.45 -9.7 59.33 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.875 -0.787 . . . . 1.79 108.875 179.237 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.6 t -63.73 -53.8 40.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 120.862 -1.149 . . . . 1.0 108.961 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.44 -40.15 93.42 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.246 -0.909 . . . . 1.77 110.102 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 86.6 mm-40 -70.03 -43.01 72.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.038 -1.039 . . . . 2.7 110.347 -179.263 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.4 ' HG3' HG21 ' A' ' 31' ' ' ILE . 65.4 mm-40 -63.55 -39.86 95.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.078 -1.014 . . . . 1.51 110.288 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.36 -46.01 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.833 -1.167 . . . . 0.93 108.816 179.304 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -60.0 -39.8 87.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.143 -0.973 . . . . 1.81 108.69 -179.723 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -60.0 -41.62 92.49 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.724 -1.213 . . . . 2.78 107.724 178.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -63.45 -49.35 74.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.362 -0.836 . . . . 0.78 109.032 178.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.94 -48.67 80.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.382 -0.823 . . . . 1.07 109.038 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.5 t -63.64 -44.21 94.54 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.01 -1.056 . . . . 1.12 108.741 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.94 -48.58 85.36 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.851 -1.699 . . . . 0.84 108.851 179.315 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -65.34 -32.52 74.21 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.327 -1.102 . . . . 3.09 108.451 179.158 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.36 -39.92 84.82 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.803 -0.814 . . . . 0.88 108.803 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 51' ' ' SER . 33.6 ttpt -65.36 -74.38 0.11 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.962 -1.125 . . . . 2.59 107.962 179.189 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.45 -30.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.51 -0.744 . . . . 0.7 111.26 -178.423 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 49' ' ' LYS . 44.0 t -59.98 -54.39 46.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.706 -1.246 . . . . 1.4 108.397 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.62 -40.09 84.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.835 . . . . 0.67 111.054 -179.139 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -61.9 -46.56 88.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.68 -1.263 . . . . 1.66 110.128 -179.316 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.11 -40.03 88.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.14 -0.975 . . . . 1.58 109.018 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -60.31 -40.04 89.13 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.38 -0.825 . . . . 1.35 109.174 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.4 m -64.45 -44.24 91.74 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.243 -0.91 . . . . 0.77 108.64 178.783 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.5 mt -61.31 -39.88 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.848 -0.797 . . . . 0.63 108.848 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -59.69 -50.34 74.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.955 . . . . 1.14 109.17 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.9 m -59.95 -36.53 77.27 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.396 -0.815 . . . . 0.79 110.025 -178.136 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -66.17 -38.48 88.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.976 -1.077 . . . . 1.53 109.161 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.71 -45.02 88.34 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.585 -0.697 . . . . 0.57 109.948 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.9 -51.57 58.17 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 120.025 -1.083 . . . . 0.75 110.435 -179.15 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.95 -45.67 66.92 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.096 -1.238 . . . . 1.59 109.809 -179.397 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.6 m -67.17 -61.26 2.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.73 111.709 -178.36 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.01 -52.7 3.76 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.135 -0.978 . . . . 0.75 111.473 -177.872 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.11 -165.18 26.7 Favored Glycine 0 N--CA 1.501 3.033 0 C-N-CA 119.615 -1.278 . . . . 1.22 111.152 179.638 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -70.05 -25.16 63.41 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.804 -0.821 . . . . 5.81 110.696 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -60.75 -37.35 81.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.998 . . . . 3.37 110.224 -179.596 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.566 ' HA ' HD12 ' A' ' 72' ' ' ILE . 42.6 mmtm -99.59 -18.03 17.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.45 -0.781 . . . . 1.77 110.296 -179.444 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -70.01 -45.37 67.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.973 -1.079 . . . . 1.65 110.457 -179.298 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.5 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -66.14 -27.29 67.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.394 -0.816 . . . . 0.77 109.931 -178.571 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' A' ' 69' ' ' LYS . 81.7 mt -60.07 -41.49 86.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.038 -1.039 . . . . 0.8 109.14 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -69.1 -37.16 78.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.035 -1.041 . . . . 0.88 109.959 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -60.0 -40.28 88.66 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.799 -1.188 . . . . 1.37 108.867 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.84 -49.52 75.1 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.36 -1.896 . . . . 0.62 108.36 178.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -60.12 -46.63 88.99 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.374 -1.074 . . . . 1.5 108.462 179.418 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.96 -50.02 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -0.797 . . . . 0.63 109.193 179.148 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.8 ttp -60.53 -39.97 89.77 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.156 -0.965 . . . . 1.51 109.811 -179.294 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.091 HD22 HD23 ' B' ' 347' ' ' LEU . 53.3 tp -66.9 -39.93 87.57 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.632 -0.668 . . . . 0.77 110.118 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.92 -39.78 94.95 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.637 -0.825 . . . . 0.62 109.68 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -82.54 7.64 13.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.087 -1.008 . . . . 1.47 109.598 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 63.5 t0 -49.87 134.72 20.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.179 -0.951 . . . . 1.47 110.279 -178.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.479 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 95.2 mt-10 -58.84 -26.7 64.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.784 -0.572 . . . . 1.78 111.637 -178.266 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.09 -31.0 62.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.899 -1.125 . . . . 2.53 110.096 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 79' ' ' LEU . 86.4 mt -70.01 -42.53 72.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.337 -0.852 . . . . 0.8 110.095 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.08 -48.17 82.85 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.502 -0.749 . . . . 1.42 110.621 -178.365 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -69.93 -42.92 72.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.958 . . . . 1.71 111.285 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.39 -40.01 74.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.11 -0.994 . . . . 1.57 111.624 -178.66 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.37 -45.89 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.897 -1.127 . . . . 0.65 109.786 -179.164 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.6 mt -69.93 -38.29 75.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.433 -0.792 . . . . 0.82 110.294 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.43 -40.87 98.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.083 -1.011 . . . . 0.79 111.049 -179.076 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.3 mt -61.24 -45.56 94.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.828 -1.17 . . . . 0.95 109.348 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.9 mt -61.92 -48.18 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 122.048 0.928 . . . . 0.66 109.206 179.262 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -70.02 -40.03 75.47 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.608 -0.682 . . . . 2.2 110.298 -179.23 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.73 -53.67 5.73 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.164 -0.96 . . . . 1.65 111.91 -178.568 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -89.97 -0.83 57.79 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.011 -1.056 . . . . 2.03 112.035 -177.274 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 70.7 m80 57.24 36.56 27.53 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.035 -1.041 . . . . 1.42 110.179 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 99.6 mtp -92.07 166.99 12.39 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.519 -0.738 . . . . 1.18 109.375 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 35.0 p -80.75 162.81 23.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.98 109.747 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.45 -39.87 81.3 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.357 -0.84 . . . . 0.64 109.744 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -64.36 -39.05 93.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 2.07 109.55 179.319 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.91 -41.21 23.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.407 -0.808 . . . . 0.73 110.322 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.46 -48.0 65.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 0.54 110.19 -179.192 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.94 -45.75 91.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.997 -1.064 . . . . 0.56 109.447 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.488 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 84.9 t60 -60.01 -40.0 87.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.406 -0.809 . . . . 1.54 109.731 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.0 -41.97 93.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.264 -0.897 . . . . 1.33 110.048 -179.443 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.7 t -68.88 -51.31 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.068 -1.02 . . . . 0.72 110.422 -178.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.39 -40.92 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.035 -1.041 . . . . 0.85 108.512 179.609 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.488 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 86.3 tt0 -65.29 -40.0 93.28 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.443 -0.947 . . . . 2.44 108.443 178.731 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.13 -50.16 70.66 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.159 -1.176 . . . . 0.98 110.159 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -65.34 -51.15 62.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.931 -1.335 . . . . 1.41 109.421 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.49 -40.86 75.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.166 -0.959 . . . . 1.2 109.206 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.7 m -59.97 -40.04 87.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.089 -1.007 . . . . 1.7 108.443 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.97 -39.95 90.85 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.641 -0.874 . . . . 1.47 108.641 178.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.472 HD22 ' HB3' ' B' ' 351' ' ' GLN . 87.1 mt -65.71 -42.65 90.88 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.091 -1.005 . . . . 1.56 109.474 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -59.88 -39.05 84.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.916 -1.115 . . . . 2.2 109.848 -178.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -49.98 -19.99 0.83 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.005 -1.059 . . . . 2.12 109.555 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 29.2 mt -62.72 140.02 58.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.012 -1.055 . . . . 2.0 109.043 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -93.16 40.41 1.06 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.176 -0.953 . . . . 3.23 110.289 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -126.13 134.2 51.39 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.266 -0.896 . . . . 2.49 109.518 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.53 -30.42 68.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.451 -0.78 . . . . 3.95 109.919 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.497 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.0 t80 -69.99 -39.02 76.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.347 -0.845 . . . . 2.0 110.32 179.327 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.442 HD22 ' O ' ' B' ' 351' ' ' GLN . 84.5 mt -80.76 -31.94 35.7 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.06 -1.025 . . . . 1.86 109.248 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -60.94 -40.76 94.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 2.84 109.003 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 64.7 mm-40 -64.22 -40.0 95.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 2.73 109.015 178.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.48 ' NH1' ' CD ' ' B' ' 351' ' ' GLN . 0.1 OUTLIER -59.97 -39.99 87.56 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.295 -1.002 . . . . 2.77 108.295 179.436 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.3 -26.13 66.28 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.595 -0.891 . . . . 1.19 108.595 178.962 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -67.68 -39.94 84.45 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.947 -0.76 . . . . 1.2 108.947 179.435 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.86 -39.99 79.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 1.55 109.681 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.7 -44.38 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.8 108.563 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -60.49 -37.38 80.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 3.09 108.918 178.825 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -59.82 -39.66 85.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.493 -0.755 . . . . 1.46 109.664 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.96 -40.4 82.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.04 -1.037 . . . . 0.71 108.873 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.08 -35.99 64.31 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.048 -1.221 . . . . 0.57 110.048 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -60.05 -49.9 75.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.115 -1.226 . . . . 2.59 109.931 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.402 ' HG2' HH21 ' A' ' 139' ' ' ARG . 87.6 mtm180 -67.66 -33.34 74.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.021 -1.049 . . . . 2.83 109.501 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.04 -43.25 95.49 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.249 -0.907 . . . . 1.25 109.074 -179.567 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.04 -42.52 94.58 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.192 -0.943 . . . . 0.7 109.985 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.609 HH11 HD11 ' A' ' 24' ' ' ILE . 63.1 mtm-85 -71.39 -39.29 71.26 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.394 -0.816 . . . . 2.57 109.352 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -65.57 -34.37 78.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.726 . . . . 1.23 111.259 -179.197 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.3 mt -70.01 -45.35 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.416 -1.427 . . . . 0.81 108.037 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.7 mt -69.89 -30.79 68.31 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 120.137 -0.625 . . . . 1.0 109.454 179.135 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.89 41.73 8.02 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.034 -1.626 . . . . 0.89 109.034 -179.172 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 tp -74.88 157.23 35.41 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.468 -1.019 . . . . 1.14 109.411 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.21 146.62 53.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.886 . . . . 4.6 110.062 -179.449 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.7 mt -119.9 127.78 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 108.826 -0.805 . . . . 1.24 108.826 179.351 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 27.6 mm -55.4 -49.68 71.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.36 -0.837 . . . . 1.54 110.212 -178.251 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.4 t0 66.24 103.92 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.528 -0.732 . . . . 1.5 109.338 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.8 mt -79.61 -5.77 55.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.42 -0.8 . . . . 0.79 110.179 -178.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.3 t -81.67 -20.52 39.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.942 -1.099 . . . . 1.4 109.634 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.04 21.53 0.7 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.297 -0.877 . . . . 0.92 111.66 -178.285 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 39.5 mm -89.12 129.49 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.565 -1.334 . . . . 0.88 108.965 179.517 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -110.53 -11.31 14.48 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.586 -0.696 . . . . 2.45 110.059 -179.234 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -118.3 148.11 42.79 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.177 -0.952 . . . . 1.52 110.457 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.24 133.95 52.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 1.58 109.214 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.9 m -153.33 166.33 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.42 -0.8 . . . . 0.69 109.439 179.081 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.3 mt -94.06 147.42 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.545 -1.65 . . . . 0.61 106.545 177.608 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 49.7 tp -94.27 113.58 25.51 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.011 -1.055 . . . . 0.87 110.101 -177.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.42 HG12 HG22 ' A' ' 209' ' ' THR . 46.7 t -118.68 125.22 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 108.663 -0.866 . . . . 0.71 108.663 179.478 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.442 ' CB ' HD21 ' A' ' 163' ' ' LEU . . . -155.68 160.65 40.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.991 -1.068 . . . . 0.81 109.465 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.45 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -78.82 -29.08 44.57 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.487 -1.383 . . . . 0.98 109.02 179.199 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 161' ' ' ALA . 14.5 m-20 -167.36 133.41 2.14 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.31 -0.869 . . . . 2.25 109.169 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.442 HD21 ' CB ' ' A' ' 160' ' ' ALA . 57.7 mt -118.15 130.04 55.87 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 108.781 -0.822 . . . . 0.78 108.781 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 20.8 p -93.84 149.99 37.9 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.079 -1.013 . . . . 0.98 109.737 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -39.38 -36.58 0.98 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.64 2.227 . . . . 0.81 113.636 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.6 m -59.98 -40.05 87.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.894 -1.129 . . . . 0.9 110.028 -178.194 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.61 -39.82 80.69 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.256 -0.902 . . . . 1.61 110.249 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.7 p -57.39 -38.08 73.71 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.059 -1.025 . . . . 0.61 112.036 -177.852 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.97 -47.8 70.46 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.521 -1.362 . . . . 0.6 110.027 -179.239 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -85.68 33.83 0.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.327 -0.99 . . . . 1.4 108.327 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.3 tp -102.78 137.5 40.9 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.788 -0.819 . . . . 0.7 108.788 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 -86.96 104.72 16.55 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.476 -0.935 . . . . 2.35 108.476 179.575 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.55 -40.11 92.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.895 . . . . 1.51 111.598 -178.186 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -69.87 -25.5 63.75 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.746 -1.221 . . . . 2.33 111.744 -177.553 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -93.73 -10.04 35.66 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.706 -1.246 . . . . 1.92 110.242 -178.719 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 178' ' ' GLY . 95.0 t -100.94 113.22 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.029 -1.044 . . . . 0.67 108.339 178.633 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.4 mt -80.76 2.1 27.6 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.238 -0.913 . . . . 1.53 110.853 -177.781 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.507 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 166.25 177.99 38.67 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.3 -1.52 . . . . 0.48 109.3 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.586 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 7.4 m-85 -132.31 128.23 37.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.484 -1.009 . . . . 0.55 109.489 -179.387 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 93.8 mt -130.74 124.21 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.507 -0.746 . . . . 0.65 109.03 179.096 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 52.8 p -150.88 161.92 41.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.813 -1.18 . . . . 0.82 110.721 -179.794 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 37.1 p-10 -103.56 25.17 10.02 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.564 -0.71 . . . . 2.46 109.456 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.43 -158.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.863 -1.148 . . . . 1.28 111.703 -178.259 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.14 -54.4 5.24 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.84 -0.695 . . . . 2.19 111.44 -178.412 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 165.23 -139.17 5.65 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 118.968 -1.587 . . . . 2.13 111.07 -179.608 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 186' ' ' ARG . 0.4 OUTLIER -69.93 -22.88 63.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.608 -0.937 . . . . 5.86 111.175 -178.761 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 66.7 p -70.27 1.25 5.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.848 -1.157 . . . . 3.72 109.546 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.0 t -90.89 133.83 34.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.267 -0.896 . . . . 1.74 110.482 -179.634 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -47.48 -53.22 14.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.497 -0.752 . . . . 0.95 110.21 -179.771 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.7 m -60.11 -40.44 89.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.341 -0.849 . . . . 1.55 111.473 -178.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 17.3 t -60.0 -40.73 90.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.829 -1.169 . . . . 1.51 110.12 -179.026 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 85.7 mt -61.39 -37.93 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.874 . . . . 1.67 109.728 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.3 mtp -60.07 -39.96 87.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.842 . . . . 1.02 109.692 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.07 88.69 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.713 -1.242 . . . . 0.68 108.633 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -60.06 -51.06 71.24 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.714 -0.794 . . . . 2.93 110.319 -179.234 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.9 m -74.88 -34.25 62.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.083 -1.011 . . . . 0.86 112.022 -178.374 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.1 mt -73.55 -11.5 60.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.632 -1.293 . . . . 0.67 109.829 -178.477 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 60.1 50.08 6.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.573 -0.704 . . . . 1.5 110.975 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.2 mt -128.77 149.92 73.48 Favored Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 107.602 -1.258 . . . . 0.72 107.602 178.504 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.81 140.75 47.22 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 122.16 1.907 . . . . 0.61 112.158 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.04 151.52 3.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.965 -1.084 . . . . 0.66 111.418 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.7 mt -123.45 138.15 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.521 -1.288 . . . . 0.79 107.521 178.731 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 17.3 m -121.83 -11.86 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 O-C-N 120.738 -1.226 . . . . 0.91 111.478 -178.195 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -105.97 23.88 28.08 Favored Glycine 0 N--CA 1.5 2.934 0 N-CA-C 110.309 -1.117 . . . . 1.01 110.309 -179.456 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.7 p -44.29 -41.15 5.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.202 -1.175 . . . . 0.99 109.928 -179.439 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.41 -50.48 4.23 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 120.211 -0.995 . . . . 1.12 110.982 179.17 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 30.5 t -159.12 38.05 0.21 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.611 -1.523 . . . . 1.72 111.402 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.82 -35.54 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.934 -1.104 . . . . 0.89 108.673 178.133 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.42 HG22 HG12 ' A' ' 159' ' ' VAL . 76.7 p -54.73 -30.1 55.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.844 . . . . 1.03 110.148 -179.479 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.0 p -81.92 -12.62 58.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.112 -0.992 . . . . 1.83 110.228 -179.459 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 30.2 mm100 -101.71 -10.24 20.15 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.339 -0.851 . . . . 2.27 109.674 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 92.5 t -107.37 134.82 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.303 -0.873 . . . . 0.92 111.47 -178.013 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -113.44 155.22 25.68 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.746 -1.576 . . . . 2.2 106.746 177.223 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 57.4 t30 -59.98 138.3 57.88 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.935 -1.103 . . . . 2.36 110.572 -178.829 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 16.3 t0 85.9 0.06 0.69 Allowed 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 116.342 -0.39 . . . . 2.38 110.836 179.054 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -71.8 148.28 46.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.77 -1.206 . . . . 2.09 108.94 179.01 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -95.3 119.01 33.06 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.083 -1.08 . . . . 1.27 108.083 179.125 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 16' ' ' ALA . 83.0 mt -125.59 145.14 50.26 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.411 -0.806 . . . . 0.75 110.456 -179.05 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.1 mt -113.88 128.4 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.463 -1.31 . . . . 0.63 107.463 177.502 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 20.6 tp -100.36 117.56 34.79 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.004 -1.06 . . . . 0.7 108.786 -179.415 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 10' ' ' GLY . 32.3 t0 -77.13 -44.3 30.88 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.151 -1.055 . . . . 2.31 108.151 179.638 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.881 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 54.03 13.71 0.61 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.256 -0.646 . . . . 0.78 109.256 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 87.8 t -130.5 -42.94 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.146 -1.427 . . . . 1.04 107.146 177.95 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.45 ' ND2' ' OE1' ' A' ' 226' ' ' GLN . 47.9 t-20 -96.69 0.04 49.06 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.226 -1.398 . . . . 2.44 107.226 178.154 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 60.07 44.64 12.88 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.849 -0.532 . . . . 1.55 109.585 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.45 ' OE1' ' ND2' ' A' ' 224' ' ' ASN . 97.8 mt-30 -139.96 151.77 45.8 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.192 -0.943 . . . . 1.99 110.454 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.1 t -118.78 129.96 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.507 -0.923 . . . . 0.77 108.507 178.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -102.95 127.34 50.21 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.758 -0.831 . . . . 0.98 108.758 179.293 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.0 t -100.19 109.95 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.362 -0.836 . . . . 0.85 110.947 -178.495 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 41.2 t30 50.11 64.43 8.41 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.145 -0.972 . . . . 1.66 110.895 179.443 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -85.84 156.16 10.17 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.795 2.33 . . . . 0.95 111.986 179.166 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 82.4 p -70.44 160.42 32.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 1.84 110.078 -179.504 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -59.9 -34.69 73.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.435 -0.791 . . . . 2.74 108.873 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -59.93 -40.09 87.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.476 -0.765 . . . . 2.89 109.344 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.72 -40.02 83.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.194 -0.941 . . . . 1.3 109.276 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.34 -40.47 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.24 -0.913 . . . . 1.09 110.31 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -60.22 -40.04 88.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.001 -1.062 . . . . 2.43 109.325 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -68.76 -40.91 79.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.491 -0.755 . . . . 2.78 109.485 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 93.1 mtp -70.06 -33.42 71.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.574 -0.704 . . . . 1.25 110.159 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -65.19 -40.03 93.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.002 . . . . 2.63 110.433 -179.561 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -63.49 -40.62 97.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.888 -1.132 . . . . 1.8 108.935 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.92 -40.05 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.457 -0.777 . . . . 2.13 109.143 179.449 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 20.7 tm0? -57.19 -42.43 81.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 3.17 109.738 -179.076 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.39 -39.99 95.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.034 -1.042 . . . . 1.78 109.214 179.402 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -64.61 -40.12 94.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.155 -0.965 . . . . 2.47 109.285 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.83 -40.0 85.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.406 -0.808 . . . . 2.09 109.343 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.17 -40.16 70.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.272 -0.892 . . . . 2.54 109.057 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 66.1 p -61.06 -36.93 80.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 2.99 109.314 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.75 -18.1 63.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.378 -0.826 . . . . 3.34 110.666 -179.244 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -75.62 13.59 0.77 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.987 . . . . 3.88 109.486 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -72.62 -60.3 2.3 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.15 -1.056 . . . . 4.43 108.15 178.791 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 179.84 -61.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.978 -1.119 . . . . 5.42 107.978 179.146 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 32.3 mt 65.26 64.11 0.63 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.864 -1.161 . . . . 6.1 107.864 -178.003 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -133.11 9.64 4.12 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.239 -0.652 . . . . 7.37 109.239 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.464 ' NZ ' ' CB ' ' A' ' 255' ' ' LYS . 5.6 ttpm? -78.41 145.59 35.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 8.01 110.165 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 10.9 mp -82.88 27.95 0.52 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.454 -0.779 . . . . 9.05 109.121 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -154.19 67.81 0.73 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.821 -0.807 . . . . 10.56 108.821 179.326 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -158.9 -32.92 0.07 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.368 -0.832 . . . . 11.32 109.71 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 9.0 tpm_? . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.052 -0.975 . . . . 12.42 109.109 -179.751 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 41.5 ttm . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.596 0.713 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -150.27 147.09 27.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.338 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -150.83 161.77 42.04 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.921 -1.112 . . . . 0.0 110.546 -179.203 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 304' ' ' GLN . . . . . 0.477 ' NE2' HG11 ' B' ' 378' ' ' VAL . 56.8 tt0 -153.37 150.01 28.41 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.309 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 305' ' ' GLU . . . . . 0.567 ' CD ' ' H ' ' B' ' 305' ' ' GLU . 0.6 OUTLIER -115.81 135.47 53.98 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.244 -0.91 . . . . 0.0 109.971 179.278 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -138.64 129.84 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 CA-C-O 122.523 1.154 . . . . 0.0 113.052 -177.184 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 90.9 m -76.69 106.36 8.3 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.467 -178.602 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.463 HG22 ' H ' ' B' ' 310' ' ' ALA . 92.3 mt -52.45 126.07 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 122.412 1.101 . . . . 0.0 110.82 -177.749 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 22.3 p -109.99 20.07 18.34 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.372 -178.899 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.463 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -79.4 117.02 64.82 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.851 -1.156 . . . . 0.0 109.109 179.673 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.28 -11.68 6.53 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 CA-C-N 120.233 1.119 . . . . 0.0 113.212 -179.095 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -119.45 6.66 11.11 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 179.708 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.47 -179.4 40.24 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 107.961 -2.055 . . . . 0.0 107.961 -178.731 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.497 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -85.42 92.24 8.43 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.868 -1.372 . . . . 0.0 108.454 -179.525 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.461 ' C ' ' NH2' ' A' ' 126' ' ' ARG . 5.2 p80 -94.29 -160.91 0.81 Allowed 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.179 -0.951 . . . . 0.0 110.642 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.9 m -57.35 -43.92 83.88 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.204 -0.935 . . . . 0.0 112.651 -175.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.5 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -60.75 -61.74 7.37 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 120.443 -1.411 . . . . 0.0 112.139 -178.508 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -57.33 -31.55 91.31 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 CA-C-N 120.219 1.114 . . . . 0.0 111.781 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.07 -51.51 69.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 109.069 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.7 -41.12 63.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.17 -178.665 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -72.71 -40.1 66.44 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.882 179.065 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -60.81 -52.46 64.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -0.813 . . . . 0.0 110.869 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.28 -38.07 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.685 -1.259 . . . . 0.0 109.334 -178.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.419 ' CB ' ' NZ ' ' B' ' 324' ' ' LYS . 4.1 ttpm? -59.98 -46.17 90.31 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.751 -179.133 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -63.33 -40.06 96.26 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.925 -1.11 . . . . 0.0 108.789 179.127 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -61.08 -51.31 69.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.422 -0.798 . . . . 0.0 110.312 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -56.92 -11.95 1.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.373 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -73.25 -27.48 68.06 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.239 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -105.4 143.19 33.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 27.4 p -91.16 -12.59 34.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.902 -1.124 . . . . 0.0 110.16 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.426 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 67.8 p -60.13 147.64 38.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.075 -1.015 . . . . 0.0 109.418 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -67.11 136.38 55.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.108 -0.995 . . . . 0.0 108.581 179.629 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 90.0 mt -131.41 130.15 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.653 -0.654 . . . . 0.0 109.803 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 54.1 m -124.23 148.76 47.09 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.109 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 92.3 t -115.87 136.91 51.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.2 m -128.85 122.62 30.8 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.148 -0.97 . . . . 0.0 109.038 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 91.8 p -138.18 116.71 12.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.306 -0.871 . . . . 0.0 110.386 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 33.2 m120 45.7 62.69 2.09 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.462 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 75.16 -11.96 7.59 Favored Glycine 0 N--CA 1.498 2.77 0 O-C-N 120.399 -1.438 . . . . 0.0 112.924 176.467 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -115.81 127.53 55.14 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 118.951 1.375 . . . . 0.0 109.818 -179.604 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 21.2 m -126.12 148.61 49.35 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.872 0.844 . . . . 0.0 110.399 -179.016 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -142.43 164.15 30.9 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.405 0.622 . . . . 0.0 109.929 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 58.6 m -86.96 136.59 32.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.606 -0.684 . . . . 0.0 109.934 -179.388 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -73.77 -13.49 60.96 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.04 -1.037 . . . . 0.0 109.693 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -90.82 21.68 3.99 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.399 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 68.0 m -144.84 93.36 2.39 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.944 -179.071 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 1.091 HD23 HD22 ' A' ' 79' ' ' LEU . 37.9 tp -59.12 -34.75 72.4 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.417 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.797 ' CE2' HD11 ' A' ' 79' ' ' LEU . 66.1 m-85 -57.87 -56.38 22.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.508 -0.745 . . . . 0.0 109.79 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -70.04 -20.05 63.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.869 . . . . 0.0 111.008 -178.556 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.63 ' O ' ' N ' ' B' ' 352' ' ' THR . 50.2 mt -72.03 -58.32 3.54 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.669 -1.269 . . . . 0.0 108.233 178.073 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.48 ' CD ' ' NH1' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -40.28 -10.25 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.769 -178.279 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.63 ' N ' ' O ' ' B' ' 350' ' ' LEU . 81.0 p -91.93 -11.43 36.25 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.574 -1.329 . . . . 0.0 110.446 -179.224 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 66.0 mt -92.47 120.07 32.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.996 -1.065 . . . . 0.0 108.972 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.88 92.95 0.83 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 31.1 mt -103.25 93.81 5.18 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.396 -1.061 . . . . 0.0 109.343 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 57.8 p -95.72 179.98 4.93 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.046 -1.034 . . . . 0.0 110.548 -179.518 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -68.45 111.82 4.91 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.506 -0.747 . . . . 0.0 109.945 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 105.75 9.69 32.27 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 97.6 m -87.83 106.21 17.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -1.172 . . . . 0.0 110.302 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 3.9 t -77.01 117.84 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 122.296 1.046 . . . . 0.0 109.004 -177.563 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 19.6 m -113.68 177.73 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.832 -177.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 93.9 m -132.0 130.04 40.89 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 176.85 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 96.5 mt -105.35 120.51 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.36 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 58.2 m -120.07 131.72 55.18 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.689 -0.632 . . . . 0.0 109.543 -178.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.71 153.76 41.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 109.715 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -146.33 123.02 11.18 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 160.91 -155.39 26.55 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 118.681 -1.723 . . . . 0.0 111.86 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -58.94 -50.46 73.97 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.154 -0.523 . . . . 0.0 112.394 -177.032 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.426 ' H ' ' HB3' ' B' ' 331' ' ' SER . 97.8 m-20 -110.29 15.28 22.41 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.926 -1.109 . . . . 0.0 111.275 -177.605 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' B' ' 369' ' ' ASP . 16.2 pt-20 -39.54 -38.28 0.58 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.421 -0.8 . . . . 0.0 111.453 -179.034 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -66.73 -48.15 70.07 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.723 -1.236 . . . . 0.0 110.622 -178.233 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -70.02 -52.52 23.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.977 -1.077 . . . . 0.0 109.899 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.01 -38.71 3.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.429 -0.794 . . . . 0.0 111.229 -178.661 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.457 ' O ' HG23 ' B' ' 378' ' ' VAL . 77.2 t -70.05 -39.98 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.515 -1.366 . . . . 0.0 109.251 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.91 -66.83 0.5 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.971 . . . . 0.0 111.637 -178.025 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 376' ' ' HIS . . . . . 0.442 ' O ' ' N ' ' B' ' 380' ' ' LEU . 32.2 m170 -59.92 -45.2 93.33 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.652 -1.28 . . . . 0.0 112.103 -177.171 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 98.0 mt -59.98 -42.0 93.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.328 -1.483 . . . . 0.0 108.841 -179.13 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.477 HG11 ' NE2' ' B' ' 304' ' ' GLN . 53.4 t -68.7 -40.14 81.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -80.67 -10.94 59.7 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.969 -1.082 . . . . 0.0 109.831 178.855 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' B' ' 376' ' ' HIS . 61.3 tp -82.39 -25.98 33.25 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.473 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 3.4 ttp -82.75 -25.68 32.61 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.467 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -84.37 -10.07 57.89 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.599 -0.688 . . . . 0.0 110.03 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -108.55 -0.86 20.1 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.309 -0.869 . . . . 0.0 110.344 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 44.4 mt -98.94 119.99 38.64 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.009 -1.057 . . . . 0.0 109.727 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 385' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 53.3 mp0 . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 117.967 -1.016 . . . . 0.0 108.978 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.6 mtp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.881 -0.415 . . . . 2.91 109.881 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.2 mt -94.76 121.28 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.066 -1.022 . . . . 1.2 109.814 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.7 m -138.75 149.07 44.63 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.716 -0.846 . . . . 1.4 108.716 179.578 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.02 -161.4 12.21 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 109.357 -1.497 . . . . 1.05 109.357 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' LEU . 97.8 mt -92.07 -12.89 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -1.189 . . . . 1.15 109.944 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' ILE . 63.0 tp 53.92 101.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.059 -1.025 . . . . 0.98 108.717 -179.515 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.06 -39.94 24.95 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.764 -0.828 . . . . 0.88 108.764 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 m -141.05 135.28 15.16 Favored Pre-proline 0 N--CA 1.5 2.025 0 O-C-N 121.583 -0.698 . . . . 1.69 109.524 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.17 147.4 20.71 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.391 2.061 . . . . 0.85 112.877 179.741 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.862 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.45 -162.2 34.21 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.9 -1.68 . . . . 0.92 108.9 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.5 mt -149.56 150.42 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.01 -1.288 . . . . 0.81 108.565 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.45 159.31 38.55 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.701 -1.249 . . . . 0.51 110.615 179.246 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -140.03 129.08 23.58 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.884 -1.154 . . . . 0.62 107.884 179.068 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.66 -177.95 47.33 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 118.782 -1.675 . . . . 0.55 110.893 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -79.39 159.53 27.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.762 -0.846 . . . . 2.1 109.298 -179.743 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.611 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -107.8 137.39 45.9 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.374 -0.829 . . . . 0.77 111.119 -179.022 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.5 tp -107.32 132.59 52.96 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 107.283 -1.377 . . . . 0.91 107.283 178.501 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.2 tp -111.83 121.17 44.32 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.23 -0.919 . . . . 0.93 109.699 -179.314 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 31.0 mt -85.79 100.19 11.87 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.415 -0.803 . . . . 0.93 109.907 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -88.78 135.98 33.24 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.47 -0.769 . . . . 2.75 109.327 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -132.74 122.87 25.21 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.026 -1.101 . . . . 3.0 108.026 178.392 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -83.06 150.3 26.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.878 -1.139 . . . . 2.77 109.426 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -62.6 140.04 58.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 2.94 109.81 -179.61 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.6 mt -81.67 132.06 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 0.95 108.862 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.53 126.31 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.263 -0.898 . . . . 1.28 110.181 -179.133 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.5 mt -110.01 130.06 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 107.954 -1.128 . . . . 1.21 107.954 179.321 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -88.79 120.33 30.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.836 -1.165 . . . . 1.81 110.102 -179.218 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -89.95 -4.49 57.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 2.8 108.708 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -69.98 137.99 51.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 2.87 109.255 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -82.91 155.45 24.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 2.35 109.815 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.683 HD13 ' HG3' ' A' ' 39' ' ' GLU . 2.9 pt -98.84 168.47 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.445 -0.785 . . . . 0.97 109.339 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.9 p -89.99 173.55 8.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.08 -1.012 . . . . 1.17 108.481 178.47 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.04 -17.04 63.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.009 -1.057 . . . . 1.18 110.994 -179.367 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -84.57 -26.03 28.26 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.659 -1.276 . . . . 2.56 108.42 178.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -82.15 -7.95 59.64 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.131 -0.692 . . . . 1.79 109.131 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.0 t -60.01 -52.82 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.251 -0.905 . . . . 1.0 108.615 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -60.04 -40.05 88.02 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.354 -0.841 . . . . 1.77 109.208 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -64.06 -40.12 95.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 2.7 110.281 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.683 ' HG3' HD13 ' A' ' 31' ' ' ILE . 71.1 mm-40 -63.46 -44.41 94.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.756 -1.215 . . . . 1.51 110.023 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -60.03 -47.16 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.865 -1.147 . . . . 0.93 108.665 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -60.03 -46.69 88.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.302 -0.874 . . . . 1.81 108.984 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -60.21 -42.75 95.8 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.919 -1.113 . . . . 2.78 108.17 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -63.44 -47.73 80.68 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.535 -0.913 . . . . 0.78 108.535 178.31 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.3 tp -60.01 -48.68 80.72 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.516 -0.92 . . . . 1.07 108.516 -179.514 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 46.7 t -63.04 -43.85 97.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 1.12 108.903 179.075 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.99 -46.8 93.51 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.309 -1.917 . . . . 0.84 108.309 179.212 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.419 HH21 ' HG2' ' A' ' 81' ' ' GLU . 43.1 ttt-85 -60.1 -39.94 87.9 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.347 -0.983 . . . . 3.09 108.347 178.303 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -48.1 -46.23 33.69 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.148 -0.686 . . . . 0.88 109.148 -179.699 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 50' ' ' ALA . 6.4 ttpm? -64.06 -74.08 0.11 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.92 -1.141 . . . . 2.59 107.92 179.261 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.62 -35.83 0.21 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.532 -0.73 . . . . 0.7 111.143 -178.588 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.2 t -53.76 -60.62 3.08 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.619 -1.301 . . . . 1.4 108.716 179.557 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.6 -39.99 84.77 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.508 -0.745 . . . . 0.67 111.648 -178.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -66.77 -41.3 87.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.693 -1.254 . . . . 1.66 110.302 -178.939 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.54 -39.98 95.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.863 -1.148 . . . . 1.58 108.873 179.198 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -65.83 -38.64 89.44 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.522 -0.736 . . . . 1.35 109.723 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.63 -40.87 98.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.014 . . . . 0.77 109.535 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.517 ' CD1' HH22 ' A' ' 136' ' ' ARG . 82.8 mt -60.19 -40.0 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.63 109.218 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -58.94 -50.03 75.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.847 . . . . 1.14 109.579 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -58.14 -28.76 64.98 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.316 -0.865 . . . . 0.79 110.618 -178.064 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -70.05 -39.1 75.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.063 -1.023 . . . . 1.53 109.878 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.04 -46.92 76.1 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.596 -0.69 . . . . 0.57 109.9 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.78 -54.06 32.9 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.928 -1.269 . . . . 0.75 109.928 -179.197 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.02 -45.53 60.51 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.045 -1.268 . . . . 1.59 110.588 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.5 m -68.34 -63.05 1.14 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.952 -1.092 . . . . 0.73 112.717 -177.386 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -95.7 -46.97 6.39 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.849 -1.157 . . . . 0.75 111.089 -177.68 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.93 -167.31 25.69 Favored Glycine 0 N--CA 1.5 2.943 0 O-C-N 120.839 -1.163 . . . . 1.22 111.143 179.485 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -75.6 -22.54 56.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.925 -0.75 . . . . 5.81 110.078 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.425 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.5 tp10 -61.12 -36.22 79.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.88 . . . . 3.37 110.211 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.422 ' HA ' HD12 ' A' ' 72' ' ' ILE . 32.3 mmtp -100.72 -20.14 15.73 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.275 -0.89 . . . . 1.77 110.226 -179.486 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -68.51 -39.92 81.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.047 -1.033 . . . . 1.65 110.34 -179.106 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.536 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.5 -26.57 67.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.213 -0.93 . . . . 0.77 109.431 -179.362 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 69' ' ' LYS . 81.8 mt -60.05 -40.82 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.081 -1.012 . . . . 0.8 108.732 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -70.04 -37.97 75.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.188 -0.945 . . . . 0.88 110.638 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -60.0 -40.11 88.08 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.656 -1.277 . . . . 1.37 108.642 179.351 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.07 -43.01 97.9 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.957 -1.657 . . . . 0.62 108.957 179.156 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.2 m170 -66.63 -41.31 88.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.302 -1.117 . . . . 1.5 108.969 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.4 mt -69.95 -45.44 76.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.323 -0.861 . . . . 0.63 108.987 179.354 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.4 ttp -60.69 -40.21 91.32 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.099 -1.001 . . . . 1.51 109.536 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.966 HD22 HD23 ' B' ' 347' ' ' LEU . 50.4 tp -64.95 -40.06 94.45 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.525 -0.735 . . . . 0.77 109.579 179.663 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.1 tp -63.62 -38.0 89.46 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.627 -0.67 . . . . 0.62 109.411 -179.213 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.419 ' HG2' HH21 ' A' ' 47' ' ' ARG . 100.0 mt-10 -82.4 4.39 24.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.159 -0.963 . . . . 1.47 110.913 -178.7 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -49.98 130.06 21.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.761 -1.212 . . . . 1.47 109.42 -179.655 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -57.54 -18.88 21.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.487 -0.758 . . . . 1.78 110.933 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.72 -34.56 69.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.77 -1.207 . . . . 2.53 108.878 178.722 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.2 mt -72.33 -42.52 65.31 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.73 -0.606 . . . . 0.8 110.567 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -60.0 -48.75 80.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.147 -0.971 . . . . 1.42 110.468 -178.819 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -69.95 -40.09 75.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.207 -0.933 . . . . 1.71 110.904 -178.788 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.03 -39.96 75.46 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.042 -1.036 . . . . 1.57 111.413 -179.219 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.2 mt -66.59 -49.94 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.949 -1.094 . . . . 0.65 109.539 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.3 mt -69.79 -39.99 78.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.562 -0.711 . . . . 0.82 110.013 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.04 -48.77 80.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.12 -0.987 . . . . 0.79 110.783 -179.543 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 96' ' ' LYS . 55.8 mt -59.97 -46.36 89.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.046 -1.034 . . . . 0.95 110.146 -179.089 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.9 -49.81 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.66 108.826 179.451 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -69.99 -40.96 75.0 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 120.276 -0.57 . . . . 2.2 111.19 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -85.07 -49.97 7.83 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.861 -1.15 . . . . 1.65 112.012 -178.228 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 92' ' ' LEU . 32.8 mmtp -89.18 -0.45 57.46 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.111 -0.993 . . . . 2.03 111.164 -177.229 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.2 m80 55.81 32.6 19.87 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.937 -1.102 . . . . 1.42 109.595 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.0 mtt -89.65 168.82 11.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.358 -0.839 . . . . 1.18 109.428 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.7 p -83.45 158.16 22.17 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.19 -0.944 . . . . 0.98 109.051 179.736 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.61 -39.95 92.07 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.267 -0.896 . . . . 0.64 109.262 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.481 ' OD1' HD22 ' A' ' 138' ' ' LEU . 40.4 t0 -65.55 -40.02 92.4 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.419 -0.801 . . . . 2.07 109.764 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.45 -41.52 24.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 0.73 110.147 -179.51 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.88 -45.45 64.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -0.946 . . . . 0.54 110.63 -179.316 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.05 -43.31 95.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.039 -1.038 . . . . 0.56 110.122 -179.45 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -60.01 -39.95 87.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 1.54 110.193 -178.686 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -61.46 -41.81 97.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.995 -1.066 . . . . 1.33 110.517 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.4 t -60.05 -50.85 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.14 -0.975 . . . . 0.72 110.598 -178.653 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.8 mm -69.94 -39.99 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.116 -0.99 . . . . 0.85 109.252 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -62.11 -39.38 92.31 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.584 -0.895 . . . . 2.44 108.584 179.099 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.0 -52.19 54.38 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.812 -0.915 . . . . 0.98 110.812 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.493 ' NE2' ' CB ' ' B' ' 348' ' ' PHE . 15.5 mm100 -64.04 -49.76 71.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.7 -1.47 . . . . 1.41 109.697 -179.436 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.91 83.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.189 -0.944 . . . . 1.2 109.027 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.8 t -59.98 -42.24 93.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.921 . . . . 1.7 108.873 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.29 -40.0 94.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.858 . . . . 1.47 109.882 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.417 HD22 ' HB3' ' B' ' 351' ' ' GLN . 59.4 mt -65.42 -40.26 93.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.787 -1.196 . . . . 1.56 109.674 -178.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.06 -31.06 69.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.9 -1.125 . . . . 2.2 109.75 -179.656 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -55.81 -23.57 31.04 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.084 -1.01 . . . . 2.12 108.396 179.778 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.1 mt -63.23 148.91 46.82 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.576 -0.898 . . . . 2.0 108.576 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -99.81 47.07 0.95 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.025 -1.047 . . . . 3.23 110.204 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 34.6 t0 -137.44 150.17 47.43 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.174 -0.954 . . . . 2.49 109.772 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 124' ' ' LYS . 98.4 mt-10 -74.44 -67.97 0.57 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.299 -0.876 . . . . 3.95 109.259 178.825 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.634 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 4.8 t80 -39.25 -39.5 0.63 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.863 -0.523 . . . . 2.0 111.153 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.611 HD23 HH22 ' A' ' 126' ' ' ARG . 88.9 mt -69.97 -36.59 75.33 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.745 -1.222 . . . . 1.86 108.508 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 121' ' ' GLU . 74.6 tttt -69.23 -35.98 76.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.446 -0.784 . . . . 2.84 110.309 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.536 ' N ' ' OE1' ' A' ' 125' ' ' GLU . 0.4 OUTLIER -60.05 -46.31 89.97 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.966 -1.084 . . . . 2.73 110.603 -178.485 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.634 ' NH1' ' CE1' ' A' ' 122' ' ' TYR . 27.8 mtm-85 -63.14 -39.67 95.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.504 -1.372 . . . . 2.77 108.593 179.413 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.0 -36.6 77.55 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.459 -0.941 . . . . 1.19 108.459 179.057 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.22 88.58 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.216 -1.031 . . . . 1.2 108.216 179.098 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.88 -40.02 87.67 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.927 -0.768 . . . . 1.55 108.927 179.15 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 51.2 t -59.95 -42.9 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.8 109.052 179.384 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -60.04 -39.92 87.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 3.09 109.485 179.16 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -59.91 -40.05 87.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.427 -0.796 . . . . 1.46 110.196 -179.617 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.99 -42.17 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.127 -0.983 . . . . 0.71 110.447 -178.877 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.45 -34.46 54.23 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.805 -1.188 . . . . 0.57 110.236 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -60.05 -46.22 90.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -1.183 . . . . 2.59 109.684 -179.13 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.517 HH22 ' CD1' ' A' ' 57' ' ' ILE . 62.4 mtp180 -65.24 -34.5 78.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.125 -0.984 . . . . 2.83 110.108 -179.316 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.036 -1.04 . . . . 1.25 109.015 -179.597 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.481 HD22 ' OD1' ' A' ' 101' ' ' ASP . 90.4 mt -60.53 -40.06 90.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 0.7 108.537 178.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -65.62 -39.93 92.02 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.825 -0.805 . . . . 2.57 108.825 179.187 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -69.47 -34.23 74.06 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.717 -0.614 . . . . 1.23 111.328 -179.245 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.26 -39.85 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.454 -1.404 . . . . 0.81 109.243 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.9 mt -73.84 -19.17 60.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.597 -0.689 . . . . 1.0 109.943 -179.263 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.64 39.33 14.54 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.721 -1.752 . . . . 0.89 108.721 -179.289 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.8 tp -73.89 147.05 43.57 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.489 -1.006 . . . . 1.14 110.004 -179.001 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.74 141.05 49.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.351 -0.843 . . . . 4.6 109.713 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 90.2 mt -113.35 130.01 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.825 0.821 . . . . 1.24 108.838 179.108 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.4 mt -68.29 -39.94 81.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.857 -0.527 . . . . 1.54 110.874 -177.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.8 t0 63.92 102.83 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.396 -0.815 . . . . 1.5 109.267 -179.3 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.2 mt -72.95 -1.73 18.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.412 -0.805 . . . . 0.79 110.669 -179.069 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.2 p -85.24 -16.07 41.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.791 -1.193 . . . . 1.4 109.766 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.62 28.02 0.27 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.172 -0.955 . . . . 0.92 111.859 -177.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 40.9 mm -85.99 125.94 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.491 -1.381 . . . . 0.88 109.191 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -106.91 -13.95 15.09 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.496 -0.752 . . . . 2.45 109.665 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -126.68 150.97 48.7 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.341 -0.85 . . . . 1.52 110.034 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.69 136.62 57.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 1.58 109.0 179.496 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.2 m -152.82 165.96 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.324 -0.86 . . . . 0.69 109.835 179.634 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.4 mt -95.55 145.95 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 105.661 -1.978 . . . . 0.61 105.661 176.783 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 37.7 tp -100.23 119.67 38.73 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.907 -1.121 . . . . 0.87 110.54 -178.092 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.0 125.72 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.605 -0.684 . . . . 0.71 109.225 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -152.78 158.67 42.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.985 -1.072 . . . . 0.81 109.494 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.01 -32.12 70.13 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.395 -1.44 . . . . 0.98 108.294 179.076 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 56.2 t0 -169.86 142.15 2.37 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.451 -0.944 . . . . 2.25 108.451 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.528 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 81.4 mt -110.74 129.03 55.94 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.325 -0.859 . . . . 0.78 108.968 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 43.5 p -90.17 149.89 42.24 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.299 -0.876 . . . . 0.98 109.22 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -37.85 -38.92 0.75 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 122.241 1.961 . . . . 0.81 112.439 179.667 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.1 m -59.51 -39.98 85.6 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.251 -0.906 . . . . 0.9 109.9 -178.219 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.14 -40.05 86.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.086 -1.009 . . . . 1.61 110.356 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.7 p -57.21 -32.6 66.67 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.981 -1.074 . . . . 0.61 111.124 -178.229 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.3 -46.96 53.47 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.984 -1.073 . . . . 0.6 109.97 -179.794 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -89.95 40.06 0.99 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.788 -1.19 . . . . 1.4 107.788 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.8 tp -106.96 126.44 52.32 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 109.082 -0.711 . . . . 0.7 109.082 179.208 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -84.68 105.71 15.68 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.075 -1.083 . . . . 2.35 108.075 178.884 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.12 -44.53 84.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.37 -0.831 . . . . 1.51 111.39 -178.131 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -69.99 -21.76 63.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.76 -1.213 . . . . 2.33 111.809 -177.386 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -93.91 -9.27 37.7 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.699 -1.251 . . . . 1.92 110.214 -178.943 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.593 HG12 ' H ' ' A' ' 178' ' ' GLY . 99.8 t -108.76 119.94 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.385 -0.822 . . . . 0.67 108.912 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 89.5 mt -85.12 3.73 37.62 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.558 -0.714 . . . . 1.53 110.845 -178.182 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.593 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 166.55 175.23 36.61 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 119.224 -1.465 . . . . 0.48 109.75 179.637 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -133.69 129.41 36.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.551 -0.97 . . . . 0.55 108.411 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 90.3 mt -128.98 123.72 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.552 -0.907 . . . . 0.65 108.552 179.232 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 69.9 p -149.96 162.38 40.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.654 -1.279 . . . . 0.82 110.9 -179.706 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 183' ' ' ALA . 7.2 p30 -101.9 22.54 12.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.757 -0.589 . . . . 2.46 109.522 179.64 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -54.32 -162.98 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.817 -1.177 . . . . 1.28 112.048 -178.204 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.99 -54.0 5.97 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.809 -0.917 . . . . 2.19 110.809 -179.034 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 164.42 -139.01 5.59 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 118.94 -1.6 . . . . 2.13 110.707 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -71.59 -9.99 59.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.931 . . . . 5.86 110.625 -178.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 53.5 p -78.99 1.52 23.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.928 -1.108 . . . . 3.72 109.672 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 12.2 t -90.94 130.8 36.84 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.081 -1.012 . . . . 1.74 110.076 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -47.06 -50.27 19.99 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.447 -0.783 . . . . 0.95 109.966 179.998 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.41 HG23 ' N ' ' A' ' 191' ' ' SER . 14.5 t -57.48 -37.16 72.46 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.304 -0.873 . . . . 1.55 110.973 -178.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.41 ' N ' HG23 ' A' ' 190' ' ' THR . 82.6 p -59.99 -41.01 91.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.739 -1.226 . . . . 1.51 110.851 -179.087 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 88.7 mt -61.09 -38.93 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.125 -0.984 . . . . 1.67 109.399 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 92.7 mtp -60.59 -39.93 89.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.555 -0.716 . . . . 1.02 110.395 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.27 -43.49 87.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.737 -1.227 . . . . 0.68 109.388 -179.453 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' A' ' 195' ' ' ARG . 2.2 mtt-85 -60.02 -49.92 75.77 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.288 -0.965 . . . . 2.93 109.911 -179.29 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 72.1 m -69.96 -34.43 73.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.088 -1.008 . . . . 0.86 111.026 -179.224 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.5 mt -71.47 -18.24 62.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.921 -1.112 . . . . 0.67 109.499 -179.536 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 60.99 47.92 7.0 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.294 0.569 . . . . 1.5 110.536 -179.415 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 38.5 mt -126.99 149.48 69.36 Favored Pre-proline 0 N--CA 1.499 2.021 0 N-CA-C 107.724 -1.213 . . . . 0.72 107.724 178.549 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.79 139.98 49.58 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.122 1.881 . . . . 0.61 112.102 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.99 150.59 3.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.112 -0.992 . . . . 0.66 111.052 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 93.1 mt -125.22 142.32 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 108.399 -0.963 . . . . 0.79 108.399 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.3 m -127.04 -7.97 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 120.816 -1.178 . . . . 0.91 111.322 -178.673 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.9 21.31 29.92 Favored Glycine 0 N--CA 1.503 3.135 0 O-C-N 121.211 -0.931 . . . . 1.01 110.867 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 8.3 p -45.84 -43.99 13.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.951 -1.323 . . . . 0.99 110.165 -179.313 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.34 -49.46 2.67 Favored Glycine 0 N--CA 1.498 2.784 0 C-N-CA 120.017 -1.087 . . . . 1.12 111.034 179.445 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.7 m -160.77 37.74 0.16 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.651 -1.5 . . . . 1.72 111.246 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 42.4 t -80.74 -31.5 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.991 -1.068 . . . . 0.89 108.86 178.206 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.7 p -59.95 -33.52 72.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.45 -0.781 . . . . 1.03 110.062 -179.081 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 91.2 p -78.21 -10.06 59.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.994 -1.066 . . . . 1.83 109.412 -179.664 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -103.6 -11.1 17.92 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.491 -0.756 . . . . 2.27 110.228 -179.304 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.4 t -103.42 136.2 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.213 -0.93 . . . . 0.92 110.806 -178.693 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -112.32 151.0 30.22 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.462 -1.31 . . . . 2.2 107.462 178.507 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.444 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 11.3 p-10 -57.92 139.53 54.1 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.058 -1.026 . . . . 2.36 110.069 -179.143 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.7 m-20 81.15 3.02 1.59 Allowed 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.13 0.491 . . . . 2.38 110.007 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 56.7 t0 -72.01 138.61 48.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.156 -0.965 . . . . 2.09 108.803 178.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.489 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 41.3 t80 -89.85 118.63 29.58 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.074 -1.084 . . . . 1.27 108.074 179.078 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.611 HD12 ' HB2' ' A' ' 16' ' ' ALA . 61.5 mt -128.47 149.05 50.74 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.498 -0.751 . . . . 0.75 110.642 -178.629 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.9 mt -115.15 130.01 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 107.703 -1.221 . . . . 0.63 107.703 177.615 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 63.5 tp -99.97 115.92 30.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.08 -1.013 . . . . 0.7 109.314 -179.207 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 223' ' ' VAL . 97.3 m-20 -74.22 -42.72 59.3 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.918 -1.142 . . . . 2.31 107.918 178.368 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.862 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.54 11.22 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.404 -0.961 . . . . 0.78 108.404 -179.108 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.503 ' H ' ' C ' ' A' ' 221' ' ' ASP . 57.2 t -128.33 -39.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.327 -1.36 . . . . 1.04 107.327 179.057 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -100.43 3.23 42.93 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.047 -1.094 . . . . 2.44 108.047 178.68 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 60.57 43.8 12.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.71 -0.619 . . . . 1.55 110.601 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -149.18 156.79 42.7 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.885 -1.134 . . . . 1.99 109.976 179.204 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -122.92 124.93 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.685 -0.857 . . . . 0.77 108.685 179.158 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -84.76 122.83 29.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.701 -1.249 . . . . 0.98 109.556 -179.23 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.406 HG22 HD22 ' A' ' 218' ' ' LEU . 62.5 t -98.96 116.3 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.474 -0.766 . . . . 0.85 109.481 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 65.08 68.96 0.69 Allowed Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.227 -0.92 . . . . 1.66 109.372 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -89.18 124.05 1.4 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.181 2.587 . . . . 0.95 112.255 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.2 p -70.41 171.75 9.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 1.84 109.725 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -59.97 -40.16 88.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.323 -0.86 . . . . 2.74 109.921 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -64.33 -34.61 78.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.033 -1.042 . . . . 2.89 109.217 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.79 -42.7 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.121 -0.987 . . . . 1.3 108.613 178.87 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 95.1 mt -67.1 -41.99 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.747 -0.834 . . . . 1.09 108.747 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -59.86 -40.06 87.33 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.596 -0.89 . . . . 2.43 108.596 178.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -59.51 -46.71 88.05 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.393 -0.965 . . . . 2.78 108.393 -179.578 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.541 ' O ' ' N ' ' A' ' 242' ' ' VAL . 93.3 mtp -65.69 -77.3 0.06 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.19 -1.411 . . . . 1.25 107.19 178.741 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.503 ' C ' ' O ' ' A' ' 239' ' ' MET . 29.6 mmt180 -23.19 -45.07 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 120.983 0.421 . . . . 2.63 111.889 -178.798 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 241' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 239' ' ' MET . . . -63.88 -50.01 70.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.943 -1.098 . . . . 1.8 109.612 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 239' ' ' MET . 74.8 t -60.06 -38.13 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.228 -0.92 . . . . 2.13 108.884 179.498 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.96 -40.08 87.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.498 -0.751 . . . . 3.17 109.063 -179.474 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.38 -40.03 89.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.146 -0.971 . . . . 1.78 108.968 179.136 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -66.74 -40.09 88.18 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.238 -0.914 . . . . 2.47 108.964 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 53.6 t -66.05 -40.17 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.332 -0.855 . . . . 2.09 109.073 179.739 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.82 -39.77 91.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.42 -0.8 . . . . 2.54 109.493 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 57.8 m -60.02 -39.96 87.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.253 -0.904 . . . . 2.99 109.576 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -65.86 -40.03 91.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.951 . . . . 3.34 109.549 179.802 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -82.76 -2.29 53.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.408 -0.807 . . . . 3.88 109.845 -179.051 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.481 ' O ' ' NZ ' ' A' ' 257' ' ' LYS . . . -65.73 -39.39 91.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.811 -1.181 . . . . 4.43 110.588 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -163.2 -17.57 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.591 -1.318 . . . . 5.42 110.973 -179.056 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.99 -40.03 75.54 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.565 -1.334 . . . . 6.1 109.565 179.463 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 255' ' ' LYS . . . -118.44 4.87 11.76 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.534 -0.728 . . . . 7.37 110.659 -179.269 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 254' ' ' ALA . 43.6 pttt 33.12 -117.04 0.07 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.577 -0.702 . . . . 8.01 110.91 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 256' ' ' LEU . 0.2 OUTLIER 59.94 19.54 8.57 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.862 -1.162 . . . . 9.05 107.862 -179.27 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.481 ' NZ ' ' O ' ' A' ' 251' ' ' ALA . 87.5 mttt -66.52 -46.15 77.13 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.631 -0.828 . . . . 10.56 109.554 178.652 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -147.79 25.88 1.03 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.37 -0.831 . . . . 11.32 109.423 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.081 -1.012 . . . . 12.42 109.036 -179.972 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 16.9 ttt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -149.49 147.98 28.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.26 -0.9 . . . . 0.0 109.267 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -149.67 159.63 44.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.066 -1.021 . . . . 0.0 110.618 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -153.66 150.41 28.56 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -109.84 132.25 54.32 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.373 -0.83 . . . . 0.0 109.781 179.628 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.49 121.63 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 122.371 1.081 . . . . 0.0 112.729 -177.4 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 56.0 m -78.19 104.01 8.49 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.924 0.868 . . . . 0.0 110.02 -178.874 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.476 HG22 ' H ' ' B' ' 310' ' ' ALA . 96.6 mt -52.64 125.62 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 122.635 1.207 . . . . 0.0 111.073 -177.562 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 67.1 p -109.97 20.9 17.46 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.978 -179.023 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.476 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -75.29 116.87 58.55 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.048 -1.032 . . . . 0.0 108.945 179.426 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -54.53 -16.22 10.29 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 CA-C-N 120.276 1.134 . . . . 0.0 113.249 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -120.17 11.41 11.61 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.383 -0.823 . . . . 0.0 109.621 -179.191 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.85 179.25 32.14 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 108.431 -1.867 . . . . 0.0 108.431 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.457 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -87.08 93.13 9.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.952 -1.322 . . . . 0.0 108.998 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.404 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 5.8 p80 -95.43 -160.0 0.76 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.945 -1.097 . . . . 0.0 109.811 179.054 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 9.6 m -58.39 -43.99 88.75 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.021 -1.05 . . . . 0.0 112.629 -176.071 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.536 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.1 tpt180 -61.97 -62.05 6.57 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.352 -1.467 . . . . 0.0 112.184 -178.236 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.404 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 11.0 Cg_endo -58.02 -29.6 87.34 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 CA-C-N 120.136 1.084 . . . . 0.0 111.548 -179.196 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.34 -49.96 75.83 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.085 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.34 -41.18 65.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.464 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -70.02 -40.61 75.1 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.768 -1.207 . . . . 0.0 108.911 178.478 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -65.5 -55.46 17.74 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.521 -0.737 . . . . 0.0 109.951 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 323' ' ' VAL . . . . . 0.431 HG13 ' O ' ' B' ' 344' ' ' ALA . 88.3 t -67.83 -29.72 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.872 -1.142 . . . . 0.0 111.058 -178.482 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -64.05 -42.96 96.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.966 -1.084 . . . . 0.0 109.876 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -66.23 -40.41 90.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.107 -0.995 . . . . 0.0 110.499 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -65.75 -53.13 44.73 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.745 -1.222 . . . . 0.0 110.389 -179.608 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -51.94 -15.64 0.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 109.964 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -75.49 -23.93 71.91 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -105.59 141.32 37.26 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.404 -1.057 . . . . 0.0 108.945 179.669 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 26.5 m -89.8 -11.48 42.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.997 -1.064 . . . . 0.0 109.937 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.434 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 63.3 p -61.32 148.88 39.81 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.973 -1.079 . . . . 0.0 109.241 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -68.53 134.63 50.35 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.116 -0.99 . . . . 0.0 108.908 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.3 mt -133.01 133.22 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.642 -0.661 . . . . 0.0 109.787 -179.57 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 32.4 m -129.9 149.03 51.81 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.487 -0.758 . . . . 0.0 109.089 179.245 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 87.1 t -122.3 116.48 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.327 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 33.3 m -105.67 132.12 52.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 33.8 t -140.02 116.49 10.7 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.768 0.794 . . . . 0.0 111.105 -179.79 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 45.52 51.96 9.48 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.723 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 90.0 -14.03 63.09 Favored Glycine 0 N--CA 1.503 3.142 0 O-C-N 120.156 -1.59 . . . . 0.0 113.099 176.52 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -119.76 131.16 55.28 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 119.495 1.647 . . . . 0.0 110.06 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 18.1 m -129.99 150.23 51.36 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.83 0.824 . . . . 0.0 110.426 -179.412 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 342' ' ' ALA . . . . . 0.423 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -146.52 171.86 14.44 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.511 0.672 . . . . 0.0 110.145 -179.229 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 9.6 m -89.68 139.95 30.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.533 -0.73 . . . . 0.0 109.725 -179.514 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.441 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -81.51 -12.47 58.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.0 -1.062 . . . . 0.0 109.018 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -86.62 21.26 2.23 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.5 -1.666 . . . . 0.0 106.5 178.602 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 346' ' ' SER . . . . . 0.441 ' H ' ' C ' ' B' ' 344' ' ' ALA . 52.7 m -149.96 98.67 2.75 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.226 -179.053 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.966 HD23 HD22 ' A' ' 79' ' ' LEU . 26.0 tp -59.91 -34.4 73.15 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.8 ' CE2' HD11 ' A' ' 79' ' ' LEU . 58.0 m-85 -59.93 -55.56 32.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.265 -0.897 . . . . 0.0 110.11 -179.37 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -69.35 -22.4 63.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 111.178 -177.214 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' B' ' 352' ' ' THR . 65.1 mt -68.94 -52.78 25.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.645 -1.284 . . . . 0.0 108.09 177.839 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.552 ' OE1' ' N ' ' B' ' 351' ' ' GLN . 0.8 OUTLIER -40.85 -16.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.977 -178.22 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.545 ' N ' ' O ' ' B' ' 350' ' ' LEU . 63.5 p -87.44 -10.01 53.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.405 -1.435 . . . . 0.0 109.941 -179.167 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.423 HD11 ' HB3' ' B' ' 342' ' ' ALA . 67.8 mt -95.42 117.81 31.02 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.07 -1.019 . . . . 0.0 109.081 178.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.35 94.04 0.91 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.742 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 18.1 mt -101.42 88.73 3.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.282 -1.128 . . . . 0.0 108.86 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 77.2 p -90.33 169.99 10.63 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.01 -1.056 . . . . 0.0 110.785 -179.068 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 357' ' ' GLN . . . . . 0.449 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 1.1 tm0? -61.46 113.78 2.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.721 -0.612 . . . . 0.0 110.973 -179.079 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 358' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 100.32 8.07 50.68 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.751 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.1 m -83.31 111.52 19.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.339 -1.095 . . . . 0.0 110.513 -179.683 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 6.1 t -77.31 114.59 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 122.292 1.044 . . . . 0.0 109.257 -177.636 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 14.5 m -111.7 177.68 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.458 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 90.3 m -131.29 129.35 41.39 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 176.845 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 71.9 mt -102.63 116.42 46.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 56.8 p -120.01 132.3 55.43 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.659 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.35 153.14 40.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 0.0 109.873 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -144.88 124.41 13.18 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.289 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.464 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 159.88 -160.34 31.46 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 118.804 -1.665 . . . . 0.0 111.578 -179.773 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -60.06 -50.93 71.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 122.132 -0.628 . . . . 0.0 112.133 -177.641 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.434 ' H ' ' HB3' ' B' ' 331' ' ' SER . 71.3 m-20 -109.93 10.93 24.27 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.903 -1.123 . . . . 0.0 111.643 -177.2 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.554 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -42.04 -34.88 0.78 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.988 -1.07 . . . . 0.0 111.848 -178.392 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 371' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 91.3 mt-30 -70.72 -38.65 73.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.745 -1.222 . . . . 0.0 110.034 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -65.38 -50.04 67.02 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.926 -1.108 . . . . 0.0 109.011 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.05 -76.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.584 -0.697 . . . . 0.0 111.069 -178.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.579 ' O ' HG23 ' B' ' 378' ' ' VAL . 23.5 t -43.08 -38.13 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.343 -0.848 . . . . 0.0 110.973 -177.471 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.92 -42.39 85.48 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.351 -1.468 . . . . 0.0 110.32 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -81.03 -43.43 19.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.795 -1.191 . . . . 0.0 109.909 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.09 -39.41 86.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.223 -179.405 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.579 HG23 ' O ' ' B' ' 374' ' ' VAL . 55.9 t -62.02 -43.23 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.057 -1.027 . . . . 0.0 109.342 179.542 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -70.02 -56.38 7.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.703 -1.248 . . . . 0.0 107.64 178.439 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 52.0 tp -56.2 -35.06 66.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.564 -0.71 . . . . 0.0 110.058 -177.861 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 1.5 tpt -71.49 -39.93 70.53 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.543 -1.348 . . . . 0.0 108.669 178.165 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.75 -4.44 57.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.473 -0.767 . . . . 0.0 110.574 179.672 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.428 ' O ' ' OE2' ' B' ' 385' ' ' GLU . 73.2 mm-40 -111.68 -2.61 15.3 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.105 -0.997 . . . . 0.0 110.995 -179.563 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 13.1 mt -80.01 133.02 36.12 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.379 -1.45 . . . . 0.0 109.493 179.129 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 385' ' ' GLU . . . . . 0.525 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 42.9 mp0 . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.211 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mtp . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.5 -0.556 . . . . 2.91 109.5 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.2 mt -109.97 129.94 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.51 -0.744 . . . . 1.2 109.692 -179.84 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 m -131.65 147.61 52.53 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.719 -0.613 . . . . 1.4 109.456 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.44 -164.99 10.13 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 108.834 -1.706 . . . . 1.05 108.834 179.522 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.6 mt -87.41 -18.33 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.016 -1.285 . . . . 1.15 109.704 -179.356 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.4 tp 54.86 103.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.668 -0.864 . . . . 0.98 108.668 -179.138 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.5 -24.57 16.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.88 108.675 179.509 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 13.4 t -141.77 123.43 8.96 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.574 -0.704 . . . . 1.69 110.011 -179.889 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.98 147.48 21.2 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.184 1.923 . . . . 0.85 112.531 179.284 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.909 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 150.29 172.64 19.78 Favored Glycine 0 N--CA 1.5 2.918 0 N-CA-C 108.918 -1.673 . . . . 0.92 108.918 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.9 mt -127.45 132.31 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.875 -1.367 . . . . 0.81 109.677 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.43 151.89 50.0 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.317 -0.864 . . . . 0.51 109.957 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -127.28 130.84 50.31 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.866 -1.161 . . . . 0.62 107.866 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.72 178.82 48.65 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 118.583 -1.77 . . . . 0.55 111.183 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -79.96 155.56 27.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.799 -0.824 . . . . 2.1 109.325 -179.899 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.6 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -106.52 125.78 51.43 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 121.794 0.807 . . . . 0.77 111.369 -178.967 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.0 tp -99.47 137.52 37.85 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.529 -1.286 . . . . 0.91 107.529 178.195 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.5 tp -119.53 128.65 54.14 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.476 -0.765 . . . . 0.93 109.692 -179.211 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.1 mt -91.62 105.91 18.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.694 -0.629 . . . . 0.93 110.275 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -106.1 131.79 52.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.162 -1.051 . . . . 2.75 108.162 178.605 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -129.23 148.58 51.17 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.383 -0.823 . . . . 3.0 109.381 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -83.15 142.42 31.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.455 -0.778 . . . . 2.77 109.33 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -60.2 142.52 54.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.126 -0.983 . . . . 2.94 109.133 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -75.97 126.58 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.977 . . . . 0.95 109.985 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.57 125.33 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.343 -0.848 . . . . 1.28 110.166 -179.522 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 84.8 mt -110.18 132.29 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.607 -0.886 . . . . 1.21 108.607 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -92.23 117.92 30.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.764 -1.21 . . . . 1.81 109.474 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.447 HH11 ' HG2' ' A' ' 28' ' ' ARG . 5.3 mmt-85 -87.11 -4.39 59.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.164 -0.96 . . . . 2.8 109.342 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -68.25 140.77 56.03 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.194 -0.941 . . . . 2.87 109.248 179.612 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -84.02 154.49 23.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.899 . . . . 2.35 109.849 -179.696 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.546 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.3 pt -96.5 167.17 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 0.97 109.467 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.7 p -90.31 172.76 8.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.04 -1.037 . . . . 1.17 108.363 178.574 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.08 -18.09 63.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.938 -1.102 . . . . 1.18 110.994 -179.285 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 64.8 t0 -86.37 -24.62 25.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.626 -1.296 . . . . 2.56 108.392 178.842 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -81.29 -9.97 59.66 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.786 -0.82 . . . . 1.79 108.786 179.1 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 t -60.94 -52.02 66.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -61.08 -39.88 91.57 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.377 -0.827 . . . . 1.77 110.273 -179.619 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -69.24 -40.91 77.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.078 -1.014 . . . . 2.7 111.022 -178.309 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HG3' HG21 ' A' ' 31' ' ' ILE . 68.7 mm-40 -65.91 -39.86 90.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.0 -1.063 . . . . 1.51 110.854 -179.21 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.8 t -61.33 -45.04 99.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.484 -1.385 . . . . 0.93 108.45 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -60.01 -41.5 92.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.043 -1.036 . . . . 1.81 109.622 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -60.17 -45.25 93.71 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.967 -1.093 . . . . 2.78 108.069 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -60.36 -48.29 82.37 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.889 -0.782 . . . . 0.78 108.889 178.199 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.465 ' CD1' HH21 ' A' ' 47' ' ' ARG . 43.2 tp -60.2 -48.81 80.16 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.048 -0.723 . . . . 1.07 109.048 -179.567 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.459 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 44.4 t -63.56 -43.18 97.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.021 -1.05 . . . . 1.12 108.386 178.83 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.56 -47.42 91.25 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.537 -1.825 . . . . 0.84 108.537 179.059 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.465 HH21 ' CD1' ' A' ' 44' ' ' LEU . 44.2 ttp180 -60.18 -38.78 84.27 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.888 -1.153 . . . . 3.09 107.888 178.656 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -52.9 -46.49 68.02 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.952 -0.758 . . . . 0.88 108.952 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 50' ' ' ALA . 34.0 ttpt -59.92 -74.82 0.07 Allowed 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.548 -1.279 . . . . 2.59 107.548 179.257 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.35 -39.61 0.3 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.356 -0.84 . . . . 0.7 111.907 -178.148 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.0 m -59.34 -52.17 66.8 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.458 -1.401 . . . . 1.4 108.707 -179.749 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.52 -40.71 89.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.365 -0.834 . . . . 0.67 110.58 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -63.3 -42.17 99.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.0 -1.062 . . . . 1.66 109.878 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.6 mt -64.11 -40.46 96.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.021 -1.049 . . . . 1.58 109.538 179.553 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.7 -39.87 90.15 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.109 -0.995 . . . . 1.35 108.708 179.671 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.418 HG22 ' HZ3' ' A' ' 60' ' ' LYS . 89.3 m -62.23 -43.49 98.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.361 -0.837 . . . . 0.77 109.711 179.097 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 81.7 mt -61.47 -39.85 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.325 -0.859 . . . . 0.63 109.598 179.612 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -57.56 -50.22 73.81 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.255 -0.903 . . . . 1.14 109.872 -179.041 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -58.44 -37.68 75.9 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.25 -0.906 . . . . 0.79 110.491 -177.751 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.418 ' HZ3' HG22 ' A' ' 56' ' ' THR . 59.0 mttp -68.47 -36.88 79.6 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.911 -1.118 . . . . 1.53 109.352 179.461 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.438 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.27 -47.34 70.97 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.57 -0.706 . . . . 0.57 109.979 -179.636 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -54.59 -52.8 42.89 Favored Glycine 0 N--CA 1.484 1.858 0 C-N-CA 119.993 -1.099 . . . . 0.75 110.452 -178.909 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.42 -41.84 72.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.032 -1.275 . . . . 1.59 111.083 -178.996 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.8 m -66.34 -61.93 1.74 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.025 -1.047 . . . . 0.73 112.181 -177.503 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -96.68 -44.47 7.1 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.827 -1.171 . . . . 0.75 111.439 -177.546 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.39 -168.08 25.58 Favored Glycine 0 N--CA 1.499 2.882 0 C-N-CA 119.822 -1.18 . . . . 1.22 110.925 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -69.95 -22.82 63.14 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.981 -0.717 . . . . 5.81 110.115 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.506 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 50.4 tp10 -59.99 -35.71 75.61 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.466 -0.771 . . . . 3.37 111.31 -179.14 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -96.51 -16.22 21.23 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.166 -0.959 . . . . 1.77 109.748 -179.699 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -71.6 -43.13 66.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.219 -0.926 . . . . 1.65 110.373 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.59 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -63.69 -34.53 78.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.435 -0.79 . . . . 0.77 110.119 -178.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.86 -40.61 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.909 -1.119 . . . . 0.8 109.108 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -65.04 -39.52 93.47 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.986 -1.071 . . . . 0.88 110.314 -179.78 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -60.12 -40.06 88.42 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.979 -1.076 . . . . 1.37 109.342 -179.182 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.99 -44.75 95.49 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.181 -1.968 . . . . 0.62 108.181 178.376 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -63.36 -45.88 89.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.529 -0.983 . . . . 1.5 109.142 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 98.5 mt -70.08 -45.51 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.108 -0.995 . . . . 0.63 109.319 179.575 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.0 ttp -62.65 -41.49 99.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.847 -1.158 . . . . 1.51 110.09 -179.488 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.005 HD22 HD23 ' B' ' 347' ' ' LEU . 45.7 tp -65.07 -40.83 95.22 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.541 -0.724 . . . . 0.77 110.065 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.7 tp -68.73 -39.52 80.33 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.636 -0.665 . . . . 0.62 110.311 -179.096 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -79.67 0.94 28.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.043 -1.036 . . . . 1.47 109.935 -179.062 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 53.3 t0 -47.28 133.83 11.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.086 -1.009 . . . . 1.47 109.736 -179.311 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.458 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 99.3 mt-10 -64.92 -18.66 65.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.683 -0.636 . . . . 1.78 110.899 -178.749 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -75.51 -33.31 60.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.779 -1.201 . . . . 2.53 109.035 178.68 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 79' ' ' LEU . 88.9 mt -70.02 -39.99 75.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.479 -0.763 . . . . 0.8 109.371 179.5 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.91 -49.53 77.31 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.429 -0.794 . . . . 1.42 110.16 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.4 -39.41 81.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.855 . . . . 1.71 110.787 -179.226 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -68.87 -40.25 79.37 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.719 -1.238 . . . . 1.57 111.221 -179.439 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.44 -43.19 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.601 -1.312 . . . . 0.65 109.402 179.529 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.78 -39.17 77.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.552 -0.717 . . . . 0.82 110.749 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.78 95.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.117 -0.989 . . . . 0.79 110.098 -179.114 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 21.1 mt -63.65 -45.4 90.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.094 -1.004 . . . . 0.95 109.333 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.9 mt -64.15 -48.98 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.406 -0.809 . . . . 0.66 109.18 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.99 -40.77 75.11 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.733 -0.787 . . . . 2.2 110.576 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -84.82 -55.86 3.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.969 -1.082 . . . . 1.65 112.134 -178.142 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -87.1 -1.44 57.89 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.866 -1.146 . . . . 2.03 111.872 -177.321 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 44.3 m80 58.58 35.01 24.31 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.995 -1.066 . . . . 1.42 110.304 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.2 mtp -86.89 166.27 15.28 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.256 -0.903 . . . . 1.18 109.889 -179.474 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.426 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 64.4 p -79.62 161.9 25.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.206 -0.934 . . . . 0.98 108.864 179.536 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.06 -40.54 87.11 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.0 -1.062 . . . . 0.64 109.541 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 23.9 p-10 -69.94 -35.72 74.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 2.07 109.925 179.825 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.12 -40.09 39.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.094 -1.004 . . . . 0.73 109.333 179.279 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.76 -48.33 63.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.862 . . . . 0.54 110.361 -179.368 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.81 -32.54 73.75 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.81 -1.181 . . . . 0.56 109.757 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.525 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 86.3 t60 -60.53 -45.07 95.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 1.54 109.56 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -66.41 -39.96 89.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.792 . . . . 1.33 110.997 -178.879 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.1 t -62.3 -53.35 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.165 -0.96 . . . . 0.72 111.493 -177.902 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.8 mm -72.59 -37.12 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.751 -1.218 . . . . 0.85 110.004 -179.382 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.525 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 84.5 tt0 -67.35 -34.2 76.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.172 -0.955 . . . . 2.44 108.537 179.623 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.59 -49.07 82.66 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.357 -1.097 . . . . 0.98 110.357 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.8 mm-40 -65.92 -50.71 63.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.802 -1.411 . . . . 1.41 109.192 -179.537 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.87 -40.43 80.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 1.2 109.097 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 61.8 m -60.03 -40.18 88.48 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.114 -0.991 . . . . 1.7 108.436 179.733 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.26 -39.65 95.19 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.391 -0.818 . . . . 1.47 109.304 179.662 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.6 mt -67.82 -43.16 80.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.993 -1.083 . . . . 1.56 109.461 -179.468 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -55.5 -25.4 36.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.85 -1.156 . . . . 2.2 109.723 -179.31 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -66.2 -22.0 66.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.973 -1.079 . . . . 2.12 108.765 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.441 HD13 HD13 ' A' ' 123' ' ' LEU . 51.8 mt -63.25 143.94 57.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.314 -0.866 . . . . 2.0 109.882 -179.617 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -92.55 14.31 17.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.201 -0.937 . . . . 3.23 109.358 179.03 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -103.22 127.83 50.41 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.32 -0.862 . . . . 2.49 110.516 -178.944 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -70.62 -28.94 65.22 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.366 0.603 . . . . 3.95 110.234 179.239 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.535 ' OH ' ' N ' ' B' ' 315' ' ' HIS . 15.7 t80 -64.26 -40.58 96.28 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.209 -0.932 . . . . 2.0 110.212 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.91 HD22 ' O ' ' B' ' 351' ' ' GLN . 64.2 mt -77.38 -37.15 52.7 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.51 -0.744 . . . . 1.86 109.875 -178.934 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -59.98 -40.9 90.7 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.249 -0.907 . . . . 2.84 109.329 -179.752 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 78.1 mm-40 -61.28 -46.02 92.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.958 -1.089 . . . . 2.73 108.877 179.401 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.44 HH21 ' CD2' ' A' ' 123' ' ' LEU . 17.5 ttp180 -61.16 -39.96 92.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.899 . . . . 2.77 108.59 179.203 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.88 -28.9 70.36 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.766 -0.827 . . . . 1.19 108.766 179.011 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -59.95 -40.03 87.58 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.087 -1.079 . . . . 1.2 108.087 179.571 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -62.07 -42.24 98.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.522 -0.736 . . . . 1.55 109.503 179.741 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.11 -41.4 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.197 -0.939 . . . . 0.8 108.571 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -60.13 -39.33 85.94 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.688 -0.633 . . . . 3.09 109.458 179.32 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -60.04 -41.85 93.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.38 -0.825 . . . . 1.46 110.676 -179.304 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.16 -46.19 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.056 -1.028 . . . . 0.71 110.055 -179.088 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.99 97.85 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.996 -1.242 . . . . 0.57 109.996 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -59.8 -49.72 76.63 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.326 -1.102 . . . . 2.59 110.142 -179.658 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -70.05 -32.08 70.02 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.101 -0.999 . . . . 2.83 110.501 -179.808 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.9 tp -57.81 -46.74 84.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.97 . . . . 1.25 108.925 -178.884 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.96 -39.64 86.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.138 -0.977 . . . . 0.7 108.565 179.116 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -68.22 -40.0 82.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.356 -0.84 . . . . 2.57 108.884 178.595 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -60.16 -38.49 83.3 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.862 -0.524 . . . . 1.23 110.999 -178.995 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.5 mt -72.8 -40.87 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.653 -1.28 . . . . 0.81 108.727 179.397 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.68 -25.58 61.31 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.62 -0.675 . . . . 1.0 109.848 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.6 37.16 27.66 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.96 -1.656 . . . . 0.89 108.96 -179.309 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 58.5 tp -73.14 141.59 47.47 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.497 -1.002 . . . . 1.14 109.381 -179.401 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -61.96 140.06 58.35 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.845 0.831 . . . . 4.6 111.12 -178.698 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 97.0 mt -115.66 132.25 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.716 -0.846 . . . . 1.24 108.716 178.604 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 24.7 mm -57.02 -43.74 81.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.455 -0.778 . . . . 1.54 109.924 -178.392 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 11.8 t0 70.18 94.31 0.08 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.063 -0.718 . . . . 1.5 109.063 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.8 mt -66.36 -6.52 14.54 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.382 -0.824 . . . . 0.79 110.841 -178.761 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.0 t -82.93 -16.85 45.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.716 -1.24 . . . . 1.4 110.534 -179.186 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.33 24.29 0.83 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.068 -1.02 . . . . 0.92 112.581 -177.529 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.0 mm -79.28 126.5 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.305 -1.497 . . . . 0.88 108.793 179.531 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.4 ' O ' ' OD1' ' A' ' 154' ' ' ASP . 77.5 mt-30 -102.8 -11.92 17.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.558 -0.714 . . . . 2.45 110.158 -179.247 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 153' ' ' GLN . 97.7 m-20 -136.85 156.09 48.94 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.117 -0.989 . . . . 1.52 110.39 -178.975 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.08 135.17 56.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.321 -0.862 . . . . 1.58 109.137 179.871 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.9 m -152.65 164.48 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.42 -0.8 . . . . 0.69 109.802 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.7 mt -92.5 147.15 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 105.752 -1.944 . . . . 0.61 105.752 176.651 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.4 tp -99.69 119.21 37.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.173 -0.954 . . . . 0.87 110.464 -178.246 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.1 t -125.13 130.3 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.196 -1.038 . . . . 0.71 108.196 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.84 167.21 28.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -0.991 . . . . 0.81 109.221 -179.768 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.26 -37.31 74.88 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.781 -1.199 . . . . 0.98 108.715 179.013 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.6 p-10 -170.42 149.01 3.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.57 -0.706 . . . . 2.25 109.602 -179.655 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.1 mt -119.36 133.72 55.58 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.453 -0.779 . . . . 0.78 109.663 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.4 p -93.35 143.89 27.41 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.013 . . . . 0.98 108.624 179.157 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -41.47 -34.23 1.92 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.302 2.001 . . . . 0.81 113.159 -179.669 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.7 m -59.92 -40.12 87.8 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.768 -1.207 . . . . 0.9 109.294 -178.97 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.5 -40.24 80.94 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.012 -1.055 . . . . 1.61 109.308 179.474 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 63.8 p -52.94 -30.02 32.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.064 -1.022 . . . . 0.61 110.57 -178.92 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -70.72 -57.47 4.64 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.816 -1.178 . . . . 0.6 109.701 179.565 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -80.36 34.83 0.32 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.13 -0.693 . . . . 1.4 109.13 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.4 tp -100.08 136.54 39.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.426 -0.796 . . . . 0.7 109.763 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -86.18 96.89 10.07 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.926 -1.139 . . . . 2.35 107.926 178.494 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.9 -41.72 97.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 1.51 110.87 -178.577 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -68.02 -25.34 65.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.993 -1.067 . . . . 2.33 111.812 -177.4 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -93.7 -8.74 39.99 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.727 -1.233 . . . . 1.92 110.541 -178.506 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.458 HG12 ' H ' ' A' ' 178' ' ' GLY . 87.5 t -107.58 118.58 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.182 -1.044 . . . . 0.67 108.182 178.613 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 95.3 mt -89.85 6.48 41.66 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.446 -0.784 . . . . 1.53 111.051 -177.342 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.458 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 175.82 166.16 32.87 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.419 -1.472 . . . . 0.48 109.419 179.511 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -132.2 128.44 37.96 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.344 -0.984 . . . . 0.55 108.344 179.573 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.416 ' CG2' HG21 ' A' ' 205' ' ' THR . 86.2 mt -130.47 124.04 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.612 -1.255 . . . . 0.65 107.612 178.489 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.4 p -140.79 156.81 46.08 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.205 1.002 . . . . 0.82 111.386 -178.189 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.491 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 65.6 t0 -102.97 26.03 8.65 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.914 -0.585 . . . . 2.46 110.101 -179.567 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.67 -164.12 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.233 -1.542 . . . . 1.28 111.551 -178.045 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.82 -54.0 8.93 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.261 -1.136 . . . . 2.19 110.261 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.65 -154.44 13.71 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.764 -1.684 . . . . 2.13 111.68 -179.635 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -64.37 -11.28 31.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.89 -0.771 . . . . 5.86 110.745 -178.759 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 59.6 p -79.94 5.38 14.07 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.119 -0.988 . . . . 3.72 109.699 -179.005 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.0 t -88.67 142.48 27.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 1.74 109.894 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -53.36 -39.15 63.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.385 -0.822 . . . . 0.95 108.919 -179.831 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 89.5 m -59.77 -42.23 92.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.69 -0.631 . . . . 1.55 110.908 -179.33 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.3 p -60.98 -40.08 92.05 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.846 -1.159 . . . . 1.51 110.962 -178.871 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.8 mm -61.42 -41.19 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.204 -0.935 . . . . 1.67 110.096 -178.558 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.5 mtp -61.32 -42.94 99.5 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.989 -1.069 . . . . 1.02 110.333 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.96 -47.0 71.78 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.522 -1.361 . . . . 0.68 109.92 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -60.21 -50.26 74.37 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.903 -1.119 . . . . 2.93 110.003 -179.687 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.7 m -69.14 -36.07 77.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.773 -1.204 . . . . 0.86 111.069 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 197' ' ' LEU . 94.7 mt -72.06 -26.39 62.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.822 -1.174 . . . . 0.67 109.45 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 68.42 45.26 1.19 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.098 0.475 . . . . 1.5 110.778 -179.593 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.479 ' O ' ' CB ' ' A' ' 8' ' ' SER . 62.3 mt -126.69 148.67 65.8 Favored Pre-proline 0 N--CA 1.501 2.116 0 N-CA-C 107.852 -1.166 . . . . 0.72 107.852 178.239 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.86 137.82 78.75 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.192 1.928 . . . . 0.61 112.111 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.31 147.49 3.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.03 -1.044 . . . . 0.66 111.319 -179.669 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.4 mt -125.34 144.27 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.371 -1.344 . . . . 0.79 107.371 178.434 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 23.9 m -126.77 -11.78 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 O-C-N 121.106 -0.996 . . . . 0.91 111.144 -178.602 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -109.97 24.61 18.55 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.734 -1.346 . . . . 1.01 109.734 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.416 HG21 ' CG2' ' A' ' 180' ' ' ILE . 3.0 p -43.3 -46.68 6.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.333 -1.099 . . . . 0.99 109.897 -179.008 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.491 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 95.51 -50.95 1.81 Allowed Glycine 0 N--CA 1.498 2.813 0 C-N-CA 120.218 -0.991 . . . . 1.12 111.496 178.998 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 46.8 t -157.07 30.87 0.3 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.245 -1.738 . . . . 1.72 110.745 -178.665 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 40.7 t -72.11 -40.04 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.096 -1.002 . . . . 0.89 109.263 178.512 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.437 ' H ' HG23 ' A' ' 209' ' ' THR . 6.4 p -54.17 -29.39 45.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -0.927 . . . . 1.03 110.191 -179.301 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 47.5 t -79.78 -20.96 44.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.156 -0.965 . . . . 1.83 110.349 -178.932 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -96.08 -10.61 27.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.044 -1.035 . . . . 2.27 110.393 -179.287 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 56.2 t -106.63 136.75 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.281 -0.887 . . . . 0.92 111.538 -177.809 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -112.52 154.54 25.76 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.293 -1.373 . . . . 2.2 107.293 178.86 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 33.6 p-10 -60.5 139.63 57.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.694 -1.253 . . . . 2.36 110.389 -179.166 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.4 t0 81.03 7.66 1.2 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.586 -0.524 . . . . 2.38 109.586 179.688 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 58.2 t0 -76.59 132.95 39.76 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.298 -0.876 . . . . 2.09 109.215 179.457 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.411 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 33.7 t80 -84.05 119.95 25.56 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.012 -1.107 . . . . 1.27 108.012 179.412 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.6 HD12 ' HB2' ' A' ' 16' ' ' ALA . 86.5 mt -130.42 149.82 51.92 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.334 -0.854 . . . . 0.75 110.927 -178.429 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 63.8 mt -115.22 126.62 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 106.907 -1.516 . . . . 0.63 106.907 177.091 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 45.1 tp -101.24 120.18 39.86 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.09 -1.006 . . . . 0.7 109.031 -178.832 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.472 ' C ' ' N ' ' A' ' 223' ' ' VAL . 91.8 m-20 -78.11 -46.99 19.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.088 -1.007 . . . . 2.31 110.263 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.909 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 50.05 16.45 0.24 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.115 -1.069 . . . . 0.78 108.115 -178.537 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.472 ' N ' ' C ' ' A' ' 221' ' ' ASP . 38.5 t -131.21 -47.04 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.321 -1.363 . . . . 1.04 107.321 179.235 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -99.62 3.62 45.33 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.357 -1.349 . . . . 2.44 107.357 177.88 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 48.6 t30 60.55 44.28 11.89 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 116.117 -0.492 . . . . 1.55 110.259 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -144.37 156.75 44.37 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.869 -1.144 . . . . 1.99 110.273 179.603 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 79.7 t -125.96 129.94 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.269 -0.641 . . . . 0.77 109.269 179.791 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -95.97 122.69 39.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.042 -1.036 . . . . 0.98 108.784 179.354 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 39.0 t -98.92 116.24 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.361 -0.837 . . . . 0.85 109.99 -179.157 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 63.53 68.42 0.9 Allowed Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.488 -0.757 . . . . 1.66 110.509 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -91.1 130.3 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.492 2.795 . . . . 0.95 112.471 179.7 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.483 HG22 ' N ' ' A' ' 233' ' ' ASN . 23.7 m -67.9 166.1 16.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.16 -0.962 . . . . 1.84 109.894 -179.461 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.483 ' N ' HG22 ' A' ' 232' ' ' THR . 69.6 m-20 -60.13 -40.0 88.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.248 -0.907 . . . . 2.74 110.338 -179.392 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -60.27 -37.21 79.73 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.09 -1.006 . . . . 2.89 108.972 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 70.2 t -64.73 -40.14 88.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.351 -0.843 . . . . 1.3 109.76 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.36 -39.75 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.111 -0.993 . . . . 1.09 110.017 -179.784 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -60.01 -39.83 87.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.064 -1.023 . . . . 2.43 108.376 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -66.39 -41.64 89.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.411 -0.806 . . . . 2.78 109.212 179.11 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 80.3 mtp -69.94 -31.22 68.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.423 -0.798 . . . . 1.25 109.259 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.486 HH11 ' HG2' ' A' ' 240' ' ' ARG . 1.6 mmt-85 -64.83 -38.5 91.17 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.33 -0.856 . . . . 2.63 109.209 179.179 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.71 -41.23 90.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 1.8 109.208 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.99 -39.86 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.185 -0.947 . . . . 2.13 109.53 179.47 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -60.12 -40.13 88.66 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.295 -0.878 . . . . 3.17 110.583 -179.88 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -60.17 -43.52 95.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.154 -0.966 . . . . 1.78 109.604 -179.169 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -67.44 -40.24 85.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.427 -0.796 . . . . 2.47 109.413 179.509 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.5 t -66.99 -40.32 85.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.49 -0.757 . . . . 2.09 109.234 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.96 85.74 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.644 -0.66 . . . . 2.54 109.658 -179.719 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 96.6 p -59.92 -40.27 88.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 2.99 109.755 -179.588 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.414 ' O ' ' OE2' ' A' ' 249' ' ' GLU . 3.7 tm-20 -66.05 -39.1 89.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.023 -1.048 . . . . 3.34 109.453 179.686 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -101.69 41.38 1.21 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.394 -0.816 . . . . 3.88 109.688 -179.086 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -152.32 25.44 0.61 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.362 -0.837 . . . . 4.43 111.004 179.837 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -80.05 -70.62 0.5 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.704 -1.248 . . . . 5.42 108.814 179.456 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 72.8 mt -137.78 -46.05 0.54 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.237 -1.023 . . . . 6.1 108.237 178.493 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -162.45 -63.04 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.574 -0.704 . . . . 7.37 110.039 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 17.7 tptp 57.25 23.05 8.3 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.291 -1.003 . . . . 8.01 108.291 -179.483 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.661 ' O ' HD23 ' A' ' 256' ' ' LEU . 3.5 tt -57.29 -39.1 75.03 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.376 -0.601 . . . . 9.05 109.376 -179.445 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 256' ' ' LEU . 4.6 tppt? -36.22 132.02 0.58 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.496 -0.753 . . . . 10.56 111.749 -178.837 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 256' ' ' LEU . 4.5 p30 161.31 113.44 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.043 -1.095 . . . . 11.32 108.043 179.083 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.982 -1.009 . . . . 12.42 109.391 179.975 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 3.6 ttt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -150.54 150.32 31.09 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.367 -0.833 . . . . 0.0 109.057 179.082 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 303' ' ' GLN . . . . . 0.484 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 3.4 pm0 -150.18 157.83 43.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.135 -0.978 . . . . 0.0 110.926 -179.047 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -155.47 150.89 27.1 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.048 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -113.4 129.45 56.54 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.113 -0.992 . . . . 0.0 109.833 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.59 126.85 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 CA-C-O 122.512 1.149 . . . . 0.0 112.458 -177.737 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 31.4 m -77.99 102.37 7.35 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.925 -178.257 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 87.1 mt -51.48 123.92 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 122.277 1.037 . . . . 0.0 110.053 -178.072 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 25.6 p -109.25 20.05 18.74 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.693 -178.713 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' B' ' 385' ' ' GLU . . . -74.6 116.64 55.34 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 108.719 179.554 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.24 -16.1 44.38 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 CA-C-N 120.362 1.165 . . . . 0.0 112.546 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -112.27 12.15 20.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.523 -0.736 . . . . 0.0 109.652 -179.115 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.25 172.21 5.53 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 -178.913 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.425 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 2.6 tp -84.53 88.51 7.32 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.871 -1.37 . . . . 0.0 108.427 -179.133 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.535 ' N ' ' OH ' ' A' ' 122' ' ' TYR . 5.0 p80 -90.94 -161.92 0.86 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 120.74 -1.225 . . . . 0.0 109.412 178.965 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.2 m -56.82 -41.18 77.38 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.147 -0.971 . . . . 0.0 112.605 -176.223 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.59 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 2.4 tpt180 -62.5 -62.67 5.31 Favored Pre-proline 0 N--CA 1.501 2.124 0 O-C-N 120.478 -1.389 . . . . 0.0 112.159 -178.494 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.434 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 12.3 Cg_endo -57.77 -31.5 92.42 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 CA-C-N 120.004 1.037 . . . . 0.0 111.975 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.88 -50.53 73.42 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.006 -1.059 . . . . 0.0 108.233 179.637 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.73 -40.04 59.51 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.904 -179.12 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 321' ' ' GLN . . . . . 0.534 ' OE1' ' NH2' ' B' ' 317' ' ' ARG . 42.3 mt-30 -69.88 -41.83 74.25 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.981 -1.075 . . . . 0.0 109.57 179.074 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -61.02 -52.69 63.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.33 -0.856 . . . . 0.0 110.101 -179.25 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.19 -30.79 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.798 -1.188 . . . . 0.0 110.014 -178.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -59.36 -47.59 84.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.061 -1.024 . . . . 0.0 109.569 -179.685 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.53 -50.74 64.09 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.001 -1.062 . . . . 0.0 109.868 -179.091 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 326' ' ' ALA . . . . . 0.417 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -60.32 -51.09 71.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.677 -1.264 . . . . 0.0 110.074 -179.622 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -48.31 -19.27 0.28 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.498 -0.751 . . . . 0.0 109.126 -179.091 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 328' ' ' GLY . . . . . 0.417 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -80.49 -16.11 76.62 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -105.54 141.07 37.65 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.178 -1.189 . . . . 0.0 109.694 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 330' ' ' THR . . . . . 0.409 ' O ' HG22 ' B' ' 330' ' ' THR . 46.0 m -90.43 -12.39 37.57 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.307 -0.87 . . . . 0.0 109.165 179.211 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 95.2 p -61.32 150.02 36.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.147 -0.97 . . . . 0.0 108.862 179.412 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -71.28 135.65 47.54 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.387 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.9 132.29 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.575 -0.703 . . . . 0.0 109.861 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 96.7 m -130.86 147.9 52.57 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 63.0 t -121.99 119.07 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.299 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 21.6 m -103.4 121.34 42.59 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.028 -1.045 . . . . 0.0 109.145 -178.969 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 18.4 t -134.81 119.67 18.43 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.895 0.855 . . . . 0.0 110.569 -179.669 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 30.3 m120 43.89 57.61 4.03 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 177.468 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 75.26 -12.81 6.64 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.578 -1.326 . . . . 0.0 112.155 177.208 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -111.96 121.13 44.16 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.955 -1.32 . . . . 0.0 109.959 -178.764 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 69.0 m -108.49 157.49 18.4 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.749 0.785 . . . . 0.0 110.945 -178.998 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -153.05 153.72 33.44 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.465 0.65 . . . . 0.0 109.984 179.214 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 17.7 m -91.82 136.57 33.05 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.422 -0.799 . . . . 0.0 110.598 -179.142 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.405 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -70.71 -20.95 62.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.903 . . . . 0.0 109.757 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -84.07 18.69 2.01 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.24 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 346' ' ' SER . . . . . 0.405 ' H ' ' C ' ' B' ' 344' ' ' ALA . 13.2 m -148.49 93.14 2.1 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.72 0.771 . . . . 0.0 111.273 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 1.005 HD23 HD22 ' A' ' 79' ' ' LEU . 55.6 tp -56.29 -35.46 67.52 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.211 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.759 ' CE2' HD11 ' A' ' 79' ' ' LEU . 50.0 m-85 -56.16 -50.02 72.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.54 -0.725 . . . . 0.0 110.575 -179.06 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -69.85 -39.86 76.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.705 -1.247 . . . . 0.0 110.243 -178.601 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' B' ' 352' ' ' THR . 38.0 mt -50.04 -56.01 12.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.732 -1.23 . . . . 0.0 108.165 179.481 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.91 ' O ' HD22 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -41.36 -17.05 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.535 -0.728 . . . . 0.0 110.747 -179.151 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.551 ' N ' ' O ' ' B' ' 350' ' ' LEU . 52.7 p -85.87 -13.69 47.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.037 -1.665 . . . . 0.0 110.281 -178.897 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 29.4 mt -95.04 122.5 37.76 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.106 -0.996 . . . . 0.0 109.057 178.666 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.21 96.3 1.1 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 178.94 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 46.2 mt -102.33 90.38 3.88 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.293 -1.122 . . . . 0.0 109.925 -179.37 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 21.1 p -97.6 -177.43 3.79 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.267 -0.896 . . . . 0.0 111.253 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -69.74 111.76 5.74 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.9 -179.315 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.2 10.84 35.51 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 179.267 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 28.5 m -87.12 108.58 18.96 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.059 -1.26 . . . . 0.0 110.791 -179.579 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 32.4 t -77.89 113.79 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 122.058 0.933 . . . . 0.0 109.521 -178.204 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 34.7 m -109.68 178.28 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.409 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 19.1 m -130.43 123.18 29.21 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.522 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.5 mt -97.69 111.57 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.834 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 52.2 p -116.3 130.48 56.8 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.212 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.45 150.51 37.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.92 . . . . 0.0 109.48 -178.82 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -142.07 123.61 14.97 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.413 -0.804 . . . . 0.0 108.891 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.591 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.31 -162.64 33.43 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.395 -1.383 . . . . 0.0 111.057 -179.845 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.91 -50.33 74.2 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.207 -0.584 . . . . 0.0 112.518 -177.78 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.435 ' H ' ' HB3' ' B' ' 331' ' ' SER . 71.8 m-20 -106.38 10.61 31.5 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 120.668 -1.27 . . . . 0.0 110.92 -177.575 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.591 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.3 pt-20 -44.19 -34.87 2.0 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.29 -0.882 . . . . 0.0 111.45 -179.236 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -70.55 -41.19 72.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.876 -1.14 . . . . 0.0 110.017 -179.414 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -67.06 -47.14 72.19 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.341 -179.307 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.24 -74.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.341 -0.849 . . . . 0.0 110.848 -179.06 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.598 ' O ' HG23 ' B' ' 378' ' ' VAL . 64.3 t -45.87 -34.74 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.93 -1.106 . . . . 0.0 110.871 -177.434 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.17 -47.78 72.86 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.361 -1.462 . . . . 0.0 110.592 179.613 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -78.82 -44.11 23.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.969 -1.082 . . . . 0.0 110.628 -179.495 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.99 -36.26 76.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 0.0 109.383 -179.637 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.598 HG23 ' O ' ' B' ' 374' ' ' VAL . 39.8 t -63.05 -43.91 99.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.109 -0.994 . . . . 0.0 109.287 179.736 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -69.96 -56.84 5.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.605 -1.309 . . . . 0.0 108.248 178.519 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 36.1 tp -55.72 -32.21 63.15 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.435 -0.791 . . . . 0.0 109.682 -178.123 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 26.2 ttm -71.97 -40.49 68.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.57 -1.331 . . . . 0.0 109.319 178.236 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.14 -3.93 57.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.458 -0.776 . . . . 0.0 110.17 179.662 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -111.75 -4.39 14.68 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.196 -0.94 . . . . 0.0 110.917 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.7 mt -80.45 133.67 35.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.36 -1.463 . . . . 0.0 109.365 179.062 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 385' ' ' GLU . . . . . 0.402 ' O ' ' HB1' ' B' ' 310' ' ' ALA . 45.3 mt-10 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.324 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.5 mtt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.365 -0.606 . . . . 2.91 109.365 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.4 mt -109.89 129.92 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.447 -0.783 . . . . 1.2 109.366 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 m -138.83 118.78 13.32 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -0.888 . . . . 1.4 108.771 179.799 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.587 ' N ' HD22 ' A' ' 225' ' ' ASN . . . -91.83 -161.0 36.61 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.572 -1.411 . . . . 1.05 109.572 -179.848 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 5' ' ' ILE . 87.0 mt -94.95 -10.42 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.259 -1.142 . . . . 1.15 110.653 -178.953 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.1 tp 55.01 100.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.977 -1.077 . . . . 0.98 109.183 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.96 -34.23 24.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.88 108.936 179.56 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.0 t -139.14 133.4 16.21 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.497 -0.752 . . . . 1.69 109.231 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.27 143.74 15.91 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.193 1.929 . . . . 0.85 112.672 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.708 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 163.49 -162.03 34.59 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.792 -1.323 . . . . 0.92 109.792 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.6 mt -148.02 146.88 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.169 -1.195 . . . . 0.81 108.334 179.023 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.19 159.62 37.9 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.829 -1.169 . . . . 0.51 110.656 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.8 m-85 -137.93 127.45 24.97 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.547 -1.279 . . . . 0.62 107.547 178.859 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.59 177.22 48.31 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 118.452 -1.832 . . . . 0.55 110.965 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -78.74 159.5 27.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.782 -0.834 . . . . 2.1 110.107 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.94 123.46 45.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.719 . . . . 0.77 110.994 -179.028 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.2 tp -99.3 134.06 42.7 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 106.498 -1.667 . . . . 0.91 106.498 177.566 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.6 tp -117.63 122.81 44.59 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.146 -0.971 . . . . 0.93 109.908 -179.354 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.4 mt -87.32 104.54 16.51 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.476 0.655 . . . . 0.93 109.986 -179.678 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -92.47 136.0 33.58 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.681 -0.859 . . . . 2.75 108.681 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -130.57 139.05 50.43 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.323 -0.86 . . . . 3.0 109.623 179.76 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -93.47 140.79 29.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.243 -0.91 . . . . 2.77 109.122 179.656 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -59.94 139.97 57.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.166 -0.959 . . . . 2.94 109.634 -179.849 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -79.69 131.81 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.906 . . . . 0.95 108.757 179.889 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.5 t -93.91 124.88 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.132 -0.98 . . . . 1.28 110.053 -179.236 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.3 mt -101.0 139.97 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.403 -0.811 . . . . 1.21 109.036 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -98.5 115.76 29.27 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.08 -1.012 . . . . 1.81 109.88 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -90.98 0.07 57.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.213 -0.93 . . . . 2.8 108.969 179.601 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -62.67 143.46 57.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.441 -0.787 . . . . 2.87 109.695 -179.434 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -83.7 139.39 32.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.413 -0.805 . . . . 2.35 109.873 -179.671 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.565 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.3 pt -89.83 165.28 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.97 109.807 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.8 p -89.71 170.59 10.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.235 -0.915 . . . . 1.17 108.812 178.783 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.36 -22.02 64.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.988 -1.07 . . . . 1.18 109.939 -179.852 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -82.13 -24.65 34.99 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.529 -1.286 . . . . 2.56 107.529 178.71 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -82.04 -9.8 59.43 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.547 -0.908 . . . . 1.79 108.547 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.3 t -62.94 -52.49 58.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.099 -1.001 . . . . 1.0 108.903 179.759 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -63.2 -39.89 95.93 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.259 -0.901 . . . . 1.77 109.466 179.661 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -67.32 -41.11 85.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.03 -1.044 . . . . 2.7 110.292 -178.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.565 ' HG3' HG21 ' A' ' 31' ' ' ILE . 61.9 mm-40 -66.51 -39.99 88.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.15 -0.968 . . . . 1.51 110.129 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.45 -44.51 96.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.766 -1.208 . . . . 0.93 108.186 178.706 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -59.94 -36.08 76.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.319 -0.863 . . . . 1.81 109.472 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.534 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 99.1 mtt180 -59.75 -40.32 87.72 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 118.71 -1.196 . . . . 2.78 108.114 179.522 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -63.83 -48.28 77.43 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.33 -0.856 . . . . 0.78 108.706 177.82 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.6 tp -60.09 -48.86 79.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.46 -0.775 . . . . 1.07 109.216 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.9 t -64.86 -45.11 87.42 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.218 -0.993 . . . . 1.12 108.993 179.557 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.47 -45.06 96.95 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.26 -1.936 . . . . 0.84 108.26 179.098 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -65.6 -31.63 72.77 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.389 -0.967 . . . . 3.09 108.389 178.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.0 87.45 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.451 -0.781 . . . . 0.88 109.019 179.99 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 51' ' ' SER . 11.9 ttmm -65.51 -73.8 0.12 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.752 -1.203 . . . . 2.59 107.752 179.025 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.72 -32.08 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.552 -0.718 . . . . 0.7 111.222 -178.42 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 49' ' ' LYS . 29.7 t -59.74 -54.65 43.9 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.771 -1.205 . . . . 1.4 108.109 179.141 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.53 -41.02 85.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.383 -0.823 . . . . 0.67 111.292 -179.126 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -67.55 -40.54 84.98 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.726 -1.234 . . . . 1.66 110.037 -179.135 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.3 mt -64.85 -40.14 94.69 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.894 -1.129 . . . . 1.58 108.41 179.661 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -61.36 -39.95 92.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.26 -0.9 . . . . 1.35 109.35 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.9 m -67.13 -44.06 80.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.113 -0.992 . . . . 0.77 109.645 -179.854 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.55 -39.99 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.158 -0.964 . . . . 0.63 108.86 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -53.88 -50.64 65.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.501 -0.75 . . . . 1.14 110.034 -179.368 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -60.0 -38.8 83.68 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.449 -0.782 . . . . 0.79 111.134 -177.668 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -63.55 -39.67 95.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.833 -1.167 . . . . 1.53 109.613 -179.621 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.21 -43.89 93.64 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.365 0.602 . . . . 0.57 109.769 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.43 -52.48 52.94 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 120.009 -1.091 . . . . 0.75 110.536 -179.066 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.87 -44.81 69.07 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.073 -1.251 . . . . 1.59 110.465 -179.169 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.4 m -66.23 -62.28 1.56 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.999 -1.063 . . . . 0.73 112.24 -178.165 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -95.61 -49.56 5.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.889 -1.132 . . . . 0.75 111.171 -178.33 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.22 -167.72 25.99 Favored Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.843 -1.17 . . . . 1.22 110.905 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.94 -23.74 63.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.802 -0.823 . . . . 5.81 110.461 -179.344 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.423 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.7 tp10 -60.07 -36.02 76.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.254 -0.904 . . . . 3.37 110.211 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -98.23 -19.39 17.88 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.177 -0.952 . . . . 1.77 110.225 -179.283 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -70.12 -45.46 66.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.96 -1.087 . . . . 1.65 110.55 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.592 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -62.95 -30.58 71.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.433 -0.792 . . . . 0.77 110.235 -178.626 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.5 mt -59.72 -40.29 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.963 -1.086 . . . . 0.8 108.871 -179.588 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -65.05 -39.96 94.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.031 -1.043 . . . . 0.88 109.987 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -60.21 -40.06 88.79 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.965 -1.085 . . . . 1.37 109.444 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.5 -41.84 99.64 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.16 -1.576 . . . . 0.62 109.16 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -67.66 -39.98 84.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.283 -1.128 . . . . 1.5 109.728 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.4 mt -69.1 -46.4 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.005 -1.06 . . . . 0.63 109.104 179.555 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.3 ttp -59.9 -45.93 90.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.041 -1.037 . . . . 1.51 110.425 -179.239 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.873 HD22 HD23 ' B' ' 347' ' ' LEU . 55.2 tp -60.93 -40.07 91.84 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.245 -0.91 . . . . 0.77 109.809 179.792 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.7 tp -63.14 -40.01 96.35 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.376 -0.828 . . . . 0.62 109.642 -179.047 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -82.46 9.18 9.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.37 -0.831 . . . . 1.47 109.901 -179.34 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -55.68 132.3 48.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.991 -1.068 . . . . 1.47 110.139 -179.246 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -59.94 -21.21 60.85 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.511 -0.743 . . . . 1.78 111.129 -178.562 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -72.03 -34.51 68.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.787 -1.196 . . . . 2.53 109.686 178.93 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.9 -40.77 75.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.539 -0.726 . . . . 0.8 109.76 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -60.11 -50.1 75.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.857 . . . . 1.42 110.413 -179.137 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -70.61 -40.1 73.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.187 -0.945 . . . . 1.71 111.439 -179.171 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -69.91 -40.12 75.79 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.94 -1.1 . . . . 1.57 111.489 -178.569 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.57 -41.97 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.076 -1.015 . . . . 0.65 109.422 -179.505 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.02 -37.84 73.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.432 -0.792 . . . . 0.82 110.602 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.0 -46.28 89.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.79 110.803 -178.592 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 96' ' ' LYS . 29.3 mt -63.27 -45.83 89.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.755 -1.216 . . . . 0.95 109.411 -179.741 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.08 -50.0 81.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.954 0.883 . . . . 0.66 108.796 179.523 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -70.2 -41.0 74.26 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.851 -0.74 . . . . 2.2 110.258 179.616 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -80.38 -53.05 6.97 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.062 -1.024 . . . . 1.65 112.252 -177.877 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 92' ' ' LEU . 25.9 mtpp -89.96 -3.92 57.76 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.023 -1.048 . . . . 2.03 111.854 -177.395 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 25.9 m170 58.62 38.82 25.12 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.988 -1.07 . . . . 1.42 109.306 -179.362 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.0 mtp -97.87 165.81 11.76 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.592 -0.692 . . . . 1.18 109.959 -179.526 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 46.4 p -76.65 162.22 27.91 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.402 -0.811 . . . . 0.98 109.586 -179.906 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.82 -37.18 79.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.335 -0.853 . . . . 0.64 110.482 -179.479 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 35.2 p-10 -69.96 -36.94 75.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.86 -1.15 . . . . 2.07 109.633 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.498 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -77.04 -44.97 28.81 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.4 -0.813 . . . . 0.73 109.843 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.02 -41.65 74.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.54 109.523 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.16 -37.94 81.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.065 -1.022 . . . . 0.56 109.71 179.651 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -60.11 -41.01 91.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.436 -0.79 . . . . 1.54 109.938 -178.679 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.04 -40.12 96.78 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.271 -0.893 . . . . 1.33 110.383 -179.447 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.74 -55.77 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.108 -0.995 . . . . 0.72 111.542 -177.797 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.417 HG21 ' HA3' ' A' ' 134' ' ' GLY . 47.3 mm -70.08 -40.04 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.645 -1.284 . . . . 0.85 109.22 -178.903 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -69.95 -38.11 76.03 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.344 -0.984 . . . . 2.44 108.344 178.869 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.08 -46.77 93.61 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.82 -1.312 . . . . 0.98 109.82 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -64.88 -49.04 72.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.894 -1.356 . . . . 1.41 108.866 179.577 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.87 -39.68 86.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.465 -0.772 . . . . 1.2 109.269 179.615 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.5 t -54.85 -40.0 69.18 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.326 -0.859 . . . . 1.7 109.035 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.81 -36.74 78.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 1.47 109.917 179.768 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.35 -46.17 81.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.09 -1.006 . . . . 1.56 110.558 -178.75 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -62.89 -22.06 66.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.495 -1.378 . . . . 2.2 110.268 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -67.43 -21.08 65.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.803 -1.185 . . . . 2.12 108.566 178.932 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 123' ' ' LEU . 19.4 mt -63.88 142.51 58.38 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.158 -1.053 . . . . 2.0 108.158 179.245 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 29.4 p-10 -90.78 53.24 2.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.873 -1.142 . . . . 3.23 110.516 -179.65 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 64.9 t0 -136.33 135.07 38.58 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.176 -0.953 . . . . 2.49 109.795 179.331 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.477 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 99.2 mt-10 -70.17 -32.54 70.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.297 -0.877 . . . . 3.95 110.447 -179.881 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.495 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.9 t80 -70.08 -37.22 75.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.257 -0.902 . . . . 2.0 110.46 179.538 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 118' ' ' LEU . 77.1 mt -74.0 -39.95 63.26 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.236 -0.915 . . . . 1.86 109.256 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.8 -44.32 96.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.941 . . . . 2.84 109.964 179.538 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 45.8 mt-10 -60.1 -41.3 92.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.111 -0.993 . . . . 2.73 109.29 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.55 HH21 HD23 ' A' ' 123' ' ' LEU . 9.9 ttp180 -66.73 -38.74 87.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.153 -1.054 . . . . 2.77 108.153 179.057 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.21 -26.22 64.66 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.077 -1.083 . . . . 1.19 108.077 178.62 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -69.79 -40.25 76.12 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.111 -1.07 . . . . 1.2 108.111 178.709 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -64.79 -40.15 94.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.405 -0.809 . . . . 1.55 109.206 179.693 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.53 -39.98 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.278 -1.008 . . . . 0.8 108.278 179.471 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -60.28 -39.88 88.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.479 -0.763 . . . . 3.09 109.125 179.267 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -58.14 -40.24 80.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 1.46 109.888 -179.269 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.01 -46.69 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.998 -1.064 . . . . 0.71 109.42 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.417 ' HA3' HG21 ' A' ' 108' ' ' ILE . . . -69.79 -31.54 70.25 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.791 -1.324 . . . . 0.57 109.791 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.69 -49.67 76.84 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.244 -1.151 . . . . 2.59 109.208 -179.477 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.521 HH11 ' HG2' ' A' ' 136' ' ' ARG . 17.6 mtt-85 -67.07 -36.01 81.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.08 -1.012 . . . . 2.83 109.67 179.672 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.8 tp -54.54 -49.01 71.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.476 -0.765 . . . . 1.25 109.801 -178.726 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.09 -40.07 88.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.369 -0.832 . . . . 0.7 109.565 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -72.78 -36.1 67.55 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.264 -0.897 . . . . 2.57 108.661 178.542 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.401 ' CG ' ' O ' ' A' ' 136' ' ' ARG . 68.5 m-20 -60.15 -39.75 87.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.836 -0.54 . . . . 1.23 110.97 -179.227 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.8 mt -71.09 -45.13 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.758 -1.214 . . . . 0.81 108.65 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.6 mt -69.97 -40.07 75.61 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.523 -0.871 . . . . 1.0 108.949 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.68 51.57 3.04 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.072 -1.611 . . . . 0.89 109.072 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.6 tp -73.72 148.57 42.53 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.314 -1.109 . . . . 1.14 109.009 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -66.57 141.22 57.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 4.6 109.641 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.2 mt -113.53 130.0 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-O 121.762 0.791 . . . . 1.24 110.069 -179.578 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.3 mp -68.01 -40.09 82.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.746 -0.596 . . . . 1.54 110.309 -178.599 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.3 t0 63.29 123.25 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.396 -0.815 . . . . 1.5 108.947 -178.776 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.9 mt -90.13 -0.74 57.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 0.79 110.088 -179.06 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.5 t -86.08 -17.49 34.95 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.042 -1.036 . . . . 1.4 110.17 -179.553 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.98 24.8 0.73 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.139 -0.975 . . . . 0.92 110.734 -178.838 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 41.8 mm -90.82 120.69 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.77 -1.206 . . . . 0.88 109.276 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -101.23 -17.51 16.56 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.436 -0.79 . . . . 2.45 110.259 -179.379 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -115.34 145.97 41.99 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.637 -0.665 . . . . 1.52 110.874 -178.846 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -63.8 135.23 56.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.523 -0.736 . . . . 1.58 109.4 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.0 m -151.55 164.57 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.649 -0.657 . . . . 0.69 109.452 179.39 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 86.0 mt -94.96 147.2 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 105.999 -1.852 . . . . 0.61 105.999 177.474 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 51.9 tp -96.99 117.96 32.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.035 -1.04 . . . . 0.87 110.767 -177.374 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.539 HG12 HG22 ' A' ' 209' ' ' THR . 42.3 t -121.75 127.47 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.451 -0.944 . . . . 0.71 108.451 178.846 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -156.91 161.53 39.65 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 0.81 108.717 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.93 -31.71 63.19 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.26 -1.525 . . . . 0.98 109.172 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 64.9 t0 -169.23 141.92 2.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.434 -0.791 . . . . 2.25 109.128 -179.706 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 24.6 mt -112.08 142.71 44.17 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.362 -0.837 . . . . 0.78 110.226 -179.24 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.0 p -99.56 146.8 32.42 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.466 -0.771 . . . . 0.98 109.247 179.449 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -43.56 -36.7 7.33 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.952 1.768 . . . . 0.81 112.691 179.215 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.6 m -60.0 -39.94 87.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.267 -0.896 . . . . 0.9 109.767 -178.72 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.46 -41.31 93.52 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.187 -0.945 . . . . 1.61 109.992 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 41.1 p -56.44 -33.94 66.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.61 110.959 -178.4 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.4 -53.9 20.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.91 -1.119 . . . . 0.6 109.58 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -86.47 36.34 0.69 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.604 -0.888 . . . . 1.4 108.604 179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.2 tp -100.46 130.6 46.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.817 . . . . 0.7 109.166 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -82.79 98.96 9.39 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.276 -1.009 . . . . 2.35 108.276 179.412 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 71.0 mt -65.13 -41.14 95.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.403 -0.811 . . . . 1.51 111.085 -178.569 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -66.61 -25.59 66.68 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.844 -1.16 . . . . 2.33 111.571 -177.752 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -93.32 -8.2 42.68 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.768 -1.207 . . . . 1.92 110.479 -179.037 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 178' ' ' GLY . 63.3 t -109.31 119.65 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.385 -0.968 . . . . 0.67 108.385 178.578 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.8 mt -91.42 7.1 42.78 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.262 -0.899 . . . . 1.53 110.947 -177.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.496 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.44 171.07 36.97 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.355 -1.402 . . . . 0.48 109.626 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.473 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 12.9 m-85 -133.94 129.76 36.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.463 -1.022 . . . . 0.55 109.066 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.3 mt -132.1 127.28 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.235 -1.024 . . . . 0.65 108.235 178.428 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 43.1 p -147.44 159.93 43.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.879 -1.138 . . . . 0.82 110.406 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -104.27 21.74 16.04 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.914 -0.773 . . . . 2.46 108.914 179.813 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.14 -159.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.995 -1.066 . . . . 1.28 111.202 -178.094 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.46 -53.15 8.99 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.357 -1.097 . . . . 2.19 110.357 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 157.07 -124.27 1.41 Allowed Glycine 0 N--CA 1.494 2.558 0 O-C-N 120.897 -1.355 . . . . 2.13 110.64 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -69.69 -23.9 63.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.39 -1.065 . . . . 5.86 111.014 -178.815 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 59.8 p -70.53 0.12 7.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.928 -1.107 . . . . 3.72 109.756 -179.29 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 39.2 m -89.46 124.7 34.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.08 -1.013 . . . . 1.74 110.119 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -46.48 -50.87 16.36 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.436 -0.79 . . . . 0.95 109.924 -179.549 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.82 -35.59 61.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.402 -0.811 . . . . 1.55 110.549 -178.812 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.5 t -60.07 -45.6 92.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.929 -1.107 . . . . 1.51 110.73 -179.185 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.08 -40.64 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 1.67 109.735 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.0 mtp -61.44 -40.03 92.99 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.084 -1.01 . . . . 1.02 109.964 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.61 -42.71 67.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.737 -1.227 . . . . 0.68 108.915 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -59.57 -50.06 75.36 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.461 -0.895 . . . . 2.93 109.517 -179.02 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 67.1 m -72.4 -33.13 66.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.204 -0.935 . . . . 0.86 111.114 -179.221 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.05 -22.81 63.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.952 -1.093 . . . . 0.67 109.515 -179.5 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 63.71 48.78 3.17 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.437 0.636 . . . . 1.5 110.055 -178.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 60.1 mt -130.25 150.1 75.19 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 107.797 -1.186 . . . . 0.72 107.797 178.693 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.56 144.98 62.71 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.949 1.766 . . . . 0.61 111.567 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -173.36 153.56 2.43 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.064 -1.055 . . . . 0.66 111.102 179.688 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 92.7 mt -124.72 151.62 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 107.669 -1.234 . . . . 0.79 107.669 178.832 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.0 m -133.67 -11.44 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 120.844 -1.16 . . . . 0.91 111.249 -178.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -111.17 25.73 13.49 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.655 -0.978 . . . . 1.01 110.655 -179.375 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.448 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.3 p -47.46 -38.21 13.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.759 -1.436 . . . . 0.99 109.595 -179.206 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.18 -51.06 3.4 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 120.085 -1.055 . . . . 1.12 111.257 178.782 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 207' ' ' SER . 12.9 t -156.51 33.24 0.32 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.558 -1.554 . . . . 1.72 111.4 -178.83 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 22.8 t -74.52 -36.02 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.66 -1.275 . . . . 0.89 108.348 178.159 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.539 HG22 HG12 ' A' ' 159' ' ' VAL . 44.4 p -59.97 -38.37 82.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.449 -0.782 . . . . 1.03 110.159 -179.553 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 50.4 m -82.01 -11.06 59.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.995 -1.065 . . . . 1.83 110.308 -179.162 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -99.05 -13.23 19.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.043 -1.036 . . . . 2.27 110.601 -179.231 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 213' ' ' LYS . 80.8 t -114.62 154.0 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.247 -0.908 . . . . 0.92 110.955 -178.74 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.482 ' N ' HG12 ' A' ' 212' ' ' VAL . 12.1 mptt -113.17 154.56 26.47 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.261 -1.385 . . . . 2.2 107.261 178.658 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 24.8 p-10 -59.82 141.52 55.17 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.974 -1.078 . . . . 2.36 110.134 -179.461 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 m-20 85.67 6.36 0.43 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.213 0.53 . . . . 2.38 110.032 179.692 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 53.2 t0 -76.62 150.16 36.46 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.262 -0.898 . . . . 2.09 108.71 179.037 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.526 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 50.8 t80 -95.25 122.85 38.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.066 -1.021 . . . . 1.27 108.844 179.725 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.0 mt -126.88 138.5 53.32 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.299 -0.875 . . . . 0.75 110.702 -179.288 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.4 HG23 ' CD2' ' A' ' 13' ' ' PHE . 83.6 mt -110.19 128.25 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 106.453 -1.684 . . . . 0.63 106.453 176.385 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 42.9 tp -103.36 119.92 39.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.065 -1.022 . . . . 0.7 109.901 -178.302 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 10' ' ' GLY . 30.9 t0 -83.44 -41.75 17.73 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.631 -0.877 . . . . 2.31 108.631 179.259 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.84 25.35 0.72 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.927 -0.768 . . . . 0.78 108.927 -179.574 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 37.4 t -130.74 -42.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.329 -1.36 . . . . 1.04 107.329 178.861 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.528 ' ND2' ' OE1' ' A' ' 226' ' ' GLN . 50.7 p30 -111.34 1.66 17.2 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.04 -1.467 . . . . 2.44 107.04 178.228 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.587 HD22 ' N ' ' A' ' 4' ' ' GLY . 32.8 t-20 62.15 50.12 4.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.93 -0.577 . . . . 1.55 110.258 -179.794 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.528 ' OE1' ' ND2' ' A' ' 224' ' ' ASN . 52.5 mt-30 -132.12 145.0 51.1 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.308 -0.87 . . . . 1.99 109.426 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 66.5 t -118.36 129.08 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.345 -0.983 . . . . 0.77 108.345 179.013 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -104.29 124.56 49.39 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.385 -0.969 . . . . 0.98 108.385 179.446 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.7 t -101.25 110.69 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.471 -0.768 . . . . 0.85 110.005 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 230' ' ' ASN . 30.9 t-20 48.64 67.01 4.92 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.31 -0.868 . . . . 1.66 110.571 179.541 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -86.72 157.22 8.96 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.843 2.362 . . . . 0.95 111.96 179.304 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.4 m -69.86 161.63 29.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 1.84 110.216 -179.071 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -60.04 -39.2 85.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.381 -0.824 . . . . 2.74 109.733 -179.689 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -60.04 -37.02 78.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.208 -0.932 . . . . 2.89 109.56 -179.146 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.27 -40.75 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.017 -1.052 . . . . 1.3 109.123 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.3 mt -66.13 -40.0 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.44 -0.788 . . . . 1.09 109.764 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -59.87 -39.96 87.0 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.993 -1.067 . . . . 2.43 108.436 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -66.58 -40.42 88.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 2.78 108.818 178.795 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 94.0 mtp -69.69 -33.48 72.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.513 -0.742 . . . . 1.25 109.405 179.605 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -68.44 -40.01 81.3 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.246 -0.909 . . . . 2.63 109.323 179.88 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.08 89.96 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.605 -0.887 . . . . 1.8 108.605 179.223 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 70.0 t -66.99 -40.77 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.358 -0.839 . . . . 2.13 109.252 179.99 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -60.06 -40.5 89.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 3.17 109.272 179.75 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.01 -42.02 97.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 1.78 109.742 179.593 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -60.98 -40.01 91.82 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.255 -0.903 . . . . 2.47 108.92 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 77.8 t -59.87 -40.77 83.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.399 -0.813 . . . . 2.09 109.414 -179.557 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.95 -41.69 99.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.196 -0.94 . . . . 2.54 109.21 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.0 t -60.43 -40.18 90.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.267 -0.896 . . . . 2.99 109.158 179.663 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.99 -35.53 75.21 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.589 -0.694 . . . . 3.34 109.427 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.93 -40.07 87.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 3.88 109.558 -179.546 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -59.9 -44.72 94.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 4.43 109.309 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -60.22 -39.88 88.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.504 -0.748 . . . . 5.42 109.612 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 255' ' ' LYS . 83.1 mt -60.12 -46.97 87.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.43 -0.794 . . . . 6.1 109.113 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 255' ' ' LYS . . . 45.21 22.03 0.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.356 -0.84 . . . . 7.37 110.204 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' A' ' 257' ' ' LYS . 59.8 mttm 48.05 -176.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.137 -0.977 . . . . 8.01 109.733 179.625 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.559 ' O ' HD13 ' A' ' 256' ' ' LEU . 0.2 OUTLIER 70.62 -31.77 0.23 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.12 -0.987 . . . . 9.05 109.333 -179.865 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 255' ' ' LYS . 16.0 mtpp 50.58 58.6 5.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.768 -1.208 . . . . 10.56 109.2 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 259' ' ' ARG . 29.8 p-10 -54.47 -47.5 72.89 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.101 -0.999 . . . . 11.32 109.245 -179.444 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.509 ' N ' ' OD1' ' A' ' 258' ' ' ASP . 18.4 ptt-85 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.007 -0.997 . . . . 12.42 109.503 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 35.1 ttp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.391 0.615 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -153.13 149.01 27.62 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.33 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -149.33 160.03 43.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.845 -1.159 . . . . 0.0 110.506 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -152.41 149.69 28.86 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 305' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 57.4 mp0 -107.84 130.69 54.97 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.239 -0.913 . . . . 0.0 109.555 179.381 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.83 119.09 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 122.316 1.055 . . . . 0.0 112.503 -177.726 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 94.9 m -76.86 104.07 7.15 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.159 0.98 . . . . 0.0 110.115 -178.907 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.542 HD12 ' HB ' ' B' ' 359' ' ' THR . 66.0 mt -52.56 116.35 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 122.35 1.072 . . . . 0.0 110.61 -178.017 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 30.5 p -102.08 22.3 13.37 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.632 -178.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.406 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -81.41 123.21 81.34 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.093 179.463 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -70.09 -9.02 25.03 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 CA-C-N 120.203 1.108 . . . . 0.0 112.058 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -119.76 4.22 11.05 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 75.7 178.52 43.64 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.495 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -88.49 97.21 10.95 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.129 -1.218 . . . . 0.0 108.389 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.447 ' CE1' ' H ' ' B' ' 317' ' ' ARG . 6.9 p80 -95.0 -160.62 0.8 Allowed 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.097 -1.002 . . . . 0.0 110.034 179.677 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 19.5 m -59.9 -42.05 92.99 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.017 -1.052 . . . . 0.0 112.681 -175.831 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.592 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.3 tpt180 -61.82 -64.2 3.36 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 120.229 -1.544 . . . . 0.0 111.396 -178.313 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -55.38 -32.46 81.75 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 CA-C-N 120.096 1.07 . . . . 0.0 111.929 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.88 -51.6 69.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 108.845 179.525 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.51 -40.07 65.11 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 0.0 109.652 -179.274 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 321' ' ' GLN . . . . . 0.526 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 73.1 tp60 -68.21 -45.19 74.01 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.958 -1.089 . . . . 0.0 108.961 179.258 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -60.0 -50.83 72.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.485 -0.759 . . . . 0.0 110.52 -179.245 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.55 -30.69 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.623 -1.298 . . . . 0.0 109.698 -179.166 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.526 ' NZ ' ' OE1' ' B' ' 321' ' ' GLN . 0.4 OUTLIER -59.96 -45.38 92.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.868 . . . . 0.0 109.093 179.701 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -68.28 -40.06 81.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.392 -0.818 . . . . 0.0 110.951 -178.909 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 326' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' B' ' 328' ' ' GLY . . . -74.08 -53.97 8.82 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.752 -1.218 . . . . 0.0 111.252 -178.74 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -49.51 -14.6 0.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 110.336 -178.581 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 328' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' B' ' 326' ' ' ALA . . . -79.98 -16.27 77.24 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.0 -179.897 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -105.73 143.31 34.06 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.378 -1.072 . . . . 0.0 109.308 179.577 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 31.8 m -90.19 -12.46 38.05 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.984 -1.072 . . . . 0.0 110.301 -179.564 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.432 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 13.5 p -60.49 145.01 49.99 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.93 -1.106 . . . . 0.0 109.232 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -67.66 137.06 55.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.087 -1.008 . . . . 0.0 108.75 179.678 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.3 mt -134.04 134.02 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.535 -0.728 . . . . 0.0 110.137 -179.194 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 51.9 m -129.36 149.02 51.32 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.446 -0.784 . . . . 0.0 109.164 178.959 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 64.6 t -123.34 116.63 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.063 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 93.0 m -105.95 129.32 54.11 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.088 -1.007 . . . . 0.0 109.153 -179.143 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 1.4 m -136.03 115.37 12.6 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.756 0.789 . . . . 0.0 110.666 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 40.1 t30 46.03 52.57 9.94 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 177.492 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.15 -13.73 53.19 Favored Glycine 0 N--CA 1.5 2.908 0 O-C-N 120.222 -1.549 . . . . 0.0 112.65 176.778 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 13.1 tptm -115.46 125.82 53.57 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 118.959 1.379 . . . . 0.0 108.834 -179.517 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 82.6 p -127.42 149.98 49.84 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.92 0.867 . . . . 0.0 110.574 -178.685 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 342' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -145.58 167.75 22.29 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.434 0.635 . . . . 0.0 110.234 -178.653 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 49.0 m -88.92 138.89 31.0 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.609 -0.682 . . . . 0.0 110.434 -179.233 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.47 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -81.09 -15.55 55.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.024 -1.048 . . . . 0.0 110.456 -179.366 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -84.05 22.26 1.21 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 178.33 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 346' ' ' SER . . . . . 0.47 ' H ' ' C ' ' B' ' 344' ' ' ALA . 63.6 m -150.81 101.67 2.93 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.661 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.873 HD23 HD22 ' A' ' 79' ' ' LEU . 17.3 tp -59.86 -36.6 77.21 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.388 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.852 ' CE2' HD11 ' A' ' 79' ' ' LEU . 52.6 m-85 -57.95 -53.04 62.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.86 . . . . 0.0 110.299 -179.574 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -68.53 -21.74 64.55 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.272 -0.892 . . . . 0.0 111.241 -176.884 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' B' ' 352' ' ' THR . 76.8 mt -69.26 -52.61 25.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.395 -1.44 . . . . 0.0 108.886 178.442 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.539 ' O ' HD22 ' A' ' 123' ' ' LEU . 0.8 OUTLIER -39.4 -22.33 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.696 -0.627 . . . . 0.0 110.953 -178.156 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.519 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.1 p -80.12 -10.81 59.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.18 -1.575 . . . . 0.0 110.235 -179.13 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' B' ' 342' ' ' ALA . 44.4 mt -96.48 117.79 31.64 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.085 -1.009 . . . . 0.0 108.925 178.729 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.5 95.46 0.78 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.359 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 92.6 mt -95.68 78.62 3.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -1.185 . . . . 0.0 108.691 179.252 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 75.6 p -90.97 179.75 5.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.944 . . . . 0.0 110.549 -178.338 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 357' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' B' ' 359' ' ' THR . 12.1 tt0 -50.79 157.47 0.79 Allowed 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 122.188 0.994 . . . . 0.0 111.097 -179.494 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 358' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 38.39 26.55 0.04 OUTLIER Glycine 0 N--CA 1.498 2.804 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.336 177.691 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 359' ' ' THR . . . . . 0.542 ' HB ' HD12 ' B' ' 308' ' ' ILE . 13.6 m -84.83 106.77 16.61 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.612 -1.522 . . . . 0.0 110.131 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 11.7 t -78.27 113.52 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 122.248 1.023 . . . . 0.0 110.231 -177.556 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 34.4 m -111.58 179.06 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -178.973 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 37.2 m -130.16 128.28 41.45 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 176.869 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.17 116.31 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.573 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 24.9 p -120.23 132.92 55.54 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.417 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.79 153.93 40.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 0.0 109.917 -178.888 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -147.03 125.8 12.64 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.075 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.458 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 159.23 -158.45 29.52 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.086 -1.53 . . . . 0.0 111.335 -179.654 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.14 -49.86 75.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 122.017 -0.696 . . . . 0.0 112.485 -177.385 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.432 ' H ' ' HB3' ' B' ' 331' ' ' SER . 76.9 m-20 -114.28 13.64 17.91 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.914 -1.116 . . . . 0.0 111.528 -177.039 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.551 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -42.91 -33.8 0.85 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.23 -0.919 . . . . 0.0 111.035 -179.1 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 371' ' ' GLN . . . . . 0.532 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 92.4 mm-40 -69.95 -44.2 70.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.059 -1.026 . . . . 0.0 110.412 -178.896 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -67.52 -47.63 69.36 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.544 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.67 -76.83 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.334 -0.854 . . . . 0.0 110.61 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.61 ' O ' HG23 ' B' ' 378' ' ' VAL . 94.4 t -46.4 -35.36 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 110.969 -177.319 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -67.11 -46.16 75.03 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.221 -1.549 . . . . 0.0 110.238 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -77.61 -43.48 31.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.807 -1.183 . . . . 0.0 109.546 179.165 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.05 -39.59 86.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 0.0 109.968 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.61 HG23 ' O ' ' B' ' 374' ' ' VAL . 48.5 t -60.06 -45.21 95.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.772 -1.171 . . . . 0.0 109.168 179.657 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' B' ' 383' ' ' GLU . 99.3 mttt -70.0 -56.59 6.59 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.655 -1.278 . . . . 0.0 108.114 178.565 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 42.3 tp -54.88 -35.35 63.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.402 -0.811 . . . . 0.0 109.709 -178.024 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 381' ' ' MET . . . . . 0.502 ' O ' ' CE ' ' B' ' 381' ' ' MET . 0.0 OUTLIER -73.47 -39.9 64.55 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.44 -1.304 . . . . 0.0 107.826 177.635 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.48 -4.75 50.09 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.184 -0.948 . . . . 0.0 110.205 179.534 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' B' ' 379' ' ' LYS . 69.6 mm-40 -111.81 1.08 16.42 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.198 -0.939 . . . . 0.0 110.723 179.86 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 16.1 mt -90.36 129.3 36.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.761 -1.212 . . . . 0.0 109.261 179.362 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.326 -179.501 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.8 mtp . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.232 -0.655 . . . . 2.91 109.232 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.1 mt -110.49 124.85 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.499 -0.75 . . . . 1.2 109.601 -179.804 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.427 ' HB3' HD22 ' A' ' 225' ' ' ASN . 60.5 m -133.28 145.6 50.62 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.563 -0.71 . . . . 1.4 109.154 179.956 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -129.37 -164.36 11.43 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 108.868 -1.693 . . . . 1.05 108.868 179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.1 mt -88.23 -9.93 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.922 -1.34 . . . . 1.15 110.116 -179.098 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 54.6 tp 50.3 98.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.16 -0.963 . . . . 0.98 109.13 179.804 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.11 -31.13 12.27 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.164 -0.96 . . . . 0.88 109.201 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 12.1 t -131.46 119.49 17.44 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 108.947 -0.761 . . . . 1.69 108.947 179.697 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -81.51 148.85 16.39 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.104 1.869 . . . . 0.85 112.812 -179.764 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.93 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 143.76 176.83 18.15 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 108.829 -1.708 . . . . 0.92 108.829 179.755 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 88.4 mt -120.0 153.78 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.147 -1.207 . . . . 0.81 109.833 -179.351 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.11 152.15 29.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.51 109.773 179.761 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.3 m-85 -133.47 127.58 33.59 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.334 -0.987 . . . . 0.62 108.334 179.565 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.78 175.47 47.37 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 118.885 -1.626 . . . . 0.55 110.687 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -78.66 155.4 29.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.654 -0.91 . . . . 2.1 109.529 -179.523 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.518 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -102.12 131.48 48.59 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.376 -0.828 . . . . 0.77 111.121 -178.586 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.9 tp -100.23 134.86 42.54 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.681 -1.229 . . . . 0.91 107.681 178.31 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.2 tp -115.35 119.97 38.06 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.252 -0.905 . . . . 0.93 110.144 -179.458 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt -88.87 101.11 13.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.503 -0.748 . . . . 0.93 109.944 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -95.78 133.66 39.64 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.235 -1.024 . . . . 2.75 108.235 179.441 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.535 ' CG ' HH21 ' A' ' 139' ' ' ARG . 81.8 tt0 -131.54 141.08 49.64 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.242 -0.911 . . . . 3.0 109.696 -179.398 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -88.24 141.9 28.19 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.453 -0.779 . . . . 2.77 109.662 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.52 139.98 58.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.038 -1.039 . . . . 2.94 109.078 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.5 mt -83.03 136.64 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -0.943 . . . . 0.95 108.915 179.495 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.7 t -102.69 129.55 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.444 -0.785 . . . . 1.28 109.329 -179.612 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.6 mt -106.8 138.92 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.834 -0.802 . . . . 1.21 108.834 179.919 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -92.87 119.27 32.02 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.01 -1.056 . . . . 1.81 109.586 -179.59 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.428 HH11 ' HG3' ' A' ' 28' ' ' ARG . 23.8 mmm-85 -86.95 -2.96 59.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.563 -0.711 . . . . 2.8 109.557 -179.5 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.7 144.37 56.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.125 -0.984 . . . . 2.87 109.902 179.575 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -87.99 151.17 22.98 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.837 -0.801 . . . . 2.35 108.837 179.563 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.5 pt -98.12 166.73 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.076 -1.015 . . . . 0.97 110.46 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.8 p -90.45 174.5 7.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 1.17 108.762 178.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.89 -18.7 63.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.14 -0.975 . . . . 1.18 111.087 -179.332 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -83.27 -27.4 29.89 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.565 -1.334 . . . . 2.56 108.709 178.974 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -81.19 -8.42 59.75 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.242 -0.651 . . . . 1.79 109.242 179.45 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.5 t -61.54 -54.13 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.224 -0.923 . . . . 1.0 108.917 179.516 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -62.14 -39.89 94.12 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.42 -0.8 . . . . 1.77 109.829 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -63.93 -42.78 97.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.033 -1.042 . . . . 2.7 110.104 -179.36 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -64.15 -39.79 94.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.923 -1.111 . . . . 1.51 110.328 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.85 -47.52 91.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.665 -1.272 . . . . 0.93 108.458 -179.877 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -60.04 -41.12 91.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.949 -1.094 . . . . 1.81 108.855 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -60.04 -44.47 94.63 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.842 -1.17 . . . . 2.78 107.842 178.705 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -60.32 -47.58 85.41 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.744 -0.836 . . . . 0.78 108.744 178.129 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.4 tp -59.9 -49.33 78.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 1.07 109.224 179.869 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.0 t -62.42 -43.58 98.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.024 -1.047 . . . . 1.12 109.44 179.582 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.26 -46.39 94.02 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.132 -1.587 . . . . 0.84 109.132 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -67.24 -30.71 70.68 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.328 -1.101 . . . . 3.09 108.454 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.8 -45.75 91.36 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.458 -0.776 . . . . 0.88 109.244 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 50' ' ' ALA . 30.6 ttpt -61.4 -72.69 0.11 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.901 -1.148 . . . . 2.59 107.901 179.427 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.86 -33.68 0.06 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.477 -0.764 . . . . 0.7 111.725 -178.188 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 64.1 m -59.95 -50.65 72.92 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.064 -1.454 . . . . 1.4 107.95 179.452 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.62 -40.09 76.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.44 -0.788 . . . . 0.67 111.211 -179.215 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -66.45 -40.04 89.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.663 -1.273 . . . . 1.66 110.116 -179.427 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.1 mt -65.09 -40.0 93.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.925 . . . . 1.58 109.783 -179.464 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -61.85 -38.04 86.75 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.98 -1.075 . . . . 1.35 109.694 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -63.63 -41.62 98.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 0.77 109.774 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.3 -39.89 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.198 -0.939 . . . . 0.63 109.077 179.756 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -55.67 -50.05 71.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -0.842 . . . . 1.14 109.542 -179.586 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -57.34 -33.23 67.53 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.223 -0.923 . . . . 0.79 110.062 -178.457 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -69.82 -39.76 76.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.944 -1.097 . . . . 1.53 110.594 179.593 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.407 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.13 -44.36 80.07 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.232 -0.918 . . . . 0.57 110.218 -178.931 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.78 -50.89 62.83 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.931 -1.268 . . . . 0.75 109.931 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.9 -43.93 70.75 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.99 -1.3 . . . . 1.59 109.985 -179.783 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.0 m -66.43 -62.73 1.31 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.118 -0.989 . . . . 0.73 111.742 -178.09 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -95.43 -48.71 5.74 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.872 -1.143 . . . . 0.75 111.316 -178.071 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.83 -166.64 25.86 Favored Glycine 0 N--CA 1.504 3.173 0 C-N-CA 119.818 -1.182 . . . . 1.22 111.043 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.51 -23.42 64.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.673 -0.898 . . . . 5.81 109.618 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -60.73 -37.69 82.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.816 . . . . 3.37 110.872 -179.579 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -99.43 -15.01 18.88 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.007 -1.058 . . . . 1.77 109.858 -179.567 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -70.03 -39.99 75.42 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.081 -1.012 . . . . 1.65 109.085 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.496 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.68 -31.5 72.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.622 -0.674 . . . . 0.77 109.946 -179.466 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 80.8 mt -59.89 -41.2 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.828 -1.17 . . . . 0.8 108.538 179.836 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -65.3 -39.32 92.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.959 . . . . 0.88 110.501 179.707 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -60.01 -39.85 87.21 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.697 -1.252 . . . . 1.37 109.086 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.41 -48.96 68.36 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.462 -1.855 . . . . 0.62 108.462 178.677 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -62.02 -44.72 96.11 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.264 -1.139 . . . . 1.5 108.682 179.203 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 80.9 mt -68.7 -48.6 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.266 -0.896 . . . . 0.63 109.344 179.429 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 52.3 ttp -60.17 -40.83 91.3 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.939 -1.101 . . . . 1.51 109.764 -179.168 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.848 HD22 HD23 ' B' ' 347' ' ' LEU . 53.5 tp -64.97 -39.9 94.18 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.338 -0.851 . . . . 0.77 109.907 179.639 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.0 tp -64.27 -40.1 95.29 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.497 -0.752 . . . . 0.62 110.268 -179.137 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -81.06 7.85 9.95 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.904 -1.123 . . . . 1.47 110.557 -178.853 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -56.91 129.78 43.03 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.081 -1.012 . . . . 1.47 110.134 -178.974 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -60.33 -15.36 24.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.33 -0.857 . . . . 1.78 110.438 -179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -69.9 -35.98 75.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.956 -1.09 . . . . 2.53 108.675 178.677 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.2 mt -71.17 -42.84 68.56 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.49 0.662 . . . . 0.8 110.054 179.735 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.59 -47.77 84.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.907 . . . . 1.42 110.551 -179.138 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -70.74 -43.92 67.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.089 -1.007 . . . . 1.71 111.746 -178.737 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -70.41 -38.65 74.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.127 -0.983 . . . . 1.57 111.525 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.53 -42.23 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.044 -1.035 . . . . 0.65 110.016 -179.062 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.81 -37.78 77.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.42 -0.8 . . . . 0.82 110.17 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.01 -46.45 89.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.137 -0.977 . . . . 0.79 111.13 -179.03 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.2 mt -60.96 -45.55 94.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.734 -1.228 . . . . 0.95 109.992 -178.964 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.36 -50.02 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 0.66 109.42 -179.577 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.04 -40.91 74.85 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.833 -0.747 . . . . 2.2 110.487 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -81.54 -50.5 9.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.129 -0.982 . . . . 1.65 112.249 -178.185 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -93.04 -2.24 55.83 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.071 -1.018 . . . . 2.03 111.982 -176.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 57.4 35.97 26.57 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.059 -1.026 . . . . 1.42 109.793 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.5 mtt -90.39 168.04 12.18 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.45 -0.781 . . . . 1.18 110.128 -179.457 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.5 p -80.15 160.64 25.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.489 -0.757 . . . . 0.98 109.597 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.82 -39.72 76.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.64 110.381 -179.557 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 34.2 p-10 -66.31 -39.2 89.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.052 -1.03 . . . . 2.07 109.821 -179.626 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.484 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -78.93 -51.59 9.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.73 109.704 179.417 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.48 77.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.537 -0.727 . . . . 0.54 111.131 -179.002 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.04 -45.92 91.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.065 -1.022 . . . . 0.56 110.018 -179.059 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -58.39 -37.16 74.7 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.308 -0.87 . . . . 1.54 109.917 -179.706 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.92 -39.99 91.5 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.26 -0.9 . . . . 1.33 111.014 -179.127 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.85 -49.97 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.832 -1.168 . . . . 0.72 110.58 -178.631 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.7 mm -67.42 -40.24 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.992 -1.067 . . . . 0.85 108.237 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -66.92 -37.2 83.89 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.184 -1.043 . . . . 2.44 108.184 178.836 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.93 -49.0 83.34 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.009 -1.236 . . . . 0.98 110.009 -179.484 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -65.86 -48.05 72.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.853 -1.38 . . . . 1.41 109.123 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.383 -0.823 . . . . 1.2 109.222 -179.825 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 58.5 m -60.02 -40.1 88.15 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.267 -1.012 . . . . 1.7 108.267 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.35 -43.5 96.45 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.45 -0.944 . . . . 1.47 108.45 179.074 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.7 mt -64.04 -48.83 74.72 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.159 -1.052 . . . . 1.56 108.159 179.302 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -49.48 -31.86 10.91 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.321 -0.862 . . . . 2.2 109.998 -179.11 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.74 -20.28 55.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.892 -1.13 . . . . 2.12 108.668 179.555 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 74.1 mt -63.15 140.05 58.83 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.511 -0.922 . . . . 2.0 108.511 179.317 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -99.11 49.01 0.95 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.116 -0.99 . . . . 3.23 111.02 -178.531 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 24.7 t0 -137.38 153.22 50.23 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.145 -0.972 . . . . 2.49 109.119 178.993 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.457 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 99.5 mt-10 -72.44 -64.78 0.88 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.95 -1.13 . . . . 3.95 107.95 178.352 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.437 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 6.6 t80 -41.33 -43.74 2.56 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.91 -0.494 . . . . 2.0 110.895 -179.234 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.607 HD23 HH21 ' A' ' 126' ' ' ARG . 85.3 mt -69.88 -40.05 75.92 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.604 -1.31 . . . . 1.86 109.028 -179.836 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -65.33 -37.36 86.85 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.525 -0.735 . . . . 2.84 109.563 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 95.0 mt-10 -59.83 -42.15 92.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.391 -0.818 . . . . 2.73 110.268 -179.031 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.607 HH21 HD23 ' A' ' 123' ' ' LEU . 82.2 mtm180 -70.05 -32.72 70.98 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.924 -1.11 . . . . 2.77 108.812 179.621 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.22 -22.77 65.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.735 -1.209 . . . . 1.19 107.735 178.458 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -73.72 -40.04 63.85 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.511 -0.922 . . . . 1.2 108.511 178.609 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.99 -41.22 99.51 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.433 -0.792 . . . . 1.55 110.377 -179.587 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.8 t -68.67 -40.45 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.047 -1.033 . . . . 0.8 108.873 179.776 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.415 HH11 ' HG2' ' A' ' 131' ' ' ARG . 36.3 ttt-85 -60.19 -37.69 81.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 3.09 108.779 178.602 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 61.6 t0 -59.84 -38.97 83.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.527 -0.733 . . . . 1.46 109.68 -179.483 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.04 -40.65 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.083 -1.011 . . . . 0.71 109.563 -179.486 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.13 -26.85 67.53 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.848 -1.301 . . . . 0.57 109.848 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -60.1 -49.62 76.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -1.186 . . . . 2.59 109.575 -179.217 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.412 HH22 ' HB3' ' A' ' 166' ' ' SER . 98.5 mtt180 -68.32 -32.96 73.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.786 -1.197 . . . . 2.83 110.559 179.545 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.6 tp -54.34 -43.96 71.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.936 -1.103 . . . . 1.25 108.795 -179.338 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.92 -39.98 93.91 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.124 -0.985 . . . . 0.7 109.037 178.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.624 HH12 HD23 ' A' ' 144' ' ' LEU . 3.2 mtt-85 -68.13 -40.02 82.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.856 . . . . 2.57 109.714 179.407 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -68.76 -38.27 79.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.458 -0.776 . . . . 1.23 112.265 -178.439 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.91 -40.09 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.321 -1.487 . . . . 0.81 108.791 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 92.2 mt -76.03 -28.69 57.8 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.509 -0.744 . . . . 1.0 110.167 -179.429 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.81 38.95 18.46 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.423 -1.471 . . . . 0.89 109.423 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.624 HD23 HH12 ' A' ' 139' ' ' ARG . 3.3 tp -73.89 147.18 43.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.259 -1.141 . . . . 1.14 108.619 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -66.43 137.02 56.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.034 -1.041 . . . . 4.6 109.653 -179.153 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 83.2 mt -109.83 132.92 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 122.218 1.008 . . . . 1.24 108.512 179.548 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.3 mt -65.02 -39.97 87.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 115.637 -0.71 . . . . 1.54 110.768 -178.304 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 41.3 t0 63.21 102.23 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.412 -0.805 . . . . 1.5 108.861 -179.255 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.9 mt -70.02 -1.11 8.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.365 -0.834 . . . . 0.79 111.49 -178.023 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.7 t -84.66 -13.15 52.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.524 -1.36 . . . . 1.4 110.324 -179.734 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.93 31.64 0.2 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.092 -1.005 . . . . 0.92 112.052 -178.07 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.8 mm -86.04 120.0 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.234 -1.541 . . . . 0.88 109.087 179.546 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -101.41 -9.32 21.22 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.321 -0.862 . . . . 2.45 110.462 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -140.31 159.93 41.1 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.039 -1.038 . . . . 1.52 110.867 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.83 132.88 50.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.501 -0.75 . . . . 1.58 109.162 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.0 m -152.06 165.5 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.274 -0.891 . . . . 0.69 110.074 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.9 mt -97.09 145.29 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 105.522 -2.029 . . . . 0.61 105.522 176.958 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.3 tp -95.41 115.49 27.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.873 -1.142 . . . . 0.87 110.614 -177.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.526 HG12 HG22 ' A' ' 209' ' ' THR . 57.0 t -120.28 128.07 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 N-CA-C 108.257 -1.016 . . . . 0.71 108.257 179.026 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.48 165.58 30.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.025 -1.047 . . . . 0.81 109.27 -179.582 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.77 -38.0 73.41 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.363 -1.461 . . . . 0.98 108.567 178.61 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 54.0 t0 -171.7 147.16 2.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.582 -0.699 . . . . 2.25 109.468 -179.667 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.412 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 17.6 mt -119.91 136.72 54.4 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.281 -0.887 . . . . 0.78 108.859 179.505 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.5 p -89.98 149.98 42.75 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.179 -0.951 . . . . 0.98 110.009 -179.424 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -40.63 -39.39 2.95 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.563 2.175 . . . . 0.81 113.438 179.58 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.412 ' HB3' HH22 ' A' ' 136' ' ' ARG . 66.1 m -59.99 -39.96 87.51 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.966 -1.084 . . . . 0.9 109.253 -179.122 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.68 -40.08 94.78 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.346 -0.846 . . . . 1.61 110.129 -179.828 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 51.7 p -57.97 -34.55 70.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.163 -0.96 . . . . 0.61 111.225 -177.973 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -69.4 -50.91 41.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.962 -1.086 . . . . 0.6 109.914 -179.659 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -85.7 36.67 0.67 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.421 -0.799 . . . . 1.4 108.9 -179.612 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.2 tp -99.97 140.01 34.8 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.451 -0.781 . . . . 0.7 109.491 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -84.4 104.63 14.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.021 -1.049 . . . . 2.35 108.62 179.185 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 63.2 mt -65.75 -40.97 92.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.442 -0.786 . . . . 1.51 111.612 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -81.25 -15.01 56.82 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.638 -1.289 . . . . 2.33 112.162 -177.172 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -95.33 -10.63 29.59 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.611 -1.305 . . . . 1.92 109.132 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 178' ' ' GLY . 99.9 t -110.28 120.08 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.401 -0.812 . . . . 0.67 108.82 178.669 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -91.64 7.85 39.59 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.027 -1.045 . . . . 1.53 110.723 -178.794 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.27 172.37 38.04 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.543 -1.423 . . . . 0.48 109.543 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -132.94 129.89 38.88 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.326 -1.102 . . . . 0.55 109.403 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.439 ' CG2' HG21 ' A' ' 205' ' ' THR . 96.2 mt -132.02 124.26 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.865 -0.791 . . . . 0.65 108.865 178.67 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 53.6 p -146.97 159.8 43.12 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.132 -0.98 . . . . 0.82 110.761 -179.615 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.8 OUTLIER -96.35 21.63 8.83 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.124 -0.695 . . . . 2.46 109.124 179.686 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.485 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -45.58 -176.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 122.341 1.067 . . . . 1.28 112.847 -177.898 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.93 -56.77 4.71 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 111.131 -0.788 . . . . 2.19 111.131 -179.119 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.46 -144.24 5.1 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.118 -1.515 . . . . 2.13 110.79 -179.34 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 188' ' ' SER . 82.1 mtm180 -69.66 -28.14 65.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.54 -0.976 . . . . 5.86 110.302 -178.977 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 69.7 p -62.95 5.82 0.12 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.194 -0.942 . . . . 3.72 110.614 -178.756 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 186' ' ' ARG . 40.4 t -90.67 128.35 36.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.987 -1.071 . . . . 1.74 109.894 -179.982 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -47.52 -44.17 25.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.316 -0.865 . . . . 0.95 108.825 179.687 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 45.3 p -57.8 -39.56 77.82 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.78 -0.575 . . . . 1.55 110.425 -179.058 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 58.5 m -59.94 -40.17 88.04 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.997 -1.064 . . . . 1.51 110.899 -178.868 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.555 HD12 ' N ' ' A' ' 192' ' ' ILE . 2.2 mp -64.75 -40.07 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.951 -1.093 . . . . 1.67 110.295 -179.035 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.5 mtp -61.25 -41.14 96.39 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.843 -1.161 . . . . 1.02 110.615 -179.441 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.86 -44.1 94.32 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.505 -1.372 . . . . 0.68 109.541 -179.73 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.43 HH11 ' HG2' ' A' ' 195' ' ' ARG . 30.0 mtt-85 -60.23 -50.1 74.99 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.272 -0.893 . . . . 2.93 109.996 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 39.4 m -72.0 -35.72 69.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.11 -0.994 . . . . 0.86 111.823 -178.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.6 mt -76.67 -13.24 60.07 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.499 -1.376 . . . . 0.67 110.194 -178.702 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 59.81 46.08 11.87 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.533 -0.73 . . . . 1.5 110.547 179.392 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.409 ' O ' ' CB ' ' A' ' 8' ' ' SER . 90.6 mt -122.85 128.91 25.2 Favored Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 108.687 -0.857 . . . . 0.72 108.687 179.313 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -43.41 133.92 6.8 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.82 1.68 . . . . 0.61 112.073 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -167.27 147.17 5.32 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.575 -1.25 . . . . 0.66 111.89 -179.483 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.7 mt -125.58 141.07 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 107.772 -1.196 . . . . 0.79 107.772 178.362 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 11.2 m -126.71 -7.29 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 120.806 -1.184 . . . . 0.91 110.589 -179.067 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.15 22.06 25.84 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.544 -1.022 . . . . 1.01 110.544 -179.62 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.456 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 12.6 p -47.14 -44.58 21.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.834 -1.392 . . . . 0.99 109.782 -179.287 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.69 -53.96 4.07 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 120.022 -1.085 . . . . 1.12 112.036 178.688 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.0 t -150.03 28.27 0.76 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 120.485 -1.597 . . . . 1.72 111.905 -178.2 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 45.6 t -70.25 -40.07 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.74 -1.225 . . . . 0.89 109.126 178.314 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.526 HG22 HG12 ' A' ' 159' ' ' VAL . 75.9 p -53.79 -30.82 46.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.377 -0.827 . . . . 1.03 111.392 -178.945 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.7 m -81.28 -12.95 58.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.823 -1.173 . . . . 1.83 110.283 -179.132 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -102.57 -12.14 17.98 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.141 -0.974 . . . . 2.27 110.351 -179.612 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 85.0 t -107.86 139.24 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.177 -0.952 . . . . 0.92 111.675 -177.66 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -114.25 150.01 35.02 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.356 -1.35 . . . . 2.2 107.356 178.212 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.507 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 21.3 p-10 -57.1 140.45 49.28 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.735 -1.228 . . . . 2.36 109.9 -179.356 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.1 t0 87.15 4.07 0.37 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 109.525 -0.546 . . . . 2.38 109.525 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 64.8 t0 -74.7 139.41 43.44 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.204 -0.935 . . . . 2.09 109.561 179.512 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.469 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 48.4 t80 -91.94 116.56 29.02 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.524 -1.287 . . . . 1.27 107.524 178.456 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.518 HD12 ' HB2' ' A' ' 16' ' ' ALA . 76.4 mt -127.37 149.4 50.08 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.468 -0.77 . . . . 0.75 110.297 -178.631 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 63.1 mt -114.66 129.71 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 106.859 -1.534 . . . . 0.63 106.859 176.905 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 55.0 tp -100.14 119.17 37.92 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.078 -1.082 . . . . 0.7 108.078 -179.153 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.459 ' C ' ' N ' ' A' ' 223' ' ' VAL . 78.7 m-20 -81.4 -46.73 14.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.965 -1.084 . . . . 2.31 109.51 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.93 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 48.23 17.27 0.11 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.792 -0.818 . . . . 0.78 108.792 -179.251 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.459 ' N ' ' C ' ' A' ' 221' ' ' ASP . 55.3 t -127.19 -49.42 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.256 -1.387 . . . . 1.04 107.256 178.387 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -100.31 2.87 42.98 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.412 -1.329 . . . . 2.44 107.412 178.37 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.427 HD22 ' HB3' ' A' ' 3' ' ' SER . 49.7 t30 59.82 49.18 8.24 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.04 -0.726 . . . . 1.55 109.04 -179.071 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -136.85 147.11 46.33 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.438 -0.789 . . . . 1.99 109.572 -179.642 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.5 t -119.89 126.84 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.269 -1.011 . . . . 0.77 108.269 179.474 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -100.1 117.56 34.61 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.185 -0.947 . . . . 0.98 108.934 179.854 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.3 t -98.8 111.52 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.734 -0.604 . . . . 0.85 109.914 -179.044 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 43.3 t30 55.18 68.54 2.47 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.311 -0.868 . . . . 1.66 111.235 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -90.67 145.42 3.86 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 123.13 2.553 . . . . 0.95 112.122 178.944 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 61.2 p -69.95 163.98 24.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.039 -1.038 . . . . 1.84 109.646 -179.618 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -60.19 -40.38 89.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 2.74 110.071 -178.945 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -60.07 -39.98 87.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.057 -1.027 . . . . 2.89 109.522 -179.785 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.69 -40.4 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.052 -1.03 . . . . 1.3 109.299 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.456 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 93.0 mt -61.61 -39.78 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.266 -0.896 . . . . 1.09 109.085 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -59.94 -40.06 87.66 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.155 -0.965 . . . . 2.43 109.021 179.657 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -65.18 -42.63 93.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 2.78 109.116 179.39 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 91.1 mtp -67.79 -34.33 76.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.35 -0.844 . . . . 1.25 109.142 179.604 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.571 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -63.19 -39.98 96.21 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.374 -0.829 . . . . 2.63 109.663 179.38 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.15 87.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.015 -1.053 . . . . 1.8 108.879 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.86 -39.98 83.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.371 -0.83 . . . . 2.13 109.008 179.557 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -59.97 -40.88 90.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.092 -1.005 . . . . 3.17 109.364 179.586 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.63 -40.0 93.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 1.78 109.026 179.496 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -60.79 -39.69 89.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.444 -0.785 . . . . 2.47 109.639 179.558 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 73.9 t -59.58 -39.88 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.465 -0.772 . . . . 2.09 109.793 -178.901 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.3 85.05 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.156 -0.965 . . . . 2.54 108.866 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 54.3 p -68.84 -33.68 74.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.478 -0.764 . . . . 2.99 109.954 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -60.48 -33.68 72.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.069 -1.019 . . . . 3.34 109.555 -179.755 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -60.01 -39.56 86.21 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.493 -0.928 . . . . 3.88 108.493 -179.711 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.541 ' C ' ' H ' ' A' ' 253' ' ' LEU . . . -65.06 -59.95 3.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.291 -0.881 . . . . 4.43 108.816 179.137 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 54.49 1.08 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.407 -0.808 . . . . 5.42 110.13 179.406 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.541 ' H ' ' C ' ' A' ' 251' ' ' ALA . 38.5 mt 48.86 44.79 22.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.826 -1.171 . . . . 6.1 109.424 179.656 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.3 -35.92 74.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.944 . . . . 7.37 109.807 -179.577 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -60.07 -40.02 88.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.021 . . . . 8.01 108.776 -179.785 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 8.2 tp -97.26 30.64 2.73 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.786 -1.191 . . . . 9.05 107.786 179.08 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 253' ' ' LEU . 45.6 mmtm 56.33 -171.7 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.146 -1.057 . . . . 10.56 108.146 -179.021 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -153.18 88.27 1.3 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.775 -1.203 . . . . 11.32 110.172 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.402 HH11 ' HG2' ' A' ' 259' ' ' ARG . 32.2 ttt-85 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.981 . . . . 12.42 109.422 179.566 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 301' ' ' MET . . . . . 0.482 ' N ' ' OE1' ' B' ' 366' ' ' GLU . 11.0 ttt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.488 0.661 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -156.93 154.23 29.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.382 -0.824 . . . . 0.0 109.056 178.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -151.21 162.44 40.88 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.916 -1.115 . . . . 0.0 110.737 -178.951 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 304' ' ' GLN . . . . . 0.418 ' NE2' HG11 ' B' ' 378' ' ' VAL . 49.0 tt0 -154.96 152.16 29.37 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.611 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -113.0 133.93 54.74 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.094 -1.004 . . . . 0.0 110.346 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.1 p -134.45 125.61 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 CA-C-O 122.415 1.102 . . . . 0.0 112.475 -178.492 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 307' ' ' THR . . . . . 0.487 ' O ' HG23 ' B' ' 309' ' ' THR . 93.9 m -77.83 106.29 9.57 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.306 -177.875 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.9 mt -52.13 122.02 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 122.222 1.01 . . . . 0.0 110.413 -178.186 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 309' ' ' THR . . . . . 0.487 HG23 ' O ' ' B' ' 307' ' ' THR . 62.4 p -110.73 18.62 19.45 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.697 -178.579 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.25 115.98 53.69 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.083 -1.011 . . . . 0.0 109.584 179.642 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -49.5 -15.4 0.9 Allowed 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 121.114 1.209 . . . . 0.0 114.266 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -118.92 9.44 11.93 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.199 -0.938 . . . . 0.0 109.694 -179.42 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.2 177.74 26.64 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -179.118 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.437 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.0 tp -83.73 93.86 8.02 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.034 -1.274 . . . . 0.0 109.716 -178.32 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -95.92 -162.52 0.96 Allowed 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.661 -1.274 . . . . 0.0 110.391 179.274 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 25.8 m -55.9 -40.01 72.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.154 -0.967 . . . . 0.0 112.377 -176.31 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.517 HH21 ' CD ' ' B' ' 321' ' ' GLN . 1.7 tpt180 -62.9 -61.65 7.09 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 120.677 -1.265 . . . . 0.0 112.507 -178.37 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.98 -32.54 95.53 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 CA-C-N 120.275 1.134 . . . . 0.0 111.896 -179.24 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.94 -50.07 75.21 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.139 -1.024 . . . . 0.0 108.457 179.363 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.65 -40.61 60.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.71 -179.423 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 321' ' ' GLN . . . . . 0.517 ' CD ' HH21 ' B' ' 317' ' ' ARG . 27.2 mt-30 -72.8 -40.06 66.18 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.827 -1.149 . . . . 0.0 109.457 178.631 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -60.28 -51.5 69.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.18 -0.95 . . . . 0.0 109.996 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 92.4 t -69.01 -24.73 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.936 -1.103 . . . . 0.0 110.501 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.466 ' HZ1' ' HA ' ' B' ' 321' ' ' GLN . 0.9 OUTLIER -60.03 -42.49 94.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.859 -1.15 . . . . 0.0 108.823 179.9 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -69.5 -60.06 2.58 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.626 -0.671 . . . . 0.0 111.562 -178.185 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.1 -9.01 43.1 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.822 -1.174 . . . . 0.0 112.698 -177.512 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -83.67 -20.3 33.81 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.441 -1.412 . . . . 0.0 110.113 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -87.52 -10.97 69.56 Favored Glycine 0 N--CA 1.498 2.78 0 C-N-CA 120.084 -1.055 . . . . 0.0 111.158 -178.915 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -102.45 143.23 32.44 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.961 -1.317 . . . . 0.0 109.417 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 57.9 p -89.59 -13.84 36.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.034 -1.041 . . . . 0.0 110.06 -179.739 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 82.2 p -58.9 145.24 41.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.109 -0.994 . . . . 0.0 109.095 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 332' ' ' GLU . . . . . 0.462 ' OE1' ' N ' ' B' ' 332' ' ' GLU . 49.5 mp0 -68.26 130.1 41.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.187 -0.946 . . . . 0.0 109.069 -179.804 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 86.1 mt -132.18 132.55 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.589 -0.695 . . . . 0.0 110.21 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 95.3 m -131.06 151.3 51.56 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.5 -0.75 . . . . 0.0 109.725 179.393 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 96.3 t -125.12 120.05 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.765 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 95.1 m -116.84 130.09 56.49 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.037 -1.039 . . . . 0.0 110.329 -178.321 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 2.0 m -133.75 117.62 17.13 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.883 0.849 . . . . 0.0 110.037 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 48.3 t30 49.66 50.51 18.17 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 176.96 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.84 -12.01 65.03 Favored Glycine 0 N--CA 1.504 3.19 0 O-C-N 119.682 -1.886 . . . . 0.0 113.434 176.286 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -120.56 132.5 55.19 Favored 'General case' 0 N--CA 1.506 2.375 0 CA-C-N 119.292 1.546 . . . . 0.0 108.957 -179.498 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 95.7 p -135.78 156.15 49.26 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 121.94 0.876 . . . . 0.0 111.249 -178.317 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -145.65 167.36 23.29 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.583 0.706 . . . . 0.0 110.183 -179.401 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 3.7 t -85.38 133.54 34.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.614 -0.679 . . . . 0.0 110.212 -179.392 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -70.71 -19.11 62.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.126 -0.984 . . . . 0.0 110.687 -179.361 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -88.49 21.36 2.95 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.168 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 346' ' ' SER . . . . . 0.42 ' H ' ' C ' ' B' ' 344' ' ' ALA . 59.7 p -144.42 93.81 2.48 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.863 -179.037 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.848 HD23 HD22 ' A' ' 79' ' ' LEU . 44.4 tp -59.84 -38.97 83.6 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.669 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.715 ' CE2' HD11 ' A' ' 79' ' ' LEU . 57.5 m-85 -54.16 -52.28 61.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.185 -0.947 . . . . 0.0 110.946 -179.22 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -69.64 -39.24 77.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.432 -1.417 . . . . 0.0 110.102 -179.378 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' B' ' 352' ' ' THR . 23.7 mt -50.12 -59.78 3.59 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.73 -1.232 . . . . 0.0 109.534 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.551 ' OE1' ' NH1' ' A' ' 126' ' ' ARG . 13.1 mm-40 -43.29 -11.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.555 -0.716 . . . . 0.0 111.4 -177.499 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.586 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.3 p -89.47 -8.96 51.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.586 -1.321 . . . . 0.0 109.638 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 68.8 mt -93.44 120.0 33.2 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.011 -1.055 . . . . 0.0 108.664 178.58 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.04 94.81 0.81 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 44.2 mt -102.26 88.22 3.25 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.429 -1.041 . . . . 0.0 109.569 179.691 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 71.8 p -93.11 170.8 9.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.071 -1.018 . . . . 0.0 110.528 -179.566 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -64.45 116.39 6.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.758 -0.589 . . . . 0.0 110.99 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 102.26 4.83 50.14 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.511 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 49.7 m -85.67 110.83 19.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.37 -1.077 . . . . 0.0 110.84 -179.244 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 45.7 t -76.23 115.9 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.965 0.888 . . . . 0.0 109.206 -177.301 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 13.3 m -110.21 175.79 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -178.266 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 26.4 m -130.86 131.29 44.47 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 177.463 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 78.3 mt -108.71 120.84 60.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.432 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 78.3 p -127.2 136.81 52.56 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.021 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.53 155.21 41.64 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.88 -1.138 . . . . 0.0 110.66 -179.271 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 366' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' B' ' 301' ' ' MET . 12.6 tp10 -144.84 121.98 11.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.476 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.452 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 161.07 -158.71 30.37 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 118.474 -1.822 . . . . 0.0 112.08 179.573 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -59.98 -51.89 67.73 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.396 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -110.13 11.31 23.78 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.958 -1.089 . . . . 0.0 111.239 -177.086 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' B' ' 371' ' ' GLN . 0.0 OUTLIER -40.52 -31.66 0.16 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.279 -0.888 . . . . 0.0 112.469 -178.43 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 371' ' ' GLN . . . . . 0.553 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 63.9 mt-30 -66.81 -48.3 69.38 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.374 -1.454 . . . . 0.0 110.958 -177.861 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -66.86 -48.17 69.66 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.53 -1.268 . . . . 0.0 108.339 179.669 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -42.6 -40.85 2.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.702 -0.624 . . . . 0.0 111.697 -178.614 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.506 ' O ' HG23 ' B' ' 378' ' ' VAL . 62.4 t -80.05 -32.63 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.283 -1.511 . . . . 0.0 109.769 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.98 -41.64 74.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.823 . . . . 0.0 112.392 -177.682 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 376' ' ' HIS . . . . . 0.488 ' O ' ' N ' ' B' ' 380' ' ' LEU . 67.1 m80 -86.54 -42.38 13.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.398 -1.438 . . . . 0.0 110.382 -179.513 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.05 -40.01 83.79 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.956 -1.097 . . . . 0.0 108.285 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.506 HG23 ' O ' ' B' ' 374' ' ' VAL . 51.1 t -64.36 -46.38 93.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.595 179.129 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -80.09 -9.5 59.71 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.785 -1.197 . . . . 0.0 109.786 178.492 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' B' ' 376' ' ' HIS . 49.5 tp -83.54 -28.27 28.74 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 176.769 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 56.9 tpp -81.42 -29.56 33.82 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.121 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.21 -9.6 59.76 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.891 -0.506 . . . . 0.0 109.902 179.413 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -106.96 1.48 24.52 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.231 -0.918 . . . . 0.0 110.998 -179.652 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 384' ' ' LEU . . . . . 0.405 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 20.6 mt -78.59 117.89 20.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.275 -1.516 . . . . 0.0 110.002 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 117.912 -1.042 . . . . 0.0 108.736 178.715 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 mmt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.197 -0.668 . . . . 2.91 109.197 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 99.3 mt -109.77 126.42 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.407 -0.96 . . . . 1.2 108.407 179.202 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -125.13 121.6 34.71 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.604 -0.685 . . . . 1.4 110.018 -178.78 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.72 -164.97 32.99 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.186 -1.566 . . . . 1.05 109.186 179.166 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' LEU . 88.2 mt -88.68 -13.6 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.02 -1.283 . . . . 1.15 109.854 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 5' ' ' ILE . 56.2 tp 46.07 99.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.227 -0.921 . . . . 0.98 110.342 179.094 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.51 -29.48 12.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.031 -1.043 . . . . 0.88 108.963 179.063 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 40.9 t -119.22 116.46 33.86 Favored Pre-proline 0 N--CA 1.501 2.101 0 N-CA-C 109.039 -0.726 . . . . 1.69 109.039 179.46 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.22 142.83 17.19 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.618 1.545 . . . . 0.85 111.877 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.734 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 161.4 -159.72 31.51 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.218 -1.553 . . . . 0.92 109.218 -179.713 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.3 mt -148.51 148.37 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 120.808 -1.407 . . . . 0.81 109.09 179.638 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.18 153.12 30.24 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.899 -1.126 . . . . 0.51 111.291 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 8.7 m-85 -133.16 129.94 38.52 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.72 -1.585 . . . . 0.62 106.72 177.891 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.67 175.68 46.63 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 117.936 -2.078 . . . . 0.55 111.245 -179.725 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -77.47 160.02 28.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.889 -0.771 . . . . 2.1 109.11 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.447 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -100.45 127.15 46.87 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.312 -0.867 . . . . 0.77 110.927 -179.06 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.5 tp -100.79 134.35 43.89 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 106.972 -1.492 . . . . 0.91 106.972 178.011 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.2 tp -120.4 122.32 40.49 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.123 -0.985 . . . . 0.93 110.044 -179.564 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 62.0 mt -80.85 102.61 10.14 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.499 0.666 . . . . 0.93 109.678 -179.421 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -99.34 131.09 45.6 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.451 -0.781 . . . . 2.75 109.883 -179.219 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -127.39 139.11 53.07 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.969 -0.752 . . . . 3.0 108.969 -179.948 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 61.6 t0 -82.7 149.71 27.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.983 -1.073 . . . . 2.77 109.171 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.55 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 70.7 tt0 -68.08 147.31 52.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 2.94 109.269 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.3 mt -97.62 133.78 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.232 -0.918 . . . . 0.95 109.181 -179.747 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.3 t -103.43 127.86 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.249 -0.907 . . . . 1.28 110.164 -179.056 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 84.1 mt -99.2 142.48 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.477 -0.765 . . . . 1.21 109.293 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -97.11 117.32 31.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.065 -1.022 . . . . 1.81 109.449 -179.762 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -89.27 3.61 51.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.172 -0.955 . . . . 2.8 109.153 -179.644 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -67.22 140.1 57.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 2.87 110.283 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -84.8 141.93 30.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 2.35 109.333 179.631 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.431 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.8 pt -89.84 164.1 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.97 109.365 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 100.0 p -95.86 171.63 8.52 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.042 -1.036 . . . . 1.17 108.77 179.338 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.38 -48.35 80.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.882 -1.136 . . . . 1.18 109.376 -179.443 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -55.91 -30.38 61.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.698 -1.251 . . . . 2.56 109.878 -179.855 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -80.94 -9.69 59.8 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.214 -0.929 . . . . 1.79 109.837 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 40' ' ' VAL . 40.9 t -62.41 -50.17 80.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 120.781 -1.199 . . . . 1.0 108.796 179.758 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -65.49 -40.11 92.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.842 -1.161 . . . . 1.77 110.199 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -69.97 -40.12 75.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.11 -0.993 . . . . 2.7 109.895 -179.282 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.544 ' OE2' ' NH1' ' A' ' 42' ' ' ARG . 28.1 mm-40 -68.37 -40.07 81.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 1.51 110.301 -179.242 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 36' ' ' VAL . 53.1 t -59.95 -41.21 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.608 -1.256 . . . . 0.93 107.608 179.173 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -58.38 -37.97 76.34 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.563 -0.71 . . . . 1.81 109.626 -179.873 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.544 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 99.3 mtt180 -58.7 -41.71 86.95 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.865 -1.134 . . . . 2.78 108.016 179.443 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -62.73 -47.88 81.65 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.409 -0.959 . . . . 0.78 108.409 178.243 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 65.8 tp -59.85 -49.06 79.17 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.901 -1.148 . . . . 1.07 107.901 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.1 t -60.58 -45.15 95.01 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.464 -0.939 . . . . 1.12 108.464 178.653 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.93 -43.89 97.66 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.151 -1.98 . . . . 0.84 108.151 178.962 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -63.26 -33.09 74.75 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.476 -1.014 . . . . 3.09 108.72 178.34 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.25 -39.94 84.39 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.553 -0.717 . . . . 0.88 109.57 -179.207 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 50' ' ' ALA . 26.1 ttmt -70.67 -74.03 0.15 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.258 -1.386 . . . . 2.59 107.258 178.999 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.59 -39.61 0.34 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.944 -0.472 . . . . 0.7 111.126 -178.763 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.4 t -56.25 -59.04 5.52 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.338 -1.477 . . . . 1.4 108.559 179.598 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.17 -39.98 90.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.367 -0.833 . . . . 0.67 111.105 -179.267 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -69.82 -40.7 75.74 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.837 -1.164 . . . . 1.66 110.471 -178.931 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.3 mt -62.49 -39.95 95.15 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.915 -1.116 . . . . 1.58 108.063 179.408 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -62.87 -38.43 90.85 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.375 -0.828 . . . . 1.35 109.194 178.762 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.7 m -64.01 -43.81 94.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.77 109.477 179.137 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.3 mt -61.69 -37.84 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 0.63 109.192 179.693 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -58.8 -50.21 74.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 1.14 109.56 -179.422 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -57.49 -33.69 68.28 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.494 -0.754 . . . . 0.79 110.676 -177.737 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -69.62 -37.96 77.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.225 -0.922 . . . . 1.53 109.366 -179.438 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.41 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -66.29 -48.6 69.87 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.34 -0.85 . . . . 0.57 109.762 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.08 -55.67 22.88 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 120.169 -1.015 . . . . 0.75 110.572 -179.146 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -70.18 -43.59 70.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.085 -1.244 . . . . 1.59 111.016 -178.844 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.5 m -63.09 -62.81 1.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.0 -1.063 . . . . 0.73 111.617 -177.742 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -97.4 -43.53 7.25 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.954 -1.091 . . . . 0.75 111.541 -177.926 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.65 -171.4 24.4 Favored Glycine 0 N--CA 1.501 3.032 0 O-C-N 120.703 -1.248 . . . . 1.22 111.298 179.619 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -68.95 -23.02 64.09 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.816 -0.814 . . . . 5.81 109.59 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.512 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.9 tp10 -60.01 -34.3 73.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.807 -0.558 . . . . 3.37 110.741 -179.508 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -98.71 -18.86 17.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.199 -0.938 . . . . 1.77 109.62 -179.695 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -67.68 -39.44 84.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 1.65 109.916 -179.799 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.579 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.91 -34.21 76.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.77 110.304 -178.685 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 85.1 mt -59.77 -40.43 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.635 -1.291 . . . . 0.8 108.682 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -64.2 -38.74 92.14 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.1 -1.0 . . . . 0.88 110.175 179.068 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -59.06 -39.7 82.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.161 -0.962 . . . . 1.37 109.141 -179.602 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.0 -41.02 95.47 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.179 -1.568 . . . . 0.62 109.179 179.069 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -66.02 -49.65 66.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.998 -1.295 . . . . 1.5 108.472 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.2 mt -61.91 -49.32 84.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.577 -0.702 . . . . 0.63 109.372 179.279 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 40.5 ttp -59.93 -46.29 89.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.331 -0.855 . . . . 1.51 109.802 -179.698 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.871 HD11 ' CE2' ' B' ' 348' ' ' PHE . 57.1 tp -60.13 -41.49 92.77 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.353 -0.842 . . . . 0.77 109.347 179.698 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.2 -39.64 89.81 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.181 -0.608 . . . . 0.62 110.065 -178.677 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -79.12 2.76 19.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.188 -0.945 . . . . 1.47 109.37 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -51.14 129.41 24.17 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.296 -0.878 . . . . 1.47 110.415 -178.939 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.63 -16.54 39.68 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.8 -0.562 . . . . 1.78 110.138 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -74.13 -35.74 64.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.027 -1.045 . . . . 2.53 109.494 178.933 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.58 -41.06 72.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.453 -0.779 . . . . 0.8 110.754 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -60.01 -49.48 77.48 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.246 -0.909 . . . . 1.42 110.394 -178.644 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -69.77 -40.47 76.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 1.71 110.91 -178.916 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -67.9 -40.15 83.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.971 -1.081 . . . . 1.57 110.874 -178.975 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.93 -47.52 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.906 -1.121 . . . . 0.65 109.636 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -65.36 -38.57 82.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.618 -0.676 . . . . 0.82 110.263 179.974 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.63 85.09 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.221 -0.924 . . . . 0.79 111.244 -178.937 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.2 mt -59.87 -43.93 94.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.853 -1.154 . . . . 0.95 109.243 -179.043 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.8 mt -63.34 -48.49 87.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.437 -0.79 . . . . 0.66 109.501 179.424 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -68.57 -40.34 80.63 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.116 -0.99 . . . . 2.2 110.189 179.766 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.74 -52.43 7.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 1.65 111.604 -178.403 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -91.15 -3.08 57.37 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.117 -0.99 . . . . 2.03 112.247 -177.805 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 80.0 m80 57.29 39.05 28.81 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.816 -1.177 . . . . 1.42 109.834 -179.421 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 94.2 mtp -89.2 170.04 10.94 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.37 -0.832 . . . . 1.18 110.079 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.0 p -80.46 156.52 26.55 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.954 -0.758 . . . . 0.98 108.954 179.586 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.91 -39.9 75.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.11 -0.994 . . . . 0.64 110.2 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.58 -42.57 96.97 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.062 -1.024 . . . . 2.07 110.459 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.71 -46.33 14.43 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.374 -0.829 . . . . 0.73 110.494 -179.253 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.06 -48.26 82.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.372 -0.83 . . . . 0.54 110.364 -179.157 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.488 ' HB1' HD21 ' A' ' 137' ' ' LEU . . . -59.97 -47.51 85.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.929 . . . . 0.56 110.522 -179.094 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.655 ' HB2' HD21 ' A' ' 138' ' ' LEU . 85.0 t60 -60.15 -35.21 74.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.997 -1.065 . . . . 1.54 110.392 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.28 -39.91 88.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.012 -1.055 . . . . 1.33 110.559 -179.222 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.67 -50.09 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.803 -1.185 . . . . 0.72 110.973 -178.679 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.4 mm -68.96 -40.14 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 120.801 -1.187 . . . . 0.85 109.134 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -64.03 -38.32 90.65 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.799 -0.815 . . . . 2.44 108.799 178.771 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.97 -50.04 71.94 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 120.247 -0.977 . . . . 0.98 110.839 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -65.24 -53.43 44.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.866 -1.373 . . . . 1.41 110.484 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.54 -39.16 70.21 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.998 -1.064 . . . . 1.2 109.301 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.6 t -53.82 -40.66 66.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.295 -0.878 . . . . 1.7 108.663 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.84 70.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.505 -0.747 . . . . 1.47 109.483 179.025 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.0 mt -65.78 -43.84 87.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.026 -1.046 . . . . 1.56 109.818 -178.804 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.97 -38.5 82.71 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.499 -1.376 . . . . 2.2 108.912 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -54.74 -18.88 5.21 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.225 -0.922 . . . . 2.12 109.538 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.439 HD13 HD13 ' A' ' 123' ' ' LEU . 85.4 mt -61.57 139.98 58.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.085 -1.009 . . . . 2.0 109.479 -179.598 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -90.9 11.45 22.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.254 -0.904 . . . . 3.23 109.714 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -99.01 117.0 32.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.151 -0.968 . . . . 2.49 109.207 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -60.2 -30.59 69.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.272 -0.892 . . . . 3.95 109.363 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.451 ' OH ' ' CA ' ' B' ' 315' ' ' HIS . 19.8 t80 -61.02 -42.08 97.79 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.995 0.902 . . . . 2.0 109.161 179.274 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.893 HD22 ' O ' ' B' ' 351' ' ' GLN . 74.9 mt -80.4 -26.9 38.25 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.975 -0.75 . . . . 1.86 108.975 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -60.07 -43.94 95.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.47 -0.937 . . . . 2.84 108.47 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -60.61 -45.61 93.35 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.115 -1.068 . . . . 2.73 108.115 178.553 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -60.68 -39.43 88.43 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.748 -0.781 . . . . 2.77 109.08 178.403 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.17 -28.27 66.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.388 -0.82 . . . . 1.19 109.162 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.31 -38.78 71.72 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.225 -0.922 . . . . 1.2 109.677 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.5 -40.58 95.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.025 -1.047 . . . . 1.55 110.466 -179.368 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.435 HG21 HE22 ' B' ' 351' ' ' GLN . 38.1 t -69.82 -42.0 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.873 -1.142 . . . . 0.8 109.801 -179.912 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -60.59 -38.6 85.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.762 -1.211 . . . . 3.09 109.407 179.427 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -58.68 -39.74 81.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.395 -0.816 . . . . 1.46 110.011 -178.892 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.99 -41.45 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.091 -1.005 . . . . 0.71 109.921 -179.611 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.94 -35.75 92.48 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.919 -1.272 . . . . 0.57 109.919 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -60.05 -48.57 81.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.318 -1.107 . . . . 2.59 110.995 -178.717 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.417 HH22 ' CB ' ' A' ' 166' ' ' SER . 98.0 mtt180 -67.69 -30.89 70.53 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.571 -1.331 . . . . 2.83 110.383 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.488 HD21 ' HB1' ' A' ' 104' ' ' ALA . 63.9 tp -58.53 -44.96 89.75 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.268 -1.012 . . . . 1.25 108.268 -179.175 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.655 HD21 ' HB2' ' A' ' 105' ' ' HIS . 66.1 mt -61.43 -43.97 97.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.7 110.192 178.631 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -70.02 -40.21 75.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.89 . . . . 2.57 109.891 -179.821 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -65.79 -37.92 87.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.671 -0.643 . . . . 1.23 111.048 -178.923 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.4 mt -66.98 -46.79 84.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 120.638 -1.289 . . . . 0.81 108.165 179.583 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 92.3 mt -70.16 -31.71 69.33 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.644 -0.66 . . . . 1.0 109.675 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.87 42.41 6.79 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.017 -1.633 . . . . 0.89 109.017 -178.908 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 tp -74.52 152.96 39.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.466 -1.02 . . . . 1.14 109.095 -179.654 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -64.23 143.24 58.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.083 -1.01 . . . . 4.6 109.626 -179.487 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.8 mt -115.4 121.77 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 CA-C-O 122.434 1.112 . . . . 1.24 109.22 179.279 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.2 mt -60.13 -47.74 90.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-N 115.019 -0.991 . . . . 1.54 110.858 -178.659 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.5 t0 62.92 106.04 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.615 -0.883 . . . . 1.5 108.615 -178.818 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.5 mt -69.33 0.3 5.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.296 -0.877 . . . . 0.79 110.174 -178.58 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 83.1 p -83.66 -13.87 53.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.048 -1.032 . . . . 1.4 110.379 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.64 28.23 0.49 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.112 -0.992 . . . . 0.92 111.916 -178.374 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 32.3 mm -90.58 118.15 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.484 -1.385 . . . . 0.88 108.405 179.184 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -104.88 -10.59 17.22 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.391 -0.818 . . . . 2.45 110.337 -178.863 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -126.48 150.94 48.42 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.097 -1.002 . . . . 1.52 109.832 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -63.98 133.02 52.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.436 -0.79 . . . . 1.58 109.731 -179.434 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.4 m -152.66 166.43 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.425 -0.797 . . . . 0.69 110.321 179.729 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 76.3 mt -95.82 147.86 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 105.994 -1.854 . . . . 0.61 105.994 177.214 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 48.7 tp -100.04 119.22 37.94 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.714 -1.241 . . . . 0.87 110.626 -177.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.84 129.96 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 107.978 -1.119 . . . . 0.71 107.978 178.64 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.46 161.96 35.55 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.125 -0.984 . . . . 0.81 109.069 -179.157 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.94 -37.25 75.82 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.111 -1.618 . . . . 0.98 107.294 178.412 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 13.1 p-10 -171.15 147.0 2.49 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.385 -0.598 . . . . 2.25 109.385 178.922 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.7 mt -106.04 141.36 37.55 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.336 -0.853 . . . . 0.78 108.926 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 82.1 p -94.38 144.66 28.35 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.22 -0.925 . . . . 0.98 108.828 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -40.13 -40.54 2.85 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.887 1.724 . . . . 0.81 112.268 179.724 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.417 ' CB ' HH22 ' A' ' 136' ' ' ARG . 61.4 m -60.42 -40.0 89.45 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.391 -0.818 . . . . 0.9 110.218 -179.646 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.45 -43.47 85.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.145 -0.972 . . . . 1.61 110.147 -179.099 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 40.2 p -55.67 -31.87 62.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.067 -1.021 . . . . 0.61 111.007 -178.007 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -69.73 -50.78 40.26 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.064 -1.023 . . . . 0.6 110.106 -179.547 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.41 ' H ' ' HG2' ' A' ' 170' ' ' GLN . 15.2 pt20 -88.7 39.36 0.92 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.482 -0.933 . . . . 1.4 108.482 -179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.5 tp -103.35 138.03 40.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.683 -0.636 . . . . 0.7 109.567 179.328 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -87.55 101.32 13.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.345 -0.847 . . . . 2.35 109.648 179.849 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 46.6 mt -64.23 -42.22 96.65 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.403 -0.811 . . . . 1.51 110.379 -179.34 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.53 -27.56 66.2 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.846 -1.158 . . . . 2.33 112.45 -177.737 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -92.69 -8.31 44.33 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.584 -1.322 . . . . 1.92 110.429 -178.657 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 178' ' ' GLY . 68.9 t -107.7 119.83 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.198 -0.939 . . . . 0.67 108.959 179.112 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.1 mt -88.84 8.37 29.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.287 -0.883 . . . . 1.53 111.227 -177.706 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.568 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 167.58 175.14 37.23 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.535 -1.426 . . . . 0.48 109.535 179.346 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -134.79 130.04 35.5 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.365 -1.079 . . . . 0.55 108.62 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.418 ' CG2' HG21 ' A' ' 205' ' ' THR . 95.7 mt -132.34 126.54 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.194 -0.941 . . . . 0.65 109.156 179.381 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 41.0 p -149.89 162.87 39.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.925 -1.109 . . . . 0.82 111.051 -179.696 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 183' ' ' ALA . 35.5 p-10 -106.19 23.23 14.4 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.787 -0.57 . . . . 2.46 109.505 -179.767 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -56.62 -161.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.778 -1.201 . . . . 1.28 111.588 -177.689 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.04 -56.54 5.71 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.772 -0.931 . . . . 2.19 110.772 -178.652 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 171.83 -142.37 6.89 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 118.612 -1.756 . . . . 2.13 111.349 -179.448 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.456 ' C ' ' H ' ' A' ' 188' ' ' SER . 97.3 mtt180 -69.66 -31.02 68.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.853 -0.793 . . . . 5.86 110.905 -178.535 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 82.5 p -62.62 2.17 0.31 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.0 -1.063 . . . . 3.72 109.803 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 186' ' ' ARG . 78.4 p -91.71 139.71 30.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.937 -1.102 . . . . 1.74 110.552 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -55.5 -39.53 70.59 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.784 -0.821 . . . . 0.95 108.784 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 190' ' ' THR . 2.0 p -57.52 -41.42 80.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.613 -0.68 . . . . 1.55 109.543 -179.538 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 186' ' ' ARG . 82.8 p -69.28 -38.08 78.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.178 -0.951 . . . . 1.51 111.255 -179.402 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.12 -44.48 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.885 -1.134 . . . . 1.67 110.106 -178.375 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.1 mtp -61.41 -40.3 93.92 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.041 -1.037 . . . . 1.02 111.18 -179.374 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.82 -42.66 76.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.683 -1.26 . . . . 0.68 109.113 -179.776 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -59.99 -51.79 68.15 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.088 -1.007 . . . . 2.93 109.263 -179.267 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.0 m -68.5 -36.89 79.56 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.449 -0.782 . . . . 0.86 111.106 -179.128 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 87.6 mt -69.91 -27.89 65.16 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.984 -1.117 . . . . 0.67 107.984 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 63.54 50.0 2.93 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.147 0.499 . . . . 1.5 110.587 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.477 ' O ' ' CB ' ' A' ' 8' ' ' SER . 77.0 mt -130.64 147.86 67.77 Favored Pre-proline 0 N--CA 1.505 2.285 0 N-CA-C 108.401 -0.963 . . . . 0.72 108.401 178.501 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -44.82 126.23 7.21 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.163 1.909 . . . . 0.61 112.65 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.32 139.85 12.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.537 -1.352 . . . . 0.66 111.963 179.44 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.6 mt -125.28 146.05 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.287 -1.375 . . . . 0.79 107.287 178.147 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.4 -4.82 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 120.84 -1.163 . . . . 0.91 110.588 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.91 21.21 27.9 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 110.831 -0.908 . . . . 1.01 110.831 -179.08 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.418 HG21 ' CG2' ' A' ' 180' ' ' ILE . 7.1 p -45.01 -41.06 7.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.03 -1.277 . . . . 0.99 110.261 -179.516 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.83 -50.98 3.79 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.201 -0.999 . . . . 1.12 111.005 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.3 t -158.57 38.45 0.23 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.588 -1.536 . . . . 1.72 111.354 -179.093 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.9 t -76.65 -39.38 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.819 -1.175 . . . . 0.89 108.967 178.582 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.438 HG23 ' H ' ' A' ' 209' ' ' THR . 2.8 p -57.09 -39.79 75.71 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.648 -0.657 . . . . 1.03 111.174 -177.877 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.0 p -80.03 -13.41 59.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.014 -1.053 . . . . 1.83 110.129 -178.894 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -95.51 -14.58 23.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.119 -0.988 . . . . 2.27 109.882 -179.404 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 213' ' ' LYS . 55.1 t -114.16 152.74 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.358 -0.839 . . . . 0.92 110.994 -178.845 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.447 ' N ' HG12 ' A' ' 212' ' ' VAL . 10.5 mptt -122.12 158.57 29.02 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.875 -1.158 . . . . 2.2 107.875 179.179 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 13.0 t-20 -54.69 140.36 35.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.177 -0.952 . . . . 2.36 111.075 -179.04 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.7 t70 84.38 10.58 0.39 Allowed 'General case' 0 N--CA 1.504 2.249 0 CA-C-O 120.991 0.424 . . . . 2.38 110.88 179.105 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -80.1 139.75 36.73 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.923 -1.11 . . . . 2.09 109.049 179.211 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -87.44 128.07 35.22 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.034 -1.098 . . . . 1.27 108.034 179.154 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.447 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 58.3 mt -131.71 138.76 48.8 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.199 -0.938 . . . . 0.75 110.532 -178.863 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.9 mt -111.61 125.48 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.484 -1.673 . . . . 0.63 106.484 176.802 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 29.8 tp -103.51 119.74 39.49 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.861 -1.149 . . . . 0.7 108.944 -179.234 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.626 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 23.2 p-10 -81.51 -37.13 28.35 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.048 -1.093 . . . . 2.31 108.048 178.966 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.86 17.93 0.06 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.732 -0.84 . . . . 0.78 108.732 -179.304 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 221' ' ' ASP . 55.3 t -135.96 -41.02 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.912 -1.144 . . . . 1.04 107.912 178.941 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -97.75 1.09 48.07 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.623 -1.251 . . . . 2.44 107.623 178.386 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.535 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 29.7 t-20 60.53 42.96 13.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.753 -0.592 . . . . 1.55 109.964 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.626 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 92.0 mt-30 -140.94 148.26 40.11 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.177 -0.952 . . . . 1.99 109.611 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -120.06 126.56 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.115 -1.068 . . . . 0.77 108.115 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -98.67 126.23 44.21 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.526 -1.287 . . . . 0.98 107.526 178.906 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.86 125.1 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.634 -0.666 . . . . 0.85 110.177 -177.958 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 53.78 68.4 2.86 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.135 -0.978 . . . . 1.66 108.839 -179.656 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -91.22 131.5 1.42 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 123.25 2.634 . . . . 0.95 112.588 -178.914 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 233' ' ' ASN . 23.5 m -63.54 166.51 6.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.315 -0.866 . . . . 1.84 109.769 -179.232 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.457 ' N ' HG22 ' A' ' 232' ' ' THR . 21.3 m120 -60.04 -40.08 88.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.134 -0.979 . . . . 2.74 110.045 -179.311 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -64.55 -32.18 73.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.965 -1.084 . . . . 2.89 110.092 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.53 -39.61 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.058 -1.026 . . . . 1.3 108.532 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.8 mt -66.65 -40.09 85.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.377 -0.827 . . . . 1.09 109.022 179.219 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.56 -40.88 93.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.197 -0.939 . . . . 2.43 109.58 179.605 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -68.39 -40.18 81.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.091 -1.006 . . . . 2.78 109.517 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 86.2 mtp -71.89 -24.52 61.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.11 -0.993 . . . . 1.25 109.827 179.251 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -72.67 -40.09 66.56 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.015 -1.053 . . . . 2.63 109.378 178.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.84 94.7 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.269 -1.012 . . . . 1.8 108.269 179.498 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.95 -40.13 78.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.741 -0.837 . . . . 2.13 108.741 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -60.17 -42.55 95.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.44 -0.788 . . . . 3.17 109.844 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.01 -40.15 88.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -0.854 . . . . 1.78 109.369 -179.812 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -65.02 -40.08 94.35 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.957 -1.089 . . . . 2.47 108.664 179.803 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.55 -45.37 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.842 -0.799 . . . . 2.09 108.842 179.51 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.55 -42.1 98.39 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.563 -0.903 . . . . 2.54 108.563 179.443 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 94.7 p -64.69 -41.51 95.99 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.5 -0.75 . . . . 2.99 109.351 179.734 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 253' ' ' LEU . 17.5 tp10 -64.31 -39.92 94.88 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.757 0.789 . . . . 3.34 108.969 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -60.4 -42.74 96.57 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.659 -0.651 . . . . 3.88 110.815 -179.521 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -73.67 -40.63 63.55 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.148 -0.97 . . . . 4.43 110.999 -179.175 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' A' ' 253' ' ' LEU . 67.8 mm-40 -90.96 -15.62 29.41 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.337 -0.852 . . . . 5.42 110.998 -178.27 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 249' ' ' GLU . 3.8 mp 44.26 34.68 1.07 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.098 -1.001 . . . . 6.1 109.907 -179.525 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 258' ' ' ASP . . . -87.64 35.39 0.72 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.431 -0.952 . . . . 7.37 108.431 179.692 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.426 ' N ' ' OE2' ' A' ' 249' ' ' GLU . 87.3 tttt -59.87 -49.03 79.29 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.374 -0.829 . . . . 8.01 110.0 -179.011 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 62.4 tp -69.22 -41.1 77.49 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.817 -1.177 . . . . 9.05 109.326 179.247 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -70.64 -60.08 2.46 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.431 -0.793 . . . . 10.56 109.83 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 254' ' ' ALA . 60.4 m-20 -105.91 75.5 1.12 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.502 -0.749 . . . . 11.32 109.093 -179.822 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 . . . . . 0 C--N 1.296 -1.752 0 CA-C-O 117.926 -1.035 . . . . 12.42 109.185 179.5 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' B' B ' 301' ' ' MET . . . . . 0.415 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 37.0 ttp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.407 0.622 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 302' ' ' PHE . . . . . 0.415 ' N ' ' CG ' ' B' ' 301' ' ' MET . 16.8 t80 -152.44 148.8 27.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.353 -0.842 . . . . 0.0 108.871 179.552 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -152.36 163.59 39.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.889 -1.132 . . . . 0.0 110.573 -179.317 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -156.81 153.57 28.5 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.618 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 305' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 56.4 mp0 -115.08 130.9 57.04 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.203 -0.936 . . . . 0.0 109.414 179.029 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.55 125.32 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.425 0 CA-C-O 122.371 1.082 . . . . 0.0 111.435 -178.13 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 36.6 m -81.07 103.65 11.02 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.913 0.863 . . . . 0.0 111.114 -178.02 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.6 mt -52.22 121.5 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.456 1.122 . . . . 0.0 110.952 -177.627 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 74.1 p -106.33 18.01 22.6 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.066 -178.427 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.32 118.89 71.45 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.65 -1.281 . . . . 0.0 109.221 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -52.41 -15.01 3.42 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 CA-C-N 120.176 1.098 . . . . 0.0 112.569 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -118.91 8.52 11.71 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.54 177.89 31.98 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -179.298 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.435 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -85.93 93.19 8.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -1.184 . . . . 0.0 108.527 -179.192 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.483 ' CE1' ' HB3' ' B' ' 317' ' ' ARG . 24.1 p-80 -96.66 -160.15 0.78 Allowed 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.109 -0.994 . . . . 0.0 109.958 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.3 m -59.38 -43.12 92.96 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.831 -1.168 . . . . 0.0 112.146 -176.032 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.579 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 2.5 tpt180 -57.56 -61.82 6.51 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.453 -1.404 . . . . 0.0 111.703 -178.485 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.409 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 13.8 Cg_endo -59.42 -32.99 97.4 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 CA-C-N 119.932 1.011 . . . . 0.0 111.516 -179.431 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.27 -51.53 69.14 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.162 -0.961 . . . . 0.0 109.072 179.74 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.2 -41.71 62.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -0.85 . . . . 0.0 109.587 -178.791 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -71.33 -40.03 71.0 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.911 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -61.95 -54.78 37.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.426 -0.796 . . . . 0.0 109.784 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 89.8 t -61.33 -26.56 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.957 -1.09 . . . . 0.0 110.173 -178.899 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -63.02 -44.24 96.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.426 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -69.89 -40.14 75.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.383 -0.823 . . . . 0.0 111.731 -178.027 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 326' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' B' ' 328' ' ' GLY . . . -65.53 -55.86 15.49 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.3 -1.5 . . . . 0.0 111.924 -178.354 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -48.21 -10.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.033 -1.042 . . . . 0.0 110.281 -178.814 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 328' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' B' ' 326' ' ' ALA . . . -81.63 -15.35 76.01 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.23 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -107.07 140.42 39.91 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.377 -1.072 . . . . 0.0 109.255 179.433 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 16.9 m -91.31 -11.64 37.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 110.238 -179.981 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 35.9 m -64.77 155.11 34.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.759 -1.213 . . . . 0.0 109.591 179.656 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -70.76 133.83 46.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.89 -1.131 . . . . 0.0 108.315 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 90.2 mt -131.79 133.5 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-O 121.362 0.601 . . . . 0.0 109.954 -179.692 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.4 m -130.08 148.61 51.95 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.445 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 79.7 t -120.29 114.96 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 177.459 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 92.7 m -105.46 124.95 50.4 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.227 -0.92 . . . . 0.0 109.709 -178.289 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 48.4 t -134.35 120.5 19.97 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.139 0.971 . . . . 0.0 111.59 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 66.6 t30 45.37 50.99 9.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 176.717 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.7 -11.97 68.62 Favored Glycine 0 N--CA 1.501 3.031 0 O-C-N 120.155 -1.591 . . . . 0.0 113.15 176.472 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -126.44 138.87 53.58 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 119.389 1.594 . . . . 0.0 109.432 -179.809 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 60.2 p -130.58 152.69 49.67 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.118 0.961 . . . . 0.0 111.236 -178.512 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 342' ' ' ALA . . . . . 0.47 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -143.31 163.59 32.59 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.494 0.664 . . . . 0.0 109.52 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 10.8 t -87.52 135.89 33.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.637 -0.665 . . . . 0.0 110.821 -178.878 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.47 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -68.06 -21.31 65.0 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.107 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -80.3 25.18 0.41 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.037 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 346' ' ' SER . . . . . 0.47 ' H ' ' C ' ' B' ' 344' ' ' ALA . 58.4 m -152.92 92.94 1.69 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.814 -1.154 . . . . 0.0 113.266 -178.992 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.668 HD23 HD22 ' A' ' 79' ' ' LEU . 57.8 tp -59.53 -34.26 72.41 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 177.225 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.871 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.4 m-85 -58.81 -53.3 59.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.707 -0.621 . . . . 0.0 110.264 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -78.26 -16.45 57.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.771 -1.206 . . . . 0.0 110.619 -177.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.604 ' O ' ' N ' ' B' ' 352' ' ' THR . 26.4 mt -69.64 -56.16 8.02 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.146 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.893 ' O ' HD22 ' A' ' 123' ' ' LEU . 30.3 mt-30 -40.82 -12.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.103 -178.62 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.604 ' N ' ' O ' ' B' ' 350' ' ' LEU . 59.2 p -90.82 -8.19 50.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.52 -1.362 . . . . 0.0 109.954 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' B' ' 342' ' ' ALA . 85.0 mt -96.74 121.1 38.22 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.092 -1.005 . . . . 0.0 109.384 179.371 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.5 90.53 0.94 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.793 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 20.2 mt -99.79 91.94 5.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.19 -1.182 . . . . 0.0 108.855 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 38.0 p -94.01 -179.19 4.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.276 -0.89 . . . . 0.0 110.545 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -69.84 110.1 4.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.849 -0.532 . . . . 0.0 110.118 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 358' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 104.16 9.72 35.94 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 28.4 m -84.76 110.77 19.04 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.156 -1.202 . . . . 0.0 110.888 -179.482 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 27.2 t -77.12 111.86 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 122.237 1.018 . . . . 0.0 109.747 -177.328 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 17.5 m -109.03 175.02 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.296 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 32.3 m -131.79 128.61 39.15 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.647 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 95.0 mt -103.33 115.41 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.521 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 77.3 p -120.13 132.65 55.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.393 -0.817 . . . . 0.0 109.128 -179.356 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.81 152.61 40.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.898 . . . . 0.0 108.949 -179.057 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -147.71 125.45 11.87 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.16 -0.963 . . . . 0.0 109.471 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.495 ' O ' ' OE1' ' B' ' 370' ' ' GLU . . . 154.02 -148.97 20.26 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.277 -1.44 . . . . 0.0 111.532 179.824 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -60.02 -51.69 68.56 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.542 ' N ' ' OG ' ' B' ' 331' ' ' SER . 89.1 m-20 -112.71 13.77 19.89 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 120.835 -1.165 . . . . 0.0 111.267 -177.681 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.584 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 1.0 OUTLIER -42.39 -32.57 0.54 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.271 -0.893 . . . . 0.0 111.477 -179.011 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 371' ' ' GLN . . . . . 0.514 ' H ' ' CD ' ' B' ' 370' ' ' GLU . 10.3 pt20 -70.94 -43.2 68.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.853 -1.154 . . . . 0.0 110.205 -178.745 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -69.43 -54.25 15.26 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.377 -0.827 . . . . 0.0 109.159 179.473 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.86 -34.51 8.93 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.621 -0.674 . . . . 0.0 112.252 -178.398 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 69.4 t -80.99 -36.29 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.468 -1.395 . . . . 0.0 108.926 178.756 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -70.89 -38.97 73.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.657 -0.652 . . . . 0.0 111.269 179.815 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -82.54 -48.98 10.39 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.798 -1.189 . . . . 0.0 111.694 -178.235 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.02 -30.68 69.33 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.164 -0.96 . . . . 0.0 109.464 -179.096 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 55.0 t -79.78 -31.62 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 0.0 109.416 179.25 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -77.35 -22.22 52.11 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.689 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 31.9 tp -78.25 -67.76 0.7 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.492 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 5.6 ttp -56.01 -22.99 30.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.925 . . . . 0.0 109.788 -178.619 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.83 -22.2 58.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.928 -1.108 . . . . 0.0 108.705 177.87 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -104.21 2.52 31.81 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.42 -0.8 . . . . 0.0 111.677 -178.362 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 85.0 mt -85.03 125.47 32.76 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.219 -1.551 . . . . 0.0 109.739 179.739 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.052 179.004 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.2 mtp . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.255 -0.646 . . . . 2.91 109.255 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.446 ' O ' ' O ' ' A' ' 225' ' ' ASN . 89.8 mt -107.58 129.02 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.613 -0.884 . . . . 1.2 108.613 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.9 m -130.76 141.45 50.36 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.606 -0.684 . . . . 1.4 109.744 -179.653 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.679 ' H ' HD22 ' A' ' 225' ' ' ASN . . . -138.07 -165.04 10.2 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 108.291 -1.924 . . . . 1.05 108.291 179.122 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.8 mt -91.99 -10.83 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.888 -1.36 . . . . 1.15 110.377 -179.05 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 5' ' ' ILE . 34.9 tp 52.62 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.973 -1.08 . . . . 0.98 108.839 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.59 -34.25 23.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 0.88 109.042 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -143.4 132.33 11.45 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.416 -0.803 . . . . 1.69 108.881 179.509 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.92 147.19 18.91 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.193 1.929 . . . . 0.85 113.477 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.782 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.53 -164.66 37.43 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.576 -1.41 . . . . 0.92 109.576 179.474 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.5 mt -146.45 147.82 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.26 -1.141 . . . . 0.81 108.741 179.053 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.91 154.64 31.53 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.541 -1.35 . . . . 0.51 110.979 -179.618 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.5 m-85 -136.31 129.26 31.15 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 108.245 -1.02 . . . . 0.62 108.245 178.819 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.5 -179.7 45.65 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.577 -1.773 . . . . 0.55 110.802 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -80.4 152.85 28.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.613 -0.934 . . . . 2.1 108.95 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.417 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -99.24 132.0 44.87 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.093 -1.004 . . . . 0.77 110.906 -178.078 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.4 tp -100.37 133.61 44.54 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.389 -1.338 . . . . 0.91 107.389 178.084 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.1 tp -115.43 121.34 42.46 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.207 -0.933 . . . . 0.93 109.949 -179.025 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 66.8 mt -91.29 106.22 18.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.521 -0.737 . . . . 0.93 109.881 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.475 ' NZ ' ' CB ' ' A' ' 20' ' ' LYS . 7.8 mtpm? -101.87 137.69 39.83 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.89 -0.781 . . . . 2.75 108.89 179.234 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 55.4 mp0 -127.81 128.76 45.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.373 -0.829 . . . . 3.0 108.795 179.689 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -71.89 149.85 44.77 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.044 -1.035 . . . . 2.77 108.474 179.639 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -67.52 139.98 57.0 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.924 -1.11 . . . . 2.94 108.576 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.8 mt -80.17 130.27 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.95 109.172 -179.463 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.1 t -99.24 129.75 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.203 -0.936 . . . . 1.28 111.08 -178.413 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.0 mt -109.85 131.21 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.654 -0.869 . . . . 1.21 108.654 179.031 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -81.61 127.37 32.8 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.878 -1.139 . . . . 1.81 109.815 -179.449 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.52 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.6 mmt-85 -90.75 -5.72 55.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.514 -0.742 . . . . 2.8 109.221 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -70.76 139.95 51.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 2.87 109.548 -179.668 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -80.96 151.97 28.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 2.35 109.027 179.184 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.462 HG21 ' HG3' ' A' ' 39' ' ' GLU . 5.2 pt -93.68 165.08 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.97 109.884 -179.932 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.8 p -98.22 168.72 10.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.997 -1.064 . . . . 1.17 108.952 178.989 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.15 -13.65 39.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.126 -0.984 . . . . 1.18 110.104 -179.675 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -86.1 -30.19 22.75 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.678 -1.23 . . . . 2.56 107.678 178.511 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -83.38 -7.58 59.54 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.515 -0.55 . . . . 1.79 109.515 179.082 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 t -64.97 -56.33 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.734 -1.229 . . . . 1.0 109.174 179.719 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.06 -39.91 87.62 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.236 -0.915 . . . . 1.77 109.472 179.718 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -70.22 -41.06 74.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 2.7 110.688 -179.254 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.462 ' HG3' HG21 ' A' ' 31' ' ' ILE . 63.2 mm-40 -65.3 -39.98 93.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.031 -1.043 . . . . 1.51 110.134 -179.442 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.94 -44.58 94.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.882 -1.136 . . . . 0.93 107.96 179.424 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -59.91 -38.96 83.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.14 -0.975 . . . . 1.81 108.978 179.641 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -59.87 -43.03 94.93 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.635 -1.246 . . . . 2.78 107.635 179.335 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.96 -49.28 78.29 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.229 -1.026 . . . . 0.78 108.229 178.053 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.6 tp -60.0 -47.99 83.53 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.954 -0.758 . . . . 1.07 108.954 179.334 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.444 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 46.5 t -60.75 -44.5 96.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.949 -1.094 . . . . 1.12 108.782 178.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.09 -41.29 98.0 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.723 -2.151 . . . . 0.84 107.723 178.965 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -64.35 -34.86 79.12 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.557 -0.967 . . . . 3.09 108.514 178.26 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -54.48 -42.72 71.03 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.482 -0.761 . . . . 0.88 109.523 -179.286 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.533 ' HZ1' ' CA ' ' A' ' 140' ' ' ASN . 19.7 ttpp -73.9 -73.06 0.24 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.629 -1.249 . . . . 2.59 107.629 179.368 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.57 -34.24 0.09 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.445 -0.784 . . . . 0.7 111.035 -178.852 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 48' ' ' ALA . 90.3 p -57.43 -57.4 12.82 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.576 -1.327 . . . . 1.4 107.699 179.17 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.83 80.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.604 -0.685 . . . . 0.67 111.604 -179.2 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -68.86 -40.28 79.41 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.562 -1.337 . . . . 1.66 110.314 -178.646 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.49 -40.13 89.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.01 -1.056 . . . . 1.58 108.801 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.485 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 65.3 mm-40 -62.87 -40.0 96.15 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.251 -0.906 . . . . 1.35 109.11 179.104 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.469 HG22 ' HZ3' ' A' ' 60' ' ' LYS . 94.8 m -63.08 -39.92 96.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.77 110.133 179.857 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.0 mt -61.15 -40.98 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.012 -1.055 . . . . 0.63 108.973 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.485 ' NZ ' ' OE1' ' A' ' 55' ' ' GLU . 5.4 ttpm? -59.91 -50.45 73.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.279 -0.888 . . . . 1.14 110.103 -179.641 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -60.14 -39.98 88.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.79 110.841 -177.979 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.469 ' HZ3' HG22 ' A' ' 56' ' ' THR . 24.3 mttp -62.82 -38.66 91.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -0.911 . . . . 1.53 109.442 179.684 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.24 -39.97 96.11 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.541 -0.724 . . . . 0.57 109.435 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.63 -55.99 23.98 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.309 -1.516 . . . . 0.75 109.309 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.07 -49.86 72.86 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.973 -1.31 . . . . 1.59 109.694 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.1 m -65.8 -61.36 2.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.067 -1.02 . . . . 0.73 111.679 -177.749 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -94.73 -56.24 2.85 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.996 -1.065 . . . . 0.75 111.256 -178.236 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.4 -165.21 26.79 Favored Glycine 0 N--CA 1.5 2.956 0 C-N-CA 119.811 -1.185 . . . . 1.22 111.131 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -70.01 -25.77 63.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.935 -0.744 . . . . 5.81 110.553 -179.115 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.43 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.6 tp10 -60.29 -37.45 80.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.039 -1.038 . . . . 3.37 110.162 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.436 ' HA ' HD12 ' A' ' 72' ' ' ILE . 32.2 mmtp -100.22 -19.86 16.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.397 -0.814 . . . . 1.77 110.72 -179.179 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -69.92 -42.96 72.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.793 -1.192 . . . . 1.65 110.174 -179.427 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.538 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.22 -30.72 70.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.505 -0.747 . . . . 0.77 109.499 -179.315 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 69' ' ' LYS . 80.0 mt -60.1 -43.18 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.107 -0.996 . . . . 0.8 109.872 -179.569 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -74.84 -30.61 61.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.242 -0.911 . . . . 0.88 110.579 -178.828 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -61.57 -39.93 92.92 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.814 -1.179 . . . . 1.37 109.522 178.674 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.23 -46.95 93.44 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.87 -1.692 . . . . 0.62 108.87 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 17.0 m-70 -60.01 -44.44 94.58 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.343 -1.093 . . . . 1.5 108.515 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.4 mt -62.75 -50.02 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 109.053 -0.721 . . . . 0.63 109.053 179.35 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -60.01 -40.59 89.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 1.51 109.54 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.9 HD22 HD23 ' B' ' 347' ' ' LEU . 43.8 tp -63.86 -40.03 95.6 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.518 -0.739 . . . . 0.77 109.552 179.335 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -68.85 -38.42 79.76 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.768 -0.583 . . . . 0.62 110.437 -178.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.34 0.36 29.33 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.017 -1.052 . . . . 1.47 110.048 -179.292 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.7 t0 -47.78 130.86 14.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.201 -0.937 . . . . 1.47 110.38 -178.934 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.41 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 93.9 mt-10 -61.94 -18.54 60.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.659 . . . . 1.78 111.086 -179.192 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.88 -33.72 66.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.818 -1.176 . . . . 2.53 108.855 178.995 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.07 -41.01 74.68 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.099 -0.704 . . . . 0.8 109.099 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.88 -48.68 80.7 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.216 -0.928 . . . . 1.42 110.76 -179.13 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.23 -39.99 74.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.415 -0.803 . . . . 1.71 111.076 -178.579 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -69.81 -39.93 76.24 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.277 -0.89 . . . . 1.57 110.839 -178.581 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.9 mt -69.02 -41.57 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.28 -0.888 . . . . 0.65 109.398 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.4 mt -69.73 -39.68 78.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.505 -0.747 . . . . 0.82 110.3 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.0 -42.88 99.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.222 -0.924 . . . . 0.79 111.208 -178.992 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 49.1 mt -60.81 -46.97 88.44 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.709 -1.245 . . . . 0.95 109.372 -179.694 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.3 mt -60.17 -49.2 85.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.851 0.834 . . . . 0.66 108.9 179.509 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -69.98 -40.53 75.3 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.909 -0.495 . . . . 2.2 111.309 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -81.02 -57.0 3.73 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.952 -1.092 . . . . 1.65 112.099 -177.78 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -90.95 0.08 57.61 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.093 -1.004 . . . . 2.03 112.603 -176.858 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 54.6 m80 58.29 39.76 25.27 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.928 -1.108 . . . . 1.42 109.877 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.0 mtp -89.54 166.85 13.4 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.516 -0.74 . . . . 1.18 110.036 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.452 ' OG1' ' HB3' ' A' ' 102' ' ' ALA . 43.6 p -80.37 159.67 25.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.365 -0.835 . . . . 0.98 108.923 179.491 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.67 -40.06 80.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.113 -0.992 . . . . 0.64 109.965 -179.679 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 32.2 p-10 -68.0 -37.12 81.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 2.07 109.57 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.503 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -81.56 -41.38 21.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.73 109.824 179.216 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.03 -47.68 73.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.277 -0.889 . . . . 0.54 109.705 -179.686 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.86 87.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.115 -0.991 . . . . 0.56 109.543 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -59.89 -40.09 87.54 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.337 -0.852 . . . . 1.54 110.12 -179.244 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -60.92 -44.17 97.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.347 -0.846 . . . . 1.33 110.792 -179.365 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.6 t -61.54 -50.47 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.16 -0.963 . . . . 0.72 111.009 -177.847 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.5 mm -69.32 -39.88 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.021 -1.049 . . . . 0.85 108.637 179.493 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.401 ' CD ' HH12 ' A' ' 131' ' ' ARG . 41.3 tp10 -61.53 -40.0 93.07 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.869 -0.789 . . . . 2.44 108.869 179.198 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.56 -48.41 84.84 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.534 -0.841 . . . . 0.98 111.235 -178.8 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -69.15 -49.85 53.11 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.686 -1.479 . . . . 1.41 110.827 -178.335 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.98 87.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.916 -1.115 . . . . 1.2 109.559 -179.257 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 40.8 t -59.45 -40.08 85.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.019 -1.05 . . . . 1.7 108.995 179.962 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.56 -43.85 96.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.3 -0.875 . . . . 1.47 109.2 179.451 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' B' ' 351' ' ' GLN . 76.7 mt -61.7 -41.0 97.02 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.33 -0.856 . . . . 1.56 109.45 -178.993 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -59.99 -37.77 80.63 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.076 -1.015 . . . . 2.2 109.483 -179.291 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -52.06 -22.18 3.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.043 -1.036 . . . . 2.12 109.169 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 49.7 mt -62.32 140.1 58.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.051 -1.031 . . . . 2.0 109.01 -179.649 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -89.93 38.01 0.91 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.127 -0.983 . . . . 3.23 110.249 -178.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 57.9 t0 -129.8 145.95 51.56 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.344 -0.848 . . . . 2.49 109.228 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 124' ' ' LYS . 88.0 tt0 -72.71 -66.52 0.65 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.412 -0.805 . . . . 3.95 109.1 179.656 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 121' ' ' GLU . 3.5 t80 -38.71 -36.19 0.24 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.789 -0.569 . . . . 2.0 110.622 -178.874 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.0 mt -79.24 -34.76 42.42 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.736 -1.228 . . . . 1.86 108.569 179.192 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 121' ' ' GLU . 7.4 ttpm? -68.17 -39.99 82.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 2.84 109.546 179.473 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.89 -40.31 94.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 2.73 109.265 -179.615 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.536 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -60.84 -38.23 84.79 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.429 -0.952 . . . . 2.77 108.429 -179.892 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.33 -26.92 65.44 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.518 -0.919 . . . . 1.19 108.518 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.47 -39.99 81.18 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.447 -0.946 . . . . 1.2 108.447 178.627 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -66.84 -42.72 85.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.505 -0.747 . . . . 1.55 109.998 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.23 -41.25 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 0.8 108.922 179.448 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.401 HH12 ' CD ' ' A' ' 109' ' ' GLU . 37.6 ttm-85 -60.64 -39.92 90.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.072 -1.017 . . . . 3.09 108.817 178.93 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -60.15 -34.43 73.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.57 -0.706 . . . . 1.46 109.617 -179.72 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.1 -43.09 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.135 -0.978 . . . . 0.71 109.55 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.92 -27.61 62.24 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.838 -1.305 . . . . 0.57 109.838 -179.621 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -59.98 -50.19 74.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.981 -1.305 . . . . 2.59 110.094 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -67.75 -32.11 72.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.999 -1.063 . . . . 2.83 109.348 -179.619 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.39 -41.67 89.94 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.914 -0.773 . . . . 1.25 108.914 -179.486 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.3 -40.01 94.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.967 . . . . 0.7 109.182 179.386 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.405 HH21 HD23 ' A' ' 144' ' ' LEU . 58.6 mtp180 -70.04 -40.06 75.38 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.971 0.891 . . . . 2.57 108.729 179.104 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.533 ' CA ' ' HZ1' ' A' ' 49' ' ' LYS . 2.2 m120 -60.74 -38.23 84.47 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 116.002 -0.544 . . . . 1.23 111.466 -178.539 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.3 mt -70.33 -39.94 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.811 -1.181 . . . . 0.81 109.811 -179.745 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 54.2 mt -71.85 -20.56 61.8 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.397 -0.814 . . . . 1.0 110.241 -178.555 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.9 40.84 13.5 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.044 -1.622 . . . . 0.89 109.044 -179.189 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.405 HD23 HH21 ' A' ' 139' ' ' ARG . 3.3 tp -75.24 149.98 38.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.362 -1.081 . . . . 1.14 109.859 -179.361 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -74.71 141.79 44.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.513 -0.742 . . . . 4.6 109.949 -179.867 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.3 129.77 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 122.29 1.043 . . . . 1.24 108.84 178.802 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 15.0 mt -69.66 -39.96 78.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 115.411 -0.813 . . . . 1.54 110.398 -177.937 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.8 t0 68.18 127.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.741 -0.837 . . . . 1.5 108.741 -179.251 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.411 ' O ' HD13 ' A' ' 152' ' ' ILE . 19.5 mt -92.03 0.04 57.47 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.316 -0.865 . . . . 0.79 110.266 -178.95 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 24.5 t -95.61 -11.79 26.7 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.041 -1.037 . . . . 1.4 110.185 -179.683 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.24 15.48 1.55 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.066 -1.021 . . . . 0.92 111.333 -178.581 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.411 HD13 ' O ' ' A' ' 149' ' ' LEU . 2.8 mp -86.1 137.14 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.446 -1.409 . . . . 0.88 108.417 179.517 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -111.95 -10.45 13.96 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.537 -0.727 . . . . 2.45 109.356 -179.411 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -123.21 148.0 46.29 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.744 -0.597 . . . . 1.52 109.775 -179.522 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.33 138.91 58.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.449 -0.782 . . . . 1.58 109.164 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.5 m -152.59 166.65 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.658 -0.652 . . . . 0.69 109.804 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 92.9 mt -96.51 146.07 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 106.191 -1.781 . . . . 0.61 106.191 176.964 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.1 tp -96.69 118.33 32.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.891 -1.13 . . . . 0.87 110.94 -177.764 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.0 t -119.6 123.25 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 109.015 -0.735 . . . . 0.71 109.015 179.095 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -153.06 159.97 42.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.81 109.012 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.27 -31.35 64.02 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.346 -1.472 . . . . 0.98 108.956 179.287 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 46.2 t0 -169.97 140.51 2.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.415 -0.803 . . . . 2.25 108.933 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.488 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 26.5 mt -114.77 131.55 56.75 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.371 -0.831 . . . . 0.78 109.031 -179.582 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.9 p -95.07 148.6 34.95 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.132 -0.98 . . . . 0.98 110.128 -179.526 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -37.32 -39.06 0.56 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.652 2.235 . . . . 0.81 112.56 179.19 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.3 m -57.58 -39.87 77.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.282 -0.886 . . . . 0.9 108.93 -179.052 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -69.9 -39.9 75.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.169 -0.957 . . . . 1.61 109.666 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 45.7 p -56.57 -24.01 44.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.033 -1.042 . . . . 0.61 110.51 -178.23 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.39 -55.78 4.96 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.967 -1.083 . . . . 0.6 109.358 179.432 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -83.84 40.78 0.76 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.98 -1.119 . . . . 1.4 107.98 179.411 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 35.1 tp -103.37 130.14 50.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.739 -0.601 . . . . 0.7 109.611 179.501 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 172' ' ' ASN . 10.6 p-10 -86.15 97.92 10.61 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.954 -1.128 . . . . 2.35 107.954 178.243 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 56.3 mt -67.5 -41.49 84.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 1.51 111.119 -178.245 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -69.91 -26.83 64.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.658 -1.276 . . . . 2.33 112.222 -177.747 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -92.0 -5.94 52.1 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.556 -1.34 . . . . 1.92 109.513 -178.793 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.627 HG12 ' H ' ' A' ' 178' ' ' GLY . 60.9 t -107.28 119.66 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.688 -1.227 . . . . 0.67 107.688 178.168 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.1 mt -84.7 7.21 21.24 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.379 -0.825 . . . . 1.53 110.675 -177.861 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.627 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 163.53 178.11 36.94 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.192 -1.563 . . . . 0.48 109.192 179.781 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.462 ' CE1' HG11 ' A' ' 176' ' ' VAL . 13.2 m-85 -134.46 130.43 36.72 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.393 -1.063 . . . . 0.55 109.038 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.414 ' CG2' HG21 ' A' ' 205' ' ' THR . 91.5 mt -130.63 125.2 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.204 -1.035 . . . . 0.65 108.204 178.844 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 65.6 p -149.69 160.32 43.62 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.845 -1.159 . . . . 0.82 110.682 -179.073 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.457 ' CB ' ' H ' ' A' ' 206' ' ' GLY . 4.1 p30 -108.69 27.19 9.68 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.513 -0.921 . . . . 2.46 108.513 179.283 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.25 -164.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.122 -0.986 . . . . 1.28 112.079 -177.547 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.63 -79.89 0.09 OUTLIER Glycine 0 N--CA 1.492 2.387 0 CA-C-N 115.793 -0.64 . . . . 2.19 111.579 -178.593 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.13 -151.64 6.07 Favored Glycine 0 N--CA 1.494 2.553 0 O-C-N 120.711 -1.464 . . . . 2.13 111.17 -178.858 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -79.73 -9.97 59.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.828 -0.807 . . . . 5.86 110.553 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.9 p -84.55 3.12 38.09 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.101 -1.0 . . . . 3.72 110.856 -178.768 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.3 t -72.02 143.07 49.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.827 -1.17 . . . . 1.74 110.18 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -49.55 -50.21 43.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.235 -0.916 . . . . 0.95 110.128 -179.302 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.3 m -59.86 -40.23 87.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.368 -0.832 . . . . 1.55 110.32 -178.642 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 52.2 p -59.93 -40.17 87.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.933 -1.104 . . . . 1.51 110.453 -178.941 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.426 HG12 HH21 ' A' ' 195' ' ' ARG . 96.9 mt -60.0 -38.92 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.935 . . . . 1.67 109.526 -179.739 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.5 mtp -60.25 -39.89 88.36 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.858 . . . . 1.02 110.207 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.12 -45.71 83.25 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.834 -1.166 . . . . 0.68 109.725 -179.476 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.426 HH21 HG12 ' A' ' 192' ' ' ILE . 83.6 mtm180 -60.36 -49.79 76.19 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.077 -1.049 . . . . 2.93 110.298 -179.911 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 30.6 m -69.94 -34.7 73.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.715 -1.24 . . . . 0.86 110.525 -179.268 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 84.4 mt -72.67 -21.59 61.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.009 -1.057 . . . . 0.67 108.973 179.914 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 62.15 50.79 3.8 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.395 0.617 . . . . 1.5 110.886 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 96.5 mt -126.35 149.96 68.8 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 107.468 -1.308 . . . . 0.72 107.468 178.355 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.3 135.5 50.55 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 122.25 1.967 . . . . 0.61 111.845 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.99 149.97 3.72 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.595 -1.242 . . . . 0.66 111.941 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.0 mt -126.54 146.03 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.787 -1.19 . . . . 0.79 107.787 179.147 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.48 -9.25 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 120.86 -1.15 . . . . 0.91 111.547 -179.268 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.58 23.83 23.45 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 110.048 -1.221 . . . . 1.01 110.048 -179.584 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.414 HG21 ' CG2' ' A' ' 180' ' ' ILE . 7.9 p -45.55 -45.98 13.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.189 -1.183 . . . . 0.99 109.987 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.457 ' H ' ' CB ' ' A' ' 182' ' ' ASP . . . 93.47 -54.77 2.39 Favored Glycine 0 N--CA 1.503 3.119 0 O-C-N 121.017 -1.052 . . . . 1.12 112.025 178.811 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 93.3 p -152.76 29.58 0.52 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.551 -1.558 . . . . 1.72 111.248 -179.042 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 76.2 t -76.26 -34.95 26.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.948 -1.095 . . . . 0.89 108.957 178.838 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.6 p -57.46 -30.44 65.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.461 -0.774 . . . . 1.03 110.291 -179.124 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 57.5 p -83.77 -15.18 49.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.783 -1.198 . . . . 1.83 110.06 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -96.21 -12.75 24.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.09 -1.006 . . . . 2.27 109.953 -179.587 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 73.9 t -103.73 136.65 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.363 -0.836 . . . . 0.92 110.38 -178.479 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -110.1 150.1 29.08 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.748 -1.204 . . . . 2.2 107.748 178.803 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.479 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 40.8 p-10 -58.6 137.08 57.71 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.902 -1.124 . . . . 2.36 110.053 -179.355 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.4 m-20 85.64 0.04 0.73 Allowed 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.2 0.524 . . . . 2.38 110.025 179.722 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 60.1 t0 -70.67 144.1 51.16 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.193 -0.942 . . . . 2.09 109.246 179.416 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.402 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 40.9 t80 -93.77 120.27 33.82 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.383 -0.969 . . . . 1.27 108.383 178.951 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.417 HD12 ' HB2' ' A' ' 16' ' ' ALA . 89.4 mt -129.39 150.81 50.58 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.458 -0.776 . . . . 0.75 110.766 -178.696 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.5 mt -115.28 127.88 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.143 -1.429 . . . . 0.63 107.143 177.362 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 61.8 tp -100.54 118.95 37.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.972 -1.08 . . . . 0.7 108.469 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.43 ' C ' ' N ' ' A' ' 223' ' ' VAL . 18.8 t0 -81.33 -41.23 22.38 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.846 -1.168 . . . . 2.31 107.846 179.403 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.782 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 48.21 18.76 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.013 -0.736 . . . . 0.78 109.013 -179.961 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.43 ' N ' ' C ' ' A' ' 221' ' ' ASP . 39.2 t -128.45 -42.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.114 -1.439 . . . . 1.04 107.114 178.507 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 70.4 m-80 -104.78 8.11 34.81 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.509 -1.293 . . . . 2.44 107.509 178.062 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.679 HD22 ' H ' ' A' ' 4' ' ' GLY . 45.1 t30 59.62 49.45 8.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.878 -0.514 . . . . 1.55 110.245 179.703 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -147.94 149.9 33.05 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.817 -1.177 . . . . 1.99 110.766 179.885 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.45 122.05 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.304 -0.998 . . . . 0.77 108.304 179.035 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -87.67 128.98 35.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.626 -1.296 . . . . 0.98 109.218 -179.491 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 33.1 t -104.06 119.55 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.421 -0.8 . . . . 0.85 110.197 -179.014 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 57.02 69.4 1.7 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.058 -1.026 . . . . 1.66 109.598 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -91.3 135.64 1.81 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.525 2.817 . . . . 0.95 112.8 -179.689 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 233' ' ' ASN . 55.8 m -65.87 159.76 24.78 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.212 -0.93 . . . . 1.84 108.791 179.626 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.431 ' N ' HG22 ' A' ' 232' ' ' THR . 34.6 m120 -59.71 -38.06 80.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 2.74 108.939 -179.486 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.23 -39.33 86.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.361 -0.837 . . . . 2.89 109.533 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 88.1 t -61.28 -41.35 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.34 -0.85 . . . . 1.3 109.459 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.32 -40.0 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 1.09 109.865 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -59.82 -40.24 87.78 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.974 -1.079 . . . . 2.43 109.238 179.972 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -63.84 -45.91 87.39 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.335 -0.853 . . . . 2.78 108.916 179.204 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 88.5 mtp -68.71 -32.8 72.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.514 -0.742 . . . . 1.25 109.917 179.808 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -63.07 -38.69 92.2 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.952 -1.093 . . . . 2.63 108.943 179.043 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.85 93.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 1.8 108.595 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 55.2 t -62.21 -40.44 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.907 . . . . 2.13 108.926 178.846 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -60.12 -38.57 83.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.484 -0.76 . . . . 3.17 109.479 -179.925 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -60.28 -40.72 91.42 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.135 -0.978 . . . . 1.78 109.182 -179.462 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -65.0 -39.63 93.75 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.904 -1.123 . . . . 2.47 108.283 179.271 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.9 t -61.71 -36.06 71.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.278 -1.008 . . . . 2.09 108.278 178.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.28 -38.04 79.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.525 -0.735 . . . . 2.54 109.24 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 64.0 m -60.0 -40.32 88.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.139 -0.976 . . . . 2.99 108.631 179.561 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -63.44 -35.76 81.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.612 -0.68 . . . . 3.34 109.744 178.938 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -57.61 -32.78 67.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.526 -0.734 . . . . 3.88 109.143 -179.464 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 253' ' ' LEU . . . -63.18 -42.21 99.33 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.621 -0.881 . . . . 4.43 108.621 179.052 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 60.6 -38.28 0.09 Allowed 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.032 0.444 . . . . 5.42 111.12 179.534 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.569 ' C ' ' H ' ' A' ' 255' ' ' LYS . 57.5 mt -82.25 -60.36 2.24 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.915 -1.115 . . . . 6.1 110.101 -179.249 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 253' ' ' LEU . . . 70.79 -34.47 0.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.663 -0.866 . . . . 7.37 108.663 -179.0 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.569 ' H ' ' C ' ' A' ' 253' ' ' LEU . 68.2 mttm -149.75 162.85 39.45 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.714 -0.847 . . . . 8.01 108.714 -179.864 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 256' ' ' LEU . 4.0 mm? -79.71 99.15 7.28 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.922 -1.111 . . . . 9.05 109.357 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -135.13 -29.79 1.08 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.651 -0.656 . . . . 10.56 109.398 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -88.31 66.42 8.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.933 . . . . 11.32 108.894 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 . . . . . 0 C--N 1.3 -1.574 0 CA-C-O 117.92 -1.038 . . . . 12.42 109.848 -179.748 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 8.1 ttt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -150.7 149.05 29.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.796 . . . . 0.0 109.243 179.334 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -149.36 160.99 42.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.078 -1.014 . . . . 0.0 110.116 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -153.42 149.75 28.1 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.796 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -111.62 131.38 55.31 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.23 -0.919 . . . . 0.0 109.815 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.17 122.71 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-O 122.287 1.041 . . . . 0.0 112.491 -176.898 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 95.5 m -75.59 103.9 5.9 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.849 0.833 . . . . 0.0 110.148 -178.647 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.58 HG22 ' H ' ' B' ' 310' ' ' ALA . 96.6 mt -51.95 124.42 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 122.176 0.989 . . . . 0.0 109.977 -178.218 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 75.0 p -105.81 22.1 16.16 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.845 -178.745 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.58 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -80.58 149.32 67.92 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.769 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.61 -72.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.259 0 CA-C-N 119.455 0.841 . . . . 0.0 112.062 -179.655 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -86.29 23.87 1.48 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.123 -0.986 . . . . 0.0 110.819 -177.834 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 82.62 -163.14 42.11 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.542 -1.313 . . . . 0.0 109.841 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.413 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.0 tp -90.31 93.65 9.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.354 -1.086 . . . . 0.0 109.79 -178.094 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.483 ' CE1' ' H ' ' B' ' 317' ' ' ARG . 10.4 p80 -94.39 -160.25 0.76 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.728 -1.232 . . . . 0.0 109.304 178.628 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.6 m -58.31 -45.16 88.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.83 -1.168 . . . . 0.0 112.752 -176.094 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.546 HH21 ' NE2' ' B' ' 321' ' ' GLN . 3.8 tpt180 -59.46 -64.51 2.9 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.111 -1.618 . . . . 0.0 111.375 -177.911 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.403 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 7.3 Cg_endo -55.08 -34.11 86.16 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 CA-C-N 120.176 1.099 . . . . 0.0 112.047 179.953 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.2 -52.36 65.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.001 -1.062 . . . . 0.0 109.402 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.48 -41.05 63.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.217 -0.927 . . . . 0.0 109.633 -178.962 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 321' ' ' GLN . . . . . 0.546 ' NE2' HH21 ' B' ' 317' ' ' ARG . 62.3 mt-30 -70.81 -40.87 72.24 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.824 -1.172 . . . . 0.0 108.924 179.152 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -60.14 -50.5 73.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.298 -0.876 . . . . 0.0 110.854 -179.242 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 74.0 t -69.89 -31.16 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.753 -1.217 . . . . 0.0 109.792 -178.628 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -59.76 -47.99 83.49 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.229 -0.92 . . . . 0.0 109.859 -179.56 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -67.08 -40.05 86.93 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 111.078 -178.834 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 326' ' ' ALA . . . . . 0.406 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -63.46 -53.22 55.56 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.998 -1.064 . . . . 0.0 111.393 -178.934 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -56.12 -10.2 0.79 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.015 -1.053 . . . . 0.0 109.526 -179.381 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 328' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -69.79 -30.26 70.59 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 178.892 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -102.67 141.73 35.0 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.594 -0.945 . . . . 0.0 109.172 179.772 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 330' ' ' THR . . . . . 0.418 HG22 ' O ' ' B' ' 330' ' ' THR . 44.5 m -89.78 -11.32 42.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.154 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 61.8 p -59.34 156.68 12.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.374 -0.829 . . . . 0.0 110.034 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -72.9 127.93 33.99 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.351 -0.843 . . . . 0.0 108.956 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.7 mt -134.52 133.54 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 334' ' ' THR . . . . . 0.425 HG22 ' N ' ' B' ' 335' ' ' VAL . 87.9 m -132.85 155.88 48.18 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.508 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 335' ' ' VAL . . . . . 0.425 ' N ' HG22 ' B' ' 334' ' ' THR . 58.3 t -117.2 140.68 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.427 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 64.9 m -129.05 123.17 31.6 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.447 -0.783 . . . . 0.0 109.134 179.763 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 66.9 p -139.45 117.41 11.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.353 -0.842 . . . . 0.0 110.418 -179.725 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 59.8 t30 45.6 56.53 5.72 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 177.208 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.02 -13.29 26.32 Favored Glycine 0 N--CA 1.501 3.004 0 O-C-N 120.055 -1.653 . . . . 0.0 112.924 176.438 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -111.75 122.93 49.12 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-N 119.037 1.418 . . . . 0.0 109.52 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.1 m -118.53 143.53 46.69 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.769 0.795 . . . . 0.0 110.544 -178.953 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -139.87 161.0 38.62 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.822 0.82 . . . . 0.0 110.174 -179.441 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 15.5 t -89.59 140.0 29.99 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.619 -0.675 . . . . 0.0 109.446 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -76.78 -12.63 60.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.085 -1.009 . . . . 0.0 109.785 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.42 19.87 4.21 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.649 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 16.3 t -149.37 96.91 2.58 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.912 -179.224 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.9 HD23 HD22 ' A' ' 79' ' ' LEU . 28.8 tp -59.97 -32.04 70.45 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.933 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.721 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.9 m-85 -58.09 -52.34 65.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 109.915 -179.28 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 349' ' ' LYS . . . . . 0.432 ' O ' ' OG1' ' B' ' 352' ' ' THR . 33.8 mtmm -69.93 -39.92 75.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.692 -1.255 . . . . 0.0 110.163 -178.292 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' B' ' 352' ' ' THR . 39.6 mt -50.63 -58.24 6.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.775 -1.203 . . . . 0.0 108.024 179.219 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.47 ' HB3' HD22 ' A' ' 115' ' ' LEU . 0.0 OUTLIER -38.28 -27.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.871 -0.518 . . . . 0.0 111.127 -178.361 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.464 ' N ' ' O ' ' B' ' 350' ' ' LEU . 51.0 p -77.75 -11.48 59.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.091 -1.006 . . . . 0.0 110.388 -178.855 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 24.8 mt -92.78 115.41 28.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.888 -1.133 . . . . 0.0 109.195 179.221 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.1 92.75 0.75 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.919 -1.673 . . . . 0.0 108.919 179.504 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 44.3 mt -100.61 91.62 4.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.24 -1.153 . . . . 0.0 108.913 179.529 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 81.0 p -91.86 177.9 6.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.956 -1.09 . . . . 0.0 110.512 -178.502 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 357' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' B' ' 359' ' ' THR . 61.8 tt0 -46.48 155.68 0.22 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.664 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 39.46 25.23 0.05 OUTLIER Glycine 0 N--CA 1.495 2.595 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 177.597 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 359' ' ' THR . . . . . 0.465 ' N ' ' O ' ' B' ' 357' ' ' GLN . 9.2 m -82.47 112.44 19.41 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.708 -1.466 . . . . 0.0 109.283 179.423 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 16.4 t -77.37 115.8 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 122.214 1.007 . . . . 0.0 110.358 -176.882 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.3 m -110.34 176.85 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.386 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 30.8 m -132.19 129.81 40.24 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.943 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.4 mt -105.84 122.09 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.402 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 52.7 p -120.82 132.19 54.87 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.639 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.93 151.87 37.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.905 -1.122 . . . . 0.0 110.955 -178.828 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -144.87 124.49 13.25 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.691 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 160.16 -162.73 33.41 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 118.981 -1.58 . . . . 0.0 111.367 179.823 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -59.96 -55.64 31.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 122.258 -0.554 . . . . 0.0 111.759 -178.425 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.41 ' H ' ' HB3' ' B' ' 331' ' ' SER . 94.5 m-20 -104.93 7.48 34.24 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.996 -1.065 . . . . 0.0 111.105 -177.314 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' B' ' 369' ' ' ASP . 1.3 pp20? -42.91 -32.12 0.59 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.244 -0.91 . . . . 0.0 110.507 -179.12 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -70.08 -43.7 70.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 109.996 -179.293 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -64.7 -48.99 72.63 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.199 -0.938 . . . . 0.0 109.332 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.9 -75.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.425 -0.797 . . . . 0.0 110.705 -178.834 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.566 ' O ' HG23 ' B' ' 378' ' ' VAL . 45.4 t -44.5 -38.77 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.099 -1.001 . . . . 0.0 110.895 -177.564 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -64.86 -47.23 78.68 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.624 -1.298 . . . . 0.0 110.513 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -82.75 -41.72 18.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.919 -1.113 . . . . 0.0 110.445 -179.454 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.9 -39.23 77.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.904 -1.122 . . . . 0.0 108.284 -179.617 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.566 HG23 ' O ' ' B' ' 374' ' ' VAL . 48.1 t -62.38 -40.24 87.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.213 179.13 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' B' ' 383' ' ' GLU . 20.8 mtpp -68.54 -55.78 10.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.595 -1.315 . . . . 0.0 108.824 178.604 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 56.1 tp -57.78 -35.85 71.36 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.762 -1.211 . . . . 0.0 109.734 -178.699 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 28.8 ttm -70.66 -40.05 73.22 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.257 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.31 -9.99 59.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.528 -0.733 . . . . 0.0 110.968 179.164 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' B' ' 379' ' ' LYS . 93.9 mt-10 -110.03 0.83 18.62 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.042 -1.036 . . . . 0.0 111.549 -178.191 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 13.2 mt -82.38 125.89 31.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.178 -1.576 . . . . 0.0 109.224 179.136 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.318 -179.978 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.7 mmm . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.255 -0.646 . . . . 2.91 109.255 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.7 mt -110.0 130.03 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.611 -0.681 . . . . 1.2 109.164 179.671 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.5 m -120.92 144.28 48.52 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.579 -0.701 . . . . 1.4 109.747 -179.707 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -121.67 -162.82 11.75 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 108.894 -1.682 . . . . 1.05 108.894 179.751 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 6' ' ' LEU . 91.4 mt -89.28 -13.97 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.9 -1.353 . . . . 1.15 110.176 -179.218 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.9 tp 53.74 102.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.224 -0.922 . . . . 0.98 109.062 -179.883 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.64 -29.43 12.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.262 -0.899 . . . . 0.88 109.153 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 30.8 m -129.44 116.02 18.47 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 109.024 -0.732 . . . . 1.69 109.024 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.25 146.72 20.02 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.76 1.64 . . . . 0.85 112.079 -179.74 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.808 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.61 -154.4 25.5 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.462 -1.455 . . . . 0.92 109.462 -179.85 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.0 mt -148.36 150.33 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.36 -1.082 . . . . 0.81 108.587 178.947 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.84 156.32 34.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.939 -1.101 . . . . 0.51 110.752 179.663 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.2 m-85 -137.41 128.51 27.66 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.895 -1.15 . . . . 0.62 107.895 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.67 174.29 46.92 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 118.736 -1.697 . . . . 0.55 110.743 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -76.52 158.87 30.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.769 -0.842 . . . . 2.1 109.26 -179.735 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.99 126.11 46.13 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.358 -0.839 . . . . 0.77 111.377 -178.351 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.7 tp -101.36 129.96 47.46 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.876 -1.527 . . . . 0.91 106.876 177.57 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.2 tp -114.02 121.64 44.47 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.308 -0.87 . . . . 0.93 110.021 -178.914 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.2 mt -85.87 100.09 11.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.49 -0.756 . . . . 0.93 109.051 179.358 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -84.42 142.0 30.43 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.27 -1.011 . . . . 2.75 108.27 179.532 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -130.76 135.65 47.98 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.023 -1.048 . . . . 3.0 109.106 179.392 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -94.78 156.4 16.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.322 -0.861 . . . . 2.77 109.55 -179.916 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -78.58 136.98 37.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 2.94 109.321 179.787 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.6 mt -79.79 130.17 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.258 -0.901 . . . . 0.95 108.728 179.931 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.8 t -93.27 125.76 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.18 -0.95 . . . . 1.28 109.684 -179.461 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.8 mt -105.97 138.06 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.517 -0.739 . . . . 1.21 109.12 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -96.23 120.06 35.84 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.159 -0.963 . . . . 1.81 109.974 -179.585 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.542 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.0 mmt-85 -90.02 -0.24 57.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.402 -0.812 . . . . 2.8 109.692 -179.795 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -69.9 135.5 49.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.069 -1.02 . . . . 2.87 109.164 -179.895 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -83.02 154.81 24.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.107 -0.996 . . . . 2.35 109.419 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.529 HD13 ' HG3' ' A' ' 39' ' ' GLU . 2.9 pt -98.92 166.41 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.207 -0.933 . . . . 0.97 109.609 179.568 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.2 p -93.41 174.81 7.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.3 -0.875 . . . . 1.17 108.658 178.437 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.07 -48.56 81.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 1.18 110.292 -179.425 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -55.51 -31.48 62.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.767 -1.208 . . . . 2.56 110.568 -179.057 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -81.59 -8.98 59.78 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.177 -0.952 . . . . 1.79 110.289 -179.357 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.9 t -60.06 -50.09 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.776 -1.203 . . . . 1.0 109.087 179.825 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -60.11 -39.91 87.87 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.369 -0.832 . . . . 1.77 109.078 -179.663 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -64.19 -42.02 96.83 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.546 -0.721 . . . . 2.7 110.916 -178.717 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.529 ' HG3' HD13 ' A' ' 31' ' ' ILE . 68.7 mm-40 -62.83 -41.84 99.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.68 -1.263 . . . . 1.51 110.422 -179.224 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.7 t -63.73 -47.04 92.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.675 -1.266 . . . . 0.93 108.987 -179.763 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -60.0 -46.2 90.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.055 -1.028 . . . . 1.81 108.957 179.863 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -59.98 -48.59 81.1 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.026 -1.07 . . . . 2.78 108.766 179.5 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.451 ' CZ ' HD13 ' A' ' 89' ' ' ILE . 88.1 t80 -60.15 -44.61 94.84 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.162 -0.961 . . . . 0.78 108.879 178.659 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.1 tp -59.95 -47.34 86.21 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.827 -1.175 . . . . 1.07 107.827 179.427 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 27.6 t -63.53 -43.62 96.6 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.571 -0.852 . . . . 1.12 108.979 178.963 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.97 -48.24 87.28 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.986 -1.646 . . . . 0.84 108.986 179.34 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -63.2 -31.5 72.66 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.365 -1.08 . . . . 3.09 108.2 179.114 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.61 -40.05 82.17 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.813 -0.81 . . . . 0.88 108.813 179.887 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.546 ' HZ3' ' HB3' ' A' ' 49' ' ' LYS . 6.8 ttpm? -65.73 -74.31 0.11 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.932 -1.136 . . . . 2.59 107.932 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.94 -40.54 0.47 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.366 -0.834 . . . . 0.7 111.758 -178.255 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 64.0 m -54.48 -53.7 50.74 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.465 -1.397 . . . . 1.4 108.982 -179.875 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.23 -41.18 77.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.226 -0.921 . . . . 0.67 110.819 -179.318 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -66.89 -39.97 87.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.908 -1.12 . . . . 1.66 109.989 -179.511 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.9 mt -61.03 -39.95 91.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.892 -1.13 . . . . 1.58 108.725 179.066 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -61.94 -35.08 77.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.477 -0.765 . . . . 1.35 109.573 179.482 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -64.3 -43.04 95.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.034 -1.041 . . . . 0.77 109.35 179.816 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.9 -39.63 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.855 . . . . 0.63 108.917 179.681 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -57.07 -50.43 72.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.442 -0.786 . . . . 1.14 109.971 -179.368 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -57.1 -31.62 65.46 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.319 -0.863 . . . . 0.79 110.377 -177.888 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -70.02 -38.14 75.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.05 -1.031 . . . . 1.53 109.436 -179.897 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.8 -45.91 76.91 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.615 -0.678 . . . . 0.57 110.641 -179.128 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.88 -50.87 63.04 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.755 -1.212 . . . . 0.75 110.424 -178.637 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -70.24 -43.8 69.85 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.934 -1.333 . . . . 1.59 110.18 -179.792 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.4 m -69.98 -57.8 4.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.067 -1.021 . . . . 0.73 111.698 -178.042 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -98.31 -54.36 3.08 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.138 -0.976 . . . . 0.75 111.483 -178.168 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.26 -164.58 26.88 Favored Glycine 0 N--CA 1.5 2.914 0 C-N-CA 119.676 -1.25 . . . . 1.22 110.931 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -71.4 -25.92 62.55 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.884 -0.774 . . . . 5.81 110.795 -179.409 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.4 -35.9 78.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.165 -0.959 . . . . 3.37 110.197 -179.255 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -100.01 -20.28 16.14 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.331 -0.856 . . . . 1.77 110.269 -179.222 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -69.92 -40.32 75.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.962 -1.087 . . . . 1.65 110.501 -178.826 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.621 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -67.36 -26.1 66.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.133 -0.979 . . . . 0.77 109.972 -179.058 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.73 -39.99 81.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 118.954 -1.099 . . . . 0.8 108.345 179.77 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -67.82 -39.99 83.84 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.055 -1.028 . . . . 0.88 110.311 179.885 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.419 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 80.2 tt0 -59.91 -40.78 89.97 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.759 -1.213 . . . . 1.37 109.454 179.464 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.86 -48.98 76.55 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.029 -1.628 . . . . 0.62 109.029 179.518 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.5 m170 -63.05 -42.96 99.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.463 -1.022 . . . . 1.5 109.485 179.916 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.02 -45.1 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.235 -0.916 . . . . 0.63 109.784 -179.737 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.0 ttp -60.27 -40.11 89.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.891 -1.13 . . . . 1.51 109.121 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.969 HD22 HD23 ' B' ' 347' ' ' LEU . 48.1 tp -63.09 -39.34 94.41 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.683 -0.636 . . . . 0.77 109.956 179.626 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.2 tp -66.26 -38.3 87.53 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.523 -0.735 . . . . 0.62 110.248 -179.483 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -80.35 3.28 21.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.958 -1.089 . . . . 1.47 110.258 -179.045 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -49.75 130.03 20.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.0 -1.063 . . . . 1.47 109.642 -179.614 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.18 -17.73 58.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.534 -0.729 . . . . 1.78 110.629 -179.536 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -71.85 -35.05 69.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.975 -1.078 . . . . 2.53 108.713 178.767 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.8 mt -69.96 -40.36 75.47 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.492 0.663 . . . . 0.8 109.831 179.761 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.04 -45.37 93.04 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.329 -0.857 . . . . 1.42 109.917 -179.22 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -69.99 -40.0 75.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 1.71 110.334 -179.14 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.96 -40.05 75.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.288 -0.882 . . . . 1.57 110.912 -179.175 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.451 HD13 ' CZ ' ' A' ' 43' ' ' PHE . 87.3 mt -68.37 -42.45 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.991 -1.068 . . . . 0.65 109.595 -179.588 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.01 -38.78 76.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.564 -0.71 . . . . 0.82 110.633 -179.533 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.45 77.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.102 -0.999 . . . . 0.79 111.247 -178.615 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.81 -47.54 84.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.769 -1.207 . . . . 0.95 110.419 -178.964 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.42 -49.9 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.114 -0.991 . . . . 0.66 109.183 179.957 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -70.27 -43.9 69.54 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.375 -0.53 . . . . 2.2 111.132 -179.721 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -80.98 -49.87 10.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.986 -1.072 . . . . 1.65 111.991 -177.813 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -90.12 -2.43 58.08 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.001 -1.062 . . . . 2.03 111.584 -177.372 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 56.43 35.12 25.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.859 -1.15 . . . . 1.42 109.435 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.0 mtt -88.4 169.26 11.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.472 -0.768 . . . . 1.18 109.907 -179.417 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.4 p -81.88 160.0 23.54 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.342 -0.849 . . . . 0.98 108.776 179.532 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.77 -39.88 88.0 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.22 -0.925 . . . . 0.64 110.258 -179.472 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 35.9 p-10 -67.02 -35.07 79.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.081 -1.012 . . . . 2.07 109.335 -179.735 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.507 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.96 -47.39 13.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.317 -0.865 . . . . 0.73 109.604 179.661 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.63 -48.32 81.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.385 -0.822 . . . . 0.54 110.007 -179.612 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.28 -36.24 79.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.935 . . . . 0.56 109.844 -179.891 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.415 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 80.3 t60 -60.03 -42.67 94.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.286 -0.884 . . . . 1.54 109.98 -178.761 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' A' ' 110' ' ' GLY . 41.3 tt0 -64.36 -40.01 94.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.164 -0.96 . . . . 1.33 110.242 -179.469 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.2 t -60.57 -56.09 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.352 -0.842 . . . . 0.72 111.446 -178.06 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.1 mm -69.93 -39.97 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.942 -1.099 . . . . 0.85 108.936 -179.789 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.415 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 88.8 tt0 -64.78 -38.87 92.44 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.567 -0.901 . . . . 2.44 108.567 178.639 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.02 -49.2 77.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.813 -0.915 . . . . 0.98 110.813 -179.066 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -68.79 -52.34 31.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.716 -1.461 . . . . 1.41 109.527 -179.521 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.62 -40.05 78.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.296 -0.877 . . . . 1.2 109.26 179.868 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.6 t -58.24 -41.4 84.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.175 -0.953 . . . . 1.7 108.963 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.81 -40.5 91.91 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.258 -0.901 . . . . 1.47 109.028 179.192 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.431 HD22 ' HB3' ' B' ' 351' ' ' GLN . 76.5 mt -61.4 -45.24 95.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.107 -0.996 . . . . 1.56 109.62 -179.682 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -57.25 -32.32 66.45 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.143 -0.973 . . . . 2.2 109.846 -178.48 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -58.11 -21.74 47.66 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.022 -1.049 . . . . 2.12 108.605 179.773 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 123' ' ' LEU . 54.4 mt -62.37 139.95 58.54 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.264 -0.898 . . . . 2.0 108.577 179.636 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -90.09 10.08 25.71 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.114 -0.991 . . . . 3.23 110.86 -178.722 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -94.39 133.59 37.8 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.777 -1.202 . . . . 2.49 109.828 -179.75 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -69.92 -28.99 66.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.571 -0.706 . . . . 3.95 109.954 -179.861 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.484 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.7 t80 -69.24 -36.86 77.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.376 -0.827 . . . . 2.0 110.244 179.417 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.654 HD22 ' O ' ' B' ' 351' ' ' GLN . 90.6 mt -77.49 -35.21 53.84 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.093 -1.004 . . . . 1.86 109.57 179.838 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -59.99 -45.33 93.08 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.229 -0.919 . . . . 2.84 109.678 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 77.6 mm-40 -60.55 -45.37 94.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -0.964 . . . . 2.73 109.296 -179.655 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -61.94 -39.88 93.62 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.117 -1.068 . . . . 2.77 108.117 179.101 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.79 -23.25 51.54 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.184 -1.043 . . . . 1.19 108.184 178.796 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -69.96 -40.09 75.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.814 -0.81 . . . . 1.2 108.814 178.954 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.54 -40.09 94.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.528 -0.733 . . . . 1.55 110.294 -179.497 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.93 -40.56 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.08 -1.013 . . . . 0.8 108.402 179.842 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -60.09 -38.69 83.68 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.964 -0.754 . . . . 3.09 108.964 178.474 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -59.53 -39.57 84.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.745 . . . . 1.46 109.986 -179.52 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.93 -40.78 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.052 -1.03 . . . . 0.71 109.686 -179.623 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.63 -41.42 96.01 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.979 -1.105 . . . . 0.57 110.769 -179.44 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -59.93 -47.07 87.3 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.964 -1.315 . . . . 2.59 111.279 -178.799 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.621 HH12 ' CB ' ' A' ' 166' ' ' SER . 98.6 mtt180 -69.97 -30.47 67.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.504 -1.372 . . . . 2.83 109.927 -179.622 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.0 -46.15 90.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 1.25 109.152 -179.968 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.5 mt -59.88 -40.04 87.35 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.396 -0.815 . . . . 0.7 109.464 179.236 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.414 ' NE ' HD23 ' A' ' 144' ' ' LEU . 53.5 mtp180 -69.16 -40.02 78.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.397 -0.814 . . . . 2.57 110.206 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -69.93 -20.91 63.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.337 -0.852 . . . . 1.23 112.383 -178.136 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.5 mt -68.68 -40.02 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.19 -1.569 . . . . 0.81 108.408 179.664 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.13 -29.32 21.9 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.436 -0.79 . . . . 1.0 109.621 -179.699 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.96 54.35 2.05 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 108.695 -1.762 . . . . 0.89 108.695 -178.958 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.414 HD23 ' NE ' ' A' ' 139' ' ' ARG . 19.0 tp -74.73 147.31 41.48 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.625 -0.926 . . . . 1.14 110.009 -179.168 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -60.19 141.42 55.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.342 -0.848 . . . . 4.6 109.867 -179.867 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.3 mt -119.96 127.06 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-O 122.01 0.91 . . . . 1.24 109.414 179.52 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.5 mt -60.11 -45.9 95.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 116.063 -0.517 . . . . 1.54 109.952 -178.504 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.4 t0 64.22 101.52 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.498 -0.751 . . . . 1.5 109.256 -179.57 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.1 mt -71.74 -5.27 32.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.368 -0.833 . . . . 0.79 109.868 -179.269 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.6 m -80.21 -18.57 49.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.056 -1.028 . . . . 1.4 109.56 179.758 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.1 24.04 0.81 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.271 -0.893 . . . . 0.92 111.777 -178.002 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 39.2 mm -90.97 115.98 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.496 -1.378 . . . . 0.88 108.64 179.19 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -100.04 -9.68 22.39 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.34 -0.85 . . . . 2.45 110.545 -178.748 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -119.92 149.48 42.04 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.188 -0.945 . . . . 1.52 110.336 -179.392 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.01 133.81 52.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.388 -0.82 . . . . 1.58 109.1 179.766 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -151.77 164.7 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.448 -0.783 . . . . 0.69 109.597 179.678 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.8 mt -93.69 147.32 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.038 -1.838 . . . . 0.61 106.038 177.0 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 60.9 tp -97.3 117.01 30.57 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.879 -1.138 . . . . 0.87 110.642 -177.952 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 35.5 t -122.12 127.74 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.197 -1.038 . . . . 0.71 108.197 179.228 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.07 160.65 39.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.987 -1.07 . . . . 0.81 108.711 -179.895 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.96 -34.7 73.74 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.261 -1.524 . . . . 0.98 108.16 178.977 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -160.14 170.69 20.69 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.806 -0.813 . . . . 2.25 108.806 179.935 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.6 mt -141.96 129.95 21.93 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.041 -1.037 . . . . 0.78 108.733 178.989 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 63.1 p -90.56 144.23 30.32 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.084 -1.01 . . . . 0.98 109.293 -179.741 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -40.1 -37.6 1.83 Allowed 'Trans proline' 0 N--CA 1.488 1.196 0 C-N-CA 122.116 1.877 . . . . 0.81 112.457 179.39 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.621 ' CB ' HH12 ' A' ' 136' ' ' ARG . 50.2 m -59.98 -40.95 90.9 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.352 -0.843 . . . . 0.9 109.591 -179.238 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -62.78 -43.24 99.32 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.261 -0.9 . . . . 1.61 110.195 -179.644 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 62.4 p -57.85 -28.71 64.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.61 110.531 -178.679 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.99 -57.5 4.93 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.015 -1.053 . . . . 0.6 109.775 179.7 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -83.5 35.39 0.5 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.102 -0.703 . . . . 1.4 109.102 -179.446 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.3 tp -100.66 139.04 36.9 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.347 -0.846 . . . . 0.7 109.345 179.588 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -85.43 103.73 14.59 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.267 -0.896 . . . . 2.35 108.763 179.545 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 63.1 mt -63.62 -45.36 90.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.476 -0.765 . . . . 1.51 110.273 -178.694 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -70.06 -20.39 63.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.024 -1.048 . . . . 2.33 112.572 -178.328 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -93.15 -10.12 36.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.471 -1.393 . . . . 1.92 109.26 -179.185 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 178' ' ' GLY . 89.4 t -109.79 117.64 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.317 -0.864 . . . . 0.67 109.356 179.465 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 78.4 mt -88.77 5.49 43.25 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.348 -0.845 . . . . 1.53 110.676 -178.407 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.514 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.59 173.16 38.96 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.2 -1.56 . . . . 0.48 109.2 179.808 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.432 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 22.6 m-85 -133.09 129.94 38.64 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.258 -1.142 . . . . 0.55 110.105 -179.598 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.555 ' CG2' HG21 ' A' ' 205' ' ' THR . 58.9 mt -128.9 122.89 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.037 -1.097 . . . . 0.65 108.037 177.971 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 11.7 p -143.52 157.03 44.75 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.986 -1.072 . . . . 0.82 110.982 -179.202 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 183' ' ' ALA . 1.1 m-20 -96.19 21.35 9.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.436 -0.79 . . . . 2.46 109.631 -179.891 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -46.9 -173.93 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.977 -1.077 . . . . 1.28 112.723 -177.922 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -85.85 -49.75 4.19 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 111.377 -0.689 . . . . 2.19 111.377 -178.979 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -174.18 -154.46 10.86 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 118.525 -1.798 . . . . 2.13 111.71 -179.291 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.543 ' C ' ' H ' ' A' ' 188' ' ' SER . 8.7 mtt-85 -62.42 -33.99 75.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.782 -0.834 . . . . 5.86 111.151 -178.632 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 29.1 p -60.04 6.99 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.839 -1.163 . . . . 3.72 110.639 -178.302 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.543 ' H ' ' C ' ' A' ' 186' ' ' ARG . 92.7 p -90.85 130.76 36.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.871 -1.143 . . . . 1.74 109.941 179.717 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -47.62 -45.87 28.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.203 -0.935 . . . . 0.95 109.548 -179.849 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 93.3 m -58.41 -40.26 81.96 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 1.55 110.171 -178.317 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 186' ' ' ARG . 81.1 p -63.29 -38.8 92.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.822 -1.174 . . . . 1.51 109.849 -179.881 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.591 HD13 HH22 ' A' ' 195' ' ' ARG . 41.9 mm -60.09 -45.81 95.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.299 -0.876 . . . . 1.67 109.09 -179.459 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.16 -46.45 89.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.415 -0.803 . . . . 1.02 110.639 -179.698 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.43 -48.73 76.38 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.805 -1.185 . . . . 0.68 111.219 -178.273 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.591 HH22 HD13 ' A' ' 192' ' ' ILE . 26.8 mtm-85 -60.88 -50.04 75.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.684 -1.26 . . . . 2.93 110.458 -178.903 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 48.7 m -71.29 -34.98 71.14 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.834 -1.166 . . . . 0.86 111.6 -178.506 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 99.0 mt -81.52 -11.13 59.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.696 -1.253 . . . . 0.67 110.796 -178.356 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 56.91 46.48 19.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.166 -0.959 . . . . 1.5 110.696 179.592 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 8' ' ' SER . 92.2 mt -116.31 121.26 33.75 Favored Pre-proline 0 N--CA 1.5 2.072 0 N-CA-C 108.341 -0.985 . . . . 0.72 108.341 179.055 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -42.35 129.61 4.76 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.83 1.687 . . . . 0.61 111.952 -179.42 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -170.01 152.17 4.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.982 -1.074 . . . . 0.66 111.649 -179.221 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.7 mt -126.87 144.0 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.654 -1.239 . . . . 0.79 107.654 178.607 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 20.5 m -124.05 -9.43 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 O-C-N 120.796 -1.19 . . . . 0.91 111.381 -178.446 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.46 23.69 24.0 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 110.875 -0.89 . . . . 1.01 110.875 -178.829 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.555 HG21 ' CG2' ' A' ' 180' ' ' ILE . 19.2 p -47.19 -42.86 20.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.833 -1.392 . . . . 0.99 110.105 -179.276 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.77 -52.26 4.18 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 120.039 -1.077 . . . . 1.12 111.924 178.833 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.5 t -155.36 35.1 0.37 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.37 -1.665 . . . . 1.72 111.819 -178.759 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 29.5 t -75.95 -38.01 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.857 -1.152 . . . . 0.89 109.195 178.422 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.441 HG23 ' H ' ' A' ' 209' ' ' THR . 2.2 p -60.03 -40.07 88.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.591 -0.693 . . . . 1.03 111.55 -177.985 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.7 p -78.47 -11.37 59.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.799 -1.188 . . . . 1.83 110.264 -178.74 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -96.97 -12.24 23.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.233 -0.917 . . . . 2.27 110.408 -179.698 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 213' ' ' LYS . 91.8 t -116.34 156.2 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.321 -0.862 . . . . 0.92 110.592 -179.344 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.505 ' N ' HG12 ' A' ' 212' ' ' VAL . 62.3 mmtt -114.71 154.12 29.04 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.207 -1.035 . . . . 2.2 108.207 179.687 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 39.0 p-10 -59.73 135.96 57.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.868 -1.145 . . . . 2.36 110.095 -179.404 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.7 OUTLIER 94.5 -1.72 0.08 Allowed 'General case' 0 N--CA 1.511 2.614 0 CA-C-O 121.581 0.705 . . . . 2.38 109.988 179.502 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 48.8 t0 -70.08 151.2 45.76 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.434 -0.792 . . . . 2.09 109.792 -179.961 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 51.0 t80 -95.37 120.13 35.07 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.371 -0.831 . . . . 1.27 108.804 179.602 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 90.2 mt -123.34 138.34 54.63 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.386 -0.821 . . . . 0.75 110.657 -179.297 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.9 mt -112.35 130.0 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 106.436 -1.69 . . . . 0.63 106.436 176.317 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 57.0 tp -100.32 115.01 28.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.115 -0.991 . . . . 0.7 109.542 -178.303 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 223' ' ' VAL . 55.8 m-20 -70.6 -46.92 62.51 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.924 -1.139 . . . . 2.31 107.924 178.996 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.808 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 52.12 9.15 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.917 -0.771 . . . . 0.78 108.917 -179.644 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' A' ' 221' ' ' ASP . 75.5 t -125.9 -38.89 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 107.094 -1.447 . . . . 1.04 107.094 178.797 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -104.32 0.01 28.71 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.928 -1.138 . . . . 2.44 107.928 178.243 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 60.08 45.9 11.35 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.156 -0.683 . . . . 1.55 109.156 -179.524 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -136.41 156.26 48.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.398 -0.814 . . . . 1.99 109.599 -179.752 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.5 t -124.37 129.98 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 108.798 -0.816 . . . . 0.77 108.798 178.957 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 228' ' ' TYR . . . . . 0.536 ' CE1' ' SD ' ' A' ' 239' ' ' MET . 62.4 m-85 -105.22 125.86 51.45 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.513 -0.921 . . . . 0.98 108.513 179.192 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.9 t -103.89 113.99 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.202 -0.936 . . . . 0.85 110.404 -179.406 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 49.48 62.67 11.61 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.099 -1.001 . . . . 1.66 110.707 178.916 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -85.35 156.16 10.87 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.832 2.355 . . . . 0.95 112.173 179.319 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.0 m -65.92 159.28 25.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.342 -0.849 . . . . 1.84 109.637 -179.423 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.462 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 41.9 p-10 -61.61 -38.58 88.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.257 -0.902 . . . . 2.74 111.006 -178.916 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.462 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 16.8 pt-20 -65.62 -30.83 71.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.79 -1.194 . . . . 2.89 109.708 -179.492 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.6 -43.15 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 1.3 108.564 179.286 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.89 -41.53 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.536 -0.728 . . . . 1.09 109.963 179.885 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -60.0 -41.9 93.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.037 -1.039 . . . . 2.43 109.409 -179.904 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -61.34 -46.23 91.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 2.78 110.347 -179.566 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 239' ' ' MET . . . . . 0.536 ' SD ' ' CE1' ' A' ' 228' ' ' TYR . 11.7 mtm -70.33 -29.46 66.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.139 -0.975 . . . . 1.25 109.695 -179.896 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 23.6 mmm-85 -69.91 -37.9 76.09 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.329 -0.857 . . . . 2.63 109.526 178.913 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.0 -43.5 95.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 1.8 109.327 -179.618 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 76.1 t -62.92 -38.0 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.175 -0.953 . . . . 2.13 108.526 179.127 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -59.7 -39.66 85.32 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.57 -0.9 . . . . 3.17 108.57 179.802 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.94 -40.03 87.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.179 -0.951 . . . . 1.78 108.821 179.455 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.29 -39.96 89.72 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.231 -1.026 . . . . 2.47 108.231 179.076 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 53.5 t -69.08 -40.07 80.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.281 -1.007 . . . . 2.09 108.281 178.948 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.63 -39.43 84.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.718 -0.614 . . . . 2.54 109.514 -179.849 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 63.2 m -59.97 -40.12 88.0 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.961 -1.087 . . . . 2.99 108.99 -179.968 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -62.22 -39.59 93.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.087 -1.008 . . . . 3.34 109.182 179.214 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -94.62 33.34 1.46 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.299 -0.876 . . . . 3.88 109.419 -179.838 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -151.55 26.24 0.67 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.14 -0.975 . . . . 4.43 111.07 -179.457 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -104.96 54.13 0.72 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.086 -1.009 . . . . 5.42 109.628 179.403 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.417 ' C ' ' H ' ' A' ' 255' ' ' LYS . 15.1 mt 60.38 20.06 9.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.433 -0.792 . . . . 6.1 109.104 -179.001 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -75.14 11.59 1.11 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.977 -0.749 . . . . 7.37 108.977 179.62 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 253' ' ' LEU . 63.1 tttp -60.01 -50.31 74.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.464 -0.772 . . . . 8.01 109.517 -179.715 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 38.3 mt -148.63 -29.83 0.28 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.297 -0.877 . . . . 9.05 109.419 178.853 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 258' ' ' ASP . 46.7 mtmt -72.01 -9.41 58.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 10.56 110.431 -178.776 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.545 ' C ' ' O ' ' A' ' 257' ' ' LYS . 13.5 t0 14.09 67.09 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.676 0 CA-C-O 120.974 0.416 . . . . 11.32 111.861 178.566 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 117.93 -1.033 . . . . 12.42 109.177 -179.717 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 3.0 ttt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.509 0.671 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -151.98 150.07 29.59 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.995 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -148.34 159.17 44.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.007 -1.058 . . . . 0.0 110.14 -179.275 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -152.98 150.06 28.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.631 -0.668 . . . . 0.0 109.344 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 305' ' ' GLU . . . . . 0.481 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 1.6 pm0 -114.87 134.69 54.94 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.313 -0.867 . . . . 0.0 109.969 179.43 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 1.3 p -135.63 124.92 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 CA-C-O 122.029 0.919 . . . . 0.0 112.44 -177.212 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 88.7 m -77.72 106.35 9.47 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.93 0.871 . . . . 0.0 109.969 -179.385 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.472 HG22 ' H ' ' B' ' 310' ' ' ALA . 92.3 mt -50.78 124.16 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 122.449 1.118 . . . . 0.0 110.274 -177.407 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 74.8 p -108.06 19.93 19.35 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.54 -178.955 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.472 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -74.57 118.21 68.27 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.907 . . . . 0.0 108.606 179.308 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -61.18 -13.4 27.96 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 CA-C-N 120.477 1.206 . . . . 0.0 112.288 -179.815 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -117.5 9.52 13.26 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.524 -0.735 . . . . 0.0 110.422 -178.581 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.96 172.08 16.78 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.311 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.484 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -82.34 87.92 6.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.951 -1.323 . . . . 0.0 109.557 -178.285 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.537 ' CE1' ' HB3' ' B' ' 317' ' ' ARG . 23.4 p-80 -90.56 -163.39 1.02 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.796 -1.19 . . . . 0.0 109.713 178.76 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.1 m -58.1 -41.29 83.21 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.806 -1.184 . . . . 0.0 112.595 -175.775 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.621 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 16.3 tpt180 -59.35 -59.58 13.38 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 120.379 -1.451 . . . . 0.0 111.658 -179.49 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.412 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 14.9 Cg_endo -60.43 -34.86 92.71 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 CA-C-N 120.522 1.222 . . . . 0.0 111.693 -179.653 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.98 -51.97 67.4 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.318 -0.864 . . . . 0.0 108.978 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -54.27 -41.8 69.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.687 -178.934 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -70.08 -41.13 74.49 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.982 -1.074 . . . . 0.0 108.669 178.772 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -60.73 -51.67 68.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.548 -0.72 . . . . 0.0 111.247 -179.362 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 323' ' ' VAL . . . . . 0.41 HG13 ' O ' ' B' ' 344' ' ' ALA . 86.1 t -67.76 -27.04 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.565 -1.334 . . . . 0.0 109.259 -179.125 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.419 ' NZ ' ' OE1' ' A' ' 74' ' ' GLU . 31.1 ttmt -60.04 -47.52 85.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.552 -0.718 . . . . 0.0 109.645 179.741 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -64.39 -45.22 88.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 110.557 -179.255 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.09 -52.79 63.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.854 -1.154 . . . . 0.0 110.751 -178.792 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -55.22 -16.63 3.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.174 -0.954 . . . . 0.0 109.808 179.706 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.96 -30.64 69.97 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.462 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.29 140.47 39.17 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.465 -1.02 . . . . 0.0 109.27 179.844 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 19.8 m -89.94 -10.71 44.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.124 -0.985 . . . . 0.0 109.607 -179.97 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.495 ' OG ' ' N ' ' B' ' 368' ' ' GLU . 72.9 m -57.74 146.55 30.82 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.051 -1.03 . . . . 0.0 108.679 179.451 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.7 132.66 50.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.186 -0.946 . . . . 0.0 109.499 -179.326 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.8 mt -132.34 131.8 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.471 -0.768 . . . . 0.0 108.964 179.694 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 334' ' ' THR . . . . . 0.403 HG22 ' N ' ' B' ' 335' ' ' VAL . 52.1 m -128.73 153.48 47.31 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.778 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 335' ' ' VAL . . . . . 0.403 ' N ' HG22 ' B' ' 334' ' ' THR . 98.9 t -118.51 140.03 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.504 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 34.3 m -128.04 123.51 34.82 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 179.225 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 86.9 p -138.54 114.98 10.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.261 -0.899 . . . . 0.0 110.87 -179.191 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 28.9 m120 45.17 50.04 9.63 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 176.906 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.92 -14.21 62.5 Favored Glycine 0 N--CA 1.501 3.028 0 O-C-N 120.077 -1.639 . . . . 0.0 112.947 176.873 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -116.02 126.69 54.15 Favored 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 119.225 1.512 . . . . 0.0 109.699 179.834 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 52.9 m -118.43 144.6 45.84 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.731 0.777 . . . . 0.0 110.648 -178.943 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 342' ' ' ALA . . . . . 0.506 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -143.18 162.11 36.46 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.571 0.7 . . . . 0.0 110.005 -179.765 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 41.4 t -87.94 132.5 34.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.669 -0.644 . . . . 0.0 110.745 -178.906 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.41 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -68.96 -16.75 63.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 108.689 179.358 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -88.73 19.4 4.03 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 178.737 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 346' ' ' SER . . . . . 0.745 ' CB ' ' HZ3' ' B' ' 349' ' ' LYS . 53.9 p -146.62 94.99 2.52 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.774 0.797 . . . . 0.0 112.406 -179.428 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.969 HD23 HD22 ' A' ' 79' ' ' LEU . 52.9 tp -60.0 -36.51 77.34 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.728 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.763 ' CE2' HD11 ' A' ' 79' ' ' LEU . 58.3 m-85 -56.51 -53.52 56.5 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.324 -0.86 . . . . 0.0 110.708 -179.181 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 349' ' ' LYS . . . . . 0.745 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 33.6 mtmm -70.04 -38.78 75.94 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.875 -1.141 . . . . 0.0 109.609 -178.846 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' B' ' 352' ' ' THR . 35.7 mt -48.2 -59.51 3.36 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.946 -1.096 . . . . 0.0 108.496 179.415 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.654 ' O ' HD22 ' A' ' 123' ' ' LEU . 0.9 OUTLIER -39.14 -25.92 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.695 -0.628 . . . . 0.0 111.124 -179.088 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.46 ' N ' ' O ' ' B' ' 350' ' ' LEU . 66.3 p -79.45 -9.94 59.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.344 -1.472 . . . . 0.0 110.198 -178.295 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' B' ' 342' ' ' ALA . 61.1 mt -92.54 114.43 26.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.018 -1.051 . . . . 0.0 108.644 178.6 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.77 90.04 0.66 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 179.575 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 22.7 mt -100.62 93.54 5.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.316 -1.108 . . . . 0.0 108.674 179.426 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 70.9 p -93.36 167.34 11.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.135 -0.978 . . . . 0.0 110.625 -179.053 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 13.3 tm0? -57.84 113.01 1.67 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.782 -0.574 . . . . 0.0 110.693 -179.32 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.78 9.25 38.05 Favored Glycine 0 N--CA 1.498 2.821 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.737 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.6 m -87.19 110.65 20.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.388 -1.066 . . . . 0.0 111.415 -179.113 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 5.0 t -77.03 115.43 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 122.165 0.983 . . . . 0.0 109.703 -177.775 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 18.3 m -113.31 177.18 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.855 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 93.3 m -132.15 132.58 43.34 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.052 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 59.3 mt -107.94 126.07 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.194 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 54.0 m -125.36 133.51 52.53 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.447 -0.783 . . . . 0.0 109.17 -179.491 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -148.53 155.62 41.38 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.94 -1.1 . . . . 0.0 111.001 -178.812 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -149.55 128.68 12.76 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.824 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.461 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 156.65 -152.16 23.54 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.155 -1.498 . . . . 0.0 111.726 179.548 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 368' ' ' GLU . . . . . 0.495 ' N ' ' OG ' ' B' ' 331' ' ' SER . 54.5 tp10 -58.64 -52.1 67.13 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 122.099 -0.647 . . . . 0.0 112.376 -177.15 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' B' ' 370' ' ' GLU . 89.2 m-20 -114.98 15.63 17.23 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.011 -1.056 . . . . 0.0 111.416 -177.11 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.54 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.0 OUTLIER -41.25 -37.3 0.92 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.255 -0.903 . . . . 0.0 111.718 -178.488 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' B' B ' 371' ' ' GLN . . . . . 0.516 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 24.6 mm100 -68.05 -44.53 76.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.602 -1.311 . . . . 0.0 110.376 -178.083 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -68.29 -51.56 43.51 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.094 -1.004 . . . . 0.0 109.033 179.806 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -46.32 -38.08 8.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.698 -0.626 . . . . 0.0 111.665 -178.87 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.467 ' O ' HG23 ' B' ' 378' ' ' VAL . 70.4 t -73.02 -39.47 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.624 -1.297 . . . . 0.0 109.332 179.505 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.98 -58.67 7.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 0.0 111.507 -178.807 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -68.96 -40.45 78.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.525 -1.359 . . . . 0.0 111.791 -177.956 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.02 -41.87 93.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.715 -1.241 . . . . 0.0 108.853 -178.871 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.467 HG23 ' O ' ' B' ' 374' ' ' VAL . 52.6 t -61.07 -44.58 98.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.221 -0.925 . . . . 0.0 109.624 179.367 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' B' ' 383' ' ' GLU . 45.7 mtpt -69.26 -55.3 10.93 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.108 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 48.7 tp -54.87 -35.9 64.55 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.317 -0.864 . . . . 0.0 109.393 -178.271 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 38.3 ttm -70.77 -40.02 72.88 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.623 -1.298 . . . . 0.0 108.689 177.829 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.86 -4.28 58.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.625 -0.672 . . . . 0.0 110.533 179.728 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' B' ' 379' ' ' LYS . 98.4 mt-10 -112.11 -4.79 14.34 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.087 -1.008 . . . . 0.0 110.986 -179.701 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 16.5 mt -80.27 132.86 35.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.455 -1.403 . . . . 0.0 108.483 178.579 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.284 -179.904 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mmm . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.197 0.522 . . . . 2.91 109.777 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.4 mt -99.69 122.9 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.267 -0.895 . . . . 1.2 109.042 179.505 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.3 m -139.03 119.39 13.75 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.302 -0.874 . . . . 1.4 109.683 -179.482 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.08 -163.01 29.72 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.108 -1.597 . . . . 1.05 109.108 179.648 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.2 mt -90.6 -7.77 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.118 -1.224 . . . . 1.15 110.684 -179.048 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.2 tp 54.85 96.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.969 -1.082 . . . . 0.98 109.246 -179.829 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.45 -25.77 26.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.142 -0.974 . . . . 0.88 109.375 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 t -150.93 131.21 7.0 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.152 -0.967 . . . . 1.69 109.101 179.659 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.11 140.31 15.66 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.954 1.769 . . . . 0.85 111.836 179.608 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.691 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 166.61 -164.59 37.82 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.382 -1.487 . . . . 0.92 109.382 -179.583 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.3 mt -147.24 147.27 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.897 -1.355 . . . . 0.81 108.589 179.37 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.06 157.67 37.91 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.924 -1.11 . . . . 0.51 110.07 179.755 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -139.02 128.13 23.89 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.01 -1.107 . . . . 0.62 108.01 179.312 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.52 178.78 47.4 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.473 -1.822 . . . . 0.55 110.792 179.714 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -77.43 158.15 30.17 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.761 -0.847 . . . . 2.1 109.431 -179.658 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.36 132.3 45.81 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.315 -0.866 . . . . 0.77 111.515 -178.563 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.3 tp -101.58 133.3 46.47 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.468 -1.308 . . . . 0.91 107.468 178.004 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.0 tp -116.35 123.13 46.85 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.853 0.835 . . . . 0.93 110.19 -178.798 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.429 HD12 ' HB2' ' A' ' 160' ' ' ALA . 18.3 mt -92.75 102.29 14.69 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.206 0.527 . . . . 0.93 110.586 -179.022 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mtmt -105.15 136.0 45.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.369 -0.832 . . . . 2.75 109.482 179.713 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -130.64 139.49 50.37 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.44 -0.787 . . . . 3.0 109.354 179.437 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -87.5 152.63 22.06 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.147 -0.971 . . . . 2.77 109.493 179.547 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -70.07 140.64 52.8 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.103 -0.998 . . . . 2.94 110.383 -179.781 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.6 mt -81.88 136.65 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.476 -0.935 . . . . 0.95 108.476 179.124 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.6 t -103.66 127.68 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.231 -0.918 . . . . 1.28 110.776 -178.82 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -102.96 136.69 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.791 -0.818 . . . . 1.21 108.791 179.481 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.13 124.55 34.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.987 -1.07 . . . . 1.81 109.238 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -88.99 1.12 55.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -0.873 . . . . 2.8 109.526 -179.762 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -61.85 140.33 58.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 2.87 110.129 179.859 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -85.58 141.73 29.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.612 -0.884 . . . . 2.35 108.612 179.452 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.495 HG21 ' HG3' ' A' ' 39' ' ' GLU . 7.7 pt -90.12 164.99 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.823 -1.173 . . . . 0.97 110.944 -179.12 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.3 p -97.07 172.46 7.82 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.551 -0.907 . . . . 1.17 108.551 178.566 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.02 -48.69 80.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.02 -1.05 . . . . 1.18 109.819 -179.473 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 40.1 t0 -55.5 -30.05 59.93 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.822 -1.174 . . . . 2.56 109.367 -179.889 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.86 -10.04 59.42 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.446 -0.784 . . . . 1.79 110.272 -179.756 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.5 t -64.08 -53.28 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.497 -1.377 . . . . 1.0 108.995 179.578 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.25 -40.04 96.3 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.436 -0.79 . . . . 1.77 110.121 -179.906 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -69.89 -40.25 75.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.095 -1.003 . . . . 2.7 110.497 -178.934 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.495 ' HG3' HG21 ' A' ' 31' ' ' ILE . 66.4 mm-40 -65.81 -40.04 91.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.846 -1.159 . . . . 1.51 109.955 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.88 -46.48 96.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.963 -1.086 . . . . 0.93 108.514 178.919 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -60.26 -40.43 90.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.19 -0.944 . . . . 1.81 109.315 179.561 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -60.07 -44.14 94.96 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.097 -1.075 . . . . 2.78 108.097 179.099 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.33 -48.63 80.46 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.231 -0.918 . . . . 0.78 109.046 178.114 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.5 tp -59.81 -45.24 92.97 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.217 -1.031 . . . . 1.07 108.217 -179.472 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 41.2 t -60.34 -40.02 89.21 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.156 -0.965 . . . . 1.12 108.548 178.538 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.9 -48.87 80.89 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.641 -1.784 . . . . 0.84 108.641 179.32 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -60.33 -39.02 85.57 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.821 -1.177 . . . . 3.09 107.821 178.28 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -51.06 -40.79 59.14 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.582 -0.896 . . . . 0.88 108.582 179.887 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 50' ' ' ALA . 14.5 ttmm -66.91 -73.78 0.13 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.386 -1.338 . . . . 2.59 107.386 178.417 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.83 -38.7 0.19 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.659 -0.65 . . . . 0.7 111.139 -178.557 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.2 m -53.75 -55.25 27.97 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.513 -1.367 . . . . 1.4 108.184 179.206 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.91 -46.96 66.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.521 -0.737 . . . . 0.67 111.027 -179.63 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -62.47 -43.54 98.56 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.885 -1.134 . . . . 1.66 110.5 -179.058 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.6 mt -60.12 -40.07 88.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.06 -1.025 . . . . 1.58 108.924 179.694 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -62.71 -34.39 77.06 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.429 -0.794 . . . . 1.35 109.618 179.507 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -64.6 -44.15 91.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.991 -1.068 . . . . 0.77 109.744 179.881 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.9 mt -60.23 -39.86 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.63 109.343 179.822 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.9 ttpp -54.08 -50.19 67.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.492 -0.755 . . . . 1.14 109.7 -179.076 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.7 m -58.13 -37.98 75.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -0.939 . . . . 0.79 110.667 -177.884 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.85 -38.92 92.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.878 -1.139 . . . . 1.53 109.768 -179.696 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.65 -46.8 77.81 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.541 -0.724 . . . . 0.57 109.865 -179.613 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.13 -52.21 52.79 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.913 -1.275 . . . . 0.75 109.913 -179.124 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -70.08 -47.56 61.39 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.146 -1.208 . . . . 1.59 109.996 -179.728 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 49.0 m -63.63 -65.45 0.68 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.299 -0.876 . . . . 0.73 112.744 -177.569 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -95.58 -45.03 7.22 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.609 -1.307 . . . . 0.75 111.151 -177.944 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.17 -169.98 24.79 Favored Glycine 0 N--CA 1.5 2.91 0 O-C-N 120.672 -1.268 . . . . 1.22 110.863 179.67 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.0 -24.36 63.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.93 -0.747 . . . . 5.81 109.652 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -60.0 -34.01 72.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -0.802 . . . . 3.37 110.195 -179.682 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.417 ' HA ' HD12 ' A' ' 72' ' ' ILE . 29.5 mmtp -100.33 -17.46 17.25 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.316 -0.865 . . . . 1.77 110.006 179.683 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -68.8 -46.44 68.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.262 -0.899 . . . . 1.65 110.284 -179.342 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.553 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -62.47 -28.2 69.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.412 -0.805 . . . . 0.77 109.945 -178.802 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 69' ' ' LYS . 93.0 mt -60.06 -41.14 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.917 -1.114 . . . . 0.8 109.389 -179.621 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -68.19 -38.16 81.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.961 -1.087 . . . . 0.88 110.279 -179.567 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.401 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 74.4 tt0 -59.94 -39.95 87.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.922 -1.111 . . . . 1.37 109.485 179.676 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.1 -41.69 99.7 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.11 -1.596 . . . . 0.62 109.11 179.522 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.4 m170 -64.02 -40.97 97.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.398 -1.06 . . . . 1.5 109.502 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -68.91 -47.2 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.174 -0.954 . . . . 0.63 109.022 179.488 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -60.61 -40.24 91.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.095 -1.003 . . . . 1.51 110.472 -179.457 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.86 HD11 ' CE2' ' B' ' 348' ' ' PHE . 27.2 tp -67.48 -40.0 85.26 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.079 -1.013 . . . . 0.77 109.3 179.72 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.63 -39.98 92.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.468 -0.77 . . . . 0.62 110.368 -179.503 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -80.26 5.05 15.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.995 -1.066 . . . . 1.47 110.262 -178.706 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 61.9 t0 -51.57 130.03 27.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.059 -1.026 . . . . 1.47 109.618 -179.855 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.404 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.7 mt-10 -61.21 -15.18 31.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.48 -0.763 . . . . 1.78 110.173 -179.337 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -72.55 -36.86 68.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.106 -0.996 . . . . 2.53 108.673 178.758 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.04 -40.06 75.35 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.574 0.702 . . . . 0.8 109.41 -179.915 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.12 -49.16 78.75 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.259 -0.9 . . . . 1.42 109.597 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -69.99 -40.29 75.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.377 -0.827 . . . . 1.71 111.316 -179.008 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.07 -39.92 75.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.881 -1.137 . . . . 1.57 110.997 -178.678 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.3 mt -70.0 -41.97 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.02 -1.05 . . . . 0.65 109.585 -179.744 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.7 mt -68.53 -37.79 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.444 -0.785 . . . . 0.82 109.633 179.39 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.28 86.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.79 110.818 -178.701 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 96' ' ' LYS . 97.8 mt -60.09 -45.99 91.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.81 -1.181 . . . . 0.95 109.393 -179.284 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.2 mt -61.68 -49.43 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.297 -0.877 . . . . 0.66 109.097 179.479 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -69.86 -40.0 76.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.306 -0.872 . . . . 2.2 110.67 179.805 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -83.64 -52.86 6.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.037 -1.039 . . . . 1.65 112.057 -177.948 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 92' ' ' LEU . 7.1 mtpm? -93.4 -3.22 53.63 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.078 -1.014 . . . . 2.03 112.295 -177.123 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.2 m170 59.21 39.98 22.13 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.839 -1.163 . . . . 1.42 109.573 -179.585 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.5 mtp -91.27 164.97 13.69 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.459 -0.775 . . . . 1.18 110.112 -179.834 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 65.4 p -79.99 163.62 24.1 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.514 -0.741 . . . . 0.98 109.197 179.732 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.09 -41.23 82.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.64 110.458 -179.305 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -67.48 -37.69 83.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 2.07 109.577 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.29 -41.15 34.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.293 -0.879 . . . . 0.73 110.169 179.967 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.1 -47.02 63.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.895 . . . . 0.54 110.452 -179.25 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.45 -40.4 90.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.974 -1.079 . . . . 0.56 110.18 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.45 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 84.8 t60 -59.91 -40.12 87.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.251 -0.905 . . . . 1.54 110.17 -178.564 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -64.52 -40.12 95.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.057 -1.027 . . . . 1.33 110.795 -178.931 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.08 -51.85 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.072 -1.017 . . . . 0.72 111.06 -178.093 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mm -69.66 -39.97 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.777 -1.202 . . . . 0.85 108.574 -179.837 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.45 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 88.2 tt0 -62.78 -39.35 93.93 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.622 -0.881 . . . . 2.44 108.622 178.825 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.94 -50.61 65.8 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.199 -1.161 . . . . 0.98 110.199 -179.545 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -66.24 -48.11 71.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.79 -1.418 . . . . 1.41 109.112 179.955 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.05 93.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.139 -0.976 . . . . 1.2 108.673 179.431 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.1 t -58.19 -39.94 80.25 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.71 -0.848 . . . . 1.7 108.71 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.92 -40.0 94.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.403 -0.811 . . . . 1.47 109.631 179.485 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.04 -41.19 91.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.976 -1.078 . . . . 1.56 109.604 -179.431 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.83 -33.81 72.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.57 -1.331 . . . . 2.2 109.452 -179.246 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -54.5 -22.18 12.16 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.418 -0.956 . . . . 2.12 108.418 179.437 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.467 HD13 HD13 ' A' ' 123' ' ' LEU . 61.7 mt -64.09 144.84 56.8 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.378 -0.826 . . . . 2.0 109.319 179.912 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -100.63 46.67 0.94 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.248 -0.907 . . . . 3.23 110.489 -179.727 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 64.6 t0 -131.51 138.02 48.77 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.14 -0.975 . . . . 2.49 109.943 179.964 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.541 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 47.5 mt-10 -69.94 -32.0 70.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.599 -0.688 . . . . 3.95 110.504 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.463 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.3 t80 -72.18 -39.95 68.29 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.309 -0.87 . . . . 2.0 110.536 179.582 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.642 ' CD2' HH21 ' A' ' 126' ' ' ARG . 80.9 mt -70.54 -37.31 74.05 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.094 -1.004 . . . . 1.86 108.825 -179.855 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -60.41 -39.83 88.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 2.84 109.792 179.333 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 73.3 mm-40 -59.46 -48.94 79.7 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.112 -0.992 . . . . 2.73 109.692 -179.232 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.642 HH21 ' CD2' ' A' ' 123' ' ' LEU . 77.4 mtm180 -63.88 -38.52 91.39 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.134 -1.026 . . . . 2.77 108.672 179.105 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.67 -26.63 56.91 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.951 -1.129 . . . . 1.19 107.951 178.888 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -71.08 -38.08 72.45 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.403 -0.962 . . . . 1.2 108.403 178.347 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -64.98 -40.1 94.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.581 -0.699 . . . . 1.55 109.658 -179.527 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.2 t -68.84 -43.02 82.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.26 -0.9 . . . . 0.8 109.233 179.811 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.434 HH11 ' HG2' ' A' ' 131' ' ' ARG . 28.6 ttt-85 -60.6 -39.68 89.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 3.09 108.842 179.14 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -60.0 -39.98 87.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.557 -0.714 . . . . 1.46 110.422 -179.447 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 94.3 mt -60.04 -43.91 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.887 -1.133 . . . . 0.71 109.997 -179.261 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.98 -34.43 70.92 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.894 -1.283 . . . . 0.57 109.894 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -60.0 -49.97 75.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -1.177 . . . . 2.59 109.673 -179.219 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.405 ' HG2' HH21 ' A' ' 139' ' ' ARG . 86.1 mtm180 -69.85 -30.85 68.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.851 -1.156 . . . . 2.83 110.04 -179.936 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.04 -43.24 95.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.07 -1.018 . . . . 1.25 109.083 -179.586 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.6 mt -60.39 -39.9 88.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.304 -0.873 . . . . 0.7 109.352 179.208 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.405 HH21 ' HG2' ' A' ' 136' ' ' ARG . 57.0 mtm180 -69.64 -38.17 77.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 2.57 108.485 179.072 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.482 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.4 m120 -60.16 -36.71 78.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.819 -0.551 . . . . 1.23 110.626 -179.136 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.3 mt -70.07 -42.98 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.782 -1.199 . . . . 0.81 109.512 -179.767 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.8 mt -81.08 -38.03 28.0 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.402 -0.812 . . . . 1.0 110.021 -179.89 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.89 45.87 4.08 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 108.758 -1.737 . . . . 0.89 108.758 -178.941 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.4 tp -74.18 149.87 40.68 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.482 -1.01 . . . . 1.14 109.777 -179.273 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 142.56 53.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 4.6 109.655 -179.61 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.05 123.19 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-O 121.611 0.72 . . . . 1.24 109.214 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.414 HG12 ' H ' ' A' ' 147' ' ' ILE . 23.9 mm -49.18 -52.91 9.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.583 -0.698 . . . . 1.54 109.384 -178.943 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.6 t0 66.41 100.08 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.494 0.664 . . . . 1.5 109.527 -179.893 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.51 ' O ' HD12 ' A' ' 152' ' ' ILE . 67.8 mt -70.91 -9.0 56.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.507 -0.746 . . . . 0.79 109.945 -179.337 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.9 p -74.99 -17.28 60.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.066 -1.021 . . . . 1.4 109.592 179.778 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.94 28.74 0.67 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.455 -0.778 . . . . 0.92 111.316 -177.716 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 149' ' ' LEU . 49.9 mt -90.02 116.87 32.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.848 -1.157 . . . . 0.88 109.37 -179.434 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -98.97 -14.27 19.58 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.357 -0.84 . . . . 2.45 110.087 -178.982 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -127.17 149.91 49.75 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.193 -0.942 . . . . 1.52 110.23 -179.173 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -63.75 139.73 58.8 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.621 -0.881 . . . . 1.58 108.621 179.814 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.7 m -153.09 164.95 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 0.69 109.699 -179.693 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.1 mt -93.51 149.15 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 105.834 -1.913 . . . . 0.61 105.834 176.533 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.415 HD11 HD11 ' A' ' 19' ' ' LEU . 43.4 tp -97.37 113.91 25.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.934 -1.104 . . . . 0.87 110.481 -177.725 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 62.6 t -121.18 129.98 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 108.255 -1.017 . . . . 0.71 108.255 179.067 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.429 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -163.25 169.22 19.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 0.81 108.872 179.888 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.17 -35.37 68.98 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.696 -1.253 . . . . 0.98 108.023 178.375 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -167.46 175.52 7.14 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.812 -1.181 . . . . 2.25 107.812 179.961 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 58.0 mt -135.59 145.64 47.12 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.076 -1.015 . . . . 0.78 109.09 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 40.0 p -97.37 127.9 36.63 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.242 -1.021 . . . . 0.98 108.242 179.166 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -37.0 -35.9 0.25 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.985 1.79 . . . . 0.81 112.616 -179.407 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.3 m -60.01 -39.87 87.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.075 -1.016 . . . . 0.9 109.016 -179.722 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -67.88 -40.16 83.59 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.171 -0.955 . . . . 1.61 110.138 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 55.8 p -56.46 -33.79 66.25 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.145 -0.972 . . . . 0.61 111.382 -177.991 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.76 -45.08 65.43 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.676 -1.265 . . . . 0.6 109.71 -179.871 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.437 ' H ' ' HG2' ' A' ' 170' ' ' GLN . 14.5 pt20 -90.73 35.63 0.89 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.374 -0.972 . . . . 1.4 108.374 179.68 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.4 tp -106.71 130.73 54.39 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.12 -1.067 . . . . 0.7 108.12 178.577 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -82.05 103.86 11.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.171 -0.956 . . . . 2.35 109.177 -179.75 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.25 -41.06 96.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.046 -1.033 . . . . 1.51 110.234 -179.471 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.52 -27.22 68.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 2.33 111.359 -178.049 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -92.75 -10.43 37.05 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.603 -1.31 . . . . 1.92 109.933 -178.867 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.448 HG11 ' CE1' ' A' ' 179' ' ' PHE . 58.1 t -103.23 112.83 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.15 -0.969 . . . . 0.67 108.698 179.031 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.9 mt -87.29 3.99 44.56 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.27 -0.894 . . . . 1.53 110.719 -178.336 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.406 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 176.31 168.91 37.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.112 -1.595 . . . . 0.48 109.112 179.719 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.456 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 23.2 m-85 -130.91 127.12 37.84 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.386 -1.067 . . . . 0.55 109.277 -179.945 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 95.8 mt -130.48 123.58 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.449 -1.315 . . . . 0.65 107.449 177.915 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.3 p -141.88 159.15 42.8 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.204 1.002 . . . . 0.82 111.068 -178.824 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 183' ' ' ALA . 59.2 t0 -96.88 18.34 14.81 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.685 -0.634 . . . . 2.46 109.737 -179.8 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -44.28 -178.87 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.91 -1.119 . . . . 1.28 112.653 -178.032 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.71 -54.31 4.63 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 111.23 -0.748 . . . . 2.19 111.23 -179.355 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.1 -163.82 13.63 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.06 -1.543 . . . . 2.13 111.285 -178.835 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.452 HH11 ' HG2' ' A' ' 186' ' ' ARG . 12.6 ptt-85 -72.39 -10.54 59.92 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.794 -0.827 . . . . 5.86 110.738 -179.116 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.6 p -80.9 7.42 10.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.955 -1.091 . . . . 3.72 109.898 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 95.1 p -84.92 142.69 29.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 1.74 110.481 -179.69 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -48.27 -44.53 33.63 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.867 -0.79 . . . . 0.95 108.867 179.601 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.411 ' H ' HG23 ' A' ' 190' ' ' THR . 3.2 p -56.08 -40.08 73.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.626 -0.671 . . . . 1.55 109.806 -179.475 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 48.3 t -61.67 -40.28 94.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -0.93 . . . . 1.51 111.03 -179.241 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.9 mm -62.18 -41.52 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.084 -1.01 . . . . 1.67 110.115 -178.813 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.9 mtp -60.02 -45.62 92.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.039 -1.038 . . . . 1.02 110.683 -178.38 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.97 -42.68 94.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.688 -1.257 . . . . 0.68 109.708 -179.308 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 -60.04 -51.23 70.53 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.272 -0.892 . . . . 2.93 110.618 -178.919 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 52.6 m -77.74 -32.44 52.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.923 -1.111 . . . . 0.86 111.866 -178.336 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.7 mt -70.4 -20.31 62.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.634 -1.292 . . . . 0.67 109.459 -179.425 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 64.17 49.94 2.53 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.309 0.576 . . . . 1.5 110.546 -179.733 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 83.2 mt -130.35 151.0 77.77 Favored Pre-proline 0 N--CA 1.5 2.058 0 N-CA-C 108.163 -1.051 . . . . 0.72 108.163 178.679 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.65 139.43 69.56 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.002 1.801 . . . . 0.61 111.043 179.599 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.55 153.98 3.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.763 -1.21 . . . . 0.66 111.525 -179.721 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.64 152.32 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.053 -1.091 . . . . 0.79 108.053 179.362 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.2 m -131.88 -13.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 121.064 -1.023 . . . . 0.91 111.295 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -111.36 26.47 12.02 Favored Glycine 0 N--CA 1.502 3.088 0 N-CA-C 110.645 -0.982 . . . . 1.01 110.645 -178.826 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 204' ' ' GLY . 3.2 p -43.38 -45.06 5.97 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.23 -1.159 . . . . 0.99 109.962 -179.622 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.465 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 93.89 -53.95 2.26 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 120.204 -0.998 . . . . 1.12 111.2 179.128 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 64.3 m -154.4 31.49 0.43 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.321 -1.694 . . . . 1.72 111.449 -179.024 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.02 -40.08 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.85 -1.156 . . . . 0.89 108.885 178.581 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 75.0 p -53.29 -29.52 33.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.424 -0.798 . . . . 1.03 110.563 -179.219 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.0 t -83.7 -15.13 49.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.973 -1.08 . . . . 1.83 110.428 -178.855 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -100.09 -15.92 18.03 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.226 -0.921 . . . . 2.27 110.955 -179.009 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 88.5 t -105.29 139.72 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.136 -0.978 . . . . 0.92 111.001 -178.16 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.13 152.59 30.88 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.585 -1.265 . . . . 2.2 107.585 178.473 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 30.8 t30 -58.27 139.16 55.62 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.948 -1.095 . . . . 2.36 110.283 -179.255 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 12.5 t0 87.74 8.61 0.17 Allowed 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 121.335 0.588 . . . . 2.38 109.796 179.633 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 56.2 t0 -79.07 140.5 37.87 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.326 -0.859 . . . . 2.09 109.317 179.551 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.531 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 55.3 t80 -91.78 118.39 30.64 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.346 -1.353 . . . . 1.27 107.346 178.476 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.522 HD22 HG22 ' A' ' 229' ' ' VAL . 82.7 mt -126.52 147.36 49.86 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.325 -0.86 . . . . 0.75 110.69 -178.631 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.449 HD12 ' HG3' ' A' ' 231' ' ' PRO . 81.6 mt -118.57 126.71 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.819 -1.548 . . . . 0.63 106.819 176.875 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 48.6 tp -102.02 124.84 48.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.241 -0.912 . . . . 0.7 108.645 -179.268 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.658 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 27.9 p-10 -87.94 -35.62 17.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.203 -0.935 . . . . 2.31 108.607 179.686 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 44.52 18.59 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.826 -0.805 . . . . 0.78 108.826 -179.224 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 221' ' ' ASP . 16.6 t -125.82 -46.89 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.127 -1.434 . . . . 1.04 107.127 179.579 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -100.75 -1.03 36.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.873 -1.529 . . . . 2.44 106.873 177.745 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 61.76 50.39 4.37 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.439 0.638 . . . . 1.55 109.587 179.996 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.658 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 95.6 mt-30 -138.77 151.16 46.85 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.522 -0.736 . . . . 1.99 109.311 179.76 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 84.2 t -119.41 127.73 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.421 -0.955 . . . . 0.77 108.421 178.882 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -102.26 123.98 47.03 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.331 -0.989 . . . . 0.98 108.331 179.443 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.522 HG22 HD22 ' A' ' 218' ' ' LEU . 58.5 t -104.21 115.0 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.492 -0.755 . . . . 0.85 110.369 -178.911 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 60.4 t30 53.61 69.55 2.19 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.912 . . . . 1.66 110.341 179.718 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.449 ' HG3' HD12 ' A' ' 219' ' ' ILE . 98.2 Cg_endo -90.91 148.58 3.89 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 123.408 2.739 . . . . 0.95 112.478 179.541 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.7 m -69.99 160.88 31.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 1.84 109.701 -179.431 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.55 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 38.2 p30 -60.02 -39.94 87.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 2.74 111.481 -178.669 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.55 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 13.1 pt-20 -60.04 -31.22 69.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.58 -1.325 . . . . 2.89 109.641 -179.352 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 83.2 t -70.03 -42.41 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.033 -1.042 . . . . 1.3 109.282 179.115 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.07 -40.67 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.313 -0.867 . . . . 1.09 110.396 -179.762 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -59.94 -41.65 92.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.812 -1.18 . . . . 2.43 108.861 -179.614 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -65.97 -40.12 90.96 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.248 -0.908 . . . . 2.78 109.25 179.591 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 96.2 mtp -68.11 -37.38 81.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.446 -0.784 . . . . 1.25 109.645 179.615 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -66.55 -37.78 85.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.4 -0.813 . . . . 2.63 109.857 179.989 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.12 -40.97 91.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.217 -0.927 . . . . 1.8 109.716 -179.606 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.82 -41.39 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 2.13 109.789 -179.672 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 13.5 tm0? -60.08 -40.12 88.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.205 -0.935 . . . . 3.17 110.033 -179.397 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -60.53 -44.89 95.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 1.78 109.783 -179.725 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -60.22 -40.01 88.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 2.47 109.631 -179.876 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 92.5 t -59.95 -39.79 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 2.09 109.139 -179.205 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.98 -48.46 78.35 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.212 -0.93 . . . . 2.54 109.116 179.85 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 62.4 m -62.52 -39.9 95.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.116 -0.99 . . . . 2.99 110.216 179.838 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.15 -39.96 92.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.319 -0.863 . . . . 3.34 111.188 -178.503 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.98 23.46 0.35 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.756 -1.215 . . . . 3.88 109.863 -179.337 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.25 -22.54 2.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.115 -0.99 . . . . 4.43 108.677 179.695 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.485 ' OE1' ' N ' ' A' ' 252' ' ' GLU . 57.1 mp0 -69.93 -31.54 69.36 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.812 -0.81 . . . . 5.42 108.812 179.475 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.463 ' CB ' ' O ' ' A' ' 252' ' ' GLU . 8.6 mt 95.17 -44.89 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 106.969 -1.493 . . . . 6.1 106.969 -178.321 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 60.04 20.19 9.35 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.724 -0.61 . . . . 7.37 109.647 179.595 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.471 ' C ' HD22 ' A' ' 256' ' ' LEU . 44.7 tttp -135.97 139.1 42.94 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.437 -0.789 . . . . 8.01 109.031 179.777 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.685 HD22 ' N ' ' A' ' 256' ' ' LEU . 3.0 mm? -98.63 30.8 3.12 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.559 -0.713 . . . . 9.05 109.991 -179.047 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -155.9 -80.0 0.08 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.99 -1.069 . . . . 10.56 109.86 179.834 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 46.6 t0 60.15 71.38 0.57 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.519 -0.738 . . . . 11.32 109.741 -179.588 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.459 HH11 ' HG2' ' A' ' 259' ' ' ARG . 43.0 mtt-85 . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 117.985 -1.007 . . . . 12.42 109.283 179.729 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 10.4 ttt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' B' B ' 302' ' ' PHE . . . . . 0.504 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 22.8 t80 -154.84 154.07 32.15 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.312 -0.868 . . . . 0.0 110.05 179.542 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 303' ' ' GLN . . . . . 0.504 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 2.9 pm0 -146.98 156.62 43.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.183 -0.948 . . . . 0.0 110.661 -179.621 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 304' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 0.4 OUTLIER -152.15 147.31 26.28 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.454 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' B' B ' 305' ' ' GLU . . . . . 0.517 ' N ' ' OE1' ' B' ' 304' ' ' GLN . 98.9 mt-10 -107.21 131.32 54.3 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.959 -1.088 . . . . 0.0 109.694 179.102 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.453 ' O ' HG13 ' B' ' 306' ' ' VAL . 7.4 p -131.26 120.61 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 CA-C-O 122.045 0.926 . . . . 0.0 112.544 -177.745 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 307' ' ' THR . . . . . 0.538 ' O ' HG23 ' B' ' 309' ' ' THR . 8.8 m -76.91 107.11 9.01 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.874 0.845 . . . . 0.0 111.359 -177.711 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.6 mt -52.23 118.13 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 122.098 0.951 . . . . 0.0 109.717 -178.944 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 309' ' ' THR . . . . . 0.599 ' C ' HE22 ' B' ' 357' ' ' GLN . 67.4 p -107.3 19.95 19.61 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.714 -178.249 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.522 ' N ' ' OE1' ' B' ' 357' ' ' GLN . . . -81.2 114.52 49.74 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.192 -0.943 . . . . 0.0 109.845 179.686 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -50.4 -9.72 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.733 0 CA-C-N 120.199 1.107 . . . . 0.0 113.308 -179.332 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 312' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' B' ' 310' ' ' ALA . 97.8 m-20 -120.5 4.04 10.7 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.437 -0.789 . . . . 0.0 109.265 179.829 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 74.0 -178.75 43.0 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.428 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.463 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.5 tp -83.64 89.82 7.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.05 -1.265 . . . . 0.0 109.027 -179.193 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.4 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 4.7 p80 -92.8 -162.2 0.91 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.924 -1.11 . . . . 0.0 109.989 179.18 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.8 m -58.07 -42.3 85.25 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.041 -1.037 . . . . 0.0 112.873 -175.932 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.553 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.4 tpt180 -59.87 -61.52 7.73 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 120.327 -1.483 . . . . 0.0 111.523 -178.571 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.4 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 9.9 Cg_endo -58.11 -33.63 97.6 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.231 1.118 . . . . 0.0 111.473 179.975 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.29 74.53 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.515 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.2 -44.02 74.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.662 -0.649 . . . . 0.0 109.338 -179.905 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -70.01 -42.01 73.59 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.598 179.061 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -59.99 -50.41 73.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.635 -0.666 . . . . 0.0 110.543 -179.371 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.44 -30.25 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.591 -1.318 . . . . 0.0 109.172 -179.485 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.401 ' NZ ' ' OE1' ' A' ' 74' ' ' GLU . 19.9 ttmt -60.01 -47.14 87.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.413 -0.804 . . . . 0.0 109.199 179.535 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -67.56 -48.89 65.64 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.184 -0.948 . . . . 0.0 110.896 -179.227 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -66.08 -52.72 46.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.798 -1.189 . . . . 0.0 110.709 -178.748 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -54.78 -14.5 1.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.088 -179.02 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -74.59 -20.95 79.37 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.358 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -103.79 146.96 27.86 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.439 -1.036 . . . . 0.0 108.719 179.686 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 13.9 t -91.2 -13.65 32.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.767 -1.208 . . . . 0.0 109.653 -179.898 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.43 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 63.7 p -60.13 147.58 39.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 -179.863 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 332' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' B' ' 332' ' ' GLU . 58.2 mp0 -68.87 134.49 49.7 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.104 -0.998 . . . . 0.0 108.636 179.758 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.1 mt -133.17 133.63 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.497 -0.752 . . . . 0.0 109.688 -179.222 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 82.4 m -129.05 149.81 50.71 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.478 -0.764 . . . . 0.0 109.288 179.409 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 53.9 t -122.84 114.07 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.338 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 96.5 m -104.97 134.18 48.51 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.212 -0.93 . . . . 0.0 109.394 -178.411 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 24.7 p -139.46 111.67 7.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.336 -0.853 . . . . 0.0 110.944 -179.48 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 48.89 50.81 17.06 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 176.685 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 90.04 -14.84 60.96 Favored Glycine 0 N--CA 1.501 2.998 0 O-C-N 119.941 -1.724 . . . . 0.0 112.503 177.104 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -118.64 131.44 56.18 Favored 'General case' 0 N--CA 1.508 2.447 0 CA-C-N 119.019 1.41 . . . . 0.0 109.69 -179.809 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 79.6 p -132.51 151.8 51.78 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.933 0.873 . . . . 0.0 110.681 -178.872 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -143.26 167.2 22.7 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -179.758 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 15.2 m -87.56 138.16 31.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.47 -0.769 . . . . 0.0 110.255 -179.273 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -77.13 -14.59 59.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.959 -1.088 . . . . 0.0 109.997 -179.394 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -89.59 20.46 3.98 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.126 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 346' ' ' SER . . . . . 0.453 ' CB ' ' HZ3' ' B' ' 349' ' ' LYS . 9.0 t -145.74 94.44 2.49 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.535 -179.649 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.733 HD23 HD22 ' A' ' 79' ' ' LEU . 58.5 tp -59.97 -36.32 76.86 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.069 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.86 ' CE2' HD11 ' A' ' 79' ' ' LEU . 51.0 m-85 -54.54 -50.42 67.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 0.0 110.699 -179.376 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 349' ' ' LYS . . . . . 0.453 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 35.9 mtmm -69.95 -40.02 75.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.911 -1.118 . . . . 0.0 111.237 -177.975 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' B' ' 352' ' ' THR . 88.2 mt -49.28 -56.99 7.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.875 -1.14 . . . . 0.0 109.443 -178.933 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.567 HE22 ' CD1' ' B' ' 347' ' ' LEU . 1.2 mp0 -42.23 -14.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.414 -0.804 . . . . 0.0 111.342 -178.101 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.55 ' N ' ' O ' ' B' ' 350' ' ' LEU . 59.3 p -88.72 -11.48 45.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.287 -1.508 . . . . 0.0 110.185 -179.132 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 79.3 mt -91.58 117.52 29.79 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.84 -1.162 . . . . 0.0 108.807 178.646 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -69.79 89.2 0.3 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 58.0 mt -98.73 86.81 3.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -1.162 . . . . 0.0 108.456 179.03 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 67.2 p -89.26 168.97 11.84 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.041 -1.037 . . . . 0.0 110.063 -178.926 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 357' ' ' GLN . . . . . 0.599 HE22 ' C ' ' B' ' 309' ' ' THR . 15.8 tp60 -62.99 114.94 3.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.631 -0.668 . . . . 0.0 110.61 -179.031 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.24 8.72 40.71 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.713 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 31.6 m -87.2 111.7 21.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.261 -1.14 . . . . 0.0 111.394 -178.986 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 48.5 t -76.98 118.09 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 122.267 1.032 . . . . 0.0 109.548 -177.914 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.0 m -112.9 177.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -177.952 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 48.9 m -130.71 128.79 41.56 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.45 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.6 mt -103.06 117.58 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.154 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 72.7 m -120.99 132.09 54.7 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.289 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.24 153.34 40.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.069 -1.019 . . . . 0.0 110.489 -179.296 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 366' ' ' GLU . . . . . 0.441 ' OE1' ' OE1' ' B' ' 370' ' ' GLU . 17.1 tp10 -144.47 122.32 11.97 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.082 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.494 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 159.8 -157.11 28.34 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.954 -1.593 . . . . 0.0 111.595 -179.97 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -59.99 -51.88 67.77 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.338 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.43 ' H ' ' HB3' ' B' ' 331' ' ' SER . 42.6 m-20 -109.15 12.5 25.0 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.754 -1.216 . . . . 0.0 111.176 -177.256 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 11.8 pt-20 -42.33 -38.17 1.75 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.157 -0.965 . . . . 0.0 111.807 -178.816 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -69.89 -40.51 75.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.638 -1.289 . . . . 0.0 110.249 -178.341 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -68.75 -51.39 41.85 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.171 -0.956 . . . . 0.0 109.482 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -49.64 -34.28 17.85 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.634 -0.666 . . . . 0.0 112.228 -178.413 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.505 ' O ' HG23 ' B' ' 378' ' ' VAL . 56.2 t -74.82 -39.21 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.657 -1.277 . . . . 0.0 109.766 179.567 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -68.23 -40.01 82.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.168 -0.957 . . . . 0.0 112.37 -177.785 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -84.61 -43.07 14.78 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.193 -1.567 . . . . 0.0 110.901 -179.363 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.93 -40.09 87.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.998 -1.064 . . . . 0.0 108.843 -179.196 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.505 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.9 t -61.02 -45.98 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.217 -0.927 . . . . 0.0 109.412 179.42 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' B' ' 383' ' ' GLU . 62.3 mttp -68.62 -54.75 14.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.788 -1.195 . . . . 0.0 107.86 178.503 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 52.8 tp -55.8 -36.25 67.21 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.308 -0.87 . . . . 0.0 109.182 -178.29 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 23.8 ttm -70.65 -40.08 73.25 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.698 -1.251 . . . . 0.0 108.335 177.792 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.21 -4.93 58.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.526 -0.734 . . . . 0.0 110.606 179.585 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' B' ' 379' ' ' LYS . 96.8 mt-10 -112.16 -3.67 14.61 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.17 -0.956 . . . . 0.0 111.106 -179.46 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.2 mt -79.88 136.55 36.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.464 -1.397 . . . . 0.0 109.47 179.011 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 N--CA 1.497 1.918 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.368 -179.901 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.9 mtp . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.506 -0.553 . . . . 2.91 109.506 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.4 mt -110.18 129.98 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.417 -0.802 . . . . 1.2 109.71 -179.928 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.2 m -132.67 149.84 52.24 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.402 -0.811 . . . . 1.4 109.408 179.686 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.416 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -140.7 -169.92 11.91 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.041 -1.624 . . . . 1.05 109.041 179.757 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.9 mt -85.48 -19.08 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.879 -1.365 . . . . 1.15 110.432 -178.831 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.7 tp 52.92 102.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.176 -0.952 . . . . 0.98 109.03 -179.732 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.11 -26.99 13.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.101 -0.999 . . . . 0.88 109.645 -179.881 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -134.77 117.97 13.17 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.469 -0.769 . . . . 1.69 109.004 -179.843 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.19 148.12 21.19 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.766 1.644 . . . . 0.85 112.562 -179.631 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.721 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.05 -155.41 26.21 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.754 -1.738 . . . . 0.92 108.754 -179.818 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.5 mt -149.6 151.18 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 120.909 -1.347 . . . . 0.81 108.715 179.041 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.47 150.85 30.06 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.901 -1.125 . . . . 0.51 110.719 179.772 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.8 m-85 -133.9 127.12 31.85 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 107.923 -1.14 . . . . 0.62 107.923 178.616 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.92 -176.69 46.39 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 118.37 -1.872 . . . . 0.55 111.203 179.713 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -79.23 155.64 28.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.985 -0.715 . . . . 2.1 109.841 -179.693 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.82 124.36 49.3 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.579 -0.7 . . . . 0.77 109.978 179.892 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.0 tp -94.22 135.19 35.88 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.472 -1.307 . . . . 0.91 107.472 178.582 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.9 tp -116.01 122.66 45.86 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.22 -0.925 . . . . 0.93 109.946 -179.08 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.7 mt -84.98 100.74 11.85 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.586 0.708 . . . . 0.93 109.955 -179.63 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -100.04 124.79 45.8 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.533 -0.914 . . . . 2.75 108.533 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.461 ' OE1' HD11 ' A' ' 147' ' ' ILE . 36.9 tp10 -132.03 141.82 49.37 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.237 -0.915 . . . . 3.0 109.462 -179.954 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.59 ' OD2' HD11 ' A' ' 144' ' ' LEU . 9.9 p-10 -77.73 149.19 34.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.385 -0.822 . . . . 2.77 109.558 179.649 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -70.15 149.61 47.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.166 -0.959 . . . . 2.94 109.595 -179.741 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 84.7 mt -82.34 126.51 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.186 -0.946 . . . . 0.95 110.154 -179.604 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.67 123.63 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.278 -0.889 . . . . 1.28 108.744 179.074 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -100.55 145.23 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.333 -0.855 . . . . 1.21 109.363 -179.555 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -98.51 113.42 25.43 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.172 -0.955 . . . . 1.81 109.519 -179.879 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.479 HH11 ' HG2' ' A' ' 28' ' ' ARG . 7.4 mmt-85 -86.32 -2.13 58.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 2.8 109.449 -179.855 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -66.12 142.8 57.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.934 . . . . 2.87 109.225 179.714 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -83.43 149.6 26.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 2.35 109.544 -179.749 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.439 HG21 ' HG3' ' A' ' 39' ' ' GLU . 6.4 pt -93.2 165.02 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.032 -1.042 . . . . 0.97 109.091 179.311 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.9 p -94.72 169.53 10.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.948 -1.095 . . . . 1.17 108.485 178.963 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.68 -12.83 60.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 1.18 109.561 -179.967 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -88.32 -28.86 20.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.111 -0.993 . . . . 2.56 108.406 178.787 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -81.65 -8.91 59.76 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.748 -0.834 . . . . 1.79 108.748 178.963 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.3 t -62.46 -53.59 45.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.083 -1.01 . . . . 1.0 108.912 179.815 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -60.04 -40.05 88.06 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.171 -0.956 . . . . 1.77 109.928 -179.87 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -69.94 -40.2 75.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.948 -1.095 . . . . 2.7 110.899 -179.37 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.439 ' HG3' HG21 ' A' ' 31' ' ' ILE . 68.7 mm-40 -65.27 -40.07 93.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.674 -1.266 . . . . 1.51 110.199 -179.895 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -61.64 -47.8 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.639 -1.288 . . . . 0.93 108.537 179.083 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.03 -45.9 91.29 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.175 -0.953 . . . . 1.81 109.538 179.677 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -60.04 -42.94 95.49 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.688 -1.226 . . . . 2.78 107.688 179.146 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -61.2 -49.93 75.16 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.645 -0.659 . . . . 0.78 109.491 178.927 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.91 -45.48 94.49 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.457 -0.777 . . . . 1.07 109.721 -179.718 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 31.9 t -66.46 -45.68 78.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.027 -1.045 . . . . 1.12 109.332 179.682 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.85 -44.56 97.69 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.026 -2.029 . . . . 0.84 108.026 178.9 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 80' ' ' LEU . 69.2 ttt180 -62.98 -35.31 79.75 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.357 -0.979 . . . . 3.09 108.357 178.638 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -55.87 -39.93 72.22 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.834 -0.802 . . . . 0.88 108.834 179.801 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 50' ' ' ALA . 18.9 ttmt -63.32 -74.63 0.09 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.088 -1.078 . . . . 2.59 108.088 179.531 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.38 -31.82 0.06 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.363 -0.836 . . . . 0.7 111.682 -177.978 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.6 p -60.1 -54.17 49.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.562 -1.336 . . . . 1.4 108.669 179.988 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.99 -42.44 73.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.339 -0.851 . . . . 0.67 111.055 -179.298 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.45 -40.5 97.3 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.826 -1.171 . . . . 1.66 110.552 -178.805 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.27 -39.66 92.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.874 -1.141 . . . . 1.58 108.993 179.603 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -59.95 -37.85 80.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.35 -0.844 . . . . 1.35 109.515 179.379 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -64.7 -41.2 96.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.77 110.46 -179.67 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.411 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.5 mt -64.62 -39.83 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.108 -0.995 . . . . 0.63 109.373 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.444 ' NZ ' ' OE2' ' A' ' 70' ' ' GLU . 13.2 ttpp -59.35 -49.98 75.73 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.275 -0.89 . . . . 1.14 109.121 -179.858 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.1 m -61.13 -40.03 92.26 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.211 -0.931 . . . . 0.79 110.493 -178.795 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -63.7 -38.86 92.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.096 -1.003 . . . . 1.53 109.155 179.692 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.484 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -65.14 -41.56 94.66 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.582 -0.699 . . . . 0.57 109.746 179.574 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.65 -50.39 66.7 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 110.24 -1.144 . . . . 0.75 110.24 -179.488 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.89 -43.0 72.67 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.881 -1.364 . . . . 1.59 109.654 -179.65 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.9 m -71.27 -59.84 2.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.035 -1.041 . . . . 0.73 112.06 -178.476 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -91.18 -54.16 4.05 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.678 -1.264 . . . . 0.75 110.603 -178.801 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.58 -169.32 25.21 Favored Glycine 0 N--CA 1.5 2.916 0 C-N-CA 120.071 -1.062 . . . . 1.22 111.224 179.748 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -70.01 -24.14 63.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.951 -0.735 . . . . 5.81 109.958 -179.954 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.507 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.8 tp10 -60.45 -38.04 82.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.888 . . . . 3.37 109.899 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -99.44 -19.43 16.96 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.395 -0.815 . . . . 1.77 110.604 -179.317 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.444 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 61.8 tt0 -68.1 -39.99 82.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.902 -1.124 . . . . 1.65 109.837 -179.528 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.431 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.28 -33.78 76.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.411 -0.806 . . . . 0.77 110.384 -178.886 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.07 -42.37 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.752 -1.217 . . . . 0.8 109.222 -179.849 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 57.4 m-85 -72.59 -34.8 67.68 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.39 -0.819 . . . . 0.88 110.487 -179.213 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.465 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 72.6 tt0 -59.97 -40.07 87.81 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.838 -1.164 . . . . 1.37 109.198 179.035 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.98 -41.2 97.8 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.41 -1.876 . . . . 0.62 108.41 179.081 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -61.78 -48.53 80.25 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.341 -1.093 . . . . 1.5 108.785 179.365 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.3 -50.56 79.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.563 -0.711 . . . . 0.63 109.851 -179.776 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.6 ttp -60.98 -44.2 97.7 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.009 -1.057 . . . . 1.51 109.238 -179.639 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.811 HD22 HD23 ' B' ' 347' ' ' LEU . 44.9 tp -60.05 -39.91 87.59 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.579 -0.701 . . . . 0.77 109.114 179.214 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.52 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 58.6 tp -69.66 -35.06 74.83 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.604 -0.685 . . . . 0.62 109.968 -179.387 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -85.43 0.43 52.28 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.92 -1.112 . . . . 1.47 110.002 -179.276 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -46.3 130.07 10.5 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.201 -0.937 . . . . 1.47 109.879 -179.221 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -61.36 -22.33 64.84 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.458 -0.776 . . . . 1.78 111.011 -179.124 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.99 -31.76 69.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.874 -1.141 . . . . 2.53 109.417 179.15 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 79' ' ' LEU . 91.2 mt -71.98 -40.02 68.87 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.673 0.749 . . . . 0.8 109.368 179.093 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.03 -49.25 78.38 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.724 -0.61 . . . . 1.42 110.827 -178.964 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -70.0 -42.01 73.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.17 -0.957 . . . . 1.71 111.061 -178.498 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.94 -39.94 75.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.964 . . . . 1.57 111.491 -178.824 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.7 mt -68.0 -45.22 84.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 120.973 -1.08 . . . . 0.65 109.782 -179.517 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -69.76 -38.79 76.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.322 -0.861 . . . . 0.82 110.089 179.831 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.66 -45.23 93.77 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 0.79 111.593 -178.913 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 99.3 mt -60.07 -44.22 94.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.83 -1.169 . . . . 0.95 109.533 -178.633 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.3 mt -61.19 -50.11 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.166 -0.959 . . . . 0.66 109.291 179.406 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -67.51 -40.01 85.13 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 120.22 -0.592 . . . . 2.2 111.436 -179.318 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -83.66 -52.14 6.69 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.752 -1.218 . . . . 1.65 112.025 -178.557 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -90.01 -0.05 57.37 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.119 -0.988 . . . . 2.03 112.026 -177.218 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 80.7 m80 55.1 33.81 21.21 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.834 -1.166 . . . . 1.42 109.486 -179.812 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 75.2 mtp -84.9 166.4 16.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.55 -0.719 . . . . 1.18 109.599 -179.625 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 76.8 p -78.64 154.85 29.88 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.171 -1.048 . . . . 0.98 108.171 179.187 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.0 -39.26 75.97 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.062 -1.024 . . . . 0.64 110.015 -179.707 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.538 ' OD1' HG21 ' A' ' 141' ' ' ILE . 86.5 m-20 -63.23 -40.19 96.75 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.101 -1.0 . . . . 2.07 109.621 -179.695 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.05 -46.12 14.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.104 -0.997 . . . . 0.73 109.655 179.463 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.98 -46.15 90.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.454 -0.779 . . . . 0.54 109.71 -179.539 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.96 75.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.149 -0.97 . . . . 0.56 109.478 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -59.98 -34.79 73.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.861 . . . . 1.54 110.042 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -60.0 -41.27 91.71 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.176 -0.952 . . . . 1.33 109.103 -179.653 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.8 t -64.78 -49.96 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 0.72 110.072 -179.46 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.1 mm -69.05 -40.28 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.047 -1.033 . . . . 0.85 109.027 179.622 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -64.92 -40.01 94.4 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.722 -0.844 . . . . 2.44 108.722 179.362 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.97 -49.26 80.5 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.244 -1.142 . . . . 0.98 110.244 -179.76 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -66.4 -51.81 53.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.929 -1.336 . . . . 1.41 109.11 -179.493 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.97 93.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 1.2 109.718 179.583 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.8 p -58.38 -39.69 80.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 1.7 108.8 -179.701 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.96 -35.6 75.32 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.34 -0.85 . . . . 1.47 109.214 179.664 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.5 mt -66.2 -42.88 88.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.974 -1.079 . . . . 1.56 109.485 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -56.99 -32.71 66.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.072 -1.018 . . . . 2.2 109.327 -179.091 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.03 -28.43 67.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -0.889 . . . . 2.12 108.966 179.859 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.554 HD13 HD13 ' A' ' 123' ' ' LEU . 59.6 mt -64.23 148.29 50.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.366 -0.834 . . . . 2.0 109.199 -179.927 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -100.07 57.1 0.96 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.175 -0.953 . . . . 3.23 109.448 179.802 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 58.8 t0 -136.0 135.23 39.32 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.247 -0.908 . . . . 2.49 110.514 -179.681 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.465 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 38.7 mt-10 -70.0 -32.46 70.64 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.338 -0.851 . . . . 3.95 109.903 179.313 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -69.6 -36.4 76.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.45 -0.781 . . . . 2.0 110.815 -179.805 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.554 HD13 HD13 ' A' ' 118' ' ' LEU . 66.2 mt -80.73 -34.66 34.27 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.754 -1.216 . . . . 1.86 109.47 179.866 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -60.49 -44.46 95.92 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.121 -0.987 . . . . 2.84 109.235 179.447 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -69.53 -40.09 77.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 2.73 109.516 -179.912 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -60.64 -40.07 90.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.229 -0.92 . . . . 2.77 108.565 179.408 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 128' ' ' ALA . . . -59.44 -45.59 91.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.137 -0.977 . . . . 1.19 108.459 179.689 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 127' ' ' ALA . . . -44.3 -43.89 7.71 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.097 -0.705 . . . . 1.2 109.097 179.992 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -61.9 -45.85 91.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.389 -0.82 . . . . 1.55 109.868 179.389 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.14 -39.98 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.21 -0.931 . . . . 0.8 108.918 -179.896 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.712 ' HE ' ' NZ ' ' A' ' 135' ' ' LYS . 69.4 ttt180 -60.0 -39.41 85.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 3.09 109.147 179.528 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -60.02 -37.8 80.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.228 -0.92 . . . . 1.46 109.934 -179.749 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.03 -44.32 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.048 -1.032 . . . . 0.71 109.657 -179.205 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.95 -33.83 59.42 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.709 -1.234 . . . . 0.57 110.172 179.882 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.712 ' NZ ' ' HE ' ' A' ' 131' ' ' ARG . 37.5 mmtm -59.99 -46.88 88.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.151 -1.205 . . . . 2.59 110.061 -179.011 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.411 HH22 ' CD1' ' A' ' 57' ' ' ILE . 66.4 mtp180 -65.93 -34.21 77.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.802 -1.186 . . . . 2.83 109.452 179.86 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.0 tp -57.24 -42.01 80.65 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.655 -0.868 . . . . 1.25 108.655 -179.252 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.412 HD21 ' O ' ' A' ' 101' ' ' ASP . 83.5 mt -60.88 -40.12 91.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.7 109.296 178.377 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.473 HH11 ' HG2' ' A' ' 139' ' ' ARG . 47.2 mtt-85 -69.68 -40.11 76.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 2.57 109.52 -179.915 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -66.93 -37.96 85.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.584 -0.698 . . . . 1.23 111.757 -178.827 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.538 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.8 mt -71.22 -40.01 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.411 -1.43 . . . . 0.81 109.43 179.61 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 60.8 mt -75.48 -12.25 60.2 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.618 -0.676 . . . . 1.0 110.819 -178.344 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.98 35.43 57.93 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.636 -1.785 . . . . 0.89 108.636 -179.286 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.59 HD11 ' OD2' ' A' ' 22' ' ' ASP . 15.0 tp -73.4 142.43 46.96 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.485 -1.009 . . . . 1.14 109.275 -179.19 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -72.37 140.77 48.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.38 -0.825 . . . . 4.6 110.441 -179.062 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.4 mt -112.58 129.96 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-O 122.007 0.908 . . . . 1.24 109.289 179.468 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.461 HD11 ' OE1' ' A' ' 21' ' ' GLU . 6.3 mt -62.07 -43.21 97.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.912 -0.585 . . . . 1.54 110.783 -178.588 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.9 t0 66.58 122.35 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.529 -0.732 . . . . 1.5 109.079 -179.016 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.5 mt -92.69 0.67 57.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.394 -0.816 . . . . 0.79 110.637 -179.034 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.7 p -83.61 -15.3 49.56 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.745 -1.222 . . . . 1.4 110.413 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.99 29.97 0.33 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.115 -0.991 . . . . 0.92 112.199 -177.997 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.3 mm -83.77 125.17 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.379 -1.45 . . . . 0.88 109.188 179.623 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -104.32 -12.74 16.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.4 -0.813 . . . . 2.45 109.755 -179.826 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -137.83 156.96 47.38 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.237 -0.914 . . . . 1.52 110.213 -179.107 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.66 135.11 56.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.282 -0.886 . . . . 1.58 109.226 -179.64 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.7 m -153.05 168.14 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.398 -0.813 . . . . 0.69 110.146 179.403 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 80.6 mt -98.79 143.89 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 105.772 -1.936 . . . . 0.61 105.772 177.212 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 47.4 tp -97.68 120.1 37.45 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.772 -1.205 . . . . 0.87 109.993 -178.464 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.0 t -119.79 127.9 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.059 -0.719 . . . . 0.71 109.059 179.833 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.443 ' HB3' HD21 ' A' ' 163' ' ' LEU . . . -159.86 161.5 34.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.899 . . . . 0.81 108.888 179.87 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.82 -32.72 67.86 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.438 -1.414 . . . . 0.98 108.077 178.579 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -170.35 143.49 2.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.493 -0.754 . . . . 2.25 109.564 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.443 HD21 ' HB3' ' A' ' 160' ' ' ALA . 54.9 mt -116.53 141.03 48.71 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.44 -0.788 . . . . 0.78 109.554 -179.499 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 48.4 p -95.29 145.82 30.22 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.14 -0.975 . . . . 0.98 110.226 -179.429 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -40.6 -36.78 1.95 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.512 2.141 . . . . 0.81 112.802 179.029 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 63.9 m -59.03 -39.87 83.26 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.317 -0.864 . . . . 0.9 109.183 -179.076 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.58 -40.05 84.85 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.295 -0.878 . . . . 1.61 109.91 -179.709 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.7 p -58.17 -23.29 54.9 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.956 -1.09 . . . . 0.61 110.408 -178.863 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -75.78 -56.44 4.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.092 -1.005 . . . . 0.6 109.562 179.694 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -84.17 42.24 0.87 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.805 -1.183 . . . . 1.4 107.805 179.611 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.5 tp -101.81 140.99 35.36 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.207 -0.664 . . . . 0.7 109.207 179.472 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.512 ' O ' HG23 ' A' ' 176' ' ' VAL . 98.6 m-20 -89.95 103.02 15.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.155 -0.965 . . . . 2.35 108.681 179.293 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 70.5 mt -67.19 -44.09 80.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.418 -0.801 . . . . 1.51 111.914 -178.072 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -69.98 -25.47 63.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.759 -1.213 . . . . 2.33 112.512 -177.525 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -93.4 -5.5 49.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.621 -1.299 . . . . 1.92 110.722 -178.328 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 172' ' ' ASN . 23.0 t -86.13 139.99 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.834 -1.167 . . . . 0.67 110.496 -179.845 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.0 mt -103.91 -12.37 16.91 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 109.593 -0.521 . . . . 1.53 109.593 178.587 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 162.6 179.51 37.23 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.247 -1.541 . . . . 0.48 109.247 179.986 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -130.51 129.37 42.79 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.221 -1.164 . . . . 0.55 110.158 -179.95 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.416 ' CG2' HG21 ' A' ' 205' ' ' THR . 66.5 mt -128.65 120.55 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.383 -0.969 . . . . 0.65 108.383 177.756 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 61.0 p -148.78 160.81 42.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.742 -1.224 . . . . 0.82 110.555 -179.654 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -110.08 30.29 6.86 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.123 -0.695 . . . . 2.46 109.123 179.321 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -74.66 -158.3 0.07 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.67 -1.269 . . . . 1.28 112.339 -177.499 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -54.56 -80.95 0.07 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.676 -0.97 . . . . 2.19 110.676 -179.403 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 163.02 -115.88 0.68 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.369 -1.396 . . . . 2.13 110.405 -179.836 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.53 HH11 ' HG2' ' A' ' 186' ' ' ARG . 0.5 OUTLIER -68.49 -30.2 68.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.469 -1.018 . . . . 5.86 111.002 -178.856 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.0 p -79.97 7.42 9.01 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.006 -1.059 . . . . 3.72 110.544 -178.62 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 61.0 m -90.95 128.6 36.85 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.821 -1.174 . . . . 1.74 110.702 -179.528 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -47.27 -48.62 24.69 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.381 -0.824 . . . . 0.95 109.493 179.929 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.2 m -60.04 -39.92 87.6 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 1.55 109.961 -179.153 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 62.1 m -60.01 -39.95 87.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.985 -1.072 . . . . 1.51 109.335 -179.38 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.5 mm -66.31 -40.28 86.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.278 -0.889 . . . . 1.67 109.235 -179.92 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 92.9 mtp -64.63 -39.99 94.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.123 -0.986 . . . . 1.02 111.254 -179.538 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.61 -43.27 93.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.313 -1.492 . . . . 0.68 108.978 -179.644 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -59.93 -49.92 75.79 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.244 -0.91 . . . . 2.93 109.786 -179.566 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.5 m -70.03 -34.21 72.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.039 -1.038 . . . . 0.86 110.631 -179.226 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.0 mt -76.07 -21.68 56.48 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.08 -1.012 . . . . 0.67 109.533 -179.413 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 61.28 47.7 6.76 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.543 -0.723 . . . . 1.5 110.633 -179.646 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 63.4 mt -121.52 135.58 25.22 Favored Pre-proline 0 N--CA 1.501 2.124 0 N-CA-C 108.514 -0.921 . . . . 0.72 108.514 178.662 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -43.64 128.93 6.83 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.021 1.814 . . . . 0.61 112.124 -179.947 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -166.42 144.32 5.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.597 -1.315 . . . . 0.66 112.151 -179.79 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 94.9 mt -124.55 144.53 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 106.763 -1.569 . . . . 0.79 106.763 177.656 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.48 -10.56 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 120.78 -1.2 . . . . 0.91 111.554 -178.372 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -103.6 23.76 31.83 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.592 -1.403 . . . . 1.01 109.592 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.416 HG21 ' CG2' ' A' ' 180' ' ' ILE . 7.6 p -45.98 -42.44 13.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -1.125 . . . . 0.99 109.971 -179.194 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 89.94 -49.1 3.29 Favored Glycine 0 N--CA 1.498 2.767 0 O-C-N 120.963 -1.086 . . . . 1.12 111.113 179.336 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.8 t -165.92 40.41 0.06 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.714 -1.463 . . . . 1.72 110.731 -179.612 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 49.2 t -79.45 -37.71 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.081 -1.081 . . . . 0.89 108.081 177.865 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 209' ' ' THR . 2.8 p -52.56 -27.22 15.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.663 -0.648 . . . . 1.03 109.703 -179.906 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 69.8 m -78.94 -26.5 43.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 1.83 109.856 -179.629 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -92.3 -8.3 45.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.043 -1.036 . . . . 2.27 109.856 -179.672 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 64.8 t -105.17 133.77 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.436 -0.79 . . . . 0.92 110.272 -178.955 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.404 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 70.2 mmtt -113.39 154.0 27.66 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 106.976 -1.49 . . . . 2.2 106.976 178.309 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 55.7 t-20 -59.95 138.98 57.7 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.955 -1.091 . . . . 2.36 110.238 -178.622 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 84.85 -1.69 0.9 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 121.116 0.484 . . . . 2.38 110.801 179.115 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.404 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 92.7 m-20 -70.38 148.1 48.79 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.13 -0.981 . . . . 2.09 109.107 178.978 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -96.9 119.98 36.39 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.913 -1.144 . . . . 1.27 107.913 179.16 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 16' ' ' ALA . 87.1 mt -126.72 147.26 49.98 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.369 -0.832 . . . . 0.75 110.237 -178.876 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 99.9 mt -117.79 127.21 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.152 -1.425 . . . . 0.63 107.152 177.291 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 17.7 tp -100.94 120.6 40.41 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.257 -0.902 . . . . 0.7 109.584 -178.657 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 223' ' ' VAL . 7.1 t70 -76.01 -41.45 51.02 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.025 -1.102 . . . . 2.31 108.025 179.42 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 49.01 9.94 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.722 -0.611 . . . . 0.78 109.83 179.788 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.514 ' N ' ' O ' ' A' ' 221' ' ' ASP . 60.4 t -126.73 -35.12 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.619 -1.252 . . . . 1.04 107.619 178.66 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.486 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 98.6 m-20 -108.39 3.58 23.48 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.297 -1.001 . . . . 2.44 108.297 178.686 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.416 HD21 ' H ' ' A' ' 4' ' ' GLY . 38.7 t30 59.86 45.52 12.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.64 -0.662 . . . . 1.55 110.352 179.981 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -138.92 144.55 39.13 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.168 -0.957 . . . . 1.99 109.792 179.392 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.2 t -115.35 130.13 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.66 -0.867 . . . . 0.77 108.66 179.381 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -104.63 126.13 51.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.444 -0.785 . . . . 0.98 108.98 179.5 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.1 t -100.03 106.99 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.272 -0.893 . . . . 0.85 109.954 -179.55 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 39.3 t30 49.92 61.0 14.46 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.189 -0.945 . . . . 1.66 111.422 178.002 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.83 158.39 27.74 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.494 2.13 . . . . 0.95 111.538 178.964 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.2 m -68.42 159.68 31.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.044 -1.035 . . . . 1.84 110.354 -178.923 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -59.95 -40.0 87.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.549 -0.719 . . . . 2.74 109.732 -179.619 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.05 -39.25 85.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 2.89 109.389 -179.985 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.9 t -67.5 -39.96 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.312 -0.868 . . . . 1.3 108.91 179.359 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.9 mt -66.47 -39.88 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.319 -0.863 . . . . 1.09 109.247 179.32 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -59.2 -43.18 92.24 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.078 -1.014 . . . . 2.43 108.619 -179.713 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -64.88 -40.01 94.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.293 -0.879 . . . . 2.78 108.766 178.976 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 93.9 mtp -70.77 -30.16 66.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.39 -0.819 . . . . 1.25 109.241 179.019 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -64.91 -40.02 94.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.275 -0.891 . . . . 2.63 109.366 179.502 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -64.06 -40.22 95.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 1.8 108.849 179.701 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.16 -40.09 82.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.477 -0.765 . . . . 2.13 109.073 179.467 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -57.26 -44.51 83.98 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.171 -0.955 . . . . 3.17 108.99 -179.416 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.0 -40.85 95.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.152 -0.967 . . . . 1.78 109.244 179.632 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -70.03 -44.24 69.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.336 -0.853 . . . . 2.47 109.783 179.746 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.17 -40.79 84.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.29 -0.882 . . . . 2.09 109.027 -179.735 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.8 -50.04 75.06 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.375 -0.828 . . . . 2.54 109.412 179.502 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 30.6 t -71.92 -41.31 68.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 2.99 110.55 -179.565 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -64.93 -40.48 95.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.242 -0.911 . . . . 3.34 110.96 -178.667 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 254' ' ' ALA . 29.5 ttmt -70.07 -59.98 2.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.926 -1.109 . . . . 3.88 110.719 -178.272 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.646 ' O ' ' N ' ' A' ' 253' ' ' LEU . . . 46.51 12.39 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.31 -0.869 . . . . 4.43 109.6 -179.715 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 250' ' ' LYS . 88.2 tt0 59.68 -58.99 0.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.851 0.834 . . . . 5.42 108.979 -179.327 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.646 ' N ' ' O ' ' A' ' 251' ' ' ALA . 64.3 mt -72.21 13.14 0.34 Allowed 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.781 -0.574 . . . . 6.1 110.085 -178.279 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 250' ' ' LYS . . . -59.97 -49.95 75.68 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.45 -1.315 . . . . 7.37 107.45 178.532 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -177.53 143.59 0.36 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.455 -1.313 . . . . 8.01 107.455 178.98 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 256' ' ' LEU . 3.5 mm? -59.98 -37.66 80.28 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.922 -1.111 . . . . 9.05 108.031 179.626 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -101.09 -172.11 2.11 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.446 -0.946 . . . . 10.56 108.446 179.378 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -140.52 -108.25 0.15 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.948 -1.095 . . . . 11.32 108.84 179.807 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.404 HH11 ' HG3' ' A' ' 259' ' ' ARG . 41.2 mtm-85 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.975 -1.012 . . . . 12.42 109.515 179.935 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 45.5 ttm . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.408 0.623 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -151.02 148.17 28.02 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.153 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 -152.19 161.6 42.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.935 -1.103 . . . . 0.0 111.039 -178.989 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -156.23 155.06 31.75 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.91 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -110.45 135.71 50.72 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.295 -0.878 . . . . 0.0 111.102 -179.055 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.548 HG22 ' N ' ' B' ' 307' ' ' THR . 2.7 p -120.06 165.27 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.94 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 307' ' ' THR . . . . . 0.548 ' N ' HG22 ' B' ' 306' ' ' VAL . 70.9 m -119.11 115.96 25.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.101 -1.0 . . . . 0.0 108.328 178.526 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.59 HD12 ' HB ' ' B' ' 359' ' ' THR . 60.2 mt -56.22 120.9 3.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-O 122.366 1.079 . . . . 0.0 110.893 -178.434 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 65.2 p -109.47 24.34 13.21 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.863 -179.945 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -85.17 116.65 66.38 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 108.725 179.618 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -68.33 -7.42 20.04 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 CA-C-N 120.201 1.108 . . . . 0.0 111.477 -179.948 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -119.12 6.61 11.27 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.634 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.52 175.76 43.86 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.366 -1.893 . . . . 0.0 108.366 -179.039 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 3.3 tp -83.65 95.51 8.38 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.008 -1.289 . . . . 0.0 108.952 -178.874 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -96.66 -160.48 0.8 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.835 -1.165 . . . . 0.0 109.805 179.15 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 4.0 m -59.97 -43.46 95.06 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.942 -1.099 . . . . 0.0 112.278 -176.287 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.507 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 2.6 tpt180 -54.82 -62.06 4.78 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.44 -1.412 . . . . 0.0 111.299 -178.65 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -58.73 -36.42 97.14 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 CA-C-N 120.221 1.115 . . . . 0.0 111.181 179.787 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.71 72.65 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.503 -0.748 . . . . 0.0 108.989 179.77 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -56.84 -44.07 81.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.774 -179.182 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -69.91 -42.29 73.56 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.013 -1.055 . . . . 0.0 108.48 179.353 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -59.87 -50.04 75.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.673 -0.642 . . . . 0.0 111.192 -179.204 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 72.7 t -70.94 -28.65 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.556 -1.34 . . . . 0.0 109.875 -179.175 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 324' ' ' LYS . . . . . 0.465 ' NZ ' ' OE1' ' A' ' 74' ' ' GLU . 22.7 ttmt -60.05 -47.69 84.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.2 -0.938 . . . . 0.0 109.905 -179.203 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 325' ' ' GLU . . . . . 0.481 ' OE1' HD22 ' B' ' 380' ' ' LEU . 85.3 tt0 -65.31 -40.02 93.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.087 -1.008 . . . . 0.0 110.239 -179.292 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.67 -52.94 62.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.913 -1.117 . . . . 0.0 111.129 -179.025 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -60.58 -13.02 11.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.874 -1.141 . . . . 0.0 109.708 -179.515 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -67.46 -30.4 75.07 Favored Glycine 0 N--CA 1.485 1.967 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 178.608 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -106.11 144.15 33.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.654 -0.909 . . . . 0.0 108.942 179.587 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 25.3 p -90.34 -12.35 37.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.989 -1.069 . . . . 0.0 109.626 -179.993 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.43 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 15.7 t -58.49 147.98 29.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 109.117 179.768 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -66.71 131.89 46.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.247 -0.908 . . . . 0.0 109.201 -179.813 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 79.3 mt -130.92 130.33 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.492 -0.755 . . . . 0.0 109.293 179.938 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 28.6 m -131.46 153.8 49.38 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.569 -0.707 . . . . 0.0 109.433 179.568 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 68.7 t -116.09 139.27 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.081 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.7 m -129.49 121.99 28.37 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.177 -0.952 . . . . 0.0 108.995 179.771 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 42.0 p -138.72 119.37 14.03 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.013 0.911 . . . . 0.0 111.052 -179.272 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 57.5 t30 41.78 59.01 2.63 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 177.265 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 82.0 -14.6 31.64 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 120.369 -1.457 . . . . 0.0 113.087 176.316 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -115.94 128.68 55.95 Favored 'General case' 0 N--CA 1.506 2.34 0 CA-C-N 119.264 1.532 . . . . 0.0 109.425 179.978 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 81.0 p -129.55 150.82 50.72 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.807 0.813 . . . . 0.0 110.172 -179.089 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 342' ' ' ALA . . . . . 0.453 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -143.54 166.49 24.66 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.682 0.753 . . . . 0.0 110.185 -179.223 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 4.6 t -91.27 142.41 27.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.662 -0.648 . . . . 0.0 109.643 -179.587 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -80.02 -12.42 59.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 109.984 -179.508 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -91.16 18.96 6.24 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.427 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 19.7 m -146.05 95.92 2.71 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.279 -179.09 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.811 HD23 HD22 ' A' ' 79' ' ' LEU . 8.3 tp -59.96 -32.29 70.67 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.663 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.609 ' CE2' HD11 ' A' ' 79' ' ' LEU . 60.0 m-85 -59.87 -54.53 45.07 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.524 -0.735 . . . . 0.0 110.636 -178.858 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -67.0 -40.09 87.25 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.56 -1.337 . . . . 0.0 109.387 -178.633 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' B' ' 352' ' ' THR . 32.8 mt -50.19 -57.08 8.55 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.122 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.516 ' O ' HD22 ' A' ' 123' ' ' LEU . 22.3 mt-30 -41.02 -17.66 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.864 -0.523 . . . . 0.0 111.099 -178.833 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.539 ' N ' ' O ' ' B' ' 350' ' ' LEU . 82.0 p -90.61 -5.98 55.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.183 -1.573 . . . . 0.0 110.567 -179.135 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.453 HD11 ' HB3' ' B' ' 342' ' ' ALA . 83.6 mt -92.96 108.63 20.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.945 -1.097 . . . . 0.0 109.639 179.434 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -68.25 84.67 0.18 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 107.81 -2.116 . . . . 0.0 107.81 178.774 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 71.0 mt -99.16 95.97 7.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.326 -1.103 . . . . 0.0 108.326 179.483 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 44.8 p -98.32 176.6 5.65 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.255 -0.903 . . . . 0.0 110.461 -178.604 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -44.62 159.15 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.355 1.074 . . . . 0.0 111.413 -179.327 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 41.09 23.3 0.08 OUTLIER Glycine 0 N--CA 1.497 2.701 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.601 177.608 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 359' ' ' THR . . . . . 0.59 ' HB ' HD12 ' B' ' 308' ' ' ILE . 4.5 m -87.4 108.04 18.82 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.459 -1.612 . . . . 0.0 109.501 179.595 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 57.8 t -77.28 123.2 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.784 -177.36 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.6 m -122.43 175.77 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -178.477 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 94.0 m -125.07 132.32 53.19 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.726 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 96.8 mt -100.73 121.78 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.484 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 54.0 p -124.09 133.92 53.5 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.524 -0.735 . . . . 0.0 109.471 -179.054 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.53 152.18 39.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.425 -0.797 . . . . 0.0 109.368 -179.489 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -141.97 119.77 11.89 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.529 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.539 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 159.68 -154.51 25.56 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.76 -1.686 . . . . 0.0 112.046 -179.935 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -58.05 -54.72 43.71 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -177.271 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.43 ' H ' ' HB2' ' B' ' 331' ' ' SER . 83.4 m-20 -112.39 14.42 20.37 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.028 -1.045 . . . . 0.0 111.177 -177.644 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.1 pt-20 -39.19 -37.52 0.41 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.621 -0.674 . . . . 0.0 110.926 -179.437 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -69.42 -46.18 67.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.022 -1.049 . . . . 0.0 111.064 -178.025 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.86 -49.48 65.54 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.864 -1.148 . . . . 0.0 110.374 -179.12 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -55.23 -35.15 64.63 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.082 -1.011 . . . . 0.0 111.477 -178.048 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.591 ' O ' HG23 ' B' ' 378' ' ' VAL . 72.8 t -69.94 -41.04 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.458 -1.401 . . . . 0.0 108.264 178.996 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -63.86 -59.45 4.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.522 -0.736 . . . . 0.0 111.916 -178.737 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -67.84 -40.11 83.75 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.63 -1.294 . . . . 0.0 111.963 -177.306 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.4 -38.01 73.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.553 -1.342 . . . . 0.0 108.757 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.591 HG23 ' O ' ' B' ' 374' ' ' VAL . 51.5 t -60.01 -42.04 88.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.255 -0.903 . . . . 0.0 109.285 179.499 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.441 ' O ' ' OE2' ' B' ' 383' ' ' GLU . 19.1 mmmt -69.43 -55.02 11.5 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.082 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.481 HD22 ' OE1' ' B' ' 325' ' ' GLU . 64.3 tp -54.22 -38.65 65.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.786 -0.571 . . . . 0.0 110.604 -177.377 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 381' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' B' ' 381' ' ' MET . 0.0 OUTLIER -73.34 -40.01 64.76 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.619 -1.232 . . . . 0.0 108.607 178.238 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' B' B ' 382' ' ' ALA . . . . . 0.515 ' HB3' ' OE2' ' B' ' 383' ' ' GLU . . . -80.08 -3.4 48.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.095 -1.003 . . . . 0.0 109.775 179.411 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.515 ' OE2' ' HB3' ' B' ' 382' ' ' ALA . 0.0 OUTLIER -111.65 -3.02 15.18 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.378 -0.827 . . . . 0.0 111.026 -179.331 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.03 128.9 40.65 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.499 -1.376 . . . . 0.0 109.688 179.411 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 118.103 -0.951 . . . . 0.0 109.218 179.524 . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.7 mtt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.471 -0.566 . . . . 2.91 109.471 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 87.5 mt -106.85 120.09 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.525 -0.734 . . . . 1.2 109.095 179.937 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.7 m -132.85 133.34 43.2 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.468 -0.77 . . . . 1.4 109.228 179.829 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.27 -162.38 13.54 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 108.44 -1.864 . . . . 1.05 108.44 179.496 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 6' ' ' LEU . 79.5 mt -91.6 -12.9 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.95 -1.324 . . . . 1.15 109.648 -179.478 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.468 HD11 ' O ' ' A' ' 8' ' ' SER . 60.0 tp 53.75 99.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.145 -0.972 . . . . 0.98 108.822 -179.569 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.15 -40.18 74.9 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.687 -0.857 . . . . 0.88 108.687 179.315 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.468 ' O ' HD11 ' A' ' 6' ' ' LEU . 46.5 m -149.05 147.95 25.49 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.431 -0.793 . . . . 1.69 109.744 179.574 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.73 146.99 17.02 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.671 2.248 . . . . 0.85 113.272 -179.925 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.677 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.19 -164.04 36.89 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 109.105 -1.598 . . . . 0.92 109.105 179.756 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.1 mt -149.84 149.88 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 120.914 -1.344 . . . . 0.81 109.124 179.208 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.38 156.22 33.5 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.037 -1.04 . . . . 0.51 110.552 179.214 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.4 m-85 -137.02 129.14 29.47 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 107.85 -1.167 . . . . 0.62 107.85 178.597 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.22 -179.13 44.83 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 118.652 -1.737 . . . . 0.55 110.996 179.847 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -79.89 155.21 27.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.747 -0.854 . . . . 2.1 109.533 -179.972 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.479 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -101.89 129.99 48.26 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.45 -0.781 . . . . 0.77 110.563 -179.3 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.0 tp -96.31 135.17 38.51 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.205 -1.406 . . . . 0.91 107.205 178.42 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.4 tp -113.48 118.29 34.07 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.219 -0.925 . . . . 0.93 109.773 -179.532 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.614 HD12 ' HB2' ' A' ' 160' ' ' ALA . 51.0 mt -85.98 102.88 14.17 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.432 0.635 . . . . 0.93 109.502 -179.947 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -97.56 137.33 36.65 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.376 -0.828 . . . . 2.75 109.971 -179.39 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -130.5 132.99 45.92 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.72 -0.844 . . . . 3.0 108.72 179.492 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -78.69 138.34 38.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.967 -1.083 . . . . 2.77 109.053 179.748 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.81 139.97 57.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 2.94 108.762 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.7 mt -85.22 132.76 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.95 109.416 -179.264 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.6 t -106.96 129.69 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.25 -0.906 . . . . 1.28 109.762 -179.748 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.3 mt -99.21 141.14 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.36 -0.838 . . . . 1.21 109.074 179.734 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -98.96 118.94 36.88 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.162 -0.961 . . . . 1.81 109.441 -179.961 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -90.11 3.07 54.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.465 -0.772 . . . . 2.8 109.887 -179.275 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -59.97 144.18 49.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.043 -1.036 . . . . 2.87 109.67 -179.895 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -92.0 143.5 26.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.208 -0.932 . . . . 2.35 108.963 179.654 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 pt -93.55 165.79 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.131 -0.981 . . . . 0.97 110.438 -179.346 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.2 p -88.96 170.42 10.7 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.02 -1.104 . . . . 1.17 108.02 178.281 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.19 -18.47 63.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.879 -1.138 . . . . 1.18 110.176 -179.799 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 53.7 t0 -83.55 -26.75 29.84 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.893 -1.129 . . . . 2.56 108.605 179.14 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -82.18 -7.64 59.63 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.983 -0.747 . . . . 1.79 108.983 179.036 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.3 t -60.49 -53.14 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.254 -0.904 . . . . 1.0 109.253 179.77 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.81 -39.96 90.89 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.321 -0.862 . . . . 1.77 109.969 -179.447 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -63.46 -40.21 96.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.246 -0.909 . . . . 2.7 110.997 -179.298 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -65.94 -40.03 91.02 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.742 -1.224 . . . . 1.51 110.593 -179.395 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.01 -46.9 93.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 118.163 -1.415 . . . . 0.93 108.379 -179.614 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.03 -41.57 92.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.839 -1.163 . . . . 1.81 109.703 179.806 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.402 ' HG2' HH11 ' A' ' 42' ' ' ARG . 57.2 mtt-85 -59.95 -44.82 94.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.805 -1.185 . . . . 2.78 108.576 179.131 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -63.18 -47.44 82.59 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.456 -0.778 . . . . 0.78 109.523 178.886 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.0 tp -59.96 -49.08 79.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.294 -0.879 . . . . 1.07 109.075 -179.069 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.8 t -64.27 -42.25 96.55 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.965 -1.084 . . . . 1.12 108.874 179.452 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.25 -48.86 84.04 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.544 -1.823 . . . . 0.84 108.544 179.117 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -60.64 -38.69 85.64 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.436 -1.038 . . . . 3.09 108.434 178.594 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.41 -40.06 70.96 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.096 -0.705 . . . . 0.88 109.096 -179.855 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 51' ' ' SER . 24.1 ttmt -61.16 -74.48 0.08 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.439 -1.319 . . . . 2.59 107.439 179.46 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.68 -30.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.39 -0.819 . . . . 0.7 111.427 -178.254 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 49' ' ' LYS . 18.3 t -60.0 -54.59 44.2 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.771 -1.172 . . . . 1.4 108.587 179.673 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.69 -42.81 77.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.611 -0.68 . . . . 0.67 111.161 -179.016 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.85 -45.68 93.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.801 -1.187 . . . . 1.66 110.675 -179.046 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.99 -40.18 94.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.927 -1.108 . . . . 1.58 109.477 -179.406 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -60.87 -39.77 90.43 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.252 -0.905 . . . . 1.35 110.031 179.861 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -65.41 -43.34 90.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.934 -1.104 . . . . 0.77 109.269 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.567 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.8 mt -61.68 -39.87 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.63 108.922 179.537 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -54.98 -50.38 69.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.752 . . . . 1.14 109.657 -179.469 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -57.33 -33.87 68.17 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.321 -0.862 . . . . 0.79 110.492 -178.088 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -69.83 -37.46 76.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 1.53 109.45 179.622 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.86 -46.07 79.82 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.677 -0.639 . . . . 0.57 110.192 -179.67 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.19 -52.81 44.71 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 110.159 -1.176 . . . . 0.75 110.159 -179.011 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -70.04 -43.92 70.3 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.997 -1.296 . . . . 1.59 110.255 -179.513 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.4 m -65.28 -65.25 0.7 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.092 -1.005 . . . . 0.73 112.987 -177.453 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -97.83 -42.59 7.5 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.812 -1.18 . . . . 0.75 111.667 -177.621 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.25 -168.98 25.22 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.752 -1.218 . . . . 1.22 111.014 179.499 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -73.77 -23.69 59.75 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.04 -0.682 . . . . 5.81 110.246 -179.966 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -62.46 -33.58 75.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 3.37 110.462 -179.077 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HA ' HD12 ' A' ' 72' ' ' ILE . 34.5 mmtm -99.06 -20.03 16.92 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.274 -0.891 . . . . 1.77 109.61 -179.801 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -69.92 -40.24 75.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.312 -0.868 . . . . 1.65 110.531 -178.845 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.643 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -69.15 -27.31 65.43 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.183 -0.948 . . . . 0.77 109.879 -179.002 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 69' ' ' LYS . 94.2 mt -60.01 -40.4 83.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.793 -1.188 . . . . 0.8 107.793 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -62.1 -41.91 98.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -0.888 . . . . 0.88 108.906 179.281 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -60.86 -39.91 90.93 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.633 -0.827 . . . . 1.37 109.345 179.15 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.44 -47.82 88.51 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.881 -1.687 . . . . 0.62 108.881 179.531 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -64.06 -40.12 95.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.496 -1.002 . . . . 1.5 109.032 179.582 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.2 mt -69.4 -45.73 78.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.342 -0.849 . . . . 0.63 109.451 179.717 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.4 ttp -63.61 -40.07 95.99 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.04 -1.038 . . . . 1.51 110.16 -178.69 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.887 HD22 HD23 ' B' ' 347' ' ' LEU . 58.0 tp -65.95 -40.03 90.98 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.396 -0.815 . . . . 0.77 109.959 -179.961 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.7 tp -65.5 -39.94 92.46 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.684 -0.635 . . . . 0.62 110.207 -178.775 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -84.68 4.72 31.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.896 -1.127 . . . . 1.47 110.039 -178.897 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.1 t0 -49.18 134.55 17.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.175 -0.953 . . . . 1.47 109.765 -179.666 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.46 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.6 mt-10 -60.69 -20.02 59.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.612 -0.68 . . . . 1.78 110.798 -178.728 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -71.36 -33.39 69.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.055 -1.028 . . . . 2.53 110.171 179.569 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.9 mt -75.02 -41.09 60.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.477 -0.764 . . . . 0.8 110.146 179.864 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.05 -50.05 75.24 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.227 -0.921 . . . . 1.42 110.732 -178.92 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.03 -40.74 74.98 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.05 -1.031 . . . . 1.71 111.665 -178.802 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -69.98 -39.16 76.11 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.031 -1.043 . . . . 1.57 111.354 -178.818 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.8 mt -67.67 -42.05 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.93 . . . . 0.65 109.116 -179.757 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.7 mt -65.82 -39.21 84.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.51 -0.744 . . . . 0.82 109.622 179.38 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.09 -49.45 77.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 0.79 111.451 -178.629 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.8 mt -60.99 -46.4 90.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.711 -1.243 . . . . 0.95 109.821 -178.866 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.03 -50.01 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 122.115 0.96 . . . . 0.66 109.075 179.729 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -70.43 -40.21 73.94 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 120.091 -0.644 . . . . 2.2 110.834 -179.762 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -81.13 -62.48 1.65 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.036 -1.04 . . . . 1.65 112.078 -178.135 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -82.55 -0.97 49.21 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.043 -1.036 . . . . 2.03 111.999 -177.025 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 73.3 m80 57.57 38.19 27.81 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.92 -1.112 . . . . 1.42 109.927 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.1 mtp -92.67 169.07 10.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.484 -0.76 . . . . 1.18 109.595 -179.937 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.7 p -81.55 160.23 23.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.28 -0.887 . . . . 0.98 109.559 -179.692 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.4 -39.72 77.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.33 -0.856 . . . . 0.64 109.937 -179.772 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -67.01 -40.04 87.19 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -0.888 . . . . 2.07 109.498 179.817 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.65 -43.86 25.15 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.43 -0.794 . . . . 0.73 109.868 179.618 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.99 -42.92 72.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.339 -0.851 . . . . 0.54 110.568 -179.222 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.05 -44.12 96.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.166 -0.959 . . . . 0.56 109.819 -179.495 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -59.98 -38.71 83.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.321 -0.862 . . . . 1.54 110.386 -179.202 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.98 -40.28 88.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.012 . . . . 1.33 110.379 -179.172 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.1 t -64.74 -49.09 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.838 -1.164 . . . . 0.72 110.055 -179.38 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.5 mm -67.58 -40.09 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.069 -1.019 . . . . 0.85 109.214 -179.802 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.46 -38.87 88.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 2.44 108.808 179.336 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.96 -45.69 95.45 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 120.313 -0.946 . . . . 0.98 110.749 -179.487 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 50.3 mm-40 -70.04 -52.56 23.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.7 -1.471 . . . . 1.41 110.039 -179.118 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.2 88.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.855 . . . . 1.2 109.811 -179.497 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.2 t -57.88 -39.64 78.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.174 -0.954 . . . . 1.7 109.559 -179.287 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.16 -39.45 94.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 1.47 109.562 179.63 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.3 mt -61.94 -39.97 93.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.105 -0.997 . . . . 1.56 109.671 -179.202 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.438 ' CD ' ' NH2' ' A' ' 131' ' ' ARG . 36.3 mt-10 -58.91 -33.27 70.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.608 -1.307 . . . . 2.2 109.705 -179.141 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -56.33 -21.57 25.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.873 -1.142 . . . . 2.12 108.713 179.264 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.432 HD13 HD13 ' A' ' 123' ' ' LEU . 74.8 mt -62.54 140.4 58.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 2.0 108.939 179.687 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -90.63 21.66 3.9 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.208 -0.932 . . . . 3.23 110.126 -179.426 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 51.9 t0 -112.86 141.28 46.86 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.402 -0.811 . . . . 2.49 109.569 -179.737 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 124' ' ' LYS . 92.8 mt-10 -72.54 -63.2 1.21 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.265 -1.013 . . . . 3.95 108.265 178.631 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.46 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.8 t80 -38.65 -41.42 0.69 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.031 -0.418 . . . . 2.0 110.932 -178.935 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.433 HD22 ' O ' ' B' ' 351' ' ' GLN . 87.2 mt -69.85 -39.92 76.1 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.63 -1.293 . . . . 1.86 108.239 179.549 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 121' ' ' GLU . 63.1 tttp -60.77 -40.07 91.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 2.84 110.022 179.718 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 41.3 mt-10 -60.02 -45.01 94.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.017 -1.052 . . . . 2.73 109.77 -179.28 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.872 ' HE ' HE22 ' B' ' 351' ' ' GLN . 65.6 mtp180 -60.54 -39.94 89.7 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.167 -0.958 . . . . 2.77 108.505 179.214 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.76 -27.35 67.9 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.556 -0.905 . . . . 1.19 108.556 179.027 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -64.18 -40.05 95.29 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.135 -1.061 . . . . 1.2 108.135 178.792 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -64.16 -40.09 95.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.518 -0.739 . . . . 1.55 109.21 179.653 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.89 -42.73 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -0.864 . . . . 0.8 108.733 179.945 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.438 ' NH2' ' CD ' ' A' ' 116' ' ' GLU . 44.1 ttm180 -60.33 -36.72 78.62 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.522 0.677 . . . . 3.09 109.203 179.361 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -58.45 -39.61 80.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.438 -0.789 . . . . 1.46 109.036 -179.671 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.87 -45.45 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.209 -0.932 . . . . 0.71 108.838 179.843 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.18 -41.34 99.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.771 -1.332 . . . . 0.57 109.771 179.689 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -59.99 -50.04 75.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.188 -1.184 . . . . 2.59 110.274 -179.927 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.567 HH22 ' CD1' ' A' ' 57' ' ' ILE . 62.1 mtp180 -69.64 -32.37 71.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.807 -1.183 . . . . 2.83 109.72 -179.631 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -57.3 -47.86 80.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 1.25 108.772 -179.139 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.9 mt -61.13 -39.69 90.98 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.254 -0.904 . . . . 0.7 108.955 178.407 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.512 HH11 ' CD2' ' A' ' 144' ' ' LEU . 50.0 mtt-85 -67.61 -40.05 84.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.89 . . . . 2.57 109.259 179.542 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -66.53 -39.88 88.83 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.629 -0.669 . . . . 1.23 110.456 -179.012 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.9 mt -71.78 -43.1 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 120.478 -1.389 . . . . 0.81 108.303 178.822 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.0 -32.25 70.35 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.74 -0.6 . . . . 1.0 109.733 179.944 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.86 44.38 6.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.178 -1.569 . . . . 0.89 109.178 -179.373 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.512 ' CD2' HH11 ' A' ' 139' ' ' ARG . 12.3 tp -74.85 148.45 40.22 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.414 -1.05 . . . . 1.14 109.376 -179.44 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -70.45 143.16 51.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.24 -0.913 . . . . 4.6 109.896 -179.48 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.7 mt -115.22 129.98 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.984 0.897 . . . . 1.24 108.915 179.373 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 10.5 mt -66.85 -39.95 84.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 115.869 -0.605 . . . . 1.54 110.717 -178.23 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.6 t0 67.5 97.29 0.06 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.745 -0.835 . . . . 1.5 108.745 -179.329 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.2 mt -68.1 -1.13 5.37 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.443 -0.786 . . . . 0.79 110.939 -178.575 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 80.8 p -82.97 -14.0 54.9 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.695 -1.253 . . . . 1.4 110.111 -179.723 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.92 33.34 0.33 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.284 -0.885 . . . . 0.92 111.96 -177.955 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 45.1 mm -85.94 120.22 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.421 -1.425 . . . . 0.88 108.96 179.491 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.414 ' O ' ' OD1' ' A' ' 154' ' ' ASP . 50.6 tt0 -99.85 -12.14 20.12 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.33 -0.856 . . . . 2.45 109.93 -179.364 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 153' ' ' GLN . 95.7 m-20 -139.26 157.89 45.12 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.944 -1.098 . . . . 1.52 110.285 -179.398 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.95 137.03 57.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.45 -0.782 . . . . 1.58 109.63 -179.62 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.5 m -153.3 167.9 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.462 -0.774 . . . . 0.69 109.982 179.609 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 81.5 mt -97.16 144.74 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.727 -1.583 . . . . 0.61 106.727 177.689 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.511 HD11 HD11 ' A' ' 19' ' ' LEU . 40.9 tp -94.2 117.08 29.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.911 -1.118 . . . . 0.87 110.367 -178.222 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.786 HG12 HG22 ' A' ' 209' ' ' THR . 44.6 t -123.12 129.41 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 108.667 -0.864 . . . . 0.71 108.667 179.199 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.614 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.14 165.31 29.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.119 -0.988 . . . . 0.81 109.354 -179.627 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.42 -30.63 61.99 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.261 -1.524 . . . . 0.98 108.378 178.823 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -165.51 168.41 16.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.913 -0.773 . . . . 2.25 108.913 -179.61 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.1 mt -139.6 133.19 30.36 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.169 -0.957 . . . . 0.78 108.869 179.286 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 69.3 p -99.13 149.35 35.7 Favored Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.318 -0.864 . . . . 0.98 109.769 -179.717 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -40.62 -37.77 2.32 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.541 2.16 . . . . 0.81 113.263 179.515 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 65.1 m -59.99 -39.99 87.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.9 109.677 -178.794 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -69.08 -44.21 72.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.287 -0.883 . . . . 1.61 110.503 -179.445 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.0 p -54.9 -30.17 57.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.043 -1.036 . . . . 0.61 111.717 -177.458 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.79 -48.58 24.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.7 -1.25 . . . . 0.6 109.901 -179.522 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 170' ' ' GLN . . . . . 0.421 ' H ' ' HG2' ' A' ' 170' ' ' GLN . 13.9 pt20 -86.43 40.12 0.87 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.899 -1.149 . . . . 1.4 107.899 179.636 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.3 tp -111.26 136.14 50.78 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.36 -0.978 . . . . 0.7 108.36 178.485 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.428 ' O ' HG23 ' A' ' 176' ' ' VAL . 87.2 m-20 -90.43 108.42 19.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.966 -1.084 . . . . 2.35 110.096 -179.728 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 71.9 mt -64.91 -40.43 95.06 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.458 -0.776 . . . . 1.51 111.071 -178.906 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -70.05 -25.04 63.37 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.87 -1.144 . . . . 2.33 111.708 -178.131 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -93.62 -8.99 39.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.784 -1.198 . . . . 1.92 110.373 -178.632 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.581 HG12 ' H ' ' A' ' 178' ' ' GLY . 85.4 t -103.27 117.85 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.194 -0.941 . . . . 0.67 108.948 179.434 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 81.6 mt -86.73 6.42 31.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.456 -0.778 . . . . 1.53 110.571 -177.875 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.581 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 165.66 175.4 36.15 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.305 -1.518 . . . . 0.48 109.305 179.806 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.443 ' CE1' HG11 ' A' ' 176' ' ' VAL . 21.8 m-85 -132.18 130.67 41.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.477 -1.013 . . . . 0.55 109.198 -179.877 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.417 ' CG2' HG21 ' A' ' 205' ' ' THR . 98.2 mt -132.93 124.85 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.483 -0.76 . . . . 0.65 108.963 178.869 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 47.5 p -148.02 160.61 42.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.97 -1.081 . . . . 0.82 110.917 -179.622 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 183' ' ' ALA . 0.8 OUTLIER -99.65 20.13 14.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.558 -0.714 . . . . 2.46 109.717 179.969 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.17 -163.32 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.812 -1.18 . . . . 1.28 111.607 -178.295 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -85.56 -46.92 5.32 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 111.224 -0.751 . . . . 2.19 111.224 -178.603 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 165.66 -136.44 4.18 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.963 -1.589 . . . . 2.13 110.612 -179.598 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' ' 186' ' ' ARG . 24.2 mmt-85 -70.21 -10.43 58.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.481 -1.011 . . . . 5.86 109.739 -179.219 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 78.1 p -76.08 -7.15 54.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.114 -0.992 . . . . 3.72 109.732 -179.471 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.2 p -91.39 131.87 36.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.134 -0.979 . . . . 1.74 109.889 179.819 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -49.69 -47.59 50.22 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.426 -0.796 . . . . 0.95 109.843 -179.559 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.414 ' H ' HG22 ' A' ' 190' ' ' THR . 0.6 OUTLIER -56.96 -39.62 74.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.381 -0.824 . . . . 1.55 110.576 -178.949 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.4 t -60.03 -41.23 91.79 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.888 -1.132 . . . . 1.51 110.753 -179.267 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.7 mm -60.21 -40.01 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.135 -0.978 . . . . 1.67 109.338 -179.5 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.7 mtp -60.04 -40.13 88.31 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.27 -0.894 . . . . 1.02 110.055 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.48 -44.38 72.56 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.734 -1.228 . . . . 0.68 108.931 179.986 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -60.06 -52.42 65.46 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.346 -0.942 . . . . 2.93 110.518 -179.703 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 56.4 m -69.88 -34.68 73.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.025 -1.047 . . . . 0.86 110.79 -178.465 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.97 -29.68 66.85 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.955 -1.128 . . . . 0.67 107.955 179.593 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 65.09 47.34 2.51 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.454 0.645 . . . . 1.5 110.153 -179.629 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 93.6 mt -124.85 150.52 66.19 Favored Pre-proline 0 N--CA 1.5 2.05 0 N-CA-C 108.439 -0.948 . . . . 0.72 108.439 178.891 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -56.15 138.59 83.51 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.858 1.705 . . . . 0.61 111.135 179.841 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.94 151.03 3.22 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.744 -1.182 . . . . 0.66 111.778 -179.647 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.1 mt -127.23 143.89 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.069 -1.086 . . . . 0.79 108.069 179.116 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.9 m -130.0 -11.45 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 O-C-N 120.837 -1.165 . . . . 0.91 111.315 -178.825 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.51 25.85 18.25 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 110.064 -1.214 . . . . 1.01 110.064 -179.506 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.417 HG21 ' CG2' ' A' ' 180' ' ' ILE . 4.6 p -45.3 -45.59 12.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -1.158 . . . . 0.99 109.814 -179.562 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.8 -52.79 2.62 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.216 -0.993 . . . . 1.12 111.181 179.287 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.5 t -155.02 29.04 0.41 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.585 -1.538 . . . . 1.72 111.451 -179.032 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 56.0 t -70.18 -40.08 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.947 -1.095 . . . . 0.89 109.131 178.309 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.786 HG22 HG12 ' A' ' 159' ' ' VAL . 63.2 p -60.0 -26.53 66.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.423 -0.798 . . . . 1.03 110.621 -179.131 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 79.3 p -81.7 -20.69 38.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.921 -1.112 . . . . 1.83 110.181 -179.361 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -101.01 -9.1 21.76 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.344 -0.848 . . . . 2.27 109.967 -179.688 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.2 t -103.32 138.23 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.38 -0.825 . . . . 0.92 110.18 -179.053 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.87 155.34 26.99 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.606 -1.257 . . . . 2.2 107.606 178.938 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 55.3 t30 -59.56 139.43 57.16 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.872 -1.143 . . . . 2.36 109.738 -179.603 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.5 m-20 82.07 5.06 1.17 Allowed 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 121.144 0.497 . . . . 2.38 110.018 179.884 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 63.1 t0 -73.1 136.91 44.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 2.09 108.912 179.077 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.515 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 34.9 t80 -88.93 114.8 25.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.931 -1.105 . . . . 1.27 108.42 179.471 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.479 HD12 ' HB2' ' A' ' 16' ' ' ALA . 72.2 mt -124.67 146.15 49.28 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.52 -0.738 . . . . 0.75 110.343 -178.897 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.9 mt -112.87 128.7 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 107.741 -1.207 . . . . 0.63 107.741 178.187 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 49.5 tp -101.22 116.42 32.76 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.922 -1.111 . . . . 0.7 108.992 -179.523 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.503 ' OD2' ' ND2' ' A' ' 224' ' ' ASN . 38.5 t0 -80.7 -41.93 22.84 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.173 -1.047 . . . . 2.31 108.173 178.948 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.83 19.61 0.18 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.967 -0.753 . . . . 0.78 108.967 -179.401 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.434 ' N ' ' C ' ' A' ' 221' ' ' ASP . 47.3 t -128.61 -39.72 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.097 -1.445 . . . . 1.04 107.097 178.539 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.503 ' ND2' ' OD2' ' A' ' 221' ' ' ASP . 86.1 m-20 -108.85 4.78 23.89 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.836 -1.172 . . . . 2.44 107.836 178.072 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 60.06 47.66 9.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.721 -0.612 . . . . 1.55 110.059 -179.884 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -140.84 140.29 34.62 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.134 -0.979 . . . . 1.99 110.252 179.889 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -118.31 120.14 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 108.533 -0.914 . . . . 0.77 108.533 179.104 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -88.57 130.02 35.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.978 -1.076 . . . . 0.98 109.366 -179.479 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.462 HG22 HD22 ' A' ' 218' ' ' LEU . 58.2 t -103.34 115.1 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.6 -0.688 . . . . 0.85 110.027 -179.056 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.6 t30 48.44 66.73 5.3 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.311 -0.868 . . . . 1.66 111.058 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -90.1 154.04 4.76 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.809 2.339 . . . . 0.95 111.687 178.851 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 232' ' ' THR . 1.8 t -77.98 168.88 19.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.03 -1.044 . . . . 1.84 110.257 -179.162 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -59.99 -38.97 84.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.696 -0.628 . . . . 2.74 111.321 -179.114 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -59.97 -39.98 87.5 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.936 -1.103 . . . . 2.89 110.137 -178.109 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.51 -39.9 79.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.089 -1.007 . . . . 1.3 109.306 179.572 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.88 -40.16 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 1.09 110.309 -179.617 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -60.06 -41.73 93.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.779 -1.2 . . . . 2.43 109.588 -179.758 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -64.46 -42.09 96.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.451 -0.78 . . . . 2.78 109.65 179.754 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 93.6 mtp -70.04 -33.7 72.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.506 -0.747 . . . . 1.25 110.421 179.614 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -70.07 -39.68 75.48 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.243 -0.91 . . . . 2.63 109.834 -179.975 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -56.1 -44.87 79.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -0.918 . . . . 1.8 109.414 -179.26 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.02 -43.74 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.14 -0.975 . . . . 2.13 108.992 179.557 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -60.04 -41.28 91.92 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.381 -0.824 . . . . 3.17 110.018 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.08 -39.87 87.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.229 -0.919 . . . . 1.78 109.872 -179.631 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -61.66 -37.46 84.11 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.327 -0.858 . . . . 2.47 109.894 180.0 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 53.4 t -60.13 -49.36 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.42 -0.8 . . . . 2.09 109.999 -178.781 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.02 -39.93 83.04 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.009 -1.057 . . . . 2.54 109.636 -179.888 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 30.3 t -70.87 -41.52 71.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.377 -0.827 . . . . 2.99 111.775 -178.972 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -71.04 -27.59 63.76 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.759 -1.213 . . . . 3.34 110.672 -178.603 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -79.89 -3.76 49.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.249 -0.907 . . . . 3.88 111.006 -178.649 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -109.97 -3.09 16.74 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.949 -1.095 . . . . 4.43 110.254 -179.722 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.09 -49.95 75.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.001 -1.062 . . . . 5.42 109.682 -179.631 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -175.82 33.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.284 -0.885 . . . . 6.1 109.401 179.518 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 52.98 33.78 15.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.441 -0.787 . . . . 7.37 109.294 -179.936 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.511 ' C ' ' H ' ' A' ' 257' ' ' LYS . 58.0 pttt -63.01 -39.68 95.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.389 -0.819 . . . . 8.01 109.383 179.637 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.401 ' N ' ' CG ' ' A' ' 255' ' ' LYS . 9.4 mp 53.57 5.42 0.06 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.962 -0.755 . . . . 9.05 108.962 -179.053 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.511 ' H ' ' C ' ' A' ' 255' ' ' LYS . 78.0 mttt -150.8 161.08 43.33 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.892 -1.13 . . . . 10.56 109.583 179.689 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 257' ' ' LYS . 80.4 m-20 -142.77 -132.98 0.09 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.143 -1.058 . . . . 11.32 108.143 179.203 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.508 HH11 ' HG2' ' A' ' 259' ' ' ARG . 11.1 ttt-85 . . . . . 0 C--N 1.296 -1.735 0 CA-C-O 117.948 -1.025 . . . . 12.42 109.532 -179.508 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 55.6 ttm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -149.48 146.87 27.63 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.011 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.35 159.86 44.15 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.943 -1.098 . . . . 0.0 110.423 -179.101 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -158.44 154.63 27.18 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.614 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 305' ' ' GLU . . . . . 0.462 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 54.6 mp0 -115.15 130.77 57.01 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.074 -1.016 . . . . 0.0 109.787 179.575 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.35 126.3 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 CA-C-O 122.181 0.991 . . . . 0.0 112.297 -177.526 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 35.5 m -79.04 102.68 8.5 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.072 0.939 . . . . 0.0 110.936 -178.403 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.453 HG22 ' H ' ' B' ' 310' ' ' ALA . 96.7 mt -51.28 126.02 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 122.29 1.043 . . . . 0.0 110.742 -177.839 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 72.6 p -110.06 19.27 19.16 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.147 -179.103 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.453 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -76.71 126.28 86.12 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.902 -1.124 . . . . 0.0 108.134 178.942 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -65.7 -11.48 30.86 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 CA-C-N 120.312 1.147 . . . . 0.0 112.75 -178.866 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -119.98 10.06 11.4 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.464 -0.773 . . . . 0.0 109.589 -179.844 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.74 179.99 33.12 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -179.132 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.519 ' O ' ' NH1' ' A' ' 126' ' ' ARG . 3.2 tp -84.38 87.9 7.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.918 -1.342 . . . . 0.0 109.062 -178.801 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.438 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 3.7 p80 -90.38 -163.12 0.97 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.862 -1.149 . . . . 0.0 109.997 179.187 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.0 m -55.88 -44.64 78.32 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.186 -0.946 . . . . 0.0 112.917 -176.054 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.643 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 12.7 tpt180 -60.02 -60.0 12.04 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 120.576 -1.327 . . . . 0.0 112.087 -178.991 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.438 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 11.5 Cg_endo -59.5 -34.5 97.05 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 CA-C-N 120.634 1.262 . . . . 0.0 111.873 -179.147 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.0 75.46 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.421 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.46 -44.52 76.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.512 -0.743 . . . . 0.0 110.159 -179.221 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -70.02 -41.06 74.81 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.746 -1.221 . . . . 0.0 108.537 178.898 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -62.1 -52.88 62.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.455 -0.778 . . . . 0.0 110.151 -179.776 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 95.3 t -66.17 -25.35 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.823 -1.173 . . . . 0.0 109.974 -178.975 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -60.0 -44.51 94.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.135 -0.978 . . . . 0.0 108.574 179.948 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.18 -52.56 46.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.461 -0.774 . . . . 0.0 110.991 -179.228 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 326' ' ' ALA . . . . . 0.428 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -53.13 -56.89 12.77 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.618 -1.301 . . . . 0.0 111.474 -178.444 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -50.06 -16.2 0.28 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.032 -1.042 . . . . 0.0 109.359 -179.912 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 328' ' ' GLY . . . . . 0.428 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -81.68 -17.05 71.57 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.361 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -106.22 141.39 37.66 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.607 -0.937 . . . . 0.0 109.257 179.571 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.2 p -92.14 -14.28 29.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.905 -1.122 . . . . 0.0 110.21 -179.998 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.487 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 47.4 t -59.99 143.85 50.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.073 -1.017 . . . . 0.0 109.404 -179.78 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -66.58 137.9 57.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.424 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 93.5 mt -134.11 134.18 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.469 -0.769 . . . . 0.0 110.327 -179.149 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 99.7 m -129.07 149.62 50.81 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.798 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 74.8 t -115.63 141.47 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.325 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 59.1 m -131.61 121.94 25.2 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.155 -0.966 . . . . 0.0 109.359 179.547 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.3 t -139.2 120.22 14.55 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.086 0.946 . . . . 0.0 110.737 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 42.47 50.08 4.73 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 177.365 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.28 -14.65 57.14 Favored Glycine 0 N--CA 1.503 3.16 0 O-C-N 120.186 -1.571 . . . . 0.0 113.351 176.391 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -112.65 121.65 45.38 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 119.368 1.584 . . . . 0.0 109.906 -179.532 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 53.2 m -106.23 154.03 21.31 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.968 0.89 . . . . 0.0 111.069 -178.668 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -150.75 150.18 30.7 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.374 0.606 . . . . 0.0 109.573 179.452 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 68.0 m -87.69 135.2 33.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.334 -0.854 . . . . 0.0 110.136 -179.56 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.429 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -69.31 -20.2 63.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.075 -1.015 . . . . 0.0 108.49 179.366 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -84.29 20.44 1.63 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.841 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 346' ' ' SER . . . . . 0.429 ' H ' ' C ' ' B' ' 344' ' ' ALA . 2.6 m -149.1 91.71 1.88 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.014 -179.762 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.887 HD23 HD22 ' A' ' 79' ' ' LEU . 59.5 tp -56.54 -37.55 70.67 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.383 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.806 ' CE2' HD11 ' A' ' 79' ' ' LEU . 62.3 m-85 -54.54 -50.09 68.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.354 -0.841 . . . . 0.0 111.039 -179.273 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 349' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' B' ' 350' ' ' LEU . 35.1 mtmm -69.97 -39.89 75.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.675 -1.265 . . . . 0.0 110.645 -178.525 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' B' ' 352' ' ' THR . 96.7 mt -46.63 -56.8 5.53 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.979 -1.076 . . . . 0.0 108.879 -179.494 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.872 HE22 ' HE ' ' A' ' 126' ' ' ARG . 56.9 mm-40 -39.49 -26.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.847 -0.533 . . . . 0.0 111.208 -178.571 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.445 ' N ' ' O ' ' B' ' 350' ' ' LEU . 67.8 p -79.3 -11.15 59.94 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.498 -1.376 . . . . 0.0 110.56 -178.078 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 24.3 mt -96.34 120.01 35.86 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.922 -1.111 . . . . 0.0 109.54 178.72 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.35 92.1 1.06 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.135 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.2 mt -98.41 92.01 5.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.301 -1.117 . . . . 0.0 109.331 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 70.1 p -92.89 175.79 6.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.133 -0.979 . . . . 0.0 111.352 -178.516 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -65.22 110.82 2.7 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.447 -179.543 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 102.65 12.93 31.38 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.688 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 50.1 m -88.36 110.09 20.51 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -1.137 . . . . 0.0 111.343 -179.092 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 31.0 t -77.45 113.83 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 122.119 0.962 . . . . 0.0 109.826 -177.752 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.5 m -109.78 176.6 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -177.875 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 29.8 m -131.58 127.57 37.41 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.477 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.0 mt -104.21 115.86 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.435 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 50.2 p -120.37 133.35 55.46 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.513 -0.742 . . . . 0.0 109.042 -179.664 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.61 150.05 36.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.114 -0.991 . . . . 0.0 110.086 -179.024 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -139.29 120.5 14.77 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.65 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.574 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 165.04 -167.07 38.53 Favored Glycine 0 N--CA 1.485 1.909 0 C-N-CA 119.119 -1.515 . . . . 0.0 111.117 -179.492 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -58.09 -47.03 84.47 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.359 -0.495 . . . . 0.0 111.707 -177.785 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.487 ' H ' ' HB2' ' B' ' 331' ' ' SER . 2.7 p30 -107.98 10.46 28.35 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.878 -1.139 . . . . 0.0 111.373 -177.681 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -43.92 -32.02 1.01 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.408 -0.808 . . . . 0.0 110.963 -178.96 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -69.46 -45.16 69.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.137 -0.977 . . . . 0.0 110.045 -178.481 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -67.5 -47.98 68.41 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.176 -0.953 . . . . 0.0 108.847 -179.632 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.15 -78.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.399 -0.813 . . . . 0.0 110.67 -179.471 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.583 ' O ' HG23 ' B' ' 378' ' ' VAL . 38.7 t -46.34 -35.75 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.042 -1.036 . . . . 0.0 110.633 -177.458 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -64.9 -49.84 68.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.528 -1.357 . . . . 0.0 110.591 -179.963 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -80.49 -41.78 23.69 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.956 -1.09 . . . . 0.0 110.493 -179.667 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 97.0 mt -59.94 -37.19 78.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 109.08 -179.133 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.583 HG23 ' O ' ' B' ' 374' ' ' VAL . 50.2 t -65.46 -40.04 87.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.312 -0.867 . . . . 0.0 109.574 179.265 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -69.71 -57.03 5.63 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.772 -1.205 . . . . 0.0 108.408 179.213 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 57.3 tp -55.17 -26.73 40.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 0.0 110.403 -178.216 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 33.7 ttm -74.72 -38.13 62.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.691 -1.256 . . . . 0.0 109.027 177.857 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.89 -4.41 58.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.512 -0.742 . . . . 0.0 110.509 179.588 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -110.48 -6.66 14.87 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.122 -0.986 . . . . 0.0 111.245 -178.739 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.6 mt -78.56 132.37 37.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.3 -1.5 . . . . 0.0 109.029 179.141 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.366 -179.705 . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.2 mmm . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.332 -0.618 . . . . 2.91 109.332 . . . . . . . . . 0 0 . 1 . 035 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.0 mt -111.13 126.99 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.578 -0.701 . . . . 1.2 109.828 179.809 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.8 m -140.51 150.18 43.42 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.371 -0.83 . . . . 1.4 109.778 -179.832 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.417 ' H ' ' CG ' ' A' ' 225' ' ' ASN . . . -138.7 -163.81 9.68 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.858 -1.697 . . . . 1.05 108.858 179.274 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 6' ' ' LEU . 97.4 mt -93.3 -16.82 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.95 -1.324 . . . . 1.15 110.125 -179.118 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.1 tp 54.55 105.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.397 -0.815 . . . . 0.98 109.407 179.906 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.31 -35.25 11.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.561 -0.903 . . . . 0.88 108.561 179.064 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 7.6 m -129.26 129.28 23.29 Favored Pre-proline 0 N--CA 1.502 2.136 0 N-CA-C 109.362 -0.607 . . . . 1.69 109.362 179.848 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.15 146.1 15.69 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.272 1.981 . . . . 0.85 112.807 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.807 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 160.53 -160.35 31.74 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 109.827 -1.309 . . . . 0.92 109.827 179.594 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.0 mt -149.98 149.64 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.268 -1.136 . . . . 0.81 108.195 179.215 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.04 149.82 25.07 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.568 -1.333 . . . . 0.51 111.128 179.628 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 4.0 m-85 -131.06 129.79 42.4 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 108.917 -0.771 . . . . 0.62 108.917 179.23 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.93 -173.79 46.03 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 118.509 -1.805 . . . . 0.55 110.948 179.3 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -82.55 155.46 24.49 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.949 -0.736 . . . . 2.1 110.026 -179.513 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.578 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -102.35 129.51 48.82 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.383 -0.823 . . . . 0.77 110.853 -179.532 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.3 tp -99.38 133.52 43.58 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.109 -1.441 . . . . 0.91 107.109 178.412 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.4 tp -118.72 125.41 49.6 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.235 -0.916 . . . . 0.93 109.652 -179.697 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.56 HD21 HD21 ' A' ' 149' ' ' LEU . 85.5 mt -87.36 103.73 15.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.583 -0.698 . . . . 0.93 109.578 179.627 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.98 132.15 43.79 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.557 -0.905 . . . . 2.75 108.557 179.367 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -131.26 130.32 42.71 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.972 -1.08 . . . . 3.0 109.003 179.03 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -79.46 154.1 29.16 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.166 -0.959 . . . . 2.77 108.777 179.448 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -67.74 141.18 56.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.043 -1.035 . . . . 2.94 109.838 -179.915 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.4 mt -79.44 135.45 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.241 -1.022 . . . . 0.95 108.241 179.532 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.1 t -103.39 124.33 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.175 -0.953 . . . . 1.28 109.998 -179.294 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.9 mt -99.03 140.77 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.849 -0.797 . . . . 1.21 108.849 179.803 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -92.15 121.39 33.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.063 -1.023 . . . . 1.81 109.359 -179.699 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -94.86 5.47 51.8 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.495 -0.928 . . . . 2.8 108.495 179.701 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -65.78 142.13 58.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.484 -0.76 . . . . 2.87 109.52 -179.783 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -88.53 140.32 29.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.226 -0.921 . . . . 2.35 109.119 -179.906 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.517 HG21 ' HG3' ' A' ' 39' ' ' GLU . 3.3 pt -94.39 164.43 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.885 -1.134 . . . . 0.97 109.746 -179.819 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.0 p -95.42 169.86 9.76 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.412 -0.958 . . . . 1.17 108.412 178.918 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.34 -13.24 49.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.952 -1.092 . . . . 1.18 110.085 -179.769 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -88.59 -30.33 19.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.868 -1.145 . . . . 2.56 108.977 179.576 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -82.64 -7.73 59.63 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.758 -0.83 . . . . 1.79 108.758 179.556 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 t -59.98 -51.96 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.24 -0.913 . . . . 1.0 108.832 179.613 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -60.01 -39.03 84.38 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.29 -0.882 . . . . 1.77 109.292 179.612 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -67.26 -41.8 84.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.053 -1.029 . . . . 2.7 110.915 -178.816 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.517 ' HG3' HG21 ' A' ' 31' ' ' ILE . 63.2 mm-40 -64.47 -40.08 95.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.597 -1.315 . . . . 1.51 110.181 -179.435 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.13 -47.02 93.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 120.622 -1.299 . . . . 0.93 108.449 179.242 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -59.89 -40.16 87.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 1.81 109.538 -179.777 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -60.02 -43.34 95.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.749 -1.219 . . . . 2.78 108.268 178.523 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.424 ' CE1' HD13 ' A' ' 89' ' ' ILE . 69.5 t80 -60.13 -49.31 78.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.344 -0.848 . . . . 0.78 108.907 178.59 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 21.0 tp -59.98 -49.04 79.23 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.762 -0.586 . . . . 1.07 109.453 -179.825 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 22.2 t -63.27 -46.13 88.24 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.43 -0.908 . . . . 1.12 109.033 179.121 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.19 -48.1 87.61 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.415 -1.874 . . . . 0.84 108.415 179.443 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 -60.61 -38.1 83.58 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.302 -0.999 . . . . 3.09 108.302 178.689 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -50.35 -42.16 52.61 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.382 -0.599 . . . . 0.88 109.382 -179.527 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.434 ' O ' ' C ' ' A' ' 50' ' ' ALA . 19.8 ttmt -66.99 -73.73 0.13 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.869 -1.16 . . . . 2.59 107.869 178.952 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.31 -39.91 0.48 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.516 -0.74 . . . . 0.7 111.01 -178.825 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.8 t -51.77 -61.72 2.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.769 -1.207 . . . . 1.4 109.368 179.797 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.87 82.94 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.391 -0.818 . . . . 0.67 111.41 -178.56 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -62.73 -40.69 97.99 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.854 -1.154 . . . . 1.66 110.063 -178.716 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.41 -40.05 95.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.113 -0.992 . . . . 1.58 109.695 -179.839 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -62.2 -37.64 86.09 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.341 -0.85 . . . . 1.35 109.285 -179.773 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.6 m -65.15 -42.7 93.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.77 109.174 -179.918 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.26 -39.91 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.21 -0.931 . . . . 0.63 109.334 179.876 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -58.87 -49.95 75.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.166 -0.959 . . . . 1.14 109.958 -179.06 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.8 m -56.65 -35.63 68.6 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.021 -1.049 . . . . 0.79 110.018 -178.198 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -65.7 -37.05 85.38 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.199 -0.938 . . . . 1.53 108.896 -179.844 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.433 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.87 -49.03 64.37 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.349 0.595 . . . . 0.57 110.215 179.82 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.97 -51.83 54.89 Favored Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.837 -1.173 . . . . 0.75 110.319 -178.937 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -70.13 -40.74 74.64 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.167 -1.196 . . . . 1.59 110.322 -179.44 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.9 m -69.95 -61.39 1.8 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.028 -1.045 . . . . 0.73 112.38 -177.532 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -93.74 -47.52 6.74 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.831 -1.168 . . . . 0.75 111.036 -177.752 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.73 -168.72 25.48 Favored Glycine 0 N--CA 1.5 2.934 0 C-N-CA 119.848 -1.167 . . . . 1.22 111.238 179.612 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -68.6 -26.41 65.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.824 -0.81 . . . . 5.81 110.359 -179.586 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -60.54 -35.22 75.49 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.331 -0.855 . . . . 3.37 110.484 -179.598 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -96.07 -19.07 19.71 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.105 -0.997 . . . . 1.77 110.117 -179.743 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -69.27 -40.94 77.5 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.704 -1.248 . . . . 1.65 109.665 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.566 ' CB ' HH11 ' B' ' 317' ' ' ARG . . . -67.07 -36.46 82.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.44 -0.788 . . . . 0.77 110.67 -178.597 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 77.2 mt -60.69 -43.66 95.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.697 -1.252 . . . . 0.8 109.006 179.643 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 10.8 m-85 -70.29 -33.31 71.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 0.88 109.581 179.776 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -63.98 -40.03 95.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.023 -1.048 . . . . 1.37 109.731 179.475 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.29 -39.86 91.99 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.013 -1.635 . . . . 0.62 109.013 179.426 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -60.19 -48.85 80.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.431 -1.041 . . . . 1.5 109.38 -179.908 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -66.52 -45.28 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 0.63 109.764 179.929 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.1 ttp -60.35 -40.16 89.75 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.099 -1.001 . . . . 1.51 109.27 -178.918 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.874 HD11 ' CE2' ' B' ' 348' ' ' PHE . 25.1 tp -61.13 -35.9 78.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.77 108.689 178.709 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.8 tp -67.96 -30.26 69.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.496 -0.753 . . . . 0.62 109.514 179.968 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -83.43 4.64 26.77 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.21 -0.932 . . . . 1.47 110.336 -179.483 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 57.1 t0 -56.83 130.57 46.26 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.974 -1.079 . . . . 1.47 111.212 -178.651 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.423 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 47.7 mt-10 -61.07 -18.59 58.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.929 -0.482 . . . . 1.78 111.179 -179.223 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -72.71 -34.33 67.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.625 -1.297 . . . . 2.53 108.813 178.877 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.1 mt -69.77 -43.1 72.87 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.353 0.597 . . . . 0.8 111.002 -179.252 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -62.74 -42.06 99.48 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.348 -0.845 . . . . 1.42 111.17 -178.032 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -70.12 -42.58 72.44 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.833 -1.167 . . . . 1.71 111.619 -178.289 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -68.16 -38.29 81.93 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.196 -0.94 . . . . 1.57 111.855 -177.87 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.424 HD13 ' CE1' ' A' ' 43' ' ' PHE . 96.8 mt -66.53 -42.29 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.67 -1.269 . . . . 0.65 109.445 -179.759 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.3 mt -70.04 -39.93 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 0.82 110.616 179.606 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.95 -43.06 96.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.25 -0.906 . . . . 0.79 111.748 -178.104 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.3 mt -63.68 -46.56 84.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.585 -1.322 . . . . 0.95 109.632 -179.357 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -59.84 -49.53 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 122.038 0.923 . . . . 0.66 109.434 179.531 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -70.04 -40.23 75.28 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 120.079 -0.649 . . . . 2.2 111.099 -179.635 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -81.86 -55.79 4.38 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.753 -1.217 . . . . 1.65 112.278 -178.346 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -90.04 -1.26 57.93 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.91 -1.119 . . . . 2.03 112.425 -177.03 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 59.57 40.07 20.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.842 -1.162 . . . . 1.42 110.082 179.377 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 79.1 mtp -95.27 167.21 11.49 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.31 -0.868 . . . . 1.18 109.656 -179.72 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 56.6 p -81.5 160.15 24.01 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.276 -0.89 . . . . 0.98 109.04 179.635 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.82 -39.79 94.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.895 . . . . 0.64 110.268 -179.639 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -69.3 -33.42 73.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.027 -1.046 . . . . 2.07 109.278 -179.619 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.73 -41.06 24.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -0.963 . . . . 0.73 109.377 179.442 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.47 -45.7 61.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.311 -0.868 . . . . 0.54 110.197 -179.813 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.37 -33.4 75.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.125 -0.985 . . . . 0.56 109.355 179.979 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -59.82 -44.94 93.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.568 -0.707 . . . . 1.54 109.958 -179.822 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -60.19 -40.29 89.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 1.33 110.966 -179.2 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.04 -65.95 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.239 -0.913 . . . . 0.72 112.38 -177.413 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.407 HG21 ' CA ' ' A' ' 134' ' ' GLY . 43.2 mm -68.78 -41.0 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.788 -1.195 . . . . 0.85 110.236 -178.446 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -67.79 -31.57 71.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.213 -0.93 . . . . 2.44 108.651 179.731 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.8 -46.61 66.32 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.917 -1.273 . . . . 0.98 109.917 -179.761 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -60.29 -50.33 74.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.929 -1.336 . . . . 1.41 110.048 -179.292 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.89 -36.08 74.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.371 -0.831 . . . . 1.2 109.84 179.839 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.2 t -59.72 -42.39 92.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.955 -1.091 . . . . 1.7 108.518 -179.893 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.4 94.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -0.838 . . . . 1.47 109.024 179.249 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.5 mt -62.07 -41.22 97.93 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.407 -0.808 . . . . 1.56 109.617 -179.495 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.93 -31.91 67.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.069 -1.019 . . . . 2.2 109.657 -179.387 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -60.16 -26.22 66.14 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.212 -0.93 . . . . 2.12 108.947 179.684 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.402 HD13 HD13 ' A' ' 123' ' ' LEU . 31.6 mt -61.72 144.8 54.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.142 -0.974 . . . . 2.0 108.913 -179.56 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -98.36 51.59 1.01 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.027 -1.046 . . . . 3.23 109.538 179.668 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 61.7 t0 -134.27 132.83 40.09 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.445 -0.784 . . . . 2.49 109.321 179.89 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.404 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 83.9 tt0 -69.95 -31.94 69.94 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.475 -0.766 . . . . 3.95 109.865 -179.836 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.454 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.3 t80 -70.09 -36.88 75.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.535 -0.728 . . . . 2.0 111.075 -179.679 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.464 HD22 ' O ' ' B' ' 351' ' ' GLN . 79.7 mt -78.56 -37.81 41.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.047 -1.033 . . . . 1.86 109.701 -179.703 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -60.14 -48.99 79.39 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.109 -0.994 . . . . 2.84 109.957 179.849 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.76 -39.78 92.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.085 -1.009 . . . . 2.73 109.091 179.956 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.619 HH21 HD11 ' B' ' 347' ' ' LEU . 65.8 ttt180 -60.13 -40.04 88.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 2.77 108.711 179.824 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' VAL . . . -59.54 -47.93 83.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.932 -1.105 . . . . 1.19 108.543 179.496 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 127' ' ' ALA . . . -43.65 -39.12 3.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.669 -0.645 . . . . 1.2 109.299 179.89 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -66.11 -42.72 88.83 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.213 -0.93 . . . . 1.55 108.604 179.197 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 127' ' ' ALA . 55.4 t -69.9 -40.32 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.34 -0.85 . . . . 0.8 108.926 178.776 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -59.97 -39.13 84.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.378 -0.826 . . . . 3.09 109.033 179.25 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -59.98 -39.8 86.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.516 -0.74 . . . . 1.46 110.377 -179.559 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.8 mt -59.64 -41.25 84.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.907 -1.121 . . . . 0.71 108.98 -179.234 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.407 ' CA ' HG21 ' A' ' 108' ' ' ILE . . . -67.24 -37.65 91.19 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.931 -1.267 . . . . 0.57 109.931 179.516 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.63 -49.02 78.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.181 -1.188 . . . . 2.59 111.027 -178.872 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -66.62 -29.48 69.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.897 -1.127 . . . . 2.83 109.423 -179.445 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.8 tp -59.59 -41.76 90.99 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.72 -0.844 . . . . 1.25 108.72 -178.967 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.36 -39.9 94.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 0.7 108.55 179.226 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -68.75 -39.6 80.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.361 -0.837 . . . . 2.57 109.329 178.704 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -65.65 -34.46 78.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.452 -0.78 . . . . 1.23 110.84 -179.42 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 91.1 mt -70.44 -42.6 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 120.737 -1.227 . . . . 0.81 108.092 179.071 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.36 -33.74 71.8 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.118 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.24 43.63 5.55 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 108.129 -1.988 . . . . 0.89 108.129 -178.901 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.4 tp -75.15 150.84 38.63 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.644 -0.915 . . . . 1.14 110.263 -178.866 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.435 ' HD3' ' N ' ' A' ' 146' ' ' ILE . 9.6 tmtm? -69.61 149.31 48.28 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.722 -0.844 . . . . 4.6 108.722 179.464 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.435 ' N ' ' HD3' ' A' ' 145' ' ' LYS . 86.8 mt -119.81 125.14 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 121.933 0.873 . . . . 1.24 109.036 178.881 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.445 HG12 ' H ' ' A' ' 147' ' ' ILE . 6.3 mm -49.42 -54.76 5.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.624 -0.673 . . . . 1.54 109.762 -178.485 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.8 t0 69.39 104.23 0.06 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.547 -0.72 . . . . 1.5 110.59 -179.903 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.562 ' O ' HD12 ' A' ' 152' ' ' ILE . 95.9 mt -74.44 -7.18 52.11 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.524 -0.735 . . . . 0.79 109.977 179.84 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.0 t -81.45 -16.83 50.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.148 -0.97 . . . . 1.4 109.485 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.16 23.43 0.58 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.533 -0.729 . . . . 0.92 110.196 -178.543 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 149' ' ' LEU . 63.9 mt -92.2 115.24 30.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.133 -0.979 . . . . 0.88 109.738 -179.085 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -100.66 -15.24 17.81 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.251 -0.906 . . . . 2.45 109.63 -179.83 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -118.19 145.86 44.64 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.498 -0.556 . . . . 1.52 109.498 -178.988 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.08 136.48 57.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 1.58 109.346 -179.739 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 26.9 m -151.6 163.3 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 109.328 -0.619 . . . . 0.69 109.328 179.99 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 82.3 mt -91.78 146.71 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 106.177 -1.786 . . . . 0.61 106.177 177.266 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.2 tp -99.01 118.96 36.96 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.022 -1.049 . . . . 0.87 110.423 -178.194 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.5 t -123.31 129.98 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.489 -0.93 . . . . 0.71 108.489 179.727 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.0 159.37 40.28 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.136 -0.977 . . . . 0.81 108.551 -179.839 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.45 -33.43 64.9 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.23 -1.544 . . . . 0.98 107.932 178.523 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -168.3 136.87 2.29 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.329 -0.989 . . . . 2.25 108.329 179.959 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 62.9 mt -106.8 138.68 42.53 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.247 -0.908 . . . . 0.78 109.565 -179.496 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.9 p -94.05 153.56 40.77 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.47 -0.769 . . . . 0.98 109.02 -179.838 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.04 -34.84 9.61 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.635 1.557 . . . . 0.81 111.952 179.222 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.1 m -58.65 -40.25 82.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.9 110.305 -178.306 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -68.04 -42.58 80.33 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.282 -0.886 . . . . 1.61 110.716 -179.302 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.5 p -53.88 -31.74 50.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.047 -1.033 . . . . 0.61 110.546 -178.264 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . . . -72.52 -54.58 8.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.951 -1.093 . . . . 0.6 109.682 179.689 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -85.4 40.74 0.85 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.999 -1.112 . . . . 1.4 107.999 179.81 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.84 133.0 47.3 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.888 -0.782 . . . . 0.7 108.888 179.083 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -89.69 102.14 14.83 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.334 -0.987 . . . . 2.35 108.334 179.348 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.94 -44.78 88.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.461 -0.775 . . . . 1.51 110.908 -178.294 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -70.18 -22.61 62.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.868 -1.145 . . . . 2.33 111.88 -178.337 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -93.56 -10.37 34.98 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.55 -1.344 . . . . 1.92 110.274 -178.465 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 178' ' ' GLY . 94.3 t -106.76 117.22 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.232 -0.918 . . . . 0.67 109.274 179.568 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 51.4 mt -83.55 4.31 28.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.43 -0.794 . . . . 1.53 110.985 -177.817 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.557 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.72 172.12 36.71 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.561 -1.416 . . . . 0.48 109.561 -179.806 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.51 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 25.3 m-85 -132.56 129.15 38.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.508 -0.995 . . . . 0.55 108.75 179.901 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.0 mt -129.98 126.05 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.687 -1.227 . . . . 0.65 107.687 178.426 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.4 p -143.51 157.37 44.49 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.379 1.085 . . . . 0.82 111.397 -179.007 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 64.4 t0 -94.61 18.06 12.16 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.783 -0.644 . . . . 2.46 109.265 179.878 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -54.3 -164.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.529 -1.357 . . . . 1.28 111.701 -178.025 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.37 -42.39 5.53 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.607 -0.806 . . . . 2.19 111.306 -178.395 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 175.83 -149.77 10.26 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 118.429 -1.843 . . . . 2.13 111.242 -179.539 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.428 ' N ' ' CD ' ' A' ' 186' ' ' ARG . 0.2 OUTLIER -70.11 -18.3 63.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.813 -0.816 . . . . 5.86 110.558 -178.956 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 82.5 p -69.97 -1.82 10.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.02 -1.05 . . . . 3.72 110.003 -179.177 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.3 m -84.92 130.72 34.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 1.74 110.419 -179.157 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -44.93 -55.38 5.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.524 -0.735 . . . . 0.95 110.224 -179.748 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 191' ' ' SER . 8.8 t -58.07 -39.67 79.1 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.411 -0.806 . . . . 1.55 110.721 -178.992 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.427 ' N ' HG23 ' A' ' 190' ' ' THR . 23.3 t -61.55 -40.53 95.03 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.953 -1.092 . . . . 1.51 110.797 -179.298 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.88 -40.01 81.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.235 -0.915 . . . . 1.67 109.614 -179.521 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.2 -40.22 89.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.856 . . . . 1.02 110.197 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.53 88.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.455 -1.403 . . . . 0.68 109.12 -179.735 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -59.92 -50.18 74.77 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.073 -1.051 . . . . 2.93 109.396 -179.297 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 37.1 m -70.41 -35.42 73.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.158 -0.964 . . . . 0.86 110.98 -178.989 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 74.1 mt -70.27 -24.74 63.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.922 -1.111 . . . . 0.67 109.185 179.996 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 66.45 49.89 1.34 Allowed 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.273 0.559 . . . . 1.5 110.828 -179.323 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 199' ' ' LEU . . . . . 0.4 ' O ' ' CB ' ' A' ' 8' ' ' SER . 78.6 mt -127.23 149.71 70.37 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 107.504 -1.295 . . . . 0.72 107.504 178.18 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.97 139.12 71.91 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.17 1.914 . . . . 0.61 112.091 -179.7 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.51 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -170.17 147.23 3.12 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.955 -1.091 . . . . 0.66 110.995 -179.749 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 90.5 mt -120.04 139.1 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 106.842 -1.54 . . . . 0.79 106.842 178.223 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.05 -12.22 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 120.602 -1.311 . . . . 0.91 111.427 -178.238 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.74 26.13 16.92 Favored Glycine 0 N--CA 1.502 3.052 0 N-CA-C 110.898 -0.881 . . . . 1.01 110.898 -179.121 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.8 p -44.25 -38.36 3.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.972 -1.311 . . . . 0.99 110.573 -179.179 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.455 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 88.09 -50.47 3.9 Favored Glycine 0 N--CA 1.502 3.064 0 C-N-CA 120.201 -1.0 . . . . 1.12 111.302 179.337 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.2 m -162.67 41.48 0.12 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.491 -1.594 . . . . 1.72 111.157 -179.381 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.5 t -80.24 -37.81 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.988 -1.07 . . . . 0.89 109.085 178.42 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.5 p -58.92 -33.09 70.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.571 -0.706 . . . . 1.03 110.048 -178.862 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.1 m -76.59 -18.42 58.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.332 -0.855 . . . . 1.83 110.157 -178.977 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -102.84 -9.66 19.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.324 -0.86 . . . . 2.27 110.241 -179.144 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 55.2 t -102.01 140.32 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.003 -1.061 . . . . 0.92 110.545 -179.122 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -109.29 150.07 28.52 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.704 -1.221 . . . . 2.2 107.704 178.988 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 19.2 p30 -60.61 138.89 58.0 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.86 -1.15 . . . . 2.36 109.947 -179.52 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.481 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.5 t0 81.17 9.61 0.98 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.303 0.573 . . . . 2.38 109.615 179.466 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.2 t0 -79.06 141.78 37.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.377 -0.827 . . . . 2.09 108.936 179.11 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.519 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 47.3 t80 -88.0 121.75 30.78 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.152 -0.967 . . . . 1.27 108.873 -179.992 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' A' ' 16' ' ' ALA . 85.9 mt -130.01 150.19 51.4 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.37 -0.832 . . . . 0.75 110.886 -179.021 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.49 HG23 ' CD2' ' A' ' 13' ' ' PHE . 73.1 mt -117.4 128.73 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.379 -1.711 . . . . 0.63 106.379 176.951 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 44.1 tp -101.05 116.65 33.35 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.977 -1.077 . . . . 0.7 109.438 -178.731 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.511 ' C ' ' H ' ' A' ' 223' ' ' VAL . 85.9 m-20 -74.45 -44.8 50.02 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.447 -0.946 . . . . 2.31 108.447 179.092 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 50.92 11.41 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.808 -0.812 . . . . 0.78 108.808 -179.656 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 221' ' ' ASP . 54.7 t -126.95 -43.11 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 106.859 -1.534 . . . . 1.04 106.859 178.702 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -100.42 -0.01 38.94 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.728 -1.212 . . . . 2.44 107.728 178.611 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.417 ' CG ' ' H ' ' A' ' 4' ' ' GLY . 6.1 t-20 60.56 42.0 14.74 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.3 -0.63 . . . . 1.55 109.3 -179.442 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -138.14 142.9 40.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.287 -0.883 . . . . 1.99 109.238 179.735 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 80.3 t -118.57 120.87 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 108.925 -0.769 . . . . 0.77 108.925 179.57 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -88.69 128.94 35.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.153 -0.967 . . . . 0.98 109.351 -179.438 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.45 114.06 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.735 -0.603 . . . . 0.85 110.244 -179.111 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 45.4 t30 50.97 63.75 9.3 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.33 -0.856 . . . . 1.66 111.509 179.064 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -85.83 148.39 9.58 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.38 2.053 . . . . 0.95 112.103 178.958 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 233' ' ' ASN . 39.5 m -67.98 158.17 33.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.288 -0.883 . . . . 1.84 110.077 -179.473 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 47.7 p-10 -59.97 -37.9 80.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.312 -0.867 . . . . 2.74 110.679 -178.991 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 234' ' ' GLU . . . . . 0.544 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 99.0 mt-10 -59.82 -37.03 78.04 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.791 -1.193 . . . . 2.89 107.859 -179.998 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.9 t -70.04 -39.9 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.546 -0.721 . . . . 1.3 109.45 179.095 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.1 mt -64.77 -39.92 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.109 -0.994 . . . . 1.09 108.966 179.533 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -59.99 -40.12 88.05 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.159 -0.963 . . . . 2.43 108.67 -179.882 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -67.4 -40.21 85.61 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.481 -0.933 . . . . 2.78 108.481 179.22 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 89.5 mtp -70.01 -32.58 70.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.356 -0.84 . . . . 1.25 109.796 178.908 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -67.07 -39.92 86.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -0.945 . . . . 2.63 109.209 179.095 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.03 87.28 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.391 -0.966 . . . . 1.8 108.391 179.732 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.32 -39.17 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.549 -0.72 . . . . 2.13 109.146 179.12 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -57.83 -40.05 79.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.056 . . . . 3.17 109.306 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.31 -40.02 89.06 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.296 -0.877 . . . . 1.78 109.789 -179.782 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -67.07 -40.05 86.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.99 -1.069 . . . . 2.47 108.607 179.516 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.73 -40.24 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.803 -0.814 . . . . 2.09 108.803 179.743 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 247' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 251' ' ' ALA . . . -63.77 -34.97 79.1 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.294 -0.879 . . . . 2.54 109.395 179.993 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 252' ' ' GLU . 35.8 t -61.24 -49.04 78.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.275 -0.891 . . . . 2.99 110.254 -179.395 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -70.19 -28.96 65.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.102 -0.999 . . . . 3.34 110.048 -179.275 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -95.61 28.5 2.97 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.449 -0.945 . . . . 3.88 108.449 179.567 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 247' ' ' ALA . . . -167.09 -49.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.083 -1.011 . . . . 4.43 111.032 179.943 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 248' ' ' SER . 95.5 mt-10 -140.56 105.75 5.02 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.122 -0.986 . . . . 5.42 108.918 -179.696 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' A' ' 254' ' ' ALA . 86.5 mt -62.41 -17.72 59.92 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.992 -1.484 . . . . 6.1 106.992 178.251 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 253' ' ' LEU . . . 64.53 26.12 13.31 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.677 -0.692 . . . . 7.37 109.759 -179.771 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 96.7 mttt 57.5 20.7 6.33 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.693 -0.629 . . . . 8.01 109.842 179.473 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 8.1 tp 52.55 42.49 31.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 9.05 109.306 179.838 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 259' ' ' ARG . 58.9 tttp -52.72 -60.16 3.6 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.269 -0.973 . . . . 10.56 108.657 -179.746 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.545 ' C ' ' O ' ' A' ' 257' ' ' LYS . 94.8 m-20 -7.71 75.41 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.65 0 CA-C-O 121.606 0.717 . . . . 11.32 111.768 179.36 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.547 ' N ' ' O ' ' A' ' 257' ' ' LYS . 86.6 mtm180 . . . . . 0 C--N 1.3 -1.56 0 CA-C-O 117.97 -1.014 . . . . 12.42 109.534 -179.868 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 301' ' ' MET . . . . . 0.405 ' HG2' ' N ' ' B' ' 302' ' ' PHE . 57.1 ttm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 302' ' ' PHE . . . . . 0.405 ' N ' ' HG2' ' B' ' 301' ' ' MET . 41.4 t80 -149.05 147.71 28.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -0.922 . . . . 0.0 108.962 179.501 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -150.86 160.06 44.14 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.98 -1.075 . . . . 0.0 111.124 -178.366 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -154.66 152.48 30.02 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.566 -0.708 . . . . 0.0 109.199 178.861 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 305' ' ' GLU . . . . . 0.428 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 58.1 mp0 -113.89 131.01 56.44 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.311 -0.868 . . . . 0.0 110.266 179.842 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.0 p -131.95 126.78 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 CA-C-O 122.522 1.153 . . . . 0.0 112.995 -177.899 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 32.2 m -79.27 102.43 8.58 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 122.023 0.916 . . . . 0.0 110.772 -178.724 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.5 mt -51.37 125.0 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 122.552 1.168 . . . . 0.0 110.853 -177.878 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 33.2 p -109.73 20.09 18.45 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.602 -179.249 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.434 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -67.47 149.11 98.52 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.11 -0.994 . . . . 0.0 108.582 179.366 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 311' ' ' PRO . . . . . 0.449 ' CD ' ' O ' ' B' ' 385' ' ' GLU . 28.9 Cg_endo -72.28 -30.38 12.99 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.112 1.208 . . . . 0.0 113.138 -179.622 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 54.4 m-20 -120.26 23.16 11.07 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.778 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.59 -177.58 52.74 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.266 -1.933 . . . . 0.0 108.266 -179.028 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.454 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -84.38 93.32 8.24 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.96 -1.317 . . . . 0.0 109.484 -179.013 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -98.01 -159.52 0.74 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.044 -1.035 . . . . 0.0 109.536 178.971 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.5 m -60.06 -49.97 75.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.559 -1.338 . . . . 0.0 112.16 -176.459 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.566 HH11 ' CB ' ' A' ' 71' ' ' ALA . 11.9 tpt180 -47.35 -60.31 4.24 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.653 -1.279 . . . . 0.0 111.133 -179.104 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -61.56 -31.35 87.2 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 CA-C-N 120.559 1.235 . . . . 0.0 111.02 179.022 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.02 -53.79 53.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.399 -0.813 . . . . 0.0 109.485 -179.737 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.86 -42.67 62.8 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.074 -178.951 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.79 -39.94 76.29 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.024 -1.047 . . . . 0.0 108.784 179.243 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -65.71 -55.75 15.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 109.936 -179.485 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 323' ' ' VAL . . . . . 0.458 ' CG1' ' NZ ' ' B' ' 327' ' ' LYS . 41.3 t -64.13 -30.95 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.585 -1.322 . . . . 0.0 110.278 -178.704 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -60.44 -46.29 90.57 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.994 -1.066 . . . . 0.0 109.763 179.9 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -61.89 -44.35 96.97 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.326 -0.859 . . . . 0.0 111.072 -178.569 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -66.03 -52.17 51.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.988 -1.07 . . . . 0.0 111.691 -178.412 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 327' ' ' LYS . . . . . 0.458 ' NZ ' ' CG1' ' B' ' 323' ' ' VAL . 32.2 mttp -49.29 -18.07 0.32 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.007 -1.058 . . . . 0.0 110.744 -178.789 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -80.13 -16.57 76.31 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 178.882 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -104.02 136.72 43.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.693 -0.886 . . . . 0.0 109.532 179.825 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 76.8 p -91.49 -13.42 32.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.398 -0.814 . . . . 0.0 109.939 179.727 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.589 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 69.3 m -60.94 150.25 33.89 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.268 -0.895 . . . . 0.0 109.848 -179.982 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -69.33 136.21 51.48 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.682 179.389 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 80.7 mt -133.63 132.43 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.315 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 81.5 m -130.34 151.15 51.15 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.296 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 67.3 t -115.73 142.07 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.535 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 50.5 m -130.84 122.86 27.84 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.264 -0.897 . . . . 0.0 109.662 179.37 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 337' ' ' SER . . . . . 0.4 ' O ' ' OD1' ' B' ' 338' ' ' ASN . 2.6 t -137.16 118.63 14.78 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.031 0.919 . . . . 0.0 109.698 179.536 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 338' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' B' ' 338' ' ' ASN . 8.2 p-10 38.0 62.97 0.87 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.079 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 77.25 -14.18 8.91 Favored Glycine 0 N--CA 1.503 3.143 0 O-C-N 120.83 -1.169 . . . . 0.0 113.521 175.873 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -110.29 121.72 45.96 Favored 'General case' 0 N--CA 1.507 2.376 0 CA-C-N 119.056 1.428 . . . . 0.0 110.277 -179.733 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 83.3 p -109.06 157.65 18.5 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.774 0.797 . . . . 0.0 110.924 -179.082 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -152.54 151.93 31.27 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.821 -0.549 . . . . 0.0 109.925 179.58 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 16.1 m -87.64 136.21 33.04 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.303 -0.873 . . . . 0.0 109.61 -179.96 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -76.91 -14.67 59.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.951 -1.093 . . . . 0.0 110.095 -179.445 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -88.77 20.79 3.31 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 178.441 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 346' ' ' SER . . . . . 0.412 ' H ' ' C ' ' B' ' 344' ' ' ALA . 74.0 m -147.36 91.4 1.97 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.727 179.797 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.665 HD23 HD22 ' A' ' 79' ' ' LEU . 57.8 tp -57.04 -35.28 69.12 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.584 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.874 ' CE2' HD11 ' A' ' 79' ' ' LEU . 70.8 m-85 -56.18 -53.95 51.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.922 . . . . 0.0 109.88 179.787 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -70.17 -21.31 63.07 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.577 -0.702 . . . . 0.0 111.045 -177.64 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' B' ' 352' ' ' THR . 77.9 mt -67.48 -50.82 57.31 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 118.314 -1.354 . . . . 0.0 108.648 178.526 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.464 ' O ' HD22 ' A' ' 123' ' ' LEU . 17.5 mt-30 -46.07 -12.83 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.424 -0.798 . . . . 0.0 111.47 -177.741 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.487 ' N ' ' O ' ' B' ' 350' ' ' LEU . 67.3 p -85.73 -16.51 38.71 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 119.912 -1.743 . . . . 0.0 111.466 -178.509 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 29.4 mt -92.05 122.23 34.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.737 -1.227 . . . . 0.0 108.834 178.707 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.99 92.52 0.93 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 179.423 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 16.7 mt -101.26 93.72 5.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.417 -1.049 . . . . 0.0 108.755 179.949 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 71.0 p -92.79 177.05 6.21 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.939 -1.101 . . . . 0.0 111.316 -178.844 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 357' ' ' GLN . . . . . 0.409 ' CD ' ' O ' ' B' ' 310' ' ' ALA . 7.5 tt0 -65.49 113.23 4.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.81 -0.556 . . . . 0.0 110.787 -179.703 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 358' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 99.18 9.63 50.9 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.419 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 24.0 m -85.88 113.1 21.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.335 -1.097 . . . . 0.0 110.313 -179.79 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 11.0 t -78.07 114.45 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 122.307 1.051 . . . . 0.0 109.961 -177.073 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 14.0 m -110.49 177.16 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.91 -177.856 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 40.8 m -130.98 126.89 37.21 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.232 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 83.7 mt -103.63 118.03 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.487 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 49.0 m -122.93 133.65 54.38 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.552 -0.717 . . . . 0.0 109.249 -178.88 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.49 151.61 38.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.095 -1.003 . . . . 0.0 110.496 -178.738 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -140.64 120.72 13.73 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.414 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.412 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 164.08 -164.55 36.62 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 118.57 -1.776 . . . . 0.0 111.778 179.455 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -56.53 -50.03 73.02 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.939 -0.631 . . . . 0.0 111.743 -177.889 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.589 ' N ' ' OG ' ' B' ' 331' ' ' SER . 99.6 m-20 -109.87 11.8 24.11 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.033 -1.042 . . . . 0.0 111.574 -177.857 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 11.8 pt-20 -42.23 -31.96 0.44 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.946 -1.096 . . . . 0.0 111.212 -178.877 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -70.06 -43.04 72.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.816 -1.178 . . . . 0.0 110.347 -178.81 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -67.7 -47.97 67.89 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.78 -1.2 . . . . 0.0 108.666 -179.905 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.44 -77.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 110.113 -179.914 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.582 ' O ' HG23 ' B' ' 378' ' ' VAL . 51.2 t -45.18 -38.79 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.213 -0.93 . . . . 0.0 109.751 -178.19 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -67.63 -42.44 82.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.65 -1.281 . . . . 0.0 110.099 179.221 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -82.18 -45.41 15.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.121 -0.987 . . . . 0.0 110.481 -179.83 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 97.8 mt -59.91 -36.51 77.15 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.11 -0.994 . . . . 0.0 109.303 -179.054 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.582 HG23 ' O ' ' B' ' 374' ' ' VAL . 53.5 t -69.95 -39.58 77.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 121.524 -0.735 . . . . 0.0 109.907 -179.989 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -79.18 -22.47 44.93 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.009 -1.057 . . . . 0.0 110.859 179.945 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 55.9 tp -82.25 -20.8 36.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.204 -1.56 . . . . 0.0 108.697 178.561 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.0 ttm -81.1 -30.75 34.56 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.161 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -84.34 -9.63 58.29 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.637 -0.665 . . . . 0.0 109.521 178.59 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -106.32 -2.01 22.76 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.316 -0.865 . . . . 0.0 110.919 -179.188 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 22.1 mt -91.53 124.9 36.05 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.949 -1.095 . . . . 0.0 110.636 -179.338 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' B' B ' 385' ' ' GLU . . . . . 0.449 ' O ' ' CD ' ' B' ' 311' ' ' PRO . 19.1 pt-20 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 118.017 -0.992 . . . . 0.0 108.755 178.675 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.519 -0.549 . . . . 2.91 109.519 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.9 mt -110.04 127.65 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.479 -0.934 . . . . 1.2 108.479 179.553 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.3 m -128.57 126.43 40.3 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.551 -0.718 . . . . 1.4 109.512 -179.343 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.79 -161.97 34.65 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.311 -1.516 . . . . 1.05 109.311 179.6 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.5 mt -88.75 -14.42 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -1.195 . . . . 1.15 110.316 -179.367 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.6 tp 52.67 100.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.07 -1.019 . . . . 0.98 109.07 -179.794 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.09 -28.33 12.76 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.113 -0.992 . . . . 0.88 109.267 179.388 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.9 m -132.08 115.31 15.27 Favored Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 109.111 -0.7 . . . . 1.69 109.111 -179.659 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.38 147.98 18.35 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.018 1.812 . . . . 0.85 112.964 -179.685 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.862 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.33 -156.04 26.59 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.606 -1.797 . . . . 0.92 108.606 -179.51 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.4 mt -149.0 151.06 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 120.904 -1.351 . . . . 0.81 108.866 178.68 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.58 156.62 36.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.048 -1.033 . . . . 0.51 110.241 179.397 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.2 m-85 -137.87 127.37 24.94 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.762 -1.199 . . . . 0.62 107.762 179.1 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.98 178.86 48.74 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 118.591 -1.766 . . . . 0.55 110.913 179.947 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -78.39 156.42 29.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.979 -0.719 . . . . 2.1 109.898 -179.525 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.54 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -100.32 129.98 46.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.43 -0.794 . . . . 0.77 110.844 -179.11 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.2 tp -105.98 134.59 48.86 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.469 -1.308 . . . . 0.91 107.469 178.286 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.9 tp -115.77 123.81 49.18 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.381 -0.824 . . . . 0.93 110.091 -179.419 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 160' ' ' ALA . 25.5 mt -81.96 100.57 9.75 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 120.035 -0.666 . . . . 0.93 109.421 179.92 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -94.55 138.26 32.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.259 -0.901 . . . . 2.75 109.706 -179.667 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 58.0 mp0 -130.37 136.79 49.45 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.478 -0.764 . . . . 3.0 109.136 179.206 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -84.31 147.32 27.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 2.77 109.494 179.664 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.89 145.51 55.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.9 . . . . 2.94 109.671 -179.811 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.2 mt -98.41 132.73 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.396 -0.815 . . . . 0.95 109.372 179.888 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.6 t -106.81 128.25 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.427 -0.796 . . . . 1.28 109.84 -179.475 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.1 mt -98.36 142.42 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.494 -0.754 . . . . 1.21 109.134 179.976 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -83.6 123.77 30.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.985 -1.072 . . . . 1.81 109.056 179.834 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -93.47 -6.91 45.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.249 -0.907 . . . . 2.8 109.479 -179.64 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.71 138.55 52.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 2.87 109.594 -179.727 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -83.75 155.31 23.13 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.202 -1.036 . . . . 2.35 108.202 179.136 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.689 HD13 ' HG3' ' A' ' 39' ' ' GLU . 3.1 pt -99.04 165.66 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.071 -1.018 . . . . 0.97 109.936 -179.947 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.4 p -91.76 173.55 7.81 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.603 -0.888 . . . . 1.17 108.603 178.712 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.62 -15.47 63.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.134 -0.979 . . . . 1.18 110.696 -179.479 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 60.0 t0 -83.69 -30.67 26.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.822 -1.173 . . . . 2.56 108.842 179.47 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -82.65 -6.84 59.59 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.42 -0.585 . . . . 1.79 109.42 179.992 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 t -60.01 -51.81 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.182 -0.949 . . . . 1.0 109.254 179.949 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -60.14 -39.84 87.73 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.231 -0.918 . . . . 1.77 108.78 179.832 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -63.68 -40.23 96.3 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.308 -0.87 . . . . 2.7 110.133 -179.723 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.689 ' HG3' HD13 ' A' ' 31' ' ' ILE . 71.0 mm-40 -64.39 -41.55 96.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.847 -1.158 . . . . 1.51 110.28 -179.778 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.8 t -59.99 -45.7 95.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 120.671 -1.268 . . . . 0.93 108.085 179.996 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -59.89 -42.43 93.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.368 -0.833 . . . . 1.81 108.934 -179.78 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.433 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 96.6 mtt180 -60.04 -47.56 85.35 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.846 -1.168 . . . . 2.78 107.846 178.49 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -60.02 -45.22 93.51 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.202 -0.666 . . . . 0.78 109.202 178.897 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.92 -50.07 75.19 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.311 -0.996 . . . . 1.07 108.311 179.661 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -60.45 -42.71 96.7 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.277 -0.889 . . . . 1.12 108.997 179.081 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.18 -47.71 89.6 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.549 -1.421 . . . . 0.84 109.549 179.99 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -69.73 -31.66 69.78 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.284 -1.127 . . . . 3.09 108.402 179.337 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.65 89.71 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.566 -0.709 . . . . 0.88 109.12 -179.988 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.4 ttpt -67.25 -73.77 0.13 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.196 -0.94 . . . . 2.59 108.787 179.333 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.29 -41.81 0.65 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.325 -0.86 . . . . 0.7 111.265 -178.356 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.8 m -52.2 -57.87 8.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.587 -1.321 . . . . 1.4 109.106 179.873 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.64 -40.97 84.57 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.218 -0.926 . . . . 0.67 110.836 -179.267 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -68.14 -40.33 82.47 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.982 -1.074 . . . . 1.66 109.763 -179.693 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.6 mt -61.66 -40.19 94.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.892 -1.13 . . . . 1.58 109.092 179.108 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -64.37 -35.54 81.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 1.35 109.152 179.487 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -62.04 -41.85 98.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.27 -0.894 . . . . 0.77 109.161 179.536 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.533 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.5 mt -64.17 -39.84 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.432 -0.792 . . . . 0.63 109.43 179.622 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -54.35 -51.17 65.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.864 . . . . 1.14 109.826 -178.96 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.3 m -59.94 -37.27 79.04 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.238 -0.914 . . . . 0.79 110.837 -178.317 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -64.14 -39.77 94.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.892 -1.13 . . . . 1.53 109.479 -179.559 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.426 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -66.52 -42.99 86.46 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.762 -0.586 . . . . 0.57 110.125 -179.392 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.38 -51.08 60.98 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.161 -1.176 . . . . 0.75 110.161 -179.174 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.0 -44.81 68.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.114 -1.227 . . . . 1.59 110.043 -179.855 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.0 m -69.91 -59.13 3.12 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 0.73 111.768 -178.248 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -97.3 -54.4 3.16 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.021 -1.049 . . . . 0.75 111.357 -178.056 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.83 -163.41 26.95 Favored Glycine 0 N--CA 1.501 3.006 0 C-N-CA 119.697 -1.239 . . . . 1.22 111.156 179.676 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.25 -23.96 62.99 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.912 -0.758 . . . . 5.81 110.841 -179.385 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -62.03 -39.6 92.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.959 -1.088 . . . . 3.37 110.361 -179.545 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -96.29 -18.85 19.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.228 -0.92 . . . . 1.77 110.434 -179.258 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -72.14 -40.77 67.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.043 -1.036 . . . . 1.65 110.466 -179.118 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.601 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.63 -30.89 70.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 0.77 109.984 -178.953 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.1 -40.27 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 118.82 -1.152 . . . . 0.8 108.822 -179.588 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -64.76 -40.07 94.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.047 -1.033 . . . . 0.88 109.885 -179.899 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -60.38 -40.89 92.49 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.89 -1.131 . . . . 1.37 109.863 179.519 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.9 -40.81 99.73 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.881 -1.688 . . . . 0.62 108.881 179.535 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.7 m170 -70.01 -40.06 75.47 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.396 -1.061 . . . . 1.5 109.208 179.767 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.9 mt -70.9 -46.47 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.383 -0.823 . . . . 0.63 109.986 179.828 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.7 ttp -60.35 -43.65 96.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 1.51 110.563 -178.452 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.687 HD11 ' CE2' ' B' ' 348' ' ' PHE . 44.8 tp -64.77 -39.44 93.61 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.293 -0.879 . . . . 0.77 109.938 -179.947 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.7 tp -63.81 -40.1 95.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.437 -0.79 . . . . 0.62 109.789 -179.72 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -78.87 4.07 15.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 1.47 110.099 -178.795 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 63.5 t0 -52.32 129.87 29.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.167 -0.958 . . . . 1.47 110.38 -179.37 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.423 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.8 mt-10 -60.16 -15.19 21.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.566 -0.709 . . . . 1.78 110.124 -179.982 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.02 -37.03 75.51 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.156 -0.965 . . . . 2.53 108.517 178.578 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.1 mt -69.98 -40.09 75.56 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.37 0.605 . . . . 0.8 109.876 179.426 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.07 -50.05 75.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.46 -0.775 . . . . 1.42 110.265 -178.975 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -74.36 -40.62 62.02 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.393 -0.817 . . . . 1.71 111.224 -178.801 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.92 -41.03 75.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.013 -1.054 . . . . 1.57 111.487 -178.675 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.9 mt -70.15 -46.12 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.857 -1.152 . . . . 0.65 109.445 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.8 mt -65.72 -37.45 79.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.625 -0.672 . . . . 0.82 110.121 -179.841 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.07 90.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.048 -1.033 . . . . 0.79 110.507 -178.829 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.3 mt -62.21 -45.49 93.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.947 -1.095 . . . . 0.95 109.579 -179.781 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.1 mt -62.05 -50.0 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.66 109.596 -179.907 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -71.21 -42.18 69.26 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.681 -0.808 . . . . 2.2 111.385 179.826 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -83.25 -50.42 8.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.952 -1.092 . . . . 1.65 112.197 -177.648 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -90.19 -2.61 58.07 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.871 -1.143 . . . . 2.03 111.474 -177.497 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 56.19 39.02 30.39 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.797 -1.189 . . . . 1.42 109.521 -179.413 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 54.7 mtt -92.04 169.33 10.73 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.44 -0.788 . . . . 1.18 109.652 -179.723 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.9 p -83.82 159.65 21.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.942 . . . . 0.98 108.956 179.514 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.76 -36.8 78.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 0.64 109.801 -179.635 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.433 ' OD1' HG21 ' A' ' 141' ' ' ILE . 95.7 m-20 -68.66 -39.68 80.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -0.97 . . . . 2.07 110.203 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.59 -44.89 18.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.026 -1.046 . . . . 0.73 109.61 179.855 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.75 -50.25 67.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.449 -0.782 . . . . 0.54 110.211 -179.487 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.23 -37.3 79.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.074 -1.017 . . . . 0.56 109.445 179.917 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -59.91 -42.65 94.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.476 -0.765 . . . . 1.54 110.266 -179.013 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 110' ' ' GLY . 88.9 tt0 -64.9 -40.2 94.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.007 -1.058 . . . . 1.33 109.983 -179.634 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 70.1 t -61.74 -53.22 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.21 -0.931 . . . . 0.72 110.53 -178.509 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.1 mm -69.99 -39.98 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.136 -0.978 . . . . 0.85 109.197 179.857 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -68.95 -36.75 78.28 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.486 -0.931 . . . . 2.44 108.486 179.015 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.45 -49.82 72.87 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.061 -1.215 . . . . 0.98 110.061 -179.573 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -68.73 -48.53 63.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.749 -1.442 . . . . 1.41 109.41 -179.874 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.87 92.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 1.2 109.382 179.902 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.5 t -57.43 -39.34 76.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 1.7 109.025 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.04 94.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.313 -0.867 . . . . 1.47 109.393 179.437 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.3 mt -64.26 -42.47 96.45 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.153 -0.967 . . . . 1.56 109.827 -179.06 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.424 ' C ' ' N ' ' A' ' 118' ' ' LEU . 78.6 tt0 -59.87 -38.66 82.79 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.661 -1.274 . . . . 2.2 109.522 -178.659 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -50.08 -17.69 0.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.902 -1.124 . . . . 2.12 109.147 179.671 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.424 ' N ' ' C ' ' A' ' 116' ' ' GLU . 79.4 mt -63.36 146.77 52.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 2.0 108.542 179.585 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -95.83 10.81 35.86 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.086 -1.009 . . . . 3.23 111.439 -178.459 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 57.2 t0 -103.07 148.76 25.32 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.953 -1.092 . . . . 2.49 109.583 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 36.4 tt0 -72.04 -65.75 0.73 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.417 -0.957 . . . . 3.95 108.417 179.096 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.481 ' OH ' ' CZ ' ' A' ' 126' ' ' ARG . 11.2 t80 -39.19 -40.26 0.71 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.783 -0.573 . . . . 2.0 110.442 -179.127 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.537 HD22 ' O ' ' B' ' 351' ' ' GLN . 95.1 mt -70.31 -39.57 74.74 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.86 -1.15 . . . . 1.86 108.95 178.897 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 121' ' ' GLU . 64.4 tttp -60.03 -40.0 87.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.389 -0.819 . . . . 2.84 109.586 -179.882 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -60.02 -39.43 85.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.859 . . . . 2.73 108.828 179.953 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.643 ' NE ' HE22 ' B' ' 351' ' ' GLN . 8.3 mtt180 -59.86 -39.79 86.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.17 -0.956 . . . . 2.77 108.793 179.314 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.38 -25.57 64.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 1.19 108.82 179.313 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.02 -40.03 75.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 1.2 109.39 179.378 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -66.74 -43.08 85.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.985 . . . . 1.55 109.838 179.925 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.5 t -69.9 -40.46 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.977 -1.077 . . . . 0.8 108.616 179.464 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -65.45 -35.67 81.61 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.501 -0.75 . . . . 3.09 109.443 179.51 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -59.97 -40.1 87.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 1.46 109.653 -179.747 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.36 -43.01 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.024 . . . . 0.71 109.187 179.805 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.8 -40.01 98.24 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.735 -1.346 . . . . 0.57 109.735 179.73 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -60.14 -49.96 75.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.397 -1.061 . . . . 2.59 109.705 -179.122 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.533 HH22 ' CD1' ' A' ' 57' ' ' ILE . 58.6 mtp180 -67.03 -32.61 73.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.125 -0.984 . . . . 2.83 110.255 -179.147 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 64.8 tp -60.04 -41.22 91.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.064 -1.023 . . . . 1.25 108.445 -179.539 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 94.5 mt -60.5 -39.99 89.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.367 -0.833 . . . . 0.7 109.265 179.323 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -69.16 -39.93 78.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.267 -0.895 . . . . 2.57 109.036 179.712 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -62.2 -39.97 94.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.606 -0.684 . . . . 1.23 111.343 -179.024 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.433 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.5 mt -73.74 -45.44 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 120.429 -1.419 . . . . 0.81 109.399 179.891 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.6 mt -69.97 -31.53 69.28 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.65 -0.656 . . . . 1.0 110.084 -179.273 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.38 36.58 10.61 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.45 -1.46 . . . . 0.89 109.45 -179.565 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.85 141.07 47.96 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.21 -1.171 . . . . 1.14 108.779 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -60.68 140.05 57.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.31 -0.869 . . . . 4.6 109.477 -179.433 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.6 mt -108.07 128.88 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 108.835 -0.802 . . . . 1.24 108.835 179.668 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 27.4 mm -58.04 -50.02 79.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.724 -0.61 . . . . 1.54 110.801 -177.432 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 33.9 t0 65.89 102.72 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.883 -0.784 . . . . 1.5 108.883 -178.857 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.531 ' O ' HD12 ' A' ' 152' ' ' ILE . 59.5 mt -73.07 -3.72 28.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.483 -0.761 . . . . 0.79 110.034 -179.207 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.9 t -83.11 -13.7 55.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.012 -1.055 . . . . 1.4 109.066 179.22 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.72 24.61 0.47 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.564 -0.71 . . . . 0.92 109.947 -178.695 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.531 HD12 ' O ' ' A' ' 149' ' ' LEU . 63.7 mt -91.42 122.07 42.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.328 -0.858 . . . . 0.88 108.74 -179.423 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -110.33 -9.22 14.64 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.461 -0.775 . . . . 2.45 110.455 -179.008 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -126.43 151.33 47.86 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.276 -0.89 . . . . 1.52 110.488 -178.583 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.01 133.55 51.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 1.58 108.621 179.224 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 19.9 m -153.24 165.93 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.438 -0.789 . . . . 0.69 109.542 179.64 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.0 mt -94.2 149.1 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 105.896 -1.89 . . . . 0.61 105.896 176.749 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.9 tp -98.39 117.19 32.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.939 -1.1 . . . . 0.87 110.893 -177.486 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.3 t -121.44 127.81 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 108.804 -0.813 . . . . 0.71 108.804 179.495 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.438 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -157.84 160.68 37.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.084 -1.01 . . . . 0.81 108.688 -179.979 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.04 -33.3 71.79 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.116 -1.615 . . . . 0.98 108.449 178.801 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -160.27 171.46 19.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.456 -0.777 . . . . 2.25 108.931 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.6 mt -141.69 133.92 27.87 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.875 -1.141 . . . . 0.78 109.168 179.74 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 66.7 p -100.46 149.67 36.29 Favored Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 121.173 -0.955 . . . . 0.98 110.262 -179.65 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -43.04 -38.47 7.26 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.561 2.174 . . . . 0.81 113.466 179.203 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.1 m -59.84 -40.04 87.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.974 -1.079 . . . . 0.9 109.801 -178.084 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.92 -40.83 83.31 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.151 -0.968 . . . . 1.61 110.421 -179.746 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.2 p -58.03 -30.77 66.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.112 -0.993 . . . . 0.61 111.092 -178.218 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -72.15 -46.72 55.36 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.699 -1.25 . . . . 0.6 110.03 179.935 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -90.25 37.28 0.89 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.31 -0.996 . . . . 1.4 108.31 -179.88 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.5 tp -107.76 132.54 53.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.616 -0.678 . . . . 0.7 109.616 179.777 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -86.51 103.64 15.22 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.318 -0.864 . . . . 2.35 108.725 178.992 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 59.0 mt -64.09 -41.59 97.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 1.51 110.363 -179.294 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -66.03 -26.05 67.34 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.841 -1.162 . . . . 2.33 112.01 -177.591 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -92.41 -8.08 45.82 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.655 -1.278 . . . . 1.92 109.976 -178.656 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 178' ' ' GLY . 80.1 t -107.69 118.48 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.337 -0.852 . . . . 0.67 109.108 179.031 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.5 mt -85.41 4.06 37.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.345 -0.847 . . . . 1.53 111.114 -178.026 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.552 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 169.66 173.03 36.83 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.342 -1.408 . . . . 0.48 109.748 179.877 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -131.52 127.55 37.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.456 -1.026 . . . . 0.55 109.027 179.812 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 77.4 mt -129.04 123.22 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.616 -0.883 . . . . 0.65 108.616 179.059 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 63.7 p -145.49 158.32 43.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.139 -0.976 . . . . 0.82 111.109 -179.436 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -103.68 25.89 9.22 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.779 -0.823 . . . . 2.46 108.779 179.724 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.13 -159.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.006 -1.059 . . . . 1.28 111.229 -178.195 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.33 -51.56 12.84 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.029 -1.229 . . . . 2.19 110.029 -179.613 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.74 -108.97 0.39 Allowed Glycine 0 N--CA 1.493 2.441 0 O-C-N 121.084 -1.245 . . . . 2.13 110.207 -179.988 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.462 ' CB ' HH11 ' A' ' 186' ' ' ARG . 0.0 OUTLIER -79.91 -10.12 59.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.289 -1.124 . . . . 5.86 110.393 -179.29 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 78.5 p -83.89 0.77 46.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.125 -0.984 . . . . 3.72 110.324 -178.708 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.6 t -90.76 118.86 30.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.003 -1.061 . . . . 1.74 109.655 179.73 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -42.23 -52.73 4.34 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.602 -0.686 . . . . 0.95 109.7 -179.826 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.2 m -54.15 -30.67 50.0 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.34 -0.85 . . . . 1.55 110.759 -179.388 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 16.3 t -60.03 -44.75 94.41 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.601 -1.312 . . . . 1.51 109.746 -179.502 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.0 mm -60.09 -39.69 81.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.611 -0.885 . . . . 1.67 108.611 179.749 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.3 mtp -60.05 -39.89 87.52 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.456 -0.777 . . . . 1.02 110.002 -179.586 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.04 -44.36 94.71 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.654 -1.279 . . . . 0.68 109.504 -179.665 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.445 HH22 ' HG2' ' A' ' 186' ' ' ARG . 95.1 mtt180 -62.39 -57.78 10.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.111 -0.993 . . . . 2.93 109.981 -179.313 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 66.8 m -60.91 -40.01 91.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.857 . . . . 0.86 111.993 -178.684 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 91.6 mt -79.94 -10.93 59.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.766 -1.208 . . . . 0.67 110.876 -177.846 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 59.14 49.96 8.64 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.136 -0.977 . . . . 1.5 110.28 179.881 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 66.7 mt -121.91 126.2 26.43 Favored Pre-proline 0 N--CA 1.501 2.106 0 N-CA-C 108.955 -0.757 . . . . 0.72 108.955 179.517 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -43.09 129.44 5.82 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.842 1.695 . . . . 0.61 112.077 179.497 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.26 145.47 6.99 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.452 -1.299 . . . . 0.66 112.102 -179.512 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.6 mt -124.3 144.72 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.533 -1.284 . . . . 0.79 107.533 178.336 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.7 m -129.29 -6.69 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 120.695 -1.253 . . . . 0.91 111.031 -178.87 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.9 20.87 26.13 Favored Glycine 0 N--CA 1.5 2.958 0 N-CA-C 110.963 -0.855 . . . . 1.01 110.963 -179.406 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.44 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 2.9 p -46.61 -41.36 14.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.711 -1.464 . . . . 0.99 109.725 -179.483 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.61 -50.38 3.22 Favored Glycine 0 N--CA 1.498 2.823 0 C-N-CA 120.034 -1.079 . . . . 1.12 111.767 178.477 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 74.2 m -161.88 42.26 0.14 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.596 -1.532 . . . . 1.72 111.334 -179.177 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 23.5 t -78.89 -38.14 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.932 -1.105 . . . . 0.89 108.666 178.348 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.451 ' H ' HG23 ' A' ' 209' ' ' THR . 4.3 p -55.3 -35.62 65.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.459 -0.776 . . . . 1.03 110.611 -179.062 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 63.4 m -84.29 -9.8 58.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.963 -1.086 . . . . 1.83 110.142 -179.374 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -96.16 -16.5 21.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.065 -1.022 . . . . 2.27 110.485 -179.39 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 213' ' ' LYS . 18.2 t -123.66 162.92 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.403 -0.81 . . . . 0.92 109.714 -179.596 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.487 ' N ' HG12 ' A' ' 212' ' ' VAL . 0.5 OUTLIER -121.89 160.02 25.62 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.597 -0.89 . . . . 2.2 108.597 -179.615 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.458 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 39.8 p-10 -60.4 145.28 48.59 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.394 -0.816 . . . . 2.36 111.168 -179.02 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 84.29 -1.44 1.0 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.519 0.676 . . . . 2.38 110.326 178.594 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.46 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 96.5 m-20 -72.54 155.09 40.43 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.623 -0.831 . . . . 2.09 108.838 179.269 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -97.64 119.31 35.98 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.445 -0.946 . . . . 1.27 108.445 179.852 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.54 HD12 ' HB2' ' A' ' 16' ' ' ALA . 96.1 mt -122.83 142.24 50.97 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.439 -0.788 . . . . 0.75 110.504 -179.077 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.452 HD12 ' HG3' ' A' ' 231' ' ' PRO . 83.2 mt -114.82 128.37 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 106.299 -1.741 . . . . 0.63 106.299 176.365 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 56.7 tp -97.89 116.58 30.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.932 -1.105 . . . . 0.7 108.505 -179.358 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 223' ' ' VAL . 21.3 t0 -74.1 -44.66 53.07 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.466 -1.309 . . . . 2.31 107.466 179.553 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.862 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.82 8.49 0.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.834 -0.541 . . . . 0.78 109.654 179.073 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.508 ' H ' ' C ' ' A' ' 221' ' ' ASP . 95.2 t -126.75 -39.17 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 107.384 -1.339 . . . . 1.04 107.384 178.262 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -102.77 -0.41 31.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.878 -1.156 . . . . 2.44 107.878 178.637 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 61.94 45.77 7.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.817 -0.552 . . . . 1.55 109.839 -179.814 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -139.6 150.66 45.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.293 -0.879 . . . . 1.99 109.891 179.575 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 90.5 t -119.0 128.07 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.423 -0.955 . . . . 0.77 108.423 178.989 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -102.67 123.56 46.6 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.596 -0.89 . . . . 0.98 108.596 179.461 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.3 t -100.02 110.01 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.38 -0.825 . . . . 0.85 110.607 -178.865 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 50.94 60.65 14.45 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.44 -0.788 . . . . 1.66 111.516 179.047 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.452 ' HG3' HD12 ' A' ' 219' ' ' ILE . 90.7 Cg_endo -79.51 153.04 23.47 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.703 2.268 . . . . 0.95 111.277 178.386 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 232' ' ' THR . . . . . 0.435 HG22 ' N ' ' A' ' 233' ' ' ASN . 25.8 m -64.7 159.92 21.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 1.84 110.135 -179.25 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 233' ' ' ASN . . . . . 0.435 ' N ' HG22 ' A' ' 232' ' ' THR . 98.6 m-20 -61.18 -40.08 92.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.39 -0.818 . . . . 2.74 110.342 -179.632 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.01 -36.07 76.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.081 -1.012 . . . . 2.89 109.265 179.794 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.97 -39.93 78.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.564 -0.902 . . . . 1.3 108.564 179.261 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 236' ' ' ILE . . . . . 0.483 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 91.8 mt -67.06 -40.07 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.444 -0.785 . . . . 1.09 110.001 179.931 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -59.91 -40.32 88.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.064 -1.022 . . . . 2.43 109.069 -179.598 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -67.33 -40.0 85.89 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.775 -0.824 . . . . 2.78 108.775 179.165 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 93.6 mtp -69.38 -34.83 75.13 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.462 -0.774 . . . . 1.25 108.928 178.823 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.517 HH11 ' HG2' ' A' ' 240' ' ' ARG . 0.1 OUTLIER -64.11 -35.47 80.87 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.308 -0.87 . . . . 2.63 108.975 178.889 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.43 -44.67 89.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.141 -0.974 . . . . 1.8 108.835 179.949 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.09 -40.77 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.144 -0.973 . . . . 2.13 108.415 179.051 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -60.29 -40.93 92.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.452 -0.78 . . . . 3.17 110.083 -179.83 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.82 -40.65 93.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.055 -1.028 . . . . 1.78 109.76 -179.667 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -60.73 -40.1 91.13 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.229 -0.919 . . . . 2.47 108.877 179.949 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.4 t -62.29 -40.63 88.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.596 -0.69 . . . . 2.09 109.585 -179.931 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.67 -40.22 96.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 2.54 109.885 -179.37 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 26.0 t -69.67 -39.86 76.77 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.298 -0.876 . . . . 2.99 109.808 -179.685 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -60.13 -43.38 95.73 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.249 -0.907 . . . . 3.34 110.211 -179.084 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -83.89 -7.85 59.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.022 -1.049 . . . . 3.88 110.565 -179.172 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -106.74 -15.67 14.69 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.769 -1.207 . . . . 4.43 109.694 179.895 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 254' ' ' ALA . 86.6 mt-10 -84.09 60.82 6.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.022 -1.049 . . . . 5.42 109.358 -179.978 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 89.8 mt -49.6 -13.37 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.467 -0.771 . . . . 6.1 109.127 179.67 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 252' ' ' GLU . . . -59.99 -36.23 76.73 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.525 -0.917 . . . . 7.37 108.525 179.402 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 255' ' ' LYS . . . . . 0.507 ' HG2' ' H ' ' A' ' 257' ' ' LYS . 61.3 tttp -134.89 131.46 37.36 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.384 -0.969 . . . . 8.01 108.384 179.595 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 256' ' ' LEU . 7.7 mp -86.83 -9.6 55.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.294 -0.879 . . . . 9.05 109.252 -179.459 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 257' ' ' LYS . . . . . 0.507 ' H ' ' HG2' ' A' ' 255' ' ' LYS . 60.3 tttm 53.17 72.22 0.44 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.589 -0.694 . . . . 10.56 109.159 -179.99 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.427 ' O ' ' O ' ' A' ' 259' ' ' ARG . 27.6 p-10 -141.83 56.16 1.49 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.99 -0.745 . . . . 11.32 108.99 179.933 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 259' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' A' ' 258' ' ' ASP . 13.6 ptm180 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.107 -0.949 . . . . 12.42 109.61 -179.907 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 036 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -155.19 153.65 31.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.267 -0.896 . . . . 0.0 109.499 179.485 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -145.56 155.48 43.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.214 -0.929 . . . . 0.0 109.55 -179.83 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 304' ' ' GLN . . . . . 0.583 ' NE2' ' O ' ' B' ' 305' ' ' GLU . 17.0 tm0? -154.49 150.02 27.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.515 -0.741 . . . . 0.0 109.015 -179.587 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 305' ' ' GLU . . . . . 0.583 ' O ' ' NE2' ' B' ' 304' ' ' GLN . 95.0 mt-10 -109.85 131.72 54.8 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.3 -0.875 . . . . 0.0 110.162 179.388 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 306' ' ' VAL . . . . . 0.409 ' O ' HG13 ' B' ' 306' ' ' VAL . 6.9 p -132.9 121.02 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 CA-C-O 122.121 0.962 . . . . 0.0 112.134 -178.136 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 307' ' ' THR . . . . . 0.477 ' O ' HG23 ' B' ' 309' ' ' THR . 87.8 m -80.0 103.01 9.6 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.696 0.76 . . . . 0.0 110.384 -178.93 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.5 mt -51.51 117.52 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.446 1.117 . . . . 0.0 109.971 -178.079 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 309' ' ' THR . . . . . 0.477 HG23 ' O ' ' B' ' 307' ' ' THR . 62.2 p -104.69 19.01 21.19 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.414 -177.954 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.46 115.98 44.73 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.327 -0.858 . . . . 0.0 109.098 179.507 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -53.05 -15.47 4.98 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 CA-C-N 120.306 1.145 . . . . 0.0 112.923 -179.704 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -115.27 4.98 14.59 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.506 -0.746 . . . . 0.0 109.036 -179.888 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.26 174.46 19.12 Favored Glycine 0 N--CA 1.481 1.692 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 -179.042 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.442 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.0 tp -85.84 95.59 9.48 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.163 -1.198 . . . . 0.0 108.696 -179.066 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -95.25 -162.55 0.96 Allowed 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.161 -0.962 . . . . 0.0 110.411 179.737 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 7.9 m -59.63 -39.96 86.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.056 -1.027 . . . . 0.0 112.581 -175.776 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.601 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -60.15 -60.82 9.38 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.33 -1.481 . . . . 0.0 111.27 -179.257 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -59.4 -32.4 96.48 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.14 1.086 . . . . 0.0 111.628 -179.9 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.88 67.67 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.398 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -50.37 -40.02 48.28 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.819 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 321' ' ' GLN . . . . . 0.423 HE21 HD11 ' B' ' 380' ' ' LEU . 61.8 tt0 -69.99 -41.47 74.37 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 108.923 178.369 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -61.2 -52.78 63.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.83 . . . . 0.0 110.946 -179.365 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 87.9 t -65.41 -27.67 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.639 -1.288 . . . . 0.0 109.761 -178.957 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -45.16 93.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.404 -0.81 . . . . 0.0 109.411 179.581 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -66.52 -44.89 81.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.418 -0.801 . . . . 0.0 111.2 -178.437 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 326' ' ' ALA . . . . . 0.42 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -61.55 -53.87 50.61 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.724 -1.235 . . . . 0.0 111.144 -178.646 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -52.66 -13.43 0.39 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.724 -1.235 . . . . 0.0 109.317 179.673 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 328' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -72.6 -28.73 66.85 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.69 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -106.03 146.78 29.67 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.443 -1.033 . . . . 0.0 109.942 -179.676 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 51.6 p -91.11 -11.79 37.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.925 . . . . 0.0 110.134 179.997 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.427 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 56.4 p -65.3 157.87 27.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.196 -0.94 . . . . 0.0 110.323 -179.165 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -72.62 131.55 42.59 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.377 -0.827 . . . . 0.0 108.922 179.375 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 80.2 mt -132.33 132.69 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.873 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 334' ' ' THR . . . . . 0.417 HG22 ' N ' ' B' ' 335' ' ' VAL . 62.7 m -131.6 155.89 46.74 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.48 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 335' ' ' VAL . . . . . 0.417 ' N ' HG22 ' B' ' 334' ' ' THR . 61.9 t -119.1 140.49 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.318 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 26.7 m -128.9 123.89 33.78 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.128 -0.982 . . . . 0.0 108.561 179.95 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 337' ' ' SER . . . . . 0.4 ' CB ' HG12 ' B' ' 361' ' ' VAL . 93.0 p -137.93 116.61 12.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.966 -1.084 . . . . 0.0 110.82 -179.387 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 22.9 m120 45.14 53.43 7.86 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.318 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.74 -11.59 66.08 Favored Glycine 0 N--CA 1.502 3.07 0 O-C-N 120.06 -1.65 . . . . 0.0 113.052 176.264 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -120.92 132.35 54.9 Favored 'General case' 0 N--CA 1.506 2.37 0 CA-C-N 119.285 1.542 . . . . 0.0 109.512 -179.655 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 77.4 p -127.88 151.39 49.13 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.928 0.87 . . . . 0.0 110.886 -178.834 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.48 164.47 30.79 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.64 0.734 . . . . 0.0 110.423 -178.94 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 48.0 t -87.56 133.21 33.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.806 -0.559 . . . . 0.0 110.359 -179.353 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -70.13 -20.27 63.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.944 . . . . 0.0 108.911 179.289 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -84.61 17.36 2.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.494 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 3.0 m -146.45 95.43 2.6 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.773 0.797 . . . . 0.0 112.421 -179.368 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.659 HD23 HD22 ' A' ' 79' ' ' LEU . 42.7 tp -59.98 -39.05 84.36 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.415 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.687 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.0 m-85 -51.31 -51.15 56.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.979 -1.076 . . . . 0.0 110.459 -179.569 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -71.66 -39.72 70.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.955 -1.09 . . . . 0.0 111.277 -178.2 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' B' ' 352' ' ' THR . 20.6 mt -47.81 -59.95 2.94 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.718 -1.239 . . . . 0.0 109.754 -179.153 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.643 HE22 ' NE ' ' A' ' 126' ' ' ARG . 7.6 mm100 -42.07 -20.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.399 -0.813 . . . . 0.0 111.192 -177.724 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.493 ' N ' ' O ' ' B' ' 350' ' ' LEU . 69.5 p -79.25 -12.76 59.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.081 -1.637 . . . . 0.0 109.53 -179.294 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 32.0 mt -94.09 122.7 36.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.114 -0.991 . . . . 0.0 108.993 178.383 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -72.03 96.89 0.71 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.718 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.5 mt -100.07 80.29 2.27 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.265 -1.138 . . . . 0.0 109.06 179.282 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 75.1 p -91.13 166.28 13.05 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.967 -1.083 . . . . 0.0 111.055 -178.83 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -59.92 111.58 1.53 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.132 0.491 . . . . 0.0 110.642 -179.591 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 358' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 103.01 5.57 46.88 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.762 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 52.4 m -80.14 109.78 14.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.051 -1.264 . . . . 0.0 110.855 -179.468 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 360' ' ' VAL . . . . . 0.439 HG22 ' OG1' ' B' ' 307' ' ' THR . 11.9 t -78.54 112.71 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.108 0.956 . . . . 0.0 109.943 -177.907 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 361' ' ' VAL . . . . . 0.4 HG12 ' CB ' ' B' ' 337' ' ' SER . 36.0 m -113.31 176.85 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 -178.735 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 57.4 m -126.64 130.02 49.63 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 176.648 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.5 mt -106.43 124.52 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.357 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 63.2 m -131.53 138.85 49.1 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.5 -0.75 . . . . 0.0 109.771 -178.979 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.41 155.24 42.44 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.217 -0.927 . . . . 0.0 109.763 -179.507 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -146.51 123.34 11.28 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.409 -0.807 . . . . 0.0 109.171 179.848 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.508 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.89 -153.47 24.73 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.248 -1.453 . . . . 0.0 111.548 179.868 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -59.97 -51.69 68.58 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.222 -0.575 . . . . 0.0 112.503 -177.292 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.427 ' H ' ' HB3' ' B' ' 331' ' ' SER . 62.5 m-20 -111.91 11.06 20.67 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.892 -1.13 . . . . 0.0 111.434 -177.267 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 11.1 pt-20 -39.14 -34.5 0.18 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.452 -0.78 . . . . 0.0 111.657 -179.16 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -69.99 -41.0 74.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.036 -1.04 . . . . 0.0 110.667 -178.148 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -69.68 -49.89 49.16 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.223 -179.609 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -45.77 -79.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 110.417 -179.653 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.607 ' O ' HG23 ' B' ' 378' ' ' VAL . 15.1 t -45.24 -38.38 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.154 -0.966 . . . . 0.0 110.367 -177.696 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -69.86 -40.25 75.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.535 -1.353 . . . . 0.0 110.111 179.738 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -83.32 -45.54 13.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.974 -1.079 . . . . 0.0 109.707 179.499 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.08 -35.51 75.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 109.673 -179.211 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.607 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.4 t -68.88 -40.06 80.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.123 -0.986 . . . . 0.0 109.758 179.819 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -79.98 -10.0 59.73 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.705 -1.247 . . . . 0.0 108.611 178.251 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.423 HD11 HE21 ' B' ' 321' ' ' GLN . 44.1 tp -82.08 -26.81 33.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.997 -1.064 . . . . 0.0 108.697 178.377 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 38.7 mtt -83.36 -21.02 33.21 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 176.813 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -85.97 -11.3 53.38 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.583 -0.698 . . . . 0.0 109.451 178.789 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -109.98 -4.72 15.74 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.387 -0.821 . . . . 0.0 110.868 -178.998 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 31.1 mt -89.77 123.97 34.23 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.681 -1.262 . . . . 0.0 109.859 -179.79 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.406 -179.82 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 mmt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.457 -0.572 . . . . 2.91 109.457 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.3 mt -107.31 121.38 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.644 -0.873 . . . . 1.2 108.644 179.745 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 m -133.62 120.09 20.25 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.424 -0.798 . . . . 1.4 109.178 179.981 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.64 -161.7 37.72 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.422 -1.471 . . . . 1.05 109.422 179.917 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.7 mt -93.03 -10.13 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.038 -1.272 . . . . 1.15 110.005 -179.392 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' ILE . 55.2 tp 53.21 101.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -0.963 . . . . 0.98 109.548 -179.959 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.13 -26.24 20.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 0.88 109.631 179.928 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.1 t -144.6 130.18 9.58 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.213 -0.929 . . . . 1.69 109.433 179.923 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.94 143.43 16.31 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.175 1.916 . . . . 0.85 112.806 -179.926 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.663 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 163.74 -162.14 34.8 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.033 -1.627 . . . . 0.92 109.033 179.881 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.8 mt -149.52 149.8 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.922 -1.34 . . . . 0.81 108.466 178.841 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.5 158.4 37.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.749 -1.22 . . . . 0.51 110.794 179.83 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -139.97 129.19 23.82 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.897 -1.149 . . . . 0.62 107.897 178.817 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.93 -178.91 46.53 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 118.869 -1.634 . . . . 0.55 110.442 179.911 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -79.93 156.63 27.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.544 -0.974 . . . . 2.1 109.886 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -105.4 127.5 53.01 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.478 0.656 . . . . 0.77 110.925 -179.434 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.8 tp -101.25 140.08 36.04 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.772 -1.195 . . . . 0.91 107.772 178.537 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.7 tp -118.35 125.59 50.34 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.374 -0.829 . . . . 0.93 109.951 -179.442 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.8 mt -84.04 104.41 14.09 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.531 0.682 . . . . 0.93 109.963 -179.795 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -99.29 128.58 45.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.455 -0.778 . . . . 2.75 109.354 -179.789 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -130.06 127.94 40.92 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.41 -0.806 . . . . 3.0 109.072 179.256 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -76.74 147.31 37.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.282 -0.886 . . . . 2.77 109.418 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -63.61 141.55 58.72 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.23 -0.919 . . . . 2.94 108.995 -179.983 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.9 mt -76.97 131.88 33.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.229 -0.919 . . . . 0.95 109.162 -179.516 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.7 t -93.88 124.1 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.287 -0.883 . . . . 1.28 109.813 -179.621 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.6 mt -109.8 138.11 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.611 -0.681 . . . . 1.21 109.929 -179.462 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -97.45 116.93 30.58 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.13 -0.981 . . . . 1.81 109.441 179.834 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.53 HH11 ' HG2' ' A' ' 28' ' ' ARG . 2.3 mmt-85 -85.67 -0.95 56.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.393 -0.817 . . . . 2.8 109.62 -179.431 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -60.54 144.11 52.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.935 . . . . 2.87 109.632 -179.712 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -87.71 147.88 25.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.192 -0.942 . . . . 2.35 109.046 -179.928 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 pt -94.66 164.82 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.997 -1.064 . . . . 0.97 109.823 179.924 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.418 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 53.9 p -90.23 175.64 7.05 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.477 -0.935 . . . . 1.17 108.477 178.576 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.06 -20.34 63.23 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.937 -1.102 . . . . 1.18 111.266 -178.95 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.418 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 7.5 p-10 -85.97 -23.19 27.0 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.501 -1.375 . . . . 2.56 108.553 179.001 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -81.84 -9.41 59.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.592 -0.892 . . . . 1.79 108.592 178.818 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 t -62.09 -53.66 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.487 -0.758 . . . . 1.0 109.309 179.711 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -62.17 -40.06 94.76 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.339 -0.851 . . . . 1.77 109.349 179.691 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -61.91 -42.2 98.81 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.422 -0.799 . . . . 2.7 110.598 -178.766 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -66.15 -39.96 90.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.711 -1.243 . . . . 1.51 110.376 -179.036 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.14 -47.88 90.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.708 -1.245 . . . . 0.93 108.681 179.586 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -61.46 -44.21 97.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.062 . . . . 1.81 109.652 179.846 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.463 HH11 ' HG2' ' A' ' 42' ' ' ARG . 25.8 mtt-85 -60.02 -41.13 91.53 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.937 -1.135 . . . . 2.78 107.937 179.139 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -62.31 -45.78 91.69 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.958 -1.127 . . . . 0.78 107.958 177.545 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.02 -47.63 85.03 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.828 -0.804 . . . . 1.07 108.828 179.694 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 18.1 t -62.39 -42.95 99.82 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.394 -0.922 . . . . 1.12 109.009 179.355 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.44 -48.58 84.22 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.866 -1.694 . . . . 0.84 108.866 179.477 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -62.27 -34.9 77.44 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.33 -1.1 . . . . 3.09 108.197 178.694 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.59 -43.81 80.46 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.613 -0.679 . . . . 0.88 109.285 -179.911 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.3 ttpt -65.78 -74.24 0.11 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.17 -1.418 . . . . 2.59 107.17 179.301 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.25 -31.35 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.318 -0.864 . . . . 0.7 111.118 -179.238 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 49' ' ' LYS . 34.4 t -57.06 -56.07 26.46 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.547 -1.346 . . . . 1.4 108.473 179.801 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.45 -40.03 81.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.433 -0.792 . . . . 0.67 111.204 -179.182 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -67.14 -40.03 86.68 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.699 -1.251 . . . . 1.66 110.42 -179.1 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.43 -39.95 94.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.886 -1.134 . . . . 1.58 109.504 179.815 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -62.24 -33.99 75.65 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.174 -0.954 . . . . 1.35 109.448 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.62 -41.39 98.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.955 . . . . 0.77 109.832 -179.986 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.36 -39.95 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.193 -0.942 . . . . 0.63 109.55 -180.0 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -56.69 -50.6 71.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 1.14 109.921 -178.962 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -59.41 -36.63 76.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.371 -0.83 . . . . 0.79 110.968 -177.472 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -64.29 -38.26 90.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.895 -1.128 . . . . 1.53 109.573 179.891 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.31 -43.43 97.83 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.467 -0.771 . . . . 0.57 109.732 -179.926 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.15 -50.85 63.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.498 -1.441 . . . . 0.75 109.498 -179.335 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.26 -50.1 56.09 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.139 -1.212 . . . . 1.59 109.5 179.628 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.1 m -63.03 -64.76 0.82 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 0.73 112.32 -177.893 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -97.65 -48.3 5.29 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.868 -1.145 . . . . 0.75 111.825 -178.079 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.91 -169.77 25.15 Favored Glycine 0 N--CA 1.5 2.943 0 O-C-N 120.662 -1.274 . . . . 1.22 110.943 179.889 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.03 -26.87 64.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.897 -0.767 . . . . 5.81 110.287 -179.705 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -61.04 -33.15 72.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.447 -0.783 . . . . 3.37 110.087 -179.67 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -100.33 -22.59 15.03 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.341 -0.849 . . . . 1.77 109.891 179.995 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -64.95 -40.76 95.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.132 -0.98 . . . . 1.65 110.02 -179.311 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.599 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -67.1 -25.82 66.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.401 -0.812 . . . . 0.77 110.431 -178.913 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.99 -40.53 83.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.969 -1.082 . . . . 0.8 108.499 -179.706 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -69.96 -35.76 74.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.144 -0.973 . . . . 0.88 110.107 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -60.01 -40.06 87.94 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.762 -1.211 . . . . 1.37 109.312 179.831 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.99 -42.62 94.63 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.463 -1.855 . . . . 0.62 108.463 179.09 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -61.06 -44.56 97.2 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.468 -1.019 . . . . 1.5 108.612 179.334 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.98 -43.53 79.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.674 -0.641 . . . . 0.63 109.799 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -64.11 -40.02 95.29 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.906 -1.121 . . . . 1.51 109.827 -179.356 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.801 HD11 ' CE2' ' B' ' 348' ' ' PHE . 35.9 tp -65.47 -39.97 92.61 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.237 -0.914 . . . . 0.77 109.44 179.536 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.5 tp -65.71 -37.09 85.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.557 -0.714 . . . . 0.62 109.177 -179.493 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -82.66 1.66 37.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 1.47 110.086 -179.372 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -48.56 130.01 16.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.965 -1.084 . . . . 1.47 109.672 -179.405 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.46 -18.4 51.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.542 -0.723 . . . . 1.78 110.354 -179.259 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.47 -35.1 73.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.005 -1.059 . . . . 2.53 108.739 178.353 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.3 mt -70.15 -42.12 72.93 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.521 0.677 . . . . 0.8 109.909 179.506 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -60.15 -48.81 80.18 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.36 -0.837 . . . . 1.42 110.028 -179.126 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -69.95 -41.31 74.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 1.71 110.705 -179.451 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.98 -40.04 75.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.16 -0.963 . . . . 1.57 111.735 -178.629 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 91.8 mt -69.47 -42.04 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.905 -1.122 . . . . 0.65 109.178 -179.571 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.7 mt -69.98 -39.62 77.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.638 -0.664 . . . . 0.82 109.943 179.329 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.99 -47.77 84.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -0.863 . . . . 0.79 110.81 -179.244 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 96' ' ' LYS . 93.2 mt -61.48 -47.51 85.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.994 -1.067 . . . . 0.95 109.921 -179.44 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.33 -49.63 83.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.296 -0.877 . . . . 0.66 109.185 179.632 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -70.09 -43.03 71.93 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.901 -0.719 . . . . 2.2 110.667 179.636 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -80.69 -47.39 14.09 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.103 -0.998 . . . . 1.65 111.79 -178.349 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 92' ' ' LEU . 65.8 mmtt -91.81 -2.3 56.96 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.973 -1.079 . . . . 2.03 111.659 -177.679 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 56.05 34.68 24.22 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.797 -1.189 . . . . 1.42 109.489 -179.845 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 59.0 mtt -91.63 169.84 10.41 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.518 -0.739 . . . . 1.18 110.03 -179.39 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.5 p -82.32 162.34 22.29 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.42 -0.8 . . . . 0.98 109.408 179.986 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.03 -39.71 75.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.417 -0.802 . . . . 0.64 109.892 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.94 -40.04 83.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 2.07 110.011 -179.753 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.49 -44.08 19.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.018 -1.051 . . . . 0.73 110.283 -179.506 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.63 -47.68 68.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.54 110.2 -179.306 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.03 87.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.178 -0.951 . . . . 0.56 109.659 -179.862 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -59.99 -40.87 90.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.43 -0.794 . . . . 1.54 110.01 -178.559 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -63.21 -40.02 96.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.913 . . . . 1.33 110.131 -179.596 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.3 -52.59 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.111 -0.993 . . . . 0.72 110.528 -178.721 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -70.02 -40.02 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.973 -1.079 . . . . 0.85 109.328 -179.752 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.61 -39.19 91.27 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.644 -0.872 . . . . 2.44 108.644 179.327 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.33 -47.86 87.12 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.74 -1.344 . . . . 0.98 109.74 -179.668 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -67.53 -51.65 48.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.942 -1.328 . . . . 1.41 109.197 -179.992 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.85 -42.5 89.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.375 -0.828 . . . . 1.2 109.591 -179.748 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.4 t -57.56 -39.5 76.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.059 -1.026 . . . . 1.7 109.056 -179.851 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.95 -39.93 90.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.935 . . . . 1.47 109.656 179.424 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.1 mt -64.66 -42.01 95.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.022 -1.049 . . . . 1.56 109.999 -178.827 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.95 -37.58 79.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.746 -1.222 . . . . 2.2 109.335 -179.596 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -53.45 -20.25 4.5 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.202 -0.936 . . . . 2.12 109.265 179.827 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 65.7 mt -62.46 139.99 58.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.044 -1.035 . . . . 2.0 108.798 179.861 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -90.99 48.23 1.5 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.04 -1.037 . . . . 3.23 109.393 179.894 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.42 ' OD1' ' OE2' ' A' ' 121' ' ' GLU . 58.3 t0 -135.18 130.13 34.85 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.368 -0.833 . . . . 2.49 109.282 -179.713 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.2 pm0 -69.35 -28.87 66.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.532 -0.73 . . . . 3.95 110.071 -179.677 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.545 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 2.4 t80 -73.2 -41.03 64.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.259 -0.901 . . . . 2.0 110.599 179.586 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.624 ' CD2' HH22 ' A' ' 126' ' ' ARG . 41.3 mt -74.92 -29.71 61.04 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.044 -1.035 . . . . 1.86 108.344 179.31 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -68.51 -39.1 81.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.5 -0.75 . . . . 2.84 110.1 179.523 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -59.98 -44.02 94.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.987 -1.071 . . . . 2.73 110.063 -178.905 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.714 ' HE ' ' NE2' ' B' ' 351' ' ' GLN . 22.2 mtm-85 -69.96 -28.91 65.94 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.315 -1.354 . . . . 2.77 108.797 179.805 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.75 -26.64 65.84 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.865 -1.161 . . . . 1.19 107.865 178.741 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.56 -39.98 64.28 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.088 -0.708 . . . . 1.2 109.088 178.795 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -65.85 -39.99 91.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.358 -0.838 . . . . 1.55 110.53 -179.442 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.5 t -65.11 -41.02 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.877 -1.139 . . . . 0.8 109.065 179.999 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -59.98 -37.86 80.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.092 -1.005 . . . . 3.09 108.522 178.868 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 57.2 t0 -60.03 -38.96 84.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.578 -0.701 . . . . 1.46 109.985 -179.614 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 94.5 mt -60.08 -42.5 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.92 -1.113 . . . . 0.71 110.101 -178.89 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.76 -29.3 59.56 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.647 -1.381 . . . . 0.57 109.647 179.867 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt -59.93 -49.04 79.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.299 -1.118 . . . . 2.59 109.464 -179.515 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.467 HH11 ' HG2' ' A' ' 136' ' ' ARG . 27.1 mtt-85 -65.16 -36.7 85.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.083 -1.011 . . . . 2.83 109.596 179.861 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.2 tp -57.08 -40.92 77.86 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.355 -0.84 . . . . 1.25 109.018 -178.652 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.16 -41.35 98.21 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.193 -0.942 . . . . 0.7 109.762 179.405 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -70.09 -39.94 75.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.23 -0.919 . . . . 2.57 109.014 179.384 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 23.4 m120 -63.87 -35.66 81.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.675 -0.641 . . . . 1.23 111.093 -179.31 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 83.6 mt -71.13 -45.9 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.487 -1.383 . . . . 0.81 108.75 179.522 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 77.2 mt -70.03 -34.96 73.93 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.51 -0.744 . . . . 1.0 109.518 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.91 43.74 5.31 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.188 -1.565 . . . . 0.89 109.188 -179.479 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 tp -74.29 149.83 40.5 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.324 -1.103 . . . . 1.14 109.012 -179.854 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -67.1 141.72 57.36 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.178 -0.951 . . . . 4.6 109.678 -179.553 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 89.1 mt -115.63 126.6 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 122.269 1.033 . . . . 1.24 109.269 179.635 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 148' ' ' ASP . 7.5 mt -70.01 -40.0 78.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 115.594 -0.73 . . . . 1.54 110.743 -178.219 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 147' ' ' ILE . 25.8 t0 63.49 131.29 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.642 -0.873 . . . . 1.5 108.642 -178.918 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 152' ' ' ILE . 38.9 mt -89.89 -0.62 57.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.047 -1.033 . . . . 0.79 109.646 -179.324 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.7 m -84.83 -8.88 58.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 1.4 109.21 179.566 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.03 27.33 0.78 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.446 -0.784 . . . . 0.92 110.683 -178.207 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.415 ' O ' ' NZ ' ' A' ' 175' ' ' LYS . 54.4 mt -89.88 120.03 37.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 O-C-N 121.117 -0.99 . . . . 0.88 109.395 -179.16 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.42 ' O ' ' OD1' ' A' ' 154' ' ' ASP . 72.2 mt-30 -97.07 -9.67 27.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.298 -0.876 . . . . 2.45 111.083 -178.765 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 153' ' ' GLN . 96.4 m-20 -139.7 157.89 45.02 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.898 -1.126 . . . . 1.52 110.815 -178.763 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -62.7 138.22 58.45 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.735 -0.839 . . . . 1.58 108.735 179.606 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.1 m -153.13 165.71 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.69 109.767 179.88 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.5 mt -95.48 148.84 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.414 -1.698 . . . . 0.61 106.414 176.967 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.3 tp -98.61 117.66 33.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.084 -1.01 . . . . 0.87 111.049 -177.684 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.0 t -122.42 130.04 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.622 -0.881 . . . . 0.71 108.622 178.416 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.63 161.24 38.64 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.584 -0.895 . . . . 0.81 108.584 179.996 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.485 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -72.09 -32.88 67.44 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.201 -1.562 . . . . 0.98 107.687 178.699 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 20.2 t0 -162.27 167.73 23.47 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.142 -1.059 . . . . 2.25 108.142 179.8 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.498 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 86.5 mt -141.67 130.61 23.12 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.907 -1.12 . . . . 0.78 109.586 179.689 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 63.8 p -93.05 144.62 28.66 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 108.543 -0.91 . . . . 0.98 108.543 179.363 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -42.11 -29.86 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.846 1.697 . . . . 0.81 112.65 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.3 m -59.71 -39.98 86.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.017 . . . . 0.9 109.711 -178.405 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -70.06 -42.11 73.29 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.12 -0.988 . . . . 1.61 110.354 -179.662 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 77.9 p -53.93 -29.97 44.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.228 -0.92 . . . . 0.61 111.356 -177.994 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.14 -56.6 5.3 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.945 -1.097 . . . . 0.6 110.53 -179.7 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -84.05 37.34 0.6 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.451 -0.78 . . . . 1.4 108.939 -179.599 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.9 tp -109.76 129.47 55.62 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.457 -0.942 . . . . 0.7 108.457 178.494 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -79.97 105.15 11.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.082 -1.011 . . . . 2.35 109.27 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 77.0 mt -66.84 -40.26 87.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.426 -0.796 . . . . 1.51 111.229 -178.564 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -70.0 -23.62 63.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.939 -1.1 . . . . 2.33 110.852 -178.029 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 175' ' ' LYS . . . . . 0.415 ' NZ ' ' O ' ' A' ' 152' ' ' ILE . 41.4 mtpt -93.97 -6.44 45.42 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.032 -1.043 . . . . 1.92 109.861 -178.657 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.585 HG12 ' H ' ' A' ' 178' ' ' GLY . 93.1 t -107.92 121.4 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.179 -0.95 . . . . 0.67 108.605 179.069 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 42.1 mt -85.66 7.12 24.59 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.391 -0.818 . . . . 1.53 111.777 -177.07 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.585 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 164.11 177.55 36.93 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.17 -1.49 . . . . 0.48 109.662 179.914 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.461 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 22.5 m-85 -134.78 130.27 35.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.453 -1.028 . . . . 0.55 109.26 -179.695 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 91.0 mt -133.17 128.29 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.025 -0.731 . . . . 0.65 109.025 179.191 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 33.8 p -149.87 159.42 44.38 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.043 -1.035 . . . . 0.82 109.763 179.741 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 53.8 p-10 -106.27 27.55 8.59 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.519 -0.919 . . . . 2.46 108.519 178.847 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.5 -157.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.056 0.931 . . . . 1.28 111.972 -178.172 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.6 -80.48 0.08 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.875 -0.89 . . . . 2.19 110.875 -179.179 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.68 -130.57 1.37 Allowed Glycine 0 N--CA 1.49 2.288 0 O-C-N 120.892 -1.358 . . . . 2.13 110.112 -179.491 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -79.42 -9.31 59.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.305 -1.115 . . . . 5.86 111.031 -179.138 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.2 p -87.43 9.13 21.77 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.947 -1.096 . . . . 3.72 110.238 -179.085 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.7 m -90.19 139.32 30.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.941 -1.1 . . . . 1.74 110.358 -179.602 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -45.12 -53.38 8.08 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.473 -0.767 . . . . 0.95 109.99 -179.744 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.4 m -56.6 -39.01 72.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.401 -0.812 . . . . 1.55 110.164 -178.903 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 27.8 p -60.0 -37.67 80.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.858 -1.151 . . . . 1.51 110.003 -179.554 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 192' ' ' ILE . . . . . 0.41 HG12 HH21 ' A' ' 195' ' ' ARG . 82.5 mt -60.03 -39.91 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.115 -0.991 . . . . 1.67 108.935 179.985 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 90.7 mtp -60.04 -43.01 95.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.429 -0.795 . . . . 1.02 110.33 -179.038 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.39 -44.25 88.88 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.583 -1.323 . . . . 0.68 109.36 -179.341 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.41 HH21 HG12 ' A' ' 192' ' ' ILE . 82.8 mtm180 -62.55 -58.64 6.84 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.107 -1.037 . . . . 2.93 109.925 -179.606 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.6 m -61.96 -39.97 93.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.122 -0.986 . . . . 0.86 112.022 -178.548 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.0 mt -74.91 -20.53 59.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.753 -1.217 . . . . 0.67 110.338 -178.697 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 68.81 52.21 0.55 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.678 -0.639 . . . . 1.5 110.456 -179.762 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.5 mt -129.68 149.93 74.33 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 108.072 -1.084 . . . . 0.72 108.072 178.794 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.52 143.55 63.38 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.063 1.842 . . . . 0.61 112.088 -179.654 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -172.63 150.74 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.083 -1.01 . . . . 0.66 111.286 -179.897 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.8 mt -121.51 146.68 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 107.664 -1.236 . . . . 0.79 107.664 178.432 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.8 m -128.35 -12.39 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 O-C-N 120.878 -1.139 . . . . 0.91 110.528 -179.051 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.05 25.25 16.79 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 110.824 -0.91 . . . . 1.01 110.824 -179.233 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.8 p -46.28 -40.62 11.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.913 -1.345 . . . . 0.99 109.803 -179.459 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.403 ' H ' ' HB2' ' A' ' 182' ' ' ASP . . . 90.29 -51.42 3.39 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 120.127 -1.035 . . . . 1.12 110.85 179.385 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.6 m -161.94 34.97 0.12 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.621 -1.517 . . . . 1.72 111.204 -179.471 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.12 -40.15 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.923 -1.111 . . . . 0.89 108.621 177.999 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.451 ' H ' HG23 ' A' ' 209' ' ' THR . 1.2 p -56.23 -34.08 65.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.699 -0.625 . . . . 1.03 110.004 -179.088 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 39.8 t -86.5 -12.97 47.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.069 -1.019 . . . . 1.83 110.467 -179.169 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -94.0 -12.93 27.62 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.889 -1.132 . . . . 2.27 110.837 -179.538 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 213' ' ' LYS . 44.6 t -123.75 165.1 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 O-C-N 121.185 -0.947 . . . . 0.92 110.267 -179.483 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.572 ' N ' HG12 ' A' ' 212' ' ' VAL . 18.4 mmmt -118.14 156.45 28.67 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.558 -0.904 . . . . 2.2 108.558 -179.363 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 5.5 p30 -60.99 140.36 57.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 2.36 110.711 -179.474 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 6.5 t0 86.48 2.47 0.52 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.108 0.48 . . . . 2.38 110.204 179.102 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.442 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 89.9 m-20 -77.71 159.19 29.27 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.15 -0.969 . . . . 2.09 108.581 178.877 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -97.27 120.31 37.4 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.215 -0.928 . . . . 1.27 109.288 -179.351 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.506 HD12 ' HB2' ' A' ' 16' ' ' ALA . 88.8 mt -126.08 140.88 52.23 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.361 -0.837 . . . . 0.75 110.342 -179.812 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.7 mt -113.47 129.88 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.053 -1.462 . . . . 0.63 107.053 176.967 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 24.6 tp -103.12 120.13 40.12 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.215 -0.928 . . . . 0.7 109.255 -179.106 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.694 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 30.4 p-10 -80.77 -39.64 26.49 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.056 -1.027 . . . . 2.31 108.5 179.055 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.79 17.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.851 -0.796 . . . . 0.78 108.851 -179.003 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.5 t -130.25 -40.73 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.235 -1.394 . . . . 1.04 107.235 178.593 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -103.68 -0.69 29.18 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.139 -1.43 . . . . 2.44 107.139 177.905 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.539 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 47.7 t-20 60.03 48.74 8.28 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.354 0.597 . . . . 1.55 110.231 179.812 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.694 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 96.5 mt-30 -140.03 153.04 46.7 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.403 -0.81 . . . . 1.99 109.401 179.577 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 66.5 t -119.55 129.94 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.942 -0.762 . . . . 0.77 108.942 179.494 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -103.76 124.87 49.68 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.541 -0.911 . . . . 0.98 108.541 179.247 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 40.6 t -100.74 108.05 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.456 -0.777 . . . . 0.85 110.347 -178.978 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 49.39 66.71 5.3 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.199 -0.938 . . . . 1.66 110.367 179.012 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -85.57 156.23 10.56 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.875 2.383 . . . . 0.95 111.716 179.469 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 42.3 p -72.89 162.6 29.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.207 -0.933 . . . . 1.84 109.673 -179.558 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -59.86 -39.68 86.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.444 -0.785 . . . . 2.74 110.228 -179.537 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -58.03 -39.37 78.2 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.234 -0.916 . . . . 2.89 109.461 -179.037 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 77.1 t -68.96 -41.65 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.019 -1.051 . . . . 1.3 109.369 179.653 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.51 -39.96 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.145 -0.972 . . . . 1.09 109.881 -179.889 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.03 -39.98 87.76 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.796 -1.19 . . . . 2.43 108.706 179.813 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -65.05 -41.63 95.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.316 -0.865 . . . . 2.78 108.923 179.132 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 96.9 mtp -69.96 -34.31 73.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.495 -0.753 . . . . 1.25 109.527 179.891 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -66.56 -40.07 88.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.329 -0.857 . . . . 2.63 109.664 179.689 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.66 -44.07 96.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.141 -0.975 . . . . 1.8 109.532 179.949 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 88.0 t -60.14 -40.59 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.298 -0.876 . . . . 2.13 109.249 -179.982 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -59.97 -40.06 87.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 3.17 109.337 179.916 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.05 -40.02 87.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.924 . . . . 1.78 109.869 -179.65 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -68.77 -40.02 79.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.094 -1.004 . . . . 2.47 109.478 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 74.5 t -62.32 -40.52 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.327 -0.858 . . . . 2.09 109.26 -179.968 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.03 95.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 2.54 109.62 -179.915 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.0 t -60.32 -39.94 88.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 2.99 109.84 -179.802 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -60.31 -39.97 88.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.335 -0.853 . . . . 3.34 110.3 -179.679 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -97.94 24.97 6.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.236 -0.915 . . . . 3.88 109.872 -178.956 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -101.51 -27.21 13.24 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.252 -0.905 . . . . 4.43 109.904 -179.571 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -84.22 -95.18 0.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.027 -1.046 . . . . 5.42 109.842 -179.631 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.529 ' O ' ' HB2' ' A' ' 254' ' ' ALA . 88.5 mt -79.96 -70.11 0.54 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 6.1 109.716 -179.142 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.529 ' HB2' ' O ' ' A' ' 253' ' ' LEU . . . 175.15 -45.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.008 -1.057 . . . . 7.37 109.82 179.85 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -171.42 -154.2 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.111 -0.993 . . . . 8.01 109.969 -179.587 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.89 -40.03 87.38 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.189 -0.944 . . . . 9.05 109.234 -179.429 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -55.58 129.32 38.53 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.958 -1.089 . . . . 10.56 109.233 179.873 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -131.71 31.91 4.19 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.498 -0.751 . . . . 11.32 109.045 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.994 -1.003 . . . . 12.42 109.302 -179.964 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' B' B ' 301' ' ' MET . . . . . 0.426 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 40.7 ttp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.613 0.72 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 302' ' ' PHE . . . . . 0.426 ' N ' ' CG ' ' B' ' 301' ' ' MET . 15.7 t80 -149.81 146.57 27.22 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.451 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 303' ' ' GLN . . . . . 0.473 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 0.2 OUTLIER -150.25 159.98 44.04 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.882 -1.136 . . . . 0.0 110.551 -179.312 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -157.78 154.71 28.56 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.021 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -115.14 133.33 56.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.258 -0.901 . . . . 0.0 109.951 179.6 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 4.2 p -128.95 124.55 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-O 122.279 1.037 . . . . 0.0 112.364 -176.881 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 307' ' ' THR . . . . . 0.415 ' O ' HG23 ' B' ' 309' ' ' THR . 91.6 m -77.81 102.49 7.23 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.825 0.821 . . . . 0.0 110.898 -178.245 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' B' ' 358' ' ' GLY . 97.4 mt -52.92 123.28 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 122.403 1.097 . . . . 0.0 110.813 -178.201 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 309' ' ' THR . . . . . 0.415 HG23 ' O ' ' B' ' 307' ' ' THR . 77.6 p -109.99 20.02 18.4 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.768 -178.368 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -83.13 115.47 59.13 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.1 -1.0 . . . . 0.0 109.854 179.894 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -54.03 -7.2 0.61 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 CA-C-N 120.174 1.098 . . . . 0.0 112.973 179.809 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -117.42 3.53 12.5 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.301 -0.874 . . . . 0.0 109.451 -179.987 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 68.09 -178.9 20.33 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -178.764 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.476 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -83.0 83.29 7.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.686 -1.479 . . . . 0.0 109.593 -178.444 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.472 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 2.6 p80 -91.89 -160.02 0.7 Allowed 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.132 -0.98 . . . . 0.0 109.769 178.403 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.2 m -56.76 -47.7 79.5 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.806 -1.184 . . . . 0.0 112.984 -175.852 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.599 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 11.3 tpt180 -56.35 -59.72 11.19 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 120.388 -1.445 . . . . 0.0 111.919 -179.23 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.472 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 12.0 Cg_endo -58.83 -34.63 99.13 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 CA-C-N 120.369 1.168 . . . . 0.0 111.521 -179.525 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.68 72.8 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.986 179.914 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.78 -44.09 77.41 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.48 -179.078 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -70.01 -41.67 74.03 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.964 -1.095 . . . . 0.0 108.528 179.347 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -63.04 -53.96 45.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.448 -0.783 . . . . 0.0 110.346 -179.733 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 84.2 t -61.77 -28.23 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.528 -1.357 . . . . 0.0 109.768 -179.006 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -64.56 -42.56 95.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.063 -1.023 . . . . 0.0 109.48 -179.92 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -69.77 -42.04 74.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.321 -0.862 . . . . 0.0 111.429 -178.509 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 326' ' ' ALA . . . . . 0.421 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -61.65 -54.66 39.74 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.498 -1.376 . . . . 0.0 111.244 -178.591 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -54.15 -10.21 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.894 -1.129 . . . . 0.0 109.633 -179.672 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 328' ' ' GLY . . . . . 0.421 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -71.96 -28.8 67.99 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.249 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -104.59 144.08 32.18 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.335 -1.097 . . . . 0.0 109.458 -179.661 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 330' ' ' THR . . . . . 0.403 HG22 ' O ' ' B' ' 330' ' ' THR . 91.5 m -90.56 -11.46 40.0 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.137 -0.977 . . . . 0.0 109.742 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 58.9 m -65.58 153.73 40.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.998 . . . . 0.0 109.45 179.999 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.44 134.98 49.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.078 -1.014 . . . . 0.0 109.164 -179.74 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.1 mt -131.89 132.81 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.519 -0.738 . . . . 0.0 109.453 -179.718 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 24.6 m -129.12 149.89 50.74 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.462 -0.774 . . . . 0.0 109.618 -179.814 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 90.8 t -123.66 115.4 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.404 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 94.0 m -113.73 122.8 48.21 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.09 -1.007 . . . . 0.0 110.928 -177.903 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 337' ' ' SER . . . . . 0.428 ' C ' ' H ' ' B' ' 339' ' ' GLY . 16.8 t -121.98 127.84 50.79 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.414 0.626 . . . . 0.0 109.312 178.873 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 35.6 m120 57.77 6.37 0.44 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.601 0.715 . . . . 0.0 109.481 -178.777 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 339' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' B' ' 337' ' ' SER . . . 101.19 13.16 34.23 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.23 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -104.57 121.15 42.91 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.616 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 58.2 p -100.16 151.54 21.31 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.259 1.028 . . . . 0.0 112.54 -177.026 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -149.76 148.72 29.56 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.35 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 343' ' ' SER . . . . . 0.414 ' H ' ' HE2' ' B' ' 349' ' ' LYS . 1.8 t -89.27 130.01 35.74 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.991 -1.068 . . . . 0.0 110.777 -178.725 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -70.16 -19.91 63.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.267 -0.896 . . . . 0.0 110.311 -179.663 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -84.19 21.71 1.34 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.8 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 346' ' ' SER . . . . . 0.589 ' CB ' ' HZ3' ' B' ' 349' ' ' LYS . 14.6 p -152.08 98.14 2.4 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.877 0.846 . . . . 0.0 111.21 179.583 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.65 HD23 HD22 ' A' ' 79' ' ' LEU . 45.9 tp -59.69 -32.74 70.78 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.832 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.801 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.9 m-85 -52.93 -51.88 59.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.329 -0.857 . . . . 0.0 111.386 -179.625 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 349' ' ' LYS . . . . . 0.589 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 33.6 mtmm -70.01 -40.0 75.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.727 -1.233 . . . . 0.0 111.108 -178.324 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' B' ' 352' ' ' THR . 88.7 mt -49.08 -57.09 7.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.798 -1.189 . . . . 0.0 109.931 -178.832 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.714 ' NE2' ' HE ' ' A' ' 126' ' ' ARG . 4.0 mm100 -44.86 -10.84 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.053 -1.029 . . . . 0.0 111.15 -177.697 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.565 ' N ' ' O ' ' B' ' 350' ' ' LEU . 72.5 p -87.24 -13.34 44.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 119.895 -1.753 . . . . 0.0 110.258 -178.978 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 53.0 mt -94.77 122.41 37.36 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.931 -1.106 . . . . 0.0 109.499 179.001 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.1 92.14 1.04 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 179.368 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 25.8 mt -101.83 95.37 6.36 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.424 -1.045 . . . . 0.0 109.176 179.817 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 75.0 p -93.64 -179.74 5.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.222 -0.924 . . . . 0.0 111.048 -178.954 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -69.27 114.16 7.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.711 -0.618 . . . . 0.0 110.51 -179.508 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 358' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 99.99 10.17 46.73 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.759 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 53.2 m -87.18 111.39 20.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -1.094 . . . . 0.0 110.195 -179.822 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 68.0 t -77.08 114.61 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.024 0.916 . . . . 0.0 109.61 -177.384 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 11.8 m -108.26 176.7 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -178.936 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 43.3 m -131.61 126.62 35.19 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.597 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.3 mt -103.49 117.79 49.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.398 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 64.8 m -118.72 130.82 56.03 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.108 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.41 150.8 39.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.267 -178.995 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -145.49 124.36 12.7 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.268 -0.895 . . . . 0.0 109.059 179.579 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.558 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.6 -154.49 25.57 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.403 -1.38 . . . . 0.0 111.072 -179.602 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -59.98 -50.63 73.01 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.468 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.419 ' N ' ' OG ' ' B' ' 331' ' ' SER . 85.1 m-20 -110.03 11.03 24.06 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.838 -1.163 . . . . 0.0 111.192 -177.193 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -40.84 -36.21 0.6 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.334 -0.853 . . . . 0.0 111.79 -178.992 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -69.13 -41.32 77.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.65 -1.281 . . . . 0.0 110.007 -178.526 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -72.97 -54.93 7.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.001 -1.062 . . . . 0.0 110.062 179.763 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -42.33 -34.33 0.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.545 -0.722 . . . . 0.0 111.238 -178.766 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.561 ' O ' HG23 ' B' ' 378' ' ' VAL . 93.3 t -80.0 -35.47 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.758 -1.214 . . . . 0.0 109.55 179.289 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -69.95 -39.99 75.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 112.303 -179.112 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -80.08 -46.61 16.21 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.383 -1.448 . . . . 0.0 110.432 -179.465 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.0 -38.03 81.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.889 . . . . 0.0 108.995 -179.637 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.561 HG23 ' O ' ' B' ' 374' ' ' VAL . 26.9 t -61.5 -48.22 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.277 -0.889 . . . . 0.0 109.718 179.381 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.02 -56.51 6.77 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.625 -1.297 . . . . 0.0 107.613 178.785 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.449 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 46.6 tp -52.51 -32.19 39.12 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.364 -0.835 . . . . 0.0 109.201 -179.176 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 34.3 ttm -76.07 -39.63 54.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 0.0 108.63 177.74 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.12 -5.06 50.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.58 -0.7 . . . . 0.0 109.873 179.614 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -108.26 3.74 23.89 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.29 -0.881 . . . . 0.0 110.499 -179.364 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' B' B ' 384' ' ' LEU . . . . . 0.449 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 27.6 mt -74.84 125.4 28.73 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.453 -1.404 . . . . 0.0 109.543 179.708 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.323 179.715 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtt . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.449 -0.575 . . . . 2.91 109.449 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.1 mt -109.9 129.23 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.504 -0.748 . . . . 1.2 109.201 179.808 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.6 m -140.64 122.33 15.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.306 -0.871 . . . . 1.4 109.607 -179.903 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.44 -161.47 31.4 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 108.962 -1.655 . . . . 1.05 108.962 179.319 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 5' ' ' ILE . 97.3 mt -90.22 -9.96 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.114 -1.227 . . . . 1.15 110.42 -179.028 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.6 tp 52.55 99.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.974 -1.079 . . . . 0.98 109.441 179.884 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.27 -27.31 15.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.118 -0.989 . . . . 0.88 109.535 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.0 t -136.4 121.14 12.91 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.385 -0.822 . . . . 1.69 109.22 179.944 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.08 144.77 24.02 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.788 1.659 . . . . 0.85 111.989 -179.949 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.885 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.72 -159.88 30.99 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.117 -1.593 . . . . 0.92 109.117 -179.576 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.479 HD12 HE22 ' A' ' 243' ' ' GLN . 86.8 mt -149.94 151.64 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 121.248 -1.148 . . . . 0.81 108.587 179.041 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.78 156.49 34.87 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.735 -1.228 . . . . 0.51 110.561 179.261 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -138.27 128.4 25.74 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.375 -1.343 . . . . 0.62 107.375 178.752 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.85 -179.84 47.61 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 118.666 -1.73 . . . . 0.55 110.823 -179.819 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -80.07 159.38 26.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.757 -0.849 . . . . 2.1 109.35 -179.832 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.524 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -107.09 131.51 54.02 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.408 -0.807 . . . . 0.77 111.011 -179.076 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.7 tp -98.7 139.54 34.25 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.245 -1.391 . . . . 0.91 107.245 178.161 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 34.2 tp -117.06 121.32 40.98 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.288 -0.883 . . . . 0.93 110.305 -178.971 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.422 HD12 ' HB2' ' A' ' 160' ' ' ALA . 45.4 mt -96.41 107.74 20.17 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.384 0.611 . . . . 0.93 110.036 179.905 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.623 ' HB2' ' HZ3' ' A' ' 20' ' ' LYS . 1.5 mtmp? -101.87 139.61 37.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.462 -0.774 . . . . 2.75 109.044 179.493 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -128.27 121.75 30.04 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.407 -0.808 . . . . 3.0 108.829 179.419 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 59.3 t0 -75.79 146.53 39.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.084 -1.01 . . . . 2.77 109.598 179.859 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.5 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 84.9 tt0 -61.63 140.19 58.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.406 -0.809 . . . . 2.94 109.823 -179.793 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.4 mt -78.89 132.93 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 0.95 108.872 179.954 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -94.81 122.33 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.022 -1.049 . . . . 1.28 109.961 -179.389 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.05 138.54 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.083 -0.71 . . . . 1.21 109.083 179.979 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -89.43 123.47 33.6 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.059 -1.026 . . . . 1.81 110.255 -179.347 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.547 HH11 ' HG2' ' A' ' 28' ' ' ARG . 0.8 OUTLIER -93.96 3.81 54.82 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.379 -0.826 . . . . 2.8 109.651 -179.962 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -72.92 151.34 41.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.272 -0.892 . . . . 2.87 111.17 -178.753 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -93.24 145.61 24.31 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.581 -0.896 . . . . 2.35 108.581 179.092 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -98.46 167.02 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.071 -1.018 . . . . 0.97 110.297 -179.907 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.2 p -93.74 171.79 8.66 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.492 -0.929 . . . . 1.17 108.492 178.658 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.07 -47.21 86.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.044 -1.035 . . . . 1.18 109.45 -179.915 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -55.86 -31.9 63.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.951 -1.093 . . . . 2.56 109.834 -179.26 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -81.5 -10.23 59.52 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.347 -0.845 . . . . 1.79 110.608 -179.091 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.4 t -60.09 -49.98 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.977 -1.077 . . . . 1.0 109.132 -179.96 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.96 -40.02 91.76 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.341 -0.85 . . . . 1.77 109.614 179.799 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.58 -46.0 87.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.245 -0.909 . . . . 2.7 111.551 -178.837 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -61.39 -42.53 98.88 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.599 -1.313 . . . . 1.51 110.457 -179.085 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.04 -46.58 94.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.55 -1.344 . . . . 0.93 108.184 179.92 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -61.6 -43.9 98.0 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.257 -0.902 . . . . 1.81 109.786 179.34 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -59.99 -41.15 91.43 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.745 -1.222 . . . . 2.78 107.764 179.557 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -63.3 -44.61 94.52 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.708 -0.849 . . . . 0.78 108.708 178.246 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.08 -47.84 84.19 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.57 -0.706 . . . . 1.07 109.222 179.971 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.1 t -63.96 -44.98 91.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.065 -1.022 . . . . 1.12 108.908 179.362 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.56 -39.95 98.04 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.763 -2.135 . . . . 0.84 107.763 178.554 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.421 HH21 ' HA ' ' A' ' 81' ' ' GLU . 68.5 ttt180 -67.16 -35.81 80.47 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.572 -0.899 . . . . 3.09 108.572 178.63 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.97 87.62 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.554 -0.716 . . . . 0.88 109.621 -179.611 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.9 ttpt -64.91 -73.77 0.12 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.883 -1.136 . . . . 2.59 108.372 179.491 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.67 -38.57 0.28 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.38 -0.825 . . . . 0.7 111.203 -178.165 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.1 m -54.04 -56.85 14.1 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.718 -1.239 . . . . 1.4 108.939 179.732 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.92 88.3 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.22 -0.925 . . . . 0.67 111.123 -179.163 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -68.46 -40.07 81.17 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.956 -1.09 . . . . 1.66 109.978 -179.2 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.6 mt -65.54 -40.01 92.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.077 -1.014 . . . . 1.58 109.975 179.897 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.539 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 69.3 mm-40 -61.53 -39.96 92.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.084 -1.01 . . . . 1.35 109.869 -179.815 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -62.84 -40.03 96.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.021 -1.049 . . . . 0.77 109.967 -179.931 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.05 -39.85 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.179 -0.95 . . . . 0.63 108.911 179.669 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.539 ' NZ ' ' OE1' ' A' ' 55' ' ' GLU . 5.2 ttpm? -55.92 -49.98 71.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.92 . . . . 1.14 109.081 179.74 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -57.51 -33.54 68.15 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.374 -0.829 . . . . 0.79 110.512 -178.318 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -69.97 -38.86 76.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.897 -1.127 . . . . 1.53 110.005 179.965 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.462 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.23 -45.51 76.54 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.401 -0.812 . . . . 0.57 110.487 -179.241 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.66 -50.03 72.15 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.917 -1.135 . . . . 0.75 110.45 -178.68 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.95 -42.88 72.62 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.076 -1.25 . . . . 1.59 110.325 -179.563 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.9 m -70.13 -61.37 1.8 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.206 -0.934 . . . . 0.73 112.744 -177.678 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -93.3 -49.36 5.99 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.679 -1.263 . . . . 0.75 110.711 -178.437 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.76 -167.89 25.77 Favored Glycine 0 N--CA 1.5 2.918 0 C-N-CA 119.936 -1.125 . . . . 1.22 110.849 179.65 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -68.55 -22.12 64.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.805 -0.821 . . . . 5.81 109.859 -179.889 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -60.04 -36.22 76.82 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.654 -0.653 . . . . 3.37 110.371 -179.531 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -101.19 -15.43 17.35 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.352 -0.843 . . . . 1.77 110.322 -179.449 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -69.97 -40.2 75.51 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.933 -1.104 . . . . 1.65 110.585 -179.311 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.563 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -69.8 -28.65 65.91 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.611 -0.836 . . . . 0.77 109.91 -178.564 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.7 mt -60.06 -41.92 88.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.022 -1.071 . . . . 0.8 109.143 -179.903 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -65.88 -40.01 91.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.954 -1.091 . . . . 0.88 109.921 179.99 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -60.15 -40.41 89.77 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.9 -1.125 . . . . 1.37 109.254 179.834 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.86 -41.48 98.76 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.064 -2.014 . . . . 0.62 108.064 178.9 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.3 m170 -70.09 -43.69 70.56 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.618 -0.931 . . . . 1.5 108.595 179.169 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.9 mt -70.04 -46.63 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.367 -0.833 . . . . 0.63 109.369 179.433 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.5 ttp -60.68 -44.8 96.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.057 -1.027 . . . . 1.51 109.687 -179.61 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.859 HD11 ' CE2' ' B' ' 348' ' ' PHE . 50.8 tp -60.0 -40.06 87.91 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.802 -0.814 . . . . 0.77 108.802 179.142 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.7 tp -62.94 -39.95 96.16 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.671 -0.643 . . . . 0.62 109.537 179.614 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.421 ' HA ' HH21 ' A' ' 47' ' ' ARG . 99.7 mt-10 -79.44 5.2 13.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -0.861 . . . . 1.47 110.127 -179.14 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -56.08 128.99 38.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 1.47 110.291 -179.309 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -63.04 -14.08 43.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.591 -0.693 . . . . 1.78 110.059 -179.985 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -70.08 -37.08 75.37 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.231 -1.025 . . . . 2.53 108.231 178.505 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.03 -39.98 75.46 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.658 0.742 . . . . 0.8 109.757 179.407 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -60.05 -45.48 92.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.59 -0.694 . . . . 1.42 110.895 -178.417 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -70.78 -48.55 53.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.257 -0.902 . . . . 1.71 111.667 -178.584 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -64.16 -39.9 95.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.352 -0.842 . . . . 1.57 111.734 -177.409 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -66.27 -47.77 83.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 120.838 -1.164 . . . . 0.65 109.857 -179.541 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -70.01 -39.04 76.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.415 -0.803 . . . . 0.82 110.671 -179.674 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.97 -48.86 79.95 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.173 -0.954 . . . . 0.79 111.045 -178.917 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 96' ' ' LYS . 75.7 mt -60.01 -44.9 94.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.917 -1.115 . . . . 0.95 109.501 -178.955 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.8 mt -60.23 -50.0 81.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.76 -1.2 . . . . 0.66 107.76 178.86 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -65.07 -40.05 94.14 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 120.024 -0.67 . . . . 2.2 110.243 179.359 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 91' ' ' ALA . 56.7 t0 -84.26 -55.11 4.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.995 -1.066 . . . . 1.65 112.277 -178.241 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 92' ' ' LEU . 99.0 mttt -90.04 -1.98 58.05 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.812 -1.18 . . . . 2.03 112.145 -177.348 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 57.85 37.54 26.99 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.846 -1.159 . . . . 1.42 109.379 -179.534 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.9 mtt -93.04 166.38 12.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.497 -0.752 . . . . 1.18 109.879 -179.758 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.4 p -79.95 160.0 26.11 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.034 -0.728 . . . . 0.98 109.034 179.678 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.05 77.59 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.321 -0.862 . . . . 0.64 109.755 -179.999 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.43 ' OD1' HD22 ' A' ' 138' ' ' LEU . 20.3 t0 -65.51 -40.03 92.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.084 -1.01 . . . . 2.07 109.521 179.665 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.6 -43.12 23.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.73 110.352 -179.684 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.05 -41.69 73.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 0.54 110.278 -179.442 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.95 -39.68 95.39 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.122 -0.986 . . . . 0.56 109.474 179.956 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.546 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 81.1 t60 -59.62 -40.07 86.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.551 -0.718 . . . . 1.54 109.578 -178.804 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.422 ' O ' ' N ' ' A' ' 110' ' ' GLY . 87.2 tt0 -64.61 -40.02 94.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.305 -0.872 . . . . 1.33 110.55 -179.655 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.3 t -63.86 -60.61 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.148 -0.97 . . . . 0.72 111.478 -178.308 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.0 mm -65.06 -39.96 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.855 -1.153 . . . . 0.85 109.268 -179.459 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.546 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 85.3 tt0 -67.04 -39.98 87.08 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.076 -1.083 . . . . 2.44 108.076 178.275 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -56.82 -52.14 52.67 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.23 -1.148 . . . . 0.98 110.23 -179.27 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -65.07 -48.14 74.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.785 -1.421 . . . . 1.41 109.197 -179.848 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.08 85.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 1.2 109.03 179.676 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.5 m -59.57 -39.87 85.5 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.468 -0.77 . . . . 1.7 109.018 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.44 -40.03 92.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 1.47 109.015 179.02 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.2 mt -64.2 -41.87 96.88 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.273 -0.892 . . . . 1.56 109.784 -179.247 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.02 -33.78 72.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.822 -1.174 . . . . 2.2 109.783 -179.272 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -56.92 -20.52 23.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.108 -0.995 . . . . 2.12 108.927 179.949 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.0 mt -62.63 138.66 58.54 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.188 -1.041 . . . . 2.0 108.188 179.469 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 57.9 t0 -94.69 54.97 1.84 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.931 -1.105 . . . . 3.23 110.086 -179.611 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 58.9 t0 -136.1 136.7 40.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.345 -0.847 . . . . 2.49 108.938 179.23 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.461 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 98.9 mt-10 -70.02 -31.61 69.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.42 -0.8 . . . . 3.95 109.964 -179.537 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.508 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.4 t80 -72.64 -38.86 67.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.871 . . . . 2.0 110.728 179.886 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.409 HD22 ' O ' ' B' ' 351' ' ' GLN . 70.7 mt -74.12 -36.26 64.18 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.975 -1.078 . . . . 1.86 109.745 -179.369 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -60.04 -40.0 87.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.015 -1.053 . . . . 2.84 109.357 179.601 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -60.0 -47.31 86.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 2.73 109.482 179.957 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.545 HH21 ' NE2' ' B' ' 351' ' ' GLN . 62.0 mtp180 -60.18 -39.98 88.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.963 . . . . 2.77 108.663 179.201 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.53 -36.12 77.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.82 . . . . 1.19 108.846 178.972 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.89 -40.02 96.26 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.081 -0.711 . . . . 1.2 109.081 179.684 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -64.22 -40.93 97.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 1.55 110.111 -179.352 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.55 -41.88 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.8 109.616 -179.889 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -60.01 -38.1 81.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.141 -0.974 . . . . 3.09 109.4 179.48 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -59.92 -40.88 90.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 1.46 110.361 -178.948 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.19 -45.01 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.894 -1.129 . . . . 0.71 109.581 179.815 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.97 -37.91 93.64 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.713 -1.355 . . . . 0.57 109.713 179.995 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -60.03 -47.6 85.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -1.111 . . . . 2.59 109.56 -179.378 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.418 HH12 ' HB3' ' A' ' 166' ' ' SER . 61.0 mtp180 -68.76 -33.16 73.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.238 -0.914 . . . . 2.83 109.637 -179.772 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.7 tp -57.28 -43.7 83.37 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.355 -0.841 . . . . 1.25 108.995 -179.788 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.43 HD22 ' OD1' ' A' ' 101' ' ' ASP . 84.1 mt -63.66 -39.96 95.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.13 -0.982 . . . . 0.7 108.654 179.145 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.6 mtp180 -66.89 -39.97 87.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.912 -0.773 . . . . 2.57 108.912 179.465 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -69.44 -31.7 70.18 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.554 -0.716 . . . . 1.23 110.941 -179.31 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.0 mt -70.04 -43.29 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.401 -1.437 . . . . 0.81 108.193 178.728 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 88.9 mt -71.56 -29.99 65.36 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.792 -0.568 . . . . 1.0 109.901 -179.708 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.69 40.33 8.31 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.983 -1.647 . . . . 0.89 108.983 -179.28 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.405 ' HA ' HD12 ' A' ' 144' ' ' LEU . 18.5 tp -73.99 146.36 43.88 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.386 -1.067 . . . . 1.14 109.14 -179.479 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -65.08 147.92 52.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -0.894 . . . . 4.6 110.002 -178.892 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 98.6 mt -118.89 125.63 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 122.093 0.949 . . . . 1.24 109.325 179.49 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 148' ' ' ASP . 5.5 mt -62.38 -43.58 98.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.87 -0.605 . . . . 1.54 110.219 -178.859 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 147' ' ' ILE . 32.2 t0 62.01 125.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.968 -0.753 . . . . 1.5 108.968 -179.126 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.4 mt -87.08 -2.09 58.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.256 -0.903 . . . . 0.79 109.639 -179.274 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 93.8 p -82.26 -9.96 59.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.916 -1.115 . . . . 1.4 108.752 178.951 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -88.71 18.54 4.61 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.666 . . . . 0.92 110.925 -177.818 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 65.2 mt -91.74 116.92 33.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.871 -1.143 . . . . 0.88 109.15 179.621 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -103.03 -12.03 17.72 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.251 -0.905 . . . . 2.45 110.206 -179.268 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -116.01 145.72 42.74 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.318 -0.864 . . . . 1.52 110.347 -178.805 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.81 131.97 50.63 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.496 -0.928 . . . . 1.58 108.496 179.584 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.7 m -152.57 165.23 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.69 109.954 -179.947 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.5 mt -93.31 148.8 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 105.215 -2.142 . . . . 0.61 105.215 176.776 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 39.9 tp -99.35 120.01 38.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.838 -1.164 . . . . 0.87 110.609 -177.836 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 49.6 t -123.59 130.08 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 108.752 -0.833 . . . . 0.71 108.752 179.343 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 160' ' ' ALA . . . . . 0.422 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -156.72 162.69 39.78 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.4 -0.963 . . . . 0.81 108.4 179.837 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.95 -35.83 74.8 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.185 -1.572 . . . . 0.98 107.315 178.547 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 20.8 p-10 -171.21 144.69 2.09 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.582 -0.895 . . . . 2.25 108.582 179.287 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.2 mt -111.78 139.83 46.93 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.253 -0.905 . . . . 0.78 109.863 -179.438 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.1 p -93.19 145.28 29.77 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.392 -0.818 . . . . 0.98 109.501 -179.929 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -39.36 -36.94 1.03 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.405 2.07 . . . . 0.81 113.273 179.458 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.418 ' HB3' HH12 ' A' ' 136' ' ' ARG . 68.5 m -60.01 -39.97 87.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.026 -1.046 . . . . 0.9 109.776 -178.661 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.03 -42.0 90.19 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.023 -1.048 . . . . 1.61 110.217 -179.506 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 67.8 p -54.96 -30.61 59.41 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.136 -0.977 . . . . 0.61 110.598 -178.4 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.462 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -71.36 -54.27 11.33 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.028 -1.045 . . . . 0.6 109.879 179.77 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -87.32 39.15 0.85 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.183 -1.043 . . . . 1.4 108.183 179.88 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 33.7 tp -100.22 130.62 46.37 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.622 -0.674 . . . . 0.7 109.307 179.472 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 172' ' ' ASN . . . . . 0.469 ' O ' HG23 ' A' ' 176' ' ' VAL . 77.8 m-20 -82.12 98.5 8.71 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.185 -1.043 . . . . 2.35 108.185 179.307 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 73.6 mt -67.16 -40.52 86.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.378 -0.826 . . . . 1.51 110.872 -178.592 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.39 -30.32 71.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.651 -1.281 . . . . 2.33 112.094 -177.714 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.65 -5.86 50.57 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.712 -1.243 . . . . 1.92 110.061 -178.734 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 178' ' ' GLY . 84.0 t -106.24 116.62 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.134 -0.979 . . . . 0.67 109.307 179.652 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 78.1 mt -88.04 9.96 20.71 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.475 -0.765 . . . . 1.53 110.997 -177.786 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.507 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 165.64 176.59 37.22 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.62 -1.392 . . . . 0.48 109.62 179.858 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -137.64 131.21 31.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.456 -1.026 . . . . 0.55 108.853 -179.82 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.402 ' CG2' HG21 ' A' ' 205' ' ' THR . 97.4 mt -133.46 130.0 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.772 -0.825 . . . . 0.65 108.772 179.002 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 72.1 p -148.4 160.0 43.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.965 -1.084 . . . . 0.82 110.855 -179.82 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -109.03 31.18 5.9 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.192 -1.04 . . . . 2.46 108.192 178.966 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.35 -160.44 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.919 -1.113 . . . . 1.28 111.516 -177.605 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.4 -67.68 1.99 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.34 -1.104 . . . . 2.19 110.34 -179.092 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 178.39 -130.98 1.65 Allowed Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.974 -1.584 . . . . 2.13 110.981 -179.802 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -79.46 -10.01 59.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.634 -0.921 . . . . 5.86 111.025 -178.504 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 42.9 p -81.8 4.87 20.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.968 -1.083 . . . . 3.72 109.687 -179.253 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.421 ' OG ' ' OG ' ' A' ' 191' ' ' SER . 23.4 p -90.43 137.54 32.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.134 -0.979 . . . . 1.74 110.593 -179.522 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -48.34 -47.86 36.7 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.475 -0.766 . . . . 0.95 109.673 179.977 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 98.5 m -57.4 -37.79 73.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.455 -0.778 . . . . 1.55 110.717 -178.992 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.421 ' OG ' ' OG ' ' A' ' 188' ' ' SER . 52.8 m -60.03 -39.9 87.49 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.854 -1.154 . . . . 1.51 110.354 -178.97 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 45.1 mm -64.85 -40.05 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 1.67 110.128 -179.599 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.3 mtp -60.1 -46.87 88.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.091 -1.006 . . . . 1.02 110.701 -179.765 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.71 -45.58 77.86 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.537 -1.352 . . . . 0.68 109.378 -179.589 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -60.1 -54.98 39.57 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.0 -1.062 . . . . 2.93 109.468 179.67 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 69.3 m -63.09 -40.05 96.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 0.86 110.966 -179.3 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.16 -29.17 64.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.985 -1.072 . . . . 0.67 108.468 179.73 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.97 50.03 1.09 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.285 0.564 . . . . 1.5 110.277 -179.842 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 32.7 mt -124.95 145.97 51.89 Favored Pre-proline 0 N--CA 1.503 2.212 0 N-CA-C 108.497 -0.927 . . . . 0.72 108.497 178.91 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.27 125.29 7.04 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.094 1.862 . . . . 0.61 112.555 179.737 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.26 141.23 7.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.489 -1.382 . . . . 0.66 112.154 179.866 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.84 147.14 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 107.173 -1.417 . . . . 0.79 107.173 177.811 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 17.3 m -130.78 -7.53 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 120.833 -1.167 . . . . 0.91 111.177 -178.991 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.99 23.05 24.37 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.454 -1.058 . . . . 1.01 110.454 -179.497 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.415 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 2.4 p -45.38 -44.18 11.67 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.93 -1.335 . . . . 0.99 109.88 -179.602 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 93.5 -51.65 2.38 Favored Glycine 0 N--CA 1.5 2.93 0 C-N-CA 120.129 -1.034 . . . . 1.12 111.742 178.692 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.3 t -161.9 36.23 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.577 -1.543 . . . . 1.72 110.676 -179.354 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 52.6 t -74.32 -40.83 50.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.215 -0.928 . . . . 0.89 108.934 178.409 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 209' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 209' ' ' THR . 1.5 p -53.1 -31.93 44.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.403 -0.811 . . . . 1.03 110.063 -179.147 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 39.8 t -71.11 -33.35 70.05 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.168 -0.957 . . . . 1.83 109.741 -179.741 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -89.46 -9.95 48.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 2.27 110.274 -178.995 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 69.6 t -101.52 132.85 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.254 -0.904 . . . . 0.92 110.463 -178.887 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -114.15 153.52 29.4 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.549 -1.278 . . . . 2.2 107.549 178.834 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 42.4 t30 -58.8 138.7 57.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.946 -1.097 . . . . 2.36 110.345 -178.605 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 11.6 t0 83.78 5.28 0.76 Allowed 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.113 0.482 . . . . 2.38 109.998 179.699 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.4 t0 -75.72 140.86 42.68 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.071 -1.018 . . . . 2.09 108.862 179.146 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.498 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 51.3 t80 -93.29 117.06 29.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.146 -0.971 . . . . 1.27 108.41 179.155 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.524 HD12 ' HB2' ' A' ' 16' ' ' ALA . 57.4 mt -126.42 147.35 49.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.526 -0.734 . . . . 0.75 110.379 -178.929 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 219' ' ' ILE . . . . . 0.413 HG23 ' CD2' ' A' ' 13' ' ' PHE . 86.8 mt -114.34 130.02 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 107.664 -1.236 . . . . 0.63 107.664 177.554 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 32.7 tp -100.17 118.18 35.96 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.938 -1.101 . . . . 0.7 109.571 -179.096 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.645 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 26.4 p-10 -77.64 -42.84 33.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.068 -1.02 . . . . 2.31 108.591 179.231 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.885 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 52.1 17.27 0.66 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.796 -1.187 . . . . 0.78 107.796 -178.905 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.436 ' N ' ' C ' ' A' ' 221' ' ' ASP . 45.6 t -130.86 -43.66 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.708 -1.219 . . . . 1.04 107.708 179.362 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -99.14 -0.52 41.5 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.805 -1.554 . . . . 2.44 106.805 177.942 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.521 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 40.4 t-20 60.06 46.72 10.43 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.423 -0.584 . . . . 1.55 109.423 -179.933 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 226' ' ' GLN . . . . . 0.645 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 95.3 mt-30 -140.46 157.23 45.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.385 -0.822 . . . . 1.99 109.647 -179.945 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 69.5 t -119.96 130.58 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 109.085 -0.709 . . . . 0.77 109.085 179.437 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -99.33 122.74 42.89 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.576 -0.898 . . . . 0.98 108.576 179.001 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 229' ' ' VAL . . . . . 0.502 HG22 HD22 ' A' ' 218' ' ' LEU . 59.4 t -105.61 120.0 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.568 -0.707 . . . . 0.85 109.445 -179.242 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 52.5 t30 62.96 66.76 1.17 Allowed Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.372 -0.83 . . . . 1.66 109.53 -179.731 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -89.16 127.78 1.79 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 123.142 2.561 . . . . 0.95 112.517 -179.664 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 26.0 p -75.33 170.47 16.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 1.84 109.623 -179.753 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -60.03 -39.44 85.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 2.74 109.088 179.67 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.08 -39.97 87.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.409 -0.807 . . . . 2.89 109.634 -179.382 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.6 t -67.24 -41.7 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.062 -1.024 . . . . 1.3 109.152 179.96 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 87.7 mt -64.97 -40.19 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.193 -0.942 . . . . 1.09 109.921 -179.628 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -60.09 -46.02 90.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.872 -1.142 . . . . 2.43 108.276 179.745 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 8.3 ttpm? -61.03 -43.38 98.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.3 -0.875 . . . . 2.78 108.853 179.013 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 92.6 mtp -67.93 -34.68 77.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.404 -0.81 . . . . 1.25 109.864 -179.94 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -62.98 -40.03 96.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.076 -1.015 . . . . 2.63 109.535 179.463 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.77 -39.3 84.4 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.175 -0.953 . . . . 1.8 108.532 179.781 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 89.9 t -59.93 -39.43 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.456 -0.942 . . . . 2.13 108.456 179.201 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 243' ' ' GLN . . . . . 0.479 HE22 HD12 ' A' ' 11' ' ' ILE . 40.2 tp60 -60.0 -39.9 87.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.411 -0.806 . . . . 3.17 109.601 -179.947 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -60.04 -40.03 87.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.082 -1.012 . . . . 1.78 109.344 -179.911 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -68.89 -40.03 79.42 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.106 -0.996 . . . . 2.47 108.565 179.291 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 68.2 t -68.03 -39.51 81.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.858 -0.793 . . . . 2.09 108.858 179.333 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.33 -39.96 84.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.51 -0.744 . . . . 2.54 109.715 -179.364 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 29.0 t -60.0 -43.51 95.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.852 -1.155 . . . . 2.99 108.676 179.434 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -70.03 -40.01 75.44 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.461 -0.774 . . . . 3.34 109.021 179.551 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -66.77 -34.3 77.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.833 . . . . 3.88 108.83 179.615 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -64.18 -52.83 57.06 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.225 -0.922 . . . . 4.43 109.885 -179.844 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -69.98 -40.09 75.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.295 -0.878 . . . . 5.42 111.076 -179.283 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 5.4 mt 49.91 55.49 9.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.97 -1.081 . . . . 6.1 108.158 -179.002 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -160.72 47.16 0.22 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.377 -0.827 . . . . 7.37 109.309 179.92 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -141.66 163.57 32.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.256 -0.903 . . . . 8.01 109.016 -179.777 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 35.8 mt -44.22 110.62 0.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.542 -0.724 . . . . 9.05 109.87 -179.509 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -86.03 7.43 24.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.301 -0.875 . . . . 10.56 108.809 179.54 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -60.02 -40.07 88.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.685 -1.259 . . . . 11.32 109.951 -179.743 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? . . . . . 0 N--CA 1.491 1.604 0 O-C-N 120.828 -1.17 . . . . 12.42 109.354 -179.979 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 43.9 ttm . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.581 0.705 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 038 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -151.16 149.4 29.43 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.121 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -146.19 154.98 42.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.063 -1.023 . . . . 0.0 110.393 -179.226 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -150.36 146.72 26.89 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.598 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 305' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 56.8 mp0 -110.21 127.82 55.16 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.249 -0.907 . . . . 0.0 109.623 179.334 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.35 122.8 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 CA-C-O 122.295 1.045 . . . . 0.0 112.807 -176.849 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 58.8 m -77.95 101.52 6.9 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.997 0.903 . . . . 0.0 110.268 -178.987 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 308' ' ' ILE . . . . . 0.522 HG22 ' H ' ' B' ' 310' ' ' ALA . 96.9 mt -50.81 118.45 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 122.204 1.002 . . . . 0.0 109.923 -177.874 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 19.1 p -100.35 22.14 12.04 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.676 -178.776 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.522 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -86.82 114.24 57.16 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.97 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -68.82 -4.86 14.17 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 CA-C-N 120.227 1.117 . . . . 0.0 112.456 -179.283 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -108.76 4.81 24.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.518 -0.738 . . . . 0.0 109.101 179.741 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.6 169.77 8.65 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 -179.051 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.508 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -86.14 92.05 8.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.3 . . . . 0.0 108.846 -179.138 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.405 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 5.4 p80 -95.23 -159.94 0.75 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.085 -1.009 . . . . 0.0 109.98 179.029 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.3 m -58.92 -44.67 91.36 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.931 -1.106 . . . . 0.0 112.611 -175.995 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.629 HH21 ' NE2' ' B' ' 321' ' ' GLN . 1.6 tpt180 -59.88 -60.59 10.09 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 120.487 -1.383 . . . . 0.0 112.027 -178.257 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.405 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 12.0 Cg_endo -59.94 -32.04 94.55 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 CA-C-N 120.362 1.165 . . . . 0.0 111.338 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.28 70.32 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.431 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.78 -40.09 65.99 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.601 -179.079 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 321' ' ' GLN . . . . . 0.629 ' NE2' HH21 ' B' ' 317' ' ' ARG . 55.3 mt-30 -69.87 -41.0 75.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.985 -1.072 . . . . 0.0 108.662 179.061 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -60.05 -51.26 70.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.72 -0.612 . . . . 0.0 110.343 -179.223 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 323' ' ' VAL . . . . . 0.401 HG13 ' O ' ' B' ' 344' ' ' ALA . 71.1 t -69.68 -35.75 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.946 -1.096 . . . . 0.0 109.743 -179.134 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -50.05 -49.89 49.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.387 -0.821 . . . . 0.0 109.122 -179.792 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -60.07 -49.9 75.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.269 -0.895 . . . . 0.0 109.339 -179.387 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -63.14 -47.11 84.11 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.157 -0.964 . . . . 0.0 109.765 179.765 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -48.4 -26.64 2.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.531 -0.73 . . . . 0.0 109.678 -179.339 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -82.59 -15.74 72.7 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.655 -179.181 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -105.72 135.0 47.92 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.26 -1.141 . . . . 0.0 109.434 179.736 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 16.9 m -90.6 -13.36 34.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.977 -1.077 . . . . 0.0 109.246 179.651 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 52.0 p -55.05 148.77 13.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.228 -0.92 . . . . 0.0 108.848 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -68.35 128.72 37.61 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.002 -1.061 . . . . 0.0 108.567 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 95.3 mt -132.34 132.32 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.675 -0.641 . . . . 0.0 109.352 -179.809 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 27.1 m -130.63 152.36 50.08 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.449 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 46.0 t -114.73 140.16 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 178.521 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 94.2 m -130.13 122.69 28.72 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.196 -0.94 . . . . 0.0 108.646 179.604 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 2.8 t -140.53 118.14 11.59 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.936 0.875 . . . . 0.0 112.065 -178.906 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 64.1 t30 50.05 50.5 18.42 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 175.806 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.95 -10.77 72.77 Favored Glycine 0 N--CA 1.502 3.089 0 O-C-N 119.802 -1.811 . . . . 0.0 113.85 176.11 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -128.26 140.31 51.96 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 120.022 1.911 . . . . 0.0 109.514 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.7 m -126.74 147.79 49.95 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.818 0.818 . . . . 0.0 111.377 -178.266 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.3 164.58 29.86 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.309 0.576 . . . . 0.0 109.694 179.98 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 27.3 m -88.63 138.01 31.8 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.319 -0.863 . . . . 0.0 110.03 -179.326 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.401 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -78.9 -12.0 60.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.896 -1.127 . . . . 0.0 109.86 -179.479 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -91.87 20.15 5.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 178.042 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 42.6 t -145.89 94.44 2.48 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.013 -179.699 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.816 HD23 HD22 ' A' ' 79' ' ' LEU . 60.8 tp -59.88 -33.85 72.38 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.829 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 79' ' ' LEU . 58.9 m-85 -57.25 -53.68 55.38 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.32 -0.863 . . . . 0.0 110.76 -179.337 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -70.01 -29.63 66.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.868 -1.145 . . . . 0.0 110.951 -177.989 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' B' ' 352' ' ' THR . 84.8 mt -60.06 -52.86 63.55 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.157 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.61 HE22 HD11 ' B' ' 347' ' ' LEU . 0.7 OUTLIER -42.42 -21.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.436 -0.79 . . . . 0.0 110.674 -178.009 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.463 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.1 p -81.74 -12.25 58.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.406 -1.434 . . . . 0.0 109.964 -179.112 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 31.4 mt -95.39 120.08 35.0 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.95 -1.094 . . . . 0.0 109.082 178.409 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -80.89 92.5 1.45 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.364 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 22.9 mt -98.42 93.07 5.98 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.111 -1.229 . . . . 0.0 108.139 178.695 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 53.6 p -95.17 -179.96 4.99 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.084 -1.01 . . . . 0.0 111.279 -178.249 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 357' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' B' ' 359' ' ' THR . 61.3 tt0 -46.86 154.65 0.31 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.175 0.988 . . . . 0.0 111.035 -179.546 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.98 26.88 0.05 OUTLIER Glycine 0 N--CA 1.497 2.743 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.157 177.754 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 359' ' ' THR . . . . . 0.447 ' N ' ' O ' ' B' ' 357' ' ' GLN . 23.8 m -84.61 111.27 19.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.798 -1.413 . . . . 0.0 109.744 179.922 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 12.6 t -78.16 113.06 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 122.297 1.046 . . . . 0.0 109.774 -177.587 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 16.0 m -110.09 178.51 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.173 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 25.5 m -131.48 127.13 36.71 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.176 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 60.4 mt -103.43 118.9 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.96 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 58.3 p -121.19 133.23 55.17 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.401 -0.812 . . . . 0.0 109.283 -179.459 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.79 148.25 35.31 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.048 -1.032 . . . . 0.0 110.527 -179.046 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -140.03 121.19 14.78 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.275 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.561 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.38 -163.52 33.99 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.048 -1.549 . . . . 0.0 111.53 -179.758 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -59.97 -52.76 64.0 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 122.162 -0.61 . . . . 0.0 111.998 -177.896 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.507 ' H ' ' HB3' ' B' ' 331' ' ' SER . 96.0 m-20 -105.2 10.1 33.86 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.974 -1.079 . . . . 0.0 111.128 -177.407 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.561 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -42.18 -36.2 1.14 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.222 -0.924 . . . . 0.0 111.392 -179.155 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -70.0 -40.04 75.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.921 -1.112 . . . . 0.0 109.899 -179.012 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -66.51 -48.41 69.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.021 -1.049 . . . . 0.0 109.394 -179.441 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.07 -75.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 110.686 -179.098 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.64 ' O ' HG23 ' B' ' 378' ' ' VAL . 37.4 t -44.64 -38.26 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.235 -0.915 . . . . 0.0 110.881 -177.519 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.03 -51.37 64.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.576 -1.328 . . . . 0.0 110.887 -179.597 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -74.54 -40.67 61.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.88 -1.138 . . . . 0.0 109.976 -179.668 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.01 -39.79 87.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.897 . . . . 0.0 110.095 -179.502 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.64 HG23 ' O ' ' B' ' 374' ' ' VAL . 55.4 t -62.18 -43.39 97.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.211 -0.931 . . . . 0.0 109.968 -179.867 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -68.56 -54.59 15.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.615 -1.303 . . . . 0.0 108.617 178.687 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 50.1 tp -58.56 -34.72 71.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.23 -0.919 . . . . 0.0 109.937 -178.126 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 32.0 ttm -70.59 -40.05 73.46 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.408 -1.317 . . . . 0.0 108.42 177.927 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.24 -7.17 59.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.456 -0.777 . . . . 0.0 110.716 179.57 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -110.84 -1.74 16.41 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.077 -1.015 . . . . 0.0 111.54 -178.804 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.7 mt -81.89 130.25 35.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.297 -1.502 . . . . 0.0 109.197 178.823 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.328 179.937 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtt . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.61 -0.515 . . . . 2.91 109.61 . . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.39 127.74 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.297 -0.877 . . . . 1.2 109.491 -179.736 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.0 m -139.61 152.45 46.82 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.923 -0.769 . . . . 1.4 108.923 -179.929 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.89 -164.05 10.36 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 108.759 -1.736 . . . . 1.05 108.759 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.7 mt -88.57 -16.29 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.895 -1.356 . . . . 1.15 110.306 -179.133 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.1 tp 51.06 103.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.282 -0.886 . . . . 0.98 109.51 179.932 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.9 -25.38 14.63 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.06 -1.025 . . . . 0.88 109.523 179.604 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.5 m -134.83 121.19 14.69 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.511 -0.743 . . . . 1.69 109.432 -179.875 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -81.09 151.42 18.23 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.163 1.909 . . . . 0.85 112.81 179.947 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.926 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 142.35 177.82 17.77 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 109.248 -1.541 . . . . 0.92 109.248 179.597 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.6 mt -128.17 131.36 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 120.847 -1.384 . . . . 0.81 110.07 -179.555 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.4 155.98 49.35 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.252 -0.905 . . . . 0.51 109.888 -179.785 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.5 m-85 -129.44 129.63 44.9 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.655 -0.869 . . . . 0.62 108.655 179.879 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.79 171.7 44.29 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.979 -1.582 . . . . 0.55 110.583 179.841 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -77.39 158.42 30.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.682 -0.893 . . . . 2.1 109.294 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.451 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -101.89 129.63 48.18 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.385 -0.822 . . . . 0.77 111.775 -178.247 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.7 tp -100.17 132.26 45.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.179 -1.415 . . . . 0.91 107.179 177.928 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.0 tp -115.89 123.73 48.85 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.186 -0.946 . . . . 0.93 110.265 -179.218 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.2 mt -89.78 102.21 14.9 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.277 0.56 . . . . 0.93 110.541 -179.202 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -94.08 135.14 35.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.383 -0.823 . . . . 2.75 108.931 179.378 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -131.43 134.0 45.77 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.148 -0.97 . . . . 3.0 108.858 179.108 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -83.95 139.78 32.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 2.77 109.246 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.45 140.25 58.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.905 . . . . 2.94 109.42 -179.822 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.2 mt -82.83 133.69 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.878 . . . . 0.95 108.864 179.916 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.67 129.97 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.329 -0.857 . . . . 1.28 109.356 -179.666 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.0 mt -102.22 141.39 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.487 -0.758 . . . . 1.21 109.383 -179.84 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -96.13 120.48 36.49 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.153 -0.967 . . . . 1.81 109.721 -179.655 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.503 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.5 mmt-85 -87.48 -0.67 57.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.523 -0.735 . . . . 2.8 109.712 -179.627 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -67.9 136.55 54.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 2.87 109.235 179.991 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -81.3 150.73 28.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.105 -0.997 . . . . 2.35 109.117 179.718 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.459 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.1 pt -93.15 166.67 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.191 -0.943 . . . . 0.97 109.798 -179.933 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.9 p -96.75 171.67 8.38 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.499 -0.926 . . . . 1.17 108.499 178.705 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -48.81 80.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.121 -0.987 . . . . 1.18 109.868 -179.492 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 4.8 p-10 -57.14 -26.07 59.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.738 -1.226 . . . . 2.56 109.437 -179.639 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -82.76 -10.09 59.05 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.262 -0.899 . . . . 1.79 109.826 179.833 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -64.06 -52.48 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.964 -1.085 . . . . 1.0 109.368 -179.731 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.24 -40.05 94.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.335 -0.853 . . . . 1.77 109.478 179.817 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -67.66 -42.79 81.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.161 -0.962 . . . . 2.7 110.98 -178.926 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.485 ' OE2' ' NH1' ' A' ' 42' ' ' ARG . 72.6 mm-40 -66.67 -40.02 88.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.747 -1.221 . . . . 1.51 110.182 -179.504 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -59.97 -45.49 95.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 120.739 -1.226 . . . . 0.93 108.025 178.938 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -60.03 -39.95 87.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.35 -0.844 . . . . 1.81 109.319 179.649 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.485 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 99.0 mtt180 -60.02 -43.99 94.88 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.782 -1.192 . . . . 2.78 107.782 178.838 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -60.84 -47.06 88.08 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.743 -0.836 . . . . 0.78 108.743 178.076 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.3 tp -60.01 -48.71 80.57 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.516 -0.92 . . . . 1.07 108.516 -179.857 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 47.6 t -61.4 -42.28 98.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 1.12 108.86 179.255 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.39 -46.5 94.26 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.735 -1.746 . . . . 0.84 108.735 179.273 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.408 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 38.1 ttt-85 -62.89 -32.74 74.07 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.168 -1.049 . . . . 3.09 108.168 178.422 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.55 -43.83 93.43 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.237 -0.653 . . . . 0.88 109.237 -179.516 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 50' ' ' ALA . 26.5 ttpp -68.81 -74.25 0.13 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.854 -1.154 . . . . 2.59 108.331 179.473 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.22 -35.3 0.11 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.335 -0.853 . . . . 0.7 111.378 -178.366 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.7 t -58.44 -53.32 59.64 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.317 -1.353 . . . . 1.4 108.301 179.559 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.35 -39.99 81.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -0.857 . . . . 0.67 111.088 -179.232 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 92.3 mt-30 -67.57 -40.11 84.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.745 -1.222 . . . . 1.66 109.968 -179.598 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.6 mt -63.84 -40.01 95.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.978 -1.077 . . . . 1.58 108.819 179.842 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -63.93 -37.92 89.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.354 -0.841 . . . . 1.35 109.52 179.252 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -62.87 -43.5 98.62 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.098 -1.001 . . . . 0.77 108.548 179.175 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.46 -39.98 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 109.022 -0.733 . . . . 0.63 109.022 179.498 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 ttpp -56.98 -51.84 67.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.165 -0.959 . . . . 1.14 109.876 -179.781 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -58.78 -30.8 67.84 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.431 -0.793 . . . . 0.79 110.29 -178.083 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -69.64 -38.86 77.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.092 -1.005 . . . . 1.53 109.071 -179.826 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.2 -42.91 93.07 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.692 -0.63 . . . . 0.57 109.72 -179.8 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.37 -52.37 52.09 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.839 -1.305 . . . . 0.75 109.839 -179.318 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.2 -47.53 61.12 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.08 -1.247 . . . . 1.59 110.122 -179.962 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.4 m -66.49 -62.7 1.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.966 . . . . 0.73 112.399 -177.449 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -95.34 -48.48 5.86 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.761 -1.212 . . . . 0.75 111.105 -178.218 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.31 -169.68 24.96 Favored Glycine 0 N--CA 1.5 2.917 0 C-N-CA 119.801 -1.19 . . . . 1.22 111.045 179.608 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -69.95 -23.83 63.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.819 -0.812 . . . . 5.81 109.547 179.881 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -61.93 -35.92 79.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.734 -0.603 . . . . 3.37 110.947 -179.27 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.468 ' HA ' HD12 ' A' ' 72' ' ' ILE . 61.2 mmtt -99.4 -17.53 17.94 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.208 -0.932 . . . . 1.77 109.315 -179.934 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -69.2 -40.08 78.25 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.404 -0.81 . . . . 1.65 109.968 -179.187 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.566 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -69.18 -26.8 65.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.288 -0.883 . . . . 0.77 109.991 -179.137 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 69' ' ' LYS . 81.9 mt -59.95 -42.12 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.098 -1.001 . . . . 0.8 108.608 -179.973 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -66.2 -40.03 90.08 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.392 -0.923 . . . . 0.88 109.706 179.845 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -59.96 -41.17 91.31 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.939 -1.101 . . . . 1.37 109.294 179.503 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.28 -44.87 97.05 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.69 -1.764 . . . . 0.62 108.69 179.353 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.9 m170 -66.86 -49.95 64.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.417 -1.049 . . . . 1.5 109.134 179.563 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.98 -50.01 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.329 -0.857 . . . . 0.63 109.322 179.719 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.3 ttp -60.12 -39.88 87.78 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.12 -0.987 . . . . 1.51 109.774 -179.265 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.836 HD22 HD23 ' B' ' 347' ' ' LEU . 55.5 tp -67.52 -40.0 85.1 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.403 -0.81 . . . . 0.77 109.946 179.7 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.1 tp -63.63 -39.87 95.46 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.576 -0.703 . . . . 0.62 109.611 -179.488 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -83.25 6.42 19.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.935 . . . . 1.47 109.758 -179.101 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 60.9 t0 -49.88 134.12 21.4 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.318 -0.864 . . . . 1.47 110.648 -179.074 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.481 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.9 mt-10 -59.98 -25.06 64.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.724 -0.61 . . . . 1.78 111.148 -179.464 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -70.95 -33.81 70.85 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.068 -1.02 . . . . 2.53 109.346 179.629 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 79' ' ' LEU . 87.8 mt -69.94 -40.21 75.6 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.571 0.7 . . . . 0.8 109.846 179.743 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.03 -47.1 87.23 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.373 -0.829 . . . . 1.42 110.594 -178.921 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -69.96 -41.28 74.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 1.71 111.184 -178.706 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.07 -39.91 75.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.03 -1.044 . . . . 1.57 111.697 -178.63 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.82 -47.19 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.033 -1.042 . . . . 0.65 109.94 -179.233 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.43 -39.56 82.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.538 -0.727 . . . . 0.82 109.999 -179.949 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.42 85.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.164 -0.96 . . . . 0.79 110.844 -179.195 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.09 -46.85 88.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.026 -1.046 . . . . 0.95 109.859 -179.238 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.8 mt -61.64 -49.93 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 0.66 109.015 179.681 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -67.29 -41.48 85.36 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.649 -0.657 . . . . 2.2 110.89 -179.247 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -83.87 -50.51 8.0 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.84 -1.162 . . . . 1.65 112.013 -178.642 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -90.16 -3.74 57.69 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.985 -1.072 . . . . 2.03 111.699 -177.337 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.3 m80 56.77 37.56 28.89 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.782 -1.199 . . . . 1.42 109.457 -179.518 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 54.8 mtt -90.04 168.82 11.7 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.574 -0.704 . . . . 1.18 109.733 -179.683 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 63.4 p -80.38 160.03 25.52 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.33 -0.856 . . . . 0.98 108.722 179.315 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.8 -37.75 76.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.064 -1.023 . . . . 0.64 110.422 -179.271 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 38.0 p-10 -69.96 -36.74 75.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.898 -1.127 . . . . 2.07 109.799 -179.566 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.515 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.86 -42.89 20.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 0.73 109.624 179.569 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.55 -47.96 74.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.41 -0.806 . . . . 0.54 109.992 -179.514 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.97 -38.56 82.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.084 -1.01 . . . . 0.56 109.746 -179.776 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -59.94 -39.97 87.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.395 -0.816 . . . . 1.54 110.275 -178.561 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -63.8 -39.97 95.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.01 . . . . 1.33 110.809 -178.779 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.3 t -62.17 -50.07 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.034 -1.041 . . . . 0.72 111.037 -178.401 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.9 mm -69.56 -40.0 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.963 -1.086 . . . . 0.85 108.988 -179.862 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -60.03 -38.62 83.26 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.103 -0.703 . . . . 2.44 109.103 179.056 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.03 -49.95 72.8 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 120.562 -0.828 . . . . 0.98 111.219 -179.111 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -66.64 -50.02 64.31 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.77 -1.43 . . . . 1.41 110.442 -178.528 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.2 88.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.905 -1.122 . . . . 1.2 109.231 -179.704 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.0 t -60.07 -40.72 90.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.306 -0.871 . . . . 1.7 109.074 -179.557 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.98 92.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.27 -0.894 . . . . 1.47 109.12 179.291 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.6 mt -65.98 -42.3 90.0 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.117 -0.989 . . . . 1.56 109.397 -179.634 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.95 -37.91 80.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.663 -1.273 . . . . 2.2 109.302 -179.473 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -52.42 -21.46 3.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.024 -1.048 . . . . 2.12 108.681 179.539 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.515 HD13 HD13 ' A' ' 123' ' ' LEU . 59.2 mt -63.64 152.31 39.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.145 -0.972 . . . . 2.0 108.877 179.612 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -98.66 41.06 1.15 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.08 -1.012 . . . . 3.23 110.363 -179.568 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.73 149.71 49.29 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.129 -0.982 . . . . 2.49 110.227 -179.798 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 58.5 mp0 -74.96 -67.08 0.68 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.742 0.782 . . . . 3.95 109.514 178.956 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.5 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.1 t80 -39.48 -38.65 0.6 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.8 -0.562 . . . . 2.0 111.236 -178.732 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.515 HD13 HD13 ' A' ' 118' ' ' LEU . 88.7 mt -68.31 -39.92 81.85 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.714 -1.241 . . . . 1.86 108.844 -179.335 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 121' ' ' GLU . 7.7 ttpm? -67.14 -31.08 71.27 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.361 -0.837 . . . . 2.84 109.477 179.311 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -46.12 90.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.287 -0.883 . . . . 2.73 109.759 -179.405 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.472 HH21 ' CD2' ' A' ' 123' ' ' LEU . 83.8 mtm180 -65.51 -37.27 86.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.978 -1.076 . . . . 2.77 108.373 178.754 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.94 -29.05 68.13 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.284 -1.006 . . . . 1.19 108.284 178.544 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.12 -40.3 78.38 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.598 -0.89 . . . . 1.2 108.598 179.108 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.43 -40.0 96.01 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.244 -1.021 . . . . 1.55 108.244 178.976 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.6 t -66.01 -40.01 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 108.535 -0.913 . . . . 0.8 108.535 178.939 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 -60.01 -39.42 85.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.45 -0.781 . . . . 3.09 109.169 179.1 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 60.5 t0 -59.94 -39.56 85.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.384 -0.823 . . . . 1.46 109.934 -179.724 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.88 -46.6 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.108 -0.995 . . . . 0.71 110.303 -178.76 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.77 -34.32 66.38 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.519 -1.432 . . . . 0.57 109.519 179.735 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -60.0 -50.16 74.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.421 -1.046 . . . . 2.59 110.368 -179.221 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -69.98 -31.47 69.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.946 -1.096 . . . . 2.83 110.02 -179.574 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.06 -41.71 92.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.315 -0.866 . . . . 1.25 108.963 -179.153 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.43 -40.08 95.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.14 -0.975 . . . . 0.7 109.2 179.408 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.2 mtm180 -69.24 -40.0 78.15 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.309 -0.869 . . . . 2.57 108.798 179.465 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 140' ' ' ASN . . . . . 0.593 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.3 m120 -64.41 -35.39 80.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.67 -0.644 . . . . 1.23 111.456 -178.853 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.4 mt -71.09 -44.63 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.52 -1.362 . . . . 0.81 109.152 179.81 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.05 -29.01 65.92 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.663 -0.648 . . . . 1.0 109.616 -179.678 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.57 40.01 11.52 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.614 -1.795 . . . . 0.89 108.614 -179.01 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 56.5 tp -73.76 147.49 43.43 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.524 -0.986 . . . . 1.14 109.192 -179.445 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -61.06 139.58 58.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 4.6 109.63 -179.273 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.48 130.11 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-O 121.957 0.884 . . . . 1.24 109.279 179.496 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.8 mt -60.1 -47.35 92.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 115.994 -0.548 . . . . 1.54 110.76 -177.833 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.6 t0 66.11 99.7 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.44 -0.948 . . . . 1.5 108.44 -179.045 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.1 mt -70.9 -2.04 13.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.327 -0.858 . . . . 0.79 110.73 -178.653 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.9 p -84.32 -13.53 52.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.737 -1.227 . . . . 1.4 109.744 179.999 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.51 29.45 0.24 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.226 -0.921 . . . . 0.92 112.004 -177.913 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 39.5 mm -87.64 120.29 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.467 -1.396 . . . . 0.88 109.691 -179.86 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -100.38 -9.96 21.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.396 -0.815 . . . . 2.45 110.3 -179.736 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -139.39 158.09 44.74 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.986 -1.071 . . . . 1.52 110.219 -179.395 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.84 136.95 57.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.141 -0.975 . . . . 1.58 109.307 179.944 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 26.9 m -152.84 165.64 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.564 -0.71 . . . . 0.69 109.371 179.381 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.3 mt -95.55 148.0 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 105.662 -1.977 . . . . 0.61 105.662 177.208 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 60.2 tp -98.37 116.14 29.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.053 -1.029 . . . . 0.87 111.003 -177.365 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.5 t -119.98 128.24 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.493 -0.928 . . . . 0.71 108.493 178.811 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.6 160.26 37.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.111 -0.993 . . . . 0.81 108.725 -179.982 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -70.32 -33.71 71.84 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.205 -1.559 . . . . 0.98 107.848 178.669 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 162' ' ' ASP . 20.2 p-10 -161.95 170.92 18.51 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.993 -0.743 . . . . 2.25 108.993 179.859 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.3 mt -142.86 129.99 20.81 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.058 -1.026 . . . . 0.78 108.841 179.189 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 61.8 p -88.49 146.1 36.85 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.073 -1.017 . . . . 0.98 109.202 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -41.83 -35.56 2.98 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.949 1.766 . . . . 0.81 112.513 179.277 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 57.0 m -60.05 -39.98 87.85 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.066 -1.021 . . . . 0.9 109.142 -179.364 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.75 -42.85 97.77 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.377 -0.827 . . . . 1.61 109.816 179.984 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.3 p -56.53 -30.33 62.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.28 -0.887 . . . . 0.61 111.529 -178.094 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.43 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -73.19 -56.78 4.63 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.65 -1.281 . . . . 0.6 109.937 -179.974 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -79.39 36.59 0.31 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.327 -0.99 . . . . 1.4 108.327 -179.896 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.43 ' H ' ' C ' ' A' ' 169' ' ' ALA . 15.6 tp -103.2 134.33 46.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 0.7 109.593 179.466 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -86.35 101.02 12.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.882 -1.155 . . . . 2.35 107.882 178.436 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 76.3 mt -65.16 -40.97 95.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 1.51 110.947 -178.483 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -69.87 -21.77 63.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.763 -1.211 . . . . 2.33 111.086 -178.087 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -93.89 -10.69 33.07 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.796 -1.19 . . . . 1.92 109.693 -179.533 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 178' ' ' GLY . 71.5 t -105.59 116.57 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.397 -0.964 . . . . 0.67 108.397 178.599 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.9 mt -85.41 5.45 30.9 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.216 -0.928 . . . . 1.53 110.235 -178.215 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.562 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 169.4 174.44 37.82 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.4 -1.48 . . . . 0.48 109.4 179.71 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.477 ' CE1' HG11 ' A' ' 176' ' ' VAL . 18.0 m-85 -132.69 128.77 37.68 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.487 -1.008 . . . . 0.55 108.817 179.974 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.04 126.07 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.82 -0.807 . . . . 0.65 108.82 178.958 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.1 p -149.43 160.02 43.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.122 -0.986 . . . . 0.82 110.459 -179.208 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 182' ' ' ASP . 42.8 p-10 -108.23 28.85 7.89 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.764 -0.828 . . . . 2.46 108.764 179.256 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.39 -158.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.971 0.891 . . . . 1.28 112.227 -177.702 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.13 -71.4 0.8 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.959 -0.857 . . . . 2.19 110.959 -178.804 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 161.93 -131.82 2.66 Favored Glycine 0 N--CA 1.492 2.406 0 O-C-N 120.764 -1.433 . . . . 2.13 110.631 -179.658 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.764 ' HE ' HH12 ' A' ' 195' ' ' ARG . 33.2 ttt-85 -61.38 -39.99 92.7 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.586 -0.949 . . . . 5.86 111.506 -178.702 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 18.0 p -64.8 5.33 0.33 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.829 -1.169 . . . . 3.72 110.602 -178.532 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 186' ' ' ARG . 48.0 t -90.87 130.07 36.86 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.953 -1.092 . . . . 1.74 110.702 -179.591 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -49.33 -44.81 44.77 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.423 -0.798 . . . . 0.95 109.255 179.509 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 88.8 m -60.01 -39.43 85.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.615 -0.678 . . . . 1.55 109.73 -179.26 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.5 t -58.66 -42.81 89.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.892 -1.13 . . . . 1.51 110.214 -179.225 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 93.9 mt -60.8 -38.82 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 1.67 109.844 -179.991 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.7 mtp -59.97 -46.01 90.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 1.02 110.539 -179.246 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.99 -44.43 94.52 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.825 -1.172 . . . . 0.68 110.097 -179.381 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.764 HH12 ' HE ' ' A' ' 186' ' ' ARG . 51.7 mtp180 -60.03 -50.06 75.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.133 -0.979 . . . . 2.93 110.71 -179.01 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.6 m -73.41 -33.59 65.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.001 -1.062 . . . . 0.86 111.553 -178.665 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 86.8 mt -80.55 -11.07 59.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.735 -1.228 . . . . 0.67 110.475 -178.435 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 58.56 49.94 9.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.307 -0.871 . . . . 1.5 110.706 179.384 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 86.5 mt -123.84 122.98 26.29 Favored Pre-proline 0 N--CA 1.502 2.135 0 N-CA-C 108.456 -0.942 . . . . 0.72 108.456 179.0 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -43.28 133.48 6.56 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.037 1.825 . . . . 0.61 112.582 -179.845 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -170.58 150.01 3.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.846 -1.159 . . . . 0.66 111.375 179.819 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.0 mt -125.0 142.82 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 107.924 -1.139 . . . . 0.79 107.924 178.879 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.5 m -123.17 -8.57 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 O-C-N 120.85 -1.156 . . . . 0.91 111.057 -178.842 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.3 23.73 15.42 Favored Glycine 0 N--CA 1.5 2.962 0 O-C-N 121.381 -0.824 . . . . 1.01 111.203 -179.03 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 10.4 p -45.49 -44.36 12.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.776 -1.426 . . . . 0.99 109.751 -179.357 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 206' ' ' GLY . . . . . 0.417 ' H ' ' CB ' ' A' ' 182' ' ' ASP . . . 95.15 -51.28 1.89 Allowed Glycine 0 N--CA 1.499 2.88 0 C-N-CA 120.178 -1.01 . . . . 1.12 111.354 178.763 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 69.4 m -160.0 39.5 0.18 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.498 -1.59 . . . . 1.72 111.566 -179.242 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 30.9 t -79.96 -33.06 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.827 -1.171 . . . . 0.89 108.589 178.355 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.1 p -60.11 -40.01 88.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.608 -0.683 . . . . 1.03 111.095 -179.134 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 56.4 m -81.3 -13.56 58.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.971 -1.081 . . . . 1.83 110.563 -178.507 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -93.71 -11.91 30.43 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.073 -1.017 . . . . 2.27 110.755 -179.416 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 212' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 213' ' ' LYS . 46.4 t -121.27 161.78 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 O-C-N 121.19 -0.944 . . . . 0.92 110.601 -179.56 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.556 ' N ' HG12 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -120.58 158.02 28.24 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.714 -0.847 . . . . 2.2 108.714 -179.441 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 215' ' ' ASP . 57.6 t-20 -59.71 139.93 56.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 2.36 110.461 -179.384 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 3.1 t70 86.33 2.59 0.53 Allowed 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.15 0.5 . . . . 2.38 110.205 179.373 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 47.2 t0 -74.86 151.95 38.95 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.133 -0.979 . . . . 2.09 108.56 178.96 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.543 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 47.9 t80 -96.56 120.19 36.43 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.421 -0.955 . . . . 1.27 108.421 179.52 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.451 HD12 ' HB2' ' A' ' 16' ' ' ALA . 91.9 mt -124.8 141.68 51.94 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.426 -0.796 . . . . 0.75 110.754 -179.224 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 88.6 mt -109.93 129.34 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.417 -1.697 . . . . 0.63 106.417 176.32 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 45.0 tp -101.28 117.67 35.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.027 -1.045 . . . . 0.7 109.024 -178.799 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 224' ' ' ASN . 8.5 t70 -76.96 -47.46 20.79 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.158 -0.964 . . . . 2.31 108.578 179.653 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.926 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 52.77 18.38 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.21 -0.663 . . . . 0.78 109.21 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 72.8 t -132.67 -41.94 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.069 -1.456 . . . . 1.04 107.069 178.556 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.51 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 35.3 m120 -106.52 1.83 25.73 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.168 -1.419 . . . . 2.44 107.168 177.828 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.01 47.34 9.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.84 -0.538 . . . . 1.55 110.128 -179.868 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -136.97 148.51 46.96 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.314 -0.866 . . . . 1.99 109.614 179.235 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 86.1 t -123.88 125.5 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.294 -0.632 . . . . 0.77 109.294 179.659 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -91.83 122.45 34.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.135 -0.978 . . . . 0.98 108.588 179.651 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 37.0 t -102.23 118.46 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.423 -0.798 . . . . 0.85 109.478 -179.401 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.6 t30 67.57 68.77 0.52 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.441 -0.787 . . . . 1.66 108.923 -179.479 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -89.12 124.88 1.49 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.207 2.605 . . . . 0.95 112.761 -179.39 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.3 m -63.29 162.77 11.57 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -0.895 . . . . 1.84 108.881 179.684 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -60.11 -39.91 87.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.064 -1.022 . . . . 2.74 108.751 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -60.03 -38.88 84.04 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.4 -0.813 . . . . 2.89 109.193 179.534 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.64 -42.09 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.299 -0.876 . . . . 1.3 109.751 -179.75 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.85 -44.35 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.121 -0.987 . . . . 1.09 109.471 -179.994 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -59.99 -43.87 94.89 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.239 -0.913 . . . . 2.43 109.52 -179.596 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -61.39 -48.25 82.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 2.78 109.457 179.681 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 95.8 mtp -64.91 -32.75 74.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.348 -0.845 . . . . 1.25 109.886 -179.447 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -68.95 -40.06 79.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.081 -1.012 . . . . 2.63 109.127 179.161 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.01 81.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 1.8 109.066 179.623 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.86 -40.05 85.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.348 -0.845 . . . . 2.13 109.343 179.671 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -60.02 -39.96 87.64 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.179 -0.951 . . . . 3.17 108.962 -179.743 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.18 -40.02 88.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.116 -0.99 . . . . 1.78 108.73 179.216 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -65.69 -36.25 83.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.669 -0.644 . . . . 2.47 109.377 179.863 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.99 -41.47 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.335 -0.853 . . . . 2.09 109.215 -179.458 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.83 93.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.91 . . . . 2.54 108.842 179.548 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 248' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 251' ' ' ALA . 60.2 p -70.0 -36.29 75.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.342 -0.849 . . . . 2.99 109.155 179.485 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -59.92 -40.03 87.47 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.034 -0.728 . . . . 3.34 109.034 179.963 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 251' ' ' ALA . 59.4 tttp -74.87 -3.63 33.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.427 -0.796 . . . . 3.88 109.36 -179.904 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 251' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 250' ' ' LYS . . . -36.7 -41.49 0.32 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.604 -0.685 . . . . 4.43 111.117 -179.598 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -162.79 36.83 0.1 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.883 -1.136 . . . . 5.42 110.742 179.913 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 95.6 mt -117.63 -9.6 10.74 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.328 -0.858 . . . . 6.1 110.239 179.673 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -155.57 -4.4 0.13 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.836 -1.165 . . . . 7.37 110.113 179.66 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -68.0 -31.12 70.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.975 . . . . 8.01 110.131 179.894 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.92 -40.16 87.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.108 -0.995 . . . . 9.05 110.36 -178.85 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -109.88 -156.27 0.58 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.12 -0.987 . . . . 10.56 109.713 -179.542 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 25.5 t0 72.66 -0.2 3.41 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.875 -0.516 . . . . 11.32 109.672 -179.416 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 117.975 -1.012 . . . . 12.42 109.268 -179.852 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' B' B ' 301' ' ' MET . . . . . 0.404 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 32.2 ttp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.493 0.663 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 302' ' ' PHE . . . . . 0.404 ' N ' ' CG ' ' B' ' 301' ' ' MET . 32.7 t80 -153.75 150.26 28.32 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.34 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 303' ' ' GLN . . . . . 0.444 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 3.9 pm0 -150.87 160.97 43.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.848 -1.158 . . . . 0.0 111.133 -179.398 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -152.19 148.89 28.14 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.554 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -114.03 132.13 56.11 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.218 -0.927 . . . . 0.0 109.827 179.282 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.21 127.97 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 CA-C-O 122.397 1.094 . . . . 0.0 112.61 -177.374 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 30.0 m -77.07 106.94 9.08 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.973 0.892 . . . . 0.0 110.603 -178.361 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 87.1 mt -52.2 124.05 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.408 1.099 . . . . 0.0 110.508 -177.927 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 82.5 p -109.61 20.04 18.56 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.144 -178.697 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -79.13 115.71 54.74 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.28 -0.888 . . . . 0.0 109.005 179.291 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.38 -10.95 9.65 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 CA-C-N 120.376 1.17 . . . . 0.0 113.487 -179.348 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -114.83 9.94 16.37 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.227 -0.921 . . . . 0.0 110.396 -178.898 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 68.63 172.41 7.45 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -179.036 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.5 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -85.13 92.11 8.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.867 -1.372 . . . . 0.0 109.967 -178.298 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.454 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 4.7 p80 -96.68 -159.29 0.72 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.008 -1.057 . . . . 0.0 109.62 178.163 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 4.4 m -59.4 -47.47 85.31 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.783 -1.198 . . . . 0.0 112.764 -176.182 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.566 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 10.9 tpt180 -55.74 -58.97 12.84 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 120.506 -1.372 . . . . 0.0 111.734 -179.102 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.454 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 14.3 Cg_endo -61.81 -32.5 85.8 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 120.559 1.235 . . . . 0.0 111.388 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.67 -51.23 66.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.455 -0.778 . . . . 0.0 109.27 179.491 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.37 -39.99 64.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 109.373 -179.268 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 -68.7 -42.4 77.8 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.917 -1.114 . . . . 0.0 108.57 178.995 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -59.91 -50.4 73.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.526 -0.734 . . . . 0.0 110.298 -179.03 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 86.3 t -69.14 -29.15 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.722 -1.236 . . . . 0.0 110.207 -179.03 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -59.13 -49.26 78.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.112 -0.992 . . . . 0.0 109.7 -178.83 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -66.42 -40.95 89.86 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.024 -1.047 . . . . 0.0 111.102 -179.179 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.04 -54.61 43.95 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.516 -1.365 . . . . 0.0 110.993 -178.855 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -55.16 -15.91 2.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.073 -1.017 . . . . 0.0 109.007 179.702 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -70.35 -29.65 69.94 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 178.729 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -105.78 146.82 29.36 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.602 -0.94 . . . . 0.0 109.553 -179.916 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 32.0 p -90.57 -12.1 38.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.084 -1.01 . . . . 0.0 109.907 179.966 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.458 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 47.6 t -61.47 144.69 53.78 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.282 -0.886 . . . . 0.0 109.507 179.928 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -67.57 136.63 54.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.134 -0.979 . . . . 0.0 108.644 179.623 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.9 mt -130.73 131.02 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.5 -0.75 . . . . 0.0 110.002 -179.728 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 91.8 m -128.14 147.01 50.53 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.276 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.65 115.57 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.658 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 89.0 m -102.82 128.8 49.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.124 -0.985 . . . . 0.0 109.041 -178.566 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 90.8 p -139.23 114.31 9.51 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.892 0.853 . . . . 0.0 111.136 -179.217 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 27.5 m120 49.43 49.99 18.9 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 176.45 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.81 -13.86 59.93 Favored Glycine 0 N--CA 1.501 2.994 0 O-C-N 119.804 -1.81 . . . . 0.0 112.289 176.946 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -117.01 129.0 55.73 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.999 -1.295 . . . . 0.0 109.419 -179.871 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 48.4 p -126.57 147.92 49.81 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.884 0.85 . . . . 0.0 110.754 -178.962 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.45 168.03 21.07 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.505 0.669 . . . . 0.0 109.825 -179.666 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 28.2 t -90.94 136.09 33.3 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.567 -0.708 . . . . 0.0 110.835 -178.775 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -71.42 -17.52 62.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.347 -0.845 . . . . 0.0 108.795 179.159 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -88.34 16.67 6.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.599 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 10.9 t -143.94 92.12 2.3 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.732 0.777 . . . . 0.0 111.287 -179.345 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.836 HD23 HD22 ' A' ' 79' ' ' LEU . 58.9 tp -58.74 -36.86 75.01 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.379 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.805 ' CE2' HD11 ' A' ' 79' ' ' LEU . 61.1 m-85 -55.55 -50.06 71.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.854 . . . . 0.0 111.07 -179.14 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 349' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' B' ' 350' ' ' LEU . 25.2 mtmm -69.94 -40.03 75.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.722 -1.236 . . . . 0.0 110.721 -177.915 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' B' ' 352' ' ' THR . 87.9 mt -46.87 -55.69 7.57 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.995 -1.066 . . . . 0.0 109.106 -179.407 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.59 HE22 ' HG ' ' B' ' 347' ' ' LEU . 0.0 OUTLIER -39.38 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.569 -0.707 . . . . 0.0 111.169 -178.76 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.483 ' N ' ' O ' ' B' ' 350' ' ' LEU . 75.6 p -81.27 -10.15 59.64 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.127 -1.608 . . . . 0.0 109.995 -179.096 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 32.9 mt -95.29 114.99 26.83 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.062 -1.024 . . . . 0.0 109.11 178.612 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.65 94.46 0.86 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 179.307 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 34.4 mt -101.77 89.56 3.72 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.366 -1.079 . . . . 0.0 109.279 179.721 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 46.9 p -94.16 177.02 6.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.102 -0.998 . . . . 0.0 110.934 -179.129 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -67.6 113.51 5.47 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.643 -0.661 . . . . 0.0 110.135 -179.918 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.93 9.41 34.66 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.974 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 66.3 m -90.85 107.64 19.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -1.139 . . . . 0.0 110.91 -179.536 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 14.5 t -76.89 118.15 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.201 1.0 . . . . 0.0 109.152 -177.641 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.0 m -113.42 178.14 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.968 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 58.1 m -130.86 128.27 40.27 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.287 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 93.9 mt -100.6 112.51 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.639 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 60.6 m -117.79 130.82 56.52 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.621 -0.675 . . . . 0.0 109.346 -179.217 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.79 151.99 39.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.815 . . . . 0.0 109.245 -179.493 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -145.83 125.51 13.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.4 -0.812 . . . . 0.0 108.867 179.666 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.537 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.11 -155.77 26.65 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.14 -1.505 . . . . 0.0 111.455 -179.984 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.73 -51.6 69.08 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 122.224 -0.574 . . . . 0.0 112.333 -177.508 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.458 ' H ' ' HB2' ' B' ' 331' ' ' SER . 72.0 m-20 -110.01 13.17 23.44 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.829 -1.17 . . . . 0.0 111.221 -177.399 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -41.55 -34.33 0.56 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.292 -0.88 . . . . 0.0 111.507 -178.866 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -69.05 -41.15 78.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.589 -1.319 . . . . 0.0 109.994 -178.266 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -69.47 -50.1 48.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.842 -179.629 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -54.34 -36.22 63.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.86 . . . . 0.0 111.885 -178.077 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.574 ' O ' HG23 ' B' ' 378' ' ' VAL . 71.1 t -74.31 -39.96 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.134 -1.604 . . . . 0.0 109.191 179.294 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.89 -56.01 14.04 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.331 -0.855 . . . . 0.0 111.923 -178.25 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -69.98 -39.97 75.62 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.31 -1.494 . . . . 0.0 111.905 -178.377 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 89.1 mt -57.99 -37.16 73.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.607 -1.308 . . . . 0.0 108.676 -179.286 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.574 HG23 ' O ' ' B' ' 374' ' ' VAL . 48.9 t -60.03 -47.61 91.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.196 -0.94 . . . . 0.0 109.402 179.163 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 379' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' B' ' 383' ' ' GLU . 4.3 mptp? -69.98 -56.38 7.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.643 -1.285 . . . . 0.0 108.079 178.493 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.48 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 62.8 tp -50.99 -36.39 38.92 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.187 -0.946 . . . . 0.0 108.787 -178.648 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 40.9 tpp -73.01 -39.92 65.61 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.421 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.09 -4.2 46.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.74 -0.6 . . . . 0.0 109.959 179.463 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' B' ' 379' ' ' LYS . 95.5 mt-10 -108.05 3.54 24.08 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.249 -0.907 . . . . 0.0 110.234 179.909 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 384' ' ' LEU . . . . . 0.48 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 15.1 mt -79.34 114.21 18.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.369 -1.457 . . . . 0.0 107.753 178.184 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.459 -179.777 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.187 -0.671 . . . . 2.91 109.187 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.7 mt -109.99 129.99 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.365 -0.834 . . . . 1.2 109.241 179.863 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.1 m -129.34 151.09 50.36 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.713 -0.617 . . . . 1.4 109.846 -179.379 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.526 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -135.22 -162.15 9.62 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.01 -1.636 . . . . 1.05 109.01 179.869 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.8 mt -90.11 -18.88 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.867 -1.373 . . . . 1.15 109.561 -179.535 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.5 tp 55.71 107.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.491 -0.755 . . . . 0.98 109.189 -179.507 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.32 -26.97 13.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.406 -0.809 . . . . 0.88 108.99 179.529 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.1 m -137.59 120.93 11.55 Favored Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.499 -0.751 . . . . 1.69 109.215 179.555 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.59 151.09 19.42 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.121 1.881 . . . . 0.85 112.825 179.928 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.9 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 146.79 173.01 17.65 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 109.469 -1.452 . . . . 0.92 109.469 179.705 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.7 mt -125.77 130.88 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 120.964 -1.315 . . . . 0.81 109.223 -179.74 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.89 150.65 48.37 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.169 -0.957 . . . . 0.51 110.048 -179.265 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 13' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 9.3 m-85 -123.22 129.94 52.07 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.267 -1.012 . . . . 0.62 108.267 179.765 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.59 172.76 45.14 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 118.81 -1.662 . . . . 0.55 110.69 179.988 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -78.66 158.82 28.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.609 -0.936 . . . . 2.1 108.906 179.655 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.548 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.05 131.62 51.12 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.325 -0.859 . . . . 0.77 111.107 -178.684 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.2 tp -101.52 135.01 43.74 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.167 -1.42 . . . . 0.91 107.167 178.161 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.3 tp -116.72 126.48 53.2 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.295 -0.878 . . . . 0.93 109.87 -179.06 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.4 mt -89.32 102.01 14.68 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.365 0.602 . . . . 0.93 110.214 -179.515 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -92.52 136.37 33.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.445 -0.784 . . . . 2.75 109.003 179.619 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -131.15 117.44 19.08 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.3 -0.875 . . . . 3.0 109.629 179.743 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 54.1 t0 -71.55 144.5 49.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.889 -1.132 . . . . 2.77 109.45 179.772 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.51 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 88.8 tt0 -63.52 139.95 58.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 2.94 109.526 -179.878 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.5 mt -83.89 134.5 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.791 -0.818 . . . . 0.95 108.791 -179.773 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.4 t -101.99 127.04 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.29 -0.881 . . . . 1.28 110.279 -179.11 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.9 mt -105.7 137.85 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.794 -0.817 . . . . 1.21 108.794 179.304 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -97.52 113.59 25.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.994 -1.066 . . . . 1.81 109.318 179.71 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -84.83 5.24 29.53 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.536 -0.913 . . . . 2.8 108.536 179.9 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -60.56 146.35 45.46 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.544 -0.722 . . . . 2.87 109.36 179.916 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -88.88 141.69 28.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 2.35 108.963 179.616 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 pt -94.47 165.73 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.1 -1.0 . . . . 0.97 109.383 179.773 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.0 p -97.91 174.21 6.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.004 -1.06 . . . . 1.17 108.72 178.856 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.83 84.18 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.362 -0.935 . . . . 1.18 109.297 -179.631 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 52.2 t0 -56.71 -30.39 63.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.773 -1.204 . . . . 2.56 109.923 -179.94 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -81.82 -10.56 59.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.235 -0.916 . . . . 1.79 110.02 -179.645 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -62.98 -51.67 68.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.908 -1.12 . . . . 1.0 108.68 179.713 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -61.7 -40.07 93.71 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.454 -0.779 . . . . 1.77 109.887 -179.588 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -68.84 -40.32 79.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 2.7 111.295 -178.492 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -66.14 -40.18 90.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.399 -1.438 . . . . 1.51 110.351 -179.528 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.95 -47.97 91.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.706 -1.246 . . . . 0.93 109.195 179.444 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -61.89 -44.13 97.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.005 -1.059 . . . . 1.81 109.935 179.977 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -60.06 -44.03 95.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.862 -1.149 . . . . 2.78 108.117 179.803 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -63.0 -46.98 85.12 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.196 -0.668 . . . . 0.78 109.196 179.062 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.5 tp -59.87 -46.19 90.08 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.608 -0.886 . . . . 1.07 108.608 179.933 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.9 t -65.76 -43.74 87.97 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.265 -0.974 . . . . 1.12 108.861 179.276 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.21 -44.23 97.39 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.83 -2.108 . . . . 0.84 107.83 178.703 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.428 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 25.5 ttt-85 -65.39 -34.67 78.86 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.34 -0.985 . . . . 3.09 108.34 178.228 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.77 -40.0 86.76 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.732 -0.84 . . . . 0.88 108.732 -179.862 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 50' ' ' ALA . 1.2 ttmp? -61.47 -73.95 0.09 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.043 -1.095 . . . . 2.59 108.043 179.111 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.07 -34.94 0.09 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.253 -0.905 . . . . 0.7 111.904 -177.775 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.0 t -59.67 -50.37 74.14 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.344 -1.342 . . . . 1.4 108.291 179.846 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.05 92.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.501 -0.749 . . . . 0.67 110.504 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.9 -40.19 91.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.805 -1.184 . . . . 1.66 110.188 -179.118 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.07 -39.88 91.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.975 -1.078 . . . . 1.58 109.199 179.633 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -60.27 -39.93 88.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.541 -0.724 . . . . 1.35 110.136 179.853 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.466 HG22 ' HZ3' ' A' ' 60' ' ' LYS . 94.4 m -62.83 -43.87 97.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.019 -1.051 . . . . 0.77 109.459 179.724 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.621 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.9 mt -61.35 -39.68 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.48 -0.763 . . . . 0.63 109.588 -179.919 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -57.43 -51.86 67.73 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.175 -0.953 . . . . 1.14 110.403 -179.43 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -58.88 -35.38 72.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.357 -0.839 . . . . 0.79 110.832 -177.396 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.466 ' HZ3' HG22 ' A' ' 56' ' ' THR . 27.3 mttp -66.02 -38.16 87.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.056 -1.028 . . . . 1.53 109.332 179.841 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.443 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -65.81 -45.86 80.77 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.74 -0.6 . . . . 0.57 110.2 -179.529 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.4 -53.38 45.39 Favored Glycine 0 N--CA 1.485 1.93 0 C-N-CA 120.09 -1.052 . . . . 0.75 110.61 -178.548 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.07 -41.78 73.68 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.938 -1.331 . . . . 1.59 110.382 -179.06 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.0 m -70.03 -60.05 2.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.92 -1.113 . . . . 0.73 111.981 -177.838 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.428 ' CE1' ' O ' ' A' ' 168' ' ' THR . 76.7 m-85 -95.94 -50.56 4.82 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.862 -1.149 . . . . 0.75 111.243 -178.178 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.75 -166.87 26.1 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 119.899 -1.143 . . . . 1.22 110.683 -179.974 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -69.98 -24.97 63.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.78 -0.836 . . . . 5.81 110.353 -179.479 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.418 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 48.5 tp10 -60.36 -34.91 74.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.38 -0.825 . . . . 3.37 110.294 -179.366 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.483 ' HA ' HD12 ' A' ' 72' ' ' ILE . 43.9 mmtm -100.28 -17.51 17.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.295 -0.878 . . . . 1.77 110.291 -179.318 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -69.98 -44.51 69.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.067 -1.02 . . . . 1.65 110.667 -179.248 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.557 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.69 -25.64 65.78 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.386 -0.822 . . . . 0.77 109.885 -178.393 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 69' ' ' LYS . 80.9 mt -59.91 -41.18 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.0 -1.062 . . . . 0.8 108.764 -179.886 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -69.99 -36.6 75.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.077 -1.014 . . . . 0.88 110.805 -179.789 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -59.93 -40.1 87.76 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.92 -1.112 . . . . 1.37 109.434 -179.495 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.79 -43.54 93.84 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.587 -1.805 . . . . 0.62 108.587 178.742 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 57.4 m170 -60.0 -46.14 90.44 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.357 -1.084 . . . . 1.5 108.761 179.703 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.67 -45.16 96.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.226 -0.921 . . . . 0.63 108.677 179.147 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.3 ttp -60.89 -43.05 99.0 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.309 -0.869 . . . . 1.51 110.036 -179.864 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.457 HD13 HD23 ' B' ' 347' ' ' LEU . 12.5 tp -61.21 -41.9 97.65 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.715 -0.846 . . . . 0.77 108.715 179.869 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.16 -38.14 89.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.636 -0.665 . . . . 0.62 109.917 -179.636 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -85.39 4.4 35.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.067 -1.02 . . . . 1.47 110.206 -179.101 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -50.1 131.4 23.32 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.964 -1.085 . . . . 1.47 110.44 -179.124 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -58.46 -20.65 46.96 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.67 -0.644 . . . . 1.78 110.14 -179.403 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.89 -33.08 71.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.118 -0.989 . . . . 2.53 108.735 179.477 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.0 mt -71.98 -40.1 68.82 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.352 0.596 . . . . 0.8 109.876 179.348 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -60.18 -50.02 75.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.477 -0.765 . . . . 1.42 110.374 -179.0 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -70.96 -40.81 71.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.051 -1.031 . . . . 1.71 111.099 -178.961 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.11 -39.97 75.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.117 -0.99 . . . . 1.57 111.573 -178.544 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.72 -46.19 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.026 . . . . 0.65 109.547 -179.309 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.85 -39.63 80.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.645 -0.66 . . . . 0.82 109.969 -179.822 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.33 -48.67 80.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.79 111.256 -179.033 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 96' ' ' LYS . 93.9 mt -63.04 -46.88 85.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.885 -1.134 . . . . 0.95 110.194 -178.927 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.1 mt -60.25 -49.48 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 122.18 0.991 . . . . 0.66 108.57 179.555 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -70.1 -40.46 74.93 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.785 -0.643 . . . . 2.2 110.578 -179.428 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -83.44 -49.7 9.04 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.901 -1.124 . . . . 1.65 111.718 -178.521 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 92' ' ' LEU . 71.0 mmtt -90.97 -1.83 57.78 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.102 -0.999 . . . . 2.03 111.73 -177.396 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 54.28 32.17 15.69 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.699 -1.251 . . . . 1.42 109.604 179.944 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.5 mtt -90.36 167.5 12.59 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.003 -0.74 . . . . 1.18 109.003 -179.848 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 68.5 p -75.42 155.14 36.65 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.844 -1.169 . . . . 0.98 107.844 178.956 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.8 -39.59 76.48 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.955 -1.09 . . . . 0.64 110.237 -179.065 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 34.4 p-10 -63.23 -38.65 91.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.855 -1.153 . . . . 2.07 109.387 179.552 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.504 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -78.29 -47.28 18.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.957 . . . . 0.73 109.44 179.509 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.85 -47.32 86.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.475 -0.766 . . . . 0.54 109.714 -179.925 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.5 -35.37 79.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 0.56 109.458 179.646 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -59.87 -44.25 94.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 1.54 108.746 -179.319 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 110' ' ' GLY . 85.8 tt0 -61.15 -40.02 92.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.265 -0.897 . . . . 1.33 109.462 179.298 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.76 -53.81 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.897 . . . . 0.72 110.475 -178.972 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.453 HG21 ' HA3' ' A' ' 134' ' ' GLY . 47.0 mm -69.87 -40.14 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.992 -1.068 . . . . 0.85 109.303 179.634 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -68.07 -38.76 82.76 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.57 -0.9 . . . . 2.44 108.57 179.045 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -59.74 -47.92 88.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.494 -1.042 . . . . 0.98 110.494 -179.182 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -67.97 -54.37 19.09 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.769 -1.43 . . . . 1.41 109.721 -179.685 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.89 -40.02 69.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 1.2 109.616 -179.925 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 54.3 m -59.95 -39.98 87.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.094 -1.004 . . . . 1.7 108.796 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.25 89.01 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.204 -0.935 . . . . 1.47 108.676 178.829 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.431 ' CD1' ' OE1' ' B' ' 351' ' ' GLN . 25.5 mt -65.57 -39.96 92.25 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.124 -0.985 . . . . 1.56 109.399 -179.643 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -57.75 -31.62 66.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.736 -1.228 . . . . 2.2 109.189 -179.264 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -59.38 -23.54 62.67 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.175 -1.046 . . . . 2.12 108.175 179.388 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 52.7 mt -62.17 139.93 58.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.23 -0.919 . . . . 2.0 108.617 -179.823 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -94.49 26.08 3.61 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.172 -0.955 . . . . 3.23 109.835 -179.699 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -110.76 129.99 55.7 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.367 -0.833 . . . . 2.49 109.729 -179.712 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -69.66 -29.36 66.79 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.48 0.657 . . . . 3.95 109.233 179.91 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.48 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.4 t80 -69.95 -39.97 75.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.702 -0.624 . . . . 2.0 110.845 -179.99 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.53 HD22 ' O ' ' B' ' 351' ' ' GLN . 96.9 mt -76.41 -32.47 58.53 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.844 -1.16 . . . . 1.86 109.582 179.918 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -60.1 -40.56 90.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.054 -1.029 . . . . 2.84 108.684 179.318 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 98.9 mt-10 -59.93 -42.92 95.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.247 -0.908 . . . . 2.73 108.964 179.615 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -61.92 -40.05 94.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 2.77 108.57 178.97 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.52 -30.81 71.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.89 . . . . 1.19 108.716 179.021 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -60.19 -39.57 86.99 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.827 -0.805 . . . . 1.2 108.827 179.607 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -68.25 -39.85 82.13 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.349 -0.845 . . . . 1.55 109.279 -179.919 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.74 -39.97 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.421 -0.8 . . . . 0.8 109.057 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -65.18 -40.04 93.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.174 -0.954 . . . . 3.09 109.963 179.629 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 1.46 110.551 -178.938 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.12 -41.22 85.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.99 -1.069 . . . . 0.71 109.667 -179.7 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.453 ' HA3' HG21 ' A' ' 108' ' ' ILE . . . -59.97 -46.02 94.87 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.009 -1.237 . . . . 0.57 110.009 -179.761 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -59.87 -46.92 87.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.104 -1.233 . . . . 2.59 111.324 -179.511 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.621 HH22 ' CD1' ' A' ' 57' ' ' ILE . 60.4 mtp180 -63.85 -37.08 86.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.835 -1.166 . . . . 2.83 110.407 -179.385 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.6 tp -58.43 -42.88 88.27 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.353 -0.842 . . . . 1.25 110.132 -178.753 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.83 -39.96 93.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.001 -1.062 . . . . 0.7 108.961 179.628 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -65.72 -39.51 91.24 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.789 -0.819 . . . . 2.57 108.789 178.791 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -64.38 -36.96 85.83 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.649 -0.657 . . . . 1.23 110.951 -179.63 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.3 mt -70.54 -42.06 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.521 -1.362 . . . . 0.81 108.44 179.002 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.63 -38.75 73.94 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.609 0.718 . . . . 1.0 109.063 179.684 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.56 43.85 4.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.276 -1.93 . . . . 0.89 108.276 -178.767 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 144' ' ' LEU . 21.3 tp -74.51 142.86 44.77 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.484 -1.009 . . . . 1.14 109.46 -179.183 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -62.3 137.87 58.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.423 -0.798 . . . . 4.6 109.795 -179.325 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 92.8 mt -113.94 129.97 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.217 1.008 . . . . 1.24 109.583 179.396 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.7 mt -64.44 -41.51 92.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.802 -0.635 . . . . 1.54 110.968 -178.145 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 47.4 t0 61.26 105.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.323 -0.861 . . . . 1.5 109.581 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 152' ' ' ILE . 58.8 mt -68.75 -6.69 28.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.474 -0.766 . . . . 0.79 110.12 -179.357 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.5 t -83.37 -13.77 54.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.13 -0.981 . . . . 1.4 108.922 179.314 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.34 18.51 2.64 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.608 -0.683 . . . . 0.92 110.239 -178.442 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.415 HD12 ' O ' ' A' ' 149' ' ' LEU . 66.1 mt -90.31 111.21 23.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.028 -1.045 . . . . 0.88 108.845 -179.778 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -97.31 -9.71 27.03 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.285 -0.884 . . . . 2.45 110.836 -178.559 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -120.47 149.12 42.89 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.214 -0.929 . . . . 1.52 110.175 -178.987 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -64.89 131.22 46.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.422 -0.799 . . . . 1.58 109.216 -179.9 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -151.95 163.77 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.511 -0.743 . . . . 0.69 109.343 179.614 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 83.3 mt -92.76 151.08 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 105.939 -1.875 . . . . 0.61 105.939 177.156 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 56.4 tp -102.07 118.73 37.51 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.121 -0.987 . . . . 0.87 110.798 -177.961 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.2 t -126.22 132.08 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 108.538 -0.912 . . . . 0.71 108.538 179.543 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.6 168.73 24.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.179 -0.951 . . . . 0.81 109.05 179.797 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.0 -37.78 75.78 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.489 -1.382 . . . . 0.98 108.287 178.735 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -170.66 148.51 3.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.58 -0.7 . . . . 2.25 109.189 179.737 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.4 mt -116.1 134.43 54.94 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.49 -0.757 . . . . 0.78 109.553 -179.641 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 77.7 p -94.15 149.96 37.64 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.428 -0.795 . . . . 0.98 109.038 179.501 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -39.63 -34.75 0.8 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.334 2.023 . . . . 0.81 113.005 179.562 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 59.6 m -58.04 -42.51 85.54 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.217 -0.993 . . . . 0.9 109.353 -178.503 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -70.07 -39.96 75.31 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.163 -0.961 . . . . 1.61 109.792 179.456 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.428 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 68.8 p -52.79 -26.62 14.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -0.905 . . . . 0.61 111.112 -178.051 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -82.06 -55.88 4.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.874 -1.141 . . . . 0.6 109.963 179.624 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -80.25 40.14 0.48 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.677 -1.231 . . . . 1.4 107.677 179.775 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.458 ' H ' ' C ' ' A' ' 169' ' ' ALA . 17.7 tp -97.91 124.55 42.39 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.98 -0.748 . . . . 0.7 108.98 179.858 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -81.61 97.8 8.04 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.112 -1.07 . . . . 2.35 108.112 179.189 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.54 -44.85 95.33 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.565 -0.709 . . . . 1.51 110.62 -178.591 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -62.38 -32.02 72.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.1 -1.0 . . . . 2.33 112.47 -177.394 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -93.29 -10.27 36.07 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.684 -1.26 . . . . 1.92 110.787 -177.862 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 176' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 178' ' ' GLY . 91.4 t -102.36 113.11 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.048 -1.032 . . . . 0.67 108.749 178.986 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 39.6 mt -85.75 5.14 33.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.188 -0.945 . . . . 1.53 110.687 -178.31 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.463 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 175.09 168.62 35.92 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.309 -1.424 . . . . 0.48 109.82 179.531 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.441 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 23.0 m-85 -130.52 127.93 40.13 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.494 -1.003 . . . . 0.55 108.745 179.787 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.403 ' CG2' HG21 ' A' ' 205' ' ' THR . 62.2 mt -130.56 124.19 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.332 -0.988 . . . . 0.65 108.332 178.725 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 36.0 p -139.53 152.0 46.57 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.343 -0.848 . . . . 0.82 110.642 -179.247 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 182' ' ' ASP . . . . . 0.543 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.7 OUTLIER -100.62 26.71 6.47 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.75 -0.833 . . . . 2.46 108.75 179.356 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.37 -161.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.103 -0.998 . . . . 1.28 111.574 -177.819 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.9 -57.34 6.42 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.974 -0.85 . . . . 2.19 110.974 -178.874 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.51 -132.69 2.04 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 118.887 -1.625 . . . . 2.13 111.2 -179.33 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 186' ' ' ARG . . . . . 0.513 ' NH2' ' NH1' ' A' ' 195' ' ' ARG . 10.7 mtp-105 -80.18 -10.11 59.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.474 -1.015 . . . . 5.86 110.533 -178.663 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 71.5 p -81.49 5.99 16.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.008 -1.058 . . . . 3.72 109.906 -179.231 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.5 t -88.34 134.15 33.89 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.048 -1.033 . . . . 1.74 110.191 -179.63 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -48.21 -43.2 31.82 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.237 -0.914 . . . . 0.95 108.681 179.645 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 93.5 m -59.4 -39.91 84.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.831 -0.543 . . . . 1.55 109.83 -179.517 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 55.8 p -59.9 -38.32 81.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.999 -1.063 . . . . 1.51 110.264 -179.397 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.6 mm -59.95 -40.0 81.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.322 -0.862 . . . . 1.67 109.371 -179.782 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.5 mtp -58.78 -49.93 75.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.269 -0.894 . . . . 1.02 110.55 -178.971 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -50.59 -44.3 56.88 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.855 -1.153 . . . . 0.68 109.524 -178.98 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 195' ' ' ARG . . . . . 0.513 ' NH1' ' NH2' ' A' ' 186' ' ' ARG . 65.4 mtp180 -59.94 -51.53 69.28 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.62 -0.832 . . . . 2.93 110.349 -178.709 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.7 m -76.07 -32.03 59.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.945 -1.097 . . . . 0.86 111.711 -178.152 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.3 -20.33 48.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.737 -1.227 . . . . 0.67 110.017 -179.197 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 60.41 46.81 9.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.205 -0.934 . . . . 1.5 110.223 -179.36 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 97.4 mt -121.09 129.18 25.39 Favored Pre-proline 0 N--CA 1.501 2.115 0 N-CA-C 108.375 -0.972 . . . . 0.72 108.375 178.715 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -43.52 131.2 7.17 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.975 1.783 . . . . 0.61 112.753 -179.571 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -168.91 146.54 3.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.703 -1.248 . . . . 0.66 111.607 179.962 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.3 mt -122.42 144.35 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 106.966 -1.494 . . . . 0.79 106.966 178.011 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 13.6 m -123.56 -13.2 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 O-C-N 120.854 -1.154 . . . . 0.91 111.454 -178.223 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.12 26.24 19.59 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.498 -1.041 . . . . 1.01 110.498 -179.172 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.456 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 7.7 p -47.23 -39.44 14.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.837 -1.39 . . . . 0.99 110.047 -179.117 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.81 -51.68 4.34 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 119.913 -1.137 . . . . 1.12 111.851 178.671 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 49.9 m -158.33 40.99 0.26 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.474 -1.603 . . . . 1.72 111.489 -178.766 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 18.5 t -79.52 -33.39 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.88 -1.138 . . . . 0.89 108.106 178.192 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.0 p -54.44 -31.61 55.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.657 -0.652 . . . . 1.03 110.92 -179.139 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 35.3 m -80.66 -10.91 59.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.99 -1.069 . . . . 1.83 110.304 -179.108 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -104.85 -13.98 15.65 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.274 -0.891 . . . . 2.27 110.788 -179.224 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.4 t -108.01 138.71 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.141 -0.974 . . . . 0.92 110.824 -178.497 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 213' ' ' LYS . . . . . 0.455 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 0.1 OUTLIER -118.31 150.6 39.2 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.38 -1.341 . . . . 2.2 107.38 178.434 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 214' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 17.9 p30 -51.81 138.58 23.58 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.065 -1.022 . . . . 2.36 111.001 -178.488 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.6 m-20 80.01 5.27 1.88 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 116.424 -0.353 . . . . 2.38 111.332 178.789 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.455 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 91.8 m-20 -73.7 140.4 46.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.648 -1.283 . . . . 2.09 109.025 178.977 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.03 116.85 24.5 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.358 -0.979 . . . . 1.27 108.358 179.508 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' A' ' 16' ' ' ALA . 86.3 mt -126.66 146.17 50.29 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.382 -0.824 . . . . 0.75 110.784 -178.92 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 78.6 mt -113.32 127.29 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.081 -1.822 . . . . 0.63 106.081 177.206 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 54.7 tp -101.21 119.23 38.45 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.865 -1.147 . . . . 0.7 108.51 -179.112 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.491 ' C ' ' N ' ' A' ' 223' ' ' VAL . 92.6 m-20 -77.07 -45.27 27.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.131 -0.98 . . . . 2.31 109.378 179.893 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 222' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 49.78 14.23 0.12 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.355 -0.979 . . . . 0.78 108.355 -178.996 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 223' ' ' VAL . . . . . 0.491 ' N ' ' C ' ' A' ' 221' ' ' ASP . 49.0 t -130.65 -45.3 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 106.601 -1.629 . . . . 1.04 106.601 178.542 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 224' ' ' ASN . . . . . 0.426 ' H ' ' HB3' ' A' ' 221' ' ' ASP . 20.0 t-20 -99.67 -2.71 34.76 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.416 -1.327 . . . . 2.44 107.416 178.064 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 225' ' ' ASN . . . . . 0.526 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 62.56 40.0 10.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.917 -0.489 . . . . 1.55 110.194 179.837 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -136.99 148.25 46.77 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.248 -0.907 . . . . 1.99 109.751 178.939 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.7 t -119.85 121.17 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.792 -0.568 . . . . 0.77 109.675 179.946 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -90.25 128.02 36.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.003 -1.06 . . . . 0.98 109.442 -179.887 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.8 t -100.73 111.51 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.469 -0.769 . . . . 0.85 110.205 -179.256 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 43.1 t30 50.01 65.74 6.51 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.193 -0.942 . . . . 1.66 111.482 178.899 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -90.05 156.49 4.83 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.969 2.446 . . . . 0.95 112.232 178.822 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.3 m -66.16 156.37 34.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.231 -0.918 . . . . 1.84 110.334 -179.237 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -60.01 -38.3 82.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.514 -0.741 . . . . 2.74 109.414 179.99 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -59.74 -36.05 75.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.117 -0.989 . . . . 2.89 108.903 -179.925 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.4 t -68.33 -40.11 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 1.3 108.718 178.913 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.6 mt -65.43 -39.58 85.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.424 -0.798 . . . . 1.09 109.29 179.255 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.97 -40.09 87.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.95 -1.094 . . . . 2.43 109.112 -179.459 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -67.52 -40.07 85.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.115 -0.991 . . . . 2.78 109.345 179.177 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 94.8 mtp -70.08 -32.3 70.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.234 -0.916 . . . . 1.25 109.667 179.461 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -67.95 -40.16 83.28 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.244 -0.91 . . . . 2.63 109.583 179.929 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.78 -42.47 93.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.038 -1.039 . . . . 1.8 109.531 179.822 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 75.0 t -60.06 -40.13 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.319 -0.863 . . . . 2.13 109.341 179.916 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.94 -40.15 87.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.264 -0.898 . . . . 3.17 109.622 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.92 -43.3 94.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 1.78 109.47 -179.429 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -64.15 -38.82 92.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.327 -0.858 . . . . 2.47 109.315 179.576 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 67.5 t -60.01 -40.55 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.52 -0.737 . . . . 2.09 109.804 -179.231 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.59 97.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.066 -1.021 . . . . 2.54 109.09 179.866 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 79.2 p -62.63 -37.4 86.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.307 -0.87 . . . . 2.99 109.287 179.691 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.5 -37.54 85.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.492 -0.755 . . . . 3.34 109.967 -179.757 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -69.77 5.38 1.51 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.121 -0.987 . . . . 3.88 110.019 -179.56 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -62.35 -22.34 66.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.432 -0.792 . . . . 4.43 109.792 -179.848 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 252' ' ' GLU . . . . . 0.54 ' C ' ' H ' ' A' ' 254' ' ' ALA . 96.9 mt-10 55.94 11.94 0.81 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.595 0.712 . . . . 5.42 109.165 -179.507 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.424 ' O ' ' HB3' ' A' ' 254' ' ' ALA . 17.3 mt 54.09 -2.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.786 -0.571 . . . . 6.1 111.284 179.62 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 254' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' A' ' 252' ' ' GLU . . . 60.53 19.89 9.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.697 -1.252 . . . . 7.37 110.327 179.792 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -62.43 -39.67 94.07 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.066 -1.022 . . . . 8.01 109.666 179.611 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 60.2 tp -69.95 -24.02 63.28 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.399 -0.813 . . . . 9.05 110.995 -178.9 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -67.48 -76.31 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.549 -1.345 . . . . 10.56 109.811 -179.411 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -172.3 -52.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 11.32 109.538 179.864 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 117.935 -1.031 . . . . 12.42 109.483 -179.899 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 58.1 ttp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.694 0.759 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -153.87 150.67 28.64 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.831 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -152.32 160.91 43.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.024 -1.047 . . . . 0.0 110.719 -179.099 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -156.62 154.16 29.73 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.081 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 305' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 55.2 mp0 -110.31 129.53 55.72 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.252 -0.905 . . . . 0.0 109.709 179.577 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.41 121.95 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 CA-C-O 121.942 0.877 . . . . 0.0 112.157 -177.247 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 48.7 m -78.87 105.7 10.37 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 122.163 0.982 . . . . 0.0 111.444 -177.915 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.9 mt -53.08 123.52 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 122.438 1.113 . . . . 0.0 111.151 -177.863 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 76.0 p -111.42 19.88 17.79 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.895 -179.61 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.91 129.12 87.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.905 -1.122 . . . . 0.0 109.403 -179.932 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -51.17 -23.84 13.76 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 CA-C-N 119.983 1.03 . . . . 0.0 113.364 -179.506 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -122.16 11.42 10.16 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.348 -0.845 . . . . 0.0 109.203 -179.94 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.7 -171.25 55.15 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -178.481 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.48 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.7 tp -88.81 93.93 9.75 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.857 -1.378 . . . . 0.0 108.791 -179.618 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.401 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 4.3 p80 -98.21 -159.02 0.71 Allowed 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.357 -0.839 . . . . 0.0 110.853 179.793 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 7.7 m -57.38 -47.01 82.8 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.246 -0.909 . . . . 0.0 112.699 -176.299 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.557 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.2 tpt180 -58.88 -60.25 11.12 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 120.434 -1.416 . . . . 0.0 112.217 -178.072 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.401 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 10.3 Cg_endo -60.3 -30.71 91.66 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 CA-C-N 120.449 1.196 . . . . 0.0 111.45 -179.679 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.04 75.31 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.147 -0.971 . . . . 0.0 108.413 179.527 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.85 -43.52 77.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.444 -0.785 . . . . 0.0 109.673 -179.492 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -71.47 -41.76 68.97 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.913 -1.117 . . . . 0.0 108.792 178.763 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.58 -52.82 61.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.331 -0.856 . . . . 0.0 110.54 -179.76 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 74.9 t -67.19 -27.85 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.719 -1.238 . . . . 0.0 110.12 -178.781 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -60.25 -42.75 95.98 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.642 179.514 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -65.53 -55.59 16.94 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.9 -1.125 . . . . 0.0 109.794 -179.778 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.93 71.81 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.923 -1.111 . . . . 0.0 110.469 -179.447 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -48.92 -22.48 0.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 108.99 -179.278 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -82.59 -13.05 79.16 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.778 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -104.95 141.84 35.83 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.363 -1.08 . . . . 0.0 108.894 179.416 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 38.9 p -90.9 -13.6 33.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.785 -1.197 . . . . 0.0 110.014 -179.832 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 331' ' ' SER . . . . . 0.49 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 67.5 p -59.98 142.77 53.23 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.039 -1.038 . . . . 0.0 109.181 179.909 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 332' ' ' GLU . . . . . 0.405 ' OE1' ' N ' ' B' ' 332' ' ' GLU . 40.2 mp0 -65.58 132.84 49.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.999 -1.063 . . . . 0.0 108.54 179.619 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 95.8 mt -130.92 132.42 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.447 -0.783 . . . . 0.0 109.712 -179.859 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 27.1 m -129.93 147.09 51.65 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.514 -0.742 . . . . 0.0 109.33 179.492 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 59.9 t -120.76 116.73 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.386 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 71.9 m -104.93 121.51 43.87 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.164 -0.96 . . . . 0.0 109.712 -178.66 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 94.5 p -133.92 121.89 22.34 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.901 0.857 . . . . 0.0 111.233 -179.616 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 58.9 t30 47.51 54.5 9.59 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 176.938 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.92 -11.54 41.18 Favored Glycine 0 N--CA 1.499 2.868 0 O-C-N 120.009 -1.682 . . . . 0.0 112.843 176.481 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -121.88 134.65 54.87 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 119.087 1.444 . . . . 0.0 108.776 -179.712 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 59.7 p -133.63 152.77 51.96 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.371 -0.831 . . . . 0.0 110.947 -178.231 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -147.18 169.95 18.25 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.382 0.61 . . . . 0.0 109.842 -179.859 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 72.3 m -88.16 140.94 28.97 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.472 -0.768 . . . . 0.0 110.403 -179.38 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.484 ' HA ' HD11 ' B' ' 350' ' ' LEU . . . -81.91 -15.39 54.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.043 -1.035 . . . . 0.0 109.442 179.677 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -86.4 16.33 4.6 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.52 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 346' ' ' SER . . . . . 0.426 ' H ' ' C ' ' B' ' 344' ' ' ALA . 13.5 p -147.97 93.38 2.18 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.278 -179.362 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 347' ' ' LEU . . . . . 0.506 ' HA ' HD12 ' B' ' 350' ' ' LEU . 21.8 tp -60.76 -32.93 72.22 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.746 -0.596 . . . . 0.0 109.704 178.97 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -53.22 -51.92 60.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.68 -1.263 . . . . 0.0 110.064 -179.558 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -70.69 -39.91 73.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 0.0 110.831 -179.408 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 350' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' B' ' 352' ' ' THR . 86.1 mt -48.05 -54.44 13.07 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.771 -1.206 . . . . 0.0 109.293 -179.311 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.53 ' O ' HD22 ' A' ' 123' ' ' LEU . 37.7 mt-30 -40.99 -15.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.592 -0.693 . . . . 0.0 110.931 -178.726 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 352' ' ' THR . . . . . 0.587 ' N ' ' O ' ' B' ' 350' ' ' LEU . 62.0 p -87.72 -10.22 51.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.456 -1.402 . . . . 0.0 110.247 -179.424 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 60.3 mt -95.01 116.77 29.12 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.93 -1.106 . . . . 0.0 109.454 179.0 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.88 94.17 1.08 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.081 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 25.5 mt -100.64 92.04 4.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.297 -1.119 . . . . 0.0 109.507 -179.632 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 44.6 p -90.03 172.41 8.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.93 -1.106 . . . . 0.0 111.197 -178.862 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -66.84 116.9 8.23 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.359 0.599 . . . . 0.0 110.491 -179.856 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 99.61 8.92 51.37 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.7 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 45.6 m -87.61 111.3 21.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.404 -1.056 . . . . 0.0 110.404 -179.604 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 22.0 t -77.48 116.34 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 122.202 1.001 . . . . 0.0 109.448 -177.662 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 18.4 m -110.98 177.2 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.025 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 42.6 m -130.88 126.98 37.59 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.491 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.3 111.75 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.923 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 61.7 p -118.24 132.87 56.28 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.796 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.3 150.66 37.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.91 . . . . 0.0 109.974 -178.974 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 366' ' ' GLU . . . . . 0.402 ' O ' ' OE1' ' B' ' 332' ' ' GLU . 18.4 tp10 -141.61 122.42 14.4 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.505 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 367' ' ' GLY . . . . . 0.463 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 160.36 -160.61 31.91 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.053 -1.546 . . . . 0.0 111.477 -179.886 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -59.81 -50.14 74.97 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.979 -0.718 . . . . 0.0 112.42 -177.245 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 369' ' ' ASP . . . . . 0.49 ' H ' ' HB3' ' B' ' 331' ' ' SER . 70.7 m-20 -109.95 13.65 23.35 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.035 -1.041 . . . . 0.0 111.22 -177.223 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 370' ' ' GLU . . . . . 0.564 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -45.44 -34.96 3.43 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.081 -1.012 . . . . 0.0 111.852 -178.876 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' B' B ' 371' ' ' GLN . . . . . 0.518 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 96.6 mt-30 -70.94 -41.4 71.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.809 -1.182 . . . . 0.0 110.098 -179.001 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -66.41 -43.26 86.24 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.338 -0.852 . . . . 0.0 109.725 -178.869 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -53.95 -71.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 110.977 -178.965 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 374' ' ' VAL . . . . . 0.588 ' O ' HG23 ' B' ' 378' ' ' VAL . 60.0 t -46.86 -37.69 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.914 -1.116 . . . . 0.0 110.204 -177.682 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -63.74 -50.0 70.8 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.75 -1.219 . . . . 0.0 110.345 179.518 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -78.5 -42.83 28.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.065 -1.022 . . . . 0.0 110.157 -179.894 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.95 -37.46 79.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.25 -0.906 . . . . 0.0 109.631 -179.306 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 378' ' ' VAL . . . . . 0.588 HG23 ' O ' ' B' ' 374' ' ' VAL . 46.7 t -63.68 -40.2 88.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.209 -0.932 . . . . 0.0 109.325 179.836 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -70.59 -57.46 4.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.616 -1.303 . . . . 0.0 107.929 178.134 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 54.4 tp -57.41 -34.65 69.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.513 -0.742 . . . . 0.0 110.348 -178.151 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.9 ttm -70.51 -40.02 73.77 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.424 -1.423 . . . . 0.0 108.199 177.831 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.69 -7.25 59.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.811 -0.555 . . . . 0.0 110.794 179.324 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 383' ' ' GLU . . . . . 0.406 ' O ' ' OE2' ' B' ' 385' ' ' GLU . 96.7 mt-10 -111.73 -0.22 16.05 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.978 -1.076 . . . . 0.0 111.585 -179.388 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.1 mt -83.21 130.48 35.09 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.421 -1.424 . . . . 0.0 109.684 179.456 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' B' B ' 385' ' ' GLU . . . . . 0.428 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 35.4 mp0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.177 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.722 0 CA-C-O 121.191 0.519 . . . . 2.91 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 94.9 mt -109.41 124.72 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.914 -0.773 . . . . 1.2 108.914 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.6 m -130.07 130.31 44.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.978 -0.749 . . . . 1.4 108.978 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.795 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -115.49 -166.93 15.05 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 108.754 -1.738 . . . . 1.05 108.754 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 5' ' ' ILE . 72.5 mt -91.06 -10.48 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.033 -1.275 . . . . 1.15 110.562 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.485 HD11 ' O ' ' A' ' 8' ' ' SER . 57.5 tp 53.3 98.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.684 -1.26 . . . . 0.98 109.8 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.97 -38.7 44.57 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.848 -0.797 . . . . 0.88 108.848 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.485 ' O ' HD11 ' A' ' 6' ' ' LEU . 5.0 m -141.27 140.2 20.43 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.498 -0.751 . . . . 1.69 109.595 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -80.48 140.33 13.38 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.529 2.153 . . . . 0.85 112.821 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.748 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.99 -163.68 36.94 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.05 -1.62 . . . . 0.92 109.05 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.2 mt -148.64 149.63 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.208 -1.172 . . . . 0.81 108.156 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.38 155.58 33.88 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.572 -1.33 . . . . 0.51 110.721 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -137.89 129.68 28.43 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.072 -1.084 . . . . 0.62 108.072 178.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.43 -178.13 46.35 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 118.699 -1.715 . . . . 0.55 110.905 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -80.07 156.51 27.05 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.811 -0.817 . . . . 2.1 109.519 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.585 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.11 129.75 51.81 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.449 -0.782 . . . . 0.77 110.934 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.3 tp -100.09 135.83 40.93 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.307 -1.368 . . . . 0.91 107.307 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.2 tp -117.77 127.45 53.92 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.262 -0.899 . . . . 0.93 109.951 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.4 mt -88.28 101.22 13.64 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 120.115 -0.634 . . . . 0.93 109.352 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.31 137.58 32.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 2.75 108.701 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -130.48 133.33 46.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.217 -0.927 . . . . 3.0 108.998 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -81.42 149.84 28.63 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.105 -0.997 . . . . 2.77 108.94 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -66.75 146.84 54.02 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.0 -1.062 . . . . 2.94 108.893 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.8 mt -94.45 130.91 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.283 -0.886 . . . . 0.95 108.633 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.3 t -101.61 129.66 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.271 -0.893 . . . . 1.28 110.752 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -108.34 132.1 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.585 -0.894 . . . . 1.21 108.585 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -87.36 120.59 28.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.79 -1.194 . . . . 1.81 109.495 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -88.71 0.1 56.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.388 -0.82 . . . . 2.8 108.879 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -68.83 146.49 52.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 2.87 109.252 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -89.22 150.07 22.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 2.35 109.335 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.502 HG21 ' HG3' ' A' ' 39' ' ' GLU . 3.5 pt -93.92 166.18 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.321 -0.862 . . . . 0.97 109.793 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.5 p -97.59 171.12 8.56 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.224 -1.028 . . . . 1.17 108.224 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.69 -49.39 77.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.948 -1.095 . . . . 1.18 108.94 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -53.89 -29.94 43.84 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.81 -1.181 . . . . 2.56 109.516 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -82.84 -10.0 59.05 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.395 -0.816 . . . . 1.79 110.413 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.57 -53.84 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.831 -1.168 . . . . 1.0 108.691 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.21 -40.07 88.83 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.481 -0.762 . . . . 1.77 109.677 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.23 -41.96 93.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -0.901 . . . . 2.7 110.891 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.502 ' HG3' HG21 ' A' ' 31' ' ' ILE . 67.4 mm-40 -65.76 -39.98 91.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 1.51 110.419 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.0 -46.17 94.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.701 -1.249 . . . . 0.93 108.491 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -59.98 -40.63 89.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.01 -1.056 . . . . 1.81 109.192 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -60.07 -43.03 95.73 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.901 -1.125 . . . . 2.78 108.438 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -66.39 -42.97 87.09 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.842 -0.799 . . . . 0.78 108.842 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.91 -50.63 73.01 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.282 -1.007 . . . . 1.07 108.282 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 42.8 t -63.86 -42.76 97.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.371 -0.932 . . . . 1.12 108.872 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.33 -42.51 98.85 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.575 -1.81 . . . . 0.84 108.575 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.442 HH11 ' HG2' ' A' ' 47' ' ' ARG . 21.4 ttt-85 -64.95 -35.12 80.16 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.184 -1.043 . . . . 3.09 108.184 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -53.76 -39.94 65.77 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.773 -0.825 . . . . 0.88 108.773 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.565 ' HZ3' ' HB3' ' A' ' 49' ' ' LYS . 7.0 ttpm? -72.46 -73.7 0.19 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.89 -1.152 . . . . 2.59 107.89 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.439 ' HB2' ' OD1' ' A' ' 140' ' ' ASN . . . -37.02 -41.11 0.33 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.334 -0.854 . . . . 0.7 112.084 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.2 p -57.93 -55.07 39.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.591 -1.318 . . . . 1.4 108.816 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.06 95.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.446 -0.784 . . . . 0.67 110.85 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -62.16 -46.05 90.71 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.997 -1.064 . . . . 1.66 110.685 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.74 -40.21 94.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.13 -0.981 . . . . 1.58 109.418 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -62.84 -40.02 96.15 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.306 -0.871 . . . . 1.35 109.603 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.9 m -65.87 -41.5 91.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.021 -1.05 . . . . 0.77 109.983 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.1 mt -61.64 -40.0 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.112 -0.992 . . . . 0.63 108.793 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -55.44 -50.87 68.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.471 -0.768 . . . . 1.14 109.771 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -58.82 -37.51 76.56 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.329 -0.857 . . . . 0.79 110.254 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -61.7 -38.74 88.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.073 -1.017 . . . . 1.53 109.39 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.413 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -66.98 -46.9 73.19 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.745 -0.597 . . . . 0.57 110.162 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.84 -53.27 37.41 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.829 -1.308 . . . . 0.75 109.829 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.54 -44.82 66.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.05 -1.265 . . . . 1.59 110.462 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.5 m -66.53 -64.04 0.94 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.124 -0.985 . . . . 0.73 112.74 -177.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -95.8 -45.25 7.06 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.747 -1.221 . . . . 0.75 111.002 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.4 -167.47 25.5 Favored Glycine 0 N--CA 1.498 2.786 0 C-N-CA 119.771 -1.204 . . . . 1.22 110.792 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.21 -24.18 63.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 122.032 -0.687 . . . . 5.81 109.819 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.516 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.4 tp10 -60.96 -35.83 77.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.407 -0.808 . . . . 3.37 110.786 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -97.62 -19.46 18.29 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.133 -0.979 . . . . 1.77 109.764 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -68.89 -40.22 79.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.248 -0.908 . . . . 1.65 110.402 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.54 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -66.48 -32.65 74.14 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.393 -0.817 . . . . 0.77 110.144 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.06 -40.41 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 118.836 -1.145 . . . . 0.8 108.672 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -64.43 -40.14 95.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.104 -0.998 . . . . 0.88 109.15 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -60.08 -41.93 93.5 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.299 -0.876 . . . . 1.37 109.438 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.05 -43.73 97.95 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.173 -1.571 . . . . 0.62 109.173 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.4 m170 -70.0 -40.02 75.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -1.117 . . . . 1.5 109.167 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.0 -47.22 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.101 -0.999 . . . . 0.63 109.019 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.1 ttp -60.08 -40.49 89.75 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.992 -1.068 . . . . 1.51 109.836 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.882 HD11 ' CE2' ' B' ' 348' ' ' PHE . 32.2 tp -68.53 -39.93 80.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.444 -0.785 . . . . 0.77 109.289 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.34 -39.97 94.83 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.424 -0.798 . . . . 0.62 109.481 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -79.42 1.72 24.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.319 -0.863 . . . . 1.47 110.171 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -49.42 128.19 16.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.831 -1.168 . . . . 1.47 109.953 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -62.41 -16.82 57.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.55 -0.719 . . . . 1.78 110.566 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.67 -32.71 66.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.788 -1.195 . . . . 2.53 108.813 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.8 mt -70.74 -43.58 68.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.69 -0.631 . . . . 0.8 110.442 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -60.03 -43.31 95.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.046 -1.034 . . . . 1.42 110.47 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.96 -42.87 72.6 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.05 -1.031 . . . . 1.71 110.812 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.14 -39.97 75.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.959 -1.088 . . . . 1.57 111.333 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.6 mt -64.05 -50.03 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.65 109.985 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.5 mt -69.34 -35.36 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.448 -0.783 . . . . 0.82 110.173 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.63 -45.85 92.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 0.79 110.847 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.56 -47.53 85.77 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.911 -1.118 . . . . 0.95 109.982 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.9 mt -60.24 -49.67 83.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 122.093 0.949 . . . . 0.66 108.932 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -69.8 -39.94 76.28 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.15 -0.62 . . . . 2.2 111.175 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -84.83 -57.99 2.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.769 -1.207 . . . . 1.65 112.345 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -83.61 -0.94 52.69 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.964 -1.085 . . . . 2.03 111.419 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 57.34 36.63 27.44 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.117 -0.99 . . . . 1.42 109.854 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.5 mtt -90.27 167.96 12.28 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.568 -0.707 . . . . 1.18 109.976 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.9 p -80.88 160.58 24.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.473 -0.767 . . . . 0.98 109.339 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.56 -40.86 80.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.102 -0.999 . . . . 0.64 110.069 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 31.4 p-10 -64.36 -36.78 85.24 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.252 -0.905 . . . . 2.07 109.221 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.431 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.96 -48.61 12.05 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.036 -1.04 . . . . 0.73 109.844 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.65 -48.95 79.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.527 -0.733 . . . . 0.54 110.952 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.09 93.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.032 -1.043 . . . . 0.56 110.296 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.417 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 81.6 t60 -59.08 -38.27 79.06 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.055 -1.028 . . . . 1.54 110.397 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.71 -41.12 97.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.874 -1.141 . . . . 1.33 110.968 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.05 -52.19 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.013 -1.055 . . . . 0.72 110.715 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.0 mm -66.96 -39.96 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.063 -1.023 . . . . 0.85 108.402 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.417 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 89.2 tt0 -66.22 -38.2 87.37 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.737 -0.838 . . . . 2.44 108.737 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.88 -47.36 90.92 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.312 -1.115 . . . . 0.98 110.312 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -68.33 -53.48 23.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.688 -1.478 . . . . 1.41 108.677 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.89 -39.95 59.86 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.096 -1.002 . . . . 1.2 109.106 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 46.2 t -60.06 -42.74 95.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.099 -1.001 . . . . 1.7 108.544 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.89 87.37 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.394 -0.816 . . . . 1.47 109.188 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.6 mt -67.44 -41.6 84.48 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.909 -1.119 . . . . 1.56 108.986 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -53.65 -31.42 47.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.071 -1.018 . . . . 2.2 109.164 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.6 -24.88 65.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.275 -0.89 . . . . 2.12 108.717 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.42 HD13 HD13 ' A' ' 123' ' ' LEU . 61.0 mt -62.79 143.55 57.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 2.0 109.272 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -99.33 48.98 0.95 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.325 -0.86 . . . . 3.23 109.257 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 56.9 t0 -134.61 132.89 39.55 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.296 -0.878 . . . . 2.49 109.795 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.441 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 18.4 pt-20 -70.25 -29.01 65.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.568 -0.707 . . . . 3.95 109.898 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.478 ' OH ' ' NH1' ' A' ' 126' ' ' ARG . 3.5 t80 -71.1 -39.92 71.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.38 -0.825 . . . . 2.0 110.383 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.464 HD22 ' O ' ' B' ' 351' ' ' GLN . 88.9 mt -79.63 -40.05 30.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.99 . . . . 1.86 109.775 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -60.15 -49.91 75.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.982 -1.074 . . . . 2.84 109.706 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 96.6 mt-10 -61.82 -40.17 94.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 2.73 108.862 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.702 ' CG ' HE22 ' B' ' 351' ' ' GLN . 31.6 ttt180 -60.03 -40.07 88.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.857 -1.164 . . . . 2.77 107.857 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.66 -23.51 66.81 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.261 -1.015 . . . . 1.19 108.261 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -61.46 -40.03 93.05 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.58 -1.267 . . . . 1.2 107.58 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -61.54 -41.44 97.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.515 -0.741 . . . . 1.55 109.082 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 73.1 t -63.65 -40.08 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.273 -1.01 . . . . 0.8 108.273 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -62.7 -33.52 75.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.608 -0.683 . . . . 3.09 109.476 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -59.95 -41.58 92.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 1.46 109.487 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.1 mt -60.09 -45.58 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.163 -0.961 . . . . 0.71 109.863 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.66 -43.31 99.17 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.397 -0.906 . . . . 0.57 111.014 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -59.99 -47.87 84.05 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.011 -1.288 . . . . 2.59 110.901 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.594 HH12 ' CB ' ' A' ' 166' ' ' SER . 99.0 mtt180 -69.32 -29.02 66.77 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.832 -1.167 . . . . 2.83 109.903 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 57.6 tp -59.52 -41.57 90.25 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.555 -0.906 . . . . 1.25 108.555 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.6 mt -61.89 -40.12 94.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.141 -0.974 . . . . 0.7 109.317 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.87 -39.97 83.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.488 -0.757 . . . . 2.57 108.978 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.535 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.9 m120 -60.09 -39.11 84.98 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.583 -0.698 . . . . 1.23 111.279 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.1 mt -73.46 -41.2 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.764 -1.21 . . . . 0.81 109.675 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.2 mt -70.43 -31.79 69.13 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.55 -0.719 . . . . 1.0 109.434 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.12 37.94 6.98 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.215 -1.554 . . . . 0.89 109.215 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 144' ' ' LEU . 16.0 tp -73.63 142.56 46.51 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.263 -1.139 . . . . 1.14 108.644 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -69.16 142.72 54.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.207 -0.933 . . . . 4.6 110.668 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.02 129.99 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-O 122.063 0.935 . . . . 1.24 109.343 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.2 mt -61.48 -43.91 97.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.865 -0.607 . . . . 1.54 110.691 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.6 t0 63.76 103.36 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.38 -0.825 . . . . 1.5 109.094 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.492 ' O ' HD13 ' A' ' 152' ' ' ILE . 22.5 mt -70.53 -6.04 33.39 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.522 -0.736 . . . . 0.79 110.184 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 93.7 p -85.09 -14.0 48.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.128 -0.983 . . . . 1.4 108.681 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.87 14.65 2.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.687 -0.633 . . . . 0.92 111.176 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.492 HD13 ' O ' ' A' ' 149' ' ' LEU . 2.5 mp -89.4 134.34 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.603 -1.31 . . . . 0.88 108.188 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -117.53 -9.02 10.9 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.736 -0.602 . . . . 2.45 109.741 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -119.03 149.98 40.75 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.21 -0.932 . . . . 1.52 110.473 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -63.65 130.97 46.48 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.689 -0.856 . . . . 1.58 108.689 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.4 m -152.07 163.59 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.883 . . . . 0.69 109.518 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.0 mt -94.42 147.85 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 106.036 -1.839 . . . . 0.61 106.036 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.2 tp -97.31 117.4 31.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.086 -1.009 . . . . 0.87 110.905 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.91 126.42 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.215 -1.031 . . . . 0.71 108.215 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.88 161.26 40.61 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.094 -1.004 . . . . 0.81 109.201 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.42 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.35 -31.45 69.89 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.133 -1.604 . . . . 0.98 107.847 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -167.59 173.92 8.2 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.559 -0.904 . . . . 2.25 108.559 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 89.9 mt -141.22 130.04 22.99 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.076 -1.015 . . . . 0.78 108.823 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.8 p -87.89 147.91 42.17 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.03 -1.044 . . . . 0.98 109.23 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -43.38 -36.43 6.55 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.817 1.678 . . . . 0.81 112.125 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.594 ' CB ' HH12 ' A' ' 136' ' ' ARG . 50.3 m -60.04 -39.94 87.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.371 -0.831 . . . . 0.9 109.875 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.1 -40.87 78.12 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.155 -0.966 . . . . 1.61 109.751 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.8 p -55.64 -29.75 59.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.96 -1.087 . . . . 0.61 110.605 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -71.79 -51.21 23.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.879 -1.138 . . . . 0.6 109.573 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -85.02 38.52 0.72 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.417 -0.957 . . . . 1.4 108.417 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.401 HD11 HG21 ' A' ' 176' ' ' VAL . 61.8 tp -102.92 130.6 50.02 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.693 -0.63 . . . . 0.7 109.303 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -83.75 103.65 13.22 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.868 -0.789 . . . . 2.35 108.868 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 77.6 mt -64.86 -43.65 92.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.416 -0.803 . . . . 1.51 111.344 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -69.83 -25.24 63.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.893 -1.13 . . . . 2.33 112.417 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -93.18 -10.12 36.89 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.615 -1.303 . . . . 1.92 110.517 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 178' ' ' GLY . 62.3 t -109.18 119.94 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.137 -1.06 . . . . 0.67 108.137 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.1 mt -90.94 8.09 36.9 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.184 -0.947 . . . . 1.53 111.09 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.505 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.96 172.64 37.4 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.153 -1.499 . . . . 0.48 109.87 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -133.7 128.51 35.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.656 -0.908 . . . . 0.55 108.594 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 97.3 mt -132.67 127.2 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.778 . . . . 0.65 109.204 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 50.4 p -150.02 162.0 41.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.904 -1.123 . . . . 0.82 110.516 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 38.1 p-10 -104.0 23.27 13.19 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.186 -0.672 . . . . 2.46 109.186 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.44 -159.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.057 -1.027 . . . . 1.28 111.644 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.66 -54.22 6.09 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.906 -0.877 . . . . 2.19 110.906 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 160.7 -131.46 2.63 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.147 -1.501 . . . . 2.13 110.732 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.522 HH11 ' HG2' ' A' ' 186' ' ' ARG . 12.5 mtt-85 -69.91 -20.78 63.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.67 -0.9 . . . . 5.86 111.065 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 25.1 p -73.04 -0.17 13.13 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.938 -1.101 . . . . 3.72 110.322 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.9 m -91.09 132.36 36.09 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.067 -1.021 . . . . 1.74 110.064 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -49.89 -48.19 51.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.334 -0.854 . . . . 0.95 109.526 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.455 ' H ' HG22 ' A' ' 190' ' ' THR . 0.0 OUTLIER -56.75 -39.83 74.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.33 -0.856 . . . . 1.55 110.085 -179.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 19.7 t -60.09 -43.04 95.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.928 -1.108 . . . . 1.51 109.907 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.33 -41.34 91.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.181 -0.95 . . . . 1.67 109.798 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 86.6 mtp -63.31 -39.98 96.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.168 -0.957 . . . . 1.02 110.175 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.74 -42.89 76.05 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.561 -1.337 . . . . 0.68 108.821 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -59.89 -50.1 75.11 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.455 -0.778 . . . . 2.93 110.041 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.0 m -70.32 -33.95 72.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.093 -1.004 . . . . 0.86 110.711 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 81.8 mt -70.0 -21.36 63.23 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.107 -0.996 . . . . 0.67 109.264 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 60.74 48.89 6.67 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.239 0.542 . . . . 1.5 110.751 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.8 mt -126.42 149.57 67.9 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.218 -1.401 . . . . 0.72 107.218 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.44 137.71 66.59 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.84 1.693 . . . . 0.61 111.593 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.17 151.0 3.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.876 -1.14 . . . . 0.66 111.478 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.8 mt -126.87 143.62 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.964 -1.124 . . . . 0.79 107.964 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.8 m -128.49 -8.8 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 O-C-N 120.736 -1.227 . . . . 0.91 110.864 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.58 21.53 25.77 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 110.397 -1.081 . . . . 1.01 110.397 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 23.0 p -44.46 -44.17 8.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.114 -1.227 . . . . 0.99 110.048 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 93.94 -51.86 2.25 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 120.328 -0.939 . . . . 1.12 111.03 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.9 p -157.34 35.01 0.28 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.516 -1.579 . . . . 1.72 111.444 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.0 t -73.37 -39.86 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.969 -1.082 . . . . 0.89 108.907 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.0 p -56.14 -34.01 65.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.761 . . . . 1.03 110.666 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 23.0 t -71.19 -31.64 67.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.136 -0.977 . . . . 1.83 109.794 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -89.84 -8.22 52.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.838 . . . . 2.27 110.728 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 75.0 t -102.79 131.99 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.011 -1.056 . . . . 0.92 110.528 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -111.33 145.08 39.46 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.066 -1.457 . . . . 2.2 107.066 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.477 ' O ' ' OD1' ' A' ' 215' ' ' ASP . 44.4 p-10 -54.25 137.8 40.29 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.201 -0.937 . . . . 2.36 111.051 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER 89.3 -2.53 0.38 Allowed 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.321 0.581 . . . . 2.38 110.768 178.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -71.36 150.51 45.0 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.336 -0.853 . . . . 2.09 109.497 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -99.09 120.0 38.76 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.234 -1.024 . . . . 1.27 108.234 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 16' ' ' ALA . 73.8 mt -126.64 149.78 49.31 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.565 -0.709 . . . . 0.75 109.861 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.421 HG23 ' CD2' ' A' ' 13' ' ' PHE . 86.9 mt -119.26 129.95 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.301 -1.37 . . . . 0.63 107.301 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 23.9 tp -102.25 119.95 39.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.23 -0.919 . . . . 0.7 109.437 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 223' ' ' VAL . 29.0 t70 -80.1 -41.86 24.71 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.303 -0.873 . . . . 2.31 108.769 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.76 11.67 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.691 -0.63 . . . . 0.78 109.96 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 221' ' ' ASP . 46.7 t -118.84 -35.22 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 106.693 -1.595 . . . . 1.04 106.693 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.452 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 19.9 m120 -112.85 4.6 17.01 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.375 -1.343 . . . . 2.44 107.375 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.795 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.9 OUTLIER 57.58 50.61 10.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.855 -0.528 . . . . 1.55 110.235 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -136.95 147.5 46.38 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.216 -0.927 . . . . 1.99 109.548 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 76.0 t -115.02 129.3 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.545 -0.909 . . . . 0.77 108.545 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -104.48 121.06 42.67 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.768 -0.827 . . . . 0.98 108.768 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 43.1 t -100.08 110.95 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.593 -0.692 . . . . 0.85 109.805 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.487 HD22 ' C ' ' A' ' 230' ' ' ASN . 0.4 OUTLIER 51.69 69.94 2.22 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.41 -0.806 . . . . 1.66 110.911 179.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -90.67 147.64 4.06 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.33 2.687 . . . . 0.95 112.245 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 233' ' ' ASN . 11.0 m -71.02 165.38 23.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.057 -1.027 . . . . 1.84 109.932 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.434 ' N ' HG22 ' A' ' 232' ' ' THR . 41.5 t30 -59.98 -39.92 87.33 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.318 -0.864 . . . . 2.74 109.88 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -60.02 -39.86 87.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.984 . . . . 2.89 109.64 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.32 -44.21 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.155 -0.965 . . . . 1.3 109.049 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 1.09 109.655 -179.813 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 21.8 ttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -153.95 150.84 28.73 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.36 -0.838 . . . . 0.0 108.965 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -148.66 160.05 43.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.98 -1.075 . . . . 0.0 110.171 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -152.12 149.24 28.58 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -109.82 130.24 55.54 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.39 -0.818 . . . . 0.0 109.673 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 1.5 p -131.95 121.51 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 122.167 0.984 . . . . 0.0 112.021 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 50.6 m -75.74 106.1 7.13 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.828 0.823 . . . . 0.0 110.524 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.512 HG22 ' H ' ' B' ' 310' ' ' ALA . 77.9 mt -52.16 123.17 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 122.476 1.131 . . . . 0.0 110.296 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 77.7 p -104.0 23.2 13.3 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.776 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.512 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -82.66 119.47 74.63 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.142 -0.974 . . . . 0.0 109.262 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -66.3 -7.91 18.92 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 120.362 1.165 . . . . 0.0 111.884 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -117.39 6.44 12.64 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.69 176.93 34.25 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.229 -1.949 . . . . 0.0 108.229 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.465 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.3 tp -86.74 96.18 10.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.946 -1.326 . . . . 0.0 108.723 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -97.69 -159.97 0.77 Allowed 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.29 -0.881 . . . . 0.0 110.71 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 24.5 m -59.82 -43.03 94.73 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.033 -1.042 . . . . 0.0 112.303 -175.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.54 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.5 tpt180 -59.74 -64.33 3.14 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 120.356 -1.465 . . . . 0.0 111.428 -178.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -55.37 -33.78 86.66 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 CA-C-N 120.281 1.136 . . . . 0.0 111.782 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.95 71.72 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.46 -40.88 62.8 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.247 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -70.43 -40.06 74.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.031 -1.043 . . . . 0.0 108.674 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -61.44 -53.04 61.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.437 -0.789 . . . . 0.0 110.432 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 77.7 t -68.93 -35.12 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.766 -1.208 . . . . 0.0 109.756 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -59.97 -47.06 87.38 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.869 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -66.34 -40.05 89.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.096 -1.002 . . . . 0.0 109.999 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . 0.419 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -64.65 -52.33 57.91 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.019 -1.051 . . . . 0.0 110.789 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -54.49 -10.21 0.39 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.021 -1.049 . . . . 0.0 109.555 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -71.94 -26.19 73.12 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -101.99 144.99 29.91 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.39 -1.065 . . . . 0.0 109.272 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 8.8 m -90.87 -13.73 33.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.907 -1.121 . . . . 0.0 108.996 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.0 t -62.61 149.88 42.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 109.04 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -67.61 134.62 51.51 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.256 -0.903 . . . . 0.0 109.171 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 90.3 mt -131.12 130.45 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.711 -0.618 . . . . 0.0 109.654 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 98.3 m -129.62 152.36 49.22 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.594 -0.691 . . . . 0.0 109.187 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 61.6 t -116.94 140.47 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 70.4 m -130.36 126.12 36.31 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.211 -0.931 . . . . 0.0 109.497 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 10.8 t -138.65 111.75 7.93 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.232 -0.917 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 46.39 56.38 6.42 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 84.56 -16.2 36.87 Favored Glycine 0 N--CA 1.499 2.873 0 O-C-N 120.223 -1.548 . . . . 0.0 112.299 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -110.65 121.61 45.74 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.922 -1.34 . . . . 0.0 109.482 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 88.4 p -128.25 148.19 50.63 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.811 0.815 . . . . 0.0 109.855 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . 0.553 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -144.84 170.38 16.23 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.662 0.744 . . . . 0.0 110.11 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 70.4 m -88.53 140.47 29.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.605 -0.684 . . . . 0.0 109.582 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -83.13 -12.45 57.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.024 -1.048 . . . . 0.0 110.248 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -88.93 20.56 3.51 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 56.1 m -147.81 98.06 2.9 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.734 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.56 HD23 HD22 ' A' ' 79' ' ' LEU . 29.1 tp -60.0 -34.68 73.66 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.882 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.7 m-85 -57.65 -53.53 57.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.709 -1.244 . . . . 0.0 109.942 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -70.05 -21.4 63.18 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.09 -1.006 . . . . 0.0 111.17 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' B' ' 352' ' ' THR . 21.4 mt -69.42 -52.68 24.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.771 -1.206 . . . . 0.0 108.165 178.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.702 HE22 ' CG ' ' A' ' 126' ' ' ARG . 10.3 mm100 -38.33 -22.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.293 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.533 ' N ' ' O ' ' B' ' 350' ' ' LEU . 58.5 p -82.08 -10.2 59.29 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.962 -1.086 . . . . 0.0 110.215 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.553 HD11 ' HB3' ' B' ' 342' ' ' ALA . 70.6 mt -95.5 116.24 28.55 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.066 -1.021 . . . . 0.0 109.076 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -80.27 94.43 1.49 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 27.8 mt -99.82 92.64 5.4 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.237 -1.155 . . . . 0.0 108.556 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 68.4 p -94.6 179.82 5.13 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.07 -1.019 . . . . 0.0 110.632 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' B' ' 359' ' ' THR . 62.2 tt0 -48.62 157.44 0.37 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.232 1.015 . . . . 0.0 111.236 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.61 23.98 0.02 OUTLIER Glycine 0 N--CA 1.497 2.708 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.499 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . 0.5 ' N ' ' O ' ' B' ' 357' ' ' GLN . 19.1 m -84.4 111.58 19.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.732 -1.452 . . . . 0.0 109.448 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 23.4 t -76.27 115.68 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 122.318 1.056 . . . . 0.0 109.629 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 19.0 m -112.66 176.6 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 45.9 m -130.74 129.49 42.58 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 84.3 mt -102.96 118.24 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 22.1 m -123.67 134.0 53.81 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.322 -0.861 . . . . 0.0 109.232 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.29 150.55 38.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.179 -0.951 . . . . 0.0 109.74 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -140.09 119.81 13.34 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.555 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.74 -160.93 32.37 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 118.855 -1.641 . . . . 0.0 111.691 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -59.95 -51.65 68.78 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 122.371 -0.487 . . . . 0.0 112.311 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -105.52 9.36 33.49 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.857 -1.152 . . . . 0.0 110.939 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.9 pt-20 -42.7 -34.08 0.84 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.151 -0.968 . . . . 0.0 111.088 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -70.11 -41.31 74.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.963 . . . . 0.0 110.135 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -68.12 -49.89 58.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.2 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.27 -76.03 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.382 -0.824 . . . . 0.0 110.997 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.577 ' O ' HG23 ' B' ' 378' ' ' VAL . 82.0 t -45.3 -36.49 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.98 -1.075 . . . . 0.0 111.033 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -64.53 -52.57 57.11 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.427 -1.421 . . . . 0.0 110.637 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -76.81 -40.18 48.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.665 -1.272 . . . . 0.0 110.588 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 87.7 mt -59.62 -39.28 83.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.014 . . . . 0.0 109.088 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.577 HG23 ' O ' ' B' ' 374' ' ' VAL . 50.6 t -60.98 -41.1 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.104 -0.998 . . . . 0.0 109.283 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' B' ' 383' ' ' GLU . 7.7 mtmp? -69.05 -55.2 11.5 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.567 -1.333 . . . . 0.0 108.62 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 63.3 tp -55.97 -35.07 66.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.946 -1.096 . . . . 0.0 109.783 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 6.0 ttm -70.29 -39.99 74.53 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.661 -1.275 . . . . 0.0 107.759 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.27 -7.02 58.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.766 -0.584 . . . . 0.0 110.782 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' B' ' 379' ' ' LYS . 49.3 mt-10 -111.34 1.77 17.26 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.953 -1.092 . . . . 0.0 110.989 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 17.8 mt -87.1 126.62 34.89 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.283 -1.511 . . . . 0.0 109.224 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.302 -179.775 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.028 -0.731 . . . . 2.91 109.028 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 95.2 mt -110.02 128.49 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.542 -0.724 . . . . 1.2 109.306 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.7 m -140.06 150.08 43.92 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.398 -0.813 . . . . 1.4 109.654 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.445 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -136.99 -162.94 9.55 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.297 -1.921 . . . . 1.05 108.297 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' LEU . 93.7 mt -90.4 -17.45 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.745 -1.444 . . . . 1.15 109.875 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.9 tp 51.51 103.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.365 -0.834 . . . . 0.98 109.304 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.7 -29.09 12.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.099 -1.0 . . . . 0.88 109.008 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.1 m -130.84 115.11 16.7 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.636 -0.665 . . . . 1.69 109.276 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -80.15 151.02 20.59 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 121.924 1.749 . . . . 0.85 112.627 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.887 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 150.18 169.18 16.01 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.704 -1.759 . . . . 0.92 108.704 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.9 mt -120.04 129.99 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 O-C-N 121.046 -1.267 . . . . 0.81 109.839 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.33 150.38 50.94 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.083 -1.01 . . . . 0.51 110.455 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.5 m-85 -126.87 128.46 46.53 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 107.924 -1.139 . . . . 0.62 107.924 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.56 178.55 48.47 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.583 -1.77 . . . . 0.55 110.977 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -79.98 158.81 26.48 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.892 -0.77 . . . . 2.1 109.244 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.844 ' HB3' ' OD1' ' A' ' 216' ' ' ASP . . . -106.92 129.71 54.7 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.331 -0.855 . . . . 0.77 110.92 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.7 tp -100.34 133.12 45.24 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.11 -1.441 . . . . 0.91 107.11 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.4 tp -114.83 127.32 55.65 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.258 -0.901 . . . . 0.93 109.536 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.4 mt -89.45 102.08 14.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.473 -0.767 . . . . 0.93 110.368 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -103.0 131.82 49.7 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.132 -0.692 . . . . 2.75 109.132 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -130.52 133.82 46.55 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.323 -0.861 . . . . 3.0 109.389 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -73.48 153.49 40.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.063 -1.023 . . . . 2.77 109.521 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -67.63 143.16 56.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 2.94 109.766 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.2 mt -83.13 128.15 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.895 . . . . 0.95 109.342 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.1 t -93.57 131.53 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.234 -0.916 . . . . 1.28 110.652 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.6 mt -107.97 133.57 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.861 -0.792 . . . . 1.21 108.861 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -92.29 119.25 31.69 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.04 -1.038 . . . . 1.81 109.317 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -90.7 -2.51 57.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.299 -0.875 . . . . 2.8 109.506 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -69.17 139.59 54.61 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.16 -0.963 . . . . 2.87 109.218 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -86.05 153.51 22.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.178 -0.951 . . . . 2.35 109.059 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.638 HD13 ' HG3' ' A' ' 39' ' ' GLU . 2.5 pt -98.29 166.19 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.223 -0.923 . . . . 0.97 109.711 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 81.3 p -90.08 171.66 9.38 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.299 -0.876 . . . . 1.17 109.041 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.53 -17.06 64.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.056 -1.027 . . . . 1.18 110.611 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -86.5 -26.64 24.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.863 -1.148 . . . . 2.56 108.012 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -82.31 -8.43 59.64 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.769 -0.826 . . . . 1.79 108.769 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 t -58.4 -50.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.98 -40.01 87.66 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.208 -0.933 . . . . 1.77 108.707 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -61.48 -46.55 89.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.404 -0.81 . . . . 2.7 110.926 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.638 ' HG3' HD13 ' A' ' 31' ' ' ILE . 64.5 mm-40 -60.16 -44.07 95.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.727 -1.233 . . . . 1.51 109.961 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.05 -46.15 94.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 120.918 -1.114 . . . . 0.93 108.737 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -60.03 -41.25 91.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 1.81 109.193 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -60.01 -45.99 90.96 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.914 -1.116 . . . . 2.78 108.092 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -60.52 -48.23 82.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.531 -0.731 . . . . 0.78 109.075 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.04 -49.93 75.73 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.873 -0.788 . . . . 1.07 108.873 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.457 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 47.6 t -61.47 -44.58 96.84 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.175 -0.953 . . . . 1.12 108.515 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.52 -42.84 99.85 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.454 -1.859 . . . . 0.84 108.454 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.401 ' NH1' ' HG2' ' A' ' 47' ' ' ARG . 41.0 ttt-85 -66.08 -31.08 71.73 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.324 -0.991 . . . . 3.09 108.324 178.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.59 -40.02 82.01 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.175 -0.676 . . . . 0.88 109.175 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.7 ttmt -72.33 -73.43 0.19 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.979 -1.076 . . . . 2.59 108.178 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.53 -34.7 0.15 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.339 -0.851 . . . . 0.7 110.736 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.0 m -57.14 -61.29 2.56 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.65 -1.281 . . . . 1.4 108.54 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.0 82.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 0.67 111.248 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -66.28 -42.63 88.12 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.77 -1.206 . . . . 1.66 110.374 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.98 -39.99 96.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.837 -1.165 . . . . 1.58 108.899 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.25 -35.18 79.75 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.324 -0.86 . . . . 1.35 108.822 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -63.66 -41.68 98.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 0.77 109.779 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.22 -40.05 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.124 -0.985 . . . . 0.63 108.917 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -54.75 -49.93 69.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.46 -0.775 . . . . 1.14 109.712 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -58.38 -37.33 75.03 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.344 -0.848 . . . . 0.79 109.868 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -68.18 -37.52 81.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.001 -1.062 . . . . 1.53 109.277 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.715 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -66.65 -46.56 75.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.657 -0.652 . . . . 0.57 109.862 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.96 -50.02 72.26 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.57 -1.012 . . . . 0.75 110.57 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -70.0 -40.66 75.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.944 -1.327 . . . . 1.59 110.103 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.4 m -69.98 -58.26 4.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.061 -1.025 . . . . 0.73 111.474 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.416 ' CE1' ' O ' ' A' ' 168' ' ' THR . 89.2 m-85 -96.3 -51.39 4.4 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.031 -1.043 . . . . 0.75 111.189 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.86 -167.66 25.88 Favored Glycine 0 N--CA 1.503 3.167 0 C-N-CA 119.555 -1.307 . . . . 1.22 111.339 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -66.9 -25.12 66.22 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.866 -0.785 . . . . 5.81 109.991 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.442 ' OE2' ' NH1' ' B' ' 317' ' ' ARG . 23.3 tp10 -60.06 -34.86 74.0 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.604 -0.685 . . . . 3.37 110.81 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -98.12 -19.54 17.87 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.175 -0.953 . . . . 1.77 110.529 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -69.36 -40.01 77.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.785 -1.197 . . . . 1.65 110.029 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.557 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -63.22 -33.98 76.66 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.367 -0.833 . . . . 0.77 109.695 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.8 mt -60.0 -42.88 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.077 -1.015 . . . . 0.8 109.813 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -63.34 -38.67 92.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.911 -1.118 . . . . 0.88 110.327 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -59.96 -39.99 87.49 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.859 -1.151 . . . . 1.37 109.038 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.53 -54.57 34.79 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.424 -1.47 . . . . 0.62 109.424 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -61.31 -48.21 82.43 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.167 -1.196 . . . . 1.5 109.256 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.6 mt -61.79 -50.01 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.257 -0.902 . . . . 0.63 109.18 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.0 ttp -59.98 -40.79 90.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.073 -1.017 . . . . 1.51 110.173 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.844 HD11 ' CE2' ' B' ' 348' ' ' PHE . 35.0 tp -66.54 -39.89 88.79 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.31 -0.868 . . . . 0.77 109.343 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -64.03 -38.76 92.25 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.528 -0.733 . . . . 0.62 109.329 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -80.22 2.54 23.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 1.47 110.06 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -49.17 130.5 19.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.136 -0.978 . . . . 1.47 109.689 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -63.01 -19.07 64.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.696 -0.627 . . . . 1.78 111.411 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -71.98 -32.38 67.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.656 -1.277 . . . . 2.53 108.611 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.1 mt -71.13 -41.39 70.55 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.541 0.686 . . . . 0.8 109.957 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -60.04 -45.66 92.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.868 . . . . 1.42 110.277 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.97 -41.9 73.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.895 . . . . 1.71 110.734 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.97 -39.96 75.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.157 -0.965 . . . . 1.57 111.746 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 93.8 mt -65.4 -49.09 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.977 -1.077 . . . . 0.65 109.652 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -68.25 -37.71 78.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.619 -0.676 . . . . 0.82 110.877 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.97 83.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.057 -1.027 . . . . 0.79 111.054 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 96' ' ' LYS . 78.5 mt -61.89 -46.21 90.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.908 -1.12 . . . . 0.95 110.28 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.0 mt -60.02 -49.77 82.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.084 -1.01 . . . . 0.66 108.655 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -69.95 -40.15 75.63 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.907 -0.588 . . . . 2.2 110.67 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -84.02 -46.96 11.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.016 -1.053 . . . . 1.65 111.72 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 92' ' ' LEU . 30.9 mmtp -94.64 -2.22 51.74 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.014 -1.053 . . . . 2.03 111.952 -177.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 56.26 35.82 26.43 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.788 -1.195 . . . . 1.42 109.638 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.7 mtp -91.64 167.92 11.86 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.461 -0.774 . . . . 1.18 109.54 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.1 p -82.58 160.23 22.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.145 -0.972 . . . . 0.98 109.407 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.5 -39.92 85.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.237 -0.915 . . . . 0.64 110.195 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -65.06 -37.98 89.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.123 -0.986 . . . . 2.07 109.679 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.13 -48.98 11.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.319 -0.863 . . . . 0.73 110.034 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.91 -49.56 74.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.403 -0.81 . . . . 0.54 110.532 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.06 -43.01 95.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -0.967 . . . . 0.56 109.72 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.465 ' HB2' HD21 ' A' ' 138' ' ' LEU . 78.0 t60 -59.99 -40.0 87.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 1.54 110.531 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.06 -39.98 91.91 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.962 -1.086 . . . . 1.33 109.902 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.5 t -62.2 -53.48 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.232 -0.917 . . . . 0.72 110.991 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.4 mm -69.95 -39.98 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.983 -1.073 . . . . 0.85 109.409 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.21 -39.85 94.13 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.393 -0.966 . . . . 2.44 108.393 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.06 -52.78 50.76 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.712 -0.955 . . . . 0.98 110.712 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -69.28 -44.79 71.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.762 -1.434 . . . . 1.41 109.861 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.88 -44.49 91.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.881 -1.137 . . . . 1.2 108.55 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 88.7 p -59.96 -36.74 77.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 1.7 109.066 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.99 94.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 1.47 109.067 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.4 mt -65.8 -42.27 90.9 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.12 -0.988 . . . . 1.56 109.508 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.43 ' C ' ' N ' ' A' ' 118' ' ' LEU . 85.5 tt0 -59.97 -39.59 86.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.909 -1.119 . . . . 2.2 110.082 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -49.26 -17.92 0.3 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.941 -1.1 . . . . 2.12 109.168 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.43 ' N ' ' C ' ' A' ' 116' ' ' GLU . 68.0 mt -62.65 140.4 58.69 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.526 -0.916 . . . . 2.0 108.526 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 49.8 t0 -93.94 44.15 1.12 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.006 -1.059 . . . . 3.23 111.124 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -137.44 150.9 47.96 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.971 -1.08 . . . . 2.49 109.575 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 124' ' ' LYS . 71.8 mm-40 -72.63 -65.82 0.74 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.144 -0.972 . . . . 3.95 109.13 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.638 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 4.0 t80 -39.11 -42.16 0.89 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.836 -0.54 . . . . 2.0 110.404 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.721 HD23 HH22 ' A' ' 126' ' ' ARG . 87.6 mt -70.58 -39.95 73.57 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.845 -1.159 . . . . 1.86 108.03 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 121' ' ' GLU . 32.8 ttmt -62.07 -38.34 88.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.673 -0.642 . . . . 2.84 110.256 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -60.06 -47.32 86.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.082 -1.011 . . . . 2.73 110.633 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.721 HH22 HD23 ' A' ' 123' ' ' LEU . 21.8 mtm-85 -70.08 -30.16 67.33 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.888 -1.133 . . . . 2.77 108.964 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.99 -27.95 67.28 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.428 -1.323 . . . . 1.19 107.428 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.17 -38.94 72.14 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.49 -0.93 . . . . 1.2 108.49 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -62.27 -42.4 99.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.583 -0.698 . . . . 1.55 110.504 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.75 -40.39 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.058 -1.026 . . . . 0.8 109.112 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.541 HH11 ' HG2' ' A' ' 131' ' ' ARG . 2.4 ttt-85 -60.62 -38.63 85.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.907 . . . . 3.09 109.356 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.02 -40.03 87.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.35 -0.844 . . . . 1.46 110.563 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.0 mt -59.94 -45.21 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.796 -1.19 . . . . 0.71 109.446 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.19 -39.98 96.48 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.928 -1.269 . . . . 0.57 109.928 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -59.98 -49.95 75.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.255 -1.144 . . . . 2.59 110.028 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.416 HH12 ' HB3' ' A' ' 166' ' ' SER . 59.8 mtp180 -68.42 -32.15 71.98 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.017 -1.052 . . . . 2.83 110.062 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.5 tp -60.0 -40.58 89.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.098 -1.001 . . . . 1.25 108.758 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.465 HD21 ' HB2' ' A' ' 105' ' ' HIS . 75.5 mt -60.03 -40.55 89.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.173 -0.954 . . . . 0.7 109.26 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -69.97 -40.08 75.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.476 -0.765 . . . . 2.57 109.72 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -62.72 -35.86 81.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.478 -0.764 . . . . 1.23 111.249 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.0 mt -72.92 -41.39 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.617 -1.302 . . . . 0.81 109.273 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.04 -26.32 63.98 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.668 -0.645 . . . . 1.0 109.462 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.27 35.53 20.33 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.688 -1.765 . . . . 0.89 108.688 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 tp -73.27 144.77 46.53 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.484 -1.009 . . . . 1.14 108.831 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -67.06 140.32 57.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -0.914 . . . . 4.6 110.427 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 89.5 mt -110.03 128.6 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.443 -0.947 . . . . 1.24 108.443 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 14.0 mm -60.21 -44.44 95.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.775 -0.578 . . . . 1.54 110.58 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 42.2 t0 62.62 113.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.438 -0.789 . . . . 1.5 108.951 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.12 -1.93 42.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.366 -0.834 . . . . 0.79 110.079 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.2 m -89.02 -17.18 29.91 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.932 -1.105 . . . . 1.4 110.543 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.27 17.75 0.34 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.107 -0.996 . . . . 0.92 111.721 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 32.7 mm -80.21 132.26 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.469 -1.395 . . . . 0.88 109.978 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -110.43 -11.32 14.51 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.685 -0.634 . . . . 2.45 109.525 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -129.96 152.13 49.77 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.578 -0.701 . . . . 1.52 110.012 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -65.36 136.51 56.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.089 -1.007 . . . . 1.58 109.514 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.8 m -153.36 166.69 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.411 -0.806 . . . . 0.69 109.838 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.4 mt -95.84 149.59 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.026 -1.842 . . . . 0.61 106.026 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.1 tp -104.31 119.38 38.82 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.969 -1.082 . . . . 0.87 110.815 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.417 HG12 HG22 ' A' ' 209' ' ' THR . 4.2 t -123.32 132.12 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.663 -0.865 . . . . 0.71 108.663 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -158.46 163.99 36.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.843 -1.161 . . . . 0.81 109.605 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.04 -35.44 71.96 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.3 -1.5 . . . . 0.98 108.485 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 62.8 t0 -169.56 142.76 2.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.133 -0.692 . . . . 2.25 109.133 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.466 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 90.7 mt -111.62 139.52 47.0 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.397 -0.815 . . . . 0.78 109.651 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 64.2 p -94.62 142.88 25.36 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.337 -0.852 . . . . 0.98 109.409 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -40.28 -38.31 2.23 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.195 1.93 . . . . 0.81 112.751 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.416 ' HB3' HH12 ' A' ' 136' ' ' ARG . 52.5 m -56.77 -40.08 75.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.044 -1.035 . . . . 0.9 108.514 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -66.31 -40.66 90.12 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.392 -0.817 . . . . 1.61 109.901 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.416 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 75.6 p -55.66 -24.23 32.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.996 -1.065 . . . . 0.61 110.083 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.715 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -76.74 -58.2 3.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.112 -0.993 . . . . 0.6 109.784 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -82.27 39.75 0.6 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.558 -0.904 . . . . 1.4 108.558 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.5 tp -104.43 133.48 49.24 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.794 -0.817 . . . . 0.7 108.794 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -93.26 103.51 15.76 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.142 -0.974 . . . . 2.35 108.752 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.37 -45.76 89.64 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.26 -0.9 . . . . 1.51 110.084 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -63.79 -28.48 69.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.967 -1.083 . . . . 2.33 112.207 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -92.51 -10.27 38.36 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.521 -1.362 . . . . 1.92 109.825 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 178' ' ' GLY . 63.1 t -109.64 119.91 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.76 -1.2 . . . . 0.67 107.76 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 89.5 mt -89.26 4.92 47.15 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.201 -0.937 . . . . 1.53 111.422 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.463 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 171.26 173.65 38.43 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.134 -1.508 . . . . 0.48 109.679 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -137.4 129.99 29.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.372 -1.076 . . . . 0.55 108.84 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.3 mt -127.98 125.72 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.463 -0.94 . . . . 0.65 108.463 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 19.7 p -145.54 156.86 43.97 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.746 -1.221 . . . . 0.82 111.113 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 183' ' ' ALA . 0.7 OUTLIER -101.04 26.54 6.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.624 -0.673 . . . . 2.46 109.371 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -47.85 -172.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.364 1.078 . . . . 1.28 112.417 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.14 -55.17 4.89 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 111.062 -0.815 . . . . 2.19 111.062 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -160.5 -156.52 8.23 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 118.876 -1.63 . . . . 2.13 111.129 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.411 ' HD2' HH21 ' A' ' 195' ' ' ARG . 86.3 mtm180 -79.94 -10.06 59.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.696 -0.885 . . . . 5.86 109.918 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 60.6 p -74.6 3.14 8.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.153 -0.967 . . . . 3.72 109.477 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.9 t -76.85 133.37 39.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.859 . . . . 1.74 110.049 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -48.26 -50.68 28.82 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.3 -0.875 . . . . 0.95 110.026 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.442 HG23 ' N ' ' A' ' 191' ' ' SER . 14.7 t -58.26 -38.62 77.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.274 -0.891 . . . . 1.55 110.584 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.442 ' N ' HG23 ' A' ' 190' ' ' THR . 25.8 t -60.0 -40.16 88.26 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.0 -1.063 . . . . 1.51 110.288 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.17 -39.91 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 1.67 109.753 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.3 mtp -60.51 -41.58 94.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 1.02 110.901 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.1 95.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.547 -1.346 . . . . 0.68 109.673 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.411 HH21 ' HD2' ' A' ' 186' ' ' ARG . 66.9 mtt-85 -59.97 -47.54 85.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.108 -0.995 . . . . 2.93 109.952 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.5 m -76.57 -32.44 58.16 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.998 -1.063 . . . . 0.86 111.792 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 96.1 mt -79.98 -12.14 59.74 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.641 -1.287 . . . . 0.67 110.364 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 58.33 51.75 8.0 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.38 -0.825 . . . . 1.5 110.917 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.0 mt -127.44 131.94 24.09 Favored Pre-proline 0 N--CA 1.502 2.127 0 N-CA-C 108.892 -0.781 . . . . 0.72 108.892 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -43.45 123.53 3.65 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.937 1.758 . . . . 0.61 112.112 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.96 140.29 9.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.694 -1.254 . . . . 0.66 111.587 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.4 mt -122.84 141.74 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 107.155 -1.424 . . . . 0.79 107.155 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.7 m -124.88 -8.4 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 120.956 -1.09 . . . . 0.91 111.273 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.05 21.24 25.19 Favored Glycine 0 N--CA 1.501 3.024 0 N-CA-C 110.866 -0.894 . . . . 1.01 110.866 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.436 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.0 p -45.28 -43.79 10.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.891 -1.358 . . . . 0.99 110.048 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 93.01 -51.28 2.52 Favored Glycine 0 N--CA 1.5 2.935 0 C-N-CA 120.076 -1.059 . . . . 1.12 111.726 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.428 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 3.6 m -156.92 38.36 0.31 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.528 -1.571 . . . . 1.72 111.209 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.7 t -80.01 -31.26 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.024 -1.048 . . . . 0.89 108.518 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.417 HG22 HG12 ' A' ' 159' ' ' VAL . 55.6 p -58.79 -30.78 67.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.43 -0.794 . . . . 1.03 110.576 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 20.9 t -78.81 -17.94 54.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.926 -1.109 . . . . 1.83 109.731 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -98.64 -8.85 25.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.238 -0.914 . . . . 2.27 110.377 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.415 HG22 HD11 ' A' ' 218' ' ' LEU . 55.1 t -104.83 130.25 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.282 -0.886 . . . . 0.92 110.869 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -108.31 148.79 29.54 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.371 -1.344 . . . . 2.2 107.371 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.439 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 30.0 p-10 -59.97 136.99 58.18 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.101 -1.0 . . . . 2.36 110.901 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.9 m-20 82.59 -0.03 1.3 Allowed 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 116.187 -0.461 . . . . 2.38 111.547 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.844 ' OD1' ' HB3' ' A' ' 16' ' ' ALA . 24.4 p-10 -74.04 158.54 34.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.418 -1.426 . . . . 2.09 108.385 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -99.29 119.56 38.12 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.385 -0.969 . . . . 1.27 108.385 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 16' ' ' ALA . 80.7 mt -125.85 148.73 49.08 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.479 -0.763 . . . . 0.75 109.99 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 78.8 mt -116.16 129.97 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 107.086 -1.449 . . . . 0.63 107.086 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 40.6 tp -105.88 124.33 49.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.029 -1.045 . . . . 0.7 109.11 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.673 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 29.6 p-10 -87.95 -37.47 16.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.043 -1.036 . . . . 2.31 109.866 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.887 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 45.71 16.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.968 -0.752 . . . . 0.78 108.968 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.5 t -126.06 -41.19 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.497 -1.297 . . . . 1.04 107.497 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.412 ' HB3' HE21 ' A' ' 226' ' ' GLN . 80.9 m-20 -106.53 -0.15 24.16 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.831 -1.174 . . . . 2.44 107.831 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.445 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 0.4 OUTLIER 61.69 49.66 4.83 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.401 0.619 . . . . 1.55 109.771 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.673 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 43.9 mt-30 -139.97 150.31 44.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.452 -0.78 . . . . 1.99 109.502 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.1 t -122.68 129.99 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.194 -1.039 . . . . 0.77 108.194 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -101.11 116.66 33.36 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.251 -0.906 . . . . 0.98 109.208 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 36.0 t -98.33 117.09 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.49 -0.756 . . . . 0.85 109.251 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 68.55 70.17 0.42 Allowed Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.27 -0.894 . . . . 1.66 109.408 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -89.79 118.27 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 123.376 2.717 . . . . 0.95 112.744 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.615 HG22 ' N ' ' A' ' 233' ' ' ASN . 96.4 m -67.97 170.52 8.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.174 -0.954 . . . . 1.84 108.989 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.615 ' N ' HG22 ' A' ' 232' ' ' THR . 11.9 m120 -59.84 -40.12 87.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.0 -1.062 . . . . 2.74 109.238 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.58 -39.91 92.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.838 . . . . 2.89 109.197 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.54 -42.74 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 1.3 109.882 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.194 -0.941 . . . . 1.09 109.577 -179.804 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 49.7 ttp . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.448 0.642 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -150.11 147.35 27.67 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -147.7 157.13 43.4 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.865 -1.147 . . . . 0.0 110.817 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -153.51 148.92 27.14 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -112.59 131.05 55.8 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.142 -0.974 . . . . 0.0 109.656 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.407 ' CG1' ' SD ' ' B' ' 381' ' ' MET . 1.9 p -132.79 125.15 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-O 122.146 0.974 . . . . 0.0 112.073 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 21.1 m -77.21 104.8 7.93 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.046 0.927 . . . . 0.0 110.766 -178.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' B' ' 358' ' ' GLY . 97.0 mt -52.81 124.64 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 122.429 1.109 . . . . 0.0 111.026 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 62.4 p -112.5 20.19 16.86 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.682 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.402 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -66.15 118.68 55.12 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.988 -1.07 . . . . 0.0 108.891 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -49.58 -26.07 12.05 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 CA-C-N 120.354 1.162 . . . . 0.0 112.718 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -120.52 17.58 12.09 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.642 -0.661 . . . . 0.0 109.352 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.76 179.75 32.74 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.468 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -87.86 94.8 9.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -1.223 . . . . 0.0 109.309 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -96.08 -160.43 0.79 Allowed 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.948 -1.095 . . . . 0.0 110.09 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 15.5 m -58.87 -42.79 90.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.076 -1.015 . . . . 0.0 112.546 -175.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.557 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.5 tpt180 -61.13 -61.41 8.02 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 120.452 -1.405 . . . . 0.0 112.119 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -59.3 -33.67 97.82 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 CA-C-N 120.394 1.176 . . . . 0.0 111.656 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.98 75.53 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.13 -41.4 65.01 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.474 -0.766 . . . . 0.0 109.801 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -69.97 -40.03 75.62 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.971 -1.08 . . . . 0.0 108.24 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -61.2 -52.47 64.65 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.2 -0.937 . . . . 0.0 110.432 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 94.7 t -62.79 -28.92 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.659 -1.275 . . . . 0.0 109.587 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -59.95 -44.6 94.3 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.537 -0.727 . . . . 0.0 109.041 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -67.65 -42.71 81.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.89 . . . . 0.0 111.378 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . 0.4 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -59.9 -53.89 52.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.556 -1.34 . . . . 0.0 110.97 -178.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 32.3 mttp -52.82 -12.57 0.32 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 109.768 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . 0.4 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -77.74 -24.14 65.49 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -105.82 140.09 39.38 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.558 -0.966 . . . . 0.0 109.087 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 26.1 p -90.43 -10.93 41.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.109 -0.994 . . . . 0.0 109.926 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.486 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 79.7 p -67.49 152.36 45.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -0.939 . . . . 0.0 109.502 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.9 137.71 51.84 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.138 -0.976 . . . . 0.0 108.559 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 76.8 mt -131.85 132.68 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.666 -0.646 . . . . 0.0 109.293 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 24.0 m -129.52 148.67 51.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.552 -0.718 . . . . 0.0 109.089 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 70.0 t -123.19 116.16 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 45.9 m -105.57 130.35 53.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.304 -0.872 . . . . 0.0 109.337 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 43.2 t -139.32 119.07 13.17 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.028 0.918 . . . . 0.0 111.272 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 43.92 50.1 7.11 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.13 -14.41 60.78 Favored Glycine 0 N--CA 1.501 3.03 0 O-C-N 120.15 -1.594 . . . . 0.0 112.786 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -117.24 128.45 55.1 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-N 119.208 1.504 . . . . 0.0 110.082 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 80.3 p -126.33 148.33 49.57 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.774 0.797 . . . . 0.0 110.453 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -142.91 166.01 25.79 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 121.534 0.683 . . . . 0.0 110.145 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 25.1 m -87.25 133.62 33.65 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.473 -0.767 . . . . 0.0 110.377 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -72.63 -17.37 61.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.073 -1.017 . . . . 0.0 109.911 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -87.21 20.94 2.55 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 7.3 m -149.08 96.02 2.48 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.836 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.715 HD23 HD22 ' A' ' 79' ' ' LEU . 61.6 tp -58.16 -36.2 72.66 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.844 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.8 m-85 -54.68 -54.01 47.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.796 -1.19 . . . . 0.0 110.193 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -71.3 -19.56 62.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.923 . . . . 0.0 111.699 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' B' ' 352' ' ' THR . 73.6 mt -71.01 -57.96 4.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.453 -1.404 . . . . 0.0 110.318 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.562 ' NE2' ' HE ' ' A' ' 126' ' ' ARG . 9.2 mm100 -43.16 -12.56 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.681 -0.637 . . . . 0.0 111.348 -176.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.571 ' N ' ' O ' ' B' ' 350' ' ' LEU . 77.1 p -86.01 -10.89 54.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.328 -1.483 . . . . 0.0 110.104 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 59.1 mt -92.74 117.98 30.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.03 -1.044 . . . . 0.0 109.021 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -71.96 90.24 0.49 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 23.7 mt -100.4 90.13 4.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.353 -1.086 . . . . 0.0 109.043 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 31.7 p -92.65 154.59 18.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.906 -1.121 . . . . 0.0 110.436 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -50.87 119.34 3.82 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.611 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 102.09 3.07 51.62 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 44.2 m -87.72 114.92 24.79 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.219 -1.165 . . . . 0.0 111.852 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.99 115.16 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 122.171 0.986 . . . . 0.0 109.939 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 14.5 m -110.49 177.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 22.5 m -130.53 129.3 42.68 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 48.5 mt -102.64 112.95 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 69.2 p -118.62 131.05 56.18 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.157 -0.964 . . . . 0.0 109.287 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.15 151.28 39.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.201 -0.937 . . . . 0.0 109.627 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -146.45 125.93 13.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.346 -0.846 . . . . 0.0 109.394 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.555 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.05 -156.24 26.92 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.496 -1.335 . . . . 0.0 111.182 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.03 -50.71 72.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.109 -0.642 . . . . 0.0 112.271 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.486 ' H ' ' HB3' ' B' ' 331' ' ' SER . 93.0 m-20 -106.42 11.36 30.91 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.868 -1.145 . . . . 0.0 111.336 -177.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.9 pt-20 -44.75 -35.7 2.83 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.986 -1.071 . . . . 0.0 111.117 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -70.53 -42.67 70.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.926 -1.109 . . . . 0.0 110.026 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.95 -48.97 66.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.397 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -46.61 -75.13 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.432 -0.792 . . . . 0.0 110.882 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.497 ' O ' HG23 ' B' ' 378' ' ' VAL . 32.6 t -44.66 -34.81 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.068 -1.02 . . . . 0.0 110.942 -177.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -66.47 -46.09 77.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.421 -1.424 . . . . 0.0 110.301 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -80.37 -42.31 23.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.766 -1.209 . . . . 0.0 109.742 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 109.485 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.497 HG23 ' O ' ' B' ' 374' ' ' VAL . 44.0 t -61.95 -42.0 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.003 -1.061 . . . . 0.0 109.51 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -69.89 -55.1 10.61 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.451 -1.3 . . . . 0.0 107.909 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 48.8 tp -57.56 -35.07 69.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.231 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . 0.407 ' SD ' ' CG1' ' B' ' 306' ' ' VAL . 39.6 ttm -70.46 -39.94 74.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.217 -1.552 . . . . 0.0 108.359 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.49 -4.83 58.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.586 -0.696 . . . . 0.0 110.335 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -113.6 -3.39 13.63 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.034 -1.041 . . . . 0.0 111.072 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 13.7 mt -79.29 135.36 36.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.331 -1.481 . . . . 0.0 109.437 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.497 -179.572 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 mmt . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.466 -0.568 . . . . 2.91 109.466 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.5 mt -110.18 129.69 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.689 -0.856 . . . . 1.2 108.689 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.9 m -138.37 119.49 14.52 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.288 -0.883 . . . . 1.4 109.05 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.81 -162.02 36.64 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.123 -1.591 . . . . 1.05 109.123 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 5' ' ' ILE . 97.2 mt -93.5 -9.91 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.046 -1.267 . . . . 1.15 110.058 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.471 HD11 ' O ' ' A' ' 8' ' ' SER . 58.8 tp 54.94 96.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.18 -0.95 . . . . 0.98 109.184 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.66 -40.15 73.17 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.665 -0.865 . . . . 0.88 108.665 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.471 ' O ' HD11 ' A' ' 6' ' ' LEU . 3.4 p -145.9 143.22 19.05 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.482 -0.761 . . . . 1.69 109.049 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.52 143.17 16.89 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.21 1.94 . . . . 0.85 112.705 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.875 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.45 -163.88 36.88 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.299 -1.52 . . . . 0.92 109.299 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.1 mt -149.34 149.69 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.051 -1.264 . . . . 0.81 108.332 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.88 151.62 31.52 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.954 -1.091 . . . . 0.51 110.183 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.5 m-85 -134.88 125.27 26.43 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.391 -0.966 . . . . 0.62 108.391 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.75 179.32 47.11 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 118.87 -1.633 . . . . 0.55 110.607 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -76.96 154.73 33.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.759 -0.848 . . . . 2.1 109.006 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -100.02 136.52 39.8 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.336 -0.852 . . . . 0.77 111.052 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.1 tp -104.99 133.28 50.05 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.533 -1.284 . . . . 0.91 107.533 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 64.4 tp -115.14 122.27 45.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.252 -0.905 . . . . 0.93 110.222 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.7 mt -88.71 100.51 13.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.677 -0.639 . . . . 0.93 109.761 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -86.84 139.51 30.6 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.072 -1.084 . . . . 2.75 108.072 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -130.93 136.6 48.73 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.025 -1.047 . . . . 3.0 109.41 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -91.77 137.89 31.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.11 -0.994 . . . . 2.77 109.147 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.03 139.97 57.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 2.94 109.857 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.5 mt -82.51 130.11 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.449 -0.782 . . . . 0.95 109.597 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.5 t -97.21 128.16 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.231 -0.918 . . . . 1.28 110.066 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -109.98 130.05 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.746 -0.835 . . . . 1.21 108.746 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -82.03 127.03 32.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.091 -1.005 . . . . 1.81 110.355 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -89.96 -1.64 58.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.384 -0.823 . . . . 2.8 109.149 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.37 142.18 52.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 2.87 109.681 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -85.19 150.1 25.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.279 -0.888 . . . . 2.35 109.275 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.496 HG21 ' HG3' ' A' ' 39' ' ' GLU . 5.5 pt -91.09 164.56 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.162 -0.961 . . . . 0.97 110.072 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.2 p -89.55 170.59 10.37 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.425 -0.954 . . . . 1.17 108.425 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.32 -19.8 63.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.848 -1.158 . . . . 1.18 110.402 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -82.74 -24.02 33.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.776 -1.203 . . . . 2.56 107.925 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -81.88 -8.75 59.7 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.889 -0.782 . . . . 1.79 108.889 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.68 -53.85 39.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.089 -1.007 . . . . 1.0 108.646 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -62.79 -40.15 96.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 1.77 109.644 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -69.96 -40.07 75.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.079 -1.013 . . . . 2.7 109.976 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.496 ' HG3' HG21 ' A' ' 31' ' ' ILE . 51.3 mm-40 -67.09 -40.0 86.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.067 -1.021 . . . . 1.51 109.689 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.31 -46.44 96.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.92 -1.113 . . . . 0.93 108.34 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -60.07 -40.88 91.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.918 . . . . 1.81 108.941 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.428 HH11 ' HG2' ' A' ' 42' ' ' ARG . 52.1 mtt-85 -60.08 -45.98 91.09 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.897 -1.149 . . . . 2.78 107.897 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -60.07 -49.2 78.57 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.442 -0.786 . . . . 0.78 108.944 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.04 -47.72 84.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.287 -0.883 . . . . 1.07 108.7 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.7 t -61.8 -41.38 97.68 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.228 -1.027 . . . . 1.12 108.228 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.54 -49.77 73.39 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.819 -1.712 . . . . 0.84 108.819 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -65.38 -35.47 81.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.343 -1.093 . . . . 3.09 108.468 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.53 -47.71 72.83 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.356 -0.84 . . . . 0.88 109.097 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 50' ' ' ALA . 32.5 ttpt -63.5 -72.97 0.12 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.889 -1.124 . . . . 2.59 107.972 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.88 -34.0 0.1 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.298 -0.876 . . . . 0.7 111.34 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.5 t -57.22 -52.85 63.67 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.616 -1.303 . . . . 1.4 108.526 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.14 -40.07 78.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 0.67 110.914 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -64.65 -40.13 94.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.081 -1.012 . . . . 1.66 109.974 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.6 -40.02 95.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.854 -1.154 . . . . 1.58 108.487 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -62.1 -34.36 76.18 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.657 -0.868 . . . . 1.35 108.657 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -65.32 -42.96 92.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 0.77 109.086 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.07 -39.94 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.302 -0.873 . . . . 0.63 108.815 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -55.17 -49.71 71.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.618 -0.677 . . . . 1.14 109.38 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.1 m -56.86 -33.47 66.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.337 -0.852 . . . . 0.79 110.747 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -68.17 -38.63 82.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.891 -1.131 . . . . 1.53 109.869 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.52 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -68.07 -47.22 68.9 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.606 -0.684 . . . . 0.57 110.915 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.03 -52.15 50.98 Favored Glycine 0 N--CA 1.486 1.983 0 C-N-CA 119.79 -1.195 . . . . 0.75 110.283 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.03 -42.91 72.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.838 -1.389 . . . . 1.59 110.592 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.0 m -69.96 -58.43 3.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.129 -0.982 . . . . 0.73 112.232 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -95.62 -54.58 3.32 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.978 -1.076 . . . . 0.75 111.159 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.01 -160.49 26.72 Favored Glycine 0 N--CA 1.501 3.033 0 O-C-N 120.849 -1.157 . . . . 1.22 110.415 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -70.01 -22.94 63.06 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.481 -1.011 . . . . 5.81 110.311 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -59.9 -37.66 80.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 3.37 110.296 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.519 ' HA ' HD12 ' A' ' 72' ' ' ILE . 67.3 mmtt -98.59 -18.48 18.1 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.33 -0.856 . . . . 1.77 110.829 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -70.0 -42.79 72.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.575 -1.328 . . . . 1.65 110.542 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.511 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.52 -30.35 71.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 0.77 109.672 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 69' ' ' LYS . 81.6 mt -60.03 -43.64 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.104 -0.997 . . . . 0.8 109.943 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -66.03 -39.97 90.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.949 -1.094 . . . . 0.88 110.531 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -60.07 -39.98 87.93 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.808 -1.182 . . . . 1.37 108.949 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.06 -49.77 64.95 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.929 -1.669 . . . . 0.62 108.929 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -64.72 -41.22 96.14 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.368 -1.078 . . . . 1.5 108.852 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.8 mt -69.96 -42.58 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.114 -0.991 . . . . 0.63 109.214 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.31 -39.98 88.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.985 -1.072 . . . . 1.51 109.737 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.833 HD22 HD23 ' B' ' 347' ' ' LEU . 59.1 tp -66.56 -40.03 88.83 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.503 -0.748 . . . . 0.77 109.806 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.4 tp -60.05 -40.09 88.22 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.638 -0.825 . . . . 0.62 109.155 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -82.64 10.03 8.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.272 -0.893 . . . . 1.47 109.55 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 55.8 t0 -59.94 133.27 55.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.892 . . . . 1.47 110.421 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.468 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 96.7 mt-10 -59.91 -16.04 26.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.699 -0.625 . . . . 1.78 110.445 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -70.05 -37.46 75.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.969 -1.082 . . . . 2.53 108.859 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -73.69 -43.66 58.72 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.461 0.648 . . . . 0.8 110.642 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -59.95 -50.0 75.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.935 . . . . 1.42 110.851 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.51 -42.15 71.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.082 -1.011 . . . . 1.71 111.11 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.88 -39.97 72.54 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.058 -1.026 . . . . 1.57 112.273 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.04 -42.26 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.813 -1.179 . . . . 0.65 109.86 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.03 -39.29 77.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.584 -0.698 . . . . 0.82 110.303 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.93 -50.0 75.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.122 -0.986 . . . . 0.79 111.723 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.94 -44.3 94.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.661 -1.275 . . . . 0.95 109.641 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.6 mt -61.77 -46.66 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -0.866 . . . . 0.66 108.883 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -70.02 -40.98 74.88 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.924 -0.71 . . . . 2.2 110.74 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -82.24 -51.88 7.5 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.071 -1.018 . . . . 1.65 112.151 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.07 -3.16 58.1 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.961 -1.087 . . . . 2.03 111.684 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.2 m170 57.62 38.58 27.8 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.954 -1.091 . . . . 1.42 109.78 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.0 mtp -89.3 169.94 11.0 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.476 -0.765 . . . . 1.18 110.015 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 102' ' ' ALA . 72.7 p -79.9 159.73 26.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.921 . . . . 0.98 109.664 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.03 -40.04 75.4 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.46 -0.775 . . . . 0.64 109.99 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 31.4 p-10 -69.49 -38.82 77.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.14 -0.975 . . . . 2.07 110.229 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.436 ' HB3' ' OG1' ' A' ' 99' ' ' THR . . . -81.02 -40.67 23.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.972 -1.08 . . . . 0.73 109.933 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.11 -47.43 61.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.54 110.623 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.87 92.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.003 -1.061 . . . . 0.56 110.008 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -59.94 -38.6 82.88 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.289 -0.882 . . . . 1.54 110.406 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.0 -39.95 93.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.017 -1.052 . . . . 1.33 110.682 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.7 t -64.76 -50.14 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.938 -1.101 . . . . 0.72 110.815 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.17 -39.92 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.873 -1.142 . . . . 0.85 108.599 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -66.36 -37.42 85.26 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.718 -0.845 . . . . 2.44 108.718 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.439 ' O ' ' OG ' ' A' ' 113' ' ' SER . . . -60.07 -49.9 73.5 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 120.547 -0.835 . . . . 0.98 111.019 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -66.0 -50.43 64.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.503 -1.586 . . . . 1.41 109.746 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.15 84.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.844 . . . . 1.2 109.693 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 110' ' ' GLY . 85.0 p -55.56 -39.75 71.03 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.062 -1.024 . . . . 1.7 109.0 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.91 -31.36 69.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.913 . . . . 1.47 109.883 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.4 mt -69.93 -41.15 74.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.784 -1.197 . . . . 1.56 110.235 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -69.33 -22.57 63.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.131 -1.606 . . . . 2.2 109.367 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -59.85 -20.58 57.9 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.387 -1.338 . . . . 2.12 107.387 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 123' ' ' LEU . 35.0 mt -62.94 140.06 58.81 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.106 -1.072 . . . . 2.0 108.106 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -85.76 41.51 0.91 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.952 -1.093 . . . . 3.23 109.134 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 53.3 t0 -131.96 142.46 49.63 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.575 -0.703 . . . . 2.49 109.707 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.499 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 81.6 mm-40 -73.87 -65.33 0.85 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.799 0.809 . . . . 3.95 108.835 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.633 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 4.1 t80 -39.28 -42.33 1.0 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.937 -0.477 . . . . 2.0 111.082 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.531 HD23 HH22 ' A' ' 126' ' ' ARG . 66.1 mt -70.56 -40.04 73.58 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.561 -1.337 . . . . 1.86 108.225 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 121' ' ' GLU . 62.8 tttp -68.67 -33.69 74.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.545 -0.722 . . . . 2.84 109.491 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 187' ' ' THR . 69.1 mm-40 -59.99 -44.9 94.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.806 -1.184 . . . . 2.73 109.629 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.672 ' HE ' HE22 ' B' ' 351' ' ' GLN . 20.5 mtm-85 -69.97 -30.36 67.7 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.895 -1.128 . . . . 2.77 108.592 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.89 -28.08 67.26 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.888 -1.153 . . . . 1.19 107.888 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.91 -38.88 69.85 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.158 -1.053 . . . . 1.2 108.158 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.85 -40.08 94.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 1.55 110.229 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.01 -40.0 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.993 -1.067 . . . . 0.8 108.446 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -60.01 -38.68 83.37 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.48 -0.933 . . . . 3.09 108.48 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -59.98 -37.43 79.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.567 -0.708 . . . . 1.46 109.545 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.98 -41.84 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.71 110.253 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.35 -31.75 53.74 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.574 -1.298 . . . . 0.57 110.354 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -60.05 -49.9 75.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.121 -1.223 . . . . 2.59 110.129 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -65.41 -31.99 73.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.912 -1.117 . . . . 2.83 109.829 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.89 -40.03 87.33 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.674 -0.862 . . . . 1.25 108.674 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.6 mt -61.03 -40.06 92.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.7 109.287 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.448 HH11 ' HG2' ' A' ' 139' ' ' ARG . 46.8 mtt-85 -65.44 -39.76 92.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 2.57 108.908 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -67.0 -33.38 75.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.606 -0.684 . . . . 1.23 111.759 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.03 -39.91 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.29 -1.507 . . . . 0.81 109.409 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.1 mt -77.26 -21.05 54.28 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.774 -0.77 . . . . 1.0 110.275 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.9 37.15 13.55 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.343 -1.903 . . . . 0.89 108.343 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 tp -73.1 140.83 47.42 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.591 -0.947 . . . . 1.14 108.761 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -73.92 138.38 44.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 4.6 109.613 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.1 mt -107.0 135.01 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-O 122.262 1.03 . . . . 1.24 110.065 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 148' ' ' ASP . 11.4 mt -69.52 -39.92 79.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.396 -0.82 . . . . 1.54 110.651 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 147' ' ' ILE . 48.9 t0 60.17 125.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.565 -0.709 . . . . 1.5 109.651 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.51 ' O ' HD12 ' A' ' 152' ' ' ILE . 43.0 mt -83.84 -3.41 57.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.24 -0.912 . . . . 0.79 109.783 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.6 m -81.79 -12.9 58.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.135 -0.978 . . . . 1.4 109.188 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.72 27.97 0.28 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.575 -0.703 . . . . 0.92 110.418 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 149' ' ' LEU . 57.9 mt -91.29 119.88 39.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.123 -0.986 . . . . 0.88 109.739 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -101.38 -9.49 21.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.297 -0.877 . . . . 2.45 109.997 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -139.17 158.38 44.28 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.072 -1.018 . . . . 1.52 110.207 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.73 138.59 58.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.864 . . . . 1.58 109.026 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 24.6 m -153.12 166.24 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.439 -0.788 . . . . 0.69 109.772 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.7 mt -96.63 146.15 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 105.415 -2.069 . . . . 0.61 105.415 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 45.7 tp -95.94 116.81 29.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.907 -1.12 . . . . 0.87 110.461 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.9 t -120.03 127.92 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.684 -1.228 . . . . 0.71 107.684 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -158.97 164.5 35.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.997 -1.064 . . . . 0.81 108.903 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.29 -35.11 68.6 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.405 -1.434 . . . . 0.98 108.806 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 58.5 t0 -170.51 146.48 2.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.366 -0.834 . . . . 2.25 109.586 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.515 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 39.3 mt -118.36 140.03 50.45 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.274 -0.891 . . . . 0.78 109.75 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.6 p -101.91 151.59 38.01 Favored Pre-proline 0 N--CA 1.5 2.075 0 O-C-N 121.351 -0.843 . . . . 0.98 109.785 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -40.26 -40.11 2.84 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.652 2.235 . . . . 0.81 113.233 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.8 m -59.96 -40.01 87.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 0.9 109.7 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.31 -40.6 86.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.125 -0.984 . . . . 1.61 110.375 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 67.3 p -58.73 -32.79 69.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.107 -0.995 . . . . 0.61 111.311 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -69.64 -49.63 51.95 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.693 -1.254 . . . . 0.6 109.966 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -86.99 38.08 0.79 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.919 -1.141 . . . . 1.4 107.919 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.9 tp -106.28 130.3 54.16 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.002 -0.74 . . . . 0.7 109.002 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.412 ' N ' HD22 ' A' ' 172' ' ' ASN . 3.1 m120 -84.06 105.39 14.89 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.482 -0.933 . . . . 2.35 108.482 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.49 -40.53 93.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.808 . . . . 1.51 110.816 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -69.81 -23.1 63.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.779 -1.201 . . . . 2.33 111.836 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -93.31 -8.64 41.48 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.669 -1.27 . . . . 1.92 110.003 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.553 HG12 ' H ' ' A' ' 178' ' ' GLY . 90.1 t -110.03 119.97 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.541 -0.911 . . . . 0.67 108.541 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 65.9 mt -90.65 6.61 43.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.294 -0.879 . . . . 1.53 110.476 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.553 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.58 170.39 36.3 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.279 -1.528 . . . . 0.48 109.279 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.407 ' CE1' HG11 ' A' ' 176' ' ' VAL . 27.0 m-85 -129.98 129.09 43.3 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.508 -0.995 . . . . 0.55 108.834 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.437 ' CG2' HG21 ' A' ' 205' ' ' THR . 72.7 mt -131.05 121.85 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.546 -0.909 . . . . 0.65 108.546 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.3 p -142.5 156.68 45.17 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.332 -0.855 . . . . 0.82 111.197 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 183' ' ' ALA . 94.3 m-20 -90.09 18.61 5.69 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.596 -0.69 . . . . 2.46 109.266 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.37 -162.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.872 -1.143 . . . . 1.28 111.355 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -102.51 -33.99 4.3 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.527 -1.029 . . . . 2.19 110.527 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 157.24 -143.1 9.2 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 118.822 -1.656 . . . . 2.13 111.235 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -59.96 -28.39 67.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.826 -0.808 . . . . 5.86 110.692 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . 0.431 ' O ' ' OE1' ' A' ' 125' ' ' GLU . 61.4 p -59.99 -10.27 3.98 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.991 -1.068 . . . . 3.72 109.145 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.5 t -91.64 124.66 35.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 1.74 109.41 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 62.0 t60 -48.05 -49.76 30.26 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.034 -1.041 . . . . 0.95 109.868 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.459 ' H ' HG22 ' A' ' 190' ' ' THR . 0.0 OUTLIER -53.19 -40.48 64.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.32 -0.863 . . . . 1.55 110.358 -179.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 56.1 m -60.04 -40.0 87.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.958 -1.089 . . . . 1.51 110.529 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.6 mm -61.12 -43.58 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.288 -0.882 . . . . 1.67 110.115 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.4 mtp -62.87 -40.06 96.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 1.02 110.681 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.92 78.11 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.58 -1.325 . . . . 0.68 109.054 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -60.03 -49.92 75.78 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.413 -0.805 . . . . 2.93 110.089 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.0 m -72.75 -33.44 66.35 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.086 -1.009 . . . . 0.86 110.534 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.7 mt -71.55 -26.82 62.79 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.144 -0.973 . . . . 0.67 108.384 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 61.45 50.57 4.57 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.978 -0.451 . . . . 1.5 110.833 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 73.4 mt -124.36 146.88 53.38 Favored Pre-proline 0 N--CA 1.505 2.307 0 N-CA-C 108.792 -0.818 . . . . 0.72 108.792 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -45.06 121.83 3.9 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.829 1.686 . . . . 0.61 111.715 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -158.18 136.78 11.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.382 -1.449 . . . . 0.66 111.966 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.519 ' CD1' HD11 ' A' ' 220' ' ' LEU . 61.6 mt -121.03 145.32 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 106.691 -1.596 . . . . 0.79 106.691 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.5 -7.19 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.731 -1.231 . . . . 0.91 111.287 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -106.4 22.61 30.42 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.874 -1.29 . . . . 1.01 109.874 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.437 HG21 ' CG2' ' A' ' 180' ' ' ILE . 2.0 p -51.16 -41.41 60.13 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.051 -1.264 . . . . 0.99 110.333 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.426 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 84.67 -77.15 2.14 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.667 -1.254 . . . . 1.12 111.781 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 79.5 p -125.13 27.68 6.59 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 121.253 -1.145 . . . . 1.72 112.882 -177.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.96 -40.89 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.295 -1.503 . . . . 0.89 109.123 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 209' ' ' THR . 12.4 p -52.64 -26.75 14.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.878 . . . . 1.03 110.222 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.2 m -80.42 -15.83 55.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.016 -1.053 . . . . 1.83 109.931 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -103.78 -9.54 18.98 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.364 -0.835 . . . . 2.27 110.257 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 63.3 t -110.4 134.61 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.404 -0.81 . . . . 0.92 111.645 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -113.87 150.69 33.26 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.362 -1.348 . . . . 2.2 107.362 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 8.8 p30 -54.51 139.49 37.64 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.815 -1.178 . . . . 2.36 109.983 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.8 m-20 83.53 10.72 0.48 Allowed 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 121.19 0.519 . . . . 2.38 110.188 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.8 t0 -80.06 139.88 36.73 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.334 -0.853 . . . . 2.09 109.407 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.54 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 28.0 t80 -88.98 115.26 26.4 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.32 -0.993 . . . . 1.27 108.32 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 83.0 mt -127.78 149.23 50.35 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.49 -0.756 . . . . 0.75 110.505 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.402 HG23 ' CD2' ' A' ' 13' ' ' PHE . 85.6 mt -115.24 129.06 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 106.859 -1.534 . . . . 0.63 106.859 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.519 HD11 ' CD1' ' A' ' 202' ' ' ILE . 26.1 tp -99.89 119.31 38.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.063 -1.023 . . . . 0.7 110.044 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.496 ' C ' ' N ' ' A' ' 223' ' ' VAL . 84.1 m-20 -76.47 -44.46 35.43 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.233 -0.917 . . . . 2.31 108.569 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.875 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 48.89 15.8 0.1 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.35 -0.982 . . . . 0.78 108.35 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.496 ' N ' ' C ' ' A' ' 221' ' ' ASP . 41.6 t -132.19 -46.12 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.293 -1.373 . . . . 1.04 107.293 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -97.8 0.51 46.95 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.469 -1.308 . . . . 2.44 107.469 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 60.07 45.35 12.01 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.036 -0.728 . . . . 1.55 109.036 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -138.68 150.07 45.81 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.402 -0.811 . . . . 1.99 109.83 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.0 t -121.08 130.01 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.615 -0.883 . . . . 0.77 108.615 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -98.1 119.91 37.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.317 -0.864 . . . . 0.98 108.955 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.9 t -100.35 113.52 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.632 -0.667 . . . . 0.85 109.981 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 8.1 t30 69.25 69.92 0.4 Allowed Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.439 -0.788 . . . . 1.66 109.425 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -90.8 126.39 1.17 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 123.588 2.858 . . . . 0.95 112.73 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 35.0 p -70.97 166.55 21.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.16 -0.963 . . . . 1.84 109.48 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -59.96 -40.0 87.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.27 -0.894 . . . . 2.74 110.558 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -59.94 -40.03 87.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 2.89 110.337 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.21 -40.01 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.985 -1.072 . . . . 1.3 109.49 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.191 -0.943 . . . . 1.09 110.017 -179.571 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 10.9 ttt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.471 0.653 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -152.38 151.99 31.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 109.512 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -147.84 158.84 44.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.128 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . 0.43 ' NE2' ' OE2' ' B' ' 305' ' ' GLU . 54.3 tp60 -152.51 148.32 27.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . 0.486 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 1.4 pm0 -114.9 133.49 55.94 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.266 -0.896 . . . . 0.0 110.103 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.31 123.69 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 CA-C-O 122.006 0.907 . . . . 0.0 112.22 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 35.9 m -78.01 105.47 9.23 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.972 0.892 . . . . 0.0 110.343 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.0 mt -51.66 122.15 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 122.434 1.111 . . . . 0.0 110.505 -177.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 19.3 p -107.36 18.87 21.05 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.226 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.478 ' O ' ' CG ' ' B' ' 357' ' ' GLN . . . -74.94 133.21 76.12 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.048 -1.032 . . . . 0.0 108.329 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -69.99 -13.13 33.7 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 CA-C-N 120.161 1.093 . . . . 0.0 112.298 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -120.67 8.94 10.68 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.436 -0.79 . . . . 0.0 109.619 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.55 179.95 32.39 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.483 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.6 tp -86.92 93.12 9.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.079 -1.248 . . . . 0.0 109.641 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -96.54 -159.78 0.75 Allowed 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.138 -0.976 . . . . 0.0 110.204 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.2 m -57.12 -45.11 83.74 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.17 -0.956 . . . . 0.0 112.816 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.511 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 3.1 tpt180 -61.59 -61.46 7.8 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 120.571 -1.33 . . . . 0.0 112.166 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -59.69 -31.91 94.95 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 120.335 1.155 . . . . 0.0 111.797 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.03 -50.29 74.32 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -50.81 -40.89 56.68 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.432 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . 0.436 ' NE2' ' NE ' ' B' ' 317' ' ' ARG . 56.8 mt-30 -69.95 -40.19 75.59 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.16 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -61.99 -52.61 63.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.466 -0.771 . . . . 0.0 110.483 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 86.4 t -69.21 -32.35 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.729 -1.232 . . . . 0.0 110.005 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -59.98 -47.55 85.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.226 -0.921 . . . . 0.0 110.038 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.99 -42.36 73.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.077 -1.014 . . . . 0.0 110.819 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.71 -54.02 11.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.746 -1.222 . . . . 0.0 110.011 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -49.96 -17.34 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.573 -0.704 . . . . 0.0 109.619 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.16 -17.88 79.72 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -106.09 147.2 29.21 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.289 -1.124 . . . . 0.0 109.067 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 3.6 t -90.49 -13.05 35.5 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.065 -1.022 . . . . 0.0 109.831 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.548 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 52.8 m -58.04 144.09 41.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 0.0 109.673 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -67.7 131.59 45.86 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.6 mt -132.61 132.68 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.47 -0.769 . . . . 0.0 109.645 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 50.7 m -128.93 148.88 50.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.448 -0.782 . . . . 0.0 109.328 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.96 114.99 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 55.2 m -103.15 123.53 46.87 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.246 -0.909 . . . . 0.0 108.818 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 47.8 t -136.58 120.29 17.3 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.003 0.906 . . . . 0.0 111.639 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . 0.456 HD21 HG23 ' B' ' 359' ' ' THR . 83.3 m-20 49.45 49.2 20.25 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 176.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 86.05 -11.13 63.46 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 119.863 -1.773 . . . . 0.0 112.438 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -122.59 133.45 54.55 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.008 -1.289 . . . . 0.0 109.503 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 14.8 m -128.46 150.24 50.23 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.973 0.892 . . . . 0.0 110.713 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -145.69 168.02 21.7 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.539 0.685 . . . . 0.0 109.825 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 28.6 m -89.06 139.6 30.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.518 -0.739 . . . . 0.0 110.136 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -77.64 -15.87 58.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 108.985 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -87.19 17.19 4.46 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 49.8 m -145.71 95.34 2.63 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.045 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.833 HD23 HD22 ' A' ' 79' ' ' LEU . 59.5 tp -60.03 -38.29 82.3 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.825 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 59.9 m-85 -55.22 -51.65 65.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.076 -1.015 . . . . 0.0 110.849 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -69.11 -39.92 78.67 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.767 -1.208 . . . . 0.0 109.799 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' B' ' 352' ' ' THR . 36.8 mt -48.18 -58.28 4.75 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.836 -1.165 . . . . 0.0 109.35 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.672 HE22 ' HE ' ' A' ' 126' ' ' ARG . 73.9 mm-40 -38.37 -23.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.523 -0.736 . . . . 0.0 111.355 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.522 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.6 p -80.09 -13.14 59.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.753 -1.217 . . . . 0.0 110.876 -178.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 27.5 mt -93.25 119.29 32.25 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.682 -1.262 . . . . 0.0 109.32 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.23 94.0 1.12 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 21.0 mt -101.67 92.05 4.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.336 -1.096 . . . . 0.0 108.835 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 74.3 p -92.22 175.22 6.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.217 -0.927 . . . . 0.0 110.608 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . 0.478 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 15.2 tm0? -63.92 111.32 2.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.742 -0.599 . . . . 0.0 110.926 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 102.12 9.97 40.73 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . 0.456 HG23 HD21 ' B' ' 338' ' ' ASN . 51.9 m -84.74 111.79 19.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.225 -1.162 . . . . 0.0 110.514 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 20.1 t -76.74 115.32 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.277 1.037 . . . . 0.0 109.732 -177.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 10.8 m -111.9 176.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 56.0 m -131.9 129.19 40.01 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . 0.462 HD11 ' SD ' ' B' ' 381' ' ' MET . 85.5 mt -103.41 117.41 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 61.4 p -120.3 132.92 55.51 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.26 151.92 38.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.006 -1.059 . . . . 0.0 110.589 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -144.82 122.84 12.07 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.456 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 159.55 -158.61 29.77 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.02 -1.562 . . . . 0.0 111.596 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.07 -51.7 68.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.049 -0.677 . . . . 0.0 112.524 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.548 ' N ' ' OG ' ' B' ' 331' ' ' SER . 91.7 m-20 -109.65 13.59 23.76 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.796 -1.19 . . . . 0.0 111.047 -177.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -44.39 -36.68 2.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.033 -1.042 . . . . 0.0 111.278 -178.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . 0.533 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 78.1 mt-30 -70.02 -41.7 73.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.855 -1.153 . . . . 0.0 109.816 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -68.06 -49.52 60.85 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.685 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' B' ' 374' ' ' VAL . . . -50.18 -74.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.325 -0.86 . . . . 0.0 110.95 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.561 ' O ' HG23 ' B' ' 378' ' ' VAL . 38.9 t -44.1 -40.01 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -65.46 -45.76 82.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.793 -1.192 . . . . 0.0 110.171 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -80.41 -43.42 21.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.945 -1.097 . . . . 0.0 110.132 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 98.6 mt -59.99 -37.77 80.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.081 -1.012 . . . . 0.0 108.872 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.561 HG23 ' O ' ' B' ' 374' ' ' VAL . 30.7 t -61.32 -40.96 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.088 -1.008 . . . . 0.0 108.8 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' B' ' 383' ' ' GLU . 62.0 mttp -67.92 -55.32 13.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.849 -1.157 . . . . 0.0 108.21 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 59.6 tp -57.82 -36.26 72.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.008 -1.057 . . . . 0.0 109.285 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . 0.462 ' SD ' HD11 ' B' ' 363' ' ' ILE . 38.1 ttm -74.56 -41.53 60.38 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.99 -10.0 59.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.27 -0.894 . . . . 0.0 109.415 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' B' ' 379' ' ' LYS . 71.3 mm-40 -108.19 10.43 27.92 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.512 -0.742 . . . . 0.0 110.966 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 16.6 mt -66.19 109.55 2.67 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.416 -1.428 . . . . 0.0 109.181 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.499 1.98 0 CA-C-O 118.003 -0.999 . . . . 0.0 108.927 179.524 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.136 -0.69 . . . . 2.91 109.136 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.7 mt -110.07 126.82 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.481 -0.762 . . . . 1.2 109.125 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.3 m -130.01 138.6 50.88 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.092 -0.707 . . . . 1.4 109.092 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.49 -161.92 19.43 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.221 -1.552 . . . . 1.05 109.221 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.7 mt -89.54 -18.55 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -1.211 . . . . 1.15 109.877 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 5' ' ' ILE . 62.6 tp 51.02 103.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.348 -0.845 . . . . 0.98 109.69 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.94 -29.39 12.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.254 -0.904 . . . . 0.88 109.037 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 64.8 m -119.67 115.87 33.5 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.513 -0.742 . . . . 1.69 109.47 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.64 146.46 16.89 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.029 1.819 . . . . 0.85 112.249 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.646 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.18 -152.13 23.98 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.878 -1.689 . . . . 0.92 108.878 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.5 mt -150.31 151.52 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 120.768 -1.43 . . . . 0.81 108.801 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.1 150.83 32.25 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.908 -1.12 . . . . 0.51 110.545 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -133.74 125.32 28.31 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.821 -1.178 . . . . 0.62 107.821 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.52 177.39 47.15 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 118.476 -1.821 . . . . 0.55 110.999 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 157' ' ' ILE . 85.2 mttt -79.87 160.02 26.21 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.831 -0.805 . . . . 2.1 108.905 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.589 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -105.44 134.89 47.81 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.355 -0.841 . . . . 0.77 111.527 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.1 tp -101.48 138.72 38.12 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.352 -1.351 . . . . 0.91 107.352 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.8 tp -118.64 124.9 48.53 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.156 -0.965 . . . . 0.93 110.199 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.8 mt -93.14 103.45 15.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.8 -0.563 . . . . 0.93 110.189 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -98.66 133.06 43.52 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.388 -0.967 . . . . 2.75 108.388 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -130.07 128.23 41.5 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.62 -0.882 . . . . 3.0 108.62 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -75.46 149.83 38.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 2.77 109.901 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -69.13 143.12 54.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.486 -0.758 . . . . 2.94 108.992 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.2 mt -80.13 131.28 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.95 109.387 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 56.0 t -97.27 125.08 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.25 -0.906 . . . . 1.28 109.542 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.0 mt -107.9 135.32 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.434 -0.791 . . . . 1.21 108.921 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -93.87 121.13 35.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.12 -0.988 . . . . 1.81 109.699 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.501 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.8 mmt-85 -89.1 2.12 54.58 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.512 -0.742 . . . . 2.8 110.228 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -67.48 149.5 50.11 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.93 -1.106 . . . . 2.87 109.356 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -93.01 149.77 20.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.164 -0.96 . . . . 2.35 109.596 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.48 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.0 pt -96.44 167.7 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.213 -0.929 . . . . 0.97 110.246 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 61.8 p -100.66 176.2 5.39 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.484 -0.932 . . . . 1.17 108.484 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.85 76.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.156 -0.965 . . . . 1.18 110.695 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -58.05 -27.92 64.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.687 -1.258 . . . . 2.56 109.697 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -81.68 -11.01 59.25 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.34 -0.85 . . . . 1.79 109.808 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.5 t -62.91 -51.89 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.003 -1.061 . . . . 1.0 108.95 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.91 -40.11 96.59 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.247 -0.908 . . . . 1.77 110.113 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -66.28 -40.08 89.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.005 -1.059 . . . . 2.7 110.579 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.48 ' HG3' HG21 ' A' ' 31' ' ' ILE . 75.1 mm-40 -67.91 -40.07 83.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.778 -1.201 . . . . 1.51 110.302 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.04 -45.26 95.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 120.648 -1.283 . . . . 0.93 108.297 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -58.28 -39.9 80.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.997 -1.064 . . . . 1.81 108.594 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.458 HH11 ' HG2' ' A' ' 42' ' ' ARG . 44.5 mtt-85 -59.93 -43.68 94.81 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.287 -1.375 . . . . 2.78 107.287 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -63.5 -45.78 89.09 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.522 -0.736 . . . . 0.78 109.254 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.05 -50.08 75.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 1.07 108.567 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.7 t -63.45 -44.1 95.5 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.483 -0.887 . . . . 1.12 108.852 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.08 -43.33 99.57 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.859 -1.696 . . . . 0.84 108.859 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -67.44 -32.7 73.73 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.427 -1.043 . . . . 3.09 108.323 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.55 -40.99 89.06 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.508 -0.745 . . . . 0.88 109.348 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 34.6 ttpt -68.91 -74.73 0.12 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.953 -1.092 . . . . 2.59 108.447 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.1 -35.08 0.14 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.346 -0.846 . . . . 0.7 111.504 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.5 p -57.46 -56.63 19.33 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.55 -1.26 . . . . 1.4 108.586 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.03 -40.74 75.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.419 -0.8 . . . . 0.67 111.413 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.41 -40.04 95.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.633 -1.292 . . . . 1.66 110.889 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.18 -40.01 93.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.848 -1.158 . . . . 1.58 109.367 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -60.01 -37.46 79.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 1.35 109.834 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.24 -40.55 96.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.078 -1.014 . . . . 0.77 110.198 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.723 HD11 HH22 ' A' ' 136' ' ' ARG . 96.8 mt -62.11 -39.94 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.25 -0.906 . . . . 0.63 109.58 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -59.5 -50.0 75.63 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.457 -0.777 . . . . 1.14 109.577 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.3 m -59.37 -39.5 83.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.99 -1.069 . . . . 0.79 110.097 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -64.35 -38.37 90.8 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.09 -1.006 . . . . 1.53 109.247 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.46 -43.98 92.52 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.594 -0.691 . . . . 0.57 109.915 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.24 -50.04 66.08 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.836 -1.173 . . . . 0.75 110.174 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.13 -45.54 80.71 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.228 -1.16 . . . . 1.59 109.708 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.9 m -72.56 -57.9 3.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.327 -0.858 . . . . 0.73 112.306 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -94.81 -54.35 3.51 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.8 -1.187 . . . . 0.75 111.09 -177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.35 -169.18 25.54 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 119.692 -1.242 . . . . 1.22 111.464 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.07 -28.78 66.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 122.043 -0.681 . . . . 5.81 111.145 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.448 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 50.8 tp10 -61.47 -34.86 76.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.066 -1.021 . . . . 3.37 110.516 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -99.46 -21.01 16.15 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.202 -0.936 . . . . 1.77 110.22 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -66.84 -42.61 85.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.115 -0.991 . . . . 1.65 110.314 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.464 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -66.21 -32.21 73.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.514 -0.741 . . . . 0.77 110.53 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.1 -42.49 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.996 -1.065 . . . . 0.8 109.987 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.562 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 69.4 m-85 -71.56 -34.19 69.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.977 -1.077 . . . . 0.88 109.951 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -59.94 -39.81 86.8 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.228 -0.92 . . . . 1.37 109.284 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.45 -42.31 97.64 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.209 -1.557 . . . . 0.62 109.209 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -60.25 -41.42 93.15 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.357 -1.084 . . . . 1.5 108.893 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.8 mt -70.03 -45.44 76.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.239 -0.913 . . . . 0.63 109.45 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.6 ttp -60.25 -40.6 90.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.111 -0.993 . . . . 1.51 109.935 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.86 HD11 ' CE2' ' B' ' 348' ' ' PHE . 33.2 tp -67.26 -39.3 86.09 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.256 -0.902 . . . . 0.77 109.198 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.41 -39.94 92.57 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.039 -0.726 . . . . 0.62 109.039 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -83.07 5.81 21.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.316 -0.865 . . . . 1.47 109.585 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -49.83 130.36 21.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.219 -0.926 . . . . 1.47 109.428 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.16 -21.32 61.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.381 -0.824 . . . . 1.78 111.699 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.13 -33.02 69.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.623 -1.298 . . . . 2.53 108.878 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.7 mt -70.42 -40.74 73.65 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.488 0.661 . . . . 0.8 109.827 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.13 -49.66 76.76 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.449 -0.782 . . . . 1.42 109.827 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -69.97 -41.16 74.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.407 -0.808 . . . . 1.71 111.243 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.05 -39.97 75.39 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.934 -1.104 . . . . 1.57 111.682 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.08 -44.37 81.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 120.831 -1.168 . . . . 0.65 109.767 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.03 -38.6 75.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.403 -0.811 . . . . 0.82 110.131 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.5 -45.06 88.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.272 -0.892 . . . . 0.79 111.672 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 66.3 mt -61.57 -45.97 91.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.706 -1.247 . . . . 0.95 109.56 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 57.1 mt -61.36 -47.66 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.906 0.86 . . . . 0.66 109.082 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -70.04 -40.0 75.41 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.039 -0.664 . . . . 2.2 110.652 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -81.46 -61.55 1.9 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.039 -1.038 . . . . 1.65 112.116 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -82.2 0.54 40.67 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.097 -1.002 . . . . 2.03 111.68 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 57.17 37.8 28.59 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.132 -0.98 . . . . 1.42 109.923 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 79.7 mtp -90.85 166.97 12.79 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.63 -0.668 . . . . 1.18 109.499 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.2 p -80.89 161.88 24.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.948 . . . . 0.98 109.274 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.31 -39.93 85.95 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.256 -0.902 . . . . 0.64 109.581 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -68.45 -37.38 80.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.268 -0.895 . . . . 2.07 109.42 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.56 -45.56 21.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.73 109.445 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.43 -48.89 75.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.486 -0.759 . . . . 0.54 109.766 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.08 -36.0 76.42 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 0.56 109.284 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.544 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 84.5 t60 -59.96 -40.71 89.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.381 -0.824 . . . . 1.54 109.511 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -65.04 -40.53 94.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.334 -0.854 . . . . 1.33 111.149 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.34 -57.19 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.085 -1.01 . . . . 0.72 111.767 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.5 mm -66.92 -40.04 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.82 -1.175 . . . . 0.85 109.01 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.544 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 88.0 tt0 -63.11 -40.09 96.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 2.44 108.678 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.28 -52.61 50.54 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.504 -0.855 . . . . 0.98 110.987 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -62.8 -48.95 76.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.803 -1.41 . . . . 1.41 109.375 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.35 88.79 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.16 -0.962 . . . . 1.2 109.014 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.2 m -59.97 -40.26 88.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.1 -1.0 . . . . 1.7 108.876 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.85 87.26 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.255 -0.903 . . . . 1.47 109.116 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.8 mt -64.84 -39.97 94.43 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.873 -1.142 . . . . 1.56 108.774 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -59.23 -30.92 68.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.054 -1.029 . . . . 2.2 109.306 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.0 -27.54 66.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.105 -0.997 . . . . 2.12 108.514 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.46 HD13 HD13 ' A' ' 123' ' ' LEU . 28.4 mt -62.32 143.76 56.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 2.0 109.283 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -97.42 52.57 1.12 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.154 -0.966 . . . . 3.23 109.531 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -136.12 133.05 36.86 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.252 -0.905 . . . . 2.49 109.811 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.48 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 45.1 mp0 -70.04 -30.72 68.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.367 -0.833 . . . . 3.95 110.061 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.459 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.9 t80 -69.9 -38.06 76.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.195 -0.941 . . . . 2.0 110.091 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.46 HD13 HD13 ' A' ' 118' ' ' LEU . 65.1 mt -77.57 -39.81 44.47 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.094 -1.004 . . . . 1.86 109.788 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -61.58 -43.72 98.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.96 . . . . 2.84 110.445 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 65.9 mm-40 -67.12 -41.09 86.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.92 -1.112 . . . . 2.73 109.755 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.612 ' CD ' HE22 ' B' ' 351' ' ' GLN . 27.4 ttp180 -60.08 -40.03 88.12 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.779 -1.193 . . . . 2.77 107.779 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.81 -23.14 67.12 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.418 -0.956 . . . . 1.19 108.418 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -59.9 -40.02 87.35 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.606 -1.257 . . . . 1.2 107.606 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -66.75 -40.42 88.28 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.008 -0.677 . . . . 1.55 109.916 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 59.5 t -62.4 -40.0 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.933 -1.104 . . . . 0.8 108.437 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.513 HH11 ' HG2' ' A' ' 131' ' ' ARG . 9.1 ttt-85 -63.37 -36.22 82.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.414 -0.804 . . . . 3.09 109.931 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.36 -40.15 85.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.224 -0.922 . . . . 1.46 109.59 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.94 -43.18 91.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.038 -1.039 . . . . 0.71 108.805 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.43 -45.37 96.53 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.678 -0.969 . . . . 0.57 110.678 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -60.03 -44.68 94.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -1.23 . . . . 2.59 110.831 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.723 HH22 HD11 ' A' ' 57' ' ' ILE . 60.2 mtp180 -69.22 -34.88 75.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.482 -1.386 . . . . 2.83 110.157 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.7 tp -59.8 -45.25 92.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.149 -0.969 . . . . 1.25 109.731 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.57 -39.84 92.59 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.119 -0.988 . . . . 0.7 108.87 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -67.2 -39.8 86.4 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.62 -0.675 . . . . 2.57 110.238 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -68.62 -25.54 64.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.137 -0.977 . . . . 1.23 111.383 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.72 -43.64 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.334 -1.479 . . . . 0.81 108.36 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.5 mt -69.94 -31.16 68.76 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.752 -0.592 . . . . 1.0 109.918 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.53 36.95 7.18 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.074 -1.61 . . . . 0.89 109.074 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 56.7 tp -73.2 143.0 47.35 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.432 -1.04 . . . . 1.14 109.229 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -60.7 144.98 51.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.369 -0.832 . . . . 4.6 109.877 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.2 mt -114.88 121.31 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.29 -1.004 . . . . 1.24 108.29 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 16.9 mm -52.98 -52.17 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.568 -0.707 . . . . 1.54 110.409 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.8 t0 66.01 102.46 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.779 -0.822 . . . . 1.5 108.779 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.1 mt -73.34 -1.77 19.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.538 -0.726 . . . . 0.79 110.45 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.3 p -80.01 -11.54 59.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.899 -1.126 . . . . 1.4 109.343 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -88.37 21.05 3.01 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.615 -0.678 . . . . 0.92 111.448 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.437 ' HB ' HD21 ' A' ' 172' ' ' ASN . 48.9 mt -92.74 111.72 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.771 -1.205 . . . . 0.88 108.734 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -100.11 -8.45 23.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.195 -0.94 . . . . 2.45 111.165 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -117.22 147.43 42.51 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.152 -0.967 . . . . 1.52 110.176 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.38 131.35 46.95 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.979 -0.749 . . . . 1.58 108.979 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -152.42 164.72 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.506 -0.746 . . . . 0.69 109.515 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.423 ' N ' ' O ' ' A' ' 15' ' ' LYS . 97.0 mt -92.62 152.37 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 105.384 -2.08 . . . . 0.61 105.384 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.9 tp -101.23 120.07 39.69 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.976 -1.077 . . . . 0.87 111.131 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.51 129.93 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.898 -0.779 . . . . 0.71 108.898 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.03 163.44 36.37 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.37 -0.974 . . . . 0.81 108.37 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.07 -36.69 75.14 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.416 -1.427 . . . . 0.98 108.223 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -170.54 146.35 2.74 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.889 -0.782 . . . . 2.25 108.889 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.7 mt -115.09 131.18 57.01 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.309 -0.869 . . . . 0.78 110.382 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.4 p -93.4 151.75 40.49 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.467 -0.771 . . . . 0.98 109.226 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -39.76 -36.43 1.23 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 122.118 1.878 . . . . 0.81 112.52 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.3 m -58.12 -45.16 87.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.9 109.221 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -69.94 -42.6 73.02 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.096 -1.003 . . . . 1.61 109.991 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 27.5 p -57.42 -16.1 8.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.198 -0.939 . . . . 0.61 110.731 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.562 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . . . -90.66 -51.8 5.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.827 -1.171 . . . . 0.6 110.043 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -85.39 42.18 0.94 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.001 -1.111 . . . . 1.4 108.001 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.7 tp -109.99 132.8 53.83 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.704 -0.851 . . . . 0.7 108.704 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.437 HD21 ' HB ' ' A' ' 152' ' ' ILE . 0.8 OUTLIER -91.23 108.52 19.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.226 -0.921 . . . . 2.35 109.285 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.75 -43.63 98.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.469 -0.77 . . . . 1.51 110.99 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -64.53 -23.58 67.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.924 -1.11 . . . . 2.33 111.957 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -93.58 -11.11 32.56 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.689 -1.257 . . . . 1.92 109.794 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 178' ' ' GLY . 98.8 t -110.05 118.89 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.186 -0.946 . . . . 0.67 109.413 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.1 mt -89.87 6.38 42.13 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.142 -0.973 . . . . 1.53 111.248 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.486 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 175.22 170.11 37.8 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.169 -1.572 . . . . 0.48 109.169 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -132.67 128.88 37.96 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.269 -1.136 . . . . 0.55 109.901 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.401 ' CG2' HG21 ' A' ' 205' ' ' THR . 98.4 mt -132.17 125.11 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.727 -0.842 . . . . 0.65 108.727 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.1 p -143.21 157.94 44.06 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.22 -0.925 . . . . 0.82 110.625 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 183' ' ' ALA . 1.1 m-20 -99.2 22.69 10.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.557 -0.715 . . . . 2.46 109.803 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.513 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -45.41 -175.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.41 1.1 . . . . 1.28 112.586 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.71 -54.59 4.89 Favored Glycine 0 N--CA 1.492 2.412 0 O-C-N 121.527 -0.733 . . . . 2.19 111.315 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -149.97 -161.84 10.11 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 120.631 -1.511 . . . . 2.13 111.278 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.425 ' O ' ' OG ' ' A' ' 191' ' ' SER . 41.1 ttp180 -80.01 -9.87 59.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.789 -0.83 . . . . 5.86 110.205 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 64.0 p -79.94 4.85 15.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.97 . . . . 3.72 109.85 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.7 t -71.57 134.46 46.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.265 -0.897 . . . . 1.74 110.81 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -41.3 -60.84 1.15 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.528 0.68 . . . . 0.95 110.758 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.7 t -51.12 -33.65 27.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.189 -0.944 . . . . 1.55 110.452 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 186' ' ' ARG . 28.0 p -60.0 -40.12 88.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.973 -1.08 . . . . 1.51 109.689 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.5 -40.09 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.823 . . . . 1.67 110.176 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 35.1 mtm -59.89 -49.27 78.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.808 -1.182 . . . . 1.02 110.494 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.08 -44.17 94.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.753 -1.217 . . . . 0.68 110.626 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -60.03 -52.07 66.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 2.93 110.459 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.2 m -70.94 -33.58 70.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.125 -0.984 . . . . 0.86 110.723 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.04 -22.99 59.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.018 -1.051 . . . . 0.67 109.652 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 66.45 52.37 1.07 Allowed 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.576 0.703 . . . . 1.5 110.543 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.414 ' O ' ' CB ' ' A' ' 8' ' ' SER . 62.9 mt -127.28 132.31 24.26 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 107.722 -1.214 . . . . 0.72 107.722 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -43.45 134.35 6.83 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.805 1.67 . . . . 0.61 112.317 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -166.85 145.35 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.71 -1.196 . . . . 0.66 111.824 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.5 mt -123.16 145.67 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.403 -1.332 . . . . 0.79 107.403 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.1 m -129.7 -12.24 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 120.795 -1.191 . . . . 0.91 111.143 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.72 24.86 22.72 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 110.06 -1.216 . . . . 1.01 110.06 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.427 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 6.3 p -46.32 -42.29 14.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.059 -1.259 . . . . 0.99 110.04 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.78 -57.36 4.66 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.947 -1.121 . . . . 1.12 111.308 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 24.5 m -150.8 32.78 0.61 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.56 -1.553 . . . . 1.72 111.786 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.0 t -70.15 -44.63 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.796 -1.19 . . . . 0.89 109.134 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.441 ' H ' HG23 ' A' ' 209' ' ' THR . 3.0 p -50.59 -29.96 12.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.54 -0.725 . . . . 1.03 111.33 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 29.6 t -69.97 -27.13 64.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.723 -1.236 . . . . 1.83 109.844 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -96.94 -7.02 34.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.151 -0.968 . . . . 2.27 110.53 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 73.8 t -105.93 132.15 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.249 -0.907 . . . . 0.92 110.912 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.439 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 9.9 mtpt -120.12 149.54 42.05 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.621 -1.252 . . . . 2.2 107.621 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.469 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 23.6 p-10 -50.07 138.65 15.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.11 -0.994 . . . . 2.36 111.326 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.469 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 8.3 t0 82.3 5.44 1.07 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 116.165 -0.47 . . . . 2.38 110.538 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 91.9 m-20 -77.56 143.49 38.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.965 -1.084 . . . . 2.09 108.877 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -92.28 119.93 32.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.183 -0.948 . . . . 1.27 108.587 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.589 HD12 ' HB2' ' A' ' 16' ' ' ALA . 86.4 mt -127.21 146.6 50.35 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.41 -0.806 . . . . 0.75 110.636 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.2 mt -118.75 129.28 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 107.193 -1.41 . . . . 0.63 107.193 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.6 tp -104.1 119.93 40.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.107 -0.995 . . . . 0.7 108.787 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.644 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 21.6 p-10 -79.78 -39.09 31.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.214 -0.929 . . . . 2.31 109.114 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.69 16.61 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.782 -0.822 . . . . 0.78 108.782 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 221' ' ' ASP . 47.6 t -126.28 -38.76 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.526 -1.287 . . . . 1.04 107.526 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -109.81 -1.1 18.08 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.797 -1.186 . . . . 2.44 107.797 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 61.45 49.97 4.92 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.369 0.604 . . . . 1.55 109.935 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.644 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 27.4 mt-30 -137.64 153.34 49.88 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.573 -0.705 . . . . 1.99 109.305 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.93 128.87 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.144 -0.687 . . . . 0.77 109.144 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -103.05 122.44 44.65 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.784 -1.191 . . . . 0.98 107.784 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.8 t -101.04 111.86 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.429 -0.794 . . . . 0.85 110.89 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 42.8 t30 49.96 63.5 10.02 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.318 -0.864 . . . . 1.66 110.318 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.4 150.2 15.1 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.705 2.27 . . . . 0.95 111.9 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.407 ' OG1' HG23 ' A' ' 235' ' ' VAL . 68.1 p -67.47 163.74 20.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.142 -0.974 . . . . 1.84 110.131 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -60.18 -40.2 89.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.5 -0.75 . . . . 2.74 110.19 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -62.05 -34.57 76.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -0.917 . . . . 2.89 109.997 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.407 HG23 ' OG1' ' A' ' 232' ' ' THR . 55.3 t -69.78 -39.99 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.343 -0.848 . . . . 1.3 109.299 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.7 mt . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 1.09 109.404 179.875 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 44.4 ttp . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.407 0.622 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -154.6 151.8 29.26 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -146.8 158.52 43.93 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.042 -1.036 . . . . 0.0 110.354 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . 0.495 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 7.4 tm0? -149.53 145.22 26.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.461 -0.774 . . . . 0.0 108.977 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . 0.495 ' N ' ' CD ' ' B' ' 304' ' ' GLN . 93.4 mt-10 -111.69 131.13 55.5 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.16 -0.963 . . . . 0.0 110.09 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 1.2 p -130.17 120.84 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.799 0.809 . . . . 0.0 111.31 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . 0.438 ' O ' HG23 ' B' ' 309' ' ' THR . 86.3 m -73.88 113.88 11.55 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.217 1.008 . . . . 0.0 110.563 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 60.9 mt -57.95 115.78 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 122.623 1.201 . . . . 0.0 111.317 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . 0.438 HG23 ' O ' ' B' ' 307' ' ' THR . 67.5 p -111.72 19.95 17.54 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.643 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.95 124.4 90.67 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.888 -1.132 . . . . 0.0 109.206 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -55.27 -18.38 18.27 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 CA-C-N 120.154 1.091 . . . . 0.0 112.921 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -121.32 10.1 10.51 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.293 -0.879 . . . . 0.0 110.027 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.85 -178.21 40.31 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.459 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -87.11 93.65 9.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.151 -1.205 . . . . 0.0 110.301 -178.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -96.37 -160.63 0.81 Allowed 'General case' 0 N--CA 1.509 2.496 0 O-C-N 120.662 -1.274 . . . . 0.0 110.134 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 13.6 m -58.73 -45.05 90.48 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.93 -1.106 . . . . 0.0 112.064 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.492 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.4 tpt180 -53.13 -62.43 3.49 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 120.564 -1.335 . . . . 0.0 111.127 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -57.25 -32.7 94.38 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 CA-C-N 120.135 1.084 . . . . 0.0 112.184 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.85 76.07 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.488 -0.885 . . . . 0.0 108.901 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.46 -45.49 76.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.459 -0.775 . . . . 0.0 110.474 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . 0.674 HE22 ' NZ ' ' B' ' 324' ' ' LYS . 94.0 mm-40 -70.13 -40.04 75.08 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.879 -1.138 . . . . 0.0 108.641 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -61.07 -51.81 67.57 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.596 -0.69 . . . . 0.0 110.643 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . 0.577 ' CG1' ' HZ2' ' B' ' 327' ' ' LYS . 75.4 t -70.21 -33.1 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.775 -1.203 . . . . 0.0 110.017 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . 0.674 ' NZ ' HE22 ' B' ' 321' ' ' GLN . 32.3 ttpt -60.04 -46.36 89.78 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 108.878 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -62.32 -45.33 93.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.169 -0.957 . . . . 0.0 109.819 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.91 -50.93 71.84 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.207 -0.933 . . . . 0.0 110.742 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . 0.577 ' HZ2' ' CG1' ' B' ' 323' ' ' VAL . 42.4 mttp -55.96 -14.37 2.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.981 -1.074 . . . . 0.0 109.456 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -68.99 -30.04 72.31 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -104.67 145.06 30.87 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.333 -1.098 . . . . 0.0 109.096 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 37.9 p -90.63 -11.8 38.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.017 -1.052 . . . . 0.0 109.547 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.48 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 81.1 p -60.01 153.4 21.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -0.844 . . . . 0.0 109.568 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -71.12 132.94 45.8 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.178 -0.951 . . . . 0.0 108.701 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.6 mt -129.78 129.95 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.669 -0.644 . . . . 0.0 109.458 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 30.6 m -126.61 150.05 49.13 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 92.1 t -115.15 137.47 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 56.7 m -130.07 122.57 28.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.281 -0.887 . . . . 0.0 109.157 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 83.1 p -136.1 119.5 16.86 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.805 0.812 . . . . 0.0 110.215 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 36.27 61.08 0.82 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.76 -15.34 20.69 Favored Glycine 0 N--CA 1.499 2.834 0 O-C-N 120.608 -1.307 . . . . 0.0 113.129 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -108.28 119.57 39.86 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 119.463 1.631 . . . . 0.0 109.642 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 66.1 m -118.74 142.24 47.88 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.812 0.815 . . . . 0.0 110.168 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . 0.464 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -141.19 163.21 33.57 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.572 0.701 . . . . 0.0 109.779 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 4.7 t -87.97 140.01 29.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.475 -0.766 . . . . 0.0 109.318 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.42 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -82.35 -10.0 59.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.937 -1.102 . . . . 0.0 110.157 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -90.26 22.18 3.45 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 48.1 t -149.72 99.51 2.87 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.611 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.704 HD23 HD22 ' A' ' 79' ' ' LEU . 60.9 tp -59.83 -31.89 70.15 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.86 ' CE2' HD11 ' A' ' 79' ' ' LEU . 53.4 m-85 -59.87 -54.54 44.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.009 -1.057 . . . . 0.0 110.031 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -68.98 -24.1 64.19 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.079 -1.013 . . . . 0.0 111.717 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' B' ' 352' ' ' THR . 82.6 mt -68.01 -51.76 43.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.386 -1.446 . . . . 0.0 108.191 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.612 HE22 ' CD ' ' A' ' 126' ' ' ARG . 61.8 mm-40 -39.06 -26.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.65 -178.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.43 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.9 p -79.88 -7.07 58.52 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.69 -1.256 . . . . 0.0 110.717 -177.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' B' ' 342' ' ' ALA . 60.5 mt -92.52 109.33 20.73 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.956 -1.09 . . . . 0.0 109.308 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.53 88.82 0.62 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.7 mt -97.24 90.13 5.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.219 -1.166 . . . . 0.0 109.165 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 28.9 p -96.4 142.81 28.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.096 -1.002 . . . . 0.0 110.076 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -44.99 119.98 2.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.695 -0.628 . . . . 0.0 110.187 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 114.44 -3.95 23.39 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 52.4 m -99.17 129.75 45.44 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.424 -1.044 . . . . 0.0 109.084 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 13.8 t -92.44 134.79 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 119.773 -1.829 . . . . 0.0 109.109 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 29.8 m -112.07 174.98 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 30.3 m -131.13 127.88 38.98 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 84.2 mt -100.91 114.26 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 88.3 p -119.89 132.81 55.66 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.521 -0.737 . . . . 0.0 109.035 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.28 154.45 41.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.352 -0.842 . . . . 0.0 109.494 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -146.64 124.49 11.95 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 159.52 -158.58 29.74 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 118.798 -1.668 . . . . 0.0 111.59 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -60.04 -53.67 55.05 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.48 ' H ' ' HB3' ' B' ' 331' ' ' SER . 95.8 m-20 -110.51 9.98 23.17 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.98 -1.075 . . . . 0.0 110.897 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -42.08 -32.29 0.45 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.234 -0.916 . . . . 0.0 111.634 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -69.98 -39.77 75.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.737 -1.227 . . . . 0.0 109.849 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -68.75 -52.26 32.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.959 . . . . 0.0 109.326 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.8 -32.94 6.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.394 -0.816 . . . . 0.0 111.248 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.504 ' O ' HG23 ' B' ' 378' ' ' VAL . 84.2 t -75.74 -39.33 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.611 -1.305 . . . . 0.0 109.615 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.59 -49.86 75.83 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.346 -0.846 . . . . 0.0 111.804 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -77.46 -41.37 39.9 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.888 -1.132 . . . . 0.0 111.514 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.09 -41.43 92.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.724 -1.235 . . . . 0.0 108.543 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.6 t -61.46 -46.12 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.285 -0.884 . . . . 0.0 109.22 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' B' ' 383' ' ' GLU . 65.6 mttm -69.99 -55.81 8.61 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 58.7 tp -57.64 -35.85 71.05 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.527 -0.733 . . . . 0.0 109.645 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 34.7 ttm -71.25 -40.04 71.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.387 -1.446 . . . . 0.0 108.016 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -79.07 -7.66 58.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.705 -0.622 . . . . 0.0 110.613 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' B' ' 379' ' ' LYS . 76.8 mm-40 -111.88 2.96 17.27 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.063 -1.023 . . . . 0.0 111.269 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 22.5 mt -96.19 126.6 41.53 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.667 -1.27 . . . . 0.0 109.508 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.896 -1.05 . . . . 0.0 109.246 179.471 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.179 0.514 . . . . 2.91 109.805 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 225' ' ' ASN . 88.1 mt -110.05 130.01 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.429 -0.794 . . . . 1.2 109.26 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.1 m -127.47 129.34 47.28 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.584 -0.697 . . . . 1.4 109.629 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.645 ' N ' HD21 ' A' ' 225' ' ' ASN . . . -113.93 -160.48 13.66 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 108.814 -1.714 . . . . 1.05 108.814 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.5 mt -88.85 -17.26 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.985 -1.303 . . . . 1.15 109.943 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.3 tp 55.4 105.46 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.291 -0.881 . . . . 0.98 108.828 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.64 -24.82 16.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.141 -0.974 . . . . 0.88 109.672 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.8 t -142.52 127.46 10.14 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.283 -0.886 . . . . 1.69 109.853 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.92 143.13 17.99 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.908 1.739 . . . . 0.85 111.624 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.853 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 167.64 -168.89 40.9 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.312 -1.515 . . . . 0.92 109.312 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.6 mt -149.14 126.77 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.352 -1.087 . . . . 0.81 108.222 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.99 149.76 43.63 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.958 -1.089 . . . . 0.51 111.025 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 3.0 m-85 -124.66 129.94 51.49 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.733 -1.21 . . . . 0.62 107.733 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.81 177.32 47.88 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 118.695 -1.717 . . . . 0.55 111.02 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -78.48 157.94 28.76 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.707 -0.878 . . . . 2.1 109.289 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.626 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -106.34 126.09 51.8 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.336 -0.852 . . . . 0.77 110.873 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.4 tp -97.27 138.02 35.4 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.378 -1.341 . . . . 0.91 107.378 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 39.5 tp -116.6 123.31 47.02 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.247 -0.908 . . . . 0.93 109.448 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 160' ' ' ALA . 27.2 mt -88.06 106.66 18.3 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.556 0.693 . . . . 0.93 110.55 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -98.77 133.66 42.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.485 -0.759 . . . . 2.75 109.281 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -128.86 128.24 43.46 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.275 -0.891 . . . . 3.0 108.853 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -79.01 153.68 30.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.969 . . . . 2.77 110.067 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -73.78 140.91 46.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.282 -0.886 . . . . 2.94 108.769 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.7 mt -80.02 132.48 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.958 . . . . 0.95 108.83 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.9 t -95.65 122.35 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.321 -0.862 . . . . 1.28 108.995 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.9 mt -105.3 138.68 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.538 -0.726 . . . . 1.21 109.09 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -87.82 123.4 32.56 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.163 -0.961 . . . . 1.81 109.712 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -93.04 2.79 56.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.886 . . . . 2.8 109.833 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -69.98 149.77 47.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.059 -1.026 . . . . 2.87 110.077 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -87.93 144.03 26.78 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.384 -0.969 . . . . 2.35 108.384 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.406 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.1 pt -90.36 164.33 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.845 -1.159 . . . . 0.97 109.947 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.0 p -93.64 170.83 9.29 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.993 -1.114 . . . . 1.17 107.993 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.94 -48.27 82.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.764 -1.21 . . . . 1.18 109.222 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 62.8 t0 -54.13 -30.16 47.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.997 -1.064 . . . . 2.56 109.68 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -81.26 -9.09 59.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.358 -0.838 . . . . 1.79 110.362 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -65.6 -55.18 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.543 -1.348 . . . . 1.0 109.042 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -39.93 87.64 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.352 -0.843 . . . . 1.77 109.81 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.38 -41.78 76.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 2.7 111.033 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.406 ' HG3' HG21 ' A' ' 31' ' ' ILE . 69.7 mm-40 -64.25 -40.14 95.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.693 -1.255 . . . . 1.51 110.179 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.09 -44.66 95.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.79 -1.194 . . . . 0.93 107.993 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -59.97 -40.1 87.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 1.81 108.321 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.48 HH11 ' HG2' ' A' ' 42' ' ' ARG . 20.6 mtt-85 -59.96 -44.33 94.49 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.489 -1.3 . . . . 2.78 107.489 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -60.88 -47.62 85.53 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.601 -0.889 . . . . 0.78 108.601 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.01 -47.15 87.01 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.247 -1.02 . . . . 1.07 108.247 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.7 t -59.95 -41.44 91.88 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.322 -0.992 . . . . 1.12 108.322 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.61 -42.9 99.84 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.363 -1.895 . . . . 0.84 108.363 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -65.54 -38.81 90.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.121 -1.066 . . . . 3.09 108.121 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.02 -42.8 77.05 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.885 -0.51 . . . . 0.88 109.734 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.3 ttpt -71.19 -74.4 0.15 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.999 -1.111 . . . . 2.59 107.999 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.27 -38.78 0.37 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.267 -0.896 . . . . 0.7 111.443 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.0 t -55.71 -54.92 38.42 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.393 -1.442 . . . . 1.4 108.494 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.99 -41.75 73.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.377 -0.827 . . . . 0.67 111.356 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -66.87 -40.26 87.78 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.758 -1.213 . . . . 1.66 110.521 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.3 mt -60.37 -39.96 89.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.812 -1.18 . . . . 1.58 109.067 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -61.84 -32.05 72.35 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.348 -0.845 . . . . 1.35 109.724 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.4 m -67.87 -44.75 76.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.795 -1.191 . . . . 0.77 110.124 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.5 mt -59.98 -37.98 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.127 -0.983 . . . . 0.63 108.573 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -56.6 -50.03 73.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.708 -0.62 . . . . 1.14 109.376 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 m -56.62 -31.95 64.82 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.23 -0.919 . . . . 0.79 110.332 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -69.86 -39.8 76.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 1.53 110.192 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.503 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -68.09 -48.33 65.81 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.526 -0.734 . . . . 0.57 109.662 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -51.51 -56.57 14.83 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 110.209 -1.157 . . . . 0.75 110.209 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.06 -42.0 73.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.127 -1.219 . . . . 1.59 111.061 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.6 m -66.09 -62.39 1.51 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.844 -1.16 . . . . 0.73 111.996 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -94.56 -45.88 7.21 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.864 -1.148 . . . . 0.75 111.239 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.73 -167.93 25.43 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.908 -1.139 . . . . 1.22 110.819 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -70.16 -23.93 63.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.863 -0.786 . . . . 5.81 110.261 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.494 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.8 tp10 -59.93 -33.39 71.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.465 -0.772 . . . . 3.37 110.086 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -98.76 -18.91 17.74 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.252 -0.905 . . . . 1.77 110.469 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -67.71 -40.06 84.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.893 -1.129 . . . . 1.65 109.83 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.591 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -63.49 -32.82 74.38 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.414 -0.804 . . . . 0.77 110.218 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.7 mt -59.94 -41.83 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.902 -1.124 . . . . 0.8 109.594 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -64.57 -39.84 94.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.129 -0.982 . . . . 0.88 110.881 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -60.07 -40.0 88.0 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.916 -1.115 . . . . 1.37 109.458 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.81 -47.07 92.55 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.07 -1.612 . . . . 0.62 109.07 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -61.17 -47.88 84.15 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.408 -1.054 . . . . 1.5 109.326 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.15 -48.79 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.303 -0.873 . . . . 0.63 109.788 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.4 ttp -59.97 -41.52 92.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.964 -1.085 . . . . 1.51 110.588 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.948 HD22 HD23 ' B' ' 347' ' ' LEU . 57.9 tp -65.89 -39.94 91.11 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.358 -0.839 . . . . 0.77 109.928 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.46 -40.07 95.03 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.562 -0.711 . . . . 0.62 109.663 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -82.14 5.84 18.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.057 -1.027 . . . . 1.47 110.228 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -50.03 133.21 23.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.0 . . . . 1.47 110.423 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.49 -22.58 63.69 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.606 -0.684 . . . . 1.78 110.919 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.58 -34.12 71.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.928 -1.108 . . . . 2.53 109.1 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.0 -42.11 73.49 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.388 0.613 . . . . 0.8 110.257 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.03 -50.03 75.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 1.42 110.191 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -70.28 -42.53 71.95 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.352 -0.843 . . . . 1.71 110.983 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.07 -40.11 75.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.043 -1.035 . . . . 1.57 111.068 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 84.5 mt -67.47 -49.07 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.043 -1.036 . . . . 0.65 109.451 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 88.1 mt -66.25 -36.76 78.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.608 -0.683 . . . . 0.82 110.248 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.27 82.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.174 -0.954 . . . . 0.79 110.988 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 96' ' ' LYS . 93.5 mt -59.95 -45.81 91.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.051 -1.031 . . . . 0.95 110.3 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.0 mt -60.39 -49.91 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.029 -1.044 . . . . 0.66 108.833 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -65.79 -45.83 80.98 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.992 -0.683 . . . . 2.2 110.525 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -79.01 -48.83 13.71 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.044 -1.035 . . . . 1.65 112.103 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 92' ' ' LEU . 96.5 mttt -92.79 -3.03 55.43 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 120.719 -1.238 . . . . 2.03 112.48 -177.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 57.32 39.73 28.22 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.788 -1.195 . . . . 1.42 109.945 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 95.2 mtp -93.5 168.1 11.26 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.61 -0.681 . . . . 1.18 110.291 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.1 p -82.67 161.12 22.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.433 -0.792 . . . . 0.98 109.663 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.72 -40.04 88.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.344 -0.848 . . . . 0.64 109.491 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.573 ' OD1' HD22 ' A' ' 138' ' ' LEU . 39.5 t0 -63.24 -40.07 96.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.149 -0.97 . . . . 2.07 109.541 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.48 -51.21 9.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.431 -0.793 . . . . 0.73 110.35 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.02 75.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.362 -0.836 . . . . 0.54 110.444 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.03 -41.83 93.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.023 -1.048 . . . . 0.56 109.81 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -59.8 -40.19 87.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.352 -0.843 . . . . 1.54 110.141 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -64.93 -40.11 94.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 1.33 111.077 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 86.1 t -64.79 -50.46 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.001 -1.062 . . . . 0.72 110.689 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.3 mm -70.05 -40.03 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.879 -1.138 . . . . 0.85 108.387 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -65.34 -38.54 90.44 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.257 -1.016 . . . . 2.44 108.257 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.69 -52.91 49.53 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.106 -1.198 . . . . 0.98 110.106 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -60.73 -49.93 75.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.902 -1.352 . . . . 1.41 108.987 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.13 -39.95 88.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.372 -0.83 . . . . 1.2 109.498 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.1 m -59.94 -40.09 87.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.11 -0.994 . . . . 1.7 109.119 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.4 -39.62 87.99 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.237 -0.914 . . . . 1.47 108.876 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.0 mt -62.47 -42.8 99.74 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.273 -0.892 . . . . 1.56 109.514 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -53.99 -31.34 50.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.99 -1.069 . . . . 2.2 109.676 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.97 -24.52 64.48 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.169 -0.957 . . . . 2.12 108.526 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 54.1 mt -62.74 139.98 58.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.931 . . . . 2.0 109.235 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -96.39 45.66 1.06 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.139 -0.975 . . . . 3.23 109.737 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 41.1 t0 -133.33 143.59 49.1 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.333 -0.855 . . . . 2.49 109.182 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.495 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 77.8 mm-40 -71.56 -64.86 0.84 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.195 -1.039 . . . . 3.95 108.195 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.457 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.7 t80 -39.11 -39.97 0.64 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.023 -0.423 . . . . 2.0 110.904 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.2 mt -79.98 -40.04 28.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.61 -1.306 . . . . 1.86 108.884 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.99 -40.57 96.09 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.502 -0.925 . . . . 2.84 108.502 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.89 -34.05 73.04 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.2 -1.037 . . . . 2.73 108.2 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.424 ' NH1' ' OH ' ' A' ' 122' ' ' TYR . 1.9 tpt180 -59.92 -39.42 85.37 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.389 -1.337 . . . . 2.77 107.389 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.55 -25.49 66.68 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.456 0.646 . . . . 1.19 109.285 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.11 94.3 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.037 -1.098 . . . . 1.2 108.037 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.5 -40.07 85.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.759 . . . . 1.55 109.613 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.88 -40.07 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.047 -1.033 . . . . 0.8 108.904 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -60.09 -40.6 90.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.149 -0.969 . . . . 3.09 108.985 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.09 -39.05 84.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.65 -0.656 . . . . 1.46 110.832 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.9 mt -59.96 -42.87 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.919 -1.113 . . . . 0.71 110.248 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.19 -27.47 71.78 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.407 -1.477 . . . . 0.57 109.407 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -59.91 -50.0 75.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.389 -1.065 . . . . 2.59 110.301 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.475 HH11 ' HG2' ' A' ' 136' ' ' ARG . 22.2 mtt-85 -65.71 -37.89 87.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.855 -1.153 . . . . 2.83 109.98 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.5 tp -55.22 -44.25 75.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -0.915 . . . . 1.25 109.323 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.573 HD22 ' OD1' ' A' ' 101' ' ' ASP . 89.3 mt -60.38 -39.98 89.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.24 -0.912 . . . . 0.7 109.511 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 139' ' ' ARG . 51.9 mtt-85 -69.43 -39.83 77.6 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.28 -0.887 . . . . 2.57 108.831 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -64.5 -34.16 77.58 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.704 -0.623 . . . . 1.23 111.104 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.92 -45.74 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.18 -1.575 . . . . 0.81 107.788 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 99.4 mt -70.06 -37.42 75.5 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.392 0.615 . . . . 1.0 109.488 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.89 45.73 7.05 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.116 -1.993 . . . . 0.89 108.116 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.8 tp -76.51 160.05 29.82 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.532 -0.981 . . . . 1.14 109.498 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -68.54 143.83 54.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.447 -0.783 . . . . 4.6 109.823 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.6 mt -120.0 125.1 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 122.004 0.907 . . . . 1.24 109.188 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 148' ' ' ASP . 5.3 mt -64.86 -41.98 93.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 115.962 -0.563 . . . . 1.54 110.225 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 147' ' ' ILE . 23.4 t0 63.73 125.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.213 -1.032 . . . . 1.5 108.213 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.462 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 40.7 mt -86.17 0.47 53.55 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.105 -0.997 . . . . 0.79 110.019 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.7 p -87.29 -8.55 56.6 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.178 -0.951 . . . . 1.4 109.397 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.96 21.82 1.26 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.353 -0.842 . . . . 0.92 111.255 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 32.2 mm -88.4 119.97 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.614 -1.304 . . . . 0.88 108.796 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -100.33 -9.36 22.37 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.453 -0.779 . . . . 2.45 110.687 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -130.14 152.86 49.11 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.232 -0.918 . . . . 1.52 110.499 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -63.52 133.87 54.6 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.369 -0.832 . . . . 1.58 109.218 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.1 m -152.49 164.23 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.911 -0.774 . . . . 0.69 108.911 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.1 mt -92.59 151.53 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 106.029 -1.841 . . . . 0.61 106.029 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 33.7 tp -102.56 118.89 37.83 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.992 -1.068 . . . . 0.87 110.231 -177.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 12.3 t -125.72 134.34 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.805 -0.813 . . . . 0.71 108.805 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.411 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.31 166.13 28.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.931 . . . . 0.81 108.981 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.401 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -70.08 -38.74 75.81 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.34 -1.475 . . . . 0.98 107.306 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -171.17 144.15 2.02 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.961 -0.755 . . . . 2.25 108.961 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 40.9 mt -109.79 137.08 48.1 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.267 -0.896 . . . . 0.78 109.268 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 58.7 p -87.54 149.1 45.74 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 120.993 -1.067 . . . . 0.98 108.979 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -41.71 -36.97 3.59 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.128 1.885 . . . . 0.81 112.827 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.9 m -59.94 -47.18 86.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 0.9 109.661 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.66 -43.81 97.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.915 . . . . 1.61 110.024 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 30.6 p -55.22 -26.67 41.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.266 -0.896 . . . . 0.61 111.702 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -83.19 -43.9 15.62 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.555 -1.34 . . . . 0.6 110.099 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -89.28 36.93 0.84 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.028 -1.101 . . . . 1.4 108.028 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.1 tp -103.24 133.55 48.14 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.454 0.645 . . . . 0.7 109.697 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.645 ' ND2' ' NZ ' ' A' ' 175' ' ' LYS . 2.9 p30 -82.9 99.26 9.65 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.332 -0.988 . . . . 2.35 108.332 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 90.9 mt -65.07 -42.28 94.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 1.51 110.975 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -62.68 -32.36 73.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.988 -1.07 . . . . 2.33 112.678 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.645 ' NZ ' ' ND2' ' A' ' 172' ' ' ASN . 9.4 mtmp? -92.04 -5.09 53.56 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.64 -1.287 . . . . 1.92 110.341 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.522 HG12 ' H ' ' A' ' 178' ' ' GLY . 72.3 t -104.68 116.46 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.067 -1.086 . . . . 0.67 108.067 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.6 mt -85.93 7.23 25.03 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.17 -0.957 . . . . 1.53 111.326 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.522 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.45 172.86 37.24 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.128 -1.511 . . . . 0.48 109.82 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.482 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 11.4 m-85 -134.3 129.34 35.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.501 -0.999 . . . . 0.55 108.87 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 93.9 mt -134.72 130.33 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.329 -0.857 . . . . 0.65 108.973 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.7 p -151.6 162.17 41.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.956 -1.09 . . . . 0.82 110.531 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 183' ' ' ALA . 38.3 p-10 -109.63 26.73 10.31 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.905 -0.776 . . . . 2.46 108.905 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -54.31 -164.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.987 -1.071 . . . . 1.28 111.64 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.07 -59.33 5.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.562 -1.015 . . . . 2.19 110.562 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -174.07 -156.8 14.2 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 118.748 -1.691 . . . . 2.13 111.22 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.469 ' C ' ' H ' ' A' ' 188' ' ' SER . 46.8 ttp180 -62.33 -30.05 70.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.923 -0.751 . . . . 5.86 110.614 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 30.6 p -61.85 5.17 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.819 -1.176 . . . . 3.72 110.692 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 186' ' ' ARG . 50.2 p -90.87 140.18 30.05 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.871 -1.143 . . . . 1.74 110.419 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -50.0 -43.47 50.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.423 -0.798 . . . . 0.95 109.672 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.8 m -56.97 -40.49 76.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.625 -0.672 . . . . 1.55 109.633 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.9 m -60.14 -39.9 87.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.208 -0.933 . . . . 1.51 110.116 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.8 mt -60.04 -45.12 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.463 -0.773 . . . . 1.67 110.504 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 30.1 mtm -59.94 -47.61 85.08 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.88 -1.137 . . . . 1.02 110.496 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.71 -45.74 63.67 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.681 -1.262 . . . . 0.68 109.897 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -59.93 -50.33 74.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.926 -1.109 . . . . 2.93 110.994 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.1 m -77.02 -30.19 55.68 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.612 -1.305 . . . . 0.86 111.104 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.0 -29.41 66.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.741 -1.224 . . . . 0.67 108.449 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 68.49 47.98 0.87 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.277 0.561 . . . . 1.5 110.317 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 89.4 mt -128.7 149.93 73.43 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 107.865 -1.161 . . . . 0.72 107.865 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.73 138.76 85.05 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 121.925 1.75 . . . . 0.61 111.69 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -172.7 149.17 2.0 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.147 -1.021 . . . . 0.66 110.891 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.5 mt -124.99 150.41 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.173 -1.417 . . . . 0.79 107.173 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.0 -12.11 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.464 0 O-C-N 120.931 -1.106 . . . . 0.91 111.869 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -114.68 25.98 9.84 Favored Glycine 0 N--CA 1.502 3.063 0 N-CA-C 110.076 -1.21 . . . . 1.01 110.076 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.457 ' HB ' HG23 ' A' ' 208' ' ' VAL . 58.3 p -44.26 -47.29 9.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -1.165 . . . . 0.99 110.469 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 106.73 -51.39 0.74 Allowed Glycine 0 N--CA 1.5 2.941 0 N-CA-C 111.018 -0.833 . . . . 1.12 111.018 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 81.1 p -162.82 44.66 0.13 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.473 -1.604 . . . . 1.72 111.962 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . 0.457 HG23 ' HB ' ' A' ' 205' ' ' THR . 14.8 t -71.38 -41.02 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.685 -1.26 . . . . 0.89 108.513 178.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.423 ' H ' HG23 ' A' ' 209' ' ' THR . 8.3 p -50.66 -29.94 12.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.841 . . . . 1.03 109.512 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.1 m -81.92 -12.4 58.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 1.83 109.346 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -115.53 15.16 16.68 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.63 -0.669 . . . . 2.27 109.798 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 42.7 t -138.05 134.55 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.407 -0.808 . . . . 0.92 110.394 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.453 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 10.8 mptt -117.42 153.0 33.82 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.368 -1.345 . . . . 2.2 107.368 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.462 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 11.2 p30 -55.51 140.84 39.16 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.995 -1.066 . . . . 2.36 110.367 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.0 m-20 83.06 2.43 1.05 Allowed 'General case' 0 N--CA 1.502 2.147 0 CA-C-N 116.27 -0.423 . . . . 2.38 110.747 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 94.1 m-20 -74.82 141.58 44.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.743 -1.223 . . . . 2.09 109.153 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -90.69 116.42 28.55 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.933 -1.136 . . . . 1.27 107.933 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 16' ' ' ALA . 79.9 mt -125.56 147.55 49.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.441 -0.787 . . . . 0.75 110.365 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.495 HG23 ' CD2' ' A' ' 13' ' ' PHE . 71.5 mt -115.86 129.83 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 106.627 -1.62 . . . . 0.63 106.627 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 61.0 tp -102.59 119.84 39.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.875 -1.141 . . . . 0.7 109.528 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.645 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 23.2 p-10 -76.22 -40.03 53.14 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.148 -1.056 . . . . 2.31 108.148 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.853 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 48.46 18.42 0.17 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.769 -0.826 . . . . 0.78 108.769 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.45 ' N ' ' C ' ' A' ' 221' ' ' ASP . 53.9 t -129.18 -36.66 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.953 -1.129 . . . . 1.04 107.953 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -110.07 -2.81 16.79 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.135 -1.431 . . . . 2.44 107.135 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.645 HD21 ' N ' ' A' ' 4' ' ' GLY . 27.8 t-20 63.66 51.4 2.48 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.498 0.666 . . . . 1.55 109.689 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.645 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 42.4 mt-30 -137.31 152.72 50.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.499 -0.751 . . . . 1.99 109.213 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.86 130.01 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.426 -0.953 . . . . 0.77 108.426 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -102.52 120.82 41.19 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.776 -0.824 . . . . 0.98 108.776 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.6 t -100.95 113.23 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.506 -0.746 . . . . 0.85 110.149 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 50.02 66.75 5.16 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.187 -0.946 . . . . 1.66 111.127 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -89.17 148.07 5.48 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 123.186 2.591 . . . . 0.95 112.339 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 24.8 p -70.72 166.17 21.44 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.18 -0.95 . . . . 1.84 110.744 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.666 -0.646 . . . . 2.74 109.773 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.02 -37.73 80.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.249 -0.907 . . . . 2.89 109.611 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.02 -41.84 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.169 -0.957 . . . . 1.3 109.056 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.4 mt . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 1.09 109.932 -179.664 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 56.9 ttm . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -149.55 146.89 27.6 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.41 162.32 41.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.004 -1.06 . . . . 0.0 110.375 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . 0.46 ' NE2' HG21 ' B' ' 378' ' ' VAL . 6.4 tt0 -156.03 153.9 30.18 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -114.93 134.57 55.05 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.077 -1.014 . . . . 0.0 110.056 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 p -131.82 124.0 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 CA-C-O 122.173 0.987 . . . . 0.0 112.751 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 89.0 m -77.25 104.29 7.67 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.935 0.874 . . . . 0.0 110.673 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.463 HG22 ' H ' ' B' ' 310' ' ' ALA . 92.7 mt -52.15 124.94 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.368 1.08 . . . . 0.0 110.657 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 71.2 p -110.03 20.05 18.34 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.027 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.463 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -74.8 118.5 70.79 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.944 -1.098 . . . . 0.0 109.233 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -53.4 -16.05 6.8 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 CA-C-N 120.251 1.125 . . . . 0.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -120.28 10.08 11.2 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.558 -0.714 . . . . 0.0 109.268 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 69.29 -176.75 30.37 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.714 -1.755 . . . . 0.0 108.714 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.457 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.4 tp -85.45 89.59 7.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.055 -1.262 . . . . 0.0 110.129 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.494 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 4.3 p80 -94.94 -159.97 0.75 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.981 -1.074 . . . . 0.0 109.641 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.8 m -59.73 -47.43 85.68 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.859 -1.151 . . . . 0.0 112.916 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.591 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.4 tpt180 -57.98 -55.89 40.43 Favored Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 120.44 -1.412 . . . . 0.0 112.223 -178.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.494 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 18.1 Cg_endo -64.84 -30.21 58.41 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 CA-C-N 120.583 1.244 . . . . 0.0 111.37 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.03 75.35 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.14 -41.83 72.27 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.569 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . 0.41 ' NE2' HH21 ' B' ' 317' ' ' ARG . 12.7 tt0 -69.97 -43.13 72.12 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.026 -1.046 . . . . 0.0 108.615 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -60.41 -50.96 71.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.414 -0.804 . . . . 0.0 110.556 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 58.4 t -66.49 -26.52 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.722 -1.236 . . . . 0.0 109.889 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.33 -45.69 93.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.398 -0.814 . . . . 0.0 110.219 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -69.75 -41.6 75.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.229 -0.919 . . . . 0.0 112.205 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.24 -51.76 68.2 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.455 -1.403 . . . . 0.0 110.954 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -57.71 -11.91 2.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.044 -1.035 . . . . 0.0 109.415 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -70.33 -28.59 71.12 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -105.68 144.66 32.11 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.661 -0.905 . . . . 0.0 109.325 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 18.2 p -91.03 -11.74 37.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.138 -0.976 . . . . 0.0 110.055 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.492 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 90.6 p -58.03 153.64 14.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.164 -0.96 . . . . 0.0 110.135 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.11 130.81 42.47 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 79.8 mt -132.45 131.13 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.465 -0.772 . . . . 0.0 109.646 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 29.3 m -128.12 154.11 46.11 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 76.3 t -118.36 139.56 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 54.6 m -130.5 121.29 25.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.387 -0.82 . . . . 0.0 109.213 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . 0.524 ' O ' ' ND2' ' B' ' 338' ' ' ASN . 29.3 t -136.61 117.7 14.39 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.906 0.86 . . . . 0.0 110.921 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' B' ' 337' ' ' SER . 7.3 p30 42.22 52.26 4.51 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 88.52 -13.39 62.41 Favored Glycine 0 N--CA 1.501 3.015 0 O-C-N 120.31 -1.494 . . . . 0.0 113.507 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -113.84 122.12 46.09 Favored 'General case' 0 N--CA 1.508 2.469 0 CA-C-N 119.602 1.701 . . . . 0.0 110.457 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 77.8 p -103.53 154.97 18.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.421 -0.799 . . . . 0.0 110.701 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . 0.424 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -154.18 154.31 33.29 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.765 -0.584 . . . . 0.0 109.916 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . 0.415 ' H ' ' HE2' ' B' ' 349' ' ' LYS . 4.6 t -91.05 138.09 31.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.346 -0.846 . . . . 0.0 109.971 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.405 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -78.09 -14.87 59.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.987 -1.071 . . . . 0.0 110.624 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -87.74 21.12 2.71 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . 0.432 ' CB ' ' HZ3' ' B' ' 349' ' ' LYS . 12.3 t -149.17 97.03 2.62 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.856 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.948 HD23 HD22 ' A' ' 79' ' ' LEU . 19.6 tp -59.55 -32.12 70.04 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.818 ' CE2' HD11 ' A' ' 79' ' ' LEU . 61.0 m-85 -57.63 -51.64 68.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.375 -0.828 . . . . 0.0 110.529 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . 0.432 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 36.2 mtmm -69.59 -40.01 76.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.572 -1.33 . . . . 0.0 110.002 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.612 ' O ' ' N ' ' B' ' 352' ' ' THR . 86.3 mt -50.62 -55.81 14.65 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.743 -1.223 . . . . 0.0 108.117 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -38.51 -16.07 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.039 -0.413 . . . . 0.0 111.294 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.612 ' N ' ' O ' ' B' ' 350' ' ' LEU . 75.4 p -91.68 -12.02 35.28 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.813 -1.18 . . . . 0.0 110.952 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.424 HD11 ' HB3' ' B' ' 342' ' ' ALA . 55.8 mt -92.56 119.41 31.99 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.896 -1.128 . . . . 0.0 109.179 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.8 91.63 0.99 Allowed Glycine 0 N--CA 1.485 1.958 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 66.2 mt -100.85 94.91 6.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.412 -1.052 . . . . 0.0 108.521 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 75.2 p -91.68 178.79 5.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.349 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . 0.404 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 16.1 tm0? -69.16 113.97 7.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.69 -0.631 . . . . 0.0 110.246 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 102.08 9.49 42.13 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 25.5 m -86.45 111.98 21.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.187 -1.184 . . . . 0.0 110.593 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 42.0 t -77.36 116.24 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 122.018 0.913 . . . . 0.0 110.325 -177.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.7 m -110.74 176.6 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 36.8 m -131.43 130.65 42.78 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 76.3 mt -103.93 115.67 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 77.4 p -118.11 131.66 56.41 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.351 -0.843 . . . . 0.0 109.3 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.27 151.55 38.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.105 -0.997 . . . . 0.0 110.187 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . 0.438 ' OE2' ' OE2' ' B' ' 370' ' ' GLU . 11.7 tp10 -141.98 119.76 11.87 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.467 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 164.19 -163.89 36.28 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 118.323 -1.894 . . . . 0.0 111.963 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 55.1 tp10 -59.85 -50.73 72.66 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.022 -0.589 . . . . 0.0 111.379 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.492 ' H ' ' HB3' ' B' ' 331' ' ' SER . 75.3 m-20 -103.97 8.57 36.76 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.854 -1.154 . . . . 0.0 111.456 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.1 pt-20 -42.04 -32.96 0.5 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.117 -0.99 . . . . 0.0 111.355 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -66.15 -46.92 75.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.674 -1.266 . . . . 0.0 109.801 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -69.98 -52.07 27.38 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.176 -0.952 . . . . 0.0 109.601 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . 0.407 ' O ' HD12 ' B' ' 377' ' ' LEU . . . -42.16 -38.05 1.61 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.548 -0.72 . . . . 0.0 111.676 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.566 ' O ' HG23 ' B' ' 378' ' ' VAL . 62.9 t -79.06 -34.84 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.502 -1.374 . . . . 0.0 110.012 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -65.66 -49.98 66.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.13 -0.981 . . . . 0.0 112.766 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -77.11 -40.37 46.08 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.267 -1.52 . . . . 0.0 110.869 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.407 HD12 ' O ' ' B' ' 373' ' ' ALA . 96.9 mt -60.04 -40.46 89.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.875 -1.141 . . . . 0.0 108.99 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.566 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.5 t -62.27 -45.17 99.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.112 -0.993 . . . . 0.0 109.613 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.8 mttt -69.76 -55.97 8.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 38.7 tp -53.56 -35.71 61.06 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . 0.42 ' CE ' HD13 ' B' ' 314' ' ' LEU . 11.1 tpt -69.97 -39.73 75.81 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.06 -5.78 56.46 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.665 -0.647 . . . . 0.0 110.594 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' B' ' 379' ' ' LYS . 99.2 mt-10 -114.42 -0.54 13.75 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.888 -1.132 . . . . 0.0 111.045 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 10.8 mt -81.14 131.88 35.32 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.406 -1.434 . . . . 0.0 109.746 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 56.4 mp0 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.961 -1.019 . . . . 0.0 108.996 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.349 -0.611 . . . . 2.91 109.349 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.0 mt -110.0 129.92 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.506 -0.746 . . . . 1.2 109.566 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.5 m -130.16 134.95 47.67 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.044 -0.725 . . . . 1.4 109.044 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.72 -163.99 23.32 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.585 -1.806 . . . . 1.05 108.585 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.9 mt -92.18 -11.08 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.91 -1.347 . . . . 1.15 109.539 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.567 HD11 ' O ' ' A' ' 8' ' ' SER . 52.6 tp 53.55 103.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.293 -0.879 . . . . 0.98 109.533 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.23 -21.15 21.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.239 -0.913 . . . . 0.88 109.99 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.567 ' O ' HD11 ' A' ' 6' ' ' LEU . 21.4 m -148.67 135.7 10.57 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 120.895 -1.128 . . . . 1.69 109.596 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.73 142.45 14.24 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.707 2.271 . . . . 0.85 113.489 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.857 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 157.53 -158.44 29.0 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.206 -1.558 . . . . 0.92 109.206 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -149.28 150.5 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 107.851 -1.166 . . . . 0.81 107.851 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.67 141.5 21.06 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.808 -1.183 . . . . 0.51 110.712 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -125.76 126.44 44.57 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.884 -1.154 . . . . 0.62 107.884 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.06 178.29 48.16 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 118.482 -1.818 . . . . 0.55 110.879 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -78.32 158.89 28.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.853 -0.792 . . . . 2.1 109.227 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -101.42 128.77 47.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.407 -0.808 . . . . 0.77 110.663 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.8 tp -99.11 134.94 41.23 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 106.865 -1.532 . . . . 0.91 106.865 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -117.39 118.27 31.77 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.408 -0.808 . . . . 0.93 110.121 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.4 mt -84.88 103.46 13.97 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.316 -0.624 . . . . 0.93 109.316 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -100.2 135.39 41.7 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.372 -0.83 . . . . 2.75 110.008 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -130.61 133.94 46.57 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.522 -0.736 . . . . 3.0 109.118 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -79.14 158.05 27.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.969 -1.082 . . . . 2.77 109.14 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -71.88 149.99 44.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.278 -0.889 . . . . 2.94 110.176 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.4 mt -95.48 130.34 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.214 -0.929 . . . . 0.95 108.938 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.17 129.71 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.121 -0.987 . . . . 1.28 110.115 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.7 mt -107.58 137.1 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 108.617 -0.882 . . . . 1.21 108.617 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -94.86 119.89 34.17 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.94 -1.1 . . . . 1.81 110.265 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.494 HH11 ' HG2' ' A' ' 28' ' ' ARG . 5.0 mmt-85 -88.71 0.05 56.83 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.53 -0.731 . . . . 2.8 109.79 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -70.35 141.43 52.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 2.87 109.921 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -82.41 150.55 27.04 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.204 -0.935 . . . . 2.35 109.301 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.447 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.5 pt -95.1 166.2 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.244 -0.91 . . . . 0.97 109.657 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.4 p -96.41 172.95 7.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.178 -0.951 . . . . 1.17 108.767 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.02 -49.29 78.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.047 -1.033 . . . . 1.18 109.335 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -54.86 -30.05 56.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.863 -1.148 . . . . 2.56 109.471 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -82.44 -10.75 58.91 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.407 -0.808 . . . . 1.79 110.265 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.27 -51.84 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.865 -1.147 . . . . 1.0 108.766 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.96 -39.98 93.99 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.364 -0.835 . . . . 1.77 110.055 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -68.38 -39.97 81.54 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.139 -0.976 . . . . 2.7 111.248 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.447 ' HG3' HG21 ' A' ' 31' ' ' ILE . 71.4 mm-40 -67.96 -39.96 83.29 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.8 -1.188 . . . . 1.51 110.184 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -62.98 -47.8 91.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 120.861 -1.149 . . . . 0.93 108.771 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -61.89 -41.6 98.08 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.104 -0.998 . . . . 1.81 109.347 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.18 -40.47 90.09 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.827 -1.149 . . . . 2.78 108.217 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -67.3 -42.02 84.4 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.55 -0.907 . . . . 0.78 108.55 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.92 -48.26 82.44 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.914 -1.143 . . . . 1.07 107.914 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.425 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 35.7 t -63.93 -44.02 94.15 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.756 -0.831 . . . . 1.12 108.756 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.14 -45.45 96.51 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.282 -1.927 . . . . 0.84 108.282 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.546 ' NH2' ' O ' ' A' ' 80' ' ' LEU . 8.5 ttt180 -63.75 -34.11 77.15 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.681 -1.229 . . . . 3.09 107.681 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -60.04 -40.96 91.19 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.303 -0.628 . . . . 0.88 109.303 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 23.5 ttmt -63.64 -74.39 0.1 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.836 -1.172 . . . . 2.59 107.836 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.17 -39.6 0.43 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.45 -0.782 . . . . 0.7 111.316 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.2 m -53.01 -53.98 42.04 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.517 -1.365 . . . . 1.4 108.527 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.02 -39.96 75.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.469 -0.769 . . . . 0.67 111.501 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -68.89 -39.97 79.48 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.739 -1.225 . . . . 1.66 110.194 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 79.1 mt -63.11 -40.07 96.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.139 -0.976 . . . . 1.58 109.377 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -60.73 -35.26 75.9 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.248 -0.908 . . . . 1.35 109.432 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -62.58 -41.85 99.2 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.159 -0.963 . . . . 0.77 109.402 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.8 mt -62.77 -40.04 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.3 -0.875 . . . . 0.63 109.039 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -56.02 -50.03 72.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.11 -0.994 . . . . 1.14 109.197 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -56.02 -35.4 66.8 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.318 -0.864 . . . . 0.79 109.816 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -69.95 -37.91 75.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 1.53 109.815 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.13 -46.16 85.35 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.491 -0.756 . . . . 0.57 110.183 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.54 -50.03 72.13 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.497 -1.441 . . . . 0.75 109.497 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -68.23 -49.67 59.19 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.204 -1.174 . . . . 1.59 109.502 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.6 m -65.05 -63.8 1.02 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 0.73 112.332 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -95.27 -51.74 4.48 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.879 -1.138 . . . . 0.75 111.288 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.71 -167.99 25.72 Favored Glycine 0 N--CA 1.502 3.073 0 C-N-CA 119.706 -1.235 . . . . 1.22 111.128 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -70.22 -27.01 64.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 122.007 -0.702 . . . . 5.81 110.461 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -60.88 -35.72 77.35 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.3 -0.875 . . . . 3.37 110.571 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -101.04 -20.83 15.21 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.338 -0.851 . . . . 1.77 110.159 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -65.94 -40.06 91.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.026 -1.046 . . . . 1.65 110.002 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.545 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -64.75 -26.77 68.5 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.279 -0.888 . . . . 0.77 109.997 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.04 -39.96 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 118.717 -1.193 . . . . 0.8 108.531 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -66.42 -42.11 88.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.032 . . . . 0.88 110.282 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -60.13 -40.2 88.97 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.853 -1.155 . . . . 1.37 108.939 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.44 -49.95 66.07 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.945 -1.662 . . . . 0.62 108.945 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.503 ' CG ' HD11 ' A' ' 133' ' ' ILE . 38.5 m170 -62.9 -47.2 84.32 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.328 -1.101 . . . . 1.5 109.181 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.4 mt -65.69 -46.8 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.293 -0.879 . . . . 0.63 108.885 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.9 ttp -59.99 -40.12 88.11 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.01 -1.056 . . . . 1.51 109.048 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.018 HD22 HD23 ' B' ' 347' ' ' LEU . 44.4 tp -64.43 -39.99 94.89 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.457 0.646 . . . . 0.77 109.443 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.546 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 62.8 tp -63.18 -39.99 96.24 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.575 -0.703 . . . . 0.62 110.157 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -84.74 7.23 21.3 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.049 -1.032 . . . . 1.47 110.261 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 61.4 t0 -50.14 134.23 22.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.12 -0.987 . . . . 1.47 109.979 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.485 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 93.6 mt-10 -60.12 -23.51 63.93 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.634 -0.667 . . . . 1.78 110.941 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -70.81 -34.24 71.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.971 -1.08 . . . . 2.53 109.415 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.9 mt -71.02 -40.51 71.72 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.573 0.701 . . . . 0.8 109.692 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -59.98 -46.56 89.04 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.115 -0.991 . . . . 1.42 110.231 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -69.97 -42.24 73.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.211 -0.93 . . . . 1.71 111.594 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -69.99 -39.97 75.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.039 -1.038 . . . . 1.57 112.095 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.07 -48.14 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.142 -0.974 . . . . 0.65 109.625 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.92 -39.62 80.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 121.262 0.553 . . . . 0.82 110.179 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.17 -47.69 84.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.79 110.768 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.4 mt -60.0 -48.35 82.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.989 -1.07 . . . . 0.95 109.941 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.2 mt -61.61 -48.59 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 121.957 0.884 . . . . 0.66 108.878 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -67.76 -40.16 84.11 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 120.203 -0.599 . . . . 2.2 110.857 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -86.57 -50.66 6.67 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.915 -1.115 . . . . 1.65 112.356 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -90.14 -2.9 58.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.984 -1.072 . . . . 2.03 111.71 -177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.9 m170 57.94 35.81 25.65 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.893 -1.129 . . . . 1.42 109.474 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.8 mtp -90.33 163.88 14.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.47 -0.769 . . . . 1.18 109.752 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.6 p -76.06 158.36 31.92 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.29 -0.881 . . . . 0.98 108.648 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.55 -39.97 77.11 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.137 -0.977 . . . . 0.64 110.078 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.84 -39.86 95.66 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.225 -0.922 . . . . 2.07 109.678 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.35 -44.49 19.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.73 109.942 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.37 -49.29 76.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.328 -0.857 . . . . 0.54 110.191 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.21 90.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.127 -0.983 . . . . 0.56 110.025 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -60.05 -40.01 87.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 1.54 109.858 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -61.34 -40.12 93.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.063 -1.023 . . . . 1.33 110.395 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.0 t -62.81 -50.62 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.169 -0.957 . . . . 0.72 110.509 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.9 mm -69.99 -39.99 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.103 -0.998 . . . . 0.85 109.674 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -66.47 -39.21 88.67 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.29 -0.881 . . . . 2.44 108.699 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.27 -49.28 80.27 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.564 -1.014 . . . . 0.98 110.564 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -63.9 -47.51 80.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.938 -1.33 . . . . 1.41 110.135 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.43 -39.35 83.24 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.238 -0.914 . . . . 1.2 109.153 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.2 m -59.9 -40.07 87.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.142 -0.974 . . . . 1.7 108.997 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.94 87.67 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.231 -1.026 . . . . 1.47 108.231 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.3 mt -65.18 -41.74 94.3 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.313 -0.955 . . . . 1.56 108.55 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -57.8 -32.29 67.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.117 -0.989 . . . . 2.2 109.688 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.21 -26.71 61.12 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.084 -1.01 . . . . 2.12 108.466 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 25.3 mt -63.2 144.07 57.24 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.451 -0.944 . . . . 2.0 108.451 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -92.8 13.43 20.33 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.189 -0.944 . . . . 3.23 110.757 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 19.2 t0 -102.67 148.7 25.26 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.053 -1.029 . . . . 2.49 110.085 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 98.0 mt-10 -73.8 -65.05 0.88 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.483 -0.761 . . . . 3.95 109.34 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.483 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 4.1 t80 -39.33 -35.43 0.26 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.893 -0.504 . . . . 2.0 110.616 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 78.6 mt -78.39 -40.04 37.3 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.834 -1.166 . . . . 1.86 109.342 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 121' ' ' GLU . 87.9 tttt -69.93 -42.6 73.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.189 -0.944 . . . . 2.84 110.807 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -63.35 -43.08 98.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.106 -0.997 . . . . 2.73 109.9 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.546 ' CZ ' ' NE2' ' B' ' 351' ' ' GLN . 26.8 ttp180 -59.99 -38.5 82.77 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.212 -0.93 . . . . 2.77 108.984 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.26 -43.64 92.45 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.141 -1.059 . . . . 1.19 108.141 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -44.7 -41.75 7.03 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.948 -0.76 . . . . 1.2 108.948 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.32 -39.93 94.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 1.55 109.708 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.36 -43.17 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.02 -1.05 . . . . 0.8 108.96 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -60.0 -39.92 87.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.109 -0.994 . . . . 3.09 109.372 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -57.17 -37.92 72.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.888 . . . . 1.46 109.742 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.503 HD11 ' CG ' ' A' ' 76' ' ' HIS . 96.9 mt -59.94 -41.66 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.146 -0.971 . . . . 0.71 109.116 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.24 -30.72 58.37 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.769 -1.332 . . . . 0.57 109.769 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -59.98 -47.47 85.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.148 -1.207 . . . . 2.59 109.799 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -68.15 -31.14 70.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.814 -1.179 . . . . 2.83 109.63 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.09 -41.55 92.74 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.167 -0.958 . . . . 1.25 109.364 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.02 -40.05 87.93 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.209 -1.034 . . . . 0.7 108.209 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.404 HH11 ' CD2' ' A' ' 144' ' ' LEU . 62.3 mtt-85 -68.21 -38.04 81.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.662 -0.649 . . . . 2.57 109.305 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -68.6 -34.8 76.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 1.23 111.668 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.9 mt -70.4 -42.51 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.275 -1.516 . . . . 0.81 108.97 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.1 -25.4 63.49 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.636 -0.665 . . . . 1.0 109.591 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.78 36.24 19.79 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.378 -1.889 . . . . 0.89 108.378 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.404 ' CD2' HH11 ' A' ' 139' ' ' ARG . 5.1 tp -73.89 145.46 44.81 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.668 -0.901 . . . . 1.14 109.259 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -68.94 140.09 55.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -0.855 . . . . 4.6 109.924 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.5 mt -106.52 130.05 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-O 121.694 0.759 . . . . 1.24 109.21 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 16.8 mm -56.27 -49.12 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.682 -0.637 . . . . 1.54 110.367 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.6 t0 70.87 95.12 0.07 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.603 -0.686 . . . . 1.5 109.245 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.406 ' O ' ' OD1' ' A' ' 172' ' ' ASN . 33.4 mt -73.02 -4.08 30.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.352 -0.843 . . . . 0.79 110.968 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 81.2 p -82.85 -14.63 53.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.754 -1.216 . . . . 1.4 109.361 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.21 18.19 2.71 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.329 -0.857 . . . . 0.92 112.605 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.3 mp -91.33 115.82 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.121 -1.612 . . . . 0.88 108.02 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -100.17 -8.52 23.52 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.293 -0.88 . . . . 2.45 109.952 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -108.14 144.96 34.83 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.352 -0.843 . . . . 1.52 110.163 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -66.35 130.82 44.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.339 -0.851 . . . . 1.58 109.028 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.7 m -153.11 167.24 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.472 -0.768 . . . . 0.69 109.565 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -93.77 148.24 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 106.318 -1.734 . . . . 0.61 106.318 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 171' ' ' LEU . 47.1 tp -96.89 117.45 31.13 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.872 -1.143 . . . . 0.87 111.066 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 8.5 t -121.41 127.97 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 108.516 -0.92 . . . . 0.71 108.516 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.04 162.06 36.61 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.213 -0.929 . . . . 0.81 108.74 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.475 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.94 -33.73 72.52 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.405 -1.434 . . . . 0.98 107.756 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.5 p-10 -166.8 175.33 7.86 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.318 -0.993 . . . . 2.25 108.318 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 51.6 mt -140.23 125.73 19.05 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.118 -1.067 . . . . 0.78 108.118 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 36.1 p -87.11 146.97 41.54 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.032 -1.043 . . . . 0.98 108.768 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -36.54 -38.13 0.32 Allowed 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.365 2.043 . . . . 0.81 112.295 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.2 m -60.04 -40.03 87.99 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.361 -0.837 . . . . 0.9 109.778 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.01 -44.42 69.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.105 -0.997 . . . . 1.61 110.192 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.8 p -55.53 -20.44 13.1 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.265 -0.897 . . . . 0.61 111.116 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.51 -47.57 12.03 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.868 -1.145 . . . . 0.6 109.871 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -90.24 38.41 0.93 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.221 -1.029 . . . . 1.4 108.221 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.597 HD11 HD22 ' A' ' 158' ' ' LEU . 9.3 tp -100.25 135.96 40.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.7 108.811 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.578 ' O ' HG23 ' A' ' 176' ' ' VAL . 30.7 m120 -86.67 102.12 13.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.194 -0.941 . . . . 2.35 109.307 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 80.9 mt -64.83 -41.67 95.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 1.51 110.799 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -69.12 -28.04 66.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.939 -1.101 . . . . 2.33 111.911 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -92.84 -11.43 33.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.748 -1.22 . . . . 1.92 109.159 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.581 HG11 ' CE1' ' A' ' 179' ' ' PHE . 85.9 t -99.07 108.16 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.611 -1.255 . . . . 0.67 107.611 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.8 4.07 30.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.269 -0.894 . . . . 1.53 110.265 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.08 171.04 38.09 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.679 -1.768 . . . . 0.48 108.679 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.581 ' CE1' HG11 ' A' ' 176' ' ' VAL . 35.0 m-85 -129.49 128.6 43.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.348 -1.089 . . . . 0.55 108.834 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 91.3 mt -131.44 123.2 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.595 -0.891 . . . . 0.65 108.595 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 203' ' ' VAL . 41.0 p -147.1 158.91 44.09 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.008 -1.057 . . . . 0.82 110.252 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 50.1 p30 -108.51 25.2 11.97 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.208 -0.664 . . . . 2.46 109.208 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.77 -162.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.029 -1.044 . . . . 1.28 111.358 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -64.22 -64.74 3.42 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.198 -1.161 . . . . 2.19 110.198 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.79 -131.45 1.66 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.19 -1.481 . . . . 2.13 110.8 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -79.95 -9.78 59.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.62 -0.929 . . . . 5.86 110.563 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 52.2 p -84.7 0.92 48.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.985 -1.072 . . . . 3.72 110.708 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 81.0 p -88.36 144.23 26.52 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.907 -1.121 . . . . 1.74 110.298 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -53.18 -41.06 64.86 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.344 -0.847 . . . . 0.95 108.844 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 190' ' ' THR . 0.7 OUTLIER -53.38 -36.39 61.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.628 -0.67 . . . . 1.55 109.462 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 53.5 m -60.0 -40.02 87.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.194 -0.942 . . . . 1.51 109.981 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.6 mt -60.01 -40.09 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.926 . . . . 1.67 109.597 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 90.5 mtp -57.39 -48.83 78.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.082 -1.012 . . . . 1.02 110.435 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.94 -42.82 94.83 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.727 -1.233 . . . . 0.68 109.768 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -61.98 -59.25 5.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.131 -0.981 . . . . 2.93 110.389 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 61.5 m -67.11 -39.39 86.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.139 -0.975 . . . . 0.86 112.421 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 91.2 mt -70.22 -26.64 63.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.616 -1.303 . . . . 0.67 109.306 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 68.08 45.19 1.34 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.21 0.528 . . . . 1.5 110.535 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 93.6 mt -120.74 149.93 51.56 Favored Pre-proline 0 N--CA 1.503 2.202 0 N-CA-C 107.64 -1.245 . . . . 0.72 107.64 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.11 141.69 94.64 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.927 1.751 . . . . 0.61 111.301 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -171.49 152.41 3.23 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.523 -1.271 . . . . 0.66 111.898 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.6 mt -121.84 146.4 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.695 -1.224 . . . . 0.79 107.695 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 181' ' ' THR . 21.4 m -127.66 -15.43 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 O-C-N 121.149 -0.97 . . . . 0.91 110.694 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.0 27.4 14.56 Favored Glycine 0 N--CA 1.504 3.193 0 O-C-N 121.389 -0.819 . . . . 1.01 111.098 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.0 p -49.14 -33.42 12.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.741 -1.446 . . . . 0.99 110.164 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 84.68 -87.31 1.55 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.708 -1.357 . . . . 1.12 109.708 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 27.5 t -125.31 39.16 4.03 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.558 -0.966 . . . . 1.72 112.571 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.15 -40.62 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.444 -1.41 . . . . 0.89 109.036 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 209' ' ' THR . 1.4 p -56.36 -31.41 63.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.263 -0.898 . . . . 1.03 109.94 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 23.0 t -71.71 -28.96 64.05 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.168 -0.957 . . . . 1.83 109.338 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -94.92 -9.57 33.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.283 -0.885 . . . . 2.27 111.176 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 63.6 t -102.61 137.14 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.95 -1.093 . . . . 0.92 110.632 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -114.11 155.04 26.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.751 -1.203 . . . . 2.2 107.751 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 57.5 t-20 -59.89 139.89 57.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.004 -1.06 . . . . 2.36 109.92 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.0 t0 84.55 6.44 0.57 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.407 0.622 . . . . 2.38 109.434 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 54.8 t0 -76.01 136.81 39.97 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.374 -0.829 . . . . 2.09 108.959 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.508 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 35.5 t80 -89.84 117.47 28.7 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.674 -1.232 . . . . 1.27 107.674 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 86.6 mt -125.97 145.01 50.47 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.287 -0.883 . . . . 0.75 110.808 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.1 mt -115.27 129.95 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.102 -1.073 . . . . 0.63 108.102 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 35.5 tp -103.95 117.66 34.85 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.14 -0.975 . . . . 0.7 109.133 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 223' ' ' VAL . 92.4 m-20 -74.85 -43.48 54.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.069 -1.019 . . . . 2.31 108.962 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.857 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.24 9.84 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.255 -0.646 . . . . 0.78 109.255 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.51 ' H ' ' C ' ' A' ' 221' ' ' ASP . 47.0 t -129.82 -40.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 107.5 -1.296 . . . . 1.04 107.5 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.42 ' HB3' HE21 ' A' ' 226' ' ' GLN . 94.2 m-20 -101.97 1.81 37.12 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.771 -0.825 . . . . 2.44 108.771 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 59.99 41.95 16.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.604 -0.685 . . . . 1.55 109.698 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.42 HE21 ' HB3' ' A' ' 224' ' ' ASN . 40.1 mt-30 -136.6 146.22 45.81 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.316 -0.865 . . . . 1.99 110.079 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.32 130.01 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.266 -1.013 . . . . 0.77 108.266 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -100.68 123.68 45.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.367 -0.833 . . . . 0.98 108.879 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.0 t -99.1 110.84 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.373 -0.829 . . . . 0.85 110.93 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 34.5 t30 49.68 59.93 16.05 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.503 -0.748 . . . . 1.66 111.047 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.67 151.93 19.57 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.694 2.263 . . . . 0.95 111.925 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.444 ' OG1' HG23 ' A' ' 235' ' ' VAL . 41.7 p -68.39 161.27 27.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.117 -0.99 . . . . 1.84 109.761 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.03 -38.28 82.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 2.74 108.972 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -59.87 -40.08 87.47 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.682 -0.859 . . . . 2.89 108.682 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.444 HG23 ' OG1' ' A' ' 232' ' ' THR . 54.5 t -67.33 -39.87 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 1.3 109.36 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 91.6 mt . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.186 -0.946 . . . . 1.09 109.147 179.554 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . 0.418 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 27.5 ttp . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.451 0.643 . . . . 0.0 109.573 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . 0.418 ' N ' ' CG ' ' B' ' 301' ' ' MET . 16.3 t80 -152.7 149.91 28.9 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . 0.408 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 14.6 pt20 -149.34 159.75 44.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.988 -1.07 . . . . 0.0 110.413 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -153.16 149.4 27.99 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -111.47 134.86 52.75 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.075 -1.016 . . . . 0.0 109.94 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.86 121.29 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 122.333 1.063 . . . . 0.0 112.735 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 16.9 m -75.92 105.35 6.91 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.941 0.877 . . . . 0.0 109.538 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.549 HG22 ' H ' ' B' ' 310' ' ' ALA . 96.0 mt -53.13 123.64 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 122.469 1.128 . . . . 0.0 111.104 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 44.4 p -107.48 23.65 14.11 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.079 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.549 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -86.38 114.26 56.66 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.376 -0.828 . . . . 0.0 109.384 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -65.89 -6.9 15.27 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 120.289 1.139 . . . . 0.0 112.17 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -113.31 2.67 15.6 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.28 176.07 18.48 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.483 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -84.18 87.4 7.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.761 -1.435 . . . . 0.0 108.812 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.459 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 3.6 p80 -92.65 -160.26 0.73 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.193 -0.942 . . . . 0.0 109.696 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 5.5 m -57.89 -49.7 75.83 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.912 -1.117 . . . . 0.0 112.168 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.545 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 11.4 tpt180 -52.35 -59.04 9.41 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 120.63 -1.294 . . . . 0.0 112.024 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.459 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 17.8 Cg_endo -63.36 -35.03 64.28 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 CA-C-N 120.613 1.255 . . . . 0.0 111.483 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.35 78.01 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -57.57 -44.86 85.62 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.313 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -69.1 -44.53 72.27 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.626 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -60.01 -50.05 75.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.694 -0.629 . . . . 0.0 111.004 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.52 -29.18 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.529 -1.357 . . . . 0.0 109.206 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -59.93 -46.6 88.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.53 -0.731 . . . . 0.0 109.833 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -69.26 -40.6 77.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 0.0 111.426 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.19 -51.48 69.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.55 -1.344 . . . . 0.0 109.997 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -58.97 -13.33 6.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 109.307 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.6 -30.85 70.67 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -105.54 141.8 36.39 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.54 -0.977 . . . . 0.0 108.534 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 35.2 m -90.2 -11.43 41.04 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.841 -1.162 . . . . 0.0 109.539 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.478 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 93.8 p -57.99 151.2 18.96 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.139 -0.976 . . . . 0.0 108.784 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -68.06 130.48 43.09 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.213 -0.929 . . . . 0.0 108.813 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 80.1 mt -130.65 130.48 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.5 -0.75 . . . . 0.0 109.143 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 45.3 m -127.85 152.13 48.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.478 -0.764 . . . . 0.0 108.996 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 75.5 t -119.12 138.43 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 98.8 m -132.21 129.31 39.55 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.262 -0.899 . . . . 0.0 110.204 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . 0.454 ' C ' ' H ' ' B' ' 339' ' ' GLY . 80.2 p -136.91 126.77 25.72 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.466 -0.771 . . . . 0.0 109.791 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 56.8 t30 57.09 5.58 0.26 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.59 0.71 . . . . 0.0 109.505 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' B' ' 337' ' ' SER . . . 101.91 10.16 40.85 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -100.56 119.27 38.28 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 32.4 m -99.06 149.75 22.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.182 -0.949 . . . . 0.0 111.908 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . 0.492 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -149.69 149.54 30.76 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . 0.434 ' H ' ' HE3' ' B' ' 349' ' ' LYS . 8.8 t -90.55 131.43 36.28 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.119 -0.988 . . . . 0.0 110.297 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -70.06 -16.63 63.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.152 -0.967 . . . . 0.0 110.047 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . 0.48 ' NZ ' ' CB ' ' B' ' 345' ' ' LYS . 0.1 OUTLIER -89.52 19.59 4.46 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 28.4 t -147.99 99.0 3.02 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.057 0.932 . . . . 0.0 111.572 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 1.018 HD23 HD22 ' A' ' 79' ' ' LEU . 58.9 tp -58.98 -36.2 74.48 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.739 ' CE2' HD11 ' A' ' 79' ' ' LEU . 58.2 m-85 -55.17 -53.05 60.94 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.312 -0.868 . . . . 0.0 111.363 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . 0.434 ' HE3' ' H ' ' B' ' 343' ' ' SER . 49.8 mtmt -70.04 -29.75 66.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 0.0 109.74 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' B' ' 347' ' ' LEU . 55.7 mt -59.75 -39.4 84.64 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.414 -0.804 . . . . 0.0 111.196 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.546 ' NE2' ' CZ ' ' A' ' 126' ' ' ARG . 3.0 mm100 -65.78 -14.75 61.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.187 -1.571 . . . . 0.0 111.673 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 40.5 p -77.53 -10.89 59.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.13 -1.607 . . . . 0.0 110.156 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.492 HD11 ' HB3' ' B' ' 342' ' ' ALA . 52.8 mt -93.44 115.08 27.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.113 -0.992 . . . . 0.0 109.043 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -72.24 93.97 0.62 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 107.772 -2.131 . . . . 0.0 107.772 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . 0.45 HD22 HG11 ' B' ' 361' ' ' VAL . 80.6 mt -100.21 88.08 3.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.241 -1.152 . . . . 0.0 110.341 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 44.7 p -92.31 -179.99 5.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.977 -1.077 . . . . 0.0 110.651 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -71.23 114.07 8.92 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.597 -0.689 . . . . 0.0 110.605 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.77 10.65 32.33 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 25.6 m -90.99 108.17 19.68 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.353 -1.086 . . . . 0.0 110.578 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 99.8 t -76.99 118.17 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 122.181 0.991 . . . . 0.0 109.366 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . 0.45 HG11 HD22 ' B' ' 355' ' ' LEU . 14.9 m -111.92 178.19 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 28.2 m -131.74 129.42 40.62 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 78.6 mt -105.33 120.63 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 75.6 p -120.32 132.32 55.25 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.548 -0.72 . . . . 0.0 109.184 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.21 149.56 36.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 109.799 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -147.0 125.84 12.69 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 158.72 -158.9 29.78 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 118.913 -1.613 . . . . 0.0 111.401 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -59.94 -52.53 65.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 122.178 -0.601 . . . . 0.0 111.794 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.478 ' H ' ' HB3' ' B' ' 331' ' ' SER . 70.9 m-20 -107.59 11.75 28.32 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.973 -1.079 . . . . 0.0 111.384 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 369' ' ' ASP . 12.9 pt-20 -37.78 -33.59 0.08 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.402 -0.812 . . . . 0.0 111.578 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -66.7 -51.17 59.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.906 -1.121 . . . . 0.0 110.925 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -64.08 -48.9 74.38 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.908 -1.12 . . . . 0.0 108.915 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.31 -40.75 3.7 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.53 -0.731 . . . . 0.0 111.594 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 94.7 t -76.13 -35.86 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.615 -1.303 . . . . 0.0 109.708 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.7 -59.07 5.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.103 -0.998 . . . . 0.0 111.832 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -70.02 -40.79 74.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.762 -1.211 . . . . 0.0 111.867 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.98 -41.14 91.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.676 -1.265 . . . . 0.0 109.422 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.63 -44.6 99.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.897 -1.127 . . . . 0.0 109.732 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' B' ' 383' ' ' GLU . 57.7 mtpt -68.97 -55.99 9.2 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 53.8 tp -54.49 -37.71 65.59 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.732 -0.605 . . . . 0.0 109.404 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 6.4 tpp -72.79 -40.0 66.26 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.602 -1.311 . . . . 0.0 108.441 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -79.97 -5.27 55.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.545 -0.722 . . . . 0.0 110.19 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' B' ' 379' ' ' LYS . 53.7 mm-40 -110.61 0.97 17.76 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.19 -0.944 . . . . 0.0 111.069 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 17.4 mt -90.8 124.59 35.26 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.518 -1.364 . . . . 0.0 109.107 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . 0.417 ' H ' ' HG2' ' B' ' 385' ' ' GLU . 15.1 pt-20 . . . . . 0 N--CA 1.499 1.986 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.376 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.7 mtm . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.356 -0.609 . . . . 2.91 109.356 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.3 mt -110.36 129.0 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.533 -0.73 . . . . 1.2 109.311 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.7 m -140.79 120.55 13.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.375 -0.828 . . . . 1.4 109.23 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.7 -164.98 39.18 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.743 -1.343 . . . . 1.05 109.743 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 5' ' ' ILE . 88.1 mt -86.44 -1.54 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.172 -1.193 . . . . 1.15 110.583 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.2 tp 52.53 88.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.799 -1.188 . . . . 0.98 109.07 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.74 -38.0 64.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.254 -0.904 . . . . 0.88 109.509 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.0 t -149.71 135.52 10.12 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.375 -0.828 . . . . 1.69 109.427 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -80.43 145.56 16.78 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.23 1.954 . . . . 0.85 113.772 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.689 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.84 -159.37 30.59 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.189 -1.564 . . . . 0.92 109.189 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.2 mt -149.54 150.01 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.047 -1.266 . . . . 0.81 108.955 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.44 150.37 26.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.054 -1.029 . . . . 0.51 110.53 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -130.25 126.22 36.77 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 107.969 -1.123 . . . . 0.62 107.969 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.8 178.04 48.4 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.429 -1.843 . . . . 0.55 111.096 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -80.01 159.61 26.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.89 -0.771 . . . . 2.1 109.679 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -100.38 132.04 45.97 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.376 -0.828 . . . . 0.77 111.582 -178.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.0 tp -105.27 133.42 50.07 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.717 -1.586 . . . . 0.91 106.717 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.8 tp -117.11 123.51 46.96 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.138 -0.976 . . . . 0.93 110.747 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' A' ' 160' ' ' ALA . 48.7 mt -92.43 104.13 16.49 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.755 -0.59 . . . . 0.93 110.473 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.66 137.56 32.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.318 -0.864 . . . . 2.75 109.341 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -131.12 134.14 46.27 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.241 -0.912 . . . . 3.0 109.492 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -88.21 139.96 29.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.116 -0.99 . . . . 2.77 109.074 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -62.31 140.78 58.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.034 -1.041 . . . . 2.94 109.268 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.3 mt -79.18 132.3 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.95 108.766 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.2 t -104.64 126.66 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.426 -0.797 . . . . 1.28 109.897 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -100.27 138.61 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.789 -0.819 . . . . 1.21 108.789 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -90.61 125.65 35.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.997 -1.064 . . . . 1.81 109.204 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -89.94 1.43 56.25 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.692 -0.855 . . . . 2.8 108.692 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.95 139.93 57.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.42 -0.8 . . . . 2.87 109.747 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -88.04 137.92 31.9 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.305 -0.872 . . . . 2.35 109.24 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.8 pt -90.57 159.98 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.994 -1.067 . . . . 0.97 109.442 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.4 p -94.65 171.78 8.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.061 -1.024 . . . . 1.17 108.687 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.58 -46.69 83.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 1.18 108.997 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 25.6 t0 -55.84 -32.7 63.84 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.758 -1.214 . . . . 2.56 109.516 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -81.51 -9.98 59.58 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.12 -0.988 . . . . 1.79 110.425 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 t -64.15 -53.02 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.6 -1.312 . . . . 1.0 108.8 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -61.72 -39.99 93.47 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.439 -0.788 . . . . 1.77 110.027 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.429 HE21 ' NH2' ' A' ' 42' ' ' ARG . 27.2 mm100 -67.96 -41.87 81.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 2.7 110.492 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -65.42 -39.98 92.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.065 -1.022 . . . . 1.51 110.575 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.98 -46.17 94.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.688 -1.258 . . . . 0.93 108.79 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -60.03 -40.01 87.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.846 -1.159 . . . . 1.81 108.94 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.505 HH11 ' HG2' ' A' ' 42' ' ' ARG . 17.9 mtt-85 -60.01 -43.28 95.35 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.973 -1.121 . . . . 2.78 107.973 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 28.6 t80 -60.84 -50.05 74.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.475 -0.766 . . . . 0.78 109.064 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.6 tp -61.87 -44.66 96.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.414 -0.804 . . . . 1.07 109.035 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.6 t -65.47 -43.74 89.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -0.943 . . . . 1.12 109.176 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.98 -45.71 95.43 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.684 -2.166 . . . . 0.84 107.684 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -60.66 -39.28 87.76 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.389 -0.967 . . . . 3.09 108.389 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.26 -40.18 64.42 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.286 -0.635 . . . . 0.88 109.286 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 50' ' ' ALA . 22.3 ttmt -65.81 -73.58 0.13 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.168 -1.419 . . . . 2.59 107.168 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.91 -38.99 0.34 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.35 -0.844 . . . . 0.7 111.222 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 t -51.93 -56.03 16.64 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.603 -1.311 . . . . 1.4 108.816 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.81 -40.72 79.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.86 . . . . 0.67 111.15 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -69.95 -40.05 75.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.748 -1.22 . . . . 1.66 110.008 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.04 -40.05 94.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.996 -1.065 . . . . 1.58 108.964 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -64.26 -33.93 76.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.26 -0.9 . . . . 1.35 109.361 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.5 m -64.87 -42.5 94.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.035 -1.041 . . . . 0.77 109.784 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.595 ' CD1' HH22 ' A' ' 136' ' ' ARG . 97.9 mt -62.27 -40.07 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.63 109.086 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -51.92 -49.99 61.99 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.447 -0.783 . . . . 1.14 109.426 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.6 m -59.44 -40.0 85.36 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.124 -0.985 . . . . 0.79 110.878 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -63.5 -37.88 88.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.745 -1.222 . . . . 1.53 109.835 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.407 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -65.32 -46.59 79.7 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.62 -0.675 . . . . 0.57 110.097 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.98 -49.57 77.08 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.274 -1.13 . . . . 0.75 110.274 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.97 -44.95 71.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.857 -1.378 . . . . 1.59 110.161 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.1 m -69.66 -57.23 5.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.73 111.54 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -97.11 -57.34 2.29 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.026 -1.046 . . . . 0.75 110.948 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.0 -163.75 26.94 Favored Glycine 0 N--CA 1.503 3.133 0 C-N-CA 119.802 -1.19 . . . . 1.22 111.041 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -67.92 -26.2 65.86 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.712 -0.875 . . . . 5.81 110.605 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -60.0 -36.36 77.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 3.37 110.211 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -100.5 -18.71 16.53 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.471 -0.768 . . . . 1.77 110.729 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -70.27 -43.1 71.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.779 -1.201 . . . . 1.65 110.838 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.57 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -66.41 -32.29 73.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.301 -0.874 . . . . 0.77 110.226 -178.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.08 -39.92 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.854 -1.153 . . . . 0.8 109.307 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -64.48 -40.04 94.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.753 -1.217 . . . . 0.88 109.687 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.51 -40.37 91.2 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.105 -0.997 . . . . 1.37 109.614 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.98 -49.2 63.82 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.76 -1.736 . . . . 0.62 108.76 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.2 m170 -59.98 -43.35 95.18 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.374 -1.074 . . . . 1.5 108.687 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.81 -48.98 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.122 -0.986 . . . . 0.63 109.1 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.0 ttp -60.1 -42.7 95.26 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.043 -1.035 . . . . 1.51 109.491 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.852 HD11 ' CE2' ' B' ' 348' ' ' PHE . 46.8 tp -61.96 -39.36 91.88 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.37 -0.831 . . . . 0.77 108.772 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.05 -39.97 87.8 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.501 -0.749 . . . . 0.62 109.328 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -83.73 9.9 10.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.348 -0.845 . . . . 1.47 109.804 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 62.5 t0 -53.37 133.23 40.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.946 . . . . 1.47 109.984 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.469 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 99.2 mt-10 -59.06 -24.04 62.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.684 -0.635 . . . . 1.78 111.496 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -71.09 -34.65 71.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.896 -1.128 . . . . 2.53 109.871 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.9 mt -70.2 -40.02 74.85 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.585 0.707 . . . . 0.8 109.858 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.96 -48.9 79.81 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.364 -0.835 . . . . 1.42 110.31 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -70.13 -42.96 71.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.369 -0.832 . . . . 1.71 111.57 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.01 -40.02 75.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.082 -1.011 . . . . 1.57 112.119 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.75 -47.73 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.852 -1.155 . . . . 0.65 109.842 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.5 mt -66.51 -38.57 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.796 . . . . 0.82 109.904 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.9 88.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.178 -0.951 . . . . 0.79 111.26 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.1 mt -60.0 -46.61 88.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.773 -1.205 . . . . 0.95 109.945 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.1 mt -59.96 -46.14 94.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.751 -1.203 . . . . 0.66 107.751 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -67.99 -40.36 83.1 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.925 -0.71 . . . . 2.2 110.238 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -80.74 -55.9 4.51 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.035 -1.041 . . . . 1.65 112.437 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.01 -3.25 58.09 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.973 -1.08 . . . . 2.03 111.971 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 74.9 m80 57.13 41.12 27.71 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.885 -1.134 . . . . 1.42 109.236 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 68.0 mtp -95.62 169.18 10.21 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.445 0.641 . . . . 1.18 110.103 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 68.2 p -78.58 160.36 27.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.386 -0.821 . . . . 0.98 109.576 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.0 -39.12 87.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.64 110.155 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 18.2 p-10 -70.04 -34.06 72.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.013 -1.054 . . . . 2.07 109.349 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.08 -44.08 22.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.73 109.776 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.04 -43.12 71.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.448 -0.783 . . . . 0.54 110.229 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.93 87.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.99 -1.069 . . . . 0.56 109.72 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.466 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 82.4 t60 -60.05 -40.01 87.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.394 -0.816 . . . . 1.54 110.574 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.32 -41.87 93.54 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.044 -1.035 . . . . 1.33 110.74 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.89 -50.73 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.002 -1.061 . . . . 0.72 110.851 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.8 mm -69.9 -40.08 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.918 -1.114 . . . . 0.85 109.01 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.466 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.0 tt0 -63.82 -37.83 88.83 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.36 -0.978 . . . . 2.44 108.36 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.96 -54.1 40.25 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.598 -1.001 . . . . 0.98 110.598 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -64.77 -49.87 69.05 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.756 -1.438 . . . . 1.41 109.219 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.89 -41.93 88.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 1.2 109.085 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.9 t -58.84 -39.97 82.83 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.349 -0.844 . . . . 1.7 108.95 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.05 96.25 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.354 -0.841 . . . . 1.47 109.366 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.5 mt -63.58 -40.64 97.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.049 -1.032 . . . . 1.56 109.892 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.86 -36.54 77.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.846 -1.159 . . . . 2.2 109.508 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -53.85 -21.93 8.7 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.247 -0.908 . . . . 2.12 108.89 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 123' ' ' LEU . 35.5 mt -62.95 142.6 58.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 2.0 109.349 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -91.11 12.78 18.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.406 -0.809 . . . . 3.23 109.425 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -100.4 126.5 46.79 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.261 -0.899 . . . . 2.49 110.147 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.402 ' O ' ' CD ' ' A' ' 121' ' ' GLU . 5.0 tm-20 -69.92 -29.96 67.26 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.686 0.755 . . . . 3.95 109.014 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.426 ' OH ' ' C ' ' B' ' 314' ' ' LEU . 19.3 t80 -62.83 -42.84 99.9 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 122.007 0.908 . . . . 2.0 110.109 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.912 HD22 ' O ' ' B' ' 351' ' ' GLN . 79.2 mt -76.16 -31.24 58.46 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.771 -0.825 . . . . 1.86 108.771 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -60.07 -40.85 90.94 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.475 -0.765 . . . . 2.84 108.985 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.11 -44.24 95.01 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.574 -0.899 . . . . 2.73 108.574 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.69 HH21 ' NE2' ' B' ' 351' ' ' GLN . 62.5 mtp180 -62.07 -39.67 93.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 2.77 109.138 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.98 -32.57 70.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.448 -0.782 . . . . 1.19 109.449 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.06 94.29 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.656 -0.868 . . . . 1.2 108.656 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -62.61 -40.08 95.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.421 -0.799 . . . . 1.55 110.192 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.06 -43.04 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 0.8 109.924 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -60.01 -40.0 87.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.081 -1.012 . . . . 3.09 109.538 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.03 -38.23 82.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.348 -0.845 . . . . 1.46 109.931 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.97 -43.31 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.122 -0.986 . . . . 0.71 110.358 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.2 -32.62 62.67 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.673 -1.251 . . . . 0.57 110.114 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -59.96 -49.97 75.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.107 -1.231 . . . . 2.59 109.283 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.595 HH22 ' CD1' ' A' ' 57' ' ' ILE . 59.5 mtp180 -65.61 -34.99 79.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 2.83 109.994 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.0 tp -59.96 -43.46 95.05 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.224 -0.922 . . . . 1.25 109.48 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.14 -39.96 94.36 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.087 -1.008 . . . . 0.7 108.815 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.416 HH11 ' HG2' ' A' ' 139' ' ' ARG . 58.6 mtt-85 -70.11 -39.9 75.22 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.461 -0.94 . . . . 2.57 108.461 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -62.04 -37.05 83.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.811 -0.556 . . . . 1.23 111.165 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.06 -43.56 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.698 -1.251 . . . . 0.81 108.221 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.98 -38.03 75.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.695 -0.628 . . . . 1.0 109.579 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.49 45.45 5.24 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.255 -1.938 . . . . 0.89 108.255 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.407 ' CD2' ' NH1' ' A' ' 139' ' ' ARG . 12.0 tp -74.58 150.02 39.88 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.499 -1.001 . . . . 1.14 109.548 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -63.02 142.84 58.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.341 -0.85 . . . . 4.6 110.428 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.2 mt -119.9 126.72 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.565 -0.902 . . . . 1.24 108.565 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.4 mt -59.97 -44.89 95.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.826 -0.546 . . . . 1.54 110.298 -178.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.4 t0 67.72 94.63 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.83 -0.804 . . . . 1.5 108.83 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.553 ' O ' HD12 ' A' ' 152' ' ' ILE . 34.7 mt -67.07 -8.1 27.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.457 -0.777 . . . . 0.79 109.951 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.8 t -79.94 -13.8 59.09 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.993 -1.067 . . . . 1.4 108.286 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.12 24.76 0.76 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.786 -0.571 . . . . 0.92 110.395 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.553 HD12 ' O ' ' A' ' 149' ' ' LEU . 42.6 mt -92.97 118.1 37.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.021 -1.05 . . . . 0.88 108.688 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -104.83 -11.22 16.88 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.222 -0.924 . . . . 2.45 110.391 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -119.71 147.31 44.73 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.615 -0.678 . . . . 1.52 110.12 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -64.11 136.52 57.33 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.408 -0.96 . . . . 1.58 108.408 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.2 m -153.52 168.54 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.233 -0.917 . . . . 0.69 109.99 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 74.0 mt -95.94 144.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 105.883 -1.895 . . . . 0.61 105.883 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 22.1 tp -92.99 115.86 28.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.905 -1.122 . . . . 0.87 110.48 -177.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.544 HG12 HG22 ' A' ' 209' ' ' THR . 45.7 t -123.38 129.94 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 108.76 -0.829 . . . . 0.71 108.76 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.497 ' C ' HG21 ' A' ' 209' ' ' THR . . . -162.16 164.67 27.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.905 . . . . 0.81 108.795 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.44 -35.35 70.89 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.257 -1.527 . . . . 0.98 107.781 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -164.56 173.87 11.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.411 -0.959 . . . . 2.25 108.411 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.4 mt -136.48 143.1 43.64 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.115 -0.991 . . . . 0.78 109.201 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 74.7 p -95.27 141.99 23.99 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.241 -0.912 . . . . 0.98 109.342 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -39.99 -39.88 2.48 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.278 1.985 . . . . 0.81 112.514 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 68.9 m -60.04 -39.97 87.78 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.26 -0.9 . . . . 0.9 109.097 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.5 -43.69 96.47 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.27 -0.894 . . . . 1.61 110.108 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.9 p -53.87 -25.85 21.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.187 -0.946 . . . . 0.61 110.823 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -80.55 -54.76 5.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.82 -1.175 . . . . 0.6 109.817 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -83.76 39.85 0.71 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.698 -0.853 . . . . 1.4 108.698 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.0 tp -105.2 135.66 46.14 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.709 -0.849 . . . . 0.7 108.709 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.43 ' O ' HG23 ' A' ' 176' ' ' VAL . 6.4 m120 -84.96 103.41 13.98 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.194 -0.941 . . . . 2.35 108.93 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 36.3 mt -67.14 -40.53 86.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.511 -0.743 . . . . 1.51 110.881 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -69.97 -24.15 63.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.757 -1.215 . . . . 2.33 111.433 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -92.78 -6.79 48.2 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.802 -1.186 . . . . 1.92 109.853 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 178' ' ' GLY . 84.0 t -106.56 116.67 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.329 -0.857 . . . . 0.67 108.702 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 71.3 mt -89.99 7.24 38.52 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.283 -0.886 . . . . 1.53 110.243 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.512 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 171.89 171.88 37.32 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.176 -1.57 . . . . 0.48 109.176 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.474 ' CE1' HG11 ' A' ' 176' ' ' VAL . 26.8 m-85 -132.37 129.66 39.69 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.321 -1.105 . . . . 0.55 109.207 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 94.7 mt -134.07 127.51 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.525 -0.917 . . . . 0.65 108.525 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.1 p -149.94 162.75 39.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.938 -1.101 . . . . 0.82 110.681 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.481 ' O ' ' O ' ' A' ' 183' ' ' ALA . 0.9 OUTLIER -100.24 20.31 14.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.506 -0.747 . . . . 2.46 109.726 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -46.69 -174.7 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 122.322 1.058 . . . . 1.28 112.823 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.36 -56.69 3.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 111.396 -0.682 . . . . 2.19 111.396 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -167.36 -159.09 12.34 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 118.484 -1.817 . . . . 2.13 111.416 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.425 HH11 ' HG2' ' A' ' 186' ' ' ARG . 17.8 ptt-85 -72.29 -15.93 61.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.749 -0.854 . . . . 5.86 110.849 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 71.5 p -71.23 3.42 3.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.831 -1.168 . . . . 3.72 109.271 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 40.7 t -83.4 134.29 34.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 1.74 110.275 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -49.88 -38.96 37.91 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.169 -1.049 . . . . 0.95 108.169 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.6 p -59.94 -41.49 91.93 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.928 -0.578 . . . . 1.55 110.493 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 41.2 t -62.06 -38.61 89.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.113 -0.992 . . . . 1.51 110.669 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.3 mm -60.0 -39.35 80.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.236 -0.915 . . . . 1.67 109.19 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.1 mtp -59.5 -44.43 93.11 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.245 -0.909 . . . . 1.02 110.102 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.36 -44.48 80.15 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.647 -1.283 . . . . 0.68 109.712 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.409 HH22 ' HD2' ' A' ' 186' ' ' ARG . 98.9 mtt180 -62.96 -57.81 9.49 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.142 -1.023 . . . . 2.93 110.778 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.1 m -62.7 -39.97 95.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.997 -1.064 . . . . 0.86 112.111 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.9 mt -69.95 -15.7 63.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.864 -1.147 . . . . 0.67 110.25 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 62.13 49.67 4.35 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.626 -0.671 . . . . 1.5 110.175 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 78.5 mt -130.39 149.91 74.73 Favored Pre-proline 0 N--CA 1.499 1.999 0 N-CA-C 107.682 -1.229 . . . . 0.72 107.682 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.79 147.5 62.82 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.316 2.01 . . . . 0.61 111.846 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -173.88 158.76 3.27 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.922 -1.111 . . . . 0.66 112.035 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.8 mt -130.96 144.75 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.281 -1.007 . . . . 0.79 108.281 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 28.0 m -128.98 -7.53 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.99 -1.069 . . . . 0.91 111.064 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.75 24.48 13.17 Favored Glycine 0 N--CA 1.501 3.032 0 N-CA-C 110.799 -0.92 . . . . 1.01 110.799 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.429 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.1 p -46.77 -44.14 18.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.876 -1.367 . . . . 0.99 109.748 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.57 -55.5 2.71 Favored Glycine 0 N--CA 1.498 2.803 0 C-N-CA 120.166 -1.016 . . . . 1.12 111.825 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 34.3 p -149.82 25.92 0.83 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.6 -1.53 . . . . 1.72 111.646 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.97 -39.62 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.773 -1.205 . . . . 0.89 108.964 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.544 HG22 HG12 ' A' ' 159' ' ' VAL . 50.4 p -58.0 -36.65 72.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.498 -0.751 . . . . 1.03 110.173 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 80.9 p -84.99 -11.74 54.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.013 -1.054 . . . . 1.83 110.25 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -95.87 -14.93 22.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.054 -1.029 . . . . 2.27 110.305 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 213' ' ' LYS . 21.7 t -114.79 154.37 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.275 -0.891 . . . . 0.92 110.469 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.44 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 11.1 mptt -117.2 156.45 27.67 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.701 -1.222 . . . . 2.2 107.701 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 27.5 p30 -60.02 142.68 53.53 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.053 -1.029 . . . . 2.36 110.431 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 11.0 t0 86.62 0.83 0.56 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 120.919 0.39 . . . . 2.38 110.359 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 91.8 m-20 -75.05 153.78 38.25 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.938 -1.101 . . . . 2.09 108.814 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -96.44 131.27 43.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.226 -1.027 . . . . 1.27 108.226 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 82.6 mt -129.52 149.65 51.2 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.192 -0.943 . . . . 0.75 110.994 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 85.5 mt -120.59 122.64 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.816 -1.549 . . . . 0.63 106.816 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 57.2 tp -98.73 115.51 28.89 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.733 -1.23 . . . . 0.7 109.223 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 223' ' ' VAL . 96.0 m-20 -75.57 -44.61 42.36 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.031 -1.043 . . . . 2.31 108.29 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.95 17.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.978 0.894 . . . . 0.78 108.62 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.1 t -132.08 -45.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 106.654 -1.609 . . . . 1.04 106.654 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -100.33 1.93 42.04 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.685 -1.228 . . . . 2.44 107.685 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 60.53 44.15 12.1 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.79 -0.569 . . . . 1.55 109.824 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -139.65 141.84 37.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.323 -0.86 . . . . 1.99 109.525 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 97.2 t -119.98 120.85 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 109.112 -0.699 . . . . 0.77 109.112 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -89.04 131.67 35.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.981 -1.074 . . . . 0.98 108.715 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 64.2 t -109.33 122.92 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.709 -0.619 . . . . 0.85 109.64 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 62.49 69.15 0.94 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.524 -0.735 . . . . 1.66 109.745 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -90.18 127.85 1.48 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 123.417 2.744 . . . . 0.95 112.276 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.0 167.18 12.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.095 -1.003 . . . . 1.84 109.341 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -59.94 -40.0 87.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 2.74 110.07 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.453 ' H ' ' CD ' ' A' ' 234' ' ' GLU . 58.3 mp0 -60.0 -39.98 87.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -0.945 . . . . 2.89 110.085 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.32 -39.4 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 1.3 110.049 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.9 mt . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 1.09 110.903 -179.234 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . 0.485 ' N ' ' OE1' ' B' ' 366' ' ' GLU . 21.6 ttt . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 22.3 t80 -156.08 154.55 31.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 109.48 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . 0.506 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 20.6 pt20 -148.5 160.03 43.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.288 -0.883 . . . . 0.0 109.674 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -151.81 149.97 29.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.309 -0.869 . . . . 0.0 109.596 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 56.5 mp0 -105.94 130.63 53.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.382 -0.824 . . . . 0.0 109.742 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.491 ' O ' HG13 ' B' ' 306' ' ' VAL . 10.2 p -130.58 117.73 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-O 122.25 1.024 . . . . 0.0 113.071 -177.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 86.7 m -78.24 105.21 9.32 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.057 0.932 . . . . 0.0 110.53 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.7 mt -53.13 125.96 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 122.429 1.109 . . . . 0.0 111.264 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 22.6 p -112.04 19.94 17.37 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.557 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.71 120.65 82.31 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.746 -1.221 . . . . 0.0 109.402 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -50.96 -18.9 4.86 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 CA-C-N 120.205 1.109 . . . . 0.0 113.463 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -119.43 14.29 12.81 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.233 -0.917 . . . . 0.0 109.603 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.61 179.45 35.25 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.426 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 3.9 tp -85.38 95.41 9.23 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.05 -1.265 . . . . 0.0 109.477 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.401 ' CA ' ' OH ' ' A' ' 122' ' ' TYR . 3.7 p80 -97.96 -160.72 0.82 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.934 -1.104 . . . . 0.0 110.108 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 7.9 m -59.92 -41.94 92.83 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.095 -1.003 . . . . 0.0 112.295 -176.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.654 HH21 ' NE2' ' B' ' 321' ' ' GLN . 1.0 OUTLIER -55.33 -62.13 4.89 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.538 -1.351 . . . . 0.0 111.224 -178.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.05 -33.23 97.05 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 120.242 1.122 . . . . 0.0 111.765 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.95 -50.79 72.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.254 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.46 -43.12 75.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.464 -0.772 . . . . 0.0 110.736 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . 0.654 ' NE2' HH21 ' B' ' 317' ' ' ARG . 27.7 mt-30 -73.49 -40.08 64.36 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.037 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -60.09 -50.26 74.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 0.0 110.431 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . 0.462 HG13 ' O ' ' B' ' 344' ' ' ALA . 54.6 t -66.45 -40.02 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.566 -1.334 . . . . 0.0 108.981 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -59.9 -45.77 91.48 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -62.49 -45.88 91.0 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.103 -0.998 . . . . 0.0 108.437 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.09 -51.21 70.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.617 -0.677 . . . . 0.0 110.308 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -57.72 -10.46 1.63 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.913 -1.117 . . . . 0.0 109.082 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.91 -29.89 70.57 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -103.36 144.89 30.78 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.561 -0.964 . . . . 0.0 108.915 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 16.6 p -91.39 -13.19 32.85 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.789 -1.195 . . . . 0.0 109.916 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 83.9 p -58.97 151.34 22.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.983 -1.073 . . . . 0.0 108.905 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.1 133.36 47.96 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.006 -1.059 . . . . 0.0 108.579 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.1 mt -131.88 131.05 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.753 -0.592 . . . . 0.0 109.802 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . 0.405 HG22 ' N ' ' B' ' 335' ' ' VAL . 89.2 m -129.82 153.51 48.19 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . 0.405 ' N ' HG22 ' B' ' 334' ' ' THR . 84.9 t -116.11 138.27 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 77.6 m -130.03 125.4 35.2 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.119 -0.988 . . . . 0.0 109.133 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 51.6 p -139.58 117.0 11.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.197 -0.939 . . . . 0.0 110.906 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 34.4 m120 42.75 57.75 3.43 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 83.98 -14.26 44.53 Favored Glycine 0 N--CA 1.499 2.858 0 O-C-N 120.303 -1.498 . . . . 0.0 112.806 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -115.58 126.88 54.78 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-N 119.108 1.454 . . . . 0.0 109.974 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 80.0 p -127.27 148.92 50.22 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.929 0.871 . . . . 0.0 110.28 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -140.97 164.28 30.69 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.508 0.67 . . . . 0.0 109.903 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 23.2 t -87.35 137.23 32.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.493 -0.754 . . . . 0.0 109.202 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.462 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -76.73 -13.39 60.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.979 -1.076 . . . . 0.0 109.858 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.07 20.67 4.13 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 67.4 m -146.25 94.25 2.43 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.714 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.815 HD23 HD22 ' A' ' 79' ' ' LEU . 56.9 tp -59.92 -33.34 71.74 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.852 ' CE2' HD11 ' A' ' 79' ' ' LEU . 54.9 m-85 -56.75 -52.79 63.65 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.396 -0.815 . . . . 0.0 110.616 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -69.33 -39.79 77.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.632 -1.292 . . . . 0.0 110.089 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' B' ' 352' ' ' THR . 20.9 mt -48.59 -58.49 4.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.062 -1.024 . . . . 0.0 109.07 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.912 ' O ' HD22 ' A' ' 123' ' ' LEU . 1.3 mp0 -41.6 -14.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.555 -0.716 . . . . 0.0 111.19 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.574 ' N ' ' O ' ' B' ' 350' ' ' LEU . 50.2 p -87.65 -7.62 57.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.039 -1.663 . . . . 0.0 109.966 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 66.5 mt -97.42 116.14 29.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.129 -0.982 . . . . 0.0 109.493 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.67 93.06 1.02 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 21.8 mt -103.31 96.27 6.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.35 -1.088 . . . . 0.0 108.9 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 19.2 p -94.67 170.55 9.38 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.147 -0.971 . . . . 0.0 110.774 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.44 115.83 3.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.831 -0.543 . . . . 0.0 111.035 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 100.62 7.36 51.31 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 53.4 m -85.03 111.5 19.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.205 -1.173 . . . . 0.0 110.827 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 7.6 t -78.03 116.25 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 122.222 1.01 . . . . 0.0 109.503 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.1 m -113.64 178.62 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 86.6 m -130.45 130.86 44.79 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.4 mt -106.86 126.26 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 71.1 m -129.96 137.17 50.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.554 -0.716 . . . . 0.0 109.48 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.32 156.54 43.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.337 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . 0.485 ' OE1' ' N ' ' B' ' 301' ' ' MET . 8.8 tp10 -145.96 122.84 11.31 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 157.42 -152.88 24.16 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 118.853 -1.641 . . . . 0.0 111.715 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -60.0 -52.96 63.15 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 122.268 -0.548 . . . . 0.0 112.357 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -110.2 11.26 23.66 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.838 -1.164 . . . . 0.0 111.224 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -42.58 -38.0 1.85 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.073 -1.017 . . . . 0.0 111.817 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -69.32 -44.17 72.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.531 -1.356 . . . . 0.0 110.158 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -70.83 -54.28 12.17 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.016 -1.053 . . . . 0.0 109.242 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.62 -35.95 1.95 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.627 -0.671 . . . . 0.0 110.771 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.562 ' O ' HG23 ' B' ' 378' ' ' VAL . 53.2 t -70.04 -40.02 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.799 -1.188 . . . . 0.0 109.283 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.39 -65.38 0.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.985 -1.072 . . . . 0.0 111.668 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -59.96 -42.05 93.24 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.626 -1.296 . . . . 0.0 111.57 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 93.3 mt -59.92 -42.04 93.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.652 -1.28 . . . . 0.0 108.311 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.562 HG23 ' O ' ' B' ' 374' ' ' VAL . 53.8 t -63.03 -42.36 96.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.297 -0.877 . . . . 0.0 109.684 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.4 mttt -69.99 -56.17 7.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.708 -1.245 . . . . 0.0 107.915 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 54.3 tp -54.51 -36.09 63.85 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . 0.433 ' SD ' HG11 ' B' ' 306' ' ' VAL . 28.2 ttm -70.52 -40.25 73.58 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.391 -1.324 . . . . 0.0 108.413 177.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.46 -5.56 58.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.654 -0.654 . . . . 0.0 110.682 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' B' ' 379' ' ' LYS . 67.9 mt-10 -112.24 -1.96 15.03 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.052 -1.03 . . . . 0.0 110.708 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . 0.614 HD21 ' NE2' ' B' ' 321' ' ' GLN . 15.3 mt -83.68 136.94 34.01 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.427 -1.42 . . . . 0.0 109.066 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.405 -179.639 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.7 mmm . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.448 -0.575 . . . . 2.91 109.448 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.4 mt -110.06 129.95 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.54 -0.911 . . . . 1.2 108.54 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.6 m -135.85 150.1 49.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.39 -0.819 . . . . 1.4 110.405 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.614 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -132.93 -164.62 10.94 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 108.081 -2.008 . . . . 1.05 108.081 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.6 mt -89.2 -14.46 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.632 -1.511 . . . . 1.15 110.353 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.0 tp 55.27 102.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.148 -0.97 . . . . 0.98 108.53 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.04 -22.86 19.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.994 -1.066 . . . . 0.88 109.633 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.5 m -149.99 133.4 8.62 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.097 -1.002 . . . . 1.69 109.677 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -80.37 141.01 13.98 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.4 2.067 . . . . 0.85 112.15 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.712 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 166.0 -165.58 38.19 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.712 -1.355 . . . . 0.92 109.712 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -147.54 148.01 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.22 -1.164 . . . . 0.81 108.52 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.17 156.55 34.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.939 -1.101 . . . . 0.51 110.487 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -137.01 129.64 30.26 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.315 -1.365 . . . . 0.62 107.315 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.38 -174.81 47.23 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 118.37 -1.871 . . . . 0.55 110.986 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -80.04 156.7 27.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.942 -0.74 . . . . 2.1 109.95 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.564 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.5 117.73 34.86 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.436 -0.79 . . . . 0.77 110.118 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.4 tp -89.99 131.55 35.82 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.507 -1.294 . . . . 0.91 107.507 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.5 tp -113.55 120.0 39.46 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.329 -0.857 . . . . 0.93 109.243 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 160' ' ' ALA . 40.2 mt -82.74 102.76 11.75 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.515 0.674 . . . . 0.93 109.656 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -103.0 129.39 49.74 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.751 -0.833 . . . . 2.75 108.751 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.456 ' OE2' ' NZ ' ' A' ' 135' ' ' LYS . 87.0 tt0 -130.36 140.76 50.6 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.223 -0.923 . . . . 3.0 109.372 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -80.16 142.99 34.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.351 -0.843 . . . . 2.77 109.501 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -61.7 143.53 56.03 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.129 -0.982 . . . . 2.94 108.801 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.6 mt -78.16 129.16 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.084 -1.01 . . . . 0.95 109.119 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.7 t -94.14 127.59 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.223 -0.923 . . . . 1.28 109.998 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.6 mt -110.02 134.33 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.637 -0.664 . . . . 1.21 109.229 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -93.84 123.08 36.95 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.169 -0.957 . . . . 1.81 110.249 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.417 HH11 ' HG3' ' A' ' 28' ' ' ARG . 24.7 mmm-85 -90.0 -0.2 57.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.446 -0.784 . . . . 2.8 109.182 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -67.32 145.37 55.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.264 -0.897 . . . . 2.87 109.92 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -92.01 149.28 21.62 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.239 -0.913 . . . . 2.35 109.253 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.559 HD13 ' HG3' ' A' ' 39' ' ' GLU . 3.0 pt -95.7 165.81 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.998 -1.064 . . . . 0.97 109.046 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.2 p -93.11 173.93 7.48 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.419 -0.956 . . . . 1.17 108.419 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.26 78.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.898 -1.126 . . . . 1.18 109.669 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 51.8 t0 -54.93 -30.68 59.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.93 -1.106 . . . . 2.56 110.162 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -82.17 -8.67 59.66 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.177 -0.952 . . . . 1.79 110.249 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.98 -50.31 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.763 -1.21 . . . . 1.0 108.578 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -60.41 -39.96 89.26 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.359 -0.838 . . . . 1.77 108.926 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -62.25 -40.99 98.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.494 -0.753 . . . . 2.7 110.598 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.559 ' HG3' HD13 ' A' ' 31' ' ' ILE . 71.3 mm-40 -64.36 -41.63 96.62 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.813 -1.179 . . . . 1.51 110.166 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.07 -46.7 93.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.909 -1.119 . . . . 0.93 109.069 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -60.05 -40.79 90.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.055 -1.028 . . . . 1.81 109.551 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -60.06 -44.56 94.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.9 -1.125 . . . . 2.78 108.458 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -60.09 -49.16 78.76 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.313 -0.995 . . . . 0.78 108.313 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.1 -46.63 88.96 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.402 -0.962 . . . . 1.07 108.402 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 23.2 t -60.56 -44.47 96.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 1.12 108.875 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.02 -40.01 96.44 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.247 -1.941 . . . . 0.84 108.247 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.523 HH11 ' HG2' ' A' ' 47' ' ' ARG . 1.4 ttt-85 -69.11 -22.61 63.96 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.562 -0.964 . . . . 3.09 108.64 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.07 -46.37 88.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.259 -0.901 . . . . 0.88 109.155 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.555 ' CG ' ' H ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -78.15 -68.96 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.554 -1.258 . . . . 2.59 108.585 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.555 ' H ' ' CG ' ' A' ' 49' ' ' LYS . . . -37.84 -35.79 0.16 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 120.058 1.299 . . . . 0.7 110.462 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.3 t -57.97 -64.43 0.91 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.907 -1.121 . . . . 1.4 108.666 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.97 -40.07 79.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.475 -0.765 . . . . 0.67 110.832 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -63.11 -40.96 99.16 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.812 -1.18 . . . . 1.66 110.361 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 57.5 mt -62.94 -39.86 95.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.881 -1.137 . . . . 1.58 109.216 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -60.11 -38.95 84.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 1.35 110.014 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.6 m -61.24 -41.96 97.78 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.075 -1.015 . . . . 0.77 109.9 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.678 ' CD1' HH22 ' A' ' 136' ' ' ARG . 82.2 mt -61.2 -39.91 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -0.837 . . . . 0.63 109.522 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -59.97 -50.43 73.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.083 -1.011 . . . . 1.14 109.659 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -59.96 -39.14 84.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.281 -0.887 . . . . 0.79 110.125 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -66.03 -37.75 86.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.989 -1.07 . . . . 1.53 109.14 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.79 -45.53 85.91 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.599 -0.688 . . . . 0.57 109.89 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.41 -50.03 71.06 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.626 -1.39 . . . . 0.75 109.626 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -67.3 -45.87 75.24 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.294 -1.121 . . . . 1.59 109.871 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.9 m -65.23 -64.16 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.363 -0.836 . . . . 0.73 112.347 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.42 -47.91 6.65 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.723 -1.236 . . . . 0.75 111.188 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.35 -169.83 24.92 Favored Glycine 0 N--CA 1.501 3.016 0 C-N-CA 119.824 -1.179 . . . . 1.22 111.467 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.65 -27.3 64.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 122.01 -0.7 . . . . 5.81 110.41 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.514 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.3 tp10 -59.95 -32.92 71.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.275 -0.89 . . . . 3.37 110.258 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.5 ' NZ ' ' NE2' ' A' ' 189' ' ' HIS . 14.5 mmmt -98.99 -22.46 15.73 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.226 -0.921 . . . . 1.77 110.259 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.94 -40.07 94.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.954 -1.091 . . . . 1.65 109.893 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.505 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -59.82 -37.57 79.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.87 . . . . 0.77 110.309 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.01 -40.6 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.782 -1.199 . . . . 0.8 109.87 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -70.02 -34.11 72.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.858 -1.151 . . . . 0.88 109.609 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -61.18 -39.98 92.21 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.875 -1.141 . . . . 1.37 109.221 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.91 -41.84 95.2 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.547 -1.421 . . . . 0.62 109.547 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 60.9 m170 -60.16 -43.42 95.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -1.122 . . . . 1.5 109.582 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.3 mt -69.91 -43.55 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.116 -0.99 . . . . 0.63 109.491 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.2 ttp -59.96 -44.92 94.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.845 -1.159 . . . . 1.51 110.309 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.875 HD11 ' CE2' ' B' ' 348' ' ' PHE . 53.9 tp -62.02 -39.82 93.59 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.358 -0.839 . . . . 0.77 109.987 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.5 tp -62.16 -39.57 93.09 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.44 -0.788 . . . . 0.62 110.157 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -82.02 8.66 10.08 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.996 -1.065 . . . . 1.47 110.204 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 59.7 t0 -56.71 130.51 45.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.976 -1.077 . . . . 1.47 109.977 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.407 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.8 mt-10 -59.69 -18.43 42.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.482 -0.761 . . . . 1.78 111.019 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.89 -36.92 72.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.723 -1.235 . . . . 2.53 108.592 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.6 mt -69.99 -40.05 75.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.594 -0.691 . . . . 0.8 110.177 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.02 -49.99 75.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 1.42 110.483 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.13 -39.94 75.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.174 -0.954 . . . . 1.71 111.269 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.97 -40.18 75.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.835 -1.166 . . . . 1.57 111.66 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.2 mt -69.99 -44.15 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.739 -1.225 . . . . 0.65 109.917 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.9 mt -70.02 -37.83 73.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.616 -0.678 . . . . 0.82 110.374 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.68 84.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.988 . . . . 0.79 110.796 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.22 -47.06 87.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.082 -1.012 . . . . 0.95 109.986 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.2 mt -60.66 -50.04 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.309 -0.869 . . . . 0.66 109.447 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -70.08 -42.32 72.94 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.727 -0.789 . . . . 2.2 110.576 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -80.09 -52.79 7.36 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.188 -0.945 . . . . 1.65 112.417 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -90.12 -3.05 58.14 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.973 -1.08 . . . . 2.03 111.675 -177.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.1 m80 59.69 37.5 22.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.959 -1.088 . . . . 1.42 109.467 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 53.2 mtt -93.87 166.24 12.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.443 -0.786 . . . . 1.18 109.782 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.7 p -80.55 162.32 24.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.381 -0.824 . . . . 0.98 109.28 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.51 -37.61 85.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.64 110.102 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 27.4 p-10 -69.87 -35.71 74.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 2.07 109.458 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.85 -41.05 27.09 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.296 -0.878 . . . . 0.73 109.56 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.2 -48.17 53.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.345 -0.847 . . . . 0.54 110.339 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.6 91.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 0.56 109.612 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.53 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 78.5 t60 -60.12 -40.0 88.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 1.54 109.617 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.54 -41.3 98.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.893 . . . . 1.33 110.81 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.28 -53.18 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.012 -1.055 . . . . 0.72 111.313 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.6 mm -70.0 -39.93 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.817 -1.177 . . . . 0.85 109.36 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.53 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 88.4 tt0 -64.65 -38.62 91.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.118 -0.989 . . . . 2.44 108.877 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.95 -43.7 97.86 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.479 -1.049 . . . . 0.98 110.479 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -69.94 -55.26 10.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.922 -1.34 . . . . 1.41 109.531 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.73 -40.31 69.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.183 -0.948 . . . . 1.2 109.343 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 33.8 t -57.77 -40.06 78.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.063 -1.023 . . . . 1.7 108.29 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.81 -39.56 87.77 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.743 -0.836 . . . . 1.47 108.743 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.9 mt -61.78 -42.48 99.04 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.119 -0.988 . . . . 1.56 109.673 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.43 -33.37 72.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.665 -1.272 . . . . 2.2 109.684 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.37 -23.17 35.98 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.984 -1.072 . . . . 2.12 108.506 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.535 HD13 HD13 ' A' ' 123' ' ' LEU . 21.9 mt -61.83 139.49 58.35 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.226 -1.027 . . . . 2.0 108.226 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -92.65 46.25 1.23 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.056 -1.027 . . . . 3.23 108.983 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -132.11 129.61 40.12 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.688 0.756 . . . . 2.49 109.664 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -70.05 -29.98 67.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.735 -0.603 . . . . 3.95 109.946 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.448 ' OH ' ' CA ' ' B' ' 315' ' ' HIS . 17.1 t80 -66.97 -42.97 84.24 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.958 0.885 . . . . 2.0 110.802 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.826 HD22 ' O ' ' B' ' 351' ' ' GLN . 91.4 mt -70.67 -32.79 70.19 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.569 -0.707 . . . . 1.86 109.774 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -60.07 -39.98 87.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.312 -0.868 . . . . 2.84 108.86 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 125' ' ' GLU . 0.4 OUTLIER -59.51 -49.1 79.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.191 -0.943 . . . . 2.73 109.493 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.623 HH21 ' CD2' ' A' ' 123' ' ' LEU . 59.4 mtm180 -60.21 -39.6 87.18 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.569 -1.252 . . . . 2.77 108.418 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.44 -28.32 66.85 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.472 -0.936 . . . . 1.19 108.472 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -60.05 -46.75 88.52 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.407 -0.808 . . . . 1.2 108.978 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -61.29 -41.3 96.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 1.55 109.703 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.72 -44.39 98.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.299 -0.875 . . . . 0.8 109.445 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -63.6 -40.04 95.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.127 -0.983 . . . . 3.09 109.914 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -60.01 -41.09 91.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 1.46 110.341 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.96 -46.8 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.916 -1.115 . . . . 0.71 109.85 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.3 -40.34 98.89 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.756 -1.338 . . . . 0.57 109.756 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.456 ' NZ ' ' OE2' ' A' ' 21' ' ' GLU . 57.6 tttm -59.97 -49.78 76.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -1.081 . . . . 2.59 110.472 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.678 HH22 ' CD1' ' A' ' 57' ' ' ILE . 63.1 mtp180 -63.12 -39.37 94.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.123 -0.985 . . . . 2.83 110.952 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.81 -40.11 87.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 1.25 110.111 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' A' ' 105' ' ' HIS . 23.9 mt -62.35 -40.0 94.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.776 -1.203 . . . . 0.7 109.109 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -68.97 -38.74 79.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -0.846 . . . . 2.57 109.782 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -69.99 -31.22 68.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.45 -0.781 . . . . 1.23 111.887 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.56 -46.07 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.136 -1.603 . . . . 0.81 108.484 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.1 -31.23 68.7 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.634 -0.666 . . . . 1.0 109.561 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.61 45.93 4.46 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.507 -1.437 . . . . 0.89 109.507 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 tp -74.32 145.63 43.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.39 -1.065 . . . . 1.14 108.939 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -69.89 139.1 52.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.012 -1.055 . . . . 4.6 109.245 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.4 mt -111.75 129.96 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.936 0.874 . . . . 1.24 109.26 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.6 mt -59.89 -44.17 93.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.873 -0.517 . . . . 1.54 109.955 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.2 t0 66.37 99.03 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.516 0.674 . . . . 1.5 109.23 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.5 mt -66.46 -7.28 18.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.518 -0.739 . . . . 0.79 109.208 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -84.78 -16.82 40.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.463 -0.773 . . . . 1.4 109.208 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.31 13.08 3.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.436 -0.79 . . . . 0.92 111.162 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.593 HD12 ' N ' ' A' ' 152' ' ' ILE . 1.4 mp -90.28 126.21 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.58 -1.325 . . . . 0.88 108.804 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -104.09 -7.47 20.21 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.547 -0.721 . . . . 2.45 110.213 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -119.94 147.8 44.3 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.444 -0.785 . . . . 1.52 110.481 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.67 136.9 57.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.438 -0.789 . . . . 1.58 109.442 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.8 m -152.11 163.22 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -0.781 . . . . 0.69 109.334 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 79.5 mt -91.15 148.96 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 106.008 -1.849 . . . . 0.61 106.008 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 35.3 tp -96.38 113.98 25.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.869 -1.145 . . . . 0.87 110.39 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.581 HG12 HG22 ' A' ' 209' ' ' THR . 50.4 t -121.76 129.92 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.83 -0.804 . . . . 0.71 108.83 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.445 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -159.96 162.26 34.35 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.243 -1.021 . . . . 0.81 108.243 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.9 -34.78 71.9 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.26 -1.525 . . . . 0.98 108.03 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -159.93 171.38 19.5 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.442 -0.947 . . . . 2.25 108.442 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.7 mt -139.76 140.04 36.62 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.063 -1.023 . . . . 0.78 109.592 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.3 p -100.19 135.43 20.33 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.415 -0.803 . . . . 0.98 109.501 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -38.61 -35.61 0.51 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.358 2.039 . . . . 0.81 113.437 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.5 m -59.9 -40.01 87.35 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.921 -1.112 . . . . 0.9 109.205 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.23 -40.98 90.63 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.308 -0.87 . . . . 1.61 109.948 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 67.3 p -57.21 -29.8 64.03 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.204 -0.935 . . . . 0.61 111.271 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.82 -53.91 13.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.682 -1.261 . . . . 0.6 109.768 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -86.98 36.36 0.72 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.022 -0.733 . . . . 1.4 109.022 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.4 tp -101.19 139.42 36.9 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.866 -0.79 . . . . 0.7 108.866 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -85.83 101.96 13.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.984 . . . . 2.35 108.954 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.09 -40.04 94.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.33 -0.856 . . . . 1.51 110.821 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -69.56 -25.46 64.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.966 -1.084 . . . . 2.33 111.458 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -93.15 -9.37 39.64 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.848 -1.157 . . . . 1.92 110.548 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.578 HG11 ' CE1' ' A' ' 179' ' ' PHE . 70.8 t -101.44 111.19 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.185 -1.043 . . . . 0.67 108.185 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.2 mt -83.52 3.27 33.03 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.228 -0.92 . . . . 1.53 110.577 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.29 170.49 37.62 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.147 -1.581 . . . . 0.48 109.147 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.578 ' CE1' HG11 ' A' ' 176' ' ' VAL . 27.7 m-85 -131.31 128.62 40.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.454 -1.027 . . . . 0.55 109.374 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 84.9 mt -132.4 126.25 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.485 -0.931 . . . . 0.65 108.485 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 23.6 p -148.67 161.5 41.61 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.024 -1.048 . . . . 0.82 110.876 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.476 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 55.8 t0 -105.78 24.54 12.13 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.426 -0.583 . . . . 2.46 109.426 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.93 -161.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.241 -1.537 . . . . 1.28 111.195 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.02 -50.61 7.57 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.097 -1.201 . . . . 2.19 110.097 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 161.79 -133.68 3.23 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.27 -1.443 . . . . 2.13 110.909 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.494 ' C ' ' H ' ' A' ' 188' ' ' SER . 41.5 ttt-85 -60.02 -39.98 87.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.563 -0.963 . . . . 5.86 111.415 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 67.2 p -59.7 2.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.616 -1.302 . . . . 3.72 110.385 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 186' ' ' ARG . 24.8 t -92.0 127.96 37.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.969 -1.082 . . . . 1.74 109.898 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.5 ' NE2' ' NZ ' ' A' ' 69' ' ' LYS . 56.9 t60 -43.9 -48.52 8.47 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.356 -0.84 . . . . 0.95 109.458 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 61.6 m -55.04 -36.83 65.95 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.763 -0.585 . . . . 1.55 110.949 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.3 m -59.96 -39.99 87.53 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.679 -1.263 . . . . 1.51 110.441 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.8 mm -64.52 -39.91 87.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.134 -0.979 . . . . 1.67 109.122 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.0 mtp -59.94 -45.0 94.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.275 -0.891 . . . . 1.02 110.532 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.45 -45.52 84.65 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.381 -1.449 . . . . 0.68 109.956 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -62.4 -57.21 12.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.975 -1.078 . . . . 2.93 110.737 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.3 m -63.36 -40.02 96.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.002 -1.061 . . . . 0.86 111.997 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.34 -25.36 61.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.821 -1.175 . . . . 0.67 109.744 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 70.2 47.33 0.56 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.3 0.571 . . . . 1.5 110.218 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 62.7 mt -124.21 149.78 61.72 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 107.8 -1.185 . . . . 0.72 107.8 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.67 138.62 59.68 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 122.268 1.979 . . . . 0.61 111.832 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.77 152.01 2.97 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.605 -1.238 . . . . 0.66 111.713 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.8 mt -125.98 147.69 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.473 -1.306 . . . . 0.79 107.473 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.8 m -128.55 -9.92 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 O-C-N 120.932 -1.105 . . . . 0.91 110.812 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -114.73 24.58 10.91 Favored Glycine 0 N--CA 1.502 3.063 0 N-CA-C 110.435 -1.066 . . . . 1.01 110.435 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 204' ' ' GLY . 3.1 p -42.73 -47.17 5.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.262 -1.14 . . . . 0.99 110.192 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.443 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 98.71 -56.69 0.98 Allowed Glycine 0 N--CA 1.503 3.13 0 C-N-CA 120.221 -0.99 . . . . 1.12 111.549 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 26.1 p -148.99 26.62 0.88 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.445 -1.621 . . . . 1.72 111.103 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.23 -40.04 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.989 -1.069 . . . . 0.89 109.395 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.581 HG22 HG12 ' A' ' 159' ' ' VAL . 31.7 p -62.06 -29.27 70.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.169 -0.957 . . . . 1.03 109.765 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 94.9 p -79.94 -20.99 44.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.209 -0.932 . . . . 1.83 109.561 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -96.5 -8.34 32.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.25 -0.906 . . . . 2.27 109.534 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.94 138.72 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-O 121.622 0.725 . . . . 0.92 110.853 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.433 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 2.1 mptp? -112.59 154.72 25.57 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.655 -1.239 . . . . 2.2 107.655 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.466 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 17.9 p-10 -59.85 139.8 57.08 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.025 -1.047 . . . . 2.36 110.113 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.4 m-20 83.82 4.32 0.81 Allowed 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.121 0.486 . . . . 2.38 110.162 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 86.2 m-20 -73.57 138.16 44.76 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.136 -0.978 . . . . 2.09 109.231 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -90.09 117.91 29.23 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.501 -1.296 . . . . 1.27 107.501 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.564 HD12 ' HB2' ' A' ' 16' ' ' ALA . 74.5 mt -127.18 150.82 49.34 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.519 -0.738 . . . . 0.75 110.927 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.471 HG23 ' CD2' ' A' ' 13' ' ' PHE . 76.2 mt -117.61 129.99 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.147 -1.427 . . . . 0.63 107.147 177.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 22.2 tp -102.38 120.19 40.08 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.001 -1.062 . . . . 0.7 109.701 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.669 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 25.1 p-10 -80.05 -39.9 28.84 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.082 -1.011 . . . . 2.31 108.863 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 48.04 19.68 0.2 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.338 -0.986 . . . . 0.78 108.338 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.451 ' N ' ' C ' ' A' ' 221' ' ' ASP . 21.4 t -133.12 -44.3 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.339 -1.356 . . . . 1.04 107.339 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -100.1 0.02 39.91 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.747 -1.205 . . . . 2.44 107.747 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.614 HD21 ' H ' ' A' ' 4' ' ' GLY . 38.6 t30 60.02 46.88 10.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.714 -0.616 . . . . 1.55 109.57 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.669 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 76.9 mt-30 -140.04 151.82 45.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.43 -0.794 . . . . 1.99 109.622 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 83.1 t -119.12 129.96 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.419 -0.956 . . . . 0.77 108.419 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -99.95 118.79 37.11 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.477 -0.934 . . . . 0.98 108.477 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.4 t -99.98 115.13 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.544 -0.722 . . . . 0.85 110.503 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 52.45 63.09 9.39 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 1.66 111.164 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -88.99 148.46 5.67 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.557 2.172 . . . . 0.95 111.871 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 58.9 p -68.78 161.38 28.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 1.84 109.576 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -60.03 -39.97 87.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.843 . . . . 2.74 110.519 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -60.32 -32.96 71.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.932 -1.105 . . . . 2.89 109.816 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.33 -39.98 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -0.985 . . . . 1.3 109.141 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.883 . . . . 1.09 109.284 179.433 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 40.7 ttp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.46 0.648 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 30.1 t80 -155.78 155.37 32.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.482 -0.761 . . . . 0.0 109.1 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . 0.539 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 12.9 pt20 -146.75 157.03 43.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.166 -0.959 . . . . 0.0 109.939 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -152.94 150.07 28.88 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -114.99 135.2 54.49 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.169 -0.957 . . . . 0.0 110.638 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.0 p -134.89 123.45 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 CA-C-O 122.033 0.92 . . . . 0.0 112.277 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 89.8 m -80.19 107.19 12.79 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.957 0.884 . . . . 0.0 111.201 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.0 mt -51.65 121.21 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 122.329 1.062 . . . . 0.0 110.438 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 23.7 p -108.61 16.86 22.58 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.786 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.7 129.06 84.37 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 120.743 -1.223 . . . . 0.0 108.175 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -64.34 -10.99 25.98 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 CA-C-N 120.154 1.091 . . . . 0.0 112.752 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -115.78 8.6 14.9 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.364 -0.835 . . . . 0.0 109.782 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.59 173.91 14.8 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.422 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 3.2 tp -81.66 90.24 6.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.895 -1.356 . . . . 0.0 109.693 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.448 ' CA ' ' OH ' ' A' ' 122' ' ' TYR . 4.4 p80 -95.13 -161.37 0.85 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.84 -1.162 . . . . 0.0 109.939 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.0 m -58.01 -40.4 80.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.007 -1.058 . . . . 0.0 112.31 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.573 HH21 ' NE2' ' B' ' 321' ' ' GLN . 2.2 tpt180 -59.58 -61.94 6.87 Favored Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 120.402 -1.436 . . . . 0.0 111.591 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.421 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 9.4 Cg_endo -56.07 -32.79 87.82 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 CA-C-N 120.028 1.046 . . . . 0.0 111.832 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.95 -51.6 68.96 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.416 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.61 64.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.227 -0.92 . . . . 0.0 110.006 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . 0.573 ' NE2' HH21 ' B' ' 317' ' ' ARG . 86.9 mt-30 -70.82 -39.95 72.74 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.829 -1.17 . . . . 0.0 109.062 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -62.73 -54.79 33.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.364 -0.835 . . . . 0.0 110.463 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 60.1 t -63.6 -38.51 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.666 -1.271 . . . . 0.0 108.806 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -59.98 -47.1 87.2 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.217 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -62.58 -49.76 73.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.359 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.16 -51.56 52.29 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.256 -0.903 . . . . 0.0 110.883 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -52.04 -14.42 0.41 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.118 -0.989 . . . . 0.0 109.897 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -79.92 -17.23 75.31 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -106.01 140.55 38.83 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.319 -1.106 . . . . 0.0 108.758 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 5.3 p -91.42 -13.79 31.73 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.792 -1.192 . . . . 0.0 110.158 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 29.5 p -57.28 150.46 17.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.938 -1.101 . . . . 0.0 108.474 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.05 132.46 46.66 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.855 -1.153 . . . . 0.0 108.627 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.8 mt -133.4 133.64 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.615 -0.678 . . . . 0.0 109.531 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.7 m -130.04 152.28 49.66 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.481 -0.762 . . . . 0.0 109.117 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 72.0 t -123.88 114.68 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 87.0 m -105.22 130.45 53.37 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.144 -0.972 . . . . 0.0 109.177 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 97.0 p -136.47 114.01 10.97 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.92 0.867 . . . . 0.0 110.777 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 45.35 51.85 9.22 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.98 -13.82 63.63 Favored Glycine 0 N--CA 1.503 3.135 0 O-C-N 120.102 -1.624 . . . . 0.0 112.935 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -118.67 130.37 55.81 Favored 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 119.414 1.607 . . . . 0.0 109.367 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 82.2 p -128.51 150.75 50.03 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.968 0.889 . . . . 0.0 110.845 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -145.24 166.64 24.9 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.573 0.701 . . . . 0.0 110.126 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.8 m -88.99 139.94 29.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.449 -0.782 . . . . 0.0 110.052 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -78.78 -14.35 59.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.916 -1.115 . . . . 0.0 110.071 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -89.98 20.3 4.32 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 90.5 p -145.8 92.14 2.18 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.407 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.77 HD23 HD22 ' A' ' 79' ' ' LEU . 57.1 tp -59.98 -34.54 73.44 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.875 ' CE2' HD11 ' A' ' 79' ' ' LEU . 64.2 m-85 -56.33 -53.48 56.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.169 -0.957 . . . . 0.0 110.393 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -69.43 -39.81 77.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 110.387 -177.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' B' ' 352' ' ' THR . 23.2 mt -47.67 -59.66 3.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.158 -0.964 . . . . 0.0 108.978 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.826 ' O ' HD22 ' A' ' 123' ' ' LEU . 1.5 mp0 -39.27 -21.12 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.721 -0.612 . . . . 0.0 111.298 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.528 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.1 p -78.03 -10.1 59.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.102 -1.624 . . . . 0.0 110.216 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 49.9 mt -96.09 118.32 32.45 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.134 -0.979 . . . . 0.0 109.14 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.35 96.74 0.92 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 32.2 mt -106.77 95.29 5.63 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.447 -1.031 . . . . 0.0 109.582 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 17.8 p -98.31 176.42 5.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.217 -0.927 . . . . 0.0 110.462 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -63.93 111.89 2.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.806 -0.559 . . . . 0.0 110.586 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.76 7.7 38.49 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 46.9 m -84.83 110.23 18.67 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.087 -1.243 . . . . 0.0 111.067 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 4.9 t -78.12 115.62 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 122.113 0.959 . . . . 0.0 110.167 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 29.1 m -112.65 177.52 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 86.6 m -131.11 130.31 42.97 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 82.3 mt -105.34 120.35 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 58.7 m -121.38 132.56 54.83 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.25 153.9 41.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 110.034 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -146.77 122.91 10.83 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.486 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 159.53 -155.29 26.38 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 118.586 -1.768 . . . . 0.0 111.932 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.93 -53.36 58.78 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -107.31 11.61 28.97 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.898 -1.126 . . . . 0.0 111.383 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.3 pt-20 -40.23 -37.54 0.65 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.431 -0.793 . . . . 0.0 111.581 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.04 -44.31 72.92 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.73 -1.231 . . . . 0.0 110.787 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -69.79 -51.78 30.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.782 -1.199 . . . . 0.0 109.167 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -45.81 -37.22 5.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.646 -0.659 . . . . 0.0 111.278 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.53 ' O ' HG23 ' B' ' 378' ' ' VAL . 81.8 t -69.98 -39.98 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.698 -1.251 . . . . 0.0 109.151 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.99 -64.45 0.86 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 111.163 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -60.06 -45.82 91.59 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.683 -1.261 . . . . 0.0 111.771 -177.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.9 mt -59.98 -41.39 91.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.623 -1.298 . . . . 0.0 108.813 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.53 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.7 t -65.88 -42.05 91.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.158 -0.964 . . . . 0.0 109.742 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -71.29 -57.96 3.98 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.742 -1.224 . . . . 0.0 107.85 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.411 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 60.2 tp -56.22 -32.48 64.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.397 -0.814 . . . . 0.0 109.839 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 45.2 ttm -74.44 -40.02 62.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.007 -1.058 . . . . 0.0 108.813 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.67 -4.45 46.18 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.682 -0.636 . . . . 0.0 110.121 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -110.84 3.36 18.9 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.319 -0.863 . . . . 0.0 110.963 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . 0.411 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 32.3 mt -69.87 130.03 41.13 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.397 -1.439 . . . . 0.0 109.764 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.079 179.45 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.301 -0.629 . . . . 2.91 109.301 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.5 mt -108.88 128.69 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.644 -0.873 . . . . 1.2 108.644 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.1 m -118.85 154.04 33.54 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.081 -0.711 . . . . 1.4 109.081 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.801 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -141.75 179.05 20.12 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.359 -1.897 . . . . 1.05 108.359 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.5 mt -85.21 -4.69 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.88 -1.365 . . . . 1.15 110.607 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.4 HD11 ' HB1' ' A' ' 222' ' ' ALA . 43.5 tp 52.31 93.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.64 -1.288 . . . . 0.98 109.362 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.22 -40.03 78.2 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.219 -1.03 . . . . 0.88 108.219 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 p -154.08 146.88 17.73 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 108.943 -0.762 . . . . 1.69 108.943 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -80.32 144.2 16.12 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.74 2.293 . . . . 0.85 113.5 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.883 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.67 164.51 13.27 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.544 -1.422 . . . . 0.92 109.544 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -117.42 152.82 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.13 -1.218 . . . . 0.81 110.072 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.91 155.98 35.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.228 -0.92 . . . . 0.51 109.83 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.9 OUTLIER -137.71 128.07 26.35 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.604 -0.888 . . . . 0.62 108.604 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.91 179.32 47.25 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 118.902 -1.618 . . . . 0.55 110.534 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -78.94 157.08 28.27 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.629 -0.924 . . . . 2.1 109.064 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.586 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -102.31 134.28 45.85 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.376 -0.827 . . . . 0.77 110.701 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.9 tp -106.93 139.39 41.41 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.346 -1.353 . . . . 0.91 107.346 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.0 tp -119.06 121.03 38.91 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.309 -0.87 . . . . 0.93 110.146 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.8 mt -81.91 102.89 11.18 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.003 -0.679 . . . . 0.93 109.809 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -95.5 131.48 41.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.413 -0.804 . . . . 2.75 109.543 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -126.12 137.83 53.63 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.714 -0.847 . . . . 3.0 108.714 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 47.5 t0 -87.24 147.86 25.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.07 -1.019 . . . . 2.77 109.557 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.461 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 88.3 tt0 -64.18 149.88 46.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.906 . . . . 2.94 109.335 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.9 mt -91.87 127.46 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.374 -0.829 . . . . 0.95 108.897 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.6 t -93.62 124.07 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.159 -0.963 . . . . 1.28 109.738 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -106.74 135.66 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.796 -0.816 . . . . 1.21 108.796 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -95.04 117.04 29.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.001 -1.062 . . . . 1.81 109.328 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -89.83 2.11 55.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.431 -0.793 . . . . 2.8 109.097 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -58.81 146.13 38.27 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.291 -0.881 . . . . 2.87 109.583 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -84.76 137.6 33.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.423 -0.798 . . . . 2.35 109.035 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.403 HG21 ' HG3' ' A' ' 39' ' ' GLU . 5.0 pt -91.73 163.25 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.966 -1.084 . . . . 0.97 109.92 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.3 p -97.18 174.93 6.48 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.925 . . . . 1.17 108.761 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.05 83.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 1.18 109.689 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -57.35 -30.22 64.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.741 -1.224 . . . . 2.56 109.433 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -81.45 -10.2 59.55 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.185 -0.947 . . . . 1.79 109.891 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.9 -53.42 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.705 -1.247 . . . . 1.0 108.519 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.14 -40.01 94.52 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.59 -0.694 . . . . 1.77 110.14 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -69.87 -41.2 75.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.024 -1.047 . . . . 2.7 110.436 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.403 ' HG3' HG21 ' A' ' 31' ' ' ILE . 69.4 mm-40 -64.91 -40.02 94.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.832 -1.168 . . . . 1.51 110.069 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.3 t -62.84 -47.0 94.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.905 -1.122 . . . . 0.93 108.937 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -64.59 -42.8 95.35 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.047 -1.033 . . . . 1.81 110.063 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -60.07 -42.19 94.02 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.425 -1.324 . . . . 2.78 107.425 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -61.16 -50.04 74.8 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.151 -0.685 . . . . 0.78 109.151 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.9 tp -59.99 -42.32 93.95 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.444 -0.947 . . . . 1.07 108.444 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 36.8 t -63.6 -39.98 95.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 1.12 109.325 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.56 -48.98 77.69 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.702 -1.759 . . . . 0.84 108.702 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -61.1 -39.99 92.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.337 -1.096 . . . . 3.09 108.256 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -46.64 -43.27 17.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.558 -0.714 . . . . 0.88 109.14 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 50' ' ' ALA . 24.7 ttmt -66.07 -72.83 0.15 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.678 -1.23 . . . . 2.59 107.678 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.92 -42.45 0.62 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.359 -0.838 . . . . 0.7 111.37 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.2 t -51.37 -56.36 13.54 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.59 -1.319 . . . . 1.4 109.177 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.71 -41.95 74.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.195 -0.94 . . . . 0.67 110.794 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.7 -40.06 88.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.932 -1.105 . . . . 1.66 109.794 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.7 mt -60.62 -40.05 90.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.99 -1.069 . . . . 1.58 108.713 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.412 ' OE2' HD13 ' A' ' 77' ' ' ILE . 51.4 mm-40 -60.85 -33.54 73.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.455 -0.778 . . . . 1.35 109.429 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -65.15 -44.09 89.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.039 -1.038 . . . . 0.77 109.427 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.05 -38.98 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.884 -0.784 . . . . 0.63 108.884 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -59.45 -49.97 75.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.468 -0.77 . . . . 1.14 109.67 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -59.58 -37.45 78.55 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.273 -0.892 . . . . 0.79 110.223 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -63.93 -38.91 92.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.96 -1.087 . . . . 1.53 109.595 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.541 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -63.26 -42.27 99.12 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.373 -0.829 . . . . 0.57 109.15 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.44 -51.4 58.97 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.101 -1.2 . . . . 0.75 110.101 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.39 -46.72 66.24 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.928 -1.337 . . . . 1.59 110.02 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.1 m -67.25 -63.08 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.73 112.442 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.474 ' CE2' ' O ' ' A' ' 168' ' ' THR . 95.4 m-85 -92.9 -50.5 5.52 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.749 -1.219 . . . . 0.75 110.917 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.46 -169.9 24.93 Favored Glycine 0 N--CA 1.499 2.894 0 C-N-CA 119.954 -1.117 . . . . 1.22 110.939 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -69.74 -24.19 63.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.894 -0.768 . . . . 5.81 109.714 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -60.04 -35.55 75.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.569 -0.707 . . . . 3.37 110.175 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -100.37 -18.5 16.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.329 -0.857 . . . . 1.77 110.415 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -70.05 -40.01 75.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.778 -1.202 . . . . 1.65 110.643 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.536 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.51 -30.58 70.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.217 -0.927 . . . . 0.77 110.22 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.9 mt -59.94 -40.63 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.051 -1.031 . . . . 0.8 109.291 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 16.9 m-85 -70.04 -38.18 75.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.88 110.947 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -60.05 -39.93 87.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.859 -1.151 . . . . 1.37 109.8 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.97 -43.36 99.01 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.306 -1.518 . . . . 0.62 109.306 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -61.98 -42.93 99.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.388 -1.066 . . . . 1.5 109.705 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.412 HD13 ' OE2' ' A' ' 55' ' ' GLU . 98.7 mt -70.05 -43.34 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.225 -0.922 . . . . 0.63 109.741 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.8 ttp -59.97 -40.09 87.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.841 -1.162 . . . . 1.51 109.512 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.856 HD11 ' CE2' ' B' ' 348' ' ' PHE . 31.7 tp -65.21 -38.03 89.16 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.471 -0.768 . . . . 0.77 109.699 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.9 -40.09 95.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.455 -0.778 . . . . 0.62 109.964 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -81.0 6.29 13.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.238 -0.914 . . . . 1.47 110.219 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -52.75 133.47 36.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.073 -1.017 . . . . 1.47 110.473 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.44 -19.45 63.5 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.556 -0.715 . . . . 1.78 110.658 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.07 -33.87 72.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.92 -1.113 . . . . 2.53 108.887 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.0 mt -70.13 -41.46 73.89 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.41 0.624 . . . . 0.8 110.055 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -60.05 -48.79 80.25 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.3 -0.875 . . . . 1.42 110.943 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -70.0 -40.93 74.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.07 -1.019 . . . . 1.71 111.323 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -69.97 -40.02 75.63 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.031 -1.043 . . . . 1.57 111.485 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 84.2 mt -65.88 -49.87 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.975 -1.078 . . . . 0.65 109.69 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.7 mt -65.1 -37.15 79.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.686 -0.634 . . . . 0.82 110.401 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.03 -49.63 76.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.103 -0.998 . . . . 0.79 110.763 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.43 -45.89 91.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.83 -1.169 . . . . 0.95 109.748 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.7 mt -61.51 -49.96 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.981 0.896 . . . . 0.66 109.159 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -67.93 -44.92 75.72 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 120.163 -0.615 . . . . 2.2 111.144 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -80.19 -51.18 9.26 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.878 -1.138 . . . . 1.65 112.152 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -90.1 -3.38 57.95 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.91 -1.119 . . . . 2.03 112.13 -177.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 39.0 m80 57.76 34.82 24.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.892 -1.13 . . . . 1.42 110.605 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 71.0 mtm -90.81 169.91 10.55 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.013 -1.054 . . . . 1.18 109.38 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.6 p -75.3 154.28 37.47 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.093 -1.005 . . . . 0.98 108.465 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.95 -36.87 75.59 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.1 -1.0 . . . . 0.64 110.541 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 38.2 p-10 -65.62 -38.71 90.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.99 -1.069 . . . . 2.07 109.766 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.522 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.53 -44.4 19.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.142 -0.974 . . . . 0.73 109.318 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.88 92.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.396 -0.815 . . . . 0.54 109.44 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.06 94.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.87 . . . . 0.56 109.557 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -59.49 -39.97 85.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.822 . . . . 1.54 109.573 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 110' ' ' GLY . 86.1 tt0 -63.12 -40.02 96.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.117 -0.989 . . . . 1.33 109.28 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.5 t -61.61 -52.27 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.471 -0.768 . . . . 0.72 110.731 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.5 mm -70.08 -39.98 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.916 -1.115 . . . . 0.85 108.934 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -67.24 -38.29 84.96 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.231 -1.026 . . . . 2.44 108.231 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.24 -50.0 70.59 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.33 -1.108 . . . . 0.98 110.33 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.431 HE21 ' CB ' ' B' ' 348' ' ' PHE . 14.8 mm100 -66.84 -52.22 46.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.654 -1.497 . . . . 1.41 109.06 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.85 -39.98 75.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 1.2 108.964 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.1 t -55.74 -39.46 71.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.238 -0.914 . . . . 1.7 108.708 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.05 -37.55 75.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.162 -0.961 . . . . 1.47 109.784 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.3 mt -67.47 -48.59 66.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.117 -0.989 . . . . 1.56 110.704 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -60.49 -21.96 62.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.391 -1.443 . . . . 2.2 110.194 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -67.97 -16.0 63.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.814 -1.179 . . . . 2.12 108.783 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.494 HD13 HD13 ' A' ' 123' ' ' LEU . 28.4 mt -63.05 145.61 55.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.296 -0.877 . . . . 2.0 108.95 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -90.53 28.81 1.4 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.248 -0.908 . . . . 3.23 110.458 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 55.5 t0 -117.36 131.89 56.7 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.333 -0.854 . . . . 2.49 109.78 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.418 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 47.1 mt-10 -69.97 -28.94 65.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.515 -0.74 . . . . 3.95 109.934 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.514 ' OH ' ' NH1' ' A' ' 126' ' ' ARG . 2.7 t80 -69.89 -37.87 76.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 2.0 109.999 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.494 HD13 HD13 ' A' ' 118' ' ' LEU . 72.4 mt -77.14 -31.32 55.59 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.08 -1.013 . . . . 1.86 109.036 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -60.02 -40.06 87.98 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.195 -0.941 . . . . 2.84 108.645 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -47.01 87.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -0.811 . . . . 2.73 109.305 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.514 ' NH1' ' OH ' ' A' ' 122' ' ' TYR . 4.2 mmm-85 -60.02 -40.05 87.95 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.282 -0.887 . . . . 2.77 109.898 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.37 76.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.035 -1.04 . . . . 1.19 108.656 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.08 95.65 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.067 -0.716 . . . . 1.2 109.067 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -66.59 -42.43 86.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.369 -0.832 . . . . 1.55 109.453 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.94 -40.38 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.287 -0.883 . . . . 0.8 108.625 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -60.24 -41.31 92.88 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.465 -0.772 . . . . 3.09 109.101 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -59.92 -40.01 87.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.514 -0.741 . . . . 1.46 110.726 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.9 mt -60.07 -41.28 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 0.71 110.304 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.53 -40.44 94.25 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.646 -1.264 . . . . 0.57 110.02 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -60.01 -45.27 93.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.292 -1.122 . . . . 2.59 110.314 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -65.96 -35.88 81.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.589 -1.319 . . . . 2.83 110.038 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.94 -41.6 92.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.107 -0.995 . . . . 1.25 109.441 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.01 -40.01 87.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.108 -0.995 . . . . 0.7 108.908 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -65.77 -39.98 91.55 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.749 -0.834 . . . . 2.57 108.749 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -69.73 -29.03 66.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.628 -0.67 . . . . 1.23 111.85 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.3 mt -70.02 -40.77 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.255 -1.528 . . . . 0.81 108.624 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.7 -29.66 59.07 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.676 -0.64 . . . . 1.0 109.747 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.19 45.82 4.62 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 108.954 -1.658 . . . . 0.89 108.954 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.6 tp -74.81 149.99 39.46 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.457 -1.025 . . . . 1.14 109.503 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -70.21 143.77 52.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.206 -0.934 . . . . 4.6 109.881 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.6 mt -114.91 128.8 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 122.037 0.922 . . . . 1.24 109.274 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.8 mt -69.93 -40.12 78.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.873 -0.603 . . . . 1.54 110.654 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.1 t0 63.39 103.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.27 -0.894 . . . . 1.5 109.223 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 57.7 mt -68.45 -1.25 6.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.395 -0.816 . . . . 0.79 109.88 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.6 p -81.67 -14.61 56.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.02 -1.05 . . . . 1.4 109.878 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.8 26.42 0.83 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.239 -0.913 . . . . 0.92 112.225 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 36.1 mm -90.8 122.49 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 120.367 -1.458 . . . . 0.88 109.122 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -104.39 -12.52 16.52 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.428 -0.795 . . . . 2.45 110.415 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -122.3 147.78 45.82 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.286 -0.884 . . . . 1.52 110.182 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.92 135.76 56.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.82 . . . . 1.58 109.487 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.0 m -152.8 166.63 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.608 -0.682 . . . . 0.69 109.799 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 86.3 mt -94.74 148.9 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.485 -1.672 . . . . 0.61 106.485 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 14.9 tp -97.78 118.19 33.76 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.867 -1.146 . . . . 0.87 110.383 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.8 t -123.12 130.01 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.808 -0.812 . . . . 0.71 108.808 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -156.66 160.67 39.58 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.385 -0.968 . . . . 0.81 108.385 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.84 -31.83 65.04 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.266 -1.521 . . . . 0.98 107.588 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -157.94 165.62 34.7 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.853 -0.795 . . . . 2.25 108.853 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 78.0 mt -136.95 132.16 34.01 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.162 -0.961 . . . . 0.78 108.964 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.1 p -102.44 148.99 36.27 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.389 -0.82 . . . . 0.98 108.975 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -41.59 -34.13 2.02 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.97 1.78 . . . . 0.81 112.211 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 43.7 m -57.46 -43.37 83.95 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.354 -0.841 . . . . 0.9 109.961 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.94 -40.96 75.19 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.126 -0.984 . . . . 1.61 110.252 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.474 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 72.0 p -58.03 -19.9 34.88 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.166 -0.959 . . . . 0.61 111.581 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.541 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -85.69 -43.18 13.62 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.634 -1.291 . . . . 0.6 109.773 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -96.98 41.53 1.11 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.39 -0.967 . . . . 1.4 108.39 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.479 HD11 HG21 ' A' ' 176' ' ' VAL . 58.9 tp -105.29 131.51 52.66 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.588 -0.893 . . . . 0.7 108.588 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.431 ' O ' HG23 ' A' ' 176' ' ' VAL . 16.7 m120 -84.03 103.33 13.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.008 -1.058 . . . . 2.35 108.847 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.77 -40.8 95.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.854 . . . . 1.51 110.814 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -65.59 -27.39 68.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.82 -1.175 . . . . 2.33 111.286 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.454 ' N ' ' CD ' ' A' ' 175' ' ' LYS . 1.1 mptm? -93.32 -11.83 31.48 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.895 -1.128 . . . . 1.92 109.723 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.479 HG21 HD11 ' A' ' 171' ' ' LEU . 87.6 t -100.01 110.03 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.138 -0.977 . . . . 0.67 108.908 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 89.9 mt -83.76 7.32 18.16 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.229 -0.919 . . . . 1.53 110.377 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.462 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 167.94 176.26 38.35 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.247 -1.541 . . . . 0.48 109.247 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.475 ' CE1' HG11 ' A' ' 176' ' ' VAL . 11.9 m-85 -133.24 129.9 38.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.353 -1.087 . . . . 0.55 108.658 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.2 mt -132.93 126.51 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.309 -0.869 . . . . 0.65 109.28 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.4 p -145.35 158.03 43.92 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.034 -1.041 . . . . 0.82 111.189 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.529 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -103.14 26.84 7.77 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.789 -0.819 . . . . 2.46 108.789 179.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -67.42 -158.96 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.055 -1.028 . . . . 1.28 112.028 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.14 -50.55 10.23 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.07 -1.212 . . . . 2.19 110.07 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.85 -120.05 1.1 Allowed Glycine 0 N--CA 1.493 2.459 0 O-C-N 120.868 -1.372 . . . . 2.13 110.766 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.566 ' NE ' HH22 ' A' ' 195' ' ' ARG . 58.4 mtp180 -60.96 -37.6 82.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.774 -0.839 . . . . 5.86 111.627 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 32.7 p -67.31 3.02 1.36 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.9 -1.125 . . . . 3.72 110.909 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.8 t -90.39 118.89 30.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.746 -1.222 . . . . 1.74 109.952 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -43.11 -52.63 5.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.355 -0.841 . . . . 0.95 109.636 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -52.33 -33.16 41.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.352 -0.842 . . . . 1.55 110.706 -179.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.1 t -59.99 -42.03 93.35 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.727 -1.233 . . . . 1.51 110.225 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.3 mm -60.37 -39.95 82.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.357 -0.84 . . . . 1.67 109.005 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.6 mtp -60.01 -40.56 89.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.495 -0.753 . . . . 1.02 110.919 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.36 95.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.673 -1.267 . . . . 0.68 109.149 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.566 HH22 ' NE ' ' A' ' 186' ' ' ARG . 98.4 mtt180 -59.96 -53.34 59.04 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.221 -0.924 . . . . 2.93 110.375 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.3 m -69.73 -35.66 75.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.067 -1.021 . . . . 0.86 111.267 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.03 -28.6 65.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.865 -1.147 . . . . 0.67 108.906 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 70.24 45.73 0.65 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.506 0.669 . . . . 1.5 109.644 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 88.2 mt -122.73 150.04 57.47 Favored Pre-proline 0 N--CA 1.498 1.963 0 N-CA-C 107.84 -1.171 . . . . 0.72 107.84 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.79 142.68 70.78 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.002 1.801 . . . . 0.61 111.536 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -170.01 151.15 3.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.983 -1.073 . . . . 0.66 111.388 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.7 mt -123.47 143.47 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.783 -1.191 . . . . 0.79 107.783 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 5.8 m -126.67 -10.08 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 120.694 -1.254 . . . . 0.91 110.54 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.1 23.14 26.01 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 110.323 -1.111 . . . . 1.01 110.323 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.417 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.5 p -46.02 -43.24 14.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.089 -1.242 . . . . 0.99 109.715 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.88 -52.6 3.92 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 120.144 -1.027 . . . . 1.12 111.532 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.9 m -157.38 33.76 0.28 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.54 -1.565 . . . . 1.72 111.425 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 56.1 t -72.77 -40.1 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.908 -1.12 . . . . 0.89 109.111 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.432 ' H ' HG23 ' A' ' 209' ' ' THR . 1.4 p -54.82 -32.36 60.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.431 -0.793 . . . . 1.03 110.578 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 84.9 p -76.43 -16.29 59.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.985 -1.072 . . . . 1.83 109.421 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -101.64 -13.73 17.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.498 -0.751 . . . . 2.27 109.95 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 55.9 t -104.77 137.92 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.359 -0.838 . . . . 0.92 110.555 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -112.79 151.7 30.03 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.686 -1.227 . . . . 2.2 107.686 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 30.5 p-10 -57.92 137.03 57.11 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.016 -1.053 . . . . 2.36 110.251 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.8 OUTLIER 82.79 8.69 0.72 Allowed 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.14 0.495 . . . . 2.38 110.432 179.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 60.5 t0 -77.8 143.57 37.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.12 -0.987 . . . . 2.09 109.131 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.527 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 33.9 t80 -88.32 118.24 27.8 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.025 -1.047 . . . . 1.27 109.041 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.586 HD12 ' HB2' ' A' ' 16' ' ' ALA . 91.7 mt -130.63 149.42 52.29 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.515 -0.741 . . . . 0.75 110.544 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.7 mt -118.28 128.56 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 106.85 -1.537 . . . . 0.63 106.85 177.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.7 tp -100.61 122.5 43.38 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.961 -1.087 . . . . 0.7 109.466 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.419 ' C ' ' N ' ' A' ' 223' ' ' VAL . 19.3 m-20 -87.53 -42.77 12.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.982 -1.074 . . . . 2.31 109.884 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.883 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.15 22.81 0.25 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.674 -0.861 . . . . 0.78 108.674 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.419 ' N ' ' C ' ' A' ' 221' ' ' ASP . 18.0 t -127.25 -42.82 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.903 -1.517 . . . . 1.04 106.903 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -109.84 7.39 24.04 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.0 -1.111 . . . . 2.44 108.0 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.801 HD21 ' H ' ' A' ' 4' ' ' GLY . 36.6 t-20 60.04 52.12 5.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.794 -0.566 . . . . 1.55 110.532 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -147.17 158.56 43.99 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.784 -1.198 . . . . 1.99 110.463 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.6 t -126.81 130.04 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.496 -0.927 . . . . 0.77 108.496 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -98.43 122.93 42.22 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.426 -0.796 . . . . 0.98 109.212 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 18.2 t -100.79 111.28 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.551 -0.718 . . . . 0.85 110.083 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 54.98 63.14 7.17 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.235 -0.916 . . . . 1.66 111.244 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -86.87 150.07 8.43 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.571 2.181 . . . . 0.95 112.246 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 39.8 p -74.43 165.02 25.9 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.318 -0.864 . . . . 1.84 109.437 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -60.0 -34.43 73.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.426 -0.796 . . . . 2.74 110.592 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -59.94 -39.29 85.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.053 -1.029 . . . . 2.89 109.756 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 76.1 t -70.02 -40.27 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.031 -1.043 . . . . 1.3 109.18 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 99.4 mt . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.342 -0.849 . . . . 1.09 109.658 -179.715 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 7.5 ttt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -151.69 149.54 29.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.368 -0.832 . . . . 0.0 109.099 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -148.91 159.96 43.71 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.053 -1.029 . . . . 0.0 110.655 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -152.7 148.74 27.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.475 -0.766 . . . . 0.0 109.314 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -107.03 131.11 54.45 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.135 -0.978 . . . . 0.0 109.646 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.59 119.06 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 122.186 0.993 . . . . 0.0 112.782 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . 0.472 ' O ' HG23 ' B' ' 309' ' ' THR . 94.6 m -78.34 104.75 9.13 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.919 0.866 . . . . 0.0 110.004 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' B' ' 358' ' ' GLY . 70.4 mt -51.74 118.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 122.317 1.056 . . . . 0.0 110.295 -177.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . 0.472 HG23 ' O ' ' B' ' 307' ' ' THR . 51.6 p -108.1 17.08 22.73 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.24 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.405 ' O ' ' CG ' ' B' ' 357' ' ' GLN . . . -71.92 117.14 55.29 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.063 -1.023 . . . . 0.0 108.54 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -51.92 -16.07 3.86 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 CA-C-N 120.35 1.161 . . . . 0.0 113.594 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -120.47 10.57 11.19 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.329 -0.857 . . . . 0.0 109.357 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.14 -179.79 31.4 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.494 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -88.66 93.98 9.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.351 -1.088 . . . . 0.0 109.353 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.411 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 6.5 p80 -96.58 -160.01 0.77 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.897 -1.127 . . . . 0.0 110.564 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.2 m -57.33 -44.03 83.89 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.005 -1.059 . . . . 0.0 112.367 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.577 HH21 ' NE2' ' B' ' 321' ' ' GLN . 2.1 tpt180 -59.92 -60.57 10.17 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 120.651 -1.28 . . . . 0.0 112.233 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.411 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 10.9 Cg_endo -58.73 -29.82 90.72 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 CA-C-N 120.444 1.194 . . . . 0.0 111.595 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.92 -52.01 67.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 108.861 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.65 -41.49 61.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.944 . . . . 0.0 109.4 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . 0.577 ' NE2' HH21 ' B' ' 317' ' ' ARG . 89.5 mt-30 -69.96 -40.04 75.64 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.15 -0.969 . . . . 0.0 108.753 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -60.86 -52.88 63.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.519 -0.738 . . . . 0.0 110.989 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 71.9 t -67.74 -29.34 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.646 -1.284 . . . . 0.0 109.997 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -61.16 -45.53 94.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.942 . . . . 0.0 109.3 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -64.02 -45.04 90.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.332 -0.855 . . . . 0.0 110.178 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -61.44 -53.66 53.59 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.016 -1.053 . . . . 0.0 111.41 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -57.51 -13.26 3.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.868 -1.145 . . . . 0.0 109.496 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -68.24 -29.74 73.37 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -103.85 147.22 27.57 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.503 -0.998 . . . . 0.0 109.253 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 17.6 p -91.06 -11.88 37.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.975 -1.078 . . . . 0.0 109.85 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.417 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 80.8 p -64.09 158.01 23.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.342 -0.849 . . . . 0.0 110.478 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -74.85 132.96 41.92 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.0 mt -132.32 133.01 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.617 -0.677 . . . . 0.0 109.209 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 69.4 m -127.92 151.04 49.58 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.48 -0.763 . . . . 0.0 109.491 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 60.8 t -117.04 137.83 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 87.6 m -128.96 125.12 36.76 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.184 -0.948 . . . . 0.0 109.083 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . 0.418 ' HB2' HG12 ' B' ' 361' ' ' VAL . 12.2 t -138.67 119.12 13.8 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.959 0.885 . . . . 0.0 110.798 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' B' ' 338' ' ' ASN . 8.1 p-10 39.01 65.13 0.7 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 79.3 -12.36 26.35 Favored Glycine 0 N--CA 1.5 2.947 0 O-C-N 120.833 -1.167 . . . . 0.0 113.668 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -120.67 133.09 55.38 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-N 119.564 1.682 . . . . 0.0 109.963 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 78.7 p -129.91 150.4 51.21 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.8 0.809 . . . . 0.0 110.513 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.23 167.33 22.68 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.528 0.68 . . . . 0.0 110.11 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 12.2 m -88.93 138.94 30.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.504 -0.748 . . . . 0.0 109.808 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -76.8 -13.03 60.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.907 -1.121 . . . . 0.0 108.974 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -89.69 16.58 7.66 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 67.3 m -145.61 94.79 2.55 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.607 0.717 . . . . 0.0 111.068 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.717 HD23 HD22 ' A' ' 79' ' ' LEU . 52.9 tp -59.89 -33.96 72.54 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.856 ' CE2' HD11 ' A' ' 79' ' ' LEU . 54.2 m-85 -55.79 -52.84 62.59 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.928 -1.108 . . . . 0.0 109.852 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -69.99 -20.77 63.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -0.898 . . . . 0.0 111.889 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.97 -46.76 64.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.428 -1.42 . . . . 0.0 110.817 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.57 ' NE2' ' O ' ' B' ' 347' ' ' LEU . 0.7 OUTLIER -47.92 -21.11 0.38 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.894 -1.129 . . . . 0.0 111.695 -177.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 71.3 p -77.31 -12.97 60.01 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.168 -1.582 . . . . 0.0 109.974 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 30.0 mt -96.21 119.68 35.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.107 -0.995 . . . . 0.0 109.431 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.13 97.3 0.93 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 90.5 mt -98.64 81.56 2.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.327 -1.102 . . . . 0.0 109.399 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 46.5 p -89.77 176.48 6.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.149 -0.969 . . . . 0.0 110.964 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . 0.405 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 21.9 tm0? -70.64 112.19 6.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.694 -0.629 . . . . 0.0 110.379 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 104.26 8.74 37.87 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 19.2 m -86.55 109.2 18.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.122 -1.223 . . . . 0.0 110.357 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . 0.416 HG22 ' OG1' ' B' ' 307' ' ' THR . 7.9 t -77.6 115.49 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 122.329 1.061 . . . . 0.0 109.556 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . 0.418 HG12 ' HB2' ' B' ' 337' ' ' SER . 33.2 m -113.01 178.41 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 34.6 m -130.5 128.87 42.06 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 38.6 mt -104.69 121.55 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 68.8 p -126.46 136.12 52.23 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.71 153.25 40.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.208 -0.932 . . . . 0.0 109.923 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -146.16 125.82 13.38 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 158.98 -158.76 29.73 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.116 -1.516 . . . . 0.0 111.256 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.81 -51.99 67.36 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 122.077 -0.661 . . . . 0.0 112.177 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' B' ' 331' ' ' SER . 97.2 m-20 -111.27 11.92 21.7 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.998 -1.064 . . . . 0.0 111.023 -177.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -43.53 -31.85 0.81 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.231 -0.918 . . . . 0.0 110.746 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . 0.403 ' HG2' ' H ' ' B' ' 371' ' ' GLN . 3.2 pt20 -65.13 -47.31 77.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.881 -1.137 . . . . 0.0 109.532 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -65.84 -49.28 68.75 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 109.209 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.49 -37.04 3.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.661 -0.649 . . . . 0.0 112.041 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.544 ' O ' HG23 ' B' ' 378' ' ' VAL . 99.5 t -80.51 -35.38 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.479 -1.388 . . . . 0.0 109.964 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -67.04 -39.97 87.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.898 -1.126 . . . . 0.0 111.072 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -80.5 -46.64 15.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.759 -1.213 . . . . 0.0 110.57 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 89.8 mt -61.69 -39.95 93.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.194 -0.941 . . . . 0.0 109.865 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.544 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.8 t -60.19 -49.16 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.041 -1.037 . . . . 0.0 109.624 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' B' ' 383' ' ' GLU . 10.6 mtpm? -68.07 -54.2 20.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.703 -1.199 . . . . 0.0 107.993 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 50.1 tp -56.83 -34.97 68.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 110.182 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -72.09 -40.31 68.31 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 118.286 -1.366 . . . . 0.0 108.805 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.07 -6.45 59.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.525 -0.734 . . . . 0.0 110.533 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' B' ' 379' ' ' LYS . 74.2 mm-40 -110.28 -2.42 16.77 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.129 -0.982 . . . . 0.0 111.377 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 12.7 mt -80.98 129.99 34.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.276 -1.515 . . . . 0.0 108.722 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.381 -179.783 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.6 mtp . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.143 -0.688 . . . . 2.91 109.143 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.9 mt -96.39 135.78 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.336 -0.853 . . . . 1.2 109.31 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.6 m -119.34 149.83 41.16 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.775 0.798 . . . . 1.4 109.895 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.859 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -139.79 -173.43 13.21 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.9 -1.68 . . . . 1.05 108.9 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.5 mt -85.48 -7.18 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.896 -1.355 . . . . 1.15 110.087 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.4 tp 50.42 95.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.91 -1.119 . . . . 0.98 109.453 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.11 -35.06 16.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.88 109.378 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 2.8 p -134.67 130.84 19.95 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.495 -0.753 . . . . 1.69 109.364 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.36 141.14 14.07 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.206 1.937 . . . . 0.85 112.779 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.698 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.94 -162.72 34.87 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.978 -1.249 . . . . 0.92 109.978 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.2 mt -146.28 147.09 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.265 -1.138 . . . . 0.81 108.376 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.69 141.45 18.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.524 -1.36 . . . . 0.51 111.455 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -122.14 126.15 47.7 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 107.773 -1.195 . . . . 0.62 107.773 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.08 178.52 48.53 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 118.551 -1.785 . . . . 0.55 111.188 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -79.13 160.95 26.79 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.863 -0.786 . . . . 2.1 110.135 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -102.44 127.28 49.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.549 -0.719 . . . . 0.77 111.256 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.3 tp -106.87 134.56 49.84 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.618 -1.623 . . . . 0.91 106.618 177.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.6 tp -117.66 123.09 45.29 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.243 -0.911 . . . . 0.93 110.523 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.415 HD12 ' HB2' ' A' ' 160' ' ' ALA . 36.8 mt -86.0 103.3 14.57 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.358 0.599 . . . . 0.93 109.644 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -93.98 135.21 35.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -0.896 . . . . 2.75 108.75 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -130.14 132.48 46.1 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.555 -0.906 . . . . 3.0 108.555 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -80.97 148.08 29.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.094 -1.004 . . . . 2.77 110.006 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -62.65 149.47 43.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.38 -0.825 . . . . 2.94 109.263 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.544 HD11 ' NH1' ' A' ' 139' ' ' ARG . 42.0 mt -90.67 125.5 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.223 -0.923 . . . . 0.95 108.89 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.5 t -92.1 125.82 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.096 -1.002 . . . . 1.28 109.989 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.54 130.59 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.028 -1.101 . . . . 1.21 108.028 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -90.68 123.06 33.99 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.824 -1.173 . . . . 1.81 110.245 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -86.63 -1.32 57.58 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.57 -0.9 . . . . 2.8 108.57 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -65.1 140.07 58.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.417 -0.802 . . . . 2.87 109.974 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -87.9 151.31 22.92 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.085 -1.079 . . . . 2.35 108.085 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.673 HD13 ' HG3' ' A' ' 39' ' ' GLU . 3.9 pt -101.48 166.91 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.918 -1.114 . . . . 0.97 109.882 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.0 p -97.96 178.83 4.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.259 -0.901 . . . . 1.17 109.407 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.15 -49.39 77.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.362 -0.836 . . . . 1.18 110.469 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -56.37 -31.5 63.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.616 -1.302 . . . . 2.56 110.248 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -81.8 -9.34 59.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.307 -0.871 . . . . 1.79 110.448 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.0 t -59.97 -50.09 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.937 -1.102 . . . . 1.0 108.75 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -62.61 -40.05 95.72 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.278 -0.889 . . . . 1.77 109.152 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -60.58 -46.03 91.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.296 -0.877 . . . . 2.7 110.488 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.673 ' HG3' HD13 ' A' ' 31' ' ' ILE . 74.9 mm-40 -60.72 -44.35 96.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.825 -1.172 . . . . 1.51 109.851 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.3 t -60.06 -46.37 94.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.95 -1.094 . . . . 0.93 108.743 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -58.75 -40.06 82.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.38 -0.825 . . . . 1.81 109.099 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -60.91 -44.5 97.09 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.007 -1.108 . . . . 2.78 108.007 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -60.12 -49.48 77.46 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.95 -0.759 . . . . 0.78 108.95 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.0 -47.38 86.06 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.281 -1.007 . . . . 1.07 108.281 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.523 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 29.7 t -60.85 -43.82 97.81 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.353 -0.939 . . . . 1.12 108.869 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.99 -45.16 96.39 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.551 -1.819 . . . . 0.84 108.551 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.0 ttt-85 -60.06 -36.34 77.11 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.132 -1.062 . . . . 3.09 108.132 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -53.04 -40.39 63.9 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.939 -0.763 . . . . 0.88 108.939 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.1 ttmt -75.08 -74.08 0.22 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.614 -1.254 . . . . 2.59 107.614 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.53 -39.64 0.33 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.533 -0.729 . . . . 0.7 111.222 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.6 p -56.64 -59.09 5.52 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.658 -1.276 . . . . 1.4 108.895 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.76 -39.97 94.5 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.347 -0.846 . . . . 0.67 110.939 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -67.73 -39.96 84.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.812 -1.18 . . . . 1.66 110.202 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.6 mt -65.64 -40.06 92.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.062 -1.024 . . . . 1.58 109.614 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.425 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 74.9 mm-40 -62.63 -39.95 95.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.089 -1.007 . . . . 1.35 109.846 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -64.14 -41.85 97.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.059 -1.026 . . . . 0.77 110.012 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.413 HD11 HH22 ' A' ' 136' ' ' ARG . 82.8 mt -61.41 -40.0 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.912 . . . . 0.63 109.858 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.425 ' NZ ' ' OE1' ' A' ' 55' ' ' GLU . 5.1 ttpm? -58.16 -49.92 75.32 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.194 -0.941 . . . . 1.14 109.876 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.4 m -58.55 -36.09 73.35 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.364 -0.835 . . . . 0.79 110.886 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -65.83 -38.72 89.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.971 -1.08 . . . . 1.53 109.644 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.97 92.32 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.531 -0.73 . . . . 0.57 110.256 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.08 -50.0 72.2 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.362 -1.495 . . . . 0.75 109.362 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -66.91 -49.5 65.38 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.269 -1.136 . . . . 1.59 109.579 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.8 m -69.74 -61.61 1.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.492 -0.755 . . . . 0.73 112.694 -177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -93.63 -51.82 4.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.763 -1.21 . . . . 0.75 110.949 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.24 -173.01 23.55 Favored Glycine 0 N--CA 1.501 3.019 0 C-N-CA 119.767 -1.206 . . . . 1.22 111.444 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -71.13 -27.75 63.79 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.356 0.598 . . . . 5.81 110.495 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -63.58 -33.99 76.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.372 -0.83 . . . . 3.37 110.8 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -100.73 -24.99 14.29 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.104 -0.997 . . . . 1.77 109.843 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -62.83 -40.02 96.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 1.65 109.935 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.522 ' HB2' ' NH1' ' B' ' 317' ' ' ARG . . . -59.8 -29.88 68.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.398 -0.814 . . . . 0.77 109.732 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.7 mt -59.98 -40.09 82.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.453 -1.314 . . . . 0.8 107.453 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 81.3 m-85 -70.99 -40.06 72.11 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.605 -0.685 . . . . 0.88 111.005 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -64.12 -42.04 97.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.601 -1.312 . . . . 1.37 109.712 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.88 -40.59 96.99 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.586 -1.806 . . . . 0.62 108.586 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.8 m170 -64.55 -43.15 94.85 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.387 -1.067 . . . . 1.5 109.332 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.1 mt -67.32 -47.59 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 0.63 109.983 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.9 ttp -60.1 -40.62 90.28 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.941 -1.099 . . . . 1.51 110.235 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.788 HD11 ' CE2' ' B' ' 348' ' ' PHE . 35.5 tp -66.29 -36.81 83.93 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.539 -0.726 . . . . 0.77 109.639 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.49 -39.34 91.79 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.528 -0.733 . . . . 0.62 109.84 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -78.65 6.88 7.81 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.959 -1.088 . . . . 1.47 110.082 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 57.4 t0 -53.46 132.6 40.14 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.215 -0.928 . . . . 1.47 110.93 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.437 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 93.6 mt-10 -63.34 -18.71 63.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.725 -0.609 . . . . 1.78 110.602 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.02 -34.97 69.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 2.53 108.919 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.48 -39.56 81.29 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.694 0.759 . . . . 0.8 109.241 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.9 -44.47 94.23 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.646 -0.659 . . . . 1.42 110.527 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -70.07 -43.15 71.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.157 -0.964 . . . . 1.71 111.628 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -69.95 -40.07 75.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.001 -1.062 . . . . 1.57 112.476 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.63 -44.53 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.75 -1.219 . . . . 0.65 109.938 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.63 -38.59 76.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.487 -0.758 . . . . 0.82 110.168 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.07 -50.11 74.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.159 -0.963 . . . . 0.79 111.501 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.1 mt -60.97 -45.87 93.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.849 -1.157 . . . . 0.95 109.882 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.1 mt -60.86 -50.03 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.182 -0.948 . . . . 0.66 109.025 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -70.0 -40.59 75.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.65 -0.656 . . . . 2.2 110.857 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -81.16 -62.5 1.64 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.197 -0.939 . . . . 1.65 112.189 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -83.59 -1.0 52.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.122 -0.987 . . . . 2.03 111.934 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 58.98 39.08 23.98 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.929 -1.107 . . . . 1.42 109.741 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.6 mtp -92.36 167.43 12.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.482 -0.761 . . . . 1.18 109.645 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.0 p -84.2 163.44 19.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.98 109.945 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.57 -39.75 80.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.397 -0.814 . . . . 0.64 109.242 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -62.24 -42.45 99.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.306 -0.871 . . . . 2.07 110.231 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.87 -42.85 18.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.327 -0.858 . . . . 0.73 110.701 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.69 -47.32 66.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.16 -0.962 . . . . 0.54 110.791 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.6 -38.98 93.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.017 -1.052 . . . . 0.56 109.346 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.589 ' HB2' HD21 ' A' ' 138' ' ' LEU . 77.2 t60 -59.28 -40.85 87.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.519 -0.738 . . . . 1.54 109.808 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 110' ' ' GLY . 87.0 tt0 -64.32 -39.94 94.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 1.33 110.373 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.8 t -62.19 -55.51 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.148 -0.97 . . . . 0.72 111.132 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.431 HG21 ' CA ' ' A' ' 134' ' ' GLY . 45.6 mm -69.15 -40.04 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.804 -1.185 . . . . 0.85 108.82 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.459 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.4 tt0 -64.89 -39.88 94.22 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.832 -1.173 . . . . 2.44 107.832 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.02 -49.17 77.56 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.882 -1.287 . . . . 0.98 109.882 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -69.52 -51.66 33.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.948 -1.325 . . . . 1.41 109.222 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.91 -42.75 85.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.915 . . . . 1.2 109.282 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 40.5 t -58.36 -38.64 77.63 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.352 -0.842 . . . . 1.7 109.164 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.76 89.52 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.2 -0.938 . . . . 1.47 108.893 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.2 mt -63.05 -42.74 99.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.905 -1.122 . . . . 1.56 109.646 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.99 -33.08 71.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.871 -1.143 . . . . 2.2 109.468 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.57 -20.96 51.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 2.12 109.075 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.615 HD13 HD13 ' A' ' 123' ' ' LEU . 29.5 mt -61.59 142.35 57.18 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.97 -1.081 . . . . 2.0 108.293 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -92.37 28.58 1.9 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.03 -1.044 . . . . 3.23 110.883 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -116.89 128.5 55.3 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.189 -0.944 . . . . 2.49 109.733 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -67.86 -28.04 67.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.557 -0.714 . . . . 3.95 109.522 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.96 -41.81 97.45 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.237 1.018 . . . . 2.0 109.133 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.772 HD22 ' O ' ' B' ' 351' ' ' GLN . 91.7 mt -75.93 -33.03 59.84 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.208 -0.664 . . . . 1.86 109.208 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -60.06 -40.56 89.88 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.861 -0.792 . . . . 2.84 108.861 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -60.0 -48.36 82.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 2.73 109.163 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.786 ' NE ' HE22 ' B' ' 351' ' ' GLN . 61.1 mtm180 -69.33 -30.38 68.41 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.136 -1.026 . . . . 2.77 108.608 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.56 -27.0 68.87 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.39 -0.967 . . . . 1.19 108.39 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.0 -39.93 72.12 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.89 -0.782 . . . . 1.2 108.89 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -60.05 -44.44 94.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.416 -0.802 . . . . 1.55 110.567 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.06 -39.97 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.003 -1.061 . . . . 0.8 108.772 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -61.38 -39.95 92.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.299 -0.875 . . . . 3.09 109.894 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.95 -40.0 87.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 1.46 110.566 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 93.7 mt -60.04 -43.41 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.038 -1.039 . . . . 0.71 109.669 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.431 ' CA ' HG21 ' A' ' 108' ' ' ILE . . . -60.05 -43.93 97.75 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.894 -1.283 . . . . 0.57 109.894 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.09 -45.73 91.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -1.188 . . . . 2.59 110.561 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.413 HH22 HD11 ' A' ' 57' ' ' ILE . 56.4 mtp180 -64.82 -34.95 79.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.831 -1.168 . . . . 2.83 109.641 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.1 tp -59.97 -42.08 93.35 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.315 -0.866 . . . . 1.25 109.333 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 105' ' ' HIS . 59.3 mt -60.18 -41.83 93.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.088 -1.007 . . . . 0.7 109.703 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.544 ' NH1' HD11 ' A' ' 24' ' ' ILE . 64.4 mtm-85 -70.79 -40.04 72.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.111 -0.993 . . . . 2.57 109.802 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -61.02 -37.18 81.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 1.23 111.048 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.2 mt -69.99 -42.62 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.562 -1.336 . . . . 0.81 108.854 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.6 mt -70.03 -26.96 64.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.248 -0.649 . . . . 1.0 109.248 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.2 41.28 8.07 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.958 -1.657 . . . . 0.89 108.958 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.64 143.85 46.12 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.34 -1.094 . . . . 1.14 108.351 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -69.97 144.64 52.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.244 -0.91 . . . . 4.6 110.163 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.8 mt -109.88 127.93 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 122.176 0.989 . . . . 1.24 108.76 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.7 mt -69.99 -40.03 78.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-N 115.582 -0.736 . . . . 1.54 110.272 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 31.4 t0 64.22 123.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.514 -0.741 . . . . 1.5 109.442 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 mt -89.9 0.01 57.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.592 -0.692 . . . . 0.79 109.569 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.3 m -88.18 -18.46 28.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.234 -0.916 . . . . 1.4 110.716 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.69 16.52 2.16 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.072 -1.017 . . . . 0.92 112.008 -177.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.12 119.19 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.427 -1.421 . . . . 0.88 108.72 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -99.38 -9.51 23.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.183 -0.948 . . . . 2.45 110.806 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -110.19 144.82 38.29 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.405 -0.809 . . . . 1.52 110.052 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -65.61 135.61 55.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 1.58 108.993 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.4 m -152.86 166.47 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.571 -0.706 . . . . 0.69 109.419 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 83.7 mt -94.75 144.65 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 105.563 -2.014 . . . . 0.61 105.563 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 12.2 tp -96.58 117.45 30.98 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.812 -1.18 . . . . 0.87 110.48 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.3 t -122.37 130.03 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.595 -0.891 . . . . 0.71 108.595 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.415 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -159.27 164.2 35.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.095 -1.003 . . . . 0.81 109.074 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.46 ' O ' ' OD1' ' A' ' 162' ' ' ASP . . . -75.3 -30.61 60.41 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.317 -1.489 . . . . 0.98 108.681 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 66.6 m-20 -159.54 167.87 27.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.52 -0.738 . . . . 2.25 109.398 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 86.7 mt -141.68 125.83 17.4 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.175 -0.953 . . . . 0.78 108.473 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 70.3 p -93.23 148.49 35.74 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.083 -1.01 . . . . 0.98 109.827 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -39.64 -37.87 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.243 1.962 . . . . 0.81 112.389 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 73.8 m -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.207 -0.933 . . . . 0.9 109.673 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.8 -41.6 97.87 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.194 -0.941 . . . . 1.61 109.497 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 59.5 p -55.6 -31.63 62.4 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.178 -0.951 . . . . 0.61 111.389 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . . . -71.82 -55.01 8.36 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.578 -1.326 . . . . 0.6 109.446 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -82.43 40.35 0.65 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.8 -1.185 . . . . 1.4 107.8 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.409 ' H ' ' C ' ' A' ' 169' ' ' ALA . 62.3 tp -105.31 130.92 53.33 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.316 -0.994 . . . . 0.7 108.316 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -88.63 105.43 17.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.024 -1.048 . . . . 2.35 109.104 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 93.4 mt -63.69 -44.12 94.61 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.291 -0.881 . . . . 1.51 110.788 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -72.4 -22.29 61.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.854 -1.153 . . . . 2.33 112.528 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -93.45 -9.99 36.63 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.527 -1.358 . . . . 1.92 109.663 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.6 HG12 ' H ' ' A' ' 178' ' ' GLY . 99.2 t -107.99 119.05 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.306 -0.871 . . . . 0.67 109.254 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 70.1 mt -85.74 4.92 34.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.403 -0.811 . . . . 1.53 110.525 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.6 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 168.03 175.22 37.58 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.296 -1.522 . . . . 0.48 109.296 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.492 ' CE1' HG11 ' A' ' 176' ' ' VAL . 16.3 m-85 -133.61 130.48 38.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.402 -1.058 . . . . 0.55 109.144 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.415 ' CG2' HG21 ' A' ' 205' ' ' THR . 79.4 mt -130.66 122.21 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.568 -0.901 . . . . 0.65 108.568 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 59.0 p -144.7 159.77 42.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.111 -0.993 . . . . 0.82 111.279 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 53.3 t0 -103.02 25.87 8.87 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.353 -0.61 . . . . 2.46 109.353 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.7 -161.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.178 -1.576 . . . . 1.28 111.747 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.61 -54.87 6.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.588 -1.005 . . . . 2.19 110.588 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.96 -114.37 0.65 Allowed Glycine 0 N--CA 1.495 2.61 0 O-C-N 120.778 -1.424 . . . . 2.13 111.263 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -69.98 -24.14 63.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.677 -0.896 . . . . 5.86 111.648 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 75.7 p -82.85 3.15 30.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.597 -1.314 . . . . 3.72 110.664 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 34.3 t -91.61 126.86 36.84 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.918 -1.114 . . . . 1.74 111.08 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -55.98 -46.37 78.68 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.277 -0.89 . . . . 0.95 110.32 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -54.19 -39.99 67.14 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.14 -0.975 . . . . 1.55 110.238 -179.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 24.8 p -60.36 -39.6 87.75 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.003 -1.061 . . . . 1.51 110.454 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.9 -41.1 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.966 . . . . 1.67 110.188 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 91.6 mtp -62.57 -40.06 95.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.035 -1.04 . . . . 1.02 110.666 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.99 -40.45 73.34 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.613 -1.304 . . . . 0.68 108.594 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -59.62 -49.67 76.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 2.93 109.699 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 62.9 m -76.12 -31.24 58.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.18 -0.95 . . . . 0.86 110.798 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.82 -21.93 60.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.954 -1.091 . . . . 0.67 109.547 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 64.39 43.93 4.42 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.93 -0.481 . . . . 1.5 111.514 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.453 ' O ' ' OG ' ' A' ' 8' ' ' SER . 46.5 mt -121.08 142.1 34.17 Favored Pre-proline 0 N--CA 1.503 2.219 0 N-CA-C 107.601 -1.259 . . . . 0.72 107.601 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.72 143.84 99.46 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.508 1.472 . . . . 0.61 111.441 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.96 152.22 3.5 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.935 -1.106 . . . . 0.66 111.49 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.9 mt -124.27 143.46 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.739 -1.208 . . . . 0.79 107.739 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.5 m -125.49 -10.77 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.996 -1.065 . . . . 0.91 111.19 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -113.11 25.97 10.91 Favored Glycine 0 N--CA 1.501 3.012 0 N-CA-C 111.063 -0.815 . . . . 1.01 111.063 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.415 HG21 ' CG2' ' A' ' 180' ' ' ILE . 11.4 p -43.56 -43.75 5.76 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.001 -1.294 . . . . 0.99 109.757 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.434 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 96.01 -50.7 1.71 Allowed Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.439 -0.886 . . . . 1.12 111.418 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.2 m -160.08 40.0 0.18 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.53 -1.571 . . . . 1.72 111.457 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 12.1 t -77.54 -32.02 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.889 -1.132 . . . . 0.89 108.775 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 31.9 p -60.0 -39.89 87.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.558 -0.714 . . . . 1.03 110.829 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 81.8 p -82.47 -10.7 58.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.973 -1.079 . . . . 1.83 110.731 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -98.53 -16.82 19.01 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.21 -0.931 . . . . 2.27 110.724 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 213' ' ' LYS . 44.8 t -116.56 154.73 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 O-C-N 121.265 -0.897 . . . . 0.92 111.025 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.452 ' N ' HG12 ' A' ' 212' ' ' VAL . 2.8 mptp? -116.01 154.83 29.18 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.558 -1.275 . . . . 2.2 107.558 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 20.9 p30 -59.74 140.11 56.76 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.956 -1.09 . . . . 2.36 110.474 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.4 t0 88.97 5.7 0.16 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.049 0.452 . . . . 2.38 110.368 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 16' ' ' ALA . 59.4 m-20 -79.78 153.71 28.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.049 -1.032 . . . . 2.09 109.706 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -95.01 129.93 41.88 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.416 -0.802 . . . . 1.27 108.868 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.6 mt -130.72 151.18 51.45 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.136 -0.977 . . . . 0.75 110.769 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.9 mt -120.13 122.03 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 107.235 -1.394 . . . . 0.63 107.235 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 45.2 tp -103.33 120.02 39.98 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.823 -1.173 . . . . 0.7 108.73 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 10' ' ' GLY . 32.3 t0 -87.24 -37.36 17.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.936 -1.102 . . . . 2.31 108.918 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 45.52 24.49 0.18 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.594 -0.691 . . . . 0.78 109.363 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 45.0 t -137.28 -44.63 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 106.965 -1.494 . . . . 1.04 106.965 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -99.94 2.69 43.88 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.131 -1.433 . . . . 2.44 107.131 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.859 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.8 OUTLIER 59.94 45.11 12.68 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 116.101 -0.5 . . . . 1.55 110.03 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -139.48 138.38 36.35 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.137 -0.977 . . . . 1.99 109.828 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 97.1 t -120.01 122.38 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.807 -0.812 . . . . 0.77 108.807 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -90.61 130.71 36.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.87 -1.144 . . . . 0.98 108.499 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 62.9 t -107.69 123.19 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.58 -0.7 . . . . 0.85 109.709 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 66.6 t30 56.65 67.34 2.72 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.284 -0.885 . . . . 1.66 109.271 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -88.53 130.87 2.37 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 123.144 2.563 . . . . 0.95 112.827 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.654 HG22 ' N ' ' A' ' 233' ' ' ASN . 95.1 m -73.2 173.23 9.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.368 -0.832 . . . . 1.84 109.082 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.654 ' N ' HG22 ' A' ' 232' ' ' THR . 70.3 m-80 -60.0 -40.0 87.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.168 -0.957 . . . . 2.74 109.886 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.48 -39.99 92.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 2.89 109.944 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.2 t -68.29 -39.95 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.093 -1.004 . . . . 1.3 109.544 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.4 mt . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.076 -1.015 . . . . 1.09 108.672 179.508 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 31.7 ttp . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.414 0.626 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -154.86 152.43 29.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.057 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -150.04 162.8 39.68 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.061 -1.025 . . . . 0.0 109.958 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -154.3 151.64 29.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 0.0 109.255 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -108.99 130.98 55.48 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.302 -0.874 . . . . 0.0 110.059 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.433 ' O ' HG13 ' B' ' 306' ' ' VAL . 7.2 p -132.86 121.75 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-O 122.235 1.017 . . . . 0.0 112.512 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . 0.465 ' O ' HG23 ' B' ' 309' ' ' THR . 18.1 m -76.7 106.72 8.53 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.944 0.878 . . . . 0.0 111.086 -177.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 97.1 mt -53.18 121.36 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 122.191 0.996 . . . . 0.0 110.566 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . 0.465 HG23 ' O ' ' B' ' 307' ' ' THR . 81.8 p -110.76 19.98 18.06 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.232 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.92 118.02 59.33 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 120.928 -1.108 . . . . 0.0 108.826 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -49.65 -20.34 4.29 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 CA-C-N 120.216 1.113 . . . . 0.0 112.945 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -116.15 15.3 16.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.371 -0.831 . . . . 0.0 109.714 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.53 174.35 20.01 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.175 -1.97 . . . . 0.0 108.175 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 3.5 tp -83.52 94.27 8.0 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.981 -1.305 . . . . 0.0 109.459 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.413 ' NE2' ' HB3' ' B' ' 317' ' ' ARG . 3.6 p80 -99.94 -158.81 0.7 Allowed 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.085 -1.01 . . . . 0.0 109.978 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.7 m -59.95 -43.84 94.77 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.968 -1.083 . . . . 0.0 112.572 -175.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.541 HH12 ' NE2' ' B' ' 321' ' ' GLN . 11.9 tpt180 -54.1 -59.19 10.59 Favored Pre-proline 0 N--CA 1.499 2.025 0 O-C-N 120.335 -1.478 . . . . 0.0 111.271 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -60.59 -34.51 92.34 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 CA-C-N 120.531 1.225 . . . . 0.0 111.503 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.08 -50.88 71.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.364 -0.835 . . . . 0.0 109.034 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.71 -43.0 76.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.785 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . 0.541 ' NE2' HH12 ' B' ' 317' ' ' ARG . 83.0 mm-40 -70.02 -41.47 74.24 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.807 -1.183 . . . . 0.0 108.898 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -62.01 -52.91 62.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.548 -0.72 . . . . 0.0 110.554 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 87.0 t -65.73 -28.01 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.909 -1.119 . . . . 0.0 109.844 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -60.13 -46.66 88.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.123 -0.986 . . . . 0.0 110.057 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . 0.485 ' OE1' HD22 ' B' ' 380' ' ' LEU . 86.8 tt0 -66.1 -47.7 73.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.13 -0.981 . . . . 0.0 111.284 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.9 -53.4 58.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.64 -1.288 . . . . 0.0 111.34 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -57.16 -15.48 5.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.924 -1.11 . . . . 0.0 109.702 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -74.86 -30.07 60.06 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -101.71 146.23 28.03 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.318 -1.107 . . . . 0.0 108.594 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 24.3 p -89.79 -12.83 38.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.916 -1.115 . . . . 0.0 110.218 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.493 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 23.2 t -55.2 148.2 14.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.122 -0.986 . . . . 0.0 109.577 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -70.24 128.87 37.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.223 -0.923 . . . . 0.0 108.523 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.7 mt -131.48 131.15 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.568 -0.708 . . . . 0.0 109.817 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . 0.421 HG22 ' N ' ' B' ' 335' ' ' VAL . 89.4 m -130.39 154.48 47.65 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.548 -0.72 . . . . 0.0 109.531 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . 0.421 ' N ' HG22 ' B' ' 334' ' ' THR . 56.1 t -116.44 137.87 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 91.3 m -129.11 126.42 39.3 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.107 -0.995 . . . . 0.0 108.898 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 49.4 p -139.94 114.4 9.24 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.128 -0.983 . . . . 0.0 111.678 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 46.76 52.95 10.79 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 176.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.94 -13.92 63.31 Favored Glycine 0 N--CA 1.502 3.094 0 O-C-N 119.992 -1.692 . . . . 0.0 112.776 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -119.89 131.42 55.24 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-N 119.13 1.465 . . . . 0.0 109.86 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 89.4 p -132.0 151.5 51.7 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.776 0.798 . . . . 0.0 110.332 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.3 169.84 17.13 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.479 0.657 . . . . 0.0 109.929 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 3.6 t -91.63 140.11 30.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.342 -0.849 . . . . 0.0 110.707 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.47 ' HA ' HD11 ' B' ' 350' ' ' LEU . . . -79.47 -16.01 56.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 0.0 109.798 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -84.05 16.02 3.13 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . 0.419 ' H ' ' C ' ' B' ' 344' ' ' ALA . 93.4 p -149.99 95.7 2.33 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.048 0.928 . . . . 0.0 111.835 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.716 HD23 HD22 ' A' ' 79' ' ' LEU . 47.6 tp -60.17 -32.72 71.32 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.788 ' CE2' HD11 ' A' ' 79' ' ' LEU . 53.3 m-85 -54.61 -52.88 60.83 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.902 -1.124 . . . . 0.0 109.817 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -70.01 -39.89 75.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.246 -0.909 . . . . 0.0 110.549 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' B' ' 352' ' ' THR . 88.9 mt -49.93 -59.69 3.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.888 -1.132 . . . . 0.0 109.578 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.786 HE22 ' NE ' ' A' ' 126' ' ' ARG . 17.7 mm100 -42.21 -10.23 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.779 -0.575 . . . . 0.0 112.074 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.603 ' N ' ' O ' ' B' ' 350' ' ' LEU . 60.1 p -88.04 -5.07 58.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.336 -1.477 . . . . 0.0 109.48 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 91.4 mt -96.83 116.76 29.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.344 -0.848 . . . . 0.0 109.074 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.63 96.11 1.14 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 31.1 mt -106.17 96.81 6.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.342 -1.093 . . . . 0.0 109.634 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 21.4 p -97.55 159.64 14.8 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.942 -1.099 . . . . 0.0 110.687 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -52.81 119.29 4.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.691 -0.631 . . . . 0.0 110.66 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 101.51 4.07 52.86 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 63.2 m -87.52 111.25 21.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.454 -1.027 . . . . 0.0 111.093 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 45.2 t -77.12 117.74 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 122.291 1.044 . . . . 0.0 109.448 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 30.3 m -112.11 177.14 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 42.0 m -130.76 129.01 41.92 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 88.5 mt -104.7 122.36 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 69.6 m -126.95 135.98 51.65 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.63 156.21 42.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.199 -0.938 . . . . 0.0 109.527 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -147.95 124.57 11.1 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 159.15 -157.09 28.18 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.629 -1.748 . . . . 0.0 111.848 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -59.95 -55.06 38.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 122.249 -0.56 . . . . 0.0 111.995 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.493 ' H ' ' HB2' ' B' ' 331' ' ' SER . 95.9 m-20 -108.8 10.16 26.71 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.037 -1.039 . . . . 0.0 111.416 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.487 ' OE2' ' NE2' ' B' ' 371' ' ' GLN . 0.6 OUTLIER -43.97 -30.6 0.74 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.979 -1.075 . . . . 0.0 110.618 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . 0.487 ' NE2' ' OE2' ' B' ' 370' ' ' GLU . 92.1 mm-40 -70.04 -41.0 74.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.053 -1.029 . . . . 0.0 109.541 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -67.98 -49.45 61.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.128 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.78 -76.75 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.448 -0.783 . . . . 0.0 111.258 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.543 ' O ' HG23 ' B' ' 378' ' ' VAL . 46.3 t -45.31 -37.32 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 120.923 -1.111 . . . . 0.0 110.763 -177.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.73 -43.15 80.63 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.505 -1.372 . . . . 0.0 109.974 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -85.34 -43.18 13.91 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.751 -1.218 . . . . 0.0 110.09 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 84.9 mt -57.22 -38.17 73.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.95 -1.094 . . . . 0.0 108.919 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.543 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.5 t -66.78 -40.04 85.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.671 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -80.47 -10.08 59.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.67 -1.269 . . . . 0.0 109.727 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.485 HD22 ' OE1' ' B' ' 325' ' ' GLU . 57.2 tp -83.6 -26.78 29.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.654 -1.279 . . . . 0.0 108.08 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 18.3 tpp -80.64 -24.66 38.84 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -85.21 -9.57 57.63 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.767 -0.583 . . . . 0.0 109.736 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -110.6 -2.19 16.5 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.29 -0.881 . . . . 0.0 110.496 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 25.0 mt -91.45 119.63 31.59 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.82 -1.175 . . . . 0.0 109.334 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.498 1.94 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.019 179.751 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.616 -0.512 . . . . 2.91 109.616 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.5 mt -110.0 129.02 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.806 -0.813 . . . . 1.2 108.806 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -132.5 134.84 45.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.444 -0.785 . . . . 1.4 108.985 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.67 -163.11 19.57 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 108.723 -1.751 . . . . 1.05 108.723 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.498 ' CG2' ' HE ' ' A' ' 186' ' ' ARG . 96.9 mt -90.93 -10.38 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.033 -1.275 . . . . 1.15 109.891 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.4 tp 54.92 98.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.076 -1.015 . . . . 0.98 109.194 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.85 -36.65 62.35 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.565 -0.71 . . . . 0.88 109.5 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -149.75 144.46 17.77 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.135 -0.978 . . . . 1.69 109.949 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -80.05 140.93 14.48 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.693 2.262 . . . . 0.85 113.145 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.812 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 164.94 -163.93 36.72 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 109.468 -1.453 . . . . 0.92 109.468 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -149.98 150.0 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 121.12 -1.224 . . . . 0.81 108.784 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.73 155.74 33.65 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.813 -1.179 . . . . 0.51 110.682 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.8 m-85 -137.5 128.53 27.5 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.407 -0.96 . . . . 0.62 108.407 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.09 -179.92 46.92 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 118.814 -1.66 . . . . 0.55 110.769 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -79.9 157.33 26.95 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.734 -0.863 . . . . 2.1 108.97 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -101.02 129.49 46.87 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.434 -0.791 . . . . 0.77 111.157 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.5 tp -97.31 134.29 40.8 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 106.951 -1.5 . . . . 0.91 106.951 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.9 tp -118.71 122.17 41.85 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.333 -0.855 . . . . 0.93 110.836 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.9 mt -100.37 110.36 22.57 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.832 -0.543 . . . . 0.93 110.886 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -114.57 143.84 44.35 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.525 -0.734 . . . . 2.75 109.272 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.434 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 49.9 mp0 -127.93 130.72 48.94 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.34 -0.85 . . . . 3.0 108.99 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -72.47 144.3 48.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 2.77 109.492 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -61.74 140.36 58.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.304 -0.872 . . . . 2.94 108.972 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.4 mt -79.6 131.95 33.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.224 -0.922 . . . . 0.95 108.786 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.93 123.7 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.25 -0.906 . . . . 1.28 109.485 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -105.67 136.44 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.642 -0.874 . . . . 1.21 108.642 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -90.97 128.36 36.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.033 -1.042 . . . . 1.81 110.552 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.419 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.0 mmm-85 -92.57 7.37 43.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.639 -0.663 . . . . 2.8 109.316 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.55 145.27 54.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 2.87 109.744 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -87.86 139.45 30.5 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.386 -0.821 . . . . 2.35 109.267 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -90.59 163.62 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.896 -1.128 . . . . 0.97 109.899 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.7 p -94.52 169.15 10.4 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.244 -0.91 . . . . 1.17 108.939 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.75 -17.91 63.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.278 -0.889 . . . . 1.18 110.603 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -84.33 -28.45 27.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.688 -1.258 . . . . 2.56 108.094 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -82.07 -8.97 59.68 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.094 -0.706 . . . . 1.79 109.094 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.2 t -65.51 -54.73 25.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 120.916 -1.115 . . . . 1.0 108.571 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -59.97 -40.0 87.6 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.286 -0.884 . . . . 1.77 109.655 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -69.25 -41.84 76.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.228 -0.92 . . . . 2.7 110.684 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -63.33 -40.05 96.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.892 -1.13 . . . . 1.51 110.165 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.23 -46.82 95.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.785 -1.197 . . . . 0.93 108.153 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.26 -44.69 95.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.374 -0.829 . . . . 1.81 109.586 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.01 -43.15 95.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.942 -1.099 . . . . 2.78 108.281 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.422 ' CZ ' HD13 ' A' ' 89' ' ' ILE . 91.0 t80 -64.05 -46.06 86.07 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.345 -0.847 . . . . 0.78 108.902 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.04 -48.34 82.11 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.562 -0.903 . . . . 1.07 108.562 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -64.85 -42.79 94.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.183 -0.948 . . . . 1.12 108.551 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.88 -47.46 88.69 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.478 -1.849 . . . . 0.84 108.478 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -63.79 -37.97 89.35 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.076 -1.083 . . . . 3.09 108.076 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.14 -39.99 70.08 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.562 -0.903 . . . . 0.88 108.562 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 50' ' ' ALA . 31.9 ttpt -61.17 -74.06 0.09 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.655 -1.239 . . . . 2.59 107.655 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.18 -33.18 0.05 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.304 -0.872 . . . . 0.7 111.912 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.2 m -60.02 -50.3 74.29 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.385 -1.447 . . . . 1.4 108.603 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.15 75.85 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.412 -0.805 . . . . 0.67 110.943 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -66.6 -40.0 88.66 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.802 -1.186 . . . . 1.66 110.442 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.87 -40.11 95.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.951 -1.093 . . . . 1.58 109.595 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -60.04 -36.13 76.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 1.35 109.557 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.0 -42.28 98.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -0.977 . . . . 0.77 109.678 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.31 -39.99 87.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.401 -0.812 . . . . 0.63 109.714 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -54.64 -51.59 64.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.264 -0.897 . . . . 1.14 110.123 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -59.7 -34.57 73.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.79 110.791 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -67.13 -39.58 86.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.087 -1.008 . . . . 1.53 109.877 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.18 -42.42 96.71 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.607 -0.683 . . . . 0.57 109.527 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.21 -55.64 29.57 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.926 -1.269 . . . . 0.75 109.926 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.75 -48.09 70.21 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.885 -1.362 . . . . 1.59 109.656 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.6 m -62.84 -65.08 0.74 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 0.73 112.17 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -96.45 -48.74 5.44 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.717 -1.24 . . . . 0.75 111.357 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.76 -168.67 25.51 Favored Glycine 0 N--CA 1.502 3.075 0 C-N-CA 119.536 -1.316 . . . . 1.22 111.436 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -70.04 -26.29 63.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.993 -0.71 . . . . 5.81 110.695 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.486 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 52.8 tp10 -61.4 -35.25 76.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.309 -0.869 . . . . 3.37 110.679 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.45 ' HA ' HD12 ' A' ' 72' ' ' ILE . 40.9 mmtm -98.95 -20.8 16.59 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.175 -0.953 . . . . 1.77 109.984 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -70.03 -40.25 75.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.149 -0.97 . . . . 1.65 110.589 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.489 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.54 -31.71 72.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 0.77 109.788 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 69' ' ' LYS . 95.7 mt -59.97 -40.65 83.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.17 -0.956 . . . . 0.8 109.07 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -62.67 -40.91 98.55 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.131 -0.981 . . . . 0.88 109.503 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.518 ' CD ' ' NZ ' ' B' ' 324' ' ' LYS . 66.5 tt0 -63.32 -39.88 95.79 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.715 -0.794 . . . . 1.37 109.834 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.78 98.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.757 -1.737 . . . . 0.62 108.757 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -67.73 -42.26 82.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.386 -1.067 . . . . 1.5 109.4 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.1 mt -66.86 -46.37 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.209 -0.932 . . . . 0.63 109.106 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.8 ttp -60.09 -44.26 94.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.144 -0.973 . . . . 1.51 110.129 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.838 HD11 ' CE2' ' B' ' 348' ' ' PHE . 44.9 tp -59.95 -40.13 87.96 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.172 -0.955 . . . . 0.77 108.909 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.6 -39.23 93.35 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.868 -0.52 . . . . 0.62 110.231 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -81.86 2.39 30.55 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.073 -1.017 . . . . 1.47 111.082 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -48.81 125.96 11.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.777 -1.202 . . . . 1.47 109.056 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.1 -15.33 22.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.259 -0.901 . . . . 1.78 110.259 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -72.0 -35.03 69.32 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.987 -1.07 . . . . 2.53 108.61 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.03 -40.79 74.98 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.363 0.602 . . . . 0.8 110.05 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.28 -43.76 95.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 1.42 109.774 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -70.05 -41.62 73.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.547 -0.721 . . . . 1.71 111.17 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.02 -40.11 75.42 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.905 -1.122 . . . . 1.57 111.301 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.422 HD13 ' CZ ' ' A' ' 43' ' ' PHE . 72.5 mt -64.9 -49.41 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.113 -0.992 . . . . 0.65 109.561 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.41 -39.49 78.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.798 -0.564 . . . . 0.82 110.572 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.81 84.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.016 . . . . 0.79 110.821 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.07 -45.16 93.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.973 -1.079 . . . . 0.95 109.707 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.8 mt -61.37 -49.94 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.092 -1.005 . . . . 0.66 108.599 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -64.58 -41.41 96.3 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 120.067 -0.653 . . . . 2.2 110.157 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -80.14 -56.3 4.32 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.992 -1.068 . . . . 1.65 112.177 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -90.54 -2.47 57.9 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.103 -0.998 . . . . 2.03 112.677 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 57.5 39.65 27.73 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.693 -1.254 . . . . 1.42 109.585 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.7 mtp -92.11 169.22 10.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.545 -0.722 . . . . 1.18 109.82 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 42.9 p -83.37 160.63 21.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.362 -0.836 . . . . 0.98 109.412 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.56 88.55 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.499 -0.751 . . . . 0.64 110.335 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 32.7 p-10 -69.8 -35.91 75.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.189 -0.944 . . . . 2.07 109.627 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.432 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.5 -44.09 19.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.73 110.124 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.43 -44.97 70.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -0.963 . . . . 0.54 109.974 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.1 -39.39 85.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.134 -0.979 . . . . 0.56 109.655 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.525 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 85.5 t60 -59.93 -41.33 91.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.315 -0.866 . . . . 1.54 110.037 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.17 -39.92 86.53 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.142 -0.974 . . . . 1.33 111.214 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.3 t -58.24 -58.08 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.03 -1.044 . . . . 0.72 111.218 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.2 mm -70.1 -40.0 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.946 -1.097 . . . . 0.85 109.417 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.525 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 87.7 tt0 -60.41 -39.98 89.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 2.44 109.144 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.09 -50.13 71.05 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.432 -1.067 . . . . 0.98 110.432 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -61.12 -50.63 72.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.911 -1.347 . . . . 1.41 109.826 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.6 83.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.323 -0.861 . . . . 1.2 110.521 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.8 m -59.66 -39.97 86.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.892 -1.13 . . . . 1.7 108.781 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.66 -40.0 93.37 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.227 -0.92 . . . . 1.47 108.94 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.7 mt -61.19 -42.67 98.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.977 . . . . 1.56 109.47 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -55.15 -32.45 62.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.046 -1.034 . . . . 2.2 109.433 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -59.99 -23.61 63.79 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.192 -0.943 . . . . 2.12 108.93 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.414 HD13 HD13 ' A' ' 123' ' ' LEU . 58.2 mt -62.08 140.02 58.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.97 . . . . 2.0 109.02 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.7 p-10 -91.4 41.43 1.07 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.194 -0.941 . . . . 3.23 110.404 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 40.6 t0 -134.88 145.28 48.12 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.208 -0.932 . . . . 2.49 109.565 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.524 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 97.5 mt-10 -72.99 -64.7 0.92 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.439 -0.788 . . . . 3.95 109.045 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.453 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 4.1 t80 -38.55 -40.13 0.54 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.905 -0.497 . . . . 2.0 110.684 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.414 HD13 HD13 ' A' ' 118' ' ' LEU . 91.1 mt -72.44 -39.97 67.42 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.78 -1.2 . . . . 1.86 108.427 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 121' ' ' GLU . 19.9 ttpp -64.98 -40.87 95.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.485 -0.76 . . . . 2.84 109.058 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 94.8 mt-10 -62.53 -42.55 99.59 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.172 -1.047 . . . . 2.73 108.172 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.516 ' NH2' ' CB ' ' B' ' 319' ' ' ALA . 57.7 ttt180 -60.13 -40.02 88.33 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.923 -1.139 . . . . 2.77 107.923 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.73 -25.85 68.39 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.727 -0.842 . . . . 1.19 108.727 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -60.75 -41.07 94.67 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.168 -1.049 . . . . 1.2 108.168 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.18 -40.1 90.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.49 -0.756 . . . . 1.55 109.637 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.428 ' CG2' HE22 ' B' ' 351' ' ' GLN . 56.0 t -63.0 -41.37 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.132 -0.98 . . . . 0.8 109.469 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -63.06 -39.83 95.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.152 -0.967 . . . . 3.09 109.398 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -60.19 -40.55 90.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.363 -0.836 . . . . 1.46 110.393 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 98.3 mt -60.01 -45.77 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.098 -1.001 . . . . 0.71 110.382 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.94 -34.89 55.13 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.826 -1.31 . . . . 0.57 109.826 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.464 ' NZ ' HH21 ' A' ' 139' ' ' ARG . 24.8 tptp -59.99 -49.54 77.29 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.4 -1.059 . . . . 2.59 109.658 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -64.74 -33.57 76.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.917 -1.114 . . . . 2.83 109.793 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.2 tp -59.98 -41.02 91.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.363 -0.836 . . . . 1.25 109.094 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.44 -39.99 89.49 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.258 -0.901 . . . . 0.7 108.698 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.464 HH21 ' NZ ' ' A' ' 135' ' ' LYS . 98.8 mtt180 -67.06 -39.93 87.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.491 -0.756 . . . . 2.57 109.429 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -70.2 -25.68 63.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.45 -0.781 . . . . 1.23 111.64 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.3 mt -70.28 -40.09 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.211 -1.556 . . . . 0.81 109.008 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.6 mt -82.34 -26.83 32.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.459 -0.775 . . . . 1.0 110.202 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.95 47.61 5.22 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.034 -1.626 . . . . 0.89 109.034 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.1 tp -74.29 145.48 43.95 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.381 -1.07 . . . . 1.14 109.448 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.24 137.19 58.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 4.6 109.584 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.0 mt -113.97 130.03 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-O 121.975 0.893 . . . . 1.24 109.283 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.51 -42.2 94.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.769 -0.582 . . . . 1.54 110.366 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.6 t0 68.22 91.97 0.09 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.49 -0.756 . . . . 1.5 109.011 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.7 mt -64.08 -6.64 6.77 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.515 -0.741 . . . . 0.79 111.231 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.5 m -82.82 -14.74 53.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.651 -1.281 . . . . 1.4 110.069 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.41 30.91 0.4 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.108 -0.995 . . . . 0.92 112.133 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 41.9 mm -90.31 121.19 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 120.485 -1.384 . . . . 0.88 109.205 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -103.06 -12.54 17.34 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.337 -0.852 . . . . 2.45 110.537 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -128.37 152.09 48.58 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.077 -1.015 . . . . 1.52 110.46 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.32 137.0 57.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.497 -0.752 . . . . 1.58 109.402 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.5 m -152.54 164.38 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.943 -0.762 . . . . 0.69 108.943 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -93.77 146.49 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.486 -1.672 . . . . 0.61 106.486 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.5 tp -94.56 114.59 26.58 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.18 -0.95 . . . . 0.87 110.679 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.523 ' CG1' HG22 ' A' ' 209' ' ' THR . 49.6 t -120.03 127.12 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 108.042 -1.095 . . . . 0.71 108.042 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.05 160.0 40.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.168 -0.958 . . . . 0.81 108.999 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.462 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -76.43 -30.09 57.26 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.266 -1.521 . . . . 0.98 107.872 178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 57.2 t0 -170.05 134.09 1.23 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.334 -0.854 . . . . 2.25 108.894 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.445 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 81.8 mt -111.22 125.02 53.37 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.217 -0.927 . . . . 0.78 108.905 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 51.9 p -83.83 146.6 49.66 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.98 109.292 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -39.91 -37.15 1.52 Allowed 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.298 1.998 . . . . 0.81 113.235 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.6 m -59.99 -41.04 91.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.069 -1.019 . . . . 0.9 109.699 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.13 -40.66 71.27 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.222 -0.924 . . . . 1.61 110.342 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.1 p -53.12 -29.88 33.41 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.015 -1.053 . . . . 0.61 111.447 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -76.46 -56.82 4.28 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.754 -1.216 . . . . 0.6 110.327 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -77.12 37.04 0.19 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.36 -0.978 . . . . 1.4 108.36 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.491 ' H ' ' C ' ' A' ' 169' ' ' ALA . 58.6 tp -102.06 137.32 40.5 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.369 -0.604 . . . . 0.7 109.369 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.461 ' O ' HG23 ' A' ' 176' ' ' VAL . 18.2 m120 -82.76 101.08 10.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.163 -0.96 . . . . 2.35 109.239 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 99.5 mt -66.19 -41.98 89.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.167 -0.958 . . . . 1.51 110.719 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -65.92 -28.82 69.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.857 -1.152 . . . . 2.33 111.568 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -92.52 -8.26 45.01 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.778 -1.201 . . . . 1.92 110.133 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 172' ' ' ASN . 94.3 t -101.8 112.18 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.28 -1.008 . . . . 0.67 108.28 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.03 5.15 30.62 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.28 -0.888 . . . . 1.53 110.709 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.435 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.97 173.38 38.04 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.309 -1.517 . . . . 0.48 109.309 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.448 ' CE1' HG11 ' A' ' 176' ' ' VAL . 15.4 m-85 -132.08 129.61 40.19 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.467 -1.02 . . . . 0.55 109.186 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.2 mt -134.12 127.09 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.372 -0.83 . . . . 0.65 108.943 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.5 p -149.78 160.26 43.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.982 -1.074 . . . . 0.82 110.387 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 20.1 p-10 -102.41 23.02 12.44 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.411 -0.806 . . . . 2.46 109.458 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -52.68 -165.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.081 -1.012 . . . . 1.28 111.951 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -75.52 -54.31 5.57 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.869 -0.892 . . . . 2.19 110.869 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 173.61 -140.28 5.47 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.053 -1.546 . . . . 2.13 110.824 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.498 ' HE ' ' CG2' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -65.55 -34.14 77.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.634 -0.921 . . . . 5.86 111.159 -178.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 12.9 p -59.95 4.24 0.05 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.942 -1.099 . . . . 3.72 110.879 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.497 ' H ' ' C ' ' A' ' 186' ' ' ARG . 17.1 m -91.93 131.66 37.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.771 -1.205 . . . . 1.74 110.29 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -47.26 -37.58 10.86 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.827 -1.175 . . . . 0.95 107.827 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.412 ' H ' HG23 ' A' ' 190' ' ' THR . 7.4 p -57.7 -41.85 82.51 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.546 -0.752 . . . . 1.55 110.368 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 75.4 m -61.38 -40.08 93.04 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.158 -0.964 . . . . 1.51 111.518 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.91 -40.48 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.114 -0.991 . . . . 1.67 109.548 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 76.9 mtp -58.89 -49.53 77.43 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.353 -0.842 . . . . 1.02 109.94 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.33 -47.05 62.8 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.961 -1.087 . . . . 0.68 110.024 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -62.53 -57.97 9.24 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 118.565 -1.254 . . . . 2.93 109.957 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.1 m -61.24 -40.01 92.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.048 -1.033 . . . . 0.86 111.657 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.96 -23.69 62.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.887 -1.133 . . . . 0.67 109.824 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 64.9 47.81 2.53 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.444 0.64 . . . . 1.5 109.547 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 86.0 mt -126.95 150.05 70.79 Favored Pre-proline 0 N--CA 1.501 2.103 0 N-CA-C 108.568 -0.901 . . . . 0.72 108.568 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.56 141.58 74.03 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.213 1.942 . . . . 0.61 111.67 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.58 153.82 3.56 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.797 -1.161 . . . . 0.66 111.518 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.8 mt -128.08 139.47 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.818 -1.179 . . . . 0.79 107.818 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.5 m -121.83 -11.31 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 120.959 -1.088 . . . . 0.91 111.362 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.1 26.42 15.32 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 110.465 -1.054 . . . . 1.01 110.465 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.8 p -46.42 -42.21 14.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.102 -1.234 . . . . 0.99 109.841 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.59 -54.04 4.1 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 120.125 -1.036 . . . . 1.12 111.104 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 84.9 p -152.58 28.41 0.55 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.556 -1.555 . . . . 1.72 111.567 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 73.0 t -74.03 -40.71 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.666 -1.271 . . . . 0.89 109.136 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.523 HG22 ' CG1' ' A' ' 159' ' ' VAL . 7.7 p -60.95 -30.87 70.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.102 -0.999 . . . . 1.03 110.5 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 79.3 p -79.97 -10.94 59.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.981 -1.074 . . . . 1.83 109.363 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -105.14 -10.92 16.82 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.569 -0.707 . . . . 2.27 109.948 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 79.8 t -101.64 139.99 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.407 -0.808 . . . . 0.92 109.957 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.68 145.89 38.45 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.393 -1.336 . . . . 2.2 107.393 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.476 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 10.4 p30 -54.78 138.2 42.9 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.016 -1.053 . . . . 2.36 110.42 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.3 m-20 86.81 3.66 0.43 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 120.988 0.423 . . . . 2.38 110.434 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -76.26 150.39 37.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.015 -1.053 . . . . 2.09 109.156 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -99.43 119.84 38.64 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.261 -1.015 . . . . 1.27 108.261 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 67.8 mt -126.57 148.51 49.74 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.398 -0.814 . . . . 0.75 110.782 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.8 mt -115.59 128.3 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 107.502 -1.296 . . . . 0.63 107.502 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.0 tp -100.7 118.19 36.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.122 -0.986 . . . . 0.7 109.432 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 10' ' ' GLY . 94.7 m-20 -77.15 -43.2 34.83 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.213 -0.929 . . . . 2.31 108.557 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.89 17.64 0.67 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.857 -1.164 . . . . 0.78 107.857 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.441 ' N ' ' C ' ' A' ' 221' ' ' ASP . 56.4 t -136.05 -36.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.942 -1.133 . . . . 1.04 107.942 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -105.51 3.44 29.43 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.845 -1.169 . . . . 2.44 107.845 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 60.54 43.67 12.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.822 -0.549 . . . . 1.55 111.259 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.415 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 11.9 pt20 -150.0 152.78 35.45 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.723 -1.236 . . . . 1.99 110.314 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 91.1 t -119.94 123.38 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 109.043 -0.725 . . . . 0.77 109.043 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.415 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 74.0 m-85 -84.62 128.19 34.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.011 -1.055 . . . . 0.98 109.221 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.18 116.62 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.472 -0.768 . . . . 0.85 109.152 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 62.32 67.48 1.2 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 1.66 109.989 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -87.05 131.1 3.08 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 123.048 2.498 . . . . 0.95 112.375 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.464 HG22 ' N ' ' A' ' 233' ' ' ASN . 25.3 m -68.56 163.85 22.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 1.84 109.59 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.464 ' N ' HG22 ' A' ' 232' ' ' THR . 43.0 t30 -59.93 -42.1 93.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.293 -0.879 . . . . 2.74 110.681 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.42 -33.6 72.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.818 -1.176 . . . . 2.89 109.335 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.77 -40.34 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.252 -0.905 . . . . 1.3 109.361 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.8 mt . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.231 -0.918 . . . . 1.09 109.863 -179.872 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 43.3 ttm . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.468 0.652 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -149.23 144.97 26.87 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -150.76 160.0 44.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.874 -1.141 . . . . 0.0 110.787 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -154.64 149.57 26.75 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -117.66 134.68 54.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.252 -0.905 . . . . 0.0 109.629 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.8 129.97 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 CA-C-O 122.192 0.996 . . . . 0.0 112.356 -177.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . 0.448 ' OG1' HG22 ' B' ' 360' ' ' VAL . 57.3 m -76.24 108.06 8.92 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.31 1.052 . . . . 0.0 110.958 -178.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 90.5 mt -53.82 120.93 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 122.413 1.102 . . . . 0.0 111.278 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 60.3 p -109.82 19.97 18.54 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.005 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.0 136.09 87.32 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.964 -1.085 . . . . 0.0 108.429 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -65.9 -21.82 56.79 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 CA-C-N 119.929 1.01 . . . . 0.0 112.609 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -121.99 15.24 10.78 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.417 -0.802 . . . . 0.0 108.931 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.19 -175.76 52.3 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.453 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -85.85 91.97 8.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.05 -1.265 . . . . 0.0 109.063 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -92.43 -162.8 0.96 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.831 -1.168 . . . . 0.0 109.969 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 16.0 m -58.56 -43.35 89.33 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.888 -1.133 . . . . 0.0 112.47 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.7 HH21 ' NE2' ' B' ' 321' ' ' GLN . 1.9 tpt180 -55.58 -61.07 6.82 Favored Pre-proline 0 N--CA 1.5 2.025 0 O-C-N 120.517 -1.364 . . . . 0.0 111.46 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -60.22 -36.79 86.92 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 CA-C-N 120.229 1.118 . . . . 0.0 111.939 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . 0.516 ' CB ' ' NH2' ' A' ' 126' ' ' ARG . . . -63.26 -16.82 61.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 0.0 109.357 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -82.46 -44.47 15.98 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . 0.7 ' NE2' HH21 ' B' ' 317' ' ' ARG . 95.4 mt-30 -72.48 -39.13 67.93 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -62.08 -54.55 39.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 110.302 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . 0.41 HG13 ' O ' ' B' ' 344' ' ' ALA . 52.7 t -63.82 -28.58 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.706 -1.246 . . . . 0.0 110.001 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . 0.518 ' NZ ' ' CD ' ' A' ' 74' ' ' GLU . 11.7 ttmm -60.33 -45.69 92.55 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 109.818 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -62.33 -49.55 75.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.52 -0.738 . . . . 0.0 110.375 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.02 -54.03 50.88 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.054 -1.029 . . . . 0.0 111.468 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -53.86 -16.17 1.67 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.788 -1.195 . . . . 0.0 109.904 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.7 -25.16 75.84 Favored Glycine 0 N--CA 1.487 2.033 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -105.97 141.69 36.94 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.518 -0.989 . . . . 0.0 109.726 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . 0.454 HG22 ' O ' ' B' ' 330' ' ' THR . 54.3 m -89.04 -10.04 48.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.237 -0.914 . . . . 0.0 109.242 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 26.8 m -62.36 150.96 38.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.084 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.86 133.47 49.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.061 -1.025 . . . . 0.0 109.086 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 87.1 mt -129.9 130.12 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.557 -0.714 . . . . 0.0 109.167 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 78.2 m -126.85 148.75 49.96 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.502 0.668 . . . . 0.0 109.287 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 48.3 t -114.07 139.55 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 28.7 m -130.18 121.28 25.94 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.173 -0.954 . . . . 0.0 109.046 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 31.0 t -138.5 115.11 10.58 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.888 0.851 . . . . 0.0 110.525 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 47.56 51.92 13.16 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.04 -14.55 48.63 Favored Glycine 0 N--CA 1.5 2.952 0 O-C-N 119.971 -1.705 . . . . 0.0 112.629 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -111.67 121.73 45.9 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 119.104 1.452 . . . . 0.0 110.222 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 39.1 m -106.57 156.31 18.72 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.719 0.771 . . . . 0.0 110.796 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . 0.44 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -152.47 152.66 32.22 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.427 0.632 . . . . 0.0 110.036 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 8.6 t -87.99 131.42 34.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.303 -0.873 . . . . 0.0 109.686 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.41 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -70.83 -16.21 62.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.093 -1.005 . . . . 0.0 109.771 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . 0.422 ' HG2' ' H ' ' B' ' 345' ' ' LYS . 12.6 ptmt -86.83 21.08 2.35 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 10.7 t -150.8 98.53 2.62 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.18 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.828 HD23 HD22 ' A' ' 79' ' ' LEU . 19.3 tp -60.06 -30.6 69.31 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.838 ' CE2' HD11 ' A' ' 79' ' ' LEU . 63.2 m-85 -58.09 -54.36 47.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.414 -0.804 . . . . 0.0 110.718 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -68.28 -40.06 81.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.885 -1.134 . . . . 0.0 109.509 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.59 ' O ' ' N ' ' B' ' 352' ' ' THR . 30.9 mt -49.87 -56.99 8.37 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.934 -1.104 . . . . 0.0 108.102 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.428 HE22 ' CG2' ' A' ' 130' ' ' VAL . 28.6 mt-30 -40.23 -13.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.044 -0.41 . . . . 0.0 111.799 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.59 ' N ' ' O ' ' B' ' 350' ' ' LEU . 77.0 p -93.99 -13.21 27.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.451 -1.406 . . . . 0.0 110.613 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' B' ' 342' ' ' ALA . 63.3 mt -90.54 118.89 30.35 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.847 -1.158 . . . . 0.0 109.077 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.8 90.95 0.67 Allowed Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 20.8 mt -96.77 84.69 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -1.168 . . . . 0.0 108.265 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 30.7 p -88.29 174.3 8.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.431 -0.793 . . . . 0.0 110.566 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -69.16 114.71 7.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.532 -0.73 . . . . 0.0 110.891 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.98 8.94 38.25 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 28.7 m -93.58 111.08 22.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -1.167 . . . . 0.0 110.921 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . 0.448 HG22 ' OG1' ' B' ' 307' ' ' THR . 11.2 t -77.25 120.23 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 122.141 0.972 . . . . 0.0 109.773 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 18.3 m -112.51 177.32 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 62.0 m -131.37 129.57 41.53 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 77.0 mt -104.53 117.46 50.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 96.8 p -126.27 136.75 53.16 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.426 -0.796 . . . . 0.0 109.593 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.23 154.02 40.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.395 -0.816 . . . . 0.0 109.886 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -142.99 122.47 13.17 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.494 ' O ' ' OE1' ' B' ' 370' ' ' GLU . . . 162.23 -160.24 32.39 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 118.689 -1.72 . . . . 0.0 111.81 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . 0.471 ' N ' ' OG ' ' B' ' 331' ' ' SER . 52.2 tp10 -59.97 -50.08 75.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.145 -0.621 . . . . 0.0 112.322 -177.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.491 ' N ' ' OG ' ' B' ' 331' ' ' SER . 49.5 m-20 -113.3 12.8 18.98 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.869 -1.144 . . . . 0.0 111.592 -177.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.584 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 1.1 pm0 -43.09 -27.86 0.24 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.177 -0.952 . . . . 0.0 110.351 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . 0.489 ' N ' ' CD ' ' B' ' 370' ' ' GLU . 4.4 pt20 -70.08 -42.37 72.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 0.0 109.84 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -65.17 -48.38 73.7 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.203 -0.936 . . . . 0.0 108.918 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.23 -76.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.401 -0.812 . . . . 0.0 110.859 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.462 ' O ' HG23 ' B' ' 378' ' ' VAL . 59.6 t -46.0 -37.41 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.0 -1.062 . . . . 0.0 110.817 -177.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.34 -49.28 74.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.595 -1.316 . . . . 0.0 110.446 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -77.55 -43.59 31.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.004 -1.06 . . . . 0.0 110.521 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 44.5 mt -60.63 -39.73 89.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -0.893 . . . . 0.0 110.197 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.462 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.7 t -64.34 -39.99 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.958 -1.089 . . . . 0.0 109.291 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -70.01 -56.55 6.68 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.768 -1.208 . . . . 0.0 107.859 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 64.5 tp -58.01 -28.38 64.38 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.449 -0.782 . . . . 0.0 111.33 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . 0.517 ' SD ' ' O ' ' B' ' 381' ' ' MET . 0.0 OUTLIER -73.67 -38.13 65.03 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.104 -1.623 . . . . 0.0 108.382 178.24 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.7 -4.52 54.69 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 110.321 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -111.37 -1.91 15.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.158 -0.964 . . . . 0.0 111.075 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . 0.427 ' CD2' ' OE1' ' B' ' 321' ' ' GLN . 23.8 mt -89.16 127.4 35.73 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.332 -1.48 . . . . 0.0 110.179 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 117.974 -1.012 . . . . 0.0 108.75 179.049 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.088 0.471 . . . . 2.91 109.884 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 94.5 mt -106.94 120.02 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.442 -0.786 . . . . 1.2 109.108 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.8 m -132.42 134.97 45.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.503 -0.748 . . . . 1.4 109.392 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.776 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -119.34 -162.01 11.84 Favored Glycine 0 N--CA 1.501 2.99 0 N-CA-C 108.872 -1.691 . . . . 1.05 108.872 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.468 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.5 mt -89.4 -18.46 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.938 -1.331 . . . . 1.15 110.249 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 5' ' ' ILE . 62.7 tp 54.68 105.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.369 -0.832 . . . . 0.98 108.849 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.15 -24.1 14.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.132 -0.98 . . . . 0.88 109.338 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 19.5 t -138.33 124.74 12.91 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.446 -0.784 . . . . 1.69 109.81 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.65 145.18 16.12 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.974 1.783 . . . . 0.85 112.122 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.805 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 158.03 -158.83 29.49 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.481 -1.448 . . . . 0.92 109.481 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.7 mt -149.68 150.81 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.169 -1.194 . . . . 0.81 108.661 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.44 155.47 33.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.073 -1.017 . . . . 0.51 110.168 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.2 m-85 -136.58 129.56 31.02 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.679 -1.23 . . . . 0.62 107.679 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.29 -178.76 47.62 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 118.349 -1.881 . . . . 0.55 110.951 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -79.96 157.09 26.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.814 -0.815 . . . . 2.1 109.53 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.434 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -102.82 129.19 49.4 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.363 -0.836 . . . . 0.77 111.108 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.0 tp -99.66 131.05 45.9 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.629 -1.249 . . . . 0.91 107.629 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.5 tp -111.21 120.09 41.11 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.08 -1.012 . . . . 0.93 109.5 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 160' ' ' ALA . 35.7 mt -85.51 104.04 14.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.55 -0.718 . . . . 0.93 109.467 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -93.19 135.48 34.34 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.7 -0.852 . . . . 2.75 108.7 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.01 118.45 20.62 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.686 -0.857 . . . . 3.0 108.686 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -76.7 141.64 40.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.102 -0.998 . . . . 2.77 109.448 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -60.06 140.07 57.07 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.325 -0.859 . . . . 2.94 108.774 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 84.8 mt -77.76 135.24 26.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.556 -0.905 . . . . 0.95 108.556 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.7 t -100.6 122.63 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.271 -0.893 . . . . 1.28 109.878 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.1 mt -95.43 141.86 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.969 -0.752 . . . . 1.21 108.969 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -97.67 119.44 36.24 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.171 -0.956 . . . . 1.81 109.491 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -94.47 3.24 55.4 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.282 -0.886 . . . . 2.8 109.467 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -59.97 139.98 57.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.419 -0.801 . . . . 2.87 109.908 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -93.07 144.94 24.78 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.158 -0.963 . . . . 2.35 108.597 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 pt -103.17 166.92 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.121 -0.987 . . . . 0.97 110.863 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.9 p -96.9 177.63 5.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.349 -0.844 . . . . 1.17 109.332 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.08 -49.9 75.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.452 -0.78 . . . . 1.18 110.877 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -58.06 -29.81 65.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.525 -1.359 . . . . 2.56 109.991 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -81.56 -11.44 59.16 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.147 -0.97 . . . . 1.79 110.242 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.7 t -60.04 -50.03 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.861 -1.149 . . . . 1.0 108.729 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -61.22 -39.96 92.21 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.479 -0.763 . . . . 1.77 109.347 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -64.14 -43.45 95.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.411 -0.806 . . . . 2.7 111.274 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -63.56 -41.11 98.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.74 -1.225 . . . . 1.51 110.168 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.04 -46.08 94.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 118.709 -1.196 . . . . 0.93 108.794 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -60.03 -42.33 94.15 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.068 -1.02 . . . . 1.81 109.382 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.484 HH11 ' HG2' ' A' ' 42' ' ' ARG . 25.1 mtt-85 -60.06 -44.66 94.56 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.937 -1.134 . . . . 2.78 107.937 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -60.18 -45.76 92.03 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.393 -0.966 . . . . 0.78 108.393 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.98 -49.82 76.15 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.801 -0.815 . . . . 1.07 108.801 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.505 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 28.8 t -60.05 -42.2 93.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.048 -1.032 . . . . 1.12 109.174 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.0 -42.55 98.41 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.191 -1.964 . . . . 0.84 108.191 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.1 ttm-85 -60.07 -32.97 71.43 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.225 -1.028 . . . . 3.09 108.225 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.9 -40.09 83.44 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.743 -0.598 . . . . 0.88 109.631 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 50' ' ' ALA . 12.1 ttmt -75.16 -74.82 0.19 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.55 -1.26 . . . . 2.59 108.384 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -39.0 -39.32 0.53 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.16 -0.963 . . . . 0.7 111.459 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.9 p -55.95 -59.11 5.36 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.704 -1.247 . . . . 1.4 109.252 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.21 -40.01 82.23 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.249 -0.907 . . . . 0.67 111.331 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -63.39 -40.63 97.74 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.772 -1.205 . . . . 1.66 110.975 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.5 -40.07 96.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.758 -1.213 . . . . 1.58 109.078 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -59.92 -38.57 82.72 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.41 -0.806 . . . . 1.35 109.995 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -64.62 -43.68 92.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.915 -1.116 . . . . 0.77 109.226 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.441 ' CD1' HH22 ' A' ' 136' ' ' ARG . 87.9 mt -60.01 -40.01 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 0.63 108.936 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -55.58 -50.03 71.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.39 -0.818 . . . . 1.14 109.958 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -59.41 -36.32 75.64 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.316 -0.865 . . . . 0.79 111.002 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -62.37 -39.64 93.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.914 -1.116 . . . . 1.53 109.534 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.35 -45.25 80.82 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.629 -0.669 . . . . 0.57 110.218 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.63 -52.25 51.6 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.705 -1.358 . . . . 0.75 109.705 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.08 -46.5 64.78 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.135 -1.215 . . . . 1.59 110.214 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.7 m -67.27 -63.45 1.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.195 -0.94 . . . . 0.73 112.697 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -96.23 -45.08 6.99 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.786 -1.196 . . . . 0.75 111.29 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.64 -174.04 23.22 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 119.644 -1.265 . . . . 1.22 111.309 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -70.05 -26.68 64.13 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.395 0.617 . . . . 5.81 110.348 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -60.98 -32.76 72.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.447 -0.783 . . . . 3.37 110.703 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -100.44 -20.51 15.75 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.37 -0.831 . . . . 1.77 109.374 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -66.24 -40.09 89.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 1.65 110.329 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.579 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -66.35 -26.92 67.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.77 109.718 -178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.0 mt -60.03 -41.81 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.952 -1.092 . . . . 0.8 109.174 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -66.56 -39.84 88.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.264 -0.898 . . . . 0.88 110.089 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.51 ' CD ' ' NZ ' ' B' ' 324' ' ' LYS . 61.6 tt0 -60.06 -39.95 87.8 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.232 -0.917 . . . . 1.37 109.387 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.89 -46.06 95.3 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.308 -1.517 . . . . 0.62 109.308 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.4 m170 -60.09 -42.05 93.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.201 -1.176 . . . . 1.5 109.459 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.1 mt -68.43 -45.9 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.342 -0.849 . . . . 0.63 109.526 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.2 ttp -59.98 -44.12 94.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.83 -1.168 . . . . 1.51 110.074 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.854 HD11 ' CE2' ' B' ' 348' ' ' PHE . 26.5 tp -64.53 -39.94 94.7 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.202 -0.937 . . . . 0.77 109.248 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.2 tp -62.78 -39.87 95.53 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.567 -0.708 . . . . 0.62 109.589 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -84.69 4.15 33.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.215 -0.928 . . . . 1.47 110.152 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.6 t0 -50.02 133.06 23.16 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.127 -0.983 . . . . 1.47 110.867 -178.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.45 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 95.4 mt-10 -61.46 -20.31 62.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.571 -0.706 . . . . 1.78 110.005 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -68.22 -32.73 73.14 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.902 -1.147 . . . . 2.53 107.902 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 79' ' ' LEU . 94.0 mt -75.97 -40.0 54.79 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.509 0.671 . . . . 0.8 110.28 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -60.06 -49.98 75.52 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.269 -0.894 . . . . 1.42 110.282 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -70.7 -41.64 71.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.114 -0.991 . . . . 1.71 110.656 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.08 -39.92 75.33 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.21 -0.931 . . . . 1.57 111.822 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.04 -43.9 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.765 -1.21 . . . . 0.65 109.35 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.7 mt -70.04 -39.34 77.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.574 -0.704 . . . . 0.82 110.101 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.05 -48.3 82.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.249 -0.907 . . . . 0.79 111.248 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 96' ' ' LYS . 92.5 mt -60.1 -44.96 94.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.855 -1.153 . . . . 0.95 109.862 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.96 -49.19 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.343 -0.984 . . . . 0.66 108.343 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -69.33 -41.79 76.21 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.123 -0.631 . . . . 2.2 110.759 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -81.34 -50.33 9.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.002 -1.061 . . . . 1.65 112.043 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 92' ' ' LEU . 68.2 mmtt -92.46 -1.85 56.69 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.041 -1.037 . . . . 2.03 111.838 -177.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 55.72 33.84 22.15 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.785 -1.197 . . . . 1.42 109.562 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 93.9 mtp -89.56 168.95 11.76 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.526 -0.734 . . . . 1.18 110.047 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.3 p -81.11 160.01 24.55 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.74 -0.837 . . . . 0.98 108.74 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.41 -38.9 91.33 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.054 -1.029 . . . . 0.64 109.282 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -66.68 -39.3 88.07 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.281 -0.887 . . . . 2.07 109.532 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.76 -44.2 33.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.73 110.113 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.13 -45.35 73.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.893 . . . . 0.54 109.895 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.67 83.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.117 -0.989 . . . . 0.56 109.547 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -59.88 -44.63 94.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.351 -0.843 . . . . 1.54 110.266 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 110' ' ' GLY . 88.6 tt0 -62.6 -40.69 97.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.898 . . . . 1.33 110.441 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.74 -55.74 21.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.229 -0.919 . . . . 0.72 110.84 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.476 HG21 ' HA3' ' A' ' 134' ' ' GLY . 43.1 mm -70.54 -40.04 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.784 -1.197 . . . . 0.85 109.491 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.438 ' OE2' ' OG ' ' A' ' 113' ' ' SER . 12.2 tm-20 -68.3 -39.97 81.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 2.44 108.8 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -60.57 -45.85 95.52 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.04 -1.224 . . . . 0.98 110.04 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.484 HE21 ' CB ' ' B' ' 348' ' ' PHE . 16.5 mm100 -69.95 -53.06 19.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.989 -1.301 . . . . 1.41 109.749 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.93 -40.04 69.49 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.088 -1.008 . . . . 1.2 109.229 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.438 ' OG ' ' OE2' ' A' ' 109' ' ' GLU . 59.1 m -60.0 -40.07 87.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.959 . . . . 1.7 109.275 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.09 -33.53 75.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 1.47 109.128 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.2 mt -69.06 -39.97 78.78 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.075 -1.016 . . . . 1.56 109.66 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.02 -27.94 67.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.858 -1.151 . . . . 2.2 109.194 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -59.94 -23.49 63.6 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.364 -0.976 . . . . 2.12 108.364 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.464 HD13 HD13 ' A' ' 123' ' ' LEU . 24.6 mt -62.15 151.54 35.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 2.0 109.115 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -99.49 30.05 3.75 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.214 -0.929 . . . . 3.23 110.16 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -118.07 131.27 56.46 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.19 -0.944 . . . . 2.49 110.637 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -70.07 -29.77 66.85 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.11 -0.7 . . . . 3.95 109.11 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.469 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.4 t80 -69.72 -38.93 77.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.603 -0.686 . . . . 2.0 110.38 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.506 HD22 ' O ' ' B' ' 351' ' ' GLN . 88.2 mt -73.15 -32.94 65.19 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.069 -1.019 . . . . 1.86 109.262 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -60.02 -40.06 88.0 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.271 -0.893 . . . . 2.84 108.646 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -59.95 -46.15 90.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.888 . . . . 2.73 109.017 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.48 ' HE ' ' NE2' ' B' ' 351' ' ' GLN . 15.3 mmm-85 -60.11 -39.96 88.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.127 -0.983 . . . . 2.77 108.885 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.13 -34.93 75.77 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.469 -0.937 . . . . 1.19 108.469 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.18 -39.97 92.15 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.394 -0.965 . . . . 1.2 108.394 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -68.57 -39.94 80.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.402 -0.811 . . . . 1.55 109.172 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.44 -39.92 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.11 -1.07 . . . . 0.8 108.11 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.513 HH11 ' HG2' ' A' ' 131' ' ' ARG . 7.2 ttt-85 -67.25 -34.42 77.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.449 -0.782 . . . . 3.09 109.44 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.03 -41.22 91.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 1.46 109.587 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.3 mt -61.06 -44.01 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.71 109.272 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.476 ' HA3' HG21 ' A' ' 108' ' ' ILE . . . -60.13 -45.0 96.79 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.155 -1.178 . . . . 0.57 110.155 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -59.97 -45.4 92.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.158 -1.201 . . . . 2.59 109.561 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.441 HH22 ' CD1' ' A' ' 57' ' ' ILE . 60.3 mtp180 -67.32 -36.05 80.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.042 -1.036 . . . . 2.83 110.112 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.0 -43.31 95.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 1.25 109.513 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.34 -40.49 97.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.121 -0.987 . . . . 0.7 109.433 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -69.88 -38.09 76.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.188 -0.945 . . . . 2.57 108.672 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -59.97 -38.82 83.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.829 -0.545 . . . . 1.23 110.565 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -73.74 -44.18 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.829 -1.169 . . . . 0.81 108.917 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.96 -40.01 75.68 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.47 -0.769 . . . . 1.0 109.853 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.74 47.06 4.36 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.186 -1.566 . . . . 0.89 109.186 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.7 tp -73.66 148.76 42.47 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.439 -1.036 . . . . 1.14 109.396 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -66.89 140.67 57.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 4.6 109.391 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.3 mt -119.77 129.93 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 CA-C-O 121.77 0.795 . . . . 1.24 109.728 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 148' ' ' ASP . 1.4 mp -66.66 -39.94 84.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.786 -0.571 . . . . 1.54 110.323 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 147' ' ' ILE . 29.1 t0 62.27 127.03 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.822 -0.807 . . . . 1.5 108.822 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.1 mt -85.06 -4.51 59.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.054 -1.029 . . . . 0.79 109.366 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.4 t -86.75 -14.39 42.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.457 -0.777 . . . . 1.4 109.69 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.88 17.02 1.26 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -0.909 . . . . 0.92 110.473 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 38.3 mm -88.86 124.24 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.872 -1.142 . . . . 0.88 109.203 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -105.76 -9.78 17.07 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.423 -0.798 . . . . 2.45 109.833 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -124.05 149.62 45.9 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.319 -0.863 . . . . 1.52 110.311 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.21 134.62 55.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.351 -0.843 . . . . 1.58 109.595 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -151.95 164.64 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.492 -0.755 . . . . 0.69 109.525 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.7 mt -91.67 150.65 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 106.137 -1.801 . . . . 0.61 106.137 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 51.2 tp -99.98 115.9 30.78 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.936 -1.103 . . . . 0.87 110.611 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.62 130.04 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 109.028 -0.73 . . . . 0.71 109.028 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.503 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -159.78 163.35 34.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.184 -0.948 . . . . 0.81 108.647 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.36 -35.42 73.53 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.426 -1.421 . . . . 0.98 107.68 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -160.99 173.46 15.23 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.983 -0.747 . . . . 2.25 108.983 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.7 mt -138.91 139.19 37.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.18 -0.95 . . . . 0.78 109.037 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.4 p -96.09 140.29 22.19 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.168 -0.957 . . . . 0.98 109.141 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -40.25 -34.75 1.12 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.901 1.734 . . . . 0.81 112.216 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.419 ' HB3' HH12 ' A' ' 136' ' ' ARG . 59.3 m -59.94 -42.85 94.88 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.883 . . . . 0.9 109.787 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -69.56 -41.3 76.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.249 -0.907 . . . . 1.61 109.844 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.8 p -54.28 -23.85 16.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.61 111.528 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -86.01 -50.12 7.3 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.407 -1.433 . . . . 0.6 109.867 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -81.49 35.87 0.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.479 -0.934 . . . . 1.4 108.479 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.416 HD11 HG21 ' A' ' 176' ' ' VAL . 59.1 tp -101.38 132.4 46.98 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.257 -0.645 . . . . 0.7 109.257 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.418 ' O ' HG23 ' A' ' 176' ' ' VAL . 32.9 t-20 -83.41 101.77 11.59 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.164 -0.96 . . . . 2.35 108.716 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.34 -40.18 96.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 1.51 111.111 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -67.7 -26.11 66.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.837 -1.164 . . . . 2.33 111.915 -177.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -93.74 -11.43 31.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.62 -1.3 . . . . 1.92 110.231 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 172' ' ' ASN . 63.3 t -101.59 111.53 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.148 -0.97 . . . . 0.67 108.468 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.37 2.93 33.96 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.226 -0.921 . . . . 1.53 111.263 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.8 171.09 37.94 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.37 -1.492 . . . . 0.48 109.37 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.538 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 14.5 m-85 -132.04 128.43 38.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.498 -1.001 . . . . 0.55 109.491 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.95 126.19 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.101 -1.074 . . . . 0.65 108.101 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 203' ' ' VAL . 16.6 p -146.21 158.62 43.89 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.013 -1.055 . . . . 0.82 110.842 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 59.5 t0 -106.15 28.13 7.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.748 -0.595 . . . . 2.46 109.452 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -52.99 -168.52 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.448 -1.408 . . . . 1.28 111.369 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.13 -54.93 6.0 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.49 -1.044 . . . . 2.19 110.49 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -166.51 -156.04 9.3 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.037 -1.554 . . . . 2.13 111.01 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.435 HH11 ' HG2' ' A' ' 186' ' ' ARG . 16.6 ptt-85 -70.05 -18.0 63.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.8 -0.823 . . . . 5.86 111.327 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 69.5 p -73.13 5.25 3.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.768 -1.207 . . . . 3.72 110.305 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.7 p -82.11 137.8 34.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.93 -1.106 . . . . 1.74 109.991 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -49.3 -49.93 41.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.321 -0.862 . . . . 0.95 110.152 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -37.62 71.48 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.362 -0.836 . . . . 1.55 110.965 -178.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.9 t -60.03 -39.97 87.7 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.752 -1.217 . . . . 1.51 110.371 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.86 -39.74 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.855 . . . . 1.67 110.17 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.5 mtm -59.93 -45.0 94.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.966 -1.084 . . . . 1.02 110.42 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.99 -45.45 71.42 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.799 -1.188 . . . . 0.68 109.46 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -60.01 -53.44 57.85 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.998 -1.081 . . . . 2.93 110.445 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.4 m -68.21 -37.8 81.26 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.068 -1.02 . . . . 0.86 111.973 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.38 -22.95 62.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.698 -1.251 . . . . 0.67 109.906 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 66.56 49.3 1.35 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.322 0.582 . . . . 1.5 110.079 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.47 ' O ' ' CB ' ' A' ' 8' ' ' SER . 97.0 mt -129.53 148.98 71.54 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 108.027 -1.101 . . . . 0.72 108.027 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.54 138.31 69.59 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.276 1.984 . . . . 0.61 112.194 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.01 149.73 2.97 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.076 -1.05 . . . . 0.66 111.354 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.5 mt -122.99 144.09 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 107.21 -1.404 . . . . 0.79 107.21 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 181' ' ' THR . 17.9 m -122.34 -12.81 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.006 -1.059 . . . . 0.91 111.127 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -112.65 26.77 10.48 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.88 -0.888 . . . . 1.01 110.88 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 204' ' ' GLY . 14.0 p -41.96 -46.57 4.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.15 -1.206 . . . . 0.99 110.12 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.454 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 94.74 -54.18 1.96 Allowed Glycine 0 N--CA 1.5 2.951 0 C-N-CA 120.332 -0.937 . . . . 1.12 111.587 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 207' ' ' SER . 7.4 t -150.01 29.94 0.72 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.329 -1.689 . . . . 1.72 111.024 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 41.8 t -75.25 -36.87 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.709 -1.244 . . . . 0.89 109.249 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.456 ' H ' HG23 ' A' ' 209' ' ' THR . 8.4 p -60.05 -33.73 72.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.922 . . . . 1.03 111.117 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.2 t -78.37 -22.44 47.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.935 -1.103 . . . . 1.83 110.306 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -94.7 -8.35 38.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.185 -0.947 . . . . 2.27 110.499 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 86.4 t -108.02 140.02 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.28 -0.888 . . . . 0.92 110.729 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.497 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 65.2 mmtt -117.15 156.87 26.91 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.895 -1.521 . . . . 2.2 106.895 177.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 29.9 p-10 -60.04 142.53 53.84 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.802 -1.186 . . . . 2.36 111.115 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.438 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.7 m-20 82.11 3.2 1.28 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 116.061 -0.518 . . . . 2.38 110.832 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.497 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 88.9 m-20 -74.95 145.01 42.93 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.889 -1.132 . . . . 2.09 109.301 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -94.59 120.0 34.13 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.231 -0.918 . . . . 1.27 108.847 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.434 HD12 ' HB2' ' A' ' 16' ' ' ALA . 59.6 mt -126.86 147.49 50.04 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.414 -0.804 . . . . 0.75 110.433 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 85.7 mt -114.11 128.28 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 106.906 -1.516 . . . . 0.63 106.906 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.1 tp -100.83 117.07 34.19 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.866 -1.146 . . . . 0.7 109.595 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 223' ' ' VAL . 96.1 m-20 -74.03 -43.9 56.26 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.242 -0.911 . . . . 2.31 108.728 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.805 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 50.35 11.74 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.846 -0.798 . . . . 0.78 108.846 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.493 ' H ' ' C ' ' A' ' 221' ' ' ASP . 73.5 t -131.05 -44.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.817 -1.179 . . . . 1.04 107.817 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -100.04 3.23 44.0 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.61 -1.255 . . . . 2.44 107.61 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.776 HD21 ' H ' ' A' ' 4' ' ' GLY . 1.0 OUTLIER 59.61 43.67 15.51 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 116.246 -0.433 . . . . 1.55 110.192 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -140.09 144.46 36.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.122 -0.986 . . . . 1.99 110.042 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 87.8 t -120.03 125.68 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.926 -0.768 . . . . 0.77 108.926 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -90.99 118.15 30.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.85 -1.156 . . . . 0.98 109.679 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.76 116.69 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.475 -0.766 . . . . 0.85 109.529 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 68.22 67.67 0.52 Allowed Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.468 -0.77 . . . . 1.66 109.947 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -91.02 121.35 0.71 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 123.426 2.751 . . . . 0.95 112.955 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.626 HG22 ' N ' ' A' ' 233' ' ' ASN . 93.9 m -67.03 169.77 7.85 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.256 -0.903 . . . . 1.84 109.685 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.626 ' N ' HG22 ' A' ' 232' ' ' THR . 7.3 m120 -60.06 -40.0 87.97 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.307 -0.871 . . . . 2.74 109.544 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.91 -38.63 82.86 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.189 -0.945 . . . . 2.89 108.753 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.72 -40.06 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 1.3 109.559 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.291 -0.881 . . . . 1.09 109.86 -179.844 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 38.1 ttp . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.497 0.665 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -155.84 153.44 29.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.494 -0.754 . . . . 0.0 109.136 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -150.9 161.9 41.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.08 -1.012 . . . . 0.0 110.399 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -153.38 149.95 28.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.644 -0.66 . . . . 0.0 109.389 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.17 128.56 55.54 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -131.66 124.59 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 CA-C-O 122.192 0.996 . . . . 0.0 112.388 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 91.4 m -77.84 103.87 8.04 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.03 0.919 . . . . 0.0 110.869 -178.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 88.8 mt -51.71 124.75 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 122.467 1.127 . . . . 0.0 110.464 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 75.7 p -110.02 19.33 19.12 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.206 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.404 ' O ' ' CD ' ' B' ' 357' ' ' GLN . . . -69.33 147.21 97.07 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.94 -1.1 . . . . 0.0 108.578 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -72.82 -24.69 17.69 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 120.892 1.061 . . . . 0.0 112.672 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -121.05 17.61 11.66 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.17 -173.37 53.97 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.989 -2.045 . . . . 0.0 107.989 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.469 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.5 tp -86.3 90.42 8.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.889 -1.359 . . . . 0.0 108.88 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.424 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 4.5 p80 -93.14 -161.42 0.84 Allowed 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.033 -1.042 . . . . 0.0 111.102 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.1 m -55.79 -45.32 78.24 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.569 -0.707 . . . . 0.0 112.71 -175.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.579 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.5 tpt180 -61.22 -58.58 17.98 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 120.526 -1.359 . . . . 0.0 112.176 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 11.5 Cg_endo -59.37 -32.03 95.91 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 120.307 1.145 . . . . 0.0 111.907 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.96 75.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.11 -0.994 . . . . 0.0 108.515 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.73 -42.76 68.45 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.248 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -69.95 -42.96 72.51 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.129 -0.982 . . . . 0.0 108.944 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.26 -52.55 64.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.462 -0.774 . . . . 0.0 110.622 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . 0.408 HG13 ' O ' ' B' ' 344' ' ' ALA . 92.5 t -64.66 -30.84 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.757 -1.214 . . . . 0.0 109.521 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . 0.51 ' NZ ' ' CD ' ' A' ' 74' ' ' GLU . 12.0 ttmm -60.03 -48.11 83.07 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.392 -0.818 . . . . 0.0 110.102 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . 0.517 ' OE1' HD22 ' B' ' 380' ' ' LEU . 84.9 tt0 -67.64 -44.45 77.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 111.239 -178.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.04 -52.43 65.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.587 -1.32 . . . . 0.0 110.465 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -56.42 -14.1 2.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.009 . . . . 0.0 109.376 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -71.94 -21.53 79.02 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -105.8 143.68 33.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.669 -0.9 . . . . 0.0 108.721 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 15.3 t -91.02 -13.16 33.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.027 -1.046 . . . . 0.0 109.279 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.42 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 52.8 p -62.72 146.9 51.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.481 -0.762 . . . . 0.0 109.119 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.63 137.04 57.07 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.148 -0.97 . . . . 0.0 108.98 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 94.3 mt -132.94 133.21 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.604 -0.685 . . . . 0.0 109.679 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 46.5 m -130.34 152.42 49.77 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 62.3 t -117.41 139.51 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 97.9 m -130.7 126.09 35.62 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.105 -0.997 . . . . 0.0 109.714 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 73.5 p -140.16 118.19 11.88 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.863 0.84 . . . . 0.0 110.574 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 9.3 m120 42.09 54.45 4.09 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.2 -15.7 43.0 Favored Glycine 0 N--CA 1.502 3.067 0 O-C-N 120.206 -1.559 . . . . 0.0 113.138 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -112.44 124.22 52.03 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 119.327 1.563 . . . . 0.0 109.371 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 85.8 p -122.07 147.59 45.91 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.941 0.876 . . . . 0.0 111.044 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.24 159.78 41.49 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.671 0.748 . . . . 0.0 109.849 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 22.1 m -88.74 136.74 32.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.473 -0.767 . . . . 0.0 110.463 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.44 ' HA ' HD11 ' B' ' 350' ' ' LEU . . . -73.93 -16.78 61.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.051 -1.031 . . . . 0.0 109.876 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -87.36 19.9 3.06 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 25.1 t -149.75 94.83 2.23 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.733 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.544 ' HB3' HD13 ' A' ' 79' ' ' LEU . 36.0 tp -59.96 -32.72 71.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.854 ' CE2' HD11 ' A' ' 79' ' ' LEU . 60.4 m-85 -54.75 -53.55 53.64 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.031 -1.043 . . . . 0.0 110.175 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -70.07 -35.89 74.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 0.0 110.273 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' B' ' 347' ' ' LEU . 81.8 mt -53.92 -50.1 67.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.878 -1.139 . . . . 0.0 110.232 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.506 ' O ' HD22 ' A' ' 123' ' ' LEU . 3.6 mt-30 -49.99 -17.59 0.41 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.668 -1.27 . . . . 0.0 111.337 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 82.1 p -79.81 -14.55 58.61 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.275 -1.516 . . . . 0.0 110.972 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 30.9 mt -91.82 118.66 30.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.749 -1.22 . . . . 0.0 109.201 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.35 92.81 0.77 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 20.9 mt -100.47 89.72 4.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.37 -1.077 . . . . 0.0 109.309 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 38.2 p -90.01 177.87 6.35 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.095 -1.003 . . . . 0.0 110.449 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . 0.404 ' CD ' ' O ' ' B' ' 310' ' ' ALA . 48.5 tt0 -69.87 115.14 8.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.632 -0.667 . . . . 0.0 110.926 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 100.2 9.54 47.79 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 52.1 m -87.21 114.12 23.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.228 -1.16 . . . . 0.0 110.888 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.97 115.15 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 122.116 0.96 . . . . 0.0 109.785 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 32.8 m -110.99 176.38 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 33.0 m -130.64 127.64 39.34 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 72.9 mt -102.88 116.64 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 84.1 p -119.98 131.6 55.22 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.304 -0.872 . . . . 0.0 109.47 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.69 151.55 39.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.19 -0.944 . . . . 0.0 109.587 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -144.07 122.99 12.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.406 -0.809 . . . . 0.0 108.889 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.552 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.06 -158.06 29.37 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.062 -1.542 . . . . 0.0 111.481 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -59.85 -50.02 75.44 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.42 ' H ' ' HB3' ' B' ' 331' ' ' SER . 96.0 m-20 -108.99 13.4 24.7 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.819 -1.176 . . . . 0.0 110.963 -177.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.552 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.2 pt-20 -44.95 -36.25 3.28 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.077 -1.014 . . . . 0.0 110.89 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.14 -46.25 68.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.95 -1.094 . . . . 0.0 110.226 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -66.39 -48.15 71.03 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.154 -0.966 . . . . 0.0 109.727 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.12 -75.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 110.501 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.562 ' O ' HG23 ' B' ' 378' ' ' VAL . 68.8 t -45.96 -38.82 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.097 -1.002 . . . . 0.0 110.557 -177.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -63.72 -49.96 71.01 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.598 -1.314 . . . . 0.0 110.475 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.11 -40.66 37.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.978 -1.076 . . . . 0.0 110.062 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 82.4 mt -59.99 -38.66 83.22 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.111 -0.993 . . . . 0.0 109.296 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.562 HG23 ' O ' ' B' ' 374' ' ' VAL . 39.8 t -61.44 -39.96 84.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.28 -0.887 . . . . 0.0 108.647 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.72 -55.55 12.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.963 -1.086 . . . . 0.0 108.218 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.517 HD22 ' OE1' ' B' ' 325' ' ' GLU . 57.6 tp -58.21 -32.25 68.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.127 -0.983 . . . . 0.0 109.932 -178.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.8 tpp -71.78 -40.77 69.04 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.354 -1.338 . . . . 0.0 108.875 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.6 -5.84 59.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -0.775 . . . . 0.0 110.349 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -110.13 -3.86 16.13 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.223 -0.923 . . . . 0.0 111.237 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 12.4 mt -76.48 129.99 37.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.303 -1.498 . . . . 0.0 108.957 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.161 -179.868 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.34 -0.615 . . . . 2.91 109.34 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.0 mt -110.06 129.96 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.579 -0.701 . . . . 1.2 109.251 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.0 m -119.48 152.34 37.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.629 -0.669 . . . . 1.4 109.244 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.594 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -135.66 -165.22 10.61 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 108.441 -1.864 . . . . 1.05 108.441 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 6' ' ' LEU . 97.0 mt -89.49 -18.82 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.69 -1.476 . . . . 1.15 110.571 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' ILE . 37.1 tp 54.79 104.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.174 -0.954 . . . . 0.98 109.17 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.88 -27.02 13.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.258 -0.901 . . . . 0.88 109.238 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.8 t -133.69 118.39 14.52 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.575 -0.703 . . . . 1.69 109.17 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.27 148.58 18.96 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.964 1.776 . . . . 0.85 112.542 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.791 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.47 -156.77 27.09 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 108.897 -1.681 . . . . 0.92 108.897 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.2 mt -147.66 150.64 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.021 -1.281 . . . . 0.81 108.318 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.8 155.02 35.06 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.776 -1.203 . . . . 0.51 110.807 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.9 OUTLIER -139.01 129.5 25.79 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.551 -1.277 . . . . 0.62 107.551 178.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.08 -178.07 48.23 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.482 -1.818 . . . . 0.55 111.039 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -79.69 159.16 26.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.833 -0.804 . . . . 2.1 109.165 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.605 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -109.5 132.1 54.45 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.479 -0.763 . . . . 0.77 110.859 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.6 tp -102.99 139.39 38.62 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.102 -1.073 . . . . 0.91 108.102 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.9 tp -117.69 122.3 43.15 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.346 -0.846 . . . . 0.93 109.674 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' A' ' 160' ' ' ALA . 54.8 mt -87.98 104.28 16.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.538 -0.726 . . . . 0.93 109.834 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -101.07 132.74 46.37 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.783 -0.821 . . . . 2.75 108.783 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -124.82 136.19 53.6 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.757 -0.831 . . . . 3.0 108.757 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.21 142.98 34.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.093 -1.004 . . . . 2.77 109.641 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.49 140.02 58.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.875 . . . . 2.94 108.824 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.4 mt -81.6 130.53 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.211 -0.93 . . . . 0.95 109.627 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 t -96.43 128.47 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.217 -0.927 . . . . 1.28 110.181 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.8 mt -109.0 135.41 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.178 -0.675 . . . . 1.21 109.178 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -91.53 121.36 33.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.124 -0.985 . . . . 1.81 109.794 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.1 mmm-85 -90.02 -0.04 57.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.378 -0.826 . . . . 2.8 109.888 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.54 146.1 54.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.043 -1.035 . . . . 2.87 109.468 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -88.45 147.27 24.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.296 -0.878 . . . . 2.35 109.282 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.568 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.3 pt -94.15 164.02 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.012 -1.055 . . . . 0.97 109.413 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -94.07 168.29 11.04 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.144 -0.972 . . . . 1.17 108.886 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.05 -15.52 59.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.067 -1.021 . . . . 1.18 109.943 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -87.41 -27.96 22.43 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.85 -1.167 . . . . 2.56 107.85 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -81.74 -9.24 59.69 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.723 -0.843 . . . . 1.79 108.723 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.8 t -62.87 -53.88 40.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.124 -0.985 . . . . 1.0 108.572 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -61.94 -39.97 93.91 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.33 -0.856 . . . . 1.77 110.123 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -69.84 -40.12 76.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.132 -0.98 . . . . 2.7 110.563 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.568 ' HG3' HG21 ' A' ' 31' ' ' ILE . 69.3 mm-40 -67.62 -39.83 84.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.925 -1.109 . . . . 1.51 110.029 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.14 -46.69 94.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 120.756 -1.215 . . . . 0.93 108.624 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -60.15 -42.18 94.34 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.147 -0.971 . . . . 1.81 109.495 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.02 -45.32 93.19 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.901 -1.119 . . . . 2.78 108.38 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -60.43 -46.13 91.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.326 -0.858 . . . . 0.78 108.764 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.2 tp -60.1 -47.98 83.63 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.616 -0.883 . . . . 1.07 108.616 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 41.4 t -61.82 -42.29 98.84 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.413 -0.915 . . . . 1.12 108.761 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.13 -45.83 95.3 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.346 -1.902 . . . . 0.84 108.346 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.459 ' NH1' ' HG3' ' A' ' 47' ' ' ARG . 31.9 ttm-85 -62.32 -32.92 73.74 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.433 -1.04 . . . . 3.09 108.307 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -54.81 -40.01 69.07 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.888 -0.782 . . . . 0.88 108.888 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.8 ttmt -72.44 -73.14 0.21 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.927 -1.138 . . . . 2.59 107.927 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.48 -37.93 0.14 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.362 -0.836 . . . . 0.7 111.844 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 m -59.99 -52.52 65.02 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.433 -1.417 . . . . 1.4 108.517 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.34 -40.0 93.12 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.866 . . . . 0.67 110.809 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -66.63 -40.07 88.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.036 -1.04 . . . . 1.66 110.766 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.87 -39.99 94.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.829 -1.169 . . . . 1.58 108.976 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' OE2' HD13 ' A' ' 77' ' ' ILE . 79.1 mm-40 -65.17 -35.83 82.31 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.274 -0.892 . . . . 1.35 108.926 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -64.52 -43.3 94.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 0.77 109.902 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.16 -39.88 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.987 . . . . 0.63 108.819 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -53.18 -52.48 58.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 1.14 110.064 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -57.01 -33.74 67.47 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.26 -0.9 . . . . 0.79 110.309 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -69.32 -37.25 77.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.909 -1.119 . . . . 1.53 109.435 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.99 -45.9 76.23 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.548 -0.72 . . . . 0.57 110.074 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.03 -51.95 55.78 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.333 -1.107 . . . . 0.75 110.333 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.75 -41.11 79.39 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.986 -1.302 . . . . 1.59 110.185 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.6 m -70.11 -62.48 1.37 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.053 -1.029 . . . . 0.73 112.739 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -96.52 -45.88 6.57 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.787 -1.195 . . . . 0.75 111.573 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.08 -166.74 25.91 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 119.705 -1.236 . . . . 1.22 110.977 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -71.26 -24.01 62.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.914 -0.757 . . . . 5.81 110.663 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -62.7 -36.12 81.92 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.278 -0.889 . . . . 3.37 111.502 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -98.42 -18.43 18.26 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.034 -1.041 . . . . 1.77 109.548 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -67.23 -40.07 86.31 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.281 -0.887 . . . . 1.65 110.104 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB2' ' NH1' ' B' ' 317' ' ' ARG . . . -64.94 -28.37 69.48 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.287 -0.883 . . . . 0.77 109.974 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.84 -41.39 85.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 118.951 -1.1 . . . . 0.8 108.704 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -66.43 -42.51 87.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.88 110.493 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -63.11 -40.82 98.73 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.804 -1.185 . . . . 1.37 109.154 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.65 -40.71 98.34 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.344 -1.902 . . . . 0.62 108.344 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -70.05 -41.83 73.69 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.516 -0.991 . . . . 1.5 109.209 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.448 HD13 ' OE2' ' A' ' 55' ' ' GLU . 96.0 mt -69.71 -45.62 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.396 -0.815 . . . . 0.63 109.655 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.3 ttp -60.13 -46.52 89.35 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.916 -1.115 . . . . 1.51 109.802 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.831 HD11 ' CE2' ' B' ' 348' ' ' PHE . 32.7 tp -60.79 -40.54 93.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.314 -0.866 . . . . 0.77 109.328 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.436 ' HG ' HH12 ' A' ' 47' ' ' ARG . 63.9 tp -62.23 -40.01 94.73 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.538 -0.726 . . . . 0.62 109.931 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -82.12 8.81 9.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.173 -0.954 . . . . 1.47 110.152 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.7 t0 -54.58 132.98 46.23 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.186 -0.946 . . . . 1.47 110.258 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.415 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 39.9 mt-10 -60.38 -19.65 56.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.613 -0.679 . . . . 1.78 111.301 -178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.4 -35.06 73.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.665 -1.272 . . . . 2.53 108.799 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.01 -43.58 71.09 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.491 0.663 . . . . 0.8 110.385 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.11 -48.76 80.39 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.967 -1.083 . . . . 1.42 110.55 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -70.0 -40.26 75.38 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.369 -0.832 . . . . 1.71 111.083 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.0 -40.04 75.52 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.906 -1.121 . . . . 1.57 111.61 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.8 mt -67.47 -45.21 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.946 -1.097 . . . . 0.65 109.756 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.92 -39.82 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.604 -0.685 . . . . 0.82 110.053 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.44 -46.91 88.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 0.79 110.579 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 96' ' ' LYS . 85.3 mt -60.12 -47.51 85.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.857 -1.152 . . . . 0.95 109.693 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.0 mt -63.22 -48.97 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.943 0.878 . . . . 0.66 108.926 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -69.84 -40.21 75.98 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.494 -0.754 . . . . 2.2 110.588 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -85.51 -51.55 6.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.04 -1.037 . . . . 1.65 111.952 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 92' ' ' LEU . 65.4 mmtt -89.76 -1.7 58.06 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.013 -1.054 . . . . 2.03 111.603 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 55.73 32.32 19.2 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.869 -1.145 . . . . 1.42 109.962 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.2 mtt -83.8 166.94 17.56 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.361 -0.837 . . . . 1.18 109.721 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 19.3 p -78.17 155.15 30.58 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.529 -0.915 . . . . 0.98 108.529 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.35 93.0 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.134 -0.979 . . . . 0.64 109.445 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -62.86 -39.83 95.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.546 -0.721 . . . . 2.07 109.985 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.66 -45.95 20.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.103 -0.998 . . . . 0.73 110.181 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.01 -50.68 72.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.403 -0.811 . . . . 0.54 110.56 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.72 86.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.004 -1.06 . . . . 0.56 109.919 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.509 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 78.1 t60 -59.97 -41.03 91.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 1.54 110.082 -178.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -63.54 -39.98 95.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.288 -0.882 . . . . 1.33 111.419 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.8 t -62.9 -53.98 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.76 -1.213 . . . . 0.72 112.018 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.3 mm -69.99 -39.94 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.578 -1.326 . . . . 0.85 108.68 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.509 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 87.5 tt0 -60.89 -39.95 91.21 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.736 -0.838 . . . . 2.44 108.736 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.27 94.53 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 120.512 -0.851 . . . . 0.98 111.018 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -70.02 -60.03 2.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.659 -1.495 . . . . 1.41 110.203 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.05 -41.28 25.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.113 -0.992 . . . . 1.2 110.051 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 78.6 p -59.81 -39.87 86.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.058 -1.026 . . . . 1.7 108.719 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.53 -38.85 81.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.248 -0.908 . . . . 1.47 109.293 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.8 mt -65.97 -40.99 91.75 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.12 -0.988 . . . . 1.56 110.155 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -59.92 -34.83 73.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.719 -1.238 . . . . 2.2 109.625 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -57.47 -19.31 23.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.155 -0.965 . . . . 2.12 109.912 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.5 HD13 HD13 ' A' ' 123' ' ' LEU . 40.7 mt -62.65 149.76 42.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.859 -1.15 . . . . 2.0 109.203 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -89.98 10.59 23.44 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.312 -0.868 . . . . 3.23 110.254 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -101.42 128.98 47.37 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.198 -0.939 . . . . 2.49 110.331 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.01 -29.18 66.19 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.581 0.705 . . . . 3.95 109.437 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.462 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 6.7 t80 -70.22 -39.28 75.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.587 -0.695 . . . . 2.0 110.342 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.53 HD22 ' O ' ' B' ' 351' ' ' GLN . 90.5 mt -69.97 -35.39 74.42 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.02 -1.05 . . . . 1.86 108.416 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -59.99 -39.07 84.46 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.072 -0.714 . . . . 2.84 109.072 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -58.24 -43.56 87.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 2.73 109.198 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.599 ' NH2' ' O ' ' B' ' 314' ' ' LEU . 89.9 mtt180 -62.23 -39.93 94.47 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.176 -1.01 . . . . 2.77 109.22 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.82 80.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 1.19 109.621 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.07 -48.76 80.36 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.363 -0.835 . . . . 1.2 109.416 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -63.5 -40.07 96.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 1.55 109.628 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.42 -40.12 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.085 -1.009 . . . . 0.8 108.471 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.54 HH11 ' HG2' ' A' ' 131' ' ' ARG . 3.8 ttt-85 -60.32 -38.62 84.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.517 -0.739 . . . . 3.09 109.233 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -59.94 -40.08 87.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.425 -0.797 . . . . 1.46 110.363 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.08 -45.99 94.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.905 -1.122 . . . . 0.71 109.377 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.88 -41.06 93.66 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 120.291 -0.957 . . . . 0.57 110.942 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -60.07 -46.33 89.92 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.906 -1.349 . . . . 2.59 109.954 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.631 HH12 ' CB ' ' A' ' 166' ' ' SER . 98.2 mtt180 -68.88 -29.91 68.29 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.932 -1.105 . . . . 2.83 109.48 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.1 tp -60.05 -43.13 95.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.948 . . . . 1.25 109.071 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.9 mt -61.02 -39.82 91.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.281 -0.887 . . . . 0.7 109.89 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -67.39 -39.94 85.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 2.57 108.933 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -61.34 -36.18 79.44 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.623 -0.673 . . . . 1.23 111.217 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.2 mt -70.7 -43.24 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.444 -1.41 . . . . 0.81 109.05 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.1 mt -71.04 -30.15 66.26 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.435 -0.79 . . . . 1.0 109.489 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.18 43.47 6.27 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.862 -1.695 . . . . 0.89 108.862 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.7 tp -74.44 149.47 40.37 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.427 -1.043 . . . . 1.14 109.241 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -72.11 142.29 49.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 4.6 109.58 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 93.9 mt -113.06 128.94 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-O 122.203 1.002 . . . . 1.24 109.927 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.5 mt -64.21 -43.77 97.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 115.485 -0.779 . . . . 1.54 110.87 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.3 t0 65.21 102.66 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.395 -0.816 . . . . 1.5 108.969 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.5 mt -69.02 -1.02 6.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.265 -0.897 . . . . 0.79 110.625 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 74.0 m -87.92 -10.88 49.23 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.852 -1.155 . . . . 1.4 109.395 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.84 15.97 2.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.336 -0.852 . . . . 0.92 112.588 -177.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.1 mp -90.32 119.98 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 120.213 -1.554 . . . . 0.88 109.215 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -100.45 -9.26 22.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.467 -0.771 . . . . 2.45 110.217 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -116.92 148.21 41.55 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.291 -0.881 . . . . 1.52 110.442 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -65.06 132.59 49.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.541 -0.724 . . . . 1.58 109.588 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.0 m -152.35 164.66 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.473 -0.767 . . . . 0.69 109.538 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.5 mt -91.84 149.53 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.023 -1.843 . . . . 0.61 106.023 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 52.3 tp -99.3 117.11 33.03 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.967 -1.083 . . . . 0.87 110.035 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.723 HG12 HG22 ' A' ' 209' ' ' THR . 19.4 t -123.48 129.98 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.481 -0.933 . . . . 0.71 108.481 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.488 ' C ' HG21 ' A' ' 209' ' ' THR . . . -159.29 164.74 34.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.058 -1.026 . . . . 0.81 108.924 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.17 -38.07 69.22 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.379 -1.451 . . . . 0.98 108.378 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -171.07 142.83 1.87 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.825 -0.806 . . . . 2.25 108.825 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 19.9 mt -117.4 137.49 52.45 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.324 -0.86 . . . . 0.78 109.504 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.4 p -83.08 147.23 53.51 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.94 . . . . 0.98 108.722 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -43.52 -31.83 3.34 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.567 1.511 . . . . 0.81 111.814 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.631 ' CB ' HH12 ' A' ' 136' ' ' ARG . 38.5 m -59.96 -40.16 88.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.907 . . . . 0.9 108.975 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.58 -43.21 85.55 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.441 -0.787 . . . . 1.61 109.658 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 54.2 p -52.68 -29.08 24.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.13 -0.981 . . . . 0.61 110.092 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.29 -57.74 3.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 0.6 110.063 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -81.83 36.03 0.44 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.066 -0.716 . . . . 1.4 109.066 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 171' ' ' LEU . 14.2 tp -97.96 138.21 35.62 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.494 -0.754 . . . . 0.7 109.006 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -86.27 102.92 14.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.08 -1.013 . . . . 2.35 109.196 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 66.2 mt -62.21 -45.64 92.47 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.265 -0.897 . . . . 1.51 110.209 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -66.42 -28.93 69.0 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.058 -1.027 . . . . 2.33 112.715 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -93.17 -13.03 28.92 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.46 -1.4 . . . . 1.92 109.95 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.542 HG11 ' CE1' ' A' ' 179' ' ' PHE . 87.2 t -101.41 109.27 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.179 -0.95 . . . . 0.67 108.727 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.2 mt -82.76 6.53 17.82 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.897 . . . . 1.53 110.274 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.457 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 169.09 175.85 38.71 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.312 -1.515 . . . . 0.48 109.312 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.542 ' CE1' HG11 ' A' ' 176' ' ' VAL . 10.8 m-85 -135.76 130.16 33.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.394 -1.062 . . . . 0.55 109.299 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.423 ' CG2' HG21 ' A' ' 205' ' ' THR . 94.5 mt -131.13 126.97 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.736 -0.839 . . . . 0.65 108.736 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.1 p -145.7 157.29 43.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.033 -1.042 . . . . 0.82 110.7 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.658 ' OD1' HG23 ' A' ' 209' ' ' THR . 7.2 m-20 -105.52 27.04 8.76 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.462 -0.94 . . . . 2.46 108.462 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.57 -157.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.201 -0.937 . . . . 1.28 112.225 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.84 -71.2 0.85 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 111.258 -0.737 . . . . 2.19 111.258 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 167.11 -133.66 2.99 Favored Glycine 0 N--CA 1.491 2.342 0 O-C-N 120.705 -1.468 . . . . 2.13 110.563 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 188' ' ' SER . 28.0 mtm-85 -60.08 -40.04 88.19 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.427 -1.043 . . . . 5.86 111.01 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.4 p -65.78 8.88 0.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.066 -1.021 . . . . 3.72 110.471 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 186' ' ' ARG . 29.1 t -90.79 129.59 36.85 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.015 -1.053 . . . . 1.74 110.255 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -42.79 -52.0 5.19 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.783 0.801 . . . . 0.95 109.38 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 190' ' ' THR . 9.5 p -55.38 -36.69 66.66 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.768 -0.582 . . . . 1.55 111.175 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.7 t -59.94 -40.03 87.57 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.846 -1.159 . . . . 1.51 110.903 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.6 mt -65.7 -40.02 86.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.123 -0.985 . . . . 1.67 110.109 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.7 mtp -60.05 -45.31 93.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.846 . . . . 1.02 111.06 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.3 -43.8 92.58 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.927 -1.108 . . . . 0.68 109.59 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' ' 195' ' ' ARG . 51.4 mtt-85 -59.96 -51.61 68.92 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.901 -1.12 . . . . 2.93 109.361 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.5 m -70.11 -35.03 73.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.86 110.76 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.0 mt -76.12 -21.44 56.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 0.67 109.66 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 62.15 50.04 4.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.605 -0.684 . . . . 1.5 109.86 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.48 130.59 23.85 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 108.821 -0.807 . . . . 0.72 108.821 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -43.88 130.31 7.78 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.905 1.737 . . . . 0.61 112.343 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -168.84 145.67 3.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.736 -1.227 . . . . 0.66 111.661 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 91.2 mt -124.88 148.87 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 107.168 -1.419 . . . . 0.79 107.168 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 6.9 m -129.98 -9.83 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 O-C-N 120.819 -1.176 . . . . 0.91 110.894 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.68 22.38 26.26 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 110.228 -1.149 . . . . 1.01 110.228 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.44 ' OG1' ' OD2' ' A' ' 182' ' ' ASP . 3.3 p -47.14 -40.0 14.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.894 -1.356 . . . . 0.99 109.836 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.52 ' N ' ' OD2' ' A' ' 182' ' ' ASP . . . 89.11 -52.07 3.81 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 120.914 -1.116 . . . . 1.12 111.342 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.48 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 15.1 m -156.17 37.97 0.34 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.523 -1.575 . . . . 1.72 111.819 -178.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 12.8 t -77.05 -34.88 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.754 -1.216 . . . . 0.89 108.045 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.723 HG22 HG12 ' A' ' 159' ' ' VAL . 53.8 p -59.72 -34.26 72.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.571 -0.706 . . . . 1.03 110.284 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.4 t -77.16 -16.97 58.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.046 -1.034 . . . . 1.83 109.962 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -99.27 -11.86 20.89 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.245 -0.909 . . . . 2.27 110.319 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.5 t -102.33 135.3 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.24 -0.913 . . . . 0.92 111.08 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.45 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 43.5 mmtm -110.38 150.48 28.73 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.518 -1.66 . . . . 2.2 106.518 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.489 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 13.1 p-10 -59.91 141.04 56.22 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.789 -1.194 . . . . 2.36 110.85 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.3 t0 85.24 1.04 0.74 Allowed 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.071 0.463 . . . . 2.38 110.012 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.45 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 98.1 m-20 -73.99 147.0 43.37 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.146 -0.971 . . . . 2.09 109.252 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -97.34 119.88 36.67 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.614 -1.254 . . . . 1.27 107.614 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 16' ' ' ALA . 66.4 mt -126.98 148.99 50.07 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.475 -0.766 . . . . 0.75 110.489 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.0 mt -116.18 129.91 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 107.675 -1.231 . . . . 0.63 107.675 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 35.2 tp -102.28 119.33 38.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.883 -1.136 . . . . 0.7 108.075 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.613 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 6.6 p30 -78.47 -40.13 36.41 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.886 -1.134 . . . . 2.31 108.751 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.791 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.35 13.64 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.439 -0.948 . . . . 0.78 108.439 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.472 ' N ' ' C ' ' A' ' 221' ' ' ASP . 24.9 t -127.65 -40.64 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.457 -1.312 . . . . 1.04 107.457 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -102.5 0.39 33.56 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.976 -1.12 . . . . 2.44 107.976 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.594 HD21 ' H ' ' A' ' 4' ' ' GLY . 48.8 t-20 59.78 44.96 13.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.834 -0.542 . . . . 1.55 110.297 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.613 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 80.5 mt-30 -140.22 158.38 44.13 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.174 -0.954 . . . . 1.99 109.709 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 81.3 t -120.14 130.05 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.032 -0.729 . . . . 0.77 109.032 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -101.61 120.98 41.16 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.383 -0.823 . . . . 0.98 108.918 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.445 HG22 HD22 ' A' ' 218' ' ' LEU . 49.0 t -103.36 119.23 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.548 -0.72 . . . . 0.85 109.759 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 63.79 66.9 1.03 Allowed Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.186 -0.946 . . . . 1.66 109.931 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -91.34 128.34 1.17 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 123.255 2.636 . . . . 0.95 112.661 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 30.4 p -69.01 169.37 11.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 1.84 109.422 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -60.07 -39.4 85.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 2.74 108.942 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.02 -38.22 82.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.344 -0.848 . . . . 2.89 110.083 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.61 -40.22 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.841 -1.162 . . . . 1.3 108.836 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 94.3 mt . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.047 -1.033 . . . . 1.09 109.374 179.909 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 33.1 ttp . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.513 0.673 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -150.96 148.53 28.5 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -150.02 159.36 44.46 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.087 -1.008 . . . . 0.0 110.397 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -157.56 154.02 27.85 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 -111.69 131.57 55.2 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.115 -0.99 . . . . 0.0 110.203 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.27 121.77 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-O 122.348 1.071 . . . . 0.0 112.307 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . 0.533 ' O ' HG23 ' B' ' 309' ' ' THR . 56.7 m -80.4 101.2 8.87 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.804 0.811 . . . . 0.0 110.799 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' B' ' 358' ' ' GLY . 97.5 mt -50.71 116.73 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.258 1.028 . . . . 0.0 109.673 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . 0.533 HG23 ' O ' ' B' ' 307' ' ' THR . 25.1 p -106.59 14.1 27.44 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.946 -177.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.42 116.67 42.37 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.994 -1.066 . . . . 0.0 108.445 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -51.85 -17.08 4.79 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 CA-C-N 120.216 1.113 . . . . 0.0 113.725 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -111.0 11.3 22.14 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.257 -0.902 . . . . 0.0 109.991 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 69.47 169.78 6.93 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.599 ' O ' ' NH2' ' A' ' 126' ' ' ARG . 3.1 tp -84.6 93.27 8.34 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.087 -1.243 . . . . 0.0 109.333 -178.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.58 ' C ' HH21 ' A' ' 126' ' ' ARG . 3.8 p80 -96.48 -161.48 0.87 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 120.885 -1.134 . . . . 0.0 109.902 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 4.0 m -58.06 -41.58 83.63 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.884 -1.135 . . . . 0.0 112.726 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.603 ' NH1' ' HB2' ' A' ' 71' ' ' ALA . 14.7 tpt180 -57.31 -59.44 12.8 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 120.308 -1.495 . . . . 0.0 111.068 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.92 -42.9 17.56 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 CA-C-N 120.485 1.209 . . . . 0.0 111.606 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.89 -17.28 35.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.178 -0.951 . . . . 0.0 110.392 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -82.16 -38.55 24.53 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -72.16 -34.81 68.76 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -64.65 -58.28 6.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.39 -0.819 . . . . 0.0 109.796 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.68 -32.91 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.82 -1.175 . . . . 0.0 109.085 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -59.93 -46.65 88.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.422 -0.799 . . . . 0.0 109.112 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.29 -44.06 84.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 110.422 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' B' ' 328' ' ' GLY . . . -60.03 -53.41 58.19 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.855 -1.153 . . . . 0.0 111.248 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -51.72 -10.45 0.11 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.883 -1.135 . . . . 0.0 110.136 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' B' ' 326' ' ' ALA . . . -75.9 -24.75 68.64 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -105.23 139.14 40.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.41 -1.053 . . . . 0.0 109.248 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 8.8 p -90.61 -9.8 45.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.275 -0.89 . . . . 0.0 110.115 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.479 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 14.0 t -64.47 155.21 33.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.101 -1.0 . . . . 0.0 109.963 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.6 131.73 45.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.907 . . . . 0.0 108.792 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 82.9 mt -132.44 132.95 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.392 -0.818 . . . . 0.0 109.938 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.4 m -131.56 149.94 52.33 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.484 -0.76 . . . . 0.0 109.128 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 66.6 t -122.43 117.41 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 94.7 m -107.5 133.43 52.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.228 -0.92 . . . . 0.0 109.697 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 4.8 p -139.85 115.94 10.41 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.766 0.793 . . . . 0.0 110.631 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 45.22 50.02 9.77 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.641 -0.662 . . . . 0.0 112.744 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.32 -16.41 48.92 Favored Glycine 0 N--CA 1.5 2.957 0 O-C-N 120.058 -1.651 . . . . 0.0 112.242 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -110.69 121.32 45.03 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 118.87 1.335 . . . . 0.0 109.69 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 86.4 p -126.76 148.33 49.91 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.815 0.816 . . . . 0.0 110.151 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -145.23 170.57 16.02 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.563 0.697 . . . . 0.0 110.093 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 17.3 m -89.04 134.73 33.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.519 -0.738 . . . . 0.0 110.518 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.451 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -75.91 -16.38 60.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.053 -1.03 . . . . 0.0 109.504 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -84.7 20.87 1.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . 0.451 ' H ' ' C ' ' B' ' 344' ' ' ALA . 93.8 p -151.61 96.91 2.31 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.43 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.676 HD23 HD22 ' A' ' 79' ' ' LEU . 51.7 tp -60.05 -33.76 72.48 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.831 ' CE2' HD11 ' A' ' 79' ' ' LEU . 60.0 m-85 -56.27 -52.95 62.6 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.931 -1.106 . . . . 0.0 110.034 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -69.82 -28.67 65.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 110.421 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.576 HD12 ' HA ' ' B' ' 347' ' ' LEU . 80.8 mt -59.96 -50.01 75.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.101 -0.999 . . . . 0.0 109.728 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.53 ' O ' HD22 ' A' ' 123' ' ' LEU . 1.2 mp0 -45.07 -20.22 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.017 -1.052 . . . . 0.0 111.189 -178.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.415 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.3 p -80.3 -10.61 59.76 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.19 -1.568 . . . . 0.0 109.444 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.415 HD11 ' HB3' ' B' ' 342' ' ' ALA . 45.9 mt -95.79 115.29 27.21 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.176 -0.953 . . . . 0.0 108.77 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.84 95.21 1.24 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 22.8 mt -103.9 94.25 5.31 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.416 -1.05 . . . . 0.0 109.286 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 79.0 p -100.72 153.57 19.33 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.233 -0.917 . . . . 0.0 111.234 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -41.95 111.9 0.28 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.202 0.525 . . . . 0.0 110.664 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 103.14 6.09 45.78 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 91.7 m -83.69 111.24 18.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.157 . . . . 0.0 111.22 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 8.6 t -78.47 111.99 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 122.15 0.976 . . . . 0.0 109.801 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 12.3 m -110.08 177.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 40.4 m -130.26 126.9 38.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 64.0 mt -103.82 117.44 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 53.6 m -121.13 132.33 54.79 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.79 148.31 38.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.279 -0.888 . . . . 0.0 109.572 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -142.38 121.85 13.24 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.532 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.91 -158.39 29.07 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 119.192 -1.48 . . . . 0.0 111.159 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -59.9 -51.08 71.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 122.293 -0.534 . . . . 0.0 112.219 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.479 ' H ' ' HB2' ' B' ' 331' ' ' SER . 85.1 m-20 -108.27 10.78 27.68 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 120.86 -1.15 . . . . 0.0 111.249 -177.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.4 pt-20 -39.9 -34.12 0.25 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.338 -0.852 . . . . 0.0 112.232 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -68.3 -42.64 79.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.535 -1.353 . . . . 0.0 110.432 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -71.1 -52.56 18.66 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.991 -1.068 . . . . 0.0 109.653 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.69 -36.78 2.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.333 -0.854 . . . . 0.0 111.519 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.513 ' O ' HG23 ' B' ' 378' ' ' VAL . 58.9 t -81.14 -36.02 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.521 -1.362 . . . . 0.0 109.502 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -69.98 -40.01 75.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.375 -0.828 . . . . 0.0 111.921 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -77.59 -46.78 21.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.612 -1.305 . . . . 0.0 110.151 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.35 -36.38 80.02 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.294 -0.879 . . . . 0.0 109.116 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.513 HG23 ' O ' ' B' ' 374' ' ' VAL . 53.8 t -73.68 -37.45 49.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -74.83 -17.01 60.67 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' B' ' 383' ' ' GLU . 41.9 tp -78.87 -68.07 0.69 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 57.3 mtt -54.3 -19.5 5.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.01 -1.056 . . . . 0.0 109.136 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.2 -23.72 51.44 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' B' ' 380' ' ' LEU . 97.5 mt-10 -108.62 4.37 23.88 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.626 -0.671 . . . . 0.0 110.962 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 69.0 mt -82.67 122.31 27.98 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.578 -1.326 . . . . 0.0 110.129 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.041 -0.98 . . . . 0.0 108.933 179.231 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.188 0.518 . . . . 2.91 109.691 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 87.7 mt -110.03 127.94 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.73 -0.841 . . . . 1.2 108.73 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.2 m -140.04 150.73 44.75 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.296 -0.877 . . . . 1.4 109.258 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.86 -163.89 9.7 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 108.465 -1.854 . . . . 1.05 108.465 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 6' ' ' LEU . 89.9 mt -90.37 -17.37 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.747 -1.443 . . . . 1.15 109.575 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.4 tp 55.1 106.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.496 -0.752 . . . . 0.98 109.184 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.26 -29.12 12.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.333 -0.855 . . . . 0.88 109.065 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 14.8 m -127.62 116.62 21.09 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 109.356 -0.609 . . . . 1.69 109.356 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.85 148.05 19.61 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 121.991 1.794 . . . . 0.85 112.453 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.91 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 143.36 178.78 19.47 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 108.853 -1.699 . . . . 0.92 108.853 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.412 HG22 ' N ' ' A' ' 12' ' ' ALA . 96.7 mt -122.13 156.36 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.231 -1.158 . . . . 0.81 109.436 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.412 ' N ' HG22 ' A' ' 11' ' ' ILE . . . -155.55 156.56 35.36 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.965 -1.084 . . . . 0.51 110.625 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.4 m-85 -137.69 128.99 27.85 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.03 -1.1 . . . . 0.62 108.03 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.43 178.38 47.77 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 118.505 -1.807 . . . . 0.55 110.842 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -78.86 156.7 28.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.786 -0.832 . . . . 2.1 109.14 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.593 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -107.62 133.03 52.65 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.392 -0.817 . . . . 0.77 110.923 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.3 tp -107.45 137.85 44.73 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 107.997 -1.112 . . . . 0.91 107.997 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 66.2 tp -115.76 122.66 46.12 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.526 -0.734 . . . . 0.93 109.561 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.9 mt -82.26 103.21 11.68 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.414 -0.804 . . . . 0.93 109.416 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -94.25 136.56 34.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.296 -0.878 . . . . 2.75 109.496 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 58.2 mp0 -131.02 134.84 47.05 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.361 -0.837 . . . . 3.0 109.086 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.17 150.76 28.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.133 -0.98 . . . . 2.77 109.133 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -65.96 149.22 50.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.943 -1.098 . . . . 2.94 109.245 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.527 ' CG1' HH12 ' A' ' 139' ' ' ARG . 88.2 mt -89.78 124.83 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 0.95 109.22 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.63 122.87 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.236 -0.915 . . . . 1.28 109.477 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.9 mt -108.09 133.22 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.802 -0.814 . . . . 1.21 108.802 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -86.97 118.27 26.24 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.792 -1.192 . . . . 1.81 109.58 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -87.51 -1.0 57.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 2.8 109.613 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.81 136.86 49.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.112 -0.993 . . . . 2.87 109.184 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -80.99 159.51 24.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.952 -1.092 . . . . 2.35 109.488 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.416 HD13 ' HG3' ' A' ' 39' ' ' GLU . 2.9 pt -102.57 167.67 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.303 -0.873 . . . . 0.97 109.883 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.3 p -94.1 175.27 6.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.229 -0.92 . . . . 1.17 109.093 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.74 -50.97 71.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.089 -1.007 . . . . 1.18 110.746 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 55.8 t0 -54.71 -29.41 53.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.561 -1.337 . . . . 2.56 109.681 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -82.02 -10.04 59.36 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.316 -0.865 . . . . 1.79 110.386 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.0 t -60.22 -50.3 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.824 -1.172 . . . . 1.0 109.068 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.67 -39.9 93.04 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.404 -0.81 . . . . 1.77 109.54 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -62.68 -43.79 97.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.903 . . . . 2.7 110.981 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.416 ' HG3' HD13 ' A' ' 31' ' ' ILE . 75.5 mm-40 -61.89 -40.19 94.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.84 -1.162 . . . . 1.51 110.171 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 66.4 t -59.87 -46.23 94.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 C-N-CA 118.722 -1.191 . . . . 0.93 108.86 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -59.93 -42.58 94.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.881 -1.137 . . . . 1.81 109.434 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.26 -41.52 93.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.807 -1.183 . . . . 2.78 108.222 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -64.01 -46.9 82.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.355 -0.841 . . . . 0.78 109.143 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.1 tp -59.96 -48.81 80.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.28 -0.887 . . . . 1.07 108.672 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.0 t -63.26 -41.95 99.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.075 -1.015 . . . . 1.12 109.543 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.62 -46.21 92.73 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.154 -1.578 . . . . 0.84 109.154 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -63.3 -33.56 75.78 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.261 -1.141 . . . . 3.09 108.739 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.25 -42.85 87.33 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.369 -0.832 . . . . 0.88 109.283 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 50' ' ' ALA . 1.2 ttmp? -63.68 -73.62 0.11 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.792 -1.193 . . . . 2.59 107.915 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.19 -41.14 0.37 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.415 -0.803 . . . . 0.7 111.411 -178.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.2 p -54.22 -54.77 35.42 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.42 -1.425 . . . . 1.4 108.699 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.99 -39.97 83.17 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.462 -0.774 . . . . 0.67 111.301 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -68.37 -39.95 81.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.77 -1.206 . . . . 1.66 110.668 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.13 -39.97 96.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.979 -1.076 . . . . 1.58 108.736 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -63.91 -34.14 77.29 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.454 -0.779 . . . . 1.35 109.087 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.6 m -65.89 -44.13 86.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 0.77 108.883 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.9 mt -60.14 -37.75 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.675 -0.861 . . . . 0.63 108.675 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -59.8 -51.06 71.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.473 -0.767 . . . . 1.14 110.204 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 m -55.78 -33.28 64.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.051 -1.03 . . . . 0.79 110.042 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -69.92 -37.96 76.11 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.422 -0.798 . . . . 1.53 109.555 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.413 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -68.78 -47.67 65.6 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.204 0.526 . . . . 0.57 111.227 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.68 -50.97 61.81 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 110.004 -1.239 . . . . 0.75 110.004 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.96 -42.11 73.63 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.005 -1.291 . . . . 1.59 110.562 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.5 m -69.28 -60.69 2.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.088 -1.007 . . . . 0.73 112.111 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -96.52 -50.93 4.54 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.935 -1.103 . . . . 0.75 111.422 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.15 -163.86 26.98 Favored Glycine 0 N--CA 1.501 2.974 0 O-C-N 120.731 -1.231 . . . . 1.22 111.048 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.02 -25.15 63.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.772 -0.84 . . . . 5.81 110.65 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -60.33 -36.76 78.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.902 . . . . 3.37 110.197 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.479 ' NZ ' ' CE1' ' A' ' 189' ' ' HIS . 69.3 mmtt -97.78 -19.85 17.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.251 -0.905 . . . . 1.77 110.352 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.1 -46.13 68.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.909 -1.119 . . . . 1.65 110.224 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.617 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -62.7 -32.91 74.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.643 -0.661 . . . . 0.77 110.116 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.09 -40.83 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.867 -1.146 . . . . 0.8 109.045 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -65.11 -39.83 93.67 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.14 -0.975 . . . . 0.88 109.776 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -60.09 -39.98 88.02 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.085 -1.009 . . . . 1.37 109.528 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.14 -49.3 72.55 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.623 -1.791 . . . . 0.62 108.623 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -60.91 -43.61 98.32 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.344 -1.091 . . . . 1.5 108.837 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.1 mt -68.94 -47.71 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.254 -0.903 . . . . 0.63 109.09 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.8 ttp -60.25 -42.94 96.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.899 -1.126 . . . . 1.51 109.792 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.841 HD11 ' CE2' ' B' ' 348' ' ' PHE . 63.4 tp -64.81 -40.0 94.5 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.376 -0.828 . . . . 0.77 109.772 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.7 tp -64.52 -40.05 94.9 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.292 -0.88 . . . . 0.62 110.189 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -81.55 4.86 19.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.974 -1.078 . . . . 1.47 109.844 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 51.7 t0 -50.26 132.02 24.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 1.47 110.07 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 97.7 mt-10 -62.02 -18.96 62.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.637 -0.664 . . . . 1.78 110.754 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -72.42 -36.05 68.5 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.853 -1.154 . . . . 2.53 108.935 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.17 -40.38 78.18 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.974 -0.75 . . . . 0.8 108.974 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.04 -49.87 75.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.566 -0.709 . . . . 1.42 110.023 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.13 -41.42 73.96 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.329 -0.857 . . . . 1.71 111.284 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.64 -40.35 73.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.947 -1.096 . . . . 1.57 111.512 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.8 -49.34 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.88 -1.137 . . . . 0.65 109.591 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.4 mt -65.29 -37.64 80.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.634 -0.666 . . . . 0.82 110.275 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.29 98.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 0.79 110.365 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 96' ' ' LYS . 81.5 mt -61.67 -46.38 89.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.885 -1.134 . . . . 0.95 109.085 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.2 mt -61.06 -50.2 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.963 0.887 . . . . 0.66 109.261 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.02 -40.95 74.9 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 120.008 -0.677 . . . . 2.2 110.451 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -82.34 -49.5 9.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.308 -0.87 . . . . 1.65 111.805 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 92' ' ' LEU . 65.7 mmtt -92.24 -2.05 56.73 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.033 -1.042 . . . . 2.03 111.788 -177.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 38.4 m170 55.51 32.77 19.7 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.844 -1.16 . . . . 1.42 109.082 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 93.5 mtp -90.18 166.72 13.21 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.707 -0.621 . . . . 1.18 109.826 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.2 p -78.39 158.62 28.69 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.451 -0.944 . . . . 0.98 108.451 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.99 -35.73 74.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.985 -1.072 . . . . 0.64 109.901 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -67.14 -40.01 86.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 2.07 109.437 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.41 -41.88 21.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.395 -0.816 . . . . 0.73 109.698 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.68 -50.5 66.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.418 -0.802 . . . . 0.54 110.417 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.07 88.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.164 -0.96 . . . . 0.56 109.836 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -58.34 -39.93 80.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 1.54 109.761 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.79 -40.13 96.39 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.217 -0.927 . . . . 1.33 110.034 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.3 t -66.51 -52.53 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.213 -0.929 . . . . 0.72 111.56 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.9 mm -69.34 -39.91 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.824 -1.173 . . . . 0.85 108.772 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.41 -34.85 76.75 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.615 -0.883 . . . . 2.44 108.615 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.32 -47.49 90.58 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 120.645 -0.788 . . . . 0.98 111.135 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -66.17 -48.12 71.78 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.614 -1.521 . . . . 1.41 109.602 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.74 78.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.895 . . . . 1.2 109.505 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 84.1 p -57.69 -40.2 78.91 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.091 -1.005 . . . . 1.7 108.748 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.8 89.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 1.47 109.614 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.4 mt -63.53 -43.35 97.39 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.798 -1.189 . . . . 1.56 110.274 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.18 -30.47 69.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.681 -1.262 . . . . 2.2 109.739 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.95 -23.72 63.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.991 -1.068 . . . . 2.12 108.598 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.48 HD13 HD13 ' A' ' 123' ' ' LEU . 26.0 mt -62.4 147.73 47.59 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.291 -0.881 . . . . 2.0 109.128 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -94.95 49.16 1.21 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.085 -1.009 . . . . 3.23 109.734 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -136.25 130.27 32.8 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.198 -0.939 . . . . 2.49 109.888 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.06 -30.32 67.55 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.445 -0.784 . . . . 3.95 110.248 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.512 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.1 t80 -72.11 -38.24 69.34 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.287 -0.883 . . . . 2.0 110.716 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.576 HD22 ' O ' ' B' ' 351' ' ' GLN . 89.4 mt -70.0 -32.28 70.39 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.045 -1.034 . . . . 1.86 108.249 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -60.24 -39.21 85.9 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.601 -0.888 . . . . 2.84 108.601 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -59.75 -48.35 82.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.331 -0.856 . . . . 2.73 110.108 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.6 HH21 ' C ' ' B' ' 315' ' ' HIS . 84.5 mtt180 -60.12 -39.68 87.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.679 -1.263 . . . . 2.77 108.495 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.51 -32.32 68.72 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.294 -0.879 . . . . 1.19 108.65 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.8 -40.22 88.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 1.2 109.588 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -65.55 -40.12 92.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 1.55 109.515 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.49 -41.85 86.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.45 -0.781 . . . . 0.8 109.292 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -62.03 -36.31 81.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 3.09 109.5 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -60.0 -40.01 87.76 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.263 -0.898 . . . . 1.46 110.077 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.26 -44.16 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.151 -0.968 . . . . 0.71 109.791 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.37 -39.72 98.13 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.474 -1.051 . . . . 0.57 110.474 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -58.94 -45.78 89.61 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.893 -1.357 . . . . 2.59 109.624 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.502 HH11 ' HG2' ' A' ' 136' ' ' ARG . 24.3 mtt-85 -63.22 -36.33 83.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.874 -1.141 . . . . 2.83 110.339 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.6 tp -56.19 -44.59 79.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.309 -0.869 . . . . 1.25 109.974 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.96 -40.07 91.96 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.032 -1.043 . . . . 0.7 108.791 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.634 HH11 ' HG2' ' A' ' 139' ' ' ARG . 11.5 mtt-85 -67.73 -39.94 84.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.348 -0.845 . . . . 2.57 109.339 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -68.06 -38.03 81.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.632 -0.667 . . . . 1.23 111.668 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.3 mt -73.73 -45.55 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.227 -1.546 . . . . 0.81 108.571 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.7 mt -70.0 -33.7 72.37 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.614 -0.679 . . . . 1.0 109.493 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.78 40.2 7.27 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.193 -1.563 . . . . 0.89 109.193 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.2 tp -74.94 150.39 39.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.521 -0.987 . . . . 1.14 110.17 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -68.4 141.29 55.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.322 -0.861 . . . . 4.6 110.174 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.9 mt -116.48 129.95 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 121.785 0.802 . . . . 1.24 109.474 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 15.0 mm -56.79 -50.17 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.794 -0.566 . . . . 1.54 111.137 -177.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.0 t0 67.09 104.31 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.266 -0.896 . . . . 1.5 109.5 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.4 mt -81.06 -7.58 59.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.275 -0.89 . . . . 0.79 110.799 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.7 p -80.13 -17.32 52.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.65 -1.281 . . . . 1.4 109.355 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.8 17.62 3.31 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.509 -0.745 . . . . 0.92 111.825 -177.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 50.1 mt -91.04 114.57 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.727 -1.233 . . . . 0.88 109.145 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -101.34 -11.01 19.76 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.385 -0.822 . . . . 2.45 110.604 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -110.53 146.6 35.75 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.16 -0.962 . . . . 1.52 109.442 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.94 130.58 43.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.148 -0.97 . . . . 1.58 109.407 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.1 m -152.27 163.71 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.939 -0.763 . . . . 0.69 108.939 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.1 mt -93.14 149.75 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 106.028 -1.842 . . . . 0.61 106.028 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.426 HD22 HD11 ' A' ' 171' ' ' LEU . 52.5 tp -100.44 117.81 35.37 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.996 -1.065 . . . . 0.87 110.908 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.1 t -121.94 129.92 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 N-CA-C 108.694 -0.854 . . . . 0.71 108.694 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.22 164.49 35.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.976 -1.077 . . . . 0.81 109.153 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.433 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.86 -35.69 74.9 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.362 -1.461 . . . . 0.98 108.775 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 52.3 t0 -170.6 143.81 2.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.441 -0.948 . . . . 2.25 108.441 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.545 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 26.1 mt -112.71 129.72 56.31 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.52 -0.919 . . . . 0.78 108.52 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.3 p -83.63 145.42 47.57 Favored Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.239 -0.913 . . . . 0.98 109.004 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -38.01 -36.28 0.46 Allowed 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.031 1.821 . . . . 0.81 111.581 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.4 m -59.87 -40.0 87.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.407 -0.808 . . . . 0.9 109.656 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.5 -40.19 77.14 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.13 -0.982 . . . . 1.61 109.713 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 68.5 p -56.1 -28.14 56.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.067 -1.021 . . . . 0.61 110.739 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -74.58 -56.35 4.92 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.821 -1.174 . . . . 0.6 109.711 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -78.88 39.58 0.37 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.532 -1.285 . . . . 1.4 107.532 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.466 ' H ' ' C ' ' A' ' 169' ' ' ALA . 15.3 tp -99.93 131.86 45.63 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.695 -0.628 . . . . 0.7 109.522 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -88.05 100.27 12.8 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.144 -1.058 . . . . 2.35 108.144 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 65.9 mt -64.66 -42.98 95.03 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.323 -0.861 . . . . 1.51 110.791 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -69.89 -24.24 63.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.66 -1.275 . . . . 2.33 111.569 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -94.39 -13.51 26.23 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.6 -1.312 . . . . 1.92 109.767 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 178' ' ' GLY . 69.6 t -104.85 116.17 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.238 -0.914 . . . . 0.67 108.541 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.7 mt -83.25 2.19 37.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.936 . . . . 1.53 111.007 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.493 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 171.86 172.33 37.73 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.231 -1.461 . . . . 0.48 109.735 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.429 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 14.2 m-85 -130.63 126.67 37.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.516 -0.991 . . . . 0.55 108.846 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.02 126.25 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.2 -0.938 . . . . 0.65 108.623 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.407 ' C ' ' HG1' ' A' ' 205' ' ' THR . 80.6 p -147.94 158.43 44.04 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.903 -1.123 . . . . 0.82 110.771 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 44.1 p30 -103.92 24.67 10.96 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.956 -0.757 . . . . 2.46 108.956 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -57.78 -159.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.993 -1.067 . . . . 1.28 110.794 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.87 -54.38 9.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.155 -1.178 . . . . 2.19 110.155 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 156.69 -129.94 2.55 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 120.937 -1.331 . . . . 2.13 110.502 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.462 ' C ' ' H ' ' A' ' 188' ' ' SER . 30.2 ttt-85 -63.2 -39.87 95.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.486 -1.008 . . . . 5.86 110.49 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 37.4 p -62.0 1.88 0.26 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.161 -0.962 . . . . 3.72 110.231 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 186' ' ' ARG . 47.5 t -91.52 130.0 37.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.03 -1.044 . . . . 1.74 109.716 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . 0.479 ' CE1' ' NZ ' ' A' ' 69' ' ' LYS . 84.8 t60 -48.28 -44.15 33.38 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.897 0.856 . . . . 0.95 108.967 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.409 ' H ' HG23 ' A' ' 190' ' ' THR . 4.1 p -51.95 -36.33 49.0 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 116.116 -0.493 . . . . 1.55 110.869 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 49.6 m -65.96 -40.83 91.62 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.947 -1.096 . . . . 1.51 111.843 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.2 mm -63.88 -43.2 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.976 -1.077 . . . . 1.67 110.668 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.2 mtp -66.02 -39.95 90.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.249 -0.907 . . . . 1.02 111.036 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.14 -43.34 82.37 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.468 -1.395 . . . . 0.68 109.083 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -59.93 -48.85 80.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.125 -0.984 . . . . 2.93 110.086 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.2 m -68.09 -35.11 77.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.043 -1.036 . . . . 0.86 110.084 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 30.2 mt -71.56 -26.22 62.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.182 -0.949 . . . . 0.67 108.543 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 62.01 51.54 3.64 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.428 0.632 . . . . 1.5 110.494 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 8' ' ' SER . 72.0 mt -129.59 133.07 24.66 Favored Pre-proline 0 N--CA 1.501 2.125 0 N-CA-C 108.541 -0.911 . . . . 0.72 108.541 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -42.16 130.73 4.64 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.0 1.8 . . . . 0.61 112.427 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -169.31 148.8 3.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.93 -1.106 . . . . 0.66 111.326 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 78.8 mt -127.82 146.2 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 N-CA-C 107.985 -1.117 . . . . 0.79 107.985 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.0 m -126.0 -10.55 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 O-C-N 120.734 -1.229 . . . . 0.91 111.51 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.0 22.52 27.41 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 110.323 -1.111 . . . . 1.01 110.323 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.407 ' HG1' ' C ' ' A' ' 181' ' ' THR . 2.8 p -43.99 -42.99 6.36 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.317 -1.108 . . . . 0.99 109.834 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.73 -50.96 3.23 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.204 -0.998 . . . . 1.12 111.068 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 29.1 p -159.25 39.27 0.21 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.547 -1.56 . . . . 1.72 111.299 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.2 -35.76 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.952 -1.093 . . . . 0.89 108.378 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.463 ' H ' HG23 ' A' ' 209' ' ' THR . 6.4 p -55.72 -32.14 63.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.506 -0.746 . . . . 1.03 110.301 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 72.4 p -80.04 -15.65 56.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.951 -1.093 . . . . 1.83 109.84 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -99.76 -13.07 19.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.412 -0.805 . . . . 2.27 110.041 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 52.7 t -106.72 138.07 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 CA-C-O 121.773 0.797 . . . . 0.92 110.713 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.423 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -114.83 153.67 30.01 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.216 -1.402 . . . . 2.2 107.216 178.339 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.459 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 17.5 p-10 -57.63 138.91 54.83 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.914 -1.116 . . . . 2.36 110.546 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.5 m-20 84.36 5.09 0.67 Allowed 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 120.984 0.421 . . . . 2.38 110.758 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 74.8 m-20 -74.62 137.88 42.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.935 -1.103 . . . . 2.09 109.638 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -88.1 118.12 27.45 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.504 -1.295 . . . . 1.27 107.504 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.593 HD12 ' HB2' ' A' ' 16' ' ' ALA . 60.6 mt -128.95 150.36 50.41 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.493 -0.754 . . . . 0.75 110.611 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.9 mt -117.67 128.14 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.317 -1.734 . . . . 0.63 106.317 177.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.3 tp -101.08 120.88 40.85 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.043 -1.036 . . . . 0.7 109.385 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 223' ' ' VAL . 95.3 m-20 -76.32 -44.79 35.26 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.951 -1.093 . . . . 2.31 109.491 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.91 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.25 16.6 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.463 -0.94 . . . . 0.78 108.463 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 221' ' ' ASP . 45.9 t -135.48 -42.97 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.549 -1.278 . . . . 1.04 107.549 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.433 ' H ' ' HB3' ' A' ' 221' ' ' ASP . 84.4 m-20 -99.79 2.74 44.33 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.014 -1.106 . . . . 2.44 108.014 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 60.24 42.42 15.19 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.806 -0.559 . . . . 1.55 109.697 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -141.96 155.46 45.47 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.173 -0.955 . . . . 1.99 110.119 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.0 t -124.8 131.39 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.594 -0.891 . . . . 0.77 108.594 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -102.48 121.74 42.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.326 -0.859 . . . . 0.98 109.325 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 43.9 t -100.59 113.93 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.455 -0.778 . . . . 0.85 110.13 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 25.5 t30 53.48 61.96 10.04 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.237 -0.914 . . . . 1.66 111.59 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -87.35 149.27 7.77 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.976 2.451 . . . . 0.95 112.865 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 42.8 p -70.32 162.62 28.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.444 -0.785 . . . . 1.84 110.271 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -59.66 -35.19 73.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.489 -0.757 . . . . 2.74 109.304 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -59.96 -40.12 87.98 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.359 -0.838 . . . . 2.89 109.953 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.5 -39.53 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.0 -1.063 . . . . 1.3 109.328 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 85.5 mt . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.108 -0.995 . . . . 1.09 109.445 179.349 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 45.0 ttp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 42.1 t80 -153.64 152.31 30.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.446 -0.784 . . . . 0.0 109.194 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . 0.443 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 14.0 pt20 -148.75 158.46 44.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.993 -1.067 . . . . 0.0 110.876 -178.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -152.84 149.88 28.75 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -111.93 131.26 55.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.313 -0.867 . . . . 0.0 110.051 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.4 ' CG1' ' SD ' ' B' ' 381' ' ' MET . 7.4 p -131.16 123.1 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 CA-C-O 122.474 1.131 . . . . 0.0 112.987 -177.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 61.2 m -79.38 103.91 9.63 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.805 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.6 mt -50.8 122.68 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 122.346 1.069 . . . . 0.0 110.296 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 34.6 p -108.43 15.71 23.69 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.697 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.77 116.33 48.91 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.919 -1.113 . . . . 0.0 108.716 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -53.53 -15.26 5.94 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 CA-C-N 120.308 1.146 . . . . 0.0 113.879 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -114.65 12.93 17.3 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.229 -0.919 . . . . 0.0 109.375 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 68.03 174.8 8.51 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.56 ' O ' ' NH2' ' A' ' 126' ' ' ARG . 4.0 tp -84.4 92.39 8.03 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.234 -1.156 . . . . 0.0 110.281 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.6 ' C ' HH21 ' A' ' 126' ' ' ARG . 5.1 p80 -95.94 -162.23 0.93 Allowed 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.778 -1.201 . . . . 0.0 110.06 179.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 22.6 m -58.33 -40.1 81.22 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.93 -1.107 . . . . 0.0 112.661 -175.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.617 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -60.82 -62.79 5.26 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 120.17 -1.581 . . . . 0.0 111.395 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -54.56 -34.37 82.35 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 CA-C-N 120.034 1.048 . . . . 0.0 111.812 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.92 -53.35 59.21 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.337 -0.945 . . . . 0.0 108.948 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.72 -40.66 66.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 0.0 109.387 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -69.96 -41.57 74.31 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 108.878 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.07 -50.97 71.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.557 -0.715 . . . . 0.0 110.535 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . 0.417 HG13 ' O ' ' B' ' 344' ' ' ALA . 89.4 t -70.23 -28.83 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.982 -1.074 . . . . 0.0 110.011 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -60.03 -45.82 91.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.142 -0.973 . . . . 0.0 108.472 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -60.6 -49.31 78.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.397 -0.815 . . . . 0.0 109.745 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . 0.413 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -63.02 -50.91 68.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.302 -0.874 . . . . 0.0 110.85 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt -49.72 -16.65 0.26 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.085 -1.009 . . . . 0.0 109.671 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . 0.413 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -79.3 -23.55 62.89 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.828 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -104.18 139.93 38.53 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.115 -1.227 . . . . 0.0 109.559 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 89.2 m -91.63 -13.32 32.05 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.13 -0.981 . . . . 0.0 110.388 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.476 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 64.6 p -58.85 154.84 14.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.948 -1.095 . . . . 0.0 109.388 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.98 130.87 42.69 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.119 -1.032 . . . . 0.0 108.406 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.9 mt -132.33 133.32 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.603 -0.686 . . . . 0.0 109.583 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.6 m -130.09 151.56 50.5 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.515 -0.741 . . . . 0.0 109.578 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 97.2 t -115.86 139.2 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 91.3 m -129.77 123.95 32.23 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.165 -0.959 . . . . 0.0 109.101 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 11.3 p -138.79 118.22 12.87 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.97 0.891 . . . . 0.0 110.768 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 61.6 t30 42.86 58.05 3.37 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.06 -13.53 31.5 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 120.31 -1.494 . . . . 0.0 113.069 176.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -115.61 127.24 55.07 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 119.336 1.568 . . . . 0.0 109.443 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 74.6 m -123.98 146.56 48.43 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.882 0.849 . . . . 0.0 110.531 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -140.97 163.1 33.87 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.468 0.651 . . . . 0.0 109.624 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 3.4 t -87.05 137.02 32.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.558 -0.714 . . . . 0.0 109.638 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.417 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -76.73 -13.78 60.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.881 -1.137 . . . . 0.0 109.8 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -91.12 19.8 5.51 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 4.6 m -144.28 95.23 2.68 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.269 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.809 HD23 HD22 ' A' ' 79' ' ' LEU . 43.0 tp -59.88 -36.75 77.58 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.841 ' CE2' HD11 ' A' ' 79' ' ' LEU . 63.0 m-85 -56.15 -52.21 65.18 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.092 -1.005 . . . . 0.0 110.964 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -73.77 -23.6 59.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.783 -1.198 . . . . 0.0 110.866 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' B' ' 350' ' ' LEU . 29.9 mt -60.08 -45.61 92.34 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.322 -1.351 . . . . 0.0 108.734 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.588 ' N ' ' NE2' ' B' ' 351' ' ' GLN . 0.1 OUTLIER -50.78 -26.57 5.81 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.123 -0.986 . . . . 0.0 111.892 -178.416 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 44.2 p -72.8 -10.08 59.39 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 119.93 -1.731 . . . . 0.0 109.864 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 39.8 mt -97.46 116.17 29.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.212 -0.93 . . . . 0.0 109.398 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.69 96.34 1.16 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 19.3 mt -103.04 92.17 4.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.355 -1.085 . . . . 0.0 109.105 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 64.9 p -93.5 167.08 11.93 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.959 -1.088 . . . . 0.0 110.946 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -57.02 114.74 2.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.705 -0.622 . . . . 0.0 110.699 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 100.09 7.53 52.33 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 52.2 m -83.8 112.59 20.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -1.107 . . . . 0.0 110.634 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 13.5 t -78.03 114.36 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 122.263 1.03 . . . . 0.0 109.625 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 11.8 m -110.81 177.46 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 62.4 m -131.25 129.3 41.41 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 89.3 mt -104.11 118.4 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 37.3 p -121.64 133.65 54.98 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.11 154.07 40.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.087 -1.008 . . . . 0.0 110.239 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -144.61 122.39 11.91 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 160.28 -159.29 30.67 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 118.972 -1.585 . . . . 0.0 111.596 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -59.98 -51.8 68.13 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.169 -0.606 . . . . 0.0 112.295 -177.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.476 ' H ' ' HB3' ' B' ' 331' ' ' SER . 75.2 m-20 -109.31 10.37 25.62 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.775 -1.203 . . . . 0.0 111.059 -177.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.414 ' C ' ' OE1' ' B' ' 370' ' ' GLU . 0.7 OUTLIER -43.64 -34.9 1.58 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.096 -1.003 . . . . 0.0 111.718 -178.352 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -70.06 -42.69 72.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.378 -1.451 . . . . 0.0 110.866 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -69.23 -50.61 45.68 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.902 -1.124 . . . . 0.0 109.562 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -51.45 -31.29 22.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 111.381 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.518 ' O ' HG23 ' B' ' 378' ' ' VAL . 70.3 t -71.74 -39.92 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.545 -1.347 . . . . 0.0 108.845 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -64.48 -62.4 1.62 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.24 -0.913 . . . . 0.0 110.908 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -60.68 -43.69 97.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.392 -1.443 . . . . 0.0 111.416 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.03 -40.12 88.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.437 -1.414 . . . . 0.0 108.359 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.518 HG23 ' O ' ' B' ' 374' ' ' VAL . 52.3 t -66.67 -40.22 85.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.535 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -70.94 -58.5 3.52 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.453 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 55.6 tp -54.41 -34.06 60.58 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.8 -0.563 . . . . 0.0 109.952 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . 0.4 ' SD ' ' CG1' ' B' ' 306' ' ' VAL . 2.8 ttt -73.83 -40.03 63.62 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 108.819 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -79.19 -4.89 52.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.572 -0.705 . . . . 0.0 109.904 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -109.03 0.47 19.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.294 -0.879 . . . . 0.0 111.313 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . 0.453 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 20.4 mt -69.79 131.1 43.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.179 -1.576 . . . . 0.0 108.508 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.593 -179.334 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.7 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.424 -0.584 . . . . 2.91 109.424 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.2 mt -109.97 129.92 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.523 -0.736 . . . . 1.2 109.12 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.6 m -130.3 143.08 50.56 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.46 -0.775 . . . . 1.4 109.558 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.505 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -112.85 -160.0 14.29 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 108.944 -1.662 . . . . 1.05 108.944 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.469 ' O ' ' O ' ' A' ' 6' ' ' LEU . 92.0 mt -94.21 -15.5 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.997 -1.296 . . . . 1.15 110.086 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.9 tp 50.85 103.0 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.248 -0.908 . . . . 0.98 109.505 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.14 -25.79 14.42 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.988 -1.07 . . . . 0.88 109.273 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 35.0 m -133.73 119.67 15.08 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.427 -0.796 . . . . 1.69 109.573 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.91 147.29 16.79 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.08 1.854 . . . . 0.85 112.683 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.819 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.46 -159.33 30.41 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.082 -1.607 . . . . 0.92 109.082 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.4 mt -149.21 150.14 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.167 -1.196 . . . . 0.81 108.669 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.55 157.84 37.47 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.968 -1.083 . . . . 0.51 110.756 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -139.5 128.7 23.91 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.021 -1.103 . . . . 0.62 108.021 178.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.0 -177.29 47.09 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 118.758 -1.687 . . . . 0.55 110.92 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 157' ' ' ILE . 98.1 mttt -79.8 159.67 26.44 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.589 -0.948 . . . . 2.1 110.099 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.568 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -106.6 137.38 44.72 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.596 -0.69 . . . . 0.77 110.131 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.5 tp -104.05 131.12 51.63 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.882 -1.155 . . . . 0.91 107.882 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.3 tp -113.04 124.33 52.37 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.195 -0.941 . . . . 0.93 110.022 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.404 HD12 ' HB2' ' A' ' 160' ' ' ALA . 26.3 mt -95.42 103.64 15.51 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.667 -0.646 . . . . 0.93 111.005 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -107.22 136.93 46.22 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.541 -0.724 . . . . 2.75 109.925 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -130.15 138.2 50.52 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.356 -0.84 . . . . 3.0 109.377 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -78.04 158.77 29.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.067 -1.021 . . . . 2.77 109.944 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -72.32 144.21 48.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.424 -0.798 . . . . 2.94 108.905 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.8 mt -84.5 129.61 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.104 -0.998 . . . . 0.95 109.464 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.5 t -94.14 124.73 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.341 -0.849 . . . . 1.28 110.684 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.4 mt -110.37 134.28 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.52 -0.738 . . . . 1.21 109.355 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -93.66 116.45 28.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.978 -1.076 . . . . 1.81 109.141 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -83.72 -1.41 54.06 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.153 -0.967 . . . . 2.8 109.407 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.14 139.99 58.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 2.87 109.655 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -83.13 151.2 25.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.089 -1.007 . . . . 2.35 108.999 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -94.57 166.73 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.864 . . . . 0.97 110.149 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 83.9 p -96.78 173.43 7.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -0.947 . . . . 1.17 108.666 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.79 -49.69 76.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.072 -1.018 . . . . 1.18 109.512 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -53.57 -30.99 44.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.096 -1.003 . . . . 2.56 109.29 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -83.32 -9.92 58.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.58 -0.7 . . . . 1.79 110.669 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.97 -54.0 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.652 -1.28 . . . . 1.0 109.288 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -64.56 -40.14 95.03 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.31 -0.869 . . . . 1.77 110.036 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.51 HE21 HH21 ' A' ' 42' ' ' ARG . 27.3 mt-30 -65.99 -43.63 87.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.976 -1.078 . . . . 2.7 110.351 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -63.9 -40.04 95.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.86 -1.15 . . . . 1.51 110.168 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.0 -48.16 90.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.778 -1.201 . . . . 0.93 108.647 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -62.25 -43.96 97.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.157 -0.965 . . . . 1.81 109.505 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.51 HH21 HE21 ' A' ' 38' ' ' GLN . 21.8 mtt-85 -60.05 -43.15 95.57 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.857 -1.164 . . . . 2.78 107.857 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -60.73 -49.98 75.32 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.454 -0.943 . . . . 0.78 108.454 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.6 tp -60.06 -43.71 95.23 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.69 -0.856 . . . . 1.07 108.69 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.0 t -66.56 -41.96 87.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 1.12 109.292 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.29 -44.3 66.34 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.214 -1.954 . . . . 0.84 108.214 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.435 HH22 ' HG2' ' A' ' 81' ' ' GLU . 41.2 ttt-85 -62.77 -36.6 83.62 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.14 -1.059 . . . . 3.09 108.14 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.03 -39.39 78.25 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.581 -0.896 . . . . 0.88 108.581 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.2 ttpt -59.5 -73.66 0.08 Allowed 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.355 -1.35 . . . . 2.59 107.355 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.61 -37.73 0.23 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.439 -0.788 . . . . 0.7 111.153 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 52' ' ' ALA . 21.7 p -53.25 -53.61 48.2 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.578 -1.326 . . . . 1.4 108.478 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.402 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . -67.85 -40.86 83.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -0.899 . . . . 0.67 110.884 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -70.01 -39.96 75.52 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.796 -1.19 . . . . 1.66 109.746 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.13 -40.05 96.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.053 -1.029 . . . . 1.58 109.11 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.37 -38.58 84.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.383 -0.823 . . . . 1.35 109.831 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -61.34 -40.47 94.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.77 110.048 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.3 mt -61.58 -39.98 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.374 -0.829 . . . . 0.63 109.188 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -56.58 -50.82 70.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 1.14 109.949 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -60.0 -31.76 70.23 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.376 -0.827 . . . . 0.79 110.729 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -67.87 -39.48 83.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.044 -1.035 . . . . 1.53 109.302 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.7 -41.48 95.99 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.663 -0.648 . . . . 0.57 110.026 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.83 -50.25 69.74 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.493 -1.443 . . . . 0.75 109.493 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.17 -51.55 24.2 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.929 -1.336 . . . . 1.59 109.929 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.7 m -60.11 -65.7 0.64 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.73 112.202 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -94.22 -50.15 5.4 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.802 -1.186 . . . . 0.75 111.439 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.65 -168.24 25.61 Favored Glycine 0 N--CA 1.502 3.071 0 C-N-CA 119.732 -1.223 . . . . 1.22 111.198 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.0 -26.78 64.24 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.939 -0.742 . . . . 5.81 110.21 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.508 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.0 tp10 -60.1 -34.29 73.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.378 -0.826 . . . . 3.37 110.629 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -100.0 -18.01 17.24 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.079 -1.013 . . . . 1.77 109.799 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -69.26 -39.99 78.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.103 -0.998 . . . . 1.65 109.974 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.495 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -63.25 -31.5 72.67 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.308 -0.87 . . . . 0.77 109.47 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.0 mt -60.12 -42.21 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -0.985 . . . . 0.8 109.656 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -65.02 -39.88 94.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.994 -1.066 . . . . 0.88 110.317 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -59.79 -40.12 87.23 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.954 -1.091 . . . . 1.37 108.771 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.47 -46.34 94.01 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.649 -1.781 . . . . 0.62 108.649 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -65.34 -45.06 85.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -1.133 . . . . 1.5 109.646 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.7 mt -69.08 -45.0 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.078 -1.049 . . . . 0.63 109.09 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.3 ttp -61.1 -39.9 91.71 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.936 -1.102 . . . . 1.51 109.436 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.891 HD22 HD23 ' B' ' 347' ' ' LEU . 46.0 tp -63.15 -39.13 93.78 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.495 -0.753 . . . . 0.77 109.506 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 34.6 tp -66.1 -30.27 70.74 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.404 -0.81 . . . . 0.62 109.027 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.435 ' HG2' HH22 ' A' ' 47' ' ' ARG . 96.4 mt-10 -87.2 6.86 30.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.137 -0.977 . . . . 1.47 110.009 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 63.1 t0 -55.86 130.0 41.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.963 -1.085 . . . . 1.47 109.887 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.407 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 99.8 mt-10 -60.5 -19.43 56.88 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.528 -0.732 . . . . 1.78 111.058 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.96 -33.53 72.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.759 -1.213 . . . . 2.53 108.337 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 76.9 mt -71.94 -41.99 67.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.64 -0.663 . . . . 0.8 110.08 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -60.15 -50.12 74.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.02 -1.05 . . . . 1.42 111.056 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -70.12 -40.09 75.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.107 -0.996 . . . . 1.71 110.876 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.88 -39.99 75.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.22 -0.925 . . . . 1.57 111.01 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.2 -49.99 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.997 -1.064 . . . . 0.65 109.676 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.02 -39.11 80.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.538 -0.726 . . . . 0.82 110.436 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.11 -44.03 95.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 0.79 110.631 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.2 mt -62.47 -46.96 86.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.796 -1.19 . . . . 0.95 109.719 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.8 -50.06 81.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-O 121.911 0.862 . . . . 0.66 108.939 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -67.66 -42.54 82.02 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.456 -0.777 . . . . 2.2 110.758 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -80.33 -54.11 6.01 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.965 -1.085 . . . . 1.65 111.956 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -90.06 -1.94 58.03 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.111 -0.993 . . . . 2.03 112.35 -177.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.9 m80 58.32 35.06 24.6 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.837 -1.164 . . . . 1.42 109.776 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.6 mtp -86.56 165.17 16.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.409 -0.807 . . . . 1.18 110.17 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.5 p -79.22 161.37 26.42 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.0 -0.741 . . . . 0.98 109.0 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.29 -42.0 84.51 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.174 -0.954 . . . . 0.64 109.613 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -62.15 -40.04 94.61 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.192 -0.943 . . . . 2.07 109.445 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.27 -41.44 22.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.73 110.111 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.26 -52.02 60.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.333 -0.855 . . . . 0.54 110.402 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.99 87.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.109 -0.994 . . . . 0.56 109.785 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.526 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 82.7 t60 -60.02 -40.22 88.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 1.54 110.048 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.01 -40.05 92.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.145 -0.972 . . . . 1.33 110.671 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.23 -59.95 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.094 -1.004 . . . . 0.72 111.439 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.3 mm -62.28 -42.96 97.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.974 -1.079 . . . . 0.85 109.075 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.526 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 88.7 tt0 -61.47 -40.04 93.1 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.565 -0.902 . . . . 2.44 108.565 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.16 -51.03 61.36 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.367 -1.093 . . . . 0.98 110.367 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' B' ' 348' ' ' PHE . 14.6 mm100 -62.15 -49.96 73.75 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.889 -1.36 . . . . 1.41 109.126 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.07 -40.06 88.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 1.2 109.636 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 56.6 m -60.04 -39.97 87.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.116 -0.99 . . . . 1.7 109.213 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.06 82.21 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.023 -1.048 . . . . 1.47 108.407 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 118' ' ' LEU . 51.8 mt -62.0 -46.47 89.08 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.111 -0.993 . . . . 1.56 108.662 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -47.76 -30.82 4.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.897 -1.127 . . . . 2.2 109.689 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.41 -27.12 68.79 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.013 -1.054 . . . . 2.12 108.354 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 115' ' ' LEU . 74.4 mt -63.32 140.6 58.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.862 . . . . 2.0 108.952 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -94.23 10.12 35.27 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.075 -1.016 . . . . 3.23 110.42 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -98.3 147.0 25.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.005 -1.06 . . . . 2.49 109.891 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.488 ' O ' ' N ' ' A' ' 124' ' ' LYS . 98.9 mt-10 -72.98 -65.53 0.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.52 -0.738 . . . . 3.95 109.159 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.412 ' C ' ' O ' ' A' ' 121' ' ' GLU . 4.7 t80 -39.37 -40.05 0.74 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.867 -0.52 . . . . 2.0 110.602 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.627 ' CD2' HH21 ' A' ' 126' ' ' ARG . 81.0 mt -70.83 -40.0 72.67 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.744 -1.223 . . . . 1.86 108.551 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 121' ' ' GLU . 82.1 tttt -68.3 -34.52 76.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.553 -0.717 . . . . 2.84 109.579 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -60.08 -40.02 88.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.262 -0.899 . . . . 2.73 110.19 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.627 HH21 ' CD2' ' A' ' 123' ' ' LEU . 76.2 mtm180 -68.06 -33.44 74.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.934 -1.104 . . . . 2.77 109.258 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.88 78.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.11 -0.994 . . . . 1.19 108.621 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.27 96.86 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.797 -1.186 . . . . 1.2 107.797 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -69.96 -40.0 75.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.611 -0.681 . . . . 1.55 109.478 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.64 -39.99 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.197 -1.038 . . . . 0.8 108.197 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -65.49 -35.65 81.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.31 -0.868 . . . . 3.09 109.099 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -59.91 -40.12 87.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.252 -0.905 . . . . 1.46 109.541 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.06 -43.09 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.371 -0.83 . . . . 0.71 109.827 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.18 -36.69 50.38 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 120.197 -1.001 . . . . 0.57 110.659 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -59.55 -42.55 92.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.069 -1.254 . . . . 2.59 109.649 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -68.7 -34.37 75.53 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.707 -1.245 . . . . 2.83 109.46 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.6 tp -59.95 -43.07 95.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 1.25 109.478 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.09 -40.17 94.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.003 -1.06 . . . . 0.7 109.146 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -70.11 -36.84 75.13 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 2.57 109.488 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -69.87 -25.58 63.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.353 -0.842 . . . . 1.23 111.24 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.91 -43.76 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.472 -1.393 . . . . 0.81 108.931 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.59 -28.45 58.93 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.494 -0.754 . . . . 1.0 110.079 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.34 5.61 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.112 -1.995 . . . . 0.89 108.112 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.7 tp -73.59 146.87 44.36 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.632 -0.922 . . . . 1.14 109.229 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -60.81 144.12 53.24 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.24 -0.913 . . . . 4.6 109.515 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 97.2 mt -114.49 120.61 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.583 -0.895 . . . . 1.24 108.583 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 10.7 mm -52.6 -53.23 21.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.651 -0.656 . . . . 1.54 110.384 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.2 t0 66.37 103.32 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.548 -0.72 . . . . 1.5 109.285 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 17.1 mt -74.82 -3.08 29.66 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.673 -0.642 . . . . 0.79 110.374 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 53.1 m -86.83 -15.68 38.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.171 -0.955 . . . . 1.4 109.573 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.99 15.83 1.03 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.362 -0.836 . . . . 0.92 111.458 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.547 HD12 ' N ' ' A' ' 152' ' ' ILE . 1.3 mp -90.4 124.71 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.541 -1.349 . . . . 0.88 109.068 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -103.67 -7.09 20.96 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.386 -0.822 . . . . 2.45 110.101 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -119.36 149.43 41.84 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.477 -0.764 . . . . 1.52 110.496 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.35 135.42 54.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.419 -0.8 . . . . 1.58 109.161 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.0 m -152.07 166.02 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.428 -0.795 . . . . 0.69 109.538 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 15' ' ' LYS . 86.3 mt -93.47 149.3 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 105.823 -1.918 . . . . 0.61 105.823 176.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.2 tp -97.06 115.26 27.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.942 -1.099 . . . . 0.87 110.799 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 64.2 t -120.11 124.69 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.679 -0.638 . . . . 0.71 109.436 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.404 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -159.45 162.66 35.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.168 -0.958 . . . . 0.81 108.481 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.02 -36.42 75.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.508 -1.37 . . . . 0.98 108.444 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 20.4 p-10 -170.77 146.79 2.67 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.21 -0.663 . . . . 2.25 109.21 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 44.8 mt -112.98 137.54 51.22 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.362 -0.836 . . . . 0.78 109.906 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 70.9 p -92.82 146.42 32.11 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.157 -0.964 . . . . 0.98 108.483 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -40.2 -37.81 1.98 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.02 1.814 . . . . 0.81 112.731 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.9 m -59.99 -40.76 90.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.912 . . . . 0.9 110.146 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.94 -40.63 75.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.05 -1.031 . . . . 1.61 109.824 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 66.5 p -59.14 -20.33 52.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.364 -0.835 . . . . 0.61 111.833 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.5 -47.45 9.9 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.471 -1.393 . . . . 0.6 109.739 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -85.62 36.29 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.581 -0.896 . . . . 1.4 108.581 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.0 tp -107.91 139.9 41.84 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.932 -0.766 . . . . 0.7 108.932 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.416 HD21 ' HB ' ' A' ' 152' ' ' ILE . 6.2 p30 -89.37 106.39 18.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.045 -1.034 . . . . 2.35 108.912 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 59.6 mt -67.39 -40.16 85.65 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.576 -0.703 . . . . 1.51 111.678 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -68.75 -21.83 64.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.646 -1.284 . . . . 2.33 111.17 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -94.29 -8.37 39.26 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.89 -1.131 . . . . 1.92 109.96 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 178' ' ' GLY . 84.4 t -101.0 112.42 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.216 -0.927 . . . . 0.67 108.719 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.52 1.49 29.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -0.91 . . . . 1.53 110.7 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.473 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.26 173.33 37.5 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.33 -1.508 . . . . 0.48 109.33 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.488 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 26.9 m-85 -127.98 125.07 38.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.562 -0.963 . . . . 0.55 108.713 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 93.4 mt -130.85 125.38 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.399 -0.963 . . . . 0.65 108.399 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 31.6 p -151.42 163.43 38.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.885 -1.134 . . . . 0.82 111.172 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.501 ' O ' ' O ' ' A' ' 183' ' ' ALA . 57.4 t0 -100.84 27.35 6.03 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.993 -0.549 . . . . 2.46 109.675 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -46.96 -177.24 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.001 -1.687 . . . . 1.28 111.862 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.29 -54.39 6.92 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.254 -1.138 . . . . 2.19 110.254 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -161.4 -156.12 8.17 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.416 -1.373 . . . . 2.13 110.357 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.803 ' HE ' HH21 ' A' ' 195' ' ' ARG . 66.6 mtp180 -78.4 -9.48 59.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.633 -0.922 . . . . 5.86 109.354 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 39.6 p -77.75 2.78 15.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 3.72 110.067 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 78.0 p -82.31 139.61 34.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.954 -1.091 . . . . 1.74 109.655 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -49.18 -50.05 39.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.986 -1.071 . . . . 0.95 109.918 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.6 t -53.64 -36.17 61.78 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.214 -0.929 . . . . 1.55 110.394 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 66.7 m -59.92 -40.07 87.63 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.804 -1.185 . . . . 1.51 110.155 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.3 mt -61.02 -39.99 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 1.67 109.567 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 76.6 mtp -56.92 -41.39 78.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.251 -0.906 . . . . 1.02 109.978 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.08 -40.8 90.82 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.996 -1.065 . . . . 0.68 108.769 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.803 HH21 ' HE ' ' A' ' 186' ' ' ARG . 95.0 mtt180 -62.62 -59.98 4.16 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.346 -0.942 . . . . 2.93 110.281 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.4 m -63.42 -39.99 95.99 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.213 -0.929 . . . . 0.86 112.101 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.1 -22.42 63.03 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.854 -1.154 . . . . 0.67 109.307 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 61.35 47.02 7.19 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.694 -0.629 . . . . 1.5 109.782 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 8' ' ' SER . 97.5 mt -122.19 148.6 52.43 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 107.757 -1.201 . . . . 0.72 107.757 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.45 138.12 68.96 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.975 1.783 . . . . 0.61 111.39 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.488 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -170.01 150.96 3.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.942 -1.099 . . . . 0.66 111.588 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.6 mt -124.4 141.16 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 107.211 -1.403 . . . . 0.79 107.211 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.8 m -124.22 -9.22 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.52 0 O-C-N 120.522 -1.361 . . . . 0.91 111.406 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -111.36 23.34 18.45 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 110.607 -0.997 . . . . 1.01 110.607 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.412 ' C ' ' O ' ' A' ' 204' ' ' GLY . 2.9 p -43.07 -46.89 5.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.222 -1.163 . . . . 0.99 110.108 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.438 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 95.69 -54.0 1.7 Allowed Glycine 0 N--CA 1.501 2.973 0 C-N-CA 120.163 -1.018 . . . . 1.12 111.587 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 78.7 p -149.03 29.62 0.8 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.49 -1.594 . . . . 1.72 111.505 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 41.7 t -74.34 -36.35 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.691 -1.256 . . . . 0.89 109.299 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 53.5 p -58.96 -26.01 64.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.92 -1.112 . . . . 1.03 109.796 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.7 m -84.2 -15.27 47.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.105 -0.997 . . . . 1.83 109.892 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -102.46 -6.75 22.58 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.268 -0.895 . . . . 2.27 109.868 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 78.6 t -110.19 133.44 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.514 -0.742 . . . . 0.92 110.819 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -115.16 151.08 35.02 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.149 -1.426 . . . . 2.2 107.149 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.454 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 61.7 t30 -54.89 139.76 39.18 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.02 -1.05 . . . . 2.36 110.79 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.454 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.1 m-20 83.18 2.47 1.02 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-N 116.322 -0.399 . . . . 2.38 110.632 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -74.3 145.12 44.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.895 -1.128 . . . . 2.09 109.489 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -95.51 118.85 32.98 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.997 -1.112 . . . . 1.27 107.997 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.568 HD12 ' HB2' ' A' ' 16' ' ' ALA . 58.1 mt -128.04 151.22 49.42 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.559 -0.713 . . . . 0.75 110.151 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 83.0 mt -116.89 130.02 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.224 -1.398 . . . . 0.63 107.224 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 63.5 tp -97.95 115.19 27.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.967 -1.083 . . . . 0.7 109.069 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.538 ' C ' ' H ' ' A' ' 223' ' ' VAL . 20.2 t0 -72.93 -47.15 48.1 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.597 -1.261 . . . . 2.31 107.597 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.819 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 52.7 5.52 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.814 -0.554 . . . . 0.78 109.791 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.538 ' H ' ' C ' ' A' ' 221' ' ' ASP . 69.5 t -116.59 -40.21 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 107.473 -1.306 . . . . 1.04 107.473 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -108.43 5.39 25.3 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.976 -1.12 . . . . 2.44 107.976 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.505 HD21 ' H ' ' A' ' 4' ' ' GLY . 1.4 t-20 59.37 49.37 8.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.85 -0.531 . . . . 1.55 110.011 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -138.49 150.9 46.89 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.382 -0.824 . . . . 1.99 109.444 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 49.7 t -119.25 129.77 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.066 -1.087 . . . . 0.77 108.066 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -99.75 119.13 37.66 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.063 -1.088 . . . . 0.98 108.063 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.476 HG22 HD22 ' A' ' 218' ' ' LEU . 56.1 t -101.39 116.44 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.505 -0.747 . . . . 0.85 110.595 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 230' ' ' ASN . 16.9 t30 49.98 60.13 15.62 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 1.66 110.836 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -85.69 149.68 9.93 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.571 2.181 . . . . 0.95 112.119 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 68.5 p -67.93 164.11 20.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.288 -0.882 . . . . 1.84 110.568 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -60.1 -38.74 83.84 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.84 -0.8 . . . . 2.74 108.84 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.97 -39.64 86.34 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.55 -0.719 . . . . 2.89 109.473 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.68 -40.09 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.019 -1.05 . . . . 1.3 109.968 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.493 1.724 0 O-C-N 120.996 -1.065 . . . . 1.09 109.157 179.363 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 3.3 ttt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.532 0.682 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -151.56 148.48 28.05 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.11 161.06 43.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.796 -1.19 . . . . 0.0 111.037 -178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -154.01 151.13 29.01 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -106.96 132.71 52.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 109.248 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.3 122.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 CA-C-O 122.387 1.089 . . . . 0.0 112.74 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . 0.486 ' O ' HG23 ' B' ' 309' ' ' THR . 29.4 m -79.27 106.84 11.59 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.671 -178.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' B' ' 358' ' ' GLY . 81.7 mt -51.97 117.14 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 122.135 0.969 . . . . 0.0 110.007 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . 0.486 HG23 ' O ' ' B' ' 307' ' ' THR . 77.4 p -106.91 18.68 21.5 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.462 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -75.39 116.69 57.06 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.067 -1.02 . . . . 0.0 108.949 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -51.96 -13.11 1.59 Allowed 'Trans proline' 0 N--CA 1.499 1.823 0 CA-C-N 120.261 1.129 . . . . 0.0 113.442 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -118.13 6.77 12.05 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.307 -0.871 . . . . 0.0 109.449 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.85 174.92 27.27 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 3.0 tp -85.05 96.07 9.3 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.03 -1.276 . . . . 0.0 108.59 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -97.79 -160.18 0.79 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.082 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 9.2 m -59.0 -41.84 88.64 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.032 -1.042 . . . . 0.0 112.439 -176.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.508 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 1.4 tpt180 -60.4 -62.18 6.45 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 120.429 -1.42 . . . . 0.0 111.794 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -57.9 -32.02 94.06 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.199 1.107 . . . . 0.0 111.461 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.83 72.22 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.64 -41.6 63.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.441 -0.787 . . . . 0.0 109.25 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -69.98 -41.3 74.6 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.167 -1.013 . . . . 0.0 108.7 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -60.97 -51.96 67.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.471 -0.768 . . . . 0.0 110.435 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . 0.431 HG13 ' O ' ' B' ' 344' ' ' ALA . 70.0 t -68.36 -30.82 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.653 -1.279 . . . . 0.0 109.841 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -59.99 -44.32 94.6 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.231 -0.988 . . . . 0.0 108.608 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -69.41 -40.72 77.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 110.646 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.1 -52.08 66.89 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.516 -1.365 . . . . 0.0 109.343 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -57.33 -15.23 5.81 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.598 -0.689 . . . . 0.0 109.193 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.96 -29.78 70.55 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -104.83 147.23 27.95 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.455 -1.027 . . . . 0.0 109.109 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 22.6 p -91.36 -12.93 33.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.841 -1.162 . . . . 0.0 109.585 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' B' ' 368' ' ' GLU . 5.8 m -59.46 152.52 21.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.297 -0.877 . . . . 0.0 109.663 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -70.78 134.1 47.11 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.165 -0.96 . . . . 0.0 108.681 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 86.2 mt -132.91 131.24 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.537 -0.727 . . . . 0.0 110.292 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 39.4 m -130.63 153.48 48.88 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 72.4 t -118.61 139.69 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 96.9 m -126.97 123.64 37.59 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.271 -0.893 . . . . 0.0 108.904 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 40.1 p -135.91 116.71 14.07 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.12 -0.988 . . . . 0.0 109.832 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' B' ' 338' ' ' ASN . 9.2 p30 39.95 69.05 0.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 72.31 -11.92 3.66 Favored Glycine 0 N--CA 1.5 2.966 0 O-C-N 120.762 -1.211 . . . . 0.0 113.411 176.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -115.4 129.13 56.48 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-N 119.473 1.637 . . . . 0.0 109.39 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 83.0 p -129.35 151.1 50.36 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.777 0.798 . . . . 0.0 110.699 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -146.14 166.53 25.89 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.595 0.712 . . . . 0.0 110.299 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 34.3 t -89.38 140.09 29.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.554 -0.717 . . . . 0.0 110.061 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.431 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -77.57 -14.66 59.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.015 -1.053 . . . . 0.0 109.613 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' B' ' 345' ' ' LYS . 47.3 tttp -86.98 18.52 3.5 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 88.2 p -146.12 96.54 2.81 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.403 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.891 HD23 HD22 ' A' ' 79' ' ' LEU . 11.9 tp -60.01 -34.56 73.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.748 ' CE2' HD11 ' A' ' 79' ' ' LEU . 50.9 m-85 -59.74 -54.94 40.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.536 -0.727 . . . . 0.0 110.6 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -63.64 -40.07 95.94 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.705 -1.247 . . . . 0.0 109.007 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.594 ' O ' ' N ' ' B' ' 352' ' ' THR . 60.0 mt -52.18 -56.49 14.24 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.526 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -39.44 -14.55 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.872 -0.517 . . . . 0.0 111.758 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.594 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.1 p -93.24 -9.99 37.2 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.516 -1.365 . . . . 0.0 110.792 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 47.0 mt -94.36 119.94 33.85 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.854 -1.154 . . . . 0.0 109.914 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -71.02 94.23 0.52 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 85.0 mt -99.98 83.6 2.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.35 -1.088 . . . . 0.0 109.271 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 82.3 p -93.5 169.89 10.01 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.054 -1.029 . . . . 0.0 110.998 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.55 112.55 2.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.868 -0.52 . . . . 0.0 110.339 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 105.48 6.04 38.96 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.0 m -84.81 108.16 17.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -1.204 . . . . 0.0 111.062 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 17.0 t -77.7 115.03 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 122.236 1.017 . . . . 0.0 109.491 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.23 178.45 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 81.6 m -128.87 131.28 47.63 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.9 mt -102.85 120.28 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 41.6 m -120.69 130.06 53.93 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.534 -0.729 . . . . 0.0 109.474 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.16 151.21 40.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.396 -0.815 . . . . 0.0 109.498 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -147.16 122.34 10.18 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.461 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 160.23 -153.56 24.51 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 118.767 -1.683 . . . . 0.0 111.827 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . 0.517 ' N ' ' OG ' ' B' ' 331' ' ' SER . 85.5 tt0 -60.04 -50.42 73.78 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 122.203 -0.587 . . . . 0.0 112.22 -177.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.439 ' N ' ' OG ' ' B' ' 331' ' ' SER . 85.8 m-20 -112.59 12.3 19.82 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 120.924 -1.11 . . . . 0.0 111.628 -177.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.0 OUTLIER -39.65 -33.65 0.19 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.179 -0.951 . . . . 0.0 111.653 -178.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . 0.49 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 12.2 pt20 -65.7 -54.03 32.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.763 -1.211 . . . . 0.0 110.404 -178.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -64.43 -49.38 71.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.622 -1.299 . . . . 0.0 108.619 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -41.48 -42.27 2.3 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.724 -0.61 . . . . 0.0 111.186 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.535 ' O ' HG23 ' B' ' 378' ' ' VAL . 76.3 t -74.71 -36.89 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.546 -1.346 . . . . 0.0 109.574 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -63.19 -64.93 0.77 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.01 -1.056 . . . . 0.0 110.498 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . 0.438 ' O ' ' N ' ' B' ' 380' ' ' LEU . 34.4 m170 -59.97 -45.31 93.11 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.776 -1.202 . . . . 0.0 112.07 -177.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.4 mt -60.0 -40.22 88.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.394 -1.441 . . . . 0.0 108.568 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.535 HG23 ' O ' ' B' ' 374' ' ' VAL . 46.0 t -64.81 -49.54 79.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 110.164 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -80.17 -9.68 59.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.817 -1.177 . . . . 0.0 110.407 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' B' ' 376' ' ' HIS . 56.7 tp -83.34 -27.92 29.38 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 41.6 ttm -80.46 -30.07 37.5 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.065 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -84.82 -7.66 59.1 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.54 -0.725 . . . . 0.0 109.837 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -110.21 -2.96 16.56 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.253 -0.904 . . . . 0.0 110.029 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 22.0 mt -90.98 125.63 35.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.011 -1.056 . . . . 0.0 109.091 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 117.917 -1.039 . . . . 0.0 109.597 -179.862 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.424 0.63 . . . . 2.91 109.777 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.5 mt -110.1 130.12 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.229 -0.656 . . . . 1.2 109.229 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.431 ' CB ' ' OD1' ' A' ' 225' ' ' ASN . 61.9 m -137.13 153.54 50.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.379 -0.825 . . . . 1.4 109.681 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.85 -158.17 8.1 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 108.47 -1.852 . . . . 1.05 108.47 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.418 ' O ' ' O ' ' A' ' 6' ' ' LEU . 82.3 mt -90.43 -18.56 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.751 -1.44 . . . . 1.15 109.568 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.45 HD21 ' O ' ' A' ' 222' ' ' ALA . 59.1 tp 44.01 93.65 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.167 -0.958 . . . . 0.98 110.366 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.41 -22.66 18.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.954 -1.091 . . . . 0.88 109.267 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 70.7 m -121.06 112.4 33.37 Favored Pre-proline 0 N--CA 1.504 2.244 0 O-C-N 121.463 -0.773 . . . . 1.69 109.53 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -80.94 151.35 18.57 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.027 1.818 . . . . 0.85 112.408 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.828 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 145.92 175.84 19.3 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.959 -1.656 . . . . 0.92 108.959 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 12' ' ' ALA . 97.0 mt -120.72 155.7 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 O-C-N 121.427 -1.043 . . . . 0.81 109.609 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.413 ' N ' HG22 ' A' ' 11' ' ' ILE . . . -154.19 155.26 34.96 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.057 -1.027 . . . . 0.51 110.326 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 5.3 m-85 -135.28 126.37 27.92 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.012 -1.107 . . . . 0.62 108.012 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.29 -179.21 48.18 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 118.642 -1.742 . . . . 0.55 110.907 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -79.97 158.09 26.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.985 -0.715 . . . . 2.1 109.822 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.591 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -106.44 125.51 51.1 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.531 -0.731 . . . . 0.77 110.469 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.5 tp -97.53 136.76 37.49 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.03 -1.1 . . . . 0.91 108.03 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.9 tp -120.39 128.02 52.83 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.486 -0.759 . . . . 0.93 109.385 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.86 107.51 19.15 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.485 -0.76 . . . . 0.93 110.278 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -100.12 129.87 46.2 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.145 -1.057 . . . . 2.75 108.145 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -130.95 139.76 50.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.185 -0.947 . . . . 3.0 109.712 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 52.9 t0 -81.85 143.89 31.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 2.77 109.088 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.482 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 86.9 tt0 -64.88 140.41 58.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -0.972 . . . . 2.94 109.493 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.7 mt -81.68 135.3 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.331 -0.855 . . . . 0.95 108.818 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.2 t -110.75 128.89 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.368 -0.832 . . . . 1.28 110.093 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.0 mt -98.06 143.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.483 -0.932 . . . . 1.21 108.483 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -94.85 121.43 36.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.865 -1.147 . . . . 1.81 109.738 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.8 mmm-85 -88.02 -0.31 56.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.583 -0.698 . . . . 2.8 109.553 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.52 139.65 58.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.071 -1.018 . . . . 2.87 108.761 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -85.26 149.99 25.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 2.35 109.376 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.483 HG21 ' HG3' ' A' ' 39' ' ' GLU . 5.4 pt -91.48 165.15 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.97 109.494 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.2 p -97.2 172.56 7.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.15 -0.968 . . . . 1.17 108.464 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.56 77.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.952 -1.093 . . . . 1.18 109.355 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.05 -29.64 57.91 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.71 -1.243 . . . . 2.56 109.311 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -81.87 -9.62 59.54 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.256 -0.902 . . . . 1.79 109.971 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.9 t -65.37 -54.54 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.695 -1.253 . . . . 1.0 109.157 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.05 -39.98 87.83 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.294 -0.879 . . . . 1.77 109.56 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -67.82 -44.91 76.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.177 -0.952 . . . . 2.7 110.347 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.483 ' HG3' HG21 ' A' ' 31' ' ' ILE . 64.1 mm-40 -61.28 -41.02 96.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.915 -1.116 . . . . 1.51 110.44 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.37 -47.16 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.66 -1.275 . . . . 0.93 107.957 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -62.11 -47.57 84.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.552 -0.717 . . . . 1.81 109.697 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -60.1 -41.42 92.47 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.621 -1.252 . . . . 2.78 107.621 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -64.53 -46.34 83.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.69 -0.631 . . . . 0.78 109.341 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 48' ' ' ALA . 63.6 tp -59.86 -44.84 93.92 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.508 -0.923 . . . . 1.07 108.508 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.5 t -65.03 -44.02 90.47 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.441 -0.904 . . . . 1.12 109.007 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.39 -43.13 95.47 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.282 -1.927 . . . . 0.84 108.282 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.493 ' NH2' ' O ' ' A' ' 80' ' ' LEU . 68.1 ttt180 -66.4 -37.0 84.24 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.01 -1.107 . . . . 3.09 108.01 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -60.0 -39.76 86.88 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.921 -0.77 . . . . 0.88 108.921 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 50' ' ' ALA . 18.0 ttpp -60.06 -73.64 0.09 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.108 -0.995 . . . . 2.59 108.486 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.67 -33.95 0.09 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.163 -0.961 . . . . 0.7 111.944 -177.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.0 m -60.0 -49.79 76.3 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.361 -1.462 . . . . 1.4 108.586 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.82 -40.06 79.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.853 . . . . 0.67 110.725 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -65.86 -40.09 91.34 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.897 -1.127 . . . . 1.66 110.021 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.0 mt -60.73 -39.95 90.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.093 -1.004 . . . . 1.58 108.687 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -59.98 -39.71 86.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.618 -0.676 . . . . 1.35 110.168 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.9 m -63.93 -43.38 96.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.72 -1.237 . . . . 0.77 108.609 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.532 ' CD1' HH22 ' A' ' 136' ' ' ARG . 82.3 mt -61.18 -39.94 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.464 -0.772 . . . . 0.63 109.027 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -56.63 -49.99 73.36 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.475 -0.935 . . . . 1.14 108.475 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -59.91 -35.21 74.38 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.675 -0.641 . . . . 0.79 110.464 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -68.16 -39.92 82.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.858 -1.151 . . . . 1.53 109.627 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.98 82.68 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.574 -0.704 . . . . 0.57 110.097 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.01 -51.11 60.91 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 119.905 -1.14 . . . . 0.75 110.394 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.09 -44.72 68.49 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.09 -1.241 . . . . 1.59 109.966 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.9 m -67.17 -62.46 1.42 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.936 . . . . 0.73 112.178 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -94.65 -49.13 5.77 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.905 -1.122 . . . . 0.75 111.058 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.79 -169.6 25.17 Favored Glycine 0 N--CA 1.502 3.043 0 C-N-CA 119.702 -1.237 . . . . 1.22 111.445 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -66.71 -26.32 66.96 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.939 -0.742 . . . . 5.81 110.109 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.12 -36.19 76.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.292 -0.88 . . . . 3.37 110.36 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HA ' HD12 ' A' ' 72' ' ' ILE . 66.8 mmtt -97.23 -17.51 19.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.234 -0.916 . . . . 1.77 109.961 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -71.34 -42.79 68.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.054 -1.029 . . . . 1.65 110.264 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.5 -28.41 69.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.542 -0.724 . . . . 0.77 109.756 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 69' ' ' LYS . 81.9 mt -60.06 -40.76 84.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.095 -1.003 . . . . 0.8 108.9 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -69.99 -37.14 75.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 0.88 111.248 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.442 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 65.0 tt0 -60.01 -40.37 89.03 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.626 -1.296 . . . . 1.37 109.63 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.63 -43.2 96.78 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.932 -1.667 . . . . 0.62 108.932 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -60.74 -45.19 95.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.306 -1.114 . . . . 1.5 109.14 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.2 mt -68.75 -47.19 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.63 109.786 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.7 ttp -60.0 -43.35 95.27 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.964 -1.085 . . . . 1.51 110.031 -178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.907 HD22 HD23 ' B' ' 347' ' ' LEU . 34.1 tp -60.25 -39.94 88.56 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.445 -0.785 . . . . 0.77 109.565 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.493 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 58.8 tp -61.67 -39.89 93.0 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.726 -0.608 . . . . 0.62 110.074 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.16 9.93 7.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.166 -0.959 . . . . 1.47 110.913 -178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -53.88 130.85 38.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.66 -1.275 . . . . 1.47 109.704 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -57.73 -21.02 38.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.498 -0.751 . . . . 1.78 110.395 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -70.49 -34.43 72.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.004 -1.06 . . . . 2.53 108.991 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 44.9 mt -69.99 -40.51 75.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.634 -0.666 . . . . 0.8 109.827 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.15 -47.14 87.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.151 -0.968 . . . . 1.42 110.45 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -69.91 -42.8 72.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.121 -0.987 . . . . 1.71 111.323 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -70.1 -39.98 75.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.992 -1.068 . . . . 1.57 111.171 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 91.4 mt -66.6 -49.57 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.976 -1.077 . . . . 0.65 109.668 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.462 HG23 ' HZ2' ' A' ' 94' ' ' LYS . 84.8 mt -69.66 -39.96 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.587 -0.696 . . . . 0.82 110.521 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.0 -47.86 84.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.081 -1.012 . . . . 0.79 110.888 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.06 -46.84 88.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.987 -1.071 . . . . 0.95 109.897 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.48 -49.54 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.66 109.711 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.462 ' HZ2' HG23 ' A' ' 90' ' ' ILE . 54.2 mttp -69.91 -45.84 66.69 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.419 -0.801 . . . . 2.2 111.173 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -80.16 -49.55 11.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.998 -1.063 . . . . 1.65 112.148 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -91.13 -3.62 56.92 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.938 -1.101 . . . . 2.03 111.944 -177.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 54.73 36.23 25.8 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.752 -1.217 . . . . 1.42 109.209 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 51.3 mtt -87.24 169.77 12.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.541 -0.725 . . . . 1.18 109.399 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 65.6 p -80.53 156.76 26.35 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.187 -0.946 . . . . 0.98 108.915 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.97 75.64 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.229 -0.919 . . . . 0.64 109.344 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -63.16 -40.08 96.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.897 . . . . 2.07 109.82 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.44 -49.32 10.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.73 109.87 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.49 -41.34 96.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.477 -0.764 . . . . 0.54 110.555 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.09 -54.02 36.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.927 -1.108 . . . . 0.56 110.349 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -63.15 -27.75 69.59 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.037 -1.039 . . . . 1.54 109.344 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.12 -40.12 88.59 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.286 -0.883 . . . . 1.33 109.39 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.26 -46.64 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.969 -1.082 . . . . 0.72 109.407 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.9 mm -61.15 -41.89 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.31 -0.869 . . . . 0.85 109.187 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -68.99 -34.3 75.08 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.153 -1.055 . . . . 2.44 108.153 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.48 -45.17 95.97 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.301 -1.12 . . . . 0.98 110.301 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -69.98 -46.85 64.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.755 -1.438 . . . . 1.41 109.807 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.01 86.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 1.2 109.909 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 58.0 m -60.01 -40.09 88.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.052 -1.03 . . . . 1.7 109.441 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.72 91.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 1.47 109.3 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 127' ' ' ALA . 20.1 mt -63.75 -40.08 95.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.072 -1.018 . . . . 1.56 109.581 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -58.35 -31.21 67.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.81 -1.181 . . . . 2.2 109.542 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -58.66 -25.59 62.92 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.339 -0.986 . . . . 2.12 108.339 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.442 HD13 HD13 ' A' ' 123' ' ' LEU . 44.0 mt -62.71 144.71 56.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.878 . . . . 2.0 108.805 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -96.54 45.4 1.06 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.089 -1.007 . . . . 3.23 109.92 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 51.4 t0 -136.05 146.14 46.78 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.253 -0.904 . . . . 2.49 109.604 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.538 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -73.9 -63.6 1.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.569 -0.9 . . . . 3.95 108.569 178.319 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.496 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.0 t80 -39.23 -41.73 0.9 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.905 -0.497 . . . . 2.0 111.187 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.442 HD13 HD13 ' A' ' 118' ' ' LEU . 91.4 mt -70.02 -40.01 75.45 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.64 -1.287 . . . . 1.86 108.651 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 121' ' ' GLU . 33.4 ttmt -62.38 -39.87 94.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.451 -0.781 . . . . 2.84 109.836 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 98.9 mt-10 -60.07 -40.91 91.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.236 -0.915 . . . . 2.73 110.225 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -62.09 -39.97 94.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.971 -1.081 . . . . 2.77 108.816 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.45 ' HB2' HD12 ' A' ' 115' ' ' LEU . . . -63.22 -28.47 70.06 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.507 -0.923 . . . . 1.19 108.507 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -60.02 -42.04 93.46 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.323 -0.992 . . . . 1.2 108.323 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.59 -40.01 95.86 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.586 -0.894 . . . . 1.55 108.586 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.8 t -66.26 -40.06 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.884 -0.784 . . . . 0.8 108.884 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.415 HH11 ' HG2' ' A' ' 131' ' ' ARG . 36.3 ttt-85 -60.56 -37.35 80.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.334 -0.854 . . . . 3.09 108.963 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -60.01 -42.74 94.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.419 -0.801 . . . . 1.46 109.992 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.0 -47.63 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.822 -1.174 . . . . 0.71 109.322 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.94 -41.06 97.67 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.302 -1.519 . . . . 0.57 109.302 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -60.15 -49.86 75.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.352 -1.087 . . . . 2.59 109.671 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.532 HH22 ' CD1' ' A' ' 57' ' ' ILE . 63.3 mtp180 -64.59 -36.04 82.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 2.83 110.333 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.94 -44.39 94.39 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.419 -0.8 . . . . 1.25 109.371 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.25 -42.59 95.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -0.954 . . . . 0.7 110.095 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -72.63 -35.85 67.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.052 -1.03 . . . . 2.57 109.288 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -60.06 -39.84 87.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.609 -0.682 . . . . 1.23 110.845 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.0 mt -74.98 -42.59 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.844 -1.16 . . . . 0.81 109.736 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.99 -29.95 67.17 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.574 -0.704 . . . . 1.0 109.934 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.46 40.6 10.89 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.74 -1.744 . . . . 0.89 108.74 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.3 tp -73.02 148.45 44.14 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.474 -1.015 . . . . 1.14 109.004 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -68.47 148.45 50.59 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.189 -0.944 . . . . 4.6 110.426 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.8 mt -119.98 122.67 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.989 0.899 . . . . 1.24 109.709 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.9 mt -61.0 -42.5 93.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 109.28 -0.637 . . . . 1.54 109.28 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.9 t0 62.47 123.92 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.779 -0.576 . . . . 1.5 110.125 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.505 ' O ' HD12 ' A' ' 152' ' ' ILE . 83.4 mt -78.13 -5.78 52.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 0.79 108.68 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.8 t -81.84 -10.07 59.42 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.683 -0.858 . . . . 1.4 108.683 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.74 19.71 1.28 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.754 -0.591 . . . . 0.92 110.109 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.505 HD12 ' O ' ' A' ' 149' ' ' LEU . 56.3 mt -91.58 120.69 41.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 121.253 -0.905 . . . . 0.88 109.161 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -108.01 -8.53 15.85 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.356 -0.84 . . . . 2.45 109.874 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -129.57 152.07 49.49 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.413 -0.805 . . . . 1.52 109.884 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.15 133.51 53.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -0.91 . . . . 1.58 108.872 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.5 m -152.83 166.35 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.402 -0.812 . . . . 0.69 109.757 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.3 mt -93.06 147.94 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 106.015 -1.846 . . . . 0.61 106.015 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.9 tp -102.13 117.61 35.14 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.052 -1.03 . . . . 0.87 109.9 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.7 t -125.02 134.31 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.36 -0.978 . . . . 0.71 108.36 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.81 168.63 22.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.113 -0.992 . . . . 0.81 109.14 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.91 -38.26 69.93 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.318 -1.489 . . . . 0.98 107.941 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -171.17 145.58 2.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.599 -0.688 . . . . 2.25 109.486 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.2 mt -115.91 137.46 52.08 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.415 -0.803 . . . . 0.78 109.615 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.2 p -91.22 149.97 40.71 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.233 -0.917 . . . . 0.98 109.512 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -42.36 -36.99 4.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.488 2.126 . . . . 0.81 113.564 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 72.3 m -59.99 -40.05 87.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.881 -1.137 . . . . 0.9 109.314 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.75 -43.09 89.99 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.148 -0.97 . . . . 1.61 109.432 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 79.1 p -59.1 -19.57 45.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.39 -0.819 . . . . 0.61 111.555 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -83.86 -46.72 11.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.769 -1.207 . . . . 0.6 110.26 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -90.73 39.32 0.98 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.312 -0.996 . . . . 1.4 108.312 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.459 HD13 HD13 ' A' ' 149' ' ' LEU . 56.6 tp -105.6 137.1 44.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.567 -0.708 . . . . 0.7 110.231 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -89.91 101.57 14.27 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.285 -0.884 . . . . 2.35 108.872 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.32 -39.99 94.84 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.385 -0.822 . . . . 1.51 111.109 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -66.54 -24.22 66.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.115 -0.991 . . . . 2.33 111.543 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -93.74 -10.96 32.52 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.706 -1.246 . . . . 1.92 110.358 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.521 HG11 ' CE1' ' A' ' 179' ' ' PHE . 80.4 t -102.76 112.77 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.099 -1.001 . . . . 0.67 109.355 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.7 mt -83.62 3.8 31.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.252 -0.905 . . . . 1.53 110.354 -178.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.509 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 173.38 169.91 36.33 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.554 -1.418 . . . . 0.48 109.554 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.521 ' CE1' HG11 ' A' ' 176' ' ' VAL . 7.0 m-85 -134.47 130.23 36.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.395 -1.062 . . . . 0.55 108.517 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.423 ' CG2' HG21 ' A' ' 205' ' ' THR . 67.2 mt -130.45 125.48 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.567 -0.901 . . . . 0.65 108.567 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 7.7 p -143.07 154.33 43.84 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.21 -0.931 . . . . 0.82 111.046 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -106.28 27.88 8.27 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.797 -0.816 . . . . 2.46 108.797 179.279 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.04 -157.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.825 -1.172 . . . . 1.28 111.908 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -53.4 -80.98 0.06 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.863 -1.295 . . . . 2.19 109.863 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . 0.45 ' O ' ' OG ' ' A' ' 191' ' ' SER . . . -178.3 -131.97 1.64 Allowed Glycine 0 N--CA 1.488 2.1 0 C-N-CA 119.424 -1.369 . . . . 2.13 110.286 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.402 ' NH1' ' HG3' ' A' ' 186' ' ' ARG . 7.1 ptm180 -73.28 -10.53 59.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.628 -0.925 . . . . 5.86 111.122 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 51.7 p -92.83 7.84 42.08 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.804 -1.185 . . . . 3.72 110.984 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 78.7 p -89.08 143.43 26.85 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.733 -1.23 . . . . 1.74 110.124 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -47.37 -47.48 26.08 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.383 -0.823 . . . . 0.95 109.338 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.0 m -56.53 -39.64 73.72 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.742 -0.599 . . . . 1.55 109.857 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 185' ' ' GLY . 53.7 m -59.89 -40.04 87.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.98 -1.075 . . . . 1.51 110.923 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 89.1 mt -60.06 -41.26 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.0 . . . . 1.67 110.161 -178.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.8 mtp -60.07 -50.37 73.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.093 -1.005 . . . . 1.02 111.116 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -50.94 -45.41 60.6 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.908 -1.12 . . . . 0.68 109.646 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -60.03 -51.65 68.75 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.07 -1.052 . . . . 2.93 109.733 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.8 m -71.99 -35.06 69.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.075 -1.016 . . . . 0.86 110.86 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.46 -30.02 65.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.645 -1.284 . . . . 0.67 108.318 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 66.4 49.8 1.37 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.357 0.598 . . . . 1.5 110.138 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.445 ' O ' ' CB ' ' A' ' 8' ' ' SER . 86.1 mt -127.77 141.39 40.94 Favored Pre-proline 0 N--CA 1.503 2.215 0 N-CA-C 108.677 -0.86 . . . . 0.72 108.677 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -44.37 128.42 8.01 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.94 1.76 . . . . 0.61 112.039 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.8 141.51 6.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.875 -1.141 . . . . 0.66 111.471 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.2 mt -123.76 142.3 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.069 -1.456 . . . . 0.79 107.069 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 18.2 m -126.01 -12.03 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 120.952 -1.092 . . . . 0.91 111.382 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -106.11 23.06 29.95 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.014 -1.234 . . . . 1.01 110.014 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.435 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 2.8 p -44.91 -43.58 9.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -1.129 . . . . 0.99 110.083 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.76 -55.38 4.11 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 119.964 -1.112 . . . . 1.12 111.881 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 35.1 m -153.04 36.08 0.48 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.56 -1.553 . . . . 1.72 111.479 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.5 t -72.39 -40.15 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.914 -1.116 . . . . 0.89 108.53 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 38.3 p -52.98 -25.49 12.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.57 -0.706 . . . . 1.03 110.233 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.7 m -77.45 -30.91 53.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.037 -1.039 . . . . 1.83 110.551 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -93.33 -9.29 39.4 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.969 -1.082 . . . . 2.27 111.127 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.8 t -105.88 134.77 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.13 -0.981 . . . . 0.92 111.077 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -111.2 154.89 23.75 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.146 -1.427 . . . . 2.2 107.146 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 57.8 t-20 -59.87 138.9 57.69 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.781 -1.199 . . . . 2.36 109.728 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 7.7 t0 80.76 6.47 1.43 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.015 0.436 . . . . 2.38 110.172 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -71.97 128.96 37.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.029 -1.045 . . . . 2.09 109.059 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -79.45 114.78 18.65 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.914 -1.143 . . . . 1.27 107.914 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.591 HD12 ' HB2' ' A' ' 16' ' ' ALA . 75.1 mt -127.04 150.56 49.39 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.526 -0.734 . . . . 0.75 110.508 -178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.3 mt -116.35 128.94 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 106.043 -1.836 . . . . 0.63 106.043 177.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 31.5 tp -99.98 118.85 37.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.794 -1.191 . . . . 0.7 108.194 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 223' ' ' VAL . 20.7 t0 -80.66 -39.94 26.41 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.889 -1.132 . . . . 2.31 108.275 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 43.13 19.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.533 0.682 . . . . 0.78 109.377 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.4 t -134.32 -42.99 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.356 -1.35 . . . . 1.04 107.356 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -100.03 2.99 43.89 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.293 -1.373 . . . . 2.44 107.293 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.431 ' OD1' ' CB ' ' A' ' 3' ' ' SER . 9.8 t-20 59.96 48.5 8.69 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.506 -0.553 . . . . 1.55 109.506 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -142.0 150.37 41.24 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.158 -0.964 . . . . 1.99 110.29 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.4 t -119.96 128.75 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.84 -1.17 . . . . 0.77 107.84 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -104.96 120.05 40.5 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.285 -0.884 . . . . 0.98 108.913 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.423 HG22 HD22 ' A' ' 218' ' ' LEU . 46.4 t -100.28 114.7 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.503 -0.748 . . . . 0.85 110.194 -178.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 50.96 69.11 2.78 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.272 -0.892 . . . . 1.66 110.819 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -90.43 144.16 3.87 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.298 2.665 . . . . 0.95 112.135 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 5.2 m -68.59 164.16 22.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 1.84 110.14 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -59.96 -36.74 77.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.532 -0.73 . . . . 2.74 110.051 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.03 -39.56 86.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 2.89 109.466 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.8 t -70.67 -36.09 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.014 -1.054 . . . . 1.3 109.451 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.494 1.753 0 O-C-N 121.117 -0.989 . . . . 1.09 109.774 179.605 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.564 0.697 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 19.0 t80 -152.64 151.4 30.55 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . 0.466 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 12.9 pt20 -145.58 155.04 42.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.995 -1.065 . . . . 0.0 110.708 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' B' ' 305' ' ' GLU . 12.5 tm0? -149.58 145.34 26.75 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . 0.506 ' O ' ' NE2' ' B' ' 304' ' ' GLN . 39.2 mp0 -109.09 131.8 54.72 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.067 -1.02 . . . . 0.0 110.46 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.07 119.12 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-O 122.077 0.941 . . . . 0.0 112.452 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 35.6 m -77.3 104.65 7.93 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.99 0.9 . . . . 0.0 111.024 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.8 mt -53.03 123.87 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.318 1.056 . . . . 0.0 110.729 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 71.9 p -111.37 20.11 17.59 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.257 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.14 120.39 80.01 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.831 -1.168 . . . . 0.0 109.682 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -49.57 -21.5 5.34 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 CA-C-N 120.137 1.084 . . . . 0.0 113.069 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -120.74 13.7 11.6 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.46 -0.775 . . . . 0.0 109.775 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.34 -178.6 37.83 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.496 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -84.42 91.06 7.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.111 -1.229 . . . . 0.0 110.191 -178.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -95.35 -160.35 0.78 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.673 -1.267 . . . . 0.0 109.995 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 5.3 m -59.61 -40.6 88.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.847 -1.158 . . . . 0.0 112.492 -175.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.603 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.2 tpt180 -62.75 -61.74 6.96 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 120.329 -1.482 . . . . 0.0 112.069 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.05 -30.32 93.0 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 CA-C-N 120.151 1.09 . . . . 0.0 111.824 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.05 -50.53 73.36 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.55 -39.32 61.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.344 -0.848 . . . . 0.0 109.431 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -68.99 -43.83 74.09 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.998 -1.064 . . . . 0.0 108.342 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -60.04 -52.27 66.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.439 -0.788 . . . . 0.0 110.984 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . 0.43 HG13 ' O ' ' B' ' 344' ' ' ALA . 72.1 t -68.42 -28.92 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.728 -1.232 . . . . 0.0 110.7 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . 0.442 ' NZ ' ' OE1' ' A' ' 74' ' ' GLU . 24.7 ttmt -61.77 -45.8 92.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.109 -0.994 . . . . 0.0 110.252 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -69.97 -40.05 75.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.987 -1.07 . . . . 0.0 111.417 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -61.53 -52.8 62.97 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.469 -1.394 . . . . 0.0 110.26 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -53.34 -11.23 0.28 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.169 -0.957 . . . . 0.0 109.648 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -75.93 -25.62 66.49 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -105.05 141.1 37.21 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.629 -0.924 . . . . 0.0 108.798 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . 0.421 HG22 ' O ' ' B' ' 330' ' ' THR . 89.7 m -89.94 -10.51 44.84 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.941 -1.099 . . . . 0.0 109.871 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.597 ' HG ' ' H ' ' B' ' 369' ' ' ASP . 75.6 m -61.49 149.62 38.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.705 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -67.67 132.77 48.11 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.0 mt -133.33 134.17 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.653 -0.654 . . . . 0.0 109.564 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . 0.433 HG22 ' N ' ' B' ' 335' ' ' VAL . 51.5 m -131.68 155.04 48.33 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . 0.433 ' N ' HG22 ' B' ' 334' ' ' THR . 75.9 t -117.41 140.02 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 70.2 m -130.47 122.25 27.34 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.217 -0.927 . . . . 0.0 109.22 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 1.8 m -140.21 120.22 13.65 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 122.054 0.93 . . . . 0.0 110.657 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 47.56 57.8 5.56 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 75.28 -11.55 8.58 Favored Glycine 0 N--CA 1.498 2.787 0 O-C-N 120.19 -1.569 . . . . 0.0 112.52 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -114.43 125.1 53.45 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 118.923 1.361 . . . . 0.0 109.289 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 51.8 m -126.56 148.32 49.76 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.616 0.722 . . . . 0.0 110.196 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.77 167.44 22.58 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.515 0.674 . . . . 0.0 109.955 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 19.8 m -87.09 139.05 30.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.43 -0.794 . . . . 0.0 109.595 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.43 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -78.7 -14.27 59.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.001 -1.062 . . . . 0.0 109.195 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -86.81 18.19 3.6 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 61.2 m -145.27 93.23 2.35 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.601 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.907 HD23 HD22 ' A' ' 79' ' ' LEU . 13.4 tp -55.74 -36.66 67.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.746 ' CE2' HD11 ' A' ' 79' ' ' LEU . 47.1 m-85 -58.69 -52.52 65.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 110.165 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -68.68 -21.11 64.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.992 -1.067 . . . . 0.0 110.987 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' B' ' 352' ' ' THR . 90.2 mt -69.94 -52.16 26.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.532 -1.355 . . . . 0.0 108.523 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' B' ' 347' ' ' LEU . 0.1 OUTLIER -39.21 -18.85 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.817 -0.552 . . . . 0.0 111.07 -178.301 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.564 ' N ' ' O ' ' B' ' 350' ' ' LEU . 71.1 p -85.92 -11.12 53.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.225 -1.547 . . . . 0.0 110.647 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 42.3 mt -94.82 116.95 29.36 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.931 -1.106 . . . . 0.0 109.247 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.94 94.23 0.98 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 24.1 mt -103.31 94.58 5.58 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.453 -1.028 . . . . 0.0 108.947 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 43.3 p -93.3 161.01 14.57 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.101 -0.999 . . . . 0.0 110.427 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -54.22 119.36 5.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.551 -0.718 . . . . 0.0 110.225 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 98.74 4.65 56.89 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.036 -1.625 . . . . 0.0 109.036 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.9 m -84.2 112.64 20.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.406 -1.055 . . . . 0.0 110.574 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 19.3 t -78.44 116.62 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 122.081 0.943 . . . . 0.0 109.939 -177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 17.3 m -110.38 177.5 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -178.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 58.5 m -131.35 130.01 42.12 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 78.3 mt -102.82 115.39 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 73.3 m -117.28 130.79 56.78 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.558 -0.714 . . . . 0.0 109.13 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.89 152.27 39.98 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.171 -0.956 . . . . 0.0 110.363 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . 0.436 ' OE2' ' OE2' ' B' ' 370' ' ' GLU . 9.9 tp10 -143.02 120.25 11.51 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.16 -163.88 36.78 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.466 -1.826 . . . . 0.0 111.947 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -59.2 -49.95 75.88 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 115.029 -0.586 . . . . 0.0 112.006 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.597 ' H ' ' HG ' ' B' ' 331' ' ' SER . 92.0 m-20 -105.77 10.74 32.58 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.979 -1.076 . . . . 0.0 111.066 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.436 ' OE2' ' OE2' ' B' ' 366' ' ' GLU . 14.7 pt-20 -40.98 -30.6 0.14 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.167 -0.958 . . . . 0.0 110.88 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -69.58 -40.46 76.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.06 -1.025 . . . . 0.0 109.204 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -72.16 -55.11 7.83 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 108.983 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -41.83 -35.63 0.87 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.694 -0.629 . . . . 0.0 111.771 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.468 ' O ' HG23 ' B' ' 378' ' ' VAL . 62.2 t -79.93 -32.44 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.541 -1.35 . . . . 0.0 109.68 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.3 -60.05 3.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.978 -1.076 . . . . 0.0 111.939 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -73.31 -40.85 64.17 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.483 -1.386 . . . . 0.0 112.66 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.99 -40.05 87.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.528 -1.357 . . . . 0.0 109.042 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.5 t -61.08 -47.65 92.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.132 -0.98 . . . . 0.0 109.831 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -69.54 -55.75 9.27 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.728 -1.232 . . . . 0.0 108.154 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.476 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 60.7 tp -53.04 -34.08 54.83 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.504 -0.747 . . . . 0.0 109.7 -178.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 39.5 ttm -75.44 -38.54 59.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.945 -1.097 . . . . 0.0 108.55 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.17 -5.42 51.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.685 -0.634 . . . . 0.0 110.496 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -110.45 4.54 20.62 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.085 -1.009 . . . . 0.0 110.812 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . 0.476 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 26.3 mt -72.2 121.97 20.25 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.34 -1.475 . . . . 0.0 109.947 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.989 -1.005 . . . . 0.0 108.942 179.152 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.6 mtm . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.076 -0.712 . . . . 2.91 109.076 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.7 mt -110.45 122.32 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.414 -0.804 . . . . 1.2 108.958 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.6 m -139.26 146.64 40.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.416 -0.802 . . . . 1.4 109.104 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.68 -162.79 9.25 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 108.719 -1.752 . . . . 1.05 108.719 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.6 mt -89.81 -13.71 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.863 -1.375 . . . . 1.15 110.302 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.3 tp 55.8 102.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 0.98 108.88 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.83 -23.12 17.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.0 . . . . 0.88 109.593 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 16.0 t -147.78 130.55 7.89 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.069 -1.019 . . . . 1.69 109.739 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.34 144.42 16.24 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.13 1.887 . . . . 0.85 112.902 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.908 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.28 167.27 16.05 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.745 -1.342 . . . . 0.92 109.745 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.0 mt -123.66 130.42 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.088 -1.243 . . . . 0.81 109.601 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.9 150.07 49.2 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.202 -0.936 . . . . 0.51 110.619 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.1 m-85 -126.29 129.97 49.94 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.793 -1.188 . . . . 0.62 107.793 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.04 178.94 48.59 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 118.354 -1.879 . . . . 0.55 110.969 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -78.87 158.46 28.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.764 -0.845 . . . . 2.1 109.195 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -106.17 131.55 53.29 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.559 -0.713 . . . . 0.77 110.485 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.8 tp -99.75 136.31 39.86 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.593 -1.262 . . . . 0.91 107.593 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.4 tp -115.84 119.96 37.7 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.309 -0.869 . . . . 0.93 109.613 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.484 HD12 ' HB2' ' A' ' 160' ' ' ALA . 56.8 mt -90.69 105.79 18.06 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.767 -0.583 . . . . 0.93 109.803 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -101.48 136.61 41.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.368 -0.833 . . . . 2.75 109.252 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -127.34 122.19 33.08 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.799 -0.815 . . . . 3.0 108.799 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -71.19 148.25 47.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 2.77 109.904 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -65.18 141.86 58.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 2.94 109.489 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -82.02 130.12 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.95 109.176 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.6 t -93.9 124.06 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.255 -0.903 . . . . 1.28 109.868 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.5 mt -103.74 138.46 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.436 -0.79 . . . . 1.21 109.119 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -97.22 117.73 32.09 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.152 -0.967 . . . . 1.81 109.208 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -86.92 -2.3 58.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.367 -0.833 . . . . 2.8 109.372 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -64.34 141.3 58.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 2.87 109.68 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -87.73 150.14 23.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.913 . . . . 2.35 108.997 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.544 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.7 pt -92.95 165.64 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.365 -0.834 . . . . 0.97 110.475 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.4 p -99.15 171.22 8.15 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.349 -0.982 . . . . 1.17 108.349 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.19 -47.93 80.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 1.18 109.089 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -55.63 -32.3 63.04 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.0 -1.062 . . . . 2.56 109.656 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -82.16 -9.91 59.35 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.287 -0.883 . . . . 1.79 110.246 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.63 -53.31 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.506 -1.371 . . . . 1.0 109.499 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.78 -40.05 95.73 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.023 -1.048 . . . . 1.77 110.006 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -69.98 -39.96 75.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.036 -1.04 . . . . 2.7 110.463 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.544 ' HG3' HG21 ' A' ' 31' ' ' ILE . 66.1 mm-40 -67.11 -40.05 86.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.006 -1.058 . . . . 1.51 110.069 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.99 -43.19 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.712 -1.242 . . . . 0.93 108.361 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -59.55 -37.1 77.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 1.81 108.895 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -60.04 -43.14 95.55 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.908 -1.145 . . . . 2.78 107.908 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -62.24 -49.78 74.34 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.449 -0.782 . . . . 0.78 109.409 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.5 tp -59.91 -48.4 81.87 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.397 -0.814 . . . . 1.07 109.024 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.5 t -62.21 -43.32 99.1 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.995 -1.065 . . . . 1.12 108.735 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.29 -45.42 96.02 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.732 -1.747 . . . . 0.84 108.732 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -67.48 -32.67 73.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.396 -1.061 . . . . 3.09 108.423 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.29 -40.03 84.88 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.643 -0.873 . . . . 0.88 108.643 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 50' ' ' ALA . 27.9 ttpt -67.25 -74.58 0.11 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.417 -0.956 . . . . 2.59 108.417 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.05 -33.22 0.08 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.203 -0.936 . . . . 0.7 111.489 -178.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 83.3 p -60.06 -54.53 44.89 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.563 -1.336 . . . . 1.4 108.697 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.02 -40.2 75.36 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.372 -0.83 . . . . 0.67 111.157 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -65.16 -40.13 93.89 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.73 -1.231 . . . . 1.66 110.735 -178.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.28 -39.97 93.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.857 -1.152 . . . . 1.58 109.018 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -60.35 -37.13 79.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.385 -0.822 . . . . 1.35 109.419 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.5 m -65.41 -43.23 91.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.831 -1.168 . . . . 0.77 109.007 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.668 ' CD1' HH22 ' A' ' 136' ' ' ARG . 78.9 mt -62.04 -40.01 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.504 -0.925 . . . . 0.63 108.504 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -55.57 -50.22 70.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.4 -0.813 . . . . 1.14 109.527 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -57.99 -33.0 68.44 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.159 -0.963 . . . . 0.79 110.19 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -68.79 -37.87 79.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 1.53 109.145 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.464 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.45 -45.29 76.43 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.702 -0.624 . . . . 0.57 110.393 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.72 -50.78 64.06 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.861 -1.162 . . . . 0.75 110.272 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.07 -42.09 73.25 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.12 -1.223 . . . . 1.59 110.379 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.2 m -69.96 -59.11 3.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.03 -1.043 . . . . 0.73 111.729 -178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -97.07 -52.25 3.92 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.959 -1.088 . . . . 0.75 111.103 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.67 -165.38 26.49 Favored Glycine 0 N--CA 1.5 2.905 0 C-N-CA 119.706 -1.235 . . . . 1.22 110.955 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -70.75 -22.62 62.39 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.89 -0.771 . . . . 5.81 110.354 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.458 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.1 tp10 -62.05 -37.64 85.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 3.37 110.904 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -99.67 -18.02 17.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.184 -0.947 . . . . 1.77 110.12 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -69.76 -39.93 76.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.119 -0.988 . . . . 1.65 110.423 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.492 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.04 -30.92 71.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.382 -0.824 . . . . 0.77 109.834 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.0 -41.46 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.036 -1.04 . . . . 0.8 109.085 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -62.61 -40.45 96.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.065 -1.022 . . . . 0.88 109.966 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -60.78 -39.92 90.63 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.188 -1.005 . . . . 1.37 109.335 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.18 -41.26 98.43 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.671 -1.772 . . . . 0.62 108.671 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.7 m170 -69.77 -42.44 73.82 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.376 -1.073 . . . . 1.5 108.935 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.4 mt -70.14 -46.19 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.285 -0.884 . . . . 0.63 109.359 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.1 ttp -61.16 -40.93 95.71 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.087 -1.008 . . . . 1.51 110.05 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.863 HD11 ' CE2' ' B' ' 348' ' ' PHE . 59.0 tp -66.47 -40.05 89.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.164 -0.96 . . . . 0.77 109.444 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.2 tp -66.53 -39.88 88.83 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.502 -0.749 . . . . 0.62 110.012 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -79.99 -1.56 40.15 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.186 -0.946 . . . . 1.47 110.192 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -47.88 130.26 14.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.032 . . . . 1.47 109.904 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.28 -16.38 60.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.662 -0.649 . . . . 1.78 110.198 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.26 -35.18 73.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.941 -1.099 . . . . 2.53 108.512 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.12 -40.01 68.44 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.462 0.649 . . . . 0.8 109.275 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.04 -49.96 75.61 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.559 -0.713 . . . . 1.42 109.993 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -70.65 -40.31 73.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.257 -0.902 . . . . 1.71 110.839 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -69.74 -40.02 76.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.059 -1.025 . . . . 1.57 110.567 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.8 mt -68.6 -45.8 81.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.112 -0.992 . . . . 0.65 108.944 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.26 -39.1 80.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.528 -0.733 . . . . 0.82 109.963 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.07 -47.15 87.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.195 -0.94 . . . . 0.79 110.452 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 96' ' ' LYS . 85.7 mt -62.64 -45.77 91.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.896 -1.127 . . . . 0.95 109.43 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.79 -50.05 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 0.66 109.135 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -70.03 -40.56 75.11 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.707 -0.797 . . . . 2.2 110.338 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -81.3 -50.16 9.85 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.997 -1.064 . . . . 1.65 111.716 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 92' ' ' LEU . 19.7 mmmt -90.38 -1.83 57.93 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.933 -1.104 . . . . 2.03 111.64 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.3 m80 55.88 35.3 25.19 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.889 -1.132 . . . . 1.42 109.529 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.5 mtt -89.38 168.57 12.12 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.629 -0.669 . . . . 1.18 110.147 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 102' ' ' ALA . 32.9 p -80.72 158.51 25.52 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.42 -0.8 . . . . 0.98 109.26 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.89 -40.06 87.64 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.243 -0.91 . . . . 0.64 109.662 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -67.87 -39.9 83.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.277 -0.89 . . . . 2.07 109.616 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.405 ' HB3' ' OG1' ' A' ' 99' ' ' THR . . . -80.99 -42.52 21.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.73 109.897 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.53 -50.46 71.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.54 109.571 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.42 -33.41 72.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.228 -0.92 . . . . 0.56 109.509 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.546 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 86.2 t60 -60.06 -46.12 90.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.264 -0.897 . . . . 1.54 109.734 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -60.36 -40.0 89.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.353 -0.842 . . . . 1.33 111.007 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 41.9 t -63.28 -62.84 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.959 -1.088 . . . . 0.72 111.435 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.5 mm -63.9 -41.67 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.875 -1.141 . . . . 0.85 109.419 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.546 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 80.8 tt0 -63.53 -38.7 92.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 2.44 108.927 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.04 -46.44 94.18 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.712 -0.955 . . . . 0.98 110.712 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.434 HE21 ' HB3' ' B' ' 348' ' ' PHE . 28.6 mm100 -68.54 -44.04 75.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.746 -1.443 . . . . 1.41 109.67 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.43 78.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.092 -1.005 . . . . 1.2 109.055 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 29.5 t -60.02 -40.42 89.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.182 -0.949 . . . . 1.7 109.144 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.48 97.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 1.47 109.094 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.6 mt -67.82 -41.87 82.38 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.151 -0.968 . . . . 1.56 109.044 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.58 -33.62 70.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.781 -1.199 . . . . 2.2 109.774 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -57.81 -22.15 45.88 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.025 -1.047 . . . . 2.12 108.765 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.47 HD13 HD13 ' A' ' 123' ' ' LEU . 48.8 mt -63.28 139.91 58.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 2.0 108.787 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -84.41 -16.8 41.42 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.142 -0.974 . . . . 3.23 110.195 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -66.4 130.02 41.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.169 -0.957 . . . . 2.49 110.124 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.616 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 8.0 pm0 -70.13 -30.04 67.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.454 -0.779 . . . . 3.95 110.245 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.491 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.8 t80 -67.58 -34.16 76.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.406 -0.809 . . . . 2.0 110.194 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.64 HD22 ' O ' ' B' ' 351' ' ' GLN . 86.4 mt -80.15 -26.67 39.26 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.103 -0.998 . . . . 1.86 108.882 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -61.95 -47.05 86.62 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.212 -0.93 . . . . 2.84 108.604 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 121' ' ' GLU . 7.6 mp0 -65.66 -36.69 84.39 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.264 -0.897 . . . . 2.73 108.77 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.552 ' CZ ' ' NE2' ' B' ' 351' ' ' GLN . 0.2 OUTLIER -59.69 -40.03 86.51 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.855 -1.165 . . . . 2.77 107.855 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.27 -23.4 67.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.425 -0.797 . . . . 1.19 109.008 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -66.44 -39.96 89.18 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.655 -0.869 . . . . 1.2 108.655 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -64.18 -40.67 96.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.385 -0.822 . . . . 1.55 109.233 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 77.3 t -69.89 -40.15 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.487 -0.931 . . . . 0.8 108.487 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.506 HH11 ' HG2' ' A' ' 131' ' ' ARG . 11.6 ttt-85 -59.98 -40.03 87.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.397 -0.814 . . . . 3.09 108.94 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -60.44 -39.93 89.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.534 -0.729 . . . . 1.46 110.06 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.99 -43.33 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.266 -0.896 . . . . 0.71 110.861 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.71 -33.86 71.82 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.754 -1.212 . . . . 0.57 110.168 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -59.98 -48.6 81.05 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -1.174 . . . . 2.59 110.022 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.668 HH22 ' CD1' ' A' ' 57' ' ' ILE . 67.0 mtp180 -68.32 -32.22 72.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.906 -1.121 . . . . 2.83 109.602 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.88 -45.54 92.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.26 -0.9 . . . . 1.25 108.647 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.54 -40.26 90.91 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.395 -0.816 . . . . 0.7 109.062 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.482 HH11 ' HG2' ' A' ' 139' ' ' ARG . 43.4 mtt-85 -69.91 -40.09 75.8 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.426 -0.953 . . . . 2.57 108.426 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.404 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 4.5 m120 -60.5 -40.04 89.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.848 -0.533 . . . . 1.23 110.759 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.9 mt -73.15 -42.09 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.788 -1.195 . . . . 0.81 108.313 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.8 mt -70.06 -38.4 75.75 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.235 0.541 . . . . 1.0 109.807 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.16 43.78 8.5 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.963 -1.655 . . . . 0.89 108.963 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 tp -75.68 152.78 37.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.58 -0.953 . . . . 1.14 109.652 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -63.91 140.97 58.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 4.6 109.265 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.4 mt -119.83 130.08 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 122.151 0.977 . . . . 1.24 109.77 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.1 mt -59.39 -47.63 89.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 115.657 -0.702 . . . . 1.54 110.922 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 31.2 t0 66.2 99.25 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.652 -0.87 . . . . 1.5 108.652 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 25.1 mt -68.83 -3.78 13.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.79 109.709 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 59.3 m -83.45 -13.4 54.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.096 -1.003 . . . . 1.4 108.891 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.17 20.28 1.98 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.459 -0.776 . . . . 0.92 111.08 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 40.9 mm -90.05 121.18 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.598 -1.313 . . . . 0.88 108.708 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -101.32 -9.0 21.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.263 -0.898 . . . . 2.45 110.473 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -125.45 149.78 47.91 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.34 -0.85 . . . . 1.52 110.434 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.87 135.36 56.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.346 -0.847 . . . . 1.58 109.14 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.5 m -152.34 166.37 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.576 -0.703 . . . . 0.69 109.872 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 94.1 mt -95.16 149.57 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.293 -1.743 . . . . 0.61 106.293 177.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.441 HD11 HD11 ' A' ' 19' ' ' LEU . 38.3 tp -100.01 117.88 35.21 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.985 -1.072 . . . . 0.87 110.854 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.555 HG12 HG22 ' A' ' 209' ' ' THR . 84.3 t -121.54 129.44 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.408 -0.96 . . . . 0.71 108.408 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.513 ' C ' HG21 ' A' ' 209' ' ' THR . . . -160.09 165.02 32.57 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.109 -0.994 . . . . 0.81 109.091 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.45 -38.28 74.46 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.178 -1.576 . . . . 0.98 107.841 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -170.68 145.28 2.47 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.76 -0.83 . . . . 2.25 108.76 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.4 mt -112.17 140.22 47.05 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.248 -0.907 . . . . 0.78 109.818 -179.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.0 p -92.18 141.59 25.27 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.279 -0.888 . . . . 0.98 109.121 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -39.64 -36.5 1.15 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.208 1.938 . . . . 0.81 113.194 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.5 m -60.38 -40.03 89.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.033 -1.042 . . . . 0.9 110.242 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.59 -41.52 92.75 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.006 -1.058 . . . . 1.61 109.799 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.9 p -57.54 -32.92 67.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.192 -0.943 . . . . 0.61 111.293 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.464 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -70.14 -43.92 69.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.669 -1.27 . . . . 0.6 109.732 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -94.88 34.94 1.29 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.625 -0.879 . . . . 1.4 108.625 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.7 tp -107.48 138.98 42.71 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.814 -0.81 . . . . 0.7 108.814 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.469 ' O ' HG23 ' A' ' 176' ' ' VAL . 94.2 m-20 -86.47 103.87 15.41 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.141 -0.974 . . . . 2.35 109.539 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.85 -39.99 95.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.477 -0.764 . . . . 1.51 110.812 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -67.96 -25.92 65.68 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.994 -1.066 . . . . 2.33 111.76 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -93.37 -8.81 40.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.588 -1.32 . . . . 1.92 109.895 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.515 HG11 ' CE1' ' A' ' 179' ' ' PHE . 81.8 t -97.04 110.38 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.101 -0.999 . . . . 0.67 108.792 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.0 mt -77.77 2.91 15.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.222 -0.924 . . . . 1.53 110.334 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.513 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 165.6 177.04 37.6 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.198 -1.561 . . . . 0.48 109.198 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.609 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 17.8 m-85 -132.96 129.98 38.96 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.425 -1.044 . . . . 0.55 108.521 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.6 mt -134.47 127.7 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.21 -0.931 . . . . 0.65 109.348 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 29.1 p -149.74 160.02 43.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.82 110.401 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' A' ' 182' ' ' ASP . 35.1 p-10 -109.16 27.57 9.38 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.684 -0.858 . . . . 2.46 108.684 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.04 -157.18 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.197 -0.939 . . . . 1.28 111.929 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.3 -80.83 0.06 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.087 -1.205 . . . . 2.19 110.087 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.55 -134.2 2.73 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.839 -1.305 . . . . 2.13 109.839 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.414 ' C ' ' H ' ' A' ' 188' ' ' SER . 14.6 tpp180 -60.01 -40.01 87.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.404 -1.056 . . . . 5.86 110.63 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.1 p -64.97 7.79 0.15 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.065 -1.022 . . . . 3.72 111.258 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.414 ' H ' ' C ' ' A' ' 186' ' ' ARG . 15.9 m -90.72 135.32 33.79 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.66 -1.275 . . . . 1.74 110.827 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -46.12 -52.55 11.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.448 -0.783 . . . . 0.95 109.761 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.418 ' H ' HG22 ' A' ' 190' ' ' THR . 0.1 OUTLIER -53.99 -37.1 63.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.492 -0.755 . . . . 1.55 110.247 -179.101 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.3 t -60.05 -45.24 93.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.111 -0.993 . . . . 1.51 111.03 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.01 -40.49 83.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.321 -0.862 . . . . 1.67 110.406 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.2 mtp -60.14 -45.78 91.9 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.069 -1.019 . . . . 1.02 110.164 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.19 -45.97 65.38 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.549 -1.344 . . . . 0.68 109.484 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -63.48 -58.06 8.23 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.057 -1.057 . . . . 2.93 110.327 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.4 m -60.27 -39.93 88.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.897 -1.127 . . . . 0.86 111.655 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.35 -22.36 62.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.834 -1.167 . . . . 0.67 109.498 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 69.99 47.82 0.57 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.38 0.609 . . . . 1.5 110.31 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.438 ' O ' ' CB ' ' A' ' 8' ' ' SER . 68.6 mt -129.16 149.96 74.09 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 107.994 -1.113 . . . . 0.72 107.994 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.07 146.14 75.85 Favored 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 122.459 2.106 . . . . 0.61 112.05 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.609 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -177.0 154.12 1.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.106 -0.996 . . . . 0.66 111.004 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.0 mt -125.67 151.11 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.45 -1.315 . . . . 0.79 107.45 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.2 m -131.06 -12.03 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 120.866 -1.146 . . . . 0.91 111.04 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.01 25.02 17.47 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.09 -1.204 . . . . 1.01 110.09 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 22.4 p -45.32 -42.83 10.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.125 -1.221 . . . . 0.99 109.903 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 94.01 -52.52 2.23 Favored Glycine 0 N--CA 1.497 2.748 0 O-C-N 121.139 -0.976 . . . . 1.12 111.447 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 80.6 p -156.78 34.7 0.3 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.579 -1.542 . . . . 1.72 111.332 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 23.0 t -75.76 -39.42 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.061 -1.024 . . . . 0.89 108.904 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.555 HG22 HG12 ' A' ' 159' ' ' VAL . 72.7 p -56.72 -27.2 58.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 1.03 110.674 -179.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.3 m -80.25 -24.62 39.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.835 -1.166 . . . . 1.83 110.308 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -95.55 -8.66 34.47 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.152 -0.967 . . . . 2.27 110.444 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 56.0 t -102.35 136.17 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.226 -0.921 . . . . 0.92 109.943 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.48 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 2.2 mptp? -116.28 152.92 32.87 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.567 -1.271 . . . . 2.2 107.567 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.455 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 16.6 p-10 -56.29 139.46 48.15 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.999 -1.063 . . . . 2.36 110.618 -178.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.0 m-20 82.02 8.74 0.88 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.028 0.442 . . . . 2.38 110.376 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.48 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 90.6 m-20 -79.32 139.82 37.7 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.025 -1.047 . . . . 2.09 109.346 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -91.65 115.04 27.71 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.031 -1.099 . . . . 1.27 108.031 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.502 HD12 ' HB2' ' A' ' 16' ' ' ALA . 59.6 mt -125.42 150.27 47.43 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.651 -0.655 . . . . 0.75 110.627 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.3 mt -115.38 127.67 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.281 -1.377 . . . . 0.63 107.281 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 54.7 tp -100.7 119.99 39.41 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.936 -1.102 . . . . 0.7 108.702 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 223' ' ' VAL . 83.0 m-20 -78.88 -43.1 25.68 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.067 -1.02 . . . . 2.31 109.373 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.908 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.01 15.34 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.4 -0.963 . . . . 0.78 108.4 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 221' ' ' ASP . 53.2 t -131.5 -38.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.287 -1.375 . . . . 1.04 107.287 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -105.69 0.54 26.39 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.682 -1.229 . . . . 2.44 107.682 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 60.19 44.28 12.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.814 -0.554 . . . . 1.55 110.357 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -141.81 151.37 42.73 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.07 -1.019 . . . . 1.99 109.762 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.5 t -119.48 130.08 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.519 -0.919 . . . . 0.77 108.519 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -101.7 124.01 46.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.52 -0.737 . . . . 0.98 109.25 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 18.0 t -101.05 113.9 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.637 -0.665 . . . . 0.85 109.903 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 50.64 67.66 4.13 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.194 -0.941 . . . . 1.66 111.208 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -90.12 148.68 4.63 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 123.048 2.499 . . . . 0.95 112.346 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 71.5 p -72.45 166.26 22.95 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.099 -1.001 . . . . 1.84 109.897 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -59.94 -35.47 74.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 2.74 109.736 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.95 -39.99 87.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 2.89 109.686 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.85 -39.97 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.142 -0.974 . . . . 1.3 109.144 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.8 mt . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 1.09 109.693 179.985 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 6.1 ttt . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.367 0.604 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -153.99 151.56 29.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.411 -0.806 . . . . 0.0 109.17 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -149.56 159.93 43.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.076 -1.015 . . . . 0.0 110.479 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -154.72 150.97 28.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . 0.486 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 2.0 pm0 -116.45 133.89 55.49 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.22 -0.925 . . . . 0.0 110.325 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.48 128.11 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 CA-C-O 122.351 1.072 . . . . 0.0 112.546 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 86.4 m -78.1 103.31 7.96 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.877 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.505 HG22 ' H ' ' B' ' 310' ' ' ALA . 88.4 mt -51.19 122.65 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 122.446 1.117 . . . . 0.0 109.815 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 54.2 p -103.23 21.09 16.48 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.202 -178.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.505 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -86.6 115.29 61.74 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.062 -1.024 . . . . 0.0 108.938 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -68.13 -3.29 10.42 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 CA-C-N 120.309 1.146 . . . . 0.0 111.511 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -111.31 -0.64 16.32 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.91 172.82 26.91 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 107.684 -2.167 . . . . 0.0 107.684 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.491 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -85.58 94.93 9.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.862 -1.375 . . . . 0.0 108.241 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -93.75 -162.79 0.97 Allowed 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.991 -1.068 . . . . 0.0 110.698 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.0 m -56.78 -42.5 79.56 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.098 -1.001 . . . . 0.0 112.514 -176.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.516 HH11 ' HG2' ' B' ' 317' ' ' ARG . 0.9 OUTLIER -61.37 -60.0 11.86 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 120.639 -1.288 . . . . 0.0 112.241 -178.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -60.78 -32.04 92.49 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 120.295 1.141 . . . . 0.0 111.811 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.44 73.74 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.25 -40.65 61.97 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.443 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -70.19 -40.73 74.46 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.043 -1.036 . . . . 0.0 108.768 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -60.26 -51.78 68.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.425 -0.797 . . . . 0.0 110.452 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 87.2 t -69.91 -30.63 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.758 -1.214 . . . . 0.0 110.35 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -60.08 -45.6 92.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 108.999 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -67.19 -40.05 86.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.84 . . . . 0.0 110.528 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -64.91 -53.61 43.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.77 -1.206 . . . . 0.0 111.033 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -52.96 -10.05 0.16 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.121 -0.987 . . . . 0.0 110.458 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -79.23 -21.06 68.27 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -106.23 140.18 39.57 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.55 -0.971 . . . . 0.0 109.26 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 17.2 m -90.89 -11.08 40.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.045 -1.034 . . . . 0.0 110.342 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.495 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 84.4 p -62.93 153.66 32.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.907 -1.12 . . . . 0.0 109.712 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -69.44 133.14 47.39 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.5 mt -134.47 133.77 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.674 -0.641 . . . . 0.0 109.99 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 85.9 m -131.17 152.01 50.88 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 67.3 t -123.56 117.62 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 49.5 m -106.32 132.72 52.03 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.088 -1.007 . . . . 0.0 109.333 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 82.1 p -140.01 115.46 9.98 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.924 0.869 . . . . 0.0 110.798 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 24.0 m120 46.96 49.8 14.37 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 176.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.97 -12.96 65.92 Favored Glycine 0 N--CA 1.505 3.244 0 O-C-N 120.155 -1.59 . . . . 0.0 113.327 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -118.5 130.06 55.72 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-N 119.579 1.689 . . . . 0.0 109.503 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 38.9 m -128.75 150.4 50.3 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.871 0.843 . . . . 0.0 110.954 -178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . 0.542 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -146.45 169.28 19.23 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.646 0.736 . . . . 0.0 110.293 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 60.8 m -88.17 139.57 30.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.637 -0.665 . . . . 0.0 109.903 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.452 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -79.78 -15.8 56.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.938 -1.101 . . . . 0.0 109.852 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -85.38 20.61 1.96 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . 0.452 ' H ' ' C ' ' B' ' 344' ' ' ALA . 17.3 t -147.97 95.95 2.57 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.31 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.854 HD23 HD22 ' A' ' 79' ' ' LEU . 61.2 tp -59.92 -34.7 73.57 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.863 ' CE2' HD11 ' A' ' 79' ' ' LEU . 59.7 m-85 -54.56 -51.85 63.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.63 -0.669 . . . . 0.0 110.994 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . 0.434 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 34.1 mtmm -80.89 -12.73 59.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.731 -1.23 . . . . 0.0 111.207 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 27.4 mt -69.48 -49.78 51.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.48 -1.387 . . . . 0.0 109.214 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.64 ' O ' HD22 ' A' ' 123' ' ' LEU . 2.0 mm100 -50.0 -20.1 0.86 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.144 -0.972 . . . . 0.0 111.451 -177.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 74.6 p -76.05 -10.02 59.08 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.233 -1.542 . . . . 0.0 109.242 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.542 HD11 ' HB3' ' B' ' 342' ' ' ALA . 53.0 mt -95.43 118.08 31.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.353 -0.842 . . . . 0.0 109.323 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.49 93.07 1.0 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 38.4 mt -97.51 85.49 3.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.232 -1.158 . . . . 0.0 108.344 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 31.9 p -93.64 179.96 5.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.195 -0.941 . . . . 0.0 110.81 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . 0.52 ' O ' ' N ' ' B' ' 359' ' ' THR . 62.0 tt0 -49.5 156.91 0.57 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 122.371 1.081 . . . . 0.0 111.412 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.23 23.62 0.02 OUTLIER Glycine 0 N--CA 1.496 2.65 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.226 177.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . 0.52 ' N ' ' O ' ' B' ' 357' ' ' GLN . 27.6 m -83.75 110.04 18.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.803 -1.41 . . . . 0.0 109.858 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 6.8 t -77.28 113.73 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 122.296 1.046 . . . . 0.0 109.833 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.2 m -109.67 176.19 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 56.2 m -131.96 129.95 40.87 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.5 mt -107.84 121.74 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 24.2 p -122.02 133.19 54.8 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.05 149.85 38.77 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.084 -1.01 . . . . 0.0 109.83 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -144.51 121.96 11.69 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.435 -0.79 . . . . 0.0 109.094 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.544 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.05 -152.95 24.28 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.125 -1.512 . . . . 0.0 111.724 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -58.82 -52.82 64.1 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.495 ' H ' ' HB3' ' B' ' 331' ' ' SER . 70.7 m-20 -109.96 12.71 23.65 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.015 -1.053 . . . . 0.0 111.32 -177.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.8 pt-20 -41.95 -35.56 0.89 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.286 -0.883 . . . . 0.0 111.362 -178.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -69.55 -41.0 76.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.574 -1.329 . . . . 0.0 109.991 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -71.76 -54.3 10.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.966 -1.084 . . . . 0.0 109.413 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.39 -35.27 1.5 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.6 -0.687 . . . . 0.0 111.934 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.54 ' O ' HG23 ' B' ' 378' ' ' VAL . 58.7 t -80.19 -33.21 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.492 -1.38 . . . . 0.0 109.297 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -70.0 -40.65 75.16 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.224 -0.922 . . . . 0.0 112.495 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -84.7 -44.65 13.19 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.438 -1.413 . . . . 0.0 110.687 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 90.9 mt -59.92 -39.34 85.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.099 -1.0 . . . . 0.0 109.159 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.54 HG23 ' O ' ' B' ' 374' ' ' VAL . 49.3 t -64.36 -43.74 97.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.28 -0.888 . . . . 0.0 109.784 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -79.93 -9.86 59.72 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.054 -1.029 . . . . 0.0 109.457 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 43.0 tp -82.34 -24.88 34.32 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.1 tpp -82.79 -25.01 33.14 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -85.03 -11.11 56.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.687 -0.633 . . . . 0.0 110.202 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -107.33 -0.29 22.57 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.233 -0.917 . . . . 0.0 110.835 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 34.4 mt -94.95 119.3 33.24 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.76 -1.212 . . . . 0.0 110.084 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . 0.567 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 1.3 pm0 . . . . . 0 N--CA 1.499 2.0 0 CA-C-O 117.94 -1.028 . . . . 0.0 109.479 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.9 mtm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.465 -0.569 . . . . 2.91 109.465 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 94.4 mt -110.06 126.37 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.479 -0.763 . . . . 1.2 109.625 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.5 m -136.75 134.06 36.7 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.893 -0.78 . . . . 1.4 108.893 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.537 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -105.92 -158.59 22.4 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 108.888 -1.685 . . . . 1.05 108.888 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.8 mt -91.65 -9.95 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.995 -1.297 . . . . 1.15 110.448 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.4 tp 55.01 98.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.956 -1.09 . . . . 0.98 108.773 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.75 -34.1 40.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.626 -0.672 . . . . 0.88 109.515 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 m -150.02 141.6 15.02 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.275 -0.89 . . . . 1.69 109.618 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.91 143.67 16.52 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.459 2.106 . . . . 0.85 112.488 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.885 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.91 -165.95 38.36 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.472 -1.451 . . . . 0.92 109.472 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.1 mt -149.2 149.97 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.169 -1.194 . . . . 0.81 108.506 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.27 144.2 19.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.945 -1.097 . . . . 0.51 110.363 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 16.3 m-85 -125.23 128.59 48.54 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.21 -1.033 . . . . 0.62 108.21 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.78 -178.84 44.63 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.717 -1.706 . . . . 0.55 110.816 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -80.19 158.14 26.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.774 -0.839 . . . . 2.1 109.542 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.492 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -105.04 131.24 52.8 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.434 -0.791 . . . . 0.77 110.671 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.6 tp -97.89 136.4 38.24 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.206 -1.405 . . . . 0.91 107.206 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 tp -120.29 124.61 46.04 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.337 -0.852 . . . . 0.93 109.407 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.8 mt -88.18 106.6 18.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.492 -0.755 . . . . 0.93 109.895 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.458 ' NZ ' ' CB ' ' A' ' 20' ' ' LYS . 7.4 mtpm? -102.23 128.78 48.61 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.744 -0.835 . . . . 2.75 108.744 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.531 ' OE1' ' NH2' ' A' ' 139' ' ' ARG . 98.6 mt-10 -126.19 137.95 53.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.312 -0.867 . . . . 3.0 109.135 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -79.15 143.56 35.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.22 -0.925 . . . . 2.77 109.035 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -61.23 140.01 58.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 2.94 109.547 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.6 mt -81.3 131.17 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.409 -0.807 . . . . 0.95 109.192 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.0 t -101.12 123.24 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.302 -0.874 . . . . 1.28 109.58 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.7 mt -98.13 142.94 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.398 -0.814 . . . . 1.21 108.938 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -91.09 122.16 33.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.019 -1.051 . . . . 1.81 109.48 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.533 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.6 mmt-85 -91.12 0.08 57.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 2.8 109.223 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.67 141.67 53.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -0.851 . . . . 2.87 109.654 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -85.78 146.8 26.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.195 -0.941 . . . . 2.35 109.281 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 pt -90.79 164.69 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.97 110.216 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.8 p -97.06 174.14 6.91 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.568 -0.901 . . . . 1.17 108.568 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.96 -48.58 81.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.151 -0.968 . . . . 1.18 110.032 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -54.51 -31.47 56.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.764 -1.21 . . . . 2.56 109.441 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -82.3 -9.05 59.62 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.466 -0.772 . . . . 1.79 110.276 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.2 t -68.05 -56.46 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.436 -1.415 . . . . 1.0 109.146 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.16 -39.97 88.28 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.384 -0.822 . . . . 1.77 109.739 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -67.14 -41.88 85.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.082 -1.011 . . . . 2.7 110.356 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -62.98 -40.08 96.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.904 -1.122 . . . . 1.51 110.405 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.15 -48.67 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.749 -1.22 . . . . 0.93 109.197 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -61.73 -47.81 83.55 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.184 -0.947 . . . . 1.81 109.861 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.421 HH11 ' HG2' ' A' ' 42' ' ' ARG . 49.6 mtt-85 -60.11 -41.91 93.61 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.078 -1.082 . . . . 2.78 108.078 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.433 ' CD1' ' HB1' ' A' ' 100' ' ' ALA . 61.8 t80 -70.07 -39.94 75.32 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.513 -0.742 . . . . 0.78 109.344 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.5 tp -60.05 -48.53 81.34 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.28 -1.378 . . . . 1.07 107.28 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -63.69 -39.98 95.65 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.288 -1.004 . . . . 1.12 108.288 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.26 -50.02 72.17 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 108.491 -1.844 . . . . 0.84 108.491 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.409 HH11 ' HB3' ' A' ' 47' ' ' ARG . 1.4 ttt-85 -61.35 -39.78 91.85 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.709 -1.219 . . . . 3.09 107.709 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.96 87.84 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.971 -0.751 . . . . 0.88 108.971 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 33.6 ttpt -58.03 -74.99 0.05 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.021 -1.072 . . . . 2.59 108.21 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.61 -33.01 0.09 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.15 -0.969 . . . . 0.7 111.715 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.6 m -57.58 -47.54 81.82 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.138 -1.425 . . . . 1.4 108.365 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.8 -41.66 74.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.115 -0.991 . . . . 0.67 110.863 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -67.31 -39.97 85.95 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.806 -1.184 . . . . 1.66 110.163 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.47 -39.38 87.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.943 -1.098 . . . . 1.58 109.222 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -59.99 -36.54 77.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 1.35 109.942 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -63.96 -42.83 97.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.827 -1.171 . . . . 0.77 109.109 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.524 HD11 HH22 ' A' ' 136' ' ' ARG . 85.4 mt -61.68 -37.09 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.63 109.134 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -58.19 -49.98 75.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.861 . . . . 1.14 109.178 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -59.59 -34.18 72.4 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.372 -0.83 . . . . 0.79 110.709 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -69.22 -39.37 78.61 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.847 -1.158 . . . . 1.53 109.598 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.95 -42.06 99.7 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.591 -0.693 . . . . 0.57 109.971 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.1 -50.53 66.67 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.576 -1.41 . . . . 0.75 109.576 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.28 -51.77 34.12 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.011 -1.287 . . . . 1.59 109.515 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.7 m -60.45 -65.68 0.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.355 -0.841 . . . . 0.73 112.179 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.507 ' CE1' ' O ' ' A' ' 168' ' ' THR . 84.3 m-85 -96.12 -49.31 5.3 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.757 -1.215 . . . . 0.75 111.519 -177.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.03 -169.54 25.28 Favored Glycine 0 N--CA 1.503 3.142 0 C-N-CA 119.659 -1.258 . . . . 1.22 111.298 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.05 -25.23 63.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.877 -0.778 . . . . 5.81 109.991 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.517 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.1 tp10 -59.99 -34.57 73.5 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.52 -0.737 . . . . 3.37 110.267 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -100.8 -16.34 17.33 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.366 -0.833 . . . . 1.77 109.91 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -70.35 -42.03 72.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 1.65 110.501 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.521 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.68 -28.47 69.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.898 . . . . 0.77 109.846 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 83.7 mt -60.12 -40.06 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.129 -1.029 . . . . 0.8 108.877 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -66.56 -41.72 88.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.035 . . . . 0.88 110.498 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -60.52 -40.03 89.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.888 -1.132 . . . . 1.37 109.832 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.43 99.41 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.24 -1.544 . . . . 0.62 109.24 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 60.2 m170 -66.99 -41.1 87.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -1.158 . . . . 1.5 109.384 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.63 -46.52 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.923 . . . . 0.63 109.826 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.7 ttp -60.08 -43.95 95.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.03 -1.044 . . . . 1.51 110.207 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.828 HD11 ' CE2' ' B' ' 348' ' ' PHE . 41.4 tp -62.62 -40.03 95.67 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.256 -0.903 . . . . 0.77 109.893 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.5 tp -62.65 -39.95 95.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.27 -0.894 . . . . 0.62 110.215 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -82.75 9.47 9.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.119 -0.988 . . . . 1.47 110.069 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 48.3 t0 -54.88 133.1 47.79 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.118 -0.989 . . . . 1.47 110.445 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 95.5 mt-10 -60.26 -21.07 61.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.64 -0.662 . . . . 1.78 110.734 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.54 -34.72 72.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.667 -1.271 . . . . 2.53 109.355 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.3 mt -70.05 -39.9 75.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.8 109.312 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -60.08 -49.95 75.64 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.446 -0.784 . . . . 1.42 109.804 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -70.14 -41.13 74.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 1.71 110.597 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.72 -40.45 69.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.007 -1.058 . . . . 1.57 111.646 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.1 mt -69.98 -40.32 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.981 -1.074 . . . . 0.65 109.885 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.3 mt -68.99 -36.81 75.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.505 -0.747 . . . . 0.82 109.96 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.76 -49.98 75.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.79 111.183 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.9 mt -60.55 -46.16 91.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.638 -1.289 . . . . 0.95 109.808 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.93 -50.07 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.926 . . . . 0.66 109.461 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -74.13 -42.41 60.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.645 -0.66 . . . . 2.2 111.393 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -79.92 -50.06 10.99 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.901 -1.124 . . . . 1.65 112.052 -177.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -91.03 -4.18 56.59 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.964 -1.085 . . . . 2.03 111.497 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 m80 56.02 36.43 27.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.911 -1.118 . . . . 1.42 109.072 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 53.7 mtt -90.87 169.98 10.46 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.661 -0.65 . . . . 1.18 109.639 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 102' ' ' ALA . 82.1 p -77.79 153.72 32.57 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.928 -1.138 . . . . 0.98 107.928 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 43' ' ' PHE . . . -70.59 -36.64 73.67 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.944 -1.098 . . . . 0.64 111.028 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -68.57 -39.42 81.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.93 -1.106 . . . . 2.07 109.797 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.412 ' HB3' ' OG1' ' A' ' 99' ' ' THR . . . -78.5 -41.48 32.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.73 109.806 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.38 -42.88 67.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.283 -0.886 . . . . 0.54 110.272 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.68 -40.11 96.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.103 -0.998 . . . . 0.56 109.587 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -59.9 -40.05 87.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.5 -0.75 . . . . 1.54 110.3 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 110' ' ' GLY . 86.3 tt0 -60.74 -39.97 90.66 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.138 -0.976 . . . . 1.33 109.994 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.61 -52.15 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.297 -0.877 . . . . 0.72 110.657 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.2 mm -70.06 -40.01 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.989 -1.069 . . . . 0.85 108.327 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -68.15 -32.94 73.56 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.452 -0.944 . . . . 2.44 108.452 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -65.22 -51.3 51.04 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.174 -1.17 . . . . 0.98 110.174 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -60.04 -49.3 78.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.967 -1.314 . . . . 1.41 109.248 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.67 81.4 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.311 -0.868 . . . . 1.2 109.691 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.9 p -59.3 -39.94 84.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.041 -1.037 . . . . 1.7 109.287 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.21 -40.06 94.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 1.47 108.823 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.0 mt -63.4 -42.68 98.79 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.123 -0.986 . . . . 1.56 109.096 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -56.82 -34.38 67.65 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.019 -1.051 . . . . 2.2 109.291 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.11 -23.15 65.29 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.245 -0.91 . . . . 2.12 109.267 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 55.4 mt -62.14 140.75 58.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.04 -1.037 . . . . 2.0 108.519 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -93.84 49.09 1.31 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.911 -1.118 . . . . 3.23 110.836 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -135.35 137.9 42.83 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.129 -0.982 . . . . 2.49 109.835 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 52.0 mp0 -70.12 -31.62 69.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.605 -0.684 . . . . 3.95 110.308 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.62 ' CZ ' ' NH1' ' A' ' 126' ' ' ARG . 3.5 t80 -73.8 -40.11 63.63 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.109 -0.994 . . . . 2.0 110.916 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.685 HD23 HH22 ' A' ' 126' ' ' ARG . 60.7 mt -69.44 -36.56 76.76 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.109 -0.995 . . . . 1.86 108.604 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.19 -36.99 85.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 2.84 110.004 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -59.82 -45.19 93.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.948 -1.095 . . . . 2.73 110.796 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.685 HH22 HD23 ' A' ' 123' ' ' LEU . 25.6 mtm-85 -66.06 -34.51 78.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.599 -1.313 . . . . 2.77 108.756 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.27 -35.47 73.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 1.19 108.519 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.95 92.93 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.345 -0.983 . . . . 1.2 108.345 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -68.42 -39.94 81.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.407 -0.808 . . . . 1.55 109.856 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.417 HG21 HE22 ' B' ' 351' ' ' GLN . 43.7 t -69.38 -40.03 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.004 -1.06 . . . . 0.8 108.749 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -60.07 -38.91 84.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 3.09 108.42 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -59.97 -38.82 83.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.541 -0.724 . . . . 1.46 109.916 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.9 -42.83 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.046 -1.034 . . . . 0.71 109.679 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.87 -35.27 72.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.724 -1.35 . . . . 0.57 109.724 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.98 -48.9 79.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -1.207 . . . . 2.59 110.185 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.524 HH22 HD11 ' A' ' 57' ' ' ILE . 59.1 mtp180 -67.07 -27.89 67.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.615 -1.303 . . . . 2.83 109.914 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.8 tp -59.54 -42.03 91.4 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.232 -1.025 . . . . 1.25 108.232 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.6 -40.05 95.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.7 109.414 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.531 ' NH2' ' OE1' ' A' ' 21' ' ' GLU . 99.0 mtt180 -67.58 -39.94 84.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.305 -0.872 . . . . 2.57 109.965 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -69.86 -31.6 69.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 1.23 112.062 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.1 mt -68.91 -51.62 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.087 -1.633 . . . . 0.81 108.226 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 98.5 mt -70.04 -39.94 75.43 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.068 -0.653 . . . . 1.0 109.348 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.16 52.59 2.35 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.497 -1.441 . . . . 0.89 109.497 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 tp -73.84 150.03 41.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.235 -1.156 . . . . 1.14 108.493 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.65 139.56 53.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.03 -1.044 . . . . 4.6 110.051 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.2 mt -110.01 129.96 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 122.046 0.927 . . . . 1.24 109.297 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.0 mt -69.8 -40.0 78.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 115.778 -0.646 . . . . 1.54 110.166 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 39.8 t0 63.29 131.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.451 0.643 . . . . 1.5 109.361 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 152' ' ' ILE . 83.3 mt -85.44 -2.62 58.31 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.706 -0.85 . . . . 0.79 108.706 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.5 p -83.95 -9.6 58.57 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.82 -0.807 . . . . 1.4 108.82 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -86.04 22.72 1.65 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.531 -0.731 . . . . 0.92 109.798 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.503 HD12 ' O ' ' A' ' 149' ' ' LEU . 66.0 mt -90.48 120.99 40.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.337 -0.852 . . . . 0.88 109.045 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -102.74 -13.98 16.84 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.269 -0.895 . . . . 2.45 110.123 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -130.23 151.61 50.56 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.59 -0.693 . . . . 1.52 110.11 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.28 137.15 58.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 1.58 108.768 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.8 m -153.14 168.05 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.519 -0.738 . . . . 0.69 110.067 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -95.11 146.16 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 106.564 -1.643 . . . . 0.61 106.564 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 49.6 tp -96.83 120.21 36.75 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.106 -0.996 . . . . 0.87 110.8 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.431 HG12 HG22 ' A' ' 209' ' ' THR . 42.2 t -126.41 130.03 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 108.981 -0.748 . . . . 0.71 108.981 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.8 168.57 24.48 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.197 -0.939 . . . . 0.81 109.043 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.78 -37.92 73.36 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.364 -1.46 . . . . 0.98 108.006 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -170.59 145.36 2.53 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.743 -0.836 . . . . 2.25 108.743 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 48.1 mt -112.87 134.67 54.27 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.324 -0.86 . . . . 0.78 109.443 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 11.6 p -90.76 148.84 39.3 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.198 -0.939 . . . . 0.98 109.122 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.35 -32.98 5.73 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.949 1.766 . . . . 0.81 112.485 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 66.7 m -55.88 -45.56 78.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.085 -1.009 . . . . 0.9 109.444 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -69.96 -40.08 75.63 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.372 -0.83 . . . . 1.61 109.539 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.507 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 44.0 p -55.3 -18.37 6.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.233 -0.917 . . . . 0.61 110.935 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -88.46 -46.93 8.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.793 -1.192 . . . . 0.6 109.643 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -90.11 41.2 1.04 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.926 -1.138 . . . . 1.4 107.926 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.1 tp -105.0 131.19 52.84 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.733 -0.604 . . . . 0.7 109.591 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -85.43 97.51 10.06 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.175 -1.046 . . . . 2.35 108.175 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.28 -39.87 95.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.435 -0.791 . . . . 1.51 110.804 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -64.86 -25.51 67.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.082 -1.011 . . . . 2.33 111.033 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -93.96 -10.16 34.61 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.746 -1.221 . . . . 1.92 110.164 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.494 HG12 ' H ' ' A' ' 178' ' ' GLY . 62.6 t -107.12 119.91 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.225 -0.922 . . . . 0.67 108.678 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.1 mt -94.45 11.58 30.23 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.399 -0.813 . . . . 1.53 111.051 -177.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.494 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 171.17 170.27 35.11 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.267 -1.533 . . . . 0.48 109.267 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -136.75 133.56 36.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.365 -1.079 . . . . 0.55 109.118 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.41 ' CG2' HG21 ' A' ' 205' ' ' THR . 75.6 mt -135.41 128.4 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.751 -0.833 . . . . 0.65 108.751 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' A' ' 205' ' ' THR . 34.3 p -144.98 158.64 43.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 0.82 110.626 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 183' ' ' ALA . 86.2 m-20 -94.05 17.23 12.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.602 -0.686 . . . . 2.46 109.778 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -44.32 -179.51 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.496 1.141 . . . . 1.28 113.029 -177.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.8 -52.99 5.57 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.281 -1.127 . . . . 2.19 110.281 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -168.33 -159.88 14.91 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 118.558 -1.782 . . . . 2.13 111.46 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.424 ' O ' ' OG ' ' A' ' 191' ' ' SER . 11.3 ptt180 -69.98 -13.88 62.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 122.18 -0.6 . . . . 5.86 111.129 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 41.2 p -74.32 5.22 4.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.882 -1.136 . . . . 3.72 109.036 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 91.7 p -87.63 141.23 28.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.368 -0.832 . . . . 1.74 110.39 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -54.88 -38.66 67.82 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.293 -0.879 . . . . 0.95 108.997 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 190' ' ' THR . 14.2 p -59.85 -39.95 86.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.682 -0.637 . . . . 1.55 109.941 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 186' ' ' ARG . 93.9 p -61.31 -38.24 86.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 1.51 110.113 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.2 mm -60.01 -39.92 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 1.67 109.074 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.0 mtp -56.14 -49.69 73.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.094 -1.004 . . . . 1.02 109.967 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.96 -44.71 78.74 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.093 -1.004 . . . . 0.68 109.915 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -61.64 -58.96 6.01 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.293 -0.963 . . . . 2.93 110.601 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.2 m -63.12 -39.67 95.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.204 -0.935 . . . . 0.86 111.554 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.7 mt -70.04 -30.05 67.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.831 -1.168 . . . . 0.67 109.402 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 70.52 49.56 0.41 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.342 0.592 . . . . 1.5 109.671 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 55.9 mt -130.1 150.03 74.89 Favored Pre-proline 0 N--CA 1.503 2.193 0 N-CA-C 108.256 -1.016 . . . . 0.72 108.256 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.74 138.18 84.82 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 122.204 1.936 . . . . 0.61 112.051 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.43 151.13 3.63 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.402 -0.919 . . . . 0.66 111.139 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.41 ' CG2' HG23 ' A' ' 205' ' ' THR . 75.7 mt -127.67 139.77 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 107.208 -1.405 . . . . 0.79 107.208 178.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 32.4 m -123.05 -14.41 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.204 -0.935 . . . . 0.91 111.424 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -106.04 26.94 19.11 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.489 -1.444 . . . . 1.01 109.489 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 181' ' ' THR . 1.7 p -52.64 -37.2 58.12 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.234 -1.156 . . . . 0.99 110.41 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.63 -80.54 1.68 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.488 -1.339 . . . . 1.12 110.668 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 21.9 t -129.81 31.89 4.66 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 121.426 -1.044 . . . . 1.72 112.333 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 55.7 t -69.83 -40.22 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.408 -1.432 . . . . 0.89 107.931 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.431 HG22 HG12 ' A' ' 159' ' ' VAL . 72.3 p -53.88 -28.91 39.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.644 -0.66 . . . . 1.03 109.898 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.1 p -80.56 -19.4 45.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.021 -1.05 . . . . 1.83 110.135 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -96.62 -13.56 22.78 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.165 -0.96 . . . . 2.27 110.148 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.2 t -102.53 136.5 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.271 -0.893 . . . . 0.92 110.635 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -115.24 157.04 24.29 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.46 -1.311 . . . . 2.2 107.46 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 46.9 p-10 -60.03 139.99 57.1 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.814 -1.179 . . . . 2.36 110.265 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.7 m-20 80.87 4.29 1.59 Allowed 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.109 0.48 . . . . 2.38 110.028 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -71.13 130.03 40.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.197 -0.939 . . . . 2.09 109.022 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -84.63 112.92 20.88 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.111 -1.07 . . . . 1.27 108.111 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.492 HD12 ' HB2' ' A' ' 16' ' ' ALA . 54.8 mt -123.77 147.26 47.68 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.595 -0.69 . . . . 0.75 110.87 -178.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.409 HD12 ' HG3' ' A' ' 231' ' ' PRO . 75.8 mt -114.38 127.68 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.813 -1.551 . . . . 0.63 106.813 177.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.4 tp -100.4 118.14 36.03 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.826 -1.171 . . . . 0.7 109.622 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.536 ' C ' ' H ' ' A' ' 223' ' ' VAL . 96.0 m-20 -75.7 -43.4 47.36 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.096 -1.002 . . . . 2.31 108.407 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.885 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 50.04 10.55 0.05 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.948 -0.76 . . . . 0.78 108.948 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.536 ' H ' ' C ' ' A' ' 221' ' ' ASP . 52.9 t -130.31 -37.31 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 106.985 -1.487 . . . . 1.04 106.985 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -102.07 -2.9 28.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.388 -1.338 . . . . 2.44 107.388 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.537 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 62.67 40.11 10.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.902 -0.499 . . . . 1.55 110.578 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -140.95 147.18 38.39 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.112 -0.993 . . . . 1.99 109.923 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.96 123.04 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.492 -0.755 . . . . 0.77 109.388 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -91.26 134.3 34.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.026 -1.046 . . . . 0.98 109.156 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.457 HG22 HD22 ' A' ' 218' ' ' LEU . 44.1 t -105.17 115.32 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.545 -0.722 . . . . 0.85 110.115 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 50.12 61.12 14.15 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.145 -0.972 . . . . 1.66 111.712 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.409 ' HG3' HD12 ' A' ' 219' ' ' ILE . 92.7 Cg_endo -83.17 153.05 14.21 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.745 2.296 . . . . 0.95 111.875 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 82.1 p -70.32 162.3 28.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.145 -0.972 . . . . 1.84 110.697 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.48 ' H ' ' ND2' ' A' ' 233' ' ' ASN . 2.6 p30 -60.13 -36.1 76.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.639 -0.663 . . . . 2.74 110.029 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -60.05 -38.29 82.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.197 -0.939 . . . . 2.89 108.858 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.6 t -69.71 -40.0 78.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.319 -0.863 . . . . 1.3 109.223 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.6 mt . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 1.09 110.299 -179.741 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' B' ' 302' ' ' PHE . 13.1 tmm? . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.641 0.734 . . . . 0.0 109.649 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . 0.591 ' N ' ' SD ' ' B' ' 301' ' ' MET . 24.5 t80 -152.69 150.1 29.1 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -146.55 155.31 42.41 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.139 -0.976 . . . . 0.0 110.501 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . 0.404 ' HG2' HG21 ' B' ' 378' ' ' VAL . 72.9 tp60 -152.26 147.94 26.96 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -108.88 127.61 54.19 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.0 p -128.43 123.91 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 CA-C-O 122.407 1.099 . . . . 0.0 111.94 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 27.1 m -77.5 103.58 7.52 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.066 0.936 . . . . 0.0 110.926 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.524 HG22 ' H ' ' B' ' 310' ' ' ALA . 89.5 mt -52.23 122.0 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 122.449 1.118 . . . . 0.0 110.049 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 71.2 p -103.02 23.4 12.36 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.708 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.524 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -83.38 116.72 65.9 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.95 . . . . 0.0 109.052 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -66.52 -6.95 16.42 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 CA-C-N 120.23 1.118 . . . . 0.0 111.504 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -118.09 5.96 12.05 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.48 177.47 34.55 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.468 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -87.28 94.34 9.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.153 -1.204 . . . . 0.0 108.824 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -96.88 -159.53 0.74 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.172 -0.955 . . . . 0.0 110.181 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 16.9 m -58.18 -46.84 85.07 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.971 -1.08 . . . . 0.0 112.637 -176.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.624 ' NH2' ' NE2' ' B' ' 321' ' ' GLN . 1.8 tpt180 -58.86 -61.45 7.74 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 120.425 -1.422 . . . . 0.0 112.09 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -58.8 -32.31 96.89 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 CA-C-N 120.373 1.169 . . . . 0.0 111.579 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.31 70.19 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.961 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.89 -41.0 67.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.882 . . . . 0.0 109.815 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . 0.624 ' NE2' ' NH2' ' B' ' 317' ' ' ARG . 40.3 mt-30 -69.97 -42.76 72.73 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.948 -1.095 . . . . 0.0 108.896 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -61.02 -51.67 68.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 110.348 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 73.8 t -67.72 -30.12 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.625 -1.297 . . . . 0.0 109.981 -179.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -60.05 -45.69 92.02 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.335 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -60.16 -49.95 75.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.037 -1.039 . . . . 0.0 109.225 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.97 74.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.305 -0.872 . . . . 0.0 110.657 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -49.65 -20.05 0.72 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.287 -0.883 . . . . 0.0 109.37 -178.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -81.6 -17.05 71.75 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -106.15 140.55 38.94 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.322 -1.105 . . . . 0.0 109.771 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . 0.416 HG22 ' O ' ' B' ' 330' ' ' THR . 51.3 m -90.72 -12.98 34.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.109 -0.994 . . . . 0.0 109.34 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 58.5 m -61.24 144.74 53.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.335 -0.853 . . . . 0.0 109.587 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -67.32 135.98 54.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.059 -1.026 . . . . 0.0 109.298 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 88.8 mt -133.98 134.14 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.615 -0.678 . . . . 0.0 109.983 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 85.5 m -129.26 148.44 51.19 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.504 -0.747 . . . . 0.0 109.152 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 63.3 t -120.5 114.78 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 98.0 m -106.52 130.39 54.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.169 -0.957 . . . . 0.0 109.477 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 25.2 p -139.4 119.36 13.43 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.778 0.799 . . . . 0.0 110.787 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 41.71 52.87 4.01 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 177.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 84.06 -16.26 33.97 Favored Glycine 0 N--CA 1.5 2.938 0 O-C-N 120.293 -1.504 . . . . 0.0 112.507 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -110.56 122.63 48.22 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.796 -1.414 . . . . 0.0 109.472 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 56.7 p -129.84 150.62 51.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.741 0.782 . . . . 0.0 110.431 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -146.46 170.01 17.73 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.644 0.735 . . . . 0.0 110.204 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 16.5 m -88.62 139.04 30.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.575 -0.703 . . . . 0.0 110.011 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.494 ' HA ' HD11 ' B' ' 350' ' ' LEU . . . -80.49 -13.88 58.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.958 -1.089 . . . . 0.0 110.321 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -88.52 20.29 3.46 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . 0.432 ' H ' ' C ' ' B' ' 344' ' ' ALA . 45.0 t -148.37 95.74 2.5 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.699 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.609 HD23 HD22 ' A' ' 79' ' ' LEU . 59.0 tp -60.35 -34.62 74.11 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.828 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.1 m-85 -55.67 -52.49 63.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.134 -0.979 . . . . 0.0 109.891 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -69.58 -40.13 76.91 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.264 -0.898 . . . . 0.0 110.226 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' B' ' 352' ' ' THR . 80.5 mt -50.88 -54.68 21.9 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.984 -1.073 . . . . 0.0 108.608 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.417 HE22 HG21 ' A' ' 130' ' ' VAL . 27.2 mt-30 -40.15 -12.43 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.855 -0.528 . . . . 0.0 111.647 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.626 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.5 p -93.64 -10.78 33.39 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.589 -1.319 . . . . 0.0 110.627 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 64.0 mt -93.38 119.79 32.9 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.764 -1.21 . . . . 0.0 109.837 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.06 91.01 1.0 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 29.4 mt -96.56 86.83 4.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -1.127 . . . . 0.0 108.199 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 65.9 p -92.5 -179.72 5.28 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.19 -0.944 . . . . 0.0 111.257 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' B' ' 359' ' ' THR . 7.4 tt0 -49.53 153.99 1.03 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.331 1.062 . . . . 0.0 111.303 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.73 26.88 0.05 OUTLIER Glycine 0 N--CA 1.495 2.58 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.906 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . 0.459 ' N ' ' O ' ' B' ' 357' ' ' GLN . 24.1 m -84.87 110.42 18.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.884 -1.363 . . . . 0.0 109.449 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 23.3 t -77.33 114.58 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 122.333 1.063 . . . . 0.0 109.698 -177.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 15.1 m -109.98 177.91 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 27.8 m -130.31 126.9 38.33 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 65.7 mt -102.36 112.65 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 44.8 p -115.5 130.05 56.75 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.2 149.5 38.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.296 -0.877 . . . . 0.0 109.618 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -143.88 123.94 13.63 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.438 ' H ' ' HG2' ' B' ' 370' ' ' GLU . . . 160.82 -161.85 33.09 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.157 -1.497 . . . . 0.0 111.577 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.85 -50.5 73.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 122.211 -0.582 . . . . 0.0 112.296 -177.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.528 ' N ' ' OG ' ' B' ' 331' ' ' SER . 95.8 m-20 -111.08 10.65 22.02 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.919 -1.113 . . . . 0.0 110.837 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' B' ' 367' ' ' GLY . 0.7 OUTLIER -45.59 -32.87 2.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.036 -1.04 . . . . 0.0 111.334 -178.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -71.81 -40.06 69.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.857 -1.152 . . . . 0.0 109.87 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -68.46 -40.38 81.08 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 110.802 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.53 -64.01 0.98 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.58 -1.325 . . . . 0.0 111.088 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.586 ' O ' HG23 ' B' ' 378' ' ' VAL . 45.2 t -45.33 -39.56 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.015 -1.053 . . . . 0.0 109.988 -177.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -61.37 -51.56 68.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.917 -1.114 . . . . 0.0 110.341 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -75.15 -39.93 60.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.015 -1.053 . . . . 0.0 111.094 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.22 -37.27 77.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.11 -0.994 . . . . 0.0 108.827 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.586 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.9 t -62.48 -43.44 98.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.209 -0.932 . . . . 0.0 109.607 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' B' ' 383' ' ' GLU . 0.5 OUTLIER -70.02 -55.72 8.83 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.615 -1.303 . . . . 0.0 107.735 178.525 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 60.4 tp -56.52 -35.92 68.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 109.935 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 33.7 ttm -71.72 -40.6 69.33 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.704 -1.248 . . . . 0.0 109.011 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.39 -5.38 57.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.652 -0.655 . . . . 0.0 110.139 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' B' ' 379' ' ' LYS . 64.3 mm-40 -110.66 -1.07 16.92 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.228 -0.92 . . . . 0.0 110.833 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.9 mt -87.24 128.5 35.15 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.546 -1.346 . . . . 0.0 108.783 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.44 -179.629 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mpp? . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.266 0.555 . . . . 2.91 109.816 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -111.18 130.02 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.608 -0.683 . . . . 1.2 109.346 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.2 m -132.24 121.13 23.16 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.233 -0.917 . . . . 1.4 108.712 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.18 -166.75 32.78 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.611 -1.395 . . . . 1.05 109.611 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 5' ' ' ILE . 88.9 mt -87.42 -6.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.03 -1.276 . . . . 1.15 109.758 -179.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 23.7 tp 57.35 89.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.394 -0.816 . . . . 0.98 109.359 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.73 83.14 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.866 -1.161 . . . . 0.88 107.866 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 p -150.54 146.26 19.49 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 109.006 -0.739 . . . . 1.69 109.006 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.56 143.75 15.37 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.587 2.191 . . . . 0.85 113.272 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.7 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.88 -163.35 36.68 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.221 -1.552 . . . . 0.92 109.221 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.9 mt -148.58 147.54 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.971 -1.311 . . . . 0.81 108.933 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.88 147.84 28.42 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.875 -1.141 . . . . 0.51 110.537 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -128.5 120.71 27.32 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.818 -1.179 . . . . 0.62 107.818 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.82 -179.91 45.82 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 117.943 -2.075 . . . . 0.55 111.228 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -80.28 160.05 25.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.913 -0.757 . . . . 2.1 110.174 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.59 130.51 49.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.686 -0.634 . . . . 0.77 110.931 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.4 tp -100.38 135.42 41.85 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 107.486 -1.302 . . . . 0.91 107.486 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.1 tp -121.4 124.23 44.01 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.226 -0.921 . . . . 0.93 110.027 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.725 HD21 HD21 ' A' ' 149' ' ' LEU . 65.7 mt -81.66 103.31 11.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 0.93 109.758 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -96.88 121.69 39.02 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.267 -1.012 . . . . 2.75 108.267 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -130.36 133.68 46.6 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.27 -0.894 . . . . 3.0 110.153 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 42.5 t0 -69.7 141.76 53.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 2.77 109.505 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.496 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 86.3 tt0 -63.58 142.63 58.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.932 . . . . 2.94 109.232 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.422 HD11 ' HE ' ' A' ' 139' ' ' ARG . 80.4 mt -79.73 128.73 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.145 -0.972 . . . . 0.95 108.898 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.5 t -102.56 128.78 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.26 -0.9 . . . . 1.28 109.646 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.55 139.42 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.352 -0.843 . . . . 1.21 109.319 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -91.38 123.63 34.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.083 -1.011 . . . . 1.81 108.955 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.468 HH11 ' HG2' ' A' ' 28' ' ' ARG . 5.4 mmt-85 -89.96 -0.89 57.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.442 -0.786 . . . . 2.8 109.15 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -68.56 139.78 55.59 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.42 -0.8 . . . . 2.87 109.707 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -86.13 146.17 26.71 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.556 -0.905 . . . . 2.35 108.556 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.614 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.6 pt -92.66 165.98 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.97 109.95 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.3 p -99.71 173.87 6.5 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.488 -0.93 . . . . 1.17 108.488 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.01 -48.13 82.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.947 . . . . 1.18 109.3 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -57.37 -29.08 63.74 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.677 -1.264 . . . . 2.56 109.599 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -82.41 -10.52 59.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 1.79 110.257 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 40' ' ' VAL . 40.3 t -62.15 -52.21 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.951 -1.093 . . . . 1.0 108.568 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.89 -40.24 96.94 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.407 -0.808 . . . . 1.77 110.156 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -70.9 -40.14 72.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.132 -0.98 . . . . 2.7 110.542 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.614 ' HG3' HG21 ' A' ' 31' ' ' ILE . 62.4 mm-40 -66.06 -40.11 90.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.113 -0.992 . . . . 1.51 110.161 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 36' ' ' VAL . 77.2 t -61.68 -43.35 96.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.082 -1.011 . . . . 0.93 108.444 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -59.97 -39.71 86.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 1.81 108.984 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -60.06 -40.93 91.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.935 -1.103 . . . . 2.78 108.228 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -63.92 -47.87 78.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 0.78 108.612 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.5 -49.56 77.07 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.435 -0.58 . . . . 1.07 109.435 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 47.2 t -60.74 -43.3 98.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.113 -0.992 . . . . 1.12 108.81 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.81 -45.66 96.04 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.714 -1.754 . . . . 0.84 108.714 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -65.36 -32.81 74.64 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.954 -1.128 . . . . 3.09 107.954 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.65 -39.16 76.37 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.578 -0.701 . . . . 0.88 109.255 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.7 ttmt -72.78 -72.98 0.22 Allowed 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.768 -1.197 . . . . 2.59 107.768 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.76 -35.7 0.15 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.449 -0.782 . . . . 0.7 111.068 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.3 p -59.86 -56.29 23.61 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.451 -1.406 . . . . 1.4 108.627 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.67 -42.68 81.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.144 -0.973 . . . . 0.67 110.644 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -65.24 -39.99 93.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.063 -1.023 . . . . 1.66 110.621 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.9 mt -66.63 -40.2 88.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.743 -1.223 . . . . 1.58 109.818 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -62.04 -36.33 81.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.991 -1.068 . . . . 1.35 109.554 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.9 m -64.04 -40.38 96.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.189 -0.944 . . . . 0.77 110.311 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.54 -38.81 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.131 -0.981 . . . . 0.63 109.45 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -55.62 -50.43 70.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.392 -0.817 . . . . 1.14 110.612 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -59.67 -39.92 86.09 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.199 -0.938 . . . . 0.79 110.224 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -66.22 -35.65 80.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 1.53 109.513 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.661 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -63.1 -43.11 99.39 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.498 -0.751 . . . . 0.57 109.942 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.38 -50.69 42.5 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.942 -1.263 . . . . 0.75 109.942 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.41 -45.97 92.12 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.202 -1.175 . . . . 1.59 108.642 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.5 m -68.52 -58.64 4.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.457 -0.777 . . . . 0.73 111.663 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -97.96 -54.17 3.17 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.002 -1.061 . . . . 0.75 111.265 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.35 -169.31 25.49 Favored Glycine 0 N--CA 1.504 3.191 0 O-C-N 120.694 -1.254 . . . . 1.22 111.573 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -68.59 -27.79 66.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.913 -0.757 . . . . 5.81 111.001 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -62.56 -36.31 82.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 3.37 110.089 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -98.51 -22.37 16.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.397 -0.814 . . . . 1.77 110.228 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -67.92 -40.14 83.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.0 -1.062 . . . . 1.65 110.457 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.571 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -69.34 -26.09 64.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.77 110.08 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.4 mt -59.88 -40.65 83.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 120.872 -1.142 . . . . 0.8 108.068 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 20.5 m-85 -69.98 -37.61 75.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.428 -0.795 . . . . 0.88 110.139 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.498 ' OE2' ' NZ ' ' B' ' 324' ' ' LYS . 65.6 tt0 -60.65 -40.11 90.81 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.081 -1.012 . . . . 1.37 109.696 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.46 -45.91 81.72 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.381 -1.488 . . . . 0.62 109.381 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -60.43 -42.57 96.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -1.147 . . . . 1.5 109.539 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.1 mt -69.82 -41.09 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.124 -0.985 . . . . 0.63 109.531 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.8 ttp -62.57 -40.2 96.09 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.947 -1.096 . . . . 1.51 109.536 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.777 HD11 ' CE2' ' B' ' 348' ' ' PHE . 54.1 tp -64.89 -38.55 91.35 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.454 -0.779 . . . . 0.77 109.855 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.5 tp -62.08 -40.14 94.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.438 -0.789 . . . . 0.62 110.305 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -84.29 5.84 25.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.011 -1.055 . . . . 1.47 110.287 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 61.5 t0 -49.29 133.36 19.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.007 -1.058 . . . . 1.47 110.114 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.475 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 45.7 mt-10 -59.15 -21.22 59.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.809 -0.557 . . . . 1.78 110.507 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -71.03 -34.31 71.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.939 -1.101 . . . . 2.53 109.309 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.4 mt -71.07 -41.03 71.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.566 -0.709 . . . . 0.8 110.111 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -60.48 -47.69 85.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.533 -0.729 . . . . 1.42 110.653 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -69.82 -40.61 75.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.06 -1.025 . . . . 1.71 110.227 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.63 -39.9 70.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 1.57 111.875 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.55 -47.82 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.758 -1.213 . . . . 0.65 109.83 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.7 mt -69.66 -38.48 76.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.243 -0.911 . . . . 0.82 109.99 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.81 93.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.011 -1.056 . . . . 0.79 109.964 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.4 -45.98 88.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.839 -1.163 . . . . 0.95 109.406 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.66 -46.8 93.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.303 -0.873 . . . . 0.66 108.88 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -69.82 -42.36 73.77 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.334 -0.854 . . . . 2.2 111.602 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -86.08 -51.64 6.2 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.78 -1.2 . . . . 1.65 112.596 -177.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -88.8 -2.6 58.67 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.941 -1.099 . . . . 2.03 111.479 -177.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 56.8 37.98 29.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.908 -1.12 . . . . 1.42 109.709 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.1 mtt -87.44 169.21 12.43 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.548 -0.72 . . . . 1.18 110.043 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.1 p -84.37 160.3 20.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.875 . . . . 0.98 108.85 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.75 -38.94 87.62 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.05 -1.032 . . . . 0.64 110.032 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 38.6 p-10 -69.66 -36.8 76.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.983 -1.073 . . . . 2.07 110.168 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.48 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -81.57 -47.47 13.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.958 -1.088 . . . . 0.73 110.065 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.19 -49.76 76.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -0.875 . . . . 0.54 109.845 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.38 85.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.1 -1.0 . . . . 0.56 109.561 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.53 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 78.7 t60 -60.19 -41.99 94.1 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 1.54 110.263 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -62.34 -40.03 95.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.077 -1.014 . . . . 1.33 110.804 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.31 -56.33 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.948 -1.095 . . . . 0.72 111.613 -177.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.1 mm -69.24 -39.95 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.654 -1.279 . . . . 0.85 109.627 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.53 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.7 tt0 -60.31 -40.05 89.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.083 -1.011 . . . . 2.44 109.413 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.78 -49.37 79.33 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.405 -1.078 . . . . 0.98 110.405 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -67.97 -56.34 9.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.974 -1.31 . . . . 1.41 109.607 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.22 -42.7 63.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.726 -1.234 . . . . 1.2 109.041 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.4 t -59.84 -40.16 87.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.029 -1.045 . . . . 1.7 108.723 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.29 93.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.34 -0.85 . . . . 1.47 109.206 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.9 mt -66.47 -40.09 89.18 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.239 -0.913 . . . . 1.56 109.385 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.07 -33.52 72.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.986 -1.071 . . . . 2.2 109.941 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -58.74 -21.02 54.25 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.983 -1.073 . . . . 2.12 108.768 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.457 HD13 HD13 ' A' ' 123' ' ' LEU . 57.2 mt -62.77 139.64 58.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.232 -0.918 . . . . 2.0 109.247 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -92.46 46.1 1.23 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.981 -1.075 . . . . 3.23 108.929 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -132.12 130.74 41.57 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.4 -0.812 . . . . 2.49 110.033 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -69.9 -33.83 72.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.534 -0.729 . . . . 3.95 110.641 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.487 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.2 t80 -70.24 -40.21 74.6 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.121 -0.987 . . . . 2.0 110.566 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.589 ' CD2' HH21 ' A' ' 126' ' ' ARG . 82.4 mt -70.05 -35.96 74.64 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.954 -1.091 . . . . 1.86 108.747 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -59.93 -40.0 87.42 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.658 -0.651 . . . . 2.84 109.285 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -59.79 -46.5 89.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.857 -1.152 . . . . 2.73 110.011 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.589 HH21 ' CD2' ' A' ' 123' ' ' LEU . 74.0 mtm180 -62.62 -35.81 80.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.634 -1.291 . . . . 2.77 108.766 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.9 -32.29 70.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.368 -0.833 . . . . 1.19 108.813 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.64 -40.05 94.77 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.803 -0.814 . . . . 1.2 108.803 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -68.07 -40.54 82.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.442 -0.787 . . . . 1.55 110.039 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.49 HG21 HE22 ' B' ' 351' ' ' GLN . 49.9 t -70.22 -40.31 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.049 -1.032 . . . . 0.8 109.263 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -60.9 -40.34 92.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.955 -1.09 . . . . 3.09 108.449 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -60.03 -38.97 84.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.579 -0.701 . . . . 1.46 110.181 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.4 mt -59.75 -42.48 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.199 -0.938 . . . . 0.71 111.262 -178.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.94 -32.34 58.91 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.395 -1.384 . . . . 0.57 110.566 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -59.99 -48.57 81.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.037 -1.273 . . . . 2.59 110.408 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -69.33 -29.98 67.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.761 -1.212 . . . . 2.83 110.219 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.6 -40.08 86.3 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.043 -1.036 . . . . 1.25 108.277 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.89 -39.89 93.55 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.192 -1.04 . . . . 0.7 108.192 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.422 ' HE ' HD11 ' A' ' 24' ' ' ILE . 96.9 mtt180 -68.65 -39.87 80.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.322 -0.862 . . . . 2.57 109.582 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -64.98 -33.77 76.85 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.401 -0.812 . . . . 1.23 111.16 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -73.19 -45.83 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.571 -1.33 . . . . 0.81 109.615 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.2 mt -69.98 -30.08 67.33 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.681 -0.808 . . . . 1.0 108.989 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.34 40.61 6.02 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.811 -1.716 . . . . 0.89 108.811 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.421 ' HA ' HD12 ' A' ' 144' ' ' LEU . 24.3 tp -74.31 147.52 42.22 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.408 -1.054 . . . . 1.14 109.026 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -65.87 147.31 53.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.309 -0.869 . . . . 4.6 110.217 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.4 mt -115.63 123.17 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 108.524 -0.917 . . . . 1.24 108.524 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.54 -49.01 85.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.765 -0.585 . . . . 1.54 110.574 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.2 t0 67.72 101.42 0.05 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.51 -0.744 . . . . 1.5 109.085 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.725 HD21 HD21 ' A' ' 19' ' ' LEU . 91.2 mt -72.68 -1.97 18.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -0.867 . . . . 0.79 110.195 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.5 t -81.85 -10.84 59.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 1.4 108.402 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.03 26.25 0.63 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.739 -0.6 . . . . 0.92 110.496 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.452 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 50.3 mt -91.69 123.66 43.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.209 -0.932 . . . . 0.88 109.425 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -105.86 -10.95 16.41 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.213 -0.93 . . . . 2.45 109.975 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -134.02 155.07 50.65 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.137 -0.977 . . . . 1.52 110.512 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.31 134.51 56.59 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.695 0.76 . . . . 1.58 109.53 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.1 m -151.85 164.16 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.729 -0.841 . . . . 0.69 108.729 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.5 mt -94.96 144.72 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.766 -1.568 . . . . 0.61 106.766 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -92.64 117.63 30.18 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.814 -1.178 . . . . 0.87 110.131 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 3.5 t -126.44 132.99 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.619 -0.882 . . . . 0.71 108.619 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.64 165.46 30.59 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.344 -0.847 . . . . 0.81 108.912 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.0 -34.53 71.44 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.452 -1.405 . . . . 0.98 107.464 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 12.9 t70 -162.34 167.37 23.91 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.366 -0.976 . . . . 2.25 108.366 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.421 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 92.8 mt -140.55 132.48 27.67 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.215 -0.928 . . . . 0.78 108.746 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 5.6 p -98.95 153.99 37.55 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.302 -0.874 . . . . 0.98 109.606 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -45.37 -33.62 9.22 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.861 1.708 . . . . 0.81 112.327 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.7 m -53.27 -50.08 65.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.945 . . . . 0.9 109.941 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.65 -40.03 94.73 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.444 -0.785 . . . . 1.61 110.703 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 44.7 p -58.13 -18.67 26.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.61 111.749 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.661 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -86.08 -45.95 10.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.814 -1.179 . . . . 0.6 109.034 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -91.69 41.8 1.08 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.762 -1.199 . . . . 1.4 107.762 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.457 HD11 HG21 ' A' ' 176' ' ' VAL . 57.7 tp -108.74 138.79 44.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.639 -0.663 . . . . 0.7 109.513 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -93.38 99.54 12.03 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.291 -0.881 . . . . 2.35 108.78 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 25.1 mt -65.22 -40.36 94.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.195 -0.94 . . . . 1.51 109.679 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -62.48 -29.57 70.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.067 -1.021 . . . . 2.33 110.792 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.17 -9.2 37.13 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.826 -1.171 . . . . 1.92 110.721 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 178' ' ' GLY . 77.5 t -104.14 118.18 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.036 -1.04 . . . . 0.67 108.578 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.96 9.41 25.12 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.473 -0.767 . . . . 1.53 111.266 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 166.58 175.41 36.79 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.31 -1.516 . . . . 0.48 109.31 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.411 ' CE1' HG11 ' A' ' 176' ' ' VAL . 18.8 m-85 -134.14 131.27 38.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.46 -1.023 . . . . 0.55 108.835 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 98.0 mt -132.05 124.26 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.723 -0.843 . . . . 0.65 108.723 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 17.6 p -145.4 159.6 42.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.901 -1.124 . . . . 0.82 110.947 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -100.35 19.98 15.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.51 -0.744 . . . . 2.46 109.844 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.23 -162.01 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.695 -1.253 . . . . 1.28 111.379 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -87.26 -45.83 5.19 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 111.305 -0.718 . . . . 2.19 111.305 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 166.83 -145.66 10.11 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 118.43 -1.843 . . . . 2.13 111.245 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -60.69 -9.97 4.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.675 -0.897 . . . . 5.86 110.749 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 82.1 p -78.36 -1.09 31.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.862 -1.148 . . . . 3.72 109.868 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.8 t -91.83 129.78 37.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.178 -0.951 . . . . 1.74 109.927 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -46.26 -48.02 18.01 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.149 -0.97 . . . . 0.95 109.617 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 89.7 m -59.71 -38.51 81.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.61 -0.681 . . . . 1.55 110.866 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 96.6 p -59.81 -39.84 86.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.691 -1.255 . . . . 1.51 110.346 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.4 mm -62.61 -37.9 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 1.67 109.199 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.7 mtp -60.15 -43.79 95.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.37 -0.831 . . . . 1.02 110.162 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.28 -42.88 82.49 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.605 -1.309 . . . . 0.68 108.609 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -60.05 -54.12 49.73 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.619 -0.832 . . . . 2.93 110.425 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.4 m -71.26 -34.36 70.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.133 -0.979 . . . . 0.86 111.199 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.36 -29.74 66.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.01 -1.056 . . . . 0.67 108.724 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 69.99 49.87 0.48 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.236 0.541 . . . . 1.5 110.696 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 43.8 mt -128.27 149.28 70.93 Favored Pre-proline 0 N--CA 1.505 2.311 0 N-CA-C 107.799 -1.185 . . . . 0.72 107.799 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.14 143.53 99.74 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 122.21 1.94 . . . . 0.61 112.157 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -172.46 153.37 2.88 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.232 -0.987 . . . . 0.66 111.161 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.2 mt -128.0 143.55 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.847 -1.168 . . . . 0.79 107.847 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 28.3 m -128.78 -11.52 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 O-C-N 120.819 -1.176 . . . . 0.91 111.037 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.64 26.59 17.49 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.413 -1.075 . . . . 1.01 110.413 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.446 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.6 p -45.99 -42.2 12.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.105 -1.232 . . . . 0.99 109.542 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.34 -51.44 4.2 Favored Glycine 0 N--CA 1.494 2.547 0 C-N-CA 120.143 -1.027 . . . . 1.12 111.641 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 14.1 t -158.7 35.42 0.22 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.483 -1.598 . . . . 1.72 111.478 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.82 -40.04 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.128 -0.983 . . . . 0.89 108.747 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 47.2 p -54.77 -27.41 41.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.711 -0.618 . . . . 1.03 110.404 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.8 t -85.75 -12.13 51.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.16 -0.962 . . . . 1.83 110.624 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -104.19 -14.59 15.79 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.168 -0.957 . . . . 2.27 110.673 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.464 HG11 HD11 ' A' ' 218' ' ' LEU . 18.7 t -110.79 146.12 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.15 -0.969 . . . . 0.92 111.208 -177.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -113.36 150.11 33.08 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.747 -1.575 . . . . 2.2 106.747 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 56.6 t30 -55.82 139.96 43.83 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.944 -1.097 . . . . 2.36 110.014 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.7 t70 88.92 11.86 0.08 Allowed 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.27 0.557 . . . . 2.38 109.988 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 52.7 t0 -83.41 141.86 31.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.2 -0.938 . . . . 2.09 109.31 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.553 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 51.3 t80 -89.97 117.5 28.82 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.982 -1.118 . . . . 1.27 107.982 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.464 HD11 HG11 ' A' ' 212' ' ' VAL . 78.0 mt -124.42 142.17 51.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.57 -0.706 . . . . 0.75 109.749 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 88.7 mt -110.2 124.75 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.968 -1.493 . . . . 0.63 106.968 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 21.4 tp -98.36 115.9 29.43 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.901 -1.124 . . . . 0.7 108.064 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 223' ' ' VAL . 15.0 m-20 -79.43 -44.25 21.74 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.524 -0.917 . . . . 2.31 108.524 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.96 14.75 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.043 -0.725 . . . . 0.78 109.043 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 221' ' ' ASP . 47.0 t -124.71 -36.29 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.629 -1.619 . . . . 1.04 106.629 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.415 ' OD1' ' NE2' ' A' ' 226' ' ' GLN . 15.6 t-20 -108.61 0.06 20.52 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.864 -1.162 . . . . 2.44 107.864 178.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 65.07 46.22 2.84 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.905 -0.497 . . . . 1.55 111.324 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.415 ' NE2' ' OD1' ' A' ' 224' ' ' ASN . 23.0 pt20 -150.07 150.21 31.4 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.751 -1.218 . . . . 1.99 109.631 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.88 123.84 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.557 -0.905 . . . . 0.77 108.557 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -85.92 129.09 34.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.934 -1.104 . . . . 0.98 109.283 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.59 118.41 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.541 -0.724 . . . . 0.85 109.641 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 60.68 69.8 1.07 Allowed Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.112 -0.993 . . . . 1.66 110.294 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -90.45 132.07 1.73 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 123.532 2.821 . . . . 0.95 112.63 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.8 m -63.96 161.9 14.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.284 -0.885 . . . . 1.84 110.032 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.23 -42.49 95.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.209 -0.932 . . . . 2.74 110.479 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -60.81 -33.0 72.34 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.975 -1.078 . . . . 2.89 109.43 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.17 -40.07 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 1.3 109.3 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.1 mt . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.238 -0.914 . . . . 1.09 109.464 179.528 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 41.5 ttp . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.444 0.64 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -153.31 150.05 28.52 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -150.93 159.7 44.39 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.866 -1.146 . . . . 0.0 111.064 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -157.6 155.53 30.28 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.696 -0.628 . . . . 0.0 109.331 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -115.28 133.48 55.99 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.147 -0.971 . . . . 0.0 110.559 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.2 p -133.59 124.31 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 CA-C-O 122.11 0.957 . . . . 0.0 112.139 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . 0.436 ' O ' HG23 ' B' ' 309' ' ' THR . 25.8 m -78.02 107.08 10.32 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.026 0.917 . . . . 0.0 111.195 -177.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.7 mt -52.92 120.21 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 122.477 1.132 . . . . 0.0 110.451 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . 0.436 HG23 ' O ' ' B' ' 307' ' ' THR . 30.6 p -108.45 18.68 20.7 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.967 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.457 ' O ' ' CG ' ' B' ' 357' ' ' GLN . . . -73.01 128.47 87.85 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -63.02 -14.63 42.76 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 CA-C-N 120.309 1.146 . . . . 0.0 112.859 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -120.4 10.32 11.17 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.78 -179.13 49.9 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.487 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 2.8 tp -82.28 87.45 6.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.765 -1.432 . . . . 0.0 109.033 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.406 ' NE2' ' HB3' ' B' ' 317' ' ' ARG . 2.6 p80 -92.54 -160.89 0.78 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.918 -1.114 . . . . 0.0 109.865 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.8 m -56.87 -45.66 82.36 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.986 -1.071 . . . . 0.0 112.789 -176.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.571 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 11.9 tpt180 -56.14 -59.1 12.8 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 120.613 -1.305 . . . . 0.0 111.933 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.4 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 18.0 Cg_endo -62.04 -36.62 69.67 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 120.369 1.167 . . . . 0.0 111.921 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.71 84.74 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.26 -46.23 76.11 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.567 -0.708 . . . . 0.0 109.756 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -70.03 -39.88 75.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.824 -1.172 . . . . 0.0 108.355 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -61.57 -54.97 36.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.406 -0.809 . . . . 0.0 110.603 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.91 -30.63 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.667 -1.271 . . . . 0.0 110.091 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . 0.498 ' NZ ' ' OE2' ' A' ' 74' ' ' GLU . 29.7 ttmt -60.01 -45.41 92.87 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.173 -0.954 . . . . 0.0 109.076 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . 0.41 ' OE1' HD22 ' B' ' 380' ' ' LEU . 81.5 tt0 -68.31 -54.87 14.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 111.029 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -65.0 -54.91 23.04 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.848 -1.158 . . . . 0.0 112.284 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -52.97 -17.25 1.33 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.797 -1.189 . . . . 0.0 109.636 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -73.79 -16.85 79.17 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -105.48 150.54 25.22 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.15 -1.206 . . . . 0.0 109.248 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 14.6 t -89.76 -12.85 38.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.062 -1.024 . . . . 0.0 110.261 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.488 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 43.7 t -60.22 142.61 54.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -0.957 . . . . 0.0 109.496 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -67.59 136.08 53.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 108.656 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 79.1 mt -135.46 135.82 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.499 -0.751 . . . . 0.0 109.346 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 96.4 m -130.6 149.69 52.14 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 58.8 t -120.29 114.73 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 55.4 m -104.27 123.58 47.61 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.216 -0.927 . . . . 0.0 109.365 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 56.7 p -130.77 115.25 16.37 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.789 0.804 . . . . 0.0 110.489 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 44.67 59.18 3.49 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 177.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.12 -15.04 18.21 Favored Glycine 0 N--CA 1.498 2.805 0 O-C-N 120.321 -1.487 . . . . 0.0 112.688 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -115.98 127.4 54.91 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-N 118.833 1.317 . . . . 0.0 109.285 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 53.9 p -129.61 150.18 51.05 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.844 0.831 . . . . 0.0 110.369 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.83 168.17 20.39 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 5.6 m -87.82 130.0 35.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.388 -0.82 . . . . 0.0 111.086 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -68.23 -20.27 64.8 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.395 -0.815 . . . . 0.0 109.322 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.02 21.16 1.09 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . 0.465 ' H ' ' C ' ' B' ' 344' ' ' ALA . 16.7 m -151.39 96.29 2.26 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.756 0.789 . . . . 0.0 111.981 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.663 HD23 HD22 ' A' ' 79' ' ' LEU . 58.9 tp -59.94 -33.75 72.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.777 ' CE2' HD11 ' A' ' 79' ' ' LEU . 69.1 m-85 -54.62 -52.46 62.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.391 -0.818 . . . . 0.0 110.716 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -70.34 -40.1 74.3 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.05 -1.032 . . . . 0.0 110.255 -178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.604 ' O ' ' N ' ' B' ' 352' ' ' THR . 79.3 mt -49.76 -55.16 15.06 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.826 -1.171 . . . . 0.0 108.69 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.49 HE22 HG21 ' A' ' 130' ' ' VAL . 32.3 mt-30 -41.42 -13.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.792 -0.568 . . . . 0.0 110.955 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.604 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.0 p -93.33 -10.41 35.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.286 -1.509 . . . . 0.0 110.158 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 70.2 mt -92.07 117.94 30.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.106 -0.996 . . . . 0.0 108.838 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -71.02 88.96 0.39 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.8 mt -98.33 88.51 4.17 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.224 -1.162 . . . . 0.0 109.189 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 34.3 p -89.95 175.82 7.04 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.943 -1.098 . . . . 0.0 110.96 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . 0.457 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 20.5 tm0? -68.97 113.02 5.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.638 -0.664 . . . . 0.0 110.227 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.97 9.14 37.84 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 45.2 m -87.64 112.05 21.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.165 -1.197 . . . . 0.0 110.847 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 39.0 t -76.5 116.98 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 122.137 0.97 . . . . 0.0 109.861 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 27.3 m -112.57 176.03 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 70.5 m -131.52 128.38 39.21 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 88.2 mt -101.16 113.46 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 51.1 m -116.72 130.57 56.81 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.21 152.72 39.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.126 -0.984 . . . . 0.0 110.654 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -143.77 122.99 12.97 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.571 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.62 -156.55 27.24 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.153 -1.499 . . . . 0.0 111.369 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -59.89 -53.8 53.64 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.488 ' H ' ' HB2' ' B' ' 331' ' ' SER . 12.0 t70 -103.3 11.37 36.84 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.107 -0.995 . . . . 0.0 111.434 -176.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 10.6 pt-20 -48.02 -41.62 26.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.102 -0.999 . . . . 0.0 111.779 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . 0.415 ' N ' ' CG ' ' B' ' 370' ' ' GLU . 97.7 mt-30 -69.97 -48.52 57.95 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.636 -1.29 . . . . 0.0 110.335 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -66.11 -45.37 81.37 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.463 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -49.74 -74.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.042 -1.036 . . . . 0.0 110.647 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.575 ' O ' HG23 ' B' ' 378' ' ' VAL . 39.3 t -45.3 -38.62 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.004 -1.06 . . . . 0.0 110.42 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -63.77 -48.15 78.12 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.828 -1.17 . . . . 0.0 109.861 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -79.52 -42.58 24.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.0 -1.063 . . . . 0.0 110.571 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.9 mt -59.4 -37.14 77.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.924 -1.11 . . . . 0.0 109.079 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.575 HG23 ' O ' ' B' ' 374' ' ' VAL . 43.1 t -63.15 -40.23 88.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 119.204 -0.998 . . . . 0.0 109.309 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.5 mttt -69.45 -55.61 9.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.694 -1.254 . . . . 0.0 108.476 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.41 HD22 ' OE1' ' B' ' 325' ' ' GLU . 58.0 tp -57.09 -32.75 66.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 109.452 -178.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 4.6 tpp -71.29 -40.01 71.13 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.543 -1.263 . . . . 0.0 107.885 177.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.4 -7.97 59.66 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.659 -0.651 . . . . 0.0 110.818 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.449 ' O ' ' OE2' ' B' ' 385' ' ' GLU . 96.5 mt-10 -110.33 -0.27 17.71 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 120.822 -1.173 . . . . 0.0 111.317 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.1 mt -82.31 132.36 35.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.394 -1.441 . . . . 0.0 110.238 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 56.4 mp0 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 118.148 -0.929 . . . . 0.0 108.926 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.104 -0.702 . . . . 2.91 109.104 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.4 mt -110.0 130.04 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.398 -0.814 . . . . 1.2 109.822 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.5 m -133.8 147.86 51.28 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.466 -0.771 . . . . 1.4 109.401 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.52 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -127.42 -162.32 11.09 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 108.766 -1.734 . . . . 1.05 108.766 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.8 mt -92.83 -14.64 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.844 -1.386 . . . . 1.15 109.775 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.8 tp 55.21 103.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.528 -0.916 . . . . 0.98 108.528 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.01 -30.08 17.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 0.88 109.104 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.0 t -141.57 126.89 10.8 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.454 -0.779 . . . . 1.69 109.457 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.55 142.82 18.66 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.738 1.625 . . . . 0.85 111.599 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.784 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.2 -164.16 36.97 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.35 -1.5 . . . . 0.92 109.35 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -147.32 148.62 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.009 -1.289 . . . . 0.81 109.005 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.33 152.45 32.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.094 -1.004 . . . . 0.51 110.105 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -135.09 124.85 25.35 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.122 -1.066 . . . . 0.62 108.122 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.71 -175.95 47.39 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 118.739 -1.696 . . . . 0.55 110.701 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -79.57 155.63 28.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.868 -0.784 . . . . 2.1 109.534 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -103.04 130.17 50.08 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.48 -0.763 . . . . 0.77 110.461 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.2 tp -98.36 135.51 39.85 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.024 -1.102 . . . . 0.91 108.024 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.9 tp -117.88 124.44 48.31 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.743 0.783 . . . . 0.93 109.756 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.2 mt -99.97 109.97 22.3 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.742 -0.598 . . . . 0.93 110.916 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -110.66 140.84 44.65 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.559 -0.713 . . . . 2.75 109.191 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -126.78 130.86 51.11 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.31 -0.869 . . . . 3.0 108.782 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.2 p-10 -77.58 155.33 31.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.05 -1.032 . . . . 2.77 109.104 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -72.05 141.26 49.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 2.94 109.511 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -82.44 136.4 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.286 -0.884 . . . . 0.95 108.632 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -95.23 129.42 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.098 -1.001 . . . . 1.28 110.071 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.01 135.87 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.598 -0.688 . . . . 1.21 109.303 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -90.93 123.54 34.51 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.995 -1.066 . . . . 1.81 110.242 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -90.04 -3.91 57.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.591 -0.693 . . . . 2.8 110.469 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -70.33 142.79 52.15 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.004 -1.06 . . . . 2.87 110.6 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp -84.3 153.17 23.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.217 -0.927 . . . . 2.35 108.91 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.63 HG21 ' HG3' ' A' ' 39' ' ' GLU . 3.6 pt -95.05 165.83 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.161 -0.962 . . . . 0.97 109.835 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -93.74 170.75 9.34 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.144 -1.058 . . . . 1.17 108.144 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.41 77.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.812 -1.18 . . . . 1.18 109.722 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -55.49 -28.73 56.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.744 -1.222 . . . . 2.56 109.303 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -81.52 -11.28 59.24 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.39 -0.818 . . . . 1.79 110.069 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -63.34 -51.71 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.751 -1.218 . . . . 1.0 108.94 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -61.47 -39.99 92.9 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.32 -0.862 . . . . 1.77 109.758 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -69.14 -41.33 77.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.896 . . . . 2.7 110.781 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.63 ' HG3' HG21 ' A' ' 31' ' ' ILE . 74.9 mm-40 -65.0 -40.05 94.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.831 -1.168 . . . . 1.51 110.015 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.6 -45.18 97.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.503 -1.295 . . . . 0.93 107.503 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -60.09 -42.7 95.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 1.81 109.125 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -60.05 -40.16 88.44 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.657 -1.238 . . . . 2.78 107.657 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -66.39 -43.95 84.43 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.421 -0.955 . . . . 0.78 108.421 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.08 -50.01 75.4 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.448 -0.945 . . . . 1.07 108.448 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 22.7 t -62.34 -43.52 98.64 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.542 -0.863 . . . . 1.12 108.731 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.76 -44.22 98.22 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.266 -1.934 . . . . 0.84 108.266 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.407 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 32.8 ttt-85 -64.1 -36.03 82.69 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.35 -0.981 . . . . 3.09 108.35 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -54.77 -40.04 68.99 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.852 -0.795 . . . . 0.88 108.852 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 50' ' ' ALA . 17.1 ttmt -67.96 -74.79 0.11 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.166 -1.05 . . . . 2.59 108.166 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.27 -31.86 0.06 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.529 -0.732 . . . . 0.7 111.028 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 49' ' ' LYS . 47.4 t -59.57 -58.79 7.05 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.706 -1.246 . . . . 1.4 108.634 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.24 -44.51 71.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.275 -0.891 . . . . 0.67 111.261 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -61.05 -44.43 97.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.89 -1.131 . . . . 1.66 110.879 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.52 -40.01 93.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.947 -1.096 . . . . 1.58 110.066 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -60.01 -35.58 75.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.054 -1.029 . . . . 1.35 109.875 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -64.31 -41.42 96.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.04 -1.037 . . . . 0.77 110.145 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.8 mt -60.15 -39.94 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.099 -1.001 . . . . 0.63 109.455 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -59.74 -50.15 74.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 1.14 109.638 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -60.55 -40.02 90.04 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.453 -0.779 . . . . 0.79 110.804 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.57 -39.62 94.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.831 -1.168 . . . . 1.53 109.493 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.603 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -65.86 -42.8 89.95 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.583 -0.698 . . . . 0.57 110.064 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.06 -50.17 65.65 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.986 -1.102 . . . . 0.75 110.358 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.78 -42.94 76.69 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.949 -1.324 . . . . 1.59 109.658 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -70.25 -59.12 3.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.73 111.944 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 168' ' ' THR . 95.8 m-85 -95.09 -53.39 3.83 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.975 -1.078 . . . . 0.75 111.358 -177.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.14 -167.58 26.0 Favored Glycine 0 N--CA 1.502 3.043 0 C-N-CA 119.773 -1.203 . . . . 1.22 111.474 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -73.29 -26.51 61.11 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.97 -0.724 . . . . 5.81 111.251 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -61.97 -34.69 76.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.006 -1.059 . . . . 3.37 110.245 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -98.83 -24.12 15.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.13 -0.981 . . . . 1.77 110.27 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.61 -40.19 92.35 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.983 -1.073 . . . . 1.65 110.913 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.601 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -60.11 -32.02 70.6 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.213 -0.929 . . . . 0.77 109.747 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.97 -41.67 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.11 -0.994 . . . . 0.8 109.313 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -70.13 -38.14 75.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.299 -0.876 . . . . 0.88 111.229 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -59.93 -40.05 87.62 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.723 -1.235 . . . . 1.37 109.683 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.49 -43.94 97.4 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.941 -1.664 . . . . 0.62 108.941 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 59.7 m170 -61.96 -43.03 99.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.457 -1.025 . . . . 1.5 109.403 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.0 mt -68.89 -45.22 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.63 109.697 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.0 ttp -59.99 -40.22 88.41 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.024 -1.048 . . . . 1.51 109.902 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.855 HD11 ' CE2' ' B' ' 348' ' ' PHE . 33.1 tp -65.23 -38.07 89.23 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.493 -0.755 . . . . 0.77 109.912 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.3 tp -66.28 -40.03 89.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.471 -0.768 . . . . 0.62 110.354 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -81.8 4.67 21.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.893 -1.129 . . . . 1.47 109.711 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -50.48 131.86 24.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.364 -0.835 . . . . 1.47 110.183 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -62.34 -17.63 59.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.508 -0.745 . . . . 1.78 110.483 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.95 -35.2 74.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.94 -1.1 . . . . 2.53 108.362 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.07 -40.02 75.29 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.468 0.651 . . . . 0.8 109.83 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.1 -49.99 75.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.508 -0.745 . . . . 1.42 110.12 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -71.9 -41.74 67.57 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.277 -0.89 . . . . 1.71 110.63 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.04 -40.74 74.95 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.054 -1.029 . . . . 1.57 111.596 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.9 mt -68.62 -45.74 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.835 -1.166 . . . . 0.65 109.79 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -69.61 -35.09 64.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.378 -0.826 . . . . 0.82 110.048 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.79 99.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.79 110.653 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.75 -48.09 83.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.913 -1.117 . . . . 0.95 109.579 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 55.8 mt -60.13 -48.15 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 121.981 0.896 . . . . 0.66 108.862 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -69.93 -40.05 75.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.759 -0.588 . . . . 2.2 111.187 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -83.54 -52.35 6.56 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.984 -1.073 . . . . 1.65 112.041 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -90.08 -2.27 58.08 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.073 -1.017 . . . . 2.03 111.679 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 56.9 34.68 25.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.918 -1.114 . . . . 1.42 109.305 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.4 mtp -90.31 166.63 13.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.432 -0.793 . . . . 1.18 110.158 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.413 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 67.2 p -77.63 160.41 28.54 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.457 -0.777 . . . . 0.98 109.279 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.61 -40.04 84.71 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.182 -0.949 . . . . 0.64 110.114 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 34.1 p-10 -68.37 -37.13 80.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.07 -1.019 . . . . 2.07 109.309 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.469 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -78.99 -39.96 32.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.041 -1.037 . . . . 0.73 109.593 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.46 -46.72 63.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.862 . . . . 0.54 110.498 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.04 93.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.092 -1.005 . . . . 0.56 109.652 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.528 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 85.3 t60 -59.91 -39.91 87.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.839 . . . . 1.54 109.717 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.13 -43.05 95.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.21 -0.931 . . . . 1.33 110.221 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.86 -59.45 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.185 -0.947 . . . . 0.72 110.83 -178.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.1 mm -63.57 -40.02 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.891 -1.131 . . . . 0.85 108.974 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.528 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 86.7 tt0 -64.01 -40.13 95.65 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.73 -1.211 . . . . 2.44 107.73 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.07 -48.6 85.31 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.952 -1.259 . . . . 0.98 109.952 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -68.03 -50.73 53.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.933 -1.333 . . . . 1.41 109.188 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.33 88.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 1.2 108.606 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 30.3 t -59.91 -40.8 90.05 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.437 -0.949 . . . . 1.7 108.437 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.22 96.31 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.33 -0.856 . . . . 1.47 108.781 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.8 mt -66.37 -42.13 88.42 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.305 -0.958 . . . . 1.56 109.248 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -60.05 -40.01 87.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.737 -1.227 . . . . 2.2 109.444 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -50.22 -20.17 0.97 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.991 -1.068 . . . . 2.12 109.02 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.573 HD13 HD13 ' A' ' 123' ' ' LEU . 54.1 mt -64.19 144.46 57.11 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.141 -0.975 . . . . 2.0 108.611 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 -100.23 52.5 0.89 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.119 -0.988 . . . . 3.23 110.271 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 57.5 t0 -135.58 130.47 34.54 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.134 -0.979 . . . . 2.49 109.627 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 67.0 mt-10 -61.95 -32.97 73.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.741 . . . . 3.95 109.837 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.495 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.0 t80 -70.05 -38.53 75.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 2.0 110.421 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.573 HD13 HD13 ' A' ' 118' ' ' LEU . 87.6 mt -80.42 -32.77 37.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.927 -1.108 . . . . 1.86 109.51 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -60.01 -40.48 89.4 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.905 -1.122 . . . . 2.84 108.177 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 98.9 mt-10 -65.1 -40.07 94.06 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.511 -0.922 . . . . 2.73 108.511 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.455 ' NE ' ' NE2' ' B' ' 351' ' ' GLN . 0.0 OUTLIER -61.11 -39.95 91.94 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.643 -0.873 . . . . 2.77 108.643 179.416 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.18 -22.56 66.95 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.929 -0.767 . . . . 1.19 108.929 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -70.56 -42.59 70.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.645 -0.659 . . . . 1.2 109.78 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -63.88 -40.01 95.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 1.55 110.204 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.24 -41.68 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.106 -0.996 . . . . 0.8 109.427 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.424 HH11 ' HG2' ' A' ' 131' ' ' ARG . 30.3 ttt-85 -60.55 -37.34 80.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 3.09 109.221 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -59.99 -39.82 87.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.631 -0.668 . . . . 1.46 109.387 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.93 -42.04 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.01 -1.056 . . . . 0.71 109.46 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.41 -32.36 68.2 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.785 -1.326 . . . . 0.57 109.785 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.554 ' NZ ' ' HE ' ' A' ' 139' ' ' ARG . 50.3 tttm -59.92 -48.32 82.2 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.133 -1.216 . . . . 2.59 109.028 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.458 HH21 ' HB3' ' A' ' 166' ' ' SER . 1.8 mtt-85 -61.88 -35.34 78.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.993 . . . . 2.83 109.657 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.57 -44.18 93.39 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.507 -0.745 . . . . 1.25 110.275 -177.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 49.6 mt -65.12 -40.14 94.06 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.875 -1.141 . . . . 0.7 109.95 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.554 ' HE ' ' NZ ' ' A' ' 135' ' ' LYS . 59.2 mtt-85 -68.84 -38.96 80.18 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.485 -0.932 . . . . 2.57 108.485 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.505 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.4 m120 -65.07 -38.53 91.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.749 -0.594 . . . . 1.23 110.98 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.6 mt -70.0 -43.16 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.548 -1.345 . . . . 0.81 108.946 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.03 -31.0 68.42 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.623 -0.673 . . . . 1.0 109.727 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.33 39.12 13.04 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.759 -1.737 . . . . 0.89 108.759 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.8 tp -73.96 149.55 41.3 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.469 -1.019 . . . . 1.14 109.623 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -61.42 146.74 47.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.509 -0.745 . . . . 4.6 110.127 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.51 121.93 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-O 122.077 0.941 . . . . 1.24 108.503 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 148' ' ' ASP . 6.0 mt -62.77 -44.32 99.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.839 -0.619 . . . . 1.54 110.823 -178.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 147' ' ' ILE . 50.7 t0 61.87 121.33 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.6 -0.688 . . . . 1.5 109.199 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 59.9 mt -87.97 0.85 55.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.406 -0.808 . . . . 0.79 109.999 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 62.1 m -82.67 -18.8 39.74 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.878 -1.139 . . . . 1.4 110.716 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.52 29.99 0.43 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.965 -1.085 . . . . 0.92 111.642 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 45.7 mm -90.55 119.19 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.682 -1.261 . . . . 0.88 108.38 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -100.15 -9.9 22.02 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.355 -0.841 . . . . 2.45 110.454 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -126.46 150.94 48.38 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.1 -1.0 . . . . 1.52 110.35 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.64 137.2 58.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.835 . . . . 1.58 109.413 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.6 m -152.18 163.5 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.992 -0.744 . . . . 0.69 108.992 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.3 mt -93.42 148.49 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 106.351 -1.722 . . . . 0.61 106.351 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 38.3 tp -96.8 114.28 25.9 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.862 -1.148 . . . . 0.87 110.299 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.51 130.08 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.525 -0.917 . . . . 0.71 108.525 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.08 162.05 39.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.169 -0.957 . . . . 0.81 108.899 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.94 -32.23 65.14 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.209 -1.557 . . . . 0.98 108.713 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 60.1 t0 -167.24 137.8 3.01 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.628 -0.879 . . . . 2.25 108.628 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.514 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 69.3 mt -112.89 131.41 55.74 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.347 -0.845 . . . . 0.78 109.926 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.5 p -100.56 148.92 35.63 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.419 -0.801 . . . . 0.98 108.906 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -38.22 -36.98 0.58 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.274 1.983 . . . . 0.81 112.717 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.458 ' HB3' HH21 ' A' ' 136' ' ' ARG . 4.2 m -50.34 -58.13 6.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 0.9 109.979 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -60.61 -39.85 89.7 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.38 -0.825 . . . . 1.61 110.755 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.445 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 64.4 p -60.03 -19.59 53.53 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.788 -1.195 . . . . 0.61 110.916 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.603 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -83.42 -38.6 21.7 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.852 -1.155 . . . . 0.6 109.556 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -104.66 39.3 1.71 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.663 -0.866 . . . . 1.4 108.663 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.6 tp -106.15 140.08 39.67 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.608 -0.886 . . . . 0.7 108.608 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -85.15 106.85 16.9 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.054 -1.029 . . . . 2.35 109.375 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 94.5 mt -62.84 -41.9 99.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.368 -0.833 . . . . 1.51 111.157 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -70.06 -24.49 63.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.155 -0.966 . . . . 2.33 111.859 -177.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -93.69 -10.52 34.14 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.654 -1.279 . . . . 1.92 109.711 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 68.8 t -98.62 107.02 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.154 -0.967 . . . . 0.67 108.6 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.3 mt -81.92 3.83 24.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.227 -0.92 . . . . 1.53 110.062 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 169.95 173.58 37.48 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.866 -1.294 . . . . 0.48 109.866 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.492 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 7.8 m-85 -129.31 126.93 40.07 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.411 -1.052 . . . . 0.55 109.24 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.415 ' CG2' HG21 ' A' ' 205' ' ' THR . 75.5 mt -128.45 123.69 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.815 -1.18 . . . . 0.65 107.815 177.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 35.1 p -147.05 160.61 42.18 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.806 -1.184 . . . . 0.82 111.504 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 61.6 t0 -103.93 25.95 9.28 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.233 -0.654 . . . . 2.46 109.233 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.42 -162.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.317 -1.49 . . . . 1.28 111.562 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.69 -58.16 4.63 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 111.162 -0.775 . . . . 2.19 111.162 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -168.84 -149.79 6.37 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 118.506 -1.807 . . . . 2.13 111.515 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -77.93 -9.01 58.87 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.817 -0.814 . . . . 5.86 111.013 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 74.5 p -83.13 4.62 25.71 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.814 -1.179 . . . . 3.72 110.557 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 191' ' ' SER . 22.7 p -82.14 143.3 31.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.887 -1.133 . . . . 1.74 110.394 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -46.65 -52.45 13.72 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.335 -0.853 . . . . 0.95 110.096 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 190' ' ' THR . 0.1 OUTLIER -56.11 -38.0 70.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.361 -0.837 . . . . 1.55 110.725 -178.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 188' ' ' SER . 80.5 p -61.69 -40.54 95.35 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.891 -1.131 . . . . 1.51 111.029 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.9 mt -60.09 -39.71 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.014 . . . . 1.67 109.123 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.0 mtp -59.98 -45.3 93.15 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.556 -0.715 . . . . 1.02 110.214 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.72 91.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.601 -1.312 . . . . 0.68 110.292 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -61.1 -52.04 66.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.853 -1.154 . . . . 2.93 110.607 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 62.1 m -70.4 -34.73 72.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.001 -1.062 . . . . 0.86 111.759 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.23 -9.98 59.05 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.702 -1.249 . . . . 0.67 110.543 -178.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 61.91 50.21 4.31 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.482 -0.761 . . . . 1.5 111.423 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 20.9 mt -128.36 149.48 71.61 Favored Pre-proline 0 N--CA 1.5 2.048 0 N-CA-C 107.664 -1.235 . . . . 0.72 107.664 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.06 139.5 46.96 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 122.245 1.963 . . . . 0.61 111.718 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -169.5 150.56 4.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.845 -1.159 . . . . 0.66 111.725 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 91.9 mt -126.86 142.12 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.792 -1.188 . . . . 0.79 107.792 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 18.2 m -123.03 -8.99 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 120.827 -1.17 . . . . 0.91 111.542 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -113.14 24.29 12.86 Favored Glycine 0 N--CA 1.502 3.07 0 N-CA-C 110.677 -0.969 . . . . 1.01 110.677 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.415 HG21 ' CG2' ' A' ' 180' ' ' ILE . 17.5 p -43.41 -47.91 7.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.121 -1.223 . . . . 0.99 110.074 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.433 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 97.03 -55.04 1.33 Allowed Glycine 0 N--CA 1.499 2.897 0 C-N-CA 120.341 -0.933 . . . . 1.12 111.611 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 85.6 p -148.52 28.59 0.87 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.397 -1.649 . . . . 1.72 111.584 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 18.3 t -70.03 -36.74 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.717 -1.24 . . . . 0.89 108.839 178.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.3 p -58.02 -30.66 66.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 1.03 110.964 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.1 t -83.02 -19.4 37.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.803 -1.186 . . . . 1.83 110.389 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -96.98 -11.93 23.97 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.089 -1.007 . . . . 2.27 110.471 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.2 t -107.93 137.41 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.256 -0.902 . . . . 0.92 110.628 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -114.89 149.71 36.76 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.48 -1.304 . . . . 2.2 107.48 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 8.2 t-20 -56.25 138.58 50.12 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.083 -1.011 . . . . 2.36 110.955 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.0 m-20 83.88 7.42 0.62 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.138 0.494 . . . . 2.38 110.229 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -77.91 145.9 35.89 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.207 -0.933 . . . . 2.09 108.871 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -95.34 117.12 29.76 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.273 -1.01 . . . . 1.27 108.273 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' A' ' 16' ' ' ALA . 72.0 mt -126.75 150.7 48.94 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.578 -0.701 . . . . 0.75 110.278 -179.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.7 mt -115.93 128.55 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 106.846 -1.539 . . . . 0.63 106.846 177.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 60.9 tp -99.98 120.09 39.27 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.947 -1.096 . . . . 0.7 109.186 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 223' ' ' VAL . 12.2 t70 -80.18 -41.13 25.87 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.281 -1.007 . . . . 2.31 108.281 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.784 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.27 12.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.775 -0.578 . . . . 0.78 109.55 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 221' ' ' ASP . 42.8 t -124.85 -35.44 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.283 -1.377 . . . . 1.04 107.283 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.519 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 71.9 m-80 -111.76 2.61 17.23 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.99 -1.115 . . . . 2.44 107.99 178.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.52 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.6 OUTLIER 59.63 47.77 10.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.776 -0.578 . . . . 1.55 110.376 179.715 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -135.5 148.22 49.11 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.147 -0.97 . . . . 1.99 109.864 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.7 t -117.84 125.72 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.545 -0.909 . . . . 0.77 108.545 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -101.13 121.87 42.6 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.405 -0.809 . . . . 0.98 109.177 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.4 HG22 HD22 ' A' ' 218' ' ' LEU . 32.1 t -101.85 113.16 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.462 -0.774 . . . . 0.85 110.897 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 52.02 60.75 13.2 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.052 -1.03 . . . . 1.66 111.3 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -86.67 152.64 8.83 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.653 2.236 . . . . 0.95 111.822 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.4 p -74.2 168.44 19.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.097 -1.002 . . . . 1.84 110.526 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -59.99 -37.94 81.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.663 -0.648 . . . . 2.74 110.265 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.57 -38.9 82.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 2.89 109.846 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.95 -41.35 79.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.218 -0.927 . . . . 1.3 109.236 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.494 1.744 0 O-C-N 121.221 -0.924 . . . . 1.09 109.569 -179.999 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -151.3 149.15 29.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -0.837 . . . . 0.0 108.83 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . 0.491 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 0.4 OUTLIER -146.15 154.65 42.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.199 -0.938 . . . . 0.0 110.171 -178.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -152.73 149.38 28.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.535 -0.728 . . . . 0.0 109.113 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -112.52 131.78 55.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.287 -0.883 . . . . 0.0 109.101 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.0 123.59 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-O 122.284 1.04 . . . . 0.0 112.476 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 29.3 m -77.84 104.05 8.15 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.999 0.904 . . . . 0.0 110.126 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.543 HG22 ' H ' ' B' ' 310' ' ' ALA . 90.1 mt -51.59 119.58 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 122.487 1.137 . . . . 0.0 110.366 -177.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 23.7 p -99.9 24.63 8.23 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.587 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.543 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -88.28 113.62 55.98 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -70.99 -5.24 16.54 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 CA-C-N 120.215 1.113 . . . . 0.0 111.864 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -110.45 0.65 17.9 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 74.26 172.17 26.91 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.495 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.5 tp -86.05 93.81 9.08 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.956 -1.32 . . . . 0.0 108.333 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -93.47 -161.58 0.86 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.205 -0.935 . . . . 0.0 110.418 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . 0.404 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 2.9 m -59.3 -44.59 92.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.126 -0.984 . . . . 0.0 112.416 -176.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.601 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.3 tpt180 -57.11 -62.52 5.03 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 120.436 -1.415 . . . . 0.0 111.532 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.75 -30.68 85.44 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 120.2 1.107 . . . . 0.0 111.539 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.11 -50.62 72.96 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.371 -0.931 . . . . 0.0 108.83 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -54.88 -43.17 72.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 109.874 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -70.1 -41.32 74.18 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.809 -1.156 . . . . 0.0 108.826 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -60.08 -50.19 74.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.455 -0.778 . . . . 0.0 110.356 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 80.4 t -68.93 -27.72 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.713 -1.242 . . . . 0.0 109.74 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -60.02 -49.14 78.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.881 . . . . 0.0 110.332 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . 0.475 ' OE1' HD22 ' B' ' 380' ' ' LEU . 86.4 tt0 -68.52 -40.15 80.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.075 -1.015 . . . . 0.0 111.326 -178.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.87 -53.3 58.99 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.561 -1.337 . . . . 0.0 111.108 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -57.69 -11.61 2.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.095 -1.003 . . . . 0.0 109.426 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -68.07 -29.98 73.72 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -104.98 144.21 32.11 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.451 -1.029 . . . . 0.0 109.159 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 7.7 m -90.22 -11.28 41.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.062 -1.024 . . . . 0.0 109.443 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.475 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 33.8 m -57.99 149.02 24.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 109.846 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.91 132.9 48.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.905 . . . . 0.0 109.236 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.9 mt -133.4 132.28 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.307 -0.871 . . . . 0.0 110.041 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . 0.408 HG22 ' N ' ' B' ' 335' ' ' VAL . 52.7 m -128.17 153.15 47.2 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . 0.408 ' N ' HG22 ' B' ' 334' ' ' THR . 84.0 t -119.85 139.87 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 96.8 m -130.33 123.03 29.04 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.275 -0.891 . . . . 0.0 108.739 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 59.8 p -140.11 121.86 15.4 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.081 0.943 . . . . 0.0 111.314 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 57.4 t30 43.49 52.68 5.95 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.35 -12.27 59.0 Favored Glycine 0 N--CA 1.5 2.941 0 O-C-N 120.182 -1.574 . . . . 0.0 112.904 176.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -118.94 129.45 55.18 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-N 119.268 1.534 . . . . 0.0 109.925 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 69.7 m -122.32 146.13 47.6 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.763 0.792 . . . . 0.0 110.078 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -140.42 161.05 38.63 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.472 0.653 . . . . 0.0 109.805 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.8 t -86.09 136.29 33.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.517 -0.739 . . . . 0.0 109.246 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.424 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -79.11 -14.12 59.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.978 -1.076 . . . . 0.0 110.418 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . 0.404 ' H ' ' HG2' ' B' ' 345' ' ' LYS . 19.7 pttp -87.36 21.47 2.45 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . 0.424 ' H ' ' C ' ' B' ' 344' ' ' ALA . 69.2 m -149.62 99.39 2.87 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.795 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.702 HD23 HD22 ' A' ' 79' ' ' LEU . 58.0 tp -60.11 -35.28 74.89 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.855 ' CE2' HD11 ' A' ' 79' ' ' LEU . 51.7 m-85 -55.38 -54.43 43.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.956 -1.09 . . . . 0.0 109.786 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -69.93 -20.57 63.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.29 -0.881 . . . . 0.0 111.29 -177.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' B' ' 352' ' ' THR . 32.8 mt -70.32 -57.91 4.34 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.716 -1.24 . . . . 0.0 110.666 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.552 ' O ' HD22 ' A' ' 123' ' ' LEU . 2.9 mm100 -44.92 -14.77 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.093 -1.005 . . . . 0.0 111.409 -176.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.511 ' N ' ' O ' ' B' ' 350' ' ' LEU . 70.4 p -80.3 -13.44 59.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.196 -1.565 . . . . 0.0 110.278 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 34.9 mt -93.03 119.26 32.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.098 -1.002 . . . . 0.0 108.778 178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.14 91.22 0.91 Allowed Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 18.9 mt -96.5 87.31 4.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.327 -1.102 . . . . 0.0 108.527 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 64.3 p -92.2 -179.48 5.26 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.802 0.81 . . . . 0.0 110.668 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . 0.424 ' O ' ' N ' ' B' ' 359' ' ' THR . 65.8 tt0 -49.41 155.57 0.72 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 122.268 1.033 . . . . 0.0 111.109 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.88 27.58 0.06 OUTLIER Glycine 0 N--CA 1.497 2.729 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.56 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . 0.424 ' N ' ' O ' ' B' ' 357' ' ' GLN . 11.8 m -86.57 109.95 19.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.767 -1.431 . . . . 0.0 109.864 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.25 114.77 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.343 1.068 . . . . 0.0 110.147 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 9.9 m -111.93 177.52 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 49.7 m -130.95 130.1 43.0 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 81.9 mt -106.36 122.28 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 77.3 p -125.05 134.67 52.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.22 152.2 38.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.142 -0.973 . . . . 0.0 110.119 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -142.18 121.73 13.31 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.407 ' H ' ' HG2' ' B' ' 370' ' ' GLU . . . 164.43 -163.28 36.04 Favored Glycine 0 N--CA 1.485 1.923 0 C-N-CA 118.636 -1.745 . . . . 0.0 111.536 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -59.57 -50.07 75.32 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.01 -0.595 . . . . 0.0 111.673 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.475 ' N ' ' OG ' ' B' ' 331' ' ' SER . 85.2 m-20 -111.6 10.3 21.15 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.974 -1.079 . . . . 0.0 110.936 -177.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' B' ' 367' ' ' GLY . 0.7 OUTLIER -44.02 -33.78 1.54 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.113 -0.992 . . . . 0.0 111.596 -178.61 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -69.89 -40.36 75.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.619 -1.301 . . . . 0.0 109.594 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -68.29 -48.15 65.75 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.173 -0.954 . . . . 0.0 109.862 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -50.44 -74.38 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.149 -0.97 . . . . 0.0 110.91 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.586 ' O ' HG23 ' B' ' 378' ' ' VAL . 67.6 t -44.11 -40.75 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.254 -0.904 . . . . 0.0 110.697 -177.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.86 -50.16 72.03 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.526 -1.358 . . . . 0.0 110.481 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -75.81 -40.03 55.72 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.802 -1.186 . . . . 0.0 110.669 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 98.9 mt -59.0 -37.51 77.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.011 -1.056 . . . . 0.0 108.606 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.586 HG23 ' O ' ' B' ' 374' ' ' VAL . 47.1 t -60.74 -40.21 84.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.279 -0.888 . . . . 0.0 109.093 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' B' ' 383' ' ' GLU . 20.3 mmmt -67.97 -55.04 14.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.705 -1.247 . . . . 0.0 107.939 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.475 HD22 ' OE1' ' B' ' 325' ' ' GLU . 63.6 tp -56.36 -35.57 67.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.358 -0.839 . . . . 0.0 110.241 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 34.7 ttm -72.45 -41.06 66.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.727 -1.233 . . . . 0.0 109.107 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.59 -5.69 58.27 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.346 -0.846 . . . . 0.0 110.215 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' B' ' 379' ' ' LYS . 96.2 mt-10 -109.72 -2.78 17.19 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.132 -0.98 . . . . 0.0 111.37 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.4 mt -83.7 130.02 34.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.285 -1.509 . . . . 0.0 109.027 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 N--CA 1.499 1.984 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.629 -179.656 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.251 0.548 . . . . 2.91 109.679 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.0 mt -110.18 129.88 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.47 -0.769 . . . . 1.2 109.114 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.8 m -130.81 148.78 52.62 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.514 -0.741 . . . . 1.4 109.173 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.42 ' H ' ' ND2' ' A' ' 225' ' ' ASN . . . -130.95 -163.54 10.99 Favored Glycine 0 N--CA 1.499 2.861 0 N-CA-C 108.142 -1.983 . . . . 1.05 108.142 179.323 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.451 ' O ' ' O ' ' A' ' 6' ' ' LEU . 95.7 mt -89.16 -14.79 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.659 -1.495 . . . . 1.15 110.068 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.0 tp 54.18 103.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.311 -0.868 . . . . 0.98 109.038 -179.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.94 -27.28 14.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.186 -0.946 . . . . 0.88 109.424 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 m -140.57 124.8 10.65 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.426 -0.796 . . . . 1.69 109.465 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.77 150.08 18.48 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.456 2.104 . . . . 0.85 112.904 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.9 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 146.93 171.78 16.53 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 109.811 -1.316 . . . . 0.92 109.811 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.7 mt -122.85 130.01 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 O-C-N 121.026 -1.279 . . . . 0.81 110.518 -179.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.74 149.32 51.47 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.354 -0.842 . . . . 0.51 110.046 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.4 m-85 -126.52 129.1 47.96 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.726 -1.213 . . . . 0.62 107.726 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.12 176.39 46.85 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 118.732 -1.699 . . . . 0.55 110.998 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -79.94 158.75 26.55 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.443 -1.033 . . . . 2.1 109.438 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.59 137.04 43.02 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.522 -0.737 . . . . 0.77 111.015 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.1 tp -106.64 133.36 51.42 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 106.936 -1.505 . . . . 0.91 106.936 177.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.0 tp -113.55 122.14 46.33 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.169 -0.957 . . . . 0.93 109.687 -179.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.1 mt -85.17 100.78 11.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.617 -0.677 . . . . 0.93 109.399 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -99.37 133.23 43.97 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.441 -0.787 . . . . 2.75 109.463 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -130.19 134.88 47.6 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.462 -0.774 . . . . 3.0 108.938 179.307 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -79.69 158.21 27.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.294 -0.879 . . . . 2.77 109.995 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -70.45 145.78 50.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.351 -0.843 . . . . 2.94 109.225 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.8 mt -89.64 129.09 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.094 -1.003 . . . . 0.95 108.967 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t -93.78 125.47 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.181 -0.949 . . . . 1.28 110.38 -179.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.06 133.72 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.521 -0.918 . . . . 1.21 108.521 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -94.34 117.94 30.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.008 -1.058 . . . . 1.81 109.847 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.2 mmt-85 -89.89 3.8 51.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.294 -0.879 . . . . 2.8 109.415 -179.556 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -62.95 149.42 44.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.943 . . . . 2.87 109.647 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -91.77 141.91 28.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.364 -0.835 . . . . 2.35 109.217 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 pt -93.77 164.39 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.852 -1.155 . . . . 0.97 109.995 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.6 p -92.42 171.53 8.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.22 -0.925 . . . . 1.17 108.664 178.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.27 -15.53 63.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.106 -0.996 . . . . 1.18 110.285 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -85.6 -28.61 24.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.874 -1.141 . . . . 2.56 108.447 178.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -81.58 -8.41 59.71 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.14 -0.689 . . . . 1.79 109.14 179.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.0 t -63.72 -54.91 26.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.115 -0.991 . . . . 1.0 109.129 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.45 -39.72 88.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.077 -1.014 . . . . 1.77 109.355 179.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -65.7 -42.63 90.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 2.7 110.156 -179.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.59 -40.15 95.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.901 -1.124 . . . . 1.51 110.66 -179.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.63 -46.59 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.576 -1.328 . . . . 0.93 108.182 179.206 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -60.14 -44.32 95.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.175 -0.953 . . . . 1.81 109.389 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -59.98 -43.41 95.13 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.908 -1.145 . . . . 2.78 107.908 179.217 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -64.45 -40.02 94.92 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.451 -0.944 . . . . 0.78 108.451 179.008 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.21 -49.95 75.58 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.354 -0.98 . . . . 1.07 108.354 179.481 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.3 t -63.21 -43.5 97.95 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.22 -0.992 . . . . 1.12 108.92 179.086 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.64 -40.02 95.71 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.347 -1.901 . . . . 0.84 108.347 179.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.562 ' CG ' HH11 ' A' ' 47' ' ' ARG . 0.7 OUTLIER -66.65 -39.4 88.21 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.871 -1.159 . . . . 3.09 107.871 178.396 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.0 75.15 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.278 -0.638 . . . . 0.88 109.278 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ALA . 22.2 ttmt -60.72 -74.77 0.07 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.102 -1.073 . . . . 2.59 108.102 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.73 -34.12 0.1 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.435 -0.791 . . . . 0.7 111.471 -177.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.6 m -60.27 -54.68 42.84 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.536 -1.352 . . . . 1.4 108.674 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.82 -41.22 75.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.339 -0.851 . . . . 0.67 111.161 -178.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.33 -39.92 95.87 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.783 -1.198 . . . . 1.66 110.218 -179.289 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.1 mt -66.33 -39.79 89.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.0 -1.063 . . . . 1.58 109.963 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -59.97 -38.95 84.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.143 -0.973 . . . . 1.35 109.592 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -61.87 -41.18 97.55 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.059 -1.025 . . . . 0.77 110.095 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.34 -37.19 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.255 -0.903 . . . . 0.63 109.6 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -57.29 -51.16 70.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.432 -0.792 . . . . 1.14 110.665 -178.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -60.62 -37.2 80.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.017 . . . . 0.79 111.672 -177.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.1 -39.85 94.95 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.869 -1.145 . . . . 1.53 110.267 -179.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.426 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -64.13 -42.3 96.88 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.533 -0.729 . . . . 0.57 109.936 -179.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.84 -52.16 54.11 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.703 -1.359 . . . . 0.75 109.703 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.63 -48.04 73.55 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.167 -1.196 . . . . 1.59 109.806 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.7 m -70.07 -58.74 3.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.344 -0.848 . . . . 0.73 112.144 -177.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -96.85 -53.68 3.45 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.912 -1.117 . . . . 0.75 111.292 -178.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.51 -167.42 25.84 Favored Glycine 0 N--CA 1.5 2.96 0 C-N-CA 119.678 -1.248 . . . . 1.22 111.31 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -70.01 -25.51 63.63 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.799 -0.824 . . . . 5.81 110.685 -179.397 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -61.6 -35.59 78.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -0.954 . . . . 3.37 110.46 -179.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.418 ' HA ' HD12 ' A' ' 72' ' ' ILE . 43.9 mmtm -100.38 -19.83 16.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.31 -0.868 . . . . 1.77 110.282 -179.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -69.94 -39.97 75.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.98 -1.075 . . . . 1.65 110.263 -179.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.551 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.85 -27.99 68.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.351 -0.843 . . . . 0.77 109.486 -179.174 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 69' ' ' LYS . 85.3 mt -60.08 -40.49 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.18 -0.95 . . . . 0.8 108.928 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -69.74 -36.84 76.16 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.193 -0.942 . . . . 0.88 110.705 -179.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -59.88 -40.04 87.34 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.919 -1.113 . . . . 1.37 109.289 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.04 -43.82 95.23 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.523 -1.431 . . . . 0.62 109.523 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -62.62 -41.56 99.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -1.113 . . . . 1.5 109.043 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.7 mt -68.67 -46.46 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.766 -0.828 . . . . 0.63 108.766 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.1 ttp -60.25 -42.95 96.4 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.222 -0.924 . . . . 1.51 109.786 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.831 HD22 HD23 ' B' ' 347' ' ' LEU . 55.2 tp -63.91 -40.71 97.12 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.416 -0.803 . . . . 0.77 109.44 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.557 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 61.8 tp -64.99 -39.81 94.02 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.63 -0.669 . . . . 0.62 109.827 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -79.68 2.14 23.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 1.47 110.677 -178.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -48.95 128.01 15.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.843 -1.16 . . . . 1.47 109.777 -179.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.15 -17.17 51.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.595 -0.69 . . . . 1.78 110.211 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -74.09 -32.95 63.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.074 -1.016 . . . . 2.53 109.43 178.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.07 -41.16 74.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.472 -0.767 . . . . 0.8 109.345 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -60.76 -46.22 91.31 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.383 -0.823 . . . . 1.42 110.159 -179.428 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -70.05 -41.93 73.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.344 -0.847 . . . . 1.71 110.44 -178.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.07 -39.9 75.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.912 . . . . 1.57 110.096 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.7 mt -66.68 -47.06 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.259 -0.901 . . . . 0.65 109.592 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.9 -37.57 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.82 110.111 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.04 -48.31 82.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.183 -0.948 . . . . 0.79 110.913 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.2 mt -60.3 -46.99 87.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.074 -1.016 . . . . 0.95 110.191 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.0 mt -61.13 -49.94 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.66 108.674 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -65.22 -43.28 92.0 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.107 -0.637 . . . . 2.2 110.491 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -80.02 -53.04 7.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.957 -1.09 . . . . 1.65 111.992 -178.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -90.48 -2.43 57.92 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.957 -1.089 . . . . 2.03 112.37 -177.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.3 m80 57.12 36.55 27.73 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.785 -1.197 . . . . 1.42 109.729 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 77.2 mtp -88.22 165.55 14.97 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.293 -0.879 . . . . 1.18 109.34 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.401 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 33.6 p -76.56 159.48 30.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.064 -1.022 . . . . 0.98 108.49 179.348 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.79 -39.96 91.47 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.285 -0.966 . . . . 0.64 110.047 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 24.1 p-10 -66.58 -34.87 78.86 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.122 -0.986 . . . . 2.07 109.312 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.17 -42.2 23.87 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.282 -0.886 . . . . 0.73 109.708 179.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.12 -48.4 68.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.54 109.9 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.7 92.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.56 109.845 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -60.0 -40.67 90.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 1.54 110.204 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.03 -40.26 95.09 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.305 -0.872 . . . . 1.33 110.342 -179.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.4 -53.16 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.076 -1.015 . . . . 0.72 111.028 -178.377 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.88 -40.05 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.861 -1.149 . . . . 0.85 109.307 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -64.64 -36.1 83.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 2.44 108.901 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.51 -49.93 65.99 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.805 -0.712 . . . . 0.98 111.688 -179.114 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.626 HE21 ' CB ' ' B' ' 348' ' ' PHE . 19.4 mm100 -64.05 -47.01 81.83 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.55 -1.559 . . . . 1.41 110.01 -178.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.87 -39.49 85.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.067 -1.021 . . . . 1.2 109.512 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 91.2 p -59.79 -40.05 86.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.946 . . . . 1.7 109.746 -179.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.82 -39.86 86.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.858 -1.151 . . . . 1.47 108.929 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 35.3 mt -61.27 -42.89 99.41 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.832 -1.167 . . . . 1.56 108.912 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.541 ' OE2' ' NH2' ' A' ' 131' ' ' ARG . 98.3 mt-10 -50.18 -26.08 4.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.092 -1.005 . . . . 2.2 109.567 -179.387 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -65.53 -26.49 67.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.084 -1.01 . . . . 2.12 108.716 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 59.6 mt -63.09 144.09 57.21 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.382 -0.824 . . . . 2.0 109.521 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -97.04 14.45 25.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.153 -0.967 . . . . 3.23 109.945 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 58.0 t0 -102.98 143.3 32.73 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.174 -0.954 . . . . 2.49 109.788 -179.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.542 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 66.6 mm-40 -71.57 -63.94 1.02 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.979 -1.119 . . . . 3.95 107.979 178.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.459 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.8 t80 -38.49 -40.0 0.52 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 116.032 -0.531 . . . . 2.0 110.818 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.442 HD22 ' O ' ' B' ' 351' ' ' GLN . 83.9 mt -70.85 -40.09 72.55 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.724 -1.235 . . . . 1.86 109.189 179.417 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 121' ' ' GLU . 61.4 tttp -60.73 -38.95 86.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.244 -0.91 . . . . 2.84 109.836 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -59.78 -39.78 86.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.371 -0.831 . . . . 2.73 109.258 -179.38 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.402 HH11 ' HG3' ' B' ' 351' ' ' GLN . 1.1 mtt-85 -60.11 -39.96 88.01 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.106 -0.996 . . . . 2.77 109.019 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.92 -31.15 71.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.25 -0.906 . . . . 1.19 109.505 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.52 -40.54 95.0 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.384 -0.926 . . . . 1.2 108.565 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -67.28 -40.17 86.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.435 -0.791 . . . . 1.55 109.681 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.04 -40.54 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.353 -0.98 . . . . 0.8 108.353 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.541 ' NH2' ' OE2' ' A' ' 116' ' ' GLU . 39.6 ttm180 -62.29 -37.48 85.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.619 -0.676 . . . . 3.09 109.472 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -59.74 -40.56 88.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.211 -0.931 . . . . 1.46 109.457 -178.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.09 -43.44 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.092 -1.005 . . . . 0.71 109.313 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.22 -44.61 97.9 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.098 -1.201 . . . . 0.57 110.098 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -60.82 -49.67 76.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.166 -1.196 . . . . 2.59 111.148 -179.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -64.88 -35.92 82.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.81 -1.181 . . . . 2.83 110.246 -178.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 64.9 tp -60.08 -40.6 90.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 1.25 109.04 -179.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 138' ' ' LEU . 89.7 mt -62.36 -39.93 94.75 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.32 -0.863 . . . . 0.7 109.264 179.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -69.66 -34.63 74.26 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.673 -0.862 . . . . 2.57 108.673 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -66.69 -36.1 81.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.537 -0.727 . . . . 1.23 110.849 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.4 mt -70.66 -40.96 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 120.571 -1.331 . . . . 0.81 108.754 179.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.17 -35.2 68.93 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.569 -0.707 . . . . 1.0 109.73 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.49 34.94 8.19 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.043 -1.623 . . . . 0.89 109.043 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 29.1 tp -73.57 144.67 45.96 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.35 -1.088 . . . . 1.14 109.626 -179.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -61.15 143.76 54.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.449 -0.782 . . . . 4.6 110.486 -179.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.4 mt -111.67 127.27 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.362 -0.977 . . . . 1.24 108.362 178.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 148' ' ' ASP . 14.5 mm -59.94 -48.14 88.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.468 -0.77 . . . . 1.54 110.505 -177.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 147' ' ' ILE . 31.2 t0 62.46 118.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.344 -0.848 . . . . 1.5 109.007 -179.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.0 mt -84.91 -1.73 56.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.699 -0.626 . . . . 0.79 110.39 -178.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 92.4 p -83.38 -10.32 58.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.802 -1.186 . . . . 1.4 108.608 178.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.6 17.61 2.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.728 -0.607 . . . . 0.92 110.955 -177.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 52.2 mt -90.88 122.9 42.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.894 -1.129 . . . . 0.88 108.981 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -104.74 -7.35 19.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.496 -0.752 . . . . 2.45 110.613 -178.505 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -126.96 150.66 49.27 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.425 -0.797 . . . . 1.52 110.064 -179.067 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.4 136.35 57.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.224 -0.923 . . . . 1.58 108.827 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.8 m -153.08 167.88 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.477 -0.764 . . . . 0.69 109.975 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 76.4 mt -94.8 148.27 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 105.85 -1.907 . . . . 0.61 105.85 176.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 33.6 tp -97.15 118.31 33.29 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.732 -1.23 . . . . 0.87 110.71 -177.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.522 HG12 HG22 ' A' ' 209' ' ' THR . 89.2 t -120.79 126.39 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.675 -0.64 . . . . 0.71 109.551 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.529 ' C ' HG21 ' A' ' 209' ' ' THR . . . -159.74 160.71 34.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.12 -0.987 . . . . 0.81 108.986 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.92 -33.12 70.22 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.362 -1.461 . . . . 0.98 108.672 178.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 25.1 p-10 -171.09 142.03 1.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.576 -0.703 . . . . 2.25 109.119 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.9 mt -114.53 131.28 56.7 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.35 -0.844 . . . . 0.78 108.899 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.8 p -88.67 149.41 43.95 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.967 -1.083 . . . . 0.98 108.786 179.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -40.73 -34.39 1.28 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.942 1.761 . . . . 0.81 112.039 179.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 72.5 m -59.03 -40.14 84.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.189 -0.945 . . . . 0.9 109.194 -178.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -70.25 -40.52 74.37 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.305 -0.958 . . . . 1.61 109.615 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.5 p -57.24 -22.6 42.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.354 -0.841 . . . . 0.61 111.87 -177.545 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -85.09 -49.49 8.22 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.539 -1.351 . . . . 0.6 109.925 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -83.92 38.05 0.63 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.924 -1.139 . . . . 1.4 107.924 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.426 HD11 HG21 ' A' ' 176' ' ' VAL . 57.6 tp -107.6 130.99 54.84 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.303 -0.629 . . . . 0.7 109.303 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -86.44 103.52 15.06 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.109 -1.071 . . . . 2.35 108.109 178.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.19 -40.98 94.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.407 -0.808 . . . . 1.51 111.23 -178.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -63.54 -26.07 68.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.701 -1.249 . . . . 2.33 111.541 -177.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -93.57 -9.44 38.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.753 -1.217 . . . . 1.92 110.045 -178.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 178' ' ' GLY . 93.1 t -104.71 115.23 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.346 -0.846 . . . . 0.67 108.792 179.044 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.4 mt -85.74 7.71 22.58 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.129 -0.982 . . . . 1.53 110.626 -178.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.53 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 166.91 174.66 36.35 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.725 -1.35 . . . . 0.48 109.725 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.517 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 12.1 m-85 -130.98 129.11 41.68 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.393 -1.063 . . . . 0.55 109.069 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.417 ' CG2' HG21 ' A' ' 205' ' ' THR . 89.6 mt -131.7 125.53 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.413 -0.804 . . . . 0.65 109.246 178.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 42.0 p -152.51 162.18 41.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.057 -1.027 . . . . 0.82 110.478 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 182' ' ' ASP . 36.7 p30 -107.85 26.89 9.79 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.658 -0.651 . . . . 2.46 109.358 179.354 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.69 -159.39 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.903 -1.123 . . . . 1.28 111.687 -178.285 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.44 -64.01 3.44 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 111.205 -0.758 . . . . 2.19 111.205 -178.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.12 -135.48 3.91 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.021 -1.562 . . . . 2.13 110.84 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.424 HH11 ' HG2' ' A' ' 186' ' ' ARG . 44.8 mtt-85 -61.1 -32.42 72.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.506 -0.996 . . . . 5.86 110.862 -178.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 11.3 p -71.53 1.73 6.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.963 -1.086 . . . . 3.72 110.275 -178.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.9 t -90.95 131.28 36.66 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.995 -1.066 . . . . 1.74 110.49 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -46.16 -44.94 16.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.346 -0.846 . . . . 0.95 108.965 179.285 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 190' ' ' THR . 2.4 p -56.37 -42.79 78.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.809 -0.557 . . . . 1.55 111.001 -178.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.4 m -60.22 -40.08 88.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.922 -1.111 . . . . 1.51 110.919 -178.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 91.2 mt -61.9 -40.9 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.084 -1.01 . . . . 1.67 110.157 -178.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 86.9 mtp -60.12 -43.35 95.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.103 -0.998 . . . . 1.02 110.141 -179.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.2 94.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.77 -1.206 . . . . 0.68 110.279 -179.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -60.26 -51.78 68.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 2.93 111.228 -178.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 69.1 m -72.6 -34.44 67.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.914 -1.116 . . . . 0.86 111.93 -178.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.6 -14.05 58.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.71 -1.244 . . . . 0.67 110.378 -178.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 57.97 48.37 13.44 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.355 -0.841 . . . . 1.5 110.349 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 94.8 mt -118.01 122.21 30.71 Favored Pre-proline 0 N--CA 1.501 2.107 0 N-CA-C 108.182 -1.044 . . . . 0.72 108.182 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -42.02 130.3 4.39 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.809 1.673 . . . . 0.61 112.377 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.517 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.46 152.43 3.25 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.012 -1.075 . . . . 0.66 111.483 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.0 mt -126.91 141.8 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 107.729 -1.212 . . . . 0.79 107.729 178.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.7 m -124.92 -8.86 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 O-C-N 120.731 -1.23 . . . . 0.91 110.983 -178.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.48 22.89 23.64 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.254 -1.139 . . . . 1.01 110.254 -179.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.417 HG21 ' CG2' ' A' ' 180' ' ' ILE . 11.6 p -44.92 -42.56 8.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.163 -1.198 . . . . 0.99 109.835 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.79 -51.24 2.91 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 120.149 -1.024 . . . . 1.12 111.006 179.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.9 m -157.9 37.36 0.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.523 -1.575 . . . . 1.72 111.427 -178.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 35.4 t -79.52 -32.04 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.789 -1.194 . . . . 0.89 108.749 178.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.529 HG21 ' C ' ' A' ' 160' ' ' ALA . 74.3 p -59.93 -35.02 74.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.503 -0.748 . . . . 1.03 111.143 -178.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 85.2 p -80.14 -12.13 59.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.916 -1.115 . . . . 1.83 110.413 -179.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -100.06 -12.51 19.63 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.24 -0.913 . . . . 2.27 110.465 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 91.9 t -106.31 140.12 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.295 -0.878 . . . . 0.92 111.053 -178.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -113.7 152.9 29.84 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.306 -1.368 . . . . 2.2 107.306 178.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.494 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 28.9 p-10 -57.86 137.59 56.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.011 -1.056 . . . . 2.36 110.561 -178.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 6.2 t0 85.29 2.1 0.69 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 122.117 -0.364 . . . . 2.38 110.734 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.98 143.84 50.69 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.867 -1.146 . . . . 2.09 108.713 179.036 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -93.16 113.72 26.03 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.081 -1.081 . . . . 1.27 108.081 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.479 HD22 HG22 ' A' ' 229' ' ' VAL . 61.0 mt -123.29 145.55 48.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.607 -0.683 . . . . 0.75 110.349 -179.119 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 79.9 mt -111.36 129.87 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 106.21 -1.774 . . . . 0.63 106.21 176.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 51.4 tp -100.35 118.93 37.63 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.889 -1.132 . . . . 0.7 108.534 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 10' ' ' GLY . 38.5 t0 -77.84 -45.97 22.82 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.189 -0.944 . . . . 2.31 108.819 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.75 16.59 0.5 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.991 -1.115 . . . . 0.78 107.991 -178.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.456 ' N ' ' C ' ' A' ' 221' ' ' ASP . 42.0 t -126.17 -46.14 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 106.74 -1.578 . . . . 1.04 106.74 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.536 ' CG ' HE21 ' A' ' 226' ' ' GLN . 55.3 t-20 -102.25 2.92 37.66 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.44 -1.319 . . . . 2.44 107.44 178.129 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.42 ' ND2' ' H ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 59.84 46.24 11.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.976 -0.452 . . . . 1.55 110.048 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.536 HE21 ' CG ' ' A' ' 224' ' ' ASN . 42.9 mt-30 -140.42 154.07 46.53 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.214 -0.929 . . . . 1.99 109.898 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 88.5 t -119.97 131.5 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.079 -0.712 . . . . 0.77 109.079 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -94.99 119.06 32.86 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.177 -0.952 . . . . 0.98 108.487 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.479 HG22 HD22 ' A' ' 218' ' ' LEU . 91.6 t -99.69 115.24 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.323 -0.861 . . . . 0.85 109.618 -179.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 67.09 71.07 0.44 Allowed Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.58 -0.7 . . . . 1.66 109.634 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -90.19 124.9 1.18 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.337 2.692 . . . . 0.95 112.6 -179.679 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 233' ' ' ASN . 63.6 m -67.01 159.68 28.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.413 -0.804 . . . . 1.84 109.261 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.441 ' N ' HG22 ' A' ' 232' ' ' THR . 27.7 p-10 -60.08 -38.74 83.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.087 -1.008 . . . . 2.74 109.972 -179.342 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -60.12 -40.16 88.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.106 -0.996 . . . . 2.89 109.599 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.61 -39.97 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.218 -0.926 . . . . 1.3 109.919 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.2 mt . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.021 -1.05 . . . . 1.09 109.436 179.726 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . 0.402 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 50.4 ttp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.485 0.66 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 23.7 t80 -151.58 149.65 29.41 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . 0.418 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 19.2 pt20 -149.65 159.68 44.14 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.876 -1.14 . . . . 0.0 110.521 -178.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -152.48 148.58 27.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.68 -0.638 . . . . 0.0 109.456 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -110.58 131.49 55.01 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.09 -1.006 . . . . 0.0 109.803 179.212 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.74 122.84 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-O 122.262 1.03 . . . . 0.0 112.294 -177.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . 0.407 ' O ' HG23 ' B' ' 309' ' ' THR . 46.2 m -77.48 106.77 9.46 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.062 0.934 . . . . 0.0 110.184 -178.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.7 mt -52.44 121.85 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 122.361 1.077 . . . . 0.0 110.651 -177.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . 0.407 HG23 ' O ' ' B' ' 307' ' ' THR . 30.0 p -109.97 19.14 19.35 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.38 -178.562 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.86 129.04 77.47 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.795 -1.19 . . . . 0.0 108.525 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -62.66 -10.7 20.48 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 CA-C-N 120.356 1.163 . . . . 0.0 112.981 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -120.96 5.94 10.39 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.294 -0.879 . . . . 0.0 109.418 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.68 -175.39 37.64 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.459 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.5 tp -83.11 85.62 7.16 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.123 -1.222 . . . . 0.0 109.932 -178.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.419 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 4.7 p80 -91.84 -161.98 0.88 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.864 -1.148 . . . . 0.0 109.914 178.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 10.0 m -58.22 -43.82 87.89 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.864 -1.147 . . . . 0.0 112.831 -175.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.551 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.2 tpt180 -60.08 -61.35 8.09 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 120.42 -1.425 . . . . 0.0 112.29 -178.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.419 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 9.3 Cg_endo -57.7 -29.41 85.5 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 CA-C-N 120.288 1.138 . . . . 0.0 111.655 -179.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.93 -51.78 68.21 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.351 -0.939 . . . . 0.0 108.524 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.18 -42.44 66.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.431 -0.793 . . . . 0.0 109.269 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -70.22 -40.07 74.76 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.929 -1.107 . . . . 0.0 108.719 177.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -63.92 -55.46 22.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.734 -0.604 . . . . 0.0 109.795 -179.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 54.2 t -68.05 -36.71 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.816 -1.178 . . . . 0.0 109.682 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -60.0 -44.62 94.42 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.755 -179.286 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -66.79 -40.07 88.0 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.955 -1.091 . . . . 0.0 109.872 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -64.67 -51.7 61.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.125 -0.984 . . . . 0.0 110.132 -179.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -57.55 -11.54 2.1 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.083 -1.01 . . . . 0.0 109.131 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -67.9 -30.45 74.3 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.716 -1.753 . . . . 0.0 108.716 179.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -105.31 143.28 33.7 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.598 -0.942 . . . . 0.0 109.15 179.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 27.9 m -89.95 -11.8 40.65 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.978 -1.076 . . . . 0.0 109.845 -179.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.442 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 60.1 p -60.02 153.8 20.63 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.049 -1.032 . . . . 0.0 108.764 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.75 129.5 40.12 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.181 -0.949 . . . . 0.0 109.558 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.3 mt -129.15 129.95 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.626 -0.671 . . . . 0.0 109.35 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . 0.401 HG22 ' N ' ' B' ' 335' ' ' VAL . 93.9 m -128.06 152.57 47.81 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.509 -0.744 . . . . 0.0 109.626 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . 0.401 ' N ' HG22 ' B' ' 334' ' ' THR . 63.5 t -118.03 137.47 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 55.0 m -129.98 122.24 28.09 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.215 -0.928 . . . . 0.0 108.999 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 91.4 p -137.36 118.49 14.45 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.014 0.912 . . . . 0.0 111.102 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 44.38 57.41 4.38 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 177.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 83.16 -12.5 49.87 Favored Glycine 0 N--CA 1.5 2.956 0 O-C-N 120.164 -1.585 . . . . 0.0 113.388 176.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -119.11 131.27 55.9 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-N 119.367 1.584 . . . . 0.0 110.067 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 70.6 m -124.86 146.71 49.15 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.903 0.859 . . . . 0.0 110.599 -179.113 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . 0.433 ' CB ' HD11 ' B' ' 353' ' ' LEU . . . -138.81 161.81 36.32 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.634 0.73 . . . . 0.0 109.596 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 51.0 m -86.08 131.87 34.17 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.558 -0.713 . . . . 0.0 109.994 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -69.86 -17.51 63.37 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.075 -1.016 . . . . 0.0 109.141 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -89.26 20.93 3.49 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 5.7 m -145.41 92.34 2.23 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.451 -179.344 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.831 HD23 HD22 ' A' ' 79' ' ' LEU . 58.7 tp -59.95 -37.22 78.92 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.274 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.773 ' CE2' HD11 ' A' ' 79' ' ' LEU . 59.1 m-85 -54.61 -51.34 65.66 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.25 -0.906 . . . . 0.0 111.138 -179.287 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' B' ' 350' ' ' LEU . 34.0 mtmm -69.25 -39.98 78.14 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.91 -1.118 . . . . 0.0 109.781 -178.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' B' ' 352' ' ' THR . 18.2 mt -47.16 -57.21 5.37 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.12 -0.988 . . . . 0.0 108.671 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' B' ' 347' ' ' LEU . 1.4 mp0 -39.33 -22.56 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.525 -0.734 . . . . 0.0 111.088 -179.009 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.52 ' N ' ' O ' ' B' ' 350' ' ' LEU . 72.4 p -82.88 -10.89 58.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.348 -1.47 . . . . 0.0 110.796 -178.155 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.433 HD11 ' CB ' ' B' ' 342' ' ' ALA . 49.6 mt -94.89 117.84 30.8 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.816 -1.178 . . . . 0.0 109.513 178.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.05 92.24 0.83 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.3 mt -99.57 91.35 4.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.233 -1.157 . . . . 0.0 109.279 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 33.4 p -89.71 168.29 12.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.812 -1.18 . . . . 0.0 111.046 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -63.13 115.94 4.94 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.228 0.537 . . . . 0.0 110.763 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 100.75 7.39 50.94 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 24.1 m -86.82 114.68 23.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.485 -1.009 . . . . 0.0 111.066 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 14.9 t -76.43 116.56 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.322 1.058 . . . . 0.0 109.865 -177.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.1 m -111.45 176.95 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 29.7 m -130.53 129.44 42.84 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 83.0 mt -104.98 118.97 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 178.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 74.1 m -123.59 133.47 53.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.506 -0.746 . . . . 0.0 109.43 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.44 152.46 40.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.302 -179.454 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -146.36 123.13 11.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 108.953 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.531 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.96 -156.22 27.15 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 118.987 -1.578 . . . . 0.0 111.342 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.97 -52.82 63.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 122.319 -0.518 . . . . 0.0 112.008 -177.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.442 ' H ' ' HB3' ' B' ' 331' ' ' SER . 80.1 m-20 -106.93 9.5 30.74 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.782 -1.199 . . . . 0.0 111.567 -177.31 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.2 pt-20 -38.76 -33.29 0.1 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.398 -0.814 . . . . 0.0 111.232 -179.039 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -67.24 -42.3 84.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.889 -1.132 . . . . 0.0 109.618 -178.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -69.98 -52.9 20.49 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.453 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -42.06 -38.55 1.69 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.51 -0.744 . . . . 0.0 111.39 -178.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.525 ' O ' HG23 ' B' ' 378' ' ' VAL . 92.0 t -80.05 -34.87 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.687 -1.258 . . . . 0.0 109.928 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.51 -40.06 77.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.945 -1.097 . . . . 0.0 111.702 -178.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -81.63 -45.62 15.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.398 -1.439 . . . . 0.0 110.126 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.9 mt -60.18 -40.33 89.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 109.209 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.525 HG23 ' O ' ' B' ' 374' ' ' VAL . 53.3 t -61.92 -47.16 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.101 -0.999 . . . . 0.0 109.803 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' B' ' 383' ' ' GLU . 60.9 mttp -68.27 -54.7 15.79 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.515 -1.274 . . . . 0.0 107.762 178.597 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 59.8 tp -55.24 -33.86 63.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 110.088 -178.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 9.0 tpt -72.4 -40.19 67.4 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.378 -1.451 . . . . 0.0 109.013 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.93 -4.67 58.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 110.168 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' B' ' 379' ' ' LYS . 95.6 mt-10 -110.56 -3.47 15.95 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.07 -1.019 . . . . 0.0 111.178 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.1 mt -79.51 130.63 35.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.427 -1.421 . . . . 0.0 109.547 179.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 2.3 pm0 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.271 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.561 -0.533 . . . . 2.91 109.561 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.7 mt -110.19 129.4 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.433 -0.792 . . . . 1.2 109.321 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.1 m -140.05 151.71 45.63 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.382 -0.824 . . . . 1.4 109.122 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.441 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -136.34 -166.12 10.79 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 108.495 -1.842 . . . . 1.05 108.495 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.8 mt -93.8 -9.91 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.78 -1.424 . . . . 1.15 110.334 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.3 tp 53.36 101.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.134 -0.979 . . . . 0.98 109.41 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.57 -24.67 20.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.055 -1.028 . . . . 0.88 109.867 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.4 m -146.16 134.82 10.98 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.036 -1.04 . . . . 1.69 109.723 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -80.62 139.63 12.74 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.287 1.991 . . . . 0.85 112.634 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.778 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 164.79 -165.4 37.52 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.359 -1.496 . . . . 0.92 109.359 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.6 mt -147.81 149.8 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.091 -1.24 . . . . 0.81 108.196 178.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.77 156.91 38.6 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.867 -1.146 . . . . 0.51 110.543 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -139.63 124.89 18.93 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.013 -1.106 . . . . 0.62 108.013 179.194 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.43 -179.75 48.55 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 118.776 -1.678 . . . . 0.55 110.559 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -79.29 158.62 27.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.743 -0.857 . . . . 2.1 109.462 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.545 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -101.45 129.73 47.55 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.37 -0.831 . . . . 0.77 110.923 -178.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.454 HD12 HD21 ' A' ' 214' ' ' ASN . 53.9 tp -98.22 132.17 43.94 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.189 -1.411 . . . . 0.91 107.189 178.369 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.488 ' H ' HD22 ' A' ' 214' ' ' ASN . 36.8 tp -118.34 122.65 43.38 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.25 -0.906 . . . . 0.93 109.592 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.1 mt -87.35 103.4 15.44 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.599 0.714 . . . . 0.93 110.167 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -93.01 135.32 34.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.447 -0.783 . . . . 2.75 109.233 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 57.3 mp0 -130.94 136.89 48.98 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.349 -0.844 . . . . 3.0 109.485 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 63.0 t0 -86.55 140.74 29.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.109 -0.995 . . . . 2.77 108.889 179.048 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 85.4 tt0 -60.33 139.99 57.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 2.94 109.548 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.5 mt -86.4 134.37 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.31 -0.869 . . . . 0.95 109.172 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.8 t -98.8 129.12 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.253 -0.905 . . . . 1.28 110.459 -179.004 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.8 mt -105.95 137.42 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.618 -0.882 . . . . 1.21 108.618 179.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -88.54 121.81 31.32 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.95 -1.094 . . . . 1.81 109.949 -179.379 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -90.63 -6.22 54.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 2.8 109.717 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -71.03 137.87 49.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.98 -1.075 . . . . 2.87 109.63 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -81.66 158.1 24.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 2.35 108.967 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.68 HD13 ' HG3' ' A' ' 39' ' ' GLU . 2.9 pt -100.43 166.28 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.139 -0.976 . . . . 0.97 109.495 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.0 p -90.46 174.77 7.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.162 -0.961 . . . . 1.17 108.765 178.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.85 -16.78 63.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.091 -1.006 . . . . 1.18 110.758 -179.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.3 -27.45 25.94 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.892 -1.13 . . . . 2.56 108.456 179.195 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -82.69 -7.36 59.65 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.195 -0.668 . . . . 1.79 109.195 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.8 t -59.95 -51.53 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.153 -0.967 . . . . 1.0 108.475 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.91 -40.04 87.48 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.385 -0.822 . . . . 1.77 109.084 179.111 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -63.3 -40.52 97.58 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.337 -0.852 . . . . 2.7 110.277 -178.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.68 ' HG3' HD13 ' A' ' 31' ' ' ILE . 60.5 mm-40 -62.93 -44.71 95.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.749 -1.219 . . . . 1.51 109.865 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.5 -49.81 81.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.041 -1.037 . . . . 0.93 109.718 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -60.66 -48.2 82.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.976 -1.077 . . . . 1.81 109.518 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.473 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 86.5 mtm180 -60.03 -40.13 88.28 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.853 -1.154 . . . . 2.78 108.407 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -65.09 -47.52 76.95 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.348 -0.845 . . . . 0.78 109.075 178.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.06 -44.6 94.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 1.07 109.151 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 t -65.36 -43.16 91.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.047 . . . . 1.12 109.315 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.52 -42.54 97.44 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.014 -2.034 . . . . 0.84 108.014 178.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.448 HH22 ' HG2' ' A' ' 81' ' ' GLU . 36.9 ttt-85 -63.51 -38.52 91.43 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.731 -0.864 . . . . 3.09 108.808 178.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.76 -40.61 72.81 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.505 -0.747 . . . . 0.88 109.083 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 50' ' ' ALA . 6.5 ttpm? -62.52 -73.44 0.11 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.737 -1.209 . . . . 2.59 107.737 178.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.71 -35.64 0.09 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.429 -0.794 . . . . 0.7 112.164 -177.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 98.2 p -59.42 -49.98 75.72 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.318 -1.489 . . . . 1.4 108.335 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.46 -39.85 92.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.47 -0.769 . . . . 0.67 110.646 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -65.99 -40.1 90.88 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.819 -1.176 . . . . 1.66 110.2 -179.159 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 71.4 mt -62.64 -40.05 95.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.146 -0.971 . . . . 1.58 109.689 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -62.56 -39.76 94.67 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.252 -0.905 . . . . 1.35 110.161 -179.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -64.82 -43.84 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.06 -1.025 . . . . 0.77 110.018 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.8 mt -59.93 -39.34 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.63 109.222 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -57.51 -51.41 69.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.367 -0.833 . . . . 1.14 110.411 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -56.62 -29.16 61.87 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.447 -0.783 . . . . 0.79 110.556 -177.515 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -69.75 -39.09 76.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.969 -1.082 . . . . 1.53 110.376 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.6 -46.98 74.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.304 -0.872 . . . . 0.57 110.096 -179.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.21 -50.02 53.74 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 109.743 -1.343 . . . . 0.75 109.743 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.24 -46.34 42.24 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.334 -1.098 . . . . 1.59 111.026 -179.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.4 m -67.57 -62.63 1.32 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.091 -1.005 . . . . 0.73 112.806 -177.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.448 ' CE1' ' O ' ' A' ' 168' ' ' THR . 77.6 m-85 -93.54 -45.77 7.6 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.684 -1.26 . . . . 0.75 110.87 -178.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.29 -170.6 24.59 Favored Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.011 -1.09 . . . . 1.22 110.737 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -70.02 -25.39 63.56 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.844 -0.798 . . . . 5.81 109.878 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.493 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 51.0 tp10 -60.0 -31.34 69.83 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.518 -0.739 . . . . 3.37 109.747 -179.354 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -98.98 -19.67 17.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.306 -0.871 . . . . 1.77 110.065 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -69.89 -40.02 75.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.012 -1.055 . . . . 1.65 109.977 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.479 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -63.55 -31.38 72.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.391 -0.818 . . . . 0.77 109.742 -179.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 88.8 mt -60.04 -40.99 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.108 -0.995 . . . . 0.8 109.116 -179.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -65.57 -39.7 91.96 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.222 -0.924 . . . . 0.88 110.699 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -59.95 -40.04 87.63 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.817 -1.177 . . . . 1.37 108.834 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.61 -47.0 93.32 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.971 -2.052 . . . . 0.62 107.971 178.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -61.58 -49.44 76.65 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.398 -1.06 . . . . 1.5 109.102 179.222 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.05 -48.98 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.276 -0.89 . . . . 0.63 109.542 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.7 ttp -60.06 -43.03 95.71 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.108 -0.995 . . . . 1.51 110.063 -178.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.884 HD11 ' CE2' ' B' ' 348' ' ' PHE . 56.4 tp -63.29 -40.01 96.16 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.318 -0.864 . . . . 0.77 109.425 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.45 -39.9 89.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.78 -0.822 . . . . 0.62 108.78 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.448 ' HG2' HH22 ' A' ' 47' ' ' ARG . 42.0 mt-10 -83.28 8.15 14.31 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.229 -0.919 . . . . 1.47 110.485 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -56.64 130.89 47.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.785 -1.197 . . . . 1.47 109.529 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.51 -18.47 52.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.468 -0.77 . . . . 1.78 110.467 -179.014 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -70.14 -36.28 74.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.823 -1.173 . . . . 2.53 109.109 178.531 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.2 mt -70.2 -41.77 73.26 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.411 -0.806 . . . . 0.8 110.031 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -60.03 -48.67 80.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 1.42 110.372 -178.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -70.05 -40.83 74.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 1.71 110.726 -179.009 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.07 -40.02 75.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.194 -0.941 . . . . 1.57 111.516 -178.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.99 -43.87 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.03 -1.043 . . . . 0.65 109.616 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.5 mt -70.06 -40.0 77.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.379 -0.826 . . . . 0.82 110.309 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.01 75.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.105 -0.997 . . . . 0.79 111.307 -178.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 96' ' ' LYS . 17.6 mt -60.9 -45.73 93.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.089 -1.007 . . . . 0.95 109.703 -178.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.44 -49.89 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.66 109.134 179.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -70.38 -41.18 73.41 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.876 -0.73 . . . . 2.2 110.916 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -82.52 -53.68 5.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.998 -1.064 . . . . 1.65 112.1 -178.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 92' ' ' LEU . 90.6 mttt -90.06 -1.39 57.95 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.048 -1.032 . . . . 2.03 112.124 -177.172 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 57.05 35.7 26.72 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.746 -1.221 . . . . 1.42 109.196 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 38.4 mtt -83.8 164.96 19.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.513 -0.742 . . . . 1.18 109.823 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.7 p -79.58 158.73 27.07 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.496 -0.927 . . . . 0.98 108.496 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.0 -40.08 75.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.994 -1.066 . . . . 0.64 109.702 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.94 -39.94 95.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.975 . . . . 2.07 109.79 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.57 -46.47 14.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.125 -0.984 . . . . 0.73 109.434 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.05 -49.67 76.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.442 -0.786 . . . . 0.54 109.89 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.57 85.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.171 -0.956 . . . . 0.56 109.634 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.534 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 80.7 t60 -59.99 -39.0 84.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.327 -0.858 . . . . 1.54 109.858 -179.207 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 110' ' ' GLY . 41.3 tt0 -60.36 -41.57 93.96 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.106 -0.996 . . . . 1.33 109.541 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.7 t -65.91 -50.87 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.1 -1.0 . . . . 0.72 110.198 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.5 mm -69.31 -40.12 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.044 -1.035 . . . . 0.85 108.581 179.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.534 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 89.1 tt0 -67.09 -37.21 83.55 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.405 -0.961 . . . . 2.44 108.405 178.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -60.02 -47.32 91.61 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.74 -1.344 . . . . 0.98 109.74 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -69.34 -55.8 9.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.052 -1.263 . . . . 1.41 109.004 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.83 -42.83 65.52 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.976 . . . . 1.2 108.937 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 110' ' ' GLY . 63.8 p -59.98 -40.02 87.69 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.192 -0.942 . . . . 1.7 108.67 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.98 -40.06 91.99 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.33 -0.856 . . . . 1.47 108.697 179.066 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.0 mt -65.23 -42.0 93.84 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.134 -0.979 . . . . 1.56 108.914 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -56.75 -32.88 66.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.731 -1.23 . . . . 2.2 109.414 -179.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -59.19 -22.54 61.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.023 -1.048 . . . . 2.12 108.309 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 123' ' ' LEU . 60.3 mt -62.97 148.05 48.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.342 -0.849 . . . . 2.0 108.861 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -100.21 37.1 1.72 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.242 -0.911 . . . . 3.23 109.955 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 56.8 t0 -125.25 134.64 52.24 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.382 -0.824 . . . . 2.49 110.438 -179.315 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.487 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 12.4 pt-20 -70.44 -30.12 66.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.783 -0.573 . . . . 3.95 110.58 179.529 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.651 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 3.0 t80 -71.87 -40.01 69.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.057 -1.027 . . . . 2.0 110.65 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.496 ' CD2' HH22 ' A' ' 126' ' ' ARG . 60.1 mt -71.77 -31.76 66.96 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.256 -0.902 . . . . 1.86 108.584 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -66.0 -39.97 90.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.605 -0.685 . . . . 2.84 110.018 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.0 -46.34 89.8 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.21 -0.931 . . . . 2.73 110.824 -178.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.768 ' HE ' HE22 ' B' ' 351' ' ' GLN . 21.3 mtm-85 -70.01 -27.1 64.41 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.755 -1.178 . . . . 2.77 108.863 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.91 -26.07 66.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.902 -1.147 . . . . 1.19 107.902 178.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.97 -40.16 75.56 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.481 -0.933 . . . . 1.2 108.481 178.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -62.23 -44.29 96.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.574 -0.704 . . . . 1.55 109.18 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.6 t -61.48 -40.26 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.654 -0.869 . . . . 0.8 108.654 179.28 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -60.49 -37.34 80.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.49 -0.756 . . . . 3.09 109.713 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -60.0 -41.0 91.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.173 -0.954 . . . . 1.46 109.996 -178.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.02 -49.55 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.97 -1.081 . . . . 0.71 109.176 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.21 -42.87 98.83 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.682 -1.367 . . . . 0.57 109.682 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -60.05 -49.96 75.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.147 -1.207 . . . . 2.59 110.27 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.548 HH12 ' CB ' ' A' ' 166' ' ' SER . 98.9 mtt180 -68.88 -27.18 65.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.774 -1.204 . . . . 2.83 109.838 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.95 -43.43 95.0 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.184 -0.947 . . . . 1.25 108.587 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.69 -40.03 93.56 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.397 -0.814 . . . . 0.7 109.083 178.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -63.54 -39.95 95.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.311 -0.868 . . . . 2.57 108.665 179.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -67.13 -39.95 86.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.711 -0.618 . . . . 1.23 111.258 -179.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.97 -43.05 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.438 -1.414 . . . . 0.81 108.061 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.01 -30.07 67.29 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 179.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.01 40.28 9.46 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.832 -1.707 . . . . 0.89 108.832 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 tp -74.68 149.97 39.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.374 -1.074 . . . . 1.14 109.341 -179.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -71.1 147.97 47.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.341 -0.849 . . . . 4.6 109.725 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.4 mt -118.82 129.47 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 122.041 0.924 . . . . 1.24 109.313 179.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 11.1 mt -67.05 -40.07 84.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.807 -0.633 . . . . 1.54 110.506 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 41.6 t0 60.89 105.07 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.669 -0.863 . . . . 1.5 108.669 -178.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 55.2 mt -67.76 -0.12 3.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.305 -0.872 . . . . 0.79 110.128 -178.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.2 m -83.2 -11.8 57.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.92 -1.113 . . . . 1.4 109.511 179.591 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.15 25.57 0.83 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.152 -0.967 . . . . 0.92 111.179 -178.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 40.5 mm -90.97 117.18 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.59 -1.319 . . . . 0.88 108.729 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -99.92 -9.35 22.92 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.258 -0.901 . . . . 2.45 110.481 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -129.18 152.11 49.12 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.296 -0.878 . . . . 1.52 110.057 -179.2 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.52 136.78 57.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.504 -0.748 . . . . 1.58 109.273 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.5 m -151.92 164.8 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.328 -0.858 . . . . 0.69 109.671 179.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.3 mt -92.1 146.52 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 105.954 -1.869 . . . . 0.61 105.954 177.028 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.6 tp -94.23 115.83 28.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.795 -1.191 . . . . 0.87 110.495 -178.149 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.2 t -123.2 129.94 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.512 -0.921 . . . . 0.71 108.512 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.24 162.24 36.15 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.275 -1.009 . . . . 0.81 108.275 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.6 -35.25 72.91 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.214 -1.553 . . . . 0.98 108.048 178.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -170.48 140.91 1.86 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.186 -1.042 . . . . 2.25 108.186 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.7 mt -113.48 134.61 54.58 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.231 -0.918 . . . . 0.78 109.955 -179.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 18.0 p -87.27 147.19 41.74 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.305 -0.872 . . . . 0.98 108.783 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -43.24 -33.07 3.53 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.12 1.88 . . . . 0.81 113.319 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.548 ' CB ' HH12 ' A' ' 136' ' ' ARG . 13.8 m -59.95 -48.55 81.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.808 -1.183 . . . . 0.9 108.928 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.04 -44.92 94.33 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.386 -0.822 . . . . 1.61 109.438 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.448 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 67.9 p -56.72 -18.87 14.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.877 . . . . 0.61 110.537 -178.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.36 -48.76 8.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.949 -1.095 . . . . 0.6 109.378 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -90.82 38.64 0.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.537 -0.912 . . . . 1.4 108.537 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.5 tp -104.85 134.39 48.05 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.92 -0.77 . . . . 0.7 108.92 179.382 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 176' ' ' VAL . 86.3 m-20 -80.86 101.72 9.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 2.35 108.79 179.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 97.2 mt -62.93 -39.96 96.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.269 -0.894 . . . . 1.51 110.337 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -67.02 -24.25 66.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.081 -1.012 . . . . 2.33 110.883 -178.121 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -93.92 -11.46 30.93 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.737 -1.227 . . . . 1.92 109.478 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.463 HG11 ' CE1' ' A' ' 179' ' ' PHE . 72.4 t -101.17 110.14 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.197 -0.94 . . . . 0.67 108.737 179.064 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.16 5.99 31.42 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.204 -0.935 . . . . 1.53 110.57 -178.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.18 170.41 37.44 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.991 -1.644 . . . . 0.48 108.991 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.463 ' CE1' HG11 ' A' ' 176' ' ' VAL . 22.3 m-85 -130.86 128.93 41.61 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.334 -1.097 . . . . 0.55 109.288 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 90.0 mt -132.55 125.38 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.484 -0.932 . . . . 0.65 108.484 178.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.3 p -145.94 160.04 42.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.062 -1.023 . . . . 0.82 110.84 -179.236 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 59.6 t0 -101.82 23.13 11.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.599 -0.688 . . . . 2.46 109.885 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.41 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -58.19 -161.17 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.287 -1.508 . . . . 1.28 110.792 -178.498 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -83.75 -44.34 6.86 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.607 -0.997 . . . . 2.19 110.607 -179.181 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 147.57 -115.25 0.75 Allowed Glycine 0 N--CA 1.497 2.724 0 O-C-N 120.83 -1.394 . . . . 2.13 110.32 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.422 ' HG2' HH22 ' A' ' 195' ' ' ARG . 46.4 mtt-85 -59.92 -38.06 81.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.49 -1.006 . . . . 5.86 110.927 -179.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 73.4 p -70.25 0.09 7.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.914 -1.116 . . . . 3.72 110.432 -178.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 39.8 t -92.32 117.27 29.73 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.972 -1.08 . . . . 1.74 110.712 -179.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -47.71 -42.3 24.74 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.197 -0.939 . . . . 0.95 108.541 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.432 ' H ' HG23 ' A' ' 190' ' ' THR . 23.4 p -52.18 -34.66 46.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.801 -0.562 . . . . 1.55 109.96 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 74.9 m -60.01 -40.06 87.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.011 -1.056 . . . . 1.51 110.472 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.2 mm -63.98 -40.35 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.17 -0.956 . . . . 1.67 110.112 -178.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 82.9 mtp -59.99 -49.04 79.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.956 -1.09 . . . . 1.02 110.969 -178.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.52 -44.17 89.43 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.705 -1.247 . . . . 0.68 109.968 -178.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.422 HH22 ' HG2' ' A' ' 186' ' ' ARG . 98.2 mtt180 -61.75 -54.93 35.81 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.29 -0.964 . . . . 2.93 110.503 -179.183 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.3 m -70.0 -35.89 74.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.027 -1.046 . . . . 0.86 112.148 -178.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.55 -12.35 60.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.604 -1.31 . . . . 0.67 110.585 -178.114 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 62.14 49.56 4.39 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.495 -0.753 . . . . 1.5 111.055 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 96.4 mt -130.62 150.03 75.22 Favored Pre-proline 0 N--CA 1.499 2.002 0 N-CA-C 107.641 -1.244 . . . . 0.72 107.641 178.004 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.11 143.85 73.26 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.035 1.823 . . . . 0.61 111.418 179.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.91 151.74 4.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.746 -1.221 . . . . 0.66 111.889 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.6 mt -125.81 139.67 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.025 -1.102 . . . . 0.79 108.025 178.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.1 m -122.77 -12.67 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 120.985 -1.072 . . . . 0.91 110.968 -178.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.98 26.56 13.63 Favored Glycine 0 N--CA 1.501 2.978 0 N-CA-C 110.897 -0.881 . . . . 1.01 110.897 -178.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.7 p -43.2 -44.82 5.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.066 -1.255 . . . . 0.99 110.096 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.447 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 93.01 -52.12 2.54 Favored Glycine 0 N--CA 1.498 2.795 0 C-N-CA 120.224 -0.988 . . . . 1.12 110.741 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.2 t -158.91 33.64 0.21 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.617 -1.519 . . . . 1.72 111.186 -179.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.6 -40.05 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.985 -1.072 . . . . 0.89 109.082 178.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.452 ' H ' HG23 ' A' ' 209' ' ' THR . 7.0 p -54.54 -30.0 52.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.431 -0.793 . . . . 1.03 110.108 -179.08 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.5 t -80.89 -21.1 40.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.061 -1.024 . . . . 1.83 110.161 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -96.96 -13.41 22.39 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.128 -0.982 . . . . 2.27 110.125 -179.416 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.8 t -102.05 136.62 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.361 -0.837 . . . . 0.92 110.216 -178.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -112.23 154.54 25.43 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.04 -1.467 . . . . 2.2 107.04 178.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.497 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 15.5 t-20 -60.04 139.02 57.73 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.839 -1.163 . . . . 2.36 110.169 -179.145 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 9.6 t0 84.91 7.24 0.48 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.16 0.505 . . . . 2.38 110.019 179.49 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 55.3 t0 -76.87 142.07 40.35 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.204 -0.935 . . . . 2.09 109.096 179.232 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.493 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 49.3 t80 -92.81 117.98 30.61 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.977 -1.12 . . . . 1.27 107.977 178.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.545 HD12 ' HB2' ' A' ' 16' ' ' ALA . 69.9 mt -127.16 147.47 50.19 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.503 -0.748 . . . . 0.75 110.55 -178.554 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.403 HD12 ' HG3' ' A' ' 231' ' ' PRO . 80.5 mt -118.39 129.59 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 107.469 -1.308 . . . . 0.63 107.469 177.461 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 34.3 tp -104.22 123.65 47.71 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.668 -0.864 . . . . 0.7 108.668 -179.193 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 10' ' ' GLY . 29.1 t0 -85.75 -35.76 20.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.107 -0.995 . . . . 2.31 108.38 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 45.71 21.41 0.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.742 0.782 . . . . 0.78 108.919 -179.319 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 221' ' ' ASP . 42.1 t -133.41 -44.07 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.121 -1.437 . . . . 1.04 107.121 178.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.465 ' ND2' ' OD2' ' A' ' 221' ' ' ASP . 84.3 m-20 -102.25 2.1 36.66 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.057 -1.09 . . . . 2.44 108.057 178.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.441 HD21 ' H ' ' A' ' 4' ' ' GLY . 10.1 t-20 59.98 43.91 14.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.805 -0.559 . . . . 1.55 110.307 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -136.41 149.37 48.25 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.216 -0.928 . . . . 1.99 110.112 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.6 129.96 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.454 -0.943 . . . . 0.77 108.454 178.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -100.87 123.03 44.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.423 -0.798 . . . . 0.98 109.303 179.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 19.4 t -100.03 110.52 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.373 -0.83 . . . . 0.85 109.98 -179.312 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 230' ' ' ASN . 3.9 t30 56.61 67.43 2.69 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.325 -0.859 . . . . 1.66 111.368 179.221 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.403 ' HG3' HD12 ' A' ' 219' ' ' ILE . 81.6 Cg_endo -91.05 150.02 3.82 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.266 2.644 . . . . 0.95 112.568 178.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.0 m -70.07 160.03 32.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.345 -0.847 . . . . 1.84 110.29 -179.23 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -59.99 -36.84 78.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.392 -0.817 . . . . 2.74 109.608 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -60.03 -38.43 82.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 2.89 109.221 -179.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.36 -40.05 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.096 -1.003 . . . . 1.3 109.405 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.496 1.859 0 O-C-N 121.164 -0.96 . . . . 1.09 110.104 -179.856 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 50.5 ttp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.573 0.701 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 36.2 t80 -154.92 152.83 30.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . 0.463 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 13.8 pt20 -149.78 159.99 43.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.937 -1.102 . . . . 0.0 110.474 -179.436 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -153.94 150.44 28.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -112.49 134.08 54.21 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.225 -0.922 . . . . 0.0 110.583 -179.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -129.71 121.52 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-O 122.251 1.024 . . . . 0.0 112.546 -177.485 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . 0.462 ' O ' HG23 ' B' ' 309' ' ' THR . 25.4 m -76.45 105.1 7.31 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.79 0.805 . . . . 0.0 110.42 -178.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 98.9 mt -53.26 121.62 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 122.318 1.056 . . . . 0.0 110.375 -178.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . 0.462 HG23 ' O ' ' B' ' 307' ' ' THR . 78.1 p -110.11 19.95 18.42 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.36 -178.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.14 126.14 91.97 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.901 -1.124 . . . . 0.0 109.168 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.65 -18.72 27.38 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 CA-C-N 120.404 1.18 . . . . 0.0 112.327 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -120.45 10.16 11.1 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 75.33 -176.98 49.47 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.098 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.515 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -83.45 87.54 6.99 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.088 -1.242 . . . . 0.0 108.988 -178.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.419 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 3.9 p80 -90.29 -162.92 0.94 Allowed 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.825 -1.172 . . . . 0.0 110.123 179.09 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 9.6 m -57.09 -41.78 79.49 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.852 -1.155 . . . . 0.0 112.486 -175.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.493 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 0.7 OUTLIER -60.02 -60.88 9.17 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 120.62 -1.3 . . . . 0.0 111.855 -178.835 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.419 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 13.1 Cg_endo -59.38 -34.33 97.56 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 CA-C-N 120.139 1.085 . . . . 0.0 111.801 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.52 73.42 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.74 -41.96 67.66 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.02 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . 0.582 ' HA ' ' HZ2' ' B' ' 324' ' ' LYS . 27.3 mm100 -70.0 -41.4 74.42 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 108.692 178.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . 0.486 ' CE1' ' SD ' ' B' ' 381' ' ' MET . 55.1 t80 -61.93 -52.23 64.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.583 -0.698 . . . . 0.0 110.813 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.51 -29.23 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.596 -1.315 . . . . 0.0 109.299 -179.288 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . 0.582 ' HZ2' ' HA ' ' B' ' 321' ' ' GLN . 0.2 OUTLIER -60.13 -46.25 90.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.406 -0.809 . . . . 0.0 109.636 179.495 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -67.19 -45.62 76.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.346 -0.846 . . . . 0.0 110.893 -178.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.0 -53.0 62.97 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.706 -1.246 . . . . 0.0 110.833 -178.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . 0.438 ' HZ2' ' HG3' ' B' ' 345' ' ' LYS . 28.5 mttp -54.12 -12.64 0.65 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.067 -1.021 . . . . 0.0 109.452 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.1 -20.14 73.42 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -106.03 146.66 29.82 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.387 -1.066 . . . . 0.0 108.599 179.531 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 70.0 p -91.51 -14.29 30.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.86 -1.15 . . . . 0.0 109.435 179.586 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.419 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 77.9 p -64.52 149.18 49.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.665 -179.535 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -69.85 138.25 52.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.129 -0.982 . . . . 0.0 108.795 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.6 mt -134.14 134.6 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.603 -0.686 . . . . 0.0 109.56 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 48.4 m -128.62 149.82 50.49 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.451 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 76.5 t -121.99 113.15 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.35 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 44.3 m -105.29 133.16 50.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.951 . . . . 0.0 109.28 -178.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 34.1 p -137.83 110.67 7.66 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.758 0.789 . . . . 0.0 110.248 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 22.4 m120 45.97 53.48 9.02 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 177.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.96 -15.45 59.35 Favored Glycine 0 N--CA 1.504 3.169 0 O-C-N 120.246 -1.534 . . . . 0.0 113.207 176.413 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . 0.528 ' NZ ' ' O ' ' B' ' 352' ' ' THR . 9.7 mtpm? -116.06 127.92 55.27 Favored 'General case' 0 N--CA 1.507 2.423 0 CA-C-N 119.338 1.569 . . . . 0.0 109.614 -179.517 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 67.2 m -127.2 148.58 50.19 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.968 0.889 . . . . 0.0 111.15 -178.395 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.94 164.69 29.49 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.348 0.594 . . . . 0.0 109.712 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 47.4 t -88.58 132.41 34.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.474 -0.766 . . . . 0.0 110.922 -178.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.443 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -69.86 -21.63 63.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.888 . . . . 0.0 108.871 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' B' ' 345' ' ' LYS . 24.0 ttpp -83.12 18.0 1.82 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . 0.443 ' H ' ' C ' ' B' ' 344' ' ' ALA . 11.2 t -147.12 95.33 2.54 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.14 -179.489 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.804 HD23 HD22 ' A' ' 79' ' ' LEU . 60.8 tp -59.91 -39.7 86.28 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.542 -0.724 . . . . 0.0 109.132 179.02 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.884 ' CE2' HD11 ' A' ' 79' ' ' LEU . 60.9 m-85 -54.02 -52.49 60.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.104 -0.998 . . . . 0.0 110.771 -179.404 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -65.89 -39.99 91.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.152 -0.968 . . . . 0.0 109.704 -178.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' B' ' 352' ' ' THR . 17.6 mt -49.71 -58.35 5.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.193 -0.942 . . . . 0.0 109.915 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.768 HE22 ' HE ' ' A' ' 126' ' ' ARG . 8.2 mm100 -42.58 -13.19 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.239 -0.913 . . . . 0.0 111.869 -177.077 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.569 ' N ' ' O ' ' B' ' 350' ' ' LEU . 81.6 p -85.02 -15.01 45.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 119.95 -1.719 . . . . 0.0 110.275 -179.152 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.442 HD23 ' HZ3' ' B' ' 340' ' ' LYS . 43.3 mt -91.32 119.96 31.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.999 -1.063 . . . . 0.0 109.431 179.335 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.26 93.91 0.7 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.175 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . 0.417 HD22 HG11 ' B' ' 361' ' ' VAL . 52.0 mt -100.59 88.01 3.51 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.245 -1.15 . . . . 0.0 109.187 179.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 60.0 p -91.53 166.12 13.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.958 -1.089 . . . . 0.0 110.744 -178.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -59.41 116.64 4.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.774 -0.579 . . . . 0.0 111.077 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 101.02 7.11 50.91 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 47.7 m -86.74 110.89 20.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -1.136 . . . . 0.0 110.795 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 46.7 t -77.78 117.52 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 122.169 0.985 . . . . 0.0 109.48 -177.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . 0.417 HG11 HD22 ' B' ' 355' ' ' LEU . 25.4 m -110.22 177.67 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 91.1 m -131.35 128.74 40.29 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.174 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 69.6 mt -103.0 116.33 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 67.2 m -116.06 129.99 56.6 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.88 151.8 39.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.353 -0.842 . . . . 0.0 109.724 -178.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -145.01 121.5 11.03 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.475 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.81 -155.38 26.54 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 118.765 -1.683 . . . . 0.0 111.844 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -59.94 -50.9 71.93 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.173 -0.514 . . . . 0.0 112.224 -177.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.419 ' H ' ' HB3' ' B' ' 331' ' ' SER . 97.0 m-20 -110.27 13.47 22.99 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.777 -1.202 . . . . 0.0 111.137 -177.584 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.7 pt-20 -42.23 -36.42 1.21 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.206 -0.934 . . . . 0.0 110.655 -179.246 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . 0.407 ' HG2' ' H ' ' B' ' 371' ' ' GLN . 2.3 pt20 -69.26 -47.06 65.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.043 -1.036 . . . . 0.0 110.162 -179.148 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -69.98 -54.44 13.25 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.003 -1.06 . . . . 0.0 109.51 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . 0.427 ' O ' HD12 ' B' ' 377' ' ' LEU . . . -43.46 -34.18 1.26 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.365 -0.834 . . . . 0.0 111.179 -179.022 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.525 ' O ' HG23 ' B' ' 378' ' ' VAL . 73.4 t -76.09 -35.66 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.603 -1.311 . . . . 0.0 109.399 179.327 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -65.41 -59.4 4.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 111.853 -178.15 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -69.77 -39.99 76.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.384 -1.448 . . . . 0.0 111.707 -178.269 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . 0.427 HD12 ' O ' ' B' ' 373' ' ' ALA . 88.0 mt -58.46 -39.99 81.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.526 -1.359 . . . . 0.0 108.696 -178.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.525 HG23 ' O ' ' B' ' 374' ' ' VAL . 55.3 t -62.38 -42.72 96.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.103 -0.998 . . . . 0.0 109.596 179.401 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.6 mttt -71.25 -57.54 4.39 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.794 -1.191 . . . . 0.0 108.209 178.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 53.9 tp -53.32 -35.99 60.77 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.173 -0.954 . . . . 0.0 109.015 -178.346 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . 0.486 ' SD ' ' CE1' ' B' ' 322' ' ' PHE . 0.9 OUTLIER -72.14 -40.0 68.38 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.621 -1.299 . . . . 0.0 108.437 177.648 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.62 -4.87 58.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.595 -0.691 . . . . 0.0 110.601 179.374 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' B' ' 379' ' ' LYS . 94.6 mt-10 -111.43 -3.11 15.34 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.125 -0.985 . . . . 0.0 110.807 -179.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.6 mt -82.98 131.14 35.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.637 -1.289 . . . . 0.0 109.099 179.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.091 179.615 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.358 -0.608 . . . . 2.91 109.358 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.505 HD11 HE22 ' A' ' 211' ' ' GLN . 97.4 mt -108.37 123.71 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.438 -0.788 . . . . 1.2 109.602 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.8 m -135.98 141.14 44.39 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.72 -0.844 . . . . 1.4 108.72 179.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.824 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -109.0 -160.13 19.45 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.113 -1.595 . . . . 1.05 109.113 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.1 mt -95.23 -15.01 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.118 -1.225 . . . . 1.15 109.589 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.4 tp 51.99 104.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.798 . . . . 0.98 109.666 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.82 -23.57 17.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.079 -1.013 . . . . 0.88 109.302 179.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.459 ' OG ' ' N ' ' A' ' 201' ' ' ALA . 12.5 p -137.42 119.24 11.01 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.405 -0.81 . . . . 1.69 109.06 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.99 150.13 20.51 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.904 1.736 . . . . 0.85 112.375 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.784 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.35 -155.09 25.96 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.08 -1.608 . . . . 0.92 109.08 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.7 mt -149.08 150.59 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.016 -1.285 . . . . 0.81 109.112 179.045 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.12 146.12 22.59 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.022 -1.049 . . . . 0.51 110.315 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -127.62 127.92 44.64 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.161 -1.051 . . . . 0.62 108.161 178.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.1 176.08 46.6 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.734 -1.698 . . . . 0.55 110.588 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -77.76 156.31 30.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.699 -0.883 . . . . 2.1 109.022 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -102.59 128.33 49.29 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.416 -0.802 . . . . 0.77 111.025 -178.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.8 tp -100.13 135.33 41.73 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.069 -1.456 . . . . 0.91 107.069 178.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.0 tp -115.3 121.6 43.37 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.3 -0.875 . . . . 0.93 110.099 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.1 mt -86.69 103.01 14.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.526 -0.734 . . . . 0.93 109.73 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -90.96 142.31 27.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.395 -0.815 . . . . 2.75 109.244 179.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -130.1 133.34 46.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.426 -0.953 . . . . 3.0 108.426 179.222 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -84.07 150.69 25.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.044 -1.035 . . . . 2.77 109.429 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -66.66 147.89 52.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.932 . . . . 2.94 109.301 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 86.5 mt -96.44 126.68 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.187 -0.946 . . . . 0.95 109.05 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.1 t -94.73 126.12 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.133 -0.979 . . . . 1.28 109.997 -179.298 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.5 mt -112.37 131.93 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 109.016 -0.735 . . . . 1.21 109.016 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.01 118.35 28.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.873 -1.142 . . . . 1.81 110.335 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -85.08 -1.06 56.42 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.715 -0.846 . . . . 2.8 108.715 179.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -69.9 140.37 53.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.469 -0.769 . . . . 2.87 110.024 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -80.03 153.3 28.91 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.194 -0.941 . . . . 2.35 109.409 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.0 pt -94.6 167.48 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.179 -0.95 . . . . 0.97 109.711 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.4 p -96.28 173.04 7.59 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.147 -1.057 . . . . 1.17 108.147 178.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.99 75.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.913 -1.117 . . . . 1.18 110.501 -179.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -57.3 -26.45 60.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.703 -1.248 . . . . 2.56 109.513 -179.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -82.26 -9.83 59.34 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.302 -0.874 . . . . 1.79 109.762 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.3 t -66.49 -54.59 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.925 -1.11 . . . . 1.0 109.641 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.04 -40.08 88.14 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.269 -0.895 . . . . 1.77 109.102 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.432 HE21 HH21 ' A' ' 42' ' ' ARG . 28.2 mt-30 -62.87 -42.19 99.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.419 -0.801 . . . . 2.7 110.707 -179.295 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -62.62 -42.55 99.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.615 -1.303 . . . . 1.51 110.221 -179.498 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.98 -47.39 91.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 120.594 -1.316 . . . . 0.93 108.64 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -59.94 -45.15 93.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -0.942 . . . . 1.81 109.318 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.501 HH11 ' HG2' ' A' ' 42' ' ' ARG . 22.2 mtt-85 -60.08 -43.56 95.39 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.069 -1.086 . . . . 2.78 108.069 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -62.0 -47.2 85.85 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.737 -0.838 . . . . 0.78 108.737 178.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.2 tp -59.94 -48.92 79.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 1.07 108.837 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.442 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 29.4 t -63.04 -43.73 97.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.975 -1.078 . . . . 1.12 108.963 178.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.06 -47.51 90.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.57 -1.812 . . . . 0.84 108.57 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -61.56 -36.18 79.9 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.006 -1.109 . . . . 3.09 108.006 178.599 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -55.32 -40.01 70.64 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.317 -0.623 . . . . 0.88 109.317 -179.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ALA . 26.4 ttpp -66.34 -73.73 0.13 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.652 -1.24 . . . . 2.59 107.652 179.153 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.09 -36.34 0.2 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.46 -0.775 . . . . 0.7 111.346 -178.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 t -57.41 -55.94 28.34 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.508 -1.37 . . . . 1.4 108.612 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.08 -40.0 86.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.253 -0.904 . . . . 0.67 111.074 -179.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -67.96 -40.24 83.23 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.841 -1.162 . . . . 1.66 110.322 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.2 mt -62.03 -39.97 94.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.009 -1.057 . . . . 1.58 108.72 179.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -61.21 -38.49 86.79 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.426 -0.796 . . . . 1.35 109.713 179.26 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -64.27 -43.69 94.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.194 -0.941 . . . . 0.77 110.268 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.657 ' CD1' HH22 ' A' ' 136' ' ' ARG . 85.7 mt -63.04 -38.1 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.63 108.969 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -56.15 -50.59 70.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 1.14 109.896 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -59.94 -36.44 77.08 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.43 -0.794 . . . . 0.79 110.367 -177.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -63.79 -39.48 94.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.963 -1.086 . . . . 1.53 109.211 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.68 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.54 -45.48 75.54 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.564 -0.71 . . . . 0.57 110.033 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.14 -51.16 60.07 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 110.268 -1.133 . . . . 0.75 110.268 -179.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -69.96 -41.88 73.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.037 -1.272 . . . . 1.59 110.309 -179.446 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.3 m -69.92 -60.4 2.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.912 . . . . 0.73 112.2 -177.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -95.49 -50.77 4.84 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.964 -1.085 . . . . 0.75 111.093 -178.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.42 -163.7 26.75 Favored Glycine 0 N--CA 1.499 2.837 0 O-C-N 120.747 -1.221 . . . . 1.22 110.726 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -70.0 -23.24 63.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.751 -0.852 . . . . 5.81 110.364 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.425 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 52.7 tp10 -60.13 -37.76 81.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 3.37 110.272 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -97.4 -19.02 18.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.293 -0.88 . . . . 1.77 110.388 -178.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -70.09 -40.12 75.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.855 -1.153 . . . . 1.65 110.496 -179.712 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.601 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.82 -29.9 69.17 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.399 -0.813 . . . . 0.77 109.585 -178.761 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.02 -42.57 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.248 -0.981 . . . . 0.8 109.112 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.451 ' CZ ' HG22 ' A' ' 57' ' ' ILE . 39.5 m-85 -64.5 -40.08 94.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.112 -0.993 . . . . 0.88 110.742 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -59.98 -40.02 87.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.831 -1.168 . . . . 1.37 108.833 -179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.01 -43.53 98.73 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 107.98 -2.048 . . . . 0.62 107.98 178.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -65.21 -48.43 73.41 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.459 -1.024 . . . . 1.5 108.608 179.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.9 mt -64.36 -49.39 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.397 -0.815 . . . . 0.63 109.18 179.432 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.2 ttp -60.41 -42.73 96.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.167 -0.958 . . . . 1.51 110.37 -179.075 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.833 HD11 ' CE2' ' B' ' 348' ' ' PHE . 42.0 tp -66.04 -41.57 90.7 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.335 -0.853 . . . . 0.77 109.983 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.4 tp -63.31 -40.11 96.44 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.292 -0.88 . . . . 0.62 110.168 -179.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -82.57 8.03 12.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.188 -0.945 . . . . 1.47 110.08 -179.355 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -50.78 131.91 26.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 1.47 109.352 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.44 -20.66 60.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.701 -0.624 . . . . 1.78 111.027 -178.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.71 -34.32 67.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.901 -1.125 . . . . 2.53 109.552 179.54 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.6 mt -70.08 -40.1 75.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.538 -0.726 . . . . 0.8 109.321 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -60.08 -46.04 90.91 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.389 -0.82 . . . . 1.42 109.613 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -69.99 -40.48 75.29 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.406 -0.809 . . . . 1.71 110.244 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.02 -40.02 75.46 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.051 -1.03 . . . . 1.57 111.14 -179.417 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.0 mt -67.95 -48.88 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.919 -1.113 . . . . 0.65 109.461 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.97 -39.7 84.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.506 -0.746 . . . . 0.82 109.51 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.96 -48.89 79.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 0.79 110.532 -179.246 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 96' ' ' LYS . 84.3 mt -60.22 -47.73 84.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.928 -1.108 . . . . 0.95 109.878 -179.638 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.81 -50.05 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.89 . . . . 0.66 109.198 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -70.0 -40.49 75.25 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.857 -0.737 . . . . 2.2 110.814 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 91' ' ' ALA . 10.2 t70 -84.17 -50.9 7.49 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.041 -1.037 . . . . 1.65 112.058 -178.147 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 92' ' ' LEU . 67.2 mmtt -90.19 -2.6 58.07 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.885 -1.135 . . . . 2.03 111.606 -177.491 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.7 m80 57.6 36.71 27.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.075 -1.016 . . . . 1.42 109.478 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 79.6 mtp -93.56 164.14 13.29 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.651 -0.655 . . . . 1.18 110.343 -179.361 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.6 p -77.9 161.82 27.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.608 -0.683 . . . . 0.98 109.177 179.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.89 81.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.102 -0.999 . . . . 0.64 109.783 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.489 ' OD2' HD21 ' A' ' 142' ' ' LEU . 96.9 m-20 -64.29 -39.97 95.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.144 -0.972 . . . . 2.07 109.399 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.29 -46.76 19.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.836 . . . . 0.73 109.756 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.55 -50.01 75.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.308 -0.87 . . . . 0.54 109.838 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.57 -37.45 81.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 0.56 109.417 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -60.05 -46.91 87.97 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.514 -0.741 . . . . 1.54 110.109 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -62.65 -40.08 95.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -0.879 . . . . 1.33 110.946 -179.041 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.4 -56.29 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.005 -1.059 . . . . 0.72 111.039 -178.055 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.5 mm -68.78 -39.97 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.918 -1.114 . . . . 0.85 108.967 -179.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -63.63 -40.04 95.89 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.245 -1.02 . . . . 2.44 108.245 178.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.77 -50.43 67.67 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.057 -1.217 . . . . 0.98 110.057 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.437 HE21 ' HB3' ' B' ' 348' ' ' PHE . 26.0 mm100 -65.24 -49.49 69.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.956 -1.32 . . . . 1.41 109.262 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.56 -42.67 92.93 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.094 -1.004 . . . . 1.2 108.731 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 88.6 p -60.11 -39.86 87.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.243 -0.91 . . . . 1.7 109.023 179.175 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.3 -39.92 80.62 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.056 -1.028 . . . . 1.47 108.629 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.9 mt -62.17 -39.97 94.43 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.138 -0.976 . . . . 1.56 109.047 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -53.85 -24.37 15.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.081 -1.012 . . . . 2.2 109.514 -179.124 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -59.91 -27.83 67.07 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.534 -1.284 . . . . 2.12 107.534 179.146 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.429 HD11 ' HA ' ' B' ' 352' ' ' THR . 57.6 mt -62.99 140.38 58.86 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.712 -0.618 . . . . 2.0 109.511 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -100.12 48.92 0.92 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.232 -0.917 . . . . 3.23 109.538 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 51.1 t0 -136.34 148.53 47.94 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.311 -0.868 . . . . 2.49 109.424 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 71.4 mm-40 -73.28 -65.02 0.86 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.247 -0.908 . . . . 3.95 108.597 178.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -40.7 -39.85 1.17 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.83 -0.544 . . . . 2.0 110.948 -179.154 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.6 mt -76.33 -40.27 51.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.619 -1.301 . . . . 1.86 110.0 -179.455 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -68.64 -39.98 80.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.047 -1.033 . . . . 2.84 109.463 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.604 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 47.8 mt-10 -59.9 -43.57 94.74 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.135 -0.978 . . . . 2.73 108.527 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.705 ' NE ' HE21 ' B' ' 351' ' ' GLN . 1.6 ttp180 -60.73 -40.02 90.81 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.364 -0.976 . . . . 2.77 108.364 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.04 -19.91 48.25 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.904 -1.147 . . . . 1.19 107.904 178.555 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -69.72 -40.04 76.5 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.585 -1.265 . . . . 1.2 107.585 178.502 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -65.02 -40.05 94.3 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.501 -0.749 . . . . 1.55 109.102 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.48 -40.09 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.306 -0.998 . . . . 0.8 108.306 178.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -62.33 -37.81 87.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.542 -0.723 . . . . 3.09 109.294 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -59.98 -40.56 89.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.374 -0.829 . . . . 1.46 110.034 -178.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.01 -47.81 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.129 -0.982 . . . . 0.71 109.45 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.16 -40.24 98.91 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.09 -1.204 . . . . 0.57 110.09 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -59.96 -48.0 83.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.378 -1.071 . . . . 2.59 109.774 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.657 HH22 ' CD1' ' A' ' 57' ' ' ILE . 57.4 mtp180 -65.77 -33.5 76.0 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.038 -1.039 . . . . 2.83 109.729 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.84 -43.15 94.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.41 -0.806 . . . . 1.25 109.374 -179.234 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.05 -40.06 88.12 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.19 -0.943 . . . . 0.7 109.238 179.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.401 HH11 ' HG2' ' A' ' 139' ' ' ARG . 55.2 mtt-85 -69.94 -39.9 75.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 2.57 109.477 179.554 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -67.62 -34.66 77.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.478 -0.763 . . . . 1.23 112.096 -178.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.06 -41.46 79.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.256 -1.527 . . . . 0.81 108.784 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.489 HD21 ' OD2' ' A' ' 101' ' ' ASP . 92.1 mt -73.45 -26.19 60.82 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.32 43.41 8.02 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.374 -1.89 . . . . 0.89 108.374 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 tp -74.35 150.03 40.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.532 -0.981 . . . . 1.14 109.029 -179.129 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -64.58 142.51 58.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.29 -0.881 . . . . 4.6 110.396 -178.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.7 mt -116.86 127.6 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-O 121.89 0.852 . . . . 1.24 108.771 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.8 mt -65.43 -43.87 94.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.918 -0.489 . . . . 1.54 111.468 -177.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.0 t0 64.53 112.78 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.222 -0.924 . . . . 1.5 109.031 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 86.6 mt -79.05 -3.28 44.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.319 -0.863 . . . . 0.79 110.029 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.9 m -87.3 -15.3 38.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.275 -0.89 . . . . 1.4 109.808 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.31 14.47 2.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.281 -0.887 . . . . 0.92 111.334 -178.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.645 HD12 ' N ' ' A' ' 152' ' ' ILE . 1.5 mp -90.23 117.92 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.549 -1.344 . . . . 0.88 108.764 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -101.65 -11.87 18.85 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.303 -0.873 . . . . 2.45 110.196 -179.433 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -112.24 146.66 37.77 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.55 -0.719 . . . . 1.52 110.168 -179.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.06 132.2 47.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.484 -0.76 . . . . 1.58 109.435 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.9 m -152.81 165.05 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.457 -0.777 . . . . 0.69 109.369 179.334 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.4 mt -92.43 147.95 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 105.383 -2.081 . . . . 0.61 105.383 176.485 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -98.52 117.49 33.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.833 -1.167 . . . . 0.87 110.581 -177.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.2 t -121.61 129.43 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.662 -0.866 . . . . 0.71 108.662 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.91 164.77 33.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.104 -0.997 . . . . 0.81 108.928 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.457 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.12 -36.85 77.95 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.069 -1.644 . . . . 0.98 108.381 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 162' ' ' ASP . 33.9 p-10 -170.7 150.47 3.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.195 -0.941 . . . . 2.25 109.563 179.647 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.7 mt -118.91 136.38 54.09 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.561 -0.712 . . . . 0.78 109.629 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 22.9 p -92.94 148.37 35.71 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.262 -0.899 . . . . 0.98 109.146 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -39.97 -36.6 1.42 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.044 1.829 . . . . 0.81 112.599 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.7 m -60.0 -40.07 87.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 0.9 109.156 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.01 -43.09 88.68 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.286 -0.884 . . . . 1.61 109.635 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 22.8 p -55.8 -28.78 57.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.149 -0.969 . . . . 0.61 110.308 -178.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.68 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -74.56 -53.34 9.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.11 -0.994 . . . . 0.6 109.678 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -85.36 38.34 0.73 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.091 -1.077 . . . . 1.4 108.091 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.4 tp -100.87 129.1 46.69 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.788 -0.819 . . . . 0.7 108.788 179.26 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.727 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 0.1 OUTLIER -85.62 101.46 12.73 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.908 -1.145 . . . . 2.35 107.908 179.106 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 70.0 mt -64.67 -43.18 94.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.563 -0.71 . . . . 1.51 111.613 -178.043 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -71.23 -21.65 62.1 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.73 -1.231 . . . . 2.33 111.874 -177.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -93.22 -11.31 32.95 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.583 -1.323 . . . . 1.92 108.849 -179.35 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 178' ' ' GLY . 67.9 t -110.02 120.06 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.647 -0.871 . . . . 0.67 108.647 179.231 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.9 mt -89.01 6.35 40.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.266 -0.896 . . . . 1.53 110.98 -177.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.528 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.58 172.92 37.39 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.378 -1.391 . . . . 0.48 109.808 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -134.15 129.17 35.48 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.271 -1.135 . . . . 0.55 109.079 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.21 127.05 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.322 -0.861 . . . . 0.65 109.158 179.13 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . 0.429 ' C ' ' HG1' ' A' ' 205' ' ' THR . 25.6 p -148.79 159.84 43.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.849 -1.157 . . . . 0.82 110.771 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 37.2 p-10 -104.07 27.06 8.02 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.595 -0.691 . . . . 2.46 109.333 179.49 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -56.03 -162.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.975 -1.078 . . . . 1.28 111.318 -178.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.2 -59.17 5.14 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.958 -0.857 . . . . 2.19 110.958 -178.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -178.64 -150.66 8.94 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 118.862 -1.637 . . . . 2.13 111.085 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -69.92 -20.62 63.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.604 -0.939 . . . . 5.86 110.54 -178.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 21.4 p -68.85 4.17 1.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.04 -1.038 . . . . 3.72 109.992 -179.136 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.7 p -88.48 142.51 27.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.151 -0.968 . . . . 1.74 110.638 -179.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -49.99 -47.1 53.08 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.549 -0.719 . . . . 0.95 109.782 -179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.4 m -56.32 -39.99 73.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.498 -0.751 . . . . 1.55 110.313 -178.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.4 t -60.8 -39.96 90.88 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.034 -1.041 . . . . 1.51 111.051 -179.631 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.02 -41.12 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.018 -1.051 . . . . 1.67 110.095 -178.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.0 mtp -65.16 -41.7 94.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.032 -1.043 . . . . 1.02 111.233 -179.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.6 92.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.108 -1.62 . . . . 0.68 110.188 -179.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.02 -49.3 78.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 2.93 110.586 -178.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.4 m -72.45 -33.73 67.25 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.237 -0.914 . . . . 0.86 111.817 -178.554 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.1 mt -84.08 -8.1 59.2 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.697 -1.252 . . . . 0.67 111.118 -178.211 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 59.2 49.22 9.41 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.271 -0.893 . . . . 1.5 110.841 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 80.6 mt -121.5 122.73 27.87 Favored Pre-proline 0 N--CA 1.501 2.099 0 N-CA-C 108.588 -0.893 . . . . 0.72 108.588 178.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.17 131.4 8.76 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.8 1.667 . . . . 0.61 112.004 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.459 ' N ' ' OG ' ' A' ' 8' ' ' SER . . . -167.89 146.95 4.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.738 -1.226 . . . . 0.66 111.501 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 90.0 mt -125.47 140.79 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 107.745 -1.205 . . . . 0.79 107.745 178.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.63 -8.85 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.031 -1.043 . . . . 0.91 110.99 -178.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.41 22.0 29.68 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.219 -1.152 . . . . 1.01 110.219 -179.596 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.429 ' HG1' ' C ' ' A' ' 181' ' ' THR . 6.3 p -45.74 -42.59 12.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.031 -1.276 . . . . 0.99 109.848 -179.248 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.56 -51.09 3.29 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 120.111 -1.042 . . . . 1.12 111.303 178.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.6 t -161.1 37.8 0.15 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.71 -1.465 . . . . 1.72 110.984 -179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.88 -39.95 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.124 -0.985 . . . . 0.89 108.473 177.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.436 HG23 ' H ' ' A' ' 209' ' ' THR . 2.9 p -54.18 -29.99 47.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.529 -0.732 . . . . 1.03 110.775 -179.237 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 52.3 m -80.06 -12.64 59.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.002 -1.061 . . . . 1.83 109.643 -179.293 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.505 HE22 HD11 ' A' ' 2' ' ' ILE . 94.8 mt-30 -104.99 -12.2 16.29 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.485 -0.76 . . . . 2.27 109.773 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 71.5 t -104.64 137.7 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.333 -0.855 . . . . 0.92 110.602 -178.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.45 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -113.16 153.25 28.58 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.564 -1.272 . . . . 2.2 107.564 179.01 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.705 ' N ' HD22 ' A' ' 214' ' ' ASN . 0.0 OUTLIER -59.49 136.49 57.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.073 -1.017 . . . . 2.36 110.744 -178.623 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 10.4 t0 84.49 5.89 0.6 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.99 -0.444 . . . . 2.38 110.715 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.45 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 92.1 m-20 -75.13 145.44 42.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.79 -1.194 . . . . 2.09 109.065 178.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -92.37 117.92 30.4 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.928 -1.138 . . . . 1.27 107.928 178.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.525 HD12 ' HB2' ' A' ' 16' ' ' ALA . 83.4 mt -127.12 146.73 50.28 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.486 -0.758 . . . . 0.75 110.454 -178.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.6 mt -112.25 129.27 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.272 -1.751 . . . . 0.63 106.272 176.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 30.6 tp -98.8 115.68 29.33 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.892 -1.13 . . . . 0.7 109.506 -178.223 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' A' ' 223' ' ' VAL . 65.1 m-20 -70.95 -46.34 62.57 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.935 -1.135 . . . . 2.31 107.935 178.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.784 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 52.08 7.89 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.761 -0.829 . . . . 0.78 108.761 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.535 ' H ' ' C ' ' A' ' 221' ' ' ASP . 72.1 t -123.86 -42.78 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.192 -1.41 . . . . 1.04 107.192 179.11 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -102.58 0.03 32.78 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.658 -1.238 . . . . 2.44 107.658 178.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.824 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 59.84 42.74 16.04 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.772 -0.58 . . . . 1.55 109.737 -179.955 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -133.12 152.36 51.95 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.398 -0.814 . . . . 1.99 109.462 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.23 129.98 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.997 -0.742 . . . . 0.77 108.997 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -100.05 122.76 43.43 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.505 -0.924 . . . . 0.98 108.505 179.094 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.2 t -103.12 113.39 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.573 -0.704 . . . . 0.85 109.904 -179.368 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 66.1 t30 53.89 66.87 3.99 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.357 -0.839 . . . . 1.66 111.532 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -90.94 151.36 3.93 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.196 2.597 . . . . 0.95 112.405 178.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.412 ' OG1' HG23 ' A' ' 235' ' ' VAL . 37.9 p -70.01 162.21 28.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.15 -0.969 . . . . 1.84 110.305 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.55 -40.05 90.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.483 -0.761 . . . . 2.74 109.958 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -60.11 -37.86 81.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.426 -0.796 . . . . 2.89 109.874 -179.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.412 HG23 ' OG1' ' A' ' 232' ' ' THR . 54.3 t -65.86 -41.68 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 1.3 109.481 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 91.9 mt . . . . . 0 N--CA 1.494 1.757 0 O-C-N 121.102 -0.999 . . . . 1.09 110.08 -179.888 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . 0.407 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 37.8 ttp . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.516 0.674 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . 0.407 ' N ' ' CG ' ' B' ' 301' ' ' MET . 28.7 t80 -153.27 150.26 28.77 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.045 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -150.91 161.52 42.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.013 -1.054 . . . . 0.0 110.28 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -157.38 154.22 28.54 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -114.37 130.89 56.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.216 -0.928 . . . . 0.0 110.162 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 4.0 p -129.99 124.09 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 CA-C-O 122.18 0.991 . . . . 0.0 111.362 -178.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . 0.548 ' O ' HG23 ' B' ' 309' ' ' THR . 32.8 m -79.92 104.33 10.43 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.868 0.842 . . . . 0.0 110.71 -178.063 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' B' ' 358' ' ' GLY . 89.7 mt -50.72 116.38 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 122.313 1.054 . . . . 0.0 110.222 -177.558 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . 0.548 HG23 ' O ' ' B' ' 307' ' ' THR . 70.0 p -107.28 13.04 27.56 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.746 -178.497 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.67 116.43 49.79 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.022 -1.049 . . . . 0.0 108.829 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -58.94 -12.01 13.96 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 CA-C-N 120.579 1.243 . . . . 0.0 112.617 -179.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -103.73 2.77 33.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.3 -0.875 . . . . 0.0 109.993 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 65.69 167.49 2.07 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -178.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 2.8 tp -88.72 96.28 10.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.784 -1.421 . . . . 0.0 110.227 -177.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -100.07 -159.59 0.75 Allowed 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.975 -1.078 . . . . 0.0 109.632 178.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 93.4 m -59.95 -42.39 93.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.687 -1.258 . . . . 0.0 112.482 -176.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.601 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.4 tpt180 -57.59 -61.41 7.31 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.536 -1.353 . . . . 0.0 111.367 -178.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.26 -33.18 94.88 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 120.305 1.145 . . . . 0.0 111.454 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.93 -50.15 74.89 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.23 -41.77 65.74 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -69.89 -43.04 72.59 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.704 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -60.32 -51.58 68.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.562 -0.711 . . . . 0.0 110.208 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.34 -28.87 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.864 -1.147 . . . . 0.0 109.962 -179.072 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -59.98 -45.09 93.83 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.171 -0.956 . . . . 0.0 108.894 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.66 -46.35 69.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.305 -0.872 . . . . 0.0 110.969 -178.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.21 -54.64 19.23 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.516 -1.365 . . . . 0.0 111.118 -179.06 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -50.63 -16.56 0.4 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.217 -0.927 . . . . 0.0 109.598 -179.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -75.65 -18.67 79.63 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -103.54 143.48 32.68 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.444 -1.033 . . . . 0.0 108.876 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . 0.417 HG22 ' O ' ' B' ' 330' ' ' THR . 86.7 m -90.72 -11.09 40.71 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.041 -1.037 . . . . 0.0 110.779 -178.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.454 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 88.8 p -67.04 156.92 34.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.881 -1.137 . . . . 0.0 109.754 -179.639 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -71.93 133.57 45.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.212 -0.93 . . . . 0.0 109.168 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.2 mt -130.63 131.22 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 84.8 m -129.27 148.14 51.17 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.558 -0.713 . . . . 0.0 109.533 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 96.6 t -122.33 115.84 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 92.6 m -104.53 125.12 50.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.152 -0.968 . . . . 0.0 109.573 -178.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 15.1 p -134.4 117.25 16.11 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.861 0.838 . . . . 0.0 110.339 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 42.93 55.02 4.58 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 177.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.96 -15.19 22.7 Favored Glycine 0 N--CA 1.497 2.74 0 O-C-N 120.349 -1.469 . . . . 0.0 112.44 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -108.45 118.98 38.18 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 119.069 1.434 . . . . 0.0 109.377 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 65.2 m -116.27 143.43 45.54 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.896 0.855 . . . . 0.0 111.151 -178.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.06 159.36 42.38 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.539 0.685 . . . . 0.0 109.668 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 15.9 t -87.04 135.17 33.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.496 -0.752 . . . . 0.0 109.799 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.67 ' HA ' HD11 ' B' ' 350' ' ' LEU . . . -72.5 -16.62 61.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.998 -1.064 . . . . 0.0 109.121 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -85.4 20.96 1.87 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.136 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . 0.464 ' H ' ' C ' ' B' ' 344' ' ' ALA . 2.5 m -149.46 95.86 2.41 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.87 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.813 HD23 HD22 ' A' ' 79' ' ' LEU . 59.3 tp -59.36 -35.06 73.19 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.833 ' CE2' HD11 ' A' ' 79' ' ' LEU . 51.2 m-85 -56.32 -53.19 60.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.333 -0.854 . . . . 0.0 110.321 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -69.98 -40.06 75.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.986 -1.071 . . . . 0.0 110.505 -178.254 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.67 HD11 ' HA ' ' B' ' 344' ' ' ALA . 87.7 mt -52.86 -59.89 3.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.496 -1.378 . . . . 0.0 108.546 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.705 HE21 ' NE ' ' A' ' 126' ' ' ARG . 3.4 tp-100 -42.61 -11.89 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.674 -178.312 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.559 ' N ' ' O ' ' B' ' 350' ' ' LEU . 71.8 p -89.24 -9.96 48.77 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.577 -1.327 . . . . 0.0 109.607 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 54.1 mt -92.71 120.49 33.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.188 -0.945 . . . . 0.0 108.874 178.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.8 92.34 0.81 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 179.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.73 90.59 4.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.263 -1.14 . . . . 0.0 109.663 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . 0.45 ' O ' ' C ' ' B' ' 357' ' ' GLN . 82.1 p -97.86 139.32 33.89 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.084 -1.01 . . . . 0.0 109.774 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . 0.45 ' C ' ' O ' ' B' ' 356' ' ' THR . 16.4 tm0? -34.68 118.46 0.41 Allowed 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.393 0.616 . . . . 0.0 110.976 -178.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 103.15 5.08 47.15 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 21.6 m -87.25 109.45 19.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.318 -1.107 . . . . 0.0 110.426 -179.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 20.8 t -77.12 114.04 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 122.169 0.985 . . . . 0.0 109.46 -177.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.25 176.59 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.444 -0.946 . . . . 0.0 108.444 -178.152 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 24.9 m -130.41 126.27 36.6 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.958 -1.126 . . . . 0.0 107.958 177.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 84.4 mt -102.06 113.89 39.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.667 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 84.5 p -119.88 132.79 55.66 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.604 -0.685 . . . . 0.0 109.339 -178.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.12 150.51 38.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 109.428 -179.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -144.9 125.04 13.64 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.529 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.55 -160.92 30.98 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.679 -179.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -59.98 -50.01 75.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 122.051 -0.676 . . . . 0.0 112.16 -177.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.454 ' H ' ' HB3' ' B' ' 331' ' ' SER . 92.3 m-20 -104.94 9.89 34.44 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.733 -1.229 . . . . 0.0 111.216 -177.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.1 pt-20 -42.49 -33.52 0.69 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.211 -0.931 . . . . 0.0 111.56 -178.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -70.01 -40.19 75.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.689 -1.257 . . . . 0.0 109.92 -178.612 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -66.84 -48.68 68.11 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.074 -1.051 . . . . 0.0 109.321 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.39 -78.16 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.392 -0.818 . . . . 0.0 110.901 -179.1 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.52 ' O ' HG23 ' B' ' 378' ' ' VAL . 37.6 t -47.28 -37.89 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.057 -1.027 . . . . 0.0 110.336 -177.384 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -69.82 -41.46 74.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.812 -1.18 . . . . 0.0 109.819 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -80.16 -46.74 15.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.137 -0.977 . . . . 0.0 110.315 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.15 -33.52 73.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 110.164 -179.026 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.52 HG23 ' O ' ' B' ' 374' ' ' VAL . 71.3 t -75.61 -34.18 28.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.493 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -72.85 -23.24 60.73 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 108.582 178.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' B' ' 383' ' ' GLU . 51.7 tp -79.95 -67.06 0.8 Allowed 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.113 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 50.8 tpp -50.16 -28.24 7.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.496 -0.752 . . . . 0.0 109.068 -178.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -76.14 -22.43 55.46 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.403 178.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' B' ' 380' ' ' LEU . 78.5 mm-40 -106.94 4.63 27.43 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.324 -0.86 . . . . 0.0 111.872 -178.501 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 89.7 mt -78.2 121.64 24.62 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.16 -1.587 . . . . 0.0 108.98 179.288 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.44 179.688 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.0 mmm . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.588 -0.523 . . . . 2.91 109.588 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.1 mt -105.62 125.75 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.777 -0.823 . . . . 1.2 108.777 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.2 m -129.66 138.05 50.98 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.52 -0.738 . . . . 1.4 109.13 -179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.92 -160.17 19.55 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 109.139 -1.585 . . . . 1.05 109.139 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.7 mt -94.63 -10.87 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.116 -1.226 . . . . 1.15 110.251 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.2 tp 54.18 101.48 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.116 -0.99 . . . . 0.98 108.818 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.54 -28.48 18.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.214 -0.929 . . . . 0.88 109.775 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.6 t -143.14 131.09 11.11 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.289 -0.882 . . . . 1.69 109.646 -179.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.32 142.68 15.12 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.302 2.001 . . . . 0.85 113.147 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.881 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 161.93 -161.7 33.55 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.291 -1.524 . . . . 0.92 109.291 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.7 mt -149.5 150.02 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 121.198 -1.178 . . . . 0.81 108.435 179.203 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.49 157.99 37.8 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.746 -1.221 . . . . 0.51 110.436 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 9.8 m-85 -139.02 128.11 23.87 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.393 -0.965 . . . . 0.62 108.393 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.04 -178.8 46.66 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 118.585 -1.769 . . . . 0.55 111.188 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -79.99 157.93 26.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.731 -0.864 . . . . 2.1 109.619 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.496 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.02 135.36 45.67 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.456 -0.777 . . . . 0.77 111.078 -179.127 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.0 tp -102.1 134.83 44.72 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 107.743 -1.206 . . . . 0.91 107.743 178.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.4 tp -115.2 121.37 42.74 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.314 -0.866 . . . . 0.93 110.362 -179.107 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.4 mt -89.3 102.11 14.77 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.846 -0.534 . . . . 0.93 110.182 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -101.3 136.04 41.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.347 -0.846 . . . . 2.75 109.463 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -130.28 132.72 46.04 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.442 -0.786 . . . . 3.0 109.232 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -74.64 150.08 39.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.099 -1.0 . . . . 2.77 109.248 179.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -63.74 145.67 55.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.146 -0.971 . . . . 2.94 109.193 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.609 HD11 HH11 ' A' ' 139' ' ' ARG . 58.9 mt -84.4 125.84 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.107 -0.996 . . . . 0.95 109.4 -179.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.3 t -93.22 122.6 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.232 -0.918 . . . . 1.28 109.766 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.5 mt -103.73 139.42 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.831 -0.803 . . . . 1.21 108.831 179.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -96.89 114.95 26.61 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.134 -0.979 . . . . 1.81 109.354 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.509 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.4 mmt-85 -90.08 0.13 57.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.249 -0.907 . . . . 2.8 109.695 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -66.28 147.43 53.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.199 -0.938 . . . . 2.87 109.205 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -87.69 147.21 25.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.039 -1.038 . . . . 2.35 109.556 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.4 HG21 ' HG3' ' A' ' 39' ' ' GLU . 5.1 pt -93.89 165.28 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 0.97 109.788 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.6 p -96.22 171.25 8.71 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.048 -1.032 . . . . 1.17 108.922 179.163 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.5 -16.58 64.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.113 -0.992 . . . . 1.18 110.603 -179.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.67 -26.1 26.17 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.676 -1.231 . . . . 2.56 107.676 178.296 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -82.45 -9.7 59.33 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.875 -0.787 . . . . 1.79 108.875 179.237 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.6 t -63.73 -53.8 40.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 120.862 -1.149 . . . . 1.0 108.961 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.44 -40.15 93.42 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.246 -0.909 . . . . 1.77 110.102 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -70.03 -43.01 72.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.038 -1.039 . . . . 2.7 110.347 -179.263 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.4 ' HG3' HG21 ' A' ' 31' ' ' ILE . 65.4 mm-40 -63.55 -39.86 95.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.078 -1.014 . . . . 1.51 110.288 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.36 -46.01 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.833 -1.167 . . . . 0.93 108.816 179.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -60.0 -39.8 87.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.143 -0.973 . . . . 1.81 108.69 -179.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -60.0 -41.62 92.49 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.724 -1.213 . . . . 2.78 107.724 178.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -63.45 -49.35 74.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.362 -0.836 . . . . 0.78 109.032 178.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.94 -48.67 80.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.382 -0.823 . . . . 1.07 109.038 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.5 t -63.64 -44.21 94.54 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.01 -1.056 . . . . 1.12 108.741 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.94 -48.58 85.36 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.851 -1.699 . . . . 0.84 108.851 179.315 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -65.34 -32.52 74.21 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.327 -1.102 . . . . 3.09 108.451 179.158 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.36 -39.92 84.82 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.803 -0.814 . . . . 0.88 108.803 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 51' ' ' SER . 33.6 ttpt -65.36 -74.38 0.11 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.962 -1.125 . . . . 2.59 107.962 179.189 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.45 -30.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.51 -0.744 . . . . 0.7 111.26 -178.423 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 49' ' ' LYS . 44.0 t -59.98 -54.39 46.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.706 -1.246 . . . . 1.4 108.397 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.62 -40.09 84.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.835 . . . . 0.67 111.054 -179.139 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -61.9 -46.56 88.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.68 -1.263 . . . . 1.66 110.128 -179.316 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.11 -40.03 88.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.14 -0.975 . . . . 1.58 109.018 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -60.31 -40.04 89.13 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.38 -0.825 . . . . 1.35 109.174 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.4 m -64.45 -44.24 91.74 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.243 -0.91 . . . . 0.77 108.64 178.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.5 mt -61.31 -39.88 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.848 -0.797 . . . . 0.63 108.848 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -59.69 -50.34 74.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.955 . . . . 1.14 109.17 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.9 m -59.95 -36.53 77.27 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.396 -0.815 . . . . 0.79 110.025 -178.136 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -66.17 -38.48 88.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.976 -1.077 . . . . 1.53 109.161 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.71 -45.02 88.34 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.585 -0.697 . . . . 0.57 109.948 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.9 -51.57 58.17 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 120.025 -1.083 . . . . 0.75 110.435 -179.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.95 -45.67 66.92 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.096 -1.238 . . . . 1.59 109.809 -179.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.6 m -67.17 -61.26 2.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.73 111.709 -178.36 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.01 -52.7 3.76 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.135 -0.978 . . . . 0.75 111.473 -177.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.11 -165.18 26.7 Favored Glycine 0 N--CA 1.501 3.033 0 C-N-CA 119.615 -1.278 . . . . 1.22 111.152 179.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -70.05 -25.16 63.41 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.804 -0.821 . . . . 5.81 110.696 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -60.75 -37.35 81.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.998 . . . . 3.37 110.224 -179.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.566 ' HA ' HD12 ' A' ' 72' ' ' ILE . 42.6 mmtm -99.59 -18.03 17.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.45 -0.781 . . . . 1.77 110.296 -179.444 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -70.01 -45.37 67.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.973 -1.079 . . . . 1.65 110.457 -179.298 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.5 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -66.14 -27.29 67.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.394 -0.816 . . . . 0.77 109.931 -178.571 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' A' ' 69' ' ' LYS . 81.7 mt -60.07 -41.49 86.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.038 -1.039 . . . . 0.8 109.14 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -69.1 -37.16 78.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.035 -1.041 . . . . 0.88 109.959 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -60.0 -40.28 88.66 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.799 -1.188 . . . . 1.37 108.867 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.84 -49.52 75.1 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.36 -1.896 . . . . 0.62 108.36 178.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -60.12 -46.63 88.99 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.374 -1.074 . . . . 1.5 108.462 179.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.96 -50.02 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -0.797 . . . . 0.63 109.193 179.148 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.8 ttp -60.53 -39.97 89.77 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.156 -0.965 . . . . 1.51 109.811 -179.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.091 HD22 HD23 ' B' ' 347' ' ' LEU . 53.3 tp -66.9 -39.93 87.57 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.632 -0.668 . . . . 0.77 110.118 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.92 -39.78 94.95 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.637 -0.825 . . . . 0.62 109.68 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -82.54 7.64 13.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.087 -1.008 . . . . 1.47 109.598 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 63.5 t0 -49.87 134.72 20.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.179 -0.951 . . . . 1.47 110.279 -178.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.479 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 95.2 mt-10 -58.84 -26.7 64.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.784 -0.572 . . . . 1.78 111.637 -178.266 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.09 -31.0 62.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.899 -1.125 . . . . 2.53 110.096 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 79' ' ' LEU . 86.4 mt -70.01 -42.53 72.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.337 -0.852 . . . . 0.8 110.095 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.08 -48.17 82.85 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.502 -0.749 . . . . 1.42 110.621 -178.365 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -69.93 -42.92 72.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.958 . . . . 1.71 111.285 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.39 -40.01 74.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.11 -0.994 . . . . 1.57 111.624 -178.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.37 -45.89 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.897 -1.127 . . . . 0.65 109.786 -179.164 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.6 mt -69.93 -38.29 75.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.433 -0.792 . . . . 0.82 110.294 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.43 -40.87 98.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.083 -1.011 . . . . 0.79 111.049 -179.076 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.3 mt -61.24 -45.56 94.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.828 -1.17 . . . . 0.95 109.348 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.9 mt -61.92 -48.18 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 122.048 0.928 . . . . 0.66 109.206 179.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -70.02 -40.03 75.47 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.608 -0.682 . . . . 2.2 110.298 -179.23 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.73 -53.67 5.73 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.164 -0.96 . . . . 1.65 111.91 -178.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -89.97 -0.83 57.79 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.011 -1.056 . . . . 2.03 112.035 -177.274 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 70.7 m80 57.24 36.56 27.53 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.035 -1.041 . . . . 1.42 110.179 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 99.6 mtp -92.07 166.99 12.39 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.519 -0.738 . . . . 1.18 109.375 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 35.0 p -80.75 162.81 23.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.98 109.747 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.45 -39.87 81.3 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.357 -0.84 . . . . 0.64 109.744 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -64.36 -39.05 93.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 2.07 109.55 179.319 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.91 -41.21 23.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.407 -0.808 . . . . 0.73 110.322 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.46 -48.0 65.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 0.54 110.19 -179.192 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.94 -45.75 91.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.997 -1.064 . . . . 0.56 109.447 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.488 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 84.9 t60 -60.01 -40.0 87.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.406 -0.809 . . . . 1.54 109.731 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.0 -41.97 93.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.264 -0.897 . . . . 1.33 110.048 -179.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.7 t -68.88 -51.31 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.068 -1.02 . . . . 0.72 110.422 -178.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.39 -40.92 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.035 -1.041 . . . . 0.85 108.512 179.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.488 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 86.3 tt0 -65.29 -40.0 93.28 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.443 -0.947 . . . . 2.44 108.443 178.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.13 -50.16 70.66 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.159 -1.176 . . . . 0.98 110.159 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -65.34 -51.15 62.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.931 -1.335 . . . . 1.41 109.421 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.49 -40.86 75.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.166 -0.959 . . . . 1.2 109.206 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.7 m -59.97 -40.04 87.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.089 -1.007 . . . . 1.7 108.443 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.97 -39.95 90.85 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.641 -0.874 . . . . 1.47 108.641 178.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.472 HD22 ' HB3' ' B' ' 351' ' ' GLN . 87.1 mt -65.71 -42.65 90.88 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.091 -1.005 . . . . 1.56 109.474 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -59.88 -39.05 84.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.916 -1.115 . . . . 2.2 109.848 -178.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -49.98 -19.99 0.83 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.005 -1.059 . . . . 2.12 109.555 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 29.2 mt -62.72 140.02 58.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.012 -1.055 . . . . 2.0 109.043 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -93.16 40.41 1.06 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.176 -0.953 . . . . 3.23 110.289 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -126.13 134.2 51.39 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.266 -0.896 . . . . 2.49 109.518 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.53 -30.42 68.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.451 -0.78 . . . . 3.95 109.919 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.497 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.0 t80 -69.99 -39.02 76.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.347 -0.845 . . . . 2.0 110.32 179.327 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.442 HD22 ' O ' ' B' ' 351' ' ' GLN . 84.5 mt -80.76 -31.94 35.7 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.06 -1.025 . . . . 1.86 109.248 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -60.94 -40.76 94.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 2.84 109.003 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 64.7 mm-40 -64.22 -40.0 95.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 2.73 109.015 178.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.48 ' NH1' ' CD ' ' B' ' 351' ' ' GLN . 0.1 OUTLIER -59.97 -39.99 87.56 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.295 -1.002 . . . . 2.77 108.295 179.436 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.3 -26.13 66.28 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.595 -0.891 . . . . 1.19 108.595 178.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -67.68 -39.94 84.45 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.947 -0.76 . . . . 1.2 108.947 179.435 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.86 -39.99 79.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 1.55 109.681 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.7 -44.38 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.8 108.563 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -60.49 -37.38 80.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 3.09 108.918 178.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -59.82 -39.66 85.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.493 -0.755 . . . . 1.46 109.664 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.96 -40.4 82.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.04 -1.037 . . . . 0.71 108.873 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.08 -35.99 64.31 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.048 -1.221 . . . . 0.57 110.048 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -60.05 -49.9 75.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.115 -1.226 . . . . 2.59 109.931 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.402 ' HG2' HH21 ' A' ' 139' ' ' ARG . 87.6 mtm180 -67.66 -33.34 74.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.021 -1.049 . . . . 2.83 109.501 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.04 -43.25 95.49 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.249 -0.907 . . . . 1.25 109.074 -179.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.04 -42.52 94.58 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.192 -0.943 . . . . 0.7 109.985 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.609 HH11 HD11 ' A' ' 24' ' ' ILE . 63.1 mtm-85 -71.39 -39.29 71.26 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.394 -0.816 . . . . 2.57 109.352 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -65.57 -34.37 78.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.726 . . . . 1.23 111.259 -179.197 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.3 mt -70.01 -45.35 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.416 -1.427 . . . . 0.81 108.037 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.7 mt -69.89 -30.79 68.31 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 120.137 -0.625 . . . . 1.0 109.454 179.135 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.89 41.73 8.02 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.034 -1.626 . . . . 0.89 109.034 -179.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 tp -74.88 157.23 35.41 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.468 -1.019 . . . . 1.14 109.411 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.21 146.62 53.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.886 . . . . 4.6 110.062 -179.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.7 mt -119.9 127.78 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 108.826 -0.805 . . . . 1.24 108.826 179.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 27.6 mm -55.4 -49.68 71.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.36 -0.837 . . . . 1.54 110.212 -178.251 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.4 t0 66.24 103.92 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.528 -0.732 . . . . 1.5 109.338 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.8 mt -79.61 -5.77 55.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.42 -0.8 . . . . 0.79 110.179 -178.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.3 t -81.67 -20.52 39.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.942 -1.099 . . . . 1.4 109.634 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.04 21.53 0.7 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.297 -0.877 . . . . 0.92 111.66 -178.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 39.5 mm -89.12 129.49 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.565 -1.334 . . . . 0.88 108.965 179.517 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -110.53 -11.31 14.48 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.586 -0.696 . . . . 2.45 110.059 -179.234 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -118.3 148.11 42.79 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.177 -0.952 . . . . 1.52 110.457 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.24 133.95 52.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 1.58 109.214 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.9 m -153.33 166.33 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.42 -0.8 . . . . 0.69 109.439 179.081 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.3 mt -94.06 147.42 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.545 -1.65 . . . . 0.61 106.545 177.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 49.7 tp -94.27 113.58 25.51 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.011 -1.055 . . . . 0.87 110.101 -177.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.42 HG12 HG22 ' A' ' 209' ' ' THR . 46.7 t -118.68 125.22 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 108.663 -0.866 . . . . 0.71 108.663 179.478 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.442 ' CB ' HD21 ' A' ' 163' ' ' LEU . . . -155.68 160.65 40.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.991 -1.068 . . . . 0.81 109.465 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.45 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -78.82 -29.08 44.57 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.487 -1.383 . . . . 0.98 109.02 179.199 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 161' ' ' ALA . 14.5 m-20 -167.36 133.41 2.14 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.31 -0.869 . . . . 2.25 109.169 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.442 HD21 ' CB ' ' A' ' 160' ' ' ALA . 57.7 mt -118.15 130.04 55.87 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 108.781 -0.822 . . . . 0.78 108.781 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 20.8 p -93.84 149.99 37.9 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.079 -1.013 . . . . 0.98 109.737 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -39.38 -36.58 0.98 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.64 2.227 . . . . 0.81 113.636 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.6 m -59.98 -40.05 87.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.894 -1.129 . . . . 0.9 110.028 -178.194 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.61 -39.82 80.69 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.256 -0.902 . . . . 1.61 110.249 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.7 p -57.39 -38.08 73.71 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.059 -1.025 . . . . 0.61 112.036 -177.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.97 -47.8 70.46 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.521 -1.362 . . . . 0.6 110.027 -179.239 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -85.68 33.83 0.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.327 -0.99 . . . . 1.4 108.327 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.3 tp -102.78 137.5 40.9 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.788 -0.819 . . . . 0.7 108.788 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.682 ' ND2' ' H ' ' A' ' 175' ' ' LYS . 0.2 OUTLIER -86.96 104.72 16.55 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.476 -0.935 . . . . 2.35 108.476 179.575 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.55 -40.11 92.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.895 . . . . 1.51 111.598 -178.186 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -69.87 -25.5 63.75 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.746 -1.221 . . . . 2.33 111.744 -177.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.682 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 98.5 mttt -93.73 -10.04 35.66 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.706 -1.246 . . . . 1.92 110.242 -178.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 178' ' ' GLY . 95.0 t -100.94 113.22 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.029 -1.044 . . . . 0.67 108.339 178.633 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.4 mt -80.76 2.1 27.6 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.238 -0.913 . . . . 1.53 110.853 -177.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.507 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 166.25 177.99 38.67 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.3 -1.52 . . . . 0.48 109.3 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.586 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 7.4 m-85 -132.31 128.23 37.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.484 -1.009 . . . . 0.55 109.489 -179.387 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 93.8 mt -130.74 124.21 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.507 -0.746 . . . . 0.65 109.03 179.096 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 52.8 p -150.88 161.92 41.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.813 -1.18 . . . . 0.82 110.721 -179.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 37.1 p-10 -103.56 25.17 10.02 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.564 -0.71 . . . . 2.46 109.456 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.43 -158.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.863 -1.148 . . . . 1.28 111.703 -178.259 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.14 -54.4 5.24 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.84 -0.695 . . . . 2.19 111.44 -178.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 165.23 -139.17 5.65 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 118.968 -1.587 . . . . 2.13 111.07 -179.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 186' ' ' ARG . 0.4 OUTLIER -69.93 -22.88 63.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.608 -0.937 . . . . 5.86 111.175 -178.761 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 66.7 p -70.27 1.25 5.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.848 -1.157 . . . . 3.72 109.546 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.0 t -90.89 133.83 34.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.267 -0.896 . . . . 1.74 110.482 -179.634 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -47.48 -53.22 14.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.497 -0.752 . . . . 0.95 110.21 -179.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.7 m -60.11 -40.44 89.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.341 -0.849 . . . . 1.55 111.473 -178.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 17.3 t -60.0 -40.73 90.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.829 -1.169 . . . . 1.51 110.12 -179.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 85.7 mt -61.39 -37.93 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.874 . . . . 1.67 109.728 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.3 mtp -60.07 -39.96 87.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.842 . . . . 1.02 109.692 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.07 88.69 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.713 -1.242 . . . . 0.68 108.633 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -60.06 -51.06 71.24 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.714 -0.794 . . . . 2.93 110.319 -179.234 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.9 m -74.88 -34.25 62.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.083 -1.011 . . . . 0.86 112.022 -178.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.1 mt -73.55 -11.5 60.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.632 -1.293 . . . . 0.67 109.829 -178.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 60.1 50.08 6.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.573 -0.704 . . . . 1.5 110.975 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.2 mt -128.77 149.92 73.48 Favored Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 107.602 -1.258 . . . . 0.72 107.602 178.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.81 140.75 47.22 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 122.16 1.907 . . . . 0.61 112.158 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.04 151.52 3.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.965 -1.084 . . . . 0.66 111.418 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.7 mt -123.45 138.15 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.521 -1.288 . . . . 0.79 107.521 178.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 17.3 m -121.83 -11.86 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 O-C-N 120.738 -1.226 . . . . 0.91 111.478 -178.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -105.97 23.88 28.08 Favored Glycine 0 N--CA 1.5 2.934 0 N-CA-C 110.309 -1.117 . . . . 1.01 110.309 -179.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.7 p -44.29 -41.15 5.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.202 -1.175 . . . . 0.99 109.928 -179.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.41 -50.48 4.23 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 120.211 -0.995 . . . . 1.12 110.982 179.17 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 30.5 t -159.12 38.05 0.21 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.611 -1.523 . . . . 1.72 111.402 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.82 -35.54 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.934 -1.104 . . . . 0.89 108.673 178.133 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.42 HG22 HG12 ' A' ' 159' ' ' VAL . 76.7 p -54.73 -30.1 55.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.844 . . . . 1.03 110.148 -179.479 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.0 p -81.92 -12.62 58.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.112 -0.992 . . . . 1.83 110.228 -179.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 30.2 mm100 -101.71 -10.24 20.15 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.339 -0.851 . . . . 2.27 109.674 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 92.5 t -107.37 134.82 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.303 -0.873 . . . . 0.92 111.47 -178.013 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -113.44 155.22 25.68 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.746 -1.576 . . . . 2.2 106.746 177.223 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.7 t-20 -59.98 138.3 57.88 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.935 -1.103 . . . . 2.36 110.572 -178.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 16.3 t0 85.9 0.06 0.69 Allowed 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 116.342 -0.39 . . . . 2.38 110.836 179.054 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -71.8 148.28 46.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.77 -1.206 . . . . 2.09 108.94 179.01 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -95.3 119.01 33.06 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.083 -1.08 . . . . 1.27 108.083 179.125 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 16' ' ' ALA . 83.0 mt -125.59 145.14 50.26 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.411 -0.806 . . . . 0.75 110.456 -179.05 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.1 mt -113.88 128.4 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.463 -1.31 . . . . 0.63 107.463 177.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 20.6 tp -100.36 117.56 34.79 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.004 -1.06 . . . . 0.7 108.786 -179.415 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 10' ' ' GLY . 32.3 t0 -77.13 -44.3 30.88 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.151 -1.055 . . . . 2.31 108.151 179.638 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.881 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 54.03 13.71 0.61 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.256 -0.646 . . . . 0.78 109.256 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 87.8 t -130.5 -42.94 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.146 -1.427 . . . . 1.04 107.146 177.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.45 ' ND2' ' OE1' ' A' ' 226' ' ' GLN . 47.9 t-20 -96.69 0.04 49.06 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.226 -1.398 . . . . 2.44 107.226 178.154 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 60.07 44.64 12.88 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.849 -0.532 . . . . 1.55 109.585 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.45 ' OE1' ' ND2' ' A' ' 224' ' ' ASN . 97.8 mt-30 -139.96 151.77 45.8 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.192 -0.943 . . . . 1.99 110.454 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.1 t -118.78 129.96 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.507 -0.923 . . . . 0.77 108.507 178.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -102.95 127.34 50.21 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.758 -0.831 . . . . 0.98 108.758 179.293 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.0 t -100.19 109.95 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.362 -0.836 . . . . 0.85 110.947 -178.495 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 41.2 t30 50.11 64.43 8.41 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.145 -0.972 . . . . 1.66 110.895 179.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -85.84 156.16 10.17 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.795 2.33 . . . . 0.95 111.986 179.166 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 82.4 p -70.44 160.42 32.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 1.84 110.078 -179.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -59.9 -34.69 73.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.435 -0.791 . . . . 2.74 108.873 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -59.93 -40.09 87.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.476 -0.765 . . . . 2.89 109.344 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.72 -40.02 83.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.194 -0.941 . . . . 1.3 109.276 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.9 mt . . . . . 0 N--CA 1.495 1.799 0 O-C-N 121.24 -0.913 . . . . 1.09 110.31 -179.669 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 41.5 ttm . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.596 0.713 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -150.27 147.09 27.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -150.83 161.77 42.04 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.921 -1.112 . . . . 0.0 110.546 -179.203 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -153.37 150.01 28.41 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . 0.567 ' CD ' ' H ' ' B' ' 305' ' ' GLU . 0.6 OUTLIER -115.81 135.47 53.98 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.244 -0.91 . . . . 0.0 109.971 179.278 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -138.64 129.84 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 CA-C-O 122.523 1.154 . . . . 0.0 113.052 -177.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 90.9 m -76.69 106.36 8.3 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.467 -178.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.463 HG22 ' H ' ' B' ' 310' ' ' ALA . 92.3 mt -52.45 126.07 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 122.412 1.101 . . . . 0.0 110.82 -177.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 22.3 p -109.99 20.07 18.34 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.372 -178.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.463 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -79.4 117.02 64.82 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.851 -1.156 . . . . 0.0 109.109 179.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.28 -11.68 6.53 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 CA-C-N 120.233 1.119 . . . . 0.0 113.212 -179.095 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -119.45 6.66 11.11 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 179.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.47 -179.4 40.24 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 107.961 -2.055 . . . . 0.0 107.961 -178.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.497 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -85.42 92.24 8.43 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.868 -1.372 . . . . 0.0 108.454 -179.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.461 ' C ' ' NH2' ' A' ' 126' ' ' ARG . 5.2 p80 -94.29 -160.91 0.81 Allowed 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.179 -0.951 . . . . 0.0 110.642 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.9 m -57.35 -43.92 83.88 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.204 -0.935 . . . . 0.0 112.651 -175.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.5 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -60.75 -61.74 7.37 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 120.443 -1.411 . . . . 0.0 112.139 -178.508 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -57.33 -31.55 91.31 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 CA-C-N 120.219 1.114 . . . . 0.0 111.781 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.07 -51.51 69.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 109.069 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.7 -41.12 63.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.17 -178.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -72.71 -40.1 66.44 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.882 179.065 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -60.81 -52.46 64.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -0.813 . . . . 0.0 110.869 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.28 -38.07 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.685 -1.259 . . . . 0.0 109.334 -178.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . 0.419 ' CB ' ' NZ ' ' B' ' 324' ' ' LYS . 4.1 ttpm? -59.98 -46.17 90.31 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.751 -179.133 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -63.33 -40.06 96.26 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.925 -1.11 . . . . 0.0 108.789 179.127 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -61.08 -51.31 69.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.422 -0.798 . . . . 0.0 110.312 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -56.92 -11.95 1.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.373 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -73.25 -27.48 68.06 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.239 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -105.4 143.19 33.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 27.4 p -91.16 -12.59 34.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.902 -1.124 . . . . 0.0 110.16 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.426 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 67.8 p -60.13 147.64 38.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.075 -1.015 . . . . 0.0 109.418 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -67.11 136.38 55.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.108 -0.995 . . . . 0.0 108.581 179.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 90.0 mt -131.41 130.15 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.653 -0.654 . . . . 0.0 109.803 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 54.1 m -124.23 148.76 47.09 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.109 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 92.3 t -115.87 136.91 51.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.2 m -128.85 122.62 30.8 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.148 -0.97 . . . . 0.0 109.038 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 91.8 p -138.18 116.71 12.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.306 -0.871 . . . . 0.0 110.386 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 33.2 m120 45.7 62.69 2.09 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 75.16 -11.96 7.59 Favored Glycine 0 N--CA 1.498 2.77 0 O-C-N 120.399 -1.438 . . . . 0.0 112.924 176.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -115.81 127.53 55.14 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 118.951 1.375 . . . . 0.0 109.818 -179.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 21.2 m -126.12 148.61 49.35 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.872 0.844 . . . . 0.0 110.399 -179.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -142.43 164.15 30.9 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.405 0.622 . . . . 0.0 109.929 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 58.6 m -86.96 136.59 32.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.606 -0.684 . . . . 0.0 109.934 -179.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -73.77 -13.49 60.96 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.04 -1.037 . . . . 0.0 109.693 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -90.82 21.68 3.99 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 68.0 m -144.84 93.36 2.39 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.944 -179.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 1.091 HD23 HD22 ' A' ' 79' ' ' LEU . 37.9 tp -59.12 -34.75 72.4 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.417 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.797 ' CE2' HD11 ' A' ' 79' ' ' LEU . 66.1 m-85 -57.87 -56.38 22.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.508 -0.745 . . . . 0.0 109.79 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -70.04 -20.05 63.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.869 . . . . 0.0 111.008 -178.556 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.63 ' O ' ' N ' ' B' ' 352' ' ' THR . 50.2 mt -72.03 -58.32 3.54 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.669 -1.269 . . . . 0.0 108.233 178.073 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.48 ' CD ' ' NH1' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -40.28 -10.25 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.769 -178.279 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.63 ' N ' ' O ' ' B' ' 350' ' ' LEU . 81.0 p -91.93 -11.43 36.25 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.574 -1.329 . . . . 0.0 110.446 -179.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 66.0 mt -92.47 120.07 32.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.996 -1.065 . . . . 0.0 108.972 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.88 92.95 0.83 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 31.1 mt -103.25 93.81 5.18 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.396 -1.061 . . . . 0.0 109.343 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 57.8 p -95.72 179.98 4.93 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.046 -1.034 . . . . 0.0 110.548 -179.518 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -68.45 111.82 4.91 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.506 -0.747 . . . . 0.0 109.945 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 105.75 9.69 32.27 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 97.6 m -87.83 106.21 17.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -1.172 . . . . 0.0 110.302 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 3.9 t -77.01 117.84 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 122.296 1.046 . . . . 0.0 109.004 -177.563 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 19.6 m -113.68 177.73 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.832 -177.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 93.9 m -132.0 130.04 40.89 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 176.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 96.5 mt -105.35 120.51 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.36 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 58.2 m -120.07 131.72 55.18 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.689 -0.632 . . . . 0.0 109.543 -178.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.71 153.76 41.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 109.715 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -146.33 123.02 11.18 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 160.91 -155.39 26.55 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 118.681 -1.723 . . . . 0.0 111.86 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -58.94 -50.46 73.97 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.154 -0.523 . . . . 0.0 112.394 -177.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.426 ' H ' ' HB3' ' B' ' 331' ' ' SER . 97.8 m-20 -110.29 15.28 22.41 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.926 -1.109 . . . . 0.0 111.275 -177.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' B' ' 369' ' ' ASP . 16.2 pt-20 -39.54 -38.28 0.58 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.421 -0.8 . . . . 0.0 111.453 -179.034 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -66.73 -48.15 70.07 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.723 -1.236 . . . . 0.0 110.622 -178.233 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -70.02 -52.52 23.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.977 -1.077 . . . . 0.0 109.899 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.01 -38.71 3.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.429 -0.794 . . . . 0.0 111.229 -178.661 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.457 ' O ' HG23 ' B' ' 378' ' ' VAL . 77.2 t -70.05 -39.98 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.515 -1.366 . . . . 0.0 109.251 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.91 -66.83 0.5 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.971 . . . . 0.0 111.637 -178.025 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . 0.442 ' O ' ' N ' ' B' ' 380' ' ' LEU . 32.2 m170 -59.92 -45.2 93.33 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.652 -1.28 . . . . 0.0 112.103 -177.171 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 98.0 mt -59.98 -42.0 93.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.328 -1.483 . . . . 0.0 108.841 -179.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.457 HG23 ' O ' ' B' ' 374' ' ' VAL . 53.4 t -68.7 -40.14 81.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -80.67 -10.94 59.7 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.969 -1.082 . . . . 0.0 109.831 178.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' B' ' 376' ' ' HIS . 61.3 tp -82.39 -25.98 33.25 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.473 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 3.4 ttp -82.75 -25.68 32.61 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -84.37 -10.07 57.89 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.599 -0.688 . . . . 0.0 110.03 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -108.55 -0.86 20.1 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.309 -0.869 . . . . 0.0 110.344 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 44.4 mt -98.94 119.99 38.64 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.009 -1.057 . . . . 0.0 109.727 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 53.3 mp0 . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 117.967 -1.016 . . . . 0.0 108.978 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.6 mtp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.881 -0.415 . . . . 2.91 109.881 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.2 mt -94.76 121.28 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.066 -1.022 . . . . 1.2 109.814 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.7 m -138.75 149.07 44.63 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.716 -0.846 . . . . 1.4 108.716 179.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.02 -161.4 12.21 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 109.357 -1.497 . . . . 1.05 109.357 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' LEU . 97.8 mt -92.07 -12.89 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -1.189 . . . . 1.15 109.944 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' ILE . 63.0 tp 53.92 101.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.059 -1.025 . . . . 0.98 108.717 -179.515 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.06 -39.94 24.95 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.764 -0.828 . . . . 0.88 108.764 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 m -141.05 135.28 15.16 Favored Pre-proline 0 N--CA 1.5 2.025 0 O-C-N 121.583 -0.698 . . . . 1.69 109.524 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.17 147.4 20.71 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.391 2.061 . . . . 0.85 112.877 179.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.862 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.45 -162.2 34.21 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.9 -1.68 . . . . 0.92 108.9 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.5 mt -149.56 150.42 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.01 -1.288 . . . . 0.81 108.565 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.45 159.31 38.55 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.701 -1.249 . . . . 0.51 110.615 179.246 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -140.03 129.08 23.58 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.884 -1.154 . . . . 0.62 107.884 179.068 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.66 -177.95 47.33 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 118.782 -1.675 . . . . 0.55 110.893 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -79.39 159.53 27.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.762 -0.846 . . . . 2.1 109.298 -179.743 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.611 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -107.8 137.39 45.9 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.374 -0.829 . . . . 0.77 111.119 -179.022 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.5 tp -107.32 132.59 52.96 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 107.283 -1.377 . . . . 0.91 107.283 178.501 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.2 tp -111.83 121.17 44.32 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.23 -0.919 . . . . 0.93 109.699 -179.314 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 31.0 mt -85.79 100.19 11.87 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.415 -0.803 . . . . 0.93 109.907 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -88.78 135.98 33.24 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.47 -0.769 . . . . 2.75 109.327 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -132.74 122.87 25.21 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.026 -1.101 . . . . 3.0 108.026 178.392 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -83.06 150.3 26.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.878 -1.139 . . . . 2.77 109.426 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -62.6 140.04 58.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 2.94 109.81 -179.61 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.6 mt -81.67 132.06 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 0.95 108.862 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.53 126.31 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.263 -0.898 . . . . 1.28 110.181 -179.133 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.5 mt -110.01 130.06 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 107.954 -1.128 . . . . 1.21 107.954 179.321 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -88.79 120.33 30.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.836 -1.165 . . . . 1.81 110.102 -179.218 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -89.95 -4.49 57.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 2.8 108.708 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -69.98 137.99 51.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 2.87 109.255 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -82.91 155.45 24.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 2.35 109.815 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.683 HD13 ' HG3' ' A' ' 39' ' ' GLU . 2.9 pt -98.84 168.47 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.445 -0.785 . . . . 0.97 109.339 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.9 p -89.99 173.55 8.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.08 -1.012 . . . . 1.17 108.481 178.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.04 -17.04 63.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.009 -1.057 . . . . 1.18 110.994 -179.367 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -84.57 -26.03 28.26 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.659 -1.276 . . . . 2.56 108.42 178.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -82.15 -7.95 59.64 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.131 -0.692 . . . . 1.79 109.131 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.0 t -60.01 -52.82 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.251 -0.905 . . . . 1.0 108.615 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -60.04 -40.05 88.02 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.354 -0.841 . . . . 1.77 109.208 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -64.06 -40.12 95.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 2.7 110.281 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.683 ' HG3' HD13 ' A' ' 31' ' ' ILE . 71.1 mm-40 -63.46 -44.41 94.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.756 -1.215 . . . . 1.51 110.023 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -60.03 -47.16 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.865 -1.147 . . . . 0.93 108.665 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -60.03 -46.69 88.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.302 -0.874 . . . . 1.81 108.984 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -60.21 -42.75 95.8 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.919 -1.113 . . . . 2.78 108.17 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -63.44 -47.73 80.68 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.535 -0.913 . . . . 0.78 108.535 178.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.3 tp -60.01 -48.68 80.72 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.516 -0.92 . . . . 1.07 108.516 -179.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 46.7 t -63.04 -43.85 97.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 1.12 108.903 179.075 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.99 -46.8 93.51 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.309 -1.917 . . . . 0.84 108.309 179.212 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.419 HH21 ' HG2' ' A' ' 81' ' ' GLU . 43.1 ttt-85 -60.1 -39.94 87.9 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.347 -0.983 . . . . 3.09 108.347 178.303 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -48.1 -46.23 33.69 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.148 -0.686 . . . . 0.88 109.148 -179.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 50' ' ' ALA . 6.4 ttpm? -64.06 -74.08 0.11 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.92 -1.141 . . . . 2.59 107.92 179.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.62 -35.83 0.21 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.532 -0.73 . . . . 0.7 111.143 -178.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.2 t -53.76 -60.62 3.08 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.619 -1.301 . . . . 1.4 108.716 179.557 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.6 -39.99 84.77 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.508 -0.745 . . . . 0.67 111.648 -178.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -66.77 -41.3 87.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.693 -1.254 . . . . 1.66 110.302 -178.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.54 -39.98 95.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.863 -1.148 . . . . 1.58 108.873 179.198 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -65.83 -38.64 89.44 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.522 -0.736 . . . . 1.35 109.723 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.63 -40.87 98.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.014 . . . . 0.77 109.535 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.517 ' CD1' HH22 ' A' ' 136' ' ' ARG . 82.8 mt -60.19 -40.0 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.63 109.218 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -58.94 -50.03 75.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.847 . . . . 1.14 109.579 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -58.14 -28.76 64.98 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.316 -0.865 . . . . 0.79 110.618 -178.064 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -70.05 -39.1 75.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.063 -1.023 . . . . 1.53 109.878 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.04 -46.92 76.1 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.596 -0.69 . . . . 0.57 109.9 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.78 -54.06 32.9 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.928 -1.269 . . . . 0.75 109.928 -179.197 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.02 -45.53 60.51 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.045 -1.268 . . . . 1.59 110.588 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.5 m -68.34 -63.05 1.14 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.952 -1.092 . . . . 0.73 112.717 -177.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -95.7 -46.97 6.39 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.849 -1.157 . . . . 0.75 111.089 -177.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.93 -167.31 25.69 Favored Glycine 0 N--CA 1.5 2.943 0 O-C-N 120.839 -1.163 . . . . 1.22 111.143 179.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -75.6 -22.54 56.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.925 -0.75 . . . . 5.81 110.078 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.425 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.5 tp10 -61.12 -36.22 79.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.88 . . . . 3.37 110.211 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.422 ' HA ' HD12 ' A' ' 72' ' ' ILE . 32.3 mmtp -100.72 -20.14 15.73 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.275 -0.89 . . . . 1.77 110.226 -179.486 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -68.51 -39.92 81.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.047 -1.033 . . . . 1.65 110.34 -179.106 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.536 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.5 -26.57 67.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.213 -0.93 . . . . 0.77 109.431 -179.362 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 69' ' ' LYS . 81.8 mt -60.05 -40.82 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.081 -1.012 . . . . 0.8 108.732 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -70.04 -37.97 75.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.188 -0.945 . . . . 0.88 110.638 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -60.0 -40.11 88.08 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.656 -1.277 . . . . 1.37 108.642 179.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.07 -43.01 97.9 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.957 -1.657 . . . . 0.62 108.957 179.156 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.2 m170 -66.63 -41.31 88.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.302 -1.117 . . . . 1.5 108.969 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.4 mt -69.95 -45.44 76.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.323 -0.861 . . . . 0.63 108.987 179.354 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.4 ttp -60.69 -40.21 91.32 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.099 -1.001 . . . . 1.51 109.536 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.966 HD22 HD23 ' B' ' 347' ' ' LEU . 50.4 tp -64.95 -40.06 94.45 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.525 -0.735 . . . . 0.77 109.579 179.663 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.1 tp -63.62 -38.0 89.46 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.627 -0.67 . . . . 0.62 109.411 -179.213 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.419 ' HG2' HH21 ' A' ' 47' ' ' ARG . 100.0 mt-10 -82.4 4.39 24.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.159 -0.963 . . . . 1.47 110.913 -178.7 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -49.98 130.06 21.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.761 -1.212 . . . . 1.47 109.42 -179.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -57.54 -18.88 21.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.487 -0.758 . . . . 1.78 110.933 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.72 -34.56 69.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.77 -1.207 . . . . 2.53 108.878 178.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.2 mt -72.33 -42.52 65.31 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.73 -0.606 . . . . 0.8 110.567 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -60.0 -48.75 80.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.147 -0.971 . . . . 1.42 110.468 -178.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -69.95 -40.09 75.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.207 -0.933 . . . . 1.71 110.904 -178.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.03 -39.96 75.46 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.042 -1.036 . . . . 1.57 111.413 -179.219 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.2 mt -66.59 -49.94 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.949 -1.094 . . . . 0.65 109.539 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.3 mt -69.79 -39.99 78.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.562 -0.711 . . . . 0.82 110.013 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.04 -48.77 80.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.12 -0.987 . . . . 0.79 110.783 -179.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 96' ' ' LYS . 55.8 mt -59.97 -46.36 89.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.046 -1.034 . . . . 0.95 110.146 -179.089 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.9 -49.81 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.66 108.826 179.451 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -69.99 -40.96 75.0 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 120.276 -0.57 . . . . 2.2 111.19 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -85.07 -49.97 7.83 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.861 -1.15 . . . . 1.65 112.012 -178.228 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 92' ' ' LEU . 32.8 mmtp -89.18 -0.45 57.46 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.111 -0.993 . . . . 2.03 111.164 -177.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.2 m80 55.81 32.6 19.87 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.937 -1.102 . . . . 1.42 109.595 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.0 mtt -89.65 168.82 11.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.358 -0.839 . . . . 1.18 109.428 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.7 p -83.45 158.16 22.17 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.19 -0.944 . . . . 0.98 109.051 179.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.61 -39.95 92.07 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.267 -0.896 . . . . 0.64 109.262 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.481 ' OD1' HD22 ' A' ' 138' ' ' LEU . 40.4 t0 -65.55 -40.02 92.4 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.419 -0.801 . . . . 2.07 109.764 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.45 -41.52 24.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 0.73 110.147 -179.51 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.88 -45.45 64.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -0.946 . . . . 0.54 110.63 -179.316 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.05 -43.31 95.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.039 -1.038 . . . . 0.56 110.122 -179.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -60.01 -39.95 87.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 1.54 110.193 -178.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -61.46 -41.81 97.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.995 -1.066 . . . . 1.33 110.517 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.4 t -60.05 -50.85 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.14 -0.975 . . . . 0.72 110.598 -178.653 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.8 mm -69.94 -39.99 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.116 -0.99 . . . . 0.85 109.252 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -62.11 -39.38 92.31 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.584 -0.895 . . . . 2.44 108.584 179.099 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.0 -52.19 54.38 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.812 -0.915 . . . . 0.98 110.812 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.493 ' NE2' ' CB ' ' B' ' 348' ' ' PHE . 15.5 mm100 -64.04 -49.76 71.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.7 -1.47 . . . . 1.41 109.697 -179.436 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.91 83.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.189 -0.944 . . . . 1.2 109.027 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.8 t -59.98 -42.24 93.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.921 . . . . 1.7 108.873 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.29 -40.0 94.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.858 . . . . 1.47 109.882 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.417 HD22 ' HB3' ' B' ' 351' ' ' GLN . 59.4 mt -65.42 -40.26 93.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.787 -1.196 . . . . 1.56 109.674 -178.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.06 -31.06 69.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.9 -1.125 . . . . 2.2 109.75 -179.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -55.81 -23.57 31.04 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.084 -1.01 . . . . 2.12 108.396 179.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.1 mt -63.23 148.91 46.82 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.576 -0.898 . . . . 2.0 108.576 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -99.81 47.07 0.95 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.025 -1.047 . . . . 3.23 110.204 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 34.6 t0 -137.44 150.17 47.43 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.174 -0.954 . . . . 2.49 109.772 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 124' ' ' LYS . 98.4 mt-10 -74.44 -67.97 0.57 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.299 -0.876 . . . . 3.95 109.259 178.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.634 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 4.8 t80 -39.25 -39.5 0.63 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.863 -0.523 . . . . 2.0 111.153 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.611 HD23 HH22 ' A' ' 126' ' ' ARG . 88.9 mt -69.97 -36.59 75.33 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.745 -1.222 . . . . 1.86 108.508 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 121' ' ' GLU . 74.6 tttt -69.23 -35.98 76.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.446 -0.784 . . . . 2.84 110.309 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.536 ' N ' ' OE1' ' A' ' 125' ' ' GLU . 0.4 OUTLIER -60.05 -46.31 89.97 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.966 -1.084 . . . . 2.73 110.603 -178.485 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.634 ' NH1' ' CE1' ' A' ' 122' ' ' TYR . 27.8 mtm-85 -63.14 -39.67 95.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.504 -1.372 . . . . 2.77 108.593 179.413 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.0 -36.6 77.55 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.459 -0.941 . . . . 1.19 108.459 179.057 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.22 88.58 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.216 -1.031 . . . . 1.2 108.216 179.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.88 -40.02 87.67 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.927 -0.768 . . . . 1.55 108.927 179.15 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 51.2 t -59.95 -42.9 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.8 109.052 179.384 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -60.04 -39.92 87.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 3.09 109.485 179.16 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -59.91 -40.05 87.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.427 -0.796 . . . . 1.46 110.196 -179.617 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.99 -42.17 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.127 -0.983 . . . . 0.71 110.447 -178.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.45 -34.46 54.23 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.805 -1.188 . . . . 0.57 110.236 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -60.05 -46.22 90.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -1.183 . . . . 2.59 109.684 -179.13 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.517 HH22 ' CD1' ' A' ' 57' ' ' ILE . 62.4 mtp180 -65.24 -34.5 78.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.125 -0.984 . . . . 2.83 110.108 -179.316 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.036 -1.04 . . . . 1.25 109.015 -179.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.481 HD22 ' OD1' ' A' ' 101' ' ' ASP . 90.4 mt -60.53 -40.06 90.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 0.7 108.537 178.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -65.62 -39.93 92.02 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.825 -0.805 . . . . 2.57 108.825 179.187 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -69.47 -34.23 74.06 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.717 -0.614 . . . . 1.23 111.328 -179.245 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.26 -39.85 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.454 -1.404 . . . . 0.81 109.243 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.9 mt -73.84 -19.17 60.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.597 -0.689 . . . . 1.0 109.943 -179.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.64 39.33 14.54 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.721 -1.752 . . . . 0.89 108.721 -179.289 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.8 tp -73.89 147.05 43.57 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.489 -1.006 . . . . 1.14 110.004 -179.001 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.74 141.05 49.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.351 -0.843 . . . . 4.6 109.713 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 90.2 mt -113.35 130.01 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.825 0.821 . . . . 1.24 108.838 179.108 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.4 mt -68.29 -39.94 81.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.857 -0.527 . . . . 1.54 110.874 -177.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.8 t0 63.92 102.83 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.396 -0.815 . . . . 1.5 109.267 -179.3 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.2 mt -72.95 -1.73 18.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.412 -0.805 . . . . 0.79 110.669 -179.069 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.2 p -85.24 -16.07 41.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.791 -1.193 . . . . 1.4 109.766 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.62 28.02 0.27 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.172 -0.955 . . . . 0.92 111.859 -177.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 40.9 mm -85.99 125.94 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.491 -1.381 . . . . 0.88 109.191 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -106.91 -13.95 15.09 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.496 -0.752 . . . . 2.45 109.665 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -126.68 150.97 48.7 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.341 -0.85 . . . . 1.52 110.034 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.69 136.62 57.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 1.58 109.0 179.496 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.2 m -152.82 165.96 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.324 -0.86 . . . . 0.69 109.835 179.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.4 mt -95.55 145.95 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 105.661 -1.978 . . . . 0.61 105.661 176.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 37.7 tp -100.23 119.67 38.73 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.907 -1.121 . . . . 0.87 110.54 -178.092 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.0 125.72 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.605 -0.684 . . . . 0.71 109.225 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -152.78 158.67 42.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.985 -1.072 . . . . 0.81 109.494 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.01 -32.12 70.13 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.395 -1.44 . . . . 0.98 108.294 179.076 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 56.2 t0 -169.86 142.15 2.37 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.451 -0.944 . . . . 2.25 108.451 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.528 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 81.4 mt -110.74 129.03 55.94 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.325 -0.859 . . . . 0.78 108.968 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 43.5 p -90.17 149.89 42.24 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.299 -0.876 . . . . 0.98 109.22 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -37.85 -38.92 0.75 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 122.241 1.961 . . . . 0.81 112.439 179.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.1 m -59.51 -39.98 85.6 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.251 -0.906 . . . . 0.9 109.9 -178.219 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.14 -40.05 86.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.086 -1.009 . . . . 1.61 110.356 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.7 p -57.21 -32.6 66.67 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.981 -1.074 . . . . 0.61 111.124 -178.229 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.3 -46.96 53.47 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.984 -1.073 . . . . 0.6 109.97 -179.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -89.95 40.06 0.99 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.788 -1.19 . . . . 1.4 107.788 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.8 tp -106.96 126.44 52.32 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 109.082 -0.711 . . . . 0.7 109.082 179.208 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -84.68 105.71 15.68 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.075 -1.083 . . . . 2.35 108.075 178.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.12 -44.53 84.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.37 -0.831 . . . . 1.51 111.39 -178.131 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -69.99 -21.76 63.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.76 -1.213 . . . . 2.33 111.809 -177.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -93.91 -9.27 37.7 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.699 -1.251 . . . . 1.92 110.214 -178.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.593 HG12 ' H ' ' A' ' 178' ' ' GLY . 99.8 t -108.76 119.94 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.385 -0.822 . . . . 0.67 108.912 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 89.5 mt -85.12 3.73 37.62 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.558 -0.714 . . . . 1.53 110.845 -178.182 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.593 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 166.55 175.23 36.61 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 119.224 -1.465 . . . . 0.48 109.75 179.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -133.69 129.41 36.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.551 -0.97 . . . . 0.55 108.411 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 90.3 mt -128.98 123.72 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.552 -0.907 . . . . 0.65 108.552 179.232 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 69.9 p -149.96 162.38 40.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.654 -1.279 . . . . 0.82 110.9 -179.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 183' ' ' ALA . 7.2 p30 -101.9 22.54 12.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.757 -0.589 . . . . 2.46 109.522 179.64 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -54.32 -162.98 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.817 -1.177 . . . . 1.28 112.048 -178.204 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.99 -54.0 5.97 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.809 -0.917 . . . . 2.19 110.809 -179.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 164.42 -139.01 5.59 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 118.94 -1.6 . . . . 2.13 110.707 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -71.59 -9.99 59.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.931 . . . . 5.86 110.625 -178.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 53.5 p -78.99 1.52 23.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.928 -1.108 . . . . 3.72 109.672 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 12.2 t -90.94 130.8 36.84 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.081 -1.012 . . . . 1.74 110.076 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -47.06 -50.27 19.99 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.447 -0.783 . . . . 0.95 109.966 179.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.41 HG23 ' N ' ' A' ' 191' ' ' SER . 14.5 t -57.48 -37.16 72.46 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.304 -0.873 . . . . 1.55 110.973 -178.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.41 ' N ' HG23 ' A' ' 190' ' ' THR . 82.6 p -59.99 -41.01 91.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.739 -1.226 . . . . 1.51 110.851 -179.087 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 88.7 mt -61.09 -38.93 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.125 -0.984 . . . . 1.67 109.399 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 92.7 mtp -60.59 -39.93 89.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.555 -0.716 . . . . 1.02 110.395 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.27 -43.49 87.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.737 -1.227 . . . . 0.68 109.388 -179.453 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' A' ' 195' ' ' ARG . 2.2 mtt-85 -60.02 -49.92 75.77 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.288 -0.965 . . . . 2.93 109.911 -179.29 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 72.1 m -69.96 -34.43 73.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.088 -1.008 . . . . 0.86 111.026 -179.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.5 mt -71.47 -18.24 62.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.921 -1.112 . . . . 0.67 109.499 -179.536 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 60.99 47.92 7.0 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.294 0.569 . . . . 1.5 110.536 -179.415 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 38.5 mt -126.99 149.48 69.36 Favored Pre-proline 0 N--CA 1.499 2.021 0 N-CA-C 107.724 -1.213 . . . . 0.72 107.724 178.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.79 139.98 49.58 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.122 1.881 . . . . 0.61 112.102 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.99 150.59 3.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.112 -0.992 . . . . 0.66 111.052 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 93.1 mt -125.22 142.32 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 108.399 -0.963 . . . . 0.79 108.399 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.3 m -127.04 -7.97 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 120.816 -1.178 . . . . 0.91 111.322 -178.673 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.9 21.31 29.92 Favored Glycine 0 N--CA 1.503 3.135 0 O-C-N 121.211 -0.931 . . . . 1.01 110.867 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 8.3 p -45.84 -43.99 13.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.951 -1.323 . . . . 0.99 110.165 -179.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.34 -49.46 2.67 Favored Glycine 0 N--CA 1.498 2.784 0 C-N-CA 120.017 -1.087 . . . . 1.12 111.034 179.445 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.7 m -160.77 37.74 0.16 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.651 -1.5 . . . . 1.72 111.246 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 42.4 t -80.74 -31.5 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.991 -1.068 . . . . 0.89 108.86 178.206 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.7 p -59.95 -33.52 72.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.45 -0.781 . . . . 1.03 110.062 -179.081 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 91.2 p -78.21 -10.06 59.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.994 -1.066 . . . . 1.83 109.412 -179.664 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -103.6 -11.1 17.92 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.491 -0.756 . . . . 2.27 110.228 -179.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.4 t -103.42 136.2 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.213 -0.93 . . . . 0.92 110.806 -178.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -112.32 151.0 30.22 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.462 -1.31 . . . . 2.2 107.462 178.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.444 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 11.3 p-10 -57.92 139.53 54.1 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.058 -1.026 . . . . 2.36 110.069 -179.143 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.7 m-20 81.15 3.02 1.59 Allowed 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.13 0.491 . . . . 2.38 110.007 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 56.7 t0 -72.01 138.61 48.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.156 -0.965 . . . . 2.09 108.803 178.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.489 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 41.3 t80 -89.85 118.63 29.58 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.074 -1.084 . . . . 1.27 108.074 179.078 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.611 HD12 ' HB2' ' A' ' 16' ' ' ALA . 61.5 mt -128.47 149.05 50.74 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.498 -0.751 . . . . 0.75 110.642 -178.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.9 mt -115.15 130.01 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 107.703 -1.221 . . . . 0.63 107.703 177.615 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 63.5 tp -99.97 115.92 30.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.08 -1.013 . . . . 0.7 109.314 -179.207 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 223' ' ' VAL . 97.3 m-20 -74.22 -42.72 59.3 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.918 -1.142 . . . . 2.31 107.918 178.368 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.862 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.54 11.22 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.404 -0.961 . . . . 0.78 108.404 -179.108 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.503 ' H ' ' C ' ' A' ' 221' ' ' ASP . 57.2 t -128.33 -39.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.327 -1.36 . . . . 1.04 107.327 179.057 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.525 HD22 ' N ' ' A' ' 224' ' ' ASN . 1.3 m-80 -100.43 3.23 42.93 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.047 -1.094 . . . . 2.44 108.047 178.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 60.57 43.8 12.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.71 -0.619 . . . . 1.55 110.601 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.406 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 25.1 pt20 -149.18 156.79 42.7 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.885 -1.134 . . . . 1.99 109.976 179.204 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -122.92 124.93 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.685 -0.857 . . . . 0.77 108.685 179.158 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . 0.406 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 84.7 m-85 -84.76 122.83 29.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.701 -1.249 . . . . 0.98 109.556 -179.23 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.406 HG22 HD22 ' A' ' 218' ' ' LEU . 62.5 t -98.96 116.3 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.474 -0.766 . . . . 0.85 109.481 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 65.08 68.96 0.69 Allowed Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.227 -0.92 . . . . 1.66 109.372 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -89.18 124.05 1.4 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.181 2.587 . . . . 0.95 112.255 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.2 p -70.41 171.75 9.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 1.84 109.725 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -59.97 -40.16 88.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.323 -0.86 . . . . 2.74 109.921 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -64.33 -34.61 78.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.033 -1.042 . . . . 2.89 109.217 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.79 -42.7 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.121 -0.987 . . . . 1.3 108.613 178.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 95.1 mt . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.747 -0.834 . . . . 1.09 108.747 179.389 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 16.9 ttt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -149.49 147.98 28.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.26 -0.9 . . . . 0.0 109.267 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -149.67 159.63 44.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.066 -1.021 . . . . 0.0 110.618 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -153.66 150.41 28.56 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -109.84 132.25 54.32 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.373 -0.83 . . . . 0.0 109.781 179.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.49 121.63 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 122.371 1.081 . . . . 0.0 112.729 -177.4 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 56.0 m -78.19 104.01 8.49 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.924 0.868 . . . . 0.0 110.02 -178.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.476 HG22 ' H ' ' B' ' 310' ' ' ALA . 96.6 mt -52.64 125.62 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 122.635 1.207 . . . . 0.0 111.073 -177.562 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 67.1 p -109.97 20.9 17.46 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.978 -179.023 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.476 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -75.29 116.87 58.55 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.048 -1.032 . . . . 0.0 108.945 179.426 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -54.53 -16.22 10.29 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 CA-C-N 120.276 1.134 . . . . 0.0 113.249 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -120.17 11.41 11.61 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.383 -0.823 . . . . 0.0 109.621 -179.191 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.85 179.25 32.14 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 108.431 -1.867 . . . . 0.0 108.431 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.457 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -87.08 93.13 9.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.952 -1.322 . . . . 0.0 108.998 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.404 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 5.8 p80 -95.43 -160.0 0.76 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.945 -1.097 . . . . 0.0 109.811 179.054 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 9.6 m -58.39 -43.99 88.75 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.021 -1.05 . . . . 0.0 112.629 -176.071 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.536 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.1 tpt180 -61.97 -62.05 6.57 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.352 -1.467 . . . . 0.0 112.184 -178.236 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.404 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 11.0 Cg_endo -58.02 -29.6 87.34 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 CA-C-N 120.136 1.084 . . . . 0.0 111.548 -179.196 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.34 -49.96 75.83 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.34 -41.18 65.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.464 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -70.02 -40.61 75.1 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.768 -1.207 . . . . 0.0 108.911 178.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -65.5 -55.46 17.74 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.521 -0.737 . . . . 0.0 109.951 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . 0.431 HG13 ' O ' ' B' ' 344' ' ' ALA . 88.3 t -67.83 -29.72 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.872 -1.142 . . . . 0.0 111.058 -178.482 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -64.05 -42.96 96.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.966 -1.084 . . . . 0.0 109.876 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -66.23 -40.41 90.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.107 -0.995 . . . . 0.0 110.499 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -65.75 -53.13 44.73 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.745 -1.222 . . . . 0.0 110.389 -179.608 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -51.94 -15.64 0.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 109.964 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -75.49 -23.93 71.91 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -105.59 141.32 37.26 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.404 -1.057 . . . . 0.0 108.945 179.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 26.5 m -89.8 -11.48 42.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.997 -1.064 . . . . 0.0 109.937 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.434 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 63.3 p -61.32 148.88 39.81 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.973 -1.079 . . . . 0.0 109.241 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -68.53 134.63 50.35 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.116 -0.99 . . . . 0.0 108.908 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.3 mt -133.01 133.22 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.642 -0.661 . . . . 0.0 109.787 -179.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 32.4 m -129.9 149.03 51.81 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.487 -0.758 . . . . 0.0 109.089 179.245 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 87.1 t -122.3 116.48 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.327 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 33.3 m -105.67 132.12 52.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 33.8 t -140.02 116.49 10.7 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.768 0.794 . . . . 0.0 111.105 -179.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 45.52 51.96 9.48 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.723 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 90.0 -14.03 63.09 Favored Glycine 0 N--CA 1.503 3.142 0 O-C-N 120.156 -1.59 . . . . 0.0 113.099 176.52 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -119.76 131.16 55.28 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 119.495 1.647 . . . . 0.0 110.06 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 18.1 m -129.99 150.23 51.36 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.83 0.824 . . . . 0.0 110.426 -179.412 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . 0.423 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -146.52 171.86 14.44 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.511 0.672 . . . . 0.0 110.145 -179.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 9.6 m -89.68 139.95 30.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.533 -0.73 . . . . 0.0 109.725 -179.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.441 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -81.51 -12.47 58.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.0 -1.062 . . . . 0.0 109.018 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -86.62 21.26 2.23 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.5 -1.666 . . . . 0.0 106.5 178.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . 0.441 ' H ' ' C ' ' B' ' 344' ' ' ALA . 52.7 m -149.96 98.67 2.75 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.226 -179.053 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.966 HD23 HD22 ' A' ' 79' ' ' LEU . 26.0 tp -59.91 -34.4 73.15 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.8 ' CE2' HD11 ' A' ' 79' ' ' LEU . 58.0 m-85 -59.93 -55.56 32.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.265 -0.897 . . . . 0.0 110.11 -179.37 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -69.35 -22.4 63.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 111.178 -177.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' B' ' 352' ' ' THR . 65.1 mt -68.94 -52.78 25.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.645 -1.284 . . . . 0.0 108.09 177.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.552 ' OE1' ' N ' ' B' ' 351' ' ' GLN . 0.8 OUTLIER -40.85 -16.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.977 -178.22 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.545 ' N ' ' O ' ' B' ' 350' ' ' LEU . 63.5 p -87.44 -10.01 53.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.405 -1.435 . . . . 0.0 109.941 -179.167 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.423 HD11 ' HB3' ' B' ' 342' ' ' ALA . 67.8 mt -95.42 117.81 31.02 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.07 -1.019 . . . . 0.0 109.081 178.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.35 94.04 0.91 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 18.1 mt -101.42 88.73 3.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.282 -1.128 . . . . 0.0 108.86 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 77.2 p -90.33 169.99 10.63 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.01 -1.056 . . . . 0.0 110.785 -179.068 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . 0.449 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 1.1 tm0? -61.46 113.78 2.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.721 -0.612 . . . . 0.0 110.973 -179.079 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 100.32 8.07 50.68 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.751 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.1 m -83.31 111.52 19.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.339 -1.095 . . . . 0.0 110.513 -179.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 6.1 t -77.31 114.59 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 122.292 1.044 . . . . 0.0 109.257 -177.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 14.5 m -111.7 177.68 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 90.3 m -131.29 129.35 41.39 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 176.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 71.9 mt -102.63 116.42 46.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 56.8 p -120.01 132.3 55.43 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.35 153.14 40.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 0.0 109.873 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -144.88 124.41 13.18 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.289 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.464 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 159.88 -160.34 31.46 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 118.804 -1.665 . . . . 0.0 111.578 -179.773 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -60.06 -50.93 71.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 122.132 -0.628 . . . . 0.0 112.133 -177.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.434 ' H ' ' HB3' ' B' ' 331' ' ' SER . 71.3 m-20 -109.93 10.93 24.27 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.903 -1.123 . . . . 0.0 111.643 -177.2 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.554 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -42.04 -34.88 0.78 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.988 -1.07 . . . . 0.0 111.848 -178.392 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 26.7 mt-30 -70.72 -38.65 73.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.745 -1.222 . . . . 0.0 110.034 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -65.38 -50.04 67.02 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.926 -1.108 . . . . 0.0 109.011 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.05 -76.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.584 -0.697 . . . . 0.0 111.069 -178.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.579 ' O ' HG23 ' B' ' 378' ' ' VAL . 23.5 t -43.08 -38.13 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.343 -0.848 . . . . 0.0 110.973 -177.471 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.92 -42.39 85.48 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.351 -1.468 . . . . 0.0 110.32 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -81.03 -43.43 19.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.795 -1.191 . . . . 0.0 109.909 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.09 -39.41 86.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.223 -179.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.579 HG23 ' O ' ' B' ' 374' ' ' VAL . 55.9 t -62.02 -43.23 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.057 -1.027 . . . . 0.0 109.342 179.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -70.02 -56.38 7.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.703 -1.248 . . . . 0.0 107.64 178.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 52.0 tp -56.2 -35.06 66.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.564 -0.71 . . . . 0.0 110.058 -177.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 1.5 tpt -71.49 -39.93 70.53 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.543 -1.348 . . . . 0.0 108.669 178.165 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.75 -4.44 57.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.473 -0.767 . . . . 0.0 110.574 179.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.428 ' O ' ' OE2' ' B' ' 385' ' ' GLU . 73.2 mm-40 -111.68 -2.61 15.3 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.105 -0.997 . . . . 0.0 110.995 -179.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 13.1 mt -80.01 133.02 36.12 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.379 -1.45 . . . . 0.0 109.493 179.129 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . 0.525 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 42.9 mp0 . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.211 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mtp . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.5 -0.556 . . . . 2.91 109.5 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.2 mt -109.97 129.94 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.51 -0.744 . . . . 1.2 109.692 -179.84 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 m -131.65 147.61 52.53 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.719 -0.613 . . . . 1.4 109.456 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.44 -164.99 10.13 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 108.834 -1.706 . . . . 1.05 108.834 179.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.6 mt -87.41 -18.33 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.016 -1.285 . . . . 1.15 109.704 -179.356 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.4 tp 54.86 103.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.668 -0.864 . . . . 0.98 108.668 -179.138 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.5 -24.57 16.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.88 108.675 179.509 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 13.4 t -141.77 123.43 8.96 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.574 -0.704 . . . . 1.69 110.011 -179.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.98 147.48 21.2 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.184 1.923 . . . . 0.85 112.531 179.284 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.909 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 150.29 172.64 19.78 Favored Glycine 0 N--CA 1.5 2.918 0 N-CA-C 108.918 -1.673 . . . . 0.92 108.918 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.9 mt -127.45 132.31 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.875 -1.367 . . . . 0.81 109.677 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.43 151.89 50.0 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.317 -0.864 . . . . 0.51 109.957 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -127.28 130.84 50.31 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.866 -1.161 . . . . 0.62 107.866 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.72 178.82 48.65 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 118.583 -1.77 . . . . 0.55 111.183 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -79.96 155.56 27.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.799 -0.824 . . . . 2.1 109.325 -179.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.6 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -106.52 125.78 51.43 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 121.794 0.807 . . . . 0.77 111.369 -178.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.0 tp -99.47 137.52 37.85 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.529 -1.286 . . . . 0.91 107.529 178.195 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.5 tp -119.53 128.65 54.14 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.476 -0.765 . . . . 0.93 109.692 -179.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.1 mt -91.62 105.91 18.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.694 -0.629 . . . . 0.93 110.275 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -106.1 131.79 52.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.162 -1.051 . . . . 2.75 108.162 178.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -129.23 148.58 51.17 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.383 -0.823 . . . . 3.0 109.381 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -83.15 142.42 31.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.455 -0.778 . . . . 2.77 109.33 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -60.2 142.52 54.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.126 -0.983 . . . . 2.94 109.133 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -75.97 126.58 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.977 . . . . 0.95 109.985 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.57 125.33 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.343 -0.848 . . . . 1.28 110.166 -179.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 84.8 mt -110.18 132.29 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.607 -0.886 . . . . 1.21 108.607 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -92.23 117.92 30.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.764 -1.21 . . . . 1.81 109.474 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.447 HH11 ' HG2' ' A' ' 28' ' ' ARG . 5.3 mmt-85 -87.11 -4.39 59.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.164 -0.96 . . . . 2.8 109.342 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -68.25 140.77 56.03 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.194 -0.941 . . . . 2.87 109.248 179.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -84.02 154.49 23.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.899 . . . . 2.35 109.849 -179.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.546 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.3 pt -96.5 167.17 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 0.97 109.467 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.7 p -90.31 172.76 8.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.04 -1.037 . . . . 1.17 108.363 178.574 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.08 -18.09 63.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.938 -1.102 . . . . 1.18 110.994 -179.285 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 64.8 t0 -86.37 -24.62 25.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.626 -1.296 . . . . 2.56 108.392 178.842 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -81.29 -9.97 59.66 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.786 -0.82 . . . . 1.79 108.786 179.1 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 t -60.94 -52.02 66.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -61.08 -39.88 91.57 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.377 -0.827 . . . . 1.77 110.273 -179.619 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -69.24 -40.91 77.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.078 -1.014 . . . . 2.7 111.022 -178.309 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HG3' HG21 ' A' ' 31' ' ' ILE . 68.7 mm-40 -65.91 -39.86 90.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.0 -1.063 . . . . 1.51 110.854 -179.21 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.8 t -61.33 -45.04 99.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.484 -1.385 . . . . 0.93 108.45 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -60.01 -41.5 92.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.043 -1.036 . . . . 1.81 109.622 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -60.17 -45.25 93.71 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.967 -1.093 . . . . 2.78 108.069 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -60.36 -48.29 82.37 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.889 -0.782 . . . . 0.78 108.889 178.199 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.465 ' CD1' HH21 ' A' ' 47' ' ' ARG . 43.2 tp -60.2 -48.81 80.16 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.048 -0.723 . . . . 1.07 109.048 -179.567 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.459 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 44.4 t -63.56 -43.18 97.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.021 -1.05 . . . . 1.12 108.386 178.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.56 -47.42 91.25 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.537 -1.825 . . . . 0.84 108.537 179.059 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.465 HH21 ' CD1' ' A' ' 44' ' ' LEU . 44.2 ttp180 -60.18 -38.78 84.27 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.888 -1.153 . . . . 3.09 107.888 178.656 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -52.9 -46.49 68.02 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.952 -0.758 . . . . 0.88 108.952 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 50' ' ' ALA . 34.0 ttpt -59.92 -74.82 0.07 Allowed 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.548 -1.279 . . . . 2.59 107.548 179.257 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.35 -39.61 0.3 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.356 -0.84 . . . . 0.7 111.907 -178.148 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.0 m -59.34 -52.17 66.8 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.458 -1.401 . . . . 1.4 108.707 -179.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.52 -40.71 89.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.365 -0.834 . . . . 0.67 110.58 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -63.3 -42.17 99.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.0 -1.062 . . . . 1.66 109.878 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.6 mt -64.11 -40.46 96.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.021 -1.049 . . . . 1.58 109.538 179.553 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.7 -39.87 90.15 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.109 -0.995 . . . . 1.35 108.708 179.671 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.418 HG22 ' HZ3' ' A' ' 60' ' ' LYS . 89.3 m -62.23 -43.49 98.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.361 -0.837 . . . . 0.77 109.711 179.097 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 81.7 mt -61.47 -39.85 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.325 -0.859 . . . . 0.63 109.598 179.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -57.56 -50.22 73.81 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.255 -0.903 . . . . 1.14 109.872 -179.041 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -58.44 -37.68 75.9 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.25 -0.906 . . . . 0.79 110.491 -177.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.418 ' HZ3' HG22 ' A' ' 56' ' ' THR . 59.0 mttp -68.47 -36.88 79.6 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.911 -1.118 . . . . 1.53 109.352 179.461 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.438 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.27 -47.34 70.97 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.57 -0.706 . . . . 0.57 109.979 -179.636 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -54.59 -52.8 42.89 Favored Glycine 0 N--CA 1.484 1.858 0 C-N-CA 119.993 -1.099 . . . . 0.75 110.452 -178.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.42 -41.84 72.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.032 -1.275 . . . . 1.59 111.083 -178.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.8 m -66.34 -61.93 1.74 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.025 -1.047 . . . . 0.73 112.181 -177.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -96.68 -44.47 7.1 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.827 -1.171 . . . . 0.75 111.439 -177.546 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.39 -168.08 25.58 Favored Glycine 0 N--CA 1.499 2.882 0 C-N-CA 119.822 -1.18 . . . . 1.22 110.925 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -69.95 -22.82 63.14 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.981 -0.717 . . . . 5.81 110.115 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.506 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 50.4 tp10 -59.99 -35.71 75.61 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.466 -0.771 . . . . 3.37 111.31 -179.14 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -96.51 -16.22 21.23 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.166 -0.959 . . . . 1.77 109.748 -179.699 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -71.6 -43.13 66.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.219 -0.926 . . . . 1.65 110.373 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.59 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -63.69 -34.53 78.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.435 -0.79 . . . . 0.77 110.119 -178.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.86 -40.61 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.909 -1.119 . . . . 0.8 109.108 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -65.04 -39.52 93.47 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.986 -1.071 . . . . 0.88 110.314 -179.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -60.12 -40.06 88.42 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.979 -1.076 . . . . 1.37 109.342 -179.182 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.99 -44.75 95.49 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.181 -1.968 . . . . 0.62 108.181 178.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -63.36 -45.88 89.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.529 -0.983 . . . . 1.5 109.142 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 98.5 mt -70.08 -45.51 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.108 -0.995 . . . . 0.63 109.319 179.575 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.0 ttp -62.65 -41.49 99.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.847 -1.158 . . . . 1.51 110.09 -179.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.005 HD22 HD23 ' B' ' 347' ' ' LEU . 45.7 tp -65.07 -40.83 95.22 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.541 -0.724 . . . . 0.77 110.065 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.7 tp -68.73 -39.52 80.33 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.636 -0.665 . . . . 0.62 110.311 -179.096 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -79.67 0.94 28.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.043 -1.036 . . . . 1.47 109.935 -179.062 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 53.3 t0 -47.28 133.83 11.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.086 -1.009 . . . . 1.47 109.736 -179.311 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.458 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 99.3 mt-10 -64.92 -18.66 65.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.683 -0.636 . . . . 1.78 110.899 -178.749 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -75.51 -33.31 60.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.779 -1.201 . . . . 2.53 109.035 178.68 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 79' ' ' LEU . 88.9 mt -70.02 -39.99 75.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.479 -0.763 . . . . 0.8 109.371 179.5 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.91 -49.53 77.31 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.429 -0.794 . . . . 1.42 110.16 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.4 -39.41 81.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.855 . . . . 1.71 110.787 -179.226 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -68.87 -40.25 79.37 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.719 -1.238 . . . . 1.57 111.221 -179.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.44 -43.19 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.601 -1.312 . . . . 0.65 109.402 179.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.78 -39.17 77.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.552 -0.717 . . . . 0.82 110.749 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.78 95.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.117 -0.989 . . . . 0.79 110.098 -179.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 21.1 mt -63.65 -45.4 90.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.094 -1.004 . . . . 0.95 109.333 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.9 mt -64.15 -48.98 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.406 -0.809 . . . . 0.66 109.18 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.99 -40.77 75.11 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.733 -0.787 . . . . 2.2 110.576 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -84.82 -55.86 3.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.969 -1.082 . . . . 1.65 112.134 -178.142 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -87.1 -1.44 57.89 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.866 -1.146 . . . . 2.03 111.872 -177.321 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 44.3 m80 58.58 35.01 24.31 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.995 -1.066 . . . . 1.42 110.304 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.2 mtp -86.89 166.27 15.28 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.256 -0.903 . . . . 1.18 109.889 -179.474 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.426 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 64.4 p -79.62 161.9 25.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.206 -0.934 . . . . 0.98 108.864 179.536 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.06 -40.54 87.11 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.0 -1.062 . . . . 0.64 109.541 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 23.9 p-10 -69.94 -35.72 74.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 2.07 109.925 179.825 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.12 -40.09 39.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.094 -1.004 . . . . 0.73 109.333 179.279 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.76 -48.33 63.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.862 . . . . 0.54 110.361 -179.368 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.81 -32.54 73.75 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.81 -1.181 . . . . 0.56 109.757 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.525 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 86.3 t60 -60.53 -45.07 95.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 1.54 109.56 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -66.41 -39.96 89.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.792 . . . . 1.33 110.997 -178.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.1 t -62.3 -53.35 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.165 -0.96 . . . . 0.72 111.493 -177.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.8 mm -72.59 -37.12 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.751 -1.218 . . . . 0.85 110.004 -179.382 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.525 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 84.5 tt0 -67.35 -34.2 76.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.172 -0.955 . . . . 2.44 108.537 179.623 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.59 -49.07 82.66 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.357 -1.097 . . . . 0.98 110.357 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.684 HE21 ' CB ' ' B' ' 348' ' ' PHE . 16.3 mm100 -65.92 -50.71 63.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.802 -1.411 . . . . 1.41 109.192 -179.537 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.87 -40.43 80.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 1.2 109.097 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 61.8 m -60.03 -40.18 88.48 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.114 -0.991 . . . . 1.7 108.436 179.733 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.26 -39.65 95.19 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.391 -0.818 . . . . 1.47 109.304 179.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.6 mt -67.82 -43.16 80.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.993 -1.083 . . . . 1.56 109.461 -179.468 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -55.5 -25.4 36.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.85 -1.156 . . . . 2.2 109.723 -179.31 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -66.2 -22.0 66.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.973 -1.079 . . . . 2.12 108.765 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.441 HD13 HD13 ' A' ' 123' ' ' LEU . 51.8 mt -63.25 143.94 57.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.314 -0.866 . . . . 2.0 109.882 -179.617 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -92.55 14.31 17.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.201 -0.937 . . . . 3.23 109.358 179.03 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -103.22 127.83 50.41 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.32 -0.862 . . . . 2.49 110.516 -178.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -70.62 -28.94 65.22 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.366 0.603 . . . . 3.95 110.234 179.239 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.535 ' OH ' ' N ' ' B' ' 315' ' ' HIS . 15.7 t80 -64.26 -40.58 96.28 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.209 -0.932 . . . . 2.0 110.212 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.91 HD22 ' O ' ' B' ' 351' ' ' GLN . 64.2 mt -77.38 -37.15 52.7 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.51 -0.744 . . . . 1.86 109.875 -178.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -59.98 -40.9 90.7 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.249 -0.907 . . . . 2.84 109.329 -179.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 78.1 mm-40 -61.28 -46.02 92.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.958 -1.089 . . . . 2.73 108.877 179.401 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.44 HH21 ' CD2' ' A' ' 123' ' ' LEU . 17.5 ttp180 -61.16 -39.96 92.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.899 . . . . 2.77 108.59 179.203 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.88 -28.9 70.36 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.766 -0.827 . . . . 1.19 108.766 179.011 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -59.95 -40.03 87.58 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.087 -1.079 . . . . 1.2 108.087 179.571 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -62.07 -42.24 98.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.522 -0.736 . . . . 1.55 109.503 179.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.11 -41.4 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.197 -0.939 . . . . 0.8 108.571 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -60.13 -39.33 85.94 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.688 -0.633 . . . . 3.09 109.458 179.32 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -60.04 -41.85 93.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.38 -0.825 . . . . 1.46 110.676 -179.304 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.16 -46.19 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.056 -1.028 . . . . 0.71 110.055 -179.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.99 97.85 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.996 -1.242 . . . . 0.57 109.996 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -59.8 -49.72 76.63 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.326 -1.102 . . . . 2.59 110.142 -179.658 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -70.05 -32.08 70.02 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.101 -0.999 . . . . 2.83 110.501 -179.808 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.9 tp -57.81 -46.74 84.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.97 . . . . 1.25 108.925 -178.884 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.96 -39.64 86.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.138 -0.977 . . . . 0.7 108.565 179.116 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -68.22 -40.0 82.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.356 -0.84 . . . . 2.57 108.884 178.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -60.16 -38.49 83.3 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.862 -0.524 . . . . 1.23 110.999 -178.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.5 mt -72.8 -40.87 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.653 -1.28 . . . . 0.81 108.727 179.397 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.68 -25.58 61.31 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.62 -0.675 . . . . 1.0 109.848 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.6 37.16 27.66 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.96 -1.656 . . . . 0.89 108.96 -179.309 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 58.5 tp -73.14 141.59 47.47 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.497 -1.002 . . . . 1.14 109.381 -179.401 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -61.96 140.06 58.35 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.845 0.831 . . . . 4.6 111.12 -178.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 97.0 mt -115.66 132.25 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.716 -0.846 . . . . 1.24 108.716 178.604 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 24.7 mm -57.02 -43.74 81.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.455 -0.778 . . . . 1.54 109.924 -178.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 11.8 t0 70.18 94.31 0.08 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.063 -0.718 . . . . 1.5 109.063 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.8 mt -66.36 -6.52 14.54 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.382 -0.824 . . . . 0.79 110.841 -178.761 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.0 t -82.93 -16.85 45.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.716 -1.24 . . . . 1.4 110.534 -179.186 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.33 24.29 0.83 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.068 -1.02 . . . . 0.92 112.581 -177.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.0 mm -79.28 126.5 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.305 -1.497 . . . . 0.88 108.793 179.531 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.4 ' O ' ' OD1' ' A' ' 154' ' ' ASP . 77.5 mt-30 -102.8 -11.92 17.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.558 -0.714 . . . . 2.45 110.158 -179.247 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 153' ' ' GLN . 97.7 m-20 -136.85 156.09 48.94 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.117 -0.989 . . . . 1.52 110.39 -178.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.08 135.17 56.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.321 -0.862 . . . . 1.58 109.137 179.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.9 m -152.65 164.48 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.42 -0.8 . . . . 0.69 109.802 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.7 mt -92.5 147.15 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 105.752 -1.944 . . . . 0.61 105.752 176.651 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.4 tp -99.69 119.21 37.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.173 -0.954 . . . . 0.87 110.464 -178.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.1 t -125.13 130.3 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.196 -1.038 . . . . 0.71 108.196 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.84 167.21 28.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -0.991 . . . . 0.81 109.221 -179.768 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.26 -37.31 74.88 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.781 -1.199 . . . . 0.98 108.715 179.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.6 p-10 -170.42 149.01 3.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.57 -0.706 . . . . 2.25 109.602 -179.655 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.1 mt -119.36 133.72 55.58 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.453 -0.779 . . . . 0.78 109.663 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.4 p -93.35 143.89 27.41 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.013 . . . . 0.98 108.624 179.157 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -41.47 -34.23 1.92 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.302 2.001 . . . . 0.81 113.159 -179.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.7 m -59.92 -40.12 87.8 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.768 -1.207 . . . . 0.9 109.294 -178.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.5 -40.24 80.94 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.012 -1.055 . . . . 1.61 109.308 179.474 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 63.8 p -52.94 -30.02 32.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.064 -1.022 . . . . 0.61 110.57 -178.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -70.72 -57.47 4.64 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.816 -1.178 . . . . 0.6 109.701 179.565 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -80.36 34.83 0.32 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.13 -0.693 . . . . 1.4 109.13 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.4 tp -100.08 136.54 39.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.426 -0.796 . . . . 0.7 109.763 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -86.18 96.89 10.07 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.926 -1.139 . . . . 2.35 107.926 178.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.9 -41.72 97.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 1.51 110.87 -178.577 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -68.02 -25.34 65.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.993 -1.067 . . . . 2.33 111.812 -177.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -93.7 -8.74 39.99 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.727 -1.233 . . . . 1.92 110.541 -178.506 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.458 HG12 ' H ' ' A' ' 178' ' ' GLY . 87.5 t -107.58 118.58 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.182 -1.044 . . . . 0.67 108.182 178.613 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 95.3 mt -89.85 6.48 41.66 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.446 -0.784 . . . . 1.53 111.051 -177.342 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.458 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 175.82 166.16 32.87 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.419 -1.472 . . . . 0.48 109.419 179.511 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -132.2 128.44 37.96 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.344 -0.984 . . . . 0.55 108.344 179.573 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.416 ' CG2' HG21 ' A' ' 205' ' ' THR . 86.2 mt -130.47 124.04 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.612 -1.255 . . . . 0.65 107.612 178.489 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.4 p -140.79 156.81 46.08 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.205 1.002 . . . . 0.82 111.386 -178.189 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.491 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 65.6 t0 -102.97 26.03 8.65 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.914 -0.585 . . . . 2.46 110.101 -179.567 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.67 -164.12 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.233 -1.542 . . . . 1.28 111.551 -178.045 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.82 -54.0 8.93 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.261 -1.136 . . . . 2.19 110.261 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.65 -154.44 13.71 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.764 -1.684 . . . . 2.13 111.68 -179.635 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -64.37 -11.28 31.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.89 -0.771 . . . . 5.86 110.745 -178.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 59.6 p -79.94 5.38 14.07 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.119 -0.988 . . . . 3.72 109.699 -179.005 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.0 t -88.67 142.48 27.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 1.74 109.894 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -53.36 -39.15 63.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.385 -0.822 . . . . 0.95 108.919 -179.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 89.5 m -59.77 -42.23 92.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.69 -0.631 . . . . 1.55 110.908 -179.33 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.3 p -60.98 -40.08 92.05 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.846 -1.159 . . . . 1.51 110.962 -178.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.8 mm -61.42 -41.19 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.204 -0.935 . . . . 1.67 110.096 -178.558 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.5 mtp -61.32 -42.94 99.5 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.989 -1.069 . . . . 1.02 110.333 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.96 -47.0 71.78 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.522 -1.361 . . . . 0.68 109.92 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -60.21 -50.26 74.37 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.903 -1.119 . . . . 2.93 110.003 -179.687 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.7 m -69.14 -36.07 77.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.773 -1.204 . . . . 0.86 111.069 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 197' ' ' LEU . 94.7 mt -72.06 -26.39 62.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.822 -1.174 . . . . 0.67 109.45 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 68.42 45.26 1.19 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.098 0.475 . . . . 1.5 110.778 -179.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.479 ' O ' ' CB ' ' A' ' 8' ' ' SER . 62.3 mt -126.69 148.67 65.8 Favored Pre-proline 0 N--CA 1.501 2.116 0 N-CA-C 107.852 -1.166 . . . . 0.72 107.852 178.239 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.86 137.82 78.75 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.192 1.928 . . . . 0.61 112.111 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.31 147.49 3.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.03 -1.044 . . . . 0.66 111.319 -179.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.4 mt -125.34 144.27 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.371 -1.344 . . . . 0.79 107.371 178.434 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 23.9 m -126.77 -11.78 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 O-C-N 121.106 -0.996 . . . . 0.91 111.144 -178.602 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -109.97 24.61 18.55 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.734 -1.346 . . . . 1.01 109.734 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.416 HG21 ' CG2' ' A' ' 180' ' ' ILE . 3.0 p -43.3 -46.68 6.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.333 -1.099 . . . . 0.99 109.897 -179.008 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.491 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 95.51 -50.95 1.81 Allowed Glycine 0 N--CA 1.498 2.813 0 C-N-CA 120.218 -0.991 . . . . 1.12 111.496 178.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 46.8 t -157.07 30.87 0.3 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.245 -1.738 . . . . 1.72 110.745 -178.665 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 40.7 t -72.11 -40.04 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.096 -1.002 . . . . 0.89 109.263 178.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.437 ' H ' HG23 ' A' ' 209' ' ' THR . 6.4 p -54.17 -29.39 45.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -0.927 . . . . 1.03 110.191 -179.301 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 47.5 t -79.78 -20.96 44.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.156 -0.965 . . . . 1.83 110.349 -178.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -96.08 -10.61 27.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.044 -1.035 . . . . 2.27 110.393 -179.287 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 56.2 t -106.63 136.75 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.281 -0.887 . . . . 0.92 111.538 -177.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -112.52 154.54 25.76 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.293 -1.373 . . . . 2.2 107.293 178.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 33.6 p-10 -60.5 139.63 57.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.694 -1.253 . . . . 2.36 110.389 -179.166 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.4 t0 81.03 7.66 1.2 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.586 -0.524 . . . . 2.38 109.586 179.688 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 58.2 t0 -76.59 132.95 39.76 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.298 -0.876 . . . . 2.09 109.215 179.457 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.411 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 33.7 t80 -84.05 119.95 25.56 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.012 -1.107 . . . . 1.27 108.012 179.412 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.6 HD12 ' HB2' ' A' ' 16' ' ' ALA . 86.5 mt -130.42 149.82 51.92 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.334 -0.854 . . . . 0.75 110.927 -178.429 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 63.8 mt -115.22 126.62 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 106.907 -1.516 . . . . 0.63 106.907 177.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 45.1 tp -101.24 120.18 39.86 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.09 -1.006 . . . . 0.7 109.031 -178.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.472 ' C ' ' N ' ' A' ' 223' ' ' VAL . 91.8 m-20 -78.11 -46.99 19.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.088 -1.007 . . . . 2.31 110.263 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.909 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 50.05 16.45 0.24 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.115 -1.069 . . . . 0.78 108.115 -178.537 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.472 ' N ' ' C ' ' A' ' 221' ' ' ASP . 38.5 t -131.21 -47.04 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.321 -1.363 . . . . 1.04 107.321 179.235 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -99.62 3.62 45.33 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.357 -1.349 . . . . 2.44 107.357 177.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 48.6 t30 60.55 44.28 11.89 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 116.117 -0.492 . . . . 1.55 110.259 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -144.37 156.75 44.37 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.869 -1.144 . . . . 1.99 110.273 179.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 79.7 t -125.96 129.94 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.269 -0.641 . . . . 0.77 109.269 179.791 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -95.97 122.69 39.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.042 -1.036 . . . . 0.98 108.784 179.354 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 39.0 t -98.92 116.24 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.361 -0.837 . . . . 0.85 109.99 -179.157 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 63.53 68.42 0.9 Allowed Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.488 -0.757 . . . . 1.66 110.509 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -91.1 130.3 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.492 2.795 . . . . 0.95 112.471 179.7 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.483 HG22 ' N ' ' A' ' 233' ' ' ASN . 23.7 m -67.9 166.1 16.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.16 -0.962 . . . . 1.84 109.894 -179.461 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.483 ' N ' HG22 ' A' ' 232' ' ' THR . 69.6 m-20 -60.13 -40.0 88.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.248 -0.907 . . . . 2.74 110.338 -179.392 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -60.27 -37.21 79.73 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.09 -1.006 . . . . 2.89 108.972 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 70.2 t -64.73 -40.14 88.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.351 -0.843 . . . . 1.3 109.76 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.497 1.89 0 O-C-N 121.111 -0.993 . . . . 1.09 110.017 -179.784 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 3.6 ttt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -150.54 150.32 31.09 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.367 -0.833 . . . . 0.0 109.057 179.082 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . 0.484 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 3.4 pm0 -150.18 157.83 43.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.135 -0.978 . . . . 0.0 110.926 -179.047 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -155.47 150.89 27.1 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.048 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -113.4 129.45 56.54 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.113 -0.992 . . . . 0.0 109.833 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.59 126.85 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 CA-C-O 122.512 1.149 . . . . 0.0 112.458 -177.737 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 31.4 m -77.99 102.37 7.35 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.925 -178.257 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 87.1 mt -51.48 123.92 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 122.277 1.037 . . . . 0.0 110.053 -178.072 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 25.6 p -109.25 20.05 18.74 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.693 -178.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' B' ' 385' ' ' GLU . . . -74.6 116.64 55.34 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 108.719 179.554 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.24 -16.1 44.38 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 CA-C-N 120.362 1.165 . . . . 0.0 112.546 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -112.27 12.15 20.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.523 -0.736 . . . . 0.0 109.652 -179.115 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.25 172.21 5.53 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 -178.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.425 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 2.6 tp -84.53 88.51 7.32 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.871 -1.37 . . . . 0.0 108.427 -179.133 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.535 ' N ' ' OH ' ' A' ' 122' ' ' TYR . 5.0 p80 -90.94 -161.92 0.86 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 120.74 -1.225 . . . . 0.0 109.412 178.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.2 m -56.82 -41.18 77.38 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.147 -0.971 . . . . 0.0 112.605 -176.223 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.59 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 2.4 tpt180 -62.5 -62.67 5.31 Favored Pre-proline 0 N--CA 1.501 2.124 0 O-C-N 120.478 -1.389 . . . . 0.0 112.159 -178.494 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.434 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 12.3 Cg_endo -57.77 -31.5 92.42 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 CA-C-N 120.004 1.037 . . . . 0.0 111.975 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.88 -50.53 73.42 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.006 -1.059 . . . . 0.0 108.233 179.637 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.73 -40.04 59.51 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.904 -179.12 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . 0.534 ' OE1' ' NH2' ' B' ' 317' ' ' ARG . 42.3 mt-30 -69.88 -41.83 74.25 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.981 -1.075 . . . . 0.0 109.57 179.074 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -61.02 -52.69 63.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.33 -0.856 . . . . 0.0 110.101 -179.25 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.19 -30.79 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.798 -1.188 . . . . 0.0 110.014 -178.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -59.36 -47.59 84.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.061 -1.024 . . . . 0.0 109.569 -179.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.53 -50.74 64.09 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.001 -1.062 . . . . 0.0 109.868 -179.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . 0.417 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -60.32 -51.09 71.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.677 -1.264 . . . . 0.0 110.074 -179.622 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -48.31 -19.27 0.28 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.498 -0.751 . . . . 0.0 109.126 -179.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . 0.417 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -80.49 -16.11 76.62 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -105.54 141.07 37.65 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.178 -1.189 . . . . 0.0 109.694 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . 0.409 ' O ' HG22 ' B' ' 330' ' ' THR . 46.0 m -90.43 -12.39 37.57 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.307 -0.87 . . . . 0.0 109.165 179.211 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 95.2 p -61.32 150.02 36.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.147 -0.97 . . . . 0.0 108.862 179.412 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -71.28 135.65 47.54 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.387 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.9 132.29 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.575 -0.703 . . . . 0.0 109.861 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 96.7 m -130.86 147.9 52.57 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 63.0 t -121.99 119.07 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.299 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 21.6 m -103.4 121.34 42.59 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.028 -1.045 . . . . 0.0 109.145 -178.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 18.4 t -134.81 119.67 18.43 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.895 0.855 . . . . 0.0 110.569 -179.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 30.3 m120 43.89 57.61 4.03 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 177.468 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 75.26 -12.81 6.64 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.578 -1.326 . . . . 0.0 112.155 177.208 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -111.96 121.13 44.16 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.955 -1.32 . . . . 0.0 109.959 -178.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 69.0 m -108.49 157.49 18.4 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.749 0.785 . . . . 0.0 110.945 -178.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -153.05 153.72 33.44 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.465 0.65 . . . . 0.0 109.984 179.214 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 17.7 m -91.82 136.57 33.05 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.422 -0.799 . . . . 0.0 110.598 -179.142 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.405 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -70.71 -20.95 62.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.903 . . . . 0.0 109.757 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -84.07 18.69 2.01 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . 0.405 ' H ' ' C ' ' B' ' 344' ' ' ALA . 13.2 m -148.49 93.14 2.1 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.72 0.771 . . . . 0.0 111.273 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 1.005 HD23 HD22 ' A' ' 79' ' ' LEU . 55.6 tp -56.29 -35.46 67.52 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.211 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.759 ' CE2' HD11 ' A' ' 79' ' ' LEU . 50.0 m-85 -56.16 -50.02 72.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.54 -0.725 . . . . 0.0 110.575 -179.06 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -69.85 -39.86 76.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.705 -1.247 . . . . 0.0 110.243 -178.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' B' ' 352' ' ' THR . 38.0 mt -50.04 -56.01 12.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.732 -1.23 . . . . 0.0 108.165 179.481 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.91 ' O ' HD22 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -41.36 -17.05 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.535 -0.728 . . . . 0.0 110.747 -179.151 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.551 ' N ' ' O ' ' B' ' 350' ' ' LEU . 52.7 p -85.87 -13.69 47.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.037 -1.665 . . . . 0.0 110.281 -178.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 29.4 mt -95.04 122.5 37.76 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.106 -0.996 . . . . 0.0 109.057 178.666 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.21 96.3 1.1 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 178.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 46.2 mt -102.33 90.38 3.88 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.293 -1.122 . . . . 0.0 109.925 -179.37 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 21.1 p -97.6 -177.43 3.79 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.267 -0.896 . . . . 0.0 111.253 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -69.74 111.76 5.74 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.9 -179.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.2 10.84 35.51 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 179.267 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 28.5 m -87.12 108.58 18.96 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.059 -1.26 . . . . 0.0 110.791 -179.579 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 32.4 t -77.89 113.79 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 122.058 0.933 . . . . 0.0 109.521 -178.204 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 34.7 m -109.68 178.28 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.409 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 19.1 m -130.43 123.18 29.21 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.5 mt -97.69 111.57 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 52.2 p -116.3 130.48 56.8 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.212 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.45 150.51 37.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.92 . . . . 0.0 109.48 -178.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -142.07 123.61 14.97 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.413 -0.804 . . . . 0.0 108.891 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.591 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.31 -162.64 33.43 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.395 -1.383 . . . . 0.0 111.057 -179.845 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.91 -50.33 74.2 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.207 -0.584 . . . . 0.0 112.518 -177.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.435 ' H ' ' HB3' ' B' ' 331' ' ' SER . 71.8 m-20 -106.38 10.61 31.5 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 120.668 -1.27 . . . . 0.0 110.92 -177.575 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.591 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.3 pt-20 -44.19 -34.87 2.0 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.29 -0.882 . . . . 0.0 111.45 -179.236 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -70.55 -41.19 72.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.876 -1.14 . . . . 0.0 110.017 -179.414 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -67.06 -47.14 72.19 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.341 -179.307 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.24 -74.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.341 -0.849 . . . . 0.0 110.848 -179.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.598 ' O ' HG23 ' B' ' 378' ' ' VAL . 64.3 t -45.87 -34.74 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.93 -1.106 . . . . 0.0 110.871 -177.434 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.17 -47.78 72.86 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.361 -1.462 . . . . 0.0 110.592 179.613 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -78.82 -44.11 23.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.969 -1.082 . . . . 0.0 110.628 -179.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.99 -36.26 76.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 0.0 109.383 -179.637 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.598 HG23 ' O ' ' B' ' 374' ' ' VAL . 39.8 t -63.05 -43.91 99.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.109 -0.994 . . . . 0.0 109.287 179.736 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -69.96 -56.84 5.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.605 -1.309 . . . . 0.0 108.248 178.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 36.1 tp -55.72 -32.21 63.15 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.435 -0.791 . . . . 0.0 109.682 -178.123 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 26.2 ttm -71.97 -40.49 68.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.57 -1.331 . . . . 0.0 109.319 178.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.14 -3.93 57.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.458 -0.776 . . . . 0.0 110.17 179.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -111.75 -4.39 14.68 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.196 -0.94 . . . . 0.0 110.917 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.7 mt -80.45 133.67 35.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.36 -1.463 . . . . 0.0 109.365 179.062 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . 0.402 ' O ' ' HB1' ' B' ' 310' ' ' ALA . 45.3 mt-10 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.324 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.5 mtt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.365 -0.606 . . . . 2.91 109.365 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.4 mt -109.89 129.92 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.447 -0.783 . . . . 1.2 109.366 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 m -138.83 118.78 13.32 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -0.888 . . . . 1.4 108.771 179.799 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.733 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -91.83 -161.0 36.61 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.572 -1.411 . . . . 1.05 109.572 -179.848 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 5' ' ' ILE . 87.0 mt -94.95 -10.42 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.259 -1.142 . . . . 1.15 110.653 -178.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.1 tp 55.01 100.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.977 -1.077 . . . . 0.98 109.183 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.96 -34.23 24.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.88 108.936 179.56 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.0 t -139.14 133.4 16.21 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.497 -0.752 . . . . 1.69 109.231 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.27 143.74 15.91 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.193 1.929 . . . . 0.85 112.672 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.708 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 163.49 -162.03 34.59 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.792 -1.323 . . . . 0.92 109.792 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.6 mt -148.02 146.88 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.169 -1.195 . . . . 0.81 108.334 179.023 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.19 159.62 37.9 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.829 -1.169 . . . . 0.51 110.656 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.8 m-85 -137.93 127.45 24.97 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.547 -1.279 . . . . 0.62 107.547 178.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.59 177.22 48.31 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 118.452 -1.832 . . . . 0.55 110.965 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -78.74 159.5 27.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.782 -0.834 . . . . 2.1 110.107 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.94 123.46 45.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.719 . . . . 0.77 110.994 -179.028 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.2 tp -99.3 134.06 42.7 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 106.498 -1.667 . . . . 0.91 106.498 177.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.6 tp -117.63 122.81 44.59 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.146 -0.971 . . . . 0.93 109.908 -179.354 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.4 mt -87.32 104.54 16.51 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.476 0.655 . . . . 0.93 109.986 -179.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -92.47 136.0 33.58 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.681 -0.859 . . . . 2.75 108.681 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -130.57 139.05 50.43 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.323 -0.86 . . . . 3.0 109.623 179.76 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -93.47 140.79 29.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.243 -0.91 . . . . 2.77 109.122 179.656 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -59.94 139.97 57.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.166 -0.959 . . . . 2.94 109.634 -179.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -79.69 131.81 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.906 . . . . 0.95 108.757 179.889 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.5 t -93.91 124.88 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.132 -0.98 . . . . 1.28 110.053 -179.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.3 mt -101.0 139.97 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.403 -0.811 . . . . 1.21 109.036 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -98.5 115.76 29.27 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.08 -1.012 . . . . 1.81 109.88 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -90.98 0.07 57.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.213 -0.93 . . . . 2.8 108.969 179.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -62.67 143.46 57.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.441 -0.787 . . . . 2.87 109.695 -179.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -83.7 139.39 32.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.413 -0.805 . . . . 2.35 109.873 -179.671 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.565 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.3 pt -89.83 165.28 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.97 109.807 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.8 p -89.71 170.59 10.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.235 -0.915 . . . . 1.17 108.812 178.783 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.36 -22.02 64.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.988 -1.07 . . . . 1.18 109.939 -179.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -82.13 -24.65 34.99 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.529 -1.286 . . . . 2.56 107.529 178.71 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -82.04 -9.8 59.43 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.547 -0.908 . . . . 1.79 108.547 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.3 t -62.94 -52.49 58.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.099 -1.001 . . . . 1.0 108.903 179.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -63.2 -39.89 95.93 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.259 -0.901 . . . . 1.77 109.466 179.661 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -67.32 -41.11 85.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.03 -1.044 . . . . 2.7 110.292 -178.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.565 ' HG3' HG21 ' A' ' 31' ' ' ILE . 61.9 mm-40 -66.51 -39.99 88.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.15 -0.968 . . . . 1.51 110.129 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.45 -44.51 96.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.766 -1.208 . . . . 0.93 108.186 178.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -59.94 -36.08 76.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.319 -0.863 . . . . 1.81 109.472 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.534 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 99.1 mtt180 -59.75 -40.32 87.72 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 118.71 -1.196 . . . . 2.78 108.114 179.522 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -63.83 -48.28 77.43 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.33 -0.856 . . . . 0.78 108.706 177.82 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.6 tp -60.09 -48.86 79.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.46 -0.775 . . . . 1.07 109.216 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.9 t -64.86 -45.11 87.42 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.218 -0.993 . . . . 1.12 108.993 179.557 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.47 -45.06 96.95 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.26 -1.936 . . . . 0.84 108.26 179.098 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -65.6 -31.63 72.77 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.389 -0.967 . . . . 3.09 108.389 178.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.0 87.45 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.451 -0.781 . . . . 0.88 109.019 179.99 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 51' ' ' SER . 11.9 ttmm -65.51 -73.8 0.12 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.752 -1.203 . . . . 2.59 107.752 179.025 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.72 -32.08 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.552 -0.718 . . . . 0.7 111.222 -178.42 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 49' ' ' LYS . 29.7 t -59.74 -54.65 43.9 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.771 -1.205 . . . . 1.4 108.109 179.141 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.53 -41.02 85.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.383 -0.823 . . . . 0.67 111.292 -179.126 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -67.55 -40.54 84.98 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.726 -1.234 . . . . 1.66 110.037 -179.135 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.3 mt -64.85 -40.14 94.69 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.894 -1.129 . . . . 1.58 108.41 179.661 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -61.36 -39.95 92.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.26 -0.9 . . . . 1.35 109.35 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.9 m -67.13 -44.06 80.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.113 -0.992 . . . . 0.77 109.645 -179.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.55 -39.99 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.158 -0.964 . . . . 0.63 108.86 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -53.88 -50.64 65.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.501 -0.75 . . . . 1.14 110.034 -179.368 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -60.0 -38.8 83.68 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.449 -0.782 . . . . 0.79 111.134 -177.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -63.55 -39.67 95.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.833 -1.167 . . . . 1.53 109.613 -179.621 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.21 -43.89 93.64 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.365 0.602 . . . . 0.57 109.769 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.43 -52.48 52.94 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 120.009 -1.091 . . . . 0.75 110.536 -179.066 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.87 -44.81 69.07 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.073 -1.251 . . . . 1.59 110.465 -179.169 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.4 m -66.23 -62.28 1.56 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.999 -1.063 . . . . 0.73 112.24 -178.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -95.61 -49.56 5.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.889 -1.132 . . . . 0.75 111.171 -178.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.22 -167.72 25.99 Favored Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.843 -1.17 . . . . 1.22 110.905 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.94 -23.74 63.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.802 -0.823 . . . . 5.81 110.461 -179.344 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.423 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.7 tp10 -60.07 -36.02 76.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.254 -0.904 . . . . 3.37 110.211 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -98.23 -19.39 17.88 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.177 -0.952 . . . . 1.77 110.225 -179.283 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -70.12 -45.46 66.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.96 -1.087 . . . . 1.65 110.55 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.592 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -62.95 -30.58 71.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.433 -0.792 . . . . 0.77 110.235 -178.626 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.5 mt -59.72 -40.29 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.963 -1.086 . . . . 0.8 108.871 -179.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -65.05 -39.96 94.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.031 -1.043 . . . . 0.88 109.987 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -60.21 -40.06 88.79 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.965 -1.085 . . . . 1.37 109.444 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.5 -41.84 99.64 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.16 -1.576 . . . . 0.62 109.16 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -67.66 -39.98 84.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.283 -1.128 . . . . 1.5 109.728 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.4 mt -69.1 -46.4 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.005 -1.06 . . . . 0.63 109.104 179.555 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.3 ttp -59.9 -45.93 90.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.041 -1.037 . . . . 1.51 110.425 -179.239 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.873 HD22 HD23 ' B' ' 347' ' ' LEU . 55.2 tp -60.93 -40.07 91.84 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.245 -0.91 . . . . 0.77 109.809 179.792 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.7 tp -63.14 -40.01 96.35 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.376 -0.828 . . . . 0.62 109.642 -179.047 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -82.46 9.18 9.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.37 -0.831 . . . . 1.47 109.901 -179.34 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -55.68 132.3 48.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.991 -1.068 . . . . 1.47 110.139 -179.246 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -59.94 -21.21 60.85 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.511 -0.743 . . . . 1.78 111.129 -178.562 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -72.03 -34.51 68.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.787 -1.196 . . . . 2.53 109.686 178.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.9 -40.77 75.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.539 -0.726 . . . . 0.8 109.76 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -60.11 -50.1 75.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.857 . . . . 1.42 110.413 -179.137 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -70.61 -40.1 73.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.187 -0.945 . . . . 1.71 111.439 -179.171 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -69.91 -40.12 75.79 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.94 -1.1 . . . . 1.57 111.489 -178.569 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.57 -41.97 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.076 -1.015 . . . . 0.65 109.422 -179.505 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.02 -37.84 73.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.432 -0.792 . . . . 0.82 110.602 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.0 -46.28 89.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.79 110.803 -178.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 96' ' ' LYS . 29.3 mt -63.27 -45.83 89.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.755 -1.216 . . . . 0.95 109.411 -179.741 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.08 -50.0 81.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.954 0.883 . . . . 0.66 108.796 179.523 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -70.2 -41.0 74.26 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.851 -0.74 . . . . 2.2 110.258 179.616 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -80.38 -53.05 6.97 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.062 -1.024 . . . . 1.65 112.252 -177.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 92' ' ' LEU . 25.9 mtpp -89.96 -3.92 57.76 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.023 -1.048 . . . . 2.03 111.854 -177.395 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 25.9 m170 58.62 38.82 25.12 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.988 -1.07 . . . . 1.42 109.306 -179.362 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.0 mtp -97.87 165.81 11.76 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.592 -0.692 . . . . 1.18 109.959 -179.526 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 46.4 p -76.65 162.22 27.91 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.402 -0.811 . . . . 0.98 109.586 -179.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.82 -37.18 79.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.335 -0.853 . . . . 0.64 110.482 -179.479 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 35.2 p-10 -69.96 -36.94 75.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.86 -1.15 . . . . 2.07 109.633 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.498 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -77.04 -44.97 28.81 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.4 -0.813 . . . . 0.73 109.843 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.02 -41.65 74.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.54 109.523 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.16 -37.94 81.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.065 -1.022 . . . . 0.56 109.71 179.651 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -60.11 -41.01 91.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.436 -0.79 . . . . 1.54 109.938 -178.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.04 -40.12 96.78 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.271 -0.893 . . . . 1.33 110.383 -179.447 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.74 -55.77 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.108 -0.995 . . . . 0.72 111.542 -177.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.417 HG21 ' HA3' ' A' ' 134' ' ' GLY . 47.3 mm -70.08 -40.04 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.645 -1.284 . . . . 0.85 109.22 -178.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -69.95 -38.11 76.03 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.344 -0.984 . . . . 2.44 108.344 178.869 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.08 -46.77 93.61 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.82 -1.312 . . . . 0.98 109.82 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -64.88 -49.04 72.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.894 -1.356 . . . . 1.41 108.866 179.577 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.87 -39.68 86.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.465 -0.772 . . . . 1.2 109.269 179.615 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.5 t -54.85 -40.0 69.18 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.326 -0.859 . . . . 1.7 109.035 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.81 -36.74 78.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 1.47 109.917 179.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.35 -46.17 81.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.09 -1.006 . . . . 1.56 110.558 -178.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -62.89 -22.06 66.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.495 -1.378 . . . . 2.2 110.268 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -67.43 -21.08 65.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.803 -1.185 . . . . 2.12 108.566 178.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 123' ' ' LEU . 19.4 mt -63.88 142.51 58.38 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.158 -1.053 . . . . 2.0 108.158 179.245 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 29.4 p-10 -90.78 53.24 2.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.873 -1.142 . . . . 3.23 110.516 -179.65 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 64.9 t0 -136.33 135.07 38.58 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.176 -0.953 . . . . 2.49 109.795 179.331 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.477 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 99.2 mt-10 -70.17 -32.54 70.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.297 -0.877 . . . . 3.95 110.447 -179.881 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.495 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.9 t80 -70.08 -37.22 75.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.257 -0.902 . . . . 2.0 110.46 179.538 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 118' ' ' LEU . 77.1 mt -74.0 -39.95 63.26 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.236 -0.915 . . . . 1.86 109.256 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.8 -44.32 96.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.941 . . . . 2.84 109.964 179.538 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 45.8 mt-10 -60.1 -41.3 92.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.111 -0.993 . . . . 2.73 109.29 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.55 HH21 HD23 ' A' ' 123' ' ' LEU . 9.9 ttp180 -66.73 -38.74 87.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.153 -1.054 . . . . 2.77 108.153 179.057 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.21 -26.22 64.66 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.077 -1.083 . . . . 1.19 108.077 178.62 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -69.79 -40.25 76.12 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.111 -1.07 . . . . 1.2 108.111 178.709 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -64.79 -40.15 94.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.405 -0.809 . . . . 1.55 109.206 179.693 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.53 -39.98 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.278 -1.008 . . . . 0.8 108.278 179.471 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -60.28 -39.88 88.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.479 -0.763 . . . . 3.09 109.125 179.267 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -58.14 -40.24 80.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 1.46 109.888 -179.269 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.01 -46.69 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.998 -1.064 . . . . 0.71 109.42 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.417 ' HA3' HG21 ' A' ' 108' ' ' ILE . . . -69.79 -31.54 70.25 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.791 -1.324 . . . . 0.57 109.791 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.69 -49.67 76.84 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.244 -1.151 . . . . 2.59 109.208 -179.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.521 HH11 ' HG2' ' A' ' 136' ' ' ARG . 17.6 mtt-85 -67.07 -36.01 81.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.08 -1.012 . . . . 2.83 109.67 179.672 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.8 tp -54.54 -49.01 71.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.476 -0.765 . . . . 1.25 109.801 -178.726 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.09 -40.07 88.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.369 -0.832 . . . . 0.7 109.565 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -72.78 -36.1 67.55 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.264 -0.897 . . . . 2.57 108.661 178.542 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.401 ' CG ' ' O ' ' A' ' 136' ' ' ARG . 6.2 m120 -60.15 -39.75 87.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.836 -0.54 . . . . 1.23 110.97 -179.227 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.8 mt -71.09 -45.13 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.758 -1.214 . . . . 0.81 108.65 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.6 mt -69.97 -40.07 75.61 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.523 -0.871 . . . . 1.0 108.949 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.68 51.57 3.04 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.072 -1.611 . . . . 0.89 109.072 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.6 tp -73.72 148.57 42.53 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.314 -1.109 . . . . 1.14 109.009 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -66.57 141.22 57.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 4.6 109.641 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.2 mt -113.53 130.0 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-O 121.762 0.791 . . . . 1.24 110.069 -179.578 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.3 mp -68.01 -40.09 82.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.746 -0.596 . . . . 1.54 110.309 -178.599 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.3 t0 63.29 123.25 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.396 -0.815 . . . . 1.5 108.947 -178.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.9 mt -90.13 -0.74 57.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 0.79 110.088 -179.06 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.5 t -86.08 -17.49 34.95 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.042 -1.036 . . . . 1.4 110.17 -179.553 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.98 24.8 0.73 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.139 -0.975 . . . . 0.92 110.734 -178.838 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 41.8 mm -90.82 120.69 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.77 -1.206 . . . . 0.88 109.276 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -101.23 -17.51 16.56 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.436 -0.79 . . . . 2.45 110.259 -179.379 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -115.34 145.97 41.99 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.637 -0.665 . . . . 1.52 110.874 -178.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -63.8 135.23 56.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.523 -0.736 . . . . 1.58 109.4 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.0 m -151.55 164.57 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.649 -0.657 . . . . 0.69 109.452 179.39 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 86.0 mt -94.96 147.2 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 105.999 -1.852 . . . . 0.61 105.999 177.474 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 51.9 tp -96.99 117.96 32.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.035 -1.04 . . . . 0.87 110.767 -177.374 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.539 HG12 HG22 ' A' ' 209' ' ' THR . 42.3 t -121.75 127.47 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.451 -0.944 . . . . 0.71 108.451 178.846 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -156.91 161.53 39.65 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 0.81 108.717 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.93 -31.71 63.19 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.26 -1.525 . . . . 0.98 109.172 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 64.9 t0 -169.23 141.92 2.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.434 -0.791 . . . . 2.25 109.128 -179.706 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 24.6 mt -112.08 142.71 44.17 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.362 -0.837 . . . . 0.78 110.226 -179.24 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.0 p -99.56 146.8 32.42 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.466 -0.771 . . . . 0.98 109.247 179.449 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -43.56 -36.7 7.33 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.952 1.768 . . . . 0.81 112.691 179.215 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.6 m -60.0 -39.94 87.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.267 -0.896 . . . . 0.9 109.767 -178.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.46 -41.31 93.52 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.187 -0.945 . . . . 1.61 109.992 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 41.1 p -56.44 -33.94 66.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.61 110.959 -178.4 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.4 -53.9 20.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.91 -1.119 . . . . 0.6 109.58 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -86.47 36.34 0.69 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.604 -0.888 . . . . 1.4 108.604 179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.2 tp -100.46 130.6 46.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.817 . . . . 0.7 109.166 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.55 HD22 ' C ' ' A' ' 172' ' ' ASN . 0.2 OUTLIER -82.79 98.96 9.39 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.276 -1.009 . . . . 2.35 108.276 179.412 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 71.0 mt -65.13 -41.14 95.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.403 -0.811 . . . . 1.51 111.085 -178.569 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -66.61 -25.59 66.68 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.844 -1.16 . . . . 2.33 111.571 -177.752 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.419 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 42.8 mmtm -93.32 -8.2 42.68 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.768 -1.207 . . . . 1.92 110.479 -179.037 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 178' ' ' GLY . 63.3 t -109.31 119.65 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.385 -0.968 . . . . 0.67 108.385 178.578 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.8 mt -91.42 7.1 42.78 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.262 -0.899 . . . . 1.53 110.947 -177.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.496 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.44 171.07 36.97 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.355 -1.402 . . . . 0.48 109.626 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.473 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 12.9 m-85 -133.94 129.76 36.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.463 -1.022 . . . . 0.55 109.066 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.3 mt -132.1 127.28 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.235 -1.024 . . . . 0.65 108.235 178.428 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 43.1 p -147.44 159.93 43.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.879 -1.138 . . . . 0.82 110.406 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -104.27 21.74 16.04 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.914 -0.773 . . . . 2.46 108.914 179.813 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.14 -159.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.995 -1.066 . . . . 1.28 111.202 -178.094 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.46 -53.15 8.99 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.357 -1.097 . . . . 2.19 110.357 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 157.07 -124.27 1.41 Allowed Glycine 0 N--CA 1.494 2.558 0 O-C-N 120.897 -1.355 . . . . 2.13 110.64 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -69.69 -23.9 63.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.39 -1.065 . . . . 5.86 111.014 -178.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 59.8 p -70.53 0.12 7.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.928 -1.107 . . . . 3.72 109.756 -179.29 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 39.2 m -89.46 124.7 34.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.08 -1.013 . . . . 1.74 110.119 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -46.48 -50.87 16.36 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.436 -0.79 . . . . 0.95 109.924 -179.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.82 -35.59 61.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.402 -0.811 . . . . 1.55 110.549 -178.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.5 t -60.07 -45.6 92.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.929 -1.107 . . . . 1.51 110.73 -179.185 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.08 -40.64 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 1.67 109.735 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.0 mtp -61.44 -40.03 92.99 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.084 -1.01 . . . . 1.02 109.964 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.61 -42.71 67.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.737 -1.227 . . . . 0.68 108.915 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -59.57 -50.06 75.36 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.461 -0.895 . . . . 2.93 109.517 -179.02 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 67.1 m -72.4 -33.13 66.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.204 -0.935 . . . . 0.86 111.114 -179.221 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.05 -22.81 63.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.952 -1.093 . . . . 0.67 109.515 -179.5 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 63.71 48.78 3.17 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.437 0.636 . . . . 1.5 110.055 -178.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 60.1 mt -130.25 150.1 75.19 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 107.797 -1.186 . . . . 0.72 107.797 178.693 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.56 144.98 62.71 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.949 1.766 . . . . 0.61 111.567 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -173.36 153.56 2.43 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.064 -1.055 . . . . 0.66 111.102 179.688 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 92.7 mt -124.72 151.62 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 107.669 -1.234 . . . . 0.79 107.669 178.832 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.0 m -133.67 -11.44 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 120.844 -1.16 . . . . 0.91 111.249 -178.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -111.17 25.73 13.49 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.655 -0.978 . . . . 1.01 110.655 -179.375 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.448 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.3 p -47.46 -38.21 13.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.759 -1.436 . . . . 0.99 109.595 -179.206 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.18 -51.06 3.4 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 120.085 -1.055 . . . . 1.12 111.257 178.782 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 207' ' ' SER . 12.9 t -156.51 33.24 0.32 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.558 -1.554 . . . . 1.72 111.4 -178.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 22.8 t -74.52 -36.02 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.66 -1.275 . . . . 0.89 108.348 178.159 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.539 HG22 HG12 ' A' ' 159' ' ' VAL . 44.4 p -59.97 -38.37 82.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.449 -0.782 . . . . 1.03 110.159 -179.553 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 50.4 m -82.01 -11.06 59.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.995 -1.065 . . . . 1.83 110.308 -179.162 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -99.05 -13.23 19.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.043 -1.036 . . . . 2.27 110.601 -179.231 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 213' ' ' LYS . 80.8 t -114.62 154.0 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.247 -0.908 . . . . 0.92 110.955 -178.74 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.482 ' N ' HG12 ' A' ' 212' ' ' VAL . 12.1 mptt -113.17 154.56 26.47 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.261 -1.385 . . . . 2.2 107.261 178.658 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 24.8 p-10 -59.82 141.52 55.17 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.974 -1.078 . . . . 2.36 110.134 -179.461 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 m-20 85.67 6.36 0.43 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.213 0.53 . . . . 2.38 110.032 179.692 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 53.2 t0 -76.62 150.16 36.46 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.262 -0.898 . . . . 2.09 108.71 179.037 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.526 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 50.8 t80 -95.25 122.85 38.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.066 -1.021 . . . . 1.27 108.844 179.725 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.0 mt -126.88 138.5 53.32 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.299 -0.875 . . . . 0.75 110.702 -179.288 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.4 HG23 ' CD2' ' A' ' 13' ' ' PHE . 83.6 mt -110.19 128.25 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 106.453 -1.684 . . . . 0.63 106.453 176.385 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 42.9 tp -103.36 119.92 39.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.065 -1.022 . . . . 0.7 109.901 -178.302 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 10' ' ' GLY . 30.9 t0 -83.44 -41.75 17.73 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.631 -0.877 . . . . 2.31 108.631 179.259 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.84 25.35 0.72 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.927 -0.768 . . . . 0.78 108.927 -179.574 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 37.4 t -130.74 -42.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.329 -1.36 . . . . 1.04 107.329 178.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.528 ' ND2' ' OE1' ' A' ' 226' ' ' GLN . 50.7 p30 -111.34 1.66 17.2 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.04 -1.467 . . . . 2.44 107.04 178.228 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.733 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.5 OUTLIER 62.15 50.12 4.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.93 -0.577 . . . . 1.55 110.258 -179.794 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.528 ' OE1' ' ND2' ' A' ' 224' ' ' ASN . 52.5 mt-30 -132.12 145.0 51.1 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.308 -0.87 . . . . 1.99 109.426 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 66.5 t -118.36 129.08 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.345 -0.983 . . . . 0.77 108.345 179.013 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -104.29 124.56 49.39 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.385 -0.969 . . . . 0.98 108.385 179.446 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.7 t -101.25 110.69 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.471 -0.768 . . . . 0.85 110.005 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 230' ' ' ASN . 30.9 t-20 48.64 67.01 4.92 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.31 -0.868 . . . . 1.66 110.571 179.541 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -86.72 157.22 8.96 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.843 2.362 . . . . 0.95 111.96 179.304 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.4 m -69.86 161.63 29.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 1.84 110.216 -179.071 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -60.04 -39.2 85.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.381 -0.824 . . . . 2.74 109.733 -179.689 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -60.04 -37.02 78.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.208 -0.932 . . . . 2.89 109.56 -179.146 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.27 -40.75 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.017 -1.052 . . . . 1.3 109.123 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.3 mt . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.44 -0.788 . . . . 1.09 109.764 179.873 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 35.1 ttp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.391 0.615 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -153.13 149.01 27.62 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -149.33 160.03 43.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.845 -1.159 . . . . 0.0 110.506 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -152.41 149.69 28.86 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 57.4 mp0 -107.84 130.69 54.97 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.239 -0.913 . . . . 0.0 109.555 179.381 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.83 119.09 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 122.316 1.055 . . . . 0.0 112.503 -177.726 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 94.9 m -76.86 104.07 7.15 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.159 0.98 . . . . 0.0 110.115 -178.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.542 HD12 ' HB ' ' B' ' 359' ' ' THR . 66.0 mt -52.56 116.35 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 122.35 1.072 . . . . 0.0 110.61 -178.017 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 30.5 p -102.08 22.3 13.37 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.632 -178.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.406 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -81.41 123.21 81.34 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.093 179.463 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -70.09 -9.02 25.03 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 CA-C-N 120.203 1.108 . . . . 0.0 112.058 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -119.76 4.22 11.05 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 75.7 178.52 43.64 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.495 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -88.49 97.21 10.95 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.129 -1.218 . . . . 0.0 108.389 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.447 ' CE1' ' H ' ' B' ' 317' ' ' ARG . 6.9 p80 -95.0 -160.62 0.8 Allowed 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.097 -1.002 . . . . 0.0 110.034 179.677 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 19.5 m -59.9 -42.05 92.99 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.017 -1.052 . . . . 0.0 112.681 -175.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.592 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.3 tpt180 -61.82 -64.2 3.36 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 120.229 -1.544 . . . . 0.0 111.396 -178.313 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -55.38 -32.46 81.75 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 CA-C-N 120.096 1.07 . . . . 0.0 111.929 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.88 -51.6 69.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 108.845 179.525 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.51 -40.07 65.11 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 0.0 109.652 -179.274 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . 0.526 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 73.1 tp60 -68.21 -45.19 74.01 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.958 -1.089 . . . . 0.0 108.961 179.258 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -60.0 -50.83 72.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.485 -0.759 . . . . 0.0 110.52 -179.245 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.55 -30.69 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.623 -1.298 . . . . 0.0 109.698 -179.166 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . 0.526 ' NZ ' ' OE1' ' B' ' 321' ' ' GLN . 0.4 OUTLIER -59.96 -45.38 92.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.868 . . . . 0.0 109.093 179.701 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -68.28 -40.06 81.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.392 -0.818 . . . . 0.0 110.951 -178.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' B' ' 328' ' ' GLY . . . -74.08 -53.97 8.82 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.752 -1.218 . . . . 0.0 111.252 -178.74 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -49.51 -14.6 0.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 110.336 -178.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' B' ' 326' ' ' ALA . . . -79.98 -16.27 77.24 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.0 -179.897 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -105.73 143.31 34.06 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.378 -1.072 . . . . 0.0 109.308 179.577 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 31.8 m -90.19 -12.46 38.05 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.984 -1.072 . . . . 0.0 110.301 -179.564 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.432 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 13.5 p -60.49 145.01 49.99 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.93 -1.106 . . . . 0.0 109.232 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -67.66 137.06 55.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.087 -1.008 . . . . 0.0 108.75 179.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.3 mt -134.04 134.02 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.535 -0.728 . . . . 0.0 110.137 -179.194 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 51.9 m -129.36 149.02 51.32 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.446 -0.784 . . . . 0.0 109.164 178.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 64.6 t -123.34 116.63 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.063 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 93.0 m -105.95 129.32 54.11 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.088 -1.007 . . . . 0.0 109.153 -179.143 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 1.4 m -136.03 115.37 12.6 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.756 0.789 . . . . 0.0 110.666 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 40.1 t30 46.03 52.57 9.94 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 177.492 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.15 -13.73 53.19 Favored Glycine 0 N--CA 1.5 2.908 0 O-C-N 120.222 -1.549 . . . . 0.0 112.65 176.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 13.1 tptm -115.46 125.82 53.57 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 118.959 1.379 . . . . 0.0 108.834 -179.517 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 82.6 p -127.42 149.98 49.84 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.92 0.867 . . . . 0.0 110.574 -178.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -145.58 167.75 22.29 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.434 0.635 . . . . 0.0 110.234 -178.653 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 49.0 m -88.92 138.89 31.0 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.609 -0.682 . . . . 0.0 110.434 -179.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.47 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -81.09 -15.55 55.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.024 -1.048 . . . . 0.0 110.456 -179.366 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -84.05 22.26 1.21 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 178.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . 0.47 ' H ' ' C ' ' B' ' 344' ' ' ALA . 63.6 m -150.81 101.67 2.93 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.661 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.873 HD23 HD22 ' A' ' 79' ' ' LEU . 17.3 tp -59.86 -36.6 77.21 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.388 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.852 ' CE2' HD11 ' A' ' 79' ' ' LEU . 52.6 m-85 -57.95 -53.04 62.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.86 . . . . 0.0 110.299 -179.574 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -68.53 -21.74 64.55 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.272 -0.892 . . . . 0.0 111.241 -176.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' B' ' 352' ' ' THR . 76.8 mt -69.26 -52.61 25.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.395 -1.44 . . . . 0.0 108.886 178.442 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.539 ' O ' HD22 ' A' ' 123' ' ' LEU . 0.8 OUTLIER -39.4 -22.33 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.696 -0.627 . . . . 0.0 110.953 -178.156 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.519 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.1 p -80.12 -10.81 59.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.18 -1.575 . . . . 0.0 110.235 -179.13 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' B' ' 342' ' ' ALA . 44.4 mt -96.48 117.79 31.64 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.085 -1.009 . . . . 0.0 108.925 178.729 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.5 95.46 0.78 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.359 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 92.6 mt -95.68 78.62 3.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -1.185 . . . . 0.0 108.691 179.252 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 75.6 p -90.97 179.75 5.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.944 . . . . 0.0 110.549 -178.338 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' B' ' 359' ' ' THR . 12.1 tt0 -50.79 157.47 0.79 Allowed 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 122.188 0.994 . . . . 0.0 111.097 -179.494 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 38.39 26.55 0.04 OUTLIER Glycine 0 N--CA 1.498 2.804 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.336 177.691 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . 0.542 ' HB ' HD12 ' B' ' 308' ' ' ILE . 13.6 m -84.83 106.77 16.61 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.612 -1.522 . . . . 0.0 110.131 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 11.7 t -78.27 113.52 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 122.248 1.023 . . . . 0.0 110.231 -177.556 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 34.4 m -111.58 179.06 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -178.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 37.2 m -130.16 128.28 41.45 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 176.869 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.17 116.31 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.573 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 24.9 p -120.23 132.92 55.54 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.417 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.79 153.93 40.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 0.0 109.917 -178.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -147.03 125.8 12.64 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.075 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.458 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 159.23 -158.45 29.52 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.086 -1.53 . . . . 0.0 111.335 -179.654 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.14 -49.86 75.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 122.017 -0.696 . . . . 0.0 112.485 -177.385 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.432 ' H ' ' HB3' ' B' ' 331' ' ' SER . 76.9 m-20 -114.28 13.64 17.91 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.914 -1.116 . . . . 0.0 111.528 -177.039 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.551 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -42.91 -33.8 0.85 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.23 -0.919 . . . . 0.0 111.035 -179.1 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . 0.532 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 92.4 mm-40 -69.95 -44.2 70.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.059 -1.026 . . . . 0.0 110.412 -178.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -67.52 -47.63 69.36 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.544 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.67 -76.83 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.334 -0.854 . . . . 0.0 110.61 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.61 ' O ' HG23 ' B' ' 378' ' ' VAL . 94.4 t -46.4 -35.36 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 110.969 -177.319 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -67.11 -46.16 75.03 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.221 -1.549 . . . . 0.0 110.238 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -77.61 -43.48 31.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.807 -1.183 . . . . 0.0 109.546 179.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.05 -39.59 86.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 0.0 109.968 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.61 HG23 ' O ' ' B' ' 374' ' ' VAL . 48.5 t -60.06 -45.21 95.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.772 -1.171 . . . . 0.0 109.168 179.657 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' B' ' 383' ' ' GLU . 99.3 mttt -70.0 -56.59 6.59 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.655 -1.278 . . . . 0.0 108.114 178.565 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 42.3 tp -54.88 -35.35 63.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.402 -0.811 . . . . 0.0 109.709 -178.024 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . 0.502 ' O ' ' CE ' ' B' ' 381' ' ' MET . 0.0 OUTLIER -73.47 -39.9 64.55 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.44 -1.304 . . . . 0.0 107.826 177.635 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.48 -4.75 50.09 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.184 -0.948 . . . . 0.0 110.205 179.534 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' B' ' 379' ' ' LYS . 69.6 mm-40 -111.81 1.08 16.42 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.198 -0.939 . . . . 0.0 110.723 179.86 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 16.1 mt -90.36 129.3 36.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.761 -1.212 . . . . 0.0 109.261 179.362 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.326 -179.501 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.8 mtp . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.232 -0.655 . . . . 2.91 109.232 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.1 mt -110.49 124.85 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.499 -0.75 . . . . 1.2 109.601 -179.804 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.5 m -133.28 145.6 50.62 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.563 -0.71 . . . . 1.4 109.154 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.571 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -129.37 -164.36 11.43 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 108.868 -1.693 . . . . 1.05 108.868 179.924 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.1 mt -88.23 -9.93 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.922 -1.34 . . . . 1.15 110.116 -179.098 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 54.6 tp 50.3 98.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.16 -0.963 . . . . 0.98 109.13 179.804 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.11 -31.13 12.27 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.164 -0.96 . . . . 0.88 109.201 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 12.1 t -131.46 119.49 17.44 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 108.947 -0.761 . . . . 1.69 108.947 179.697 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -81.51 148.85 16.39 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.104 1.869 . . . . 0.85 112.812 -179.764 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.93 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 143.76 176.83 18.15 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 108.829 -1.708 . . . . 0.92 108.829 179.755 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 88.4 mt -120.0 153.78 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.147 -1.207 . . . . 0.81 109.833 -179.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.11 152.15 29.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.51 109.773 179.761 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.3 m-85 -133.47 127.58 33.59 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.334 -0.987 . . . . 0.62 108.334 179.565 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.78 175.47 47.37 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 118.885 -1.626 . . . . 0.55 110.687 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -78.66 155.4 29.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.654 -0.91 . . . . 2.1 109.529 -179.523 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.518 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -102.12 131.48 48.59 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.376 -0.828 . . . . 0.77 111.121 -178.586 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.9 tp -100.23 134.86 42.54 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.681 -1.229 . . . . 0.91 107.681 178.31 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.2 tp -115.35 119.97 38.06 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.252 -0.905 . . . . 0.93 110.144 -179.458 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt -88.87 101.11 13.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.503 -0.748 . . . . 0.93 109.944 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -95.78 133.66 39.64 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.235 -1.024 . . . . 2.75 108.235 179.441 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.535 ' CG ' HH21 ' A' ' 139' ' ' ARG . 81.8 tt0 -131.54 141.08 49.64 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.242 -0.911 . . . . 3.0 109.696 -179.398 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -88.24 141.9 28.19 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.453 -0.779 . . . . 2.77 109.662 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.52 139.98 58.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.038 -1.039 . . . . 2.94 109.078 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.5 mt -83.03 136.64 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -0.943 . . . . 0.95 108.915 179.495 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.7 t -102.69 129.55 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.444 -0.785 . . . . 1.28 109.329 -179.612 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.6 mt -106.8 138.92 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.834 -0.802 . . . . 1.21 108.834 179.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -92.87 119.27 32.02 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.01 -1.056 . . . . 1.81 109.586 -179.59 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.428 HH11 ' HG3' ' A' ' 28' ' ' ARG . 23.8 mmm-85 -86.95 -2.96 59.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.563 -0.711 . . . . 2.8 109.557 -179.5 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.7 144.37 56.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.125 -0.984 . . . . 2.87 109.902 179.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -87.99 151.17 22.98 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.837 -0.801 . . . . 2.35 108.837 179.563 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.5 pt -98.12 166.73 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.076 -1.015 . . . . 0.97 110.46 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.8 p -90.45 174.5 7.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 1.17 108.762 178.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.89 -18.7 63.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.14 -0.975 . . . . 1.18 111.087 -179.332 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -83.27 -27.4 29.89 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.565 -1.334 . . . . 2.56 108.709 178.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -81.19 -8.42 59.75 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.242 -0.651 . . . . 1.79 109.242 179.45 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.5 t -61.54 -54.13 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.224 -0.923 . . . . 1.0 108.917 179.516 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -62.14 -39.89 94.12 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.42 -0.8 . . . . 1.77 109.829 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -63.93 -42.78 97.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.033 -1.042 . . . . 2.7 110.104 -179.36 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -64.15 -39.79 94.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.923 -1.111 . . . . 1.51 110.328 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.85 -47.52 91.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.665 -1.272 . . . . 0.93 108.458 -179.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -60.04 -41.12 91.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.949 -1.094 . . . . 1.81 108.855 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -60.04 -44.47 94.63 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.842 -1.17 . . . . 2.78 107.842 178.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -60.32 -47.58 85.41 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.744 -0.836 . . . . 0.78 108.744 178.129 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.4 tp -59.9 -49.33 78.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 1.07 109.224 179.869 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.0 t -62.42 -43.58 98.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.024 -1.047 . . . . 1.12 109.44 179.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.26 -46.39 94.02 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.132 -1.587 . . . . 0.84 109.132 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -67.24 -30.71 70.68 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.328 -1.101 . . . . 3.09 108.454 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.8 -45.75 91.36 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.458 -0.776 . . . . 0.88 109.244 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 50' ' ' ALA . 30.6 ttpt -61.4 -72.69 0.11 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.901 -1.148 . . . . 2.59 107.901 179.427 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.86 -33.68 0.06 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.477 -0.764 . . . . 0.7 111.725 -178.188 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 64.1 m -59.95 -50.65 72.92 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.064 -1.454 . . . . 1.4 107.95 179.452 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.62 -40.09 76.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.44 -0.788 . . . . 0.67 111.211 -179.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -66.45 -40.04 89.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.663 -1.273 . . . . 1.66 110.116 -179.427 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.1 mt -65.09 -40.0 93.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.925 . . . . 1.58 109.783 -179.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -61.85 -38.04 86.75 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.98 -1.075 . . . . 1.35 109.694 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -63.63 -41.62 98.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 0.77 109.774 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.3 -39.89 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.198 -0.939 . . . . 0.63 109.077 179.756 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -55.67 -50.05 71.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -0.842 . . . . 1.14 109.542 -179.586 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -57.34 -33.23 67.53 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.223 -0.923 . . . . 0.79 110.062 -178.457 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -69.82 -39.76 76.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.944 -1.097 . . . . 1.53 110.594 179.593 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.407 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.13 -44.36 80.07 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.232 -0.918 . . . . 0.57 110.218 -178.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.78 -50.89 62.83 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.931 -1.268 . . . . 0.75 109.931 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.9 -43.93 70.75 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.99 -1.3 . . . . 1.59 109.985 -179.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.0 m -66.43 -62.73 1.31 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.118 -0.989 . . . . 0.73 111.742 -178.09 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -95.43 -48.71 5.74 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.872 -1.143 . . . . 0.75 111.316 -178.071 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.83 -166.64 25.86 Favored Glycine 0 N--CA 1.504 3.173 0 C-N-CA 119.818 -1.182 . . . . 1.22 111.043 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.51 -23.42 64.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.673 -0.898 . . . . 5.81 109.618 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -60.73 -37.69 82.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.816 . . . . 3.37 110.872 -179.579 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -99.43 -15.01 18.88 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.007 -1.058 . . . . 1.77 109.858 -179.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -70.03 -39.99 75.42 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.081 -1.012 . . . . 1.65 109.085 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.496 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.68 -31.5 72.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.622 -0.674 . . . . 0.77 109.946 -179.466 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 80.8 mt -59.89 -41.2 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.828 -1.17 . . . . 0.8 108.538 179.836 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -65.3 -39.32 92.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.959 . . . . 0.88 110.501 179.707 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -60.01 -39.85 87.21 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.697 -1.252 . . . . 1.37 109.086 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.41 -48.96 68.36 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.462 -1.855 . . . . 0.62 108.462 178.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -62.02 -44.72 96.11 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.264 -1.139 . . . . 1.5 108.682 179.203 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 80.9 mt -68.7 -48.6 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.266 -0.896 . . . . 0.63 109.344 179.429 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 52.3 ttp -60.17 -40.83 91.3 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.939 -1.101 . . . . 1.51 109.764 -179.168 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.848 HD22 HD23 ' B' ' 347' ' ' LEU . 53.5 tp -64.97 -39.9 94.18 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.338 -0.851 . . . . 0.77 109.907 179.639 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.0 tp -64.27 -40.1 95.29 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.497 -0.752 . . . . 0.62 110.268 -179.137 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -81.06 7.85 9.95 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.904 -1.123 . . . . 1.47 110.557 -178.853 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -56.91 129.78 43.03 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.081 -1.012 . . . . 1.47 110.134 -178.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -60.33 -15.36 24.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.33 -0.857 . . . . 1.78 110.438 -179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -69.9 -35.98 75.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.956 -1.09 . . . . 2.53 108.675 178.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.2 mt -71.17 -42.84 68.56 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.49 0.662 . . . . 0.8 110.054 179.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.59 -47.77 84.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.907 . . . . 1.42 110.551 -179.138 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -70.74 -43.92 67.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.089 -1.007 . . . . 1.71 111.746 -178.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -70.41 -38.65 74.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.127 -0.983 . . . . 1.57 111.525 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.53 -42.23 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.044 -1.035 . . . . 0.65 110.016 -179.062 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.81 -37.78 77.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.42 -0.8 . . . . 0.82 110.17 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.01 -46.45 89.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.137 -0.977 . . . . 0.79 111.13 -179.03 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.2 mt -60.96 -45.55 94.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.734 -1.228 . . . . 0.95 109.992 -178.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.36 -50.02 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 0.66 109.42 -179.577 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.04 -40.91 74.85 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.833 -0.747 . . . . 2.2 110.487 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -81.54 -50.5 9.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.129 -0.982 . . . . 1.65 112.249 -178.185 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -93.04 -2.24 55.83 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.071 -1.018 . . . . 2.03 111.982 -176.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 57.4 35.97 26.57 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.059 -1.026 . . . . 1.42 109.793 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.5 mtt -90.39 168.04 12.18 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.45 -0.781 . . . . 1.18 110.128 -179.457 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.5 p -80.15 160.64 25.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.489 -0.757 . . . . 0.98 109.597 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.82 -39.72 76.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.64 110.381 -179.557 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 34.2 p-10 -66.31 -39.2 89.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.052 -1.03 . . . . 2.07 109.821 -179.626 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.484 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -78.93 -51.59 9.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.73 109.704 179.417 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.48 77.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.537 -0.727 . . . . 0.54 111.131 -179.002 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.04 -45.92 91.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.065 -1.022 . . . . 0.56 110.018 -179.059 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -58.39 -37.16 74.7 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.308 -0.87 . . . . 1.54 109.917 -179.706 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.92 -39.99 91.5 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.26 -0.9 . . . . 1.33 111.014 -179.127 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.85 -49.97 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.832 -1.168 . . . . 0.72 110.58 -178.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.7 mm -67.42 -40.24 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.992 -1.067 . . . . 0.85 108.237 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -66.92 -37.2 83.89 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.184 -1.043 . . . . 2.44 108.184 178.836 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.93 -49.0 83.34 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.009 -1.236 . . . . 0.98 110.009 -179.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -65.86 -48.05 72.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.853 -1.38 . . . . 1.41 109.123 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.383 -0.823 . . . . 1.2 109.222 -179.825 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 58.5 m -60.02 -40.1 88.15 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.267 -1.012 . . . . 1.7 108.267 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.35 -43.5 96.45 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.45 -0.944 . . . . 1.47 108.45 179.074 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.7 mt -64.04 -48.83 74.72 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.159 -1.052 . . . . 1.56 108.159 179.302 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -49.48 -31.86 10.91 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.321 -0.862 . . . . 2.2 109.998 -179.11 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.74 -20.28 55.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.892 -1.13 . . . . 2.12 108.668 179.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 74.1 mt -63.15 140.05 58.83 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.511 -0.922 . . . . 2.0 108.511 179.317 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -99.11 49.01 0.95 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.116 -0.99 . . . . 3.23 111.02 -178.531 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 24.7 t0 -137.38 153.22 50.23 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.145 -0.972 . . . . 2.49 109.119 178.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.457 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 99.5 mt-10 -72.44 -64.78 0.88 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.95 -1.13 . . . . 3.95 107.95 178.352 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.437 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 6.6 t80 -41.33 -43.74 2.56 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.91 -0.494 . . . . 2.0 110.895 -179.234 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.607 HD23 HH21 ' A' ' 126' ' ' ARG . 85.3 mt -69.88 -40.05 75.92 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.604 -1.31 . . . . 1.86 109.028 -179.836 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -65.33 -37.36 86.85 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.525 -0.735 . . . . 2.84 109.563 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 95.0 mt-10 -59.83 -42.15 92.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.391 -0.818 . . . . 2.73 110.268 -179.031 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.607 HH21 HD23 ' A' ' 123' ' ' LEU . 82.2 mtm180 -70.05 -32.72 70.98 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.924 -1.11 . . . . 2.77 108.812 179.621 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.22 -22.77 65.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.735 -1.209 . . . . 1.19 107.735 178.458 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -73.72 -40.04 63.85 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.511 -0.922 . . . . 1.2 108.511 178.609 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.99 -41.22 99.51 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.433 -0.792 . . . . 1.55 110.377 -179.587 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.8 t -68.67 -40.45 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.047 -1.033 . . . . 0.8 108.873 179.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.415 HH11 ' HG2' ' A' ' 131' ' ' ARG . 36.3 ttt-85 -60.19 -37.69 81.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 3.09 108.779 178.602 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 61.6 t0 -59.84 -38.97 83.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.527 -0.733 . . . . 1.46 109.68 -179.483 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.04 -40.65 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.083 -1.011 . . . . 0.71 109.563 -179.486 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.13 -26.85 67.53 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.848 -1.301 . . . . 0.57 109.848 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -60.1 -49.62 76.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -1.186 . . . . 2.59 109.575 -179.217 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.412 HH22 ' HB3' ' A' ' 166' ' ' SER . 98.5 mtt180 -68.32 -32.96 73.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.786 -1.197 . . . . 2.83 110.559 179.545 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.6 tp -54.34 -43.96 71.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.936 -1.103 . . . . 1.25 108.795 -179.338 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.92 -39.98 93.91 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.124 -0.985 . . . . 0.7 109.037 178.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.624 HH12 HD23 ' A' ' 144' ' ' LEU . 3.2 mtt-85 -68.13 -40.02 82.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.856 . . . . 2.57 109.714 179.407 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -68.76 -38.27 79.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.458 -0.776 . . . . 1.23 112.265 -178.439 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.91 -40.09 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.321 -1.487 . . . . 0.81 108.791 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 92.2 mt -76.03 -28.69 57.8 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.509 -0.744 . . . . 1.0 110.167 -179.429 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.81 38.95 18.46 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.423 -1.471 . . . . 0.89 109.423 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.624 HD23 HH12 ' A' ' 139' ' ' ARG . 3.3 tp -73.89 147.18 43.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.259 -1.141 . . . . 1.14 108.619 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -66.43 137.02 56.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.034 -1.041 . . . . 4.6 109.653 -179.153 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 83.2 mt -109.83 132.92 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 122.218 1.008 . . . . 1.24 108.512 179.548 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.3 mt -65.02 -39.97 87.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 115.637 -0.71 . . . . 1.54 110.768 -178.304 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 41.3 t0 63.21 102.23 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.412 -0.805 . . . . 1.5 108.861 -179.255 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.9 mt -70.02 -1.11 8.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.365 -0.834 . . . . 0.79 111.49 -178.023 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.7 t -84.66 -13.15 52.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.524 -1.36 . . . . 1.4 110.324 -179.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.93 31.64 0.2 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.092 -1.005 . . . . 0.92 112.052 -178.07 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.8 mm -86.04 120.0 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.234 -1.541 . . . . 0.88 109.087 179.546 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -101.41 -9.32 21.22 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.321 -0.862 . . . . 2.45 110.462 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -140.31 159.93 41.1 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.039 -1.038 . . . . 1.52 110.867 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.83 132.88 50.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.501 -0.75 . . . . 1.58 109.162 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.0 m -152.06 165.5 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.274 -0.891 . . . . 0.69 110.074 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.9 mt -97.09 145.29 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 105.522 -2.029 . . . . 0.61 105.522 176.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.3 tp -95.41 115.49 27.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.873 -1.142 . . . . 0.87 110.614 -177.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.526 HG12 HG22 ' A' ' 209' ' ' THR . 57.0 t -120.28 128.07 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 N-CA-C 108.257 -1.016 . . . . 0.71 108.257 179.026 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.48 165.58 30.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.025 -1.047 . . . . 0.81 109.27 -179.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.77 -38.0 73.41 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.363 -1.461 . . . . 0.98 108.567 178.61 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 54.0 t0 -171.7 147.16 2.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.582 -0.699 . . . . 2.25 109.468 -179.667 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.412 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 17.6 mt -119.91 136.72 54.4 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.281 -0.887 . . . . 0.78 108.859 179.505 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.5 p -89.98 149.98 42.75 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.179 -0.951 . . . . 0.98 110.009 -179.424 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -40.63 -39.39 2.95 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.563 2.175 . . . . 0.81 113.438 179.58 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.412 ' HB3' HH22 ' A' ' 136' ' ' ARG . 66.1 m -59.99 -39.96 87.51 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.966 -1.084 . . . . 0.9 109.253 -179.122 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.68 -40.08 94.78 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.346 -0.846 . . . . 1.61 110.129 -179.828 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 51.7 p -57.97 -34.55 70.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.163 -0.96 . . . . 0.61 111.225 -177.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -69.4 -50.91 41.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.962 -1.086 . . . . 0.6 109.914 -179.659 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -85.7 36.67 0.67 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.421 -0.799 . . . . 1.4 108.9 -179.612 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.2 tp -99.97 140.01 34.8 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.451 -0.781 . . . . 0.7 109.491 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -84.4 104.63 14.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.021 -1.049 . . . . 2.35 108.62 179.185 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 63.2 mt -65.75 -40.97 92.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.442 -0.786 . . . . 1.51 111.612 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -81.25 -15.01 56.82 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.638 -1.289 . . . . 2.33 112.162 -177.172 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -95.33 -10.63 29.59 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.611 -1.305 . . . . 1.92 109.132 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 178' ' ' GLY . 99.9 t -110.28 120.08 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.401 -0.812 . . . . 0.67 108.82 178.669 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -91.64 7.85 39.59 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.027 -1.045 . . . . 1.53 110.723 -178.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.27 172.37 38.04 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.543 -1.423 . . . . 0.48 109.543 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -132.94 129.89 38.88 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.326 -1.102 . . . . 0.55 109.403 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.439 ' CG2' HG21 ' A' ' 205' ' ' THR . 96.2 mt -132.02 124.26 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.865 -0.791 . . . . 0.65 108.865 178.67 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 53.6 p -146.97 159.8 43.12 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.132 -0.98 . . . . 0.82 110.761 -179.615 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.8 OUTLIER -96.35 21.63 8.83 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.124 -0.695 . . . . 2.46 109.124 179.686 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.485 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -45.58 -176.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 122.341 1.067 . . . . 1.28 112.847 -177.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.93 -56.77 4.71 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 111.131 -0.788 . . . . 2.19 111.131 -179.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.46 -144.24 5.1 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.118 -1.515 . . . . 2.13 110.79 -179.34 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 188' ' ' SER . 82.1 mtm180 -69.66 -28.14 65.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.54 -0.976 . . . . 5.86 110.302 -178.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 69.7 p -62.95 5.82 0.12 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.194 -0.942 . . . . 3.72 110.614 -178.756 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 186' ' ' ARG . 40.4 t -90.67 128.35 36.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.987 -1.071 . . . . 1.74 109.894 -179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -47.52 -44.17 25.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.316 -0.865 . . . . 0.95 108.825 179.687 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 45.3 p -57.8 -39.56 77.82 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.78 -0.575 . . . . 1.55 110.425 -179.058 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 58.5 m -59.94 -40.17 88.04 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.997 -1.064 . . . . 1.51 110.899 -178.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.555 HD12 ' N ' ' A' ' 192' ' ' ILE . 2.2 mp -64.75 -40.07 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.951 -1.093 . . . . 1.67 110.295 -179.035 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.5 mtp -61.25 -41.14 96.39 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.843 -1.161 . . . . 1.02 110.615 -179.441 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.86 -44.1 94.32 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.505 -1.372 . . . . 0.68 109.541 -179.73 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.43 HH11 ' HG2' ' A' ' 195' ' ' ARG . 30.0 mtt-85 -60.23 -50.1 74.99 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.272 -0.893 . . . . 2.93 109.996 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 39.4 m -72.0 -35.72 69.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.11 -0.994 . . . . 0.86 111.823 -178.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.6 mt -76.67 -13.24 60.07 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.499 -1.376 . . . . 0.67 110.194 -178.702 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 59.81 46.08 11.87 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.533 -0.73 . . . . 1.5 110.547 179.392 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.409 ' O ' ' CB ' ' A' ' 8' ' ' SER . 90.6 mt -122.85 128.91 25.2 Favored Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 108.687 -0.857 . . . . 0.72 108.687 179.313 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -43.41 133.92 6.8 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.82 1.68 . . . . 0.61 112.073 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -167.27 147.17 5.32 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.575 -1.25 . . . . 0.66 111.89 -179.483 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.7 mt -125.58 141.07 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 107.772 -1.196 . . . . 0.79 107.772 178.362 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 11.2 m -126.71 -7.29 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 120.806 -1.184 . . . . 0.91 110.589 -179.067 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.15 22.06 25.84 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.544 -1.022 . . . . 1.01 110.544 -179.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.456 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 12.6 p -47.14 -44.58 21.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.834 -1.392 . . . . 0.99 109.782 -179.287 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.69 -53.96 4.07 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 120.022 -1.085 . . . . 1.12 112.036 178.688 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.0 t -150.03 28.27 0.76 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 120.485 -1.597 . . . . 1.72 111.905 -178.2 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 45.6 t -70.25 -40.07 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.74 -1.225 . . . . 0.89 109.126 178.314 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.526 HG22 HG12 ' A' ' 159' ' ' VAL . 75.9 p -53.79 -30.82 46.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.377 -0.827 . . . . 1.03 111.392 -178.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.7 m -81.28 -12.95 58.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.823 -1.173 . . . . 1.83 110.283 -179.132 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -102.57 -12.14 17.98 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.141 -0.974 . . . . 2.27 110.351 -179.612 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 85.0 t -107.86 139.24 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.177 -0.952 . . . . 0.92 111.675 -177.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -114.25 150.01 35.02 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.356 -1.35 . . . . 2.2 107.356 178.212 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.507 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 21.3 p-10 -57.1 140.45 49.28 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.735 -1.228 . . . . 2.36 109.9 -179.356 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.1 t0 87.15 4.07 0.37 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 109.525 -0.546 . . . . 2.38 109.525 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 64.8 t0 -74.7 139.41 43.44 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.204 -0.935 . . . . 2.09 109.561 179.512 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.469 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 48.4 t80 -91.94 116.56 29.02 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.524 -1.287 . . . . 1.27 107.524 178.456 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.518 HD12 ' HB2' ' A' ' 16' ' ' ALA . 76.4 mt -127.37 149.4 50.08 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.468 -0.77 . . . . 0.75 110.297 -178.631 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 63.1 mt -114.66 129.71 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 106.859 -1.534 . . . . 0.63 106.859 176.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 55.0 tp -100.14 119.17 37.92 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.078 -1.082 . . . . 0.7 108.078 -179.153 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.459 ' C ' ' N ' ' A' ' 223' ' ' VAL . 78.7 m-20 -81.4 -46.73 14.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.965 -1.084 . . . . 2.31 109.51 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.93 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 48.23 17.27 0.11 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.792 -0.818 . . . . 0.78 108.792 -179.251 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.459 ' N ' ' C ' ' A' ' 221' ' ' ASP . 55.3 t -127.19 -49.42 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.256 -1.387 . . . . 1.04 107.256 178.387 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -100.31 2.87 42.98 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.412 -1.329 . . . . 2.44 107.412 178.37 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.571 HD21 ' H ' ' A' ' 4' ' ' GLY . 1.1 t-20 59.82 49.18 8.24 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.04 -0.726 . . . . 1.55 109.04 -179.071 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -136.85 147.11 46.33 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.438 -0.789 . . . . 1.99 109.572 -179.642 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.5 t -119.89 126.84 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.269 -1.011 . . . . 0.77 108.269 179.474 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -100.1 117.56 34.61 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.185 -0.947 . . . . 0.98 108.934 179.854 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.3 t -98.8 111.52 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.734 -0.604 . . . . 0.85 109.914 -179.044 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 55.18 68.54 2.47 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.311 -0.868 . . . . 1.66 111.235 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -90.67 145.42 3.86 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 123.13 2.553 . . . . 0.95 112.122 178.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 61.2 p -69.95 163.98 24.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.039 -1.038 . . . . 1.84 109.646 -179.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -60.19 -40.38 89.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 2.74 110.071 -178.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -60.07 -39.98 87.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.057 -1.027 . . . . 2.89 109.522 -179.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.69 -40.4 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.052 -1.03 . . . . 1.3 109.299 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.0 mt . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.266 -0.896 . . . . 1.09 109.085 179.72 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . 0.482 ' N ' ' OE1' ' B' ' 366' ' ' GLU . 11.0 ttt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.488 0.661 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -156.93 154.23 29.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.382 -0.824 . . . . 0.0 109.056 178.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -151.21 162.44 40.88 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.916 -1.115 . . . . 0.0 110.737 -178.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -154.96 152.16 29.37 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.611 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -113.0 133.93 54.74 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.094 -1.004 . . . . 0.0 110.346 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.1 p -134.45 125.61 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 CA-C-O 122.415 1.102 . . . . 0.0 112.475 -178.492 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . 0.487 ' O ' HG23 ' B' ' 309' ' ' THR . 93.9 m -77.83 106.29 9.57 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.306 -177.875 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.9 mt -52.13 122.02 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 122.222 1.01 . . . . 0.0 110.413 -178.186 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . 0.487 HG23 ' O ' ' B' ' 307' ' ' THR . 62.4 p -110.73 18.62 19.45 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.697 -178.579 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.25 115.98 53.69 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.083 -1.011 . . . . 0.0 109.584 179.642 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -49.5 -15.4 0.9 Allowed 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 121.114 1.209 . . . . 0.0 114.266 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -118.92 9.44 11.93 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.199 -0.938 . . . . 0.0 109.694 -179.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.2 177.74 26.64 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -179.118 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.437 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.0 tp -83.73 93.86 8.02 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.034 -1.274 . . . . 0.0 109.716 -178.32 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -95.92 -162.52 0.96 Allowed 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.661 -1.274 . . . . 0.0 110.391 179.274 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 25.8 m -55.9 -40.01 72.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.154 -0.967 . . . . 0.0 112.377 -176.31 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.517 HH21 ' CD ' ' B' ' 321' ' ' GLN . 1.7 tpt180 -62.9 -61.65 7.09 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 120.677 -1.265 . . . . 0.0 112.507 -178.37 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.98 -32.54 95.53 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 CA-C-N 120.275 1.134 . . . . 0.0 111.896 -179.24 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.94 -50.07 75.21 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.139 -1.024 . . . . 0.0 108.457 179.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.65 -40.61 60.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.71 -179.423 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . 0.517 ' CD ' HH21 ' B' ' 317' ' ' ARG . 27.2 mt-30 -72.8 -40.06 66.18 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.827 -1.149 . . . . 0.0 109.457 178.631 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -60.28 -51.5 69.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.18 -0.95 . . . . 0.0 109.996 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 92.4 t -69.01 -24.73 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.936 -1.103 . . . . 0.0 110.501 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . 0.466 ' HZ1' ' HA ' ' B' ' 321' ' ' GLN . 0.9 OUTLIER -60.03 -42.49 94.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.859 -1.15 . . . . 0.0 108.823 179.9 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -69.5 -60.06 2.58 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.626 -0.671 . . . . 0.0 111.562 -178.185 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.1 -9.01 43.1 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.822 -1.174 . . . . 0.0 112.698 -177.512 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -83.67 -20.3 33.81 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.441 -1.412 . . . . 0.0 110.113 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -87.52 -10.97 69.56 Favored Glycine 0 N--CA 1.498 2.78 0 C-N-CA 120.084 -1.055 . . . . 0.0 111.158 -178.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -102.45 143.23 32.44 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.961 -1.317 . . . . 0.0 109.417 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 57.9 p -89.59 -13.84 36.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.034 -1.041 . . . . 0.0 110.06 -179.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 82.2 p -58.9 145.24 41.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.109 -0.994 . . . . 0.0 109.095 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . 0.462 ' OE1' ' N ' ' B' ' 332' ' ' GLU . 49.5 mp0 -68.26 130.1 41.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.187 -0.946 . . . . 0.0 109.069 -179.804 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 86.1 mt -132.18 132.55 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.589 -0.695 . . . . 0.0 110.21 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 95.3 m -131.06 151.3 51.56 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.5 -0.75 . . . . 0.0 109.725 179.393 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 96.3 t -125.12 120.05 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 95.1 m -116.84 130.09 56.49 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.037 -1.039 . . . . 0.0 110.329 -178.321 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 2.0 m -133.75 117.62 17.13 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.883 0.849 . . . . 0.0 110.037 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 48.3 t30 49.66 50.51 18.17 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 176.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.84 -12.01 65.03 Favored Glycine 0 N--CA 1.504 3.19 0 O-C-N 119.682 -1.886 . . . . 0.0 113.434 176.286 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -120.56 132.5 55.19 Favored 'General case' 0 N--CA 1.506 2.375 0 CA-C-N 119.292 1.546 . . . . 0.0 108.957 -179.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 95.7 p -135.78 156.15 49.26 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 121.94 0.876 . . . . 0.0 111.249 -178.317 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -145.65 167.36 23.29 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.583 0.706 . . . . 0.0 110.183 -179.401 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 3.7 t -85.38 133.54 34.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.614 -0.679 . . . . 0.0 110.212 -179.392 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -70.71 -19.11 62.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.126 -0.984 . . . . 0.0 110.687 -179.361 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -88.49 21.36 2.95 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.168 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . 0.42 ' H ' ' C ' ' B' ' 344' ' ' ALA . 59.7 p -144.42 93.81 2.48 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.863 -179.037 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.848 HD23 HD22 ' A' ' 79' ' ' LEU . 44.4 tp -59.84 -38.97 83.6 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.669 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.715 ' CE2' HD11 ' A' ' 79' ' ' LEU . 57.5 m-85 -54.16 -52.28 61.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.185 -0.947 . . . . 0.0 110.946 -179.22 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -69.64 -39.24 77.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.432 -1.417 . . . . 0.0 110.102 -179.378 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' B' ' 352' ' ' THR . 23.7 mt -50.12 -59.78 3.59 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.73 -1.232 . . . . 0.0 109.534 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.551 ' OE1' ' NH1' ' A' ' 126' ' ' ARG . 13.1 mm-40 -43.29 -11.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.555 -0.716 . . . . 0.0 111.4 -177.499 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.586 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.3 p -89.47 -8.96 51.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.586 -1.321 . . . . 0.0 109.638 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 68.8 mt -93.44 120.0 33.2 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.011 -1.055 . . . . 0.0 108.664 178.58 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.04 94.81 0.81 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 44.2 mt -102.26 88.22 3.25 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.429 -1.041 . . . . 0.0 109.569 179.691 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 71.8 p -93.11 170.8 9.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.071 -1.018 . . . . 0.0 110.528 -179.566 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -64.45 116.39 6.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.758 -0.589 . . . . 0.0 110.99 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 102.26 4.83 50.14 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 49.7 m -85.67 110.83 19.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.37 -1.077 . . . . 0.0 110.84 -179.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 45.7 t -76.23 115.9 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.965 0.888 . . . . 0.0 109.206 -177.301 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 13.3 m -110.21 175.79 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -178.266 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 26.4 m -130.86 131.29 44.47 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 177.463 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 78.3 mt -108.71 120.84 60.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.432 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 78.3 p -127.2 136.81 52.56 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.021 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.53 155.21 41.64 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.88 -1.138 . . . . 0.0 110.66 -179.271 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' B' ' 301' ' ' MET . 12.6 tp10 -144.84 121.98 11.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.476 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.452 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 161.07 -158.71 30.37 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 118.474 -1.822 . . . . 0.0 112.08 179.573 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -59.98 -51.89 67.73 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.396 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -110.13 11.31 23.78 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.958 -1.089 . . . . 0.0 111.239 -177.086 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' B' ' 371' ' ' GLN . 0.0 OUTLIER -40.52 -31.66 0.16 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.279 -0.888 . . . . 0.0 112.469 -178.43 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . 0.553 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 63.9 mt-30 -66.81 -48.3 69.38 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.374 -1.454 . . . . 0.0 110.958 -177.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -66.86 -48.17 69.66 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.53 -1.268 . . . . 0.0 108.339 179.669 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -42.6 -40.85 2.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.702 -0.624 . . . . 0.0 111.697 -178.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.506 ' O ' HG23 ' B' ' 378' ' ' VAL . 62.4 t -80.05 -32.63 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.283 -1.511 . . . . 0.0 109.769 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.98 -41.64 74.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.823 . . . . 0.0 112.392 -177.682 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . 0.488 ' O ' ' N ' ' B' ' 380' ' ' LEU . 67.1 m80 -86.54 -42.38 13.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.398 -1.438 . . . . 0.0 110.382 -179.513 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.05 -40.01 83.79 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.956 -1.097 . . . . 0.0 108.285 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.506 HG23 ' O ' ' B' ' 374' ' ' VAL . 51.1 t -64.36 -46.38 93.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.595 179.129 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -80.09 -9.5 59.71 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.785 -1.197 . . . . 0.0 109.786 178.492 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' B' ' 376' ' ' HIS . 49.5 tp -83.54 -28.27 28.74 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 176.769 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 56.9 tpp -81.42 -29.56 33.82 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.121 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.21 -9.6 59.76 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.891 -0.506 . . . . 0.0 109.902 179.413 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -106.96 1.48 24.52 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.231 -0.918 . . . . 0.0 110.998 -179.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . 0.405 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 20.6 mt -78.59 117.89 20.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.275 -1.516 . . . . 0.0 110.002 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 117.912 -1.042 . . . . 0.0 108.736 178.715 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 mmt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.197 -0.668 . . . . 2.91 109.197 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 99.3 mt -109.77 126.42 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.407 -0.96 . . . . 1.2 108.407 179.202 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -125.13 121.6 34.71 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.604 -0.685 . . . . 1.4 110.018 -178.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.72 -164.97 32.99 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.186 -1.566 . . . . 1.05 109.186 179.166 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' LEU . 88.2 mt -88.68 -13.6 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.02 -1.283 . . . . 1.15 109.854 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 5' ' ' ILE . 56.2 tp 46.07 99.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.227 -0.921 . . . . 0.98 110.342 179.094 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.51 -29.48 12.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.031 -1.043 . . . . 0.88 108.963 179.063 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 40.9 t -119.22 116.46 33.86 Favored Pre-proline 0 N--CA 1.501 2.101 0 N-CA-C 109.039 -0.726 . . . . 1.69 109.039 179.46 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.22 142.83 17.19 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.618 1.545 . . . . 0.85 111.877 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.734 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 161.4 -159.72 31.51 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.218 -1.553 . . . . 0.92 109.218 -179.713 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.3 mt -148.51 148.37 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 120.808 -1.407 . . . . 0.81 109.09 179.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.18 153.12 30.24 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.899 -1.126 . . . . 0.51 111.291 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 8.7 m-85 -133.16 129.94 38.52 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.72 -1.585 . . . . 0.62 106.72 177.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.67 175.68 46.63 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 117.936 -2.078 . . . . 0.55 111.245 -179.725 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -77.47 160.02 28.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.889 -0.771 . . . . 2.1 109.11 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.447 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -100.45 127.15 46.87 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.312 -0.867 . . . . 0.77 110.927 -179.06 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.5 tp -100.79 134.35 43.89 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 106.972 -1.492 . . . . 0.91 106.972 178.011 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.2 tp -120.4 122.32 40.49 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.123 -0.985 . . . . 0.93 110.044 -179.564 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 62.0 mt -80.85 102.61 10.14 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.499 0.666 . . . . 0.93 109.678 -179.421 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -99.34 131.09 45.6 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.451 -0.781 . . . . 2.75 109.883 -179.219 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -127.39 139.11 53.07 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.969 -0.752 . . . . 3.0 108.969 -179.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 61.6 t0 -82.7 149.71 27.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.983 -1.073 . . . . 2.77 109.171 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.55 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 70.7 tt0 -68.08 147.31 52.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 2.94 109.269 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.3 mt -97.62 133.78 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.232 -0.918 . . . . 0.95 109.181 -179.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.3 t -103.43 127.86 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.249 -0.907 . . . . 1.28 110.164 -179.056 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 84.1 mt -99.2 142.48 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.477 -0.765 . . . . 1.21 109.293 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -97.11 117.32 31.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.065 -1.022 . . . . 1.81 109.449 -179.762 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -89.27 3.61 51.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.172 -0.955 . . . . 2.8 109.153 -179.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -67.22 140.1 57.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 2.87 110.283 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -84.8 141.93 30.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 2.35 109.333 179.631 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.431 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.8 pt -89.84 164.1 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.97 109.365 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 100.0 p -95.86 171.63 8.52 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.042 -1.036 . . . . 1.17 108.77 179.338 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.38 -48.35 80.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.882 -1.136 . . . . 1.18 109.376 -179.443 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -55.91 -30.38 61.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.698 -1.251 . . . . 2.56 109.878 -179.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -80.94 -9.69 59.8 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.214 -0.929 . . . . 1.79 109.837 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 40' ' ' VAL . 40.9 t -62.41 -50.17 80.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 120.781 -1.199 . . . . 1.0 108.796 179.758 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -65.49 -40.11 92.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.842 -1.161 . . . . 1.77 110.199 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -69.97 -40.12 75.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.11 -0.993 . . . . 2.7 109.895 -179.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.544 ' OE2' ' NH1' ' A' ' 42' ' ' ARG . 28.1 mm-40 -68.37 -40.07 81.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 1.51 110.301 -179.242 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 36' ' ' VAL . 53.1 t -59.95 -41.21 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.608 -1.256 . . . . 0.93 107.608 179.173 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -58.38 -37.97 76.34 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.563 -0.71 . . . . 1.81 109.626 -179.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.544 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 99.3 mtt180 -58.7 -41.71 86.95 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.865 -1.134 . . . . 2.78 108.016 179.443 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -62.73 -47.88 81.65 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.409 -0.959 . . . . 0.78 108.409 178.243 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 65.8 tp -59.85 -49.06 79.17 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.901 -1.148 . . . . 1.07 107.901 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.1 t -60.58 -45.15 95.01 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.464 -0.939 . . . . 1.12 108.464 178.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.93 -43.89 97.66 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.151 -1.98 . . . . 0.84 108.151 178.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -63.26 -33.09 74.75 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.476 -1.014 . . . . 3.09 108.72 178.34 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.25 -39.94 84.39 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.553 -0.717 . . . . 0.88 109.57 -179.207 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 50' ' ' ALA . 26.1 ttmt -70.67 -74.03 0.15 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.258 -1.386 . . . . 2.59 107.258 178.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.59 -39.61 0.34 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.944 -0.472 . . . . 0.7 111.126 -178.763 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.4 t -56.25 -59.04 5.52 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.338 -1.477 . . . . 1.4 108.559 179.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.17 -39.98 90.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.367 -0.833 . . . . 0.67 111.105 -179.267 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -69.82 -40.7 75.74 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.837 -1.164 . . . . 1.66 110.471 -178.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.3 mt -62.49 -39.95 95.15 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.915 -1.116 . . . . 1.58 108.063 179.408 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -62.87 -38.43 90.85 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.375 -0.828 . . . . 1.35 109.194 178.762 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.7 m -64.01 -43.81 94.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.77 109.477 179.137 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.3 mt -61.69 -37.84 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 0.63 109.192 179.693 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -58.8 -50.21 74.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 1.14 109.56 -179.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -57.49 -33.69 68.28 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.494 -0.754 . . . . 0.79 110.676 -177.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -69.62 -37.96 77.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.225 -0.922 . . . . 1.53 109.366 -179.438 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.41 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -66.29 -48.6 69.87 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.34 -0.85 . . . . 0.57 109.762 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.08 -55.67 22.88 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 120.169 -1.015 . . . . 0.75 110.572 -179.146 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -70.18 -43.59 70.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.085 -1.244 . . . . 1.59 111.016 -178.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.5 m -63.09 -62.81 1.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.0 -1.063 . . . . 0.73 111.617 -177.742 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -97.4 -43.53 7.25 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.954 -1.091 . . . . 0.75 111.541 -177.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.65 -171.4 24.4 Favored Glycine 0 N--CA 1.501 3.032 0 O-C-N 120.703 -1.248 . . . . 1.22 111.298 179.619 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -68.95 -23.02 64.09 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.816 -0.814 . . . . 5.81 109.59 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.512 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.9 tp10 -60.01 -34.3 73.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.807 -0.558 . . . . 3.37 110.741 -179.508 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -98.71 -18.86 17.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.199 -0.938 . . . . 1.77 109.62 -179.695 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -67.68 -39.44 84.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 1.65 109.916 -179.799 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.579 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.91 -34.21 76.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.77 110.304 -178.685 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 85.1 mt -59.77 -40.43 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.635 -1.291 . . . . 0.8 108.682 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -64.2 -38.74 92.14 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.1 -1.0 . . . . 0.88 110.175 179.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -59.06 -39.7 82.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.161 -0.962 . . . . 1.37 109.141 -179.602 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.0 -41.02 95.47 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.179 -1.568 . . . . 0.62 109.179 179.069 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -66.02 -49.65 66.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.998 -1.295 . . . . 1.5 108.472 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.2 mt -61.91 -49.32 84.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.577 -0.702 . . . . 0.63 109.372 179.279 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 40.5 ttp -59.93 -46.29 89.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.331 -0.855 . . . . 1.51 109.802 -179.698 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.871 HD11 ' CE2' ' B' ' 348' ' ' PHE . 57.1 tp -60.13 -41.49 92.77 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.353 -0.842 . . . . 0.77 109.347 179.698 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.2 -39.64 89.81 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.181 -0.608 . . . . 0.62 110.065 -178.677 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -79.12 2.76 19.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.188 -0.945 . . . . 1.47 109.37 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -51.14 129.41 24.17 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.296 -0.878 . . . . 1.47 110.415 -178.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.63 -16.54 39.68 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.8 -0.562 . . . . 1.78 110.138 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -74.13 -35.74 64.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.027 -1.045 . . . . 2.53 109.494 178.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.58 -41.06 72.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.453 -0.779 . . . . 0.8 110.754 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -60.01 -49.48 77.48 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.246 -0.909 . . . . 1.42 110.394 -178.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -69.77 -40.47 76.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 1.71 110.91 -178.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -67.9 -40.15 83.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.971 -1.081 . . . . 1.57 110.874 -178.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.93 -47.52 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.906 -1.121 . . . . 0.65 109.636 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -65.36 -38.57 82.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.618 -0.676 . . . . 0.82 110.263 179.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.63 85.09 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.221 -0.924 . . . . 0.79 111.244 -178.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.2 mt -59.87 -43.93 94.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.853 -1.154 . . . . 0.95 109.243 -179.043 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.8 mt -63.34 -48.49 87.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.437 -0.79 . . . . 0.66 109.501 179.424 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -68.57 -40.34 80.63 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.116 -0.99 . . . . 2.2 110.189 179.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.74 -52.43 7.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 1.65 111.604 -178.403 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -91.15 -3.08 57.37 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.117 -0.99 . . . . 2.03 112.247 -177.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 80.0 m80 57.29 39.05 28.81 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.816 -1.177 . . . . 1.42 109.834 -179.421 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 94.2 mtp -89.2 170.04 10.94 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.37 -0.832 . . . . 1.18 110.079 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.0 p -80.46 156.52 26.55 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.954 -0.758 . . . . 0.98 108.954 179.586 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.91 -39.9 75.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.11 -0.994 . . . . 0.64 110.2 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.58 -42.57 96.97 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.062 -1.024 . . . . 2.07 110.459 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.71 -46.33 14.43 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.374 -0.829 . . . . 0.73 110.494 -179.253 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.06 -48.26 82.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.372 -0.83 . . . . 0.54 110.364 -179.157 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.488 ' HB1' HD21 ' A' ' 137' ' ' LEU . . . -59.97 -47.51 85.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.929 . . . . 0.56 110.522 -179.094 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.655 ' HB2' HD21 ' A' ' 138' ' ' LEU . 85.0 t60 -60.15 -35.21 74.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.997 -1.065 . . . . 1.54 110.392 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.28 -39.91 88.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.012 -1.055 . . . . 1.33 110.559 -179.222 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.67 -50.09 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.803 -1.185 . . . . 0.72 110.973 -178.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.4 mm -68.96 -40.14 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 120.801 -1.187 . . . . 0.85 109.134 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -64.03 -38.32 90.65 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.799 -0.815 . . . . 2.44 108.799 178.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.97 -50.04 71.94 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 120.247 -0.977 . . . . 0.98 110.839 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -65.24 -53.43 44.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.866 -1.373 . . . . 1.41 110.484 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.54 -39.16 70.21 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.998 -1.064 . . . . 1.2 109.301 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.6 t -53.82 -40.66 66.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.295 -0.878 . . . . 1.7 108.663 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.84 70.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.505 -0.747 . . . . 1.47 109.483 179.025 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.0 mt -65.78 -43.84 87.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.026 -1.046 . . . . 1.56 109.818 -178.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.97 -38.5 82.71 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.499 -1.376 . . . . 2.2 108.912 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -54.74 -18.88 5.21 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.225 -0.922 . . . . 2.12 109.538 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.439 HD13 HD13 ' A' ' 123' ' ' LEU . 85.4 mt -61.57 139.98 58.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.085 -1.009 . . . . 2.0 109.479 -179.598 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -90.9 11.45 22.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.254 -0.904 . . . . 3.23 109.714 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -99.01 117.0 32.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.151 -0.968 . . . . 2.49 109.207 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -60.2 -30.59 69.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.272 -0.892 . . . . 3.95 109.363 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.451 ' OH ' ' CA ' ' B' ' 315' ' ' HIS . 19.8 t80 -61.02 -42.08 97.79 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.995 0.902 . . . . 2.0 109.161 179.274 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.893 HD22 ' O ' ' B' ' 351' ' ' GLN . 74.9 mt -80.4 -26.9 38.25 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.975 -0.75 . . . . 1.86 108.975 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -60.07 -43.94 95.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.47 -0.937 . . . . 2.84 108.47 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -60.61 -45.61 93.35 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.115 -1.068 . . . . 2.73 108.115 178.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -60.68 -39.43 88.43 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.748 -0.781 . . . . 2.77 109.08 178.403 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.17 -28.27 66.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.388 -0.82 . . . . 1.19 109.162 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.31 -38.78 71.72 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.225 -0.922 . . . . 1.2 109.677 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.5 -40.58 95.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.025 -1.047 . . . . 1.55 110.466 -179.368 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.435 HG21 HE22 ' B' ' 351' ' ' GLN . 38.1 t -69.82 -42.0 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.873 -1.142 . . . . 0.8 109.801 -179.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -60.59 -38.6 85.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.762 -1.211 . . . . 3.09 109.407 179.427 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -58.68 -39.74 81.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.395 -0.816 . . . . 1.46 110.011 -178.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.99 -41.45 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.091 -1.005 . . . . 0.71 109.921 -179.611 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.94 -35.75 92.48 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.919 -1.272 . . . . 0.57 109.919 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -60.05 -48.57 81.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.318 -1.107 . . . . 2.59 110.995 -178.717 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.417 HH22 ' CB ' ' A' ' 166' ' ' SER . 98.0 mtt180 -67.69 -30.89 70.53 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.571 -1.331 . . . . 2.83 110.383 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . 0.488 HD21 ' HB1' ' A' ' 104' ' ' ALA . 63.9 tp -58.53 -44.96 89.75 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.268 -1.012 . . . . 1.25 108.268 -179.175 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.655 HD21 ' HB2' ' A' ' 105' ' ' HIS . 66.1 mt -61.43 -43.97 97.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.7 110.192 178.631 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -70.02 -40.21 75.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.89 . . . . 2.57 109.891 -179.821 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -65.79 -37.92 87.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.671 -0.643 . . . . 1.23 111.048 -178.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.4 mt -66.98 -46.79 84.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 120.638 -1.289 . . . . 0.81 108.165 179.583 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 92.3 mt -70.16 -31.71 69.33 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.644 -0.66 . . . . 1.0 109.675 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.87 42.41 6.79 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.017 -1.633 . . . . 0.89 109.017 -178.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 tp -74.52 152.96 39.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.466 -1.02 . . . . 1.14 109.095 -179.654 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -64.23 143.24 58.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.083 -1.01 . . . . 4.6 109.626 -179.487 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.8 mt -115.4 121.77 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 CA-C-O 122.434 1.112 . . . . 1.24 109.22 179.279 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.2 mt -60.13 -47.74 90.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-N 115.019 -0.991 . . . . 1.54 110.858 -178.659 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.5 t0 62.92 106.04 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.615 -0.883 . . . . 1.5 108.615 -178.818 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.5 mt -69.33 0.3 5.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.296 -0.877 . . . . 0.79 110.174 -178.58 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 83.1 p -83.66 -13.87 53.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.048 -1.032 . . . . 1.4 110.379 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.64 28.23 0.49 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.112 -0.992 . . . . 0.92 111.916 -178.374 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 32.3 mm -90.58 118.15 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.484 -1.385 . . . . 0.88 108.405 179.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -104.88 -10.59 17.22 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.391 -0.818 . . . . 2.45 110.337 -178.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -126.48 150.94 48.42 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.097 -1.002 . . . . 1.52 109.832 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -63.98 133.02 52.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.436 -0.79 . . . . 1.58 109.731 -179.434 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.4 m -152.66 166.43 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.425 -0.797 . . . . 0.69 110.321 179.729 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 76.3 mt -95.82 147.86 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 105.994 -1.854 . . . . 0.61 105.994 177.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 48.7 tp -100.04 119.22 37.94 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.714 -1.241 . . . . 0.87 110.626 -177.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.84 129.96 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 107.978 -1.119 . . . . 0.71 107.978 178.64 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.46 161.96 35.55 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.125 -0.984 . . . . 0.81 109.069 -179.157 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.94 -37.25 75.82 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.111 -1.618 . . . . 0.98 107.294 178.412 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 13.1 p-10 -171.15 147.0 2.49 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.385 -0.598 . . . . 2.25 109.385 178.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.7 mt -106.04 141.36 37.55 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.336 -0.853 . . . . 0.78 108.926 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 82.1 p -94.38 144.66 28.35 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.22 -0.925 . . . . 0.98 108.828 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -40.13 -40.54 2.85 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.887 1.724 . . . . 0.81 112.268 179.724 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.417 ' CB ' HH22 ' A' ' 136' ' ' ARG . 61.4 m -60.42 -40.0 89.45 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.391 -0.818 . . . . 0.9 110.218 -179.646 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.45 -43.47 85.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.145 -0.972 . . . . 1.61 110.147 -179.099 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 40.2 p -55.67 -31.87 62.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.067 -1.021 . . . . 0.61 111.007 -178.007 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -69.73 -50.78 40.26 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.064 -1.023 . . . . 0.6 110.106 -179.547 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.41 ' H ' ' HG2' ' A' ' 170' ' ' GLN . 15.2 pt20 -88.7 39.36 0.92 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.482 -0.933 . . . . 1.4 108.482 -179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.5 tp -103.35 138.03 40.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.683 -0.636 . . . . 0.7 109.567 179.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -87.55 101.32 13.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.345 -0.847 . . . . 2.35 109.648 179.849 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 46.6 mt -64.23 -42.22 96.65 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.403 -0.811 . . . . 1.51 110.379 -179.34 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.53 -27.56 66.2 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.846 -1.158 . . . . 2.33 112.45 -177.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -92.69 -8.31 44.33 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.584 -1.322 . . . . 1.92 110.429 -178.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 178' ' ' GLY . 68.9 t -107.7 119.83 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.198 -0.939 . . . . 0.67 108.959 179.112 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.1 mt -88.84 8.37 29.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.287 -0.883 . . . . 1.53 111.227 -177.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.568 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 167.58 175.14 37.23 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.535 -1.426 . . . . 0.48 109.535 179.346 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -134.79 130.04 35.5 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.365 -1.079 . . . . 0.55 108.62 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.418 ' CG2' HG21 ' A' ' 205' ' ' THR . 95.7 mt -132.34 126.54 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.194 -0.941 . . . . 0.65 109.156 179.381 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 41.0 p -149.89 162.87 39.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.925 -1.109 . . . . 0.82 111.051 -179.696 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 183' ' ' ALA . 35.5 p-10 -106.19 23.23 14.4 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.787 -0.57 . . . . 2.46 109.505 -179.767 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -56.62 -161.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.778 -1.201 . . . . 1.28 111.588 -177.689 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.04 -56.54 5.71 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.772 -0.931 . . . . 2.19 110.772 -178.652 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 171.83 -142.37 6.89 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 118.612 -1.756 . . . . 2.13 111.349 -179.448 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.456 ' C ' ' H ' ' A' ' 188' ' ' SER . 97.3 mtt180 -69.66 -31.02 68.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.853 -0.793 . . . . 5.86 110.905 -178.535 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 82.5 p -62.62 2.17 0.31 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.0 -1.063 . . . . 3.72 109.803 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 186' ' ' ARG . 78.4 p -91.71 139.71 30.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.937 -1.102 . . . . 1.74 110.552 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -55.5 -39.53 70.59 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.784 -0.821 . . . . 0.95 108.784 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 190' ' ' THR . 2.0 p -57.52 -41.42 80.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.613 -0.68 . . . . 1.55 109.543 -179.538 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 186' ' ' ARG . 82.8 p -69.28 -38.08 78.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.178 -0.951 . . . . 1.51 111.255 -179.402 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.12 -44.48 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.885 -1.134 . . . . 1.67 110.106 -178.375 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.1 mtp -61.41 -40.3 93.92 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.041 -1.037 . . . . 1.02 111.18 -179.374 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.82 -42.66 76.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.683 -1.26 . . . . 0.68 109.113 -179.776 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -59.99 -51.79 68.15 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.088 -1.007 . . . . 2.93 109.263 -179.267 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.0 m -68.5 -36.89 79.56 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.449 -0.782 . . . . 0.86 111.106 -179.128 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 87.6 mt -69.91 -27.89 65.16 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.984 -1.117 . . . . 0.67 107.984 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 63.54 50.0 2.93 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.147 0.499 . . . . 1.5 110.587 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.477 ' O ' ' CB ' ' A' ' 8' ' ' SER . 77.0 mt -130.64 147.86 67.77 Favored Pre-proline 0 N--CA 1.505 2.285 0 N-CA-C 108.401 -0.963 . . . . 0.72 108.401 178.501 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -44.82 126.23 7.21 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.163 1.909 . . . . 0.61 112.65 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.32 139.85 12.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.537 -1.352 . . . . 0.66 111.963 179.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.6 mt -125.28 146.05 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.287 -1.375 . . . . 0.79 107.287 178.147 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.4 -4.82 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 120.84 -1.163 . . . . 0.91 110.588 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.91 21.21 27.9 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 110.831 -0.908 . . . . 1.01 110.831 -179.08 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.418 HG21 ' CG2' ' A' ' 180' ' ' ILE . 7.1 p -45.01 -41.06 7.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.03 -1.277 . . . . 0.99 110.261 -179.516 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.83 -50.98 3.79 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.201 -0.999 . . . . 1.12 111.005 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.3 t -158.57 38.45 0.23 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.588 -1.536 . . . . 1.72 111.354 -179.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.9 t -76.65 -39.38 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.819 -1.175 . . . . 0.89 108.967 178.582 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.438 HG23 ' H ' ' A' ' 209' ' ' THR . 2.8 p -57.09 -39.79 75.71 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.648 -0.657 . . . . 1.03 111.174 -177.877 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.0 p -80.03 -13.41 59.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.014 -1.053 . . . . 1.83 110.129 -178.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -95.51 -14.58 23.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.119 -0.988 . . . . 2.27 109.882 -179.404 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 213' ' ' LYS . 55.1 t -114.16 152.74 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.358 -0.839 . . . . 0.92 110.994 -178.845 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.447 ' N ' HG12 ' A' ' 212' ' ' VAL . 10.5 mptt -122.12 158.57 29.02 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.875 -1.158 . . . . 2.2 107.875 179.179 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 13.0 t-20 -54.69 140.36 35.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.177 -0.952 . . . . 2.36 111.075 -179.04 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.7 t70 84.38 10.58 0.39 Allowed 'General case' 0 N--CA 1.504 2.249 0 CA-C-O 120.991 0.424 . . . . 2.38 110.88 179.105 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -80.1 139.75 36.73 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.923 -1.11 . . . . 2.09 109.049 179.211 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -87.44 128.07 35.22 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.034 -1.098 . . . . 1.27 108.034 179.154 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.447 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 58.3 mt -131.71 138.76 48.8 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.199 -0.938 . . . . 0.75 110.532 -178.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.9 mt -111.61 125.48 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.484 -1.673 . . . . 0.63 106.484 176.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 29.8 tp -103.51 119.74 39.49 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.861 -1.149 . . . . 0.7 108.944 -179.234 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.626 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 23.2 p-10 -81.51 -37.13 28.35 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.048 -1.093 . . . . 2.31 108.048 178.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.86 17.93 0.06 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.732 -0.84 . . . . 0.78 108.732 -179.304 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 221' ' ' ASP . 55.3 t -135.96 -41.02 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.912 -1.144 . . . . 1.04 107.912 178.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -97.75 1.09 48.07 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.623 -1.251 . . . . 2.44 107.623 178.386 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.535 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 29.7 t-20 60.53 42.96 13.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.753 -0.592 . . . . 1.55 109.964 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.626 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 92.0 mt-30 -140.94 148.26 40.11 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.177 -0.952 . . . . 1.99 109.611 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -120.06 126.56 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.115 -1.068 . . . . 0.77 108.115 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -98.67 126.23 44.21 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.526 -1.287 . . . . 0.98 107.526 178.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.86 125.1 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.634 -0.666 . . . . 0.85 110.177 -177.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 53.78 68.4 2.86 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.135 -0.978 . . . . 1.66 108.839 -179.656 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -91.22 131.5 1.42 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 123.25 2.634 . . . . 0.95 112.588 -178.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 233' ' ' ASN . 23.5 m -63.54 166.51 6.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.315 -0.866 . . . . 1.84 109.769 -179.232 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.457 ' N ' HG22 ' A' ' 232' ' ' THR . 21.3 m120 -60.04 -40.08 88.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.134 -0.979 . . . . 2.74 110.045 -179.311 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -64.55 -32.18 73.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.965 -1.084 . . . . 2.89 110.092 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.53 -39.61 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.058 -1.026 . . . . 1.3 108.532 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.8 mt . . . . . 0 C--N 1.303 -1.424 0 O-C-N 121.377 -0.827 . . . . 1.09 109.022 179.219 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . 0.415 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 37.0 ttp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.407 0.622 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . 0.415 ' N ' ' CG ' ' B' ' 301' ' ' MET . 16.8 t80 -152.44 148.8 27.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.353 -0.842 . . . . 0.0 108.871 179.552 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -152.36 163.59 39.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.889 -1.132 . . . . 0.0 110.573 -179.317 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -156.81 153.57 28.5 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.618 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 56.4 mp0 -115.08 130.9 57.04 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.203 -0.936 . . . . 0.0 109.414 179.029 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.55 125.32 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.425 0 CA-C-O 122.371 1.082 . . . . 0.0 111.435 -178.13 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 36.6 m -81.07 103.65 11.02 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.913 0.863 . . . . 0.0 111.114 -178.02 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.6 mt -52.22 121.5 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.456 1.122 . . . . 0.0 110.952 -177.627 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 74.1 p -106.33 18.01 22.6 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.066 -178.427 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.32 118.89 71.45 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.65 -1.281 . . . . 0.0 109.221 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -52.41 -15.01 3.42 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 CA-C-N 120.176 1.098 . . . . 0.0 112.569 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -118.91 8.52 11.71 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.54 177.89 31.98 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -179.298 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.435 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -85.93 93.19 8.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -1.184 . . . . 0.0 108.527 -179.192 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.451 ' CA ' ' OH ' ' A' ' 122' ' ' TYR . 4.1 p80 -96.66 -160.15 0.78 Allowed 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.109 -0.994 . . . . 0.0 109.958 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.3 m -59.38 -43.12 92.96 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.831 -1.168 . . . . 0.0 112.146 -176.032 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.579 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 2.5 tpt180 -57.56 -61.82 6.51 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.453 -1.404 . . . . 0.0 111.703 -178.485 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.409 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 13.8 Cg_endo -59.42 -32.99 97.4 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 CA-C-N 119.932 1.011 . . . . 0.0 111.516 -179.431 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.27 -51.53 69.14 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.162 -0.961 . . . . 0.0 109.072 179.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.2 -41.71 62.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -0.85 . . . . 0.0 109.587 -178.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -71.33 -40.03 71.0 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -61.95 -54.78 37.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.426 -0.796 . . . . 0.0 109.784 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 89.8 t -61.33 -26.56 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.957 -1.09 . . . . 0.0 110.173 -178.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -63.02 -44.24 96.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.426 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -69.89 -40.14 75.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.383 -0.823 . . . . 0.0 111.731 -178.027 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' B' ' 328' ' ' GLY . . . -65.53 -55.86 15.49 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.3 -1.5 . . . . 0.0 111.924 -178.354 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -48.21 -10.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.033 -1.042 . . . . 0.0 110.281 -178.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' B' ' 326' ' ' ALA . . . -81.63 -15.35 76.01 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.23 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -107.07 140.42 39.91 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.377 -1.072 . . . . 0.0 109.255 179.433 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 16.9 m -91.31 -11.64 37.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 110.238 -179.981 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 35.9 m -64.77 155.11 34.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.759 -1.213 . . . . 0.0 109.591 179.656 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -70.76 133.83 46.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.89 -1.131 . . . . 0.0 108.315 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 90.2 mt -131.79 133.5 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-O 121.362 0.601 . . . . 0.0 109.954 -179.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.4 m -130.08 148.61 51.95 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.445 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 79.7 t -120.29 114.96 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 177.459 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 92.7 m -105.46 124.95 50.4 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.227 -0.92 . . . . 0.0 109.709 -178.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 48.4 t -134.35 120.5 19.97 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.139 0.971 . . . . 0.0 111.59 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 66.6 t30 45.37 50.99 9.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 176.717 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.7 -11.97 68.62 Favored Glycine 0 N--CA 1.501 3.031 0 O-C-N 120.155 -1.591 . . . . 0.0 113.15 176.472 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -126.44 138.87 53.58 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 119.389 1.594 . . . . 0.0 109.432 -179.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 60.2 p -130.58 152.69 49.67 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.118 0.961 . . . . 0.0 111.236 -178.512 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . 0.47 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -143.31 163.59 32.59 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.494 0.664 . . . . 0.0 109.52 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 10.8 t -87.52 135.89 33.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.637 -0.665 . . . . 0.0 110.821 -178.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.47 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -68.06 -21.31 65.0 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.107 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -80.3 25.18 0.41 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.037 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . 0.47 ' H ' ' C ' ' B' ' 344' ' ' ALA . 58.4 m -152.92 92.94 1.69 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.814 -1.154 . . . . 0.0 113.266 -178.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.668 HD23 HD22 ' A' ' 79' ' ' LEU . 57.8 tp -59.53 -34.26 72.41 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 177.225 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.871 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.4 m-85 -58.81 -53.3 59.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.707 -0.621 . . . . 0.0 110.264 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -78.26 -16.45 57.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.771 -1.206 . . . . 0.0 110.619 -177.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.604 ' O ' ' N ' ' B' ' 352' ' ' THR . 26.4 mt -69.64 -56.16 8.02 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.146 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.893 ' O ' HD22 ' A' ' 123' ' ' LEU . 30.3 mt-30 -40.82 -12.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.103 -178.62 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.604 ' N ' ' O ' ' B' ' 350' ' ' LEU . 59.2 p -90.82 -8.19 50.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.52 -1.362 . . . . 0.0 109.954 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' B' ' 342' ' ' ALA . 85.0 mt -96.74 121.1 38.22 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.092 -1.005 . . . . 0.0 109.384 179.371 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.5 90.53 0.94 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 20.2 mt -99.79 91.94 5.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.19 -1.182 . . . . 0.0 108.855 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 38.0 p -94.01 -179.19 4.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.276 -0.89 . . . . 0.0 110.545 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -69.84 110.1 4.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.849 -0.532 . . . . 0.0 110.118 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 104.16 9.72 35.94 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 28.4 m -84.76 110.77 19.04 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.156 -1.202 . . . . 0.0 110.888 -179.482 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 27.2 t -77.12 111.86 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 122.237 1.018 . . . . 0.0 109.747 -177.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 17.5 m -109.03 175.02 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 32.3 m -131.79 128.61 39.15 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.647 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 95.0 mt -103.33 115.41 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.521 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 77.3 p -120.13 132.65 55.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.393 -0.817 . . . . 0.0 109.128 -179.356 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.81 152.61 40.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.898 . . . . 0.0 108.949 -179.057 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -147.71 125.45 11.87 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.16 -0.963 . . . . 0.0 109.471 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.495 ' O ' ' OE1' ' B' ' 370' ' ' GLU . . . 154.02 -148.97 20.26 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.277 -1.44 . . . . 0.0 111.532 179.824 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -60.02 -51.69 68.56 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.542 ' N ' ' OG ' ' B' ' 331' ' ' SER . 89.1 m-20 -112.71 13.77 19.89 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 120.835 -1.165 . . . . 0.0 111.267 -177.681 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.584 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 1.0 OUTLIER -42.39 -32.57 0.54 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.271 -0.893 . . . . 0.0 111.477 -179.011 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . 0.514 ' H ' ' CD ' ' B' ' 370' ' ' GLU . 10.3 pt20 -70.94 -43.2 68.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.853 -1.154 . . . . 0.0 110.205 -178.745 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -69.43 -54.25 15.26 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.377 -0.827 . . . . 0.0 109.159 179.473 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.86 -34.51 8.93 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.621 -0.674 . . . . 0.0 112.252 -178.398 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 69.4 t -80.99 -36.29 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.468 -1.395 . . . . 0.0 108.926 178.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -70.89 -38.97 73.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.657 -0.652 . . . . 0.0 111.269 179.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -82.54 -48.98 10.39 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.798 -1.189 . . . . 0.0 111.694 -178.235 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.02 -30.68 69.33 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.164 -0.96 . . . . 0.0 109.464 -179.096 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 55.0 t -79.78 -31.62 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 0.0 109.416 179.25 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -77.35 -22.22 52.11 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.689 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 31.9 tp -78.25 -67.76 0.7 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 5.6 ttp -56.01 -22.99 30.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.925 . . . . 0.0 109.788 -178.619 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.83 -22.2 58.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.928 -1.108 . . . . 0.0 108.705 177.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -104.21 2.52 31.81 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.42 -0.8 . . . . 0.0 111.677 -178.362 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 85.0 mt -85.03 125.47 32.76 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.219 -1.551 . . . . 0.0 109.739 179.739 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.052 179.004 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.2 mtp . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.255 -0.646 . . . . 2.91 109.255 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.446 ' O ' ' O ' ' A' ' 225' ' ' ASN . 89.8 mt -107.58 129.02 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.613 -0.884 . . . . 1.2 108.613 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.9 m -130.76 141.45 50.36 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.606 -0.684 . . . . 1.4 109.744 -179.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.751 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -138.07 -165.04 10.2 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 108.291 -1.924 . . . . 1.05 108.291 179.122 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.8 mt -91.99 -10.83 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.888 -1.36 . . . . 1.15 110.377 -179.05 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 5' ' ' ILE . 34.9 tp 52.62 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.973 -1.08 . . . . 0.98 108.839 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.59 -34.25 23.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 0.88 109.042 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -143.4 132.33 11.45 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.416 -0.803 . . . . 1.69 108.881 179.509 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.92 147.19 18.91 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.193 1.929 . . . . 0.85 113.477 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.782 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.53 -164.66 37.43 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.576 -1.41 . . . . 0.92 109.576 179.474 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.5 mt -146.45 147.82 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.26 -1.141 . . . . 0.81 108.741 179.053 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.91 154.64 31.53 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.541 -1.35 . . . . 0.51 110.979 -179.618 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.5 m-85 -136.31 129.26 31.15 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 108.245 -1.02 . . . . 0.62 108.245 178.819 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.5 -179.7 45.65 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.577 -1.773 . . . . 0.55 110.802 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -80.4 152.85 28.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.613 -0.934 . . . . 2.1 108.95 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.417 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -99.24 132.0 44.87 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.093 -1.004 . . . . 0.77 110.906 -178.078 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.4 tp -100.37 133.61 44.54 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.389 -1.338 . . . . 0.91 107.389 178.084 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.1 tp -115.43 121.34 42.46 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.207 -0.933 . . . . 0.93 109.949 -179.025 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 66.8 mt -91.29 106.22 18.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.521 -0.737 . . . . 0.93 109.881 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.475 ' NZ ' ' CB ' ' A' ' 20' ' ' LYS . 7.8 mtpm? -101.87 137.69 39.83 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.89 -0.781 . . . . 2.75 108.89 179.234 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 55.4 mp0 -127.81 128.76 45.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.373 -0.829 . . . . 3.0 108.795 179.689 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -71.89 149.85 44.77 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.044 -1.035 . . . . 2.77 108.474 179.639 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -67.52 139.98 57.0 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.924 -1.11 . . . . 2.94 108.576 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.8 mt -80.17 130.27 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.95 109.172 -179.463 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.1 t -99.24 129.75 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.203 -0.936 . . . . 1.28 111.08 -178.413 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.0 mt -109.85 131.21 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.654 -0.869 . . . . 1.21 108.654 179.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -81.61 127.37 32.8 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.878 -1.139 . . . . 1.81 109.815 -179.449 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.52 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.6 mmt-85 -90.75 -5.72 55.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.514 -0.742 . . . . 2.8 109.221 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -70.76 139.95 51.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 2.87 109.548 -179.668 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -80.96 151.97 28.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 2.35 109.027 179.184 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.462 HG21 ' HG3' ' A' ' 39' ' ' GLU . 5.2 pt -93.68 165.08 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.97 109.884 -179.932 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.8 p -98.22 168.72 10.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.997 -1.064 . . . . 1.17 108.952 178.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.15 -13.65 39.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.126 -0.984 . . . . 1.18 110.104 -179.675 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -86.1 -30.19 22.75 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.678 -1.23 . . . . 2.56 107.678 178.511 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -83.38 -7.58 59.54 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.515 -0.55 . . . . 1.79 109.515 179.082 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 t -64.97 -56.33 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.734 -1.229 . . . . 1.0 109.174 179.719 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.06 -39.91 87.62 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.236 -0.915 . . . . 1.77 109.472 179.718 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -70.22 -41.06 74.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 2.7 110.688 -179.254 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.462 ' HG3' HG21 ' A' ' 31' ' ' ILE . 63.2 mm-40 -65.3 -39.98 93.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.031 -1.043 . . . . 1.51 110.134 -179.442 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.94 -44.58 94.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.882 -1.136 . . . . 0.93 107.96 179.424 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -59.91 -38.96 83.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.14 -0.975 . . . . 1.81 108.978 179.641 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -59.87 -43.03 94.93 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.635 -1.246 . . . . 2.78 107.635 179.335 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.96 -49.28 78.29 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.229 -1.026 . . . . 0.78 108.229 178.053 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.6 tp -60.0 -47.99 83.53 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.954 -0.758 . . . . 1.07 108.954 179.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.444 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 46.5 t -60.75 -44.5 96.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.949 -1.094 . . . . 1.12 108.782 178.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.09 -41.29 98.0 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.723 -2.151 . . . . 0.84 107.723 178.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -64.35 -34.86 79.12 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.557 -0.967 . . . . 3.09 108.514 178.26 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -54.48 -42.72 71.03 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.482 -0.761 . . . . 0.88 109.523 -179.286 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.533 ' HZ1' ' CA ' ' A' ' 140' ' ' ASN . 19.7 ttpp -73.9 -73.06 0.24 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.629 -1.249 . . . . 2.59 107.629 179.368 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.57 -34.24 0.09 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.445 -0.784 . . . . 0.7 111.035 -178.852 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 48' ' ' ALA . 90.3 p -57.43 -57.4 12.82 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.576 -1.327 . . . . 1.4 107.699 179.17 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.83 80.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.604 -0.685 . . . . 0.67 111.604 -179.2 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -68.86 -40.28 79.41 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.562 -1.337 . . . . 1.66 110.314 -178.646 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.49 -40.13 89.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.01 -1.056 . . . . 1.58 108.801 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.485 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 65.3 mm-40 -62.87 -40.0 96.15 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.251 -0.906 . . . . 1.35 109.11 179.104 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.469 HG22 ' HZ3' ' A' ' 60' ' ' LYS . 94.8 m -63.08 -39.92 96.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.77 110.133 179.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.0 mt -61.15 -40.98 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.012 -1.055 . . . . 0.63 108.973 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.485 ' NZ ' ' OE1' ' A' ' 55' ' ' GLU . 5.4 ttpm? -59.91 -50.45 73.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.279 -0.888 . . . . 1.14 110.103 -179.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -60.14 -39.98 88.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.79 110.841 -177.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.469 ' HZ3' HG22 ' A' ' 56' ' ' THR . 24.3 mttp -62.82 -38.66 91.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -0.911 . . . . 1.53 109.442 179.684 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.24 -39.97 96.11 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.541 -0.724 . . . . 0.57 109.435 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.63 -55.99 23.98 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.309 -1.516 . . . . 0.75 109.309 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.07 -49.86 72.86 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.973 -1.31 . . . . 1.59 109.694 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.1 m -65.8 -61.36 2.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.067 -1.02 . . . . 0.73 111.679 -177.749 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -94.73 -56.24 2.85 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.996 -1.065 . . . . 0.75 111.256 -178.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.4 -165.21 26.79 Favored Glycine 0 N--CA 1.5 2.956 0 C-N-CA 119.811 -1.185 . . . . 1.22 111.131 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -70.01 -25.77 63.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.935 -0.744 . . . . 5.81 110.553 -179.115 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.43 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.6 tp10 -60.29 -37.45 80.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.039 -1.038 . . . . 3.37 110.162 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.436 ' HA ' HD12 ' A' ' 72' ' ' ILE . 32.2 mmtp -100.22 -19.86 16.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.397 -0.814 . . . . 1.77 110.72 -179.179 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -69.92 -42.96 72.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.793 -1.192 . . . . 1.65 110.174 -179.427 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.538 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.22 -30.72 70.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.505 -0.747 . . . . 0.77 109.499 -179.315 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 69' ' ' LYS . 80.0 mt -60.1 -43.18 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.107 -0.996 . . . . 0.8 109.872 -179.569 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -74.84 -30.61 61.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.242 -0.911 . . . . 0.88 110.579 -178.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -61.57 -39.93 92.92 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.814 -1.179 . . . . 1.37 109.522 178.674 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.23 -46.95 93.44 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.87 -1.692 . . . . 0.62 108.87 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -60.01 -44.44 94.58 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.343 -1.093 . . . . 1.5 108.515 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.4 mt -62.75 -50.02 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 109.053 -0.721 . . . . 0.63 109.053 179.35 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -60.01 -40.59 89.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 1.51 109.54 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.9 HD22 HD23 ' B' ' 347' ' ' LEU . 43.8 tp -63.86 -40.03 95.6 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.518 -0.739 . . . . 0.77 109.552 179.335 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -68.85 -38.42 79.76 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.768 -0.583 . . . . 0.62 110.437 -178.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.34 0.36 29.33 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.017 -1.052 . . . . 1.47 110.048 -179.292 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.7 t0 -47.78 130.86 14.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.201 -0.937 . . . . 1.47 110.38 -178.934 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.41 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 93.9 mt-10 -61.94 -18.54 60.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.659 . . . . 1.78 111.086 -179.192 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.88 -33.72 66.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.818 -1.176 . . . . 2.53 108.855 178.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.07 -41.01 74.68 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.099 -0.704 . . . . 0.8 109.099 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.88 -48.68 80.7 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.216 -0.928 . . . . 1.42 110.76 -179.13 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.23 -39.99 74.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.415 -0.803 . . . . 1.71 111.076 -178.579 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -69.81 -39.93 76.24 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.277 -0.89 . . . . 1.57 110.839 -178.581 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.9 mt -69.02 -41.57 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.28 -0.888 . . . . 0.65 109.398 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.4 mt -69.73 -39.68 78.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.505 -0.747 . . . . 0.82 110.3 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.0 -42.88 99.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.222 -0.924 . . . . 0.79 111.208 -178.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 49.1 mt -60.81 -46.97 88.44 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.709 -1.245 . . . . 0.95 109.372 -179.694 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.3 mt -60.17 -49.2 85.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.851 0.834 . . . . 0.66 108.9 179.509 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -69.98 -40.53 75.3 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.909 -0.495 . . . . 2.2 111.309 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -81.02 -57.0 3.73 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.952 -1.092 . . . . 1.65 112.099 -177.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -90.95 0.08 57.61 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.093 -1.004 . . . . 2.03 112.603 -176.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 54.6 m80 58.29 39.76 25.27 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.928 -1.108 . . . . 1.42 109.877 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.0 mtp -89.54 166.85 13.4 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.516 -0.74 . . . . 1.18 110.036 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.452 ' OG1' ' HB3' ' A' ' 102' ' ' ALA . 43.6 p -80.37 159.67 25.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.365 -0.835 . . . . 0.98 108.923 179.491 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.67 -40.06 80.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.113 -0.992 . . . . 0.64 109.965 -179.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 32.2 p-10 -68.0 -37.12 81.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 2.07 109.57 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.503 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -81.56 -41.38 21.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.73 109.824 179.216 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.03 -47.68 73.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.277 -0.889 . . . . 0.54 109.705 -179.686 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.86 87.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.115 -0.991 . . . . 0.56 109.543 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -59.89 -40.09 87.54 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.337 -0.852 . . . . 1.54 110.12 -179.244 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -60.92 -44.17 97.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.347 -0.846 . . . . 1.33 110.792 -179.365 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.6 t -61.54 -50.47 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.16 -0.963 . . . . 0.72 111.009 -177.847 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.5 mm -69.32 -39.88 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.021 -1.049 . . . . 0.85 108.637 179.493 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.401 ' CD ' HH12 ' A' ' 131' ' ' ARG . 41.3 tp10 -61.53 -40.0 93.07 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.869 -0.789 . . . . 2.44 108.869 179.198 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.56 -48.41 84.84 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.534 -0.841 . . . . 0.98 111.235 -178.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -69.15 -49.85 53.11 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.686 -1.479 . . . . 1.41 110.827 -178.335 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.98 87.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.916 -1.115 . . . . 1.2 109.559 -179.257 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 40.8 t -59.45 -40.08 85.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.019 -1.05 . . . . 1.7 108.995 179.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.56 -43.85 96.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.3 -0.875 . . . . 1.47 109.2 179.451 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' B' ' 351' ' ' GLN . 76.7 mt -61.7 -41.0 97.02 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.33 -0.856 . . . . 1.56 109.45 -178.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -59.99 -37.77 80.63 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.076 -1.015 . . . . 2.2 109.483 -179.291 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -52.06 -22.18 3.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.043 -1.036 . . . . 2.12 109.169 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 49.7 mt -62.32 140.1 58.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.051 -1.031 . . . . 2.0 109.01 -179.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -89.93 38.01 0.91 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.127 -0.983 . . . . 3.23 110.249 -178.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 57.9 t0 -129.8 145.95 51.56 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.344 -0.848 . . . . 2.49 109.228 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 124' ' ' LYS . 88.0 tt0 -72.71 -66.52 0.65 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.412 -0.805 . . . . 3.95 109.1 179.656 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 121' ' ' GLU . 3.5 t80 -38.71 -36.19 0.24 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.789 -0.569 . . . . 2.0 110.622 -178.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.0 mt -79.24 -34.76 42.42 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.736 -1.228 . . . . 1.86 108.569 179.192 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 121' ' ' GLU . 7.4 ttpm? -68.17 -39.99 82.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 2.84 109.546 179.473 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.89 -40.31 94.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 2.73 109.265 -179.615 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.536 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -60.84 -38.23 84.79 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.429 -0.952 . . . . 2.77 108.429 -179.892 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.33 -26.92 65.44 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.518 -0.919 . . . . 1.19 108.518 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.47 -39.99 81.18 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.447 -0.946 . . . . 1.2 108.447 178.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -66.84 -42.72 85.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.505 -0.747 . . . . 1.55 109.998 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.23 -41.25 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 0.8 108.922 179.448 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.401 HH12 ' CD ' ' A' ' 109' ' ' GLU . 37.6 ttm-85 -60.64 -39.92 90.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.072 -1.017 . . . . 3.09 108.817 178.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -60.15 -34.43 73.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.57 -0.706 . . . . 1.46 109.617 -179.72 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.1 -43.09 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.135 -0.978 . . . . 0.71 109.55 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.92 -27.61 62.24 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.838 -1.305 . . . . 0.57 109.838 -179.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -59.98 -50.19 74.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.981 -1.305 . . . . 2.59 110.094 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -67.75 -32.11 72.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.999 -1.063 . . . . 2.83 109.348 -179.619 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.39 -41.67 89.94 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.914 -0.773 . . . . 1.25 108.914 -179.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.3 -40.01 94.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.967 . . . . 0.7 109.182 179.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.405 HH21 HD23 ' A' ' 144' ' ' LEU . 58.6 mtp180 -70.04 -40.06 75.38 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.971 0.891 . . . . 2.57 108.729 179.104 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.533 ' CA ' ' HZ1' ' A' ' 49' ' ' LYS . 2.2 m120 -60.74 -38.23 84.47 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 116.002 -0.544 . . . . 1.23 111.466 -178.539 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.3 mt -70.33 -39.94 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.811 -1.181 . . . . 0.81 109.811 -179.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 54.2 mt -71.85 -20.56 61.8 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.397 -0.814 . . . . 1.0 110.241 -178.555 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.9 40.84 13.5 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.044 -1.622 . . . . 0.89 109.044 -179.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.405 HD23 HH21 ' A' ' 139' ' ' ARG . 3.3 tp -75.24 149.98 38.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.362 -1.081 . . . . 1.14 109.859 -179.361 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -74.71 141.79 44.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.513 -0.742 . . . . 4.6 109.949 -179.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.3 129.77 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 122.29 1.043 . . . . 1.24 108.84 178.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 15.0 mt -69.66 -39.96 78.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 115.411 -0.813 . . . . 1.54 110.398 -177.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.8 t0 68.18 127.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.741 -0.837 . . . . 1.5 108.741 -179.251 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.411 ' O ' HD13 ' A' ' 152' ' ' ILE . 19.5 mt -92.03 0.04 57.47 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.316 -0.865 . . . . 0.79 110.266 -178.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 24.5 t -95.61 -11.79 26.7 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.041 -1.037 . . . . 1.4 110.185 -179.683 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.24 15.48 1.55 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.066 -1.021 . . . . 0.92 111.333 -178.581 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.411 HD13 ' O ' ' A' ' 149' ' ' LEU . 2.8 mp -86.1 137.14 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.446 -1.409 . . . . 0.88 108.417 179.517 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -111.95 -10.45 13.96 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.537 -0.727 . . . . 2.45 109.356 -179.411 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -123.21 148.0 46.29 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.744 -0.597 . . . . 1.52 109.775 -179.522 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.33 138.91 58.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.449 -0.782 . . . . 1.58 109.164 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.5 m -152.59 166.65 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.658 -0.652 . . . . 0.69 109.804 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 92.9 mt -96.51 146.07 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 106.191 -1.781 . . . . 0.61 106.191 176.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.1 tp -96.69 118.33 32.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.891 -1.13 . . . . 0.87 110.94 -177.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.0 t -119.6 123.25 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 109.015 -0.735 . . . . 0.71 109.015 179.095 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -153.06 159.97 42.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.81 109.012 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.27 -31.35 64.02 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.346 -1.472 . . . . 0.98 108.956 179.287 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 46.2 t0 -169.97 140.51 2.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.415 -0.803 . . . . 2.25 108.933 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.488 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 26.5 mt -114.77 131.55 56.75 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.371 -0.831 . . . . 0.78 109.031 -179.582 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.9 p -95.07 148.6 34.95 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.132 -0.98 . . . . 0.98 110.128 -179.526 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -37.32 -39.06 0.56 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.652 2.235 . . . . 0.81 112.56 179.19 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.3 m -57.58 -39.87 77.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.282 -0.886 . . . . 0.9 108.93 -179.052 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -69.9 -39.9 75.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.169 -0.957 . . . . 1.61 109.666 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 45.7 p -56.57 -24.01 44.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.033 -1.042 . . . . 0.61 110.51 -178.23 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.39 -55.78 4.96 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.967 -1.083 . . . . 0.6 109.358 179.432 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -83.84 40.78 0.76 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.98 -1.119 . . . . 1.4 107.98 179.411 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 35.1 tp -103.37 130.14 50.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.739 -0.601 . . . . 0.7 109.611 179.501 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 172' ' ' ASN . 10.6 p-10 -86.15 97.92 10.61 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.954 -1.128 . . . . 2.35 107.954 178.243 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 56.3 mt -67.5 -41.49 84.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 1.51 111.119 -178.245 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -69.91 -26.83 64.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.658 -1.276 . . . . 2.33 112.222 -177.747 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -92.0 -5.94 52.1 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.556 -1.34 . . . . 1.92 109.513 -178.793 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.627 HG12 ' H ' ' A' ' 178' ' ' GLY . 60.9 t -107.28 119.66 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.688 -1.227 . . . . 0.67 107.688 178.168 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.1 mt -84.7 7.21 21.24 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.379 -0.825 . . . . 1.53 110.675 -177.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.627 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 163.53 178.11 36.94 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.192 -1.563 . . . . 0.48 109.192 179.781 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.462 ' CE1' HG11 ' A' ' 176' ' ' VAL . 13.2 m-85 -134.46 130.43 36.72 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.393 -1.063 . . . . 0.55 109.038 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.414 ' CG2' HG21 ' A' ' 205' ' ' THR . 91.5 mt -130.63 125.2 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.204 -1.035 . . . . 0.65 108.204 178.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 65.6 p -149.69 160.32 43.62 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.845 -1.159 . . . . 0.82 110.682 -179.073 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.457 ' CB ' ' H ' ' A' ' 206' ' ' GLY . 4.1 p30 -108.69 27.19 9.68 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.513 -0.921 . . . . 2.46 108.513 179.283 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.25 -164.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.122 -0.986 . . . . 1.28 112.079 -177.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.63 -79.89 0.09 OUTLIER Glycine 0 N--CA 1.492 2.387 0 CA-C-N 115.793 -0.64 . . . . 2.19 111.579 -178.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.13 -151.64 6.07 Favored Glycine 0 N--CA 1.494 2.553 0 O-C-N 120.711 -1.464 . . . . 2.13 111.17 -178.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -79.73 -9.97 59.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.828 -0.807 . . . . 5.86 110.553 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.9 p -84.55 3.12 38.09 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.101 -1.0 . . . . 3.72 110.856 -178.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.3 t -72.02 143.07 49.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.827 -1.17 . . . . 1.74 110.18 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -49.55 -50.21 43.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.235 -0.916 . . . . 0.95 110.128 -179.302 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.3 m -59.86 -40.23 87.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.368 -0.832 . . . . 1.55 110.32 -178.642 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 52.2 p -59.93 -40.17 87.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.933 -1.104 . . . . 1.51 110.453 -178.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.426 HG12 HH21 ' A' ' 195' ' ' ARG . 96.9 mt -60.0 -38.92 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.935 . . . . 1.67 109.526 -179.739 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.5 mtp -60.25 -39.89 88.36 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.858 . . . . 1.02 110.207 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.12 -45.71 83.25 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.834 -1.166 . . . . 0.68 109.725 -179.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.426 HH21 HG12 ' A' ' 192' ' ' ILE . 83.6 mtm180 -60.36 -49.79 76.19 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.077 -1.049 . . . . 2.93 110.298 -179.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 30.6 m -69.94 -34.7 73.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.715 -1.24 . . . . 0.86 110.525 -179.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 84.4 mt -72.67 -21.59 61.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.009 -1.057 . . . . 0.67 108.973 179.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 62.15 50.79 3.8 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.395 0.617 . . . . 1.5 110.886 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 96.5 mt -126.35 149.96 68.8 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 107.468 -1.308 . . . . 0.72 107.468 178.355 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.3 135.5 50.55 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 122.25 1.967 . . . . 0.61 111.845 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.99 149.97 3.72 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.595 -1.242 . . . . 0.66 111.941 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.0 mt -126.54 146.03 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.787 -1.19 . . . . 0.79 107.787 179.147 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.48 -9.25 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 120.86 -1.15 . . . . 0.91 111.547 -179.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.58 23.83 23.45 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 110.048 -1.221 . . . . 1.01 110.048 -179.584 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.414 HG21 ' CG2' ' A' ' 180' ' ' ILE . 7.9 p -45.55 -45.98 13.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.189 -1.183 . . . . 0.99 109.987 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.457 ' H ' ' CB ' ' A' ' 182' ' ' ASP . . . 93.47 -54.77 2.39 Favored Glycine 0 N--CA 1.503 3.119 0 O-C-N 121.017 -1.052 . . . . 1.12 112.025 178.811 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 93.3 p -152.76 29.58 0.52 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.551 -1.558 . . . . 1.72 111.248 -179.042 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 76.2 t -76.26 -34.95 26.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.948 -1.095 . . . . 0.89 108.957 178.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.6 p -57.46 -30.44 65.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.461 -0.774 . . . . 1.03 110.291 -179.124 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 57.5 p -83.77 -15.18 49.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.783 -1.198 . . . . 1.83 110.06 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -96.21 -12.75 24.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.09 -1.006 . . . . 2.27 109.953 -179.587 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 73.9 t -103.73 136.65 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.363 -0.836 . . . . 0.92 110.38 -178.479 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -110.1 150.1 29.08 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.748 -1.204 . . . . 2.2 107.748 178.803 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.701 ' N ' HD22 ' A' ' 214' ' ' ASN . 0.0 OUTLIER -58.6 137.08 57.71 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.902 -1.124 . . . . 2.36 110.053 -179.355 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.4 m-20 85.64 0.04 0.73 Allowed 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.2 0.524 . . . . 2.38 110.025 179.722 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 60.1 t0 -70.67 144.1 51.16 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.193 -0.942 . . . . 2.09 109.246 179.416 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.402 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 40.9 t80 -93.77 120.27 33.82 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.383 -0.969 . . . . 1.27 108.383 178.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.417 HD12 ' HB2' ' A' ' 16' ' ' ALA . 89.4 mt -129.39 150.81 50.58 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.458 -0.776 . . . . 0.75 110.766 -178.696 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.5 mt -115.28 127.88 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.143 -1.429 . . . . 0.63 107.143 177.362 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 61.8 tp -100.54 118.95 37.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.972 -1.08 . . . . 0.7 108.469 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.43 ' C ' ' N ' ' A' ' 223' ' ' VAL . 18.8 t0 -81.33 -41.23 22.38 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.846 -1.168 . . . . 2.31 107.846 179.403 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.782 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 48.21 18.76 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.013 -0.736 . . . . 0.78 109.013 -179.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.43 ' N ' ' C ' ' A' ' 221' ' ' ASP . 39.2 t -128.45 -42.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.114 -1.439 . . . . 1.04 107.114 178.507 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -104.78 8.11 34.81 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.509 -1.293 . . . . 2.44 107.509 178.062 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.751 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.9 OUTLIER 59.62 49.45 8.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.878 -0.514 . . . . 1.55 110.245 179.703 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -147.94 149.9 33.05 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.817 -1.177 . . . . 1.99 110.766 179.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.45 122.05 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.304 -0.998 . . . . 0.77 108.304 179.035 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -87.67 128.98 35.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.626 -1.296 . . . . 0.98 109.218 -179.491 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 33.1 t -104.06 119.55 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.421 -0.8 . . . . 0.85 110.197 -179.014 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 57.02 69.4 1.7 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.058 -1.026 . . . . 1.66 109.598 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -91.3 135.64 1.81 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.525 2.817 . . . . 0.95 112.8 -179.689 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 233' ' ' ASN . 55.8 m -65.87 159.76 24.78 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.212 -0.93 . . . . 1.84 108.791 179.626 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.431 ' N ' HG22 ' A' ' 232' ' ' THR . 34.6 m120 -59.71 -38.06 80.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 2.74 108.939 -179.486 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.23 -39.33 86.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.361 -0.837 . . . . 2.89 109.533 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 88.1 t -61.28 -41.35 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.34 -0.85 . . . . 1.3 109.459 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.1 mt . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 1.09 109.865 -179.956 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 8.1 ttt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -150.7 149.05 29.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.796 . . . . 0.0 109.243 179.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -149.36 160.99 42.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.078 -1.014 . . . . 0.0 110.116 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -153.42 149.75 28.1 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.796 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -111.62 131.38 55.31 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.23 -0.919 . . . . 0.0 109.815 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.17 122.71 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-O 122.287 1.041 . . . . 0.0 112.491 -176.898 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 95.5 m -75.59 103.9 5.9 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.849 0.833 . . . . 0.0 110.148 -178.647 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.58 HG22 ' H ' ' B' ' 310' ' ' ALA . 96.6 mt -51.95 124.42 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 122.176 0.989 . . . . 0.0 109.977 -178.218 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 75.0 p -105.81 22.1 16.16 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.845 -178.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.58 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -80.58 149.32 67.92 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.61 -72.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.259 0 CA-C-N 119.455 0.841 . . . . 0.0 112.062 -179.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -86.29 23.87 1.48 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.123 -0.986 . . . . 0.0 110.819 -177.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 82.62 -163.14 42.11 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.542 -1.313 . . . . 0.0 109.841 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.413 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.0 tp -90.31 93.65 9.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.354 -1.086 . . . . 0.0 109.79 -178.094 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.483 ' CE1' ' H ' ' B' ' 317' ' ' ARG . 10.4 p80 -94.39 -160.25 0.76 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.728 -1.232 . . . . 0.0 109.304 178.628 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.6 m -58.31 -45.16 88.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.83 -1.168 . . . . 0.0 112.752 -176.094 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.538 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 3.8 tpt180 -59.46 -64.51 2.9 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.111 -1.618 . . . . 0.0 111.375 -177.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.403 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 7.3 Cg_endo -55.08 -34.11 86.16 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 CA-C-N 120.176 1.099 . . . . 0.0 112.047 179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.2 -52.36 65.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.001 -1.062 . . . . 0.0 109.402 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.48 -41.05 63.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.217 -0.927 . . . . 0.0 109.633 -178.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . 0.511 ' NE2' ' NE ' ' B' ' 317' ' ' ARG . 44.6 mt-30 -70.81 -40.87 72.24 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.824 -1.172 . . . . 0.0 108.924 179.152 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -60.14 -50.5 73.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.298 -0.876 . . . . 0.0 110.854 -179.242 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 74.0 t -69.89 -31.16 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.753 -1.217 . . . . 0.0 109.792 -178.628 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -59.76 -47.99 83.49 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.229 -0.92 . . . . 0.0 109.859 -179.56 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -67.08 -40.05 86.93 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 111.078 -178.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . 0.406 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -63.46 -53.22 55.56 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.998 -1.064 . . . . 0.0 111.393 -178.934 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -56.12 -10.2 0.79 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.015 -1.053 . . . . 0.0 109.526 -179.381 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -69.79 -30.26 70.59 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 178.892 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -102.67 141.73 35.0 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.594 -0.945 . . . . 0.0 109.172 179.772 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . 0.418 HG22 ' O ' ' B' ' 330' ' ' THR . 44.5 m -89.78 -11.32 42.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.154 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 61.8 p -59.34 156.68 12.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.374 -0.829 . . . . 0.0 110.034 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -72.9 127.93 33.99 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.351 -0.843 . . . . 0.0 108.956 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.7 mt -134.52 133.54 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . 0.425 HG22 ' N ' ' B' ' 335' ' ' VAL . 87.9 m -132.85 155.88 48.18 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.508 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . 0.425 ' N ' HG22 ' B' ' 334' ' ' THR . 58.3 t -117.2 140.68 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.427 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 64.9 m -129.05 123.17 31.6 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.447 -0.783 . . . . 0.0 109.134 179.763 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 66.9 p -139.45 117.41 11.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.353 -0.842 . . . . 0.0 110.418 -179.725 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 59.8 t30 45.6 56.53 5.72 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 177.208 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.02 -13.29 26.32 Favored Glycine 0 N--CA 1.501 3.004 0 O-C-N 120.055 -1.653 . . . . 0.0 112.924 176.438 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -111.75 122.93 49.12 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-N 119.037 1.418 . . . . 0.0 109.52 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.1 m -118.53 143.53 46.69 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.769 0.795 . . . . 0.0 110.544 -178.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -139.87 161.0 38.62 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.822 0.82 . . . . 0.0 110.174 -179.441 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 15.5 t -89.59 140.0 29.99 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.619 -0.675 . . . . 0.0 109.446 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -76.78 -12.63 60.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.085 -1.009 . . . . 0.0 109.785 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.42 19.87 4.21 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.649 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 16.3 t -149.37 96.91 2.58 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.912 -179.224 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.9 HD23 HD22 ' A' ' 79' ' ' LEU . 28.8 tp -59.97 -32.04 70.45 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.933 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.721 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.9 m-85 -58.09 -52.34 65.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 109.915 -179.28 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . 0.432 ' O ' ' OG1' ' B' ' 352' ' ' THR . 33.8 mtmm -69.93 -39.92 75.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.692 -1.255 . . . . 0.0 110.163 -178.292 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' B' ' 352' ' ' THR . 39.6 mt -50.63 -58.24 6.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.775 -1.203 . . . . 0.0 108.024 179.219 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.669 HE21 ' N ' ' B' ' 351' ' ' GLN . 0.0 OUTLIER -38.28 -27.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.871 -0.518 . . . . 0.0 111.127 -178.361 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.464 ' N ' ' O ' ' B' ' 350' ' ' LEU . 51.0 p -77.75 -11.48 59.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.091 -1.006 . . . . 0.0 110.388 -178.855 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 24.8 mt -92.78 115.41 28.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.888 -1.133 . . . . 0.0 109.195 179.221 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.1 92.75 0.75 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.919 -1.673 . . . . 0.0 108.919 179.504 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 44.3 mt -100.61 91.62 4.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.24 -1.153 . . . . 0.0 108.913 179.529 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 81.0 p -91.86 177.9 6.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.956 -1.09 . . . . 0.0 110.512 -178.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' B' ' 359' ' ' THR . 61.8 tt0 -46.48 155.68 0.22 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.664 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 39.46 25.23 0.05 OUTLIER Glycine 0 N--CA 1.495 2.595 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 177.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . 0.465 ' N ' ' O ' ' B' ' 357' ' ' GLN . 9.2 m -82.47 112.44 19.41 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.708 -1.466 . . . . 0.0 109.283 179.423 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 16.4 t -77.37 115.8 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 122.214 1.007 . . . . 0.0 110.358 -176.882 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.3 m -110.34 176.85 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 30.8 m -132.19 129.81 40.24 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.4 mt -105.84 122.09 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.402 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 52.7 p -120.82 132.19 54.87 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.639 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.93 151.87 37.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.905 -1.122 . . . . 0.0 110.955 -178.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -144.87 124.49 13.25 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.691 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 160.16 -162.73 33.41 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 118.981 -1.58 . . . . 0.0 111.367 179.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -59.96 -55.64 31.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 122.258 -0.554 . . . . 0.0 111.759 -178.425 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.41 ' H ' ' HB3' ' B' ' 331' ' ' SER . 94.5 m-20 -104.93 7.48 34.24 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.996 -1.065 . . . . 0.0 111.105 -177.314 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' B' ' 369' ' ' ASP . 1.3 pp20? -42.91 -32.12 0.59 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.244 -0.91 . . . . 0.0 110.507 -179.12 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -70.08 -43.7 70.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 109.996 -179.293 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -64.7 -48.99 72.63 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.199 -0.938 . . . . 0.0 109.332 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.9 -75.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.425 -0.797 . . . . 0.0 110.705 -178.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.566 ' O ' HG23 ' B' ' 378' ' ' VAL . 45.4 t -44.5 -38.77 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.099 -1.001 . . . . 0.0 110.895 -177.564 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -64.86 -47.23 78.68 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.624 -1.298 . . . . 0.0 110.513 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -82.75 -41.72 18.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.919 -1.113 . . . . 0.0 110.445 -179.454 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.9 -39.23 77.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.904 -1.122 . . . . 0.0 108.284 -179.617 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.566 HG23 ' O ' ' B' ' 374' ' ' VAL . 48.1 t -62.38 -40.24 87.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.213 179.13 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' B' ' 383' ' ' GLU . 20.8 mtpp -68.54 -55.78 10.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.595 -1.315 . . . . 0.0 108.824 178.604 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 56.1 tp -57.78 -35.85 71.36 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.762 -1.211 . . . . 0.0 109.734 -178.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 28.8 ttm -70.66 -40.05 73.22 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.257 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.31 -9.99 59.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.528 -0.733 . . . . 0.0 110.968 179.164 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' B' ' 379' ' ' LYS . 93.9 mt-10 -110.03 0.83 18.62 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.042 -1.036 . . . . 0.0 111.549 -178.191 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 13.2 mt -82.38 125.89 31.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.178 -1.576 . . . . 0.0 109.224 179.136 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.318 -179.978 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.7 mmm . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.255 -0.646 . . . . 2.91 109.255 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.7 mt -110.0 130.03 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.611 -0.681 . . . . 1.2 109.164 179.671 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.5 m -120.92 144.28 48.52 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.579 -0.701 . . . . 1.4 109.747 -179.707 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -121.67 -162.82 11.75 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 108.894 -1.682 . . . . 1.05 108.894 179.751 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 6' ' ' LEU . 91.4 mt -89.28 -13.97 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.9 -1.353 . . . . 1.15 110.176 -179.218 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.9 tp 53.74 102.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.224 -0.922 . . . . 0.98 109.062 -179.883 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.64 -29.43 12.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.262 -0.899 . . . . 0.88 109.153 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 30.8 m -129.44 116.02 18.47 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 109.024 -0.732 . . . . 1.69 109.024 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.25 146.72 20.02 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.76 1.64 . . . . 0.85 112.079 -179.74 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.808 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.61 -154.4 25.5 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.462 -1.455 . . . . 0.92 109.462 -179.85 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.0 mt -148.36 150.33 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.36 -1.082 . . . . 0.81 108.587 178.947 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.84 156.32 34.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.939 -1.101 . . . . 0.51 110.752 179.663 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.2 m-85 -137.41 128.51 27.66 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.895 -1.15 . . . . 0.62 107.895 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.67 174.29 46.92 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 118.736 -1.697 . . . . 0.55 110.743 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -76.52 158.87 30.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.769 -0.842 . . . . 2.1 109.26 -179.735 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.99 126.11 46.13 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.358 -0.839 . . . . 0.77 111.377 -178.351 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.7 tp -101.36 129.96 47.46 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.876 -1.527 . . . . 0.91 106.876 177.57 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.2 tp -114.02 121.64 44.47 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.308 -0.87 . . . . 0.93 110.021 -178.914 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.2 mt -85.87 100.09 11.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.49 -0.756 . . . . 0.93 109.051 179.358 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -84.42 142.0 30.43 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.27 -1.011 . . . . 2.75 108.27 179.532 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -130.76 135.65 47.98 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.023 -1.048 . . . . 3.0 109.106 179.392 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -94.78 156.4 16.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.322 -0.861 . . . . 2.77 109.55 -179.916 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -78.58 136.98 37.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 2.94 109.321 179.787 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.6 mt -79.79 130.17 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.258 -0.901 . . . . 0.95 108.728 179.931 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.8 t -93.27 125.76 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.18 -0.95 . . . . 1.28 109.684 -179.461 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.8 mt -105.97 138.06 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.517 -0.739 . . . . 1.21 109.12 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -96.23 120.06 35.84 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.159 -0.963 . . . . 1.81 109.974 -179.585 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.542 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.0 mmt-85 -90.02 -0.24 57.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.402 -0.812 . . . . 2.8 109.692 -179.795 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -69.9 135.5 49.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.069 -1.02 . . . . 2.87 109.164 -179.895 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -83.02 154.81 24.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.107 -0.996 . . . . 2.35 109.419 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.529 HD13 ' HG3' ' A' ' 39' ' ' GLU . 2.9 pt -98.92 166.41 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.207 -0.933 . . . . 0.97 109.609 179.568 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.2 p -93.41 174.81 7.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.3 -0.875 . . . . 1.17 108.658 178.437 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.07 -48.56 81.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 1.18 110.292 -179.425 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -55.51 -31.48 62.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.767 -1.208 . . . . 2.56 110.568 -179.057 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -81.59 -8.98 59.78 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.177 -0.952 . . . . 1.79 110.289 -179.357 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.9 t -60.06 -50.09 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.776 -1.203 . . . . 1.0 109.087 179.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -60.11 -39.91 87.87 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.369 -0.832 . . . . 1.77 109.078 -179.663 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -64.19 -42.02 96.83 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.546 -0.721 . . . . 2.7 110.916 -178.717 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.529 ' HG3' HD13 ' A' ' 31' ' ' ILE . 68.7 mm-40 -62.83 -41.84 99.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.68 -1.263 . . . . 1.51 110.422 -179.224 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.7 t -63.73 -47.04 92.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.675 -1.266 . . . . 0.93 108.987 -179.763 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -60.0 -46.2 90.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.055 -1.028 . . . . 1.81 108.957 179.863 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -59.98 -48.59 81.1 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.026 -1.07 . . . . 2.78 108.766 179.5 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.451 ' CZ ' HD13 ' A' ' 89' ' ' ILE . 88.1 t80 -60.15 -44.61 94.84 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.162 -0.961 . . . . 0.78 108.879 178.659 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.1 tp -59.95 -47.34 86.21 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.827 -1.175 . . . . 1.07 107.827 179.427 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 27.6 t -63.53 -43.62 96.6 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.571 -0.852 . . . . 1.12 108.979 178.963 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.97 -48.24 87.28 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.986 -1.646 . . . . 0.84 108.986 179.34 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -63.2 -31.5 72.66 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.365 -1.08 . . . . 3.09 108.2 179.114 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.61 -40.05 82.17 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.813 -0.81 . . . . 0.88 108.813 179.887 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.546 ' HZ3' ' HB3' ' A' ' 49' ' ' LYS . 6.8 ttpm? -65.73 -74.31 0.11 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.932 -1.136 . . . . 2.59 107.932 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.94 -40.54 0.47 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.366 -0.834 . . . . 0.7 111.758 -178.255 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 64.0 m -54.48 -53.7 50.74 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.465 -1.397 . . . . 1.4 108.982 -179.875 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.23 -41.18 77.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.226 -0.921 . . . . 0.67 110.819 -179.318 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -66.89 -39.97 87.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.908 -1.12 . . . . 1.66 109.989 -179.511 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.9 mt -61.03 -39.95 91.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.892 -1.13 . . . . 1.58 108.725 179.066 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -61.94 -35.08 77.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.477 -0.765 . . . . 1.35 109.573 179.482 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -64.3 -43.04 95.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.034 -1.041 . . . . 0.77 109.35 179.816 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.9 -39.63 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.855 . . . . 0.63 108.917 179.681 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -57.07 -50.43 72.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.442 -0.786 . . . . 1.14 109.971 -179.368 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -57.1 -31.62 65.46 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.319 -0.863 . . . . 0.79 110.377 -177.888 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -70.02 -38.14 75.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.05 -1.031 . . . . 1.53 109.436 -179.897 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.8 -45.91 76.91 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.615 -0.678 . . . . 0.57 110.641 -179.128 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.88 -50.87 63.04 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.755 -1.212 . . . . 0.75 110.424 -178.637 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -70.24 -43.8 69.85 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.934 -1.333 . . . . 1.59 110.18 -179.792 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.4 m -69.98 -57.8 4.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.067 -1.021 . . . . 0.73 111.698 -178.042 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -98.31 -54.36 3.08 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.138 -0.976 . . . . 0.75 111.483 -178.168 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.26 -164.58 26.88 Favored Glycine 0 N--CA 1.5 2.914 0 C-N-CA 119.676 -1.25 . . . . 1.22 110.931 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -71.4 -25.92 62.55 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.884 -0.774 . . . . 5.81 110.795 -179.409 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.4 -35.9 78.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.165 -0.959 . . . . 3.37 110.197 -179.255 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -100.01 -20.28 16.14 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.331 -0.856 . . . . 1.77 110.269 -179.222 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -69.92 -40.32 75.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.962 -1.087 . . . . 1.65 110.501 -178.826 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.621 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -67.36 -26.1 66.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.133 -0.979 . . . . 0.77 109.972 -179.058 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.73 -39.99 81.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 118.954 -1.099 . . . . 0.8 108.345 179.77 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -67.82 -39.99 83.84 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.055 -1.028 . . . . 0.88 110.311 179.885 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.419 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 80.2 tt0 -59.91 -40.78 89.97 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.759 -1.213 . . . . 1.37 109.454 179.464 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.86 -48.98 76.55 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.029 -1.628 . . . . 0.62 109.029 179.518 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.5 m170 -63.05 -42.96 99.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.463 -1.022 . . . . 1.5 109.485 179.916 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.02 -45.1 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.235 -0.916 . . . . 0.63 109.784 -179.737 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.0 ttp -60.27 -40.11 89.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.891 -1.13 . . . . 1.51 109.121 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.969 HD22 HD23 ' B' ' 347' ' ' LEU . 48.1 tp -63.09 -39.34 94.41 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.683 -0.636 . . . . 0.77 109.956 179.626 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.2 tp -66.26 -38.3 87.53 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.523 -0.735 . . . . 0.62 110.248 -179.483 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -80.35 3.28 21.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.958 -1.089 . . . . 1.47 110.258 -179.045 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -49.75 130.03 20.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.0 -1.063 . . . . 1.47 109.642 -179.614 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.18 -17.73 58.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.534 -0.729 . . . . 1.78 110.629 -179.536 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -71.85 -35.05 69.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.975 -1.078 . . . . 2.53 108.713 178.767 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.8 mt -69.96 -40.36 75.47 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.492 0.663 . . . . 0.8 109.831 179.761 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.04 -45.37 93.04 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.329 -0.857 . . . . 1.42 109.917 -179.22 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -69.99 -40.0 75.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 1.71 110.334 -179.14 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.96 -40.05 75.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.288 -0.882 . . . . 1.57 110.912 -179.175 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.451 HD13 ' CZ ' ' A' ' 43' ' ' PHE . 87.3 mt -68.37 -42.45 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.991 -1.068 . . . . 0.65 109.595 -179.588 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.01 -38.78 76.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.564 -0.71 . . . . 0.82 110.633 -179.533 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.45 77.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.102 -0.999 . . . . 0.79 111.247 -178.615 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.81 -47.54 84.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.769 -1.207 . . . . 0.95 110.419 -178.964 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.42 -49.9 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.114 -0.991 . . . . 0.66 109.183 179.957 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -70.27 -43.9 69.54 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.375 -0.53 . . . . 2.2 111.132 -179.721 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -80.98 -49.87 10.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.986 -1.072 . . . . 1.65 111.991 -177.813 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -90.12 -2.43 58.08 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.001 -1.062 . . . . 2.03 111.584 -177.372 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 56.43 35.12 25.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.859 -1.15 . . . . 1.42 109.435 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.0 mtt -88.4 169.26 11.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.472 -0.768 . . . . 1.18 109.907 -179.417 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.4 p -81.88 160.0 23.54 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.342 -0.849 . . . . 0.98 108.776 179.532 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.77 -39.88 88.0 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.22 -0.925 . . . . 0.64 110.258 -179.472 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 35.9 p-10 -67.02 -35.07 79.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.081 -1.012 . . . . 2.07 109.335 -179.735 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.507 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.96 -47.39 13.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.317 -0.865 . . . . 0.73 109.604 179.661 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.63 -48.32 81.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.385 -0.822 . . . . 0.54 110.007 -179.612 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.28 -36.24 79.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.935 . . . . 0.56 109.844 -179.891 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.415 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 80.3 t60 -60.03 -42.67 94.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.286 -0.884 . . . . 1.54 109.98 -178.761 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' A' ' 110' ' ' GLY . 41.3 tt0 -64.36 -40.01 94.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.164 -0.96 . . . . 1.33 110.242 -179.469 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.2 t -60.57 -56.09 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.352 -0.842 . . . . 0.72 111.446 -178.06 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.1 mm -69.93 -39.97 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.942 -1.099 . . . . 0.85 108.936 -179.789 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.415 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 88.8 tt0 -64.78 -38.87 92.44 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.567 -0.901 . . . . 2.44 108.567 178.639 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.02 -49.2 77.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.813 -0.915 . . . . 0.98 110.813 -179.066 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -68.79 -52.34 31.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.716 -1.461 . . . . 1.41 109.527 -179.521 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.62 -40.05 78.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.296 -0.877 . . . . 1.2 109.26 179.868 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.6 t -58.24 -41.4 84.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.175 -0.953 . . . . 1.7 108.963 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.81 -40.5 91.91 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.258 -0.901 . . . . 1.47 109.028 179.192 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.431 HD22 ' HB3' ' B' ' 351' ' ' GLN . 76.5 mt -61.4 -45.24 95.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.107 -0.996 . . . . 1.56 109.62 -179.682 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -57.25 -32.32 66.45 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.143 -0.973 . . . . 2.2 109.846 -178.48 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -58.11 -21.74 47.66 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.022 -1.049 . . . . 2.12 108.605 179.773 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 123' ' ' LEU . 54.4 mt -62.37 139.95 58.54 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.264 -0.898 . . . . 2.0 108.577 179.636 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -90.09 10.08 25.71 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.114 -0.991 . . . . 3.23 110.86 -178.722 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -94.39 133.59 37.8 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.777 -1.202 . . . . 2.49 109.828 -179.75 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -69.92 -28.99 66.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.571 -0.706 . . . . 3.95 109.954 -179.861 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.484 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.7 t80 -69.24 -36.86 77.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.376 -0.827 . . . . 2.0 110.244 179.417 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.654 HD22 ' O ' ' B' ' 351' ' ' GLN . 90.6 mt -77.49 -35.21 53.84 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.093 -1.004 . . . . 1.86 109.57 179.838 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -59.99 -45.33 93.08 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.229 -0.919 . . . . 2.84 109.678 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 77.6 mm-40 -60.55 -45.37 94.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -0.964 . . . . 2.73 109.296 -179.655 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -61.94 -39.88 93.62 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.117 -1.068 . . . . 2.77 108.117 179.101 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.79 -23.25 51.54 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.184 -1.043 . . . . 1.19 108.184 178.796 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -69.96 -40.09 75.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.814 -0.81 . . . . 1.2 108.814 178.954 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.54 -40.09 94.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.528 -0.733 . . . . 1.55 110.294 -179.497 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.93 -40.56 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.08 -1.013 . . . . 0.8 108.402 179.842 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -60.09 -38.69 83.68 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.964 -0.754 . . . . 3.09 108.964 178.474 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -59.53 -39.57 84.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.745 . . . . 1.46 109.986 -179.52 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.93 -40.78 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.052 -1.03 . . . . 0.71 109.686 -179.623 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.63 -41.42 96.01 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.979 -1.105 . . . . 0.57 110.769 -179.44 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -59.93 -47.07 87.3 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.964 -1.315 . . . . 2.59 111.279 -178.799 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.621 HH12 ' CB ' ' A' ' 166' ' ' SER . 98.6 mtt180 -69.97 -30.47 67.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.504 -1.372 . . . . 2.83 109.927 -179.622 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.0 -46.15 90.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 1.25 109.152 -179.968 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.5 mt -59.88 -40.04 87.35 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.396 -0.815 . . . . 0.7 109.464 179.236 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.414 ' NE ' HD23 ' A' ' 144' ' ' LEU . 53.5 mtp180 -69.16 -40.02 78.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.397 -0.814 . . . . 2.57 110.206 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -69.93 -20.91 63.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.337 -0.852 . . . . 1.23 112.383 -178.136 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.5 mt -68.68 -40.02 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.19 -1.569 . . . . 0.81 108.408 179.664 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.13 -29.32 21.9 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.436 -0.79 . . . . 1.0 109.621 -179.699 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.96 54.35 2.05 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 108.695 -1.762 . . . . 0.89 108.695 -178.958 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.414 HD23 ' NE ' ' A' ' 139' ' ' ARG . 19.0 tp -74.73 147.31 41.48 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.625 -0.926 . . . . 1.14 110.009 -179.168 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -60.19 141.42 55.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.342 -0.848 . . . . 4.6 109.867 -179.867 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.3 mt -119.96 127.06 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-O 122.01 0.91 . . . . 1.24 109.414 179.52 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.5 mt -60.11 -45.9 95.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 116.063 -0.517 . . . . 1.54 109.952 -178.504 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.4 t0 64.22 101.52 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.498 -0.751 . . . . 1.5 109.256 -179.57 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.1 mt -71.74 -5.27 32.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.368 -0.833 . . . . 0.79 109.868 -179.269 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.6 m -80.21 -18.57 49.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.056 -1.028 . . . . 1.4 109.56 179.758 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.1 24.04 0.81 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.271 -0.893 . . . . 0.92 111.777 -178.002 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 39.2 mm -90.97 115.98 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.496 -1.378 . . . . 0.88 108.64 179.19 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -100.04 -9.68 22.39 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.34 -0.85 . . . . 2.45 110.545 -178.748 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -119.92 149.48 42.04 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.188 -0.945 . . . . 1.52 110.336 -179.392 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.01 133.81 52.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.388 -0.82 . . . . 1.58 109.1 179.766 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -151.77 164.7 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.448 -0.783 . . . . 0.69 109.597 179.678 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.8 mt -93.69 147.32 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.038 -1.838 . . . . 0.61 106.038 177.0 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 60.9 tp -97.3 117.01 30.57 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.879 -1.138 . . . . 0.87 110.642 -177.952 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 35.5 t -122.12 127.74 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.197 -1.038 . . . . 0.71 108.197 179.228 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.07 160.65 39.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.987 -1.07 . . . . 0.81 108.711 -179.895 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.96 -34.7 73.74 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.261 -1.524 . . . . 0.98 108.16 178.977 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -160.14 170.69 20.69 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.806 -0.813 . . . . 2.25 108.806 179.935 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.6 mt -141.96 129.95 21.93 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.041 -1.037 . . . . 0.78 108.733 178.989 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 63.1 p -90.56 144.23 30.32 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.084 -1.01 . . . . 0.98 109.293 -179.741 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -40.1 -37.6 1.83 Allowed 'Trans proline' 0 N--CA 1.488 1.196 0 C-N-CA 122.116 1.877 . . . . 0.81 112.457 179.39 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.621 ' CB ' HH12 ' A' ' 136' ' ' ARG . 50.2 m -59.98 -40.95 90.9 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.352 -0.843 . . . . 0.9 109.591 -179.238 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -62.78 -43.24 99.32 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.261 -0.9 . . . . 1.61 110.195 -179.644 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 62.4 p -57.85 -28.71 64.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.61 110.531 -178.679 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.99 -57.5 4.93 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.015 -1.053 . . . . 0.6 109.775 179.7 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -83.5 35.39 0.5 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.102 -0.703 . . . . 1.4 109.102 -179.446 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.3 tp -100.66 139.04 36.9 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.347 -0.846 . . . . 0.7 109.345 179.588 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -85.43 103.73 14.59 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.267 -0.896 . . . . 2.35 108.763 179.545 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 63.1 mt -63.62 -45.36 90.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.476 -0.765 . . . . 1.51 110.273 -178.694 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -70.06 -20.39 63.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.024 -1.048 . . . . 2.33 112.572 -178.328 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -93.15 -10.12 36.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.471 -1.393 . . . . 1.92 109.26 -179.185 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 178' ' ' GLY . 89.4 t -109.79 117.64 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.317 -0.864 . . . . 0.67 109.356 179.465 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 78.4 mt -88.77 5.49 43.25 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.348 -0.845 . . . . 1.53 110.676 -178.407 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.514 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.59 173.16 38.96 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.2 -1.56 . . . . 0.48 109.2 179.808 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.432 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 22.6 m-85 -133.09 129.94 38.64 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.258 -1.142 . . . . 0.55 110.105 -179.598 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.555 ' CG2' HG21 ' A' ' 205' ' ' THR . 58.9 mt -128.9 122.89 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.037 -1.097 . . . . 0.65 108.037 177.971 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 11.7 p -143.52 157.03 44.75 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.986 -1.072 . . . . 0.82 110.982 -179.202 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 183' ' ' ALA . 1.1 m-20 -96.19 21.35 9.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.436 -0.79 . . . . 2.46 109.631 -179.891 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -46.9 -173.93 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.977 -1.077 . . . . 1.28 112.723 -177.922 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -85.85 -49.75 4.19 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 111.377 -0.689 . . . . 2.19 111.377 -178.979 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -174.18 -154.46 10.86 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 118.525 -1.798 . . . . 2.13 111.71 -179.291 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.543 ' C ' ' H ' ' A' ' 188' ' ' SER . 8.7 mtt-85 -62.42 -33.99 75.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.782 -0.834 . . . . 5.86 111.151 -178.632 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 29.1 p -60.04 6.99 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.839 -1.163 . . . . 3.72 110.639 -178.302 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.543 ' H ' ' C ' ' A' ' 186' ' ' ARG . 92.7 p -90.85 130.76 36.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.871 -1.143 . . . . 1.74 109.941 179.717 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -47.62 -45.87 28.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.203 -0.935 . . . . 0.95 109.548 -179.849 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 93.3 m -58.41 -40.26 81.96 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 1.55 110.171 -178.317 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 186' ' ' ARG . 81.1 p -63.29 -38.8 92.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.822 -1.174 . . . . 1.51 109.849 -179.881 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.591 HD13 HH22 ' A' ' 195' ' ' ARG . 41.9 mm -60.09 -45.81 95.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.299 -0.876 . . . . 1.67 109.09 -179.459 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.16 -46.45 89.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.415 -0.803 . . . . 1.02 110.639 -179.698 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.43 -48.73 76.38 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.805 -1.185 . . . . 0.68 111.219 -178.273 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.591 HH22 HD13 ' A' ' 192' ' ' ILE . 26.8 mtm-85 -60.88 -50.04 75.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.684 -1.26 . . . . 2.93 110.458 -178.903 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 48.7 m -71.29 -34.98 71.14 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.834 -1.166 . . . . 0.86 111.6 -178.506 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 99.0 mt -81.52 -11.13 59.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.696 -1.253 . . . . 0.67 110.796 -178.356 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 56.91 46.48 19.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.166 -0.959 . . . . 1.5 110.696 179.592 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 8' ' ' SER . 92.2 mt -116.31 121.26 33.75 Favored Pre-proline 0 N--CA 1.5 2.072 0 N-CA-C 108.341 -0.985 . . . . 0.72 108.341 179.055 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -42.35 129.61 4.76 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.83 1.687 . . . . 0.61 111.952 -179.42 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -170.01 152.17 4.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.982 -1.074 . . . . 0.66 111.649 -179.221 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.7 mt -126.87 144.0 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.654 -1.239 . . . . 0.79 107.654 178.607 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 20.5 m -124.05 -9.43 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 O-C-N 120.796 -1.19 . . . . 0.91 111.381 -178.446 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.46 23.69 24.0 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 110.875 -0.89 . . . . 1.01 110.875 -178.829 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.555 HG21 ' CG2' ' A' ' 180' ' ' ILE . 19.2 p -47.19 -42.86 20.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.833 -1.392 . . . . 0.99 110.105 -179.276 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.77 -52.26 4.18 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 120.039 -1.077 . . . . 1.12 111.924 178.833 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.5 t -155.36 35.1 0.37 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.37 -1.665 . . . . 1.72 111.819 -178.759 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 29.5 t -75.95 -38.01 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.857 -1.152 . . . . 0.89 109.195 178.422 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.441 HG23 ' H ' ' A' ' 209' ' ' THR . 2.2 p -60.03 -40.07 88.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.591 -0.693 . . . . 1.03 111.55 -177.985 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.7 p -78.47 -11.37 59.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.799 -1.188 . . . . 1.83 110.264 -178.74 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -96.97 -12.24 23.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.233 -0.917 . . . . 2.27 110.408 -179.698 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 213' ' ' LYS . 91.8 t -116.34 156.2 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.321 -0.862 . . . . 0.92 110.592 -179.344 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.505 ' N ' HG12 ' A' ' 212' ' ' VAL . 62.3 mmtt -114.71 154.12 29.04 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.207 -1.035 . . . . 2.2 108.207 179.687 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 39.0 p-10 -59.73 135.96 57.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.868 -1.145 . . . . 2.36 110.095 -179.404 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.7 OUTLIER 94.5 -1.72 0.08 Allowed 'General case' 0 N--CA 1.511 2.614 0 CA-C-O 121.581 0.705 . . . . 2.38 109.988 179.502 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 48.8 t0 -70.08 151.2 45.76 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.434 -0.792 . . . . 2.09 109.792 -179.961 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 51.0 t80 -95.37 120.13 35.07 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.371 -0.831 . . . . 1.27 108.804 179.602 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 90.2 mt -123.34 138.34 54.63 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.386 -0.821 . . . . 0.75 110.657 -179.297 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.9 mt -112.35 130.0 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 106.436 -1.69 . . . . 0.63 106.436 176.317 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 57.0 tp -100.32 115.01 28.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.115 -0.991 . . . . 0.7 109.542 -178.303 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 223' ' ' VAL . 55.8 m-20 -70.6 -46.92 62.51 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.924 -1.139 . . . . 2.31 107.924 178.996 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.808 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 52.12 9.15 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.917 -0.771 . . . . 0.78 108.917 -179.644 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' A' ' 221' ' ' ASP . 75.5 t -125.9 -38.89 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 107.094 -1.447 . . . . 1.04 107.094 178.797 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -104.32 0.01 28.71 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.928 -1.138 . . . . 2.44 107.928 178.243 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 60.08 45.9 11.35 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.156 -0.683 . . . . 1.55 109.156 -179.524 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -136.41 156.26 48.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.398 -0.814 . . . . 1.99 109.599 -179.752 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.5 t -124.37 129.98 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 108.798 -0.816 . . . . 0.77 108.798 178.957 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -105.22 125.86 51.45 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.513 -0.921 . . . . 0.98 108.513 179.192 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.9 t -103.89 113.99 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.202 -0.936 . . . . 0.85 110.404 -179.406 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.553 HD22 ' C ' ' A' ' 230' ' ' ASN . 0.3 OUTLIER 49.48 62.67 11.61 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.099 -1.001 . . . . 1.66 110.707 178.916 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -85.35 156.16 10.87 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.832 2.355 . . . . 0.95 112.173 179.319 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.411 HG22 HD22 ' A' ' 233' ' ' ASN . 2.0 m -65.92 159.28 25.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.342 -0.849 . . . . 1.84 109.637 -179.423 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.702 ' ND2' ' H ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -61.61 -38.58 88.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.257 -0.902 . . . . 2.74 111.006 -178.916 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.702 ' H ' ' ND2' ' A' ' 233' ' ' ASN . 16.8 pt-20 -65.62 -30.83 71.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.79 -1.194 . . . . 2.89 109.708 -179.492 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.6 -43.15 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 1.3 108.564 179.286 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.536 -0.728 . . . . 1.09 109.963 179.885 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 3.0 ttt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.509 0.671 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -151.98 150.07 29.59 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.995 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -148.34 159.17 44.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.007 -1.058 . . . . 0.0 110.14 -179.275 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -152.98 150.06 28.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.631 -0.668 . . . . 0.0 109.344 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . 0.481 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 1.6 pm0 -114.87 134.69 54.94 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.313 -0.867 . . . . 0.0 109.969 179.43 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 1.3 p -135.63 124.92 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 CA-C-O 122.029 0.919 . . . . 0.0 112.44 -177.212 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 88.7 m -77.72 106.35 9.47 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.93 0.871 . . . . 0.0 109.969 -179.385 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.472 HG22 ' H ' ' B' ' 310' ' ' ALA . 92.3 mt -50.78 124.16 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 122.449 1.118 . . . . 0.0 110.274 -177.407 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 74.8 p -108.06 19.93 19.35 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.54 -178.955 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.472 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -74.57 118.21 68.27 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.907 . . . . 0.0 108.606 179.308 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -61.18 -13.4 27.96 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 CA-C-N 120.477 1.206 . . . . 0.0 112.288 -179.815 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -117.5 9.52 13.26 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.524 -0.735 . . . . 0.0 110.422 -178.581 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.96 172.08 16.78 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.311 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.484 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -82.34 87.92 6.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.951 -1.323 . . . . 0.0 109.557 -178.285 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.424 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 3.5 p80 -90.56 -163.39 1.02 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.796 -1.19 . . . . 0.0 109.713 178.76 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.1 m -58.1 -41.29 83.21 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.806 -1.184 . . . . 0.0 112.595 -175.775 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.621 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 16.3 tpt180 -59.35 -59.58 13.38 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 120.379 -1.451 . . . . 0.0 111.658 -179.49 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.424 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 14.9 Cg_endo -60.43 -34.86 92.71 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 CA-C-N 120.522 1.222 . . . . 0.0 111.693 -179.653 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.98 -51.97 67.4 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.318 -0.864 . . . . 0.0 108.978 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -54.27 -41.8 69.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.687 -178.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -70.08 -41.13 74.49 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.982 -1.074 . . . . 0.0 108.669 178.772 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -60.73 -51.67 68.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.548 -0.72 . . . . 0.0 111.247 -179.362 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . 0.41 HG13 ' O ' ' B' ' 344' ' ' ALA . 86.1 t -67.76 -27.04 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.565 -1.334 . . . . 0.0 109.259 -179.125 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . 0.419 ' NZ ' ' OE1' ' A' ' 74' ' ' GLU . 31.1 ttmt -60.04 -47.52 85.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.552 -0.718 . . . . 0.0 109.645 179.741 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -64.39 -45.22 88.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 110.557 -179.255 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.09 -52.79 63.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.854 -1.154 . . . . 0.0 110.751 -178.792 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -55.22 -16.63 3.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.174 -0.954 . . . . 0.0 109.808 179.706 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.96 -30.64 69.97 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.462 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.29 140.47 39.17 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.465 -1.02 . . . . 0.0 109.27 179.844 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 19.8 m -89.94 -10.71 44.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.124 -0.985 . . . . 0.0 109.607 -179.97 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.495 ' OG ' ' N ' ' B' ' 368' ' ' GLU . 72.9 m -57.74 146.55 30.82 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.051 -1.03 . . . . 0.0 108.679 179.451 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.7 132.66 50.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.186 -0.946 . . . . 0.0 109.499 -179.326 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.8 mt -132.34 131.8 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.471 -0.768 . . . . 0.0 108.964 179.694 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . 0.403 HG22 ' N ' ' B' ' 335' ' ' VAL . 52.1 m -128.73 153.48 47.31 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.778 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . 0.403 ' N ' HG22 ' B' ' 334' ' ' THR . 98.9 t -118.51 140.03 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.504 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 34.3 m -128.04 123.51 34.82 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 179.225 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 86.9 p -138.54 114.98 10.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.261 -0.899 . . . . 0.0 110.87 -179.191 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 28.9 m120 45.17 50.04 9.63 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 176.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.92 -14.21 62.5 Favored Glycine 0 N--CA 1.501 3.028 0 O-C-N 120.077 -1.639 . . . . 0.0 112.947 176.873 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -116.02 126.69 54.15 Favored 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 119.225 1.512 . . . . 0.0 109.699 179.834 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 52.9 m -118.43 144.6 45.84 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.731 0.777 . . . . 0.0 110.648 -178.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . 0.506 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -143.18 162.11 36.46 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.571 0.7 . . . . 0.0 110.005 -179.765 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 41.4 t -87.94 132.5 34.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.669 -0.644 . . . . 0.0 110.745 -178.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.41 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -68.96 -16.75 63.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 108.689 179.358 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -88.73 19.4 4.03 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 178.737 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . 0.745 ' CB ' ' HZ3' ' B' ' 349' ' ' LYS . 53.9 p -146.62 94.99 2.52 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.774 0.797 . . . . 0.0 112.406 -179.428 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.969 HD23 HD22 ' A' ' 79' ' ' LEU . 52.9 tp -60.0 -36.51 77.34 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.728 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.763 ' CE2' HD11 ' A' ' 79' ' ' LEU . 58.3 m-85 -56.51 -53.52 56.5 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.324 -0.86 . . . . 0.0 110.708 -179.181 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . 0.745 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 33.6 mtmm -70.04 -38.78 75.94 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.875 -1.141 . . . . 0.0 109.609 -178.846 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' B' ' 352' ' ' THR . 35.7 mt -48.2 -59.51 3.36 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.946 -1.096 . . . . 0.0 108.496 179.415 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.654 ' O ' HD22 ' A' ' 123' ' ' LEU . 0.9 OUTLIER -39.14 -25.92 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.695 -0.628 . . . . 0.0 111.124 -179.088 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.46 ' N ' ' O ' ' B' ' 350' ' ' LEU . 66.3 p -79.45 -9.94 59.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.344 -1.472 . . . . 0.0 110.198 -178.295 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' B' ' 342' ' ' ALA . 61.1 mt -92.54 114.43 26.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.018 -1.051 . . . . 0.0 108.644 178.6 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.77 90.04 0.66 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 179.575 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 22.7 mt -100.62 93.54 5.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.316 -1.108 . . . . 0.0 108.674 179.426 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 70.9 p -93.36 167.34 11.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.135 -0.978 . . . . 0.0 110.625 -179.053 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 13.3 tm0? -57.84 113.01 1.67 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.782 -0.574 . . . . 0.0 110.693 -179.32 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.78 9.25 38.05 Favored Glycine 0 N--CA 1.498 2.821 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.737 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.6 m -87.19 110.65 20.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.388 -1.066 . . . . 0.0 111.415 -179.113 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 5.0 t -77.03 115.43 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 122.165 0.983 . . . . 0.0 109.703 -177.775 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 18.3 m -113.31 177.18 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.855 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 93.3 m -132.15 132.58 43.34 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.052 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 59.3 mt -107.94 126.07 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.194 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 54.0 m -125.36 133.51 52.53 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.447 -0.783 . . . . 0.0 109.17 -179.491 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -148.53 155.62 41.38 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.94 -1.1 . . . . 0.0 111.001 -178.812 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -149.55 128.68 12.76 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.824 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.461 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 156.65 -152.16 23.54 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.155 -1.498 . . . . 0.0 111.726 179.548 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . 0.495 ' N ' ' OG ' ' B' ' 331' ' ' SER . 54.5 tp10 -58.64 -52.1 67.13 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 122.099 -0.647 . . . . 0.0 112.376 -177.15 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' B' ' 370' ' ' GLU . 89.2 m-20 -114.98 15.63 17.23 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.011 -1.056 . . . . 0.0 111.416 -177.11 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.54 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.0 OUTLIER -41.25 -37.3 0.92 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.255 -0.903 . . . . 0.0 111.718 -178.488 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . 0.516 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 72.7 mm-40 -68.05 -44.53 76.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.602 -1.311 . . . . 0.0 110.376 -178.083 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -68.29 -51.56 43.51 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.094 -1.004 . . . . 0.0 109.033 179.806 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -46.32 -38.08 8.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.698 -0.626 . . . . 0.0 111.665 -178.87 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.467 ' O ' HG23 ' B' ' 378' ' ' VAL . 70.4 t -73.02 -39.47 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.624 -1.297 . . . . 0.0 109.332 179.505 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.98 -58.67 7.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 0.0 111.507 -178.807 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -68.96 -40.45 78.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.525 -1.359 . . . . 0.0 111.791 -177.956 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.02 -41.87 93.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.715 -1.241 . . . . 0.0 108.853 -178.871 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.467 HG23 ' O ' ' B' ' 374' ' ' VAL . 52.6 t -61.07 -44.58 98.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.221 -0.925 . . . . 0.0 109.624 179.367 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' B' ' 383' ' ' GLU . 45.7 mtpt -69.26 -55.3 10.93 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.108 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 48.7 tp -54.87 -35.9 64.55 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.317 -0.864 . . . . 0.0 109.393 -178.271 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 38.3 ttm -70.77 -40.02 72.88 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.623 -1.298 . . . . 0.0 108.689 177.829 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.86 -4.28 58.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.625 -0.672 . . . . 0.0 110.533 179.728 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' B' ' 379' ' ' LYS . 98.4 mt-10 -112.11 -4.79 14.34 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.087 -1.008 . . . . 0.0 110.986 -179.701 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 16.5 mt -80.27 132.86 35.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.455 -1.403 . . . . 0.0 108.483 178.579 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.284 -179.904 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mmm . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.197 0.522 . . . . 2.91 109.777 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.4 mt -99.69 122.9 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.267 -0.895 . . . . 1.2 109.042 179.505 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.3 m -139.03 119.39 13.75 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.302 -0.874 . . . . 1.4 109.683 -179.482 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.08 -163.01 29.72 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.108 -1.597 . . . . 1.05 109.108 179.648 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.2 mt -90.6 -7.77 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.118 -1.224 . . . . 1.15 110.684 -179.048 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.2 tp 54.85 96.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.969 -1.082 . . . . 0.98 109.246 -179.829 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.45 -25.77 26.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.142 -0.974 . . . . 0.88 109.375 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 t -150.93 131.21 7.0 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.152 -0.967 . . . . 1.69 109.101 179.659 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.11 140.31 15.66 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.954 1.769 . . . . 0.85 111.836 179.608 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.691 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 166.61 -164.59 37.82 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.382 -1.487 . . . . 0.92 109.382 -179.583 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.3 mt -147.24 147.27 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.897 -1.355 . . . . 0.81 108.589 179.37 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.06 157.67 37.91 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.924 -1.11 . . . . 0.51 110.07 179.755 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -139.02 128.13 23.89 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.01 -1.107 . . . . 0.62 108.01 179.312 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.52 178.78 47.4 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.473 -1.822 . . . . 0.55 110.792 179.714 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -77.43 158.15 30.17 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.761 -0.847 . . . . 2.1 109.431 -179.658 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.36 132.3 45.81 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.315 -0.866 . . . . 0.77 111.515 -178.563 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.3 tp -101.58 133.3 46.47 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.468 -1.308 . . . . 0.91 107.468 178.004 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.0 tp -116.35 123.13 46.85 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.853 0.835 . . . . 0.93 110.19 -178.798 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.429 HD12 ' HB2' ' A' ' 160' ' ' ALA . 18.3 mt -92.75 102.29 14.69 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.206 0.527 . . . . 0.93 110.586 -179.022 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mtmt -105.15 136.0 45.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.369 -0.832 . . . . 2.75 109.482 179.713 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -130.64 139.49 50.37 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.44 -0.787 . . . . 3.0 109.354 179.437 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -87.5 152.63 22.06 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.147 -0.971 . . . . 2.77 109.493 179.547 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -70.07 140.64 52.8 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.103 -0.998 . . . . 2.94 110.383 -179.781 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.6 mt -81.88 136.65 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.476 -0.935 . . . . 0.95 108.476 179.124 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.6 t -103.66 127.68 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.231 -0.918 . . . . 1.28 110.776 -178.82 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -102.96 136.69 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.791 -0.818 . . . . 1.21 108.791 179.481 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.13 124.55 34.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.987 -1.07 . . . . 1.81 109.238 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -88.99 1.12 55.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -0.873 . . . . 2.8 109.526 -179.762 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -61.85 140.33 58.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 2.87 110.129 179.859 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -85.58 141.73 29.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.612 -0.884 . . . . 2.35 108.612 179.452 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.495 HG21 ' HG3' ' A' ' 39' ' ' GLU . 7.7 pt -90.12 164.99 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.823 -1.173 . . . . 0.97 110.944 -179.12 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.3 p -97.07 172.46 7.82 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.551 -0.907 . . . . 1.17 108.551 178.566 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.02 -48.69 80.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.02 -1.05 . . . . 1.18 109.819 -179.473 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 40.1 t0 -55.5 -30.05 59.93 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.822 -1.174 . . . . 2.56 109.367 -179.889 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.86 -10.04 59.42 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.446 -0.784 . . . . 1.79 110.272 -179.756 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.5 t -64.08 -53.28 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.497 -1.377 . . . . 1.0 108.995 179.578 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.25 -40.04 96.3 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.436 -0.79 . . . . 1.77 110.121 -179.906 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -69.89 -40.25 75.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.095 -1.003 . . . . 2.7 110.497 -178.934 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.495 ' HG3' HG21 ' A' ' 31' ' ' ILE . 66.4 mm-40 -65.81 -40.04 91.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.846 -1.159 . . . . 1.51 109.955 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.88 -46.48 96.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.963 -1.086 . . . . 0.93 108.514 178.919 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -60.26 -40.43 90.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.19 -0.944 . . . . 1.81 109.315 179.561 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -60.07 -44.14 94.96 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.097 -1.075 . . . . 2.78 108.097 179.099 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.33 -48.63 80.46 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.231 -0.918 . . . . 0.78 109.046 178.114 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.5 tp -59.81 -45.24 92.97 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.217 -1.031 . . . . 1.07 108.217 -179.472 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 41.2 t -60.34 -40.02 89.21 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.156 -0.965 . . . . 1.12 108.548 178.538 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.9 -48.87 80.89 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.641 -1.784 . . . . 0.84 108.641 179.32 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -60.33 -39.02 85.57 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.821 -1.177 . . . . 3.09 107.821 178.28 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -51.06 -40.79 59.14 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.582 -0.896 . . . . 0.88 108.582 179.887 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 50' ' ' ALA . 14.5 ttmm -66.91 -73.78 0.13 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.386 -1.338 . . . . 2.59 107.386 178.417 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.83 -38.7 0.19 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.659 -0.65 . . . . 0.7 111.139 -178.557 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.2 m -53.75 -55.25 27.97 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.513 -1.367 . . . . 1.4 108.184 179.206 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.91 -46.96 66.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.521 -0.737 . . . . 0.67 111.027 -179.63 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -62.47 -43.54 98.56 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.885 -1.134 . . . . 1.66 110.5 -179.058 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.6 mt -60.12 -40.07 88.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.06 -1.025 . . . . 1.58 108.924 179.694 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -62.71 -34.39 77.06 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.429 -0.794 . . . . 1.35 109.618 179.507 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -64.6 -44.15 91.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.991 -1.068 . . . . 0.77 109.744 179.881 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.9 mt -60.23 -39.86 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.63 109.343 179.822 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.9 ttpp -54.08 -50.19 67.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.492 -0.755 . . . . 1.14 109.7 -179.076 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.7 m -58.13 -37.98 75.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -0.939 . . . . 0.79 110.667 -177.884 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.85 -38.92 92.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.878 -1.139 . . . . 1.53 109.768 -179.696 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.65 -46.8 77.81 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.541 -0.724 . . . . 0.57 109.865 -179.613 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.13 -52.21 52.79 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.913 -1.275 . . . . 0.75 109.913 -179.124 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -70.08 -47.56 61.39 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.146 -1.208 . . . . 1.59 109.996 -179.728 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 49.0 m -63.63 -65.45 0.68 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.299 -0.876 . . . . 0.73 112.744 -177.569 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -95.58 -45.03 7.22 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.609 -1.307 . . . . 0.75 111.151 -177.944 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.17 -169.98 24.79 Favored Glycine 0 N--CA 1.5 2.91 0 O-C-N 120.672 -1.268 . . . . 1.22 110.863 179.67 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.0 -24.36 63.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.93 -0.747 . . . . 5.81 109.652 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -60.0 -34.01 72.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -0.802 . . . . 3.37 110.195 -179.682 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.417 ' HA ' HD12 ' A' ' 72' ' ' ILE . 29.5 mmtp -100.33 -17.46 17.25 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.316 -0.865 . . . . 1.77 110.006 179.683 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -68.8 -46.44 68.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.262 -0.899 . . . . 1.65 110.284 -179.342 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.553 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -62.47 -28.2 69.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.412 -0.805 . . . . 0.77 109.945 -178.802 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 69' ' ' LYS . 93.0 mt -60.06 -41.14 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.917 -1.114 . . . . 0.8 109.389 -179.621 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -68.19 -38.16 81.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.961 -1.087 . . . . 0.88 110.279 -179.567 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.401 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 74.4 tt0 -59.94 -39.95 87.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.922 -1.111 . . . . 1.37 109.485 179.676 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.1 -41.69 99.7 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.11 -1.596 . . . . 0.62 109.11 179.522 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.4 m170 -64.02 -40.97 97.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.398 -1.06 . . . . 1.5 109.502 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -68.91 -47.2 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.174 -0.954 . . . . 0.63 109.022 179.488 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -60.61 -40.24 91.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.095 -1.003 . . . . 1.51 110.472 -179.457 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.86 HD11 ' CE2' ' B' ' 348' ' ' PHE . 27.2 tp -67.48 -40.0 85.26 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.079 -1.013 . . . . 0.77 109.3 179.72 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.63 -39.98 92.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.468 -0.77 . . . . 0.62 110.368 -179.503 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -80.26 5.05 15.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.995 -1.066 . . . . 1.47 110.262 -178.706 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 61.9 t0 -51.57 130.03 27.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.059 -1.026 . . . . 1.47 109.618 -179.855 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.404 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.7 mt-10 -61.21 -15.18 31.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.48 -0.763 . . . . 1.78 110.173 -179.337 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -72.55 -36.86 68.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.106 -0.996 . . . . 2.53 108.673 178.758 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.04 -40.06 75.35 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.574 0.702 . . . . 0.8 109.41 -179.915 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.12 -49.16 78.75 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.259 -0.9 . . . . 1.42 109.597 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -69.99 -40.29 75.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.377 -0.827 . . . . 1.71 111.316 -179.008 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.07 -39.92 75.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.881 -1.137 . . . . 1.57 110.997 -178.678 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.3 mt -70.0 -41.97 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.02 -1.05 . . . . 0.65 109.585 -179.744 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.7 mt -68.53 -37.79 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.444 -0.785 . . . . 0.82 109.633 179.39 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.28 86.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.79 110.818 -178.701 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 96' ' ' LYS . 97.8 mt -60.09 -45.99 91.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.81 -1.181 . . . . 0.95 109.393 -179.284 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.2 mt -61.68 -49.43 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.297 -0.877 . . . . 0.66 109.097 179.479 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -69.86 -40.0 76.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.306 -0.872 . . . . 2.2 110.67 179.805 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -83.64 -52.86 6.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.037 -1.039 . . . . 1.65 112.057 -177.948 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 92' ' ' LEU . 7.1 mtpm? -93.4 -3.22 53.63 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.078 -1.014 . . . . 2.03 112.295 -177.123 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.2 m170 59.21 39.98 22.13 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.839 -1.163 . . . . 1.42 109.573 -179.585 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.5 mtp -91.27 164.97 13.69 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.459 -0.775 . . . . 1.18 110.112 -179.834 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 65.4 p -79.99 163.62 24.1 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.514 -0.741 . . . . 0.98 109.197 179.732 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.09 -41.23 82.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.64 110.458 -179.305 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -67.48 -37.69 83.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 2.07 109.577 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.29 -41.15 34.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.293 -0.879 . . . . 0.73 110.169 179.967 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.1 -47.02 63.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.895 . . . . 0.54 110.452 -179.25 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.45 -40.4 90.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.974 -1.079 . . . . 0.56 110.18 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.45 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 84.8 t60 -59.91 -40.12 87.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.251 -0.905 . . . . 1.54 110.17 -178.564 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -64.52 -40.12 95.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.057 -1.027 . . . . 1.33 110.795 -178.931 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.08 -51.85 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.072 -1.017 . . . . 0.72 111.06 -178.093 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mm -69.66 -39.97 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.777 -1.202 . . . . 0.85 108.574 -179.837 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.45 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 88.2 tt0 -62.78 -39.35 93.93 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.622 -0.881 . . . . 2.44 108.622 178.825 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.94 -50.61 65.8 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.199 -1.161 . . . . 0.98 110.199 -179.545 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -66.24 -48.11 71.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.79 -1.418 . . . . 1.41 109.112 179.955 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.05 93.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.139 -0.976 . . . . 1.2 108.673 179.431 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.1 t -58.19 -39.94 80.25 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.71 -0.848 . . . . 1.7 108.71 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.92 -40.0 94.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.403 -0.811 . . . . 1.47 109.631 179.485 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.04 -41.19 91.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.976 -1.078 . . . . 1.56 109.604 -179.431 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.83 -33.81 72.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.57 -1.331 . . . . 2.2 109.452 -179.246 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -54.5 -22.18 12.16 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.418 -0.956 . . . . 2.12 108.418 179.437 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.467 HD13 HD13 ' A' ' 123' ' ' LEU . 61.7 mt -64.09 144.84 56.8 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.378 -0.826 . . . . 2.0 109.319 179.912 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -100.63 46.67 0.94 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.248 -0.907 . . . . 3.23 110.489 -179.727 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 64.6 t0 -131.51 138.02 48.77 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.14 -0.975 . . . . 2.49 109.943 179.964 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.541 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 47.5 mt-10 -69.94 -32.0 70.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.599 -0.688 . . . . 3.95 110.504 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.463 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.3 t80 -72.18 -39.95 68.29 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.309 -0.87 . . . . 2.0 110.536 179.582 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.642 ' CD2' HH21 ' A' ' 126' ' ' ARG . 80.9 mt -70.54 -37.31 74.05 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.094 -1.004 . . . . 1.86 108.825 -179.855 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -60.41 -39.83 88.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 2.84 109.792 179.333 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 73.3 mm-40 -59.46 -48.94 79.7 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.112 -0.992 . . . . 2.73 109.692 -179.232 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.642 HH21 ' CD2' ' A' ' 123' ' ' LEU . 77.4 mtm180 -63.88 -38.52 91.39 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.134 -1.026 . . . . 2.77 108.672 179.105 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.67 -26.63 56.91 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.951 -1.129 . . . . 1.19 107.951 178.888 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -71.08 -38.08 72.45 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.403 -0.962 . . . . 1.2 108.403 178.347 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -64.98 -40.1 94.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.581 -0.699 . . . . 1.55 109.658 -179.527 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.2 t -68.84 -43.02 82.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.26 -0.9 . . . . 0.8 109.233 179.811 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.434 HH11 ' HG2' ' A' ' 131' ' ' ARG . 28.6 ttt-85 -60.6 -39.68 89.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 3.09 108.842 179.14 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -60.0 -39.98 87.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.557 -0.714 . . . . 1.46 110.422 -179.447 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 94.3 mt -60.04 -43.91 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.887 -1.133 . . . . 0.71 109.997 -179.261 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.98 -34.43 70.92 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.894 -1.283 . . . . 0.57 109.894 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -60.0 -49.97 75.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -1.177 . . . . 2.59 109.673 -179.219 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.405 ' HG2' HH21 ' A' ' 139' ' ' ARG . 86.1 mtm180 -69.85 -30.85 68.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.851 -1.156 . . . . 2.83 110.04 -179.936 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.04 -43.24 95.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.07 -1.018 . . . . 1.25 109.083 -179.586 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.6 mt -60.39 -39.9 88.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.304 -0.873 . . . . 0.7 109.352 179.208 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.405 HH21 ' HG2' ' A' ' 136' ' ' ARG . 57.0 mtm180 -69.64 -38.17 77.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 2.57 108.485 179.072 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.482 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.4 m120 -60.16 -36.71 78.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.819 -0.551 . . . . 1.23 110.626 -179.136 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.3 mt -70.07 -42.98 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.782 -1.199 . . . . 0.81 109.512 -179.767 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.8 mt -81.08 -38.03 28.0 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.402 -0.812 . . . . 1.0 110.021 -179.89 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.89 45.87 4.08 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 108.758 -1.737 . . . . 0.89 108.758 -178.941 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.4 tp -74.18 149.87 40.68 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.482 -1.01 . . . . 1.14 109.777 -179.273 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 142.56 53.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 4.6 109.655 -179.61 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.05 123.19 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-O 121.611 0.72 . . . . 1.24 109.214 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.414 HG12 ' H ' ' A' ' 147' ' ' ILE . 23.9 mm -49.18 -52.91 9.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.583 -0.698 . . . . 1.54 109.384 -178.943 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.6 t0 66.41 100.08 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.494 0.664 . . . . 1.5 109.527 -179.893 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.51 ' O ' HD12 ' A' ' 152' ' ' ILE . 67.8 mt -70.91 -9.0 56.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.507 -0.746 . . . . 0.79 109.945 -179.337 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.466 ' HA ' HD21 ' A' ' 172' ' ' ASN . 22.9 p -74.99 -17.28 60.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.066 -1.021 . . . . 1.4 109.592 179.778 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.94 28.74 0.67 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.455 -0.778 . . . . 0.92 111.316 -177.716 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 149' ' ' LEU . 49.9 mt -90.02 116.87 32.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.848 -1.157 . . . . 0.88 109.37 -179.434 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -98.97 -14.27 19.58 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.357 -0.84 . . . . 2.45 110.087 -178.982 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -127.17 149.91 49.75 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.193 -0.942 . . . . 1.52 110.23 -179.173 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -63.75 139.73 58.8 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.621 -0.881 . . . . 1.58 108.621 179.814 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.7 m -153.09 164.95 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 0.69 109.699 -179.693 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.1 mt -93.51 149.15 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 105.834 -1.913 . . . . 0.61 105.834 176.533 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.415 HD11 HD11 ' A' ' 19' ' ' LEU . 43.4 tp -97.37 113.91 25.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.934 -1.104 . . . . 0.87 110.481 -177.725 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 62.6 t -121.18 129.98 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 108.255 -1.017 . . . . 0.71 108.255 179.067 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.429 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -163.25 169.22 19.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 0.81 108.872 179.888 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.17 -35.37 68.98 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.696 -1.253 . . . . 0.98 108.023 178.375 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -167.46 175.52 7.14 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.812 -1.181 . . . . 2.25 107.812 179.961 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 58.0 mt -135.59 145.64 47.12 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.076 -1.015 . . . . 0.78 109.09 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 40.0 p -97.37 127.9 36.63 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.242 -1.021 . . . . 0.98 108.242 179.166 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -37.0 -35.9 0.25 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.985 1.79 . . . . 0.81 112.616 -179.407 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.3 m -60.01 -39.87 87.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.075 -1.016 . . . . 0.9 109.016 -179.722 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -67.88 -40.16 83.59 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.171 -0.955 . . . . 1.61 110.138 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 55.8 p -56.46 -33.79 66.25 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.145 -0.972 . . . . 0.61 111.382 -177.991 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.76 -45.08 65.43 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.676 -1.265 . . . . 0.6 109.71 -179.871 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.437 ' H ' ' HG2' ' A' ' 170' ' ' GLN . 14.5 pt20 -90.73 35.63 0.89 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.374 -0.972 . . . . 1.4 108.374 179.68 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.4 tp -106.71 130.73 54.39 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.12 -1.067 . . . . 0.7 108.12 178.577 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.466 HD21 ' HA ' ' A' ' 150' ' ' SER . 4.1 m-20 -82.05 103.86 11.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.171 -0.956 . . . . 2.35 109.177 -179.75 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.25 -41.06 96.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.046 -1.033 . . . . 1.51 110.234 -179.471 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.52 -27.22 68.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 2.33 111.359 -178.049 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -92.75 -10.43 37.05 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.603 -1.31 . . . . 1.92 109.933 -178.867 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.448 HG11 ' CE1' ' A' ' 179' ' ' PHE . 58.1 t -103.23 112.83 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.15 -0.969 . . . . 0.67 108.698 179.031 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.9 mt -87.29 3.99 44.56 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.27 -0.894 . . . . 1.53 110.719 -178.336 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.406 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 176.31 168.91 37.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.112 -1.595 . . . . 0.48 109.112 179.719 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.456 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 23.2 m-85 -130.91 127.12 37.84 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.386 -1.067 . . . . 0.55 109.277 -179.945 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 95.8 mt -130.48 123.58 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.449 -1.315 . . . . 0.65 107.449 177.915 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.3 p -141.88 159.15 42.8 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.204 1.002 . . . . 0.82 111.068 -178.824 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 183' ' ' ALA . 59.2 t0 -96.88 18.34 14.81 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.685 -0.634 . . . . 2.46 109.737 -179.8 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -44.28 -178.87 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.91 -1.119 . . . . 1.28 112.653 -178.032 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.71 -54.31 4.63 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 111.23 -0.748 . . . . 2.19 111.23 -179.355 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.1 -163.82 13.63 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.06 -1.543 . . . . 2.13 111.285 -178.835 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.452 HH11 ' HG2' ' A' ' 186' ' ' ARG . 12.6 ptt-85 -72.39 -10.54 59.92 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.794 -0.827 . . . . 5.86 110.738 -179.116 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.6 p -80.9 7.42 10.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.955 -1.091 . . . . 3.72 109.898 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 95.1 p -84.92 142.69 29.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 1.74 110.481 -179.69 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -48.27 -44.53 33.63 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.867 -0.79 . . . . 0.95 108.867 179.601 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.411 ' H ' HG23 ' A' ' 190' ' ' THR . 3.2 p -56.08 -40.08 73.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.626 -0.671 . . . . 1.55 109.806 -179.475 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 48.3 t -61.67 -40.28 94.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -0.93 . . . . 1.51 111.03 -179.241 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.9 mm -62.18 -41.52 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.084 -1.01 . . . . 1.67 110.115 -178.813 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.9 mtp -60.02 -45.62 92.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.039 -1.038 . . . . 1.02 110.683 -178.38 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.97 -42.68 94.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.688 -1.257 . . . . 0.68 109.708 -179.308 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 -60.04 -51.23 70.53 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.272 -0.892 . . . . 2.93 110.618 -178.919 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 52.6 m -77.74 -32.44 52.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.923 -1.111 . . . . 0.86 111.866 -178.336 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.7 mt -70.4 -20.31 62.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.634 -1.292 . . . . 0.67 109.459 -179.425 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 64.17 49.94 2.53 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.309 0.576 . . . . 1.5 110.546 -179.733 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 83.2 mt -130.35 151.0 77.77 Favored Pre-proline 0 N--CA 1.5 2.058 0 N-CA-C 108.163 -1.051 . . . . 0.72 108.163 178.679 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.65 139.43 69.56 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.002 1.801 . . . . 0.61 111.043 179.599 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.55 153.98 3.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.763 -1.21 . . . . 0.66 111.525 -179.721 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.64 152.32 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.053 -1.091 . . . . 0.79 108.053 179.362 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.2 m -131.88 -13.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 121.064 -1.023 . . . . 0.91 111.295 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -111.36 26.47 12.02 Favored Glycine 0 N--CA 1.502 3.088 0 N-CA-C 110.645 -0.982 . . . . 1.01 110.645 -178.826 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 204' ' ' GLY . 3.2 p -43.38 -45.06 5.97 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.23 -1.159 . . . . 0.99 109.962 -179.622 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.465 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 93.89 -53.95 2.26 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 120.204 -0.998 . . . . 1.12 111.2 179.128 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 64.3 m -154.4 31.49 0.43 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.321 -1.694 . . . . 1.72 111.449 -179.024 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.02 -40.08 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.85 -1.156 . . . . 0.89 108.885 178.581 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 75.0 p -53.29 -29.52 33.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.424 -0.798 . . . . 1.03 110.563 -179.219 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.0 t -83.7 -15.13 49.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.973 -1.08 . . . . 1.83 110.428 -178.855 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -100.09 -15.92 18.03 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.226 -0.921 . . . . 2.27 110.955 -179.009 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 88.5 t -105.29 139.72 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.136 -0.978 . . . . 0.92 111.001 -178.16 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.13 152.59 30.88 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.585 -1.265 . . . . 2.2 107.585 178.473 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 5.6 t-20 -58.27 139.16 55.62 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.948 -1.095 . . . . 2.36 110.283 -179.255 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 12.5 t0 87.74 8.61 0.17 Allowed 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 121.335 0.588 . . . . 2.38 109.796 179.633 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 56.2 t0 -79.07 140.5 37.87 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.326 -0.859 . . . . 2.09 109.317 179.551 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.531 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 55.3 t80 -91.78 118.39 30.64 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.346 -1.353 . . . . 1.27 107.346 178.476 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.522 HD22 HG22 ' A' ' 229' ' ' VAL . 82.7 mt -126.52 147.36 49.86 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.325 -0.86 . . . . 0.75 110.69 -178.631 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.449 HD12 ' HG3' ' A' ' 231' ' ' PRO . 81.6 mt -118.57 126.71 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.819 -1.548 . . . . 0.63 106.819 176.875 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 48.6 tp -102.02 124.84 48.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.241 -0.912 . . . . 0.7 108.645 -179.268 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.658 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 27.9 p-10 -87.94 -35.62 17.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.203 -0.935 . . . . 2.31 108.607 179.686 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 44.52 18.59 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.826 -0.805 . . . . 0.78 108.826 -179.224 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 221' ' ' ASP . 16.6 t -125.82 -46.89 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.127 -1.434 . . . . 1.04 107.127 179.579 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -100.75 -1.03 36.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.873 -1.529 . . . . 2.44 106.873 177.745 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 61.76 50.39 4.37 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.439 0.638 . . . . 1.55 109.587 179.996 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.658 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 95.6 mt-30 -138.77 151.16 46.85 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.522 -0.736 . . . . 1.99 109.311 179.76 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 84.2 t -119.41 127.73 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.421 -0.955 . . . . 0.77 108.421 178.882 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -102.26 123.98 47.03 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.331 -0.989 . . . . 0.98 108.331 179.443 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.522 HG22 HD22 ' A' ' 218' ' ' LEU . 58.5 t -104.21 115.0 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.492 -0.755 . . . . 0.85 110.369 -178.911 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 60.4 t30 53.61 69.55 2.19 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.912 . . . . 1.66 110.341 179.718 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.449 ' HG3' HD12 ' A' ' 219' ' ' ILE . 98.2 Cg_endo -90.91 148.58 3.89 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 123.408 2.739 . . . . 0.95 112.478 179.541 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.7 m -69.99 160.88 31.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 1.84 109.701 -179.431 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.55 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 38.2 p30 -60.02 -39.94 87.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 2.74 111.481 -178.669 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.55 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 13.1 pt-20 -60.04 -31.22 69.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.58 -1.325 . . . . 2.89 109.641 -179.352 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 83.2 t -70.03 -42.41 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.033 -1.042 . . . . 1.3 109.282 179.115 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.499 1.986 0 O-C-N 121.313 -0.867 . . . . 1.09 110.396 -179.762 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 10.4 ttt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . 0.504 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 22.8 t80 -154.84 154.07 32.15 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.312 -0.868 . . . . 0.0 110.05 179.542 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . 0.504 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 2.9 pm0 -146.98 156.62 43.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.183 -0.948 . . . . 0.0 110.661 -179.621 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 0.4 OUTLIER -152.15 147.31 26.28 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.454 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . 0.517 ' N ' ' OE1' ' B' ' 304' ' ' GLN . 98.9 mt-10 -107.21 131.32 54.3 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.959 -1.088 . . . . 0.0 109.694 179.102 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.453 ' O ' HG13 ' B' ' 306' ' ' VAL . 7.4 p -131.26 120.61 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 CA-C-O 122.045 0.926 . . . . 0.0 112.544 -177.745 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . 0.538 ' O ' HG23 ' B' ' 309' ' ' THR . 8.8 m -76.91 107.11 9.01 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.874 0.845 . . . . 0.0 111.359 -177.711 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.6 mt -52.23 118.13 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 122.098 0.951 . . . . 0.0 109.717 -178.944 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . 0.599 ' C ' HE22 ' B' ' 357' ' ' GLN . 67.4 p -107.3 19.95 19.61 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.714 -178.249 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.522 ' N ' ' OE1' ' B' ' 357' ' ' GLN . . . -81.2 114.52 49.74 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.192 -0.943 . . . . 0.0 109.845 179.686 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -50.4 -9.72 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.733 0 CA-C-N 120.199 1.107 . . . . 0.0 113.308 -179.332 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' B' ' 310' ' ' ALA . 97.8 m-20 -120.5 4.04 10.7 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.437 -0.789 . . . . 0.0 109.265 179.829 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 74.0 -178.75 43.0 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.428 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.463 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.5 tp -83.64 89.82 7.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.05 -1.265 . . . . 0.0 109.027 -179.193 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.4 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 4.7 p80 -92.8 -162.2 0.91 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.924 -1.11 . . . . 0.0 109.989 179.18 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.8 m -58.07 -42.3 85.25 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.041 -1.037 . . . . 0.0 112.873 -175.932 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.553 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.4 tpt180 -59.87 -61.52 7.73 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 120.327 -1.483 . . . . 0.0 111.523 -178.571 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.4 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 9.9 Cg_endo -58.11 -33.63 97.6 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.231 1.118 . . . . 0.0 111.473 179.975 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.29 74.53 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.515 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.2 -44.02 74.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.662 -0.649 . . . . 0.0 109.338 -179.905 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -70.01 -42.01 73.59 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.598 179.061 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -59.99 -50.41 73.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.635 -0.666 . . . . 0.0 110.543 -179.371 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.44 -30.25 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.591 -1.318 . . . . 0.0 109.172 -179.485 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . 0.401 ' NZ ' ' OE1' ' A' ' 74' ' ' GLU . 19.9 ttmt -60.01 -47.14 87.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.413 -0.804 . . . . 0.0 109.199 179.535 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -67.56 -48.89 65.64 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.184 -0.948 . . . . 0.0 110.896 -179.227 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -66.08 -52.72 46.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.798 -1.189 . . . . 0.0 110.709 -178.748 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -54.78 -14.5 1.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.088 -179.02 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -74.59 -20.95 79.37 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.358 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -103.79 146.96 27.86 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.439 -1.036 . . . . 0.0 108.719 179.686 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 13.9 t -91.2 -13.65 32.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.767 -1.208 . . . . 0.0 109.653 -179.898 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.43 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 63.7 p -60.13 147.58 39.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 -179.863 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' B' ' 332' ' ' GLU . 58.2 mp0 -68.87 134.49 49.7 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.104 -0.998 . . . . 0.0 108.636 179.758 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.1 mt -133.17 133.63 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.497 -0.752 . . . . 0.0 109.688 -179.222 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 82.4 m -129.05 149.81 50.71 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.478 -0.764 . . . . 0.0 109.288 179.409 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 53.9 t -122.84 114.07 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.338 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 96.5 m -104.97 134.18 48.51 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.212 -0.93 . . . . 0.0 109.394 -178.411 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 24.7 p -139.46 111.67 7.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.336 -0.853 . . . . 0.0 110.944 -179.48 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 48.89 50.81 17.06 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 176.685 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 90.04 -14.84 60.96 Favored Glycine 0 N--CA 1.501 2.998 0 O-C-N 119.941 -1.724 . . . . 0.0 112.503 177.104 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -118.64 131.44 56.18 Favored 'General case' 0 N--CA 1.508 2.447 0 CA-C-N 119.019 1.41 . . . . 0.0 109.69 -179.809 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 79.6 p -132.51 151.8 51.78 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.933 0.873 . . . . 0.0 110.681 -178.872 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -143.26 167.2 22.7 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -179.758 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 15.2 m -87.56 138.16 31.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.47 -0.769 . . . . 0.0 110.255 -179.273 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -77.13 -14.59 59.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.959 -1.088 . . . . 0.0 109.997 -179.394 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -89.59 20.46 3.98 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.126 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . 0.453 ' CB ' ' HZ3' ' B' ' 349' ' ' LYS . 9.0 t -145.74 94.44 2.49 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.535 -179.649 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.733 HD23 HD22 ' A' ' 79' ' ' LEU . 58.5 tp -59.97 -36.32 76.86 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.069 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.86 ' CE2' HD11 ' A' ' 79' ' ' LEU . 51.0 m-85 -54.54 -50.42 67.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 0.0 110.699 -179.376 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . 0.453 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 35.9 mtmm -69.95 -40.02 75.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.911 -1.118 . . . . 0.0 111.237 -177.975 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' B' ' 352' ' ' THR . 88.2 mt -49.28 -56.99 7.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.875 -1.14 . . . . 0.0 109.443 -178.933 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.567 HE22 ' CD1' ' B' ' 347' ' ' LEU . 1.2 mp0 -42.23 -14.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.414 -0.804 . . . . 0.0 111.342 -178.101 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.55 ' N ' ' O ' ' B' ' 350' ' ' LEU . 59.3 p -88.72 -11.48 45.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.287 -1.508 . . . . 0.0 110.185 -179.132 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 79.3 mt -91.58 117.52 29.79 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.84 -1.162 . . . . 0.0 108.807 178.646 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -69.79 89.2 0.3 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 58.0 mt -98.73 86.81 3.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -1.162 . . . . 0.0 108.456 179.03 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 67.2 p -89.26 168.97 11.84 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.041 -1.037 . . . . 0.0 110.063 -178.926 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . 0.599 HE22 ' C ' ' B' ' 309' ' ' THR . 15.8 tp60 -62.99 114.94 3.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.631 -0.668 . . . . 0.0 110.61 -179.031 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.24 8.72 40.71 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.713 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 31.6 m -87.2 111.7 21.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.261 -1.14 . . . . 0.0 111.394 -178.986 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 48.5 t -76.98 118.09 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 122.267 1.032 . . . . 0.0 109.548 -177.914 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.0 m -112.9 177.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -177.952 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 48.9 m -130.71 128.79 41.56 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.45 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.6 mt -103.06 117.58 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.154 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 72.7 m -120.99 132.09 54.7 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.289 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.24 153.34 40.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.069 -1.019 . . . . 0.0 110.489 -179.296 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . 0.441 ' OE1' ' OE1' ' B' ' 370' ' ' GLU . 17.1 tp10 -144.47 122.32 11.97 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.082 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.494 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 159.8 -157.11 28.34 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.954 -1.593 . . . . 0.0 111.595 -179.97 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -59.99 -51.88 67.77 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.338 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.43 ' H ' ' HB3' ' B' ' 331' ' ' SER . 42.6 m-20 -109.15 12.5 25.0 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.754 -1.216 . . . . 0.0 111.176 -177.256 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 11.8 pt-20 -42.33 -38.17 1.75 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.157 -0.965 . . . . 0.0 111.807 -178.816 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -69.89 -40.51 75.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.638 -1.289 . . . . 0.0 110.249 -178.341 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -68.75 -51.39 41.85 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.171 -0.956 . . . . 0.0 109.482 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -49.64 -34.28 17.85 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.634 -0.666 . . . . 0.0 112.228 -178.413 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.505 ' O ' HG23 ' B' ' 378' ' ' VAL . 56.2 t -74.82 -39.21 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.657 -1.277 . . . . 0.0 109.766 179.567 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -68.23 -40.01 82.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.168 -0.957 . . . . 0.0 112.37 -177.785 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -84.61 -43.07 14.78 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.193 -1.567 . . . . 0.0 110.901 -179.363 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.93 -40.09 87.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.998 -1.064 . . . . 0.0 108.843 -179.196 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.505 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.9 t -61.02 -45.98 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.217 -0.927 . . . . 0.0 109.412 179.42 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' B' ' 383' ' ' GLU . 62.3 mttp -68.62 -54.75 14.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.788 -1.195 . . . . 0.0 107.86 178.503 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 52.8 tp -55.8 -36.25 67.21 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.308 -0.87 . . . . 0.0 109.182 -178.29 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 23.8 ttm -70.65 -40.08 73.25 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.698 -1.251 . . . . 0.0 108.335 177.792 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.21 -4.93 58.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.526 -0.734 . . . . 0.0 110.606 179.585 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' B' ' 379' ' ' LYS . 96.8 mt-10 -112.16 -3.67 14.61 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.17 -0.956 . . . . 0.0 111.106 -179.46 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.2 mt -79.88 136.55 36.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.464 -1.397 . . . . 0.0 109.47 179.011 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 N--CA 1.497 1.918 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.368 -179.901 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.9 mtp . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.506 -0.553 . . . . 2.91 109.506 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.4 mt -110.18 129.98 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.417 -0.802 . . . . 1.2 109.71 -179.928 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.2 m -132.67 149.84 52.24 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.402 -0.811 . . . . 1.4 109.408 179.686 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.416 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -140.7 -169.92 11.91 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.041 -1.624 . . . . 1.05 109.041 179.757 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.9 mt -85.48 -19.08 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.879 -1.365 . . . . 1.15 110.432 -178.831 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.7 tp 52.92 102.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.176 -0.952 . . . . 0.98 109.03 -179.732 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.11 -26.99 13.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.101 -0.999 . . . . 0.88 109.645 -179.881 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -134.77 117.97 13.17 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.469 -0.769 . . . . 1.69 109.004 -179.843 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.19 148.12 21.19 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.766 1.644 . . . . 0.85 112.562 -179.631 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.721 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.05 -155.41 26.21 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.754 -1.738 . . . . 0.92 108.754 -179.818 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.5 mt -149.6 151.18 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 120.909 -1.347 . . . . 0.81 108.715 179.041 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.47 150.85 30.06 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.901 -1.125 . . . . 0.51 110.719 179.772 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.8 m-85 -133.9 127.12 31.85 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 107.923 -1.14 . . . . 0.62 107.923 178.616 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.92 -176.69 46.39 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 118.37 -1.872 . . . . 0.55 111.203 179.713 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -79.23 155.64 28.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.985 -0.715 . . . . 2.1 109.841 -179.693 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.82 124.36 49.3 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.579 -0.7 . . . . 0.77 109.978 179.892 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.0 tp -94.22 135.19 35.88 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.472 -1.307 . . . . 0.91 107.472 178.582 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.9 tp -116.01 122.66 45.86 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.22 -0.925 . . . . 0.93 109.946 -179.08 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.7 mt -84.98 100.74 11.85 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.586 0.708 . . . . 0.93 109.955 -179.63 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -100.04 124.79 45.8 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.533 -0.914 . . . . 2.75 108.533 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.461 ' OE1' HD11 ' A' ' 147' ' ' ILE . 36.9 tp10 -132.03 141.82 49.37 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.237 -0.915 . . . . 3.0 109.462 -179.954 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.59 ' OD2' HD11 ' A' ' 144' ' ' LEU . 9.9 p-10 -77.73 149.19 34.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.385 -0.822 . . . . 2.77 109.558 179.649 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -70.15 149.61 47.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.166 -0.959 . . . . 2.94 109.595 -179.741 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 84.7 mt -82.34 126.51 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.186 -0.946 . . . . 0.95 110.154 -179.604 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.67 123.63 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.278 -0.889 . . . . 1.28 108.744 179.074 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -100.55 145.23 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.333 -0.855 . . . . 1.21 109.363 -179.555 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -98.51 113.42 25.43 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.172 -0.955 . . . . 1.81 109.519 -179.879 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.479 HH11 ' HG2' ' A' ' 28' ' ' ARG . 7.4 mmt-85 -86.32 -2.13 58.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 2.8 109.449 -179.855 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -66.12 142.8 57.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.934 . . . . 2.87 109.225 179.714 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -83.43 149.6 26.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 2.35 109.544 -179.749 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.439 HG21 ' HG3' ' A' ' 39' ' ' GLU . 6.4 pt -93.2 165.02 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.032 -1.042 . . . . 0.97 109.091 179.311 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.9 p -94.72 169.53 10.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.948 -1.095 . . . . 1.17 108.485 178.963 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.68 -12.83 60.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 1.18 109.561 -179.967 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -88.32 -28.86 20.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.111 -0.993 . . . . 2.56 108.406 178.787 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -81.65 -8.91 59.76 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.748 -0.834 . . . . 1.79 108.748 178.963 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.3 t -62.46 -53.59 45.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.083 -1.01 . . . . 1.0 108.912 179.815 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -60.04 -40.05 88.06 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.171 -0.956 . . . . 1.77 109.928 -179.87 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -69.94 -40.2 75.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.948 -1.095 . . . . 2.7 110.899 -179.37 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.439 ' HG3' HG21 ' A' ' 31' ' ' ILE . 68.7 mm-40 -65.27 -40.07 93.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.674 -1.266 . . . . 1.51 110.199 -179.895 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -61.64 -47.8 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.639 -1.288 . . . . 0.93 108.537 179.083 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.03 -45.9 91.29 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.175 -0.953 . . . . 1.81 109.538 179.677 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -60.04 -42.94 95.49 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.688 -1.226 . . . . 2.78 107.688 179.146 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -61.2 -49.93 75.16 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.645 -0.659 . . . . 0.78 109.491 178.927 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.91 -45.48 94.49 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.457 -0.777 . . . . 1.07 109.721 -179.718 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 31.9 t -66.46 -45.68 78.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.027 -1.045 . . . . 1.12 109.332 179.682 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.85 -44.56 97.69 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.026 -2.029 . . . . 0.84 108.026 178.9 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 80' ' ' LEU . 69.2 ttt180 -62.98 -35.31 79.75 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.357 -0.979 . . . . 3.09 108.357 178.638 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -55.87 -39.93 72.22 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.834 -0.802 . . . . 0.88 108.834 179.801 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 50' ' ' ALA . 18.9 ttmt -63.32 -74.63 0.09 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.088 -1.078 . . . . 2.59 108.088 179.531 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.38 -31.82 0.06 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.363 -0.836 . . . . 0.7 111.682 -177.978 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.6 p -60.1 -54.17 49.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.562 -1.336 . . . . 1.4 108.669 179.988 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.99 -42.44 73.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.339 -0.851 . . . . 0.67 111.055 -179.298 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.45 -40.5 97.3 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.826 -1.171 . . . . 1.66 110.552 -178.805 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.27 -39.66 92.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.874 -1.141 . . . . 1.58 108.993 179.603 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -59.95 -37.85 80.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.35 -0.844 . . . . 1.35 109.515 179.379 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -64.7 -41.2 96.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.77 110.46 -179.67 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.411 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.5 mt -64.62 -39.83 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.108 -0.995 . . . . 0.63 109.373 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.444 ' NZ ' ' OE2' ' A' ' 70' ' ' GLU . 13.2 ttpp -59.35 -49.98 75.73 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.275 -0.89 . . . . 1.14 109.121 -179.858 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.1 m -61.13 -40.03 92.26 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.211 -0.931 . . . . 0.79 110.493 -178.795 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -63.7 -38.86 92.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.096 -1.003 . . . . 1.53 109.155 179.692 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.484 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -65.14 -41.56 94.66 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.582 -0.699 . . . . 0.57 109.746 179.574 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.65 -50.39 66.7 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 110.24 -1.144 . . . . 0.75 110.24 -179.488 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.89 -43.0 72.67 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.881 -1.364 . . . . 1.59 109.654 -179.65 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.9 m -71.27 -59.84 2.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.035 -1.041 . . . . 0.73 112.06 -178.476 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -91.18 -54.16 4.05 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.678 -1.264 . . . . 0.75 110.603 -178.801 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.58 -169.32 25.21 Favored Glycine 0 N--CA 1.5 2.916 0 C-N-CA 120.071 -1.062 . . . . 1.22 111.224 179.748 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -70.01 -24.14 63.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.951 -0.735 . . . . 5.81 109.958 -179.954 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.507 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.8 tp10 -60.45 -38.04 82.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.888 . . . . 3.37 109.899 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -99.44 -19.43 16.96 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.395 -0.815 . . . . 1.77 110.604 -179.317 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.444 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 61.8 tt0 -68.1 -39.99 82.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.902 -1.124 . . . . 1.65 109.837 -179.528 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.431 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.28 -33.78 76.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.411 -0.806 . . . . 0.77 110.384 -178.886 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.07 -42.37 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.752 -1.217 . . . . 0.8 109.222 -179.849 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 57.4 m-85 -72.59 -34.8 67.68 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.39 -0.819 . . . . 0.88 110.487 -179.213 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.465 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 72.6 tt0 -59.97 -40.07 87.81 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.838 -1.164 . . . . 1.37 109.198 179.035 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.98 -41.2 97.8 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.41 -1.876 . . . . 0.62 108.41 179.081 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -61.78 -48.53 80.25 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.341 -1.093 . . . . 1.5 108.785 179.365 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.3 -50.56 79.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.563 -0.711 . . . . 0.63 109.851 -179.776 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.6 ttp -60.98 -44.2 97.7 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.009 -1.057 . . . . 1.51 109.238 -179.639 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.811 HD22 HD23 ' B' ' 347' ' ' LEU . 44.9 tp -60.05 -39.91 87.59 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.579 -0.701 . . . . 0.77 109.114 179.214 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.52 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 58.6 tp -69.66 -35.06 74.83 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.604 -0.685 . . . . 0.62 109.968 -179.387 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -85.43 0.43 52.28 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.92 -1.112 . . . . 1.47 110.002 -179.276 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -46.3 130.07 10.5 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.201 -0.937 . . . . 1.47 109.879 -179.221 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -61.36 -22.33 64.84 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.458 -0.776 . . . . 1.78 111.011 -179.124 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.99 -31.76 69.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.874 -1.141 . . . . 2.53 109.417 179.15 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 79' ' ' LEU . 91.2 mt -71.98 -40.02 68.87 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.673 0.749 . . . . 0.8 109.368 179.093 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.03 -49.25 78.38 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.724 -0.61 . . . . 1.42 110.827 -178.964 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -70.0 -42.01 73.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.17 -0.957 . . . . 1.71 111.061 -178.498 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.94 -39.94 75.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.964 . . . . 1.57 111.491 -178.824 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.7 mt -68.0 -45.22 84.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 120.973 -1.08 . . . . 0.65 109.782 -179.517 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -69.76 -38.79 76.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.322 -0.861 . . . . 0.82 110.089 179.831 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.66 -45.23 93.77 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 0.79 111.593 -178.913 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 99.3 mt -60.07 -44.22 94.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.83 -1.169 . . . . 0.95 109.533 -178.633 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.3 mt -61.19 -50.11 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.166 -0.959 . . . . 0.66 109.291 179.406 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -67.51 -40.01 85.13 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 120.22 -0.592 . . . . 2.2 111.436 -179.318 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -83.66 -52.14 6.69 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.752 -1.218 . . . . 1.65 112.025 -178.557 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -90.01 -0.05 57.37 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.119 -0.988 . . . . 2.03 112.026 -177.218 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 80.7 m80 55.1 33.81 21.21 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.834 -1.166 . . . . 1.42 109.486 -179.812 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 75.2 mtp -84.9 166.4 16.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.55 -0.719 . . . . 1.18 109.599 -179.625 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 76.8 p -78.64 154.85 29.88 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.171 -1.048 . . . . 0.98 108.171 179.187 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.0 -39.26 75.97 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.062 -1.024 . . . . 0.64 110.015 -179.707 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.538 ' OD1' HG21 ' A' ' 141' ' ' ILE . 86.5 m-20 -63.23 -40.19 96.75 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.101 -1.0 . . . . 2.07 109.621 -179.695 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.05 -46.12 14.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.104 -0.997 . . . . 0.73 109.655 179.463 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.98 -46.15 90.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.454 -0.779 . . . . 0.54 109.71 -179.539 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.96 75.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.149 -0.97 . . . . 0.56 109.478 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -59.98 -34.79 73.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.861 . . . . 1.54 110.042 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -60.0 -41.27 91.71 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.176 -0.952 . . . . 1.33 109.103 -179.653 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.8 t -64.78 -49.96 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 0.72 110.072 -179.46 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.1 mm -69.05 -40.28 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.047 -1.033 . . . . 0.85 109.027 179.622 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -64.92 -40.01 94.4 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.722 -0.844 . . . . 2.44 108.722 179.362 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.97 -49.26 80.5 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.244 -1.142 . . . . 0.98 110.244 -179.76 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.409 HE21 ' HB3' ' B' ' 348' ' ' PHE . 15.1 mm100 -66.4 -51.81 53.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.929 -1.336 . . . . 1.41 109.11 -179.493 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.97 93.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 1.2 109.718 179.583 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.8 p -58.38 -39.69 80.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 1.7 108.8 -179.701 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.96 -35.6 75.32 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.34 -0.85 . . . . 1.47 109.214 179.664 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.5 mt -66.2 -42.88 88.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.974 -1.079 . . . . 1.56 109.485 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -56.99 -32.71 66.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.072 -1.018 . . . . 2.2 109.327 -179.091 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.03 -28.43 67.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -0.889 . . . . 2.12 108.966 179.859 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.554 HD13 HD13 ' A' ' 123' ' ' LEU . 59.6 mt -64.23 148.29 50.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.366 -0.834 . . . . 2.0 109.199 -179.927 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -100.07 57.1 0.96 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.175 -0.953 . . . . 3.23 109.448 179.802 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 58.8 t0 -136.0 135.23 39.32 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.247 -0.908 . . . . 2.49 110.514 -179.681 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.465 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 38.7 mt-10 -70.0 -32.46 70.64 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.338 -0.851 . . . . 3.95 109.903 179.313 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -69.6 -36.4 76.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.45 -0.781 . . . . 2.0 110.815 -179.805 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.554 HD13 HD13 ' A' ' 118' ' ' LEU . 66.2 mt -80.73 -34.66 34.27 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.754 -1.216 . . . . 1.86 109.47 179.866 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -60.49 -44.46 95.92 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.121 -0.987 . . . . 2.84 109.235 179.447 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -69.53 -40.09 77.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 2.73 109.516 -179.912 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -60.64 -40.07 90.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.229 -0.92 . . . . 2.77 108.565 179.408 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 128' ' ' ALA . . . -59.44 -45.59 91.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.137 -0.977 . . . . 1.19 108.459 179.689 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 127' ' ' ALA . . . -44.3 -43.89 7.71 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.097 -0.705 . . . . 1.2 109.097 179.992 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -61.9 -45.85 91.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.389 -0.82 . . . . 1.55 109.868 179.389 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.14 -39.98 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.21 -0.931 . . . . 0.8 108.918 -179.896 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.712 ' HE ' ' NZ ' ' A' ' 135' ' ' LYS . 69.4 ttt180 -60.0 -39.41 85.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 3.09 109.147 179.528 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -60.02 -37.8 80.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.228 -0.92 . . . . 1.46 109.934 -179.749 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.03 -44.32 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.048 -1.032 . . . . 0.71 109.657 -179.205 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.95 -33.83 59.42 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.709 -1.234 . . . . 0.57 110.172 179.882 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.712 ' NZ ' ' HE ' ' A' ' 131' ' ' ARG . 37.5 mmtm -59.99 -46.88 88.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.151 -1.205 . . . . 2.59 110.061 -179.011 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.411 HH22 ' CD1' ' A' ' 57' ' ' ILE . 66.4 mtp180 -65.93 -34.21 77.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.802 -1.186 . . . . 2.83 109.452 179.86 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.0 tp -57.24 -42.01 80.65 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.655 -0.868 . . . . 1.25 108.655 -179.252 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.412 HD21 ' O ' ' A' ' 101' ' ' ASP . 83.5 mt -60.88 -40.12 91.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.7 109.296 178.377 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.473 HH11 ' HG2' ' A' ' 139' ' ' ARG . 47.2 mtt-85 -69.68 -40.11 76.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 2.57 109.52 -179.915 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -66.93 -37.96 85.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.584 -0.698 . . . . 1.23 111.757 -178.827 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.538 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.8 mt -71.22 -40.01 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.411 -1.43 . . . . 0.81 109.43 179.61 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 60.8 mt -75.48 -12.25 60.2 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.618 -0.676 . . . . 1.0 110.819 -178.344 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.98 35.43 57.93 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.636 -1.785 . . . . 0.89 108.636 -179.286 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.59 HD11 ' OD2' ' A' ' 22' ' ' ASP . 15.0 tp -73.4 142.43 46.96 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.485 -1.009 . . . . 1.14 109.275 -179.19 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -72.37 140.77 48.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.38 -0.825 . . . . 4.6 110.441 -179.062 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.4 mt -112.58 129.96 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-O 122.007 0.908 . . . . 1.24 109.289 179.468 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.461 HD11 ' OE1' ' A' ' 21' ' ' GLU . 6.3 mt -62.07 -43.21 97.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.912 -0.585 . . . . 1.54 110.783 -178.588 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.9 t0 66.58 122.35 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.529 -0.732 . . . . 1.5 109.079 -179.016 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.5 mt -92.69 0.67 57.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.394 -0.816 . . . . 0.79 110.637 -179.034 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.7 p -83.61 -15.3 49.56 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.745 -1.222 . . . . 1.4 110.413 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.99 29.97 0.33 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.115 -0.991 . . . . 0.92 112.199 -177.997 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.3 mm -83.77 125.17 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.379 -1.45 . . . . 0.88 109.188 179.623 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -104.32 -12.74 16.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.4 -0.813 . . . . 2.45 109.755 -179.826 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -137.83 156.96 47.38 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.237 -0.914 . . . . 1.52 110.213 -179.107 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.66 135.11 56.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.282 -0.886 . . . . 1.58 109.226 -179.64 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.7 m -153.05 168.14 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.398 -0.813 . . . . 0.69 110.146 179.403 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 80.6 mt -98.79 143.89 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 105.772 -1.936 . . . . 0.61 105.772 177.212 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 47.4 tp -97.68 120.1 37.45 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.772 -1.205 . . . . 0.87 109.993 -178.464 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.0 t -119.79 127.9 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.059 -0.719 . . . . 0.71 109.059 179.833 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.443 ' HB3' HD21 ' A' ' 163' ' ' LEU . . . -159.86 161.5 34.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.899 . . . . 0.81 108.888 179.87 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.82 -32.72 67.86 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.438 -1.414 . . . . 0.98 108.077 178.579 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -170.35 143.49 2.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.493 -0.754 . . . . 2.25 109.564 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.443 HD21 ' HB3' ' A' ' 160' ' ' ALA . 54.9 mt -116.53 141.03 48.71 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.44 -0.788 . . . . 0.78 109.554 -179.499 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 48.4 p -95.29 145.82 30.22 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.14 -0.975 . . . . 0.98 110.226 -179.429 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -40.6 -36.78 1.95 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.512 2.141 . . . . 0.81 112.802 179.029 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 63.9 m -59.03 -39.87 83.26 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.317 -0.864 . . . . 0.9 109.183 -179.076 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.58 -40.05 84.85 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.295 -0.878 . . . . 1.61 109.91 -179.709 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.7 p -58.17 -23.29 54.9 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.956 -1.09 . . . . 0.61 110.408 -178.863 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -75.78 -56.44 4.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.092 -1.005 . . . . 0.6 109.562 179.694 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -84.17 42.24 0.87 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.805 -1.183 . . . . 1.4 107.805 179.611 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.5 tp -101.81 140.99 35.36 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.207 -0.664 . . . . 0.7 109.207 179.472 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.512 ' O ' HG23 ' A' ' 176' ' ' VAL . 98.6 m-20 -89.95 103.02 15.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.155 -0.965 . . . . 2.35 108.681 179.293 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 70.5 mt -67.19 -44.09 80.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.418 -0.801 . . . . 1.51 111.914 -178.072 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -69.98 -25.47 63.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.759 -1.213 . . . . 2.33 112.512 -177.525 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -93.4 -5.5 49.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.621 -1.299 . . . . 1.92 110.722 -178.328 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 172' ' ' ASN . 23.0 t -86.13 139.99 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.834 -1.167 . . . . 0.67 110.496 -179.845 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.0 mt -103.91 -12.37 16.91 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 109.593 -0.521 . . . . 1.53 109.593 178.587 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 162.6 179.51 37.23 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.247 -1.541 . . . . 0.48 109.247 179.986 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -130.51 129.37 42.79 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.221 -1.164 . . . . 0.55 110.158 -179.95 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.416 ' CG2' HG21 ' A' ' 205' ' ' THR . 66.5 mt -128.65 120.55 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.383 -0.969 . . . . 0.65 108.383 177.756 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 61.0 p -148.78 160.81 42.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.742 -1.224 . . . . 0.82 110.555 -179.654 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -110.08 30.29 6.86 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.123 -0.695 . . . . 2.46 109.123 179.321 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -74.66 -158.3 0.07 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.67 -1.269 . . . . 1.28 112.339 -177.499 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -54.56 -80.95 0.07 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.676 -0.97 . . . . 2.19 110.676 -179.403 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 163.02 -115.88 0.68 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.369 -1.396 . . . . 2.13 110.405 -179.836 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.53 HH11 ' HG2' ' A' ' 186' ' ' ARG . 0.5 OUTLIER -68.49 -30.2 68.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.469 -1.018 . . . . 5.86 111.002 -178.856 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.0 p -79.97 7.42 9.01 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.006 -1.059 . . . . 3.72 110.544 -178.62 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 61.0 m -90.95 128.6 36.85 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.821 -1.174 . . . . 1.74 110.702 -179.528 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -47.27 -48.62 24.69 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.381 -0.824 . . . . 0.95 109.493 179.929 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.2 m -60.04 -39.92 87.6 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 1.55 109.961 -179.153 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 62.1 m -60.01 -39.95 87.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.985 -1.072 . . . . 1.51 109.335 -179.38 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.5 mm -66.31 -40.28 86.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.278 -0.889 . . . . 1.67 109.235 -179.92 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 92.9 mtp -64.63 -39.99 94.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.123 -0.986 . . . . 1.02 111.254 -179.538 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.61 -43.27 93.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.313 -1.492 . . . . 0.68 108.978 -179.644 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -59.93 -49.92 75.79 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.244 -0.91 . . . . 2.93 109.786 -179.566 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.5 m -70.03 -34.21 72.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.039 -1.038 . . . . 0.86 110.631 -179.226 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.0 mt -76.07 -21.68 56.48 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.08 -1.012 . . . . 0.67 109.533 -179.413 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 61.28 47.7 6.76 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.543 -0.723 . . . . 1.5 110.633 -179.646 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 63.4 mt -121.52 135.58 25.22 Favored Pre-proline 0 N--CA 1.501 2.124 0 N-CA-C 108.514 -0.921 . . . . 0.72 108.514 178.662 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -43.64 128.93 6.83 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.021 1.814 . . . . 0.61 112.124 -179.947 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -166.42 144.32 5.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.597 -1.315 . . . . 0.66 112.151 -179.79 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 94.9 mt -124.55 144.53 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 106.763 -1.569 . . . . 0.79 106.763 177.656 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.48 -10.56 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 120.78 -1.2 . . . . 0.91 111.554 -178.372 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -103.6 23.76 31.83 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.592 -1.403 . . . . 1.01 109.592 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.416 HG21 ' CG2' ' A' ' 180' ' ' ILE . 7.6 p -45.98 -42.44 13.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -1.125 . . . . 0.99 109.971 -179.194 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 89.94 -49.1 3.29 Favored Glycine 0 N--CA 1.498 2.767 0 O-C-N 120.963 -1.086 . . . . 1.12 111.113 179.336 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.8 t -165.92 40.41 0.06 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.714 -1.463 . . . . 1.72 110.731 -179.612 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 49.2 t -79.45 -37.71 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.081 -1.081 . . . . 0.89 108.081 177.865 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 209' ' ' THR . 2.8 p -52.56 -27.22 15.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.663 -0.648 . . . . 1.03 109.703 -179.906 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 69.8 m -78.94 -26.5 43.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 1.83 109.856 -179.629 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -92.3 -8.3 45.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.043 -1.036 . . . . 2.27 109.856 -179.672 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 64.8 t -105.17 133.77 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.436 -0.79 . . . . 0.92 110.272 -178.955 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.404 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 70.2 mmtt -113.39 154.0 27.66 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 106.976 -1.49 . . . . 2.2 106.976 178.309 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 55.7 t-20 -59.95 138.98 57.7 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.955 -1.091 . . . . 2.36 110.238 -178.622 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 84.85 -1.69 0.9 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 121.116 0.484 . . . . 2.38 110.801 179.115 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.404 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 92.7 m-20 -70.38 148.1 48.79 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.13 -0.981 . . . . 2.09 109.107 178.978 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -96.9 119.98 36.39 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.913 -1.144 . . . . 1.27 107.913 179.16 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 16' ' ' ALA . 87.1 mt -126.72 147.26 49.98 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.369 -0.832 . . . . 0.75 110.237 -178.876 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 99.9 mt -117.79 127.21 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.152 -1.425 . . . . 0.63 107.152 177.291 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 17.7 tp -100.94 120.6 40.41 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.257 -0.902 . . . . 0.7 109.584 -178.657 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 223' ' ' VAL . 7.1 t70 -76.01 -41.45 51.02 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.025 -1.102 . . . . 2.31 108.025 179.42 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 49.01 9.94 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.722 -0.611 . . . . 0.78 109.83 179.788 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.514 ' N ' ' O ' ' A' ' 221' ' ' ASP . 60.4 t -126.73 -35.12 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.619 -1.252 . . . . 1.04 107.619 178.66 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.486 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 98.6 m-20 -108.39 3.58 23.48 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.297 -1.001 . . . . 2.44 108.297 178.686 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.416 HD21 ' H ' ' A' ' 4' ' ' GLY . 38.7 t30 59.86 45.52 12.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.64 -0.662 . . . . 1.55 110.352 179.981 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -138.92 144.55 39.13 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.168 -0.957 . . . . 1.99 109.792 179.392 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.2 t -115.35 130.13 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.66 -0.867 . . . . 0.77 108.66 179.381 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -104.63 126.13 51.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.444 -0.785 . . . . 0.98 108.98 179.5 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.1 t -100.03 106.99 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.272 -0.893 . . . . 0.85 109.954 -179.55 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 39.3 t30 49.92 61.0 14.46 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.189 -0.945 . . . . 1.66 111.422 178.002 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.83 158.39 27.74 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.494 2.13 . . . . 0.95 111.538 178.964 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.2 m -68.42 159.68 31.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.044 -1.035 . . . . 1.84 110.354 -178.923 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -59.95 -40.0 87.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.549 -0.719 . . . . 2.74 109.732 -179.619 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.05 -39.25 85.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 2.89 109.389 -179.985 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.9 t -67.5 -39.96 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.312 -0.868 . . . . 1.3 108.91 179.359 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.9 mt . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.319 -0.863 . . . . 1.09 109.247 179.32 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 45.5 ttm . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.408 0.623 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -151.02 148.17 28.02 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.153 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -152.19 161.6 42.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.935 -1.103 . . . . 0.0 111.039 -178.989 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -156.23 155.06 31.75 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.91 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -110.45 135.71 50.72 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.295 -0.878 . . . . 0.0 111.102 -179.055 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.548 HG22 ' N ' ' B' ' 307' ' ' THR . 2.7 p -120.06 165.27 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.94 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . 0.548 ' N ' HG22 ' B' ' 306' ' ' VAL . 70.9 m -119.11 115.96 25.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.101 -1.0 . . . . 0.0 108.328 178.526 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.59 HD12 ' HB ' ' B' ' 359' ' ' THR . 60.2 mt -56.22 120.9 3.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-O 122.366 1.079 . . . . 0.0 110.893 -178.434 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 65.2 p -109.47 24.34 13.21 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.863 -179.945 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -85.17 116.65 66.38 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 108.725 179.618 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -68.33 -7.42 20.04 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 CA-C-N 120.201 1.108 . . . . 0.0 111.477 -179.948 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -119.12 6.61 11.27 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.634 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.52 175.76 43.86 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.366 -1.893 . . . . 0.0 108.366 -179.039 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 3.3 tp -83.65 95.51 8.38 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.008 -1.289 . . . . 0.0 108.952 -178.874 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -96.66 -160.48 0.8 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.835 -1.165 . . . . 0.0 109.805 179.15 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 4.0 m -59.97 -43.46 95.06 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.942 -1.099 . . . . 0.0 112.278 -176.287 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.507 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 2.6 tpt180 -54.82 -62.06 4.78 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.44 -1.412 . . . . 0.0 111.299 -178.65 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -58.73 -36.42 97.14 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 CA-C-N 120.221 1.115 . . . . 0.0 111.181 179.787 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.71 72.65 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.503 -0.748 . . . . 0.0 108.989 179.77 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -56.84 -44.07 81.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.774 -179.182 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -69.91 -42.29 73.56 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.013 -1.055 . . . . 0.0 108.48 179.353 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -59.87 -50.04 75.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.673 -0.642 . . . . 0.0 111.192 -179.204 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 72.7 t -70.94 -28.65 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.556 -1.34 . . . . 0.0 109.875 -179.175 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . 0.465 ' NZ ' ' OE1' ' A' ' 74' ' ' GLU . 22.7 ttmt -60.05 -47.69 84.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.2 -0.938 . . . . 0.0 109.905 -179.203 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . 0.481 ' OE1' HD22 ' B' ' 380' ' ' LEU . 85.3 tt0 -65.31 -40.02 93.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.087 -1.008 . . . . 0.0 110.239 -179.292 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.67 -52.94 62.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.913 -1.117 . . . . 0.0 111.129 -179.025 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -60.58 -13.02 11.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.874 -1.141 . . . . 0.0 109.708 -179.515 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -67.46 -30.4 75.07 Favored Glycine 0 N--CA 1.485 1.967 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 178.608 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -106.11 144.15 33.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.654 -0.909 . . . . 0.0 108.942 179.587 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 25.3 p -90.34 -12.35 37.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.989 -1.069 . . . . 0.0 109.626 -179.993 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.43 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 15.7 t -58.49 147.98 29.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 109.117 179.768 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -66.71 131.89 46.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.247 -0.908 . . . . 0.0 109.201 -179.813 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 79.3 mt -130.92 130.33 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.492 -0.755 . . . . 0.0 109.293 179.938 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 28.6 m -131.46 153.8 49.38 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.569 -0.707 . . . . 0.0 109.433 179.568 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 68.7 t -116.09 139.27 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.081 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.7 m -129.49 121.99 28.37 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.177 -0.952 . . . . 0.0 108.995 179.771 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 42.0 p -138.72 119.37 14.03 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.013 0.911 . . . . 0.0 111.052 -179.272 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 57.5 t30 41.78 59.01 2.63 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 177.265 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 82.0 -14.6 31.64 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 120.369 -1.457 . . . . 0.0 113.087 176.316 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -115.94 128.68 55.95 Favored 'General case' 0 N--CA 1.506 2.34 0 CA-C-N 119.264 1.532 . . . . 0.0 109.425 179.978 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 81.0 p -129.55 150.82 50.72 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.807 0.813 . . . . 0.0 110.172 -179.089 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . 0.453 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -143.54 166.49 24.66 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.682 0.753 . . . . 0.0 110.185 -179.223 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 4.6 t -91.27 142.41 27.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.662 -0.648 . . . . 0.0 109.643 -179.587 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -80.02 -12.42 59.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 109.984 -179.508 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -91.16 18.96 6.24 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.427 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 19.7 m -146.05 95.92 2.71 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.279 -179.09 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.811 HD23 HD22 ' A' ' 79' ' ' LEU . 8.3 tp -59.96 -32.29 70.67 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.663 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.609 ' CE2' HD11 ' A' ' 79' ' ' LEU . 60.0 m-85 -59.87 -54.53 45.07 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.524 -0.735 . . . . 0.0 110.636 -178.858 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -67.0 -40.09 87.25 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.56 -1.337 . . . . 0.0 109.387 -178.633 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' B' ' 352' ' ' THR . 32.8 mt -50.19 -57.08 8.55 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.122 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.516 ' O ' HD22 ' A' ' 123' ' ' LEU . 22.3 mt-30 -41.02 -17.66 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.864 -0.523 . . . . 0.0 111.099 -178.833 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.539 ' N ' ' O ' ' B' ' 350' ' ' LEU . 82.0 p -90.61 -5.98 55.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.183 -1.573 . . . . 0.0 110.567 -179.135 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.453 HD11 ' HB3' ' B' ' 342' ' ' ALA . 83.6 mt -92.96 108.63 20.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.945 -1.097 . . . . 0.0 109.639 179.434 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -68.25 84.67 0.18 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 107.81 -2.116 . . . . 0.0 107.81 178.774 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 71.0 mt -99.16 95.97 7.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.326 -1.103 . . . . 0.0 108.326 179.483 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 44.8 p -98.32 176.6 5.65 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.255 -0.903 . . . . 0.0 110.461 -178.604 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -44.62 159.15 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.355 1.074 . . . . 0.0 111.413 -179.327 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 41.09 23.3 0.08 OUTLIER Glycine 0 N--CA 1.497 2.701 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.601 177.608 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . 0.59 ' HB ' HD12 ' B' ' 308' ' ' ILE . 4.5 m -87.4 108.04 18.82 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.459 -1.612 . . . . 0.0 109.501 179.595 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 57.8 t -77.28 123.2 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.784 -177.36 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.6 m -122.43 175.77 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -178.477 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 94.0 m -125.07 132.32 53.19 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.726 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 96.8 mt -100.73 121.78 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.484 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 54.0 p -124.09 133.92 53.5 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.524 -0.735 . . . . 0.0 109.471 -179.054 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.53 152.18 39.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.425 -0.797 . . . . 0.0 109.368 -179.489 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -141.97 119.77 11.89 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.529 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.539 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 159.68 -154.51 25.56 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.76 -1.686 . . . . 0.0 112.046 -179.935 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -58.05 -54.72 43.71 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -177.271 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.43 ' H ' ' HB2' ' B' ' 331' ' ' SER . 83.4 m-20 -112.39 14.42 20.37 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.028 -1.045 . . . . 0.0 111.177 -177.644 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.1 pt-20 -39.19 -37.52 0.41 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.621 -0.674 . . . . 0.0 110.926 -179.437 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -69.42 -46.18 67.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.022 -1.049 . . . . 0.0 111.064 -178.025 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.86 -49.48 65.54 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.864 -1.148 . . . . 0.0 110.374 -179.12 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -55.23 -35.15 64.63 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.082 -1.011 . . . . 0.0 111.477 -178.048 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.591 ' O ' HG23 ' B' ' 378' ' ' VAL . 72.8 t -69.94 -41.04 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.458 -1.401 . . . . 0.0 108.264 178.996 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -63.86 -59.45 4.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.522 -0.736 . . . . 0.0 111.916 -178.737 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -67.84 -40.11 83.75 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.63 -1.294 . . . . 0.0 111.963 -177.306 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.4 -38.01 73.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.553 -1.342 . . . . 0.0 108.757 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.591 HG23 ' O ' ' B' ' 374' ' ' VAL . 51.5 t -60.01 -42.04 88.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.255 -0.903 . . . . 0.0 109.285 179.499 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . 0.441 ' O ' ' OE2' ' B' ' 383' ' ' GLU . 19.1 mmmt -69.43 -55.02 11.5 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.082 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.481 HD22 ' OE1' ' B' ' 325' ' ' GLU . 64.3 tp -54.22 -38.65 65.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.786 -0.571 . . . . 0.0 110.604 -177.377 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' B' ' 381' ' ' MET . 0.0 OUTLIER -73.34 -40.01 64.76 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.619 -1.232 . . . . 0.0 108.607 178.238 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . 0.515 ' HB3' ' OE2' ' B' ' 383' ' ' GLU . . . -80.08 -3.4 48.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.095 -1.003 . . . . 0.0 109.775 179.411 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.515 ' OE2' ' HB3' ' B' ' 382' ' ' ALA . 0.0 OUTLIER -111.65 -3.02 15.18 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.378 -0.827 . . . . 0.0 111.026 -179.331 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.03 128.9 40.65 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.499 -1.376 . . . . 0.0 109.688 179.411 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 118.103 -0.951 . . . . 0.0 109.218 179.524 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.7 mtt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.471 -0.566 . . . . 2.91 109.471 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 87.5 mt -106.85 120.09 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.525 -0.734 . . . . 1.2 109.095 179.937 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.7 m -132.85 133.34 43.2 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.468 -0.77 . . . . 1.4 109.228 179.829 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.826 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -115.27 -162.38 13.54 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 108.44 -1.864 . . . . 1.05 108.44 179.496 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 6' ' ' LEU . 79.5 mt -91.6 -12.9 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.95 -1.324 . . . . 1.15 109.648 -179.478 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.468 HD11 ' O ' ' A' ' 8' ' ' SER . 60.0 tp 53.75 99.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.145 -0.972 . . . . 0.98 108.822 -179.569 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.15 -40.18 74.9 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.687 -0.857 . . . . 0.88 108.687 179.315 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.468 ' O ' HD11 ' A' ' 6' ' ' LEU . 46.5 m -149.05 147.95 25.49 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.431 -0.793 . . . . 1.69 109.744 179.574 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.73 146.99 17.02 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.671 2.248 . . . . 0.85 113.272 -179.925 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.677 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.19 -164.04 36.89 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 109.105 -1.598 . . . . 0.92 109.105 179.756 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.1 mt -149.84 149.88 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 120.914 -1.344 . . . . 0.81 109.124 179.208 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.38 156.22 33.5 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.037 -1.04 . . . . 0.51 110.552 179.214 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.4 m-85 -137.02 129.14 29.47 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 107.85 -1.167 . . . . 0.62 107.85 178.597 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.22 -179.13 44.83 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 118.652 -1.737 . . . . 0.55 110.996 179.847 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -79.89 155.21 27.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.747 -0.854 . . . . 2.1 109.533 -179.972 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.479 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -101.89 129.99 48.26 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.45 -0.781 . . . . 0.77 110.563 -179.3 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.0 tp -96.31 135.17 38.51 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.205 -1.406 . . . . 0.91 107.205 178.42 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.4 tp -113.48 118.29 34.07 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.219 -0.925 . . . . 0.93 109.773 -179.532 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.614 HD12 ' HB2' ' A' ' 160' ' ' ALA . 51.0 mt -85.98 102.88 14.17 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.432 0.635 . . . . 0.93 109.502 -179.947 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -97.56 137.33 36.65 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.376 -0.828 . . . . 2.75 109.971 -179.39 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -130.5 132.99 45.92 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.72 -0.844 . . . . 3.0 108.72 179.492 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -78.69 138.34 38.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.967 -1.083 . . . . 2.77 109.053 179.748 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.81 139.97 57.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 2.94 108.762 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.7 mt -85.22 132.76 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.95 109.416 -179.264 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.6 t -106.96 129.69 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.25 -0.906 . . . . 1.28 109.762 -179.748 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.3 mt -99.21 141.14 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.36 -0.838 . . . . 1.21 109.074 179.734 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -98.96 118.94 36.88 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.162 -0.961 . . . . 1.81 109.441 -179.961 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -90.11 3.07 54.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.465 -0.772 . . . . 2.8 109.887 -179.275 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -59.97 144.18 49.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.043 -1.036 . . . . 2.87 109.67 -179.895 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -92.0 143.5 26.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.208 -0.932 . . . . 2.35 108.963 179.654 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 pt -93.55 165.79 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.131 -0.981 . . . . 0.97 110.438 -179.346 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.2 p -88.96 170.42 10.7 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.02 -1.104 . . . . 1.17 108.02 178.281 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.19 -18.47 63.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.879 -1.138 . . . . 1.18 110.176 -179.799 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 53.7 t0 -83.55 -26.75 29.84 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.893 -1.129 . . . . 2.56 108.605 179.14 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -82.18 -7.64 59.63 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.983 -0.747 . . . . 1.79 108.983 179.036 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.3 t -60.49 -53.14 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.254 -0.904 . . . . 1.0 109.253 179.77 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.81 -39.96 90.89 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.321 -0.862 . . . . 1.77 109.969 -179.447 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -63.46 -40.21 96.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.246 -0.909 . . . . 2.7 110.997 -179.298 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -65.94 -40.03 91.02 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.742 -1.224 . . . . 1.51 110.593 -179.395 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.01 -46.9 93.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 118.163 -1.415 . . . . 0.93 108.379 -179.614 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.03 -41.57 92.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.839 -1.163 . . . . 1.81 109.703 179.806 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.402 ' HG2' HH11 ' A' ' 42' ' ' ARG . 57.2 mtt-85 -59.95 -44.82 94.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.805 -1.185 . . . . 2.78 108.576 179.131 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -63.18 -47.44 82.59 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.456 -0.778 . . . . 0.78 109.523 178.886 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.0 tp -59.96 -49.08 79.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.294 -0.879 . . . . 1.07 109.075 -179.069 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.8 t -64.27 -42.25 96.55 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.965 -1.084 . . . . 1.12 108.874 179.452 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.25 -48.86 84.04 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.544 -1.823 . . . . 0.84 108.544 179.117 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -60.64 -38.69 85.64 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.436 -1.038 . . . . 3.09 108.434 178.594 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.41 -40.06 70.96 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.096 -0.705 . . . . 0.88 109.096 -179.855 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 51' ' ' SER . 24.1 ttmt -61.16 -74.48 0.08 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.439 -1.319 . . . . 2.59 107.439 179.46 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.68 -30.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.39 -0.819 . . . . 0.7 111.427 -178.254 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 49' ' ' LYS . 18.3 t -60.0 -54.59 44.2 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.771 -1.172 . . . . 1.4 108.587 179.673 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.69 -42.81 77.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.611 -0.68 . . . . 0.67 111.161 -179.016 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.85 -45.68 93.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.801 -1.187 . . . . 1.66 110.675 -179.046 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.99 -40.18 94.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.927 -1.108 . . . . 1.58 109.477 -179.406 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -60.87 -39.77 90.43 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.252 -0.905 . . . . 1.35 110.031 179.861 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -65.41 -43.34 90.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.934 -1.104 . . . . 0.77 109.269 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.567 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.8 mt -61.68 -39.87 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.63 108.922 179.537 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -54.98 -50.38 69.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.752 . . . . 1.14 109.657 -179.469 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -57.33 -33.87 68.17 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.321 -0.862 . . . . 0.79 110.492 -178.088 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -69.83 -37.46 76.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 1.53 109.45 179.622 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.86 -46.07 79.82 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.677 -0.639 . . . . 0.57 110.192 -179.67 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.19 -52.81 44.71 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 110.159 -1.176 . . . . 0.75 110.159 -179.011 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -70.04 -43.92 70.3 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.997 -1.296 . . . . 1.59 110.255 -179.513 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.4 m -65.28 -65.25 0.7 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.092 -1.005 . . . . 0.73 112.987 -177.453 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -97.83 -42.59 7.5 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.812 -1.18 . . . . 0.75 111.667 -177.621 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.25 -168.98 25.22 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.752 -1.218 . . . . 1.22 111.014 179.499 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -73.77 -23.69 59.75 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.04 -0.682 . . . . 5.81 110.246 -179.966 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -62.46 -33.58 75.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 3.37 110.462 -179.077 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HA ' HD12 ' A' ' 72' ' ' ILE . 34.5 mmtm -99.06 -20.03 16.92 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.274 -0.891 . . . . 1.77 109.61 -179.801 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -69.92 -40.24 75.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.312 -0.868 . . . . 1.65 110.531 -178.845 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.643 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -69.15 -27.31 65.43 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.183 -0.948 . . . . 0.77 109.879 -179.002 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 69' ' ' LYS . 94.2 mt -60.01 -40.4 83.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.793 -1.188 . . . . 0.8 107.793 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -62.1 -41.91 98.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -0.888 . . . . 0.88 108.906 179.281 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -60.86 -39.91 90.93 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.633 -0.827 . . . . 1.37 109.345 179.15 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.44 -47.82 88.51 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.881 -1.687 . . . . 0.62 108.881 179.531 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -64.06 -40.12 95.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.496 -1.002 . . . . 1.5 109.032 179.582 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.2 mt -69.4 -45.73 78.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.342 -0.849 . . . . 0.63 109.451 179.717 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.4 ttp -63.61 -40.07 95.99 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.04 -1.038 . . . . 1.51 110.16 -178.69 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.887 HD22 HD23 ' B' ' 347' ' ' LEU . 58.0 tp -65.95 -40.03 90.98 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.396 -0.815 . . . . 0.77 109.959 -179.961 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.7 tp -65.5 -39.94 92.46 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.684 -0.635 . . . . 0.62 110.207 -178.775 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -84.68 4.72 31.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.896 -1.127 . . . . 1.47 110.039 -178.897 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.1 t0 -49.18 134.55 17.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.175 -0.953 . . . . 1.47 109.765 -179.666 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.46 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.6 mt-10 -60.69 -20.02 59.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.612 -0.68 . . . . 1.78 110.798 -178.728 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -71.36 -33.39 69.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.055 -1.028 . . . . 2.53 110.171 179.569 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.9 mt -75.02 -41.09 60.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.477 -0.764 . . . . 0.8 110.146 179.864 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.05 -50.05 75.24 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.227 -0.921 . . . . 1.42 110.732 -178.92 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.03 -40.74 74.98 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.05 -1.031 . . . . 1.71 111.665 -178.802 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -69.98 -39.16 76.11 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.031 -1.043 . . . . 1.57 111.354 -178.818 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.8 mt -67.67 -42.05 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.93 . . . . 0.65 109.116 -179.757 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.7 mt -65.82 -39.21 84.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.51 -0.744 . . . . 0.82 109.622 179.38 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.09 -49.45 77.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 0.79 111.451 -178.629 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.8 mt -60.99 -46.4 90.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.711 -1.243 . . . . 0.95 109.821 -178.866 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.03 -50.01 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 122.115 0.96 . . . . 0.66 109.075 179.729 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -70.43 -40.21 73.94 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 120.091 -0.644 . . . . 2.2 110.834 -179.762 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -81.13 -62.48 1.65 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.036 -1.04 . . . . 1.65 112.078 -178.135 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -82.55 -0.97 49.21 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.043 -1.036 . . . . 2.03 111.999 -177.025 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 73.3 m80 57.57 38.19 27.81 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.92 -1.112 . . . . 1.42 109.927 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.1 mtp -92.67 169.07 10.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.484 -0.76 . . . . 1.18 109.595 -179.937 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.7 p -81.55 160.23 23.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.28 -0.887 . . . . 0.98 109.559 -179.692 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.4 -39.72 77.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.33 -0.856 . . . . 0.64 109.937 -179.772 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -67.01 -40.04 87.19 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -0.888 . . . . 2.07 109.498 179.817 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.65 -43.86 25.15 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.43 -0.794 . . . . 0.73 109.868 179.618 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.99 -42.92 72.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.339 -0.851 . . . . 0.54 110.568 -179.222 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.05 -44.12 96.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.166 -0.959 . . . . 0.56 109.819 -179.495 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -59.98 -38.71 83.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.321 -0.862 . . . . 1.54 110.386 -179.202 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.98 -40.28 88.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.012 . . . . 1.33 110.379 -179.172 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.1 t -64.74 -49.09 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.838 -1.164 . . . . 0.72 110.055 -179.38 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.5 mm -67.58 -40.09 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.069 -1.019 . . . . 0.85 109.214 -179.802 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.46 -38.87 88.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 2.44 108.808 179.336 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.96 -45.69 95.45 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 120.313 -0.946 . . . . 0.98 110.749 -179.487 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.656 HE21 ' CB ' ' B' ' 348' ' ' PHE . 17.9 mm100 -70.04 -52.56 23.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.7 -1.471 . . . . 1.41 110.039 -179.118 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.2 88.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.855 . . . . 1.2 109.811 -179.497 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.2 t -57.88 -39.64 78.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.174 -0.954 . . . . 1.7 109.559 -179.287 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.16 -39.45 94.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 1.47 109.562 179.63 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.3 mt -61.94 -39.97 93.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.105 -0.997 . . . . 1.56 109.671 -179.202 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.438 ' CD ' ' NH2' ' A' ' 131' ' ' ARG . 36.3 mt-10 -58.91 -33.27 70.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.608 -1.307 . . . . 2.2 109.705 -179.141 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -56.33 -21.57 25.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.873 -1.142 . . . . 2.12 108.713 179.264 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.432 HD13 HD13 ' A' ' 123' ' ' LEU . 74.8 mt -62.54 140.4 58.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 2.0 108.939 179.687 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -90.63 21.66 3.9 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.208 -0.932 . . . . 3.23 110.126 -179.426 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 51.9 t0 -112.86 141.28 46.86 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.402 -0.811 . . . . 2.49 109.569 -179.737 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 124' ' ' LYS . 92.8 mt-10 -72.54 -63.2 1.21 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.265 -1.013 . . . . 3.95 108.265 178.631 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.46 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.8 t80 -38.65 -41.42 0.69 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.031 -0.418 . . . . 2.0 110.932 -178.935 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.433 HD22 ' O ' ' B' ' 351' ' ' GLN . 87.2 mt -69.85 -39.92 76.1 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.63 -1.293 . . . . 1.86 108.239 179.549 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 121' ' ' GLU . 63.1 tttp -60.77 -40.07 91.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 2.84 110.022 179.718 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 41.3 mt-10 -60.02 -45.01 94.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.017 -1.052 . . . . 2.73 109.77 -179.28 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.872 ' HE ' HE22 ' B' ' 351' ' ' GLN . 65.6 mtp180 -60.54 -39.94 89.7 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.167 -0.958 . . . . 2.77 108.505 179.214 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.76 -27.35 67.9 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.556 -0.905 . . . . 1.19 108.556 179.027 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -64.18 -40.05 95.29 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.135 -1.061 . . . . 1.2 108.135 178.792 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -64.16 -40.09 95.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.518 -0.739 . . . . 1.55 109.21 179.653 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.89 -42.73 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -0.864 . . . . 0.8 108.733 179.945 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.438 ' NH2' ' CD ' ' A' ' 116' ' ' GLU . 44.1 ttm180 -60.33 -36.72 78.62 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.522 0.677 . . . . 3.09 109.203 179.361 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -58.45 -39.61 80.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.438 -0.789 . . . . 1.46 109.036 -179.671 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.87 -45.45 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.209 -0.932 . . . . 0.71 108.838 179.843 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.18 -41.34 99.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.771 -1.332 . . . . 0.57 109.771 179.689 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -59.99 -50.04 75.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.188 -1.184 . . . . 2.59 110.274 -179.927 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.567 HH22 ' CD1' ' A' ' 57' ' ' ILE . 62.1 mtp180 -69.64 -32.37 71.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.807 -1.183 . . . . 2.83 109.72 -179.631 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -57.3 -47.86 80.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 1.25 108.772 -179.139 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.9 mt -61.13 -39.69 90.98 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.254 -0.904 . . . . 0.7 108.955 178.407 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.512 HH11 ' CD2' ' A' ' 144' ' ' LEU . 50.0 mtt-85 -67.61 -40.05 84.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.89 . . . . 2.57 109.259 179.542 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -66.53 -39.88 88.83 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.629 -0.669 . . . . 1.23 110.456 -179.012 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.9 mt -71.78 -43.1 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 120.478 -1.389 . . . . 0.81 108.303 178.822 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.0 -32.25 70.35 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.74 -0.6 . . . . 1.0 109.733 179.944 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.86 44.38 6.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.178 -1.569 . . . . 0.89 109.178 -179.373 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.512 ' CD2' HH11 ' A' ' 139' ' ' ARG . 12.3 tp -74.85 148.45 40.22 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.414 -1.05 . . . . 1.14 109.376 -179.44 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -70.45 143.16 51.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.24 -0.913 . . . . 4.6 109.896 -179.48 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.7 mt -115.22 129.98 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.984 0.897 . . . . 1.24 108.915 179.373 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 10.5 mt -66.85 -39.95 84.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 115.869 -0.605 . . . . 1.54 110.717 -178.23 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.6 t0 67.5 97.29 0.06 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.745 -0.835 . . . . 1.5 108.745 -179.329 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.2 mt -68.1 -1.13 5.37 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.443 -0.786 . . . . 0.79 110.939 -178.575 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 80.8 p -82.97 -14.0 54.9 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.695 -1.253 . . . . 1.4 110.111 -179.723 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.92 33.34 0.33 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.284 -0.885 . . . . 0.92 111.96 -177.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 45.1 mm -85.94 120.22 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.421 -1.425 . . . . 0.88 108.96 179.491 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.414 ' O ' ' OD1' ' A' ' 154' ' ' ASP . 50.6 tt0 -99.85 -12.14 20.12 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.33 -0.856 . . . . 2.45 109.93 -179.364 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 153' ' ' GLN . 95.7 m-20 -139.26 157.89 45.12 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.944 -1.098 . . . . 1.52 110.285 -179.398 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.95 137.03 57.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.45 -0.782 . . . . 1.58 109.63 -179.62 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.5 m -153.3 167.9 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.462 -0.774 . . . . 0.69 109.982 179.609 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 81.5 mt -97.16 144.74 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.727 -1.583 . . . . 0.61 106.727 177.689 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.511 HD11 HD11 ' A' ' 19' ' ' LEU . 40.9 tp -94.2 117.08 29.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.911 -1.118 . . . . 0.87 110.367 -178.222 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.786 HG12 HG22 ' A' ' 209' ' ' THR . 44.6 t -123.12 129.41 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 108.667 -0.864 . . . . 0.71 108.667 179.199 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.614 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.14 165.31 29.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.119 -0.988 . . . . 0.81 109.354 -179.627 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.42 -30.63 61.99 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.261 -1.524 . . . . 0.98 108.378 178.823 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -165.51 168.41 16.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.913 -0.773 . . . . 2.25 108.913 -179.61 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.1 mt -139.6 133.19 30.36 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.169 -0.957 . . . . 0.78 108.869 179.286 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 69.3 p -99.13 149.35 35.7 Favored Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.318 -0.864 . . . . 0.98 109.769 -179.717 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -40.62 -37.77 2.32 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.541 2.16 . . . . 0.81 113.263 179.515 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 65.1 m -59.99 -39.99 87.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.9 109.677 -178.794 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -69.08 -44.21 72.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.287 -0.883 . . . . 1.61 110.503 -179.445 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.0 p -54.9 -30.17 57.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.043 -1.036 . . . . 0.61 111.717 -177.458 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.79 -48.58 24.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.7 -1.25 . . . . 0.6 109.901 -179.522 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . 0.421 ' H ' ' HG2' ' A' ' 170' ' ' GLN . 13.9 pt20 -86.43 40.12 0.87 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.899 -1.149 . . . . 1.4 107.899 179.636 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.3 tp -111.26 136.14 50.78 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.36 -0.978 . . . . 0.7 108.36 178.485 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.428 ' O ' HG23 ' A' ' 176' ' ' VAL . 16.3 m120 -90.43 108.42 19.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.966 -1.084 . . . . 2.35 110.096 -179.728 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 71.9 mt -64.91 -40.43 95.06 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.458 -0.776 . . . . 1.51 111.071 -178.906 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -70.05 -25.04 63.37 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.87 -1.144 . . . . 2.33 111.708 -178.131 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -93.62 -8.99 39.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.784 -1.198 . . . . 1.92 110.373 -178.632 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.581 HG12 ' H ' ' A' ' 178' ' ' GLY . 85.4 t -103.27 117.85 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.194 -0.941 . . . . 0.67 108.948 179.434 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 81.6 mt -86.73 6.42 31.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.456 -0.778 . . . . 1.53 110.571 -177.875 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.581 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 165.66 175.4 36.15 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.305 -1.518 . . . . 0.48 109.305 179.806 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.443 ' CE1' HG11 ' A' ' 176' ' ' VAL . 21.8 m-85 -132.18 130.67 41.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.477 -1.013 . . . . 0.55 109.198 -179.877 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.417 ' CG2' HG21 ' A' ' 205' ' ' THR . 98.2 mt -132.93 124.85 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.483 -0.76 . . . . 0.65 108.963 178.869 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 47.5 p -148.02 160.61 42.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.97 -1.081 . . . . 0.82 110.917 -179.622 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 183' ' ' ALA . 0.8 OUTLIER -99.65 20.13 14.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.558 -0.714 . . . . 2.46 109.717 179.969 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.17 -163.32 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.812 -1.18 . . . . 1.28 111.607 -178.295 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -85.56 -46.92 5.32 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 111.224 -0.751 . . . . 2.19 111.224 -178.603 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 165.66 -136.44 4.18 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.963 -1.589 . . . . 2.13 110.612 -179.598 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' ' 186' ' ' ARG . 24.2 mmt-85 -70.21 -10.43 58.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.481 -1.011 . . . . 5.86 109.739 -179.219 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 78.1 p -76.08 -7.15 54.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.114 -0.992 . . . . 3.72 109.732 -179.471 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.2 p -91.39 131.87 36.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.134 -0.979 . . . . 1.74 109.889 179.819 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -49.69 -47.59 50.22 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.426 -0.796 . . . . 0.95 109.843 -179.559 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.414 ' H ' HG22 ' A' ' 190' ' ' THR . 0.6 OUTLIER -56.96 -39.62 74.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.381 -0.824 . . . . 1.55 110.576 -178.949 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.4 t -60.03 -41.23 91.79 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.888 -1.132 . . . . 1.51 110.753 -179.267 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.7 mm -60.21 -40.01 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.135 -0.978 . . . . 1.67 109.338 -179.5 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.7 mtp -60.04 -40.13 88.31 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.27 -0.894 . . . . 1.02 110.055 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.48 -44.38 72.56 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.734 -1.228 . . . . 0.68 108.931 179.986 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -60.06 -52.42 65.46 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.346 -0.942 . . . . 2.93 110.518 -179.703 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 56.4 m -69.88 -34.68 73.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.025 -1.047 . . . . 0.86 110.79 -178.465 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.97 -29.68 66.85 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.955 -1.128 . . . . 0.67 107.955 179.593 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 65.09 47.34 2.51 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.454 0.645 . . . . 1.5 110.153 -179.629 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 93.6 mt -124.85 150.52 66.19 Favored Pre-proline 0 N--CA 1.5 2.05 0 N-CA-C 108.439 -0.948 . . . . 0.72 108.439 178.891 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -56.15 138.59 83.51 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.858 1.705 . . . . 0.61 111.135 179.841 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.94 151.03 3.22 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.744 -1.182 . . . . 0.66 111.778 -179.647 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.1 mt -127.23 143.89 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.069 -1.086 . . . . 0.79 108.069 179.116 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.9 m -130.0 -11.45 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 O-C-N 120.837 -1.165 . . . . 0.91 111.315 -178.825 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.51 25.85 18.25 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 110.064 -1.214 . . . . 1.01 110.064 -179.506 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.417 HG21 ' CG2' ' A' ' 180' ' ' ILE . 4.6 p -45.3 -45.59 12.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -1.158 . . . . 0.99 109.814 -179.562 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.8 -52.79 2.62 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.216 -0.993 . . . . 1.12 111.181 179.287 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.5 t -155.02 29.04 0.41 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.585 -1.538 . . . . 1.72 111.451 -179.032 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 56.0 t -70.18 -40.08 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.947 -1.095 . . . . 0.89 109.131 178.309 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.786 HG22 HG12 ' A' ' 159' ' ' VAL . 63.2 p -60.0 -26.53 66.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.423 -0.798 . . . . 1.03 110.621 -179.131 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 79.3 p -81.7 -20.69 38.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.921 -1.112 . . . . 1.83 110.181 -179.361 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -101.01 -9.1 21.76 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.344 -0.848 . . . . 2.27 109.967 -179.688 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.2 t -103.32 138.23 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.38 -0.825 . . . . 0.92 110.18 -179.053 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.87 155.34 26.99 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.606 -1.257 . . . . 2.2 107.606 178.938 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 55.3 t30 -59.56 139.43 57.16 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.872 -1.143 . . . . 2.36 109.738 -179.603 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.5 m-20 82.07 5.06 1.17 Allowed 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 121.144 0.497 . . . . 2.38 110.018 179.884 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 63.1 t0 -73.1 136.91 44.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 2.09 108.912 179.077 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.515 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 34.9 t80 -88.93 114.8 25.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.931 -1.105 . . . . 1.27 108.42 179.471 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.479 HD12 ' HB2' ' A' ' 16' ' ' ALA . 72.2 mt -124.67 146.15 49.28 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.52 -0.738 . . . . 0.75 110.343 -178.897 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.9 mt -112.87 128.7 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 107.741 -1.207 . . . . 0.63 107.741 178.187 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 49.5 tp -101.22 116.42 32.76 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.922 -1.111 . . . . 0.7 108.992 -179.523 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.503 ' OD2' ' ND2' ' A' ' 224' ' ' ASN . 38.5 t0 -80.7 -41.93 22.84 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.173 -1.047 . . . . 2.31 108.173 178.948 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.83 19.61 0.18 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.967 -0.753 . . . . 0.78 108.967 -179.401 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.434 ' N ' ' C ' ' A' ' 221' ' ' ASP . 47.3 t -128.61 -39.72 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.097 -1.445 . . . . 1.04 107.097 178.539 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.503 ' ND2' ' OD2' ' A' ' 221' ' ' ASP . 86.1 m-20 -108.85 4.78 23.89 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.836 -1.172 . . . . 2.44 107.836 178.072 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.826 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.5 OUTLIER 60.06 47.66 9.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.721 -0.612 . . . . 1.55 110.059 -179.884 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -140.84 140.29 34.62 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.134 -0.979 . . . . 1.99 110.252 179.889 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -118.31 120.14 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 108.533 -0.914 . . . . 0.77 108.533 179.104 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -88.57 130.02 35.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.978 -1.076 . . . . 0.98 109.366 -179.479 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.462 HG22 HD22 ' A' ' 218' ' ' LEU . 58.2 t -103.34 115.1 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.6 -0.688 . . . . 0.85 110.027 -179.056 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.6 t30 48.44 66.73 5.3 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.311 -0.868 . . . . 1.66 111.058 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -90.1 154.04 4.76 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.809 2.339 . . . . 0.95 111.687 178.851 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 232' ' ' THR . 1.8 t -77.98 168.88 19.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.03 -1.044 . . . . 1.84 110.257 -179.162 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -59.99 -38.97 84.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.696 -0.628 . . . . 2.74 111.321 -179.114 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -59.97 -39.98 87.5 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.936 -1.103 . . . . 2.89 110.137 -178.109 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.51 -39.9 79.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.089 -1.007 . . . . 1.3 109.306 179.572 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.0 mt . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 1.09 110.309 -179.617 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 55.6 ttm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -149.48 146.87 27.63 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.011 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -150.35 159.86 44.15 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.943 -1.098 . . . . 0.0 110.423 -179.101 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -158.44 154.63 27.18 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.614 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . 0.462 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 54.6 mp0 -115.15 130.77 57.01 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.074 -1.016 . . . . 0.0 109.787 179.575 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.35 126.3 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 CA-C-O 122.181 0.991 . . . . 0.0 112.297 -177.526 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 35.5 m -79.04 102.68 8.5 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.072 0.939 . . . . 0.0 110.936 -178.403 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.453 HG22 ' H ' ' B' ' 310' ' ' ALA . 96.7 mt -51.28 126.02 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 122.29 1.043 . . . . 0.0 110.742 -177.839 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 72.6 p -110.06 19.27 19.16 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.147 -179.103 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.453 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -76.71 126.28 86.12 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.902 -1.124 . . . . 0.0 108.134 178.942 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -65.7 -11.48 30.86 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 CA-C-N 120.312 1.147 . . . . 0.0 112.75 -178.866 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -119.98 10.06 11.4 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.464 -0.773 . . . . 0.0 109.589 -179.844 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.74 179.99 33.12 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -179.132 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.519 ' O ' ' NH1' ' A' ' 126' ' ' ARG . 3.2 tp -84.38 87.9 7.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.918 -1.342 . . . . 0.0 109.062 -178.801 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.438 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 3.7 p80 -90.38 -163.12 0.97 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.862 -1.149 . . . . 0.0 109.997 179.187 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.0 m -55.88 -44.64 78.32 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.186 -0.946 . . . . 0.0 112.917 -176.054 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.643 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 12.7 tpt180 -60.02 -60.0 12.04 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 120.576 -1.327 . . . . 0.0 112.087 -178.991 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.438 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 11.5 Cg_endo -59.5 -34.5 97.05 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 CA-C-N 120.634 1.262 . . . . 0.0 111.873 -179.147 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.0 75.46 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.421 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.46 -44.52 76.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.512 -0.743 . . . . 0.0 110.159 -179.221 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -70.02 -41.06 74.81 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.746 -1.221 . . . . 0.0 108.537 178.898 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -62.1 -52.88 62.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.455 -0.778 . . . . 0.0 110.151 -179.776 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 95.3 t -66.17 -25.35 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.823 -1.173 . . . . 0.0 109.974 -178.975 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -60.0 -44.51 94.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.135 -0.978 . . . . 0.0 108.574 179.948 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.18 -52.56 46.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.461 -0.774 . . . . 0.0 110.991 -179.228 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . 0.428 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -53.13 -56.89 12.77 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.618 -1.301 . . . . 0.0 111.474 -178.444 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -50.06 -16.2 0.28 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.032 -1.042 . . . . 0.0 109.359 -179.912 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . 0.428 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -81.68 -17.05 71.57 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.361 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -106.22 141.39 37.66 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.607 -0.937 . . . . 0.0 109.257 179.571 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.2 p -92.14 -14.28 29.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.905 -1.122 . . . . 0.0 110.21 -179.998 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.487 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 47.4 t -59.99 143.85 50.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.073 -1.017 . . . . 0.0 109.404 -179.78 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -66.58 137.9 57.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.424 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 93.5 mt -134.11 134.18 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.469 -0.769 . . . . 0.0 110.327 -179.149 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 99.7 m -129.07 149.62 50.81 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.798 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 74.8 t -115.63 141.47 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.325 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 59.1 m -131.61 121.94 25.2 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.155 -0.966 . . . . 0.0 109.359 179.547 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.3 t -139.2 120.22 14.55 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.086 0.946 . . . . 0.0 110.737 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 42.47 50.08 4.73 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 177.365 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.28 -14.65 57.14 Favored Glycine 0 N--CA 1.503 3.16 0 O-C-N 120.186 -1.571 . . . . 0.0 113.351 176.391 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -112.65 121.65 45.38 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 119.368 1.584 . . . . 0.0 109.906 -179.532 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 53.2 m -106.23 154.03 21.31 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.968 0.89 . . . . 0.0 111.069 -178.668 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -150.75 150.18 30.7 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.374 0.606 . . . . 0.0 109.573 179.452 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 68.0 m -87.69 135.2 33.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.334 -0.854 . . . . 0.0 110.136 -179.56 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.429 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -69.31 -20.2 63.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.075 -1.015 . . . . 0.0 108.49 179.366 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -84.29 20.44 1.63 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.841 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . 0.429 ' H ' ' C ' ' B' ' 344' ' ' ALA . 2.6 m -149.1 91.71 1.88 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.014 -179.762 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.887 HD23 HD22 ' A' ' 79' ' ' LEU . 59.5 tp -56.54 -37.55 70.67 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.383 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.806 ' CE2' HD11 ' A' ' 79' ' ' LEU . 62.3 m-85 -54.54 -50.09 68.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.354 -0.841 . . . . 0.0 111.039 -179.273 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' B' ' 350' ' ' LEU . 35.1 mtmm -69.97 -39.89 75.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.675 -1.265 . . . . 0.0 110.645 -178.525 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' B' ' 352' ' ' THR . 96.7 mt -46.63 -56.8 5.53 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.979 -1.076 . . . . 0.0 108.879 -179.494 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.872 HE22 ' HE ' ' A' ' 126' ' ' ARG . 56.9 mm-40 -39.49 -26.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.847 -0.533 . . . . 0.0 111.208 -178.571 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.445 ' N ' ' O ' ' B' ' 350' ' ' LEU . 67.8 p -79.3 -11.15 59.94 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.498 -1.376 . . . . 0.0 110.56 -178.078 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 24.3 mt -96.34 120.01 35.86 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.922 -1.111 . . . . 0.0 109.54 178.72 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.35 92.1 1.06 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.135 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.2 mt -98.41 92.01 5.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.301 -1.117 . . . . 0.0 109.331 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 70.1 p -92.89 175.79 6.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.133 -0.979 . . . . 0.0 111.352 -178.516 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -65.22 110.82 2.7 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.447 -179.543 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 102.65 12.93 31.38 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.688 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 50.1 m -88.36 110.09 20.51 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -1.137 . . . . 0.0 111.343 -179.092 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 31.0 t -77.45 113.83 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 122.119 0.962 . . . . 0.0 109.826 -177.752 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.5 m -109.78 176.6 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -177.875 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 29.8 m -131.58 127.57 37.41 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.477 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.0 mt -104.21 115.86 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.435 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 50.2 p -120.37 133.35 55.46 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.513 -0.742 . . . . 0.0 109.042 -179.664 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.61 150.05 36.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.114 -0.991 . . . . 0.0 110.086 -179.024 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -139.29 120.5 14.77 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.65 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.574 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 165.04 -167.07 38.53 Favored Glycine 0 N--CA 1.485 1.909 0 C-N-CA 119.119 -1.515 . . . . 0.0 111.117 -179.492 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -58.09 -47.03 84.47 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.359 -0.495 . . . . 0.0 111.707 -177.785 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.487 ' H ' ' HB2' ' B' ' 331' ' ' SER . 2.7 p30 -107.98 10.46 28.35 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.878 -1.139 . . . . 0.0 111.373 -177.681 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -43.92 -32.02 1.01 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.408 -0.808 . . . . 0.0 110.963 -178.96 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -69.46 -45.16 69.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.137 -0.977 . . . . 0.0 110.045 -178.481 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -67.5 -47.98 68.41 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.176 -0.953 . . . . 0.0 108.847 -179.632 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.15 -78.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.399 -0.813 . . . . 0.0 110.67 -179.471 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.583 ' O ' HG23 ' B' ' 378' ' ' VAL . 38.7 t -46.34 -35.75 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.042 -1.036 . . . . 0.0 110.633 -177.458 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -64.9 -49.84 68.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.528 -1.357 . . . . 0.0 110.591 -179.963 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -80.49 -41.78 23.69 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.956 -1.09 . . . . 0.0 110.493 -179.667 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 97.0 mt -59.94 -37.19 78.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 109.08 -179.133 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.583 HG23 ' O ' ' B' ' 374' ' ' VAL . 50.2 t -65.46 -40.04 87.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.312 -0.867 . . . . 0.0 109.574 179.265 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -69.71 -57.03 5.63 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.772 -1.205 . . . . 0.0 108.408 179.213 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 57.3 tp -55.17 -26.73 40.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 0.0 110.403 -178.216 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 33.7 ttm -74.72 -38.13 62.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.691 -1.256 . . . . 0.0 109.027 177.857 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.89 -4.41 58.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.512 -0.742 . . . . 0.0 110.509 179.588 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -110.48 -6.66 14.87 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.122 -0.986 . . . . 0.0 111.245 -178.739 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.6 mt -78.56 132.37 37.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.3 -1.5 . . . . 0.0 109.029 179.141 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.366 -179.705 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.2 mmm . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.332 -0.618 . . . . 2.91 109.332 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.0 mt -111.13 126.99 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.578 -0.701 . . . . 1.2 109.828 179.809 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.8 m -140.51 150.18 43.42 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.371 -0.83 . . . . 1.4 109.778 -179.832 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.417 ' H ' ' CG ' ' A' ' 225' ' ' ASN . . . -138.7 -163.81 9.68 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.858 -1.697 . . . . 1.05 108.858 179.274 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 6' ' ' LEU . 97.4 mt -93.3 -16.82 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.95 -1.324 . . . . 1.15 110.125 -179.118 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.1 tp 54.55 105.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.397 -0.815 . . . . 0.98 109.407 179.906 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.31 -35.25 11.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.561 -0.903 . . . . 0.88 108.561 179.064 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 7.6 m -129.26 129.28 23.29 Favored Pre-proline 0 N--CA 1.502 2.136 0 N-CA-C 109.362 -0.607 . . . . 1.69 109.362 179.848 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.15 146.1 15.69 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.272 1.981 . . . . 0.85 112.807 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.807 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 160.53 -160.35 31.74 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 109.827 -1.309 . . . . 0.92 109.827 179.594 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.0 mt -149.98 149.64 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.268 -1.136 . . . . 0.81 108.195 179.215 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.04 149.82 25.07 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.568 -1.333 . . . . 0.51 111.128 179.628 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 4.0 m-85 -131.06 129.79 42.4 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 108.917 -0.771 . . . . 0.62 108.917 179.23 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.93 -173.79 46.03 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 118.509 -1.805 . . . . 0.55 110.948 179.3 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -82.55 155.46 24.49 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.949 -0.736 . . . . 2.1 110.026 -179.513 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.578 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -102.35 129.51 48.82 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.383 -0.823 . . . . 0.77 110.853 -179.532 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.3 tp -99.38 133.52 43.58 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.109 -1.441 . . . . 0.91 107.109 178.412 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.4 tp -118.72 125.41 49.6 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.235 -0.916 . . . . 0.93 109.652 -179.697 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.56 HD21 HD21 ' A' ' 149' ' ' LEU . 85.5 mt -87.36 103.73 15.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.583 -0.698 . . . . 0.93 109.578 179.627 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.98 132.15 43.79 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.557 -0.905 . . . . 2.75 108.557 179.367 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -131.26 130.32 42.71 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.972 -1.08 . . . . 3.0 109.003 179.03 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -79.46 154.1 29.16 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.166 -0.959 . . . . 2.77 108.777 179.448 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -67.74 141.18 56.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.043 -1.035 . . . . 2.94 109.838 -179.915 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.4 mt -79.44 135.45 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.241 -1.022 . . . . 0.95 108.241 179.532 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.1 t -103.39 124.33 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.175 -0.953 . . . . 1.28 109.998 -179.294 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.9 mt -99.03 140.77 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.849 -0.797 . . . . 1.21 108.849 179.803 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -92.15 121.39 33.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.063 -1.023 . . . . 1.81 109.359 -179.699 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -94.86 5.47 51.8 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.495 -0.928 . . . . 2.8 108.495 179.701 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -65.78 142.13 58.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.484 -0.76 . . . . 2.87 109.52 -179.783 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -88.53 140.32 29.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.226 -0.921 . . . . 2.35 109.119 -179.906 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.517 HG21 ' HG3' ' A' ' 39' ' ' GLU . 3.3 pt -94.39 164.43 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.885 -1.134 . . . . 0.97 109.746 -179.819 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.0 p -95.42 169.86 9.76 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.412 -0.958 . . . . 1.17 108.412 178.918 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.34 -13.24 49.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.952 -1.092 . . . . 1.18 110.085 -179.769 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -88.59 -30.33 19.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.868 -1.145 . . . . 2.56 108.977 179.576 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -82.64 -7.73 59.63 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.758 -0.83 . . . . 1.79 108.758 179.556 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 t -59.98 -51.96 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.24 -0.913 . . . . 1.0 108.832 179.613 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -60.01 -39.03 84.38 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.29 -0.882 . . . . 1.77 109.292 179.612 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -67.26 -41.8 84.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.053 -1.029 . . . . 2.7 110.915 -178.816 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.517 ' HG3' HG21 ' A' ' 31' ' ' ILE . 63.2 mm-40 -64.47 -40.08 95.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.597 -1.315 . . . . 1.51 110.181 -179.435 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.13 -47.02 93.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 120.622 -1.299 . . . . 0.93 108.449 179.242 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -59.89 -40.16 87.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 1.81 109.538 -179.777 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -60.02 -43.34 95.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.749 -1.219 . . . . 2.78 108.268 178.523 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.424 ' CE1' HD13 ' A' ' 89' ' ' ILE . 69.5 t80 -60.13 -49.31 78.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.344 -0.848 . . . . 0.78 108.907 178.59 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 21.0 tp -59.98 -49.04 79.23 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.762 -0.586 . . . . 1.07 109.453 -179.825 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 22.2 t -63.27 -46.13 88.24 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.43 -0.908 . . . . 1.12 109.033 179.121 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.19 -48.1 87.61 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.415 -1.874 . . . . 0.84 108.415 179.443 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 -60.61 -38.1 83.58 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.302 -0.999 . . . . 3.09 108.302 178.689 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -50.35 -42.16 52.61 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.382 -0.599 . . . . 0.88 109.382 -179.527 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.434 ' O ' ' C ' ' A' ' 50' ' ' ALA . 19.8 ttmt -66.99 -73.73 0.13 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.869 -1.16 . . . . 2.59 107.869 178.952 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.31 -39.91 0.48 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.516 -0.74 . . . . 0.7 111.01 -178.825 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.8 t -51.77 -61.72 2.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.769 -1.207 . . . . 1.4 109.368 179.797 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.87 82.94 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.391 -0.818 . . . . 0.67 111.41 -178.56 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -62.73 -40.69 97.99 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.854 -1.154 . . . . 1.66 110.063 -178.716 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.41 -40.05 95.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.113 -0.992 . . . . 1.58 109.695 -179.839 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -62.2 -37.64 86.09 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.341 -0.85 . . . . 1.35 109.285 -179.773 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.6 m -65.15 -42.7 93.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.77 109.174 -179.918 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.26 -39.91 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.21 -0.931 . . . . 0.63 109.334 179.876 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -58.87 -49.95 75.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.166 -0.959 . . . . 1.14 109.958 -179.06 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.8 m -56.65 -35.63 68.6 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.021 -1.049 . . . . 0.79 110.018 -178.198 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -65.7 -37.05 85.38 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.199 -0.938 . . . . 1.53 108.896 -179.844 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.433 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.87 -49.03 64.37 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.349 0.595 . . . . 0.57 110.215 179.82 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.97 -51.83 54.89 Favored Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.837 -1.173 . . . . 0.75 110.319 -178.937 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -70.13 -40.74 74.64 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.167 -1.196 . . . . 1.59 110.322 -179.44 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.9 m -69.95 -61.39 1.8 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.028 -1.045 . . . . 0.73 112.38 -177.532 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -93.74 -47.52 6.74 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.831 -1.168 . . . . 0.75 111.036 -177.752 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.73 -168.72 25.48 Favored Glycine 0 N--CA 1.5 2.934 0 C-N-CA 119.848 -1.167 . . . . 1.22 111.238 179.612 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -68.6 -26.41 65.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.824 -0.81 . . . . 5.81 110.359 -179.586 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -60.54 -35.22 75.49 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.331 -0.855 . . . . 3.37 110.484 -179.598 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -96.07 -19.07 19.71 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.105 -0.997 . . . . 1.77 110.117 -179.743 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -69.27 -40.94 77.5 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.704 -1.248 . . . . 1.65 109.665 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.566 ' CB ' HH11 ' B' ' 317' ' ' ARG . . . -67.07 -36.46 82.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.44 -0.788 . . . . 0.77 110.67 -178.597 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 77.2 mt -60.69 -43.66 95.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.697 -1.252 . . . . 0.8 109.006 179.643 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 10.8 m-85 -70.29 -33.31 71.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 0.88 109.581 179.776 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -63.98 -40.03 95.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.023 -1.048 . . . . 1.37 109.731 179.475 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.29 -39.86 91.99 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.013 -1.635 . . . . 0.62 109.013 179.426 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -60.19 -48.85 80.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.431 -1.041 . . . . 1.5 109.38 -179.908 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -66.52 -45.28 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 0.63 109.764 179.929 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.1 ttp -60.35 -40.16 89.75 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.099 -1.001 . . . . 1.51 109.27 -178.918 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.874 HD11 ' CE2' ' B' ' 348' ' ' PHE . 25.1 tp -61.13 -35.9 78.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.77 108.689 178.709 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.8 tp -67.96 -30.26 69.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.496 -0.753 . . . . 0.62 109.514 179.968 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -83.43 4.64 26.77 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.21 -0.932 . . . . 1.47 110.336 -179.483 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 57.1 t0 -56.83 130.57 46.26 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.974 -1.079 . . . . 1.47 111.212 -178.651 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.423 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 47.7 mt-10 -61.07 -18.59 58.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.929 -0.482 . . . . 1.78 111.179 -179.223 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -72.71 -34.33 67.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.625 -1.297 . . . . 2.53 108.813 178.877 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.1 mt -69.77 -43.1 72.87 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.353 0.597 . . . . 0.8 111.002 -179.252 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -62.74 -42.06 99.48 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.348 -0.845 . . . . 1.42 111.17 -178.032 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -70.12 -42.58 72.44 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.833 -1.167 . . . . 1.71 111.619 -178.289 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -68.16 -38.29 81.93 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.196 -0.94 . . . . 1.57 111.855 -177.87 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.424 HD13 ' CE1' ' A' ' 43' ' ' PHE . 96.8 mt -66.53 -42.29 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.67 -1.269 . . . . 0.65 109.445 -179.759 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.3 mt -70.04 -39.93 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 0.82 110.616 179.606 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.95 -43.06 96.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.25 -0.906 . . . . 0.79 111.748 -178.104 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.3 mt -63.68 -46.56 84.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.585 -1.322 . . . . 0.95 109.632 -179.357 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -59.84 -49.53 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 122.038 0.923 . . . . 0.66 109.434 179.531 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -70.04 -40.23 75.28 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 120.079 -0.649 . . . . 2.2 111.099 -179.635 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -81.86 -55.79 4.38 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.753 -1.217 . . . . 1.65 112.278 -178.346 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -90.04 -1.26 57.93 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.91 -1.119 . . . . 2.03 112.425 -177.03 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 59.57 40.07 20.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.842 -1.162 . . . . 1.42 110.082 179.377 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 79.1 mtp -95.27 167.21 11.49 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.31 -0.868 . . . . 1.18 109.656 -179.72 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 56.6 p -81.5 160.15 24.01 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.276 -0.89 . . . . 0.98 109.04 179.635 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.82 -39.79 94.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.895 . . . . 0.64 110.268 -179.639 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -69.3 -33.42 73.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.027 -1.046 . . . . 2.07 109.278 -179.619 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.73 -41.06 24.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -0.963 . . . . 0.73 109.377 179.442 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.47 -45.7 61.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.311 -0.868 . . . . 0.54 110.197 -179.813 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.37 -33.4 75.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.125 -0.985 . . . . 0.56 109.355 179.979 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -59.82 -44.94 93.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.568 -0.707 . . . . 1.54 109.958 -179.822 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -60.19 -40.29 89.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 1.33 110.966 -179.2 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.04 -65.95 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.239 -0.913 . . . . 0.72 112.38 -177.413 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.407 HG21 ' CA ' ' A' ' 134' ' ' GLY . 43.2 mm -68.78 -41.0 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.788 -1.195 . . . . 0.85 110.236 -178.446 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -67.79 -31.57 71.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.213 -0.93 . . . . 2.44 108.651 179.731 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.8 -46.61 66.32 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.917 -1.273 . . . . 0.98 109.917 -179.761 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -60.29 -50.33 74.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.929 -1.336 . . . . 1.41 110.048 -179.292 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.89 -36.08 74.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.371 -0.831 . . . . 1.2 109.84 179.839 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.2 t -59.72 -42.39 92.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.955 -1.091 . . . . 1.7 108.518 -179.893 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.4 94.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -0.838 . . . . 1.47 109.024 179.249 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.5 mt -62.07 -41.22 97.93 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.407 -0.808 . . . . 1.56 109.617 -179.495 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.93 -31.91 67.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.069 -1.019 . . . . 2.2 109.657 -179.387 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -60.16 -26.22 66.14 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.212 -0.93 . . . . 2.12 108.947 179.684 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.402 HD13 HD13 ' A' ' 123' ' ' LEU . 31.6 mt -61.72 144.8 54.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.142 -0.974 . . . . 2.0 108.913 -179.56 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -98.36 51.59 1.01 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.027 -1.046 . . . . 3.23 109.538 179.668 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 61.7 t0 -134.27 132.83 40.09 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.445 -0.784 . . . . 2.49 109.321 179.89 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.404 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 83.9 tt0 -69.95 -31.94 69.94 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.475 -0.766 . . . . 3.95 109.865 -179.836 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.454 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.3 t80 -70.09 -36.88 75.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.535 -0.728 . . . . 2.0 111.075 -179.679 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.464 HD22 ' O ' ' B' ' 351' ' ' GLN . 79.7 mt -78.56 -37.81 41.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.047 -1.033 . . . . 1.86 109.701 -179.703 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -60.14 -48.99 79.39 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.109 -0.994 . . . . 2.84 109.957 179.849 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.76 -39.78 92.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.085 -1.009 . . . . 2.73 109.091 179.956 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.619 HH21 HD11 ' B' ' 347' ' ' LEU . 65.8 ttt180 -60.13 -40.04 88.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 2.77 108.711 179.824 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' VAL . . . -59.54 -47.93 83.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.932 -1.105 . . . . 1.19 108.543 179.496 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 127' ' ' ALA . . . -43.65 -39.12 3.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.669 -0.645 . . . . 1.2 109.299 179.89 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -66.11 -42.72 88.83 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.213 -0.93 . . . . 1.55 108.604 179.197 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 127' ' ' ALA . 55.4 t -69.9 -40.32 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.34 -0.85 . . . . 0.8 108.926 178.776 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -59.97 -39.13 84.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.378 -0.826 . . . . 3.09 109.033 179.25 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -59.98 -39.8 86.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.516 -0.74 . . . . 1.46 110.377 -179.559 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.8 mt -59.64 -41.25 84.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.907 -1.121 . . . . 0.71 108.98 -179.234 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.407 ' CA ' HG21 ' A' ' 108' ' ' ILE . . . -67.24 -37.65 91.19 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.931 -1.267 . . . . 0.57 109.931 179.516 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.63 -49.02 78.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.181 -1.188 . . . . 2.59 111.027 -178.872 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -66.62 -29.48 69.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.897 -1.127 . . . . 2.83 109.423 -179.445 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.8 tp -59.59 -41.76 90.99 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.72 -0.844 . . . . 1.25 108.72 -178.967 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.36 -39.9 94.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 0.7 108.55 179.226 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -68.75 -39.6 80.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.361 -0.837 . . . . 2.57 109.329 178.704 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -65.65 -34.46 78.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.452 -0.78 . . . . 1.23 110.84 -179.42 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 91.1 mt -70.44 -42.6 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 120.737 -1.227 . . . . 0.81 108.092 179.071 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.36 -33.74 71.8 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.118 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.24 43.63 5.55 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 108.129 -1.988 . . . . 0.89 108.129 -178.901 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.4 tp -75.15 150.84 38.63 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.644 -0.915 . . . . 1.14 110.263 -178.866 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.435 ' HD3' ' N ' ' A' ' 146' ' ' ILE . 9.6 tmtm? -69.61 149.31 48.28 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.722 -0.844 . . . . 4.6 108.722 179.464 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.435 ' N ' ' HD3' ' A' ' 145' ' ' LYS . 86.8 mt -119.81 125.14 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 121.933 0.873 . . . . 1.24 109.036 178.881 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.445 HG12 ' H ' ' A' ' 147' ' ' ILE . 6.3 mm -49.42 -54.76 5.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.624 -0.673 . . . . 1.54 109.762 -178.485 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.8 t0 69.39 104.23 0.06 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.547 -0.72 . . . . 1.5 110.59 -179.903 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.562 ' O ' HD12 ' A' ' 152' ' ' ILE . 95.9 mt -74.44 -7.18 52.11 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.524 -0.735 . . . . 0.79 109.977 179.84 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.0 t -81.45 -16.83 50.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.148 -0.97 . . . . 1.4 109.485 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.16 23.43 0.58 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.533 -0.729 . . . . 0.92 110.196 -178.543 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 149' ' ' LEU . 63.9 mt -92.2 115.24 30.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.133 -0.979 . . . . 0.88 109.738 -179.085 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -100.66 -15.24 17.81 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.251 -0.906 . . . . 2.45 109.63 -179.83 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -118.19 145.86 44.64 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.498 -0.556 . . . . 1.52 109.498 -178.988 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.08 136.48 57.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 1.58 109.346 -179.739 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 26.9 m -151.6 163.3 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 109.328 -0.619 . . . . 0.69 109.328 179.99 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 82.3 mt -91.78 146.71 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 106.177 -1.786 . . . . 0.61 106.177 177.266 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.2 tp -99.01 118.96 36.96 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.022 -1.049 . . . . 0.87 110.423 -178.194 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.5 t -123.31 129.98 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.489 -0.93 . . . . 0.71 108.489 179.727 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.0 159.37 40.28 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.136 -0.977 . . . . 0.81 108.551 -179.839 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.45 -33.43 64.9 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.23 -1.544 . . . . 0.98 107.932 178.523 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -168.3 136.87 2.29 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.329 -0.989 . . . . 2.25 108.329 179.959 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 62.9 mt -106.8 138.68 42.53 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.247 -0.908 . . . . 0.78 109.565 -179.496 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.9 p -94.05 153.56 40.77 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.47 -0.769 . . . . 0.98 109.02 -179.838 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.04 -34.84 9.61 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.635 1.557 . . . . 0.81 111.952 179.222 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.1 m -58.65 -40.25 82.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.9 110.305 -178.306 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -68.04 -42.58 80.33 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.282 -0.886 . . . . 1.61 110.716 -179.302 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.5 p -53.88 -31.74 50.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.047 -1.033 . . . . 0.61 110.546 -178.264 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . . . -72.52 -54.58 8.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.951 -1.093 . . . . 0.6 109.682 179.689 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -85.4 40.74 0.85 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.999 -1.112 . . . . 1.4 107.999 179.81 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.84 133.0 47.3 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.888 -0.782 . . . . 0.7 108.888 179.083 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -89.69 102.14 14.83 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.334 -0.987 . . . . 2.35 108.334 179.348 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.94 -44.78 88.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.461 -0.775 . . . . 1.51 110.908 -178.294 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -70.18 -22.61 62.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.868 -1.145 . . . . 2.33 111.88 -178.337 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -93.56 -10.37 34.98 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.55 -1.344 . . . . 1.92 110.274 -178.465 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 178' ' ' GLY . 94.3 t -106.76 117.22 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.232 -0.918 . . . . 0.67 109.274 179.568 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 51.4 mt -83.55 4.31 28.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.43 -0.794 . . . . 1.53 110.985 -177.817 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.557 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.72 172.12 36.71 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.561 -1.416 . . . . 0.48 109.561 -179.806 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.51 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 25.3 m-85 -132.56 129.15 38.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.508 -0.995 . . . . 0.55 108.75 179.901 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.0 mt -129.98 126.05 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.687 -1.227 . . . . 0.65 107.687 178.426 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.4 p -143.51 157.37 44.49 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.379 1.085 . . . . 0.82 111.397 -179.007 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 64.4 t0 -94.61 18.06 12.16 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.783 -0.644 . . . . 2.46 109.265 179.878 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -54.3 -164.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.529 -1.357 . . . . 1.28 111.701 -178.025 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.37 -42.39 5.53 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.607 -0.806 . . . . 2.19 111.306 -178.395 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 175.83 -149.77 10.26 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 118.429 -1.843 . . . . 2.13 111.242 -179.539 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.428 ' N ' ' CD ' ' A' ' 186' ' ' ARG . 0.2 OUTLIER -70.11 -18.3 63.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.813 -0.816 . . . . 5.86 110.558 -178.956 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 82.5 p -69.97 -1.82 10.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.02 -1.05 . . . . 3.72 110.003 -179.177 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.3 m -84.92 130.72 34.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 1.74 110.419 -179.157 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -44.93 -55.38 5.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.524 -0.735 . . . . 0.95 110.224 -179.748 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 191' ' ' SER . 8.8 t -58.07 -39.67 79.1 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.411 -0.806 . . . . 1.55 110.721 -178.992 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.427 ' N ' HG23 ' A' ' 190' ' ' THR . 23.3 t -61.55 -40.53 95.03 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.953 -1.092 . . . . 1.51 110.797 -179.298 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.88 -40.01 81.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.235 -0.915 . . . . 1.67 109.614 -179.521 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.2 -40.22 89.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.856 . . . . 1.02 110.197 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.53 88.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.455 -1.403 . . . . 0.68 109.12 -179.735 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -59.92 -50.18 74.77 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.073 -1.051 . . . . 2.93 109.396 -179.297 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 37.1 m -70.41 -35.42 73.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.158 -0.964 . . . . 0.86 110.98 -178.989 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 74.1 mt -70.27 -24.74 63.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.922 -1.111 . . . . 0.67 109.185 179.996 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 66.45 49.89 1.34 Allowed 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.273 0.559 . . . . 1.5 110.828 -179.323 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . 0.4 ' O ' ' CB ' ' A' ' 8' ' ' SER . 78.6 mt -127.23 149.71 70.37 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 107.504 -1.295 . . . . 0.72 107.504 178.18 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.97 139.12 71.91 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.17 1.914 . . . . 0.61 112.091 -179.7 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.51 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -170.17 147.23 3.12 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.955 -1.091 . . . . 0.66 110.995 -179.749 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 90.5 mt -120.04 139.1 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 106.842 -1.54 . . . . 0.79 106.842 178.223 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.05 -12.22 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 120.602 -1.311 . . . . 0.91 111.427 -178.238 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.74 26.13 16.92 Favored Glycine 0 N--CA 1.502 3.052 0 N-CA-C 110.898 -0.881 . . . . 1.01 110.898 -179.121 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.8 p -44.25 -38.36 3.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.972 -1.311 . . . . 0.99 110.573 -179.179 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.455 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 88.09 -50.47 3.9 Favored Glycine 0 N--CA 1.502 3.064 0 C-N-CA 120.201 -1.0 . . . . 1.12 111.302 179.337 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.2 m -162.67 41.48 0.12 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.491 -1.594 . . . . 1.72 111.157 -179.381 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.5 t -80.24 -37.81 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.988 -1.07 . . . . 0.89 109.085 178.42 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.5 p -58.92 -33.09 70.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.571 -0.706 . . . . 1.03 110.048 -178.862 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.1 m -76.59 -18.42 58.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.332 -0.855 . . . . 1.83 110.157 -178.977 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -102.84 -9.66 19.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.324 -0.86 . . . . 2.27 110.241 -179.144 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 55.2 t -102.01 140.32 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.003 -1.061 . . . . 0.92 110.545 -179.122 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -109.29 150.07 28.52 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.704 -1.221 . . . . 2.2 107.704 178.988 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 19.2 p30 -60.61 138.89 58.0 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.86 -1.15 . . . . 2.36 109.947 -179.52 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.481 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.5 t0 81.17 9.61 0.98 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.303 0.573 . . . . 2.38 109.615 179.466 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.2 t0 -79.06 141.78 37.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.377 -0.827 . . . . 2.09 108.936 179.11 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.519 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 47.3 t80 -88.0 121.75 30.78 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.152 -0.967 . . . . 1.27 108.873 -179.992 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' A' ' 16' ' ' ALA . 85.9 mt -130.01 150.19 51.4 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.37 -0.832 . . . . 0.75 110.886 -179.021 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.49 HG23 ' CD2' ' A' ' 13' ' ' PHE . 73.1 mt -117.4 128.73 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.379 -1.711 . . . . 0.63 106.379 176.951 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 44.1 tp -101.05 116.65 33.35 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.977 -1.077 . . . . 0.7 109.438 -178.731 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.511 ' C ' ' H ' ' A' ' 223' ' ' VAL . 85.9 m-20 -74.45 -44.8 50.02 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.447 -0.946 . . . . 2.31 108.447 179.092 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 50.92 11.41 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.808 -0.812 . . . . 0.78 108.808 -179.656 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 221' ' ' ASP . 54.7 t -126.95 -43.11 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 106.859 -1.534 . . . . 1.04 106.859 178.702 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -100.42 -0.01 38.94 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.728 -1.212 . . . . 2.44 107.728 178.611 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.417 ' CG ' ' H ' ' A' ' 4' ' ' GLY . 6.1 t-20 60.56 42.0 14.74 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.3 -0.63 . . . . 1.55 109.3 -179.442 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -138.14 142.9 40.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.287 -0.883 . . . . 1.99 109.238 179.735 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 80.3 t -118.57 120.87 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 108.925 -0.769 . . . . 0.77 108.925 179.57 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -88.69 128.94 35.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.153 -0.967 . . . . 0.98 109.351 -179.438 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.45 114.06 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.735 -0.603 . . . . 0.85 110.244 -179.111 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 45.4 t30 50.97 63.75 9.3 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.33 -0.856 . . . . 1.66 111.509 179.064 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -85.83 148.39 9.58 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.38 2.053 . . . . 0.95 112.103 178.958 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 233' ' ' ASN . 39.5 m -67.98 158.17 33.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.288 -0.883 . . . . 1.84 110.077 -179.473 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 47.7 p-10 -59.97 -37.9 80.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.312 -0.867 . . . . 2.74 110.679 -178.991 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . 0.544 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 99.0 mt-10 -59.82 -37.03 78.04 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.791 -1.193 . . . . 2.89 107.859 -179.998 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.9 t -70.04 -39.9 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.546 -0.721 . . . . 1.3 109.45 179.095 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.1 mt . . . . . 0 N--CA 1.496 1.865 0 O-C-N 121.109 -0.994 . . . . 1.09 108.966 179.533 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . 0.405 ' HG2' ' N ' ' B' ' 302' ' ' PHE . 57.1 ttm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . 0.405 ' N ' ' HG2' ' B' ' 301' ' ' MET . 41.4 t80 -149.05 147.71 28.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -0.922 . . . . 0.0 108.962 179.501 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -150.86 160.06 44.14 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.98 -1.075 . . . . 0.0 111.124 -178.366 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -154.66 152.48 30.02 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.566 -0.708 . . . . 0.0 109.199 178.861 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . 0.428 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 58.1 mp0 -113.89 131.01 56.44 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.311 -0.868 . . . . 0.0 110.266 179.842 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.0 p -131.95 126.78 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 CA-C-O 122.522 1.153 . . . . 0.0 112.995 -177.899 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 32.2 m -79.27 102.43 8.58 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 122.023 0.916 . . . . 0.0 110.772 -178.724 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.5 mt -51.37 125.0 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 122.552 1.168 . . . . 0.0 110.853 -177.878 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 33.2 p -109.73 20.09 18.45 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.602 -179.249 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.434 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -67.47 149.11 98.52 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.11 -0.994 . . . . 0.0 108.582 179.366 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . 0.449 ' CD ' ' O ' ' B' ' 385' ' ' GLU . 28.9 Cg_endo -72.28 -30.38 12.99 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.112 1.208 . . . . 0.0 113.138 -179.622 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -120.26 23.16 11.07 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.778 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.59 -177.58 52.74 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.266 -1.933 . . . . 0.0 108.266 -179.028 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.454 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -84.38 93.32 8.24 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.96 -1.317 . . . . 0.0 109.484 -179.013 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -98.01 -159.52 0.74 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.044 -1.035 . . . . 0.0 109.536 178.971 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.5 m -60.06 -49.97 75.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.559 -1.338 . . . . 0.0 112.16 -176.459 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.566 HH11 ' CB ' ' A' ' 71' ' ' ALA . 11.9 tpt180 -47.35 -60.31 4.24 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.653 -1.279 . . . . 0.0 111.133 -179.104 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -61.56 -31.35 87.2 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 CA-C-N 120.559 1.235 . . . . 0.0 111.02 179.022 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.02 -53.79 53.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.399 -0.813 . . . . 0.0 109.485 -179.737 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.86 -42.67 62.8 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.074 -178.951 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.79 -39.94 76.29 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.024 -1.047 . . . . 0.0 108.784 179.243 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -65.71 -55.75 15.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 109.936 -179.485 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . 0.458 ' CG1' ' NZ ' ' B' ' 327' ' ' LYS . 41.3 t -64.13 -30.95 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.585 -1.322 . . . . 0.0 110.278 -178.704 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -60.44 -46.29 90.57 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.994 -1.066 . . . . 0.0 109.763 179.9 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -61.89 -44.35 96.97 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.326 -0.859 . . . . 0.0 111.072 -178.569 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -66.03 -52.17 51.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.988 -1.07 . . . . 0.0 111.691 -178.412 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . 0.458 ' NZ ' ' CG1' ' B' ' 323' ' ' VAL . 32.2 mttp -49.29 -18.07 0.32 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.007 -1.058 . . . . 0.0 110.744 -178.789 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -80.13 -16.57 76.31 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 178.882 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -104.02 136.72 43.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.693 -0.886 . . . . 0.0 109.532 179.825 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 76.8 p -91.49 -13.42 32.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.398 -0.814 . . . . 0.0 109.939 179.727 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.589 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 69.3 m -60.94 150.25 33.89 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.268 -0.895 . . . . 0.0 109.848 -179.982 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -69.33 136.21 51.48 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.682 179.389 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 80.7 mt -133.63 132.43 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.315 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 81.5 m -130.34 151.15 51.15 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.296 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 67.3 t -115.73 142.07 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.535 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 50.5 m -130.84 122.86 27.84 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.264 -0.897 . . . . 0.0 109.662 179.37 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . 0.4 ' O ' ' OD1' ' B' ' 338' ' ' ASN . 2.6 t -137.16 118.63 14.78 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.031 0.919 . . . . 0.0 109.698 179.536 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' B' ' 338' ' ' ASN . 8.2 p-10 38.0 62.97 0.87 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.079 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 77.25 -14.18 8.91 Favored Glycine 0 N--CA 1.503 3.143 0 O-C-N 120.83 -1.169 . . . . 0.0 113.521 175.873 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -110.29 121.72 45.96 Favored 'General case' 0 N--CA 1.507 2.376 0 CA-C-N 119.056 1.428 . . . . 0.0 110.277 -179.733 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 83.3 p -109.06 157.65 18.5 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.774 0.797 . . . . 0.0 110.924 -179.082 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -152.54 151.93 31.27 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.821 -0.549 . . . . 0.0 109.925 179.58 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 16.1 m -87.64 136.21 33.04 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.303 -0.873 . . . . 0.0 109.61 -179.96 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -76.91 -14.67 59.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.951 -1.093 . . . . 0.0 110.095 -179.445 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -88.77 20.79 3.31 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 178.441 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . 0.412 ' H ' ' C ' ' B' ' 344' ' ' ALA . 74.0 m -147.36 91.4 1.97 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.727 179.797 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.665 HD23 HD22 ' A' ' 79' ' ' LEU . 57.8 tp -57.04 -35.28 69.12 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.584 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.874 ' CE2' HD11 ' A' ' 79' ' ' LEU . 70.8 m-85 -56.18 -53.95 51.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.922 . . . . 0.0 109.88 179.787 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -70.17 -21.31 63.07 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.577 -0.702 . . . . 0.0 111.045 -177.64 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' B' ' 352' ' ' THR . 77.9 mt -67.48 -50.82 57.31 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 118.314 -1.354 . . . . 0.0 108.648 178.526 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.464 ' O ' HD22 ' A' ' 123' ' ' LEU . 17.5 mt-30 -46.07 -12.83 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.424 -0.798 . . . . 0.0 111.47 -177.741 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.487 ' N ' ' O ' ' B' ' 350' ' ' LEU . 67.3 p -85.73 -16.51 38.71 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 119.912 -1.743 . . . . 0.0 111.466 -178.509 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 29.4 mt -92.05 122.23 34.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.737 -1.227 . . . . 0.0 108.834 178.707 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.99 92.52 0.93 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 179.423 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 16.7 mt -101.26 93.72 5.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.417 -1.049 . . . . 0.0 108.755 179.949 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 71.0 p -92.79 177.05 6.21 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.939 -1.101 . . . . 0.0 111.316 -178.844 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . 0.409 ' CD ' ' O ' ' B' ' 310' ' ' ALA . 40.0 tt0 -65.49 113.23 4.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.81 -0.556 . . . . 0.0 110.787 -179.703 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 99.18 9.63 50.9 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.419 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 24.0 m -85.88 113.1 21.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.335 -1.097 . . . . 0.0 110.313 -179.79 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 11.0 t -78.07 114.45 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 122.307 1.051 . . . . 0.0 109.961 -177.073 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 14.0 m -110.49 177.16 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.91 -177.856 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 40.8 m -130.98 126.89 37.21 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.232 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 83.7 mt -103.63 118.03 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.487 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 49.0 m -122.93 133.65 54.38 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.552 -0.717 . . . . 0.0 109.249 -178.88 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.49 151.61 38.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.095 -1.003 . . . . 0.0 110.496 -178.738 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -140.64 120.72 13.73 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.414 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.412 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 164.08 -164.55 36.62 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 118.57 -1.776 . . . . 0.0 111.778 179.455 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -56.53 -50.03 73.02 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.939 -0.631 . . . . 0.0 111.743 -177.889 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.589 ' N ' ' OG ' ' B' ' 331' ' ' SER . 99.6 m-20 -109.87 11.8 24.11 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.033 -1.042 . . . . 0.0 111.574 -177.857 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 11.8 pt-20 -42.23 -31.96 0.44 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.946 -1.096 . . . . 0.0 111.212 -178.877 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -70.06 -43.04 72.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.816 -1.178 . . . . 0.0 110.347 -178.81 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -67.7 -47.97 67.89 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.78 -1.2 . . . . 0.0 108.666 -179.905 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.44 -77.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 110.113 -179.914 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.582 ' O ' HG23 ' B' ' 378' ' ' VAL . 51.2 t -45.18 -38.79 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.213 -0.93 . . . . 0.0 109.751 -178.19 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -67.63 -42.44 82.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.65 -1.281 . . . . 0.0 110.099 179.221 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -82.18 -45.41 15.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.121 -0.987 . . . . 0.0 110.481 -179.83 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 97.8 mt -59.91 -36.51 77.15 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.11 -0.994 . . . . 0.0 109.303 -179.054 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.582 HG23 ' O ' ' B' ' 374' ' ' VAL . 53.5 t -69.95 -39.58 77.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 121.524 -0.735 . . . . 0.0 109.907 -179.989 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -79.18 -22.47 44.93 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.009 -1.057 . . . . 0.0 110.859 179.945 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 55.9 tp -82.25 -20.8 36.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.204 -1.56 . . . . 0.0 108.697 178.561 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.0 ttm -81.1 -30.75 34.56 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.161 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -84.34 -9.63 58.29 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.637 -0.665 . . . . 0.0 109.521 178.59 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -106.32 -2.01 22.76 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.316 -0.865 . . . . 0.0 110.919 -179.188 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 22.1 mt -91.53 124.9 36.05 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.949 -1.095 . . . . 0.0 110.636 -179.338 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . 0.449 ' O ' ' CD ' ' B' ' 311' ' ' PRO . 19.1 pt-20 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 118.017 -0.992 . . . . 0.0 108.755 178.675 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.519 -0.549 . . . . 2.91 109.519 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.613 ' CD1' HE22 ' A' ' 211' ' ' GLN . 85.9 mt -110.04 127.65 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.479 -0.934 . . . . 1.2 108.479 179.553 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.3 m -128.57 126.43 40.3 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.551 -0.718 . . . . 1.4 109.512 -179.343 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.79 -161.97 34.65 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.311 -1.516 . . . . 1.05 109.311 179.6 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.5 mt -88.75 -14.42 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -1.195 . . . . 1.15 110.316 -179.367 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.6 tp 52.67 100.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.07 -1.019 . . . . 0.98 109.07 -179.794 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.09 -28.33 12.76 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.113 -0.992 . . . . 0.88 109.267 179.388 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.9 m -132.08 115.31 15.27 Favored Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 109.111 -0.7 . . . . 1.69 109.111 -179.659 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.38 147.98 18.35 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.018 1.812 . . . . 0.85 112.964 -179.685 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.862 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.33 -156.04 26.59 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.606 -1.797 . . . . 0.92 108.606 -179.51 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.4 mt -149.0 151.06 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 120.904 -1.351 . . . . 0.81 108.866 178.68 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.58 156.62 36.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.048 -1.033 . . . . 0.51 110.241 179.397 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.2 m-85 -137.87 127.37 24.94 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.762 -1.199 . . . . 0.62 107.762 179.1 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.98 178.86 48.74 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 118.591 -1.766 . . . . 0.55 110.913 179.947 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -78.39 156.42 29.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.979 -0.719 . . . . 2.1 109.898 -179.525 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.54 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -100.32 129.98 46.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.43 -0.794 . . . . 0.77 110.844 -179.11 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.2 tp -105.98 134.59 48.86 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.469 -1.308 . . . . 0.91 107.469 178.286 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.9 tp -115.77 123.81 49.18 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.381 -0.824 . . . . 0.93 110.091 -179.419 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 160' ' ' ALA . 25.5 mt -81.96 100.57 9.75 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 120.035 -0.666 . . . . 0.93 109.421 179.92 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -94.55 138.26 32.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.259 -0.901 . . . . 2.75 109.706 -179.667 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 58.0 mp0 -130.37 136.79 49.45 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.478 -0.764 . . . . 3.0 109.136 179.206 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -84.31 147.32 27.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 2.77 109.494 179.664 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.89 145.51 55.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.9 . . . . 2.94 109.671 -179.811 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.2 mt -98.41 132.73 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.396 -0.815 . . . . 0.95 109.372 179.888 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.6 t -106.81 128.25 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.427 -0.796 . . . . 1.28 109.84 -179.475 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.1 mt -98.36 142.42 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.494 -0.754 . . . . 1.21 109.134 179.976 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -83.6 123.77 30.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.985 -1.072 . . . . 1.81 109.056 179.834 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -93.47 -6.91 45.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.249 -0.907 . . . . 2.8 109.479 -179.64 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.71 138.55 52.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 2.87 109.594 -179.727 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -83.75 155.31 23.13 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.202 -1.036 . . . . 2.35 108.202 179.136 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.689 HD13 ' HG3' ' A' ' 39' ' ' GLU . 3.1 pt -99.04 165.66 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.071 -1.018 . . . . 0.97 109.936 -179.947 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.4 p -91.76 173.55 7.81 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.603 -0.888 . . . . 1.17 108.603 178.712 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.62 -15.47 63.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.134 -0.979 . . . . 1.18 110.696 -179.479 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 60.0 t0 -83.69 -30.67 26.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.822 -1.173 . . . . 2.56 108.842 179.47 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -82.65 -6.84 59.59 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.42 -0.585 . . . . 1.79 109.42 179.992 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 t -60.01 -51.81 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.182 -0.949 . . . . 1.0 109.254 179.949 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -60.14 -39.84 87.73 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.231 -0.918 . . . . 1.77 108.78 179.832 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -63.68 -40.23 96.3 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.308 -0.87 . . . . 2.7 110.133 -179.723 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.689 ' HG3' HD13 ' A' ' 31' ' ' ILE . 71.0 mm-40 -64.39 -41.55 96.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.847 -1.158 . . . . 1.51 110.28 -179.778 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.8 t -59.99 -45.7 95.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 120.671 -1.268 . . . . 0.93 108.085 179.996 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -59.89 -42.43 93.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.368 -0.833 . . . . 1.81 108.934 -179.78 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.433 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 96.6 mtt180 -60.04 -47.56 85.35 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.846 -1.168 . . . . 2.78 107.846 178.49 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -60.02 -45.22 93.51 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.202 -0.666 . . . . 0.78 109.202 178.897 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.92 -50.07 75.19 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.311 -0.996 . . . . 1.07 108.311 179.661 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -60.45 -42.71 96.7 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.277 -0.889 . . . . 1.12 108.997 179.081 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.18 -47.71 89.6 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.549 -1.421 . . . . 0.84 109.549 179.99 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -69.73 -31.66 69.78 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.284 -1.127 . . . . 3.09 108.402 179.337 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.65 89.71 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.566 -0.709 . . . . 0.88 109.12 -179.988 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.4 ttpt -67.25 -73.77 0.13 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.196 -0.94 . . . . 2.59 108.787 179.333 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.29 -41.81 0.65 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.325 -0.86 . . . . 0.7 111.265 -178.356 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.8 m -52.2 -57.87 8.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.587 -1.321 . . . . 1.4 109.106 179.873 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.64 -40.97 84.57 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.218 -0.926 . . . . 0.67 110.836 -179.267 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -68.14 -40.33 82.47 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.982 -1.074 . . . . 1.66 109.763 -179.693 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.6 mt -61.66 -40.19 94.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.892 -1.13 . . . . 1.58 109.092 179.108 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -64.37 -35.54 81.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 1.35 109.152 179.487 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -62.04 -41.85 98.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.27 -0.894 . . . . 0.77 109.161 179.536 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.533 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.5 mt -64.17 -39.84 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.432 -0.792 . . . . 0.63 109.43 179.622 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -54.35 -51.17 65.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.864 . . . . 1.14 109.826 -178.96 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.3 m -59.94 -37.27 79.04 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.238 -0.914 . . . . 0.79 110.837 -178.317 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -64.14 -39.77 94.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.892 -1.13 . . . . 1.53 109.479 -179.559 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.426 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -66.52 -42.99 86.46 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.762 -0.586 . . . . 0.57 110.125 -179.392 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.38 -51.08 60.98 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.161 -1.176 . . . . 0.75 110.161 -179.174 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.0 -44.81 68.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.114 -1.227 . . . . 1.59 110.043 -179.855 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.0 m -69.91 -59.13 3.12 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 0.73 111.768 -178.248 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -97.3 -54.4 3.16 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.021 -1.049 . . . . 0.75 111.357 -178.056 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.83 -163.41 26.95 Favored Glycine 0 N--CA 1.501 3.006 0 C-N-CA 119.697 -1.239 . . . . 1.22 111.156 179.676 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.25 -23.96 62.99 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.912 -0.758 . . . . 5.81 110.841 -179.385 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -62.03 -39.6 92.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.959 -1.088 . . . . 3.37 110.361 -179.545 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -96.29 -18.85 19.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.228 -0.92 . . . . 1.77 110.434 -179.258 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -72.14 -40.77 67.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.043 -1.036 . . . . 1.65 110.466 -179.118 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.601 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.63 -30.89 70.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 0.77 109.984 -178.953 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.1 -40.27 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 118.82 -1.152 . . . . 0.8 108.822 -179.588 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -64.76 -40.07 94.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.047 -1.033 . . . . 0.88 109.885 -179.899 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -60.38 -40.89 92.49 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.89 -1.131 . . . . 1.37 109.863 179.519 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.9 -40.81 99.73 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.881 -1.688 . . . . 0.62 108.881 179.535 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.7 m170 -70.01 -40.06 75.47 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.396 -1.061 . . . . 1.5 109.208 179.767 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.9 mt -70.9 -46.47 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.383 -0.823 . . . . 0.63 109.986 179.828 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.7 ttp -60.35 -43.65 96.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 1.51 110.563 -178.452 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.687 HD11 ' CE2' ' B' ' 348' ' ' PHE . 44.8 tp -64.77 -39.44 93.61 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.293 -0.879 . . . . 0.77 109.938 -179.947 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.7 tp -63.81 -40.1 95.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.437 -0.79 . . . . 0.62 109.789 -179.72 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -78.87 4.07 15.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 1.47 110.099 -178.795 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 63.5 t0 -52.32 129.87 29.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.167 -0.958 . . . . 1.47 110.38 -179.37 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.423 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.8 mt-10 -60.16 -15.19 21.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.566 -0.709 . . . . 1.78 110.124 -179.982 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.02 -37.03 75.51 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.156 -0.965 . . . . 2.53 108.517 178.578 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.1 mt -69.98 -40.09 75.56 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.37 0.605 . . . . 0.8 109.876 179.426 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.07 -50.05 75.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.46 -0.775 . . . . 1.42 110.265 -178.975 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -74.36 -40.62 62.02 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.393 -0.817 . . . . 1.71 111.224 -178.801 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.92 -41.03 75.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.013 -1.054 . . . . 1.57 111.487 -178.675 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.9 mt -70.15 -46.12 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.857 -1.152 . . . . 0.65 109.445 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.8 mt -65.72 -37.45 79.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.625 -0.672 . . . . 0.82 110.121 -179.841 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.07 90.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.048 -1.033 . . . . 0.79 110.507 -178.829 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.3 mt -62.21 -45.49 93.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.947 -1.095 . . . . 0.95 109.579 -179.781 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.1 mt -62.05 -50.0 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.66 109.596 -179.907 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -71.21 -42.18 69.26 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.681 -0.808 . . . . 2.2 111.385 179.826 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -83.25 -50.42 8.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.952 -1.092 . . . . 1.65 112.197 -177.648 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -90.19 -2.61 58.07 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.871 -1.143 . . . . 2.03 111.474 -177.497 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 56.19 39.02 30.39 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.797 -1.189 . . . . 1.42 109.521 -179.413 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 54.7 mtt -92.04 169.33 10.73 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.44 -0.788 . . . . 1.18 109.652 -179.723 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.9 p -83.82 159.65 21.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.942 . . . . 0.98 108.956 179.514 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.76 -36.8 78.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 0.64 109.801 -179.635 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.433 ' OD1' HG21 ' A' ' 141' ' ' ILE . 95.7 m-20 -68.66 -39.68 80.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -0.97 . . . . 2.07 110.203 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.59 -44.89 18.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.026 -1.046 . . . . 0.73 109.61 179.855 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.75 -50.25 67.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.449 -0.782 . . . . 0.54 110.211 -179.487 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.23 -37.3 79.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.074 -1.017 . . . . 0.56 109.445 179.917 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -59.91 -42.65 94.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.476 -0.765 . . . . 1.54 110.266 -179.013 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 110' ' ' GLY . 88.9 tt0 -64.9 -40.2 94.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.007 -1.058 . . . . 1.33 109.983 -179.634 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 70.1 t -61.74 -53.22 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.21 -0.931 . . . . 0.72 110.53 -178.509 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.1 mm -69.99 -39.98 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.136 -0.978 . . . . 0.85 109.197 179.857 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -68.95 -36.75 78.28 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.486 -0.931 . . . . 2.44 108.486 179.015 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.45 -49.82 72.87 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.061 -1.215 . . . . 0.98 110.061 -179.573 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -68.73 -48.53 63.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.749 -1.442 . . . . 1.41 109.41 -179.874 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.87 92.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 1.2 109.382 179.902 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.5 t -57.43 -39.34 76.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 1.7 109.025 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.04 94.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.313 -0.867 . . . . 1.47 109.393 179.437 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.3 mt -64.26 -42.47 96.45 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.153 -0.967 . . . . 1.56 109.827 -179.06 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.424 ' C ' ' N ' ' A' ' 118' ' ' LEU . 78.6 tt0 -59.87 -38.66 82.79 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.661 -1.274 . . . . 2.2 109.522 -178.659 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -50.08 -17.69 0.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.902 -1.124 . . . . 2.12 109.147 179.671 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.424 ' N ' ' C ' ' A' ' 116' ' ' GLU . 79.4 mt -63.36 146.77 52.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 2.0 108.542 179.585 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -95.83 10.81 35.86 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.086 -1.009 . . . . 3.23 111.439 -178.459 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 57.2 t0 -103.07 148.76 25.32 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.953 -1.092 . . . . 2.49 109.583 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 36.4 tt0 -72.04 -65.75 0.73 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.417 -0.957 . . . . 3.95 108.417 179.096 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.481 ' OH ' ' CZ ' ' A' ' 126' ' ' ARG . 11.2 t80 -39.19 -40.26 0.71 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.783 -0.573 . . . . 2.0 110.442 -179.127 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.537 HD22 ' O ' ' B' ' 351' ' ' GLN . 95.1 mt -70.31 -39.57 74.74 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.86 -1.15 . . . . 1.86 108.95 178.897 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 121' ' ' GLU . 64.4 tttp -60.03 -40.0 87.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.389 -0.819 . . . . 2.84 109.586 -179.882 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -60.02 -39.43 85.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.859 . . . . 2.73 108.828 179.953 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.643 ' NE ' HE22 ' B' ' 351' ' ' GLN . 8.3 mtt180 -59.86 -39.79 86.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.17 -0.956 . . . . 2.77 108.793 179.314 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.38 -25.57 64.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 1.19 108.82 179.313 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.02 -40.03 75.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 1.2 109.39 179.378 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -66.74 -43.08 85.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.985 . . . . 1.55 109.838 179.925 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.5 t -69.9 -40.46 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.977 -1.077 . . . . 0.8 108.616 179.464 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -65.45 -35.67 81.61 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.501 -0.75 . . . . 3.09 109.443 179.51 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -59.97 -40.1 87.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 1.46 109.653 -179.747 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.36 -43.01 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.024 . . . . 0.71 109.187 179.805 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.8 -40.01 98.24 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.735 -1.346 . . . . 0.57 109.735 179.73 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -60.14 -49.96 75.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.397 -1.061 . . . . 2.59 109.705 -179.122 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.533 HH22 ' CD1' ' A' ' 57' ' ' ILE . 58.6 mtp180 -67.03 -32.61 73.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.125 -0.984 . . . . 2.83 110.255 -179.147 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 64.8 tp -60.04 -41.22 91.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.064 -1.023 . . . . 1.25 108.445 -179.539 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 94.5 mt -60.5 -39.99 89.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.367 -0.833 . . . . 0.7 109.265 179.323 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -69.16 -39.93 78.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.267 -0.895 . . . . 2.57 109.036 179.712 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -62.2 -39.97 94.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.606 -0.684 . . . . 1.23 111.343 -179.024 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.433 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.5 mt -73.74 -45.44 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 120.429 -1.419 . . . . 0.81 109.399 179.891 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.6 mt -69.97 -31.53 69.28 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.65 -0.656 . . . . 1.0 110.084 -179.273 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.38 36.58 10.61 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.45 -1.46 . . . . 0.89 109.45 -179.565 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.85 141.07 47.96 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.21 -1.171 . . . . 1.14 108.779 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -60.68 140.05 57.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.31 -0.869 . . . . 4.6 109.477 -179.433 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.6 mt -108.07 128.88 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 108.835 -0.802 . . . . 1.24 108.835 179.668 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 27.4 mm -58.04 -50.02 79.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.724 -0.61 . . . . 1.54 110.801 -177.432 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 33.9 t0 65.89 102.72 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.883 -0.784 . . . . 1.5 108.883 -178.857 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.531 ' O ' HD12 ' A' ' 152' ' ' ILE . 59.5 mt -73.07 -3.72 28.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.483 -0.761 . . . . 0.79 110.034 -179.207 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.9 t -83.11 -13.7 55.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.012 -1.055 . . . . 1.4 109.066 179.22 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.72 24.61 0.47 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.564 -0.71 . . . . 0.92 109.947 -178.695 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.531 HD12 ' O ' ' A' ' 149' ' ' LEU . 63.7 mt -91.42 122.07 42.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.328 -0.858 . . . . 0.88 108.74 -179.423 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -110.33 -9.22 14.64 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.461 -0.775 . . . . 2.45 110.455 -179.008 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -126.43 151.33 47.86 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.276 -0.89 . . . . 1.52 110.488 -178.583 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.01 133.55 51.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 1.58 108.621 179.224 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 19.9 m -153.24 165.93 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.438 -0.789 . . . . 0.69 109.542 179.64 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.0 mt -94.2 149.1 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 105.896 -1.89 . . . . 0.61 105.896 176.749 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.9 tp -98.39 117.19 32.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.939 -1.1 . . . . 0.87 110.893 -177.486 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.3 t -121.44 127.81 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 108.804 -0.813 . . . . 0.71 108.804 179.495 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.438 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -157.84 160.68 37.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.084 -1.01 . . . . 0.81 108.688 -179.979 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.04 -33.3 71.79 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.116 -1.615 . . . . 0.98 108.449 178.801 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -160.27 171.46 19.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.456 -0.777 . . . . 2.25 108.931 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.6 mt -141.69 133.92 27.87 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.875 -1.141 . . . . 0.78 109.168 179.74 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 66.7 p -100.46 149.67 36.29 Favored Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 121.173 -0.955 . . . . 0.98 110.262 -179.65 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -43.04 -38.47 7.26 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.561 2.174 . . . . 0.81 113.466 179.203 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.1 m -59.84 -40.04 87.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.974 -1.079 . . . . 0.9 109.801 -178.084 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.92 -40.83 83.31 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.151 -0.968 . . . . 1.61 110.421 -179.746 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.2 p -58.03 -30.77 66.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.112 -0.993 . . . . 0.61 111.092 -178.218 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -72.15 -46.72 55.36 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.699 -1.25 . . . . 0.6 110.03 179.935 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -90.25 37.28 0.89 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.31 -0.996 . . . . 1.4 108.31 -179.88 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.5 tp -107.76 132.54 53.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.616 -0.678 . . . . 0.7 109.616 179.777 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -86.51 103.64 15.22 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.318 -0.864 . . . . 2.35 108.725 178.992 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 59.0 mt -64.09 -41.59 97.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 1.51 110.363 -179.294 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -66.03 -26.05 67.34 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.841 -1.162 . . . . 2.33 112.01 -177.591 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -92.41 -8.08 45.82 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.655 -1.278 . . . . 1.92 109.976 -178.656 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 178' ' ' GLY . 80.1 t -107.69 118.48 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.337 -0.852 . . . . 0.67 109.108 179.031 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.5 mt -85.41 4.06 37.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.345 -0.847 . . . . 1.53 111.114 -178.026 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.552 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 169.66 173.03 36.83 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.342 -1.408 . . . . 0.48 109.748 179.877 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -131.52 127.55 37.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.456 -1.026 . . . . 0.55 109.027 179.812 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 77.4 mt -129.04 123.22 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.616 -0.883 . . . . 0.65 108.616 179.059 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 63.7 p -145.49 158.32 43.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.139 -0.976 . . . . 0.82 111.109 -179.436 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -103.68 25.89 9.22 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.779 -0.823 . . . . 2.46 108.779 179.724 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.13 -159.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.006 -1.059 . . . . 1.28 111.229 -178.195 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.33 -51.56 12.84 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.029 -1.229 . . . . 2.19 110.029 -179.613 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.74 -108.97 0.39 Allowed Glycine 0 N--CA 1.493 2.441 0 O-C-N 121.084 -1.245 . . . . 2.13 110.207 -179.988 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.462 ' CB ' HH11 ' A' ' 186' ' ' ARG . 0.0 OUTLIER -79.91 -10.12 59.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.289 -1.124 . . . . 5.86 110.393 -179.29 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 78.5 p -83.89 0.77 46.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.125 -0.984 . . . . 3.72 110.324 -178.708 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.6 t -90.76 118.86 30.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.003 -1.061 . . . . 1.74 109.655 179.73 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -42.23 -52.73 4.34 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.602 -0.686 . . . . 0.95 109.7 -179.826 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.2 m -54.15 -30.67 50.0 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.34 -0.85 . . . . 1.55 110.759 -179.388 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 16.3 t -60.03 -44.75 94.41 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.601 -1.312 . . . . 1.51 109.746 -179.502 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.0 mm -60.09 -39.69 81.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.611 -0.885 . . . . 1.67 108.611 179.749 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.3 mtp -60.05 -39.89 87.52 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.456 -0.777 . . . . 1.02 110.002 -179.586 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.04 -44.36 94.71 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.654 -1.279 . . . . 0.68 109.504 -179.665 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.445 HH22 ' HG2' ' A' ' 186' ' ' ARG . 95.1 mtt180 -62.39 -57.78 10.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.111 -0.993 . . . . 2.93 109.981 -179.313 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 66.8 m -60.91 -40.01 91.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.857 . . . . 0.86 111.993 -178.684 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 91.6 mt -79.94 -10.93 59.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.766 -1.208 . . . . 0.67 110.876 -177.846 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 59.14 49.96 8.64 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.136 -0.977 . . . . 1.5 110.28 179.881 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 66.7 mt -121.91 126.2 26.43 Favored Pre-proline 0 N--CA 1.501 2.106 0 N-CA-C 108.955 -0.757 . . . . 0.72 108.955 179.517 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -43.09 129.44 5.82 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.842 1.695 . . . . 0.61 112.077 179.497 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.26 145.47 6.99 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.452 -1.299 . . . . 0.66 112.102 -179.512 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.6 mt -124.3 144.72 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.533 -1.284 . . . . 0.79 107.533 178.336 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.7 m -129.29 -6.69 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 120.695 -1.253 . . . . 0.91 111.031 -178.87 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.9 20.87 26.13 Favored Glycine 0 N--CA 1.5 2.958 0 N-CA-C 110.963 -0.855 . . . . 1.01 110.963 -179.406 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.44 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 2.9 p -46.61 -41.36 14.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.711 -1.464 . . . . 0.99 109.725 -179.483 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.61 -50.38 3.22 Favored Glycine 0 N--CA 1.498 2.823 0 C-N-CA 120.034 -1.079 . . . . 1.12 111.767 178.477 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 74.2 m -161.88 42.26 0.14 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.596 -1.532 . . . . 1.72 111.334 -179.177 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 23.5 t -78.89 -38.14 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.932 -1.105 . . . . 0.89 108.666 178.348 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.451 ' H ' HG23 ' A' ' 209' ' ' THR . 4.3 p -55.3 -35.62 65.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.459 -0.776 . . . . 1.03 110.611 -179.062 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 63.4 m -84.29 -9.8 58.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.963 -1.086 . . . . 1.83 110.142 -179.374 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . 0.613 HE22 ' CD1' ' A' ' 2' ' ' ILE . 27.2 mt-30 -96.16 -16.5 21.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.065 -1.022 . . . . 2.27 110.485 -179.39 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 213' ' ' LYS . 18.2 t -123.66 162.92 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.403 -0.81 . . . . 0.92 109.714 -179.596 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.487 ' N ' HG12 ' A' ' 212' ' ' VAL . 0.5 OUTLIER -121.89 160.02 25.62 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.597 -0.89 . . . . 2.2 108.597 -179.615 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.458 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 39.8 p-10 -60.4 145.28 48.59 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.394 -0.816 . . . . 2.36 111.168 -179.02 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 84.29 -1.44 1.0 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.519 0.676 . . . . 2.38 110.326 178.594 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.46 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 96.5 m-20 -72.54 155.09 40.43 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.623 -0.831 . . . . 2.09 108.838 179.269 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -97.64 119.31 35.98 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.445 -0.946 . . . . 1.27 108.445 179.852 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.54 HD12 ' HB2' ' A' ' 16' ' ' ALA . 96.1 mt -122.83 142.24 50.97 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.439 -0.788 . . . . 0.75 110.504 -179.077 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.452 HD12 ' HG3' ' A' ' 231' ' ' PRO . 83.2 mt -114.82 128.37 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 106.299 -1.741 . . . . 0.63 106.299 176.365 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 56.7 tp -97.89 116.58 30.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.932 -1.105 . . . . 0.7 108.505 -179.358 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 223' ' ' VAL . 21.3 t0 -74.1 -44.66 53.07 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.466 -1.309 . . . . 2.31 107.466 179.553 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.862 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.82 8.49 0.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.834 -0.541 . . . . 0.78 109.654 179.073 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.508 ' H ' ' C ' ' A' ' 221' ' ' ASP . 95.2 t -126.75 -39.17 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 107.384 -1.339 . . . . 1.04 107.384 178.262 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -102.77 -0.41 31.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.878 -1.156 . . . . 2.44 107.878 178.637 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 61.94 45.77 7.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.817 -0.552 . . . . 1.55 109.839 -179.814 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -139.6 150.66 45.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.293 -0.879 . . . . 1.99 109.891 179.575 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 90.5 t -119.0 128.07 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.423 -0.955 . . . . 0.77 108.423 178.989 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -102.67 123.56 46.6 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.596 -0.89 . . . . 0.98 108.596 179.461 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.3 t -100.02 110.01 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.38 -0.825 . . . . 0.85 110.607 -178.865 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 230' ' ' ASN . 21.3 t30 50.94 60.65 14.45 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.44 -0.788 . . . . 1.66 111.516 179.047 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.452 ' HG3' HD12 ' A' ' 219' ' ' ILE . 90.7 Cg_endo -79.51 153.04 23.47 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.703 2.268 . . . . 0.95 111.277 178.386 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . 0.435 HG22 ' N ' ' A' ' 233' ' ' ASN . 25.8 m -64.7 159.92 21.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 1.84 110.135 -179.25 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . 0.435 ' N ' HG22 ' A' ' 232' ' ' THR . 98.6 m-20 -61.18 -40.08 92.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.39 -0.818 . . . . 2.74 110.342 -179.632 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.01 -36.07 76.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.081 -1.012 . . . . 2.89 109.265 179.794 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.97 -39.93 78.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.564 -0.902 . . . . 1.3 108.564 179.261 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.444 -0.785 . . . . 1.09 110.001 179.931 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -155.19 153.65 31.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.267 -0.896 . . . . 0.0 109.499 179.485 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -145.56 155.48 43.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.214 -0.929 . . . . 0.0 109.55 -179.83 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . 0.539 HE22 ' C ' ' B' ' 305' ' ' GLU . 0.7 OUTLIER -154.49 150.02 27.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.515 -0.741 . . . . 0.0 109.015 -179.587 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . 0.539 ' C ' HE22 ' B' ' 304' ' ' GLN . 95.0 mt-10 -109.85 131.72 54.8 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.3 -0.875 . . . . 0.0 110.162 179.388 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . 0.409 ' O ' HG13 ' B' ' 306' ' ' VAL . 6.9 p -132.9 121.02 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 CA-C-O 122.121 0.962 . . . . 0.0 112.134 -178.136 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . 0.477 ' O ' HG23 ' B' ' 309' ' ' THR . 87.8 m -80.0 103.01 9.6 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.696 0.76 . . . . 0.0 110.384 -178.93 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.5 mt -51.51 117.52 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.446 1.117 . . . . 0.0 109.971 -178.079 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . 0.477 HG23 ' O ' ' B' ' 307' ' ' THR . 62.2 p -104.69 19.01 21.19 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.414 -177.954 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.46 115.98 44.73 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.327 -0.858 . . . . 0.0 109.098 179.507 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -53.05 -15.47 4.98 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 CA-C-N 120.306 1.145 . . . . 0.0 112.923 -179.704 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -115.27 4.98 14.59 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.506 -0.746 . . . . 0.0 109.036 -179.888 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.26 174.46 19.12 Favored Glycine 0 N--CA 1.481 1.692 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 -179.042 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.442 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.0 tp -85.84 95.59 9.48 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.163 -1.198 . . . . 0.0 108.696 -179.066 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -95.25 -162.55 0.96 Allowed 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.161 -0.962 . . . . 0.0 110.411 179.737 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 7.9 m -59.63 -39.96 86.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.056 -1.027 . . . . 0.0 112.581 -175.776 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.601 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -60.15 -60.82 9.38 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.33 -1.481 . . . . 0.0 111.27 -179.257 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -59.4 -32.4 96.48 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.14 1.086 . . . . 0.0 111.628 -179.9 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.88 67.67 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.398 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -50.37 -40.02 48.28 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.819 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . 0.423 HE21 HD11 ' B' ' 380' ' ' LEU . 61.8 tt0 -69.99 -41.47 74.37 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 108.923 178.369 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -61.2 -52.78 63.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.83 . . . . 0.0 110.946 -179.365 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 87.9 t -65.41 -27.67 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.639 -1.288 . . . . 0.0 109.761 -178.957 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -45.16 93.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.404 -0.81 . . . . 0.0 109.411 179.581 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -66.52 -44.89 81.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.418 -0.801 . . . . 0.0 111.2 -178.437 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . 0.42 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -61.55 -53.87 50.61 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.724 -1.235 . . . . 0.0 111.144 -178.646 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -52.66 -13.43 0.39 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.724 -1.235 . . . . 0.0 109.317 179.673 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -72.6 -28.73 66.85 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.69 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -106.03 146.78 29.67 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.443 -1.033 . . . . 0.0 109.942 -179.676 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 51.6 p -91.11 -11.79 37.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.925 . . . . 0.0 110.134 179.997 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.427 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 56.4 p -65.3 157.87 27.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.196 -0.94 . . . . 0.0 110.323 -179.165 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -72.62 131.55 42.59 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.377 -0.827 . . . . 0.0 108.922 179.375 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 80.2 mt -132.33 132.69 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.873 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . 0.417 HG22 ' N ' ' B' ' 335' ' ' VAL . 62.7 m -131.6 155.89 46.74 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.48 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . 0.417 ' N ' HG22 ' B' ' 334' ' ' THR . 61.9 t -119.1 140.49 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.318 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 26.7 m -128.9 123.89 33.78 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.128 -0.982 . . . . 0.0 108.561 179.95 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . 0.4 ' CB ' HG12 ' B' ' 361' ' ' VAL . 93.0 p -137.93 116.61 12.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.966 -1.084 . . . . 0.0 110.82 -179.387 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 22.9 m120 45.14 53.43 7.86 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.318 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.74 -11.59 66.08 Favored Glycine 0 N--CA 1.502 3.07 0 O-C-N 120.06 -1.65 . . . . 0.0 113.052 176.264 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -120.92 132.35 54.9 Favored 'General case' 0 N--CA 1.506 2.37 0 CA-C-N 119.285 1.542 . . . . 0.0 109.512 -179.655 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 77.4 p -127.88 151.39 49.13 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.928 0.87 . . . . 0.0 110.886 -178.834 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.48 164.47 30.79 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.64 0.734 . . . . 0.0 110.423 -178.94 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 48.0 t -87.56 133.21 33.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.806 -0.559 . . . . 0.0 110.359 -179.353 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -70.13 -20.27 63.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.944 . . . . 0.0 108.911 179.289 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -84.61 17.36 2.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.494 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 3.0 m -146.45 95.43 2.6 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.773 0.797 . . . . 0.0 112.421 -179.368 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.659 HD23 HD22 ' A' ' 79' ' ' LEU . 42.7 tp -59.98 -39.05 84.36 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.415 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.687 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.0 m-85 -51.31 -51.15 56.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.979 -1.076 . . . . 0.0 110.459 -179.569 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -71.66 -39.72 70.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.955 -1.09 . . . . 0.0 111.277 -178.2 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' B' ' 352' ' ' THR . 20.6 mt -47.81 -59.95 2.94 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.718 -1.239 . . . . 0.0 109.754 -179.153 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.643 HE22 ' NE ' ' A' ' 126' ' ' ARG . 7.6 mm100 -42.07 -20.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.399 -0.813 . . . . 0.0 111.192 -177.724 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.493 ' N ' ' O ' ' B' ' 350' ' ' LEU . 69.5 p -79.25 -12.76 59.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.081 -1.637 . . . . 0.0 109.53 -179.294 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 32.0 mt -94.09 122.7 36.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.114 -0.991 . . . . 0.0 108.993 178.383 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -72.03 96.89 0.71 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.718 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.5 mt -100.07 80.29 2.27 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.265 -1.138 . . . . 0.0 109.06 179.282 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 75.1 p -91.13 166.28 13.05 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.967 -1.083 . . . . 0.0 111.055 -178.83 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -59.92 111.58 1.53 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.132 0.491 . . . . 0.0 110.642 -179.591 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 103.01 5.57 46.88 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.762 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 52.4 m -80.14 109.78 14.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.051 -1.264 . . . . 0.0 110.855 -179.468 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . 0.439 HG22 ' OG1' ' B' ' 307' ' ' THR . 11.9 t -78.54 112.71 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.108 0.956 . . . . 0.0 109.943 -177.907 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . 0.4 HG12 ' CB ' ' B' ' 337' ' ' SER . 36.0 m -113.31 176.85 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 -178.735 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 57.4 m -126.64 130.02 49.63 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 176.648 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.5 mt -106.43 124.52 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.357 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 63.2 m -131.53 138.85 49.1 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.5 -0.75 . . . . 0.0 109.771 -178.979 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.41 155.24 42.44 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.217 -0.927 . . . . 0.0 109.763 -179.507 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -146.51 123.34 11.28 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.409 -0.807 . . . . 0.0 109.171 179.848 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.508 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.89 -153.47 24.73 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.248 -1.453 . . . . 0.0 111.548 179.868 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -59.97 -51.69 68.58 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.222 -0.575 . . . . 0.0 112.503 -177.292 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.427 ' H ' ' HB3' ' B' ' 331' ' ' SER . 62.5 m-20 -111.91 11.06 20.67 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.892 -1.13 . . . . 0.0 111.434 -177.267 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 11.1 pt-20 -39.14 -34.5 0.18 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.452 -0.78 . . . . 0.0 111.657 -179.16 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -69.99 -41.0 74.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.036 -1.04 . . . . 0.0 110.667 -178.148 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -69.68 -49.89 49.16 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.223 -179.609 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -45.77 -79.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 110.417 -179.653 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.607 ' O ' HG23 ' B' ' 378' ' ' VAL . 15.1 t -45.24 -38.38 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.154 -0.966 . . . . 0.0 110.367 -177.696 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -69.86 -40.25 75.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.535 -1.353 . . . . 0.0 110.111 179.738 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -83.32 -45.54 13.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.974 -1.079 . . . . 0.0 109.707 179.499 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.08 -35.51 75.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 109.673 -179.211 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.607 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.4 t -68.88 -40.06 80.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.123 -0.986 . . . . 0.0 109.758 179.819 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -79.98 -10.0 59.73 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.705 -1.247 . . . . 0.0 108.611 178.251 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.423 HD11 HE21 ' B' ' 321' ' ' GLN . 44.1 tp -82.08 -26.81 33.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.997 -1.064 . . . . 0.0 108.697 178.377 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 38.7 mtt -83.36 -21.02 33.21 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 176.813 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -85.97 -11.3 53.38 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.583 -0.698 . . . . 0.0 109.451 178.789 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -109.98 -4.72 15.74 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.387 -0.821 . . . . 0.0 110.868 -178.998 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 31.1 mt -89.77 123.97 34.23 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.681 -1.262 . . . . 0.0 109.859 -179.79 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.406 -179.82 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 mmt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.457 -0.572 . . . . 2.91 109.457 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.3 mt -107.31 121.38 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.644 -0.873 . . . . 1.2 108.644 179.745 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 m -133.62 120.09 20.25 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.424 -0.798 . . . . 1.4 109.178 179.981 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.64 -161.7 37.72 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.422 -1.471 . . . . 1.05 109.422 179.917 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.7 mt -93.03 -10.13 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.038 -1.272 . . . . 1.15 110.005 -179.392 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' ILE . 55.2 tp 53.21 101.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -0.963 . . . . 0.98 109.548 -179.959 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.13 -26.24 20.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 0.88 109.631 179.928 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.1 t -144.6 130.18 9.58 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.213 -0.929 . . . . 1.69 109.433 179.923 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.94 143.43 16.31 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.175 1.916 . . . . 0.85 112.806 -179.926 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.663 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 163.74 -162.14 34.8 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.033 -1.627 . . . . 0.92 109.033 179.881 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.8 mt -149.52 149.8 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.922 -1.34 . . . . 0.81 108.466 178.841 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.5 158.4 37.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.749 -1.22 . . . . 0.51 110.794 179.83 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -139.97 129.19 23.82 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.897 -1.149 . . . . 0.62 107.897 178.817 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.93 -178.91 46.53 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 118.869 -1.634 . . . . 0.55 110.442 179.911 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -79.93 156.63 27.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.544 -0.974 . . . . 2.1 109.886 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -105.4 127.5 53.01 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.478 0.656 . . . . 0.77 110.925 -179.434 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.8 tp -101.25 140.08 36.04 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.772 -1.195 . . . . 0.91 107.772 178.537 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.7 tp -118.35 125.59 50.34 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.374 -0.829 . . . . 0.93 109.951 -179.442 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.8 mt -84.04 104.41 14.09 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.531 0.682 . . . . 0.93 109.963 -179.795 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -99.29 128.58 45.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.455 -0.778 . . . . 2.75 109.354 -179.789 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -130.06 127.94 40.92 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.41 -0.806 . . . . 3.0 109.072 179.256 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -76.74 147.31 37.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.282 -0.886 . . . . 2.77 109.418 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -63.61 141.55 58.72 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.23 -0.919 . . . . 2.94 108.995 -179.983 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.9 mt -76.97 131.88 33.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.229 -0.919 . . . . 0.95 109.162 -179.516 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.7 t -93.88 124.1 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.287 -0.883 . . . . 1.28 109.813 -179.621 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.6 mt -109.8 138.11 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.611 -0.681 . . . . 1.21 109.929 -179.462 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -97.45 116.93 30.58 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.13 -0.981 . . . . 1.81 109.441 179.834 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.53 HH11 ' HG2' ' A' ' 28' ' ' ARG . 2.3 mmt-85 -85.67 -0.95 56.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.393 -0.817 . . . . 2.8 109.62 -179.431 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -60.54 144.11 52.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.935 . . . . 2.87 109.632 -179.712 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -87.71 147.88 25.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.192 -0.942 . . . . 2.35 109.046 -179.928 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 pt -94.66 164.82 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.997 -1.064 . . . . 0.97 109.823 179.924 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.418 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 53.9 p -90.23 175.64 7.05 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.477 -0.935 . . . . 1.17 108.477 178.576 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.06 -20.34 63.23 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.937 -1.102 . . . . 1.18 111.266 -178.95 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.418 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 7.5 p-10 -85.97 -23.19 27.0 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.501 -1.375 . . . . 2.56 108.553 179.001 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -81.84 -9.41 59.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.592 -0.892 . . . . 1.79 108.592 178.818 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 t -62.09 -53.66 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.487 -0.758 . . . . 1.0 109.309 179.711 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -62.17 -40.06 94.76 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.339 -0.851 . . . . 1.77 109.349 179.691 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -61.91 -42.2 98.81 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.422 -0.799 . . . . 2.7 110.598 -178.766 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -66.15 -39.96 90.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.711 -1.243 . . . . 1.51 110.376 -179.036 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.14 -47.88 90.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.708 -1.245 . . . . 0.93 108.681 179.586 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -61.46 -44.21 97.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.062 . . . . 1.81 109.652 179.846 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.463 HH11 ' HG2' ' A' ' 42' ' ' ARG . 25.8 mtt-85 -60.02 -41.13 91.53 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.937 -1.135 . . . . 2.78 107.937 179.139 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -62.31 -45.78 91.69 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.958 -1.127 . . . . 0.78 107.958 177.545 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.02 -47.63 85.03 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.828 -0.804 . . . . 1.07 108.828 179.694 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 18.1 t -62.39 -42.95 99.82 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.394 -0.922 . . . . 1.12 109.009 179.355 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.44 -48.58 84.22 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.866 -1.694 . . . . 0.84 108.866 179.477 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -62.27 -34.9 77.44 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.33 -1.1 . . . . 3.09 108.197 178.694 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.59 -43.81 80.46 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.613 -0.679 . . . . 0.88 109.285 -179.911 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.3 ttpt -65.78 -74.24 0.11 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.17 -1.418 . . . . 2.59 107.17 179.301 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.25 -31.35 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.318 -0.864 . . . . 0.7 111.118 -179.238 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 49' ' ' LYS . 34.4 t -57.06 -56.07 26.46 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.547 -1.346 . . . . 1.4 108.473 179.801 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.45 -40.03 81.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.433 -0.792 . . . . 0.67 111.204 -179.182 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -67.14 -40.03 86.68 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.699 -1.251 . . . . 1.66 110.42 -179.1 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.43 -39.95 94.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.886 -1.134 . . . . 1.58 109.504 179.815 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -62.24 -33.99 75.65 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.174 -0.954 . . . . 1.35 109.448 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.62 -41.39 98.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.955 . . . . 0.77 109.832 -179.986 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.36 -39.95 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.193 -0.942 . . . . 0.63 109.55 -180.0 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -56.69 -50.6 71.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 1.14 109.921 -178.962 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -59.41 -36.63 76.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.371 -0.83 . . . . 0.79 110.968 -177.472 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -64.29 -38.26 90.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.895 -1.128 . . . . 1.53 109.573 179.891 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.31 -43.43 97.83 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.467 -0.771 . . . . 0.57 109.732 -179.926 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.15 -50.85 63.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.498 -1.441 . . . . 0.75 109.498 -179.335 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.26 -50.1 56.09 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.139 -1.212 . . . . 1.59 109.5 179.628 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.1 m -63.03 -64.76 0.82 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 0.73 112.32 -177.893 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -97.65 -48.3 5.29 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.868 -1.145 . . . . 0.75 111.825 -178.079 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.91 -169.77 25.15 Favored Glycine 0 N--CA 1.5 2.943 0 O-C-N 120.662 -1.274 . . . . 1.22 110.943 179.889 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.03 -26.87 64.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.897 -0.767 . . . . 5.81 110.287 -179.705 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -61.04 -33.15 72.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.447 -0.783 . . . . 3.37 110.087 -179.67 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -100.33 -22.59 15.03 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.341 -0.849 . . . . 1.77 109.891 179.995 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -64.95 -40.76 95.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.132 -0.98 . . . . 1.65 110.02 -179.311 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.599 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -67.1 -25.82 66.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.401 -0.812 . . . . 0.77 110.431 -178.913 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.99 -40.53 83.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.969 -1.082 . . . . 0.8 108.499 -179.706 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -69.96 -35.76 74.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.144 -0.973 . . . . 0.88 110.107 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -60.01 -40.06 87.94 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.762 -1.211 . . . . 1.37 109.312 179.831 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.99 -42.62 94.63 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.463 -1.855 . . . . 0.62 108.463 179.09 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -61.06 -44.56 97.2 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.468 -1.019 . . . . 1.5 108.612 179.334 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.98 -43.53 79.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.674 -0.641 . . . . 0.63 109.799 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -64.11 -40.02 95.29 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.906 -1.121 . . . . 1.51 109.827 -179.356 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.801 HD11 ' CE2' ' B' ' 348' ' ' PHE . 35.9 tp -65.47 -39.97 92.61 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.237 -0.914 . . . . 0.77 109.44 179.536 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.5 tp -65.71 -37.09 85.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.557 -0.714 . . . . 0.62 109.177 -179.493 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -82.66 1.66 37.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 1.47 110.086 -179.372 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -48.56 130.01 16.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.965 -1.084 . . . . 1.47 109.672 -179.405 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.46 -18.4 51.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.542 -0.723 . . . . 1.78 110.354 -179.259 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.47 -35.1 73.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.005 -1.059 . . . . 2.53 108.739 178.353 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.3 mt -70.15 -42.12 72.93 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.521 0.677 . . . . 0.8 109.909 179.506 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -60.15 -48.81 80.18 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.36 -0.837 . . . . 1.42 110.028 -179.126 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -69.95 -41.31 74.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 1.71 110.705 -179.451 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.98 -40.04 75.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.16 -0.963 . . . . 1.57 111.735 -178.629 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 91.8 mt -69.47 -42.04 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.905 -1.122 . . . . 0.65 109.178 -179.571 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.7 mt -69.98 -39.62 77.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.638 -0.664 . . . . 0.82 109.943 179.329 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.99 -47.77 84.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -0.863 . . . . 0.79 110.81 -179.244 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 96' ' ' LYS . 93.2 mt -61.48 -47.51 85.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.994 -1.067 . . . . 0.95 109.921 -179.44 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.33 -49.63 83.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.296 -0.877 . . . . 0.66 109.185 179.632 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -70.09 -43.03 71.93 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.901 -0.719 . . . . 2.2 110.667 179.636 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -80.69 -47.39 14.09 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.103 -0.998 . . . . 1.65 111.79 -178.349 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 92' ' ' LEU . 65.8 mmtt -91.81 -2.3 56.96 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.973 -1.079 . . . . 2.03 111.659 -177.679 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 56.05 34.68 24.22 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.797 -1.189 . . . . 1.42 109.489 -179.845 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 59.0 mtt -91.63 169.84 10.41 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.518 -0.739 . . . . 1.18 110.03 -179.39 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.5 p -82.32 162.34 22.29 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.42 -0.8 . . . . 0.98 109.408 179.986 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.03 -39.71 75.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.417 -0.802 . . . . 0.64 109.892 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.94 -40.04 83.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 2.07 110.011 -179.753 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.49 -44.08 19.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.018 -1.051 . . . . 0.73 110.283 -179.506 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.63 -47.68 68.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.54 110.2 -179.306 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.03 87.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.178 -0.951 . . . . 0.56 109.659 -179.862 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -59.99 -40.87 90.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.43 -0.794 . . . . 1.54 110.01 -178.559 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -63.21 -40.02 96.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.913 . . . . 1.33 110.131 -179.596 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.3 -52.59 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.111 -0.993 . . . . 0.72 110.528 -178.721 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -70.02 -40.02 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.973 -1.079 . . . . 0.85 109.328 -179.752 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.61 -39.19 91.27 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.644 -0.872 . . . . 2.44 108.644 179.327 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.33 -47.86 87.12 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.74 -1.344 . . . . 0.98 109.74 -179.668 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -67.53 -51.65 48.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.942 -1.328 . . . . 1.41 109.197 -179.992 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.85 -42.5 89.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.375 -0.828 . . . . 1.2 109.591 -179.748 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.4 t -57.56 -39.5 76.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.059 -1.026 . . . . 1.7 109.056 -179.851 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.95 -39.93 90.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.935 . . . . 1.47 109.656 179.424 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.1 mt -64.66 -42.01 95.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.022 -1.049 . . . . 1.56 109.999 -178.827 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.95 -37.58 79.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.746 -1.222 . . . . 2.2 109.335 -179.596 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -53.45 -20.25 4.5 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.202 -0.936 . . . . 2.12 109.265 179.827 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 65.7 mt -62.46 139.99 58.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.044 -1.035 . . . . 2.0 108.798 179.861 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -90.99 48.23 1.5 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.04 -1.037 . . . . 3.23 109.393 179.894 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.42 ' OD1' ' OE2' ' A' ' 121' ' ' GLU . 58.3 t0 -135.18 130.13 34.85 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.368 -0.833 . . . . 2.49 109.282 -179.713 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.2 pm0 -69.35 -28.87 66.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.532 -0.73 . . . . 3.95 110.071 -179.677 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.545 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 2.4 t80 -73.2 -41.03 64.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.259 -0.901 . . . . 2.0 110.599 179.586 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.624 ' CD2' HH22 ' A' ' 126' ' ' ARG . 41.3 mt -74.92 -29.71 61.04 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.044 -1.035 . . . . 1.86 108.344 179.31 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -68.51 -39.1 81.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.5 -0.75 . . . . 2.84 110.1 179.523 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -59.98 -44.02 94.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.987 -1.071 . . . . 2.73 110.063 -178.905 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.714 ' HE ' ' NE2' ' B' ' 351' ' ' GLN . 22.2 mtm-85 -69.96 -28.91 65.94 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.315 -1.354 . . . . 2.77 108.797 179.805 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.75 -26.64 65.84 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.865 -1.161 . . . . 1.19 107.865 178.741 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.56 -39.98 64.28 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.088 -0.708 . . . . 1.2 109.088 178.795 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -65.85 -39.99 91.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.358 -0.838 . . . . 1.55 110.53 -179.442 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.5 t -65.11 -41.02 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.877 -1.139 . . . . 0.8 109.065 179.999 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -59.98 -37.86 80.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.092 -1.005 . . . . 3.09 108.522 178.868 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 57.2 t0 -60.03 -38.96 84.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.578 -0.701 . . . . 1.46 109.985 -179.614 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 94.5 mt -60.08 -42.5 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.92 -1.113 . . . . 0.71 110.101 -178.89 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.76 -29.3 59.56 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.647 -1.381 . . . . 0.57 109.647 179.867 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt -59.93 -49.04 79.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.299 -1.118 . . . . 2.59 109.464 -179.515 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.467 HH11 ' HG2' ' A' ' 136' ' ' ARG . 27.1 mtt-85 -65.16 -36.7 85.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.083 -1.011 . . . . 2.83 109.596 179.861 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.2 tp -57.08 -40.92 77.86 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.355 -0.84 . . . . 1.25 109.018 -178.652 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.16 -41.35 98.21 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.193 -0.942 . . . . 0.7 109.762 179.405 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -70.09 -39.94 75.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.23 -0.919 . . . . 2.57 109.014 179.384 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -63.87 -35.66 81.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.675 -0.641 . . . . 1.23 111.093 -179.31 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 83.6 mt -71.13 -45.9 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.487 -1.383 . . . . 0.81 108.75 179.522 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 77.2 mt -70.03 -34.96 73.93 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.51 -0.744 . . . . 1.0 109.518 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.91 43.74 5.31 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.188 -1.565 . . . . 0.89 109.188 -179.479 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 tp -74.29 149.83 40.5 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.324 -1.103 . . . . 1.14 109.012 -179.854 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -67.1 141.72 57.36 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.178 -0.951 . . . . 4.6 109.678 -179.553 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 89.1 mt -115.63 126.6 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 122.269 1.033 . . . . 1.24 109.269 179.635 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 148' ' ' ASP . 7.5 mt -70.01 -40.0 78.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 115.594 -0.73 . . . . 1.54 110.743 -178.219 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 147' ' ' ILE . 25.8 t0 63.49 131.29 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.642 -0.873 . . . . 1.5 108.642 -178.918 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 152' ' ' ILE . 38.9 mt -89.89 -0.62 57.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.047 -1.033 . . . . 0.79 109.646 -179.324 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.7 m -84.83 -8.88 58.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 1.4 109.21 179.566 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.03 27.33 0.78 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.446 -0.784 . . . . 0.92 110.683 -178.207 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.415 ' O ' ' NZ ' ' A' ' 175' ' ' LYS . 54.4 mt -89.88 120.03 37.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 O-C-N 121.117 -0.99 . . . . 0.88 109.395 -179.16 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.42 ' O ' ' OD1' ' A' ' 154' ' ' ASP . 72.2 mt-30 -97.07 -9.67 27.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.298 -0.876 . . . . 2.45 111.083 -178.765 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 153' ' ' GLN . 96.4 m-20 -139.7 157.89 45.02 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.898 -1.126 . . . . 1.52 110.815 -178.763 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -62.7 138.22 58.45 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.735 -0.839 . . . . 1.58 108.735 179.606 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.1 m -153.13 165.71 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.69 109.767 179.88 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.5 mt -95.48 148.84 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.414 -1.698 . . . . 0.61 106.414 176.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.3 tp -98.61 117.66 33.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.084 -1.01 . . . . 0.87 111.049 -177.684 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.0 t -122.42 130.04 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.622 -0.881 . . . . 0.71 108.622 178.416 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.63 161.24 38.64 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.584 -0.895 . . . . 0.81 108.584 179.996 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.485 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -72.09 -32.88 67.44 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.201 -1.562 . . . . 0.98 107.687 178.699 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 20.2 t0 -162.27 167.73 23.47 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.142 -1.059 . . . . 2.25 108.142 179.8 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.498 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 86.5 mt -141.67 130.61 23.12 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.907 -1.12 . . . . 0.78 109.586 179.689 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 63.8 p -93.05 144.62 28.66 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 108.543 -0.91 . . . . 0.98 108.543 179.363 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -42.11 -29.86 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.846 1.697 . . . . 0.81 112.65 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.3 m -59.71 -39.98 86.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.017 . . . . 0.9 109.711 -178.405 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -70.06 -42.11 73.29 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.12 -0.988 . . . . 1.61 110.354 -179.662 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 77.9 p -53.93 -29.97 44.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.228 -0.92 . . . . 0.61 111.356 -177.994 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.14 -56.6 5.3 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.945 -1.097 . . . . 0.6 110.53 -179.7 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -84.05 37.34 0.6 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.451 -0.78 . . . . 1.4 108.939 -179.599 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.9 tp -109.76 129.47 55.62 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.457 -0.942 . . . . 0.7 108.457 178.494 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -79.97 105.15 11.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.082 -1.011 . . . . 2.35 109.27 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 77.0 mt -66.84 -40.26 87.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.426 -0.796 . . . . 1.51 111.229 -178.564 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -70.0 -23.62 63.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.939 -1.1 . . . . 2.33 110.852 -178.029 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . 0.415 ' NZ ' ' O ' ' A' ' 152' ' ' ILE . 41.4 mtpt -93.97 -6.44 45.42 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.032 -1.043 . . . . 1.92 109.861 -178.657 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.585 HG12 ' H ' ' A' ' 178' ' ' GLY . 93.1 t -107.92 121.4 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.179 -0.95 . . . . 0.67 108.605 179.069 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 42.1 mt -85.66 7.12 24.59 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.391 -0.818 . . . . 1.53 111.777 -177.07 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.585 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 164.11 177.55 36.93 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.17 -1.49 . . . . 0.48 109.662 179.914 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.461 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 22.5 m-85 -134.78 130.27 35.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.453 -1.028 . . . . 0.55 109.26 -179.695 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 91.0 mt -133.17 128.29 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.025 -0.731 . . . . 0.65 109.025 179.191 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 33.8 p -149.87 159.42 44.38 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.043 -1.035 . . . . 0.82 109.763 179.741 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 53.8 p-10 -106.27 27.55 8.59 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.519 -0.919 . . . . 2.46 108.519 178.847 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.5 -157.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.056 0.931 . . . . 1.28 111.972 -178.172 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.6 -80.48 0.08 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.875 -0.89 . . . . 2.19 110.875 -179.179 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.68 -130.57 1.37 Allowed Glycine 0 N--CA 1.49 2.288 0 O-C-N 120.892 -1.358 . . . . 2.13 110.112 -179.491 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -79.42 -9.31 59.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.305 -1.115 . . . . 5.86 111.031 -179.138 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.2 p -87.43 9.13 21.77 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.947 -1.096 . . . . 3.72 110.238 -179.085 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.7 m -90.19 139.32 30.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.941 -1.1 . . . . 1.74 110.358 -179.602 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -45.12 -53.38 8.08 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.473 -0.767 . . . . 0.95 109.99 -179.744 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.4 m -56.6 -39.01 72.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.401 -0.812 . . . . 1.55 110.164 -178.903 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 27.8 p -60.0 -37.67 80.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.858 -1.151 . . . . 1.51 110.003 -179.554 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . 0.41 HG12 HH21 ' A' ' 195' ' ' ARG . 82.5 mt -60.03 -39.91 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.115 -0.991 . . . . 1.67 108.935 179.985 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 90.7 mtp -60.04 -43.01 95.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.429 -0.795 . . . . 1.02 110.33 -179.038 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.39 -44.25 88.88 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.583 -1.323 . . . . 0.68 109.36 -179.341 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.41 HH21 HG12 ' A' ' 192' ' ' ILE . 82.8 mtm180 -62.55 -58.64 6.84 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.107 -1.037 . . . . 2.93 109.925 -179.606 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.6 m -61.96 -39.97 93.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.122 -0.986 . . . . 0.86 112.022 -178.548 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.0 mt -74.91 -20.53 59.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.753 -1.217 . . . . 0.67 110.338 -178.697 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 68.81 52.21 0.55 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.678 -0.639 . . . . 1.5 110.456 -179.762 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.5 mt -129.68 149.93 74.33 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 108.072 -1.084 . . . . 0.72 108.072 178.794 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.52 143.55 63.38 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.063 1.842 . . . . 0.61 112.088 -179.654 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -172.63 150.74 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.083 -1.01 . . . . 0.66 111.286 -179.897 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.8 mt -121.51 146.68 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 107.664 -1.236 . . . . 0.79 107.664 178.432 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.8 m -128.35 -12.39 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 O-C-N 120.878 -1.139 . . . . 0.91 110.528 -179.051 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.05 25.25 16.79 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 110.824 -0.91 . . . . 1.01 110.824 -179.233 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.8 p -46.28 -40.62 11.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.913 -1.345 . . . . 0.99 109.803 -179.459 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.403 ' H ' ' HB2' ' A' ' 182' ' ' ASP . . . 90.29 -51.42 3.39 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 120.127 -1.035 . . . . 1.12 110.85 179.385 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.6 m -161.94 34.97 0.12 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.621 -1.517 . . . . 1.72 111.204 -179.471 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.12 -40.15 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.923 -1.111 . . . . 0.89 108.621 177.999 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.451 ' H ' HG23 ' A' ' 209' ' ' THR . 1.2 p -56.23 -34.08 65.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.699 -0.625 . . . . 1.03 110.004 -179.088 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 39.8 t -86.5 -12.97 47.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.069 -1.019 . . . . 1.83 110.467 -179.169 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -94.0 -12.93 27.62 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.889 -1.132 . . . . 2.27 110.837 -179.538 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 213' ' ' LYS . 44.6 t -123.75 165.1 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 O-C-N 121.185 -0.947 . . . . 0.92 110.267 -179.483 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.572 ' N ' HG12 ' A' ' 212' ' ' VAL . 18.4 mmmt -118.14 156.45 28.67 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.558 -0.904 . . . . 2.2 108.558 -179.363 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 5.5 p30 -60.99 140.36 57.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 2.36 110.711 -179.474 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 6.5 t0 86.48 2.47 0.52 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.108 0.48 . . . . 2.38 110.204 179.102 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.442 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 89.9 m-20 -77.71 159.19 29.27 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.15 -0.969 . . . . 2.09 108.581 178.877 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -97.27 120.31 37.4 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.215 -0.928 . . . . 1.27 109.288 -179.351 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.506 HD12 ' HB2' ' A' ' 16' ' ' ALA . 88.8 mt -126.08 140.88 52.23 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.361 -0.837 . . . . 0.75 110.342 -179.812 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.7 mt -113.47 129.88 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.053 -1.462 . . . . 0.63 107.053 176.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 24.6 tp -103.12 120.13 40.12 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.215 -0.928 . . . . 0.7 109.255 -179.106 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.694 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 30.4 p-10 -80.77 -39.64 26.49 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.056 -1.027 . . . . 2.31 108.5 179.055 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.79 17.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.851 -0.796 . . . . 0.78 108.851 -179.003 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.5 t -130.25 -40.73 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.235 -1.394 . . . . 1.04 107.235 178.593 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -103.68 -0.69 29.18 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.139 -1.43 . . . . 2.44 107.139 177.905 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.539 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 47.7 t-20 60.03 48.74 8.28 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.354 0.597 . . . . 1.55 110.231 179.812 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.694 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 96.5 mt-30 -140.03 153.04 46.7 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.403 -0.81 . . . . 1.99 109.401 179.577 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 66.5 t -119.55 129.94 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.942 -0.762 . . . . 0.77 108.942 179.494 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -103.76 124.87 49.68 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.541 -0.911 . . . . 0.98 108.541 179.247 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 40.6 t -100.74 108.05 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.456 -0.777 . . . . 0.85 110.347 -178.978 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 49.39 66.71 5.3 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.199 -0.938 . . . . 1.66 110.367 179.012 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -85.57 156.23 10.56 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.875 2.383 . . . . 0.95 111.716 179.469 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 42.3 p -72.89 162.6 29.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.207 -0.933 . . . . 1.84 109.673 -179.558 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -59.86 -39.68 86.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.444 -0.785 . . . . 2.74 110.228 -179.537 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -58.03 -39.37 78.2 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.234 -0.916 . . . . 2.89 109.461 -179.037 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 77.1 t -68.96 -41.65 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.019 -1.051 . . . . 1.3 109.369 179.653 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.495 1.788 0 O-C-N 121.145 -0.972 . . . . 1.09 109.881 -179.889 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . 0.426 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 40.7 ttp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.613 0.72 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . 0.426 ' N ' ' CG ' ' B' ' 301' ' ' MET . 15.7 t80 -149.81 146.57 27.22 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.451 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . 0.473 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 0.2 OUTLIER -150.25 159.98 44.04 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.882 -1.136 . . . . 0.0 110.551 -179.312 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -157.78 154.71 28.56 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.021 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -115.14 133.33 56.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.258 -0.901 . . . . 0.0 109.951 179.6 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 4.2 p -128.95 124.55 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-O 122.279 1.037 . . . . 0.0 112.364 -176.881 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . 0.415 ' O ' HG23 ' B' ' 309' ' ' THR . 91.6 m -77.81 102.49 7.23 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.825 0.821 . . . . 0.0 110.898 -178.245 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' B' ' 358' ' ' GLY . 97.4 mt -52.92 123.28 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 122.403 1.097 . . . . 0.0 110.813 -178.201 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . 0.415 HG23 ' O ' ' B' ' 307' ' ' THR . 77.6 p -109.99 20.02 18.4 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.768 -178.368 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -83.13 115.47 59.13 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.1 -1.0 . . . . 0.0 109.854 179.894 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -54.03 -7.2 0.61 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 CA-C-N 120.174 1.098 . . . . 0.0 112.973 179.809 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -117.42 3.53 12.5 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.301 -0.874 . . . . 0.0 109.451 -179.987 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 68.09 -178.9 20.33 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -178.764 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.476 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -83.0 83.29 7.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.686 -1.479 . . . . 0.0 109.593 -178.444 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.472 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 2.6 p80 -91.89 -160.02 0.7 Allowed 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.132 -0.98 . . . . 0.0 109.769 178.403 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.2 m -56.76 -47.7 79.5 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.806 -1.184 . . . . 0.0 112.984 -175.852 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.599 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 11.3 tpt180 -56.35 -59.72 11.19 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 120.388 -1.445 . . . . 0.0 111.919 -179.23 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.472 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 12.0 Cg_endo -58.83 -34.63 99.13 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 CA-C-N 120.369 1.168 . . . . 0.0 111.521 -179.525 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.68 72.8 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.986 179.914 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.78 -44.09 77.41 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.48 -179.078 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -70.01 -41.67 74.03 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.964 -1.095 . . . . 0.0 108.528 179.347 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -63.04 -53.96 45.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.448 -0.783 . . . . 0.0 110.346 -179.733 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 84.2 t -61.77 -28.23 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.528 -1.357 . . . . 0.0 109.768 -179.006 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -64.56 -42.56 95.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.063 -1.023 . . . . 0.0 109.48 -179.92 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -69.77 -42.04 74.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.321 -0.862 . . . . 0.0 111.429 -178.509 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . 0.421 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -61.65 -54.66 39.74 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.498 -1.376 . . . . 0.0 111.244 -178.591 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -54.15 -10.21 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.894 -1.129 . . . . 0.0 109.633 -179.672 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . 0.421 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -71.96 -28.8 67.99 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.249 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -104.59 144.08 32.18 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.335 -1.097 . . . . 0.0 109.458 -179.661 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . 0.403 HG22 ' O ' ' B' ' 330' ' ' THR . 91.5 m -90.56 -11.46 40.0 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.137 -0.977 . . . . 0.0 109.742 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 58.9 m -65.58 153.73 40.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.998 . . . . 0.0 109.45 179.999 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.44 134.98 49.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.078 -1.014 . . . . 0.0 109.164 -179.74 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.1 mt -131.89 132.81 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.519 -0.738 . . . . 0.0 109.453 -179.718 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 24.6 m -129.12 149.89 50.74 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.462 -0.774 . . . . 0.0 109.618 -179.814 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 90.8 t -123.66 115.4 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.404 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 94.0 m -113.73 122.8 48.21 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.09 -1.007 . . . . 0.0 110.928 -177.903 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . 0.428 ' C ' ' H ' ' B' ' 339' ' ' GLY . 16.8 t -121.98 127.84 50.79 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.414 0.626 . . . . 0.0 109.312 178.873 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 35.6 m120 57.77 6.37 0.44 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.601 0.715 . . . . 0.0 109.481 -178.777 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' B' ' 337' ' ' SER . . . 101.19 13.16 34.23 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.23 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -104.57 121.15 42.91 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.616 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 58.2 p -100.16 151.54 21.31 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.259 1.028 . . . . 0.0 112.54 -177.026 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -149.76 148.72 29.56 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.35 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . 0.414 ' H ' ' HE2' ' B' ' 349' ' ' LYS . 1.8 t -89.27 130.01 35.74 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.991 -1.068 . . . . 0.0 110.777 -178.725 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -70.16 -19.91 63.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.267 -0.896 . . . . 0.0 110.311 -179.663 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -84.19 21.71 1.34 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.8 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . 0.589 ' CB ' ' HZ3' ' B' ' 349' ' ' LYS . 14.6 p -152.08 98.14 2.4 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.877 0.846 . . . . 0.0 111.21 179.583 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.65 HD23 HD22 ' A' ' 79' ' ' LEU . 45.9 tp -59.69 -32.74 70.78 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.832 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.801 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.9 m-85 -52.93 -51.88 59.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.329 -0.857 . . . . 0.0 111.386 -179.625 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . 0.589 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 33.6 mtmm -70.01 -40.0 75.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.727 -1.233 . . . . 0.0 111.108 -178.324 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' B' ' 352' ' ' THR . 88.7 mt -49.08 -57.09 7.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.798 -1.189 . . . . 0.0 109.931 -178.832 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.714 ' NE2' ' HE ' ' A' ' 126' ' ' ARG . 4.0 mm100 -44.86 -10.84 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.053 -1.029 . . . . 0.0 111.15 -177.697 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.565 ' N ' ' O ' ' B' ' 350' ' ' LEU . 72.5 p -87.24 -13.34 44.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 119.895 -1.753 . . . . 0.0 110.258 -178.978 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 53.0 mt -94.77 122.41 37.36 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.931 -1.106 . . . . 0.0 109.499 179.001 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.1 92.14 1.04 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 179.368 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 25.8 mt -101.83 95.37 6.36 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.424 -1.045 . . . . 0.0 109.176 179.817 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 75.0 p -93.64 -179.74 5.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.222 -0.924 . . . . 0.0 111.048 -178.954 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -69.27 114.16 7.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.711 -0.618 . . . . 0.0 110.51 -179.508 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 99.99 10.17 46.73 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.759 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 53.2 m -87.18 111.39 20.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -1.094 . . . . 0.0 110.195 -179.822 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 68.0 t -77.08 114.61 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.024 0.916 . . . . 0.0 109.61 -177.384 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 11.8 m -108.26 176.7 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -178.936 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 43.3 m -131.61 126.62 35.19 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.597 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.3 mt -103.49 117.79 49.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.398 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 64.8 m -118.72 130.82 56.03 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.108 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.41 150.8 39.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.267 -178.995 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -145.49 124.36 12.7 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.268 -0.895 . . . . 0.0 109.059 179.579 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.558 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.6 -154.49 25.57 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.403 -1.38 . . . . 0.0 111.072 -179.602 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -59.98 -50.63 73.01 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.468 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.419 ' N ' ' OG ' ' B' ' 331' ' ' SER . 85.1 m-20 -110.03 11.03 24.06 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.838 -1.163 . . . . 0.0 111.192 -177.193 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -40.84 -36.21 0.6 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.334 -0.853 . . . . 0.0 111.79 -178.992 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -69.13 -41.32 77.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.65 -1.281 . . . . 0.0 110.007 -178.526 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -72.97 -54.93 7.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.001 -1.062 . . . . 0.0 110.062 179.763 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -42.33 -34.33 0.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.545 -0.722 . . . . 0.0 111.238 -178.766 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.561 ' O ' HG23 ' B' ' 378' ' ' VAL . 93.3 t -80.0 -35.47 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.758 -1.214 . . . . 0.0 109.55 179.289 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -69.95 -39.99 75.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 112.303 -179.112 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -80.08 -46.61 16.21 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.383 -1.448 . . . . 0.0 110.432 -179.465 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.0 -38.03 81.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.889 . . . . 0.0 108.995 -179.637 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.561 HG23 ' O ' ' B' ' 374' ' ' VAL . 26.9 t -61.5 -48.22 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.277 -0.889 . . . . 0.0 109.718 179.381 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.02 -56.51 6.77 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.625 -1.297 . . . . 0.0 107.613 178.785 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.449 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 46.6 tp -52.51 -32.19 39.12 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.364 -0.835 . . . . 0.0 109.201 -179.176 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 34.3 ttm -76.07 -39.63 54.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 0.0 108.63 177.74 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.12 -5.06 50.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.58 -0.7 . . . . 0.0 109.873 179.614 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -108.26 3.74 23.89 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.29 -0.881 . . . . 0.0 110.499 -179.364 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . 0.449 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 27.6 mt -74.84 125.4 28.73 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.453 -1.404 . . . . 0.0 109.543 179.708 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.323 179.715 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtt . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.449 -0.575 . . . . 2.91 109.449 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.1 mt -109.9 129.23 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.504 -0.748 . . . . 1.2 109.201 179.808 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.6 m -140.64 122.33 15.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.306 -0.871 . . . . 1.4 109.607 -179.903 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.44 -161.47 31.4 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 108.962 -1.655 . . . . 1.05 108.962 179.319 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 5' ' ' ILE . 97.3 mt -90.22 -9.96 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.114 -1.227 . . . . 1.15 110.42 -179.028 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.6 tp 52.55 99.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.974 -1.079 . . . . 0.98 109.441 179.884 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.27 -27.31 15.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.118 -0.989 . . . . 0.88 109.535 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.0 t -136.4 121.14 12.91 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.385 -0.822 . . . . 1.69 109.22 179.944 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.08 144.77 24.02 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.788 1.659 . . . . 0.85 111.989 -179.949 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.885 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.72 -159.88 30.99 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.117 -1.593 . . . . 0.92 109.117 -179.576 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.8 mt -149.94 151.64 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 121.248 -1.148 . . . . 0.81 108.587 179.041 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.78 156.49 34.87 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.735 -1.228 . . . . 0.51 110.561 179.261 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -138.27 128.4 25.74 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.375 -1.343 . . . . 0.62 107.375 178.752 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.85 -179.84 47.61 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 118.666 -1.73 . . . . 0.55 110.823 -179.819 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -80.07 159.38 26.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.757 -0.849 . . . . 2.1 109.35 -179.832 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.524 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -107.09 131.51 54.02 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.408 -0.807 . . . . 0.77 111.011 -179.076 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.7 tp -98.7 139.54 34.25 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.245 -1.391 . . . . 0.91 107.245 178.161 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 34.2 tp -117.06 121.32 40.98 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.288 -0.883 . . . . 0.93 110.305 -178.971 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.422 HD12 ' HB2' ' A' ' 160' ' ' ALA . 45.4 mt -96.41 107.74 20.17 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.384 0.611 . . . . 0.93 110.036 179.905 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.623 ' HB2' ' HZ3' ' A' ' 20' ' ' LYS . 1.5 mtmp? -101.87 139.61 37.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.462 -0.774 . . . . 2.75 109.044 179.493 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -128.27 121.75 30.04 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.407 -0.808 . . . . 3.0 108.829 179.419 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 59.3 t0 -75.79 146.53 39.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.084 -1.01 . . . . 2.77 109.598 179.859 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.5 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 84.9 tt0 -61.63 140.19 58.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.406 -0.809 . . . . 2.94 109.823 -179.793 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.4 mt -78.89 132.93 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 0.95 108.872 179.954 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -94.81 122.33 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.022 -1.049 . . . . 1.28 109.961 -179.389 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.05 138.54 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.083 -0.71 . . . . 1.21 109.083 179.979 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -89.43 123.47 33.6 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.059 -1.026 . . . . 1.81 110.255 -179.347 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.547 HH11 ' HG2' ' A' ' 28' ' ' ARG . 0.8 OUTLIER -93.96 3.81 54.82 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.379 -0.826 . . . . 2.8 109.651 -179.962 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -72.92 151.34 41.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.272 -0.892 . . . . 2.87 111.17 -178.753 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -93.24 145.61 24.31 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.581 -0.896 . . . . 2.35 108.581 179.092 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -98.46 167.02 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.071 -1.018 . . . . 0.97 110.297 -179.907 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.2 p -93.74 171.79 8.66 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.492 -0.929 . . . . 1.17 108.492 178.658 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.07 -47.21 86.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.044 -1.035 . . . . 1.18 109.45 -179.915 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -55.86 -31.9 63.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.951 -1.093 . . . . 2.56 109.834 -179.26 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -81.5 -10.23 59.52 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.347 -0.845 . . . . 1.79 110.608 -179.091 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.4 t -60.09 -49.98 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.977 -1.077 . . . . 1.0 109.132 -179.96 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.96 -40.02 91.76 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.341 -0.85 . . . . 1.77 109.614 179.799 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.58 -46.0 87.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.245 -0.909 . . . . 2.7 111.551 -178.837 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -61.39 -42.53 98.88 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.599 -1.313 . . . . 1.51 110.457 -179.085 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.04 -46.58 94.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.55 -1.344 . . . . 0.93 108.184 179.92 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -61.6 -43.9 98.0 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.257 -0.902 . . . . 1.81 109.786 179.34 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -59.99 -41.15 91.43 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.745 -1.222 . . . . 2.78 107.764 179.557 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -63.3 -44.61 94.52 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.708 -0.849 . . . . 0.78 108.708 178.246 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.08 -47.84 84.19 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.57 -0.706 . . . . 1.07 109.222 179.971 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.1 t -63.96 -44.98 91.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.065 -1.022 . . . . 1.12 108.908 179.362 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.56 -39.95 98.04 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.763 -2.135 . . . . 0.84 107.763 178.554 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.421 HH21 ' HA ' ' A' ' 81' ' ' GLU . 68.5 ttt180 -67.16 -35.81 80.47 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.572 -0.899 . . . . 3.09 108.572 178.63 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.97 87.62 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.554 -0.716 . . . . 0.88 109.621 -179.611 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.9 ttpt -64.91 -73.77 0.12 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.883 -1.136 . . . . 2.59 108.372 179.491 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.67 -38.57 0.28 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.38 -0.825 . . . . 0.7 111.203 -178.165 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.1 m -54.04 -56.85 14.1 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.718 -1.239 . . . . 1.4 108.939 179.732 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.92 88.3 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.22 -0.925 . . . . 0.67 111.123 -179.163 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -68.46 -40.07 81.17 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.956 -1.09 . . . . 1.66 109.978 -179.2 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.6 mt -65.54 -40.01 92.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.077 -1.014 . . . . 1.58 109.975 179.897 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.539 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 69.3 mm-40 -61.53 -39.96 92.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.084 -1.01 . . . . 1.35 109.869 -179.815 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -62.84 -40.03 96.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.021 -1.049 . . . . 0.77 109.967 -179.931 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.05 -39.85 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.179 -0.95 . . . . 0.63 108.911 179.669 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.539 ' NZ ' ' OE1' ' A' ' 55' ' ' GLU . 5.2 ttpm? -55.92 -49.98 71.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.92 . . . . 1.14 109.081 179.74 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -57.51 -33.54 68.15 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.374 -0.829 . . . . 0.79 110.512 -178.318 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -69.97 -38.86 76.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.897 -1.127 . . . . 1.53 110.005 179.965 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.462 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.23 -45.51 76.54 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.401 -0.812 . . . . 0.57 110.487 -179.241 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.66 -50.03 72.15 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.917 -1.135 . . . . 0.75 110.45 -178.68 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.95 -42.88 72.62 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.076 -1.25 . . . . 1.59 110.325 -179.563 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.9 m -70.13 -61.37 1.8 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.206 -0.934 . . . . 0.73 112.744 -177.678 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -93.3 -49.36 5.99 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.679 -1.263 . . . . 0.75 110.711 -178.437 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.76 -167.89 25.77 Favored Glycine 0 N--CA 1.5 2.918 0 C-N-CA 119.936 -1.125 . . . . 1.22 110.849 179.65 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -68.55 -22.12 64.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.805 -0.821 . . . . 5.81 109.859 -179.889 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -60.04 -36.22 76.82 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.654 -0.653 . . . . 3.37 110.371 -179.531 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -101.19 -15.43 17.35 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.352 -0.843 . . . . 1.77 110.322 -179.449 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -69.97 -40.2 75.51 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.933 -1.104 . . . . 1.65 110.585 -179.311 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.563 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -69.8 -28.65 65.91 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.611 -0.836 . . . . 0.77 109.91 -178.564 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.7 mt -60.06 -41.92 88.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.022 -1.071 . . . . 0.8 109.143 -179.903 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -65.88 -40.01 91.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.954 -1.091 . . . . 0.88 109.921 179.99 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -60.15 -40.41 89.77 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.9 -1.125 . . . . 1.37 109.254 179.834 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.86 -41.48 98.76 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.064 -2.014 . . . . 0.62 108.064 178.9 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.3 m170 -70.09 -43.69 70.56 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.618 -0.931 . . . . 1.5 108.595 179.169 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.9 mt -70.04 -46.63 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.367 -0.833 . . . . 0.63 109.369 179.433 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.5 ttp -60.68 -44.8 96.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.057 -1.027 . . . . 1.51 109.687 -179.61 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.859 HD11 ' CE2' ' B' ' 348' ' ' PHE . 50.8 tp -60.0 -40.06 87.91 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.802 -0.814 . . . . 0.77 108.802 179.142 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.7 tp -62.94 -39.95 96.16 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.671 -0.643 . . . . 0.62 109.537 179.614 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.421 ' HA ' HH21 ' A' ' 47' ' ' ARG . 99.7 mt-10 -79.44 5.2 13.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -0.861 . . . . 1.47 110.127 -179.14 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -56.08 128.99 38.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 1.47 110.291 -179.309 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -63.04 -14.08 43.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.591 -0.693 . . . . 1.78 110.059 -179.985 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -70.08 -37.08 75.37 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.231 -1.025 . . . . 2.53 108.231 178.505 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.03 -39.98 75.46 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.658 0.742 . . . . 0.8 109.757 179.407 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -60.05 -45.48 92.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.59 -0.694 . . . . 1.42 110.895 -178.417 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -70.78 -48.55 53.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.257 -0.902 . . . . 1.71 111.667 -178.584 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -64.16 -39.9 95.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.352 -0.842 . . . . 1.57 111.734 -177.409 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -66.27 -47.77 83.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 120.838 -1.164 . . . . 0.65 109.857 -179.541 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -70.01 -39.04 76.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.415 -0.803 . . . . 0.82 110.671 -179.674 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.97 -48.86 79.95 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.173 -0.954 . . . . 0.79 111.045 -178.917 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 96' ' ' LYS . 75.7 mt -60.01 -44.9 94.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.917 -1.115 . . . . 0.95 109.501 -178.955 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.8 mt -60.23 -50.0 81.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.76 -1.2 . . . . 0.66 107.76 178.86 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -65.07 -40.05 94.14 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 120.024 -0.67 . . . . 2.2 110.243 179.359 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 91' ' ' ALA . 56.7 t0 -84.26 -55.11 4.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.995 -1.066 . . . . 1.65 112.277 -178.241 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 92' ' ' LEU . 99.0 mttt -90.04 -1.98 58.05 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.812 -1.18 . . . . 2.03 112.145 -177.348 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 57.85 37.54 26.99 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.846 -1.159 . . . . 1.42 109.379 -179.534 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.9 mtt -93.04 166.38 12.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.497 -0.752 . . . . 1.18 109.879 -179.758 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.4 p -79.95 160.0 26.11 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.034 -0.728 . . . . 0.98 109.034 179.678 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.05 77.59 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.321 -0.862 . . . . 0.64 109.755 -179.999 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.43 ' OD1' HD22 ' A' ' 138' ' ' LEU . 20.3 t0 -65.51 -40.03 92.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.084 -1.01 . . . . 2.07 109.521 179.665 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.6 -43.12 23.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.73 110.352 -179.684 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.05 -41.69 73.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 0.54 110.278 -179.442 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.95 -39.68 95.39 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.122 -0.986 . . . . 0.56 109.474 179.956 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.546 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 81.1 t60 -59.62 -40.07 86.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.551 -0.718 . . . . 1.54 109.578 -178.804 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.422 ' O ' ' N ' ' A' ' 110' ' ' GLY . 87.2 tt0 -64.61 -40.02 94.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.305 -0.872 . . . . 1.33 110.55 -179.655 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.3 t -63.86 -60.61 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.148 -0.97 . . . . 0.72 111.478 -178.308 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.0 mm -65.06 -39.96 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.855 -1.153 . . . . 0.85 109.268 -179.459 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.546 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 85.3 tt0 -67.04 -39.98 87.08 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.076 -1.083 . . . . 2.44 108.076 178.275 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -56.82 -52.14 52.67 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.23 -1.148 . . . . 0.98 110.23 -179.27 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . 0.439 HE21 ' HB3' ' B' ' 348' ' ' PHE . 22.9 mm100 -65.07 -48.14 74.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.785 -1.421 . . . . 1.41 109.197 -179.848 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.08 85.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 1.2 109.03 179.676 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.5 m -59.57 -39.87 85.5 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.468 -0.77 . . . . 1.7 109.018 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.44 -40.03 92.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 1.47 109.015 179.02 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.2 mt -64.2 -41.87 96.88 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.273 -0.892 . . . . 1.56 109.784 -179.247 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.02 -33.78 72.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.822 -1.174 . . . . 2.2 109.783 -179.272 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -56.92 -20.52 23.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.108 -0.995 . . . . 2.12 108.927 179.949 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.0 mt -62.63 138.66 58.54 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.188 -1.041 . . . . 2.0 108.188 179.469 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 57.9 t0 -94.69 54.97 1.84 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.931 -1.105 . . . . 3.23 110.086 -179.611 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 58.9 t0 -136.1 136.7 40.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.345 -0.847 . . . . 2.49 108.938 179.23 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.461 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 98.9 mt-10 -70.02 -31.61 69.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.42 -0.8 . . . . 3.95 109.964 -179.537 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.508 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.4 t80 -72.64 -38.86 67.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.871 . . . . 2.0 110.728 179.886 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.409 HD22 ' O ' ' B' ' 351' ' ' GLN . 70.7 mt -74.12 -36.26 64.18 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.975 -1.078 . . . . 1.86 109.745 -179.369 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -60.04 -40.0 87.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.015 -1.053 . . . . 2.84 109.357 179.601 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -60.0 -47.31 86.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 2.73 109.482 179.957 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.545 HH21 ' NE2' ' B' ' 351' ' ' GLN . 62.0 mtp180 -60.18 -39.98 88.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.963 . . . . 2.77 108.663 179.201 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.53 -36.12 77.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.82 . . . . 1.19 108.846 178.972 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.89 -40.02 96.26 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.081 -0.711 . . . . 1.2 109.081 179.684 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -64.22 -40.93 97.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 1.55 110.111 -179.352 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.55 -41.88 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.8 109.616 -179.889 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -60.01 -38.1 81.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.141 -0.974 . . . . 3.09 109.4 179.48 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -59.92 -40.88 90.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 1.46 110.361 -178.948 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.19 -45.01 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.894 -1.129 . . . . 0.71 109.581 179.815 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.97 -37.91 93.64 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.713 -1.355 . . . . 0.57 109.713 179.995 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -60.03 -47.6 85.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -1.111 . . . . 2.59 109.56 -179.378 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.418 HH12 ' HB3' ' A' ' 166' ' ' SER . 61.0 mtp180 -68.76 -33.16 73.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.238 -0.914 . . . . 2.83 109.637 -179.772 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.7 tp -57.28 -43.7 83.37 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.355 -0.841 . . . . 1.25 108.995 -179.788 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.43 HD22 ' OD1' ' A' ' 101' ' ' ASP . 84.1 mt -63.66 -39.96 95.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.13 -0.982 . . . . 0.7 108.654 179.145 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.6 mtp180 -66.89 -39.97 87.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.912 -0.773 . . . . 2.57 108.912 179.465 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -69.44 -31.7 70.18 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.554 -0.716 . . . . 1.23 110.941 -179.31 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.0 mt -70.04 -43.29 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.401 -1.437 . . . . 0.81 108.193 178.728 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 88.9 mt -71.56 -29.99 65.36 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.792 -0.568 . . . . 1.0 109.901 -179.708 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.69 40.33 8.31 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.983 -1.647 . . . . 0.89 108.983 -179.28 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.405 ' HA ' HD12 ' A' ' 144' ' ' LEU . 18.5 tp -73.99 146.36 43.88 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.386 -1.067 . . . . 1.14 109.14 -179.479 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -65.08 147.92 52.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -0.894 . . . . 4.6 110.002 -178.892 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 98.6 mt -118.89 125.63 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 122.093 0.949 . . . . 1.24 109.325 179.49 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 148' ' ' ASP . 5.5 mt -62.38 -43.58 98.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.87 -0.605 . . . . 1.54 110.219 -178.859 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 147' ' ' ILE . 32.2 t0 62.01 125.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.968 -0.753 . . . . 1.5 108.968 -179.126 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.4 mt -87.08 -2.09 58.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.256 -0.903 . . . . 0.79 109.639 -179.274 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 93.8 p -82.26 -9.96 59.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.916 -1.115 . . . . 1.4 108.752 178.951 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -88.71 18.54 4.61 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.666 . . . . 0.92 110.925 -177.818 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 65.2 mt -91.74 116.92 33.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.871 -1.143 . . . . 0.88 109.15 179.621 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -103.03 -12.03 17.72 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.251 -0.905 . . . . 2.45 110.206 -179.268 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -116.01 145.72 42.74 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.318 -0.864 . . . . 1.52 110.347 -178.805 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.81 131.97 50.63 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.496 -0.928 . . . . 1.58 108.496 179.584 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.7 m -152.57 165.23 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.69 109.954 -179.947 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.5 mt -93.31 148.8 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 105.215 -2.142 . . . . 0.61 105.215 176.776 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 39.9 tp -99.35 120.01 38.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.838 -1.164 . . . . 0.87 110.609 -177.836 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 49.6 t -123.59 130.08 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 108.752 -0.833 . . . . 0.71 108.752 179.343 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . 0.422 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -156.72 162.69 39.78 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.4 -0.963 . . . . 0.81 108.4 179.837 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.95 -35.83 74.8 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.185 -1.572 . . . . 0.98 107.315 178.547 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 20.8 p-10 -171.21 144.69 2.09 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.582 -0.895 . . . . 2.25 108.582 179.287 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.2 mt -111.78 139.83 46.93 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.253 -0.905 . . . . 0.78 109.863 -179.438 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.1 p -93.19 145.28 29.77 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.392 -0.818 . . . . 0.98 109.501 -179.929 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -39.36 -36.94 1.03 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.405 2.07 . . . . 0.81 113.273 179.458 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.418 ' HB3' HH12 ' A' ' 136' ' ' ARG . 68.5 m -60.01 -39.97 87.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.026 -1.046 . . . . 0.9 109.776 -178.661 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.03 -42.0 90.19 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.023 -1.048 . . . . 1.61 110.217 -179.506 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 67.8 p -54.96 -30.61 59.41 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.136 -0.977 . . . . 0.61 110.598 -178.4 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.462 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -71.36 -54.27 11.33 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.028 -1.045 . . . . 0.6 109.879 179.77 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -87.32 39.15 0.85 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.183 -1.043 . . . . 1.4 108.183 179.88 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 33.7 tp -100.22 130.62 46.37 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.622 -0.674 . . . . 0.7 109.307 179.472 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . 0.469 ' O ' HG23 ' A' ' 176' ' ' VAL . 77.8 m-20 -82.12 98.5 8.71 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.185 -1.043 . . . . 2.35 108.185 179.307 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 73.6 mt -67.16 -40.52 86.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.378 -0.826 . . . . 1.51 110.872 -178.592 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.39 -30.32 71.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.651 -1.281 . . . . 2.33 112.094 -177.714 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.65 -5.86 50.57 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.712 -1.243 . . . . 1.92 110.061 -178.734 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 178' ' ' GLY . 84.0 t -106.24 116.62 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.134 -0.979 . . . . 0.67 109.307 179.652 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 78.1 mt -88.04 9.96 20.71 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.475 -0.765 . . . . 1.53 110.997 -177.786 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.507 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 165.64 176.59 37.22 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.62 -1.392 . . . . 0.48 109.62 179.858 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -137.64 131.21 31.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.456 -1.026 . . . . 0.55 108.853 -179.82 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.402 ' CG2' HG21 ' A' ' 205' ' ' THR . 97.4 mt -133.46 130.0 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.772 -0.825 . . . . 0.65 108.772 179.002 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 72.1 p -148.4 160.0 43.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.965 -1.084 . . . . 0.82 110.855 -179.82 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -109.03 31.18 5.9 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.192 -1.04 . . . . 2.46 108.192 178.966 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.35 -160.44 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.919 -1.113 . . . . 1.28 111.516 -177.605 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.4 -67.68 1.99 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.34 -1.104 . . . . 2.19 110.34 -179.092 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 178.39 -130.98 1.65 Allowed Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.974 -1.584 . . . . 2.13 110.981 -179.802 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -79.46 -10.01 59.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.634 -0.921 . . . . 5.86 111.025 -178.504 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 42.9 p -81.8 4.87 20.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.968 -1.083 . . . . 3.72 109.687 -179.253 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.421 ' OG ' ' OG ' ' A' ' 191' ' ' SER . 23.4 p -90.43 137.54 32.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.134 -0.979 . . . . 1.74 110.593 -179.522 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -48.34 -47.86 36.7 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.475 -0.766 . . . . 0.95 109.673 179.977 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 98.5 m -57.4 -37.79 73.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.455 -0.778 . . . . 1.55 110.717 -178.992 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.421 ' OG ' ' OG ' ' A' ' 188' ' ' SER . 52.8 m -60.03 -39.9 87.49 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.854 -1.154 . . . . 1.51 110.354 -178.97 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 45.1 mm -64.85 -40.05 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 1.67 110.128 -179.599 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.3 mtp -60.1 -46.87 88.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.091 -1.006 . . . . 1.02 110.701 -179.765 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.71 -45.58 77.86 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.537 -1.352 . . . . 0.68 109.378 -179.589 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -60.1 -54.98 39.57 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.0 -1.062 . . . . 2.93 109.468 179.67 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 69.3 m -63.09 -40.05 96.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 0.86 110.966 -179.3 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.16 -29.17 64.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.985 -1.072 . . . . 0.67 108.468 179.73 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.97 50.03 1.09 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.285 0.564 . . . . 1.5 110.277 -179.842 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 32.7 mt -124.95 145.97 51.89 Favored Pre-proline 0 N--CA 1.503 2.212 0 N-CA-C 108.497 -0.927 . . . . 0.72 108.497 178.91 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.27 125.29 7.04 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.094 1.862 . . . . 0.61 112.555 179.737 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.26 141.23 7.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.489 -1.382 . . . . 0.66 112.154 179.866 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.84 147.14 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 107.173 -1.417 . . . . 0.79 107.173 177.811 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 17.3 m -130.78 -7.53 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 120.833 -1.167 . . . . 0.91 111.177 -178.991 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.99 23.05 24.37 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.454 -1.058 . . . . 1.01 110.454 -179.497 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.415 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 2.4 p -45.38 -44.18 11.67 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.93 -1.335 . . . . 0.99 109.88 -179.602 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 93.5 -51.65 2.38 Favored Glycine 0 N--CA 1.5 2.93 0 C-N-CA 120.129 -1.034 . . . . 1.12 111.742 178.692 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.3 t -161.9 36.23 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.577 -1.543 . . . . 1.72 110.676 -179.354 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 52.6 t -74.32 -40.83 50.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.215 -0.928 . . . . 0.89 108.934 178.409 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 209' ' ' THR . 1.5 p -53.1 -31.93 44.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.403 -0.811 . . . . 1.03 110.063 -179.147 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 39.8 t -71.11 -33.35 70.05 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.168 -0.957 . . . . 1.83 109.741 -179.741 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -89.46 -9.95 48.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 2.27 110.274 -178.995 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 69.6 t -101.52 132.85 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.254 -0.904 . . . . 0.92 110.463 -178.887 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -114.15 153.52 29.4 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.549 -1.278 . . . . 2.2 107.549 178.834 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 8.9 t-20 -58.8 138.7 57.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.946 -1.097 . . . . 2.36 110.345 -178.605 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 11.6 t0 83.78 5.28 0.76 Allowed 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.113 0.482 . . . . 2.38 109.998 179.699 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.4 t0 -75.72 140.86 42.68 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.071 -1.018 . . . . 2.09 108.862 179.146 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.498 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 51.3 t80 -93.29 117.06 29.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.146 -0.971 . . . . 1.27 108.41 179.155 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.524 HD12 ' HB2' ' A' ' 16' ' ' ALA . 57.4 mt -126.42 147.35 49.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.526 -0.734 . . . . 0.75 110.379 -178.929 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . 0.413 HG23 ' CD2' ' A' ' 13' ' ' PHE . 86.8 mt -114.34 130.02 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 107.664 -1.236 . . . . 0.63 107.664 177.554 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 32.7 tp -100.17 118.18 35.96 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.938 -1.101 . . . . 0.7 109.571 -179.096 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.645 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 26.4 p-10 -77.64 -42.84 33.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.068 -1.02 . . . . 2.31 108.591 179.231 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.885 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 52.1 17.27 0.66 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.796 -1.187 . . . . 0.78 107.796 -178.905 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.436 ' N ' ' C ' ' A' ' 221' ' ' ASP . 45.6 t -130.86 -43.66 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.708 -1.219 . . . . 1.04 107.708 179.362 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -99.14 -0.52 41.5 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.805 -1.554 . . . . 2.44 106.805 177.942 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.521 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 40.4 t-20 60.06 46.72 10.43 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.423 -0.584 . . . . 1.55 109.423 -179.933 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.645 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 95.3 mt-30 -140.46 157.23 45.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.385 -0.822 . . . . 1.99 109.647 -179.945 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 69.5 t -119.96 130.58 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 109.085 -0.709 . . . . 0.77 109.085 179.437 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -99.33 122.74 42.89 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.576 -0.898 . . . . 0.98 108.576 179.001 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . 0.502 HG22 HD22 ' A' ' 218' ' ' LEU . 59.4 t -105.61 120.0 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.568 -0.707 . . . . 0.85 109.445 -179.242 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 62.96 66.76 1.17 Allowed Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.372 -0.83 . . . . 1.66 109.53 -179.731 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -89.16 127.78 1.79 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 123.142 2.561 . . . . 0.95 112.517 -179.664 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 26.0 p -75.33 170.47 16.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 1.84 109.623 -179.753 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -60.03 -39.44 85.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 2.74 109.088 179.67 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.08 -39.97 87.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.409 -0.807 . . . . 2.89 109.634 -179.382 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.6 t -67.24 -41.7 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.062 -1.024 . . . . 1.3 109.152 179.96 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 87.7 mt . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.193 -0.942 . . . . 1.09 109.921 -179.628 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 43.9 ttm . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.581 0.705 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -151.16 149.4 29.43 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.121 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -146.19 154.98 42.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.063 -1.023 . . . . 0.0 110.393 -179.226 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -150.36 146.72 26.89 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.598 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 56.8 mp0 -110.21 127.82 55.16 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.249 -0.907 . . . . 0.0 109.623 179.334 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.35 122.8 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 CA-C-O 122.295 1.045 . . . . 0.0 112.807 -176.849 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 58.8 m -77.95 101.52 6.9 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.997 0.903 . . . . 0.0 110.268 -178.987 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . 0.522 HG22 ' H ' ' B' ' 310' ' ' ALA . 96.9 mt -50.81 118.45 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 122.204 1.002 . . . . 0.0 109.923 -177.874 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 19.1 p -100.35 22.14 12.04 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.676 -178.776 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.522 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -86.82 114.24 57.16 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.97 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -68.82 -4.86 14.17 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 CA-C-N 120.227 1.117 . . . . 0.0 112.456 -179.283 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -108.76 4.81 24.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.518 -0.738 . . . . 0.0 109.101 179.741 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.6 169.77 8.65 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 -179.051 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.508 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -86.14 92.05 8.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.3 . . . . 0.0 108.846 -179.138 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.405 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 5.4 p80 -95.23 -159.94 0.75 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.085 -1.009 . . . . 0.0 109.98 179.029 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.3 m -58.92 -44.67 91.36 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.931 -1.106 . . . . 0.0 112.611 -175.995 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.615 ' NH2' ' NE2' ' B' ' 321' ' ' GLN . 1.6 tpt180 -59.88 -60.59 10.09 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 120.487 -1.383 . . . . 0.0 112.027 -178.257 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.405 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 12.0 Cg_endo -59.94 -32.04 94.55 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 CA-C-N 120.362 1.165 . . . . 0.0 111.338 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.28 70.32 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.431 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.78 -40.09 65.99 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.601 -179.079 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . 0.615 ' NE2' ' NH2' ' B' ' 317' ' ' ARG . 50.0 mt-30 -69.87 -41.0 75.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.985 -1.072 . . . . 0.0 108.662 179.061 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -60.05 -51.26 70.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.72 -0.612 . . . . 0.0 110.343 -179.223 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . 0.401 HG13 ' O ' ' B' ' 344' ' ' ALA . 71.1 t -69.68 -35.75 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.946 -1.096 . . . . 0.0 109.743 -179.134 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -50.05 -49.89 49.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.387 -0.821 . . . . 0.0 109.122 -179.792 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -60.07 -49.9 75.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.269 -0.895 . . . . 0.0 109.339 -179.387 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -63.14 -47.11 84.11 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.157 -0.964 . . . . 0.0 109.765 179.765 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -48.4 -26.64 2.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.531 -0.73 . . . . 0.0 109.678 -179.339 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -82.59 -15.74 72.7 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.655 -179.181 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -105.72 135.0 47.92 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.26 -1.141 . . . . 0.0 109.434 179.736 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 16.9 m -90.6 -13.36 34.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.977 -1.077 . . . . 0.0 109.246 179.651 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 52.0 p -55.05 148.77 13.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.228 -0.92 . . . . 0.0 108.848 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -68.35 128.72 37.61 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.002 -1.061 . . . . 0.0 108.567 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 95.3 mt -132.34 132.32 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.675 -0.641 . . . . 0.0 109.352 -179.809 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 27.1 m -130.63 152.36 50.08 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.449 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 46.0 t -114.73 140.16 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 178.521 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 94.2 m -130.13 122.69 28.72 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.196 -0.94 . . . . 0.0 108.646 179.604 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 2.8 t -140.53 118.14 11.59 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.936 0.875 . . . . 0.0 112.065 -178.906 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 50.05 50.5 18.42 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 175.806 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.95 -10.77 72.77 Favored Glycine 0 N--CA 1.502 3.089 0 O-C-N 119.802 -1.811 . . . . 0.0 113.85 176.11 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -128.26 140.31 51.96 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 120.022 1.911 . . . . 0.0 109.514 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.7 m -126.74 147.79 49.95 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.818 0.818 . . . . 0.0 111.377 -178.266 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.3 164.58 29.86 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.309 0.576 . . . . 0.0 109.694 179.98 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 27.3 m -88.63 138.01 31.8 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.319 -0.863 . . . . 0.0 110.03 -179.326 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.401 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -78.9 -12.0 60.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.896 -1.127 . . . . 0.0 109.86 -179.479 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -91.87 20.15 5.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 178.042 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 42.6 t -145.89 94.44 2.48 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.013 -179.699 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.816 HD23 HD22 ' A' ' 79' ' ' LEU . 60.8 tp -59.88 -33.85 72.38 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.829 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 79' ' ' LEU . 58.9 m-85 -57.25 -53.68 55.38 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.32 -0.863 . . . . 0.0 110.76 -179.337 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -70.01 -29.63 66.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.868 -1.145 . . . . 0.0 110.951 -177.989 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' B' ' 352' ' ' THR . 84.8 mt -60.06 -52.86 63.55 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.157 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.61 HE22 HD11 ' B' ' 347' ' ' LEU . 0.7 OUTLIER -42.42 -21.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.436 -0.79 . . . . 0.0 110.674 -178.009 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.463 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.1 p -81.74 -12.25 58.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.406 -1.434 . . . . 0.0 109.964 -179.112 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 31.4 mt -95.39 120.08 35.0 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.95 -1.094 . . . . 0.0 109.082 178.409 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -80.89 92.5 1.45 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.364 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 22.9 mt -98.42 93.07 5.98 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.111 -1.229 . . . . 0.0 108.139 178.695 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 53.6 p -95.17 -179.96 4.99 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.084 -1.01 . . . . 0.0 111.279 -178.249 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' B' ' 359' ' ' THR . 7.2 tt0 -46.86 154.65 0.31 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.175 0.988 . . . . 0.0 111.035 -179.546 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.98 26.88 0.05 OUTLIER Glycine 0 N--CA 1.497 2.743 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.157 177.754 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . 0.447 ' N ' ' O ' ' B' ' 357' ' ' GLN . 23.8 m -84.61 111.27 19.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.798 -1.413 . . . . 0.0 109.744 179.922 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 12.6 t -78.16 113.06 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 122.297 1.046 . . . . 0.0 109.774 -177.587 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 16.0 m -110.09 178.51 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.173 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 25.5 m -131.48 127.13 36.71 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.176 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 60.4 mt -103.43 118.9 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.96 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 58.3 p -121.19 133.23 55.17 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.401 -0.812 . . . . 0.0 109.283 -179.459 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.79 148.25 35.31 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.048 -1.032 . . . . 0.0 110.527 -179.046 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -140.03 121.19 14.78 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.275 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.561 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.38 -163.52 33.99 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.048 -1.549 . . . . 0.0 111.53 -179.758 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -59.97 -52.76 64.0 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 122.162 -0.61 . . . . 0.0 111.998 -177.896 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.507 ' H ' ' HB3' ' B' ' 331' ' ' SER . 96.0 m-20 -105.2 10.1 33.86 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.974 -1.079 . . . . 0.0 111.128 -177.407 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.561 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -42.18 -36.2 1.14 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.222 -0.924 . . . . 0.0 111.392 -179.155 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -70.0 -40.04 75.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.921 -1.112 . . . . 0.0 109.899 -179.012 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -66.51 -48.41 69.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.021 -1.049 . . . . 0.0 109.394 -179.441 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.07 -75.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 110.686 -179.098 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.64 ' O ' HG23 ' B' ' 378' ' ' VAL . 37.4 t -44.64 -38.26 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.235 -0.915 . . . . 0.0 110.881 -177.519 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.03 -51.37 64.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.576 -1.328 . . . . 0.0 110.887 -179.597 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -74.54 -40.67 61.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.88 -1.138 . . . . 0.0 109.976 -179.668 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.01 -39.79 87.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.897 . . . . 0.0 110.095 -179.502 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.64 HG23 ' O ' ' B' ' 374' ' ' VAL . 55.4 t -62.18 -43.39 97.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.211 -0.931 . . . . 0.0 109.968 -179.867 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -68.56 -54.59 15.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.615 -1.303 . . . . 0.0 108.617 178.687 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 50.1 tp -58.56 -34.72 71.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.23 -0.919 . . . . 0.0 109.937 -178.126 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 32.0 ttm -70.59 -40.05 73.46 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.408 -1.317 . . . . 0.0 108.42 177.927 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.24 -7.17 59.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.456 -0.777 . . . . 0.0 110.716 179.57 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -110.84 -1.74 16.41 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.077 -1.015 . . . . 0.0 111.54 -178.804 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.7 mt -81.89 130.25 35.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.297 -1.502 . . . . 0.0 109.197 178.823 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.328 179.937 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtt . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.61 -0.515 . . . . 2.91 109.61 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.39 127.74 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.297 -0.877 . . . . 1.2 109.491 -179.736 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.0 m -139.61 152.45 46.82 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.923 -0.769 . . . . 1.4 108.923 -179.929 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.89 -164.05 10.36 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 108.759 -1.736 . . . . 1.05 108.759 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.7 mt -88.57 -16.29 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.895 -1.356 . . . . 1.15 110.306 -179.133 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.1 tp 51.06 103.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.282 -0.886 . . . . 0.98 109.51 179.932 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.9 -25.38 14.63 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.06 -1.025 . . . . 0.88 109.523 179.604 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.5 m -134.83 121.19 14.69 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.511 -0.743 . . . . 1.69 109.432 -179.875 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -81.09 151.42 18.23 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.163 1.909 . . . . 0.85 112.81 179.947 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.926 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 142.35 177.82 17.77 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 109.248 -1.541 . . . . 0.92 109.248 179.597 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.6 mt -128.17 131.36 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 120.847 -1.384 . . . . 0.81 110.07 -179.555 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.4 155.98 49.35 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.252 -0.905 . . . . 0.51 109.888 -179.785 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.5 m-85 -129.44 129.63 44.9 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.655 -0.869 . . . . 0.62 108.655 179.879 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.79 171.7 44.29 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.979 -1.582 . . . . 0.55 110.583 179.841 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -77.39 158.42 30.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.682 -0.893 . . . . 2.1 109.294 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.451 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -101.89 129.63 48.18 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.385 -0.822 . . . . 0.77 111.775 -178.247 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.7 tp -100.17 132.26 45.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.179 -1.415 . . . . 0.91 107.179 177.928 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.0 tp -115.89 123.73 48.85 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.186 -0.946 . . . . 0.93 110.265 -179.218 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.2 mt -89.78 102.21 14.9 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.277 0.56 . . . . 0.93 110.541 -179.202 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -94.08 135.14 35.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.383 -0.823 . . . . 2.75 108.931 179.378 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -131.43 134.0 45.77 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.148 -0.97 . . . . 3.0 108.858 179.108 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -83.95 139.78 32.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 2.77 109.246 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.45 140.25 58.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.905 . . . . 2.94 109.42 -179.822 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.2 mt -82.83 133.69 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.878 . . . . 0.95 108.864 179.916 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.67 129.97 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.329 -0.857 . . . . 1.28 109.356 -179.666 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.0 mt -102.22 141.39 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.487 -0.758 . . . . 1.21 109.383 -179.84 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -96.13 120.48 36.49 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.153 -0.967 . . . . 1.81 109.721 -179.655 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.503 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.5 mmt-85 -87.48 -0.67 57.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.523 -0.735 . . . . 2.8 109.712 -179.627 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -67.9 136.55 54.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 2.87 109.235 179.991 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -81.3 150.73 28.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.105 -0.997 . . . . 2.35 109.117 179.718 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.459 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.1 pt -93.15 166.67 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.191 -0.943 . . . . 0.97 109.798 -179.933 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.9 p -96.75 171.67 8.38 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.499 -0.926 . . . . 1.17 108.499 178.705 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -48.81 80.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.121 -0.987 . . . . 1.18 109.868 -179.492 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 4.8 p-10 -57.14 -26.07 59.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.738 -1.226 . . . . 2.56 109.437 -179.639 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -82.76 -10.09 59.05 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.262 -0.899 . . . . 1.79 109.826 179.833 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -64.06 -52.48 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.964 -1.085 . . . . 1.0 109.368 -179.731 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.24 -40.05 94.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.335 -0.853 . . . . 1.77 109.478 179.817 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -67.66 -42.79 81.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.161 -0.962 . . . . 2.7 110.98 -178.926 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.485 ' OE2' ' NH1' ' A' ' 42' ' ' ARG . 72.6 mm-40 -66.67 -40.02 88.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.747 -1.221 . . . . 1.51 110.182 -179.504 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -59.97 -45.49 95.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 120.739 -1.226 . . . . 0.93 108.025 178.938 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -60.03 -39.95 87.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.35 -0.844 . . . . 1.81 109.319 179.649 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.485 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 99.0 mtt180 -60.02 -43.99 94.88 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.782 -1.192 . . . . 2.78 107.782 178.838 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -60.84 -47.06 88.08 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.743 -0.836 . . . . 0.78 108.743 178.076 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.3 tp -60.01 -48.71 80.57 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.516 -0.92 . . . . 1.07 108.516 -179.857 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 47.6 t -61.4 -42.28 98.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 1.12 108.86 179.255 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.39 -46.5 94.26 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.735 -1.746 . . . . 0.84 108.735 179.273 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.408 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 38.1 ttt-85 -62.89 -32.74 74.07 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.168 -1.049 . . . . 3.09 108.168 178.422 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.55 -43.83 93.43 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.237 -0.653 . . . . 0.88 109.237 -179.516 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 50' ' ' ALA . 26.5 ttpp -68.81 -74.25 0.13 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.854 -1.154 . . . . 2.59 108.331 179.473 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.22 -35.3 0.11 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.335 -0.853 . . . . 0.7 111.378 -178.366 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.7 t -58.44 -53.32 59.64 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.317 -1.353 . . . . 1.4 108.301 179.559 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.35 -39.99 81.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -0.857 . . . . 0.67 111.088 -179.232 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -67.57 -40.11 84.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.745 -1.222 . . . . 1.66 109.968 -179.598 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.6 mt -63.84 -40.01 95.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.978 -1.077 . . . . 1.58 108.819 179.842 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -63.93 -37.92 89.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.354 -0.841 . . . . 1.35 109.52 179.252 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -62.87 -43.5 98.62 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.098 -1.001 . . . . 0.77 108.548 179.175 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.46 -39.98 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 109.022 -0.733 . . . . 0.63 109.022 179.498 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 ttpp -56.98 -51.84 67.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.165 -0.959 . . . . 1.14 109.876 -179.781 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -58.78 -30.8 67.84 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.431 -0.793 . . . . 0.79 110.29 -178.083 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -69.64 -38.86 77.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.092 -1.005 . . . . 1.53 109.071 -179.826 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.2 -42.91 93.07 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.692 -0.63 . . . . 0.57 109.72 -179.8 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.37 -52.37 52.09 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.839 -1.305 . . . . 0.75 109.839 -179.318 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.2 -47.53 61.12 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.08 -1.247 . . . . 1.59 110.122 -179.962 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.4 m -66.49 -62.7 1.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.966 . . . . 0.73 112.399 -177.449 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -95.34 -48.48 5.86 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.761 -1.212 . . . . 0.75 111.105 -178.218 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.31 -169.68 24.96 Favored Glycine 0 N--CA 1.5 2.917 0 C-N-CA 119.801 -1.19 . . . . 1.22 111.045 179.608 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -69.95 -23.83 63.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.819 -0.812 . . . . 5.81 109.547 179.881 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -61.93 -35.92 79.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.734 -0.603 . . . . 3.37 110.947 -179.27 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.468 ' HA ' HD12 ' A' ' 72' ' ' ILE . 61.2 mmtt -99.4 -17.53 17.94 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.208 -0.932 . . . . 1.77 109.315 -179.934 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -69.2 -40.08 78.25 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.404 -0.81 . . . . 1.65 109.968 -179.187 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.566 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -69.18 -26.8 65.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.288 -0.883 . . . . 0.77 109.991 -179.137 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 69' ' ' LYS . 81.9 mt -59.95 -42.12 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.098 -1.001 . . . . 0.8 108.608 -179.973 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -66.2 -40.03 90.08 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.392 -0.923 . . . . 0.88 109.706 179.845 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -59.96 -41.17 91.31 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.939 -1.101 . . . . 1.37 109.294 179.503 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.28 -44.87 97.05 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.69 -1.764 . . . . 0.62 108.69 179.353 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.9 m170 -66.86 -49.95 64.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.417 -1.049 . . . . 1.5 109.134 179.563 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.98 -50.01 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.329 -0.857 . . . . 0.63 109.322 179.719 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.3 ttp -60.12 -39.88 87.78 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.12 -0.987 . . . . 1.51 109.774 -179.265 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.836 HD22 HD23 ' B' ' 347' ' ' LEU . 55.5 tp -67.52 -40.0 85.1 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.403 -0.81 . . . . 0.77 109.946 179.7 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.1 tp -63.63 -39.87 95.46 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.576 -0.703 . . . . 0.62 109.611 -179.488 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -83.25 6.42 19.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.935 . . . . 1.47 109.758 -179.101 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 60.9 t0 -49.88 134.12 21.4 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.318 -0.864 . . . . 1.47 110.648 -179.074 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.481 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.9 mt-10 -59.98 -25.06 64.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.724 -0.61 . . . . 1.78 111.148 -179.464 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -70.95 -33.81 70.85 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.068 -1.02 . . . . 2.53 109.346 179.629 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 79' ' ' LEU . 87.8 mt -69.94 -40.21 75.6 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.571 0.7 . . . . 0.8 109.846 179.743 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.03 -47.1 87.23 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.373 -0.829 . . . . 1.42 110.594 -178.921 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -69.96 -41.28 74.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 1.71 111.184 -178.706 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.07 -39.91 75.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.03 -1.044 . . . . 1.57 111.697 -178.63 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.82 -47.19 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.033 -1.042 . . . . 0.65 109.94 -179.233 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.43 -39.56 82.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.538 -0.727 . . . . 0.82 109.999 -179.949 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.42 85.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.164 -0.96 . . . . 0.79 110.844 -179.195 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.09 -46.85 88.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.026 -1.046 . . . . 0.95 109.859 -179.238 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.8 mt -61.64 -49.93 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 0.66 109.015 179.681 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -67.29 -41.48 85.36 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.649 -0.657 . . . . 2.2 110.89 -179.247 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -83.87 -50.51 8.0 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.84 -1.162 . . . . 1.65 112.013 -178.642 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -90.16 -3.74 57.69 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.985 -1.072 . . . . 2.03 111.699 -177.337 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.3 m80 56.77 37.56 28.89 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.782 -1.199 . . . . 1.42 109.457 -179.518 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 54.8 mtt -90.04 168.82 11.7 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.574 -0.704 . . . . 1.18 109.733 -179.683 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 63.4 p -80.38 160.03 25.52 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.33 -0.856 . . . . 0.98 108.722 179.315 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.8 -37.75 76.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.064 -1.023 . . . . 0.64 110.422 -179.271 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 38.0 p-10 -69.96 -36.74 75.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.898 -1.127 . . . . 2.07 109.799 -179.566 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.515 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.86 -42.89 20.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 0.73 109.624 179.569 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.55 -47.96 74.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.41 -0.806 . . . . 0.54 109.992 -179.514 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.97 -38.56 82.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.084 -1.01 . . . . 0.56 109.746 -179.776 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -59.94 -39.97 87.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.395 -0.816 . . . . 1.54 110.275 -178.561 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -63.8 -39.97 95.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.01 . . . . 1.33 110.809 -178.779 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.3 t -62.17 -50.07 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.034 -1.041 . . . . 0.72 111.037 -178.401 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.9 mm -69.56 -40.0 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.963 -1.086 . . . . 0.85 108.988 -179.862 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -60.03 -38.62 83.26 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.103 -0.703 . . . . 2.44 109.103 179.056 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.03 -49.95 72.8 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 120.562 -0.828 . . . . 0.98 111.219 -179.111 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -66.64 -50.02 64.31 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.77 -1.43 . . . . 1.41 110.442 -178.528 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.2 88.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.905 -1.122 . . . . 1.2 109.231 -179.704 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.0 t -60.07 -40.72 90.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.306 -0.871 . . . . 1.7 109.074 -179.557 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.98 92.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.27 -0.894 . . . . 1.47 109.12 179.291 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.6 mt -65.98 -42.3 90.0 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.117 -0.989 . . . . 1.56 109.397 -179.634 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.95 -37.91 80.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.663 -1.273 . . . . 2.2 109.302 -179.473 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -52.42 -21.46 3.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.024 -1.048 . . . . 2.12 108.681 179.539 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.515 HD13 HD13 ' A' ' 123' ' ' LEU . 59.2 mt -63.64 152.31 39.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.145 -0.972 . . . . 2.0 108.877 179.612 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -98.66 41.06 1.15 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.08 -1.012 . . . . 3.23 110.363 -179.568 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.73 149.71 49.29 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.129 -0.982 . . . . 2.49 110.227 -179.798 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 58.5 mp0 -74.96 -67.08 0.68 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.742 0.782 . . . . 3.95 109.514 178.956 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.5 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.1 t80 -39.48 -38.65 0.6 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.8 -0.562 . . . . 2.0 111.236 -178.732 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.515 HD13 HD13 ' A' ' 118' ' ' LEU . 88.7 mt -68.31 -39.92 81.85 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.714 -1.241 . . . . 1.86 108.844 -179.335 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 121' ' ' GLU . 7.7 ttpm? -67.14 -31.08 71.27 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.361 -0.837 . . . . 2.84 109.477 179.311 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -46.12 90.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.287 -0.883 . . . . 2.73 109.759 -179.405 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.472 HH21 ' CD2' ' A' ' 123' ' ' LEU . 83.8 mtm180 -65.51 -37.27 86.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.978 -1.076 . . . . 2.77 108.373 178.754 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.94 -29.05 68.13 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.284 -1.006 . . . . 1.19 108.284 178.544 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.12 -40.3 78.38 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.598 -0.89 . . . . 1.2 108.598 179.108 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.43 -40.0 96.01 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.244 -1.021 . . . . 1.55 108.244 178.976 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.6 t -66.01 -40.01 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 108.535 -0.913 . . . . 0.8 108.535 178.939 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 -60.01 -39.42 85.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.45 -0.781 . . . . 3.09 109.169 179.1 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 60.5 t0 -59.94 -39.56 85.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.384 -0.823 . . . . 1.46 109.934 -179.724 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.88 -46.6 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.108 -0.995 . . . . 0.71 110.303 -178.76 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.77 -34.32 66.38 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.519 -1.432 . . . . 0.57 109.519 179.735 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -60.0 -50.16 74.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.421 -1.046 . . . . 2.59 110.368 -179.221 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -69.98 -31.47 69.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.946 -1.096 . . . . 2.83 110.02 -179.574 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.06 -41.71 92.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.315 -0.866 . . . . 1.25 108.963 -179.153 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.43 -40.08 95.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.14 -0.975 . . . . 0.7 109.2 179.408 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.2 mtm180 -69.24 -40.0 78.15 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.309 -0.869 . . . . 2.57 108.798 179.465 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . 0.593 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.3 m120 -64.41 -35.39 80.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.67 -0.644 . . . . 1.23 111.456 -178.853 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.4 mt -71.09 -44.63 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.52 -1.362 . . . . 0.81 109.152 179.81 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.05 -29.01 65.92 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.663 -0.648 . . . . 1.0 109.616 -179.678 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.57 40.01 11.52 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.614 -1.795 . . . . 0.89 108.614 -179.01 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 56.5 tp -73.76 147.49 43.43 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.524 -0.986 . . . . 1.14 109.192 -179.445 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -61.06 139.58 58.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 4.6 109.63 -179.273 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.48 130.11 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-O 121.957 0.884 . . . . 1.24 109.279 179.496 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.8 mt -60.1 -47.35 92.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 115.994 -0.548 . . . . 1.54 110.76 -177.833 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.6 t0 66.11 99.7 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.44 -0.948 . . . . 1.5 108.44 -179.045 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.1 mt -70.9 -2.04 13.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.327 -0.858 . . . . 0.79 110.73 -178.653 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.9 p -84.32 -13.53 52.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.737 -1.227 . . . . 1.4 109.744 179.999 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.51 29.45 0.24 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.226 -0.921 . . . . 0.92 112.004 -177.913 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 39.5 mm -87.64 120.29 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.467 -1.396 . . . . 0.88 109.691 -179.86 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -100.38 -9.96 21.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.396 -0.815 . . . . 2.45 110.3 -179.736 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -139.39 158.09 44.74 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.986 -1.071 . . . . 1.52 110.219 -179.395 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.84 136.95 57.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.141 -0.975 . . . . 1.58 109.307 179.944 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 26.9 m -152.84 165.64 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.564 -0.71 . . . . 0.69 109.371 179.381 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.3 mt -95.55 148.0 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 105.662 -1.977 . . . . 0.61 105.662 177.208 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 60.2 tp -98.37 116.14 29.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.053 -1.029 . . . . 0.87 111.003 -177.365 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.5 t -119.98 128.24 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.493 -0.928 . . . . 0.71 108.493 178.811 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.6 160.26 37.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.111 -0.993 . . . . 0.81 108.725 -179.982 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -70.32 -33.71 71.84 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.205 -1.559 . . . . 0.98 107.848 178.669 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 162' ' ' ASP . 20.2 p-10 -161.95 170.92 18.51 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.993 -0.743 . . . . 2.25 108.993 179.859 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.3 mt -142.86 129.99 20.81 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.058 -1.026 . . . . 0.78 108.841 179.189 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 61.8 p -88.49 146.1 36.85 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.073 -1.017 . . . . 0.98 109.202 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -41.83 -35.56 2.98 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.949 1.766 . . . . 0.81 112.513 179.277 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 57.0 m -60.05 -39.98 87.85 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.066 -1.021 . . . . 0.9 109.142 -179.364 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.75 -42.85 97.77 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.377 -0.827 . . . . 1.61 109.816 179.984 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.3 p -56.53 -30.33 62.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.28 -0.887 . . . . 0.61 111.529 -178.094 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.43 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -73.19 -56.78 4.63 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.65 -1.281 . . . . 0.6 109.937 -179.974 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -79.39 36.59 0.31 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.327 -0.99 . . . . 1.4 108.327 -179.896 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.43 ' H ' ' C ' ' A' ' 169' ' ' ALA . 15.6 tp -103.2 134.33 46.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 0.7 109.593 179.466 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -86.35 101.02 12.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.882 -1.155 . . . . 2.35 107.882 178.436 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 76.3 mt -65.16 -40.97 95.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 1.51 110.947 -178.483 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -69.87 -21.77 63.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.763 -1.211 . . . . 2.33 111.086 -178.087 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -93.89 -10.69 33.07 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.796 -1.19 . . . . 1.92 109.693 -179.533 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 178' ' ' GLY . 71.5 t -105.59 116.57 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.397 -0.964 . . . . 0.67 108.397 178.599 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.9 mt -85.41 5.45 30.9 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.216 -0.928 . . . . 1.53 110.235 -178.215 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.562 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 169.4 174.44 37.82 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.4 -1.48 . . . . 0.48 109.4 179.71 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.477 ' CE1' HG11 ' A' ' 176' ' ' VAL . 18.0 m-85 -132.69 128.77 37.68 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.487 -1.008 . . . . 0.55 108.817 179.974 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.04 126.07 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.82 -0.807 . . . . 0.65 108.82 178.958 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.1 p -149.43 160.02 43.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.122 -0.986 . . . . 0.82 110.459 -179.208 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 182' ' ' ASP . 42.8 p-10 -108.23 28.85 7.89 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.764 -0.828 . . . . 2.46 108.764 179.256 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.39 -158.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.971 0.891 . . . . 1.28 112.227 -177.702 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.13 -71.4 0.8 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.959 -0.857 . . . . 2.19 110.959 -178.804 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 161.93 -131.82 2.66 Favored Glycine 0 N--CA 1.492 2.406 0 O-C-N 120.764 -1.433 . . . . 2.13 110.631 -179.658 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.764 ' HE ' HH12 ' A' ' 195' ' ' ARG . 33.2 ttt-85 -61.38 -39.99 92.7 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.586 -0.949 . . . . 5.86 111.506 -178.702 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 18.0 p -64.8 5.33 0.33 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.829 -1.169 . . . . 3.72 110.602 -178.532 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 186' ' ' ARG . 48.0 t -90.87 130.07 36.86 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.953 -1.092 . . . . 1.74 110.702 -179.591 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -49.33 -44.81 44.77 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.423 -0.798 . . . . 0.95 109.255 179.509 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 88.8 m -60.01 -39.43 85.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.615 -0.678 . . . . 1.55 109.73 -179.26 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.5 t -58.66 -42.81 89.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.892 -1.13 . . . . 1.51 110.214 -179.225 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 93.9 mt -60.8 -38.82 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 1.67 109.844 -179.991 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.7 mtp -59.97 -46.01 90.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 1.02 110.539 -179.246 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.99 -44.43 94.52 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.825 -1.172 . . . . 0.68 110.097 -179.381 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.764 HH12 ' HE ' ' A' ' 186' ' ' ARG . 51.7 mtp180 -60.03 -50.06 75.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.133 -0.979 . . . . 2.93 110.71 -179.01 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.6 m -73.41 -33.59 65.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.001 -1.062 . . . . 0.86 111.553 -178.665 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 86.8 mt -80.55 -11.07 59.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.735 -1.228 . . . . 0.67 110.475 -178.435 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 58.56 49.94 9.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.307 -0.871 . . . . 1.5 110.706 179.384 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 86.5 mt -123.84 122.98 26.29 Favored Pre-proline 0 N--CA 1.502 2.135 0 N-CA-C 108.456 -0.942 . . . . 0.72 108.456 179.0 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -43.28 133.48 6.56 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.037 1.825 . . . . 0.61 112.582 -179.845 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -170.58 150.01 3.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.846 -1.159 . . . . 0.66 111.375 179.819 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.0 mt -125.0 142.82 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 107.924 -1.139 . . . . 0.79 107.924 178.879 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.5 m -123.17 -8.57 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 O-C-N 120.85 -1.156 . . . . 0.91 111.057 -178.842 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.3 23.73 15.42 Favored Glycine 0 N--CA 1.5 2.962 0 O-C-N 121.381 -0.824 . . . . 1.01 111.203 -179.03 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 10.4 p -45.49 -44.36 12.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.776 -1.426 . . . . 0.99 109.751 -179.357 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . 0.417 ' H ' ' CB ' ' A' ' 182' ' ' ASP . . . 95.15 -51.28 1.89 Allowed Glycine 0 N--CA 1.499 2.88 0 C-N-CA 120.178 -1.01 . . . . 1.12 111.354 178.763 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 69.4 m -160.0 39.5 0.18 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.498 -1.59 . . . . 1.72 111.566 -179.242 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 30.9 t -79.96 -33.06 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.827 -1.171 . . . . 0.89 108.589 178.355 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.1 p -60.11 -40.01 88.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.608 -0.683 . . . . 1.03 111.095 -179.134 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 56.4 m -81.3 -13.56 58.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.971 -1.081 . . . . 1.83 110.563 -178.507 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -93.71 -11.91 30.43 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.073 -1.017 . . . . 2.27 110.755 -179.416 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 213' ' ' LYS . 46.4 t -121.27 161.78 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 O-C-N 121.19 -0.944 . . . . 0.92 110.601 -179.56 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.556 ' N ' HG12 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -120.58 158.02 28.24 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.714 -0.847 . . . . 2.2 108.714 -179.441 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 215' ' ' ASP . 57.6 t-20 -59.71 139.93 56.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 2.36 110.461 -179.384 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 3.1 t70 86.33 2.59 0.53 Allowed 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.15 0.5 . . . . 2.38 110.205 179.373 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 47.2 t0 -74.86 151.95 38.95 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.133 -0.979 . . . . 2.09 108.56 178.96 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.543 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 47.9 t80 -96.56 120.19 36.43 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.421 -0.955 . . . . 1.27 108.421 179.52 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.451 HD12 ' HB2' ' A' ' 16' ' ' ALA . 91.9 mt -124.8 141.68 51.94 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.426 -0.796 . . . . 0.75 110.754 -179.224 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 88.6 mt -109.93 129.34 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.417 -1.697 . . . . 0.63 106.417 176.32 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 45.0 tp -101.28 117.67 35.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.027 -1.045 . . . . 0.7 109.024 -178.799 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 224' ' ' ASN . 8.5 t70 -76.96 -47.46 20.79 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.158 -0.964 . . . . 2.31 108.578 179.653 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.926 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 52.77 18.38 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.21 -0.663 . . . . 0.78 109.21 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 72.8 t -132.67 -41.94 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.069 -1.456 . . . . 1.04 107.069 178.556 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.51 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 35.3 m120 -106.52 1.83 25.73 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.168 -1.419 . . . . 2.44 107.168 177.828 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.01 47.34 9.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.84 -0.538 . . . . 1.55 110.128 -179.868 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -136.97 148.51 46.96 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.314 -0.866 . . . . 1.99 109.614 179.235 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 86.1 t -123.88 125.5 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.294 -0.632 . . . . 0.77 109.294 179.659 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -91.83 122.45 34.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.135 -0.978 . . . . 0.98 108.588 179.651 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 37.0 t -102.23 118.46 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.423 -0.798 . . . . 0.85 109.478 -179.401 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.6 t30 67.57 68.77 0.52 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.441 -0.787 . . . . 1.66 108.923 -179.479 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -89.12 124.88 1.49 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.207 2.605 . . . . 0.95 112.761 -179.39 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.3 m -63.29 162.77 11.57 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -0.895 . . . . 1.84 108.881 179.684 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -60.11 -39.91 87.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.064 -1.022 . . . . 2.74 108.751 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -60.03 -38.88 84.04 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.4 -0.813 . . . . 2.89 109.193 179.534 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.64 -42.09 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.299 -0.876 . . . . 1.3 109.751 -179.75 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.121 -0.987 . . . . 1.09 109.471 -179.994 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . 0.404 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 32.2 ttp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.493 0.663 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . 0.404 ' N ' ' CG ' ' B' ' 301' ' ' MET . 32.7 t80 -153.75 150.26 28.32 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.34 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . 0.444 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 3.9 pm0 -150.87 160.97 43.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.848 -1.158 . . . . 0.0 111.133 -179.398 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -152.19 148.89 28.14 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.554 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -114.03 132.13 56.11 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.218 -0.927 . . . . 0.0 109.827 179.282 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.21 127.97 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 CA-C-O 122.397 1.094 . . . . 0.0 112.61 -177.374 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 30.0 m -77.07 106.94 9.08 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.973 0.892 . . . . 0.0 110.603 -178.361 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 87.1 mt -52.2 124.05 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.408 1.099 . . . . 0.0 110.508 -177.927 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 82.5 p -109.61 20.04 18.56 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.144 -178.697 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -79.13 115.71 54.74 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.28 -0.888 . . . . 0.0 109.005 179.291 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.38 -10.95 9.65 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 CA-C-N 120.376 1.17 . . . . 0.0 113.487 -179.348 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -114.83 9.94 16.37 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.227 -0.921 . . . . 0.0 110.396 -178.898 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 68.63 172.41 7.45 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -179.036 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.5 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -85.13 92.11 8.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.867 -1.372 . . . . 0.0 109.967 -178.298 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.454 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 4.7 p80 -96.68 -159.29 0.72 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.008 -1.057 . . . . 0.0 109.62 178.163 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 4.4 m -59.4 -47.47 85.31 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.783 -1.198 . . . . 0.0 112.764 -176.182 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.566 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 10.9 tpt180 -55.74 -58.97 12.84 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 120.506 -1.372 . . . . 0.0 111.734 -179.102 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.454 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 14.3 Cg_endo -61.81 -32.5 85.8 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 120.559 1.235 . . . . 0.0 111.388 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.67 -51.23 66.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.455 -0.778 . . . . 0.0 109.27 179.491 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.37 -39.99 64.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 109.373 -179.268 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . 0.513 HE21 ' HB1' ' A' ' 71' ' ' ALA . 96.5 mm-40 -68.7 -42.4 77.8 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.917 -1.114 . . . . 0.0 108.57 178.995 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -59.91 -50.4 73.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.526 -0.734 . . . . 0.0 110.298 -179.03 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 86.3 t -69.14 -29.15 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.722 -1.236 . . . . 0.0 110.207 -179.03 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -59.13 -49.26 78.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.112 -0.992 . . . . 0.0 109.7 -178.83 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -66.42 -40.95 89.86 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.024 -1.047 . . . . 0.0 111.102 -179.179 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.04 -54.61 43.95 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.516 -1.365 . . . . 0.0 110.993 -178.855 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -55.16 -15.91 2.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.073 -1.017 . . . . 0.0 109.007 179.702 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -70.35 -29.65 69.94 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 178.729 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -105.78 146.82 29.36 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.602 -0.94 . . . . 0.0 109.553 -179.916 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 32.0 p -90.57 -12.1 38.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.084 -1.01 . . . . 0.0 109.907 179.966 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.458 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 47.6 t -61.47 144.69 53.78 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.282 -0.886 . . . . 0.0 109.507 179.928 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -67.57 136.63 54.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.134 -0.979 . . . . 0.0 108.644 179.623 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.9 mt -130.73 131.02 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.5 -0.75 . . . . 0.0 110.002 -179.728 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 91.8 m -128.14 147.01 50.53 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.276 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.65 115.57 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.658 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 89.0 m -102.82 128.8 49.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.124 -0.985 . . . . 0.0 109.041 -178.566 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 90.8 p -139.23 114.31 9.51 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.892 0.853 . . . . 0.0 111.136 -179.217 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 27.5 m120 49.43 49.99 18.9 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 176.45 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.81 -13.86 59.93 Favored Glycine 0 N--CA 1.501 2.994 0 O-C-N 119.804 -1.81 . . . . 0.0 112.289 176.946 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -117.01 129.0 55.73 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.999 -1.295 . . . . 0.0 109.419 -179.871 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 48.4 p -126.57 147.92 49.81 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.884 0.85 . . . . 0.0 110.754 -178.962 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.45 168.03 21.07 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.505 0.669 . . . . 0.0 109.825 -179.666 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 28.2 t -90.94 136.09 33.3 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.567 -0.708 . . . . 0.0 110.835 -178.775 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -71.42 -17.52 62.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.347 -0.845 . . . . 0.0 108.795 179.159 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -88.34 16.67 6.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.599 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 10.9 t -143.94 92.12 2.3 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.732 0.777 . . . . 0.0 111.287 -179.345 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.836 HD23 HD22 ' A' ' 79' ' ' LEU . 58.9 tp -58.74 -36.86 75.01 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.379 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.805 ' CE2' HD11 ' A' ' 79' ' ' LEU . 61.1 m-85 -55.55 -50.06 71.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.854 . . . . 0.0 111.07 -179.14 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' B' ' 350' ' ' LEU . 25.2 mtmm -69.94 -40.03 75.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.722 -1.236 . . . . 0.0 110.721 -177.915 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' B' ' 352' ' ' THR . 87.9 mt -46.87 -55.69 7.57 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.995 -1.066 . . . . 0.0 109.106 -179.407 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.689 HE21 ' N ' ' B' ' 351' ' ' GLN . 0.0 OUTLIER -39.38 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.569 -0.707 . . . . 0.0 111.169 -178.76 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.483 ' N ' ' O ' ' B' ' 350' ' ' LEU . 75.6 p -81.27 -10.15 59.64 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.127 -1.608 . . . . 0.0 109.995 -179.096 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 32.9 mt -95.29 114.99 26.83 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.062 -1.024 . . . . 0.0 109.11 178.612 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.65 94.46 0.86 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 179.307 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 34.4 mt -101.77 89.56 3.72 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.366 -1.079 . . . . 0.0 109.279 179.721 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 46.9 p -94.16 177.02 6.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.102 -0.998 . . . . 0.0 110.934 -179.129 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -67.6 113.51 5.47 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.643 -0.661 . . . . 0.0 110.135 -179.918 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.93 9.41 34.66 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.974 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 66.3 m -90.85 107.64 19.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -1.139 . . . . 0.0 110.91 -179.536 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 14.5 t -76.89 118.15 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.201 1.0 . . . . 0.0 109.152 -177.641 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.0 m -113.42 178.14 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.968 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 58.1 m -130.86 128.27 40.27 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.287 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 93.9 mt -100.6 112.51 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.639 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 60.6 m -117.79 130.82 56.52 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.621 -0.675 . . . . 0.0 109.346 -179.217 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.79 151.99 39.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.815 . . . . 0.0 109.245 -179.493 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -145.83 125.51 13.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.4 -0.812 . . . . 0.0 108.867 179.666 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.537 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.11 -155.77 26.65 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.14 -1.505 . . . . 0.0 111.455 -179.984 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.73 -51.6 69.08 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 122.224 -0.574 . . . . 0.0 112.333 -177.508 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.458 ' H ' ' HB2' ' B' ' 331' ' ' SER . 72.0 m-20 -110.01 13.17 23.44 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.829 -1.17 . . . . 0.0 111.221 -177.399 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -41.55 -34.33 0.56 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.292 -0.88 . . . . 0.0 111.507 -178.866 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -69.05 -41.15 78.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.589 -1.319 . . . . 0.0 109.994 -178.266 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -69.47 -50.1 48.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.842 -179.629 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -54.34 -36.22 63.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.86 . . . . 0.0 111.885 -178.077 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.574 ' O ' HG23 ' B' ' 378' ' ' VAL . 71.1 t -74.31 -39.96 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.134 -1.604 . . . . 0.0 109.191 179.294 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.89 -56.01 14.04 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.331 -0.855 . . . . 0.0 111.923 -178.25 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -69.98 -39.97 75.62 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.31 -1.494 . . . . 0.0 111.905 -178.377 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 89.1 mt -57.99 -37.16 73.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.607 -1.308 . . . . 0.0 108.676 -179.286 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.574 HG23 ' O ' ' B' ' 374' ' ' VAL . 48.9 t -60.03 -47.61 91.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.196 -0.94 . . . . 0.0 109.402 179.163 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' B' ' 383' ' ' GLU . 4.3 mptp? -69.98 -56.38 7.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.643 -1.285 . . . . 0.0 108.079 178.493 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.48 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 62.8 tp -50.99 -36.39 38.92 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.187 -0.946 . . . . 0.0 108.787 -178.648 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 40.9 tpp -73.01 -39.92 65.61 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.421 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.09 -4.2 46.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.74 -0.6 . . . . 0.0 109.959 179.463 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' B' ' 379' ' ' LYS . 95.5 mt-10 -108.05 3.54 24.08 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.249 -0.907 . . . . 0.0 110.234 179.909 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . 0.48 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 15.1 mt -79.34 114.21 18.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.369 -1.457 . . . . 0.0 107.753 178.184 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.459 -179.777 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.187 -0.671 . . . . 2.91 109.187 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.7 mt -109.99 129.99 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.365 -0.834 . . . . 1.2 109.241 179.863 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.1 m -129.34 151.09 50.36 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.713 -0.617 . . . . 1.4 109.846 -179.379 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.526 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -135.22 -162.15 9.62 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.01 -1.636 . . . . 1.05 109.01 179.869 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.8 mt -90.11 -18.88 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.867 -1.373 . . . . 1.15 109.561 -179.535 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.5 tp 55.71 107.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.491 -0.755 . . . . 0.98 109.189 -179.507 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.32 -26.97 13.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.406 -0.809 . . . . 0.88 108.99 179.529 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.1 m -137.59 120.93 11.55 Favored Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.499 -0.751 . . . . 1.69 109.215 179.555 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.59 151.09 19.42 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.121 1.881 . . . . 0.85 112.825 179.928 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.9 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 146.79 173.01 17.65 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 109.469 -1.452 . . . . 0.92 109.469 179.705 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.7 mt -125.77 130.88 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 120.964 -1.315 . . . . 0.81 109.223 -179.74 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.89 150.65 48.37 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.169 -0.957 . . . . 0.51 110.048 -179.265 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 9.3 m-85 -123.22 129.94 52.07 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.267 -1.012 . . . . 0.62 108.267 179.765 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.59 172.76 45.14 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 118.81 -1.662 . . . . 0.55 110.69 179.988 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -78.66 158.82 28.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.609 -0.936 . . . . 2.1 108.906 179.655 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.548 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.05 131.62 51.12 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.325 -0.859 . . . . 0.77 111.107 -178.684 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.2 tp -101.52 135.01 43.74 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.167 -1.42 . . . . 0.91 107.167 178.161 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.3 tp -116.72 126.48 53.2 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.295 -0.878 . . . . 0.93 109.87 -179.06 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.4 mt -89.32 102.01 14.68 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.365 0.602 . . . . 0.93 110.214 -179.515 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -92.52 136.37 33.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.445 -0.784 . . . . 2.75 109.003 179.619 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -131.15 117.44 19.08 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.3 -0.875 . . . . 3.0 109.629 179.743 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 54.1 t0 -71.55 144.5 49.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.889 -1.132 . . . . 2.77 109.45 179.772 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.51 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 88.8 tt0 -63.52 139.95 58.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 2.94 109.526 -179.878 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.5 mt -83.89 134.5 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.791 -0.818 . . . . 0.95 108.791 -179.773 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.4 t -101.99 127.04 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.29 -0.881 . . . . 1.28 110.279 -179.11 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.9 mt -105.7 137.85 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.794 -0.817 . . . . 1.21 108.794 179.304 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -97.52 113.59 25.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.994 -1.066 . . . . 1.81 109.318 179.71 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -84.83 5.24 29.53 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.536 -0.913 . . . . 2.8 108.536 179.9 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -60.56 146.35 45.46 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.544 -0.722 . . . . 2.87 109.36 179.916 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -88.88 141.69 28.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 2.35 108.963 179.616 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 pt -94.47 165.73 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.1 -1.0 . . . . 0.97 109.383 179.773 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.0 p -97.91 174.21 6.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.004 -1.06 . . . . 1.17 108.72 178.856 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.83 84.18 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.362 -0.935 . . . . 1.18 109.297 -179.631 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 52.2 t0 -56.71 -30.39 63.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.773 -1.204 . . . . 2.56 109.923 -179.94 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -81.82 -10.56 59.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.235 -0.916 . . . . 1.79 110.02 -179.645 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -62.98 -51.67 68.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.908 -1.12 . . . . 1.0 108.68 179.713 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -61.7 -40.07 93.71 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.454 -0.779 . . . . 1.77 109.887 -179.588 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -68.84 -40.32 79.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 2.7 111.295 -178.492 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -66.14 -40.18 90.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.399 -1.438 . . . . 1.51 110.351 -179.528 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.95 -47.97 91.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.706 -1.246 . . . . 0.93 109.195 179.444 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -61.89 -44.13 97.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.005 -1.059 . . . . 1.81 109.935 179.977 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -60.06 -44.03 95.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.862 -1.149 . . . . 2.78 108.117 179.803 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -63.0 -46.98 85.12 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.196 -0.668 . . . . 0.78 109.196 179.062 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.5 tp -59.87 -46.19 90.08 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.608 -0.886 . . . . 1.07 108.608 179.933 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.9 t -65.76 -43.74 87.97 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.265 -0.974 . . . . 1.12 108.861 179.276 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.21 -44.23 97.39 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.83 -2.108 . . . . 0.84 107.83 178.703 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.428 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 25.5 ttt-85 -65.39 -34.67 78.86 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.34 -0.985 . . . . 3.09 108.34 178.228 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.77 -40.0 86.76 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.732 -0.84 . . . . 0.88 108.732 -179.862 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 50' ' ' ALA . 1.2 ttmp? -61.47 -73.95 0.09 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.043 -1.095 . . . . 2.59 108.043 179.111 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.07 -34.94 0.09 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.253 -0.905 . . . . 0.7 111.904 -177.775 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.0 t -59.67 -50.37 74.14 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.344 -1.342 . . . . 1.4 108.291 179.846 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.05 92.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.501 -0.749 . . . . 0.67 110.504 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.9 -40.19 91.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.805 -1.184 . . . . 1.66 110.188 -179.118 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.07 -39.88 91.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.975 -1.078 . . . . 1.58 109.199 179.633 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -60.27 -39.93 88.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.541 -0.724 . . . . 1.35 110.136 179.853 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.466 HG22 ' HZ3' ' A' ' 60' ' ' LYS . 94.4 m -62.83 -43.87 97.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.019 -1.051 . . . . 0.77 109.459 179.724 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.621 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.9 mt -61.35 -39.68 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.48 -0.763 . . . . 0.63 109.588 -179.919 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -57.43 -51.86 67.73 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.175 -0.953 . . . . 1.14 110.403 -179.43 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -58.88 -35.38 72.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.357 -0.839 . . . . 0.79 110.832 -177.396 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.466 ' HZ3' HG22 ' A' ' 56' ' ' THR . 27.3 mttp -66.02 -38.16 87.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.056 -1.028 . . . . 1.53 109.332 179.841 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.443 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -65.81 -45.86 80.77 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.74 -0.6 . . . . 0.57 110.2 -179.529 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.4 -53.38 45.39 Favored Glycine 0 N--CA 1.485 1.93 0 C-N-CA 120.09 -1.052 . . . . 0.75 110.61 -178.548 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.07 -41.78 73.68 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.938 -1.331 . . . . 1.59 110.382 -179.06 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.0 m -70.03 -60.05 2.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.92 -1.113 . . . . 0.73 111.981 -177.838 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.428 ' CE1' ' O ' ' A' ' 168' ' ' THR . 76.7 m-85 -95.94 -50.56 4.82 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.862 -1.149 . . . . 0.75 111.243 -178.178 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.75 -166.87 26.1 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 119.899 -1.143 . . . . 1.22 110.683 -179.974 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -69.98 -24.97 63.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.78 -0.836 . . . . 5.81 110.353 -179.479 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.418 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 48.5 tp10 -60.36 -34.91 74.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.38 -0.825 . . . . 3.37 110.294 -179.366 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.483 ' HA ' HD12 ' A' ' 72' ' ' ILE . 43.9 mmtm -100.28 -17.51 17.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.295 -0.878 . . . . 1.77 110.291 -179.318 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -69.98 -44.51 69.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.067 -1.02 . . . . 1.65 110.667 -179.248 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.557 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.69 -25.64 65.78 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.386 -0.822 . . . . 0.77 109.885 -178.393 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 69' ' ' LYS . 80.9 mt -59.91 -41.18 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.0 -1.062 . . . . 0.8 108.764 -179.886 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -69.99 -36.6 75.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.077 -1.014 . . . . 0.88 110.805 -179.789 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -59.93 -40.1 87.76 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.92 -1.112 . . . . 1.37 109.434 -179.495 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.79 -43.54 93.84 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.587 -1.805 . . . . 0.62 108.587 178.742 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 57.4 m170 -60.0 -46.14 90.44 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.357 -1.084 . . . . 1.5 108.761 179.703 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.67 -45.16 96.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.226 -0.921 . . . . 0.63 108.677 179.147 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.3 ttp -60.89 -43.05 99.0 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.309 -0.869 . . . . 1.51 110.036 -179.864 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.457 HD13 HD23 ' B' ' 347' ' ' LEU . 12.5 tp -61.21 -41.9 97.65 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.715 -0.846 . . . . 0.77 108.715 179.869 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.16 -38.14 89.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.636 -0.665 . . . . 0.62 109.917 -179.636 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -85.39 4.4 35.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.067 -1.02 . . . . 1.47 110.206 -179.101 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -50.1 131.4 23.32 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.964 -1.085 . . . . 1.47 110.44 -179.124 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -58.46 -20.65 46.96 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.67 -0.644 . . . . 1.78 110.14 -179.403 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.89 -33.08 71.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.118 -0.989 . . . . 2.53 108.735 179.477 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.0 mt -71.98 -40.1 68.82 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.352 0.596 . . . . 0.8 109.876 179.348 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -60.18 -50.02 75.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.477 -0.765 . . . . 1.42 110.374 -179.0 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -70.96 -40.81 71.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.051 -1.031 . . . . 1.71 111.099 -178.961 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.11 -39.97 75.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.117 -0.99 . . . . 1.57 111.573 -178.544 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.72 -46.19 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.026 . . . . 0.65 109.547 -179.309 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.85 -39.63 80.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.645 -0.66 . . . . 0.82 109.969 -179.822 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.33 -48.67 80.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.79 111.256 -179.033 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 96' ' ' LYS . 93.9 mt -63.04 -46.88 85.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.885 -1.134 . . . . 0.95 110.194 -178.927 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.1 mt -60.25 -49.48 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 122.18 0.991 . . . . 0.66 108.57 179.555 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -70.1 -40.46 74.93 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.785 -0.643 . . . . 2.2 110.578 -179.428 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -83.44 -49.7 9.04 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.901 -1.124 . . . . 1.65 111.718 -178.521 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 92' ' ' LEU . 71.0 mmtt -90.97 -1.83 57.78 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.102 -0.999 . . . . 2.03 111.73 -177.396 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 54.28 32.17 15.69 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.699 -1.251 . . . . 1.42 109.604 179.944 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.5 mtt -90.36 167.5 12.59 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.003 -0.74 . . . . 1.18 109.003 -179.848 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 68.5 p -75.42 155.14 36.65 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.844 -1.169 . . . . 0.98 107.844 178.956 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.8 -39.59 76.48 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.955 -1.09 . . . . 0.64 110.237 -179.065 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 34.4 p-10 -63.23 -38.65 91.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.855 -1.153 . . . . 2.07 109.387 179.552 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.504 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -78.29 -47.28 18.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.957 . . . . 0.73 109.44 179.509 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.85 -47.32 86.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.475 -0.766 . . . . 0.54 109.714 -179.925 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.5 -35.37 79.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 0.56 109.458 179.646 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -59.87 -44.25 94.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 1.54 108.746 -179.319 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 110' ' ' GLY . 85.8 tt0 -61.15 -40.02 92.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.265 -0.897 . . . . 1.33 109.462 179.298 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.76 -53.81 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.897 . . . . 0.72 110.475 -178.972 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.453 HG21 ' HA3' ' A' ' 134' ' ' GLY . 47.0 mm -69.87 -40.14 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.992 -1.068 . . . . 0.85 109.303 179.634 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -68.07 -38.76 82.76 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.57 -0.9 . . . . 2.44 108.57 179.045 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -59.74 -47.92 88.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.494 -1.042 . . . . 0.98 110.494 -179.182 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -67.97 -54.37 19.09 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.769 -1.43 . . . . 1.41 109.721 -179.685 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.89 -40.02 69.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 1.2 109.616 -179.925 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 54.3 m -59.95 -39.98 87.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.094 -1.004 . . . . 1.7 108.796 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.25 89.01 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.204 -0.935 . . . . 1.47 108.676 178.829 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.431 ' CD1' ' OE1' ' B' ' 351' ' ' GLN . 25.5 mt -65.57 -39.96 92.25 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.124 -0.985 . . . . 1.56 109.399 -179.643 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -57.75 -31.62 66.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.736 -1.228 . . . . 2.2 109.189 -179.264 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -59.38 -23.54 62.67 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.175 -1.046 . . . . 2.12 108.175 179.388 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 52.7 mt -62.17 139.93 58.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.23 -0.919 . . . . 2.0 108.617 -179.823 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -94.49 26.08 3.61 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.172 -0.955 . . . . 3.23 109.835 -179.699 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -110.76 129.99 55.7 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.367 -0.833 . . . . 2.49 109.729 -179.712 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -69.66 -29.36 66.79 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.48 0.657 . . . . 3.95 109.233 179.91 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.48 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.4 t80 -69.95 -39.97 75.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.702 -0.624 . . . . 2.0 110.845 -179.99 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.53 HD22 ' O ' ' B' ' 351' ' ' GLN . 96.9 mt -76.41 -32.47 58.53 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.844 -1.16 . . . . 1.86 109.582 179.918 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -60.1 -40.56 90.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.054 -1.029 . . . . 2.84 108.684 179.318 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 98.9 mt-10 -59.93 -42.92 95.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.247 -0.908 . . . . 2.73 108.964 179.615 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -61.92 -40.05 94.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 2.77 108.57 178.97 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.52 -30.81 71.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.89 . . . . 1.19 108.716 179.021 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -60.19 -39.57 86.99 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.827 -0.805 . . . . 1.2 108.827 179.607 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -68.25 -39.85 82.13 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.349 -0.845 . . . . 1.55 109.279 -179.919 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.74 -39.97 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.421 -0.8 . . . . 0.8 109.057 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -65.18 -40.04 93.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.174 -0.954 . . . . 3.09 109.963 179.629 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 1.46 110.551 -178.938 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.12 -41.22 85.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.99 -1.069 . . . . 0.71 109.667 -179.7 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.453 ' HA3' HG21 ' A' ' 108' ' ' ILE . . . -59.97 -46.02 94.87 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.009 -1.237 . . . . 0.57 110.009 -179.761 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -59.87 -46.92 87.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.104 -1.233 . . . . 2.59 111.324 -179.511 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.621 HH22 ' CD1' ' A' ' 57' ' ' ILE . 60.4 mtp180 -63.85 -37.08 86.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.835 -1.166 . . . . 2.83 110.407 -179.385 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.6 tp -58.43 -42.88 88.27 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.353 -0.842 . . . . 1.25 110.132 -178.753 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.83 -39.96 93.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.001 -1.062 . . . . 0.7 108.961 179.628 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -65.72 -39.51 91.24 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.789 -0.819 . . . . 2.57 108.789 178.791 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -64.38 -36.96 85.83 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.649 -0.657 . . . . 1.23 110.951 -179.63 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.3 mt -70.54 -42.06 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.521 -1.362 . . . . 0.81 108.44 179.002 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.63 -38.75 73.94 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.609 0.718 . . . . 1.0 109.063 179.684 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.56 43.85 4.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.276 -1.93 . . . . 0.89 108.276 -178.767 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 144' ' ' LEU . 21.3 tp -74.51 142.86 44.77 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.484 -1.009 . . . . 1.14 109.46 -179.183 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -62.3 137.87 58.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.423 -0.798 . . . . 4.6 109.795 -179.325 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 92.8 mt -113.94 129.97 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.217 1.008 . . . . 1.24 109.583 179.396 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.7 mt -64.44 -41.51 92.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.802 -0.635 . . . . 1.54 110.968 -178.145 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 47.4 t0 61.26 105.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.323 -0.861 . . . . 1.5 109.581 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 152' ' ' ILE . 58.8 mt -68.75 -6.69 28.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.474 -0.766 . . . . 0.79 110.12 -179.357 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.5 t -83.37 -13.77 54.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.13 -0.981 . . . . 1.4 108.922 179.314 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.34 18.51 2.64 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.608 -0.683 . . . . 0.92 110.239 -178.442 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.415 HD12 ' O ' ' A' ' 149' ' ' LEU . 66.1 mt -90.31 111.21 23.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.028 -1.045 . . . . 0.88 108.845 -179.778 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -97.31 -9.71 27.03 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.285 -0.884 . . . . 2.45 110.836 -178.559 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -120.47 149.12 42.89 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.214 -0.929 . . . . 1.52 110.175 -178.987 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -64.89 131.22 46.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.422 -0.799 . . . . 1.58 109.216 -179.9 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -151.95 163.77 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.511 -0.743 . . . . 0.69 109.343 179.614 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 83.3 mt -92.76 151.08 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 105.939 -1.875 . . . . 0.61 105.939 177.156 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 56.4 tp -102.07 118.73 37.51 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.121 -0.987 . . . . 0.87 110.798 -177.961 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.2 t -126.22 132.08 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 108.538 -0.912 . . . . 0.71 108.538 179.543 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.6 168.73 24.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.179 -0.951 . . . . 0.81 109.05 179.797 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.0 -37.78 75.78 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.489 -1.382 . . . . 0.98 108.287 178.735 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -170.66 148.51 3.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.58 -0.7 . . . . 2.25 109.189 179.737 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.4 mt -116.1 134.43 54.94 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.49 -0.757 . . . . 0.78 109.553 -179.641 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 77.7 p -94.15 149.96 37.64 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.428 -0.795 . . . . 0.98 109.038 179.501 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -39.63 -34.75 0.8 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.334 2.023 . . . . 0.81 113.005 179.562 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 59.6 m -58.04 -42.51 85.54 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.217 -0.993 . . . . 0.9 109.353 -178.503 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -70.07 -39.96 75.31 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.163 -0.961 . . . . 1.61 109.792 179.456 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.428 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 68.8 p -52.79 -26.62 14.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -0.905 . . . . 0.61 111.112 -178.051 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -82.06 -55.88 4.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.874 -1.141 . . . . 0.6 109.963 179.624 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -80.25 40.14 0.48 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.677 -1.231 . . . . 1.4 107.677 179.775 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.458 ' H ' ' C ' ' A' ' 169' ' ' ALA . 17.7 tp -97.91 124.55 42.39 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.98 -0.748 . . . . 0.7 108.98 179.858 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -81.61 97.8 8.04 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.112 -1.07 . . . . 2.35 108.112 179.189 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.54 -44.85 95.33 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.565 -0.709 . . . . 1.51 110.62 -178.591 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -62.38 -32.02 72.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.1 -1.0 . . . . 2.33 112.47 -177.394 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -93.29 -10.27 36.07 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.684 -1.26 . . . . 1.92 110.787 -177.862 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 176' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 178' ' ' GLY . 91.4 t -102.36 113.11 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.048 -1.032 . . . . 0.67 108.749 178.986 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 39.6 mt -85.75 5.14 33.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.188 -0.945 . . . . 1.53 110.687 -178.31 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.463 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 175.09 168.62 35.92 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.309 -1.424 . . . . 0.48 109.82 179.531 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.441 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 23.0 m-85 -130.52 127.93 40.13 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.494 -1.003 . . . . 0.55 108.745 179.787 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.403 ' CG2' HG21 ' A' ' 205' ' ' THR . 62.2 mt -130.56 124.19 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.332 -0.988 . . . . 0.65 108.332 178.725 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 36.0 p -139.53 152.0 46.57 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.343 -0.848 . . . . 0.82 110.642 -179.247 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . 0.543 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.7 OUTLIER -100.62 26.71 6.47 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.75 -0.833 . . . . 2.46 108.75 179.356 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.37 -161.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.103 -0.998 . . . . 1.28 111.574 -177.819 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.9 -57.34 6.42 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.974 -0.85 . . . . 2.19 110.974 -178.874 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.51 -132.69 2.04 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 118.887 -1.625 . . . . 2.13 111.2 -179.33 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 186' ' ' ARG . . . . . 0.513 ' NH2' ' NH1' ' A' ' 195' ' ' ARG . 10.7 mtp-105 -80.18 -10.11 59.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.474 -1.015 . . . . 5.86 110.533 -178.663 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 71.5 p -81.49 5.99 16.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.008 -1.058 . . . . 3.72 109.906 -179.231 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.5 t -88.34 134.15 33.89 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.048 -1.033 . . . . 1.74 110.191 -179.63 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -48.21 -43.2 31.82 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.237 -0.914 . . . . 0.95 108.681 179.645 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 93.5 m -59.4 -39.91 84.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.831 -0.543 . . . . 1.55 109.83 -179.517 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 55.8 p -59.9 -38.32 81.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.999 -1.063 . . . . 1.51 110.264 -179.397 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.6 mm -59.95 -40.0 81.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.322 -0.862 . . . . 1.67 109.371 -179.782 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.5 mtp -58.78 -49.93 75.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.269 -0.894 . . . . 1.02 110.55 -178.971 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -50.59 -44.3 56.88 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.855 -1.153 . . . . 0.68 109.524 -178.98 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 195' ' ' ARG . . . . . 0.513 ' NH1' ' NH2' ' A' ' 186' ' ' ARG . 65.4 mtp180 -59.94 -51.53 69.28 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.62 -0.832 . . . . 2.93 110.349 -178.709 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.7 m -76.07 -32.03 59.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.945 -1.097 . . . . 0.86 111.711 -178.152 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.3 -20.33 48.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.737 -1.227 . . . . 0.67 110.017 -179.197 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 60.41 46.81 9.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.205 -0.934 . . . . 1.5 110.223 -179.36 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 97.4 mt -121.09 129.18 25.39 Favored Pre-proline 0 N--CA 1.501 2.115 0 N-CA-C 108.375 -0.972 . . . . 0.72 108.375 178.715 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -43.52 131.2 7.17 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.975 1.783 . . . . 0.61 112.753 -179.571 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -168.91 146.54 3.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.703 -1.248 . . . . 0.66 111.607 179.962 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.3 mt -122.42 144.35 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 106.966 -1.494 . . . . 0.79 106.966 178.011 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 13.6 m -123.56 -13.2 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 O-C-N 120.854 -1.154 . . . . 0.91 111.454 -178.223 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.12 26.24 19.59 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.498 -1.041 . . . . 1.01 110.498 -179.172 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.456 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 7.7 p -47.23 -39.44 14.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.837 -1.39 . . . . 0.99 110.047 -179.117 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.81 -51.68 4.34 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 119.913 -1.137 . . . . 1.12 111.851 178.671 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 49.9 m -158.33 40.99 0.26 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.474 -1.603 . . . . 1.72 111.489 -178.766 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 18.5 t -79.52 -33.39 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.88 -1.138 . . . . 0.89 108.106 178.192 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.0 p -54.44 -31.61 55.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.657 -0.652 . . . . 1.03 110.92 -179.139 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 35.3 m -80.66 -10.91 59.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.99 -1.069 . . . . 1.83 110.304 -179.108 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -104.85 -13.98 15.65 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.274 -0.891 . . . . 2.27 110.788 -179.224 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.4 t -108.01 138.71 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.141 -0.974 . . . . 0.92 110.824 -178.497 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 213' ' ' LYS . . . . . 0.455 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 0.1 OUTLIER -118.31 150.6 39.2 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.38 -1.341 . . . . 2.2 107.38 178.434 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 17.9 p30 -51.81 138.58 23.58 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.065 -1.022 . . . . 2.36 111.001 -178.488 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.6 m-20 80.01 5.27 1.88 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 116.424 -0.353 . . . . 2.38 111.332 178.789 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.455 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 91.8 m-20 -73.7 140.4 46.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.648 -1.283 . . . . 2.09 109.025 178.977 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.03 116.85 24.5 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.358 -0.979 . . . . 1.27 108.358 179.508 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' A' ' 16' ' ' ALA . 86.3 mt -126.66 146.17 50.29 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.382 -0.824 . . . . 0.75 110.784 -178.92 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 78.6 mt -113.32 127.29 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.081 -1.822 . . . . 0.63 106.081 177.206 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 54.7 tp -101.21 119.23 38.45 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.865 -1.147 . . . . 0.7 108.51 -179.112 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.491 ' C ' ' N ' ' A' ' 223' ' ' VAL . 92.6 m-20 -77.07 -45.27 27.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.131 -0.98 . . . . 2.31 109.378 179.893 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 49.78 14.23 0.12 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.355 -0.979 . . . . 0.78 108.355 -178.996 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . 0.491 ' N ' ' C ' ' A' ' 221' ' ' ASP . 49.0 t -130.65 -45.3 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 106.601 -1.629 . . . . 1.04 106.601 178.542 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 224' ' ' ASN . . . . . 0.518 ' OD1' ' NE2' ' A' ' 226' ' ' GLN . 20.0 t-20 -99.67 -2.71 34.76 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.416 -1.327 . . . . 2.44 107.416 178.064 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 225' ' ' ASN . . . . . 0.526 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 62.56 40.0 10.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.917 -0.489 . . . . 1.55 110.194 179.837 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 226' ' ' GLN . . . . . 0.518 ' NE2' ' OD1' ' A' ' 224' ' ' ASN . 78.1 mt-30 -136.99 148.25 46.77 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.248 -0.907 . . . . 1.99 109.751 178.939 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.7 t -119.85 121.17 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.792 -0.568 . . . . 0.77 109.675 179.946 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -90.25 128.02 36.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.003 -1.06 . . . . 0.98 109.442 -179.887 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.8 t -100.73 111.51 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.469 -0.769 . . . . 0.85 110.205 -179.256 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 43.1 t30 50.01 65.74 6.51 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.193 -0.942 . . . . 1.66 111.482 178.899 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -90.05 156.49 4.83 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.969 2.446 . . . . 0.95 112.232 178.822 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.3 m -66.16 156.37 34.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.231 -0.918 . . . . 1.84 110.334 -179.237 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -60.01 -38.3 82.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.514 -0.741 . . . . 2.74 109.414 179.99 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -59.74 -36.05 75.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.117 -0.989 . . . . 2.89 108.903 -179.925 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.4 t -68.33 -40.11 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 1.3 108.718 178.913 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.6 mt . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.424 -0.798 . . . . 1.09 109.29 179.255 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 58.1 ttp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.694 0.759 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -153.87 150.67 28.64 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.831 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -152.32 160.91 43.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.024 -1.047 . . . . 0.0 110.719 -179.099 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . 0.43 ' NE2' HG21 ' B' ' 378' ' ' VAL . 6.7 tt0 -156.62 154.16 29.73 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.081 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 55.2 mp0 -110.31 129.53 55.72 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.252 -0.905 . . . . 0.0 109.709 179.577 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.41 121.95 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 CA-C-O 121.942 0.877 . . . . 0.0 112.157 -177.247 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 48.7 m -78.87 105.7 10.37 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 122.163 0.982 . . . . 0.0 111.444 -177.915 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.9 mt -53.08 123.52 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 122.438 1.113 . . . . 0.0 111.151 -177.863 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 76.0 p -111.42 19.88 17.79 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.895 -179.61 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.91 129.12 87.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.905 -1.122 . . . . 0.0 109.403 -179.932 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -51.17 -23.84 13.76 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 CA-C-N 119.983 1.03 . . . . 0.0 113.364 -179.506 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -122.16 11.42 10.16 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.348 -0.845 . . . . 0.0 109.203 -179.94 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.7 -171.25 55.15 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -178.481 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.48 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.7 tp -88.81 93.93 9.75 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.857 -1.378 . . . . 0.0 108.791 -179.618 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.401 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 4.3 p80 -98.21 -159.02 0.71 Allowed 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.357 -0.839 . . . . 0.0 110.853 179.793 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 7.7 m -57.38 -47.01 82.8 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.246 -0.909 . . . . 0.0 112.699 -176.299 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.557 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.2 tpt180 -58.88 -60.25 11.12 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 120.434 -1.416 . . . . 0.0 112.217 -178.072 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.401 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 10.3 Cg_endo -60.3 -30.71 91.66 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 CA-C-N 120.449 1.196 . . . . 0.0 111.45 -179.679 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.04 75.31 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.147 -0.971 . . . . 0.0 108.413 179.527 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.85 -43.52 77.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.444 -0.785 . . . . 0.0 109.673 -179.492 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -71.47 -41.76 68.97 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.913 -1.117 . . . . 0.0 108.792 178.763 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.58 -52.82 61.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.331 -0.856 . . . . 0.0 110.54 -179.76 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 74.9 t -67.19 -27.85 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.719 -1.238 . . . . 0.0 110.12 -178.781 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -60.25 -42.75 95.98 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.642 179.514 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -65.53 -55.59 16.94 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.9 -1.125 . . . . 0.0 109.794 -179.778 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.93 71.81 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.923 -1.111 . . . . 0.0 110.469 -179.447 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -48.92 -22.48 0.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 108.99 -179.278 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -82.59 -13.05 79.16 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.778 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -104.95 141.84 35.83 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.363 -1.08 . . . . 0.0 108.894 179.416 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 38.9 p -90.9 -13.6 33.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.785 -1.197 . . . . 0.0 110.014 -179.832 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . 0.49 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 67.5 p -59.98 142.77 53.23 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.039 -1.038 . . . . 0.0 109.181 179.909 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . 0.405 ' OE1' ' N ' ' B' ' 332' ' ' GLU . 40.2 mp0 -65.58 132.84 49.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.999 -1.063 . . . . 0.0 108.54 179.619 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 95.8 mt -130.92 132.42 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.447 -0.783 . . . . 0.0 109.712 -179.859 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 27.1 m -129.93 147.09 51.65 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.514 -0.742 . . . . 0.0 109.33 179.492 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 59.9 t -120.76 116.73 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.386 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 71.9 m -104.93 121.51 43.87 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.164 -0.96 . . . . 0.0 109.712 -178.66 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 94.5 p -133.92 121.89 22.34 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.901 0.857 . . . . 0.0 111.233 -179.616 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 58.9 t30 47.51 54.5 9.59 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 176.938 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.92 -11.54 41.18 Favored Glycine 0 N--CA 1.499 2.868 0 O-C-N 120.009 -1.682 . . . . 0.0 112.843 176.481 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -121.88 134.65 54.87 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 119.087 1.444 . . . . 0.0 108.776 -179.712 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 59.7 p -133.63 152.77 51.96 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.371 -0.831 . . . . 0.0 110.947 -178.231 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -147.18 169.95 18.25 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.382 0.61 . . . . 0.0 109.842 -179.859 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 72.3 m -88.16 140.94 28.97 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.472 -0.768 . . . . 0.0 110.403 -179.38 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.484 ' HA ' HD11 ' B' ' 350' ' ' LEU . . . -81.91 -15.39 54.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.043 -1.035 . . . . 0.0 109.442 179.677 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -86.4 16.33 4.6 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.52 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . 0.426 ' H ' ' C ' ' B' ' 344' ' ' ALA . 13.5 p -147.97 93.38 2.18 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.278 -179.362 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . 0.506 ' HA ' HD12 ' B' ' 350' ' ' LEU . 21.8 tp -60.76 -32.93 72.22 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.746 -0.596 . . . . 0.0 109.704 178.97 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -53.22 -51.92 60.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.68 -1.263 . . . . 0.0 110.064 -179.558 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -70.69 -39.91 73.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 0.0 110.831 -179.408 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' B' ' 352' ' ' THR . 86.1 mt -48.05 -54.44 13.07 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.771 -1.206 . . . . 0.0 109.293 -179.311 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.53 ' O ' HD22 ' A' ' 123' ' ' LEU . 37.7 mt-30 -40.99 -15.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.592 -0.693 . . . . 0.0 110.931 -178.726 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . 0.587 ' N ' ' O ' ' B' ' 350' ' ' LEU . 62.0 p -87.72 -10.22 51.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.456 -1.402 . . . . 0.0 110.247 -179.424 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 60.3 mt -95.01 116.77 29.12 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.93 -1.106 . . . . 0.0 109.454 179.0 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.88 94.17 1.08 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.081 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 25.5 mt -100.64 92.04 4.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.297 -1.119 . . . . 0.0 109.507 -179.632 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 44.6 p -90.03 172.41 8.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.93 -1.106 . . . . 0.0 111.197 -178.862 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -66.84 116.9 8.23 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.359 0.599 . . . . 0.0 110.491 -179.856 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 99.61 8.92 51.37 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.7 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 45.6 m -87.61 111.3 21.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.404 -1.056 . . . . 0.0 110.404 -179.604 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 22.0 t -77.48 116.34 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 122.202 1.001 . . . . 0.0 109.448 -177.662 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 18.4 m -110.98 177.2 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.025 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 42.6 m -130.88 126.98 37.59 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.491 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.3 111.75 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.923 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 61.7 p -118.24 132.87 56.28 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.796 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.3 150.66 37.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.91 . . . . 0.0 109.974 -178.974 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . 0.402 ' O ' ' OE1' ' B' ' 332' ' ' GLU . 18.4 tp10 -141.61 122.42 14.4 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.505 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . 0.463 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 160.36 -160.61 31.91 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.053 -1.546 . . . . 0.0 111.477 -179.886 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -59.81 -50.14 74.97 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.979 -0.718 . . . . 0.0 112.42 -177.245 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . 0.49 ' H ' ' HB3' ' B' ' 331' ' ' SER . 70.7 m-20 -109.95 13.65 23.35 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.035 -1.041 . . . . 0.0 111.22 -177.223 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . 0.564 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -45.44 -34.96 3.43 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.081 -1.012 . . . . 0.0 111.852 -178.876 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . 0.518 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 27.1 mt-30 -70.94 -41.4 71.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.809 -1.182 . . . . 0.0 110.098 -179.001 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -66.41 -43.26 86.24 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.338 -0.852 . . . . 0.0 109.725 -178.869 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -53.95 -71.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 110.977 -178.965 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . 0.588 ' O ' HG23 ' B' ' 378' ' ' VAL . 60.0 t -46.86 -37.69 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.914 -1.116 . . . . 0.0 110.204 -177.682 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -63.74 -50.0 70.8 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.75 -1.219 . . . . 0.0 110.345 179.518 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -78.5 -42.83 28.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.065 -1.022 . . . . 0.0 110.157 -179.894 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.95 -37.46 79.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.25 -0.906 . . . . 0.0 109.631 -179.306 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . 0.588 HG23 ' O ' ' B' ' 374' ' ' VAL . 46.7 t -63.68 -40.2 88.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.209 -0.932 . . . . 0.0 109.325 179.836 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -70.59 -57.46 4.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.616 -1.303 . . . . 0.0 107.929 178.134 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 54.4 tp -57.41 -34.65 69.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.513 -0.742 . . . . 0.0 110.348 -178.151 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.9 ttm -70.51 -40.02 73.77 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.424 -1.423 . . . . 0.0 108.199 177.831 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.69 -7.25 59.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.811 -0.555 . . . . 0.0 110.794 179.324 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . 0.406 ' O ' ' OE2' ' B' ' 385' ' ' GLU . 96.7 mt-10 -111.73 -0.22 16.05 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.978 -1.076 . . . . 0.0 111.585 -179.388 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.1 mt -83.21 130.48 35.09 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.421 -1.424 . . . . 0.0 109.684 179.456 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . 0.428 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 35.4 mp0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.177 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.722 0 CA-C-O 121.191 0.519 . . . . 2.91 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 94.9 mt -109.41 124.72 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.914 -0.773 . . . . 1.2 108.914 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.6 m -130.07 130.31 44.71 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.978 -0.749 . . . . 1.4 108.978 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.795 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -115.49 -166.93 15.05 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 108.754 -1.738 . . . . 1.05 108.754 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.445 HG22 ' O ' ' A' ' 5' ' ' ILE . 72.5 mt -91.06 -10.48 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.033 -1.275 . . . . 1.15 110.562 -178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.485 HD11 ' O ' ' A' ' 8' ' ' SER . 57.5 tp 53.3 98.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.684 -1.26 . . . . 0.98 109.8 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -77.97 -38.7 44.57 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.848 -0.797 . . . . 0.88 108.848 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.485 ' O ' HD11 ' A' ' 6' ' ' LEU . 5.0 m -141.27 140.2 20.43 Favored Pre-proline 0 N--CA 1.501 2.099 0 O-C-N 121.498 -0.751 . . . . 1.69 109.595 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -80.48 140.33 13.38 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 122.529 2.153 . . . . 0.85 112.821 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.748 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.99 -163.68 36.94 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.05 -1.62 . . . . 0.92 109.05 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.2 mt -148.64 149.63 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.194 0 O-C-N 121.208 -1.172 . . . . 0.81 108.156 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.38 155.58 33.88 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 120.572 -1.33 . . . . 0.51 110.721 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -137.89 129.68 28.43 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.072 -1.084 . . . . 0.62 108.072 178.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.43 -178.13 46.35 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 118.699 -1.715 . . . . 0.55 110.905 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -80.07 156.51 27.05 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.811 -0.817 . . . . 2.1 109.519 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.585 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.11 129.75 51.81 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.449 -0.782 . . . . 0.77 110.934 -178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.3 tp -100.09 135.83 40.93 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.307 -1.368 . . . . 0.91 107.307 178.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.2 tp -117.77 127.45 53.92 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.262 -0.899 . . . . 0.93 109.951 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.4 mt -88.28 101.22 13.64 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 120.115 -0.634 . . . . 0.93 109.352 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.31 137.58 32.25 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 2.75 108.701 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -130.48 133.33 46.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.217 -0.927 . . . . 3.0 108.998 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -81.42 149.84 28.63 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.105 -0.997 . . . . 2.77 108.94 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -66.75 146.84 54.02 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.0 -1.062 . . . . 2.94 108.893 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.8 mt -94.45 130.91 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.283 -0.886 . . . . 0.95 108.633 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 76.3 t -101.61 129.66 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.271 -0.893 . . . . 1.28 110.752 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -108.34 132.1 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 108.585 -0.894 . . . . 1.21 108.585 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -87.36 120.59 28.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.79 -1.194 . . . . 1.81 109.495 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -88.71 0.1 56.79 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.388 -0.82 . . . . 2.8 108.879 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -68.83 146.49 52.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.299 -0.876 . . . . 2.87 109.252 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -89.22 150.07 22.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.218 -0.926 . . . . 2.35 109.335 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.502 HG21 ' HG3' ' A' ' 39' ' ' GLU . 3.5 pt -93.92 166.18 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.321 -0.862 . . . . 0.97 109.793 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.5 p -97.59 171.12 8.56 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.224 -1.028 . . . . 1.17 108.224 178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.69 -49.39 77.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.948 -1.095 . . . . 1.18 108.94 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -53.89 -29.94 43.84 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.81 -1.181 . . . . 2.56 109.516 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -82.84 -10.0 59.05 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.395 -0.816 . . . . 1.79 110.413 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 27.3 t -62.57 -53.84 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.831 -1.168 . . . . 1.0 108.691 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -60.21 -40.07 88.83 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.481 -0.762 . . . . 1.77 109.677 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.23 -41.96 93.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.258 -0.901 . . . . 2.7 110.891 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.502 ' HG3' HG21 ' A' ' 31' ' ' ILE . 67.4 mm-40 -65.76 -39.98 91.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 1.51 110.419 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.0 -46.17 94.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 120.701 -1.249 . . . . 0.93 108.491 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -59.98 -40.63 89.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.01 -1.056 . . . . 1.81 109.192 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -60.07 -43.03 95.73 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.901 -1.125 . . . . 2.78 108.438 178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -66.39 -42.97 87.09 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.842 -0.799 . . . . 0.78 108.842 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.91 -50.63 73.01 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 108.282 -1.007 . . . . 1.07 108.282 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.436 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 42.8 t -63.86 -42.76 97.46 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.371 -0.932 . . . . 1.12 108.872 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.33 -42.51 98.85 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.575 -1.81 . . . . 0.84 108.575 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.442 HH11 ' HG2' ' A' ' 47' ' ' ARG . 21.4 ttt-85 -64.95 -35.12 80.16 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.184 -1.043 . . . . 3.09 108.184 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -53.76 -39.94 65.77 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.773 -0.825 . . . . 0.88 108.773 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.565 ' HZ3' ' HB3' ' A' ' 49' ' ' LYS . 7.0 ttpm? -72.46 -73.7 0.19 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.89 -1.152 . . . . 2.59 107.89 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.439 ' HB2' ' OD1' ' A' ' 140' ' ' ASN . . . -37.02 -41.11 0.33 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.334 -0.854 . . . . 0.7 112.084 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 79.2 p -57.93 -55.07 39.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.591 -1.318 . . . . 1.4 108.816 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.06 95.62 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.446 -0.784 . . . . 0.67 110.85 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -62.16 -46.05 90.71 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.997 -1.064 . . . . 1.66 110.685 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.74 -40.21 94.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.13 -0.981 . . . . 1.58 109.418 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -62.84 -40.02 96.15 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.306 -0.871 . . . . 1.35 109.603 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.9 m -65.87 -41.5 91.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.021 -1.05 . . . . 0.77 109.983 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.1 mt -61.64 -40.0 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.112 -0.992 . . . . 0.63 108.793 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -55.44 -50.87 68.71 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.471 -0.768 . . . . 1.14 109.771 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -58.82 -37.51 76.56 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.329 -0.857 . . . . 0.79 110.254 -177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.7 mttm -61.7 -38.74 88.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.073 -1.017 . . . . 1.53 109.39 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.413 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -66.98 -46.9 73.19 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.745 -0.597 . . . . 0.57 110.162 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.84 -53.27 37.41 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.829 -1.308 . . . . 0.75 109.829 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.54 -44.82 66.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.05 -1.265 . . . . 1.59 110.462 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.5 m -66.53 -64.04 0.94 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.124 -0.985 . . . . 0.73 112.74 -177.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -95.8 -45.25 7.06 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.747 -1.221 . . . . 0.75 111.002 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.4 -167.47 25.5 Favored Glycine 0 N--CA 1.498 2.786 0 C-N-CA 119.771 -1.204 . . . . 1.22 110.792 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.21 -24.18 63.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 122.032 -0.687 . . . . 5.81 109.819 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.516 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.4 tp10 -60.96 -35.83 77.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.407 -0.808 . . . . 3.37 110.786 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -97.62 -19.46 18.29 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.133 -0.979 . . . . 1.77 109.764 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -68.89 -40.22 79.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.248 -0.908 . . . . 1.65 110.402 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.54 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -66.48 -32.65 74.14 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.393 -0.817 . . . . 0.77 110.144 -178.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 83.6 mt -60.06 -40.41 83.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 118.836 -1.145 . . . . 0.8 108.672 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -64.43 -40.14 95.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.104 -0.998 . . . . 0.88 109.15 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -60.08 -41.93 93.5 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.299 -0.876 . . . . 1.37 109.438 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.05 -43.73 97.95 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.173 -1.571 . . . . 0.62 109.173 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 42.4 m170 -70.0 -40.02 75.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -1.117 . . . . 1.5 109.167 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.0 -47.22 79.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.101 -0.999 . . . . 0.63 109.019 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.1 ttp -60.08 -40.49 89.75 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 120.992 -1.068 . . . . 1.51 109.836 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.882 HD11 ' CE2' ' B' ' 348' ' ' PHE . 32.2 tp -68.53 -39.93 80.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.444 -0.785 . . . . 0.77 109.289 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.1 tp -62.34 -39.97 94.83 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.424 -0.798 . . . . 0.62 109.481 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -79.42 1.72 24.39 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.319 -0.863 . . . . 1.47 110.171 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -49.42 128.19 16.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.831 -1.168 . . . . 1.47 109.953 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -62.41 -16.82 57.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.55 -0.719 . . . . 1.78 110.566 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.67 -32.71 66.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.788 -1.195 . . . . 2.53 108.813 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.8 mt -70.74 -43.58 68.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.69 -0.631 . . . . 0.8 110.442 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -60.03 -43.31 95.41 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.046 -1.034 . . . . 1.42 110.47 -178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.96 -42.87 72.6 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.05 -1.031 . . . . 1.71 110.812 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.14 -39.97 75.09 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.959 -1.088 . . . . 1.57 111.333 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.6 mt -64.05 -50.03 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.329 -0.857 . . . . 0.65 109.985 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.5 mt -69.34 -35.36 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.448 -0.783 . . . . 0.82 110.173 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -61.63 -45.85 92.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.128 -0.983 . . . . 0.79 110.847 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 85.0 mt -60.56 -47.53 85.77 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.911 -1.118 . . . . 0.95 109.982 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.9 mt -60.24 -49.67 83.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-O 122.093 0.949 . . . . 0.66 108.932 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -69.8 -39.94 76.28 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 120.15 -0.62 . . . . 2.2 111.175 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -84.83 -57.99 2.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.769 -1.207 . . . . 1.65 112.345 -178.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -83.61 -0.94 52.69 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.964 -1.085 . . . . 2.03 111.419 -177.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.0 m-70 57.34 36.63 27.44 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.117 -0.99 . . . . 1.42 109.854 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.5 mtt -90.27 167.96 12.28 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.568 -0.707 . . . . 1.18 109.976 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 73.9 p -80.88 160.58 24.7 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.473 -0.767 . . . . 0.98 109.339 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.56 -40.86 80.44 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.102 -0.999 . . . . 0.64 110.069 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 31.4 p-10 -64.36 -36.78 85.24 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.252 -0.905 . . . . 2.07 109.221 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.431 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.96 -48.61 12.05 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.036 -1.04 . . . . 0.73 109.844 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.65 -48.95 79.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.527 -0.733 . . . . 0.54 110.952 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.0 -45.09 93.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.032 -1.043 . . . . 0.56 110.296 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.417 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 81.6 t60 -59.08 -38.27 79.06 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.055 -1.028 . . . . 1.54 110.397 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.71 -41.12 97.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.874 -1.141 . . . . 1.33 110.968 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 46.5 t -64.05 -52.19 59.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.013 -1.055 . . . . 0.72 110.715 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.0 mm -66.96 -39.96 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.063 -1.023 . . . . 0.85 108.402 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.417 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 89.2 tt0 -66.22 -38.2 87.37 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.737 -0.838 . . . . 2.44 108.737 178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.88 -47.36 90.92 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 110.312 -1.115 . . . . 0.98 110.312 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -68.33 -53.48 23.92 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.688 -1.478 . . . . 1.41 108.677 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -51.89 -39.95 59.86 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.096 -1.002 . . . . 1.2 109.106 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 46.2 t -60.06 -42.74 95.18 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.099 -1.001 . . . . 1.7 108.544 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.01 -39.89 87.37 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.394 -0.816 . . . . 1.47 109.188 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.6 mt -67.44 -41.6 84.48 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.909 -1.119 . . . . 1.56 108.986 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -53.65 -31.42 47.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.071 -1.018 . . . . 2.2 109.164 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.6 -24.88 65.83 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.275 -0.89 . . . . 2.12 108.717 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.42 HD13 HD13 ' A' ' 123' ' ' LEU . 61.0 mt -62.79 143.55 57.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.303 -0.873 . . . . 2.0 109.272 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -99.33 48.98 0.95 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.325 -0.86 . . . . 3.23 109.257 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.441 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 56.9 t0 -134.61 132.89 39.55 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.296 -0.878 . . . . 2.49 109.795 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.441 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 18.4 pt-20 -70.25 -29.01 65.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.568 -0.707 . . . . 3.95 109.898 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.478 ' OH ' ' NH1' ' A' ' 126' ' ' ARG . 3.5 t80 -71.1 -39.92 71.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.38 -0.825 . . . . 2.0 110.383 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.464 HD22 ' O ' ' B' ' 351' ' ' GLN . 88.9 mt -79.63 -40.05 30.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.117 -0.99 . . . . 1.86 109.775 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -60.15 -49.91 75.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.982 -1.074 . . . . 2.84 109.706 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 96.6 mt-10 -61.82 -40.17 94.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 2.73 108.862 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.702 ' CG ' HE22 ' B' ' 351' ' ' GLN . 31.6 ttt180 -60.03 -40.07 88.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.857 -1.164 . . . . 2.77 107.857 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -65.66 -23.51 66.81 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.261 -1.015 . . . . 1.19 108.261 178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -61.46 -40.03 93.05 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 107.58 -1.267 . . . . 1.2 107.58 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -61.54 -41.44 97.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.515 -0.741 . . . . 1.55 109.082 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 73.1 t -63.65 -40.08 87.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.273 -1.01 . . . . 0.8 108.273 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -62.7 -33.52 75.26 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.608 -0.683 . . . . 3.09 109.476 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -59.95 -41.58 92.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.258 -0.901 . . . . 1.46 109.487 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 87.1 mt -60.09 -45.58 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.163 -0.961 . . . . 0.71 109.863 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.66 -43.31 99.17 Favored Glycine 0 N--CA 1.494 2.521 0 C-N-CA 120.397 -0.906 . . . . 0.57 111.014 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -59.99 -47.87 84.05 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.011 -1.288 . . . . 2.59 110.901 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.594 HH12 ' CB ' ' A' ' 166' ' ' SER . 99.0 mtt180 -69.32 -29.02 66.77 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.832 -1.167 . . . . 2.83 109.903 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 57.6 tp -59.52 -41.57 90.25 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.555 -0.906 . . . . 1.25 108.555 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.6 mt -61.89 -40.12 94.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.141 -0.974 . . . . 0.7 109.317 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.87 -39.97 83.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.488 -0.757 . . . . 2.57 108.978 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.535 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.9 m120 -60.09 -39.11 84.98 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.583 -0.698 . . . . 1.23 111.279 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.1 mt -73.46 -41.2 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 120.764 -1.21 . . . . 0.81 109.675 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.2 mt -70.43 -31.79 69.13 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.55 -0.719 . . . . 1.0 109.434 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.12 37.94 6.98 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.215 -1.554 . . . . 0.89 109.215 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.407 HD12 ' HA ' ' A' ' 144' ' ' LEU . 16.0 tp -73.63 142.56 46.51 Favored 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.263 -1.139 . . . . 1.14 108.644 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 44.0 tptt -69.16 142.72 54.26 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.207 -0.933 . . . . 4.6 110.668 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.02 129.99 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-O 122.063 0.935 . . . . 1.24 109.343 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.2 mt -61.48 -43.91 97.64 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.865 -0.607 . . . . 1.54 110.691 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.6 t0 63.76 103.36 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.38 -0.825 . . . . 1.5 109.094 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.492 ' O ' HD13 ' A' ' 152' ' ' ILE . 22.5 mt -70.53 -6.04 33.39 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.522 -0.736 . . . . 0.79 110.184 -179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 93.7 p -85.09 -14.0 48.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.128 -0.983 . . . . 1.4 108.681 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.87 14.65 2.1 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.687 -0.633 . . . . 0.92 111.176 -178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.492 HD13 ' O ' ' A' ' 149' ' ' LEU . 2.5 mp -89.4 134.34 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.603 -1.31 . . . . 0.88 108.188 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -117.53 -9.02 10.9 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.736 -0.602 . . . . 2.45 109.741 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -119.03 149.98 40.75 Favored 'General case' 0 N--CA 1.505 2.306 0 O-C-N 121.21 -0.932 . . . . 1.52 110.473 -179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -63.65 130.97 46.48 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.689 -0.856 . . . . 1.58 108.689 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.4 m -152.07 163.59 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.883 . . . . 0.69 109.518 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.0 mt -94.42 147.85 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 106.036 -1.839 . . . . 0.61 106.036 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.2 tp -97.31 117.4 31.46 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.086 -1.009 . . . . 0.87 110.905 -178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.7 t -119.91 126.42 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 N-CA-C 108.215 -1.031 . . . . 0.71 108.215 178.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.88 161.26 40.61 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.094 -1.004 . . . . 0.81 109.201 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.42 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.35 -31.45 69.89 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.133 -1.604 . . . . 0.98 107.847 179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 39.3 p-10 -167.59 173.92 8.2 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.559 -0.904 . . . . 2.25 108.559 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 89.9 mt -141.22 130.04 22.99 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.076 -1.015 . . . . 0.78 108.823 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 21.8 p -87.89 147.91 42.17 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.03 -1.044 . . . . 0.98 109.23 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -43.38 -36.43 6.55 Favored 'Trans proline' 0 N--CA 1.492 1.437 0 C-N-CA 121.817 1.678 . . . . 0.81 112.125 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.594 ' CB ' HH12 ' A' ' 136' ' ' ARG . 50.3 m -60.04 -39.94 87.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.371 -0.831 . . . . 0.9 109.875 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -69.1 -40.87 78.12 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.155 -0.966 . . . . 1.61 109.751 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.8 p -55.64 -29.75 59.8 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.96 -1.087 . . . . 0.61 110.605 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -71.79 -51.21 23.76 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.879 -1.138 . . . . 0.6 109.573 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -85.02 38.52 0.72 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.417 -0.957 . . . . 1.4 108.417 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.401 HD11 HG21 ' A' ' 176' ' ' VAL . 61.8 tp -102.92 130.6 50.02 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.693 -0.63 . . . . 0.7 109.303 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -83.75 103.65 13.22 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.868 -0.789 . . . . 2.35 108.868 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 77.6 mt -64.86 -43.65 92.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.416 -0.803 . . . . 1.51 111.344 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -69.83 -25.24 63.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.893 -1.13 . . . . 2.33 112.417 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -93.18 -10.12 36.89 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.615 -1.303 . . . . 1.92 110.517 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 178' ' ' GLY . 62.3 t -109.18 119.94 59.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.137 -1.06 . . . . 0.67 108.137 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.1 mt -90.94 8.09 36.9 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.184 -0.947 . . . . 1.53 111.09 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.505 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.96 172.64 37.4 Favored Glycine 0 N--CA 1.491 2.335 0 C-N-CA 119.153 -1.499 . . . . 0.48 109.87 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.9 m-85 -133.7 128.51 35.11 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.656 -0.908 . . . . 0.55 108.594 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 97.3 mt -132.67 127.2 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.456 -0.778 . . . . 0.65 109.204 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 50.4 p -150.02 162.0 41.23 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.904 -1.123 . . . . 0.82 110.516 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 38.1 p-10 -104.0 23.27 13.19 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.186 -0.672 . . . . 2.46 109.186 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.44 -159.67 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.057 -1.027 . . . . 1.28 111.644 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.66 -54.22 6.09 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 110.906 -0.877 . . . . 2.19 110.906 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 160.7 -131.46 2.63 Favored Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.147 -1.501 . . . . 2.13 110.732 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.522 HH11 ' HG2' ' A' ' 186' ' ' ARG . 12.5 mtt-85 -69.91 -20.78 63.34 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.67 -0.9 . . . . 5.86 111.065 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 25.1 p -73.04 -0.17 13.13 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.938 -1.101 . . . . 3.72 110.322 -178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.9 m -91.09 132.36 36.09 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.067 -1.021 . . . . 1.74 110.064 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 65.0 t60 -49.89 -48.19 51.59 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.334 -0.854 . . . . 0.95 109.526 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.455 ' H ' HG22 ' A' ' 190' ' ' THR . 0.0 OUTLIER -56.75 -39.83 74.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.33 -0.856 . . . . 1.55 110.085 -179.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 19.7 t -60.09 -43.04 95.82 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.928 -1.108 . . . . 1.51 109.907 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.6 mt -62.33 -41.34 91.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.181 -0.95 . . . . 1.67 109.798 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 86.6 mtp -63.31 -39.98 96.08 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.168 -0.957 . . . . 1.02 110.175 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.74 -42.89 76.05 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.561 -1.337 . . . . 0.68 108.821 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -59.89 -50.1 75.11 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.455 -0.778 . . . . 2.93 110.041 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.0 m -70.32 -33.95 72.11 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.093 -1.004 . . . . 0.86 110.711 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 81.8 mt -70.0 -21.36 63.23 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.107 -0.996 . . . . 0.67 109.264 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 60.74 48.89 6.67 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.239 0.542 . . . . 1.5 110.751 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 45.8 mt -126.42 149.57 67.9 Favored Pre-proline 0 N--CA 1.499 2.0 0 N-CA-C 107.218 -1.401 . . . . 0.72 107.218 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -62.44 137.71 66.59 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 C-N-CA 121.84 1.693 . . . . 0.61 111.593 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.17 151.0 3.79 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.876 -1.14 . . . . 0.66 111.478 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.8 mt -126.87 143.62 39.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.964 -1.124 . . . . 0.79 107.964 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.8 m -128.49 -8.8 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 O-C-N 120.736 -1.227 . . . . 0.91 110.864 -178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.58 21.53 25.77 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 110.397 -1.081 . . . . 1.01 110.397 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 23.0 p -44.46 -44.17 8.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.114 -1.227 . . . . 0.99 110.048 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 93.94 -51.86 2.25 Favored Glycine 0 N--CA 1.497 2.761 0 C-N-CA 120.328 -0.939 . . . . 1.12 111.03 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.9 p -157.34 35.01 0.28 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.516 -1.579 . . . . 1.72 111.444 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.0 t -73.37 -39.86 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.969 -1.082 . . . . 0.89 108.907 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.0 p -56.14 -34.01 65.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.483 -0.761 . . . . 1.03 110.666 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 23.0 t -71.19 -31.64 67.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.136 -0.977 . . . . 1.83 109.794 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -89.84 -8.22 52.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.358 -0.838 . . . . 2.27 110.728 -178.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 75.0 t -102.79 131.99 49.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 121.011 -1.056 . . . . 0.92 110.528 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 30.8 mmtm -111.33 145.08 39.46 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.066 -1.457 . . . . 2.2 107.066 178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.477 ' O ' ' OD1' ' A' ' 215' ' ' ASP . 44.4 p-10 -54.25 137.8 40.29 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.201 -0.937 . . . . 2.36 111.051 -178.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 214' ' ' ASN . 0.2 OUTLIER 89.3 -2.53 0.38 Allowed 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.321 0.581 . . . . 2.38 110.768 178.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -71.36 150.51 45.0 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.336 -0.853 . . . . 2.09 109.497 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -99.09 120.0 38.76 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.234 -1.024 . . . . 1.27 108.234 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.585 HD12 ' HB2' ' A' ' 16' ' ' ALA . 73.8 mt -126.64 149.78 49.31 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.565 -0.709 . . . . 0.75 109.861 -178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.421 HG23 ' CD2' ' A' ' 13' ' ' PHE . 86.9 mt -119.26 129.95 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.301 -1.37 . . . . 0.63 107.301 177.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 23.9 tp -102.25 119.95 39.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.23 -0.919 . . . . 0.7 109.437 -178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 223' ' ' VAL . 29.0 t70 -80.1 -41.86 24.71 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.303 -0.873 . . . . 2.31 108.769 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.76 11.67 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.691 -0.63 . . . . 0.78 109.96 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 221' ' ' ASP . 46.7 t -118.84 -35.22 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 106.693 -1.595 . . . . 1.04 106.693 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.452 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 19.9 m120 -112.85 4.6 17.01 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.375 -1.343 . . . . 2.44 107.375 178.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.795 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.9 OUTLIER 57.58 50.61 10.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.855 -0.528 . . . . 1.55 110.235 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -136.95 147.5 46.38 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.216 -0.927 . . . . 1.99 109.548 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 76.0 t -115.02 129.3 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.545 -0.909 . . . . 0.77 108.545 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -104.48 121.06 42.67 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.768 -0.827 . . . . 0.98 108.768 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 43.1 t -100.08 110.95 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.593 -0.692 . . . . 0.85 109.805 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.487 HD22 ' C ' ' A' ' 230' ' ' ASN . 0.4 OUTLIER 51.69 69.94 2.22 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.41 -0.806 . . . . 1.66 110.911 179.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -90.67 147.64 4.06 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.33 2.687 . . . . 0.95 112.245 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.434 HG22 ' N ' ' A' ' 233' ' ' ASN . 11.0 m -71.02 165.38 23.6 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.057 -1.027 . . . . 1.84 109.932 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.434 ' N ' HG22 ' A' ' 232' ' ' THR . 41.5 t30 -59.98 -39.92 87.33 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.318 -0.864 . . . . 2.74 109.88 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -60.02 -39.86 87.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.126 -0.984 . . . . 2.89 109.64 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.32 -44.21 97.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.155 -0.965 . . . . 1.3 109.049 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.18 -40.04 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.372 -0.83 . . . . 1.09 109.655 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -59.32 -40.12 85.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.895 -1.128 . . . . 2.43 108.542 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -65.33 -42.3 93.05 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.557 -0.905 . . . . 2.78 108.557 178.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 89.0 mtp -69.88 -33.73 72.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.27 -0.894 . . . . 1.25 109.88 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.3 mmm180 -65.59 -39.26 91.39 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.12 -0.987 . . . . 2.63 109.158 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.69 -42.88 93.94 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.469 -0.77 . . . . 1.8 109.946 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 53.4 t -60.07 -40.89 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.884 -1.135 . . . . 2.13 108.596 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -59.99 -40.18 88.27 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.297 -0.877 . . . . 3.17 109.292 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -61.61 -40.21 94.02 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 1.78 109.162 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -60.82 -40.46 92.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.889 . . . . 2.47 108.824 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 79.4 t -63.44 -40.3 88.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.639 -0.663 . . . . 2.09 109.223 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.99 -42.21 93.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.272 -0.893 . . . . 2.54 109.555 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 23.0 t -65.01 -40.06 94.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.362 -0.836 . . . . 2.99 108.841 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -63.17 -33.71 76.06 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.575 -0.703 . . . . 3.34 109.522 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -59.95 -40.64 89.72 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.065 -1.022 . . . . 3.88 109.166 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -60.25 -39.94 88.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.988 -1.07 . . . . 4.43 109.25 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 60.37 19.95 9.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.445 -0.784 . . . . 5.42 109.771 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.491 ' O ' ' N ' ' A' ' 255' ' ' LYS . 88.0 mt -69.44 -25.02 63.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.166 -0.959 . . . . 6.1 109.391 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -42.42 -21.64 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.489 -0.757 . . . . 7.37 110.595 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 253' ' ' LEU . 57.6 mttp -72.48 162.27 29.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.001 -1.062 . . . . 8.01 109.5 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.516 ' N ' HD12 ' A' ' 256' ' ' LEU . 9.9 mp -58.77 -35.94 73.59 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.23 -0.919 . . . . 9.05 108.61 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -149.95 148.82 29.55 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.297 -0.877 . . . . 10.56 109.466 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -130.53 43.12 3.16 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.49 -0.756 . . . . 11.32 109.292 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 118.024 -0.989 . . . . 12.42 109.438 179.869 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 21.8 ttt . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -153.95 150.84 28.73 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.36 -0.838 . . . . 0.0 108.965 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -148.66 160.05 43.52 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.98 -1.075 . . . . 0.0 110.171 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 71.3 tp60 -152.12 149.24 28.58 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -109.82 130.24 55.54 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.39 -0.818 . . . . 0.0 109.673 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 1.5 p -131.95 121.51 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 122.167 0.984 . . . . 0.0 112.021 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 50.6 m -75.74 106.1 7.13 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.828 0.823 . . . . 0.0 110.524 -178.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.512 HG22 ' H ' ' B' ' 310' ' ' ALA . 77.9 mt -52.16 123.17 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 CA-C-O 122.476 1.131 . . . . 0.0 110.296 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 77.7 p -104.0 23.2 13.3 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.776 -178.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.512 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -82.66 119.47 74.63 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.142 -0.974 . . . . 0.0 109.262 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -66.3 -7.91 18.92 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 CA-C-N 120.362 1.165 . . . . 0.0 111.884 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -117.39 6.44 12.64 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.69 176.93 34.25 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.229 -1.949 . . . . 0.0 108.229 -178.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.465 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.3 tp -86.74 96.18 10.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.946 -1.326 . . . . 0.0 108.723 -179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -97.69 -159.97 0.77 Allowed 'General case' 0 N--CA 1.506 2.371 0 O-C-N 121.29 -0.881 . . . . 0.0 110.71 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 24.5 m -59.82 -43.03 94.73 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.033 -1.042 . . . . 0.0 112.303 -175.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.54 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.5 tpt180 -59.74 -64.33 3.14 Favored Pre-proline 0 N--CA 1.497 1.896 0 O-C-N 120.356 -1.465 . . . . 0.0 111.428 -178.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -55.37 -33.78 86.66 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 CA-C-N 120.281 1.136 . . . . 0.0 111.782 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.95 71.72 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.46 -40.88 62.8 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.247 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 66.1 mt-30 -70.43 -40.06 74.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.031 -1.043 . . . . 0.0 108.674 178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -61.44 -53.04 61.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.437 -0.789 . . . . 0.0 110.432 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 77.7 t -68.93 -35.12 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.766 -1.208 . . . . 0.0 109.756 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 31.6 ttpt -59.97 -47.06 87.38 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.462 -0.895 . . . . 0.0 109.869 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -66.34 -40.05 89.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.096 -1.002 . . . . 0.0 109.999 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . 0.419 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -64.65 -52.33 57.91 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.019 -1.051 . . . . 0.0 110.789 -179.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 52.5 mttm -54.49 -10.21 0.39 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.021 -1.049 . . . . 0.0 109.555 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . 0.419 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -71.94 -26.19 73.12 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.098 -1.601 . . . . 0.0 109.098 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -101.99 144.99 29.91 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.39 -1.065 . . . . 0.0 109.272 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 8.8 m -90.87 -13.73 33.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.907 -1.121 . . . . 0.0 108.996 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 15.0 t -62.61 149.88 42.16 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 109.04 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -67.61 134.62 51.51 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.256 -0.903 . . . . 0.0 109.171 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 90.3 mt -131.12 130.45 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.711 -0.618 . . . . 0.0 109.654 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 98.3 m -129.62 152.36 49.22 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.594 -0.691 . . . . 0.0 109.187 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 61.6 t -116.94 140.47 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 70.4 m -130.36 126.12 36.31 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.211 -0.931 . . . . 0.0 109.497 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 10.8 t -138.65 111.75 7.93 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.232 -0.917 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 46.39 56.38 6.42 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 177.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 84.56 -16.2 36.87 Favored Glycine 0 N--CA 1.499 2.873 0 O-C-N 120.223 -1.548 . . . . 0.0 112.299 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -110.65 121.61 45.74 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.922 -1.34 . . . . 0.0 109.482 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 88.4 p -128.25 148.19 50.63 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.811 0.815 . . . . 0.0 109.855 -178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . 0.553 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -144.84 170.38 16.23 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.662 0.744 . . . . 0.0 110.11 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 70.4 m -88.53 140.47 29.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.605 -0.684 . . . . 0.0 109.582 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -83.13 -12.45 57.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.024 -1.048 . . . . 0.0 110.248 -179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 20.1 pttp -88.93 20.56 3.51 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 56.1 m -147.81 98.06 2.9 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.734 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.56 HD23 HD22 ' A' ' 79' ' ' LEU . 29.1 tp -60.0 -34.68 73.66 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.882 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.7 m-85 -57.65 -53.53 57.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.709 -1.244 . . . . 0.0 109.942 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -70.05 -21.4 63.18 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.09 -1.006 . . . . 0.0 111.17 -177.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.533 ' O ' ' N ' ' B' ' 352' ' ' THR . 21.4 mt -69.42 -52.68 24.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.771 -1.206 . . . . 0.0 108.165 178.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.702 HE22 ' CG ' ' A' ' 126' ' ' ARG . 10.3 mm100 -38.33 -22.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.293 -178.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.533 ' N ' ' O ' ' B' ' 350' ' ' LEU . 58.5 p -82.08 -10.2 59.29 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.962 -1.086 . . . . 0.0 110.215 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.553 HD11 ' HB3' ' B' ' 342' ' ' ALA . 70.6 mt -95.5 116.24 28.55 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.066 -1.021 . . . . 0.0 109.076 178.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -80.27 94.43 1.49 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.024 -1.63 . . . . 0.0 109.024 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 27.8 mt -99.82 92.64 5.4 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.237 -1.155 . . . . 0.0 108.556 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 68.4 p -94.6 179.82 5.13 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.07 -1.019 . . . . 0.0 110.632 -178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . 0.5 ' O ' ' N ' ' B' ' 359' ' ' THR . 62.2 tt0 -48.62 157.44 0.37 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 122.232 1.015 . . . . 0.0 111.236 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.61 23.98 0.02 OUTLIER Glycine 0 N--CA 1.497 2.708 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.499 177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . 0.5 ' N ' ' O ' ' B' ' 357' ' ' GLN . 19.1 m -84.4 111.58 19.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.732 -1.452 . . . . 0.0 109.448 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 23.4 t -76.27 115.68 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 122.318 1.056 . . . . 0.0 109.629 -176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 19.0 m -112.66 176.6 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 45.9 m -130.74 129.49 42.58 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 84.3 mt -102.96 118.24 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.484 -1.672 . . . . 0.0 106.484 178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 22.1 m -123.67 134.0 53.81 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.322 -0.861 . . . . 0.0 109.232 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.29 150.55 38.05 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.179 -0.951 . . . . 0.0 109.74 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -140.09 119.81 13.34 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.555 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.74 -160.93 32.37 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 118.855 -1.641 . . . . 0.0 111.691 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -59.95 -51.65 68.78 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 122.371 -0.487 . . . . 0.0 112.311 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -105.52 9.36 33.49 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.857 -1.152 . . . . 0.0 110.939 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.9 pt-20 -42.7 -34.08 0.84 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.151 -0.968 . . . . 0.0 111.088 -178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -70.11 -41.31 74.18 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.963 . . . . 0.0 110.135 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -68.12 -49.89 58.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.2 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.27 -76.03 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.382 -0.824 . . . . 0.0 110.997 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.577 ' O ' HG23 ' B' ' 378' ' ' VAL . 82.0 t -45.3 -36.49 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.98 -1.075 . . . . 0.0 111.033 -177.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -64.53 -52.57 57.11 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.427 -1.421 . . . . 0.0 110.637 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -76.81 -40.18 48.89 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.665 -1.272 . . . . 0.0 110.588 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 87.7 mt -59.62 -39.28 83.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.078 -1.014 . . . . 0.0 109.088 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.577 HG23 ' O ' ' B' ' 374' ' ' VAL . 50.6 t -60.98 -41.1 87.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.104 -0.998 . . . . 0.0 109.283 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' B' ' 383' ' ' GLU . 7.7 mtmp? -69.05 -55.2 11.5 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.567 -1.333 . . . . 0.0 108.62 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 63.3 tp -55.97 -35.07 66.32 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.946 -1.096 . . . . 0.0 109.783 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 6.0 ttm -70.29 -39.99 74.53 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.661 -1.275 . . . . 0.0 107.759 177.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.27 -7.02 58.83 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.766 -0.584 . . . . 0.0 110.782 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' B' ' 379' ' ' LYS . 49.3 mt-10 -111.34 1.77 17.26 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 120.953 -1.092 . . . . 0.0 110.989 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 17.8 mt -87.1 126.62 34.89 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.283 -1.511 . . . . 0.0 109.224 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.302 -179.775 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.028 -0.731 . . . . 2.91 109.028 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 95.2 mt -110.02 128.49 66.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.542 -0.724 . . . . 1.2 109.306 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.7 m -140.06 150.08 43.92 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.398 -0.813 . . . . 1.4 109.654 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.445 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -136.99 -162.94 9.55 Favored Glycine 0 N--CA 1.496 2.671 0 N-CA-C 108.297 -1.921 . . . . 1.05 108.297 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.473 ' O ' ' O ' ' A' ' 6' ' ' LEU . 93.7 mt -90.4 -17.45 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.745 -1.444 . . . . 1.15 109.875 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.473 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.9 tp 51.51 103.6 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.365 -0.834 . . . . 0.98 109.304 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.7 -29.09 12.11 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.099 -1.0 . . . . 0.88 109.008 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.1 m -130.84 115.11 16.7 Favored Pre-proline 0 N--CA 1.499 2.008 0 O-C-N 121.636 -0.665 . . . . 1.69 109.276 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -80.15 151.02 20.59 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 121.924 1.749 . . . . 0.85 112.627 -179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.887 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 150.18 169.18 16.01 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 108.704 -1.759 . . . . 0.92 108.704 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.9 mt -120.04 129.99 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.396 0 O-C-N 121.046 -1.267 . . . . 0.81 109.839 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.33 150.38 50.94 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.083 -1.01 . . . . 0.51 110.455 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.5 m-85 -126.87 128.46 46.53 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 107.924 -1.139 . . . . 0.62 107.924 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.56 178.55 48.47 Favored Glycine 0 N--CA 1.492 2.4 0 C-N-CA 118.583 -1.77 . . . . 0.55 110.977 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.4 mtpp -79.98 158.81 26.48 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.892 -0.77 . . . . 2.1 109.244 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.844 ' HB3' ' OD1' ' A' ' 216' ' ' ASP . . . -106.92 129.71 54.7 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.331 -0.855 . . . . 0.77 110.92 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.7 tp -100.34 133.12 45.24 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 107.11 -1.441 . . . . 0.91 107.11 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 50.4 tp -114.83 127.32 55.65 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.258 -0.901 . . . . 0.93 109.536 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 58.4 mt -89.45 102.08 14.76 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.473 -0.767 . . . . 0.93 110.368 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -103.0 131.82 49.7 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 109.132 -0.692 . . . . 2.75 109.132 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -130.52 133.82 46.55 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.323 -0.861 . . . . 3.0 109.389 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -73.48 153.49 40.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.063 -1.023 . . . . 2.77 109.521 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -67.63 143.16 56.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -0.914 . . . . 2.94 109.766 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 88.2 mt -83.13 128.15 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.267 -0.895 . . . . 0.95 109.342 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.1 t -93.57 131.53 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.234 -0.916 . . . . 1.28 110.652 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.6 mt -107.97 133.57 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 108.861 -0.792 . . . . 1.21 108.861 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -92.29 119.25 31.69 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.04 -1.038 . . . . 1.81 109.317 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -90.7 -2.51 57.82 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.299 -0.875 . . . . 2.8 109.506 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -69.17 139.59 54.61 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.16 -0.963 . . . . 2.87 109.218 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -86.05 153.51 22.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.178 -0.951 . . . . 2.35 109.059 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.638 HD13 ' HG3' ' A' ' 39' ' ' GLU . 2.5 pt -98.29 166.19 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.223 -0.923 . . . . 0.97 109.711 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 81.3 p -90.08 171.66 9.38 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.299 -0.876 . . . . 1.17 109.041 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -67.53 -17.06 64.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.056 -1.027 . . . . 1.18 110.611 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -86.5 -26.64 24.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.863 -1.148 . . . . 2.56 108.012 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -82.31 -8.43 59.64 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.769 -0.826 . . . . 1.79 108.769 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.2 t -58.4 -50.07 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.351 -0.981 . . . . 1.0 108.351 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -59.98 -40.01 87.66 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 121.208 -0.933 . . . . 1.77 108.707 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -61.48 -46.55 89.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.404 -0.81 . . . . 2.7 110.926 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.638 ' HG3' HD13 ' A' ' 31' ' ' ILE . 64.5 mm-40 -60.16 -44.07 95.31 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.727 -1.233 . . . . 1.51 109.961 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.05 -46.15 94.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 120.918 -1.114 . . . . 0.93 108.737 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -60.03 -41.25 91.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.277 -0.889 . . . . 1.81 109.193 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -60.01 -45.99 90.96 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.914 -1.116 . . . . 2.78 108.092 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -60.52 -48.23 82.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.531 -0.731 . . . . 0.78 109.075 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.04 -49.93 75.73 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.873 -0.788 . . . . 1.07 108.873 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.457 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 47.6 t -61.47 -44.58 96.84 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.175 -0.953 . . . . 1.12 108.515 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.52 -42.84 99.85 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.454 -1.859 . . . . 0.84 108.454 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.401 ' NH1' ' HG2' ' A' ' 47' ' ' ARG . 41.0 ttt-85 -66.08 -31.08 71.73 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.324 -0.991 . . . . 3.09 108.324 178.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.59 -40.02 82.01 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.175 -0.676 . . . . 0.88 109.175 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.7 ttmt -72.33 -73.43 0.19 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.979 -1.076 . . . . 2.59 108.178 179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.53 -34.7 0.15 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.339 -0.851 . . . . 0.7 110.736 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.0 m -57.14 -61.29 2.56 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.65 -1.281 . . . . 1.4 108.54 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.09 -40.0 82.75 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 0.67 111.248 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -66.28 -42.63 88.12 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.77 -1.206 . . . . 1.66 110.374 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.98 -39.99 96.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.837 -1.165 . . . . 1.58 108.899 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -66.25 -35.18 79.75 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.324 -0.86 . . . . 1.35 108.822 178.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -63.66 -41.68 98.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 0.77 109.779 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.9 mt -62.22 -40.05 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.124 -0.985 . . . . 0.63 108.917 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.4 ttpt -54.75 -49.93 69.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.46 -0.775 . . . . 1.14 109.712 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -58.38 -37.33 75.03 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.344 -0.848 . . . . 0.79 109.868 -177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 81.2 mttt -68.18 -37.52 81.06 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.001 -1.062 . . . . 1.53 109.277 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.715 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -66.65 -46.56 75.35 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.657 -0.652 . . . . 0.57 109.862 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.96 -50.02 72.26 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 110.57 -1.012 . . . . 0.75 110.57 -179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -70.0 -40.66 75.16 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.944 -1.327 . . . . 1.59 110.103 -179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.4 m -69.98 -58.26 4.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.061 -1.025 . . . . 0.73 111.474 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.416 ' CE1' ' O ' ' A' ' 168' ' ' THR . 89.2 m-85 -96.3 -51.39 4.4 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.031 -1.043 . . . . 0.75 111.189 -178.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.86 -167.66 25.88 Favored Glycine 0 N--CA 1.503 3.167 0 C-N-CA 119.555 -1.307 . . . . 1.22 111.339 179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -66.9 -25.12 66.22 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.866 -0.785 . . . . 5.81 109.991 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.442 ' OE2' ' NH1' ' B' ' 317' ' ' ARG . 23.3 tp10 -60.06 -34.86 74.0 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.604 -0.685 . . . . 3.37 110.81 -179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -98.12 -19.54 17.87 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.175 -0.953 . . . . 1.77 110.529 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -69.36 -40.01 77.75 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.785 -1.197 . . . . 1.65 110.029 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.557 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -63.22 -33.98 76.66 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.367 -0.833 . . . . 0.77 109.695 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.8 mt -60.0 -42.88 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.077 -1.015 . . . . 0.8 109.813 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -63.34 -38.67 92.04 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.911 -1.118 . . . . 0.88 110.327 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -59.96 -39.99 87.49 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.859 -1.151 . . . . 1.37 109.038 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.53 -54.57 34.79 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.424 -1.47 . . . . 0.62 109.424 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.0 m170 -61.31 -48.21 82.43 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.167 -1.196 . . . . 1.5 109.256 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.6 mt -61.79 -50.01 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.257 -0.902 . . . . 0.63 109.18 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.0 ttp -59.98 -40.79 90.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.073 -1.017 . . . . 1.51 110.173 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.844 HD11 ' CE2' ' B' ' 348' ' ' PHE . 35.0 tp -66.54 -39.89 88.79 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.31 -0.868 . . . . 0.77 109.343 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.0 tp -64.03 -38.76 92.25 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.528 -0.733 . . . . 0.62 109.329 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -80.22 2.54 23.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 1.47 110.06 -179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -49.17 130.5 19.11 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.136 -0.978 . . . . 1.47 109.689 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -63.01 -19.07 64.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.696 -0.627 . . . . 1.78 111.411 -178.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -71.98 -32.38 67.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.656 -1.277 . . . . 2.53 108.611 178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.1 mt -71.13 -41.39 70.55 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-O 121.541 0.686 . . . . 0.8 109.957 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -60.04 -45.66 92.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.868 . . . . 1.42 110.277 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -69.97 -41.9 73.87 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.895 . . . . 1.71 110.734 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.97 -39.96 75.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.157 -0.965 . . . . 1.57 111.746 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 93.8 mt -65.4 -49.09 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.977 -1.077 . . . . 0.65 109.652 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -68.25 -37.71 78.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.619 -0.676 . . . . 0.82 110.877 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.97 83.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.057 -1.027 . . . . 0.79 111.054 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.505 ' O ' ' N ' ' A' ' 96' ' ' LYS . 78.5 mt -61.89 -46.21 90.39 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.908 -1.12 . . . . 0.95 110.28 -178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.0 mt -60.02 -49.77 82.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.084 -1.01 . . . . 0.66 108.655 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -69.95 -40.15 75.63 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.907 -0.588 . . . . 2.2 110.67 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.2 t0 -84.02 -46.96 11.46 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.016 -1.053 . . . . 1.65 111.72 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 92' ' ' LEU . 30.9 mmtp -94.64 -2.22 51.74 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.014 -1.053 . . . . 2.03 111.952 -177.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 56.26 35.82 26.43 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.788 -1.195 . . . . 1.42 109.638 -179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.7 mtp -91.64 167.92 11.86 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.461 -0.774 . . . . 1.18 109.54 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 50.1 p -82.58 160.23 22.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.145 -0.972 . . . . 0.98 109.407 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.5 -39.92 85.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.237 -0.915 . . . . 0.64 110.195 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -65.06 -37.98 89.31 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.123 -0.986 . . . . 2.07 109.679 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.13 -48.98 11.41 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.319 -0.863 . . . . 0.73 110.034 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.91 -49.56 74.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.403 -0.81 . . . . 0.54 110.532 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.06 -43.01 95.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.152 -0.967 . . . . 0.56 109.72 -179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.465 ' HB2' HD21 ' A' ' 138' ' ' LEU . 78.0 t60 -59.99 -40.0 87.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.311 -0.868 . . . . 1.54 110.531 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.06 -39.98 91.91 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.962 -1.086 . . . . 1.33 109.902 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 89.5 t -62.2 -53.48 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.232 -0.917 . . . . 0.72 110.991 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.4 mm -69.95 -39.98 78.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.983 -1.073 . . . . 0.85 109.409 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.21 -39.85 94.13 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.393 -0.966 . . . . 2.44 108.393 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.06 -52.78 50.76 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 110.712 -0.955 . . . . 0.98 110.712 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -69.28 -44.79 71.13 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.762 -1.434 . . . . 1.41 109.861 -179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.88 -44.49 91.14 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.881 -1.137 . . . . 1.2 108.55 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 88.7 p -59.96 -36.74 77.74 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.401 -0.812 . . . . 1.7 109.066 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.79 -39.99 94.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -0.884 . . . . 1.47 109.067 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.4 mt -65.8 -42.27 90.9 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.12 -0.988 . . . . 1.56 109.508 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.43 ' C ' ' N ' ' A' ' 118' ' ' LEU . 85.5 tt0 -59.97 -39.59 86.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.909 -1.119 . . . . 2.2 110.082 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -49.26 -17.92 0.3 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.941 -1.1 . . . . 2.12 109.168 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.43 ' N ' ' C ' ' A' ' 116' ' ' GLU . 68.0 mt -62.65 140.4 58.69 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.526 -0.916 . . . . 2.0 108.526 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 49.8 t0 -93.94 44.15 1.12 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.006 -1.059 . . . . 3.23 111.124 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -137.44 150.9 47.96 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.971 -1.08 . . . . 2.49 109.575 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 124' ' ' LYS . 71.8 mm-40 -72.63 -65.82 0.74 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.144 -0.972 . . . . 3.95 109.13 178.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.638 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 4.0 t80 -39.11 -42.16 0.89 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.836 -0.54 . . . . 2.0 110.404 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.721 HD23 HH22 ' A' ' 126' ' ' ARG . 87.6 mt -70.58 -39.95 73.57 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.845 -1.159 . . . . 1.86 108.03 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 121' ' ' GLU . 32.8 ttmt -62.07 -38.34 88.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.673 -0.642 . . . . 2.84 110.256 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -60.06 -47.32 86.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.082 -1.011 . . . . 2.73 110.633 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.721 HH22 HD23 ' A' ' 123' ' ' LEU . 21.8 mtm-85 -70.08 -30.16 67.33 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.888 -1.133 . . . . 2.77 108.964 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.99 -27.95 67.28 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.428 -1.323 . . . . 1.19 107.428 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.17 -38.94 72.14 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.49 -0.93 . . . . 1.2 108.49 178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -62.27 -42.4 99.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.583 -0.698 . . . . 1.55 110.504 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.75 -40.39 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.058 -1.026 . . . . 0.8 109.112 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.541 HH11 ' HG2' ' A' ' 131' ' ' ARG . 2.4 ttt-85 -60.62 -38.63 85.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.907 . . . . 3.09 109.356 179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -60.02 -40.03 87.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.35 -0.844 . . . . 1.46 110.563 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.0 mt -59.94 -45.21 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.796 -1.19 . . . . 0.71 109.446 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.19 -39.98 96.48 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.928 -1.269 . . . . 0.57 109.928 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -59.98 -49.95 75.66 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.255 -1.144 . . . . 2.59 110.028 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.416 HH12 ' HB3' ' A' ' 166' ' ' SER . 59.8 mtp180 -68.42 -32.15 71.98 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.017 -1.052 . . . . 2.83 110.062 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.5 tp -60.0 -40.58 89.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.098 -1.001 . . . . 1.25 108.758 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.465 HD21 ' HB2' ' A' ' 105' ' ' HIS . 75.5 mt -60.03 -40.55 89.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.173 -0.954 . . . . 0.7 109.26 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 64.1 mtm180 -69.97 -40.08 75.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.476 -0.765 . . . . 2.57 109.72 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 -62.72 -35.86 81.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.478 -0.764 . . . . 1.23 111.249 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.0 mt -72.92 -41.39 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.617 -1.302 . . . . 0.81 109.273 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.04 -26.32 63.98 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.668 -0.645 . . . . 1.0 109.462 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.27 35.53 20.33 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.688 -1.765 . . . . 0.89 108.688 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 tp -73.27 144.77 46.53 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.484 -1.009 . . . . 1.14 108.831 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -67.06 140.32 57.63 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.238 -0.914 . . . . 4.6 110.427 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 89.5 mt -110.03 128.6 66.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 108.443 -0.947 . . . . 1.24 108.443 179.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 14.0 mm -60.21 -44.44 95.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.775 -0.578 . . . . 1.54 110.58 -178.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 42.2 t0 62.62 113.91 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.438 -0.789 . . . . 1.5 108.951 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 15.7 mt -80.12 -1.93 42.29 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.366 -0.834 . . . . 0.79 110.079 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 39.2 m -89.02 -17.18 29.91 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.932 -1.105 . . . . 1.4 110.543 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.27 17.75 0.34 Allowed 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.107 -0.996 . . . . 0.92 111.721 -178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 32.7 mm -80.21 132.26 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.469 -1.395 . . . . 0.88 109.978 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -110.43 -11.32 14.51 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.685 -0.634 . . . . 2.45 109.525 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -129.96 152.13 49.77 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.578 -0.701 . . . . 1.52 110.012 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -65.36 136.51 56.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.089 -1.007 . . . . 1.58 109.514 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.8 m -153.36 166.69 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.411 -0.806 . . . . 0.69 109.838 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.4 mt -95.84 149.59 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 106.026 -1.842 . . . . 0.61 106.026 176.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.1 tp -104.31 119.38 38.82 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.969 -1.082 . . . . 0.87 110.815 -177.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.417 HG12 HG22 ' A' ' 209' ' ' THR . 4.2 t -123.32 132.12 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.663 -0.865 . . . . 0.71 108.663 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -158.46 163.99 36.64 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.843 -1.161 . . . . 0.81 109.605 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.04 -35.44 71.96 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.3 -1.5 . . . . 0.98 108.485 178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 62.8 t0 -169.56 142.76 2.63 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.133 -0.692 . . . . 2.25 109.133 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.466 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 90.7 mt -111.62 139.52 47.0 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.397 -0.815 . . . . 0.78 109.651 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 64.2 p -94.62 142.88 25.36 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.337 -0.852 . . . . 0.98 109.409 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -40.28 -38.31 2.23 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.195 1.93 . . . . 0.81 112.751 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.416 ' HB3' HH12 ' A' ' 136' ' ' ARG . 52.5 m -56.77 -40.08 75.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.044 -1.035 . . . . 0.9 108.514 -179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -66.31 -40.66 90.12 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.392 -0.817 . . . . 1.61 109.901 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.416 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 75.6 p -55.66 -24.23 32.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.996 -1.065 . . . . 0.61 110.083 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.715 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -76.74 -58.2 3.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.112 -0.993 . . . . 0.6 109.784 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -82.27 39.75 0.6 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.558 -0.904 . . . . 1.4 108.558 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.5 tp -104.43 133.48 49.24 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.794 -0.817 . . . . 0.7 108.794 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -93.26 103.51 15.76 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.142 -0.974 . . . . 2.35 108.752 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 58.4 mt -63.37 -45.76 89.64 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.26 -0.9 . . . . 1.51 110.084 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -63.79 -28.48 69.9 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.967 -1.083 . . . . 2.33 112.207 -177.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -92.51 -10.27 38.36 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.521 -1.362 . . . . 1.92 109.825 -178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 178' ' ' GLY . 63.1 t -109.64 119.91 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 107.76 -1.2 . . . . 0.67 107.76 178.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 89.5 mt -89.26 4.92 47.15 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.201 -0.937 . . . . 1.53 111.422 -177.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.463 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 171.26 173.65 38.43 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.134 -1.508 . . . . 0.48 109.679 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -137.4 129.99 29.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.372 -1.076 . . . . 0.55 108.84 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.3 mt -127.98 125.72 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.463 -0.94 . . . . 0.65 108.463 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 19.7 p -145.54 156.86 43.97 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.746 -1.221 . . . . 0.82 111.113 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 183' ' ' ALA . 0.7 OUTLIER -101.04 26.54 6.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.624 -0.673 . . . . 2.46 109.371 179.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.486 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -47.85 -172.14 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 122.364 1.078 . . . . 1.28 112.417 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.14 -55.17 4.89 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 111.062 -0.815 . . . . 2.19 111.062 -179.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -160.5 -156.52 8.23 Favored Glycine 0 N--CA 1.495 2.598 0 C-N-CA 118.876 -1.63 . . . . 2.13 111.129 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.411 ' HD2' HH21 ' A' ' 195' ' ' ARG . 86.3 mtm180 -79.94 -10.06 59.74 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.696 -0.885 . . . . 5.86 109.918 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 60.6 p -74.6 3.14 8.24 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.153 -0.967 . . . . 3.72 109.477 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 13.9 t -76.85 133.37 39.35 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.325 -0.859 . . . . 1.74 110.049 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -48.26 -50.68 28.82 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.3 -0.875 . . . . 0.95 110.026 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.442 HG23 ' N ' ' A' ' 191' ' ' SER . 14.7 t -58.26 -38.62 77.29 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.274 -0.891 . . . . 1.55 110.584 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.442 ' N ' HG23 ' A' ' 190' ' ' THR . 25.8 t -60.0 -40.16 88.26 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.0 -1.063 . . . . 1.51 110.288 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.17 -39.91 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.285 -0.885 . . . . 1.67 109.753 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.3 mtp -60.51 -41.58 94.64 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 1.02 110.901 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.1 95.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.547 -1.346 . . . . 0.68 109.673 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.411 HH21 ' HD2' ' A' ' 186' ' ' ARG . 66.9 mtt-85 -59.97 -47.54 85.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.108 -0.995 . . . . 2.93 109.952 -179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.5 m -76.57 -32.44 58.16 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.998 -1.063 . . . . 0.86 111.792 -178.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 96.1 mt -79.98 -12.14 59.74 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.641 -1.287 . . . . 0.67 110.364 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 58.33 51.75 8.0 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.38 -0.825 . . . . 1.5 110.917 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.0 mt -127.44 131.94 24.09 Favored Pre-proline 0 N--CA 1.502 2.127 0 N-CA-C 108.892 -0.781 . . . . 0.72 108.892 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -43.45 123.53 3.65 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 121.937 1.758 . . . . 0.61 112.112 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -161.96 140.29 9.14 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.694 -1.254 . . . . 0.66 111.587 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.4 mt -122.84 141.74 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 107.155 -1.424 . . . . 0.79 107.155 177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 29.7 m -124.88 -8.4 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 O-C-N 120.956 -1.09 . . . . 0.91 111.273 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.05 21.24 25.19 Favored Glycine 0 N--CA 1.501 3.024 0 N-CA-C 110.866 -0.894 . . . . 1.01 110.866 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.436 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.0 p -45.28 -43.79 10.85 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.891 -1.358 . . . . 0.99 110.048 -179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 93.01 -51.28 2.52 Favored Glycine 0 N--CA 1.5 2.935 0 C-N-CA 120.076 -1.059 . . . . 1.12 111.726 178.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.428 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 3.6 m -156.92 38.36 0.31 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.528 -1.571 . . . . 1.72 111.209 -179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.7 t -80.01 -31.26 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.024 -1.048 . . . . 0.89 108.518 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.417 HG22 HG12 ' A' ' 159' ' ' VAL . 55.6 p -58.79 -30.78 67.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.43 -0.794 . . . . 1.03 110.576 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 20.9 t -78.81 -17.94 54.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.926 -1.109 . . . . 1.83 109.731 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -98.64 -8.85 25.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.238 -0.914 . . . . 2.27 110.377 -179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.415 HG22 HD11 ' A' ' 218' ' ' LEU . 55.1 t -104.83 130.25 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 O-C-N 121.282 -0.886 . . . . 0.92 110.869 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -108.31 148.79 29.54 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.371 -1.344 . . . . 2.2 107.371 178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.439 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 30.0 p-10 -59.97 136.99 58.18 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.101 -1.0 . . . . 2.36 110.901 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.9 m-20 82.59 -0.03 1.3 Allowed 'General case' 0 N--CA 1.503 2.178 0 CA-C-N 116.187 -0.461 . . . . 2.38 111.547 178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.844 ' OD1' ' HB3' ' A' ' 16' ' ' ALA . 24.4 p-10 -74.04 158.54 34.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.418 -1.426 . . . . 2.09 108.385 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -99.29 119.56 38.12 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.385 -0.969 . . . . 1.27 108.385 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 16' ' ' ALA . 80.7 mt -125.85 148.73 49.08 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.479 -0.763 . . . . 0.75 109.99 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 78.8 mt -116.16 129.97 71.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 107.086 -1.449 . . . . 0.63 107.086 177.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 40.6 tp -105.88 124.33 49.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.029 -1.045 . . . . 0.7 109.11 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.673 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 29.6 p-10 -87.95 -37.47 16.37 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.043 -1.036 . . . . 2.31 109.866 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.887 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 45.71 16.14 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.968 -0.752 . . . . 0.78 108.968 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.5 t -126.06 -41.19 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 N-CA-C 107.497 -1.297 . . . . 1.04 107.497 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.412 ' HB3' HE21 ' A' ' 226' ' ' GLN . 80.9 m-20 -106.53 -0.15 24.16 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.831 -1.174 . . . . 2.44 107.831 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.445 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 0.4 OUTLIER 61.69 49.66 4.83 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.401 0.619 . . . . 1.55 109.771 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.673 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 43.9 mt-30 -139.97 150.31 44.34 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.452 -0.78 . . . . 1.99 109.502 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.1 t -122.68 129.99 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.194 -1.039 . . . . 0.77 108.194 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -101.11 116.66 33.36 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.251 -0.906 . . . . 0.98 109.208 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 36.0 t -98.33 117.09 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.49 -0.756 . . . . 0.85 109.251 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 68.55 70.17 0.42 Allowed Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.27 -0.894 . . . . 1.66 109.408 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -89.79 118.27 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 123.376 2.717 . . . . 0.95 112.744 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.615 HG22 ' N ' ' A' ' 233' ' ' ASN . 96.4 m -67.97 170.52 8.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.174 -0.954 . . . . 1.84 108.989 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.615 ' N ' HG22 ' A' ' 232' ' ' THR . 11.9 m120 -59.84 -40.12 87.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.0 -1.062 . . . . 2.74 109.238 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -61.58 -39.91 92.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.358 -0.838 . . . . 2.89 109.197 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.54 -42.74 96.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.308 -0.87 . . . . 1.3 109.882 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.5 mt -61.7 -40.6 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.194 -0.941 . . . . 1.09 109.577 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.403 ' OD1' ' C ' ' A' ' 237' ' ' ASP . 50.0 t0 -60.01 -42.38 94.17 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.852 -1.155 . . . . 2.43 108.721 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -62.77 -45.72 91.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.89 . . . . 2.78 109.376 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 87.8 mtp -66.72 -31.98 72.98 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.217 -0.927 . . . . 1.25 109.652 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -68.85 -32.93 72.97 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.059 -1.026 . . . . 2.63 108.325 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.03 87.92 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.23 -0.919 . . . . 1.8 108.726 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 70.4 t -61.09 -40.93 87.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.887 -1.133 . . . . 2.13 108.106 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -60.05 -39.68 86.83 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.484 -0.932 . . . . 3.17 108.484 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -59.93 -31.7 70.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.289 -0.882 . . . . 1.78 109.02 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -59.98 -39.2 84.88 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.693 -1.225 . . . . 2.47 107.693 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 91.4 t -60.0 -40.0 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 107.92 -1.141 . . . . 2.09 107.92 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.97 -31.71 70.14 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.659 -0.867 . . . . 2.54 108.659 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 251' ' ' ALA . 8.7 t -60.11 -39.2 85.39 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.619 -0.882 . . . . 2.99 108.619 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -59.97 -37.63 80.16 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.17 -1.418 . . . . 3.34 107.17 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -85.8 42.55 0.98 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.211 -1.403 . . . . 3.88 107.211 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 248' ' ' SER . . . -91.92 -0.69 57.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.964 -0.754 . . . . 4.43 108.964 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 56.97 25.91 11.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.79 -0.569 . . . . 5.42 109.892 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 98.2 mt -96.73 -18.13 19.84 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.123 -0.986 . . . . 6.1 109.435 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -88.37 -48.06 7.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 7.37 108.67 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 93.2 mttt 52.59 21.86 1.98 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.542 -0.724 . . . . 8.01 109.823 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.444 ' O ' ' O ' ' A' ' 257' ' ' LYS . 40.7 mt 50.01 28.48 2.95 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.116 -0.99 . . . . 9.05 108.751 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.444 ' O ' ' O ' ' A' ' 256' ' ' LEU . 52.1 mtpt 45.94 -172.23 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.43 0.634 . . . . 10.56 109.712 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -150.72 -123.05 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 108.281 -1.007 . . . . 11.32 108.281 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.454 HH11 ' HG2' ' A' ' 259' ' ' ARG . 24.9 ttt-85 . . . . . 0 C--N 1.3 -1.57 0 CA-C-O 117.986 -1.007 . . . . 12.42 109.49 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 49.7 ttp . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.448 0.642 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -150.11 147.35 27.67 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -147.7 157.13 43.4 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.865 -1.147 . . . . 0.0 110.817 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 59.6 tp60 -153.51 148.92 27.14 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -112.59 131.05 55.8 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.142 -0.974 . . . . 0.0 109.656 179.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.407 ' CG1' ' SD ' ' B' ' 381' ' ' MET . 1.9 p -132.79 125.15 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-O 122.146 0.974 . . . . 0.0 112.073 -177.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 21.1 m -77.21 104.8 7.93 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.046 0.927 . . . . 0.0 110.766 -178.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' B' ' 358' ' ' GLY . 97.0 mt -52.81 124.64 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 CA-C-O 122.429 1.109 . . . . 0.0 111.026 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 62.4 p -112.5 20.19 16.86 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.682 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.402 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -66.15 118.68 55.12 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 120.988 -1.07 . . . . 0.0 108.891 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -49.58 -26.07 12.05 Favored 'Trans proline' 0 N--CA 1.493 1.497 0 CA-C-N 120.354 1.162 . . . . 0.0 112.718 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -120.52 17.58 12.09 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.642 -0.661 . . . . 0.0 109.352 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.76 179.75 32.74 Favored Glycine 0 N--CA 1.485 1.964 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.468 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -87.86 94.8 9.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.121 -1.223 . . . . 0.0 109.309 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -96.08 -160.43 0.79 Allowed 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.948 -1.095 . . . . 0.0 110.09 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 15.5 m -58.87 -42.79 90.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.076 -1.015 . . . . 0.0 112.546 -175.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.557 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.5 tpt180 -61.13 -61.41 8.02 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 120.452 -1.405 . . . . 0.0 112.119 -178.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -59.3 -33.67 97.82 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 CA-C-N 120.394 1.176 . . . . 0.0 111.656 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.98 75.53 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.13 -41.4 65.01 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.474 -0.766 . . . . 0.0 109.801 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -69.97 -40.03 75.62 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.971 -1.08 . . . . 0.0 108.24 178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 56.7 t80 -61.2 -52.47 64.65 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.2 -0.937 . . . . 0.0 110.432 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 94.7 t -62.79 -28.92 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 120.659 -1.275 . . . . 0.0 109.587 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 9.8 ttmt -59.95 -44.6 94.3 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.537 -0.727 . . . . 0.0 109.041 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -67.65 -42.71 81.78 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.277 -0.89 . . . . 0.0 111.378 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . 0.4 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -59.9 -53.89 52.53 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.556 -1.34 . . . . 0.0 110.97 -178.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 32.3 mttp -52.82 -12.57 0.32 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.143 -0.973 . . . . 0.0 109.768 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . 0.4 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -77.74 -24.14 65.49 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -105.82 140.09 39.38 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.558 -0.966 . . . . 0.0 109.087 179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 26.1 p -90.43 -10.93 41.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.109 -0.994 . . . . 0.0 109.926 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.486 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 79.7 p -67.49 152.36 45.79 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.198 -0.939 . . . . 0.0 109.502 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.9 137.71 51.84 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.138 -0.976 . . . . 0.0 108.559 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 76.8 mt -131.85 132.68 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.666 -0.646 . . . . 0.0 109.293 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 24.0 m -129.52 148.67 51.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.552 -0.718 . . . . 0.0 109.089 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 70.0 t -123.19 116.16 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 178.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 45.9 m -105.57 130.35 53.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.304 -0.872 . . . . 0.0 109.337 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 43.2 t -139.32 119.07 13.17 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 122.028 0.918 . . . . 0.0 111.272 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 43.92 50.1 7.11 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.13 -14.41 60.78 Favored Glycine 0 N--CA 1.501 3.03 0 O-C-N 120.15 -1.594 . . . . 0.0 112.786 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -117.24 128.45 55.1 Favored 'General case' 0 N--CA 1.507 2.397 0 CA-C-N 119.208 1.504 . . . . 0.0 110.082 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 80.3 p -126.33 148.33 49.57 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 121.774 0.797 . . . . 0.0 110.453 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -142.91 166.01 25.79 Favored 'General case' 0 N--CA 1.501 2.1 0 CA-C-O 121.534 0.683 . . . . 0.0 110.145 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 25.1 m -87.25 133.62 33.65 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.473 -0.767 . . . . 0.0 110.377 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -72.63 -17.37 61.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.073 -1.017 . . . . 0.0 109.911 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -87.21 20.94 2.55 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 7.3 m -149.08 96.02 2.48 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 119.692 -0.803 . . . . 0.0 111.836 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.715 HD23 HD22 ' A' ' 79' ' ' LEU . 61.6 tp -58.16 -36.2 72.66 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.844 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.8 m-85 -54.68 -54.01 47.37 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.796 -1.19 . . . . 0.0 110.193 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -71.3 -19.56 62.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.923 . . . . 0.0 111.699 -177.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.571 ' O ' ' N ' ' B' ' 352' ' ' THR . 73.6 mt -71.01 -57.96 4.03 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.453 -1.404 . . . . 0.0 110.318 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.562 ' NE2' ' HE ' ' A' ' 126' ' ' ARG . 9.2 mm100 -43.16 -12.56 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.681 -0.637 . . . . 0.0 111.348 -176.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.571 ' N ' ' O ' ' B' ' 350' ' ' LEU . 77.1 p -86.01 -10.89 54.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.328 -1.483 . . . . 0.0 110.104 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 59.1 mt -92.74 117.98 30.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.03 -1.044 . . . . 0.0 109.021 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -71.96 90.24 0.49 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 23.7 mt -100.4 90.13 4.2 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.353 -1.086 . . . . 0.0 109.043 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 31.7 p -92.65 154.59 18.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.906 -1.121 . . . . 0.0 110.436 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -50.87 119.34 3.82 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 120.087 -0.645 . . . . 0.0 109.611 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 102.09 3.07 51.62 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 44.2 m -87.72 114.92 24.79 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.219 -1.165 . . . . 0.0 111.852 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 46.1 t -76.99 115.16 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 122.171 0.986 . . . . 0.0 109.939 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 14.5 m -110.49 177.32 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 22.5 m -130.53 129.3 42.68 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 48.5 mt -102.64 112.95 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 69.2 p -118.62 131.05 56.18 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.157 -0.964 . . . . 0.0 109.287 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.15 151.28 39.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.201 -0.937 . . . . 0.0 109.627 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -146.45 125.93 13.23 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.346 -0.846 . . . . 0.0 109.394 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.555 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.05 -156.24 26.92 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.496 -1.335 . . . . 0.0 111.182 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.03 -50.71 72.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.109 -0.642 . . . . 0.0 112.271 -177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.486 ' H ' ' HB3' ' B' ' 331' ' ' SER . 93.0 m-20 -106.42 11.36 30.91 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 120.868 -1.145 . . . . 0.0 111.336 -177.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.555 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.9 pt-20 -44.75 -35.7 2.83 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.986 -1.071 . . . . 0.0 111.117 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -70.53 -42.67 70.93 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.926 -1.109 . . . . 0.0 110.026 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -66.95 -48.97 66.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.397 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -46.61 -75.13 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.432 -0.792 . . . . 0.0 110.882 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.497 ' O ' HG23 ' B' ' 378' ' ' VAL . 32.6 t -44.66 -34.81 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.068 -1.02 . . . . 0.0 110.942 -177.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -66.47 -46.09 77.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.421 -1.424 . . . . 0.0 110.301 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -80.37 -42.31 23.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.766 -1.209 . . . . 0.0 109.742 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 90.1 mt -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 109.485 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.497 HG23 ' O ' ' B' ' 374' ' ' VAL . 44.0 t -61.95 -42.0 93.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.003 -1.061 . . . . 0.0 109.51 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -69.89 -55.1 10.61 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.451 -1.3 . . . . 0.0 107.909 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 48.8 tp -57.56 -35.07 69.86 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.0 110.231 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . 0.407 ' SD ' ' CG1' ' B' ' 306' ' ' VAL . 39.6 ttm -70.46 -39.94 74.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.217 -1.552 . . . . 0.0 108.359 177.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.49 -4.83 58.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.586 -0.696 . . . . 0.0 110.335 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -113.6 -3.39 13.63 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.034 -1.041 . . . . 0.0 111.072 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 13.7 mt -79.29 135.36 36.73 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.331 -1.481 . . . . 0.0 109.437 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.497 -179.572 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 mmt . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.466 -0.568 . . . . 2.91 109.466 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.5 mt -110.18 129.69 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.689 -0.856 . . . . 1.2 108.689 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.9 m -138.37 119.49 14.52 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.288 -0.883 . . . . 1.4 109.05 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.81 -162.02 36.64 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.123 -1.591 . . . . 1.05 109.123 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.46 HG22 ' O ' ' A' ' 5' ' ' ILE . 97.2 mt -93.5 -9.91 9.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.046 -1.267 . . . . 1.15 110.058 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.471 HD11 ' O ' ' A' ' 8' ' ' SER . 58.8 tp 54.94 96.41 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.18 -0.95 . . . . 0.98 109.184 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.66 -40.15 73.17 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.665 -0.865 . . . . 0.88 108.665 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.471 ' O ' HD11 ' A' ' 6' ' ' LEU . 3.4 p -145.9 143.22 19.05 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.482 -0.761 . . . . 1.69 109.049 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.52 143.17 16.89 Favored 'Trans proline' 0 N--CA 1.495 1.572 0 C-N-CA 122.21 1.94 . . . . 0.85 112.705 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.875 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.45 -163.88 36.88 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.299 -1.52 . . . . 0.92 109.299 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 75.1 mt -149.34 149.69 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.051 -1.264 . . . . 0.81 108.332 179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -151.88 151.62 31.52 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.954 -1.091 . . . . 0.51 110.183 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.5 m-85 -134.88 125.27 26.43 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 108.391 -0.966 . . . . 0.62 108.391 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.75 179.32 47.11 Favored Glycine 0 N--CA 1.491 2.323 0 C-N-CA 118.87 -1.633 . . . . 0.55 110.607 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -76.96 154.73 33.29 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.759 -0.848 . . . . 2.1 109.006 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.406 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -100.02 136.52 39.8 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.336 -0.852 . . . . 0.77 111.052 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.1 tp -104.99 133.28 50.05 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 107.533 -1.284 . . . . 0.91 107.533 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 64.4 tp -115.14 122.27 45.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.252 -0.905 . . . . 0.93 110.222 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.7 mt -88.71 100.51 13.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.677 -0.639 . . . . 0.93 109.761 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -86.84 139.51 30.6 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.072 -1.084 . . . . 2.75 108.072 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -130.93 136.6 48.73 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.025 -1.047 . . . . 3.0 109.41 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -91.77 137.89 31.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.11 -0.994 . . . . 2.77 109.147 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.03 139.97 57.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.346 -0.846 . . . . 2.94 109.857 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.5 mt -82.51 130.11 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.449 -0.782 . . . . 0.95 109.597 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.5 t -97.21 128.16 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.231 -0.918 . . . . 1.28 110.066 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -109.98 130.05 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 108.746 -0.835 . . . . 1.21 108.746 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -82.03 127.03 32.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.091 -1.005 . . . . 1.81 110.355 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -89.96 -1.64 58.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.384 -0.823 . . . . 2.8 109.149 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -70.37 142.18 52.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.281 -0.887 . . . . 2.87 109.681 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -85.19 150.1 25.05 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.279 -0.888 . . . . 2.35 109.275 179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.496 HG21 ' HG3' ' A' ' 39' ' ' GLU . 5.5 pt -91.09 164.56 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.162 -0.961 . . . . 0.97 110.072 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.2 p -89.55 170.59 10.37 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.425 -0.954 . . . . 1.17 108.425 178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.32 -19.8 63.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.848 -1.158 . . . . 1.18 110.402 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -82.74 -24.02 33.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.776 -1.203 . . . . 2.56 107.925 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -81.88 -8.75 59.7 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.889 -0.782 . . . . 1.79 108.889 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.68 -53.85 39.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 O-C-N 121.089 -1.007 . . . . 1.0 108.646 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -62.79 -40.15 96.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.123 -0.986 . . . . 1.77 109.644 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -69.96 -40.07 75.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.079 -1.013 . . . . 2.7 109.976 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.496 ' HG3' HG21 ' A' ' 31' ' ' ILE . 51.3 mm-40 -67.09 -40.0 86.86 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.067 -1.021 . . . . 1.51 109.689 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.31 -46.44 96.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 120.92 -1.113 . . . . 0.93 108.34 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -60.07 -40.88 91.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.918 . . . . 1.81 108.941 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.428 HH11 ' HG2' ' A' ' 42' ' ' ARG . 52.1 mtt-85 -60.08 -45.98 91.09 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.897 -1.149 . . . . 2.78 107.897 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -60.07 -49.2 78.57 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.442 -0.786 . . . . 0.78 108.944 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.04 -47.72 84.69 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.287 -0.883 . . . . 1.07 108.7 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.7 t -61.8 -41.38 97.68 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.228 -1.027 . . . . 1.12 108.228 178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.54 -49.77 73.39 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.819 -1.712 . . . . 0.84 108.819 179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -65.38 -35.47 81.07 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.343 -1.093 . . . . 3.09 108.468 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.53 -47.71 72.83 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.356 -0.84 . . . . 0.88 109.097 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 50' ' ' ALA . 32.5 ttpt -63.5 -72.97 0.12 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.889 -1.124 . . . . 2.59 107.972 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.88 -34.0 0.1 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.298 -0.876 . . . . 0.7 111.34 -178.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.5 t -57.22 -52.85 63.67 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.616 -1.303 . . . . 1.4 108.526 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.14 -40.07 78.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 0.67 110.914 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -64.65 -40.13 94.9 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.081 -1.012 . . . . 1.66 109.974 -179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.5 mt -62.6 -40.02 95.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.854 -1.154 . . . . 1.58 108.487 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -62.1 -34.36 76.18 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.657 -0.868 . . . . 1.35 108.657 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -65.32 -42.96 92.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.124 -0.985 . . . . 0.77 109.086 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.07 -39.94 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.302 -0.873 . . . . 0.63 108.815 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 20.3 ttpt -55.17 -49.71 71.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.618 -0.677 . . . . 1.14 109.38 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 28.1 m -56.86 -33.47 66.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.337 -0.852 . . . . 0.79 110.747 -178.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -68.17 -38.63 82.26 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.891 -1.131 . . . . 1.53 109.869 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.52 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -68.07 -47.22 68.9 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.606 -0.684 . . . . 0.57 110.915 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.03 -52.15 50.98 Favored Glycine 0 N--CA 1.486 1.983 0 C-N-CA 119.79 -1.195 . . . . 0.75 110.283 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.03 -42.91 72.33 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.838 -1.389 . . . . 1.59 110.592 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.0 m -69.96 -58.43 3.85 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.129 -0.982 . . . . 0.73 112.232 -177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -95.62 -54.58 3.32 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 120.978 -1.076 . . . . 0.75 111.159 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.01 -160.49 26.72 Favored Glycine 0 N--CA 1.501 3.033 0 O-C-N 120.849 -1.157 . . . . 1.22 110.415 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -70.01 -22.94 63.06 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.481 -1.011 . . . . 5.81 110.311 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -59.9 -37.66 80.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 3.37 110.296 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.519 ' HA ' HD12 ' A' ' 72' ' ' ILE . 67.3 mmtt -98.59 -18.48 18.1 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.33 -0.856 . . . . 1.77 110.829 -179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -70.0 -42.79 72.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.575 -1.328 . . . . 1.65 110.542 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.511 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.52 -30.35 71.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 0.77 109.672 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' A' ' 69' ' ' LYS . 81.6 mt -60.03 -43.64 93.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.104 -0.997 . . . . 0.8 109.943 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -66.03 -39.97 90.64 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.949 -1.094 . . . . 0.88 110.531 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.9 tt0 -60.07 -39.98 87.93 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.808 -1.182 . . . . 1.37 108.949 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.06 -49.77 64.95 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.929 -1.669 . . . . 0.62 108.929 179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -64.72 -41.22 96.14 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.368 -1.078 . . . . 1.5 108.852 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.8 mt -69.96 -42.58 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.114 -0.991 . . . . 0.63 109.214 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 48.4 ttp -60.31 -39.98 88.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.985 -1.072 . . . . 1.51 109.737 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.833 HD22 HD23 ' B' ' 347' ' ' LEU . 59.1 tp -66.56 -40.03 88.83 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.503 -0.748 . . . . 0.77 109.806 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.4 tp -60.05 -40.09 88.22 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.638 -0.825 . . . . 0.62 109.155 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -82.64 10.03 8.29 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.272 -0.893 . . . . 1.47 109.55 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 55.8 t0 -59.94 133.27 55.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.892 . . . . 1.47 110.421 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.468 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 96.7 mt-10 -59.91 -16.04 26.4 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.699 -0.625 . . . . 1.78 110.445 -179.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -70.05 -37.46 75.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.969 -1.082 . . . . 2.53 108.859 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.1 mt -73.69 -43.66 58.72 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.461 0.648 . . . . 0.8 110.642 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -59.95 -50.0 75.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.935 . . . . 1.42 110.851 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.51 -42.15 71.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.082 -1.011 . . . . 1.71 111.11 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.88 -39.97 72.54 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.058 -1.026 . . . . 1.57 112.273 -178.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.04 -42.26 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.813 -1.179 . . . . 0.65 109.86 -178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.03 -39.29 77.14 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.584 -0.698 . . . . 0.82 110.303 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.93 -50.0 75.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.122 -0.986 . . . . 0.79 111.723 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.94 -44.3 94.45 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.661 -1.275 . . . . 0.95 109.641 -178.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.6 mt -61.77 -46.66 96.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.314 -0.866 . . . . 0.66 108.883 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -70.02 -40.98 74.88 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 119.924 -0.71 . . . . 2.2 110.74 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -82.24 -51.88 7.5 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.071 -1.018 . . . . 1.65 112.151 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.07 -3.16 58.1 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.961 -1.087 . . . . 2.03 111.684 -177.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 17.2 m170 57.62 38.58 27.8 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.954 -1.091 . . . . 1.42 109.78 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.0 mtp -89.3 169.94 11.0 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.476 -0.765 . . . . 1.18 110.015 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.436 ' OG1' ' HB3' ' A' ' 102' ' ' ALA . 72.7 p -79.9 159.73 26.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.921 . . . . 0.98 109.664 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.03 -40.04 75.4 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.46 -0.775 . . . . 0.64 109.99 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.427 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 31.4 p-10 -69.49 -38.82 77.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.14 -0.975 . . . . 2.07 110.229 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.436 ' HB3' ' OG1' ' A' ' 99' ' ' THR . . . -81.02 -40.67 23.89 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.972 -1.08 . . . . 0.73 109.933 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.11 -47.43 61.85 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.316 -0.865 . . . . 0.54 110.623 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.9 -41.87 92.61 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.003 -1.061 . . . . 0.56 110.008 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.7 t60 -59.94 -38.6 82.88 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.289 -0.882 . . . . 1.54 110.406 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.0 -39.95 93.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.017 -1.052 . . . . 1.33 110.682 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 91.7 t -64.76 -50.14 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.938 -1.101 . . . . 0.72 110.815 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.17 -39.92 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.873 -1.142 . . . . 0.85 108.599 179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -66.36 -37.42 85.26 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.718 -0.845 . . . . 2.44 108.718 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.439 ' O ' ' OG ' ' A' ' 113' ' ' SER . . . -60.07 -49.9 73.5 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 120.547 -0.835 . . . . 0.98 111.019 -179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.8 mm-40 -66.0 -50.43 64.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.503 -1.586 . . . . 1.41 109.746 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.03 -39.15 84.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.844 . . . . 1.2 109.693 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 110' ' ' GLY . 85.0 p -55.56 -39.75 71.03 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.062 -1.024 . . . . 1.7 109.0 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.91 -31.36 69.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.913 . . . . 1.47 109.883 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 21.4 mt -69.93 -41.15 74.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.784 -1.197 . . . . 1.56 110.235 -178.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -69.33 -22.57 63.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.131 -1.606 . . . . 2.2 109.367 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -59.85 -20.58 57.9 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.387 -1.338 . . . . 2.12 107.387 178.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.403 HD13 HD13 ' A' ' 123' ' ' LEU . 35.0 mt -62.94 140.06 58.81 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 108.106 -1.072 . . . . 2.0 108.106 178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -85.76 41.51 0.91 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.952 -1.093 . . . . 3.23 109.134 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 53.3 t0 -131.96 142.46 49.63 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.575 -0.703 . . . . 2.49 109.707 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.499 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 81.6 mm-40 -73.87 -65.33 0.85 Allowed 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.799 0.809 . . . . 3.95 108.835 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.633 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 4.1 t80 -39.28 -42.33 1.0 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.937 -0.477 . . . . 2.0 111.082 -179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.531 HD23 HH22 ' A' ' 126' ' ' ARG . 66.1 mt -70.56 -40.04 73.58 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.561 -1.337 . . . . 1.86 108.225 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 121' ' ' GLU . 62.8 tttp -68.67 -33.69 74.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.545 -0.722 . . . . 2.84 109.491 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.431 ' OE1' ' O ' ' A' ' 187' ' ' THR . 69.1 mm-40 -59.99 -44.9 94.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.806 -1.184 . . . . 2.73 109.629 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.672 ' HE ' HE22 ' B' ' 351' ' ' GLN . 20.5 mtm-85 -69.97 -30.36 67.7 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.895 -1.128 . . . . 2.77 108.592 178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.89 -28.08 67.26 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.888 -1.153 . . . . 1.19 107.888 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.91 -38.88 69.85 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.158 -1.053 . . . . 1.2 108.158 178.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.85 -40.08 94.58 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 1.55 110.229 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.01 -40.0 84.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.993 -1.067 . . . . 0.8 108.446 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -60.01 -38.68 83.37 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.48 -0.933 . . . . 3.09 108.48 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -59.98 -37.43 79.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.567 -0.708 . . . . 1.46 109.545 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.98 -41.84 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.71 110.253 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.35 -31.75 53.74 Favored Glycine 0 N--CA 1.493 2.495 0 C-N-CA 119.574 -1.298 . . . . 0.57 110.354 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -60.05 -49.9 75.83 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.121 -1.223 . . . . 2.59 110.129 -178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -65.41 -31.99 73.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.912 -1.117 . . . . 2.83 109.829 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.2 tp -59.89 -40.03 87.33 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.674 -0.862 . . . . 1.25 108.674 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.6 mt -61.03 -40.06 92.15 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.262 -0.899 . . . . 0.7 109.287 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.448 HH11 ' HG2' ' A' ' 139' ' ' ARG . 46.8 mtt-85 -65.44 -39.76 92.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.301 -0.874 . . . . 2.57 108.908 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -67.0 -33.38 75.45 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.606 -0.684 . . . . 1.23 111.759 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.03 -39.91 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.29 -1.507 . . . . 0.81 109.409 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 82.1 mt -77.26 -21.05 54.28 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.774 -0.77 . . . . 1.0 110.275 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.9 37.15 13.55 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 108.343 -1.903 . . . . 0.89 108.343 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 tp -73.1 140.83 47.42 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.591 -0.947 . . . . 1.14 108.761 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 12.6 tmtt? -73.92 138.38 44.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -0.968 . . . . 4.6 109.613 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.1 mt -107.0 135.01 47.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-O 122.262 1.03 . . . . 1.24 110.065 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.447 ' O ' ' O ' ' A' ' 148' ' ' ASP . 11.4 mt -69.52 -39.92 79.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.396 -0.82 . . . . 1.54 110.651 -178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 147' ' ' ILE . 48.9 t0 60.17 125.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.565 -0.709 . . . . 1.5 109.651 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.51 ' O ' HD12 ' A' ' 152' ' ' ILE . 43.0 mt -83.84 -3.41 57.86 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.24 -0.912 . . . . 0.79 109.783 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.6 m -81.79 -12.9 58.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.135 -0.978 . . . . 1.4 109.188 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.72 27.97 0.28 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.575 -0.703 . . . . 0.92 110.418 -178.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 149' ' ' LEU . 57.9 mt -91.29 119.88 39.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.123 -0.986 . . . . 0.88 109.739 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -101.38 -9.49 21.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.297 -0.877 . . . . 2.45 109.997 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -139.17 158.38 44.28 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.072 -1.018 . . . . 1.52 110.207 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.73 138.59 58.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.317 -0.864 . . . . 1.58 109.026 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 24.6 m -153.12 166.24 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.439 -0.788 . . . . 0.69 109.772 179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.7 mt -96.63 146.15 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 105.415 -2.069 . . . . 0.61 105.415 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 45.7 tp -95.94 116.81 29.49 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.907 -1.12 . . . . 0.87 110.461 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.9 t -120.03 127.92 75.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 107.684 -1.228 . . . . 0.71 107.684 178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -158.97 164.5 35.53 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.997 -1.064 . . . . 0.81 108.903 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.29 -35.11 68.6 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.405 -1.434 . . . . 0.98 108.806 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 58.5 t0 -170.51 146.48 2.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.366 -0.834 . . . . 2.25 109.586 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.515 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 39.3 mt -118.36 140.03 50.45 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.274 -0.891 . . . . 0.78 109.75 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.6 p -101.91 151.59 38.01 Favored Pre-proline 0 N--CA 1.5 2.075 0 O-C-N 121.351 -0.843 . . . . 0.98 109.785 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -40.26 -40.11 2.84 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.652 2.235 . . . . 0.81 113.233 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.8 m -59.96 -40.01 87.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 0.9 109.7 -178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -67.31 -40.6 86.02 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.125 -0.984 . . . . 1.61 110.375 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 67.3 p -58.73 -32.79 69.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.107 -0.995 . . . . 0.61 111.311 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -69.64 -49.63 51.95 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 120.693 -1.254 . . . . 0.6 109.966 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -86.99 38.08 0.79 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.919 -1.141 . . . . 1.4 107.919 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.9 tp -106.28 130.3 54.16 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.002 -0.74 . . . . 0.7 109.002 179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.412 ' N ' HD22 ' A' ' 172' ' ' ASN . 3.1 m120 -84.06 105.39 14.89 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.482 -0.933 . . . . 2.35 108.482 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 89.3 mt -65.49 -40.53 93.21 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.808 . . . . 1.51 110.816 -178.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -69.81 -23.1 63.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.779 -1.201 . . . . 2.33 111.836 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -93.31 -8.64 41.48 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.669 -1.27 . . . . 1.92 110.003 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.553 HG12 ' H ' ' A' ' 178' ' ' GLY . 90.1 t -110.03 119.97 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 N-CA-C 108.541 -0.911 . . . . 0.67 108.541 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 65.9 mt -90.65 6.61 43.19 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.294 -0.879 . . . . 1.53 110.476 -178.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.553 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.58 170.39 36.3 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.279 -1.528 . . . . 0.48 109.279 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.407 ' CE1' HG11 ' A' ' 176' ' ' VAL . 27.0 m-85 -129.98 129.09 43.3 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.508 -0.995 . . . . 0.55 108.834 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.437 ' CG2' HG21 ' A' ' 205' ' ' THR . 72.7 mt -131.05 121.85 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 108.546 -0.909 . . . . 0.65 108.546 179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.3 p -142.5 156.68 45.17 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.332 -0.855 . . . . 0.82 111.197 -179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.439 ' O ' ' O ' ' A' ' 183' ' ' ALA . 94.3 m-20 -90.09 18.61 5.69 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.596 -0.69 . . . . 2.46 109.266 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.439 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.37 -162.92 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.872 -1.143 . . . . 1.28 111.355 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -102.51 -33.99 4.3 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.527 -1.029 . . . . 2.19 110.527 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 157.24 -143.1 9.2 Favored Glycine 0 N--CA 1.495 2.602 0 C-N-CA 118.822 -1.656 . . . . 2.13 111.235 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -59.96 -28.39 67.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.826 -0.808 . . . . 5.86 110.692 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.431 ' O ' ' OE1' ' A' ' 125' ' ' GLU . 61.4 p -59.99 -10.27 3.98 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.991 -1.068 . . . . 3.72 109.145 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 33.5 t -91.64 124.66 35.96 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 1.74 109.41 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 62.0 t60 -48.05 -49.76 30.26 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.034 -1.041 . . . . 0.95 109.868 -179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.459 ' H ' HG22 ' A' ' 190' ' ' THR . 0.0 OUTLIER -53.19 -40.48 64.43 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.32 -0.863 . . . . 1.55 110.358 -179.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 56.1 m -60.04 -40.0 87.88 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.958 -1.089 . . . . 1.51 110.529 -179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 42.6 mm -61.12 -43.58 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.288 -0.882 . . . . 1.67 110.115 -178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.4 mtp -62.87 -40.06 96.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.197 -0.939 . . . . 1.02 110.681 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.67 -41.92 78.11 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 120.58 -1.325 . . . . 0.68 109.054 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -60.03 -49.92 75.78 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.413 -0.805 . . . . 2.93 110.089 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.0 m -72.75 -33.44 66.35 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.086 -1.009 . . . . 0.86 110.534 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.7 mt -71.55 -26.82 62.79 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.144 -0.973 . . . . 0.67 108.384 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 61.45 50.57 4.57 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.978 -0.451 . . . . 1.5 110.833 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 73.4 mt -124.36 146.88 53.38 Favored Pre-proline 0 N--CA 1.505 2.307 0 N-CA-C 108.792 -0.818 . . . . 0.72 108.792 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -45.06 121.83 3.9 Favored 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.829 1.686 . . . . 0.61 111.715 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -158.18 136.78 11.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.382 -1.449 . . . . 0.66 111.966 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.519 ' CD1' HD11 ' A' ' 220' ' ' LEU . 61.6 mt -121.03 145.32 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 106.691 -1.596 . . . . 0.79 106.691 177.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.9 m -133.5 -7.19 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 120.731 -1.231 . . . . 0.91 111.287 -178.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -106.4 22.61 30.42 Favored Glycine 0 N--CA 1.498 2.812 0 N-CA-C 109.874 -1.29 . . . . 1.01 109.874 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.437 HG21 ' CG2' ' A' ' 180' ' ' ILE . 2.0 p -51.16 -41.41 60.13 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.051 -1.264 . . . . 0.99 110.333 -179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.426 ' H ' ' HA ' ' A' ' 182' ' ' ASP . . . 84.67 -77.15 2.14 Favored Glycine 0 N--CA 1.494 2.561 0 C-N-CA 119.667 -1.254 . . . . 1.12 111.781 178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 79.5 p -125.13 27.68 6.59 Favored 'General case' 0 N--CA 1.511 2.619 0 O-C-N 121.253 -1.145 . . . . 1.72 112.882 -177.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.96 -40.89 79.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.295 -1.503 . . . . 0.89 109.123 178.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 209' ' ' THR . 12.4 p -52.64 -26.75 14.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.878 . . . . 1.03 110.222 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.2 m -80.42 -15.83 55.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.016 -1.053 . . . . 1.83 109.931 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.1 mm-40 -103.78 -9.54 18.98 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.364 -0.835 . . . . 2.27 110.257 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 63.3 t -110.4 134.61 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 O-C-N 121.404 -0.81 . . . . 0.92 111.645 -177.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -113.87 150.69 33.26 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.362 -1.348 . . . . 2.2 107.362 178.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 8.8 p30 -54.51 139.49 37.64 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.815 -1.178 . . . . 2.36 109.983 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.8 m-20 83.53 10.72 0.48 Allowed 'General case' 0 N--CA 1.504 2.257 0 CA-C-O 121.19 0.519 . . . . 2.38 110.188 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.8 t0 -80.06 139.88 36.73 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.334 -0.853 . . . . 2.09 109.407 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.54 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 28.0 t80 -88.98 115.26 26.4 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.32 -0.993 . . . . 1.27 108.32 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 83.0 mt -127.78 149.23 50.35 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.49 -0.756 . . . . 0.75 110.505 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.402 HG23 ' CD2' ' A' ' 13' ' ' PHE . 85.6 mt -115.24 129.06 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 106.859 -1.534 . . . . 0.63 106.859 177.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.519 HD11 ' CD1' ' A' ' 202' ' ' ILE . 26.1 tp -99.89 119.31 38.01 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.063 -1.023 . . . . 0.7 110.044 -178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.496 ' C ' ' N ' ' A' ' 223' ' ' VAL . 84.1 m-20 -76.47 -44.46 35.43 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.233 -0.917 . . . . 2.31 108.569 179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.875 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 48.89 15.8 0.1 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.35 -0.982 . . . . 0.78 108.35 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.496 ' N ' ' C ' ' A' ' 221' ' ' ASP . 41.6 t -132.19 -46.12 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 107.293 -1.373 . . . . 1.04 107.293 179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 26.2 m120 -97.8 0.51 46.95 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.469 -1.308 . . . . 2.44 107.469 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.1 t-20 60.07 45.35 12.01 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 109.036 -0.728 . . . . 1.55 109.036 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -138.68 150.07 45.81 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.402 -0.811 . . . . 1.99 109.83 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.0 t -121.08 130.01 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.615 -0.883 . . . . 0.77 108.615 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -98.1 119.91 37.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.317 -0.864 . . . . 0.98 108.955 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.9 t -100.35 113.52 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.632 -0.667 . . . . 0.85 109.981 -179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 8.1 t30 69.25 69.92 0.4 Allowed Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.439 -0.788 . . . . 1.66 109.425 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -90.8 126.39 1.17 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 123.588 2.858 . . . . 0.95 112.73 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 35.0 p -70.97 166.55 21.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.16 -0.963 . . . . 1.84 109.48 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -59.96 -40.0 87.54 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.27 -0.894 . . . . 2.74 110.558 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -59.94 -40.03 87.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.202 -0.936 . . . . 2.89 110.337 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.4 t -66.21 -40.01 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.985 -1.072 . . . . 1.3 109.49 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.9 mt -65.84 -40.03 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.191 -0.943 . . . . 1.09 110.017 -179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -60.02 -47.19 86.85 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.102 -0.999 . . . . 2.43 108.596 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -60.39 -43.25 96.81 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.62 -0.675 . . . . 2.78 109.199 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 94.2 mtp -70.07 -33.57 72.09 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.858 . . . . 1.25 109.801 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -64.06 -40.07 95.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.107 -0.996 . . . . 2.63 109.665 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.01 -49.35 78.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.15 -0.969 . . . . 1.8 109.426 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.01 -39.97 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.251 -0.905 . . . . 2.13 109.275 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.05 -41.7 92.9 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.274 -0.891 . . . . 3.17 110.539 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -60.88 -40.04 91.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.924 -1.11 . . . . 1.78 109.965 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -61.96 -40.03 94.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.192 -0.943 . . . . 2.47 109.516 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 86.2 t -63.81 -41.58 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.461 -0.775 . . . . 2.09 109.632 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.07 -38.74 83.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.361 -0.837 . . . . 2.54 109.314 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.8 t -60.02 -38.78 83.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.515 -0.741 . . . . 2.99 109.939 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -59.99 -40.03 87.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -0.866 . . . . 3.34 109.743 -179.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.477 ' O ' ' CD2' ' A' ' 253' ' ' LEU . 68.1 mttm -75.12 0.24 16.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.044 -1.035 . . . . 3.88 109.674 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.428 ' O ' ' OE2' ' A' ' 252' ' ' GLU . . . -101.29 8.1 42.57 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.223 -0.923 . . . . 4.43 110.524 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.428 ' OE2' ' O ' ' A' ' 251' ' ' ALA . 40.3 mm-40 -129.05 40.07 3.69 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.145 -0.972 . . . . 5.42 109.654 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.724 HD23 ' H ' ' A' ' 253' ' ' LEU . 0.1 OUTLIER -67.79 -40.25 83.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.246 -0.909 . . . . 6.1 109.35 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.53 ' O ' ' N ' ' A' ' 256' ' ' LEU . . . 48.39 6.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.395 -0.816 . . . . 7.37 110.58 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.551 ' N ' ' O ' ' A' ' 253' ' ' LEU . 8.0 mtmp? 49.52 8.46 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.874 -1.141 . . . . 8.01 109.965 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.53 ' N ' ' O ' ' A' ' 254' ' ' ALA . 34.4 tp -101.54 -42.69 6.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.116 -0.99 . . . . 9.05 109.417 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -80.44 147.54 30.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.469 -0.769 . . . . 10.56 109.329 -179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 34.8 t0 57.76 67.1 1.0 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.147 -0.971 . . . . 11.32 108.956 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 10.9 ptp180 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.963 -1.018 . . . . 12.42 109.649 179.996 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 10.9 ttt . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.471 0.653 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -152.38 151.99 31.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.318 -0.864 . . . . 0.0 109.512 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -147.84 158.84 44.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.278 -0.889 . . . . 0.0 110.128 -179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . 0.43 ' NE2' ' OE2' ' B' ' 305' ' ' GLU . 54.3 tp60 -152.51 148.32 27.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . 0.486 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 1.4 pm0 -114.9 133.49 55.94 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.266 -0.896 . . . . 0.0 110.103 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 p -134.31 123.69 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 CA-C-O 122.006 0.907 . . . . 0.0 112.22 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 35.9 m -78.01 105.47 9.23 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.972 0.892 . . . . 0.0 110.343 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.0 mt -51.66 122.15 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-O 122.434 1.111 . . . . 0.0 110.505 -177.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 19.3 p -107.36 18.87 21.05 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.226 -178.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.478 ' O ' ' CG ' ' B' ' 357' ' ' GLN . . . -74.94 133.21 76.12 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.048 -1.032 . . . . 0.0 108.329 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -69.99 -13.13 33.7 Favored 'Trans proline' 0 N--CA 1.495 1.589 0 CA-C-N 120.161 1.093 . . . . 0.0 112.298 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -120.67 8.94 10.68 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.436 -0.79 . . . . 0.0 109.619 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.55 179.95 32.39 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.862 -1.695 . . . . 0.0 108.862 -179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.483 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.6 tp -86.92 93.12 9.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.079 -1.248 . . . . 0.0 109.641 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -96.54 -159.78 0.75 Allowed 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.138 -0.976 . . . . 0.0 110.204 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.2 m -57.12 -45.11 83.74 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.17 -0.956 . . . . 0.0 112.816 -176.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.511 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 3.1 tpt180 -61.59 -61.46 7.8 Favored Pre-proline 0 N--CA 1.5 2.029 0 O-C-N 120.571 -1.33 . . . . 0.0 112.166 -178.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -59.69 -31.91 94.95 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 120.335 1.155 . . . . 0.0 111.797 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.03 -50.29 74.32 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -50.81 -40.89 56.68 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.432 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . 0.436 ' NE2' ' NE ' ' B' ' 317' ' ' ARG . 56.8 mt-30 -69.95 -40.19 75.59 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.226 -0.99 . . . . 0.0 109.16 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -61.99 -52.61 63.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.466 -0.771 . . . . 0.0 110.483 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 86.4 t -69.21 -32.35 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.729 -1.232 . . . . 0.0 110.005 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 20.0 ttmt -59.98 -47.55 85.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.226 -0.921 . . . . 0.0 110.038 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -69.99 -42.36 73.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.077 -1.014 . . . . 0.0 110.819 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -71.71 -54.02 11.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.746 -1.222 . . . . 0.0 110.011 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -49.96 -17.34 0.37 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.573 -0.704 . . . . 0.0 109.619 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -76.16 -17.88 79.72 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -106.09 147.2 29.21 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.289 -1.124 . . . . 0.0 109.067 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 3.6 t -90.49 -13.05 35.5 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.065 -1.022 . . . . 0.0 109.831 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.548 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 52.8 m -58.04 144.09 41.08 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.294 -0.879 . . . . 0.0 109.673 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -67.7 131.59 45.86 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.6 mt -132.61 132.68 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.47 -0.769 . . . . 0.0 109.645 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 50.7 m -128.93 148.88 50.96 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.448 -0.782 . . . . 0.0 109.328 179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.96 114.99 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 55.2 m -103.15 123.53 46.87 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.246 -0.909 . . . . 0.0 108.818 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 47.8 t -136.58 120.29 17.3 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.003 0.906 . . . . 0.0 111.639 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . 0.456 HD21 HG23 ' B' ' 359' ' ' THR . 83.3 m-20 49.45 49.2 20.25 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 176.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 86.05 -11.13 63.46 Favored Glycine 0 N--CA 1.5 2.916 0 O-C-N 119.863 -1.773 . . . . 0.0 112.438 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -122.59 133.45 54.55 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.008 -1.289 . . . . 0.0 109.503 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 14.8 m -128.46 150.24 50.23 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 121.973 0.892 . . . . 0.0 110.713 -178.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -145.69 168.02 21.7 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.539 0.685 . . . . 0.0 109.825 -179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 28.6 m -89.06 139.6 30.3 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.518 -0.739 . . . . 0.0 110.136 -179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -77.64 -15.87 58.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 108.985 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 46.1 tttm -87.19 17.19 4.46 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 49.8 m -145.71 95.34 2.63 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.076 -0.966 . . . . 0.0 112.045 -179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.833 HD23 HD22 ' A' ' 79' ' ' LEU . 59.5 tp -60.03 -38.29 82.3 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.825 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 59.9 m-85 -55.22 -51.65 65.89 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.076 -1.015 . . . . 0.0 110.849 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 19.2 mtmm -69.11 -39.92 78.67 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 120.767 -1.208 . . . . 0.0 109.799 -178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.522 ' O ' ' N ' ' B' ' 352' ' ' THR . 36.8 mt -48.18 -58.28 4.75 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.836 -1.165 . . . . 0.0 109.35 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.672 HE22 ' HE ' ' A' ' 126' ' ' ARG . 73.9 mm-40 -38.37 -23.69 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.523 -0.736 . . . . 0.0 111.355 -177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.522 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.6 p -80.09 -13.14 59.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.753 -1.217 . . . . 0.0 110.876 -178.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 27.5 mt -93.25 119.29 32.25 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.682 -1.262 . . . . 0.0 109.32 178.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.23 94.0 1.12 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.081 -1.607 . . . . 0.0 109.081 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 21.0 mt -101.67 92.05 4.69 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.336 -1.096 . . . . 0.0 108.835 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 74.3 p -92.22 175.22 6.93 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.217 -0.927 . . . . 0.0 110.608 -179.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . 0.478 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 15.2 tm0? -63.92 111.32 2.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.742 -0.599 . . . . 0.0 110.926 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 102.12 9.97 40.73 Favored Glycine 0 N--CA 1.496 2.638 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . 0.456 HG23 HD21 ' B' ' 338' ' ' ASN . 51.9 m -84.74 111.79 19.91 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.225 -1.162 . . . . 0.0 110.514 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 20.1 t -76.74 115.32 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.277 1.037 . . . . 0.0 109.732 -177.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 10.8 m -111.9 176.71 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 56.0 m -131.9 129.19 40.01 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . 0.462 HD11 ' SD ' ' B' ' 381' ' ' MET . 85.5 mt -103.41 117.41 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 61.4 p -120.3 132.92 55.51 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.26 151.92 38.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.006 -1.059 . . . . 0.0 110.589 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 23.1 tp10 -144.82 122.84 12.07 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.456 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 159.55 -158.61 29.77 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.02 -1.562 . . . . 0.0 111.596 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.07 -51.7 68.49 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 122.049 -0.677 . . . . 0.0 112.524 -177.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.548 ' N ' ' OG ' ' B' ' 331' ' ' SER . 91.7 m-20 -109.65 13.59 23.76 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.796 -1.19 . . . . 0.0 111.047 -177.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.546 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -44.39 -36.68 2.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.033 -1.042 . . . . 0.0 111.278 -178.679 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . 0.533 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 78.1 mt-30 -70.02 -41.7 73.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.855 -1.153 . . . . 0.0 109.816 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -68.06 -49.52 60.85 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.208 -0.932 . . . . 0.0 109.685 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . 0.4 ' O ' ' C ' ' B' ' 374' ' ' VAL . . . -50.18 -74.8 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.325 -0.86 . . . . 0.0 110.95 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.561 ' O ' HG23 ' B' ' 378' ' ' VAL . 38.9 t -44.1 -40.01 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.282 -0.886 . . . . 0.0 109.983 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -65.46 -45.76 82.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.793 -1.192 . . . . 0.0 110.171 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -80.41 -43.42 21.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.945 -1.097 . . . . 0.0 110.132 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 98.6 mt -59.99 -37.77 80.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.081 -1.012 . . . . 0.0 108.872 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.561 HG23 ' O ' ' B' ' 374' ' ' VAL . 30.7 t -61.32 -40.96 87.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.088 -1.008 . . . . 0.0 108.8 178.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.454 ' O ' ' N ' ' B' ' 383' ' ' GLU . 62.0 mttp -67.92 -55.32 13.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.849 -1.157 . . . . 0.0 108.21 178.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 59.6 tp -57.82 -36.26 72.01 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.008 -1.057 . . . . 0.0 109.285 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . 0.462 ' SD ' HD11 ' B' ' 363' ' ' ILE . 38.1 ttm -74.56 -41.53 60.38 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.99 -10.0 59.07 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.27 -0.894 . . . . 0.0 109.415 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.454 ' N ' ' O ' ' B' ' 379' ' ' LYS . 71.3 mm-40 -108.19 10.43 27.92 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.512 -0.742 . . . . 0.0 110.966 -179.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 16.6 mt -66.19 109.55 2.67 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.416 -1.428 . . . . 0.0 109.181 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.499 1.98 0 CA-C-O 118.003 -0.999 . . . . 0.0 108.927 179.524 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.136 -0.69 . . . . 2.91 109.136 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.7 mt -110.07 126.82 67.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.481 -0.762 . . . . 1.2 109.125 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.3 m -130.01 138.6 50.88 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 109.092 -0.707 . . . . 1.4 109.092 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.49 -161.92 19.43 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.221 -1.552 . . . . 1.05 109.221 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.7 mt -89.54 -18.55 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.141 -1.211 . . . . 1.15 109.877 -179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 5' ' ' ILE . 62.6 tp 51.02 103.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.348 -0.845 . . . . 0.98 109.69 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.94 -29.39 12.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.254 -0.904 . . . . 0.88 109.037 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 64.8 m -119.67 115.87 33.5 Favored Pre-proline 0 N--CA 1.501 2.076 0 O-C-N 121.513 -0.742 . . . . 1.69 109.47 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -80.64 146.46 16.89 Favored 'Trans proline' 0 N--CA 1.493 1.456 0 C-N-CA 122.029 1.819 . . . . 0.85 112.249 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.646 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 151.18 -152.13 23.98 Favored Glycine 0 N--CA 1.494 2.567 0 N-CA-C 108.878 -1.689 . . . . 0.92 108.878 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.5 mt -150.31 151.52 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.321 0 O-C-N 120.768 -1.43 . . . . 0.81 108.801 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -150.1 150.83 32.25 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.908 -1.12 . . . . 0.51 110.545 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -133.74 125.32 28.31 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.821 -1.178 . . . . 0.62 107.821 178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.52 177.39 47.15 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 118.476 -1.821 . . . . 0.55 110.999 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 157' ' ' ILE . 85.2 mttt -79.87 160.02 26.21 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.831 -0.805 . . . . 2.1 108.905 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.589 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -105.44 134.89 47.81 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.355 -0.841 . . . . 0.77 111.527 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.1 tp -101.48 138.72 38.12 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.352 -1.351 . . . . 0.91 107.352 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.8 tp -118.64 124.9 48.53 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.156 -0.965 . . . . 0.93 110.199 -179.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.8 mt -93.14 103.45 15.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.8 -0.563 . . . . 0.93 110.189 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? -98.66 133.06 43.52 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.388 -0.967 . . . . 2.75 108.388 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -130.07 128.23 41.5 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.62 -0.882 . . . . 3.0 108.62 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -75.46 149.83 38.41 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 2.77 109.901 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -69.13 143.12 54.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.486 -0.758 . . . . 2.94 108.992 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.2 mt -80.13 131.28 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.233 -0.917 . . . . 0.95 109.387 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 56.0 t -97.27 125.08 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.25 -0.906 . . . . 1.28 109.542 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.0 mt -107.9 135.32 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 121.434 -0.791 . . . . 1.21 108.921 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -93.87 121.13 35.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.12 -0.988 . . . . 1.81 109.699 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.501 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.8 mmt-85 -89.1 2.12 54.58 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.512 -0.742 . . . . 2.8 110.228 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -67.48 149.5 50.11 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.93 -1.106 . . . . 2.87 109.356 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -93.01 149.77 20.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.164 -0.96 . . . . 2.35 109.596 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.48 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.0 pt -96.44 167.7 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.213 -0.929 . . . . 0.97 110.246 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 61.8 p -100.66 176.2 5.39 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.484 -0.932 . . . . 1.17 108.484 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.85 76.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.156 -0.965 . . . . 1.18 110.695 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -58.05 -27.92 64.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.687 -1.258 . . . . 2.56 109.697 -179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -81.68 -11.01 59.25 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.34 -0.85 . . . . 1.79 109.808 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.5 t -62.91 -51.89 66.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.003 -1.061 . . . . 1.0 108.95 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.91 -40.11 96.59 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.247 -0.908 . . . . 1.77 110.113 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -66.28 -40.08 89.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.005 -1.059 . . . . 2.7 110.579 -179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.48 ' HG3' HG21 ' A' ' 31' ' ' ILE . 75.1 mm-40 -67.91 -40.07 83.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.778 -1.201 . . . . 1.51 110.302 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.04 -45.26 95.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 120.648 -1.283 . . . . 0.93 108.297 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -58.28 -39.9 80.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.997 -1.064 . . . . 1.81 108.594 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.458 HH11 ' HG2' ' A' ' 42' ' ' ARG . 44.5 mtt-85 -59.93 -43.68 94.81 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 107.287 -1.375 . . . . 2.78 107.287 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -63.5 -45.78 89.09 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.522 -0.736 . . . . 0.78 109.254 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.7 tp -60.05 -50.08 75.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.244 -0.91 . . . . 1.07 108.567 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.7 t -63.45 -44.1 95.5 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.483 -0.887 . . . . 1.12 108.852 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.08 -43.33 99.57 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.859 -1.696 . . . . 0.84 108.859 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 61.8 ttt180 -67.44 -32.7 73.73 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.427 -1.043 . . . . 3.09 108.323 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.55 -40.99 89.06 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.508 -0.745 . . . . 0.88 109.348 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 34.6 ttpt -68.91 -74.73 0.12 Allowed 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.953 -1.092 . . . . 2.59 108.447 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.1 -35.08 0.14 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.346 -0.846 . . . . 0.7 111.504 -178.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 95.5 p -57.46 -56.63 19.33 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.55 -1.26 . . . . 1.4 108.586 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.03 -40.74 75.0 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.419 -0.8 . . . . 0.67 111.413 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -64.41 -40.04 95.02 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.633 -1.292 . . . . 1.66 110.889 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.9 mt -65.18 -40.01 93.67 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.848 -1.158 . . . . 1.58 109.367 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -60.01 -37.46 79.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 1.35 109.834 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.24 -40.55 96.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.078 -1.014 . . . . 0.77 110.198 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.723 HD11 HH22 ' A' ' 136' ' ' ARG . 96.8 mt -62.11 -39.94 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.25 -0.906 . . . . 0.63 109.58 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.2 ttpt -59.5 -50.0 75.63 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.457 -0.777 . . . . 1.14 109.577 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.3 m -59.37 -39.5 83.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.99 -1.069 . . . . 0.79 110.097 -178.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -64.35 -38.37 90.8 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.09 -1.006 . . . . 1.53 109.247 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.46 -43.98 92.52 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.594 -0.691 . . . . 0.57 109.915 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.24 -50.04 66.08 Favored Glycine 0 N--CA 1.489 2.181 0 C-N-CA 119.836 -1.173 . . . . 0.75 110.174 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.13 -45.54 80.71 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.228 -1.16 . . . . 1.59 109.708 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.9 m -72.56 -57.9 3.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.327 -0.858 . . . . 0.73 112.306 -178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -94.81 -54.35 3.51 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 120.8 -1.187 . . . . 0.75 111.09 -177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.35 -169.18 25.54 Favored Glycine 0 N--CA 1.501 2.971 0 C-N-CA 119.692 -1.242 . . . . 1.22 111.464 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.07 -28.78 66.82 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 122.043 -0.681 . . . . 5.81 111.145 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.448 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 50.8 tp10 -61.47 -34.86 76.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.066 -1.021 . . . . 3.37 110.516 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.1 mmtm -99.46 -21.01 16.15 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.202 -0.936 . . . . 1.77 110.22 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -66.84 -42.61 85.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.115 -0.991 . . . . 1.65 110.314 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.464 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -66.21 -32.21 73.51 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.514 -0.741 . . . . 0.77 110.53 -178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.5 mt -60.1 -42.49 90.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.996 -1.065 . . . . 0.8 109.987 -179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.562 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 69.4 m-85 -71.56 -34.19 69.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.977 -1.077 . . . . 0.88 109.951 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -59.94 -39.81 86.8 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.228 -0.92 . . . . 1.37 109.284 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.45 -42.31 97.64 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.209 -1.557 . . . . 0.62 109.209 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -60.25 -41.42 93.15 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.357 -1.084 . . . . 1.5 108.893 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.8 mt -70.03 -45.44 76.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.239 -0.913 . . . . 0.63 109.45 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.6 ttp -60.25 -40.6 90.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.111 -0.993 . . . . 1.51 109.935 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.86 HD11 ' CE2' ' B' ' 348' ' ' PHE . 33.2 tp -67.26 -39.3 86.09 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.256 -0.902 . . . . 0.77 109.198 179.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.6 tp -61.41 -39.94 92.57 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.039 -0.726 . . . . 0.62 109.039 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -83.07 5.81 21.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.316 -0.865 . . . . 1.47 109.585 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -49.83 130.36 21.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.219 -0.926 . . . . 1.47 109.428 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.16 -21.32 61.51 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.381 -0.824 . . . . 1.78 111.699 -178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -71.13 -33.02 69.69 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.623 -1.298 . . . . 2.53 108.878 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.7 mt -70.42 -40.74 73.65 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.488 0.661 . . . . 0.8 109.827 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.13 -49.66 76.76 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.449 -0.782 . . . . 1.42 109.827 -179.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -69.97 -41.16 74.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.407 -0.808 . . . . 1.71 111.243 -178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.05 -39.97 75.39 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.934 -1.104 . . . . 1.57 111.682 -179.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.08 -44.37 81.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.624 0 O-C-N 120.831 -1.168 . . . . 0.65 109.767 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.03 -38.6 75.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 O-C-N 121.403 -0.811 . . . . 0.82 110.131 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -64.5 -45.06 88.92 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.272 -0.892 . . . . 0.79 111.672 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 66.3 mt -61.57 -45.97 91.89 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.706 -1.247 . . . . 0.95 109.56 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 57.1 mt -61.36 -47.66 92.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 CA-C-O 121.906 0.86 . . . . 0.66 109.082 179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.8 mtpm? -70.04 -40.0 75.41 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 120.039 -0.664 . . . . 2.2 110.652 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -81.46 -61.55 1.9 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.039 -1.038 . . . . 1.65 112.116 -178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -82.2 0.54 40.67 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.097 -1.002 . . . . 2.03 111.68 -177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 57.17 37.8 28.59 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.132 -0.98 . . . . 1.42 109.923 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 79.7 mtp -90.85 166.97 12.79 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.63 -0.668 . . . . 1.18 109.499 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.2 p -80.89 161.88 24.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.948 . . . . 0.98 109.274 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.31 -39.93 85.95 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.256 -0.902 . . . . 0.64 109.581 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -68.45 -37.38 80.15 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.268 -0.895 . . . . 2.07 109.42 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.56 -45.56 21.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.73 109.445 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.43 -48.89 75.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.486 -0.759 . . . . 0.54 109.766 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.08 -36.0 76.42 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 0.56 109.284 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.544 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 84.5 t60 -59.96 -40.71 89.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.381 -0.824 . . . . 1.54 109.511 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -65.04 -40.53 94.94 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.334 -0.854 . . . . 1.33 111.149 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.34 -57.19 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.085 -1.01 . . . . 0.72 111.767 -177.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.5 mm -66.92 -40.04 84.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.82 -1.175 . . . . 0.85 109.01 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.544 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 88.0 tt0 -63.11 -40.09 96.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.238 -0.914 . . . . 2.44 108.678 178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.28 -52.61 50.54 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 120.504 -0.855 . . . . 0.98 110.987 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -62.8 -48.95 76.91 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.803 -1.41 . . . . 1.41 109.375 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.35 88.79 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.16 -0.962 . . . . 1.2 109.014 179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.2 m -59.97 -40.26 88.45 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.1 -1.0 . . . . 1.7 108.876 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.85 87.26 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.255 -0.903 . . . . 1.47 109.116 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.8 mt -64.84 -39.97 94.43 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.873 -1.142 . . . . 1.56 108.774 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -59.23 -30.92 68.6 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.054 -1.029 . . . . 2.2 109.306 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.0 -27.54 66.96 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.105 -0.997 . . . . 2.12 108.514 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.46 HD13 HD13 ' A' ' 123' ' ' LEU . 28.4 mt -62.32 143.76 56.54 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.263 -0.898 . . . . 2.0 109.283 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -97.42 52.57 1.12 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.154 -0.966 . . . . 3.23 109.531 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -136.12 133.05 36.86 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.252 -0.905 . . . . 2.49 109.811 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.48 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 45.1 mp0 -70.04 -30.72 68.06 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.367 -0.833 . . . . 3.95 110.061 179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.459 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.9 t80 -69.9 -38.06 76.17 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.195 -0.941 . . . . 2.0 110.091 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.46 HD13 HD13 ' A' ' 118' ' ' LEU . 65.1 mt -77.57 -39.81 44.47 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.094 -1.004 . . . . 1.86 109.788 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -61.58 -43.72 98.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.165 -0.96 . . . . 2.84 110.445 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 65.9 mm-40 -67.12 -41.09 86.77 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.92 -1.112 . . . . 2.73 109.755 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.612 ' CD ' HE22 ' B' ' 351' ' ' GLN . 27.4 ttp180 -60.08 -40.03 88.12 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.779 -1.193 . . . . 2.77 107.779 179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.81 -23.14 67.12 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.418 -0.956 . . . . 1.19 108.418 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -59.9 -40.02 87.35 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.606 -1.257 . . . . 1.2 107.606 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -66.75 -40.42 88.28 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 120.008 -0.677 . . . . 1.55 109.916 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 59.5 t -62.4 -40.0 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.933 -1.104 . . . . 0.8 108.437 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.513 HH11 ' HG2' ' A' ' 131' ' ' ARG . 9.1 ttt-85 -63.37 -36.22 82.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.414 -0.804 . . . . 3.09 109.931 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -59.36 -40.15 85.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.224 -0.922 . . . . 1.46 109.59 -178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.94 -43.18 91.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.038 -1.039 . . . . 0.71 108.805 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.43 -45.37 96.53 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 110.678 -0.969 . . . . 0.57 110.678 -179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 55.0 mtmt -60.03 -44.68 94.47 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.109 -1.23 . . . . 2.59 110.831 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.723 HH22 HD11 ' A' ' 57' ' ' ILE . 60.2 mtp180 -69.22 -34.88 75.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.482 -1.386 . . . . 2.83 110.157 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 56.7 tp -59.8 -45.25 92.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.149 -0.969 . . . . 1.25 109.731 -179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 72.7 mt -61.57 -39.84 92.59 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.119 -0.988 . . . . 0.7 108.87 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -67.2 -39.8 86.4 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.62 -0.675 . . . . 2.57 110.238 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 -68.62 -25.54 64.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.137 -0.977 . . . . 1.23 111.383 -178.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.3 mt -76.72 -43.64 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.334 -1.479 . . . . 0.81 108.36 178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.5 mt -69.94 -31.16 68.76 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.752 -0.592 . . . . 1.0 109.918 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.53 36.95 7.18 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.074 -1.61 . . . . 0.89 109.074 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 56.7 tp -73.2 143.0 47.35 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.432 -1.04 . . . . 1.14 109.229 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -60.7 144.98 51.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.369 -0.832 . . . . 4.6 109.877 -179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.2 mt -114.88 121.31 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.29 -1.004 . . . . 1.24 108.29 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 16.9 mm -52.98 -52.17 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.568 -0.707 . . . . 1.54 110.409 -177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.8 t0 66.01 102.46 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.779 -0.822 . . . . 1.5 108.779 -179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.1 mt -73.34 -1.77 19.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.538 -0.726 . . . . 0.79 110.45 -178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.3 p -80.01 -11.54 59.77 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.899 -1.126 . . . . 1.4 109.343 179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -88.37 21.05 3.01 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.615 -0.678 . . . . 0.92 111.448 -177.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.437 ' HB ' HD21 ' A' ' 172' ' ' ASN . 48.9 mt -92.74 111.72 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.771 -1.205 . . . . 0.88 108.734 179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -100.11 -8.45 23.7 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.195 -0.94 . . . . 2.45 111.165 -178.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -117.22 147.43 42.51 Favored 'General case' 0 N--CA 1.506 2.34 0 O-C-N 121.152 -0.967 . . . . 1.52 110.176 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.38 131.35 46.95 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.979 -0.749 . . . . 1.58 108.979 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -152.42 164.72 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.506 -0.746 . . . . 0.69 109.515 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.423 ' N ' ' O ' ' A' ' 15' ' ' LYS . 97.0 mt -92.62 152.37 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 105.384 -2.08 . . . . 0.61 105.384 176.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 41.9 tp -101.23 120.07 39.69 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.976 -1.077 . . . . 0.87 111.131 -177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.51 129.93 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.898 -0.779 . . . . 0.71 108.898 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.03 163.44 36.37 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.37 -0.974 . . . . 0.81 108.37 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.07 -36.69 75.14 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.416 -1.427 . . . . 0.98 108.223 178.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -170.54 146.35 2.74 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.889 -0.782 . . . . 2.25 108.889 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.7 mt -115.09 131.18 57.01 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.309 -0.869 . . . . 0.78 110.382 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.4 p -93.4 151.75 40.49 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.467 -0.771 . . . . 0.98 109.226 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -39.76 -36.43 1.23 Allowed 'Trans proline' 0 N--CA 1.491 1.354 0 C-N-CA 122.118 1.878 . . . . 0.81 112.52 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.3 m -58.12 -45.16 87.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.9 109.221 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -69.94 -42.6 73.02 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.096 -1.003 . . . . 1.61 109.991 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 27.5 p -57.42 -16.1 8.45 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.198 -0.939 . . . . 0.61 110.731 -178.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.562 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . . . -90.66 -51.8 5.2 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.827 -1.171 . . . . 0.6 110.043 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -85.39 42.18 0.94 Allowed 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.001 -1.111 . . . . 1.4 108.001 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.7 tp -109.99 132.8 53.83 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.704 -0.851 . . . . 0.7 108.704 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.437 HD21 ' HB ' ' A' ' 152' ' ' ILE . 0.8 OUTLIER -91.23 108.52 19.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.226 -0.921 . . . . 2.35 109.285 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 84.4 mt -62.75 -43.63 98.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.469 -0.77 . . . . 1.51 110.99 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -64.53 -23.58 67.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.924 -1.11 . . . . 2.33 111.957 -177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -93.58 -11.11 32.56 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.689 -1.257 . . . . 1.92 109.794 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.486 HG12 ' H ' ' A' ' 178' ' ' GLY . 98.8 t -110.05 118.89 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 O-C-N 121.186 -0.946 . . . . 0.67 109.413 179.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.1 mt -89.87 6.38 42.13 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.142 -0.973 . . . . 1.53 111.248 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.486 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 175.22 170.11 37.8 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.169 -1.572 . . . . 0.48 109.169 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -132.67 128.88 37.96 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.269 -1.136 . . . . 0.55 109.901 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.401 ' CG2' HG21 ' A' ' 205' ' ' THR . 98.4 mt -132.17 125.11 53.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.727 -0.842 . . . . 0.65 108.727 178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.1 p -143.21 157.94 44.06 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.22 -0.925 . . . . 0.82 110.625 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.513 ' O ' ' O ' ' A' ' 183' ' ' ALA . 1.1 m-20 -99.2 22.69 10.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.557 -0.715 . . . . 2.46 109.803 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.513 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -45.41 -175.43 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.41 1.1 . . . . 1.28 112.586 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.71 -54.59 4.89 Favored Glycine 0 N--CA 1.492 2.412 0 O-C-N 121.527 -0.733 . . . . 2.19 111.315 -179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -149.97 -161.84 10.11 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 120.631 -1.511 . . . . 2.13 111.278 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.425 ' O ' ' OG ' ' A' ' 191' ' ' SER . 41.1 ttp180 -80.01 -9.87 59.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.789 -0.83 . . . . 5.86 110.205 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 64.0 p -79.94 4.85 15.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.147 -0.97 . . . . 3.72 109.85 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.7 t -71.57 134.46 46.45 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.265 -0.897 . . . . 1.74 110.81 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -41.3 -60.84 1.15 Allowed 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.528 0.68 . . . . 0.95 110.758 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 2.7 t -51.12 -33.65 27.33 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.189 -0.944 . . . . 1.55 110.452 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 186' ' ' ARG . 28.0 p -60.0 -40.12 88.13 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.973 -1.08 . . . . 1.51 109.689 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.5 -40.09 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.384 -0.823 . . . . 1.67 110.176 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 35.1 mtm -59.89 -49.27 78.34 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.808 -1.182 . . . . 1.02 110.494 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.08 -44.17 94.98 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.753 -1.217 . . . . 0.68 110.626 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -60.03 -52.07 66.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.125 -0.985 . . . . 2.93 110.459 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.2 m -70.94 -33.58 70.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.125 -0.984 . . . . 0.86 110.723 -179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.04 -22.99 59.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.018 -1.051 . . . . 0.67 109.652 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 66.45 52.37 1.07 Allowed 'General case' 0 N--CA 1.502 2.159 0 CA-C-O 121.576 0.703 . . . . 1.5 110.543 -178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.414 ' O ' ' CB ' ' A' ' 8' ' ' SER . 62.9 mt -127.28 132.31 24.26 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 107.722 -1.214 . . . . 0.72 107.722 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -43.45 134.35 6.83 Favored 'Trans proline' 0 N--CA 1.498 1.773 0 C-N-CA 121.805 1.67 . . . . 0.61 112.317 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -166.85 145.35 5.19 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.71 -1.196 . . . . 0.66 111.824 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.5 mt -123.16 145.67 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 107.403 -1.332 . . . . 0.79 107.403 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.1 m -129.7 -12.24 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 120.795 -1.191 . . . . 0.91 111.143 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.72 24.86 22.72 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 110.06 -1.216 . . . . 1.01 110.06 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.427 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 6.3 p -46.32 -42.29 14.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.059 -1.259 . . . . 0.99 110.04 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.78 -57.36 4.66 Favored Glycine 0 N--CA 1.496 2.684 0 C-N-CA 119.947 -1.121 . . . . 1.12 111.308 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 24.5 m -150.8 32.78 0.61 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 120.56 -1.553 . . . . 1.72 111.786 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.0 t -70.15 -44.63 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.796 -1.19 . . . . 0.89 109.134 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.441 ' H ' HG23 ' A' ' 209' ' ' THR . 3.0 p -50.59 -29.96 12.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.54 -0.725 . . . . 1.03 111.33 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 29.6 t -69.97 -27.13 64.47 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.723 -1.236 . . . . 1.83 109.844 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -96.94 -7.02 34.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.151 -0.968 . . . . 2.27 110.53 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 73.8 t -105.93 132.15 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.249 -0.907 . . . . 0.92 110.912 -178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.439 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 9.9 mtpt -120.12 149.54 42.05 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.621 -1.252 . . . . 2.2 107.621 178.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.469 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 23.6 p-10 -50.07 138.65 15.46 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.11 -0.994 . . . . 2.36 111.326 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.469 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 8.3 t0 82.3 5.44 1.07 Allowed 'General case' 0 N--CA 1.5 2.037 0 CA-C-N 116.165 -0.47 . . . . 2.38 110.538 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 91.9 m-20 -77.56 143.49 38.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.965 -1.084 . . . . 2.09 108.877 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -92.28 119.93 32.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.183 -0.948 . . . . 1.27 108.587 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.589 HD12 ' HB2' ' A' ' 16' ' ' ALA . 86.4 mt -127.21 146.6 50.35 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.41 -0.806 . . . . 0.75 110.636 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.2 mt -118.75 129.28 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 107.193 -1.41 . . . . 0.63 107.193 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.6 tp -104.1 119.93 40.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.107 -0.995 . . . . 0.7 108.787 -179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.644 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 21.6 p-10 -79.78 -39.09 31.7 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.214 -0.929 . . . . 2.31 109.114 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.69 16.61 0.07 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.782 -0.822 . . . . 0.78 108.782 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 221' ' ' ASP . 47.6 t -126.28 -38.76 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.526 -1.287 . . . . 1.04 107.526 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -109.81 -1.1 18.08 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.797 -1.186 . . . . 2.44 107.797 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 42.4 t-20 61.45 49.97 4.92 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.369 0.604 . . . . 1.55 109.935 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.644 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 27.4 mt-30 -137.64 153.34 49.88 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.573 -0.705 . . . . 1.99 109.305 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.93 128.87 76.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 109.144 -0.687 . . . . 0.77 109.144 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -103.05 122.44 44.65 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 107.784 -1.191 . . . . 0.98 107.784 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.8 t -101.04 111.86 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.429 -0.794 . . . . 0.85 110.89 -178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 42.8 t30 49.96 63.5 10.02 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.318 -0.864 . . . . 1.66 110.318 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -82.4 150.2 15.1 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.705 2.27 . . . . 0.95 111.9 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.407 ' OG1' HG23 ' A' ' 235' ' ' VAL . 68.1 p -67.47 163.74 20.31 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.142 -0.974 . . . . 1.84 110.131 -178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -60.18 -40.2 89.19 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.5 -0.75 . . . . 2.74 110.19 -179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -62.05 -34.57 76.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.233 -0.917 . . . . 2.89 109.997 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.407 HG23 ' OG1' ' A' ' 232' ' ' THR . 55.3 t -69.78 -39.99 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.343 -0.848 . . . . 1.3 109.299 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.7 mt -65.52 -39.91 86.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 1.09 109.404 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -59.91 -40.04 87.47 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.14 -0.975 . . . . 2.43 109.106 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -67.3 -40.29 86.04 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.032 -1.043 . . . . 2.78 109.101 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 94.9 mtp -70.09 -30.23 67.39 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 1.25 109.148 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.479 HH11 ' NE2' ' A' ' 243' ' ' GLN . 15.8 mmm180 -69.97 -38.03 75.94 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.359 -0.838 . . . . 2.63 109.378 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -57.85 -45.07 86.82 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.269 -0.894 . . . . 1.8 108.618 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.6 t -63.5 -40.15 87.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 108.654 -0.869 . . . . 2.13 108.654 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.479 ' NE2' HH11 ' A' ' 240' ' ' ARG . 12.8 tt0 -62.41 -39.53 93.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.499 -0.75 . . . . 3.17 110.482 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -57.86 -39.81 78.63 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.918 -1.114 . . . . 1.78 109.138 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -68.19 -41.22 81.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.151 -0.968 . . . . 2.47 108.861 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 73.4 t -68.03 -39.97 82.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.815 -0.809 . . . . 2.09 108.815 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.497 ' O ' ' N ' ' A' ' 251' ' ' ALA . . . -59.99 -36.03 76.28 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.526 -0.734 . . . . 2.54 109.478 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 70.4 m -59.92 -40.41 88.78 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.099 -1.0 . . . . 2.99 108.965 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -60.84 -40.03 91.33 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.377 -0.827 . . . . 3.34 108.833 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.417 ' C ' ' H ' ' A' ' 252' ' ' GLU . 52.7 mtpt -124.84 53.78 1.46 Allowed 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.758 -0.83 . . . . 3.88 108.758 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.497 ' N ' ' O ' ' A' ' 247' ' ' ALA . . . -54.57 -7.16 0.14 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.625 -0.672 . . . . 4.43 110.482 -179.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 250' ' ' LYS . 56.0 tt0 63.04 3.06 1.15 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.319 -0.863 . . . . 5.42 109.857 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 93.3 mt -80.11 -69.6 0.58 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.722 -1.236 . . . . 6.1 107.768 178.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -138.79 -76.67 0.36 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.298 -1.001 . . . . 7.37 108.298 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -172.91 -2.81 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.398 -0.814 . . . . 8.01 110.963 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 13.2 tp 58.36 104.2 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.936 -1.103 . . . . 9.05 109.231 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.403 ' HG2' ' H ' ' A' ' 259' ' ' ARG . 32.0 ttmt -159.38 160.0 34.45 Favored 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.661 -0.65 . . . . 10.56 109.285 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 259' ' ' ARG . 35.4 p-10 -70.5 -37.61 74.22 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.979 -1.119 . . . . 11.32 107.979 178.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.527 ' N ' ' OD1' ' A' ' 258' ' ' ASP . 19.7 mmt180 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.07 -0.966 . . . . 12.42 109.196 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 44.4 ttp . . . . . 0 N--CA 1.489 1.481 0 CA-C-O 121.407 0.622 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -154.6 151.8 29.26 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -146.8 158.52 43.93 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.042 -1.036 . . . . 0.0 110.354 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . 0.495 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 7.4 tm0? -149.53 145.22 26.73 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.461 -0.774 . . . . 0.0 108.977 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . 0.495 ' N ' ' CD ' ' B' ' 304' ' ' GLN . 93.4 mt-10 -111.69 131.13 55.5 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.16 -0.963 . . . . 0.0 110.09 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 1.2 p -130.17 120.84 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.799 0.809 . . . . 0.0 111.31 -178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . 0.438 ' O ' HG23 ' B' ' 309' ' ' THR . 86.3 m -73.88 113.88 11.55 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.217 1.008 . . . . 0.0 110.563 -178.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 60.9 mt -57.95 115.78 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-O 122.623 1.201 . . . . 0.0 111.317 -177.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . 0.438 HG23 ' O ' ' B' ' 307' ' ' THR . 67.5 p -111.72 19.95 17.54 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-N 114.789 -1.096 . . . . 0.0 110.643 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.95 124.4 90.67 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.888 -1.132 . . . . 0.0 109.206 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -55.27 -18.38 18.27 Favored 'Trans proline' 0 N--CA 1.496 1.675 0 CA-C-N 120.154 1.091 . . . . 0.0 112.921 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -121.32 10.1 10.51 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.293 -0.879 . . . . 0.0 110.027 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.85 -178.21 40.31 Favored Glycine 0 N--CA 1.487 2.1 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.459 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -87.11 93.65 9.43 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.151 -1.205 . . . . 0.0 110.301 -178.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -96.37 -160.63 0.81 Allowed 'General case' 0 N--CA 1.509 2.496 0 O-C-N 120.662 -1.274 . . . . 0.0 110.134 178.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 13.6 m -58.73 -45.05 90.48 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.93 -1.106 . . . . 0.0 112.064 -176.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.492 HH11 ' HG2' ' B' ' 317' ' ' ARG . 1.4 tpt180 -53.13 -62.43 3.49 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 120.564 -1.335 . . . . 0.0 111.127 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -57.25 -32.7 94.38 Favored 'Trans proline' 0 N--CA 1.491 1.331 0 CA-C-N 120.135 1.084 . . . . 0.0 112.184 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.85 76.07 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.488 -0.885 . . . . 0.0 108.901 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.46 -45.49 76.91 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.459 -0.775 . . . . 0.0 110.474 -178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . 0.674 HE22 ' NZ ' ' B' ' 324' ' ' LYS . 94.0 mm-40 -70.13 -40.04 75.08 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.879 -1.138 . . . . 0.0 108.641 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -61.07 -51.81 67.57 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.596 -0.69 . . . . 0.0 110.643 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . 0.577 ' CG1' ' HZ2' ' B' ' 327' ' ' LYS . 75.4 t -70.21 -33.1 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.775 -1.203 . . . . 0.0 110.017 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.674 ' NZ ' HE22 ' B' ' 321' ' ' GLN . 32.3 ttpt -60.04 -46.36 89.78 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.3 -0.875 . . . . 0.0 108.878 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -62.32 -45.33 93.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.169 -0.957 . . . . 0.0 109.819 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.91 -50.93 71.84 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.207 -0.933 . . . . 0.0 110.742 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.577 ' HZ2' ' CG1' ' B' ' 323' ' ' VAL . 42.4 mttp -55.96 -14.37 2.47 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.981 -1.074 . . . . 0.0 109.456 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -68.99 -30.04 72.31 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -104.67 145.06 30.87 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.333 -1.098 . . . . 0.0 109.096 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 37.9 p -90.63 -11.8 38.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.017 -1.052 . . . . 0.0 109.547 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.48 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 81.1 p -60.01 153.4 21.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -0.844 . . . . 0.0 109.568 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 13.7 tm-20 -71.12 132.94 45.8 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.178 -0.951 . . . . 0.0 108.701 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.6 mt -129.78 129.95 66.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.669 -0.644 . . . . 0.0 109.458 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 30.6 m -126.61 150.05 49.13 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 92.1 t -115.15 137.47 48.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 56.7 m -130.07 122.57 28.58 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.281 -0.887 . . . . 0.0 109.157 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 83.1 p -136.1 119.5 16.86 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.805 0.812 . . . . 0.0 110.215 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 36.27 61.08 0.82 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 178.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.76 -15.34 20.69 Favored Glycine 0 N--CA 1.499 2.834 0 O-C-N 120.608 -1.307 . . . . 0.0 113.129 176.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -108.28 119.57 39.86 Favored 'General case' 0 N--CA 1.505 2.277 0 CA-C-N 119.463 1.631 . . . . 0.0 109.642 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 66.1 m -118.74 142.24 47.88 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.812 0.815 . . . . 0.0 110.168 -179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . 0.464 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -141.19 163.21 33.57 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.572 0.701 . . . . 0.0 109.779 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 4.7 t -87.97 140.01 29.93 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.475 -0.766 . . . . 0.0 109.318 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.42 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -82.35 -10.0 59.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.937 -1.102 . . . . 0.0 110.157 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -90.26 22.18 3.45 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 48.1 t -149.72 99.51 2.87 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.611 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.704 HD23 HD22 ' A' ' 79' ' ' LEU . 60.9 tp -59.83 -31.89 70.15 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.86 ' CE2' HD11 ' A' ' 79' ' ' LEU . 53.4 m-85 -59.87 -54.54 44.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.009 -1.057 . . . . 0.0 110.031 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -68.98 -24.1 64.19 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.079 -1.013 . . . . 0.0 111.717 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.43 ' O ' ' N ' ' B' ' 352' ' ' THR . 82.6 mt -68.01 -51.76 43.45 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.386 -1.446 . . . . 0.0 108.191 177.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.612 HE22 ' CD ' ' A' ' 126' ' ' ARG . 61.8 mm-40 -39.06 -26.67 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.65 -178.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.43 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.9 p -79.88 -7.07 58.52 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.69 -1.256 . . . . 0.0 110.717 -177.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' B' ' 342' ' ' ALA . 60.5 mt -92.52 109.33 20.73 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.956 -1.09 . . . . 0.0 109.308 178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.53 88.82 0.62 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.7 mt -97.24 90.13 5.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.219 -1.166 . . . . 0.0 109.165 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 28.9 p -96.4 142.81 28.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.096 -1.002 . . . . 0.0 110.076 -179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -44.99 119.98 2.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.695 -0.628 . . . . 0.0 110.187 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 114.44 -3.95 23.39 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 52.4 m -99.17 129.75 45.44 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.424 -1.044 . . . . 0.0 109.084 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 13.8 t -92.44 134.79 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 119.773 -1.829 . . . . 0.0 109.109 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 29.8 m -112.07 174.98 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 30.3 m -131.13 127.88 38.98 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 84.2 mt -100.91 114.26 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 88.3 p -119.89 132.81 55.66 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.521 -0.737 . . . . 0.0 109.035 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.28 154.45 41.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.352 -0.842 . . . . 0.0 109.494 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -146.64 124.49 11.95 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 159.52 -158.58 29.74 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 118.798 -1.668 . . . . 0.0 111.59 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -60.04 -53.67 55.05 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.48 ' H ' ' HB3' ' B' ' 331' ' ' SER . 95.8 m-20 -110.51 9.98 23.17 Favored 'General case' 0 N--CA 1.505 2.31 0 O-C-N 120.98 -1.075 . . . . 0.0 110.897 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -42.08 -32.29 0.45 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.234 -0.916 . . . . 0.0 111.634 -178.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -69.98 -39.77 75.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.737 -1.227 . . . . 0.0 109.849 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -68.75 -52.26 32.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.166 -0.959 . . . . 0.0 109.326 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.8 -32.94 6.59 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.394 -0.816 . . . . 0.0 111.248 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.504 ' O ' HG23 ' B' ' 378' ' ' VAL . 84.2 t -75.74 -39.33 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.611 -1.305 . . . . 0.0 109.615 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.59 -49.86 75.83 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.346 -0.846 . . . . 0.0 111.804 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -77.46 -41.37 39.9 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.888 -1.132 . . . . 0.0 111.514 -178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.09 -41.43 92.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.724 -1.235 . . . . 0.0 108.543 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.504 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.6 t -61.46 -46.12 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.285 -0.884 . . . . 0.0 109.22 179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' B' ' 383' ' ' GLU . 65.6 mttm -69.99 -55.81 8.61 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 58.7 tp -57.64 -35.85 71.05 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.527 -0.733 . . . . 0.0 109.645 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 34.7 ttm -71.25 -40.04 71.25 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.387 -1.446 . . . . 0.0 108.016 177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -79.07 -7.66 58.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.705 -0.622 . . . . 0.0 110.613 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' B' ' 379' ' ' LYS . 76.8 mm-40 -111.88 2.96 17.27 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.063 -1.023 . . . . 0.0 111.269 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 22.5 mt -96.19 126.6 41.53 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.667 -1.27 . . . . 0.0 109.508 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.896 -1.05 . . . . 0.0 109.246 179.471 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.179 0.514 . . . . 2.91 109.805 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 225' ' ' ASN . 88.1 mt -110.05 130.01 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.429 -0.794 . . . . 1.2 109.26 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.1 m -127.47 129.34 47.28 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.584 -0.697 . . . . 1.4 109.629 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.645 ' N ' HD21 ' A' ' 225' ' ' ASN . . . -113.93 -160.48 13.66 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 108.814 -1.714 . . . . 1.05 108.814 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.5 mt -88.85 -17.26 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.985 -1.303 . . . . 1.15 109.943 -179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.3 tp 55.4 105.46 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.291 -0.881 . . . . 0.98 108.828 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.64 -24.82 16.39 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.141 -0.974 . . . . 0.88 109.672 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.8 t -142.52 127.46 10.14 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.283 -0.886 . . . . 1.69 109.853 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.92 143.13 17.99 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.908 1.739 . . . . 0.85 111.624 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.853 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 167.64 -168.89 40.9 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.312 -1.515 . . . . 0.92 109.312 -179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 79.6 mt -149.14 126.77 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 O-C-N 121.352 -1.087 . . . . 0.81 108.222 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -139.99 149.76 43.63 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.958 -1.089 . . . . 0.51 111.025 -179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 3.0 m-85 -124.66 129.94 51.49 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 107.733 -1.21 . . . . 0.62 107.733 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.81 177.32 47.88 Favored Glycine 0 N--CA 1.495 2.576 0 C-N-CA 118.695 -1.717 . . . . 0.55 111.02 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -78.48 157.94 28.76 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.707 -0.878 . . . . 2.1 109.289 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.626 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -106.34 126.09 51.8 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.336 -0.852 . . . . 0.77 110.873 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.4 tp -97.27 138.02 35.4 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.378 -1.341 . . . . 0.91 107.378 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 39.5 tp -116.6 123.31 47.02 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.247 -0.908 . . . . 0.93 109.448 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.411 HD12 ' HB2' ' A' ' 160' ' ' ALA . 27.2 mt -88.06 106.66 18.3 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.556 0.693 . . . . 0.93 110.55 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -98.77 133.66 42.77 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.485 -0.759 . . . . 2.75 109.281 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -128.86 128.24 43.46 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.275 -0.891 . . . . 3.0 108.853 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -79.01 153.68 30.09 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.149 -0.969 . . . . 2.77 110.067 -179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -73.78 140.91 46.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.282 -0.886 . . . . 2.94 108.769 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 66.7 mt -80.02 132.48 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.958 . . . . 0.95 108.83 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.9 t -95.65 122.35 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.321 -0.862 . . . . 1.28 108.995 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.9 mt -105.3 138.68 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.538 -0.726 . . . . 1.21 109.09 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -87.82 123.4 32.56 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.163 -0.961 . . . . 1.81 109.712 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.9 mmt180 -93.04 2.79 56.6 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.886 . . . . 2.8 109.833 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -69.98 149.77 47.39 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.059 -1.026 . . . . 2.87 110.077 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -87.93 144.03 26.78 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.384 -0.969 . . . . 2.35 108.384 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.406 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.1 pt -90.36 164.33 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.845 -1.159 . . . . 0.97 109.947 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.0 p -93.64 170.83 9.29 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.993 -1.114 . . . . 1.17 107.993 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.94 -48.27 82.4 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.764 -1.21 . . . . 1.18 109.222 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 62.8 t0 -54.13 -30.16 47.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.997 -1.064 . . . . 2.56 109.68 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -81.26 -9.09 59.83 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.358 -0.838 . . . . 1.79 110.362 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 45.1 t -65.6 -55.18 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 120.543 -1.348 . . . . 1.0 109.042 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -60.04 -39.93 87.64 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.352 -0.843 . . . . 1.77 109.81 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -69.38 -41.78 76.04 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 2.7 111.033 -178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.406 ' HG3' HG21 ' A' ' 31' ' ' ILE . 69.7 mm-40 -64.25 -40.14 95.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.693 -1.255 . . . . 1.51 110.179 -179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.09 -44.66 95.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 120.79 -1.194 . . . . 0.93 107.993 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -59.97 -40.1 87.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.077 -1.014 . . . . 1.81 108.321 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.48 HH11 ' HG2' ' A' ' 42' ' ' ARG . 20.6 mtt-85 -59.96 -44.33 94.49 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.489 -1.3 . . . . 2.78 107.489 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -60.88 -47.62 85.53 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.601 -0.889 . . . . 0.78 108.601 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.01 -47.15 87.01 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.247 -1.02 . . . . 1.07 108.247 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.7 t -59.95 -41.44 91.88 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.322 -0.992 . . . . 1.12 108.322 179.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.61 -42.9 99.84 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.363 -1.895 . . . . 0.84 108.363 178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -65.54 -38.81 90.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.121 -1.066 . . . . 3.09 108.121 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.02 -42.8 77.05 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.885 -0.51 . . . . 0.88 109.734 -179.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.3 ttpt -71.19 -74.4 0.15 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.999 -1.111 . . . . 2.59 107.999 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.27 -38.78 0.37 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.267 -0.896 . . . . 0.7 111.443 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.0 t -55.71 -54.92 38.42 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.393 -1.442 . . . . 1.4 108.494 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.99 -41.75 73.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.377 -0.827 . . . . 0.67 111.356 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -66.87 -40.26 87.78 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.758 -1.213 . . . . 1.66 110.521 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 80.3 mt -60.37 -39.96 89.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.812 -1.18 . . . . 1.58 109.067 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -61.84 -32.05 72.35 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.348 -0.845 . . . . 1.35 109.724 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.4 m -67.87 -44.75 76.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.795 -1.191 . . . . 0.77 110.124 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 88.5 mt -59.98 -37.98 74.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.127 -0.983 . . . . 0.63 108.573 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -56.6 -50.03 73.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.708 -0.62 . . . . 1.14 109.376 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.4 m -56.62 -31.95 64.82 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.23 -0.919 . . . . 0.79 110.332 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -69.86 -39.8 76.15 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.039 -1.038 . . . . 1.53 110.192 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.503 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -68.09 -48.33 65.81 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.526 -0.734 . . . . 0.57 109.662 -179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -51.51 -56.57 14.83 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 110.209 -1.157 . . . . 0.75 110.209 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.06 -42.0 73.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.127 -1.219 . . . . 1.59 111.061 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.6 m -66.09 -62.39 1.51 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.844 -1.16 . . . . 0.73 111.996 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -94.56 -45.88 7.21 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.864 -1.148 . . . . 0.75 111.239 -178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.73 -167.93 25.43 Favored Glycine 0 N--CA 1.5 2.963 0 C-N-CA 119.908 -1.139 . . . . 1.22 110.819 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -70.16 -23.93 63.07 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.863 -0.786 . . . . 5.81 110.261 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.494 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.8 tp10 -59.93 -33.39 71.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.465 -0.772 . . . . 3.37 110.086 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -98.76 -18.91 17.74 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.252 -0.905 . . . . 1.77 110.469 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -67.71 -40.06 84.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.893 -1.129 . . . . 1.65 109.83 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.591 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -63.49 -32.82 74.38 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.414 -0.804 . . . . 0.77 110.218 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.7 mt -59.94 -41.83 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 120.902 -1.124 . . . . 0.8 109.594 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -64.57 -39.84 94.47 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.129 -0.982 . . . . 0.88 110.881 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.2 tt0 -60.07 -40.0 88.0 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.916 -1.115 . . . . 1.37 109.458 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.81 -47.07 92.55 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.07 -1.612 . . . . 0.62 109.07 179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.5 m170 -61.17 -47.88 84.15 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.408 -1.054 . . . . 1.5 109.326 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.15 -48.79 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.303 -0.873 . . . . 0.63 109.788 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.4 ttp -59.97 -41.52 92.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.964 -1.085 . . . . 1.51 110.588 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.948 HD22 HD23 ' B' ' 347' ' ' LEU . 57.9 tp -65.89 -39.94 91.11 Favored 'General case' 0 C--N 1.295 -1.771 0 O-C-N 121.358 -0.839 . . . . 0.77 109.928 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.6 tp -64.46 -40.07 95.03 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.562 -0.711 . . . . 0.62 109.663 -178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -82.14 5.84 18.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.057 -1.027 . . . . 1.47 110.228 -179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -50.03 133.21 23.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.1 -1.0 . . . . 1.47 110.423 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -60.49 -22.58 63.69 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.606 -0.684 . . . . 1.78 110.919 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -70.58 -34.12 71.84 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.928 -1.108 . . . . 2.53 109.1 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.0 -42.11 73.49 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.388 0.613 . . . . 0.8 110.257 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.03 -50.03 75.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.449 -0.782 . . . . 1.42 110.191 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -70.28 -42.53 71.95 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.352 -0.843 . . . . 1.71 110.983 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -70.07 -40.11 75.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.043 -1.035 . . . . 1.57 111.068 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 84.5 mt -67.47 -49.07 74.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.043 -1.036 . . . . 0.65 109.451 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 88.1 mt -66.25 -36.76 78.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.608 -0.683 . . . . 0.82 110.248 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.95 -48.27 82.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.174 -0.954 . . . . 0.79 110.988 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.425 ' O ' ' N ' ' A' ' 96' ' ' LYS . 93.5 mt -59.95 -45.81 91.44 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.051 -1.031 . . . . 0.95 110.3 -178.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.0 mt -60.39 -49.91 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.029 -1.044 . . . . 0.66 108.833 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 31.9 mttp -65.79 -45.83 80.98 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.992 -0.683 . . . . 2.2 110.525 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -79.01 -48.83 13.71 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.044 -1.035 . . . . 1.65 112.103 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 92' ' ' LEU . 96.5 mttt -92.79 -3.03 55.43 Favored 'General case' 0 N--CA 1.507 2.378 0 O-C-N 120.719 -1.238 . . . . 2.03 112.48 -177.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 57.32 39.73 28.22 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.788 -1.195 . . . . 1.42 109.945 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 95.2 mtp -93.5 168.1 11.26 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.61 -0.681 . . . . 1.18 110.291 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 27.1 p -82.67 161.12 22.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.433 -0.792 . . . . 0.98 109.663 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.72 -40.04 88.24 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.344 -0.848 . . . . 0.64 109.491 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.573 ' OD1' HD22 ' A' ' 138' ' ' LEU . 39.5 t0 -63.24 -40.07 96.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.149 -0.97 . . . . 2.07 109.541 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.48 -51.21 9.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.431 -0.793 . . . . 0.73 110.35 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.02 75.41 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.362 -0.836 . . . . 0.54 110.444 -178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.03 -41.83 93.08 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.023 -1.048 . . . . 0.56 109.81 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -59.8 -40.19 87.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.352 -0.843 . . . . 1.54 110.141 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -64.93 -40.11 94.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 1.33 111.077 -178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 86.1 t -64.79 -50.46 75.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.001 -1.062 . . . . 0.72 110.689 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.3 mm -70.05 -40.03 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 120.879 -1.138 . . . . 0.85 108.387 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -65.34 -38.54 90.44 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.257 -1.016 . . . . 2.44 108.257 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.69 -52.91 49.53 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.106 -1.198 . . . . 0.98 110.106 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 92.6 mm-40 -60.73 -49.93 75.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.902 -1.352 . . . . 1.41 108.987 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.13 -39.95 88.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.372 -0.83 . . . . 1.2 109.498 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 59.1 m -59.94 -40.09 87.76 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.11 -0.994 . . . . 1.7 109.119 -179.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.4 -39.62 87.99 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.237 -0.914 . . . . 1.47 108.876 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 68.0 mt -62.47 -42.8 99.74 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.273 -0.892 . . . . 1.56 109.514 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -53.99 -31.34 50.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.99 -1.069 . . . . 2.2 109.676 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -59.97 -24.52 64.48 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.169 -0.957 . . . . 2.12 108.526 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 54.1 mt -62.74 139.98 58.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.211 -0.931 . . . . 2.0 109.235 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -96.39 45.66 1.06 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.139 -0.975 . . . . 3.23 109.737 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 41.1 t0 -133.33 143.59 49.1 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.333 -0.855 . . . . 2.49 109.182 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.495 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 77.8 mm-40 -71.56 -64.86 0.84 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.195 -1.039 . . . . 3.95 108.195 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.457 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.7 t80 -39.11 -39.97 0.64 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 122.023 -0.423 . . . . 2.0 110.904 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 75.2 mt -79.98 -40.04 28.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.61 -1.306 . . . . 1.86 108.884 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.99 -40.57 96.09 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.502 -0.925 . . . . 2.84 108.502 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -69.89 -34.05 73.04 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.2 -1.037 . . . . 2.73 108.2 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.424 ' NH1' ' OH ' ' A' ' 122' ' ' TYR . 1.9 tpt180 -59.92 -39.42 85.37 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.389 -1.337 . . . . 2.77 107.389 178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.55 -25.49 66.68 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.456 0.646 . . . . 1.19 109.285 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.89 -40.11 94.3 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.037 -1.098 . . . . 1.2 108.037 179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -67.5 -40.07 85.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.486 -0.759 . . . . 1.55 109.613 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.2 t -66.88 -40.07 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.047 -1.033 . . . . 0.8 108.904 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -60.09 -40.6 90.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.149 -0.969 . . . . 3.09 108.985 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -60.09 -39.05 84.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.65 -0.656 . . . . 1.46 110.832 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.9 mt -59.96 -42.87 90.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.919 -1.113 . . . . 0.71 110.248 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.19 -27.47 71.78 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.407 -1.477 . . . . 0.57 109.407 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 49.3 tttp -59.91 -50.0 75.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.389 -1.065 . . . . 2.59 110.301 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.475 HH11 ' HG2' ' A' ' 136' ' ' ARG . 22.2 mtt-85 -65.71 -37.89 87.68 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.855 -1.153 . . . . 2.83 109.98 -179.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.5 tp -55.22 -44.25 75.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -0.915 . . . . 1.25 109.323 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.573 HD22 ' OD1' ' A' ' 101' ' ' ASP . 89.3 mt -60.38 -39.98 89.22 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.24 -0.912 . . . . 0.7 109.511 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' A' ' 139' ' ' ARG . 51.9 mtt-85 -69.43 -39.83 77.6 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.28 -0.887 . . . . 2.57 108.831 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 -64.5 -34.16 77.58 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.704 -0.623 . . . . 1.23 111.104 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.92 -45.74 80.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.18 -1.575 . . . . 0.81 107.788 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 99.4 mt -70.06 -37.42 75.5 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.392 0.615 . . . . 1.0 109.488 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.89 45.73 7.05 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.116 -1.993 . . . . 0.89 108.116 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.8 tp -76.51 160.05 29.82 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.532 -0.981 . . . . 1.14 109.498 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -68.54 143.83 54.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.447 -0.783 . . . . 4.6 109.823 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.6 mt -120.0 125.1 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 CA-C-O 122.004 0.907 . . . . 1.24 109.188 179.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.415 ' O ' ' O ' ' A' ' 148' ' ' ASP . 5.3 mt -64.86 -41.98 93.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 115.962 -0.563 . . . . 1.54 110.225 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.415 ' O ' ' O ' ' A' ' 147' ' ' ILE . 23.4 t0 63.73 125.47 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.213 -1.032 . . . . 1.5 108.213 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.462 ' O ' ' ND2' ' A' ' 172' ' ' ASN . 40.7 mt -86.17 0.47 53.55 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.105 -0.997 . . . . 0.79 110.019 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.7 p -87.29 -8.55 56.6 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.178 -0.951 . . . . 1.4 109.397 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.96 21.82 1.26 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.353 -0.842 . . . . 0.92 111.255 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 32.2 mm -88.4 119.97 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.614 -1.304 . . . . 0.88 108.796 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -100.33 -9.36 22.37 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.453 -0.779 . . . . 2.45 110.687 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -130.14 152.86 49.11 Favored 'General case' 0 N--CA 1.505 2.287 0 O-C-N 121.232 -0.918 . . . . 1.52 110.499 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -63.52 133.87 54.6 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.369 -0.832 . . . . 1.58 109.218 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 32.1 m -152.49 164.23 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 108.911 -0.774 . . . . 0.69 108.911 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.1 mt -92.59 151.53 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 106.029 -1.841 . . . . 0.61 106.029 177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 33.7 tp -102.56 118.89 37.83 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.992 -1.068 . . . . 0.87 110.231 -177.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 12.3 t -125.72 134.34 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 108.805 -0.813 . . . . 0.71 108.805 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.411 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.31 166.13 28.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.931 . . . . 0.81 108.981 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.401 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -70.08 -38.74 75.81 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 120.34 -1.475 . . . . 0.98 107.306 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -171.17 144.15 2.02 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.961 -0.755 . . . . 2.25 108.961 179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 40.9 mt -109.79 137.08 48.1 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.267 -0.896 . . . . 0.78 109.268 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 58.7 p -87.54 149.1 45.74 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 120.993 -1.067 . . . . 0.98 108.979 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -41.71 -36.97 3.59 Favored 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.128 1.885 . . . . 0.81 112.827 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.9 m -59.94 -47.18 86.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 0.9 109.661 -178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.66 -43.81 97.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.235 -0.915 . . . . 1.61 110.024 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 30.6 p -55.22 -26.67 41.0 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.266 -0.896 . . . . 0.61 111.702 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.503 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -83.19 -43.9 15.62 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.555 -1.34 . . . . 0.6 110.099 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -89.28 36.93 0.84 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.028 -1.101 . . . . 1.4 108.028 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.1 tp -103.24 133.55 48.14 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.454 0.645 . . . . 0.7 109.697 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.645 ' ND2' ' NZ ' ' A' ' 175' ' ' LYS . 2.9 p30 -82.9 99.26 9.65 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.332 -0.988 . . . . 2.35 108.332 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 90.9 mt -65.07 -42.28 94.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.442 -0.786 . . . . 1.51 110.975 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -62.68 -32.36 73.43 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.988 -1.07 . . . . 2.33 112.678 -177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.645 ' NZ ' ' ND2' ' A' ' 172' ' ' ASN . 9.4 mtmp? -92.04 -5.09 53.56 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.64 -1.287 . . . . 1.92 110.341 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.522 HG12 ' H ' ' A' ' 178' ' ' GLY . 72.3 t -104.68 116.46 48.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.067 -1.086 . . . . 0.67 108.067 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.6 mt -85.93 7.23 25.03 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.17 -0.957 . . . . 1.53 111.326 -177.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.522 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.45 172.86 37.24 Favored Glycine 0 N--CA 1.491 2.34 0 C-N-CA 119.128 -1.511 . . . . 0.48 109.82 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.482 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 11.4 m-85 -134.3 129.34 35.42 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.501 -0.999 . . . . 0.55 108.87 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 93.9 mt -134.72 130.33 52.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.329 -0.857 . . . . 0.65 108.973 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.7 p -151.6 162.17 41.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.956 -1.09 . . . . 0.82 110.531 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 183' ' ' ALA . 38.3 p-10 -109.63 26.73 10.31 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.905 -0.776 . . . . 2.46 108.905 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -54.31 -164.67 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.987 -1.071 . . . . 1.28 111.64 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.07 -59.33 5.11 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.562 -1.015 . . . . 2.19 110.562 -178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -174.07 -156.8 14.2 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 118.748 -1.691 . . . . 2.13 111.22 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.469 ' C ' ' H ' ' A' ' 188' ' ' SER . 46.8 ttp180 -62.33 -30.05 70.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.923 -0.751 . . . . 5.86 110.614 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 30.6 p -61.85 5.17 0.09 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.819 -1.176 . . . . 3.72 110.692 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.469 ' H ' ' C ' ' A' ' 186' ' ' ARG . 50.2 p -90.87 140.18 30.05 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.871 -1.143 . . . . 1.74 110.419 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 60.3 t60 -50.0 -43.47 50.52 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.423 -0.798 . . . . 0.95 109.672 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.8 m -56.97 -40.49 76.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.625 -0.672 . . . . 1.55 109.633 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.9 m -60.14 -39.9 87.96 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.208 -0.933 . . . . 1.51 110.116 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.8 mt -60.04 -45.12 95.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.463 -0.773 . . . . 1.67 110.504 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 30.1 mtm -59.94 -47.61 85.08 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.88 -1.137 . . . . 1.02 110.496 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.71 -45.74 63.67 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.681 -1.262 . . . . 0.68 109.897 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -59.93 -50.33 74.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.926 -1.109 . . . . 2.93 110.994 -178.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.1 m -77.02 -30.19 55.68 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.612 -1.305 . . . . 0.86 111.104 -178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.0 -29.41 66.47 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.741 -1.224 . . . . 0.67 108.449 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 68.49 47.98 0.87 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.277 0.561 . . . . 1.5 110.317 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 89.4 mt -128.7 149.93 73.43 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 107.865 -1.161 . . . . 0.72 107.865 178.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -59.73 138.76 85.05 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 121.925 1.75 . . . . 0.61 111.69 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.482 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -172.7 149.17 2.0 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.147 -1.021 . . . . 0.66 110.891 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.5 mt -124.99 150.41 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 107.173 -1.417 . . . . 0.79 107.173 178.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.8 m -130.0 -12.11 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.464 0 O-C-N 120.931 -1.106 . . . . 0.91 111.869 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -114.68 25.98 9.84 Favored Glycine 0 N--CA 1.502 3.063 0 N-CA-C 110.076 -1.21 . . . . 1.01 110.076 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.457 ' HB ' HG23 ' A' ' 208' ' ' VAL . 58.3 p -44.26 -47.29 9.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -1.165 . . . . 0.99 110.469 -179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 106.73 -51.39 0.74 Allowed Glycine 0 N--CA 1.5 2.941 0 N-CA-C 111.018 -0.833 . . . . 1.12 111.018 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 81.1 p -162.82 44.66 0.13 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.473 -1.604 . . . . 1.72 111.962 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . 0.457 HG23 ' HB ' ' A' ' 205' ' ' THR . 14.8 t -71.38 -41.02 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.685 -1.26 . . . . 0.89 108.513 178.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.423 ' H ' HG23 ' A' ' 209' ' ' THR . 8.3 p -50.66 -29.94 12.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.354 -0.841 . . . . 1.03 109.512 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.1 m -81.92 -12.4 58.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 1.83 109.346 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -115.53 15.16 16.68 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.63 -0.669 . . . . 2.27 109.798 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 42.7 t -138.05 134.55 44.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.407 -0.808 . . . . 0.92 110.394 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.453 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 10.8 mptt -117.42 153.0 33.82 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.368 -1.345 . . . . 2.2 107.368 178.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.462 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 11.2 p30 -55.51 140.84 39.16 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 120.995 -1.066 . . . . 2.36 110.367 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.462 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.0 m-20 83.06 2.43 1.05 Allowed 'General case' 0 N--CA 1.502 2.147 0 CA-C-N 116.27 -0.423 . . . . 2.38 110.747 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.453 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 94.1 m-20 -74.82 141.58 44.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.743 -1.223 . . . . 2.09 109.153 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -90.69 116.42 28.55 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.933 -1.136 . . . . 1.27 107.933 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 16' ' ' ALA . 79.9 mt -125.56 147.55 49.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.441 -0.787 . . . . 0.75 110.365 -178.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.495 HG23 ' CD2' ' A' ' 13' ' ' PHE . 71.5 mt -115.86 129.83 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 106.627 -1.62 . . . . 0.63 106.627 177.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 61.0 tp -102.59 119.84 39.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.875 -1.141 . . . . 0.7 109.528 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.645 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 23.2 p-10 -76.22 -40.03 53.14 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.148 -1.056 . . . . 2.31 108.148 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.853 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 48.46 18.42 0.17 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.769 -0.826 . . . . 0.78 108.769 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.45 ' N ' ' C ' ' A' ' 221' ' ' ASP . 53.9 t -129.18 -36.66 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.953 -1.129 . . . . 1.04 107.953 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -110.07 -2.81 16.79 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.135 -1.431 . . . . 2.44 107.135 177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.645 HD21 ' N ' ' A' ' 4' ' ' GLY . 27.8 t-20 63.66 51.4 2.48 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.498 0.666 . . . . 1.55 109.689 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.645 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 42.4 mt-30 -137.31 152.72 50.05 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.499 -0.751 . . . . 1.99 109.213 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.1 t -118.86 130.01 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.426 -0.953 . . . . 0.77 108.426 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -102.52 120.82 41.19 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.776 -0.824 . . . . 0.98 108.776 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.6 t -100.95 113.23 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.506 -0.746 . . . . 0.85 110.149 -179.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 50.02 66.75 5.16 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 121.187 -0.946 . . . . 1.66 111.127 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -89.17 148.07 5.48 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 123.186 2.591 . . . . 0.95 112.339 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 24.8 p -70.72 166.17 21.44 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.18 -0.95 . . . . 1.84 110.744 -179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.666 -0.646 . . . . 2.74 109.773 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -60.02 -37.73 80.62 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.249 -0.907 . . . . 2.89 109.611 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.02 -41.84 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.169 -0.957 . . . . 1.3 109.056 179.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.4 mt -64.99 -40.69 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 1.09 109.932 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -60.04 -42.35 94.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.856 -1.152 . . . . 2.43 108.586 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -60.93 -43.13 99.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.43 -0.794 . . . . 2.78 109.104 179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 95.2 mtp -70.02 -33.52 72.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.515 -0.741 . . . . 1.25 109.983 179.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 13.8 mmm180 -65.35 -39.79 92.78 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.136 -0.977 . . . . 2.63 109.15 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.02 87.77 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.332 -0.855 . . . . 1.8 108.93 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 74.6 t -62.52 -39.58 85.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.37 -0.832 . . . . 2.13 109.174 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -59.52 -39.82 85.12 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.421 -0.8 . . . . 3.17 109.609 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.89 -40.03 87.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.977 -1.077 . . . . 1.78 108.65 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -63.65 -39.54 94.6 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.244 -0.91 . . . . 2.47 108.682 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 66.1 t -60.04 -40.01 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 109.083 -0.71 . . . . 2.09 109.083 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -54.6 -41.79 70.36 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.074 -1.016 . . . . 2.54 108.307 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 48.1 t -65.41 -38.81 91.06 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.526 -0.734 . . . . 2.99 109.154 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -60.05 -45.09 93.99 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.228 -0.92 . . . . 3.34 109.422 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -61.53 -40.32 94.22 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.946 -1.096 . . . . 3.88 108.47 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 52.76 56.95 6.9 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.568 -0.707 . . . . 4.43 109.622 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 53.3 tp10 -52.28 -29.52 23.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 5.42 108.563 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.477 ' O ' ' HB3' ' A' ' 254' ' ' ALA . 81.2 mt -79.25 -64.59 1.15 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.192 -1.04 . . . . 6.1 108.192 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 253' ' ' LEU . . . 66.49 16.23 10.35 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.542 -0.724 . . . . 7.37 110.159 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.573 ' O ' ' N ' ' A' ' 257' ' ' LYS . 62.7 tttm -85.83 -96.18 0.07 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.983 -1.073 . . . . 8.01 109.024 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 49.5 mt 42.72 15.75 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.142 -0.974 . . . . 9.05 110.796 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 255' ' ' LYS . 61.3 mttp 55.31 51.08 13.63 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.351 -0.843 . . . . 10.56 109.398 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 255' ' ' LYS . 38.0 p-10 -142.47 93.39 2.52 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.355 -0.98 . . . . 11.32 108.355 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 118.001 -0.999 . . . . 12.42 109.446 -179.131 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 56.9 ttm . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -149.55 146.89 27.6 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.41 162.32 41.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.004 -1.06 . . . . 0.0 110.375 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . 0.46 ' NE2' HG21 ' B' ' 378' ' ' VAL . 6.4 tt0 -156.03 153.9 30.18 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -114.93 134.57 55.05 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.077 -1.014 . . . . 0.0 110.056 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 p -131.82 124.0 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 CA-C-O 122.173 0.987 . . . . 0.0 112.751 -176.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 89.0 m -77.25 104.29 7.67 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.935 0.874 . . . . 0.0 110.673 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.463 HG22 ' H ' ' B' ' 310' ' ' ALA . 92.7 mt -52.15 124.94 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.368 1.08 . . . . 0.0 110.657 -177.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 71.2 p -110.03 20.05 18.34 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.153 -0.93 . . . . 0.0 110.027 -178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.463 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -74.8 118.5 70.79 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 120.944 -1.098 . . . . 0.0 109.233 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -53.4 -16.05 6.8 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 CA-C-N 120.251 1.125 . . . . 0.0 112.484 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -120.28 10.08 11.2 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.558 -0.714 . . . . 0.0 109.268 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 69.29 -176.75 30.37 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.714 -1.755 . . . . 0.0 108.714 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.457 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.4 tp -85.45 89.59 7.73 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.055 -1.262 . . . . 0.0 110.129 -179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.494 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 4.3 p80 -94.94 -159.97 0.75 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 120.981 -1.074 . . . . 0.0 109.641 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.8 m -59.73 -47.43 85.68 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.859 -1.151 . . . . 0.0 112.916 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.591 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.4 tpt180 -57.98 -55.89 40.43 Favored Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 120.44 -1.412 . . . . 0.0 112.223 -178.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.494 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 18.1 Cg_endo -64.84 -30.21 58.41 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 CA-C-N 120.583 1.244 . . . . 0.0 111.37 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.03 75.35 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.14 -41.83 72.27 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.569 -179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . 0.41 ' NE2' HH21 ' B' ' 317' ' ' ARG . 12.7 tt0 -69.97 -43.13 72.12 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.026 -1.046 . . . . 0.0 108.615 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -60.41 -50.96 71.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.414 -0.804 . . . . 0.0 110.556 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 58.4 t -66.49 -26.52 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.722 -1.236 . . . . 0.0 109.889 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.33 -45.69 93.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.398 -0.814 . . . . 0.0 110.219 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -69.75 -41.6 75.0 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.229 -0.919 . . . . 0.0 112.205 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.24 -51.76 68.2 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.455 -1.403 . . . . 0.0 110.954 -178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -57.71 -11.91 2.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.044 -1.035 . . . . 0.0 109.415 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -70.33 -28.59 71.12 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 178.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -105.68 144.66 32.11 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.661 -0.905 . . . . 0.0 109.325 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 18.2 p -91.03 -11.74 37.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.138 -0.976 . . . . 0.0 110.055 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.492 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 90.6 p -58.03 153.64 14.14 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.164 -0.96 . . . . 0.0 110.135 -179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.11 130.81 42.47 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 79.8 mt -132.45 131.13 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 121.465 -0.772 . . . . 0.0 109.646 -179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 29.3 m -128.12 154.11 46.11 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 76.3 t -118.36 139.56 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 54.6 m -130.5 121.29 25.52 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.387 -0.82 . . . . 0.0 109.213 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . 0.524 ' O ' ' ND2' ' B' ' 338' ' ' ASN . 29.3 t -136.61 117.7 14.39 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.906 0.86 . . . . 0.0 110.921 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' B' ' 337' ' ' SER . 7.3 p30 42.22 52.26 4.51 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 113.194 0.812 . . . . 0.0 113.194 177.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 88.52 -13.39 62.41 Favored Glycine 0 N--CA 1.501 3.015 0 O-C-N 120.31 -1.494 . . . . 0.0 113.507 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -113.84 122.12 46.09 Favored 'General case' 0 N--CA 1.508 2.469 0 CA-C-N 119.602 1.701 . . . . 0.0 110.457 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 77.8 p -103.53 154.97 18.89 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.421 -0.799 . . . . 0.0 110.701 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . 0.424 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -154.18 154.31 33.29 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.765 -0.584 . . . . 0.0 109.916 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . 0.415 ' H ' ' HE2' ' B' ' 349' ' ' LYS . 4.6 t -91.05 138.09 31.87 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.346 -0.846 . . . . 0.0 109.971 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.405 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -78.09 -14.87 59.32 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.987 -1.071 . . . . 0.0 110.624 -178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -87.74 21.12 2.71 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . 0.432 ' CB ' ' HZ3' ' B' ' 349' ' ' LYS . 12.3 t -149.17 97.03 2.62 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.856 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.948 HD23 HD22 ' A' ' 79' ' ' LEU . 19.6 tp -59.55 -32.12 70.04 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.818 ' CE2' HD11 ' A' ' 79' ' ' LEU . 61.0 m-85 -57.63 -51.64 68.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.375 -0.828 . . . . 0.0 110.529 -179.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . 0.432 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 36.2 mtmm -69.59 -40.01 76.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.572 -1.33 . . . . 0.0 110.002 -178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.612 ' O ' ' N ' ' B' ' 352' ' ' THR . 86.3 mt -50.62 -55.81 14.65 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.743 -1.223 . . . . 0.0 108.117 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 17.8 mt-30 -38.51 -16.07 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.039 -0.413 . . . . 0.0 111.294 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.612 ' N ' ' O ' ' B' ' 350' ' ' LEU . 75.4 p -91.68 -12.02 35.28 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.813 -1.18 . . . . 0.0 110.952 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.424 HD11 ' HB3' ' B' ' 342' ' ' ALA . 55.8 mt -92.56 119.41 31.99 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.896 -1.128 . . . . 0.0 109.179 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.8 91.63 0.99 Allowed Glycine 0 N--CA 1.485 1.958 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 66.2 mt -100.85 94.91 6.29 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.412 -1.052 . . . . 0.0 108.521 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 75.2 p -91.68 178.79 5.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.229 -0.919 . . . . 0.0 110.349 -179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . 0.404 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 16.1 tm0? -69.16 113.97 7.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.69 -0.631 . . . . 0.0 110.246 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 102.08 9.49 42.13 Favored Glycine 0 N--CA 1.498 2.808 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 25.5 m -86.45 111.98 21.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.187 -1.184 . . . . 0.0 110.593 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 42.0 t -77.36 116.24 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 CA-C-O 122.018 0.913 . . . . 0.0 110.325 -177.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.7 m -110.74 176.6 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 36.8 m -131.43 130.65 42.78 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 76.3 mt -103.93 115.67 46.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 77.4 p -118.11 131.66 56.41 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.351 -0.843 . . . . 0.0 109.3 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.27 151.55 38.53 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.105 -0.997 . . . . 0.0 110.187 -178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . 0.438 ' OE2' ' OE2' ' B' ' 370' ' ' GLU . 11.7 tp10 -141.98 119.76 11.87 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.467 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 164.19 -163.89 36.28 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 118.323 -1.894 . . . . 0.0 111.963 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 55.1 tp10 -59.85 -50.73 72.66 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 115.022 -0.589 . . . . 0.0 111.379 -177.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.492 ' H ' ' HB3' ' B' ' 331' ' ' SER . 75.3 m-20 -103.97 8.57 36.76 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.854 -1.154 . . . . 0.0 111.456 -177.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.1 pt-20 -42.04 -32.96 0.5 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.117 -0.99 . . . . 0.0 111.355 -178.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -66.15 -46.92 75.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.674 -1.266 . . . . 0.0 109.801 -178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -69.98 -52.07 27.38 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.176 -0.952 . . . . 0.0 109.601 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . 0.407 ' O ' HD12 ' B' ' 377' ' ' LEU . . . -42.16 -38.05 1.61 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.548 -0.72 . . . . 0.0 111.676 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.566 ' O ' HG23 ' B' ' 378' ' ' VAL . 62.9 t -79.06 -34.84 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.502 -1.374 . . . . 0.0 110.012 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -65.66 -49.98 66.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.13 -0.981 . . . . 0.0 112.766 -178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -77.11 -40.37 46.08 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.267 -1.52 . . . . 0.0 110.869 -178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.407 HD12 ' O ' ' B' ' 373' ' ' ALA . 96.9 mt -60.04 -40.46 89.49 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.875 -1.141 . . . . 0.0 108.99 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.566 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.5 t -62.27 -45.17 99.39 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.112 -0.993 . . . . 0.0 109.613 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.434 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.8 mttt -69.76 -55.97 8.44 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 38.7 tp -53.56 -35.71 61.06 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -178.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . 0.42 ' CE ' HD13 ' B' ' 314' ' ' LEU . 11.1 tpt -69.97 -39.73 75.81 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.06 -5.78 56.46 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.665 -0.647 . . . . 0.0 110.594 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' B' ' 379' ' ' LYS . 99.2 mt-10 -114.42 -0.54 13.75 Favored 'General case' 0 N--CA 1.505 2.305 0 O-C-N 120.888 -1.132 . . . . 0.0 111.045 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 10.8 mt -81.14 131.88 35.32 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.406 -1.434 . . . . 0.0 109.746 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 56.4 mp0 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.961 -1.019 . . . . 0.0 108.996 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.349 -0.611 . . . . 2.91 109.349 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.0 mt -110.0 129.92 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.506 -0.746 . . . . 1.2 109.566 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.5 m -130.16 134.95 47.67 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 109.044 -0.725 . . . . 1.4 109.044 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.72 -163.99 23.32 Favored Glycine 0 N--CA 1.497 2.743 0 N-CA-C 108.585 -1.806 . . . . 1.05 108.585 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.9 mt -92.18 -11.08 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.91 -1.347 . . . . 1.15 109.539 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.567 HD11 ' O ' ' A' ' 8' ' ' SER . 52.6 tp 53.55 103.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.293 -0.879 . . . . 0.98 109.533 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.23 -21.15 21.25 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.239 -0.913 . . . . 0.88 109.99 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.567 ' O ' HD11 ' A' ' 6' ' ' LEU . 21.4 m -148.67 135.7 10.57 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 120.895 -1.128 . . . . 1.69 109.596 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.73 142.45 14.24 Favored 'Trans proline' 0 N--CA 1.5 1.885 0 C-N-CA 122.707 2.271 . . . . 0.85 113.489 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.857 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 157.53 -158.44 29.0 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.206 -1.558 . . . . 0.92 109.206 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.7 mt -149.28 150.5 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 N-CA-C 107.851 -1.166 . . . . 0.81 107.851 178.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.67 141.5 21.06 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.808 -1.183 . . . . 0.51 110.712 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.636 ' CE2' ' NH1' ' A' ' 240' ' ' ARG . 17.0 m-85 -125.76 126.44 44.57 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.884 -1.154 . . . . 0.62 107.884 179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.06 178.29 48.16 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 118.482 -1.818 . . . . 0.55 110.879 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -78.32 158.89 28.69 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.853 -0.792 . . . . 2.1 109.227 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -101.42 128.77 47.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.407 -0.808 . . . . 0.77 110.663 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.8 tp -99.11 134.94 41.23 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 106.865 -1.532 . . . . 0.91 106.865 177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.1 tp -117.39 118.27 31.77 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.408 -0.808 . . . . 0.93 110.121 -178.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.4 mt -84.88 103.46 13.97 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.316 -0.624 . . . . 0.93 109.316 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -100.2 135.39 41.7 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.372 -0.83 . . . . 2.75 110.008 -179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -130.61 133.94 46.57 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.522 -0.736 . . . . 3.0 109.118 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -79.14 158.05 27.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.969 -1.082 . . . . 2.77 109.14 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -71.88 149.99 44.64 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.278 -0.889 . . . . 2.94 110.176 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.4 mt -95.48 130.34 44.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.214 -0.929 . . . . 0.95 108.938 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.9 t -96.17 129.71 45.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.121 -0.987 . . . . 1.28 110.115 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.7 mt -107.58 137.1 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 N-CA-C 108.617 -0.882 . . . . 1.21 108.617 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -94.86 119.89 34.17 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.94 -1.1 . . . . 1.81 110.265 -179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.494 HH11 ' HG2' ' A' ' 28' ' ' ARG . 5.0 mmt-85 -88.71 0.05 56.83 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.53 -0.731 . . . . 2.8 109.79 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -70.35 141.43 52.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 2.87 109.921 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -82.41 150.55 27.04 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.204 -0.935 . . . . 2.35 109.301 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.447 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.5 pt -95.1 166.2 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.244 -0.91 . . . . 0.97 109.657 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.4 p -96.41 172.95 7.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.178 -0.951 . . . . 1.17 108.767 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.02 -49.29 78.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.047 -1.033 . . . . 1.18 109.335 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -54.86 -30.05 56.79 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.863 -1.148 . . . . 2.56 109.471 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.4 mt-30 -82.44 -10.75 58.91 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.407 -0.808 . . . . 1.79 110.265 -179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.5 t -63.27 -51.84 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 120.865 -1.147 . . . . 1.0 108.766 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -61.96 -39.98 93.99 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.364 -0.835 . . . . 1.77 110.055 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.7 mm100 -68.38 -39.97 81.54 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.139 -0.976 . . . . 2.7 111.248 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.447 ' HG3' HG21 ' A' ' 31' ' ' ILE . 71.4 mm-40 -67.96 -39.96 83.29 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.8 -1.188 . . . . 1.51 110.184 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -62.98 -47.8 91.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 120.861 -1.149 . . . . 0.93 108.771 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -61.89 -41.6 98.08 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.104 -0.998 . . . . 1.81 109.347 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -60.18 -40.47 90.09 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.827 -1.149 . . . . 2.78 108.217 179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -67.3 -42.02 84.4 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.55 -0.907 . . . . 0.78 108.55 178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.8 tp -59.92 -48.26 82.44 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.914 -1.143 . . . . 1.07 107.914 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.425 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 35.7 t -63.93 -44.02 94.15 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.756 -0.831 . . . . 1.12 108.756 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.14 -45.45 96.51 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.282 -1.927 . . . . 0.84 108.282 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.546 ' NH2' ' O ' ' A' ' 80' ' ' LEU . 8.5 ttt180 -63.75 -34.11 77.15 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.681 -1.229 . . . . 3.09 107.681 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -60.04 -40.96 91.19 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 109.303 -0.628 . . . . 0.88 109.303 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 23.5 ttmt -63.64 -74.39 0.1 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.836 -1.172 . . . . 2.59 107.836 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.17 -39.6 0.43 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.45 -0.782 . . . . 0.7 111.316 -178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.2 m -53.01 -53.98 42.04 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.517 -1.365 . . . . 1.4 108.527 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.02 -39.96 75.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.469 -0.769 . . . . 0.67 111.501 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -68.89 -39.97 79.48 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.739 -1.225 . . . . 1.66 110.194 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 79.1 mt -63.11 -40.07 96.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.139 -0.976 . . . . 1.58 109.377 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -60.73 -35.26 75.9 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.248 -0.908 . . . . 1.35 109.432 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -62.58 -41.85 99.2 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.159 -0.963 . . . . 0.77 109.402 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 89.8 mt -62.77 -40.04 87.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.3 -0.875 . . . . 0.63 109.039 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.3 ttpt -56.02 -50.03 72.05 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.11 -0.994 . . . . 1.14 109.197 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -56.02 -35.4 66.8 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.318 -0.864 . . . . 0.79 109.816 -178.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -69.95 -37.91 75.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 1.53 109.815 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.13 -46.16 85.35 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.491 -0.756 . . . . 0.57 110.183 -179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.54 -50.03 72.13 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.497 -1.441 . . . . 0.75 109.497 -179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -68.23 -49.67 59.19 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.204 -1.174 . . . . 1.59 109.502 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.6 m -65.05 -63.8 1.02 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.888 . . . . 0.73 112.332 -177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -95.27 -51.74 4.48 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.879 -1.138 . . . . 0.75 111.288 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.71 -167.99 25.72 Favored Glycine 0 N--CA 1.502 3.073 0 C-N-CA 119.706 -1.235 . . . . 1.22 111.128 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -70.22 -27.01 64.13 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 122.007 -0.702 . . . . 5.81 110.461 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -60.88 -35.72 77.35 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.3 -0.875 . . . . 3.37 110.571 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -101.04 -20.83 15.21 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.338 -0.851 . . . . 1.77 110.159 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.1 tt0 -65.94 -40.06 91.05 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.026 -1.046 . . . . 1.65 110.002 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.545 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -64.75 -26.77 68.5 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.279 -0.888 . . . . 0.77 109.997 -179.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.04 -39.96 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 118.717 -1.193 . . . . 0.8 108.531 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -66.42 -42.11 88.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.032 . . . . 0.88 110.282 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -60.13 -40.2 88.97 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.853 -1.155 . . . . 1.37 108.939 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.44 -49.95 66.07 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.945 -1.662 . . . . 0.62 108.945 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.503 ' CG ' HD11 ' A' ' 133' ' ' ILE . 38.5 m170 -62.9 -47.2 84.32 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.328 -1.101 . . . . 1.5 109.181 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.4 mt -65.69 -46.8 88.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.293 -0.879 . . . . 0.63 108.885 179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.9 ttp -59.99 -40.12 88.11 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.01 -1.056 . . . . 1.51 109.048 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.018 HD22 HD23 ' B' ' 347' ' ' LEU . 44.4 tp -64.43 -39.99 94.89 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 121.457 0.646 . . . . 0.77 109.443 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.546 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 62.8 tp -63.18 -39.99 96.24 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.575 -0.703 . . . . 0.62 110.157 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -84.74 7.23 21.3 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.049 -1.032 . . . . 1.47 110.261 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 61.4 t0 -50.14 134.23 22.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.12 -0.987 . . . . 1.47 109.979 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.485 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 93.6 mt-10 -60.12 -23.51 63.93 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.634 -0.667 . . . . 1.78 110.941 -179.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -70.81 -34.24 71.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.971 -1.08 . . . . 2.53 109.415 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 92.9 mt -71.02 -40.51 71.72 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.573 0.701 . . . . 0.8 109.692 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -59.98 -46.56 89.04 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.115 -0.991 . . . . 1.42 110.231 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -69.97 -42.24 73.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.211 -0.93 . . . . 1.71 111.594 -179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -69.99 -39.97 75.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.039 -1.038 . . . . 1.57 112.095 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.07 -48.14 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.142 -0.974 . . . . 0.65 109.625 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.92 -39.62 80.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 121.262 0.553 . . . . 0.82 110.179 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.17 -47.69 84.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.222 -0.924 . . . . 0.79 110.768 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.4 mt -60.0 -48.35 82.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.989 -1.07 . . . . 0.95 109.941 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.2 mt -61.61 -48.59 88.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-O 121.957 0.884 . . . . 0.66 108.878 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.8 mtpt -67.76 -40.16 84.11 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 120.203 -0.599 . . . . 2.2 110.857 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -86.57 -50.66 6.67 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.915 -1.115 . . . . 1.65 112.356 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -90.14 -2.9 58.14 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.984 -1.072 . . . . 2.03 111.71 -177.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 14.9 m170 57.94 35.81 25.65 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.893 -1.129 . . . . 1.42 109.474 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.8 mtp -90.33 163.88 14.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.47 -0.769 . . . . 1.18 109.752 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 45.6 p -76.06 158.36 31.92 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.29 -0.881 . . . . 0.98 108.648 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.55 -39.97 77.11 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.137 -0.977 . . . . 0.64 110.078 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -62.84 -39.86 95.66 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.225 -0.922 . . . . 2.07 109.678 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.35 -44.49 19.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.73 109.942 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.37 -49.29 76.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.328 -0.857 . . . . 0.54 110.191 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.41 -40.21 90.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.127 -0.983 . . . . 0.56 110.025 -179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -60.05 -40.01 87.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 1.54 109.858 -178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -61.34 -40.12 93.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.063 -1.023 . . . . 1.33 110.395 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.0 t -62.81 -50.62 78.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.169 -0.957 . . . . 0.72 110.509 -178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.9 mm -69.99 -39.99 78.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.103 -0.998 . . . . 0.85 109.674 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -66.47 -39.21 88.67 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.29 -0.881 . . . . 2.44 108.699 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.27 -49.28 80.27 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 110.564 -1.014 . . . . 0.98 110.564 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -63.9 -47.51 80.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.938 -1.33 . . . . 1.41 110.135 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.43 -39.35 83.24 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.238 -0.914 . . . . 1.2 109.153 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 66.2 m -59.9 -40.07 87.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.142 -0.974 . . . . 1.7 108.997 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.94 87.67 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.231 -1.026 . . . . 1.47 108.231 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.3 mt -65.18 -41.74 94.3 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.313 -0.955 . . . . 1.56 108.55 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -57.8 -32.29 67.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.117 -0.989 . . . . 2.2 109.688 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -57.21 -26.71 61.12 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.084 -1.01 . . . . 2.12 108.466 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 25.3 mt -63.2 144.07 57.24 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.451 -0.944 . . . . 2.0 108.451 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 46.6 p-10 -92.8 13.43 20.33 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.189 -0.944 . . . . 3.23 110.757 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 19.2 t0 -102.67 148.7 25.26 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.053 -1.029 . . . . 2.49 110.085 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.522 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 98.0 mt-10 -73.8 -65.05 0.88 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.483 -0.761 . . . . 3.95 109.34 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.483 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 4.1 t80 -39.33 -35.43 0.26 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.893 -0.504 . . . . 2.0 110.616 -178.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 78.6 mt -78.39 -40.04 37.3 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.834 -1.166 . . . . 1.86 109.342 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 121' ' ' GLU . 87.9 tttt -69.93 -42.6 73.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.189 -0.944 . . . . 2.84 110.807 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -63.35 -43.08 98.71 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.106 -0.997 . . . . 2.73 109.9 -179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.546 ' CZ ' ' NE2' ' B' ' 351' ' ' GLN . 26.8 ttp180 -59.99 -38.5 82.77 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.212 -0.93 . . . . 2.77 108.984 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.26 -43.64 92.45 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.141 -1.059 . . . . 1.19 108.141 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -44.7 -41.75 7.03 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.948 -0.76 . . . . 1.2 108.948 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.32 -39.93 94.89 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.276 -0.89 . . . . 1.55 109.708 178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.36 -43.17 93.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.02 -1.05 . . . . 0.8 108.96 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -60.0 -39.92 87.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.109 -0.994 . . . . 3.09 109.372 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -57.17 -37.92 72.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.888 . . . . 1.46 109.742 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.503 HD11 ' CG ' ' A' ' 76' ' ' HIS . 96.9 mt -59.94 -41.66 86.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.146 -0.971 . . . . 0.71 109.116 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.24 -30.72 58.37 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.769 -1.332 . . . . 0.57 109.769 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 81.6 tttt -59.98 -47.47 85.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.148 -1.207 . . . . 2.59 109.799 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 86.9 mtm180 -68.15 -31.14 70.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.814 -1.179 . . . . 2.83 109.63 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 57.2 tp -60.09 -41.55 92.74 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.167 -0.958 . . . . 1.25 109.364 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.02 -40.05 87.93 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.209 -1.034 . . . . 0.7 108.209 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.404 HH11 ' CD2' ' A' ' 144' ' ' LEU . 62.3 mtt-85 -68.21 -38.04 81.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.662 -0.649 . . . . 2.57 109.305 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -68.6 -34.8 76.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.367 -0.833 . . . . 1.23 111.668 -178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.9 mt -70.4 -42.51 78.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.275 -1.516 . . . . 0.81 108.97 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.1 -25.4 63.49 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.636 -0.665 . . . . 1.0 109.591 -179.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.78 36.24 19.79 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.378 -1.889 . . . . 0.89 108.378 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.404 ' CD2' HH11 ' A' ' 139' ' ' ARG . 5.1 tp -73.89 145.46 44.81 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.668 -0.901 . . . . 1.14 109.259 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -68.94 140.09 55.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -0.855 . . . . 4.6 109.924 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.5 mt -106.52 130.05 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-O 121.694 0.759 . . . . 1.24 109.21 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 16.8 mm -56.27 -49.12 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.682 -0.637 . . . . 1.54 110.367 -177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.6 t0 70.87 95.12 0.07 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.603 -0.686 . . . . 1.5 109.245 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.406 ' O ' ' OD1' ' A' ' 172' ' ' ASN . 33.4 mt -73.02 -4.08 30.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.352 -0.843 . . . . 0.79 110.968 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 81.2 p -82.85 -14.63 53.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.754 -1.216 . . . . 1.4 109.361 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.21 18.19 2.71 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.329 -0.857 . . . . 0.92 112.605 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.3 mp -91.33 115.82 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.121 -1.612 . . . . 0.88 108.02 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -100.17 -8.52 23.52 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.293 -0.88 . . . . 2.45 109.952 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -108.14 144.96 34.83 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.352 -0.843 . . . . 1.52 110.163 -179.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -66.35 130.82 44.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.339 -0.851 . . . . 1.58 109.028 179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.7 m -153.11 167.24 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.472 -0.768 . . . . 0.69 109.565 179.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -93.77 148.24 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 106.318 -1.734 . . . . 0.61 106.318 177.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.597 HD22 HD11 ' A' ' 171' ' ' LEU . 47.1 tp -96.89 117.45 31.13 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.872 -1.143 . . . . 0.87 111.066 -177.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 8.5 t -121.41 127.97 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 N-CA-C 108.516 -0.92 . . . . 0.71 108.516 179.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.04 162.06 36.61 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.213 -0.929 . . . . 0.81 108.74 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.475 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.94 -33.73 72.52 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 120.405 -1.434 . . . . 0.98 107.756 178.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 42.5 p-10 -166.8 175.33 7.86 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.318 -0.993 . . . . 2.25 108.318 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 51.6 mt -140.23 125.73 19.05 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.118 -1.067 . . . . 0.78 108.118 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 36.1 p -87.11 146.97 41.54 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.032 -1.043 . . . . 0.98 108.768 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -36.54 -38.13 0.32 Allowed 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 122.365 2.043 . . . . 0.81 112.295 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.2 m -60.04 -40.03 87.99 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.361 -0.837 . . . . 0.9 109.778 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.01 -44.42 69.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.105 -0.997 . . . . 1.61 110.192 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.8 p -55.53 -20.44 13.1 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.265 -0.897 . . . . 0.61 111.116 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.51 -47.57 12.03 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.868 -1.145 . . . . 0.6 109.871 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -90.24 38.41 0.93 Allowed 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.221 -1.029 . . . . 1.4 108.221 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.597 HD11 HD22 ' A' ' 158' ' ' LEU . 9.3 tp -100.25 135.96 40.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.7 108.811 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.578 ' O ' HG23 ' A' ' 176' ' ' VAL . 30.7 m120 -86.67 102.12 13.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.194 -0.941 . . . . 2.35 109.307 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 80.9 mt -64.83 -41.67 95.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.185 -0.947 . . . . 1.51 110.799 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -69.12 -28.04 66.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.939 -1.101 . . . . 2.33 111.911 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -92.84 -11.43 33.64 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.748 -1.22 . . . . 1.92 109.159 -179.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.581 HG11 ' CE1' ' A' ' 179' ' ' PHE . 85.9 t -99.07 108.16 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.611 -1.255 . . . . 0.67 107.611 178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.4 mt -83.8 4.07 30.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.269 -0.894 . . . . 1.53 110.265 -177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.08 171.04 38.09 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.679 -1.768 . . . . 0.48 108.679 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.581 ' CE1' HG11 ' A' ' 176' ' ' VAL . 35.0 m-85 -129.49 128.6 43.21 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.348 -1.089 . . . . 0.55 108.834 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 91.3 mt -131.44 123.2 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 108.595 -0.891 . . . . 0.65 108.595 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 203' ' ' VAL . 41.0 p -147.1 158.91 44.09 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.008 -1.057 . . . . 0.82 110.252 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 50.1 p30 -108.51 25.2 11.97 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 109.208 -0.664 . . . . 2.46 109.208 179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.423 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.77 -162.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.029 -1.044 . . . . 1.28 111.358 -178.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -64.22 -64.74 3.42 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 110.198 -1.161 . . . . 2.19 110.198 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.79 -131.45 1.66 Allowed Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.19 -1.481 . . . . 2.13 110.8 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -79.95 -9.78 59.71 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.62 -0.929 . . . . 5.86 110.563 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 52.2 p -84.7 0.92 48.73 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.985 -1.072 . . . . 3.72 110.708 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 81.0 p -88.36 144.23 26.52 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.907 -1.121 . . . . 1.74 110.298 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -53.18 -41.06 64.86 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.344 -0.847 . . . . 0.95 108.844 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 190' ' ' THR . 0.7 OUTLIER -53.38 -36.39 61.38 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.628 -0.67 . . . . 1.55 109.462 179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 53.5 m -60.0 -40.02 87.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.194 -0.942 . . . . 1.51 109.981 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.6 mt -60.01 -40.09 82.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.219 -0.926 . . . . 1.67 109.597 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 90.5 mtp -57.39 -48.83 78.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.082 -1.012 . . . . 1.02 110.435 -178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.94 -42.82 94.83 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.727 -1.233 . . . . 0.68 109.768 -179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -61.98 -59.25 5.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.131 -0.981 . . . . 2.93 110.389 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 61.5 m -67.11 -39.39 86.68 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.139 -0.975 . . . . 0.86 112.421 -177.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 91.2 mt -70.22 -26.64 63.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.616 -1.303 . . . . 0.67 109.306 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 68.08 45.19 1.34 Allowed 'General case' 0 N--CA 1.499 1.982 0 CA-C-O 121.21 0.528 . . . . 1.5 110.535 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 93.6 mt -120.74 149.93 51.56 Favored Pre-proline 0 N--CA 1.503 2.202 0 N-CA-C 107.64 -1.245 . . . . 0.72 107.64 178.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -61.11 141.69 94.64 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 121.927 1.751 . . . . 0.61 111.301 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -171.49 152.41 3.23 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 118.523 -1.271 . . . . 0.66 111.898 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.6 mt -121.84 146.4 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.695 -1.224 . . . . 0.79 107.695 178.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.404 ' C ' ' O ' ' A' ' 181' ' ' THR . 21.4 m -127.66 -15.43 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 O-C-N 121.149 -0.97 . . . . 0.91 110.694 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.0 27.4 14.56 Favored Glycine 0 N--CA 1.504 3.193 0 O-C-N 121.389 -0.819 . . . . 1.01 111.098 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.0 p -49.14 -33.42 12.04 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.741 -1.446 . . . . 0.99 110.164 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 84.68 -87.31 1.55 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.708 -1.357 . . . . 1.12 109.708 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 27.5 t -125.31 39.16 4.03 Favored 'General case' 0 N--CA 1.511 2.604 0 O-C-N 121.558 -0.966 . . . . 1.72 112.571 -177.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 53.5 t -76.15 -40.62 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.444 -1.41 . . . . 0.89 109.036 177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.423 HG23 ' H ' ' A' ' 209' ' ' THR . 1.4 p -56.36 -31.41 63.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.263 -0.898 . . . . 1.03 109.94 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 23.0 t -71.71 -28.96 64.05 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.168 -0.957 . . . . 1.83 109.338 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -94.92 -9.57 33.76 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.283 -0.885 . . . . 2.27 111.176 -178.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 63.6 t -102.61 137.14 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 120.95 -1.093 . . . . 0.92 110.632 -178.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -114.11 155.04 26.74 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.751 -1.203 . . . . 2.2 107.751 179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.484 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 57.5 t-20 -59.89 139.89 57.04 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.004 -1.06 . . . . 2.36 109.92 -179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.484 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.0 t0 84.55 6.44 0.57 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.407 0.622 . . . . 2.38 109.434 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 54.8 t0 -76.01 136.81 39.97 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.374 -0.829 . . . . 2.09 108.959 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.508 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 35.5 t80 -89.84 117.47 28.7 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.674 -1.232 . . . . 1.27 107.674 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 86.6 mt -125.97 145.01 50.47 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.287 -0.883 . . . . 0.75 110.808 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.1 mt -115.27 129.95 70.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 108.102 -1.073 . . . . 0.63 108.102 178.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 35.5 tp -103.95 117.66 34.85 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.14 -0.975 . . . . 0.7 109.133 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.51 ' C ' ' H ' ' A' ' 223' ' ' VAL . 92.4 m-20 -74.85 -43.48 54.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.069 -1.019 . . . . 2.31 108.962 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.857 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.24 9.84 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.255 -0.646 . . . . 0.78 109.255 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.51 ' H ' ' C ' ' A' ' 221' ' ' ASP . 47.0 t -129.82 -40.96 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 107.5 -1.296 . . . . 1.04 107.5 178.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.42 ' HB3' HE21 ' A' ' 226' ' ' GLN . 94.2 m-20 -101.97 1.81 37.12 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.771 -0.825 . . . . 2.44 108.771 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 39.2 t-20 59.99 41.95 16.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.604 -0.685 . . . . 1.55 109.698 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.42 HE21 ' HB3' ' A' ' 224' ' ' ASN . 40.1 mt-30 -136.6 146.22 45.81 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.316 -0.865 . . . . 1.99 110.079 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 87.6 t -121.32 130.01 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 108.266 -1.013 . . . . 0.77 108.266 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -100.68 123.68 45.23 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.367 -0.833 . . . . 0.98 108.879 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 45.0 t -99.1 110.84 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.373 -0.829 . . . . 0.85 110.93 -178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 34.5 t30 49.68 59.93 16.05 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.503 -0.748 . . . . 1.66 111.047 178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -80.67 151.93 19.57 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 C-N-CA 122.694 2.263 . . . . 0.95 111.925 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.444 ' OG1' HG23 ' A' ' 235' ' ' VAL . 41.7 p -68.39 161.27 27.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.117 -0.99 . . . . 1.84 109.761 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -60.03 -38.28 82.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 2.74 108.972 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -59.87 -40.08 87.47 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.682 -0.859 . . . . 2.89 108.682 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.444 HG23 ' OG1' ' A' ' 232' ' ' THR . 54.5 t -67.33 -39.87 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.356 -0.84 . . . . 1.3 109.36 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 91.6 mt -69.22 -40.01 79.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.186 -0.946 . . . . 1.09 109.147 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -59.96 -39.93 87.32 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.358 -0.839 . . . . 2.43 108.841 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -60.1 -40.81 90.94 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 107.934 -1.136 . . . . 2.78 107.934 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.541 ' O ' ' N ' ' A' ' 242' ' ' VAL . 98.1 mtp -68.05 -79.03 0.06 Allowed 'General case' 0 C--N 1.307 -1.277 0 N-CA-C 106.186 -1.783 . . . . 1.25 106.186 178.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.636 ' NH1' ' CE2' ' A' ' 13' ' ' PHE . 15.3 mmt-85 -23.23 -43.83 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 N-CA-C 112.061 0.393 . . . . 2.63 112.061 -179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 239' ' ' MET . . . -59.97 -50.04 75.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.777 -1.202 . . . . 1.8 108.833 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 239' ' ' MET . 55.0 t -60.2 -39.96 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.074 -1.016 . . . . 2.13 108.56 178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -60.07 -39.78 87.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.388 -0.82 . . . . 3.17 109.782 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -55.13 -38.49 68.28 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.0 -1.062 . . . . 1.78 109.072 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -60.01 -39.95 87.58 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.976 -1.12 . . . . 2.47 107.976 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 91.7 t -67.98 -38.12 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 108.839 -0.8 . . . . 2.09 108.839 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.16 -39.76 72.84 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.918 -0.771 . . . . 2.54 108.918 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 46.4 m -71.52 -39.39 70.8 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.107 -0.996 . . . . 2.99 109.811 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -63.05 -40.08 96.65 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.285 -0.884 . . . . 3.34 111.772 -178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -70.01 -19.08 63.34 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.568 -1.332 . . . . 3.88 110.558 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -60.04 -43.26 95.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.854 -1.153 . . . . 4.43 108.856 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 50.01 40.08 20.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.414 -0.803 . . . . 5.42 110.615 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 86.4 mt -100.43 7.61 44.11 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.829 -1.17 . . . . 6.1 108.731 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -100.09 -79.48 0.49 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.759 -0.83 . . . . 7.37 108.759 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -137.44 162.82 32.62 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.627 -0.879 . . . . 8.01 108.627 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.616 ' N ' HD12 ' A' ' 256' ' ' LEU . 8.8 mp -59.92 -38.68 83.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.184 -0.948 . . . . 9.05 110.11 -179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -148.34 159.95 43.49 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.952 -1.093 . . . . 10.56 109.725 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.524 ' CG ' ' H ' ' A' ' 259' ' ' ARG . 27.5 p-10 -157.3 -115.07 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.147 -0.97 . . . . 11.32 108.946 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.524 ' H ' ' CG ' ' A' ' 258' ' ' ASP . 38.1 ttm-85 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.016 -0.992 . . . . 12.42 109.35 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . 0.418 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 27.5 ttp . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.451 0.643 . . . . 0.0 109.573 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . 0.418 ' N ' ' CG ' ' B' ' 301' ' ' MET . 16.3 t80 -152.7 149.91 28.9 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . 0.408 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 14.6 pt20 -149.34 159.75 44.01 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.988 -1.07 . . . . 0.0 110.413 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -153.16 149.4 27.99 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -111.47 134.86 52.75 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.075 -1.016 . . . . 0.0 109.94 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.86 121.29 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-O 122.333 1.063 . . . . 0.0 112.735 -176.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 16.9 m -75.92 105.35 6.91 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.941 0.877 . . . . 0.0 109.538 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.549 HG22 ' H ' ' B' ' 310' ' ' ALA . 96.0 mt -53.13 123.64 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-O 122.469 1.128 . . . . 0.0 111.104 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 44.4 p -107.48 23.65 14.11 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.079 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.549 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -86.38 114.26 56.66 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.376 -0.828 . . . . 0.0 109.384 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -65.89 -6.9 15.27 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 120.289 1.139 . . . . 0.0 112.17 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -113.31 2.67 15.6 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.28 176.07 18.48 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.483 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -84.18 87.4 7.17 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.761 -1.435 . . . . 0.0 108.812 -178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.459 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 3.6 p80 -92.65 -160.26 0.73 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.193 -0.942 . . . . 0.0 109.696 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 5.5 m -57.89 -49.7 75.83 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.912 -1.117 . . . . 0.0 112.168 -176.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.545 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 11.4 tpt180 -52.35 -59.04 9.41 Favored Pre-proline 0 N--CA 1.5 2.055 0 O-C-N 120.63 -1.294 . . . . 0.0 112.024 -179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.459 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 17.8 Cg_endo -63.36 -35.03 64.28 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 CA-C-N 120.613 1.255 . . . . 0.0 111.483 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.35 78.01 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -57.57 -44.86 85.62 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 119.742 -0.783 . . . . 0.0 109.313 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 56.2 tp60 -69.1 -44.53 72.27 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.408 -0.917 . . . . 0.0 108.626 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -60.01 -50.05 75.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.694 -0.629 . . . . 0.0 111.004 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 74.3 t -65.52 -29.18 46.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.529 -1.357 . . . . 0.0 109.206 -179.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 17.9 ttmt -59.93 -46.6 88.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.53 -0.731 . . . . 0.0 109.833 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -69.26 -40.6 77.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 0.0 111.426 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.19 -51.48 69.4 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.55 -1.344 . . . . 0.0 109.997 -179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -58.97 -13.33 6.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.339 -0.851 . . . . 0.0 109.307 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.6 -30.85 70.67 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -105.54 141.8 36.39 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.54 -0.977 . . . . 0.0 108.534 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 35.2 m -90.2 -11.43 41.04 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.841 -1.162 . . . . 0.0 109.539 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.478 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 93.8 p -57.99 151.2 18.96 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.139 -0.976 . . . . 0.0 108.784 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -68.06 130.48 43.09 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.213 -0.929 . . . . 0.0 108.813 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 80.1 mt -130.65 130.48 64.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.5 -0.75 . . . . 0.0 109.143 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 45.3 m -127.85 152.13 48.19 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.478 -0.764 . . . . 0.0 108.996 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 75.5 t -119.12 138.43 49.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 98.8 m -132.21 129.31 39.55 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.262 -0.899 . . . . 0.0 110.204 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . 0.454 ' C ' ' H ' ' B' ' 339' ' ' GLY . 80.2 p -136.91 126.77 25.72 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.466 -0.771 . . . . 0.0 109.791 179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 56.8 t30 57.09 5.58 0.26 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 121.59 0.71 . . . . 0.0 109.505 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . 0.454 ' H ' ' C ' ' B' ' 337' ' ' SER . . . 101.91 10.16 40.85 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.026 -1.629 . . . . 0.0 109.026 -178.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 42.3 mttp -100.56 119.27 38.28 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 32.4 m -99.06 149.75 22.7 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.182 -0.949 . . . . 0.0 111.908 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . 0.492 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -149.69 149.54 30.76 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . 0.434 ' H ' ' HE3' ' B' ' 349' ' ' LYS . 8.8 t -90.55 131.43 36.28 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.119 -0.988 . . . . 0.0 110.297 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -70.06 -16.63 63.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.152 -0.967 . . . . 0.0 110.047 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . 0.48 ' NZ ' ' CB ' ' B' ' 345' ' ' LYS . 0.1 OUTLIER -89.52 19.59 4.46 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 28.4 t -147.99 99.0 3.02 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 122.057 0.932 . . . . 0.0 111.572 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 1.018 HD23 HD22 ' A' ' 79' ' ' LEU . 58.9 tp -58.98 -36.2 74.48 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.739 ' CE2' HD11 ' A' ' 79' ' ' LEU . 58.2 m-85 -55.17 -53.05 60.94 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.312 -0.868 . . . . 0.0 111.363 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . 0.434 ' HE3' ' H ' ' B' ' 343' ' ' SER . 49.8 mtmt -70.04 -29.75 66.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 0.0 109.74 -178.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.433 HD12 ' HA ' ' B' ' 347' ' ' LEU . 55.7 mt -59.75 -39.4 84.64 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.414 -0.804 . . . . 0.0 111.196 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.546 ' NE2' ' CZ ' ' A' ' 126' ' ' ARG . 3.0 mm100 -65.78 -14.75 61.97 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.187 -1.571 . . . . 0.0 111.673 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 40.5 p -77.53 -10.89 59.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.13 -1.607 . . . . 0.0 110.156 -178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.492 HD11 ' HB3' ' B' ' 342' ' ' ALA . 52.8 mt -93.44 115.08 27.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.113 -0.992 . . . . 0.0 109.043 178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -72.24 93.97 0.62 Allowed Glycine 0 N--CA 1.494 2.509 0 N-CA-C 107.772 -2.131 . . . . 0.0 107.772 179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . 0.45 HD22 HG11 ' B' ' 361' ' ' VAL . 80.6 mt -100.21 88.08 3.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.241 -1.152 . . . . 0.0 110.341 -179.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 44.7 p -92.31 -179.99 5.39 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.977 -1.077 . . . . 0.0 110.651 -179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -71.23 114.07 8.92 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.597 -0.689 . . . . 0.0 110.605 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.77 10.65 32.33 Favored Glycine 0 N--CA 1.498 2.787 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 25.6 m -90.99 108.17 19.68 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.353 -1.086 . . . . 0.0 110.578 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 99.8 t -76.99 118.17 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 CA-C-O 122.181 0.991 . . . . 0.0 109.366 -177.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . 0.45 HG11 HD22 ' B' ' 355' ' ' LEU . 14.9 m -111.92 178.19 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 28.2 m -131.74 129.42 40.62 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 176.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 78.6 mt -105.33 120.63 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 75.6 p -120.32 132.32 55.25 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.548 -0.72 . . . . 0.0 109.184 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.21 149.56 36.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -0.955 . . . . 0.0 109.799 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -147.0 125.84 12.69 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 158.72 -158.9 29.78 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 118.913 -1.613 . . . . 0.0 111.401 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 54.5 tp10 -59.94 -52.53 65.02 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 122.178 -0.601 . . . . 0.0 111.794 -177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.478 ' H ' ' HB3' ' B' ' 331' ' ' SER . 70.9 m-20 -107.59 11.75 28.32 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.973 -1.079 . . . . 0.0 111.384 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' B' ' 369' ' ' ASP . 12.9 pt-20 -37.78 -33.59 0.08 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.402 -0.812 . . . . 0.0 111.578 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -66.7 -51.17 59.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.906 -1.121 . . . . 0.0 110.925 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -64.08 -48.9 74.38 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.908 -1.12 . . . . 0.0 108.915 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.31 -40.75 3.7 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.53 -0.731 . . . . 0.0 111.594 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 94.7 t -76.13 -35.86 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 120.615 -1.303 . . . . 0.0 109.708 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.7 -59.07 5.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.103 -0.998 . . . . 0.0 111.832 -178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -70.02 -40.79 74.99 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.762 -1.211 . . . . 0.0 111.867 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.98 -41.14 91.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.676 -1.265 . . . . 0.0 109.422 -178.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 54.7 t -62.63 -44.6 99.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.897 -1.127 . . . . 0.0 109.732 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.514 ' O ' ' N ' ' B' ' 383' ' ' GLU . 57.7 mtpt -68.97 -55.99 9.2 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 53.8 tp -54.49 -37.71 65.59 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.732 -0.605 . . . . 0.0 109.404 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 6.4 tpp -72.79 -40.0 66.26 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.602 -1.311 . . . . 0.0 108.441 177.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -79.97 -5.27 55.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.545 -0.722 . . . . 0.0 110.19 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.514 ' N ' ' O ' ' B' ' 379' ' ' LYS . 53.7 mm-40 -110.61 0.97 17.76 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.19 -0.944 . . . . 0.0 111.069 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 17.4 mt -90.8 124.59 35.26 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.518 -1.364 . . . . 0.0 109.107 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . 0.417 ' H ' ' HG2' ' B' ' 385' ' ' GLU . 15.1 pt-20 . . . . . 0 N--CA 1.499 1.986 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.376 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.7 mtm . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.356 -0.609 . . . . 2.91 109.356 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.3 mt -110.36 129.0 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.533 -0.73 . . . . 1.2 109.311 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.7 m -140.79 120.55 13.44 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.375 -0.828 . . . . 1.4 109.23 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.7 -164.98 39.18 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.743 -1.343 . . . . 1.05 109.743 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 5' ' ' ILE . 88.1 mt -86.44 -1.54 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.172 -1.193 . . . . 1.15 110.583 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.2 tp 52.53 88.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.799 -1.188 . . . . 0.98 109.07 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.74 -38.0 64.9 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.254 -0.904 . . . . 0.88 109.509 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.0 t -149.71 135.52 10.12 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.375 -0.828 . . . . 1.69 109.427 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -80.43 145.56 16.78 Favored 'Trans proline' 0 N--CA 1.497 1.707 0 C-N-CA 122.23 1.954 . . . . 0.85 113.772 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.689 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.84 -159.37 30.59 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.189 -1.564 . . . . 0.92 109.189 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.2 mt -149.54 150.01 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.047 -1.266 . . . . 0.81 108.955 179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.44 150.37 26.59 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.054 -1.029 . . . . 0.51 110.53 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -130.25 126.22 36.77 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 107.969 -1.123 . . . . 0.62 107.969 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.8 178.04 48.4 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 118.429 -1.843 . . . . 0.55 111.096 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -80.01 159.61 26.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.89 -0.771 . . . . 2.1 109.679 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -100.38 132.04 45.97 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.376 -0.828 . . . . 0.77 111.582 -178.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.0 tp -105.27 133.42 50.07 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 106.717 -1.586 . . . . 0.91 106.717 177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.8 tp -117.11 123.51 46.96 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.138 -0.976 . . . . 0.93 110.747 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.425 HD12 ' HB2' ' A' ' 160' ' ' ALA . 48.7 mt -92.43 104.13 16.49 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.755 -0.59 . . . . 0.93 110.473 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -93.66 137.56 32.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.318 -0.864 . . . . 2.75 109.341 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -131.12 134.14 46.27 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.241 -0.912 . . . . 3.0 109.492 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -88.21 139.96 29.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.116 -0.99 . . . . 2.77 109.074 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -62.31 140.78 58.5 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.034 -1.041 . . . . 2.94 109.268 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.3 mt -79.18 132.3 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.95 108.766 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 90.2 t -104.64 126.66 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.426 -0.797 . . . . 1.28 109.897 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -100.27 138.61 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 108.789 -0.819 . . . . 1.21 108.789 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -90.61 125.65 35.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.997 -1.064 . . . . 1.81 109.204 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -89.94 1.43 56.25 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.692 -0.855 . . . . 2.8 108.692 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.95 139.93 57.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.42 -0.8 . . . . 2.87 109.747 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -88.04 137.92 31.9 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.305 -0.872 . . . . 2.35 109.24 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.8 pt -90.57 159.98 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.994 -1.067 . . . . 0.97 109.442 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.4 p -94.65 171.78 8.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.061 -1.024 . . . . 1.17 108.687 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.58 -46.69 83.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 1.18 108.997 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.439 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 25.6 t0 -55.84 -32.7 63.84 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.758 -1.214 . . . . 2.56 109.516 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -81.51 -9.98 59.58 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.12 -0.988 . . . . 1.79 110.425 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.6 t -64.15 -53.02 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.6 -1.312 . . . . 1.0 108.8 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -61.72 -39.99 93.47 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.439 -0.788 . . . . 1.77 110.027 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.429 HE21 ' NH2' ' A' ' 42' ' ' ARG . 27.2 mm100 -67.96 -41.87 81.79 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 2.7 110.492 -178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -65.42 -39.98 92.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.065 -1.022 . . . . 1.51 110.575 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.98 -46.17 94.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 120.688 -1.258 . . . . 0.93 108.79 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -60.03 -40.01 87.85 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.846 -1.159 . . . . 1.81 108.94 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.505 HH11 ' HG2' ' A' ' 42' ' ' ARG . 17.9 mtt-85 -60.01 -43.28 95.35 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.973 -1.121 . . . . 2.78 107.973 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 28.6 t80 -60.84 -50.05 74.99 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.475 -0.766 . . . . 0.78 109.064 178.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.6 tp -61.87 -44.66 96.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.414 -0.804 . . . . 1.07 109.035 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.6 t -65.47 -43.74 89.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -0.943 . . . . 1.12 109.176 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.98 -45.71 95.43 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 107.684 -2.166 . . . . 0.84 107.684 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -60.66 -39.28 87.76 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.389 -0.967 . . . . 3.09 108.389 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.26 -40.18 64.42 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 109.286 -0.635 . . . . 0.88 109.286 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 50' ' ' ALA . 22.3 ttmt -65.81 -73.58 0.13 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.168 -1.419 . . . . 2.59 107.168 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.91 -38.99 0.34 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.35 -0.844 . . . . 0.7 111.222 -178.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 t -51.93 -56.03 16.64 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.603 -1.311 . . . . 1.4 108.816 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.81 -40.72 79.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.325 -0.86 . . . . 0.67 111.15 -179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -69.95 -40.05 75.69 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.748 -1.22 . . . . 1.66 110.008 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.9 mt -62.04 -40.05 94.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.996 -1.065 . . . . 1.58 108.964 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -64.26 -33.93 76.95 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.26 -0.9 . . . . 1.35 109.361 179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.5 m -64.87 -42.5 94.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.035 -1.041 . . . . 0.77 109.784 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.595 ' CD1' HH22 ' A' ' 136' ' ' ARG . 97.9 mt -62.27 -40.07 86.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.178 -0.951 . . . . 0.63 109.086 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -51.92 -49.99 61.99 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.447 -0.783 . . . . 1.14 109.426 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.6 m -59.44 -40.0 85.36 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.124 -0.985 . . . . 0.79 110.878 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -63.5 -37.88 88.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.745 -1.222 . . . . 1.53 109.835 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.407 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -65.32 -46.59 79.7 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.62 -0.675 . . . . 0.57 110.097 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.98 -49.57 77.08 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.274 -1.13 . . . . 0.75 110.274 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.97 -44.95 71.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.857 -1.378 . . . . 1.59 110.161 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.1 m -69.66 -57.23 5.41 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.211 -0.931 . . . . 0.73 111.54 -178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -97.11 -57.34 2.29 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.026 -1.046 . . . . 0.75 110.948 -178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.0 -163.75 26.94 Favored Glycine 0 N--CA 1.503 3.133 0 C-N-CA 119.802 -1.19 . . . . 1.22 111.041 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -67.92 -26.2 65.86 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.712 -0.875 . . . . 5.81 110.605 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.3 tp10 -60.0 -36.36 77.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.321 -0.862 . . . . 3.37 110.211 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -100.5 -18.71 16.53 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.471 -0.768 . . . . 1.77 110.729 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -70.27 -43.1 71.17 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.779 -1.201 . . . . 1.65 110.838 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.57 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -66.41 -32.29 73.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.301 -0.874 . . . . 0.77 110.226 -178.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.08 -39.92 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.854 -1.153 . . . . 0.8 109.307 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -64.48 -40.04 94.94 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.753 -1.217 . . . . 0.88 109.687 178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.51 -40.37 91.2 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.105 -0.997 . . . . 1.37 109.614 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.98 -49.2 63.82 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 108.76 -1.736 . . . . 0.62 108.76 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.2 m170 -59.98 -43.35 95.18 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.374 -1.074 . . . . 1.5 108.687 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.81 -48.98 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.122 -0.986 . . . . 0.63 109.1 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.0 ttp -60.1 -42.7 95.26 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.043 -1.035 . . . . 1.51 109.491 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.852 HD11 ' CE2' ' B' ' 348' ' ' PHE . 46.8 tp -61.96 -39.36 91.88 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.37 -0.831 . . . . 0.77 108.772 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.05 -39.97 87.8 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.501 -0.749 . . . . 0.62 109.328 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -83.73 9.9 10.69 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.348 -0.845 . . . . 1.47 109.804 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 62.5 t0 -53.37 133.23 40.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.187 -0.946 . . . . 1.47 109.984 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.469 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 99.2 mt-10 -59.06 -24.04 62.55 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.684 -0.635 . . . . 1.78 111.496 -178.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -71.09 -34.65 71.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.896 -1.128 . . . . 2.53 109.871 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.9 mt -70.2 -40.02 74.85 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.585 0.707 . . . . 0.8 109.858 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.96 -48.9 79.81 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.364 -0.835 . . . . 1.42 110.31 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -70.13 -42.96 71.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.369 -0.832 . . . . 1.71 111.57 -178.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.01 -40.02 75.49 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.082 -1.011 . . . . 1.57 112.119 -177.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.75 -47.73 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.852 -1.155 . . . . 0.65 109.842 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.5 mt -66.51 -38.57 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.796 . . . . 0.82 109.904 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.9 88.06 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.178 -0.951 . . . . 0.79 111.26 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.1 mt -60.0 -46.61 88.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.773 -1.205 . . . . 0.95 109.945 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.1 mt -59.96 -46.14 94.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 107.751 -1.203 . . . . 0.66 107.751 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.5 mtmt -67.99 -40.36 83.1 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.925 -0.71 . . . . 2.2 110.238 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -80.74 -55.9 4.51 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.035 -1.041 . . . . 1.65 112.437 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -90.01 -3.25 58.09 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 120.973 -1.08 . . . . 2.03 111.971 -177.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 74.9 m80 57.13 41.12 27.71 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.885 -1.134 . . . . 1.42 109.236 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 68.0 mtp -95.62 169.18 10.21 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.445 0.641 . . . . 1.18 110.103 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 68.2 p -78.58 160.36 27.63 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.386 -0.821 . . . . 0.98 109.576 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.0 -39.12 87.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.64 110.155 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.483 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 18.2 p-10 -70.04 -34.06 72.76 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.013 -1.054 . . . . 2.07 109.349 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.08 -44.08 22.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.73 109.776 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.04 -43.12 71.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.448 -0.783 . . . . 0.54 110.229 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.05 -39.93 87.68 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.99 -1.069 . . . . 0.56 109.72 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.466 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 82.4 t60 -60.05 -40.01 87.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.394 -0.816 . . . . 1.54 110.574 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.32 -41.87 93.54 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.044 -1.035 . . . . 1.33 110.74 -179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.0 t -62.89 -50.73 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.002 -1.061 . . . . 0.72 110.851 -178.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.8 mm -69.9 -40.08 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.918 -1.114 . . . . 0.85 109.01 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.466 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.0 tt0 -63.82 -37.83 88.83 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.36 -0.978 . . . . 2.44 108.36 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.96 -54.1 40.25 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.598 -1.001 . . . . 0.98 110.598 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.9 mm-40 -64.77 -49.87 69.05 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.756 -1.438 . . . . 1.41 109.219 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.89 -41.93 88.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.25 -0.906 . . . . 1.2 109.085 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.9 t -58.84 -39.97 82.83 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.349 -0.844 . . . . 1.7 108.95 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.33 -40.05 96.25 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.354 -0.841 . . . . 1.47 109.366 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.5 mt -63.58 -40.64 97.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.049 -1.032 . . . . 1.56 109.892 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.86 -36.54 77.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.846 -1.159 . . . . 2.2 109.508 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -53.85 -21.93 8.7 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.247 -0.908 . . . . 2.12 108.89 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.416 HD13 HD13 ' A' ' 123' ' ' LEU . 35.5 mt -62.95 142.6 58.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.222 -0.924 . . . . 2.0 109.349 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -91.11 12.78 18.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.406 -0.809 . . . . 3.23 109.425 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -100.4 126.5 46.79 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.261 -0.899 . . . . 2.49 110.147 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.402 ' O ' ' CD ' ' A' ' 121' ' ' GLU . 5.0 tm-20 -69.92 -29.96 67.26 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.686 0.755 . . . . 3.95 109.014 179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.426 ' OH ' ' C ' ' B' ' 314' ' ' LEU . 19.3 t80 -62.83 -42.84 99.9 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 122.007 0.908 . . . . 2.0 110.109 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.912 HD22 ' O ' ' B' ' 351' ' ' GLN . 79.2 mt -76.16 -31.24 58.46 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.771 -0.825 . . . . 1.86 108.771 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -60.07 -40.85 90.94 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.475 -0.765 . . . . 2.84 108.985 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.11 -44.24 95.01 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.574 -0.899 . . . . 2.73 108.574 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.69 HH21 ' NE2' ' B' ' 351' ' ' GLN . 62.5 mtp180 -62.07 -39.67 93.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.361 -0.837 . . . . 2.77 109.138 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.98 -32.57 70.96 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.448 -0.782 . . . . 1.19 109.449 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.06 94.29 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.656 -0.868 . . . . 1.2 108.656 179.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -62.61 -40.08 95.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.421 -0.799 . . . . 1.55 110.192 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.6 t -68.06 -43.04 85.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.922 . . . . 0.8 109.924 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -60.01 -40.0 87.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.081 -1.012 . . . . 3.09 109.538 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.03 -38.23 82.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.348 -0.845 . . . . 1.46 109.931 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.6 mt -59.97 -43.31 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.122 -0.986 . . . . 0.71 110.358 -179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.2 -32.62 62.67 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.673 -1.251 . . . . 0.57 110.114 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 56.9 tttp -59.96 -49.97 75.58 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.107 -1.231 . . . . 2.59 109.283 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.595 HH22 ' CD1' ' A' ' 57' ' ' ILE . 59.5 mtp180 -65.61 -34.99 79.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 2.83 109.994 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.0 tp -59.96 -43.46 95.05 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.224 -0.922 . . . . 1.25 109.48 -178.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.14 -39.96 94.36 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.087 -1.008 . . . . 0.7 108.815 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.416 HH11 ' HG2' ' A' ' 139' ' ' ARG . 58.6 mtt-85 -70.11 -39.9 75.22 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.461 -0.94 . . . . 2.57 108.461 178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -62.04 -37.05 83.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.811 -0.556 . . . . 1.23 111.165 -178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.06 -43.56 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 120.698 -1.251 . . . . 0.81 108.221 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.7 mt -69.98 -38.03 75.94 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.695 -0.628 . . . . 1.0 109.579 179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 87.49 45.45 5.24 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.255 -1.938 . . . . 0.89 108.255 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.407 ' CD2' ' NH1' ' A' ' 139' ' ' ARG . 12.0 tp -74.58 150.02 39.88 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.499 -1.001 . . . . 1.14 109.548 -179.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -63.02 142.84 58.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.341 -0.85 . . . . 4.6 110.428 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.2 mt -119.9 126.72 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 N-CA-C 108.565 -0.902 . . . . 1.24 108.565 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.4 mt -59.97 -44.89 95.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 O-C-N 121.826 -0.546 . . . . 1.54 110.298 -178.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.4 t0 67.72 94.63 0.07 Allowed 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.83 -0.804 . . . . 1.5 108.83 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.553 ' O ' HD12 ' A' ' 152' ' ' ILE . 34.7 mt -67.07 -8.1 27.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.457 -0.777 . . . . 0.79 109.951 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.8 t -79.94 -13.8 59.09 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 120.993 -1.067 . . . . 1.4 108.286 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.12 24.76 0.76 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.786 -0.571 . . . . 0.92 110.395 -178.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.553 HD12 ' O ' ' A' ' 149' ' ' LEU . 42.6 mt -92.97 118.1 37.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.021 -1.05 . . . . 0.88 108.688 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -104.83 -11.22 16.88 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.222 -0.924 . . . . 2.45 110.391 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -119.71 147.31 44.73 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.615 -0.678 . . . . 1.52 110.12 -179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -64.11 136.52 57.33 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.408 -0.96 . . . . 1.58 108.408 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.2 m -153.52 168.54 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.233 -0.917 . . . . 0.69 109.99 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 74.0 mt -95.94 144.41 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 105.883 -1.895 . . . . 0.61 105.883 177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 22.1 tp -92.99 115.86 28.52 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.905 -1.122 . . . . 0.87 110.48 -177.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.544 HG12 HG22 ' A' ' 209' ' ' THR . 45.7 t -123.38 129.94 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 N-CA-C 108.76 -0.829 . . . . 0.71 108.76 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.497 ' C ' HG21 ' A' ' 209' ' ' THR . . . -162.16 164.67 27.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.905 . . . . 0.81 108.795 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.44 -35.35 70.89 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.257 -1.527 . . . . 0.98 107.781 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 40.8 p-10 -164.56 173.87 11.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.411 -0.959 . . . . 2.25 108.411 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.4 mt -136.48 143.1 43.64 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.115 -0.991 . . . . 0.78 109.201 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 74.7 p -95.27 141.99 23.99 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.241 -0.912 . . . . 0.98 109.342 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -39.99 -39.88 2.48 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 122.278 1.985 . . . . 0.81 112.514 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 68.9 m -60.04 -39.97 87.78 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.26 -0.9 . . . . 0.9 109.097 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -63.5 -43.69 96.47 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.27 -0.894 . . . . 1.61 110.108 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.9 p -53.87 -25.85 21.88 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.187 -0.946 . . . . 0.61 110.823 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -80.55 -54.76 5.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.82 -1.175 . . . . 0.6 109.817 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -83.76 39.85 0.71 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.698 -0.853 . . . . 1.4 108.698 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.0 tp -105.2 135.66 46.14 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.709 -0.849 . . . . 0.7 108.709 178.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.43 ' O ' HG23 ' A' ' 176' ' ' VAL . 6.4 m120 -84.96 103.41 13.98 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.194 -0.941 . . . . 2.35 108.93 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 36.3 mt -67.14 -40.53 86.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.511 -0.743 . . . . 1.51 110.881 -178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -69.97 -24.15 63.28 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.757 -1.215 . . . . 2.33 111.433 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -92.78 -6.79 48.2 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.802 -1.186 . . . . 1.92 109.853 -178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.512 HG12 ' H ' ' A' ' 178' ' ' GLY . 84.0 t -106.56 116.67 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 O-C-N 121.329 -0.857 . . . . 0.67 108.702 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 71.3 mt -89.99 7.24 38.52 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.283 -0.886 . . . . 1.53 110.243 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.512 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 171.89 171.88 37.32 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.176 -1.57 . . . . 0.48 109.176 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.474 ' CE1' HG11 ' A' ' 176' ' ' VAL . 26.8 m-85 -132.37 129.66 39.69 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.321 -1.105 . . . . 0.55 109.207 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 94.7 mt -134.07 127.51 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.525 -0.917 . . . . 0.65 108.525 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.1 p -149.94 162.75 39.73 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.938 -1.101 . . . . 0.82 110.681 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.481 ' O ' ' O ' ' A' ' 183' ' ' ALA . 0.9 OUTLIER -100.24 20.31 14.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.506 -0.747 . . . . 2.46 109.726 -179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -46.69 -174.7 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 CA-C-O 122.322 1.058 . . . . 1.28 112.823 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.36 -56.69 3.86 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 111.396 -0.682 . . . . 2.19 111.396 -178.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -167.36 -159.09 12.34 Favored Glycine 0 N--CA 1.493 2.447 0 C-N-CA 118.484 -1.817 . . . . 2.13 111.416 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.425 HH11 ' HG2' ' A' ' 186' ' ' ARG . 17.8 ptt-85 -72.29 -15.93 61.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.749 -0.854 . . . . 5.86 110.849 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 71.5 p -71.23 3.42 3.62 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.831 -1.168 . . . . 3.72 109.271 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 40.7 t -83.4 134.29 34.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 1.74 110.275 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -49.88 -38.96 37.91 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.169 -1.049 . . . . 0.95 108.169 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.6 p -59.94 -41.49 91.93 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.928 -0.578 . . . . 1.55 110.493 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 41.2 t -62.06 -38.61 89.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.113 -0.992 . . . . 1.51 110.669 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.3 mm -60.0 -39.35 80.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.236 -0.915 . . . . 1.67 109.19 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.1 mtp -59.5 -44.43 93.11 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.245 -0.909 . . . . 1.02 110.102 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.36 -44.48 80.15 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.647 -1.283 . . . . 0.68 109.712 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.409 HH22 ' HD2' ' A' ' 186' ' ' ARG . 98.9 mtt180 -62.96 -57.81 9.49 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.142 -1.023 . . . . 2.93 110.778 -179.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.1 m -62.7 -39.97 95.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.997 -1.064 . . . . 0.86 112.111 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.9 mt -69.95 -15.7 63.09 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.864 -1.147 . . . . 0.67 110.25 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 62.13 49.67 4.35 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.626 -0.671 . . . . 1.5 110.175 -179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 78.5 mt -130.39 149.91 74.73 Favored Pre-proline 0 N--CA 1.499 1.999 0 N-CA-C 107.682 -1.229 . . . . 0.72 107.682 178.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.79 147.5 62.82 Favored 'Trans proline' 0 N--CA 1.5 1.884 0 C-N-CA 122.316 2.01 . . . . 0.61 111.846 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -173.88 158.76 3.27 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.922 -1.111 . . . . 0.66 112.035 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.8 mt -130.96 144.75 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.281 -1.007 . . . . 0.79 108.281 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 28.0 m -128.98 -7.53 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 O-C-N 120.99 -1.069 . . . . 0.91 111.064 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.75 24.48 13.17 Favored Glycine 0 N--CA 1.501 3.032 0 N-CA-C 110.799 -0.92 . . . . 1.01 110.799 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.429 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.1 p -46.77 -44.14 18.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.876 -1.367 . . . . 0.99 109.748 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.57 -55.5 2.71 Favored Glycine 0 N--CA 1.498 2.803 0 C-N-CA 120.166 -1.016 . . . . 1.12 111.825 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 34.3 p -149.82 25.92 0.83 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.6 -1.53 . . . . 1.72 111.646 -178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 54.6 t -69.97 -39.62 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.773 -1.205 . . . . 0.89 108.964 178.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.544 HG22 HG12 ' A' ' 159' ' ' VAL . 50.4 p -58.0 -36.65 72.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.498 -0.751 . . . . 1.03 110.173 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 80.9 p -84.99 -11.74 54.8 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.013 -1.054 . . . . 1.83 110.25 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 21.5 mm100 -95.87 -14.93 22.79 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.054 -1.029 . . . . 2.27 110.305 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 213' ' ' LYS . 21.7 t -114.79 154.37 16.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 O-C-N 121.275 -0.891 . . . . 0.92 110.469 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.44 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 11.1 mptt -117.2 156.45 27.67 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.701 -1.222 . . . . 2.2 107.701 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.5 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 27.5 p30 -60.02 142.68 53.53 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.053 -1.029 . . . . 2.36 110.431 -179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.5 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 11.0 t0 86.62 0.83 0.56 Allowed 'General case' 0 N--CA 1.502 2.15 0 CA-C-O 120.919 0.39 . . . . 2.38 110.359 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.44 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 91.8 m-20 -75.05 153.78 38.25 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.938 -1.101 . . . . 2.09 108.814 178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -96.44 131.27 43.19 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.226 -1.027 . . . . 1.27 108.226 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.525 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 82.6 mt -129.52 149.65 51.2 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.192 -0.943 . . . . 0.75 110.994 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 85.5 mt -120.59 122.64 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 106.816 -1.549 . . . . 0.63 106.816 175.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 57.2 tp -98.73 115.51 28.89 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.733 -1.23 . . . . 0.7 109.223 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 223' ' ' VAL . 96.0 m-20 -75.57 -44.61 42.36 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.031 -1.043 . . . . 2.31 108.29 178.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.95 17.63 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 121.978 0.894 . . . . 0.78 108.62 -179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.1 t -132.08 -45.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 N-CA-C 106.654 -1.609 . . . . 1.04 106.654 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -100.33 1.93 42.04 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.685 -1.228 . . . . 2.44 107.685 178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 60.53 44.15 12.1 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.79 -0.569 . . . . 1.55 109.824 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -139.65 141.84 37.01 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.323 -0.86 . . . . 1.99 109.525 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 97.2 t -119.98 120.85 64.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 109.112 -0.699 . . . . 0.77 109.112 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -89.04 131.67 35.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.981 -1.074 . . . . 0.98 108.715 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 64.2 t -109.33 122.92 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.709 -0.619 . . . . 0.85 109.64 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 62.49 69.15 0.94 Allowed Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.524 -0.735 . . . . 1.66 109.745 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -90.18 127.85 1.48 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 123.417 2.744 . . . . 0.95 112.276 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -67.0 167.18 12.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.095 -1.003 . . . . 1.84 109.341 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -59.94 -40.0 87.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 2.74 110.07 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.453 ' H ' ' CD ' ' A' ' 234' ' ' GLU . 58.3 mp0 -60.0 -39.98 87.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.188 -0.945 . . . . 2.89 110.085 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.32 -39.4 85.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 1.3 110.049 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.9 mt -66.77 -39.93 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 1.09 110.903 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.492 ' OD1' ' N ' ' A' ' 238' ' ' LYS . 1.0 OUTLIER -60.0 -41.49 92.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.607 -1.308 . . . . 2.43 108.969 -179.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.492 ' N ' ' OD1' ' A' ' 237' ' ' ASP . 8.3 ttpm? -60.14 -46.52 89.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.595 -0.69 . . . . 2.78 110.227 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 78.3 mtp -72.4 -23.26 61.07 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.288 -0.882 . . . . 1.25 110.058 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.404 HH11 ' HG3' ' A' ' 240' ' ' ARG . 15.4 mmm-85 -70.27 -40.14 74.51 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.022 -1.049 . . . . 2.63 109.105 178.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.18 -43.08 96.15 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.345 -0.847 . . . . 1.8 109.01 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.2 t -59.99 -45.95 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.392 -0.818 . . . . 2.13 108.889 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -60.18 -40.0 88.44 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.849 . . . . 3.17 109.962 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -61.46 -40.19 93.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.035 -1.041 . . . . 1.78 109.736 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -61.38 -39.95 92.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 2.47 109.985 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 91.2 t -60.04 -45.5 95.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.14 -0.975 . . . . 2.09 108.947 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.13 -50.13 74.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.399 -0.813 . . . . 2.54 109.685 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 252' ' ' GLU . 66.3 m -60.07 -40.0 88.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.303 -0.873 . . . . 2.99 109.616 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -63.92 -39.91 95.26 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.386 -0.821 . . . . 3.34 109.067 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -91.53 -0.06 57.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.587 -0.696 . . . . 3.88 110.395 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -130.78 -45.76 1.05 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.445 -1.409 . . . . 4.43 110.606 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 248' ' ' SER . 86.3 tt0 -167.42 109.41 0.64 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 120.946 -1.097 . . . . 5.42 109.006 -179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 21.4 mt -65.5 -27.13 68.26 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.21 -1.033 . . . . 6.1 108.21 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.406 ' O ' ' C ' ' A' ' 255' ' ' LYS . . . 60.27 12.98 3.65 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.868 -0.52 . . . . 7.37 109.691 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.491 ' C ' ' H ' ' A' ' 257' ' ' LYS . 51.6 tttm 39.97 -129.97 0.34 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.702 -0.624 . . . . 8.01 110.171 179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 257' ' ' LYS . 0.5 OUTLIER 67.61 -6.24 0.69 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.22 -0.925 . . . . 9.05 109.045 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.491 ' H ' ' C ' ' A' ' 255' ' ' LYS . 31.8 ttmt 55.8 155.89 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.544 0.688 . . . . 10.56 110.214 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -164.37 -89.41 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.023 -1.048 . . . . 11.32 109.675 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 . . . . . 0 N--CA 1.497 1.911 0 CA-C-O 117.949 -1.024 . . . . 12.42 109.447 -179.93 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . 0.485 ' N ' ' OE1' ' B' ' 366' ' ' GLU . 21.6 ttt . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 22.3 t80 -156.08 154.55 31.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.313 -0.867 . . . . 0.0 109.48 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . 0.506 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 20.6 pt20 -148.5 160.03 43.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.288 -0.883 . . . . 0.0 109.674 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -151.81 149.97 29.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.309 -0.869 . . . . 0.0 109.596 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 56.5 mp0 -105.94 130.63 53.84 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.382 -0.824 . . . . 0.0 109.742 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.491 ' O ' HG13 ' B' ' 306' ' ' VAL . 10.2 p -130.58 117.73 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.293 0 CA-C-O 122.25 1.024 . . . . 0.0 113.071 -177.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 86.7 m -78.24 105.21 9.32 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 122.057 0.932 . . . . 0.0 110.53 -178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.7 mt -53.13 125.96 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-O 122.429 1.109 . . . . 0.0 111.264 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 22.6 p -112.04 19.94 17.37 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.557 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -73.71 120.65 82.31 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.746 -1.221 . . . . 0.0 109.402 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -50.96 -18.9 4.86 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 CA-C-N 120.205 1.109 . . . . 0.0 113.463 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -119.43 14.29 12.81 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.233 -0.917 . . . . 0.0 109.603 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.61 179.45 35.25 Favored Glycine 0 N--CA 1.485 1.944 0 N-CA-C 108.237 -1.945 . . . . 0.0 108.237 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.426 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 3.9 tp -85.38 95.41 9.23 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.05 -1.265 . . . . 0.0 109.477 -178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.401 ' CA ' ' OH ' ' A' ' 122' ' ' TYR . 3.7 p80 -97.96 -160.72 0.82 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 120.934 -1.104 . . . . 0.0 110.108 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 7.9 m -59.92 -41.94 92.83 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.095 -1.003 . . . . 0.0 112.295 -176.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.654 HH21 ' NE2' ' B' ' 321' ' ' GLN . 1.0 OUTLIER -55.33 -62.13 4.89 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.538 -1.351 . . . . 0.0 111.224 -178.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -58.05 -33.23 97.05 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 CA-C-N 120.242 1.122 . . . . 0.0 111.765 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.95 -50.79 72.36 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.254 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.46 -43.12 75.16 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.464 -0.772 . . . . 0.0 110.736 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . 0.654 ' NE2' HH21 ' B' ' 317' ' ' ARG . 27.7 mt-30 -73.49 -40.08 64.36 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.037 179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -60.09 -50.26 74.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.362 -0.836 . . . . 0.0 110.431 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . 0.462 HG13 ' O ' ' B' ' 344' ' ' ALA . 54.6 t -66.45 -40.02 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.566 -1.334 . . . . 0.0 108.981 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 3.5 ttpm? -59.9 -45.77 91.48 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -62.49 -45.88 91.0 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.103 -0.998 . . . . 0.0 108.437 178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.09 -51.21 70.61 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.617 -0.677 . . . . 0.0 110.308 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -57.72 -10.46 1.63 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.913 -1.117 . . . . 0.0 109.082 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.91 -29.89 70.57 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -103.36 144.89 30.78 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.561 -0.964 . . . . 0.0 108.915 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 16.6 p -91.39 -13.19 32.85 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.789 -1.195 . . . . 0.0 109.916 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 83.9 p -58.97 151.34 22.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.983 -1.073 . . . . 0.0 108.905 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.1 133.36 47.96 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.006 -1.059 . . . . 0.0 108.579 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.1 mt -131.88 131.05 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.753 -0.592 . . . . 0.0 109.802 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . 0.405 HG22 ' N ' ' B' ' 335' ' ' VAL . 89.2 m -129.82 153.51 48.19 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . 0.405 ' N ' HG22 ' B' ' 334' ' ' THR . 84.9 t -116.11 138.27 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 77.6 m -130.03 125.4 35.2 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.119 -0.988 . . . . 0.0 109.133 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 51.6 p -139.58 117.0 11.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.197 -0.939 . . . . 0.0 110.906 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 34.4 m120 42.75 57.75 3.43 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.342 0.868 . . . . 0.0 113.342 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 83.98 -14.26 44.53 Favored Glycine 0 N--CA 1.499 2.858 0 O-C-N 120.303 -1.498 . . . . 0.0 112.806 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 25.5 mtpp -115.58 126.88 54.78 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-N 119.108 1.454 . . . . 0.0 109.974 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 80.0 p -127.27 148.92 50.22 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.929 0.871 . . . . 0.0 110.28 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -140.97 164.28 30.69 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.508 0.67 . . . . 0.0 109.903 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 23.2 t -87.35 137.23 32.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.493 -0.754 . . . . 0.0 109.202 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.462 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -76.73 -13.39 60.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.979 -1.076 . . . . 0.0 109.858 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.07 20.67 4.13 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 67.4 m -146.25 94.25 2.43 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.714 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.815 HD23 HD22 ' A' ' 79' ' ' LEU . 56.9 tp -59.92 -33.34 71.74 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.852 ' CE2' HD11 ' A' ' 79' ' ' LEU . 54.9 m-85 -56.75 -52.79 63.65 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.396 -0.815 . . . . 0.0 110.616 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -69.33 -39.79 77.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.632 -1.292 . . . . 0.0 110.089 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' B' ' 352' ' ' THR . 20.9 mt -48.59 -58.49 4.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.062 -1.024 . . . . 0.0 109.07 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.912 ' O ' HD22 ' A' ' 123' ' ' LEU . 1.3 mp0 -41.6 -14.22 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.555 -0.716 . . . . 0.0 111.19 -178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.574 ' N ' ' O ' ' B' ' 350' ' ' LEU . 50.2 p -87.65 -7.62 57.21 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.039 -1.663 . . . . 0.0 109.966 -179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 66.5 mt -97.42 116.14 29.06 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.129 -0.982 . . . . 0.0 109.493 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.67 93.06 1.02 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.793 -1.723 . . . . 0.0 108.793 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 21.8 mt -103.31 96.27 6.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.35 -1.088 . . . . 0.0 108.9 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 19.2 p -94.67 170.55 9.38 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.147 -0.971 . . . . 0.0 110.774 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.44 115.83 3.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.831 -0.543 . . . . 0.0 111.035 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 100.62 7.36 51.31 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 53.4 m -85.03 111.5 19.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.205 -1.173 . . . . 0.0 110.827 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 7.6 t -78.03 116.25 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 122.222 1.01 . . . . 0.0 109.503 -177.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.1 m -113.64 178.62 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 86.6 m -130.45 130.86 44.79 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.4 mt -106.86 126.26 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 71.1 m -129.96 137.17 50.18 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.554 -0.716 . . . . 0.0 109.48 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.32 156.54 43.0 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.324 -0.86 . . . . 0.0 109.337 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . 0.485 ' OE1' ' N ' ' B' ' 301' ' ' MET . 8.8 tp10 -145.96 122.84 11.31 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 157.42 -152.88 24.16 Favored Glycine 0 N--CA 1.49 2.293 0 C-N-CA 118.853 -1.641 . . . . 0.0 111.715 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -60.0 -52.96 63.15 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 122.268 -0.548 . . . . 0.0 112.357 -177.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -110.2 11.26 23.66 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.838 -1.164 . . . . 0.0 111.224 -177.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -42.58 -38.0 1.85 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.073 -1.017 . . . . 0.0 111.817 -178.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -69.32 -44.17 72.26 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.531 -1.356 . . . . 0.0 110.158 -178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -70.83 -54.28 12.17 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.016 -1.053 . . . . 0.0 109.242 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.62 -35.95 1.95 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.627 -0.671 . . . . 0.0 110.771 -179.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.562 ' O ' HG23 ' B' ' 378' ' ' VAL . 53.2 t -70.04 -40.02 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.799 -1.188 . . . . 0.0 109.283 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.39 -65.38 0.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.985 -1.072 . . . . 0.0 111.668 -178.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -59.96 -42.05 93.24 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.626 -1.296 . . . . 0.0 111.57 -177.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 93.3 mt -59.92 -42.04 93.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.652 -1.28 . . . . 0.0 108.311 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.562 HG23 ' O ' ' B' ' 374' ' ' VAL . 53.8 t -63.03 -42.36 96.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 121.297 -0.877 . . . . 0.0 109.684 179.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.549 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.4 mttt -69.99 -56.17 7.7 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.708 -1.245 . . . . 0.0 107.915 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 54.3 tp -54.51 -36.09 63.85 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . 0.433 ' SD ' HG11 ' B' ' 306' ' ' VAL . 28.2 ttm -70.52 -40.25 73.58 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 118.391 -1.324 . . . . 0.0 108.413 177.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.46 -5.56 58.77 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.654 -0.654 . . . . 0.0 110.682 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.549 ' N ' ' O ' ' B' ' 379' ' ' LYS . 67.9 mt-10 -112.24 -1.96 15.03 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.052 -1.03 . . . . 0.0 110.708 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . 0.614 HD21 ' NE2' ' B' ' 321' ' ' GLN . 15.3 mt -83.68 136.94 34.01 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.427 -1.42 . . . . 0.0 109.066 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.405 -179.639 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.7 mmm . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.448 -0.575 . . . . 2.91 109.448 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.4 mt -110.06 129.95 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.54 -0.911 . . . . 1.2 108.54 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 46.6 m -135.85 150.1 49.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.39 -0.819 . . . . 1.4 110.405 -178.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.614 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -132.93 -164.62 10.94 Favored Glycine 0 N--CA 1.495 2.607 0 N-CA-C 108.081 -2.008 . . . . 1.05 108.081 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.6 mt -89.2 -14.46 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.632 -1.511 . . . . 1.15 110.353 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.0 tp 55.27 102.24 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.148 -0.97 . . . . 0.98 108.53 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.04 -22.86 19.72 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.994 -1.066 . . . . 0.88 109.633 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.5 m -149.99 133.4 8.62 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.097 -1.002 . . . . 1.69 109.677 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -80.37 141.01 13.98 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.4 2.067 . . . . 0.85 112.15 179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.712 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 166.0 -165.58 38.19 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 109.712 -1.355 . . . . 0.92 109.712 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.6 mt -147.54 148.01 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.22 -1.164 . . . . 0.81 108.52 178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.17 156.55 34.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.939 -1.101 . . . . 0.51 110.487 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -137.01 129.64 30.26 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.315 -1.365 . . . . 0.62 107.315 178.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.38 -174.81 47.23 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 118.37 -1.871 . . . . 0.55 110.986 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -80.04 156.7 27.0 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.942 -0.74 . . . . 2.1 109.95 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.564 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.5 117.73 34.86 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.436 -0.79 . . . . 0.77 110.118 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.4 tp -89.99 131.55 35.82 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 107.507 -1.294 . . . . 0.91 107.507 178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 46.5 tp -113.55 120.0 39.46 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.329 -0.857 . . . . 0.93 109.243 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.445 HD12 ' HB2' ' A' ' 160' ' ' ALA . 40.2 mt -82.74 102.76 11.75 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.515 0.674 . . . . 0.93 109.656 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -103.0 129.39 49.74 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.751 -0.833 . . . . 2.75 108.751 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.456 ' OE2' ' NZ ' ' A' ' 135' ' ' LYS . 87.0 tt0 -130.36 140.76 50.6 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.223 -0.923 . . . . 3.0 109.372 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -80.16 142.99 34.23 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.351 -0.843 . . . . 2.77 109.501 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -61.7 143.53 56.03 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.129 -0.982 . . . . 2.94 108.801 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.6 mt -78.16 129.16 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.084 -1.01 . . . . 0.95 109.119 -179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 84.7 t -94.14 127.59 46.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.223 -0.923 . . . . 1.28 109.998 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.6 mt -110.02 134.33 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.637 -0.664 . . . . 1.21 109.229 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -93.84 123.08 36.95 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.169 -0.957 . . . . 1.81 110.249 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.417 HH11 ' HG3' ' A' ' 28' ' ' ARG . 24.7 mmm-85 -90.0 -0.2 57.45 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.446 -0.784 . . . . 2.8 109.182 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -67.32 145.37 55.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.264 -0.897 . . . . 2.87 109.92 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -92.01 149.28 21.62 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.239 -0.913 . . . . 2.35 109.253 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.559 HD13 ' HG3' ' A' ' 39' ' ' GLU . 3.0 pt -95.7 165.81 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.998 -1.064 . . . . 0.97 109.046 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.2 p -93.11 173.93 7.48 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.419 -0.956 . . . . 1.17 108.419 178.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.26 78.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.898 -1.126 . . . . 1.18 109.669 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.412 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 51.8 t0 -54.93 -30.68 59.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.93 -1.106 . . . . 2.56 110.162 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 60.5 mt-30 -82.17 -8.67 59.66 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.177 -0.952 . . . . 1.79 110.249 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.3 t -59.98 -50.31 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 120.763 -1.21 . . . . 1.0 108.578 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -60.41 -39.96 89.26 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.359 -0.838 . . . . 1.77 108.926 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.6 mm100 -62.25 -40.99 98.02 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.494 -0.753 . . . . 2.7 110.598 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.559 ' HG3' HD13 ' A' ' 31' ' ' ILE . 71.3 mm-40 -64.36 -41.63 96.62 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.813 -1.179 . . . . 1.51 110.166 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.07 -46.7 93.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 120.909 -1.119 . . . . 0.93 109.069 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -60.05 -40.79 90.63 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.055 -1.028 . . . . 1.81 109.551 -179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -60.06 -44.56 94.64 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.9 -1.125 . . . . 2.78 108.458 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -60.09 -49.16 78.76 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.313 -0.995 . . . . 0.78 108.313 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 tp -60.1 -46.63 88.96 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.402 -0.962 . . . . 1.07 108.402 179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.449 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 23.2 t -60.56 -44.47 96.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 1.12 108.875 178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.02 -40.01 96.44 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.247 -1.941 . . . . 0.84 108.247 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.523 HH11 ' HG2' ' A' ' 47' ' ' ARG . 1.4 ttt-85 -69.11 -22.61 63.96 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.562 -0.964 . . . . 3.09 108.64 178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.07 -46.37 88.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.259 -0.901 . . . . 0.88 109.155 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.555 ' CG ' ' H ' ' A' ' 50' ' ' ALA . 0.2 OUTLIER -78.15 -68.96 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 118.554 -1.258 . . . . 2.59 108.585 179.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.555 ' H ' ' CG ' ' A' ' 49' ' ' LYS . . . -37.84 -35.79 0.16 Allowed 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 120.058 1.299 . . . . 0.7 110.462 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.3 t -57.97 -64.43 0.91 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.907 -1.121 . . . . 1.4 108.666 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.97 -40.07 79.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.475 -0.765 . . . . 0.67 110.832 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -63.11 -40.96 99.16 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.812 -1.18 . . . . 1.66 110.361 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 57.5 mt -62.94 -39.86 95.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.881 -1.137 . . . . 1.58 109.216 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -60.11 -38.95 84.56 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.363 -0.836 . . . . 1.35 110.014 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.6 m -61.24 -41.96 97.78 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.075 -1.015 . . . . 0.77 109.9 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.678 ' CD1' HH22 ' A' ' 136' ' ' ARG . 82.2 mt -61.2 -39.91 84.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.36 -0.837 . . . . 0.63 109.522 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -59.97 -50.43 73.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.083 -1.011 . . . . 1.14 109.659 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -59.96 -39.14 84.61 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.281 -0.887 . . . . 0.79 110.125 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -66.03 -37.75 86.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.989 -1.07 . . . . 1.53 109.14 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.79 -45.53 85.91 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.599 -0.688 . . . . 0.57 109.89 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.41 -50.03 71.06 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.626 -1.39 . . . . 0.75 109.626 -179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -67.3 -45.87 75.24 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.294 -1.121 . . . . 1.59 109.871 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.9 m -65.23 -64.16 0.93 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.363 -0.836 . . . . 0.73 112.347 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -93.42 -47.91 6.65 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.723 -1.236 . . . . 0.75 111.188 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.35 -169.83 24.92 Favored Glycine 0 N--CA 1.501 3.016 0 C-N-CA 119.824 -1.179 . . . . 1.22 111.467 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -69.65 -27.3 64.93 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 122.01 -0.7 . . . . 5.81 110.41 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.514 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.3 tp10 -59.95 -32.92 71.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.275 -0.89 . . . . 3.37 110.258 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.5 ' NZ ' ' NE2' ' A' ' 189' ' ' HIS . 14.5 mmmt -98.99 -22.46 15.73 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.226 -0.921 . . . . 1.77 110.259 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -64.94 -40.07 94.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.954 -1.091 . . . . 1.65 109.893 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.505 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -59.82 -37.57 79.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.307 -0.87 . . . . 0.77 110.309 -178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.01 -40.6 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.782 -1.199 . . . . 0.8 109.87 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -70.02 -34.11 72.86 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.858 -1.151 . . . . 0.88 109.609 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.3 tt0 -61.18 -39.98 92.21 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.875 -1.141 . . . . 1.37 109.221 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.91 -41.84 95.2 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.547 -1.421 . . . . 0.62 109.547 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 60.9 m170 -60.16 -43.42 95.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -1.122 . . . . 1.5 109.582 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.3 mt -69.91 -43.55 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.116 -0.99 . . . . 0.63 109.491 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.2 ttp -59.96 -44.92 94.13 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.845 -1.159 . . . . 1.51 110.309 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.875 HD11 ' CE2' ' B' ' 348' ' ' PHE . 53.9 tp -62.02 -39.82 93.59 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.358 -0.839 . . . . 0.77 109.987 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.5 tp -62.16 -39.57 93.09 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.44 -0.788 . . . . 0.62 110.157 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -82.02 8.66 10.08 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.996 -1.065 . . . . 1.47 110.204 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 59.7 t0 -56.71 130.51 45.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.976 -1.077 . . . . 1.47 109.977 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.407 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.8 mt-10 -59.69 -18.43 42.25 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.482 -0.761 . . . . 1.78 111.019 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.89 -36.92 72.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.723 -1.235 . . . . 2.53 108.592 178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.6 mt -69.99 -40.05 75.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.594 -0.691 . . . . 0.8 110.177 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.02 -49.99 75.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.316 -0.865 . . . . 1.42 110.483 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.13 -39.94 75.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.174 -0.954 . . . . 1.71 111.269 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -69.97 -40.18 75.54 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.835 -1.166 . . . . 1.57 111.66 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.2 mt -69.99 -44.15 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.739 -1.225 . . . . 0.65 109.917 -179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.9 mt -70.02 -37.83 73.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.616 -0.678 . . . . 0.82 110.374 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.68 84.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.988 . . . . 0.79 110.796 -179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.22 -47.06 87.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.082 -1.012 . . . . 0.95 109.986 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.2 mt -60.66 -50.04 82.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.309 -0.869 . . . . 0.66 109.447 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -70.08 -42.32 72.94 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.727 -0.789 . . . . 2.2 110.576 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.6 t0 -80.09 -52.79 7.36 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.188 -0.945 . . . . 1.65 112.417 -177.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.6 mtpt -90.12 -3.05 58.14 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.973 -1.08 . . . . 2.03 111.675 -177.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 18.1 m80 59.69 37.5 22.26 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.959 -1.088 . . . . 1.42 109.467 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 53.2 mtt -93.87 166.24 12.28 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.443 -0.786 . . . . 1.18 109.782 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.7 p -80.55 162.32 24.37 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.381 -0.824 . . . . 0.98 109.28 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.51 -37.61 85.42 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.266 -0.896 . . . . 0.64 110.102 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.41 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 27.4 p-10 -69.87 -35.71 74.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.969 . . . . 2.07 109.458 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.85 -41.05 27.09 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.296 -0.878 . . . . 0.73 109.56 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.2 -48.17 53.09 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.345 -0.847 . . . . 0.54 110.339 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.3 -40.6 91.07 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.084 -1.01 . . . . 0.56 109.612 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.53 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 78.5 t60 -60.12 -40.0 88.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.276 -0.89 . . . . 1.54 109.617 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.54 -41.3 98.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.272 -0.893 . . . . 1.33 110.81 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.28 -53.18 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.012 -1.055 . . . . 0.72 111.313 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 7.6 mm -70.0 -39.93 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.817 -1.177 . . . . 0.85 109.36 -179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.53 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 88.4 tt0 -64.65 -38.62 91.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.118 -0.989 . . . . 2.44 108.877 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.95 -43.7 97.86 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.479 -1.049 . . . . 0.98 110.479 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -69.94 -55.26 10.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.922 -1.34 . . . . 1.41 109.531 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.73 -40.31 69.12 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.183 -0.948 . . . . 1.2 109.343 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 33.8 t -57.77 -40.06 78.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.063 -1.023 . . . . 1.7 108.29 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.81 -39.56 87.77 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.743 -0.836 . . . . 1.47 108.743 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 45.9 mt -61.78 -42.48 99.04 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.119 -0.988 . . . . 1.56 109.673 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -60.43 -33.37 72.43 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.665 -1.272 . . . . 2.2 109.684 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -56.37 -23.17 35.98 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.984 -1.072 . . . . 2.12 108.506 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.535 HD13 HD13 ' A' ' 123' ' ' LEU . 21.9 mt -61.83 139.49 58.35 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.226 -1.027 . . . . 2.0 108.226 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -92.65 46.25 1.23 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.056 -1.027 . . . . 3.23 108.983 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -132.11 129.61 40.12 Favored 'General case' 0 N--CA 1.498 1.95 0 CA-C-O 121.688 0.756 . . . . 2.49 109.664 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 30.6 tp10 -70.05 -29.98 67.14 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.735 -0.603 . . . . 3.95 109.946 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.448 ' OH ' ' CA ' ' B' ' 315' ' ' HIS . 17.1 t80 -66.97 -42.97 84.24 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-O 121.958 0.885 . . . . 2.0 110.802 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.826 HD22 ' O ' ' B' ' 351' ' ' GLN . 91.4 mt -70.67 -32.79 70.19 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.569 -0.707 . . . . 1.86 109.774 -179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -60.07 -39.98 87.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.312 -0.868 . . . . 2.84 108.86 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.524 ' N ' ' OE1' ' A' ' 125' ' ' GLU . 0.4 OUTLIER -59.51 -49.1 79.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.191 -0.943 . . . . 2.73 109.493 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.623 HH21 ' CD2' ' A' ' 123' ' ' LEU . 59.4 mtm180 -60.21 -39.6 87.18 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.569 -1.252 . . . . 2.77 108.418 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.44 -28.32 66.85 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.472 -0.936 . . . . 1.19 108.472 179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -60.05 -46.75 88.52 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.407 -0.808 . . . . 1.2 108.978 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -61.29 -41.3 96.74 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 1.55 109.703 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.72 -44.39 98.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 121.299 -0.875 . . . . 0.8 109.445 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 70.5 ttt180 -63.6 -40.04 95.9 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.127 -0.983 . . . . 3.09 109.914 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -60.01 -41.09 91.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.122 -0.986 . . . . 1.46 110.341 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.96 -46.8 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.916 -1.115 . . . . 0.71 109.85 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.3 -40.34 98.89 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.756 -1.338 . . . . 0.57 109.756 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.456 ' NZ ' ' OE2' ' A' ' 21' ' ' GLU . 57.6 tttm -59.97 -49.78 76.33 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -1.081 . . . . 2.59 110.472 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.678 HH22 ' CD1' ' A' ' 57' ' ' ILE . 63.1 mtp180 -63.12 -39.37 94.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.123 -0.985 . . . . 2.83 110.952 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.81 -40.11 87.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 1.25 110.111 -177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' A' ' 105' ' ' HIS . 23.9 mt -62.35 -40.0 94.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.776 -1.203 . . . . 0.7 109.109 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.9 mtm180 -68.97 -38.74 79.57 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.347 -0.846 . . . . 2.57 109.782 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -69.99 -31.22 68.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.45 -0.781 . . . . 1.23 111.887 -178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.56 -46.07 71.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.136 -1.603 . . . . 0.81 108.484 179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.4 mt -70.1 -31.23 68.7 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.634 -0.666 . . . . 1.0 109.561 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.61 45.93 4.46 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.507 -1.437 . . . . 0.89 109.507 -179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.1 tp -74.32 145.63 43.75 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.39 -1.065 . . . . 1.14 108.939 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -69.89 139.1 52.96 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.012 -1.055 . . . . 4.6 109.245 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.4 mt -111.75 129.96 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 CA-C-O 121.936 0.874 . . . . 1.24 109.26 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 3.6 mt -59.89 -44.17 93.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.873 -0.517 . . . . 1.54 109.955 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 27.2 t0 66.37 99.03 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.516 0.674 . . . . 1.5 109.23 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.5 mt -66.46 -7.28 18.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.518 -0.739 . . . . 0.79 109.208 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -84.78 -16.82 40.19 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.463 -0.773 . . . . 1.4 109.208 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.31 13.08 3.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.436 -0.79 . . . . 0.92 111.162 -178.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.593 HD12 ' N ' ' A' ' 152' ' ' ILE . 1.4 mp -90.28 126.21 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 120.58 -1.325 . . . . 0.88 108.804 179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -104.09 -7.47 20.21 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.547 -0.721 . . . . 2.45 110.213 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -119.94 147.8 44.3 Favored 'General case' 0 N--CA 1.506 2.326 0 O-C-N 121.444 -0.785 . . . . 1.52 110.481 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.67 136.9 57.46 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.438 -0.789 . . . . 1.58 109.442 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.8 m -152.11 163.22 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -0.781 . . . . 0.69 109.334 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 79.5 mt -91.15 148.96 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 106.008 -1.849 . . . . 0.61 106.008 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 35.3 tp -96.38 113.98 25.61 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.869 -1.145 . . . . 0.87 110.39 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.581 HG12 HG22 ' A' ' 209' ' ' THR . 50.4 t -121.76 129.92 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 N-CA-C 108.83 -0.804 . . . . 0.71 108.83 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.445 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -159.96 162.26 34.35 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.243 -1.021 . . . . 0.81 108.243 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.9 -34.78 71.9 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.26 -1.525 . . . . 0.98 108.03 178.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 40.1 p-10 -159.93 171.38 19.5 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.442 -0.947 . . . . 2.25 108.442 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.7 mt -139.76 140.04 36.62 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.063 -1.023 . . . . 0.78 109.592 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.3 p -100.19 135.43 20.33 Favored Pre-proline 0 N--CA 1.497 1.908 0 O-C-N 121.415 -0.803 . . . . 0.98 109.501 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -38.61 -35.61 0.51 Allowed 'Trans proline' 0 N--CA 1.495 1.604 0 C-N-CA 122.358 2.039 . . . . 0.81 113.437 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 60.5 m -59.9 -40.01 87.35 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.921 -1.112 . . . . 0.9 109.205 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -66.23 -40.98 90.63 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.308 -0.87 . . . . 1.61 109.948 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 67.3 p -57.21 -29.8 64.03 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.204 -0.935 . . . . 0.61 111.271 -178.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.82 -53.91 13.57 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.682 -1.261 . . . . 0.6 109.768 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -86.98 36.36 0.72 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 109.022 -0.733 . . . . 1.4 109.022 -179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.4 tp -101.19 139.42 36.9 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.866 -0.79 . . . . 0.7 108.866 178.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -85.83 101.96 13.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.125 -0.984 . . . . 2.35 108.954 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.09 -40.04 94.04 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.33 -0.856 . . . . 1.51 110.821 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -69.56 -25.46 64.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.966 -1.084 . . . . 2.33 111.458 -177.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -93.15 -9.37 39.64 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.848 -1.157 . . . . 1.92 110.548 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.578 HG11 ' CE1' ' A' ' 179' ' ' PHE . 70.8 t -101.44 111.19 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 N-CA-C 108.185 -1.043 . . . . 0.67 108.185 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.2 mt -83.52 3.27 33.03 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.228 -0.92 . . . . 1.53 110.577 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.29 170.49 37.62 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.147 -1.581 . . . . 0.48 109.147 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.578 ' CE1' HG11 ' A' ' 176' ' ' VAL . 27.7 m-85 -131.31 128.62 40.12 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.454 -1.027 . . . . 0.55 109.374 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 84.9 mt -132.4 126.25 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.485 -0.931 . . . . 0.65 108.485 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 23.6 p -148.67 161.5 41.61 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.024 -1.048 . . . . 0.82 110.876 -179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.476 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 55.8 t0 -105.78 24.54 12.13 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 109.426 -0.583 . . . . 2.46 109.426 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.93 -161.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.241 -1.537 . . . . 1.28 111.195 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.02 -50.61 7.57 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.097 -1.201 . . . . 2.19 110.097 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 161.79 -133.68 3.23 Favored Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.27 -1.443 . . . . 2.13 110.909 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.494 ' C ' ' H ' ' A' ' 188' ' ' SER . 41.5 ttt-85 -60.02 -39.98 87.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.563 -0.963 . . . . 5.86 111.415 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 67.2 p -59.7 2.99 0.06 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.616 -1.302 . . . . 3.72 110.385 -178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.494 ' H ' ' C ' ' A' ' 186' ' ' ARG . 24.8 t -92.0 127.96 37.66 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.969 -1.082 . . . . 1.74 109.898 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.5 ' NE2' ' NZ ' ' A' ' 69' ' ' LYS . 56.9 t60 -43.9 -48.52 8.47 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.356 -0.84 . . . . 0.95 109.458 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 61.6 m -55.04 -36.83 65.95 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.763 -0.585 . . . . 1.55 110.949 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 69.3 m -59.96 -39.99 87.53 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.679 -1.263 . . . . 1.51 110.441 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.8 mm -64.52 -39.91 87.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.134 -0.979 . . . . 1.67 109.122 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.0 mtp -59.94 -45.0 94.03 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.275 -0.891 . . . . 1.02 110.532 -178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.45 -45.52 84.65 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.381 -1.449 . . . . 0.68 109.956 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -62.4 -57.21 12.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.975 -1.078 . . . . 2.93 110.737 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.3 m -63.36 -40.02 96.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.002 -1.061 . . . . 0.86 111.997 -178.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.6 mt -72.34 -25.36 61.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.821 -1.175 . . . . 0.67 109.744 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 85.4 mt-10 70.2 47.33 0.56 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.3 0.571 . . . . 1.5 110.218 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 62.7 mt -124.21 149.78 61.72 Favored Pre-proline 0 N--CA 1.499 2.02 0 N-CA-C 107.8 -1.185 . . . . 0.72 107.8 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.67 138.62 59.68 Favored 'Trans proline' 0 N--CA 1.5 1.902 0 C-N-CA 122.268 1.979 . . . . 0.61 111.832 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.77 152.01 2.97 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 118.605 -1.238 . . . . 0.66 111.713 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.8 mt -125.98 147.69 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 107.473 -1.306 . . . . 0.79 107.473 178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.8 m -128.55 -9.92 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.373 0 O-C-N 120.932 -1.105 . . . . 0.91 110.812 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.414 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -114.73 24.58 10.91 Favored Glycine 0 N--CA 1.502 3.063 0 N-CA-C 110.435 -1.066 . . . . 1.01 110.435 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 204' ' ' GLY . 3.1 p -42.73 -47.17 5.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.262 -1.14 . . . . 0.99 110.192 -179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.443 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 98.71 -56.69 0.98 Allowed Glycine 0 N--CA 1.503 3.13 0 C-N-CA 120.221 -0.99 . . . . 1.12 111.549 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 26.1 p -148.99 26.62 0.88 Allowed 'General case' 0 N--CA 1.503 2.221 0 O-C-N 120.445 -1.621 . . . . 1.72 111.103 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 55.9 t -71.23 -40.04 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.989 -1.069 . . . . 0.89 109.395 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.581 HG22 HG12 ' A' ' 159' ' ' VAL . 31.7 p -62.06 -29.27 70.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.169 -0.957 . . . . 1.03 109.765 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 94.9 p -79.94 -20.99 44.37 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.209 -0.932 . . . . 1.83 109.561 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.6 mt-30 -96.5 -8.34 32.33 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.25 -0.906 . . . . 2.27 109.534 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 58.9 t -105.94 138.72 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-O 121.622 0.725 . . . . 0.92 110.853 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.433 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 2.1 mptp? -112.59 154.72 25.57 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.655 -1.239 . . . . 2.2 107.655 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.466 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 17.9 p-10 -59.85 139.8 57.08 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.025 -1.047 . . . . 2.36 110.113 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.466 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.4 m-20 83.82 4.32 0.81 Allowed 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 121.121 0.486 . . . . 2.38 110.162 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.433 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 86.2 m-20 -73.57 138.16 44.76 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.136 -0.978 . . . . 2.09 109.231 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -90.09 117.91 29.23 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.501 -1.296 . . . . 1.27 107.501 178.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.564 HD12 ' HB2' ' A' ' 16' ' ' ALA . 74.5 mt -127.18 150.82 49.34 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.519 -0.738 . . . . 0.75 110.927 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.471 HG23 ' CD2' ' A' ' 13' ' ' PHE . 76.2 mt -117.61 129.99 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.147 -1.427 . . . . 0.63 107.147 177.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 22.2 tp -102.38 120.19 40.08 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.001 -1.062 . . . . 0.7 109.701 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.669 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 25.1 p-10 -80.05 -39.9 28.84 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.082 -1.011 . . . . 2.31 108.863 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.712 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 48.04 19.68 0.2 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.338 -0.986 . . . . 0.78 108.338 -178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.451 ' N ' ' C ' ' A' ' 221' ' ' ASP . 21.4 t -133.12 -44.3 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 107.339 -1.356 . . . . 1.04 107.339 179.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -100.1 0.02 39.91 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.747 -1.205 . . . . 2.44 107.747 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.614 HD21 ' H ' ' A' ' 4' ' ' GLY . 38.6 t30 60.02 46.88 10.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.714 -0.616 . . . . 1.55 109.57 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.669 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 76.9 mt-30 -140.04 151.82 45.72 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.43 -0.794 . . . . 1.99 109.622 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 83.1 t -119.12 129.96 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.419 -0.956 . . . . 0.77 108.419 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -99.95 118.79 37.11 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.477 -0.934 . . . . 0.98 108.477 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 14.4 t -99.98 115.13 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.544 -0.722 . . . . 0.85 110.503 -178.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 52.45 63.09 9.39 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 1.66 111.164 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -88.99 148.46 5.67 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.557 2.172 . . . . 0.95 111.871 178.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 58.9 p -68.78 161.38 28.58 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 1.84 109.576 -179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -60.03 -39.97 87.74 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.352 -0.843 . . . . 2.74 110.519 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -60.32 -32.96 71.73 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.932 -1.105 . . . . 2.89 109.816 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.33 -39.98 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -0.985 . . . . 1.3 109.141 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.3 mt -61.6 -40.18 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -0.883 . . . . 1.09 109.284 179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -59.97 -41.87 92.89 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.129 -0.982 . . . . 2.43 109.06 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -64.15 -42.62 96.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.292 -0.88 . . . . 2.78 108.752 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 93.6 mtp -64.75 -38.68 91.81 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.49 -0.756 . . . . 1.25 109.376 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -68.66 -40.05 80.36 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.256 -0.903 . . . . 2.63 109.438 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.84 95.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.128 -0.982 . . . . 1.8 108.786 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.53 -39.97 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.61 -0.681 . . . . 2.13 109.292 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.25 -41.68 84.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.017 -1.052 . . . . 3.17 108.851 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -61.03 -40.08 92.22 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 107.984 -1.117 . . . . 1.78 107.984 178.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 -66.58 -36.6 83.04 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.662 -0.649 . . . . 2.47 109.419 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.99 -40.75 83.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.359 -0.838 . . . . 2.09 109.351 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.07 -40.87 90.98 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.295 -0.878 . . . . 2.54 109.165 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 18.9 t -65.15 -40.06 93.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.299 -0.876 . . . . 2.99 109.649 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -60.16 -39.98 88.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.258 -0.901 . . . . 3.34 109.309 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -65.76 -10.64 39.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.455 -0.778 . . . . 3.88 110.119 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.519 ' O ' ' NZ ' ' A' ' 255' ' ' LYS . . . -79.29 27.21 0.26 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.157 -0.965 . . . . 4.43 110.058 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -140.04 27.83 2.15 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.103 -0.998 . . . . 5.42 109.694 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 60.1 mt -58.54 -50.02 75.3 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.06 -1.025 . . . . 6.1 109.535 -179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -161.41 58.27 0.28 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.804 -1.185 . . . . 7.37 110.405 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.519 ' NZ ' ' O ' ' A' ' 251' ' ' ALA . 45.1 mmtm -68.85 -44.98 72.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.119 -0.988 . . . . 8.01 109.663 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 23.5 tp -117.06 -51.38 2.55 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 108.55 -0.907 . . . . 9.05 108.55 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 7.2 ttpm? -149.99 157.68 43.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.454 -0.779 . . . . 10.56 109.407 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -58.45 -59.19 5.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.292 -0.88 . . . . 11.32 109.723 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.405 ' HG2' HH11 ' A' ' 259' ' ' ARG . 39.3 ttt-85 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.946 -1.026 . . . . 12.42 109.413 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 40.7 ttp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.46 0.648 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 30.1 t80 -155.78 155.37 32.92 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.482 -0.761 . . . . 0.0 109.1 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . 0.539 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 12.9 pt20 -146.75 157.03 43.59 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.166 -0.959 . . . . 0.0 109.939 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -152.94 150.07 28.88 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -114.99 135.2 54.49 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.169 -0.957 . . . . 0.0 110.638 -179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.0 p -134.89 123.45 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.218 0 CA-C-O 122.033 0.92 . . . . 0.0 112.277 -177.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 89.8 m -80.19 107.19 12.79 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.957 0.884 . . . . 0.0 111.201 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.0 mt -51.65 121.21 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 122.329 1.062 . . . . 0.0 110.438 -178.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 23.7 p -108.61 16.86 22.58 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.786 -178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -74.7 129.06 84.37 Favored Pre-proline 0 C--N 1.303 -1.433 0 O-C-N 120.743 -1.223 . . . . 0.0 108.175 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -64.34 -10.99 25.98 Favored 'Trans proline' 0 N--CA 1.497 1.73 0 CA-C-N 120.154 1.091 . . . . 0.0 112.752 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -115.78 8.6 14.9 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.364 -0.835 . . . . 0.0 109.782 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.59 173.91 14.8 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 108.542 -1.823 . . . . 0.0 108.542 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.422 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 3.2 tp -81.66 90.24 6.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.895 -1.356 . . . . 0.0 109.693 -178.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.448 ' CA ' ' OH ' ' A' ' 122' ' ' TYR . 4.4 p80 -95.13 -161.37 0.85 Allowed 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.84 -1.162 . . . . 0.0 109.939 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.0 m -58.01 -40.4 80.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.007 -1.058 . . . . 0.0 112.31 -176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.573 HH21 ' NE2' ' B' ' 321' ' ' GLN . 2.2 tpt180 -59.58 -61.94 6.87 Favored Pre-proline 0 N--CA 1.499 2.013 0 O-C-N 120.402 -1.436 . . . . 0.0 111.591 -178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.421 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 9.4 Cg_endo -56.07 -32.79 87.82 Favored 'Trans proline' 0 N--CA 1.49 1.291 0 CA-C-N 120.028 1.046 . . . . 0.0 111.832 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.95 -51.6 68.96 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.386 -0.926 . . . . 0.0 109.416 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.61 64.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.227 -0.92 . . . . 0.0 110.006 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . 0.573 ' NE2' HH21 ' B' ' 317' ' ' ARG . 86.9 mt-30 -70.82 -39.95 72.74 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.829 -1.17 . . . . 0.0 109.062 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -62.73 -54.79 33.76 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.364 -0.835 . . . . 0.0 110.463 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 60.1 t -63.6 -38.51 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.666 -1.271 . . . . 0.0 108.806 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -59.98 -47.1 87.2 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.714 -0.794 . . . . 0.0 109.217 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -62.58 -49.76 73.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.359 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.16 -51.56 52.29 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.256 -0.903 . . . . 0.0 110.883 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 18.1 ttmm -52.04 -14.42 0.41 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.118 -0.989 . . . . 0.0 109.897 -178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -79.92 -17.23 75.31 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -106.01 140.55 38.83 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.319 -1.106 . . . . 0.0 108.758 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 5.3 p -91.42 -13.79 31.73 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.792 -1.192 . . . . 0.0 110.158 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 29.5 p -57.28 150.46 17.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.938 -1.101 . . . . 0.0 108.474 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.05 132.46 46.66 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.855 -1.153 . . . . 0.0 108.627 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.8 mt -133.4 133.64 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.615 -0.678 . . . . 0.0 109.531 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.7 m -130.04 152.28 49.66 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.481 -0.762 . . . . 0.0 109.117 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 72.0 t -123.88 114.68 42.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 87.0 m -105.22 130.45 53.37 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.144 -0.972 . . . . 0.0 109.177 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 97.0 p -136.47 114.01 10.97 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.92 0.867 . . . . 0.0 110.777 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 45.35 51.85 9.22 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.98 -13.82 63.63 Favored Glycine 0 N--CA 1.503 3.135 0 O-C-N 120.102 -1.624 . . . . 0.0 112.935 176.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -118.67 130.37 55.81 Favored 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 119.414 1.607 . . . . 0.0 109.367 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 82.2 p -128.51 150.75 50.03 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.968 0.889 . . . . 0.0 110.845 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -145.24 166.64 24.9 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-O 121.573 0.701 . . . . 0.0 110.126 -179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.8 m -88.99 139.94 29.94 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.449 -0.782 . . . . 0.0 110.052 -179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -78.78 -14.35 59.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.916 -1.115 . . . . 0.0 110.071 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -89.98 20.3 4.32 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 106.487 -1.671 . . . . 0.0 106.487 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 90.5 p -145.8 92.14 2.18 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.734 -1.121 . . . . 0.0 111.407 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.77 HD23 HD22 ' A' ' 79' ' ' LEU . 57.1 tp -59.98 -34.54 73.44 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.875 ' CE2' HD11 ' A' ' 79' ' ' LEU . 64.2 m-85 -56.33 -53.48 56.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.169 -0.957 . . . . 0.0 110.393 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -69.43 -39.81 77.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.929 . . . . 0.0 110.387 -177.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.528 ' O ' ' N ' ' B' ' 352' ' ' THR . 23.2 mt -47.67 -59.66 3.12 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.158 -0.964 . . . . 0.0 108.978 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.826 ' O ' HD22 ' A' ' 123' ' ' LEU . 1.5 mp0 -39.27 -21.12 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.721 -0.612 . . . . 0.0 111.298 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.528 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.1 p -78.03 -10.1 59.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.102 -1.624 . . . . 0.0 110.216 -178.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 49.9 mt -96.09 118.32 32.45 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.134 -0.979 . . . . 0.0 109.14 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.35 96.74 0.92 Allowed Glycine 0 N--CA 1.489 2.185 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 32.2 mt -106.77 95.29 5.63 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.447 -1.031 . . . . 0.0 109.582 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 17.8 p -98.31 176.42 5.71 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.217 -0.927 . . . . 0.0 110.462 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -63.93 111.89 2.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.806 -0.559 . . . . 0.0 110.586 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.76 7.7 38.49 Favored Glycine 0 N--CA 1.498 2.791 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 46.9 m -84.83 110.23 18.67 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.087 -1.243 . . . . 0.0 111.067 -179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 4.9 t -78.12 115.62 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 122.113 0.959 . . . . 0.0 110.167 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 29.1 m -112.65 177.52 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 86.6 m -131.11 130.31 42.97 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 82.3 mt -105.34 120.35 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 178.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 58.7 m -121.38 132.56 54.83 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.25 153.9 41.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.249 -0.907 . . . . 0.0 110.034 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -146.77 122.91 10.83 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.486 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 159.53 -155.29 26.38 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 118.586 -1.768 . . . . 0.0 111.932 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.93 -53.36 58.78 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -107.31 11.61 28.97 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 120.898 -1.126 . . . . 0.0 111.383 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.3 pt-20 -40.23 -37.54 0.65 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.431 -0.793 . . . . 0.0 111.581 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.04 -44.31 72.92 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.73 -1.231 . . . . 0.0 110.787 -178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -69.79 -51.78 30.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.782 -1.199 . . . . 0.0 109.167 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -45.81 -37.22 5.86 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.646 -0.659 . . . . 0.0 111.278 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.53 ' O ' HG23 ' B' ' 378' ' ' VAL . 81.8 t -69.98 -39.98 78.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.698 -1.251 . . . . 0.0 109.151 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.99 -64.45 0.86 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 111.163 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -60.06 -45.82 91.59 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.683 -1.261 . . . . 0.0 111.771 -177.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.9 mt -59.98 -41.39 91.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.623 -1.298 . . . . 0.0 108.813 -178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.53 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.7 t -65.88 -42.05 91.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.158 -0.964 . . . . 0.0 109.742 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -71.29 -57.96 3.98 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.742 -1.224 . . . . 0.0 107.85 178.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.411 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 60.2 tp -56.22 -32.48 64.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.397 -0.814 . . . . 0.0 109.839 -178.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 45.2 ttm -74.44 -40.02 62.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.007 -1.058 . . . . 0.0 108.813 178.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.67 -4.45 46.18 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.682 -0.636 . . . . 0.0 110.121 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -110.84 3.36 18.9 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.319 -0.863 . . . . 0.0 110.963 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . 0.411 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 32.3 mt -69.87 130.03 41.13 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.397 -1.439 . . . . 0.0 109.764 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 . . . . . 0 N--CA 1.497 1.917 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.079 179.45 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.301 -0.629 . . . . 2.91 109.301 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.5 mt -108.88 128.69 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.644 -0.873 . . . . 1.2 108.644 179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.1 m -118.85 154.04 33.54 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.081 -0.711 . . . . 1.4 109.081 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.801 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -141.75 179.05 20.12 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.359 -1.897 . . . . 1.05 108.359 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.513 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.5 mt -85.21 -4.69 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.88 -1.365 . . . . 1.15 110.607 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.4 HD11 ' HB1' ' A' ' 222' ' ' ALA . 43.5 tp 52.31 93.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.64 -1.288 . . . . 0.98 109.362 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.22 -40.03 78.2 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.219 -1.03 . . . . 0.88 108.219 179.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.6 p -154.08 146.88 17.73 Favored Pre-proline 0 N--CA 1.494 1.774 0 N-CA-C 108.943 -0.762 . . . . 1.69 108.943 179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -80.32 144.2 16.12 Favored 'Trans proline' 0 N--CA 1.5 1.866 0 C-N-CA 122.74 2.293 . . . . 0.85 113.5 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.883 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.67 164.51 13.27 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 109.544 -1.422 . . . . 0.92 109.544 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 95.3 mt -117.42 152.82 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 O-C-N 121.13 -1.218 . . . . 0.81 110.072 -179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.91 155.98 35.27 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.228 -0.92 . . . . 0.51 109.83 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.9 OUTLIER -137.71 128.07 26.35 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.604 -0.888 . . . . 0.62 108.604 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.91 179.32 47.25 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 118.902 -1.618 . . . . 0.55 110.534 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -78.94 157.08 28.27 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.629 -0.924 . . . . 2.1 109.064 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.586 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -102.31 134.28 45.85 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.376 -0.827 . . . . 0.77 110.701 -179.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 57.9 tp -106.93 139.39 41.41 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.346 -1.353 . . . . 0.91 107.346 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.0 tp -119.06 121.03 38.91 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 121.309 -0.87 . . . . 0.93 110.146 -178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 26.8 mt -81.91 102.89 11.18 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 120.003 -0.679 . . . . 0.93 109.809 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -95.5 131.48 41.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.413 -0.804 . . . . 2.75 109.543 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -126.12 137.83 53.63 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 108.714 -0.847 . . . . 3.0 108.714 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 47.5 t0 -87.24 147.86 25.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.07 -1.019 . . . . 2.77 109.557 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.461 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 88.3 tt0 -64.18 149.88 46.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.251 -0.906 . . . . 2.94 109.335 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.9 mt -91.87 127.46 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.374 -0.829 . . . . 0.95 108.897 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.6 t -93.62 124.07 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.159 -0.963 . . . . 1.28 109.738 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -106.74 135.66 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 108.796 -0.816 . . . . 1.21 108.796 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -95.04 117.04 29.49 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.001 -1.062 . . . . 1.81 109.328 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -89.83 2.11 55.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.431 -0.793 . . . . 2.8 109.097 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -58.81 146.13 38.27 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.291 -0.881 . . . . 2.87 109.583 -179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -84.76 137.6 33.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.423 -0.798 . . . . 2.35 109.035 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.403 HG21 ' HG3' ' A' ' 39' ' ' GLU . 5.0 pt -91.73 163.25 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.966 -1.084 . . . . 0.97 109.92 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.3 p -97.18 174.93 6.48 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.219 -0.925 . . . . 1.17 108.761 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.91 -48.05 83.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.196 -0.94 . . . . 1.18 109.689 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -57.35 -30.22 64.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.741 -1.224 . . . . 2.56 109.433 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -81.45 -10.2 59.55 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.185 -0.947 . . . . 1.79 109.891 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -64.9 -53.42 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.705 -1.247 . . . . 1.0 108.519 179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.14 -40.01 94.52 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.59 -0.694 . . . . 1.77 110.14 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -69.87 -41.2 75.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.024 -1.047 . . . . 2.7 110.436 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.403 ' HG3' HG21 ' A' ' 31' ' ' ILE . 69.4 mm-40 -64.91 -40.02 94.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.832 -1.168 . . . . 1.51 110.069 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 65.3 t -62.84 -47.0 94.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 120.905 -1.122 . . . . 0.93 108.937 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -64.59 -42.8 95.35 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.047 -1.033 . . . . 1.81 110.063 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -60.07 -42.19 94.02 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.425 -1.324 . . . . 2.78 107.425 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -61.16 -50.04 74.8 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 109.151 -0.685 . . . . 0.78 109.151 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.9 tp -59.99 -42.32 93.95 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.444 -0.947 . . . . 1.07 108.444 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 36.8 t -63.6 -39.98 95.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.211 -0.931 . . . . 1.12 109.325 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.56 -48.98 77.69 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 108.702 -1.759 . . . . 0.84 108.702 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -61.1 -39.99 92.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.337 -1.096 . . . . 3.09 108.256 178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -46.64 -43.27 17.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.558 -0.714 . . . . 0.88 109.14 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 50' ' ' ALA . 24.7 ttmt -66.07 -72.83 0.15 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.678 -1.23 . . . . 2.59 107.678 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.92 -42.45 0.62 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.359 -0.838 . . . . 0.7 111.37 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 30.2 t -51.37 -56.36 13.54 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.59 -1.319 . . . . 1.4 109.177 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.71 -41.95 74.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.195 -0.94 . . . . 0.67 110.794 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -66.7 -40.06 88.31 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.932 -1.105 . . . . 1.66 109.794 -179.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 50.7 mt -60.62 -40.05 90.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.99 -1.069 . . . . 1.58 108.713 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.412 ' OE2' HD13 ' A' ' 77' ' ' ILE . 51.4 mm-40 -60.85 -33.54 73.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.455 -0.778 . . . . 1.35 109.429 179.141 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -65.15 -44.09 89.71 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.039 -1.038 . . . . 0.77 109.427 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.05 -38.98 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.884 -0.784 . . . . 0.63 108.884 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -59.45 -49.97 75.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.468 -0.77 . . . . 1.14 109.67 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -59.58 -37.45 78.55 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.273 -0.892 . . . . 0.79 110.223 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -63.93 -38.91 92.83 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.96 -1.087 . . . . 1.53 109.595 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.541 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -63.26 -42.27 99.12 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.373 -0.829 . . . . 0.57 109.15 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.44 -51.4 58.97 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.101 -1.2 . . . . 0.75 110.101 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -69.39 -46.72 66.24 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.928 -1.337 . . . . 1.59 110.02 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.1 m -67.25 -63.08 1.13 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.73 112.442 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.474 ' CE2' ' O ' ' A' ' 168' ' ' THR . 95.4 m-85 -92.9 -50.5 5.52 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.749 -1.219 . . . . 0.75 110.917 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.46 -169.9 24.93 Favored Glycine 0 N--CA 1.499 2.894 0 C-N-CA 119.954 -1.117 . . . . 1.22 110.939 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -69.74 -24.19 63.5 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.894 -0.768 . . . . 5.81 109.714 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -60.04 -35.55 75.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.569 -0.707 . . . . 3.37 110.175 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 56.6 mmtt -100.37 -18.5 16.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.329 -0.857 . . . . 1.77 110.415 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -70.05 -40.01 75.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.778 -1.202 . . . . 1.65 110.643 -178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.536 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.51 -30.58 70.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.217 -0.927 . . . . 0.77 110.22 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 95.9 mt -59.94 -40.63 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.051 -1.031 . . . . 0.8 109.291 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 16.9 m-85 -70.04 -38.18 75.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.321 -0.862 . . . . 0.88 110.947 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.1 tt0 -60.05 -39.93 87.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.859 -1.151 . . . . 1.37 109.8 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.97 -43.36 99.01 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.306 -1.518 . . . . 0.62 109.306 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -61.98 -42.93 99.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.388 -1.066 . . . . 1.5 109.705 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.412 HD13 ' OE2' ' A' ' 55' ' ' GLU . 98.7 mt -70.05 -43.34 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.225 -0.922 . . . . 0.63 109.741 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.8 ttp -59.97 -40.09 87.89 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.841 -1.162 . . . . 1.51 109.512 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.856 HD11 ' CE2' ' B' ' 348' ' ' PHE . 31.7 tp -65.21 -38.03 89.16 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.471 -0.768 . . . . 0.77 109.699 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.6 tp -63.9 -40.09 95.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.455 -0.778 . . . . 0.62 109.964 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -81.0 6.29 13.88 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.238 -0.914 . . . . 1.47 110.219 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -52.75 133.47 36.92 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.073 -1.017 . . . . 1.47 110.473 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.44 -19.45 63.5 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.556 -0.715 . . . . 1.78 110.658 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.07 -33.87 72.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.92 -1.113 . . . . 2.53 108.887 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.0 mt -70.13 -41.46 73.89 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.41 0.624 . . . . 0.8 110.055 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -60.05 -48.79 80.25 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.3 -0.875 . . . . 1.42 110.943 -178.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -70.0 -40.93 74.97 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.07 -1.019 . . . . 1.71 111.323 -178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -69.97 -40.02 75.63 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.031 -1.043 . . . . 1.57 111.485 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 84.2 mt -65.88 -49.87 74.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.975 -1.078 . . . . 0.65 109.69 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.7 mt -65.1 -37.15 79.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 O-C-N 121.686 -0.634 . . . . 0.82 110.401 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.03 -49.63 76.92 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.103 -0.998 . . . . 0.79 110.763 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.3 mt -62.43 -45.89 91.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.83 -1.169 . . . . 0.95 109.748 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.7 mt -61.51 -49.96 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 CA-C-O 121.981 0.896 . . . . 0.66 109.159 179.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -67.93 -44.92 75.72 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 120.163 -0.615 . . . . 2.2 111.144 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -80.19 -51.18 9.26 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.878 -1.138 . . . . 1.65 112.152 -178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -90.1 -3.38 57.95 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.91 -1.119 . . . . 2.03 112.13 -177.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 39.0 m80 57.76 34.82 24.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.892 -1.13 . . . . 1.42 110.605 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 71.0 mtm -90.81 169.91 10.55 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.013 -1.054 . . . . 1.18 109.38 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.6 p -75.3 154.28 37.47 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.093 -1.005 . . . . 0.98 108.465 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.95 -36.87 75.59 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.1 -1.0 . . . . 0.64 110.541 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 38.2 p-10 -65.62 -38.71 90.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.99 -1.069 . . . . 2.07 109.766 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.522 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.53 -44.4 19.14 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.142 -0.974 . . . . 0.73 109.318 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.52 -44.88 92.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.396 -0.815 . . . . 0.54 109.44 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.97 -40.06 94.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.87 . . . . 0.56 109.557 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -59.49 -39.97 85.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.384 -0.822 . . . . 1.54 109.573 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 110' ' ' GLY . 86.1 tt0 -63.12 -40.02 96.37 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.117 -0.989 . . . . 1.33 109.28 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.5 t -61.61 -52.27 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.471 -0.768 . . . . 0.72 110.731 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.5 mm -70.08 -39.98 77.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.916 -1.115 . . . . 0.85 108.934 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -67.24 -38.29 84.96 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.231 -1.026 . . . . 2.44 108.231 178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.24 -50.0 70.59 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.33 -1.108 . . . . 0.98 110.33 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.431 HE21 ' CB ' ' B' ' 348' ' ' PHE . 14.8 mm100 -66.84 -52.22 46.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.654 -1.497 . . . . 1.41 109.06 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.85 -39.98 75.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.904 . . . . 1.2 108.964 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.1 t -55.74 -39.46 71.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.238 -0.914 . . . . 1.7 108.708 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.05 -37.55 75.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.162 -0.961 . . . . 1.47 109.784 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.3 mt -67.47 -48.59 66.74 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.117 -0.989 . . . . 1.56 110.704 -178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -60.49 -21.96 62.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.391 -1.443 . . . . 2.2 110.194 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -67.97 -16.0 63.86 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.814 -1.179 . . . . 2.12 108.783 179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.494 HD13 HD13 ' A' ' 123' ' ' LEU . 28.4 mt -63.05 145.61 55.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.296 -0.877 . . . . 2.0 108.95 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -90.53 28.81 1.4 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.248 -0.908 . . . . 3.23 110.458 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.418 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 55.5 t0 -117.36 131.89 56.7 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.333 -0.854 . . . . 2.49 109.78 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.418 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 47.1 mt-10 -69.97 -28.94 65.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.515 -0.74 . . . . 3.95 109.934 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.514 ' OH ' ' NH1' ' A' ' 126' ' ' ARG . 2.7 t80 -69.89 -37.87 76.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 2.0 109.999 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.494 HD13 HD13 ' A' ' 118' ' ' LEU . 72.4 mt -77.14 -31.32 55.59 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.08 -1.013 . . . . 1.86 109.036 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 55.7 tttm -60.02 -40.06 87.98 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.195 -0.941 . . . . 2.84 108.645 179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -47.01 87.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -0.811 . . . . 2.73 109.305 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.514 ' NH1' ' OH ' ' A' ' 122' ' ' TYR . 4.2 mmm-85 -60.02 -40.05 87.95 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.282 -0.887 . . . . 2.77 109.898 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.37 76.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.035 -1.04 . . . . 1.19 108.656 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -63.93 -40.08 95.65 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.067 -0.716 . . . . 1.2 109.067 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -66.59 -42.43 86.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.369 -0.832 . . . . 1.55 109.453 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.1 t -66.94 -40.38 85.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.287 -0.883 . . . . 0.8 108.625 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 45.7 ttp180 -60.24 -41.31 92.88 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.465 -0.772 . . . . 3.09 109.101 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 43.8 t0 -59.92 -40.01 87.42 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.514 -0.741 . . . . 1.46 110.726 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.9 mt -60.07 -41.28 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 120.951 -1.093 . . . . 0.71 110.304 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.53 -40.44 94.25 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.646 -1.264 . . . . 0.57 110.02 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -60.01 -45.27 93.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.292 -1.122 . . . . 2.59 110.314 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 84.8 mtm180 -65.96 -35.88 81.81 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.589 -1.319 . . . . 2.83 110.038 -179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 55.4 tp -59.94 -41.6 92.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.107 -0.995 . . . . 1.25 109.441 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 91.1 mt -60.01 -40.01 87.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.108 -0.995 . . . . 0.7 108.908 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 56.5 mtt-85 -65.77 -39.98 91.55 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.749 -0.834 . . . . 2.57 108.749 178.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -69.73 -29.03 66.32 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.628 -0.67 . . . . 1.23 111.85 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.3 mt -70.02 -40.77 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.255 -1.528 . . . . 0.81 108.624 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.7 -29.66 59.07 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.676 -0.64 . . . . 1.0 109.747 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.19 45.82 4.62 Favored Glycine 0 N--CA 1.495 2.571 0 N-CA-C 108.954 -1.658 . . . . 0.89 108.954 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.6 tp -74.81 149.99 39.46 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.457 -1.025 . . . . 1.14 109.503 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -70.21 143.77 52.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.206 -0.934 . . . . 4.6 109.881 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.6 mt -114.91 128.8 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-O 122.037 0.922 . . . . 1.24 109.274 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.8 mt -69.93 -40.12 78.36 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.873 -0.603 . . . . 1.54 110.654 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.1 t0 63.39 103.91 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.27 -0.894 . . . . 1.5 109.223 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 57.7 mt -68.45 -1.25 6.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.395 -0.816 . . . . 0.79 109.88 -179.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 60.6 p -81.67 -14.61 56.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.02 -1.05 . . . . 1.4 109.878 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.8 26.42 0.83 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.239 -0.913 . . . . 0.92 112.225 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 36.1 mm -90.8 122.49 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 120.367 -1.458 . . . . 0.88 109.122 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -104.39 -12.52 16.52 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.428 -0.795 . . . . 2.45 110.415 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -122.3 147.78 45.82 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.286 -0.884 . . . . 1.52 110.182 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.92 135.76 56.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.387 -0.82 . . . . 1.58 109.487 -179.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.0 m -152.8 166.63 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.608 -0.682 . . . . 0.69 109.799 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 86.3 mt -94.74 148.9 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 106.485 -1.672 . . . . 0.61 106.485 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 14.9 tp -97.78 118.19 33.76 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.867 -1.146 . . . . 0.87 110.383 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 55.8 t -123.12 130.01 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.808 -0.812 . . . . 0.71 108.808 179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -156.66 160.67 39.58 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.385 -0.968 . . . . 0.81 108.385 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.84 -31.83 65.04 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.266 -1.521 . . . . 0.98 107.588 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -157.94 165.62 34.7 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.853 -0.795 . . . . 2.25 108.853 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 78.0 mt -136.95 132.16 34.01 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.162 -0.961 . . . . 0.78 108.964 179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 33.1 p -102.44 148.99 36.27 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.389 -0.82 . . . . 0.98 108.975 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -41.59 -34.13 2.02 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.97 1.78 . . . . 0.81 112.211 179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 43.7 m -57.46 -43.37 83.95 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.354 -0.841 . . . . 0.9 109.961 -178.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.94 -40.96 75.19 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.126 -0.984 . . . . 1.61 110.252 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.474 ' O ' ' CE2' ' A' ' 65' ' ' PHE . 72.0 p -58.03 -19.9 34.88 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.166 -0.959 . . . . 0.61 111.581 -177.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.541 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -85.69 -43.18 13.62 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.634 -1.291 . . . . 0.6 109.773 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -96.98 41.53 1.11 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.39 -0.967 . . . . 1.4 108.39 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.479 HD11 HG21 ' A' ' 176' ' ' VAL . 58.9 tp -105.29 131.51 52.66 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.588 -0.893 . . . . 0.7 108.588 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.431 ' O ' HG23 ' A' ' 176' ' ' VAL . 16.7 m120 -84.03 103.33 13.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.008 -1.058 . . . . 2.35 108.847 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.77 -40.8 95.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.854 . . . . 1.51 110.814 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -65.59 -27.39 68.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.82 -1.175 . . . . 2.33 111.286 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.454 ' N ' ' CD ' ' A' ' 175' ' ' LYS . 1.1 mptm? -93.32 -11.83 31.48 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.895 -1.128 . . . . 1.92 109.723 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.479 HG21 HD11 ' A' ' 171' ' ' LEU . 87.6 t -100.01 110.03 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 121.138 -0.977 . . . . 0.67 108.908 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 89.9 mt -83.76 7.32 18.16 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.229 -0.919 . . . . 1.53 110.377 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.462 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 167.94 176.26 38.35 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.247 -1.541 . . . . 0.48 109.247 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.475 ' CE1' HG11 ' A' ' 176' ' ' VAL . 11.9 m-85 -133.24 129.9 38.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.353 -1.087 . . . . 0.55 108.658 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.2 mt -132.93 126.51 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.309 -0.869 . . . . 0.65 109.28 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.4 p -145.35 158.03 43.92 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.034 -1.041 . . . . 0.82 111.189 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.529 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -103.14 26.84 7.77 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.789 -0.819 . . . . 2.46 108.789 179.124 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -67.42 -158.96 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.055 -1.028 . . . . 1.28 112.028 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.14 -50.55 10.23 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.07 -1.212 . . . . 2.19 110.07 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.85 -120.05 1.1 Allowed Glycine 0 N--CA 1.493 2.459 0 O-C-N 120.868 -1.372 . . . . 2.13 110.766 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.566 ' NE ' HH22 ' A' ' 195' ' ' ARG . 58.4 mtp180 -60.96 -37.6 82.96 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.774 -0.839 . . . . 5.86 111.627 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 32.7 p -67.31 3.02 1.36 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.9 -1.125 . . . . 3.72 110.909 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 19.8 t -90.39 118.89 30.22 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.746 -1.222 . . . . 1.74 109.952 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 81.0 t60 -43.11 -52.63 5.35 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.355 -0.841 . . . . 0.95 109.636 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -52.33 -33.16 41.4 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.352 -0.842 . . . . 1.55 110.706 -179.463 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 39.1 t -59.99 -42.03 93.35 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.727 -1.233 . . . . 1.51 110.225 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.3 mm -60.37 -39.95 82.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.357 -0.84 . . . . 1.67 109.005 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.6 mtp -60.01 -40.56 89.67 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.495 -0.753 . . . . 1.02 110.919 -179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.01 -43.36 95.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.673 -1.267 . . . . 0.68 109.149 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.566 HH22 ' NE ' ' A' ' 186' ' ' ARG . 98.4 mtt180 -59.96 -53.34 59.04 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.221 -0.924 . . . . 2.93 110.375 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.3 m -69.73 -35.66 75.19 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.067 -1.021 . . . . 0.86 111.267 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 85.7 mt -70.03 -28.6 65.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.865 -1.147 . . . . 0.67 108.906 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 70.24 45.73 0.65 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.506 0.669 . . . . 1.5 109.644 -179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 88.2 mt -122.73 150.04 57.47 Favored Pre-proline 0 N--CA 1.498 1.963 0 N-CA-C 107.84 -1.171 . . . . 0.72 107.84 178.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.79 142.68 70.78 Favored 'Trans proline' 0 N--CA 1.498 1.762 0 C-N-CA 122.002 1.801 . . . . 0.61 111.536 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -170.01 151.15 3.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.983 -1.073 . . . . 0.66 111.388 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.7 mt -123.47 143.47 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 107.783 -1.191 . . . . 0.79 107.783 178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 5.8 m -126.67 -10.08 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 120.694 -1.254 . . . . 0.91 110.54 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.1 23.14 26.01 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 110.323 -1.111 . . . . 1.01 110.323 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.417 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.5 p -46.02 -43.24 14.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.089 -1.242 . . . . 0.99 109.715 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.88 -52.6 3.92 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 120.144 -1.027 . . . . 1.12 111.532 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.9 m -157.38 33.76 0.28 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.54 -1.565 . . . . 1.72 111.425 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 56.1 t -72.77 -40.1 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 120.908 -1.12 . . . . 0.89 109.111 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.432 ' H ' HG23 ' A' ' 209' ' ' THR . 1.4 p -54.82 -32.36 60.3 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.431 -0.793 . . . . 1.03 110.578 -178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 84.9 p -76.43 -16.29 59.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.985 -1.072 . . . . 1.83 109.421 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -101.64 -13.73 17.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.498 -0.751 . . . . 2.27 109.95 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 55.9 t -104.77 137.92 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.359 -0.838 . . . . 0.92 110.555 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -112.79 151.7 30.03 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.686 -1.227 . . . . 2.2 107.686 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 30.5 p-10 -57.92 137.03 57.11 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.016 -1.053 . . . . 2.36 110.251 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.8 OUTLIER 82.79 8.69 0.72 Allowed 'General case' 0 N--CA 1.502 2.125 0 CA-C-O 121.14 0.495 . . . . 2.38 110.432 179.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 60.5 t0 -77.8 143.57 37.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.12 -0.987 . . . . 2.09 109.131 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.527 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 33.9 t80 -88.32 118.24 27.8 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.025 -1.047 . . . . 1.27 109.041 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.586 HD12 ' HB2' ' A' ' 16' ' ' ALA . 91.7 mt -130.63 149.42 52.29 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.515 -0.741 . . . . 0.75 110.544 -179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 77.7 mt -118.28 128.56 75.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 106.85 -1.537 . . . . 0.63 106.85 177.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.7 tp -100.61 122.5 43.38 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.961 -1.087 . . . . 0.7 109.466 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.419 ' C ' ' N ' ' A' ' 223' ' ' VAL . 19.3 m-20 -87.53 -42.77 12.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.982 -1.074 . . . . 2.31 109.884 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.883 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.15 22.81 0.25 Allowed 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.674 -0.861 . . . . 0.78 108.674 -178.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.419 ' N ' ' C ' ' A' ' 221' ' ' ASP . 18.0 t -127.25 -42.82 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 106.903 -1.517 . . . . 1.04 106.903 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -109.84 7.39 24.04 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.0 -1.111 . . . . 2.44 108.0 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.801 HD21 ' H ' ' A' ' 4' ' ' GLY . 36.6 t-20 60.04 52.12 5.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.794 -0.566 . . . . 1.55 110.532 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -147.17 158.56 43.99 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.784 -1.198 . . . . 1.99 110.463 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.6 t -126.81 130.04 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 N-CA-C 108.496 -0.927 . . . . 0.77 108.496 179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -98.43 122.93 42.22 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.426 -0.796 . . . . 0.98 109.212 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 18.2 t -100.79 111.28 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.551 -0.718 . . . . 0.85 110.083 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 54.98 63.14 7.17 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.235 -0.916 . . . . 1.66 111.244 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -86.87 150.07 8.43 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.571 2.181 . . . . 0.95 112.246 178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 39.8 p -74.43 165.02 25.9 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.318 -0.864 . . . . 1.84 109.437 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -60.0 -34.43 73.33 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.426 -0.796 . . . . 2.74 110.592 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -59.94 -39.29 85.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.053 -1.029 . . . . 2.89 109.756 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 76.1 t -70.02 -40.27 78.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.031 -1.043 . . . . 1.3 109.18 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.527 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 99.4 mt -64.39 -40.05 87.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.342 -0.849 . . . . 1.09 109.658 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -60.08 -41.51 92.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.911 -1.118 . . . . 2.43 109.088 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -66.2 -39.97 90.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.275 -0.891 . . . . 2.78 108.627 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 96.8 mtp -69.11 -36.63 77.74 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.568 -0.708 . . . . 1.25 109.176 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.527 ' NH1' ' CG2' ' A' ' 236' ' ' ILE . 1.8 mmt-85 -60.99 -40.1 92.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 2.63 109.904 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.68 -42.6 97.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.102 -0.999 . . . . 1.8 109.042 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.5 t -61.62 -40.03 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.5 -0.75 . . . . 2.13 109.178 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -59.82 -39.88 86.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.369 -0.832 . . . . 3.17 109.456 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -41.23 91.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.085 -1.009 . . . . 1.78 109.641 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -66.2 -40.09 90.11 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.039 -1.038 . . . . 2.47 108.884 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 71.2 t -66.0 -40.0 86.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 108.898 -0.779 . . . . 2.09 108.898 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.83 -38.83 83.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.512 -0.743 . . . . 2.54 109.409 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 67.5 m -60.01 -40.0 87.76 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.141 -0.974 . . . . 2.99 109.234 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -67.17 -39.97 86.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.436 -0.79 . . . . 3.34 109.827 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.54 ' C ' ' H ' ' A' ' 252' ' ' GLU . 32.8 mmtp -90.0 5.99 44.19 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.321 -0.862 . . . . 3.88 109.951 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -66.1 28.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.998 -1.063 . . . . 4.43 110.461 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.54 ' H ' ' C ' ' A' ' 250' ' ' LYS . 63.9 mm-40 54.15 79.62 0.13 Allowed 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.004 -1.06 . . . . 5.42 109.193 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 66.9 mt -56.89 -33.42 66.87 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.253 -1.388 . . . . 6.1 107.253 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -111.26 -84.91 0.56 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.534 -0.913 . . . . 7.37 108.534 178.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -176.47 -36.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 106.644 -1.613 . . . . 8.01 106.644 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 3.1 pp -151.7 160.58 43.55 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.077 -1.083 . . . . 9.05 108.077 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -143.52 156.28 44.57 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.306 -0.998 . . . . 10.56 108.306 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 43.6 t0 -140.98 82.48 1.84 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.978 -1.077 . . . . 11.32 109.693 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 35.1 ttm180 . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 118.222 -0.894 . . . . 12.42 109.389 -179.768 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 7.5 ttt . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -151.69 149.54 29.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.368 -0.832 . . . . 0.0 109.099 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -148.91 159.96 43.71 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.053 -1.029 . . . . 0.0 110.655 -179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 71.2 tp60 -152.7 148.74 27.62 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.475 -0.766 . . . . 0.0 109.314 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -107.03 131.11 54.45 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.135 -0.978 . . . . 0.0 109.646 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.59 119.06 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 122.186 0.993 . . . . 0.0 112.782 -177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . 0.472 ' O ' HG23 ' B' ' 309' ' ' THR . 94.6 m -78.34 104.75 9.13 Favored 'General case' 0 N--CA 1.493 1.724 0 CA-C-O 121.919 0.866 . . . . 0.0 110.004 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' B' ' 358' ' ' GLY . 70.4 mt -51.74 118.91 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 122.317 1.056 . . . . 0.0 110.295 -177.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . 0.472 HG23 ' O ' ' B' ' 307' ' ' THR . 51.6 p -108.1 17.08 22.73 Favored 'General case' 0 N--CA 1.499 2.006 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.24 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.405 ' O ' ' CG ' ' B' ' 357' ' ' GLN . . . -71.92 117.14 55.29 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.063 -1.023 . . . . 0.0 108.54 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -51.92 -16.07 3.86 Favored 'Trans proline' 0 N--CA 1.499 1.836 0 CA-C-N 120.35 1.161 . . . . 0.0 113.594 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -120.47 10.57 11.19 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.329 -0.857 . . . . 0.0 109.357 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.14 -179.79 31.4 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.494 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -88.66 93.98 9.74 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.351 -1.088 . . . . 0.0 109.353 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.411 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 6.5 p80 -96.58 -160.01 0.77 Allowed 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.897 -1.127 . . . . 0.0 110.564 179.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.2 m -57.33 -44.03 83.89 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.005 -1.059 . . . . 0.0 112.367 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.577 HH21 ' NE2' ' B' ' 321' ' ' GLN . 2.1 tpt180 -59.92 -60.57 10.17 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 120.651 -1.28 . . . . 0.0 112.233 -178.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.411 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 10.9 Cg_endo -58.73 -29.82 90.72 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 CA-C-N 120.444 1.194 . . . . 0.0 111.595 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.92 -52.01 67.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.205 -0.935 . . . . 0.0 108.861 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.65 -41.49 61.38 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.189 -0.944 . . . . 0.0 109.4 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . 0.577 ' NE2' HH21 ' B' ' 317' ' ' ARG . 89.5 mt-30 -69.96 -40.04 75.64 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.15 -0.969 . . . . 0.0 108.753 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -60.86 -52.88 63.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.519 -0.738 . . . . 0.0 110.989 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 71.9 t -67.74 -29.34 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.646 -1.284 . . . . 0.0 109.997 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 30.5 ttmt -61.16 -45.53 94.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.942 . . . . 0.0 109.3 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -64.02 -45.04 90.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.332 -0.855 . . . . 0.0 110.178 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -61.44 -53.66 53.59 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.016 -1.053 . . . . 0.0 111.41 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -57.51 -13.26 3.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.868 -1.145 . . . . 0.0 109.496 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -68.24 -29.74 73.37 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.009 -1.636 . . . . 0.0 109.009 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -103.85 147.22 27.57 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.503 -0.998 . . . . 0.0 109.253 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 17.6 p -91.06 -11.88 37.36 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.975 -1.078 . . . . 0.0 109.85 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.417 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 80.8 p -64.09 158.01 23.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.342 -0.849 . . . . 0.0 110.478 -178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -74.85 132.96 41.92 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.0 mt -132.32 133.01 60.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.617 -0.677 . . . . 0.0 109.209 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 69.4 m -127.92 151.04 49.58 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.48 -0.763 . . . . 0.0 109.491 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 60.8 t -117.04 137.83 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 87.6 m -128.96 125.12 36.76 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.184 -0.948 . . . . 0.0 109.083 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . 0.418 ' HB2' HG12 ' B' ' 361' ' ' VAL . 12.2 t -138.67 119.12 13.8 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 121.959 0.885 . . . . 0.0 110.798 -179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' B' ' 338' ' ' ASN . 8.1 p-10 39.01 65.13 0.7 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 113.345 0.869 . . . . 0.0 113.345 178.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 79.3 -12.36 26.35 Favored Glycine 0 N--CA 1.5 2.947 0 O-C-N 120.833 -1.167 . . . . 0.0 113.668 175.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 33.8 mtmm -120.67 133.09 55.38 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-N 119.564 1.682 . . . . 0.0 109.963 -179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 78.7 p -129.91 150.4 51.21 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.8 0.809 . . . . 0.0 110.513 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.23 167.33 22.68 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.528 0.68 . . . . 0.0 110.11 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 12.2 m -88.93 138.94 30.96 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.504 -0.748 . . . . 0.0 109.808 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -76.8 -13.03 60.05 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.907 -1.121 . . . . 0.0 108.974 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -89.69 16.58 7.66 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 67.3 m -145.61 94.79 2.55 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.607 0.717 . . . . 0.0 111.068 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.717 HD23 HD22 ' A' ' 79' ' ' LEU . 52.9 tp -59.89 -33.96 72.54 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.856 ' CE2' HD11 ' A' ' 79' ' ' LEU . 54.2 m-85 -55.79 -52.84 62.59 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.928 -1.108 . . . . 0.0 109.852 179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -69.99 -20.77 63.28 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.264 -0.898 . . . . 0.0 111.889 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 91.6 mt -69.97 -46.76 64.54 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.428 -1.42 . . . . 0.0 110.817 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.57 ' NE2' ' O ' ' B' ' 347' ' ' LEU . 0.7 OUTLIER -47.92 -21.11 0.38 Allowed 'General case' 0 N--CA 1.502 2.148 0 O-C-N 120.894 -1.129 . . . . 0.0 111.695 -177.371 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 71.3 p -77.31 -12.97 60.01 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.168 -1.582 . . . . 0.0 109.974 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 30.0 mt -96.21 119.68 35.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.107 -0.995 . . . . 0.0 109.431 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.13 97.3 0.93 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 90.5 mt -98.64 81.56 2.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.327 -1.102 . . . . 0.0 109.399 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 46.5 p -89.77 176.48 6.82 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.149 -0.969 . . . . 0.0 110.964 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . 0.405 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 21.9 tm0? -70.64 112.19 6.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.694 -0.629 . . . . 0.0 110.379 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 104.26 8.74 37.87 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.766 -1.334 . . . . 0.0 109.766 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 19.2 m -86.55 109.2 18.96 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.122 -1.223 . . . . 0.0 110.357 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . 0.416 HG22 ' OG1' ' B' ' 307' ' ' THR . 7.9 t -77.6 115.49 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-O 122.329 1.061 . . . . 0.0 109.556 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . 0.418 HG12 ' HB2' ' B' ' 337' ' ' SER . 33.2 m -113.01 178.41 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -178.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 34.6 m -130.5 128.87 42.06 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 38.6 mt -104.69 121.55 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 68.8 p -126.46 136.12 52.23 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.71 153.25 40.04 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.208 -0.932 . . . . 0.0 109.923 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -146.16 125.82 13.38 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 158.98 -158.76 29.73 Favored Glycine 0 N--CA 1.49 2.278 0 C-N-CA 119.116 -1.516 . . . . 0.0 111.256 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.81 -51.99 67.36 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 122.077 -0.661 . . . . 0.0 112.177 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' B' ' 331' ' ' SER . 97.2 m-20 -111.27 11.92 21.7 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.998 -1.064 . . . . 0.0 111.023 -177.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -43.53 -31.85 0.81 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.231 -0.918 . . . . 0.0 110.746 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . 0.403 ' HG2' ' H ' ' B' ' 371' ' ' GLN . 3.2 pt20 -65.13 -47.31 77.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.881 -1.137 . . . . 0.0 109.532 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -65.84 -49.28 68.75 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 109.209 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.49 -37.04 3.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.661 -0.649 . . . . 0.0 112.041 -178.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.544 ' O ' HG23 ' B' ' 378' ' ' VAL . 99.5 t -80.51 -35.38 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 120.479 -1.388 . . . . 0.0 109.964 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -67.04 -39.97 87.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.898 -1.126 . . . . 0.0 111.072 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.9 m80 -80.5 -46.64 15.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.759 -1.213 . . . . 0.0 110.57 -179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 89.8 mt -61.69 -39.95 93.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.194 -0.941 . . . . 0.0 109.865 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.544 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.8 t -60.19 -49.16 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.041 -1.037 . . . . 0.0 109.624 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' B' ' 383' ' ' GLU . 10.6 mtpm? -68.07 -54.2 20.02 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 118.703 -1.199 . . . . 0.0 107.993 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 50.1 tp -56.83 -34.97 68.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.173 -0.954 . . . . 0.0 110.182 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -72.09 -40.31 68.31 Favored 'General case' 0 N--CA 1.491 1.625 0 C-N-CA 118.286 -1.366 . . . . 0.0 108.805 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.07 -6.45 59.17 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.525 -0.734 . . . . 0.0 110.533 179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.423 ' N ' ' O ' ' B' ' 379' ' ' LYS . 74.2 mm-40 -110.28 -2.42 16.77 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.129 -0.982 . . . . 0.0 111.377 -179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 12.7 mt -80.98 129.99 34.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.276 -1.515 . . . . 0.0 108.722 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 . . . . . 0 N--CA 1.496 1.866 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.381 -179.783 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.6 mtp . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.143 -0.688 . . . . 2.91 109.143 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.9 mt -96.39 135.78 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.336 -0.853 . . . . 1.2 109.31 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.6 m -119.34 149.83 41.16 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.775 0.798 . . . . 1.4 109.895 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.859 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -139.79 -173.43 13.21 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 108.9 -1.68 . . . . 1.05 108.9 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.487 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.5 mt -85.48 -7.18 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.896 -1.355 . . . . 1.15 110.087 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.4 tp 50.42 95.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.91 -1.119 . . . . 0.98 109.453 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.11 -35.06 16.5 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.88 109.378 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 199' ' ' LEU . 2.8 p -134.67 130.84 19.95 Favored Pre-proline 0 N--CA 1.502 2.154 0 O-C-N 121.495 -0.753 . . . . 1.69 109.364 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -80.36 141.14 14.07 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 122.206 1.937 . . . . 0.85 112.779 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.698 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.94 -162.72 34.87 Favored Glycine 0 N--CA 1.496 2.635 0 N-CA-C 109.978 -1.249 . . . . 0.92 109.978 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 80.2 mt -146.28 147.09 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 O-C-N 121.265 -1.138 . . . . 0.81 108.376 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.69 141.45 18.01 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.524 -1.36 . . . . 0.51 111.455 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -122.14 126.15 47.7 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 107.773 -1.195 . . . . 0.62 107.773 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.08 178.52 48.53 Favored Glycine 0 N--CA 1.493 2.49 0 C-N-CA 118.551 -1.785 . . . . 0.55 111.188 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -79.13 160.95 26.79 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.863 -0.786 . . . . 2.1 110.135 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 216' ' ' ASP . . . -102.44 127.28 49.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.549 -0.719 . . . . 0.77 111.256 -178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.3 tp -106.87 134.56 49.84 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 106.618 -1.623 . . . . 0.91 106.618 177.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.6 tp -117.66 123.09 45.29 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.243 -0.911 . . . . 0.93 110.523 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.415 HD12 ' HB2' ' A' ' 160' ' ' ALA . 36.8 mt -86.0 103.3 14.57 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.358 0.599 . . . . 0.93 109.644 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -93.98 135.21 35.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.267 -0.896 . . . . 2.75 108.75 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -130.14 132.48 46.1 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.555 -0.906 . . . . 3.0 108.555 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -80.97 148.08 29.95 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.094 -1.004 . . . . 2.77 110.006 -179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -62.65 149.47 43.4 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.38 -0.825 . . . . 2.94 109.263 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.544 HD11 ' NH1' ' A' ' 139' ' ' ARG . 42.0 mt -90.67 125.5 43.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.223 -0.923 . . . . 0.95 108.89 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.5 t -92.1 125.82 44.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.096 -1.002 . . . . 1.28 109.989 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.54 130.59 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 N-CA-C 108.028 -1.101 . . . . 1.21 108.028 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -90.68 123.06 33.99 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.824 -1.173 . . . . 1.81 110.245 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -86.63 -1.32 57.58 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.57 -0.9 . . . . 2.8 108.57 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -65.1 140.07 58.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.417 -0.802 . . . . 2.87 109.974 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -87.9 151.31 22.92 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.085 -1.079 . . . . 2.35 108.085 178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.673 HD13 ' HG3' ' A' ' 39' ' ' GLU . 3.9 pt -101.48 166.91 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 120.918 -1.114 . . . . 0.97 109.882 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 60.0 p -97.96 178.83 4.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.259 -0.901 . . . . 1.17 109.407 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.15 -49.39 77.81 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.362 -0.836 . . . . 1.18 110.469 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -56.37 -31.5 63.87 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.616 -1.302 . . . . 2.56 110.248 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -81.8 -9.34 59.65 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.307 -0.871 . . . . 1.79 110.448 -179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.0 t -59.97 -50.09 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.937 -1.102 . . . . 1.0 108.75 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -62.61 -40.05 95.72 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.278 -0.889 . . . . 1.77 109.152 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -60.58 -46.03 91.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.296 -0.877 . . . . 2.7 110.488 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.673 ' HG3' HD13 ' A' ' 31' ' ' ILE . 74.9 mm-40 -60.72 -44.35 96.73 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.825 -1.172 . . . . 1.51 109.851 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.3 t -60.06 -46.37 94.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.95 -1.094 . . . . 0.93 108.743 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -58.75 -40.06 82.75 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.38 -0.825 . . . . 1.81 109.099 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -60.91 -44.5 97.09 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.007 -1.108 . . . . 2.78 108.007 178.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -60.12 -49.48 77.46 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.95 -0.759 . . . . 0.78 108.95 178.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.2 tp -60.0 -47.38 86.06 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.281 -1.007 . . . . 1.07 108.281 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.523 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 29.7 t -60.85 -43.82 97.81 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.353 -0.939 . . . . 1.12 108.869 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.99 -45.16 96.39 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.551 -1.819 . . . . 0.84 108.551 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.0 ttt-85 -60.06 -36.34 77.11 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.132 -1.062 . . . . 3.09 108.132 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -53.04 -40.39 63.9 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.939 -0.763 . . . . 0.88 108.939 -179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.1 ttmt -75.08 -74.08 0.22 Allowed 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.614 -1.254 . . . . 2.59 107.614 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.53 -39.64 0.33 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.533 -0.729 . . . . 0.7 111.222 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.6 p -56.64 -59.09 5.52 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.658 -1.276 . . . . 1.4 108.895 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.76 -39.97 94.5 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.347 -0.846 . . . . 0.67 110.939 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -67.73 -39.96 84.23 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.812 -1.18 . . . . 1.66 110.202 -179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.6 mt -65.64 -40.06 92.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.062 -1.024 . . . . 1.58 109.614 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.425 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 74.9 mm-40 -62.63 -39.95 95.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.089 -1.007 . . . . 1.35 109.846 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -64.14 -41.85 97.02 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.059 -1.026 . . . . 0.77 110.012 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.413 HD11 HH22 ' A' ' 136' ' ' ARG . 82.8 mt -61.41 -40.0 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.24 -0.912 . . . . 0.63 109.858 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.425 ' NZ ' ' OE1' ' A' ' 55' ' ' GLU . 5.1 ttpm? -58.16 -49.92 75.32 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.194 -0.941 . . . . 1.14 109.876 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.4 m -58.55 -36.09 73.35 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.364 -0.835 . . . . 0.79 110.886 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -65.83 -38.72 89.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.971 -1.08 . . . . 1.53 109.644 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.53 -43.97 92.32 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.531 -0.73 . . . . 0.57 110.256 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.08 -50.0 72.2 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.362 -1.495 . . . . 0.75 109.362 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -66.91 -49.5 65.38 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.269 -1.136 . . . . 1.59 109.579 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.8 m -69.74 -61.61 1.71 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.492 -0.755 . . . . 0.73 112.694 -177.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -93.63 -51.82 4.76 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 120.763 -1.21 . . . . 0.75 110.949 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.24 -173.01 23.55 Favored Glycine 0 N--CA 1.501 3.019 0 C-N-CA 119.767 -1.206 . . . . 1.22 111.444 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -71.13 -27.75 63.79 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.356 0.598 . . . . 5.81 110.495 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -63.58 -33.99 76.83 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.372 -0.83 . . . . 3.37 110.8 -178.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -100.73 -24.99 14.29 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.104 -0.997 . . . . 1.77 109.843 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -62.83 -40.02 96.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.157 -0.964 . . . . 1.65 109.935 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.522 ' HB2' ' NH1' ' B' ' 317' ' ' ARG . . . -59.8 -29.88 68.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.398 -0.814 . . . . 0.77 109.732 -178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.7 mt -59.98 -40.09 82.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 N-CA-C 107.453 -1.314 . . . . 0.8 107.453 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 81.3 m-85 -70.99 -40.06 72.11 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.605 -0.685 . . . . 0.88 111.005 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -64.12 -42.04 97.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.601 -1.312 . . . . 1.37 109.712 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.88 -40.59 96.99 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.586 -1.806 . . . . 0.62 108.586 179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.8 m170 -64.55 -43.15 94.85 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.387 -1.067 . . . . 1.5 109.332 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 78.1 mt -67.32 -47.59 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 0.63 109.983 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 51.9 ttp -60.1 -40.62 90.28 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.941 -1.099 . . . . 1.51 110.235 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.788 HD11 ' CE2' ' B' ' 348' ' ' PHE . 35.5 tp -66.29 -36.81 83.93 Favored 'General case' 0 C--N 1.294 -1.846 0 O-C-N 121.539 -0.726 . . . . 0.77 109.639 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.49 -39.34 91.79 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.528 -0.733 . . . . 0.62 109.84 -179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -78.65 6.88 7.81 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.959 -1.088 . . . . 1.47 110.082 -179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 57.4 t0 -53.46 132.6 40.14 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.215 -0.928 . . . . 1.47 110.93 -178.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.437 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 93.6 mt-10 -63.34 -18.71 63.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.725 -0.609 . . . . 1.78 110.602 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.02 -34.97 69.25 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 2.53 108.919 179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.9 mt -68.48 -39.56 81.29 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.694 0.759 . . . . 0.8 109.241 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.9 -44.47 94.23 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.646 -0.659 . . . . 1.42 110.527 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -70.07 -43.15 71.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.157 -0.964 . . . . 1.71 111.628 -178.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -69.95 -40.07 75.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.001 -1.062 . . . . 1.57 112.476 -177.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.63 -44.53 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 120.75 -1.219 . . . . 0.65 109.938 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.63 -38.59 76.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.487 -0.758 . . . . 0.82 110.168 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.07 -50.11 74.99 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.159 -0.963 . . . . 0.79 111.501 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.1 mt -60.97 -45.87 93.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.849 -1.157 . . . . 0.95 109.882 -179.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.1 mt -60.86 -50.03 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.182 -0.948 . . . . 0.66 109.025 179.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -70.0 -40.59 75.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.65 -0.656 . . . . 2.2 110.857 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -81.16 -62.5 1.64 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.197 -0.939 . . . . 1.65 112.189 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -83.59 -1.0 52.85 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.122 -0.987 . . . . 2.03 111.934 -177.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 58.98 39.08 23.98 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.929 -1.107 . . . . 1.42 109.741 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.6 mtp -92.36 167.43 12.0 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.482 -0.761 . . . . 1.18 109.645 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.0 p -84.2 163.44 19.73 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.98 109.945 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.57 -39.75 80.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.397 -0.814 . . . . 0.64 109.242 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -62.24 -42.45 99.33 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.306 -0.871 . . . . 2.07 110.231 179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.87 -42.85 18.99 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.327 -0.858 . . . . 0.73 110.701 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.69 -47.32 66.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.16 -0.962 . . . . 0.54 110.791 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.6 -38.98 93.17 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.017 -1.052 . . . . 0.56 109.346 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.589 ' HB2' HD21 ' A' ' 138' ' ' LEU . 77.2 t60 -59.28 -40.85 87.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.519 -0.738 . . . . 1.54 109.808 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 110' ' ' GLY . 87.0 tt0 -64.32 -39.94 94.92 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.273 -0.892 . . . . 1.33 110.373 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 94.8 t -62.19 -55.51 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.148 -0.97 . . . . 0.72 111.132 -178.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.431 HG21 ' CA ' ' A' ' 134' ' ' GLY . 45.6 mm -69.15 -40.04 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 120.804 -1.185 . . . . 0.85 108.82 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.459 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.4 tt0 -64.89 -39.88 94.22 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.832 -1.173 . . . . 2.44 107.832 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.02 -49.17 77.56 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.882 -1.287 . . . . 0.98 109.882 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -69.52 -51.66 33.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.948 -1.325 . . . . 1.41 109.222 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.91 -42.75 85.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.915 . . . . 1.2 109.282 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 40.5 t -58.36 -38.64 77.63 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.352 -0.842 . . . . 1.7 109.164 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.31 -39.76 89.52 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.2 -0.938 . . . . 1.47 108.893 179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 41.2 mt -63.05 -42.74 99.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.905 -1.122 . . . . 1.56 109.646 -179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.99 -33.08 71.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.871 -1.143 . . . . 2.2 109.468 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -58.57 -20.96 51.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.159 -0.963 . . . . 2.12 109.075 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.615 HD13 HD13 ' A' ' 123' ' ' LEU . 29.5 mt -61.59 142.35 57.18 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.97 -1.081 . . . . 2.0 108.293 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 34.3 p-10 -92.37 28.58 1.9 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.03 -1.044 . . . . 3.23 110.883 -178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -116.89 128.5 55.3 Favored 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.189 -0.944 . . . . 2.49 109.733 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -67.86 -28.04 67.2 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.557 -0.714 . . . . 3.95 109.522 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -63.96 -41.81 97.45 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.237 1.018 . . . . 2.0 109.133 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.772 HD22 ' O ' ' B' ' 351' ' ' GLN . 91.7 mt -75.93 -33.03 59.84 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.208 -0.664 . . . . 1.86 109.208 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -60.06 -40.56 89.88 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.861 -0.792 . . . . 2.84 108.861 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -60.0 -48.36 82.02 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.314 -0.866 . . . . 2.73 109.163 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.786 ' NE ' HE22 ' B' ' 351' ' ' GLN . 61.1 mtm180 -69.33 -30.38 68.41 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.136 -1.026 . . . . 2.77 108.608 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.56 -27.0 68.87 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.39 -0.967 . . . . 1.19 108.39 178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.0 -39.93 72.12 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.89 -0.782 . . . . 1.2 108.89 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -60.05 -44.44 94.69 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.416 -0.802 . . . . 1.55 110.567 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.3 t -69.06 -39.97 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.003 -1.061 . . . . 0.8 108.772 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -61.38 -39.95 92.53 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.299 -0.875 . . . . 3.09 109.894 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -59.95 -40.0 87.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.257 -0.902 . . . . 1.46 110.566 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 93.7 mt -60.04 -43.41 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.038 -1.039 . . . . 0.71 109.669 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.431 ' CA ' HG21 ' A' ' 108' ' ' ILE . . . -60.05 -43.93 97.75 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.894 -1.283 . . . . 0.57 109.894 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -60.09 -45.73 91.97 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.18 -1.188 . . . . 2.59 110.561 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.413 HH22 HD11 ' A' ' 57' ' ' ILE . 56.4 mtp180 -64.82 -34.95 79.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.831 -1.168 . . . . 2.83 109.641 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.1 tp -59.97 -42.08 93.35 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.315 -0.866 . . . . 1.25 109.333 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.589 HD21 ' HB2' ' A' ' 105' ' ' HIS . 59.3 mt -60.18 -41.83 93.75 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.088 -1.007 . . . . 0.7 109.703 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.544 ' NH1' HD11 ' A' ' 24' ' ' ILE . 64.4 mtm-85 -70.79 -40.04 72.79 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.111 -0.993 . . . . 2.57 109.802 179.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -61.02 -37.18 81.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.311 -0.868 . . . . 1.23 111.048 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.2 mt -69.99 -42.62 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 120.562 -1.336 . . . . 0.81 108.854 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 90.6 mt -70.03 -26.96 64.29 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 109.248 -0.649 . . . . 1.0 109.248 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.2 41.28 8.07 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.958 -1.657 . . . . 0.89 108.958 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.5 tp -73.64 143.85 46.12 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.34 -1.094 . . . . 1.14 108.351 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -69.97 144.64 52.27 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.244 -0.91 . . . . 4.6 110.163 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.8 mt -109.88 127.93 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 122.176 0.989 . . . . 1.24 108.76 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.7 mt -69.99 -40.03 78.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 CA-C-N 115.582 -0.736 . . . . 1.54 110.272 -178.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 31.4 t0 64.22 123.83 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.514 -0.741 . . . . 1.5 109.442 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 37.5 mt -89.9 0.01 57.31 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.592 -0.692 . . . . 0.79 109.569 -179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.3 m -88.18 -18.46 28.66 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.234 -0.916 . . . . 1.4 110.716 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.69 16.52 2.16 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.072 -1.017 . . . . 0.92 112.008 -177.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.12 119.19 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.427 -1.421 . . . . 0.88 108.72 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -99.38 -9.51 23.4 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.183 -0.948 . . . . 2.45 110.806 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -110.19 144.82 38.29 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.405 -0.809 . . . . 1.52 110.052 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -65.61 135.61 55.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 1.58 108.993 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 28.4 m -152.86 166.47 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.571 -0.706 . . . . 0.69 109.419 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 83.7 mt -94.75 144.65 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 105.563 -2.014 . . . . 0.61 105.563 176.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 12.2 tp -96.58 117.45 30.98 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.812 -1.18 . . . . 0.87 110.48 -177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.3 t -122.37 130.03 74.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.595 -0.891 . . . . 0.71 108.595 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.415 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -159.27 164.2 35.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.095 -1.003 . . . . 0.81 109.074 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.46 ' O ' ' OD1' ' A' ' 162' ' ' ASP . . . -75.3 -30.61 60.41 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.317 -1.489 . . . . 0.98 108.681 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 66.6 m-20 -159.54 167.87 27.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.52 -0.738 . . . . 2.25 109.398 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 86.7 mt -141.68 125.83 17.4 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.175 -0.953 . . . . 0.78 108.473 178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 70.3 p -93.23 148.49 35.74 Favored Pre-proline 0 N--CA 1.496 1.856 0 O-C-N 121.083 -1.01 . . . . 0.98 109.827 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -39.64 -37.87 1.51 Allowed 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.243 1.962 . . . . 0.81 112.389 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 73.8 m -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.207 -0.933 . . . . 0.9 109.673 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -63.8 -41.6 97.87 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.194 -0.941 . . . . 1.61 109.497 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 59.5 p -55.6 -31.63 62.4 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.178 -0.951 . . . . 0.61 111.389 -178.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . . . -71.82 -55.01 8.36 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.578 -1.326 . . . . 0.6 109.446 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -82.43 40.35 0.65 Allowed 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.8 -1.185 . . . . 1.4 107.8 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.409 ' H ' ' C ' ' A' ' 169' ' ' ALA . 62.3 tp -105.31 130.92 53.33 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.316 -0.994 . . . . 0.7 108.316 178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -88.63 105.43 17.66 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.024 -1.048 . . . . 2.35 109.104 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 93.4 mt -63.69 -44.12 94.61 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.291 -0.881 . . . . 1.51 110.788 -179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -72.4 -22.29 61.14 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.854 -1.153 . . . . 2.33 112.528 -177.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -93.45 -9.99 36.63 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.527 -1.358 . . . . 1.92 109.663 -178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.6 HG12 ' H ' ' A' ' 178' ' ' GLY . 99.2 t -107.99 119.05 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.306 -0.871 . . . . 0.67 109.254 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 70.1 mt -85.74 4.92 34.62 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.403 -0.811 . . . . 1.53 110.525 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.6 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 168.03 175.22 37.58 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.296 -1.522 . . . . 0.48 109.296 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.492 ' CE1' HG11 ' A' ' 176' ' ' VAL . 16.3 m-85 -133.61 130.48 38.38 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.402 -1.058 . . . . 0.55 109.144 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.415 ' CG2' HG21 ' A' ' 205' ' ' THR . 79.4 mt -130.66 122.21 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 108.568 -0.901 . . . . 0.65 108.568 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 59.0 p -144.7 159.77 42.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.111 -0.993 . . . . 0.82 111.279 -179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 53.3 t0 -103.02 25.87 8.87 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.353 -0.61 . . . . 2.46 109.353 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.7 -161.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.178 -1.576 . . . . 1.28 111.747 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.61 -54.87 6.35 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.588 -1.005 . . . . 2.19 110.588 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 149.96 -114.37 0.65 Allowed Glycine 0 N--CA 1.495 2.61 0 O-C-N 120.778 -1.424 . . . . 2.13 111.263 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -69.98 -24.14 63.27 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.677 -0.896 . . . . 5.86 111.648 -178.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 75.7 p -82.85 3.15 30.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.597 -1.314 . . . . 3.72 110.664 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 34.3 t -91.61 126.86 36.84 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.918 -1.114 . . . . 1.74 111.08 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -55.98 -46.37 78.68 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.277 -0.89 . . . . 0.95 110.32 -179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.432 HG22 ' H ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -54.19 -39.99 67.14 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.14 -0.975 . . . . 1.55 110.238 -179.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 24.8 p -60.36 -39.6 87.75 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.003 -1.061 . . . . 1.51 110.454 -179.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.9 -41.1 84.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.154 -0.966 . . . . 1.67 110.188 -178.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 91.6 mtp -62.57 -40.06 95.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.035 -1.04 . . . . 1.02 110.666 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.99 -40.45 73.34 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.613 -1.304 . . . . 0.68 108.594 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 -59.62 -49.67 76.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.37 -0.831 . . . . 2.93 109.699 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 62.9 m -76.12 -31.24 58.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.18 -0.95 . . . . 0.86 110.798 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.5 mt -72.82 -21.93 60.89 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.954 -1.091 . . . . 0.67 109.547 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 64.39 43.93 4.42 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.93 -0.481 . . . . 1.5 111.514 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.453 ' O ' ' OG ' ' A' ' 8' ' ' SER . 46.5 mt -121.08 142.1 34.17 Favored Pre-proline 0 N--CA 1.503 2.219 0 N-CA-C 107.601 -1.259 . . . . 0.72 107.601 177.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.72 143.84 99.46 Favored 'Trans proline' 0 N--CA 1.496 1.669 0 C-N-CA 121.508 1.472 . . . . 0.61 111.441 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.96 152.22 3.5 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 118.935 -1.106 . . . . 0.66 111.49 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 89.9 mt -124.27 143.46 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 107.739 -1.208 . . . . 0.79 107.739 178.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.5 m -125.49 -10.77 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 120.996 -1.065 . . . . 0.91 111.19 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.409 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -113.11 25.97 10.91 Favored Glycine 0 N--CA 1.501 3.012 0 N-CA-C 111.063 -0.815 . . . . 1.01 111.063 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.415 HG21 ' CG2' ' A' ' 180' ' ' ILE . 11.4 p -43.56 -43.75 5.76 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.001 -1.294 . . . . 0.99 109.757 -179.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.434 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 96.01 -50.7 1.71 Allowed Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.439 -0.886 . . . . 1.12 111.418 178.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.2 m -160.08 40.0 0.18 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.53 -1.571 . . . . 1.72 111.457 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 12.1 t -77.54 -32.02 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.889 -1.132 . . . . 0.89 108.775 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 31.9 p -60.0 -39.89 87.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.558 -0.714 . . . . 1.03 110.829 -179.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 81.8 p -82.47 -10.7 58.92 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.973 -1.079 . . . . 1.83 110.731 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -98.53 -16.82 19.01 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.21 -0.931 . . . . 2.27 110.724 -179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.452 HG12 ' N ' ' A' ' 213' ' ' LYS . 44.8 t -116.56 154.73 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 O-C-N 121.265 -0.897 . . . . 0.92 111.025 -179.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.452 ' N ' HG12 ' A' ' 212' ' ' VAL . 2.8 mptp? -116.01 154.83 29.18 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.558 -1.275 . . . . 2.2 107.558 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 20.9 p30 -59.74 140.11 56.76 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.956 -1.09 . . . . 2.36 110.474 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.4 t0 88.97 5.7 0.16 Allowed 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.049 0.452 . . . . 2.38 110.368 179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 16' ' ' ALA . 59.4 m-20 -79.78 153.71 28.99 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.049 -1.032 . . . . 2.09 109.706 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -95.01 129.93 41.88 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.416 -0.802 . . . . 1.27 108.868 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.404 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 84.6 mt -130.72 151.18 51.45 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.136 -0.977 . . . . 0.75 110.769 -179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 84.9 mt -120.13 122.03 67.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 107.235 -1.394 . . . . 0.63 107.235 176.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 45.2 tp -103.33 120.02 39.98 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.823 -1.173 . . . . 0.7 108.73 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.475 ' O ' ' O ' ' A' ' 10' ' ' GLY . 32.3 t0 -87.24 -37.36 17.3 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.936 -1.102 . . . . 2.31 108.918 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 45.52 24.49 0.18 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.594 -0.691 . . . . 0.78 109.363 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 45.0 t -137.28 -44.63 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 106.965 -1.494 . . . . 1.04 106.965 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -99.94 2.69 43.88 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.131 -1.433 . . . . 2.44 107.131 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.859 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.8 OUTLIER 59.94 45.11 12.68 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 116.101 -0.5 . . . . 1.55 110.03 -179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -139.48 138.38 36.35 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.137 -0.977 . . . . 1.99 109.828 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 97.1 t -120.01 122.38 68.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.807 -0.812 . . . . 0.77 108.807 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.49 ' CD2' ' SD ' ' A' ' 239' ' ' MET . 99.2 m-85 -90.61 130.71 36.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.87 -1.144 . . . . 0.98 108.499 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 62.9 t -107.69 123.19 62.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.58 -0.7 . . . . 0.85 109.709 -179.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 66.6 t30 56.65 67.34 2.72 Favored Pre-proline 0 N--CA 1.493 1.702 0 O-C-N 121.284 -0.885 . . . . 1.66 109.271 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -88.53 130.87 2.37 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 123.144 2.563 . . . . 0.95 112.827 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.654 HG22 ' N ' ' A' ' 233' ' ' ASN . 95.1 m -73.2 173.23 9.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.368 -0.832 . . . . 1.84 109.082 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.654 ' N ' HG22 ' A' ' 232' ' ' THR . 70.3 m-80 -60.0 -40.0 87.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.168 -0.957 . . . . 2.74 109.886 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -61.48 -39.99 92.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 2.89 109.944 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.2 t -68.29 -39.95 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.093 -1.004 . . . . 1.3 109.544 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 89.4 mt -65.66 -42.27 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.076 -1.015 . . . . 1.09 108.672 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -61.31 -39.53 90.81 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.031 -0.729 . . . . 2.43 109.031 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -59.95 -49.67 76.77 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.522 -0.918 . . . . 2.78 108.522 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.546 ' O ' ' N ' ' A' ' 242' ' ' VAL . 96.2 mtp -62.66 -75.12 0.08 Allowed 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.728 -1.582 . . . . 1.25 106.728 178.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.528 ' C ' ' O ' ' A' ' 239' ' ' MET . 13.1 mmm-85 -18.31 -55.73 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.456 0 N-CA-C 112.112 0.412 . . . . 2.63 112.112 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 239' ' ' MET . . . -59.99 -50.61 73.08 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.894 -1.129 . . . . 1.8 109.82 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 239' ' ' MET . 54.5 t -62.84 -39.9 86.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.368 -0.832 . . . . 2.13 109.364 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 15.0 tm0? -59.73 -39.08 83.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.905 . . . . 3.17 109.555 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.97 -39.97 87.48 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.715 -1.24 . . . . 1.78 108.859 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -61.29 -40.04 92.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.243 -0.911 . . . . 2.47 108.802 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 62.4 t -60.82 -39.95 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 109.034 -0.728 . . . . 2.09 109.034 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.92 82.75 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.37 -0.831 . . . . 2.54 109.617 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 58.1 m -60.09 -39.96 87.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.082 -1.011 . . . . 2.99 109.201 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.455 ' C ' ' N ' ' A' ' 251' ' ' ALA . 46.9 tp10 -60.1 -40.02 88.19 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 3.34 109.191 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -50.81 -13.47 0.15 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.231 -0.918 . . . . 3.88 108.885 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.455 ' N ' ' C ' ' A' ' 249' ' ' GLU . . . -60.05 -46.71 88.65 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.491 -0.756 . . . . 4.43 109.275 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -151.5 75.37 1.17 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.212 -0.93 . . . . 5.42 109.682 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.485 HD12 ' N ' ' A' ' 254' ' ' ALA . 0.3 OUTLIER -92.55 5.85 49.36 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.115 -0.991 . . . . 6.1 109.07 179.588 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.485 ' N ' HD12 ' A' ' 253' ' ' LEU . . . -69.96 -26.47 64.12 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.276 -0.89 . . . . 7.37 109.432 179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -60.02 -49.9 75.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 8.01 110.226 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.19 -40.08 93.75 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.003 -1.061 . . . . 9.05 109.514 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -80.87 158.29 25.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.334 -0.854 . . . . 10.56 109.92 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -97.08 11.94 34.4 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.329 -0.857 . . . . 11.32 109.54 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.181 -0.949 . . . . 12.42 109.589 -179.952 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 31.7 ttp . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.414 0.626 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -154.86 152.43 29.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.493 -0.754 . . . . 0.0 109.057 179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -150.04 162.8 39.68 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.061 -1.025 . . . . 0.0 109.958 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -154.3 151.64 29.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.383 -0.823 . . . . 0.0 109.255 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -108.99 130.98 55.48 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.302 -0.874 . . . . 0.0 110.059 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.433 ' O ' HG13 ' B' ' 306' ' ' VAL . 7.2 p -132.86 121.75 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-O 122.235 1.017 . . . . 0.0 112.512 -178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . 0.465 ' O ' HG23 ' B' ' 309' ' ' THR . 18.1 m -76.7 106.72 8.53 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.944 0.878 . . . . 0.0 111.086 -177.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 97.1 mt -53.18 121.36 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-O 122.191 0.996 . . . . 0.0 110.566 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . 0.465 HG23 ' O ' ' B' ' 307' ' ' THR . 81.8 p -110.76 19.98 18.06 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.232 -179.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -69.92 118.02 59.33 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 120.928 -1.108 . . . . 0.0 108.826 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -49.65 -20.34 4.29 Favored 'Trans proline' 0 N--CA 1.495 1.568 0 CA-C-N 120.216 1.113 . . . . 0.0 112.945 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -116.15 15.3 16.02 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.371 -0.831 . . . . 0.0 109.714 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.53 174.35 20.01 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.175 -1.97 . . . . 0.0 108.175 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 3.5 tp -83.52 94.27 8.0 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.981 -1.305 . . . . 0.0 109.459 -178.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.413 ' NE2' ' HB3' ' B' ' 317' ' ' ARG . 3.6 p80 -99.94 -158.81 0.7 Allowed 'General case' 0 N--CA 1.509 2.492 0 O-C-N 121.085 -1.01 . . . . 0.0 109.978 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.7 m -59.95 -43.84 94.77 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.968 -1.083 . . . . 0.0 112.572 -175.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.541 HH12 ' NE2' ' B' ' 321' ' ' GLN . 11.9 tpt180 -54.1 -59.19 10.59 Favored Pre-proline 0 N--CA 1.499 2.025 0 O-C-N 120.335 -1.478 . . . . 0.0 111.271 -179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -60.59 -34.51 92.34 Favored 'Trans proline' 0 N--CA 1.49 1.288 0 CA-C-N 120.531 1.225 . . . . 0.0 111.503 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.08 -50.88 71.97 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.364 -0.835 . . . . 0.0 109.034 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.71 -43.0 76.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.785 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . 0.541 ' NE2' HH12 ' B' ' 317' ' ' ARG . 83.0 mm-40 -70.02 -41.47 74.24 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 120.807 -1.183 . . . . 0.0 108.898 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -62.01 -52.91 62.07 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.548 -0.72 . . . . 0.0 110.554 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 87.0 t -65.73 -28.01 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.909 -1.119 . . . . 0.0 109.844 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -60.13 -46.66 88.89 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.123 -0.986 . . . . 0.0 110.057 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . 0.485 ' OE1' HD22 ' B' ' 380' ' ' LEU . 86.8 tt0 -66.1 -47.7 73.35 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.13 -0.981 . . . . 0.0 111.284 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.9 -53.4 58.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.64 -1.288 . . . . 0.0 111.34 -178.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -57.16 -15.48 5.74 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.924 -1.11 . . . . 0.0 109.702 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -74.86 -30.07 60.06 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -101.71 146.23 28.03 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.318 -1.107 . . . . 0.0 108.594 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 24.3 p -89.79 -12.83 38.07 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.916 -1.115 . . . . 0.0 110.218 -179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.493 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 23.2 t -55.2 148.2 14.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.122 -0.986 . . . . 0.0 109.577 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -70.24 128.87 37.73 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.223 -0.923 . . . . 0.0 108.523 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.7 mt -131.48 131.15 62.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 121.568 -0.708 . . . . 0.0 109.817 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . 0.421 HG22 ' N ' ' B' ' 335' ' ' VAL . 89.4 m -130.39 154.48 47.65 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.548 -0.72 . . . . 0.0 109.531 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . 0.421 ' N ' HG22 ' B' ' 334' ' ' THR . 56.1 t -116.44 137.87 48.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 178.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 91.3 m -129.11 126.42 39.3 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.107 -0.995 . . . . 0.0 108.898 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 49.4 p -139.94 114.4 9.24 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.128 -0.983 . . . . 0.0 111.678 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 46.76 52.95 10.79 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 176.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.94 -13.92 63.31 Favored Glycine 0 N--CA 1.502 3.094 0 O-C-N 119.992 -1.692 . . . . 0.0 112.776 176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -119.89 131.42 55.24 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-N 119.13 1.465 . . . . 0.0 109.86 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 89.4 p -132.0 151.5 51.7 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.776 0.798 . . . . 0.0 110.332 -179.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.3 169.84 17.13 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-O 121.479 0.657 . . . . 0.0 109.929 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 3.6 t -91.63 140.11 30.04 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.342 -0.849 . . . . 0.0 110.707 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.47 ' HA ' HD11 ' B' ' 350' ' ' LEU . . . -79.47 -16.01 56.8 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.946 . . . . 0.0 109.798 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 53.5 pttt -84.05 16.02 3.13 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . 0.419 ' H ' ' C ' ' B' ' 344' ' ' ALA . 93.4 p -149.99 95.7 2.33 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.048 0.928 . . . . 0.0 111.835 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.716 HD23 HD22 ' A' ' 79' ' ' LEU . 47.6 tp -60.17 -32.72 71.32 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 178.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.788 ' CE2' HD11 ' A' ' 79' ' ' LEU . 53.3 m-85 -54.61 -52.88 60.83 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.902 -1.124 . . . . 0.0 109.817 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -70.01 -39.89 75.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.246 -0.909 . . . . 0.0 110.549 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.603 ' O ' ' N ' ' B' ' 352' ' ' THR . 88.9 mt -49.93 -59.69 3.63 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.888 -1.132 . . . . 0.0 109.578 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.786 HE22 ' NE ' ' A' ' 126' ' ' ARG . 17.7 mm100 -42.21 -10.23 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.779 -0.575 . . . . 0.0 112.074 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.603 ' N ' ' O ' ' B' ' 350' ' ' LEU . 60.1 p -88.04 -5.07 58.68 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.336 -1.477 . . . . 0.0 109.48 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 91.4 mt -96.83 116.76 29.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.344 -0.848 . . . . 0.0 109.074 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.63 96.11 1.14 Allowed Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.901 -1.68 . . . . 0.0 108.901 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 31.1 mt -106.17 96.81 6.74 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.342 -1.093 . . . . 0.0 109.634 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 21.4 p -97.55 159.64 14.8 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.942 -1.099 . . . . 0.0 110.687 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -52.81 119.29 4.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.691 -0.631 . . . . 0.0 110.66 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 101.51 4.07 52.86 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 63.2 m -87.52 111.25 21.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.454 -1.027 . . . . 0.0 111.093 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 45.2 t -77.12 117.74 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 122.291 1.044 . . . . 0.0 109.448 -177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 30.3 m -112.11 177.14 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 42.0 m -130.76 129.01 41.92 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 88.5 mt -104.7 122.36 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 69.6 m -126.95 135.98 51.65 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.63 156.21 42.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.199 -0.938 . . . . 0.0 109.527 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -147.95 124.57 11.1 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 159.15 -157.09 28.18 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.629 -1.748 . . . . 0.0 111.848 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -59.95 -55.06 38.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 122.249 -0.56 . . . . 0.0 111.995 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.493 ' H ' ' HB2' ' B' ' 331' ' ' SER . 95.9 m-20 -108.8 10.16 26.71 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.037 -1.039 . . . . 0.0 111.416 -177.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.487 ' OE2' ' NE2' ' B' ' 371' ' ' GLN . 0.6 OUTLIER -43.97 -30.6 0.74 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.979 -1.075 . . . . 0.0 110.618 -179.113 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . 0.487 ' NE2' ' OE2' ' B' ' 370' ' ' GLU . 92.1 mm-40 -70.04 -41.0 74.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.053 -1.029 . . . . 0.0 109.541 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -67.98 -49.45 61.58 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.199 -0.938 . . . . 0.0 109.128 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.78 -76.75 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.448 -0.783 . . . . 0.0 111.258 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.543 ' O ' HG23 ' B' ' 378' ' ' VAL . 46.3 t -45.31 -37.32 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 120.923 -1.111 . . . . 0.0 110.763 -177.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -67.73 -43.15 80.63 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.505 -1.372 . . . . 0.0 109.974 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -85.34 -43.18 13.91 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.751 -1.218 . . . . 0.0 110.09 179.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 84.9 mt -57.22 -38.17 73.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.95 -1.094 . . . . 0.0 108.919 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.543 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.5 t -66.78 -40.04 85.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.247 -0.908 . . . . 0.0 109.671 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -80.47 -10.08 59.75 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.67 -1.269 . . . . 0.0 109.727 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.485 HD22 ' OE1' ' B' ' 325' ' ' GLU . 57.2 tp -83.6 -26.78 29.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.654 -1.279 . . . . 0.0 108.08 177.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 18.3 tpp -80.64 -24.66 38.84 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -85.21 -9.57 57.63 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.767 -0.583 . . . . 0.0 109.736 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -110.6 -2.19 16.5 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.29 -0.881 . . . . 0.0 110.496 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 25.0 mt -91.45 119.63 31.59 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.82 -1.175 . . . . 0.0 109.334 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.498 1.94 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.019 179.751 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.616 -0.512 . . . . 2.91 109.616 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.5 mt -110.0 129.02 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 108.806 -0.813 . . . . 1.2 108.806 179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.6 m -132.5 134.84 45.51 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.444 -0.785 . . . . 1.4 108.985 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.67 -163.11 19.57 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 108.723 -1.751 . . . . 1.05 108.723 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.498 ' CG2' ' HE ' ' A' ' 186' ' ' ARG . 96.9 mt -90.93 -10.38 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.033 -1.275 . . . . 1.15 109.891 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.4 tp 54.92 98.39 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.076 -1.015 . . . . 0.98 109.194 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -74.85 -36.65 62.35 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.565 -0.71 . . . . 0.88 109.5 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.7 m -149.75 144.46 17.77 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.135 -0.978 . . . . 1.69 109.949 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -80.05 140.93 14.48 Favored 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.693 2.262 . . . . 0.85 113.145 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.812 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 164.94 -163.93 36.72 Favored Glycine 0 N--CA 1.497 2.763 0 N-CA-C 109.468 -1.453 . . . . 0.92 109.468 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -149.98 150.0 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 121.12 -1.224 . . . . 0.81 108.784 179.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.73 155.74 33.65 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.813 -1.179 . . . . 0.51 110.682 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.505 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.8 m-85 -137.5 128.53 27.5 Favored 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.407 -0.96 . . . . 0.62 108.407 178.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.09 -179.92 46.92 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 118.814 -1.66 . . . . 0.55 110.769 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -79.9 157.33 26.95 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.734 -0.863 . . . . 2.1 108.97 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -101.02 129.49 46.87 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.434 -0.791 . . . . 0.77 111.157 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.5 tp -97.31 134.29 40.8 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 106.951 -1.5 . . . . 0.91 106.951 178.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.9 tp -118.71 122.17 41.85 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.333 -0.855 . . . . 0.93 110.836 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 71.9 mt -100.37 110.36 22.57 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.832 -0.543 . . . . 0.93 110.886 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -114.57 143.84 44.35 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.525 -0.734 . . . . 2.75 109.272 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.434 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 49.9 mp0 -127.93 130.72 48.94 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.34 -0.85 . . . . 3.0 108.99 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -72.47 144.3 48.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.199 -0.938 . . . . 2.77 109.492 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -61.74 140.36 58.22 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.304 -0.872 . . . . 2.94 108.972 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 37.4 mt -79.6 131.95 33.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.224 -0.922 . . . . 0.95 108.786 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 25.4 t -97.93 123.7 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.25 -0.906 . . . . 1.28 109.485 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.7 mt -105.67 136.44 39.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 108.642 -0.874 . . . . 1.21 108.642 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -90.97 128.36 36.77 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.033 -1.042 . . . . 1.81 110.552 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.419 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.0 mmm-85 -92.57 7.37 43.57 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.639 -0.663 . . . . 2.8 109.316 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -68.55 145.27 54.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 2.87 109.744 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -87.86 139.45 30.5 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.386 -0.821 . . . . 2.35 109.267 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.9 pt -90.59 163.62 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.896 -1.128 . . . . 0.97 109.899 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.7 p -94.52 169.15 10.4 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.244 -0.91 . . . . 1.17 108.939 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.75 -17.91 63.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.278 -0.889 . . . . 1.18 110.603 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -84.33 -28.45 27.05 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.688 -1.258 . . . . 2.56 108.094 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -82.07 -8.97 59.68 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.094 -0.706 . . . . 1.79 109.094 179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.2 t -65.51 -54.73 25.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 O-C-N 120.916 -1.115 . . . . 1.0 108.571 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -59.97 -40.0 87.6 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.286 -0.884 . . . . 1.77 109.655 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -69.25 -41.84 76.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.228 -0.92 . . . . 2.7 110.684 -178.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -63.33 -40.05 96.25 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.892 -1.13 . . . . 1.51 110.165 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.23 -46.82 95.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 120.785 -1.197 . . . . 0.93 108.153 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.26 -44.69 95.07 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.374 -0.829 . . . . 1.81 109.586 179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.01 -43.15 95.41 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.942 -1.099 . . . . 2.78 108.281 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.422 ' CZ ' HD13 ' A' ' 89' ' ' ILE . 91.0 t80 -64.05 -46.06 86.07 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.345 -0.847 . . . . 0.78 108.902 178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.04 -48.34 82.11 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.562 -0.903 . . . . 1.07 108.562 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -64.85 -42.79 94.6 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.183 -0.948 . . . . 1.12 108.551 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.88 -47.46 88.69 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.478 -1.849 . . . . 0.84 108.478 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -63.79 -37.97 89.35 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.076 -1.083 . . . . 3.09 108.076 178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.14 -39.99 70.08 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.562 -0.903 . . . . 0.88 108.562 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 50' ' ' ALA . 31.9 ttpt -61.17 -74.06 0.09 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 107.655 -1.239 . . . . 2.59 107.655 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.18 -33.18 0.05 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.304 -0.872 . . . . 0.7 111.912 -178.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.2 m -60.02 -50.3 74.29 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 120.385 -1.447 . . . . 1.4 108.603 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.15 75.85 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.412 -0.805 . . . . 0.67 110.943 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -66.6 -40.0 88.66 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.802 -1.186 . . . . 1.66 110.442 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.7 mt -63.87 -40.11 95.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.951 -1.093 . . . . 1.58 109.595 179.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -60.04 -36.13 76.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 1.35 109.557 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.0 -42.28 98.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -0.977 . . . . 0.77 109.678 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.1 mt -64.31 -39.99 87.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.401 -0.812 . . . . 0.63 109.714 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -54.64 -51.59 64.92 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.264 -0.897 . . . . 1.14 110.123 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -59.7 -34.57 73.06 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.277 -0.889 . . . . 0.79 110.791 -177.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -67.13 -39.58 86.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.087 -1.008 . . . . 1.53 109.877 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.18 -42.42 96.71 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.607 -0.683 . . . . 0.57 109.527 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.21 -55.64 29.57 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.926 -1.269 . . . . 0.75 109.926 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.75 -48.09 70.21 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.885 -1.362 . . . . 1.59 109.656 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 21.6 m -62.84 -65.08 0.74 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 0.73 112.17 -178.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -96.45 -48.74 5.44 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 120.717 -1.24 . . . . 0.75 111.357 -178.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.76 -168.67 25.51 Favored Glycine 0 N--CA 1.502 3.075 0 C-N-CA 119.536 -1.316 . . . . 1.22 111.436 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -70.04 -26.29 63.96 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.993 -0.71 . . . . 5.81 110.695 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.486 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 52.8 tp10 -61.4 -35.25 76.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.309 -0.869 . . . . 3.37 110.679 -179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.45 ' HA ' HD12 ' A' ' 72' ' ' ILE . 40.9 mmtm -98.95 -20.8 16.59 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.175 -0.953 . . . . 1.77 109.984 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.6 tt0 -70.03 -40.25 75.27 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.149 -0.97 . . . . 1.65 110.589 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.489 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.54 -31.71 72.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.257 -0.902 . . . . 0.77 109.788 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 69' ' ' LYS . 95.7 mt -59.97 -40.65 83.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.17 -0.956 . . . . 0.8 109.07 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -62.67 -40.91 98.55 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.131 -0.981 . . . . 0.88 109.503 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.518 ' CD ' ' NZ ' ' B' ' 324' ' ' LYS . 66.5 tt0 -63.32 -39.88 95.79 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.715 -0.794 . . . . 1.37 109.834 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.13 -41.78 98.26 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.757 -1.737 . . . . 0.62 108.757 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -67.73 -42.26 82.18 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.386 -1.067 . . . . 1.5 109.4 179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.1 mt -66.86 -46.37 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.209 -0.932 . . . . 0.63 109.106 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 36.8 ttp -60.09 -44.26 94.92 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.144 -0.973 . . . . 1.51 110.129 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.838 HD11 ' CE2' ' B' ' 348' ' ' PHE . 44.9 tp -59.95 -40.13 87.96 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.172 -0.955 . . . . 0.77 108.909 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.8 tp -64.6 -39.23 93.35 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.868 -0.52 . . . . 0.62 110.231 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -81.86 2.39 30.55 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.073 -1.017 . . . . 1.47 111.082 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -48.81 125.96 11.18 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.777 -1.202 . . . . 1.47 109.056 -179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.1 -15.33 22.41 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.259 -0.901 . . . . 1.78 110.259 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -72.0 -35.03 69.32 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.987 -1.07 . . . . 2.53 108.61 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.03 -40.79 74.98 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.363 0.602 . . . . 0.8 110.05 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.28 -43.76 95.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 1.42 109.774 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -70.05 -41.62 73.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.547 -0.721 . . . . 1.71 111.17 -178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.02 -40.11 75.42 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.905 -1.122 . . . . 1.57 111.301 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.422 HD13 ' CZ ' ' A' ' 43' ' ' PHE . 72.5 mt -64.9 -49.41 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.113 -0.992 . . . . 0.65 109.561 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.41 -39.49 78.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.798 -0.564 . . . . 0.82 110.572 -179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.81 84.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.074 -1.016 . . . . 0.79 110.821 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.07 -45.16 93.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.973 -1.079 . . . . 0.95 109.707 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 77.8 mt -61.37 -49.94 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.092 -1.005 . . . . 0.66 108.599 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.5 mttp -64.58 -41.41 96.3 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 120.067 -0.653 . . . . 2.2 110.157 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -80.14 -56.3 4.32 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.992 -1.068 . . . . 1.65 112.177 -178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -90.54 -2.47 57.9 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.103 -0.998 . . . . 2.03 112.677 -177.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 57.5 39.65 27.73 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 120.693 -1.254 . . . . 1.42 109.585 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.7 mtp -92.11 169.22 10.8 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.545 -0.722 . . . . 1.18 109.82 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 42.9 p -83.37 160.63 21.59 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.362 -0.836 . . . . 0.98 109.412 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.1 -38.56 88.55 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.499 -0.751 . . . . 0.64 110.335 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 32.7 p-10 -69.8 -35.91 75.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.189 -0.944 . . . . 2.07 109.627 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.432 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.5 -44.09 19.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.271 -0.893 . . . . 0.73 110.124 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.43 -44.97 70.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.159 -0.963 . . . . 0.54 109.974 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.1 -39.39 85.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.134 -0.979 . . . . 0.56 109.655 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.525 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 85.5 t60 -59.93 -41.33 91.54 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.315 -0.866 . . . . 1.54 110.037 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.17 -39.92 86.53 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.142 -0.974 . . . . 1.33 111.214 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.3 t -58.24 -58.08 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.03 -1.044 . . . . 0.72 111.218 -177.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.2 mm -70.1 -40.0 77.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.946 -1.097 . . . . 0.85 109.417 -179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.525 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 87.7 tt0 -60.41 -39.98 89.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.156 -0.965 . . . . 2.44 109.144 179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.09 -50.13 71.05 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.432 -1.067 . . . . 0.98 110.432 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -61.12 -50.63 72.42 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.911 -1.347 . . . . 1.41 109.826 -179.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.6 83.31 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.323 -0.861 . . . . 1.2 110.521 -179.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 68.8 m -59.66 -39.97 86.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.892 -1.13 . . . . 1.7 108.781 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.66 -40.0 93.37 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.227 -0.92 . . . . 1.47 108.94 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.7 mt -61.19 -42.67 98.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.136 -0.977 . . . . 1.56 109.47 -179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -55.15 -32.45 62.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.046 -1.034 . . . . 2.2 109.433 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -59.99 -23.61 63.79 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.192 -0.943 . . . . 2.12 108.93 179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.414 HD13 HD13 ' A' ' 123' ' ' LEU . 58.2 mt -62.08 140.02 58.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.149 -0.97 . . . . 2.0 109.02 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 32.7 p-10 -91.4 41.43 1.07 Allowed 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.194 -0.941 . . . . 3.23 110.404 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 40.6 t0 -134.88 145.28 48.12 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.208 -0.932 . . . . 2.49 109.565 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.524 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 97.5 mt-10 -72.99 -64.7 0.92 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.439 -0.788 . . . . 3.95 109.045 179.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.453 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 4.1 t80 -38.55 -40.13 0.54 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.905 -0.497 . . . . 2.0 110.684 -178.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.414 HD13 HD13 ' A' ' 118' ' ' LEU . 91.1 mt -72.44 -39.97 67.42 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 120.78 -1.2 . . . . 1.86 108.427 179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.501 ' N ' ' O ' ' A' ' 121' ' ' GLU . 19.9 ttpp -64.98 -40.87 95.63 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.485 -0.76 . . . . 2.84 109.058 179.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.499 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 94.8 mt-10 -62.53 -42.55 99.59 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.172 -1.047 . . . . 2.73 108.172 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.516 ' NH2' ' CB ' ' B' ' 319' ' ' ALA . 57.7 ttt180 -60.13 -40.02 88.33 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 107.923 -1.139 . . . . 2.77 107.923 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.73 -25.85 68.39 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.727 -0.842 . . . . 1.19 108.727 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -60.75 -41.07 94.67 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.168 -1.049 . . . . 1.2 108.168 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -66.18 -40.1 90.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.49 -0.756 . . . . 1.55 109.637 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.428 ' CG2' HE22 ' B' ' 351' ' ' GLN . 56.0 t -63.0 -41.37 92.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.132 -0.98 . . . . 0.8 109.469 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -63.06 -39.83 95.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.152 -0.967 . . . . 3.09 109.398 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -60.19 -40.55 90.45 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.363 -0.836 . . . . 1.46 110.393 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 98.3 mt -60.01 -45.77 95.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.098 -1.001 . . . . 0.71 110.382 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.94 -34.89 55.13 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.826 -1.31 . . . . 0.57 109.826 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.464 ' NZ ' HH21 ' A' ' 139' ' ' ARG . 24.8 tptp -59.99 -49.54 77.29 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.4 -1.059 . . . . 2.59 109.658 -179.221 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 69.3 mtp180 -64.74 -33.57 76.28 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.917 -1.114 . . . . 2.83 109.793 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.2 tp -59.98 -41.02 91.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.363 -0.836 . . . . 1.25 109.094 -178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.44 -39.99 89.49 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.258 -0.901 . . . . 0.7 108.698 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.464 HH21 ' NZ ' ' A' ' 135' ' ' LYS . 98.8 mtt180 -67.06 -39.93 87.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.491 -0.756 . . . . 2.57 109.429 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 70.0 m-80 -70.2 -25.68 63.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.45 -0.781 . . . . 1.23 111.64 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.3 mt -70.28 -40.09 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.211 -1.556 . . . . 0.81 109.008 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.6 mt -82.34 -26.83 32.62 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.459 -0.775 . . . . 1.0 110.202 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.95 47.61 5.22 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.034 -1.626 . . . . 0.89 109.034 -179.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.1 tp -74.29 145.48 43.95 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.381 -1.07 . . . . 1.14 109.448 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.24 137.19 58.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 4.6 109.584 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.0 mt -113.97 130.03 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 CA-C-O 121.975 0.893 . . . . 1.24 109.283 179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.51 -42.2 94.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.769 -0.582 . . . . 1.54 110.366 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.6 t0 68.22 91.97 0.09 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.49 -0.756 . . . . 1.5 109.011 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 60.7 mt -64.08 -6.64 6.77 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.515 -0.741 . . . . 0.79 111.231 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.5 m -82.82 -14.74 53.8 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.651 -1.281 . . . . 1.4 110.069 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.41 30.91 0.4 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.108 -0.995 . . . . 0.92 112.133 -177.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 41.9 mm -90.31 121.19 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 120.485 -1.384 . . . . 0.88 109.205 179.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -103.06 -12.54 17.34 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.337 -0.852 . . . . 2.45 110.537 -179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -128.37 152.09 48.58 Favored 'General case' 0 N--CA 1.508 2.444 0 O-C-N 121.077 -1.015 . . . . 1.52 110.46 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.32 137.0 57.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.497 -0.752 . . . . 1.58 109.402 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.5 m -152.54 164.38 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 108.943 -0.762 . . . . 0.69 108.943 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -93.77 146.49 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 106.486 -1.672 . . . . 0.61 106.486 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 54.5 tp -94.56 114.59 26.58 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.18 -0.95 . . . . 0.87 110.679 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.523 ' CG1' HG22 ' A' ' 209' ' ' THR . 49.6 t -120.03 127.12 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 108.042 -1.095 . . . . 0.71 108.042 178.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.05 160.0 40.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.168 -0.958 . . . . 0.81 108.999 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.462 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -76.43 -30.09 57.26 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 120.266 -1.521 . . . . 0.98 107.872 178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 57.2 t0 -170.05 134.09 1.23 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.334 -0.854 . . . . 2.25 108.894 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.445 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 81.8 mt -111.22 125.02 53.37 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.217 -0.927 . . . . 0.78 108.905 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 51.9 p -83.83 146.6 49.66 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.98 109.292 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_exo -39.91 -37.15 1.52 Allowed 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 122.298 1.998 . . . . 0.81 113.235 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.6 m -59.99 -41.04 91.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.069 -1.019 . . . . 0.9 109.699 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -71.13 -40.66 71.27 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.222 -0.924 . . . . 1.61 110.342 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.1 p -53.12 -29.88 33.41 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.015 -1.053 . . . . 0.61 111.447 -177.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -76.46 -56.82 4.28 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.754 -1.216 . . . . 0.6 110.327 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -77.12 37.04 0.19 Allowed 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.36 -0.978 . . . . 1.4 108.36 -179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.491 ' H ' ' C ' ' A' ' 169' ' ' ALA . 58.6 tp -102.06 137.32 40.5 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.369 -0.604 . . . . 0.7 109.369 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.461 ' O ' HG23 ' A' ' 176' ' ' VAL . 18.2 m120 -82.76 101.08 10.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.163 -0.96 . . . . 2.35 109.239 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 99.5 mt -66.19 -41.98 89.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.167 -0.958 . . . . 1.51 110.719 -179.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -65.92 -28.82 69.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.857 -1.152 . . . . 2.33 111.568 -177.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 12.3 mptt -92.52 -8.26 45.01 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.778 -1.201 . . . . 1.92 110.133 -178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 172' ' ' ASN . 94.3 t -101.8 112.18 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 108.28 -1.008 . . . . 0.67 108.28 178.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.03 5.15 30.62 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.28 -0.888 . . . . 1.53 110.709 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.435 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.97 173.38 38.04 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.309 -1.517 . . . . 0.48 109.309 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.448 ' CE1' HG11 ' A' ' 176' ' ' VAL . 15.4 m-85 -132.08 129.61 40.19 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.467 -1.02 . . . . 0.55 109.186 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.2 mt -134.12 127.09 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.372 -0.83 . . . . 0.65 108.943 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 22.5 p -149.78 160.26 43.69 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.982 -1.074 . . . . 0.82 110.387 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 20.1 p-10 -102.41 23.02 12.44 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.411 -0.806 . . . . 2.46 109.458 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -52.68 -165.45 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.081 -1.012 . . . . 1.28 111.951 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -75.52 -54.31 5.57 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 110.869 -0.892 . . . . 2.19 110.869 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 173.61 -140.28 5.47 Favored Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.053 -1.546 . . . . 2.13 110.824 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.498 ' HE ' ' CG2' ' A' ' 5' ' ' ILE . 0.6 OUTLIER -65.55 -34.14 77.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.634 -0.921 . . . . 5.86 111.159 -178.854 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 12.9 p -59.95 4.24 0.05 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.942 -1.099 . . . . 3.72 110.879 -178.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.497 ' H ' ' C ' ' A' ' 186' ' ' ARG . 17.1 m -91.93 131.66 37.08 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.771 -1.205 . . . . 1.74 110.29 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.1 t60 -47.26 -37.58 10.86 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 107.827 -1.175 . . . . 0.95 107.827 179.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.412 ' H ' HG23 ' A' ' 190' ' ' THR . 7.4 p -57.7 -41.85 82.51 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.546 -0.752 . . . . 1.55 110.368 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 75.4 m -61.38 -40.08 93.04 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.158 -0.964 . . . . 1.51 111.518 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.91 -40.48 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.114 -0.991 . . . . 1.67 109.548 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 76.9 mtp -58.89 -49.53 77.43 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.353 -0.842 . . . . 1.02 109.94 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -51.33 -47.05 62.8 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.961 -1.087 . . . . 0.68 110.024 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -62.53 -57.97 9.24 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 118.565 -1.254 . . . . 2.93 109.957 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.1 m -61.24 -40.01 92.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.048 -1.033 . . . . 0.86 111.657 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 93.9 mt -70.96 -23.69 62.27 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.887 -1.133 . . . . 0.67 109.824 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 64.9 47.81 2.53 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-O 121.444 0.64 . . . . 1.5 109.547 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 86.0 mt -126.95 150.05 70.79 Favored Pre-proline 0 N--CA 1.501 2.103 0 N-CA-C 108.568 -0.901 . . . . 0.72 108.568 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.56 141.58 74.03 Favored 'Trans proline' 0 N--CA 1.497 1.72 0 C-N-CA 122.213 1.942 . . . . 0.61 111.67 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.58 153.82 3.56 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.797 -1.161 . . . . 0.66 111.518 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.8 mt -128.08 139.47 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 107.818 -1.179 . . . . 0.79 107.818 179.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.5 m -121.83 -11.31 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 120.959 -1.088 . . . . 0.91 111.362 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.1 26.42 15.32 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 110.465 -1.054 . . . . 1.01 110.465 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.8 p -46.42 -42.21 14.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.102 -1.234 . . . . 0.99 109.841 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.59 -54.04 4.1 Favored Glycine 0 N--CA 1.494 2.539 0 C-N-CA 120.125 -1.036 . . . . 1.12 111.104 179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 84.9 p -152.58 28.41 0.55 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.556 -1.555 . . . . 1.72 111.567 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 73.0 t -74.03 -40.71 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.666 -1.271 . . . . 0.89 109.136 178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.523 HG22 ' CG1' ' A' ' 159' ' ' VAL . 7.7 p -60.95 -30.87 70.48 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.102 -0.999 . . . . 1.03 110.5 -179.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 79.3 p -79.97 -10.94 59.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.981 -1.074 . . . . 1.83 109.363 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -105.14 -10.92 16.82 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.569 -0.707 . . . . 2.27 109.948 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 79.8 t -101.64 139.99 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.407 -0.808 . . . . 0.92 109.957 -179.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.68 145.89 38.45 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.393 -1.336 . . . . 2.2 107.393 178.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.476 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 10.4 p30 -54.78 138.2 42.9 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.016 -1.053 . . . . 2.36 110.42 -178.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.476 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.3 m-20 86.81 3.66 0.43 Allowed 'General case' 0 N--CA 1.504 2.228 0 CA-C-O 120.988 0.423 . . . . 2.38 110.434 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -76.26 150.39 37.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.015 -1.053 . . . . 2.09 109.156 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -99.43 119.84 38.64 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.261 -1.015 . . . . 1.27 108.261 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 67.8 mt -126.57 148.51 49.74 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.398 -0.814 . . . . 0.75 110.782 -178.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.8 mt -115.59 128.3 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 107.502 -1.296 . . . . 0.63 107.502 177.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 19.0 tp -100.7 118.19 36.33 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.122 -0.986 . . . . 0.7 109.432 -179.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 10' ' ' GLY . 94.7 m-20 -77.15 -43.2 34.83 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.213 -0.929 . . . . 2.31 108.557 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.812 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.89 17.64 0.67 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 107.857 -1.164 . . . . 0.78 107.857 -178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.441 ' N ' ' C ' ' A' ' 221' ' ' ASP . 56.4 t -136.05 -36.2 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 107.942 -1.133 . . . . 1.04 107.942 179.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -105.51 3.44 29.43 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.845 -1.169 . . . . 2.44 107.845 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 60.54 43.67 12.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.822 -0.549 . . . . 1.55 111.259 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.415 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 11.9 pt20 -150.0 152.78 35.45 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.723 -1.236 . . . . 1.99 110.314 179.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 91.1 t -119.94 123.38 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 109.043 -0.725 . . . . 0.77 109.043 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.415 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 74.0 m-85 -84.62 128.19 34.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.011 -1.055 . . . . 0.98 109.221 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 48.6 t -103.18 116.62 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.472 -0.768 . . . . 0.85 109.152 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 62.32 67.48 1.2 Allowed Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.3 -0.875 . . . . 1.66 109.989 -179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -87.05 131.1 3.08 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 123.048 2.498 . . . . 0.95 112.375 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.464 HG22 ' N ' ' A' ' 233' ' ' ASN . 25.3 m -68.56 163.85 22.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 1.84 109.59 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.464 ' N ' HG22 ' A' ' 232' ' ' THR . 43.0 t30 -59.93 -42.1 93.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.293 -0.879 . . . . 2.74 110.681 -178.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -60.42 -33.6 72.74 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.818 -1.176 . . . . 2.89 109.335 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.5 t -68.77 -40.34 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.252 -0.905 . . . . 1.3 109.361 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.8 mt -65.36 -42.68 94.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.231 -0.918 . . . . 1.09 109.863 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -60.1 -42.09 93.95 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.111 -0.993 . . . . 2.43 109.564 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -64.16 -42.04 96.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.372 -0.83 . . . . 2.78 109.341 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 99.4 mtp -70.02 -32.6 70.84 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.393 -0.817 . . . . 1.25 109.772 -179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -67.4 -40.09 85.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.129 -0.982 . . . . 2.63 109.136 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.04 -40.83 82.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.341 -0.849 . . . . 1.8 109.469 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 52.9 t -61.22 -38.11 79.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.345 -0.847 . . . . 2.13 109.239 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -59.64 -40.06 86.38 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.351 -0.843 . . . . 3.17 109.372 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.84 -40.07 96.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.853 -1.154 . . . . 1.78 109.165 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -61.12 -36.04 78.68 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.482 -0.761 . . . . 2.47 109.552 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 79.1 t -60.02 -41.65 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.945 . . . . 2.09 109.055 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.33 -39.93 88.84 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.295 -0.878 . . . . 2.54 108.896 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 7.0 p -81.62 -35.27 30.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 2.99 110.214 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 15.5 tm-20 -59.99 -44.74 94.31 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.204 -0.935 . . . . 3.34 111.13 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.592 ' O ' ' N ' ' A' ' 252' ' ' GLU . 51.9 pttt -59.99 -42.69 94.78 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.809 -1.182 . . . . 3.88 109.716 -179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.416 ' N ' ' CG ' ' A' ' 250' ' ' LYS . . . 40.04 17.63 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.656 -0.652 . . . . 4.43 110.856 179.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 250' ' ' LYS . 87.6 tt0 -75.09 -25.04 58.26 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.204 -0.935 . . . . 5.42 110.064 -179.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' A' ' 254' ' ' ALA . 90.7 mt -52.75 -59.98 3.83 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.179 -0.951 . . . . 6.1 109.703 -178.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 253' ' ' LEU . . . 175.17 78.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.327 -0.858 . . . . 7.37 109.097 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 15.8 ptpt -60.06 139.37 57.51 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.09 -1.006 . . . . 8.01 109.214 179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.431 ' N ' HD12 ' A' ' 256' ' ' LEU . 8.6 mp -84.75 -1.93 56.95 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.9 . . . . 9.05 109.308 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -67.35 -55.47 13.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.03 -1.044 . . . . 10.56 109.38 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 49.2 t0 -156.79 92.27 1.27 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.327 -0.858 . . . . 11.32 109.364 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 118.033 -0.984 . . . . 12.42 109.918 179.895 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 43.3 ttm . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.468 0.652 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -149.23 144.97 26.87 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -150.76 160.0 44.15 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.874 -1.141 . . . . 0.0 110.787 -178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -154.64 149.57 26.75 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -117.66 134.68 54.63 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.252 -0.905 . . . . 0.0 109.629 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.8 129.97 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 CA-C-O 122.192 0.996 . . . . 0.0 112.356 -177.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . 0.448 ' OG1' HG22 ' B' ' 360' ' ' VAL . 57.3 m -76.24 108.06 8.92 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.31 1.052 . . . . 0.0 110.958 -178.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 90.5 mt -53.82 120.93 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 CA-C-O 122.413 1.102 . . . . 0.0 111.278 -178.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 60.3 p -109.82 19.97 18.54 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.005 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -70.0 136.09 87.32 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 120.964 -1.085 . . . . 0.0 108.429 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -65.9 -21.82 56.79 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 CA-C-N 119.929 1.01 . . . . 0.0 112.609 -179.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -121.99 15.24 10.78 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.417 -0.802 . . . . 0.0 108.931 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.19 -175.76 52.3 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.453 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -85.85 91.97 8.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.05 -1.265 . . . . 0.0 109.063 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.2 p80 -92.43 -162.8 0.96 Allowed 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.831 -1.168 . . . . 0.0 109.969 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 16.0 m -58.56 -43.35 89.33 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.888 -1.133 . . . . 0.0 112.47 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.7 HH21 ' NE2' ' B' ' 321' ' ' GLN . 1.9 tpt180 -55.58 -61.07 6.82 Favored Pre-proline 0 N--CA 1.5 2.025 0 O-C-N 120.517 -1.364 . . . . 0.0 111.46 -179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -60.22 -36.79 86.92 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 CA-C-N 120.229 1.118 . . . . 0.0 111.939 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . 0.516 ' CB ' ' NH2' ' A' ' 126' ' ' ARG . . . -63.26 -16.82 61.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.287 -0.883 . . . . 0.0 109.357 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -82.46 -44.47 15.98 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . 0.7 ' NE2' HH21 ' B' ' 317' ' ' ARG . 95.4 mt-30 -72.48 -39.13 67.93 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -62.08 -54.55 39.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 110.302 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . 0.41 HG13 ' O ' ' B' ' 344' ' ' ALA . 52.7 t -63.82 -28.58 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.706 -1.246 . . . . 0.0 110.001 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.518 ' NZ ' ' CD ' ' A' ' 74' ' ' GLU . 11.7 ttmm -60.33 -45.69 92.55 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.341 -0.849 . . . . 0.0 109.818 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.2 tp10 -62.33 -49.55 75.14 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.52 -0.738 . . . . 0.0 110.375 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.02 -54.03 50.88 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.054 -1.029 . . . . 0.0 111.468 -178.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -53.86 -16.17 1.67 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.788 -1.195 . . . . 0.0 109.904 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.7 -25.16 75.84 Favored Glycine 0 N--CA 1.487 2.033 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 179.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -105.97 141.69 36.94 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.518 -0.989 . . . . 0.0 109.726 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . 0.454 HG22 ' O ' ' B' ' 330' ' ' THR . 54.3 m -89.04 -10.04 48.99 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.237 -0.914 . . . . 0.0 109.242 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 26.8 m -62.36 150.96 38.15 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.265 -0.897 . . . . 0.0 109.084 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -67.86 133.47 49.23 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.061 -1.025 . . . . 0.0 109.086 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 87.1 mt -129.9 130.12 66.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.557 -0.714 . . . . 0.0 109.167 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 78.2 m -126.85 148.75 49.96 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.502 0.668 . . . . 0.0 109.287 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 48.3 t -114.07 139.55 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 178.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 28.7 m -130.18 121.28 25.94 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.173 -0.954 . . . . 0.0 109.046 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 31.0 t -138.5 115.11 10.58 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.888 0.851 . . . . 0.0 110.525 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 47.56 51.92 13.16 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.496 0.924 . . . . 0.0 113.496 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.04 -14.55 48.63 Favored Glycine 0 N--CA 1.5 2.952 0 O-C-N 119.971 -1.705 . . . . 0.0 112.629 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -111.67 121.73 45.9 Favored 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 119.104 1.452 . . . . 0.0 110.222 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 39.1 m -106.57 156.31 18.72 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.719 0.771 . . . . 0.0 110.796 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . 0.44 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -152.47 152.66 32.22 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.427 0.632 . . . . 0.0 110.036 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 8.6 t -87.99 131.42 34.63 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.303 -0.873 . . . . 0.0 109.686 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.41 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -70.83 -16.21 62.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.093 -1.005 . . . . 0.0 109.771 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . 0.422 ' HG2' ' H ' ' B' ' 345' ' ' LYS . 12.6 ptmt -86.83 21.08 2.35 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 178.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 10.7 t -150.8 98.53 2.62 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.867 -0.733 . . . . 0.0 112.18 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.828 HD23 HD22 ' A' ' 79' ' ' LEU . 19.3 tp -60.06 -30.6 69.31 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.838 ' CE2' HD11 ' A' ' 79' ' ' LEU . 63.2 m-85 -58.09 -54.36 47.88 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.414 -0.804 . . . . 0.0 110.718 -178.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 35.6 mtmm -68.28 -40.06 81.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.885 -1.134 . . . . 0.0 109.509 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.59 ' O ' ' N ' ' B' ' 352' ' ' THR . 30.9 mt -49.87 -56.99 8.37 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.934 -1.104 . . . . 0.0 108.102 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.428 HE22 ' CG2' ' A' ' 130' ' ' VAL . 28.6 mt-30 -40.23 -13.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 122.044 -0.41 . . . . 0.0 111.799 -178.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.59 ' N ' ' O ' ' B' ' 350' ' ' LEU . 77.0 p -93.99 -13.21 27.24 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.451 -1.406 . . . . 0.0 110.613 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.44 HD11 ' HB3' ' B' ' 342' ' ' ALA . 63.3 mt -90.54 118.89 30.35 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.847 -1.158 . . . . 0.0 109.077 179.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.8 90.95 0.67 Allowed Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.436 -1.866 . . . . 0.0 108.436 179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 20.8 mt -96.77 84.69 3.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -1.168 . . . . 0.0 108.265 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 30.7 p -88.29 174.3 8.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.431 -0.793 . . . . 0.0 110.566 -178.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -69.16 114.71 7.68 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.532 -0.73 . . . . 0.0 110.891 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.98 8.94 38.25 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 28.7 m -93.58 111.08 22.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.217 -1.167 . . . . 0.0 110.921 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . 0.448 HG22 ' OG1' ' B' ' 307' ' ' THR . 11.2 t -77.25 120.23 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 CA-C-O 122.141 0.972 . . . . 0.0 109.773 -177.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 18.3 m -112.51 177.32 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 62.0 m -131.37 129.57 41.53 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 77.0 mt -104.53 117.46 50.16 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 96.8 p -126.27 136.75 53.16 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.426 -0.796 . . . . 0.0 109.593 -178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.23 154.02 40.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.395 -0.816 . . . . 0.0 109.886 -179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -142.99 122.47 13.17 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.494 ' O ' ' OE1' ' B' ' 370' ' ' GLU . . . 162.23 -160.24 32.39 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 118.689 -1.72 . . . . 0.0 111.81 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . 0.471 ' N ' ' OG ' ' B' ' 331' ' ' SER . 52.2 tp10 -59.97 -50.08 75.16 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 122.145 -0.621 . . . . 0.0 112.322 -177.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.491 ' N ' ' OG ' ' B' ' 331' ' ' SER . 49.5 m-20 -113.3 12.8 18.98 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.869 -1.144 . . . . 0.0 111.592 -177.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.584 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 1.1 pm0 -43.09 -27.86 0.24 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.177 -0.952 . . . . 0.0 110.351 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . 0.489 ' N ' ' CD ' ' B' ' 370' ' ' GLU . 4.4 pt20 -70.08 -42.37 72.85 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 0.0 109.84 -179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -65.17 -48.38 73.7 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.203 -0.936 . . . . 0.0 108.918 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.23 -76.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.401 -0.812 . . . . 0.0 110.859 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.462 ' O ' HG23 ' B' ' 378' ' ' VAL . 59.6 t -46.0 -37.41 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.0 -1.062 . . . . 0.0 110.817 -177.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.34 -49.28 74.56 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.595 -1.316 . . . . 0.0 110.446 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 80.9 m80 -77.55 -43.59 31.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.004 -1.06 . . . . 0.0 110.521 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 44.5 mt -60.63 -39.73 89.31 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.271 -0.893 . . . . 0.0 110.197 -179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.462 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.7 t -64.34 -39.99 87.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 120.958 -1.089 . . . . 0.0 109.291 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -70.01 -56.55 6.68 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 120.768 -1.208 . . . . 0.0 107.859 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 64.5 tp -58.01 -28.38 64.38 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.449 -0.782 . . . . 0.0 111.33 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . 0.517 ' SD ' ' O ' ' B' ' 381' ' ' MET . 0.0 OUTLIER -73.67 -38.13 65.03 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.104 -1.623 . . . . 0.0 108.382 178.24 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.7 -4.52 54.69 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 110.321 179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -111.37 -1.91 15.81 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.158 -0.964 . . . . 0.0 111.075 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . 0.427 ' CD2' ' OE1' ' B' ' 321' ' ' GLN . 23.8 mt -89.16 127.4 35.73 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.332 -1.48 . . . . 0.0 110.179 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 117.974 -1.012 . . . . 0.0 108.75 179.049 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.088 0.471 . . . . 2.91 109.884 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 94.5 mt -106.94 120.02 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.442 -0.786 . . . . 1.2 109.108 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 28.8 m -132.42 134.97 45.76 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.503 -0.748 . . . . 1.4 109.392 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.776 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -119.34 -162.01 11.84 Favored Glycine 0 N--CA 1.501 2.99 0 N-CA-C 108.872 -1.691 . . . . 1.05 108.872 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.468 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.5 mt -89.4 -18.46 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.938 -1.331 . . . . 1.15 110.249 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 5' ' ' ILE . 62.7 tp 54.68 105.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.369 -0.832 . . . . 0.98 108.849 -179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.15 -24.1 14.99 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.132 -0.98 . . . . 0.88 109.338 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 19.5 t -138.33 124.74 12.91 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.446 -0.784 . . . . 1.69 109.81 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.65 145.18 16.12 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 121.974 1.783 . . . . 0.85 112.122 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.805 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 158.03 -158.83 29.49 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.481 -1.448 . . . . 0.92 109.481 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 84.7 mt -149.68 150.81 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.169 -1.194 . . . . 0.81 108.661 179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.44 155.47 33.6 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.073 -1.017 . . . . 0.51 110.168 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.2 m-85 -136.58 129.56 31.02 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 107.679 -1.23 . . . . 0.62 107.679 179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.29 -178.76 47.62 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 118.349 -1.881 . . . . 0.55 110.951 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -79.96 157.09 26.94 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.814 -0.815 . . . . 2.1 109.53 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.434 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -102.82 129.19 49.4 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.363 -0.836 . . . . 0.77 111.108 -178.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.0 tp -99.66 131.05 45.9 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.629 -1.249 . . . . 0.91 107.629 178.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 61.5 tp -111.21 120.09 41.11 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.08 -1.012 . . . . 0.93 109.5 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 160' ' ' ALA . 35.7 mt -85.51 104.04 14.92 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.55 -0.718 . . . . 0.93 109.467 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -93.19 135.48 34.34 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.7 -0.852 . . . . 2.75 108.7 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -131.01 118.45 20.62 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 108.686 -0.857 . . . . 3.0 108.686 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -76.7 141.64 40.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.102 -0.998 . . . . 2.77 109.448 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -60.06 140.07 57.07 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.325 -0.859 . . . . 2.94 108.774 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 84.8 mt -77.76 135.24 26.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 N-CA-C 108.556 -0.905 . . . . 0.95 108.556 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.7 t -100.6 122.63 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.271 -0.893 . . . . 1.28 109.878 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.1 mt -95.43 141.86 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 N-CA-C 108.969 -0.752 . . . . 1.21 108.969 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -97.67 119.44 36.24 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.171 -0.956 . . . . 1.81 109.491 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -94.47 3.24 55.4 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.282 -0.886 . . . . 2.8 109.467 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -59.97 139.98 57.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.419 -0.801 . . . . 2.87 109.908 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -93.07 144.94 24.78 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.158 -0.963 . . . . 2.35 108.597 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 pt -103.17 166.92 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 O-C-N 121.121 -0.987 . . . . 0.97 110.863 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.9 p -96.9 177.63 5.56 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.349 -0.844 . . . . 1.17 109.332 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.08 -49.9 75.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.452 -0.78 . . . . 1.18 110.877 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -58.06 -29.81 65.69 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.525 -1.359 . . . . 2.56 109.991 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -81.56 -11.44 59.16 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.147 -0.97 . . . . 1.79 110.242 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.7 t -60.04 -50.03 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.861 -1.149 . . . . 1.0 108.729 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -61.22 -39.96 92.21 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.479 -0.763 . . . . 1.77 109.347 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -64.14 -43.45 95.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.411 -0.806 . . . . 2.7 111.274 -178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -63.56 -41.11 98.43 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.74 -1.225 . . . . 1.51 110.168 -179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.04 -46.08 94.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 C-N-CA 118.709 -1.196 . . . . 0.93 108.794 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -60.03 -42.33 94.15 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.068 -1.02 . . . . 1.81 109.382 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.484 HH11 ' HG2' ' A' ' 42' ' ' ARG . 25.1 mtt-85 -60.06 -44.66 94.56 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.937 -1.134 . . . . 2.78 107.937 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -60.18 -45.76 92.03 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.393 -0.966 . . . . 0.78 108.393 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.1 tp -59.98 -49.82 76.15 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.801 -0.815 . . . . 1.07 108.801 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.505 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 28.8 t -60.05 -42.2 93.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.048 -1.032 . . . . 1.12 109.174 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.0 -42.55 98.41 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.191 -1.964 . . . . 0.84 108.191 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 37.1 ttm-85 -60.07 -32.97 71.43 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.225 -1.028 . . . . 3.09 108.225 178.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.9 -40.09 83.44 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.743 -0.598 . . . . 0.88 109.631 -179.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 50' ' ' ALA . 12.1 ttmt -75.16 -74.82 0.19 Allowed 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 118.55 -1.26 . . . . 2.59 108.384 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -39.0 -39.32 0.53 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.16 -0.963 . . . . 0.7 111.459 -178.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.9 p -55.95 -59.11 5.36 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.704 -1.247 . . . . 1.4 109.252 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.21 -40.01 82.23 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.249 -0.907 . . . . 0.67 111.331 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -63.39 -40.63 97.74 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.772 -1.205 . . . . 1.66 110.975 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.5 mt -63.5 -40.07 96.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.758 -1.213 . . . . 1.58 109.078 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -59.92 -38.57 82.72 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.41 -0.806 . . . . 1.35 109.995 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -64.62 -43.68 92.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.915 -1.116 . . . . 0.77 109.226 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.441 ' CD1' HH22 ' A' ' 136' ' ' ARG . 87.9 mt -60.01 -40.01 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.471 -0.768 . . . . 0.63 108.936 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -55.58 -50.03 71.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.39 -0.818 . . . . 1.14 109.958 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -59.41 -36.32 75.64 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.316 -0.865 . . . . 0.79 111.002 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -62.37 -39.64 93.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.914 -1.116 . . . . 1.53 109.534 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.35 -45.25 80.82 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.629 -0.669 . . . . 0.57 110.218 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.63 -52.25 51.6 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 109.705 -1.358 . . . . 0.75 109.705 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -70.08 -46.5 64.78 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.135 -1.215 . . . . 1.59 110.214 -179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.7 m -67.27 -63.45 1.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.195 -0.94 . . . . 0.73 112.697 -177.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -96.23 -45.08 6.99 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.786 -1.196 . . . . 0.75 111.29 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.64 -174.04 23.22 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 119.644 -1.265 . . . . 1.22 111.309 179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -70.05 -26.68 64.13 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-O 121.395 0.617 . . . . 5.81 110.348 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -60.98 -32.76 72.3 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.447 -0.783 . . . . 3.37 110.703 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -100.44 -20.51 15.75 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.37 -0.831 . . . . 1.77 109.374 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -66.24 -40.09 89.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.334 -0.854 . . . . 1.65 110.329 -179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.579 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -66.35 -26.92 67.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.77 109.718 -178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.0 mt -60.03 -41.81 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.952 -1.092 . . . . 0.8 109.174 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -66.56 -39.84 88.73 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.264 -0.898 . . . . 0.88 110.089 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.51 ' CD ' ' NZ ' ' B' ' 324' ' ' LYS . 61.6 tt0 -60.06 -39.95 87.8 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.232 -0.917 . . . . 1.37 109.387 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.89 -46.06 95.3 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.308 -1.517 . . . . 0.62 109.308 179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 47.4 m170 -60.09 -42.05 93.79 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.201 -1.176 . . . . 1.5 109.459 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.1 mt -68.43 -45.9 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.342 -0.849 . . . . 0.63 109.526 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.2 ttp -59.98 -44.12 94.68 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.83 -1.168 . . . . 1.51 110.074 -179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.854 HD11 ' CE2' ' B' ' 348' ' ' PHE . 26.5 tp -64.53 -39.94 94.7 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.202 -0.937 . . . . 0.77 109.248 179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.2 tp -62.78 -39.87 95.53 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.567 -0.708 . . . . 0.62 109.589 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -84.69 4.15 33.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.215 -0.928 . . . . 1.47 110.152 -179.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.45 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.6 t0 -50.02 133.06 23.16 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.127 -0.983 . . . . 1.47 110.867 -178.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.45 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 95.4 mt-10 -61.46 -20.31 62.99 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.571 -0.706 . . . . 1.78 110.005 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 -68.22 -32.73 73.14 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.902 -1.147 . . . . 2.53 107.902 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 79' ' ' LEU . 94.0 mt -75.97 -40.0 54.79 Favored 'General case' 0 N--CA 1.488 1.47 0 CA-C-O 121.509 0.671 . . . . 0.8 110.28 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -60.06 -49.98 75.52 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.269 -0.894 . . . . 1.42 110.282 -178.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -70.7 -41.64 71.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.114 -0.991 . . . . 1.71 110.656 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.08 -39.92 75.33 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.21 -0.931 . . . . 1.57 111.822 -178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.04 -43.9 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.765 -1.21 . . . . 0.65 109.35 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 93.7 mt -70.04 -39.34 77.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.574 -0.704 . . . . 0.82 110.101 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.05 -48.3 82.29 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.249 -0.907 . . . . 0.79 111.248 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.45 ' O ' ' N ' ' A' ' 96' ' ' LYS . 92.5 mt -60.1 -44.96 94.45 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.855 -1.153 . . . . 0.95 109.862 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.3 mt -59.96 -49.19 84.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 108.343 -0.984 . . . . 0.66 108.343 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 19.7 mttp -69.33 -41.79 76.21 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 120.123 -0.631 . . . . 2.2 110.759 179.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -81.34 -50.33 9.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.002 -1.061 . . . . 1.65 112.043 -178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.45 ' N ' ' O ' ' A' ' 92' ' ' LEU . 68.2 mmtt -92.46 -1.85 56.69 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.041 -1.037 . . . . 2.03 111.838 -177.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 55.72 33.84 22.15 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 120.785 -1.197 . . . . 1.42 109.562 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 93.9 mtp -89.56 168.95 11.76 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.526 -0.734 . . . . 1.18 110.047 -179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.3 p -81.11 160.01 24.55 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.74 -0.837 . . . . 0.98 108.74 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.41 -38.9 91.33 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.054 -1.029 . . . . 0.64 109.282 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -66.68 -39.3 88.07 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.281 -0.887 . . . . 2.07 109.532 179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.76 -44.2 33.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.73 110.113 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.13 -45.35 73.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.27 -0.893 . . . . 0.54 109.895 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.06 -38.67 83.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.117 -0.989 . . . . 0.56 109.547 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -59.88 -44.63 94.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.351 -0.843 . . . . 1.54 110.266 -178.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 110' ' ' GLY . 88.6 tt0 -62.6 -40.69 97.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.898 . . . . 1.33 110.441 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.8 t -62.74 -55.74 21.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.229 -0.919 . . . . 0.72 110.84 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.476 HG21 ' HA3' ' A' ' 134' ' ' GLY . 43.1 mm -70.54 -40.04 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.784 -1.197 . . . . 0.85 109.491 -179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.438 ' OE2' ' OG ' ' A' ' 113' ' ' SER . 12.2 tm-20 -68.3 -39.97 81.89 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.353 -0.842 . . . . 2.44 108.8 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -60.57 -45.85 95.52 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.04 -1.224 . . . . 0.98 110.04 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.484 HE21 ' CB ' ' B' ' 348' ' ' PHE . 16.5 mm100 -69.95 -53.06 19.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.989 -1.301 . . . . 1.41 109.749 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.93 -40.04 69.49 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.088 -1.008 . . . . 1.2 109.229 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.438 ' OG ' ' OE2' ' A' ' 109' ' ' GLU . 59.1 m -60.0 -40.07 87.94 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.959 . . . . 1.7 109.275 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.09 -33.53 75.64 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 1.47 109.128 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.2 mt -69.06 -39.97 78.78 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.075 -1.016 . . . . 1.56 109.66 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -60.02 -27.94 67.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.858 -1.151 . . . . 2.2 109.194 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -59.94 -23.49 63.6 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.364 -0.976 . . . . 2.12 108.364 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.464 HD13 HD13 ' A' ' 123' ' ' LEU . 24.6 mt -62.15 151.54 35.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.313 -0.867 . . . . 2.0 109.115 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -99.49 30.05 3.75 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.214 -0.929 . . . . 3.23 110.16 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -118.07 131.27 56.46 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.19 -0.944 . . . . 2.49 110.637 -179.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -70.07 -29.77 66.85 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 109.11 -0.7 . . . . 3.95 109.11 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.469 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.4 t80 -69.72 -38.93 77.08 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.603 -0.686 . . . . 2.0 110.38 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.506 HD22 ' O ' ' B' ' 351' ' ' GLN . 88.2 mt -73.15 -32.94 65.19 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.069 -1.019 . . . . 1.86 109.262 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 24.9 ttpp -60.02 -40.06 88.0 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.271 -0.893 . . . . 2.84 108.646 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -59.95 -46.15 90.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.28 -0.888 . . . . 2.73 109.017 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.48 ' HE ' ' NE2' ' B' ' 351' ' ' GLN . 15.3 mmm-85 -60.11 -39.96 88.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.127 -0.983 . . . . 2.77 108.885 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.13 -34.93 75.77 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.469 -0.937 . . . . 1.19 108.469 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.18 -39.97 92.15 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.394 -0.965 . . . . 1.2 108.394 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -68.57 -39.94 80.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.402 -0.811 . . . . 1.55 109.172 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.44 -39.92 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.11 -1.07 . . . . 0.8 108.11 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.513 HH11 ' HG2' ' A' ' 131' ' ' ARG . 7.2 ttt-85 -67.25 -34.42 77.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.449 -0.782 . . . . 3.09 109.44 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -60.03 -41.22 91.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.198 -0.939 . . . . 1.46 109.587 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 91.3 mt -61.06 -44.01 97.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.71 109.272 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.476 ' HA3' HG21 ' A' ' 108' ' ' ILE . . . -60.13 -45.0 96.79 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.155 -1.178 . . . . 0.57 110.155 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -59.97 -45.4 92.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.158 -1.201 . . . . 2.59 109.561 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.441 HH22 ' CD1' ' A' ' 57' ' ' ILE . 60.3 mtp180 -67.32 -36.05 80.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.042 -1.036 . . . . 2.83 110.112 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.4 tp -60.0 -43.31 95.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 1.25 109.513 -178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.34 -40.49 97.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.121 -0.987 . . . . 0.7 109.433 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -69.88 -38.09 76.26 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.188 -0.945 . . . . 2.57 108.672 178.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -59.97 -38.82 83.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.829 -0.545 . . . . 1.23 110.565 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -73.74 -44.18 52.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.829 -1.169 . . . . 0.81 108.917 179.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -69.96 -40.01 75.68 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.47 -0.769 . . . . 1.0 109.853 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.74 47.06 4.36 Favored Glycine 0 N--CA 1.495 2.582 0 N-CA-C 109.186 -1.566 . . . . 0.89 109.186 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 20.7 tp -73.66 148.76 42.47 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.439 -1.036 . . . . 1.14 109.396 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -66.89 140.67 57.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.236 -0.915 . . . . 4.6 109.391 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.3 mt -119.77 129.93 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 CA-C-O 121.77 0.795 . . . . 1.24 109.728 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 148' ' ' ASP . 1.4 mp -66.66 -39.94 84.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.786 -0.571 . . . . 1.54 110.323 -178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 147' ' ' ILE . 29.1 t0 62.27 127.03 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.822 -0.807 . . . . 1.5 108.822 -179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.1 mt -85.06 -4.51 59.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.054 -1.029 . . . . 0.79 109.366 -179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 18.4 t -86.75 -14.39 42.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.457 -0.777 . . . . 1.4 109.69 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.88 17.02 1.26 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.245 -0.909 . . . . 0.92 110.473 -178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 38.3 mm -88.86 124.24 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 120.872 -1.142 . . . . 0.88 109.203 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -105.76 -9.78 17.07 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.423 -0.798 . . . . 2.45 109.833 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 -124.05 149.62 45.9 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.319 -0.863 . . . . 1.52 110.311 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.21 134.62 55.13 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.351 -0.843 . . . . 1.58 109.595 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -151.95 164.64 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.492 -0.755 . . . . 0.69 109.525 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.7 mt -91.67 150.65 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 106.137 -1.801 . . . . 0.61 106.137 177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 51.2 tp -99.98 115.9 30.78 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.936 -1.103 . . . . 0.87 110.611 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 39.5 t -122.62 130.04 74.78 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 109.028 -0.73 . . . . 0.71 109.028 179.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.503 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -159.78 163.35 34.66 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.184 -0.948 . . . . 0.81 108.647 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.36 -35.42 73.53 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.426 -1.421 . . . . 0.98 107.68 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.7 p-10 -160.99 173.46 15.23 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.983 -0.747 . . . . 2.25 108.983 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.7 mt -138.91 139.19 37.96 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.18 -0.95 . . . . 0.78 109.037 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.4 p -96.09 140.29 22.19 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.168 -0.957 . . . . 0.98 109.141 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -40.25 -34.75 1.12 Allowed 'Trans proline' 0 N--CA 1.49 1.281 0 C-N-CA 121.901 1.734 . . . . 0.81 112.216 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.419 ' HB3' HH12 ' A' ' 136' ' ' ARG . 59.3 m -59.94 -42.85 94.88 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.883 . . . . 0.9 109.787 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -69.56 -41.3 76.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.249 -0.907 . . . . 1.61 109.844 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.8 p -54.28 -23.85 16.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.275 -0.891 . . . . 0.61 111.528 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.41 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -86.01 -50.12 7.3 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.407 -1.433 . . . . 0.6 109.867 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -81.49 35.87 0.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.479 -0.934 . . . . 1.4 108.479 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.416 HD11 HG21 ' A' ' 176' ' ' VAL . 59.1 tp -101.38 132.4 46.98 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.257 -0.645 . . . . 0.7 109.257 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.418 ' O ' HG23 ' A' ' 176' ' ' VAL . 32.9 t-20 -83.41 101.77 11.59 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.164 -0.96 . . . . 2.35 108.716 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.34 -40.18 96.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.762 . . . . 1.51 111.111 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -67.7 -26.11 66.01 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.837 -1.164 . . . . 2.33 111.915 -177.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -93.74 -11.43 31.43 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.62 -1.3 . . . . 1.92 110.231 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 172' ' ' ASN . 63.3 t -101.59 111.53 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.148 -0.97 . . . . 0.67 108.468 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.37 2.93 33.96 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 121.226 -0.921 . . . . 1.53 111.263 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 173.8 171.09 37.94 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.37 -1.492 . . . . 0.48 109.37 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.538 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 14.5 m-85 -132.04 128.43 38.27 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.498 -1.001 . . . . 0.55 109.491 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.0 mt -130.95 126.19 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.101 -1.074 . . . . 0.65 108.101 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 203' ' ' VAL . 16.6 p -146.21 158.62 43.89 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.013 -1.055 . . . . 0.82 110.842 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 59.5 t0 -106.15 28.13 7.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.748 -0.595 . . . . 2.46 109.452 179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -52.99 -168.52 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.448 -1.408 . . . . 1.28 111.369 -178.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.13 -54.93 6.0 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.49 -1.044 . . . . 2.19 110.49 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -166.51 -156.04 9.3 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.037 -1.554 . . . . 2.13 111.01 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.435 HH11 ' HG2' ' A' ' 186' ' ' ARG . 16.6 ptt-85 -70.05 -18.0 63.27 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.8 -0.823 . . . . 5.86 111.327 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 69.5 p -73.13 5.25 3.58 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.768 -1.207 . . . . 3.72 110.305 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.7 p -82.11 137.8 34.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.93 -1.106 . . . . 1.74 109.991 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -49.3 -49.93 41.65 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.321 -0.862 . . . . 0.95 110.152 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -37.62 71.48 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.362 -0.836 . . . . 1.55 110.965 -178.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 34.9 t -60.03 -39.97 87.7 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.752 -1.217 . . . . 1.51 110.371 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.86 -39.74 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.333 -0.855 . . . . 1.67 110.17 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 34.5 mtm -59.93 -45.0 94.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.966 -1.084 . . . . 1.02 110.42 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.99 -45.45 71.42 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.799 -1.188 . . . . 0.68 109.46 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -60.01 -53.44 57.85 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.998 -1.081 . . . . 2.93 110.445 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 75.4 m -68.21 -37.8 81.26 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.068 -1.02 . . . . 0.86 111.973 -178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.38 -22.95 62.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.698 -1.251 . . . . 0.67 109.906 -179.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 66.56 49.3 1.35 Allowed 'General case' 0 N--CA 1.5 2.04 0 CA-C-O 121.322 0.582 . . . . 1.5 110.079 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.47 ' O ' ' CB ' ' A' ' 8' ' ' SER . 97.0 mt -129.53 148.98 71.54 Favored Pre-proline 0 N--CA 1.5 2.046 0 N-CA-C 108.027 -1.101 . . . . 0.72 108.027 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.54 138.31 69.59 Favored 'Trans proline' 0 N--CA 1.499 1.851 0 C-N-CA 122.276 1.984 . . . . 0.61 112.194 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.01 149.73 2.97 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.076 -1.05 . . . . 0.66 111.354 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.5 mt -122.99 144.09 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 107.21 -1.404 . . . . 0.79 107.21 178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 181' ' ' THR . 17.9 m -122.34 -12.81 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.285 0 O-C-N 121.006 -1.059 . . . . 0.91 111.127 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -112.65 26.77 10.48 Favored Glycine 0 N--CA 1.5 2.933 0 N-CA-C 110.88 -0.888 . . . . 1.01 110.88 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 204' ' ' GLY . 14.0 p -41.96 -46.57 4.15 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.15 -1.206 . . . . 0.99 110.12 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.454 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 94.74 -54.18 1.96 Allowed Glycine 0 N--CA 1.5 2.951 0 C-N-CA 120.332 -0.937 . . . . 1.12 111.587 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 207' ' ' SER . 7.4 t -150.01 29.94 0.72 Allowed 'General case' 0 N--CA 1.503 2.202 0 O-C-N 120.329 -1.689 . . . . 1.72 111.024 -178.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 41.8 t -75.25 -36.87 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.709 -1.244 . . . . 0.89 109.249 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.456 ' H ' HG23 ' A' ' 209' ' ' THR . 8.4 p -60.05 -33.73 72.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.922 . . . . 1.03 111.117 -178.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 6.2 t -78.37 -22.44 47.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.935 -1.103 . . . . 1.83 110.306 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 73.4 mm-40 -94.7 -8.35 38.04 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.185 -0.947 . . . . 2.27 110.499 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 86.4 t -108.02 140.02 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 121.28 -0.888 . . . . 0.92 110.729 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.497 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 65.2 mmtt -117.15 156.87 26.91 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.895 -1.521 . . . . 2.2 106.895 177.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.438 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 29.9 p-10 -60.04 142.53 53.84 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 120.802 -1.186 . . . . 2.36 111.115 -178.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.438 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.7 m-20 82.11 3.2 1.28 Allowed 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 116.061 -0.518 . . . . 2.38 110.832 178.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.497 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 88.9 m-20 -74.95 145.01 42.93 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.889 -1.132 . . . . 2.09 109.301 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -94.59 120.0 34.13 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.231 -0.918 . . . . 1.27 108.847 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.434 HD12 ' HB2' ' A' ' 16' ' ' ALA . 59.6 mt -126.86 147.49 50.04 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.414 -0.804 . . . . 0.75 110.433 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 85.7 mt -114.11 128.28 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 106.906 -1.516 . . . . 0.63 106.906 177.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.1 tp -100.83 117.07 34.19 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.866 -1.146 . . . . 0.7 109.595 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 223' ' ' VAL . 96.1 m-20 -74.03 -43.9 56.26 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.242 -0.911 . . . . 2.31 108.728 179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.805 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 50.35 11.74 0.08 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.846 -0.798 . . . . 0.78 108.846 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.493 ' H ' ' C ' ' A' ' 221' ' ' ASP . 73.5 t -131.05 -44.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 N-CA-C 107.817 -1.179 . . . . 1.04 107.817 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 10.4 m-20 -100.04 3.23 44.0 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 107.61 -1.255 . . . . 2.44 107.61 178.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.776 HD21 ' H ' ' A' ' 4' ' ' GLY . 1.0 OUTLIER 59.61 43.67 15.51 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 116.246 -0.433 . . . . 1.55 110.192 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -140.09 144.46 36.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.122 -0.986 . . . . 1.99 110.042 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 87.8 t -120.03 125.68 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.926 -0.768 . . . . 0.77 108.926 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -90.99 118.15 30.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.85 -1.156 . . . . 0.98 109.679 -179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.8 t -94.76 116.69 36.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.475 -0.766 . . . . 0.85 109.529 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 68.22 67.67 0.52 Allowed Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.468 -0.77 . . . . 1.66 109.947 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -91.02 121.35 0.71 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 123.426 2.751 . . . . 0.95 112.955 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.626 HG22 ' N ' ' A' ' 233' ' ' ASN . 93.9 m -67.03 169.77 7.85 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.256 -0.903 . . . . 1.84 109.685 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.626 ' N ' HG22 ' A' ' 232' ' ' THR . 7.3 m120 -60.06 -40.0 87.97 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.307 -0.871 . . . . 2.74 109.544 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -59.91 -38.63 82.86 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.189 -0.945 . . . . 2.89 108.753 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 76.7 t -63.72 -40.06 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 1.3 109.559 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.43 -40.93 82.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.291 -0.881 . . . . 1.09 109.86 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -59.96 -47.0 87.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.996 -1.065 . . . . 2.43 109.061 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -60.08 -43.93 95.12 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.486 -0.758 . . . . 2.78 109.67 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 94.5 mtp -72.67 -24.8 61.07 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.359 -0.838 . . . . 1.25 110.511 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.3 mmm-85 -73.34 -39.96 64.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.796 -1.19 . . . . 2.63 110.008 179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -62.54 -40.75 97.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.237 -0.914 . . . . 1.8 109.459 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.65 -41.36 91.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.315 -0.866 . . . . 2.13 109.542 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -60.64 -41.83 95.73 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.038 -1.039 . . . . 3.17 109.607 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -60.09 -40.0 88.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.144 -0.972 . . . . 1.78 108.96 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 58.0 tt0 -60.95 -37.53 82.69 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.668 -0.645 . . . . 2.47 109.652 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 78.7 t -59.99 -43.69 93.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 2.09 109.516 -179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.32 -42.63 99.01 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.291 -0.881 . . . . 2.54 109.89 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 27.4 t -70.0 -40.41 75.31 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.194 -0.941 . . . . 2.99 111.05 -179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -62.57 -39.94 95.28 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.095 -1.003 . . . . 3.34 110.791 -178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -82.32 3.41 27.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.02 -1.05 . . . . 3.88 110.718 -178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -121.92 -45.3 2.27 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.049 -1.032 . . . . 4.43 109.942 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -62.07 -44.44 96.67 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.106 -0.996 . . . . 5.42 110.816 -179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 1.5 mp -119.68 -24.54 6.18 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.527 -0.733 . . . . 6.1 109.542 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 53.02 35.99 20.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 7.37 109.815 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 39.4 tttm -147.83 139.64 23.99 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.979 -1.119 . . . . 8.01 107.979 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.558 ' N ' HD12 ' A' ' 256' ' ' LEU . 8.4 mp -87.13 105.71 17.37 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.006 -1.059 . . . . 9.05 108.985 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -52.2 146.47 9.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.468 -0.77 . . . . 10.56 109.62 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 258' ' ' ASP . 16.8 p-10 -150.84 40.44 0.73 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.336 -0.853 . . . . 11.32 109.603 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 117.977 -1.011 . . . . 12.42 109.487 -179.845 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 38.1 ttp . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.497 0.665 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -155.84 153.44 29.75 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.494 -0.754 . . . . 0.0 109.136 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -150.9 161.9 41.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.08 -1.012 . . . . 0.0 110.399 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -153.38 149.95 28.35 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.644 -0.66 . . . . 0.0 109.389 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -110.17 128.56 55.54 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -131.66 124.59 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 CA-C-O 122.192 0.996 . . . . 0.0 112.388 -177.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 91.4 m -77.84 103.87 8.04 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 122.03 0.919 . . . . 0.0 110.869 -178.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 88.8 mt -51.71 124.75 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 122.467 1.127 . . . . 0.0 110.464 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 75.7 p -110.02 19.33 19.12 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.206 -178.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.404 ' O ' ' CD ' ' B' ' 357' ' ' GLN . . . -69.33 147.21 97.07 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.94 -1.1 . . . . 0.0 108.578 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -72.82 -24.69 17.69 Favored 'Trans proline' 0 N--CA 1.498 1.751 0 C-N-CA 120.892 1.061 . . . . 0.0 112.672 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -121.05 17.61 11.66 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.17 -173.37 53.97 Favored Glycine 0 N--CA 1.486 1.983 0 N-CA-C 107.989 -2.045 . . . . 0.0 107.989 -178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.469 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.5 tp -86.3 90.42 8.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.889 -1.359 . . . . 0.0 108.88 -179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.424 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 4.5 p80 -93.14 -161.42 0.84 Allowed 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.033 -1.042 . . . . 0.0 111.102 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.1 m -55.79 -45.32 78.24 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.569 -0.707 . . . . 0.0 112.71 -175.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.579 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.5 tpt180 -61.22 -58.58 17.98 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 120.526 -1.359 . . . . 0.0 112.176 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' B' ' 317' ' ' ARG . 11.5 Cg_endo -59.37 -32.03 95.91 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 CA-C-N 120.307 1.145 . . . . 0.0 111.907 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.96 75.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.11 -0.994 . . . . 0.0 108.515 179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.73 -42.76 68.45 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.248 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 67.6 tp60 -69.95 -42.96 72.51 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.129 -0.982 . . . . 0.0 108.944 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.26 -52.55 64.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.462 -0.774 . . . . 0.0 110.622 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . 0.408 HG13 ' O ' ' B' ' 344' ' ' ALA . 92.5 t -64.66 -30.84 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 120.757 -1.214 . . . . 0.0 109.521 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.51 ' NZ ' ' CD ' ' A' ' 74' ' ' GLU . 12.0 ttmm -60.03 -48.11 83.07 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.392 -0.818 . . . . 0.0 110.102 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . 0.517 ' OE1' HD22 ' B' ' 380' ' ' LEU . 84.9 tt0 -67.64 -44.45 77.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.955 . . . . 0.0 111.239 -178.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.04 -52.43 65.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.587 -1.32 . . . . 0.0 110.465 -178.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -56.42 -14.1 2.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.009 . . . . 0.0 109.376 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -71.94 -21.53 79.02 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 178.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -105.8 143.68 33.61 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.669 -0.9 . . . . 0.0 108.721 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 15.3 t -91.02 -13.16 33.79 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.027 -1.046 . . . . 0.0 109.279 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.42 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 52.8 p -62.72 146.9 51.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.481 -0.762 . . . . 0.0 109.119 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -65.63 137.04 57.07 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.148 -0.97 . . . . 0.0 108.98 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 94.3 mt -132.94 133.21 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.604 -0.685 . . . . 0.0 109.679 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 46.5 m -130.34 152.42 49.77 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 62.3 t -117.41 139.51 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 97.9 m -130.7 126.09 35.62 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.105 -0.997 . . . . 0.0 109.714 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 73.5 p -140.16 118.19 11.88 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.863 0.84 . . . . 0.0 110.574 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 9.3 m120 42.09 54.45 4.09 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.2 -15.7 43.0 Favored Glycine 0 N--CA 1.502 3.067 0 O-C-N 120.206 -1.559 . . . . 0.0 113.138 176.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? -112.44 124.22 52.03 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-N 119.327 1.563 . . . . 0.0 109.371 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 85.8 p -122.07 147.59 45.91 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-O 121.941 0.876 . . . . 0.0 111.044 -178.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.24 159.78 41.49 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-O 121.671 0.748 . . . . 0.0 109.849 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 22.1 m -88.74 136.74 32.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.473 -0.767 . . . . 0.0 110.463 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.44 ' HA ' HD11 ' B' ' 350' ' ' LEU . . . -73.93 -16.78 61.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.051 -1.031 . . . . 0.0 109.876 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -87.36 19.9 3.06 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 25.1 t -149.75 94.83 2.23 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.733 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.544 ' HB3' HD13 ' A' ' 79' ' ' LEU . 36.0 tp -59.96 -32.72 71.08 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.854 ' CE2' HD11 ' A' ' 79' ' ' LEU . 60.4 m-85 -54.75 -53.55 53.64 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.031 -1.043 . . . . 0.0 110.175 -179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -70.07 -35.89 74.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.293 -0.879 . . . . 0.0 110.273 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.51 HD12 ' HA ' ' B' ' 347' ' ' LEU . 81.8 mt -53.92 -50.1 67.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.878 -1.139 . . . . 0.0 110.232 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.506 ' O ' HD22 ' A' ' 123' ' ' LEU . 3.6 mt-30 -49.99 -17.59 0.41 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.668 -1.27 . . . . 0.0 111.337 -178.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 82.1 p -79.81 -14.55 58.61 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.275 -1.516 . . . . 0.0 110.972 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 30.9 mt -91.82 118.66 30.91 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.749 -1.22 . . . . 0.0 109.201 179.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.35 92.81 0.77 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.828 -1.709 . . . . 0.0 108.828 179.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 20.9 mt -100.47 89.72 4.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.37 -1.077 . . . . 0.0 109.309 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 38.2 p -90.01 177.87 6.35 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.095 -1.003 . . . . 0.0 110.449 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . 0.404 ' CD ' ' O ' ' B' ' 310' ' ' ALA . 48.5 tt0 -69.87 115.14 8.75 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.632 -0.667 . . . . 0.0 110.926 -179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 100.2 9.54 47.79 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 52.1 m -87.21 114.12 23.55 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.228 -1.16 . . . . 0.0 110.888 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 22.0 t -76.97 115.15 18.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-O 122.116 0.96 . . . . 0.0 109.785 -177.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 32.8 m -110.99 176.38 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 33.0 m -130.64 127.64 39.34 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 72.9 mt -102.88 116.64 46.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 84.1 p -119.98 131.6 55.22 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.304 -0.872 . . . . 0.0 109.47 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.69 151.55 39.09 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.19 -0.944 . . . . 0.0 109.587 -179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -144.07 122.99 12.74 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.406 -0.809 . . . . 0.0 108.889 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.552 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.06 -158.06 29.37 Favored Glycine 0 N--CA 1.49 2.282 0 C-N-CA 119.062 -1.542 . . . . 0.0 111.481 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -59.85 -50.02 75.44 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 112.403 0.519 . . . . 0.0 112.403 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.42 ' H ' ' HB3' ' B' ' 331' ' ' SER . 96.0 m-20 -108.99 13.4 24.7 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.819 -1.176 . . . . 0.0 110.963 -177.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.552 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.2 pt-20 -44.95 -36.25 3.28 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.077 -1.014 . . . . 0.0 110.89 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -69.14 -46.25 68.08 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.95 -1.094 . . . . 0.0 110.226 -178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -66.39 -48.15 71.03 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.154 -0.966 . . . . 0.0 109.727 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.12 -75.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 110.501 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.562 ' O ' HG23 ' B' ' 378' ' ' VAL . 68.8 t -45.96 -38.82 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.097 -1.002 . . . . 0.0 110.557 -177.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -63.72 -49.96 71.01 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.598 -1.314 . . . . 0.0 110.475 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -78.11 -40.66 37.56 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.978 -1.076 . . . . 0.0 110.062 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 82.4 mt -59.99 -38.66 83.22 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.111 -0.993 . . . . 0.0 109.296 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.562 HG23 ' O ' ' B' ' 374' ' ' VAL . 39.8 t -61.44 -39.96 84.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.28 -0.887 . . . . 0.0 108.647 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -67.72 -55.55 12.71 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.963 -1.086 . . . . 0.0 108.218 178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.517 HD22 ' OE1' ' B' ' 325' ' ' GLU . 57.6 tp -58.21 -32.25 68.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.127 -0.983 . . . . 0.0 109.932 -178.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.8 tpp -71.78 -40.77 69.04 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.354 -1.338 . . . . 0.0 108.875 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.6 -5.84 59.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.461 -0.775 . . . . 0.0 110.349 179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -110.13 -3.86 16.13 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.223 -0.923 . . . . 0.0 111.237 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 12.4 mt -76.48 129.99 37.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.303 -1.498 . . . . 0.0 108.957 178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 . . . . . 0 N--CA 1.497 1.883 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.161 -179.868 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtt . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.34 -0.615 . . . . 2.91 109.34 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.0 mt -110.06 129.96 64.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.579 -0.701 . . . . 1.2 109.251 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 63.0 m -119.48 152.34 37.08 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.629 -0.669 . . . . 1.4 109.244 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.594 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -135.66 -165.22 10.61 Favored Glycine 0 N--CA 1.498 2.796 0 N-CA-C 108.441 -1.864 . . . . 1.05 108.441 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.45 ' O ' ' O ' ' A' ' 6' ' ' LEU . 97.0 mt -89.49 -18.82 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.69 -1.476 . . . . 1.15 110.571 -178.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' ILE . 37.1 tp 54.79 104.1 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.174 -0.954 . . . . 0.98 109.17 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.88 -27.02 13.55 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.258 -0.901 . . . . 0.88 109.238 179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.8 t -133.69 118.39 14.52 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.575 -0.703 . . . . 1.69 109.17 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.27 148.58 18.96 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 121.964 1.776 . . . . 0.85 112.542 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.791 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.47 -156.77 27.09 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 108.897 -1.681 . . . . 0.92 108.897 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.2 mt -147.66 150.64 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 O-C-N 121.021 -1.281 . . . . 0.81 108.318 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.8 155.02 35.06 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.776 -1.203 . . . . 0.51 110.807 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.554 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 0.9 OUTLIER -139.01 129.5 25.79 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.551 -1.277 . . . . 0.62 107.551 178.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.08 -178.07 48.23 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 118.482 -1.818 . . . . 0.55 111.039 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -79.69 159.16 26.79 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.833 -0.804 . . . . 2.1 109.165 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.605 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -109.5 132.1 54.45 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.479 -0.763 . . . . 0.77 110.859 -179.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.6 tp -102.99 139.39 38.62 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.102 -1.073 . . . . 0.91 108.102 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 41.9 tp -117.69 122.3 43.15 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.346 -0.846 . . . . 0.93 109.674 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.405 HD12 ' HB2' ' A' ' 160' ' ' ALA . 54.8 mt -87.98 104.28 16.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.538 -0.726 . . . . 0.93 109.834 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -101.07 132.74 46.37 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 108.783 -0.821 . . . . 2.75 108.783 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -124.82 136.19 53.6 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 108.757 -0.831 . . . . 3.0 108.757 179.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -80.21 142.98 34.15 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.093 -1.004 . . . . 2.77 109.641 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.49 140.02 58.6 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.875 . . . . 2.94 108.824 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.4 mt -81.6 130.53 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.211 -0.93 . . . . 0.95 109.627 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 t -96.43 128.47 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.217 -0.927 . . . . 1.28 110.181 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.8 mt -109.0 135.41 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 109.178 -0.675 . . . . 1.21 109.178 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -91.53 121.36 33.15 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.124 -0.985 . . . . 1.81 109.794 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.1 mmm-85 -90.02 -0.04 57.37 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.378 -0.826 . . . . 2.8 109.888 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.54 146.1 54.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.043 -1.035 . . . . 2.87 109.468 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -88.45 147.27 24.77 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.296 -0.878 . . . . 2.35 109.282 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.568 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.3 pt -94.15 164.02 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.012 -1.055 . . . . 0.97 109.413 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -94.07 168.29 11.04 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.144 -0.972 . . . . 1.17 108.886 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.05 -15.52 59.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.067 -1.021 . . . . 1.18 109.943 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -87.41 -27.96 22.43 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.85 -1.167 . . . . 2.56 107.85 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -81.74 -9.24 59.69 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.723 -0.843 . . . . 1.79 108.723 178.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 16.8 t -62.87 -53.88 40.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.124 -0.985 . . . . 1.0 108.572 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -61.94 -39.97 93.91 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.33 -0.856 . . . . 1.77 110.123 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -69.84 -40.12 76.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.132 -0.98 . . . . 2.7 110.563 -178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.568 ' HG3' HG21 ' A' ' 31' ' ' ILE . 69.3 mm-40 -67.62 -39.83 84.71 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.925 -1.109 . . . . 1.51 110.029 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.14 -46.69 94.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 120.756 -1.215 . . . . 0.93 108.624 179.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -60.15 -42.18 94.34 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.147 -0.971 . . . . 1.81 109.495 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.02 -45.32 93.19 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 118.901 -1.119 . . . . 2.78 108.38 179.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -60.43 -46.13 91.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.326 -0.858 . . . . 0.78 108.764 178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.2 tp -60.1 -47.98 83.63 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 108.616 -0.883 . . . . 1.07 108.616 179.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 41.4 t -61.82 -42.29 98.84 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.413 -0.915 . . . . 1.12 108.761 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.13 -45.83 95.3 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 108.346 -1.902 . . . . 0.84 108.346 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.459 ' NH1' ' HG3' ' A' ' 47' ' ' ARG . 31.9 ttm-85 -62.32 -32.92 73.74 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.433 -1.04 . . . . 3.09 108.307 178.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -54.81 -40.01 69.07 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.888 -0.782 . . . . 0.88 108.888 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.8 ttmt -72.44 -73.14 0.21 Allowed 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.927 -1.138 . . . . 2.59 107.927 179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.48 -37.93 0.14 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.362 -0.836 . . . . 0.7 111.844 -177.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.3 m -59.99 -52.52 65.02 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.433 -1.417 . . . . 1.4 108.517 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.34 -40.0 93.12 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.866 . . . . 0.67 110.809 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -66.63 -40.07 88.59 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.036 -1.04 . . . . 1.66 110.766 -179.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.6 mt -64.87 -39.99 94.42 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.829 -1.169 . . . . 1.58 108.976 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' OE2' HD13 ' A' ' 77' ' ' ILE . 79.1 mm-40 -65.17 -35.83 82.31 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.274 -0.892 . . . . 1.35 108.926 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -64.52 -43.3 94.5 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 0.77 109.902 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.3 mt -63.16 -39.88 86.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.12 -0.987 . . . . 0.63 108.819 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -53.18 -52.48 58.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.289 -0.882 . . . . 1.14 110.064 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -57.01 -33.74 67.47 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.26 -0.9 . . . . 0.79 110.309 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -69.32 -37.25 77.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.909 -1.119 . . . . 1.53 109.435 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.99 -45.9 76.23 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.548 -0.72 . . . . 0.57 110.074 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.03 -51.95 55.78 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.333 -1.107 . . . . 0.75 110.333 -178.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -68.75 -41.11 79.39 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 120.986 -1.302 . . . . 1.59 110.185 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.6 m -70.11 -62.48 1.37 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.053 -1.029 . . . . 0.73 112.739 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -96.52 -45.88 6.57 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 120.787 -1.195 . . . . 0.75 111.573 -177.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.08 -166.74 25.91 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 119.705 -1.236 . . . . 1.22 110.977 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -71.26 -24.01 62.09 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.914 -0.757 . . . . 5.81 110.663 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -62.7 -36.12 81.92 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.278 -0.889 . . . . 3.37 111.502 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -98.42 -18.43 18.26 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.034 -1.041 . . . . 1.77 109.548 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -67.23 -40.07 86.31 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.281 -0.887 . . . . 1.65 110.104 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB2' ' NH1' ' B' ' 317' ' ' ARG . . . -64.94 -28.37 69.48 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.287 -0.883 . . . . 0.77 109.974 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.84 -41.39 85.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 118.951 -1.1 . . . . 0.8 108.704 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -66.43 -42.51 87.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.88 110.493 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -63.11 -40.82 98.73 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.804 -1.185 . . . . 1.37 109.154 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.65 -40.71 98.34 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.344 -1.902 . . . . 0.62 108.344 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 59.2 m170 -70.05 -41.83 73.69 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.516 -0.991 . . . . 1.5 109.209 179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.448 HD13 ' OE2' ' A' ' 55' ' ' GLU . 96.0 mt -69.71 -45.62 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.396 -0.815 . . . . 0.63 109.655 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.3 ttp -60.13 -46.52 89.35 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.916 -1.115 . . . . 1.51 109.802 -179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.831 HD11 ' CE2' ' B' ' 348' ' ' PHE . 32.7 tp -60.79 -40.54 93.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.314 -0.866 . . . . 0.77 109.328 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.436 ' HG ' HH12 ' A' ' 47' ' ' ARG . 63.9 tp -62.23 -40.01 94.73 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.538 -0.726 . . . . 0.62 109.931 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -82.12 8.81 9.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.173 -0.954 . . . . 1.47 110.152 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.7 t0 -54.58 132.98 46.23 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.186 -0.946 . . . . 1.47 110.258 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.415 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 39.9 mt-10 -60.38 -19.65 56.63 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.613 -0.679 . . . . 1.78 111.301 -178.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.4 -35.06 73.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.665 -1.272 . . . . 2.53 108.799 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.01 -43.58 71.09 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.491 0.663 . . . . 0.8 110.385 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -60.11 -48.76 80.39 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.967 -1.083 . . . . 1.42 110.55 -178.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -70.0 -40.26 75.38 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.369 -0.832 . . . . 1.71 111.083 -178.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.0 -40.04 75.52 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.906 -1.121 . . . . 1.57 111.61 -178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.8 mt -67.47 -45.21 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.946 -1.097 . . . . 0.65 109.756 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.92 -39.82 78.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.604 -0.685 . . . . 0.82 110.053 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.44 -46.91 88.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 0.79 110.579 -179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.44 ' O ' ' N ' ' A' ' 96' ' ' LYS . 85.3 mt -60.12 -47.51 85.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.857 -1.152 . . . . 0.95 109.693 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.0 mt -63.22 -48.97 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.943 0.878 . . . . 0.66 108.926 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -69.84 -40.21 75.98 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.494 -0.754 . . . . 2.2 110.588 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -85.51 -51.55 6.43 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.04 -1.037 . . . . 1.65 111.952 -178.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.44 ' N ' ' O ' ' A' ' 92' ' ' LEU . 65.4 mmtt -89.76 -1.7 58.06 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.013 -1.054 . . . . 2.03 111.603 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 55.73 32.32 19.2 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.869 -1.145 . . . . 1.42 109.962 179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.2 mtt -83.8 166.94 17.56 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.361 -0.837 . . . . 1.18 109.721 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 19.3 p -78.17 155.15 30.58 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.529 -0.915 . . . . 0.98 108.529 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -60.96 -40.35 93.0 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.134 -0.979 . . . . 0.64 109.445 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -62.86 -39.83 95.6 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.546 -0.721 . . . . 2.07 109.985 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.66 -45.95 20.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.103 -0.998 . . . . 0.73 110.181 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.01 -50.68 72.39 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.403 -0.811 . . . . 0.54 110.56 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.72 86.81 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.004 -1.06 . . . . 0.56 109.919 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.509 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 78.1 t60 -59.97 -41.03 91.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.373 -0.829 . . . . 1.54 110.082 -178.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -63.54 -39.98 95.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.288 -0.882 . . . . 1.33 111.419 -178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.8 t -62.9 -53.98 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 120.76 -1.213 . . . . 0.72 112.018 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.3 mm -69.99 -39.94 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.578 -1.326 . . . . 0.85 108.68 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.509 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 87.5 tt0 -60.89 -39.95 91.21 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.736 -0.838 . . . . 2.44 108.736 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.17 -46.27 94.53 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 120.512 -0.851 . . . . 0.98 111.018 -179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -70.02 -60.03 2.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.659 -1.495 . . . . 1.41 110.203 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -48.05 -41.28 25.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.113 -0.992 . . . . 1.2 110.051 -179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 78.6 p -59.81 -39.87 86.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.058 -1.026 . . . . 1.7 108.719 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.53 -38.85 81.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.248 -0.908 . . . . 1.47 109.293 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.8 mt -65.97 -40.99 91.75 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.12 -0.988 . . . . 1.56 110.155 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -59.92 -34.83 73.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.719 -1.238 . . . . 2.2 109.625 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -57.47 -19.31 23.47 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.155 -0.965 . . . . 2.12 109.912 -179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.5 HD13 HD13 ' A' ' 123' ' ' LEU . 40.7 mt -62.65 149.76 42.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.859 -1.15 . . . . 2.0 109.203 -179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -89.98 10.59 23.44 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.312 -0.868 . . . . 3.23 110.254 -178.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -101.42 128.98 47.37 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.198 -0.939 . . . . 2.49 110.331 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.01 -29.18 66.19 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.581 0.705 . . . . 3.95 109.437 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.462 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 6.7 t80 -70.22 -39.28 75.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.587 -0.695 . . . . 2.0 110.342 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.53 HD22 ' O ' ' B' ' 351' ' ' GLN . 90.5 mt -69.97 -35.39 74.42 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.02 -1.05 . . . . 1.86 108.416 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 44.5 tttp -59.99 -39.07 84.46 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.072 -0.714 . . . . 2.84 109.072 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -58.24 -43.56 87.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 2.73 109.198 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.599 ' NH2' ' O ' ' B' ' 314' ' ' LEU . 89.9 mtt180 -62.23 -39.93 94.47 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.176 -1.01 . . . . 2.77 109.22 178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.94 -37.82 80.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.279 -0.888 . . . . 1.19 109.621 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.07 -48.76 80.36 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.363 -0.835 . . . . 1.2 109.416 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -63.5 -40.07 96.09 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.297 -0.877 . . . . 1.55 109.628 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -63.42 -40.12 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.085 -1.009 . . . . 0.8 108.471 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.54 HH11 ' HG2' ' A' ' 131' ' ' ARG . 3.8 ttt-85 -60.32 -38.62 84.28 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.517 -0.739 . . . . 3.09 109.233 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -59.94 -40.08 87.72 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.425 -0.797 . . . . 1.46 110.363 -179.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 84.1 mt -60.08 -45.99 94.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.905 -1.122 . . . . 0.71 109.377 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.88 -41.06 93.66 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 120.291 -0.957 . . . . 0.57 110.942 -179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -60.07 -46.33 89.92 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.906 -1.349 . . . . 2.59 109.954 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.631 HH12 ' CB ' ' A' ' 166' ' ' SER . 98.2 mtt180 -68.88 -29.91 68.29 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.932 -1.105 . . . . 2.83 109.48 -179.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.1 tp -60.05 -43.13 95.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.184 -0.948 . . . . 1.25 109.071 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.9 mt -61.02 -39.82 91.21 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.281 -0.887 . . . . 0.7 109.89 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 67.9 mtm180 -67.39 -39.94 85.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.22 -0.925 . . . . 2.57 108.933 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 65.8 m-20 -61.34 -36.18 79.44 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.623 -0.673 . . . . 1.23 111.217 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.2 mt -70.7 -43.24 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.444 -1.41 . . . . 0.81 109.05 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.1 mt -71.04 -30.15 66.26 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.435 -0.79 . . . . 1.0 109.489 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.18 43.47 6.27 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 108.862 -1.695 . . . . 0.89 108.862 -179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.7 tp -74.44 149.47 40.37 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.427 -1.043 . . . . 1.14 109.241 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 17.9 tptm -72.11 142.29 49.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -0.912 . . . . 4.6 109.58 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 93.9 mt -113.06 128.94 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-O 122.203 1.002 . . . . 1.24 109.927 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 9.5 mt -64.21 -43.77 97.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 CA-C-N 115.485 -0.779 . . . . 1.54 110.87 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.3 t0 65.21 102.66 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.395 -0.816 . . . . 1.5 108.969 -179.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.5 mt -69.02 -1.02 6.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.265 -0.897 . . . . 0.79 110.625 -178.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 74.0 m -87.92 -10.88 49.23 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.852 -1.155 . . . . 1.4 109.395 179.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.84 15.97 2.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.336 -0.852 . . . . 0.92 112.588 -177.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 4.1 mp -90.32 119.98 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 O-C-N 120.213 -1.554 . . . . 0.88 109.215 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -100.45 -9.26 22.33 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.467 -0.771 . . . . 2.45 110.217 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -116.92 148.21 41.55 Favored 'General case' 0 N--CA 1.506 2.333 0 O-C-N 121.291 -0.881 . . . . 1.52 110.442 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -65.06 132.59 49.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.541 -0.724 . . . . 1.58 109.588 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.0 m -152.35 164.66 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.473 -0.767 . . . . 0.69 109.538 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 78.5 mt -91.84 149.53 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.023 -1.843 . . . . 0.61 106.023 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 52.3 tp -99.3 117.11 33.03 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.967 -1.083 . . . . 0.87 110.035 -178.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.723 HG12 HG22 ' A' ' 209' ' ' THR . 19.4 t -123.48 129.98 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 N-CA-C 108.481 -0.933 . . . . 0.71 108.481 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.488 ' C ' HG21 ' A' ' 209' ' ' THR . . . -159.29 164.74 34.62 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.058 -1.026 . . . . 0.81 108.924 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.17 -38.07 69.22 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.379 -1.451 . . . . 0.98 108.378 178.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -171.07 142.83 1.87 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.825 -0.806 . . . . 2.25 108.825 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 19.9 mt -117.4 137.49 52.45 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.324 -0.86 . . . . 0.78 109.504 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 19.4 p -83.08 147.23 53.51 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.94 . . . . 0.98 108.722 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -43.52 -31.83 3.34 Favored 'Trans proline' 0 N--CA 1.491 1.33 0 C-N-CA 121.567 1.511 . . . . 0.81 111.814 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.631 ' CB ' HH12 ' A' ' 136' ' ' ARG . 38.5 m -59.96 -40.16 88.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.907 . . . . 0.9 108.975 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -66.58 -43.21 85.55 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.441 -0.787 . . . . 1.61 109.658 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 54.2 p -52.68 -29.08 24.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.13 -0.981 . . . . 0.61 110.092 -179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.29 -57.74 3.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -0.942 . . . . 0.6 110.063 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -81.83 36.03 0.44 Allowed 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 109.066 -0.716 . . . . 1.4 109.066 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 171' ' ' LEU . 14.2 tp -97.96 138.21 35.62 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.494 -0.754 . . . . 0.7 109.006 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -86.27 102.92 14.39 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.08 -1.013 . . . . 2.35 109.196 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 66.2 mt -62.21 -45.64 92.47 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.265 -0.897 . . . . 1.51 110.209 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -66.42 -28.93 69.0 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.058 -1.027 . . . . 2.33 112.715 -177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -93.17 -13.03 28.92 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.46 -1.4 . . . . 1.92 109.95 -178.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.542 HG11 ' CE1' ' A' ' 179' ' ' PHE . 87.2 t -101.41 109.27 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.179 -0.95 . . . . 0.67 108.727 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.2 mt -82.76 6.53 17.82 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.264 -0.897 . . . . 1.53 110.274 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.457 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 169.09 175.85 38.71 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.312 -1.515 . . . . 0.48 109.312 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.542 ' CE1' HG11 ' A' ' 176' ' ' VAL . 10.8 m-85 -135.76 130.16 33.67 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.394 -1.062 . . . . 0.55 109.299 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.423 ' CG2' HG21 ' A' ' 205' ' ' THR . 94.5 mt -131.13 126.97 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.736 -0.839 . . . . 0.65 108.736 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.1 p -145.7 157.29 43.96 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.033 -1.042 . . . . 0.82 110.7 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.658 ' OD1' HG23 ' A' ' 209' ' ' THR . 7.2 m-20 -105.52 27.04 8.76 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.462 -0.94 . . . . 2.46 108.462 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.57 -157.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.201 -0.937 . . . . 1.28 112.225 -177.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.84 -71.2 0.85 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 111.258 -0.737 . . . . 2.19 111.258 -178.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 167.11 -133.66 2.99 Favored Glycine 0 N--CA 1.491 2.342 0 O-C-N 120.705 -1.468 . . . . 2.13 110.563 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 188' ' ' SER . 28.0 mtm-85 -60.08 -40.04 88.19 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.427 -1.043 . . . . 5.86 111.01 -178.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.4 p -65.78 8.88 0.16 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.066 -1.021 . . . . 3.72 110.471 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 186' ' ' ARG . 29.1 t -90.79 129.59 36.85 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.015 -1.053 . . . . 1.74 110.255 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -42.79 -52.0 5.19 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.783 0.801 . . . . 0.95 109.38 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 190' ' ' THR . 9.5 p -55.38 -36.69 66.66 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.768 -0.582 . . . . 1.55 111.175 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.7 t -59.94 -40.03 87.57 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.846 -1.159 . . . . 1.51 110.903 -178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.6 mt -65.7 -40.02 86.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.123 -0.985 . . . . 1.67 110.109 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.7 mtp -60.05 -45.31 93.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.846 . . . . 1.02 111.06 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.3 -43.8 92.58 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.927 -1.108 . . . . 0.68 109.59 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.414 HH11 ' HG2' ' A' ' 195' ' ' ARG . 51.4 mtt-85 -59.96 -51.61 68.92 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.901 -1.12 . . . . 2.93 109.361 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.5 m -70.11 -35.03 73.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.21 -0.931 . . . . 0.86 110.76 -179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.0 mt -76.12 -21.44 56.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.009 -1.057 . . . . 0.67 109.66 -179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 62.15 50.04 4.16 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.605 -0.684 . . . . 1.5 109.86 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.48 130.59 23.85 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 108.821 -0.807 . . . . 0.72 108.821 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -43.88 130.31 7.78 Favored 'Trans proline' 0 N--CA 1.498 1.741 0 C-N-CA 121.905 1.737 . . . . 0.61 112.343 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -168.84 145.67 3.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.736 -1.227 . . . . 0.66 111.661 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 91.2 mt -124.88 148.87 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 107.168 -1.419 . . . . 0.79 107.168 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 6.9 m -129.98 -9.83 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.408 0 O-C-N 120.819 -1.176 . . . . 0.91 110.894 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.68 22.38 26.26 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 110.228 -1.149 . . . . 1.01 110.228 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.44 ' OG1' ' OD2' ' A' ' 182' ' ' ASP . 3.3 p -47.14 -40.0 14.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.894 -1.356 . . . . 0.99 109.836 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.52 ' N ' ' OD2' ' A' ' 182' ' ' ASP . . . 89.11 -52.07 3.81 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 120.914 -1.116 . . . . 1.12 111.342 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.48 ' N ' ' OD2' ' A' ' 182' ' ' ASP . 15.1 m -156.17 37.97 0.34 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.523 -1.575 . . . . 1.72 111.819 -178.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 12.8 t -77.05 -34.88 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 120.754 -1.216 . . . . 0.89 108.045 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.723 HG22 HG12 ' A' ' 159' ' ' VAL . 53.8 p -59.72 -34.26 72.69 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.571 -0.706 . . . . 1.03 110.284 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 8.4 t -77.16 -16.97 58.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.046 -1.034 . . . . 1.83 109.962 -179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 29.2 mm100 -99.27 -11.86 20.89 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.245 -0.909 . . . . 2.27 110.319 -179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.5 t -102.33 135.3 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 121.24 -0.913 . . . . 0.92 111.08 -178.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.45 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 43.5 mmtm -110.38 150.48 28.73 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 106.518 -1.66 . . . . 2.2 106.518 178.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.489 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 13.1 p-10 -59.91 141.04 56.22 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.789 -1.194 . . . . 2.36 110.85 -178.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.489 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.3 t0 85.24 1.04 0.74 Allowed 'General case' 0 N--CA 1.502 2.147 0 CA-C-O 121.071 0.463 . . . . 2.38 110.012 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.45 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 98.1 m-20 -73.99 147.0 43.37 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.146 -0.971 . . . . 2.09 109.252 179.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -97.34 119.88 36.67 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 107.614 -1.254 . . . . 1.27 107.614 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' A' ' 16' ' ' ALA . 66.4 mt -126.98 148.99 50.07 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.475 -0.766 . . . . 0.75 110.489 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.0 mt -116.18 129.91 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 N-CA-C 107.675 -1.231 . . . . 0.63 107.675 177.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 35.2 tp -102.28 119.33 38.63 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.883 -1.136 . . . . 0.7 108.075 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.613 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 6.6 p30 -78.47 -40.13 36.41 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.886 -1.134 . . . . 2.31 108.751 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.791 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.35 13.64 0.2 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.439 -0.948 . . . . 0.78 108.439 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.472 ' N ' ' C ' ' A' ' 221' ' ' ASP . 24.9 t -127.65 -40.64 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.457 -1.312 . . . . 1.04 107.457 179.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -102.5 0.39 33.56 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.976 -1.12 . . . . 2.44 107.976 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.594 HD21 ' H ' ' A' ' 4' ' ' GLY . 48.8 t-20 59.78 44.96 13.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.834 -0.542 . . . . 1.55 110.297 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.613 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 80.5 mt-30 -140.22 158.38 44.13 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.174 -0.954 . . . . 1.99 109.709 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 81.3 t -120.14 130.05 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 N-CA-C 109.032 -0.729 . . . . 0.77 109.032 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -101.61 120.98 41.16 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.383 -0.823 . . . . 0.98 108.918 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.445 HG22 HD22 ' A' ' 218' ' ' LEU . 49.0 t -103.36 119.23 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.548 -0.72 . . . . 0.85 109.759 -179.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 63.79 66.9 1.03 Allowed Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.186 -0.946 . . . . 1.66 109.931 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -91.34 128.34 1.17 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 123.255 2.636 . . . . 0.95 112.661 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 30.4 p -69.01 169.37 11.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.006 . . . . 1.84 109.422 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -60.07 -39.4 85.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 2.74 108.942 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.02 -38.22 82.05 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.344 -0.848 . . . . 2.89 110.083 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.61 -40.22 87.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.841 -1.162 . . . . 1.3 108.836 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 94.3 mt -66.64 -40.89 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.047 -1.033 . . . . 1.09 109.374 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -62.93 -40.1 96.62 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.138 -0.976 . . . . 2.43 109.048 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 18.7 ttmm -67.66 -42.1 82.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 2.78 108.748 179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 94.7 mtp -69.98 -30.68 68.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.591 -0.693 . . . . 1.25 109.816 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 17.3 mmt180 -69.2 -39.91 78.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.953 -1.092 . . . . 2.63 109.503 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.42 -40.1 89.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.359 -0.838 . . . . 1.8 109.57 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 69.7 t -62.84 -41.31 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.881 . . . . 2.13 109.476 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -60.09 -42.14 93.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.331 -0.855 . . . . 3.17 109.79 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -62.46 -39.85 94.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.131 -0.981 . . . . 1.78 108.977 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -60.98 -37.02 80.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.5 -0.75 . . . . 2.47 109.298 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 69.6 t -59.96 -40.04 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -0.9 . . . . 2.09 109.009 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.02 -46.4 89.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.297 -0.877 . . . . 2.54 109.464 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 68.9 m -76.97 -22.12 53.69 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.183 -0.948 . . . . 2.99 109.357 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -60.03 -39.97 87.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.458 -0.776 . . . . 3.34 111.087 -178.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.436 ' O ' ' N ' ' A' ' 252' ' ' GLU . 17.5 pttp -56.65 -34.42 67.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.794 -1.191 . . . . 3.88 109.63 -178.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.467 ' C ' ' H ' ' A' ' 253' ' ' LEU . . . -71.2 51.93 0.17 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.891 -1.131 . . . . 4.43 108.826 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 250' ' ' LYS . 25.4 tp10 -62.83 0.29 0.56 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.388 -0.82 . . . . 5.42 109.228 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.467 ' H ' ' C ' ' A' ' 251' ' ' ALA . 54.7 mt -60.97 -40.06 91.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.141 -0.974 . . . . 6.1 109.477 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 55.57 50.1 15.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.122 -0.986 . . . . 7.37 109.432 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -60.07 -43.03 95.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 8.01 109.414 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 58.5 mt -80.08 -69.93 0.55 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.995 -1.065 . . . . 9.05 108.572 179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? 177.17 115.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.944 -0.761 . . . . 10.56 108.944 178.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.464 ' N ' ' OD1' ' A' ' 258' ' ' ASP . 25.7 p-10 -92.61 -56.56 2.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.032 -1.042 . . . . 11.32 108.676 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.454 ' N ' ' OD1' ' A' ' 258' ' ' ASP . 61.4 mtp180 . . . . . 0 C--N 1.303 -1.455 0 CA-C-O 118.051 -0.976 . . . . 12.42 109.497 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 33.1 ttp . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.513 0.673 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -150.96 148.53 28.5 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -150.02 159.36 44.46 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.087 -1.008 . . . . 0.0 110.397 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -157.56 154.02 27.85 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 57.7 mp0 -111.69 131.57 55.2 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.115 -0.99 . . . . 0.0 110.203 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.8 p -129.27 121.77 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 CA-C-O 122.348 1.071 . . . . 0.0 112.307 -177.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . 0.533 ' O ' HG23 ' B' ' 309' ' ' THR . 56.7 m -80.4 101.2 8.87 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.804 0.811 . . . . 0.0 110.799 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.541 ' O ' ' N ' ' B' ' 358' ' ' GLY . 97.5 mt -50.71 116.73 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 CA-C-O 122.258 1.028 . . . . 0.0 109.673 -178.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . 0.533 HG23 ' O ' ' B' ' 307' ' ' THR . 25.1 p -106.59 14.1 27.44 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.946 -177.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -68.42 116.67 42.37 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 120.994 -1.066 . . . . 0.0 108.445 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -51.85 -17.08 4.79 Favored 'Trans proline' 0 N--CA 1.498 1.742 0 CA-C-N 120.216 1.113 . . . . 0.0 113.725 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -111.0 11.3 22.14 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.257 -0.902 . . . . 0.0 109.991 -179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 69.47 169.78 6.93 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 107.92 -2.072 . . . . 0.0 107.92 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.599 ' O ' ' NH2' ' A' ' 126' ' ' ARG . 3.1 tp -84.6 93.27 8.34 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.087 -1.243 . . . . 0.0 109.333 -178.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.58 ' C ' HH21 ' A' ' 126' ' ' ARG . 3.8 p80 -96.48 -161.48 0.87 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 120.885 -1.134 . . . . 0.0 109.902 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 4.0 m -58.06 -41.58 83.63 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.884 -1.135 . . . . 0.0 112.726 -176.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.603 ' NH1' ' HB2' ' A' ' 71' ' ' ALA . 14.7 tpt180 -57.31 -59.44 12.8 Favored Pre-proline 0 N--CA 1.501 2.086 0 O-C-N 120.308 -1.495 . . . . 0.0 111.068 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -63.92 -42.9 17.56 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 CA-C-N 120.485 1.209 . . . . 0.0 111.606 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.89 -17.28 35.89 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.178 -0.951 . . . . 0.0 110.392 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -82.16 -38.55 24.53 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -72.16 -34.81 68.76 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -64.65 -58.28 6.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.39 -0.819 . . . . 0.0 109.796 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 72.6 t -61.68 -32.91 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.82 -1.175 . . . . 0.0 109.085 -179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 1.6 ttmp? -59.93 -46.65 88.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.422 -0.799 . . . . 0.0 109.112 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -66.29 -44.06 84.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 110.422 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . 0.437 ' O ' ' N ' ' B' ' 328' ' ' GLY . . . -60.03 -53.41 58.19 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.855 -1.153 . . . . 0.0 111.248 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -51.72 -10.45 0.11 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.883 -1.135 . . . . 0.0 110.136 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' B' ' 326' ' ' ALA . . . -75.9 -24.75 68.64 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.194 -1.563 . . . . 0.0 109.194 179.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -105.23 139.14 40.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.41 -1.053 . . . . 0.0 109.248 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 8.8 p -90.61 -9.8 45.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.275 -0.89 . . . . 0.0 110.115 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.479 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 14.0 t -64.47 155.21 33.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.101 -1.0 . . . . 0.0 109.963 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.6 131.73 45.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.25 -0.907 . . . . 0.0 108.792 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 82.9 mt -132.44 132.95 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.392 -0.818 . . . . 0.0 109.938 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 93.4 m -131.56 149.94 52.33 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.484 -0.76 . . . . 0.0 109.128 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 66.6 t -122.43 117.41 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 94.7 m -107.5 133.43 52.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.228 -0.92 . . . . 0.0 109.697 -178.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 4.8 p -139.85 115.94 10.41 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.766 0.793 . . . . 0.0 110.631 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 45.22 50.02 9.77 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.641 -0.662 . . . . 0.0 112.744 177.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.32 -16.41 48.92 Favored Glycine 0 N--CA 1.5 2.957 0 O-C-N 120.058 -1.651 . . . . 0.0 112.242 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -110.69 121.32 45.03 Favored 'General case' 0 N--CA 1.505 2.279 0 CA-C-N 118.87 1.335 . . . . 0.0 109.69 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 86.4 p -126.76 148.33 49.91 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.815 0.816 . . . . 0.0 110.151 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -145.23 170.57 16.02 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 121.563 0.697 . . . . 0.0 110.093 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 17.3 m -89.04 134.73 33.89 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.519 -0.738 . . . . 0.0 110.518 -178.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.451 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -75.91 -16.38 60.04 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.053 -1.03 . . . . 0.0 109.504 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -84.7 20.87 1.65 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . 0.451 ' H ' ' C ' ' B' ' 344' ' ' ALA . 93.8 p -151.61 96.91 2.31 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.43 179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.676 HD23 HD22 ' A' ' 79' ' ' LEU . 51.7 tp -60.05 -33.76 72.48 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.831 ' CE2' HD11 ' A' ' 79' ' ' LEU . 60.0 m-85 -56.27 -52.95 62.6 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.931 -1.106 . . . . 0.0 110.034 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 13.5 mtpp -69.82 -28.67 65.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 0.0 110.421 -177.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.576 HD12 ' HA ' ' B' ' 347' ' ' LEU . 80.8 mt -59.96 -50.01 75.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.101 -0.999 . . . . 0.0 109.728 179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.53 ' O ' HD22 ' A' ' 123' ' ' LEU . 1.2 mp0 -45.07 -20.22 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.017 -1.052 . . . . 0.0 111.189 -178.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.415 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.3 p -80.3 -10.61 59.76 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.19 -1.568 . . . . 0.0 109.444 -179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.415 HD11 ' HB3' ' B' ' 342' ' ' ALA . 45.9 mt -95.79 115.29 27.21 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.176 -0.953 . . . . 0.0 108.77 178.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.84 95.21 1.24 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 22.8 mt -103.9 94.25 5.31 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.416 -1.05 . . . . 0.0 109.286 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 79.0 p -100.72 153.57 19.33 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.233 -0.917 . . . . 0.0 111.234 -179.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -41.95 111.9 0.28 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 121.202 0.525 . . . . 0.0 110.664 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 103.14 6.09 45.78 Favored Glycine 0 N--CA 1.497 2.766 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 91.7 m -83.69 111.24 18.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.234 -1.157 . . . . 0.0 111.22 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 8.6 t -78.47 111.99 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 CA-C-O 122.15 0.976 . . . . 0.0 109.801 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 12.3 m -110.08 177.76 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 40.4 m -130.26 126.9 38.43 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 177.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 64.0 mt -103.82 117.44 49.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 178.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 53.6 m -121.13 132.33 54.79 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.79 148.31 38.71 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.279 -0.888 . . . . 0.0 109.572 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -142.38 121.85 13.24 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.532 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.91 -158.39 29.07 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 119.192 -1.48 . . . . 0.0 111.159 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -59.9 -51.08 71.21 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 122.293 -0.534 . . . . 0.0 112.219 -177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.479 ' H ' ' HB2' ' B' ' 331' ' ' SER . 85.1 m-20 -108.27 10.78 27.68 Favored 'General case' 0 N--CA 1.506 2.372 0 O-C-N 120.86 -1.15 . . . . 0.0 111.249 -177.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.532 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.4 pt-20 -39.9 -34.12 0.25 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.338 -0.852 . . . . 0.0 112.232 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -68.3 -42.64 79.14 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.535 -1.353 . . . . 0.0 110.432 -178.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -71.1 -52.56 18.66 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.991 -1.068 . . . . 0.0 109.653 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.69 -36.78 2.34 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.333 -0.854 . . . . 0.0 111.519 -178.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.513 ' O ' HG23 ' B' ' 378' ' ' VAL . 58.9 t -81.14 -36.02 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.521 -1.362 . . . . 0.0 109.502 179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -69.98 -40.01 75.6 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.375 -0.828 . . . . 0.0 111.921 -178.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 5.8 m80 -77.59 -46.78 21.16 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.612 -1.305 . . . . 0.0 110.151 -179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.35 -36.38 80.02 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.294 -0.879 . . . . 0.0 109.116 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.513 HG23 ' O ' ' B' ' 374' ' ' VAL . 53.8 t -73.68 -37.45 49.36 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -74.83 -17.01 60.67 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' B' ' 383' ' ' GLU . 41.9 tp -78.87 -68.07 0.69 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 57.3 mtt -54.3 -19.5 5.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.01 -1.056 . . . . 0.0 109.136 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.2 -23.72 51.44 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' B' ' 380' ' ' LEU . 97.5 mt-10 -108.62 4.37 23.88 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.626 -0.671 . . . . 0.0 110.962 -179.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 69.0 mt -82.67 122.31 27.98 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.578 -1.326 . . . . 0.0 110.129 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.495 1.791 0 CA-C-O 118.041 -0.98 . . . . 0.0 108.933 179.231 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.188 0.518 . . . . 2.91 109.691 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 87.7 mt -110.03 127.94 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.73 -0.841 . . . . 1.2 108.73 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.2 m -140.04 150.73 44.75 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.296 -0.877 . . . . 1.4 109.258 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.86 -163.89 9.7 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 108.465 -1.854 . . . . 1.05 108.465 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.462 ' O ' ' O ' ' A' ' 6' ' ' LEU . 89.9 mt -90.37 -17.37 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.747 -1.443 . . . . 1.15 109.575 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.462 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.4 tp 55.1 106.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.496 -0.752 . . . . 0.98 109.184 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.26 -29.12 12.26 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.333 -0.855 . . . . 0.88 109.065 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 14.8 m -127.62 116.62 21.09 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 109.356 -0.609 . . . . 1.69 109.356 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -79.85 148.05 19.61 Favored 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 121.991 1.794 . . . . 0.85 112.453 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.91 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 143.36 178.78 19.47 Favored Glycine 0 N--CA 1.497 2.751 0 N-CA-C 108.853 -1.699 . . . . 0.92 108.853 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.412 HG22 ' N ' ' A' ' 12' ' ' ALA . 96.7 mt -122.13 156.36 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.231 -1.158 . . . . 0.81 109.436 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.412 ' N ' HG22 ' A' ' 11' ' ' ILE . . . -155.55 156.56 35.36 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.965 -1.084 . . . . 0.51 110.625 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.4 m-85 -137.69 128.99 27.85 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.03 -1.1 . . . . 0.62 108.03 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.43 178.38 47.77 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 118.505 -1.807 . . . . 0.55 110.842 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -78.86 156.7 28.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.786 -0.832 . . . . 2.1 109.14 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.593 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -107.62 133.03 52.65 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.392 -0.817 . . . . 0.77 110.923 -178.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.3 tp -107.45 137.85 44.73 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 107.997 -1.112 . . . . 0.91 107.997 178.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 66.2 tp -115.76 122.66 46.12 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.526 -0.734 . . . . 0.93 109.561 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.9 mt -82.26 103.21 11.68 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.414 -0.804 . . . . 0.93 109.416 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.3 mttp -94.25 136.56 34.41 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.296 -0.878 . . . . 2.75 109.496 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 58.2 mp0 -131.02 134.84 47.05 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.361 -0.837 . . . . 3.0 109.086 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -81.17 150.76 28.54 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.133 -0.98 . . . . 2.77 109.133 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -65.96 149.22 50.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.943 -1.098 . . . . 2.94 109.245 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.527 ' CG1' HH12 ' A' ' 139' ' ' ARG . 88.2 mt -89.78 124.83 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.34 -0.85 . . . . 0.95 109.22 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 46.4 t -96.63 122.87 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.236 -0.915 . . . . 1.28 109.477 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.9 mt -108.09 133.22 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.802 -0.814 . . . . 1.21 108.802 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -86.97 118.27 26.24 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.792 -1.192 . . . . 1.81 109.58 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -87.51 -1.0 57.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.338 -0.851 . . . . 2.8 109.613 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.81 136.86 49.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.112 -0.993 . . . . 2.87 109.184 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 56.6 mttp -80.99 159.51 24.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.952 -1.092 . . . . 2.35 109.488 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.416 HD13 ' HG3' ' A' ' 39' ' ' GLU . 2.9 pt -102.57 167.67 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.303 -0.873 . . . . 0.97 109.883 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.3 p -94.1 175.27 6.77 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.229 -0.92 . . . . 1.17 109.093 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.74 -50.97 71.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.089 -1.007 . . . . 1.18 110.746 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.422 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 55.8 t0 -54.71 -29.41 53.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.561 -1.337 . . . . 2.56 109.681 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 -82.02 -10.04 59.36 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.316 -0.865 . . . . 1.79 110.386 -179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.0 t -60.22 -50.3 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.824 -1.172 . . . . 1.0 109.068 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -61.67 -39.9 93.04 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.404 -0.81 . . . . 1.77 109.54 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.1 mm-40 -62.68 -43.79 97.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.903 . . . . 2.7 110.981 -178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.416 ' HG3' HD13 ' A' ' 31' ' ' ILE . 75.5 mm-40 -61.89 -40.19 94.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.84 -1.162 . . . . 1.51 110.171 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 66.4 t -59.87 -46.23 94.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 C-N-CA 118.722 -1.191 . . . . 0.93 108.86 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -59.93 -42.58 94.28 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.881 -1.137 . . . . 1.81 109.434 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.26 -41.52 93.45 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.807 -1.183 . . . . 2.78 108.222 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -64.01 -46.9 82.44 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.355 -0.841 . . . . 0.78 109.143 178.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 67.1 tp -59.96 -48.81 80.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.28 -0.887 . . . . 1.07 108.672 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 48.0 t -63.26 -41.95 99.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.075 -1.015 . . . . 1.12 109.543 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.62 -46.21 92.73 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.154 -1.578 . . . . 0.84 109.154 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -63.3 -33.56 75.78 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.261 -1.141 . . . . 3.09 108.739 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.25 -42.85 87.33 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.369 -0.832 . . . . 0.88 109.283 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.44 ' O ' ' C ' ' A' ' 50' ' ' ALA . 1.2 ttmp? -63.68 -73.62 0.11 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 120.792 -1.193 . . . . 2.59 107.915 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.44 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.19 -41.14 0.37 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.415 -0.803 . . . . 0.7 111.411 -178.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 93.2 p -54.22 -54.77 35.42 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.42 -1.425 . . . . 1.4 108.699 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.99 -39.97 83.17 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.462 -0.774 . . . . 0.67 111.301 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -68.37 -39.95 81.59 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.77 -1.206 . . . . 1.66 110.668 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.4 mt -63.13 -39.97 96.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.979 -1.076 . . . . 1.58 108.736 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -63.91 -34.14 77.29 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.454 -0.779 . . . . 1.35 109.087 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 30.6 m -65.89 -44.13 86.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.181 -0.949 . . . . 0.77 108.883 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 90.9 mt -60.14 -37.75 74.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 108.675 -0.861 . . . . 0.63 108.675 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -59.8 -51.06 71.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.473 -0.767 . . . . 1.14 110.204 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.3 m -55.78 -33.28 64.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.051 -1.03 . . . . 0.79 110.042 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -69.92 -37.96 76.11 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.422 -0.798 . . . . 1.53 109.555 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.413 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -68.78 -47.67 65.6 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-O 121.204 0.526 . . . . 0.57 111.227 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.68 -50.97 61.81 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 110.004 -1.239 . . . . 0.75 110.004 -178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -69.96 -42.11 73.63 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.005 -1.291 . . . . 1.59 110.562 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 87.5 m -69.28 -60.69 2.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.088 -1.007 . . . . 0.73 112.111 -177.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -96.52 -50.93 4.54 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 120.935 -1.103 . . . . 0.75 111.422 -178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.15 -163.86 26.98 Favored Glycine 0 N--CA 1.501 2.974 0 O-C-N 120.731 -1.231 . . . . 1.22 111.048 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.02 -25.15 63.44 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.772 -0.84 . . . . 5.81 110.65 -179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -60.33 -36.76 78.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.256 -0.902 . . . . 3.37 110.197 -179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.479 ' NZ ' ' CE1' ' A' ' 189' ' ' HIS . 69.3 mmtt -97.78 -19.85 17.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.251 -0.905 . . . . 1.77 110.352 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.1 -46.13 68.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.909 -1.119 . . . . 1.65 110.224 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.617 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -62.7 -32.91 74.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.643 -0.661 . . . . 0.77 110.116 -178.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.09 -40.83 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.867 -1.146 . . . . 0.8 109.045 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -65.11 -39.83 93.67 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.14 -0.975 . . . . 0.88 109.776 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -60.09 -39.98 88.02 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.085 -1.009 . . . . 1.37 109.528 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.14 -49.3 72.55 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 108.623 -1.791 . . . . 0.62 108.623 179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.1 m170 -60.91 -43.61 98.32 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.344 -1.091 . . . . 1.5 108.837 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.1 mt -68.94 -47.71 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.254 -0.903 . . . . 0.63 109.09 179.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.8 ttp -60.25 -42.94 96.37 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.899 -1.126 . . . . 1.51 109.792 -179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.841 HD11 ' CE2' ' B' ' 348' ' ' PHE . 63.4 tp -64.81 -40.0 94.5 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.376 -0.828 . . . . 0.77 109.772 179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.7 tp -64.52 -40.05 94.9 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.292 -0.88 . . . . 0.62 110.189 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -81.55 4.86 19.8 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.974 -1.078 . . . . 1.47 109.844 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 51.7 t0 -50.26 132.02 24.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.172 -0.955 . . . . 1.47 110.07 -179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 97.7 mt-10 -62.02 -18.96 62.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.637 -0.664 . . . . 1.78 110.754 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -72.42 -36.05 68.5 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.853 -1.154 . . . . 2.53 108.935 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.17 -40.38 78.18 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.974 -0.75 . . . . 0.8 108.974 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -60.04 -49.87 75.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.566 -0.709 . . . . 1.42 110.023 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.13 -41.42 73.96 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.329 -0.857 . . . . 1.71 111.284 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.64 -40.35 73.12 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.947 -1.096 . . . . 1.57 111.512 -178.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.8 -49.34 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.88 -1.137 . . . . 0.65 109.591 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.4 mt -65.29 -37.64 80.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.634 -0.666 . . . . 0.82 110.275 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.06 -41.29 98.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.097 -1.002 . . . . 0.79 110.365 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.509 ' O ' ' N ' ' A' ' 96' ' ' LYS . 81.5 mt -61.67 -46.38 89.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.885 -1.134 . . . . 0.95 109.085 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.2 mt -61.06 -50.2 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-O 121.963 0.887 . . . . 0.66 109.261 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.02 -40.95 74.9 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 120.008 -0.677 . . . . 2.2 110.451 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -82.34 -49.5 9.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.308 -0.87 . . . . 1.65 111.805 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 92' ' ' LEU . 65.7 mmtt -92.24 -2.05 56.73 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.033 -1.042 . . . . 2.03 111.788 -177.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 38.4 m170 55.51 32.77 19.7 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.844 -1.16 . . . . 1.42 109.082 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 93.5 mtp -90.18 166.72 13.21 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.707 -0.621 . . . . 1.18 109.826 -179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.2 p -78.39 158.62 28.69 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.451 -0.944 . . . . 0.98 108.451 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.99 -35.73 74.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.985 -1.072 . . . . 0.64 109.901 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -67.14 -40.01 86.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.165 -0.959 . . . . 2.07 109.437 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.41 -41.88 21.24 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.395 -0.816 . . . . 0.73 109.698 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.68 -50.5 66.76 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.418 -0.802 . . . . 0.54 110.417 -179.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.07 88.57 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.164 -0.96 . . . . 0.56 109.836 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.6 t60 -58.34 -39.93 80.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 1.54 109.761 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -62.79 -40.13 96.39 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.217 -0.927 . . . . 1.33 110.034 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 96.3 t -66.51 -52.53 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 121.213 -0.929 . . . . 0.72 111.56 -178.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.9 mm -69.34 -39.91 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 120.824 -1.173 . . . . 0.85 108.772 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.41 -34.85 76.75 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.615 -0.883 . . . . 2.44 108.615 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.32 -47.49 90.58 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 120.645 -0.788 . . . . 0.98 111.135 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -66.17 -48.12 71.78 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.614 -1.521 . . . . 1.41 109.602 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.74 78.37 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.895 . . . . 1.2 109.505 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 84.1 p -57.69 -40.2 78.91 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.091 -1.005 . . . . 1.7 108.748 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.8 89.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.253 -0.904 . . . . 1.47 109.614 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.4 mt -63.53 -43.35 97.39 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.798 -1.189 . . . . 1.56 110.274 -178.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.18 -30.47 69.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.681 -1.262 . . . . 2.2 109.739 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.95 -23.72 63.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.991 -1.068 . . . . 2.12 108.598 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.48 HD13 HD13 ' A' ' 123' ' ' LEU . 26.0 mt -62.4 147.73 47.59 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.291 -0.881 . . . . 2.0 109.128 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -94.95 49.16 1.21 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.085 -1.009 . . . . 3.23 109.734 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -136.25 130.27 32.8 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.198 -0.939 . . . . 2.49 109.888 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -70.06 -30.32 67.55 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.445 -0.784 . . . . 3.95 110.248 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.512 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.1 t80 -72.11 -38.24 69.34 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.287 -0.883 . . . . 2.0 110.716 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.576 HD22 ' O ' ' B' ' 351' ' ' GLN . 89.4 mt -70.0 -32.28 70.39 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.045 -1.034 . . . . 1.86 108.249 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -60.24 -39.21 85.9 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.601 -0.888 . . . . 2.84 108.601 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -59.75 -48.35 82.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.331 -0.856 . . . . 2.73 110.108 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.6 HH21 ' C ' ' B' ' 315' ' ' HIS . 84.5 mtt180 -60.12 -39.68 87.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.679 -1.263 . . . . 2.77 108.495 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -58.51 -32.32 68.72 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.294 -0.879 . . . . 1.19 108.65 179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -66.8 -40.22 88.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 1.2 109.588 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -65.55 -40.12 92.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.223 -0.923 . . . . 1.55 109.515 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.3 t -67.49 -41.85 86.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.45 -0.781 . . . . 0.8 109.292 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -62.03 -36.31 81.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.288 -0.882 . . . . 3.09 109.5 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -60.0 -40.01 87.76 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.263 -0.898 . . . . 1.46 110.077 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.1 mt -60.26 -44.16 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.151 -0.968 . . . . 0.71 109.791 -179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.37 -39.72 98.13 Favored Glycine 0 N--CA 1.493 2.475 0 N-CA-C 110.474 -1.051 . . . . 0.57 110.474 -179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -58.94 -45.78 89.61 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.893 -1.357 . . . . 2.59 109.624 -179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.502 HH11 ' HG2' ' A' ' 136' ' ' ARG . 24.3 mtt-85 -63.22 -36.33 83.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.874 -1.141 . . . . 2.83 110.339 -179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.6 tp -56.19 -44.59 79.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.309 -0.869 . . . . 1.25 109.974 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 88.5 mt -60.96 -40.07 91.96 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.032 -1.043 . . . . 0.7 108.791 179.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.634 HH11 ' HG2' ' A' ' 139' ' ' ARG . 11.5 mtt-85 -67.73 -39.94 84.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.348 -0.845 . . . . 2.57 109.339 179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -68.06 -38.03 81.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.632 -0.667 . . . . 1.23 111.668 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.3 mt -73.73 -45.55 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.227 -1.546 . . . . 0.81 108.571 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.7 mt -70.0 -33.7 72.37 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.614 -0.679 . . . . 1.0 109.493 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.78 40.2 7.27 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 109.193 -1.563 . . . . 0.89 109.193 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.2 tp -74.94 150.39 39.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.521 -0.987 . . . . 1.14 110.17 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -68.4 141.29 55.75 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.322 -0.861 . . . . 4.6 110.174 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.9 mt -116.48 129.95 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 CA-C-O 121.785 0.802 . . . . 1.24 109.474 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 15.0 mm -56.79 -50.17 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.794 -0.566 . . . . 1.54 111.137 -177.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 28.0 t0 67.09 104.31 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.266 -0.896 . . . . 1.5 109.5 -179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.4 mt -81.06 -7.58 59.59 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.275 -0.89 . . . . 0.79 110.799 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.7 p -80.13 -17.32 52.85 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.65 -1.281 . . . . 1.4 109.355 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.8 17.62 3.31 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.509 -0.745 . . . . 0.92 111.825 -177.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 50.1 mt -91.04 114.57 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.727 -1.233 . . . . 0.88 109.145 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -101.34 -11.01 19.76 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.385 -0.822 . . . . 2.45 110.604 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -110.53 146.6 35.75 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.16 -0.962 . . . . 1.52 109.442 -179.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.94 130.58 43.61 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.148 -0.97 . . . . 1.58 109.407 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.1 m -152.27 163.71 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.939 -0.763 . . . . 0.69 108.939 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.1 mt -93.14 149.75 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 106.028 -1.842 . . . . 0.61 106.028 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.426 HD22 HD11 ' A' ' 171' ' ' LEU . 52.5 tp -100.44 117.81 35.37 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.996 -1.065 . . . . 0.87 110.908 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 42.1 t -121.94 129.92 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 N-CA-C 108.694 -0.854 . . . . 0.71 108.694 179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.22 164.49 35.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.976 -1.077 . . . . 0.81 109.153 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.433 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.86 -35.69 74.9 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.362 -1.461 . . . . 0.98 108.775 179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.545 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 52.3 t0 -170.6 143.81 2.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.441 -0.948 . . . . 2.25 108.441 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.545 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 26.1 mt -112.71 129.72 56.31 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.52 -0.919 . . . . 0.78 108.52 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.3 p -83.63 145.42 47.57 Favored Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.239 -0.913 . . . . 0.98 109.004 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_exo -38.01 -36.28 0.46 Allowed 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 122.031 1.821 . . . . 0.81 111.581 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 56.4 m -59.87 -40.0 87.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.407 -0.808 . . . . 0.9 109.656 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.5 -40.19 77.14 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.13 -0.982 . . . . 1.61 109.713 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 68.5 p -56.1 -28.14 56.57 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.067 -1.021 . . . . 0.61 110.739 -178.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -74.58 -56.35 4.92 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.821 -1.174 . . . . 0.6 109.711 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -78.88 39.58 0.37 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.532 -1.285 . . . . 1.4 107.532 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.466 ' H ' ' C ' ' A' ' 169' ' ' ALA . 15.3 tp -99.93 131.86 45.63 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.695 -0.628 . . . . 0.7 109.522 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -88.05 100.27 12.8 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.144 -1.058 . . . . 2.35 108.144 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 65.9 mt -64.66 -42.98 95.03 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.323 -0.861 . . . . 1.51 110.791 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.8 mttp -69.89 -24.24 63.37 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.66 -1.275 . . . . 2.33 111.569 -178.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -94.39 -13.51 26.23 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 120.6 -1.312 . . . . 1.92 109.767 -178.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.493 HG12 ' H ' ' A' ' 178' ' ' GLY . 69.6 t -104.85 116.17 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.238 -0.914 . . . . 0.67 108.541 179.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.7 mt -83.25 2.19 37.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.936 . . . . 1.53 111.007 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.493 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 171.86 172.33 37.73 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.231 -1.461 . . . . 0.48 109.735 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.429 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 14.2 m-85 -130.63 126.67 37.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.516 -0.991 . . . . 0.55 108.846 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.02 126.25 59.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.2 -0.938 . . . . 0.65 108.623 178.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.407 ' C ' ' HG1' ' A' ' 205' ' ' THR . 80.6 p -147.94 158.43 44.04 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.903 -1.123 . . . . 0.82 110.771 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.433 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 44.1 p30 -103.92 24.67 10.96 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.956 -0.757 . . . . 2.46 108.956 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -57.78 -159.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.993 -1.067 . . . . 1.28 110.794 -178.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.87 -54.38 9.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.155 -1.178 . . . . 2.19 110.155 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 156.69 -129.94 2.55 Favored Glycine 0 N--CA 1.491 2.302 0 O-C-N 120.937 -1.331 . . . . 2.13 110.502 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.462 ' C ' ' H ' ' A' ' 188' ' ' SER . 30.2 ttt-85 -63.2 -39.87 95.87 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.486 -1.008 . . . . 5.86 110.49 -179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 37.4 p -62.0 1.88 0.26 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.161 -0.962 . . . . 3.72 110.231 -178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 186' ' ' ARG . 47.5 t -91.52 130.0 37.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.03 -1.044 . . . . 1.74 109.716 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . 0.479 ' CE1' ' NZ ' ' A' ' 69' ' ' LYS . 84.8 t60 -48.28 -44.15 33.38 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-O 121.897 0.856 . . . . 0.95 108.967 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.409 ' H ' HG23 ' A' ' 190' ' ' THR . 4.1 p -51.95 -36.33 49.0 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 116.116 -0.493 . . . . 1.55 110.869 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 49.6 m -65.96 -40.83 91.62 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.947 -1.096 . . . . 1.51 111.843 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 36.2 mm -63.88 -43.2 97.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.976 -1.077 . . . . 1.67 110.668 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.2 mtp -66.02 -39.95 90.66 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.249 -0.907 . . . . 1.02 111.036 -178.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.14 -43.34 82.37 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.468 -1.395 . . . . 0.68 109.083 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -59.93 -48.85 80.02 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.125 -0.984 . . . . 2.93 110.086 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.2 m -68.09 -35.11 77.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.043 -1.036 . . . . 0.86 110.084 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 30.2 mt -71.56 -26.22 62.53 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.182 -0.949 . . . . 0.67 108.543 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 62.01 51.54 3.64 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-O 121.428 0.632 . . . . 1.5 110.494 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.489 ' O ' ' CB ' ' A' ' 8' ' ' SER . 72.0 mt -129.59 133.07 24.66 Favored Pre-proline 0 N--CA 1.501 2.125 0 N-CA-C 108.541 -0.911 . . . . 0.72 108.541 179.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -42.16 130.73 4.64 Favored 'Trans proline' 0 N--CA 1.499 1.795 0 C-N-CA 122.0 1.8 . . . . 0.61 112.427 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.429 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -169.31 148.8 3.96 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.93 -1.106 . . . . 0.66 111.326 -179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 78.8 mt -127.82 146.2 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 N-CA-C 107.985 -1.117 . . . . 0.79 107.985 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.0 m -126.0 -10.55 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 O-C-N 120.734 -1.229 . . . . 0.91 111.51 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.0 22.52 27.41 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 110.323 -1.111 . . . . 1.01 110.323 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.407 ' HG1' ' C ' ' A' ' 181' ' ' THR . 2.8 p -43.99 -42.99 6.36 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.317 -1.108 . . . . 0.99 109.834 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.73 -50.96 3.23 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 120.204 -0.998 . . . . 1.12 111.068 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 29.1 p -159.25 39.27 0.21 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.547 -1.56 . . . . 1.72 111.299 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.2 -35.76 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.952 -1.093 . . . . 0.89 108.378 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.463 ' H ' HG23 ' A' ' 209' ' ' THR . 6.4 p -55.72 -32.14 63.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.506 -0.746 . . . . 1.03 110.301 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 72.4 p -80.04 -15.65 56.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.951 -1.093 . . . . 1.83 109.84 -179.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.5 mm-40 -99.76 -13.07 19.43 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.412 -0.805 . . . . 2.27 110.041 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 52.7 t -106.72 138.07 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 CA-C-O 121.773 0.797 . . . . 0.92 110.713 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.423 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -114.83 153.67 30.01 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.216 -1.402 . . . . 2.2 107.216 178.339 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.459 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 17.5 p-10 -57.63 138.91 54.83 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.914 -1.116 . . . . 2.36 110.546 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.5 m-20 84.36 5.09 0.67 Allowed 'General case' 0 N--CA 1.505 2.284 0 CA-C-O 120.984 0.421 . . . . 2.38 110.758 179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.423 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 74.8 m-20 -74.62 137.88 42.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.935 -1.103 . . . . 2.09 109.638 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -88.1 118.12 27.45 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.504 -1.295 . . . . 1.27 107.504 178.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.593 HD12 ' HB2' ' A' ' 16' ' ' ALA . 60.6 mt -128.95 150.36 50.41 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.493 -0.754 . . . . 0.75 110.611 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.9 mt -117.67 128.14 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 106.317 -1.734 . . . . 0.63 106.317 177.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 62.3 tp -101.08 120.88 40.85 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.043 -1.036 . . . . 0.7 109.385 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' A' ' 223' ' ' VAL . 95.3 m-20 -76.32 -44.79 35.26 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 120.951 -1.093 . . . . 2.31 109.491 179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.91 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.25 16.6 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.463 -0.94 . . . . 0.78 108.463 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' A' ' 221' ' ' ASP . 45.9 t -135.48 -42.97 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.549 -1.278 . . . . 1.04 107.549 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.433 ' H ' ' HB3' ' A' ' 221' ' ' ASP . 84.4 m-20 -99.79 2.74 44.33 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.014 -1.106 . . . . 2.44 108.014 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 60.24 42.42 15.19 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.806 -0.559 . . . . 1.55 109.697 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -141.96 155.46 45.47 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.173 -0.955 . . . . 1.99 110.119 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.0 t -124.8 131.39 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.594 -0.891 . . . . 0.77 108.594 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -102.48 121.74 42.95 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.326 -0.859 . . . . 0.98 109.325 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 43.9 t -100.59 113.93 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.455 -0.778 . . . . 0.85 110.13 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 25.5 t30 53.48 61.96 10.04 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.237 -0.914 . . . . 1.66 111.59 179.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -87.35 149.27 7.77 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 122.976 2.451 . . . . 0.95 112.865 178.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 42.8 p -70.32 162.62 28.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.444 -0.785 . . . . 1.84 110.271 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -59.66 -35.19 73.93 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.489 -0.757 . . . . 2.74 109.304 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -59.96 -40.12 87.98 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.359 -0.838 . . . . 2.89 109.953 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.5 -39.53 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.0 -1.063 . . . . 1.3 109.328 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.545 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 85.5 mt -63.93 -39.63 86.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.108 -0.995 . . . . 1.09 109.445 179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -60.13 -40.15 88.77 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.08 -1.012 . . . . 2.43 108.47 179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -67.04 -40.03 87.07 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.369 -0.832 . . . . 2.78 108.974 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 98.1 mtp -69.81 -29.87 67.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.331 -0.856 . . . . 1.25 108.692 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.582 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -69.77 -36.87 76.12 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.526 -0.916 . . . . 2.63 108.526 178.53 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.78 -39.18 84.05 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.994 -0.743 . . . . 1.8 108.994 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 58.4 t -59.94 -41.43 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.281 -0.887 . . . . 2.13 108.844 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -61.33 -40.21 93.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.185 -0.947 . . . . 3.17 109.702 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -60.88 -39.18 88.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.239 -0.913 . . . . 1.78 109.858 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -59.98 -38.84 83.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.194 -0.941 . . . . 2.47 109.498 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 54.1 t -59.92 -43.49 92.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.389 -0.819 . . . . 2.09 109.382 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.68 -44.24 94.3 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.163 -0.96 . . . . 2.54 109.123 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 22.8 t -70.83 -26.68 63.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.342 -0.849 . . . . 2.99 109.734 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -60.17 -46.56 89.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.084 -1.01 . . . . 3.34 109.113 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.579 ' O ' ' N ' ' A' ' 252' ' ' GLU . 67.2 mttm -80.27 -71.85 0.44 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.034 -1.041 . . . . 3.88 108.968 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . 63.83 -40.42 0.22 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.316 0.579 . . . . 4.43 109.725 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.579 ' N ' ' O ' ' A' ' 250' ' ' LYS . 54.0 tp10 -150.49 88.42 1.5 Allowed 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.39 -0.967 . . . . 5.42 108.39 179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.598 ' H ' HD12 ' A' ' 253' ' ' LEU . 3.0 mp -41.31 -32.78 0.32 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.608 -0.683 . . . . 6.1 109.769 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 253' ' ' LEU . . . 68.99 -17.13 0.21 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.667 -0.646 . . . . 7.37 109.856 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.515 ' H ' ' C ' ' A' ' 253' ' ' LEU . 26.5 mtpp -143.37 124.45 14.45 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.111 -0.993 . . . . 8.01 109.214 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.46 ' N ' HD12 ' A' ' 256' ' ' LEU . 9.6 mp -62.43 -25.9 68.21 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.114 -0.992 . . . . 9.05 108.43 179.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -67.85 -52.35 37.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.502 -0.749 . . . . 10.56 110.368 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 50.9 t0 50.57 62.88 2.46 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.55 -0.908 . . . . 11.32 108.55 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.52 HH11 ' HG2' ' A' ' 259' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.981 0 CA-C-O 117.937 -1.03 . . . . 12.42 108.821 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 45.0 ttp . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . 0.443 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 42.1 t80 -153.64 152.31 30.7 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.446 -0.784 . . . . 0.0 109.194 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . 0.443 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 14.0 pt20 -148.75 158.46 44.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.993 -1.067 . . . . 0.0 110.876 -178.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -152.84 149.88 28.75 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -111.93 131.26 55.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.313 -0.867 . . . . 0.0 110.051 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.4 ' CG1' ' SD ' ' B' ' 381' ' ' MET . 7.4 p -131.16 123.1 52.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 CA-C-O 122.474 1.131 . . . . 0.0 112.987 -177.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 61.2 m -79.38 103.91 9.63 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.805 -178.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.6 mt -50.8 122.68 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 CA-C-O 122.346 1.069 . . . . 0.0 110.296 -177.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 34.6 p -108.43 15.71 23.69 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.697 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.77 116.33 48.91 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.919 -1.113 . . . . 0.0 108.716 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -53.53 -15.26 5.94 Favored 'Trans proline' 0 N--CA 1.5 1.858 0 CA-C-N 120.308 1.146 . . . . 0.0 113.879 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -114.65 12.93 17.3 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.229 -0.919 . . . . 0.0 109.375 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 68.03 174.8 8.51 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.523 -1.831 . . . . 0.0 108.523 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.56 ' O ' ' NH2' ' A' ' 126' ' ' ARG . 4.0 tp -84.4 92.39 8.03 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.234 -1.156 . . . . 0.0 110.281 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.6 ' C ' HH21 ' A' ' 126' ' ' ARG . 5.1 p80 -95.94 -162.23 0.93 Allowed 'General case' 0 N--CA 1.506 2.351 0 O-C-N 120.778 -1.201 . . . . 0.0 110.06 179.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 22.6 m -58.33 -40.1 81.22 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.93 -1.107 . . . . 0.0 112.661 -175.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.617 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -60.82 -62.79 5.26 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 120.17 -1.581 . . . . 0.0 111.395 -178.402 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -54.56 -34.37 82.35 Favored 'Trans proline' 0 N--CA 1.489 1.256 0 CA-C-N 120.034 1.048 . . . . 0.0 111.812 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.92 -53.35 59.21 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.337 -0.945 . . . . 0.0 108.948 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.72 -40.66 66.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.195 -0.941 . . . . 0.0 109.387 -179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -69.96 -41.57 74.31 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.205 -0.934 . . . . 0.0 108.878 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -60.07 -50.97 71.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.557 -0.715 . . . . 0.0 110.535 -179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . 0.417 HG13 ' O ' ' B' ' 344' ' ' ALA . 89.4 t -70.23 -28.83 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.982 -1.074 . . . . 0.0 110.011 -179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt -60.03 -45.82 91.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.142 -0.973 . . . . 0.0 108.472 179.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -60.6 -49.31 78.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.397 -0.815 . . . . 0.0 109.745 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . 0.413 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -63.02 -50.91 68.83 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.302 -0.874 . . . . 0.0 110.85 -179.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 57.4 mmtt -49.72 -16.65 0.26 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.085 -1.009 . . . . 0.0 109.671 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . 0.413 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -79.3 -23.55 62.89 Favored Glycine 0 N--CA 1.492 2.428 0 C-N-CA 119.956 -1.116 . . . . 0.0 110.828 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -104.18 139.93 38.53 Favored 'General case' 0 N--CA 1.502 2.161 0 O-C-N 121.115 -1.227 . . . . 0.0 109.559 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 89.2 m -91.63 -13.32 32.05 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.13 -0.981 . . . . 0.0 110.388 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.476 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 64.6 p -58.85 154.84 14.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.948 -1.095 . . . . 0.0 109.388 -179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.98 130.87 42.69 Favored 'General case' 0 N--CA 1.486 1.366 0 C-N-CA 119.119 -1.032 . . . . 0.0 108.406 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.9 mt -132.33 133.32 60.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.603 -0.686 . . . . 0.0 109.583 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.6 m -130.09 151.56 50.5 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.515 -0.741 . . . . 0.0 109.578 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 97.2 t -115.86 139.2 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 177.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 91.3 m -129.77 123.95 32.23 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.165 -0.959 . . . . 0.0 109.101 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 11.3 p -138.79 118.22 12.87 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 121.97 0.891 . . . . 0.0 110.768 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 61.6 t30 42.86 58.05 3.37 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.06 -13.53 31.5 Favored Glycine 0 N--CA 1.495 2.633 0 O-C-N 120.31 -1.494 . . . . 0.0 113.069 176.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -115.61 127.24 55.07 Favored 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 119.336 1.568 . . . . 0.0 109.443 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 74.6 m -123.98 146.56 48.43 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.882 0.849 . . . . 0.0 110.531 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -140.97 163.1 33.87 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.468 0.651 . . . . 0.0 109.624 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 3.4 t -87.05 137.02 32.7 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.558 -0.714 . . . . 0.0 109.638 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.417 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -76.73 -13.78 60.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.881 -1.137 . . . . 0.0 109.8 -179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -91.12 19.8 5.51 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 177.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 4.6 m -144.28 95.23 2.68 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.269 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.809 HD23 HD22 ' A' ' 79' ' ' LEU . 43.0 tp -59.88 -36.75 77.58 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.841 ' CE2' HD11 ' A' ' 79' ' ' LEU . 63.0 m-85 -56.15 -52.21 65.18 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.092 -1.005 . . . . 0.0 110.964 -179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 33.4 mtmm -73.77 -23.6 59.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.783 -1.198 . . . . 0.0 110.866 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' B' ' 350' ' ' LEU . 29.9 mt -60.08 -45.61 92.34 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.322 -1.351 . . . . 0.0 108.734 179.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.588 ' N ' ' NE2' ' B' ' 351' ' ' GLN . 0.1 OUTLIER -50.78 -26.57 5.81 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.123 -0.986 . . . . 0.0 111.892 -178.416 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 44.2 p -72.8 -10.08 59.39 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 119.93 -1.731 . . . . 0.0 109.864 -178.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 39.8 mt -97.46 116.17 29.17 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.212 -0.93 . . . . 0.0 109.398 178.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.69 96.34 1.16 Allowed Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.698 -1.761 . . . . 0.0 108.698 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 19.3 mt -103.04 92.17 4.43 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.355 -1.085 . . . . 0.0 109.105 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 64.9 p -93.5 167.08 11.93 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.959 -1.088 . . . . 0.0 110.946 -179.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 16.3 tm0? -57.02 114.74 2.25 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.705 -0.622 . . . . 0.0 110.699 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 100.09 7.53 52.33 Favored Glycine 0 N--CA 1.497 2.74 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 52.2 m -83.8 112.59 20.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -1.107 . . . . 0.0 110.634 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 13.5 t -78.03 114.36 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-O 122.263 1.03 . . . . 0.0 109.625 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 11.8 m -110.81 177.46 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 62.4 m -131.25 129.3 41.41 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 89.3 mt -104.11 118.4 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 37.3 p -121.64 133.65 54.98 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.11 154.07 40.69 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.087 -1.008 . . . . 0.0 110.239 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -144.61 122.39 11.91 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 160.28 -159.29 30.67 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 118.972 -1.585 . . . . 0.0 111.596 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -59.98 -51.8 68.13 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.169 -0.606 . . . . 0.0 112.295 -177.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.476 ' H ' ' HB3' ' B' ' 331' ' ' SER . 75.2 m-20 -109.31 10.37 25.62 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.775 -1.203 . . . . 0.0 111.059 -177.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.414 ' C ' ' OE1' ' B' ' 370' ' ' GLU . 0.7 OUTLIER -43.64 -34.9 1.58 Allowed 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.096 -1.003 . . . . 0.0 111.718 -178.352 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -70.06 -42.69 72.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.378 -1.451 . . . . 0.0 110.866 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -69.23 -50.61 45.68 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.902 -1.124 . . . . 0.0 109.562 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -51.45 -31.29 22.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.311 -0.868 . . . . 0.0 111.381 -178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.518 ' O ' HG23 ' B' ' 378' ' ' VAL . 70.3 t -71.74 -39.92 69.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.545 -1.347 . . . . 0.0 108.845 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -64.48 -62.4 1.62 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.24 -0.913 . . . . 0.0 110.908 -178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 58.8 m80 -60.68 -43.69 97.39 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.392 -1.443 . . . . 0.0 111.416 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.03 -40.12 88.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.437 -1.414 . . . . 0.0 108.359 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.518 HG23 ' O ' ' B' ' 374' ' ' VAL . 52.3 t -66.67 -40.22 85.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.535 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -70.94 -58.5 3.52 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.453 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 55.6 tp -54.41 -34.06 60.58 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.8 -0.563 . . . . 0.0 109.952 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . 0.4 ' SD ' ' CG1' ' B' ' 306' ' ' VAL . 2.8 ttt -73.83 -40.03 63.62 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.247 -0.908 . . . . 0.0 108.819 177.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -79.19 -4.89 52.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.572 -0.705 . . . . 0.0 109.904 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -109.03 0.47 19.98 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.294 -0.879 . . . . 0.0 111.313 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . 0.453 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 20.4 mt -69.79 131.1 43.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.179 -1.576 . . . . 0.0 108.508 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.593 -179.334 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.7 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.424 -0.584 . . . . 2.91 109.424 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.2 mt -109.97 129.92 64.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 121.523 -0.736 . . . . 1.2 109.12 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.6 m -130.3 143.08 50.56 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.46 -0.775 . . . . 1.4 109.558 -179.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.505 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -112.85 -160.0 14.29 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 108.944 -1.662 . . . . 1.05 108.944 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.469 ' O ' ' O ' ' A' ' 6' ' ' LEU . 92.0 mt -94.21 -15.5 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 120.997 -1.296 . . . . 1.15 110.086 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.9 tp 50.85 103.0 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.248 -0.908 . . . . 0.98 109.505 179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.14 -25.79 14.42 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.988 -1.07 . . . . 0.88 109.273 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.485 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 35.0 m -133.73 119.67 15.08 Favored Pre-proline 0 N--CA 1.5 2.033 0 O-C-N 121.427 -0.796 . . . . 1.69 109.573 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.91 147.29 16.79 Favored 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.08 1.854 . . . . 0.85 112.683 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.819 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.46 -159.33 30.41 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 109.082 -1.607 . . . . 0.92 109.082 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.4 mt -149.21 150.14 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 O-C-N 121.167 -1.196 . . . . 0.81 108.669 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.55 157.84 37.47 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.968 -1.083 . . . . 0.51 110.756 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -139.5 128.7 23.91 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.021 -1.103 . . . . 0.62 108.021 178.817 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.0 -177.29 47.09 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 118.758 -1.687 . . . . 0.55 110.92 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 157' ' ' ILE . 98.1 mttt -79.8 159.67 26.44 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.589 -0.948 . . . . 2.1 110.099 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.568 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -106.6 137.38 44.72 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.596 -0.69 . . . . 0.77 110.131 -179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.5 tp -104.05 131.12 51.63 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.882 -1.155 . . . . 0.91 107.882 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.3 tp -113.04 124.33 52.37 Favored 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.195 -0.941 . . . . 0.93 110.022 -179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.404 HD12 ' HB2' ' A' ' 160' ' ' ALA . 26.3 mt -95.42 103.64 15.51 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.667 -0.646 . . . . 0.93 111.005 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -107.22 136.93 46.22 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.541 -0.724 . . . . 2.75 109.925 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -130.15 138.2 50.52 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.356 -0.84 . . . . 3.0 109.377 179.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.4 m-20 -78.04 158.77 29.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.067 -1.021 . . . . 2.77 109.944 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -72.32 144.21 48.39 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.424 -0.798 . . . . 2.94 108.905 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 45.8 mt -84.5 129.61 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.104 -0.998 . . . . 0.95 109.464 -179.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 99.5 t -94.14 124.73 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.341 -0.849 . . . . 1.28 110.684 -179.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.4 mt -110.37 134.28 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.52 -0.738 . . . . 1.21 109.355 179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -93.66 116.45 28.94 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.978 -1.076 . . . . 1.81 109.141 179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -83.72 -1.41 54.06 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.153 -0.967 . . . . 2.8 109.407 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -65.14 139.99 58.74 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 2.87 109.655 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -83.13 151.2 25.84 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.089 -1.007 . . . . 2.35 108.999 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.7 pt -94.57 166.73 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.318 -0.864 . . . . 0.97 110.149 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 83.9 p -96.78 173.43 7.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -0.947 . . . . 1.17 108.666 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.79 -49.69 76.74 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.072 -1.018 . . . . 1.18 109.512 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -53.57 -30.99 44.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.096 -1.003 . . . . 2.56 109.29 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -83.32 -9.92 58.8 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.58 -0.7 . . . . 1.79 110.669 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.97 -54.0 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.652 -1.28 . . . . 1.0 109.288 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -64.56 -40.14 95.03 Favored 'General case' 0 C--N 1.295 -1.77 0 O-C-N 121.31 -0.869 . . . . 1.77 110.036 -179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.51 HE21 HH21 ' A' ' 42' ' ' ARG . 27.3 mt-30 -65.99 -43.63 87.24 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.976 -1.078 . . . . 2.7 110.351 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 -63.9 -40.04 95.57 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.86 -1.15 . . . . 1.51 110.168 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.3 t -61.0 -48.16 90.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 120.778 -1.201 . . . . 0.93 108.647 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -62.25 -43.96 97.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.157 -0.965 . . . . 1.81 109.505 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.51 HH21 HE21 ' A' ' 38' ' ' GLN . 21.8 mtt-85 -60.05 -43.15 95.57 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.857 -1.164 . . . . 2.78 107.857 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -60.73 -49.98 75.32 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.454 -0.943 . . . . 0.78 108.454 177.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.6 tp -60.06 -43.71 95.23 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.69 -0.856 . . . . 1.07 108.69 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.0 t -66.56 -41.96 87.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 1.12 109.292 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -69.29 -44.3 66.34 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.214 -1.954 . . . . 0.84 108.214 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.435 HH22 ' HG2' ' A' ' 81' ' ' GLU . 41.2 ttt-85 -62.77 -36.6 83.62 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.14 -1.059 . . . . 3.09 108.14 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.03 -39.39 78.25 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.581 -0.896 . . . . 0.88 108.581 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.2 ttpt -59.5 -73.66 0.08 Allowed 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.355 -1.35 . . . . 2.59 107.355 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.61 -37.73 0.23 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.439 -0.788 . . . . 0.7 111.153 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.402 ' OG ' ' N ' ' A' ' 52' ' ' ALA . 21.7 p -53.25 -53.61 48.2 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.578 -1.326 . . . . 1.4 108.478 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.402 ' N ' ' OG ' ' A' ' 51' ' ' SER . . . -67.85 -40.86 83.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -0.899 . . . . 0.67 110.884 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -70.01 -39.96 75.52 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.796 -1.19 . . . . 1.66 109.746 -179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.8 mt -63.13 -40.05 96.47 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.053 -1.029 . . . . 1.58 109.11 179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -60.37 -38.58 84.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.383 -0.823 . . . . 1.35 109.831 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -61.34 -40.47 94.38 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.22 -0.925 . . . . 0.77 110.048 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 63.3 mt -61.58 -39.98 84.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.374 -0.829 . . . . 0.63 109.188 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -56.58 -50.82 70.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.295 -0.878 . . . . 1.14 109.949 -179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -60.0 -31.76 70.23 Favored 'General case' 0 C--N 1.297 -1.686 0 O-C-N 121.376 -0.827 . . . . 0.79 110.729 -178.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -67.87 -39.48 83.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.044 -1.035 . . . . 1.53 109.302 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.7 -41.48 95.99 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.663 -0.648 . . . . 0.57 110.026 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.83 -50.25 69.74 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.493 -1.443 . . . . 0.75 109.493 -179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.17 -51.55 24.2 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.929 -1.336 . . . . 1.59 109.929 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 28.7 m -60.11 -65.7 0.64 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.73 112.202 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -94.22 -50.15 5.4 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.802 -1.186 . . . . 0.75 111.439 -178.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.65 -168.24 25.61 Favored Glycine 0 N--CA 1.502 3.071 0 C-N-CA 119.732 -1.223 . . . . 1.22 111.198 179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -70.0 -26.78 64.24 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.939 -0.742 . . . . 5.81 110.21 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.508 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.0 tp10 -60.1 -34.29 73.28 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.378 -0.826 . . . . 3.37 110.629 -179.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -100.0 -18.01 17.24 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.079 -1.013 . . . . 1.77 109.799 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -69.26 -39.99 78.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.103 -0.998 . . . . 1.65 109.974 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.495 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -63.25 -31.5 72.67 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.308 -0.87 . . . . 0.77 109.47 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 96.0 mt -60.12 -42.21 89.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.124 -0.985 . . . . 0.8 109.656 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -65.02 -39.88 94.03 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.994 -1.066 . . . . 0.88 110.317 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -59.79 -40.12 87.23 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.954 -1.091 . . . . 1.37 108.771 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.47 -46.34 94.01 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.649 -1.781 . . . . 0.62 108.649 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.4 m170 -65.34 -45.06 85.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -1.133 . . . . 1.5 109.646 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.7 mt -69.08 -45.0 80.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 C-N-CA 119.078 -1.049 . . . . 0.63 109.09 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 44.3 ttp -61.1 -39.9 91.71 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.936 -1.102 . . . . 1.51 109.436 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.891 HD22 HD23 ' B' ' 347' ' ' LEU . 46.0 tp -63.15 -39.13 93.78 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.495 -0.753 . . . . 0.77 109.506 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 34.6 tp -66.1 -30.27 70.74 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.404 -0.81 . . . . 0.62 109.027 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.435 ' HG2' HH22 ' A' ' 47' ' ' ARG . 96.4 mt-10 -87.2 6.86 30.93 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.137 -0.977 . . . . 1.47 110.009 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 63.1 t0 -55.86 130.0 41.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.963 -1.085 . . . . 1.47 109.887 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.407 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 99.8 mt-10 -60.5 -19.43 56.88 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.528 -0.732 . . . . 1.78 111.058 -178.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.96 -33.53 72.22 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.759 -1.213 . . . . 2.53 108.337 178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 76.9 mt -71.94 -41.99 67.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.64 -0.663 . . . . 0.8 110.08 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -60.15 -50.12 74.92 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.02 -1.05 . . . . 1.42 111.056 -178.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -70.12 -40.09 75.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.107 -0.996 . . . . 1.71 110.876 -178.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.88 -39.99 75.97 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.22 -0.925 . . . . 1.57 111.01 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 80.0 mt -64.2 -49.99 78.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.997 -1.064 . . . . 0.65 109.676 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.02 -39.11 80.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.538 -0.726 . . . . 0.82 110.436 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.11 -44.03 95.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.91 . . . . 0.79 110.631 -179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.2 mt -62.47 -46.96 86.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.796 -1.19 . . . . 0.95 109.719 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.5 mt -62.8 -50.06 81.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-O 121.911 0.862 . . . . 0.66 108.939 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -67.66 -42.54 82.02 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.456 -0.777 . . . . 2.2 110.758 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -80.33 -54.11 6.01 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.965 -1.085 . . . . 1.65 111.956 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -90.06 -1.94 58.03 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.111 -0.993 . . . . 2.03 112.35 -177.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 35.9 m80 58.32 35.06 24.6 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.837 -1.164 . . . . 1.42 109.776 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.6 mtp -86.56 165.17 16.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.409 -0.807 . . . . 1.18 110.17 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.5 p -79.22 161.37 26.42 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 109.0 -0.741 . . . . 0.98 109.0 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.29 -42.0 84.51 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.174 -0.954 . . . . 0.64 109.613 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -62.15 -40.04 94.61 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.192 -0.943 . . . . 2.07 109.445 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.27 -41.44 22.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.73 110.111 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.26 -52.02 60.71 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.333 -0.855 . . . . 0.54 110.402 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.91 -39.99 87.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.109 -0.994 . . . . 0.56 109.785 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.526 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 82.7 t60 -60.02 -40.22 88.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.18 -0.95 . . . . 1.54 110.048 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -61.01 -40.05 92.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.145 -0.972 . . . . 1.33 110.671 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 67.1 t -65.23 -59.95 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.094 -1.004 . . . . 0.72 111.439 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 41.3 mm -62.28 -42.96 97.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 120.974 -1.079 . . . . 0.85 109.075 -179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.526 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 88.7 tt0 -61.47 -40.04 93.1 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.565 -0.902 . . . . 2.44 108.565 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.16 -51.03 61.36 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.367 -1.093 . . . . 0.98 110.367 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' B' ' 348' ' ' PHE . 14.6 mm100 -62.15 -49.96 73.75 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.889 -1.36 . . . . 1.41 109.126 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.07 -40.06 88.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 1.2 109.636 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 56.6 m -60.04 -39.97 87.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.116 -0.99 . . . . 1.7 109.213 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.61 -40.06 82.21 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.023 -1.048 . . . . 1.47 108.407 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 118' ' ' LEU . 51.8 mt -62.0 -46.47 89.08 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.111 -0.993 . . . . 1.56 108.662 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -47.76 -30.82 4.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.897 -1.127 . . . . 2.2 109.689 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.41 -27.12 68.79 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.013 -1.054 . . . . 2.12 108.354 179.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 115' ' ' LEU . 74.4 mt -63.32 140.6 58.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.322 -0.862 . . . . 2.0 108.952 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -94.23 10.12 35.27 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.075 -1.016 . . . . 3.23 110.42 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -98.3 147.0 25.1 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.005 -1.06 . . . . 2.49 109.891 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.488 ' O ' ' N ' ' A' ' 124' ' ' LYS . 98.9 mt-10 -72.98 -65.53 0.79 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.52 -0.738 . . . . 3.95 109.159 178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.412 ' C ' ' O ' ' A' ' 121' ' ' GLU . 4.7 t80 -39.37 -40.05 0.74 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.867 -0.52 . . . . 2.0 110.602 -178.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.627 ' CD2' HH21 ' A' ' 126' ' ' ARG . 81.0 mt -70.83 -40.0 72.67 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.744 -1.223 . . . . 1.86 108.551 179.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 121' ' ' GLU . 82.1 tttt -68.3 -34.52 76.3 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.553 -0.717 . . . . 2.84 109.579 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -60.08 -40.02 88.1 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.262 -0.899 . . . . 2.73 110.19 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.627 HH21 ' CD2' ' A' ' 123' ' ' LEU . 76.2 mtm180 -68.06 -33.44 74.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.934 -1.104 . . . . 2.77 109.258 179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.95 -36.88 78.02 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.11 -0.994 . . . . 1.19 108.621 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.4 -41.27 96.86 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.797 -1.186 . . . . 1.2 107.797 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -69.96 -40.0 75.68 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.611 -0.681 . . . . 1.55 109.478 179.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.64 -39.99 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 108.197 -1.038 . . . . 0.8 108.197 179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.6 ttm-85 -65.49 -35.65 81.52 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.31 -0.868 . . . . 3.09 109.099 178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -59.91 -40.12 87.73 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.252 -0.905 . . . . 1.46 109.541 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.06 -43.09 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.371 -0.83 . . . . 0.71 109.827 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.18 -36.69 50.38 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 120.197 -1.001 . . . . 0.57 110.659 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -59.55 -42.55 92.64 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.069 -1.254 . . . . 2.59 109.649 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -68.7 -34.37 75.53 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.707 -1.245 . . . . 2.83 109.46 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.6 tp -59.95 -43.07 95.22 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 1.25 109.478 -179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.5 mt -62.09 -40.17 94.95 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.003 -1.06 . . . . 0.7 109.146 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 78.4 mtm180 -70.11 -36.84 75.13 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.327 -0.858 . . . . 2.57 109.488 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -69.87 -25.58 63.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.353 -0.842 . . . . 1.23 111.24 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.0 mt -69.91 -43.76 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.472 -1.393 . . . . 0.81 108.931 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.9 mt -75.59 -28.45 58.93 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.494 -0.754 . . . . 1.0 110.079 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.18 42.34 5.61 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 108.112 -1.995 . . . . 0.89 108.112 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 21.7 tp -73.59 146.87 44.36 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.632 -0.922 . . . . 1.14 109.229 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -60.81 144.12 53.24 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.24 -0.913 . . . . 4.6 109.515 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 97.2 mt -114.49 120.61 64.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 N-CA-C 108.583 -0.895 . . . . 1.24 108.583 179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 10.7 mm -52.6 -53.23 21.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.651 -0.656 . . . . 1.54 110.384 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.2 t0 66.37 103.32 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.548 -0.72 . . . . 1.5 109.285 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 17.1 mt -74.82 -3.08 29.66 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.673 -0.642 . . . . 0.79 110.374 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 53.1 m -86.83 -15.68 38.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.171 -0.955 . . . . 1.4 109.573 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.99 15.83 1.03 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.362 -0.836 . . . . 0.92 111.458 -178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.547 HD12 ' N ' ' A' ' 152' ' ' ILE . 1.3 mp -90.4 124.71 43.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.541 -1.349 . . . . 0.88 109.068 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -103.67 -7.09 20.96 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.386 -0.822 . . . . 2.45 110.101 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -119.36 149.43 41.84 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.477 -0.764 . . . . 1.52 110.496 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.35 135.42 54.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.419 -0.8 . . . . 1.58 109.161 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.0 m -152.07 166.02 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.428 -0.795 . . . . 0.69 109.538 178.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 15' ' ' LYS . 86.3 mt -93.47 149.3 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 105.823 -1.918 . . . . 0.61 105.823 176.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 57.2 tp -97.06 115.26 27.15 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.942 -1.099 . . . . 0.87 110.799 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 64.2 t -120.11 124.69 73.18 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.125 0 O-C-N 121.679 -0.638 . . . . 0.71 109.436 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.404 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -159.45 162.66 35.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.168 -0.958 . . . . 0.81 108.481 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.02 -36.42 75.07 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.508 -1.37 . . . . 0.98 108.444 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 20.4 p-10 -170.77 146.79 2.67 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.21 -0.663 . . . . 2.25 109.21 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 44.8 mt -112.98 137.54 51.22 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.362 -0.836 . . . . 0.78 109.906 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 70.9 p -92.82 146.42 32.11 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.157 -0.964 . . . . 0.98 108.483 178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -40.2 -37.81 1.98 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.02 1.814 . . . . 0.81 112.731 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.9 m -59.99 -40.76 90.29 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.24 -0.912 . . . . 0.9 110.146 -178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -69.94 -40.63 75.36 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.05 -1.031 . . . . 1.61 109.824 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 66.5 p -59.14 -20.33 52.69 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.364 -0.835 . . . . 0.61 111.833 -177.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.5 -47.45 9.9 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.471 -1.393 . . . . 0.6 109.739 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -85.62 36.29 0.65 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.581 -0.896 . . . . 1.4 108.581 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.0 tp -107.91 139.9 41.84 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.932 -0.766 . . . . 0.7 108.932 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.416 HD21 ' HB ' ' A' ' 152' ' ' ILE . 6.2 p30 -89.37 106.39 18.42 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.045 -1.034 . . . . 2.35 108.912 179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 59.6 mt -67.39 -40.16 85.65 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.576 -0.703 . . . . 1.51 111.678 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -68.75 -21.83 64.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.646 -1.284 . . . . 2.33 111.17 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -94.29 -8.37 39.26 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.89 -1.131 . . . . 1.92 109.96 -179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 178' ' ' GLY . 84.4 t -101.0 112.42 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.216 -0.927 . . . . 0.67 108.719 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.2 mt -80.52 1.49 29.27 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -0.91 . . . . 1.53 110.7 -178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.473 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.26 173.33 37.5 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.33 -1.508 . . . . 0.48 109.33 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.488 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 26.9 m-85 -127.98 125.07 38.74 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.562 -0.963 . . . . 0.55 108.713 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 93.4 mt -130.85 125.38 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.399 -0.963 . . . . 0.65 108.399 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 31.6 p -151.42 163.43 38.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.885 -1.134 . . . . 0.82 111.172 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.501 ' O ' ' O ' ' A' ' 183' ' ' ALA . 57.4 t0 -100.84 27.35 6.03 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 115.993 -0.549 . . . . 2.46 109.675 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.501 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -46.96 -177.24 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.001 -1.687 . . . . 1.28 111.862 -178.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.29 -54.39 6.92 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.254 -1.138 . . . . 2.19 110.254 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -161.4 -156.12 8.17 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.416 -1.373 . . . . 2.13 110.357 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.803 ' HE ' HH21 ' A' ' 195' ' ' ARG . 66.6 mtp180 -78.4 -9.48 59.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.633 -0.922 . . . . 5.86 109.354 -179.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 39.6 p -77.75 2.78 15.91 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -0.885 . . . . 3.72 110.067 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 78.0 p -82.31 139.61 34.05 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.954 -1.091 . . . . 1.74 109.655 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 86.7 t60 -49.18 -50.05 39.79 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.986 -1.071 . . . . 0.95 109.918 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.6 t -53.64 -36.17 61.78 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.214 -0.929 . . . . 1.55 110.394 -179.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 66.7 m -59.92 -40.07 87.63 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.804 -1.185 . . . . 1.51 110.155 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 87.3 mt -61.02 -39.99 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 1.67 109.567 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 76.6 mtp -56.92 -41.39 78.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.251 -0.906 . . . . 1.02 109.978 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.08 -40.8 90.82 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.996 -1.065 . . . . 0.68 108.769 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.803 HH21 ' HE ' ' A' ' 186' ' ' ARG . 95.0 mtt180 -62.62 -59.98 4.16 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.346 -0.942 . . . . 2.93 110.281 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.4 m -63.42 -39.99 95.99 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.213 -0.929 . . . . 0.86 112.101 -177.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.1 -22.42 63.03 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.854 -1.154 . . . . 0.67 109.307 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 61.35 47.02 7.19 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.694 -0.629 . . . . 1.5 109.782 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.485 ' O ' ' CB ' ' A' ' 8' ' ' SER . 97.5 mt -122.19 148.6 52.43 Favored Pre-proline 0 N--CA 1.497 1.899 0 N-CA-C 107.757 -1.201 . . . . 0.72 107.757 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -62.45 138.12 68.96 Favored 'Trans proline' 0 N--CA 1.498 1.749 0 C-N-CA 121.975 1.783 . . . . 0.61 111.39 -179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.488 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -170.01 150.96 3.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.942 -1.099 . . . . 0.66 111.588 -178.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.6 mt -124.4 141.16 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 107.211 -1.403 . . . . 0.79 107.211 178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 34.8 m -124.22 -9.22 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.52 0 O-C-N 120.522 -1.361 . . . . 0.91 111.406 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -111.36 23.34 18.45 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 110.607 -0.997 . . . . 1.01 110.607 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.412 ' C ' ' O ' ' A' ' 204' ' ' GLY . 2.9 p -43.07 -46.89 5.86 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.222 -1.163 . . . . 0.99 110.108 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.438 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 95.69 -54.0 1.7 Allowed Glycine 0 N--CA 1.501 2.973 0 C-N-CA 120.163 -1.018 . . . . 1.12 111.587 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 78.7 p -149.03 29.62 0.8 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.49 -1.594 . . . . 1.72 111.505 -178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 41.7 t -74.34 -36.35 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.691 -1.256 . . . . 0.89 109.299 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 53.5 p -58.96 -26.01 64.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.92 -1.112 . . . . 1.03 109.796 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.7 m -84.2 -15.27 47.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.105 -0.997 . . . . 1.83 109.892 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -102.46 -6.75 22.58 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.268 -0.895 . . . . 2.27 109.868 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 78.6 t -110.19 133.44 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.514 -0.742 . . . . 0.92 110.819 -178.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -115.16 151.08 35.02 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.149 -1.426 . . . . 2.2 107.149 178.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.454 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 61.7 t30 -54.89 139.76 39.18 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.02 -1.05 . . . . 2.36 110.79 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.454 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.1 m-20 83.18 2.47 1.02 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-N 116.322 -0.399 . . . . 2.38 110.632 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -74.3 145.12 44.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.895 -1.128 . . . . 2.09 109.489 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -95.51 118.85 32.98 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.997 -1.112 . . . . 1.27 107.997 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.568 HD12 ' HB2' ' A' ' 16' ' ' ALA . 58.1 mt -128.04 151.22 49.42 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.559 -0.713 . . . . 0.75 110.151 -178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 83.0 mt -116.89 130.02 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 107.224 -1.398 . . . . 0.63 107.224 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 63.5 tp -97.95 115.19 27.65 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.967 -1.083 . . . . 0.7 109.069 -178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.538 ' C ' ' H ' ' A' ' 223' ' ' VAL . 20.2 t0 -72.93 -47.15 48.1 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.597 -1.261 . . . . 2.31 107.597 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.819 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 52.7 5.52 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.814 -0.554 . . . . 0.78 109.791 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.538 ' H ' ' C ' ' A' ' 221' ' ' ASP . 69.5 t -116.59 -40.21 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 107.473 -1.306 . . . . 1.04 107.473 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -108.43 5.39 25.3 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 107.976 -1.12 . . . . 2.44 107.976 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.505 HD21 ' H ' ' A' ' 4' ' ' GLY . 1.4 t-20 59.37 49.37 8.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.85 -0.531 . . . . 1.55 110.011 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -138.49 150.9 46.89 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.382 -0.824 . . . . 1.99 109.444 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 49.7 t -119.25 129.77 74.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 108.066 -1.087 . . . . 0.77 108.066 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -99.75 119.13 37.66 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.063 -1.088 . . . . 0.98 108.063 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.476 HG22 HD22 ' A' ' 218' ' ' LEU . 56.1 t -101.39 116.44 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.505 -0.747 . . . . 0.85 110.595 -178.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 230' ' ' ASN . 16.9 t30 49.98 60.13 15.62 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 1.66 110.836 179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -85.69 149.68 9.93 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.571 2.181 . . . . 0.95 112.119 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 68.5 p -67.93 164.11 20.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.288 -0.882 . . . . 1.84 110.568 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -60.1 -38.74 83.84 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.84 -0.8 . . . . 2.74 108.84 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -59.97 -39.64 86.34 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.55 -0.719 . . . . 2.89 109.473 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.68 -40.09 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.019 -1.05 . . . . 1.3 109.968 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.09 -39.99 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.996 -1.065 . . . . 1.09 109.157 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -59.95 -39.74 86.61 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.879 -1.156 . . . . 2.43 107.879 178.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -59.9 -41.07 90.86 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.003 -1.11 . . . . 2.78 108.003 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.562 ' O ' ' N ' ' A' ' 242' ' ' VAL . 94.4 mtp -69.86 -78.51 0.07 Allowed 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 106.694 -1.595 . . . . 1.25 106.694 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.497 ' C ' ' O ' ' A' ' 239' ' ' MET . 28.4 mmt180 -21.77 -47.64 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 120.855 0.36 . . . . 2.63 111.901 -179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.484 ' N ' ' O ' ' A' ' 239' ' ' MET . . . -59.83 -50.93 71.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.866 -1.146 . . . . 1.8 109.151 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.562 ' N ' ' O ' ' A' ' 239' ' ' MET . 69.6 t -61.73 -37.34 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.466 -0.771 . . . . 2.13 109.079 179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -59.9 -39.97 87.2 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.402 -0.811 . . . . 3.17 109.71 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -59.92 -39.52 85.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.993 -1.067 . . . . 1.78 108.762 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -60.12 -38.69 83.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.396 -0.815 . . . . 2.47 109.444 179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 80.0 t -59.96 -41.79 87.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.369 -0.832 . . . . 2.09 109.72 -178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.84 -44.76 96.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.082 -1.011 . . . . 2.54 109.263 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.9 t -63.88 -38.56 91.55 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.392 -0.817 . . . . 2.99 109.374 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -60.01 -31.64 70.12 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.564 -0.71 . . . . 3.34 109.979 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -60.01 -40.14 88.22 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.135 -0.978 . . . . 3.88 109.672 -179.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -90.04 4.58 49.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.69 -1.256 . . . . 4.43 110.309 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 59.7 tt0 -94.85 15.55 18.27 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.012 -1.055 . . . . 5.42 108.769 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 89.1 mt -73.54 -10.38 59.65 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.851 -1.156 . . . . 6.1 108.779 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -67.39 -39.95 85.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.472 -0.768 . . . . 7.37 109.03 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.426 ' C ' ' H ' ' A' ' 257' ' ' LYS . 62.3 mttp -78.15 -156.22 0.09 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.372 -0.83 . . . . 8.01 109.765 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 71.8 mt -67.09 6.65 0.5 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.418 -0.801 . . . . 9.05 110.521 -179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 255' ' ' LYS . 45.4 mtpt 66.56 26.61 9.83 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.815 -0.553 . . . . 10.56 109.515 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 257' ' ' LYS . 7.6 p-10 40.13 69.94 0.28 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.636 -0.665 . . . . 11.32 110.424 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 21.7 tpt180 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.989 -1.005 . . . . 12.42 109.11 -179.936 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 3.3 ttt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.532 0.682 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -151.56 148.48 28.05 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.11 161.06 43.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.796 -1.19 . . . . 0.0 111.037 -178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -154.01 151.13 29.01 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 56.6 mp0 -106.96 132.71 52.6 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.275 -0.891 . . . . 0.0 109.248 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -134.3 122.0 39.02 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.354 0 CA-C-O 122.387 1.089 . . . . 0.0 112.74 -178.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . 0.486 ' O ' HG23 ' B' ' 309' ' ' THR . 29.4 m -79.27 106.84 11.59 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.671 -178.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.499 ' O ' ' N ' ' B' ' 358' ' ' GLY . 81.7 mt -51.97 117.14 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 122.135 0.969 . . . . 0.0 110.007 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . 0.486 HG23 ' O ' ' B' ' 307' ' ' THR . 77.4 p -106.91 18.68 21.5 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.462 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -75.39 116.69 57.06 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.067 -1.02 . . . . 0.0 108.949 179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_exo -51.96 -13.11 1.59 Allowed 'Trans proline' 0 N--CA 1.499 1.823 0 CA-C-N 120.261 1.129 . . . . 0.0 113.442 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -118.13 6.77 12.05 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.307 -0.871 . . . . 0.0 109.449 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.85 174.92 27.27 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.589 -1.804 . . . . 0.0 108.589 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 3.0 tp -85.05 96.07 9.3 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.03 -1.276 . . . . 0.0 108.59 -179.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -97.79 -160.18 0.79 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.052 -1.03 . . . . 0.0 110.082 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 9.2 m -59.0 -41.84 88.64 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.032 -1.042 . . . . 0.0 112.439 -176.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.508 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 1.4 tpt180 -60.4 -62.18 6.45 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 120.429 -1.42 . . . . 0.0 111.794 -178.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -57.9 -32.02 94.06 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.199 1.107 . . . . 0.0 111.461 -179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.92 -50.83 72.22 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.64 -41.6 63.89 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.441 -0.787 . . . . 0.0 109.25 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 64.9 tp60 -69.98 -41.3 74.6 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.167 -1.013 . . . . 0.0 108.7 178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -60.97 -51.96 67.04 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.471 -0.768 . . . . 0.0 110.435 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . 0.431 HG13 ' O ' ' B' ' 344' ' ' ALA . 70.0 t -68.36 -30.82 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.653 -1.279 . . . . 0.0 109.841 -179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 20.4 ttmt -59.99 -44.32 94.6 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.231 -0.988 . . . . 0.0 108.608 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -69.41 -40.72 77.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 110.646 -179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.1 -52.08 66.89 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.516 -1.365 . . . . 0.0 109.343 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 53.7 mttm -57.33 -15.23 5.81 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.598 -0.689 . . . . 0.0 109.193 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.96 -29.78 70.55 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -104.83 147.23 27.95 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.455 -1.027 . . . . 0.0 109.109 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 22.6 p -91.36 -12.93 33.5 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.841 -1.162 . . . . 0.0 109.585 179.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' B' ' 368' ' ' GLU . 5.8 m -59.46 152.52 21.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.297 -0.877 . . . . 0.0 109.663 -179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -70.78 134.1 47.11 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.165 -0.96 . . . . 0.0 108.681 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 86.2 mt -132.91 131.24 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.537 -0.727 . . . . 0.0 110.292 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 39.4 m -130.63 153.48 48.88 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 72.4 t -118.61 139.69 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 96.9 m -126.97 123.64 37.59 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.271 -0.893 . . . . 0.0 108.904 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 40.1 p -135.91 116.71 14.07 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.12 -0.988 . . . . 0.0 109.832 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . 0.44 ' O ' ' OD1' ' B' ' 338' ' ' ASN . 9.2 p30 39.95 69.05 0.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 178.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 72.31 -11.92 3.66 Favored Glycine 0 N--CA 1.5 2.966 0 O-C-N 120.762 -1.211 . . . . 0.0 113.411 176.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 27.1 mtmm -115.4 129.13 56.48 Favored 'General case' 0 N--CA 1.509 2.498 0 CA-C-N 119.473 1.637 . . . . 0.0 109.39 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 83.0 p -129.35 151.1 50.36 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-O 121.777 0.798 . . . . 0.0 110.699 -178.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -146.14 166.53 25.89 Favored 'General case' 0 N--CA 1.5 2.055 0 CA-C-O 121.595 0.712 . . . . 0.0 110.299 -179.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 34.3 t -89.38 140.09 29.86 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.554 -0.717 . . . . 0.0 110.061 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.431 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -77.57 -14.66 59.6 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.015 -1.053 . . . . 0.0 109.613 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . 0.401 ' O ' ' HG2' ' B' ' 345' ' ' LYS . 47.3 tttp -86.98 18.52 3.5 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 88.2 p -146.12 96.54 2.81 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.403 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.891 HD23 HD22 ' A' ' 79' ' ' LEU . 11.9 tp -60.01 -34.56 73.52 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.748 ' CE2' HD11 ' A' ' 79' ' ' LEU . 50.9 m-85 -59.74 -54.94 40.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.536 -0.727 . . . . 0.0 110.6 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -63.64 -40.07 95.94 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.705 -1.247 . . . . 0.0 109.007 -178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.594 ' O ' ' N ' ' B' ' 352' ' ' THR . 60.0 mt -52.18 -56.49 14.24 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.242 -0.983 . . . . 0.0 108.526 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -39.44 -14.55 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.872 -0.517 . . . . 0.0 111.758 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.594 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.1 p -93.24 -9.99 37.2 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.516 -1.365 . . . . 0.0 110.792 -179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 47.0 mt -94.36 119.94 33.85 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.854 -1.154 . . . . 0.0 109.914 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -71.02 94.23 0.52 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 85.0 mt -99.98 83.6 2.74 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.35 -1.088 . . . . 0.0 109.271 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 82.3 p -93.5 169.89 10.01 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.054 -1.029 . . . . 0.0 110.998 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -63.55 112.55 2.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.868 -0.52 . . . . 0.0 110.339 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 105.48 6.04 38.96 Favored Glycine 0 N--CA 1.497 2.767 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.0 m -84.81 108.16 17.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -1.204 . . . . 0.0 111.062 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 17.0 t -77.7 115.03 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-O 122.236 1.017 . . . . 0.0 109.491 -177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 32.7 m -115.23 178.45 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 81.6 m -128.87 131.28 47.63 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 176.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.9 mt -102.85 120.28 52.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 41.6 m -120.69 130.06 53.93 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.534 -0.729 . . . . 0.0 109.474 -179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.16 151.21 40.4 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.396 -0.815 . . . . 0.0 109.498 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -147.16 122.34 10.18 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.461 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 160.23 -153.56 24.51 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 118.767 -1.683 . . . . 0.0 111.827 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . 0.517 ' N ' ' OG ' ' B' ' 331' ' ' SER . 85.5 tt0 -60.04 -50.42 73.78 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 122.203 -0.587 . . . . 0.0 112.22 -177.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.439 ' N ' ' OG ' ' B' ' 331' ' ' SER . 85.8 m-20 -112.59 12.3 19.82 Favored 'General case' 0 N--CA 1.505 2.313 0 O-C-N 120.924 -1.11 . . . . 0.0 111.628 -177.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.0 OUTLIER -39.65 -33.65 0.19 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.179 -0.951 . . . . 0.0 111.653 -178.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . 0.49 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 12.2 pt20 -65.7 -54.03 32.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.763 -1.211 . . . . 0.0 110.404 -178.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -64.43 -49.38 71.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.622 -1.299 . . . . 0.0 108.619 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -41.48 -42.27 2.3 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.724 -0.61 . . . . 0.0 111.186 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.535 ' O ' HG23 ' B' ' 378' ' ' VAL . 76.3 t -74.71 -36.89 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.546 -1.346 . . . . 0.0 109.574 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -63.19 -64.93 0.77 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.01 -1.056 . . . . 0.0 110.498 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . 0.438 ' O ' ' N ' ' B' ' 380' ' ' LEU . 34.4 m170 -59.97 -45.31 93.11 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.776 -1.202 . . . . 0.0 112.07 -177.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.4 mt -60.0 -40.22 88.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.394 -1.441 . . . . 0.0 108.568 -178.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.535 HG23 ' O ' ' B' ' 374' ' ' VAL . 46.0 t -64.81 -49.54 79.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.228 -0.92 . . . . 0.0 110.164 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -80.17 -9.68 59.73 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.817 -1.177 . . . . 0.0 110.407 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' B' ' 376' ' ' HIS . 56.7 tp -83.34 -27.92 29.38 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 41.6 ttm -80.46 -30.07 37.5 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.065 178.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -84.82 -7.66 59.1 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.54 -0.725 . . . . 0.0 109.837 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -110.21 -2.96 16.56 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.253 -0.904 . . . . 0.0 110.029 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 22.0 mt -90.98 125.63 35.84 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.011 -1.056 . . . . 0.0 109.091 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 117.917 -1.039 . . . . 0.0 109.597 -179.862 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.4 mtt . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.424 0.63 . . . . 2.91 109.777 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.5 mt -110.1 130.12 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 109.229 -0.656 . . . . 1.2 109.229 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.431 ' CB ' ' OD1' ' A' ' 225' ' ' ASN . 61.9 m -137.13 153.54 50.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.379 -0.825 . . . . 1.4 109.681 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.85 -158.17 8.1 Favored Glycine 0 N--CA 1.498 2.82 0 N-CA-C 108.47 -1.852 . . . . 1.05 108.47 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.418 ' O ' ' O ' ' A' ' 6' ' ' LEU . 82.3 mt -90.43 -18.56 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.751 -1.44 . . . . 1.15 109.568 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.45 HD21 ' O ' ' A' ' 222' ' ' ALA . 59.1 tp 44.01 93.65 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.167 -0.958 . . . . 0.98 110.366 179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.41 -22.66 18.16 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.954 -1.091 . . . . 0.88 109.267 179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 70.7 m -121.06 112.4 33.37 Favored Pre-proline 0 N--CA 1.504 2.244 0 O-C-N 121.463 -0.773 . . . . 1.69 109.53 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -80.94 151.35 18.57 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 122.027 1.818 . . . . 0.85 112.408 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.828 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 145.92 175.84 19.3 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 108.959 -1.656 . . . . 0.92 108.959 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 12' ' ' ALA . 97.0 mt -120.72 155.7 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 O-C-N 121.427 -1.043 . . . . 0.81 109.609 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.413 ' N ' HG22 ' A' ' 11' ' ' ILE . . . -154.19 155.26 34.96 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.057 -1.027 . . . . 0.51 110.326 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.519 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 5.3 m-85 -135.28 126.37 27.92 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.012 -1.107 . . . . 0.62 108.012 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.29 -179.21 48.18 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 118.642 -1.742 . . . . 0.55 110.907 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -79.97 158.09 26.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.985 -0.715 . . . . 2.1 109.822 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.591 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -106.44 125.51 51.1 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.531 -0.731 . . . . 0.77 110.469 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 66.5 tp -97.53 136.76 37.49 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.03 -1.1 . . . . 0.91 108.03 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.9 tp -120.39 128.02 52.83 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.486 -0.759 . . . . 0.93 109.385 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 89.3 mt -89.86 107.51 19.15 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.485 -0.76 . . . . 0.93 110.278 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -100.12 129.87 46.2 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.145 -1.057 . . . . 2.75 108.145 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 81.6 tt0 -130.95 139.76 50.09 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.185 -0.947 . . . . 3.0 109.712 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 52.9 t0 -81.85 143.89 31.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.364 -0.835 . . . . 2.77 109.088 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.482 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 86.9 tt0 -64.88 140.41 58.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.145 -0.972 . . . . 2.94 109.493 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.7 mt -81.68 135.3 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.331 -0.855 . . . . 0.95 108.818 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.2 t -110.75 128.89 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.368 -0.832 . . . . 1.28 110.093 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.0 mt -98.06 143.23 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.483 -0.932 . . . . 1.21 108.483 179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -94.85 121.43 36.44 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.865 -1.147 . . . . 1.81 109.738 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.436 HH11 ' HG3' ' A' ' 28' ' ' ARG . 21.8 mmm-85 -88.02 -0.31 56.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.583 -0.698 . . . . 2.8 109.553 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.52 139.65 58.5 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.071 -1.018 . . . . 2.87 108.761 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -85.26 149.99 25.1 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.044 -1.035 . . . . 2.35 109.376 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.483 HG21 ' HG3' ' A' ' 39' ' ' GLU . 5.4 pt -91.48 165.15 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.97 109.494 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.2 p -97.2 172.56 7.73 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.15 -0.968 . . . . 1.17 108.464 178.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -49.56 77.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.952 -1.093 . . . . 1.18 109.355 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.05 -29.64 57.91 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 120.71 -1.243 . . . . 2.56 109.311 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -81.87 -9.62 59.54 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.256 -0.902 . . . . 1.79 109.971 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.9 t -65.37 -54.54 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.695 -1.253 . . . . 1.0 109.157 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.05 -39.98 87.83 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.294 -0.879 . . . . 1.77 109.56 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -67.82 -44.91 76.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.177 -0.952 . . . . 2.7 110.347 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.483 ' HG3' HG21 ' A' ' 31' ' ' ILE . 64.1 mm-40 -61.28 -41.02 96.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.915 -1.116 . . . . 1.51 110.44 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -64.37 -47.16 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.66 -1.275 . . . . 0.93 107.957 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -62.11 -47.57 84.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.552 -0.717 . . . . 1.81 109.697 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -60.1 -41.42 92.47 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.621 -1.252 . . . . 2.78 107.621 179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -64.53 -46.34 83.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.69 -0.631 . . . . 0.78 109.341 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 48' ' ' ALA . 63.6 tp -59.86 -44.84 93.92 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.508 -0.923 . . . . 1.07 108.508 -179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.5 t -65.03 -44.02 90.47 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.441 -0.904 . . . . 1.12 109.007 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.39 -43.13 95.47 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 108.282 -1.927 . . . . 0.84 108.282 179.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.493 ' NH2' ' O ' ' A' ' 80' ' ' LEU . 68.1 ttt180 -66.4 -37.0 84.24 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.01 -1.107 . . . . 3.09 108.01 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.417 ' N ' ' O ' ' A' ' 44' ' ' LEU . . . -60.0 -39.76 86.88 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.921 -0.77 . . . . 0.88 108.921 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 50' ' ' ALA . 18.0 ttpp -60.06 -73.64 0.09 Allowed 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.108 -0.995 . . . . 2.59 108.486 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.67 -33.95 0.09 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.163 -0.961 . . . . 0.7 111.944 -177.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.0 m -60.0 -49.79 76.3 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.361 -1.462 . . . . 1.4 108.586 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.82 -40.06 79.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.853 . . . . 0.67 110.725 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -65.86 -40.09 91.34 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.897 -1.127 . . . . 1.66 110.021 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 37.0 mt -60.73 -39.95 90.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.093 -1.004 . . . . 1.58 108.687 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -59.98 -39.71 86.62 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.618 -0.676 . . . . 1.35 110.168 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 93.9 m -63.93 -43.38 96.05 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.72 -1.237 . . . . 0.77 108.609 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.532 ' CD1' HH22 ' A' ' 136' ' ' ARG . 82.3 mt -61.18 -39.94 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.464 -0.772 . . . . 0.63 109.027 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -56.63 -49.99 73.36 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.475 -0.935 . . . . 1.14 108.475 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -59.91 -35.21 74.38 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.675 -0.641 . . . . 0.79 110.464 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -68.16 -39.92 82.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.858 -1.151 . . . . 1.53 109.627 -179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.75 -43.98 82.68 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.574 -0.704 . . . . 0.57 110.097 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.01 -51.11 60.91 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 119.905 -1.14 . . . . 0.75 110.394 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -70.09 -44.72 68.49 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.09 -1.241 . . . . 1.59 109.966 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.9 m -67.17 -62.46 1.42 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.936 . . . . 0.73 112.178 -177.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -94.65 -49.13 5.77 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.905 -1.122 . . . . 0.75 111.058 -178.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.79 -169.6 25.17 Favored Glycine 0 N--CA 1.502 3.043 0 C-N-CA 119.702 -1.237 . . . . 1.22 111.445 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -66.71 -26.32 66.96 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.939 -0.742 . . . . 5.81 110.109 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.12 -36.19 76.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.292 -0.88 . . . . 3.37 110.36 -179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.504 ' HA ' HD12 ' A' ' 72' ' ' ILE . 66.8 mmtt -97.23 -17.51 19.8 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.234 -0.916 . . . . 1.77 109.961 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 76.1 tt0 -71.34 -42.79 68.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.054 -1.029 . . . . 1.65 110.264 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.603 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.5 -28.41 69.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.542 -0.724 . . . . 0.77 109.756 -179.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 69' ' ' LYS . 81.9 mt -60.06 -40.76 84.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.095 -1.003 . . . . 0.8 108.9 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -69.99 -37.14 75.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.246 -0.909 . . . . 0.88 111.248 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.442 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 65.0 tt0 -60.01 -40.37 89.03 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.626 -1.296 . . . . 1.37 109.63 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.63 -43.2 96.78 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.932 -1.667 . . . . 0.62 108.932 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -60.74 -45.19 95.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.306 -1.114 . . . . 1.5 109.14 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.2 mt -68.75 -47.19 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.202 -0.936 . . . . 0.63 109.786 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 46.7 ttp -60.0 -43.35 95.27 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 120.964 -1.085 . . . . 1.51 110.031 -178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.907 HD22 HD23 ' B' ' 347' ' ' LEU . 34.1 tp -60.25 -39.94 88.56 Favored 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.445 -0.785 . . . . 0.77 109.565 179.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.493 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 58.8 tp -61.67 -39.89 93.0 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.726 -0.608 . . . . 0.62 110.074 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.16 9.93 7.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.166 -0.959 . . . . 1.47 110.913 -178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -53.88 130.85 38.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.66 -1.275 . . . . 1.47 109.704 -179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -57.73 -21.02 38.69 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.498 -0.751 . . . . 1.78 110.395 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -70.49 -34.43 72.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.004 -1.06 . . . . 2.53 108.991 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 44.9 mt -69.99 -40.51 75.27 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.634 -0.666 . . . . 0.8 109.827 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.15 -47.14 87.15 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.151 -0.968 . . . . 1.42 110.45 -179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 -69.91 -42.8 72.87 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.121 -0.987 . . . . 1.71 111.323 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -70.1 -39.98 75.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.992 -1.068 . . . . 1.57 111.171 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 91.4 mt -66.6 -49.57 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.976 -1.077 . . . . 0.65 109.668 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.462 HG23 ' HZ2' ' A' ' 94' ' ' LYS . 84.8 mt -69.66 -39.96 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.587 -0.696 . . . . 0.82 110.521 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.0 -47.86 84.1 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.081 -1.012 . . . . 0.79 110.888 -178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 82.2 mt -60.06 -46.84 88.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.987 -1.071 . . . . 0.95 109.897 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.48 -49.54 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.227 -0.921 . . . . 0.66 109.711 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.462 ' HZ2' HG23 ' A' ' 90' ' ' ILE . 54.2 mttp -69.91 -45.84 66.69 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.419 -0.801 . . . . 2.2 111.173 -179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -80.16 -49.55 11.53 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.998 -1.063 . . . . 1.65 112.148 -178.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -91.13 -3.62 56.92 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.938 -1.101 . . . . 2.03 111.944 -177.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 54.73 36.23 25.8 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.752 -1.217 . . . . 1.42 109.209 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 51.3 mtt -87.24 169.77 12.04 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.541 -0.725 . . . . 1.18 109.399 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 65.6 p -80.53 156.76 26.35 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.187 -0.946 . . . . 0.98 108.915 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.98 -39.97 75.64 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.229 -0.919 . . . . 0.64 109.344 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -63.16 -40.08 96.53 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.897 . . . . 2.07 109.82 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.44 -49.32 10.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.215 -0.928 . . . . 0.73 109.87 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.49 -41.34 96.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.477 -0.764 . . . . 0.54 110.555 -179.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -65.09 -54.02 36.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.927 -1.108 . . . . 0.56 110.349 -179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -63.15 -27.75 69.59 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.037 -1.039 . . . . 1.54 109.344 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.12 -40.12 88.59 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.286 -0.883 . . . . 1.33 109.39 -179.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.5 t -70.26 -46.64 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 120.969 -1.082 . . . . 0.72 109.407 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.9 mm -61.15 -41.89 91.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.31 -0.869 . . . . 0.85 109.187 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -68.99 -34.3 75.08 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.153 -1.055 . . . . 2.44 108.153 179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.48 -45.17 95.97 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 110.301 -1.12 . . . . 0.98 110.301 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -69.98 -46.85 64.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.755 -1.438 . . . . 1.41 109.807 -179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.76 -40.01 86.77 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.294 -0.879 . . . . 1.2 109.909 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 58.0 m -60.01 -40.09 88.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.052 -1.03 . . . . 1.7 109.441 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.6 -38.72 91.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 1.47 109.3 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 127' ' ' ALA . 20.1 mt -63.75 -40.08 95.85 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.072 -1.018 . . . . 1.56 109.581 -179.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -58.35 -31.21 67.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.81 -1.181 . . . . 2.2 109.542 -179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -58.66 -25.59 62.92 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.339 -0.986 . . . . 2.12 108.339 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.442 HD13 HD13 ' A' ' 123' ' ' LEU . 44.0 mt -62.71 144.71 56.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.294 -0.878 . . . . 2.0 108.805 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -96.54 45.4 1.06 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.089 -1.007 . . . . 3.23 109.92 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 51.4 t0 -136.05 146.14 46.78 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.253 -0.904 . . . . 2.49 109.604 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.538 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 0.3 OUTLIER -73.9 -63.6 1.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.569 -0.9 . . . . 3.95 108.569 178.319 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.496 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.0 t80 -39.23 -41.73 0.9 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.905 -0.497 . . . . 2.0 111.187 -179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.442 HD13 HD13 ' A' ' 118' ' ' LEU . 91.4 mt -70.02 -40.01 75.45 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.64 -1.287 . . . . 1.86 108.651 179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.432 ' N ' ' O ' ' A' ' 121' ' ' GLU . 33.4 ttmt -62.38 -39.87 94.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.451 -0.781 . . . . 2.84 109.836 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.44 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 98.9 mt-10 -60.07 -40.91 91.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.236 -0.915 . . . . 2.73 110.225 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -62.09 -39.97 94.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.971 -1.081 . . . . 2.77 108.816 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.45 ' HB2' HD12 ' A' ' 115' ' ' LEU . . . -63.22 -28.47 70.06 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.507 -0.923 . . . . 1.19 108.507 179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -60.02 -42.04 93.46 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.323 -0.992 . . . . 1.2 108.323 179.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.59 -40.01 95.86 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.586 -0.894 . . . . 1.55 108.586 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.8 t -66.26 -40.06 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 108.884 -0.784 . . . . 0.8 108.884 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.415 HH11 ' HG2' ' A' ' 131' ' ' ARG . 36.3 ttt-85 -60.56 -37.35 80.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.334 -0.854 . . . . 3.09 108.963 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -60.01 -42.74 94.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.419 -0.801 . . . . 1.46 109.992 -179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.0 -47.63 91.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.822 -1.174 . . . . 0.71 109.322 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -59.94 -41.06 97.67 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.302 -1.519 . . . . 0.57 109.302 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -60.15 -49.86 75.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.352 -1.087 . . . . 2.59 109.671 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.532 HH22 ' CD1' ' A' ' 57' ' ' ILE . 63.3 mtp180 -64.59 -36.04 82.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 2.83 110.333 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.94 -44.39 94.39 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.419 -0.8 . . . . 1.25 109.371 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.25 -42.59 95.64 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.174 -0.954 . . . . 0.7 110.095 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 83.7 mtm180 -72.63 -35.85 67.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.052 -1.03 . . . . 2.57 109.288 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -60.06 -39.84 87.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.609 -0.682 . . . . 1.23 110.845 -178.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 86.0 mt -74.98 -42.59 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.844 -1.16 . . . . 0.81 109.736 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.4 mt -69.99 -29.95 67.17 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.574 -0.704 . . . . 1.0 109.934 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.46 40.6 10.89 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.74 -1.744 . . . . 0.89 108.74 -179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.3 tp -73.02 148.45 44.14 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.474 -1.015 . . . . 1.14 109.004 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 23.2 ttpt -68.47 148.45 50.59 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.189 -0.944 . . . . 4.6 110.426 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.8 mt -119.98 122.67 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 CA-C-O 121.989 0.899 . . . . 1.24 109.709 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 4.9 mt -61.0 -42.5 93.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 109.28 -0.637 . . . . 1.54 109.28 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.9 t0 62.47 123.92 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.779 -0.576 . . . . 1.5 110.125 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.505 ' O ' HD12 ' A' ' 152' ' ' ILE . 83.4 mt -78.13 -5.78 52.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 0.79 108.68 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.8 t -81.84 -10.07 59.42 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.683 -0.858 . . . . 1.4 108.683 178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.74 19.71 1.28 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.754 -0.591 . . . . 0.92 110.109 -178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.505 HD12 ' O ' ' A' ' 149' ' ' LEU . 56.3 mt -91.58 120.69 41.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 121.253 -0.905 . . . . 0.88 109.161 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -108.01 -8.53 15.85 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.356 -0.84 . . . . 2.45 109.874 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -129.57 152.07 49.49 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.413 -0.805 . . . . 1.52 109.884 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.15 133.51 53.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -0.91 . . . . 1.58 108.872 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.5 m -152.83 166.35 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.402 -0.812 . . . . 0.69 109.757 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.3 mt -93.06 147.94 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 106.015 -1.846 . . . . 0.61 106.015 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.9 tp -102.13 117.61 35.14 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.052 -1.03 . . . . 0.87 109.9 -178.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 5.7 t -125.02 134.31 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 N-CA-C 108.36 -0.978 . . . . 0.71 108.36 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -161.81 168.63 22.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.113 -0.992 . . . . 0.81 109.14 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.91 -38.26 69.93 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 120.318 -1.489 . . . . 0.98 107.941 178.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.3 p-10 -171.17 145.58 2.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.599 -0.688 . . . . 2.25 109.486 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.2 mt -115.91 137.46 52.08 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.415 -0.803 . . . . 0.78 109.615 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.2 p -91.22 149.97 40.71 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.233 -0.917 . . . . 0.98 109.512 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -42.36 -36.99 4.77 Favored 'Trans proline' 0 N--CA 1.497 1.713 0 C-N-CA 122.488 2.126 . . . . 0.81 113.564 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 72.3 m -59.99 -40.05 87.83 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.881 -1.137 . . . . 0.9 109.314 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.75 -43.09 89.99 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.148 -0.97 . . . . 1.61 109.432 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 79.1 p -59.1 -19.57 45.71 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.39 -0.819 . . . . 0.61 111.555 -177.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -83.86 -46.72 11.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.769 -1.207 . . . . 0.6 110.26 -179.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -90.73 39.32 0.98 Allowed 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.312 -0.996 . . . . 1.4 108.312 179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.459 HD13 HD13 ' A' ' 149' ' ' LEU . 56.6 tp -105.6 137.1 44.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.567 -0.708 . . . . 0.7 110.231 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -89.91 101.57 14.27 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.285 -0.884 . . . . 2.35 108.872 178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 95.5 mt -62.32 -39.99 94.84 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.385 -0.822 . . . . 1.51 111.109 -178.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -66.54 -24.22 66.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.115 -0.991 . . . . 2.33 111.543 -177.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -93.74 -10.96 32.52 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.706 -1.246 . . . . 1.92 110.358 -179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.521 HG11 ' CE1' ' A' ' 179' ' ' PHE . 80.4 t -102.76 112.77 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 O-C-N 121.099 -1.001 . . . . 0.67 109.355 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.7 mt -83.62 3.8 31.18 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.252 -0.905 . . . . 1.53 110.354 -178.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.509 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 173.38 169.91 36.33 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.554 -1.418 . . . . 0.48 109.554 179.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.521 ' CE1' HG11 ' A' ' 176' ' ' VAL . 7.0 m-85 -134.47 130.23 36.39 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.395 -1.062 . . . . 0.55 108.517 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.423 ' CG2' HG21 ' A' ' 205' ' ' THR . 67.2 mt -130.45 125.48 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 108.567 -0.901 . . . . 0.65 108.567 178.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 7.7 p -143.07 154.33 43.84 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.21 -0.931 . . . . 0.82 111.046 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -106.28 27.88 8.27 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.797 -0.816 . . . . 2.46 108.797 179.279 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.04 -157.61 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.825 -1.172 . . . . 1.28 111.908 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -53.4 -80.98 0.06 OUTLIER Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.863 -1.295 . . . . 2.19 109.863 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . 0.45 ' O ' ' OG ' ' A' ' 191' ' ' SER . . . -178.3 -131.97 1.64 Allowed Glycine 0 N--CA 1.488 2.1 0 C-N-CA 119.424 -1.369 . . . . 2.13 110.286 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.402 ' NH1' ' HG3' ' A' ' 186' ' ' ARG . 7.1 ptm180 -73.28 -10.53 59.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.628 -0.925 . . . . 5.86 111.122 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 51.7 p -92.83 7.84 42.08 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.804 -1.185 . . . . 3.72 110.984 -178.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 78.7 p -89.08 143.43 26.85 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.733 -1.23 . . . . 1.74 110.124 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.4 t60 -47.37 -47.48 26.08 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.383 -0.823 . . . . 0.95 109.338 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 67.0 m -56.53 -39.64 73.72 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.742 -0.599 . . . . 1.55 109.857 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.45 ' OG ' ' O ' ' A' ' 185' ' ' GLY . 53.7 m -59.89 -40.04 87.39 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.98 -1.075 . . . . 1.51 110.923 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 89.1 mt -60.06 -41.26 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.1 -1.0 . . . . 1.67 110.161 -178.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.8 mtp -60.07 -50.37 73.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.093 -1.005 . . . . 1.02 111.116 -178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -50.94 -45.41 60.6 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 120.908 -1.12 . . . . 0.68 109.646 -178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -60.03 -51.65 68.75 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.07 -1.052 . . . . 2.93 109.733 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 19.8 m -71.99 -35.06 69.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.075 -1.016 . . . . 0.86 110.86 -178.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 93.9 mt -71.46 -30.02 65.53 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.645 -1.284 . . . . 0.67 108.318 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 66.4 49.8 1.37 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.357 0.598 . . . . 1.5 110.138 -179.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.445 ' O ' ' CB ' ' A' ' 8' ' ' SER . 86.1 mt -127.77 141.39 40.94 Favored Pre-proline 0 N--CA 1.503 2.215 0 N-CA-C 108.677 -0.86 . . . . 0.72 108.677 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -44.37 128.42 8.01 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 121.94 1.76 . . . . 0.61 112.039 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -164.8 141.51 6.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.875 -1.141 . . . . 0.66 111.471 -179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.2 mt -123.76 142.3 40.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.069 -1.456 . . . . 0.79 107.069 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 18.2 m -126.01 -12.03 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.347 0 O-C-N 120.952 -1.092 . . . . 0.91 111.382 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -106.11 23.06 29.95 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.014 -1.234 . . . . 1.01 110.014 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.435 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 2.8 p -44.91 -43.58 9.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -1.129 . . . . 0.99 110.083 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.76 -55.38 4.11 Favored Glycine 0 N--CA 1.498 2.805 0 C-N-CA 119.964 -1.112 . . . . 1.12 111.881 178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 35.1 m -153.04 36.08 0.48 Allowed 'General case' 0 N--CA 1.503 2.196 0 O-C-N 120.56 -1.553 . . . . 1.72 111.479 -178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.5 t -72.39 -40.15 63.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.914 -1.116 . . . . 0.89 108.53 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 38.3 p -52.98 -25.49 12.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.57 -0.706 . . . . 1.03 110.233 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 68.7 m -77.45 -30.91 53.5 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.037 -1.039 . . . . 1.83 110.551 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -93.33 -9.29 39.4 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.969 -1.082 . . . . 2.27 111.127 -178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.8 t -105.88 134.77 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.161 0 O-C-N 121.13 -0.981 . . . . 0.92 111.077 -178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -111.2 154.89 23.75 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.146 -1.427 . . . . 2.2 107.146 178.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 57.8 t-20 -59.87 138.9 57.69 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.781 -1.199 . . . . 2.36 109.728 -179.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.474 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 7.7 t0 80.76 6.47 1.43 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-O 121.015 0.436 . . . . 2.38 110.172 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 63.6 t0 -71.97 128.96 37.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.029 -1.045 . . . . 2.09 109.059 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -79.45 114.78 18.65 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 107.914 -1.143 . . . . 1.27 107.914 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.591 HD12 ' HB2' ' A' ' 16' ' ' ALA . 75.1 mt -127.04 150.56 49.39 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.526 -0.734 . . . . 0.75 110.508 -178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.3 mt -116.35 128.94 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 106.043 -1.836 . . . . 0.63 106.043 177.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 31.5 tp -99.98 118.85 37.25 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.794 -1.191 . . . . 0.7 108.194 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.54 ' O ' ' N ' ' A' ' 223' ' ' VAL . 20.7 t0 -80.66 -39.94 26.41 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 120.889 -1.132 . . . . 2.31 108.275 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.828 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 43.13 19.28 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.533 0.682 . . . . 0.78 109.377 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.54 ' N ' ' O ' ' A' ' 221' ' ' ASP . 25.4 t -134.32 -42.99 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 107.356 -1.35 . . . . 1.04 107.356 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -100.03 2.99 43.89 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 107.293 -1.373 . . . . 2.44 107.293 178.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.431 ' OD1' ' CB ' ' A' ' 3' ' ' SER . 9.8 t-20 59.96 48.5 8.69 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.506 -0.553 . . . . 1.55 109.506 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -142.0 150.37 41.24 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.158 -0.964 . . . . 1.99 110.29 -179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.4 t -119.96 128.75 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 107.84 -1.17 . . . . 0.77 107.84 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -104.96 120.05 40.5 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.285 -0.884 . . . . 0.98 108.913 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.423 HG22 HD22 ' A' ' 218' ' ' LEU . 46.4 t -100.28 114.7 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.503 -0.748 . . . . 0.85 110.194 -178.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 50.96 69.11 2.78 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.272 -0.892 . . . . 1.66 110.819 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -90.43 144.16 3.87 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.298 2.665 . . . . 0.95 112.135 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 5.2 m -68.59 164.16 22.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.234 -0.916 . . . . 1.84 110.14 -179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -59.96 -36.74 77.74 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.532 -0.73 . . . . 2.74 110.051 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.03 -39.56 86.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 2.89 109.466 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 78.8 t -70.67 -36.09 63.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.014 -1.054 . . . . 1.3 109.451 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.464 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 96.8 mt -70.09 -40.03 77.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.117 -0.989 . . . . 1.09 109.774 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -60.05 -40.42 89.36 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.03 -1.044 . . . . 2.43 108.209 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -62.55 -39.16 92.76 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.311 0.577 . . . . 2.78 109.774 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 98.1 mtp -82.49 -19.31 39.04 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.137 -0.977 . . . . 1.25 110.48 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.498 HH11 ' HG2' ' A' ' 240' ' ' ARG . 0.6 OUTLIER -70.8 -39.97 72.79 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.784 -1.197 . . . . 2.63 109.125 179.127 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.15 -40.16 82.44 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.255 -1.017 . . . . 1.8 108.255 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.14 -38.72 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.397 -0.964 . . . . 2.13 108.397 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -60.0 -40.59 89.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.35 -0.844 . . . . 3.17 109.206 -179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.01 -40.03 87.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.065 -1.022 . . . . 1.78 108.381 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -64.86 -39.87 94.25 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.506 -0.746 . . . . 2.47 109.216 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 54.8 t -59.97 -40.47 83.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.501 -0.749 . . . . 2.09 109.897 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.97 -40.98 90.95 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.209 -0.932 . . . . 2.54 109.188 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 66.9 m -60.03 -40.1 88.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.38 -0.825 . . . . 2.99 109.715 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -60.06 -40.0 87.97 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.258 -0.901 . . . . 3.34 109.607 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.454 ' O ' ' CD2' ' A' ' 253' ' ' LEU . 68.3 mttm -72.42 0.71 9.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.218 -0.926 . . . . 3.88 109.5 -179.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -108.36 18.32 21.15 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.675 -0.641 . . . . 4.43 109.336 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -127.28 28.08 5.78 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.565 -0.709 . . . . 5.42 109.741 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.544 HD23 ' H ' ' A' ' 253' ' ' LEU . 0.0 OUTLIER -63.46 -47.57 81.28 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.995 -1.066 . . . . 6.1 109.306 -179.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 42.59 25.26 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.446 -0.784 . . . . 7.37 110.324 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 253' ' ' LEU . 35.6 ttpt -172.61 -21.11 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.096 -1.002 . . . . 8.01 110.07 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.474 ' C ' HD23 ' A' ' 256' ' ' LEU . 4.0 tt -81.25 88.46 6.05 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.152 -0.968 . . . . 9.05 109.808 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 41.2 mmtm -109.32 5.17 23.37 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 107.195 -1.409 . . . . 10.56 107.195 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -62.41 -64.32 0.96 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.853 -0.795 . . . . 11.32 108.853 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 . . . . . 0 N--CA 1.498 1.948 0 CA-C-O 118.036 -0.983 . . . . 12.42 109.349 -179.808 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.564 0.697 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 19.0 t80 -152.64 151.4 30.55 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . 0.466 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 12.9 pt20 -145.58 155.04 42.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.995 -1.065 . . . . 0.0 110.708 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' B' ' 305' ' ' GLU . 12.5 tm0? -149.58 145.34 26.75 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . 0.506 ' O ' ' NE2' ' B' ' 304' ' ' GLN . 39.2 mp0 -109.09 131.8 54.72 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.067 -1.02 . . . . 0.0 110.46 -179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.07 119.12 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 CA-C-O 122.077 0.941 . . . . 0.0 112.452 -177.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 35.6 m -77.3 104.65 7.93 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.99 0.9 . . . . 0.0 111.024 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.8 mt -53.03 123.87 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 CA-C-O 122.318 1.056 . . . . 0.0 110.729 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 71.9 p -111.37 20.11 17.59 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.257 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.14 120.39 80.01 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 120.831 -1.168 . . . . 0.0 109.682 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -49.57 -21.5 5.34 Favored 'Trans proline' 0 N--CA 1.498 1.754 0 CA-C-N 120.137 1.084 . . . . 0.0 113.069 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -120.74 13.7 11.6 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.46 -0.775 . . . . 0.0 109.775 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.34 -178.6 37.83 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.496 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -84.42 91.06 7.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.111 -1.229 . . . . 0.0 110.191 -178.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -95.35 -160.35 0.78 Allowed 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.673 -1.267 . . . . 0.0 109.995 178.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 5.3 m -59.61 -40.6 88.08 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.847 -1.158 . . . . 0.0 112.492 -175.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.603 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.2 tpt180 -62.75 -61.74 6.96 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 120.329 -1.482 . . . . 0.0 112.069 -178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.05 -30.32 93.0 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 CA-C-N 120.151 1.09 . . . . 0.0 111.824 -179.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.05 -50.53 73.36 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.55 -39.32 61.3 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.344 -0.848 . . . . 0.0 109.431 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -68.99 -43.83 74.09 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 120.998 -1.064 . . . . 0.0 108.342 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -60.04 -52.27 66.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.439 -0.788 . . . . 0.0 110.984 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . 0.43 HG13 ' O ' ' B' ' 344' ' ' ALA . 72.1 t -68.42 -28.92 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 120.728 -1.232 . . . . 0.0 110.7 -178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.442 ' NZ ' ' OE1' ' A' ' 74' ' ' GLU . 24.7 ttmt -61.77 -45.8 92.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.109 -0.994 . . . . 0.0 110.252 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -69.97 -40.05 75.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.987 -1.07 . . . . 0.0 111.417 -178.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -61.53 -52.8 62.97 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.469 -1.394 . . . . 0.0 110.26 -179.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -53.34 -11.23 0.28 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.169 -0.957 . . . . 0.0 109.648 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -75.93 -25.62 66.49 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 108.866 -1.694 . . . . 0.0 108.866 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -105.05 141.1 37.21 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.629 -0.924 . . . . 0.0 108.798 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . 0.421 HG22 ' O ' ' B' ' 330' ' ' THR . 89.7 m -89.94 -10.51 44.84 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.941 -1.099 . . . . 0.0 109.871 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.597 ' HG ' ' H ' ' B' ' 369' ' ' ASP . 75.6 m -61.49 149.62 38.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.087 -1.008 . . . . 0.0 109.705 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -67.67 132.77 48.11 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.0 mt -133.33 134.17 57.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.653 -0.654 . . . . 0.0 109.564 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . 0.433 HG22 ' N ' ' B' ' 335' ' ' VAL . 51.5 m -131.68 155.04 48.33 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.308 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . 0.433 ' N ' HG22 ' B' ' 334' ' ' THR . 75.9 t -117.41 140.02 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 70.2 m -130.47 122.25 27.34 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.217 -0.927 . . . . 0.0 109.22 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 1.8 m -140.21 120.22 13.65 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 122.054 0.93 . . . . 0.0 110.657 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 47.56 57.8 5.56 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 177.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 75.28 -11.55 8.58 Favored Glycine 0 N--CA 1.498 2.787 0 O-C-N 120.19 -1.569 . . . . 0.0 112.52 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -114.43 125.1 53.45 Favored 'General case' 0 N--CA 1.502 2.174 0 CA-C-N 118.923 1.361 . . . . 0.0 109.289 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 51.8 m -126.56 148.32 49.76 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-O 121.616 0.722 . . . . 0.0 110.196 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.77 167.44 22.58 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 121.515 0.674 . . . . 0.0 109.955 -179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 19.8 m -87.09 139.05 30.96 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.43 -0.794 . . . . 0.0 109.595 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.43 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -78.7 -14.27 59.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.001 -1.062 . . . . 0.0 109.195 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -86.81 18.19 3.6 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 61.2 m -145.27 93.23 2.35 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.601 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.907 HD23 HD22 ' A' ' 79' ' ' LEU . 13.4 tp -55.74 -36.66 67.52 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.238 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.746 ' CE2' HD11 ' A' ' 79' ' ' LEU . 47.1 m-85 -58.69 -52.52 65.32 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 110.165 -179.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -68.68 -21.11 64.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.992 -1.067 . . . . 0.0 110.987 -177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.564 ' O ' ' N ' ' B' ' 352' ' ' THR . 90.2 mt -69.94 -52.16 26.82 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.532 -1.355 . . . . 0.0 108.523 178.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.507 ' NE2' ' O ' ' B' ' 347' ' ' LEU . 0.1 OUTLIER -39.21 -18.85 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.817 -0.552 . . . . 0.0 111.07 -178.301 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.564 ' N ' ' O ' ' B' ' 350' ' ' LEU . 71.1 p -85.92 -11.12 53.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.225 -1.547 . . . . 0.0 110.647 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 42.3 mt -94.82 116.95 29.36 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.931 -1.106 . . . . 0.0 109.247 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.94 94.23 0.98 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 24.1 mt -103.31 94.58 5.58 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.453 -1.028 . . . . 0.0 108.947 179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 43.3 p -93.3 161.01 14.57 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.101 -0.999 . . . . 0.0 110.427 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -54.22 119.36 5.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.551 -0.718 . . . . 0.0 110.225 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 98.74 4.65 56.89 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.036 -1.625 . . . . 0.0 109.036 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.9 m -84.2 112.64 20.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.406 -1.055 . . . . 0.0 110.574 -179.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 19.3 t -78.44 116.62 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-O 122.081 0.943 . . . . 0.0 109.939 -177.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 17.3 m -110.38 177.5 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 -178.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 58.5 m -131.35 130.01 42.12 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 78.3 mt -102.82 115.39 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 73.3 m -117.28 130.79 56.78 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.558 -0.714 . . . . 0.0 109.13 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.89 152.27 39.98 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.171 -0.956 . . . . 0.0 110.363 -178.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . 0.436 ' OE2' ' OE2' ' B' ' 370' ' ' GLU . 9.9 tp10 -143.02 120.25 11.51 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.16 -163.88 36.78 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.466 -1.826 . . . . 0.0 111.947 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -59.2 -49.95 75.88 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 115.029 -0.586 . . . . 0.0 112.006 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.597 ' H ' ' HG ' ' B' ' 331' ' ' SER . 92.0 m-20 -105.77 10.74 32.58 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.979 -1.076 . . . . 0.0 111.066 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.436 ' OE2' ' OE2' ' B' ' 366' ' ' GLU . 14.7 pt-20 -40.98 -30.6 0.14 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.167 -0.958 . . . . 0.0 110.88 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -69.58 -40.46 76.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.06 -1.025 . . . . 0.0 109.204 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -72.16 -55.11 7.83 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 108.983 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -41.83 -35.63 0.87 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.694 -0.629 . . . . 0.0 111.771 -178.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.468 ' O ' HG23 ' B' ' 378' ' ' VAL . 62.2 t -79.93 -32.44 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.541 -1.35 . . . . 0.0 109.68 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -65.3 -60.05 3.4 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.978 -1.076 . . . . 0.0 111.939 -178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -73.31 -40.85 64.17 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.483 -1.386 . . . . 0.0 112.66 -177.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.99 -40.05 87.84 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.528 -1.357 . . . . 0.0 109.042 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.468 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.5 t -61.08 -47.65 92.6 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 O-C-N 121.132 -0.98 . . . . 0.0 109.831 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 50.1 mtpt -69.54 -55.75 9.27 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.728 -1.232 . . . . 0.0 108.154 179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.476 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 60.7 tp -53.04 -34.08 54.83 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.504 -0.747 . . . . 0.0 109.7 -178.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 39.5 ttm -75.44 -38.54 59.68 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.945 -1.097 . . . . 0.0 108.55 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.17 -5.42 51.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.685 -0.634 . . . . 0.0 110.496 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -110.45 4.54 20.62 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.085 -1.009 . . . . 0.0 110.812 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . 0.476 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 26.3 mt -72.2 121.97 20.25 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.34 -1.475 . . . . 0.0 109.947 179.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 . . . . . 0 N--CA 1.494 1.772 0 CA-C-O 117.989 -1.005 . . . . 0.0 108.942 179.152 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 75.6 mtm . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.076 -0.712 . . . . 2.91 109.076 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 89.7 mt -110.45 122.32 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 121.414 -0.804 . . . . 1.2 108.958 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.6 m -139.26 146.64 40.66 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.416 -0.802 . . . . 1.4 109.104 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.68 -162.79 9.25 Favored Glycine 0 N--CA 1.495 2.608 0 N-CA-C 108.719 -1.752 . . . . 1.05 108.719 179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.6 mt -89.81 -13.71 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.863 -1.375 . . . . 1.15 110.302 -178.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.3 tp 55.8 102.81 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.166 -0.959 . . . . 0.98 108.88 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.83 -23.12 17.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.0 . . . . 0.88 109.593 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.438 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 16.0 t -147.78 130.55 7.89 Favored Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.069 -1.019 . . . . 1.69 109.739 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.34 144.42 16.24 Favored 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 122.13 1.887 . . . . 0.85 112.902 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.908 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.28 167.27 16.05 Favored Glycine 0 N--CA 1.499 2.873 0 N-CA-C 109.745 -1.342 . . . . 0.92 109.745 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 93.0 mt -123.66 130.42 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.277 0 O-C-N 121.088 -1.243 . . . . 0.81 109.601 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -135.9 150.07 49.2 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.202 -0.936 . . . . 0.51 110.619 -179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.1 m-85 -126.29 129.97 49.94 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 107.793 -1.188 . . . . 0.62 107.793 179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.04 178.94 48.59 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 118.354 -1.879 . . . . 0.55 110.969 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 84.7 mttt -78.87 158.46 28.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.764 -0.845 . . . . 2.1 109.195 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.502 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -106.17 131.55 53.29 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.559 -0.713 . . . . 0.77 110.485 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.8 tp -99.75 136.31 39.86 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.593 -1.262 . . . . 0.91 107.593 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.4 tp -115.84 119.96 37.7 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.309 -0.869 . . . . 0.93 109.613 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.484 HD12 ' HB2' ' A' ' 160' ' ' ALA . 56.8 mt -90.69 105.79 18.06 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.767 -0.583 . . . . 0.93 109.803 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -101.48 136.61 41.03 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.368 -0.833 . . . . 2.75 109.252 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -127.34 122.19 33.08 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.799 -0.815 . . . . 3.0 108.799 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -71.19 148.25 47.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 2.77 109.904 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -65.18 141.86 58.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 2.94 109.489 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 73.8 mt -82.02 130.12 36.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.329 -0.857 . . . . 0.95 109.176 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.6 t -93.9 124.06 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.255 -0.903 . . . . 1.28 109.868 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.5 mt -103.74 138.46 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.436 -0.79 . . . . 1.21 109.119 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -97.22 117.73 32.09 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.152 -0.967 . . . . 1.81 109.208 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.6 mmt180 -86.92 -2.3 58.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.367 -0.833 . . . . 2.8 109.372 -179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -64.34 141.3 58.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 2.87 109.68 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -87.73 150.14 23.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.24 -0.913 . . . . 2.35 108.997 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.544 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.7 pt -92.95 165.64 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.365 -0.834 . . . . 0.97 110.475 -179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 97.4 p -99.15 171.22 8.15 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.349 -0.982 . . . . 1.17 108.349 178.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.19 -47.93 80.03 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.075 -1.016 . . . . 1.18 109.089 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -55.63 -32.3 63.04 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.0 -1.062 . . . . 2.56 109.656 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -82.16 -9.91 59.35 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.287 -0.883 . . . . 1.79 110.246 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.63 -53.31 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.506 -1.371 . . . . 1.0 109.499 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.78 -40.05 95.73 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.023 -1.048 . . . . 1.77 110.006 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -69.98 -39.96 75.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.036 -1.04 . . . . 2.7 110.463 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.544 ' HG3' HG21 ' A' ' 31' ' ' ILE . 66.1 mm-40 -67.11 -40.05 86.81 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.006 -1.058 . . . . 1.51 110.069 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -59.99 -43.19 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.712 -1.242 . . . . 0.93 108.361 179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.6 tp10 -59.55 -37.1 77.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 1.81 108.895 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -60.04 -43.14 95.55 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.908 -1.145 . . . . 2.78 107.908 179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -62.24 -49.78 74.34 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.449 -0.782 . . . . 0.78 109.409 178.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 57.5 tp -59.91 -48.4 81.87 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.397 -0.814 . . . . 1.07 109.024 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 27.5 t -62.21 -43.32 99.1 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.995 -1.065 . . . . 1.12 108.735 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.29 -45.42 96.02 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.732 -1.747 . . . . 0.84 108.732 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -67.48 -32.67 73.67 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.396 -1.061 . . . . 3.09 108.423 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.29 -40.03 84.88 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.643 -0.873 . . . . 0.88 108.643 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 50' ' ' ALA . 27.9 ttpt -67.25 -74.58 0.11 Allowed 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.417 -0.956 . . . . 2.59 108.417 179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.05 -33.22 0.08 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.203 -0.936 . . . . 0.7 111.489 -178.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 83.3 p -60.06 -54.53 44.89 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.563 -1.336 . . . . 1.4 108.697 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.02 -40.2 75.36 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.372 -0.83 . . . . 0.67 111.157 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -65.16 -40.13 93.89 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.73 -1.231 . . . . 1.66 110.735 -178.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.28 -39.97 93.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.857 -1.152 . . . . 1.58 109.018 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -60.35 -37.13 79.69 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.385 -0.822 . . . . 1.35 109.419 179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.5 m -65.41 -43.23 91.23 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.831 -1.168 . . . . 0.77 109.007 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.668 ' CD1' HH22 ' A' ' 136' ' ' ARG . 78.9 mt -62.04 -40.01 85.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.504 -0.925 . . . . 0.63 108.504 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.7 ttpt -55.57 -50.22 70.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.4 -0.813 . . . . 1.14 109.527 -179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.0 m -57.99 -33.0 68.44 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.159 -0.963 . . . . 0.79 110.19 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -68.79 -37.87 79.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.164 -0.96 . . . . 1.53 109.145 179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.464 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.45 -45.29 76.43 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.702 -0.624 . . . . 0.57 110.393 -179.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.72 -50.78 64.06 Favored Glycine 0 N--CA 1.489 2.169 0 C-N-CA 119.861 -1.162 . . . . 0.75 110.272 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.07 -42.09 73.25 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.12 -1.223 . . . . 1.59 110.379 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.2 m -69.96 -59.11 3.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.03 -1.043 . . . . 0.73 111.729 -178.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -97.07 -52.25 3.92 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.959 -1.088 . . . . 0.75 111.103 -178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.67 -165.38 26.49 Favored Glycine 0 N--CA 1.5 2.905 0 C-N-CA 119.706 -1.235 . . . . 1.22 110.955 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -70.75 -22.62 62.39 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.89 -0.771 . . . . 5.81 110.354 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.458 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.1 tp10 -62.05 -37.64 85.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 3.37 110.904 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -99.67 -18.02 17.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.184 -0.947 . . . . 1.77 110.12 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.0 tt0 -69.76 -39.93 76.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.119 -0.988 . . . . 1.65 110.423 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.492 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.04 -30.92 71.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.382 -0.824 . . . . 0.77 109.834 -179.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 81.5 mt -60.0 -41.46 86.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.036 -1.04 . . . . 0.8 109.085 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -62.61 -40.45 96.98 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.065 -1.022 . . . . 0.88 109.966 179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 58.4 tt0 -60.78 -39.92 90.63 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.188 -1.005 . . . . 1.37 109.335 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.18 -41.26 98.43 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.671 -1.772 . . . . 0.62 108.671 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.7 m170 -69.77 -42.44 73.82 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.376 -1.073 . . . . 1.5 108.935 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.4 mt -70.14 -46.19 73.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.285 -0.884 . . . . 0.63 109.359 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.1 ttp -61.16 -40.93 95.71 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.087 -1.008 . . . . 1.51 110.05 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.863 HD11 ' CE2' ' B' ' 348' ' ' PHE . 59.0 tp -66.47 -40.05 89.14 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.164 -0.96 . . . . 0.77 109.444 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.2 tp -66.53 -39.88 88.83 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.502 -0.749 . . . . 0.62 110.012 -179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -79.99 -1.56 40.15 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.186 -0.946 . . . . 1.47 110.192 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -47.88 130.26 14.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.032 . . . . 1.47 109.904 -179.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.28 -16.38 60.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.662 -0.649 . . . . 1.78 110.198 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.26 -35.18 73.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.941 -1.099 . . . . 2.53 108.512 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 81.2 mt -72.12 -40.01 68.44 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.462 0.649 . . . . 0.8 109.275 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -60.04 -49.96 75.61 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.559 -0.713 . . . . 1.42 109.993 -179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -70.65 -40.31 73.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.257 -0.902 . . . . 1.71 110.839 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -69.74 -40.02 76.43 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.059 -1.025 . . . . 1.57 110.567 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.8 mt -68.6 -45.8 81.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.112 -0.992 . . . . 0.65 108.944 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.26 -39.1 80.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.528 -0.733 . . . . 0.82 109.963 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.07 -47.15 87.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.195 -0.94 . . . . 0.79 110.452 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' A' ' 96' ' ' LYS . 85.7 mt -62.64 -45.77 91.3 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.896 -1.127 . . . . 0.95 109.43 -179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.79 -50.05 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.215 -0.928 . . . . 0.66 109.135 179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -70.03 -40.56 75.11 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.707 -0.797 . . . . 2.2 110.338 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -81.3 -50.16 9.85 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.997 -1.064 . . . . 1.65 111.716 -178.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.46 ' N ' ' O ' ' A' ' 92' ' ' LEU . 19.7 mmmt -90.38 -1.83 57.93 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.933 -1.104 . . . . 2.03 111.64 -177.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.3 m80 55.88 35.3 25.19 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.889 -1.132 . . . . 1.42 109.529 -179.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.5 mtt -89.38 168.57 12.12 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.629 -0.669 . . . . 1.18 110.147 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.405 ' OG1' ' HB3' ' A' ' 102' ' ' ALA . 32.9 p -80.72 158.51 25.52 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.42 -0.8 . . . . 0.98 109.26 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.89 -40.06 87.64 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.243 -0.91 . . . . 0.64 109.662 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -67.87 -39.9 83.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.277 -0.89 . . . . 2.07 109.616 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.405 ' HB3' ' OG1' ' A' ' 99' ' ' THR . . . -80.99 -42.52 21.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.342 -0.849 . . . . 0.73 109.897 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.53 -50.46 71.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.54 109.571 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.42 -33.41 72.47 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.228 -0.92 . . . . 0.56 109.509 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.546 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 86.2 t60 -60.06 -46.12 90.6 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.264 -0.897 . . . . 1.54 109.734 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -60.36 -40.0 89.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.353 -0.842 . . . . 1.33 111.007 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 41.9 t -63.28 -62.84 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.959 -1.088 . . . . 0.72 111.435 -177.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.5 mm -63.9 -41.67 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.875 -1.141 . . . . 0.85 109.419 -178.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.546 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 80.8 tt0 -63.53 -38.7 92.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.223 -0.923 . . . . 2.44 108.927 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.04 -46.44 94.18 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.712 -0.955 . . . . 0.98 110.712 -179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.434 HE21 ' HB3' ' B' ' 348' ' ' PHE . 28.6 mm100 -68.54 -44.04 75.39 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.746 -1.443 . . . . 1.41 109.67 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.58 -42.43 78.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.092 -1.005 . . . . 1.2 109.055 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 29.5 t -60.02 -40.42 89.2 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.182 -0.949 . . . . 1.7 109.144 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.97 -40.48 97.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 1.47 109.094 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 44.6 mt -67.82 -41.87 82.38 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.151 -0.968 . . . . 1.56 109.044 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.58 -33.62 70.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.781 -1.199 . . . . 2.2 109.774 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -57.81 -22.15 45.88 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.025 -1.047 . . . . 2.12 108.765 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.47 HD13 HD13 ' A' ' 123' ' ' LEU . 48.8 mt -63.28 139.91 58.82 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.183 -0.948 . . . . 2.0 108.787 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -84.41 -16.8 41.42 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.142 -0.974 . . . . 3.23 110.195 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -66.4 130.02 41.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.169 -0.957 . . . . 2.49 110.124 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.616 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 8.0 pm0 -70.13 -30.04 67.11 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.454 -0.779 . . . . 3.95 110.245 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.491 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.8 t80 -67.58 -34.16 76.48 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.406 -0.809 . . . . 2.0 110.194 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.64 HD22 ' O ' ' B' ' 351' ' ' GLN . 86.4 mt -80.15 -26.67 39.26 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.103 -0.998 . . . . 1.86 108.882 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -61.95 -47.05 86.62 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.212 -0.93 . . . . 2.84 108.604 178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.448 ' OE1' ' O ' ' A' ' 121' ' ' GLU . 7.6 mp0 -65.66 -36.69 84.39 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.264 -0.897 . . . . 2.73 108.77 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.552 ' CZ ' ' NE2' ' B' ' 351' ' ' GLN . 0.2 OUTLIER -59.69 -40.03 86.51 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.855 -1.165 . . . . 2.77 107.855 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.27 -23.4 67.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.425 -0.797 . . . . 1.19 109.008 178.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -66.44 -39.96 89.18 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.655 -0.869 . . . . 1.2 108.655 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -64.18 -40.67 96.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.385 -0.822 . . . . 1.55 109.233 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 77.3 t -69.89 -40.15 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 N-CA-C 108.487 -0.931 . . . . 0.8 108.487 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.506 HH11 ' HG2' ' A' ' 131' ' ' ARG . 11.6 ttt-85 -59.98 -40.03 87.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.397 -0.814 . . . . 3.09 108.94 179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -60.44 -39.93 89.27 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.534 -0.729 . . . . 1.46 110.06 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.99 -43.33 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.266 -0.896 . . . . 0.71 110.861 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.71 -33.86 71.82 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.754 -1.212 . . . . 0.57 110.168 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -59.98 -48.6 81.05 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -1.174 . . . . 2.59 110.022 -179.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.668 HH22 ' CD1' ' A' ' 57' ' ' ILE . 67.0 mtp180 -68.32 -32.22 72.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.906 -1.121 . . . . 2.83 109.602 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.88 -45.54 92.19 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.26 -0.9 . . . . 1.25 108.647 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.0 mt -60.54 -40.26 90.91 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.395 -0.816 . . . . 0.7 109.062 179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.482 HH11 ' HG2' ' A' ' 139' ' ' ARG . 43.4 mtt-85 -69.91 -40.09 75.8 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.426 -0.953 . . . . 2.57 108.426 178.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.404 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 4.5 m120 -60.5 -40.04 89.92 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.848 -0.533 . . . . 1.23 110.759 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.9 mt -73.15 -42.09 58.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.788 -1.195 . . . . 0.81 108.313 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 86.8 mt -70.06 -38.4 75.75 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 121.235 0.541 . . . . 1.0 109.807 -179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.16 43.78 8.5 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.963 -1.655 . . . . 0.89 108.963 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 tp -75.68 152.78 37.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.58 -0.953 . . . . 1.14 109.652 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 43.1 tptt -63.91 140.97 58.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 4.6 109.265 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.4 mt -119.83 130.08 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 122.151 0.977 . . . . 1.24 109.77 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.1 mt -59.39 -47.63 89.94 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 115.657 -0.702 . . . . 1.54 110.922 -177.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 31.2 t0 66.2 99.25 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.652 -0.87 . . . . 1.5 108.652 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 25.1 mt -68.83 -3.78 13.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.3 -0.875 . . . . 0.79 109.709 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 59.3 m -83.45 -13.4 54.81 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.096 -1.003 . . . . 1.4 108.891 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.17 20.28 1.98 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.459 -0.776 . . . . 0.92 111.08 -178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 40.9 mm -90.05 121.18 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.598 -1.313 . . . . 0.88 108.708 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -101.32 -9.0 21.58 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.263 -0.898 . . . . 2.45 110.473 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -125.45 149.78 47.91 Favored 'General case' 0 N--CA 1.506 2.366 0 O-C-N 121.34 -0.85 . . . . 1.52 110.434 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -63.87 135.36 56.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.346 -0.847 . . . . 1.58 109.14 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.5 m -152.34 166.37 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.576 -0.703 . . . . 0.69 109.872 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 94.1 mt -95.16 149.57 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 106.293 -1.743 . . . . 0.61 106.293 177.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.441 HD11 HD11 ' A' ' 19' ' ' LEU . 38.3 tp -100.01 117.88 35.21 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.985 -1.072 . . . . 0.87 110.854 -178.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.555 HG12 HG22 ' A' ' 209' ' ' THR . 84.3 t -121.54 129.44 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 N-CA-C 108.408 -0.96 . . . . 0.71 108.408 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.513 ' C ' HG21 ' A' ' 209' ' ' THR . . . -160.09 165.02 32.57 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.109 -0.994 . . . . 0.81 109.091 -179.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.45 -38.28 74.46 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 120.178 -1.576 . . . . 0.98 107.841 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -170.68 145.28 2.47 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.76 -0.83 . . . . 2.25 108.76 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 33.4 mt -112.17 140.22 47.05 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.248 -0.907 . . . . 0.78 109.818 -179.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.0 p -92.18 141.59 25.27 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.279 -0.888 . . . . 0.98 109.121 179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -39.64 -36.5 1.15 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 122.208 1.938 . . . . 0.81 113.194 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.5 m -60.38 -40.03 89.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.033 -1.042 . . . . 0.9 110.242 -179.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.59 -41.52 92.75 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.006 -1.058 . . . . 1.61 109.799 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 81.9 p -57.54 -32.92 67.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.192 -0.943 . . . . 0.61 111.293 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.464 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -70.14 -43.92 69.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.669 -1.27 . . . . 0.6 109.732 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -94.88 34.94 1.29 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.625 -0.879 . . . . 1.4 108.625 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 47.7 tp -107.48 138.98 42.71 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.814 -0.81 . . . . 0.7 108.814 179.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.469 ' O ' HG23 ' A' ' 176' ' ' VAL . 94.2 m-20 -86.47 103.87 15.41 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.141 -0.974 . . . . 2.35 109.539 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 88.2 mt -63.85 -39.99 95.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.477 -0.764 . . . . 1.51 110.812 -178.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.8 mtpt -67.96 -25.92 65.68 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.994 -1.066 . . . . 2.33 111.76 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -93.37 -8.81 40.79 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.588 -1.32 . . . . 1.92 109.895 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.515 HG11 ' CE1' ' A' ' 179' ' ' PHE . 81.8 t -97.04 110.38 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.101 -0.999 . . . . 0.67 108.792 179.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 82.0 mt -77.77 2.91 15.54 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.222 -0.924 . . . . 1.53 110.334 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.513 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 165.6 177.04 37.6 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.198 -1.561 . . . . 0.48 109.198 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.609 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 17.8 m-85 -132.96 129.98 38.96 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.425 -1.044 . . . . 0.55 108.521 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.6 mt -134.47 127.7 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.21 -0.931 . . . . 0.65 109.348 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 29.1 p -149.74 160.02 43.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.204 -0.935 . . . . 0.82 110.401 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.417 ' OD1' ' C ' ' A' ' 182' ' ' ASP . 35.1 p-10 -109.16 27.57 9.38 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 108.684 -0.858 . . . . 2.46 108.684 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.04 -157.18 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.197 -0.939 . . . . 1.28 111.929 -177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -52.3 -80.83 0.06 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.087 -1.205 . . . . 2.19 110.087 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 174.55 -134.2 2.73 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.839 -1.305 . . . . 2.13 109.839 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.414 ' C ' ' H ' ' A' ' 188' ' ' SER . 14.6 tpp180 -60.01 -40.01 87.78 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.404 -1.056 . . . . 5.86 110.63 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.1 p -64.97 7.79 0.15 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.065 -1.022 . . . . 3.72 111.258 -178.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.414 ' H ' ' C ' ' A' ' 186' ' ' ARG . 15.9 m -90.72 135.32 33.79 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.66 -1.275 . . . . 1.74 110.827 -179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -46.12 -52.55 11.94 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.448 -0.783 . . . . 0.95 109.761 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.418 ' H ' HG22 ' A' ' 190' ' ' THR . 0.1 OUTLIER -53.99 -37.1 63.64 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.492 -0.755 . . . . 1.55 110.247 -179.101 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 13.3 t -60.05 -45.24 93.49 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.111 -0.993 . . . . 1.51 111.03 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.4 mt -60.01 -40.49 83.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 121.321 -0.862 . . . . 1.67 110.406 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.2 mtp -60.14 -45.78 91.9 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.069 -1.019 . . . . 1.02 110.164 -179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -52.19 -45.97 65.38 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.549 -1.344 . . . . 0.68 109.484 -179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -63.48 -58.06 8.23 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.057 -1.057 . . . . 2.93 110.327 -179.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.4 m -60.27 -39.93 88.59 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.897 -1.127 . . . . 0.86 111.655 -178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.2 mt -70.35 -22.36 62.8 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.834 -1.167 . . . . 0.67 109.498 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 69.99 47.82 0.57 Allowed 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.38 0.609 . . . . 1.5 110.31 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.438 ' O ' ' CB ' ' A' ' 8' ' ' SER . 68.6 mt -129.16 149.96 74.09 Favored Pre-proline 0 N--CA 1.498 1.932 0 N-CA-C 107.994 -1.113 . . . . 0.72 107.994 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.07 146.14 75.85 Favored 'Trans proline' 0 N--CA 1.5 1.882 0 C-N-CA 122.459 2.106 . . . . 0.61 112.05 -179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.609 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -177.0 154.12 1.06 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.106 -0.996 . . . . 0.66 111.004 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.0 mt -125.67 151.11 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 107.45 -1.315 . . . . 0.79 107.45 178.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.2 m -131.06 -12.03 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.283 0 O-C-N 120.866 -1.146 . . . . 0.91 111.04 -178.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.01 25.02 17.47 Favored Glycine 0 N--CA 1.499 2.845 0 N-CA-C 110.09 -1.204 . . . . 1.01 110.09 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 22.4 p -45.32 -42.83 10.23 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.125 -1.221 . . . . 0.99 109.903 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 94.01 -52.52 2.23 Favored Glycine 0 N--CA 1.497 2.748 0 O-C-N 121.139 -0.976 . . . . 1.12 111.447 178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 80.6 p -156.78 34.7 0.3 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 120.579 -1.542 . . . . 1.72 111.332 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 23.0 t -75.76 -39.42 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.061 -1.024 . . . . 0.89 108.904 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.555 HG22 HG12 ' A' ' 159' ' ' VAL . 72.7 p -56.72 -27.2 58.72 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.396 -0.815 . . . . 1.03 110.674 -179.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.3 m -80.25 -24.62 39.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.835 -1.166 . . . . 1.83 110.308 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -95.55 -8.66 34.47 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.152 -0.967 . . . . 2.27 110.444 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 56.0 t -102.35 136.17 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.008 0 O-C-N 121.226 -0.921 . . . . 0.92 109.943 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.48 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 2.2 mptp? -116.28 152.92 32.87 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.567 -1.271 . . . . 2.2 107.567 178.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.455 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 16.6 p-10 -56.29 139.46 48.15 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.999 -1.063 . . . . 2.36 110.618 -178.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.455 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.0 m-20 82.02 8.74 0.88 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.028 0.442 . . . . 2.38 110.376 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.48 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 90.6 m-20 -79.32 139.82 37.7 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.025 -1.047 . . . . 2.09 109.346 179.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -91.65 115.04 27.71 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.031 -1.099 . . . . 1.27 108.031 179.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.502 HD12 ' HB2' ' A' ' 16' ' ' ALA . 59.6 mt -125.42 150.27 47.43 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.651 -0.655 . . . . 0.75 110.627 -178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 59.3 mt -115.38 127.67 72.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 107.281 -1.377 . . . . 0.63 107.281 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 54.7 tp -100.7 119.99 39.41 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.936 -1.102 . . . . 0.7 108.702 -179.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 223' ' ' VAL . 83.0 m-20 -78.88 -43.1 25.68 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.067 -1.02 . . . . 2.31 109.373 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.908 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.01 15.34 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 108.4 -0.963 . . . . 0.78 108.4 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 221' ' ' ASP . 53.2 t -131.5 -38.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 N-CA-C 107.287 -1.375 . . . . 1.04 107.287 179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -105.69 0.54 26.39 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.682 -1.229 . . . . 2.44 107.682 178.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 33.3 t-20 60.19 44.28 12.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.814 -0.554 . . . . 1.55 110.357 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -141.81 151.37 42.73 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.07 -1.019 . . . . 1.99 109.762 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.5 t -119.48 130.08 74.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 108.519 -0.919 . . . . 0.77 108.519 179.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -101.7 124.01 46.64 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.52 -0.737 . . . . 0.98 109.25 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 18.0 t -101.05 113.9 38.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.637 -0.665 . . . . 0.85 109.903 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 50.64 67.66 4.13 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.194 -0.941 . . . . 1.66 111.208 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -90.12 148.68 4.63 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 123.048 2.499 . . . . 0.95 112.346 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 71.5 p -72.45 166.26 22.95 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.099 -1.001 . . . . 1.84 109.897 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -59.94 -35.47 74.99 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.406 -0.809 . . . . 2.74 109.736 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.95 -39.99 87.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 2.89 109.686 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.85 -39.97 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.142 -0.974 . . . . 1.3 109.144 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.8 mt -65.4 -40.0 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -0.882 . . . . 1.09 109.693 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -60.02 -41.38 92.04 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.859 -1.151 . . . . 2.43 109.114 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -67.08 -40.04 86.93 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.665 -0.865 . . . . 2.78 108.665 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 95.8 mtp -70.76 -32.73 69.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.547 -0.721 . . . . 1.25 109.221 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.534 ' NH2' ' OE1' ' A' ' 243' ' ' GLN . 2.2 mmp_? -61.35 -40.17 93.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.218 -0.926 . . . . 2.63 109.17 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -64.81 -37.98 89.44 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.41 -0.806 . . . . 1.8 109.039 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 56.0 t -60.03 -41.37 86.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.457 -0.777 . . . . 2.13 109.524 -179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.534 ' OE1' ' NH2' ' A' ' 240' ' ' ARG . 60.2 tt0 -60.07 -40.39 89.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.171 -0.956 . . . . 3.17 109.812 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -59.95 -39.72 86.56 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.924 -1.11 . . . . 1.78 108.89 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -59.88 -40.16 87.75 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.529 -0.732 . . . . 2.47 109.047 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 76.2 t -59.92 -40.52 83.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.389 -0.819 . . . . 2.09 110.11 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.26 -40.66 96.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.08 -1.013 . . . . 2.54 109.383 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 42.1 t -65.52 -34.19 77.69 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.355 -0.84 . . . . 2.99 109.288 179.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -59.97 -40.1 87.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.465 -0.772 . . . . 3.34 109.333 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -60.41 -40.34 90.62 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.421 -0.799 . . . . 3.88 110.507 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -85.86 0.44 53.04 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.236 -0.915 . . . . 4.43 109.374 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -77.89 -8.72 58.46 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.566 -0.709 . . . . 5.42 109.842 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 87.8 mt 49.97 73.27 0.27 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.904 -1.122 . . . . 6.1 108.264 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -71.6 -8.75 55.99 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.787 -0.571 . . . . 7.37 110.432 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -94.3 131.87 39.47 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.015 -1.053 . . . . 8.01 109.512 -179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 5.6 tp 55.35 39.99 31.35 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.092 -1.005 . . . . 9.05 108.804 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.435 ' O ' ' OD1' ' A' ' 258' ' ' ASP . 31.9 mtmm -49.42 -60.06 3.17 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.703 -0.623 . . . . 10.56 109.858 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.435 ' OD1' ' O ' ' A' ' 257' ' ' LYS . 85.9 m-20 -143.7 16.0 1.79 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.359 -0.838 . . . . 11.32 109.86 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 9.9 ptp180 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.065 . . . . 12.42 109.469 -179.773 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 6.1 ttt . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.367 0.604 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -153.99 151.56 29.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.411 -0.806 . . . . 0.0 109.17 179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -149.56 159.93 43.9 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.076 -1.015 . . . . 0.0 110.479 -179.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -154.72 150.97 28.17 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . 0.486 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 2.0 pm0 -116.45 133.89 55.49 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.22 -0.925 . . . . 0.0 110.325 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 p -134.48 128.11 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 CA-C-O 122.351 1.072 . . . . 0.0 112.546 -177.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 86.4 m -78.1 103.31 7.96 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.877 -178.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.505 HG22 ' H ' ' B' ' 310' ' ' ALA . 88.4 mt -51.19 122.65 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-O 122.446 1.117 . . . . 0.0 109.815 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 54.2 p -103.23 21.09 16.48 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.202 -178.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.505 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -86.6 115.29 61.74 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.062 -1.024 . . . . 0.0 108.938 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -68.13 -3.29 10.42 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 CA-C-N 120.309 1.146 . . . . 0.0 111.511 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -111.31 -0.64 16.32 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.91 172.82 26.91 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 107.684 -2.167 . . . . 0.0 107.684 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.491 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -85.58 94.93 9.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.862 -1.375 . . . . 0.0 108.241 -179.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.6 p80 -93.75 -162.79 0.97 Allowed 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.991 -1.068 . . . . 0.0 110.698 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.0 m -56.78 -42.5 79.56 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.098 -1.001 . . . . 0.0 112.514 -176.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.516 HH11 ' HG2' ' B' ' 317' ' ' ARG . 0.9 OUTLIER -61.37 -60.0 11.86 Favored Pre-proline 0 N--CA 1.497 1.906 0 O-C-N 120.639 -1.288 . . . . 0.0 112.241 -178.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -60.78 -32.04 92.49 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 CA-C-N 120.295 1.141 . . . . 0.0 111.811 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.44 73.74 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.25 -40.65 61.97 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.651 -0.82 . . . . 0.0 109.443 -179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 -70.19 -40.73 74.46 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.043 -1.036 . . . . 0.0 108.768 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -60.26 -51.78 68.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.425 -0.797 . . . . 0.0 110.452 -179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 87.2 t -69.91 -30.63 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.758 -1.214 . . . . 0.0 110.35 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 24.4 ttmt -60.08 -45.6 92.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 108.999 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -67.19 -40.05 86.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.84 . . . . 0.0 110.528 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -64.91 -53.61 43.84 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.77 -1.206 . . . . 0.0 111.033 -178.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -52.96 -10.05 0.16 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.121 -0.987 . . . . 0.0 110.458 -178.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -79.23 -21.06 68.27 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 179.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -106.23 140.18 39.57 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.55 -0.971 . . . . 0.0 109.26 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 17.2 m -90.89 -11.08 40.28 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.045 -1.034 . . . . 0.0 110.342 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.495 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 84.4 p -62.93 153.66 32.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.907 -1.12 . . . . 0.0 109.712 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -69.44 133.14 47.39 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.5 mt -134.47 133.77 54.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.674 -0.641 . . . . 0.0 109.99 -179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 85.9 m -131.17 152.01 50.88 Favored 'General case' 0 N--CA 1.5 2.044 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 67.3 t -123.56 117.62 51.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 49.5 m -106.32 132.72 52.03 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.088 -1.007 . . . . 0.0 109.333 -179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 82.1 p -140.01 115.46 9.98 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.924 0.869 . . . . 0.0 110.798 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 24.0 m120 46.96 49.8 14.37 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 176.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.97 -12.96 65.92 Favored Glycine 0 N--CA 1.505 3.244 0 O-C-N 120.155 -1.59 . . . . 0.0 113.327 176.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -118.5 130.06 55.72 Favored 'General case' 0 N--CA 1.509 2.481 0 CA-C-N 119.579 1.689 . . . . 0.0 109.503 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 38.9 m -128.75 150.4 50.3 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 121.871 0.843 . . . . 0.0 110.954 -178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . 0.542 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -146.45 169.28 19.23 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.646 0.736 . . . . 0.0 110.293 -179.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 60.8 m -88.17 139.57 30.37 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.637 -0.665 . . . . 0.0 109.903 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.452 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -79.78 -15.8 56.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.938 -1.101 . . . . 0.0 109.852 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 5.7 ptmm? -85.38 20.61 1.96 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 178.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . 0.452 ' H ' ' C ' ' B' ' 344' ' ' ALA . 17.3 t -147.97 95.95 2.57 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.31 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.854 HD23 HD22 ' A' ' 79' ' ' LEU . 61.2 tp -59.92 -34.7 73.57 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.863 ' CE2' HD11 ' A' ' 79' ' ' LEU . 59.7 m-85 -54.56 -51.85 63.93 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.63 -0.669 . . . . 0.0 110.994 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . 0.434 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 34.1 mtmm -80.89 -12.73 59.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.731 -1.23 . . . . 0.0 111.207 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 27.4 mt -69.48 -49.78 51.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.48 -1.387 . . . . 0.0 109.214 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.64 ' O ' HD22 ' A' ' 123' ' ' LEU . 2.0 mm100 -50.0 -20.1 0.86 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.144 -0.972 . . . . 0.0 111.451 -177.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 74.6 p -76.05 -10.02 59.08 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.233 -1.542 . . . . 0.0 109.242 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.542 HD11 ' HB3' ' B' ' 342' ' ' ALA . 53.0 mt -95.43 118.08 31.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.353 -0.842 . . . . 0.0 109.323 178.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.49 93.07 1.0 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 38.4 mt -97.51 85.49 3.63 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.232 -1.158 . . . . 0.0 108.344 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 31.9 p -93.64 179.96 5.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.195 -0.941 . . . . 0.0 110.81 -178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . 0.52 ' O ' ' N ' ' B' ' 359' ' ' THR . 62.0 tt0 -49.5 156.91 0.57 Allowed 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 122.371 1.081 . . . . 0.0 111.412 -179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.23 23.62 0.02 OUTLIER Glycine 0 N--CA 1.496 2.65 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.226 177.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . 0.52 ' N ' ' O ' ' B' ' 357' ' ' GLN . 27.6 m -83.75 110.04 18.0 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.803 -1.41 . . . . 0.0 109.858 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 6.8 t -77.28 113.73 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 CA-C-O 122.296 1.046 . . . . 0.0 109.833 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.2 m -109.67 176.19 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -178.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 56.2 m -131.96 129.95 40.87 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.5 mt -107.84 121.74 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 24.2 p -122.02 133.19 54.8 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.05 149.85 38.77 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.084 -1.01 . . . . 0.0 109.83 -179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -144.51 121.96 11.69 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.435 -0.79 . . . . 0.0 109.094 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.544 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.05 -152.95 24.28 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 119.125 -1.512 . . . . 0.0 111.724 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -58.82 -52.82 64.1 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.495 ' H ' ' HB3' ' B' ' 331' ' ' SER . 70.7 m-20 -109.96 12.71 23.65 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.015 -1.053 . . . . 0.0 111.32 -177.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.544 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.8 pt-20 -41.95 -35.56 0.89 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.286 -0.883 . . . . 0.0 111.362 -178.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -69.55 -41.0 76.48 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.574 -1.329 . . . . 0.0 109.991 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -71.76 -54.3 10.68 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.966 -1.084 . . . . 0.0 109.413 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -43.39 -35.27 1.5 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.6 -0.687 . . . . 0.0 111.934 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.54 ' O ' HG23 ' B' ' 378' ' ' VAL . 58.7 t -80.19 -33.21 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 120.492 -1.38 . . . . 0.0 109.297 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -70.0 -40.65 75.16 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.224 -0.922 . . . . 0.0 112.495 -178.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -84.7 -44.65 13.19 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.438 -1.413 . . . . 0.0 110.687 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 90.9 mt -59.92 -39.34 85.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.099 -1.0 . . . . 0.0 109.159 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.54 HG23 ' O ' ' B' ' 374' ' ' VAL . 49.3 t -64.36 -43.74 97.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.28 -0.888 . . . . 0.0 109.784 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -79.93 -9.86 59.72 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.054 -1.029 . . . . 0.0 109.457 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 43.0 tp -82.34 -24.88 34.32 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.1 tpp -82.79 -25.01 33.14 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -85.03 -11.11 56.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.687 -0.633 . . . . 0.0 110.202 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -107.33 -0.29 22.57 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.233 -0.917 . . . . 0.0 110.835 -179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 34.4 mt -94.95 119.3 33.24 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.76 -1.212 . . . . 0.0 110.084 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . 0.567 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 1.3 pm0 . . . . . 0 N--CA 1.499 2.0 0 CA-C-O 117.94 -1.028 . . . . 0.0 109.479 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.9 mtm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.465 -0.569 . . . . 2.91 109.465 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 94.4 mt -110.06 126.37 67.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.479 -0.763 . . . . 1.2 109.625 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.5 m -136.75 134.06 36.7 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.893 -0.78 . . . . 1.4 108.893 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.537 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -105.92 -158.59 22.4 Favored Glycine 0 N--CA 1.497 2.716 0 N-CA-C 108.888 -1.685 . . . . 1.05 108.888 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.481 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.8 mt -91.65 -9.95 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.995 -1.297 . . . . 1.15 110.448 -179.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.4 tp 55.01 98.94 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.956 -1.09 . . . . 0.98 108.773 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.75 -34.1 40.15 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.626 -0.672 . . . . 0.88 109.515 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.7 m -150.02 141.6 15.02 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.275 -0.89 . . . . 1.69 109.618 -179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.91 143.67 16.52 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.459 2.106 . . . . 0.85 112.488 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.885 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.91 -165.95 38.36 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.472 -1.451 . . . . 0.92 109.472 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 81.1 mt -149.2 149.97 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 121.169 -1.194 . . . . 0.81 108.506 178.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.27 144.2 19.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.945 -1.097 . . . . 0.51 110.363 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 16.3 m-85 -125.23 128.59 48.54 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 108.21 -1.033 . . . . 0.62 108.21 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 172.78 -178.84 44.63 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.717 -1.706 . . . . 0.55 110.816 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -80.19 158.14 26.36 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.774 -0.839 . . . . 2.1 109.542 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.492 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -105.04 131.24 52.8 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.434 -0.791 . . . . 0.77 110.671 -179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.6 tp -97.89 136.4 38.24 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.206 -1.405 . . . . 0.91 107.206 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 51.6 tp -120.29 124.61 46.04 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.337 -0.852 . . . . 0.93 109.407 -179.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 95.8 mt -88.18 106.6 18.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.492 -0.755 . . . . 0.93 109.895 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.458 ' NZ ' ' CB ' ' A' ' 20' ' ' LYS . 7.4 mtpm? -102.23 128.78 48.61 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.744 -0.835 . . . . 2.75 108.744 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.531 ' OE1' ' NH2' ' A' ' 139' ' ' ARG . 98.6 mt-10 -126.19 137.95 53.6 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.312 -0.867 . . . . 3.0 109.135 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -79.15 143.56 35.32 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.22 -0.925 . . . . 2.77 109.035 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -61.23 140.01 58.03 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.191 -0.943 . . . . 2.94 109.547 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.6 mt -81.3 131.17 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.409 -0.807 . . . . 0.95 109.192 -179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.0 t -101.12 123.24 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.302 -0.874 . . . . 1.28 109.58 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.7 mt -98.13 142.94 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.398 -0.814 . . . . 1.21 108.938 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -91.09 122.16 33.5 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.019 -1.051 . . . . 1.81 109.48 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.533 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.6 mmt-85 -91.12 0.08 57.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.383 -0.823 . . . . 2.8 109.223 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.67 141.67 53.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.339 -0.851 . . . . 2.87 109.654 -179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -85.78 146.8 26.61 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.195 -0.941 . . . . 2.35 109.281 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.1 pt -90.79 164.69 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.97 110.216 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.8 p -97.06 174.14 6.91 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.568 -0.901 . . . . 1.17 108.568 178.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.96 -48.58 81.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.151 -0.968 . . . . 1.18 110.032 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -54.51 -31.47 56.15 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.764 -1.21 . . . . 2.56 109.441 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -82.3 -9.05 59.62 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.466 -0.772 . . . . 1.79 110.276 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 42.2 t -68.05 -56.46 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.436 -1.415 . . . . 1.0 109.146 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.16 -39.97 88.28 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.384 -0.822 . . . . 1.77 109.739 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 87.6 mt-30 -67.14 -41.88 85.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.082 -1.011 . . . . 2.7 110.356 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -62.98 -40.08 96.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.904 -1.122 . . . . 1.51 110.405 -179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.8 t -64.15 -48.67 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.749 -1.22 . . . . 0.93 109.197 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -61.73 -47.81 83.55 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.184 -0.947 . . . . 1.81 109.861 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.421 HH11 ' HG2' ' A' ' 42' ' ' ARG . 49.6 mtt-85 -60.11 -41.91 93.61 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.078 -1.082 . . . . 2.78 108.078 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.433 ' CD1' ' HB1' ' A' ' 100' ' ' ALA . 61.8 t80 -70.07 -39.94 75.32 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.513 -0.742 . . . . 0.78 109.344 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.5 tp -60.05 -48.53 81.34 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 107.28 -1.378 . . . . 1.07 107.28 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -63.69 -39.98 95.65 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.288 -1.004 . . . . 1.12 108.288 178.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.26 -50.02 72.17 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 108.491 -1.844 . . . . 0.84 108.491 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.409 HH11 ' HB3' ' A' ' 47' ' ' ARG . 1.4 ttt-85 -61.35 -39.78 91.85 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.709 -1.219 . . . . 3.09 107.709 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.07 -39.96 87.84 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.971 -0.751 . . . . 0.88 108.971 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.425 ' O ' ' C ' ' A' ' 50' ' ' ALA . 33.6 ttpt -58.03 -74.99 0.05 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.021 -1.072 . . . . 2.59 108.21 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.61 -33.01 0.09 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.15 -0.969 . . . . 0.7 111.715 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.6 m -57.58 -47.54 81.82 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 118.138 -1.425 . . . . 1.4 108.365 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.8 -41.66 74.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.115 -0.991 . . . . 0.67 110.863 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -67.31 -39.97 85.95 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.806 -1.184 . . . . 1.66 110.163 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.47 -39.38 87.4 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.943 -1.098 . . . . 1.58 109.222 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -59.99 -36.54 77.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.286 -0.884 . . . . 1.35 109.942 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -63.96 -42.83 97.17 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.827 -1.171 . . . . 0.77 109.109 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.524 HD11 HH22 ' A' ' 136' ' ' ARG . 85.4 mt -61.68 -37.09 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.369 -0.832 . . . . 0.63 109.134 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -58.19 -49.98 75.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.861 . . . . 1.14 109.178 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 m -59.59 -34.18 72.4 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.372 -0.83 . . . . 0.79 110.709 -178.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -69.22 -39.37 78.61 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.847 -1.158 . . . . 1.53 109.598 -179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.95 -42.06 99.7 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.591 -0.693 . . . . 0.57 109.971 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.1 -50.53 66.67 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.576 -1.41 . . . . 0.75 109.576 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -69.28 -51.77 34.12 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.011 -1.287 . . . . 1.59 109.515 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 41.7 m -60.45 -65.68 0.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.355 -0.841 . . . . 0.73 112.179 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.507 ' CE1' ' O ' ' A' ' 168' ' ' THR . 84.3 m-85 -96.12 -49.31 5.3 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 120.757 -1.215 . . . . 0.75 111.519 -177.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.03 -169.54 25.28 Favored Glycine 0 N--CA 1.503 3.142 0 C-N-CA 119.659 -1.258 . . . . 1.22 111.298 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.05 -25.23 63.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.877 -0.778 . . . . 5.81 109.991 -179.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.517 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.1 tp10 -59.99 -34.57 73.5 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.52 -0.737 . . . . 3.37 110.267 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -100.8 -16.34 17.33 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.366 -0.833 . . . . 1.77 109.91 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.1 tt0 -70.35 -42.03 72.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 1.65 110.501 -179.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.521 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.68 -28.47 69.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.898 . . . . 0.77 109.846 -178.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 83.7 mt -60.12 -40.06 82.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 C-N-CA 119.129 -1.029 . . . . 0.8 108.877 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -66.56 -41.72 88.17 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.043 -1.035 . . . . 0.88 110.498 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -60.52 -40.03 89.98 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.888 -1.132 . . . . 1.37 109.832 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.99 -41.43 99.41 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.24 -1.544 . . . . 0.62 109.24 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 60.2 m170 -66.99 -41.1 87.35 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.232 -1.158 . . . . 1.5 109.384 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.63 -46.52 82.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.923 . . . . 0.63 109.826 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.7 ttp -60.08 -43.95 95.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.03 -1.044 . . . . 1.51 110.207 -179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.828 HD11 ' CE2' ' B' ' 348' ' ' PHE . 41.4 tp -62.62 -40.03 95.67 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.256 -0.903 . . . . 0.77 109.893 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.5 tp -62.65 -39.95 95.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.27 -0.894 . . . . 0.62 110.215 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -82.75 9.47 9.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.119 -0.988 . . . . 1.47 110.069 -179.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 48.3 t0 -54.88 133.1 47.79 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.118 -0.989 . . . . 1.47 110.445 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.424 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 95.5 mt-10 -60.26 -21.07 61.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.64 -0.662 . . . . 1.78 110.734 -179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -70.54 -34.72 72.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.667 -1.271 . . . . 2.53 109.355 178.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.3 mt -70.05 -39.9 75.42 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.513 -0.742 . . . . 0.8 109.312 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -60.08 -49.95 75.64 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.446 -0.784 . . . . 1.42 109.804 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -70.14 -41.13 74.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.257 -0.902 . . . . 1.71 110.597 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.72 -40.45 69.45 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.007 -1.058 . . . . 1.57 111.646 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.1 mt -69.98 -40.32 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 120.981 -1.074 . . . . 0.65 109.885 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.3 mt -68.99 -36.81 75.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.505 -0.747 . . . . 0.82 109.96 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.76 -49.98 75.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.292 -0.88 . . . . 0.79 111.183 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 79.9 mt -60.55 -46.16 91.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.638 -1.289 . . . . 0.95 109.808 -179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 81.1 mt -59.93 -50.07 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.218 -0.926 . . . . 0.66 109.461 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 77.3 mttt -74.13 -42.41 60.06 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.645 -0.66 . . . . 2.2 111.393 -179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -79.92 -50.06 10.99 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.901 -1.124 . . . . 1.65 112.052 -177.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -91.03 -4.18 56.59 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.964 -1.085 . . . . 2.03 111.497 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 78.1 m80 56.02 36.43 27.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.911 -1.118 . . . . 1.42 109.072 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 53.7 mtt -90.87 169.98 10.46 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.661 -0.65 . . . . 1.18 109.639 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 102' ' ' ALA . 82.1 p -77.79 153.72 32.57 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.928 -1.138 . . . . 0.98 107.928 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 43' ' ' PHE . . . -70.59 -36.64 73.67 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.944 -1.098 . . . . 0.64 111.028 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -68.57 -39.42 81.01 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.93 -1.106 . . . . 2.07 109.797 -179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.412 ' HB3' ' OG1' ' A' ' 99' ' ' THR . . . -78.5 -41.48 32.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -0.91 . . . . 0.73 109.806 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.38 -42.88 67.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.283 -0.886 . . . . 0.54 110.272 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.68 -40.11 96.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.103 -0.998 . . . . 0.56 109.587 -179.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -59.9 -40.05 87.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.5 -0.75 . . . . 1.54 110.3 -179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.48 ' O ' ' N ' ' A' ' 110' ' ' GLY . 86.3 tt0 -60.74 -39.97 90.66 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.138 -0.976 . . . . 1.33 109.994 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.9 t -62.61 -52.15 63.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.297 -0.877 . . . . 0.72 110.657 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.2 mm -70.06 -40.01 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.989 -1.069 . . . . 0.85 108.327 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -68.15 -32.94 73.56 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.452 -0.944 . . . . 2.44 108.452 178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -65.22 -51.3 51.04 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 110.174 -1.17 . . . . 0.98 110.174 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -60.04 -49.3 78.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.967 -1.314 . . . . 1.41 109.248 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.69 -39.67 81.4 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.311 -0.868 . . . . 1.2 109.691 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.9 p -59.3 -39.94 84.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.041 -1.037 . . . . 1.7 109.287 -179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.21 -40.06 94.83 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 1.47 108.823 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 62.0 mt -63.4 -42.68 98.79 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.123 -0.986 . . . . 1.56 109.096 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -56.82 -34.38 67.65 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.019 -1.051 . . . . 2.2 109.291 -179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.11 -23.15 65.29 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.245 -0.91 . . . . 2.12 109.267 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 55.4 mt -62.14 140.75 58.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.04 -1.037 . . . . 2.0 108.519 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -93.84 49.09 1.31 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.911 -1.118 . . . . 3.23 110.836 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -135.35 137.9 42.83 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.129 -0.982 . . . . 2.49 109.835 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.511 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 52.0 mp0 -70.12 -31.62 69.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.605 -0.684 . . . . 3.95 110.308 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.62 ' CZ ' ' NH1' ' A' ' 126' ' ' ARG . 3.5 t80 -73.8 -40.11 63.63 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.109 -0.994 . . . . 2.0 110.916 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.685 HD23 HH22 ' A' ' 126' ' ' ARG . 60.7 mt -69.44 -36.56 76.76 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.109 -0.995 . . . . 1.86 108.604 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.19 -36.99 85.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.304 -0.873 . . . . 2.84 110.004 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -59.82 -45.19 93.16 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.948 -1.095 . . . . 2.73 110.796 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.685 HH22 HD23 ' A' ' 123' ' ' LEU . 25.6 mtm-85 -66.06 -34.51 78.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.599 -1.313 . . . . 2.77 108.756 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.27 -35.47 73.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.186 -0.946 . . . . 1.19 108.519 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.54 -39.95 92.93 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.345 -0.983 . . . . 1.2 108.345 178.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -68.42 -39.94 81.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.407 -0.808 . . . . 1.55 109.856 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.417 HG21 HE22 ' B' ' 351' ' ' GLN . 43.7 t -69.38 -40.03 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.004 -1.06 . . . . 0.8 108.749 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -60.07 -38.91 84.29 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.17 -0.956 . . . . 3.09 108.42 178.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -59.97 -38.82 83.64 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.541 -0.724 . . . . 1.46 109.916 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.9 -42.83 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.046 -1.034 . . . . 0.71 109.679 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.87 -35.27 72.47 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.724 -1.35 . . . . 0.57 109.724 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.98 -48.9 79.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.148 -1.207 . . . . 2.59 110.185 -179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.524 HH22 HD11 ' A' ' 57' ' ' ILE . 59.1 mtp180 -67.07 -27.89 67.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.615 -1.303 . . . . 2.83 109.914 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 51.8 tp -59.54 -42.03 91.4 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.232 -1.025 . . . . 1.25 108.232 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.2 mt -62.6 -40.05 95.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.206 -0.934 . . . . 0.7 109.414 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.531 ' NH2' ' OE1' ' A' ' 21' ' ' GLU . 99.0 mtt180 -67.58 -39.94 84.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.305 -0.872 . . . . 2.57 109.965 179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -69.86 -31.6 69.53 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.452 -0.78 . . . . 1.23 112.062 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.1 mt -68.91 -51.62 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.087 -1.633 . . . . 0.81 108.226 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 98.5 mt -70.04 -39.94 75.43 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.068 -0.653 . . . . 1.0 109.348 179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.16 52.59 2.35 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.497 -1.441 . . . . 0.89 109.497 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 tp -73.84 150.03 41.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.235 -1.156 . . . . 1.14 108.493 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -69.65 139.56 53.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.03 -1.044 . . . . 4.6 110.051 -179.265 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 88.2 mt -110.01 129.96 64.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 122.046 0.927 . . . . 1.24 109.297 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.0 mt -69.8 -40.0 78.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 CA-C-N 115.778 -0.646 . . . . 1.54 110.166 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 39.8 t0 63.29 131.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.451 0.643 . . . . 1.5 109.361 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.503 ' O ' HD12 ' A' ' 152' ' ' ILE . 83.3 mt -85.44 -2.62 58.31 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.706 -0.85 . . . . 0.79 108.706 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.5 p -83.95 -9.6 58.57 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.82 -0.807 . . . . 1.4 108.82 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -86.04 22.72 1.65 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.531 -0.731 . . . . 0.92 109.798 -178.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.503 HD12 ' O ' ' A' ' 149' ' ' LEU . 66.0 mt -90.48 120.99 40.3 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 O-C-N 121.337 -0.852 . . . . 0.88 109.045 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -102.74 -13.98 16.84 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.269 -0.895 . . . . 2.45 110.123 -179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -130.23 151.61 50.56 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.59 -0.693 . . . . 1.52 110.11 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -62.28 137.15 58.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 1.58 108.768 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.8 m -153.14 168.05 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.519 -0.738 . . . . 0.69 110.067 179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.6 mt -95.11 146.16 7.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 106.564 -1.643 . . . . 0.61 106.564 177.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 49.6 tp -96.83 120.21 36.75 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.106 -0.996 . . . . 0.87 110.8 -177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.431 HG12 HG22 ' A' ' 209' ' ' THR . 42.2 t -126.41 130.03 71.88 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 108.981 -0.748 . . . . 0.71 108.981 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.8 168.57 24.48 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.197 -0.939 . . . . 0.81 109.043 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.78 -37.92 73.36 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.364 -1.46 . . . . 0.98 108.006 178.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -170.59 145.36 2.53 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.743 -0.836 . . . . 2.25 108.743 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 48.1 mt -112.87 134.67 54.27 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.324 -0.86 . . . . 0.78 109.443 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 11.6 p -90.76 148.84 39.3 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.198 -0.939 . . . . 0.98 109.122 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -44.35 -32.98 5.73 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.949 1.766 . . . . 0.81 112.485 179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 66.7 m -55.88 -45.56 78.55 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.085 -1.009 . . . . 0.9 109.444 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -69.96 -40.08 75.63 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.372 -0.83 . . . . 1.61 109.539 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.507 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 44.0 p -55.3 -18.37 6.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.233 -0.917 . . . . 0.61 110.935 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -88.46 -46.93 8.73 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.793 -1.192 . . . . 0.6 109.643 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -90.11 41.2 1.04 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.926 -1.138 . . . . 1.4 107.926 179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 62.1 tp -105.0 131.19 52.84 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.733 -0.604 . . . . 0.7 109.591 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -85.43 97.51 10.06 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 108.175 -1.046 . . . . 2.35 108.175 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.28 -39.87 95.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.435 -0.791 . . . . 1.51 110.804 -178.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -64.86 -25.51 67.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.082 -1.011 . . . . 2.33 111.033 -178.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -93.96 -10.16 34.61 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.746 -1.221 . . . . 1.92 110.164 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.494 HG12 ' H ' ' A' ' 178' ' ' GLY . 62.6 t -107.12 119.91 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.225 -0.922 . . . . 0.67 108.678 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.1 mt -94.45 11.58 30.23 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.399 -0.813 . . . . 1.53 111.051 -177.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.494 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 171.17 170.27 35.11 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.267 -1.533 . . . . 0.48 109.267 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -136.75 133.56 36.17 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.365 -1.079 . . . . 0.55 109.118 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.41 ' CG2' HG21 ' A' ' 205' ' ' THR . 75.6 mt -135.41 128.4 48.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.751 -0.833 . . . . 0.65 108.751 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.423 ' O ' ' OG1' ' A' ' 205' ' ' THR . 34.3 p -144.98 158.64 43.75 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.345 -0.847 . . . . 0.82 110.626 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 183' ' ' ALA . 86.2 m-20 -94.05 17.23 12.78 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.602 -0.686 . . . . 2.46 109.778 179.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.482 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -44.32 -179.51 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.496 1.141 . . . . 1.28 113.029 -177.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.8 -52.99 5.57 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 110.281 -1.127 . . . . 2.19 110.281 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -168.33 -159.88 14.91 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 118.558 -1.782 . . . . 2.13 111.46 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.424 ' O ' ' OG ' ' A' ' 191' ' ' SER . 11.3 ptt180 -69.98 -13.88 62.44 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 122.18 -0.6 . . . . 5.86 111.129 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 41.2 p -74.32 5.22 4.76 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.882 -1.136 . . . . 3.72 109.036 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 91.7 p -87.63 141.23 28.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.368 -0.832 . . . . 1.74 110.39 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -54.88 -38.66 67.82 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.293 -0.879 . . . . 0.95 108.997 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 190' ' ' THR . 14.2 p -59.85 -39.95 86.93 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.682 -0.637 . . . . 1.55 109.941 -179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 186' ' ' ARG . 93.9 p -61.31 -38.24 86.12 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.121 -0.987 . . . . 1.51 110.113 -179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.2 mm -60.01 -39.92 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.271 -0.893 . . . . 1.67 109.074 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.0 mtp -56.14 -49.69 73.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.094 -1.004 . . . . 1.02 109.967 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.96 -44.71 78.74 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.093 -1.004 . . . . 0.68 109.915 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -61.64 -58.96 6.01 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.293 -0.963 . . . . 2.93 110.601 -179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 73.2 m -63.12 -39.67 95.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.204 -0.935 . . . . 0.86 111.554 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.7 mt -70.04 -30.05 67.23 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.831 -1.168 . . . . 0.67 109.402 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 71.7 mt-10 70.52 49.56 0.41 Allowed 'General case' 0 N--CA 1.5 2.035 0 CA-C-O 121.342 0.592 . . . . 1.5 109.671 -179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 55.9 mt -130.1 150.03 74.89 Favored Pre-proline 0 N--CA 1.503 2.193 0 N-CA-C 108.256 -1.016 . . . . 0.72 108.256 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -57.74 138.18 84.82 Favored 'Trans proline' 0 N--CA 1.5 1.896 0 C-N-CA 122.204 1.936 . . . . 0.61 112.051 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.43 151.13 3.63 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.402 -0.919 . . . . 0.66 111.139 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.41 ' CG2' HG23 ' A' ' 205' ' ' THR . 75.7 mt -127.67 139.77 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 N-CA-C 107.208 -1.405 . . . . 0.79 107.208 178.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 32.4 m -123.05 -14.41 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 O-C-N 121.204 -0.935 . . . . 0.91 111.424 -178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -106.04 26.94 19.11 Favored Glycine 0 N--CA 1.499 2.84 0 N-CA-C 109.489 -1.444 . . . . 1.01 109.489 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 181' ' ' THR . 1.7 p -52.64 -37.2 58.12 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.234 -1.156 . . . . 0.99 110.41 -179.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.63 -80.54 1.68 Allowed Glycine 0 N--CA 1.491 2.364 0 C-N-CA 119.488 -1.339 . . . . 1.12 110.668 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 21.9 t -129.81 31.89 4.66 Favored 'General case' 0 N--CA 1.508 2.445 0 O-C-N 121.426 -1.044 . . . . 1.72 112.333 -177.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 55.7 t -69.83 -40.22 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.408 -1.432 . . . . 0.89 107.931 177.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.431 HG22 HG12 ' A' ' 159' ' ' VAL . 72.3 p -53.88 -28.91 39.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.644 -0.66 . . . . 1.03 109.898 -179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.1 p -80.56 -19.4 45.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.021 -1.05 . . . . 1.83 110.135 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -96.62 -13.56 22.78 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.165 -0.96 . . . . 2.27 110.148 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.2 t -102.53 136.5 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.271 -0.893 . . . . 0.92 110.635 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -115.24 157.04 24.29 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.46 -1.311 . . . . 2.2 107.46 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 46.9 p-10 -60.03 139.99 57.1 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.814 -1.179 . . . . 2.36 110.265 -178.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.434 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.7 m-20 80.87 4.29 1.59 Allowed 'General case' 0 N--CA 1.501 2.076 0 CA-C-O 121.109 0.48 . . . . 2.38 110.028 179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -71.13 130.03 40.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.197 -0.939 . . . . 2.09 109.022 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -84.63 112.92 20.88 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.111 -1.07 . . . . 1.27 108.111 179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.492 HD12 ' HB2' ' A' ' 16' ' ' ALA . 54.8 mt -123.77 147.26 47.68 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.595 -0.69 . . . . 0.75 110.87 -178.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.409 HD12 ' HG3' ' A' ' 231' ' ' PRO . 75.8 mt -114.38 127.68 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.813 -1.551 . . . . 0.63 106.813 177.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 58.4 tp -100.4 118.14 36.03 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.826 -1.171 . . . . 0.7 109.622 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.536 ' C ' ' H ' ' A' ' 223' ' ' VAL . 96.0 m-20 -75.7 -43.4 47.36 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.096 -1.002 . . . . 2.31 108.407 178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.885 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 50.04 10.55 0.05 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.948 -0.76 . . . . 0.78 108.948 -179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.536 ' H ' ' C ' ' A' ' 221' ' ' ASP . 52.9 t -130.31 -37.31 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 106.985 -1.487 . . . . 1.04 106.985 178.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -102.07 -2.9 28.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.388 -1.338 . . . . 2.44 107.388 178.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.537 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 62.67 40.11 10.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.902 -0.499 . . . . 1.55 110.578 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -140.95 147.18 38.39 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.112 -0.993 . . . . 1.99 109.923 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 91.8 t -119.96 123.04 70.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.492 -0.755 . . . . 0.77 109.388 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -91.26 134.3 34.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.026 -1.046 . . . . 0.98 109.156 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.457 HG22 HD22 ' A' ' 218' ' ' LEU . 44.1 t -105.17 115.32 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 O-C-N 121.545 -0.722 . . . . 0.85 110.115 -178.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 50.12 61.12 14.15 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.145 -0.972 . . . . 1.66 111.712 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.409 ' HG3' HD12 ' A' ' 219' ' ' ILE . 92.7 Cg_endo -83.17 153.05 14.21 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.745 2.296 . . . . 0.95 111.875 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 82.1 p -70.32 162.3 28.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.145 -0.972 . . . . 1.84 110.697 -178.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.48 ' H ' ' ND2' ' A' ' 233' ' ' ASN . 2.6 p30 -60.13 -36.1 76.76 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.639 -0.663 . . . . 2.74 110.029 179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -60.05 -38.29 82.35 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.197 -0.939 . . . . 2.89 108.858 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 55.6 t -69.71 -40.0 78.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.319 -0.863 . . . . 1.3 109.223 179.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.6 mt -68.45 -39.95 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.185 -0.947 . . . . 1.09 110.299 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -60.03 -41.27 91.87 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.844 -1.16 . . . . 2.43 108.47 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 34.8 ttmt -65.29 -40.01 93.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.482 -0.761 . . . . 2.78 109.141 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 93.8 mtp -71.25 -30.31 66.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.407 -0.808 . . . . 1.25 109.882 179.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.488 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.1 OUTLIER -68.23 -41.35 81.37 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.183 -0.948 . . . . 2.63 109.344 179.537 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.19 -39.93 92.03 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.178 -0.951 . . . . 1.8 108.474 179.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.4 t -62.19 -42.34 94.82 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 N-CA-C 108.951 -0.759 . . . . 2.13 108.951 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -60.27 -40.16 89.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.431 -0.793 . . . . 3.17 108.963 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.06 -40.09 88.26 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.361 -0.837 . . . . 1.78 109.424 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -63.97 -40.05 95.52 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.353 -0.98 . . . . 2.47 108.353 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.25 -40.41 88.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.809 -0.811 . . . . 2.09 108.809 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.54 -37.52 87.63 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.517 -0.74 . . . . 2.54 109.343 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 63.0 m -59.99 -40.18 88.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.243 -0.911 . . . . 2.99 109.434 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -63.71 -31.94 73.28 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.449 -0.782 . . . . 3.34 109.665 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -59.9 -37.82 80.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.326 -0.859 . . . . 3.88 110.04 -179.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -58.42 -37.77 76.04 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.214 -0.929 . . . . 4.43 110.418 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 252' ' ' GLU . 31.2 mp0 -54.99 -17.93 4.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.054 -1.029 . . . . 5.42 109.835 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 98.3 mt -69.25 -39.17 78.62 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.026 -1.047 . . . . 6.1 109.265 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 255' ' ' LYS . . . -76.15 -9.07 58.34 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.249 -0.907 . . . . 7.37 109.221 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.53 ' C ' ' H ' ' A' ' 257' ' ' LYS . 44.1 pttt 30.08 -121.26 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 120.811 0.338 . . . . 8.01 111.698 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 88.5 mt 55.79 4.33 0.11 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.278 -0.889 . . . . 9.05 109.111 -178.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.53 ' H ' ' C ' ' A' ' 255' ' ' LYS . 61.4 tttp -163.84 145.99 9.33 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.609 -0.886 . . . . 10.56 108.609 179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 257' ' ' LYS . 58.3 m-20 -157.79 90.76 1.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.988 -1.07 . . . . 11.32 109.274 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.013 -0.994 . . . . 12.42 109.254 179.926 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' B' ' 302' ' ' PHE . 13.1 tmm? . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.641 0.734 . . . . 0.0 109.649 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . 0.591 ' N ' ' SD ' ' B' ' 301' ' ' MET . 24.5 t80 -152.69 150.1 29.1 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -146.55 155.31 42.41 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.139 -0.976 . . . . 0.0 110.501 -179.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . 0.404 ' HG2' HG21 ' B' ' 378' ' ' VAL . 72.9 tp60 -152.26 147.94 26.96 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -108.88 127.61 54.19 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.0 p -128.43 123.91 60.85 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 CA-C-O 122.407 1.099 . . . . 0.0 111.94 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 27.1 m -77.5 103.58 7.52 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 122.066 0.936 . . . . 0.0 110.926 -177.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.524 HG22 ' H ' ' B' ' 310' ' ' ALA . 89.5 mt -52.23 122.0 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-O 122.449 1.118 . . . . 0.0 110.049 -178.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 71.2 p -103.02 23.4 12.36 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.708 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.524 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -83.38 116.72 65.9 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.95 . . . . 0.0 109.052 179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -66.52 -6.95 16.42 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 CA-C-N 120.23 1.118 . . . . 0.0 111.504 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -118.09 5.96 12.05 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.48 177.47 34.55 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.468 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -87.28 94.34 9.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.153 -1.204 . . . . 0.0 108.824 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -96.88 -159.53 0.74 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.172 -0.955 . . . . 0.0 110.181 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 16.9 m -58.18 -46.84 85.07 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.971 -1.08 . . . . 0.0 112.637 -176.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.624 ' NH2' ' NE2' ' B' ' 321' ' ' GLN . 1.8 tpt180 -58.86 -61.45 7.74 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 120.425 -1.422 . . . . 0.0 112.09 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -58.8 -32.31 96.89 Favored 'Trans proline' 0 N--CA 1.492 1.433 0 CA-C-N 120.373 1.169 . . . . 0.0 111.579 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.31 70.19 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.622 -0.831 . . . . 0.0 108.961 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.89 -41.0 67.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.882 . . . . 0.0 109.815 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . 0.624 ' NE2' ' NH2' ' B' ' 317' ' ' ARG . 40.3 mt-30 -69.97 -42.76 72.73 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.948 -1.095 . . . . 0.0 108.896 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -61.02 -51.67 68.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.425 -0.797 . . . . 0.0 110.348 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 73.8 t -67.72 -30.12 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.625 -1.297 . . . . 0.0 109.981 -179.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 24.5 ttmt -60.05 -45.69 92.02 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.237 -0.985 . . . . 0.0 109.335 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -60.16 -49.95 75.59 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.037 -1.039 . . . . 0.0 109.225 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -61.6 -49.97 74.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.305 -0.872 . . . . 0.0 110.657 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 4.3 tptp -49.65 -20.05 0.72 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.287 -0.883 . . . . 0.0 109.37 -178.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -81.6 -17.05 71.75 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -106.15 140.55 38.94 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.322 -1.105 . . . . 0.0 109.771 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . 0.416 HG22 ' O ' ' B' ' 330' ' ' THR . 51.3 m -90.72 -12.98 34.98 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.109 -0.994 . . . . 0.0 109.34 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.528 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 58.5 m -61.24 144.74 53.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.335 -0.853 . . . . 0.0 109.587 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -67.32 135.98 54.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.059 -1.026 . . . . 0.0 109.298 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 88.8 mt -133.98 134.14 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.615 -0.678 . . . . 0.0 109.983 -179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 85.5 m -129.26 148.44 51.19 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.504 -0.747 . . . . 0.0 109.152 179.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 63.3 t -120.5 114.78 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 98.0 m -106.52 130.39 54.31 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.169 -0.957 . . . . 0.0 109.477 -178.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 25.2 p -139.4 119.36 13.43 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.778 0.799 . . . . 0.0 110.787 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 41.71 52.87 4.01 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 177.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 84.06 -16.26 33.97 Favored Glycine 0 N--CA 1.5 2.938 0 O-C-N 120.293 -1.504 . . . . 0.0 112.507 177.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -110.56 122.63 48.22 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.796 -1.414 . . . . 0.0 109.472 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 56.7 p -129.84 150.62 51.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.741 0.782 . . . . 0.0 110.431 -178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -146.46 170.01 17.73 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.644 0.735 . . . . 0.0 110.204 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 16.5 m -88.62 139.04 30.88 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.575 -0.703 . . . . 0.0 110.011 -179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.494 ' HA ' HD11 ' B' ' 350' ' ' LEU . . . -80.49 -13.88 58.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.958 -1.089 . . . . 0.0 110.321 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -88.52 20.29 3.46 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . 0.432 ' H ' ' C ' ' B' ' 344' ' ' ALA . 45.0 t -148.37 95.74 2.5 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 114.7 -1.136 . . . . 0.0 111.699 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.609 HD23 HD22 ' A' ' 79' ' ' LEU . 59.0 tp -60.35 -34.62 74.11 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.828 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.1 m-85 -55.67 -52.49 63.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.134 -0.979 . . . . 0.0 109.891 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -69.58 -40.13 76.91 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.264 -0.898 . . . . 0.0 110.226 -178.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.626 ' O ' ' N ' ' B' ' 352' ' ' THR . 80.5 mt -50.88 -54.68 21.9 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.984 -1.073 . . . . 0.0 108.608 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.417 HE22 HG21 ' A' ' 130' ' ' VAL . 27.2 mt-30 -40.15 -12.43 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.855 -0.528 . . . . 0.0 111.647 -178.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.626 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.5 p -93.64 -10.78 33.39 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.589 -1.319 . . . . 0.0 110.627 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 64.0 mt -93.38 119.79 32.9 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.764 -1.21 . . . . 0.0 109.837 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.06 91.01 1.0 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.075 -1.61 . . . . 0.0 109.075 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 29.4 mt -96.56 86.83 4.22 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.283 -1.127 . . . . 0.0 108.199 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 65.9 p -92.5 -179.72 5.28 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.19 -0.944 . . . . 0.0 111.257 -177.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . 0.459 ' O ' ' N ' ' B' ' 359' ' ' THR . 7.4 tt0 -49.53 153.99 1.03 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.331 1.062 . . . . 0.0 111.303 -178.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.73 26.88 0.05 OUTLIER Glycine 0 N--CA 1.495 2.58 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.906 177.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . 0.459 ' N ' ' O ' ' B' ' 357' ' ' GLN . 24.1 m -84.87 110.42 18.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.884 -1.363 . . . . 0.0 109.449 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 23.3 t -77.33 114.58 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 CA-C-O 122.333 1.063 . . . . 0.0 109.698 -177.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 15.1 m -109.98 177.91 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 27.8 m -130.31 126.9 38.33 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 65.7 mt -102.36 112.65 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 44.8 p -115.5 130.05 56.75 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.2 149.5 38.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.296 -0.877 . . . . 0.0 109.618 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -143.88 123.94 13.63 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.438 ' H ' ' HG2' ' B' ' 370' ' ' GLU . . . 160.82 -161.85 33.09 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.157 -1.497 . . . . 0.0 111.577 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -59.85 -50.5 73.53 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 122.211 -0.582 . . . . 0.0 112.296 -177.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.528 ' N ' ' OG ' ' B' ' 331' ' ' SER . 95.8 m-20 -111.08 10.65 22.02 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 120.919 -1.113 . . . . 0.0 110.837 -178.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' B' ' 367' ' ' GLY . 0.7 OUTLIER -45.59 -32.87 2.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.036 -1.04 . . . . 0.0 111.334 -178.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -71.81 -40.06 69.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.857 -1.152 . . . . 0.0 109.87 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -68.46 -40.38 81.08 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.366 -0.834 . . . . 0.0 110.802 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -64.53 -64.01 0.98 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.58 -1.325 . . . . 0.0 111.088 -178.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.586 ' O ' HG23 ' B' ' 378' ' ' VAL . 45.2 t -45.33 -39.56 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.015 -1.053 . . . . 0.0 109.988 -177.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.4 mm-40 -61.37 -51.56 68.29 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.917 -1.114 . . . . 0.0 110.341 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -75.15 -39.93 60.04 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.015 -1.053 . . . . 0.0 111.094 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.22 -37.27 77.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.11 -0.994 . . . . 0.0 108.827 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.586 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.9 t -62.48 -43.44 98.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.209 -0.932 . . . . 0.0 109.607 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' B' ' 383' ' ' GLU . 0.5 OUTLIER -70.02 -55.72 8.83 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.615 -1.303 . . . . 0.0 107.735 178.525 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 60.4 tp -56.52 -35.92 68.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 0.0 109.935 -178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 33.7 ttm -71.72 -40.6 69.33 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.704 -1.248 . . . . 0.0 109.011 177.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.39 -5.38 57.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.652 -0.655 . . . . 0.0 110.139 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' B' ' 379' ' ' LYS . 64.3 mm-40 -110.66 -1.07 16.92 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.228 -0.92 . . . . 0.0 110.833 -179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.9 mt -87.24 128.5 35.15 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.546 -1.346 . . . . 0.0 108.783 178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 . . . . . 0 N--CA 1.496 1.861 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.44 -179.629 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.6 mpp? . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.266 0.555 . . . . 2.91 109.816 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 84.5 mt -111.18 130.02 65.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 121.608 -0.683 . . . . 1.2 109.346 179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.2 m -132.24 121.13 23.16 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.233 -0.917 . . . . 1.4 108.712 178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.18 -166.75 32.78 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.611 -1.395 . . . . 1.05 109.611 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.471 HG22 ' O ' ' A' ' 5' ' ' ILE . 88.9 mt -87.42 -6.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.03 -1.276 . . . . 1.15 109.758 -179.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 23.7 tp 57.35 89.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.394 -0.816 . . . . 0.98 109.359 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -67.7 -41.73 83.14 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.866 -1.161 . . . . 0.88 107.866 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 p -150.54 146.26 19.49 Favored Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 109.006 -0.739 . . . . 1.69 109.006 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -80.56 143.75 15.37 Favored 'Trans proline' 0 N--CA 1.498 1.781 0 C-N-CA 122.587 2.191 . . . . 0.85 113.272 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.7 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.88 -163.35 36.68 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.221 -1.552 . . . . 0.92 109.221 179.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.9 mt -148.58 147.54 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.971 -1.311 . . . . 0.81 108.933 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -149.88 147.84 28.42 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.875 -1.141 . . . . 0.51 110.537 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -128.5 120.71 27.32 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.818 -1.179 . . . . 0.62 107.818 179.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.82 -179.91 45.82 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 117.943 -2.075 . . . . 0.55 111.228 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -80.28 160.05 25.65 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.913 -0.757 . . . . 2.1 110.174 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -102.59 130.51 49.49 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.686 -0.634 . . . . 0.77 110.931 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.4 tp -100.38 135.42 41.85 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 107.486 -1.302 . . . . 0.91 107.486 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.1 tp -121.4 124.23 44.01 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.226 -0.921 . . . . 0.93 110.027 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.725 HD21 HD21 ' A' ' 149' ' ' LEU . 65.7 mt -81.66 103.31 11.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 0.93 109.758 179.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -96.88 121.69 39.02 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.267 -1.012 . . . . 2.75 108.267 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -130.36 133.68 46.6 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.27 -0.894 . . . . 3.0 110.153 -179.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 42.5 t0 -69.7 141.76 53.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 2.77 109.505 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.496 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 86.3 tt0 -63.58 142.63 58.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.208 -0.932 . . . . 2.94 109.232 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.422 HD11 ' HE ' ' A' ' 139' ' ' ARG . 80.4 mt -79.73 128.73 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.145 -0.972 . . . . 0.95 108.898 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.5 t -102.56 128.78 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.26 -0.9 . . . . 1.28 109.646 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.1 mt -99.55 139.42 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.352 -0.843 . . . . 1.21 109.319 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -91.38 123.63 34.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.083 -1.011 . . . . 1.81 108.955 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.468 HH11 ' HG2' ' A' ' 28' ' ' ARG . 5.4 mmt-85 -89.96 -0.89 57.83 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.442 -0.786 . . . . 2.8 109.15 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -68.56 139.78 55.59 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.42 -0.8 . . . . 2.87 109.707 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -86.13 146.17 26.71 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.556 -0.905 . . . . 2.35 108.556 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.614 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.6 pt -92.66 165.98 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.161 -0.962 . . . . 0.97 109.95 -179.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 57.3 p -99.71 173.87 6.5 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.488 -0.93 . . . . 1.17 108.488 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.01 -48.13 82.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.947 . . . . 1.18 109.3 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -57.37 -29.08 63.74 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.677 -1.264 . . . . 2.56 109.599 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -82.41 -10.52 59.02 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.063 -1.023 . . . . 1.79 110.257 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 40' ' ' VAL . 40.3 t -62.15 -52.21 63.02 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 120.951 -1.093 . . . . 1.0 108.568 179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -62.89 -40.24 96.94 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.407 -0.808 . . . . 1.77 110.156 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -70.9 -40.14 72.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.132 -0.98 . . . . 2.7 110.542 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.614 ' HG3' HG21 ' A' ' 31' ' ' ILE . 62.4 mm-40 -66.06 -40.11 90.66 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.113 -0.992 . . . . 1.51 110.161 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 36' ' ' VAL . 77.2 t -61.68 -43.35 96.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.082 -1.011 . . . . 0.93 108.444 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -59.97 -39.71 86.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -0.848 . . . . 1.81 108.984 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.7 mtp180 -60.06 -40.93 91.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.935 -1.103 . . . . 2.78 108.228 178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -63.92 -47.87 78.82 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -0.888 . . . . 0.78 108.612 178.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.5 -49.56 77.07 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.435 -0.58 . . . . 1.07 109.435 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.429 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 47.2 t -60.74 -43.3 98.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.113 -0.992 . . . . 1.12 108.81 179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.81 -45.66 96.04 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 108.714 -1.754 . . . . 0.84 108.714 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -65.36 -32.81 74.64 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.954 -1.128 . . . . 3.09 107.954 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.429 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -57.65 -39.16 76.37 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.578 -0.701 . . . . 0.88 109.255 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 50' ' ' ALA . 25.7 ttmt -72.78 -72.98 0.22 Allowed 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.768 -1.197 . . . . 2.59 107.768 179.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.76 -35.7 0.15 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.449 -0.782 . . . . 0.7 111.068 -178.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 78.3 p -59.86 -56.29 23.61 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 120.451 -1.406 . . . . 1.4 108.627 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.67 -42.68 81.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.144 -0.973 . . . . 0.67 110.644 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -65.24 -39.99 93.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.063 -1.023 . . . . 1.66 110.621 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 60.9 mt -66.63 -40.2 88.66 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.743 -1.223 . . . . 1.58 109.818 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -62.04 -36.33 81.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.991 -1.068 . . . . 1.35 109.554 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.9 m -64.04 -40.38 96.17 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.189 -0.944 . . . . 0.77 110.311 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -64.54 -38.81 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.131 -0.981 . . . . 0.63 109.45 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -55.62 -50.43 70.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.392 -0.817 . . . . 1.14 110.612 -179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -59.67 -39.92 86.09 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.199 -0.938 . . . . 0.79 110.224 -176.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -66.22 -35.65 80.98 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.054 -1.029 . . . . 1.53 109.513 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.661 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -63.1 -43.11 99.39 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.498 -0.751 . . . . 0.57 109.942 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -67.38 -50.69 42.5 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.942 -1.263 . . . . 0.75 109.942 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.41 -45.97 92.12 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.202 -1.175 . . . . 1.59 108.642 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 95.5 m -68.52 -58.64 4.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.457 -0.777 . . . . 0.73 111.663 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -97.96 -54.17 3.17 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.002 -1.061 . . . . 0.75 111.265 -178.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.35 -169.31 25.49 Favored Glycine 0 N--CA 1.504 3.191 0 O-C-N 120.694 -1.254 . . . . 1.22 111.573 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -68.59 -27.79 66.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.913 -0.757 . . . . 5.81 111.001 -179.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 tp10 -62.56 -36.31 82.25 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.121 -0.987 . . . . 3.37 110.089 -179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -98.51 -22.37 16.04 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.397 -0.814 . . . . 1.77 110.228 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.6 tt0 -67.92 -40.14 83.43 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.0 -1.062 . . . . 1.65 110.457 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.571 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -69.34 -26.09 64.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.77 110.08 -178.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 87.4 mt -59.88 -40.65 83.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 120.872 -1.142 . . . . 0.8 108.068 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.491 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 20.5 m-85 -69.98 -37.61 75.81 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.428 -0.795 . . . . 0.88 110.139 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.498 ' OE2' ' NZ ' ' B' ' 324' ' ' LYS . 65.6 tt0 -60.65 -40.11 90.81 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.081 -1.012 . . . . 1.37 109.696 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.46 -45.91 81.72 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 109.381 -1.488 . . . . 0.62 109.381 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -60.43 -42.57 96.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.251 -1.147 . . . . 1.5 109.539 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.1 mt -69.82 -41.09 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.124 -0.985 . . . . 0.63 109.531 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.8 ttp -62.57 -40.2 96.09 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.947 -1.096 . . . . 1.51 109.536 -179.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.777 HD11 ' CE2' ' B' ' 348' ' ' PHE . 54.1 tp -64.89 -38.55 91.35 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.454 -0.779 . . . . 0.77 109.855 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 36.5 tp -62.08 -40.14 94.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.438 -0.789 . . . . 0.62 110.305 -179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -84.29 5.84 25.2 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.011 -1.055 . . . . 1.47 110.287 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 61.5 t0 -49.29 133.36 19.59 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.007 -1.058 . . . . 1.47 110.114 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.475 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 45.7 mt-10 -59.15 -21.22 59.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.809 -0.557 . . . . 1.78 110.507 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -71.03 -34.31 71.16 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.939 -1.101 . . . . 2.53 109.309 179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.4 mt -71.07 -41.03 71.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.566 -0.709 . . . . 0.8 110.111 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 89.3 tt0 -60.48 -47.69 85.01 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.533 -0.729 . . . . 1.42 110.653 -178.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -69.82 -40.61 75.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.06 -1.025 . . . . 1.71 110.227 -178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.63 -39.9 70.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.34 -0.85 . . . . 1.57 111.875 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.4 mt -69.55 -47.82 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.758 -1.213 . . . . 0.65 109.83 -179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.7 mt -69.66 -38.48 76.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.243 -0.911 . . . . 0.82 109.99 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.24 -41.81 93.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.011 -1.056 . . . . 0.79 109.964 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.4 -45.98 88.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.839 -1.163 . . . . 0.95 109.406 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.8 mt -63.66 -46.8 93.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.303 -0.873 . . . . 0.66 108.88 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -69.82 -42.36 73.77 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.334 -0.854 . . . . 2.2 111.602 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -86.08 -51.64 6.2 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 120.78 -1.2 . . . . 1.65 112.596 -177.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -88.8 -2.6 58.67 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.941 -1.099 . . . . 2.03 111.479 -177.235 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 56.8 37.98 29.16 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.908 -1.12 . . . . 1.42 109.709 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.1 mtt -87.44 169.21 12.43 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.548 -0.72 . . . . 1.18 110.043 -179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 29.1 p -84.37 160.3 20.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.301 -0.875 . . . . 0.98 108.85 179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.75 -38.94 87.62 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.05 -1.032 . . . . 0.64 110.032 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 38.6 p-10 -69.66 -36.8 76.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.983 -1.073 . . . . 2.07 110.168 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.48 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -81.57 -47.47 13.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.958 -1.088 . . . . 0.73 110.065 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.19 -49.76 76.34 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.3 -0.875 . . . . 0.54 109.845 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.38 85.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.1 -1.0 . . . . 0.56 109.561 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.53 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 78.7 t60 -60.19 -41.99 94.1 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 1.54 110.263 -178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -62.34 -40.03 95.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.077 -1.014 . . . . 1.33 110.804 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.1 t -61.31 -56.33 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.948 -1.095 . . . . 0.72 111.613 -177.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.1 mm -69.24 -39.95 79.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.654 -1.279 . . . . 0.85 109.627 -179.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.53 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 86.7 tt0 -60.31 -40.05 89.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.083 -1.011 . . . . 2.44 109.413 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.78 -49.37 79.33 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.405 -1.078 . . . . 0.98 110.405 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -67.97 -56.34 9.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.974 -1.31 . . . . 1.41 109.607 -179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.22 -42.7 63.77 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.726 -1.234 . . . . 1.2 109.041 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 28.4 t -59.84 -40.16 87.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.029 -1.045 . . . . 1.7 108.723 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.59 -39.29 93.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.34 -0.85 . . . . 1.47 109.206 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.9 mt -66.47 -40.09 89.18 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.239 -0.913 . . . . 1.56 109.385 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -60.07 -33.52 72.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.986 -1.071 . . . . 2.2 109.941 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -58.74 -21.02 54.25 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.983 -1.073 . . . . 2.12 108.768 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.457 HD13 HD13 ' A' ' 123' ' ' LEU . 57.2 mt -62.77 139.64 58.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.232 -0.918 . . . . 2.0 109.247 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -92.46 46.1 1.23 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.981 -1.075 . . . . 3.23 108.929 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -132.12 130.74 41.57 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.4 -0.812 . . . . 2.49 110.033 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -69.9 -33.83 72.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.534 -0.729 . . . . 3.95 110.641 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.487 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.2 t80 -70.24 -40.21 74.6 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.121 -0.987 . . . . 2.0 110.566 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.589 ' CD2' HH21 ' A' ' 126' ' ' ARG . 82.4 mt -70.05 -35.96 74.64 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.954 -1.091 . . . . 1.86 108.747 179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -59.93 -40.0 87.42 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.658 -0.651 . . . . 2.84 109.285 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 84.6 mt-10 -59.79 -46.5 89.02 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.857 -1.152 . . . . 2.73 110.011 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.589 HH21 ' CD2' ' A' ' 123' ' ' LEU . 74.0 mtm180 -62.62 -35.81 80.78 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.634 -1.291 . . . . 2.77 108.766 178.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.9 -32.29 70.61 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.368 -0.833 . . . . 1.19 108.813 178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.64 -40.05 94.77 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.803 -0.814 . . . . 1.2 108.803 179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -68.07 -40.54 82.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.442 -0.787 . . . . 1.55 110.039 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.49 HG21 HE22 ' B' ' 351' ' ' GLN . 49.9 t -70.22 -40.31 77.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.049 -1.032 . . . . 0.8 109.263 179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 48.7 ttt-85 -60.9 -40.34 92.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.955 -1.09 . . . . 3.09 108.449 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -60.03 -38.97 84.31 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.579 -0.701 . . . . 1.46 110.181 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.4 mt -59.75 -42.48 88.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.199 -0.938 . . . . 0.71 111.262 -178.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -73.94 -32.34 58.91 Favored Glycine 0 N--CA 1.495 2.633 0 C-N-CA 119.395 -1.384 . . . . 0.57 110.566 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 16.2 ttmm -59.99 -48.57 81.15 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.037 -1.273 . . . . 2.59 110.408 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 63.0 mtp180 -69.33 -29.98 67.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.761 -1.212 . . . . 2.83 110.219 -179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.4 tp -59.6 -40.08 86.3 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.043 -1.036 . . . . 1.25 108.277 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.3 mt -61.89 -39.89 93.55 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.192 -1.04 . . . . 0.7 108.192 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.422 ' HE ' HD11 ' A' ' 24' ' ' ILE . 96.9 mtt180 -68.65 -39.87 80.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.322 -0.862 . . . . 2.57 109.582 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 -64.98 -33.77 76.85 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.401 -0.812 . . . . 1.23 111.16 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -73.19 -45.83 52.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 120.571 -1.33 . . . . 0.81 109.615 179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 93.2 mt -69.98 -30.08 67.33 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.681 -0.808 . . . . 1.0 108.989 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.34 40.61 6.02 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.811 -1.716 . . . . 0.89 108.811 -179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.421 ' HA ' HD12 ' A' ' 144' ' ' LEU . 24.3 tp -74.31 147.52 42.22 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.408 -1.054 . . . . 1.14 109.026 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -65.87 147.31 53.57 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.309 -0.869 . . . . 4.6 110.217 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.4 mt -115.63 123.17 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 N-CA-C 108.524 -0.917 . . . . 1.24 108.524 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 20.6 mm -59.54 -49.01 85.26 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.765 -0.585 . . . . 1.54 110.574 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.2 t0 67.72 101.42 0.05 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.51 -0.744 . . . . 1.5 109.085 -179.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.725 HD21 HD21 ' A' ' 19' ' ' LEU . 91.2 mt -72.68 -1.97 18.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.313 -0.867 . . . . 0.79 110.195 -179.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 45.5 t -81.85 -10.84 59.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 1.4 108.402 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.03 26.25 0.63 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.739 -0.6 . . . . 0.92 110.496 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.452 ' CD1' ' O ' ' A' ' 149' ' ' LEU . 50.3 mt -91.69 123.66 43.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 121.209 -0.932 . . . . 0.88 109.425 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -105.86 -10.95 16.41 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.213 -0.93 . . . . 2.45 109.975 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -134.02 155.07 50.65 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.137 -0.977 . . . . 1.52 110.512 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.31 134.51 56.59 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.695 0.76 . . . . 1.58 109.53 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.1 m -151.85 164.16 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 N-CA-C 108.729 -0.841 . . . . 0.69 108.729 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.5 mt -94.96 144.72 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.766 -1.568 . . . . 0.61 106.766 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -92.64 117.63 30.18 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.814 -1.178 . . . . 0.87 110.131 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 3.5 t -126.44 132.99 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 N-CA-C 108.619 -0.882 . . . . 0.71 108.619 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.64 165.46 30.59 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.344 -0.847 . . . . 0.81 108.912 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.0 -34.53 71.44 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.452 -1.405 . . . . 0.98 107.464 177.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 12.9 t70 -162.34 167.37 23.91 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.366 -0.976 . . . . 2.25 108.366 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.421 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 92.8 mt -140.55 132.48 27.67 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.215 -0.928 . . . . 0.78 108.746 179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 5.6 p -98.95 153.99 37.55 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.302 -0.874 . . . . 0.98 109.606 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -45.37 -33.62 9.22 Favored 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 121.861 1.708 . . . . 0.81 112.327 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.7 m -53.27 -50.08 65.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.945 . . . . 0.9 109.941 -178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.65 -40.03 94.73 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.444 -0.785 . . . . 1.61 110.703 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 44.7 p -58.13 -18.67 26.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.286 -0.884 . . . . 0.61 111.749 -177.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.661 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -86.08 -45.95 10.92 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.814 -1.179 . . . . 0.6 109.034 179.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -91.69 41.8 1.08 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.762 -1.199 . . . . 1.4 107.762 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.457 HD11 HG21 ' A' ' 176' ' ' VAL . 57.7 tp -108.74 138.79 44.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.639 -0.663 . . . . 0.7 109.513 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -93.38 99.54 12.03 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.291 -0.881 . . . . 2.35 108.78 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 25.1 mt -65.22 -40.36 94.0 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.195 -0.94 . . . . 1.51 109.679 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -62.48 -29.57 70.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.067 -1.021 . . . . 2.33 110.792 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -94.17 -9.2 37.13 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.826 -1.171 . . . . 1.92 110.721 -178.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 178' ' ' GLY . 77.5 t -104.14 118.18 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 O-C-N 121.036 -1.04 . . . . 0.67 108.578 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 86.4 mt -88.96 9.41 25.12 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.473 -0.767 . . . . 1.53 111.266 -177.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 166.58 175.41 36.79 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.31 -1.516 . . . . 0.48 109.31 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.411 ' CE1' HG11 ' A' ' 176' ' ' VAL . 18.8 m-85 -134.14 131.27 38.48 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.46 -1.023 . . . . 0.55 108.835 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 98.0 mt -132.05 124.26 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.723 -0.843 . . . . 0.65 108.723 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 17.6 p -145.4 159.6 42.82 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.901 -1.124 . . . . 0.82 110.947 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -100.35 19.98 15.65 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.51 -0.744 . . . . 2.46 109.844 -179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.23 -162.01 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.695 -1.253 . . . . 1.28 111.379 -178.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -87.26 -45.83 5.19 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 111.305 -0.718 . . . . 2.19 111.305 -178.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 166.83 -145.66 10.11 Favored Glycine 0 N--CA 1.495 2.614 0 C-N-CA 118.43 -1.843 . . . . 2.13 111.245 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -60.69 -9.97 4.67 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.675 -0.897 . . . . 5.86 110.749 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 82.1 p -78.36 -1.09 31.66 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.862 -1.148 . . . . 3.72 109.868 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.8 t -91.83 129.78 37.73 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.178 -0.951 . . . . 1.74 109.927 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -46.26 -48.02 18.01 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.149 -0.97 . . . . 0.95 109.617 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 89.7 m -59.71 -38.51 81.83 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.61 -0.681 . . . . 1.55 110.866 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 96.6 p -59.81 -39.84 86.37 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.691 -1.255 . . . . 1.51 110.346 -178.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 48.4 mm -62.61 -37.9 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.145 -0.972 . . . . 1.67 109.199 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.7 mtp -60.15 -43.79 95.48 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.37 -0.831 . . . . 1.02 110.162 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.28 -42.88 82.49 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.605 -1.309 . . . . 0.68 108.609 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -60.05 -54.12 49.73 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.619 -0.832 . . . . 2.93 110.425 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 58.4 m -71.26 -34.36 70.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.133 -0.979 . . . . 0.86 111.199 -178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.36 -29.74 66.49 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.01 -1.056 . . . . 0.67 108.724 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 69.99 49.87 0.48 Allowed 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 121.236 0.541 . . . . 1.5 110.696 -179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 43.8 mt -128.27 149.28 70.93 Favored Pre-proline 0 N--CA 1.505 2.311 0 N-CA-C 107.799 -1.185 . . . . 0.72 107.799 178.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.14 143.53 99.74 Favored 'Trans proline' 0 N--CA 1.5 1.899 0 C-N-CA 122.21 1.94 . . . . 0.61 112.157 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -172.46 153.37 2.88 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.232 -0.987 . . . . 0.66 111.161 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.2 mt -128.0 143.55 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 N-CA-C 107.847 -1.168 . . . . 0.79 107.847 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 28.3 m -128.78 -11.52 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 O-C-N 120.819 -1.176 . . . . 0.91 111.037 -178.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.64 26.59 17.49 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.413 -1.075 . . . . 1.01 110.413 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.446 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.6 p -45.99 -42.2 12.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.105 -1.232 . . . . 0.99 109.542 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.34 -51.44 4.2 Favored Glycine 0 N--CA 1.494 2.547 0 C-N-CA 120.143 -1.027 . . . . 1.12 111.641 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 14.1 t -158.7 35.42 0.22 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 120.483 -1.598 . . . . 1.72 111.478 -179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 44.4 t -73.82 -40.04 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.128 -0.983 . . . . 0.89 108.747 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 47.2 p -54.77 -27.41 41.16 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.711 -0.618 . . . . 1.03 110.404 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 9.8 t -85.75 -12.13 51.83 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.16 -0.962 . . . . 1.83 110.624 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -104.19 -14.59 15.79 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.168 -0.957 . . . . 2.27 110.673 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.464 HG11 HD11 ' A' ' 218' ' ' LEU . 18.7 t -110.79 146.12 16.29 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 O-C-N 121.15 -0.969 . . . . 0.92 111.208 -177.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? -113.36 150.11 33.08 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.747 -1.575 . . . . 2.2 106.747 177.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.525 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 56.6 t30 -55.82 139.96 43.83 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.944 -1.097 . . . . 2.36 110.014 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.525 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 4.7 t70 88.92 11.86 0.08 Allowed 'General case' 0 N--CA 1.504 2.232 0 CA-C-O 121.27 0.557 . . . . 2.38 109.988 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 52.7 t0 -83.41 141.86 31.41 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.2 -0.938 . . . . 2.09 109.31 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.553 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 51.3 t80 -89.97 117.5 28.82 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.982 -1.118 . . . . 1.27 107.982 178.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.464 HD11 HG11 ' A' ' 212' ' ' VAL . 78.0 mt -124.42 142.17 51.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.57 -0.706 . . . . 0.75 109.749 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 88.7 mt -110.2 124.75 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 106.968 -1.493 . . . . 0.63 106.968 177.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 21.4 tp -98.36 115.9 29.43 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.901 -1.124 . . . . 0.7 108.064 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.507 ' O ' ' N ' ' A' ' 223' ' ' VAL . 15.0 m-20 -79.43 -44.25 21.74 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 108.524 -0.917 . . . . 2.31 108.524 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.96 14.75 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 109.043 -0.725 . . . . 0.78 109.043 -179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.507 ' N ' ' O ' ' A' ' 221' ' ' ASP . 47.0 t -124.71 -36.29 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.629 -1.619 . . . . 1.04 106.629 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.415 ' OD1' ' NE2' ' A' ' 226' ' ' GLN . 15.6 t-20 -108.61 0.06 20.52 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.864 -1.162 . . . . 2.44 107.864 178.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 65.07 46.22 2.84 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.905 -0.497 . . . . 1.55 111.324 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.415 ' NE2' ' OD1' ' A' ' 224' ' ' ASN . 23.0 pt20 -150.07 150.21 31.4 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 120.751 -1.218 . . . . 1.99 109.631 178.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.88 123.84 71.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.557 -0.905 . . . . 0.77 108.557 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -85.92 129.09 34.93 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.934 -1.104 . . . . 0.98 109.283 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.8 t -104.59 118.41 51.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.541 -0.724 . . . . 0.85 109.641 -179.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 60.68 69.8 1.07 Allowed Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.112 -0.993 . . . . 1.66 110.294 179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -90.45 132.07 1.73 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 123.532 2.821 . . . . 0.95 112.63 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.8 m -63.96 161.9 14.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.284 -0.885 . . . . 1.84 110.032 -179.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.23 -42.49 95.35 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.209 -0.932 . . . . 2.74 110.479 -178.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -60.81 -33.0 72.34 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.975 -1.078 . . . . 2.89 109.43 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.17 -40.07 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 1.3 109.3 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 86.1 mt -64.37 -41.38 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.238 -0.914 . . . . 1.09 109.464 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -60.32 -42.46 95.66 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.993 -1.067 . . . . 2.43 108.789 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -62.59 -44.09 97.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.377 -0.827 . . . . 2.78 109.054 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 84.5 mtp -71.29 -30.62 66.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.492 -0.755 . . . . 1.25 110.68 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 20.8 mmt180 -65.04 -44.26 89.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.766 -1.209 . . . . 2.63 109.601 -179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.27 -40.55 90.8 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.53 -0.915 . . . . 1.8 108.53 179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 61.2 t -66.84 -39.94 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.803 -0.814 . . . . 2.13 108.803 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -60.08 -42.91 95.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.366 -0.834 . . . . 3.17 108.822 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -69.82 -36.87 75.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.376 -0.828 . . . . 1.78 109.184 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -60.56 -40.26 90.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.29 -0.881 . . . . 2.47 109.86 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.5 -45.63 98.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.133 -0.979 . . . . 2.09 109.08 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.44 -40.1 93.21 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.559 -0.713 . . . . 2.54 109.597 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.533 ' O ' ' N ' ' A' ' 252' ' ' GLU . 4.0 t -67.28 -41.84 84.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.377 -0.827 . . . . 2.99 110.589 -179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -60.3 -39.61 87.56 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.226 -0.921 . . . . 3.34 109.604 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -59.97 -39.32 85.23 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.824 -0.548 . . . . 3.88 111.664 -178.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -126.35 -34.77 2.46 Favored 'General case' 0 N--CA 1.507 2.385 0 O-C-N 120.917 -1.114 . . . . 4.43 111.674 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 248' ' ' SER . 92.9 mt-10 -90.1 69.95 7.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.739 -1.226 . . . . 5.42 109.82 -178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 31.3 mt -84.85 -2.59 57.96 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.023 -1.103 . . . . 6.1 108.023 178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -68.5 -31.49 70.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.593 -0.692 . . . . 7.37 110.386 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 20.7 pttp -61.01 -15.63 34.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.882 -1.136 . . . . 8.01 109.938 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 258' ' ' ASP . 55.1 tp -59.74 -43.19 94.35 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.243 -0.91 . . . . 9.05 108.71 179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -55.82 86.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.392 -0.817 . . . . 10.56 110.161 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 256' ' ' LEU . 9.4 p-10 -58.03 -62.94 1.45 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.942 -0.703 . . . . 11.32 109.378 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.49 ' H ' ' CG ' ' A' ' 258' ' ' ASP . 18.9 ttt-85 . . . . . 0 N--CA 1.495 1.797 0 CA-C-O 118.075 -0.964 . . . . 12.42 109.6 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 41.5 ttp . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.444 0.64 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -153.31 150.05 28.52 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -150.93 159.7 44.39 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.866 -1.146 . . . . 0.0 111.064 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -157.6 155.53 30.28 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.696 -0.628 . . . . 0.0 109.331 178.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -115.28 133.48 55.99 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.147 -0.971 . . . . 0.0 110.559 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.2 p -133.59 124.31 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 CA-C-O 122.11 0.957 . . . . 0.0 112.139 -177.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . 0.436 ' O ' HG23 ' B' ' 309' ' ' THR . 25.8 m -78.02 107.08 10.32 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 122.026 0.917 . . . . 0.0 111.195 -177.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.7 mt -52.92 120.21 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 122.477 1.132 . . . . 0.0 110.451 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . 0.436 HG23 ' O ' ' B' ' 307' ' ' THR . 30.6 p -108.45 18.68 20.7 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.967 -178.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.457 ' O ' ' CG ' ' B' ' 357' ' ' GLN . . . -73.01 128.47 87.85 Favored Pre-proline 0 C--N 1.302 -1.493 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -63.02 -14.63 42.76 Favored 'Trans proline' 0 N--CA 1.499 1.811 0 CA-C-N 120.309 1.146 . . . . 0.0 112.859 -179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -120.4 10.32 11.17 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 76.78 -179.13 49.9 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 108.851 -1.7 . . . . 0.0 108.851 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.487 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 2.8 tp -82.28 87.45 6.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.765 -1.432 . . . . 0.0 109.033 -178.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.406 ' NE2' ' HB3' ' B' ' 317' ' ' ARG . 2.6 p80 -92.54 -160.89 0.78 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.918 -1.114 . . . . 0.0 109.865 178.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.8 m -56.87 -45.66 82.36 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.986 -1.071 . . . . 0.0 112.789 -176.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.571 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 11.9 tpt180 -56.14 -59.1 12.8 Favored Pre-proline 0 N--CA 1.503 2.211 0 O-C-N 120.613 -1.305 . . . . 0.0 111.933 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.4 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 18.0 Cg_endo -62.04 -36.62 69.67 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 120.369 1.167 . . . . 0.0 111.921 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.06 -47.71 84.74 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.26 -46.23 76.11 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.567 -0.708 . . . . 0.0 109.756 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 48.8 tp60 -70.03 -39.88 75.51 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 120.824 -1.172 . . . . 0.0 108.355 179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -61.57 -54.97 36.03 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.406 -0.809 . . . . 0.0 110.603 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.91 -30.63 50.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.667 -1.271 . . . . 0.0 110.091 -178.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.498 ' NZ ' ' OE2' ' A' ' 74' ' ' GLU . 29.7 ttmt -60.01 -45.41 92.87 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.173 -0.954 . . . . 0.0 109.076 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . 0.41 ' OE1' HD22 ' B' ' 380' ' ' LEU . 81.5 tt0 -68.31 -54.87 14.5 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.226 -0.921 . . . . 0.0 111.029 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -65.0 -54.91 23.04 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.848 -1.158 . . . . 0.0 112.284 -178.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 27.2 ttpp -52.97 -17.25 1.33 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.797 -1.189 . . . . 0.0 109.636 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -73.79 -16.85 79.17 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -105.48 150.54 25.22 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.15 -1.206 . . . . 0.0 109.248 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 14.6 t -89.76 -12.85 38.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.062 -1.024 . . . . 0.0 110.261 -179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.488 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 43.7 t -60.22 142.61 54.21 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.169 -0.957 . . . . 0.0 109.496 179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -67.59 136.08 53.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 108.656 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 79.1 mt -135.46 135.82 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.499 -0.751 . . . . 0.0 109.346 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 96.4 m -130.6 149.69 52.14 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.814 -0.809 . . . . 0.0 108.814 179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 58.8 t -120.29 114.73 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 55.4 m -104.27 123.58 47.61 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.216 -0.927 . . . . 0.0 109.365 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 56.7 p -130.77 115.25 16.37 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.789 0.804 . . . . 0.0 110.489 -179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 44.67 59.18 3.49 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 177.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.12 -15.04 18.21 Favored Glycine 0 N--CA 1.498 2.805 0 O-C-N 120.321 -1.487 . . . . 0.0 112.688 176.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -115.98 127.4 54.91 Favored 'General case' 0 N--CA 1.504 2.251 0 CA-C-N 118.833 1.317 . . . . 0.0 109.285 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 53.9 p -129.61 150.18 51.05 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.844 0.831 . . . . 0.0 110.369 -178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.83 168.17 20.39 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 5.6 m -87.82 130.0 35.01 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.388 -0.82 . . . . 0.0 111.086 -178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -68.23 -20.27 64.8 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.395 -0.815 . . . . 0.0 109.322 179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.02 21.16 1.09 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . 0.465 ' H ' ' C ' ' B' ' 344' ' ' ALA . 16.7 m -151.39 96.29 2.26 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.756 0.789 . . . . 0.0 111.981 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.663 HD23 HD22 ' A' ' 79' ' ' LEU . 58.9 tp -59.94 -33.75 72.32 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 178.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.777 ' CE2' HD11 ' A' ' 79' ' ' LEU . 69.1 m-85 -54.62 -52.46 62.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.391 -0.818 . . . . 0.0 110.716 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -70.34 -40.1 74.3 Favored 'General case' 0 N--CA 1.485 1.285 0 O-C-N 121.05 -1.032 . . . . 0.0 110.255 -178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.604 ' O ' ' N ' ' B' ' 352' ' ' THR . 79.3 mt -49.76 -55.16 15.06 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.826 -1.171 . . . . 0.0 108.69 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.49 HE22 HG21 ' A' ' 130' ' ' VAL . 32.3 mt-30 -41.42 -13.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.792 -0.568 . . . . 0.0 110.955 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.604 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.0 p -93.33 -10.41 35.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.286 -1.509 . . . . 0.0 110.158 -179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 70.2 mt -92.07 117.94 30.32 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.106 -0.996 . . . . 0.0 108.838 179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -71.02 88.96 0.39 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.8 mt -98.33 88.51 4.17 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.224 -1.162 . . . . 0.0 109.189 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 34.3 p -89.95 175.82 7.04 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.943 -1.098 . . . . 0.0 110.96 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . 0.457 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 20.5 tm0? -68.97 113.02 5.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.638 -0.664 . . . . 0.0 110.227 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.97 9.14 37.84 Favored Glycine 0 N--CA 1.497 2.737 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 45.2 m -87.64 112.05 21.91 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.165 -1.197 . . . . 0.0 110.847 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 39.0 t -76.5 116.98 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 CA-C-O 122.137 0.97 . . . . 0.0 109.861 -177.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 27.3 m -112.57 176.03 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -178.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 70.5 m -131.52 128.38 39.21 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 88.2 mt -101.16 113.46 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 51.1 m -116.72 130.57 56.81 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.21 152.72 39.67 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.126 -0.984 . . . . 0.0 110.654 -178.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -143.77 122.99 12.97 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.571 -0.899 . . . . 0.0 108.571 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.571 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.62 -156.55 27.24 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.153 -1.499 . . . . 0.0 111.369 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -59.89 -53.8 53.64 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.488 ' H ' ' HB2' ' B' ' 331' ' ' SER . 12.0 t70 -103.3 11.37 36.84 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.107 -0.995 . . . . 0.0 111.434 -176.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.571 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 10.6 pt-20 -48.02 -41.62 26.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.102 -0.999 . . . . 0.0 111.779 -178.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . 0.415 ' N ' ' CG ' ' B' ' 370' ' ' GLU . 97.7 mt-30 -69.97 -48.52 57.95 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.636 -1.29 . . . . 0.0 110.335 -178.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -66.11 -45.37 81.37 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 119.151 -1.02 . . . . 0.0 109.463 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -49.74 -74.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.042 -1.036 . . . . 0.0 110.647 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.575 ' O ' HG23 ' B' ' 378' ' ' VAL . 39.3 t -45.3 -38.62 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.004 -1.06 . . . . 0.0 110.42 -177.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -63.77 -48.15 78.12 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.828 -1.17 . . . . 0.0 109.861 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -79.52 -42.58 24.86 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.0 -1.063 . . . . 0.0 110.571 -179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.9 mt -59.4 -37.14 77.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.924 -1.11 . . . . 0.0 109.079 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.575 HG23 ' O ' ' B' ' 374' ' ' VAL . 43.1 t -63.15 -40.23 88.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 C-N-CA 119.204 -0.998 . . . . 0.0 109.309 179.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.426 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.5 mttt -69.45 -55.61 9.79 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.694 -1.254 . . . . 0.0 108.476 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.41 HD22 ' OE1' ' B' ' 325' ' ' GLU . 58.0 tp -57.09 -32.75 66.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 109.452 -178.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 4.6 tpp -71.29 -40.01 71.13 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 118.543 -1.263 . . . . 0.0 107.885 177.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.4 -7.97 59.66 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.659 -0.651 . . . . 0.0 110.818 179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.449 ' O ' ' OE2' ' B' ' 385' ' ' GLU . 96.5 mt-10 -110.33 -0.27 17.71 Favored 'General case' 0 N--CA 1.509 2.518 0 O-C-N 120.822 -1.173 . . . . 0.0 111.317 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.1 mt -82.31 132.36 35.22 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.394 -1.441 . . . . 0.0 110.238 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . 0.519 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 56.4 mp0 . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 118.148 -0.929 . . . . 0.0 108.926 179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mtm . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.104 -0.702 . . . . 2.91 109.104 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.4 mt -110.0 130.04 63.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 O-C-N 121.398 -0.814 . . . . 1.2 109.822 -179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.5 m -133.8 147.86 51.28 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.466 -0.771 . . . . 1.4 109.401 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.52 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -127.42 -162.32 11.09 Favored Glycine 0 N--CA 1.5 2.902 0 N-CA-C 108.766 -1.734 . . . . 1.05 108.766 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.453 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.8 mt -92.83 -14.64 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.844 -1.386 . . . . 1.15 109.775 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.8 tp 55.21 103.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.528 -0.916 . . . . 0.98 108.528 -179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.01 -30.08 17.0 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 0.88 109.104 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.0 t -141.57 126.89 10.8 Favored Pre-proline 0 N--CA 1.496 1.85 0 O-C-N 121.454 -0.779 . . . . 1.69 109.457 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -78.55 142.82 18.66 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 121.738 1.625 . . . . 0.85 111.599 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.784 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.2 -164.16 36.97 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.35 -1.5 . . . . 0.92 109.35 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 97.6 mt -147.32 148.62 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.009 -1.289 . . . . 0.81 109.005 179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.33 152.45 32.12 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.094 -1.004 . . . . 0.51 110.105 179.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.566 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -135.09 124.85 25.35 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 108.122 -1.066 . . . . 0.62 108.122 179.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.71 -175.95 47.39 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 118.739 -1.696 . . . . 0.55 110.701 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -79.57 155.63 28.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.868 -0.784 . . . . 2.1 109.534 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -103.04 130.17 50.08 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.48 -0.763 . . . . 0.77 110.461 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.2 tp -98.36 135.51 39.85 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.024 -1.102 . . . . 0.91 108.024 178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.9 tp -117.88 124.44 48.31 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 121.743 0.783 . . . . 0.93 109.756 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.2 mt -99.97 109.97 22.3 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.742 -0.598 . . . . 0.93 110.916 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 22.9 mtpp -110.66 140.84 44.65 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.559 -0.713 . . . . 2.75 109.191 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -126.78 130.86 51.11 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.31 -0.869 . . . . 3.0 108.782 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 34.2 p-10 -77.58 155.33 31.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.05 -1.032 . . . . 2.77 109.104 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -72.05 141.26 49.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.911 . . . . 2.94 109.511 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.9 mt -82.44 136.4 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.286 -0.884 . . . . 0.95 108.632 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 77.7 t -95.23 129.42 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.098 -1.001 . . . . 1.28 110.071 -179.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -110.01 135.87 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 O-C-N 121.598 -0.688 . . . . 1.21 109.303 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 -90.93 123.54 34.51 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.995 -1.066 . . . . 1.81 110.242 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.3 mmt180 -90.04 -3.91 57.69 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.591 -0.693 . . . . 2.8 110.469 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -70.33 142.79 52.15 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.004 -1.06 . . . . 2.87 110.6 -179.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.0 mmtp -84.3 153.17 23.68 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.217 -0.927 . . . . 2.35 108.91 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.63 HG21 ' HG3' ' A' ' 39' ' ' GLU . 3.6 pt -95.05 165.83 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.161 -0.962 . . . . 0.97 109.835 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.7 p -93.74 170.75 9.34 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.144 -1.058 . . . . 1.17 108.144 178.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.41 77.79 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.812 -1.18 . . . . 1.18 109.722 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -55.49 -28.73 56.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.744 -1.222 . . . . 2.56 109.303 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -81.52 -11.28 59.24 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.39 -0.818 . . . . 1.79 110.069 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.3 t -63.34 -51.71 67.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.751 -1.218 . . . . 1.0 108.94 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -61.47 -39.99 92.9 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.32 -0.862 . . . . 1.77 109.758 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -69.14 -41.33 77.47 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.267 -0.896 . . . . 2.7 110.781 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.63 ' HG3' HG21 ' A' ' 31' ' ' ILE . 74.9 mm-40 -65.0 -40.05 94.38 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.831 -1.168 . . . . 1.51 110.015 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.6 -45.18 97.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.503 -1.295 . . . . 0.93 107.503 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -60.09 -42.7 95.23 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.148 -0.97 . . . . 1.81 109.125 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -60.05 -40.16 88.44 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.657 -1.238 . . . . 2.78 107.657 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -66.39 -43.95 84.43 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.421 -0.955 . . . . 0.78 108.421 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.08 -50.01 75.4 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.448 -0.945 . . . . 1.07 108.448 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.42 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 22.7 t -62.34 -43.52 98.64 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 119.542 -0.863 . . . . 1.12 108.731 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.76 -44.22 98.22 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.266 -1.934 . . . . 0.84 108.266 179.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.407 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 32.8 ttt-85 -64.1 -36.03 82.69 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.35 -0.981 . . . . 3.09 108.35 178.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -54.77 -40.04 68.99 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.852 -0.795 . . . . 0.88 108.852 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 50' ' ' ALA . 17.1 ttmt -67.96 -74.79 0.11 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.166 -1.05 . . . . 2.59 108.166 179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.27 -31.86 0.06 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.529 -0.732 . . . . 0.7 111.028 -178.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.412 ' N ' ' O ' ' A' ' 49' ' ' LYS . 47.4 t -59.57 -58.79 7.05 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.706 -1.246 . . . . 1.4 108.634 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.24 -44.51 71.81 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.275 -0.891 . . . . 0.67 111.261 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -61.05 -44.43 97.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.89 -1.131 . . . . 1.66 110.879 -178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.52 -40.01 93.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.947 -1.096 . . . . 1.58 110.066 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -60.01 -35.58 75.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.054 -1.029 . . . . 1.35 109.875 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -64.31 -41.42 96.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.04 -1.037 . . . . 0.77 110.145 -179.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 76.8 mt -60.15 -39.94 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.099 -1.001 . . . . 0.63 109.455 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -59.74 -50.15 74.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.249 -0.907 . . . . 1.14 109.638 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 m -60.55 -40.02 90.04 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.453 -0.779 . . . . 0.79 110.804 -177.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -62.57 -39.62 94.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.831 -1.168 . . . . 1.53 109.493 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.603 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -65.86 -42.8 89.95 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.583 -0.698 . . . . 0.57 110.064 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -63.06 -50.17 65.65 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.986 -1.102 . . . . 0.75 110.358 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.78 -42.94 76.69 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.949 -1.324 . . . . 1.59 109.658 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 99.3 m -70.25 -59.12 3.07 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.73 111.944 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.445 ' CE1' ' O ' ' A' ' 168' ' ' THR . 95.8 m-85 -95.09 -53.39 3.83 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.975 -1.078 . . . . 0.75 111.358 -177.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.14 -167.58 26.0 Favored Glycine 0 N--CA 1.502 3.043 0 C-N-CA 119.773 -1.203 . . . . 1.22 111.474 179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -73.29 -26.51 61.11 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.97 -0.724 . . . . 5.81 111.251 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.0 tp10 -61.97 -34.69 76.61 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.006 -1.059 . . . . 3.37 110.245 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -98.83 -24.12 15.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.13 -0.981 . . . . 1.77 110.27 -179.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.61 -40.19 92.35 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.983 -1.073 . . . . 1.65 110.913 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.601 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -60.11 -32.02 70.6 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.213 -0.929 . . . . 0.77 109.747 -178.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.6 mt -59.97 -41.67 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.11 -0.994 . . . . 0.8 109.313 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -70.13 -38.14 75.47 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.299 -0.876 . . . . 0.88 111.229 -179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -59.93 -40.05 87.62 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.723 -1.235 . . . . 1.37 109.683 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.49 -43.94 97.4 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.941 -1.664 . . . . 0.62 108.941 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 59.7 m170 -61.96 -43.03 99.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.457 -1.025 . . . . 1.5 109.403 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.0 mt -68.89 -45.22 80.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.63 109.697 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.0 ttp -59.99 -40.22 88.41 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.024 -1.048 . . . . 1.51 109.902 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.855 HD11 ' CE2' ' B' ' 348' ' ' PHE . 33.1 tp -65.23 -38.07 89.23 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.493 -0.755 . . . . 0.77 109.912 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.3 tp -66.28 -40.03 89.79 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.471 -0.768 . . . . 0.62 110.354 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -81.8 4.67 21.29 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.893 -1.129 . . . . 1.47 109.711 -178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -50.48 131.86 24.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.364 -0.835 . . . . 1.47 110.183 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -62.34 -17.63 59.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.508 -0.745 . . . . 1.78 110.483 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.95 -35.2 74.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.94 -1.1 . . . . 2.53 108.362 178.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.0 mt -70.07 -40.02 75.29 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.468 0.651 . . . . 0.8 109.83 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.1 -49.99 75.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.508 -0.745 . . . . 1.42 110.12 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -71.9 -41.74 67.57 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.277 -0.89 . . . . 1.71 110.63 -179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -70.04 -40.74 74.95 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.054 -1.029 . . . . 1.57 111.596 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 85.9 mt -68.62 -45.74 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.835 -1.166 . . . . 0.65 109.79 -179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -69.61 -35.09 64.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.378 -0.826 . . . . 0.82 110.048 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.09 -42.79 99.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.79 110.653 -179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.3 mt -60.75 -48.09 83.37 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.913 -1.117 . . . . 0.95 109.579 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 55.8 mt -60.13 -48.15 89.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 121.981 0.896 . . . . 0.66 108.862 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 24.9 mtpp -69.93 -40.05 75.76 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.759 -0.588 . . . . 2.2 111.187 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -83.54 -52.35 6.56 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.984 -1.073 . . . . 1.65 112.041 -178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -90.08 -2.27 58.08 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.073 -1.017 . . . . 2.03 111.679 -177.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 56.9 34.68 25.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.918 -1.114 . . . . 1.42 109.305 -179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.4 mtp -90.31 166.63 13.21 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.432 -0.793 . . . . 1.18 110.158 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.413 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 67.2 p -77.63 160.41 28.54 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.457 -0.777 . . . . 0.98 109.279 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.61 -40.04 84.71 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.182 -0.949 . . . . 0.64 110.114 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 34.1 p-10 -68.37 -37.13 80.15 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.07 -1.019 . . . . 2.07 109.309 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.469 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -78.99 -39.96 32.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.041 -1.037 . . . . 0.73 109.593 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.46 -46.72 63.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.862 . . . . 0.54 110.498 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.08 -42.04 93.75 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.092 -1.005 . . . . 0.56 109.652 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.528 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 85.3 t60 -59.91 -39.91 87.01 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.839 . . . . 1.54 109.717 -179.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -60.13 -43.05 95.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.21 -0.931 . . . . 1.33 110.221 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -62.86 -59.45 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.185 -0.947 . . . . 0.72 110.83 -178.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.1 mm -63.57 -40.02 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 120.891 -1.131 . . . . 0.85 108.974 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.528 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 86.7 tt0 -64.01 -40.13 95.65 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.73 -1.211 . . . . 2.44 107.73 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.07 -48.6 85.31 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.952 -1.259 . . . . 0.98 109.952 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 96.8 mm-40 -68.03 -50.73 53.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.933 -1.333 . . . . 1.41 109.188 -179.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.0 -40.33 88.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.26 -0.9 . . . . 1.2 108.606 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 30.3 t -59.91 -40.8 90.05 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.437 -0.949 . . . . 1.7 108.437 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.63 -40.22 96.31 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.33 -0.856 . . . . 1.47 108.781 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 54.8 mt -66.37 -42.13 88.42 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 119.305 -0.958 . . . . 1.56 109.248 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -60.05 -40.01 87.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.737 -1.227 . . . . 2.2 109.444 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -50.22 -20.17 0.97 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.991 -1.068 . . . . 2.12 109.02 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.573 HD13 HD13 ' A' ' 123' ' ' LEU . 54.1 mt -64.19 144.46 57.11 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.141 -0.975 . . . . 2.0 108.611 179.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 43.0 p-10 -100.23 52.5 0.89 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.119 -0.988 . . . . 3.23 110.271 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.433 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 57.5 t0 -135.58 130.47 34.54 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.134 -0.979 . . . . 2.49 109.627 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.433 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 67.0 mt-10 -61.95 -32.97 73.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.515 -0.741 . . . . 3.95 109.837 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.495 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.0 t80 -70.05 -38.53 75.83 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.904 . . . . 2.0 110.421 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.573 HD13 HD13 ' A' ' 118' ' ' LEU . 87.6 mt -80.42 -32.77 37.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.927 -1.108 . . . . 1.86 109.51 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -60.01 -40.48 89.4 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.905 -1.122 . . . . 2.84 108.177 179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.416 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 98.9 mt-10 -65.1 -40.07 94.06 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.511 -0.922 . . . . 2.73 108.511 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.455 ' NE ' ' NE2' ' B' ' 351' ' ' GLN . 0.0 OUTLIER -61.11 -39.95 91.94 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.643 -0.873 . . . . 2.77 108.643 179.416 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.18 -22.56 66.95 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.929 -0.767 . . . . 1.19 108.929 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -70.56 -42.59 70.92 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.645 -0.659 . . . . 1.2 109.78 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -63.88 -40.01 95.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.22 -0.925 . . . . 1.55 110.204 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.24 -41.68 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.106 -0.996 . . . . 0.8 109.427 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.424 HH11 ' HG2' ' A' ' 131' ' ' ARG . 30.3 ttt-85 -60.55 -37.34 80.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.187 -0.946 . . . . 3.09 109.221 179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -59.99 -39.82 87.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.631 -0.668 . . . . 1.46 109.387 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.4 mt -59.93 -42.04 88.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.01 -1.056 . . . . 0.71 109.46 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.41 -32.36 68.2 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.785 -1.326 . . . . 0.57 109.785 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.554 ' NZ ' ' HE ' ' A' ' 139' ' ' ARG . 50.3 tttm -59.92 -48.32 82.2 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.133 -1.216 . . . . 2.59 109.028 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.458 HH21 ' HB3' ' A' ' 166' ' ' SER . 1.8 mtt-85 -61.88 -35.34 78.04 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.993 . . . . 2.83 109.657 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -59.57 -44.18 93.39 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.507 -0.745 . . . . 1.25 110.275 -177.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 49.6 mt -65.12 -40.14 94.06 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.875 -1.141 . . . . 0.7 109.95 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.554 ' HE ' ' NZ ' ' A' ' 135' ' ' LYS . 59.2 mtt-85 -68.84 -38.96 80.18 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.485 -0.932 . . . . 2.57 108.485 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.505 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.4 m120 -65.07 -38.53 91.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.749 -0.594 . . . . 1.23 110.98 -179.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.6 mt -70.0 -43.16 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.548 -1.345 . . . . 0.81 108.946 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.6 mt -70.03 -31.0 68.42 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.623 -0.673 . . . . 1.0 109.727 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.33 39.12 13.04 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 108.759 -1.737 . . . . 0.89 108.759 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.8 tp -73.96 149.55 41.3 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.469 -1.019 . . . . 1.14 109.623 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -61.42 146.74 47.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.509 -0.745 . . . . 4.6 110.127 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.51 121.93 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 CA-C-O 122.077 0.941 . . . . 1.24 108.503 179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 148' ' ' ASP . 6.0 mt -62.77 -44.32 99.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.839 -0.619 . . . . 1.54 110.823 -178.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 147' ' ' ILE . 50.7 t0 61.87 121.33 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.6 -0.688 . . . . 1.5 109.199 -179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 59.9 mt -87.97 0.85 55.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.406 -0.808 . . . . 0.79 109.999 -179.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 62.1 m -82.67 -18.8 39.74 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.878 -1.139 . . . . 1.4 110.716 -179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.52 29.99 0.43 Allowed 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.965 -1.085 . . . . 0.92 111.642 -178.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 45.7 mm -90.55 119.19 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.682 -1.261 . . . . 0.88 108.38 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -100.15 -9.9 22.02 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.355 -0.841 . . . . 2.45 110.454 -178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -126.46 150.94 48.38 Favored 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.1 -1.0 . . . . 1.52 110.35 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.64 137.2 58.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.365 -0.835 . . . . 1.58 109.413 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.6 m -152.18 163.5 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 108.992 -0.744 . . . . 0.69 108.992 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.3 mt -93.42 148.49 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 106.351 -1.722 . . . . 0.61 106.351 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 38.3 tp -96.8 114.28 25.9 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.862 -1.148 . . . . 0.87 110.299 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.4 t -121.51 130.08 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.025 0 N-CA-C 108.525 -0.917 . . . . 0.71 108.525 178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.08 162.05 39.47 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.169 -0.957 . . . . 0.81 108.899 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.94 -32.23 65.14 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.209 -1.557 . . . . 0.98 108.713 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 60.1 t0 -167.24 137.8 3.01 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.628 -0.879 . . . . 2.25 108.628 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.514 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 69.3 mt -112.89 131.41 55.74 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.347 -0.845 . . . . 0.78 109.926 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.5 p -100.56 148.92 35.63 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.419 -0.801 . . . . 0.98 108.906 179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -38.22 -36.98 0.58 Allowed 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.274 1.983 . . . . 0.81 112.717 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.458 ' HB3' HH21 ' A' ' 136' ' ' ARG . 4.2 m -50.34 -58.13 6.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.93 . . . . 0.9 109.979 -179.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -60.61 -39.85 89.7 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.38 -0.825 . . . . 1.61 110.755 -178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.445 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 64.4 p -60.03 -19.59 53.53 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.788 -1.195 . . . . 0.61 110.916 -178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.603 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -83.42 -38.6 21.7 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.852 -1.155 . . . . 0.6 109.556 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -104.66 39.3 1.71 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.663 -0.866 . . . . 1.4 108.663 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.6 tp -106.15 140.08 39.67 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.608 -0.886 . . . . 0.7 108.608 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -85.15 106.85 16.9 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.054 -1.029 . . . . 2.35 109.375 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 94.5 mt -62.84 -41.9 99.53 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.368 -0.833 . . . . 1.51 111.157 -179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -70.06 -24.49 63.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.155 -0.966 . . . . 2.33 111.859 -177.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -93.69 -10.52 34.14 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.654 -1.279 . . . . 1.92 109.711 -179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . . . . . . . . . 68.8 t -98.62 107.02 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.154 -0.967 . . . . 0.67 108.6 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 80.3 mt -81.92 3.83 24.83 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.227 -0.92 . . . . 1.53 110.062 -179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 169.95 173.58 37.48 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.866 -1.294 . . . . 0.48 109.866 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.492 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 7.8 m-85 -129.31 126.93 40.07 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.411 -1.052 . . . . 0.55 109.24 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.415 ' CG2' HG21 ' A' ' 205' ' ' THR . 75.5 mt -128.45 123.69 60.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 N-CA-C 107.815 -1.18 . . . . 0.65 107.815 177.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 35.1 p -147.05 160.61 42.18 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.806 -1.184 . . . . 0.82 111.504 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 61.6 t0 -103.93 25.95 9.28 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 109.233 -0.654 . . . . 2.46 109.233 179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.42 -162.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.317 -1.49 . . . . 1.28 111.562 -177.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.69 -58.16 4.63 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 111.162 -0.775 . . . . 2.19 111.162 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -168.84 -149.79 6.37 Favored Glycine 0 N--CA 1.494 2.508 0 C-N-CA 118.506 -1.807 . . . . 2.13 111.515 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.8 ptt180 -77.93 -9.01 58.87 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.817 -0.814 . . . . 5.86 111.013 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 74.5 p -83.13 4.62 25.71 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.814 -1.179 . . . . 3.72 110.557 -178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 191' ' ' SER . 22.7 p -82.14 143.3 31.55 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.887 -1.133 . . . . 1.74 110.394 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -46.65 -52.45 13.72 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.335 -0.853 . . . . 0.95 110.096 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.429 HG22 ' H ' ' A' ' 190' ' ' THR . 0.1 OUTLIER -56.11 -38.0 70.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.361 -0.837 . . . . 1.55 110.725 -178.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 188' ' ' SER . 80.5 p -61.69 -40.54 95.35 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.891 -1.131 . . . . 1.51 111.029 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.9 mt -60.09 -39.71 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.078 -1.014 . . . . 1.67 109.123 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.0 mtp -59.98 -45.3 93.15 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.556 -0.715 . . . . 1.02 110.214 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.95 -45.72 91.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.601 -1.312 . . . . 0.68 110.292 -179.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 77.9 mtm180 -61.1 -52.04 66.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.853 -1.154 . . . . 2.93 110.607 -179.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 62.1 m -70.4 -34.73 72.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.001 -1.062 . . . . 0.86 111.759 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.5 mt -76.23 -9.98 59.05 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.702 -1.249 . . . . 0.67 110.543 -178.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 61.91 50.21 4.31 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.482 -0.761 . . . . 1.5 111.423 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 20.9 mt -128.36 149.48 71.61 Favored Pre-proline 0 N--CA 1.5 2.048 0 N-CA-C 107.664 -1.235 . . . . 0.72 107.664 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.06 139.5 46.96 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 122.245 1.963 . . . . 0.61 111.718 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -169.5 150.56 4.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.845 -1.159 . . . . 0.66 111.725 -179.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 91.9 mt -126.86 142.12 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 107.792 -1.188 . . . . 0.79 107.792 179.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 18.2 m -123.03 -8.99 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.422 0 O-C-N 120.827 -1.17 . . . . 0.91 111.542 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -113.14 24.29 12.86 Favored Glycine 0 N--CA 1.502 3.07 0 N-CA-C 110.677 -0.969 . . . . 1.01 110.677 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.415 HG21 ' CG2' ' A' ' 180' ' ' ILE . 17.5 p -43.41 -47.91 7.02 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.121 -1.223 . . . . 0.99 110.074 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.433 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 97.03 -55.04 1.33 Allowed Glycine 0 N--CA 1.499 2.897 0 C-N-CA 120.341 -0.933 . . . . 1.12 111.611 179.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 85.6 p -148.52 28.59 0.87 Allowed 'General case' 0 N--CA 1.503 2.216 0 O-C-N 120.397 -1.649 . . . . 1.72 111.584 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 18.3 t -70.03 -36.74 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.717 -1.24 . . . . 0.89 108.839 178.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 65.3 p -58.02 -30.66 66.29 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.22 -0.925 . . . . 1.03 110.964 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 31.1 t -83.02 -19.4 37.02 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.803 -1.186 . . . . 1.83 110.389 -179.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 92.5 mm-40 -96.98 -11.93 23.97 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.089 -1.007 . . . . 2.27 110.471 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.2 t -107.93 137.41 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 O-C-N 121.256 -0.902 . . . . 0.92 110.628 -178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 3.5 mptt -114.89 149.71 36.76 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.48 -1.304 . . . . 2.2 107.48 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.453 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 8.2 t-20 -56.25 138.58 50.12 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.083 -1.011 . . . . 2.36 110.955 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.453 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.0 m-20 83.88 7.42 0.62 Allowed 'General case' 0 N--CA 1.502 2.143 0 CA-C-O 121.138 0.494 . . . . 2.38 110.229 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -77.91 145.9 35.89 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.207 -0.933 . . . . 2.09 108.871 178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -95.34 117.12 29.76 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.273 -1.01 . . . . 1.27 108.273 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' A' ' 16' ' ' ALA . 72.0 mt -126.75 150.7 48.94 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.578 -0.701 . . . . 0.75 110.278 -179.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.7 mt -115.93 128.55 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 106.846 -1.539 . . . . 0.63 106.846 177.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 60.9 tp -99.98 120.09 39.27 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.947 -1.096 . . . . 0.7 109.186 -178.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 223' ' ' VAL . 12.2 t70 -80.18 -41.13 25.87 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.281 -1.007 . . . . 2.31 108.281 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.784 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.27 12.7 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.775 -0.578 . . . . 0.78 109.55 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 221' ' ' ASP . 42.8 t -124.85 -35.44 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 107.283 -1.377 . . . . 1.04 107.283 178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.519 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 71.9 m-80 -111.76 2.61 17.23 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.99 -1.115 . . . . 2.44 107.99 178.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.52 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.6 OUTLIER 59.63 47.77 10.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.776 -0.578 . . . . 1.55 110.376 179.715 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 -135.5 148.22 49.11 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.147 -0.97 . . . . 1.99 109.864 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.7 t -117.84 125.72 74.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 108.545 -0.909 . . . . 0.77 108.545 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -101.13 121.87 42.6 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.405 -0.809 . . . . 0.98 109.177 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.4 HG22 HD22 ' A' ' 218' ' ' LEU . 32.1 t -101.85 113.16 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.462 -0.774 . . . . 0.85 110.897 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 52.02 60.75 13.2 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.052 -1.03 . . . . 1.66 111.3 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -86.67 152.64 8.83 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.653 2.236 . . . . 0.95 111.822 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 76.4 p -74.2 168.44 19.59 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.097 -1.002 . . . . 1.84 110.526 -179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -59.99 -37.94 81.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.663 -0.648 . . . . 2.74 110.265 -179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.57 -38.9 82.38 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.259 -0.901 . . . . 2.89 109.846 -178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.7 t -69.95 -41.35 79.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.218 -0.927 . . . . 1.3 109.236 179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.58 -39.97 87.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.221 -0.924 . . . . 1.09 109.569 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -60.14 -39.95 88.12 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.91 -1.119 . . . . 2.43 108.495 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -66.9 -40.74 87.79 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.481 -0.762 . . . . 2.78 109.343 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 97.0 mtp -69.87 -38.19 76.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.266 -0.896 . . . . 1.25 109.793 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -61.04 -39.95 91.77 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.366 -0.834 . . . . 2.63 109.61 179.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.72 95.27 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 1.8 110.075 -179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 73.3 t -60.34 -40.09 82.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.941 . . . . 2.13 109.392 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -59.97 -40.98 90.96 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.206 -0.934 . . . . 3.17 109.035 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.19 -39.83 94.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 1.78 109.023 179.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.99 -39.97 87.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.543 -0.723 . . . . 2.47 109.249 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 66.1 t -60.09 -40.25 82.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.434 -0.791 . . . . 2.09 109.348 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.17 94.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 2.54 109.524 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 83.1 p -62.57 -40.02 95.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -0.947 . . . . 2.99 109.326 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.42 -38.68 91.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.449 -0.782 . . . . 3.34 109.397 179.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 252' ' ' GLU . 54.7 tttm -59.93 -39.99 87.38 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.485 -0.759 . . . . 3.88 110.038 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -46.39 -17.92 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.096 -1.003 . . . . 4.43 109.686 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 250' ' ' LYS . 81.1 mm-40 -69.95 -28.72 65.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.37 -0.831 . . . . 5.42 109.228 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 9.5 mt 42.17 27.72 0.08 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.506 -0.746 . . . . 6.1 110.157 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 252' ' ' GLU . . . -110.01 21.85 16.32 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.474 -0.766 . . . . 7.37 109.619 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.465 ' C ' ' H ' ' A' ' 257' ' ' LYS . 34.8 mtmm 52.02 36.33 18.39 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.499 -0.926 . . . . 8.01 108.499 -179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.501 ' O ' ' CB ' ' A' ' 257' ' ' LYS . 1.7 tt -74.07 42.5 0.15 Allowed 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.751 -0.833 . . . . 9.05 108.751 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.501 ' CB ' ' O ' ' A' ' 256' ' ' LEU . 42.6 tttp 86.01 157.94 0.09 Allowed 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.122 -0.695 . . . . 10.56 109.122 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 257' ' ' LYS . 78.9 m-20 -148.96 -29.49 0.27 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.416 -0.802 . . . . 11.32 109.398 179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.465 HH11 ' HG2' ' A' ' 259' ' ' ARG . 28.2 mtt-85 . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 118.062 -0.97 . . . . 12.42 109.632 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 25.4 t80 -151.3 149.15 29.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.36 -0.837 . . . . 0.0 108.83 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . 0.491 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 0.4 OUTLIER -146.15 154.65 42.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.199 -0.938 . . . . 0.0 110.171 -178.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -152.73 149.38 28.31 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.535 -0.728 . . . . 0.0 109.113 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -112.52 131.78 55.42 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.287 -0.883 . . . . 0.0 109.101 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.0 123.59 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-O 122.284 1.04 . . . . 0.0 112.476 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 29.3 m -77.84 104.05 8.15 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.999 0.904 . . . . 0.0 110.126 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.543 HG22 ' H ' ' B' ' 310' ' ' ALA . 90.1 mt -51.59 119.58 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 122.487 1.137 . . . . 0.0 110.366 -177.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 23.7 p -99.9 24.63 8.23 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.587 -178.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.543 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -88.28 113.62 55.98 Favored Pre-proline 0 N--CA 1.492 1.652 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -70.99 -5.24 16.54 Favored 'Trans proline' 0 N--CA 1.494 1.517 0 CA-C-N 120.215 1.113 . . . . 0.0 111.864 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -110.45 0.65 17.9 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 74.26 172.17 26.91 Favored Glycine 0 N--CA 1.485 1.9 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.495 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.5 tp -86.05 93.81 9.08 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.956 -1.32 . . . . 0.0 108.333 -179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -93.47 -161.58 0.86 Allowed 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.205 -0.935 . . . . 0.0 110.418 179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . 0.404 ' HA ' ' HE ' ' A' ' 126' ' ' ARG . 2.9 m -59.3 -44.59 92.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.126 -0.984 . . . . 0.0 112.416 -176.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.601 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.3 tpt180 -57.11 -62.52 5.03 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 120.436 -1.415 . . . . 0.0 111.532 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -56.75 -30.68 85.44 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 CA-C-N 120.2 1.107 . . . . 0.0 111.539 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.11 -50.62 72.96 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.371 -0.931 . . . . 0.0 108.83 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -54.88 -43.17 72.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.353 -0.842 . . . . 0.0 109.874 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -70.1 -41.32 74.18 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 118.809 -1.156 . . . . 0.0 108.826 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -60.08 -50.19 74.68 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.455 -0.778 . . . . 0.0 110.356 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 80.4 t -68.93 -27.72 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.713 -1.242 . . . . 0.0 109.74 -179.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -60.02 -49.14 78.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.291 -0.881 . . . . 0.0 110.332 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . 0.475 ' OE1' HD22 ' B' ' 380' ' ' LEU . 86.4 tt0 -68.52 -40.15 80.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.075 -1.015 . . . . 0.0 111.326 -178.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.87 -53.3 58.99 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.561 -1.337 . . . . 0.0 111.108 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -57.69 -11.61 2.29 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.095 -1.003 . . . . 0.0 109.426 -179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -68.07 -29.98 73.72 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.583 -1.807 . . . . 0.0 108.583 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -104.98 144.21 32.11 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.451 -1.029 . . . . 0.0 109.159 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 7.7 m -90.22 -11.28 41.44 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.062 -1.024 . . . . 0.0 109.443 179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.475 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 33.8 m -57.99 149.02 24.18 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 109.846 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -66.91 132.9 48.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.905 . . . . 0.0 109.236 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.9 mt -133.4 132.28 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.307 -0.871 . . . . 0.0 110.041 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . 0.408 HG22 ' N ' ' B' ' 335' ' ' VAL . 52.7 m -128.17 153.15 47.2 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . 0.408 ' N ' HG22 ' B' ' 334' ' ' THR . 84.0 t -119.85 139.87 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 178.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 96.8 m -130.33 123.03 29.04 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.275 -0.891 . . . . 0.0 108.739 179.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 59.8 p -140.11 121.86 15.4 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.081 0.943 . . . . 0.0 111.314 -179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 57.4 t30 43.49 52.68 5.95 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 177.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.35 -12.27 59.0 Favored Glycine 0 N--CA 1.5 2.941 0 O-C-N 120.182 -1.574 . . . . 0.0 112.904 176.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -118.94 129.45 55.18 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-N 119.268 1.534 . . . . 0.0 109.925 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 69.7 m -122.32 146.13 47.6 Favored 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.763 0.792 . . . . 0.0 110.078 -179.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -140.42 161.05 38.63 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 121.472 0.653 . . . . 0.0 109.805 -179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.8 t -86.09 136.29 33.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.517 -0.739 . . . . 0.0 109.246 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.424 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -79.11 -14.12 59.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.978 -1.076 . . . . 0.0 110.418 -178.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . 0.404 ' H ' ' HG2' ' B' ' 345' ' ' LYS . 19.7 pttp -87.36 21.47 2.45 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 177.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . 0.424 ' H ' ' C ' ' B' ' 344' ' ' ALA . 69.2 m -149.62 99.39 2.87 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.795 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.702 HD23 HD22 ' A' ' 79' ' ' LEU . 58.0 tp -60.11 -35.28 74.89 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.855 ' CE2' HD11 ' A' ' 79' ' ' LEU . 51.7 m-85 -55.38 -54.43 43.81 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.956 -1.09 . . . . 0.0 109.786 179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -69.93 -20.57 63.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.29 -0.881 . . . . 0.0 111.29 -177.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' B' ' 352' ' ' THR . 32.8 mt -70.32 -57.91 4.34 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.716 -1.24 . . . . 0.0 110.666 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.552 ' O ' HD22 ' A' ' 123' ' ' LEU . 2.9 mm100 -44.92 -14.77 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.093 -1.005 . . . . 0.0 111.409 -176.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.511 ' N ' ' O ' ' B' ' 350' ' ' LEU . 70.4 p -80.3 -13.44 59.19 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.196 -1.565 . . . . 0.0 110.278 -179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 34.9 mt -93.03 119.26 32.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.098 -1.002 . . . . 0.0 108.778 178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.14 91.22 0.91 Allowed Glycine 0 N--CA 1.487 2.053 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 18.9 mt -96.5 87.31 4.37 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.327 -1.102 . . . . 0.0 108.527 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 64.3 p -92.2 -179.48 5.26 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.802 0.81 . . . . 0.0 110.668 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . 0.424 ' O ' ' N ' ' B' ' 359' ' ' THR . 65.8 tt0 -49.41 155.57 0.72 Allowed 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 122.268 1.033 . . . . 0.0 111.109 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.88 27.58 0.06 OUTLIER Glycine 0 N--CA 1.497 2.729 0 CA-C-N 115.333 -0.848 . . . . 0.0 111.56 177.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . 0.424 ' N ' ' O ' ' B' ' 357' ' ' GLN . 11.8 m -86.57 109.95 19.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.767 -1.431 . . . . 0.0 109.864 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 21.2 t -77.25 114.77 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-O 122.343 1.068 . . . . 0.0 110.147 -177.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 9.9 m -111.93 177.52 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 49.7 m -130.95 130.1 43.0 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 81.9 mt -106.36 122.28 59.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 77.3 p -125.05 134.67 52.44 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.22 152.2 38.83 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.142 -0.973 . . . . 0.0 110.119 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -142.18 121.73 13.31 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.407 ' H ' ' HG2' ' B' ' 370' ' ' GLU . . . 164.43 -163.28 36.04 Favored Glycine 0 N--CA 1.485 1.923 0 C-N-CA 118.636 -1.745 . . . . 0.0 111.536 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -59.57 -50.07 75.32 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 115.01 -0.595 . . . . 0.0 111.673 -177.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.475 ' N ' ' OG ' ' B' ' 331' ' ' SER . 85.2 m-20 -111.6 10.3 21.15 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.974 -1.079 . . . . 0.0 110.936 -177.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' B' ' 367' ' ' GLY . 0.7 OUTLIER -44.02 -33.78 1.54 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.113 -0.992 . . . . 0.0 111.596 -178.61 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -69.89 -40.36 75.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.619 -1.301 . . . . 0.0 109.594 -178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -68.29 -48.15 65.75 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.173 -0.954 . . . . 0.0 109.862 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -50.44 -74.38 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.149 -0.97 . . . . 0.0 110.91 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.586 ' O ' HG23 ' B' ' 378' ' ' VAL . 67.6 t -44.11 -40.75 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.254 -0.904 . . . . 0.0 110.697 -177.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.86 -50.16 72.03 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.526 -1.358 . . . . 0.0 110.481 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 60.1 m-70 -75.81 -40.03 55.72 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.802 -1.186 . . . . 0.0 110.669 -179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 98.9 mt -59.0 -37.51 77.03 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.011 -1.056 . . . . 0.0 108.606 -179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.586 HG23 ' O ' ' B' ' 374' ' ' VAL . 47.1 t -60.74 -40.21 84.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.279 -0.888 . . . . 0.0 109.093 179.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' B' ' 383' ' ' GLU . 20.3 mmmt -67.97 -55.04 14.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.705 -1.247 . . . . 0.0 107.939 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.475 HD22 ' OE1' ' B' ' 325' ' ' GLU . 63.6 tp -56.36 -35.57 67.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.358 -0.839 . . . . 0.0 110.241 -178.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 34.7 ttm -72.45 -41.06 66.53 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.727 -1.233 . . . . 0.0 109.107 178.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.59 -5.69 58.27 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.346 -0.846 . . . . 0.0 110.215 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' B' ' 379' ' ' LYS . 96.2 mt-10 -109.72 -2.78 17.19 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.132 -0.98 . . . . 0.0 111.37 -178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.4 mt -83.7 130.02 34.96 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.285 -1.509 . . . . 0.0 109.027 178.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 . . . . . 0 N--CA 1.499 1.984 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.629 -179.656 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.251 0.548 . . . . 2.91 109.679 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.0 mt -110.18 129.88 64.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.47 -0.769 . . . . 1.2 109.114 179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 24.8 m -130.81 148.78 52.62 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.514 -0.741 . . . . 1.4 109.173 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.42 ' H ' ' ND2' ' A' ' 225' ' ' ASN . . . -130.95 -163.54 10.99 Favored Glycine 0 N--CA 1.499 2.861 0 N-CA-C 108.142 -1.983 . . . . 1.05 108.142 179.323 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.451 ' O ' ' O ' ' A' ' 6' ' ' LEU . 95.7 mt -89.16 -14.79 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 120.659 -1.495 . . . . 1.15 110.068 -179.261 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.451 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.0 tp 54.18 103.64 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.311 -0.868 . . . . 0.98 109.038 -179.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.94 -27.28 14.72 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.186 -0.946 . . . . 0.88 109.424 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.0 m -140.57 124.8 10.65 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.426 -0.796 . . . . 1.69 109.465 -179.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -80.77 150.08 18.48 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.456 2.104 . . . . 0.85 112.904 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.9 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 146.93 171.78 16.53 Favored Glycine 0 N--CA 1.501 2.982 0 N-CA-C 109.811 -1.316 . . . . 0.92 109.811 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 89.7 mt -122.85 130.01 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 O-C-N 121.026 -1.279 . . . . 0.81 110.518 -179.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -133.74 149.32 51.47 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.354 -0.842 . . . . 0.51 110.046 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.552 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.4 m-85 -126.52 129.1 47.96 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 107.726 -1.213 . . . . 0.62 107.726 179.489 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.12 176.39 46.85 Favored Glycine 0 N--CA 1.496 2.644 0 C-N-CA 118.732 -1.699 . . . . 0.55 110.998 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -79.94 158.75 26.55 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.443 -1.033 . . . . 2.1 109.438 -179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -104.59 137.04 43.02 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.522 -0.737 . . . . 0.77 111.015 -178.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.1 tp -106.64 133.36 51.42 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 106.936 -1.505 . . . . 0.91 106.936 177.729 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 52.0 tp -113.55 122.14 46.33 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.169 -0.957 . . . . 0.93 109.687 -179.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 23.1 mt -85.17 100.78 11.97 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.617 -0.677 . . . . 0.93 109.399 -179.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -99.37 133.23 43.97 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.441 -0.787 . . . . 2.75 109.463 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -130.19 134.88 47.6 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.462 -0.774 . . . . 3.0 108.938 179.307 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -79.69 158.21 27.03 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.294 -0.879 . . . . 2.77 109.995 -179.372 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.7 tp10 -70.45 145.78 50.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.351 -0.843 . . . . 2.94 109.225 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 49.8 mt -89.64 129.09 41.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.094 -1.003 . . . . 0.95 108.967 -179.885 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t -93.78 125.47 46.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.181 -0.949 . . . . 1.28 110.38 -179.108 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.06 133.72 50.85 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 N-CA-C 108.521 -0.918 . . . . 1.21 108.521 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -94.34 117.94 30.87 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.008 -1.058 . . . . 1.81 109.847 -179.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.496 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.2 mmt-85 -89.89 3.8 51.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.294 -0.879 . . . . 2.8 109.415 -179.556 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -62.95 149.42 44.76 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.943 . . . . 2.87 109.647 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -91.77 141.91 28.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.364 -0.835 . . . . 2.35 109.217 179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.3 pt -93.77 164.39 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 120.852 -1.155 . . . . 0.97 109.995 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.6 p -92.42 171.53 8.98 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.22 -0.925 . . . . 1.17 108.664 178.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.27 -15.53 63.61 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.106 -0.996 . . . . 1.18 110.285 -179.76 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 76.3 m-20 -85.6 -28.61 24.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.874 -1.141 . . . . 2.56 108.447 178.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -81.58 -8.41 59.71 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.14 -0.689 . . . . 1.79 109.14 179.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.0 t -63.72 -54.91 26.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.115 -0.991 . . . . 1.0 109.129 -179.884 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -60.45 -39.72 88.58 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.077 -1.014 . . . . 1.77 109.355 179.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.2 mm100 -65.7 -42.63 90.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 2.7 110.156 -179.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -64.59 -40.15 95.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.901 -1.124 . . . . 1.51 110.66 -179.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.63 -46.59 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.576 -1.328 . . . . 0.93 108.182 179.206 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -60.14 -44.32 95.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.175 -0.953 . . . . 1.81 109.389 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -59.98 -43.41 95.13 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.908 -1.145 . . . . 2.78 107.908 179.217 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -64.45 -40.02 94.92 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.451 -0.944 . . . . 0.78 108.451 179.008 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.21 -49.95 75.58 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.354 -0.98 . . . . 1.07 108.354 179.481 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.3 t -63.21 -43.5 97.95 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.22 -0.992 . . . . 1.12 108.92 179.086 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.64 -40.02 95.71 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.347 -1.901 . . . . 0.84 108.347 179.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.562 ' CG ' HH11 ' A' ' 47' ' ' ARG . 0.7 OUTLIER -66.65 -39.4 88.21 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.871 -1.159 . . . . 3.09 107.871 178.396 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.0 75.15 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 109.278 -0.638 . . . . 0.88 109.278 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ALA . 22.2 ttmt -60.72 -74.77 0.07 Allowed 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.102 -1.073 . . . . 2.59 108.102 179.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.73 -34.12 0.1 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.435 -0.791 . . . . 0.7 111.471 -177.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.6 m -60.27 -54.68 42.84 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.536 -1.352 . . . . 1.4 108.674 179.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.82 -41.22 75.26 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.339 -0.851 . . . . 0.67 111.161 -178.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.33 -39.92 95.87 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.783 -1.198 . . . . 1.66 110.218 -179.289 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 75.1 mt -66.33 -39.79 89.47 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.0 -1.063 . . . . 1.58 109.963 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -59.97 -38.95 84.02 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.143 -0.973 . . . . 1.35 109.592 -179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -61.87 -41.18 97.55 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.059 -1.025 . . . . 0.77 110.095 179.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.34 -37.19 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.255 -0.903 . . . . 0.63 109.6 -179.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -57.29 -51.16 70.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.432 -0.792 . . . . 1.14 110.665 -178.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -60.62 -37.2 80.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.074 -1.017 . . . . 0.79 111.672 -177.327 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -64.1 -39.85 94.95 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.869 -1.145 . . . . 1.53 110.267 -179.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.426 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -64.13 -42.3 96.88 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.533 -0.729 . . . . 0.57 109.936 -179.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.84 -52.16 54.11 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.703 -1.359 . . . . 0.75 109.703 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -65.63 -48.04 73.55 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.167 -1.196 . . . . 1.59 109.806 -179.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.7 m -70.07 -58.74 3.47 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.344 -0.848 . . . . 0.73 112.144 -177.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -96.85 -53.68 3.45 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 120.912 -1.117 . . . . 0.75 111.292 -178.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.51 -167.42 25.84 Favored Glycine 0 N--CA 1.5 2.96 0 C-N-CA 119.678 -1.248 . . . . 1.22 111.31 179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -70.01 -25.51 63.63 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.799 -0.824 . . . . 5.81 110.685 -179.397 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -61.6 -35.59 78.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.174 -0.954 . . . . 3.37 110.46 -179.461 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.418 ' HA ' HD12 ' A' ' 72' ' ' ILE . 43.9 mmtm -100.38 -19.83 16.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.31 -0.868 . . . . 1.77 110.282 -179.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -69.94 -39.97 75.76 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.98 -1.075 . . . . 1.65 110.263 -179.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.551 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.85 -27.99 68.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.351 -0.843 . . . . 0.77 109.486 -179.174 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 69' ' ' LYS . 85.3 mt -60.08 -40.49 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.18 -0.95 . . . . 0.8 108.928 -179.855 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -69.74 -36.84 76.16 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.193 -0.942 . . . . 0.88 110.705 -179.506 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -59.88 -40.04 87.34 Favored 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.919 -1.113 . . . . 1.37 109.289 179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.04 -43.82 95.23 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.523 -1.431 . . . . 0.62 109.523 179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -62.62 -41.56 99.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.308 -1.113 . . . . 1.5 109.043 -179.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.7 mt -68.67 -46.46 79.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.766 -0.828 . . . . 0.63 108.766 179.348 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.1 ttp -60.25 -42.95 96.4 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.222 -0.924 . . . . 1.51 109.786 -179.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.831 HD22 HD23 ' B' ' 347' ' ' LEU . 55.2 tp -63.91 -40.71 97.12 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.416 -0.803 . . . . 0.77 109.44 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.557 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 61.8 tp -64.99 -39.81 94.02 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.63 -0.669 . . . . 0.62 109.827 -179.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -79.68 2.14 23.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 1.47 110.677 -178.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -48.95 128.01 15.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.843 -1.16 . . . . 1.47 109.777 -179.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -61.15 -17.17 51.46 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.595 -0.69 . . . . 1.78 110.211 -179.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -74.09 -32.95 63.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.074 -1.016 . . . . 2.53 109.43 178.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.6 mt -70.07 -41.16 74.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.472 -0.767 . . . . 0.8 109.345 179.499 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -60.76 -46.22 91.31 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.383 -0.823 . . . . 1.42 110.159 -179.428 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -70.05 -41.93 73.54 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.344 -0.847 . . . . 1.71 110.44 -178.978 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.07 -39.9 75.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.24 -0.912 . . . . 1.57 110.096 -179.096 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 82.7 mt -66.68 -47.06 84.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.259 -0.901 . . . . 0.65 109.592 179.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.9 -37.57 73.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.239 -0.913 . . . . 0.82 110.111 179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.04 -48.31 82.26 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.183 -0.948 . . . . 0.79 110.913 -179.258 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 93.2 mt -60.3 -46.99 87.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.074 -1.016 . . . . 0.95 110.191 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.0 mt -61.13 -49.94 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.934 . . . . 0.66 108.674 179.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -65.22 -43.28 92.0 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.107 -0.637 . . . . 2.2 110.491 -179.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -80.02 -53.04 7.1 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.957 -1.09 . . . . 1.65 111.992 -178.421 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt -90.48 -2.43 57.92 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 120.957 -1.089 . . . . 2.03 112.37 -177.195 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.3 m80 57.12 36.55 27.73 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.785 -1.197 . . . . 1.42 109.729 -179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 77.2 mtp -88.22 165.55 14.97 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.293 -0.879 . . . . 1.18 109.34 -179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.401 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 33.6 p -76.56 159.48 30.29 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.064 -1.022 . . . . 0.98 108.49 179.348 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.79 -39.96 91.47 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.285 -0.966 . . . . 0.64 110.047 -179.705 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 24.1 p-10 -66.58 -34.87 78.86 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.122 -0.986 . . . . 2.07 109.312 -179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.476 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.17 -42.2 23.87 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.282 -0.886 . . . . 0.73 109.708 179.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.12 -48.4 68.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.54 109.9 -179.588 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.7 92.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.278 -0.889 . . . . 0.56 109.845 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -60.0 -40.67 90.03 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 1.54 110.204 -179.039 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.03 -40.26 95.09 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.305 -0.872 . . . . 1.33 110.342 -179.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.4 t -65.4 -53.16 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.076 -1.015 . . . . 0.72 111.028 -178.377 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.88 -40.05 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.861 -1.149 . . . . 0.85 109.307 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.0 tm-20 -64.64 -36.1 83.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.29 -0.881 . . . . 2.44 108.901 179.153 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -63.51 -49.93 65.99 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 120.805 -0.712 . . . . 0.98 111.688 -179.114 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.626 HE21 ' CB ' ' B' ' 348' ' ' PHE . 19.4 mm100 -64.05 -47.01 81.83 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.55 -1.559 . . . . 1.41 110.01 -178.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.87 -39.49 85.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.067 -1.021 . . . . 1.2 109.512 179.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 91.2 p -59.79 -40.05 86.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.946 . . . . 1.7 109.746 -179.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.82 -39.86 86.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.858 -1.151 . . . . 1.47 108.929 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 35.3 mt -61.27 -42.89 99.41 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.832 -1.167 . . . . 1.56 108.912 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.541 ' OE2' ' NH2' ' A' ' 131' ' ' ARG . 98.3 mt-10 -50.18 -26.08 4.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.092 -1.005 . . . . 2.2 109.567 -179.387 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -65.53 -26.49 67.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.084 -1.01 . . . . 2.12 108.716 179.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 59.6 mt -63.09 144.09 57.21 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.382 -0.824 . . . . 2.0 109.521 -179.746 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 37.0 p-10 -97.04 14.45 25.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.153 -0.967 . . . . 3.23 109.945 -179.694 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 58.0 t0 -102.98 143.3 32.73 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.174 -0.954 . . . . 2.49 109.788 -179.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.542 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 66.6 mm-40 -71.57 -63.94 1.02 Allowed 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 107.979 -1.119 . . . . 3.95 107.979 178.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.459 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.8 t80 -38.49 -40.0 0.52 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 116.032 -0.531 . . . . 2.0 110.818 -179.428 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.442 HD22 ' O ' ' B' ' 351' ' ' GLN . 83.9 mt -70.85 -40.09 72.55 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.724 -1.235 . . . . 1.86 109.189 179.417 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.469 ' N ' ' O ' ' A' ' 121' ' ' GLU . 61.4 tttp -60.73 -38.95 86.85 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.244 -0.91 . . . . 2.84 109.836 179.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -59.78 -39.78 86.04 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.371 -0.831 . . . . 2.73 109.258 -179.38 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.402 HH11 ' HG3' ' B' ' 351' ' ' GLN . 1.1 mtt-85 -60.11 -39.96 88.01 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.106 -0.996 . . . . 2.77 109.019 179.59 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.92 -31.15 71.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.25 -0.906 . . . . 1.19 109.505 179.676 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.52 -40.54 95.0 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.384 -0.926 . . . . 1.2 108.565 179.513 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -67.28 -40.17 86.09 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.435 -0.791 . . . . 1.55 109.681 179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 59.7 t -70.04 -40.54 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.353 -0.98 . . . . 0.8 108.353 179.375 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.541 ' NH2' ' OE2' ' A' ' 116' ' ' GLU . 39.6 ttm180 -62.29 -37.48 85.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.619 -0.676 . . . . 3.09 109.472 179.447 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -59.74 -40.56 88.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.211 -0.931 . . . . 1.46 109.457 -178.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.09 -43.44 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.092 -1.005 . . . . 0.71 109.313 179.656 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.22 -44.61 97.9 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.098 -1.201 . . . . 0.57 110.098 -179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -60.82 -49.67 76.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.166 -1.196 . . . . 2.59 111.148 -179.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 61.8 mtp180 -64.88 -35.92 82.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.81 -1.181 . . . . 2.83 110.246 -178.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 64.9 tp -60.08 -40.6 90.13 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 1.25 109.04 -179.244 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 138' ' ' LEU . 89.7 mt -62.36 -39.93 94.75 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.32 -0.863 . . . . 0.7 109.264 179.607 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 64.9 mtm180 -69.66 -34.63 74.26 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.673 -0.862 . . . . 2.57 108.673 179.796 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -66.69 -36.1 81.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.537 -0.727 . . . . 1.23 110.849 -179.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 94.4 mt -70.66 -40.96 77.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 120.571 -1.331 . . . . 0.81 108.754 179.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 91.9 mt -72.17 -35.2 68.93 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.569 -0.707 . . . . 1.0 109.73 179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.49 34.94 8.19 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.043 -1.623 . . . . 0.89 109.043 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 29.1 tp -73.57 144.67 45.96 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.35 -1.088 . . . . 1.14 109.626 -179.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 20.0 tptm -61.15 143.76 54.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.449 -0.782 . . . . 4.6 110.486 -179.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.4 mt -111.67 127.27 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 108.362 -0.977 . . . . 1.24 108.362 178.583 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.404 ' O ' ' O ' ' A' ' 148' ' ' ASP . 14.5 mm -59.94 -48.14 88.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.468 -0.77 . . . . 1.54 110.505 -177.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.404 ' O ' ' O ' ' A' ' 147' ' ' ILE . 31.2 t0 62.46 118.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.344 -0.848 . . . . 1.5 109.007 -179.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.0 mt -84.91 -1.73 56.98 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.699 -0.626 . . . . 0.79 110.39 -178.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 92.4 p -83.38 -10.32 58.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.802 -1.186 . . . . 1.4 108.608 178.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.6 17.61 2.64 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.728 -0.607 . . . . 0.92 110.955 -177.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 52.2 mt -90.88 122.9 42.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.894 -1.129 . . . . 0.88 108.981 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -104.74 -7.35 19.59 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.496 -0.752 . . . . 2.45 110.613 -178.505 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -126.96 150.66 49.27 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.425 -0.797 . . . . 1.52 110.064 -179.067 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -64.4 136.35 57.02 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.224 -0.923 . . . . 1.58 108.827 179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.8 m -153.08 167.88 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.477 -0.764 . . . . 0.69 109.975 179.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 76.4 mt -94.8 148.27 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 105.85 -1.907 . . . . 0.61 105.85 176.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 33.6 tp -97.15 118.31 33.29 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.732 -1.23 . . . . 0.87 110.71 -177.638 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.522 HG12 HG22 ' A' ' 209' ' ' THR . 89.2 t -120.79 126.39 75.17 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.189 0 O-C-N 121.675 -0.64 . . . . 0.71 109.551 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.529 ' C ' HG21 ' A' ' 209' ' ' THR . . . -159.74 160.71 34.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.12 -0.987 . . . . 0.81 108.986 179.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.92 -33.12 70.22 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.362 -1.461 . . . . 0.98 108.672 178.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.458 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 25.1 p-10 -171.09 142.03 1.74 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.576 -0.703 . . . . 2.25 109.119 179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 14.9 mt -114.53 131.28 56.7 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.35 -0.844 . . . . 0.78 108.899 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 30.8 p -88.67 149.41 43.95 Favored Pre-proline 0 N--CA 1.495 1.798 0 O-C-N 120.967 -1.083 . . . . 0.98 108.786 179.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -40.73 -34.39 1.28 Allowed 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 121.942 1.761 . . . . 0.81 112.039 179.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 72.5 m -59.03 -40.14 84.13 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.189 -0.945 . . . . 0.9 109.194 -178.892 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -70.25 -40.52 74.37 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.305 -0.958 . . . . 1.61 109.615 -179.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.5 p -57.24 -22.6 42.29 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.354 -0.841 . . . . 0.61 111.87 -177.545 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -85.09 -49.49 8.22 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.539 -1.351 . . . . 0.6 109.925 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -83.92 38.05 0.63 Allowed 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 107.924 -1.139 . . . . 1.4 107.924 179.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.426 HD11 HG21 ' A' ' 176' ' ' VAL . 57.6 tp -107.6 130.99 54.84 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.303 -0.629 . . . . 0.7 109.303 179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -86.44 103.52 15.06 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.109 -1.071 . . . . 2.35 108.109 178.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 87.7 mt -65.19 -40.98 94.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.407 -0.808 . . . . 1.51 111.23 -178.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -63.54 -26.07 68.54 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.701 -1.249 . . . . 2.33 111.541 -177.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -93.57 -9.44 38.14 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.753 -1.217 . . . . 1.92 110.045 -178.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 178' ' ' GLY . 93.1 t -104.71 115.23 46.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.346 -0.846 . . . . 0.67 108.792 179.044 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 96.4 mt -85.74 7.71 22.58 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.129 -0.982 . . . . 1.53 110.626 -178.403 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.53 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 166.91 174.66 36.35 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.725 -1.35 . . . . 0.48 109.725 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.517 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 12.1 m-85 -130.98 129.11 41.68 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.393 -1.063 . . . . 0.55 109.069 179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.417 ' CG2' HG21 ' A' ' 205' ' ' THR . 89.6 mt -131.7 125.53 55.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.413 -0.804 . . . . 0.65 109.246 178.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 42.0 p -152.51 162.18 41.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.057 -1.027 . . . . 0.82 110.478 -179.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 182' ' ' ASP . 36.7 p30 -107.85 26.89 9.79 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.658 -0.651 . . . . 2.46 109.358 179.354 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.69 -159.39 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.903 -1.123 . . . . 1.28 111.687 -178.285 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.44 -64.01 3.44 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 111.205 -0.758 . . . . 2.19 111.205 -178.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 162.12 -135.48 3.91 Favored Glycine 0 N--CA 1.49 2.254 0 C-N-CA 119.021 -1.562 . . . . 2.13 110.84 -179.547 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.424 HH11 ' HG2' ' A' ' 186' ' ' ARG . 44.8 mtt-85 -61.1 -32.42 72.09 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.506 -0.996 . . . . 5.86 110.862 -178.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 11.3 p -71.53 1.73 6.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.963 -1.086 . . . . 3.72 110.275 -178.591 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.9 t -90.95 131.28 36.66 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.995 -1.066 . . . . 1.74 110.49 -179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -46.16 -44.94 16.31 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.346 -0.846 . . . . 0.95 108.965 179.285 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 190' ' ' THR . 2.4 p -56.37 -42.79 78.42 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.809 -0.557 . . . . 1.55 111.001 -178.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.4 m -60.22 -40.08 88.88 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.922 -1.111 . . . . 1.51 110.919 -178.865 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 91.2 mt -61.9 -40.9 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.084 -1.01 . . . . 1.67 110.157 -178.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 86.9 mtp -60.12 -43.35 95.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.103 -0.998 . . . . 1.02 110.141 -179.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.27 -45.2 94.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.77 -1.206 . . . . 0.68 110.279 -179.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -60.26 -51.78 68.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.217 -0.927 . . . . 2.93 111.228 -178.838 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 69.1 m -72.6 -34.44 67.38 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.914 -1.116 . . . . 0.86 111.93 -178.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.6 -14.05 58.52 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.71 -1.244 . . . . 0.67 110.378 -178.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 57.97 48.37 13.44 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.355 -0.841 . . . . 1.5 110.349 179.738 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 94.8 mt -118.01 122.21 30.71 Favored Pre-proline 0 N--CA 1.501 2.107 0 N-CA-C 108.182 -1.044 . . . . 0.72 108.182 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -42.02 130.3 4.39 Favored 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 121.809 1.673 . . . . 0.61 112.377 -179.467 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.517 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.46 152.43 3.25 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.012 -1.075 . . . . 0.66 111.483 -179.551 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.0 mt -126.91 141.8 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 N-CA-C 107.729 -1.212 . . . . 0.79 107.729 178.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.7 m -124.92 -8.86 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 O-C-N 120.731 -1.23 . . . . 0.91 110.983 -178.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.48 22.89 23.64 Favored Glycine 0 N--CA 1.499 2.836 0 N-CA-C 110.254 -1.139 . . . . 1.01 110.254 -179.636 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.417 HG21 ' CG2' ' A' ' 180' ' ' ILE . 11.6 p -44.92 -42.56 8.22 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.163 -1.198 . . . . 0.99 109.835 -179.355 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 91.79 -51.24 2.91 Favored Glycine 0 N--CA 1.494 2.541 0 C-N-CA 120.149 -1.024 . . . . 1.12 111.006 179.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.9 m -157.9 37.36 0.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.523 -1.575 . . . . 1.72 111.427 -178.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 35.4 t -79.52 -32.04 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 120.789 -1.194 . . . . 0.89 108.749 178.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.529 HG21 ' C ' ' A' ' 160' ' ' ALA . 74.3 p -59.93 -35.02 74.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.503 -0.748 . . . . 1.03 111.143 -178.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 85.2 p -80.14 -12.13 59.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.916 -1.115 . . . . 1.83 110.413 -179.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -100.06 -12.51 19.63 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.24 -0.913 . . . . 2.27 110.465 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 91.9 t -106.31 140.12 25.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.145 0 O-C-N 121.295 -0.878 . . . . 0.92 111.053 -178.227 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -113.7 152.9 29.84 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.306 -1.368 . . . . 2.2 107.306 178.022 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.494 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 28.9 p-10 -57.86 137.59 56.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.011 -1.056 . . . . 2.36 110.561 -178.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.494 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 6.2 t0 85.29 2.1 0.69 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 122.117 -0.364 . . . . 2.38 110.734 179.04 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.98 143.84 50.69 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.867 -1.146 . . . . 2.09 108.713 179.036 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -93.16 113.72 26.03 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.081 -1.081 . . . . 1.27 108.081 179.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.479 HD22 HG22 ' A' ' 229' ' ' VAL . 61.0 mt -123.29 145.55 48.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.607 -0.683 . . . . 0.75 110.349 -179.119 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 79.9 mt -111.36 129.87 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 106.21 -1.774 . . . . 0.63 106.21 176.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 51.4 tp -100.35 118.93 37.63 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.889 -1.132 . . . . 0.7 108.534 -179.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 10' ' ' GLY . 38.5 t0 -77.84 -45.97 22.82 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.189 -0.944 . . . . 2.31 108.819 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.75 16.59 0.5 Allowed 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.991 -1.115 . . . . 0.78 107.991 -178.847 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.456 ' N ' ' C ' ' A' ' 221' ' ' ASP . 42.0 t -126.17 -46.14 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 N-CA-C 106.74 -1.578 . . . . 1.04 106.74 178.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.536 ' CG ' HE21 ' A' ' 226' ' ' GLN . 55.3 t-20 -102.25 2.92 37.66 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.44 -1.319 . . . . 2.44 107.44 178.129 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.42 ' ND2' ' H ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 59.84 46.24 11.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.976 -0.452 . . . . 1.55 110.048 -179.951 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.536 HE21 ' CG ' ' A' ' 224' ' ' ASN . 42.9 mt-30 -140.42 154.07 46.53 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.214 -0.929 . . . . 1.99 109.898 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 88.5 t -119.97 131.5 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.079 -0.712 . . . . 0.77 109.079 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -94.99 119.06 32.86 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.177 -0.952 . . . . 0.98 108.487 179.026 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.479 HG22 HD22 ' A' ' 218' ' ' LEU . 91.6 t -99.69 115.24 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.323 -0.861 . . . . 0.85 109.618 -179.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 67.09 71.07 0.44 Allowed Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.58 -0.7 . . . . 1.66 109.634 179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -90.19 124.9 1.18 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 123.337 2.692 . . . . 0.95 112.6 -179.679 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 233' ' ' ASN . 63.6 m -67.01 159.68 28.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.413 -0.804 . . . . 1.84 109.261 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.441 ' N ' HG22 ' A' ' 232' ' ' THR . 27.7 p-10 -60.08 -38.74 83.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.087 -1.008 . . . . 2.74 109.972 -179.342 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -60.12 -40.16 88.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.106 -0.996 . . . . 2.89 109.599 -179.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 58.8 t -61.61 -39.97 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.218 -0.926 . . . . 1.3 109.919 -179.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.2 mt -61.86 -38.05 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.021 -1.05 . . . . 1.09 109.436 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -59.92 -40.06 87.61 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.014 -1.054 . . . . 2.43 108.394 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -64.83 -44.84 88.54 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.574 -0.899 . . . . 2.78 108.574 178.571 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 93.9 mtp -70.01 -26.13 63.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.693 -0.63 . . . . 1.25 110.078 179.52 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.47 ' HE ' ' CA ' ' A' ' 240' ' ' ARG . 0.0 OUTLIER -64.59 -41.37 96.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.059 -1.026 . . . . 2.63 108.964 179.339 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -61.0 -39.86 91.34 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.248 -1.019 . . . . 1.8 108.248 179.149 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 77.0 t -59.96 -42.36 89.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 108.922 -0.77 . . . . 2.13 108.922 179.732 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.47 ' OE1' ' NH2' ' A' ' 240' ' ' ARG . 63.6 tt0 -60.18 -40.19 89.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.115 -0.99 . . . . 3.17 108.922 -179.663 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -62.21 -40.03 94.72 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.097 -1.002 . . . . 1.78 109.002 179.38 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -65.43 -39.99 92.77 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.934 -0.765 . . . . 2.47 108.934 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 71.7 t -62.27 -39.9 85.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 108.456 -0.942 . . . . 2.09 108.456 179.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.476 ' O ' ' N ' ' A' ' 251' ' ' ALA . . . -53.4 -48.89 68.29 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.503 -0.748 . . . . 2.54 109.103 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 72.3 m -60.16 -41.3 92.5 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.991 -1.084 . . . . 2.99 108.13 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -61.99 -40.22 94.87 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.244 -1.391 . . . . 3.34 107.244 178.157 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -69.97 -32.02 70.03 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 108.469 -0.937 . . . . 3.88 108.469 178.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 247' ' ' ALA . . . 62.98 63.25 0.96 Allowed 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.516 0.674 . . . . 4.43 111.404 179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 24.9 tp10 -130.06 30.01 4.86 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.37 -1.344 . . . . 5.42 107.37 177.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.659 ' O ' ' HB2' ' A' ' 254' ' ' ALA . 78.6 mt -119.0 -33.5 4.16 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 109.088 -0.708 . . . . 6.1 109.088 179.646 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.659 ' HB2' ' O ' ' A' ' 253' ' ' LEU . . . 156.92 72.47 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 109.216 -0.661 . . . . 7.37 109.216 179.62 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 18.9 mtpp -141.82 170.19 16.19 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.076 -1.015 . . . . 8.01 109.807 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 65.0 mt -69.07 70.85 0.23 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.324 -0.86 . . . . 9.05 110.551 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 57.5 mttp 46.09 -134.54 0.87 Allowed 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.688 -0.633 . . . . 10.56 109.794 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -79.38 68.59 5.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.189 -0.945 . . . . 11.32 109.252 -179.798 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 117.985 -1.007 . . . . 12.42 109.46 179.611 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . 0.402 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 50.4 ttp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.485 0.66 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 23.7 t80 -151.58 149.65 29.41 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . 0.418 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 19.2 pt20 -149.65 159.68 44.14 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.876 -1.14 . . . . 0.0 110.521 -178.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -152.48 148.58 27.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.68 -0.638 . . . . 0.0 109.456 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -110.58 131.49 55.01 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.09 -1.006 . . . . 0.0 109.803 179.212 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.74 122.84 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-O 122.262 1.03 . . . . 0.0 112.294 -177.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . 0.407 ' O ' HG23 ' B' ' 309' ' ' THR . 46.2 m -77.48 106.77 9.46 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 122.062 0.934 . . . . 0.0 110.184 -178.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.7 mt -52.44 121.85 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-O 122.361 1.077 . . . . 0.0 110.651 -177.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . 0.407 HG23 ' O ' ' B' ' 307' ' ' THR . 30.0 p -109.97 19.14 19.35 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.38 -178.562 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.86 129.04 77.47 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.795 -1.19 . . . . 0.0 108.525 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -62.66 -10.7 20.48 Favored 'Trans proline' 0 N--CA 1.496 1.638 0 CA-C-N 120.356 1.163 . . . . 0.0 112.981 -179.626 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -120.96 5.94 10.39 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.294 -0.879 . . . . 0.0 109.418 179.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.68 -175.39 37.64 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.84 -1.704 . . . . 0.0 108.84 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.459 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.5 tp -83.11 85.62 7.16 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.123 -1.222 . . . . 0.0 109.932 -178.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.419 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 4.7 p80 -91.84 -161.98 0.88 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.864 -1.148 . . . . 0.0 109.914 178.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 10.0 m -58.22 -43.82 87.89 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.864 -1.147 . . . . 0.0 112.831 -175.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.551 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.2 tpt180 -60.08 -61.35 8.09 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 120.42 -1.425 . . . . 0.0 112.29 -178.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.419 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 9.3 Cg_endo -57.7 -29.41 85.5 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 CA-C-N 120.288 1.138 . . . . 0.0 111.655 -179.573 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.93 -51.78 68.21 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 119.351 -0.939 . . . . 0.0 108.524 179.616 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.18 -42.44 66.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.431 -0.793 . . . . 0.0 109.269 -179.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 19.6 mm100 -70.22 -40.07 74.76 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.929 -1.107 . . . . 0.0 108.719 177.8 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 44.6 t80 -63.92 -55.46 22.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.734 -0.604 . . . . 0.0 109.795 -179.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 54.2 t -68.05 -36.71 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.816 -1.178 . . . . 0.0 109.682 -179.165 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp -60.0 -44.62 94.42 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.017 -1.073 . . . . 0.0 109.755 -179.286 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -66.79 -40.07 88.0 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.955 -1.091 . . . . 0.0 109.872 179.914 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -64.67 -51.7 61.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.125 -0.984 . . . . 0.0 110.132 -179.537 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -57.55 -11.54 2.1 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.083 -1.01 . . . . 0.0 109.131 179.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -67.9 -30.45 74.3 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 108.716 -1.753 . . . . 0.0 108.716 179.182 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -105.31 143.28 33.7 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.598 -0.942 . . . . 0.0 109.15 179.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 27.9 m -89.95 -11.8 40.65 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.978 -1.076 . . . . 0.0 109.845 -179.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.442 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 60.1 p -60.02 153.8 20.63 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.049 -1.032 . . . . 0.0 108.764 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.75 129.5 40.12 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.181 -0.949 . . . . 0.0 109.558 -179.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.3 mt -129.15 129.95 67.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.626 -0.671 . . . . 0.0 109.35 179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . 0.401 HG22 ' N ' ' B' ' 335' ' ' VAL . 93.9 m -128.06 152.57 47.81 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.509 -0.744 . . . . 0.0 109.626 179.78 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . 0.401 ' N ' HG22 ' B' ' 334' ' ' THR . 63.5 t -118.03 137.47 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 177.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 55.0 m -129.98 122.24 28.09 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.215 -0.928 . . . . 0.0 108.999 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 91.4 p -137.36 118.49 14.45 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.014 0.912 . . . . 0.0 111.102 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 44.38 57.41 4.38 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 177.298 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 83.16 -12.5 49.87 Favored Glycine 0 N--CA 1.5 2.956 0 O-C-N 120.164 -1.585 . . . . 0.0 113.388 176.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -119.11 131.27 55.9 Favored 'General case' 0 N--CA 1.505 2.32 0 CA-C-N 119.367 1.584 . . . . 0.0 110.067 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 70.6 m -124.86 146.71 49.15 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.903 0.859 . . . . 0.0 110.599 -179.113 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . 0.433 ' CB ' HD11 ' B' ' 353' ' ' LEU . . . -138.81 161.81 36.32 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.634 0.73 . . . . 0.0 109.596 -179.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 51.0 m -86.08 131.87 34.17 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.558 -0.713 . . . . 0.0 109.994 -179.471 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -69.86 -17.51 63.37 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.075 -1.016 . . . . 0.0 109.141 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 45.2 pttt -89.26 20.93 3.49 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 177.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 5.7 m -145.41 92.34 2.23 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.451 -179.344 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.831 HD23 HD22 ' A' ' 79' ' ' LEU . 58.7 tp -59.95 -37.22 78.92 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.274 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.773 ' CE2' HD11 ' A' ' 79' ' ' LEU . 59.1 m-85 -54.61 -51.34 65.66 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.25 -0.906 . . . . 0.0 111.138 -179.287 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . 0.409 ' O ' ' C ' ' B' ' 350' ' ' LEU . 34.0 mtmm -69.25 -39.98 78.14 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.91 -1.118 . . . . 0.0 109.781 -178.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.52 ' O ' ' N ' ' B' ' 352' ' ' THR . 18.2 mt -47.16 -57.21 5.37 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.12 -0.988 . . . . 0.0 108.671 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.537 ' NE2' ' O ' ' B' ' 347' ' ' LEU . 1.4 mp0 -39.33 -22.56 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.525 -0.734 . . . . 0.0 111.088 -179.009 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.52 ' N ' ' O ' ' B' ' 350' ' ' LEU . 72.4 p -82.88 -10.89 58.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.348 -1.47 . . . . 0.0 110.796 -178.155 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.433 HD11 ' CB ' ' B' ' 342' ' ' ALA . 49.6 mt -94.89 117.84 30.8 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.816 -1.178 . . . . 0.0 109.513 178.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.05 92.24 0.83 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.017 -1.633 . . . . 0.0 109.017 179.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.3 mt -99.57 91.35 4.85 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.233 -1.157 . . . . 0.0 109.279 179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 33.4 p -89.71 168.29 12.22 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.812 -1.18 . . . . 0.0 111.046 -178.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -63.13 115.94 4.94 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 121.228 0.537 . . . . 0.0 110.763 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 100.75 7.39 50.94 Favored Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 24.1 m -86.82 114.68 23.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.485 -1.009 . . . . 0.0 111.066 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 14.9 t -76.43 116.56 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 122.322 1.058 . . . . 0.0 109.865 -177.54 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.1 m -111.45 176.95 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.749 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 29.7 m -130.53 129.44 42.84 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 83.0 mt -104.98 118.97 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 178.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 74.1 m -123.59 133.47 53.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.506 -0.746 . . . . 0.0 109.43 -179.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.44 152.46 40.68 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 0.0 109.302 -179.454 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -146.36 123.13 11.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.359 -0.838 . . . . 0.0 108.953 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.531 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.96 -156.22 27.15 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 118.987 -1.578 . . . . 0.0 111.342 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.97 -52.82 63.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 122.319 -0.518 . . . . 0.0 112.008 -177.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.442 ' H ' ' HB3' ' B' ' 331' ' ' SER . 80.1 m-20 -106.93 9.5 30.74 Favored 'General case' 0 N--CA 1.503 2.185 0 O-C-N 120.782 -1.199 . . . . 0.0 111.567 -177.31 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.2 pt-20 -38.76 -33.29 0.1 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.398 -0.814 . . . . 0.0 111.232 -179.039 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -67.24 -42.3 84.19 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.889 -1.132 . . . . 0.0 109.618 -178.474 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -69.98 -52.9 20.49 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.453 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -42.06 -38.55 1.69 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.51 -0.744 . . . . 0.0 111.39 -178.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.525 ' O ' HG23 ' B' ' 378' ' ' VAL . 92.0 t -80.05 -34.87 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.687 -1.258 . . . . 0.0 109.928 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -69.51 -40.06 77.21 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.945 -1.097 . . . . 0.0 111.702 -178.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -81.63 -45.62 15.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.398 -1.439 . . . . 0.0 110.126 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.9 mt -60.18 -40.33 89.62 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.177 -0.952 . . . . 0.0 109.209 -179.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.525 HG23 ' O ' ' B' ' 374' ' ' VAL . 53.3 t -61.92 -47.16 94.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.101 -0.999 . . . . 0.0 109.803 179.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' B' ' 383' ' ' GLU . 60.9 mttp -68.27 -54.7 15.79 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.515 -1.274 . . . . 0.0 107.762 178.597 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 59.8 tp -55.24 -33.86 63.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 110.088 -178.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 9.0 tpt -72.4 -40.19 67.4 Favored 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.378 -1.451 . . . . 0.0 109.013 178.191 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.93 -4.67 58.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 110.168 179.671 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' B' ' 379' ' ' LYS . 95.6 mt-10 -110.56 -3.47 15.95 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.07 -1.019 . . . . 0.0 111.178 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.1 mt -79.51 130.63 35.58 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.427 -1.421 . . . . 0.0 109.547 179.415 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . 0.523 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 2.3 pm0 . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.271 179.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.561 -0.533 . . . . 2.91 109.561 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.7 mt -110.19 129.4 65.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.433 -0.792 . . . . 1.2 109.321 -179.881 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.1 m -140.05 151.71 45.63 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.382 -0.824 . . . . 1.4 109.122 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.441 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -136.34 -166.12 10.79 Favored Glycine 0 N--CA 1.498 2.779 0 N-CA-C 108.495 -1.842 . . . . 1.05 108.495 179.251 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.464 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.8 mt -93.8 -9.91 9.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.78 -1.424 . . . . 1.15 110.334 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.3 tp 53.36 101.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.134 -0.979 . . . . 0.98 109.41 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.57 -24.67 20.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.055 -1.028 . . . . 0.88 109.867 -179.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.4 m -146.16 134.82 10.98 Favored Pre-proline 0 N--CA 1.5 2.039 0 O-C-N 121.036 -1.04 . . . . 1.69 109.723 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -80.62 139.63 12.74 Favored 'Trans proline' 0 N--CA 1.496 1.667 0 C-N-CA 122.287 1.991 . . . . 0.85 112.634 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.778 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 164.79 -165.4 37.52 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.359 -1.496 . . . . 0.92 109.359 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.6 mt -147.81 149.8 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.091 -1.24 . . . . 0.81 108.196 178.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -153.77 156.91 38.6 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.867 -1.146 . . . . 0.51 110.543 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -139.63 124.89 18.93 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.013 -1.106 . . . . 0.62 108.013 179.194 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 178.43 -179.75 48.55 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 118.776 -1.678 . . . . 0.55 110.559 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 34.1 mtmm -79.29 158.62 27.49 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.743 -0.857 . . . . 2.1 109.462 -179.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.545 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -101.45 129.73 47.55 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.37 -0.831 . . . . 0.77 110.923 -178.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.454 HD12 HD21 ' A' ' 214' ' ' ASN . 53.9 tp -98.22 132.17 43.94 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.189 -1.411 . . . . 0.91 107.189 178.369 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.488 ' H ' HD22 ' A' ' 214' ' ' ASN . 36.8 tp -118.34 122.65 43.38 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.25 -0.906 . . . . 0.93 109.592 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.1 mt -87.35 103.4 15.44 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.599 0.714 . . . . 0.93 110.167 -179.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -93.01 135.32 34.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.447 -0.783 . . . . 2.75 109.233 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 57.3 mp0 -130.94 136.89 48.98 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.349 -0.844 . . . . 3.0 109.485 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 63.0 t0 -86.55 140.74 29.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.109 -0.995 . . . . 2.77 108.889 179.048 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 85.4 tt0 -60.33 139.99 57.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 2.94 109.548 -179.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.5 mt -86.4 134.37 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.31 -0.869 . . . . 0.95 109.172 179.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 63.8 t -98.8 129.12 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 121.253 -0.905 . . . . 1.28 110.459 -179.004 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.8 mt -105.95 137.42 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 108.618 -0.882 . . . . 1.21 108.618 179.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -88.54 121.81 31.32 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.95 -1.094 . . . . 1.81 109.949 -179.379 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -90.63 -6.22 54.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.257 -0.902 . . . . 2.8 109.717 -179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -71.03 137.87 49.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.98 -1.075 . . . . 2.87 109.63 -179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -81.66 158.1 24.4 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 2.35 108.967 179.288 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.68 HD13 ' HG3' ' A' ' 39' ' ' GLU . 2.9 pt -100.43 166.28 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.139 -0.976 . . . . 0.97 109.495 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.0 p -90.46 174.77 7.37 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.162 -0.961 . . . . 1.17 108.765 178.764 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.85 -16.78 63.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.091 -1.006 . . . . 1.18 110.758 -179.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.3 -27.45 25.94 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.892 -1.13 . . . . 2.56 108.456 179.195 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -82.69 -7.36 59.65 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.195 -0.668 . . . . 1.79 109.195 179.253 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.8 t -59.95 -51.53 71.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.153 -0.967 . . . . 1.0 108.475 -179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -59.91 -40.04 87.48 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.385 -0.822 . . . . 1.77 109.084 179.111 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -63.3 -40.52 97.58 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.337 -0.852 . . . . 2.7 110.277 -178.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.68 ' HG3' HD13 ' A' ' 31' ' ' ILE . 60.5 mm-40 -62.93 -44.71 95.34 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.749 -1.219 . . . . 1.51 109.865 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.5 -49.81 81.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.041 -1.037 . . . . 0.93 109.718 -179.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.3 tp10 -60.66 -48.2 82.86 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.976 -1.077 . . . . 1.81 109.518 179.775 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.473 ' NH2' ' OE2' ' A' ' 39' ' ' GLU . 86.5 mtm180 -60.03 -40.13 88.28 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 120.853 -1.154 . . . . 2.78 108.407 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -65.09 -47.52 76.95 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.348 -0.845 . . . . 0.78 109.075 178.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.1 tp -60.06 -44.6 94.59 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.304 -0.872 . . . . 1.07 109.151 -179.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.6 t -65.36 -43.16 91.67 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.025 -1.047 . . . . 1.12 109.315 179.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.52 -42.54 97.44 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.014 -2.034 . . . . 0.84 108.014 178.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.448 HH22 ' HG2' ' A' ' 81' ' ' GLU . 36.9 ttt-85 -63.51 -38.52 91.43 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.731 -0.864 . . . . 3.09 108.808 178.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.76 -40.61 72.81 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.505 -0.747 . . . . 0.88 109.083 -179.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' A' ' 50' ' ' ALA . 6.5 ttpm? -62.52 -73.44 0.11 Allowed 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.737 -1.209 . . . . 2.59 107.737 178.934 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.71 -35.64 0.09 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.429 -0.794 . . . . 0.7 112.164 -177.818 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 98.2 p -59.42 -49.98 75.72 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.318 -1.489 . . . . 1.4 108.335 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.46 -39.85 92.49 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.47 -0.769 . . . . 0.67 110.646 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -65.99 -40.1 90.88 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.819 -1.176 . . . . 1.66 110.2 -179.159 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 71.4 mt -62.64 -40.05 95.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.146 -0.971 . . . . 1.58 109.689 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -62.56 -39.76 94.67 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.252 -0.905 . . . . 1.35 110.161 -179.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -64.82 -43.84 91.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.06 -1.025 . . . . 0.77 110.018 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.8 mt -59.93 -39.34 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 0.63 109.222 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -57.51 -51.41 69.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.367 -0.833 . . . . 1.14 110.411 -179.364 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -56.62 -29.16 61.87 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.447 -0.783 . . . . 0.79 110.556 -177.515 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -69.75 -39.09 76.93 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.969 -1.082 . . . . 1.53 110.376 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.6 -46.98 74.16 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.304 -0.872 . . . . 0.57 110.096 -179.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.21 -50.02 53.74 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 109.743 -1.343 . . . . 0.75 109.743 -179.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.24 -46.34 42.24 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.334 -1.098 . . . . 1.59 111.026 -179.349 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.4 m -67.57 -62.63 1.32 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.091 -1.005 . . . . 0.73 112.806 -177.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.448 ' CE1' ' O ' ' A' ' 168' ' ' THR . 77.6 m-85 -93.54 -45.77 7.6 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.684 -1.26 . . . . 0.75 110.87 -178.277 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.29 -170.6 24.59 Favored Glycine 0 N--CA 1.498 2.796 0 C-N-CA 120.011 -1.09 . . . . 1.22 110.737 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -70.02 -25.39 63.56 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.844 -0.798 . . . . 5.81 109.878 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.493 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 51.0 tp10 -60.0 -31.34 69.83 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.518 -0.739 . . . . 3.37 109.747 -179.354 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -98.98 -19.67 17.17 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.306 -0.871 . . . . 1.77 110.065 -179.925 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -69.89 -40.02 75.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.012 -1.055 . . . . 1.65 109.977 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.479 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -63.55 -31.38 72.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.391 -0.818 . . . . 0.77 109.742 -179.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 88.8 mt -60.04 -40.99 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.108 -0.995 . . . . 0.8 109.116 -179.436 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -65.57 -39.7 91.96 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.222 -0.924 . . . . 0.88 110.699 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.4 tt0 -59.95 -40.04 87.63 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.817 -1.177 . . . . 1.37 108.834 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.61 -47.0 93.32 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 107.971 -2.052 . . . . 0.62 107.971 178.188 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -61.58 -49.44 76.65 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.398 -1.06 . . . . 1.5 109.102 179.222 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.05 -48.98 85.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.276 -0.89 . . . . 0.63 109.542 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 43.7 ttp -60.06 -43.03 95.71 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.108 -0.995 . . . . 1.51 110.063 -178.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.884 HD11 ' CE2' ' B' ' 348' ' ' PHE . 56.4 tp -63.29 -40.01 96.16 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.318 -0.864 . . . . 0.77 109.425 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.45 -39.9 89.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.78 -0.822 . . . . 0.62 108.78 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.448 ' HG2' HH22 ' A' ' 47' ' ' ARG . 42.0 mt-10 -83.28 8.15 14.31 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.229 -0.919 . . . . 1.47 110.485 -179.928 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -56.64 130.89 47.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.785 -1.197 . . . . 1.47 109.529 -179.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.51 -18.47 52.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.468 -0.77 . . . . 1.78 110.467 -179.014 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -70.14 -36.28 74.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.823 -1.173 . . . . 2.53 109.109 178.531 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.2 mt -70.2 -41.77 73.26 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.411 -0.806 . . . . 0.8 110.031 179.566 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -60.03 -48.67 80.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 1.42 110.372 -178.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -70.05 -40.83 74.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 1.71 110.726 -179.009 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.07 -40.02 75.29 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.194 -0.941 . . . . 1.57 111.516 -178.743 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.99 -43.87 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.03 -1.043 . . . . 0.65 109.616 -179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 89.5 mt -70.06 -40.0 77.91 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 121.379 -0.826 . . . . 0.82 110.309 179.989 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.01 75.41 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.105 -0.997 . . . . 0.79 111.307 -178.599 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.406 ' O ' ' N ' ' A' ' 96' ' ' LYS . 17.6 mt -60.9 -45.73 93.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.089 -1.007 . . . . 0.95 109.703 -178.776 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.4 mt -61.44 -49.89 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.66 109.134 179.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -70.38 -41.18 73.41 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.876 -0.73 . . . . 2.2 110.916 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -82.52 -53.68 5.78 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.998 -1.064 . . . . 1.65 112.1 -178.229 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.406 ' N ' ' O ' ' A' ' 92' ' ' LEU . 90.6 mttt -90.06 -1.39 57.95 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.048 -1.032 . . . . 2.03 112.124 -177.172 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 74.7 m-70 57.05 35.7 26.72 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.746 -1.221 . . . . 1.42 109.196 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 38.4 mtt -83.8 164.96 19.21 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.513 -0.742 . . . . 1.18 109.823 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 43.7 p -79.58 158.73 27.07 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.496 -0.927 . . . . 0.98 108.496 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.0 -40.08 75.48 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.994 -1.066 . . . . 0.64 109.702 -179.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -63.94 -39.94 95.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.975 . . . . 2.07 109.79 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.57 -46.47 14.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.125 -0.984 . . . . 0.73 109.434 179.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.05 -49.67 76.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.442 -0.786 . . . . 0.54 109.89 -179.63 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.57 85.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.171 -0.956 . . . . 0.56 109.634 -179.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.534 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 80.7 t60 -59.99 -39.0 84.24 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.327 -0.858 . . . . 1.54 109.858 -179.207 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.427 ' O ' ' N ' ' A' ' 110' ' ' GLY . 41.3 tt0 -60.36 -41.57 93.96 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.106 -0.996 . . . . 1.33 109.541 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.7 t -65.91 -50.87 67.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.1 -1.0 . . . . 0.72 110.198 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 37.5 mm -69.31 -40.12 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.044 -1.035 . . . . 0.85 108.581 179.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.534 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 89.1 tt0 -67.09 -37.21 83.55 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.405 -0.961 . . . . 2.44 108.405 178.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -60.02 -47.32 91.61 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.74 -1.344 . . . . 0.98 109.74 -179.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 95.8 mm-40 -69.34 -55.8 9.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.052 -1.263 . . . . 1.41 109.004 179.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -52.83 -42.83 65.52 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.139 -0.976 . . . . 1.2 108.937 179.598 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 110' ' ' GLY . 63.8 p -59.98 -40.02 87.69 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.192 -0.942 . . . . 1.7 108.67 179.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.98 -40.06 91.99 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.33 -0.856 . . . . 1.47 108.697 179.066 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.0 mt -65.23 -42.0 93.84 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.134 -0.979 . . . . 1.56 108.914 -179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -56.75 -32.88 66.02 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.731 -1.23 . . . . 2.2 109.414 -179.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -59.19 -22.54 61.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.023 -1.048 . . . . 2.12 108.309 179.618 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 123' ' ' LEU . 60.3 mt -62.97 148.05 48.75 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.342 -0.849 . . . . 2.0 108.861 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 43.5 p-10 -100.21 37.1 1.72 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.242 -0.911 . . . . 3.23 109.955 -179.785 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 56.8 t0 -125.25 134.64 52.24 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.382 -0.824 . . . . 2.49 110.438 -179.315 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.487 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 12.4 pt-20 -70.44 -30.12 66.88 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.783 -0.573 . . . . 3.95 110.58 179.529 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.651 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 3.0 t80 -71.87 -40.01 69.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.057 -1.027 . . . . 2.0 110.65 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.496 ' CD2' HH22 ' A' ' 126' ' ' ARG . 60.1 mt -71.77 -31.76 66.96 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.256 -0.902 . . . . 1.86 108.584 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 12.5 ttmm -66.0 -39.97 90.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.605 -0.685 . . . . 2.84 110.018 179.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -60.0 -46.34 89.8 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.21 -0.931 . . . . 2.73 110.824 -178.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.768 ' HE ' HE22 ' B' ' 351' ' ' GLN . 21.3 mtm-85 -70.01 -27.1 64.41 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.755 -1.178 . . . . 2.77 108.863 -179.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -66.91 -26.07 66.68 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.902 -1.147 . . . . 1.19 107.902 178.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.97 -40.16 75.56 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.481 -0.933 . . . . 1.2 108.481 178.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -62.23 -44.29 96.89 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.574 -0.704 . . . . 1.55 109.18 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.6 t -61.48 -40.26 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 108.654 -0.869 . . . . 0.8 108.654 179.28 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -60.49 -37.34 80.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.49 -0.756 . . . . 3.09 109.713 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -60.0 -41.0 91.15 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.173 -0.954 . . . . 1.46 109.996 -178.862 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.02 -49.55 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.97 -1.081 . . . . 0.71 109.176 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.21 -42.87 98.83 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.682 -1.367 . . . . 0.57 109.682 179.744 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 14.1 ttmm -60.05 -49.96 75.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.147 -1.207 . . . . 2.59 110.27 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.548 HH12 ' CB ' ' A' ' 166' ' ' SER . 98.9 mtt180 -68.88 -27.18 65.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.774 -1.204 . . . . 2.83 109.838 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.95 -43.43 95.0 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.184 -0.947 . . . . 1.25 108.587 -179.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.69 -40.03 93.56 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.397 -0.814 . . . . 0.7 109.083 178.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -63.54 -39.95 95.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.311 -0.868 . . . . 2.57 108.665 179.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 70.1 m-20 -67.13 -39.95 86.7 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.711 -0.618 . . . . 1.23 111.258 -179.294 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.97 -43.05 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.438 -1.414 . . . . 0.81 108.061 178.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.01 -30.07 67.29 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.256 -0.646 . . . . 1.0 109.256 179.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.01 40.28 9.46 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.832 -1.707 . . . . 0.89 108.832 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 2.9 tp -74.68 149.97 39.72 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.374 -1.074 . . . . 1.14 109.341 -179.481 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.2 tptt -71.1 147.97 47.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.341 -0.849 . . . . 4.6 109.725 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.4 mt -118.82 129.47 74.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 122.041 0.924 . . . . 1.24 109.313 179.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 11.1 mt -67.05 -40.07 84.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 CA-C-N 115.807 -0.633 . . . . 1.54 110.506 -178.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 41.6 t0 60.89 105.07 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.669 -0.863 . . . . 1.5 108.669 -178.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 55.2 mt -67.76 -0.12 3.81 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.305 -0.872 . . . . 0.79 110.128 -178.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.2 m -83.2 -11.8 57.49 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.92 -1.113 . . . . 1.4 109.511 179.591 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.15 25.57 0.83 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.152 -0.967 . . . . 0.92 111.179 -178.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 40.5 mm -90.97 117.18 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 120.59 -1.319 . . . . 0.88 108.729 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -99.92 -9.35 22.92 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.258 -0.901 . . . . 2.45 110.481 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -129.18 152.11 49.12 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.296 -0.878 . . . . 1.52 110.057 -179.2 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.52 136.78 57.81 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.504 -0.748 . . . . 1.58 109.273 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 34.5 m -151.92 164.8 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.328 -0.858 . . . . 0.69 109.671 179.51 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.3 mt -92.1 146.52 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 105.954 -1.869 . . . . 0.61 105.954 177.028 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.6 tp -94.23 115.83 28.14 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.795 -1.191 . . . . 0.87 110.495 -178.149 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.2 t -123.2 129.94 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.512 -0.921 . . . . 0.71 108.512 178.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.24 162.24 36.15 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.275 -1.009 . . . . 0.81 108.275 -179.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.6 -35.25 72.91 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 120.214 -1.553 . . . . 0.98 108.048 178.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -170.48 140.91 1.86 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.186 -1.042 . . . . 2.25 108.186 179.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 25.7 mt -113.48 134.61 54.58 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.231 -0.918 . . . . 0.78 109.955 -179.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 18.0 p -87.27 147.19 41.74 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.305 -0.872 . . . . 0.98 108.783 179.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_exo -43.24 -33.07 3.53 Favored 'Trans proline' 0 N--CA 1.495 1.58 0 C-N-CA 122.12 1.88 . . . . 0.81 113.319 179.877 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.548 ' CB ' HH12 ' A' ' 136' ' ' ARG . 13.8 m -59.95 -48.55 81.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.808 -1.183 . . . . 0.9 108.928 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.04 -44.92 94.33 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.386 -0.822 . . . . 1.61 109.438 179.835 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.448 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 67.9 p -56.72 -18.87 14.01 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.296 -0.877 . . . . 0.61 110.537 -178.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.36 -48.76 8.72 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.949 -1.095 . . . . 0.6 109.378 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -90.82 38.64 0.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.537 -0.912 . . . . 1.4 108.537 179.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.5 tp -104.85 134.39 48.05 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.92 -0.77 . . . . 0.7 108.92 179.382 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 176' ' ' VAL . 86.3 m-20 -80.86 101.72 9.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.252 -0.905 . . . . 2.35 108.79 179.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 97.2 mt -62.93 -39.96 96.19 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.269 -0.894 . . . . 1.51 110.337 -179.215 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -67.02 -24.25 66.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.081 -1.012 . . . . 2.33 110.883 -178.121 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 67.4 mmtt -93.92 -11.46 30.93 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.737 -1.227 . . . . 1.92 109.478 -179.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.463 HG11 ' CE1' ' A' ' 179' ' ' PHE . 72.4 t -101.17 110.14 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 O-C-N 121.197 -0.94 . . . . 0.67 108.737 179.064 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 91.1 mt -86.16 5.99 31.42 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.204 -0.935 . . . . 1.53 110.57 -178.658 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 174.18 170.41 37.44 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 108.991 -1.644 . . . . 0.48 108.991 179.711 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.463 ' CE1' HG11 ' A' ' 176' ' ' VAL . 22.3 m-85 -130.86 128.93 41.61 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.334 -1.097 . . . . 0.55 109.288 -179.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 90.0 mt -132.55 125.38 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 N-CA-C 108.484 -0.932 . . . . 0.65 108.484 178.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.3 p -145.94 160.04 42.4 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.062 -1.023 . . . . 0.82 110.84 -179.236 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 59.6 t0 -101.82 23.13 11.81 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.599 -0.688 . . . . 2.46 109.885 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.41 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -58.19 -161.17 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.287 -1.508 . . . . 1.28 110.792 -178.498 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -83.75 -44.34 6.86 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.607 -0.997 . . . . 2.19 110.607 -179.181 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 147.57 -115.25 0.75 Allowed Glycine 0 N--CA 1.497 2.724 0 O-C-N 120.83 -1.394 . . . . 2.13 110.32 -179.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.422 ' HG2' HH22 ' A' ' 195' ' ' ARG . 46.4 mtt-85 -59.92 -38.06 81.25 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.49 -1.006 . . . . 5.86 110.927 -179.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 73.4 p -70.25 0.09 7.01 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.914 -1.116 . . . . 3.72 110.432 -178.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 39.8 t -92.32 117.27 29.73 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.972 -1.08 . . . . 1.74 110.712 -179.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -47.71 -42.3 24.74 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.197 -0.939 . . . . 0.95 108.541 179.026 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.432 ' H ' HG23 ' A' ' 190' ' ' THR . 23.4 p -52.18 -34.66 46.14 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.801 -0.562 . . . . 1.55 109.96 -179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 74.9 m -60.01 -40.06 87.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.011 -1.056 . . . . 1.51 110.472 -179.614 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 39.2 mm -63.98 -40.35 88.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.17 -0.956 . . . . 1.67 110.112 -178.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 82.9 mtp -59.99 -49.04 79.23 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.956 -1.09 . . . . 1.02 110.969 -178.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.52 -44.17 89.43 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 120.705 -1.247 . . . . 0.68 109.968 -178.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.422 HH22 ' HG2' ' A' ' 186' ' ' ARG . 98.2 mtt180 -61.75 -54.93 35.81 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.29 -0.964 . . . . 2.93 110.503 -179.183 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.3 m -70.0 -35.89 74.73 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.027 -1.046 . . . . 0.86 112.148 -178.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.4 mt -74.55 -12.35 60.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.604 -1.31 . . . . 0.67 110.585 -178.114 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 62.14 49.56 4.39 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.495 -0.753 . . . . 1.5 111.055 -179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 96.4 mt -130.62 150.03 75.22 Favored Pre-proline 0 N--CA 1.499 2.002 0 N-CA-C 107.641 -1.244 . . . . 0.72 107.641 178.004 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.11 143.85 73.26 Favored 'Trans proline' 0 N--CA 1.497 1.716 0 C-N-CA 122.035 1.823 . . . . 0.61 111.418 179.867 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.91 151.74 4.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.746 -1.221 . . . . 0.66 111.889 -179.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.6 mt -125.81 139.67 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 N-CA-C 108.025 -1.102 . . . . 0.79 108.025 178.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.1 m -122.77 -12.67 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.397 0 O-C-N 120.985 -1.072 . . . . 0.91 110.968 -178.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.98 26.56 13.63 Favored Glycine 0 N--CA 1.501 2.978 0 N-CA-C 110.897 -0.881 . . . . 1.01 110.897 -178.838 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 5.7 p -43.2 -44.82 5.38 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.066 -1.255 . . . . 0.99 110.096 -179.393 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.447 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 93.01 -52.12 2.54 Favored Glycine 0 N--CA 1.498 2.795 0 C-N-CA 120.224 -0.988 . . . . 1.12 110.741 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.2 t -158.91 33.64 0.21 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.617 -1.519 . . . . 1.72 111.186 -179.259 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 47.1 t -72.6 -40.05 62.01 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.985 -1.072 . . . . 0.89 109.082 178.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.452 ' H ' HG23 ' A' ' 209' ' ' THR . 7.0 p -54.54 -30.0 52.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.431 -0.793 . . . . 1.03 110.108 -179.08 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.5 t -80.89 -21.1 40.89 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.061 -1.024 . . . . 1.83 110.161 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -96.96 -13.41 22.39 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.128 -0.982 . . . . 2.27 110.125 -179.416 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.8 t -102.05 136.62 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 O-C-N 121.361 -0.837 . . . . 0.92 110.216 -178.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -112.23 154.54 25.43 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.04 -1.467 . . . . 2.2 107.04 178.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.497 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 15.5 t-20 -60.04 139.02 57.73 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 120.839 -1.163 . . . . 2.36 110.169 -179.145 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 9.6 t0 84.91 7.24 0.48 Allowed 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.16 0.505 . . . . 2.38 110.019 179.49 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.493 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 55.3 t0 -76.87 142.07 40.35 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.204 -0.935 . . . . 2.09 109.096 179.232 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.493 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 49.3 t80 -92.81 117.98 30.61 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 107.977 -1.12 . . . . 1.27 107.977 178.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.545 HD12 ' HB2' ' A' ' 16' ' ' ALA . 69.9 mt -127.16 147.47 50.19 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.503 -0.748 . . . . 0.75 110.55 -178.554 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.403 HD12 ' HG3' ' A' ' 231' ' ' PRO . 80.5 mt -118.39 129.59 74.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 107.469 -1.308 . . . . 0.63 107.469 177.461 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 34.3 tp -104.22 123.65 47.71 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.668 -0.864 . . . . 0.7 108.668 -179.193 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 10' ' ' GLY . 29.1 t0 -85.75 -35.76 20.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.107 -0.995 . . . . 2.31 108.38 179.574 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.778 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 45.71 21.41 0.08 Allowed 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 121.742 0.782 . . . . 0.78 108.919 -179.319 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.455 ' N ' ' O ' ' A' ' 221' ' ' ASP . 42.1 t -133.41 -44.07 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 107.121 -1.437 . . . . 1.04 107.121 178.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.465 ' ND2' ' OD2' ' A' ' 221' ' ' ASP . 84.3 m-20 -102.25 2.1 36.66 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.057 -1.09 . . . . 2.44 108.057 178.606 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.441 HD21 ' H ' ' A' ' 4' ' ' GLY . 10.1 t-20 59.98 43.91 14.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.805 -0.559 . . . . 1.55 110.307 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -136.41 149.37 48.25 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.216 -0.928 . . . . 1.99 110.112 179.227 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.6 129.96 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.454 -0.943 . . . . 0.77 108.454 178.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -100.87 123.03 44.46 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.423 -0.798 . . . . 0.98 109.303 179.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 19.4 t -100.03 110.52 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.373 -0.83 . . . . 0.85 109.98 -179.312 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 230' ' ' ASN . 3.9 t30 56.61 67.43 2.69 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.325 -0.859 . . . . 1.66 111.368 179.221 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.403 ' HG3' HD12 ' A' ' 219' ' ' ILE . 81.6 Cg_endo -91.05 150.02 3.82 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 123.266 2.644 . . . . 0.95 112.568 178.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 2.0 m -70.07 160.03 32.76 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.345 -0.847 . . . . 1.84 110.29 -179.23 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 25.9 p-10 -59.99 -36.84 78.04 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.392 -0.817 . . . . 2.74 109.608 -179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -60.03 -38.43 82.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 2.89 109.221 -179.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.8 t -67.36 -40.05 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.096 -1.003 . . . . 1.3 109.405 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.34 -40.11 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.164 -0.96 . . . . 1.09 110.104 -179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -59.92 -43.83 94.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.806 -1.183 . . . . 2.43 109.117 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 8.1 ttpm? -62.01 -43.94 97.77 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.374 -0.829 . . . . 2.78 110.047 -179.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 96.2 mtp -69.92 -34.72 73.84 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.325 -0.859 . . . . 1.25 110.324 -179.564 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -62.04 -40.01 94.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.159 -0.963 . . . . 2.63 110.166 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -64.18 -43.29 95.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.995 -1.066 . . . . 1.8 109.756 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 56.7 t -60.81 -40.16 84.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.249 -0.907 . . . . 2.13 109.229 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -59.93 -40.16 87.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.306 -0.872 . . . . 3.17 109.62 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -59.97 -41.39 91.86 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.243 -0.911 . . . . 1.78 109.385 -179.6 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -70.0 -40.01 75.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 2.47 109.641 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 54.1 t -61.27 -45.11 99.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.462 -0.773 . . . . 2.09 109.603 -179.403 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.03 -49.98 75.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 2.54 109.429 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 70.5 m -61.68 -39.93 93.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.309 -0.87 . . . . 2.99 109.527 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -64.13 -40.04 95.33 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.567 -0.708 . . . . 3.34 110.206 -179.134 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -171.55 80.07 0.07 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.144 -0.973 . . . . 3.88 108.59 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.462 ' O ' HD23 ' A' ' 253' ' ' LEU . . . -80.9 -6.85 59.18 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.27 -0.894 . . . . 4.43 109.077 179.19 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.437 ' CB ' ' O ' ' A' ' 251' ' ' ALA . 2.6 tm-20 75.56 -41.44 0.44 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.521 -0.737 . . . . 5.42 109.388 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 251' ' ' ALA . 0.1 OUTLIER -100.16 46.2 0.96 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.075 -1.083 . . . . 6.1 108.075 179.27 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -152.71 -0.54 0.27 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.307 -0.871 . . . . 7.37 111.005 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.464 ' O ' ' O ' ' A' ' 256' ' ' LEU . 55.6 tttp -145.93 6.14 1.03 Allowed 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.68 -1.263 . . . . 8.01 109.404 179.959 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 255' ' ' LYS . 54.1 mt 56.52 114.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.244 -0.91 . . . . 9.05 109.825 179.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -123.87 14.83 9.3 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 108.271 -1.011 . . . . 10.56 108.271 179.042 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.495 ' N ' ' OD1' ' A' ' 258' ' ' ASP . 22.0 p-10 -84.73 36.35 0.6 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.732 -1.23 . . . . 11.32 109.657 -179.646 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 117.976 -1.012 . . . . 12.42 109.125 179.624 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 50.5 ttp . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.573 0.701 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 36.2 t80 -154.92 152.83 30.21 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 178.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . 0.463 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 13.8 pt20 -149.78 159.99 43.91 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.937 -1.102 . . . . 0.0 110.474 -179.436 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -153.94 150.44 28.33 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.568 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -112.49 134.08 54.21 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.225 -0.922 . . . . 0.0 110.583 -179.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -129.71 121.52 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.278 0 CA-C-O 122.251 1.024 . . . . 0.0 112.546 -177.485 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . 0.462 ' O ' HG23 ' B' ' 309' ' ' THR . 25.4 m -76.45 105.1 7.31 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.79 0.805 . . . . 0.0 110.42 -178.437 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 98.9 mt -53.26 121.62 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-O 122.318 1.056 . . . . 0.0 110.375 -178.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . 0.462 HG23 ' O ' ' B' ' 307' ' ' THR . 78.1 p -110.11 19.95 18.42 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.36 -178.622 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.14 126.14 91.97 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 120.901 -1.124 . . . . 0.0 109.168 179.652 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.65 -18.72 27.38 Favored 'Trans proline' 0 N--CA 1.493 1.464 0 CA-C-N 120.404 1.18 . . . . 0.0 112.327 -179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -120.45 10.16 11.1 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 75.33 -176.98 49.47 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 -179.098 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.515 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -83.45 87.54 6.99 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.088 -1.242 . . . . 0.0 108.988 -178.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.419 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 3.9 p80 -90.29 -162.92 0.94 Allowed 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.825 -1.172 . . . . 0.0 110.123 179.09 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 9.6 m -57.09 -41.78 79.49 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.852 -1.155 . . . . 0.0 112.486 -175.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.493 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 0.7 OUTLIER -60.02 -60.88 9.17 Favored Pre-proline 0 N--CA 1.497 1.893 0 O-C-N 120.62 -1.3 . . . . 0.0 111.855 -178.835 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.419 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 13.1 Cg_endo -59.38 -34.33 97.56 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 CA-C-N 120.139 1.085 . . . . 0.0 111.801 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.98 -50.52 73.42 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.74 -41.96 67.66 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.02 -179.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . 0.582 ' HA ' ' HZ2' ' B' ' 324' ' ' LYS . 27.3 mm100 -70.0 -41.4 74.42 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 108.692 178.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . 0.486 ' CE1' ' SD ' ' B' ' 381' ' ' MET . 55.1 t80 -61.93 -52.23 64.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.583 -0.698 . . . . 0.0 110.813 -179.116 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 93.8 t -65.51 -29.23 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.596 -1.315 . . . . 0.0 109.299 -179.288 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.582 ' HZ2' ' HA ' ' B' ' 321' ' ' GLN . 0.2 OUTLIER -60.13 -46.25 90.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.406 -0.809 . . . . 0.0 109.636 179.495 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 34.6 tp10 -67.19 -45.62 76.36 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.346 -0.846 . . . . 0.0 110.893 -178.54 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.0 -53.0 62.97 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.706 -1.246 . . . . 0.0 110.833 -178.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.438 ' HZ2' ' HG3' ' B' ' 345' ' ' LYS . 28.5 mttp -54.12 -12.64 0.65 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.067 -1.021 . . . . 0.0 109.452 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.1 -20.14 73.42 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -106.03 146.66 29.82 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.387 -1.066 . . . . 0.0 108.599 179.531 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 70.0 p -91.51 -14.29 30.67 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.86 -1.15 . . . . 0.0 109.435 179.586 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.419 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 77.9 p -64.52 149.18 49.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.665 -179.535 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 15.3 tm-20 -69.85 138.25 52.41 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.129 -0.982 . . . . 0.0 108.795 179.629 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.6 mt -134.14 134.6 55.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.603 -0.686 . . . . 0.0 109.56 -179.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 48.4 m -128.62 149.82 50.49 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 179.451 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 76.5 t -121.99 113.15 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 178.35 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 44.3 m -105.29 133.16 50.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.179 -0.951 . . . . 0.0 109.28 -178.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 34.1 p -137.83 110.67 7.66 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.758 0.789 . . . . 0.0 110.248 -179.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 22.4 m120 45.97 53.48 9.02 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 177.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.96 -15.45 59.35 Favored Glycine 0 N--CA 1.504 3.169 0 O-C-N 120.246 -1.534 . . . . 0.0 113.207 176.413 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . 0.528 ' NZ ' ' O ' ' B' ' 352' ' ' THR . 9.7 mtpm? -116.06 127.92 55.27 Favored 'General case' 0 N--CA 1.507 2.423 0 CA-C-N 119.338 1.569 . . . . 0.0 109.614 -179.517 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 67.2 m -127.2 148.58 50.19 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.968 0.889 . . . . 0.0 111.15 -178.395 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.94 164.69 29.49 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.348 0.594 . . . . 0.0 109.712 -179.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 47.4 t -88.58 132.41 34.55 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.474 -0.766 . . . . 0.0 110.922 -178.735 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.443 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -69.86 -21.63 63.33 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.28 -0.888 . . . . 0.0 108.871 179.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . 0.449 ' CG ' ' O ' ' B' ' 345' ' ' LYS . 24.0 ttpp -83.12 18.0 1.82 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . 0.443 ' H ' ' C ' ' B' ' 344' ' ' ALA . 11.2 t -147.12 95.33 2.54 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.36 -0.836 . . . . 0.0 112.14 -179.489 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.804 HD23 HD22 ' A' ' 79' ' ' LEU . 60.8 tp -59.91 -39.7 86.28 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.542 -0.724 . . . . 0.0 109.132 179.02 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.884 ' CE2' HD11 ' A' ' 79' ' ' LEU . 60.9 m-85 -54.02 -52.49 60.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.104 -0.998 . . . . 0.0 110.771 -179.404 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -65.89 -39.99 91.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.152 -0.968 . . . . 0.0 109.704 -178.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.569 ' O ' ' N ' ' B' ' 352' ' ' THR . 17.6 mt -49.71 -58.35 5.47 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.193 -0.942 . . . . 0.0 109.915 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.768 HE22 ' HE ' ' A' ' 126' ' ' ARG . 8.2 mm100 -42.58 -13.19 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.239 -0.913 . . . . 0.0 111.869 -177.077 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.569 ' N ' ' O ' ' B' ' 350' ' ' LEU . 81.6 p -85.02 -15.01 45.56 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 119.95 -1.719 . . . . 0.0 110.275 -179.152 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.442 HD23 ' HZ3' ' B' ' 340' ' ' LYS . 43.3 mt -91.32 119.96 31.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.999 -1.063 . . . . 0.0 109.431 179.335 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.26 93.91 0.7 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 179.175 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . 0.417 HD22 HG11 ' B' ' 361' ' ' VAL . 52.0 mt -100.59 88.01 3.51 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.245 -1.15 . . . . 0.0 109.187 179.656 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 60.0 p -91.53 166.12 13.0 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.958 -1.089 . . . . 0.0 110.744 -178.974 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -59.41 116.64 4.09 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.774 -0.579 . . . . 0.0 111.077 -179.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 101.02 7.11 50.91 Favored Glycine 0 N--CA 1.496 2.639 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 47.7 m -86.74 110.89 20.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.268 -1.136 . . . . 0.0 110.795 -179.532 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 46.7 t -77.78 117.52 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 CA-C-O 122.169 0.985 . . . . 0.0 109.48 -177.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . 0.417 HG11 HD22 ' B' ' 355' ' ' LEU . 25.4 m -110.22 177.67 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -178.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 91.1 m -131.35 128.74 40.29 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 177.174 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 69.6 mt -103.0 116.33 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.647 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 67.2 m -116.06 129.99 56.6 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.88 151.8 39.27 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.353 -0.842 . . . . 0.0 109.724 -178.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -145.01 121.5 11.03 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.475 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.81 -155.38 26.54 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 118.765 -1.683 . . . . 0.0 111.844 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 19.8 tp10 -59.94 -50.9 71.93 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 115.173 -0.514 . . . . 0.0 112.224 -177.151 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.419 ' H ' ' HB3' ' B' ' 331' ' ' SER . 97.0 m-20 -110.27 13.47 22.99 Favored 'General case' 0 N--CA 1.504 2.274 0 O-C-N 120.777 -1.202 . . . . 0.0 111.137 -177.584 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.7 pt-20 -42.23 -36.42 1.21 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.206 -0.934 . . . . 0.0 110.655 -179.246 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . 0.407 ' HG2' ' H ' ' B' ' 371' ' ' GLN . 2.3 pt20 -69.26 -47.06 65.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.043 -1.036 . . . . 0.0 110.162 -179.148 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 19.2 ttmm -69.98 -54.44 13.25 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.003 -1.06 . . . . 0.0 109.51 179.75 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . 0.427 ' O ' HD12 ' B' ' 377' ' ' LEU . . . -43.46 -34.18 1.26 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.365 -0.834 . . . . 0.0 111.179 -179.022 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.525 ' O ' HG23 ' B' ' 378' ' ' VAL . 73.4 t -76.09 -35.66 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.603 -1.311 . . . . 0.0 109.399 179.327 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -65.41 -59.4 4.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.285 -0.885 . . . . 0.0 111.853 -178.15 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -69.77 -39.99 76.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.384 -1.448 . . . . 0.0 111.707 -178.269 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . 0.427 HD12 ' O ' ' B' ' 373' ' ' ALA . 88.0 mt -58.46 -39.99 81.42 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.526 -1.359 . . . . 0.0 108.696 -178.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.525 HG23 ' O ' ' B' ' 374' ' ' VAL . 55.3 t -62.38 -42.72 96.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 O-C-N 121.103 -0.998 . . . . 0.0 109.596 179.401 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' B' ' 383' ' ' GLU . 98.6 mttt -71.25 -57.54 4.39 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.794 -1.191 . . . . 0.0 108.209 178.853 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 53.9 tp -53.32 -35.99 60.77 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.173 -0.954 . . . . 0.0 109.015 -178.346 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . 0.486 ' SD ' ' CE1' ' B' ' 322' ' ' PHE . 0.9 OUTLIER -72.14 -40.0 68.38 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 120.621 -1.299 . . . . 0.0 108.437 177.648 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.62 -4.87 58.37 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.595 -0.691 . . . . 0.0 110.601 179.374 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.542 ' N ' ' O ' ' B' ' 379' ' ' LYS . 94.6 mt-10 -111.43 -3.11 15.34 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 121.125 -0.985 . . . . 0.0 110.807 -179.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.6 mt -82.98 131.14 35.2 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.637 -1.289 . . . . 0.0 109.099 179.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.091 179.615 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.358 -0.608 . . . . 2.91 109.358 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.505 HD11 HE22 ' A' ' 211' ' ' GLN . 97.4 mt -108.37 123.71 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.438 -0.788 . . . . 1.2 109.602 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 37.8 m -135.98 141.14 44.39 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.72 -0.844 . . . . 1.4 108.72 179.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.824 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -109.0 -160.13 19.45 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 109.113 -1.595 . . . . 1.05 109.113 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.1 mt -95.23 -15.01 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.118 -1.225 . . . . 1.15 109.589 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.4 tp 51.99 104.18 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.424 -0.798 . . . . 0.98 109.666 179.665 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -94.82 -23.57 17.43 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.079 -1.013 . . . . 0.88 109.302 179.51 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.459 ' OG ' ' N ' ' A' ' 201' ' ' ALA . 12.5 p -137.42 119.24 11.01 Favored Pre-proline 0 N--CA 1.5 2.027 0 O-C-N 121.405 -0.81 . . . . 1.69 109.06 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -79.99 150.13 20.51 Favored 'Trans proline' 0 N--CA 1.494 1.526 0 C-N-CA 121.904 1.736 . . . . 0.85 112.375 -179.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.784 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.35 -155.09 25.96 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.08 -1.608 . . . . 0.92 109.08 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.7 mt -149.08 150.59 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 O-C-N 121.016 -1.285 . . . . 0.81 109.112 179.045 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.12 146.12 22.59 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.022 -1.049 . . . . 0.51 110.315 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.542 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -127.62 127.92 44.64 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.161 -1.051 . . . . 0.62 108.161 178.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.1 176.08 46.6 Favored Glycine 0 N--CA 1.493 2.442 0 C-N-CA 118.734 -1.698 . . . . 0.55 110.588 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -77.76 156.31 30.65 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.699 -0.883 . . . . 2.1 109.022 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -102.59 128.33 49.29 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.416 -0.802 . . . . 0.77 111.025 -178.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.8 tp -100.13 135.33 41.73 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.069 -1.456 . . . . 0.91 107.069 178.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.0 tp -115.3 121.6 43.37 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.3 -0.875 . . . . 0.93 110.099 -178.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.1 mt -86.69 103.01 14.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.526 -0.734 . . . . 0.93 109.73 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -90.96 142.31 27.91 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.395 -0.815 . . . . 2.75 109.244 179.713 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -130.1 133.34 46.6 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.426 -0.953 . . . . 3.0 108.426 179.222 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -84.07 150.69 25.41 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.044 -1.035 . . . . 2.77 109.429 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -66.66 147.89 52.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.208 -0.932 . . . . 2.94 109.301 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 86.5 mt -96.44 126.68 49.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.187 -0.946 . . . . 0.95 109.05 -179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.1 t -94.73 126.12 47.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.133 -0.979 . . . . 1.28 109.997 -179.298 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.5 mt -112.37 131.93 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 N-CA-C 109.016 -0.735 . . . . 1.21 109.016 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -89.01 118.35 28.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.873 -1.142 . . . . 1.81 110.335 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.9 mmt180 -85.08 -1.06 56.42 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.715 -0.846 . . . . 2.8 108.715 179.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -69.9 140.37 53.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.469 -0.769 . . . . 2.87 110.024 -179.76 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 38.3 mtmt -80.03 153.3 28.91 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.194 -0.941 . . . . 2.35 109.409 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.0 pt -94.6 167.48 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.179 -0.95 . . . . 0.97 109.711 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.4 p -96.28 173.04 7.59 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.147 -1.057 . . . . 1.17 108.147 178.22 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.94 -49.99 75.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.913 -1.117 . . . . 1.18 110.501 -179.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -57.3 -26.45 60.91 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.703 -1.248 . . . . 2.56 109.513 -179.275 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -82.26 -9.83 59.34 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.302 -0.874 . . . . 1.79 109.762 179.794 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 50.3 t -66.49 -54.59 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.925 -1.11 . . . . 1.0 109.641 -179.588 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -60.04 -40.08 88.14 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.269 -0.895 . . . . 1.77 109.102 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.432 HE21 HH21 ' A' ' 42' ' ' ARG . 28.2 mt-30 -62.87 -42.19 99.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.419 -0.801 . . . . 2.7 110.707 -179.295 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -62.62 -42.55 99.65 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.615 -1.303 . . . . 1.51 110.221 -179.498 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -59.98 -47.39 91.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 120.594 -1.316 . . . . 0.93 108.64 179.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -59.94 -45.15 93.53 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.193 -0.942 . . . . 1.81 109.318 179.846 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.501 HH11 ' HG2' ' A' ' 42' ' ' ARG . 22.2 mtt-85 -60.08 -43.56 95.39 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.069 -1.086 . . . . 2.78 108.069 179.199 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -62.0 -47.2 85.85 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.737 -0.838 . . . . 0.78 108.737 178.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.2 tp -59.94 -48.92 79.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.409 -0.807 . . . . 1.07 108.837 179.74 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.442 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 29.4 t -63.04 -43.73 97.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.975 -1.078 . . . . 1.12 108.963 178.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.06 -47.51 90.85 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.57 -1.812 . . . . 0.84 108.57 179.173 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.6 ttp180 -61.56 -36.18 79.9 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.006 -1.109 . . . . 3.09 108.006 178.599 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -55.32 -40.01 70.64 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.317 -0.623 . . . . 0.88 109.317 -179.618 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ALA . 26.4 ttpp -66.34 -73.73 0.13 Allowed 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.652 -1.24 . . . . 2.59 107.652 179.153 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.09 -36.34 0.2 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.46 -0.775 . . . . 0.7 111.346 -178.544 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.7 t -57.41 -55.94 28.34 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.508 -1.37 . . . . 1.4 108.612 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.08 -40.0 86.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.253 -0.904 . . . . 0.67 111.074 -179.49 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -67.96 -40.24 83.23 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.841 -1.162 . . . . 1.66 110.322 -178.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 77.2 mt -62.03 -39.97 94.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.009 -1.057 . . . . 1.58 108.72 179.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -61.21 -38.49 86.79 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.426 -0.796 . . . . 1.35 109.713 179.26 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -64.27 -43.69 94.05 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.194 -0.941 . . . . 0.77 110.268 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.657 ' CD1' HH22 ' A' ' 136' ' ' ARG . 85.7 mt -63.04 -38.1 81.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.178 -0.951 . . . . 0.63 108.969 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -56.15 -50.59 70.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.265 -0.897 . . . . 1.14 109.896 -179.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -59.94 -36.44 77.08 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.43 -0.794 . . . . 0.79 110.367 -177.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -63.79 -39.48 94.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.963 -1.086 . . . . 1.53 109.211 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.68 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.54 -45.48 75.54 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.564 -0.71 . . . . 0.57 110.033 -179.556 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.14 -51.16 60.07 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 110.268 -1.133 . . . . 0.75 110.268 -179.036 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -69.96 -41.88 73.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.037 -1.272 . . . . 1.59 110.309 -179.446 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.3 m -69.92 -60.4 2.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.912 . . . . 0.73 112.2 -177.546 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -95.49 -50.77 4.84 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.964 -1.085 . . . . 0.75 111.093 -178.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.42 -163.7 26.75 Favored Glycine 0 N--CA 1.499 2.837 0 O-C-N 120.747 -1.221 . . . . 1.22 110.726 179.678 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -70.0 -23.24 63.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.751 -0.852 . . . . 5.81 110.364 -179.69 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.425 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 52.7 tp10 -60.13 -37.76 81.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 3.37 110.272 -179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -97.4 -19.02 18.73 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.293 -0.88 . . . . 1.77 110.388 -178.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.7 tt0 -70.09 -40.12 75.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.855 -1.153 . . . . 1.65 110.496 -179.712 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.601 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.82 -29.9 69.17 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.399 -0.813 . . . . 0.77 109.585 -178.761 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.02 -42.57 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 C-N-CA 119.248 -0.981 . . . . 0.8 109.112 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.451 ' CZ ' HG22 ' A' ' 57' ' ' ILE . 39.5 m-85 -64.5 -40.08 94.99 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.112 -0.993 . . . . 0.88 110.742 -179.97 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -59.98 -40.02 87.69 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.831 -1.168 . . . . 1.37 108.833 -179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.01 -43.53 98.73 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 107.98 -2.048 . . . . 0.62 107.98 178.514 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -65.21 -48.43 73.41 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.459 -1.024 . . . . 1.5 108.608 179.253 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 83.9 mt -64.36 -49.39 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.397 -0.815 . . . . 0.63 109.18 179.432 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.2 ttp -60.41 -42.73 96.6 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.167 -0.958 . . . . 1.51 110.37 -179.075 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.833 HD11 ' CE2' ' B' ' 348' ' ' PHE . 42.0 tp -66.04 -41.57 90.7 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.335 -0.853 . . . . 0.77 109.983 -179.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.4 tp -63.31 -40.11 96.44 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.292 -0.88 . . . . 0.62 110.168 -179.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -82.57 8.03 12.95 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.188 -0.945 . . . . 1.47 110.08 -179.355 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -50.78 131.91 26.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 1.47 109.352 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -60.44 -20.66 60.6 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.701 -0.624 . . . . 1.78 111.027 -178.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.71 -34.32 67.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.901 -1.125 . . . . 2.53 109.552 179.54 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 45.6 mt -70.08 -40.1 75.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.538 -0.726 . . . . 0.8 109.321 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -60.08 -46.04 90.91 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.389 -0.82 . . . . 1.42 109.613 -179.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -69.99 -40.48 75.29 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.406 -0.809 . . . . 1.71 110.244 -179.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.02 -40.02 75.46 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.051 -1.03 . . . . 1.57 111.14 -179.417 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.0 mt -67.95 -48.88 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.919 -1.113 . . . . 0.65 109.461 -179.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.97 -39.7 84.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.506 -0.746 . . . . 0.82 109.51 179.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.96 -48.89 79.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.279 -0.888 . . . . 0.79 110.532 -179.246 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.474 ' O ' ' N ' ' A' ' 96' ' ' LYS . 84.3 mt -60.22 -47.73 84.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.928 -1.108 . . . . 0.95 109.878 -179.638 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.81 -50.05 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.89 . . . . 0.66 109.198 179.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -70.0 -40.49 75.25 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.857 -0.737 . . . . 2.2 110.814 179.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 91' ' ' ALA . 10.2 t70 -84.17 -50.9 7.49 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.041 -1.037 . . . . 1.65 112.058 -178.147 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.474 ' N ' ' O ' ' A' ' 92' ' ' LEU . 67.2 mmtt -90.19 -2.6 58.07 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.885 -1.135 . . . . 2.03 111.606 -177.491 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 71.7 m80 57.6 36.71 27.07 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.075 -1.016 . . . . 1.42 109.478 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 79.6 mtp -93.56 164.14 13.29 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.651 -0.655 . . . . 1.18 110.343 -179.361 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 33.6 p -77.9 161.82 27.29 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.608 -0.683 . . . . 0.98 109.177 179.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.39 -39.89 81.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.102 -0.999 . . . . 0.64 109.783 -179.847 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.489 ' OD2' HD21 ' A' ' 142' ' ' LEU . 96.9 m-20 -64.29 -39.97 95.0 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.144 -0.972 . . . . 2.07 109.399 179.709 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.29 -46.76 19.37 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.836 . . . . 0.73 109.756 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.55 -50.01 75.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.308 -0.87 . . . . 0.54 109.838 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.57 -37.45 81.35 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.203 -0.936 . . . . 0.56 109.417 179.641 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -60.05 -46.91 87.97 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.514 -0.741 . . . . 1.54 110.109 -179.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -62.65 -40.08 95.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.294 -0.879 . . . . 1.33 110.946 -179.041 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.4 -56.29 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.005 -1.059 . . . . 0.72 111.039 -178.055 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.5 mm -68.78 -39.97 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 120.918 -1.114 . . . . 0.85 108.967 -179.326 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -63.63 -40.04 95.89 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.245 -1.02 . . . . 2.44 108.245 178.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.77 -50.43 67.67 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.057 -1.217 . . . . 0.98 110.057 -179.875 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.437 HE21 ' HB3' ' B' ' 348' ' ' PHE . 26.0 mm100 -65.24 -49.49 69.43 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.956 -1.32 . . . . 1.41 109.262 -179.801 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.56 -42.67 92.93 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.094 -1.004 . . . . 1.2 108.731 179.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 88.6 p -60.11 -39.86 87.69 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.243 -0.91 . . . . 1.7 109.023 179.175 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -58.3 -39.92 80.62 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.056 -1.028 . . . . 1.47 108.629 179.81 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.9 mt -62.17 -39.97 94.43 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.138 -0.976 . . . . 1.56 109.047 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -53.85 -24.37 15.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.081 -1.012 . . . . 2.2 109.514 -179.124 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -59.91 -27.83 67.07 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.534 -1.284 . . . . 2.12 107.534 179.146 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.429 HD11 ' HA ' ' B' ' 352' ' ' THR . 57.6 mt -62.99 140.38 58.86 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.712 -0.618 . . . . 2.0 109.511 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -100.12 48.92 0.92 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.232 -0.917 . . . . 3.23 109.538 179.693 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 51.1 t0 -136.34 148.53 47.94 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.311 -0.868 . . . . 2.49 109.424 -179.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.531 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 71.4 mm-40 -73.28 -65.02 0.86 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.247 -0.908 . . . . 3.95 108.597 178.636 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -40.7 -39.85 1.17 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.83 -0.544 . . . . 2.0 110.948 -179.154 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 83.6 mt -76.33 -40.27 51.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.619 -1.301 . . . . 1.86 110.0 -179.455 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -68.64 -39.98 80.5 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.047 -1.033 . . . . 2.84 109.463 -179.788 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.604 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 47.8 mt-10 -59.9 -43.57 94.74 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.135 -0.978 . . . . 2.73 108.527 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.705 ' NE ' HE21 ' B' ' 351' ' ' GLN . 1.6 ttp180 -60.73 -40.02 90.81 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 108.364 -0.976 . . . . 2.77 108.364 179.428 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.04 -19.91 48.25 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.904 -1.147 . . . . 1.19 107.904 178.555 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -69.72 -40.04 76.5 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.585 -1.265 . . . . 1.2 107.585 178.502 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -65.02 -40.05 94.3 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.501 -0.749 . . . . 1.55 109.102 179.456 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.8 t -65.48 -40.09 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.306 -0.998 . . . . 0.8 108.306 178.997 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 64.3 ttt180 -62.33 -37.81 87.04 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.542 -0.723 . . . . 3.09 109.294 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -59.98 -40.56 89.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.374 -0.829 . . . . 1.46 110.034 -178.85 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.01 -47.81 90.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.129 -0.982 . . . . 0.71 109.45 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -63.16 -40.24 98.91 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 110.09 -1.204 . . . . 0.57 110.09 -179.841 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.1 tmmm? -59.96 -48.0 83.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.378 -1.071 . . . . 2.59 109.774 -179.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.657 HH22 ' CD1' ' A' ' 57' ' ' ILE . 57.4 mtp180 -65.77 -33.5 76.0 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.038 -1.039 . . . . 2.83 109.729 -179.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.3 tp -59.84 -43.15 94.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.41 -0.806 . . . . 1.25 109.374 -179.234 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.05 -40.06 88.12 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.19 -0.943 . . . . 0.7 109.238 179.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.401 HH11 ' HG2' ' A' ' 139' ' ' ARG . 55.2 mtt-85 -69.94 -39.9 75.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 2.57 109.477 179.554 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -67.62 -34.66 77.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.478 -0.763 . . . . 1.23 112.096 -178.576 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.06 -41.46 79.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.256 -1.527 . . . . 0.81 108.784 179.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.489 HD21 ' OD2' ' A' ' 101' ' ' ASP . 92.1 mt -73.45 -26.19 60.82 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.802 -0.814 . . . . 1.0 108.802 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.32 43.41 8.02 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 108.374 -1.89 . . . . 0.89 108.374 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.2 tp -74.35 150.03 40.3 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.532 -0.981 . . . . 1.14 109.029 -179.129 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -64.58 142.51 58.4 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.29 -0.881 . . . . 4.6 110.396 -178.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.7 mt -116.86 127.6 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 CA-C-O 121.89 0.852 . . . . 1.24 108.771 179.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.8 mt -65.43 -43.87 94.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.918 -0.489 . . . . 1.54 111.468 -177.644 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 17.0 t0 64.53 112.78 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.222 -0.924 . . . . 1.5 109.031 -178.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 86.6 mt -79.05 -3.28 44.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.319 -0.863 . . . . 0.79 110.029 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.9 m -87.3 -15.3 38.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.275 -0.89 . . . . 1.4 109.808 179.848 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.31 14.47 2.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.281 -0.887 . . . . 0.92 111.334 -178.503 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.645 HD12 ' N ' ' A' ' 152' ' ' ILE . 1.5 mp -90.23 117.92 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.549 -1.344 . . . . 0.88 108.764 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -101.65 -11.87 18.85 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.303 -0.873 . . . . 2.45 110.196 -179.433 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -112.24 146.66 37.77 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.55 -0.719 . . . . 1.52 110.168 -179.212 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.06 132.2 47.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.484 -0.76 . . . . 1.58 109.435 179.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.9 m -152.81 165.05 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.457 -0.777 . . . . 0.69 109.369 179.334 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.4 mt -92.43 147.95 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 105.383 -2.081 . . . . 0.61 105.383 176.485 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.0 tp -98.52 117.49 33.08 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.833 -1.167 . . . . 0.87 110.581 -177.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 34.2 t -121.61 129.43 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 108.662 -0.866 . . . . 0.71 108.662 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.91 164.77 33.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.104 -0.997 . . . . 0.81 108.928 179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.457 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -69.12 -36.85 77.95 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.069 -1.644 . . . . 0.98 108.381 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 162' ' ' ASP . 33.9 p-10 -170.7 150.47 3.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.195 -0.941 . . . . 2.25 109.563 179.647 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.7 mt -118.91 136.38 54.09 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.561 -0.712 . . . . 0.78 109.629 -179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 22.9 p -92.94 148.37 35.71 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.262 -0.899 . . . . 0.98 109.146 179.707 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_exo -39.97 -36.6 1.42 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.044 1.829 . . . . 0.81 112.599 179.613 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.7 m -60.0 -40.07 87.94 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.013 -1.054 . . . . 0.9 109.156 -179.733 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -66.01 -43.09 88.68 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.286 -0.884 . . . . 1.61 109.635 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 22.8 p -55.8 -28.78 57.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.149 -0.969 . . . . 0.61 110.308 -178.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.68 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -74.56 -53.34 9.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.11 -0.994 . . . . 0.6 109.678 179.817 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -85.36 38.34 0.73 Allowed 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.091 -1.077 . . . . 1.4 108.091 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.4 tp -100.87 129.1 46.69 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.788 -0.819 . . . . 0.7 108.788 179.26 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.727 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 0.1 OUTLIER -85.62 101.46 12.73 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 107.908 -1.145 . . . . 2.35 107.908 179.106 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 70.0 mt -64.67 -43.18 94.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.563 -0.71 . . . . 1.51 111.613 -178.043 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -71.23 -21.65 62.1 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.73 -1.231 . . . . 2.33 111.874 -177.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -93.22 -11.31 32.95 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.583 -1.323 . . . . 1.92 108.849 -179.35 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.528 HG12 ' H ' ' A' ' 178' ' ' GLY . 67.9 t -110.02 120.06 60.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 N-CA-C 108.647 -0.871 . . . . 0.67 108.647 179.231 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.9 mt -89.01 6.35 40.06 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.266 -0.896 . . . . 1.53 110.98 -177.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.528 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.58 172.92 37.39 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.378 -1.391 . . . . 0.48 109.808 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -134.15 129.17 35.48 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.271 -1.135 . . . . 0.55 109.079 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.21 127.05 60.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.322 -0.861 . . . . 0.65 109.158 179.13 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . 0.429 ' C ' ' HG1' ' A' ' 205' ' ' THR . 25.6 p -148.79 159.84 43.77 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.849 -1.157 . . . . 0.82 110.771 -179.721 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 37.2 p-10 -104.07 27.06 8.02 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.595 -0.691 . . . . 2.46 109.333 179.49 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -56.03 -162.14 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.975 -1.078 . . . . 1.28 111.318 -178.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.2 -59.17 5.14 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 110.958 -0.857 . . . . 2.19 110.958 -178.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -178.64 -150.66 8.94 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 118.862 -1.637 . . . . 2.13 111.085 -179.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -69.92 -20.62 63.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.604 -0.939 . . . . 5.86 110.54 -178.75 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 21.4 p -68.85 4.17 1.62 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.04 -1.038 . . . . 3.72 109.992 -179.136 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.7 p -88.48 142.51 27.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.151 -0.968 . . . . 1.74 110.638 -179.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 70.2 t60 -49.99 -47.1 53.08 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.549 -0.719 . . . . 0.95 109.782 -179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.4 m -56.32 -39.99 73.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.498 -0.751 . . . . 1.55 110.313 -178.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.4 t -60.8 -39.96 90.88 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.034 -1.041 . . . . 1.51 111.051 -179.631 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.02 -41.12 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.018 -1.051 . . . . 1.67 110.095 -178.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.0 mtp -65.16 -41.7 94.44 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.032 -1.043 . . . . 1.02 111.233 -179.214 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.6 92.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.108 -1.62 . . . . 0.68 110.188 -179.399 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -60.02 -49.3 78.19 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 2.93 110.586 -178.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 74.4 m -72.45 -33.73 67.25 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.237 -0.914 . . . . 0.86 111.817 -178.554 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.1 mt -84.08 -8.1 59.2 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.697 -1.252 . . . . 0.67 111.118 -178.211 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 59.2 49.22 9.41 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.271 -0.893 . . . . 1.5 110.841 179.463 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 80.6 mt -121.5 122.73 27.87 Favored Pre-proline 0 N--CA 1.501 2.099 0 N-CA-C 108.588 -0.893 . . . . 0.72 108.588 178.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -44.17 131.4 8.76 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.8 1.667 . . . . 0.61 112.004 -179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.459 ' N ' ' OG ' ' A' ' 8' ' ' SER . . . -167.89 146.95 4.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.738 -1.226 . . . . 0.66 111.501 179.913 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 90.0 mt -125.47 140.79 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 N-CA-C 107.745 -1.205 . . . . 0.79 107.745 178.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.63 -8.85 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 O-C-N 121.031 -1.043 . . . . 0.91 110.99 -178.8 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.41 22.0 29.68 Favored Glycine 0 N--CA 1.5 2.904 0 N-CA-C 110.219 -1.152 . . . . 1.01 110.219 -179.596 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.429 ' HG1' ' C ' ' A' ' 181' ' ' THR . 6.3 p -45.74 -42.59 12.1 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.031 -1.276 . . . . 0.99 109.848 -179.248 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.56 -51.09 3.29 Favored Glycine 0 N--CA 1.497 2.734 0 C-N-CA 120.111 -1.042 . . . . 1.12 111.303 178.901 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.6 t -161.1 37.8 0.15 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.71 -1.465 . . . . 1.72 110.984 -179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 40.0 t -74.88 -39.95 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.124 -0.985 . . . . 0.89 108.473 177.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.436 HG23 ' H ' ' A' ' 209' ' ' THR . 2.9 p -54.18 -29.99 47.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.529 -0.732 . . . . 1.03 110.775 -179.237 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 52.3 m -80.06 -12.64 59.67 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.002 -1.061 . . . . 1.83 109.643 -179.293 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.505 HE22 HD11 ' A' ' 2' ' ' ILE . 94.8 mt-30 -104.99 -12.2 16.29 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.485 -0.76 . . . . 2.27 109.773 -179.731 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 71.5 t -104.64 137.7 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.333 -0.855 . . . . 0.92 110.602 -178.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.45 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 0.0 OUTLIER -113.16 153.25 28.58 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.564 -1.272 . . . . 2.2 107.564 179.01 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.705 ' N ' HD22 ' A' ' 214' ' ' ASN . 0.0 OUTLIER -59.49 136.49 57.99 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.073 -1.017 . . . . 2.36 110.744 -178.623 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 10.4 t0 84.49 5.89 0.6 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.99 -0.444 . . . . 2.38 110.715 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.45 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 92.1 m-20 -75.13 145.44 42.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.79 -1.194 . . . . 2.09 109.065 178.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -92.37 117.92 30.4 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.928 -1.138 . . . . 1.27 107.928 178.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.525 HD12 ' HB2' ' A' ' 16' ' ' ALA . 83.4 mt -127.12 146.73 50.28 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.486 -0.758 . . . . 0.75 110.454 -178.893 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.6 mt -112.25 129.27 68.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 106.272 -1.751 . . . . 0.63 106.272 176.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 30.6 tp -98.8 115.68 29.33 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.892 -1.13 . . . . 0.7 109.506 -178.223 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.535 ' C ' ' H ' ' A' ' 223' ' ' VAL . 65.1 m-20 -70.95 -46.34 62.57 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.935 -1.135 . . . . 2.31 107.935 178.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.784 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 52.08 7.89 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.761 -0.829 . . . . 0.78 108.761 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.535 ' H ' ' C ' ' A' ' 221' ' ' ASP . 72.1 t -123.86 -42.78 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 107.192 -1.41 . . . . 1.04 107.192 179.11 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -102.58 0.03 32.78 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.658 -1.238 . . . . 2.44 107.658 178.267 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.824 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 59.84 42.74 16.04 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.772 -0.58 . . . . 1.55 109.737 -179.955 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -133.12 152.36 51.95 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.398 -0.814 . . . . 1.99 109.462 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.23 129.98 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.997 -0.742 . . . . 0.77 108.997 179.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -100.05 122.76 43.43 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 108.505 -0.924 . . . . 0.98 108.505 179.094 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 24.2 t -103.12 113.39 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.573 -0.704 . . . . 0.85 109.904 -179.368 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 66.1 t30 53.89 66.87 3.99 Favored Pre-proline 0 N--CA 1.498 1.97 0 O-C-N 121.357 -0.839 . . . . 1.66 111.532 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -90.94 151.36 3.93 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 123.196 2.597 . . . . 0.95 112.405 178.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.412 ' OG1' HG23 ' A' ' 235' ' ' VAL . 37.9 p -70.01 162.21 28.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.15 -0.969 . . . . 1.84 110.305 -179.34 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -60.55 -40.05 90.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.483 -0.761 . . . . 2.74 109.958 -179.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -60.11 -37.86 81.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.426 -0.796 . . . . 2.89 109.874 -179.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.412 HG23 ' OG1' ' A' ' 232' ' ' THR . 54.3 t -65.86 -41.68 90.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.225 -0.922 . . . . 1.3 109.481 -179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.562 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 91.9 mt -62.36 -42.81 96.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.102 -0.999 . . . . 1.09 110.08 -179.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -59.96 -44.78 94.22 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.864 -1.148 . . . . 2.43 108.493 -179.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -60.31 -47.28 86.71 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.321 -0.862 . . . . 2.78 108.845 179.069 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 95.0 mtp -60.65 -40.07 90.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.356 -0.84 . . . . 1.25 109.174 179.243 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.562 ' NH1' ' CG2' ' A' ' 236' ' ' ILE . 0.4 OUTLIER -60.2 -36.24 77.23 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.395 -0.816 . . . . 2.63 109.437 179.38 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.91 -41.85 88.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.225 -0.922 . . . . 1.8 108.805 -179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 96.4 t -60.04 -40.03 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.332 -0.988 . . . . 2.13 108.332 178.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -59.93 -38.67 83.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.574 -0.704 . . . . 3.17 109.307 179.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.97 -39.24 85.0 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.163 -0.961 . . . . 1.78 108.871 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -59.98 -39.93 87.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 2.47 108.857 179.556 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 87.4 t -59.98 -40.03 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.422 -0.799 . . . . 2.09 109.141 -179.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.99 -47.15 87.03 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.208 -0.932 . . . . 2.54 108.566 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 57.7 m -60.0 -40.9 90.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.249 -0.907 . . . . 2.99 109.039 179.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.503 ' OE2' ' N ' ' A' ' 254' ' ' ALA . 27.0 tp10 -69.74 -39.95 76.48 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.639 -0.875 . . . . 3.34 108.639 179.341 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -63.05 -35.07 79.02 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.12 -0.696 . . . . 3.88 109.12 -179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -43.05 -68.5 0.19 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.573 -0.704 . . . . 4.43 110.296 -179.126 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -174.58 22.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.374 -0.829 . . . . 5.42 110.138 179.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 16.7 mt -85.57 -71.55 0.53 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.331 -1.481 . . . . 6.1 109.832 -179.612 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.503 ' N ' ' OE2' ' A' ' 249' ' ' GLU . . . 45.75 29.68 0.72 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.314 -0.866 . . . . 7.37 109.446 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -61.05 -42.33 98.28 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.407 -0.808 . . . . 8.01 111.301 -179.219 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.584 ' N ' HD12 ' A' ' 256' ' ' LEU . 9.9 mp -63.86 -40.13 95.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.766 -1.208 . . . . 9.05 109.696 -179.548 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 80.9 tttt 50.12 63.74 2.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.092 -1.005 . . . . 10.56 109.062 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -68.22 -18.27 64.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 11.32 109.705 -179.302 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.425 HH11 ' HG2' ' A' ' 259' ' ' ARG . 29.7 ttt-85 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.057 -1.027 . . . . 12.42 109.73 179.756 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . 0.407 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 37.8 ttp . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.516 0.674 . . . . 0.0 109.541 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . 0.407 ' N ' ' CG ' ' B' ' 301' ' ' MET . 28.7 t80 -153.27 150.26 28.77 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.045 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -150.91 161.52 42.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.013 -1.054 . . . . 0.0 110.28 -179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -157.38 154.22 28.54 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.259 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -114.37 130.89 56.71 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.216 -0.928 . . . . 0.0 110.162 179.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 4.0 p -129.99 124.09 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 CA-C-O 122.18 0.991 . . . . 0.0 111.362 -178.764 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . 0.548 ' O ' HG23 ' B' ' 309' ' ' THR . 32.8 m -79.92 104.33 10.43 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.868 0.842 . . . . 0.0 110.71 -178.063 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.5 ' O ' ' N ' ' B' ' 358' ' ' GLY . 89.7 mt -50.72 116.38 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 122.313 1.054 . . . . 0.0 110.222 -177.558 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . 0.548 HG23 ' O ' ' B' ' 307' ' ' THR . 70.0 p -107.28 13.04 27.56 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.746 -178.497 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.67 116.43 49.79 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.022 -1.049 . . . . 0.0 108.829 179.562 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -58.94 -12.01 13.96 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 CA-C-N 120.579 1.243 . . . . 0.0 112.617 -179.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -103.73 2.77 33.42 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.3 -0.875 . . . . 0.0 109.993 -179.281 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 65.69 167.49 2.07 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -178.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 2.8 tp -88.72 96.28 10.6 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.784 -1.421 . . . . 0.0 110.227 -177.628 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -100.07 -159.59 0.75 Allowed 'General case' 0 N--CA 1.506 2.334 0 O-C-N 120.975 -1.078 . . . . 0.0 109.632 178.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 93.4 m -59.95 -42.39 93.96 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.687 -1.258 . . . . 0.0 112.482 -176.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.601 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.4 tpt180 -57.59 -61.41 7.31 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.536 -1.353 . . . . 0.0 111.367 -178.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.26 -33.18 94.88 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 CA-C-N 120.305 1.145 . . . . 0.0 111.454 179.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.93 -50.15 74.89 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.203 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.23 -41.77 65.74 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -69.89 -43.04 72.59 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.704 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -60.32 -51.58 68.92 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.562 -0.711 . . . . 0.0 110.208 -179.572 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 85.2 t -67.34 -28.87 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.864 -1.147 . . . . 0.0 109.962 -179.072 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -59.98 -45.09 93.83 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.171 -0.956 . . . . 0.0 108.894 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -68.66 -46.35 69.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.305 -0.872 . . . . 0.0 110.969 -178.968 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -67.21 -54.64 19.23 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.516 -1.365 . . . . 0.0 111.118 -179.06 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -50.63 -16.56 0.4 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.217 -0.927 . . . . 0.0 109.598 -179.285 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -75.65 -18.67 79.63 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -103.54 143.48 32.68 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.444 -1.033 . . . . 0.0 108.876 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . 0.417 HG22 ' O ' ' B' ' 330' ' ' THR . 86.7 m -90.72 -11.09 40.71 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.041 -1.037 . . . . 0.0 110.779 -178.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.454 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 88.8 p -67.04 156.92 34.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.881 -1.137 . . . . 0.0 109.754 -179.639 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 31.0 mm-40 -71.93 133.57 45.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.212 -0.93 . . . . 0.0 109.168 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.2 mt -130.63 131.22 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -179.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 84.8 m -129.27 148.14 51.17 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.558 -0.713 . . . . 0.0 109.533 179.937 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 96.6 t -122.33 115.84 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 92.6 m -104.53 125.12 50.4 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.152 -0.968 . . . . 0.0 109.573 -178.44 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 15.1 p -134.4 117.25 16.11 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.861 0.838 . . . . 0.0 110.339 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 42.93 55.02 4.58 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 177.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.96 -15.19 22.7 Favored Glycine 0 N--CA 1.497 2.74 0 O-C-N 120.349 -1.469 . . . . 0.0 112.44 176.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -108.45 118.98 38.18 Favored 'General case' 0 N--CA 1.502 2.132 0 CA-C-N 119.069 1.434 . . . . 0.0 109.377 -179.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 65.2 m -116.27 143.43 45.54 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.896 0.855 . . . . 0.0 111.151 -178.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.06 159.36 42.38 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.539 0.685 . . . . 0.0 109.668 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 15.9 t -87.04 135.17 33.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.496 -0.752 . . . . 0.0 109.799 -179.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.67 ' HA ' HD11 ' B' ' 350' ' ' LEU . . . -72.5 -16.62 61.79 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.998 -1.064 . . . . 0.0 109.121 179.853 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -85.4 20.96 1.87 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.136 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . 0.464 ' H ' ' C ' ' B' ' 344' ' ' ALA . 2.5 m -149.46 95.86 2.41 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.87 -179.461 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.813 HD23 HD22 ' A' ' 79' ' ' LEU . 59.3 tp -59.36 -35.06 73.19 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.833 ' CE2' HD11 ' A' ' 79' ' ' LEU . 51.2 m-85 -56.32 -53.19 60.27 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.333 -0.854 . . . . 0.0 110.321 -179.878 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -69.98 -40.06 75.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.986 -1.071 . . . . 0.0 110.505 -178.254 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.67 HD11 ' HA ' ' B' ' 344' ' ' ALA . 87.7 mt -52.86 -59.89 3.96 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.496 -1.378 . . . . 0.0 108.546 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.705 HE21 ' NE ' ' A' ' 126' ' ' ARG . 3.4 tp-100 -42.61 -11.89 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.674 -178.312 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.559 ' N ' ' O ' ' B' ' 350' ' ' LEU . 71.8 p -89.24 -9.96 48.77 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.577 -1.327 . . . . 0.0 109.607 178.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 54.1 mt -92.71 120.49 33.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.188 -0.945 . . . . 0.0 108.874 178.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.8 92.34 0.81 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 179.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 25.7 mt -99.73 90.59 4.51 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.263 -1.14 . . . . 0.0 109.663 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . 0.45 ' O ' ' C ' ' B' ' 357' ' ' GLN . 82.1 p -97.86 139.32 33.89 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.084 -1.01 . . . . 0.0 109.774 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . 0.45 ' C ' ' O ' ' B' ' 356' ' ' THR . 16.4 tm0? -34.68 118.46 0.41 Allowed 'General case' 0 N--CA 1.501 2.075 0 CA-C-O 121.393 0.616 . . . . 0.0 110.976 -178.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 103.15 5.08 47.15 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 -179.439 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 21.6 m -87.25 109.45 19.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.318 -1.107 . . . . 0.0 110.426 -179.784 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 20.8 t -77.12 114.04 17.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-O 122.169 0.985 . . . . 0.0 109.46 -177.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 30.5 m -110.25 176.59 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.444 -0.946 . . . . 0.0 108.444 -178.152 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 24.9 m -130.41 126.27 36.6 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.958 -1.126 . . . . 0.0 107.958 177.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 84.4 mt -102.06 113.89 39.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.667 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 84.5 p -119.88 132.79 55.66 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.604 -0.685 . . . . 0.0 109.339 -178.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.12 150.51 38.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 109.428 -179.43 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -144.9 125.04 13.64 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.529 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.55 -160.92 30.98 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 119.366 -1.397 . . . . 0.0 110.679 -179.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -59.98 -50.01 75.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 122.051 -0.676 . . . . 0.0 112.16 -177.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.454 ' H ' ' HB3' ' B' ' 331' ' ' SER . 92.3 m-20 -104.94 9.89 34.44 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.733 -1.229 . . . . 0.0 111.216 -177.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.529 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.1 pt-20 -42.49 -33.52 0.69 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.211 -0.931 . . . . 0.0 111.56 -178.901 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -70.01 -40.19 75.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.689 -1.257 . . . . 0.0 109.92 -178.612 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -66.84 -48.68 68.11 Favored 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.074 -1.051 . . . . 0.0 109.321 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.39 -78.16 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.392 -0.818 . . . . 0.0 110.901 -179.1 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.52 ' O ' HG23 ' B' ' 378' ' ' VAL . 37.6 t -47.28 -37.89 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.057 -1.027 . . . . 0.0 110.336 -177.384 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -69.82 -41.46 74.96 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.812 -1.18 . . . . 0.0 109.819 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -80.16 -46.74 15.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.137 -0.977 . . . . 0.0 110.315 -179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.15 -33.52 73.55 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 110.164 -179.026 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.52 HG23 ' O ' ' B' ' 374' ' ' VAL . 71.3 t -75.61 -34.18 28.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.205 -0.934 . . . . 0.0 109.493 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -72.85 -23.24 60.73 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.143 -0.973 . . . . 0.0 108.582 178.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' B' ' 383' ' ' GLU . 51.7 tp -79.95 -67.06 0.8 Allowed 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.113 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 50.8 tpp -50.16 -28.24 7.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.496 -0.752 . . . . 0.0 109.068 -178.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -76.14 -22.43 55.46 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.266 -0.896 . . . . 0.0 109.403 178.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' B' ' 380' ' ' LEU . 78.5 mm-40 -106.94 4.63 27.43 Favored 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.324 -0.86 . . . . 0.0 111.872 -178.501 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 89.7 mt -78.2 121.64 24.62 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.16 -1.587 . . . . 0.0 108.98 179.288 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 . . . . . 0 N--CA 1.498 1.934 0 CA-C-O 117.937 -1.03 . . . . 0.0 109.44 179.688 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.0 mmm . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.588 -0.523 . . . . 2.91 109.588 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.1 mt -105.62 125.75 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 N-CA-C 108.777 -0.823 . . . . 1.2 108.777 179.845 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.2 m -129.66 138.05 50.98 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.52 -0.738 . . . . 1.4 109.13 -179.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -108.92 -160.17 19.55 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 109.139 -1.585 . . . . 1.05 109.139 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.462 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.7 mt -94.63 -10.87 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.116 -1.226 . . . . 1.15 110.251 -179.369 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.2 tp 54.18 101.48 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.116 -0.99 . . . . 0.98 108.818 -179.471 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.54 -28.48 18.48 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.214 -0.929 . . . . 0.88 109.775 -179.359 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.6 t -143.14 131.09 11.11 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.289 -0.882 . . . . 1.69 109.646 -179.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -80.32 142.68 15.12 Favored 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 122.302 2.001 . . . . 0.85 113.147 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.881 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 161.93 -161.7 33.55 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.291 -1.524 . . . . 0.92 109.291 -179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.7 mt -149.5 150.02 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.312 0 O-C-N 121.198 -1.178 . . . . 0.81 108.435 179.203 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.49 157.99 37.8 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.746 -1.221 . . . . 0.51 110.436 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 9.8 m-85 -139.02 128.11 23.87 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 108.393 -0.965 . . . . 0.62 108.393 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.04 -178.8 46.66 Favored Glycine 0 N--CA 1.496 2.679 0 C-N-CA 118.585 -1.769 . . . . 0.55 111.188 179.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -79.99 157.93 26.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.731 -0.864 . . . . 2.1 109.619 -179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.496 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.02 135.36 45.67 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.456 -0.777 . . . . 0.77 111.078 -179.127 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.0 tp -102.1 134.83 44.72 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 107.743 -1.206 . . . . 0.91 107.743 178.409 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 40.4 tp -115.2 121.37 42.74 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.314 -0.866 . . . . 0.93 110.362 -179.107 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 25.4 mt -89.3 102.11 14.77 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.846 -0.534 . . . . 0.93 110.182 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -101.3 136.04 41.79 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.347 -0.846 . . . . 2.75 109.463 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -130.28 132.72 46.04 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.442 -0.786 . . . . 3.0 109.232 179.098 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -74.64 150.08 39.73 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.099 -1.0 . . . . 2.77 109.248 179.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -63.74 145.67 55.31 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.146 -0.971 . . . . 2.94 109.193 -179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.609 HD11 HH11 ' A' ' 139' ' ' ARG . 58.9 mt -84.4 125.84 40.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.107 -0.996 . . . . 0.95 109.4 -179.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 22.3 t -93.22 122.6 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.232 -0.918 . . . . 1.28 109.766 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.5 mt -103.73 139.42 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 108.831 -0.803 . . . . 1.21 108.831 179.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -96.89 114.95 26.61 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.134 -0.979 . . . . 1.81 109.354 -179.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.509 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.4 mmt-85 -90.08 0.13 57.3 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.249 -0.907 . . . . 2.8 109.695 -179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -66.28 147.43 53.33 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.199 -0.938 . . . . 2.87 109.205 179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -87.69 147.21 25.34 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.039 -1.038 . . . . 2.35 109.556 -179.926 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.4 HG21 ' HG3' ' A' ' 39' ' ' GLU . 5.1 pt -93.89 165.28 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.925 . . . . 0.97 109.788 -179.964 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 82.6 p -96.22 171.25 8.71 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.048 -1.032 . . . . 1.17 108.922 179.163 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.5 -16.58 64.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.113 -0.992 . . . . 1.18 110.603 -179.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -85.67 -26.1 26.17 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.676 -1.231 . . . . 2.56 107.676 178.296 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -82.45 -9.7 59.33 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.875 -0.787 . . . . 1.79 108.875 179.237 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.6 t -63.73 -53.8 40.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 O-C-N 120.862 -1.149 . . . . 1.0 108.961 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.44 -40.15 93.42 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.246 -0.909 . . . . 1.77 110.102 -179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -70.03 -43.01 72.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.038 -1.039 . . . . 2.7 110.347 -179.263 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.4 ' HG3' HG21 ' A' ' 31' ' ' ILE . 65.4 mm-40 -63.55 -39.86 95.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.078 -1.014 . . . . 1.51 110.288 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.7 t -61.36 -46.01 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 120.833 -1.167 . . . . 0.93 108.816 179.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -60.0 -39.8 87.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.143 -0.973 . . . . 1.81 108.69 -179.723 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -60.0 -41.62 92.49 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.724 -1.213 . . . . 2.78 107.724 178.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -63.45 -49.35 74.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.362 -0.836 . . . . 0.78 109.032 178.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.94 -48.67 80.76 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.382 -0.823 . . . . 1.07 109.038 -179.331 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.5 t -63.64 -44.21 94.54 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.01 -1.056 . . . . 1.12 108.741 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.94 -48.58 85.36 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.851 -1.699 . . . . 0.84 108.851 179.315 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -65.34 -32.52 74.21 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.327 -1.102 . . . . 3.09 108.451 179.158 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.36 -39.92 84.82 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.803 -0.814 . . . . 0.88 108.803 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.449 ' O ' ' N ' ' A' ' 51' ' ' SER . 33.6 ttpt -65.36 -74.38 0.11 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.962 -1.125 . . . . 2.59 107.962 179.189 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.45 -30.81 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.51 -0.744 . . . . 0.7 111.26 -178.423 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.449 ' N ' ' O ' ' A' ' 49' ' ' LYS . 44.0 t -59.98 -54.39 46.58 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.706 -1.246 . . . . 1.4 108.397 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.62 -40.09 84.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.835 . . . . 0.67 111.054 -179.139 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -61.9 -46.56 88.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.68 -1.263 . . . . 1.66 110.128 -179.316 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.3 mt -60.11 -40.03 88.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.14 -0.975 . . . . 1.58 109.018 -179.715 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 70.6 mm-40 -60.31 -40.04 89.13 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.38 -0.825 . . . . 1.35 109.174 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 97.4 m -64.45 -44.24 91.74 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.243 -0.91 . . . . 0.77 108.64 178.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.5 mt -61.31 -39.88 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 N-CA-C 108.848 -0.797 . . . . 0.63 108.848 179.243 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -59.69 -50.34 74.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.955 . . . . 1.14 109.17 179.972 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.9 m -59.95 -36.53 77.27 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.396 -0.815 . . . . 0.79 110.025 -178.136 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -66.17 -38.48 88.16 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.976 -1.077 . . . . 1.53 109.161 179.145 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.71 -45.02 88.34 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.585 -0.697 . . . . 0.57 109.948 -179.888 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.9 -51.57 58.17 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 120.025 -1.083 . . . . 0.75 110.435 -179.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.95 -45.67 66.92 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.096 -1.238 . . . . 1.59 109.809 -179.397 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.6 m -67.17 -61.26 2.01 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.206 -0.934 . . . . 0.73 111.709 -178.36 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -97.01 -52.7 3.76 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.135 -0.978 . . . . 0.75 111.473 -177.872 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.11 -165.18 26.7 Favored Glycine 0 N--CA 1.501 3.033 0 C-N-CA 119.615 -1.278 . . . . 1.22 111.152 179.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -70.05 -25.16 63.41 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.804 -0.821 . . . . 5.81 110.696 -179.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -60.75 -37.35 81.51 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.998 . . . . 3.37 110.224 -179.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.566 ' HA ' HD12 ' A' ' 72' ' ' ILE . 42.6 mmtm -99.59 -18.03 17.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.45 -0.781 . . . . 1.77 110.296 -179.444 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 60.1 tt0 -70.01 -45.37 67.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.973 -1.079 . . . . 1.65 110.457 -179.298 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.5 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -66.14 -27.29 67.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.394 -0.816 . . . . 0.77 109.931 -178.571 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.566 HD12 ' HA ' ' A' ' 69' ' ' LYS . 81.7 mt -60.07 -41.49 86.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.038 -1.039 . . . . 0.8 109.14 -179.858 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -69.1 -37.16 78.27 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.035 -1.041 . . . . 0.88 109.959 -179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -60.0 -40.28 88.66 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.799 -1.188 . . . . 1.37 108.867 179.798 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.84 -49.52 75.1 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.36 -1.896 . . . . 0.62 108.36 178.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -60.12 -46.63 88.99 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.374 -1.074 . . . . 1.5 108.462 179.418 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.1 mt -63.96 -50.02 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -0.797 . . . . 0.63 109.193 179.148 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.8 ttp -60.53 -39.97 89.77 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.156 -0.965 . . . . 1.51 109.811 -179.294 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.091 HD22 HD23 ' B' ' 347' ' ' LEU . 53.3 tp -66.9 -39.93 87.57 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.632 -0.668 . . . . 0.77 110.118 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 56.4 tp -63.92 -39.78 94.95 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.637 -0.825 . . . . 0.62 109.68 -179.828 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -82.54 7.64 13.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.087 -1.008 . . . . 1.47 109.598 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.479 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 63.5 t0 -49.87 134.72 20.71 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.179 -0.951 . . . . 1.47 110.279 -178.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.479 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 95.2 mt-10 -58.84 -26.7 64.43 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.784 -0.572 . . . . 1.78 111.637 -178.266 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.09 -31.0 62.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.899 -1.125 . . . . 2.53 110.096 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.407 HD12 ' O ' ' A' ' 79' ' ' LEU . 86.4 mt -70.01 -42.53 72.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.337 -0.852 . . . . 0.8 110.095 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -60.08 -48.17 82.85 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.502 -0.749 . . . . 1.42 110.621 -178.365 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 -69.93 -42.92 72.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.958 . . . . 1.71 111.285 -178.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.39 -40.01 74.2 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.11 -0.994 . . . . 1.57 111.624 -178.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -69.37 -45.89 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 120.897 -1.127 . . . . 0.65 109.786 -179.164 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.6 mt -69.93 -38.29 75.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.433 -0.792 . . . . 0.82 110.294 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.43 -40.87 98.31 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.083 -1.011 . . . . 0.79 111.049 -179.076 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.3 mt -61.24 -45.56 94.03 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.828 -1.17 . . . . 0.95 109.348 -179.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.9 mt -61.92 -48.18 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 122.048 0.928 . . . . 0.66 109.206 179.262 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.1 mtmt -70.02 -40.03 75.47 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.608 -0.682 . . . . 2.2 110.298 -179.23 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.9 t0 -82.73 -53.67 5.73 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.164 -0.96 . . . . 1.65 111.91 -178.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -89.97 -0.83 57.79 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.011 -1.056 . . . . 2.03 112.035 -177.274 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 70.7 m80 57.24 36.56 27.53 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.035 -1.041 . . . . 1.42 110.179 179.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 99.6 mtp -92.07 166.99 12.39 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.519 -0.738 . . . . 1.18 109.375 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 35.0 p -80.75 162.81 23.92 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.98 109.747 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.45 -39.87 81.3 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.357 -0.84 . . . . 0.64 109.744 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -64.36 -39.05 93.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 2.07 109.55 179.319 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.91 -41.21 23.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.407 -0.808 . . . . 0.73 110.322 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.46 -48.0 65.66 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 0.54 110.19 -179.192 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.94 -45.75 91.59 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.997 -1.064 . . . . 0.56 109.447 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.488 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 84.9 t60 -60.01 -40.0 87.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.406 -0.809 . . . . 1.54 109.731 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.0 -41.97 93.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.264 -0.897 . . . . 1.33 110.048 -179.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.7 t -68.88 -51.31 46.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.068 -1.02 . . . . 0.72 110.422 -178.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.39 -40.92 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.035 -1.041 . . . . 0.85 108.512 179.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.488 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 86.3 tt0 -65.29 -40.0 93.28 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.443 -0.947 . . . . 2.44 108.443 178.731 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.13 -50.16 70.66 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 110.159 -1.176 . . . . 0.98 110.159 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -65.34 -51.15 62.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.931 -1.335 . . . . 1.41 109.421 -179.726 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -56.49 -40.86 75.67 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.166 -0.959 . . . . 1.2 109.206 179.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 75.7 m -59.97 -40.04 87.73 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.089 -1.007 . . . . 1.7 108.443 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.97 -39.95 90.85 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.641 -0.874 . . . . 1.47 108.641 178.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.472 HD22 ' HB3' ' B' ' 351' ' ' GLN . 87.1 mt -65.71 -42.65 90.88 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.091 -1.005 . . . . 1.56 109.474 -179.864 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.5 tt0 -59.88 -39.05 84.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.916 -1.115 . . . . 2.2 109.848 -178.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -49.98 -19.99 0.83 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.005 -1.059 . . . . 2.12 109.555 -179.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 29.2 mt -62.72 140.02 58.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.012 -1.055 . . . . 2.0 109.043 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -93.16 40.41 1.06 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.176 -0.953 . . . . 3.23 110.289 -179.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -126.13 134.2 51.39 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 121.266 -0.896 . . . . 2.49 109.518 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.53 -30.42 68.24 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.451 -0.78 . . . . 3.95 109.919 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.497 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.0 t80 -69.99 -39.02 76.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.347 -0.845 . . . . 2.0 110.32 179.327 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.442 HD22 ' O ' ' B' ' 351' ' ' GLN . 84.5 mt -80.76 -31.94 35.7 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.06 -1.025 . . . . 1.86 109.248 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -60.94 -40.76 94.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -0.905 . . . . 2.84 109.003 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 64.7 mm-40 -64.22 -40.0 95.15 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -0.878 . . . . 2.73 109.015 178.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.48 ' NH1' ' CD ' ' B' ' 351' ' ' GLN . 0.1 OUTLIER -59.97 -39.99 87.56 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.295 -1.002 . . . . 2.77 108.295 179.436 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.3 -26.13 66.28 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.595 -0.891 . . . . 1.19 108.595 178.962 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -67.68 -39.94 84.45 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.947 -0.76 . . . . 1.2 108.947 179.435 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.86 -39.99 79.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.244 -0.91 . . . . 1.55 109.681 179.834 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.7 -44.38 93.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.162 -0.961 . . . . 0.8 108.563 179.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -60.49 -37.38 80.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.351 -0.843 . . . . 3.09 108.918 178.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -59.82 -39.66 85.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.493 -0.755 . . . . 1.46 109.664 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.96 -40.4 82.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.04 -1.037 . . . . 0.71 108.873 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.08 -35.99 64.31 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.048 -1.221 . . . . 0.57 110.048 179.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 5.8 mtpm? -60.05 -49.9 75.85 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.115 -1.226 . . . . 2.59 109.931 -179.373 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.402 ' HG2' HH21 ' A' ' 139' ' ' ARG . 87.6 mtm180 -67.66 -33.34 74.74 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.021 -1.049 . . . . 2.83 109.501 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.04 -43.25 95.49 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.249 -0.907 . . . . 1.25 109.074 -179.567 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.04 -42.52 94.58 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.192 -0.943 . . . . 0.7 109.985 179.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.609 HH11 HD11 ' A' ' 24' ' ' ILE . 63.1 mtm-85 -71.39 -39.29 71.26 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.394 -0.816 . . . . 2.57 109.352 179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -65.57 -34.37 78.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.538 -0.726 . . . . 1.23 111.259 -179.197 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.3 mt -70.01 -45.35 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.416 -1.427 . . . . 0.81 108.037 179.317 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.7 mt -69.89 -30.79 68.31 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 120.137 -0.625 . . . . 1.0 109.454 179.135 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.89 41.73 8.02 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.034 -1.626 . . . . 0.89 109.034 -179.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.0 tp -74.88 157.23 35.41 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.468 -1.019 . . . . 1.14 109.411 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.21 146.62 53.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.283 -0.886 . . . . 4.6 110.062 -179.449 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.7 mt -119.9 127.78 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 108.826 -0.805 . . . . 1.24 108.826 179.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 27.6 mm -55.4 -49.68 71.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.36 -0.837 . . . . 1.54 110.212 -178.251 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.4 t0 66.24 103.92 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.528 -0.732 . . . . 1.5 109.338 -179.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.8 mt -79.61 -5.77 55.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.42 -0.8 . . . . 0.79 110.179 -178.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.3 t -81.67 -20.52 39.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.942 -1.099 . . . . 1.4 109.634 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.04 21.53 0.7 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.297 -0.877 . . . . 0.92 111.66 -178.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 39.5 mm -89.12 129.49 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 120.565 -1.334 . . . . 0.88 108.965 179.517 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -110.53 -11.31 14.48 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.586 -0.696 . . . . 2.45 110.059 -179.234 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -118.3 148.11 42.79 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.177 -0.952 . . . . 1.52 110.457 -179.086 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -65.24 133.95 52.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 1.58 109.214 179.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.9 m -153.33 166.33 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.42 -0.8 . . . . 0.69 109.439 179.081 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.3 mt -94.06 147.42 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 106.545 -1.65 . . . . 0.61 106.545 177.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 49.7 tp -94.27 113.58 25.51 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.011 -1.055 . . . . 0.87 110.101 -177.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.42 HG12 HG22 ' A' ' 209' ' ' THR . 46.7 t -118.68 125.22 74.24 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 108.663 -0.866 . . . . 0.71 108.663 179.478 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.442 ' CB ' HD21 ' A' ' 163' ' ' LEU . . . -155.68 160.65 40.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.991 -1.068 . . . . 0.81 109.465 -179.49 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.45 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -78.82 -29.08 44.57 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.487 -1.383 . . . . 0.98 109.02 179.199 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 161' ' ' ALA . 14.5 m-20 -167.36 133.41 2.14 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.31 -0.869 . . . . 2.25 109.169 -179.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.442 HD21 ' CB ' ' A' ' 160' ' ' ALA . 57.7 mt -118.15 130.04 55.87 Favored 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 108.781 -0.822 . . . . 0.78 108.781 179.66 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 20.8 p -93.84 149.99 37.9 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.079 -1.013 . . . . 0.98 109.737 -179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_exo -39.38 -36.58 0.98 Allowed 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.64 2.227 . . . . 0.81 113.636 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.6 m -59.98 -40.05 87.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.894 -1.129 . . . . 0.9 110.028 -178.194 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.61 -39.82 80.69 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.256 -0.902 . . . . 1.61 110.249 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 80.7 p -57.39 -38.08 73.71 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.059 -1.025 . . . . 0.61 112.036 -177.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -66.97 -47.8 70.46 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.521 -1.362 . . . . 0.6 110.027 -179.239 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -85.68 33.83 0.58 Allowed 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.327 -0.99 . . . . 1.4 108.327 -179.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 60.3 tp -102.78 137.5 40.9 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.788 -0.819 . . . . 0.7 108.788 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.682 ' ND2' ' H ' ' A' ' 175' ' ' LYS . 0.2 OUTLIER -86.96 104.72 16.55 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.476 -0.935 . . . . 2.35 108.476 179.575 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 91.6 mt -65.55 -40.11 92.48 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.269 -0.895 . . . . 1.51 111.598 -178.186 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -69.87 -25.5 63.75 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.746 -1.221 . . . . 2.33 111.744 -177.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.682 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 98.5 mttt -93.73 -10.04 35.66 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.706 -1.246 . . . . 1.92 110.242 -178.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 178' ' ' GLY . 95.0 t -100.94 113.22 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.029 -1.044 . . . . 0.67 108.339 178.633 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 90.4 mt -80.76 2.1 27.6 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.238 -0.913 . . . . 1.53 110.853 -177.781 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.507 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 166.25 177.99 38.67 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.3 -1.52 . . . . 0.48 109.3 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.586 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 7.4 m-85 -132.31 128.23 37.31 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.484 -1.009 . . . . 0.55 109.489 -179.387 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 93.8 mt -130.74 124.21 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.507 -0.746 . . . . 0.65 109.03 179.096 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 52.8 p -150.88 161.92 41.76 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.813 -1.18 . . . . 0.82 110.721 -179.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 37.1 p-10 -103.56 25.17 10.02 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.564 -0.71 . . . . 2.46 109.456 179.655 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.43 -158.59 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.863 -1.148 . . . . 1.28 111.703 -178.259 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -76.14 -54.4 5.24 Favored Glycine 0 N--CA 1.493 2.469 0 C-N-CA 120.84 -0.695 . . . . 2.19 111.44 -178.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 165.23 -139.17 5.65 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 118.968 -1.587 . . . . 2.13 111.07 -179.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.461 ' N ' ' CD ' ' A' ' 186' ' ' ARG . 0.4 OUTLIER -69.93 -22.88 63.15 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.608 -0.937 . . . . 5.86 111.175 -178.761 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 66.7 p -70.27 1.25 5.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.848 -1.157 . . . . 3.72 109.546 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 26.0 t -90.89 133.83 34.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.267 -0.896 . . . . 1.74 110.482 -179.634 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -47.48 -53.22 14.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.497 -0.752 . . . . 0.95 110.21 -179.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.7 m -60.11 -40.44 89.7 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.341 -0.849 . . . . 1.55 111.473 -178.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 17.3 t -60.0 -40.73 90.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.829 -1.169 . . . . 1.51 110.12 -179.026 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 85.7 mt -61.39 -37.93 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.874 . . . . 1.67 109.728 -179.863 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.3 mtp -60.07 -39.96 87.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.842 . . . . 1.02 109.692 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.9 -42.07 88.69 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.713 -1.242 . . . . 0.68 108.633 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -60.06 -51.06 71.24 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.714 -0.794 . . . . 2.93 110.319 -179.234 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 55.9 m -74.88 -34.25 62.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.083 -1.011 . . . . 0.86 112.022 -178.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.1 mt -73.55 -11.5 60.46 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.632 -1.293 . . . . 0.67 109.829 -178.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 60.1 50.08 6.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.573 -0.704 . . . . 1.5 110.975 179.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 81.2 mt -128.77 149.92 73.48 Favored Pre-proline 0 N--CA 1.499 2.015 0 N-CA-C 107.602 -1.258 . . . . 0.72 107.602 178.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -68.81 140.75 47.22 Favored 'Trans proline' 0 N--CA 1.502 1.974 0 C-N-CA 122.16 1.907 . . . . 0.61 112.158 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.04 151.52 3.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.965 -1.084 . . . . 0.66 111.418 -179.83 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.7 mt -123.45 138.15 54.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.521 -1.288 . . . . 0.79 107.521 178.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 17.3 m -121.83 -11.86 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.392 0 O-C-N 120.738 -1.226 . . . . 0.91 111.478 -178.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -105.97 23.88 28.08 Favored Glycine 0 N--CA 1.5 2.934 0 N-CA-C 110.309 -1.117 . . . . 1.01 110.309 -179.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 6.7 p -44.29 -41.15 5.76 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.202 -1.175 . . . . 0.99 109.928 -179.439 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.41 -50.48 4.23 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 120.211 -0.995 . . . . 1.12 110.982 179.17 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 30.5 t -159.12 38.05 0.21 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.611 -1.523 . . . . 1.72 111.402 -179.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 46.8 t -78.82 -35.54 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.934 -1.104 . . . . 0.89 108.673 178.133 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.42 HG22 HG12 ' A' ' 159' ' ' VAL . 76.7 p -54.73 -30.1 55.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.844 . . . . 1.03 110.148 -179.479 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 70.0 p -81.92 -12.62 58.32 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.112 -0.992 . . . . 1.83 110.228 -179.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 30.2 mm100 -101.71 -10.24 20.15 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.339 -0.851 . . . . 2.27 109.674 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 92.5 t -107.37 134.82 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.303 -0.873 . . . . 0.92 111.47 -178.013 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 2.9 mptp? -113.44 155.22 25.68 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.746 -1.576 . . . . 2.2 106.746 177.223 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.486 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 1.7 t-20 -59.98 138.3 57.88 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 120.935 -1.103 . . . . 2.36 110.572 -178.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.486 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 16.3 t0 85.9 0.06 0.69 Allowed 'General case' 0 N--CA 1.503 2.177 0 CA-C-N 116.342 -0.39 . . . . 2.38 110.836 179.054 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -71.8 148.28 46.41 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.77 -1.206 . . . . 2.09 108.94 179.01 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -95.3 119.01 33.06 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.083 -1.08 . . . . 1.27 108.083 179.125 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.496 HD12 ' HB2' ' A' ' 16' ' ' ALA . 83.0 mt -125.59 145.14 50.26 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.411 -0.806 . . . . 0.75 110.456 -179.05 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 72.1 mt -113.88 128.4 70.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 N-CA-C 107.463 -1.31 . . . . 0.63 107.463 177.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 20.6 tp -100.36 117.56 34.79 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.004 -1.06 . . . . 0.7 108.786 -179.415 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 10' ' ' GLY . 32.3 t0 -77.13 -44.3 30.88 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 108.151 -1.055 . . . . 2.31 108.151 179.638 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.881 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 54.03 13.71 0.61 Allowed 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.256 -0.646 . . . . 0.78 109.256 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 87.8 t -130.5 -42.94 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.146 -1.427 . . . . 1.04 107.146 177.95 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.45 ' ND2' ' OE1' ' A' ' 226' ' ' GLN . 47.9 t-20 -96.69 0.04 49.06 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.226 -1.398 . . . . 2.44 107.226 178.154 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 60.07 44.64 12.88 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.849 -0.532 . . . . 1.55 109.585 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.45 ' OE1' ' ND2' ' A' ' 224' ' ' ASN . 97.8 mt-30 -139.96 151.77 45.8 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 121.192 -0.943 . . . . 1.99 110.454 -179.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.1 t -118.78 129.96 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.507 -0.923 . . . . 0.77 108.507 178.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -102.95 127.34 50.21 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.758 -0.831 . . . . 0.98 108.758 179.293 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.0 t -100.19 109.95 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.362 -0.836 . . . . 0.85 110.947 -178.495 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 41.2 t30 50.11 64.43 8.41 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.145 -0.972 . . . . 1.66 110.895 179.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -85.84 156.16 10.17 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.795 2.33 . . . . 0.95 111.986 179.166 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 82.4 p -70.44 160.42 32.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.276 -0.89 . . . . 1.84 110.078 -179.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.4 m120 -59.9 -34.69 73.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.435 -0.791 . . . . 2.74 108.873 179.138 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.2 tm-20 -59.93 -40.09 87.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.476 -0.765 . . . . 2.89 109.344 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -67.72 -40.02 83.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.194 -0.941 . . . . 1.3 109.276 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.9 mt -68.34 -40.47 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.24 -0.913 . . . . 1.09 110.31 -179.669 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -60.22 -40.04 88.75 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.001 -1.062 . . . . 2.43 109.325 179.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -68.76 -40.91 79.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.491 -0.755 . . . . 2.78 109.485 179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 93.1 mtp -70.06 -33.42 71.91 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.574 -0.704 . . . . 1.25 110.159 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -65.19 -40.03 93.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.096 -1.002 . . . . 2.63 110.433 -179.561 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -63.49 -40.62 97.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.888 -1.132 . . . . 1.8 108.935 179.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.92 -40.05 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.457 -0.777 . . . . 2.13 109.143 179.449 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 20.7 tm0? -57.19 -42.43 81.22 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.295 -0.878 . . . . 3.17 109.738 -179.076 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -62.39 -39.99 95.05 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.034 -1.042 . . . . 1.78 109.214 179.402 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -64.61 -40.12 94.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.155 -0.965 . . . . 2.47 109.285 179.854 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.83 -40.0 85.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.406 -0.808 . . . . 2.09 109.343 -179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -55.17 -40.16 70.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.272 -0.892 . . . . 2.54 109.057 -179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 66.1 p -61.06 -36.93 80.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.305 -0.872 . . . . 2.99 109.314 179.477 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -69.75 -18.1 63.48 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.378 -0.826 . . . . 3.34 110.666 -179.244 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -75.62 13.59 0.77 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.12 -0.987 . . . . 3.88 109.486 -179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -72.62 -60.3 2.3 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.15 -1.056 . . . . 4.43 108.15 178.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 179.84 -61.86 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 107.978 -1.119 . . . . 5.42 107.978 179.146 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 32.3 mt 65.26 64.11 0.63 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.864 -1.161 . . . . 6.1 107.864 -178.003 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -133.11 9.64 4.12 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.239 -0.652 . . . . 7.37 109.239 179.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.464 ' NZ ' ' CB ' ' A' ' 255' ' ' LYS . 5.6 ttpm? -78.41 145.59 35.04 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.288 -0.882 . . . . 8.01 110.165 -179.73 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 10.9 mp -82.88 27.95 0.52 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.454 -0.779 . . . . 9.05 109.121 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -154.19 67.81 0.73 Allowed 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.821 -0.807 . . . . 10.56 108.821 179.326 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -158.9 -32.92 0.07 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.368 -0.832 . . . . 11.32 109.71 -179.76 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 9.0 tpm_? . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.052 -0.975 . . . . 12.42 109.109 -179.751 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 41.5 ttm . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.596 0.713 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -150.27 147.09 27.23 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.338 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -150.83 161.77 42.04 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.921 -1.112 . . . . 0.0 110.546 -179.203 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -153.37 150.01 28.41 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . 0.567 ' CD ' ' H ' ' B' ' 305' ' ' GLU . 0.6 OUTLIER -115.81 135.47 53.98 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.244 -0.91 . . . . 0.0 109.971 179.278 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.6 p -138.64 129.84 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 CA-C-O 122.523 1.154 . . . . 0.0 113.052 -177.184 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 90.9 m -76.69 106.36 8.3 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.467 -178.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.463 HG22 ' H ' ' B' ' 310' ' ' ALA . 92.3 mt -52.45 126.07 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 122.412 1.101 . . . . 0.0 110.82 -177.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 22.3 p -109.99 20.07 18.34 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.372 -178.899 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.463 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -79.4 117.02 64.82 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.851 -1.156 . . . . 0.0 109.109 179.673 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -56.28 -11.68 6.53 Favored 'Trans proline' 0 N--CA 1.498 1.776 0 CA-C-N 120.233 1.119 . . . . 0.0 113.212 -179.095 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -119.45 6.66 11.11 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.652 -0.869 . . . . 0.0 108.652 179.708 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 73.47 -179.4 40.24 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 107.961 -2.055 . . . . 0.0 107.961 -178.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.497 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -85.42 92.24 8.43 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 120.868 -1.372 . . . . 0.0 108.454 -179.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.461 ' C ' ' NH2' ' A' ' 126' ' ' ARG . 5.2 p80 -94.29 -160.91 0.81 Allowed 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.179 -0.951 . . . . 0.0 110.642 179.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.9 m -57.35 -43.92 83.88 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.204 -0.935 . . . . 0.0 112.651 -175.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.5 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -60.75 -61.74 7.37 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 120.443 -1.411 . . . . 0.0 112.139 -178.508 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -57.33 -31.55 91.31 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 CA-C-N 120.219 1.114 . . . . 0.0 111.781 -179.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.07 -51.51 69.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 109.069 179.648 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.7 -41.12 63.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 0.0 110.17 -178.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -72.71 -40.1 66.44 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.075 -1.05 . . . . 0.0 108.882 179.065 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -60.81 -52.46 64.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.4 -0.813 . . . . 0.0 110.869 -179.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 53.6 t -68.28 -38.07 78.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 120.685 -1.259 . . . . 0.0 109.334 -178.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.419 ' CB ' ' NZ ' ' B' ' 324' ' ' LYS . 4.1 ttpm? -59.98 -46.17 90.31 Favored 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.751 -179.133 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -63.33 -40.06 96.26 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.925 -1.11 . . . . 0.0 108.789 179.127 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -61.08 -51.31 69.69 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.422 -0.798 . . . . 0.0 110.312 -179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 18.6 mttp -56.92 -11.95 1.73 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.255 -0.903 . . . . 0.0 109.373 179.974 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -73.25 -27.48 68.06 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.239 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -105.4 143.19 33.91 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 27.4 p -91.16 -12.59 34.97 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.902 -1.124 . . . . 0.0 110.16 -179.733 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.426 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 67.8 p -60.13 147.64 38.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.075 -1.015 . . . . 0.0 109.418 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -67.11 136.38 55.06 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.108 -0.995 . . . . 0.0 108.581 179.629 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 90.0 mt -131.41 130.15 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.653 -0.654 . . . . 0.0 109.803 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 54.1 m -124.23 148.76 47.09 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 179.109 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 92.3 t -115.87 136.91 51.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 177.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.2 m -128.85 122.62 30.8 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.148 -0.97 . . . . 0.0 109.038 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 91.8 p -138.18 116.71 12.08 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.306 -0.871 . . . . 0.0 110.386 -179.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 33.2 m120 45.7 62.69 2.09 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 177.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 75.16 -11.96 7.59 Favored Glycine 0 N--CA 1.498 2.77 0 O-C-N 120.399 -1.438 . . . . 0.0 112.924 176.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -115.81 127.53 55.14 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-N 118.951 1.375 . . . . 0.0 109.818 -179.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 21.2 m -126.12 148.61 49.35 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.872 0.844 . . . . 0.0 110.399 -179.016 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -142.43 164.15 30.9 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-O 121.405 0.622 . . . . 0.0 109.929 -179.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 58.6 m -86.96 136.59 32.88 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.606 -0.684 . . . . 0.0 109.934 -179.388 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -73.77 -13.49 60.96 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.04 -1.037 . . . . 0.0 109.693 -179.643 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -90.82 21.68 3.99 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 178.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 68.0 m -144.84 93.36 2.39 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.907 -0.717 . . . . 0.0 111.944 -179.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 1.091 HD23 HD22 ' A' ' 79' ' ' LEU . 37.9 tp -59.12 -34.75 72.4 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 178.417 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.797 ' CE2' HD11 ' A' ' 79' ' ' LEU . 66.1 m-85 -57.87 -56.38 22.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.508 -0.745 . . . . 0.0 109.79 179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -70.04 -20.05 63.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.869 . . . . 0.0 111.008 -178.556 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.63 ' O ' ' N ' ' B' ' 352' ' ' THR . 50.2 mt -72.03 -58.32 3.54 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.669 -1.269 . . . . 0.0 108.233 178.073 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.48 ' CD ' ' NH1' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -40.28 -10.25 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.769 -178.279 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.63 ' N ' ' O ' ' B' ' 350' ' ' LEU . 81.0 p -91.93 -11.43 36.25 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.574 -1.329 . . . . 0.0 110.446 -179.224 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 66.0 mt -92.47 120.07 32.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.996 -1.065 . . . . 0.0 108.972 179.118 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.88 92.95 0.83 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 31.1 mt -103.25 93.81 5.18 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.396 -1.061 . . . . 0.0 109.343 179.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 57.8 p -95.72 179.98 4.93 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.046 -1.034 . . . . 0.0 110.548 -179.518 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -68.45 111.82 4.91 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.506 -0.747 . . . . 0.0 109.945 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 105.75 9.69 32.27 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 97.6 m -87.83 106.21 17.93 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.208 -1.172 . . . . 0.0 110.302 -179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 3.9 t -77.01 117.84 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 CA-C-O 122.296 1.046 . . . . 0.0 109.004 -177.563 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 19.6 m -113.68 177.73 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.832 -177.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 93.9 m -132.0 130.04 40.89 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 176.85 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 96.5 mt -105.35 120.51 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 178.36 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 58.2 m -120.07 131.72 55.18 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.689 -0.632 . . . . 0.0 109.543 -178.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.71 153.76 41.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.255 -0.903 . . . . 0.0 109.715 -179.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -146.33 123.02 11.18 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 160.91 -155.39 26.55 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 118.681 -1.723 . . . . 0.0 111.86 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -58.94 -50.46 73.97 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.154 -0.523 . . . . 0.0 112.394 -177.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.426 ' H ' ' HB3' ' B' ' 331' ' ' SER . 97.8 m-20 -110.29 15.28 22.41 Favored 'General case' 0 N--CA 1.505 2.286 0 O-C-N 120.926 -1.109 . . . . 0.0 111.275 -177.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.403 ' C ' ' O ' ' B' ' 369' ' ' ASP . 16.2 pt-20 -39.54 -38.28 0.58 Allowed 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.421 -0.8 . . . . 0.0 111.453 -179.034 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -66.73 -48.15 70.07 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.723 -1.236 . . . . 0.0 110.622 -178.233 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -70.02 -52.52 23.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.977 -1.077 . . . . 0.0 109.899 -179.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.01 -38.71 3.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.429 -0.794 . . . . 0.0 111.229 -178.661 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.457 ' O ' HG23 ' B' ' 378' ' ' VAL . 77.2 t -70.05 -39.98 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 120.515 -1.366 . . . . 0.0 109.251 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.91 -66.83 0.5 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.146 -0.971 . . . . 0.0 111.637 -178.025 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . 0.442 ' O ' ' N ' ' B' ' 380' ' ' LEU . 32.2 m170 -59.92 -45.2 93.33 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.652 -1.28 . . . . 0.0 112.103 -177.171 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 98.0 mt -59.98 -42.0 93.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.328 -1.483 . . . . 0.0 108.841 -179.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.457 HG23 ' O ' ' B' ' 374' ' ' VAL . 53.4 t -68.7 -40.14 81.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 O-C-N 121.29 -0.881 . . . . 0.0 109.382 179.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -80.67 -10.94 59.7 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.969 -1.082 . . . . 0.0 109.831 178.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.442 ' N ' ' O ' ' B' ' 376' ' ' HIS . 61.3 tp -82.39 -25.98 33.25 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 177.473 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 3.4 ttp -82.75 -25.68 32.61 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -84.37 -10.07 57.89 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.599 -0.688 . . . . 0.0 110.03 179.165 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -108.55 -0.86 20.1 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.309 -0.869 . . . . 0.0 110.344 -179.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 44.4 mt -98.94 119.99 38.64 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.009 -1.057 . . . . 0.0 109.727 179.757 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . 0.503 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 53.3 mp0 . . . . . 0 N--CA 1.497 1.899 0 CA-C-O 117.967 -1.016 . . . . 0.0 108.978 179.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.6 mtp . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.881 -0.415 . . . . 2.91 109.881 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.2 mt -94.76 121.28 45.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.066 -1.022 . . . . 1.2 109.814 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.7 m -138.75 149.07 44.63 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.716 -0.846 . . . . 1.4 108.716 179.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.02 -161.4 12.21 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 109.357 -1.497 . . . . 1.05 109.357 -179.769 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.449 ' O ' ' O ' ' A' ' 6' ' ' LEU . 97.8 mt -92.07 -12.89 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -1.189 . . . . 1.15 109.944 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.449 ' O ' ' O ' ' A' ' 5' ' ' ILE . 63.0 tp 53.92 101.21 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.059 -1.025 . . . . 0.98 108.717 -179.515 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -81.06 -39.94 24.95 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.764 -0.828 . . . . 0.88 108.764 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.2 m -141.05 135.28 15.16 Favored Pre-proline 0 N--CA 1.5 2.025 0 O-C-N 121.583 -0.698 . . . . 1.69 109.524 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -79.17 147.4 20.71 Favored 'Trans proline' 0 N--CA 1.499 1.8 0 C-N-CA 122.391 2.061 . . . . 0.85 112.877 179.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.862 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 162.45 -162.2 34.21 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 108.9 -1.68 . . . . 0.92 108.9 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 86.5 mt -149.56 150.42 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 121.01 -1.288 . . . . 0.81 108.565 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.45 159.31 38.55 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.701 -1.249 . . . . 0.51 110.615 179.246 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.558 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -140.03 129.08 23.58 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 107.884 -1.154 . . . . 0.62 107.884 179.068 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 175.66 -177.95 47.33 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 118.782 -1.675 . . . . 0.55 110.893 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -79.39 159.53 27.05 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.762 -0.846 . . . . 2.1 109.298 -179.743 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.611 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -107.8 137.39 45.9 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.374 -0.829 . . . . 0.77 111.119 -179.022 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.5 tp -107.32 132.59 52.96 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 107.283 -1.377 . . . . 0.91 107.283 178.501 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.2 tp -111.83 121.17 44.32 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.23 -0.919 . . . . 0.93 109.699 -179.314 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 31.0 mt -85.79 100.19 11.87 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.415 -0.803 . . . . 0.93 109.907 -179.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -88.78 135.98 33.24 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.47 -0.769 . . . . 2.75 109.327 179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -132.74 122.87 25.21 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.026 -1.101 . . . . 3.0 108.026 178.392 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -83.06 150.3 26.4 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.878 -1.139 . . . . 2.77 109.426 -179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -62.6 140.04 58.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 2.94 109.81 -179.61 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.6 mt -81.67 132.06 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.34 -0.85 . . . . 0.95 108.862 179.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -93.53 126.31 45.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.263 -0.898 . . . . 1.28 110.181 -179.133 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.5 mt -110.01 130.06 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 N-CA-C 107.954 -1.128 . . . . 1.21 107.954 179.321 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -88.79 120.33 30.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.836 -1.165 . . . . 1.81 110.102 -179.218 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -89.95 -4.49 57.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 2.8 108.708 179.387 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.3 mtpp -69.98 137.99 51.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 2.87 109.255 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -82.91 155.45 24.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.144 -0.973 . . . . 2.35 109.815 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.683 HD13 ' HG3' ' A' ' 39' ' ' GLU . 2.9 pt -98.84 168.47 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.445 -0.785 . . . . 0.97 109.339 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 87.9 p -89.99 173.55 8.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.08 -1.012 . . . . 1.17 108.481 178.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.04 -17.04 63.24 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.009 -1.057 . . . . 1.18 110.994 -179.367 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -84.57 -26.03 28.26 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.659 -1.276 . . . . 2.56 108.42 178.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -82.15 -7.95 59.64 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.131 -0.692 . . . . 1.79 109.131 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.0 t -60.01 -52.82 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.251 -0.905 . . . . 1.0 108.615 179.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -60.04 -40.05 88.02 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.354 -0.841 . . . . 1.77 109.208 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -64.06 -40.12 95.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 2.7 110.281 -179.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.683 ' HG3' HD13 ' A' ' 31' ' ' ILE . 71.1 mm-40 -63.46 -44.41 94.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.756 -1.215 . . . . 1.51 110.023 -179.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -60.03 -47.16 92.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 120.865 -1.147 . . . . 0.93 108.665 179.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -60.03 -46.69 88.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.302 -0.874 . . . . 1.81 108.984 -179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.8 mtp180 -60.21 -42.75 95.8 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.919 -1.113 . . . . 2.78 108.17 178.949 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -63.44 -47.73 80.68 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.535 -0.913 . . . . 0.78 108.535 178.31 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.3 tp -60.01 -48.68 80.72 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 108.516 -0.92 . . . . 1.07 108.516 -179.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 46.7 t -63.04 -43.85 97.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 1.12 108.903 179.075 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.99 -46.8 93.51 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.309 -1.917 . . . . 0.84 108.309 179.212 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.419 HH21 ' HG2' ' A' ' 81' ' ' GLU . 43.1 ttt-85 -60.1 -39.94 87.9 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.347 -0.983 . . . . 3.09 108.347 178.303 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -48.1 -46.23 33.69 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 109.148 -0.686 . . . . 0.88 109.148 -179.699 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.427 ' O ' ' C ' ' A' ' 50' ' ' ALA . 6.4 ttpm? -64.06 -74.08 0.11 Allowed 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.92 -1.141 . . . . 2.59 107.92 179.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.62 -35.83 0.21 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.532 -0.73 . . . . 0.7 111.143 -178.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.2 t -53.76 -60.62 3.08 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.619 -1.301 . . . . 1.4 108.716 179.557 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.6 -39.99 84.77 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.508 -0.745 . . . . 0.67 111.648 -178.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -66.77 -41.3 87.92 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.693 -1.254 . . . . 1.66 110.302 -178.939 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.3 mt -62.54 -39.98 95.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.863 -1.148 . . . . 1.58 108.873 179.198 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -65.83 -38.64 89.44 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.522 -0.736 . . . . 1.35 109.723 179.895 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.63 -40.87 98.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.077 -1.014 . . . . 0.77 109.535 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.517 ' CD1' HH22 ' A' ' 136' ' ' ARG . 82.8 mt -60.19 -40.0 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.22 -0.925 . . . . 0.63 109.218 179.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -58.94 -50.03 75.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.344 -0.847 . . . . 1.14 109.579 -179.661 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -58.14 -28.76 64.98 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.316 -0.865 . . . . 0.79 110.618 -178.064 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -70.05 -39.1 75.91 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.063 -1.023 . . . . 1.53 109.878 179.78 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.04 -46.92 76.1 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.596 -0.69 . . . . 0.57 109.9 -179.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.78 -54.06 32.9 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.928 -1.269 . . . . 0.75 109.928 -179.197 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.02 -45.53 60.51 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.045 -1.268 . . . . 1.59 110.588 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.5 m -68.34 -63.05 1.14 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.952 -1.092 . . . . 0.73 112.717 -177.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -95.7 -46.97 6.39 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.849 -1.157 . . . . 0.75 111.089 -177.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.93 -167.31 25.69 Favored Glycine 0 N--CA 1.5 2.943 0 O-C-N 120.839 -1.163 . . . . 1.22 111.143 179.485 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -75.6 -22.54 56.8 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.925 -0.75 . . . . 5.81 110.078 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.425 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.5 tp10 -61.12 -36.22 79.15 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.88 . . . . 3.37 110.211 -179.501 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.422 ' HA ' HD12 ' A' ' 72' ' ' ILE . 32.3 mmtp -100.72 -20.14 15.73 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.275 -0.89 . . . . 1.77 110.226 -179.486 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -68.51 -39.92 81.05 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.047 -1.033 . . . . 1.65 110.34 -179.106 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.536 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.5 -26.57 67.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.213 -0.93 . . . . 0.77 109.431 -179.362 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 69' ' ' LYS . 81.8 mt -60.05 -40.82 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.081 -1.012 . . . . 0.8 108.732 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -70.04 -37.97 75.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.188 -0.945 . . . . 0.88 110.638 -179.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -60.0 -40.11 88.08 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.656 -1.277 . . . . 1.37 108.642 179.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.07 -43.01 97.9 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.957 -1.657 . . . . 0.62 108.957 179.156 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.2 m170 -66.63 -41.31 88.53 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.302 -1.117 . . . . 1.5 108.969 179.764 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.4 mt -69.95 -45.44 76.69 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.323 -0.861 . . . . 0.63 108.987 179.354 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 35.4 ttp -60.69 -40.21 91.32 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.099 -1.001 . . . . 1.51 109.536 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.966 HD22 HD23 ' B' ' 347' ' ' LEU . 50.4 tp -64.95 -40.06 94.45 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.525 -0.735 . . . . 0.77 109.579 179.663 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.1 tp -63.62 -38.0 89.46 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.627 -0.67 . . . . 0.62 109.411 -179.213 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.419 ' HG2' HH21 ' A' ' 47' ' ' ARG . 100.0 mt-10 -82.4 4.39 24.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.159 -0.963 . . . . 1.47 110.913 -178.7 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -49.98 130.06 21.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.761 -1.212 . . . . 1.47 109.42 -179.655 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -57.54 -18.88 21.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.487 -0.758 . . . . 1.78 110.933 -178.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.72 -34.56 69.67 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.77 -1.207 . . . . 2.53 108.878 178.722 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.2 mt -72.33 -42.52 65.31 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.73 -0.606 . . . . 0.8 110.567 -179.716 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -60.0 -48.75 80.42 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.147 -0.971 . . . . 1.42 110.468 -178.819 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -69.95 -40.09 75.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.207 -0.933 . . . . 1.71 110.904 -178.788 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.03 -39.96 75.46 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.042 -1.036 . . . . 1.57 111.413 -179.219 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.2 mt -66.59 -49.94 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.949 -1.094 . . . . 0.65 109.539 -179.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.3 mt -69.79 -39.99 78.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.562 -0.711 . . . . 0.82 110.013 -179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.04 -48.77 80.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.12 -0.987 . . . . 0.79 110.783 -179.543 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.407 ' O ' ' N ' ' A' ' 96' ' ' LYS . 55.8 mt -59.97 -46.36 89.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.046 -1.034 . . . . 0.95 110.146 -179.089 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 78.2 mt -60.9 -49.81 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.193 -0.942 . . . . 0.66 108.826 179.451 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -69.99 -40.96 75.0 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 120.276 -0.57 . . . . 2.2 111.19 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -85.07 -49.97 7.83 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.861 -1.15 . . . . 1.65 112.012 -178.228 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.407 ' N ' ' O ' ' A' ' 92' ' ' LEU . 32.8 mmtp -89.18 -0.45 57.46 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.111 -0.993 . . . . 2.03 111.164 -177.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 20.2 m80 55.81 32.6 19.87 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.937 -1.102 . . . . 1.42 109.595 179.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 56.0 mtt -89.65 168.82 11.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.358 -0.839 . . . . 1.18 109.428 -179.605 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.7 p -83.45 158.16 22.17 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.19 -0.944 . . . . 0.98 109.051 179.736 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -65.61 -39.95 92.07 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.267 -0.896 . . . . 0.64 109.262 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.481 ' OD1' HD22 ' A' ' 138' ' ' LEU . 40.4 t0 -65.55 -40.02 92.4 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.419 -0.801 . . . . 2.07 109.764 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.45 -41.52 24.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.221 -0.925 . . . . 0.73 110.147 -179.51 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.88 -45.45 64.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -0.946 . . . . 0.54 110.63 -179.316 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.05 -43.31 95.46 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.039 -1.038 . . . . 0.56 110.122 -179.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -60.01 -39.95 87.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 1.54 110.193 -178.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -61.46 -41.81 97.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.995 -1.066 . . . . 1.33 110.517 -179.48 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 85.4 t -60.05 -50.85 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.14 -0.975 . . . . 0.72 110.598 -178.653 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 46.8 mm -69.94 -39.99 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.116 -0.99 . . . . 0.85 109.252 179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -62.11 -39.38 92.31 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.584 -0.895 . . . . 2.44 108.584 179.099 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.0 -52.19 54.38 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.812 -0.915 . . . . 0.98 110.812 -179.155 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.493 ' NE2' ' CB ' ' B' ' 348' ' ' PHE . 15.5 mm100 -64.04 -49.76 71.09 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.7 -1.47 . . . . 1.41 109.697 -179.436 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.0 -39.91 83.3 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.189 -0.944 . . . . 1.2 109.027 -179.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.8 t -59.98 -42.24 93.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.921 . . . . 1.7 108.873 179.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.29 -40.0 94.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.326 -0.858 . . . . 1.47 109.882 179.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.417 HD22 ' HB3' ' B' ' 351' ' ' GLN . 59.4 mt -65.42 -40.26 93.15 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.787 -1.196 . . . . 1.56 109.674 -178.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.06 -31.06 69.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.9 -1.125 . . . . 2.2 109.75 -179.656 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -55.81 -23.57 31.04 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.084 -1.01 . . . . 2.12 108.396 179.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 32.1 mt -63.23 148.91 46.82 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.576 -0.898 . . . . 2.0 108.576 179.637 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -99.81 47.07 0.95 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.025 -1.047 . . . . 3.23 110.204 -179.524 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 34.6 t0 -137.44 150.17 47.43 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.174 -0.954 . . . . 2.49 109.772 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 124' ' ' LYS . 98.4 mt-10 -74.44 -67.97 0.57 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.299 -0.876 . . . . 3.95 109.259 178.825 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.634 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 4.8 t80 -39.25 -39.5 0.63 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.863 -0.523 . . . . 2.0 111.153 -179.031 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.611 HD23 HH22 ' A' ' 126' ' ' ARG . 88.9 mt -69.97 -36.59 75.33 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.745 -1.222 . . . . 1.86 108.508 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 121' ' ' GLU . 74.6 tttt -69.23 -35.98 76.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.446 -0.784 . . . . 2.84 110.309 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.536 ' N ' ' OE1' ' A' ' 125' ' ' GLU . 0.4 OUTLIER -60.05 -46.31 89.97 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.966 -1.084 . . . . 2.73 110.603 -178.485 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.634 ' NH1' ' CE1' ' A' ' 122' ' ' TYR . 27.8 mtm-85 -63.14 -39.67 95.34 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.504 -1.372 . . . . 2.77 108.593 179.413 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.0 -36.6 77.55 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.459 -0.941 . . . . 1.19 108.459 179.057 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.22 88.58 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.216 -1.031 . . . . 1.2 108.216 179.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -66.88 -40.02 87.67 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.927 -0.768 . . . . 1.55 108.927 179.15 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 51.2 t -59.95 -42.9 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.297 -0.877 . . . . 0.8 109.052 179.384 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.4 ttp180 -60.04 -39.92 87.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.324 -0.86 . . . . 3.09 109.485 179.16 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 58.5 t0 -59.91 -40.05 87.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.427 -0.796 . . . . 1.46 110.196 -179.617 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.99 -42.17 88.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.127 -0.983 . . . . 0.71 110.447 -178.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.45 -34.46 54.23 Favored Glycine 0 N--CA 1.492 2.394 0 C-N-CA 119.805 -1.188 . . . . 0.57 110.236 -179.721 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 53.6 tttp -60.05 -46.22 90.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.189 -1.183 . . . . 2.59 109.684 -179.13 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.517 HH22 ' CD1' ' A' ' 57' ' ' ILE . 62.4 mtp180 -65.24 -34.5 78.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.125 -0.984 . . . . 2.83 110.108 -179.316 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.05 -39.95 87.74 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.036 -1.04 . . . . 1.25 109.015 -179.597 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.481 HD22 ' OD1' ' A' ' 101' ' ' ASP . 90.4 mt -60.53 -40.06 90.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 0.7 108.537 178.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -65.62 -39.93 92.02 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.825 -0.805 . . . . 2.57 108.825 179.187 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -69.47 -34.23 74.06 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.717 -0.614 . . . . 1.23 111.328 -179.245 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.7 mt -71.26 -39.85 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 120.454 -1.404 . . . . 0.81 109.243 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 74.9 mt -73.84 -19.17 60.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.597 -0.689 . . . . 1.0 109.943 -179.263 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.64 39.33 14.54 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 108.721 -1.752 . . . . 0.89 108.721 -179.289 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 16.8 tp -73.89 147.05 43.57 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.489 -1.006 . . . . 1.14 110.004 -179.001 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -71.74 141.05 49.78 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.351 -0.843 . . . . 4.6 109.713 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 90.2 mt -113.35 130.01 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-O 121.825 0.821 . . . . 1.24 108.838 179.108 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.4 mt -68.29 -39.94 81.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.857 -0.527 . . . . 1.54 110.874 -177.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.8 t0 63.92 102.83 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.396 -0.815 . . . . 1.5 109.267 -179.3 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 40.2 mt -72.95 -1.73 18.15 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.412 -0.805 . . . . 0.79 110.669 -179.069 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 79.2 p -85.24 -16.07 41.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.791 -1.193 . . . . 1.4 109.766 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.62 28.02 0.27 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.172 -0.955 . . . . 0.92 111.859 -177.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 40.9 mm -85.99 125.94 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 120.491 -1.381 . . . . 0.88 109.191 179.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -106.91 -13.95 15.09 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.496 -0.752 . . . . 2.45 109.665 -179.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -126.68 150.97 48.7 Favored 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.341 -0.85 . . . . 1.52 110.034 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.69 136.62 57.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.326 -0.859 . . . . 1.58 109.0 179.496 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.2 m -152.82 165.96 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.324 -0.86 . . . . 0.69 109.835 179.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 73.4 mt -95.55 145.95 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 105.661 -1.978 . . . . 0.61 105.661 176.783 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 37.7 tp -100.23 119.67 38.73 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.907 -1.121 . . . . 0.87 110.54 -178.092 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.2 t -119.0 125.72 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.605 -0.684 . . . . 0.71 109.225 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -152.78 158.67 42.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.985 -1.072 . . . . 0.81 109.494 179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.01 -32.12 70.13 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.395 -1.44 . . . . 0.98 108.294 179.076 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 56.2 t0 -169.86 142.15 2.37 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.451 -0.944 . . . . 2.25 108.451 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.528 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 81.4 mt -110.74 129.03 55.94 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.325 -0.859 . . . . 0.78 108.968 179.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 43.5 p -90.17 149.89 42.24 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.299 -0.876 . . . . 0.98 109.22 -179.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -37.85 -38.92 0.75 Allowed 'Trans proline' 0 N--CA 1.489 1.252 0 C-N-CA 122.241 1.961 . . . . 0.81 112.439 179.667 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.1 m -59.51 -39.98 85.6 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.251 -0.906 . . . . 0.9 109.9 -178.219 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.14 -40.05 86.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.086 -1.009 . . . . 1.61 110.356 -179.517 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.7 p -57.21 -32.6 66.67 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.981 -1.074 . . . . 0.61 111.124 -178.229 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.3 -46.96 53.47 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.984 -1.073 . . . . 0.6 109.97 -179.794 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -89.95 40.06 0.99 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.788 -1.19 . . . . 1.4 107.788 179.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.8 tp -106.96 126.44 52.32 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 109.082 -0.711 . . . . 0.7 109.082 179.208 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -84.68 105.71 15.68 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.075 -1.083 . . . . 2.35 108.075 178.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 93.6 mt -66.12 -44.53 84.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.37 -0.831 . . . . 1.51 111.39 -178.131 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -69.99 -21.76 63.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.76 -1.213 . . . . 2.33 111.809 -177.386 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -93.91 -9.27 37.7 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.699 -1.251 . . . . 1.92 110.214 -178.943 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.593 HG12 ' H ' ' A' ' 178' ' ' GLY . 99.8 t -108.76 119.94 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.385 -0.822 . . . . 0.67 108.912 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 89.5 mt -85.12 3.73 37.62 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.558 -0.714 . . . . 1.53 110.845 -178.182 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.593 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 166.55 175.23 36.61 Favored Glycine 0 N--CA 1.487 2.062 0 C-N-CA 119.224 -1.465 . . . . 0.48 109.75 179.637 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -133.69 129.41 36.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.551 -0.97 . . . . 0.55 108.411 179.731 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 90.3 mt -128.98 123.72 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.552 -0.907 . . . . 0.65 108.552 179.232 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 69.9 p -149.96 162.38 40.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.654 -1.279 . . . . 0.82 110.9 -179.706 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 183' ' ' ALA . 7.2 p30 -101.9 22.54 12.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.757 -0.589 . . . . 2.46 109.522 179.64 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.433 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -54.32 -162.98 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.817 -1.177 . . . . 1.28 112.048 -178.204 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.99 -54.0 5.97 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 110.809 -0.917 . . . . 2.19 110.809 -179.034 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 164.42 -139.01 5.59 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 118.94 -1.6 . . . . 2.13 110.707 -179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -71.59 -9.99 59.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.617 -0.931 . . . . 5.86 110.625 -178.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 53.5 p -78.99 1.52 23.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.928 -1.108 . . . . 3.72 109.672 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 12.2 t -90.94 130.8 36.84 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.081 -1.012 . . . . 1.74 110.076 -179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 65.4 t60 -47.06 -50.27 19.99 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.447 -0.783 . . . . 0.95 109.966 179.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.41 HG23 ' N ' ' A' ' 191' ' ' SER . 14.5 t -57.48 -37.16 72.46 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.304 -0.873 . . . . 1.55 110.973 -178.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.41 ' N ' HG23 ' A' ' 190' ' ' THR . 82.6 p -59.99 -41.01 91.15 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.739 -1.226 . . . . 1.51 110.851 -179.087 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 88.7 mt -61.09 -38.93 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.125 -0.984 . . . . 1.67 109.399 -179.871 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 92.7 mtp -60.59 -39.93 89.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.555 -0.716 . . . . 1.02 110.395 179.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.27 -43.49 87.97 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.737 -1.227 . . . . 0.68 109.388 -179.453 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.588 ' CG ' HH11 ' A' ' 195' ' ' ARG . 2.2 mtt-85 -60.02 -49.92 75.77 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.288 -0.965 . . . . 2.93 109.911 -179.29 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 72.1 m -69.96 -34.43 73.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.088 -1.008 . . . . 0.86 111.026 -179.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 35.5 mt -71.47 -18.24 62.31 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.921 -1.112 . . . . 0.67 109.499 -179.536 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 60.99 47.92 7.0 Favored 'General case' 0 N--CA 1.496 1.875 0 CA-C-O 121.294 0.569 . . . . 1.5 110.536 -179.415 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 38.5 mt -126.99 149.48 69.36 Favored Pre-proline 0 N--CA 1.499 2.021 0 N-CA-C 107.724 -1.213 . . . . 0.72 107.724 178.549 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.79 139.98 49.58 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.122 1.881 . . . . 0.61 112.102 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.99 150.59 3.84 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.112 -0.992 . . . . 0.66 111.052 -179.86 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 93.1 mt -125.22 142.32 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 N-CA-C 108.399 -0.963 . . . . 0.79 108.399 179.421 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.3 m -127.04 -7.97 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.443 0 O-C-N 120.816 -1.178 . . . . 0.91 111.322 -178.673 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.9 21.31 29.92 Favored Glycine 0 N--CA 1.503 3.135 0 O-C-N 121.211 -0.931 . . . . 1.01 110.867 -178.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 8.3 p -45.84 -43.99 13.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.951 -1.323 . . . . 0.99 110.165 -179.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.34 -49.46 2.67 Favored Glycine 0 N--CA 1.498 2.784 0 C-N-CA 120.017 -1.087 . . . . 1.12 111.034 179.445 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.7 m -160.77 37.74 0.16 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.651 -1.5 . . . . 1.72 111.246 -179.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 42.4 t -80.74 -31.5 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.991 -1.068 . . . . 0.89 108.86 178.206 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 2.7 p -59.95 -33.52 72.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.45 -0.781 . . . . 1.03 110.062 -179.081 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 91.2 p -78.21 -10.06 59.48 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.994 -1.066 . . . . 1.83 109.412 -179.664 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 90.7 mt-30 -103.6 -11.1 17.92 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.491 -0.756 . . . . 2.27 110.228 -179.304 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.4 t -103.42 136.2 37.35 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 121.213 -0.93 . . . . 0.92 110.806 -178.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -112.32 151.0 30.22 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.462 -1.31 . . . . 2.2 107.462 178.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.444 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 11.3 p-10 -57.92 139.53 54.1 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.058 -1.026 . . . . 2.36 110.069 -179.143 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.7 m-20 81.15 3.02 1.59 Allowed 'General case' 0 N--CA 1.5 2.071 0 CA-C-O 121.13 0.491 . . . . 2.38 110.007 179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 56.7 t0 -72.01 138.61 48.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.156 -0.965 . . . . 2.09 108.803 178.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.489 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 41.3 t80 -89.85 118.63 29.58 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 108.074 -1.084 . . . . 1.27 108.074 179.078 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.611 HD12 ' HB2' ' A' ' 16' ' ' ALA . 61.5 mt -128.47 149.05 50.74 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.498 -0.751 . . . . 0.75 110.642 -178.629 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.9 mt -115.15 130.01 70.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 107.703 -1.221 . . . . 0.63 107.703 177.615 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 63.5 tp -99.97 115.92 30.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.08 -1.013 . . . . 0.7 109.314 -179.207 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.503 ' C ' ' H ' ' A' ' 223' ' ' VAL . 97.3 m-20 -74.22 -42.72 59.3 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.918 -1.142 . . . . 2.31 107.918 178.368 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.862 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.54 11.22 0.12 Allowed 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.404 -0.961 . . . . 0.78 108.404 -179.108 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.503 ' H ' ' C ' ' A' ' 221' ' ' ASP . 57.2 t -128.33 -39.41 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.327 -1.36 . . . . 1.04 107.327 179.057 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.525 HD22 ' N ' ' A' ' 224' ' ' ASN . 1.3 m-80 -100.43 3.23 42.93 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.047 -1.094 . . . . 2.44 108.047 178.68 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 60.57 43.8 12.37 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.71 -0.619 . . . . 1.55 110.601 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.406 ' NE2' ' OH ' ' A' ' 228' ' ' TYR . 25.1 pt20 -149.18 156.79 42.7 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.885 -1.134 . . . . 1.99 109.976 179.204 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -122.92 124.93 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.685 -0.857 . . . . 0.77 108.685 179.158 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.406 ' OH ' ' NE2' ' A' ' 226' ' ' GLN . 84.7 m-85 -84.76 122.83 29.68 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.701 -1.249 . . . . 0.98 109.556 -179.23 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.406 HG22 HD22 ' A' ' 218' ' ' LEU . 62.5 t -98.96 116.3 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.474 -0.766 . . . . 0.85 109.481 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 65.08 68.96 0.69 Allowed Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.227 -0.92 . . . . 1.66 109.372 -179.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -89.18 124.05 1.4 Allowed 'Trans proline' 0 C--N 1.307 -1.639 0 C-N-CA 123.181 2.587 . . . . 0.95 112.255 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.2 p -70.41 171.75 9.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.269 -0.894 . . . . 1.84 109.725 -179.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -59.97 -40.16 88.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.323 -0.86 . . . . 2.74 109.921 -179.116 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -64.33 -34.61 78.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.033 -1.042 . . . . 2.89 109.217 179.908 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.5 t -65.79 -42.7 92.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.121 -0.987 . . . . 1.3 108.613 178.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 95.1 mt -67.1 -41.99 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.747 -0.834 . . . . 1.09 108.747 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 57.7 t0 -59.86 -40.06 87.33 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.596 -0.89 . . . . 2.43 108.596 178.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -59.51 -46.71 88.05 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 108.393 -0.965 . . . . 2.78 108.393 -179.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.541 ' O ' ' N ' ' A' ' 242' ' ' VAL . 93.3 mtp -65.69 -77.3 0.06 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.19 -1.411 . . . . 1.25 107.19 178.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.503 ' C ' ' O ' ' A' ' 239' ' ' MET . 29.6 mmt180 -23.19 -45.07 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.407 0 CA-C-O 120.983 0.421 . . . . 2.63 111.889 -178.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . 0.508 ' N ' ' O ' ' A' ' 239' ' ' MET . . . -63.88 -50.01 70.47 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.943 -1.098 . . . . 1.8 109.612 179.771 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 239' ' ' MET . 74.8 t -60.06 -38.13 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.228 -0.92 . . . . 2.13 108.884 179.498 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.96 -40.08 87.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.498 -0.751 . . . . 3.17 109.063 -179.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -60.38 -40.03 89.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.146 -0.971 . . . . 1.78 108.968 179.136 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -66.74 -40.09 88.18 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.238 -0.914 . . . . 2.47 108.964 179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 53.6 t -66.05 -40.17 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.332 -0.855 . . . . 2.09 109.073 179.739 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -65.82 -39.77 91.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.42 -0.8 . . . . 2.54 109.493 179.831 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 57.8 m -60.02 -39.96 87.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.253 -0.904 . . . . 2.99 109.576 -179.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -65.86 -40.03 91.29 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.178 -0.951 . . . . 3.34 109.549 179.802 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -82.76 -2.29 53.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.408 -0.807 . . . . 3.88 109.845 -179.051 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.481 ' O ' ' NZ ' ' A' ' 257' ' ' LYS . . . -65.73 -39.39 91.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.811 -1.181 . . . . 4.43 110.588 -179.592 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -163.2 -17.57 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.591 -1.318 . . . . 5.42 110.973 -179.056 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 95.5 mt -69.99 -40.03 75.54 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.565 -1.334 . . . . 6.1 109.565 179.463 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.457 ' O ' ' C ' ' A' ' 255' ' ' LYS . . . -118.44 4.87 11.76 Favored 'General case' 0 N--CA 1.504 2.227 0 O-C-N 121.534 -0.728 . . . . 7.37 110.659 -179.269 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 254' ' ' ALA . 43.6 pttt 33.12 -117.04 0.07 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.577 -0.702 . . . . 8.01 110.91 -179.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.405 HD22 ' HA ' ' A' ' 256' ' ' LEU . 0.2 OUTLIER 59.94 19.54 8.57 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.862 -1.162 . . . . 9.05 107.862 -179.27 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.481 ' NZ ' ' O ' ' A' ' 251' ' ' ALA . 87.5 mttt -66.52 -46.15 77.13 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.631 -0.828 . . . . 10.56 109.554 178.652 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 28.4 p-10 -147.79 25.88 1.03 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.37 -0.831 . . . . 11.32 109.423 -179.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 26.2 tpt180 . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.081 -1.012 . . . . 12.42 109.036 -179.972 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 16.9 ttt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -149.49 147.98 28.86 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.26 -0.9 . . . . 0.0 109.267 179.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -149.67 159.63 44.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.066 -1.021 . . . . 0.0 110.618 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -153.66 150.41 28.56 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.389 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -109.84 132.25 54.32 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.373 -0.83 . . . . 0.0 109.781 179.628 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -131.49 121.63 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 CA-C-O 122.371 1.081 . . . . 0.0 112.729 -177.4 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 56.0 m -78.19 104.01 8.49 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.924 0.868 . . . . 0.0 110.02 -178.874 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.476 HG22 ' H ' ' B' ' 310' ' ' ALA . 96.6 mt -52.64 125.62 6.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-O 122.635 1.207 . . . . 0.0 111.073 -177.562 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 67.1 p -109.97 20.9 17.46 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.978 -179.023 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.476 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -75.29 116.87 58.55 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.048 -1.032 . . . . 0.0 108.945 179.426 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -54.53 -16.22 10.29 Favored 'Trans proline' 0 N--CA 1.498 1.77 0 CA-C-N 120.276 1.134 . . . . 0.0 113.249 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -120.17 11.41 11.61 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.383 -0.823 . . . . 0.0 109.621 -179.191 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.85 179.25 32.14 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 108.431 -1.867 . . . . 0.0 108.431 -179.243 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.457 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -87.08 93.13 9.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.952 -1.322 . . . . 0.0 108.998 -179.234 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.404 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 5.8 p80 -95.43 -160.0 0.76 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 120.945 -1.097 . . . . 0.0 109.811 179.054 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 9.6 m -58.39 -43.99 88.75 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.021 -1.05 . . . . 0.0 112.629 -176.071 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.536 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.1 tpt180 -61.97 -62.05 6.57 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.352 -1.467 . . . . 0.0 112.184 -178.236 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.404 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 11.0 Cg_endo -58.02 -29.6 87.34 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 CA-C-N 120.136 1.084 . . . . 0.0 111.548 -179.196 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.34 -49.96 75.83 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 179.085 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.34 -41.18 65.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.412 -0.805 . . . . 0.0 109.464 -179.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -70.02 -40.61 75.1 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.768 -1.207 . . . . 0.0 108.911 178.478 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -65.5 -55.46 17.74 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.521 -0.737 . . . . 0.0 109.951 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . 0.431 HG13 ' O ' ' B' ' 344' ' ' ALA . 88.3 t -67.83 -29.72 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.872 -1.142 . . . . 0.0 111.058 -178.482 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -64.05 -42.96 96.86 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.966 -1.084 . . . . 0.0 109.876 179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -66.23 -40.41 90.24 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.107 -0.995 . . . . 0.0 110.499 -179.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -65.75 -53.13 44.73 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.745 -1.222 . . . . 0.0 110.389 -179.608 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -51.94 -15.64 0.58 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 109.964 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -75.49 -23.93 71.91 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.73 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -105.59 141.32 37.26 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.404 -1.057 . . . . 0.0 108.945 179.669 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 26.5 m -89.8 -11.48 42.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.997 -1.064 . . . . 0.0 109.937 -179.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.434 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 63.3 p -61.32 148.88 39.81 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.973 -1.079 . . . . 0.0 109.241 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -68.53 134.63 50.35 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.116 -0.99 . . . . 0.0 108.908 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.3 mt -133.01 133.22 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.642 -0.661 . . . . 0.0 109.787 -179.57 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 32.4 m -129.9 149.03 51.81 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.487 -0.758 . . . . 0.0 109.089 179.245 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 87.1 t -122.3 116.48 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 178.327 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 33.3 m -105.67 132.12 52.2 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.207 -0.933 . . . . 0.0 109.498 -178.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 33.8 t -140.02 116.49 10.7 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.768 0.794 . . . . 0.0 111.105 -179.79 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 45.52 51.96 9.48 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 176.723 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 90.0 -14.03 63.09 Favored Glycine 0 N--CA 1.503 3.142 0 O-C-N 120.156 -1.59 . . . . 0.0 113.099 176.52 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -119.76 131.16 55.28 Favored 'General case' 0 N--CA 1.509 2.487 0 CA-C-N 119.495 1.647 . . . . 0.0 110.06 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 18.1 m -129.99 150.23 51.36 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.83 0.824 . . . . 0.0 110.426 -179.412 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . 0.423 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -146.52 171.86 14.44 Favored 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.511 0.672 . . . . 0.0 110.145 -179.229 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 9.6 m -89.68 139.95 30.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.533 -0.73 . . . . 0.0 109.725 -179.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.441 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -81.51 -12.47 58.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.0 -1.062 . . . . 0.0 109.018 179.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -86.62 21.26 2.23 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.5 -1.666 . . . . 0.0 106.5 178.602 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . 0.441 ' H ' ' C ' ' B' ' 344' ' ' ALA . 52.7 m -149.96 98.67 2.75 Favored 'General case' 0 N--CA 1.495 1.791 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.226 -179.053 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.966 HD23 HD22 ' A' ' 79' ' ' LEU . 26.0 tp -59.91 -34.4 73.15 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 179.015 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.8 ' CE2' HD11 ' A' ' 79' ' ' LEU . 58.0 m-85 -59.93 -55.56 32.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.265 -0.897 . . . . 0.0 110.11 -179.37 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -69.35 -22.4 63.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.189 -0.944 . . . . 0.0 111.178 -177.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.545 ' O ' ' N ' ' B' ' 352' ' ' THR . 65.1 mt -68.94 -52.78 25.57 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.645 -1.284 . . . . 0.0 108.09 177.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.552 ' OE1' ' N ' ' B' ' 351' ' ' GLN . 0.8 OUTLIER -40.85 -16.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.977 -178.22 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.545 ' N ' ' O ' ' B' ' 350' ' ' LEU . 63.5 p -87.44 -10.01 53.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.405 -1.435 . . . . 0.0 109.941 -179.167 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.423 HD11 ' HB3' ' B' ' 342' ' ' ALA . 67.8 mt -95.42 117.81 31.02 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.07 -1.019 . . . . 0.0 109.081 178.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.35 94.04 0.91 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 18.1 mt -101.42 88.73 3.53 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.282 -1.128 . . . . 0.0 108.86 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 77.2 p -90.33 169.99 10.63 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.01 -1.056 . . . . 0.0 110.785 -179.068 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . 0.449 ' CG ' ' O ' ' B' ' 310' ' ' ALA . 1.1 tm0? -61.46 113.78 2.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.721 -0.612 . . . . 0.0 110.973 -179.079 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 100.32 8.07 50.68 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.205 -1.558 . . . . 0.0 109.205 179.751 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.1 m -83.31 111.52 19.06 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.339 -1.095 . . . . 0.0 110.513 -179.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 6.1 t -77.31 114.59 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 122.292 1.044 . . . . 0.0 109.257 -177.636 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 14.5 m -111.7 177.68 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -178.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 90.3 m -131.29 129.35 41.39 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 176.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 71.9 mt -102.63 116.42 46.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 179.176 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 56.8 p -120.01 132.3 55.43 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.35 153.14 40.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 0.0 109.873 -178.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -144.88 124.41 13.18 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.289 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.464 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 159.88 -160.34 31.46 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 118.804 -1.665 . . . . 0.0 111.578 -179.773 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -60.06 -50.93 71.8 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 122.132 -0.628 . . . . 0.0 112.133 -177.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.434 ' H ' ' HB3' ' B' ' 331' ' ' SER . 71.3 m-20 -109.93 10.93 24.27 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.903 -1.123 . . . . 0.0 111.643 -177.2 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.554 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -42.04 -34.88 0.78 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.988 -1.07 . . . . 0.0 111.848 -178.392 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . 0.525 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 26.7 mt-30 -70.72 -38.65 73.6 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.745 -1.222 . . . . 0.0 110.034 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -65.38 -50.04 67.02 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 120.926 -1.108 . . . . 0.0 109.011 -179.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.05 -76.47 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.584 -0.697 . . . . 0.0 111.069 -178.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.579 ' O ' HG23 ' B' ' 378' ' ' VAL . 23.5 t -43.08 -38.13 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.343 -0.848 . . . . 0.0 110.973 -177.471 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.92 -42.39 85.48 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.351 -1.468 . . . . 0.0 110.32 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -81.03 -43.43 19.56 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.795 -1.191 . . . . 0.0 109.909 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.09 -39.41 86.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.223 -179.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.579 HG23 ' O ' ' B' ' 374' ' ' VAL . 55.9 t -62.02 -43.23 97.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.057 -1.027 . . . . 0.0 109.342 179.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -70.02 -56.38 7.12 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.703 -1.248 . . . . 0.0 107.64 178.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 52.0 tp -56.2 -35.06 66.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.564 -0.71 . . . . 0.0 110.058 -177.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 1.5 tpt -71.49 -39.93 70.53 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 120.543 -1.348 . . . . 0.0 108.669 178.165 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.75 -4.44 57.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.473 -0.767 . . . . 0.0 110.574 179.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.428 ' O ' ' OE2' ' B' ' 385' ' ' GLU . 73.2 mm-40 -111.68 -2.61 15.3 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 121.105 -0.997 . . . . 0.0 110.995 -179.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 13.1 mt -80.01 133.02 36.12 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.379 -1.45 . . . . 0.0 109.493 179.129 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . 0.525 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 42.9 mp0 . . . . . 0 N--CA 1.496 1.831 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.211 179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mtp . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.5 -0.556 . . . . 2.91 109.5 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.2 mt -109.97 129.94 64.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.51 -0.744 . . . . 1.2 109.692 -179.84 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.8 m -131.65 147.61 52.53 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.719 -0.613 . . . . 1.4 109.456 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.44 -164.99 10.13 Favored Glycine 0 N--CA 1.495 2.617 0 N-CA-C 108.834 -1.706 . . . . 1.05 108.834 179.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.458 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.6 mt -87.41 -18.33 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.016 -1.285 . . . . 1.15 109.704 -179.356 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.4 tp 54.86 103.82 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.668 -0.864 . . . . 0.98 108.668 -179.138 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.5 -24.57 16.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.88 108.675 179.509 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.479 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 13.4 t -141.77 123.43 8.96 Favored Pre-proline 0 N--CA 1.497 1.89 0 O-C-N 121.574 -0.704 . . . . 1.69 110.011 -179.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.98 147.48 21.2 Favored 'Trans proline' 0 N--CA 1.498 1.765 0 C-N-CA 122.184 1.923 . . . . 0.85 112.531 179.284 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.909 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 150.29 172.64 19.78 Favored Glycine 0 N--CA 1.5 2.918 0 N-CA-C 108.918 -1.673 . . . . 0.92 108.918 179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.9 mt -127.45 132.31 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 120.875 -1.367 . . . . 0.81 109.677 -179.905 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.43 151.89 50.0 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.317 -0.864 . . . . 0.51 109.957 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.579 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.1 m-85 -127.28 130.84 50.31 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 107.866 -1.161 . . . . 0.62 107.866 179.485 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.72 178.82 48.65 Favored Glycine 0 N--CA 1.494 2.518 0 C-N-CA 118.583 -1.77 . . . . 0.55 111.183 -179.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -79.96 155.56 27.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.799 -0.824 . . . . 2.1 109.325 -179.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.6 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -106.52 125.78 51.43 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-O 121.794 0.807 . . . . 0.77 111.369 -178.967 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.0 tp -99.47 137.52 37.85 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 107.529 -1.286 . . . . 0.91 107.529 178.195 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 65.5 tp -119.53 128.65 54.14 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.476 -0.765 . . . . 0.93 109.692 -179.211 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 53.1 mt -91.62 105.91 18.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.694 -0.629 . . . . 0.93 110.275 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -106.1 131.79 52.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.162 -1.051 . . . . 2.75 108.162 178.605 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -129.23 148.58 51.17 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.383 -0.823 . . . . 3.0 109.381 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -83.15 142.42 31.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.455 -0.778 . . . . 2.77 109.33 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -60.2 142.52 54.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.126 -0.983 . . . . 2.94 109.133 179.974 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 75.5 mt -75.97 126.58 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.977 . . . . 0.95 109.985 -179.273 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.57 125.33 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.343 -0.848 . . . . 1.28 110.166 -179.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 84.8 mt -110.18 132.29 58.88 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.607 -0.886 . . . . 1.21 108.607 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -92.23 117.92 30.36 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.764 -1.21 . . . . 1.81 109.474 -179.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.447 HH11 ' HG2' ' A' ' 28' ' ' ARG . 5.3 mmt-85 -87.11 -4.39 59.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.164 -0.96 . . . . 2.8 109.342 179.815 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -68.25 140.77 56.03 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.194 -0.941 . . . . 2.87 109.248 179.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -84.02 154.49 23.24 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.261 -0.899 . . . . 2.35 109.849 -179.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.546 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.3 pt -96.5 167.17 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -0.924 . . . . 0.97 109.467 179.725 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 88.7 p -90.31 172.76 8.54 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.04 -1.037 . . . . 1.17 108.363 178.574 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.08 -18.09 63.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.938 -1.102 . . . . 1.18 110.994 -179.285 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 64.8 t0 -86.37 -24.62 25.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.626 -1.296 . . . . 2.56 108.392 178.842 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -81.29 -9.97 59.66 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.786 -0.82 . . . . 1.79 108.786 179.1 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.7 t -60.94 -52.02 66.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 N-CA-C 108.799 -0.815 . . . . 1.0 108.799 179.676 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -61.08 -39.88 91.57 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.377 -0.827 . . . . 1.77 110.273 -179.619 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -69.24 -40.91 77.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.078 -1.014 . . . . 2.7 111.022 -178.309 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.546 ' HG3' HG21 ' A' ' 31' ' ' ILE . 68.7 mm-40 -65.91 -39.86 90.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.0 -1.063 . . . . 1.51 110.854 -179.21 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.8 t -61.33 -45.04 99.42 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 120.484 -1.385 . . . . 0.93 108.45 179.59 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.7 tp10 -60.01 -41.5 92.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.043 -1.036 . . . . 1.81 109.622 179.786 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -60.17 -45.25 93.71 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 118.967 -1.093 . . . . 2.78 108.069 179.209 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -60.36 -48.29 82.37 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.889 -0.782 . . . . 0.78 108.889 178.199 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.465 ' CD1' HH21 ' A' ' 47' ' ' ARG . 43.2 tp -60.2 -48.81 80.16 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.048 -0.723 . . . . 1.07 109.048 -179.567 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.459 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 44.4 t -63.56 -43.18 97.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.021 -1.05 . . . . 1.12 108.386 178.83 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.56 -47.42 91.25 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.537 -1.825 . . . . 0.84 108.537 179.059 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.465 HH21 ' CD1' ' A' ' 44' ' ' LEU . 44.2 ttp180 -60.18 -38.78 84.27 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 107.888 -1.153 . . . . 3.09 107.888 178.656 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -52.9 -46.49 68.02 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.952 -0.758 . . . . 0.88 108.952 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 50' ' ' ALA . 34.0 ttpt -59.92 -74.82 0.07 Allowed 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.548 -1.279 . . . . 2.59 107.548 179.257 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.35 -39.61 0.3 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.356 -0.84 . . . . 0.7 111.907 -178.148 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 72.0 m -59.34 -52.17 66.8 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.458 -1.401 . . . . 1.4 108.707 -179.749 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.52 -40.71 89.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.365 -0.834 . . . . 0.67 110.58 -179.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -63.3 -42.17 99.03 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.0 -1.062 . . . . 1.66 109.878 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.6 mt -64.11 -40.46 96.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.021 -1.049 . . . . 1.58 109.538 179.553 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -60.7 -39.87 90.15 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.109 -0.995 . . . . 1.35 108.708 179.671 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.418 HG22 ' HZ3' ' A' ' 60' ' ' LYS . 89.3 m -62.23 -43.49 98.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.361 -0.837 . . . . 0.77 109.711 179.097 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 81.7 mt -61.47 -39.85 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.325 -0.859 . . . . 0.63 109.598 179.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.8 ttpt -57.56 -50.22 73.81 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.255 -0.903 . . . . 1.14 109.872 -179.041 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 m -58.44 -37.68 75.9 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.25 -0.906 . . . . 0.79 110.491 -177.751 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.418 ' HZ3' HG22 ' A' ' 56' ' ' THR . 59.0 mttp -68.47 -36.88 79.6 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.911 -1.118 . . . . 1.53 109.352 179.461 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.438 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.27 -47.34 70.97 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.57 -0.706 . . . . 0.57 109.979 -179.636 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -54.59 -52.8 42.89 Favored Glycine 0 N--CA 1.484 1.858 0 C-N-CA 119.993 -1.099 . . . . 0.75 110.452 -178.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.42 -41.84 72.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.032 -1.275 . . . . 1.59 111.083 -178.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 90.8 m -66.34 -61.93 1.74 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.025 -1.047 . . . . 0.73 112.181 -177.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -96.68 -44.47 7.1 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.827 -1.171 . . . . 0.75 111.439 -177.546 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.39 -168.08 25.58 Favored Glycine 0 N--CA 1.499 2.882 0 C-N-CA 119.822 -1.18 . . . . 1.22 110.925 179.866 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -69.95 -22.82 63.14 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.981 -0.717 . . . . 5.81 110.115 -179.823 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.506 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 50.4 tp10 -59.99 -35.71 75.61 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.466 -0.771 . . . . 3.37 111.31 -179.14 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.1 mmtm -96.51 -16.22 21.23 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.166 -0.959 . . . . 1.77 109.748 -179.699 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -71.6 -43.13 66.77 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.219 -0.926 . . . . 1.65 110.373 179.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.59 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -63.69 -34.53 78.07 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.435 -0.79 . . . . 0.77 110.119 -178.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.86 -40.61 83.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.909 -1.119 . . . . 0.8 109.108 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -65.04 -39.52 93.47 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.986 -1.071 . . . . 0.88 110.314 -179.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -60.12 -40.06 88.42 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 120.979 -1.076 . . . . 1.37 109.342 -179.182 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.99 -44.75 95.49 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 108.181 -1.968 . . . . 0.62 108.181 178.376 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.1 m170 -63.36 -45.88 89.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.529 -0.983 . . . . 1.5 109.142 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 98.5 mt -70.08 -45.51 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.108 -0.995 . . . . 0.63 109.319 179.575 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.0 ttp -62.65 -41.49 99.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.847 -1.158 . . . . 1.51 110.09 -179.488 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.005 HD22 HD23 ' B' ' 347' ' ' LEU . 45.7 tp -65.07 -40.83 95.22 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.541 -0.724 . . . . 0.77 110.065 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.7 tp -68.73 -39.52 80.33 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.636 -0.665 . . . . 0.62 110.311 -179.096 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -79.67 0.94 28.23 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.043 -1.036 . . . . 1.47 109.935 -179.062 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.458 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 53.3 t0 -47.28 133.83 11.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.086 -1.009 . . . . 1.47 109.736 -179.311 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.458 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 99.3 mt-10 -64.92 -18.66 65.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.683 -0.636 . . . . 1.78 110.899 -178.749 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -75.51 -33.31 60.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.779 -1.201 . . . . 2.53 109.035 178.68 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 79' ' ' LEU . 88.9 mt -70.02 -39.99 75.49 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.479 -0.763 . . . . 0.8 109.371 179.5 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -59.91 -49.53 77.31 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.429 -0.794 . . . . 1.42 110.16 -179.435 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -68.4 -39.41 81.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.855 . . . . 1.71 110.787 -179.226 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -68.87 -40.25 79.37 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.719 -1.238 . . . . 1.57 111.221 -179.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.44 -43.19 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.601 -1.312 . . . . 0.65 109.402 179.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.78 -39.17 77.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.552 -0.717 . . . . 0.82 110.749 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.78 95.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.117 -0.989 . . . . 0.79 110.098 -179.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 21.1 mt -63.65 -45.4 90.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.094 -1.004 . . . . 0.95 109.333 -179.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 73.9 mt -64.15 -48.98 83.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.406 -0.809 . . . . 0.66 109.18 179.947 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -69.99 -40.77 75.11 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.733 -0.787 . . . . 2.2 110.576 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -84.82 -55.86 3.88 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.969 -1.082 . . . . 1.65 112.134 -178.142 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -87.1 -1.44 57.89 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.866 -1.146 . . . . 2.03 111.872 -177.321 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 44.3 m80 58.58 35.01 24.31 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.995 -1.066 . . . . 1.42 110.304 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.2 mtp -86.89 166.27 15.28 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.256 -0.903 . . . . 1.18 109.889 -179.474 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.426 ' OG1' ' OD1' ' A' ' 101' ' ' ASP . 64.4 p -79.62 161.9 25.62 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.206 -0.934 . . . . 0.98 108.864 179.536 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -67.06 -40.54 87.11 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.0 -1.062 . . . . 0.64 109.541 179.977 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 101' ' ' ASP . 23.9 p-10 -69.94 -35.72 74.73 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.047 -1.033 . . . . 2.07 109.925 179.825 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.12 -40.09 39.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.094 -1.004 . . . . 0.73 109.333 179.279 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -68.76 -48.33 63.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.862 . . . . 0.54 110.361 -179.368 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.81 -32.54 73.75 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.81 -1.181 . . . . 0.56 109.757 -179.953 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.525 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 86.3 t60 -60.53 -45.07 95.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.249 -0.907 . . . . 1.54 109.56 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -66.41 -39.96 89.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.432 -0.792 . . . . 1.33 110.997 -178.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 90.1 t -62.3 -53.35 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.165 -0.96 . . . . 0.72 111.493 -177.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.8 mm -72.59 -37.12 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 120.751 -1.218 . . . . 0.85 110.004 -179.382 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.525 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 84.5 tt0 -67.35 -34.2 76.83 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.172 -0.955 . . . . 2.44 108.537 179.623 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.59 -49.07 82.66 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 110.357 -1.097 . . . . 0.98 110.357 -179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.684 HE21 ' CB ' ' B' ' 348' ' ' PHE . 16.3 mm100 -65.92 -50.71 63.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.802 -1.411 . . . . 1.41 109.192 -179.537 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.87 -40.43 80.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 1.2 109.097 179.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 61.8 m -60.03 -40.18 88.48 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.114 -0.991 . . . . 1.7 108.436 179.733 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.26 -39.65 95.19 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.391 -0.818 . . . . 1.47 109.304 179.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.6 mt -67.82 -43.16 80.26 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.993 -1.083 . . . . 1.56 109.461 -179.468 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -55.5 -25.4 36.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.85 -1.156 . . . . 2.2 109.723 -179.31 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -66.2 -22.0 66.33 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.973 -1.079 . . . . 2.12 108.765 179.874 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.441 HD13 HD13 ' A' ' 123' ' ' LEU . 51.8 mt -63.25 143.94 57.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.314 -0.866 . . . . 2.0 109.882 -179.617 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -92.55 14.31 17.21 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.201 -0.937 . . . . 3.23 109.358 179.03 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 45.7 t0 -103.22 127.83 50.41 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.32 -0.862 . . . . 2.49 110.516 -178.944 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -70.62 -28.94 65.22 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-O 121.366 0.603 . . . . 3.95 110.234 179.239 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.535 ' OH ' ' N ' ' B' ' 315' ' ' HIS . 15.7 t80 -64.26 -40.58 96.28 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.209 -0.932 . . . . 2.0 110.212 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.91 HD22 ' O ' ' B' ' 351' ' ' GLN . 64.2 mt -77.38 -37.15 52.7 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.51 -0.744 . . . . 1.86 109.875 -178.934 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -59.98 -40.9 90.7 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.249 -0.907 . . . . 2.84 109.329 -179.752 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.452 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 78.1 mm-40 -61.28 -46.02 92.08 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.958 -1.089 . . . . 2.73 108.877 179.401 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.44 HH21 ' CD2' ' A' ' 123' ' ' LEU . 17.5 ttp180 -61.16 -39.96 92.06 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.899 . . . . 2.77 108.59 179.203 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -62.88 -28.9 70.36 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.766 -0.827 . . . . 1.19 108.766 179.011 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -59.95 -40.03 87.58 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.087 -1.079 . . . . 1.2 108.087 179.571 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -62.07 -42.24 98.99 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.522 -0.736 . . . . 1.55 109.503 179.741 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.6 t -62.11 -41.4 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.197 -0.939 . . . . 0.8 108.571 179.264 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 -60.13 -39.33 85.94 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.688 -0.633 . . . . 3.09 109.458 179.32 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -60.04 -41.85 93.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.38 -0.825 . . . . 1.46 110.676 -179.304 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.16 -46.19 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.056 -1.028 . . . . 0.71 110.055 -179.088 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -60.08 -40.99 97.85 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.996 -1.242 . . . . 0.57 109.996 -179.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.0 mmmm -59.8 -49.72 76.63 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.326 -1.102 . . . . 2.59 110.142 -179.658 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 88.2 mtm180 -70.05 -32.08 70.02 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.101 -0.999 . . . . 2.83 110.501 -179.808 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.9 tp -57.81 -46.74 84.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.147 -0.97 . . . . 1.25 108.925 -178.884 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.3 mt -59.96 -39.64 86.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.138 -0.977 . . . . 0.7 108.565 179.116 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -68.22 -40.0 82.22 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.356 -0.84 . . . . 2.57 108.884 178.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -60.16 -38.49 83.3 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.862 -0.524 . . . . 1.23 110.999 -178.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.5 mt -72.8 -40.87 61.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 120.653 -1.28 . . . . 0.81 108.727 179.397 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 96.1 mt -72.68 -25.58 61.31 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.62 -0.675 . . . . 1.0 109.848 -179.798 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.6 37.16 27.66 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.96 -1.656 . . . . 0.89 108.96 -179.309 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 58.5 tp -73.14 141.59 47.47 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.497 -1.002 . . . . 1.14 109.381 -179.401 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 5.4 tppt? -61.96 140.06 58.35 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.845 0.831 . . . . 4.6 111.12 -178.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 97.0 mt -115.66 132.25 65.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.716 -0.846 . . . . 1.24 108.716 178.604 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 24.7 mm -57.02 -43.74 81.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.455 -0.778 . . . . 1.54 109.924 -178.392 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 11.8 t0 70.18 94.31 0.08 Allowed 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.063 -0.718 . . . . 1.5 109.063 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 33.8 mt -66.36 -6.52 14.54 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.382 -0.824 . . . . 0.79 110.841 -178.761 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 21.0 t -82.93 -16.85 45.77 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.716 -1.24 . . . . 1.4 110.534 -179.186 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.33 24.29 0.83 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.068 -1.02 . . . . 0.92 112.581 -177.529 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.0 mm -79.28 126.5 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 120.305 -1.497 . . . . 0.88 108.793 179.531 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.4 ' O ' ' OD1' ' A' ' 154' ' ' ASP . 77.5 mt-30 -102.8 -11.92 17.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.558 -0.714 . . . . 2.45 110.158 -179.247 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 153' ' ' GLN . 97.7 m-20 -136.85 156.09 48.94 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.117 -0.989 . . . . 1.52 110.39 -178.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.08 135.17 56.16 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.321 -0.862 . . . . 1.58 109.137 179.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 30.9 m -152.65 164.48 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.42 -0.8 . . . . 0.69 109.802 -179.894 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.7 mt -92.5 147.15 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 N-CA-C 105.752 -1.944 . . . . 0.61 105.752 176.651 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 63.4 tp -99.69 119.21 37.75 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.173 -0.954 . . . . 0.87 110.464 -178.246 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 21.1 t -125.13 130.3 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.196 -1.038 . . . . 0.71 108.196 179.561 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.84 167.21 28.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -0.991 . . . . 0.81 109.221 -179.768 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.26 -37.31 74.88 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 120.781 -1.199 . . . . 0.98 108.715 179.013 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 29.6 p-10 -170.42 149.01 3.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.57 -0.706 . . . . 2.25 109.602 -179.655 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.1 mt -119.36 133.72 55.58 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.453 -0.779 . . . . 0.78 109.663 -179.609 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.4 p -93.35 143.89 27.41 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.079 -1.013 . . . . 0.98 108.624 179.157 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -41.47 -34.23 1.92 Allowed 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.302 2.001 . . . . 0.81 113.159 -179.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.7 m -59.92 -40.12 87.8 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.768 -1.207 . . . . 0.9 109.294 -178.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -68.5 -40.24 80.94 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.012 -1.055 . . . . 1.61 109.308 179.474 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 63.8 p -52.94 -30.02 32.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.064 -1.022 . . . . 0.61 110.57 -178.92 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -70.72 -57.47 4.64 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.816 -1.178 . . . . 0.6 109.701 179.565 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -80.36 34.83 0.32 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.13 -0.693 . . . . 1.4 109.13 -179.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.4 tp -100.08 136.54 39.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.426 -0.796 . . . . 0.7 109.763 179.437 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -86.18 96.89 10.07 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.926 -1.139 . . . . 2.35 107.926 178.494 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.9 -41.72 97.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 1.51 110.87 -178.577 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -68.02 -25.34 65.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.993 -1.067 . . . . 2.33 111.812 -177.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 17.5 mtpp -93.7 -8.74 39.99 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.727 -1.233 . . . . 1.92 110.541 -178.506 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.458 HG12 ' H ' ' A' ' 178' ' ' GLY . 87.5 t -107.58 118.58 55.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 N-CA-C 108.182 -1.044 . . . . 0.67 108.182 178.613 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 95.3 mt -89.85 6.48 41.66 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.446 -0.784 . . . . 1.53 111.051 -177.342 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.458 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 175.82 166.16 32.87 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 109.419 -1.472 . . . . 0.48 109.419 179.511 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -132.2 128.44 37.96 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.344 -0.984 . . . . 0.55 108.344 179.573 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.416 ' CG2' HG21 ' A' ' 205' ' ' THR . 86.2 mt -130.47 124.04 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 N-CA-C 107.612 -1.255 . . . . 0.65 107.612 178.489 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 25.4 p -140.79 156.81 46.08 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 122.205 1.002 . . . . 0.82 111.386 -178.189 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.491 ' OD2' ' O ' ' A' ' 206' ' ' GLY . 65.6 t0 -102.97 26.03 8.65 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 115.914 -0.585 . . . . 2.46 110.101 -179.567 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.67 -164.12 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.233 -1.542 . . . . 1.28 111.551 -178.045 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.82 -54.0 8.93 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.261 -1.136 . . . . 2.19 110.261 -179.516 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 179.65 -154.44 13.71 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.764 -1.684 . . . . 2.13 111.68 -179.635 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -64.37 -11.28 31.01 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.89 -0.771 . . . . 5.86 110.745 -178.759 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 59.6 p -79.94 5.38 14.07 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.119 -0.988 . . . . 3.72 109.699 -179.005 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.0 t -88.67 142.48 27.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 1.74 109.894 179.856 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -53.36 -39.15 63.94 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.385 -0.822 . . . . 0.95 108.919 -179.831 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 89.5 m -59.77 -42.23 92.85 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.69 -0.631 . . . . 1.55 110.908 -179.33 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 54.3 p -60.98 -40.08 92.05 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.846 -1.159 . . . . 1.51 110.962 -178.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.8 mm -61.42 -41.19 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.204 -0.935 . . . . 1.67 110.096 -178.558 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.5 mtp -61.32 -42.94 99.5 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.989 -1.069 . . . . 1.02 110.333 179.989 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.96 -47.0 71.78 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.522 -1.361 . . . . 0.68 109.92 -179.762 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -60.21 -50.26 74.37 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.903 -1.119 . . . . 2.93 110.003 -179.687 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 71.7 m -69.14 -36.07 77.05 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.773 -1.204 . . . . 0.86 111.069 -179.216 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 197' ' ' LEU . 94.7 mt -72.06 -26.39 62.16 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.822 -1.174 . . . . 0.67 109.45 -179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 68.42 45.26 1.19 Allowed 'General case' 0 N--CA 1.499 2.02 0 CA-C-O 121.098 0.475 . . . . 1.5 110.778 -179.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.479 ' O ' ' CB ' ' A' ' 8' ' ' SER . 62.3 mt -126.69 148.67 65.8 Favored Pre-proline 0 N--CA 1.501 2.116 0 N-CA-C 107.852 -1.166 . . . . 0.72 107.852 178.239 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -59.86 137.82 78.75 Favored 'Trans proline' 0 N--CA 1.499 1.825 0 C-N-CA 122.192 1.928 . . . . 0.61 112.111 -179.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.31 147.49 3.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.03 -1.044 . . . . 0.66 111.319 -179.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.4 mt -125.34 144.27 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.371 -1.344 . . . . 0.79 107.371 178.434 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 23.9 m -126.77 -11.78 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 O-C-N 121.106 -0.996 . . . . 0.91 111.144 -178.602 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -109.97 24.61 18.55 Favored Glycine 0 N--CA 1.498 2.827 0 N-CA-C 109.734 -1.346 . . . . 1.01 109.734 179.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.416 HG21 ' CG2' ' A' ' 180' ' ' ILE . 3.0 p -43.3 -46.68 6.43 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.333 -1.099 . . . . 0.99 109.897 -179.008 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.491 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 95.51 -50.95 1.81 Allowed Glycine 0 N--CA 1.498 2.813 0 C-N-CA 120.218 -0.991 . . . . 1.12 111.496 178.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 46.8 t -157.07 30.87 0.3 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.245 -1.738 . . . . 1.72 110.745 -178.665 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 40.7 t -72.11 -40.04 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.096 -1.002 . . . . 0.89 109.263 178.512 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.437 ' H ' HG23 ' A' ' 209' ' ' THR . 6.4 p -54.17 -29.39 45.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.217 -0.927 . . . . 1.03 110.191 -179.301 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 47.5 t -79.78 -20.96 44.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.156 -0.965 . . . . 1.83 110.349 -178.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -96.08 -10.61 27.95 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.044 -1.035 . . . . 2.27 110.393 -179.287 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 56.2 t -106.63 136.75 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 121.281 -0.887 . . . . 0.92 111.538 -177.809 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -112.52 154.54 25.76 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.293 -1.373 . . . . 2.2 107.293 178.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 33.6 p-10 -60.5 139.63 57.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.694 -1.253 . . . . 2.36 110.389 -179.166 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.47 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.4 t0 81.03 7.66 1.2 Allowed 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 109.586 -0.524 . . . . 2.38 109.586 179.688 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 58.2 t0 -76.59 132.95 39.76 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.298 -0.876 . . . . 2.09 109.215 179.457 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.411 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 33.7 t80 -84.05 119.95 25.56 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.012 -1.107 . . . . 1.27 108.012 179.412 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.6 HD12 ' HB2' ' A' ' 16' ' ' ALA . 86.5 mt -130.42 149.82 51.92 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.334 -0.854 . . . . 0.75 110.927 -178.429 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 63.8 mt -115.22 126.62 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 106.907 -1.516 . . . . 0.63 106.907 177.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 45.1 tp -101.24 120.18 39.86 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.09 -1.006 . . . . 0.7 109.031 -178.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.472 ' C ' ' N ' ' A' ' 223' ' ' VAL . 91.8 m-20 -78.11 -46.99 19.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.088 -1.007 . . . . 2.31 110.263 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.909 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 50.05 16.45 0.24 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.115 -1.069 . . . . 0.78 108.115 -178.537 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.472 ' N ' ' C ' ' A' ' 221' ' ' ASP . 38.5 t -131.21 -47.04 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.321 -1.363 . . . . 1.04 107.321 179.235 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -99.62 3.62 45.33 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.357 -1.349 . . . . 2.44 107.357 177.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 48.6 t30 60.55 44.28 11.89 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 116.117 -0.492 . . . . 1.55 110.259 -179.938 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -144.37 156.75 44.37 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.869 -1.144 . . . . 1.99 110.273 179.603 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 79.7 t -125.96 129.94 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 109.269 -0.641 . . . . 0.77 109.269 179.791 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 67.4 m-85 -95.97 122.69 39.05 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.042 -1.036 . . . . 0.98 108.784 179.354 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 39.0 t -98.92 116.24 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.361 -0.837 . . . . 0.85 109.99 -179.157 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 63.53 68.42 0.9 Allowed Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.488 -0.757 . . . . 1.66 110.509 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -91.1 130.3 1.38 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.492 2.795 . . . . 0.95 112.471 179.7 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.483 HG22 ' N ' ' A' ' 233' ' ' ASN . 23.7 m -67.9 166.1 16.3 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.16 -0.962 . . . . 1.84 109.894 -179.461 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.483 ' N ' HG22 ' A' ' 232' ' ' THR . 69.6 m-20 -60.13 -40.0 88.26 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.248 -0.907 . . . . 2.74 110.338 -179.392 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -60.27 -37.21 79.73 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.09 -1.006 . . . . 2.89 108.972 179.804 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 70.2 t -64.73 -40.14 88.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.351 -0.843 . . . . 1.3 109.76 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 92.6 mt -64.36 -39.75 86.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.111 -0.993 . . . . 1.09 110.017 -179.784 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -60.01 -39.83 87.16 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.064 -1.023 . . . . 2.43 108.376 -179.421 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -66.39 -41.64 89.07 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.411 -0.806 . . . . 2.78 109.212 179.11 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 80.3 mtp -69.94 -31.22 68.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.423 -0.798 . . . . 1.25 109.259 -179.879 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.486 HH11 ' HG2' ' A' ' 240' ' ' ARG . 1.6 mmt-85 -64.83 -38.5 91.17 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.33 -0.856 . . . . 2.63 109.209 179.179 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.71 -41.23 90.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.165 -0.959 . . . . 1.8 109.208 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.5 t -64.99 -39.86 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.185 -0.947 . . . . 2.13 109.53 179.47 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -60.12 -40.13 88.66 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.295 -0.878 . . . . 3.17 110.583 -179.88 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -60.17 -43.52 95.77 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.154 -0.966 . . . . 1.78 109.604 -179.169 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -67.44 -40.24 85.46 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.427 -0.796 . . . . 2.47 109.413 179.509 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.5 t -66.99 -40.32 85.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.49 -0.757 . . . . 2.09 109.234 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -64.08 -36.96 85.74 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.644 -0.66 . . . . 2.54 109.658 -179.719 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 96.6 p -59.92 -40.27 88.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.216 -0.927 . . . . 2.99 109.755 -179.588 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.414 ' O ' ' OE2' ' A' ' 249' ' ' GLU . 3.7 tm-20 -66.05 -39.1 89.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.023 -1.048 . . . . 3.34 109.453 179.686 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -101.69 41.38 1.21 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.394 -0.816 . . . . 3.88 109.688 -179.086 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -152.32 25.44 0.61 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.362 -0.837 . . . . 4.43 111.004 179.837 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 81.4 mm-40 -80.05 -70.62 0.5 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.704 -1.248 . . . . 5.42 108.814 179.456 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 72.8 mt -137.78 -46.05 0.54 Allowed 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.237 -1.023 . . . . 6.1 108.237 178.493 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -162.45 -63.04 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.574 -0.704 . . . . 7.37 110.039 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 17.7 tptp 57.25 23.05 8.3 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.291 -1.003 . . . . 8.01 108.291 -179.483 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.661 ' O ' HD23 ' A' ' 256' ' ' LEU . 3.5 tt -57.29 -39.1 75.03 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.376 -0.601 . . . . 9.05 109.376 -179.445 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 256' ' ' LEU . 4.6 tppt? -36.22 132.02 0.58 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.496 -0.753 . . . . 10.56 111.749 -178.837 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 256' ' ' LEU . 4.5 p30 161.31 113.44 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.043 -1.095 . . . . 11.32 108.043 179.083 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.982 -1.009 . . . . 12.42 109.391 179.975 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 3.6 ttt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -150.54 150.32 31.09 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.367 -0.833 . . . . 0.0 109.057 179.082 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . 0.484 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 3.4 pm0 -150.18 157.83 43.52 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.135 -0.978 . . . . 0.0 110.926 -179.047 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -155.47 150.89 27.1 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 179.048 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -113.4 129.45 56.54 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.113 -0.992 . . . . 0.0 109.833 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -130.59 126.85 61.32 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.358 0 CA-C-O 122.512 1.149 . . . . 0.0 112.458 -177.737 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 31.4 m -77.99 102.37 7.35 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 115.04 -0.982 . . . . 0.0 110.925 -178.257 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 87.1 mt -51.48 123.92 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 CA-C-O 122.277 1.037 . . . . 0.0 110.053 -178.072 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 25.6 p -109.25 20.05 18.74 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 115.399 -0.818 . . . . 0.0 109.693 -178.713 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.402 ' HB1' ' O ' ' B' ' 385' ' ' GLU . . . -74.6 116.64 55.34 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.923 . . . . 0.0 108.719 179.554 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.24 -16.1 44.38 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 CA-C-N 120.362 1.165 . . . . 0.0 112.546 -179.544 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -112.27 12.15 20.26 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.523 -0.736 . . . . 0.0 109.652 -179.115 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 67.25 172.21 5.53 Favored Glycine 0 N--CA 1.484 1.857 0 N-CA-C 107.798 -2.121 . . . . 0.0 107.798 -178.913 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.425 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 2.6 tp -84.53 88.51 7.32 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.871 -1.37 . . . . 0.0 108.427 -179.133 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.535 ' N ' ' OH ' ' A' ' 122' ' ' TYR . 5.0 p80 -90.94 -161.92 0.86 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 120.74 -1.225 . . . . 0.0 109.412 178.965 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.2 m -56.82 -41.18 77.38 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.147 -0.971 . . . . 0.0 112.605 -176.223 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.59 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 2.4 tpt180 -62.5 -62.67 5.31 Favored Pre-proline 0 N--CA 1.501 2.124 0 O-C-N 120.478 -1.389 . . . . 0.0 112.159 -178.494 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.434 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 12.3 Cg_endo -57.77 -31.5 92.42 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 CA-C-N 120.004 1.037 . . . . 0.0 111.975 -179.609 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.88 -50.53 73.42 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.006 -1.059 . . . . 0.0 108.233 179.637 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.73 -40.04 59.51 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 119.921 -0.712 . . . . 0.0 109.904 -179.12 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . 0.534 ' OE1' ' NH2' ' B' ' 317' ' ' ARG . 42.3 mt-30 -69.88 -41.83 74.25 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 120.981 -1.075 . . . . 0.0 109.57 179.074 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -61.02 -52.69 63.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.33 -0.856 . . . . 0.0 110.101 -179.25 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 97.5 t -66.19 -30.79 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.798 -1.188 . . . . 0.0 110.014 -178.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 14.1 ttmt -59.36 -47.59 84.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.061 -1.024 . . . . 0.0 109.569 -179.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -65.53 -50.74 64.09 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.001 -1.062 . . . . 0.0 109.868 -179.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . 0.417 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -60.32 -51.09 71.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.677 -1.264 . . . . 0.0 110.074 -179.622 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 4.9 tppt? -48.31 -19.27 0.28 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.498 -0.751 . . . . 0.0 109.126 -179.091 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . 0.417 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -80.49 -16.11 76.62 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 179.824 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -105.54 141.07 37.65 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 121.178 -1.189 . . . . 0.0 109.694 179.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . 0.409 ' O ' HG22 ' B' ' 330' ' ' THR . 46.0 m -90.43 -12.39 37.57 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.307 -0.87 . . . . 0.0 109.165 179.211 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.435 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 95.2 p -61.32 150.02 36.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.147 -0.97 . . . . 0.0 108.862 179.412 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -71.28 135.65 47.54 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.387 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 95.9 mt -130.9 132.29 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.575 -0.703 . . . . 0.0 109.861 -179.87 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 96.7 m -130.86 147.9 52.57 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.816 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 63.0 t -121.99 119.07 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.299 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 21.6 m -103.4 121.34 42.59 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.028 -1.045 . . . . 0.0 109.145 -178.969 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 18.4 t -134.81 119.67 18.43 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.895 0.855 . . . . 0.0 110.569 -179.669 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 30.3 m120 43.89 57.61 4.03 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 177.468 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 75.26 -12.81 6.64 Favored Glycine 0 N--CA 1.498 2.779 0 O-C-N 120.578 -1.326 . . . . 0.0 112.155 177.208 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 64.5 mttp -111.96 121.13 44.16 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 120.955 -1.32 . . . . 0.0 109.959 -178.764 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 69.0 m -108.49 157.49 18.4 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.749 0.785 . . . . 0.0 110.945 -178.998 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -153.05 153.72 33.44 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.465 0.65 . . . . 0.0 109.984 179.214 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 17.7 m -91.82 136.57 33.05 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.422 -0.799 . . . . 0.0 110.598 -179.142 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.405 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -70.71 -20.95 62.62 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.256 -0.903 . . . . 0.0 109.757 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 14.3 ptpt -84.07 18.69 2.01 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.24 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . 0.405 ' H ' ' C ' ' B' ' 344' ' ' ALA . 13.2 m -148.49 93.14 2.1 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 121.72 0.771 . . . . 0.0 111.273 -179.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 1.005 HD23 HD22 ' A' ' 79' ' ' LEU . 55.6 tp -56.29 -35.46 67.52 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.211 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.759 ' CE2' HD11 ' A' ' 79' ' ' LEU . 50.0 m-85 -56.16 -50.02 72.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.54 -0.725 . . . . 0.0 110.575 -179.06 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -69.85 -39.86 76.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.705 -1.247 . . . . 0.0 110.243 -178.601 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.551 ' O ' ' N ' ' B' ' 352' ' ' THR . 38.0 mt -50.04 -56.01 12.5 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.732 -1.23 . . . . 0.0 108.165 179.481 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.91 ' O ' HD22 ' A' ' 123' ' ' LEU . 0.0 OUTLIER -41.36 -17.05 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.535 -0.728 . . . . 0.0 110.747 -179.151 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.551 ' N ' ' O ' ' B' ' 350' ' ' LEU . 52.7 p -85.87 -13.69 47.18 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.037 -1.665 . . . . 0.0 110.281 -178.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 29.4 mt -95.04 122.5 37.76 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.106 -0.996 . . . . 0.0 109.057 178.666 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.21 96.3 1.1 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.974 -2.05 . . . . 0.0 107.974 178.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 46.2 mt -102.33 90.38 3.88 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.293 -1.122 . . . . 0.0 109.925 -179.37 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 21.1 p -97.6 -177.43 3.79 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.267 -0.896 . . . . 0.0 111.253 -179.46 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 39.0 tt0 -69.74 111.76 5.74 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.9 -179.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.2 10.84 35.51 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 109.739 -1.345 . . . . 0.0 109.739 179.267 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 28.5 m -87.12 108.58 18.96 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.059 -1.26 . . . . 0.0 110.791 -179.579 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 32.4 t -77.89 113.79 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 CA-C-O 122.058 0.933 . . . . 0.0 109.521 -178.204 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 34.7 m -109.68 178.28 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.409 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 19.1 m -130.43 123.18 29.21 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.522 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.5 mt -97.69 111.57 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 178.834 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 52.2 p -116.3 130.48 56.8 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.212 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.45 150.51 37.78 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.229 -0.92 . . . . 0.0 109.48 -178.82 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -142.07 123.61 14.97 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.413 -0.804 . . . . 0.0 108.891 179.581 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.591 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.31 -162.64 33.43 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.395 -1.383 . . . . 0.0 111.057 -179.845 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -59.91 -50.33 74.2 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 122.207 -0.584 . . . . 0.0 112.518 -177.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.435 ' H ' ' HB3' ' B' ' 331' ' ' SER . 71.8 m-20 -106.38 10.61 31.5 Favored 'General case' 0 N--CA 1.506 2.368 0 O-C-N 120.668 -1.27 . . . . 0.0 110.92 -177.575 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.591 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.3 pt-20 -44.19 -34.87 2.0 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.29 -0.882 . . . . 0.0 111.45 -179.236 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -70.55 -41.19 72.8 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.876 -1.14 . . . . 0.0 110.017 -179.414 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -67.06 -47.14 72.19 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.264 -0.897 . . . . 0.0 109.341 -179.307 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.24 -74.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.341 -0.849 . . . . 0.0 110.848 -179.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.598 ' O ' HG23 ' B' ' 378' ' ' VAL . 64.3 t -45.87 -34.74 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.93 -1.106 . . . . 0.0 110.871 -177.434 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.17 -47.78 72.86 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.361 -1.462 . . . . 0.0 110.592 179.613 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -78.82 -44.11 23.78 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.969 -1.082 . . . . 0.0 110.628 -179.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.99 -36.26 76.8 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.159 -0.963 . . . . 0.0 109.383 -179.637 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.598 HG23 ' O ' ' B' ' 374' ' ' VAL . 39.8 t -63.05 -43.91 99.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.109 -0.994 . . . . 0.0 109.287 179.736 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -69.96 -56.84 5.95 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.605 -1.309 . . . . 0.0 108.248 178.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 36.1 tp -55.72 -32.21 63.15 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.435 -0.791 . . . . 0.0 109.682 -178.123 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 26.2 ttm -71.97 -40.49 68.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.57 -1.331 . . . . 0.0 109.319 178.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.14 -3.93 57.85 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.458 -0.776 . . . . 0.0 110.17 179.662 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -111.75 -4.39 14.68 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.196 -0.94 . . . . 0.0 110.917 -179.352 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.7 mt -80.45 133.67 35.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.36 -1.463 . . . . 0.0 109.365 179.062 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . 0.402 ' O ' ' HB1' ' B' ' 310' ' ' ALA . 45.3 mt-10 . . . . . 0 N--CA 1.496 1.849 0 CA-C-O 118.039 -0.982 . . . . 0.0 109.324 -179.964 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.5 mtt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.365 -0.606 . . . . 2.91 109.365 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.4 mt -109.89 129.92 63.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.447 -0.783 . . . . 1.2 109.366 -179.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 m -138.83 118.78 13.32 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -0.888 . . . . 1.4 108.771 179.799 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.733 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -91.83 -161.0 36.61 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 109.572 -1.411 . . . . 1.05 109.572 -179.848 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.463 HG22 ' O ' ' A' ' 5' ' ' ILE . 87.0 mt -94.95 -10.42 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.259 -1.142 . . . . 1.15 110.653 -178.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.1 tp 55.01 100.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.977 -1.077 . . . . 0.98 109.183 -179.502 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -83.96 -34.23 24.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.88 108.936 179.56 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.0 t -139.14 133.4 16.21 Favored Pre-proline 0 N--CA 1.499 2.022 0 O-C-N 121.497 -0.752 . . . . 1.69 109.231 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -80.27 143.74 15.91 Favored 'Trans proline' 0 N--CA 1.5 1.864 0 C-N-CA 122.193 1.929 . . . . 0.85 112.672 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.708 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 163.49 -162.03 34.59 Favored Glycine 0 N--CA 1.494 2.52 0 N-CA-C 109.792 -1.323 . . . . 0.92 109.792 179.661 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.6 mt -148.02 146.88 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.169 -1.195 . . . . 0.81 108.334 179.023 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -157.19 159.62 37.9 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.829 -1.169 . . . . 0.51 110.656 179.649 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.535 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.8 m-85 -137.93 127.45 24.97 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 107.547 -1.279 . . . . 0.62 107.547 178.859 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.59 177.22 48.31 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 118.452 -1.832 . . . . 0.55 110.965 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -78.74 159.5 27.9 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.782 -0.834 . . . . 2.1 110.107 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.94 123.46 45.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.549 -0.719 . . . . 0.77 110.994 -179.028 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.2 tp -99.3 134.06 42.7 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 106.498 -1.667 . . . . 0.91 106.498 177.566 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.6 tp -117.63 122.81 44.59 Favored 'General case' 0 N--CA 1.505 2.288 0 O-C-N 121.146 -0.971 . . . . 0.93 109.908 -179.354 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 56.4 mt -87.32 104.54 16.51 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 121.476 0.655 . . . . 0.93 109.986 -179.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -92.47 136.0 33.58 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.681 -0.859 . . . . 2.75 108.681 179.754 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -130.57 139.05 50.43 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.323 -0.86 . . . . 3.0 109.623 179.76 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -93.47 140.79 29.19 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.243 -0.91 . . . . 2.77 109.122 179.656 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -59.94 139.97 57.03 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.166 -0.959 . . . . 2.94 109.634 -179.849 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -79.69 131.81 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.906 . . . . 0.95 108.757 179.889 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.5 t -93.91 124.88 46.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.132 -0.98 . . . . 1.28 110.053 -179.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.3 mt -101.0 139.97 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 121.403 -0.811 . . . . 1.21 109.036 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -98.5 115.76 29.27 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.08 -1.012 . . . . 1.81 109.88 -179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -90.98 0.07 57.62 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.213 -0.93 . . . . 2.8 108.969 179.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.0 mtpt -62.67 143.46 57.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.441 -0.787 . . . . 2.87 109.695 -179.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -83.7 139.39 32.79 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.413 -0.805 . . . . 2.35 109.873 -179.671 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.565 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.3 pt -89.83 165.28 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.257 -0.902 . . . . 0.97 109.807 -179.824 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 76.8 p -89.71 170.59 10.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.235 -0.915 . . . . 1.17 108.812 178.783 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.36 -22.02 64.69 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.988 -1.07 . . . . 1.18 109.939 -179.852 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -82.13 -24.65 34.99 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.529 -1.286 . . . . 2.56 107.529 178.71 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -82.04 -9.8 59.43 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.547 -0.908 . . . . 1.79 108.547 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 20.3 t -62.94 -52.49 58.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.099 -1.001 . . . . 1.0 108.903 179.759 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -63.2 -39.89 95.93 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.259 -0.901 . . . . 1.77 109.466 179.661 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 -67.32 -41.11 85.84 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.03 -1.044 . . . . 2.7 110.292 -178.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.565 ' HG3' HG21 ' A' ' 31' ' ' ILE . 61.9 mm-40 -66.51 -39.99 88.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.15 -0.968 . . . . 1.51 110.129 -179.666 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.45 -44.51 96.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 120.766 -1.208 . . . . 0.93 108.186 178.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -59.94 -36.08 76.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.319 -0.863 . . . . 1.81 109.472 -179.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.534 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 99.1 mtt180 -59.75 -40.32 87.72 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 118.71 -1.196 . . . . 2.78 108.114 179.522 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -63.83 -48.28 77.43 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.33 -0.856 . . . . 0.78 108.706 177.82 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.6 tp -60.09 -48.86 79.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.46 -0.775 . . . . 1.07 109.216 -179.717 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.9 t -64.86 -45.11 87.42 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 119.218 -0.993 . . . . 1.12 108.993 179.557 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.47 -45.06 96.95 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 108.26 -1.936 . . . . 0.84 108.26 179.098 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -65.6 -31.63 72.77 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.389 -0.967 . . . . 3.09 108.389 178.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.0 87.45 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.451 -0.781 . . . . 0.88 109.019 179.99 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.443 ' O ' ' N ' ' A' ' 51' ' ' SER . 11.9 ttmm -65.51 -73.8 0.12 Allowed 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.752 -1.203 . . . . 2.59 107.752 179.025 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.443 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.72 -32.08 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.552 -0.718 . . . . 0.7 111.222 -178.42 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 49' ' ' LYS . 29.7 t -59.74 -54.65 43.9 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.771 -1.205 . . . . 1.4 108.109 179.141 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.53 -41.02 85.01 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.383 -0.823 . . . . 0.67 111.292 -179.126 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -67.55 -40.54 84.98 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.726 -1.234 . . . . 1.66 110.037 -179.135 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 61.3 mt -64.85 -40.14 94.69 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.894 -1.129 . . . . 1.58 108.41 179.661 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -61.36 -39.95 92.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.26 -0.9 . . . . 1.35 109.35 178.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 87.9 m -67.13 -44.06 80.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.113 -0.992 . . . . 0.77 109.645 -179.854 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.55 -39.99 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.158 -0.964 . . . . 0.63 108.86 179.667 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -53.88 -50.64 65.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.501 -0.75 . . . . 1.14 110.034 -179.368 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -60.0 -38.8 83.68 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.449 -0.782 . . . . 0.79 111.134 -177.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -63.55 -39.67 95.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.833 -1.167 . . . . 1.53 109.613 -179.621 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.21 -43.89 93.64 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-O 121.365 0.602 . . . . 0.57 109.769 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.43 -52.48 52.94 Favored Glycine 0 N--CA 1.488 2.143 0 C-N-CA 120.009 -1.091 . . . . 0.75 110.536 -179.066 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -69.87 -44.81 69.07 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.073 -1.251 . . . . 1.59 110.465 -179.169 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.4 m -66.23 -62.28 1.56 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.999 -1.063 . . . . 0.73 112.24 -178.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -95.61 -49.56 5.33 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.889 -1.132 . . . . 0.75 111.171 -178.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.22 -167.72 25.99 Favored Glycine 0 N--CA 1.499 2.858 0 C-N-CA 119.843 -1.17 . . . . 1.22 110.905 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -69.94 -23.74 63.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.802 -0.823 . . . . 5.81 110.461 -179.344 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.423 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.7 tp10 -60.07 -36.02 76.45 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.254 -0.904 . . . . 3.37 110.211 179.923 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -98.23 -19.39 17.88 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.177 -0.952 . . . . 1.77 110.225 -179.283 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -70.12 -45.46 66.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.96 -1.087 . . . . 1.65 110.55 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.592 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -62.95 -30.58 71.68 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.433 -0.792 . . . . 0.77 110.235 -178.626 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.5 mt -59.72 -40.29 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.963 -1.086 . . . . 0.8 108.871 -179.588 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -65.05 -39.96 94.07 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.031 -1.043 . . . . 0.88 109.987 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -60.21 -40.06 88.79 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.965 -1.085 . . . . 1.37 109.444 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.5 -41.84 99.64 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.16 -1.576 . . . . 0.62 109.16 179.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -67.66 -39.98 84.51 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.283 -1.128 . . . . 1.5 109.728 -179.956 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 95.4 mt -69.1 -46.4 78.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.005 -1.06 . . . . 0.63 109.104 179.555 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.3 ttp -59.9 -45.93 90.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.041 -1.037 . . . . 1.51 110.425 -179.239 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.873 HD22 HD23 ' B' ' 347' ' ' LEU . 55.2 tp -60.93 -40.07 91.84 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.245 -0.91 . . . . 0.77 109.809 179.792 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.7 tp -63.14 -40.01 96.35 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.376 -0.828 . . . . 0.62 109.642 -179.047 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -82.46 9.18 9.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.37 -0.831 . . . . 1.47 109.901 -179.34 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -55.68 132.3 48.69 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.991 -1.068 . . . . 1.47 110.139 -179.246 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -59.94 -21.21 60.85 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.511 -0.743 . . . . 1.78 111.129 -178.562 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -72.03 -34.51 68.87 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.787 -1.196 . . . . 2.53 109.686 178.93 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 83.2 mt -69.9 -40.77 75.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.539 -0.726 . . . . 0.8 109.76 -179.687 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -60.11 -50.1 75.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.328 -0.857 . . . . 1.42 110.413 -179.137 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -70.61 -40.1 73.37 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.187 -0.945 . . . . 1.71 111.439 -179.171 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -69.91 -40.12 75.79 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.94 -1.1 . . . . 1.57 111.489 -178.569 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.57 -41.97 83.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.076 -1.015 . . . . 0.65 109.422 -179.505 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -70.02 -37.84 73.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.432 -0.792 . . . . 0.82 110.602 179.793 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.0 -46.28 89.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.79 110.803 -178.592 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 96' ' ' LYS . 29.3 mt -63.27 -45.83 89.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.755 -1.216 . . . . 0.95 109.411 -179.741 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.08 -50.0 81.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-O 121.954 0.883 . . . . 0.66 108.796 179.523 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.2 mtmt -70.2 -41.0 74.26 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.851 -0.74 . . . . 2.2 110.258 179.616 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -80.38 -53.05 6.97 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.062 -1.024 . . . . 1.65 112.252 -177.877 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 92' ' ' LEU . 25.9 mtpp -89.96 -3.92 57.76 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.023 -1.048 . . . . 2.03 111.854 -177.395 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 25.9 m170 58.62 38.82 25.12 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.988 -1.07 . . . . 1.42 109.306 -179.362 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.0 mtp -97.87 165.81 11.76 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.592 -0.692 . . . . 1.18 109.959 -179.526 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 46.4 p -76.65 162.22 27.91 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.402 -0.811 . . . . 0.98 109.586 -179.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.82 -37.18 79.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.335 -0.853 . . . . 0.64 110.482 -179.479 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 35.2 p-10 -69.96 -36.94 75.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.86 -1.15 . . . . 2.07 109.633 179.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.498 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -77.04 -44.97 28.81 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.4 -0.813 . . . . 0.73 109.843 -179.982 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.02 -41.65 74.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.26 -0.9 . . . . 0.54 109.523 179.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.16 -37.94 81.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.065 -1.022 . . . . 0.56 109.71 179.651 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -60.11 -41.01 91.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.436 -0.79 . . . . 1.54 109.938 -178.679 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -63.04 -40.12 96.78 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.271 -0.893 . . . . 1.33 110.383 -179.447 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.2 t -66.74 -55.77 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.108 -0.995 . . . . 0.72 111.542 -177.797 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.417 HG21 ' HA3' ' A' ' 134' ' ' GLY . 47.3 mm -70.08 -40.04 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.645 -1.284 . . . . 0.85 109.22 -178.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -69.95 -38.11 76.03 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.344 -0.984 . . . . 2.44 108.344 178.869 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.08 -46.77 93.61 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.82 -1.312 . . . . 0.98 109.82 -179.712 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -64.88 -49.04 72.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.894 -1.356 . . . . 1.41 108.866 179.577 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.87 -39.68 86.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.465 -0.772 . . . . 1.2 109.269 179.615 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.5 t -54.85 -40.0 69.18 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.326 -0.859 . . . . 1.7 109.035 -179.892 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.81 -36.74 78.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.913 . . . . 1.47 109.917 179.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.35 -46.17 81.27 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.09 -1.006 . . . . 1.56 110.558 -178.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -62.89 -22.06 66.45 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.495 -1.378 . . . . 2.2 110.268 -179.432 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -67.43 -21.08 65.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.803 -1.185 . . . . 2.12 108.566 178.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 123' ' ' LEU . 19.4 mt -63.88 142.51 58.38 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 108.158 -1.053 . . . . 2.0 108.158 179.245 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 119' ' ' ASP . 29.4 p-10 -90.78 53.24 2.35 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.873 -1.142 . . . . 3.23 110.516 -179.65 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 64.9 t0 -136.33 135.07 38.58 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.176 -0.953 . . . . 2.49 109.795 179.331 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.477 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 99.2 mt-10 -70.17 -32.54 70.54 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.297 -0.877 . . . . 3.95 110.447 -179.881 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.495 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.9 t80 -70.08 -37.22 75.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.257 -0.902 . . . . 2.0 110.46 179.538 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.56 HD13 HD13 ' A' ' 118' ' ' LEU . 77.1 mt -74.0 -39.95 63.26 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.236 -0.915 . . . . 1.86 109.256 -179.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.8 -44.32 96.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.194 -0.941 . . . . 2.84 109.964 179.538 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 45.8 mt-10 -60.1 -41.3 92.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.111 -0.993 . . . . 2.73 109.29 -179.752 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.55 HH21 HD23 ' A' ' 123' ' ' LEU . 9.9 ttp180 -66.73 -38.74 87.28 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.153 -1.054 . . . . 2.77 108.153 179.057 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.21 -26.22 64.66 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.077 -1.083 . . . . 1.19 108.077 178.62 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -69.79 -40.25 76.12 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.111 -1.07 . . . . 1.2 108.111 178.709 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -64.79 -40.15 94.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.405 -0.809 . . . . 1.55 109.206 179.693 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.53 -39.98 86.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.278 -1.008 . . . . 0.8 108.278 179.471 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.5 ttp180 -60.28 -39.88 88.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.479 -0.763 . . . . 3.09 109.125 179.267 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 63.7 t0 -58.14 -40.24 80.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 1.46 109.888 -179.269 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.01 -46.69 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.998 -1.064 . . . . 0.71 109.42 -179.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.417 ' HA3' HG21 ' A' ' 108' ' ' ILE . . . -69.79 -31.54 70.25 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.791 -1.324 . . . . 0.57 109.791 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -59.69 -49.67 76.84 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.244 -1.151 . . . . 2.59 109.208 -179.477 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.521 HH11 ' HG2' ' A' ' 136' ' ' ARG . 17.6 mtt-85 -67.07 -36.01 81.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.08 -1.012 . . . . 2.83 109.67 179.672 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.8 tp -54.54 -49.01 71.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.476 -0.765 . . . . 1.25 109.801 -178.726 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.09 -40.07 88.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.369 -0.832 . . . . 0.7 109.565 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.0 mtm180 -72.78 -36.1 67.55 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.264 -0.897 . . . . 2.57 108.661 178.542 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.401 ' CG ' ' O ' ' A' ' 136' ' ' ARG . 6.2 m120 -60.15 -39.75 87.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.836 -0.54 . . . . 1.23 110.97 -179.227 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.8 mt -71.09 -45.13 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.758 -1.214 . . . . 0.81 108.65 179.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.6 mt -69.97 -40.07 75.61 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.523 -0.871 . . . . 1.0 108.949 179.777 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.68 51.57 3.04 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.072 -1.611 . . . . 0.89 109.072 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.6 tp -73.72 148.57 42.53 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.314 -1.109 . . . . 1.14 109.009 -179.543 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -66.57 141.22 57.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 4.6 109.641 -179.682 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.2 mt -113.53 130.0 68.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 CA-C-O 121.762 0.791 . . . . 1.24 110.069 -179.578 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 1.3 mp -68.01 -40.09 82.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.746 -0.596 . . . . 1.54 110.309 -178.599 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.3 t0 63.29 123.25 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.396 -0.815 . . . . 1.5 108.947 -178.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 24.9 mt -90.13 -0.74 57.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.249 -0.907 . . . . 0.79 110.088 -179.06 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.5 t -86.08 -17.49 34.95 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.042 -1.036 . . . . 1.4 110.17 -179.553 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.98 24.8 0.73 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.139 -0.975 . . . . 0.92 110.734 -178.838 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 41.8 mm -90.82 120.69 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 120.77 -1.206 . . . . 0.88 109.276 179.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.5 pt20 -101.23 -17.51 16.56 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.436 -0.79 . . . . 2.45 110.259 -179.379 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -115.34 145.97 41.99 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.637 -0.665 . . . . 1.52 110.874 -178.846 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -63.8 135.23 56.46 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.523 -0.736 . . . . 1.58 109.4 -179.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 35.0 m -151.55 164.57 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.649 -0.657 . . . . 0.69 109.452 179.39 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 86.0 mt -94.96 147.2 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 105.999 -1.852 . . . . 0.61 105.999 177.474 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 51.9 tp -96.99 117.96 32.32 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.035 -1.04 . . . . 0.87 110.767 -177.374 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.539 HG12 HG22 ' A' ' 209' ' ' THR . 42.3 t -121.75 127.47 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 108.451 -0.944 . . . . 0.71 108.451 178.846 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -156.91 161.53 39.65 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.322 -0.861 . . . . 0.81 108.717 -179.851 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.93 -31.71 63.19 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.26 -1.525 . . . . 0.98 109.172 179.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 64.9 t0 -169.23 141.92 2.64 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.434 -0.791 . . . . 2.25 109.128 -179.706 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 24.6 mt -112.08 142.71 44.17 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.362 -0.837 . . . . 0.78 110.226 -179.24 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 68.0 p -99.56 146.8 32.42 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.466 -0.771 . . . . 0.98 109.247 179.449 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -43.56 -36.7 7.33 Favored 'Trans proline' 0 N--CA 1.495 1.599 0 C-N-CA 121.952 1.768 . . . . 0.81 112.691 179.215 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.6 m -60.0 -39.94 87.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.267 -0.896 . . . . 0.9 109.767 -178.72 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -65.46 -41.31 93.52 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.187 -0.945 . . . . 1.61 109.992 -179.404 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 41.1 p -56.44 -33.94 66.34 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.61 110.959 -178.4 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -68.4 -53.9 20.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.91 -1.119 . . . . 0.6 109.58 -179.966 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -86.47 36.34 0.69 Allowed 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.604 -0.888 . . . . 1.4 108.604 179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 54.2 tp -100.46 130.6 46.57 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.817 . . . . 0.7 109.166 179.102 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.55 HD22 ' C ' ' A' ' 172' ' ' ASN . 0.2 OUTLIER -82.79 98.96 9.39 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.276 -1.009 . . . . 2.35 108.276 179.412 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 71.0 mt -65.13 -41.14 95.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.403 -0.811 . . . . 1.51 111.085 -178.569 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -66.61 -25.59 66.68 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.844 -1.16 . . . . 2.33 111.571 -177.752 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.419 ' H ' ' ND2' ' A' ' 172' ' ' ASN . 42.8 mmtm -93.32 -8.2 42.68 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.768 -1.207 . . . . 1.92 110.479 -179.037 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 178' ' ' GLY . 63.3 t -109.31 119.65 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 N-CA-C 108.385 -0.968 . . . . 0.67 108.385 178.578 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.8 mt -91.42 7.1 42.78 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.262 -0.899 . . . . 1.53 110.947 -177.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.496 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.44 171.07 36.97 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.355 -1.402 . . . . 0.48 109.626 179.735 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.473 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 12.9 m-85 -133.94 129.76 36.74 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.463 -1.022 . . . . 0.55 109.066 179.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.3 mt -132.1 127.28 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.235 -1.024 . . . . 0.65 108.235 178.428 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 43.1 p -147.44 159.93 43.15 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.879 -1.138 . . . . 0.82 110.406 -179.69 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.5 OUTLIER -104.27 21.74 16.04 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.914 -0.773 . . . . 2.46 108.914 179.813 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.14 -159.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.995 -1.066 . . . . 1.28 111.202 -178.094 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.46 -53.15 8.99 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.357 -1.097 . . . . 2.19 110.357 -179.238 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 157.07 -124.27 1.41 Allowed Glycine 0 N--CA 1.494 2.558 0 O-C-N 120.897 -1.355 . . . . 2.13 110.64 -179.916 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -69.69 -23.9 63.5 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.39 -1.065 . . . . 5.86 111.014 -178.815 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 59.8 p -70.53 0.12 7.4 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.928 -1.107 . . . . 3.72 109.756 -179.29 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 39.2 m -89.46 124.7 34.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.08 -1.013 . . . . 1.74 110.119 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -46.48 -50.87 16.36 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.436 -0.79 . . . . 0.95 109.924 -179.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -53.82 -35.59 61.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.402 -0.811 . . . . 1.55 110.549 -178.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 32.5 t -60.07 -45.6 92.35 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.929 -1.107 . . . . 1.51 110.73 -179.185 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.08 -40.64 83.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 1.67 109.735 -179.409 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 96.0 mtp -61.44 -40.03 92.99 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.084 -1.01 . . . . 1.02 109.964 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -53.61 -42.71 67.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.737 -1.227 . . . . 0.68 108.915 179.939 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -59.57 -50.06 75.36 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.461 -0.895 . . . . 2.93 109.517 -179.02 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 67.1 m -72.4 -33.13 66.96 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.204 -0.935 . . . . 0.86 111.114 -179.221 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.05 -22.81 63.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.952 -1.093 . . . . 0.67 109.515 -179.5 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 63.71 48.78 3.17 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 121.437 0.636 . . . . 1.5 110.055 -178.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 60.1 mt -130.25 150.1 75.19 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 107.797 -1.186 . . . . 0.72 107.797 178.693 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.56 144.98 62.71 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.949 1.766 . . . . 0.61 111.567 179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -173.36 153.56 2.43 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.064 -1.055 . . . . 0.66 111.102 179.688 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 92.7 mt -124.72 151.62 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 N-CA-C 107.669 -1.234 . . . . 0.79 107.669 178.832 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.0 m -133.67 -11.44 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.303 0 O-C-N 120.844 -1.16 . . . . 0.91 111.249 -178.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -111.17 25.73 13.49 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 110.655 -0.978 . . . . 1.01 110.655 -179.375 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.448 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 3.3 p -47.46 -38.21 13.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.759 -1.436 . . . . 0.99 109.595 -179.206 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.18 -51.06 3.4 Favored Glycine 0 N--CA 1.495 2.617 0 C-N-CA 120.085 -1.055 . . . . 1.12 111.257 178.782 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.414 ' O ' ' OG ' ' A' ' 207' ' ' SER . 12.9 t -156.51 33.24 0.32 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.558 -1.554 . . . . 1.72 111.4 -178.83 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 22.8 t -74.52 -36.02 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.66 -1.275 . . . . 0.89 108.348 178.159 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.539 HG22 HG12 ' A' ' 159' ' ' VAL . 44.4 p -59.97 -38.37 82.32 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.449 -0.782 . . . . 1.03 110.159 -179.553 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 50.4 m -82.01 -11.06 59.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.995 -1.065 . . . . 1.83 110.308 -179.162 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -99.05 -13.23 19.95 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.043 -1.036 . . . . 2.27 110.601 -179.231 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.482 HG12 ' N ' ' A' ' 213' ' ' LYS . 80.8 t -114.62 154.0 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 O-C-N 121.247 -0.908 . . . . 0.92 110.955 -178.74 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.482 ' N ' HG12 ' A' ' 212' ' ' VAL . 12.1 mptt -113.17 154.56 26.47 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.261 -1.385 . . . . 2.2 107.261 178.658 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 24.8 p-10 -59.82 141.52 55.17 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.974 -1.078 . . . . 2.36 110.134 -179.461 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 1.2 m-20 85.67 6.36 0.43 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.213 0.53 . . . . 2.38 110.032 179.692 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 53.2 t0 -76.62 150.16 36.46 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.262 -0.898 . . . . 2.09 108.71 179.037 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.526 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 50.8 t80 -95.25 122.85 38.38 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.066 -1.021 . . . . 1.27 108.844 179.725 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 89.0 mt -126.88 138.5 53.32 Favored 'General case' 0 N--CA 1.502 2.125 0 O-C-N 121.299 -0.875 . . . . 0.75 110.702 -179.288 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.4 HG23 ' CD2' ' A' ' 13' ' ' PHE . 83.6 mt -110.19 128.25 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 N-CA-C 106.453 -1.684 . . . . 0.63 106.453 176.385 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 42.9 tp -103.36 119.92 39.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.065 -1.022 . . . . 0.7 109.901 -178.302 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 10' ' ' GLY . 30.9 t0 -83.44 -41.75 17.73 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.631 -0.877 . . . . 2.31 108.631 179.259 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.708 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.84 25.35 0.72 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.927 -0.768 . . . . 0.78 108.927 -179.574 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 37.4 t -130.74 -42.27 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 N-CA-C 107.329 -1.36 . . . . 1.04 107.329 178.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.528 ' ND2' ' OE1' ' A' ' 226' ' ' GLN . 50.7 p30 -111.34 1.66 17.2 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.04 -1.467 . . . . 2.44 107.04 178.228 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.733 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.5 OUTLIER 62.15 50.12 4.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.93 -0.577 . . . . 1.55 110.258 -179.794 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.528 ' OE1' ' ND2' ' A' ' 224' ' ' ASN . 52.5 mt-30 -132.12 145.0 51.1 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.308 -0.87 . . . . 1.99 109.426 179.324 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 66.5 t -118.36 129.08 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.345 -0.983 . . . . 0.77 108.345 179.013 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -104.29 124.56 49.39 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 108.385 -0.969 . . . . 0.98 108.385 179.446 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.7 t -101.25 110.69 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.471 -0.768 . . . . 0.85 110.005 -179.492 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 230' ' ' ASN . 30.9 t-20 48.64 67.01 4.92 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.31 -0.868 . . . . 1.66 110.571 179.541 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -86.72 157.22 8.96 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.843 2.362 . . . . 0.95 111.96 179.304 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.4 m -69.86 161.63 29.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.33 -0.856 . . . . 1.84 110.216 -179.071 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 22.2 m120 -60.04 -39.2 85.11 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.381 -0.824 . . . . 2.74 109.733 -179.689 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 51.2 tp10 -60.04 -37.02 78.57 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.208 -0.932 . . . . 2.89 109.56 -179.146 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.27 -40.75 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.017 -1.052 . . . . 1.3 109.123 179.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.3 mt -66.13 -40.0 85.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.44 -0.788 . . . . 1.09 109.764 179.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -59.87 -39.96 87.0 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.993 -1.067 . . . . 2.43 108.436 179.734 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -66.58 -40.42 88.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 2.78 108.818 178.795 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 94.0 mtp -69.69 -33.48 72.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.513 -0.742 . . . . 1.25 109.405 179.605 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 20.4 mmm180 -68.44 -40.01 81.3 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.246 -0.909 . . . . 2.63 109.323 179.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.08 89.96 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.605 -0.887 . . . . 1.8 108.605 179.223 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 70.0 t -66.99 -40.77 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.358 -0.839 . . . . 2.13 109.252 179.99 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -60.06 -40.5 89.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 3.17 109.272 179.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.01 -42.02 97.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 1.78 109.742 179.593 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 92.0 mt-30 -60.98 -40.01 91.82 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.255 -0.903 . . . . 2.47 108.92 179.866 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 77.8 t -59.87 -40.77 83.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.399 -0.813 . . . . 2.09 109.414 -179.557 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.95 -41.69 99.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.196 -0.94 . . . . 2.54 109.21 179.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.0 t -60.43 -40.18 90.13 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.267 -0.896 . . . . 2.99 109.158 179.663 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.99 -35.53 75.21 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.589 -0.694 . . . . 3.34 109.427 179.788 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -59.93 -40.07 87.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -0.93 . . . . 3.88 109.558 -179.546 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -59.9 -44.72 94.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 4.43 109.309 -179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -60.22 -39.88 88.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.504 -0.748 . . . . 5.42 109.612 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 255' ' ' LYS . 83.1 mt -60.12 -46.97 87.83 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.43 -0.794 . . . . 6.1 109.113 179.69 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 255' ' ' LYS . . . 45.21 22.03 0.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.356 -0.84 . . . . 7.37 110.204 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.52 ' C ' ' H ' ' A' ' 257' ' ' LYS . 59.8 mttm 48.05 -176.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.137 -0.977 . . . . 8.01 109.733 179.625 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.559 ' O ' HD13 ' A' ' 256' ' ' LEU . 0.2 OUTLIER 70.62 -31.77 0.23 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.12 -0.987 . . . . 9.05 109.333 -179.865 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.52 ' H ' ' C ' ' A' ' 255' ' ' LYS . 16.0 mtpp 50.58 58.6 5.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.768 -1.208 . . . . 10.56 109.2 -179.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 259' ' ' ARG . 29.8 p-10 -54.47 -47.5 72.89 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.101 -0.999 . . . . 11.32 109.245 -179.444 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.509 ' N ' ' OD1' ' A' ' 258' ' ' ASP . 18.4 ptt-85 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.007 -0.997 . . . . 12.42 109.503 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 35.1 ttp . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.391 0.615 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -153.13 149.01 27.62 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -149.33 160.03 43.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.845 -1.159 . . . . 0.0 110.506 -179.441 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -152.41 149.69 28.86 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.844 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 57.4 mp0 -107.84 130.69 54.97 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.239 -0.913 . . . . 0.0 109.555 179.381 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.83 119.09 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 CA-C-O 122.316 1.055 . . . . 0.0 112.503 -177.726 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 94.9 m -76.86 104.07 7.15 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 122.159 0.98 . . . . 0.0 110.115 -178.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.542 HD12 ' HB ' ' B' ' 359' ' ' THR . 66.0 mt -52.56 116.35 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 122.35 1.072 . . . . 0.0 110.61 -178.017 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 30.5 p -102.08 22.3 13.37 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.632 -178.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.406 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -81.41 123.21 81.34 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.093 179.463 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -70.09 -9.02 25.03 Favored 'Trans proline' 0 N--CA 1.496 1.622 0 CA-C-N 120.203 1.108 . . . . 0.0 112.058 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -119.76 4.22 11.05 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 75.7 178.52 43.64 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 -178.711 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.495 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -88.49 97.21 10.95 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.129 -1.218 . . . . 0.0 108.389 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.447 ' CE1' ' H ' ' B' ' 317' ' ' ARG . 6.9 p80 -95.0 -160.62 0.8 Allowed 'General case' 0 N--CA 1.506 2.36 0 O-C-N 121.097 -1.002 . . . . 0.0 110.034 179.677 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 19.5 m -59.9 -42.05 92.99 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.017 -1.052 . . . . 0.0 112.681 -175.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.592 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.3 tpt180 -61.82 -64.2 3.36 Favored Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 120.229 -1.544 . . . . 0.0 111.396 -178.313 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -55.38 -32.46 81.75 Favored 'Trans proline' 0 N--CA 1.491 1.357 0 CA-C-N 120.096 1.07 . . . . 0.0 111.929 -179.771 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.88 -51.6 69.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.17 -0.956 . . . . 0.0 108.845 179.525 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.51 -40.07 65.11 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.354 -0.841 . . . . 0.0 109.652 -179.274 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . 0.526 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 73.1 tp60 -68.21 -45.19 74.01 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.958 -1.089 . . . . 0.0 108.961 179.258 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -60.0 -50.83 72.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.485 -0.759 . . . . 0.0 110.52 -179.245 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.55 -30.69 50.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.623 -1.298 . . . . 0.0 109.698 -179.166 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.526 ' NZ ' ' OE1' ' B' ' 321' ' ' GLN . 0.4 OUTLIER -59.96 -45.38 92.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.312 -0.868 . . . . 0.0 109.093 179.701 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 50.7 tp10 -68.28 -40.06 81.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.392 -0.818 . . . . 0.0 110.951 -178.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' B' ' 328' ' ' GLY . . . -74.08 -53.97 8.82 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.752 -1.218 . . . . 0.0 111.252 -178.74 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 17.5 ttmm -49.51 -14.6 0.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 0.0 110.336 -178.581 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' B' ' 326' ' ' ALA . . . -79.98 -16.27 77.24 Favored Glycine 0 N--CA 1.493 2.465 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.0 -179.897 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -105.73 143.31 34.06 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.378 -1.072 . . . . 0.0 109.308 179.577 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 31.8 m -90.19 -12.46 38.05 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.984 -1.072 . . . . 0.0 110.301 -179.564 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.432 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 13.5 p -60.49 145.01 49.99 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.93 -1.106 . . . . 0.0 109.232 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -67.66 137.06 55.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.087 -1.008 . . . . 0.0 108.75 179.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.3 mt -134.04 134.02 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.535 -0.728 . . . . 0.0 110.137 -179.194 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 51.9 m -129.36 149.02 51.32 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.446 -0.784 . . . . 0.0 109.164 178.959 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 64.6 t -123.34 116.63 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.063 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 93.0 m -105.95 129.32 54.11 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.088 -1.007 . . . . 0.0 109.153 -179.143 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 1.4 m -136.03 115.37 12.6 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.756 0.789 . . . . 0.0 110.666 -179.827 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 40.1 t30 46.03 52.57 9.94 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 112.94 0.719 . . . . 0.0 112.94 177.492 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 85.15 -13.73 53.19 Favored Glycine 0 N--CA 1.5 2.908 0 O-C-N 120.222 -1.549 . . . . 0.0 112.65 176.778 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 13.1 tptm -115.46 125.82 53.57 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 118.959 1.379 . . . . 0.0 108.834 -179.517 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 82.6 p -127.42 149.98 49.84 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.92 0.867 . . . . 0.0 110.574 -178.685 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -145.58 167.75 22.29 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 121.434 0.635 . . . . 0.0 110.234 -178.653 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 49.0 m -88.92 138.89 31.0 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.609 -0.682 . . . . 0.0 110.434 -179.233 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.47 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -81.09 -15.55 55.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.024 -1.048 . . . . 0.0 110.456 -179.366 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -84.05 22.26 1.21 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.081 -1.451 . . . . 0.0 107.081 178.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . 0.47 ' H ' ' C ' ' B' ' 344' ' ' ALA . 63.6 m -150.81 101.67 2.93 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.661 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.873 HD23 HD22 ' A' ' 79' ' ' LEU . 17.3 tp -59.86 -36.6 77.21 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.388 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.852 ' CE2' HD11 ' A' ' 79' ' ' LEU . 52.6 m-85 -57.95 -53.04 62.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.323 -0.86 . . . . 0.0 110.299 -179.574 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 13.6 mtpp -68.53 -21.74 64.55 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.272 -0.892 . . . . 0.0 111.241 -176.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.519 ' O ' ' N ' ' B' ' 352' ' ' THR . 76.8 mt -69.26 -52.61 25.89 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.395 -1.44 . . . . 0.0 108.886 178.442 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.539 ' O ' HD22 ' A' ' 123' ' ' LEU . 0.8 OUTLIER -39.4 -22.33 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.696 -0.627 . . . . 0.0 110.953 -178.156 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.519 ' N ' ' O ' ' B' ' 350' ' ' LEU . 80.1 p -80.12 -10.81 59.78 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.18 -1.575 . . . . 0.0 110.235 -179.13 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' B' ' 342' ' ' ALA . 44.4 mt -96.48 117.79 31.64 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.085 -1.009 . . . . 0.0 108.925 178.729 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.5 95.46 0.78 Allowed Glycine 0 N--CA 1.487 2.04 0 N-CA-C 108.784 -1.726 . . . . 0.0 108.784 179.359 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 92.6 mt -95.68 78.62 3.32 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.185 -1.185 . . . . 0.0 108.691 179.252 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 75.6 p -90.97 179.75 5.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.944 . . . . 0.0 110.549 -178.338 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' B' ' 359' ' ' THR . 12.1 tt0 -50.79 157.47 0.79 Allowed 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 122.188 0.994 . . . . 0.0 111.097 -179.494 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 38.39 26.55 0.04 OUTLIER Glycine 0 N--CA 1.498 2.804 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.336 177.691 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . 0.542 ' HB ' HD12 ' B' ' 308' ' ' ILE . 13.6 m -84.83 106.77 16.61 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.612 -1.522 . . . . 0.0 110.131 -179.747 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 11.7 t -78.27 113.52 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 CA-C-O 122.248 1.023 . . . . 0.0 110.231 -177.556 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 34.4 m -111.58 179.06 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -178.973 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 37.2 m -130.16 128.28 41.45 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 176.869 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 53.7 mt -102.17 116.31 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 178.573 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 24.9 p -120.23 132.92 55.54 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.417 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.79 153.93 40.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.166 -0.959 . . . . 0.0 109.917 -178.888 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -147.03 125.8 12.64 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 179.075 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.458 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 159.23 -158.45 29.52 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 119.086 -1.53 . . . . 0.0 111.335 -179.654 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.14 -49.86 75.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 122.017 -0.696 . . . . 0.0 112.485 -177.385 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.432 ' H ' ' HB3' ' B' ' 331' ' ' SER . 76.9 m-20 -114.28 13.64 17.91 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.914 -1.116 . . . . 0.0 111.528 -177.039 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.551 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -42.91 -33.8 0.85 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.23 -0.919 . . . . 0.0 111.035 -179.1 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . 0.532 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 92.4 mm-40 -69.95 -44.2 70.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.059 -1.026 . . . . 0.0 110.412 -178.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -67.52 -47.63 69.36 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 118.936 -1.106 . . . . 0.0 109.544 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.67 -76.83 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.334 -0.854 . . . . 0.0 110.61 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.61 ' O ' HG23 ' B' ' 378' ' ' VAL . 94.4 t -46.4 -35.36 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 110.969 -177.319 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -67.11 -46.16 75.03 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 120.221 -1.549 . . . . 0.0 110.238 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 68.4 m80 -77.61 -43.48 31.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.807 -1.183 . . . . 0.0 109.546 179.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.05 -39.59 86.5 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 0.0 109.968 -179.108 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.61 HG23 ' O ' ' B' ' 374' ' ' VAL . 48.5 t -60.06 -45.21 95.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 C-N-CA 118.772 -1.171 . . . . 0.0 109.168 179.657 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.414 ' O ' ' N ' ' B' ' 383' ' ' GLU . 99.3 mttt -70.0 -56.59 6.59 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.655 -1.278 . . . . 0.0 108.114 178.565 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 42.3 tp -54.88 -35.35 63.99 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.402 -0.811 . . . . 0.0 109.709 -178.024 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . 0.502 ' O ' ' CE ' ' B' ' 381' ' ' MET . 0.0 OUTLIER -73.47 -39.9 64.55 Favored 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 118.44 -1.304 . . . . 0.0 107.826 177.635 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.48 -4.75 50.09 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.184 -0.948 . . . . 0.0 110.205 179.534 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' B' ' 379' ' ' LYS . 69.6 mm-40 -111.81 1.08 16.42 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.198 -0.939 . . . . 0.0 110.723 179.86 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 16.1 mt -90.36 129.3 36.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.761 -1.212 . . . . 0.0 109.261 179.362 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.326 -179.501 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.8 mtp . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.232 -0.655 . . . . 2.91 109.232 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.1 mt -110.49 124.85 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.499 -0.75 . . . . 1.2 109.601 -179.804 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.5 m -133.28 145.6 50.62 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.563 -0.71 . . . . 1.4 109.154 179.956 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.571 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -129.37 -164.36 11.43 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 108.868 -1.693 . . . . 1.05 108.868 179.924 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' LEU . 90.1 mt -88.23 -9.93 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.922 -1.34 . . . . 1.15 110.116 -179.098 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 54.6 tp 50.3 98.76 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.16 -0.963 . . . . 0.98 109.13 179.804 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.11 -31.13 12.27 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.164 -0.96 . . . . 0.88 109.201 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.409 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 12.1 t -131.46 119.49 17.44 Favored Pre-proline 0 N--CA 1.499 1.976 0 N-CA-C 108.947 -0.761 . . . . 1.69 108.947 179.697 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -81.51 148.85 16.39 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.104 1.869 . . . . 0.85 112.812 -179.764 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.93 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 143.76 176.83 18.15 Favored Glycine 0 N--CA 1.497 2.744 0 N-CA-C 108.829 -1.708 . . . . 0.92 108.829 179.755 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 88.4 mt -120.0 153.78 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.147 -1.207 . . . . 0.81 109.833 -179.351 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.11 152.15 29.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.265 -0.897 . . . . 0.51 109.773 179.761 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.3 m-85 -133.47 127.58 33.59 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.334 -0.987 . . . . 0.62 108.334 179.565 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.78 175.47 47.37 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 118.885 -1.626 . . . . 0.55 110.687 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -78.66 155.4 29.53 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.654 -0.91 . . . . 2.1 109.529 -179.523 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.518 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -102.12 131.48 48.59 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.376 -0.828 . . . . 0.77 111.121 -178.586 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.9 tp -100.23 134.86 42.54 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 107.681 -1.229 . . . . 0.91 107.681 178.31 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.2 tp -115.35 119.97 38.06 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.252 -0.905 . . . . 0.93 110.144 -179.458 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 83.0 mt -88.87 101.11 13.72 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.503 -0.748 . . . . 0.93 109.944 179.685 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -95.78 133.66 39.64 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.235 -1.024 . . . . 2.75 108.235 179.441 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.535 ' CG ' HH21 ' A' ' 139' ' ' ARG . 81.8 tt0 -131.54 141.08 49.64 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.242 -0.911 . . . . 3.0 109.696 -179.398 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -88.24 141.9 28.19 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.453 -0.779 . . . . 2.77 109.662 179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -64.52 139.98 58.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.038 -1.039 . . . . 2.94 109.078 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 85.5 mt -83.03 136.64 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.191 -0.943 . . . . 0.95 108.915 179.495 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.7 t -102.69 129.55 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.444 -0.785 . . . . 1.28 109.329 -179.612 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.6 mt -106.8 138.92 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 108.834 -0.802 . . . . 1.21 108.834 179.919 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -92.87 119.27 32.02 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.01 -1.056 . . . . 1.81 109.586 -179.59 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.428 HH11 ' HG3' ' A' ' 28' ' ' ARG . 23.8 mmm-85 -86.95 -2.96 59.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.563 -0.711 . . . . 2.8 109.557 -179.5 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -62.7 144.37 56.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.125 -0.984 . . . . 2.87 109.902 179.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -87.99 151.17 22.98 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.837 -0.801 . . . . 2.35 108.837 179.563 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.5 pt -98.12 166.73 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.076 -1.015 . . . . 0.97 110.46 -179.386 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 51.8 p -90.45 174.5 7.51 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.279 -0.888 . . . . 1.17 108.762 178.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.89 -18.7 63.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.14 -0.975 . . . . 1.18 111.087 -179.332 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -83.27 -27.4 29.89 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.565 -1.334 . . . . 2.56 108.709 178.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -81.19 -8.42 59.75 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.242 -0.651 . . . . 1.79 109.242 179.45 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.5 t -61.54 -54.13 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.224 -0.923 . . . . 1.0 108.917 179.516 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -62.14 -39.89 94.12 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.42 -0.8 . . . . 1.77 109.829 179.886 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.9 mm100 -63.93 -42.78 97.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.033 -1.042 . . . . 2.7 110.104 -179.36 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -64.15 -39.79 94.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.923 -1.111 . . . . 1.51 110.328 179.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.85 -47.52 91.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 120.665 -1.272 . . . . 0.93 108.458 -179.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -60.04 -41.12 91.61 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.949 -1.094 . . . . 1.81 108.855 179.668 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.5 mtp180 -60.04 -44.47 94.63 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.842 -1.17 . . . . 2.78 107.842 178.705 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -60.32 -47.58 85.41 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.744 -0.836 . . . . 0.78 108.744 178.129 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.4 tp -59.9 -49.33 78.13 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 1.07 109.224 179.869 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 29.0 t -62.42 -43.58 98.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.024 -1.047 . . . . 1.12 109.44 179.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.26 -46.39 94.02 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.132 -1.587 . . . . 0.84 109.132 179.549 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -67.24 -30.71 70.68 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.328 -1.101 . . . . 3.09 108.454 179.227 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.8 -45.75 91.36 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.458 -0.776 . . . . 0.88 109.244 179.952 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 50' ' ' ALA . 30.6 ttpt -61.4 -72.69 0.11 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.901 -1.148 . . . . 2.59 107.901 179.427 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.86 -33.68 0.06 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.477 -0.764 . . . . 0.7 111.725 -178.188 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 64.1 m -59.95 -50.65 72.92 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.064 -1.454 . . . . 1.4 107.95 179.452 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.62 -40.09 76.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.44 -0.788 . . . . 0.67 111.211 -179.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -66.45 -40.04 89.19 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.663 -1.273 . . . . 1.66 110.116 -179.427 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 83.1 mt -65.09 -40.0 93.97 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.925 . . . . 1.58 109.783 -179.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -61.85 -38.04 86.75 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.98 -1.075 . . . . 1.35 109.694 179.372 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.4 m -63.63 -41.62 98.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -0.967 . . . . 0.77 109.774 179.851 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -61.3 -39.89 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.198 -0.939 . . . . 0.63 109.077 179.756 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 22.5 ttpt -55.67 -50.05 71.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.353 -0.842 . . . . 1.14 109.542 -179.586 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -57.34 -33.23 67.53 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.223 -0.923 . . . . 0.79 110.062 -178.457 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -69.82 -39.76 76.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.944 -1.097 . . . . 1.53 110.594 179.593 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.407 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.13 -44.36 80.07 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.232 -0.918 . . . . 0.57 110.218 -178.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.78 -50.89 62.83 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.931 -1.268 . . . . 0.75 109.931 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.9 -43.93 70.75 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.99 -1.3 . . . . 1.59 109.985 -179.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 47.0 m -66.43 -62.73 1.31 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.118 -0.989 . . . . 0.73 111.742 -178.09 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -95.43 -48.71 5.74 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.872 -1.143 . . . . 0.75 111.316 -178.071 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 140.83 -166.64 25.86 Favored Glycine 0 N--CA 1.504 3.173 0 C-N-CA 119.818 -1.182 . . . . 1.22 111.043 179.431 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -68.51 -23.42 64.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.673 -0.898 . . . . 5.81 109.618 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -60.73 -37.69 82.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.395 -0.816 . . . . 3.37 110.872 -179.579 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -99.43 -15.01 18.88 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.007 -1.058 . . . . 1.77 109.858 -179.567 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -70.03 -39.99 75.42 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.081 -1.012 . . . . 1.65 109.085 179.916 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.496 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -65.68 -31.5 72.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.622 -0.674 . . . . 0.77 109.946 -179.466 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 80.8 mt -59.89 -41.2 85.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.828 -1.17 . . . . 0.8 108.538 179.836 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -65.3 -39.32 92.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.165 -0.959 . . . . 0.88 110.501 179.707 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -60.01 -39.85 87.21 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.697 -1.252 . . . . 1.37 109.086 179.932 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.41 -48.96 68.36 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.462 -1.855 . . . . 0.62 108.462 178.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 60.5 m170 -62.02 -44.72 96.11 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.264 -1.139 . . . . 1.5 108.682 179.203 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 80.9 mt -68.7 -48.6 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.266 -0.896 . . . . 0.63 109.344 179.429 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 52.3 ttp -60.17 -40.83 91.3 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.939 -1.101 . . . . 1.51 109.764 -179.168 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.848 HD22 HD23 ' B' ' 347' ' ' LEU . 53.5 tp -64.97 -39.9 94.18 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.338 -0.851 . . . . 0.77 109.907 179.639 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.0 tp -64.27 -40.1 95.29 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.497 -0.752 . . . . 0.62 110.268 -179.137 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -81.06 7.85 9.95 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.904 -1.123 . . . . 1.47 110.557 -178.853 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -56.91 129.78 43.03 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.081 -1.012 . . . . 1.47 110.134 -178.974 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -60.33 -15.36 24.85 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.33 -0.857 . . . . 1.78 110.438 -179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 84.7 mt-10 -69.9 -35.98 75.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.956 -1.09 . . . . 2.53 108.675 178.677 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 73.2 mt -71.17 -42.84 68.56 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.49 0.662 . . . . 0.8 110.054 179.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.59 -47.77 84.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.25 -0.907 . . . . 1.42 110.551 -179.138 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 87.7 mt-30 -70.74 -43.92 67.87 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.089 -1.007 . . . . 1.71 111.746 -178.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -70.41 -38.65 74.65 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.127 -0.983 . . . . 1.57 111.525 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.7 mt -69.53 -42.23 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.044 -1.035 . . . . 0.65 110.016 -179.062 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.81 -37.78 77.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 O-C-N 121.42 -0.8 . . . . 0.82 110.17 -179.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.01 -46.45 89.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.137 -0.977 . . . . 0.79 111.13 -179.03 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.2 mt -60.96 -45.55 94.28 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.734 -1.228 . . . . 0.95 109.992 -178.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.36 -50.02 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.172 -0.955 . . . . 0.66 109.42 -179.577 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -70.04 -40.91 74.85 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.833 -0.747 . . . . 2.2 110.487 179.464 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -81.54 -50.5 9.31 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.129 -0.982 . . . . 1.65 112.249 -178.185 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -93.04 -2.24 55.83 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.071 -1.018 . . . . 2.03 111.982 -176.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 57.4 35.97 26.57 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.059 -1.026 . . . . 1.42 109.793 -179.882 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 55.5 mtt -90.39 168.04 12.18 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.45 -0.781 . . . . 1.18 110.128 -179.457 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 30.5 p -80.15 160.64 25.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.489 -0.757 . . . . 0.98 109.597 179.986 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.82 -39.72 76.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.316 -0.865 . . . . 0.64 110.381 -179.557 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 34.2 p-10 -66.31 -39.2 89.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.052 -1.03 . . . . 2.07 109.821 -179.626 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.484 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -78.93 -51.59 9.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.215 -0.928 . . . . 0.73 109.704 179.417 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.0 -49.48 77.52 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.537 -0.727 . . . . 0.54 111.131 -179.002 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.04 -45.92 91.23 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.065 -1.022 . . . . 0.56 110.018 -179.059 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -58.39 -37.16 74.7 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.308 -0.87 . . . . 1.54 109.917 -179.706 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.92 -39.99 91.5 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.26 -0.9 . . . . 1.33 111.014 -179.127 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.6 t -66.85 -49.97 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 120.832 -1.168 . . . . 0.72 110.58 -178.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 10.7 mm -67.42 -40.24 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 120.992 -1.067 . . . . 0.85 108.237 -179.83 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -66.92 -37.2 83.89 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.184 -1.043 . . . . 2.44 108.184 178.836 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.93 -49.0 83.34 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.009 -1.236 . . . . 0.98 110.009 -179.484 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -65.86 -48.05 72.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.853 -1.38 . . . . 1.41 109.123 -179.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.95 87.62 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.383 -0.823 . . . . 1.2 109.222 -179.825 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 58.5 m -60.02 -40.1 88.15 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.267 -1.012 . . . . 1.7 108.267 179.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.35 -43.5 96.45 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.45 -0.944 . . . . 1.47 108.45 179.074 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 27.7 mt -64.04 -48.83 74.72 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.159 -1.052 . . . . 1.56 108.159 179.302 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -49.48 -31.86 10.91 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.321 -0.862 . . . . 2.2 109.998 -179.11 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -59.74 -20.28 55.55 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.892 -1.13 . . . . 2.12 108.668 179.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 74.1 mt -63.15 140.05 58.83 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.511 -0.922 . . . . 2.0 108.511 179.317 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -99.11 49.01 0.95 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.116 -0.99 . . . . 3.23 111.02 -178.531 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 24.7 t0 -137.38 153.22 50.23 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.145 -0.972 . . . . 2.49 109.119 178.993 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.457 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 99.5 mt-10 -72.44 -64.78 0.88 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.95 -1.13 . . . . 3.95 107.95 178.352 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.437 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 6.6 t80 -41.33 -43.74 2.56 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.91 -0.494 . . . . 2.0 110.895 -179.234 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.607 HD23 HH21 ' A' ' 126' ' ' ARG . 85.3 mt -69.88 -40.05 75.92 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.604 -1.31 . . . . 1.86 109.028 -179.836 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -65.33 -37.36 86.85 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.525 -0.735 . . . . 2.84 109.563 179.972 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 95.0 mt-10 -59.83 -42.15 92.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.391 -0.818 . . . . 2.73 110.268 -179.031 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.607 HH21 HD23 ' A' ' 123' ' ' LEU . 82.2 mtm180 -70.05 -32.72 70.98 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.924 -1.11 . . . . 2.77 108.812 179.621 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.22 -22.77 65.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.735 -1.209 . . . . 1.19 107.735 178.458 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -73.72 -40.04 63.85 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.511 -0.922 . . . . 1.2 108.511 178.609 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -62.99 -41.22 99.51 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.433 -0.792 . . . . 1.55 110.377 -179.587 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 38.8 t -68.67 -40.45 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.047 -1.033 . . . . 0.8 108.873 179.776 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.415 HH11 ' HG2' ' A' ' 131' ' ' ARG . 36.3 ttt-85 -60.19 -37.69 81.0 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 3.09 108.779 178.602 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.418 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 61.6 t0 -59.84 -38.97 83.58 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.527 -0.733 . . . . 1.46 109.68 -179.483 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.04 -40.65 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.083 -1.011 . . . . 0.71 109.563 -179.486 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -74.13 -26.85 67.53 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.848 -1.301 . . . . 0.57 109.848 179.866 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -60.1 -49.62 76.92 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.184 -1.186 . . . . 2.59 109.575 -179.217 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.412 HH22 ' HB3' ' A' ' 166' ' ' SER . 98.5 mtt180 -68.32 -32.96 73.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.786 -1.197 . . . . 2.83 110.559 179.545 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.6 tp -54.34 -43.96 71.69 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.936 -1.103 . . . . 1.25 108.795 -179.338 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 84.1 mt -61.92 -39.98 93.91 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.124 -0.985 . . . . 0.7 109.037 178.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.624 HH12 HD23 ' A' ' 144' ' ' LEU . 3.2 mtt-85 -68.13 -40.02 82.58 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.331 -0.856 . . . . 2.57 109.714 179.407 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -68.76 -38.27 79.96 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.458 -0.776 . . . . 1.23 112.265 -178.439 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.91 -40.09 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.321 -1.487 . . . . 0.81 108.791 179.745 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 92.2 mt -76.03 -28.69 57.8 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.509 -0.744 . . . . 1.0 110.167 -179.429 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.81 38.95 18.46 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.423 -1.471 . . . . 0.89 109.423 -179.718 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.624 HD23 HH12 ' A' ' 139' ' ' ARG . 3.3 tp -73.89 147.18 43.44 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.259 -1.141 . . . . 1.14 108.619 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -66.43 137.02 56.55 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.034 -1.041 . . . . 4.6 109.653 -179.153 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 83.2 mt -109.83 132.92 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-O 122.218 1.008 . . . . 1.24 108.512 179.548 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.3 mt -65.02 -39.97 87.45 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 115.637 -0.71 . . . . 1.54 110.768 -178.304 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 41.3 t0 63.21 102.23 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.412 -0.805 . . . . 1.5 108.861 -179.255 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.9 mt -70.02 -1.11 8.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.365 -0.834 . . . . 0.79 111.49 -178.023 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 47.7 t -84.66 -13.15 52.35 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.524 -1.36 . . . . 1.4 110.324 -179.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.93 31.64 0.2 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.092 -1.005 . . . . 0.92 112.052 -178.07 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.8 mm -86.04 120.0 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 120.234 -1.541 . . . . 0.88 109.087 179.546 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -101.41 -9.32 21.22 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.321 -0.862 . . . . 2.45 110.462 -179.908 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 83.6 m-20 -140.31 159.93 41.1 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.039 -1.038 . . . . 1.52 110.867 -178.834 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -64.83 132.88 50.68 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.501 -0.75 . . . . 1.58 109.162 179.821 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.0 m -152.06 165.5 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.274 -0.891 . . . . 0.69 110.074 179.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.9 mt -97.09 145.29 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 105.522 -2.029 . . . . 0.61 105.522 176.958 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 65.3 tp -95.41 115.49 27.51 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.873 -1.142 . . . . 0.87 110.614 -177.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.526 HG12 HG22 ' A' ' 209' ' ' THR . 57.0 t -120.28 128.07 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 N-CA-C 108.257 -1.016 . . . . 0.71 108.257 179.026 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.48 165.58 30.71 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.025 -1.047 . . . . 0.81 109.27 -179.582 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.77 -38.0 73.41 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.363 -1.461 . . . . 0.98 108.567 178.61 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 54.0 t0 -171.7 147.16 2.24 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.582 -0.699 . . . . 2.25 109.468 -179.667 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.412 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 17.6 mt -119.91 136.72 54.4 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.281 -0.887 . . . . 0.78 108.859 179.505 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.5 p -89.98 149.98 42.75 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.179 -0.951 . . . . 0.98 110.009 -179.424 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -40.63 -39.39 2.95 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.563 2.175 . . . . 0.81 113.438 179.58 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.412 ' HB3' HH22 ' A' ' 136' ' ' ARG . 66.1 m -59.99 -39.96 87.51 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.966 -1.084 . . . . 0.9 109.253 -179.122 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.68 -40.08 94.78 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.346 -0.846 . . . . 1.61 110.129 -179.828 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 51.7 p -57.97 -34.55 70.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.163 -0.96 . . . . 0.61 111.225 -177.973 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.407 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -69.4 -50.91 41.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.962 -1.086 . . . . 0.6 109.914 -179.659 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -85.7 36.67 0.67 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.421 -0.799 . . . . 1.4 108.9 -179.612 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 14.2 tp -99.97 140.01 34.8 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.451 -0.781 . . . . 0.7 109.491 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -84.4 104.63 14.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.021 -1.049 . . . . 2.35 108.62 179.185 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 63.2 mt -65.75 -40.97 92.62 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.442 -0.786 . . . . 1.51 111.612 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -81.25 -15.01 56.82 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.638 -1.289 . . . . 2.33 112.162 -177.172 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -95.33 -10.63 29.59 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.611 -1.305 . . . . 1.92 109.132 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.529 HG12 ' H ' ' A' ' 178' ' ' GLY . 99.9 t -110.28 120.08 60.5 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 O-C-N 121.401 -0.812 . . . . 0.67 108.82 178.669 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.5 mt -91.64 7.85 39.59 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.027 -1.045 . . . . 1.53 110.723 -178.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.529 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.27 172.37 38.04 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.543 -1.423 . . . . 0.48 109.543 179.752 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -132.94 129.89 38.88 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.326 -1.102 . . . . 0.55 109.403 179.977 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.439 ' CG2' HG21 ' A' ' 205' ' ' THR . 96.2 mt -132.02 124.26 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 108.865 -0.791 . . . . 0.65 108.865 178.67 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 53.6 p -146.97 159.8 43.12 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.132 -0.98 . . . . 0.82 110.761 -179.615 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.8 OUTLIER -96.35 21.63 8.83 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.124 -0.695 . . . . 2.46 109.124 179.686 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.485 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -45.58 -176.06 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.925 0 CA-C-O 122.341 1.067 . . . . 1.28 112.847 -177.898 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -74.93 -56.77 4.71 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 111.131 -0.788 . . . . 2.19 111.131 -179.119 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.46 -144.24 5.1 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 119.118 -1.515 . . . . 2.13 110.79 -179.34 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 188' ' ' SER . 82.1 mtm180 -69.66 -28.14 65.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.54 -0.976 . . . . 5.86 110.302 -178.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 69.7 p -62.95 5.82 0.12 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.194 -0.942 . . . . 3.72 110.614 -178.756 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 186' ' ' ARG . 40.4 t -90.67 128.35 36.61 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.987 -1.071 . . . . 1.74 109.894 -179.982 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -47.52 -44.17 25.49 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.316 -0.865 . . . . 0.95 108.825 179.687 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 45.3 p -57.8 -39.56 77.82 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.78 -0.575 . . . . 1.55 110.425 -179.058 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 58.5 m -59.94 -40.17 88.04 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.997 -1.064 . . . . 1.51 110.899 -178.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.555 HD12 ' N ' ' A' ' 192' ' ' ILE . 2.2 mp -64.75 -40.07 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 120.951 -1.093 . . . . 1.67 110.295 -179.035 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.5 mtp -61.25 -41.14 96.39 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.843 -1.161 . . . . 1.02 110.615 -179.441 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.86 -44.1 94.32 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 120.505 -1.372 . . . . 0.68 109.541 -179.73 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.43 HH11 ' HG2' ' A' ' 195' ' ' ARG . 30.0 mtt-85 -60.23 -50.1 74.99 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.272 -0.893 . . . . 2.93 109.996 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 39.4 m -72.0 -35.72 69.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.11 -0.994 . . . . 0.86 111.823 -178.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 95.6 mt -76.67 -13.24 60.07 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.499 -1.376 . . . . 0.67 110.194 -178.702 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 59.81 46.08 11.87 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.533 -0.73 . . . . 1.5 110.547 179.392 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.409 ' O ' ' CB ' ' A' ' 8' ' ' SER . 90.6 mt -122.85 128.91 25.2 Favored Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 108.687 -0.857 . . . . 0.72 108.687 179.313 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -43.41 133.92 6.8 Favored 'Trans proline' 0 N--CA 1.496 1.618 0 C-N-CA 121.82 1.68 . . . . 0.61 112.073 179.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -167.27 147.17 5.32 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.575 -1.25 . . . . 0.66 111.89 -179.483 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.7 mt -125.58 141.07 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 107.772 -1.196 . . . . 0.79 107.772 178.362 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 11.2 m -126.71 -7.29 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 120.806 -1.184 . . . . 0.91 110.589 -179.067 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.15 22.06 25.84 Favored Glycine 0 N--CA 1.501 2.972 0 N-CA-C 110.544 -1.022 . . . . 1.01 110.544 -179.62 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.456 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 12.6 p -47.14 -44.58 21.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.834 -1.392 . . . . 0.99 109.782 -179.287 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.69 -53.96 4.07 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 120.022 -1.085 . . . . 1.12 112.036 178.688 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.0 t -150.03 28.27 0.76 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 120.485 -1.597 . . . . 1.72 111.905 -178.2 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 45.6 t -70.25 -40.07 77.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.74 -1.225 . . . . 0.89 109.126 178.314 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.526 HG22 HG12 ' A' ' 159' ' ' VAL . 75.9 p -53.79 -30.82 46.56 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.377 -0.827 . . . . 1.03 111.392 -178.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.7 m -81.28 -12.95 58.94 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.823 -1.173 . . . . 1.83 110.283 -179.132 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -102.57 -12.14 17.98 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.141 -0.974 . . . . 2.27 110.351 -179.612 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 85.0 t -107.86 139.24 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.177 -0.952 . . . . 0.92 111.675 -177.66 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -114.25 150.01 35.02 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 107.356 -1.35 . . . . 2.2 107.356 178.212 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.507 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 21.3 p-10 -57.1 140.45 49.28 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.735 -1.228 . . . . 2.36 109.9 -179.356 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.507 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 13.1 t0 87.15 4.07 0.37 Allowed 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 109.525 -0.546 . . . . 2.38 109.525 179.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.469 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 64.8 t0 -74.7 139.41 43.44 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.204 -0.935 . . . . 2.09 109.561 179.512 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.469 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 48.4 t80 -91.94 116.56 29.02 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 107.524 -1.287 . . . . 1.27 107.524 178.456 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.518 HD12 ' HB2' ' A' ' 16' ' ' ALA . 76.4 mt -127.37 149.4 50.08 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.468 -0.77 . . . . 0.75 110.297 -178.631 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 63.1 mt -114.66 129.71 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 106.859 -1.534 . . . . 0.63 106.859 176.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 55.0 tp -100.14 119.17 37.92 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.078 -1.082 . . . . 0.7 108.078 -179.153 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.459 ' C ' ' N ' ' A' ' 223' ' ' VAL . 78.7 m-20 -81.4 -46.73 14.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.965 -1.084 . . . . 2.31 109.51 -179.852 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.93 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 48.23 17.27 0.11 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.792 -0.818 . . . . 0.78 108.792 -179.251 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.459 ' N ' ' C ' ' A' ' 221' ' ' ASP . 55.3 t -127.19 -49.42 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 N-CA-C 107.256 -1.387 . . . . 1.04 107.256 178.387 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -100.31 2.87 42.98 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.412 -1.329 . . . . 2.44 107.412 178.37 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.571 HD21 ' H ' ' A' ' 4' ' ' GLY . 1.1 t-20 59.82 49.18 8.24 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 109.04 -0.726 . . . . 1.55 109.04 -179.071 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -136.85 147.11 46.33 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.438 -0.789 . . . . 1.99 109.572 -179.642 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 61.5 t -119.89 126.84 75.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.269 -1.011 . . . . 0.77 108.269 179.474 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -100.1 117.56 34.61 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.185 -0.947 . . . . 0.98 108.934 179.854 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.3 t -98.8 111.52 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.734 -0.604 . . . . 0.85 109.914 -179.044 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 55.18 68.54 2.47 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.311 -0.868 . . . . 1.66 111.235 179.454 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -90.67 145.42 3.86 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 123.13 2.553 . . . . 0.95 112.122 178.944 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 61.2 p -69.95 163.98 24.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.039 -1.038 . . . . 1.84 109.646 -179.618 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -60.19 -40.38 89.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.911 . . . . 2.74 110.071 -178.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -60.07 -39.98 87.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.057 -1.027 . . . . 2.89 109.522 -179.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.3 t -66.69 -40.4 86.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.052 -1.03 . . . . 1.3 109.299 179.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.456 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 93.0 mt -61.61 -39.78 84.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.266 -0.896 . . . . 1.09 109.085 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -59.94 -40.06 87.66 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.155 -0.965 . . . . 2.43 109.021 179.657 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -65.18 -42.63 93.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 2.78 109.116 179.39 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 91.1 mtp -67.79 -34.33 76.57 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.35 -0.844 . . . . 1.25 109.142 179.604 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.571 ' CG ' HH11 ' A' ' 240' ' ' ARG . 0.0 OUTLIER -63.19 -39.98 96.21 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.374 -0.829 . . . . 2.63 109.663 179.38 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.87 -40.15 87.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.015 -1.053 . . . . 1.8 108.879 -179.926 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 53.9 t -60.86 -39.98 83.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.371 -0.83 . . . . 2.13 109.008 179.557 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -59.97 -40.88 90.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.092 -1.005 . . . . 3.17 109.364 179.586 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -61.63 -40.0 93.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 1.78 109.026 179.496 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -60.79 -39.69 89.82 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.444 -0.785 . . . . 2.47 109.639 179.558 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 73.9 t -59.58 -39.88 80.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.465 -0.772 . . . . 2.09 109.793 -178.901 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.93 -39.3 85.05 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.156 -0.965 . . . . 2.54 108.866 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 54.3 p -68.84 -33.68 74.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.478 -0.764 . . . . 2.99 109.954 -179.827 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -60.48 -33.68 72.95 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.069 -1.019 . . . . 3.34 109.555 -179.755 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -60.01 -39.56 86.21 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.493 -0.928 . . . . 3.88 108.493 -179.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.541 ' C ' ' H ' ' A' ' 253' ' ' LEU . . . -65.06 -59.95 3.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.291 -0.881 . . . . 4.43 108.816 179.137 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 61.6 tt0 54.49 1.08 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.407 -0.808 . . . . 5.42 110.13 179.406 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.541 ' H ' ' C ' ' A' ' 251' ' ' ALA . 38.5 mt 48.86 44.79 22.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.826 -1.171 . . . . 6.1 109.424 179.656 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.3 -35.92 74.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.944 . . . . 7.37 109.807 -179.577 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 44.5 mmtm -60.07 -40.02 88.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.066 -1.021 . . . . 8.01 108.776 -179.785 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 8.2 tp -97.26 30.64 2.73 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.786 -1.191 . . . . 9.05 107.786 179.08 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.435 ' O ' ' O ' ' A' ' 253' ' ' LEU . 45.6 mmtm 56.33 -171.7 0.08 Allowed 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.146 -1.057 . . . . 10.56 108.146 -179.021 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -153.18 88.27 1.3 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.775 -1.203 . . . . 11.32 110.172 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.402 HH11 ' HG2' ' A' ' 259' ' ' ARG . 32.2 ttt-85 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.13 -0.981 . . . . 12.42 109.422 179.566 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . 0.482 ' N ' ' OE1' ' B' ' 366' ' ' GLU . 11.0 ttt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.488 0.661 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -156.93 154.23 29.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.382 -0.824 . . . . 0.0 109.056 178.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -151.21 162.44 40.88 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.916 -1.115 . . . . 0.0 110.737 -178.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -154.96 152.16 29.37 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.611 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -113.0 133.93 54.74 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.094 -1.004 . . . . 0.0 110.346 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.1 p -134.45 125.61 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.461 0 CA-C-O 122.415 1.102 . . . . 0.0 112.475 -178.492 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . 0.487 ' O ' HG23 ' B' ' 309' ' ' THR . 93.9 m -77.83 106.29 9.57 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.306 -177.875 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.9 mt -52.13 122.02 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 CA-C-O 122.222 1.01 . . . . 0.0 110.413 -178.186 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . 0.487 HG23 ' O ' ' B' ' 307' ' ' THR . 62.4 p -110.73 18.62 19.45 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.697 -178.579 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -77.25 115.98 53.69 Favored Pre-proline 0 N--CA 1.496 1.861 0 O-C-N 121.083 -1.011 . . . . 0.0 109.584 179.642 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -49.5 -15.4 0.9 Allowed 'Trans proline' 0 N--CA 1.501 1.944 0 C-N-CA 121.114 1.209 . . . . 0.0 114.266 -179.572 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 66.8 m-80 -118.92 9.44 11.93 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.199 -0.938 . . . . 0.0 109.694 -179.42 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.2 177.74 26.64 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 -179.118 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.437 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.0 tp -83.73 93.86 8.02 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.034 -1.274 . . . . 0.0 109.716 -178.32 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -95.92 -162.52 0.96 Allowed 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.661 -1.274 . . . . 0.0 110.391 179.274 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 25.8 m -55.9 -40.01 72.42 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.154 -0.967 . . . . 0.0 112.377 -176.31 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.517 HH21 ' CD ' ' B' ' 321' ' ' GLN . 1.7 tpt180 -62.9 -61.65 7.09 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 120.677 -1.265 . . . . 0.0 112.507 -178.37 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -57.98 -32.54 95.53 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 CA-C-N 120.275 1.134 . . . . 0.0 111.896 -179.24 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.94 -50.07 75.21 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.139 -1.024 . . . . 0.0 108.457 179.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.65 -40.61 60.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.897 . . . . 0.0 109.71 -179.423 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . 0.517 ' CD ' HH21 ' B' ' 317' ' ' ARG . 27.2 mt-30 -72.8 -40.06 66.18 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 118.827 -1.149 . . . . 0.0 109.457 178.631 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -60.28 -51.5 69.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.18 -0.95 . . . . 0.0 109.996 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 92.4 t -69.01 -24.73 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.936 -1.103 . . . . 0.0 110.501 -178.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.466 ' HZ1' ' HA ' ' B' ' 321' ' ' GLN . 0.9 OUTLIER -60.03 -42.49 94.51 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.859 -1.15 . . . . 0.0 108.823 179.9 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 49.8 tp10 -69.5 -60.06 2.58 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.626 -0.671 . . . . 0.0 111.562 -178.185 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -68.1 -9.01 43.1 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.822 -1.174 . . . . 0.0 112.698 -177.512 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 15.9 ttmm -83.67 -20.3 33.81 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.441 -1.412 . . . . 0.0 110.113 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -87.52 -10.97 69.56 Favored Glycine 0 N--CA 1.498 2.78 0 C-N-CA 120.084 -1.055 . . . . 0.0 111.158 -178.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -102.45 143.23 32.44 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.961 -1.317 . . . . 0.0 109.417 179.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 57.9 p -89.59 -13.84 36.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.034 -1.041 . . . . 0.0 110.06 -179.739 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 82.2 p -58.9 145.24 41.95 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.109 -0.994 . . . . 0.0 109.095 -179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . 0.462 ' OE1' ' N ' ' B' ' 332' ' ' GLU . 49.5 mp0 -68.26 130.1 41.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.187 -0.946 . . . . 0.0 109.069 -179.804 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 86.1 mt -132.18 132.55 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.589 -0.695 . . . . 0.0 110.21 -179.438 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 95.3 m -131.06 151.3 51.56 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.5 -0.75 . . . . 0.0 109.725 179.393 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 96.3 t -125.12 120.05 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 177.765 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 95.1 m -116.84 130.09 56.49 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.037 -1.039 . . . . 0.0 110.329 -178.321 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 2.0 m -133.75 117.62 17.13 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.883 0.849 . . . . 0.0 110.037 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 48.3 t30 49.66 50.51 18.17 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 113.703 1.001 . . . . 0.0 113.703 176.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.84 -12.01 65.03 Favored Glycine 0 N--CA 1.504 3.19 0 O-C-N 119.682 -1.886 . . . . 0.0 113.434 176.286 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 39.0 tptt -120.56 132.5 55.19 Favored 'General case' 0 N--CA 1.506 2.375 0 CA-C-N 119.292 1.546 . . . . 0.0 108.957 -179.498 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 95.7 p -135.78 156.15 49.26 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-O 121.94 0.876 . . . . 0.0 111.249 -178.317 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -145.65 167.36 23.29 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 121.583 0.706 . . . . 0.0 110.183 -179.401 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 3.7 t -85.38 133.54 34.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.614 -0.679 . . . . 0.0 110.212 -179.392 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -70.71 -19.11 62.79 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.126 -0.984 . . . . 0.0 110.687 -179.361 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -88.49 21.36 2.95 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.168 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . 0.42 ' H ' ' C ' ' B' ' 344' ' ' ALA . 59.7 p -144.42 93.81 2.48 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.832 -1.076 . . . . 0.0 111.863 -179.037 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.848 HD23 HD22 ' A' ' 79' ' ' LEU . 44.4 tp -59.84 -38.97 83.6 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.669 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.715 ' CE2' HD11 ' A' ' 79' ' ' LEU . 57.5 m-85 -54.16 -52.28 61.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.185 -0.947 . . . . 0.0 110.946 -179.22 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 48.3 mtmt -69.64 -39.24 77.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.432 -1.417 . . . . 0.0 110.102 -179.378 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.586 ' O ' ' N ' ' B' ' 352' ' ' THR . 23.7 mt -50.12 -59.78 3.59 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.73 -1.232 . . . . 0.0 109.534 179.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.551 ' OE1' ' NH1' ' A' ' 126' ' ' ARG . 13.1 mm-40 -43.29 -11.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.555 -0.716 . . . . 0.0 111.4 -177.499 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.586 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.3 p -89.47 -8.96 51.81 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.586 -1.321 . . . . 0.0 109.638 179.966 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 68.8 mt -93.44 120.0 33.2 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.011 -1.055 . . . . 0.0 108.664 178.58 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.04 94.81 0.81 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.261 -1.536 . . . . 0.0 109.261 179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 44.2 mt -102.26 88.22 3.25 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.429 -1.041 . . . . 0.0 109.569 179.691 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 71.8 p -93.11 170.8 9.37 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.071 -1.018 . . . . 0.0 110.528 -179.566 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -64.45 116.39 6.07 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.758 -0.589 . . . . 0.0 110.99 -179.461 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 102.26 4.83 50.14 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 49.7 m -85.67 110.83 19.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.37 -1.077 . . . . 0.0 110.84 -179.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 45.7 t -76.23 115.9 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 121.965 0.888 . . . . 0.0 109.206 -177.301 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 13.3 m -110.21 175.79 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -178.266 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 26.4 m -130.86 131.29 44.47 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 177.463 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 78.3 mt -108.71 120.84 60.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 178.432 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 78.3 p -127.2 136.81 52.56 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -179.021 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -147.53 155.21 41.64 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.88 -1.138 . . . . 0.0 110.66 -179.271 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . 0.482 ' OE1' ' N ' ' B' ' 301' ' ' MET . 12.6 tp10 -144.84 121.98 11.47 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.476 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.452 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 161.07 -158.71 30.37 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 118.474 -1.822 . . . . 0.0 112.08 179.573 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 42.3 tp10 -59.98 -51.89 67.73 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.396 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -110.13 11.31 23.78 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.958 -1.089 . . . . 0.0 111.239 -177.086 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.553 ' OE1' ' N ' ' B' ' 371' ' ' GLN . 0.0 OUTLIER -40.52 -31.66 0.16 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.279 -0.888 . . . . 0.0 112.469 -178.43 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . 0.553 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 63.9 mt-30 -66.81 -48.3 69.38 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 120.374 -1.454 . . . . 0.0 110.958 -177.861 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -66.86 -48.17 69.66 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 118.53 -1.268 . . . . 0.0 108.339 179.669 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -42.6 -40.85 2.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.702 -0.624 . . . . 0.0 111.697 -178.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.506 ' O ' HG23 ' B' ' 378' ' ' VAL . 62.4 t -80.05 -32.63 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 120.283 -1.511 . . . . 0.0 109.769 179.717 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -69.98 -41.64 74.17 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.823 . . . . 0.0 112.392 -177.682 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . 0.488 ' O ' ' N ' ' B' ' 380' ' ' LEU . 67.1 m80 -86.54 -42.38 13.56 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.398 -1.438 . . . . 0.0 110.382 -179.513 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 88.3 mt -59.05 -40.01 83.79 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.956 -1.097 . . . . 0.0 108.285 -179.261 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.506 HG23 ' O ' ' B' ' 374' ' ' VAL . 51.1 t -64.36 -46.38 93.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 119.622 -0.831 . . . . 0.0 109.595 179.129 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -80.09 -9.5 59.71 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.785 -1.197 . . . . 0.0 109.786 178.492 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.488 ' N ' ' O ' ' B' ' 376' ' ' HIS . 49.5 tp -83.54 -28.27 28.74 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 176.769 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 56.9 tpp -81.42 -29.56 33.82 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.121 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -81.21 -9.6 59.76 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.891 -0.506 . . . . 0.0 109.902 179.413 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -106.96 1.48 24.52 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.231 -0.918 . . . . 0.0 110.998 -179.652 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . 0.405 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 20.6 mt -78.59 117.89 20.19 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.275 -1.516 . . . . 0.0 110.002 -179.657 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 N--CA 1.496 1.869 0 CA-C-O 117.912 -1.042 . . . . 0.0 108.736 178.715 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 mmt . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.197 -0.668 . . . . 2.91 109.197 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 99.3 mt -109.77 126.42 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 108.407 -0.96 . . . . 1.2 108.407 179.202 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.9 m -125.13 121.6 34.71 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.604 -0.685 . . . . 1.4 110.018 -178.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.72 -164.97 32.99 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 109.186 -1.566 . . . . 1.05 109.186 179.166 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' ' O ' ' A' ' 6' ' ' LEU . 88.2 mt -88.68 -13.6 9.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.02 -1.283 . . . . 1.15 109.854 -179.766 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 5' ' ' ILE . 56.2 tp 46.07 99.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.227 -0.921 . . . . 0.98 110.342 179.094 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.51 -29.48 12.7 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.031 -1.043 . . . . 0.88 108.963 179.063 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 40.9 t -119.22 116.46 33.86 Favored Pre-proline 0 N--CA 1.501 2.101 0 N-CA-C 109.039 -0.726 . . . . 1.69 109.039 179.46 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.22 142.83 17.19 Favored 'Trans proline' 0 N--CA 1.489 1.25 0 C-N-CA 121.618 1.545 . . . . 0.85 111.877 179.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.734 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 161.4 -159.72 31.51 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.218 -1.553 . . . . 0.92 109.218 -179.713 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.3 mt -148.51 148.37 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 O-C-N 120.808 -1.407 . . . . 0.81 109.09 179.638 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.18 153.12 30.24 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.899 -1.126 . . . . 0.51 111.291 179.561 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.469 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 8.7 m-85 -133.16 129.94 38.52 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.72 -1.585 . . . . 0.62 106.72 177.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 179.67 175.68 46.63 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 117.936 -2.078 . . . . 0.55 111.245 -179.725 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 49.8 mtpt -77.47 160.02 28.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.889 -0.771 . . . . 2.1 109.11 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.447 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . . . -100.45 127.15 46.87 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.312 -0.867 . . . . 0.77 110.927 -179.06 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.5 tp -100.79 134.35 43.89 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 106.972 -1.492 . . . . 0.91 106.972 178.011 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 43.2 tp -120.4 122.32 40.49 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.123 -0.985 . . . . 0.93 110.044 -179.564 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 62.0 mt -80.85 102.61 10.14 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.499 0.666 . . . . 0.93 109.678 -179.421 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -99.34 131.09 45.6 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.451 -0.781 . . . . 2.75 109.883 -179.219 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -127.39 139.11 53.07 Favored 'General case' 0 N--CA 1.5 2.043 0 N-CA-C 108.969 -0.752 . . . . 3.0 108.969 -179.948 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 61.6 t0 -82.7 149.71 27.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.983 -1.073 . . . . 2.77 109.171 179.591 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.55 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 70.7 tt0 -68.08 147.31 52.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 2.94 109.269 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.3 mt -97.62 133.78 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.232 -0.918 . . . . 0.95 109.181 -179.747 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.3 t -103.43 127.86 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 121.249 -0.907 . . . . 1.28 110.164 -179.056 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 84.1 mt -99.2 142.48 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.477 -0.765 . . . . 1.21 109.293 -179.48 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -97.11 117.32 31.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.065 -1.022 . . . . 1.81 109.449 -179.762 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -89.27 3.61 51.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.172 -0.955 . . . . 2.8 109.153 -179.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -67.22 140.1 57.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.107 -0.996 . . . . 2.87 110.283 -179.772 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -84.8 141.93 30.14 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 2.35 109.333 179.631 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.431 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.8 pt -89.84 164.1 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.195 -0.941 . . . . 0.97 109.365 179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 100.0 p -95.86 171.63 8.52 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.042 -1.036 . . . . 1.17 108.77 179.338 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.38 -48.35 80.91 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.882 -1.136 . . . . 1.18 109.376 -179.443 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -55.91 -30.38 61.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.698 -1.251 . . . . 2.56 109.878 -179.855 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -80.94 -9.69 59.8 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.214 -0.929 . . . . 1.79 109.837 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.469 ' O ' HG23 ' A' ' 40' ' ' VAL . 40.9 t -62.41 -50.17 80.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 120.781 -1.199 . . . . 1.0 108.796 179.758 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -65.49 -40.11 92.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.842 -1.161 . . . . 1.77 110.199 179.854 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -69.97 -40.12 75.56 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.11 -0.993 . . . . 2.7 109.895 -179.282 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.544 ' OE2' ' NH1' ' A' ' 42' ' ' ARG . 28.1 mm-40 -68.37 -40.07 81.58 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.447 -0.783 . . . . 1.51 110.301 -179.242 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 36' ' ' VAL . 53.1 t -59.95 -41.21 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 107.608 -1.256 . . . . 0.93 107.608 179.173 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -58.38 -37.97 76.34 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.563 -0.71 . . . . 1.81 109.626 -179.873 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.544 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 99.3 mtt180 -58.7 -41.71 86.95 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 118.865 -1.134 . . . . 2.78 108.016 179.443 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -62.73 -47.88 81.65 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.409 -0.959 . . . . 0.78 108.409 178.243 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 65.8 tp -59.85 -49.06 79.17 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.901 -1.148 . . . . 1.07 107.901 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.1 t -60.58 -45.15 95.01 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.464 -0.939 . . . . 1.12 108.464 178.653 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.93 -43.89 97.66 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.151 -1.98 . . . . 0.84 108.151 178.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -63.26 -33.09 74.75 Favored 'General case' 0 N--CA 1.485 1.316 0 O-C-N 121.476 -1.014 . . . . 3.09 108.72 178.34 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.25 -39.94 84.39 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.553 -0.717 . . . . 0.88 109.57 -179.207 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 50' ' ' ALA . 26.1 ttmt -70.67 -74.03 0.15 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.258 -1.386 . . . . 2.59 107.258 178.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.59 -39.61 0.34 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.944 -0.472 . . . . 0.7 111.126 -178.763 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 29.4 t -56.25 -59.04 5.52 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.338 -1.477 . . . . 1.4 108.559 179.598 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.17 -39.98 90.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.367 -0.833 . . . . 0.67 111.105 -179.267 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -69.82 -40.7 75.74 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.837 -1.164 . . . . 1.66 110.471 -178.931 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.3 mt -62.49 -39.95 95.15 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.915 -1.116 . . . . 1.58 108.063 179.408 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -62.87 -38.43 90.85 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.375 -0.828 . . . . 1.35 109.194 178.762 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 95.7 m -64.01 -43.81 94.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.182 -0.949 . . . . 0.77 109.477 179.137 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 94.3 mt -61.69 -37.84 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 0.63 109.192 179.693 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 24.7 ttpt -58.8 -50.21 74.8 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.137 -0.977 . . . . 1.14 109.56 -179.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -57.49 -33.69 68.28 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.494 -0.754 . . . . 0.79 110.676 -177.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -69.62 -37.96 77.04 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.225 -0.922 . . . . 1.53 109.366 -179.438 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.41 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -66.29 -48.6 69.87 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.34 -0.85 . . . . 0.57 109.762 -179.794 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -53.08 -55.67 22.88 Favored Glycine 0 N--CA 1.486 2.008 0 C-N-CA 120.169 -1.015 . . . . 0.75 110.572 -179.146 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -70.18 -43.59 70.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.085 -1.244 . . . . 1.59 111.016 -178.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 58.5 m -63.09 -62.81 1.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.0 -1.063 . . . . 0.73 111.617 -177.742 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -97.4 -43.53 7.25 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 120.954 -1.091 . . . . 0.75 111.541 -177.926 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.65 -171.4 24.4 Favored Glycine 0 N--CA 1.501 3.032 0 O-C-N 120.703 -1.248 . . . . 1.22 111.298 179.619 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -68.95 -23.02 64.09 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.816 -0.814 . . . . 5.81 109.59 179.978 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.512 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.9 tp10 -60.01 -34.3 73.17 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.807 -0.558 . . . . 3.37 110.741 -179.508 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.6 mmtm -98.71 -18.86 17.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.199 -0.938 . . . . 1.77 109.62 -179.695 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 74.2 tt0 -67.68 -39.44 84.46 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.366 -0.834 . . . . 1.65 109.916 -179.799 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.579 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.91 -34.21 76.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.77 110.304 -178.685 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 85.1 mt -59.77 -40.43 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.635 -1.291 . . . . 0.8 108.682 179.731 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -64.2 -38.74 92.14 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.1 -1.0 . . . . 0.88 110.175 179.068 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.7 tt0 -59.06 -39.7 82.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.161 -0.962 . . . . 1.37 109.141 -179.602 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.0 -41.02 95.47 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.179 -1.568 . . . . 0.62 109.179 179.069 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -66.02 -49.65 66.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.998 -1.295 . . . . 1.5 108.472 179.547 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.2 mt -61.91 -49.32 84.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.577 -0.702 . . . . 0.63 109.372 179.279 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 40.5 ttp -59.93 -46.29 89.88 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.331 -0.855 . . . . 1.51 109.802 -179.698 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.871 HD11 ' CE2' ' B' ' 348' ' ' PHE . 57.1 tp -60.13 -41.49 92.77 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.353 -0.842 . . . . 0.77 109.347 179.698 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.2 -39.64 89.81 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.181 -0.608 . . . . 0.62 110.065 -178.677 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -79.12 2.76 19.66 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.188 -0.945 . . . . 1.47 109.37 -179.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -51.14 129.41 24.17 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.296 -0.878 . . . . 1.47 110.415 -178.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.63 -16.54 39.68 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.8 -0.562 . . . . 1.78 110.138 -179.884 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -74.13 -35.74 64.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.027 -1.045 . . . . 2.53 109.494 178.933 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.8 mt -70.58 -41.06 72.86 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.453 -0.779 . . . . 0.8 110.754 179.946 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -60.01 -49.48 77.48 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.246 -0.909 . . . . 1.42 110.394 -178.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -69.77 -40.47 76.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.891 . . . . 1.71 110.91 -178.916 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -67.9 -40.15 83.52 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.971 -1.081 . . . . 1.57 110.874 -178.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.93 -47.52 68.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.906 -1.121 . . . . 0.65 109.636 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.4 mt -65.36 -38.57 82.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.618 -0.676 . . . . 0.82 110.263 179.974 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.09 -47.63 85.09 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.221 -0.924 . . . . 0.79 111.244 -178.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.2 mt -59.87 -43.93 94.44 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.853 -1.154 . . . . 0.95 109.243 -179.043 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 87.8 mt -63.34 -48.49 87.09 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.437 -0.79 . . . . 0.66 109.501 179.424 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -68.57 -40.34 80.63 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.116 -0.99 . . . . 2.2 110.189 179.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -80.74 -52.43 7.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.179 -0.951 . . . . 1.65 111.604 -178.403 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -91.15 -3.08 57.37 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.117 -0.99 . . . . 2.03 112.247 -177.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 80.0 m80 57.29 39.05 28.81 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.816 -1.177 . . . . 1.42 109.834 -179.421 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 94.2 mtp -89.2 170.04 10.94 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.37 -0.832 . . . . 1.18 110.079 -179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.0 p -80.46 156.52 26.55 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.954 -0.758 . . . . 0.98 108.954 179.586 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.91 -39.9 75.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.11 -0.994 . . . . 0.64 110.2 -179.713 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -60.58 -42.57 96.97 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.062 -1.024 . . . . 2.07 110.459 179.811 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -81.71 -46.33 14.43 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.374 -0.829 . . . . 0.73 110.494 -179.253 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.06 -48.26 82.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.372 -0.83 . . . . 0.54 110.364 -179.157 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.488 ' HB1' HD21 ' A' ' 137' ' ' LEU . . . -59.97 -47.51 85.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.929 . . . . 0.56 110.522 -179.094 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.655 ' HB2' HD21 ' A' ' 138' ' ' LEU . 85.0 t60 -60.15 -35.21 74.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.997 -1.065 . . . . 1.54 110.392 -179.63 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -60.28 -39.91 88.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.012 -1.055 . . . . 1.33 110.559 -179.222 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.6 t -64.67 -50.09 77.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.803 -1.185 . . . . 0.72 110.973 -178.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 44.4 mm -68.96 -40.14 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 120.801 -1.187 . . . . 0.85 109.134 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -64.03 -38.32 90.65 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.799 -0.815 . . . . 2.44 108.799 178.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -60.97 -50.04 71.94 Favored Glycine 0 N--CA 1.49 2.286 0 C-N-CA 120.247 -0.977 . . . . 0.98 110.839 -179.302 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -65.24 -53.43 44.52 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.866 -1.373 . . . . 1.41 110.484 -179.142 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -55.54 -39.16 70.21 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.998 -1.064 . . . . 1.2 109.301 -179.91 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.6 t -53.82 -40.66 66.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.295 -0.878 . . . . 1.7 108.663 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.84 70.27 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.505 -0.747 . . . . 1.47 109.483 179.025 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 71.0 mt -65.78 -43.84 87.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.026 -1.046 . . . . 1.56 109.818 -178.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -59.97 -38.5 82.71 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.499 -1.376 . . . . 2.2 108.912 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -54.74 -18.88 5.21 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.225 -0.922 . . . . 2.12 109.538 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.439 HD13 HD13 ' A' ' 123' ' ' LEU . 85.4 mt -61.57 139.98 58.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.085 -1.009 . . . . 2.0 109.479 -179.598 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 36.4 p-10 -90.9 11.45 22.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.254 -0.904 . . . . 3.23 109.714 179.917 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -99.01 117.0 32.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.151 -0.968 . . . . 2.49 109.207 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -60.2 -30.59 69.46 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.272 -0.892 . . . . 3.95 109.363 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.451 ' OH ' ' CA ' ' B' ' 315' ' ' HIS . 19.8 t80 -61.02 -42.08 97.79 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.995 0.902 . . . . 2.0 109.161 179.274 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.893 HD22 ' O ' ' B' ' 351' ' ' GLN . 74.9 mt -80.4 -26.9 38.25 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.975 -0.75 . . . . 1.86 108.975 179.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -60.07 -43.94 95.11 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.47 -0.937 . . . . 2.84 108.47 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -60.61 -45.61 93.35 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.115 -1.068 . . . . 2.73 108.115 178.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -60.68 -39.43 88.43 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.748 -0.781 . . . . 2.77 109.08 178.403 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.17 -28.27 66.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.388 -0.82 . . . . 1.19 109.162 -179.971 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -71.31 -38.78 71.72 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.225 -0.922 . . . . 1.2 109.677 179.537 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -64.5 -40.58 95.93 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.025 -1.047 . . . . 1.55 110.466 -179.368 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.435 HG21 HE22 ' B' ' 351' ' ' GLN . 38.1 t -69.82 -42.0 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.873 -1.142 . . . . 0.8 109.801 -179.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -60.59 -38.6 85.17 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.762 -1.211 . . . . 3.09 109.407 179.427 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -58.68 -39.74 81.55 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.395 -0.816 . . . . 1.46 110.011 -178.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -59.99 -41.45 86.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.091 -1.005 . . . . 0.71 109.921 -179.611 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.94 -35.75 92.48 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.919 -1.272 . . . . 0.57 109.919 -179.934 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -60.05 -48.57 81.17 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.318 -1.107 . . . . 2.59 110.995 -178.717 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.417 HH22 ' CB ' ' A' ' 166' ' ' SER . 98.0 mtt180 -67.69 -30.89 70.53 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.571 -1.331 . . . . 2.83 110.383 179.929 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.488 HD21 ' HB1' ' A' ' 104' ' ' ALA . 63.9 tp -58.53 -44.96 89.75 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.268 -1.012 . . . . 1.25 108.268 -179.175 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.655 HD21 ' HB2' ' A' ' 105' ' ' HIS . 66.1 mt -61.43 -43.97 97.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.7 110.192 178.631 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -70.02 -40.21 75.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.89 . . . . 2.57 109.891 -179.821 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -65.79 -37.92 87.6 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.671 -0.643 . . . . 1.23 111.048 -178.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 89.4 mt -66.98 -46.79 84.02 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 120.638 -1.289 . . . . 0.81 108.165 179.583 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 92.3 mt -70.16 -31.71 69.33 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 121.644 -0.66 . . . . 1.0 109.675 179.771 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.87 42.41 6.79 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.017 -1.633 . . . . 0.89 109.017 -178.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 4.9 tp -74.52 152.96 39.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.466 -1.02 . . . . 1.14 109.095 -179.654 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 38.4 tptt -64.23 143.24 58.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.083 -1.01 . . . . 4.6 109.626 -179.487 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 95.8 mt -115.4 121.77 67.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.142 0 CA-C-O 122.434 1.112 . . . . 1.24 109.22 179.279 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 8.2 mt -60.13 -47.74 90.8 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-N 115.019 -0.991 . . . . 1.54 110.858 -178.659 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.5 t0 62.92 106.04 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.615 -0.883 . . . . 1.5 108.615 -178.818 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 22.5 mt -69.33 0.3 5.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.296 -0.877 . . . . 0.79 110.174 -178.58 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 83.1 p -83.66 -13.87 53.17 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.048 -1.032 . . . . 1.4 110.379 -179.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -82.64 28.23 0.49 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.112 -0.992 . . . . 0.92 111.916 -178.374 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 32.3 mm -90.58 118.15 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.484 -1.385 . . . . 0.88 108.405 179.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -104.88 -10.59 17.22 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.391 -0.818 . . . . 2.45 110.337 -178.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -126.48 150.94 48.42 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 121.097 -1.002 . . . . 1.52 109.832 -179.788 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -63.98 133.02 52.39 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.436 -0.79 . . . . 1.58 109.731 -179.434 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.4 m -152.66 166.43 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.425 -0.797 . . . . 0.69 110.321 179.729 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 76.3 mt -95.82 147.86 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 105.994 -1.854 . . . . 0.61 105.994 177.214 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 48.7 tp -100.04 119.22 37.94 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.714 -1.241 . . . . 0.87 110.626 -177.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.8 t -119.84 129.96 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 107.978 -1.119 . . . . 0.71 107.978 178.64 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -159.46 161.96 35.55 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.125 -0.984 . . . . 0.81 109.069 -179.157 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.94 -37.25 75.82 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 120.111 -1.618 . . . . 0.98 107.294 178.412 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 13.1 p-10 -171.15 147.0 2.49 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.385 -0.598 . . . . 2.25 109.385 178.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 72.7 mt -106.04 141.36 37.55 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.336 -0.853 . . . . 0.78 108.926 179.798 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 82.1 p -94.38 144.66 28.35 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.22 -0.925 . . . . 0.98 108.828 179.629 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -40.13 -40.54 2.85 Favored 'Trans proline' 0 N--CA 1.488 1.195 0 C-N-CA 121.887 1.724 . . . . 0.81 112.268 179.724 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.417 ' CB ' HH22 ' A' ' 136' ' ' ARG . 61.4 m -60.42 -40.0 89.45 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.391 -0.818 . . . . 0.9 110.218 -179.646 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.45 -43.47 85.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.145 -0.972 . . . . 1.61 110.147 -179.099 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 40.2 p -55.67 -31.87 62.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.067 -1.021 . . . . 0.61 111.007 -178.007 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -69.73 -50.78 40.26 Favored 'General case' 0 C--N 1.297 -1.694 0 O-C-N 121.064 -1.023 . . . . 0.6 110.106 -179.547 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.41 ' H ' ' HG2' ' A' ' 170' ' ' GLN . 15.2 pt20 -88.7 39.36 0.92 Allowed 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.482 -0.933 . . . . 1.4 108.482 -179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 55.5 tp -103.35 138.03 40.66 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.683 -0.636 . . . . 0.7 109.567 179.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -87.55 101.32 13.5 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.345 -0.847 . . . . 2.35 109.648 179.849 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 46.6 mt -64.23 -42.22 96.65 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.403 -0.811 . . . . 1.51 110.379 -179.34 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.53 -27.56 66.2 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.846 -1.158 . . . . 2.33 112.45 -177.737 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 5.1 mptp? -92.69 -8.31 44.33 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 120.584 -1.322 . . . . 1.92 110.429 -178.657 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 178' ' ' GLY . 68.9 t -107.7 119.83 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 O-C-N 121.198 -0.939 . . . . 0.67 108.959 179.112 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.1 mt -88.84 8.37 29.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.287 -0.883 . . . . 1.53 111.227 -177.706 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.568 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 167.58 175.14 37.23 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.535 -1.426 . . . . 0.48 109.535 179.346 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -134.79 130.04 35.5 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.365 -1.079 . . . . 0.55 108.62 179.77 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.418 ' CG2' HG21 ' A' ' 205' ' ' THR . 95.7 mt -132.34 126.54 55.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.194 -0.941 . . . . 0.65 109.156 179.381 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 41.0 p -149.89 162.87 39.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.925 -1.109 . . . . 0.82 111.051 -179.696 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.411 ' O ' ' O ' ' A' ' 183' ' ' ALA . 35.5 p-10 -106.19 23.23 14.4 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.787 -0.57 . . . . 2.46 109.505 -179.767 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -56.62 -161.26 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.778 -1.201 . . . . 1.28 111.588 -177.689 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.04 -56.54 5.71 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 110.772 -0.931 . . . . 2.19 110.772 -178.652 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 171.83 -142.37 6.89 Favored Glycine 0 N--CA 1.489 2.227 0 C-N-CA 118.612 -1.756 . . . . 2.13 111.349 -179.448 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.456 ' C ' ' H ' ' A' ' 188' ' ' SER . 97.3 mtt180 -69.66 -31.02 68.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.853 -0.793 . . . . 5.86 110.905 -178.535 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 82.5 p -62.62 2.17 0.31 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.0 -1.063 . . . . 3.72 109.803 -179.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 186' ' ' ARG . 78.4 p -91.71 139.71 30.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.937 -1.102 . . . . 1.74 110.552 -179.964 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 68.6 t60 -55.5 -39.53 70.59 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.784 -0.821 . . . . 0.95 108.784 179.392 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.431 HG23 ' H ' ' A' ' 190' ' ' THR . 2.0 p -57.52 -41.42 80.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.613 -0.68 . . . . 1.55 109.543 -179.538 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 186' ' ' ARG . 82.8 p -69.28 -38.08 78.17 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.178 -0.951 . . . . 1.51 111.255 -179.402 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 81.6 mt -60.12 -44.48 95.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 120.885 -1.134 . . . . 1.67 110.106 -178.375 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.1 mtp -61.41 -40.3 93.92 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.041 -1.037 . . . . 1.02 111.18 -179.374 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.82 -42.66 76.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.683 -1.26 . . . . 0.68 109.113 -179.776 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -59.99 -51.79 68.15 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.088 -1.007 . . . . 2.93 109.263 -179.267 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 54.0 m -68.5 -36.89 79.56 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.449 -0.782 . . . . 0.86 111.106 -179.128 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 87.6 mt -69.91 -27.89 65.16 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.984 -1.117 . . . . 0.67 107.984 179.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 63.54 50.0 2.93 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.147 0.499 . . . . 1.5 110.587 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.477 ' O ' ' CB ' ' A' ' 8' ' ' SER . 77.0 mt -130.64 147.86 67.77 Favored Pre-proline 0 N--CA 1.505 2.285 0 N-CA-C 108.401 -0.963 . . . . 0.72 108.401 178.501 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -44.82 126.23 7.21 Favored 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.163 1.909 . . . . 0.61 112.65 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -159.32 139.85 12.3 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.537 -1.352 . . . . 0.66 111.963 179.44 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.6 mt -125.28 146.05 31.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.287 -1.375 . . . . 0.79 107.287 178.147 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 27.5 m -134.4 -4.82 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.292 0 O-C-N 120.84 -1.163 . . . . 0.91 110.588 -179.505 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.91 21.21 27.9 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 110.831 -0.908 . . . . 1.01 110.831 -179.08 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.418 HG21 ' CG2' ' A' ' 180' ' ' ILE . 7.1 p -45.01 -41.06 7.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.03 -1.277 . . . . 0.99 110.261 -179.516 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 88.83 -50.98 3.79 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.201 -0.999 . . . . 1.12 111.005 179.61 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 44.3 t -158.57 38.45 0.23 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.588 -1.536 . . . . 1.72 111.354 -179.093 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 13.9 t -76.65 -39.38 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 120.819 -1.175 . . . . 0.89 108.967 178.582 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.438 HG23 ' H ' ' A' ' 209' ' ' THR . 2.8 p -57.09 -39.79 75.71 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.648 -0.657 . . . . 1.03 111.174 -177.877 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.0 p -80.03 -13.41 59.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.014 -1.053 . . . . 1.83 110.129 -178.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -95.51 -14.58 23.55 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.119 -0.988 . . . . 2.27 109.882 -179.404 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.447 HG12 ' N ' ' A' ' 213' ' ' LYS . 55.1 t -114.16 152.74 15.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.358 -0.839 . . . . 0.92 110.994 -178.845 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.447 ' N ' HG12 ' A' ' 212' ' ' VAL . 10.5 mptt -122.12 158.57 29.02 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 107.875 -1.158 . . . . 2.2 107.875 179.179 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 13.0 t-20 -54.69 140.36 35.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.177 -0.952 . . . . 2.36 111.075 -179.04 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.48 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 5.7 t70 84.38 10.58 0.39 Allowed 'General case' 0 N--CA 1.504 2.249 0 CA-C-O 120.991 0.424 . . . . 2.38 110.88 179.105 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -80.1 139.75 36.73 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.923 -1.11 . . . . 2.09 109.049 179.211 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -87.44 128.07 35.22 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.034 -1.098 . . . . 1.27 108.034 179.154 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.447 ' CD1' ' HB2' ' A' ' 16' ' ' ALA . 58.3 mt -131.71 138.76 48.8 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.199 -0.938 . . . . 0.75 110.532 -178.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 71.9 mt -111.61 125.48 68.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 106.484 -1.673 . . . . 0.63 106.484 176.802 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 29.8 tp -103.51 119.74 39.49 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.861 -1.149 . . . . 0.7 108.944 -179.234 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.626 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 23.2 p-10 -81.51 -37.13 28.35 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.048 -1.093 . . . . 2.31 108.048 178.966 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.86 17.93 0.06 Allowed 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.732 -0.84 . . . . 0.78 108.732 -179.304 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 221' ' ' ASP . 55.3 t -135.96 -41.02 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 N-CA-C 107.912 -1.144 . . . . 1.04 107.912 178.941 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 36.9 t-20 -97.75 1.09 48.07 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.623 -1.251 . . . . 2.44 107.623 178.386 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.535 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 29.7 t-20 60.53 42.96 13.49 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.753 -0.592 . . . . 1.55 109.964 179.537 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.626 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 92.0 mt-30 -140.94 148.26 40.11 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.177 -0.952 . . . . 1.99 109.611 179.748 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -120.06 126.56 75.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.115 -1.068 . . . . 0.77 108.115 178.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -98.67 126.23 44.21 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 107.526 -1.287 . . . . 0.98 107.526 178.906 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 40.5 t -108.86 125.1 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.634 -0.666 . . . . 0.85 110.177 -177.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 53.78 68.4 2.86 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.135 -0.978 . . . . 1.66 108.839 -179.656 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -91.22 131.5 1.42 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 123.25 2.634 . . . . 0.95 112.588 -178.914 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 233' ' ' ASN . 23.5 m -63.54 166.51 6.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.315 -0.866 . . . . 1.84 109.769 -179.232 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.457 ' N ' HG22 ' A' ' 232' ' ' THR . 21.3 m120 -60.04 -40.08 88.17 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.134 -0.979 . . . . 2.74 110.045 -179.311 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -64.55 -32.18 73.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.965 -1.084 . . . . 2.89 110.092 -179.734 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.53 -39.61 84.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.058 -1.026 . . . . 1.3 108.532 179.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 93.8 mt -66.65 -40.09 85.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.377 -0.827 . . . . 1.09 109.022 179.219 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.56 -40.88 93.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.197 -0.939 . . . . 2.43 109.58 179.605 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -68.39 -40.18 81.45 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.091 -1.006 . . . . 2.78 109.517 179.887 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 86.2 mtp -71.89 -24.52 61.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.11 -0.993 . . . . 1.25 109.827 179.251 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 16.4 mmm180 -72.67 -40.09 66.56 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.015 -1.053 . . . . 2.63 109.378 178.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.84 94.7 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.269 -1.012 . . . . 1.8 108.269 179.498 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 75.9 t -69.95 -40.13 78.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.741 -0.837 . . . . 2.13 108.741 179.419 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -60.17 -42.55 95.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.44 -0.788 . . . . 3.17 109.844 -179.773 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -60.01 -40.15 88.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.334 -0.854 . . . . 1.78 109.369 -179.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -65.02 -40.08 94.35 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 120.957 -1.089 . . . . 2.47 108.664 179.803 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 77.6 t -64.55 -45.37 95.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 108.842 -0.799 . . . . 2.09 108.842 179.51 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.55 -42.1 98.39 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.563 -0.903 . . . . 2.54 108.563 179.443 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 94.7 p -64.69 -41.51 95.99 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.5 -0.75 . . . . 2.99 109.351 179.734 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 253' ' ' LEU . 17.5 tp10 -64.31 -39.92 94.88 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.757 0.789 . . . . 3.34 108.969 179.922 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 18.4 ttmm -60.4 -42.74 96.57 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.659 -0.651 . . . . 3.88 110.815 -179.521 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -73.67 -40.63 63.55 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.148 -0.97 . . . . 4.43 110.999 -179.175 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.401 ' O ' ' C ' ' A' ' 253' ' ' LEU . 67.8 mm-40 -90.96 -15.62 29.41 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.337 -0.852 . . . . 5.42 110.998 -178.27 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 249' ' ' GLU . 3.8 mp 44.26 34.68 1.07 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.098 -1.001 . . . . 6.1 109.907 -179.525 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 258' ' ' ASP . . . -87.64 35.39 0.72 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.431 -0.952 . . . . 7.37 108.431 179.692 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.426 ' N ' ' OE2' ' A' ' 249' ' ' GLU . 87.3 tttt -59.87 -49.03 79.29 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.374 -0.829 . . . . 8.01 110.0 -179.011 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 62.4 tp -69.22 -41.1 77.49 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.817 -1.177 . . . . 9.05 109.326 179.247 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -70.64 -60.08 2.46 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.431 -0.793 . . . . 10.56 109.83 -179.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.452 ' N ' ' O ' ' A' ' 254' ' ' ALA . 60.4 m-20 -105.91 75.5 1.12 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.502 -0.749 . . . . 11.32 109.093 -179.822 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 . . . . . 0 C--N 1.296 -1.752 0 CA-C-O 117.926 -1.035 . . . . 12.42 109.185 179.5 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . 0.415 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 37.0 ttp . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.407 0.622 . . . . 0.0 109.544 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . 0.415 ' N ' ' CG ' ' B' ' 301' ' ' MET . 16.8 t80 -152.44 148.8 27.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.353 -0.842 . . . . 0.0 108.871 179.552 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -152.36 163.59 39.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.889 -1.132 . . . . 0.0 110.573 -179.317 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 65.0 tp60 -156.81 153.57 28.5 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.618 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . 0.448 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 56.4 mp0 -115.08 130.9 57.04 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.203 -0.936 . . . . 0.0 109.414 179.029 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.4 p -130.55 125.32 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.425 0 CA-C-O 122.371 1.082 . . . . 0.0 111.435 -178.13 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 36.6 m -81.07 103.65 11.02 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 121.913 0.863 . . . . 0.0 111.114 -178.02 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.451 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.6 mt -52.22 121.5 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.456 1.122 . . . . 0.0 110.952 -177.627 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 74.1 p -106.33 18.01 22.6 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.066 -178.427 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.32 118.89 71.45 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 120.65 -1.281 . . . . 0.0 109.221 179.826 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -52.41 -15.01 3.42 Favored 'Trans proline' 0 N--CA 1.497 1.727 0 CA-C-N 120.176 1.098 . . . . 0.0 112.569 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -118.91 8.52 11.71 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 72.54 177.89 31.98 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.537 -1.825 . . . . 0.0 108.537 -179.298 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.435 ' C ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -85.93 93.19 8.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -1.184 . . . . 0.0 108.527 -179.192 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.451 ' CA ' ' OH ' ' A' ' 122' ' ' TYR . 4.1 p80 -96.66 -160.15 0.78 Allowed 'General case' 0 N--CA 1.507 2.384 0 O-C-N 121.109 -0.994 . . . . 0.0 109.958 179.974 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.3 m -59.38 -43.12 92.96 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.831 -1.168 . . . . 0.0 112.146 -176.032 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.579 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 2.5 tpt180 -57.56 -61.82 6.51 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 120.453 -1.404 . . . . 0.0 111.703 -178.485 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.409 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 13.8 Cg_endo -59.42 -32.99 97.4 Favored 'Trans proline' 0 N--CA 1.489 1.217 0 CA-C-N 119.932 1.011 . . . . 0.0 111.516 -179.431 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.27 -51.53 69.14 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.162 -0.961 . . . . 0.0 109.072 179.74 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.2 -41.71 62.92 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.341 -0.85 . . . . 0.0 109.587 -178.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -71.33 -40.03 71.0 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.911 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 50.8 t80 -61.95 -54.78 37.05 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.426 -0.796 . . . . 0.0 109.784 179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 89.8 t -61.33 -26.56 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.957 -1.09 . . . . 0.0 110.173 -178.899 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 15.3 ttmt -63.02 -44.24 96.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.281 -0.887 . . . . 0.0 110.426 -179.406 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -69.89 -40.14 75.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.383 -0.823 . . . . 0.0 111.731 -178.027 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . 0.536 ' O ' ' N ' ' B' ' 328' ' ' GLY . . . -65.53 -55.86 15.49 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.3 -1.5 . . . . 0.0 111.924 -178.354 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 46.3 mttm -48.21 -10.2 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.033 -1.042 . . . . 0.0 110.281 -178.814 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' B' ' 326' ' ' ALA . . . -81.63 -15.35 76.01 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.23 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -107.07 140.42 39.91 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.377 -1.072 . . . . 0.0 109.255 179.433 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 16.9 m -91.31 -11.64 37.41 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 110.238 -179.981 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 35.9 m -64.77 155.11 34.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.759 -1.213 . . . . 0.0 109.591 179.656 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -70.76 133.83 46.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.89 -1.131 . . . . 0.0 108.315 179.861 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 90.2 mt -131.79 133.5 61.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 CA-C-O 121.362 0.601 . . . . 0.0 109.954 -179.692 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.4 m -130.08 148.61 51.95 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.445 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 79.7 t -120.29 114.96 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 177.459 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 92.7 m -105.46 124.95 50.4 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.227 -0.92 . . . . 0.0 109.709 -178.289 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 48.4 t -134.35 120.5 19.97 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-O 122.139 0.971 . . . . 0.0 111.59 179.994 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 66.6 t30 45.37 50.99 9.79 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 176.717 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.7 -11.97 68.62 Favored Glycine 0 N--CA 1.501 3.031 0 O-C-N 120.155 -1.591 . . . . 0.0 113.15 176.472 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -126.44 138.87 53.58 Favored 'General case' 0 N--CA 1.507 2.405 0 CA-C-N 119.389 1.594 . . . . 0.0 109.432 -179.809 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 60.2 p -130.58 152.69 49.67 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 122.118 0.961 . . . . 0.0 111.236 -178.512 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . 0.47 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -143.31 163.59 32.59 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.494 0.664 . . . . 0.0 109.52 -179.955 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 10.8 t -87.52 135.89 33.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.637 -0.665 . . . . 0.0 110.821 -178.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.47 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -68.06 -21.31 65.0 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.107 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -80.3 25.18 0.41 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.037 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . 0.47 ' H ' ' C ' ' B' ' 344' ' ' ALA . 58.4 m -152.92 92.94 1.69 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 118.814 -1.154 . . . . 0.0 113.266 -178.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.668 HD23 HD22 ' A' ' 79' ' ' LEU . 57.8 tp -59.53 -34.26 72.41 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 177.225 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.871 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.4 m-85 -58.81 -53.3 59.98 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.707 -0.621 . . . . 0.0 110.264 -179.997 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -78.26 -16.45 57.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.771 -1.206 . . . . 0.0 110.619 -177.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.604 ' O ' ' N ' ' B' ' 352' ' ' THR . 26.4 mt -69.64 -56.16 8.02 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.146 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.893 ' O ' HD22 ' A' ' 123' ' ' LEU . 30.3 mt-30 -40.82 -12.71 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.103 -178.62 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.604 ' N ' ' O ' ' B' ' 350' ' ' LEU . 59.2 p -90.82 -8.19 50.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.52 -1.362 . . . . 0.0 109.954 -179.996 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.47 HD11 ' HB3' ' B' ' 342' ' ' ALA . 85.0 mt -96.74 121.1 38.22 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.092 -1.005 . . . . 0.0 109.384 179.371 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.5 90.53 0.94 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.793 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 20.2 mt -99.79 91.94 5.08 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.19 -1.182 . . . . 0.0 108.855 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 38.0 p -94.01 -179.19 4.88 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.276 -0.89 . . . . 0.0 110.545 -179.383 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -69.84 110.1 4.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.849 -0.532 . . . . 0.0 110.118 -179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 104.16 9.72 35.94 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 28.4 m -84.76 110.77 19.04 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.156 -1.202 . . . . 0.0 110.888 -179.482 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 27.2 t -77.12 111.86 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-O 122.237 1.018 . . . . 0.0 109.747 -177.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 17.5 m -109.03 175.02 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -178.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 32.3 m -131.79 128.61 39.15 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.647 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 95.0 mt -103.33 115.41 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 178.521 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 77.3 p -120.13 132.65 55.49 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.393 -0.817 . . . . 0.0 109.128 -179.356 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.81 152.61 40.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.898 . . . . 0.0 108.949 -179.057 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -147.71 125.45 11.87 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.16 -0.963 . . . . 0.0 109.471 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.495 ' O ' ' OE1' ' B' ' 370' ' ' GLU . . . 154.02 -148.97 20.26 Favored Glycine 0 N--CA 1.492 2.426 0 C-N-CA 119.277 -1.44 . . . . 0.0 111.532 179.824 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -60.02 -51.69 68.56 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -176.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.542 ' N ' ' OG ' ' B' ' 331' ' ' SER . 89.1 m-20 -112.71 13.77 19.89 Favored 'General case' 0 N--CA 1.51 2.527 0 O-C-N 120.835 -1.165 . . . . 0.0 111.267 -177.681 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.584 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 1.0 OUTLIER -42.39 -32.57 0.54 Allowed 'General case' 0 C--N 1.296 -1.757 0 O-C-N 121.271 -0.893 . . . . 0.0 111.477 -179.011 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . 0.514 ' H ' ' CD ' ' B' ' 370' ' ' GLU . 10.3 pt20 -70.94 -43.2 68.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.853 -1.154 . . . . 0.0 110.205 -178.745 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -69.43 -54.25 15.26 Favored 'General case' 0 C--N 1.292 -1.918 0 O-C-N 121.377 -0.827 . . . . 0.0 109.159 179.473 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.86 -34.51 8.93 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.621 -0.674 . . . . 0.0 112.252 -178.398 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 69.4 t -80.99 -36.29 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 O-C-N 120.468 -1.395 . . . . 0.0 108.926 178.756 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -70.89 -38.97 73.05 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.657 -0.652 . . . . 0.0 111.269 179.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -82.54 -48.98 10.39 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.798 -1.189 . . . . 0.0 111.694 -178.235 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.1 mt -60.02 -30.68 69.33 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.164 -0.96 . . . . 0.0 109.464 -179.096 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 55.0 t -79.78 -31.62 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.148 -0.97 . . . . 0.0 109.416 179.25 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -77.35 -22.22 52.11 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.689 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 31.9 tp -78.25 -67.76 0.7 Allowed 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 5.6 ttp -56.01 -22.99 30.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.219 -0.925 . . . . 0.0 109.788 -178.619 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -74.83 -22.2 58.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.928 -1.108 . . . . 0.0 108.705 177.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -104.21 2.52 31.81 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.42 -0.8 . . . . 0.0 111.677 -178.362 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 85.0 mt -85.03 125.47 32.76 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 120.219 -1.551 . . . . 0.0 109.739 179.739 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 . . . . . 0 N--CA 1.498 1.937 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.052 179.004 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.2 mtp . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.255 -0.646 . . . . 2.91 109.255 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.446 ' O ' ' O ' ' A' ' 225' ' ' ASN . 89.8 mt -107.58 129.02 62.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 108.613 -0.884 . . . . 1.2 108.613 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.9 m -130.76 141.45 50.36 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.606 -0.684 . . . . 1.4 109.744 -179.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.751 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -138.07 -165.04 10.2 Favored Glycine 0 N--CA 1.497 2.739 0 N-CA-C 108.291 -1.924 . . . . 1.05 108.291 179.122 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.8 mt -91.99 -10.83 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.888 -1.36 . . . . 1.15 110.377 -179.05 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 5' ' ' ILE . 34.9 tp 52.62 97.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.973 -1.08 . . . . 0.98 108.839 -179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -84.59 -34.25 23.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.164 -0.96 . . . . 0.88 109.042 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.8 m -143.4 132.33 11.45 Favored Pre-proline 0 N--CA 1.498 1.94 0 O-C-N 121.416 -0.803 . . . . 1.69 108.881 179.509 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -79.92 147.19 18.91 Favored 'Trans proline' 0 N--CA 1.502 1.978 0 C-N-CA 122.193 1.929 . . . . 0.85 113.477 -179.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.782 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.53 -164.66 37.43 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 109.576 -1.41 . . . . 0.92 109.576 179.474 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.5 mt -146.45 147.82 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.29 0 O-C-N 121.26 -1.141 . . . . 0.81 108.741 179.053 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.91 154.64 31.53 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.541 -1.35 . . . . 0.51 110.979 -179.618 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.5 m-85 -136.31 129.26 31.15 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 108.245 -1.02 . . . . 0.62 108.245 178.819 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.5 -179.7 45.65 Favored Glycine 0 N--CA 1.492 2.379 0 C-N-CA 118.577 -1.773 . . . . 0.55 110.802 179.614 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -80.4 152.85 28.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.613 -0.934 . . . . 2.1 108.95 -179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.417 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -99.24 132.0 44.87 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.093 -1.004 . . . . 0.77 110.906 -178.078 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.4 tp -100.37 133.61 44.54 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 107.389 -1.338 . . . . 0.91 107.389 178.084 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 44.1 tp -115.43 121.34 42.46 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.207 -0.933 . . . . 0.93 109.949 -179.025 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 66.8 mt -91.29 106.22 18.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.521 -0.737 . . . . 0.93 109.881 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.475 ' NZ ' ' CB ' ' A' ' 20' ' ' LYS . 7.8 mtpm? -101.87 137.69 39.83 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.89 -0.781 . . . . 2.75 108.89 179.234 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.526 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 55.4 mp0 -127.81 128.76 45.84 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.373 -0.829 . . . . 3.0 108.795 179.689 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -71.89 149.85 44.77 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.044 -1.035 . . . . 2.77 108.474 179.639 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -67.52 139.98 57.0 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.924 -1.11 . . . . 2.94 108.576 -179.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 53.8 mt -80.17 130.27 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.95 109.172 -179.463 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.1 t -99.24 129.75 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.203 -0.936 . . . . 1.28 111.08 -178.413 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 87.0 mt -109.85 131.21 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.654 -0.869 . . . . 1.21 108.654 179.031 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -81.61 127.37 32.8 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.878 -1.139 . . . . 1.81 109.815 -179.449 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.52 HH11 ' HG2' ' A' ' 28' ' ' ARG . 4.6 mmt-85 -90.75 -5.72 55.33 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.514 -0.742 . . . . 2.8 109.221 -179.897 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -70.76 139.95 51.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 2.87 109.548 -179.668 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -80.96 151.97 28.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 2.35 109.027 179.184 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.462 HG21 ' HG3' ' A' ' 39' ' ' GLU . 5.2 pt -93.68 165.08 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.207 -0.933 . . . . 0.97 109.884 -179.932 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 84.8 p -98.22 168.72 10.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.997 -1.064 . . . . 1.17 108.952 178.989 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -63.15 -13.65 39.38 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.126 -0.984 . . . . 1.18 110.104 -179.675 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -86.1 -30.19 22.75 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.678 -1.23 . . . . 2.56 107.678 178.511 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -83.38 -7.58 59.54 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.515 -0.55 . . . . 1.79 109.515 179.082 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 9.0 t -64.97 -56.33 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.734 -1.229 . . . . 1.0 109.174 179.719 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -60.06 -39.91 87.62 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.236 -0.915 . . . . 1.77 109.472 179.718 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -70.22 -41.06 74.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.038 -1.039 . . . . 2.7 110.688 -179.254 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.462 ' HG3' HG21 ' A' ' 31' ' ' ILE . 63.2 mm-40 -65.3 -39.98 93.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.031 -1.043 . . . . 1.51 110.134 -179.442 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.2 t -59.94 -44.58 94.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 120.882 -1.136 . . . . 0.93 107.96 179.424 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -59.91 -38.96 83.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.14 -0.975 . . . . 1.81 108.978 179.641 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 64.0 mtp180 -59.87 -43.03 94.93 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 107.635 -1.246 . . . . 2.78 107.635 179.335 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.96 -49.28 78.29 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.229 -1.026 . . . . 0.78 108.229 178.053 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 42.6 tp -60.0 -47.99 83.53 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.954 -0.758 . . . . 1.07 108.954 179.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.444 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 46.5 t -60.75 -44.5 96.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.949 -1.094 . . . . 1.12 108.782 178.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.09 -41.29 98.0 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 107.723 -2.151 . . . . 0.84 107.723 178.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -64.35 -34.86 79.12 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.557 -0.967 . . . . 3.09 108.514 178.26 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -54.48 -42.72 71.03 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.482 -0.761 . . . . 0.88 109.523 -179.286 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.533 ' HZ1' ' CA ' ' A' ' 140' ' ' ASN . 19.7 ttpp -73.9 -73.06 0.24 Allowed 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.629 -1.249 . . . . 2.59 107.629 179.368 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.57 -34.24 0.09 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.445 -0.784 . . . . 0.7 111.035 -178.852 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.43 ' OG ' ' O ' ' A' ' 48' ' ' ALA . 90.3 p -57.43 -57.4 12.82 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.576 -1.327 . . . . 1.4 107.699 179.17 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.83 80.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.604 -0.685 . . . . 0.67 111.604 -179.2 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -68.86 -40.28 79.41 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.562 -1.337 . . . . 1.66 110.314 -178.646 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.49 -40.13 89.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.01 -1.056 . . . . 1.58 108.801 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.485 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 65.3 mm-40 -62.87 -40.0 96.15 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.251 -0.906 . . . . 1.35 109.11 179.104 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.469 HG22 ' HZ3' ' A' ' 60' ' ' LYS . 94.8 m -63.08 -39.92 96.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.77 110.133 179.857 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 83.0 mt -61.15 -40.98 87.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.012 -1.055 . . . . 0.63 108.973 179.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.485 ' NZ ' ' OE1' ' A' ' 55' ' ' GLU . 5.4 ttpm? -59.91 -50.45 73.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.279 -0.888 . . . . 1.14 110.103 -179.641 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.9 m -60.14 -39.98 88.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.79 110.841 -177.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.469 ' HZ3' HG22 ' A' ' 56' ' ' THR . 24.3 mttp -62.82 -38.66 91.62 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -0.911 . . . . 1.53 109.442 179.684 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.24 -39.97 96.11 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 121.541 -0.724 . . . . 0.57 109.435 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.63 -55.99 23.98 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.309 -1.516 . . . . 0.75 109.309 -179.86 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -63.07 -49.86 72.86 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.973 -1.31 . . . . 1.59 109.694 179.982 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.1 m -65.8 -61.36 2.11 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.067 -1.02 . . . . 0.73 111.679 -177.749 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -94.73 -56.24 2.85 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.996 -1.065 . . . . 0.75 111.256 -178.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.4 -165.21 26.79 Favored Glycine 0 N--CA 1.5 2.956 0 C-N-CA 119.811 -1.185 . . . . 1.22 111.131 -179.774 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -70.01 -25.77 63.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.935 -0.744 . . . . 5.81 110.553 -179.115 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.43 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 53.6 tp10 -60.29 -37.45 80.56 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.039 -1.038 . . . . 3.37 110.162 -179.903 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.436 ' HA ' HD12 ' A' ' 72' ' ' ILE . 32.2 mmtp -100.22 -19.86 16.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.397 -0.814 . . . . 1.77 110.72 -179.179 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.2 tt0 -69.92 -42.96 72.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.793 -1.192 . . . . 1.65 110.174 -179.427 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.538 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.22 -30.72 70.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.505 -0.747 . . . . 0.77 109.499 -179.315 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.436 HD12 ' HA ' ' A' ' 69' ' ' LYS . 80.0 mt -60.1 -43.18 92.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.107 -0.996 . . . . 0.8 109.872 -179.569 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -74.84 -30.61 61.42 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.242 -0.911 . . . . 0.88 110.579 -178.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -61.57 -39.93 92.92 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.814 -1.179 . . . . 1.37 109.522 178.674 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.23 -46.95 93.44 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.87 -1.692 . . . . 0.62 108.87 179.385 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.2 m170 -60.01 -44.44 94.58 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.343 -1.093 . . . . 1.5 108.515 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 89.4 mt -62.75 -50.02 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 109.053 -0.721 . . . . 0.63 109.053 179.35 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -60.01 -40.59 89.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.235 -0.916 . . . . 1.51 109.54 179.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.9 HD22 HD23 ' B' ' 347' ' ' LEU . 43.8 tp -63.86 -40.03 95.6 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.518 -0.739 . . . . 0.77 109.552 179.335 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -68.85 -38.42 79.76 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.768 -0.583 . . . . 0.62 110.437 -178.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -79.34 0.36 29.33 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.017 -1.052 . . . . 1.47 110.048 -179.292 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.7 t0 -47.78 130.86 14.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.201 -0.937 . . . . 1.47 110.38 -178.934 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.41 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 93.9 mt-10 -61.94 -18.54 60.68 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.645 -0.659 . . . . 1.78 111.086 -179.192 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -72.88 -33.72 66.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.818 -1.176 . . . . 2.53 108.855 178.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.0 mt -70.07 -41.01 74.68 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 109.099 -0.704 . . . . 0.8 109.099 179.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.88 -48.68 80.7 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.216 -0.928 . . . . 1.42 110.76 -179.13 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.23 -39.99 74.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.415 -0.803 . . . . 1.71 111.076 -178.579 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -69.81 -39.93 76.24 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.277 -0.89 . . . . 1.57 110.839 -178.581 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.9 mt -69.02 -41.57 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.28 -0.888 . . . . 0.65 109.398 -179.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 82.4 mt -69.73 -39.68 78.3 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 O-C-N 121.505 -0.747 . . . . 0.82 110.3 -179.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.0 -42.88 99.97 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.222 -0.924 . . . . 0.79 111.208 -178.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 49.1 mt -60.81 -46.97 88.44 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.709 -1.245 . . . . 0.95 109.372 -179.694 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 75.3 mt -60.17 -49.2 85.06 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.851 0.834 . . . . 0.66 108.9 179.509 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 40.5 mttp -69.98 -40.53 75.3 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.909 -0.495 . . . . 2.2 111.309 179.991 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 51.5 t0 -81.02 -57.0 3.73 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.952 -1.092 . . . . 1.65 112.099 -177.78 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.2 mttp -90.95 0.08 57.61 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.093 -1.004 . . . . 2.03 112.603 -176.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 54.6 m80 58.29 39.76 25.27 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.928 -1.108 . . . . 1.42 109.877 179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.0 mtp -89.54 166.85 13.4 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.516 -0.74 . . . . 1.18 110.036 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.452 ' OG1' ' HB3' ' A' ' 102' ' ' ALA . 43.6 p -80.37 159.67 25.65 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.365 -0.835 . . . . 0.98 108.923 179.491 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.67 -40.06 80.33 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.113 -0.992 . . . . 0.64 109.965 -179.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 32.2 p-10 -68.0 -37.12 81.07 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 2.07 109.57 179.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.503 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -81.56 -41.38 21.7 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.289 -0.882 . . . . 0.73 109.824 179.216 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.03 -47.68 73.61 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.277 -0.889 . . . . 0.54 109.705 -179.686 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.86 87.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.115 -0.991 . . . . 0.56 109.543 -179.906 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -59.89 -40.09 87.54 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.337 -0.852 . . . . 1.54 110.12 -179.244 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -60.92 -44.17 97.58 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.347 -0.846 . . . . 1.33 110.792 -179.365 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.6 t -61.54 -50.47 80.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.16 -0.963 . . . . 0.72 111.009 -177.847 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 17.5 mm -69.32 -39.88 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.021 -1.049 . . . . 0.85 108.637 179.493 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.401 ' CD ' HH12 ' A' ' 131' ' ' ARG . 41.3 tp10 -61.53 -40.0 93.07 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.869 -0.789 . . . . 2.44 108.869 179.198 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.56 -48.41 84.84 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.534 -0.841 . . . . 0.98 111.235 -178.8 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 93.3 mm-40 -69.15 -49.85 53.11 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.686 -1.479 . . . . 1.41 110.827 -178.335 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.95 -39.98 87.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.916 -1.115 . . . . 1.2 109.559 -179.257 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 40.8 t -59.45 -40.08 85.7 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.019 -1.05 . . . . 1.7 108.995 179.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -60.56 -43.85 96.82 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.3 -0.875 . . . . 1.47 109.2 179.451 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.47 HD22 ' HB3' ' B' ' 351' ' ' GLN . 76.7 mt -61.7 -41.0 97.02 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.33 -0.856 . . . . 1.56 109.45 -178.993 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -59.99 -37.77 80.63 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.076 -1.015 . . . . 2.2 109.483 -179.291 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -52.06 -22.18 3.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.043 -1.036 . . . . 2.12 109.169 179.671 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 49.7 mt -62.32 140.1 58.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.051 -1.031 . . . . 2.0 109.01 -179.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 48.2 p-10 -89.93 38.01 0.91 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.127 -0.983 . . . . 3.23 110.249 -178.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 57.9 t0 -129.8 145.95 51.56 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.344 -0.848 . . . . 2.49 109.228 179.829 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 124' ' ' LYS . 88.0 tt0 -72.71 -66.52 0.65 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.412 -0.805 . . . . 3.95 109.1 179.656 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.42 ' C ' ' O ' ' A' ' 121' ' ' GLU . 3.5 t80 -38.71 -36.19 0.24 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.789 -0.569 . . . . 2.0 110.622 -178.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.0 mt -79.24 -34.76 42.42 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.736 -1.228 . . . . 1.86 108.569 179.192 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 121' ' ' GLU . 7.4 ttpm? -68.17 -39.99 82.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 2.84 109.546 179.473 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.89 -40.31 94.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.916 . . . . 2.73 109.265 -179.615 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.536 HH11 ' CG ' ' A' ' 126' ' ' ARG . 0.0 OUTLIER -60.84 -38.23 84.79 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.429 -0.952 . . . . 2.77 108.429 -179.892 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.33 -26.92 65.44 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.518 -0.919 . . . . 1.19 108.518 179.474 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.47 -39.99 81.18 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.447 -0.946 . . . . 1.2 108.447 178.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -66.84 -42.72 85.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.505 -0.747 . . . . 1.55 109.998 179.929 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.5 t -65.23 -41.25 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 0.8 108.922 179.448 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.401 HH12 ' CD ' ' A' ' 109' ' ' GLU . 37.6 ttm-85 -60.64 -39.92 90.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.072 -1.017 . . . . 3.09 108.817 178.93 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -60.15 -34.43 73.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.57 -0.706 . . . . 1.46 109.617 -179.72 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.1 -43.09 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.135 -0.978 . . . . 0.71 109.55 -179.669 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.92 -27.61 62.24 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.838 -1.305 . . . . 0.57 109.838 -179.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 17.2 ttpp -59.98 -50.19 74.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.981 -1.305 . . . . 2.59 110.094 -179.236 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -67.75 -32.11 72.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.999 -1.063 . . . . 2.83 109.348 -179.619 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.39 -41.67 89.94 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.914 -0.773 . . . . 1.25 108.914 -179.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 95.3 mt -62.3 -40.01 94.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.152 -0.967 . . . . 0.7 109.182 179.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.405 HH21 HD23 ' A' ' 144' ' ' LEU . 58.6 mtp180 -70.04 -40.06 75.38 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.971 0.891 . . . . 2.57 108.729 179.104 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.533 ' CA ' ' HZ1' ' A' ' 49' ' ' LYS . 2.2 m120 -60.74 -38.23 84.47 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 116.002 -0.544 . . . . 1.23 111.466 -178.539 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 97.3 mt -70.33 -39.94 77.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 120.811 -1.181 . . . . 0.81 109.811 -179.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 54.2 mt -71.85 -20.56 61.8 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.397 -0.814 . . . . 1.0 110.241 -178.555 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.9 40.84 13.5 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.044 -1.622 . . . . 0.89 109.044 -179.189 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.405 HD23 HH21 ' A' ' 139' ' ' ARG . 3.3 tp -75.24 149.98 38.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.362 -1.081 . . . . 1.14 109.859 -179.361 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.5 tmmm? -74.71 141.79 44.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.513 -0.742 . . . . 4.6 109.949 -179.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.7 mt -111.3 129.77 66.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 CA-C-O 122.29 1.043 . . . . 1.24 108.84 178.802 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 15.0 mt -69.66 -39.96 78.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-N 115.411 -0.813 . . . . 1.54 110.398 -177.937 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.8 t0 68.18 127.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.741 -0.837 . . . . 1.5 108.741 -179.251 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.411 ' O ' HD13 ' A' ' 152' ' ' ILE . 19.5 mt -92.03 0.04 57.47 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.316 -0.865 . . . . 0.79 110.266 -178.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 24.5 t -95.61 -11.79 26.7 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.041 -1.037 . . . . 1.4 110.185 -179.683 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.24 15.48 1.55 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.066 -1.021 . . . . 0.92 111.333 -178.581 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.411 HD13 ' O ' ' A' ' 149' ' ' LEU . 2.8 mp -86.1 137.14 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.446 -1.409 . . . . 0.88 108.417 179.517 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -111.95 -10.45 13.96 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.537 -0.727 . . . . 2.45 109.356 -179.411 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -123.21 148.0 46.29 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.744 -0.597 . . . . 1.52 109.775 -179.522 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.33 138.91 58.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.449 -0.782 . . . . 1.58 109.164 -179.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.5 m -152.59 166.65 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.658 -0.652 . . . . 0.69 109.804 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 92.9 mt -96.51 146.07 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 106.191 -1.781 . . . . 0.61 106.191 176.964 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 50.1 tp -96.69 118.33 32.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.891 -1.13 . . . . 0.87 110.94 -177.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.0 t -119.6 123.25 70.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 109.015 -0.735 . . . . 0.71 109.015 179.095 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -153.06 159.97 42.9 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.179 -0.951 . . . . 0.81 109.012 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.27 -31.35 64.02 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.346 -1.472 . . . . 0.98 108.956 179.287 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.488 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 46.2 t0 -169.97 140.51 2.04 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.415 -0.803 . . . . 2.25 108.933 -179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.488 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 26.5 mt -114.77 131.55 56.75 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.371 -0.831 . . . . 0.78 109.031 -179.582 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 42.9 p -95.07 148.6 34.95 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.132 -0.98 . . . . 0.98 110.128 -179.526 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -37.32 -39.06 0.56 Allowed 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.652 2.235 . . . . 0.81 112.56 179.19 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 67.3 m -57.58 -39.87 77.71 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.282 -0.886 . . . . 0.9 108.93 -179.052 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -69.9 -39.9 75.94 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.169 -0.957 . . . . 1.61 109.666 -179.909 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 45.7 p -56.57 -24.01 44.32 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.033 -1.042 . . . . 0.61 110.51 -178.23 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.39 -55.78 4.96 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.967 -1.083 . . . . 0.6 109.358 179.432 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.6 pt20 -83.84 40.78 0.76 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.98 -1.119 . . . . 1.4 107.98 179.411 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 35.1 tp -103.37 130.14 50.6 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.739 -0.601 . . . . 0.7 109.611 179.501 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.489 ' OD1' ' N ' ' A' ' 172' ' ' ASN . 10.6 p-10 -86.15 97.92 10.61 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.954 -1.128 . . . . 2.35 107.954 178.243 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 56.3 mt -67.5 -41.49 84.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.317 -0.864 . . . . 1.51 111.119 -178.245 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -69.91 -26.83 64.35 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.658 -1.276 . . . . 2.33 112.222 -177.747 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -92.0 -5.94 52.1 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.556 -1.34 . . . . 1.92 109.513 -178.793 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.627 HG12 ' H ' ' A' ' 178' ' ' GLY . 60.9 t -107.28 119.66 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.688 -1.227 . . . . 0.67 107.688 178.168 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 92.1 mt -84.7 7.21 21.24 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.379 -0.825 . . . . 1.53 110.675 -177.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.627 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 163.53 178.11 36.94 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.192 -1.563 . . . . 0.48 109.192 179.781 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.462 ' CE1' HG11 ' A' ' 176' ' ' VAL . 13.2 m-85 -134.46 130.43 36.72 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.393 -1.063 . . . . 0.55 109.038 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.414 ' CG2' HG21 ' A' ' 205' ' ' THR . 91.5 mt -130.63 125.2 58.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 108.204 -1.035 . . . . 0.65 108.204 178.844 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 65.6 p -149.69 160.32 43.62 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.845 -1.159 . . . . 0.82 110.682 -179.073 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.457 ' CB ' ' H ' ' A' ' 206' ' ' GLY . 4.1 p30 -108.69 27.19 9.68 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.513 -0.921 . . . . 2.46 108.513 179.283 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.25 -164.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.122 -0.986 . . . . 1.28 112.079 -177.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.63 -79.89 0.09 OUTLIER Glycine 0 N--CA 1.492 2.387 0 CA-C-N 115.793 -0.64 . . . . 2.19 111.579 -178.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -157.13 -151.64 6.07 Favored Glycine 0 N--CA 1.494 2.553 0 O-C-N 120.711 -1.464 . . . . 2.13 111.17 -178.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 47.6 ttt180 -79.73 -9.97 59.72 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.828 -0.807 . . . . 5.86 110.553 -178.448 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 22.9 p -84.55 3.12 38.09 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.101 -1.0 . . . . 3.72 110.856 -178.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 47.3 t -72.02 143.07 49.29 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.827 -1.17 . . . . 1.74 110.18 -179.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -49.55 -50.21 43.11 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.235 -0.916 . . . . 0.95 110.128 -179.302 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 85.3 m -59.86 -40.23 87.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.368 -0.832 . . . . 1.55 110.32 -178.642 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 52.2 p -59.93 -40.17 87.98 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.933 -1.104 . . . . 1.51 110.453 -178.941 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.426 HG12 HH21 ' A' ' 195' ' ' ARG . 96.9 mt -60.0 -38.92 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.205 -0.935 . . . . 1.67 109.526 -179.739 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.5 mtp -60.25 -39.89 88.36 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.858 . . . . 1.02 110.207 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -57.12 -45.71 83.25 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.834 -1.166 . . . . 0.68 109.725 -179.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.426 HH21 HG12 ' A' ' 192' ' ' ILE . 83.6 mtm180 -60.36 -49.79 76.19 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 119.077 -1.049 . . . . 2.93 110.298 -179.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 30.6 m -69.94 -34.7 73.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.715 -1.24 . . . . 0.86 110.525 -179.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 84.4 mt -72.67 -21.59 61.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.009 -1.057 . . . . 0.67 108.973 179.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 62.15 50.79 3.8 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-O 121.395 0.617 . . . . 1.5 110.886 179.959 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 96.5 mt -126.35 149.96 68.8 Favored Pre-proline 0 N--CA 1.498 1.952 0 N-CA-C 107.468 -1.308 . . . . 0.72 107.468 178.355 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.3 135.5 50.55 Favored 'Trans proline' 0 N--CA 1.503 2.044 0 C-N-CA 122.25 1.967 . . . . 0.61 111.845 -179.414 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -169.99 149.97 3.72 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.595 -1.242 . . . . 0.66 111.941 -179.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.0 mt -126.54 146.03 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.787 -1.19 . . . . 0.79 107.787 179.147 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 30.7 m -130.48 -9.25 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.401 0 O-C-N 120.86 -1.15 . . . . 0.91 111.547 -179.268 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.58 23.83 23.45 Favored Glycine 0 N--CA 1.499 2.896 0 N-CA-C 110.048 -1.221 . . . . 1.01 110.048 -179.584 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.414 HG21 ' CG2' ' A' ' 180' ' ' ILE . 7.9 p -45.55 -45.98 13.83 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.189 -1.183 . . . . 0.99 109.987 -179.644 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.457 ' H ' ' CB ' ' A' ' 182' ' ' ASP . . . 93.47 -54.77 2.39 Favored Glycine 0 N--CA 1.503 3.119 0 O-C-N 121.017 -1.052 . . . . 1.12 112.025 178.811 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 93.3 p -152.76 29.58 0.52 Allowed 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.551 -1.558 . . . . 1.72 111.248 -179.042 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 76.2 t -76.26 -34.95 26.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 O-C-N 120.948 -1.095 . . . . 0.89 108.957 178.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 7.6 p -57.46 -30.44 65.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.461 -0.774 . . . . 1.03 110.291 -179.124 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 57.5 p -83.77 -15.18 49.43 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.783 -1.198 . . . . 1.83 110.06 -179.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -96.21 -12.75 24.17 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.09 -1.006 . . . . 2.27 109.953 -179.587 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 73.9 t -103.73 136.65 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.363 -0.836 . . . . 0.92 110.38 -178.479 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -110.1 150.1 29.08 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.748 -1.204 . . . . 2.2 107.748 178.803 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.701 ' N ' HD22 ' A' ' 214' ' ' ASN . 0.0 OUTLIER -58.6 137.08 57.71 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.902 -1.124 . . . . 2.36 110.053 -179.355 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.479 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.4 m-20 85.64 0.04 0.73 Allowed 'General case' 0 N--CA 1.501 2.125 0 CA-C-O 121.2 0.524 . . . . 2.38 110.025 179.722 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.402 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 60.1 t0 -70.67 144.1 51.16 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.193 -0.942 . . . . 2.09 109.246 179.416 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.402 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 40.9 t80 -93.77 120.27 33.82 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.383 -0.969 . . . . 1.27 108.383 178.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.417 HD12 ' HB2' ' A' ' 16' ' ' ALA . 89.4 mt -129.39 150.81 50.58 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 121.458 -0.776 . . . . 0.75 110.766 -178.696 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 74.5 mt -115.28 127.88 72.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 107.143 -1.429 . . . . 0.63 107.143 177.362 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 61.8 tp -100.54 118.95 37.76 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.972 -1.08 . . . . 0.7 108.469 -179.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.43 ' C ' ' N ' ' A' ' 223' ' ' VAL . 18.8 t0 -81.33 -41.23 22.38 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.846 -1.168 . . . . 2.31 107.846 179.403 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.782 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 48.21 18.76 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 109.013 -0.736 . . . . 0.78 109.013 -179.961 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.43 ' N ' ' C ' ' A' ' 221' ' ' ASP . 39.2 t -128.45 -42.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 107.114 -1.439 . . . . 1.04 107.114 178.507 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -104.78 8.11 34.81 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.509 -1.293 . . . . 2.44 107.509 178.062 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.751 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.9 OUTLIER 59.62 49.45 8.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.878 -0.514 . . . . 1.55 110.245 179.703 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -147.94 149.9 33.05 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 120.817 -1.177 . . . . 1.99 110.766 179.885 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.45 122.05 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 N-CA-C 108.304 -0.998 . . . . 0.77 108.304 179.035 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -87.67 128.98 35.29 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.626 -1.296 . . . . 0.98 109.218 -179.491 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 33.1 t -104.06 119.55 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.421 -0.8 . . . . 0.85 110.197 -179.014 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 57.02 69.4 1.7 Allowed Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.058 -1.026 . . . . 1.66 109.598 -179.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -91.3 135.64 1.81 Allowed 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 123.525 2.817 . . . . 0.95 112.8 -179.689 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 233' ' ' ASN . 55.8 m -65.87 159.76 24.78 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.212 -0.93 . . . . 1.84 108.791 179.626 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.431 ' N ' HG22 ' A' ' 232' ' ' THR . 34.6 m120 -59.71 -38.06 80.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.276 -0.89 . . . . 2.74 108.939 -179.486 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.23 -39.33 86.29 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.361 -0.837 . . . . 2.89 109.533 179.656 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 88.1 t -61.28 -41.35 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.34 -0.85 . . . . 1.3 109.459 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.32 -40.0 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 1.09 109.865 -179.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -59.82 -40.24 87.78 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 120.974 -1.079 . . . . 2.43 109.238 179.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -63.84 -45.91 87.39 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.335 -0.853 . . . . 2.78 108.916 179.204 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 88.5 mtp -68.71 -32.8 72.85 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.514 -0.742 . . . . 1.25 109.917 179.808 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 20.2 mmm180 -63.07 -38.69 92.2 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.952 -1.093 . . . . 2.63 108.943 179.043 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.85 93.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -0.932 . . . . 1.8 108.595 179.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 55.2 t -62.21 -40.44 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.907 . . . . 2.13 108.926 178.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -60.12 -38.57 83.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.484 -0.76 . . . . 3.17 109.479 -179.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -60.28 -40.72 91.42 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.135 -0.978 . . . . 1.78 109.182 -179.462 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -65.0 -39.63 93.75 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.904 -1.123 . . . . 2.47 108.283 179.271 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.9 t -61.71 -36.06 71.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.278 -1.008 . . . . 2.09 108.278 178.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.28 -38.04 79.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.525 -0.735 . . . . 2.54 109.24 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 64.0 m -60.0 -40.32 88.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.139 -0.976 . . . . 2.99 108.631 179.561 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -63.44 -35.76 81.51 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.612 -0.68 . . . . 3.34 109.744 178.938 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -57.61 -32.78 67.56 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.526 -0.734 . . . . 3.88 109.143 -179.464 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.563 ' O ' ' N ' ' A' ' 253' ' ' LEU . . . -63.18 -42.21 99.33 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.621 -0.881 . . . . 4.43 108.621 179.052 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 60.6 -38.28 0.09 Allowed 'General case' 0 N--CA 1.501 2.111 0 CA-C-O 121.032 0.444 . . . . 5.42 111.12 179.534 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.569 ' C ' ' H ' ' A' ' 255' ' ' LYS . 57.5 mt -82.25 -60.36 2.24 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.915 -1.115 . . . . 6.1 110.101 -179.249 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 253' ' ' LEU . . . 70.79 -34.47 0.3 Allowed 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.663 -0.866 . . . . 7.37 108.663 -179.0 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.569 ' H ' ' C ' ' A' ' 253' ' ' LEU . 68.2 mttm -149.75 162.85 39.45 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.714 -0.847 . . . . 8.01 108.714 -179.864 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 256' ' ' LEU . 4.0 mm? -79.71 99.15 7.28 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.922 -1.111 . . . . 9.05 109.357 179.688 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -135.13 -29.79 1.08 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.651 -0.656 . . . . 10.56 109.398 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -88.31 66.42 8.38 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.933 . . . . 11.32 108.894 -179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 86.5 mtm180 . . . . . 0 C--N 1.3 -1.574 0 CA-C-O 117.92 -1.038 . . . . 12.42 109.848 -179.748 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 8.1 ttt . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -150.7 149.05 29.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.427 -0.796 . . . . 0.0 109.243 179.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -149.36 160.99 42.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.078 -1.014 . . . . 0.0 110.116 -179.534 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -153.42 149.75 28.1 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.796 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -111.62 131.38 55.31 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.23 -0.919 . . . . 0.0 109.815 -179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -129.17 122.71 56.81 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.244 0 CA-C-O 122.287 1.041 . . . . 0.0 112.491 -176.898 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 95.5 m -75.59 103.9 5.9 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 121.849 0.833 . . . . 0.0 110.148 -178.647 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.58 HG22 ' H ' ' B' ' 310' ' ' ALA . 96.6 mt -51.95 124.42 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 CA-C-O 122.176 0.989 . . . . 0.0 109.977 -178.218 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 75.0 p -105.81 22.1 16.16 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.845 -178.745 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.58 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -80.58 149.32 67.92 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.769 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -58.61 -72.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.489 1.259 0 CA-C-N 119.455 0.841 . . . . 0.0 112.062 -179.655 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -86.29 23.87 1.48 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.123 -0.986 . . . . 0.0 110.819 -177.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 82.62 -163.14 42.11 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.542 -1.313 . . . . 0.0 109.841 -179.916 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.413 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.0 tp -90.31 93.65 9.42 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.354 -1.086 . . . . 0.0 109.79 -178.094 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.483 ' CE1' ' H ' ' B' ' 317' ' ' ARG . 10.4 p80 -94.39 -160.25 0.76 Allowed 'General case' 0 N--CA 1.504 2.269 0 O-C-N 120.728 -1.232 . . . . 0.0 109.304 178.628 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 2.6 m -58.31 -45.16 88.56 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.83 -1.168 . . . . 0.0 112.752 -176.094 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.538 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 3.8 tpt180 -59.46 -64.51 2.9 Favored Pre-proline 0 N--CA 1.499 2.004 0 O-C-N 120.111 -1.618 . . . . 0.0 111.375 -177.911 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.403 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 7.3 Cg_endo -55.08 -34.11 86.16 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 CA-C-N 120.176 1.099 . . . . 0.0 112.047 179.953 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.2 -52.36 65.63 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.001 -1.062 . . . . 0.0 109.402 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -52.48 -41.05 63.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.217 -0.927 . . . . 0.0 109.633 -178.962 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . 0.511 ' NE2' ' NE ' ' B' ' 317' ' ' ARG . 44.6 mt-30 -70.81 -40.87 72.24 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.824 -1.172 . . . . 0.0 108.924 179.152 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -60.14 -50.5 73.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.298 -0.876 . . . . 0.0 110.854 -179.242 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 74.0 t -69.89 -31.16 47.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 120.753 -1.217 . . . . 0.0 109.792 -178.628 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 26.1 ttmt -59.76 -47.99 83.49 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.229 -0.92 . . . . 0.0 109.859 -179.56 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -67.08 -40.05 86.93 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.087 -1.008 . . . . 0.0 111.078 -178.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . 0.406 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -63.46 -53.22 55.56 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.998 -1.064 . . . . 0.0 111.393 -178.934 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -56.12 -10.2 0.79 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.015 -1.053 . . . . 0.0 109.526 -179.381 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . 0.406 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -69.79 -30.26 70.59 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.667 -1.773 . . . . 0.0 108.667 178.892 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -102.67 141.73 35.0 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.594 -0.945 . . . . 0.0 109.172 179.772 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . 0.418 HG22 ' O ' ' B' ' 330' ' ' THR . 44.5 m -89.78 -11.32 42.51 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.231 -0.918 . . . . 0.0 109.154 179.954 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.41 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 61.8 p -59.34 156.68 12.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.374 -0.829 . . . . 0.0 110.034 -179.5 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -72.9 127.93 33.99 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.351 -0.843 . . . . 0.0 108.956 179.884 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.7 mt -134.52 133.54 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 -179.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . 0.425 HG22 ' N ' ' B' ' 335' ' ' VAL . 87.9 m -132.85 155.88 48.18 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.508 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . 0.425 ' N ' HG22 ' B' ' 334' ' ' THR . 58.3 t -117.2 140.68 38.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 178.427 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 64.9 m -129.05 123.17 31.6 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.447 -0.783 . . . . 0.0 109.134 179.763 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 66.9 p -139.45 117.41 11.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.353 -0.842 . . . . 0.0 110.418 -179.725 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 59.8 t30 45.6 56.53 5.72 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 177.208 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.02 -13.29 26.32 Favored Glycine 0 N--CA 1.501 3.004 0 O-C-N 120.055 -1.653 . . . . 0.0 112.924 176.438 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -111.75 122.93 49.12 Favored 'General case' 0 N--CA 1.506 2.332 0 CA-C-N 119.037 1.418 . . . . 0.0 109.52 179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.1 m -118.53 143.53 46.69 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 121.769 0.795 . . . . 0.0 110.544 -178.953 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -139.87 161.0 38.62 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 121.822 0.82 . . . . 0.0 110.174 -179.441 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 15.5 t -89.59 140.0 29.99 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.619 -0.675 . . . . 0.0 109.446 -179.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -76.78 -12.63 60.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.085 -1.009 . . . . 0.0 109.785 -179.137 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.42 19.87 4.21 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 178.649 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 16.3 t -149.37 96.91 2.58 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.652 -0.819 . . . . 0.0 111.912 -179.224 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.9 HD23 HD22 ' A' ' 79' ' ' LEU . 28.8 tp -59.97 -32.04 70.45 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.933 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.721 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.9 m-85 -58.09 -52.34 65.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.279 -0.888 . . . . 0.0 109.915 -179.28 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . 0.432 ' O ' ' OG1' ' B' ' 352' ' ' THR . 33.8 mtmm -69.93 -39.92 75.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.692 -1.255 . . . . 0.0 110.163 -178.292 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' B' ' 352' ' ' THR . 39.6 mt -50.63 -58.24 6.32 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.775 -1.203 . . . . 0.0 108.024 179.219 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.669 HE21 ' N ' ' B' ' 351' ' ' GLN . 0.0 OUTLIER -38.28 -27.16 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.871 -0.518 . . . . 0.0 111.127 -178.361 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.464 ' N ' ' O ' ' B' ' 350' ' ' LEU . 51.0 p -77.75 -11.48 59.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.091 -1.006 . . . . 0.0 110.388 -178.855 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 24.8 mt -92.78 115.41 28.09 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.888 -1.133 . . . . 0.0 109.195 179.221 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.1 92.75 0.75 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.919 -1.673 . . . . 0.0 108.919 179.504 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 44.3 mt -100.61 91.62 4.74 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.24 -1.153 . . . . 0.0 108.913 179.529 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 81.0 p -91.86 177.9 6.05 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.956 -1.09 . . . . 0.0 110.512 -178.502 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' B' ' 359' ' ' THR . 61.8 tt0 -46.48 155.68 0.22 Allowed 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.102 -0.999 . . . . 0.0 110.664 -179.589 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 39.46 25.23 0.05 OUTLIER Glycine 0 N--CA 1.495 2.595 0 N-CA-C 111.443 -0.663 . . . . 0.0 111.443 177.597 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . 0.465 ' N ' ' O ' ' B' ' 357' ' ' GLN . 9.2 m -82.47 112.44 19.41 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.708 -1.466 . . . . 0.0 109.283 179.423 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 16.4 t -77.37 115.8 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-O 122.214 1.007 . . . . 0.0 110.358 -176.882 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.3 m -110.34 176.85 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -178.386 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 30.8 m -132.19 129.81 40.24 Favored 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.943 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.4 mt -105.84 122.09 58.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 178.402 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 52.7 p -120.82 132.19 54.87 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -179.639 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.93 151.87 37.73 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.905 -1.122 . . . . 0.0 110.955 -178.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 17.4 tp10 -144.87 124.49 13.25 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.691 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 160.16 -162.73 33.41 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 118.981 -1.58 . . . . 0.0 111.367 179.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -59.96 -55.64 31.54 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 122.258 -0.554 . . . . 0.0 111.759 -178.425 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.41 ' H ' ' HB3' ' B' ' 331' ' ' SER . 94.5 m-20 -104.93 7.48 34.24 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.996 -1.065 . . . . 0.0 111.105 -177.314 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' B' ' 369' ' ' ASP . 1.3 pp20? -42.91 -32.12 0.59 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.244 -0.91 . . . . 0.0 110.507 -179.12 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -70.08 -43.7 70.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.148 -0.97 . . . . 0.0 109.996 -179.293 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -64.7 -48.99 72.63 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.199 -0.938 . . . . 0.0 109.332 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.9 -75.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.425 -0.797 . . . . 0.0 110.705 -178.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.566 ' O ' HG23 ' B' ' 378' ' ' VAL . 45.4 t -44.5 -38.77 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.099 -1.001 . . . . 0.0 110.895 -177.564 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -64.86 -47.23 78.68 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.624 -1.298 . . . . 0.0 110.513 -179.852 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -82.75 -41.72 18.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.919 -1.113 . . . . 0.0 110.445 -179.454 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.5 mt -57.9 -39.23 77.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.904 -1.122 . . . . 0.0 108.284 -179.617 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.566 HG23 ' O ' ' B' ' 374' ' ' VAL . 48.1 t -62.38 -40.24 87.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 C-N-CA 119.811 -0.755 . . . . 0.0 109.213 179.13 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' B' ' 383' ' ' GLU . 20.8 mtpp -68.54 -55.78 10.53 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.595 -1.315 . . . . 0.0 108.824 178.604 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 56.1 tp -57.78 -35.85 71.36 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.762 -1.211 . . . . 0.0 109.734 -178.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 28.8 ttm -70.66 -40.05 73.22 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.257 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.31 -9.99 59.75 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.528 -0.733 . . . . 0.0 110.968 179.164 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' B' ' 379' ' ' LYS . 93.9 mt-10 -110.03 0.83 18.62 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.042 -1.036 . . . . 0.0 111.549 -178.191 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 13.2 mt -82.38 125.89 31.56 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.178 -1.576 . . . . 0.0 109.224 179.136 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 . . . . . 0 N--CA 1.497 1.893 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.318 -179.978 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.7 mmm . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.255 -0.646 . . . . 2.91 109.255 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.7 mt -110.0 130.03 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.611 -0.681 . . . . 1.2 109.164 179.671 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.5 m -120.92 144.28 48.52 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.579 -0.701 . . . . 1.4 109.747 -179.707 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -121.67 -162.82 11.75 Favored Glycine 0 N--CA 1.501 2.976 0 N-CA-C 108.894 -1.682 . . . . 1.05 108.894 179.751 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.454 ' O ' ' O ' ' A' ' 6' ' ' LEU . 91.4 mt -89.28 -13.97 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.9 -1.353 . . . . 1.15 110.176 -179.218 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.9 tp 53.74 102.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.224 -0.922 . . . . 0.98 109.062 -179.883 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.64 -29.43 12.32 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.262 -0.899 . . . . 0.88 109.153 179.859 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 30.8 m -129.44 116.02 18.47 Favored Pre-proline 0 N--CA 1.499 1.977 0 N-CA-C 109.024 -0.732 . . . . 1.69 109.024 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -79.25 146.72 20.02 Favored 'Trans proline' 0 N--CA 1.492 1.416 0 C-N-CA 121.76 1.64 . . . . 0.85 112.079 -179.74 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.808 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 152.61 -154.4 25.5 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.462 -1.455 . . . . 0.92 109.462 -179.85 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.0 mt -148.36 150.33 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 O-C-N 121.36 -1.082 . . . . 0.81 108.587 178.947 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.84 156.32 34.49 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.939 -1.101 . . . . 0.51 110.752 179.663 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.2 m-85 -137.41 128.51 27.66 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 107.895 -1.15 . . . . 0.62 107.895 178.821 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.67 174.29 46.92 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 118.736 -1.697 . . . . 0.55 110.743 179.932 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -76.52 158.87 30.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.769 -0.842 . . . . 2.1 109.26 -179.735 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -99.99 126.11 46.13 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.358 -0.839 . . . . 0.77 111.377 -178.351 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 31.7 tp -101.36 129.96 47.46 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.876 -1.527 . . . . 0.91 106.876 177.57 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 53.2 tp -114.02 121.64 44.47 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.308 -0.87 . . . . 0.93 110.021 -178.914 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.2 mt -85.87 100.09 11.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.49 -0.756 . . . . 0.93 109.051 179.358 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -84.42 142.0 30.43 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.27 -1.011 . . . . 2.75 108.27 179.532 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -130.76 135.65 47.98 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.023 -1.048 . . . . 3.0 109.106 179.392 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -94.78 156.4 16.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.322 -0.861 . . . . 2.77 109.55 -179.916 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -78.58 136.98 37.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 2.94 109.321 179.787 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.6 mt -79.79 130.17 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.258 -0.901 . . . . 0.95 108.728 179.931 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.8 t -93.27 125.76 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.18 -0.95 . . . . 1.28 109.684 -179.461 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.8 mt -105.97 138.06 33.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.517 -0.739 . . . . 1.21 109.12 -179.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -96.23 120.06 35.84 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.159 -0.963 . . . . 1.81 109.974 -179.585 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.542 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.0 mmt-85 -90.02 -0.24 57.48 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.402 -0.812 . . . . 2.8 109.692 -179.795 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -69.9 135.5 49.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.069 -1.02 . . . . 2.87 109.164 -179.895 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -83.02 154.81 24.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.107 -0.996 . . . . 2.35 109.419 179.962 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.529 HD13 ' HG3' ' A' ' 39' ' ' GLU . 2.9 pt -98.92 166.41 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.207 -0.933 . . . . 0.97 109.609 179.568 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 78.2 p -93.41 174.81 7.02 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.3 -0.875 . . . . 1.17 108.658 178.437 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.07 -48.56 81.22 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 1.18 110.292 -179.425 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -55.51 -31.48 62.09 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.767 -1.208 . . . . 2.56 110.568 -179.057 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 81.7 mt-30 -81.59 -8.98 59.78 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.177 -0.952 . . . . 1.79 110.289 -179.357 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.9 t -60.06 -50.09 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.776 -1.203 . . . . 1.0 109.087 179.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -60.11 -39.91 87.87 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.369 -0.832 . . . . 1.77 109.078 -179.663 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -64.19 -42.02 96.83 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.546 -0.721 . . . . 2.7 110.916 -178.717 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.529 ' HG3' HD13 ' A' ' 31' ' ' ILE . 68.7 mm-40 -62.83 -41.84 99.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.68 -1.263 . . . . 1.51 110.422 -179.224 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 78.7 t -63.73 -47.04 92.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 120.675 -1.266 . . . . 0.93 108.987 -179.763 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -60.0 -46.2 90.24 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.055 -1.028 . . . . 1.81 108.957 179.863 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.9 mtp180 -59.98 -48.59 81.1 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.026 -1.07 . . . . 2.78 108.766 179.5 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.451 ' CZ ' HD13 ' A' ' 89' ' ' ILE . 88.1 t80 -60.15 -44.61 94.84 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.162 -0.961 . . . . 0.78 108.879 178.659 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.1 tp -59.95 -47.34 86.21 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 107.827 -1.175 . . . . 1.07 107.827 179.427 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 27.6 t -63.53 -43.62 96.6 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 119.571 -0.852 . . . . 1.12 108.979 178.963 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.97 -48.24 87.28 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 108.986 -1.646 . . . . 0.84 108.986 179.34 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -63.2 -31.5 72.66 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.365 -1.08 . . . . 3.09 108.2 179.114 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.426 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -58.61 -40.05 82.17 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.813 -0.81 . . . . 0.88 108.813 179.887 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.546 ' HZ3' ' HB3' ' A' ' 49' ' ' LYS . 6.8 ttpm? -65.73 -74.31 0.11 Allowed 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.932 -1.136 . . . . 2.59 107.932 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.423 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.94 -40.54 0.47 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.366 -0.834 . . . . 0.7 111.758 -178.255 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 64.0 m -54.48 -53.7 50.74 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.465 -1.397 . . . . 1.4 108.982 -179.875 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.23 -41.18 77.35 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.226 -0.921 . . . . 0.67 110.819 -179.318 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -66.89 -39.97 87.63 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.908 -1.12 . . . . 1.66 109.989 -179.511 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 48.9 mt -61.03 -39.95 91.73 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.892 -1.13 . . . . 1.58 108.725 179.066 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -61.94 -35.08 77.35 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.477 -0.765 . . . . 1.35 109.573 179.482 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -64.3 -43.04 95.97 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.034 -1.041 . . . . 0.77 109.35 179.816 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.9 -39.63 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.331 -0.855 . . . . 0.63 108.917 179.681 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -57.07 -50.43 72.8 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.442 -0.786 . . . . 1.14 109.971 -179.368 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -57.1 -31.62 65.46 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.319 -0.863 . . . . 0.79 110.377 -177.888 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -70.02 -38.14 75.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.05 -1.031 . . . . 1.53 109.436 -179.897 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -66.8 -45.91 76.91 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.615 -0.678 . . . . 0.57 110.641 -179.128 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -58.88 -50.87 63.04 Favored Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.755 -1.212 . . . . 0.75 110.424 -178.637 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -70.24 -43.8 69.85 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.934 -1.333 . . . . 1.59 110.18 -179.792 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.4 m -69.98 -57.8 4.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.067 -1.021 . . . . 0.73 111.698 -178.042 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -98.31 -54.36 3.08 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 121.138 -0.976 . . . . 0.75 111.483 -178.168 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 142.26 -164.58 26.88 Favored Glycine 0 N--CA 1.5 2.914 0 C-N-CA 119.676 -1.25 . . . . 1.22 110.931 179.967 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -71.4 -25.92 62.55 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.884 -0.774 . . . . 5.81 110.795 -179.409 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 tp10 -61.4 -35.9 78.79 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.165 -0.959 . . . . 3.37 110.197 -179.255 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -100.01 -20.28 16.14 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.331 -0.856 . . . . 1.77 110.269 -179.222 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.5 tt0 -69.92 -40.32 75.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.962 -1.087 . . . . 1.65 110.501 -178.826 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.621 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -67.36 -26.1 66.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.133 -0.979 . . . . 0.77 109.972 -179.058 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.7 mt -59.73 -39.99 81.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 118.954 -1.099 . . . . 0.8 108.345 179.77 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -67.82 -39.99 83.84 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.055 -1.028 . . . . 0.88 110.311 179.885 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.419 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 80.2 tt0 -59.91 -40.78 89.97 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.759 -1.213 . . . . 1.37 109.454 179.464 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.86 -48.98 76.55 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.029 -1.628 . . . . 0.62 109.029 179.518 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.5 m170 -63.05 -42.96 99.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.463 -1.022 . . . . 1.5 109.485 179.916 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.02 -45.1 77.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.235 -0.916 . . . . 0.63 109.784 -179.737 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 47.0 ttp -60.27 -40.11 89.2 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.891 -1.13 . . . . 1.51 109.121 -179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.969 HD22 HD23 ' B' ' 347' ' ' LEU . 48.1 tp -63.09 -39.34 94.41 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.683 -0.636 . . . . 0.77 109.956 179.626 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.2 tp -66.26 -38.3 87.53 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.523 -0.735 . . . . 0.62 110.248 -179.483 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -80.35 3.28 21.65 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.958 -1.089 . . . . 1.47 110.258 -179.045 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -49.75 130.03 20.59 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.0 -1.063 . . . . 1.47 109.642 -179.614 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -62.18 -17.73 58.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.534 -0.729 . . . . 1.78 110.629 -179.536 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -71.85 -35.05 69.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.975 -1.078 . . . . 2.53 108.713 178.767 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.8 mt -69.96 -40.36 75.47 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.492 0.663 . . . . 0.8 109.831 179.761 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -60.04 -45.37 93.04 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.329 -0.857 . . . . 1.42 109.917 -179.22 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -69.99 -40.0 75.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 1.71 110.334 -179.14 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -69.96 -40.05 75.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.288 -0.882 . . . . 1.57 110.912 -179.175 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.451 HD13 ' CZ ' ' A' ' 43' ' ' PHE . 87.3 mt -68.37 -42.45 84.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.991 -1.068 . . . . 0.65 109.595 -179.588 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.01 -38.78 76.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.564 -0.71 . . . . 0.82 110.633 -179.533 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.88 -49.45 77.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.102 -0.999 . . . . 0.79 111.247 -178.615 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 90.7 mt -61.81 -47.54 84.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.769 -1.207 . . . . 0.95 110.419 -178.964 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 67.6 mt -60.42 -49.9 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.114 -0.991 . . . . 0.66 109.183 179.957 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.2 mtpt -70.27 -43.9 69.54 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.375 -0.53 . . . . 2.2 111.132 -179.721 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -80.98 -49.87 10.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.986 -1.072 . . . . 1.65 111.991 -177.813 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -90.12 -2.43 58.08 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.001 -1.062 . . . . 2.03 111.584 -177.372 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 56.43 35.12 25.43 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.859 -1.15 . . . . 1.42 109.435 -179.761 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 63.0 mtt -88.4 169.26 11.95 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.472 -0.768 . . . . 1.18 109.907 -179.417 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 52.4 p -81.88 160.0 23.54 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.342 -0.849 . . . . 0.98 108.776 179.532 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.77 -39.88 88.0 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.22 -0.925 . . . . 0.64 110.258 -179.472 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 35.9 p-10 -67.02 -35.07 79.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.081 -1.012 . . . . 2.07 109.335 -179.735 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.507 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.96 -47.39 13.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.317 -0.865 . . . . 0.73 109.604 179.661 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.63 -48.32 81.39 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.385 -0.822 . . . . 0.54 110.007 -179.612 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.28 -36.24 79.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.203 -0.935 . . . . 0.56 109.844 -179.891 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.415 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 80.3 t60 -60.03 -42.67 94.88 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.286 -0.884 . . . . 1.54 109.98 -178.761 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' A' ' 110' ' ' GLY . 41.3 tt0 -64.36 -40.01 94.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.164 -0.96 . . . . 1.33 110.242 -179.469 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 92.2 t -60.57 -56.09 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.352 -0.842 . . . . 0.72 111.446 -178.06 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.1 mm -69.93 -39.97 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.942 -1.099 . . . . 0.85 108.936 -179.789 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.415 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 88.8 tt0 -64.78 -38.87 92.44 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.567 -0.901 . . . . 2.44 108.567 178.639 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.02 -49.2 77.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.813 -0.915 . . . . 0.98 110.813 -179.066 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -68.79 -52.34 31.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.716 -1.461 . . . . 1.41 109.527 -179.521 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -57.62 -40.05 78.3 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.296 -0.877 . . . . 1.2 109.26 179.868 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 42.6 t -58.24 -41.4 84.1 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.175 -0.953 . . . . 1.7 108.963 179.988 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.81 -40.5 91.91 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.258 -0.901 . . . . 1.47 109.028 179.192 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.431 HD22 ' HB3' ' B' ' 351' ' ' GLN . 76.5 mt -61.4 -45.24 95.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.107 -0.996 . . . . 1.56 109.62 -179.682 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -57.25 -32.32 66.45 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.143 -0.973 . . . . 2.2 109.846 -178.48 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -58.11 -21.74 47.66 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.022 -1.049 . . . . 2.12 108.605 179.773 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 123' ' ' LEU . 54.4 mt -62.37 139.95 58.54 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.264 -0.898 . . . . 2.0 108.577 179.636 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.5 p-10 -90.09 10.08 25.71 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.114 -0.991 . . . . 3.23 110.86 -178.722 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -94.39 133.59 37.8 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.777 -1.202 . . . . 2.49 109.828 -179.75 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -69.92 -28.99 66.05 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.571 -0.706 . . . . 3.95 109.954 -179.861 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.484 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 1.7 t80 -69.24 -36.86 77.62 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.376 -0.827 . . . . 2.0 110.244 179.417 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.654 HD22 ' O ' ' B' ' 351' ' ' GLN . 90.6 mt -77.49 -35.21 53.84 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.093 -1.004 . . . . 1.86 109.57 179.838 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -59.99 -45.33 93.08 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.229 -0.919 . . . . 2.84 109.678 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 77.6 mm-40 -60.55 -45.37 94.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.158 -0.964 . . . . 2.73 109.296 -179.655 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.7 ttp180 -61.94 -39.88 93.62 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.117 -1.068 . . . . 2.77 108.117 179.101 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.79 -23.25 51.54 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.184 -1.043 . . . . 1.19 108.184 178.796 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -69.96 -40.09 75.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.814 -0.81 . . . . 1.2 108.814 178.954 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -64.54 -40.09 94.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.528 -0.733 . . . . 1.55 110.294 -179.497 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.93 -40.56 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.08 -1.013 . . . . 0.8 108.402 179.842 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 23.6 ttm-85 -60.09 -38.69 83.68 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.964 -0.754 . . . . 3.09 108.964 178.474 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -59.53 -39.57 84.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.507 -0.745 . . . . 1.46 109.986 -179.52 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.3 mt -59.93 -40.78 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.052 -1.03 . . . . 0.71 109.686 -179.623 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.63 -41.42 96.01 Favored Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.979 -1.105 . . . . 0.57 110.769 -179.44 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -59.93 -47.07 87.3 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.964 -1.315 . . . . 2.59 111.279 -178.799 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.621 HH12 ' CB ' ' A' ' 166' ' ' SER . 98.6 mtt180 -69.97 -30.47 67.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.504 -1.372 . . . . 2.83 109.927 -179.622 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.0 -46.15 90.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 1.25 109.152 -179.968 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 90.5 mt -59.88 -40.04 87.35 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.396 -0.815 . . . . 0.7 109.464 179.236 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.414 ' NE ' HD23 ' A' ' 144' ' ' LEU . 53.5 mtp180 -69.16 -40.02 78.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.397 -0.814 . . . . 2.57 110.206 179.959 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -69.93 -20.91 63.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.337 -0.852 . . . . 1.23 112.383 -178.136 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 81.5 mt -68.68 -40.02 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.19 -1.569 . . . . 0.81 108.408 179.664 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 89.1 mt -87.13 -29.32 21.9 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.436 -0.79 . . . . 1.0 109.621 -179.699 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.96 54.35 2.05 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 108.695 -1.762 . . . . 0.89 108.695 -178.958 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.414 HD23 ' NE ' ' A' ' 139' ' ' ARG . 19.0 tp -74.73 147.31 41.48 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.625 -0.926 . . . . 1.14 110.009 -179.168 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -60.19 141.42 55.99 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.342 -0.848 . . . . 4.6 109.867 -179.867 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 87.3 mt -119.96 127.06 75.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-O 122.01 0.91 . . . . 1.24 109.414 179.52 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 6.5 mt -60.11 -45.9 95.13 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 116.063 -0.517 . . . . 1.54 109.952 -178.504 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 32.4 t0 64.22 101.52 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.498 -0.751 . . . . 1.5 109.256 -179.57 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 32.1 mt -71.74 -5.27 32.74 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.368 -0.833 . . . . 0.79 109.868 -179.269 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.6 m -80.21 -18.57 49.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.056 -1.028 . . . . 1.4 109.56 179.758 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -83.1 24.04 0.81 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.271 -0.893 . . . . 0.92 111.777 -178.002 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 39.2 mm -90.97 115.98 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 120.496 -1.378 . . . . 0.88 108.64 179.19 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -100.04 -9.68 22.39 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.34 -0.85 . . . . 2.45 110.545 -178.748 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -119.92 149.48 42.04 Favored 'General case' 0 N--CA 1.506 2.346 0 O-C-N 121.188 -0.945 . . . . 1.52 110.336 -179.392 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -65.01 133.81 52.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.388 -0.82 . . . . 1.58 109.1 179.766 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -151.77 164.7 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.448 -0.783 . . . . 0.69 109.597 179.678 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.8 mt -93.69 147.32 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.038 -1.838 . . . . 0.61 106.038 177.0 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 60.9 tp -97.3 117.01 30.57 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.879 -1.138 . . . . 0.87 110.642 -177.952 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 35.5 t -122.12 127.74 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 N-CA-C 108.197 -1.038 . . . . 0.71 108.197 179.228 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.07 160.65 39.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.987 -1.07 . . . . 0.81 108.711 -179.895 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.96 -34.7 73.74 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.261 -1.524 . . . . 0.98 108.16 178.977 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -160.14 170.69 20.69 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.806 -0.813 . . . . 2.25 108.806 179.935 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.6 mt -141.96 129.95 21.93 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.041 -1.037 . . . . 0.78 108.733 178.989 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 63.1 p -90.56 144.23 30.32 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.084 -1.01 . . . . 0.98 109.293 -179.741 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_exo -40.1 -37.6 1.83 Allowed 'Trans proline' 0 N--CA 1.488 1.196 0 C-N-CA 122.116 1.877 . . . . 0.81 112.457 179.39 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.621 ' CB ' HH12 ' A' ' 136' ' ' ARG . 50.2 m -59.98 -40.95 90.9 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.352 -0.843 . . . . 0.9 109.591 -179.238 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -62.78 -43.24 99.32 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.261 -0.9 . . . . 1.61 110.195 -179.644 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 62.4 p -57.85 -28.71 64.37 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.244 -0.91 . . . . 0.61 110.531 -178.679 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -69.99 -57.5 4.93 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.015 -1.053 . . . . 0.6 109.775 179.7 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -83.5 35.39 0.5 Allowed 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 109.102 -0.703 . . . . 1.4 109.102 -179.446 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 57.3 tp -100.66 139.04 36.9 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.347 -0.846 . . . . 0.7 109.345 179.588 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -85.43 103.73 14.59 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.267 -0.896 . . . . 2.35 108.763 179.545 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 63.1 mt -63.62 -45.36 90.65 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.476 -0.765 . . . . 1.51 110.273 -178.694 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -70.06 -20.39 63.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.024 -1.048 . . . . 2.33 112.572 -178.328 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 69.8 mmtt -93.15 -10.12 36.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.471 -1.393 . . . . 1.92 109.26 -179.185 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 178' ' ' GLY . 89.4 t -109.79 117.64 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.317 -0.864 . . . . 0.67 109.356 179.465 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 78.4 mt -88.77 5.49 43.25 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.348 -0.845 . . . . 1.53 110.676 -178.407 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.514 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 172.59 173.16 38.96 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.2 -1.56 . . . . 0.48 109.2 179.808 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.432 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 22.6 m-85 -133.09 129.94 38.64 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.258 -1.142 . . . . 0.55 110.105 -179.598 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.555 ' CG2' HG21 ' A' ' 205' ' ' THR . 58.9 mt -128.9 122.89 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 N-CA-C 108.037 -1.097 . . . . 0.65 108.037 177.971 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 11.7 p -143.52 157.03 44.75 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.986 -1.072 . . . . 0.82 110.982 -179.202 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 183' ' ' ALA . 1.1 m-20 -96.19 21.35 9.01 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.436 -0.79 . . . . 2.46 109.631 -179.891 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -46.9 -173.93 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.977 -1.077 . . . . 1.28 112.723 -177.922 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -85.85 -49.75 4.19 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 111.377 -0.689 . . . . 2.19 111.377 -178.979 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -174.18 -154.46 10.86 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 118.525 -1.798 . . . . 2.13 111.71 -179.291 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.543 ' C ' ' H ' ' A' ' 188' ' ' SER . 8.7 mtt-85 -62.42 -33.99 75.89 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.782 -0.834 . . . . 5.86 111.151 -178.632 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 29.1 p -60.04 6.99 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.839 -1.163 . . . . 3.72 110.639 -178.302 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.543 ' H ' ' C ' ' A' ' 186' ' ' ARG . 92.7 p -90.85 130.76 36.78 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.871 -1.143 . . . . 1.74 109.941 179.717 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -47.62 -45.87 28.08 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.203 -0.935 . . . . 0.95 109.548 -179.849 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 93.3 m -58.41 -40.26 81.96 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.495 -0.753 . . . . 1.55 110.171 -178.317 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 186' ' ' ARG . 81.1 p -63.29 -38.8 92.57 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.822 -1.174 . . . . 1.51 109.849 -179.881 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.591 HD13 HH22 ' A' ' 195' ' ' ARG . 41.9 mm -60.09 -45.81 95.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.299 -0.876 . . . . 1.67 109.09 -179.459 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.16 -46.45 89.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.415 -0.803 . . . . 1.02 110.639 -179.698 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -56.43 -48.73 76.38 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.805 -1.185 . . . . 0.68 111.219 -178.273 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.591 HH22 HD13 ' A' ' 192' ' ' ILE . 26.8 mtm-85 -60.88 -50.04 75.03 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.684 -1.26 . . . . 2.93 110.458 -178.903 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 48.7 m -71.29 -34.98 71.14 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.834 -1.166 . . . . 0.86 111.6 -178.506 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 99.0 mt -81.52 -11.13 59.29 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.696 -1.253 . . . . 0.67 110.796 -178.356 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 56.91 46.48 19.54 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.166 -0.959 . . . . 1.5 110.696 179.592 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.427 ' O ' ' CB ' ' A' ' 8' ' ' SER . 92.2 mt -116.31 121.26 33.75 Favored Pre-proline 0 N--CA 1.5 2.072 0 N-CA-C 108.341 -0.985 . . . . 0.72 108.341 179.055 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -42.35 129.61 4.76 Favored 'Trans proline' 0 N--CA 1.497 1.703 0 C-N-CA 121.83 1.687 . . . . 0.61 111.952 -179.42 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -170.01 152.17 4.26 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.982 -1.074 . . . . 0.66 111.649 -179.221 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.7 mt -126.87 144.0 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.654 -1.239 . . . . 0.79 107.654 178.607 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 20.5 m -124.05 -9.43 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.482 0 O-C-N 120.796 -1.19 . . . . 0.91 111.381 -178.446 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.46 23.69 24.0 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 110.875 -0.89 . . . . 1.01 110.875 -178.829 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.555 HG21 ' CG2' ' A' ' 180' ' ' ILE . 19.2 p -47.19 -42.86 20.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.833 -1.392 . . . . 0.99 110.105 -179.276 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 87.77 -52.26 4.18 Favored Glycine 0 N--CA 1.497 2.736 0 C-N-CA 120.039 -1.077 . . . . 1.12 111.924 178.833 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.5 t -155.36 35.1 0.37 Allowed 'General case' 0 N--CA 1.503 2.223 0 O-C-N 120.37 -1.665 . . . . 1.72 111.819 -178.759 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 29.5 t -75.95 -38.01 35.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 120.857 -1.152 . . . . 0.89 109.195 178.422 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.441 HG23 ' H ' ' A' ' 209' ' ' THR . 2.2 p -60.03 -40.07 88.07 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.591 -0.693 . . . . 1.03 111.55 -177.985 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 78.7 p -78.47 -11.37 59.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.799 -1.188 . . . . 1.83 110.264 -178.74 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -96.97 -12.24 23.58 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.233 -0.917 . . . . 2.27 110.408 -179.698 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 213' ' ' LYS . 91.8 t -116.34 156.2 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 O-C-N 121.321 -0.862 . . . . 0.92 110.592 -179.344 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.505 ' N ' HG12 ' A' ' 212' ' ' VAL . 62.3 mmtt -114.71 154.12 29.04 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.207 -1.035 . . . . 2.2 108.207 179.687 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.482 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 39.0 p-10 -59.73 135.96 57.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.868 -1.145 . . . . 2.36 110.095 -179.404 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.7 OUTLIER 94.5 -1.72 0.08 Allowed 'General case' 0 N--CA 1.511 2.614 0 CA-C-O 121.581 0.705 . . . . 2.38 109.988 179.502 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 48.8 t0 -70.08 151.2 45.76 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.434 -0.792 . . . . 2.09 109.792 -179.961 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 51.0 t80 -95.37 120.13 35.07 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.371 -0.831 . . . . 1.27 108.804 179.602 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 90.2 mt -123.34 138.34 54.63 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.386 -0.821 . . . . 0.75 110.657 -179.297 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 76.9 mt -112.35 130.0 66.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 N-CA-C 106.436 -1.69 . . . . 0.63 106.436 176.317 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 57.0 tp -100.32 115.01 28.96 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.115 -0.991 . . . . 0.7 109.542 -178.303 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.523 ' C ' ' H ' ' A' ' 223' ' ' VAL . 55.8 m-20 -70.6 -46.92 62.51 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 107.924 -1.139 . . . . 2.31 107.924 178.996 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.808 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 52.12 9.15 0.08 Allowed 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 108.917 -0.771 . . . . 0.78 108.917 -179.644 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.523 ' H ' ' C ' ' A' ' 221' ' ' ASP . 75.5 t -125.9 -38.89 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 107.094 -1.447 . . . . 1.04 107.094 178.797 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -104.32 0.01 28.71 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 107.928 -1.138 . . . . 2.44 107.928 178.243 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 40.0 t-20 60.08 45.9 11.35 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.156 -0.683 . . . . 1.55 109.156 -179.524 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -136.41 156.26 48.86 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.398 -0.814 . . . . 1.99 109.599 -179.752 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.5 t -124.37 129.98 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 108.798 -0.816 . . . . 0.77 108.798 178.957 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . 0.536 ' CE1' ' SD ' ' A' ' 239' ' ' MET . 62.4 m-85 -105.22 125.86 51.45 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.513 -0.921 . . . . 0.98 108.513 179.192 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 20.9 t -103.89 113.99 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.039 0 O-C-N 121.202 -0.936 . . . . 0.85 110.404 -179.406 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.553 HD22 ' C ' ' A' ' 230' ' ' ASN . 0.3 OUTLIER 49.48 62.67 11.61 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.099 -1.001 . . . . 1.66 110.707 178.916 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -85.35 156.16 10.87 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.832 2.355 . . . . 0.95 112.173 179.319 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.411 HG22 HD22 ' A' ' 233' ' ' ASN . 2.0 m -65.92 159.28 25.94 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.342 -0.849 . . . . 1.84 109.637 -179.423 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.702 ' ND2' ' H ' ' A' ' 234' ' ' GLU . 0.0 OUTLIER -61.61 -38.58 88.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.257 -0.902 . . . . 2.74 111.006 -178.916 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.702 ' H ' ' ND2' ' A' ' 233' ' ' ASN . 16.8 pt-20 -65.62 -30.83 71.6 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.79 -1.194 . . . . 2.89 109.708 -179.492 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.7 t -67.6 -43.15 87.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.163 -0.961 . . . . 1.3 108.564 179.286 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.89 -41.53 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.536 -0.728 . . . . 1.09 109.963 179.885 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -60.0 -41.9 93.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.037 -1.039 . . . . 2.43 109.409 -179.904 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -61.34 -46.23 91.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 2.78 110.347 -179.566 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . 0.536 ' SD ' ' CE1' ' A' ' 228' ' ' TYR . 11.7 mtm -70.33 -29.46 66.18 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.139 -0.975 . . . . 1.25 109.695 -179.896 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 23.6 mmm-85 -69.91 -37.9 76.09 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.329 -0.857 . . . . 2.63 109.526 178.913 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.0 -43.5 95.17 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 1.8 109.327 -179.618 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 76.1 t -62.92 -38.0 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.175 -0.953 . . . . 2.13 108.526 179.127 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -59.7 -39.66 85.32 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.57 -0.9 . . . . 3.17 108.57 179.802 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.94 -40.03 87.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.179 -0.951 . . . . 1.78 108.821 179.455 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -66.29 -39.96 89.72 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.231 -1.026 . . . . 2.47 108.231 179.076 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 53.5 t -69.08 -40.07 80.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.281 -1.007 . . . . 2.09 108.281 178.948 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.63 -39.43 84.28 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.718 -0.614 . . . . 2.54 109.514 -179.849 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 63.2 m -59.97 -40.12 88.0 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.961 -1.087 . . . . 2.99 108.99 -179.968 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -62.22 -39.59 93.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.087 -1.008 . . . . 3.34 109.182 179.214 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -94.62 33.34 1.46 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.299 -0.876 . . . . 3.88 109.419 -179.838 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -151.55 26.24 0.67 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.14 -0.975 . . . . 4.43 111.07 -179.457 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -104.96 54.13 0.72 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.086 -1.009 . . . . 5.42 109.628 179.403 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.417 ' C ' ' H ' ' A' ' 255' ' ' LYS . 15.1 mt 60.38 20.06 9.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.433 -0.792 . . . . 6.1 109.104 -179.001 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -75.14 11.59 1.11 Allowed 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.977 -0.749 . . . . 7.37 108.977 179.62 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.417 ' H ' ' C ' ' A' ' 253' ' ' LEU . 63.1 tttp -60.01 -50.31 74.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.464 -0.772 . . . . 8.01 109.517 -179.715 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 38.3 mt -148.63 -29.83 0.28 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.297 -0.877 . . . . 9.05 109.419 178.853 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.545 ' O ' ' C ' ' A' ' 258' ' ' ASP . 46.7 mtmt -72.01 -9.41 58.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 10.56 110.431 -178.776 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.545 ' C ' ' O ' ' A' ' 257' ' ' LYS . 13.5 t0 14.09 67.09 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.676 0 CA-C-O 120.974 0.416 . . . . 11.32 111.861 178.566 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 117.93 -1.033 . . . . 12.42 109.177 -179.717 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 3.0 ttt . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.509 0.671 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 10.4 t80 -151.98 150.07 29.59 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.995 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -148.34 159.17 44.28 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.007 -1.058 . . . . 0.0 110.14 -179.275 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 -152.98 150.06 28.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.631 -0.668 . . . . 0.0 109.344 -179.825 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . 0.481 ' CD ' ' N ' ' B' ' 305' ' ' GLU . 1.6 pm0 -114.87 134.69 54.94 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.313 -0.867 . . . . 0.0 109.969 179.43 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 1.3 p -135.63 124.92 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 CA-C-O 122.029 0.919 . . . . 0.0 112.44 -177.212 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 88.7 m -77.72 106.35 9.47 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.93 0.871 . . . . 0.0 109.969 -179.385 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.472 HG22 ' H ' ' B' ' 310' ' ' ALA . 92.3 mt -50.78 124.16 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 CA-C-O 122.449 1.118 . . . . 0.0 110.274 -177.407 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 74.8 p -108.06 19.93 19.35 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.54 -178.955 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.472 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -74.57 118.21 68.27 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.248 -0.907 . . . . 0.0 108.606 179.308 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -61.18 -13.4 27.96 Favored 'Trans proline' 0 N--CA 1.493 1.489 0 CA-C-N 120.477 1.206 . . . . 0.0 112.288 -179.815 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -117.5 9.52 13.26 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.524 -0.735 . . . . 0.0 110.422 -178.581 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.96 172.08 16.78 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.643 -1.783 . . . . 0.0 108.643 -179.311 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.484 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.1 tp -82.34 87.92 6.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.951 -1.323 . . . . 0.0 109.557 -178.285 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.424 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 3.5 p80 -90.56 -163.39 1.02 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 120.796 -1.19 . . . . 0.0 109.713 178.76 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.1 m -58.1 -41.29 83.21 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.806 -1.184 . . . . 0.0 112.595 -175.775 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.621 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 16.3 tpt180 -59.35 -59.58 13.38 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 120.379 -1.451 . . . . 0.0 111.658 -179.49 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.424 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 14.9 Cg_endo -60.43 -34.86 92.71 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 CA-C-N 120.522 1.222 . . . . 0.0 111.693 -179.653 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.98 -51.97 67.4 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.318 -0.864 . . . . 0.0 108.978 -179.996 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -54.27 -41.8 69.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.29 -0.881 . . . . 0.0 109.687 -178.934 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -70.08 -41.13 74.49 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.982 -1.074 . . . . 0.0 108.669 178.772 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -60.73 -51.67 68.38 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.548 -0.72 . . . . 0.0 111.247 -179.362 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . 0.41 HG13 ' O ' ' B' ' 344' ' ' ALA . 86.1 t -67.76 -27.04 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.565 -1.334 . . . . 0.0 109.259 -179.125 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.419 ' NZ ' ' OE1' ' A' ' 74' ' ' GLU . 31.1 ttmt -60.04 -47.52 85.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.552 -0.718 . . . . 0.0 109.645 179.741 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -64.39 -45.22 88.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.21 -0.931 . . . . 0.0 110.557 -179.255 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.09 -52.79 63.86 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.854 -1.154 . . . . 0.0 110.751 -178.792 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -55.22 -16.63 3.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.174 -0.954 . . . . 0.0 109.808 179.706 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -69.96 -30.64 69.97 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 179.462 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -106.29 140.47 39.17 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.465 -1.02 . . . . 0.0 109.27 179.844 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 19.8 m -89.94 -10.71 44.12 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.124 -0.985 . . . . 0.0 109.607 -179.97 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.495 ' OG ' ' N ' ' B' ' 368' ' ' GLU . 72.9 m -57.74 146.55 30.82 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.051 -1.03 . . . . 0.0 108.679 179.451 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -64.7 132.66 50.26 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.186 -0.946 . . . . 0.0 109.499 -179.326 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 84.8 mt -132.34 131.8 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.471 -0.768 . . . . 0.0 108.964 179.694 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . 0.403 HG22 ' N ' ' B' ' 335' ' ' VAL . 52.1 m -128.73 153.48 47.31 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.778 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . 0.403 ' N ' HG22 ' B' ' 334' ' ' THR . 98.9 t -118.51 140.03 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.504 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 34.3 m -128.04 123.51 34.82 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 107.832 -1.174 . . . . 0.0 107.832 179.225 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 86.9 p -138.54 114.98 10.45 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.261 -0.899 . . . . 0.0 110.87 -179.191 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 28.9 m120 45.17 50.04 9.63 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 176.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.92 -14.21 62.5 Favored Glycine 0 N--CA 1.501 3.028 0 O-C-N 120.077 -1.639 . . . . 0.0 112.947 176.873 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -116.02 126.69 54.15 Favored 'General case' 0 N--CA 1.507 2.417 0 CA-C-N 119.225 1.512 . . . . 0.0 109.699 179.834 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 52.9 m -118.43 144.6 45.84 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.731 0.777 . . . . 0.0 110.648 -178.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . 0.506 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -143.18 162.11 36.46 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.571 0.7 . . . . 0.0 110.005 -179.765 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 41.4 t -87.94 132.5 34.21 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.669 -0.644 . . . . 0.0 110.745 -178.906 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.41 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -68.96 -16.75 63.82 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -0.942 . . . . 0.0 108.689 179.358 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -88.73 19.4 4.03 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 178.737 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . 0.745 ' CB ' ' HZ3' ' B' ' 349' ' ' LYS . 53.9 p -146.62 94.99 2.52 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 121.774 0.797 . . . . 0.0 112.406 -179.428 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.969 HD23 HD22 ' A' ' 79' ' ' LEU . 52.9 tp -60.0 -36.51 77.34 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.728 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.763 ' CE2' HD11 ' A' ' 79' ' ' LEU . 58.3 m-85 -56.51 -53.52 56.5 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.324 -0.86 . . . . 0.0 110.708 -179.181 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . 0.745 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 33.6 mtmm -70.04 -38.78 75.94 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.875 -1.141 . . . . 0.0 109.609 -178.846 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.46 ' O ' ' N ' ' B' ' 352' ' ' THR . 35.7 mt -48.2 -59.51 3.36 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 120.946 -1.096 . . . . 0.0 108.496 179.415 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.654 ' O ' HD22 ' A' ' 123' ' ' LEU . 0.9 OUTLIER -39.14 -25.92 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.695 -0.628 . . . . 0.0 111.124 -179.088 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.46 ' N ' ' O ' ' B' ' 350' ' ' LEU . 66.3 p -79.45 -9.94 59.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.344 -1.472 . . . . 0.0 110.198 -178.295 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.506 HD11 ' HB3' ' B' ' 342' ' ' ALA . 61.1 mt -92.54 114.43 26.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.018 -1.051 . . . . 0.0 108.644 178.6 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -73.77 90.04 0.66 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 108.586 -1.806 . . . . 0.0 108.586 179.575 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 22.7 mt -100.62 93.54 5.65 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.316 -1.108 . . . . 0.0 108.674 179.426 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 70.9 p -93.36 167.34 11.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.135 -0.978 . . . . 0.0 110.625 -179.053 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 13.3 tm0? -57.84 113.01 1.67 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.782 -0.574 . . . . 0.0 110.693 -179.32 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.78 9.25 38.05 Favored Glycine 0 N--CA 1.498 2.821 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.737 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 54.6 m -87.19 110.65 20.3 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.388 -1.066 . . . . 0.0 111.415 -179.113 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 5.0 t -77.03 115.43 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-O 122.165 0.983 . . . . 0.0 109.703 -177.775 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 18.3 m -113.31 177.18 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -178.855 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 93.3 m -132.15 132.58 43.34 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 177.052 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 59.3 mt -107.94 126.07 64.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 178.194 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 54.0 m -125.36 133.51 52.53 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.447 -0.783 . . . . 0.0 109.17 -179.491 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -148.53 155.62 41.38 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.94 -1.1 . . . . 0.0 111.001 -178.812 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 80.6 tt0 -149.55 128.68 12.76 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.824 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.461 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 156.65 -152.16 23.54 Favored Glycine 0 N--CA 1.494 2.512 0 C-N-CA 119.155 -1.498 . . . . 0.0 111.726 179.548 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . 0.495 ' N ' ' OG ' ' B' ' 331' ' ' SER . 54.5 tp10 -58.64 -52.1 67.13 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 122.099 -0.647 . . . . 0.0 112.376 -177.15 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' B' ' 370' ' ' GLU . 89.2 m-20 -114.98 15.63 17.23 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.011 -1.056 . . . . 0.0 111.416 -177.11 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.54 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.0 OUTLIER -41.25 -37.3 0.92 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.255 -0.903 . . . . 0.0 111.718 -178.488 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . 0.516 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 72.7 mm-40 -68.05 -44.53 76.17 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.602 -1.311 . . . . 0.0 110.376 -178.083 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -68.29 -51.56 43.51 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.094 -1.004 . . . . 0.0 109.033 179.806 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -46.32 -38.08 8.26 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.698 -0.626 . . . . 0.0 111.665 -178.87 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.467 ' O ' HG23 ' B' ' 378' ' ' VAL . 70.4 t -73.02 -39.47 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.624 -1.297 . . . . 0.0 109.332 179.505 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.98 -58.67 7.0 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.358 -0.839 . . . . 0.0 111.507 -178.807 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 15.1 m170 -68.96 -40.45 78.89 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.525 -1.359 . . . . 0.0 111.791 -177.956 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.02 -41.87 93.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.715 -1.241 . . . . 0.0 108.853 -178.871 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.467 HG23 ' O ' ' B' ' 374' ' ' VAL . 52.6 t -61.07 -44.58 98.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.221 -0.925 . . . . 0.0 109.624 179.367 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.472 ' O ' ' N ' ' B' ' 383' ' ' GLU . 45.7 mtpt -69.26 -55.3 10.93 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 179.108 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 48.7 tp -54.87 -35.9 64.55 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.317 -0.864 . . . . 0.0 109.393 -178.271 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 38.3 ttm -70.77 -40.02 72.88 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.623 -1.298 . . . . 0.0 108.689 177.829 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.86 -4.28 58.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.625 -0.672 . . . . 0.0 110.533 179.728 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' B' ' 379' ' ' LYS . 98.4 mt-10 -112.11 -4.79 14.34 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.087 -1.008 . . . . 0.0 110.986 -179.701 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 16.5 mt -80.27 132.86 35.91 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.455 -1.403 . . . . 0.0 108.483 178.579 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 . . . . . 0 N--CA 1.497 1.91 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.284 -179.904 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mmm . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 121.197 0.522 . . . . 2.91 109.777 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.4 mt -99.69 122.9 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 121.267 -0.895 . . . . 1.2 109.042 179.505 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.3 m -139.03 119.39 13.75 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.302 -0.874 . . . . 1.4 109.683 -179.482 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -99.08 -163.01 29.72 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 109.108 -1.597 . . . . 1.05 109.108 179.648 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.499 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.2 mt -90.6 -7.77 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.118 -1.224 . . . . 1.15 110.684 -179.048 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 34.2 tp 54.85 96.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.969 -1.082 . . . . 0.98 109.246 -179.829 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -85.45 -25.77 26.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.142 -0.974 . . . . 0.88 109.375 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.2 t -150.93 131.21 7.0 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.152 -0.967 . . . . 1.69 109.101 179.659 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -79.11 140.31 15.66 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 121.954 1.769 . . . . 0.85 111.836 179.608 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.691 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 166.61 -164.59 37.82 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 109.382 -1.487 . . . . 0.92 109.382 -179.583 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 83.3 mt -147.24 147.27 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 120.897 -1.355 . . . . 0.81 108.589 179.37 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.06 157.67 37.91 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.924 -1.11 . . . . 0.51 110.07 179.755 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -139.02 128.13 23.89 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.01 -1.107 . . . . 0.62 108.01 179.312 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 177.52 178.78 47.4 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.473 -1.822 . . . . 0.55 110.792 179.714 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -77.43 158.15 30.17 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.761 -0.847 . . . . 2.1 109.431 -179.658 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -100.36 132.3 45.81 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.315 -0.866 . . . . 0.77 111.515 -178.563 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 62.3 tp -101.58 133.3 46.47 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.468 -1.308 . . . . 0.91 107.468 178.004 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.0 tp -116.35 123.13 46.85 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-O 121.853 0.835 . . . . 0.93 110.19 -178.798 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.429 HD12 ' HB2' ' A' ' 160' ' ' ALA . 18.3 mt -92.75 102.29 14.69 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.206 0.527 . . . . 0.93 110.586 -179.022 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.8 mtmt -105.15 136.0 45.47 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.369 -0.832 . . . . 2.75 109.482 179.713 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -130.64 139.49 50.37 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.44 -0.787 . . . . 3.0 109.354 179.437 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -87.5 152.63 22.06 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.147 -0.971 . . . . 2.77 109.493 179.547 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -70.07 140.64 52.8 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.103 -0.998 . . . . 2.94 110.383 -179.781 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 79.6 mt -81.88 136.65 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.476 -0.935 . . . . 0.95 108.476 179.124 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.6 t -103.66 127.68 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 O-C-N 121.231 -0.918 . . . . 1.28 110.776 -178.82 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -102.96 136.69 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 N-CA-C 108.791 -0.818 . . . . 1.21 108.791 179.481 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.13 124.55 34.91 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.987 -1.07 . . . . 1.81 109.238 -179.976 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.4 mmm180 -88.99 1.12 55.98 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.303 -0.873 . . . . 2.8 109.526 -179.762 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -61.85 140.33 58.28 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.173 -0.954 . . . . 2.87 110.129 179.859 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -85.58 141.73 29.62 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.612 -0.884 . . . . 2.35 108.612 179.452 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.495 HG21 ' HG3' ' A' ' 39' ' ' GLU . 7.7 pt -90.12 164.99 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.823 -1.173 . . . . 0.97 110.944 -179.12 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 49.3 p -97.07 172.46 7.82 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.551 -0.907 . . . . 1.17 108.551 178.566 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.02 -48.69 80.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.02 -1.05 . . . . 1.18 109.819 -179.473 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 40.1 t0 -55.5 -30.05 59.93 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.822 -1.174 . . . . 2.56 109.367 -179.889 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -81.86 -10.04 59.42 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.446 -0.784 . . . . 1.79 110.272 -179.756 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 41.5 t -64.08 -53.28 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.497 -1.377 . . . . 1.0 108.995 179.578 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.25 -40.04 96.3 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.436 -0.79 . . . . 1.77 110.121 -179.906 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -69.89 -40.25 75.76 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.095 -1.003 . . . . 2.7 110.497 -178.934 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.495 ' HG3' HG21 ' A' ' 31' ' ' ILE . 66.4 mm-40 -65.81 -40.04 91.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.846 -1.159 . . . . 1.51 109.955 -179.988 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.6 t -61.88 -46.48 96.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.963 -1.086 . . . . 0.93 108.514 178.919 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.6 tp10 -60.26 -40.43 90.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.19 -0.944 . . . . 1.81 109.315 179.561 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -60.07 -44.14 94.96 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.097 -1.075 . . . . 2.78 108.097 179.099 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -61.33 -48.63 80.46 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.231 -0.918 . . . . 0.78 109.046 178.114 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 59.5 tp -59.81 -45.24 92.97 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.217 -1.031 . . . . 1.07 108.217 -179.472 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 41.2 t -60.34 -40.02 89.21 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.156 -0.965 . . . . 1.12 108.548 178.538 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.9 -48.87 80.89 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.641 -1.784 . . . . 0.84 108.641 179.32 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -60.33 -39.02 85.57 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.821 -1.177 . . . . 3.09 107.821 178.28 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -51.06 -40.79 59.14 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.582 -0.896 . . . . 0.88 108.582 179.887 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 50' ' ' ALA . 14.5 ttmm -66.91 -73.78 0.13 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.386 -1.338 . . . . 2.59 107.386 178.417 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.435 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -36.83 -38.7 0.19 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.659 -0.65 . . . . 0.7 111.139 -178.557 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.2 m -53.75 -55.25 27.97 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.513 -1.367 . . . . 1.4 108.184 179.206 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.91 -46.96 66.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.521 -0.737 . . . . 0.67 111.027 -179.63 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -62.47 -43.54 98.56 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.885 -1.134 . . . . 1.66 110.5 -179.058 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 84.6 mt -60.12 -40.07 88.42 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.06 -1.025 . . . . 1.58 108.924 179.694 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -62.71 -34.39 77.06 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.429 -0.794 . . . . 1.35 109.618 179.507 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -64.6 -44.15 91.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.991 -1.068 . . . . 0.77 109.744 179.881 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 85.9 mt -60.23 -39.86 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.239 -0.913 . . . . 0.63 109.343 179.822 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.9 ttpp -54.08 -50.19 67.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.492 -0.755 . . . . 1.14 109.7 -179.076 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.7 m -58.13 -37.98 75.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.197 -0.939 . . . . 0.79 110.667 -177.884 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -64.85 -38.92 92.6 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.878 -1.139 . . . . 1.53 109.768 -179.696 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.65 -46.8 77.81 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.541 -0.724 . . . . 0.57 109.865 -179.613 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.13 -52.21 52.79 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.913 -1.275 . . . . 0.75 109.913 -179.124 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -70.08 -47.56 61.39 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.146 -1.208 . . . . 1.59 109.996 -179.728 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 49.0 m -63.63 -65.45 0.68 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.299 -0.876 . . . . 0.73 112.744 -177.569 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -95.58 -45.03 7.22 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 120.609 -1.307 . . . . 0.75 111.151 -177.944 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.17 -169.98 24.79 Favored Glycine 0 N--CA 1.5 2.91 0 O-C-N 120.672 -1.268 . . . . 1.22 110.863 179.67 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -70.0 -24.36 63.29 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.93 -0.747 . . . . 5.81 109.652 -179.958 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -60.0 -34.01 72.76 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -0.802 . . . . 3.37 110.195 -179.682 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.417 ' HA ' HD12 ' A' ' 72' ' ' ILE . 29.5 mmtp -100.33 -17.46 17.25 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.316 -0.865 . . . . 1.77 110.006 179.683 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -68.8 -46.44 68.65 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.262 -0.899 . . . . 1.65 110.284 -179.342 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.553 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -62.47 -28.2 69.66 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.412 -0.805 . . . . 0.77 109.945 -178.802 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 69' ' ' LYS . 93.0 mt -60.06 -41.14 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.917 -1.114 . . . . 0.8 109.389 -179.621 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -68.19 -38.16 81.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.961 -1.087 . . . . 0.88 110.279 -179.567 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.401 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 74.4 tt0 -59.94 -39.95 87.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.922 -1.111 . . . . 1.37 109.485 179.676 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.1 -41.69 99.7 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.11 -1.596 . . . . 0.62 109.11 179.522 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 38.4 m170 -64.02 -40.97 97.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.398 -1.06 . . . . 1.5 109.502 -179.929 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -68.91 -47.2 77.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.174 -0.954 . . . . 0.63 109.022 179.488 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -60.61 -40.24 91.1 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.095 -1.003 . . . . 1.51 110.472 -179.457 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.86 HD11 ' CE2' ' B' ' 348' ' ' PHE . 27.2 tp -67.48 -40.0 85.26 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.079 -1.013 . . . . 0.77 109.3 179.72 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.63 -39.98 92.04 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.468 -0.77 . . . . 0.62 110.368 -179.503 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -80.26 5.05 15.71 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.995 -1.066 . . . . 1.47 110.262 -178.706 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 61.9 t0 -51.57 130.03 27.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.059 -1.026 . . . . 1.47 109.618 -179.855 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.404 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.7 mt-10 -61.21 -15.18 31.61 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.48 -0.763 . . . . 1.78 110.173 -179.337 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -72.55 -36.86 68.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.106 -0.996 . . . . 2.53 108.673 178.758 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 76.3 mt -70.04 -40.06 75.35 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 121.574 0.702 . . . . 0.8 109.41 -179.915 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -60.12 -49.16 78.75 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.259 -0.9 . . . . 1.42 109.597 -179.86 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -69.99 -40.29 75.4 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.377 -0.827 . . . . 1.71 111.316 -179.008 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -70.07 -39.92 75.33 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.881 -1.137 . . . . 1.57 110.997 -178.678 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 95.3 mt -70.0 -41.97 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.02 -1.05 . . . . 0.65 109.585 -179.744 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.7 mt -68.53 -37.79 78.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.444 -0.785 . . . . 0.82 109.633 179.39 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.28 86.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.79 110.818 -178.701 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.417 ' O ' ' N ' ' A' ' 96' ' ' LYS . 97.8 mt -60.09 -45.99 91.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.81 -1.181 . . . . 0.95 109.393 -179.284 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.2 mt -61.68 -49.43 84.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.297 -0.877 . . . . 0.66 109.097 179.479 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 61.6 mttm -69.86 -40.0 76.04 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.306 -0.872 . . . . 2.2 110.67 179.805 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -83.64 -52.86 6.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.037 -1.039 . . . . 1.65 112.057 -177.948 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 92' ' ' LEU . 7.1 mtpm? -93.4 -3.22 53.63 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.078 -1.014 . . . . 2.03 112.295 -177.123 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 30.2 m170 59.21 39.98 22.13 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 120.839 -1.163 . . . . 1.42 109.573 -179.585 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 97.5 mtp -91.27 164.97 13.69 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.459 -0.775 . . . . 1.18 110.112 -179.834 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 65.4 p -79.99 163.62 24.1 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.514 -0.741 . . . . 0.98 109.197 179.732 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.09 -41.23 82.16 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.228 -0.92 . . . . 0.64 110.458 -179.305 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -67.48 -37.69 83.26 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.155 -0.966 . . . . 2.07 109.577 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.29 -41.15 34.73 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.293 -0.879 . . . . 0.73 110.169 179.967 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.1 -47.02 63.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.895 . . . . 0.54 110.452 -179.25 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.45 -40.4 90.99 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.974 -1.079 . . . . 0.56 110.18 -179.702 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.45 ' CD2' ' OE1' ' A' ' 109' ' ' GLU . 84.8 t60 -59.91 -40.12 87.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.251 -0.905 . . . . 1.54 110.17 -178.564 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -64.52 -40.12 95.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.057 -1.027 . . . . 1.33 110.795 -178.931 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.08 -51.85 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.072 -1.017 . . . . 0.72 111.06 -178.093 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 42.0 mm -69.66 -39.97 78.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.777 -1.202 . . . . 0.85 108.574 -179.837 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.45 ' OE1' ' CD2' ' A' ' 105' ' ' HIS . 88.2 tt0 -62.78 -39.35 93.93 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.622 -0.881 . . . . 2.44 108.622 178.825 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.94 -50.61 65.8 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 110.199 -1.161 . . . . 0.98 110.199 -179.545 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 74.0 mm-40 -66.24 -48.11 71.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.79 -1.418 . . . . 1.41 109.112 179.955 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.05 -42.05 93.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.139 -0.976 . . . . 1.2 108.673 179.431 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 48.1 t -58.19 -39.94 80.25 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.71 -0.848 . . . . 1.7 108.71 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.92 -40.0 94.38 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.403 -0.811 . . . . 1.47 109.631 179.485 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.04 -41.19 91.2 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.976 -1.078 . . . . 1.56 109.604 -179.431 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.83 -33.81 72.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.57 -1.331 . . . . 2.2 109.452 -179.246 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -54.5 -22.18 12.16 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.418 -0.956 . . . . 2.12 108.418 179.437 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.467 HD13 HD13 ' A' ' 123' ' ' LEU . 61.7 mt -64.09 144.84 56.8 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.378 -0.826 . . . . 2.0 109.319 179.912 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -100.63 46.67 0.94 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.248 -0.907 . . . . 3.23 110.489 -179.727 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 64.6 t0 -131.51 138.02 48.77 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.14 -0.975 . . . . 2.49 109.943 179.964 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.541 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 47.5 mt-10 -69.94 -32.0 70.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.599 -0.688 . . . . 3.95 110.504 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.463 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.3 t80 -72.18 -39.95 68.29 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.309 -0.87 . . . . 2.0 110.536 179.582 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.642 ' CD2' HH21 ' A' ' 126' ' ' ARG . 80.9 mt -70.54 -37.31 74.05 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.094 -1.004 . . . . 1.86 108.825 -179.855 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -60.41 -39.83 88.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.406 -0.809 . . . . 2.84 109.792 179.333 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 73.3 mm-40 -59.46 -48.94 79.7 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.112 -0.992 . . . . 2.73 109.692 -179.232 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.642 HH21 ' CD2' ' A' ' 123' ' ' LEU . 77.4 mtm180 -63.88 -38.52 91.39 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 119.134 -1.026 . . . . 2.77 108.672 179.105 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.67 -26.63 56.91 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.951 -1.129 . . . . 1.19 107.951 178.888 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -71.08 -38.08 72.45 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.403 -0.962 . . . . 1.2 108.403 178.347 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -64.98 -40.1 94.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.581 -0.699 . . . . 1.55 109.658 -179.527 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 55.2 t -68.84 -43.02 82.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.26 -0.9 . . . . 0.8 109.233 179.811 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.434 HH11 ' HG2' ' A' ' 131' ' ' ARG . 28.6 ttt-85 -60.6 -39.68 89.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 3.09 108.842 179.14 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -60.0 -39.98 87.66 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.557 -0.714 . . . . 1.46 110.422 -179.447 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 94.3 mt -60.04 -43.91 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.887 -1.133 . . . . 0.71 109.997 -179.261 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -69.98 -34.43 70.92 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.894 -1.283 . . . . 0.57 109.894 179.959 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -60.0 -49.97 75.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.2 -1.177 . . . . 2.59 109.673 -179.219 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.405 ' HG2' HH21 ' A' ' 139' ' ' ARG . 86.1 mtm180 -69.85 -30.85 68.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.851 -1.156 . . . . 2.83 110.04 -179.936 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.3 tp -60.04 -43.24 95.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.07 -1.018 . . . . 1.25 109.083 -179.586 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 97.6 mt -60.39 -39.9 88.98 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.304 -0.873 . . . . 0.7 109.352 179.208 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.405 HH21 ' HG2' ' A' ' 136' ' ' ARG . 57.0 mtm180 -69.64 -38.17 77.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.171 -0.956 . . . . 2.57 108.485 179.072 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.482 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.4 m120 -60.16 -36.71 78.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.819 -0.551 . . . . 1.23 110.626 -179.136 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.3 mt -70.07 -42.98 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.782 -1.199 . . . . 0.81 109.512 -179.767 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 94.8 mt -81.08 -38.03 28.0 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.402 -0.812 . . . . 1.0 110.021 -179.89 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.89 45.87 4.08 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 108.758 -1.737 . . . . 0.89 108.758 -178.941 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 32.4 tp -74.18 149.87 40.68 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.482 -1.01 . . . . 1.14 109.777 -179.273 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 142.56 53.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.229 -0.919 . . . . 4.6 109.655 -179.61 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 86.0 mt -120.05 123.19 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 CA-C-O 121.611 0.72 . . . . 1.24 109.214 -179.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.414 HG12 ' H ' ' A' ' 147' ' ' ILE . 23.9 mm -49.18 -52.91 9.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 O-C-N 121.583 -0.698 . . . . 1.54 109.384 -178.943 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.6 t0 66.41 100.08 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.494 0.664 . . . . 1.5 109.527 -179.893 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.51 ' O ' HD12 ' A' ' 152' ' ' ILE . 67.8 mt -70.91 -9.0 56.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.507 -0.746 . . . . 0.79 109.945 -179.337 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.466 ' HA ' HD21 ' A' ' 172' ' ' ASN . 22.9 p -74.99 -17.28 60.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.066 -1.021 . . . . 1.4 109.592 179.778 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -84.94 28.74 0.67 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.455 -0.778 . . . . 0.92 111.316 -177.716 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.51 HD12 ' O ' ' A' ' 149' ' ' LEU . 49.9 mt -90.02 116.87 32.21 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 120.848 -1.157 . . . . 0.88 109.37 -179.434 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -98.97 -14.27 19.58 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.357 -0.84 . . . . 2.45 110.087 -178.982 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -127.17 149.91 49.75 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.193 -0.942 . . . . 1.52 110.23 -179.173 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -63.75 139.73 58.8 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.621 -0.881 . . . . 1.58 108.621 179.814 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 20.7 m -153.09 164.95 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.335 -0.853 . . . . 0.69 109.699 -179.693 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.1 mt -93.51 149.15 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 105.834 -1.913 . . . . 0.61 105.834 176.533 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.415 HD11 HD11 ' A' ' 19' ' ' LEU . 43.4 tp -97.37 113.91 25.64 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.934 -1.104 . . . . 0.87 110.481 -177.725 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 62.6 t -121.18 129.98 75.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 N-CA-C 108.255 -1.017 . . . . 0.71 108.255 179.067 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.429 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -163.25 169.22 19.51 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.21 -0.931 . . . . 0.81 108.872 179.888 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.17 -35.37 68.98 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.696 -1.253 . . . . 0.98 108.023 178.375 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -167.46 175.52 7.14 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.812 -1.181 . . . . 2.25 107.812 179.961 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 58.0 mt -135.59 145.64 47.12 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.076 -1.015 . . . . 0.78 109.09 179.722 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 40.0 p -97.37 127.9 36.63 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 108.242 -1.021 . . . . 0.98 108.242 179.166 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -37.0 -35.9 0.25 Allowed 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 121.985 1.79 . . . . 0.81 112.616 -179.407 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.3 m -60.01 -39.87 87.29 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.075 -1.016 . . . . 0.9 109.016 -179.722 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -67.88 -40.16 83.59 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.171 -0.955 . . . . 1.61 110.138 179.971 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 55.8 p -56.46 -33.79 66.25 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.145 -0.972 . . . . 0.61 111.382 -177.991 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.76 -45.08 65.43 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.676 -1.265 . . . . 0.6 109.71 -179.871 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.437 ' H ' ' HG2' ' A' ' 170' ' ' GLN . 14.5 pt20 -90.73 35.63 0.89 Allowed 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.374 -0.972 . . . . 1.4 108.374 179.68 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 61.4 tp -106.71 130.73 54.39 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 108.12 -1.067 . . . . 0.7 108.12 178.577 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.466 HD21 ' HA ' ' A' ' 150' ' ' SER . 4.1 m-20 -82.05 103.86 11.98 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.171 -0.956 . . . . 2.35 109.177 -179.75 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.25 -41.06 96.26 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.046 -1.033 . . . . 1.51 110.234 -179.471 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -61.52 -27.22 68.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.175 -0.953 . . . . 2.33 111.359 -178.049 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -92.75 -10.43 37.05 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 120.603 -1.31 . . . . 1.92 109.933 -178.867 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.448 HG11 ' CE1' ' A' ' 179' ' ' PHE . 58.1 t -103.23 112.83 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.15 -0.969 . . . . 0.67 108.698 179.031 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 84.9 mt -87.29 3.99 44.56 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.27 -0.894 . . . . 1.53 110.719 -178.336 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.406 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 176.31 168.91 37.12 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.112 -1.595 . . . . 0.48 109.112 179.719 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.456 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 23.2 m-85 -130.91 127.12 37.84 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.386 -1.067 . . . . 0.55 109.277 -179.945 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 95.8 mt -130.48 123.58 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.449 -1.315 . . . . 0.65 107.449 177.915 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.3 p -141.88 159.15 42.8 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.204 1.002 . . . . 0.82 111.068 -178.824 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 183' ' ' ALA . 59.2 t0 -96.88 18.34 14.81 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.685 -0.634 . . . . 2.46 109.737 -179.8 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.505 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -44.28 -178.87 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.91 -1.119 . . . . 1.28 112.653 -178.032 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -77.71 -54.31 4.63 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 111.23 -0.748 . . . . 2.19 111.23 -179.355 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -159.1 -163.82 13.63 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.06 -1.543 . . . . 2.13 111.285 -178.835 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.452 HH11 ' HG2' ' A' ' 186' ' ' ARG . 12.6 ptt-85 -72.39 -10.54 59.92 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.794 -0.827 . . . . 5.86 110.738 -179.116 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 80.6 p -80.9 7.42 10.63 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.955 -1.091 . . . . 3.72 109.898 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 95.1 p -84.92 142.69 29.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.193 -0.942 . . . . 1.74 110.481 -179.69 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -48.27 -44.53 33.63 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.867 -0.79 . . . . 0.95 108.867 179.601 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.411 ' H ' HG23 ' A' ' 190' ' ' THR . 3.2 p -56.08 -40.08 73.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.626 -0.671 . . . . 1.55 109.806 -179.475 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 48.3 t -61.67 -40.28 94.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -0.93 . . . . 1.51 111.03 -179.241 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.9 mm -62.18 -41.52 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.084 -1.01 . . . . 1.67 110.115 -178.813 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 95.9 mtp -60.02 -45.62 92.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.039 -1.038 . . . . 1.02 110.683 -178.38 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.97 -42.68 94.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 120.688 -1.257 . . . . 0.68 109.708 -179.308 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 58.6 mtt-85 -60.04 -51.23 70.53 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.272 -0.892 . . . . 2.93 110.618 -178.919 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 52.6 m -77.74 -32.44 52.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.923 -1.111 . . . . 0.86 111.866 -178.336 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 89.7 mt -70.4 -20.31 62.94 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.634 -1.292 . . . . 0.67 109.459 -179.425 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 64.17 49.94 2.53 Favored 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.309 0.576 . . . . 1.5 110.546 -179.733 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 83.2 mt -130.35 151.0 77.77 Favored Pre-proline 0 N--CA 1.5 2.058 0 N-CA-C 108.163 -1.051 . . . . 0.72 108.163 178.679 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -63.65 139.43 69.56 Favored 'Trans proline' 0 N--CA 1.498 1.747 0 C-N-CA 122.002 1.801 . . . . 0.61 111.043 179.599 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -171.55 153.98 3.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.763 -1.21 . . . . 0.66 111.525 -179.721 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.1 mt -127.64 152.32 35.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 108.053 -1.091 . . . . 0.79 108.053 179.362 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 12.2 m -131.88 -13.55 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.335 0 O-C-N 121.064 -1.023 . . . . 0.91 111.295 -179.096 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 205' ' ' THR . . . -111.36 26.47 12.02 Favored Glycine 0 N--CA 1.502 3.088 0 N-CA-C 110.645 -0.982 . . . . 1.01 110.645 -178.826 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.407 ' C ' ' O ' ' A' ' 204' ' ' GLY . 3.2 p -43.38 -45.06 5.97 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.23 -1.159 . . . . 0.99 109.962 -179.622 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.465 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 93.89 -53.95 2.26 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 120.204 -0.998 . . . . 1.12 111.2 179.128 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 64.3 m -154.4 31.49 0.43 Allowed 'General case' 0 N--CA 1.501 2.092 0 O-C-N 120.321 -1.694 . . . . 1.72 111.449 -179.024 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.2 t -70.02 -40.08 78.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 120.85 -1.156 . . . . 0.89 108.885 178.581 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 75.0 p -53.29 -29.52 33.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.424 -0.798 . . . . 1.03 110.563 -179.219 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 28.0 t -83.7 -15.13 49.9 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.973 -1.08 . . . . 1.83 110.428 -178.855 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -100.09 -15.92 18.03 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.226 -0.921 . . . . 2.27 110.955 -179.009 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 88.5 t -105.29 139.72 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.177 0 O-C-N 121.136 -0.978 . . . . 0.92 111.001 -178.16 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.13 152.59 30.88 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.585 -1.265 . . . . 2.2 107.585 178.473 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 5.6 t-20 -58.27 139.16 55.62 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.948 -1.095 . . . . 2.36 110.283 -179.255 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 12.5 t0 87.74 8.61 0.17 Allowed 'General case' 0 N--CA 1.503 2.221 0 CA-C-O 121.335 0.588 . . . . 2.38 109.796 179.633 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 56.2 t0 -79.07 140.5 37.87 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.326 -0.859 . . . . 2.09 109.317 179.551 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.531 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 55.3 t80 -91.78 118.39 30.64 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.346 -1.353 . . . . 1.27 107.346 178.476 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.522 HD22 HG22 ' A' ' 229' ' ' VAL . 82.7 mt -126.52 147.36 49.86 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.325 -0.86 . . . . 0.75 110.69 -178.631 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.449 HD12 ' HG3' ' A' ' 231' ' ' PRO . 81.6 mt -118.57 126.71 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 106.819 -1.548 . . . . 0.63 106.819 176.875 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 48.6 tp -102.02 124.84 48.33 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.241 -0.912 . . . . 0.7 108.645 -179.268 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.658 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 27.9 p-10 -87.94 -35.62 17.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.203 -0.935 . . . . 2.31 108.607 179.686 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 44.52 18.59 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.826 -0.805 . . . . 0.78 108.826 -179.224 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.541 ' N ' ' O ' ' A' ' 221' ' ' ASP . 16.6 t -125.82 -46.89 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 N-CA-C 107.127 -1.434 . . . . 1.04 107.127 179.579 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -100.75 -1.03 36.08 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.873 -1.529 . . . . 2.44 106.873 177.745 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 61.76 50.39 4.37 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.439 0.638 . . . . 1.55 109.587 179.996 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.658 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 95.6 mt-30 -138.77 151.16 46.85 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.522 -0.736 . . . . 1.99 109.311 179.76 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 84.2 t -119.41 127.73 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.421 -0.955 . . . . 0.77 108.421 178.882 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -102.26 123.98 47.03 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.331 -0.989 . . . . 0.98 108.331 179.443 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.522 HG22 HD22 ' A' ' 218' ' ' LEU . 58.5 t -104.21 115.0 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.492 -0.755 . . . . 0.85 110.369 -178.911 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 60.4 t30 53.61 69.55 2.19 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.912 . . . . 1.66 110.341 179.718 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.449 ' HG3' HD12 ' A' ' 219' ' ' ILE . 98.2 Cg_endo -90.91 148.58 3.89 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 123.408 2.739 . . . . 0.95 112.478 179.541 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 3.7 m -69.99 160.88 31.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.255 -0.903 . . . . 1.84 109.701 -179.431 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.55 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 38.2 p30 -60.02 -39.94 87.59 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 2.74 111.481 -178.669 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.55 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 13.1 pt-20 -60.04 -31.22 69.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.58 -1.325 . . . . 2.89 109.641 -179.352 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 83.2 t -70.03 -42.41 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.033 -1.042 . . . . 1.3 109.282 179.115 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.07 -40.67 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.313 -0.867 . . . . 1.09 110.396 -179.762 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -59.94 -41.65 92.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.812 -1.18 . . . . 2.43 108.861 -179.614 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 41.1 tttp -65.97 -40.12 90.96 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.248 -0.908 . . . . 2.78 109.25 179.591 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 96.2 mtp -68.11 -37.38 81.09 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.446 -0.784 . . . . 1.25 109.645 179.615 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -66.55 -37.78 85.72 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.4 -0.813 . . . . 2.63 109.857 179.989 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.12 -40.97 91.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.217 -0.927 . . . . 1.8 109.716 -179.606 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.82 -41.39 90.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.331 -0.856 . . . . 2.13 109.789 -179.672 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 13.5 tm0? -60.08 -40.12 88.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.205 -0.935 . . . . 3.17 110.033 -179.397 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -60.53 -44.89 95.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.156 -0.965 . . . . 1.78 109.783 -179.725 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -60.22 -40.01 88.68 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.267 -0.896 . . . . 2.47 109.631 -179.876 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 92.5 t -59.95 -39.79 81.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.252 -0.905 . . . . 2.09 109.139 -179.205 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -56.98 -48.46 78.35 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.212 -0.93 . . . . 2.54 109.116 179.85 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 62.4 m -62.52 -39.9 95.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.116 -0.99 . . . . 2.99 110.216 179.838 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.15 -39.96 92.05 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.319 -0.863 . . . . 3.34 111.188 -178.503 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.98 23.46 0.35 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.756 -1.215 . . . . 3.88 109.863 -179.337 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -51.25 -22.54 2.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.115 -0.99 . . . . 4.43 108.677 179.695 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.485 ' OE1' ' N ' ' A' ' 252' ' ' GLU . 57.1 mp0 -69.93 -31.54 69.36 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.812 -0.81 . . . . 5.42 108.812 179.475 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.463 ' CB ' ' O ' ' A' ' 252' ' ' GLU . 8.6 mt 95.17 -44.89 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 106.969 -1.493 . . . . 6.1 106.969 -178.321 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 60.04 20.19 9.35 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.724 -0.61 . . . . 7.37 109.647 179.595 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.471 ' C ' HD22 ' A' ' 256' ' ' LEU . 44.7 tttp -135.97 139.1 42.94 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.437 -0.789 . . . . 8.01 109.031 179.777 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.685 HD22 ' N ' ' A' ' 256' ' ' LEU . 3.0 mm? -98.63 30.8 3.12 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.559 -0.713 . . . . 9.05 109.991 -179.047 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -155.9 -80.0 0.08 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.99 -1.069 . . . . 10.56 109.86 179.834 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 46.6 t0 60.15 71.38 0.57 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.519 -0.738 . . . . 11.32 109.741 -179.588 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.459 HH11 ' HG2' ' A' ' 259' ' ' ARG . 43.0 mtt-85 . . . . . 0 N--CA 1.496 1.834 0 CA-C-O 117.985 -1.007 . . . . 12.42 109.283 179.729 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 10.4 ttt . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . 0.504 ' CD1' ' N ' ' B' ' 303' ' ' GLN . 22.8 t80 -154.84 154.07 32.15 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.312 -0.868 . . . . 0.0 110.05 179.542 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . 0.504 ' N ' ' CD1' ' B' ' 302' ' ' PHE . 2.9 pm0 -146.98 156.62 43.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.183 -0.948 . . . . 0.0 110.661 -179.621 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . 0.517 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 0.4 OUTLIER -152.15 147.31 26.28 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.454 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . 0.517 ' N ' ' OE1' ' B' ' 304' ' ' GLN . 98.9 mt-10 -107.21 131.32 54.3 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.959 -1.088 . . . . 0.0 109.694 179.102 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.453 ' O ' HG13 ' B' ' 306' ' ' VAL . 7.4 p -131.26 120.61 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 CA-C-O 122.045 0.926 . . . . 0.0 112.544 -177.745 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . 0.538 ' O ' HG23 ' B' ' 309' ' ' THR . 8.8 m -76.91 107.11 9.01 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 121.874 0.845 . . . . 0.0 111.359 -177.711 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.6 mt -52.23 118.13 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-O 122.098 0.951 . . . . 0.0 109.717 -178.944 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . 0.599 ' C ' HE22 ' B' ' 357' ' ' GLN . 67.4 p -107.3 19.95 19.61 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.714 -178.249 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.522 ' N ' ' OE1' ' B' ' 357' ' ' GLN . . . -81.2 114.52 49.74 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.192 -0.943 . . . . 0.0 109.845 179.686 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -50.4 -9.72 0.21 Allowed 'Trans proline' 0 N--CA 1.497 1.733 0 CA-C-N 120.199 1.107 . . . . 0.0 113.308 -179.332 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . 0.4 ' N ' ' O ' ' B' ' 310' ' ' ALA . 97.8 m-20 -120.5 4.04 10.7 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.437 -0.789 . . . . 0.0 109.265 179.829 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 74.0 -178.75 43.0 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.635 -1.786 . . . . 0.0 108.635 -179.428 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.463 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.5 tp -83.64 89.82 7.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.05 -1.265 . . . . 0.0 109.027 -179.193 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.4 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 4.7 p80 -92.8 -162.2 0.91 Allowed 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.924 -1.11 . . . . 0.0 109.989 179.18 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.8 m -58.07 -42.3 85.25 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.041 -1.037 . . . . 0.0 112.873 -175.932 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.553 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.4 tpt180 -59.87 -61.52 7.73 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 120.327 -1.483 . . . . 0.0 111.523 -178.571 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.4 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 9.9 Cg_endo -58.11 -33.63 97.6 Favored 'Trans proline' 0 N--CA 1.492 1.383 0 CA-C-N 120.231 1.118 . . . . 0.0 111.473 179.975 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.4 -50.29 74.53 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.515 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.2 -44.02 74.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.662 -0.649 . . . . 0.0 109.338 -179.905 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 64.6 tp60 -70.01 -42.01 73.59 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.105 -1.038 . . . . 0.0 108.598 179.061 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -59.99 -50.41 73.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.635 -0.666 . . . . 0.0 110.543 -179.371 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.44 -30.25 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.591 -1.318 . . . . 0.0 109.172 -179.485 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.401 ' NZ ' ' OE1' ' A' ' 74' ' ' GLU . 19.9 ttmt -60.01 -47.14 87.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.413 -0.804 . . . . 0.0 109.199 179.535 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 48.2 tp10 -67.56 -48.89 65.64 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.184 -0.948 . . . . 0.0 110.896 -179.227 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -66.08 -52.72 46.2 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.798 -1.189 . . . . 0.0 110.709 -178.748 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 17.8 ttmm -54.78 -14.5 1.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.088 -179.02 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -74.59 -20.95 79.37 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.358 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -103.79 146.96 27.86 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.439 -1.036 . . . . 0.0 108.719 179.686 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 13.9 t -91.2 -13.65 32.47 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.767 -1.208 . . . . 0.0 109.653 -179.898 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.43 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 63.7 p -60.13 147.58 39.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 -179.863 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . 0.419 ' OE1' ' N ' ' B' ' 332' ' ' GLU . 58.2 mp0 -68.87 134.49 49.7 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.104 -0.998 . . . . 0.0 108.636 179.758 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 83.1 mt -133.17 133.63 58.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.497 -0.752 . . . . 0.0 109.688 -179.222 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 82.4 m -129.05 149.81 50.71 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.478 -0.764 . . . . 0.0 109.288 179.409 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 53.9 t -122.84 114.07 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 178.338 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 96.5 m -104.97 134.18 48.51 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.212 -0.93 . . . . 0.0 109.394 -178.411 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 24.7 p -139.46 111.67 7.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.336 -0.853 . . . . 0.0 110.944 -179.48 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 48.89 50.81 17.06 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 176.685 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 90.04 -14.84 60.96 Favored Glycine 0 N--CA 1.501 2.998 0 O-C-N 119.941 -1.724 . . . . 0.0 112.503 177.104 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 21.3 mtpp -118.64 131.44 56.18 Favored 'General case' 0 N--CA 1.508 2.447 0 CA-C-N 119.019 1.41 . . . . 0.0 109.69 -179.809 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 79.6 p -132.51 151.8 51.78 Favored 'General case' 0 N--CA 1.5 2.028 0 CA-C-O 121.933 0.873 . . . . 0.0 110.681 -178.872 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -143.26 167.2 22.7 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 -179.758 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 15.2 m -87.56 138.16 31.71 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.47 -0.769 . . . . 0.0 110.255 -179.273 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -77.13 -14.59 59.77 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.959 -1.088 . . . . 0.0 109.997 -179.394 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 23.3 pttp -89.59 20.46 3.98 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.126 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . 0.453 ' CB ' ' HZ3' ' B' ' 349' ' ' LYS . 9.0 t -145.74 94.44 2.49 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.535 -179.649 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.733 HD23 HD22 ' A' ' 79' ' ' LEU . 58.5 tp -59.97 -36.32 76.86 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.069 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.86 ' CE2' HD11 ' A' ' 79' ' ' LEU . 51.0 m-85 -54.54 -50.42 67.94 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 0.0 110.699 -179.376 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . 0.453 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 35.9 mtmm -69.95 -40.02 75.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.911 -1.118 . . . . 0.0 111.237 -177.975 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.55 ' O ' ' N ' ' B' ' 352' ' ' THR . 88.2 mt -49.28 -56.99 7.6 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.875 -1.14 . . . . 0.0 109.443 -178.933 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.567 HE22 ' CD1' ' B' ' 347' ' ' LEU . 1.2 mp0 -42.23 -14.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.414 -0.804 . . . . 0.0 111.342 -178.101 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.55 ' N ' ' O ' ' B' ' 350' ' ' LEU . 59.3 p -88.72 -11.48 45.02 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.287 -1.508 . . . . 0.0 110.185 -179.132 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 79.3 mt -91.58 117.52 29.79 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.84 -1.162 . . . . 0.0 108.807 178.646 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -69.79 89.2 0.3 Allowed Glycine 0 N--CA 1.489 2.181 0 N-CA-C 108.659 -1.777 . . . . 0.0 108.659 179.733 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 58.0 mt -98.73 86.81 3.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -1.162 . . . . 0.0 108.456 179.03 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 67.2 p -89.26 168.97 11.84 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.041 -1.037 . . . . 0.0 110.063 -178.926 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . 0.599 HE22 ' C ' ' B' ' 309' ' ' THR . 15.8 tp60 -62.99 114.94 3.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.631 -0.668 . . . . 0.0 110.61 -179.031 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 103.24 8.72 40.71 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.713 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 31.6 m -87.2 111.7 21.26 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.261 -1.14 . . . . 0.0 111.394 -178.986 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 48.5 t -76.98 118.09 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 CA-C-O 122.267 1.032 . . . . 0.0 109.548 -177.914 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 20.0 m -112.9 177.12 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -177.952 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 48.9 m -130.71 128.79 41.56 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.45 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 86.6 mt -103.06 117.58 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.154 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 72.7 m -120.99 132.09 54.7 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.289 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.24 153.34 40.49 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.069 -1.019 . . . . 0.0 110.489 -179.296 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . 0.441 ' OE1' ' OE1' ' B' ' 370' ' ' GLU . 17.1 tp10 -144.47 122.32 11.97 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.082 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.494 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 159.8 -157.11 28.34 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.954 -1.593 . . . . 0.0 111.595 -179.97 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -59.99 -51.88 67.77 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.338 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.43 ' H ' ' HB3' ' B' ' 331' ' ' SER . 42.6 m-20 -109.15 12.5 25.0 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.754 -1.216 . . . . 0.0 111.176 -177.256 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.494 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 11.8 pt-20 -42.33 -38.17 1.75 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.157 -0.965 . . . . 0.0 111.807 -178.816 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -69.89 -40.51 75.62 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.638 -1.289 . . . . 0.0 110.249 -178.341 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -68.75 -51.39 41.85 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.171 -0.956 . . . . 0.0 109.482 179.874 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -49.64 -34.28 17.85 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.634 -0.666 . . . . 0.0 112.228 -178.413 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.505 ' O ' HG23 ' B' ' 378' ' ' VAL . 56.2 t -74.82 -39.21 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.657 -1.277 . . . . 0.0 109.766 179.567 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -68.23 -40.01 82.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.168 -0.957 . . . . 0.0 112.37 -177.785 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -84.61 -43.07 14.78 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.193 -1.567 . . . . 0.0 110.901 -179.363 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.3 mt -59.93 -40.09 87.73 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.998 -1.064 . . . . 0.0 108.843 -179.196 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.505 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.9 t -61.02 -45.98 97.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.217 -0.927 . . . . 0.0 109.412 179.42 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.495 ' O ' ' N ' ' B' ' 383' ' ' GLU . 62.3 mttp -68.62 -54.75 14.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.788 -1.195 . . . . 0.0 107.86 178.503 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 52.8 tp -55.8 -36.25 67.21 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.308 -0.87 . . . . 0.0 109.182 -178.29 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 23.8 ttm -70.65 -40.08 73.25 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.698 -1.251 . . . . 0.0 108.335 177.792 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.21 -4.93 58.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.526 -0.734 . . . . 0.0 110.606 179.585 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' B' ' 379' ' ' LYS . 96.8 mt-10 -112.16 -3.67 14.61 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.17 -0.956 . . . . 0.0 111.106 -179.46 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.2 mt -79.88 136.55 36.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.464 -1.397 . . . . 0.0 109.47 179.011 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 N--CA 1.497 1.918 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.368 -179.901 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.9 mtp . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.506 -0.553 . . . . 2.91 109.506 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.4 mt -110.18 129.98 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 O-C-N 121.417 -0.802 . . . . 1.2 109.71 -179.928 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.2 m -132.67 149.84 52.24 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.402 -0.811 . . . . 1.4 109.408 179.686 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.416 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -140.7 -169.92 11.91 Favored Glycine 0 N--CA 1.497 2.728 0 N-CA-C 109.041 -1.624 . . . . 1.05 109.041 179.757 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.463 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.9 mt -85.48 -19.08 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.879 -1.365 . . . . 1.15 110.432 -178.831 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.7 tp 52.92 102.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.176 -0.952 . . . . 0.98 109.03 -179.732 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.11 -26.99 13.77 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.101 -0.999 . . . . 0.88 109.645 -179.881 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 m -134.77 117.97 13.17 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.469 -0.769 . . . . 1.69 109.004 -179.843 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.19 148.12 21.19 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 121.766 1.644 . . . . 0.85 112.562 -179.631 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.721 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 155.05 -155.41 26.21 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.754 -1.738 . . . . 0.92 108.754 -179.818 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 92.5 mt -149.6 151.18 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 120.909 -1.347 . . . . 0.81 108.715 179.041 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -152.47 150.85 30.06 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.901 -1.125 . . . . 0.51 110.719 179.772 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.8 m-85 -133.9 127.12 31.85 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 107.923 -1.14 . . . . 0.62 107.923 178.616 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.92 -176.69 46.39 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 118.37 -1.872 . . . . 0.55 111.203 179.713 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -79.23 155.64 28.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.985 -0.715 . . . . 2.1 109.841 -179.693 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.534 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.82 124.36 49.3 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.579 -0.7 . . . . 0.77 109.978 179.892 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.0 tp -94.22 135.19 35.88 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.472 -1.307 . . . . 0.91 107.472 178.582 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 60.9 tp -116.01 122.66 45.86 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.22 -0.925 . . . . 0.93 109.946 -179.08 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.7 mt -84.98 100.74 11.85 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.586 0.708 . . . . 0.93 109.955 -179.63 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -100.04 124.79 45.8 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.533 -0.914 . . . . 2.75 108.533 179.497 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.461 ' OE1' HD11 ' A' ' 147' ' ' ILE . 36.9 tp10 -132.03 141.82 49.37 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.237 -0.915 . . . . 3.0 109.462 -179.954 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.59 ' OD2' HD11 ' A' ' 144' ' ' LEU . 9.9 p-10 -77.73 149.19 34.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.385 -0.822 . . . . 2.77 109.558 179.649 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -70.15 149.61 47.38 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.166 -0.959 . . . . 2.94 109.595 -179.741 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 84.7 mt -82.34 126.51 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.186 -0.946 . . . . 0.95 110.154 -179.604 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.8 t -98.67 123.63 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.278 -0.889 . . . . 1.28 108.744 179.074 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.6 mt -100.55 145.23 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.333 -0.855 . . . . 1.21 109.363 -179.555 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -98.51 113.42 25.43 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.172 -0.955 . . . . 1.81 109.519 -179.879 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.479 HH11 ' HG2' ' A' ' 28' ' ' ARG . 7.4 mmt-85 -86.32 -2.13 58.13 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 2.8 109.449 -179.855 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -66.12 142.8 57.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.205 -0.934 . . . . 2.87 109.225 179.714 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -83.43 149.6 26.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.196 -0.94 . . . . 2.35 109.544 -179.749 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.439 HG21 ' HG3' ' A' ' 39' ' ' GLU . 6.4 pt -93.2 165.02 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.032 -1.042 . . . . 0.97 109.091 179.311 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 96.9 p -94.72 169.53 10.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.948 -1.095 . . . . 1.17 108.485 178.963 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -66.68 -12.83 60.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.145 -0.972 . . . . 1.18 109.561 -179.967 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -88.32 -28.86 20.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.111 -0.993 . . . . 2.56 108.406 178.787 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -81.65 -8.91 59.76 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.748 -0.834 . . . . 1.79 108.748 178.963 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.3 t -62.46 -53.59 45.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.083 -1.01 . . . . 1.0 108.912 179.815 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -60.04 -40.05 88.06 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.171 -0.956 . . . . 1.77 109.928 -179.87 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -69.94 -40.2 75.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.948 -1.095 . . . . 2.7 110.899 -179.37 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.439 ' HG3' HG21 ' A' ' 31' ' ' ILE . 68.7 mm-40 -65.27 -40.07 93.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.674 -1.266 . . . . 1.51 110.199 -179.895 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -61.64 -47.8 91.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.639 -1.288 . . . . 0.93 108.537 179.083 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.03 -45.9 91.29 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.175 -0.953 . . . . 1.81 109.538 179.677 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 -60.04 -42.94 95.49 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.688 -1.226 . . . . 2.78 107.688 179.146 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 79.8 t80 -61.2 -49.93 75.16 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.645 -0.659 . . . . 0.78 109.491 178.927 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.6 tp -60.91 -45.48 94.49 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.457 -0.777 . . . . 1.07 109.721 -179.718 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 31.9 t -66.46 -45.68 78.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.027 -1.045 . . . . 1.12 109.332 179.682 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.85 -44.56 97.69 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 108.026 -2.029 . . . . 0.84 108.026 178.9 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.52 ' NH2' ' O ' ' A' ' 80' ' ' LEU . 69.2 ttt180 -62.98 -35.31 79.75 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 108.357 -0.979 . . . . 3.09 108.357 178.638 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -55.87 -39.93 72.22 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.834 -0.802 . . . . 0.88 108.834 179.801 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' O ' ' C ' ' A' ' 50' ' ' ALA . 18.9 ttmt -63.32 -74.63 0.09 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.088 -1.078 . . . . 2.59 108.088 179.531 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.38 -31.82 0.06 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.363 -0.836 . . . . 0.7 111.682 -177.978 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 75.6 p -60.1 -54.17 49.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.562 -1.336 . . . . 1.4 108.669 179.988 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.99 -42.44 73.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.339 -0.851 . . . . 0.67 111.055 -179.298 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -63.45 -40.5 97.3 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.826 -1.171 . . . . 1.66 110.552 -178.805 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 85.1 mt -65.27 -39.66 92.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.874 -1.141 . . . . 1.58 108.993 179.603 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 57.4 mm-40 -59.95 -37.85 80.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.35 -0.844 . . . . 1.35 109.515 179.379 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -64.7 -41.2 96.18 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.214 -0.929 . . . . 0.77 110.46 -179.67 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.411 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.5 mt -64.62 -39.83 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.108 -0.995 . . . . 0.63 109.373 -179.946 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.444 ' NZ ' ' OE2' ' A' ' 70' ' ' GLU . 13.2 ttpp -59.35 -49.98 75.73 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.275 -0.89 . . . . 1.14 109.121 -179.858 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.1 m -61.13 -40.03 92.26 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.211 -0.931 . . . . 0.79 110.493 -178.795 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -63.7 -38.86 92.69 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.096 -1.003 . . . . 1.53 109.155 179.692 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.484 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -65.14 -41.56 94.66 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.582 -0.699 . . . . 0.57 109.746 179.574 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -61.65 -50.39 66.7 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 110.24 -1.144 . . . . 0.75 110.24 -179.488 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -69.89 -43.0 72.67 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.881 -1.364 . . . . 1.59 109.654 -179.65 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 84.9 m -71.27 -59.84 2.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.035 -1.041 . . . . 0.73 112.06 -178.476 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -91.18 -54.16 4.05 Favored 'General case' 0 N--CA 1.503 2.186 0 O-C-N 120.678 -1.264 . . . . 0.75 110.603 -178.801 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.58 -169.32 25.21 Favored Glycine 0 N--CA 1.5 2.916 0 C-N-CA 120.071 -1.062 . . . . 1.22 111.224 179.748 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -70.01 -24.14 63.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.951 -0.735 . . . . 5.81 109.958 -179.954 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.507 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 54.8 tp10 -60.45 -38.04 82.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.28 -0.888 . . . . 3.37 109.899 -179.974 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -99.44 -19.43 16.96 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.395 -0.815 . . . . 1.77 110.604 -179.317 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.444 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 61.8 tt0 -68.1 -39.99 82.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.902 -1.124 . . . . 1.65 109.837 -179.528 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.431 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.28 -33.78 76.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.411 -0.806 . . . . 0.77 110.384 -178.886 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.07 -42.37 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.752 -1.217 . . . . 0.8 109.222 -179.849 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 57.4 m-85 -72.59 -34.8 67.68 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.39 -0.819 . . . . 0.88 110.487 -179.213 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.465 ' OE1' ' NZ ' ' B' ' 324' ' ' LYS . 72.6 tt0 -59.97 -40.07 87.81 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 120.838 -1.164 . . . . 1.37 109.198 179.035 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.98 -41.2 97.8 Favored Glycine 0 N--CA 1.486 1.981 0 N-CA-C 108.41 -1.876 . . . . 0.62 108.41 179.081 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -61.78 -48.53 80.25 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.341 -1.093 . . . . 1.5 108.785 179.365 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 93.9 mt -62.3 -50.56 79.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.563 -0.711 . . . . 0.63 109.851 -179.776 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.6 ttp -60.98 -44.2 97.7 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.009 -1.057 . . . . 1.51 109.238 -179.639 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.811 HD22 HD23 ' B' ' 347' ' ' LEU . 44.9 tp -60.05 -39.91 87.59 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.579 -0.701 . . . . 0.77 109.114 179.214 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.52 ' O ' ' NH2' ' A' ' 47' ' ' ARG . 58.6 tp -69.66 -35.06 74.83 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.604 -0.685 . . . . 0.62 109.968 -179.387 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -85.43 0.43 52.28 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.92 -1.112 . . . . 1.47 110.002 -179.276 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -46.3 130.07 10.5 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.201 -0.937 . . . . 1.47 109.879 -179.221 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -61.36 -22.33 64.84 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.458 -0.776 . . . . 1.78 111.011 -179.124 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.99 -31.76 69.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.874 -1.141 . . . . 2.53 109.417 179.15 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.408 HD12 ' O ' ' A' ' 79' ' ' LEU . 91.2 mt -71.98 -40.02 68.87 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.673 0.749 . . . . 0.8 109.368 179.093 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -60.03 -49.25 78.38 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.724 -0.61 . . . . 1.42 110.827 -178.964 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -70.0 -42.01 73.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.17 -0.957 . . . . 1.71 111.061 -178.498 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.94 -39.94 75.77 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.157 -0.964 . . . . 1.57 111.491 -178.824 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 87.7 mt -68.0 -45.22 84.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 O-C-N 120.973 -1.08 . . . . 0.65 109.782 -179.517 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 97.0 mt -69.76 -38.79 76.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.322 -0.861 . . . . 0.82 110.089 179.831 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -62.66 -45.23 93.77 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 0.79 111.593 -178.913 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 99.3 mt -60.07 -44.22 94.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.83 -1.169 . . . . 0.95 109.533 -178.633 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.3 mt -61.19 -50.11 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.166 -0.959 . . . . 0.66 109.291 179.406 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -67.51 -40.01 85.13 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 120.22 -0.592 . . . . 2.2 111.436 -179.318 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -83.66 -52.14 6.69 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.752 -1.218 . . . . 1.65 112.025 -178.557 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -90.01 -0.05 57.37 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.119 -0.988 . . . . 2.03 112.026 -177.218 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 80.7 m80 55.1 33.81 21.21 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.834 -1.166 . . . . 1.42 109.486 -179.812 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 75.2 mtp -84.9 166.4 16.87 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.55 -0.719 . . . . 1.18 109.599 -179.625 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 76.8 p -78.64 154.85 29.88 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.171 -1.048 . . . . 0.98 108.171 179.187 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.0 -39.26 75.97 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.062 -1.024 . . . . 0.64 110.015 -179.707 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.538 ' OD1' HG21 ' A' ' 141' ' ' ILE . 86.5 m-20 -63.23 -40.19 96.75 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.101 -1.0 . . . . 2.07 109.621 -179.695 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.05 -46.12 14.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.104 -0.997 . . . . 0.73 109.655 179.463 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.98 -46.15 90.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.454 -0.779 . . . . 0.54 109.71 -179.539 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.99 -49.96 75.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.149 -0.97 . . . . 0.56 109.478 179.951 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -59.98 -34.79 73.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.323 -0.861 . . . . 1.54 110.042 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 56.4 tt0 -60.0 -41.27 91.71 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.176 -0.952 . . . . 1.33 109.103 -179.653 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.8 t -64.78 -49.96 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.391 -0.818 . . . . 0.72 110.072 -179.46 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.1 mm -69.05 -40.28 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.047 -1.033 . . . . 0.85 109.027 179.622 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -64.92 -40.01 94.4 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.722 -0.844 . . . . 2.44 108.722 179.362 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.97 -49.26 80.5 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.244 -1.142 . . . . 0.98 110.244 -179.76 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.409 HE21 ' HB3' ' B' ' 348' ' ' PHE . 15.1 mm100 -66.4 -51.81 53.17 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.929 -1.336 . . . . 1.41 109.11 -179.493 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.99 -41.97 93.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.245 -0.909 . . . . 1.2 109.718 179.583 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 74.8 p -58.38 -39.69 80.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.054 -1.029 . . . . 1.7 108.8 -179.701 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -59.96 -35.6 75.32 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.34 -0.85 . . . . 1.47 109.214 179.664 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 67.5 mt -66.2 -42.88 88.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.974 -1.079 . . . . 1.56 109.485 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -56.99 -32.71 66.37 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.072 -1.018 . . . . 2.2 109.327 -179.091 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -60.03 -28.43 67.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.278 -0.889 . . . . 2.12 108.966 179.859 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.554 HD13 HD13 ' A' ' 123' ' ' LEU . 59.6 mt -64.23 148.29 50.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.366 -0.834 . . . . 2.0 109.199 -179.927 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -100.07 57.1 0.96 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.175 -0.953 . . . . 3.23 109.448 179.802 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 58.8 t0 -136.0 135.23 39.32 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 121.247 -0.908 . . . . 2.49 110.514 -179.681 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.465 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 38.7 mt-10 -70.0 -32.46 70.64 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.338 -0.851 . . . . 3.95 109.903 179.313 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -69.6 -36.4 76.18 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.45 -0.781 . . . . 2.0 110.815 -179.805 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.554 HD13 HD13 ' A' ' 118' ' ' LEU . 66.2 mt -80.73 -34.66 34.27 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.754 -1.216 . . . . 1.86 109.47 179.866 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -60.49 -44.46 95.92 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.121 -0.987 . . . . 2.84 109.235 179.447 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -69.53 -40.09 77.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 2.73 109.516 -179.912 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 63.6 ttt180 -60.64 -40.07 90.62 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.229 -0.92 . . . . 2.77 108.565 179.408 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.401 ' O ' ' C ' ' A' ' 128' ' ' ALA . . . -59.44 -45.59 91.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.137 -0.977 . . . . 1.19 108.459 179.689 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 127' ' ' ALA . . . -44.3 -43.89 7.71 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 109.097 -0.705 . . . . 1.2 109.097 179.992 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -61.9 -45.85 91.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.389 -0.82 . . . . 1.55 109.868 179.389 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.14 -39.98 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.21 -0.931 . . . . 0.8 108.918 -179.896 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.712 ' HE ' ' NZ ' ' A' ' 135' ' ' LYS . 69.4 ttt180 -60.0 -39.41 85.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 3.09 109.147 179.528 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -60.02 -37.8 80.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.228 -0.92 . . . . 1.46 109.934 -179.749 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 89.8 mt -60.03 -44.32 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.048 -1.032 . . . . 0.71 109.657 -179.205 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.95 -33.83 59.42 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.709 -1.234 . . . . 0.57 110.172 179.882 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.712 ' NZ ' ' HE ' ' A' ' 131' ' ' ARG . 37.5 mmtm -59.99 -46.88 88.01 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.151 -1.205 . . . . 2.59 110.061 -179.011 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.411 HH22 ' CD1' ' A' ' 57' ' ' ILE . 66.4 mtp180 -65.93 -34.21 77.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.802 -1.186 . . . . 2.83 109.452 179.86 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.0 tp -57.24 -42.01 80.65 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.655 -0.868 . . . . 1.25 108.655 -179.252 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.412 HD21 ' O ' ' A' ' 101' ' ' ASP . 83.5 mt -60.88 -40.12 91.77 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.7 109.296 178.377 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.473 HH11 ' HG2' ' A' ' 139' ' ' ARG . 47.2 mtt-85 -69.68 -40.11 76.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 2.57 109.52 -179.915 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -66.93 -37.96 85.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.584 -0.698 . . . . 1.23 111.757 -178.827 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.538 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.8 mt -71.22 -40.01 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.411 -1.43 . . . . 0.81 109.43 179.61 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 60.8 mt -75.48 -12.25 60.2 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.618 -0.676 . . . . 1.0 110.819 -178.344 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 72.98 35.43 57.93 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.636 -1.785 . . . . 0.89 108.636 -179.286 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.59 HD11 ' OD2' ' A' ' 22' ' ' ASP . 15.0 tp -73.4 142.43 46.96 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.485 -1.009 . . . . 1.14 109.275 -179.19 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 15.6 tptm -72.37 140.77 48.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.38 -0.825 . . . . 4.6 110.441 -179.062 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.4 mt -112.58 129.96 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 CA-C-O 122.007 0.908 . . . . 1.24 109.289 179.468 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.461 HD11 ' OE1' ' A' ' 21' ' ' GLU . 6.3 mt -62.07 -43.21 97.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 CA-C-N 115.912 -0.585 . . . . 1.54 110.783 -178.588 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 34.9 t0 66.58 122.35 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.529 -0.732 . . . . 1.5 109.079 -179.016 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 39.5 mt -92.69 0.67 57.46 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.394 -0.816 . . . . 0.79 110.637 -179.034 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 78.7 p -83.61 -15.3 49.56 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.745 -1.222 . . . . 1.4 110.413 -179.669 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.99 29.97 0.33 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.115 -0.991 . . . . 0.92 112.199 -177.997 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 42.3 mm -83.77 125.17 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.379 -1.45 . . . . 0.88 109.188 179.623 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -104.32 -12.74 16.44 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.4 -0.813 . . . . 2.45 109.755 -179.826 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -137.83 156.96 47.38 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.237 -0.914 . . . . 1.52 110.213 -179.107 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -63.66 135.11 56.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.282 -0.886 . . . . 1.58 109.226 -179.64 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 27.7 m -153.05 168.14 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.398 -0.813 . . . . 0.69 110.146 179.403 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 80.6 mt -98.79 143.89 12.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 105.772 -1.936 . . . . 0.61 105.772 177.212 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 47.4 tp -97.68 120.1 37.45 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.772 -1.205 . . . . 0.87 109.993 -178.464 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 24.0 t -119.79 127.9 75.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.059 -0.719 . . . . 0.71 109.059 179.833 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.443 ' HB3' HD21 ' A' ' 163' ' ' LEU . . . -159.86 161.5 34.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.261 -0.899 . . . . 0.81 108.888 179.87 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -71.82 -32.72 67.86 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.438 -1.414 . . . . 0.98 108.077 178.579 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -170.35 143.49 2.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.493 -0.754 . . . . 2.25 109.564 179.967 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.443 HD21 ' HB3' ' A' ' 160' ' ' ALA . 54.9 mt -116.53 141.03 48.71 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.44 -0.788 . . . . 0.78 109.554 -179.499 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 48.4 p -95.29 145.82 30.22 Favored Pre-proline 0 N--CA 1.5 2.069 0 O-C-N 121.14 -0.975 . . . . 0.98 110.226 -179.429 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_exo -40.6 -36.78 1.95 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 C-N-CA 122.512 2.141 . . . . 0.81 112.802 179.029 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 63.9 m -59.03 -39.87 83.26 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.317 -0.864 . . . . 0.9 109.183 -179.076 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -67.58 -40.05 84.85 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.295 -0.878 . . . . 1.61 109.91 -179.709 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.7 p -58.17 -23.29 54.9 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.956 -1.09 . . . . 0.61 110.408 -178.863 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -75.78 -56.44 4.68 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.092 -1.005 . . . . 0.6 109.562 179.694 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -84.17 42.24 0.87 Allowed 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.805 -1.183 . . . . 1.4 107.805 179.611 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 48.5 tp -101.81 140.99 35.36 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 109.207 -0.664 . . . . 0.7 109.207 179.472 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.512 ' O ' HG23 ' A' ' 176' ' ' VAL . 98.6 m-20 -89.95 103.02 15.72 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.155 -0.965 . . . . 2.35 108.681 179.293 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 70.5 mt -67.19 -44.09 80.5 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.418 -0.801 . . . . 1.51 111.914 -178.072 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -69.98 -25.47 63.63 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.759 -1.213 . . . . 2.33 112.512 -177.525 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -93.4 -5.5 49.26 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.621 -1.299 . . . . 1.92 110.722 -178.328 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 172' ' ' ASN . 23.0 t -86.13 139.99 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 120.834 -1.167 . . . . 0.67 110.496 -179.845 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 85.0 mt -103.91 -12.37 16.91 Favored 'General case' 0 N--CA 1.501 2.105 0 N-CA-C 109.593 -0.521 . . . . 1.53 109.593 178.587 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 162.6 179.51 37.23 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 109.247 -1.541 . . . . 0.48 109.247 179.986 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -130.51 129.37 42.79 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.221 -1.164 . . . . 0.55 110.158 -179.95 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.416 ' CG2' HG21 ' A' ' 205' ' ' THR . 66.5 mt -128.65 120.55 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.383 -0.969 . . . . 0.65 108.383 177.756 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 61.0 p -148.78 160.81 42.86 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.742 -1.224 . . . . 0.82 110.555 -179.654 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -110.08 30.29 6.86 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.123 -0.695 . . . . 2.46 109.123 179.321 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -74.66 -158.3 0.07 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.67 -1.269 . . . . 1.28 112.339 -177.499 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -54.56 -80.95 0.07 OUTLIER Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.676 -0.97 . . . . 2.19 110.676 -179.403 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 163.02 -115.88 0.68 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.369 -1.396 . . . . 2.13 110.405 -179.836 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.53 HH11 ' HG2' ' A' ' 186' ' ' ARG . 0.5 OUTLIER -68.49 -30.2 68.98 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.469 -1.018 . . . . 5.86 111.002 -178.856 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 77.0 p -79.97 7.42 9.01 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.006 -1.059 . . . . 3.72 110.544 -178.62 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 61.0 m -90.95 128.6 36.85 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.821 -1.174 . . . . 1.74 110.702 -179.528 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -47.27 -48.62 24.69 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.381 -0.824 . . . . 0.95 109.493 179.929 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.2 m -60.04 -39.92 87.6 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 1.55 109.961 -179.153 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 62.1 m -60.01 -39.95 87.57 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.985 -1.072 . . . . 1.51 109.335 -179.38 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 41.5 mm -66.31 -40.28 86.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.278 -0.889 . . . . 1.67 109.235 -179.92 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 92.9 mtp -64.63 -39.99 94.67 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.123 -0.986 . . . . 1.02 111.254 -179.538 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.61 -43.27 93.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.313 -1.492 . . . . 0.68 108.978 -179.644 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -59.93 -49.92 75.79 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.244 -0.91 . . . . 2.93 109.786 -179.566 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.5 m -70.03 -34.21 72.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.039 -1.038 . . . . 0.86 110.631 -179.226 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 90.0 mt -76.07 -21.68 56.48 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.08 -1.012 . . . . 0.67 109.533 -179.413 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 61.28 47.7 6.76 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.543 -0.723 . . . . 1.5 110.633 -179.646 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 63.4 mt -121.52 135.58 25.22 Favored Pre-proline 0 N--CA 1.501 2.124 0 N-CA-C 108.514 -0.921 . . . . 0.72 108.514 178.662 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_exo -43.64 128.93 6.83 Favored 'Trans proline' 0 N--CA 1.498 1.769 0 C-N-CA 122.021 1.814 . . . . 0.61 112.124 -179.947 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -166.42 144.32 5.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.597 -1.315 . . . . 0.66 112.151 -179.79 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 94.9 mt -124.55 144.53 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 N-CA-C 106.763 -1.569 . . . . 0.79 106.763 177.656 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 13.3 m -130.48 -10.56 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.405 0 O-C-N 120.78 -1.2 . . . . 0.91 111.554 -178.372 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -103.6 23.76 31.83 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.592 -1.403 . . . . 1.01 109.592 -179.975 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.416 HG21 ' CG2' ' A' ' 180' ' ' ILE . 7.6 p -45.98 -42.44 13.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -1.125 . . . . 0.99 109.971 -179.194 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 89.94 -49.1 3.29 Favored Glycine 0 N--CA 1.498 2.767 0 O-C-N 120.963 -1.086 . . . . 1.12 111.113 179.336 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.8 t -165.92 40.41 0.06 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.714 -1.463 . . . . 1.72 110.731 -179.612 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 49.2 t -79.45 -37.71 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 108.081 -1.081 . . . . 0.89 108.081 177.865 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.426 HG23 ' H ' ' A' ' 209' ' ' THR . 2.8 p -52.56 -27.22 15.83 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.663 -0.648 . . . . 1.03 109.703 -179.906 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 69.8 m -78.94 -26.5 43.61 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.186 -0.946 . . . . 1.83 109.856 -179.629 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -92.3 -8.3 45.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.043 -1.036 . . . . 2.27 109.856 -179.672 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 64.8 t -105.17 133.77 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.436 -0.79 . . . . 0.92 110.272 -178.955 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.404 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 70.2 mmtt -113.39 154.0 27.66 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 106.976 -1.49 . . . . 2.2 106.976 178.309 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.475 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 55.7 t-20 -59.95 138.98 57.7 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.955 -1.091 . . . . 2.36 110.238 -178.622 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.475 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 84.85 -1.69 0.9 Allowed 'General case' 0 N--CA 1.504 2.246 0 CA-C-O 121.116 0.484 . . . . 2.38 110.801 179.115 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.404 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 92.7 m-20 -70.38 148.1 48.79 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.13 -0.981 . . . . 2.09 109.107 178.978 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -96.9 119.98 36.39 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.913 -1.144 . . . . 1.27 107.913 179.16 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.534 HD12 ' HB2' ' A' ' 16' ' ' ALA . 87.1 mt -126.72 147.26 49.98 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.369 -0.832 . . . . 0.75 110.237 -178.876 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 99.9 mt -117.79 127.21 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 N-CA-C 107.152 -1.425 . . . . 0.63 107.152 177.291 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 17.7 tp -100.94 120.6 40.41 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.257 -0.902 . . . . 0.7 109.584 -178.657 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 223' ' ' VAL . 7.1 t70 -76.01 -41.45 51.02 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.025 -1.102 . . . . 2.31 108.025 179.42 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 49.01 9.94 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.722 -0.611 . . . . 0.78 109.83 179.788 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.514 ' N ' ' O ' ' A' ' 221' ' ' ASP . 60.4 t -126.73 -35.12 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.619 -1.252 . . . . 1.04 107.619 178.66 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.486 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 98.6 m-20 -108.39 3.58 23.48 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.297 -1.001 . . . . 2.44 108.297 178.686 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.416 HD21 ' H ' ' A' ' 4' ' ' GLY . 38.7 t30 59.86 45.52 12.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.64 -0.662 . . . . 1.55 110.352 179.981 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 -138.92 144.55 39.13 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.168 -0.957 . . . . 1.99 109.792 179.392 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.2 t -115.35 130.13 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 108.66 -0.867 . . . . 0.77 108.66 179.381 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -104.63 126.13 51.42 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.444 -0.785 . . . . 0.98 108.98 179.5 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 25.1 t -100.03 106.99 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.272 -0.893 . . . . 0.85 109.954 -179.55 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 39.3 t30 49.92 61.0 14.46 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.189 -0.945 . . . . 1.66 111.422 178.002 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.83 158.39 27.74 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.494 2.13 . . . . 0.95 111.538 178.964 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 4.2 m -68.42 159.68 31.12 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.044 -1.035 . . . . 1.84 110.354 -178.923 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -59.95 -40.0 87.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.549 -0.719 . . . . 2.74 109.732 -179.619 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.05 -39.25 85.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 2.89 109.389 -179.985 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.9 t -67.5 -39.96 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.312 -0.868 . . . . 1.3 108.91 179.359 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.9 mt -66.47 -39.88 85.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.319 -0.863 . . . . 1.09 109.247 179.32 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 66.5 t0 -59.2 -43.18 92.24 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.078 -1.014 . . . . 2.43 108.619 -179.713 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -64.88 -40.01 94.43 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.293 -0.879 . . . . 2.78 108.766 178.976 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 93.9 mtp -70.77 -30.16 66.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.39 -0.819 . . . . 1.25 109.241 179.019 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -64.91 -40.02 94.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.275 -0.891 . . . . 2.63 109.366 179.502 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -64.06 -40.22 95.79 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -0.878 . . . . 1.8 108.849 179.701 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.16 -40.09 82.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.477 -0.765 . . . . 2.13 109.073 179.467 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -57.26 -44.51 83.98 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.171 -0.955 . . . . 3.17 108.99 -179.416 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -61.0 -40.85 95.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.152 -0.967 . . . . 1.78 109.244 179.632 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -70.03 -44.24 69.65 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.336 -0.853 . . . . 2.47 109.783 179.746 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.17 -40.79 84.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.29 -0.882 . . . . 2.09 109.027 -179.735 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.8 -50.04 75.06 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.375 -0.828 . . . . 2.54 109.412 179.502 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 30.6 t -71.92 -41.31 68.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.249 -0.907 . . . . 2.99 110.55 -179.565 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -64.93 -40.48 95.12 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.242 -0.911 . . . . 3.34 110.96 -178.667 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.565 ' O ' ' HB2' ' A' ' 254' ' ' ALA . 29.5 ttmt -70.07 -59.98 2.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.926 -1.109 . . . . 3.88 110.719 -178.272 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.646 ' O ' ' N ' ' A' ' 253' ' ' LEU . . . 46.51 12.39 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.31 -0.869 . . . . 4.43 109.6 -179.715 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.559 ' N ' ' O ' ' A' ' 250' ' ' LYS . 88.2 tt0 59.68 -58.99 0.06 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.851 0.834 . . . . 5.42 108.979 -179.327 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.646 ' N ' ' O ' ' A' ' 251' ' ' ALA . 64.3 mt -72.21 13.14 0.34 Allowed 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.781 -0.574 . . . . 6.1 110.085 -178.279 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 250' ' ' LYS . . . -59.97 -49.95 75.68 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.45 -1.315 . . . . 7.37 107.45 178.532 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -177.53 143.59 0.36 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.455 -1.313 . . . . 8.01 107.455 178.98 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.523 HD22 ' N ' ' A' ' 256' ' ' LEU . 3.5 mm? -59.98 -37.66 80.28 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.922 -1.111 . . . . 9.05 108.031 179.626 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -101.09 -172.11 2.11 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.446 -0.946 . . . . 10.56 108.446 179.378 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -140.52 -108.25 0.15 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.948 -1.095 . . . . 11.32 108.84 179.807 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.404 HH11 ' HG3' ' A' ' 259' ' ' ARG . 41.2 mtm-85 . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 117.975 -1.012 . . . . 12.42 109.515 179.935 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 45.5 ttm . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.408 0.623 . . . . 0.0 109.363 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -151.02 148.17 28.02 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.153 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -152.19 161.6 42.37 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.935 -1.103 . . . . 0.0 111.039 -178.989 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -156.23 155.06 31.75 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.91 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -110.45 135.71 50.72 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.295 -0.878 . . . . 0.0 111.102 -179.055 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.548 HG22 ' N ' ' B' ' 307' ' ' THR . 2.7 p -120.06 165.27 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 -179.94 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . 0.548 ' N ' HG22 ' B' ' 306' ' ' VAL . 70.9 m -119.11 115.96 25.37 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.101 -1.0 . . . . 0.0 108.328 178.526 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.59 HD12 ' HB ' ' B' ' 359' ' ' THR . 60.2 mt -56.22 120.9 3.39 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-O 122.366 1.079 . . . . 0.0 110.893 -178.434 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 65.2 p -109.47 24.34 13.21 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.863 -179.945 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -85.17 116.65 66.38 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.218 -0.926 . . . . 0.0 108.725 179.618 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -68.33 -7.42 20.04 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 CA-C-N 120.201 1.108 . . . . 0.0 111.477 -179.948 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -119.12 6.61 11.27 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.634 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.52 175.76 43.86 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 108.366 -1.893 . . . . 0.0 108.366 -179.039 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 3.3 tp -83.65 95.51 8.38 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.008 -1.289 . . . . 0.0 108.952 -178.874 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -96.66 -160.48 0.8 Allowed 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.835 -1.165 . . . . 0.0 109.805 179.15 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 4.0 m -59.97 -43.46 95.06 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.942 -1.099 . . . . 0.0 112.278 -176.287 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.507 ' NH1' ' OE1' ' A' ' 68' ' ' GLU . 2.6 tpt180 -54.82 -62.06 4.78 Favored Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.44 -1.412 . . . . 0.0 111.299 -178.65 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -58.73 -36.42 97.14 Favored 'Trans proline' 0 N--CA 1.491 1.354 0 CA-C-N 120.221 1.115 . . . . 0.0 111.181 179.787 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.71 72.65 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.503 -0.748 . . . . 0.0 108.989 179.77 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -56.84 -44.07 81.74 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.305 -0.872 . . . . 0.0 109.774 -179.182 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -69.91 -42.29 73.56 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.013 -1.055 . . . . 0.0 108.48 179.353 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -59.87 -50.04 75.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.673 -0.642 . . . . 0.0 111.192 -179.204 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 72.7 t -70.94 -28.65 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.556 -1.34 . . . . 0.0 109.875 -179.175 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . 0.465 ' NZ ' ' OE1' ' A' ' 74' ' ' GLU . 22.7 ttmt -60.05 -47.69 84.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.2 -0.938 . . . . 0.0 109.905 -179.203 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . 0.481 ' OE1' HD22 ' B' ' 380' ' ' LEU . 85.3 tt0 -65.31 -40.02 93.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.087 -1.008 . . . . 0.0 110.239 -179.292 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.67 -52.94 62.98 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.913 -1.117 . . . . 0.0 111.129 -179.025 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -60.58 -13.02 11.75 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.874 -1.141 . . . . 0.0 109.708 -179.515 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -67.46 -30.4 75.07 Favored Glycine 0 N--CA 1.485 1.967 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 178.608 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -106.11 144.15 33.23 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.654 -0.909 . . . . 0.0 108.942 179.587 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 25.3 p -90.34 -12.35 37.95 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.989 -1.069 . . . . 0.0 109.626 -179.993 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.43 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 15.7 t -58.49 147.98 29.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.168 -0.957 . . . . 0.0 109.117 179.768 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -66.71 131.89 46.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.247 -0.908 . . . . 0.0 109.201 -179.813 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 79.3 mt -130.92 130.33 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.492 -0.755 . . . . 0.0 109.293 179.938 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 28.6 m -131.46 153.8 49.38 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.569 -0.707 . . . . 0.0 109.433 179.568 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 68.7 t -116.09 139.27 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.081 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.7 m -129.49 121.99 28.37 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.177 -0.952 . . . . 0.0 108.995 179.771 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 42.0 p -138.72 119.37 14.03 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.013 0.911 . . . . 0.0 111.052 -179.272 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 57.5 t30 41.78 59.01 2.63 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 177.265 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 82.0 -14.6 31.64 Favored Glycine 0 N--CA 1.499 2.861 0 O-C-N 120.369 -1.457 . . . . 0.0 113.087 176.316 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 38.8 mttp -115.94 128.68 55.95 Favored 'General case' 0 N--CA 1.506 2.34 0 CA-C-N 119.264 1.532 . . . . 0.0 109.425 179.978 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 81.0 p -129.55 150.82 50.72 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.807 0.813 . . . . 0.0 110.172 -179.089 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . 0.453 ' HB3' HD11 ' B' ' 353' ' ' LEU . . . -143.54 166.49 24.66 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.682 0.753 . . . . 0.0 110.185 -179.223 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 4.6 t -91.27 142.41 27.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.662 -0.648 . . . . 0.0 109.643 -179.587 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -80.02 -12.42 59.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.106 -0.996 . . . . 0.0 109.984 -179.508 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 23.3 pttm -91.16 18.96 6.24 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.427 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 19.7 m -146.05 95.92 2.71 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.279 -179.09 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.811 HD23 HD22 ' A' ' 79' ' ' LEU . 8.3 tp -59.96 -32.29 70.67 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.663 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.609 ' CE2' HD11 ' A' ' 79' ' ' LEU . 60.0 m-85 -59.87 -54.53 45.07 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.524 -0.735 . . . . 0.0 110.636 -178.858 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -67.0 -40.09 87.25 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.56 -1.337 . . . . 0.0 109.387 -178.633 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.539 ' O ' ' N ' ' B' ' 352' ' ' THR . 32.8 mt -50.19 -57.08 8.55 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.122 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.516 ' O ' HD22 ' A' ' 123' ' ' LEU . 22.3 mt-30 -41.02 -17.66 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.864 -0.523 . . . . 0.0 111.099 -178.833 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.539 ' N ' ' O ' ' B' ' 350' ' ' LEU . 82.0 p -90.61 -5.98 55.2 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.183 -1.573 . . . . 0.0 110.567 -179.135 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.453 HD11 ' HB3' ' B' ' 342' ' ' ALA . 83.6 mt -92.96 108.63 20.15 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.945 -1.097 . . . . 0.0 109.639 179.434 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -68.25 84.67 0.18 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 107.81 -2.116 . . . . 0.0 107.81 178.774 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 71.0 mt -99.16 95.97 7.46 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.326 -1.103 . . . . 0.0 108.326 179.483 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 44.8 p -98.32 176.6 5.65 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.255 -0.903 . . . . 0.0 110.461 -178.604 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -44.62 159.15 0.05 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 122.355 1.074 . . . . 0.0 111.413 -179.327 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 41.09 23.3 0.08 OUTLIER Glycine 0 N--CA 1.497 2.701 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.601 177.608 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . 0.59 ' HB ' HD12 ' B' ' 308' ' ' ILE . 4.5 m -87.4 108.04 18.82 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.459 -1.612 . . . . 0.0 109.501 179.595 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 57.8 t -77.28 123.2 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.25 -0.906 . . . . 0.0 109.784 -177.36 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.6 m -122.43 175.77 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -178.477 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 94.0 m -125.07 132.32 53.19 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.726 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 96.8 mt -100.73 121.78 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.484 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 54.0 p -124.09 133.92 53.5 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.524 -0.735 . . . . 0.0 109.471 -179.054 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.53 152.18 39.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.425 -0.797 . . . . 0.0 109.368 -179.489 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -141.97 119.77 11.89 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.529 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.539 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 159.68 -154.51 25.56 Favored Glycine 0 N--CA 1.49 2.27 0 C-N-CA 118.76 -1.686 . . . . 0.0 112.046 -179.935 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -58.05 -54.72 43.71 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -177.271 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.43 ' H ' ' HB2' ' B' ' 331' ' ' SER . 83.4 m-20 -112.39 14.42 20.37 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.028 -1.045 . . . . 0.0 111.177 -177.644 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 13.1 pt-20 -39.19 -37.52 0.41 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.621 -0.674 . . . . 0.0 110.926 -179.437 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -69.42 -46.18 67.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.022 -1.049 . . . . 0.0 111.064 -178.025 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -66.86 -49.48 65.54 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 120.864 -1.148 . . . . 0.0 110.374 -179.12 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -55.23 -35.15 64.63 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.082 -1.011 . . . . 0.0 111.477 -178.048 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.591 ' O ' HG23 ' B' ' 378' ' ' VAL . 72.8 t -69.94 -41.04 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.458 -1.401 . . . . 0.0 108.264 178.996 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -63.86 -59.45 4.52 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.522 -0.736 . . . . 0.0 111.916 -178.737 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -67.84 -40.11 83.75 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.63 -1.294 . . . . 0.0 111.963 -177.306 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 86.4 mt -57.4 -38.01 73.61 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.553 -1.342 . . . . 0.0 108.757 -179.243 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.591 HG23 ' O ' ' B' ' 374' ' ' VAL . 51.5 t -60.01 -42.04 88.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.255 -0.903 . . . . 0.0 109.285 179.499 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.441 ' O ' ' OE2' ' B' ' 383' ' ' GLU . 19.1 mmmt -69.43 -55.02 11.5 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.082 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.481 HD22 ' OE1' ' B' ' 325' ' ' GLU . 64.3 tp -54.22 -38.65 65.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.786 -0.571 . . . . 0.0 110.604 -177.377 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . 0.494 ' SD ' ' O ' ' B' ' 381' ' ' MET . 0.0 OUTLIER -73.34 -40.01 64.76 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 118.619 -1.232 . . . . 0.0 108.607 178.238 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . 0.515 ' HB3' ' OE2' ' B' ' 383' ' ' GLU . . . -80.08 -3.4 48.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.095 -1.003 . . . . 0.0 109.775 179.411 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.515 ' OE2' ' HB3' ' B' ' 382' ' ' ALA . 0.0 OUTLIER -111.65 -3.02 15.18 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.378 -0.827 . . . . 0.0 111.026 -179.331 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.03 128.9 40.65 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 120.499 -1.376 . . . . 0.0 109.688 179.411 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 . . . . . 0 N--CA 1.498 1.967 0 CA-C-O 118.103 -0.951 . . . . 0.0 109.218 179.524 . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.7 mtt . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.471 -0.566 . . . . 2.91 109.471 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 87.5 mt -106.85 120.09 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.525 -0.734 . . . . 1.2 109.095 179.937 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.7 m -132.85 133.34 43.2 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.468 -0.77 . . . . 1.4 109.228 179.829 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.826 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -115.27 -162.38 13.54 Favored Glycine 0 N--CA 1.497 2.711 0 N-CA-C 108.44 -1.864 . . . . 1.05 108.44 179.496 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 6' ' ' LEU . 79.5 mt -91.6 -12.9 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 120.95 -1.324 . . . . 1.15 109.648 -179.478 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.468 HD11 ' O ' ' A' ' 8' ' ' SER . 60.0 tp 53.75 99.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.145 -0.972 . . . . 0.98 108.822 -179.569 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -70.15 -40.18 74.9 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.687 -0.857 . . . . 0.88 108.687 179.315 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.468 ' O ' HD11 ' A' ' 6' ' ' LEU . 46.5 m -149.05 147.95 25.49 Favored Pre-proline 0 N--CA 1.498 1.95 0 O-C-N 121.431 -0.793 . . . . 1.69 109.744 179.574 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -80.73 146.99 17.02 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.671 2.248 . . . . 0.85 113.272 -179.925 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.677 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 165.19 -164.04 36.89 Favored Glycine 0 N--CA 1.497 2.761 0 N-CA-C 109.105 -1.598 . . . . 0.92 109.105 179.756 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 78.1 mt -149.84 149.88 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 O-C-N 120.914 -1.344 . . . . 0.81 109.124 179.208 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.38 156.22 33.5 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.037 -1.04 . . . . 0.51 110.552 179.214 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 6.4 m-85 -137.02 129.14 29.47 Favored 'General case' 0 N--CA 1.501 2.118 0 N-CA-C 107.85 -1.167 . . . . 0.62 107.85 178.597 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.22 -179.13 44.83 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 118.652 -1.737 . . . . 0.55 110.996 179.847 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -79.89 155.21 27.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.747 -0.854 . . . . 2.1 109.533 -179.972 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.479 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -101.89 129.99 48.26 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.45 -0.781 . . . . 0.77 110.563 -179.3 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.0 tp -96.31 135.17 38.51 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 107.205 -1.406 . . . . 0.91 107.205 178.42 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 49.4 tp -113.48 118.29 34.07 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.219 -0.925 . . . . 0.93 109.773 -179.532 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.614 HD12 ' HB2' ' A' ' 160' ' ' ALA . 51.0 mt -85.98 102.88 14.17 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.432 0.635 . . . . 0.93 109.502 -179.947 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -97.56 137.33 36.65 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.376 -0.828 . . . . 2.75 109.971 -179.39 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -130.5 132.99 45.92 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.72 -0.844 . . . . 3.0 108.72 179.492 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -78.69 138.34 38.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.967 -1.083 . . . . 2.77 109.053 179.748 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -60.81 139.97 57.77 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -0.967 . . . . 2.94 108.762 179.905 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 65.7 mt -85.22 132.76 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.316 -0.865 . . . . 0.95 109.416 -179.264 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.6 t -106.96 129.69 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.25 -0.906 . . . . 1.28 109.762 -179.748 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.3 mt -99.21 141.14 17.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.36 -0.838 . . . . 1.21 109.074 179.734 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -98.96 118.94 36.88 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.162 -0.961 . . . . 1.81 109.441 -179.961 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.5 mmm180 -90.11 3.07 54.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.465 -0.772 . . . . 2.8 109.887 -179.275 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -59.97 144.18 49.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.043 -1.036 . . . . 2.87 109.67 -179.895 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -92.0 143.5 26.41 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.208 -0.932 . . . . 2.35 108.963 179.654 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.8 pt -93.55 165.79 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.131 -0.981 . . . . 0.97 110.438 -179.346 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 91.2 p -88.96 170.42 10.7 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.02 -1.104 . . . . 1.17 108.02 178.281 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -69.19 -18.47 63.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.879 -1.138 . . . . 1.18 110.176 -179.799 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 53.7 t0 -83.55 -26.75 29.84 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.893 -1.129 . . . . 2.56 108.605 179.14 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -82.18 -7.64 59.63 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.983 -0.747 . . . . 1.79 108.983 179.036 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.3 t -60.49 -53.14 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.254 -0.904 . . . . 1.0 109.253 179.77 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -60.81 -39.96 90.89 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.321 -0.862 . . . . 1.77 109.969 -179.447 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -63.46 -40.21 96.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.246 -0.909 . . . . 2.7 110.997 -179.298 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -65.94 -40.03 91.02 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 120.742 -1.224 . . . . 1.51 110.593 -179.395 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.01 -46.9 93.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 118.163 -1.415 . . . . 0.93 108.379 -179.614 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.9 tp10 -60.03 -41.57 92.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.839 -1.163 . . . . 1.81 109.703 179.806 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.402 ' HG2' HH11 ' A' ' 42' ' ' ARG . 57.2 mtt-85 -59.95 -44.82 94.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.805 -1.185 . . . . 2.78 108.576 179.131 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -63.18 -47.44 82.59 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.456 -0.778 . . . . 0.78 109.523 178.886 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 63.0 tp -59.96 -49.08 79.09 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.294 -0.879 . . . . 1.07 109.075 -179.069 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.8 t -64.27 -42.25 96.55 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.965 -1.084 . . . . 1.12 108.874 179.452 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.25 -48.86 84.04 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.544 -1.823 . . . . 0.84 108.544 179.117 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.3 ttp180 -60.64 -38.69 85.64 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.436 -1.038 . . . . 3.09 108.434 178.594 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.41 -40.06 70.96 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 109.096 -0.705 . . . . 0.88 109.096 -179.855 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.439 ' O ' ' N ' ' A' ' 51' ' ' SER . 24.1 ttmt -61.16 -74.48 0.08 Allowed 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.439 -1.319 . . . . 2.59 107.439 179.46 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.68 -30.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.39 -0.819 . . . . 0.7 111.427 -178.254 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.439 ' N ' ' O ' ' A' ' 49' ' ' LYS . 18.3 t -60.0 -54.59 44.2 Favored 'General case' 0 C--N 1.297 -1.704 0 C-N-CA 118.771 -1.172 . . . . 1.4 108.587 179.673 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.69 -42.81 77.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.611 -0.68 . . . . 0.67 111.161 -179.016 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.85 -45.68 93.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.801 -1.187 . . . . 1.66 110.675 -179.046 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 95.0 mt -61.99 -40.18 94.74 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.927 -1.108 . . . . 1.58 109.477 -179.406 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -60.87 -39.77 90.43 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.252 -0.905 . . . . 1.35 110.031 179.861 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.2 m -65.41 -43.34 90.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.934 -1.104 . . . . 0.77 109.269 -179.962 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.567 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.8 mt -61.68 -39.87 84.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.63 108.922 179.537 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 27.8 ttpt -54.98 -50.38 69.08 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.752 . . . . 1.14 109.657 -179.469 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -57.33 -33.87 68.17 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.321 -0.862 . . . . 0.79 110.492 -178.088 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -69.83 -37.46 76.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 1.53 109.45 179.622 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.86 -46.07 79.82 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.677 -0.639 . . . . 0.57 110.192 -179.67 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.19 -52.81 44.71 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 110.159 -1.176 . . . . 0.75 110.159 -179.011 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -70.04 -43.92 70.3 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 120.997 -1.296 . . . . 1.59 110.255 -179.513 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.4 m -65.28 -65.25 0.7 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.092 -1.005 . . . . 0.73 112.987 -177.453 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -97.83 -42.59 7.5 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.812 -1.18 . . . . 0.75 111.667 -177.621 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.25 -168.98 25.22 Favored Glycine 0 N--CA 1.499 2.879 0 O-C-N 120.752 -1.218 . . . . 1.22 111.014 179.499 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -73.77 -23.69 59.75 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 122.04 -0.682 . . . . 5.81 110.246 -179.966 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.3 tp10 -62.46 -33.58 75.12 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 3.37 110.462 -179.077 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.428 ' HA ' HD12 ' A' ' 72' ' ' ILE . 34.5 mmtm -99.06 -20.03 16.92 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.274 -0.891 . . . . 1.77 109.61 -179.801 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -69.92 -40.24 75.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.312 -0.868 . . . . 1.65 110.531 -178.845 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.643 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -69.15 -27.31 65.43 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.183 -0.948 . . . . 0.77 109.879 -179.002 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 69' ' ' LYS . 94.2 mt -60.01 -40.4 83.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 107.793 -1.188 . . . . 0.8 107.793 179.894 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -62.1 -41.91 98.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -0.888 . . . . 0.88 108.906 179.281 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 65.2 tt0 -60.86 -39.91 90.93 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.633 -0.827 . . . . 1.37 109.345 179.15 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -61.44 -47.82 88.51 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 108.881 -1.687 . . . . 0.62 108.881 179.531 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 41.1 m170 -64.06 -40.12 95.57 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.496 -1.002 . . . . 1.5 109.032 179.582 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.2 mt -69.4 -45.73 78.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.342 -0.849 . . . . 0.63 109.451 179.717 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.4 ttp -63.61 -40.07 95.99 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.04 -1.038 . . . . 1.51 110.16 -178.69 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.887 HD22 HD23 ' B' ' 347' ' ' LEU . 58.0 tp -65.95 -40.03 90.98 Favored 'General case' 0 C--N 1.296 -1.717 0 O-C-N 121.396 -0.815 . . . . 0.77 109.959 -179.961 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 61.7 tp -65.5 -39.94 92.46 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.684 -0.635 . . . . 0.62 110.207 -178.775 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -84.68 4.72 31.22 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.896 -1.127 . . . . 1.47 110.039 -178.897 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 56.1 t0 -49.18 134.55 17.79 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.175 -0.953 . . . . 1.47 109.765 -179.666 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.46 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.6 mt-10 -60.69 -20.02 59.96 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.612 -0.68 . . . . 1.78 110.798 -178.728 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -71.36 -33.39 69.51 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.055 -1.028 . . . . 2.53 110.171 179.569 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.9 mt -75.02 -41.09 60.06 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.477 -0.764 . . . . 0.8 110.146 179.864 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -60.05 -50.05 75.24 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.227 -0.921 . . . . 1.42 110.732 -178.92 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.03 -40.74 74.98 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.05 -1.031 . . . . 1.71 111.665 -178.802 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -69.98 -39.16 76.11 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.031 -1.043 . . . . 1.57 111.354 -178.818 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 89.8 mt -67.67 -42.05 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.93 . . . . 0.65 109.116 -179.757 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 83.7 mt -65.82 -39.21 84.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.51 -0.744 . . . . 0.82 109.622 179.38 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.09 -49.45 77.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 0.79 111.451 -178.629 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.8 mt -60.99 -46.4 90.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.711 -1.243 . . . . 0.95 109.821 -178.866 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 74.5 mt -60.03 -50.01 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-O 122.115 0.96 . . . . 0.66 109.075 179.729 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -70.43 -40.21 73.94 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 120.091 -0.644 . . . . 2.2 110.834 -179.762 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -81.13 -62.48 1.65 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.036 -1.04 . . . . 1.65 112.078 -178.135 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -82.55 -0.97 49.21 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.043 -1.036 . . . . 2.03 111.999 -177.025 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 73.3 m80 57.57 38.19 27.81 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.92 -1.112 . . . . 1.42 109.927 -179.994 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 98.1 mtp -92.67 169.07 10.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.484 -0.76 . . . . 1.18 109.595 -179.937 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 44.7 p -81.55 160.23 23.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.28 -0.887 . . . . 0.98 109.559 -179.692 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.4 -39.72 77.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.33 -0.856 . . . . 0.64 109.937 -179.772 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -67.01 -40.04 87.19 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.28 -0.888 . . . . 2.07 109.498 179.817 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.65 -43.86 25.15 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.43 -0.794 . . . . 0.73 109.868 179.618 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -69.99 -42.92 72.44 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.339 -0.851 . . . . 0.54 110.568 -179.222 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.05 -44.12 96.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.166 -0.959 . . . . 0.56 109.819 -179.495 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.2 t60 -59.98 -38.71 83.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.321 -0.862 . . . . 1.54 110.386 -179.202 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -59.98 -40.28 88.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.012 . . . . 1.33 110.379 -179.172 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 42.1 t -64.74 -49.09 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.838 -1.164 . . . . 0.72 110.055 -179.38 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.5 mm -67.58 -40.09 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.069 -1.019 . . . . 0.85 109.214 -179.802 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -66.46 -38.87 88.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 2.44 108.808 179.336 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -59.96 -45.69 95.45 Favored Glycine 0 N--CA 1.491 2.341 0 C-N-CA 120.313 -0.946 . . . . 0.98 110.749 -179.487 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.656 HE21 ' CB ' ' B' ' 348' ' ' PHE . 17.9 mm100 -70.04 -52.56 23.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.7 -1.471 . . . . 1.41 110.039 -179.118 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.05 -40.2 88.6 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.331 -0.855 . . . . 1.2 109.811 -179.497 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.2 t -57.88 -39.64 78.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.174 -0.954 . . . . 1.7 109.559 -179.287 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.16 -39.45 94.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 1.47 109.562 179.63 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 22.3 mt -61.94 -39.97 93.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.105 -0.997 . . . . 1.56 109.671 -179.202 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.438 ' CD ' ' NH2' ' A' ' 131' ' ' ARG . 36.3 mt-10 -58.91 -33.27 70.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.608 -1.307 . . . . 2.2 109.705 -179.141 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -56.33 -21.57 25.2 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.873 -1.142 . . . . 2.12 108.713 179.264 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.432 HD13 HD13 ' A' ' 123' ' ' LEU . 74.8 mt -62.54 140.4 58.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 2.0 108.939 179.687 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -90.63 21.66 3.9 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.208 -0.932 . . . . 3.23 110.126 -179.426 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.454 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 51.9 t0 -112.86 141.28 46.86 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.402 -0.811 . . . . 2.49 109.569 -179.737 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.484 ' O ' ' N ' ' A' ' 124' ' ' LYS . 92.8 mt-10 -72.54 -63.2 1.21 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.265 -1.013 . . . . 3.95 108.265 178.631 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.46 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.8 t80 -38.65 -41.42 0.69 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 122.031 -0.418 . . . . 2.0 110.932 -178.935 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.433 HD22 ' O ' ' B' ' 351' ' ' GLN . 87.2 mt -69.85 -39.92 76.1 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 120.63 -1.293 . . . . 1.86 108.239 179.549 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.484 ' N ' ' O ' ' A' ' 121' ' ' GLU . 63.1 tttp -60.77 -40.07 91.15 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.55 -0.719 . . . . 2.84 110.022 179.718 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.439 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 41.3 mt-10 -60.02 -45.01 94.18 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.017 -1.052 . . . . 2.73 109.77 -179.28 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.872 ' HE ' HE22 ' B' ' 351' ' ' GLN . 65.6 mtp180 -60.54 -39.94 89.7 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.167 -0.958 . . . . 2.77 108.505 179.214 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.76 -27.35 67.9 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.556 -0.905 . . . . 1.19 108.556 179.027 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -64.18 -40.05 95.29 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.135 -1.061 . . . . 1.2 108.135 178.792 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -64.16 -40.09 95.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.518 -0.739 . . . . 1.55 109.21 179.653 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.9 t -66.89 -42.73 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.317 -0.864 . . . . 0.8 108.733 179.945 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.438 ' NH2' ' CD ' ' A' ' 116' ' ' GLU . 44.1 ttm180 -60.33 -36.72 78.62 Favored 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 121.522 0.677 . . . . 3.09 109.203 179.361 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.2 t0 -58.45 -39.61 80.35 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.438 -0.789 . . . . 1.46 109.036 -179.671 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 86.1 mt -59.87 -45.45 94.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.209 -0.932 . . . . 0.71 108.838 179.843 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.18 -41.34 99.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.771 -1.332 . . . . 0.57 109.771 179.689 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 41.1 mttm -59.99 -50.04 75.31 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.188 -1.184 . . . . 2.59 110.274 -179.927 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.567 HH22 ' CD1' ' A' ' 57' ' ' ILE . 62.1 mtp180 -69.64 -32.37 71.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.807 -1.183 . . . . 2.83 109.72 -179.631 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 58.7 tp -57.3 -47.86 80.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.86 . . . . 1.25 108.772 -179.139 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 86.9 mt -61.13 -39.69 90.98 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.254 -0.904 . . . . 0.7 108.955 178.407 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.512 HH11 ' CD2' ' A' ' 144' ' ' LEU . 50.0 mtt-85 -67.61 -40.05 84.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.89 . . . . 2.57 109.259 179.542 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 32.5 m-80 -66.53 -39.88 88.83 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.629 -0.669 . . . . 1.23 110.456 -179.012 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 96.9 mt -71.78 -43.1 70.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 O-C-N 120.478 -1.389 . . . . 0.81 108.303 178.822 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 87.2 mt -70.0 -32.25 70.35 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.74 -0.6 . . . . 1.0 109.733 179.944 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 83.86 44.38 6.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.178 -1.569 . . . . 0.89 109.178 -179.373 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.512 ' CD2' HH11 ' A' ' 139' ' ' ARG . 12.3 tp -74.85 148.45 40.22 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.414 -1.05 . . . . 1.14 109.376 -179.44 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -70.45 143.16 51.87 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.24 -0.913 . . . . 4.6 109.896 -179.48 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.7 mt -115.22 129.98 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 CA-C-O 121.984 0.897 . . . . 1.24 108.915 179.373 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 10.5 mt -66.85 -39.95 84.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-N 115.869 -0.605 . . . . 1.54 110.717 -178.23 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.6 t0 67.5 97.29 0.06 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.745 -0.835 . . . . 1.5 108.745 -179.329 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.2 mt -68.1 -1.13 5.37 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.443 -0.786 . . . . 0.79 110.939 -178.575 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 80.8 p -82.97 -14.0 54.9 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.695 -1.253 . . . . 1.4 110.111 -179.723 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.92 33.34 0.33 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.284 -0.885 . . . . 0.92 111.96 -177.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 45.1 mm -85.94 120.22 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.421 -1.425 . . . . 0.88 108.96 179.491 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.414 ' O ' ' OD1' ' A' ' 154' ' ' ASP . 50.6 tt0 -99.85 -12.14 20.12 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.33 -0.856 . . . . 2.45 109.93 -179.364 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.414 ' OD1' ' O ' ' A' ' 153' ' ' GLN . 95.7 m-20 -139.26 157.89 45.12 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.944 -1.098 . . . . 1.52 110.285 -179.398 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -63.95 137.03 57.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.45 -0.782 . . . . 1.58 109.63 -179.62 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 17.5 m -153.3 167.9 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.462 -0.774 . . . . 0.69 109.982 179.609 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 81.5 mt -97.16 144.74 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 106.727 -1.583 . . . . 0.61 106.727 177.689 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.511 HD11 HD11 ' A' ' 19' ' ' LEU . 40.9 tp -94.2 117.08 29.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.911 -1.118 . . . . 0.87 110.367 -178.222 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.786 HG12 HG22 ' A' ' 209' ' ' THR . 44.6 t -123.12 129.41 75.01 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 N-CA-C 108.667 -0.864 . . . . 0.71 108.667 179.199 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.614 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -161.14 165.31 29.73 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.119 -0.988 . . . . 0.81 109.354 -179.627 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -74.42 -30.63 61.99 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.261 -1.524 . . . . 0.98 108.378 178.823 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -165.51 168.41 16.56 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.913 -0.773 . . . . 2.25 108.913 -179.61 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 91.1 mt -139.6 133.19 30.36 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.169 -0.957 . . . . 0.78 108.869 179.286 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 69.3 p -99.13 149.35 35.7 Favored Pre-proline 0 N--CA 1.498 1.936 0 O-C-N 121.318 -0.864 . . . . 0.98 109.769 -179.717 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -40.62 -37.77 2.32 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.541 2.16 . . . . 0.81 113.263 179.515 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 65.1 m -59.99 -39.99 87.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.174 -0.954 . . . . 0.9 109.677 -178.794 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -69.08 -44.21 72.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.287 -0.883 . . . . 1.61 110.503 -179.445 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.0 p -54.9 -30.17 57.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.043 -1.036 . . . . 0.61 111.717 -177.458 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.79 -48.58 24.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.7 -1.25 . . . . 0.6 109.901 -179.522 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . 0.421 ' H ' ' HG2' ' A' ' 170' ' ' GLN . 13.9 pt20 -86.43 40.12 0.87 Allowed 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.899 -1.149 . . . . 1.4 107.899 179.636 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.3 tp -111.26 136.14 50.78 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.36 -0.978 . . . . 0.7 108.36 178.485 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.428 ' O ' HG23 ' A' ' 176' ' ' VAL . 16.3 m120 -90.43 108.42 19.77 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.966 -1.084 . . . . 2.35 110.096 -179.728 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 71.9 mt -64.91 -40.43 95.06 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.458 -0.776 . . . . 1.51 111.071 -178.906 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -70.05 -25.04 63.37 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.87 -1.144 . . . . 2.33 111.708 -178.131 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -93.62 -8.99 39.51 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.784 -1.198 . . . . 1.92 110.373 -178.632 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.581 HG12 ' H ' ' A' ' 178' ' ' GLY . 85.4 t -103.27 117.85 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.194 -0.941 . . . . 0.67 108.948 179.434 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 81.6 mt -86.73 6.42 31.44 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.456 -0.778 . . . . 1.53 110.571 -177.875 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.581 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 165.66 175.4 36.15 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.305 -1.518 . . . . 0.48 109.305 179.806 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.443 ' CE1' HG11 ' A' ' 176' ' ' VAL . 21.8 m-85 -132.18 130.67 41.36 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.477 -1.013 . . . . 0.55 109.198 -179.877 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.417 ' CG2' HG21 ' A' ' 205' ' ' THR . 98.2 mt -132.93 124.85 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.483 -0.76 . . . . 0.65 108.963 178.869 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 47.5 p -148.02 160.61 42.67 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.97 -1.081 . . . . 0.82 110.917 -179.622 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 183' ' ' ALA . 0.8 OUTLIER -99.65 20.13 14.58 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.558 -0.714 . . . . 2.46 109.717 179.969 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.432 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -55.17 -163.32 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.812 -1.18 . . . . 1.28 111.607 -178.295 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -85.56 -46.92 5.32 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 111.224 -0.751 . . . . 2.19 111.224 -178.603 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 165.66 -136.44 4.18 Favored Glycine 0 N--CA 1.491 2.326 0 C-N-CA 118.963 -1.589 . . . . 2.13 110.612 -179.598 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.426 HH11 ' HG2' ' A' ' 186' ' ' ARG . 24.2 mmt-85 -70.21 -10.43 58.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.481 -1.011 . . . . 5.86 109.739 -179.219 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 78.1 p -76.08 -7.15 54.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.114 -0.992 . . . . 3.72 109.732 -179.471 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 5.2 p -91.39 131.87 36.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.134 -0.979 . . . . 1.74 109.889 179.819 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -49.69 -47.59 50.22 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.426 -0.796 . . . . 0.95 109.843 -179.559 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.414 ' H ' HG22 ' A' ' 190' ' ' THR . 0.6 OUTLIER -56.96 -39.62 74.93 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.381 -0.824 . . . . 1.55 110.576 -178.949 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 30.4 t -60.03 -41.23 91.79 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.888 -1.132 . . . . 1.51 110.753 -179.267 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 38.7 mm -60.21 -40.01 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.135 -0.978 . . . . 1.67 109.338 -179.5 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 89.7 mtp -60.04 -40.13 88.31 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.27 -0.894 . . . . 1.02 110.055 -179.941 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -54.48 -44.38 72.56 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.734 -1.228 . . . . 0.68 108.931 179.986 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -60.06 -52.42 65.46 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.346 -0.942 . . . . 2.93 110.518 -179.703 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 56.4 m -69.88 -34.68 73.87 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.025 -1.047 . . . . 0.86 110.79 -178.465 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.97 -29.68 66.85 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.955 -1.128 . . . . 0.67 107.955 179.593 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 65.09 47.34 2.51 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-O 121.454 0.645 . . . . 1.5 110.153 -179.629 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 93.6 mt -124.85 150.52 66.19 Favored Pre-proline 0 N--CA 1.5 2.05 0 N-CA-C 108.439 -0.948 . . . . 0.72 108.439 178.891 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -56.15 138.59 83.51 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 121.858 1.705 . . . . 0.61 111.135 179.841 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -170.94 151.03 3.22 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.744 -1.182 . . . . 0.66 111.778 -179.647 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.1 mt -127.23 143.89 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 N-CA-C 108.069 -1.086 . . . . 0.79 108.069 179.116 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 16.9 m -130.0 -11.45 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.391 0 O-C-N 120.837 -1.165 . . . . 0.91 111.315 -178.825 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.51 25.85 18.25 Favored Glycine 0 N--CA 1.5 2.949 0 N-CA-C 110.064 -1.214 . . . . 1.01 110.064 -179.506 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.417 HG21 ' CG2' ' A' ' 180' ' ' ILE . 4.6 p -45.3 -45.59 12.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -1.158 . . . . 0.99 109.814 -179.562 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 92.8 -52.79 2.62 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.216 -0.993 . . . . 1.12 111.181 179.287 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.5 t -155.02 29.04 0.41 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.585 -1.538 . . . . 1.72 111.451 -179.032 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 56.0 t -70.18 -40.08 77.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 120.947 -1.095 . . . . 0.89 109.131 178.309 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.786 HG22 HG12 ' A' ' 159' ' ' VAL . 63.2 p -60.0 -26.53 66.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.423 -0.798 . . . . 1.03 110.621 -179.131 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 79.3 p -81.7 -20.69 38.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.921 -1.112 . . . . 1.83 110.181 -179.361 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -101.01 -9.1 21.76 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.344 -0.848 . . . . 2.27 109.967 -179.688 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 54.2 t -103.32 138.23 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 O-C-N 121.38 -0.825 . . . . 0.92 110.18 -179.053 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.87 155.34 26.99 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.606 -1.257 . . . . 2.2 107.606 178.938 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.449 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 55.3 t30 -59.56 139.43 57.16 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.872 -1.143 . . . . 2.36 109.738 -179.603 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.449 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.5 m-20 82.07 5.06 1.17 Allowed 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 121.144 0.497 . . . . 2.38 110.018 179.884 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 63.1 t0 -73.1 136.91 44.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 2.09 108.912 179.077 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.515 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 34.9 t80 -88.93 114.8 25.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.931 -1.105 . . . . 1.27 108.42 179.471 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.479 HD12 ' HB2' ' A' ' 16' ' ' ALA . 72.2 mt -124.67 146.15 49.28 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.52 -0.738 . . . . 0.75 110.343 -178.897 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 87.9 mt -112.87 128.7 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 107.741 -1.207 . . . . 0.63 107.741 178.187 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 49.5 tp -101.22 116.42 32.76 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.922 -1.111 . . . . 0.7 108.992 -179.523 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.503 ' OD2' ' ND2' ' A' ' 224' ' ' ASN . 38.5 t0 -80.7 -41.93 22.84 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.173 -1.047 . . . . 2.31 108.173 178.948 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.677 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 47.83 19.61 0.18 Allowed 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.967 -0.753 . . . . 0.78 108.967 -179.401 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.434 ' N ' ' C ' ' A' ' 221' ' ' ASP . 47.3 t -128.61 -39.72 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.097 -1.445 . . . . 1.04 107.097 178.539 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.503 ' ND2' ' OD2' ' A' ' 221' ' ' ASP . 86.1 m-20 -108.85 4.78 23.89 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 107.836 -1.172 . . . . 2.44 107.836 178.072 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.826 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.5 OUTLIER 60.06 47.66 9.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.721 -0.612 . . . . 1.55 110.059 -179.884 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -140.84 140.29 34.62 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.134 -0.979 . . . . 1.99 110.252 179.889 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.8 t -118.31 120.14 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 108.533 -0.914 . . . . 0.77 108.533 179.104 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -88.57 130.02 35.35 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.978 -1.076 . . . . 0.98 109.366 -179.479 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.462 HG22 HD22 ' A' ' 218' ' ' LEU . 58.2 t -103.34 115.1 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.6 -0.688 . . . . 0.85 110.027 -179.056 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.6 t30 48.44 66.73 5.3 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.311 -0.868 . . . . 1.66 111.058 179.656 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -90.1 154.04 4.76 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.809 2.339 . . . . 0.95 111.687 178.851 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 232' ' ' THR . 1.8 t -77.98 168.88 19.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.03 -1.044 . . . . 1.84 110.257 -179.162 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -59.99 -38.97 84.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.696 -0.628 . . . . 2.74 111.321 -179.114 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -59.97 -39.98 87.5 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.936 -1.103 . . . . 2.89 110.137 -178.109 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.3 t -69.51 -39.9 79.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 O-C-N 121.089 -1.007 . . . . 1.3 109.306 179.572 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 97.0 mt -65.88 -40.16 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.931 . . . . 1.09 110.309 -179.617 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -60.06 -41.73 93.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.779 -1.2 . . . . 2.43 109.588 -179.758 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -64.46 -42.09 96.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.451 -0.78 . . . . 2.78 109.65 179.754 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 93.6 mtp -70.04 -33.7 72.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.506 -0.747 . . . . 1.25 110.421 179.614 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 29.6 mmt180 -70.07 -39.68 75.48 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.243 -0.91 . . . . 2.63 109.834 -179.975 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -56.1 -44.87 79.48 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.232 -0.918 . . . . 1.8 109.414 -179.26 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.02 -43.74 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.14 -0.975 . . . . 2.13 108.992 179.557 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -60.04 -41.28 91.92 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.381 -0.824 . . . . 3.17 110.018 179.955 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -60.08 -39.87 87.57 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.229 -0.919 . . . . 1.78 109.872 -179.631 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -61.66 -37.46 84.11 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.327 -0.858 . . . . 2.47 109.894 180.0 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 53.4 t -60.13 -49.36 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.42 -0.8 . . . . 2.09 109.999 -178.781 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -68.02 -39.93 83.04 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.009 -1.057 . . . . 2.54 109.636 -179.888 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 30.3 t -70.87 -41.52 71.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.377 -0.827 . . . . 2.99 111.775 -178.972 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -71.04 -27.59 63.76 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.759 -1.213 . . . . 3.34 110.672 -178.603 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -79.89 -3.76 49.4 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.249 -0.907 . . . . 3.88 111.006 -178.649 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -109.97 -3.09 16.74 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 120.949 -1.095 . . . . 4.43 110.254 -179.722 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.09 -49.95 75.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.001 -1.062 . . . . 5.42 109.682 -179.631 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -175.82 33.73 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.284 -0.885 . . . . 6.1 109.401 179.518 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . 52.98 33.78 15.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.441 -0.787 . . . . 7.37 109.294 -179.936 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.511 ' C ' ' H ' ' A' ' 257' ' ' LYS . 58.0 pttt -63.01 -39.68 95.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.389 -0.819 . . . . 8.01 109.383 179.637 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.401 ' N ' ' CG ' ' A' ' 255' ' ' LYS . 9.4 mp 53.57 5.42 0.06 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.962 -0.755 . . . . 9.05 108.962 -179.053 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.511 ' H ' ' C ' ' A' ' 255' ' ' LYS . 78.0 mttt -150.8 161.08 43.33 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.892 -1.13 . . . . 10.56 109.583 179.689 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 257' ' ' LYS . 80.4 m-20 -142.77 -132.98 0.09 Allowed 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.143 -1.058 . . . . 11.32 108.143 179.203 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.508 HH11 ' HG2' ' A' ' 259' ' ' ARG . 11.1 ttt-85 . . . . . 0 C--N 1.296 -1.735 0 CA-C-O 117.948 -1.025 . . . . 12.42 109.532 -179.508 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 55.6 ttm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -149.48 146.87 27.63 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.011 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 3.3 pp0? -150.35 159.86 44.15 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.943 -1.098 . . . . 0.0 110.423 -179.101 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -158.44 154.63 27.18 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.614 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . 0.462 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 54.6 mp0 -115.15 130.77 57.01 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.074 -1.016 . . . . 0.0 109.787 179.575 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.5 p -130.35 126.3 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 CA-C-O 122.181 0.991 . . . . 0.0 112.297 -177.526 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 35.5 m -79.04 102.68 8.5 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.072 0.939 . . . . 0.0 110.936 -178.403 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.453 HG22 ' H ' ' B' ' 310' ' ' ALA . 96.7 mt -51.28 126.02 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 122.29 1.043 . . . . 0.0 110.742 -177.839 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 72.6 p -110.06 19.27 19.16 Favored 'General case' 0 N--CA 1.496 1.845 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.147 -179.103 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.453 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -76.71 126.28 86.12 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.902 -1.124 . . . . 0.0 108.134 178.942 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -65.7 -11.48 30.86 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 CA-C-N 120.312 1.147 . . . . 0.0 112.75 -178.866 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -119.98 10.06 11.4 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.464 -0.773 . . . . 0.0 109.589 -179.844 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.74 179.99 33.12 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.342 -1.903 . . . . 0.0 108.342 -179.132 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.519 ' O ' ' NH1' ' A' ' 126' ' ' ARG . 3.2 tp -84.38 87.9 7.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.918 -1.342 . . . . 0.0 109.062 -178.801 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.438 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 3.7 p80 -90.38 -163.12 0.97 Allowed 'General case' 0 N--CA 1.502 2.132 0 O-C-N 120.862 -1.149 . . . . 0.0 109.997 179.187 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 6.0 m -55.88 -44.64 78.32 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.186 -0.946 . . . . 0.0 112.917 -176.054 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.643 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 12.7 tpt180 -60.02 -60.0 12.04 Favored Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 120.576 -1.327 . . . . 0.0 112.087 -178.991 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.438 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 11.5 Cg_endo -59.5 -34.5 97.05 Favored 'Trans proline' 0 N--CA 1.491 1.382 0 CA-C-N 120.634 1.262 . . . . 0.0 111.873 -179.147 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.96 -50.0 75.46 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.421 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.46 -44.52 76.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.512 -0.743 . . . . 0.0 110.159 -179.221 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 66.2 tp60 -70.02 -41.06 74.81 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 120.746 -1.221 . . . . 0.0 108.537 178.898 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -62.1 -52.88 62.11 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.455 -0.778 . . . . 0.0 110.151 -179.776 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 95.3 t -66.17 -25.35 35.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.823 -1.173 . . . . 0.0 109.974 -178.975 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 27.8 ttmt -60.0 -44.51 94.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.135 -0.978 . . . . 0.0 108.574 179.948 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -66.18 -52.56 46.96 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.461 -0.774 . . . . 0.0 110.991 -179.228 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . 0.428 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -53.13 -56.89 12.77 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.618 -1.301 . . . . 0.0 111.474 -178.444 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -50.06 -16.2 0.28 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.032 -1.042 . . . . 0.0 109.359 -179.912 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . 0.428 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -81.68 -17.05 71.57 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.361 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 48.9 m-85 -106.22 141.39 37.66 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.607 -0.937 . . . . 0.0 109.257 179.571 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 47.2 p -92.14 -14.28 29.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.905 -1.122 . . . . 0.0 110.21 -179.998 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.487 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 47.4 t -59.99 143.85 50.74 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.073 -1.017 . . . . 0.0 109.404 -179.78 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -66.58 137.9 57.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 179.424 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 93.5 mt -134.11 134.18 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 121.469 -0.769 . . . . 0.0 110.327 -179.149 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 99.7 m -129.07 149.62 50.81 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.798 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 74.8 t -115.63 141.47 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 178.325 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 59.1 m -131.61 121.94 25.2 Favored 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.155 -0.966 . . . . 0.0 109.359 179.547 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 29.3 t -139.2 120.22 14.55 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 122.086 0.946 . . . . 0.0 110.737 179.906 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 42.47 50.08 4.73 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 177.365 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.28 -14.65 57.14 Favored Glycine 0 N--CA 1.503 3.16 0 O-C-N 120.186 -1.571 . . . . 0.0 113.351 176.391 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -112.65 121.65 45.38 Favored 'General case' 0 N--CA 1.506 2.349 0 CA-C-N 119.368 1.584 . . . . 0.0 109.906 -179.532 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 53.2 m -106.23 154.03 21.31 Favored 'General case' 0 N--CA 1.496 1.871 0 CA-C-O 121.968 0.89 . . . . 0.0 111.069 -178.668 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -150.75 150.18 30.7 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.374 0.606 . . . . 0.0 109.573 179.452 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 68.0 m -87.69 135.2 33.47 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.334 -0.854 . . . . 0.0 110.136 -179.56 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.429 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -69.31 -20.2 63.88 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.075 -1.015 . . . . 0.0 108.49 179.366 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -84.29 20.44 1.63 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.841 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . 0.429 ' H ' ' C ' ' B' ' 344' ' ' ALA . 2.6 m -149.1 91.71 1.88 Allowed 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 119.832 -0.747 . . . . 0.0 112.014 -179.762 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.887 HD23 HD22 ' A' ' 79' ' ' LEU . 59.5 tp -56.54 -37.55 70.67 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.383 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.806 ' CE2' HD11 ' A' ' 79' ' ' LEU . 62.3 m-85 -54.54 -50.09 68.72 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.354 -0.841 . . . . 0.0 111.039 -179.273 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . 0.41 ' O ' ' C ' ' B' ' 350' ' ' LEU . 35.1 mtmm -69.97 -39.89 75.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.675 -1.265 . . . . 0.0 110.645 -178.525 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.445 ' O ' ' N ' ' B' ' 352' ' ' THR . 96.7 mt -46.63 -56.8 5.53 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.979 -1.076 . . . . 0.0 108.879 -179.494 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.872 HE22 ' HE ' ' A' ' 126' ' ' ARG . 56.9 mm-40 -39.49 -26.35 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.847 -0.533 . . . . 0.0 111.208 -178.571 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.445 ' N ' ' O ' ' B' ' 350' ' ' LEU . 67.8 p -79.3 -11.15 59.94 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.498 -1.376 . . . . 0.0 110.56 -178.078 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 24.3 mt -96.34 120.01 35.86 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.922 -1.111 . . . . 0.0 109.54 178.72 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.35 92.1 1.06 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.135 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 53.2 mt -98.41 92.01 5.47 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.301 -1.117 . . . . 0.0 109.331 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 70.1 p -92.89 175.79 6.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.133 -0.979 . . . . 0.0 111.352 -178.516 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -65.22 110.82 2.7 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.447 -179.543 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 102.65 12.93 31.38 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 179.688 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 50.1 m -88.36 110.09 20.51 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -1.137 . . . . 0.0 111.343 -179.092 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 31.0 t -77.45 113.83 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 CA-C-O 122.119 0.962 . . . . 0.0 109.826 -177.752 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.5 m -109.78 176.6 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 -177.875 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 29.8 m -131.58 127.57 37.41 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.477 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.0 mt -104.21 115.86 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 178.435 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 50.2 p -120.37 133.35 55.46 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.513 -0.742 . . . . 0.0 109.042 -179.664 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.61 150.05 36.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.114 -0.991 . . . . 0.0 110.086 -179.024 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -139.29 120.5 14.77 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.65 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.574 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 165.04 -167.07 38.53 Favored Glycine 0 N--CA 1.485 1.909 0 C-N-CA 119.119 -1.515 . . . . 0.0 111.117 -179.492 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -58.09 -47.03 84.47 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 122.359 -0.495 . . . . 0.0 111.707 -177.785 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.487 ' H ' ' HB2' ' B' ' 331' ' ' SER . 2.7 p30 -107.98 10.46 28.35 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.878 -1.139 . . . . 0.0 111.373 -177.681 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.574 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -43.92 -32.02 1.01 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.408 -0.808 . . . . 0.0 110.963 -178.96 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -69.46 -45.16 69.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.137 -0.977 . . . . 0.0 110.045 -178.481 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -67.5 -47.98 68.41 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.176 -0.953 . . . . 0.0 108.847 -179.632 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -44.15 -78.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.399 -0.813 . . . . 0.0 110.67 -179.471 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.583 ' O ' HG23 ' B' ' 378' ' ' VAL . 38.7 t -46.34 -35.75 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.042 -1.036 . . . . 0.0 110.633 -177.458 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -64.9 -49.84 68.86 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.528 -1.357 . . . . 0.0 110.591 -179.963 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -80.49 -41.78 23.69 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.956 -1.09 . . . . 0.0 110.493 -179.667 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 97.0 mt -59.94 -37.19 78.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.124 -0.985 . . . . 0.0 109.08 -179.133 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.583 HG23 ' O ' ' B' ' 374' ' ' VAL . 50.2 t -65.46 -40.04 87.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.312 -0.867 . . . . 0.0 109.574 179.265 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -69.71 -57.03 5.63 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.772 -1.205 . . . . 0.0 108.408 179.213 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 57.3 tp -55.17 -26.73 40.78 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.227 -0.921 . . . . 0.0 110.403 -178.216 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 33.7 ttm -74.72 -38.13 62.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.691 -1.256 . . . . 0.0 109.027 177.857 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -83.89 -4.41 58.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.512 -0.742 . . . . 0.0 110.509 179.588 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -110.48 -6.66 14.87 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.122 -0.986 . . . . 0.0 111.245 -178.739 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.6 mt -78.56 132.37 37.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.3 -1.5 . . . . 0.0 109.029 179.141 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.366 -179.705 . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.2 mmm . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.332 -0.618 . . . . 2.91 109.332 . . . . . . . . . 0 0 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.0 mt -111.13 126.99 68.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.578 -0.701 . . . . 1.2 109.828 179.809 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.8 m -140.51 150.18 43.42 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.371 -0.83 . . . . 1.4 109.778 -179.832 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.417 ' H ' ' CG ' ' A' ' 225' ' ' ASN . . . -138.7 -163.81 9.68 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.858 -1.697 . . . . 1.05 108.858 179.274 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' A' ' 6' ' ' LEU . 97.4 mt -93.3 -16.82 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.95 -1.324 . . . . 1.15 110.125 -179.118 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' A' ' 5' ' ' ILE . 61.1 tp 54.55 105.98 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.397 -0.815 . . . . 0.98 109.407 179.906 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -95.31 -35.25 11.86 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.561 -0.903 . . . . 0.88 108.561 179.064 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 199' ' ' LEU . 7.6 m -129.26 129.28 23.29 Favored Pre-proline 0 N--CA 1.502 2.136 0 N-CA-C 109.362 -0.607 . . . . 1.69 109.362 179.848 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -81.15 146.1 15.69 Favored 'Trans proline' 0 N--CA 1.498 1.763 0 C-N-CA 122.272 1.981 . . . . 0.85 112.807 179.948 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.807 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 160.53 -160.35 31.74 Favored Glycine 0 N--CA 1.498 2.781 0 N-CA-C 109.827 -1.309 . . . . 0.92 109.827 179.594 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 71.0 mt -149.98 149.64 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 O-C-N 121.268 -1.136 . . . . 0.81 108.195 179.215 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.04 149.82 25.07 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 120.568 -1.333 . . . . 0.51 111.128 179.628 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 4.0 m-85 -131.06 129.79 42.4 Favored 'General case' 0 N--CA 1.505 2.291 0 N-CA-C 108.917 -0.771 . . . . 0.62 108.917 179.23 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 173.93 -173.79 46.03 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 118.509 -1.805 . . . . 0.55 110.948 179.3 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 61.3 mttm -82.55 155.46 24.49 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.949 -0.736 . . . . 2.1 110.026 -179.513 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.578 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -102.35 129.51 48.82 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.383 -0.823 . . . . 0.77 110.853 -179.532 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 58.3 tp -99.38 133.52 43.58 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.109 -1.441 . . . . 0.91 107.109 178.412 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 58.4 tp -118.72 125.41 49.6 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.235 -0.916 . . . . 0.93 109.652 -179.697 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.56 HD21 HD21 ' A' ' 149' ' ' LEU . 85.5 mt -87.36 103.73 15.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.583 -0.698 . . . . 0.93 109.578 179.627 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -97.98 132.15 43.79 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.557 -0.905 . . . . 2.75 108.557 179.367 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -131.26 130.32 42.71 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.972 -1.08 . . . . 3.0 109.003 179.03 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 35.0 p-10 -79.46 154.1 29.16 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.166 -0.959 . . . . 2.77 108.777 179.448 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -67.74 141.18 56.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.043 -1.035 . . . . 2.94 109.838 -179.915 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 76.4 mt -79.44 135.45 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.241 -1.022 . . . . 0.95 108.241 179.532 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.1 t -103.39 124.33 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.175 -0.953 . . . . 1.28 109.998 -179.294 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 97.9 mt -99.03 140.77 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 N-CA-C 108.849 -0.797 . . . . 1.21 108.849 179.803 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -92.15 121.39 33.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.063 -1.023 . . . . 1.81 109.359 -179.699 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.5 mmt180 -94.86 5.47 51.8 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.495 -0.928 . . . . 2.8 108.495 179.701 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -65.78 142.13 58.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.484 -0.76 . . . . 2.87 109.52 -179.783 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 83.3 mttt -88.53 140.32 29.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.226 -0.921 . . . . 2.35 109.119 -179.906 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.517 HG21 ' HG3' ' A' ' 39' ' ' GLU . 3.3 pt -94.39 164.43 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.885 -1.134 . . . . 0.97 109.746 -179.819 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 52.0 p -95.42 169.86 9.76 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.412 -0.958 . . . . 1.17 108.412 178.918 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.34 -13.24 49.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.952 -1.092 . . . . 1.18 110.085 -179.769 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -88.59 -30.33 19.34 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.868 -1.145 . . . . 2.56 108.977 179.576 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -82.64 -7.73 59.63 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.758 -0.83 . . . . 1.79 108.758 179.556 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.7 t -59.98 -51.96 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.24 -0.913 . . . . 1.0 108.832 179.613 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -60.01 -39.03 84.38 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.29 -0.882 . . . . 1.77 109.292 179.612 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -67.26 -41.8 84.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.053 -1.029 . . . . 2.7 110.915 -178.816 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.517 ' HG3' HG21 ' A' ' 31' ' ' ILE . 63.2 mm-40 -64.47 -40.08 95.01 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.597 -1.315 . . . . 1.51 110.181 -179.435 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -60.13 -47.02 93.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 120.622 -1.299 . . . . 0.93 108.449 179.242 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 45.3 tp10 -59.89 -40.16 87.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.207 -0.933 . . . . 1.81 109.538 -179.777 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -60.02 -43.34 95.35 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.749 -1.219 . . . . 2.78 108.268 178.523 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.424 ' CE1' HD13 ' A' ' 89' ' ' ILE . 69.5 t80 -60.13 -49.31 78.15 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.344 -0.848 . . . . 0.78 108.907 178.59 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 21.0 tp -59.98 -49.04 79.23 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.762 -0.586 . . . . 1.07 109.453 -179.825 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.475 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 22.2 t -63.27 -46.13 88.24 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.43 -0.908 . . . . 1.12 109.033 179.121 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.19 -48.1 87.61 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 108.415 -1.874 . . . . 0.84 108.415 179.443 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 51.1 ttt-85 -60.61 -38.1 83.58 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.302 -0.999 . . . . 3.09 108.302 178.689 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -50.35 -42.16 52.61 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.382 -0.599 . . . . 0.88 109.382 -179.527 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.434 ' O ' ' C ' ' A' ' 50' ' ' ALA . 19.8 ttmt -66.99 -73.73 0.13 Allowed 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.869 -1.16 . . . . 2.59 107.869 178.952 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.31 -39.91 0.48 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.516 -0.74 . . . . 0.7 111.01 -178.825 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.8 t -51.77 -61.72 2.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.769 -1.207 . . . . 1.4 109.368 179.797 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.06 -38.87 82.94 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.391 -0.818 . . . . 0.67 111.41 -178.56 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -62.73 -40.69 97.99 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.854 -1.154 . . . . 1.66 110.063 -178.716 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 82.2 mt -64.41 -40.05 95.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.113 -0.992 . . . . 1.58 109.695 -179.839 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -62.2 -37.64 86.09 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.341 -0.85 . . . . 1.35 109.285 -179.773 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 86.6 m -65.15 -42.7 93.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.287 -0.883 . . . . 0.77 109.174 -179.918 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 91.6 mt -62.26 -39.91 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.21 -0.931 . . . . 0.63 109.334 179.876 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.0 ttpt -58.87 -49.95 75.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.166 -0.959 . . . . 1.14 109.958 -179.06 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 16.8 m -56.65 -35.63 68.6 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.021 -1.049 . . . . 0.79 110.018 -178.198 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -65.7 -37.05 85.38 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.199 -0.938 . . . . 1.53 108.896 -179.844 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.433 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.87 -49.03 64.37 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.349 0.595 . . . . 0.57 110.215 179.82 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.97 -51.83 54.89 Favored Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.837 -1.173 . . . . 0.75 110.319 -178.937 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -70.13 -40.74 74.64 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.167 -1.196 . . . . 1.59 110.322 -179.44 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.9 m -69.95 -61.39 1.8 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.028 -1.045 . . . . 0.73 112.38 -177.532 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -93.74 -47.52 6.74 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.831 -1.168 . . . . 0.75 111.036 -177.752 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.73 -168.72 25.48 Favored Glycine 0 N--CA 1.5 2.934 0 C-N-CA 119.848 -1.167 . . . . 1.22 111.238 179.612 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -68.6 -26.41 65.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.824 -0.81 . . . . 5.81 110.359 -179.586 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -60.54 -35.22 75.49 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.331 -0.855 . . . . 3.37 110.484 -179.598 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 15.7 mmmt -96.07 -19.07 19.71 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.105 -0.997 . . . . 1.77 110.117 -179.743 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -69.27 -40.94 77.5 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.704 -1.248 . . . . 1.65 109.665 179.967 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.566 ' CB ' HH11 ' B' ' 317' ' ' ARG . . . -67.07 -36.46 82.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.44 -0.788 . . . . 0.77 110.67 -178.597 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 77.2 mt -60.69 -43.66 95.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.697 -1.252 . . . . 0.8 109.006 179.643 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.525 ' CZ ' ' HB2' ' A' ' 169' ' ' ALA . 10.8 m-85 -70.29 -33.31 71.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 0.88 109.581 179.776 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -63.98 -40.03 95.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.023 -1.048 . . . . 1.37 109.731 179.475 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.29 -39.86 91.99 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.013 -1.635 . . . . 0.62 109.013 179.426 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 62.7 m170 -60.19 -48.85 80.0 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.431 -1.041 . . . . 1.5 109.38 -179.908 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 86.5 mt -66.52 -45.28 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.186 -0.946 . . . . 0.63 109.764 179.929 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 45.1 ttp -60.35 -40.16 89.75 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.099 -1.001 . . . . 1.51 109.27 -178.918 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.874 HD11 ' CE2' ' B' ' 348' ' ' PHE . 25.1 tp -61.13 -35.9 78.29 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.28 -0.887 . . . . 0.77 108.689 178.709 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.8 tp -67.96 -30.26 69.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.496 -0.753 . . . . 0.62 109.514 179.968 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -83.43 4.64 26.77 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.21 -0.932 . . . . 1.47 110.336 -179.483 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 57.1 t0 -56.83 130.57 46.26 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.974 -1.079 . . . . 1.47 111.212 -178.651 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.423 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 47.7 mt-10 -61.07 -18.59 58.72 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.929 -0.482 . . . . 1.78 111.179 -179.223 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -72.71 -34.33 67.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.625 -1.297 . . . . 2.53 108.813 178.877 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.1 mt -69.77 -43.1 72.87 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.353 0.597 . . . . 0.8 111.002 -179.252 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -62.74 -42.06 99.48 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.348 -0.845 . . . . 1.42 111.17 -178.032 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -70.12 -42.58 72.44 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.833 -1.167 . . . . 1.71 111.619 -178.289 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -68.16 -38.29 81.93 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.196 -0.94 . . . . 1.57 111.855 -177.87 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.424 HD13 ' CE1' ' A' ' 43' ' ' PHE . 96.8 mt -66.53 -42.29 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.67 -1.269 . . . . 0.65 109.445 -179.759 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 85.3 mt -70.04 -39.93 77.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.461 -0.774 . . . . 0.82 110.616 179.606 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -63.95 -43.06 96.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.25 -0.906 . . . . 0.79 111.748 -178.104 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.3 mt -63.68 -46.56 84.97 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.585 -1.322 . . . . 0.95 109.632 -179.357 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 71.7 mt -59.84 -49.53 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 122.038 0.923 . . . . 0.66 109.434 179.531 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 56.6 mttm -70.04 -40.23 75.28 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 120.079 -0.649 . . . . 2.2 111.099 -179.635 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -81.86 -55.79 4.38 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.753 -1.217 . . . . 1.65 112.278 -178.346 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 80.6 mttt -90.04 -1.26 57.93 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.91 -1.119 . . . . 2.03 112.425 -177.03 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 59.57 40.07 20.72 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.842 -1.162 . . . . 1.42 110.082 179.377 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 79.1 mtp -95.27 167.21 11.49 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.31 -0.868 . . . . 1.18 109.656 -179.72 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 56.6 p -81.5 160.15 24.01 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.276 -0.89 . . . . 0.98 109.04 179.635 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -64.82 -39.79 94.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.267 -0.895 . . . . 0.64 110.268 -179.639 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -69.3 -33.42 73.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.027 -1.046 . . . . 2.07 109.278 -179.619 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.73 -41.06 24.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -0.963 . . . . 0.73 109.377 179.442 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.47 -45.7 61.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.311 -0.868 . . . . 0.54 110.197 -179.813 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.37 -33.4 75.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.125 -0.985 . . . . 0.56 109.355 179.979 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -59.82 -44.94 93.77 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.568 -0.707 . . . . 1.54 109.958 -179.822 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -60.19 -40.29 89.49 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 1.33 110.966 -179.2 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.04 -65.95 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.239 -0.913 . . . . 0.72 112.38 -177.413 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.407 HG21 ' CA ' ' A' ' 134' ' ' GLY . 43.2 mm -68.78 -41.0 82.14 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 120.788 -1.195 . . . . 0.85 110.236 -178.446 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.6 tm-20 -67.79 -31.57 71.53 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.213 -0.93 . . . . 2.44 108.651 179.731 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.8 -46.61 66.32 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.917 -1.273 . . . . 0.98 109.917 -179.761 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -60.29 -50.33 74.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.929 -1.336 . . . . 1.41 110.048 -179.292 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.89 -36.08 74.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.371 -0.831 . . . . 1.2 109.84 179.839 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.2 t -59.72 -42.39 92.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.955 -1.091 . . . . 1.7 108.518 -179.893 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.32 -40.4 94.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -0.838 . . . . 1.47 109.024 179.249 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.5 mt -62.07 -41.22 97.93 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.407 -0.808 . . . . 1.56 109.617 -179.495 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.93 -31.91 67.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.069 -1.019 . . . . 2.2 109.657 -179.387 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -60.16 -26.22 66.14 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.212 -0.93 . . . . 2.12 108.947 179.684 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.402 HD13 HD13 ' A' ' 123' ' ' LEU . 31.6 mt -61.72 144.8 54.08 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.142 -0.974 . . . . 2.0 108.913 -179.56 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -98.36 51.59 1.01 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.027 -1.046 . . . . 3.23 109.538 179.668 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.404 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 61.7 t0 -134.27 132.83 40.09 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.445 -0.784 . . . . 2.49 109.321 179.89 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.404 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 83.9 tt0 -69.95 -31.94 69.94 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.475 -0.766 . . . . 3.95 109.865 -179.836 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.454 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.3 t80 -70.09 -36.88 75.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.535 -0.728 . . . . 2.0 111.075 -179.679 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.464 HD22 ' O ' ' B' ' 351' ' ' GLN . 79.7 mt -78.56 -37.81 41.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.047 -1.033 . . . . 1.86 109.701 -179.703 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -60.14 -48.99 79.39 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.109 -0.994 . . . . 2.84 109.957 179.849 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -61.76 -39.78 92.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.085 -1.009 . . . . 2.73 109.091 179.956 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.619 HH21 HD11 ' B' ' 347' ' ' LEU . 65.8 ttt180 -60.13 -40.04 88.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 2.77 108.711 179.824 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.426 ' O ' ' N ' ' A' ' 130' ' ' VAL . . . -59.54 -47.93 83.62 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.932 -1.105 . . . . 1.19 108.543 179.496 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 127' ' ' ALA . . . -43.65 -39.12 3.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.669 -0.645 . . . . 1.2 109.299 179.89 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -66.11 -42.72 88.83 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.213 -0.93 . . . . 1.55 108.604 179.197 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.426 ' N ' ' O ' ' A' ' 127' ' ' ALA . 55.4 t -69.9 -40.32 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.34 -0.85 . . . . 0.8 108.926 178.776 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -59.97 -39.13 84.62 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.378 -0.826 . . . . 3.09 109.033 179.25 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -59.98 -39.8 86.92 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.516 -0.74 . . . . 1.46 110.377 -179.559 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 90.8 mt -59.64 -41.25 84.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 120.907 -1.121 . . . . 0.71 108.98 -179.234 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.407 ' CA ' HG21 ' A' ' 108' ' ' ILE . . . -67.24 -37.65 91.19 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.931 -1.267 . . . . 0.57 109.931 179.516 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.63 -49.02 78.25 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.181 -1.188 . . . . 2.59 111.027 -178.872 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 65.1 mtp180 -66.62 -29.48 69.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.897 -1.127 . . . . 2.83 109.423 -179.445 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 62.8 tp -59.59 -41.76 90.99 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.72 -0.844 . . . . 1.25 108.72 -178.967 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.36 -39.9 94.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.108 -0.995 . . . . 0.7 108.55 179.226 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -68.75 -39.6 80.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.361 -0.837 . . . . 2.57 109.329 178.704 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -65.65 -34.46 78.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.452 -0.78 . . . . 1.23 110.84 -179.42 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 91.1 mt -70.44 -42.6 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 O-C-N 120.737 -1.227 . . . . 0.81 108.092 179.071 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.36 -33.74 71.8 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.118 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.24 43.63 5.55 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 108.129 -1.988 . . . . 0.89 108.129 -178.901 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 3.4 tp -75.15 150.84 38.63 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.644 -0.915 . . . . 1.14 110.263 -178.866 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.435 ' HD3' ' N ' ' A' ' 146' ' ' ILE . 9.6 tmtm? -69.61 149.31 48.28 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.722 -0.844 . . . . 4.6 108.722 179.464 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.435 ' N ' ' HD3' ' A' ' 145' ' ' LYS . 86.8 mt -119.81 125.14 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 CA-C-O 121.933 0.873 . . . . 1.24 109.036 178.881 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.445 HG12 ' H ' ' A' ' 147' ' ' ILE . 6.3 mm -49.42 -54.76 5.6 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.624 -0.673 . . . . 1.54 109.762 -178.485 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.8 t0 69.39 104.23 0.06 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.547 -0.72 . . . . 1.5 110.59 -179.903 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.562 ' O ' HD12 ' A' ' 152' ' ' ILE . 95.9 mt -74.44 -7.18 52.11 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.524 -0.735 . . . . 0.79 109.977 179.84 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.0 t -81.45 -16.83 50.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.148 -0.97 . . . . 1.4 109.485 -179.963 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -81.16 23.43 0.58 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.533 -0.729 . . . . 0.92 110.196 -178.543 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.562 HD12 ' O ' ' A' ' 149' ' ' LEU . 63.9 mt -92.2 115.24 30.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.133 -0.979 . . . . 0.88 109.738 -179.085 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -100.66 -15.24 17.81 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.251 -0.906 . . . . 2.45 109.63 -179.83 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -118.19 145.86 44.64 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 109.498 -0.556 . . . . 1.52 109.498 -178.988 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.08 136.48 57.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 1.58 109.346 -179.739 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 26.9 m -151.6 163.3 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 109.328 -0.619 . . . . 0.69 109.328 179.99 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 82.3 mt -91.78 146.71 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 106.177 -1.786 . . . . 0.61 106.177 177.266 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.2 tp -99.01 118.96 36.96 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.022 -1.049 . . . . 0.87 110.423 -178.194 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 41.5 t -123.31 129.98 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.489 -0.93 . . . . 0.71 108.489 179.727 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.0 159.37 40.28 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.136 -0.977 . . . . 0.81 108.551 -179.839 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -73.45 -33.43 64.9 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.23 -1.544 . . . . 0.98 107.932 178.523 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -168.3 136.87 2.29 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.329 -0.989 . . . . 2.25 108.329 179.959 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 62.9 mt -106.8 138.68 42.53 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.247 -0.908 . . . . 0.78 109.565 -179.496 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 29.9 p -94.05 153.56 40.77 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.47 -0.769 . . . . 0.98 109.02 -179.838 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.04 -34.84 9.61 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.635 1.557 . . . . 0.81 111.952 179.222 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.1 m -58.65 -40.25 82.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.254 -0.904 . . . . 0.9 110.305 -178.306 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -68.04 -42.58 80.33 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.282 -0.886 . . . . 1.61 110.716 -179.302 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.5 p -53.88 -31.74 50.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.047 -1.033 . . . . 0.61 110.546 -178.264 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 73' ' ' PHE . . . -72.52 -54.58 8.82 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.951 -1.093 . . . . 0.6 109.682 179.689 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -85.4 40.74 0.85 Allowed 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.999 -1.112 . . . . 1.4 107.999 179.81 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 51.2 tp -101.84 133.0 47.3 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.888 -0.782 . . . . 0.7 108.888 179.083 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -89.69 102.14 14.83 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.334 -0.987 . . . . 2.35 108.334 179.348 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 79.9 mt -64.94 -44.78 88.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.461 -0.775 . . . . 1.51 110.908 -178.294 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -70.18 -22.61 62.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.868 -1.145 . . . . 2.33 111.88 -178.337 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 42.2 mmtm -93.56 -10.37 34.98 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.55 -1.344 . . . . 1.92 110.274 -178.465 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 178' ' ' GLY . 94.3 t -106.76 117.22 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.232 -0.918 . . . . 0.67 109.274 179.568 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 51.4 mt -83.55 4.31 28.67 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.43 -0.794 . . . . 1.53 110.985 -177.817 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.557 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 170.72 172.12 36.71 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.561 -1.416 . . . . 0.48 109.561 -179.806 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.51 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 25.3 m-85 -132.56 129.15 38.65 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.508 -0.995 . . . . 0.55 108.75 179.901 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.0 mt -129.98 126.05 61.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.687 -1.227 . . . . 0.65 107.687 178.426 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 21.4 p -143.51 157.37 44.49 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 122.379 1.085 . . . . 0.82 111.397 -179.007 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 182' ' ' ASP . 64.4 t0 -94.61 18.06 12.16 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.783 -0.644 . . . . 2.46 109.265 179.878 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' A' ' 182' ' ' ASP . . . -54.3 -164.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.529 -1.357 . . . . 1.28 111.701 -178.025 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -89.37 -42.39 5.53 Favored Glycine 0 N--CA 1.491 2.349 0 C-N-CA 120.607 -0.806 . . . . 2.19 111.306 -178.395 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 175.83 -149.77 10.26 Favored Glycine 0 N--CA 1.491 2.324 0 C-N-CA 118.429 -1.843 . . . . 2.13 111.242 -179.539 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.428 ' N ' ' CD ' ' A' ' 186' ' ' ARG . 0.2 OUTLIER -70.11 -18.3 63.24 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.813 -0.816 . . . . 5.86 110.558 -178.956 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 82.5 p -69.97 -1.82 10.78 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.02 -1.05 . . . . 3.72 110.003 -179.177 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.3 m -84.92 130.72 34.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.196 -0.94 . . . . 1.74 110.419 -179.157 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -44.93 -55.38 5.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.524 -0.735 . . . . 0.95 110.224 -179.748 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.427 HG23 ' N ' ' A' ' 191' ' ' SER . 8.8 t -58.07 -39.67 79.1 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.411 -0.806 . . . . 1.55 110.721 -178.992 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.427 ' N ' HG23 ' A' ' 190' ' ' THR . 23.3 t -61.55 -40.53 95.03 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 120.953 -1.092 . . . . 1.51 110.797 -179.298 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.88 -40.01 81.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.235 -0.915 . . . . 1.67 109.614 -179.521 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 98.1 mtp -60.2 -40.22 89.32 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.331 -0.856 . . . . 1.02 110.197 179.758 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.41 -43.53 88.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.455 -1.403 . . . . 0.68 109.12 -179.735 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -59.92 -50.18 74.77 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.073 -1.051 . . . . 2.93 109.396 -179.297 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 37.1 m -70.41 -35.42 73.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.158 -0.964 . . . . 0.86 110.98 -178.989 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 74.1 mt -70.27 -24.74 63.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.922 -1.111 . . . . 0.67 109.185 179.996 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 66.45 49.89 1.34 Allowed 'General case' 0 N--CA 1.499 1.984 0 CA-C-O 121.273 0.559 . . . . 1.5 110.828 -179.323 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . 0.4 ' O ' ' CB ' ' A' ' 8' ' ' SER . 78.6 mt -127.23 149.71 70.37 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 107.504 -1.295 . . . . 0.72 107.504 178.18 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -62.97 139.12 71.91 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.17 1.914 . . . . 0.61 112.091 -179.7 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.51 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -170.17 147.23 3.12 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.955 -1.091 . . . . 0.66 110.995 -179.749 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 90.5 mt -120.04 139.1 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 106.842 -1.54 . . . . 0.79 106.842 178.223 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.05 -12.22 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.377 0 O-C-N 120.602 -1.311 . . . . 0.91 111.427 -178.238 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.74 26.13 16.92 Favored Glycine 0 N--CA 1.502 3.052 0 N-CA-C 110.898 -0.881 . . . . 1.01 110.898 -179.121 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.8 p -44.25 -38.36 3.78 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.972 -1.311 . . . . 0.99 110.573 -179.179 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.455 ' O ' ' OD2' ' A' ' 182' ' ' ASP . . . 88.09 -50.47 3.9 Favored Glycine 0 N--CA 1.502 3.064 0 C-N-CA 120.201 -1.0 . . . . 1.12 111.302 179.337 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 13.2 m -162.67 41.48 0.12 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.491 -1.594 . . . . 1.72 111.157 -179.381 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 25.5 t -80.24 -37.81 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.988 -1.07 . . . . 0.89 109.085 178.42 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 1.5 p -58.92 -33.09 70.16 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.571 -0.706 . . . . 1.03 110.048 -178.862 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 58.1 m -76.59 -18.42 58.66 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.332 -0.855 . . . . 1.83 110.157 -178.977 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 77.9 mm-40 -102.84 -9.66 19.74 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.324 -0.86 . . . . 2.27 110.241 -179.144 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 55.2 t -102.01 140.32 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.003 -1.061 . . . . 0.92 110.545 -179.122 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 40.4 mmtm -109.29 150.07 28.52 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.704 -1.221 . . . . 2.2 107.704 178.988 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 19.2 p30 -60.61 138.89 58.0 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.86 -1.15 . . . . 2.36 109.947 -179.52 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.481 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 3.5 t0 81.17 9.61 0.98 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-O 121.303 0.573 . . . . 2.38 109.615 179.466 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.2 t0 -79.06 141.78 37.09 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.377 -0.827 . . . . 2.09 108.936 179.11 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.519 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 47.3 t80 -88.0 121.75 30.78 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.152 -0.967 . . . . 1.27 108.873 -179.992 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.578 HD12 ' HB2' ' A' ' 16' ' ' ALA . 85.9 mt -130.01 150.19 51.4 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.37 -0.832 . . . . 0.75 110.886 -179.021 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.49 HG23 ' CD2' ' A' ' 13' ' ' PHE . 73.1 mt -117.4 128.73 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.379 -1.711 . . . . 0.63 106.379 176.951 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 44.1 tp -101.05 116.65 33.35 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.977 -1.077 . . . . 0.7 109.438 -178.731 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.511 ' C ' ' H ' ' A' ' 223' ' ' VAL . 85.9 m-20 -74.45 -44.8 50.02 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.447 -0.946 . . . . 2.31 108.447 179.092 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.807 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 50.92 11.41 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.808 -0.812 . . . . 0.78 108.808 -179.656 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.511 ' H ' ' C ' ' A' ' 221' ' ' ASP . 54.7 t -126.95 -43.11 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 106.859 -1.534 . . . . 1.04 106.859 178.702 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -100.42 -0.01 38.94 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.728 -1.212 . . . . 2.44 107.728 178.611 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.417 ' CG ' ' H ' ' A' ' 4' ' ' GLY . 6.1 t-20 60.56 42.0 14.74 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.3 -0.63 . . . . 1.55 109.3 -179.442 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -138.14 142.9 40.13 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.287 -0.883 . . . . 1.99 109.238 179.735 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 80.3 t -118.57 120.87 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 N-CA-C 108.925 -0.769 . . . . 0.77 108.925 179.57 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -88.69 128.94 35.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.153 -0.967 . . . . 0.98 109.351 -179.438 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.45 114.06 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.735 -0.603 . . . . 0.85 110.244 -179.111 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 45.4 t30 50.97 63.75 9.3 Favored Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.33 -0.856 . . . . 1.66 111.509 179.064 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -85.83 148.39 9.58 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.38 2.053 . . . . 0.95 112.103 178.958 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.4 HG22 ' N ' ' A' ' 233' ' ' ASN . 39.5 m -67.98 158.17 33.41 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.288 -0.883 . . . . 1.84 110.077 -179.473 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 234' ' ' GLU . 47.7 p-10 -59.97 -37.9 80.94 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.312 -0.867 . . . . 2.74 110.679 -178.991 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . 0.544 ' N ' ' OD1' ' A' ' 233' ' ' ASN . 99.0 mt-10 -59.82 -37.03 78.04 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 120.791 -1.193 . . . . 2.89 107.859 -179.998 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 93.9 t -70.04 -39.9 77.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.546 -0.721 . . . . 1.3 109.45 179.095 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 98.1 mt -64.77 -39.92 87.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.109 -0.994 . . . . 1.09 108.966 179.533 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -59.99 -40.12 88.05 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.159 -0.963 . . . . 2.43 108.67 -179.882 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -67.4 -40.21 85.61 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.481 -0.933 . . . . 2.78 108.481 179.22 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 89.5 mtp -70.01 -32.58 70.81 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.356 -0.84 . . . . 1.25 109.796 178.908 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -67.07 -39.92 86.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.188 -0.945 . . . . 2.63 109.209 179.095 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.88 -40.03 87.28 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.391 -0.966 . . . . 1.8 108.391 179.732 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.3 t -64.32 -39.17 84.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.549 -0.72 . . . . 2.13 109.146 179.12 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -57.83 -40.05 79.12 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.056 . . . . 3.17 109.306 -179.976 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -60.31 -40.02 89.06 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.296 -0.877 . . . . 1.78 109.789 -179.782 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 98.9 mt-30 -67.07 -40.05 86.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.99 -1.069 . . . . 2.47 108.607 179.516 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 65.7 t -66.73 -40.24 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 108.803 -0.814 . . . . 2.09 108.803 179.743 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 251' ' ' ALA . . . -63.77 -34.97 79.1 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.294 -0.879 . . . . 2.54 109.395 179.993 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 252' ' ' GLU . 35.8 t -61.24 -49.04 78.7 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.275 -0.891 . . . . 2.99 110.254 -179.395 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -70.19 -28.96 65.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.102 -0.999 . . . . 3.34 110.048 -179.275 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -95.61 28.5 2.97 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.449 -0.945 . . . . 3.88 108.449 179.567 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 247' ' ' ALA . . . -167.09 -49.57 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.083 -1.011 . . . . 4.43 111.032 179.943 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.475 ' N ' ' O ' ' A' ' 248' ' ' SER . 95.5 mt-10 -140.56 105.75 5.02 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.122 -0.986 . . . . 5.42 108.918 -179.696 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' A' ' 254' ' ' ALA . 86.5 mt -62.41 -17.72 59.92 Favored 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 106.992 -1.484 . . . . 6.1 106.992 178.251 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 253' ' ' LEU . . . 64.53 26.12 13.31 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.677 -0.692 . . . . 7.37 109.759 -179.771 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 96.7 mttt 57.5 20.7 6.33 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.693 -0.629 . . . . 8.01 109.842 179.473 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 8.1 tp 52.55 42.49 31.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 9.05 109.306 179.838 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.547 ' O ' ' N ' ' A' ' 259' ' ' ARG . 58.9 tttp -52.72 -60.16 3.6 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.269 -0.973 . . . . 10.56 108.657 -179.746 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.545 ' C ' ' O ' ' A' ' 257' ' ' LYS . 94.8 m-20 -7.71 75.41 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.65 0 CA-C-O 121.606 0.717 . . . . 11.32 111.768 179.36 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.547 ' N ' ' O ' ' A' ' 257' ' ' LYS . 86.6 mtm180 . . . . . 0 C--N 1.3 -1.56 0 CA-C-O 117.97 -1.014 . . . . 12.42 109.534 -179.868 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . 0.405 ' HG2' ' N ' ' B' ' 302' ' ' PHE . 57.1 ttm . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . 0.405 ' N ' ' HG2' ' B' ' 301' ' ' MET . 41.4 t80 -149.05 147.71 28.85 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.225 -0.922 . . . . 0.0 108.962 179.501 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -150.86 160.06 44.14 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.98 -1.075 . . . . 0.0 111.124 -178.366 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -154.66 152.48 30.02 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.566 -0.708 . . . . 0.0 109.199 178.861 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . 0.428 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 58.1 mp0 -113.89 131.01 56.44 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.311 -0.868 . . . . 0.0 110.266 179.842 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.0 p -131.95 126.78 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.578 0 CA-C-O 122.522 1.153 . . . . 0.0 112.995 -177.899 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 32.2 m -79.27 102.43 8.58 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-O 122.023 0.916 . . . . 0.0 110.772 -178.724 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.5 mt -51.37 125.0 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 122.552 1.168 . . . . 0.0 110.853 -177.878 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 33.2 p -109.73 20.09 18.45 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.602 -179.249 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.434 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -67.47 149.11 98.52 Favored Pre-proline 0 C--N 1.304 -1.402 0 O-C-N 121.11 -0.994 . . . . 0.0 108.582 179.366 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . 0.449 ' CD ' ' O ' ' B' ' 385' ' ' GLU . 28.9 Cg_endo -72.28 -30.38 12.99 Favored 'Trans proline' 0 N--CA 1.499 1.813 0 C-N-CA 121.112 1.208 . . . . 0.0 113.138 -179.622 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -120.26 23.16 11.07 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.778 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.59 -177.58 52.74 Favored Glycine 0 N--CA 1.482 1.755 0 N-CA-C 108.266 -1.933 . . . . 0.0 108.266 -179.028 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.454 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -84.38 93.32 8.24 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 120.96 -1.317 . . . . 0.0 109.484 -179.013 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -98.01 -159.52 0.74 Allowed 'General case' 0 N--CA 1.503 2.212 0 O-C-N 121.044 -1.035 . . . . 0.0 109.536 178.971 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.5 m -60.06 -49.97 75.56 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.559 -1.338 . . . . 0.0 112.16 -176.459 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.566 HH11 ' CB ' ' A' ' 71' ' ' ALA . 11.9 tpt180 -47.35 -60.31 4.24 Favored Pre-proline 0 N--CA 1.499 1.985 0 O-C-N 120.653 -1.279 . . . . 0.0 111.133 -179.104 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -61.56 -31.35 87.2 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 CA-C-N 120.559 1.235 . . . . 0.0 111.02 179.022 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.02 -53.79 53.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.399 -0.813 . . . . 0.0 109.485 -179.737 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -51.86 -42.67 62.8 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.074 -178.951 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -69.79 -39.94 76.29 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.024 -1.047 . . . . 0.0 108.784 179.243 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -65.71 -55.75 15.71 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.369 -0.832 . . . . 0.0 109.936 -179.485 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . 0.458 ' CG1' ' NZ ' ' B' ' 327' ' ' LYS . 41.3 t -64.13 -30.95 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 120.585 -1.322 . . . . 0.0 110.278 -178.704 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 30.4 ttmt -60.44 -46.29 90.57 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.994 -1.066 . . . . 0.0 109.763 179.9 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -61.89 -44.35 96.97 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.326 -0.859 . . . . 0.0 111.072 -178.569 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -66.03 -52.17 51.64 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.988 -1.07 . . . . 0.0 111.691 -178.412 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . 0.458 ' NZ ' ' CG1' ' B' ' 323' ' ' VAL . 32.2 mttp -49.29 -18.07 0.32 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.007 -1.058 . . . . 0.0 110.744 -178.789 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -80.13 -16.57 76.31 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 178.882 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -104.02 136.72 43.14 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.693 -0.886 . . . . 0.0 109.532 179.825 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 76.8 p -91.49 -13.42 32.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.398 -0.814 . . . . 0.0 109.939 179.727 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.589 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 69.3 m -60.94 150.25 33.89 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.268 -0.895 . . . . 0.0 109.848 -179.982 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -69.33 136.21 51.48 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.096 -1.042 . . . . 0.0 108.682 179.389 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 80.7 mt -133.63 132.43 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.315 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 81.5 m -130.34 151.15 51.15 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.296 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 67.3 t -115.73 142.07 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 178.535 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 50.5 m -130.84 122.86 27.84 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.264 -0.897 . . . . 0.0 109.662 179.37 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . 0.4 ' O ' ' OD1' ' B' ' 338' ' ' ASN . 2.6 t -137.16 118.63 14.78 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.031 0.919 . . . . 0.0 109.698 179.536 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' B' ' 338' ' ' ASN . 8.2 p-10 38.0 62.97 0.87 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 179.079 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 77.25 -14.18 8.91 Favored Glycine 0 N--CA 1.503 3.143 0 O-C-N 120.83 -1.169 . . . . 0.0 113.521 175.873 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -110.29 121.72 45.96 Favored 'General case' 0 N--CA 1.507 2.376 0 CA-C-N 119.056 1.428 . . . . 0.0 110.277 -179.733 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 83.3 p -109.06 157.65 18.5 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.774 0.797 . . . . 0.0 110.924 -179.082 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -152.54 151.93 31.27 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.821 -0.549 . . . . 0.0 109.925 179.58 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 16.1 m -87.64 136.21 33.04 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.303 -0.873 . . . . 0.0 109.61 -179.96 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -76.91 -14.67 59.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.951 -1.093 . . . . 0.0 110.095 -179.445 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 48.1 tttm -88.77 20.79 3.31 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 178.441 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . 0.412 ' H ' ' C ' ' B' ' 344' ' ' ALA . 74.0 m -147.36 91.4 1.97 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.727 179.797 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.665 HD23 HD22 ' A' ' 79' ' ' LEU . 57.8 tp -57.04 -35.28 69.12 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.584 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.874 ' CE2' HD11 ' A' ' 79' ' ' LEU . 70.8 m-85 -56.18 -53.95 51.03 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -0.922 . . . . 0.0 109.88 179.787 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -70.17 -21.31 63.07 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.577 -0.702 . . . . 0.0 111.045 -177.64 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.487 ' O ' ' N ' ' B' ' 352' ' ' THR . 77.9 mt -67.48 -50.82 57.31 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 118.314 -1.354 . . . . 0.0 108.648 178.526 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.464 ' O ' HD22 ' A' ' 123' ' ' LEU . 17.5 mt-30 -46.07 -12.83 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.424 -0.798 . . . . 0.0 111.47 -177.741 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.487 ' N ' ' O ' ' B' ' 350' ' ' LEU . 67.3 p -85.73 -16.51 38.71 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 119.912 -1.743 . . . . 0.0 111.466 -178.509 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 29.4 mt -92.05 122.23 34.36 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.737 -1.227 . . . . 0.0 108.834 178.707 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -75.99 92.52 0.93 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 108.437 -1.865 . . . . 0.0 108.437 179.423 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 16.7 mt -101.26 93.72 5.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.417 -1.049 . . . . 0.0 108.755 179.949 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 71.0 p -92.79 177.05 6.21 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.939 -1.101 . . . . 0.0 111.316 -178.844 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . 0.409 ' CD ' ' O ' ' B' ' 310' ' ' ALA . 40.0 tt0 -65.49 113.23 4.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.81 -0.556 . . . . 0.0 110.787 -179.703 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 99.18 9.63 50.9 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.419 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 24.0 m -85.88 113.1 21.75 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.335 -1.097 . . . . 0.0 110.313 -179.79 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 11.0 t -78.07 114.45 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 122.307 1.051 . . . . 0.0 109.961 -177.073 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 14.0 m -110.49 177.16 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 CA-C-N 115.475 -0.784 . . . . 0.0 108.91 -177.856 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 40.8 m -130.98 126.89 37.21 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 177.232 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 83.7 mt -103.63 118.03 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 178.487 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 49.0 m -122.93 133.65 54.38 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 121.552 -0.717 . . . . 0.0 109.249 -178.88 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.49 151.61 38.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.095 -1.003 . . . . 0.0 110.496 -178.738 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -140.64 120.72 13.73 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.414 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.412 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 164.08 -164.55 36.62 Favored Glycine 0 N--CA 1.486 2.031 0 C-N-CA 118.57 -1.776 . . . . 0.0 111.778 179.455 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 79.8 tt0 -56.53 -50.03 73.02 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 114.939 -0.631 . . . . 0.0 111.743 -177.889 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.589 ' N ' ' OG ' ' B' ' 331' ' ' SER . 99.6 m-20 -109.87 11.8 24.11 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.033 -1.042 . . . . 0.0 111.574 -177.857 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.412 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 11.8 pt-20 -42.23 -31.96 0.44 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.946 -1.096 . . . . 0.0 111.212 -178.877 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -70.06 -43.04 72.02 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.816 -1.178 . . . . 0.0 110.347 -178.81 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -67.7 -47.97 67.89 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.78 -1.2 . . . . 0.0 108.666 -179.905 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -47.44 -77.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.175 -0.953 . . . . 0.0 110.113 -179.914 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.582 ' O ' HG23 ' B' ' 378' ' ' VAL . 51.2 t -45.18 -38.79 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.213 -0.93 . . . . 0.0 109.751 -178.19 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 55.0 mm-40 -67.63 -42.44 82.32 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.65 -1.281 . . . . 0.0 110.099 179.221 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -82.18 -45.41 15.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.121 -0.987 . . . . 0.0 110.481 -179.83 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 97.8 mt -59.91 -36.51 77.15 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.11 -0.994 . . . . 0.0 109.303 -179.054 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.582 HG23 ' O ' ' B' ' 374' ' ' VAL . 53.5 t -69.95 -39.58 77.67 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 O-C-N 121.524 -0.735 . . . . 0.0 109.907 -179.989 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -79.18 -22.47 44.93 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.009 -1.057 . . . . 0.0 110.859 179.945 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 55.9 tp -82.25 -20.8 36.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.204 -1.56 . . . . 0.0 108.697 178.561 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.0 ttm -81.1 -30.75 34.56 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.161 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -84.34 -9.63 58.29 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.637 -0.665 . . . . 0.0 109.521 178.59 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -106.32 -2.01 22.76 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.316 -0.865 . . . . 0.0 110.919 -179.188 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 22.1 mt -91.53 124.9 36.05 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.949 -1.095 . . . . 0.0 110.636 -179.338 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . 0.449 ' O ' ' CD ' ' B' ' 311' ' ' PRO . 19.1 pt-20 . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 118.017 -0.992 . . . . 0.0 108.755 178.675 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.519 -0.549 . . . . 2.91 109.519 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.613 ' CD1' HE22 ' A' ' 211' ' ' GLN . 85.9 mt -110.04 127.65 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.479 -0.934 . . . . 1.2 108.479 179.553 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.3 m -128.57 126.43 40.3 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.551 -0.718 . . . . 1.4 109.512 -179.343 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.79 -161.97 34.65 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.311 -1.516 . . . . 1.05 109.311 179.6 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.441 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.5 mt -88.75 -14.42 9.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.168 -1.195 . . . . 1.15 110.316 -179.367 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.6 tp 52.67 100.69 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.07 -1.019 . . . . 0.98 109.07 -179.794 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.09 -28.33 12.76 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.113 -0.992 . . . . 0.88 109.267 179.388 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.9 m -132.08 115.31 15.27 Favored Pre-proline 0 N--CA 1.498 1.939 0 N-CA-C 109.111 -0.7 . . . . 1.69 109.111 -179.659 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -80.38 147.98 18.35 Favored 'Trans proline' 0 N--CA 1.494 1.512 0 C-N-CA 122.018 1.812 . . . . 0.85 112.964 -179.685 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.862 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 154.33 -156.04 26.59 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 108.606 -1.797 . . . . 0.92 108.606 -179.51 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 94.4 mt -149.0 151.06 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 120.904 -1.351 . . . . 0.81 108.866 178.68 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -154.58 156.62 36.9 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.048 -1.033 . . . . 0.51 110.241 179.397 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.572 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.2 m-85 -137.87 127.37 24.94 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.762 -1.199 . . . . 0.62 107.762 179.1 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -179.98 178.86 48.74 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 118.591 -1.766 . . . . 0.55 110.913 179.947 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -78.39 156.42 29.48 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.979 -0.719 . . . . 2.1 109.898 -179.525 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.54 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -100.32 129.98 46.37 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.43 -0.794 . . . . 0.77 110.844 -179.11 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.2 tp -105.98 134.59 48.86 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.469 -1.308 . . . . 0.91 107.469 178.286 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 59.9 tp -115.77 123.81 49.18 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.381 -0.824 . . . . 0.93 110.091 -179.419 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' A' ' 160' ' ' ALA . 25.5 mt -81.96 100.57 9.75 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 120.035 -0.666 . . . . 0.93 109.421 179.92 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -94.55 138.26 32.66 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.259 -0.901 . . . . 2.75 109.706 -179.667 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 21' ' ' GLU . 58.0 mp0 -130.37 136.79 49.45 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.478 -0.764 . . . . 3.0 109.136 179.206 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -84.31 147.32 27.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.143 -0.973 . . . . 2.77 109.494 179.664 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.89 145.51 55.39 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.259 -0.9 . . . . 2.94 109.671 -179.811 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 96.2 mt -98.41 132.73 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.396 -0.815 . . . . 0.95 109.372 179.888 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.6 t -106.81 128.25 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 121.427 -0.796 . . . . 1.28 109.84 -179.475 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 95.1 mt -98.36 142.42 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.494 -0.754 . . . . 1.21 109.134 179.976 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -83.6 123.77 30.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.985 -1.072 . . . . 1.81 109.056 179.834 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -93.47 -6.91 45.84 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.249 -0.907 . . . . 2.8 109.479 -179.64 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.71 138.55 52.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.193 -0.942 . . . . 2.87 109.594 -179.727 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -83.75 155.31 23.13 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.202 -1.036 . . . . 2.35 108.202 179.136 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.689 HD13 ' HG3' ' A' ' 39' ' ' GLU . 3.1 pt -99.04 165.66 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.071 -1.018 . . . . 0.97 109.936 -179.947 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 85.4 p -91.76 173.55 7.81 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.603 -0.888 . . . . 1.17 108.603 178.712 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.62 -15.47 63.54 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.134 -0.979 . . . . 1.18 110.696 -179.479 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.402 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 60.0 t0 -83.69 -30.67 26.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.822 -1.173 . . . . 2.56 108.842 179.47 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -82.65 -6.84 59.59 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.42 -0.585 . . . . 1.79 109.42 179.992 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.6 t -60.01 -51.81 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.182 -0.949 . . . . 1.0 109.254 179.949 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -60.14 -39.84 87.73 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.231 -0.918 . . . . 1.77 108.78 179.832 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -63.68 -40.23 96.3 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.308 -0.87 . . . . 2.7 110.133 -179.723 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.689 ' HG3' HD13 ' A' ' 31' ' ' ILE . 71.0 mm-40 -64.39 -41.55 96.6 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.847 -1.158 . . . . 1.51 110.28 -179.778 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.8 t -59.99 -45.7 95.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 120.671 -1.268 . . . . 0.93 108.085 179.996 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -59.89 -42.43 93.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.368 -0.833 . . . . 1.81 108.934 -179.78 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.433 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 96.6 mtt180 -60.04 -47.56 85.35 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 107.846 -1.168 . . . . 2.78 107.846 178.49 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -60.02 -45.22 93.51 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.202 -0.666 . . . . 0.78 109.202 178.897 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.8 tp -59.92 -50.07 75.19 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.311 -0.996 . . . . 1.07 108.311 179.661 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.4 t -60.45 -42.71 96.7 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.277 -0.889 . . . . 1.12 108.997 179.081 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.18 -47.71 89.6 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.549 -1.421 . . . . 0.84 109.549 179.99 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -69.73 -31.66 69.78 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.284 -1.127 . . . . 3.09 108.402 179.337 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.65 89.71 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.566 -0.709 . . . . 0.88 109.12 -179.988 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.433 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.4 ttpt -67.25 -73.77 0.13 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.196 -0.94 . . . . 2.59 108.787 179.333 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.29 -41.81 0.65 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.325 -0.86 . . . . 0.7 111.265 -178.356 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.8 m -52.2 -57.87 8.33 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.587 -1.321 . . . . 1.4 109.106 179.873 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.64 -40.97 84.57 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.218 -0.926 . . . . 0.67 110.836 -179.267 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -68.14 -40.33 82.47 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.982 -1.074 . . . . 1.66 109.763 -179.693 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 43.6 mt -61.66 -40.19 94.04 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.892 -1.13 . . . . 1.58 109.092 179.108 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -64.37 -35.54 81.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 1.35 109.152 179.487 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -62.04 -41.85 98.56 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.27 -0.894 . . . . 0.77 109.161 179.536 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.533 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.5 mt -64.17 -39.84 86.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.432 -0.792 . . . . 0.63 109.43 179.622 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.0 ttpt -54.35 -51.17 65.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.317 -0.864 . . . . 1.14 109.826 -178.96 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.3 m -59.94 -37.27 79.04 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.238 -0.914 . . . . 0.79 110.837 -178.317 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.8 mtpt -64.14 -39.77 94.73 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.892 -1.13 . . . . 1.53 109.479 -179.559 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.426 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -66.52 -42.99 86.46 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.762 -0.586 . . . . 0.57 110.125 -179.392 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.38 -51.08 60.98 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.161 -1.176 . . . . 0.75 110.161 -179.174 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.0 -44.81 68.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.114 -1.227 . . . . 1.59 110.043 -179.855 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 93.0 m -69.91 -59.13 3.12 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 0.73 111.768 -178.248 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -97.3 -54.4 3.16 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.021 -1.049 . . . . 0.75 111.357 -178.056 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.83 -163.41 26.95 Favored Glycine 0 N--CA 1.501 3.006 0 C-N-CA 119.697 -1.239 . . . . 1.22 111.156 179.676 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.25 -23.96 62.99 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.912 -0.758 . . . . 5.81 110.841 -179.385 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -62.03 -39.6 92.84 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.959 -1.088 . . . . 3.37 110.361 -179.545 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.3 mmmm -96.29 -18.85 19.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.228 -0.92 . . . . 1.77 110.434 -179.258 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.1 tt0 -72.14 -40.77 67.81 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.043 -1.036 . . . . 1.65 110.466 -179.118 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.601 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.63 -30.89 70.58 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.219 -0.926 . . . . 0.77 109.984 -178.953 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 80.7 mt -60.1 -40.27 82.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 118.82 -1.152 . . . . 0.8 108.822 -179.588 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -64.76 -40.07 94.68 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.047 -1.033 . . . . 0.88 109.885 -179.899 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -60.38 -40.89 92.49 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 120.89 -1.131 . . . . 1.37 109.863 179.519 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -62.9 -40.81 99.73 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.881 -1.688 . . . . 0.62 108.881 179.535 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 64.7 m170 -70.01 -40.06 75.47 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.396 -1.061 . . . . 1.5 109.208 179.767 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 87.9 mt -70.9 -46.47 67.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.383 -0.823 . . . . 0.63 109.986 179.828 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 39.7 ttp -60.35 -43.65 96.28 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 1.51 110.563 -178.452 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.687 HD11 ' CE2' ' B' ' 348' ' ' PHE . 44.8 tp -64.77 -39.44 93.61 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.293 -0.879 . . . . 0.77 109.938 -179.947 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.7 tp -63.81 -40.1 95.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.437 -0.79 . . . . 0.62 109.789 -179.72 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -78.87 4.07 15.13 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.169 -0.957 . . . . 1.47 110.099 -178.795 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 63.5 t0 -52.32 129.87 29.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.167 -0.958 . . . . 1.47 110.38 -179.37 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.423 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.8 mt-10 -60.16 -15.19 21.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.566 -0.709 . . . . 1.78 110.124 -179.982 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -70.02 -37.03 75.51 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.156 -0.965 . . . . 2.53 108.517 178.578 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 84.1 mt -69.98 -40.09 75.56 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.37 0.605 . . . . 0.8 109.876 179.426 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -60.07 -50.05 75.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.46 -0.775 . . . . 1.42 110.265 -178.975 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -74.36 -40.62 62.02 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.393 -0.817 . . . . 1.71 111.224 -178.801 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.92 -41.03 75.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.013 -1.054 . . . . 1.57 111.487 -178.675 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.9 mt -70.15 -46.12 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.857 -1.152 . . . . 0.65 109.445 -179.949 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 90.8 mt -65.72 -37.45 79.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 121.625 -0.672 . . . . 0.82 110.121 -179.841 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.07 90.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.048 -1.033 . . . . 0.79 110.507 -178.829 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 71.3 mt -62.21 -45.49 93.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.947 -1.095 . . . . 0.95 109.579 -179.781 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 82.1 mt -62.05 -50.0 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.66 109.596 -179.907 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -71.21 -42.18 69.26 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.681 -0.808 . . . . 2.2 111.385 179.826 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -83.25 -50.42 8.42 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.952 -1.092 . . . . 1.65 112.197 -177.648 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -90.19 -2.61 58.07 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.871 -1.143 . . . . 2.03 111.474 -177.497 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 56.19 39.02 30.39 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.797 -1.189 . . . . 1.42 109.521 -179.413 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 54.7 mtt -92.04 169.33 10.73 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.44 -0.788 . . . . 1.18 109.652 -179.723 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 23.9 p -83.82 159.65 21.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.942 . . . . 0.98 108.956 179.514 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.76 -36.8 78.81 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.127 -0.983 . . . . 0.64 109.801 -179.635 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.433 ' OD1' HG21 ' A' ' 141' ' ' ILE . 95.7 m-20 -68.66 -39.68 80.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.148 -0.97 . . . . 2.07 110.203 179.983 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.59 -44.89 18.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.026 -1.046 . . . . 0.73 109.61 179.855 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.75 -50.25 67.61 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.449 -0.782 . . . . 0.54 110.211 -179.487 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.23 -37.3 79.92 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.074 -1.017 . . . . 0.56 109.445 179.917 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -59.91 -42.65 94.35 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.476 -0.765 . . . . 1.54 110.266 -179.013 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.505 ' O ' ' N ' ' A' ' 110' ' ' GLY . 88.9 tt0 -64.9 -40.2 94.7 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.007 -1.058 . . . . 1.33 109.983 -179.634 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 70.1 t -61.74 -53.22 51.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.21 -0.931 . . . . 0.72 110.53 -178.509 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 43.1 mm -69.99 -39.98 78.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.136 -0.978 . . . . 0.85 109.197 179.857 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -68.95 -36.75 78.28 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.486 -0.931 . . . . 2.44 108.486 179.015 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -58.45 -49.82 72.87 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 110.061 -1.215 . . . . 0.98 110.061 -179.573 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -68.73 -48.53 63.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.749 -1.442 . . . . 1.41 109.41 -179.874 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.96 -41.87 92.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -0.927 . . . . 1.2 109.382 179.902 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 47.5 t -57.43 -39.34 76.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.247 -0.908 . . . . 1.7 109.025 -179.797 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.6 -40.04 94.8 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.313 -0.867 . . . . 1.47 109.393 179.437 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.3 mt -64.26 -42.47 96.45 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.153 -0.967 . . . . 1.56 109.827 -179.06 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.424 ' C ' ' N ' ' A' ' 118' ' ' LEU . 78.6 tt0 -59.87 -38.66 82.79 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.661 -1.274 . . . . 2.2 109.522 -178.659 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -50.08 -17.69 0.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.902 -1.124 . . . . 2.12 109.147 179.671 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.424 ' N ' ' C ' ' A' ' 116' ' ' GLU . 79.4 mt -63.36 146.77 52.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.206 -0.934 . . . . 2.0 108.542 179.585 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -95.83 10.81 35.86 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.086 -1.009 . . . . 3.23 111.439 -178.459 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 57.2 t0 -103.07 148.76 25.32 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 120.953 -1.092 . . . . 2.49 109.583 179.987 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.53 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 36.4 tt0 -72.04 -65.75 0.73 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.417 -0.957 . . . . 3.95 108.417 179.096 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.481 ' OH ' ' CZ ' ' A' ' 126' ' ' ARG . 11.2 t80 -39.19 -40.26 0.71 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.783 -0.573 . . . . 2.0 110.442 -179.127 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.537 HD22 ' O ' ' B' ' 351' ' ' GLN . 95.1 mt -70.31 -39.57 74.74 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.86 -1.15 . . . . 1.86 108.95 178.897 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 121' ' ' GLU . 64.4 tttp -60.03 -40.0 87.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.389 -0.819 . . . . 2.84 109.586 -179.882 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -60.02 -39.43 85.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.859 . . . . 2.73 108.828 179.953 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.643 ' NE ' HE22 ' B' ' 351' ' ' GLN . 8.3 mtt180 -59.86 -39.79 86.43 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.17 -0.956 . . . . 2.77 108.793 179.314 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.38 -25.57 64.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 1.19 108.82 179.313 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -70.02 -40.03 75.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.278 -0.889 . . . . 1.2 109.39 179.378 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -66.74 -43.08 85.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.985 . . . . 1.55 109.838 179.925 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 53.5 t -69.9 -40.46 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.977 -1.077 . . . . 0.8 108.616 179.464 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -65.45 -35.67 81.61 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.501 -0.75 . . . . 3.09 109.443 179.51 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -59.97 -40.1 87.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.218 -0.926 . . . . 1.46 109.653 -179.747 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.36 -43.01 92.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.024 . . . . 0.71 109.187 179.805 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -61.8 -40.01 98.24 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.735 -1.346 . . . . 0.57 109.735 179.73 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -60.14 -49.96 75.58 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.397 -1.061 . . . . 2.59 109.705 -179.122 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.533 HH22 ' CD1' ' A' ' 57' ' ' ILE . 58.6 mtp180 -67.03 -32.61 73.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.125 -0.984 . . . . 2.83 110.255 -179.147 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 64.8 tp -60.04 -41.22 91.81 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.064 -1.023 . . . . 1.25 108.445 -179.539 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 94.5 mt -60.5 -39.99 89.75 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.367 -0.833 . . . . 0.7 109.265 179.323 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -69.16 -39.93 78.47 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.267 -0.895 . . . . 2.57 109.036 179.712 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 -62.2 -39.97 94.52 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.606 -0.684 . . . . 1.23 111.343 -179.024 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.433 HG21 ' OD1' ' A' ' 101' ' ' ASP . 96.5 mt -73.74 -45.44 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 120.429 -1.419 . . . . 0.81 109.399 179.891 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 84.6 mt -69.97 -31.53 69.28 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.65 -0.656 . . . . 1.0 110.084 -179.273 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.38 36.58 10.61 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.45 -1.46 . . . . 0.89 109.45 -179.565 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 45.9 tp -72.85 141.07 47.96 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.21 -1.171 . . . . 1.14 108.779 179.987 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -60.68 140.05 57.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.31 -0.869 . . . . 4.6 109.477 -179.433 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 85.6 mt -108.07 128.88 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 108.835 -0.802 . . . . 1.24 108.835 179.668 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 27.4 mm -58.04 -50.02 79.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.724 -0.61 . . . . 1.54 110.801 -177.432 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 33.9 t0 65.89 102.72 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.883 -0.784 . . . . 1.5 108.883 -178.857 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.531 ' O ' HD12 ' A' ' 152' ' ' ILE . 59.5 mt -73.07 -3.72 28.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.483 -0.761 . . . . 0.79 110.034 -179.207 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.9 t -83.11 -13.7 55.14 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.012 -1.055 . . . . 1.4 109.066 179.22 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -80.72 24.61 0.47 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.564 -0.71 . . . . 0.92 109.947 -178.695 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.531 HD12 ' O ' ' A' ' 149' ' ' LEU . 63.7 mt -91.42 122.07 42.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 121.328 -0.858 . . . . 0.88 108.74 -179.423 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -110.33 -9.22 14.64 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.461 -0.775 . . . . 2.45 110.455 -179.008 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -126.43 151.33 47.86 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.276 -0.89 . . . . 1.52 110.488 -178.583 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -66.01 133.55 51.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 1.58 108.621 179.224 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 19.9 m -153.24 165.93 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.438 -0.789 . . . . 0.69 109.542 179.64 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 97.0 mt -94.2 149.1 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 105.896 -1.89 . . . . 0.61 105.896 176.749 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 61.9 tp -98.39 117.19 32.26 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.939 -1.1 . . . . 0.87 110.893 -177.486 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 57.3 t -121.44 127.81 75.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 108.804 -0.813 . . . . 0.71 108.804 179.495 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.438 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -157.84 160.68 37.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.084 -1.01 . . . . 0.81 108.688 -179.979 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.04 -33.3 71.79 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.116 -1.615 . . . . 0.98 108.449 178.801 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -160.27 171.46 19.13 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.456 -0.777 . . . . 2.25 108.931 179.919 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 87.6 mt -141.69 133.92 27.87 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 120.875 -1.141 . . . . 0.78 109.168 179.74 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 66.7 p -100.46 149.67 36.29 Favored Pre-proline 0 N--CA 1.501 2.104 0 O-C-N 121.173 -0.955 . . . . 0.98 110.262 -179.65 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -43.04 -38.47 7.26 Favored 'Trans proline' 0 N--CA 1.497 1.682 0 C-N-CA 122.561 2.174 . . . . 0.81 113.466 179.203 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 53.1 m -59.84 -40.04 87.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.974 -1.079 . . . . 0.9 109.801 -178.084 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.92 -40.83 83.31 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.151 -0.968 . . . . 1.61 110.421 -179.746 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 76.2 p -58.03 -30.77 66.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.112 -0.993 . . . . 0.61 111.092 -178.218 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -72.15 -46.72 55.36 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.699 -1.25 . . . . 0.6 110.03 179.935 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -90.25 37.28 0.89 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.31 -0.996 . . . . 1.4 108.31 -179.88 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 59.5 tp -107.76 132.54 53.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.616 -0.678 . . . . 0.7 109.616 179.777 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -86.51 103.64 15.22 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.318 -0.864 . . . . 2.35 108.725 178.992 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 59.0 mt -64.09 -41.59 97.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 1.51 110.363 -179.294 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -66.03 -26.05 67.34 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.841 -1.162 . . . . 2.33 112.01 -177.591 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -92.41 -8.08 45.82 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.655 -1.278 . . . . 1.92 109.976 -178.656 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 178' ' ' GLY . 80.1 t -107.69 118.48 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.337 -0.852 . . . . 0.67 109.108 179.031 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 87.5 mt -85.41 4.06 37.16 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.345 -0.847 . . . . 1.53 111.114 -178.026 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.552 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 169.66 173.03 36.83 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.342 -1.408 . . . . 0.48 109.748 179.877 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -131.52 127.55 37.48 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.456 -1.026 . . . . 0.55 109.027 179.812 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 77.4 mt -129.04 123.22 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 108.616 -0.883 . . . . 0.65 108.616 179.059 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 63.7 p -145.49 158.32 43.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.139 -0.976 . . . . 0.82 111.109 -179.436 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.6 OUTLIER -103.68 25.89 9.22 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.779 -0.823 . . . . 2.46 108.779 179.724 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.13 -159.33 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.006 -1.059 . . . . 1.28 111.229 -178.195 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.33 -51.56 12.84 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 110.029 -1.229 . . . . 2.19 110.029 -179.613 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 155.74 -108.97 0.39 Allowed Glycine 0 N--CA 1.493 2.441 0 O-C-N 121.084 -1.245 . . . . 2.13 110.207 -179.988 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.462 ' CB ' HH11 ' A' ' 186' ' ' ARG . 0.0 OUTLIER -79.91 -10.12 59.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.289 -1.124 . . . . 5.86 110.393 -179.29 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 78.5 p -83.89 0.77 46.34 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.125 -0.984 . . . . 3.72 110.324 -178.708 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.6 t -90.76 118.86 30.52 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.003 -1.061 . . . . 1.74 109.655 179.73 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -42.23 -52.73 4.34 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.602 -0.686 . . . . 0.95 109.7 -179.826 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.2 m -54.15 -30.67 50.0 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.34 -0.85 . . . . 1.55 110.759 -179.388 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 16.3 t -60.03 -44.75 94.41 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.601 -1.312 . . . . 1.51 109.746 -179.502 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 43.0 mm -60.09 -39.69 81.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.611 -0.885 . . . . 1.67 108.611 179.749 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.3 mtp -60.05 -39.89 87.52 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.456 -0.777 . . . . 1.02 110.002 -179.586 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -60.04 -44.36 94.71 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.654 -1.279 . . . . 0.68 109.504 -179.665 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.445 HH22 ' HG2' ' A' ' 186' ' ' ARG . 95.1 mtt180 -62.39 -57.78 10.04 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.111 -0.993 . . . . 2.93 109.981 -179.313 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 66.8 m -60.91 -40.01 91.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.857 . . . . 0.86 111.993 -178.684 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 91.6 mt -79.94 -10.93 59.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.766 -1.208 . . . . 0.67 110.876 -177.846 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 59.14 49.96 8.64 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.136 -0.977 . . . . 1.5 110.28 179.881 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 66.7 mt -121.91 126.2 26.43 Favored Pre-proline 0 N--CA 1.501 2.106 0 N-CA-C 108.955 -0.757 . . . . 0.72 108.955 179.517 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -43.09 129.44 5.82 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 121.842 1.695 . . . . 0.61 112.077 179.497 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -165.26 145.47 6.99 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 118.452 -1.299 . . . . 0.66 112.102 -179.512 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 87.6 mt -124.3 144.72 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 N-CA-C 107.533 -1.284 . . . . 0.79 107.533 178.336 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 8.7 m -129.29 -6.69 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.298 0 O-C-N 120.695 -1.253 . . . . 0.91 111.031 -178.87 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -109.9 20.87 26.13 Favored Glycine 0 N--CA 1.5 2.958 0 N-CA-C 110.963 -0.855 . . . . 1.01 110.963 -179.406 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.44 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 2.9 p -46.61 -41.36 14.5 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.711 -1.464 . . . . 0.99 109.725 -179.483 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 90.61 -50.38 3.22 Favored Glycine 0 N--CA 1.498 2.823 0 C-N-CA 120.034 -1.079 . . . . 1.12 111.767 178.477 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 74.2 m -161.88 42.26 0.14 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.596 -1.532 . . . . 1.72 111.334 -179.177 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 23.5 t -78.89 -38.14 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.932 -1.105 . . . . 0.89 108.666 178.348 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.451 ' H ' HG23 ' A' ' 209' ' ' THR . 4.3 p -55.3 -35.62 65.29 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.459 -0.776 . . . . 1.03 110.611 -179.062 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 63.4 m -84.29 -9.8 58.17 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.963 -1.086 . . . . 1.83 110.142 -179.374 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.613 HE22 ' CD1' ' A' ' 2' ' ' ILE . 27.2 mt-30 -96.16 -16.5 21.45 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.065 -1.022 . . . . 2.27 110.485 -179.39 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 213' ' ' LYS . 18.2 t -123.66 162.92 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 121.403 -0.81 . . . . 0.92 109.714 -179.596 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.487 ' N ' HG12 ' A' ' 212' ' ' VAL . 0.5 OUTLIER -121.89 160.02 25.62 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.597 -0.89 . . . . 2.2 108.597 -179.615 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.458 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 39.8 p-10 -60.4 145.28 48.59 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.394 -0.816 . . . . 2.36 111.168 -179.02 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.458 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 0.0 OUTLIER 84.29 -1.44 1.0 Allowed 'General case' 0 N--CA 1.503 2.217 0 CA-C-O 121.519 0.676 . . . . 2.38 110.326 178.594 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.46 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 96.5 m-20 -72.54 155.09 40.43 Favored 'General case' 0 C--N 1.292 -1.904 0 C-N-CA 119.623 -0.831 . . . . 2.09 108.838 179.269 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -97.64 119.31 35.98 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.445 -0.946 . . . . 1.27 108.445 179.852 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.54 HD12 ' HB2' ' A' ' 16' ' ' ALA . 96.1 mt -122.83 142.24 50.97 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.439 -0.788 . . . . 0.75 110.504 -179.077 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.452 HD12 ' HG3' ' A' ' 231' ' ' PRO . 83.2 mt -114.82 128.37 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 N-CA-C 106.299 -1.741 . . . . 0.63 106.299 176.365 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 56.7 tp -97.89 116.58 30.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.932 -1.105 . . . . 0.7 108.505 -179.358 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.508 ' C ' ' H ' ' A' ' 223' ' ' VAL . 21.3 t0 -74.1 -44.66 53.07 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 107.466 -1.309 . . . . 2.31 107.466 179.553 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.862 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 51.82 8.49 0.06 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.834 -0.541 . . . . 0.78 109.654 179.073 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.508 ' H ' ' C ' ' A' ' 221' ' ' ASP . 95.2 t -126.75 -39.17 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 107.384 -1.339 . . . . 1.04 107.384 178.262 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -102.77 -0.41 31.55 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.878 -1.156 . . . . 2.44 107.878 178.637 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 61.94 45.77 7.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.817 -0.552 . . . . 1.55 109.839 -179.814 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -139.6 150.66 45.27 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.293 -0.879 . . . . 1.99 109.891 179.575 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 90.5 t -119.0 128.07 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.423 -0.955 . . . . 0.77 108.423 178.989 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -102.67 123.56 46.6 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.596 -0.89 . . . . 0.98 108.596 179.461 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 23.3 t -100.02 110.01 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.38 -0.825 . . . . 0.85 110.607 -178.865 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.429 ' ND2' ' O ' ' A' ' 230' ' ' ASN . 21.3 t30 50.94 60.65 14.45 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.44 -0.788 . . . . 1.66 111.516 179.047 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.452 ' HG3' HD12 ' A' ' 219' ' ' ILE . 90.7 Cg_endo -79.51 153.04 23.47 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.703 2.268 . . . . 0.95 111.277 178.386 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . 0.435 HG22 ' N ' ' A' ' 233' ' ' ASN . 25.8 m -64.7 159.92 21.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.156 -0.965 . . . . 1.84 110.135 -179.25 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . 0.435 ' N ' HG22 ' A' ' 232' ' ' THR . 98.6 m-20 -61.18 -40.08 92.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.39 -0.818 . . . . 2.74 110.342 -179.632 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -60.01 -36.07 76.42 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.081 -1.012 . . . . 2.89 109.265 179.794 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 61.8 t -69.97 -39.93 78.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.564 -0.902 . . . . 1.3 108.564 179.261 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . 0.483 ' CG2' ' NH1' ' A' ' 240' ' ' ARG . 91.8 mt -67.06 -40.07 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.444 -0.785 . . . . 1.09 110.001 179.931 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -59.91 -40.32 88.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.064 -1.022 . . . . 2.43 109.069 -179.598 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -67.33 -40.0 85.89 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.775 -0.824 . . . . 2.78 108.775 179.165 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 93.6 mtp -69.38 -34.83 75.13 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.462 -0.774 . . . . 1.25 108.928 178.823 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.517 HH11 ' HG2' ' A' ' 240' ' ' ARG . 0.1 OUTLIER -64.11 -35.47 80.87 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.308 -0.87 . . . . 2.63 108.975 178.889 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -58.43 -44.67 89.24 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.141 -0.974 . . . . 1.8 108.835 179.949 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.09 -40.77 84.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.144 -0.973 . . . . 2.13 108.415 179.051 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -60.29 -40.93 92.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.452 -0.78 . . . . 3.17 110.083 -179.83 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.82 -40.65 93.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.055 -1.028 . . . . 1.78 109.76 -179.667 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -60.73 -40.1 91.13 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.229 -0.919 . . . . 2.47 108.877 179.949 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 70.4 t -62.29 -40.63 88.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.596 -0.69 . . . . 2.09 109.585 -179.931 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.67 -40.22 96.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.27 -0.894 . . . . 2.54 109.885 -179.37 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 26.0 t -69.67 -39.86 76.77 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.298 -0.876 . . . . 2.99 109.808 -179.685 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -60.13 -43.38 95.73 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.249 -0.907 . . . . 3.34 110.211 -179.084 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -83.89 -7.85 59.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.022 -1.049 . . . . 3.88 110.565 -179.172 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -106.74 -15.67 14.69 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 120.769 -1.207 . . . . 4.43 109.694 179.895 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 254' ' ' ALA . 86.6 mt-10 -84.09 60.82 6.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.022 -1.049 . . . . 5.42 109.358 -179.978 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 89.8 mt -49.6 -13.37 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.467 -0.771 . . . . 6.1 109.127 179.67 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 252' ' ' GLU . . . -59.99 -36.23 76.73 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.525 -0.917 . . . . 7.37 108.525 179.402 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . 0.507 ' HG2' ' H ' ' A' ' 257' ' ' LYS . 61.3 tttp -134.89 131.46 37.36 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.384 -0.969 . . . . 8.01 108.384 179.595 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 256' ' ' LEU . 7.7 mp -86.83 -9.6 55.42 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.294 -0.879 . . . . 9.05 109.252 -179.459 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . 0.507 ' H ' ' HG2' ' A' ' 255' ' ' LYS . 60.3 tttm 53.17 72.22 0.44 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.589 -0.694 . . . . 10.56 109.159 -179.99 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.427 ' O ' ' O ' ' A' ' 259' ' ' ARG . 27.6 p-10 -141.83 56.16 1.49 Allowed 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.99 -0.745 . . . . 11.32 108.99 179.933 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' A' ' 258' ' ' ASP . 13.6 ptm180 . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.107 -0.949 . . . . 12.42 109.61 -179.907 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 34.4 t80 -155.19 153.65 31.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.267 -0.896 . . . . 0.0 109.499 179.485 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -145.56 155.48 43.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.214 -0.929 . . . . 0.0 109.55 -179.83 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . 0.539 HE22 ' C ' ' B' ' 305' ' ' GLU . 0.7 OUTLIER -154.49 150.02 27.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.515 -0.741 . . . . 0.0 109.015 -179.587 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . 0.539 ' C ' HE22 ' B' ' 304' ' ' GLN . 95.0 mt-10 -109.85 131.72 54.8 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.3 -0.875 . . . . 0.0 110.162 179.388 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . 0.409 ' O ' HG13 ' B' ' 306' ' ' VAL . 6.9 p -132.9 121.02 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.231 0 CA-C-O 122.121 0.962 . . . . 0.0 112.134 -178.136 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . 0.477 ' O ' HG23 ' B' ' 309' ' ' THR . 87.8 m -80.0 103.01 9.6 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.696 0.76 . . . . 0.0 110.384 -178.93 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' B' ' 358' ' ' GLY . 96.5 mt -51.51 117.52 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 CA-C-O 122.446 1.117 . . . . 0.0 109.971 -178.079 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . 0.477 HG23 ' O ' ' B' ' 307' ' ' THR . 62.2 p -104.69 19.01 21.19 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.414 -177.954 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.46 115.98 44.73 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.327 -0.858 . . . . 0.0 109.098 179.507 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -53.05 -15.47 4.98 Favored 'Trans proline' 0 N--CA 1.498 1.746 0 CA-C-N 120.306 1.145 . . . . 0.0 112.923 -179.704 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -115.27 4.98 14.59 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.506 -0.746 . . . . 0.0 109.036 -179.888 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 71.26 174.46 19.12 Favored Glycine 0 N--CA 1.481 1.692 0 N-CA-C 108.305 -1.918 . . . . 0.0 108.305 -179.042 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.442 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 4.0 tp -85.84 95.59 9.48 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.163 -1.198 . . . . 0.0 108.696 -179.066 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . . . . . . . . . 4.4 p80 -95.25 -162.55 0.96 Allowed 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.161 -0.962 . . . . 0.0 110.411 179.737 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 7.9 m -59.63 -39.96 86.06 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.056 -1.027 . . . . 0.0 112.581 -175.776 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.601 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 0.8 OUTLIER -60.15 -60.82 9.38 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 120.33 -1.481 . . . . 0.0 111.27 -179.257 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -59.4 -32.4 96.48 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 CA-C-N 120.14 1.086 . . . . 0.0 111.628 -179.9 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -57.57 -51.88 67.67 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.398 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -50.37 -40.02 48.28 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.819 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . 0.423 HE21 HD11 ' B' ' 380' ' ' LEU . 61.8 tt0 -69.99 -41.47 74.37 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.205 -0.934 . . . . 0.0 108.923 178.369 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -61.2 -52.78 63.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.371 -0.83 . . . . 0.0 110.946 -179.365 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 87.9 t -65.41 -27.67 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.639 -1.288 . . . . 0.0 109.761 -178.957 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -45.16 93.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.404 -0.81 . . . . 0.0 109.411 179.581 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -66.52 -44.89 81.28 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.418 -0.801 . . . . 0.0 111.2 -178.437 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . 0.42 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -61.55 -53.87 50.61 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.724 -1.235 . . . . 0.0 111.144 -178.646 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -52.66 -13.43 0.39 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.724 -1.235 . . . . 0.0 109.317 179.673 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -72.6 -28.73 66.85 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.69 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -106.03 146.78 29.67 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.443 -1.033 . . . . 0.0 109.942 -179.676 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 51.6 p -91.11 -11.79 37.52 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.925 . . . . 0.0 110.134 179.997 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.427 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 56.4 p -65.3 157.87 27.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.196 -0.94 . . . . 0.0 110.323 -179.165 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -72.62 131.55 42.59 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.377 -0.827 . . . . 0.0 108.922 179.375 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 80.2 mt -132.33 132.69 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.873 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . 0.417 HG22 ' N ' ' B' ' 335' ' ' VAL . 62.7 m -131.6 155.89 46.74 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.48 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . 0.417 ' N ' HG22 ' B' ' 334' ' ' THR . 61.9 t -119.1 140.49 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.318 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 26.7 m -128.9 123.89 33.78 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.128 -0.982 . . . . 0.0 108.561 179.95 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . 0.4 ' CB ' HG12 ' B' ' 361' ' ' VAL . 93.0 p -137.93 116.61 12.2 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 120.966 -1.084 . . . . 0.0 110.82 -179.387 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 22.9 m120 45.14 53.43 7.86 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 177.318 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.74 -11.59 66.08 Favored Glycine 0 N--CA 1.502 3.07 0 O-C-N 120.06 -1.65 . . . . 0.0 113.052 176.264 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 33.9 mtmm -120.92 132.35 54.9 Favored 'General case' 0 N--CA 1.506 2.37 0 CA-C-N 119.285 1.542 . . . . 0.0 109.512 -179.655 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 77.4 p -127.88 151.39 49.13 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-O 121.928 0.87 . . . . 0.0 110.886 -178.834 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.48 164.47 30.79 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-O 121.64 0.734 . . . . 0.0 110.423 -178.94 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 48.0 t -87.56 133.21 33.83 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.806 -0.559 . . . . 0.0 110.359 -179.353 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -70.13 -20.27 63.18 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.944 . . . . 0.0 108.911 179.289 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -84.61 17.36 2.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 179.494 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 3.0 m -146.45 95.43 2.6 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.773 0.797 . . . . 0.0 112.421 -179.368 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.659 HD23 HD22 ' A' ' 79' ' ' LEU . 42.7 tp -59.98 -39.05 84.36 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.415 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.687 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.0 m-85 -51.31 -51.15 56.9 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.979 -1.076 . . . . 0.0 110.459 -179.569 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 33.6 mtmm -71.66 -39.72 70.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.955 -1.09 . . . . 0.0 111.277 -178.2 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.493 ' O ' ' N ' ' B' ' 352' ' ' THR . 20.6 mt -47.81 -59.95 2.94 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.718 -1.239 . . . . 0.0 109.754 -179.153 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.643 HE22 ' NE ' ' A' ' 126' ' ' ARG . 7.6 mm100 -42.07 -20.47 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.399 -0.813 . . . . 0.0 111.192 -177.724 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.493 ' N ' ' O ' ' B' ' 350' ' ' LEU . 69.5 p -79.25 -12.76 59.95 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.081 -1.637 . . . . 0.0 109.53 -179.294 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 32.0 mt -94.09 122.7 36.88 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.114 -0.991 . . . . 0.0 108.993 178.383 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -72.03 96.89 0.71 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 179.718 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.5 mt -100.07 80.29 2.27 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.265 -1.138 . . . . 0.0 109.06 179.282 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 75.1 p -91.13 166.28 13.05 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.967 -1.083 . . . . 0.0 111.055 -178.83 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -59.92 111.58 1.53 Allowed 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.132 0.491 . . . . 0.0 110.642 -179.591 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 103.01 5.57 46.88 Favored Glycine 0 N--CA 1.498 2.783 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.762 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 52.4 m -80.14 109.78 14.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.051 -1.264 . . . . 0.0 110.855 -179.468 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . 0.439 HG22 ' OG1' ' B' ' 307' ' ' THR . 11.9 t -78.54 112.71 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.108 0.956 . . . . 0.0 109.943 -177.907 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . 0.4 HG12 ' CB ' ' B' ' 337' ' ' SER . 36.0 m -113.31 176.85 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 -178.735 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 57.4 m -126.64 130.02 49.63 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 176.648 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.5 mt -106.43 124.52 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 178.357 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 63.2 m -131.53 138.85 49.1 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.5 -0.75 . . . . 0.0 109.771 -178.979 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -146.41 155.24 42.44 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.217 -0.927 . . . . 0.0 109.763 -179.507 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -146.51 123.34 11.28 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.409 -0.807 . . . . 0.0 109.171 179.848 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.508 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.89 -153.47 24.73 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.248 -1.453 . . . . 0.0 111.548 179.868 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -59.97 -51.69 68.58 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.222 -0.575 . . . . 0.0 112.503 -177.292 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.427 ' H ' ' HB3' ' B' ' 331' ' ' SER . 62.5 m-20 -111.91 11.06 20.67 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 120.892 -1.13 . . . . 0.0 111.434 -177.267 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.508 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 11.1 pt-20 -39.14 -34.5 0.18 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.452 -0.78 . . . . 0.0 111.657 -179.16 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -69.99 -41.0 74.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.036 -1.04 . . . . 0.0 110.667 -178.148 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 52.9 mtmt -69.68 -49.89 49.16 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 118.958 -1.097 . . . . 0.0 109.223 -179.609 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -45.77 -79.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.29 -0.881 . . . . 0.0 110.417 -179.653 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.607 ' O ' HG23 ' B' ' 378' ' ' VAL . 15.1 t -45.24 -38.38 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 O-C-N 121.154 -0.966 . . . . 0.0 110.367 -177.696 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -69.86 -40.25 75.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.535 -1.353 . . . . 0.0 110.111 179.738 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -83.32 -45.54 13.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.974 -1.079 . . . . 0.0 109.707 179.499 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 86.0 mt -60.08 -35.51 75.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.212 -0.93 . . . . 0.0 109.673 -179.211 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.607 HG23 ' O ' ' B' ' 374' ' ' VAL . 54.4 t -68.88 -40.06 80.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.123 -0.986 . . . . 0.0 109.758 179.819 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -79.98 -10.0 59.73 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 120.705 -1.247 . . . . 0.0 108.611 178.251 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.423 HD11 HE21 ' B' ' 321' ' ' GLN . 44.1 tp -82.08 -26.81 33.33 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.997 -1.064 . . . . 0.0 108.697 178.377 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 38.7 mtt -83.36 -21.02 33.21 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 176.813 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -85.97 -11.3 53.38 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.583 -0.698 . . . . 0.0 109.451 178.789 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -109.98 -4.72 15.74 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.387 -0.821 . . . . 0.0 110.868 -178.998 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 31.1 mt -89.77 123.97 34.23 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.681 -1.262 . . . . 0.0 109.859 -179.79 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.406 -179.82 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.9 mmt . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.457 -0.572 . . . . 2.91 109.457 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 85.3 mt -107.31 121.38 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 108.644 -0.873 . . . . 1.2 108.644 179.745 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.4 m -133.62 120.09 20.25 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.424 -0.798 . . . . 1.4 109.178 179.981 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.64 -161.7 37.72 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.422 -1.471 . . . . 1.05 109.422 179.917 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.476 HG22 ' O ' ' A' ' 5' ' ' ILE . 96.7 mt -93.03 -10.13 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 121.038 -1.272 . . . . 1.15 110.005 -179.392 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 5' ' ' ILE . 55.2 tp 53.21 101.46 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -0.963 . . . . 0.98 109.548 -179.959 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -90.13 -26.24 20.3 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 0.88 109.631 179.928 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.1 t -144.6 130.18 9.58 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.213 -0.929 . . . . 1.69 109.433 179.923 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.94 143.43 16.31 Favored 'Trans proline' 0 N--CA 1.496 1.654 0 C-N-CA 122.175 1.916 . . . . 0.85 112.806 -179.926 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.663 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 163.74 -162.14 34.8 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.033 -1.627 . . . . 0.92 109.033 179.881 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.8 mt -149.52 149.8 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.922 -1.34 . . . . 0.81 108.466 178.841 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -156.5 158.4 37.15 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 120.749 -1.22 . . . . 0.51 110.794 179.83 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -139.97 129.19 23.82 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 107.897 -1.149 . . . . 0.62 107.897 178.817 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 174.93 -178.91 46.53 Favored Glycine 0 N--CA 1.495 2.594 0 C-N-CA 118.869 -1.634 . . . . 0.55 110.442 179.911 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -79.93 156.63 27.17 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.544 -0.974 . . . . 2.1 109.886 -179.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.506 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -105.4 127.5 53.01 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.478 0.656 . . . . 0.77 110.925 -179.434 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.8 tp -101.25 140.08 36.04 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 107.772 -1.195 . . . . 0.91 107.772 178.537 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.7 tp -118.35 125.59 50.34 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.374 -0.829 . . . . 0.93 109.951 -179.442 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 18.8 mt -84.04 104.41 14.09 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.531 0.682 . . . . 0.93 109.963 -179.795 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 57.5 mttm -99.29 128.58 45.43 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.455 -0.778 . . . . 2.75 109.354 -179.789 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -130.06 127.94 40.92 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.41 -0.806 . . . . 3.0 109.072 179.256 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -76.74 147.31 37.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.282 -0.886 . . . . 2.77 109.418 179.953 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.9 tt0 -63.61 141.55 58.72 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.23 -0.919 . . . . 2.94 108.995 -179.983 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 83.9 mt -76.97 131.88 33.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.229 -0.919 . . . . 0.95 109.162 -179.516 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.7 t -93.88 124.1 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.287 -0.883 . . . . 1.28 109.813 -179.621 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 88.6 mt -109.8 138.11 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.611 -0.681 . . . . 1.21 109.929 -179.462 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -97.45 116.93 30.58 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.13 -0.981 . . . . 1.81 109.441 179.834 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.53 HH11 ' HG2' ' A' ' 28' ' ' ARG . 2.3 mmt-85 -85.67 -0.95 56.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.393 -0.817 . . . . 2.8 109.62 -179.431 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -60.54 144.11 52.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.203 -0.935 . . . . 2.87 109.632 -179.712 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -87.71 147.88 25.01 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.192 -0.942 . . . . 2.35 109.046 -179.928 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 pt -94.66 164.82 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.997 -1.064 . . . . 0.97 109.823 179.924 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.418 ' OG ' ' OD1' ' A' ' 34' ' ' ASP . 53.9 p -90.23 175.64 7.05 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.477 -0.935 . . . . 1.17 108.477 178.576 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.06 -20.34 63.23 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.937 -1.102 . . . . 1.18 111.266 -178.95 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.418 ' OD1' ' OG ' ' A' ' 32' ' ' SER . 7.5 p-10 -85.97 -23.19 27.0 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.501 -1.375 . . . . 2.56 108.553 179.001 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -81.84 -9.41 59.62 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.592 -0.892 . . . . 1.79 108.592 178.818 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.2 t -62.09 -53.66 44.75 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 O-C-N 121.487 -0.758 . . . . 1.0 109.309 179.711 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -62.17 -40.06 94.76 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.339 -0.851 . . . . 1.77 109.349 179.691 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -61.91 -42.2 98.81 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.422 -0.799 . . . . 2.7 110.598 -178.766 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -66.15 -39.96 90.22 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.711 -1.243 . . . . 1.51 110.376 -179.036 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 53.7 t -60.14 -47.88 90.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.708 -1.245 . . . . 0.93 108.681 179.586 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -61.46 -44.21 97.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.001 -1.062 . . . . 1.81 109.652 179.846 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.463 HH11 ' HG2' ' A' ' 42' ' ' ARG . 25.8 mtt-85 -60.02 -41.13 91.53 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.937 -1.135 . . . . 2.78 107.937 179.139 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -62.31 -45.78 91.69 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.958 -1.127 . . . . 0.78 107.958 177.545 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.7 tp -60.02 -47.63 85.03 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.828 -0.804 . . . . 1.07 108.828 179.694 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 18.1 t -62.39 -42.95 99.82 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.394 -0.922 . . . . 1.12 109.009 179.355 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.44 -48.58 84.22 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.866 -1.694 . . . . 0.84 108.866 179.477 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 3.5 ttt-85 -62.27 -34.9 77.44 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.33 -1.1 . . . . 3.09 108.197 178.694 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -56.59 -43.81 80.46 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.613 -0.679 . . . . 0.88 109.285 -179.911 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.3 ttpt -65.78 -74.24 0.11 Allowed 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.17 -1.418 . . . . 2.59 107.17 179.301 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -38.25 -31.35 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.318 -0.864 . . . . 0.7 111.118 -179.238 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 49' ' ' LYS . 34.4 t -57.06 -56.07 26.46 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.547 -1.346 . . . . 1.4 108.473 179.801 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.45 -40.03 81.26 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.433 -0.792 . . . . 0.67 111.204 -179.182 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.6 mt-30 -67.14 -40.03 86.68 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.699 -1.251 . . . . 1.66 110.42 -179.1 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.43 -39.95 94.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.886 -1.134 . . . . 1.58 109.504 179.815 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -62.24 -33.99 75.65 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.174 -0.954 . . . . 1.35 109.448 -179.976 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.1 m -62.62 -41.39 98.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.955 . . . . 0.77 109.832 -179.986 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 97.0 mt -61.36 -39.95 84.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.193 -0.942 . . . . 0.63 109.55 -180.0 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -56.69 -50.6 71.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.221 -0.924 . . . . 1.14 109.921 -178.962 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -59.41 -36.63 76.21 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.371 -0.83 . . . . 0.79 110.968 -177.472 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -64.29 -38.26 90.42 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.895 -1.128 . . . . 1.53 109.573 179.891 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.31 -43.43 97.83 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.467 -0.771 . . . . 0.57 109.732 -179.926 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.15 -50.85 63.38 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.498 -1.441 . . . . 0.75 109.498 -179.335 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -68.26 -50.1 56.09 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.139 -1.212 . . . . 1.59 109.5 179.628 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.1 m -63.03 -64.76 0.82 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.417 -0.802 . . . . 0.73 112.32 -177.893 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -97.65 -48.3 5.29 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.868 -1.145 . . . . 0.75 111.825 -178.079 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.91 -169.77 25.15 Favored Glycine 0 N--CA 1.5 2.943 0 O-C-N 120.662 -1.274 . . . . 1.22 110.943 179.889 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -70.03 -26.87 64.25 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.897 -0.767 . . . . 5.81 110.287 -179.705 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.7 tp10 -61.04 -33.15 72.83 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.447 -0.783 . . . . 3.37 110.087 -179.67 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 39.5 mmtm -100.33 -22.59 15.03 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.341 -0.849 . . . . 1.77 109.891 179.995 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.5 tt0 -64.95 -40.76 95.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.132 -0.98 . . . . 1.65 110.02 -179.311 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.599 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -67.1 -25.82 66.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.401 -0.812 . . . . 0.77 110.431 -178.913 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 85.2 mt -59.99 -40.53 83.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 120.969 -1.082 . . . . 0.8 108.499 -179.706 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -69.96 -35.76 74.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.144 -0.973 . . . . 0.88 110.107 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.6 tt0 -60.01 -40.06 87.94 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.762 -1.211 . . . . 1.37 109.312 179.831 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.99 -42.62 94.63 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.463 -1.855 . . . . 0.62 108.463 179.09 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 58.4 m170 -61.06 -44.56 97.2 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.468 -1.019 . . . . 1.5 108.612 179.334 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 96.5 mt -69.98 -43.53 79.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.674 -0.641 . . . . 0.63 109.799 179.947 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 38.7 ttp -64.11 -40.02 95.29 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.906 -1.121 . . . . 1.51 109.827 -179.356 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.801 HD11 ' CE2' ' B' ' 348' ' ' PHE . 35.9 tp -65.47 -39.97 92.61 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.237 -0.914 . . . . 0.77 109.44 179.536 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.5 tp -65.71 -37.09 85.46 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.557 -0.714 . . . . 0.62 109.177 -179.493 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -82.66 1.66 37.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.199 -0.938 . . . . 1.47 110.086 -179.372 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -48.56 130.01 16.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.965 -1.084 . . . . 1.47 109.672 -179.405 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.46 -18.4 51.05 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.542 -0.723 . . . . 1.78 110.354 -179.259 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.47 -35.1 73.1 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.005 -1.059 . . . . 2.53 108.739 178.353 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.3 mt -70.15 -42.12 72.93 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.521 0.677 . . . . 0.8 109.909 179.506 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -60.15 -48.81 80.18 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.36 -0.837 . . . . 1.42 110.028 -179.126 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.7 mt-30 -69.95 -41.31 74.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.228 -0.92 . . . . 1.71 110.705 -179.451 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.98 -40.04 75.58 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.16 -0.963 . . . . 1.57 111.735 -178.629 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 91.8 mt -69.47 -42.04 80.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 120.905 -1.122 . . . . 0.65 109.178 -179.571 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 81.7 mt -69.98 -39.62 77.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 O-C-N 121.638 -0.664 . . . . 0.82 109.943 179.329 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.99 -47.77 84.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.319 -0.863 . . . . 0.79 110.81 -179.244 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 96' ' ' LYS . 93.2 mt -61.48 -47.51 85.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.994 -1.067 . . . . 0.95 109.921 -179.44 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 70.3 mt -60.33 -49.63 83.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.296 -0.877 . . . . 0.66 109.185 179.632 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -70.09 -43.03 71.93 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.901 -0.719 . . . . 2.2 110.667 179.636 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -80.69 -47.39 14.09 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.103 -0.998 . . . . 1.65 111.79 -178.349 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.441 ' N ' ' O ' ' A' ' 92' ' ' LEU . 65.8 mmtt -91.81 -2.3 56.96 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.973 -1.079 . . . . 2.03 111.659 -177.679 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 56.05 34.68 24.22 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.797 -1.189 . . . . 1.42 109.489 -179.845 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 59.0 mtt -91.63 169.84 10.41 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.518 -0.739 . . . . 1.18 110.03 -179.39 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 70.5 p -82.32 162.34 22.29 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.42 -0.8 . . . . 0.98 109.408 179.986 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.03 -39.71 75.61 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.417 -0.802 . . . . 0.64 109.892 -179.95 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -67.94 -40.04 83.36 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 2.07 110.011 -179.753 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -80.49 -44.08 19.77 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.018 -1.051 . . . . 0.73 110.283 -179.506 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.63 -47.68 68.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.172 -0.955 . . . . 0.54 110.2 -179.306 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.95 -40.03 87.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.178 -0.951 . . . . 0.56 109.659 -179.862 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -59.99 -40.87 90.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.43 -0.794 . . . . 1.54 110.01 -178.559 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -63.21 -40.02 96.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.913 . . . . 1.33 110.131 -179.596 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 61.8 t -61.3 -52.59 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.111 -0.993 . . . . 0.72 110.528 -178.721 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 39.9 mm -70.02 -40.02 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.973 -1.079 . . . . 0.85 109.328 -179.752 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.61 -39.19 91.27 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.644 -0.872 . . . . 2.44 108.644 179.327 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -58.33 -47.86 87.12 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 109.74 -1.344 . . . . 0.98 109.74 -179.668 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -67.53 -51.65 48.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.942 -1.328 . . . . 1.41 109.197 -179.992 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -58.85 -42.5 89.49 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.375 -0.828 . . . . 1.2 109.591 -179.748 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 24.4 t -57.56 -39.5 76.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.059 -1.026 . . . . 1.7 109.056 -179.851 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.95 -39.93 90.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.935 . . . . 1.47 109.656 179.424 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.1 mt -64.66 -42.01 95.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.022 -1.049 . . . . 1.56 109.999 -178.827 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.95 -37.58 79.99 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.746 -1.222 . . . . 2.2 109.335 -179.596 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -53.45 -20.25 4.5 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.202 -0.936 . . . . 2.12 109.265 179.827 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 65.7 mt -62.46 139.99 58.59 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.044 -1.035 . . . . 2.0 108.798 179.861 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -90.99 48.23 1.5 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.04 -1.037 . . . . 3.23 109.393 179.894 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.42 ' OD1' ' OE2' ' A' ' 121' ' ' GLU . 58.3 t0 -135.18 130.13 34.85 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.368 -0.833 . . . . 2.49 109.282 -179.713 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.632 ' CD ' ' H ' ' A' ' 121' ' ' GLU . 1.2 pm0 -69.35 -28.87 66.59 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.532 -0.73 . . . . 3.95 110.071 -179.677 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.545 ' CE1' ' NH1' ' A' ' 126' ' ' ARG . 2.4 t80 -73.2 -41.03 64.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.259 -0.901 . . . . 2.0 110.599 179.586 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.624 ' CD2' HH22 ' A' ' 126' ' ' ARG . 41.3 mt -74.92 -29.71 61.04 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.044 -1.035 . . . . 1.86 108.344 179.31 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -68.51 -39.1 81.39 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.5 -0.75 . . . . 2.84 110.1 179.523 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -59.98 -44.02 94.76 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.987 -1.071 . . . . 2.73 110.063 -178.905 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.714 ' HE ' ' NE2' ' B' ' 351' ' ' GLN . 22.2 mtm-85 -69.96 -28.91 65.94 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.315 -1.354 . . . . 2.77 108.797 179.805 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.75 -26.64 65.84 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 107.865 -1.161 . . . . 1.19 107.865 178.741 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -73.56 -39.98 64.28 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 109.088 -0.708 . . . . 1.2 109.088 178.795 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -65.85 -39.99 91.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.358 -0.838 . . . . 1.55 110.53 -179.442 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 39.5 t -65.11 -41.02 90.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 120.877 -1.139 . . . . 0.8 109.065 179.999 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -59.98 -37.86 80.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.092 -1.005 . . . . 3.09 108.522 178.868 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.41 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 57.2 t0 -60.03 -38.96 84.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.578 -0.701 . . . . 1.46 109.985 -179.614 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 94.5 mt -60.08 -42.5 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 120.92 -1.113 . . . . 0.71 110.101 -178.89 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.76 -29.3 59.56 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.647 -1.381 . . . . 0.57 109.647 179.867 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 19.7 ttmt -59.93 -49.04 79.25 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.299 -1.118 . . . . 2.59 109.464 -179.515 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.467 HH11 ' HG2' ' A' ' 136' ' ' ARG . 27.1 mtt-85 -65.16 -36.7 85.05 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.083 -1.011 . . . . 2.83 109.596 179.861 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 59.2 tp -57.08 -40.92 77.86 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.355 -0.84 . . . . 1.25 109.018 -178.652 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 85.4 mt -62.16 -41.35 98.21 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.193 -0.942 . . . . 0.7 109.762 179.405 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.9 mtp180 -70.09 -39.94 75.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.23 -0.919 . . . . 2.57 109.014 179.384 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -63.87 -35.66 81.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.675 -0.641 . . . . 1.23 111.093 -179.31 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 83.6 mt -71.13 -45.9 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 120.487 -1.383 . . . . 0.81 108.75 179.522 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 77.2 mt -70.03 -34.96 73.93 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.51 -0.744 . . . . 1.0 109.518 179.98 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.91 43.74 5.31 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.188 -1.565 . . . . 0.89 109.188 -179.479 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 5.0 tp -74.29 149.83 40.5 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.324 -1.103 . . . . 1.14 109.012 -179.854 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.1 tptt -67.1 141.72 57.36 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.178 -0.951 . . . . 4.6 109.678 -179.553 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 89.1 mt -115.63 126.6 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 CA-C-O 122.269 1.033 . . . . 1.24 109.269 179.635 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' A' ' 148' ' ' ASP . 7.5 mt -70.01 -40.0 78.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 CA-C-N 115.594 -0.73 . . . . 1.54 110.743 -178.219 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.417 ' O ' ' O ' ' A' ' 147' ' ' ILE . 25.8 t0 63.49 131.29 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.642 -0.873 . . . . 1.5 108.642 -178.918 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.407 ' O ' HD12 ' A' ' 152' ' ' ILE . 38.9 mt -89.89 -0.62 57.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.047 -1.033 . . . . 0.79 109.646 -179.324 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 52.7 m -84.83 -8.88 58.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 1.4 109.21 179.566 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.03 27.33 0.78 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.446 -0.784 . . . . 0.92 110.683 -178.207 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.415 ' O ' ' NZ ' ' A' ' 175' ' ' LYS . 54.4 mt -89.88 120.03 37.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 O-C-N 121.117 -0.99 . . . . 0.88 109.395 -179.16 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.42 ' O ' ' OD1' ' A' ' 154' ' ' ASP . 72.2 mt-30 -97.07 -9.67 27.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.298 -0.876 . . . . 2.45 111.083 -178.765 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.42 ' OD1' ' O ' ' A' ' 153' ' ' GLN . 96.4 m-20 -139.7 157.89 45.02 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 120.898 -1.126 . . . . 1.52 110.815 -178.763 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -62.7 138.22 58.45 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.735 -0.839 . . . . 1.58 108.735 179.606 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 18.1 m -153.13 165.71 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.444 -0.785 . . . . 0.69 109.767 179.88 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 87.5 mt -95.48 148.84 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 106.414 -1.698 . . . . 0.61 106.414 176.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 64.3 tp -98.61 117.66 33.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.084 -1.01 . . . . 0.87 111.049 -177.684 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 89.0 t -122.42 130.04 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.622 -0.881 . . . . 0.71 108.622 178.416 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.63 161.24 38.64 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.584 -0.895 . . . . 0.81 108.584 179.996 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.485 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -72.09 -32.88 67.44 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 120.201 -1.562 . . . . 0.98 107.687 178.699 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 163' ' ' LEU . 20.2 t0 -162.27 167.73 23.47 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.142 -1.059 . . . . 2.25 108.142 179.8 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.498 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 86.5 mt -141.67 130.61 23.12 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.907 -1.12 . . . . 0.78 109.586 179.689 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 63.8 p -93.05 144.62 28.66 Favored Pre-proline 0 N--CA 1.493 1.683 0 N-CA-C 108.543 -0.91 . . . . 0.98 108.543 179.363 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -42.11 -29.86 1.17 Allowed 'Trans proline' 0 N--CA 1.492 1.418 0 C-N-CA 121.846 1.697 . . . . 0.81 112.65 179.876 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 52.3 m -59.71 -39.98 86.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.073 -1.017 . . . . 0.9 109.711 -178.405 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -70.06 -42.11 73.29 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.12 -0.988 . . . . 1.61 110.354 -179.662 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 77.9 p -53.93 -29.97 44.5 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.228 -0.92 . . . . 0.61 111.356 -177.994 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -72.14 -56.6 5.3 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.945 -1.097 . . . . 0.6 110.53 -179.7 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -84.05 37.34 0.6 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.451 -0.78 . . . . 1.4 108.939 -179.599 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 65.9 tp -109.76 129.47 55.62 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.457 -0.942 . . . . 0.7 108.457 178.494 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 26.4 m120 -79.97 105.15 11.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.082 -1.011 . . . . 2.35 109.27 -179.985 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 77.0 mt -66.84 -40.26 87.9 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.426 -0.796 . . . . 1.51 111.229 -178.564 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -70.0 -23.62 63.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.939 -1.1 . . . . 2.33 110.852 -178.029 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . 0.415 ' NZ ' ' O ' ' A' ' 152' ' ' ILE . 41.4 mtpt -93.97 -6.44 45.42 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.032 -1.043 . . . . 1.92 109.861 -178.657 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.585 HG12 ' H ' ' A' ' 178' ' ' GLY . 93.1 t -107.92 121.4 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.179 -0.95 . . . . 0.67 108.605 179.069 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 42.1 mt -85.66 7.12 24.59 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.391 -0.818 . . . . 1.53 111.777 -177.07 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.585 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 164.11 177.55 36.93 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.17 -1.49 . . . . 0.48 109.662 179.914 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.461 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 22.5 m-85 -134.78 130.27 35.88 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.453 -1.028 . . . . 0.55 109.26 -179.695 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 91.0 mt -133.17 128.29 55.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.025 -0.731 . . . . 0.65 109.025 179.191 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 33.8 p -149.87 159.42 44.38 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.043 -1.035 . . . . 0.82 109.763 179.741 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.485 ' OD1' ' O ' ' A' ' 161' ' ' ALA . 53.8 p-10 -106.27 27.55 8.59 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.519 -0.919 . . . . 2.46 108.519 178.847 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.5 -157.91 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 122.056 0.931 . . . . 1.28 111.972 -178.172 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -55.6 -80.48 0.08 OUTLIER Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.875 -0.89 . . . . 2.19 110.875 -179.179 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . -176.68 -130.57 1.37 Allowed Glycine 0 N--CA 1.49 2.288 0 O-C-N 120.892 -1.358 . . . . 2.13 110.112 -179.491 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -79.42 -9.31 59.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.305 -1.115 . . . . 5.86 111.031 -179.138 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 70.2 p -87.43 9.13 21.77 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.947 -1.096 . . . . 3.72 110.238 -179.085 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 7.7 m -90.19 139.32 30.75 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.941 -1.1 . . . . 1.74 110.358 -179.602 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -45.12 -53.38 8.08 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.473 -0.767 . . . . 0.95 109.99 -179.744 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 94.4 m -56.6 -39.01 72.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.401 -0.812 . . . . 1.55 110.164 -178.903 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 27.8 p -60.0 -37.67 80.38 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.858 -1.151 . . . . 1.51 110.003 -179.554 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . 0.41 HG12 HH21 ' A' ' 195' ' ' ARG . 82.5 mt -60.03 -39.91 81.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.115 -0.991 . . . . 1.67 108.935 179.985 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 90.7 mtp -60.04 -43.01 95.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.429 -0.795 . . . . 1.02 110.33 -179.038 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -58.39 -44.25 88.88 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.583 -1.323 . . . . 0.68 109.36 -179.341 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.41 HH21 HG12 ' A' ' 192' ' ' ILE . 82.8 mtm180 -62.55 -58.64 6.84 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.107 -1.037 . . . . 2.93 109.925 -179.606 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 68.6 m -61.96 -39.97 93.94 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.122 -0.986 . . . . 0.86 112.022 -178.548 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 94.0 mt -74.91 -20.53 59.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.753 -1.217 . . . . 0.67 110.338 -178.697 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 68.81 52.21 0.55 Allowed 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.678 -0.639 . . . . 1.5 110.456 -179.762 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 79.5 mt -129.68 149.93 74.33 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 108.072 -1.084 . . . . 0.72 108.072 178.794 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.52 143.55 63.38 Favored 'Trans proline' 0 N--CA 1.499 1.802 0 C-N-CA 122.063 1.842 . . . . 0.61 112.088 -179.654 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.461 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -172.63 150.74 2.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.083 -1.01 . . . . 0.66 111.286 -179.897 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.8 mt -121.51 146.68 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 107.664 -1.236 . . . . 0.79 107.664 178.432 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 4.8 m -128.35 -12.39 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 O-C-N 120.878 -1.139 . . . . 0.91 110.528 -179.051 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -110.05 25.25 16.79 Favored Glycine 0 N--CA 1.502 3.059 0 N-CA-C 110.824 -0.91 . . . . 1.01 110.824 -179.233 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 2.8 p -46.28 -40.62 11.89 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.913 -1.345 . . . . 0.99 109.803 -179.459 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.403 ' H ' ' HB2' ' A' ' 182' ' ' ASP . . . 90.29 -51.42 3.39 Favored Glycine 0 N--CA 1.497 2.709 0 C-N-CA 120.127 -1.035 . . . . 1.12 110.85 179.385 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 2.6 m -161.94 34.97 0.12 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.621 -1.517 . . . . 1.72 111.204 -179.471 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 38.5 t -71.12 -40.15 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 120.923 -1.111 . . . . 0.89 108.621 177.999 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.451 ' H ' HG23 ' A' ' 209' ' ' THR . 1.2 p -56.23 -34.08 65.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.699 -0.625 . . . . 1.03 110.004 -179.088 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 39.8 t -86.5 -12.97 47.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.069 -1.019 . . . . 1.83 110.467 -179.169 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -94.0 -12.93 27.62 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.889 -1.132 . . . . 2.27 110.837 -179.538 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 213' ' ' LYS . 44.6 t -123.75 165.1 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.288 0 O-C-N 121.185 -0.947 . . . . 0.92 110.267 -179.483 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.572 ' N ' HG12 ' A' ' 212' ' ' VAL . 18.4 mmmt -118.14 156.45 28.67 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.558 -0.904 . . . . 2.2 108.558 -179.363 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.504 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 5.5 p30 -60.99 140.36 57.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 2.36 110.711 -179.474 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 6.5 t0 86.48 2.47 0.52 Allowed 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 121.108 0.48 . . . . 2.38 110.204 179.102 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.442 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 89.9 m-20 -77.71 159.19 29.27 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.15 -0.969 . . . . 2.09 108.581 178.877 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -97.27 120.31 37.4 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.215 -0.928 . . . . 1.27 109.288 -179.351 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.506 HD12 ' HB2' ' A' ' 16' ' ' ALA . 88.8 mt -126.08 140.88 52.23 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.361 -0.837 . . . . 0.75 110.342 -179.812 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 86.7 mt -113.47 129.88 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 107.053 -1.462 . . . . 0.63 107.053 176.967 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 24.6 tp -103.12 120.13 40.12 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.215 -0.928 . . . . 0.7 109.255 -179.106 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.694 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 30.4 p-10 -80.77 -39.64 26.49 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.056 -1.027 . . . . 2.31 108.5 179.055 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.663 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 46.79 17.66 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.851 -0.796 . . . . 0.78 108.851 -179.003 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 221' ' ' ASP . 40.5 t -130.25 -40.73 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.235 -1.394 . . . . 1.04 107.235 178.593 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -103.68 -0.69 29.18 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.139 -1.43 . . . . 2.44 107.139 177.905 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.539 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 47.7 t-20 60.03 48.74 8.28 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 121.354 0.597 . . . . 1.55 110.231 179.812 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.694 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 96.5 mt-30 -140.03 153.04 46.7 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.403 -0.81 . . . . 1.99 109.401 179.577 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 66.5 t -119.55 129.94 74.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.942 -0.762 . . . . 0.77 108.942 179.494 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -103.76 124.87 49.68 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.541 -0.911 . . . . 0.98 108.541 179.247 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 40.6 t -100.74 108.05 22.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.456 -0.777 . . . . 0.85 110.347 -178.978 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 49.39 66.71 5.3 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.199 -0.938 . . . . 1.66 110.367 179.012 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -85.57 156.23 10.56 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 C-N-CA 122.875 2.383 . . . . 0.95 111.716 179.469 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 42.3 p -72.89 162.6 29.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.207 -0.933 . . . . 1.84 109.673 -179.558 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.2 m120 -59.86 -39.68 86.07 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.444 -0.785 . . . . 2.74 110.228 -179.537 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -58.03 -39.37 78.2 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.234 -0.916 . . . . 2.89 109.461 -179.037 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 77.1 t -68.96 -41.65 81.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.019 -1.051 . . . . 1.3 109.369 179.653 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.6 mt -64.51 -39.96 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.145 -0.972 . . . . 1.09 109.881 -179.889 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.03 -39.98 87.76 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.796 -1.19 . . . . 2.43 108.706 179.813 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -65.05 -41.63 95.0 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.316 -0.865 . . . . 2.78 108.923 179.132 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 96.9 mtp -69.96 -34.31 73.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.495 -0.753 . . . . 1.25 109.527 179.891 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -66.56 -40.07 88.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.329 -0.857 . . . . 2.63 109.664 179.689 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -60.66 -44.07 96.87 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.141 -0.975 . . . . 1.8 109.532 179.949 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 88.0 t -60.14 -40.59 83.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.298 -0.876 . . . . 2.13 109.249 -179.982 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -59.97 -40.06 87.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 3.17 109.337 179.916 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.05 -40.02 87.98 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.924 . . . . 1.78 109.869 -179.65 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -68.77 -40.02 79.91 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.094 -1.004 . . . . 2.47 109.478 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 74.5 t -62.32 -40.52 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.327 -0.858 . . . . 2.09 109.26 -179.968 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -63.9 -40.03 95.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.329 -0.857 . . . . 2.54 109.62 -179.915 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 47.0 t -60.32 -39.94 88.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 2.99 109.84 -179.802 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -60.31 -39.97 88.87 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.335 -0.853 . . . . 3.34 110.3 -179.679 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -97.94 24.97 6.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.236 -0.915 . . . . 3.88 109.872 -178.956 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -101.51 -27.21 13.24 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.252 -0.905 . . . . 4.43 109.904 -179.571 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -84.22 -95.18 0.07 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.027 -1.046 . . . . 5.42 109.842 -179.631 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.529 ' O ' ' HB2' ' A' ' 254' ' ' ALA . 88.5 mt -79.96 -70.11 0.54 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 6.1 109.716 -179.142 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.529 ' HB2' ' O ' ' A' ' 253' ' ' LEU . . . 175.15 -45.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.008 -1.057 . . . . 7.37 109.82 179.85 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -171.42 -154.2 0.09 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.111 -0.993 . . . . 8.01 109.969 -179.587 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 81.0 mt -59.89 -40.03 87.38 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.189 -0.944 . . . . 9.05 109.234 -179.429 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -55.58 129.32 38.53 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.958 -1.089 . . . . 10.56 109.233 179.873 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -131.71 31.91 4.19 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.498 -0.751 . . . . 11.32 109.045 179.979 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.994 -1.003 . . . . 12.42 109.302 -179.964 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . 0.426 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 40.7 ttp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.613 0.72 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . 0.426 ' N ' ' CG ' ' B' ' 301' ' ' MET . 15.7 t80 -149.81 146.57 27.22 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.451 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . 0.473 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 0.2 OUTLIER -150.25 159.98 44.04 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.882 -1.136 . . . . 0.0 110.551 -179.312 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -157.78 154.71 28.56 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.021 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -115.14 133.33 56.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.258 -0.901 . . . . 0.0 109.951 179.6 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 4.2 p -128.95 124.55 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-O 122.279 1.037 . . . . 0.0 112.364 -176.881 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . 0.415 ' O ' HG23 ' B' ' 309' ' ' THR . 91.6 m -77.81 102.49 7.23 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.825 0.821 . . . . 0.0 110.898 -178.245 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.417 ' O ' ' N ' ' B' ' 358' ' ' GLY . 97.4 mt -52.92 123.28 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 122.403 1.097 . . . . 0.0 110.813 -178.201 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . 0.415 HG23 ' O ' ' B' ' 307' ' ' THR . 77.6 p -109.99 20.02 18.4 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.768 -178.368 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -83.13 115.47 59.13 Favored Pre-proline 0 N--CA 1.5 2.032 0 O-C-N 121.1 -1.0 . . . . 0.0 109.854 179.894 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -54.03 -7.2 0.61 Allowed 'Trans proline' 0 N--CA 1.497 1.688 0 CA-C-N 120.174 1.098 . . . . 0.0 112.973 179.809 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -117.42 3.53 12.5 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.301 -0.874 . . . . 0.0 109.451 -179.987 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 68.09 -178.9 20.33 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.047 -2.021 . . . . 0.0 108.047 -178.764 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.476 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.3 tp -83.0 83.29 7.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.686 -1.479 . . . . 0.0 109.593 -178.444 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.472 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 2.6 p80 -91.89 -160.02 0.7 Allowed 'General case' 0 N--CA 1.504 2.243 0 O-C-N 121.132 -0.98 . . . . 0.0 109.769 178.403 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.2 m -56.76 -47.7 79.5 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.806 -1.184 . . . . 0.0 112.984 -175.852 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.599 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 11.3 tpt180 -56.35 -59.72 11.19 Favored Pre-proline 0 N--CA 1.504 2.25 0 O-C-N 120.388 -1.445 . . . . 0.0 111.919 -179.23 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.472 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 12.0 Cg_endo -58.83 -34.63 99.13 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 CA-C-N 120.369 1.168 . . . . 0.0 111.521 -179.525 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -60.0 -50.68 72.8 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 119.725 -0.79 . . . . 0.0 108.986 179.914 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.78 -44.09 77.41 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.445 -0.902 . . . . 0.0 109.48 -179.078 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -70.01 -41.67 74.03 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.964 -1.095 . . . . 0.0 108.528 179.347 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -63.04 -53.96 45.68 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.448 -0.783 . . . . 0.0 110.346 -179.733 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 84.2 t -61.77 -28.23 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 120.528 -1.357 . . . . 0.0 109.768 -179.006 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -64.56 -42.56 95.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.063 -1.023 . . . . 0.0 109.48 -179.92 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 52.0 tp10 -69.77 -42.04 74.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.321 -0.862 . . . . 0.0 111.429 -178.509 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . 0.421 ' C ' ' N ' ' B' ' 328' ' ' GLY . . . -61.65 -54.66 39.74 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.498 -1.376 . . . . 0.0 111.244 -178.591 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -54.15 -10.21 0.34 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.894 -1.129 . . . . 0.0 109.633 -179.672 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . 0.421 ' N ' ' C ' ' B' ' 326' ' ' ALA . . . -71.96 -28.8 67.99 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.249 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 90.5 m-85 -104.59 144.08 32.18 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.335 -1.097 . . . . 0.0 109.458 -179.661 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . 0.403 HG22 ' O ' ' B' ' 330' ' ' THR . 91.5 m -90.56 -11.46 40.0 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.137 -0.977 . . . . 0.0 109.742 179.877 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.419 ' OG ' ' N ' ' B' ' 369' ' ' ASP . 58.9 m -65.58 153.73 40.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -0.998 . . . . 0.0 109.45 179.999 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -69.44 134.98 49.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.078 -1.014 . . . . 0.0 109.164 -179.74 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.1 mt -131.89 132.81 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 O-C-N 121.519 -0.738 . . . . 0.0 109.453 -179.718 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 24.6 m -129.12 149.89 50.74 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.462 -0.774 . . . . 0.0 109.618 -179.814 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 90.8 t -123.66 115.4 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 178.404 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 94.0 m -113.73 122.8 48.21 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.09 -1.007 . . . . 0.0 110.928 -177.903 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . 0.428 ' C ' ' H ' ' B' ' 339' ' ' GLY . 16.8 t -121.98 127.84 50.79 Favored 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.414 0.626 . . . . 0.0 109.312 178.873 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 35.6 m120 57.77 6.37 0.44 Allowed 'General case' 0 N--CA 1.499 1.978 0 CA-C-O 121.601 0.715 . . . . 0.0 109.481 -178.777 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . 0.428 ' H ' ' C ' ' B' ' 337' ' ' SER . . . 101.19 13.16 34.23 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.23 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 23.7 mtpp -104.57 121.15 42.91 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 177.616 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 58.2 p -100.16 151.54 21.31 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 122.259 1.028 . . . . 0.0 112.54 -177.026 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -149.76 148.72 29.56 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.35 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . 0.414 ' H ' ' HE2' ' B' ' 349' ' ' LYS . 1.8 t -89.27 130.01 35.74 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.991 -1.068 . . . . 0.0 110.777 -178.725 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.465 ' C ' ' H ' ' B' ' 346' ' ' SER . . . -70.16 -19.91 63.17 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.267 -0.896 . . . . 0.0 110.311 -179.663 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -84.19 21.71 1.34 Allowed 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.8 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . 0.589 ' CB ' ' HZ3' ' B' ' 349' ' ' LYS . 14.6 p -152.08 98.14 2.4 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.877 0.846 . . . . 0.0 111.21 179.583 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.65 HD23 HD22 ' A' ' 79' ' ' LEU . 45.9 tp -59.69 -32.74 70.78 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.832 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.801 ' CE2' HD11 ' A' ' 79' ' ' LEU . 55.9 m-85 -52.93 -51.88 59.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.329 -0.857 . . . . 0.0 111.386 -179.625 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . 0.589 ' HZ3' ' CB ' ' B' ' 346' ' ' SER . 33.6 mtmm -70.01 -40.0 75.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.727 -1.233 . . . . 0.0 111.108 -178.324 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' B' ' 352' ' ' THR . 88.7 mt -49.08 -57.09 7.17 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.798 -1.189 . . . . 0.0 109.931 -178.832 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.714 ' NE2' ' HE ' ' A' ' 126' ' ' ARG . 4.0 mm100 -44.86 -10.84 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.053 -1.029 . . . . 0.0 111.15 -177.697 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.565 ' N ' ' O ' ' B' ' 350' ' ' LEU . 72.5 p -87.24 -13.34 44.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 119.895 -1.753 . . . . 0.0 110.258 -178.978 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 53.0 mt -94.77 122.41 37.36 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.931 -1.106 . . . . 0.0 109.499 179.001 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -77.1 92.14 1.04 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 179.368 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 25.8 mt -101.83 95.37 6.36 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.424 -1.045 . . . . 0.0 109.176 179.817 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 75.0 p -93.64 -179.74 5.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.222 -0.924 . . . . 0.0 111.048 -178.954 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -69.27 114.16 7.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.711 -0.618 . . . . 0.0 110.51 -179.508 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' B' ' 308' ' ' ILE . . . 99.99 10.17 46.73 Favored Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 179.759 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 53.2 m -87.18 111.39 20.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -1.094 . . . . 0.0 110.195 -179.822 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 68.0 t -77.08 114.61 17.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 CA-C-O 122.024 0.916 . . . . 0.0 109.61 -177.384 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 11.8 m -108.26 176.7 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -178.936 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 43.3 m -131.61 126.62 35.19 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 177.597 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 85.3 mt -103.49 117.79 49.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 178.398 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 64.8 m -118.72 130.82 56.03 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.108 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.41 150.8 39.58 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.324 -0.86 . . . . 0.0 109.267 -178.995 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -145.49 124.36 12.7 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.268 -0.895 . . . . 0.0 109.059 179.579 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.558 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 156.6 -154.49 25.57 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.403 -1.38 . . . . 0.0 111.072 -179.602 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -59.98 -50.63 73.01 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -177.468 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.419 ' N ' ' OG ' ' B' ' 331' ' ' SER . 85.1 m-20 -110.03 11.03 24.06 Favored 'General case' 0 N--CA 1.506 2.327 0 O-C-N 120.838 -1.163 . . . . 0.0 111.192 -177.193 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -40.84 -36.21 0.6 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.334 -0.853 . . . . 0.0 111.79 -178.992 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -69.13 -41.32 77.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.65 -1.281 . . . . 0.0 110.007 -178.526 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 61.0 mttm -72.97 -54.93 7.36 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.001 -1.062 . . . . 0.0 110.062 179.763 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -42.33 -34.33 0.78 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.545 -0.722 . . . . 0.0 111.238 -178.766 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.561 ' O ' HG23 ' B' ' 378' ' ' VAL . 93.3 t -80.0 -35.47 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.758 -1.214 . . . . 0.0 109.55 179.289 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -69.95 -39.99 75.71 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.225 -0.922 . . . . 0.0 112.303 -179.112 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -80.08 -46.61 16.21 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.383 -1.448 . . . . 0.0 110.432 -179.465 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 87.9 mt -60.0 -38.03 81.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.277 -0.889 . . . . 0.0 108.995 -179.637 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.561 HG23 ' O ' ' B' ' 374' ' ' VAL . 26.9 t -61.5 -48.22 89.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.277 -0.889 . . . . 0.0 109.718 179.381 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.02 -56.51 6.77 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.625 -1.297 . . . . 0.0 107.613 178.785 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.449 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 46.6 tp -52.51 -32.19 39.12 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.364 -0.835 . . . . 0.0 109.201 -179.176 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 34.3 ttm -76.07 -39.63 54.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.145 -0.972 . . . . 0.0 108.63 177.74 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.12 -5.06 50.43 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.58 -0.7 . . . . 0.0 109.873 179.614 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -108.26 3.74 23.89 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.29 -0.881 . . . . 0.0 110.499 -179.364 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . 0.449 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 27.6 mt -74.84 125.4 28.73 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.453 -1.404 . . . . 0.0 109.543 179.708 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 118.081 -0.961 . . . . 0.0 109.323 179.715 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtt . . . . . 0 N--CA 1.489 1.478 0 N-CA-C 109.449 -0.575 . . . . 2.91 109.449 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 88.1 mt -109.9 129.23 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 121.504 -0.748 . . . . 1.2 109.201 179.808 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 59.6 m -140.64 122.33 15.28 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.306 -0.871 . . . . 1.4 109.607 -179.903 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.44 -161.47 31.4 Favored Glycine 0 N--CA 1.494 2.555 0 N-CA-C 108.962 -1.655 . . . . 1.05 108.962 179.319 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.466 HG22 ' O ' ' A' ' 5' ' ' ILE . 97.3 mt -90.22 -9.96 10.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.114 -1.227 . . . . 1.15 110.42 -179.028 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.433 ' O ' ' O ' ' A' ' 5' ' ' ILE . 58.6 tp 52.55 99.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.974 -1.079 . . . . 0.98 109.441 179.884 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.27 -27.31 15.04 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.118 -0.989 . . . . 0.88 109.535 -179.981 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 31.0 t -136.4 121.14 12.91 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.385 -0.822 . . . . 1.69 109.22 179.944 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.08 144.77 24.02 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 121.788 1.659 . . . . 0.85 111.989 -179.949 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.885 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 159.72 -159.88 30.99 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.117 -1.593 . . . . 0.92 109.117 -179.576 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.504 HD12 HE22 ' A' ' 243' ' ' GLN . 86.8 mt -149.94 151.64 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 O-C-N 121.248 -1.148 . . . . 0.81 108.587 179.041 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -155.78 156.49 34.87 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.735 -1.228 . . . . 0.51 110.561 179.261 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.571 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 1.0 OUTLIER -138.27 128.4 25.74 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 107.375 -1.343 . . . . 0.62 107.375 178.752 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 176.85 -179.84 47.61 Favored Glycine 0 N--CA 1.492 2.387 0 C-N-CA 118.666 -1.73 . . . . 0.55 110.823 -179.819 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -80.07 159.38 26.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.757 -0.849 . . . . 2.1 109.35 -179.832 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.524 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -107.09 131.51 54.02 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 121.408 -0.807 . . . . 0.77 111.011 -179.076 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.7 tp -98.7 139.54 34.25 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.245 -1.391 . . . . 0.91 107.245 178.161 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 34.2 tp -117.06 121.32 40.98 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.288 -0.883 . . . . 0.93 110.305 -178.971 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.422 HD12 ' HB2' ' A' ' 160' ' ' ALA . 45.4 mt -96.41 107.74 20.17 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.384 0.611 . . . . 0.93 110.036 179.905 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.623 ' HB2' ' HZ3' ' A' ' 20' ' ' LYS . 1.5 mtmp? -101.87 139.61 37.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.462 -0.774 . . . . 2.75 109.044 179.493 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -128.27 121.75 30.04 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.407 -0.808 . . . . 3.0 108.829 179.419 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 59.3 t0 -75.79 146.53 39.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.084 -1.01 . . . . 2.77 109.598 179.859 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.5 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 84.9 tt0 -61.63 140.19 58.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.406 -0.809 . . . . 2.94 109.823 -179.793 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 82.4 mt -78.89 132.93 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 0.95 108.872 179.954 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -94.81 122.33 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.022 -1.049 . . . . 1.28 109.961 -179.389 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 85.8 mt -107.05 138.54 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 109.083 -0.71 . . . . 1.21 109.083 179.979 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -89.43 123.47 33.6 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.059 -1.026 . . . . 1.81 110.255 -179.347 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.547 HH11 ' HG2' ' A' ' 28' ' ' ARG . 0.8 OUTLIER -93.96 3.81 54.82 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.379 -0.826 . . . . 2.8 109.651 -179.962 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -72.92 151.34 41.94 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.272 -0.892 . . . . 2.87 111.17 -178.753 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 62.7 mmtt -93.24 145.61 24.31 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.581 -0.896 . . . . 2.35 108.581 179.092 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.8 pt -98.46 167.02 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.071 -1.018 . . . . 0.97 110.297 -179.907 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 92.2 p -93.74 171.79 8.66 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.492 -0.929 . . . . 1.17 108.492 178.658 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -60.07 -47.21 86.82 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.044 -1.035 . . . . 1.18 109.45 -179.915 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -55.86 -31.9 63.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.951 -1.093 . . . . 2.56 109.834 -179.26 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -81.5 -10.23 59.52 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.347 -0.845 . . . . 1.79 110.608 -179.091 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.4 t -60.09 -49.98 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.977 -1.077 . . . . 1.0 109.132 -179.96 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.96 -40.02 91.76 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 121.341 -0.85 . . . . 1.77 109.614 179.799 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.58 -46.0 87.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.245 -0.909 . . . . 2.7 111.551 -178.837 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -61.39 -42.53 98.88 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.599 -1.313 . . . . 1.51 110.457 -179.085 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.04 -46.58 94.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 120.55 -1.344 . . . . 0.93 108.184 179.92 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -61.6 -43.9 98.0 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.257 -0.902 . . . . 1.81 109.786 179.34 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.5 mtp180 -59.99 -41.15 91.43 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.745 -1.222 . . . . 2.78 107.764 179.557 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -63.3 -44.61 94.52 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.708 -0.849 . . . . 0.78 108.708 178.246 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.08 -47.84 84.19 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.57 -0.706 . . . . 1.07 109.222 179.971 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.1 t -63.96 -44.98 91.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.065 -1.022 . . . . 1.12 108.908 179.362 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.56 -39.95 98.04 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 107.763 -2.135 . . . . 0.84 107.763 178.554 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.421 HH21 ' HA ' ' A' ' 81' ' ' GLU . 68.5 ttt180 -67.16 -35.81 80.47 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.572 -0.899 . . . . 3.09 108.572 178.63 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -60.0 -39.97 87.62 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.554 -0.716 . . . . 0.88 109.621 -179.611 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 50' ' ' ALA . 35.9 ttpt -64.91 -73.77 0.12 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 120.883 -1.136 . . . . 2.59 108.372 179.491 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.67 -38.57 0.28 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.38 -0.825 . . . . 0.7 111.203 -178.165 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.1 m -54.04 -56.85 14.1 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.718 -1.239 . . . . 1.4 108.939 179.732 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.92 88.3 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.22 -0.925 . . . . 0.67 111.123 -179.163 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -68.46 -40.07 81.17 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.956 -1.09 . . . . 1.66 109.978 -179.2 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 76.6 mt -65.54 -40.01 92.39 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.077 -1.014 . . . . 1.58 109.975 179.897 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.539 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 69.3 mm-40 -61.53 -39.96 92.92 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.084 -1.01 . . . . 1.35 109.869 -179.815 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.3 m -62.84 -40.03 96.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.021 -1.049 . . . . 0.77 109.967 -179.931 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 82.3 mt -60.05 -39.85 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.179 -0.95 . . . . 0.63 108.911 179.669 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.539 ' NZ ' ' OE1' ' A' ' 55' ' ' GLU . 5.2 ttpm? -55.92 -49.98 71.97 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.229 -0.92 . . . . 1.14 109.081 179.74 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.1 m -57.51 -33.54 68.15 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.374 -0.829 . . . . 0.79 110.512 -178.318 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -69.97 -38.86 76.19 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.897 -1.127 . . . . 1.53 110.005 179.965 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.462 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -67.23 -45.51 76.54 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.401 -0.812 . . . . 0.57 110.487 -179.241 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -59.66 -50.03 72.15 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.917 -1.135 . . . . 0.75 110.45 -178.68 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.95 -42.88 72.62 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.076 -1.25 . . . . 1.59 110.325 -179.563 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 86.9 m -70.13 -61.37 1.8 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.206 -0.934 . . . . 0.73 112.744 -177.678 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -93.3 -49.36 5.99 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.679 -1.263 . . . . 0.75 110.711 -178.437 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.76 -167.89 25.77 Favored Glycine 0 N--CA 1.5 2.918 0 C-N-CA 119.936 -1.125 . . . . 1.22 110.849 179.65 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -68.55 -22.12 64.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.805 -0.821 . . . . 5.81 109.859 -179.889 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -60.04 -36.22 76.82 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 121.654 -0.653 . . . . 3.37 110.371 -179.531 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -101.19 -15.43 17.35 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.352 -0.843 . . . . 1.77 110.322 -179.449 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -69.97 -40.2 75.51 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.933 -1.104 . . . . 1.65 110.585 -179.311 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.563 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -69.8 -28.65 65.91 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.611 -0.836 . . . . 0.77 109.91 -178.564 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 82.7 mt -60.06 -41.92 88.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 119.022 -1.071 . . . . 0.8 109.143 -179.903 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -65.88 -40.01 91.2 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.954 -1.091 . . . . 0.88 109.921 179.99 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -60.15 -40.41 89.77 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.9 -1.125 . . . . 1.37 109.254 179.834 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -63.86 -41.48 98.76 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 108.064 -2.014 . . . . 0.62 108.064 178.9 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.3 m170 -70.09 -43.69 70.56 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.618 -0.931 . . . . 1.5 108.595 179.169 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 90.9 mt -70.04 -46.63 72.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.367 -0.833 . . . . 0.63 109.369 179.433 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 37.5 ttp -60.68 -44.8 96.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.057 -1.027 . . . . 1.51 109.687 -179.61 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.859 HD11 ' CE2' ' B' ' 348' ' ' PHE . 50.8 tp -60.0 -40.06 87.91 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.802 -0.814 . . . . 0.77 108.802 179.142 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.7 tp -62.94 -39.95 96.16 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.671 -0.643 . . . . 0.62 109.537 179.614 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.421 ' HA ' HH21 ' A' ' 47' ' ' ARG . 99.7 mt-10 -79.44 5.2 13.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.322 -0.861 . . . . 1.47 110.127 -179.14 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -56.08 128.99 38.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 1.47 110.291 -179.309 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -63.04 -14.08 43.65 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.591 -0.693 . . . . 1.78 110.059 -179.985 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -70.08 -37.08 75.37 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.231 -1.025 . . . . 2.53 108.231 178.505 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.03 -39.98 75.46 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.658 0.742 . . . . 0.8 109.757 179.407 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -60.05 -45.48 92.68 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.59 -0.694 . . . . 1.42 110.895 -178.417 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -70.78 -48.55 53.67 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.257 -0.902 . . . . 1.71 111.667 -178.584 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -64.16 -39.9 95.0 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.352 -0.842 . . . . 1.57 111.734 -177.409 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 97.5 mt -66.27 -47.77 83.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 O-C-N 120.838 -1.164 . . . . 0.65 109.857 -179.541 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.9 mt -70.01 -39.04 76.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.415 -0.803 . . . . 0.82 110.671 -179.674 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.405 ' O ' ' N ' ' A' ' 95' ' ' ASP . . . -59.97 -48.86 79.95 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.173 -0.954 . . . . 0.79 111.045 -178.917 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 96' ' ' LYS . 75.7 mt -60.01 -44.9 94.26 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.917 -1.115 . . . . 0.95 109.501 -178.955 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 76.8 mt -60.23 -50.0 81.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 N-CA-C 107.76 -1.2 . . . . 0.66 107.76 178.86 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -65.07 -40.05 94.14 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 120.024 -0.67 . . . . 2.2 110.243 179.359 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.405 ' N ' ' O ' ' A' ' 91' ' ' ALA . 56.7 t0 -84.26 -55.11 4.35 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.995 -1.066 . . . . 1.65 112.277 -178.241 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 92' ' ' LEU . 99.0 mttt -90.04 -1.98 58.05 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.812 -1.18 . . . . 2.03 112.145 -177.348 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 57.85 37.54 26.99 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.846 -1.159 . . . . 1.42 109.379 -179.534 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 49.9 mtt -93.04 166.38 12.39 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.497 -0.752 . . . . 1.18 109.879 -179.758 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 40.4 p -79.95 160.0 26.11 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.034 -0.728 . . . . 0.98 109.034 179.678 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.46 -38.05 77.59 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.321 -0.862 . . . . 0.64 109.755 -179.999 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.43 ' OD1' HD22 ' A' ' 138' ' ' LEU . 20.3 t0 -65.51 -40.03 92.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.084 -1.01 . . . . 2.07 109.521 179.665 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -79.6 -43.12 23.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.3 -0.875 . . . . 0.73 110.352 -179.684 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -70.05 -41.69 73.86 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.27 -0.894 . . . . 0.54 110.278 -179.442 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.95 -39.68 95.39 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.122 -0.986 . . . . 0.56 109.474 179.956 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.546 ' NE2' ' OE1' ' A' ' 109' ' ' GLU . 81.1 t60 -59.62 -40.07 86.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.551 -0.718 . . . . 1.54 109.578 -178.804 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.422 ' O ' ' N ' ' A' ' 110' ' ' GLY . 87.2 tt0 -64.61 -40.02 94.76 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.305 -0.872 . . . . 1.33 110.55 -179.655 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 87.3 t -63.86 -60.61 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.148 -0.97 . . . . 0.72 111.478 -178.308 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.0 mm -65.06 -39.96 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.855 -1.153 . . . . 0.85 109.268 -179.459 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.546 ' OE1' ' NE2' ' A' ' 105' ' ' HIS . 85.3 tt0 -67.04 -39.98 87.08 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.076 -1.083 . . . . 2.44 108.076 178.275 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -56.82 -52.14 52.67 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 110.23 -1.148 . . . . 0.98 110.23 -179.27 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.439 HE21 ' HB3' ' B' ' 348' ' ' PHE . 22.9 mm100 -65.07 -48.14 74.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.785 -1.421 . . . . 1.41 109.197 -179.848 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.08 85.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.217 -0.927 . . . . 1.2 109.03 179.676 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 53.5 m -59.57 -39.87 85.5 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.468 -0.77 . . . . 1.7 109.018 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.44 -40.03 92.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 1.47 109.015 179.02 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.2 mt -64.2 -41.87 96.88 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.273 -0.892 . . . . 1.56 109.784 -179.247 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -60.02 -33.78 72.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.822 -1.174 . . . . 2.2 109.783 -179.272 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -56.92 -20.52 23.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.108 -0.995 . . . . 2.12 108.927 179.949 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 45.0 mt -62.63 138.66 58.54 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.188 -1.041 . . . . 2.0 108.188 179.469 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 119' ' ' ASP . 57.9 t0 -94.69 54.97 1.84 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.931 -1.105 . . . . 3.23 110.086 -179.611 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 121' ' ' GLU . 58.9 t0 -136.1 136.7 40.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.345 -0.847 . . . . 2.49 108.938 179.23 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.461 ' N ' ' OD1' ' A' ' 120' ' ' ASP . 98.9 mt-10 -70.02 -31.61 69.36 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.42 -0.8 . . . . 3.95 109.964 -179.537 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.508 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.4 t80 -72.64 -38.86 67.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.306 -0.871 . . . . 2.0 110.728 179.886 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.409 HD22 ' O ' ' B' ' 351' ' ' GLN . 70.7 mt -74.12 -36.26 64.18 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.975 -1.078 . . . . 1.86 109.745 -179.369 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -60.04 -40.0 87.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.015 -1.053 . . . . 2.84 109.357 179.601 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -60.0 -47.31 86.34 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.103 -0.998 . . . . 2.73 109.482 179.957 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.545 HH21 ' NE2' ' B' ' 351' ' ' GLN . 62.0 mtp180 -60.18 -39.98 88.39 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.16 -0.963 . . . . 2.77 108.663 179.201 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -60.53 -36.12 77.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.389 -0.82 . . . . 1.19 108.846 178.972 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -62.89 -40.02 96.26 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 109.081 -0.711 . . . . 1.2 109.081 179.684 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -64.22 -40.93 97.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.321 -0.862 . . . . 1.55 110.111 -179.352 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.55 -41.88 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 0.8 109.616 -179.889 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -60.01 -38.1 81.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.141 -0.974 . . . . 3.09 109.4 179.48 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -59.92 -40.88 90.35 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.306 -0.871 . . . . 1.46 110.361 -178.948 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.19 -45.01 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.894 -1.129 . . . . 0.71 109.581 179.815 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -65.97 -37.91 93.64 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.713 -1.355 . . . . 0.57 109.713 179.995 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -60.03 -47.6 85.16 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.311 -1.111 . . . . 2.59 109.56 -179.378 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.418 HH12 ' HB3' ' A' ' 166' ' ' SER . 61.0 mtp180 -68.76 -33.16 73.43 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.238 -0.914 . . . . 2.83 109.637 -179.772 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 60.7 tp -57.28 -43.7 83.37 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.355 -0.841 . . . . 1.25 108.995 -179.788 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.43 HD22 ' OD1' ' A' ' 101' ' ' ASP . 84.1 mt -63.66 -39.96 95.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.13 -0.982 . . . . 0.7 108.654 179.145 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 59.6 mtp180 -66.89 -39.97 87.63 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.912 -0.773 . . . . 2.57 108.912 179.465 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -69.44 -31.7 70.18 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.554 -0.716 . . . . 1.23 110.941 -179.31 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.0 mt -70.04 -43.29 79.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.401 -1.437 . . . . 0.81 108.193 178.728 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 88.9 mt -71.56 -29.99 65.36 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.792 -0.568 . . . . 1.0 109.901 -179.708 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 84.69 40.33 8.31 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 108.983 -1.647 . . . . 0.89 108.983 -179.28 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.405 ' HA ' HD12 ' A' ' 144' ' ' LEU . 18.5 tp -73.99 146.36 43.88 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.386 -1.067 . . . . 1.14 109.14 -179.479 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -65.08 147.92 52.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.269 -0.894 . . . . 4.6 110.002 -178.892 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 98.6 mt -118.89 125.63 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-O 122.093 0.949 . . . . 1.24 109.325 179.49 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' A' ' 148' ' ' ASP . 5.5 mt -62.38 -43.58 98.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.87 -0.605 . . . . 1.54 110.219 -178.859 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.432 ' O ' ' O ' ' A' ' 147' ' ' ILE . 32.2 t0 62.01 125.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.968 -0.753 . . . . 1.5 108.968 -179.126 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.4 mt -87.08 -2.09 58.37 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.256 -0.903 . . . . 0.79 109.639 -179.274 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 93.8 p -82.26 -9.96 59.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.916 -1.115 . . . . 1.4 108.752 178.951 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -88.71 18.54 4.61 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.635 -0.666 . . . . 0.92 110.925 -177.818 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 65.2 mt -91.74 116.92 33.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.871 -1.143 . . . . 0.88 109.15 179.621 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -103.03 -12.03 17.72 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.251 -0.905 . . . . 2.45 110.206 -179.268 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -116.01 145.72 42.74 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.318 -0.864 . . . . 1.52 110.347 -178.805 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -62.81 131.97 50.63 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.496 -0.928 . . . . 1.58 108.496 179.584 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 29.7 m -152.57 165.23 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.401 -0.812 . . . . 0.69 109.954 -179.947 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.5 mt -93.31 148.8 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 105.215 -2.142 . . . . 0.61 105.215 176.776 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 39.9 tp -99.35 120.01 38.88 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.838 -1.164 . . . . 0.87 110.609 -177.836 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 49.6 t -123.59 130.08 74.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 N-CA-C 108.752 -0.833 . . . . 0.71 108.752 179.343 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . 0.422 ' HB2' HD12 ' A' ' 19' ' ' LEU . . . -156.72 162.69 39.78 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.4 -0.963 . . . . 0.81 108.4 179.837 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -69.95 -35.83 74.8 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 120.185 -1.572 . . . . 0.98 107.315 178.547 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.44 ' N ' ' OD1' ' A' ' 162' ' ' ASP . 20.8 p-10 -171.21 144.69 2.09 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.582 -0.895 . . . . 2.25 108.582 179.287 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 88.2 mt -111.78 139.83 46.93 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.253 -0.905 . . . . 0.78 109.863 -179.438 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 31.1 p -93.19 145.28 29.77 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.392 -0.818 . . . . 0.98 109.501 -179.929 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -39.36 -36.94 1.03 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.405 2.07 . . . . 0.81 113.273 179.458 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.418 ' HB3' HH12 ' A' ' 136' ' ' ARG . 68.5 m -60.01 -39.97 87.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.026 -1.046 . . . . 0.9 109.776 -178.661 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -66.03 -42.0 90.19 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.023 -1.048 . . . . 1.61 110.217 -179.506 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 67.8 p -54.96 -30.61 59.41 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.136 -0.977 . . . . 0.61 110.598 -178.4 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.462 ' HB1' ' HB2' ' A' ' 61' ' ' ALA . . . -71.36 -54.27 11.33 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.028 -1.045 . . . . 0.6 109.879 179.77 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -87.32 39.15 0.85 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.183 -1.043 . . . . 1.4 108.183 179.88 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 33.7 tp -100.22 130.62 46.37 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.622 -0.674 . . . . 0.7 109.307 179.472 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . 0.469 ' O ' HG23 ' A' ' 176' ' ' VAL . 77.8 m-20 -82.12 98.5 8.71 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.185 -1.043 . . . . 2.35 108.185 179.307 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 73.6 mt -67.16 -40.52 86.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.378 -0.826 . . . . 1.51 110.872 -178.592 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -65.39 -30.32 71.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.651 -1.281 . . . . 2.33 112.094 -177.714 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.65 -5.86 50.57 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.712 -1.243 . . . . 1.92 110.061 -178.734 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 178' ' ' GLY . 84.0 t -106.24 116.62 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.134 -0.979 . . . . 0.67 109.307 179.652 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 78.1 mt -88.04 9.96 20.71 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.475 -0.765 . . . . 1.53 110.997 -177.786 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.507 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 165.64 176.59 37.22 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.62 -1.392 . . . . 0.48 109.62 179.858 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -137.64 131.21 31.18 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.456 -1.026 . . . . 0.55 108.853 -179.82 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.402 ' CG2' HG21 ' A' ' 205' ' ' THR . 97.4 mt -133.46 130.0 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 108.772 -0.825 . . . . 0.65 108.772 179.002 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 72.1 p -148.4 160.0 43.46 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.965 -1.084 . . . . 0.82 110.855 -179.82 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.549 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.4 OUTLIER -109.03 31.18 5.9 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.192 -1.04 . . . . 2.46 108.192 178.966 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.35 -160.44 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.919 -1.113 . . . . 1.28 111.516 -177.605 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -62.4 -67.68 1.99 Allowed Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.34 -1.104 . . . . 2.19 110.34 -179.092 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 178.39 -130.98 1.65 Allowed Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.974 -1.584 . . . . 2.13 110.981 -179.802 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 -79.46 -10.01 59.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.634 -0.921 . . . . 5.86 111.025 -178.504 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 42.9 p -81.8 4.87 20.54 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.968 -1.083 . . . . 3.72 109.687 -179.253 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.421 ' OG ' ' OG ' ' A' ' 191' ' ' SER . 23.4 p -90.43 137.54 32.27 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.134 -0.979 . . . . 1.74 110.593 -179.522 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -48.34 -47.86 36.7 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.475 -0.766 . . . . 0.95 109.673 179.977 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 98.5 m -57.4 -37.79 73.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.455 -0.778 . . . . 1.55 110.717 -178.992 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.421 ' OG ' ' OG ' ' A' ' 188' ' ' SER . 52.8 m -60.03 -39.9 87.49 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.854 -1.154 . . . . 1.51 110.354 -178.97 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 45.1 mm -64.85 -40.05 87.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.095 -1.003 . . . . 1.67 110.128 -179.599 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 94.3 mtp -60.1 -46.87 88.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.091 -1.006 . . . . 1.02 110.701 -179.765 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -55.71 -45.58 77.86 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.537 -1.352 . . . . 0.68 109.378 -179.589 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -60.1 -54.98 39.57 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.0 -1.062 . . . . 2.93 109.468 179.67 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 69.3 m -63.09 -40.05 96.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 0.86 110.966 -179.3 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.16 -29.17 64.87 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.985 -1.072 . . . . 0.67 108.468 179.73 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 66.97 50.03 1.09 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 121.285 0.564 . . . . 1.5 110.277 -179.842 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 32.7 mt -124.95 145.97 51.89 Favored Pre-proline 0 N--CA 1.503 2.212 0 N-CA-C 108.497 -0.927 . . . . 0.72 108.497 178.91 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.27 125.29 7.04 Favored 'Trans proline' 0 N--CA 1.501 1.932 0 C-N-CA 122.094 1.862 . . . . 0.61 112.555 179.737 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -163.26 141.23 7.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.489 -1.382 . . . . 0.66 112.154 179.866 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.84 147.14 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 107.173 -1.417 . . . . 0.79 107.173 177.811 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 17.3 m -130.78 -7.53 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.334 0 O-C-N 120.833 -1.167 . . . . 0.91 111.177 -178.991 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -108.99 23.05 24.37 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.454 -1.058 . . . . 1.01 110.454 -179.497 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.415 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 2.4 p -45.38 -44.18 11.67 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.93 -1.335 . . . . 0.99 109.88 -179.602 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 93.5 -51.65 2.38 Favored Glycine 0 N--CA 1.5 2.93 0 C-N-CA 120.129 -1.034 . . . . 1.12 111.742 178.692 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 33.3 t -161.9 36.23 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.577 -1.543 . . . . 1.72 110.676 -179.354 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 52.6 t -74.32 -40.83 50.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.215 -0.928 . . . . 0.89 108.934 178.409 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . 0.424 HG23 ' H ' ' A' ' 209' ' ' THR . 1.5 p -53.1 -31.93 44.58 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.403 -0.811 . . . . 1.03 110.063 -179.147 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 39.8 t -71.11 -33.35 70.05 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.168 -0.957 . . . . 1.83 109.741 -179.741 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 22.4 mm100 -89.46 -9.95 48.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 2.27 110.274 -178.995 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 69.6 t -101.52 132.85 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 121.254 -0.904 . . . . 0.92 110.463 -178.887 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -114.15 153.52 29.4 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 107.549 -1.278 . . . . 2.2 107.549 178.834 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 8.9 t-20 -58.8 138.7 57.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.946 -1.097 . . . . 2.36 110.345 -178.605 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.473 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 11.6 t0 83.78 5.28 0.76 Allowed 'General case' 0 N--CA 1.499 2.022 0 CA-C-O 121.113 0.482 . . . . 2.38 109.998 179.699 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 57.4 t0 -75.72 140.86 42.68 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.071 -1.018 . . . . 2.09 108.862 179.146 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.498 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 51.3 t80 -93.29 117.06 29.63 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.146 -0.971 . . . . 1.27 108.41 179.155 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.524 HD12 ' HB2' ' A' ' 16' ' ' ALA . 57.4 mt -126.42 147.35 49.8 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.526 -0.734 . . . . 0.75 110.379 -178.929 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . 0.413 HG23 ' CD2' ' A' ' 13' ' ' PHE . 86.8 mt -114.34 130.02 69.35 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 N-CA-C 107.664 -1.236 . . . . 0.63 107.664 177.554 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 32.7 tp -100.17 118.18 35.96 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.938 -1.101 . . . . 0.7 109.571 -179.096 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.645 ' CG ' ' H ' ' A' ' 226' ' ' GLN . 26.4 p-10 -77.64 -42.84 33.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.068 -1.02 . . . . 2.31 108.591 179.231 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.885 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 52.1 17.27 0.66 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.796 -1.187 . . . . 0.78 107.796 -178.905 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.436 ' N ' ' C ' ' A' ' 221' ' ' ASP . 45.6 t -130.86 -43.66 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 107.708 -1.219 . . . . 1.04 107.708 179.362 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -99.14 -0.52 41.5 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 106.805 -1.554 . . . . 2.44 106.805 177.942 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.521 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 40.4 t-20 60.06 46.72 10.43 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.423 -0.584 . . . . 1.55 109.423 -179.933 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.645 ' H ' ' CG ' ' A' ' 221' ' ' ASP . 95.3 mt-30 -140.46 157.23 45.83 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.385 -0.822 . . . . 1.99 109.647 -179.945 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 69.5 t -119.96 130.58 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 109.085 -0.709 . . . . 0.77 109.085 179.437 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 71.3 m-85 -99.33 122.74 42.89 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.576 -0.898 . . . . 0.98 108.576 179.001 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . 0.502 HG22 HD22 ' A' ' 218' ' ' LEU . 59.4 t -105.61 120.0 55.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.568 -0.707 . . . . 0.85 109.445 -179.242 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 62.96 66.76 1.17 Allowed Pre-proline 0 N--CA 1.496 1.864 0 O-C-N 121.372 -0.83 . . . . 1.66 109.53 -179.731 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -89.16 127.78 1.79 Allowed 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 123.142 2.561 . . . . 0.95 112.517 -179.664 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 26.0 p -75.33 170.47 16.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.236 -0.915 . . . . 1.84 109.623 -179.753 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -60.03 -39.44 85.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.339 -0.851 . . . . 2.74 109.088 179.67 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.08 -39.97 87.95 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.409 -0.807 . . . . 2.89 109.634 -179.382 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 53.6 t -67.24 -41.7 87.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.062 -1.024 . . . . 1.3 109.152 179.96 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 87.7 mt -64.97 -40.19 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.193 -0.942 . . . . 1.09 109.921 -179.628 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -60.09 -46.02 90.97 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.872 -1.142 . . . . 2.43 108.276 179.745 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 8.3 ttpm? -61.03 -43.38 98.97 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.3 -0.875 . . . . 2.78 108.853 179.013 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 92.6 mtp -67.93 -34.68 77.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.404 -0.81 . . . . 1.25 109.864 -179.94 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 25.6 mmt180 -62.98 -40.03 96.52 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.076 -1.015 . . . . 2.63 109.535 179.463 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.77 -39.3 84.4 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.175 -0.953 . . . . 1.8 108.532 179.781 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 89.9 t -59.93 -39.43 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 N-CA-C 108.456 -0.942 . . . . 2.13 108.456 179.201 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . 0.504 HE22 HD12 ' A' ' 11' ' ' ILE . 5.7 tp-100 -60.0 -39.9 87.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.411 -0.806 . . . . 3.17 109.601 -179.947 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -60.04 -40.03 87.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.082 -1.012 . . . . 1.78 109.344 -179.911 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -68.89 -40.03 79.42 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.106 -0.996 . . . . 2.47 108.565 179.291 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 68.2 t -68.03 -39.51 81.61 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.858 -0.793 . . . . 2.09 108.858 179.333 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -59.33 -39.96 84.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.51 -0.744 . . . . 2.54 109.715 -179.364 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 29.0 t -60.0 -43.51 95.15 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.852 -1.155 . . . . 2.99 108.676 179.434 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -70.03 -40.01 75.44 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.461 -0.774 . . . . 3.34 109.021 179.551 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -66.77 -34.3 77.53 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.368 -0.833 . . . . 3.88 108.83 179.615 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -64.18 -52.83 57.06 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.225 -0.922 . . . . 4.43 109.885 -179.844 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -69.98 -40.09 75.57 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.295 -0.878 . . . . 5.42 111.076 -179.283 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 5.4 mt 49.91 55.49 9.34 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.97 -1.081 . . . . 6.1 108.158 -179.002 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -160.72 47.16 0.22 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.377 -0.827 . . . . 7.37 109.309 179.92 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -141.66 163.57 32.57 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.256 -0.903 . . . . 8.01 109.016 -179.777 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 35.8 mt -44.22 110.62 0.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.542 -0.724 . . . . 9.05 109.87 -179.509 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 33.2 tptt -86.03 7.43 24.58 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.301 -0.875 . . . . 10.56 108.809 179.54 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -60.02 -40.07 88.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.685 -1.259 . . . . 11.32 109.951 -179.743 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? . . . . . 0 N--CA 1.491 1.604 0 O-C-N 120.828 -1.17 . . . . 12.42 109.354 -179.979 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 43.9 ttm . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 121.581 0.705 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -151.16 149.4 29.43 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.121 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -146.19 154.98 42.37 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.063 -1.023 . . . . 0.0 110.393 -179.226 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 -150.36 146.72 26.89 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.598 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . 0.527 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 56.8 mp0 -110.21 127.82 55.16 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.249 -0.907 . . . . 0.0 109.623 179.334 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -127.35 122.8 60.46 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.423 0 CA-C-O 122.295 1.045 . . . . 0.0 112.807 -176.849 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 58.8 m -77.95 101.52 6.9 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.997 0.903 . . . . 0.0 110.268 -178.987 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . 0.522 HG22 ' H ' ' B' ' 310' ' ' ALA . 96.9 mt -50.81 118.45 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 122.204 1.002 . . . . 0.0 109.923 -177.874 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 19.1 p -100.35 22.14 12.04 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.676 -178.776 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.522 ' H ' HG22 ' B' ' 308' ' ' ILE . . . -86.82 114.24 57.16 Favored Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.97 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -68.82 -4.86 14.17 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 CA-C-N 120.227 1.117 . . . . 0.0 112.456 -179.283 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -108.76 4.81 24.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.518 -0.738 . . . . 0.0 109.101 179.741 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 70.6 169.77 8.65 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 -179.051 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.508 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -86.14 92.05 8.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.3 . . . . 0.0 108.846 -179.138 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.405 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 5.4 p80 -95.23 -159.94 0.75 Allowed 'General case' 0 N--CA 1.504 2.239 0 O-C-N 121.085 -1.009 . . . . 0.0 109.98 179.029 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.3 m -58.92 -44.67 91.36 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.931 -1.106 . . . . 0.0 112.611 -175.995 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.615 ' NH2' ' NE2' ' B' ' 321' ' ' GLN . 1.6 tpt180 -59.88 -60.59 10.09 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 120.487 -1.383 . . . . 0.0 112.027 -178.257 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.405 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 12.0 Cg_endo -59.94 -32.04 94.55 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 CA-C-N 120.362 1.165 . . . . 0.0 111.338 -179.974 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.99 -51.28 70.32 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.431 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.78 -40.09 65.99 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.601 -179.079 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . 0.615 ' NE2' ' NH2' ' B' ' 317' ' ' ARG . 50.0 mt-30 -69.87 -41.0 75.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.985 -1.072 . . . . 0.0 108.662 179.061 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -60.05 -51.26 70.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.72 -0.612 . . . . 0.0 110.343 -179.223 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . 0.401 HG13 ' O ' ' B' ' 344' ' ' ALA . 71.1 t -69.68 -35.75 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.946 -1.096 . . . . 0.0 109.743 -179.134 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 14.8 ttmt -50.05 -49.89 49.65 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.387 -0.821 . . . . 0.0 109.122 -179.792 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -60.07 -49.9 75.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.269 -0.895 . . . . 0.0 109.339 -179.387 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -63.14 -47.11 84.11 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.157 -0.964 . . . . 0.0 109.765 179.765 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 5.8 tptp -48.4 -26.64 2.18 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.531 -0.73 . . . . 0.0 109.678 -179.339 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -82.59 -15.74 72.7 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.921 -1.133 . . . . 0.0 110.655 -179.181 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -105.72 135.0 47.92 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.26 -1.141 . . . . 0.0 109.434 179.736 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 16.9 m -90.6 -13.36 34.57 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.977 -1.077 . . . . 0.0 109.246 179.651 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 52.0 p -55.05 148.77 13.11 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.228 -0.92 . . . . 0.0 108.848 179.9 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -68.35 128.72 37.61 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.002 -1.061 . . . . 0.0 108.567 -179.979 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 95.3 mt -132.34 132.32 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.675 -0.641 . . . . 0.0 109.352 -179.809 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 27.1 m -130.63 152.36 50.08 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.449 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 46.0 t -114.73 140.16 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 178.521 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 94.2 m -130.13 122.69 28.72 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.196 -0.94 . . . . 0.0 108.646 179.604 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 2.8 t -140.53 118.14 11.59 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.936 0.875 . . . . 0.0 112.065 -178.906 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 50.05 50.5 18.42 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 175.806 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 89.95 -10.77 72.77 Favored Glycine 0 N--CA 1.502 3.089 0 O-C-N 119.802 -1.811 . . . . 0.0 113.85 176.11 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -128.26 140.31 51.96 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 120.022 1.911 . . . . 0.0 109.514 -179.642 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.7 m -126.74 147.79 49.95 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.818 0.818 . . . . 0.0 111.377 -178.266 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -141.3 164.58 29.86 Favored 'General case' 0 N--CA 1.502 2.164 0 CA-C-O 121.309 0.576 . . . . 0.0 109.694 179.98 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 27.3 m -88.63 138.01 31.8 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.319 -0.863 . . . . 0.0 110.03 -179.326 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.401 ' O ' HG13 ' B' ' 323' ' ' VAL . . . -78.9 -12.0 60.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.896 -1.127 . . . . 0.0 109.86 -179.479 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.0 tttt -91.87 20.15 5.95 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 178.042 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 42.6 t -145.89 94.44 2.48 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.013 -179.699 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.816 HD23 HD22 ' A' ' 79' ' ' LEU . 60.8 tp -59.88 -33.85 72.38 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.829 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 79' ' ' LEU . 58.9 m-85 -57.25 -53.68 55.38 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.32 -0.863 . . . . 0.0 110.76 -179.337 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 33.1 mtmm -70.01 -29.63 66.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.868 -1.145 . . . . 0.0 110.951 -177.989 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.463 ' O ' ' N ' ' B' ' 352' ' ' THR . 84.8 mt -60.06 -52.86 63.55 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.157 179.903 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.61 HE22 HD11 ' B' ' 347' ' ' LEU . 0.7 OUTLIER -42.42 -21.52 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.436 -0.79 . . . . 0.0 110.674 -178.009 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.463 ' N ' ' O ' ' B' ' 350' ' ' LEU . 68.1 p -81.74 -12.25 58.67 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.406 -1.434 . . . . 0.0 109.964 -179.112 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 31.4 mt -95.39 120.08 35.0 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 120.95 -1.094 . . . . 0.0 109.082 178.409 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -80.89 92.5 1.45 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.364 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 22.9 mt -98.42 93.07 5.98 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.111 -1.229 . . . . 0.0 108.139 178.695 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 53.6 p -95.17 -179.96 4.99 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.084 -1.01 . . . . 0.0 111.279 -178.249 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' B' ' 359' ' ' THR . 7.2 tt0 -46.86 154.65 0.31 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.175 0.988 . . . . 0.0 111.035 -179.546 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 38.98 26.88 0.05 OUTLIER Glycine 0 N--CA 1.497 2.743 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.157 177.754 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . 0.447 ' N ' ' O ' ' B' ' 357' ' ' GLN . 23.8 m -84.61 111.27 19.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.798 -1.413 . . . . 0.0 109.744 179.922 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 12.6 t -78.16 113.06 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 CA-C-O 122.297 1.046 . . . . 0.0 109.774 -177.587 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 16.0 m -110.09 178.51 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -178.173 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 25.5 m -131.48 127.13 36.71 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.176 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 60.4 mt -103.43 118.9 51.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.96 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 58.3 p -121.19 133.23 55.17 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.401 -0.812 . . . . 0.0 109.283 -179.459 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -143.79 148.25 35.31 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.048 -1.032 . . . . 0.0 110.527 -179.046 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -140.03 121.19 14.78 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.275 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.561 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 160.38 -163.52 33.99 Favored Glycine 0 N--CA 1.492 2.367 0 C-N-CA 119.048 -1.549 . . . . 0.0 111.53 -179.758 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -59.97 -52.76 64.0 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 122.162 -0.61 . . . . 0.0 111.998 -177.896 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.507 ' H ' ' HB3' ' B' ' 331' ' ' SER . 96.0 m-20 -105.2 10.1 33.86 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.974 -1.079 . . . . 0.0 111.128 -177.407 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.561 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -42.18 -36.2 1.14 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.222 -0.924 . . . . 0.0 111.392 -179.155 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 30.5 mm100 -70.0 -40.04 75.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.921 -1.112 . . . . 0.0 109.899 -179.012 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -66.51 -48.41 69.86 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.021 -1.049 . . . . 0.0 109.394 -179.441 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -48.07 -75.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.356 -0.84 . . . . 0.0 110.686 -179.098 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.64 ' O ' HG23 ' B' ' 378' ' ' VAL . 37.4 t -44.64 -38.26 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.235 -0.915 . . . . 0.0 110.881 -177.519 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -64.03 -51.37 64.52 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.576 -1.328 . . . . 0.0 110.887 -179.597 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -74.54 -40.67 61.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.88 -1.138 . . . . 0.0 109.976 -179.668 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 91.4 mt -60.01 -39.79 87.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.897 . . . . 0.0 110.095 -179.502 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.64 HG23 ' O ' ' B' ' 374' ' ' VAL . 55.4 t -62.18 -43.39 97.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.211 -0.931 . . . . 0.0 109.968 -179.867 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -68.56 -54.59 15.65 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.615 -1.303 . . . . 0.0 108.617 178.687 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 50.1 tp -58.56 -34.72 71.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.23 -0.919 . . . . 0.0 109.937 -178.126 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 32.0 ttm -70.59 -40.05 73.46 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 118.408 -1.317 . . . . 0.0 108.42 177.927 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -82.24 -7.17 59.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.456 -0.777 . . . . 0.0 110.716 179.57 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -110.84 -1.74 16.41 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 121.077 -1.015 . . . . 0.0 111.54 -178.804 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 14.7 mt -81.89 130.25 35.01 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.297 -1.502 . . . . 0.0 109.197 178.823 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 . . . . . 0 N--CA 1.498 1.972 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.328 179.937 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtt . . . . . 0 N--CA 1.488 1.468 0 N-CA-C 109.61 -0.515 . . . . 2.91 109.61 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.7 mt -101.39 127.74 54.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.297 -0.877 . . . . 1.2 109.491 -179.736 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.0 m -139.61 152.45 46.82 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 108.923 -0.769 . . . . 1.4 108.923 -179.929 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -134.89 -164.05 10.36 Favored Glycine 0 N--CA 1.499 2.843 0 N-CA-C 108.759 -1.736 . . . . 1.05 108.759 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.7 mt -88.57 -16.29 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.895 -1.356 . . . . 1.15 110.306 -179.133 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 5' ' ' ILE . 60.1 tp 51.06 103.8 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.282 -0.886 . . . . 0.98 109.51 179.932 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -98.9 -25.38 14.63 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.06 -1.025 . . . . 0.88 109.523 179.604 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.5 m -134.83 121.19 14.69 Favored Pre-proline 0 N--CA 1.5 2.058 0 O-C-N 121.511 -0.743 . . . . 1.69 109.432 -179.875 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -81.09 151.42 18.23 Favored 'Trans proline' 0 N--CA 1.497 1.7 0 C-N-CA 122.163 1.909 . . . . 0.85 112.81 179.947 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.926 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 142.35 177.82 17.77 Favored Glycine 0 N--CA 1.502 3.034 0 N-CA-C 109.248 -1.541 . . . . 0.92 109.248 179.597 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.6 mt -128.17 131.36 69.36 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.326 0 O-C-N 120.847 -1.384 . . . . 0.81 110.07 -179.555 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -134.4 155.98 49.35 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.252 -0.905 . . . . 0.51 109.888 -179.785 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 2.5 m-85 -129.44 129.63 44.9 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.655 -0.869 . . . . 0.62 108.655 179.879 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -177.79 171.7 44.29 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 118.979 -1.582 . . . . 0.55 110.583 179.841 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -77.39 158.42 30.09 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.682 -0.893 . . . . 2.1 109.294 -179.895 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.451 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -101.89 129.63 48.18 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.385 -0.822 . . . . 0.77 111.775 -178.247 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.7 tp -100.17 132.26 45.64 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.179 -1.415 . . . . 0.91 107.179 177.928 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 47.0 tp -115.89 123.73 48.85 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.186 -0.946 . . . . 0.93 110.265 -179.218 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.2 mt -89.78 102.21 14.9 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.277 0.56 . . . . 0.93 110.541 -179.202 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -94.08 135.14 35.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.383 -0.823 . . . . 2.75 108.931 179.378 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -131.43 134.0 45.77 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.148 -0.97 . . . . 3.0 108.858 179.108 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -83.95 139.78 32.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.249 -0.907 . . . . 2.77 109.246 179.895 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -61.45 140.25 58.09 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.905 . . . . 2.94 109.42 -179.822 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.2 mt -82.83 133.69 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.296 -0.878 . . . . 0.95 108.864 179.916 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.67 129.97 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.329 -0.857 . . . . 1.28 109.356 -179.666 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 92.0 mt -102.22 141.39 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.487 -0.758 . . . . 1.21 109.383 -179.84 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -96.13 120.48 36.49 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.153 -0.967 . . . . 1.81 109.721 -179.655 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.503 HH11 ' HG2' ' A' ' 28' ' ' ARG . 3.5 mmt-85 -87.48 -0.67 57.16 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.523 -0.735 . . . . 2.8 109.712 -179.627 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -67.9 136.55 54.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.923 . . . . 2.87 109.235 179.991 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -81.3 150.73 28.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.105 -0.997 . . . . 2.35 109.117 179.718 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.459 HG21 ' HG3' ' A' ' 39' ' ' GLU . 4.1 pt -93.15 166.67 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.191 -0.943 . . . . 0.97 109.798 -179.933 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 35.9 p -96.75 171.67 8.38 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.499 -0.926 . . . . 1.17 108.499 178.705 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.98 -48.81 80.17 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.121 -0.987 . . . . 1.18 109.868 -179.492 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.472 ' N ' ' OD1' ' A' ' 34' ' ' ASP . 4.8 p-10 -57.14 -26.07 59.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.738 -1.226 . . . . 2.56 109.437 -179.639 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -82.76 -10.09 59.05 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.262 -0.899 . . . . 1.79 109.826 179.833 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.4 t -64.06 -52.48 55.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.964 -1.085 . . . . 1.0 109.368 -179.731 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.24 -40.05 94.88 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.335 -0.853 . . . . 1.77 109.478 179.817 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 89.6 mm-40 -67.66 -42.79 81.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.161 -0.962 . . . . 2.7 110.98 -178.926 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.485 ' OE2' ' NH1' ' A' ' 42' ' ' ARG . 72.6 mm-40 -66.67 -40.02 88.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.747 -1.221 . . . . 1.51 110.182 -179.504 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.3 t -59.97 -45.49 95.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 120.739 -1.226 . . . . 0.93 108.025 178.938 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -60.03 -39.95 87.66 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.35 -0.844 . . . . 1.81 109.319 179.649 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.485 ' NH1' ' OE2' ' A' ' 39' ' ' GLU . 99.0 mtt180 -60.02 -43.99 94.88 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.782 -1.192 . . . . 2.78 107.782 178.838 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -60.84 -47.06 88.08 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.743 -0.836 . . . . 0.78 108.743 178.076 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.3 tp -60.01 -48.71 80.57 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.516 -0.92 . . . . 1.07 108.516 -179.857 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 48' ' ' ALA . 47.6 t -61.4 -42.28 98.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 1.12 108.86 179.255 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.39 -46.5 94.26 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 108.735 -1.746 . . . . 0.84 108.735 179.273 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.408 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 38.1 ttt-85 -62.89 -32.74 74.07 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.168 -1.049 . . . . 3.09 108.168 178.422 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 45' ' ' SER . . . -59.55 -43.83 93.43 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.237 -0.653 . . . . 0.88 109.237 -179.516 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 50' ' ' ALA . 26.5 ttpp -68.81 -74.25 0.13 Allowed 'General case' 0 C--N 1.306 -1.325 0 O-C-N 120.854 -1.154 . . . . 2.59 108.331 179.473 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.441 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.22 -35.3 0.11 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.335 -0.853 . . . . 0.7 111.378 -178.366 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.7 t -58.44 -53.32 59.64 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 118.317 -1.353 . . . . 1.4 108.301 179.559 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.35 -39.99 81.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.328 -0.857 . . . . 0.67 111.088 -179.232 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -67.57 -40.11 84.9 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.745 -1.222 . . . . 1.66 109.968 -179.598 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 58.6 mt -63.84 -40.01 95.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.978 -1.077 . . . . 1.58 108.819 179.842 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -63.93 -37.92 89.19 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.354 -0.841 . . . . 1.35 109.52 179.252 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 94.0 m -62.87 -43.5 98.62 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.098 -1.001 . . . . 0.77 108.548 179.175 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.46 -39.98 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 109.022 -0.733 . . . . 0.63 109.022 179.498 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 ttpp -56.98 -51.84 67.6 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.165 -0.959 . . . . 1.14 109.876 -179.781 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.7 m -58.78 -30.8 67.84 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.431 -0.793 . . . . 0.79 110.29 -178.083 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 30.0 mtpt -69.64 -38.86 77.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.092 -1.005 . . . . 1.53 109.071 -179.826 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.2 -42.91 93.07 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.692 -0.63 . . . . 0.57 109.72 -179.8 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.37 -52.37 52.09 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.839 -1.305 . . . . 0.75 109.839 -179.318 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -70.2 -47.53 61.12 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.08 -1.247 . . . . 1.59 110.122 -179.962 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.4 m -66.49 -62.7 1.32 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.155 -0.966 . . . . 0.73 112.399 -177.449 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -95.34 -48.48 5.86 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.761 -1.212 . . . . 0.75 111.105 -178.218 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.31 -169.68 24.96 Favored Glycine 0 N--CA 1.5 2.917 0 C-N-CA 119.801 -1.19 . . . . 1.22 111.045 179.608 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -69.95 -23.83 63.25 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.819 -0.812 . . . . 5.81 109.547 179.881 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 tp10 -61.93 -35.92 79.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.734 -0.603 . . . . 3.37 110.947 -179.27 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.468 ' HA ' HD12 ' A' ' 72' ' ' ILE . 61.2 mmtt -99.4 -17.53 17.94 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.208 -0.932 . . . . 1.77 109.315 -179.934 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -69.2 -40.08 78.25 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.404 -0.81 . . . . 1.65 109.968 -179.187 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.566 ' CB ' ' NH1' ' B' ' 317' ' ' ARG . . . -69.18 -26.8 65.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.288 -0.883 . . . . 0.77 109.991 -179.137 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 69' ' ' LYS . 81.9 mt -59.95 -42.12 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.098 -1.001 . . . . 0.8 108.608 -179.973 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -66.2 -40.03 90.08 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.392 -0.923 . . . . 0.88 109.706 179.845 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.7 tt0 -59.96 -41.17 91.31 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.939 -1.101 . . . . 1.37 109.294 179.503 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.28 -44.87 97.05 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.69 -1.764 . . . . 0.62 108.69 179.353 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.9 m170 -66.86 -49.95 64.06 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.417 -1.049 . . . . 1.5 109.134 179.563 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 88.3 mt -59.98 -50.01 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.329 -0.857 . . . . 0.63 109.322 179.719 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 41.3 ttp -60.12 -39.88 87.78 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.12 -0.987 . . . . 1.51 109.774 -179.265 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.836 HD22 HD23 ' B' ' 347' ' ' LEU . 55.5 tp -67.52 -40.0 85.1 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.403 -0.81 . . . . 0.77 109.946 179.7 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 59.1 tp -63.63 -39.87 95.46 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.576 -0.703 . . . . 0.62 109.611 -179.488 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -83.25 6.42 19.61 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.205 -0.935 . . . . 1.47 109.758 -179.101 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.481 ' OD1' ' N ' ' A' ' 83' ' ' GLU . 60.9 t0 -49.88 134.12 21.4 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.318 -0.864 . . . . 1.47 110.648 -179.074 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.481 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 98.9 mt-10 -59.98 -25.06 64.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.724 -0.61 . . . . 1.78 111.148 -179.464 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -70.95 -33.81 70.85 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.068 -1.02 . . . . 2.53 109.346 179.629 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 79' ' ' LEU . 87.8 mt -69.94 -40.21 75.6 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.571 0.7 . . . . 0.8 109.846 179.743 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -60.03 -47.1 87.23 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.373 -0.829 . . . . 1.42 110.594 -178.921 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -69.96 -41.28 74.72 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.277 -0.89 . . . . 1.71 111.184 -178.706 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.07 -39.91 75.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.03 -1.044 . . . . 1.57 111.697 -178.63 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 96.4 mt -68.82 -47.19 77.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.033 -1.042 . . . . 0.65 109.94 -179.233 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 96.6 mt -67.43 -39.56 82.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.538 -0.727 . . . . 0.82 109.999 -179.949 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.98 -47.42 85.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.164 -0.96 . . . . 0.79 110.844 -179.195 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.09 -46.85 88.23 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.026 -1.046 . . . . 0.95 109.859 -179.238 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 72.8 mt -61.64 -49.93 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.213 -0.929 . . . . 0.66 109.015 179.681 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -67.29 -41.48 85.36 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.649 -0.657 . . . . 2.2 110.89 -179.247 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -83.87 -50.51 8.0 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.84 -1.162 . . . . 1.65 112.013 -178.642 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -90.16 -3.74 57.69 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.985 -1.072 . . . . 2.03 111.699 -177.337 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 53.3 m80 56.77 37.56 28.89 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.782 -1.199 . . . . 1.42 109.457 -179.518 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 54.8 mtt -90.04 168.82 11.7 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.574 -0.704 . . . . 1.18 109.733 -179.683 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 63.4 p -80.38 160.03 25.52 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.33 -0.856 . . . . 0.98 108.722 179.315 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.8 -37.75 76.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.064 -1.023 . . . . 0.64 110.422 -179.271 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 38.0 p-10 -69.96 -36.74 75.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.898 -1.127 . . . . 2.07 109.799 -179.566 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.515 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -80.86 -42.89 20.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.936 . . . . 0.73 109.624 179.569 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.55 -47.96 74.07 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.41 -0.806 . . . . 0.54 109.992 -179.514 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.97 -38.56 82.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.084 -1.01 . . . . 0.56 109.746 -179.776 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -59.94 -39.97 87.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.395 -0.816 . . . . 1.54 110.275 -178.561 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -63.8 -39.97 95.53 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.083 -1.01 . . . . 1.33 110.809 -178.779 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 98.3 t -62.17 -50.07 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.034 -1.041 . . . . 0.72 111.037 -178.401 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.9 mm -69.56 -40.0 79.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 120.963 -1.086 . . . . 0.85 108.988 -179.862 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.4 tm-20 -60.03 -38.62 83.26 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.103 -0.703 . . . . 2.44 109.103 179.056 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -61.03 -49.95 72.8 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 120.562 -0.828 . . . . 0.98 111.219 -179.111 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -66.64 -50.02 64.31 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.77 -1.43 . . . . 1.41 110.442 -178.528 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.2 88.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.905 -1.122 . . . . 1.2 109.231 -179.704 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 34.0 t -60.07 -40.72 90.52 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.306 -0.871 . . . . 1.7 109.074 -179.557 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.98 92.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.27 -0.894 . . . . 1.47 109.12 179.291 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.6 mt -65.98 -42.3 90.0 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.117 -0.989 . . . . 1.56 109.397 -179.634 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -59.95 -37.91 80.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.663 -1.273 . . . . 2.2 109.302 -179.473 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -52.42 -21.46 3.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.024 -1.048 . . . . 2.12 108.681 179.539 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.515 HD13 HD13 ' A' ' 123' ' ' LEU . 59.2 mt -63.64 152.31 39.31 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.145 -0.972 . . . . 2.0 108.877 179.612 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -98.66 41.06 1.15 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.08 -1.012 . . . . 3.23 110.363 -179.568 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -135.73 149.71 49.29 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.129 -0.982 . . . . 2.49 110.227 -179.798 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.469 ' OE1' ' N ' ' A' ' 121' ' ' GLU . 58.5 mp0 -74.96 -67.08 0.68 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 121.742 0.782 . . . . 3.95 109.514 178.956 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.5 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 3.1 t80 -39.48 -38.65 0.6 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.8 -0.562 . . . . 2.0 111.236 -178.732 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.515 HD13 HD13 ' A' ' 118' ' ' LEU . 88.7 mt -68.31 -39.92 81.85 Favored 'General case' 0 C--N 1.296 -1.756 0 O-C-N 120.714 -1.241 . . . . 1.86 108.844 -179.335 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 121' ' ' GLU . 7.7 ttpm? -67.14 -31.08 71.27 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.361 -0.837 . . . . 2.84 109.477 179.311 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -60.02 -46.12 90.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.287 -0.883 . . . . 2.73 109.759 -179.405 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.472 HH21 ' CD2' ' A' ' 123' ' ' LEU . 83.8 mtm180 -65.51 -37.27 86.28 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.978 -1.076 . . . . 2.77 108.373 178.754 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.94 -29.05 68.13 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.284 -1.006 . . . . 1.19 108.284 178.544 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -69.12 -40.3 78.38 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.598 -0.89 . . . . 1.2 108.598 179.108 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -63.43 -40.0 96.01 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.244 -1.021 . . . . 1.55 108.244 178.976 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 42.6 t -66.01 -40.01 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 108.535 -0.913 . . . . 0.8 108.535 178.939 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 43.4 ttt-85 -60.01 -39.42 85.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.45 -0.781 . . . . 3.09 109.169 179.1 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.411 ' O ' ' OD1' ' A' ' 132' ' ' ASP . 60.5 t0 -59.94 -39.56 85.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.384 -0.823 . . . . 1.46 109.934 -179.724 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.88 -46.6 93.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.108 -0.995 . . . . 0.71 110.303 -178.76 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -70.77 -34.32 66.38 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.519 -1.432 . . . . 0.57 109.519 179.735 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 20.2 tptm -60.0 -50.16 74.82 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.421 -1.046 . . . . 2.59 110.368 -179.221 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 56.3 mtp180 -69.98 -31.47 69.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.946 -1.096 . . . . 2.83 110.02 -179.574 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 61.5 tp -60.06 -41.71 92.95 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.315 -0.866 . . . . 1.25 108.963 -179.153 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.43 -40.08 95.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.14 -0.975 . . . . 0.7 109.2 179.408 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 66.2 mtm180 -69.24 -40.0 78.15 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.309 -0.869 . . . . 2.57 108.798 179.465 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . 0.593 HD22 ' N ' ' A' ' 140' ' ' ASN . 1.3 m120 -64.41 -35.39 80.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.67 -0.644 . . . . 1.23 111.456 -178.853 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 88.4 mt -71.09 -44.63 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.52 -1.362 . . . . 0.81 109.152 179.81 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 95.7 mt -70.05 -29.01 65.92 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.663 -0.648 . . . . 1.0 109.616 -179.678 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.57 40.01 11.52 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.614 -1.795 . . . . 0.89 108.614 -179.01 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 56.5 tp -73.76 147.49 43.43 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.524 -0.986 . . . . 1.14 109.192 -179.445 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -61.06 139.58 58.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 4.6 109.63 -179.273 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 96.7 mt -116.48 130.11 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-O 121.957 0.884 . . . . 1.24 109.279 179.496 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 5.8 mt -60.1 -47.35 92.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 115.994 -0.548 . . . . 1.54 110.76 -177.833 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.6 t0 66.11 99.7 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 108.44 -0.948 . . . . 1.5 108.44 -179.045 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 45.1 mt -70.9 -2.04 13.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.327 -0.858 . . . . 0.79 110.73 -178.653 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 71.9 p -84.32 -13.53 52.14 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.737 -1.227 . . . . 1.4 109.744 179.999 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -79.51 29.45 0.24 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.226 -0.921 . . . . 0.92 112.004 -177.913 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 39.5 mm -87.64 120.29 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.467 -1.396 . . . . 0.88 109.691 -179.86 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -100.38 -9.96 21.7 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.396 -0.815 . . . . 2.45 110.3 -179.736 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -139.39 158.09 44.74 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 120.986 -1.071 . . . . 1.52 110.219 -179.395 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -64.84 136.95 57.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.141 -0.975 . . . . 1.58 109.307 179.944 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 26.9 m -152.84 165.64 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.564 -0.71 . . . . 0.69 109.371 179.381 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 85.3 mt -95.55 148.0 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 105.662 -1.977 . . . . 0.61 105.662 177.208 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 60.2 tp -98.37 116.14 29.96 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.053 -1.029 . . . . 0.87 111.003 -177.365 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.5 t -119.98 128.24 75.93 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 108.493 -0.928 . . . . 0.71 108.493 178.811 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -157.6 160.26 37.92 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.111 -0.993 . . . . 0.81 108.725 -179.982 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.424 ' O ' ' OD1' ' A' ' 182' ' ' ASP . . . -70.32 -33.71 71.84 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 120.205 -1.559 . . . . 0.98 107.848 178.669 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 162' ' ' ASP . 20.2 p-10 -161.95 170.92 18.51 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.993 -0.743 . . . . 2.25 108.993 179.859 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.3 mt -142.86 129.99 20.81 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.058 -1.026 . . . . 0.78 108.841 179.189 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 61.8 p -88.49 146.1 36.85 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.073 -1.017 . . . . 0.98 109.202 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -41.83 -35.56 2.98 Favored 'Trans proline' 0 N--CA 1.491 1.341 0 C-N-CA 121.949 1.766 . . . . 0.81 112.513 179.277 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 57.0 m -60.05 -39.98 87.85 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.066 -1.021 . . . . 0.9 109.142 -179.364 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.75 -42.85 97.77 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.377 -0.827 . . . . 1.61 109.816 179.984 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 82.3 p -56.53 -30.33 62.94 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.28 -0.887 . . . . 0.61 111.529 -178.094 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.43 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -73.19 -56.78 4.63 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.65 -1.281 . . . . 0.6 109.937 -179.974 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -79.39 36.59 0.31 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.327 -0.99 . . . . 1.4 108.327 -179.896 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.43 ' H ' ' C ' ' A' ' 169' ' ' ALA . 15.6 tp -103.2 134.33 46.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 0.7 109.593 179.466 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -86.35 101.02 12.72 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.882 -1.155 . . . . 2.35 107.882 178.436 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 76.3 mt -65.16 -40.97 95.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 1.51 110.947 -178.483 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -69.87 -21.77 63.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.763 -1.211 . . . . 2.33 111.086 -178.087 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -93.89 -10.69 33.07 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.796 -1.19 . . . . 1.92 109.693 -179.533 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 178' ' ' GLY . 71.5 t -105.59 116.57 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 N-CA-C 108.397 -0.964 . . . . 0.67 108.397 178.599 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 88.9 mt -85.41 5.45 30.9 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.216 -0.928 . . . . 1.53 110.235 -178.215 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.562 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 169.4 174.44 37.82 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.4 -1.48 . . . . 0.48 109.4 179.71 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.477 ' CE1' HG11 ' A' ' 176' ' ' VAL . 18.0 m-85 -132.69 128.77 37.68 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.487 -1.008 . . . . 0.55 108.817 179.974 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 96.7 mt -132.04 126.07 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.82 -0.807 . . . . 0.65 108.82 178.958 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 24.1 p -149.43 160.02 43.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.122 -0.986 . . . . 0.82 110.459 -179.208 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.425 ' OD1' ' C ' ' A' ' 182' ' ' ASP . 42.8 p-10 -108.23 28.85 7.89 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 108.764 -0.828 . . . . 2.46 108.764 179.256 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -68.39 -158.6 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 CA-C-O 121.971 0.891 . . . . 1.28 112.227 -177.702 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -61.13 -71.4 0.8 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.959 -0.857 . . . . 2.19 110.959 -178.804 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 161.93 -131.82 2.66 Favored Glycine 0 N--CA 1.492 2.406 0 O-C-N 120.764 -1.433 . . . . 2.13 110.631 -179.658 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.764 ' HE ' HH12 ' A' ' 195' ' ' ARG . 33.2 ttt-85 -61.38 -39.99 92.7 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.586 -0.949 . . . . 5.86 111.506 -178.702 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 18.0 p -64.8 5.33 0.33 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.829 -1.169 . . . . 3.72 110.602 -178.532 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.451 ' H ' ' C ' ' A' ' 186' ' ' ARG . 48.0 t -90.87 130.07 36.86 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.953 -1.092 . . . . 1.74 110.702 -179.591 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 59.3 t60 -49.33 -44.81 44.77 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.423 -0.798 . . . . 0.95 109.255 179.509 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 88.8 m -60.01 -39.43 85.79 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.615 -0.678 . . . . 1.55 109.73 -179.26 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 47.5 t -58.66 -42.81 89.28 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.892 -1.13 . . . . 1.51 110.214 -179.225 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 93.9 mt -60.8 -38.82 79.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.198 -0.939 . . . . 1.67 109.844 -179.991 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.7 mtp -59.97 -46.01 90.82 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.148 -0.97 . . . . 1.02 110.539 -179.246 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -59.99 -44.43 94.52 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 120.825 -1.172 . . . . 0.68 110.097 -179.381 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.764 HH12 ' HE ' ' A' ' 186' ' ' ARG . 51.7 mtp180 -60.03 -50.06 75.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.133 -0.979 . . . . 2.93 110.71 -179.01 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 70.6 m -73.41 -33.59 65.05 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.001 -1.062 . . . . 0.86 111.553 -178.665 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 86.8 mt -80.55 -11.07 59.71 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.735 -1.228 . . . . 0.67 110.475 -178.435 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 58.56 49.94 9.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.307 -0.871 . . . . 1.5 110.706 179.384 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 86.5 mt -123.84 122.98 26.29 Favored Pre-proline 0 N--CA 1.502 2.135 0 N-CA-C 108.456 -0.942 . . . . 0.72 108.456 179.0 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_exo -43.28 133.48 6.56 Favored 'Trans proline' 0 N--CA 1.497 1.693 0 C-N-CA 122.037 1.825 . . . . 0.61 112.582 -179.845 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -170.58 150.01 3.32 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.846 -1.159 . . . . 0.66 111.375 179.819 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.0 mt -125.0 142.82 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 107.924 -1.139 . . . . 0.79 107.924 178.879 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 7.5 m -123.17 -8.57 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.393 0 O-C-N 120.85 -1.156 . . . . 0.91 111.057 -178.842 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -112.3 23.73 15.42 Favored Glycine 0 N--CA 1.5 2.962 0 O-C-N 121.381 -0.824 . . . . 1.01 111.203 -179.03 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 10.4 p -45.49 -44.36 12.4 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.776 -1.426 . . . . 0.99 109.751 -179.357 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . 0.417 ' H ' ' CB ' ' A' ' 182' ' ' ASP . . . 95.15 -51.28 1.89 Allowed Glycine 0 N--CA 1.499 2.88 0 C-N-CA 120.178 -1.01 . . . . 1.12 111.354 178.763 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 69.4 m -160.0 39.5 0.18 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.498 -1.59 . . . . 1.72 111.566 -179.242 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 30.9 t -79.96 -33.06 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.827 -1.171 . . . . 0.89 108.589 178.355 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 3.1 p -60.11 -40.01 88.2 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.608 -0.683 . . . . 1.03 111.095 -179.134 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 56.4 m -81.3 -13.56 58.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.971 -1.081 . . . . 1.83 110.563 -178.507 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 91.6 mm-40 -93.71 -11.91 30.43 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.073 -1.017 . . . . 2.27 110.755 -179.416 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 213' ' ' LYS . 46.4 t -121.27 161.78 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.325 0 O-C-N 121.19 -0.944 . . . . 0.92 110.601 -179.56 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.556 ' N ' HG12 ' A' ' 212' ' ' VAL . 0.0 OUTLIER -120.58 158.02 28.24 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 108.714 -0.847 . . . . 2.2 108.714 -179.441 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 215' ' ' ASP . 57.6 t-20 -59.71 139.93 56.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 2.36 110.461 -179.384 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 214' ' ' ASN . 3.1 t70 86.33 2.59 0.53 Allowed 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.15 0.5 . . . . 2.38 110.205 179.373 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' A' ' 217' ' ' TYR . 47.2 t0 -74.86 151.95 38.95 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.133 -0.979 . . . . 2.09 108.56 178.96 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.543 ' N ' ' OD1' ' A' ' 216' ' ' ASP . 47.9 t80 -96.56 120.19 36.43 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.421 -0.955 . . . . 1.27 108.421 179.52 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.451 HD12 ' HB2' ' A' ' 16' ' ' ALA . 91.9 mt -124.8 141.68 51.94 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.426 -0.796 . . . . 0.75 110.754 -179.224 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 88.6 mt -109.93 129.34 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 106.417 -1.697 . . . . 0.63 106.417 176.32 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 45.0 tp -101.28 117.67 35.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.027 -1.045 . . . . 0.7 109.024 -178.799 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.51 ' OD2' ' N ' ' A' ' 224' ' ' ASN . 8.5 t70 -76.96 -47.46 20.79 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.158 -0.964 . . . . 2.31 108.578 179.653 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.926 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 52.77 18.38 1.03 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 109.21 -0.663 . . . . 0.78 109.21 -179.958 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 72.8 t -132.67 -41.94 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.069 -1.456 . . . . 1.04 107.069 178.556 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.51 ' N ' ' OD2' ' A' ' 221' ' ' ASP . 35.3 m120 -106.52 1.83 25.73 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 107.168 -1.419 . . . . 2.44 107.168 177.828 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 60.01 47.34 9.85 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.84 -0.538 . . . . 1.55 110.128 -179.868 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -136.97 148.51 46.96 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.314 -0.866 . . . . 1.99 109.614 179.235 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 86.1 t -123.88 125.5 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 N-CA-C 109.294 -0.632 . . . . 0.77 109.294 179.659 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 41.6 m-85 -91.83 122.45 34.38 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.135 -0.978 . . . . 0.98 108.588 179.651 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 37.0 t -102.23 118.46 49.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.423 -0.798 . . . . 0.85 109.478 -179.401 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 9.6 t30 67.57 68.77 0.52 Allowed Pre-proline 0 N--CA 1.495 1.812 0 O-C-N 121.441 -0.787 . . . . 1.66 108.923 -179.479 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -89.12 124.88 1.49 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 123.207 2.605 . . . . 0.95 112.761 -179.39 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 7.3 m -63.29 162.77 11.57 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.268 -0.895 . . . . 1.84 108.881 179.684 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -60.11 -39.91 87.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.064 -1.022 . . . . 2.74 108.751 179.878 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -60.03 -38.88 84.04 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.4 -0.813 . . . . 2.89 109.193 179.534 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.6 t -62.64 -42.09 94.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.299 -0.876 . . . . 1.3 109.751 -179.75 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.85 -44.35 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.121 -0.987 . . . . 1.09 109.471 -179.994 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -59.99 -43.87 94.89 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.239 -0.913 . . . . 2.43 109.52 -179.596 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -61.39 -48.25 82.11 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 2.78 109.457 179.681 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 95.8 mtp -64.91 -32.75 74.61 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.348 -0.845 . . . . 1.25 109.886 -179.447 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -68.95 -40.06 79.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.081 -1.012 . . . . 2.63 109.127 179.161 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.01 81.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.265 -0.897 . . . . 1.8 109.066 179.623 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 54.2 t -61.86 -40.05 85.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.348 -0.845 . . . . 2.13 109.343 179.671 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -60.02 -39.96 87.64 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.179 -0.951 . . . . 3.17 108.962 -179.743 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -60.18 -40.02 88.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.116 -0.99 . . . . 1.78 108.73 179.216 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -65.69 -36.25 83.1 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.669 -0.644 . . . . 2.47 109.377 179.863 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.99 -41.47 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.335 -0.853 . . . . 2.09 109.215 -179.458 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.83 93.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.91 . . . . 2.54 108.842 179.548 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . 0.437 ' O ' ' HB2' ' A' ' 251' ' ' ALA . 60.2 p -70.0 -36.29 75.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.342 -0.849 . . . . 2.99 109.155 179.485 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 53.6 tp10 -59.92 -40.03 87.47 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.034 -0.728 . . . . 3.34 109.034 179.963 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.438 ' O ' ' C ' ' A' ' 251' ' ' ALA . 59.4 tttp -74.87 -3.63 33.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.427 -0.796 . . . . 3.88 109.36 -179.904 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 250' ' ' LYS . . . -36.7 -41.49 0.32 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.604 -0.685 . . . . 4.43 111.117 -179.598 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -162.79 36.83 0.1 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.883 -1.136 . . . . 5.42 110.742 179.913 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . . . . . . . . . 95.6 mt -117.63 -9.6 10.74 Favored 'General case' 0 N--CA 1.506 2.325 0 O-C-N 121.328 -0.858 . . . . 6.1 110.239 179.673 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -155.57 -4.4 0.13 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.836 -1.165 . . . . 7.37 110.113 179.66 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -68.0 -31.12 70.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.141 -0.975 . . . . 8.01 110.131 179.894 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 91.7 mt -59.92 -40.16 87.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.108 -0.995 . . . . 9.05 110.36 -178.85 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -109.88 -156.27 0.58 Allowed 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.12 -0.987 . . . . 10.56 109.713 -179.542 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 25.5 t0 72.66 -0.2 3.41 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.875 -0.516 . . . . 11.32 109.672 -179.416 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 44.8 ttp180 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 117.975 -1.012 . . . . 12.42 109.268 -179.852 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . 0.404 ' CG ' ' N ' ' B' ' 302' ' ' PHE . 32.2 ttp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.493 0.663 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . 0.404 ' N ' ' CG ' ' B' ' 301' ' ' MET . 32.7 t80 -153.75 150.26 28.32 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.34 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . 0.444 ' N ' ' CD ' ' B' ' 303' ' ' GLN . 3.9 pm0 -150.87 160.97 43.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.848 -1.158 . . . . 0.0 111.133 -179.398 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -152.19 148.89 28.14 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.554 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -114.03 132.13 56.11 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.218 -0.927 . . . . 0.0 109.827 179.282 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.21 127.97 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.306 0 CA-C-O 122.397 1.094 . . . . 0.0 112.61 -177.374 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 30.0 m -77.07 106.94 9.08 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.973 0.892 . . . . 0.0 110.603 -178.361 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 87.1 mt -52.2 124.05 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 CA-C-O 122.408 1.099 . . . . 0.0 110.508 -177.927 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 82.5 p -109.61 20.04 18.56 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.144 -178.697 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -79.13 115.71 54.74 Favored Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.28 -0.888 . . . . 0.0 109.005 179.291 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -58.38 -10.95 9.65 Favored 'Trans proline' 0 N--CA 1.497 1.728 0 CA-C-N 120.376 1.17 . . . . 0.0 113.487 -179.348 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 35.8 m120 -114.83 9.94 16.37 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.227 -0.921 . . . . 0.0 110.396 -178.898 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 68.63 172.41 7.45 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 -179.036 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.5 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.4 tp -85.13 92.11 8.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.867 -1.372 . . . . 0.0 109.967 -178.298 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.454 ' N ' ' HG2' ' B' ' 318' ' ' PRO . 4.7 p80 -96.68 -159.29 0.72 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.008 -1.057 . . . . 0.0 109.62 178.163 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 4.4 m -59.4 -47.47 85.31 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 120.783 -1.198 . . . . 0.0 112.764 -176.182 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.566 ' NH1' ' CB ' ' A' ' 71' ' ' ALA . 10.9 tpt180 -55.74 -58.97 12.84 Favored Pre-proline 0 N--CA 1.503 2.222 0 O-C-N 120.506 -1.372 . . . . 0.0 111.734 -179.102 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.454 ' HG2' ' N ' ' B' ' 315' ' ' HIS . 14.3 Cg_endo -61.81 -32.5 85.8 Favored 'Trans proline' 0 N--CA 1.492 1.418 0 CA-C-N 120.559 1.235 . . . . 0.0 111.388 179.988 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -63.67 -51.23 66.02 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.455 -0.778 . . . . 0.0 109.27 179.491 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -53.37 -39.99 64.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.161 -0.962 . . . . 0.0 109.373 -179.268 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . 0.513 HE21 ' HB1' ' A' ' 71' ' ' ALA . 96.5 mm-40 -68.7 -42.4 77.8 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.917 -1.114 . . . . 0.0 108.57 178.995 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -59.91 -50.4 73.9 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.526 -0.734 . . . . 0.0 110.298 -179.03 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 86.3 t -69.14 -29.15 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.722 -1.236 . . . . 0.0 110.207 -179.03 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 20.2 ttmt -59.13 -49.26 78.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.112 -0.992 . . . . 0.0 109.7 -178.83 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -66.42 -40.95 89.86 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.024 -1.047 . . . . 0.0 111.102 -179.179 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -60.04 -54.61 43.95 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.516 -1.365 . . . . 0.0 110.993 -178.855 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -55.16 -15.91 2.66 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.073 -1.017 . . . . 0.0 109.007 179.702 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -70.35 -29.65 69.94 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 108.807 -1.717 . . . . 0.0 108.807 178.729 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 -105.78 146.82 29.36 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.602 -0.94 . . . . 0.0 109.553 -179.916 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 32.0 p -90.57 -12.1 38.04 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.084 -1.01 . . . . 0.0 109.907 179.966 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.458 ' HB2' ' H ' ' B' ' 369' ' ' ASP . 47.6 t -61.47 144.69 53.78 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.282 -0.886 . . . . 0.0 109.507 179.928 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 58.8 mp0 -67.57 136.63 54.8 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.134 -0.979 . . . . 0.0 108.644 179.623 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 85.9 mt -130.73 131.02 64.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.5 -0.75 . . . . 0.0 110.002 -179.728 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 91.8 m -128.14 147.01 50.53 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.276 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.65 115.57 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.658 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 89.0 m -102.82 128.8 49.43 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.124 -0.985 . . . . 0.0 109.041 -178.566 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 90.8 p -139.23 114.31 9.51 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.892 0.853 . . . . 0.0 111.136 -179.217 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 27.5 m120 49.43 49.99 18.9 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 176.45 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 87.81 -13.86 59.93 Favored Glycine 0 N--CA 1.501 2.994 0 O-C-N 119.804 -1.81 . . . . 0.0 112.289 176.946 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -117.01 129.0 55.73 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 120.999 -1.295 . . . . 0.0 109.419 -179.871 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 48.4 p -126.57 147.92 49.81 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-O 121.884 0.85 . . . . 0.0 110.754 -178.962 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -144.45 168.03 21.07 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.505 0.669 . . . . 0.0 109.825 -179.666 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 28.2 t -90.94 136.09 33.3 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.567 -0.708 . . . . 0.0 110.835 -178.775 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -71.42 -17.52 62.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.347 -0.845 . . . . 0.0 108.795 179.159 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -88.34 16.67 6.03 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.599 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 10.9 t -143.94 92.12 2.3 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.732 0.777 . . . . 0.0 111.287 -179.345 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.836 HD23 HD22 ' A' ' 79' ' ' LEU . 58.9 tp -58.74 -36.86 75.01 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.379 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.805 ' CE2' HD11 ' A' ' 79' ' ' LEU . 61.1 m-85 -55.55 -50.06 71.04 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.854 . . . . 0.0 111.07 -179.14 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' B' ' 350' ' ' LEU . 25.2 mtmm -69.94 -40.03 75.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.722 -1.236 . . . . 0.0 110.721 -177.915 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.483 ' O ' ' N ' ' B' ' 352' ' ' THR . 87.9 mt -46.87 -55.69 7.57 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.995 -1.066 . . . . 0.0 109.106 -179.407 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.689 HE21 ' N ' ' B' ' 351' ' ' GLN . 0.0 OUTLIER -39.38 -24.47 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.569 -0.707 . . . . 0.0 111.169 -178.76 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.483 ' N ' ' O ' ' B' ' 350' ' ' LEU . 75.6 p -81.27 -10.15 59.64 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.127 -1.608 . . . . 0.0 109.995 -179.096 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 32.9 mt -95.29 114.99 26.83 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.062 -1.024 . . . . 0.0 109.11 178.612 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -74.65 94.46 0.86 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 179.307 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 34.4 mt -101.77 89.56 3.72 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.366 -1.079 . . . . 0.0 109.279 179.721 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 46.9 p -94.16 177.02 6.1 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.102 -0.998 . . . . 0.0 110.934 -179.129 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -67.6 113.51 5.47 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.643 -0.661 . . . . 0.0 110.135 -179.918 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 104.93 9.41 34.66 Favored Glycine 0 N--CA 1.495 2.595 0 N-CA-C 108.923 -1.671 . . . . 0.0 108.923 -179.974 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 66.3 m -90.85 107.64 19.32 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -1.139 . . . . 0.0 110.91 -179.536 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 14.5 t -76.89 118.15 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-O 122.201 1.0 . . . . 0.0 109.152 -177.641 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 21.0 m -113.42 178.14 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -177.968 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 58.1 m -130.86 128.27 40.27 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 177.287 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 93.9 mt -100.6 112.51 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 178.639 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 60.6 m -117.79 130.82 56.52 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.621 -0.675 . . . . 0.0 109.346 -179.217 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -144.79 151.99 39.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.815 . . . . 0.0 109.245 -179.493 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -145.83 125.51 13.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.4 -0.812 . . . . 0.0 108.867 179.666 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.537 ' H ' ' CD ' ' B' ' 370' ' ' GLU . . . 157.11 -155.77 26.65 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.14 -1.505 . . . . 0.0 111.455 -179.984 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -59.73 -51.6 69.08 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 122.224 -0.574 . . . . 0.0 112.333 -177.508 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.458 ' H ' ' HB2' ' B' ' 331' ' ' SER . 72.0 m-20 -110.01 13.17 23.44 Favored 'General case' 0 N--CA 1.504 2.26 0 O-C-N 120.829 -1.17 . . . . 0.0 111.221 -177.399 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' B' ' 367' ' ' GLY . 12.5 pt-20 -41.55 -34.33 0.56 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.292 -0.88 . . . . 0.0 111.507 -178.866 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -69.05 -41.15 78.0 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.589 -1.319 . . . . 0.0 109.994 -178.266 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -69.47 -50.1 48.58 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.273 -0.892 . . . . 0.0 109.842 -179.629 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -54.34 -36.22 63.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.325 -0.86 . . . . 0.0 111.885 -178.077 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.574 ' O ' HG23 ' B' ' 378' ' ' VAL . 71.1 t -74.31 -39.96 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.134 -1.604 . . . . 0.0 109.191 179.294 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -65.89 -56.01 14.04 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.331 -0.855 . . . . 0.0 111.923 -178.25 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -69.98 -39.97 75.62 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.31 -1.494 . . . . 0.0 111.905 -178.377 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 89.1 mt -57.99 -37.16 73.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.607 -1.308 . . . . 0.0 108.676 -179.286 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.574 HG23 ' O ' ' B' ' 374' ' ' VAL . 48.9 t -60.03 -47.61 91.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.196 -0.94 . . . . 0.0 109.402 179.163 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' B' ' 383' ' ' GLU . 4.3 mptp? -69.98 -56.38 7.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.643 -1.285 . . . . 0.0 108.079 178.493 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.48 ' O ' ' CD2' ' B' ' 384' ' ' LEU . 62.8 tp -50.99 -36.39 38.92 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.187 -0.946 . . . . 0.0 108.787 -178.648 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 40.9 tpp -73.01 -39.92 65.61 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 177.421 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -78.09 -4.2 46.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.74 -0.6 . . . . 0.0 109.959 179.463 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' B' ' 379' ' ' LYS . 95.5 mt-10 -108.05 3.54 24.08 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.249 -0.907 . . . . 0.0 110.234 179.909 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . 0.48 ' CD2' ' O ' ' B' ' 380' ' ' LEU . 15.1 mt -79.34 114.21 18.09 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.369 -1.457 . . . . 0.0 107.753 178.184 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 . . . . . 0 N--CA 1.497 1.887 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.459 -179.777 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.187 -0.671 . . . . 2.91 109.187 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.7 mt -109.99 129.99 63.98 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.365 -0.834 . . . . 1.2 109.241 179.863 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.1 m -129.34 151.09 50.36 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.713 -0.617 . . . . 1.4 109.846 -179.379 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.526 ' H ' HD21 ' A' ' 225' ' ' ASN . . . -135.22 -162.15 9.62 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 109.01 -1.636 . . . . 1.05 109.01 179.869 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.459 ' O ' ' O ' ' A' ' 6' ' ' LEU . 96.8 mt -90.11 -18.88 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.867 -1.373 . . . . 1.15 109.561 -179.535 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 5' ' ' ILE . 59.5 tp 55.71 107.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.491 -0.755 . . . . 0.98 109.189 -179.507 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -100.32 -26.97 13.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.406 -0.809 . . . . 0.88 108.99 179.529 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.1 m -137.59 120.93 11.55 Favored Pre-proline 0 N--CA 1.5 2.051 0 O-C-N 121.499 -0.751 . . . . 1.69 109.215 179.555 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -80.59 151.09 19.42 Favored 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 122.121 1.881 . . . . 0.85 112.825 179.928 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.9 ' O ' ' HB3' ' A' ' 222' ' ' ALA . . . 146.79 173.01 17.65 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 109.469 -1.452 . . . . 0.92 109.469 179.705 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.7 mt -125.77 130.88 72.45 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 120.964 -1.315 . . . . 0.81 109.223 -179.74 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -136.89 150.65 48.37 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.169 -0.957 . . . . 0.51 110.048 -179.265 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 13' ' ' PHE . 9.3 m-85 -123.22 129.94 52.07 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.267 -1.012 . . . . 0.62 108.267 179.765 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -178.59 172.76 45.14 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 118.81 -1.662 . . . . 0.55 110.69 179.988 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -78.66 158.82 28.28 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.609 -0.936 . . . . 2.1 108.906 179.655 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.548 ' HB2' HD12 ' A' ' 218' ' ' LEU . . . -104.05 131.62 51.12 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.325 -0.859 . . . . 0.77 111.107 -178.684 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 61.2 tp -101.52 135.01 43.74 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 107.167 -1.42 . . . . 0.91 107.167 178.161 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 21.3 tp -116.72 126.48 53.2 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.295 -0.878 . . . . 0.93 109.87 -179.06 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.4 mt -89.32 102.01 14.68 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.365 0.602 . . . . 0.93 110.214 -179.515 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -92.52 136.37 33.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.445 -0.784 . . . . 2.75 109.003 179.619 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -131.15 117.44 19.08 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.3 -0.875 . . . . 3.0 109.629 179.743 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.51 ' OD1' ' N ' ' A' ' 23' ' ' GLU . 54.1 t0 -71.55 144.5 49.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.889 -1.132 . . . . 2.77 109.45 179.772 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.51 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 88.8 tt0 -63.52 139.95 58.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.174 -0.954 . . . . 2.94 109.526 -179.878 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 55.5 mt -83.89 134.5 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.791 -0.818 . . . . 0.95 108.791 -179.773 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 52.4 t -101.99 127.04 55.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.29 -0.881 . . . . 1.28 110.279 -179.11 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 89.9 mt -105.7 137.85 33.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.794 -0.817 . . . . 1.21 108.794 179.304 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -97.52 113.59 25.32 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.994 -1.066 . . . . 1.81 109.318 179.71 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.3 mmt180 -84.83 5.24 29.53 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.536 -0.913 . . . . 2.8 108.536 179.9 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -60.56 146.35 45.46 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.544 -0.722 . . . . 2.87 109.36 179.916 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -88.88 141.69 28.28 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 2.35 108.963 179.616 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 4.1 pt -94.47 165.73 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.1 -1.0 . . . . 0.97 109.383 179.773 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 80.0 p -97.91 174.21 6.69 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.004 -1.06 . . . . 1.17 108.72 178.856 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -59.96 -47.83 84.18 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.362 -0.935 . . . . 1.18 109.297 -179.631 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 34' ' ' ASP . 52.2 t0 -56.71 -30.39 63.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.773 -1.204 . . . . 2.56 109.923 -179.94 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -81.82 -10.56 59.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.235 -0.916 . . . . 1.79 110.02 -179.645 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.8 t -62.98 -51.67 68.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 120.908 -1.12 . . . . 1.0 108.68 179.713 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 84.2 m-20 -61.7 -40.07 93.71 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.454 -0.779 . . . . 1.77 109.887 -179.588 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -68.84 -40.32 79.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 2.7 111.295 -178.492 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -66.14 -40.18 90.42 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.399 -1.438 . . . . 1.51 110.351 -179.528 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.95 -47.97 91.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 120.706 -1.246 . . . . 0.93 109.195 179.444 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -61.89 -44.13 97.43 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.005 -1.059 . . . . 1.81 109.935 179.977 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -60.06 -44.03 95.0 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.862 -1.149 . . . . 2.78 108.117 179.803 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -63.0 -46.98 85.12 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.196 -0.668 . . . . 0.78 109.196 179.062 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 64.5 tp -59.87 -46.19 90.08 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.608 -0.886 . . . . 1.07 108.608 179.933 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.9 t -65.76 -43.74 87.97 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.265 -0.974 . . . . 1.12 108.861 179.276 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -63.21 -44.23 97.39 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 107.83 -2.108 . . . . 0.84 107.83 178.703 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.428 ' HG2' ' NH1' ' A' ' 47' ' ' ARG . 25.5 ttt-85 -65.39 -34.67 78.86 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.34 -0.985 . . . . 3.09 108.34 178.228 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.77 -40.0 86.76 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.732 -0.84 . . . . 0.88 108.732 -179.862 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 50' ' ' ALA . 1.2 ttmp? -61.47 -73.95 0.09 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.043 -1.095 . . . . 2.59 108.043 179.111 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.412 ' C ' ' O ' ' A' ' 49' ' ' LYS . . . -37.07 -34.94 0.09 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.253 -0.905 . . . . 0.7 111.904 -177.775 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.0 t -59.67 -50.37 74.14 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.344 -1.342 . . . . 1.4 108.291 179.846 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.54 -40.05 92.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.501 -0.749 . . . . 0.67 110.504 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -65.9 -40.19 91.29 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.805 -1.184 . . . . 1.66 110.188 -179.118 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.07 -39.88 91.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.975 -1.078 . . . . 1.58 109.199 179.633 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -60.27 -39.93 88.6 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.541 -0.724 . . . . 1.35 110.136 179.853 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.466 HG22 ' HZ3' ' A' ' 60' ' ' LYS . 94.4 m -62.83 -43.87 97.64 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.019 -1.051 . . . . 0.77 109.459 179.724 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.621 ' CD1' HH22 ' A' ' 136' ' ' ARG . 96.9 mt -61.35 -39.68 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.48 -0.763 . . . . 0.63 109.588 -179.919 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 30.9 ttpt -57.43 -51.86 67.73 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.175 -0.953 . . . . 1.14 110.403 -179.43 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 m -58.88 -35.38 72.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.357 -0.839 . . . . 0.79 110.832 -177.396 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.466 ' HZ3' HG22 ' A' ' 56' ' ' THR . 27.3 mttp -66.02 -38.16 87.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.056 -1.028 . . . . 1.53 109.332 179.841 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.443 ' HB2' ' HB1' ' A' ' 169' ' ' ALA . . . -65.81 -45.86 80.77 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.74 -0.6 . . . . 0.57 110.2 -179.529 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -57.4 -53.38 45.39 Favored Glycine 0 N--CA 1.485 1.93 0 C-N-CA 120.09 -1.052 . . . . 0.75 110.61 -178.548 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.07 -41.78 73.68 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.938 -1.331 . . . . 1.59 110.382 -179.06 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 98.0 m -70.03 -60.05 2.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.92 -1.113 . . . . 0.73 111.981 -177.838 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.428 ' CE1' ' O ' ' A' ' 168' ' ' THR . 76.7 m-85 -95.94 -50.56 4.82 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.862 -1.149 . . . . 0.75 111.243 -178.178 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 141.75 -166.87 26.1 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 119.899 -1.143 . . . . 1.22 110.683 -179.974 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -69.98 -24.97 63.4 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.78 -0.836 . . . . 5.81 110.353 -179.479 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.418 ' OE1' ' NH1' ' B' ' 317' ' ' ARG . 48.5 tp10 -60.36 -34.91 74.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.38 -0.825 . . . . 3.37 110.294 -179.366 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.483 ' HA ' HD12 ' A' ' 72' ' ' ILE . 43.9 mmtm -100.28 -17.51 17.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.295 -0.878 . . . . 1.77 110.291 -179.318 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -69.98 -44.51 69.27 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.067 -1.02 . . . . 1.65 110.667 -179.248 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.557 ' HB3' ' CD ' ' B' ' 317' ' ' ARG . . . -67.69 -25.64 65.78 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.386 -0.822 . . . . 0.77 109.885 -178.393 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.483 HD12 ' HA ' ' A' ' 69' ' ' LYS . 80.9 mt -59.91 -41.18 85.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.0 -1.062 . . . . 0.8 108.764 -179.886 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -69.99 -36.6 75.28 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.077 -1.014 . . . . 0.88 110.805 -179.789 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -59.93 -40.1 87.76 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.92 -1.112 . . . . 1.37 109.434 -179.495 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -65.79 -43.54 93.84 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.587 -1.805 . . . . 0.62 108.587 178.742 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 57.4 m170 -60.0 -46.14 90.44 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.357 -1.084 . . . . 1.5 108.761 179.703 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.2 mt -64.67 -45.16 96.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.226 -0.921 . . . . 0.63 108.677 179.147 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 23.3 ttp -60.89 -43.05 99.0 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.309 -0.869 . . . . 1.51 110.036 -179.864 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.457 HD13 HD23 ' B' ' 347' ' ' LEU . 12.5 tp -61.21 -41.9 97.65 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.715 -0.846 . . . . 0.77 108.715 179.869 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.9 tp -65.16 -38.14 89.6 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.636 -0.665 . . . . 0.62 109.917 -179.636 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -85.39 4.4 35.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.067 -1.02 . . . . 1.47 110.206 -179.101 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -50.1 131.4 23.32 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.964 -1.085 . . . . 1.47 110.44 -179.124 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -58.46 -20.65 46.96 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.67 -0.644 . . . . 1.78 110.14 -179.403 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -69.89 -33.08 71.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.118 -0.989 . . . . 2.53 108.735 179.477 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.0 mt -71.98 -40.1 68.82 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.352 0.596 . . . . 0.8 109.876 179.348 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -60.18 -50.02 75.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.477 -0.765 . . . . 1.42 110.374 -179.0 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -70.96 -40.81 71.77 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.051 -1.031 . . . . 1.71 111.099 -178.961 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -70.11 -39.97 75.17 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.117 -0.99 . . . . 1.57 111.573 -178.544 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.72 -46.19 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.059 -1.026 . . . . 0.65 109.547 -179.309 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.85 -39.63 80.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.645 -0.66 . . . . 0.82 109.969 -179.822 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.33 -48.67 80.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.274 -0.891 . . . . 0.79 111.256 -179.033 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.418 ' O ' ' N ' ' A' ' 96' ' ' LYS . 93.9 mt -63.04 -46.88 85.46 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.885 -1.134 . . . . 0.95 110.194 -178.927 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 69.1 mt -60.25 -49.48 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-O 122.18 0.991 . . . . 0.66 108.57 179.555 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.3 mtpt -70.1 -40.46 74.93 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-N 115.785 -0.643 . . . . 2.2 110.578 -179.428 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -83.44 -49.7 9.04 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.901 -1.124 . . . . 1.65 111.718 -178.521 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 92' ' ' LEU . 71.0 mmtt -90.97 -1.83 57.78 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.102 -0.999 . . . . 2.03 111.73 -177.396 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 54.28 32.17 15.69 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.699 -1.251 . . . . 1.42 109.604 179.944 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 60.5 mtt -90.36 167.5 12.59 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.003 -0.74 . . . . 1.18 109.003 -179.848 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 68.5 p -75.42 155.14 36.65 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.844 -1.169 . . . . 0.98 107.844 178.956 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.8 -39.59 76.48 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.955 -1.09 . . . . 0.64 110.237 -179.065 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 102' ' ' ALA . 34.4 p-10 -63.23 -38.65 91.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.855 -1.153 . . . . 2.07 109.387 179.552 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.504 ' N ' ' OD1' ' A' ' 101' ' ' ASP . . . -78.29 -47.28 18.18 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.168 -0.957 . . . . 0.73 109.44 179.509 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -60.85 -47.32 86.92 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.475 -0.766 . . . . 0.54 109.714 -179.925 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.5 -35.37 79.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 0.56 109.458 179.646 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -59.87 -44.25 94.28 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.217 -0.927 . . . . 1.54 108.746 -179.319 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.466 ' O ' ' N ' ' A' ' 110' ' ' GLY . 85.8 tt0 -61.15 -40.02 92.27 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.265 -0.897 . . . . 1.33 109.462 179.298 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 95.5 t -60.76 -53.81 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.266 -0.897 . . . . 0.72 110.475 -178.972 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.453 HG21 ' HA3' ' A' ' 134' ' ' GLY . 47.0 mm -69.87 -40.14 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.992 -1.068 . . . . 0.85 109.303 179.634 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -68.07 -38.76 82.76 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 108.57 -0.9 . . . . 2.44 108.57 179.045 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 106' ' ' GLU . . . -59.74 -47.92 88.56 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.494 -1.042 . . . . 0.98 110.494 -179.182 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -67.97 -54.37 19.09 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.769 -1.43 . . . . 1.41 109.721 -179.685 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -54.89 -40.02 69.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 1.2 109.616 -179.925 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 54.3 m -59.95 -39.98 87.43 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.094 -1.004 . . . . 1.7 108.796 -179.913 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.44 -38.25 89.01 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.204 -0.935 . . . . 1.47 108.676 178.829 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.431 ' CD1' ' OE1' ' B' ' 351' ' ' GLN . 25.5 mt -65.57 -39.96 92.25 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.124 -0.985 . . . . 1.56 109.399 -179.643 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -57.75 -31.62 66.65 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.736 -1.228 . . . . 2.2 109.189 -179.264 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -59.38 -23.54 62.67 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.175 -1.046 . . . . 2.12 108.175 179.388 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 52.7 mt -62.17 139.93 58.46 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.23 -0.919 . . . . 2.0 108.617 -179.823 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -94.49 26.08 3.61 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.172 -0.955 . . . . 3.23 109.835 -179.699 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -110.76 129.99 55.7 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.367 -0.833 . . . . 2.49 109.729 -179.712 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -69.66 -29.36 66.79 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.48 0.657 . . . . 3.95 109.233 179.91 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.48 ' OH ' ' O ' ' B' ' 314' ' ' LEU . 2.4 t80 -69.95 -39.97 75.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.702 -0.624 . . . . 2.0 110.845 -179.99 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.53 HD22 ' O ' ' B' ' 351' ' ' GLN . 96.9 mt -76.41 -32.47 58.53 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.844 -1.16 . . . . 1.86 109.582 179.918 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 29.9 ttmt -60.1 -40.56 90.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.054 -1.029 . . . . 2.84 108.684 179.318 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.412 ' O ' ' HB3' ' A' ' 128' ' ' ALA . 98.9 mt-10 -59.93 -42.92 95.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.247 -0.908 . . . . 2.73 108.964 179.615 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -61.92 -40.05 94.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.183 -0.948 . . . . 2.77 108.57 178.97 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.52 -30.81 71.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.89 . . . . 1.19 108.716 179.021 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.412 ' HB3' ' O ' ' A' ' 125' ' ' GLU . . . -60.19 -39.57 86.99 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.827 -0.805 . . . . 1.2 108.827 179.607 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -68.25 -39.85 82.13 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.349 -0.845 . . . . 1.55 109.279 -179.919 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 54.4 t -69.74 -39.97 78.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.421 -0.8 . . . . 0.8 109.057 179.901 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -65.18 -40.04 93.72 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.174 -0.954 . . . . 3.09 109.963 179.629 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -60.05 -39.96 87.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 1.46 110.551 -178.938 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.12 -41.22 85.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.99 -1.069 . . . . 0.71 109.667 -179.7 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.453 ' HA3' HG21 ' A' ' 108' ' ' ILE . . . -59.97 -46.02 94.87 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.009 -1.237 . . . . 0.57 110.009 -179.761 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -59.87 -46.92 87.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.104 -1.233 . . . . 2.59 111.324 -179.511 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.621 HH22 ' CD1' ' A' ' 57' ' ' ILE . 60.4 mtp180 -63.85 -37.08 86.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.835 -1.166 . . . . 2.83 110.407 -179.385 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 63.6 tp -58.43 -42.88 88.27 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.353 -0.842 . . . . 1.25 110.132 -178.753 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 92.9 mt -61.83 -39.96 93.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.001 -1.062 . . . . 0.7 108.961 179.628 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 57.6 mtp180 -65.72 -39.51 91.24 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.789 -0.819 . . . . 2.57 108.789 178.791 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 140' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -64.38 -36.96 85.83 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.649 -0.657 . . . . 1.23 110.951 -179.63 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 93.3 mt -70.54 -42.06 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.521 -1.362 . . . . 0.81 108.44 179.002 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 85.8 mt -70.63 -38.75 73.94 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.609 0.718 . . . . 1.0 109.063 179.684 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.56 43.85 4.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.276 -1.93 . . . . 0.89 108.276 -178.767 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.407 ' HA ' HD12 ' A' ' 144' ' ' LEU . 21.3 tp -74.51 142.86 44.77 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.484 -1.009 . . . . 1.14 109.46 -179.183 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -62.3 137.87 58.33 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.423 -0.798 . . . . 4.6 109.795 -179.325 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 92.8 mt -113.94 129.97 68.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.08 0 CA-C-O 122.217 1.008 . . . . 1.24 109.583 179.396 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 7.7 mt -64.44 -41.51 92.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.802 -0.635 . . . . 1.54 110.968 -178.145 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 47.4 t0 61.26 105.13 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.323 -0.861 . . . . 1.5 109.581 -179.57 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 152' ' ' ILE . 58.8 mt -68.75 -6.69 28.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.474 -0.766 . . . . 0.79 110.12 -179.357 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.5 t -83.37 -13.77 54.22 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.13 -0.981 . . . . 1.4 108.922 179.314 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -85.34 18.51 2.64 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.608 -0.683 . . . . 0.92 110.239 -178.442 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.415 HD12 ' O ' ' A' ' 149' ' ' LEU . 66.1 mt -90.31 111.21 23.05 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 O-C-N 121.028 -1.045 . . . . 0.88 108.845 -179.778 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -97.31 -9.71 27.03 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.285 -0.884 . . . . 2.45 110.836 -178.559 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -120.47 149.12 42.89 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.214 -0.929 . . . . 1.52 110.175 -178.987 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -64.89 131.22 46.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.422 -0.799 . . . . 1.58 109.216 -179.9 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 33.8 m -151.95 163.77 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.511 -0.743 . . . . 0.69 109.343 179.614 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 83.3 mt -92.76 151.08 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 105.939 -1.875 . . . . 0.61 105.939 177.156 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 56.4 tp -102.07 118.73 37.51 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.121 -0.987 . . . . 0.87 110.798 -177.961 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.2 t -126.22 132.08 70.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 108.538 -0.912 . . . . 0.71 108.538 179.543 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -160.6 168.73 24.36 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.179 -0.951 . . . . 0.81 109.05 179.797 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -70.0 -37.78 75.78 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.489 -1.382 . . . . 0.98 108.287 178.735 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.2 p-10 -170.66 148.51 3.01 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.58 -0.7 . . . . 2.25 109.189 179.737 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 82.4 mt -116.1 134.43 54.94 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.49 -0.757 . . . . 0.78 109.553 -179.641 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 77.7 p -94.15 149.96 37.64 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.428 -0.795 . . . . 0.98 109.038 179.501 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -39.63 -34.75 0.8 Allowed 'Trans proline' 0 N--CA 1.492 1.401 0 C-N-CA 122.334 2.023 . . . . 0.81 113.005 179.562 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 59.6 m -58.04 -42.51 85.54 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.217 -0.993 . . . . 0.9 109.353 -178.503 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -70.07 -39.96 75.31 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.163 -0.961 . . . . 1.61 109.792 179.456 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.428 ' O ' ' CE1' ' A' ' 65' ' ' PHE . 68.8 p -52.79 -26.62 14.91 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.252 -0.905 . . . . 0.61 111.112 -178.051 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.458 ' C ' ' H ' ' A' ' 171' ' ' LEU . . . -82.06 -55.88 4.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.874 -1.141 . . . . 0.6 109.963 179.624 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -80.25 40.14 0.48 Allowed 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.677 -1.231 . . . . 1.4 107.677 179.775 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.458 ' H ' ' C ' ' A' ' 169' ' ' ALA . 17.7 tp -97.91 124.55 42.39 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.98 -0.748 . . . . 0.7 108.98 179.858 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -81.61 97.8 8.04 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.112 -1.07 . . . . 2.35 108.112 179.189 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 78.3 mt -62.54 -44.85 95.33 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.565 -0.709 . . . . 1.51 110.62 -178.591 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -62.38 -32.02 72.77 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.1 -1.0 . . . . 2.33 112.47 -177.394 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm -93.29 -10.27 36.07 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.684 -1.26 . . . . 1.92 110.787 -177.862 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 176' ' ' VAL . . . . . 0.463 HG12 ' H ' ' A' ' 178' ' ' GLY . 91.4 t -102.36 113.11 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.048 -1.032 . . . . 0.67 108.749 178.986 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 39.6 mt -85.75 5.14 33.66 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.188 -0.945 . . . . 1.53 110.687 -178.31 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.463 ' H ' HG12 ' A' ' 176' ' ' VAL . . . 175.09 168.62 35.92 Favored Glycine 0 N--CA 1.49 2.264 0 C-N-CA 119.309 -1.424 . . . . 0.48 109.82 179.531 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.441 ' O ' ' HB1' ' A' ' 201' ' ' ALA . 23.0 m-85 -130.52 127.93 40.13 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.494 -1.003 . . . . 0.55 108.745 179.787 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.403 ' CG2' HG21 ' A' ' 205' ' ' THR . 62.2 mt -130.56 124.19 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 108.332 -0.988 . . . . 0.65 108.332 178.725 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 36.0 p -139.53 152.0 46.57 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.343 -0.848 . . . . 0.82 110.642 -179.247 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . 0.543 ' N ' ' OD1' ' A' ' 182' ' ' ASP . 0.7 OUTLIER -100.62 26.71 6.47 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.75 -0.833 . . . . 2.46 108.75 179.356 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.37 -161.06 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.103 -0.998 . . . . 1.28 111.574 -177.819 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.9 -57.34 6.42 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.974 -0.85 . . . . 2.19 110.974 -178.874 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 185' ' ' GLY . . . . . . . . . . . . . . . 177.51 -132.69 2.04 Favored Glycine 0 N--CA 1.491 2.339 0 C-N-CA 118.887 -1.625 . . . . 2.13 111.2 -179.33 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 186' ' ' ARG . . . . . 0.513 ' NH2' ' NH1' ' A' ' 195' ' ' ARG . 10.7 mtp-105 -80.18 -10.11 59.75 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.474 -1.015 . . . . 5.86 110.533 -178.663 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 71.5 p -81.49 5.99 16.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.008 -1.058 . . . . 3.72 109.906 -179.231 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.5 t -88.34 134.15 33.89 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.048 -1.033 . . . . 1.74 110.191 -179.63 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 189' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -48.21 -43.2 31.82 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.237 -0.914 . . . . 0.95 108.681 179.645 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 93.5 m -59.4 -39.91 84.92 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.831 -0.543 . . . . 1.55 109.83 -179.517 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 55.8 p -59.9 -38.32 81.94 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.999 -1.063 . . . . 1.51 110.264 -179.397 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 192' ' ' ILE . . . . . . . . . . . . . 40.6 mm -59.95 -40.0 81.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.322 -0.862 . . . . 1.67 109.371 -179.782 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 93.5 mtp -58.78 -49.93 75.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.269 -0.894 . . . . 1.02 110.55 -178.971 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -50.59 -44.3 56.88 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.855 -1.153 . . . . 0.68 109.524 -178.98 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 195' ' ' ARG . . . . . 0.513 ' NH1' ' NH2' ' A' ' 186' ' ' ARG . 65.4 mtp180 -59.94 -51.53 69.28 Favored 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 119.62 -0.832 . . . . 2.93 110.349 -178.709 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . . . . . . . . . 57.7 m -76.07 -32.03 59.07 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.945 -1.097 . . . . 0.86 111.711 -178.152 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 88.7 mt -79.3 -20.33 48.26 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.737 -1.227 . . . . 0.67 110.017 -179.197 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 60.41 46.81 9.46 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.205 -0.934 . . . . 1.5 110.223 -179.36 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 97.4 mt -121.09 129.18 25.39 Favored Pre-proline 0 N--CA 1.501 2.115 0 N-CA-C 108.375 -0.972 . . . . 0.72 108.375 178.715 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -43.52 131.2 7.17 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 121.975 1.783 . . . . 0.61 112.753 -179.571 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 179' ' ' PHE . . . -168.91 146.54 3.79 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.703 -1.248 . . . . 0.66 111.607 179.962 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.3 mt -122.42 144.35 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 106.966 -1.494 . . . . 0.79 106.966 178.011 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 13.6 m -123.56 -13.2 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.487 0 O-C-N 120.854 -1.154 . . . . 0.91 111.454 -178.223 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . -107.12 26.24 19.59 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 110.498 -1.041 . . . . 1.01 110.498 -179.172 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.456 ' OG1' ' OD1' ' A' ' 182' ' ' ASP . 7.7 p -47.23 -39.44 14.19 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.837 -1.39 . . . . 0.99 110.047 -179.117 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 206' ' ' GLY . . . . . . . . . . . . . . . 86.81 -51.68 4.34 Favored Glycine 0 N--CA 1.499 2.835 0 C-N-CA 119.913 -1.137 . . . . 1.12 111.851 178.671 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 49.9 m -158.33 40.99 0.26 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.474 -1.603 . . . . 1.72 111.489 -178.766 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 208' ' ' VAL . . . . . . . . . . . . . 18.5 t -79.52 -33.39 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.88 -1.138 . . . . 0.89 108.106 178.192 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 22.0 p -54.44 -31.61 55.77 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.657 -0.652 . . . . 1.03 110.92 -179.139 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 35.3 m -80.66 -10.91 59.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.99 -1.069 . . . . 1.83 110.304 -179.108 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 27.7 mm100 -104.85 -13.98 15.65 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.274 -0.891 . . . . 2.27 110.788 -179.224 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 212' ' ' VAL . . . . . . . . . . . . . 53.4 t -108.01 138.71 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 O-C-N 121.141 -0.974 . . . . 0.92 110.824 -178.497 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 213' ' ' LYS . . . . . 0.455 ' N ' ' OD2' ' A' ' 216' ' ' ASP . 0.1 OUTLIER -118.31 150.6 39.2 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.38 -1.341 . . . . 2.2 107.38 178.434 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . 0.437 ' O ' ' CB ' ' A' ' 215' ' ' ASP . 17.9 p30 -51.81 138.58 23.58 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.065 -1.022 . . . . 2.36 111.001 -178.488 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 214' ' ' ASN . 2.6 m-20 80.01 5.27 1.88 Allowed 'General case' 0 N--CA 1.501 2.107 0 CA-C-N 116.424 -0.353 . . . . 2.38 111.332 178.789 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.455 ' OD2' ' N ' ' A' ' 213' ' ' LYS . 91.8 m-20 -73.7 140.4 46.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.648 -1.283 . . . . 2.09 109.025 178.977 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.03 116.85 24.5 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.358 -0.979 . . . . 1.27 108.358 179.508 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' A' ' 16' ' ' ALA . 86.3 mt -126.66 146.17 50.29 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.382 -0.824 . . . . 0.75 110.784 -178.92 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 78.6 mt -113.32 127.29 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.081 -1.822 . . . . 0.63 106.081 177.206 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 54.7 tp -101.21 119.23 38.45 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.865 -1.147 . . . . 0.7 108.51 -179.112 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.491 ' C ' ' N ' ' A' ' 223' ' ' VAL . 92.6 m-20 -77.07 -45.27 27.61 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.131 -0.98 . . . . 2.31 109.378 179.893 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . 0.9 ' HB3' ' O ' ' A' ' 10' ' ' GLY . . . 49.78 14.23 0.12 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.355 -0.979 . . . . 0.78 108.355 -178.996 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . 0.491 ' N ' ' C ' ' A' ' 221' ' ' ASP . 49.0 t -130.65 -45.3 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 N-CA-C 106.601 -1.629 . . . . 1.04 106.601 178.542 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 224' ' ' ASN . . . . . 0.518 ' OD1' ' NE2' ' A' ' 226' ' ' GLN . 20.0 t-20 -99.67 -2.71 34.76 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.416 -1.327 . . . . 2.44 107.416 178.064 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.526 HD21 ' H ' ' A' ' 4' ' ' GLY . 0.4 OUTLIER 62.56 40.0 10.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.917 -0.489 . . . . 1.55 110.194 179.837 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 226' ' ' GLN . . . . . 0.518 ' NE2' ' OD1' ' A' ' 224' ' ' ASN . 78.1 mt-30 -136.99 148.25 46.77 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 121.248 -0.907 . . . . 1.99 109.751 178.939 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 63.7 t -119.85 121.17 65.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.792 -0.568 . . . . 0.77 109.675 179.946 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 228' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -90.25 128.02 36.29 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.003 -1.06 . . . . 0.98 109.442 -179.887 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 17.8 t -100.73 111.51 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.469 -0.769 . . . . 0.85 110.205 -179.256 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 43.1 t30 50.01 65.74 6.51 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.193 -0.942 . . . . 1.66 111.482 178.899 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -90.05 156.49 4.83 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.969 2.446 . . . . 0.95 112.232 178.822 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 232' ' ' THR . . . . . . . . . . . . . 25.3 m -66.16 156.37 34.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.231 -0.918 . . . . 1.84 110.334 -179.237 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 233' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -60.01 -38.3 82.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.514 -0.741 . . . . 2.74 109.414 179.99 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 234' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -59.74 -36.05 75.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.117 -0.989 . . . . 2.89 108.903 -179.925 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 54.4 t -68.33 -40.11 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -0.909 . . . . 1.3 108.718 178.913 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 236' ' ' ILE . . . . . . . . . . . . . 82.6 mt -65.43 -39.58 85.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.424 -0.798 . . . . 1.09 109.29 179.255 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -59.97 -40.09 87.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.95 -1.094 . . . . 2.43 109.112 -179.459 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -67.52 -40.07 85.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.115 -0.991 . . . . 2.78 109.345 179.177 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 239' ' ' MET . . . . . . . . . . . . . 94.8 mtp -70.08 -32.3 70.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.234 -0.916 . . . . 1.25 109.667 179.461 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 19.7 mmm180 -67.95 -40.16 83.28 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.244 -0.91 . . . . 2.63 109.583 179.929 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 241' ' ' ALA . . . . . . . . . . . . . . . -59.78 -42.47 93.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.038 -1.039 . . . . 1.8 109.531 179.822 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 75.0 t -60.06 -40.13 82.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.319 -0.863 . . . . 2.13 109.341 179.916 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -59.94 -40.15 87.95 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.264 -0.898 . . . . 3.17 109.622 -179.957 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.92 -43.3 94.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.19 -0.944 . . . . 1.78 109.47 -179.429 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 245' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -64.15 -38.82 92.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.327 -0.858 . . . . 2.47 109.315 179.576 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 67.5 t -60.01 -40.55 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.52 -0.737 . . . . 2.09 109.804 -179.231 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 247' ' ' ALA . . . . . . . . . . . . . . . -62.49 -40.59 97.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.066 -1.021 . . . . 2.54 109.09 179.866 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 248' ' ' SER . . . . . . . . . . . . . 79.2 p -62.63 -37.4 86.16 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.307 -0.87 . . . . 2.99 109.287 179.691 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.5 -37.54 85.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.492 -0.755 . . . . 3.34 109.967 -179.757 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -69.77 5.38 1.51 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.121 -0.987 . . . . 3.88 110.019 -179.56 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -62.35 -22.34 66.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.432 -0.792 . . . . 4.43 109.792 -179.848 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . 0.54 ' C ' ' H ' ' A' ' 254' ' ' ALA . 96.9 mt-10 55.94 11.94 0.81 Allowed 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 121.595 0.712 . . . . 5.42 109.165 -179.507 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.424 ' O ' ' HB3' ' A' ' 254' ' ' ALA . 17.3 mt 54.09 -2.87 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.786 -0.571 . . . . 6.1 111.284 179.62 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . 0.54 ' H ' ' C ' ' A' ' 252' ' ' GLU . . . 60.53 19.89 9.7 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.697 -1.252 . . . . 7.37 110.327 179.792 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 255' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -62.43 -39.67 94.07 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.066 -1.022 . . . . 8.01 109.666 179.611 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 60.2 tp -69.95 -24.02 63.28 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.399 -0.813 . . . . 9.05 110.995 -178.9 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 257' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -67.48 -76.31 0.09 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.549 -1.345 . . . . 10.56 109.811 -179.411 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -172.3 -52.51 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 11.32 109.538 179.864 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 259' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 117.935 -1.031 . . . . 12.42 109.483 -179.899 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . . . . . . . . . 58.1 ttp . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.694 0.759 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -153.87 150.67 28.64 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 178.831 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -152.32 160.91 43.25 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.024 -1.047 . . . . 0.0 110.719 -179.099 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . 0.43 ' NE2' HG21 ' B' ' 378' ' ' VAL . 6.7 tt0 -156.62 154.16 29.73 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.081 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' B' ' 305' ' ' GLU . 55.2 mp0 -110.31 129.53 55.72 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.252 -0.905 . . . . 0.0 109.709 179.577 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 3.9 p -130.41 121.95 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 CA-C-O 121.942 0.877 . . . . 0.0 112.157 -177.247 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 48.7 m -78.87 105.7 10.37 Favored 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 122.163 0.982 . . . . 0.0 111.444 -177.915 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 96.9 mt -53.08 123.52 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 CA-C-O 122.438 1.113 . . . . 0.0 111.151 -177.863 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 76.0 p -111.42 19.88 17.79 Favored 'General case' 0 N--CA 1.498 1.973 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.895 -179.61 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -72.91 129.12 87.02 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 120.905 -1.122 . . . . 0.0 109.403 -179.932 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -51.17 -23.84 13.76 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 CA-C-N 119.983 1.03 . . . . 0.0 113.364 -179.506 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 32.8 m120 -122.16 11.42 10.16 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.348 -0.845 . . . . 0.0 109.203 -179.94 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 77.7 -171.25 55.15 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 108.185 -1.966 . . . . 0.0 108.185 -178.481 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.48 ' O ' ' OH ' ' A' ' 122' ' ' TYR . 3.7 tp -88.81 93.93 9.75 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.857 -1.378 . . . . 0.0 108.791 -179.618 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.401 ' CD2' ' CD ' ' B' ' 318' ' ' PRO . 4.3 p80 -98.21 -159.02 0.71 Allowed 'General case' 0 N--CA 1.507 2.416 0 O-C-N 121.357 -0.839 . . . . 0.0 110.853 179.793 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 7.7 m -57.38 -47.01 82.8 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.246 -0.909 . . . . 0.0 112.699 -176.299 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.557 ' CD ' ' HB3' ' A' ' 71' ' ' ALA . 1.2 tpt180 -58.88 -60.25 11.12 Favored Pre-proline 0 N--CA 1.499 1.99 0 O-C-N 120.434 -1.416 . . . . 0.0 112.217 -178.072 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.401 ' CD ' ' CD2' ' B' ' 315' ' ' HIS . 10.3 Cg_endo -60.3 -30.71 91.66 Favored 'Trans proline' 0 N--CA 1.492 1.392 0 CA-C-N 120.449 1.196 . . . . 0.0 111.45 -179.679 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -59.97 -50.04 75.31 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.147 -0.971 . . . . 0.0 108.413 179.527 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -55.85 -43.52 77.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.444 -0.785 . . . . 0.0 109.673 -179.492 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -71.47 -41.76 68.97 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.913 -1.117 . . . . 0.0 108.792 178.763 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -62.58 -52.82 61.87 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.331 -0.856 . . . . 0.0 110.54 -179.76 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 74.9 t -67.19 -27.85 40.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 120.719 -1.238 . . . . 0.0 110.12 -178.781 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -60.25 -42.75 95.98 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.642 179.514 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -65.53 -55.59 16.94 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.9 -1.125 . . . . 0.0 109.794 -179.778 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.99 -50.93 71.81 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.923 -1.111 . . . . 0.0 110.469 -179.447 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -48.92 -22.48 0.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.0 108.99 -179.278 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -82.59 -13.05 79.16 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.778 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -104.95 141.84 35.83 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.363 -1.08 . . . . 0.0 108.894 179.416 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 38.9 p -90.9 -13.6 33.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.785 -1.197 . . . . 0.0 110.014 -179.832 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . 0.49 ' HB3' ' H ' ' B' ' 369' ' ' ASP . 67.5 p -59.98 142.77 53.23 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.039 -1.038 . . . . 0.0 109.181 179.909 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . 0.405 ' OE1' ' N ' ' B' ' 332' ' ' GLU . 40.2 mp0 -65.58 132.84 49.84 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.999 -1.063 . . . . 0.0 108.54 179.619 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 95.8 mt -130.92 132.42 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 O-C-N 121.447 -0.783 . . . . 0.0 109.712 -179.859 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 27.1 m -129.93 147.09 51.65 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.514 -0.742 . . . . 0.0 109.33 179.492 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 59.9 t -120.76 116.73 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.386 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 71.9 m -104.93 121.51 43.87 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.164 -0.96 . . . . 0.0 109.712 -178.66 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 94.5 p -133.92 121.89 22.34 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-O 121.901 0.857 . . . . 0.0 111.233 -179.616 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 58.9 t30 47.51 54.5 9.59 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 176.938 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 80.92 -11.54 41.18 Favored Glycine 0 N--CA 1.499 2.868 0 O-C-N 120.009 -1.682 . . . . 0.0 112.843 176.481 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 34.1 ttmt -121.88 134.65 54.87 Favored 'General case' 0 N--CA 1.506 2.329 0 CA-C-N 119.087 1.444 . . . . 0.0 108.776 -179.712 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 59.7 p -133.63 152.77 51.96 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.371 -0.831 . . . . 0.0 110.947 -178.231 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -147.18 169.95 18.25 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 121.382 0.61 . . . . 0.0 109.842 -179.859 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 72.3 m -88.16 140.94 28.97 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.472 -0.768 . . . . 0.0 110.403 -179.38 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.484 ' HA ' HD11 ' B' ' 350' ' ' LEU . . . -81.91 -15.39 54.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.043 -1.035 . . . . 0.0 109.442 179.677 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -86.4 16.33 4.6 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.52 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . 0.426 ' H ' ' C ' ' B' ' 344' ' ' ALA . 13.5 p -147.97 93.38 2.18 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.278 -179.362 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . 0.506 ' HA ' HD12 ' B' ' 350' ' ' LEU . 21.8 tp -60.76 -32.93 72.22 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.746 -0.596 . . . . 0.0 109.704 178.97 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -53.22 -51.92 60.57 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.68 -1.263 . . . . 0.0 110.064 -179.558 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -70.69 -39.91 73.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 0.0 110.831 -179.408 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . 0.587 ' O ' ' N ' ' B' ' 352' ' ' THR . 86.1 mt -48.05 -54.44 13.07 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.771 -1.206 . . . . 0.0 109.293 -179.311 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.53 ' O ' HD22 ' A' ' 123' ' ' LEU . 37.7 mt-30 -40.99 -15.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.592 -0.693 . . . . 0.0 110.931 -178.726 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . 0.587 ' N ' ' O ' ' B' ' 350' ' ' LEU . 62.0 p -87.72 -10.22 51.78 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.456 -1.402 . . . . 0.0 110.247 -179.424 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 60.3 mt -95.01 116.77 29.12 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.93 -1.106 . . . . 0.0 109.454 179.0 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -76.88 94.17 1.08 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 179.081 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 25.5 mt -100.64 92.04 4.93 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.297 -1.119 . . . . 0.0 109.507 -179.632 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 44.6 p -90.03 172.41 8.86 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.93 -1.106 . . . . 0.0 111.197 -178.862 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -66.84 116.9 8.23 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.359 0.599 . . . . 0.0 110.491 -179.856 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 99.61 8.92 51.37 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 -179.7 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 45.6 m -87.61 111.3 21.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.404 -1.056 . . . . 0.0 110.404 -179.604 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 22.0 t -77.48 116.34 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 122.202 1.001 . . . . 0.0 109.448 -177.662 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 18.4 m -110.98 177.2 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 -178.025 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 42.6 m -130.88 126.98 37.59 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 177.491 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.3 111.75 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.923 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 61.7 p -118.24 132.87 56.28 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.796 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -145.3 150.66 37.03 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.245 -0.91 . . . . 0.0 109.974 -178.974 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . 0.402 ' O ' ' OE1' ' B' ' 332' ' ' GLU . 18.4 tp10 -141.61 122.42 14.4 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 179.505 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . 0.463 ' O ' ' OE2' ' B' ' 370' ' ' GLU . . . 160.36 -160.61 31.91 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.053 -1.546 . . . . 0.0 111.477 -179.886 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 -59.81 -50.14 74.97 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.979 -0.718 . . . . 0.0 112.42 -177.245 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . 0.49 ' H ' ' HB3' ' B' ' 331' ' ' SER . 70.7 m-20 -109.95 13.65 23.35 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.035 -1.041 . . . . 0.0 111.22 -177.223 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . 0.564 ' OE1' ' N ' ' B' ' 370' ' ' GLU . 0.1 OUTLIER -45.44 -34.96 3.43 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.081 -1.012 . . . . 0.0 111.852 -178.876 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . 0.518 ' N ' ' OE1' ' B' ' 370' ' ' GLU . 27.1 mt-30 -70.94 -41.4 71.18 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.809 -1.182 . . . . 0.0 110.098 -179.001 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -66.41 -43.26 86.24 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.338 -0.852 . . . . 0.0 109.725 -178.869 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -53.95 -71.62 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -0.978 . . . . 0.0 110.977 -178.965 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . 0.588 ' O ' HG23 ' B' ' 378' ' ' VAL . 60.0 t -46.86 -37.69 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.914 -1.116 . . . . 0.0 110.204 -177.682 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -63.74 -50.0 70.8 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.75 -1.219 . . . . 0.0 110.345 179.518 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . . . . . . . . . 7.6 m80 -78.5 -42.83 28.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.065 -1.022 . . . . 0.0 110.157 -179.894 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 96.0 mt -59.95 -37.46 79.61 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.25 -0.906 . . . . 0.0 109.631 -179.306 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . 0.588 HG23 ' O ' ' B' ' 374' ' ' VAL . 46.7 t -63.68 -40.2 88.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.209 -0.932 . . . . 0.0 109.325 179.836 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -70.59 -57.46 4.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.616 -1.303 . . . . 0.0 107.929 178.134 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . . . . . . . . . 54.4 tp -57.41 -34.65 69.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.513 -0.742 . . . . 0.0 110.348 -178.151 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 31.9 ttm -70.51 -40.02 73.77 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 120.424 -1.423 . . . . 0.0 108.199 177.831 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -80.69 -7.25 59.27 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.811 -0.555 . . . . 0.0 110.794 179.324 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . 0.406 ' O ' ' OE2' ' B' ' 385' ' ' GLU . 96.7 mt-10 -111.73 -0.22 16.05 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 120.978 -1.076 . . . . 0.0 111.585 -179.388 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 15.1 mt -83.21 130.48 35.09 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.421 -1.424 . . . . 0.0 109.684 179.456 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . 0.428 ' OE1' ' N ' ' B' ' 385' ' ' GLU . 35.4 mp0 . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.177 179.8 . . . . . . . . 1 1 . 1 stop_ save_